
@article{ ISI:000439096500015,
Author = {Ranjan, Rajeev and Srivastava, Ashish and Bharti, Reena and Ray, Lipika
   and Singh, Jyotsna and Misra, Amit},
Title = {{Preparation and optimization of a dry powder for inhalation of
   second-line anti-tuberculosis drugs}},
Journal = {{INTERNATIONAL JOURNAL OF PHARMACEUTICS}},
Year = {{2018}},
Volume = {{547}},
Number = {{1-2}},
Pages = {{150-157}},
Month = {{AUG 25}},
Abstract = {{A spray drying process was standardized to prepare an inhalable powder
   comprising D-cycloserine and ethionamide, two ``second line{''} drugs
   employed for treating multi-drug resistant (MDR) tuberculosis (TB). The
   aim of the process development effort was to maximize product yield.
   Contour plots were generated using a small central composite design
   (CCD) with face centered (alpha = 1) to maximize the process yield as
   the response criterion. The design space was experimentally validated.
   Powder was prepared and characterized for drug content (HPLC), geometric
   size (laser scattering), surface morphology (scanning electron
   microscopy) aerosol behaviour (cascade impaction) and powder flow
   properties. The optimized process yielded a powder with a median mass
   aerodynamic diameter (MMAD) of 1.76 mu +/- 3.1 geometric standard
   deviation (GSD). Mass balance indicated that the major proportion of the
   particles produced by spray drying are lost to the outlet filter. The
   process represents a best-case compromise of spray-drying conditions to
   minimize loss during droplet drying, collection and process air
   discharge.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Misra, A (Reprint Author), CSIR, Cent Drug Res Inst, Sect 10A,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.
   Ranjan, Rajeev; Srivastava, Ashish; Bharti, Reena; Ray, Lipika; Misra, Amit, CSIR, Cent Drug Res Inst, Sect 10A,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.
   Ranjan, Rajeev; Srivastava, Ashish, Acad Sci \& Innovat Res AcSIR, Sect 19, Kamla Nehru Nagar 201002, Ghaziabad, India.
   Singh, Jyotsna, CSIR, Indian Inst Toxicol Res, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.}},
DOI = {{10.1016/j.ijpharm.2018.05.065}},
ISSN = {{0378-5173}},
EISSN = {{1873-3476}},
Keywords = {{Spray drying; Central cubic design; Dry powder inhalation;
   D-Cycloserine, ethionamide, multi drug resistance; Tuberculosis}},
Keywords-Plus = {{SPRAY-DRIED POWDERS; INHALABLE MICROPARTICLES; AMINO-ACIDS; THERAPY;
   AEROSOLISATION; TUBERCULOSIS; MACROPHAGES; PARTICLES; DELIVERY; MOISTURE}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy}},
Author-Email = {{rajeev4niper@gmail.mm
   vidyant@hotmail.com
   reenabharti2013@gmail.com
   lipikaray@gmail.com
   jyotsna@iitr.res.in
   amit\_misra@cdri.res.in}},
Funding-Acknowledgement = {{Department of Biotechnology, Government of India
   {[}BT/PR10468/MED/29/815/2013]; Indian Council of Medical Research
   {[}INDO/FRC/ 763/2018-IHD]}},
Funding-Text = {{Funded by the Department of Biotechnology, Government of India through
   Grant Number BT/PR10468/MED/29/815/2013 and the Indian Council of
   Medical Research through Grant Number INDO/FRC/ 763/2018-IHD this is
   CDRI Communication Number 9694. Scanning Electron Microscopy was
   conducted in the Sophisticated Analytical Instruments Facility of the
   Institute. We thank Dr. Arvind K Bansal, National Institute of
   Pharmaceutical Education and Research for Differential Scanning
   Calorimetry.}},
Cited-References = {{Adler M, 2000, PHARMACEUT RES, V17, P863, DOI 10.1023/A:1007568511399.
   Billon A, 2000, INT J PHARM, V203, P159, DOI 10.1016/S0378-5173(00)00448-8.
   Chew NYK, 2005, J PHARM SCI-US, V94, P2289, DOI 10.1002/jps.20426.
   CORRIGAN OI, 1995, THERMOCHIM ACTA, V248, P245, DOI 10.1016/0040-6031(94)01891-J.
   Dharmadhikari AS, 2013, ANTIMICROB AGENTS CH, V57, P2613, DOI 10.1128/AAC.02346-12.
   Ghosh T. K., 2004, THEORY PRACTICE CONT.
   Glinski J, 2000, BIOPHYS CHEM, V84, P99, DOI 10.1016/S0301-4622(99)00150-7.
   Hickey AJ, 2013, J PHARM SCI-US, V102, P3900, DOI 10.1002/jps.23705.
   Kanojia G, 2016, INT J PHARMACEUT, V511, P1098, DOI 10.1016/j.ijpharm.2016.08.022.
   Kaur J, 2008, EUR J PHARM SCI, V34, P56, DOI 10.1016/j.ejps.2008.02.008.
   LAZAR ME, 1956, FOOD TECHNOL-CHICAGO, V10, P129.
   Li HY, 2005, J GENE MED, V7, P343, DOI 10.1002/jgm.654.
   Maa Y F, 1997, Pharm Dev Technol, V2, P213, DOI 10.3109/10837459709031441.
   Maa YF, 1998, PHARMACEUT RES, V15, P768, DOI 10.1023/A:1011983322594.
   Mannava MKC, 2016, CRYST GROWTH DES, V16, P1591, DOI 10.1021/acs.cgd.5b01700.
   Maury M, 2005, EUR J PHARM BIOPHARM, V59, P565, DOI 10.1016/j.ejpb.2004.10.002.
   Pandya S., 2016, INHALED DRUG COMBINA.
   Pisecky J., 2012, HDB MILK POWDER MANU.
   Rabbani NR, 2004, J PHARM PHARMACOL, V56, pS32.
   Seville PC, 2007, POWDER TECHNOL, V178, P40, DOI 10.1016/j.powtec.2007.03.046.
   Sharma R, 2001, PHARMACEUT RES, V18, P1405, DOI 10.1023/A:1012296604685.
   Son YJ, 2013, INT J PHARMACEUT, V443, P137, DOI 10.1016/j.ijpharm.2013.01.003.
   Truong V, 2005, J FOOD ENG, V71, P55, DOI 10.1016/j.jfoodeng.2004.10.017.
   Weers JG, 2007, EXPERT OPIN DRUG DEL, V4, P297, DOI 10.1517/17425247.4.3.297.
   Yadav A. B., 2009, INHALABLE MICROPARTI.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Int. J. Pharm.}},
Doc-Delivery-Number = {{GN5KF}},
Unique-ID = {{ISI:000439096500015}},
DA = {{2018-08-13}},
}

@article{ ISI:000440115600049,
Author = {Wolny-Koladka, Katarzyna and Lenart-Boron, Anna},
Title = {{Antimicrobial resistance and the presence of extended-spectrum
   beta-lactamase genes in Escherichia coli isolated from the environment
   of horse riding centers}},
Journal = {{ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH}},
Year = {{2018}},
Volume = {{25}},
Number = {{22, SI}},
Pages = {{21789-21800}},
Month = {{AUG}},
Abstract = {{The aim of the study was to determine the antimicrobial resistance
   profile and the occurrence of extended-spectrum beta-lactamase genes and
   to analyze the genetic diversity of Escherichia coli strains isolated
   from the environment of horse riding centers. The study was conducted
   using E. coli strains isolated from the air, manure, and horse nostril
   swabs in three horse riding centers differing in the system of horse
   keeping-stable (OJK Pegaz and KJK Szary) and free-range (SKH Nielepice).
   Resistance to antibiotics was determined using the disk-diffusion
   method, and the PCR technique was employed to detect the
   extended-spectrum beta-lactamase (ESBL) genes, while the genetic
   diversity of strains was assessed by rep-PCR. A total of 200 strains
   were collected during the 2-year study, with the majority isolated from
   KJK Szary, while the smallest number was obtained from SKH Nielepice.
   The strains were mostly resistant to ampicillin, aztreonam, and
   ticarcillin. The tested strains were most frequently resistant to one or
   two antibiotics, with a maximum of ten antimicrobials at the same time.
   Two multidrug-resistant (MDR) strains were detected in OJK Pegaz while
   in KJK Szary there were two MDR and one extensively drug-resistant (XDR)
   strain. The ESBL mechanism was most frequently observed in OJK Pegaz
   (20.31\% of strains) followed by KJK Szary (15.53\% of strains) and SKH
   Nielepice (15.15\% of strains). Among the ESBL-determining genes, only
   blaTEM and blaCTXM-9 were detected-blaTEM was mostly found in KJK Szary
   (53.40\% of strains), while the second detected gene-blaCTXM-9-was most
   frequent in SKH Nielepice (6.06\% of strains). The rep-PCR genotyping
   showed high variation among the analyzed strains, whereas its degree
   differed between the studied facilities, indicating that the type of
   horse keeping (stable vs. free-range) affects the genetic diversity of
   the E. coli strains. Having regard to the fact that the tested strains
   of E. coli were derived from non-hospitalized horses that were not
   treated pharmacologically, we can assume that the observed antimicrobial
   resistance may be of both-natural origin, i.e., not the result of the
   selection pressure, and acquired, the source of which could be people
   present in the horse riding facilities, the remaining horses which were
   not included in the study, and air, as well as water, fodder, and litter
   of the animals. Therefore, it can be concluded that the studied horses
   are the source of resistant E. coli and it is reasonable to continue
   monitoring the changes in antimicrobial resistance in those bacteria.}},
Publisher = {{SPRINGER HEIDELBERG}},
Address = {{TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wolny-Koladka, K (Reprint Author), Agr Univ Krakow, Dept Microbiol, Mickiewicza Ave 24-28, PL-30059 Krakow, Poland.
   Wolny-Koladka, Katarzyna; Lenart-Boron, Anna, Agr Univ Krakow, Dept Microbiol, Mickiewicza Ave 24-28, PL-30059 Krakow, Poland.}},
DOI = {{10.1007/s11356-018-2274-x}},
ISSN = {{0944-1344}},
EISSN = {{1614-7499}},
Keywords = {{Antibiotics; Antimicrobial resistance; Escherichia coli;
   Extended-spectrum beta-lactamases, horses}},
Keywords-Plus = {{GRAM-NEGATIVE BACTERIA; TOF-MASS-SPECTROMETRY; ANTIBIOTIC-RESISTANCE;
   QUALITY-CONTROL; CTX-M; ENTEROBACTERIACEAE; BREAKPOINTS; MECHANISMS;
   ANIMALS; STAPHYLOCOCCUS}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{katarzyna.wolny@urk.edu.pl}},
Funding-Acknowledgement = {{Department of Microbiology, University of Agriculture in Cracow, Poland}},
Funding-Text = {{The authors would like to sincerely thank Mr. Marian Mikolajewicz (The
   Hutsul Pony Stud Farm in Nielepice), Mr. Bogdan German (The Horse Riding
   Center Pegaz in Krakow), and Mrs. Anna Szary-Ziebicka (The Horse Riding
   Club Szary in Michalowice) for allowing this research and valuable help
   during the study. This study was funded by the statutory measures of the
   Department of Microbiology, University of Agriculture in Cracow, Poland.}},
Cited-References = {{Ahmed MO, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-12.
   Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004.
   Angulo FJ, 2004, REV SCI TECH OIE, V23, P485.
   {[}Anonymous], OP MAN MAS 100TM PRO.
   Baraniak A, 2010, THESIS.
   BARRY AL, 1983, J CLIN MICROBIOL, V17, P232.
   Bohme K, 2010, J PROTEOME RES, V9, P3169, DOI 10.1021/pr100047q.
   Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001.
   Brinas L, 2002, ANTIMICROB AGENTS CH, V46, P3156, DOI 10.1128/AAC.46.10.3156-3163.2002.
   Bryan J, 2010, IRISH VET J, V63, P373, DOI 10.1186/2046-0481-63-6-373.
   Costa D, 2006, J ANTIMICROB CHEMOTH, V58, P1311, DOI 10.1093/jac/dkl415.
   Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x.
   Dolejska M, 2011, J ANTIMICROB CHEMOTH, V66, P757, DOI 10.1093/jac/dkq500.
   Drieux L, 2008, CLIN MICROBIOL INFEC, V14, P90, DOI 10.1111/j.1469-0691.2007.01846.x.
   Dunowska M, 2006, JAVMA-J AM VET MED A, V228, P1909, DOI 10.2460/javma.228.12.1909.
   European Committee on Antimicrobial Susceptibility Testing, 2017, CLIN BREAKP BACT.
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x.
   Hanberger H, 2009, INTENS CARE MED, V35, P91, DOI 10.1007/s00134-008-1237-y.
   Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009.
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030.
   Kadlec K, 2008, J ANTIMICROB CHEMOTH, V62, P469, DOI 10.1093/jac/dkn233.
   Kosikowska U., 2015, DIAGN LAB, V51, P23.
   KRONVALL G, 1984, ACTA PATH MICRO IM B, V92, P13.
   Lenart-Boron A, 2017, INT J ENVIRON SCI TE, V14, P241, DOI 10.1007/s13762-016-1155-4.
   Lenart-Boron A, 2016, VET MED-CZECH, V61, P80, DOI 10.17221/8721-VETMED.
   Lenart-Boron A, 2017, AEROBIOLOGIA, V33, P435, DOI 10.1007/s10453-017-9481-7.
   Maddox TW, 2012, EQUINE VET J, V44, P289, DOI 10.1111/j.2042-3306.2011.00441.x.
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x.
   Marcade G, 2009, J ANTIMICROB CHEMOTH, V63, P67, DOI 10.1093/jac/dkn428.
   Nunnery J, 2006, PREV VET MED, V73, P191, DOI 10.1016/j.prevetmed.2005.09.014.
   Picozzi SCM, 2014, UROL ANNALS, V6, P107, DOI 10.4103/0974-7796.130536.
   Rawat D, 2010, J GLOB INFECT DIS, V2, P263, DOI 10.4103/0974-777X.68531.
   Sader HS, 2007, J CLIN MICROBIOL, V45, P1640, DOI 10.1128/JCM.00143-07.
   Saenz Y, 2004, ANTIMICROB AGENTS CH, V48, P3996, DOI 10.1128/AAC.48.10.3996-4001.2004.
   Seng P, 2010, FUTURE MICROBIOL, V5, P1733, DOI {[}10.2217/fmb.10.127, 10.2217/FMB.10.127].
   Simarro E, 2000, J CLIN MICROBIOL, V38, P4676.
   Turnidge JD, 2011, CLIN INFECT DIS, V52, P917, DOI 10.1093/cid/cir031.
   Venglovsky J, 2009, BIORESOURCE TECHNOL, V100, P5386, DOI 10.1016/j.biortech.2009.03.068.
   Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25.
   Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x.
   Vo ATT, 2007, VET MICROBIOL, V124, P248, DOI 10.1016/j.vetmic.2007.04.027.
   Waran N, 2002, WELFARE OF HORSES, P79.
   Weese J. Scott, 2008, Animal Health Research Reviews, V9, P169, DOI 10.1017/S1466252308001485.
   Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1.
   Wolny-Koladka K, 2016, WATER AIR SOIL POLL, V227, DOI 10.1007/s11270-016-2833-z.
   Wolny-Koladka K, 2014, POL J MICROBIOL, V63, P363.
   Wolny-Koladka KA, 2017, MICRO NANO LETT, V12, P772, DOI 10.1049/mnl.2017.0129.
   Wroblewski Z., 2015, Zycie Weterynaryjne, V90, P298.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Environ. Sci. Pollut. Res.}},
Doc-Delivery-Number = {{GO6AE}},
Unique-ID = {{ISI:000440115600049}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000438703600017,
Author = {Thaker, Adarsh M. and Muthusamy, V. Raman and Sedarat, Alireza and
   Watson, Rabindra R. and Kochman, Michael L. and Ross, Andrew S. and Kim,
   Stephen},
Title = {{Duodenoscope reprocessing practice patterns in US endoscopy centers: a
   survey study}},
Journal = {{GASTROINTESTINAL ENDOSCOPY}},
Year = {{2018}},
Volume = {{88}},
Number = {{2}},
Pages = {{316+}},
Month = {{AUG}},
Abstract = {{Background and Aims: After recent outbreaks of duodenoscope-related
   infections from multidrug-resistant organisms (MDRO), the United States
   Food and Drug Administration (FDA) recommended implementing 1 or more of
   4 enhanced reprocessing measures in addition to updated manual cleaning
   methods and high-level disinfection (HLD). The implementation of these
   techniques in endoscopy facilities and provider opinions regarding
   reprocessing priorities remain unknown.
   Methods: Physicians, nurse managers, nurses, and infection control staff
   at endoscopy units performing ERCP in the United States were surveyed to
   assess current institutional practices and individual opinions regarding
   future reprocessing solutions.
   Results: A total of 249 distinct institutions participated in the
   survey. Of these, 223 (89.6\%) implemented at least 1 of the 4
   supplemental reprocessing methods after MDRO outbreaks. Overall, 63\% of
   centers used repeat HLD, 53\% performed surveillance microbiological
   culturing, 35\% used liquid chemical sterilization, and 12\% used
   ethylene oxide sterilization. Thirty-seven centers (15\%) routinely
   screened patients for MDRO. Forced-air drying after reprocessing was
   used by 47.8\% of centers. Fifty percent of individual respondents,
   including 58.6\% of physicians, believed that redesign of the
   duodenoscope is the best long-term reprocessing solution. The majority
   (55.1\%) identified efficacy to be the single most important factor in
   selecting a reprocessing technique.
   Conclusions: Although most endoscopy centers have implemented enhanced
   duodenoscope reprocessing techniques, there is a large variation in
   practice. Most providers believe that duodenoscope redesign and
   identifying reprocessing techniques with maximal efficacy are the
   long-term priorities. Improved adherence to forced-air drying in
   duodenoscope reprocessing is needed.}},
Publisher = {{MOSBY-ELSEVIER}},
Address = {{360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kim, S (Reprint Author), 200 UCLA Med Plaza,Suite 365, Los Angeles, CA 90095 USA.
   Thaker, Adarsh M.; Muthusamy, V. Raman; Sedarat, Alireza; Watson, Rabindra R.; Kim, Stephen, Univ Calif Los Angeles, Vatche \& Tamar Manoukian Div Digest Dis, Los Angeles, CA USA.
   Kochman, Michael L., Univ Penn Hlth Syst, Dept Med, Div Gastroenterol, Philadelphia, PA USA.
   Ross, Andrew S., Virginia Mason Med Ctr, Inst Digest Dis, Seattle, WA 98101 USA.}},
DOI = {{10.1016/j.gie.2018.04.2340}},
ISSN = {{0016-5107}},
EISSN = {{1097-6779}},
Keywords-Plus = {{RESISTANT ESCHERICHIA-COLI; GI ENDOSCOPES; MULTISOCIETY GUIDELINE;
   DISINFECTION; TRANSMISSION}},
Research-Areas = {{Gastroenterology \& Hepatology}},
Web-of-Science-Categories  = {{Gastroenterology \& Hepatology}},
Author-Email = {{stephenkim@mednet.ucla.edu}},
Cited-References = {{Brandabur JJ, 2016, GASTROINTEST ENDOSC, V84, P392, DOI 10.1016/j.gie.2016.03.1480.
   Chapman CG, 2017, GASTROINTEST ENDOSC, V85, P390, DOI 10.1016/j.gie.2016.07.049.
   Epstein L, 2014, JAMA-J AM MED ASSOC, V312, P1447, DOI 10.1001/jama.2014.12720.
   Gazdik MA, 2016, J CLIN MICROBIOL, V54, P312, DOI 10.1128/JCM.02754-15.
   Kim Stephen, 2016, Curr Gastroenterol Rep, V18, P54, DOI 10.1007/s11894-016-0528-7.
   Kola A, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0049-4.
   Naryzhny I, 2016, GASTROINTEST ENDOSC, V84, P259, DOI 10.1016/j.gie.2016.01.055.
   Neves MS, 2016, GASTROINTEST ENDOSC, V83, P944, DOI 10.1016/j.gie.2015.09.016.
   Petersen BT, 2017, GASTROINTEST ENDOSC, V85, P282, DOI 10.1016/j.gie.2016.10.002.
   Petersen BT, 2011, INFECT CONT HOSP EP, V32, P527, DOI 10.1086/660676.
   Ross AS, 2015, GASTROINTEST ENDOSC, V82, P477, DOI 10.1016/j.gie.2015.04.036.
   Rutala WA, 2016, AM J INFECT CONTROL, V44, pE47, DOI 10.1016/j.ajic.2015.10.037.
   Snyder GM, 2017, GASTROENTEROLOGY, V153, P1018, DOI 10.1053/j.gastro.2017.06.052.
   U.S. Food and Drug Administration, 2015, MEAS ENH DUOD REPR S.
   United States Bureau of the Census, 1994, GEOGR AR REF MAN.}},
Number-of-Cited-References = {{15}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Gastrointest. Endosc.}},
Doc-Delivery-Number = {{GN0XL}},
Unique-ID = {{ISI:000438703600017}},
DA = {{2018-08-13}},
}

@article{ ISI:000432467700055,
Author = {Druckenmueller, Katharina and Guenther, Klaus and Elbers, Gereon},
Title = {{Near-infrared spectroscopy (NIRS) as a tool to monitor exhaust air from
   poultry operations}},
Journal = {{SCIENCE OF THE TOTAL ENVIRONMENT}},
Year = {{2018}},
Volume = {{630}},
Pages = {{536-543}},
Month = {{JUL 15}},
Note = {{COST Action TD1407 Workshop on Environmental Concentrations, Cycling and
   Modeling of Technology Critical Elements, Weizmann Inst Sci, Rehovot,
   ISRAEL, JAN 18-19, 2017}},
Organization = {{COST Act TD1407; European Cooperat Sci \& Technol; NOTICE; Chorafas Inst
   Sci Exchange}},
Abstract = {{Intensive poultry operation systemsemit a considerable volume of
   inorganic and organicmatter in the surrounding environment. Monitoring
   cleaning properties of exhaust air cleaning systems and to detect small
   but significant changes in emission characteristics during a fattening
   cycle is important for both emission and fattening process control. In
   the present study, we evaluated the potential of near-infrared
   spectroscopy (NIRS) combined with chemometric techniques as a monitoring
   tool of exhaust air from poultry operation systems. To generate a
   high-quality data set for evaluation, the exhaust air of two poultry
   houses was sampled by applying state-of-theart filter sampling
   protocols. The two stables were identical except for one crucial
   difference, the presence or absence of an exhaust air cleaning system.
   In total, twenty-one exhaust air samples were collected at the two sites
   to monitor spectral differences caused by the cleaning device, and to
   followchanges in exhaust air characteristics during a fattening period.
   The total dust load was analyzed by gravimetric determination and
   included as a response variable in multivariate data analysis. The
   filter samples were directly measured with NIR spectroscopy. Principal
   component analysis (PCA), linear discriminant analysis (LDA), and factor
   analysis (FA) were effective in classifying the NIR exhaust air spectra
   according to fattening day and origin. The results indicate that the
   dust load and the composition of exhaust air (inorganic or organic
   matter) substantially influence the NIR spectral patterns. In
   conclusion, NIR spectroscopy as a tool is a promising and very rapidway
   to detect differences between exhaust air samples based on still not
   clearly defined circumstances triggered during a fattening period and
   the availability of an exhaust air cleaning system. (C) 2018 The
   Authors. Published by Elsevier B.V.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Elbers, G (Reprint Author), FH Aachen Univ Appl Sci, Fac Chem \& Biotechnol, Campus Julich, Aachen, Germany.
   Druckenmueller, Katharina; Elbers, Gereon, FH Aachen Univ Appl Sci, Fac Chem \& Biotechnol, Campus Julich, Aachen, Germany.
   Guenther, Klaus, Rheinische Friedrich Wilhelms Univ Bonn, Inst Nutr \& Food Sci, Food Chem, Bonn, Germany.}},
DOI = {{10.1016/j.scitotenv.2018.02.072}},
ISSN = {{0048-9697}},
EISSN = {{1879-1026}},
Keywords = {{NIRS; Exhaust air; Rapid detection; Poultry; Monitoring; Emission}},
Keywords-Plus = {{RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; BACTERIAL
   COMMUNITY; SCATTER-CORRECTION; RISK-ASSESSMENT; BIOAEROSOLS; HOUSES;
   REFLECTANCE; EMISSIONS; EXPOSURE}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{elbers@fh-aachen.de}},
ResearcherID-Numbers = {{Guenther, Klaus/B-3283-2010}},
ORCID-Numbers = {{Guenther, Klaus/0000-0003-0541-6980}},
Funding-Acknowledgement = {{North Rhine-Westphalia State Agency for Nature, Environment and Consumer
   Protection (LANUV NRW), Essen, Germany; FH Aachen University of Applied
   Sciences, Campus Julich, Germany; Society for Chemical Engineering and
   Biotechnology e.V. (DECHEMA), Frankfurt, Germany}},
Funding-Text = {{This work was supported by the North Rhine-Westphalia State Agency for
   Nature, Environment and Consumer Protection (LANUV NRW), Essen, Germany;
   the FH Aachen University of Applied Sciences, Campus Julich, Germany;
   and the Society for Chemical Engineering and Biotechnology e.V.
   (DECHEMA), Frankfurt, Germany.}},
Cited-References = {{Adedipe OE, 2016, J AGR FOOD CHEM, V64, P1850, DOI 10.1021/acs.jafc.5b04733.
   Brackx M, 2017, ENVIRON POLLUT, V220, P159, DOI 10.1016/j.envpol.2016.09.035.
   Casale M, 2015, CHEMOSPHERE, V134, P355, DOI 10.1016/j.chemosphere.2015.03.095.
   Chen LJ, 2013, J ENVIRON QUAL, V42, P1015, DOI 10.2134/jeq2013.01.0014.
   Decius M, 2016, EXAMINATION FUNCTION.
   Dixit Y, 2017, J FOOD SCI, V82, P1557, DOI 10.1111/1750-3841.13770.
   Ferguson DD, 2016, J AGROMEDICINE, V21, P149, DOI 10.1080/1059924X.2016.1142917.
   Friese A, 2013, APPL ENVIRON MICROB, V79, P2759, DOI 10.1128/AEM.03939-12.
   Gab M, 2006, J FOREST RES-JPN, V11, P69, DOI 10.1007/s10310-005-0186-3.
   Gartner A, 2016, GEFAHRST REINHALT L, V76, P31.
   Gartner A, 2014, GEFAHRST REINHALT L, V74, P505.
   Gartner A, 2014, GEFAHRST REINHALT L, V74, P377.
   Gallello G, 2016, SCI TOTAL ENVIRON, V544, P291, DOI 10.1016/j.scitotenv.2015.11.156.
   Galvez-Sola L, 2010, SCI TOTAL ENVIRON, V408, P1414, DOI 10.1016/j.scitotenv.2009.11.043.
   GELADI P, 1985, APPL SPECTROSC, V39, P491, DOI 10.1366/0003702854248656.
   Ghosh B, 2015, ENVIRON INT, V85, P254, DOI 10.1016/j.envint.2015.09.018.
   Gowen AA, 2008, EUR J PHARM BIOPHARM, V69, P10, DOI 10.1016/j.ejpb.2007.10.013.
   ILARI JL, 1988, APPL SPECTROSC, V42, P722, DOI 10.1366/0003702884429058.
   Jackson J. E, 1991, USERS GUIDE PRINCIPA.
   Jahne MA, 2016, J ENVIRON QUAL, V45, P666, DOI 10.2134/jeq2015.04.0187.
   Jahne MA, 2015, ENVIRON SCI TECHNOL, V49, P9842, DOI 10.1021/acs.est.5b01981.
   Jerez SB, 2014, J APPL POULTRY RES, V23, P7, DOI 10.3382/japr.2012-00710.
   Kammies TL, 2016, APPL MICROBIOL BIOT, V100, P9305, DOI 10.1007/s00253-016-7801-4.
   Kona R, 2013, INT J PHARMACEUT, V452, P63, DOI 10.1016/j.ijpharm.2013.04.039.
   Marques AD, 2013, J MICROBIOL METH, V93, P90, DOI 10.1016/j.mimet.2013.02.003.
   Marques AS, 2015, TALANTA, V134, P126, DOI 10.1016/j.talanta.2014.11.006.
   Martin E, 2012, GEFAHRST REINHALT L, V72, P99.
   Naes T, 2002, USER FRIENDLY GUIDE.
   NYDEN MR, 1988, APPL SPECTROSC, V42, P588, DOI 10.1366/0003702884429436.
   Oppliger A, 2008, ANN OCCUP HYG, V52, P405, DOI 10.1093/annhyg/men021.
   Quintelas C, 2015, INT J PHARMACEUT, V492, P199, DOI 10.1016/j.ijpharm.2015.07.005.
   Rodriguez-Saona LE, 2001, J AGR FOOD CHEM, V49, P574, DOI 10.1021/jf000776j.
   Rosas JG, 2012, TALANTA, V97, P163, DOI 10.1016/j.talanta.2012.04.012.
   Siesler H. W., 2002, NEAR INFRARED SPECTR.
   Smit LAM, 2014, OCCUP ENVIRON MED, V71, P134, DOI 10.1136/oemed-2013-101485.
   Tidwell JE, 2015, CLIN ORTHOP RELAT R, V473, P3638, DOI 10.1007/s11999-015-4497-1.
   VDI, 2006, PART MATT MEAS DUST, P1.
   Vucemilo M, 2007, CZECH J ANIM SCI, V52, P170, DOI 10.17221/2318-CJAS.
   Walser SM, 2015, INT J HYG ENVIR HEAL, V218, P577, DOI 10.1016/j.ijheh.2015.07.004.
   Workman JJ, 2008, PRACTICAL GUIDE INTE.
   Zhang C, 2014, ACTA PHARM SIN B, V4, P182, DOI 10.1016/j.apsb.2014.04.001.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Sci. Total Environ.}},
Doc-Delivery-Number = {{GG1SQ}},
Unique-ID = {{ISI:000432467700055}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000438515300001,
Author = {Rosen, Kerstin and Roesler, Uwe and Merle, Roswitha and Friese, Anika},
Title = {{Persistent and Transient Airborne MRSA Colonization of Piglets in a
   Newly Established Animal Model}},
Journal = {{FRONTIERS IN MICROBIOLOGY}},
Year = {{2018}},
Volume = {{9}},
Month = {{JUL 13}},
Abstract = {{Livestock-associated methicillin-resistant Staphylococcus aureus
   (LA-MRSA) was first found in 2005 and is up to date widespread in animal
   husbandry reservoir - focusing on pig farming. The regular detectability
   of MRSA in the air of pigsties as well as in exhaust air of pig farms
   (mean count: 10(2) cfu/m(3)) poses the question whether an airborne
   spread and, therefore, a MRSA colonization of animals via the airborne
   route exists. To answer this question, we exposed three groups of nine
   MRSA-negative tested piglets each to a defined airborne MRSA
   concentration (10(2), 10(4), and 10(6) cfu/m(3)) in our aerosol chamber
   for 24 h. In the following observation period of 21 days, the MRSA
   status of the piglets was monitored by taking different swab samples
   (nasal, pharyngeal, skin, conjunctival, and rectal swab). At the end of
   the experiment, we euthanized the piglets and investigated different
   tissues and organs for the spread of MRSA. The data of our study imply
   the presence of an airborne MRSA colonization route: the animals exposed
   to 10(6) cfu/m(3) MRSA in the air were persistent colonized. The piglets
   exposed to an airborne MRSA concentration of 10(4) cfu/m(3) were
   transient, and the piglets exposed to an airborne MRSA concentration of
   10(2) cfu/m(3) were not colonized. Consequently, a colonization via the
   airborne route was proven.}},
Publisher = {{FRONTIERS MEDIA SA}},
Address = {{AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Rosen, K (Reprint Author), Free Univ Berlin, Inst Anim Hyg \& Environm Hlth, Berlin, Germany.
   Rosen, Kerstin; Roesler, Uwe; Friese, Anika, Free Univ Berlin, Inst Anim Hyg \& Environm Hlth, Berlin, Germany.
   Merle, Roswitha, Free Univ Berlin, Inst Vet Epidemiol \& Biostat, Berlin, Germany.}},
DOI = {{10.3389/fmicb.2018.01542}},
Article-Number = {{1542}},
ISSN = {{1664-302X}},
Keywords = {{livestock; ST398; pig; aerosol chamber; swine; antibiotic resistance}},
Keywords-Plus = {{RESISTANT STAPHYLOCOCCUS-AUREUS; PIGS; TRANSMISSION; ST398}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{kerstin.rosen@fu-berlin.de}},
Funding-Acknowledgement = {{Federal Institute for risk assessment (BfR) {[}1329-530]}},
Funding-Text = {{This study was funded in parts by the Federal Institute for risk
   assessment (BfR) with grant number: 1329-530.}},
Cited-References = {{Angen O, 2017, APPL ENVIRON MICROB, V83, DOI {[}10.1128/aem.01489-17, 10.1128/AEM.01489-17].
   Becker K, 2017, VET MICROBIOL, V200, P33, DOI 10.1016/j.vetmic.2015.11.013.
   Broens EM, 2012, VET MICROBIOL, V155, P381, DOI 10.1016/j.vetmic.2011.09.010.
   Crombe F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00057.
   Crombe F, 2012, APPL ENVIRON MICROB, V78, P1631, DOI 10.1128/AEM.07356-11.
   Ferguson DD, 2016, J AGROMEDICINE, V21, P149, DOI 10.1080/1059924X.2016.1142917.
   Friese A, 2012, VET MICROBIOL, V158, P129, DOI 10.1016/j.vetmic.2012.01.019.
   Jouy E, 2012, LETT APPL MICROBIOL, V54, P518, DOI 10.1111/j.1472-765X.2012.03239.x.
   Kahl BC, 2005, J CLIN MICROBIOL, V43, P502, DOI 10.1128/JCM.43.1.502-505.2005.
   Moodley A, 2011, EPIDEMIOL INFECT, V139, P1594, DOI 10.1017/S0950268810002888.
   Pletinckx LJ, 2011, INFECT GENET EVOL, V11, P2133, DOI 10.1016/j.meegid.2011.07.008.
   Szabo I, 2012, APPL ENVIRON MICROB, V78, P541, DOI 10.1128/AEM.05327-11.
   Verstappen KM, 2014, VET MICROBIOL, V174, P483, DOI 10.1016/j.vetmic.2014.09.019.
   Vincze S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085656.
   Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428.}},
Number-of-Cited-References = {{15}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Front. Microbiol.}},
Doc-Delivery-Number = {{GM8VR}},
Unique-ID = {{ISI:000438515300001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000438680300011,
Author = {Bragoszewska, I, Ewa and Biedron, Izabela and Kozielska, Barbara and
   Pastuszka, Jozef S.},
Title = {{Microbiological indoor air quality in an office building in Gliwice,
   Poland: analysis of the case study}},
Journal = {{AIR QUALITY ATMOSPHERE AND HEALTH}},
Year = {{2018}},
Volume = {{11}},
Number = {{6}},
Pages = {{729-740}},
Month = {{JUL}},
Abstract = {{Bioaerosols play a significant role in indoor air quality (IAQ) as they
   can be the cause of several health problems, including acute allergies
   and infectious diseases. This study aimed to characterize and compare
   the microbial air quality of air-conditioned (AC) and naturally
   ventilated (NV) office rooms in the Upper Silesia region of Poland. The
   bacterial samples were collected during the late spring season.
   Culturable bacteria were deposited on the nutrient media on Petri dishes
   to investigate the viable-culturable count (VCC) of bacteria and
   bacterial community structure using a Biolog GEN III system. In total,
   12 species of bacteria were identified, with the most isolated
   Macrococcus equipercicus, Micrococcus luteus D, Staphylococcus xylosus
   (indoor), and Bacillus species (outdoor). The indoor mean concentrations
   of bacterial aerosol ranged from 10(2) to 10(3) CFU m(-3), below Polish
   proposals for threshold limit standards in office buildings. The
   indoor-to-outdoor (I/O) ratios indicated that studied air pollutants in
   the office rooms originated from the indoor air. These results, together
   with community composition of bacteria, indicate that most of the
   bacteria present in the studied office building were relatively fresh
   and of human origin. Multi-antibiotic resistance (MAR) tests showed that
   the most antibiotic-resistant features were present in Macrococcus
   species. The office building exposure dose (OBED) and mass median
   aerodynamic diameter (MMAD) of bacteria aerosol were estimated. The
   highest value of OBED over the study period was obtained for staff
   working in offices with natural ventilation (141 CFU kg(-1)), in
   contrast to the value for staff working in offices equipped with air
   conditioning (about 100 CFU kg(-1)). The MMAD of viable airborne
   bacteria was higher in AC offices (2.4 mu m) than in NV offices (2.2 mu
   m).}},
Publisher = {{SPRINGER INTERNATIONAL PUBLISHING AG}},
Address = {{GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Bragoszewska, E (Reprint Author), Silesian Tech Univ, Dept Air Protect, 22B Konarskiego St, PL-44100 Gliwice, Poland.
   Bragoszewska, Ewa, I; Kozielska, Barbara; Pastuszka, Jozef S., Silesian Tech Univ, Dept Air Protect, 22B Konarskiego St, PL-44100 Gliwice, Poland.
   Biedron, Izabela, Inst Ecol Ind Areas, Environm Microbiol Unit, 6 Kossutha St, PL-40844 Katowice, Poland.}},
DOI = {{10.1007/s11869-018-0579-z}},
ISSN = {{1873-9318}},
EISSN = {{1873-9326}},
Keywords = {{Bioaerosol; Bacteria; Air conditioning; Occupational exposure; IAQ}},
Keywords-Plus = {{AIRBORNE BACTERIA; OUTDOOR ENVIRONMENTS; FUNGAL AEROSOLS; HONG-KONG;
   EXPOSURE; SCHOOLS; URBAN; UNIVERSITY; POLLUTION; MICROBES}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{Ewa.Bragoszewska@polsl.pl}},
Funding-Acknowledgement = {{Faculty of Power and Environmental Engineering, Silesian University of
   Technology (statutory research)}},
Funding-Text = {{This work was supported by the Faculty of Power and Environmental
   Engineering, Silesian University of Technology (statutory research).}},
Cited-References = {{Abosede Sarah A, 2017, INT J ENV MON ANAL, V5, P83, DOI {[}10.11648/j.ijema.20170503.13, DOI 10.11648/J.IJEMA.20170503.13].
   Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783.
   Ankolekar C, 2009, INT J FOOD MICROBIOL, V128, P460, DOI 10.1016/j.ijfoodmicro.2008.10.006.
   Ashmore MR, 2009, ATMOS ENVIRON, V43, P128, DOI 10.1016/j.atmosenv.2008.09.024.
   Aydogdu H, 2010, ENVIRON MONIT ASSESS, V164, P53, DOI 10.1007/s10661-009-0874-0.
   Bavykin SG, 2008, CHEM-BIOL INTERACT, V171, P212, DOI 10.1016/j.cbi.2007.09.002.
   Bernstein JA, 2008, J ALLERGY CLIN IMMUN, V121, P585, DOI 10.1016/j.jaci.2007.10.045.
   Blaszczyk E, 2017, AIR QUAL ATMOS HLTH, V10, P1207, DOI 10.1007/s11869-017-0505-9.
   Bonetta S, 2010, ENVIRON MONIT ASSESS, V161, P473, DOI 10.1007/s10661-009-0761-8.
   Bragoszewska E, 2014, THESIS.
   Bragoszewska E, 2018, ATMOSPHERE, V9, DOI {[}10.3390/atmos9030087, DOI 10.3390/ATM0S9030087].
   Bragoszewska E, 2017, ATMOSPHERE-BASEL, V8, DOI 10.3390/atmos8120239.
   Bragoszewska E, 2016, ATMOSPHERE-BASEL, V7, DOI 10.3390/atmos7110142.
   Bragoszewska E, 2016, AEROBIOLOGIA, V32, P469, DOI 10.1007/s10453-015-9419-x.
   Brasche S, 2005, INT J HYG ENVIR HEAL, V208, P247, DOI 10.1016/j.ijheh.2005.03.003.
   Copeland E, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00057.
   Council NR, 2006, OV CHALL DEV COUNT A.
   Daisey JM, 2003, INDOOR AIR, V13, P53, DOI 10.1034/j.1600-0668.2003.00153.x.
   Di Giulio M, 2010, ENVIRON MONIT ASSESS, V170, P509, DOI 10.1007/s10661-009-1252-7.
   Dolovich MB, 2011, LANCET, V377, P1032, DOI 10.1016/S0140-6736(10)60926-9.
   Dumala SM, 2013, ROCZ OCHR SR, V15, P231.
   Eberhard J, 2017, CLIN ORAL INVEST, V21, P447, DOI 10.1007/s00784-016-1811-6.
   Ege MJ, 2012, ALLERGY, V67, P1565, DOI 10.1111/all.12028.
   Fang ZG, 2007, MICROB ECOL, V54, P487, DOI 10.1007/s00248-007-9216-3.
   Gawronska H, 2015, AIR QUAL ATMOS HLTH, V8, P265, DOI 10.1007/s11869-014-0285-4.
   Gizaw Z, 2016, MULTIDISCIP RESP MED, V11, DOI 10.1186/s40248-016-0061-4.
   Golofit-Szymczak M, 2010, INT J OCCUP SAF ERGO, V16, P465.
   Gorny RL, 2002, ANN AGR ENV MED, V9, P17.
   GWALTNEY JM, 1981, ANN OTO RHINOL LARYN, V90, P68.
   Hewitt KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037849.
   Hinds W.C., 1999, AEROSOL TECHNOLOGY P.
   Johnson-Restrepo B, 2009, CHEMOSPHERE, V76, P542, DOI 10.1016/j.chemosphere.2009.02.068.
   Karottki DG, 2015, INT J ENV RES PUB HE, V12, P1667, DOI 10.3390/ijerph120201667.
   Kim KY, 2007, BUILD ENVIRON, V42, P2188, DOI 10.1016/j.buildenv.2006.04.013.
   Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165.
   Kotzias D, 2005, EXP TOXICOL PATHOL, V57, P5, DOI 10.1016/j.etp.2005.05.002.
   Latif MT, 2014, AIR QUAL ATMOS HLTH, V7, P181, DOI 10.1007/s11869-013-0224-9.
   Law AKY, 2001, BUILD ENVIRON, V36, P527, DOI 10.1016/S0360-1323(00)00020-2.
   Lee SC, 2000, CHEMOSPHERE, V41, P109, DOI 10.1016/S0045-6535(99)00396-3.
   Meklin T, 2002, ATMOS ENVIRON, V36, P6031, DOI 10.1016/S1352-2310(02)00769-0.
   Mentese S, 2009, CLEAN-SOIL AIR WATER, V37, P487, DOI 10.1002/clen.200800220.
   Mirhoseini SH, 2016, AEROSOL AIR QUAL RES, V16, P1903, DOI 10.4209/aaqr.2015.08.0528.
   Moon KW, 2014, ENVIRON MONIT ASSESS, V186, P2111, DOI 10.1007/s10661-013-3521-8.
   Mui KW, 2008, BUILD ENVIRON, V43, P475, DOI 10.1016/j.buildenv.2007.01.012.
   Nasir ZA, 2010, WATER AIR SOIL POLL, V211, P367, DOI 10.1007/s11270-009-0306-3.
   Nazaroff WW, 2016, INDOOR AIR, V26, P61, DOI 10.1111/ina.12174.
   NAZAROFF WW, 1989, ENVIRON SCI TECHNOL, V23, P157, DOI 10.1021/es00179a003.
   NEVALAINEN A, 1992, ATMOS ENVIRON A-GEN, V26, P531, DOI 10.1016/0960-1686(92)90166-I.
   Nevalainen A, 1993, AEROSOL MEASUREMENT, P471.
   Ott WR, 2006, EXPOSURE ANAL.
   Pakarinen J, 2008, ENVIRON MICROBIOL, V10, P3317, DOI 10.1111/j.1462-2920.2008.01723.x.
   Park HK, 2014, J APPL MICROBIOL, V116, P718, DOI 10.1111/jam.12416.
   Pastuszka JS, 2005, POL J ENVIRON STUD, V14, P883.
   Pastuszka JS, 2000, ATMOS ENVIRON, V34, P3833, DOI 10.1016/S1352-2310(99)00527-0.
   Pegas PN, 2010, QUIM NOVA, V33, P1145, DOI 10.1590/S0100-40422010000500027.
   Raisi L, 2013, AEROBIOLOGIA, V29, P233, DOI 10.1007/s10453-012-9276-9.
   Salleh NM, 2011, INT PR CHEM BIO ENV, V6, P418.
   Shin SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126960.
   Srikanth P, 2008, INDIAN J MED MICROBI, V26, P302, DOI 10.4103/0255-0857.43555.
   Stryjakowska-Sekulska M, 2007, POL J ENVIRON STUD, V16, P623.
   Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862.
   U.S. EPA, 2011, EXP FACT HDB.
   Watson AY, 1988, AIR POLLUTION AUTOMO.
   Wichmann J, 2010, ATMOS ENVIRON, V44, P4536, DOI 10.1016/j.atmosenv.2010.08.023.
   Wilson C, 2006, B ENVIRON CONTAM TOX, V76, P392, DOI 10.1007/s00128-006-0934-x.
   Wood RA, 2002, PLANT SOIL CAPACITIE.
   Zhou Y, 2016, APPL ENVIRON MICROB, V82, P5249, DOI 10.1128/AEM.01111-16.}},
Number-of-Cited-References = {{67}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Air Qual. Atmos. Health}},
Doc-Delivery-Number = {{GN0QU}},
Unique-ID = {{ISI:000438680300011}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000434747200051,
Author = {Lorenzon, Esteban N. and Nobre, Thatyane M. and Caseli, Luciano and
   Cilli, Eduardo M. and da Hora, Gabriel C. A. and Soares, Thereza A. and
   Oliveira, Jr., Osvaldo N.},
Title = {{The ``pre-assembled state{''} of magainin 2 lysine-linked dimer
   determines its enhanced antimicrobial activity}},
Journal = {{COLLOIDS AND SURFACES B-BIOINTERFACES}},
Year = {{2018}},
Volume = {{167}},
Pages = {{432-440}},
Month = {{JUL 1}},
Abstract = {{Antimicrobial peptides (AMPs) are alternatives to conventional
   antibiotics against multi-drug resistant bacteria with low potential for
   developing microbial resistance. The design of such molecules requires
   understanding of the mechanisms of action, particularly the interaction
   with bacteria cell membranes. In this work, we determine the mechanism
   responsible for the higher activity against Escherichia coil of the
   C-terminal lysine dimer of magainin 2, (MG2)(2)K, in comparison to the
   monomeric peptide magainin 2 (MG2). Langmuir monolayers and vesicles
   made with the E. coli lipid extract were used to address the two
   possible states for the peptide-membrane interaction, namely the
   ``binding state{''} and ``pore state{''}, respectively. The
   incorporation of MG2 and (MG2)(2)K in lipid monolayers at the air-water
   interface caused slight differences in surface pressure isotherms and
   polarization-modulated infrared reflection absorption (PM-IRRAS)
   spectra, and therefore the difference in activity is not associated with
   the binding state. In contrast, large differences were observed in the
   leakage experiments where (MG2)(2)K was shown to disrupt the large
   unilamellar vesicles to a much higher extent owing to efficient pore
   formation. The binding and penetration of MG2 and (MG2)(2)K were also
   probed with molecular dynamics (MD) simulations for bilayers made with
   1-palmitoy1-2-oleoyl-sn-g/ycero-3-phosphoethanolamine:1-palmitoy1-2-oleo
   yl-snglycero-3-phosphoglycerol (POPE:POPG). (MG2)(2)K forms disordered
   toroidal pores at a significant lower concentration than for MG2. In
   summary, the combination of experimental and computational simulation
   results indicated that the ``pre-assembling state{''} of (MG2)(2)K dimer
   leads to a reduced number of molecules and shorter time being required
   to kill E. coli. (C) 2018 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lorenzon, EN (Reprint Author), Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil.
   Lorenzon, EN (Reprint Author), Univ Fed Goias, Inst Ciencias Biol, Dept Bioquim \& Biol Mol, ICB 2 Sala 118,Campus 2 Samambaia, BR-74690900 Goiania, Go, Brazil.
   Lorenzon, Esteban N.; Nobre, Thatyane M.; Oliveira, Osvaldo N., Jr., Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil.
   Caseli, Luciano, Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim \& Farmaceut, Diadema, SP, Brazil.
   Cilli, Eduardo M., Univ Estadual Paulista, Inst Quim, Araraquara, SP, Brazil.
   da Hora, Gabriel C. A.; Soares, Thereza A., Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil.
   Lorenzon, Esteban N., Univ Fed Goias, Inst Ciencias Biol, Dept Bioquim \& Biol Mol, ICB 2 Sala 118,Campus 2 Samambaia, BR-74690900 Goiania, Go, Brazil.}},
DOI = {{10.1016/j.colsurfb.2018.04.034}},
ISSN = {{0927-7765}},
EISSN = {{1873-4367}},
Keywords = {{Antimicrobial peptides; Dimerization; Molecular dynamics; Mechanism of
   action; Langmuir monolayer; Escherichia coli}},
Keywords-Plus = {{MODEL MEMBRANE INTERACTIONS; COARSE-GRAINED MODEL; PORE FORMATION;
   LIPID-MEMBRANES; ANTIBACTERIAL ACTIVITY; LANGMUIR MONOLAYERS;
   BIOLOGICAL-ACTIVITY; MOLECULAR-DYNAMICS; AUREIN 1.2; CTX-HA}},
Research-Areas = {{Biophysics; Chemistry; Materials Science}},
Web-of-Science-Categories  = {{Biophysics; Chemistry, Physical; Materials Science, Biomaterials}},
Author-Email = {{esteban@ufg.br}},
ResearcherID-Numbers = {{CEPID-FAPESP, CIBFar/J-2382-2015
   Oliveira, Osvaldo/A-1714-2008
   Institute of Physics, USP/H-5191-2017
   Sao Carlos Institute of Physics, IFSC/USP/M-2664-2016}},
ORCID-Numbers = {{CEPID-FAPESP, CIBFar/0000-0003-2719-0302
   Oliveira, Osvaldo/0000-0002-5399-5860
   }},
Funding-Acknowledgement = {{FAPESP {[}2013/07600-3, 2013/14262-7, 2015/16857-3]; CAPES; FACEPE
   {[}APQ-0732-1.06/14]; BioMol/CAPES {[}BioComp 23038.004630/2014-35];
   CNPq (Brazil)}},
Funding-Text = {{The authors are grateful to FAPESP (2013/07600-3, 2013/14262-7,
   2015/16857-3), CAPES, FACEPE (APQ-0732-1.06/14), BioMol/CAPES (BioComp
   23038.004630/2014-35) and CNPq (Brazil) for the financial support.
   Computational resources were provided by the High Performance Computing
   Center North (HPC2N) at Umea University, Sweden.}},
Cited-References = {{Arnusch CJ, 2007, BIOCHEMISTRY-US, V46, P13437, DOI 10.1021/bi7015553.
   BARTH A, 2002, REV BIOPHYS, V35, P369, DOI DOI 10.1017/S0033583502003815.
   BESSALLE R, 1990, FEBS LETT, V274, P151, DOI 10.1016/0014-5793(90)81351-N.
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098.
   Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420.
   Caseli L, 2006, LANGMUIR, V22, P8501, DOI 10.1021/la061799g.
   Cespedes GF, 2012, PROTEIN PEPTIDE LETT, V19, P596.
   Damalio JCP, 2013, BBA-BIOMEMBRANES, V1828, P1441, DOI 10.1016/j.bbamem.2013.02.003.
   de Souza KD, 2017, COLLOID SURFACE B, V160, P247, DOI 10.1016/j.colsurfb.2017.09.027.
   Dempsey CE, 2003, BIOCHEMISTRY-US, V42, P402, DOI 10.1021/bi026328h.
   Domingues TM, 2013, LANGMUIR, V29, P8609, DOI 10.1021/la401596s.
   Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591.
   Frey B. L., 2006, HDB VIBRATIONAL SPEC.
   Gesell J, 1997, J BIOMOL NMR, V9, P127, DOI 10.1023/A:1018698002314.
   Hadicke A, 2015, LANGMUIR, V31, P12203, DOI 10.1021/acs.langmuir.5b02882.
   Han E, 2013, LANGMUIR, V29, P14214, DOI 10.1021/la4036985.
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q.
   Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0.
   Hristova K, 2001, BIOPHYS J, V80, P801, DOI 10.1016/S0006-3495(01)76059-6.
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5.
   Imura Y, 2008, BIOPHYS J, V95, P5757, DOI 10.1529/biophysj.108.133488.
   Karal MA, 2015, LANGMUIR, V31, P3391, DOI 10.1021/la503318z.
   Kim C, 2009, BBA-BIOMEMBRANES, V1788, P1482, DOI 10.1016/j.bbamem.2009.04.017.
   Lee IH, 2001, BBA-GEN SUBJECTS, V1527, P141, DOI 10.1016/S0304-4165(01)00156-8.
   Lee JY, 2008, FEBS J, V275, P3911, DOI 10.1111/j.1742-4658.2008.06536.x.
   Lee TH, 2016, CURR TOP MED CHEM, V16, P25, DOI 10.2174/1568026615666150703121700.
   Lee W, 2014, CURR MICROBIOL, V69, P794, DOI 10.1007/s00284-014-0657-x.
   Lorenzon EN, 2016, BBA-BIOMEMBRANES, V1858, P1129, DOI 10.1016/j.bbamem.2016.02.010.
   Lorenzon EN, 2013, AMINO ACIDS, V44, P1521, DOI 10.1007/s00726-013-1475-3.
   Lorenzon EN, 2012, ANTIMICROB AGENTS CH, V56, P3004, DOI 10.1128/AAC.06262-11.
   Lorenzon EN, 2016, PROTEIN PEPTIDE LETT, V23, P738, DOI 10.2174/0929866523666160511150907.
   Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5.
   Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006.
   Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f.
   Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g.
   Matsuzaki K, 1996, BIOCHEMISTRY-US, V35, P11361, DOI 10.1021/bi960016v.
   MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P12553, DOI 10.1021/bi00039a009.
   MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P6521, DOI 10.1021/bi00019a033.
   Mendelsohn R, 2010, BBA-BIOMEMBRANES, V1798, P788, DOI 10.1016/j.bbamem.2009.11.024.
   MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025.
   Mukai Y, 2002, J PEPT SCI, V8, P570, DOI 10.1002/psc.416.
   Nguyen KT, 2009, J PHYS CHEM B, V113, P12358, DOI 10.1021/jp904154w.
   Ningsih Z, 2012, LANGMUIR, V28, P2217, DOI 10.1021/la203770j.
   Nobre TM, 2015, THIN SOLID FILMS, V593, P158, DOI 10.1016/j.tsf.2015.09.047.
   PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693.
   Roscia G, 2013, CURR PROTEIN PEPT SC, V14, P641, DOI 10.2174/138920371408131227155308.
   Russell AL, 2011, CHEM PHYS LIPIDS, V164, P740, DOI 10.1016/j.chemphyslip.2011.09.003.
   Santo KP, 2012, J PHYS CHEM B, V116, P3021, DOI 10.1021/jp212018f.
   Santos NA, 2015, TOXICON, V103, P160, DOI 10.1016/j.toxicon.2015.07.004.
   Schmidtchen A, 2014, ADV COLLOID INTERFAC, V205, P265, DOI 10.1016/j.cis.2013.06.009.
   Sengupta D, 2008, BBA-BIOMEMBRANES, V1778, P2308, DOI 10.1016/j.bbamem.2008.06.007.
   Strauss J, 2010, COLLOID SURFACE B, V75, P156, DOI 10.1016/j.colsurfb.2009.08.026.
   Tamba Y, 2009, J PHYS CHEM B, V113, P4846, DOI 10.1021/jp8109622.
   Toner E, 2015, HEALTH SECUR, V13, P153, DOI 10.1089/hs.2014.0088.
   Unger T, 2001, BIOCHEMISTRY-US, V40, P6388, DOI 10.1021/bi0026066.
   Vicente EF, 2015, PROTEIN PEPTIDE LETT, V22, P119, DOI 10.2174/0929866521666140508125215.
   Volinsky R, 2006, BBA-BIOMEMBRANES, V1758, P1393, DOI 10.1016/j.bbamem.2006.03.002.
   Wassenaar TA, 2015, J CHEM THEORY COMPUT, V11, P2144, DOI 10.1021/acs.jctc.5b00209.
   Welling MM, 2007, ANTIMICROB AGENTS CH, V51, P3416, DOI 10.1128/AAC.00196-07.
   Yang ST, 2009, BIOTECHNOL LETT, V31, P233, DOI 10.1007/s10529-008-9848-5.
   Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2.
   Yin LM, 2012, J BIOL CHEM, V287, P7738, DOI 10.1074/jbc.M111.303602.
   ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449.
   ZASLOFF M, 1988, P NATL ACAD SCI USA, V85, P910, DOI 10.1073/pnas.85.3.910.
   Zerweck J, 2016, EUR BIOPHYS J BIOPHY, V45, P535, DOI 10.1007/s00249-016-1120-7.
   Zhou L, 2011, AMINO ACIDS, V40, P123, DOI 10.1007/s00726-010-0565-8.
   Zhu WL, 2009, CHEM BIOL DRUG DES, V73, P209, DOI 10.1111/j.1747-0285.2008.00769.x.}},
Number-of-Cited-References = {{67}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Colloid Surf. B-Biointerfaces}},
Doc-Delivery-Number = {{GI8BQ}},
Unique-ID = {{ISI:000434747200051}},
DA = {{2018-08-13}},
}

@article{ ISI:000432745000026,
Author = {Gao, Min and Qiu, Tianlei and Sun, Yanmei and Wang, Xuming},
Title = {{The abundance and diversity of antibiotic resistance genes in the
   atmospheric environment of composting plants}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2018}},
Volume = {{116}},
Pages = {{229-238}},
Month = {{JUL}},
Abstract = {{Composting is considered to reduce the introduction of antimicrobial
   resistance genes (ARGs) into the environment through land application of
   manure; however, the possible pollution of ARGs in the atmospheric
   environment of composting plants is unknown. In this study, 29 air
   samples including up-and downwind, composting, packaging, and office
   areas from 4 composting plants were collected. Dynamic concentrations of
   22 subtypes of ARGs, class 1 integron (intl1), and 2 potential human
   pathogenic bacteria (HPB), and bacterial communities were investigated
   using droplet digital PCR and 16S rRNA gene sequencing, respectively. In
   this study, intl1 and 22 subtypes of ARGs (except tetQ) were detected in
   air of composting, packaging, office, and downwind areas. The highest
   concentration of 15 out of 22 subtypes of ARGs was detected in the
   packaging areas, and intl1 also had the maximum average concentration of
   104 copies/m3, with up to (1.78 +/- 0.49) x10(-2) copies/16S rRNA copy.
   Non-metric multi-dimensional scaling of ARGs, potential HPBs, and
   bacterial components all indicated that the bioaerosol pollutant pattern
   in packaging areas was most similar to that in composting areas,
   followed by office, downwind, and upwind areas. The co-occurrence
   between ARGs and bacterial taxa assessed by Procrustes test, mantel
   test, and network analysis implied that aerosolized ARG fragments from
   composting and packaging areas contributed to the compositions of ARG
   aerosols in office and downwind areas. The results presented here show
   that atmoshperic environments of composting plants harbor abundant and
   diverse ARGs, which highlight the urgent need for comprehensive
   evaluation of potential human health and ecological risks of composts
   during both production as well as land application.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wang, XM (Reprint Author), Beijing Acad Agr \& Forestry Sci, Beijing Agrobiotechnol Res Ctr, 9 Shuguang Middle Rd, Beijing 100097, Peoples R China.
   Gao, Min; Qiu, Tianlei; Sun, Yanmei; Wang, Xuming, Beijing Acad Agr \& Forestry Sci, Beijing Agrobiotechnol Res Ctr, Beijing Key Lab Agr Genet Resources \& Biotechnol, Beijing 100097, Peoples R China.}},
DOI = {{10.1016/j.envint.2018.04.028}},
ISSN = {{0160-4120}},
EISSN = {{1873-6750}},
Keywords = {{Bioaerosol; Antimicrobial resistance gene (ARG); Bacterial community;
   Droplet digital PCR (ddPCR); Composting}},
Keywords-Plus = {{DROPLET DIGITAL PCR; AIRBORNE MICROORGANISMS; CONFINEMENT BUILDINGS;
   BIOAEROSOL RELEASES; BACTERIAL DIVERSITY; SWINE MANURE; HEALTH;
   QUANTIFICATION; TETRACYCLINE; INDICATORS}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{wangxuming@baafs.net.cn}},
Funding-Acknowledgement = {{National Key RD Plan Grant {[}2016YFD0800205, 2017YFD0801402]; Beijing
   Agriculture Innovation Consortium {[}BAIC04-2018]; Special Program for
   Creative Ability of Beijing Academy of Agriculture and Forestry Sciences
   {[}20170302]; National Natural Science Foundation of China {[}51308047]}},
Funding-Text = {{This work was supported by the National Key R\&D Plan (Grant No.
   2016YFD0800205, 2017YFD0801402), the Beijing Agriculture Innovation
   Consortium (Grant No. BAIC04-2018), the Special Program for Creative
   Ability of Beijing Academy of Agriculture and Forestry Sciences (Grant
   No. 20170302), and the National Natural Science Foundation of China
   (Grant No. 51308047).}},
Cited-References = {{Cao YP, 2015, WATER RES, V70, P337, DOI 10.1016/j.watres.2014.12.008.
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303.
   Cave L, 2016, APPL MICROBIOL BIOT, V100, P10597, DOI 10.1007/s00253-016-7950-5.
   Cheng WX, 2013, ENVIRON INT, V61, P1, DOI 10.1016/j.envint.2013.08.023.
   D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800.
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI {[}10.1038/nmeth.2604, 10.1038/NMETH.2604].
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381.
   Fang H, 2015, ENVIRON SCI TECHNOL, V49, P1095, DOI 10.1021/es504157v.
   Fischer G, 2008, INT J HYG ENVIR HEAL, V211, P132, DOI 10.1016/j.ijheh.2007.05.003.
   Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377.
   Frohlich-Nowoisky J, 2016, ATMOS RES, V182, P346, DOI 10.1016/j.atmosres.2016.07.018.
   Gao M, 2017, ENVIRON POLLUT, V220, P1342, DOI 10.1016/j.envpol.2016.10.101.
   Gillings MR, 2017, CURR OPIN MICROBIOL, V38, P10, DOI 10.1016/j.mib.2017.03.002.
   Gillings MR, 2014, MICROBIOL MOL BIOL R, V78, P257, DOI 10.1128/MMBR.00056-13.
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g.
   Hong PY, 2012, ENVIRON MICROBIOL, V14, P1420, DOI 10.1111/j.1462-2920.2012.02726.x.
   Hospodsky D, 2010, APPL ENVIRON MICROB, V76, P7004, DOI 10.1128/AEM.01240-10.
   Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151.
   Larney FJ, 2007, BIORESOURCE TECHNOL, V98, P3221, DOI {[}10.1016/j.biortech.2006.07.005, 10.1016/j/biortech.2006.07.005].
   Le Goff O, 2012, ATMOS ENVIRON, V61, P428, DOI 10.1016/j.atmosenv.2012.07.081.
   Le Goff O, 2011, ATMOS ENVIRON, V45, P5342, DOI 10.1016/j.atmosenv.2011.06.052.
   Letourneau V, 2010, INT J HYG ENVIR HEAL, V213, P444, DOI 10.1016/j.ijheh.2010.09.008.
   Mbareche H, 2017, SCI TOTAL ENVIRON, V601, P1306, DOI 10.1016/j.scitotenv.2017.05.235.
   Neher DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079512.
   Oppegaard H, 2001, APPL ENVIRON MICROB, V67, P3732, DOI 10.1128/AEM.67.8.3732-3734.2001.
   Peccia J, 2006, ATMOS ENVIRON, V40, P3941, DOI 10.1016/j.atmosenv.2006.02.029.
   Qian X, 2016, BIORESOURCE TECHNOL, V220, P425, DOI 10.1016/j.biortech.2016.08.101.
   Qiao M, 2018, ENVIRON INT, V110, P160, DOI 10.1016/j.envint.2017.10.016.
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219.
   Rothrock MJ, 2013, ADV MICROBIOL, V03, P403, DOI {[}10.4236/aim.2013.35055, DOI 10.4236/AIM.2013.35055].
   Ruzer L.S., 2012, AEROSOLS HDB MEASURE, P286.
   Sanders R, 2011, ANAL CHEM, V83, P6474, DOI 10.1021/ac103230c.
   Selvam A, 2012, BIORESOURCE TECHNOL, V126, P383, DOI 10.1016/j.biortech.2012.03.045.
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303.
   Stegrnann E, 2015, INT J MED MICROBIOL, V305, P190, DOI 10.1016/j.ijmm.2014.12.015.
   Su JQ, 2015, ENVIRON SCI TECHNOL, V49, P7356, DOI 10.1021/acs.est.5b01012.
   Sykes P, 2007, RESOUR CONSERV RECY, V52, P410, DOI 10.1016/j.resconrec.2007.05.005.
   Taha MPM, 2006, ATMOS ENVIRON, V40, P1159, DOI 10.1016/j.atmosenv.2005.11.010.
   Taha MPM, 2005, WASTE MANAGE, V25, P445, DOI 10.1016/j.wasman.2005.02.013.
   van Kampen V, 2016, OCCUP ENVIRON MED, V73, P829, DOI 10.1136/oemed-2016-103692.
   Verhaegen B, 2016, TOXINS, V8, DOI 10.3390/toxins8050157.
   Vlassov VV, 2007, BIOESSAYS, V29, P654, DOI 10.1002/bies.20604.
   Walser SM, 2015, INT J HYG ENVIR HEAL, V218, P577, DOI 10.1016/j.ijheh.2015.07.004.
   Wang J, 2015, ENVIRON SCI-PROC IMP, V17, P1654, DOI 10.1039/c5em00132c.
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07.
   Wery N, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00042.
   Whale AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058177.
   Xie WY, 2016, ENVIRON POLLUT, V219, P182, DOI 10.1016/j.envpol.2016.10.044.
   Xu SW, 2016, J ENVIRON QUAL, V45, P528, DOI 10.2134/jeq2015.03.0146.
   Yamamoto N, 2012, ISME J, V6, P1801, DOI 10.1038/ismej.2012.30.
   Yang QX, 2014, ENVIRON SCI POLLUT R, V21, P1231, DOI 10.1007/s11356-013-1994-1.
   Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163.
   Zhang YP, 2013, ENVIRON SCI TECHNOL, V47, P10206, DOI 10.1021/es401964s.
   Zhu YG, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.270.
   Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110.}},
Number-of-Cited-References = {{55}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{28}},
Usage-Count-Since-2013 = {{28}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{GG5OG}},
Unique-ID = {{ISI:000432745000026}},
DA = {{2018-08-13}},
}

@article{ ISI:000431387100062,
Author = {Viegas, Carla and Monteiro, Ana and dos Santos, Mateus and Faria, Tiago
   and Caetano, Liliana Aranha and Carolino, Elisabete and Gomes, Anita
   Quintal and Marchand, Genevieve and Lacombe, Nancy and Viegas, Susana},
Title = {{Filters from taxis air conditioning system: A tool to characterize
   driver's occupational exposure to bioburden?}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2018}},
Volume = {{164}},
Pages = {{522-529}},
Month = {{JUL}},
Abstract = {{Bioburden proliferation in filters from air conditioning systems of
   taxis represents a possible source of occupational exposure. The aim of
   this study was to determine the occurrence of fungi and bacteria in
   filters from the air conditioning system of taxis used for patient
   transportation and to assess the exposure of drivers to bioburden.
   Filters from the air conditioning systems of 19 taxis and 28 personal
   vehicles (used as controls) operating in three Portuguese cities
   including the capital Lisbon, were collected during the winter season.
   The occurrence and significance of bioburden detected in the different
   vehicles are reported and discussed in terms of colony-forming units
   (CFU) per 1 m(2) of filter area and by the identification of the most
   frequently detected fungal isolates based on morphology. Azole-resistant
   mycobiota, fungal biomass, and molecular detection of Aspergillus
   species/strains were also determined. Bacterial growth was more
   prevalent in taxis (63.2\%) than in personal vehicles (26.3\%), whereas
   fungal growth was more prevalent in personal vehicles (53.6\%) than in
   taxis (21.1-31.6\%). Seven different azole-resistant species were
   identified in this study in 42.1\% taxi filters. Levels of fungal
   biomass were above the detection limit in 63\% taxi filters and in 75\%
   personal vehicle filters. No toxigenic species were detected by
   molecular analysis in the assessed filters. The results obtained show
   that bioburden proliferation occurs widely in filters from the air
   conditioning systems of taxis, including the proliferation of
   azole-resistant fungal species, suggesting that filters should be
   replaced more frequently. The use of culture based-methods and molecular
   tools combined enabled an improved risk characterization in this
   setting.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Viegas, C (Reprint Author), Inst Politecn Lisboa, ESTeSL Escola Super Tecnol Saude Lisboa, GIAS, Lisbon, Portugal.
   Viegas, Carla; Monteiro, Ana; dos Santos, Mateus; Faria, Tiago; Caetano, Liliana Aranha; Carolino, Elisabete; Gomes, Anita Quintal; Viegas, Susana, Inst Politecn Lisboa, ESTeSL Escola Super Tecnol Saude Lisboa, GIAS, Lisbon, Portugal.
   Viegas, Carla; Viegas, Susana, Univ Nova Lisboa, Ctr Invest Saude Publ, Escola Nacl Saude Publ, Lisbon, Portugal.
   Faria, Tiago, Univ Lisbon, Inst Super Tecn, Ctr Ciencias \& Tecnol Nucl, EN 10 Ao Km 139,7, P-2695066 Bobadela Lrs, Portugal.
   Caetano, Liliana Aranha, Univ Lisbon, Fac Pharm, Res Inst Med, iMed ULisboa, Lisbon, Portugal.
   Gomes, Anita Quintal, Univ Lisbon, Inst Mol Med, Fac Med, Lisbon, Portugal.
   Marchand, Genevieve; Lacombe, Nancy, Inst Rech Robert Sauve Sante \& Securite Travail, Montreal, PQ, Canada.}},
DOI = {{10.1016/j.envres.2018.03.032}},
ISSN = {{0013-9351}},
EISSN = {{1096-0953}},
Keywords = {{Taxis drivers; Occupational exposure; Bioburden; Filters from air
   conditioning system; Aspergillus sp.}},
Keywords-Plus = {{FUNGAL CONTAMINATION; AIRBORNE FUNGAL; ASPERGILLUS-FUMIGATUS; MICROBIAL
   COMMUNITIES; INDOOR ENVIRONMENT; NITROGEN-DIOXIDE; DRUG-RESISTANCE;
   BACTERIAL; BIOAEROSOLS; ENDOTOXIN}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{carla.viegas@estesl.ipl.pt}},
ResearcherID-Numbers = {{iMed.ULisboa, NanoBB/B-5393-2014
   }},
ORCID-Numbers = {{Aranha Caetano, Liliana/0000-0003-1496-2609}},
Funding-Acknowledgement = {{Instituto Politecnico de Lisboa, Lisbon, Portugal
   {[}IPL/2016/W2E\_ESTeSL]}},
Funding-Text = {{The authors are grateful to Instituto Politecnico de Lisboa, Lisbon,
   Portugal for funding the Project ``Waste Workers' Exposure to Bioburden
   in the Truck Cab during Waste Management - W2E Bioburden{''}
   (IPL/2016/W2E\_ESTeSL) and also to the companies that provided the taxis
   and control filters.}},
Cited-References = {{AMANN RI, 1995, MICROBIOL REV, V59, P143.
   {[}Anonymous], 2017, Nat Microbiol, V2, P17120, DOI 10.1038/nmicrobiol.2017.120.
   Arendrup M. C., 2013, CLIN MICROBIOL INFEC, V19, P278, DOI {[}10.1111/1469-0691.12148, DOI 10.1111/1469-0691.12148].
   Bergwall C, 2002, ZUCKERINDUSTRIE, V127, P259.
   Bhabhra R, 2005, MED MYCOL, V43, pS87, DOI 10.1080/13693780400029486.
   Brodzik K, 2014, J ENVIRON SCI-CHINA, V26, P1052, DOI 10.1016/S1001-0742(13)60459-3.
   BUTTNER MP, 1993, APPL ENVIRON MICROB, V59, P219.
   Chmielowiec-Korzeniowska A, 2016, ANN AGR ENV MED, V23, P54, DOI 10.5604/12321966.1196852.
   Cruz-Perez P, 2001, MOL CELL PROBE, V15, P81, DOI 10.1006/mcpr.2000.0343.
   De Hoog G. S., 2000, ATLAS CLIN FUNGI, P1, DOI 10.1093/annhyg/meg032.
   Degois J, 2017, ANN WORK EXPOS HEAL, V61, P1076, DOI 10.1093/annweh/wxx075.
   Diekmann N, 2013, APPL MICROBIOL BIOT, V97, P8777, DOI 10.1007/s00253-012-4564-4.
   Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032.
   Dudakova A, 2017, CLIN MICROBIOL REV, V30, P1065, DOI 10.1128/CMR.00095-16.
   Eduard W, 2001, OCCUP ENVIRON MED, V58, P113, DOI 10.1136/oem.58.2.113.
   Eduard W, 2009, SCAND J WORK ENV H S, V7, P30, DOI DOI 10.1093/ANNHYG/MEG032.
   Eduard W, 2012, J ENVIRON MONITOR, V14, P334, DOI 10.1039/c2em10717a.
   Fairlamb AH, 2016, NAT MICROBIOL, V1, DOI {[}10.1038/NMICROBIOL.2016.92, 10.1038/nmicrobiol.2016.92].
   FOGELMARK B, 1994, INT J EXP PATHOL, V75, P85.
   Gorny RL, 2016, INT J OCCUP MED ENV, V29, P255, DOI 10.13075/ijomeh.1896.00630.
   Goyal SM, 2011, AM J INFECT CONTROL, V39, pE30, DOI 10.1016/j.ajic.2010.10.036.
   Goyer N., 2001, 83 IRSST, P83.
   Hamada N, 2002, ATMOS ENVIRON, V36, P5443, DOI 10.1016/S1352-2310(02)00661-1.
   Heidelberg JF, 1997, APPL ENVIRON MICROB, V63, P3585.
   Janicka A, 2011, POL J ENVIRON STUD, V20, P100.
   Jo WK, 2008, ARCH ENVIRON OCCUP H, V63, P101, DOI 10.3200/AEOH.63.3.101-107.
   Jo WK, 2001, ENVIRON RES, V86, P66, DOI 10.1006/enrs.2001.4257.
   Knibbs LD, 2012, ENVIRON INT, V49, P110, DOI 10.1016/j.envint.2012.08.013.
   Knibbs LD, 2010, ENVIRON SCI TECHNOL, V44, P3546, DOI 10.1021/es9038209.
   Kontoyiannis DP, 2012, AM J MED, V125, pS25, DOI 10.1016/j.amjmed.2011.10.009.
   KUMAR P, 1990, ANN ALLERGY, V64, P174.
   Lewne M, 2006, INT ARCH OCC ENV HEA, V79, P220, DOI 10.1007/s00420-005-0047-6.
   Li J, 2013, ENVIRON SCI TECHNOL, V47, P10660, DOI 10.1021/es402848d.
   Liu CM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-255.
   Luksamijarulkul Pipat, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1032.
   Luksamijarulkul Pipat, 2004, Journal of the Medical Association of Thailand, V87, P697.
   Madureira J, 2015, ATMOS ENVIRON, V109, P139, DOI 10.1016/j.atmosenv.2015.03.026.
   Maus R, 2001, ATMOS ENVIRON, V35, P105, DOI 10.1016/S1352-2310(00)00280-6.
   Mayer Z, 2003, INT J FOOD MICROBIOL, V82, P143, DOI 10.1016/S0168-1605(02)00250-7.
   Meletiadis J, 2013, CURR FUNGAL INFECT R, V7, P351, DOI 10.1007/s12281-013-0155-9.
   Miaskiewicz-Peska E, 2011, FIBRES TEXT EAST EUR, V19, P73.
   Mille-Lindblom C, 2006, OIKOS, V113, P233, DOI 10.1111/j.2006.0030-1299.14337.x.
   Miller-Schulze JP, 2010, ENVIRON SCI TECHNOL, V44, P216, DOI 10.1021/es802392u.
   Noris F, 2011, ATMOS ENVIRON, V45, P338, DOI 10.1016/j.atmosenv.2010.10.017.
   Nowakowicz-Debek B, 2017, J OCCUP ENVIRON HYG, V14, pD169, DOI 10.1080/15459624.2017.1339165.
   O'Donoghue RT, 2007, ENVIRON INT, V33, P1, DOI 10.1016/j.envint.2006.05.005.
   Oppliger A, 2014, ANN OCCUP HYG, V58, P661, DOI 10.1093/annhyg/meu042.
   Pang XB, 2007, ATMOS ENVIRON, V41, P1819, DOI 10.1016/j.atmosenv.2006.10.057.
   Prakash N. K. U., 2014, British Microbiology Research Journal, V4, P282.
   Prussin AJ, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0144-z.
   Ramos CA, 2016, INDOOR BUILT ENVIRON, V25, P872, DOI 10.1177/1420326X15587954.
   Ross MA, 2000, ALLERGY, V55, P705, DOI 10.1034/j.1398-9995.2000.00551.x.
   Rylander R., 1997, INT J OCCUP ENV HEAL, V3, P1.
   Samson RA, 2000, INTRO FOOD AIRBORNE, P1, DOI {[}10.4103/0255-0857.43555, DOI 10.4103/0255-0857.43555].
   Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x.
   Simmons RB, 1999, CURR MICROBIOL, V39, P141, DOI 10.1007/s002849900435.
   Som D, 2007, SCI TOTAL ENVIRON, V372, P426, DOI 10.1016/j.scitotenv.2006.09.025.
   Son B, 2004, ENVIRON RES, V94, P291, DOI 10.1016/j.envres.2003.08.004.
   Srikanth P, 2008, INDIAN J MED MICROBI, V26, P302, DOI 10.4103/0255-0857.43555.
   Stephenson RE, 2014, BIOFOULING, V30, P337, DOI 10.1080/08927014.2013.873418.
   Su HJJ, 2002, ENVIRON RES, V89, P58, DOI 10.1006/enrs.2002.4345.
   Subbarao P, 2009, CMAJ, V181, P181, DOI DOI 10.1503/CMAJ.080612.
   Syed ST, 2013, J COMMUN HEALTH, V38, P976, DOI 10.1007/s10900-013-9681-1.
   United States Environmental Protection Agency (EPA), 2017, NAT EXP RES LAB NERL.
   Varga Janos, 2015, Acta Biologica Szegediensis, V59, P151.
   Vermeulen E, 2015, ANTIMICROB AGENTS CH, V59, P4569, DOI 10.1128/AAC.00233-15.
   Viegas C, 2016, OCCUPATIONAL SAFETY AND HYGIENE IV, P11.
   Viegas C, 2014, J TOXICOL ENV HEAL A, V77, P90, DOI 10.1080/15287394.2014.866925.
   Viegas C., 2017, P INT S OCC SAF HYG, P40.
   Viegas C., 2015, P INT S OCC SAF HYG.
   Viegas C, 2017, HEALTHCARE, V5, DOI 10.3390/healthcare5020024.
   Viegas C, 2017, MYCOTOXIN RES, V33, P285, DOI 10.1007/s12550-017-0288-8.
   Viegas C, 2017, J OCCUP ENVIRON HYG, V14, P771, DOI 10.1080/15459624.2017.1334901.
   Viegas C, 2016, MED PR, V67, P143, DOI 10.13075/mp.5893.00289.
   Viegas C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13030297.
   Vonberg RP, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-146.
   Walser SM, 2015, INT J HYG ENVIR HEAL, V218, P577, DOI 10.1016/j.ijheh.2015.07.004.
   Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258.
   Wang YF, 2013, ARCH ENVIRON OCCUP H, V68, P95, DOI 10.1080/19338244.2011.650798.
   Wang YF, 2011, ENVIRON ENG SCI, V28, P461, DOI 10.1089/ees.2009.0362.
   Wu FFS, 2010, ANN AGR ENV MED, V17, P327.}},
Number-of-Cited-References = {{81}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{9}},
Usage-Count-Since-2013 = {{9}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{GE7CH}},
Unique-ID = {{ISI:000431387100062}},
DA = {{2018-08-13}},
}

@article{ ISI:000434268700001,
Author = {Dutta, Debajyoti},
Title = {{Advance in Research on Mycobacterium tuberculosis FabG4 and Its
   Inhibitor}},
Journal = {{FRONTIERS IN MICROBIOLOGY}},
Year = {{2018}},
Volume = {{9}},
Month = {{JUN 6}},
Abstract = {{Increasing evidence from recent reports of drug-resistant mycobacterial
   strains poses a challenge worldwide. Drug-resistant strains often
   undergo mutations, adopt alternative pathways, and express drug efflux
   pumps to reduce or eliminate drug doses. Besides these intrinsic
   resistance mechanisms, bacteria can evade drug doses by forming
   biofilms. Biofilms are the concerted growth of adherent microorganisms,
   which can also be formed at the air-water interface. The growth is
   supported by the extracellular polymer matrix which is self-produced by
   the microorganisms. Reduced metabolic activity in a nutrient-deficient
   environment in the biofilm may cause the microorganisms to take
   alternative pathways that can make the microorganisms recalcitrant to
   the drug doses. Recent works have shown that Mycobacterium tuberculosis
   expresses several proteins during its growth in biofilm, those when
   deleted, did not show any effect on mycobacterial growth in normal
   nutrient-sufficient conditions. Studying these unconventional proteins
   in mycobacterial biofilms is therefore of utmost importance. In this
   article, I will discuss one such mycobacterial biofilm-related protein
   FabG4 that is recently shown to be important for mycobacterial survival
   in the presence of antibiotic stressors and limited nutrient condition.
   In an attempt to find more effective FabG4 inhibitors and its importance
   in biofilm forming M. tuberculosis, present knowledge about FabG4 and
   its known inhibitors are discussed. Based on the existing data, a
   putative role of FabG4 is also suggested.}},
Publisher = {{FRONTIERS MEDIA SA}},
Address = {{AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Dutta, D (Reprint Author), Univ Alberta, Fac Med \& Dent, Dept Biochem, Edmonton, AB, Canada.
   Dutta, Debajyoti, Univ Alberta, Fac Med \& Dent, Dept Biochem, Edmonton, AB, Canada.}},
DOI = {{10.3389/fmicb.2018.01184}},
Article-Number = {{1184}},
ISSN = {{1664-302X}},
Keywords = {{FabG4; Mycobacterium tuberculosis; biofilm; beta-oxo acyl-ACP reductase;
   inhibitor}},
Keywords-Plus = {{COA REDUCTASE FABG4; ACID BIOSYNTHESIS; PROTEOME ANALYSIS;
   CRYSTAL-STRUCTURE; BIOFILM FORMATION; MYCOLIC ACIDS; CELL-WALL; HTDX;
   METABOLISM; EXPRESSION}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{ddutta@ualberta.ca}},
ResearcherID-Numbers = {{Dutta, Debajyoti/E-2798-2018}},
ORCID-Numbers = {{Dutta, Debajyoti/0000-0003-0403-2192}},
Cited-References = {{Banerjee DR, 2015, BIOORG MED CHEM LETT, V25, P1343, DOI 10.1016/j.bmcl.2015.01.014.
   Banerjee DR, 2015, EUR J MED CHEM, V100, P223, DOI 10.1016/j.ejmech.2015.06.007.
   Banerjee DR, 2014, ORG BIOMOL CHEM, V12, P73, DOI 10.1039/c3ob41676c.
   Beste DJV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005349.
   Biswas R, 2013, ACTA CRYSTALLOGR F, V69, P1110, DOI 10.1107/S1744309113023452.
   Bonnett SA, 2013, CHEM BIOL, V20, P772, DOI 10.1016/j.chembiol.2013.04.014.
   Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200.
   Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023.
   Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006.
   Cukier CD, 2013, ACS CHEM BIOL, V8, P2518, DOI 10.1021/cb4005063.
   Dutta D, 2013, BIOCHEM J, V450, P127, DOI 10.1042/BJ20121107.
   Dutta D, 2012, PROTEINS, V80, P1250, DOI 10.1002/prot.24024.
   Dutta D, 2011, J STRUCT BIOL, V174, P147, DOI 10.1016/j.jsb.2010.11.012.
   Gu S, 2003, MOL CELL PROTEOMICS, V2, P1284, DOI 10.1074/mcp.M300060-MCP200.
   Gurvitz A, 2009, MOL GENET GENOMICS, V282, P407, DOI 10.1007/s00438-009-0474-2.
   Gurvitz A, 2009, J BACTERIOL, V191, P2683, DOI 10.1128/JB.01046-08.
   Hartkoorn RC, 2014, NAT CHEM BIOL, V10, P96, DOI 10.1038/nchembio.1405.
   Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200.
   Islam MS, 2012, EXPERT REV ANTI-INFE, V10, P1055, DOI {[}10.1586/ERI.12.88, 10.1586/eri.12.88].
   Jones A. C., 1896, REP 66 M BRIT ASS AD, P1015.
   Jungblut PR, 1999, MOL MICROBIOL, V33, P1103, DOI 10.1046/j.1365-2958.1999.01549.x.
   Kerns PW, 2014, PATHOG DIS, V70, P347, DOI 10.1111/2049-632X.12142.
   Marrakchi H, 2002, MICROBIOL-SGM, V148, P951, DOI 10.1099/00221287-148-4-951.
   Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011.
   Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012.
   Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x.
   Pacheco SA, 2013, J BIOL CHEM, V288, P24213, DOI 10.1074/jbc.M113.473371.
   Rastogi S, 2017, MICROBIOL-SGM, V163, P52, DOI 10.1099/mic.0.000417.
   Rosenkrands I, 2000, ELECTROPHORESIS, V21, P3740, DOI 10.1002/1522-2683(200011)21:17<3740::AID-ELPS3740>3.0.CO;2-3.
   Sacco E, 2010, J BACTERIOL, V192, P4037, DOI 10.1128/JB.00386-10.
   Sambandan D, 2013, MBIO, V4, DOI 10.1128/mBio.00222-13.
   Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100.
   Sharma P, 2010, INDIAN J MED RES, V132, P400.
   Singh Amit, 2016, Int J Mycobacteriol, V5 Suppl 1, pS123, DOI 10.1016/j.ijmyco.2016.10.028.
   Singh P, 2017, ACS OMEGA, V2, P8453, DOI 10.1021/acsomega.7b01281.
   Sinha S, 2002, COMPAR FUNCT GENOM, V3, P470, DOI 10.1002/cfg.211.
   Verma R, 2017, J PROTEOME RES, V16, P1632, DOI 10.1021/acs.jproteome.6b00983.
   Wickramasinghe SR, 2006, BIOCHEM J, V393, P447, DOI 10.1042/BJ20050832.
   Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{Front. Microbiol.}},
Doc-Delivery-Number = {{GI3JX}},
Unique-ID = {{ISI:000434268700001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000439368100017,
Author = {Ruan, Zhe and Guo, Yajun and Gao, Jing and Yang, Chunjun and Lan, Yan
   and Shen, Jie and Xu, Zimu and Cheng, Cheng and Liu, Xinghao and Zhang,
   Shumei and Du, Wenhui and Chu, Paul K.},
Title = {{Control of multidrug-resistant planktonic Acinetobacter baumannii:
   biocidal efficacy study by atmospheric-pressure air plasma}},
Journal = {{PLASMA SCIENCE \& TECHNOLOGY}},
Year = {{2018}},
Volume = {{20}},
Number = {{6}},
Month = {{JUN}},
Abstract = {{In this research, an atmospheric-pressure air plasma is used to
   inactivate the multidrug-resistant Acinetobacter baumannii in liquid.
   The efficacy of the air plasma on bacterial deactivation and the
   cytobiological variations after the plasma treatment are investigated.
   According to colony forming units, nearly all the bacteria (6-log) are
   inactivated after 10 min of air plasma treatment. However, 7\% of the
   bacteria enter a viable but non-culturable state detected by the
   resazurin based assay during the same period of plasma exposure.
   Meanwhile, 86\% of the bacteria lose their membrane integrity in the
   light of SYTO 9/PI staining assay. The morphological changes in the
   cells are examined by scanning electron microscopy and bacteria with
   morphological changes are rare after plasma exposure in the liquid. The
   concentrations of the long-living RS, such as H2O2, NO3-, and O-3, in
   liquid induced by plasma treatment are measured, and they increase with
   plasma treatment time. The changes of the intracellular ROS may be
   related to cell death, which may be attributed to oxidative stress and
   other damage effects induced by RS plasma generated in liquid. The rapid
   and effective bacteria inactivation may stem from the RS in the liquid
   generated by plasma and air plasmas may become a valuable therapy in the
   treatment of infected wounds.}},
Publisher = {{IOP PUBLISHING LTD}},
Address = {{TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Yang, CJ (Reprint Author), Anhui Med Univ, Affiliated Hosp 2, Dept Dermatol, Hefei 230601, Anhui, Peoples R China.
   Cheng, C (Reprint Author), Chinese Acad Sci, Inst Plasma Phys, Hefei 230031, Anhui, Peoples R China.
   Chu, PK (Reprint Author), City Univ Hong Kong, Dept Phys, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
   Chu, PK (Reprint Author), City Univ Hong Kong, Dept Mat Sci \& Engn, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
   Ruan, Zhe; Guo, Yajun; Gao, Jing; Yang, Chunjun, Anhui Med Univ, Affiliated Hosp 2, Dept Dermatol, Hefei 230601, Anhui, Peoples R China.
   Lan, Yan; Shen, Jie; Cheng, Cheng, Chinese Acad Sci, Inst Plasma Phys, Hefei 230031, Anhui, Peoples R China.
   Xu, Zimu; Liu, Xinghao, Hefei Univ Technol, Sch Resources \& Environm Engn, Hefei 230009, Anhui, Peoples R China.
   Zhang, Shumei; Du, Wenhui, Anhui Med Univ, Affiliated Hosp 1, Dept Dermatol, Hefei 230032, Anhui, Peoples R China.
   Chu, Paul K., City Univ Hong Kong, Dept Phys, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
   Chu, Paul K., City Univ Hong Kong, Dept Mat Sci \& Engn, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.}},
DOI = {{10.1088/2058-6272/aab302}},
Article-Number = {{UNSP 065513}},
ISSN = {{1009-0630}},
Keywords = {{atmospheric-pressure air plasma; multidrug-resistant bacteria;
   Acinetobacter baumannii; inactivation; reactive species}},
Keywords-Plus = {{BARRIER DISCHARGE PLASMA; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS;
   NONCULTURABLE STATE; NONTHERMAL PLASMA; WATER; INACTIVATION;
   COMBINATION; MECHANISM; MICROJET}},
Research-Areas = {{Physics}},
Web-of-Science-Categories  = {{Physics, Fluids \& Plasmas}},
Author-Email = {{yangchunjun9@163.com
   chengcheng@ipp.ac.cn
   paul.chu@cityu.edu.hk}},
ResearcherID-Numbers = {{Chu, Paul/B-5923-2013}},
ORCID-Numbers = {{Chu, Paul/0000-0002-5581-4883}},
Funding-Acknowledgement = {{Spark Program of the second Affiliated Hospital of Anhui Medical
   University {[}2015hhjh04]; National Natural Science Foundation of China
   {[}51777206]; Natural Science Foundation of Anhui Province
   {[}1708085MA13, 1708085MB47]; Science Foundation of Institute of Plasma
   Physics, Chinese Academy of Sciences {[}DSJJ-14-YY02]; City University
   of Hong Kong Applied Research Grant (ARG) {[}9667144]; Hong Kong
   Research Grants Council (RGC) General Research Funds (GRF) {[}CityU
   11301215]; Doctoral Fund of Ministry of Education of China
   {[}2017M612058]; Specialized Research Fund for the Doctoral Program of
   Hefei University of Technology {[}JZ2016HGBZ0768]; Foundation of Anhui
   Province Key Laboratory of Medical Physics and Technology
   {[}LMPT2017Y7BP0U1581]}},
Funding-Text = {{This work is supported by the Spark Program of the second Affiliated
   Hospital of Anhui Medical University (Grant No. 2015hhjh04), National
   Natural Science Foundation of China under Grant No. 51777206, Natural
   Science Foundation of Anhui Province (Grant No. 1708085MA13 and No.
   1708085MB47), Science Foundation of Institute of Plasma Physics, Chinese
   Academy of Sciences under Grant (No. DSJJ-14-YY02), City University of
   Hong Kong Applied Research Grant (ARG) (No. 9667144), Hong Kong Research
   Grants Council (RGC) General Research Funds (GRF) (No. CityU 11301215),
   Doctoral Fund of Ministry of Education of China (No. 2017M612058),
   Specialized Research Fund for the Doctoral Program of Hefei University
   of Technology (No. JZ2016HGBZ0768), Foundation of Anhui Province Key
   Laboratory of Medical Physics and Technology (Grant No.
   LMPT2017Y7BP0U1581).}},
Cited-References = {{Anton Y P, 2008, CLIN MICROBIOL REV, V21, P538.
   Arjunan KP, 2011, PLASMA PROCESS POLYM, V8, P1154, DOI 10.1002/ppap.201100078.
   Bai N, 2011, PLASMA PROCESS POLYM, V8, P424, DOI 10.1002/ppap.201000078.
   Baier M, 2013, POSTHARVEST BIOL TEC, V84, P81, DOI 10.1016/j.postharvbio.2013.03.022.
   Besnard V, 2002, VET RES, V33, P359, DOI 10.1051/vetres:2002022.
   Brisset JL, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034021.
   Cook KL, 2007, J APPL MICROBIOL, V103, P573, DOI 10.1111/j.1365-2672.2006.03285.x.
   Cooper M, 2010, J APPL MICROBIOL, V109, P2039, DOI 10.1111/j.1365-2672.2010.04834.x.
   Cui Y, 2012, BIOMATERIALS, V33, P2327, DOI 10.1016/j.biomaterials.2011.11.057.
   David S, 2008, PLASMA SOURCES SCI T, V17.
   Dolezalova E, 2015, BIOELECTROCHEMISTRY, V103, P7, DOI 10.1016/j.bioelechem.2014.08.018.
   Graham WG, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/17/174037.
   Guerrero DM, 2010, SURG INFECT, V11, P49, DOI 10.1089/sur.2009.022.
   GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819.
   Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700.
   Ikawa S, 2010, PLASMA PROCESS POLYM, V7, P33, DOI 10.1002/ppap.200900090.
   Jamroz P, 2014, PLASMA PROCESS POLYM, V11, P755, DOI 10.1002/ppap.201400012.
   Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002.
   Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270.
   Keidar M, 2015, PHYS PLASMAS, V22, DOI 10.1063/1.4933406.
   Keidar M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4801516.
   Kelly KN, 2012, SURGERY, V30, P640.
   Krause M, 2008, ANAL CHEM, V80, P8568, DOI 10.1021/ac8014559.
   Kuo SP, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115016.
   Lefebre MD, 2001, MICROBIOL-SGM, V147, P97, DOI 10.1099/00221287-147-1-97.
   LI Y, 2017, SCI REP, V7.
   Liu XF, 2016, INT J ANTIMICROB AG, V48, P559, DOI 10.1016/j.ijantimicag.2016.07.018.
   LIU Y, 2017, SCI REP, V7.
   Locke BR, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034006.
   Lu X, 2016, PHYS REP, V630, P1, DOI 10.1016/j.physrep.2016.03.003.
   Lu X, 2014, PHYS REP, V540, P123, DOI 10.1016/j.physrep.2014.02.006.
   Lukes P, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/1/015019.
   Machala Z, 2013, PLASMA PROCESS POLYM, V10, P649, DOI 10.1002/ppap.201200113.
   MENG LK, 2015, FEMS MICROBIOL ECOL, V25.
   Moisan M, 2002, PURE APPL CHEM, V74, P349, DOI 10.1351/pac200274030349.
   Muela A, 2008, FEMS MICROBIOL ECOL, V64, P28, DOI 10.1111/j.1574-6941.2008.00453.x.
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x.
   Pittet D, 2008, LANCET INFECT DIS, V8, P585, DOI 10.1016/S1473-3099(08)70208-1.
   Rashmei Z, 2016, J WATER HEALTH, V14, P609, DOI 10.2166/wh.2016.216.
   Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481.
   Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148.
   Roxana S T, 2011, IEEE T PLASMA SCI, V39, P2978.
   Ruef J, 1997, CIRC RES, V81, P24.
   Shang KF, 2017, PLASMA SCI TECHNOL, V19, DOI 10.1088/2058-6272/aa6616.
   Shen J, 2015, PLASMA PROCESS POLYM, V12, P252, DOI 10.1002/ppap.201400129.
   Shen J, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.110310.
   Tang YZ, 2008, PLASMA PROCESS POLYM, V5, P552, DOI 10.1002/ppap.200800014.
   Wang YY, 2017, PLASMA SCI TECHNOL, V19, DOI 10.1088/2058-6272/19/2/025503.
   Wu HY, 2012, PLASMA PROCESS POLYM, V9, P417, DOI 10.1002/ppap.201100065.
   Wu SQ, 2010, IEEE T PLASMA SCI, V38, P3404, DOI 10.1109/TPS.2010.2082571.
   Xu D, 2017, PLASMA SCI TECHNOL, V19, DOI 10.1088/2058-6272/aa61f6.
   Xu ZM, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa593f.
   Xu ZM, 2015, PLASMA PROCESS POLYM, V12, P827, DOI 10.1002/ppap.201500006.
   Xu ZM, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4921754.
   Zhang H, 2015, SCI REP-UK, V5, DOI 10.1038/srep10031.
   Zhao Y, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3588036.}},
Number-of-Cited-References = {{56}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Plasma Sci. Technol.}},
Doc-Delivery-Number = {{GN7YV}},
Unique-ID = {{ISI:000439368100017}},
DA = {{2018-08-13}},
}

@article{ ISI:000436128700011,
Author = {Elbadawy, Mohamed and Usui, Tatsuya and Yamawaki, Hideyuki and Sasaki,
   Kazuaki},
Title = {{Development of an Experimental Model for Analyzing Drug Resistance in
   Colorectal Cancer}},
Journal = {{CANCERS}},
Year = {{2018}},
Volume = {{10}},
Number = {{6}},
Month = {{JUN}},
Abstract = {{Colorectal cancer (CRC) is one of the most common cancers, for which
   combination treatment of chemotherapy is employed. However, most
   patients develop drug resistance during the course of treatment. To
   clarify the mechanisms of drug resistance, various research models have
   been developed. Recently, we established a human CRC patients-derived
   three-dimensional (3D) culture system using an air-liquid interface
   organoid method. It contained numerous cancer stem cells and showed
   resistance to 5-fluorouracil and Irinotecan. In this review, we
   introduce conventional and our established models for studying drug
   resistance in CRC.}},
Publisher = {{MDPI}},
Address = {{ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Usui, T (Reprint Author), Tokyo Univ Agr \& Technol, Fac Agr, Dept Vet Med, Lab Vet Pharmacol, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.
   Elbadawy, Mohamed; Usui, Tatsuya; Sasaki, Kazuaki, Tokyo Univ Agr \& Technol, Fac Agr, Dept Vet Med, Lab Vet Pharmacol, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.
   Elbadawy, Mohamed, Benha Univ, Fac Vet Med, Dept Pharmacol, Toukh 13736, Elqaliobiya, Egypt.
   Yamawaki, Hideyuki, Kitasato Univ, Sch Vet Med, Lab Vet Pharmacol, Towada, Aomori 0348628, Japan.}},
DOI = {{10.3390/cancers10060164}},
Article-Number = {{164}},
ISSN = {{2072-6694}},
Keywords = {{3D cell culture; colorectal cancer; drug resistance; cancer stem cells}},
Keywords-Plus = {{RESEARCH-AND-DEVELOPMENT; STEM-CELL NICHE; GROWTH-FACTOR; HUMAN COLON;
   TARGETED THERAPY; CHEMOTHERAPY; PRODUCTIVITY; STATISTICS; MECHANISMS;
   CETUXIMAB}},
Research-Areas = {{Oncology}},
Web-of-Science-Categories  = {{Oncology}},
Author-Email = {{mohamed.elbadawy@fvtm.bu.edu.eg
   fu7085@go.tuat.ac.jp
   yamawaki@vmas.kitasato-u.ac.jp
   skazuaki@cc.tuat.ac.jp}},
ORCID-Numbers = {{Elbadawy, Mohamed/0000-0001-9368-1535}},
Funding-Acknowledgement = {{Japan Society for the Promotion of Science {[}17K15370]}},
Funding-Text = {{This study was supported in part by a Grant for Scientific Research from
   the Japan Society for the Promotion of Science (17K15370 TU).}},
Cited-References = {{Alcindor T, 2011, CURR ONCOL, V18, P18.
   Boman BM, 2008, J CLIN ONCOL, V26, P2828, DOI 10.1200/JCO.2008.17.6941.
   Cartwright TH, 2012, CLIN COLORECTAL CANC, V11, P155, DOI 10.1016/j.clcc.2011.11.001.
   Chen J, 2013, CANCER CHEMOTH PHARM, V71, P265, DOI 10.1007/s00280-012-2005-9.
   Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840.
   Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025.
   Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4.
   Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023.
   Deng Yan-Hong, 2010, Chin J Cancer, V29, P810.
   Donnenberg VS, 2005, J CLIN PHARMACOL, V45, P872, DOI 10.1177/0091270005276905.
   Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498.
   Gill S, 2003, ALIMENT PHARM THERAP, V18, P683, DOI 10.1046/j.1365-2036.2003.01735.x.
   Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706.
   Graudens E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r19.
   Hong SP, 2009, INT J CANCER, V125, P2323, DOI {[}10.1002/ijc.2403, 10.1002/ijc.24573].
   Hu T, 2015, CURR PHARM DESIGN, V21, P2960, DOI 10.2174/1381612821666150514104244.
   Jensen NF, 2012, SCAND J GASTROENTERO, V47, P340, DOI 10.3109/00365521.2012.640835.
   Katano T, 2013, BIOCHEM BIOPH RES CO, V432, P558, DOI 10.1016/j.bbrc.2013.02.051.
   Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470.
   Kolligs FT, 2016, VISC MED, V32, P158, DOI 10.1159/000446488.
   Li CJ, 2014, J CANCER RES THER, V10, pC233, DOI 10.4103/0973-1482.151449.
   Lin L, 2011, BIOCHEM BIOPH RES CO, V416, P246, DOI 10.1016/j.bbrc.2011.10.112.
   Liu Zhen, 2010, Chin J Cancer, V29, P661.
   Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706.
   Mathonnet M, 2014, WORLD J GASTROENTERO, V20, P4189, DOI 10.3748/wjg.v20.i15.4189.
   Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951.
   Pammolli F, 2011, NAT REV DRUG DISCOV, V10, P428, DOI 10.1038/nrd3405.
   Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078.
   Ragnhammar P, 2001, ACTA ONCOL, V40, P282, DOI 10.1080/02841860151116367.
   Rich JN, 2007, CELL STEM CELL, V1, P353, DOI 10.1016/j.stem.2007.09.011.
   Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182.
   Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852.
   Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050.
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957.
   Schatton T, 2009, BIOESSAYS, V31, P1038, DOI 10.1002/bies.200900058.
   Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220.
   Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166.
   Stein A, 2011, EUR J CANCER, V47, pS312, DOI 10.1016/S0959-8049(11)70183-6.
   Tejpar S, 2012, ONCOLOGIST, V17, P1039, DOI 10.1634/theoncologist.2012-0068.
   Todaro M, 2008, CELL CYCLE, V7, P309, DOI 10.4161/cc.7.3.5389.
   Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001.
   Trumpp A, 2008, NAT CLIN PRACT ONCOL, V5, P337, DOI 10.1038/ncponc1110.
   Usui T., 2018, CURR PROTOC TOXICOL, V75, P22.
   Usui T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041098.
   Usui T, 2016, STEM CELLS INT, DOI 10.1155/2016/7053872.
   Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Cancers}},
Doc-Delivery-Number = {{GK4KQ}},
Unique-ID = {{ISI:000436128700011}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000434491800017,
Author = {Mercier, Clement and Hodin, Sophie and He, Zhiguo and Perek, Nathalie
   and Delavenne, Xavier},
Title = {{Pharmacological Characterization of the RPMI 2650 Model as a Relevant
   Tool for Assessing the Permeability of Intranasal Drugs}},
Journal = {{MOLECULAR PHARMACEUTICS}},
Year = {{2018}},
Volume = {{15}},
Number = {{6}},
Pages = {{2246-2256}},
Month = {{JUN}},
Abstract = {{The RPMI 2650 cell line has been described as a potent model of the
   human nasal mucosa. Nevertheless, pharmacological data are still
   insufficient, and the role of drug efflux transporters has not been
   fully elucidated. We therefore pursued the pharmacological
   characterization of this model, initially investigating the expression
   of four well-known adenosine triphosphate {[}ATP]-binding cassette (ABC)
   transporters (P-glycoprotein (P-gp), multidrug resistance associated
   protein (MRP)1, MRP2, and breast cancer resistance protein (BCRP)) by
   means of ELISA and immunofluorescence staining. The functional activity
   of the selected transporters was assessed by accumulation studies based
   on specific substrates and inhibitors. We then performed standardized
   bidirectional transport experiments under air-liquid interface (ALI)
   culture conditions, using four therapeutic compounds of local intranasal
   relevance in upper airway diseases. Protein expression of P-gp, MRP1,
   MRP2, and BCRP was detected at the membrane of the RPMI 2650 cells. In
   addition, all four transporters exhibited functional activity at the
   cellular level. In the bidirectional transport experiments, the RPMI
   2650 model was able to accurately discriminate the four therapeutic
   compounds according to their physicochemical properties. The ABC
   transporters tested did not play a major role in the efflux of these
   compounds at the barrier level. In conclusion, the RPMI 2650 model
   represents a promising tool for assessing the nasal absorption of drugs
   on the basis of preclinical pharmacological data.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mercier, C (Reprint Author), INSERM, Dysfonct Vasc \& Hemostase, U1059, CS 82301, St Etienne, France.
   Mercier, Clement; Hodin, Sophie; Perek, Nathalie; Delavenne, Xavier, INSERM, Dysfonct Vasc \& Hemostase, U1059, CS 82301, St Etienne, France.
   Hodin, Sophie; He, Zhiguo; Perek, Nathalie; Delavenne, Xavier, Univ Lyon, F-42023 St Etienne, France.
   He, Zhiguo, BiiGC, Lab Biol Ingn \& Imagerie Greffe Cornee, EA2521, St Etienne, France.
   Delavenne, Xavier, CHU St Etienne, Lab Pharmacol Toxicol Gaz Sang, CS 82301, St Etienne, France.}},
DOI = {{10.1021/acs.molpharmaceut.8b00087}},
ISSN = {{1543-8384}},
Keywords = {{ABC transporters; bidirectional transport; efflux ratio; permeability;
   RPMI 2650 model}},
Keywords-Plus = {{AIR-LIQUID-INTERFACE; ORGANIC CATION TRANSPORTERS; VITRO NASAL MODEL;
   IN-VITRO; P-GLYCOPROTEIN; CELL-LINE; CHRONIC RHINOSINUSITIS;
   MULTIDRUG-RESISTANCE; CULTURE-CONDITIONS; DELIVERY SYSTEMS}},
Research-Areas = {{Research \& Experimental Medicine; Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Medicine, Research \& Experimental; Pharmacology \& Pharmacy}},
Author-Email = {{c.mercier@univ-st-etienne.fr}},
Cited-References = {{Al-Ghabeish M, 2015, MOL PHARMACEUT, V12, P2742, DOI 10.1021/acs.molpharmaceut.5b00103.
   Allen JD, 2002, MOL CANCER THER, V1, P417.
   Anand U, 2014, FUTURE MED CHEM, V6, P1381, DOI 10.4155/fmc.14.77.
   Anderle P, 1998, J PHARM SCI, V87, P757, DOI 10.1021/js970372e.
   Bachmeier C. J., 2004, BCECF J PHARM SCI, V93, P932.
   Bai S, 2008, J PHARM SCI-US, V97, P1165, DOI 10.1002/jps.21031.
   Beery E, 2012, DRUG METAB PHARMACOK, V27, P349, DOI 10.2133/dmpk.DMPK-11-NT-068.
   Borchard G, 2002, J PHARM SCI, V91, P1561, DOI 10.1002/jps.10151.
   Boucher R C, 1987, Eur J Respir Dis Suppl, V153, P59.
   Chen Justin K, 2017, J Pediatr Pharmacol Ther, V22, P9, DOI 10.5863/1551-6776-22.1.9.
   Dilger K, 2004, INFLAMM BOWEL DIS, V10, P578, DOI 10.1097/00054725-200409000-00012.
   Dolberg AM, 2017, MOL PHARMACEUT, V14, P1577, DOI 10.1021/acs.molpharmaceut.6b00838.
   Dolberg AM, 2016, INT J PHARMACEUT, V508, P22, DOI 10.1016/j.ijpharm.2016.05.010.
   Draper MP, 1997, BRIT J CANCER, V75, P810, DOI 10.1038/bjc.1997.145.
   Estudante M, 2013, ADV DRUG DELIVER REV, V65, P1340, DOI 10.1016/j.addr.2012.09.042.
   Food and Drug Administration. Guidance for Industry, DRUG INT STUD STUD D.
   Foster KA, 2000, INT J PHARM, V208, P1, DOI 10.1016/S0378-5173(00)00452-X.
   Gai ZB, 2016, ANTIMICROB AGENTS CH, V60, P5573, DOI 10.1128/AAC.00907-16.
   Goncalves VSS, 2016, INT J PHARMACEUT, V515, P1, DOI 10.1016/j.ijpharm.2016.09.086.
   Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929.
   Grassin-Delyle S, 2012, PHARMACOL THERAPEUT, V134, P366, DOI 10.1016/j.pharmthera.2012.03.003.
   Hamilton KO, 2001, J PHARM SCI, V90, P647, DOI 10.1002/1520-6017(200105)90:5<647::AID-JPS1021>3.0.CO;2-G.
   HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736.
   Hirohashi T, 2000, J PHARMACOL EXP THER, V292, P265.
   Huang S, 2013, TOXICOL IN VITRO, V27, P1151, DOI 10.1016/j.tiv.2012.10.010.
   Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303.
   Illum L, 2003, J CONTROL RELEASE, V87, P187, DOI 10.1016/S0168-3659(02)00363-2.
   Juel-Berg N, 2017, AM J RHINOL ALLERGY, V31, pE19, DOI 10.2500/ajra.2016.30.4397.
   Kerns E H, 2004, Drug Discov Today Technol, V1, P343, DOI 10.1016/j.ddtec.2004.08.011.
   Kindla J, 2009, EXPERT OPIN DRUG MET, V5, P489, DOI {[}10.1517/17425250902911463 , 10.1517/17425250902911463].
   Kocharyan A, 2014, INT FORUM ALLERGY RH, V4, P734, DOI 10.1002/alr.21361.
   Kodama N, 2016, DRUG METAB DISPOS, V44, P1662, DOI 10.1124/dmd.116.069336.
   Kostrun S, 2017, EUR J MED CHEM, V133, P351, DOI 10.1016/j.ejmech.2017.03.056.
   Kreft ME, 2015, PHARM RES-DORDR, V32, P665, DOI 10.1007/s11095-014-1494-0.
   Lee MK, 2005, DRUG DELIV, V12, P305, DOI 10.1080/10717540500177009.
   Lenz AG, 2014, AM J RESP CELL MOL, V51, P526, DOI 10.1165/rcmb.2013-0479OC.
   Lim ST, 2002, INT J PHARM, V231, P73, DOI 10.1016/S0378-5173(01)00873-0.
   Lu XX, 2018, EUR J PHARM SCI, V115, P132, DOI 10.1016/j.ejps.2018.01.002.
   Mercier C, 2018, EUR J DRUG METAB PH, V43, P13, DOI 10.1007/s13318-017-0426-x.
   MOORHEAD PS, 1965, EXP CELL RES, V39, P190, DOI 10.1016/0014-4827(65)90022-4.
   Mukherjee M, 2012, INT J PHARMACEUT, V426, P7, DOI 10.1016/j.ijpharm.2011.12.036.
   Nickel S, 2016, EXPERT OPIN DRUG DEL, V13, P667, DOI 10.1517/17425247.2016.1140144.
   Nozinic D, 2010, CROAT CHEM ACTA, V83, P323.
   Pires A, 2009, J PHARM PHARM SCI, V12, P288, DOI 10.18433/J3NC79.
   Pozzoli M, 2016, EUR J PHARM BIOPHARM, V107, P223, DOI 10.1016/j.ejpb.2016.07.010.
   Pynnonen MA, 2013, OTOLARYNG HEAD NECK, V148, P366, DOI 10.1177/0194599812470427.
   Reichl S, 2012, J PHARM PHARMACOL, V64, P1621, DOI 10.1111/j.2042-7158.2012.01540.x.
   Rudmik L, 2013, INT FORUM ALLERGY RH, V3, P281, DOI 10.1002/alr.21096.
   Seithel A, 2007, DRUG METAB DISPOS, V35, P779, DOI 10.1124/dmd.106.014407.
   Shao D, 2013, THER DELIV, V4, P439, DOI {[}10.4155/TDE.13.10, 10.4155/tde.13.10].
   Sun HY, 2003, ADV DRUG DELIVER REV, V55, P83, DOI 10.1016/S0169-409X(02)00172-2.
   Tang FX, 2004, J PHARM SCI-US, V93, P1185, DOI 10.1002/jps.20046.
   Togami K, 2011, BIOPHARM DRUG DISPOS, V32, P389, DOI 10.1002/bdd.767.
   TULKENS PM, 1991, EUR J CLIN MICROBIOL, V10, P100, DOI 10.1007/BF01964420.
   Turker S, 2004, PHARM WORLD SCI, V26, P137, DOI 10.1023/B:PHAR.0000026823.82950.ff.
   Wei JL, 2011, LARYNGOSCOPE, V121, P1989, DOI 10.1002/lary.21923.
   Wengst A, 2010, EUR J PHARM BIOPHARM, V74, P290, DOI 10.1016/j.ejpb.2009.08.008.
   Youdim KA, 2003, DRUG DISCOV TODAY, V8, P997, DOI 10.1016/S1359-6446(03)02873-3.
   Zastre J, 2002, EUR J PHARM BIOPHARM, V54, P299, DOI 10.1016/S0939-6411(02)00119-4.
   Zhang DL, 2012, ACTA PHARM SIN B, V2, P549, DOI 10.1016/j.apsb.2012.10.004.}},
Number-of-Cited-References = {{60}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Mol. Pharm.}},
Doc-Delivery-Number = {{GI6PF}},
Unique-ID = {{ISI:000434491800017}},
DA = {{2018-08-13}},
}

@article{ ISI:000433607800001,
Author = {De Vincenti, Luca and Glasenapp, Yvana and Catto, Cristina and Villa,
   Federica and Cappitelli, Francesca and Papenbrock, Jutta},
Title = {{Hindering the formation and promoting the dispersion of medical
   biofilms: non-lethal effects of seagrass extracts}},
Journal = {{BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE}},
Year = {{2018}},
Volume = {{18}},
Month = {{MAY 30}},
Abstract = {{Background: Biofilms have great significance in healthcare-associated
   infections owing to their inherent tolerance and resistance to
   antimicrobial therapies. New approaches to prevent and treat unwanted
   biofilms are urgently required. To this end, three seagrass species
   (Enhalus acoroides, Halophila ovalis and Halodule pinifolia) collected
   in Vietnam and in India were investigated for their effects in mediating
   non-lethal interactions on sessile bacterial (Escherichia coli) and
   fungal (Candida albicans) cultures. The present study was focused on
   anti-biofilm activities of seagrass extracts, without killing cells.
   Methods: Methanolic extracts were characterized, and major compounds
   were identified by MS/MS analysis. The antibiofilm properties of the
   seagrass extracts were tested at sub-lethal concentrations by using
   microtiter plate adhesion assay. The performance of the most promising
   extract was further investigated in elegant bioreactors to reproduce
   mature biofilms both at the solid/liquid and the solid/air interfaces.
   Dispersion and bioluminescent assays were carried out to decipher the
   mode of action of the bioactive extract.
   Results: It was shown that up to 100 ppm of crude extracts did not
   adversely affect microbial growth, nor do they act as a carbon and
   energy source for the selected microorganisms. Seagrass extracts appear
   to be more effective in deterring microbial adhesion on hydrophobic
   surfaces than on hydrophilic. The results revealed that non-lethal
   concentrations of E. acoroides leaf extract: i) reduce bacterial and
   fungal coverage by 60.9 and 73.9\%, respectively; ii) affect bacterial
   biofilm maturation and promote dispersion, up to 70\%, in fungal
   biofilm; iii) increase luminescence in Vibrio harveyi by 25.8\%. The
   characterization of methanolic extracts showed the unique profile of the
   E. acoroides leaf extract.
   Conclusions: E. acoroides leaf extract proved to be the most promising
   extract among those tested. Indeed, the selected non-lethal
   concentrations of E. acoroides leaf extract were found to exert an
   antibiofilm effect on C. albicans and E. coli biofilm in the first phase
   of biofilm genesis, opening up the possibility of developing preventive
   strategies to hinder the adhesion of microbial cells to surfaces. The
   leaf extract also affected the dispersion and maturation steps in C.
   albicans and E. coli respectively, suggesting an important role in cell
   signaling processes.}},
Publisher = {{BMC}},
Address = {{CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Villa, F (Reprint Author), Univ Milan, Dipartimento Sci Alimenti Nutr \& Ambiente, Via Celoria 2, I-20133 Milan, Italy.
   De Vincenti, Luca; Catto, Cristina; Villa, Federica; Cappitelli, Francesca, Univ Milan, Dipartimento Sci Alimenti Nutr \& Ambiente, Via Celoria 2, I-20133 Milan, Italy.
   Glasenapp, Yvana; Papenbrock, Jutta, Leibniz Univ Hannover, Inst Bot, Herrenhauserstr 2, D-30419 Hannover, Germany.}},
DOI = {{10.1186/s12906-018-2232-7}},
Article-Number = {{168}},
ISSN = {{1472-6882}},
Keywords = {{Seagrass extracts; Non-lethal concentrations; Antibiofilm activity;
   Escherichia coli; Candida albicans}},
Keywords-Plus = {{ESCHERICHIA-COLI BIOFILM; CANDIDA-ALBICANS; PLANT-EXTRACTS; SUBLETHAL
   CONCENTRATIONS; ANTIBACTERIAL ACTIVITY; MICROBIAL BIOFILMS;
   MEDICINAL-PLANTS; ZOSTERIC ACID; MARINE-ALGAE; ANTIOXIDANT}},
Research-Areas = {{Integrative \& Complementary Medicine}},
Web-of-Science-Categories  = {{Integrative \& Complementary Medicine}},
Author-Email = {{federica.villa@unimi.it}},
ResearcherID-Numbers = {{Cappitelli, Francesca/H-1492-2015
   }},
ORCID-Numbers = {{CATTO', CRISTINA/0000-0002-3709-1802
   Cappitelli, Francesca/0000-0003-1237-1813
   Villa, Federica/0000-0003-2930-4684}},
Funding-Acknowledgement = {{German-Italian bilateral project ``Bioactive secondary compounds from
   halophyte species inhibit biofilm formation of plant-pathogenic
   microorganisms on plant surfaces{''} (SAB-HAL), MIUR-DAAD Joint Mobility
   Program {[}57265315]}},
Funding-Text = {{This work was supported by the German-Italian bilateral project
   ``Bioactive secondary compounds from halophyte species inhibit biofilm
   formation of plant-pathogenic microorganisms on plant surfaces{''}
   (SAB-HAL), MIUR-DAAD Joint Mobility Program, ID-57265315.}},
Cited-References = {{Abiala M, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1399-z.
   Akbari F, 2015, PATHOGENS, V4, P457, DOI 10.3390/pathogens4030457.
   Amiri A, 2005, PHYSIOL MOL PLANT P, V67, P40, DOI 10.1016/j.pmpp.2005.07.003.
   Bazargani MM, 2016, FOOD CONTROL, V61, P156, DOI 10.1016/j.foodcont.2015.09.036.
   Bisi-Johnson MA, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1802-4.
   Boestfleisch C, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu046.
   Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404.
   Calabrese EJ, 2003, ANNU REV PHARMACOL, V43, P175, DOI 10.1146/annurev.pharmtox.43.100901.140223.
   Catto C, 2017, BIOFOULING, V33, P235, DOI 10.1080/08927014.2017.1286649.
   Catto C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131519.
   Cho HS, 2015, BIOFOULING, V31, P1, DOI 10.1080/08927014.2014.991319.
   Choi Han Gil, 2009, Algae, V24, P179.
   Choi HA, 2017, J MICROBIOL BIOTECHN, V27, P1242, DOI 10.4014/jmb.1701.01026.
   Chung PY, 2017, CURR DRUG TARGETS, V18, P414, DOI 10.2174/1389450117666161019102025.
   Coffey BM, 2014, METHODS MOL BIOL, V1149, P631, DOI 10.1007/978-1-4939-0473-0\_48.
   Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7.
   da Silva DT, 2017, INT BIODETER BIODEGR, V117, P158, DOI 10.1016/j.ibiod.2016.12.007.
   Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08.
   Dewanto V, 2002, J AGR FOOD CHEM, V50, P3010, DOI 10.1021/jf0115589.
   DOSS RP, 1993, APPL ENVIRON MICROB, V59, P1786.
   Dudonne S, 2009, J AGR FOOD CHEM, V57, P1768, DOI 10.1021/jf803011r.
   Elisha IL, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1645-z.
   Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x.
   Flowers TJ, 2015, ANN BOT-LONDON, V115, P327, DOI 10.1093/aob/mcu267.
   Garuglieri E, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02698.
   Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581.
   Gillespie KM, 2007, NAT PROTOC, V2, P867, DOI 10.1038/nprot.2007.100.
   Gokce G, 2008, J ETHNOPHARMACOL, V115, P122, DOI 10.1016/j.jep.2007.09.016.
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821.
   Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777.
   Hua KF, 2006, J AGR FOOD CHEM, V54, P306, DOI 10.1021/jf0509658.
   Huang DJ, 2002, J AGR FOOD CHEM, V50, P4437, DOI 10.1021/jf0201529.
   Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139.
   Joshi R, 2015, ELUCIDATION ABIOTIC, P243, DOI {[}DOI 10.1007/978-1-4939-2540-7\_9, 10.1007/978-1-4939-2540-7\_9].
   Kannan RRR, 2012, FOOD CHEM, V135, P2470, DOI 10.1016/j.foodchem.2012.07.070.
   Koch K, 2009, PROG MATER SCI, V54, P137, DOI 10.1016/j.pmatsci.2008.07.003.
   Ksouri R, 2012, CRIT REV BIOTECHNOL, V32, P289, DOI 10.3109/07388551.2011.630647.
   Kumar CS, 2008, WORLD J MICROB BIOT, V24, P1989, DOI 10.1007/s11274-008-9695-5.
   Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14.
   Lucas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029987.
   LUSTIGMAN B, 1991, B ENVIRON CONTAM TOX, V46, P329, DOI 10.1007/BF01688928.
   Macia MD, 2014, CLIN MICROBIOL INFEC, V20, P981, DOI 10.1111/1469-0691.12651.
   Natrah FMI, 2015, SAINS MALAYS, V44, P1269, DOI 10.17576/jsm-2015-4409-08.
   Nobile CJ, 2015, ANNU REV MICROBIOL, V69, P71, DOI 10.1146/annurev-micro-091014-104330.
   Percival SL, 2015, J MED MICROBIOL, V64, P323, DOI 10.1099/jmm.0.000032.
   Rayner J, 2004, INT J FOOD MICROBIOL, V95, P29, DOI 10.1016/j.ijfoodmicro.2004.01.019.
   Reis Giada ML, 2013, FOOD PHENOLIC COMPOU, DOI {[}10.5772/51687, DOI 10.5772/51687].
   Reisner A, 2006, J BACTERIOL, V188, P3572, DOI 10.1128/JB.188.10.3572-3581.2006.
   Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x.
   Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x.
   Sanchez E, 2016, EVID-BASED COMPL ALT, DOI 10.1155/2016/1572697.
   SASTRY VMVS, 1994, BOT MAR, V37, P357, DOI 10.1515/botm.1994.37.4.357.
   Sawada Y, 2012, PHYTOCHEMISTRY, V82, P38, DOI 10.1016/j.phytochem.2012.07.007.
   Selmar D, 2008, LANDBAUFORSCH VOLK, V58, P139.
   Sharma G, 2016, J APPL MICROBIOL, V121, P309, DOI 10.1111/jam.13078.
   Smith K, 2008, J MED MICROBIOL, V57, P966, DOI 10.1099/jmm.0.47668-0.
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1.
   Teanpaisan Rawee, 2017, J Tradit Complement Med, V7, P172, DOI 10.1016/j.jtcme.2016.06.007.
   Truchado P, 2009, FOOD CHEM, V115, P1337, DOI 10.1016/j.foodchem.2009.01.065.
   Umamaheshwari R, 2009, ADV BIOL RES, V3, P140.
   Uppuluri P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000828.
   Vikram A, 2010, J APPL MICROBIOL, V109, P515, DOI 10.1111/j.1365-2672.2010.04677.x.
   Villa F, 2013, CURR TOP MED CHEM, V13, P3184, DOI 10.2174/15680266113136660225.
   Villa F, 2013, PHYTOCHEM REV, V12, P245, DOI 10.1007/s11101-013-9286-4.
   Villa F, 2012, BIOFOULING, V28, P1107, DOI 10.1080/08927014.2012.734811.
   Villa F, 2012, ENVIRON MICROBIOL, V14, P1753, DOI 10.1111/j.1462-2920.2011.02678.x.
   Villa F, 2011, MICROB ECOL, V62, P584, DOI 10.1007/s00248-011-9876-x.
   Villa F, 2010, BIOFOULING, V26, P739, DOI 10.1080/08927014.2010.511197.
   Williams DL, 2011, CURR MICROBIOL, V62, P1657, DOI 10.1007/s00284-011-9908-2.
   Nguyen XV, 2015, SYST BIODIVERS, V13, P496, DOI 10.1080/14772000.2015.1046408.
   ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875.}},
Number-of-Cited-References = {{71}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{BMC Complement. Altern. Med.}},
Doc-Delivery-Number = {{GH7FC}},
Unique-ID = {{ISI:000433607800001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000432340300009,
Author = {Ren, Yahui and Ma, Ziyu and Yu, Tong and Ling, Min and Wang, Huayan},
Title = {{Methanol fixed fibroblasts serve as feeder cells to maintain stem cells
   in the pluripotent state in vitro}},
Journal = {{SCIENTIFIC REPORTS}},
Year = {{2018}},
Volume = {{8}},
Month = {{MAY 17}},
Abstract = {{Preparation of mouse embryonic fibroblast (MEF) feeder cells to maintain
   pluripotent stem cells (PSCs) is time consuming and involved in animal
   issues. Here, we demonstrated a novel method to prepare feeder cells
   with high efficiency, timesaving, and low costs. MEFs in 3 x 10(4)
   cell/cm(2) were fixed by methanol for 5 min and air drying for 5 min.
   Thereafter, the methanol fixed MEF cells (MT-MEF) were able to be used
   directly to culture PSCs or stored at room temperature for the future
   usage. PSCs cultured on MT-MEF could be continuously expanded for over
   40 passages with the naive pluripotency. MT-MEFs could also be used to
   maintain human and pig iPSCs. Moreover, methanol fixed MEFs'culture dish
   was able to be reused for at least 4 times, and to be applied for
   antibiotic resistant screening assay to establishing stable transfected
   PSC lines. Alternatively, the immortalized cell lines, for instance
   NIH3T3 cells, could also be fixed by methanol and used as feeder cells
   to maintain PSCs. Thus, this novel means of methanol fixed feeder cells
   can completely replace the mitomycin C and gamma radiation treated MEF
   feeder cells, and be used to maintain PSCs derived from mouse as well as
   other animal species.}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wang, HY (Reprint Author), Northwest A\&F Univ, Dept Anim Biotechnol, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.
   Ren, Yahui; Ma, Ziyu; Yu, Tong; Wang, Huayan, Northwest A\&F Univ, Dept Anim Biotechnol, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.
   Ling, Min, Northwest A\&F Univ, Dept Innovat Expt Coll, Yangling 712100, Shaanxi, Peoples R China.}},
DOI = {{10.1038/s41598-018-26238-2}},
Article-Number = {{7780}},
ISSN = {{2045-2322}},
Keywords-Plus = {{TERM SELF-RENEWAL; EXTRACELLULAR-MATRIX; GROWTH-FACTORS; FREE CULTURE;
   MOUSE; INTEGRIN; MAINTENANCE; CHALLENGES; GENERATION; SCAFFOLDS}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{hhwang101@163.com}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}31571521, 31371505]}},
Funding-Text = {{This work was supported by the National Natural Science Foundation of
   China (No. 31571521 and 31371505).}},
Cited-References = {{Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147.
   Boettiger D, 2012, CURR OPIN CELL BIOL, V24, P592, DOI 10.1016/j.ceb.2012.07.002.
   Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291.
   Brafman DA, 2010, BIOMATERIALS, V31, P9135, DOI 10.1016/j.biomaterials.2010.08.007.
   Brizzi MF, 2012, CURR OPIN CELL BIOL, V24, P645, DOI 10.1016/j.ceb.2012.07.001.
   Cheng D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051778.
   DA C., 2000, CURRENT PROTOCOLS MO, DOI {[}10.1002/0471142727.mb2302s51, DOI 10.1002/0471142727.MB2302S51].
   Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922.
   Eiselleova L, 2008, INT J DEV BIOL, V52, P353, DOI 10.1387/ijdb.082590le.
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0.
   Gershlaka JR, 2015, EXP CELL RES, V330, P311, DOI 10.1016/j.yexcr.2014.09.007.
   Higuchi A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18136.
   Higuchi A, 2014, PROG POLYM SCI, V39, P1348, DOI 10.1016/j.progpolymsci.2014.01.002.
   Higuchi A, 2011, CHEM REV, V111, P3021, DOI 10.1021/cr1003612.
   Ito Y, 2007, J BIOSCI BIOENG, V103, P113, DOI 10.1263/jbb.103.113.
   Jaggy M, 2015, NANO LETT, V15, P7146, DOI 10.1021/acs.nanolett.5b03359.
   Joddar B, 2015, J MATER CHEM B, V3, P2301, DOI 10.1039/c4tb01635a.
   Jozefczuk J, 2012, JOVE-J VIS EXP, DOI 10.3791/3854.
   Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377.
   Lee JM, 2015, BIOMATERIALS, V69, P174, DOI 10.1016/j.biomaterials.2015.08.005.
   Liu L, 2014, BIOMATERIALS, V35, P6259, DOI 10.1016/j.biomaterials.2014.04.024.
   Liu L, 2012, BIOTECHNOL LETT, V34, P1951, DOI 10.1007/s10529-012-0973-9.
   Llames S, 2015, TISSUE ENG PART B-RE, V21, P345, DOI {[}10.1089/ten.TEB.2014.0547, 10.1089/ten.teb.2014.0547].
   Lu HF, 2012, BIOMATERIALS, V33, P2419, DOI 10.1016/j.biomaterials.2011.11.077.
   Lyu ZL, 2014, NANOSCALE, V6, P6959, DOI 10.1039/c4nr01540a.
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181.
   Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319.
   Narva E, 2017, STEM CELL REP, V9, P67, DOI 10.1016/j.stemcr.2017.05.021.
   Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761.
   Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620.
   Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009.
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019.
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024.
   Talbot NC, 2012, IN VITRO CELL DEV-AN, V48, P1, DOI 10.1007/s11626-011-9467-7.
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145.
   Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007.
   Villa-Diaz LG, 2013, STEM CELLS, V31, P1, DOI 10.1002/stem.1260.
   Wei JS, 2014, BIOMATERIALS, V35, P7724, DOI 10.1016/j.biomaterials.2014.05.060.
   Xie CQ, 2004, BIOCHEM BIOPH RES CO, V315, P581, DOI 10.1016/j.bbrc.2004.01.089.
   Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971.
   Yang J, 2017, NATURE, V550, P393, DOI 10.1038/nature24052.
   Yang JJ, 2015, J TISSUE ENG REGEN M, V9, P375, DOI 10.1002/term.1640.
   Yang Y, 2017, CELL, V169, P243, DOI 10.1016/j.cell.2017.02.005.
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526.
   Yue XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032707.
   Zhang SQ, 2015, STEM CELL REV REP, V11, P24, DOI 10.1007/s12015-014-9552-x.
   Zhou P, 2016, BIOMATERIALS, V87, P1, DOI 10.1016/j.biomaterials.2016.02.012.
   Zhou Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep11386.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{6}},
Usage-Count-Since-2013 = {{6}},
Journal-ISO = {{Sci Rep}},
Doc-Delivery-Number = {{GG0AM}},
Unique-ID = {{ISI:000432340300009}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000432065800002,
Author = {Ahamad, Shahzaib and Hassan, Md Imtaiyaz and Dwivedi, Neeraja},
Title = {{Designing of phenol-based beta-carbonic anhydrase1 inhibitors through
   QSAR, molecular docking, and MD simulation approach}},
Journal = {{3 BIOTECH}},
Year = {{2018}},
Volume = {{8}},
Number = {{5}},
Month = {{MAY 14}},
Abstract = {{Tuberculosis (Tb) is an airborne infectious disease caused by
   Mycobacterium tuberculosis. Beta-carbonic anhydrase 1 (beta-CA1) has
   emerged as one of the potential targets for new antitubercular drug
   development. In this work, three-dimensional quantitative
   structure-activity relationships (3D-QSAR), molecular docking, and
   molecular dynamics (MD) simulation approaches were performed on a series
   of natural and synthetic phenol-based beta-CA1 inhibitors. The developed
   3D-QSAR model (r(2) =0.94, q(2) =0.86, and pred\_r(2) = 0.74) indicated
   that the steric and electrostatic factors are important parameters to
   modulate the bioactivity of phenolic compounds. Based on this
   indication, we designed 72 new phenolic inhibitors, out of which two
   compounds (D25 and D50) effectively stabilized beta-CA1 receptor and,
   thus, are potential candidates for new generation antitubercular drug
   discovery program.}},
Publisher = {{SPRINGER HEIDELBERG}},
Address = {{TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dwivedi, N (Reprint Author), IFTM Univ, Sch Biotechnol, Delhi Rd, Lodhipur Rajpoot, Moradabad, India.
   Hassan, MI (Reprint Author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.
   Ahamad, Shahzaib; Dwivedi, Neeraja, IFTM Univ, Sch Biotechnol, Delhi Rd, Lodhipur Rajpoot, Moradabad, India.
   Hassan, Md Imtaiyaz, Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.}},
DOI = {{10.1007/s13205-018-1278-z}},
Article-Number = {{256}},
ISSN = {{2190-572X}},
EISSN = {{2190-5738}},
Keywords = {{beta-Carbonic anhydrase 1; Docking; QSAR; MD simulation; M. Tuberculosis}},
Keywords-Plus = {{DRUG-RESISTANT TUBERCULOSIS; BETA-CARBONIC ANHYDRASES;
   MYCOBACTERIUM-TUBERCULOSIS; MULTIDRUG-RESISTANT; CLINICAL-TRIALS;
   HIGH-THROUGHPUT; DISCOVERY; PATHOGENESIS; EFFICIENT; ALCOHOLS}},
Research-Areas = {{Biotechnology \& Applied Microbiology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology}},
Author-Email = {{mihassan@jmi.ac.in
   drneerajadwivedi@iftmuniversity.ac.in}},
Cited-References = {{Ahamad S, 2017, ARCH PHARM RES, V40, P676, DOI 10.1007/s12272-017-0914-1.
   Ali I, 2014, CURR DRUG TARGETS, V15, P729, DOI 10.2174/1389450115666140429104516.
   Ali I, 2013, BIOORGAN MED CHEM, V21, P3808, DOI 10.1016/j.bmc.2013.04.018.
   Ambriz-Perez D.L., 2016, REV COGENT FOOD AGR, V2.
   Amiri-Kordestani L, 2012, J NATL CANCER I, V104, P568, DOI 10.1093/jnci/djs180.
   Anantharaju PG, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0217-2.
   Aspatwar A, 2017, J ENZYM INHIB MED CH, V32, P832, DOI 10.1080/14756366.2017.1332056.
   Becerra MC, 2011, LANCET, V377, P147, DOI 10.1016/S0140-6736(10)61972-1.
   Bhatia MS, 2009, DIG J NANOMATER BIOS, V4, P579.
   Buchieri MV, 2013, BIOORG MED CHEM LETT, V23, P740, DOI 10.1016/j.bmcl.2012.11.085.
   Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0.
   Cau Y, 2016, ORG BIOMOL CHEM, V14, P8322, DOI 10.1039/c6ob01477a.
   Centis R, 2017, INT J INFECT DIS, V56, P30, DOI 10.1016/j.ijid.2016.11.416.
   Clark-Curtiss JE, 2003, ANNU REV MICROBIOL, V57, P517, DOI 10.1146/annurev.micro.57.030502.090903.
   Daina A., 2017, DRUG LIKENESS MED CH, V7, P42717.
   Davis RA, 2011, J MED CHEM, V54, P1682, DOI 10.1021/jm1013242.
   Del Prete S, 2017, BIOORGAN MED CHEM, V25, P3555, DOI 10.1016/j.bmc.2017.05.007.
   DeLano WL, 2002, PYMOL USERS MANUAL, P452.
   Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282.
   Duthie GG, 2000, NUTR RES REV, V13, P79, DOI 10.1079/095442200108729016.
   Faizi MSH, 2018, J MOL STRUCT, V1156, P457, DOI 10.1016/j.molstruc.2017.12.014.
   Ferreira LG, 2017, PHARMACOL THERAPEUT, V180, P49, DOI 10.1016/j.pharmthera.2017.06.004.
   Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2.
   George T, 2000, J CHEM SOC PERK T 1, P2529, DOI 10.1039/a808133f.
   Hanson P, 2002, J CHEM SOC PERK T 2, P1135, DOI 10.1039/b200748g.
   Haque A, 2017, J MOL STRUCT, V1146, P536, DOI 10.1016/j.molstruc.2017.06.027.
   Haque A, 2017, J MOL LIQ, V237, P201, DOI 10.1016/j.molliq.2017.04.068.
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q.
   Hoarau C, 2003, SYNLETT, P127.
   Huang WY, 2010, NUTR CANCER, V62, P1, DOI 10.1080/01635580903191585.
   Innocenti A, 2009, BIOORG MED CHEM LETT, V19, P2642, DOI 10.1016/j.bmcl.2009.03.147.
   Jain Shailesh V, 2012, Org Med Chem Lett, V2, P22, DOI 10.1186/2191-2858-2-22.
   Kobak KA, 2007, J CLIN PSYCHOPHARM, V27, P1, DOI 10.1097/JCP.0b013e31802eb4b7.
   Kumari S, 2016, J MOL GRAPH MODEL, V64, P101, DOI 10.1016/j.jmgm.2016.01.006.
   Leeson P, 2012, NATURE, V481, P455, DOI 10.1038/481455a.
   Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007.
   Liu SS, 2002, J CHEM INF COMP SCI, V42, P749, DOI 10.1021/ci010245a.
   Lule SU, 2005, FOOD REV INT, V21, P367, DOI 10.1080/87559120500222862.
   Maresca A, 2013, J ENZYM INHIB MED CH, V28, P384, DOI 10.3109/14756366.2011.645539.
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B.
   Mushtaque M, 2017, J MOL STRUCT, V1141, P417, DOI 10.1016/j.molstruc.2017.03.100.
   Nasreen K, 2018, INT J BIOL MACROMOL, V106, P130, DOI 10.1016/j.ijbiomac.2017.08.014.
   Patel HM, 2014, MED CHEM RES, V23, P4991, DOI 10.1007/s00044-014-1072-3.
   Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055.
   Rowlett RS, 2010, BBA-PROTEINS PROTEOM, V1804, P362, DOI 10.1016/j.bbapap.2009.08.002.
   Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679.
   Sharma MC, 2013, MED CHEM RES, V22, P5390, DOI 10.1007/s00044-013-0499-2.
   Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003.
   Studio D, 2009, STUD D VERS 2 5.
   Sweeney JB, 1997, CONTEMP ORG SYNTH, V4, P435, DOI 10.1039/co9970400435.
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334.
   VLife M 3. 5, 2008, MOL DES SUIT.}},
Number-of-Cited-References = {{52}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{8}},
Usage-Count-Since-2013 = {{8}},
Journal-ISO = {{3 Biotech}},
Doc-Delivery-Number = {{GF6GT}},
Unique-ID = {{ISI:000432065800002}},
DA = {{2018-08-13}},
}

@article{ ISI:000432285900001,
Author = {Lajhar, Salma A. and Brownlie, Jeremy and Barlow, Robert},
Title = {{Characterization of biofilm-forming capacity and resistance to
   sanitizers of a range of E. coli O26 pathotypes from clinical cases and
   cattle in Australia}},
Journal = {{BMC MICROBIOLOGY}},
Year = {{2018}},
Volume = {{18}},
Month = {{MAY 8}},
Abstract = {{Background: The formation of biofilms and subsequent encasement of
   bacterial cells in a complex matrix can enhance resistance to
   antimicrobials and sterilizing agents making these organisms difficult
   to eradicate and control. The aim of this study was to evaluate and
   compare the capacity of 40 E. coli O26 isolates of enterohemorrhagic E.
   coli (EHEC, n = 27), potential EHEC (pEHEC, n = 3), atypical
   enteropathogenic E. coli (aEPEC, n = 8) and non-toxigenic E. coli (NTEC,
   n = 2) from human and cattle sources to form biofilms on different
   surfaces, and determine whether extracellular matrix (ECM) components
   (cellulose, curli), motility, prophage insertion in mlrA and cell
   surface hydrophobicity could influence biofilm formation. Finally, the
   influence of biofilm formation on the sensitivity of isolates to
   quaternary ammonium compounds (QACs; Profoam, Kwiksan 22) and peracetic
   acid-based sanitizer (Topactive Des.) for 2 min on polystyrene plate
   were also evaluated.
   Results: Biofilm production on one surface may not indicate biofilm
   formation on a different surface. Biofilm was formed by different
   pathotypes on polystyrene (70\%), stainless steel (87.5\%) and glass
   slides (95\%), however only 50\% demonstrated pellicle formation. EHEC
   isolates were significantly more likely to form a pellicle at the
   air-liquid interface and biofilms on polystyrene surface at 48 h than
   aEPEC. Strains that don't produce ECM (curli or cellulose), harbor a
   prophage insertion in mlrA and are non-motile have lower biofilm forming
   capacities than those isolates possessing combinations of these
   attributes. Hydrophobicity had no impact on biofilm formation. After 2
   min exposure, none of the disinfectants tested were able to completely
   inactivate all cells within a biofilm regardless of pathotypes and the
   amount of biofilm formed.
   Conclusion: Pathotypes of E. coli O26 showed varying capacities to form
   biofilms, however, most EHEC strains had the capacity to form biofilm on
   all surfaces and at the air-liquid interface under the conditions used
   in this study. Biofilms provided a protective effect to E. coli O26
   strains against the three sanitizers, previously shown to successfully
   control the growth of their planktonic counterparts. Whether the
   characteristics of biofilm forming and non-biofilm forming strains
   observed in this study reflect their attributes within the food and
   meat-processing environments is unknown. Further studies that represent
   the food and meat-processing environments are required.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lajhar, SA (Reprint Author), Griffith Univ, Sch Environm \& Sci, Brisbane, Qld, Australia.
   Lajhar, SA (Reprint Author), CSIRO Agr \& Food, 39 Kessels Rd, Brisbane, Qld 4108, Australia.
   Lajhar, Salma A.; Brownlie, Jeremy, Griffith Univ, Sch Environm \& Sci, Brisbane, Qld, Australia.
   Lajhar, Salma A.; Barlow, Robert, CSIRO Agr \& Food, 39 Kessels Rd, Brisbane, Qld 4108, Australia.}},
DOI = {{10.1186/s12866-018-1182-z}},
Article-Number = {{41}},
ISSN = {{1471-2180}},
Keywords = {{E. coli O26; Biofilm; Food sanitizers; Curli; Cellulose; Hydrophobicity;
   Polystyrene; Stainless steel; Pellicle; mlrA}},
Keywords-Plus = {{HEMOLYTIC-UREMIC-SYNDROME; TOXIN 2-ENCODING BACTERIOPHAGE; TOXIGENIC
   ESCHERICHIA-COLI; SEROTYPE O157 H7; STAINLESS-STEEL;
   SALMONELLA-TYPHIMURIUM; LISTERIA-MONOCYTOGENES; FOOD-INDUSTRY;
   BEEF-CATTLE; IN-VITRO}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{salmaaibsais.lajhar@griffithuni.edu.au}},
Funding-Acknowledgement = {{Commonwealth Scientific and Industrial Research Organization (CSIRO);
   Department of Environment and Primary industries Victoria (DEPI-V);
   National Board of Technical and Vocational Education; Libya/Department
   of Laboratory Medicine Derna, Libya {[}2013-2022]}},
Funding-Text = {{The authors gratefully acknowledge funding from Commonwealth Scientific
   and Industrial Research Organization (CSIRO) and the Department of
   Environment and Primary industries Victoria (DEPI-V). Additional funding
   was provided by the National Board of Technical and Vocational
   Education, Libya/Department of Laboratory Medicine Derna, Libya. Grant
   No. 2013-2022. Funding bodies provided scholarship support but were not
   involved in the design of the study and collection, analysis, and
   interpretation of data and in writing the manuscript.}},
Cited-References = {{Allerberger Franz, 2003, International Journal of Infectious Diseases, V7, P42, DOI 10.1016/S1201-9712(03)90041-5.
   Barlow RS, 2010, FOODBORNE PATHOG DIS, V7, P1239, DOI 10.1089/fpd.2010.0574.
   Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI {[}10.1128/AEM.02937-06, 10.1138/AEM.02937-06].
   Bokranz W, 2005, J MED MICROBIOL, V54, P1171, DOI 10.1099/jmm.0.46064-0.
   Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536.
   Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05.
   Buvens G, 2011, FOODBORNE PATHOG DIS, V8, P421, DOI 10.1089/fpd.2010.0693.
   CARPENTIER B, 1993, J APPL BACTERIOL, V75, P499, DOI 10.1111/j.1365-2672.1993.tb01587.x.
   CDC, 2007, FOODB OUTBR ONL DAT.
   CDC, 2010, FOODB OUTBR ONL DAT.
   Centers for Disease Control and Prevention (CDC), 2015, MULT OUTBR SHIG TOX.
   Chen CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084863.
   Chia TWR, 2009, FOOD MICROBIOL, V26, P853, DOI 10.1016/j.fm.2009.05.012.
   Ethelberg S, 2004, EMERG INFECT DIS, V10, P842, DOI 10.3201/eid1005.030576.
   Ethelberg S, 2009, CLIN INFECT DIS, V48, pE78, DOI 10.1086/597502.
   European Food Safety Authority, 2014, EFSA J, V12, DOI {[}10.2903/j.efsa.2014.3590, 10.2903/j.efsa.2014.3547].
   FSIS, 2012, FED REGISTER, V77, P31975.
   Fux CA, 2004, J BACTERIOL, V186, P4486, DOI 10.1128/JB.186.14.4486-4491.2004.
   Gerber A, 2002, J INFECT DIS, V186, P493, DOI 10.1086/341940.
   Gilmour MW, 2005, J CLIN MICROBIOL, V43, P5319, DOI 10.1128/JCM.43.10.5319-5323.2005.
   Goulter RM, 2010, CURR MICROBIOL, V61, P157, DOI 10.1007/s00284-010-9589-2.
   Habimana O, 2010, APPL ENVIRON MICROB, V76, P4557, DOI 10.1128/AEM.02707-09.
   HELKE DM, 1993, J FOOD PROTECT, V56, P479, DOI 10.4315/0362-028X-56.6.479.
   Hood SK, 1997, INT J FOOD MICROBIOL, V37, P145, DOI 10.1016/S0168-1605(97)00071-8.
   Kumar CG, 1998, INT J FOOD MICROBIOL, V42, P9, DOI 10.1016/S0168-1605(98)00060-9.
   Lajhar SA, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0963-0.
   Li J, 1999, INT J FOOD MICROBIOL, V53, P185, DOI 10.1016/S0168-1605(99)00159-2.
   Madic J, 2011, APPL ENVIRON MICROB, V77, P2035, DOI 10.1128/AEM.02089-10.
   Marouani-Gadri N, 2009, INT J FOOD MICROBIOL, V133, P62, DOI 10.1016/j.ijfoodmicro.2009.04.028.
   Mellor GE, 2016, J FOOD PROTECT, V79, P1868, DOI 10.4315/0362-028X.JFP-15-507.
   Nesse LL, 2014, APPL ENVIRON MICROB, V80, P2042, DOI 10.1128/AEM.03331-13.
   Noyce JO, 2006, APPL ENVIRON MICROB, V72, P4239, DOI 10.1128/AEM.02532-05.
   Ogasawara H, 2010, FEMS MICROBIOL LETT, V312, P160, DOI 10.1111/j.1574-6968.2010.02112.x.
   Park YJ, 2015, J FOOD PROTECT, V78, P990, DOI 10.4315/0362-028X.JFP-14-382.
   Pembrey RS, 1999, APPL ENVIRON MICROB, V65, P2877.
   Rivas L, 2005, J APPL MICROBIOL, V99, P716, DOI 10.1111/j.1365-2672.2005.02688.x.
   Rivas L, 2007, J MICROBIOL METH, V69, P44, DOI 10.1016/j.mimet.2006.11.014.
   Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x.
   Schmidt H, 1999, APPL ENVIRON MICROB, V65, P3855.
   Shaikh N, 2003, J BACTERIOL, V185, P3596, DOI 10.1128/JB.185.12.3596-3605.2003.
   Solheim HT, 2013, APPL ENVIRON MICROB, V79, P896, DOI 10.1128/AEM.03512-12.
   Sonoda C, 2008, JPN J INFECT DIS, V61, P92.
   Srey S, 2013, FOOD CONTROL, V31, P572, DOI 10.1016/j.foodcont.2012.12.001.
   Stepanovic S, 2004, LETT APPL MICROBIOL, V38, P428, DOI 10.1111/j.1472-765X.2004.01513.x.
   Stoodley P, 2001, APPL ENVIRON MICROB, V67, P5608, DOI 10.1128/AEM.67.12.5608-5613.2001.
   Toth I, 2003, APPL ENVIRON MICROB, V69, P7242, DOI 10.1128/AEM.69.12.7242-7247.2003.
   Tozzi AE, 2003, EMERG INFECT DIS, V9, P106, DOI 10.3201/eid0901.020266.
   Uhlich GA, 2006, APPL ENVIRON MICROB, V72, P2564, DOI 10.1128/AEM.72.4.2564-2572.2006.
   Uhlich GA, 2014, FEMS MICROBIOL LETT, V354, P133, DOI 10.1111/1574-6968.12439.
   Uhlich GA, 2013, MICROBIOL-SGM, V159, P1586, DOI 10.1099/mic.0.066118-0.
   USDA FSIS, 1999, FED REGISTER, V64, P2803.
   Vally H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-63.
   Vogeleer P, 2016, APPL ENVIRON MICROB, V82, P1448, DOI 10.1128/AEM.02983-15.
   Wang R, 2012, J FOOD PROTECT, V75, P1418, DOI 10.4315/0362-028X.JFP-11-427.}},
Number-of-Cited-References = {{54}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{BMC Microbiol.}},
Doc-Delivery-Number = {{GF9HE}},
Unique-ID = {{ISI:000432285900001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000428101400002,
Author = {Gao, Xin-Lei and Shao, Ming-Fei and Wang, Qing and Wang, Li-Tao and
   Fang, Wen-Yan and Ouyang, Feng and Li, Ji},
Title = {{Airborne microbial communities in the atmospheric environment of urban
   hospitals in China}},
Journal = {{JOURNAL OF HAZARDOUS MATERIALS}},
Year = {{2018}},
Volume = {{349}},
Pages = {{10-17}},
Month = {{MAY 5}},
Abstract = {{Clinically relevant antibiotic-resistant bacteria (ARB) and antibiotic
   resistance genes (ARGs) in bioaerosols have become a greater threat to
   public health. However, few reports have shown that ARB and ARGs were
   found in the atmosphere. High-throughput sequencing applied to
   environmental sciences has enhanced the exploration of microbial
   populations in atmospheric samples. Thus, five nosocomial bioaerosols
   were collected, and the dominant microbial and pathogenic microorganisms
   were identified by high-throughput sequencing in this study. The results
   suggested that the dominant microorganisms at the genus level were
   Massilia, Sphingomonas, Methylobacterium, Methylophilus, Micrococcineae,
   and Corynebacterineae. The most abundant pathogenic microorganisms were
   Staphylococcus saprophyticus, Corynebacterium minutissimum,
   Streptococcus pneumoniae, Escherichia coil, Arcobacter butzleri,
   Aeromonas veronii, Pseudomonas aeruginosa, and Bacillus cereus. The
   relationship between microbial communities and environmental factors was
   evaluated with canonical correspondence analysis (CCA). Meanwhile,
   differences in the pathogenic bacteria between bioaerosols and dust in a
   typical hospital was investigated. Furthermore, cultivable
   Staphylococcus isolates with multi-drug resistance phenotype (> 3
   antibiotics) in the inpatient departments were much higher than those in
   the transfusion area and out-patient departments, possibly attributed to
   the dense usage of antibiotics in inpatient departments. The results of
   this study might be helpful for scientifically air quality control in
   hospitals.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Li, J (Reprint Author), Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen Key Lab Water Resource Utilizat \& Enviro, Shenzhen 518055, Peoples R China.
   Wang, Q (Reprint Author), Hebei Univ Engn, Coll Energy \& Environm Engn, Handan 056038, Peoples R China.
   Gao, Xin-Lei; Shao, Ming-Fei; Fang, Wen-Yan; Ouyang, Feng; Li, Ji, Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen Key Lab Water Resource Utilizat \& Enviro, Shenzhen 518055, Peoples R China.
   Wang, Qing; Wang, Li-Tao, Hebei Univ Engn, Coll Energy \& Environm Engn, Handan 056038, Peoples R China.}},
DOI = {{10.1016/j.jhazmat.2018.01.043}},
ISSN = {{0304-3894}},
EISSN = {{1873-3336}},
Keywords = {{Antibiotic resistance genes; High-throughput sequencing; Bioaerosols;
   Pathogenic; Environmental risk}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE GENES; WASTE-WATER TREATMENT; HIGH-ELEVATION SITE;
   BACTERIAL COMMUNITIES; SUSCEPTIBILITY PATTERN; SIZE DISTRIBUTION;
   MICROORGANISMS; VARIABILITY; PREVALENCE; DIVERSITY}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences}},
Author-Email = {{wangqing@hebeu.edu.cn
   liji99@hitsz.edu.cn}},
Funding-Acknowledgement = {{Program of International ST Cooperation {[}2016YFE0123400]; State
   Environmental Protection Commonweal Project of China {[}201309031];
   National Natural Science Foundation {[}41703088, 41475131]; Natural
   Science Foundation of Hebei Province {[}D2017402109]; Young Scientist
   Foundation of Hebei Education Department {[}QN2017035]; Hebei Science
   Fund of Distinguished Young Scholars {[}D2017402086]; program for the
   Outstanding Young Scholars of Hebei Province; Hebei Cultivating Project
   of Talent Development {[}A2016002022]; Innovation Team Leader Talent
   Cultivation Fund of Hebei University of Engineering}},
Funding-Text = {{This study was sponsored by the Program of International S\&T
   Cooperation (No. 2016YFE0123400), the State Environmental Protection
   Commonweal Project of China (201309031), the National Natural Science
   Foundation (No. 41703088, 41475131), Natural Science Foundation of Hebei
   Province (No. D2017402109), Young Scientist Foundation of Hebei
   Education Department (No. QN2017035), Hebei Science Fund of
   Distinguished Young Scholars (No. D2017402086), The program for the
   Outstanding Young Scholars of Hebei Province, Hebei Cultivating Project
   of Talent Development (A2016002022), the Innovation Team Leader Talent
   Cultivation Fund of Hebei University of Engineering.}},
Cited-References = {{Angenent LT, 2005, P NATL ACAD SCI USA, V102, P4860, DOI 10.1073/pnas.0501235102.
   Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006.
   Bowers RM, 2012, ATMOS ENVIRON, V50, P41, DOI 10.1016/j.atmosenv.2012.01.005.
   Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167.
   Bowers RM, 2009, APPL ENVIRON MICROB, V75, P5121, DOI 10.1128/AEM.00447-09.
   Cao C, 2014, ENVIRON SCI TECHNOL, V48, P1499, DOI 10.1021/es4048472.
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303.
   Clinical and Laboratory Standards Institute, 2007, M100S17 CLSI.
   de Abreu PM, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-118.
   Dong LJ, 2016, SCI TOTAL ENVIRON, V541, P1011, DOI 10.1016/j.scitotenv.2015.10.001.
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI {[}10.1038/nmeth.2604, 10.1038/NMETH.2604].
   Ferroni A, 2008, J CYST FIBROS, V7, P477, DOI 10.1016/j.jcf.2008.05.001.
   Fitzgerald J.R., 2013, PLOS ONE, V8.
   Gao XL, 2016, SCI TOTAL ENVIRON, V572, P681, DOI 10.1016/j.scitotenv.2016.06.208.
   Gilbert Y, 2010, AEROBIOLOGIA, V26, P185, DOI 10.1007/s10453-010-9155-1.
   Hewitt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054703.
   Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213.
   Hsu JT, 2014, J HAZARD MATER, V277, P34, DOI 10.1016/j.jhazmat.2014.02.016.
   Jiang WJ, 2015, NAT PROTOC, V10, P768, DOI 10.1038/nprot.2015.046.
   Kaczorek E, 2017, J DAIRY SCI, V100, P6442, DOI 10.3168/jds.2017-12660.
   Kembel SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087093.
   Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211.
   Korzeniewska E, 2013, ECOTOX ENVIRON SAFE, V91, P96, DOI 10.1016/j.ecoenv.2013.01.014.
   Kumarathilaka P, 2016, J NANOMATER, DOI 10.1155/2016/2813289.
   Leung MHY, 2014, APPL ENVIRON MICROB, V80, P6760, DOI 10.1128/AEM.02244-14.
   Li J, 2016, ATMOS ENVIRON, V124, P404, DOI 10.1016/j.atmosenv.2015.06.030.
   Li LG, 2017, ISME J, V11, P651, DOI 10.1038/ismej.2016.155.
   Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507.
   Messi P, 2015, AEROBIOLOGIA, V31, P381, DOI 10.1007/s10453-015-9371-9.
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759.
   Pal C, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0199-5.
   Pehrsson EC, 2016, NATURE, V533, P212, DOI 10.1038/nature17672.
   Peng S, 2017, J HAZARD MATER, V340, P16, DOI 10.1016/j.jhazmat.2017.06.059.
   Polymenakou PN, 2008, ENVIRON HEALTH PERSP, V116, P292, DOI 10.1289/ehp.10684.
   Ramos T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118207.
   Rasool K, 2015, J HAZARD MATER, V299, P453, DOI 10.1016/j.jhazmat.2015.07.044.
   Rausell A, 2014, CURR OPIN IMMUNOL, V30, P32, DOI 10.1016/j.coi.2014.06.001.
   Sherry NL, 2013, J CLIN MICROBIOL, V51, P1396, DOI 10.1128/JCM.03332-12.
   Wang FH, 2015, J HAZARD MATER, V299, P215, DOI 10.1016/j.jhazmat.2015.05.028.
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07.
   Woo AC, 2013, ATMOS ENVIRON, V74, P291, DOI 10.1016/j.atmosenv.2013.03.047.
   Yadav J, 2015, J FORMOS MED ASSOC, V114, P639, DOI 10.1016/j.jfma.2013.04.006.
   Yan D., 2016, FRONT MICROBIOL, V7.
   Ye L, 2011, ENVIRON SCI TECHNOL, V45, P7173, DOI 10.1021/es201045e.
   Zhou JM, 2015, J HAZARD MATER, V295, P176, DOI 10.1016/j.jhazmat.2015.04.010.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{54}},
Usage-Count-Since-2013 = {{54}},
Journal-ISO = {{J. Hazard. Mater.}},
Doc-Delivery-Number = {{GA1TX}},
Unique-ID = {{ISI:000428101400002}},
DA = {{2018-08-13}},
}

@article{ ISI:000431489000002,
Author = {Keri, Rangappa S. and Pandule, Sudam S. and Budagumpi, Srinivasa and
   Nagaraja, Bhari M.},
Title = {{Quinoxaline and quinoxaline-1,4-di-N-oxides: An emerging class of
   antimycobacterials}},
Journal = {{ARCHIV DER PHARMAZIE}},
Year = {{2018}},
Volume = {{351}},
Number = {{5}},
Month = {{MAY}},
Abstract = {{Tuberculosis (TB) is a highly dreaded, infectious, chronic, airborne
   disease affecting more than two million people all around the world,
   with more than eight million cases every calendar year. TB is the second
   leading infectious cause of death after HIV/AIDS. Over the past few
   decades, numerous efforts have been undertaken to develop new anti-TB
   agents. The current frontline therapy for TB consists of administering
   three or more different drugs (usually isoniazid, rifampin,
   pyrazinamide, and ethambutol) over an extended period of time. But these
   drugs will take 6-12 months to cure TB, along with many side effects;
   hence, there is an urgent need to explore new anti-TB agents.
   Quinoxaline derivatives are a class of compounds that show a spectrum of
   biological properties and the interest in these compounds is
   exponentially growing within the field of medicinal chemistry.
   Quinoxaline-1,4-di-N-oxide derivatives have shown to improve the
   biological results and are endowed with anti-viral, anti-cancer,
   anti-bacterial, and anti-protozoal activities with application in many
   other therapeutic areas. Since quinoxaline derivatives are regarded as a
   new class of effective anti-TB candidates, their 1,4-di-N-oxide
   analogues may show promising in vitro and in vivo anti-TB activities and
   might be able to prevent the drug resistance to a certain extent.
   Therefore, the main aim of this review is to focus on important
   quinoxaline and quinoxaline-1,4-di-N-oxide analogues that have shown
   anti-TB activities, and their structure-activity relationships for
   designing anti-TB agents with better efficacies. The present review will
   be helpful in providing insights for rational designs of more active and
   less toxic quinoxaline-based anti-TB prodrugs.}},
Publisher = {{WILEY-V C H VERLAG GMBH}},
Address = {{POSTFACH 101161, 69451 WEINHEIM, GERMANY}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Keri, RS (Reprint Author), Jain Univ, Ctr Nano \& Mat Sci, Organ \& Med Chem Lab, Jain Global Campus,Kanakapura Rd, Bangalore 562112, Karnataka, India.
   Keri, Rangappa S.; Budagumpi, Srinivasa; Nagaraja, Bhari M., Jain Univ, Ctr Nano \& Mat Sci, Jain Global Campus, Bangalore, Karnataka, India.
   Pandule, Sudam S., Nowrosjee Wadia Coll, Dept Chem, Pune, Maharashtra, India.}},
DOI = {{10.1002/ardp.201700325}},
Article-Number = {{e1700325}},
ISSN = {{0365-6233}},
EISSN = {{1521-4184}},
Keywords = {{anti-tubercular; heterocyclic compound; quinoxaline;
   quinoxaline-1,4-di-N-oxide; structure-activity relationship}},
Keywords-Plus = {{MYCOBACTERIUM-TUBERCULOSIS AGENTS; N-BRIDGEHEAD HETEROCYCLES; IN-VITRO
   EVALUATION; 1,4-DI-N-OXIDE DERIVATIVES; BIOLOGICAL EVALUATION;
   QUINOXALINE-2-CARBONITRILE 1,4-DI-N-OXIDE; ANTITUBERCULAR ACTIVITY;
   MULTIDRUG-RESISTANT; ANTICANCER AGENT; INHIBITORS}},
Research-Areas = {{Pharmacology \& Pharmacy; Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology \&
   Pharmacy}},
Author-Email = {{keriphd@gmail.com}},
ORCID-Numbers = {{/0000-0001-6262-8379}},
Funding-Acknowledgement = {{Jain University}},
Funding-Text = {{Jain University}},
Cited-References = {{Abid M, 2006, BIOORG MED CHEM LETT, V16, P2812, DOI 10.1016/j.bmcl.2006.01.116.
   Abu-Hashem AA, 2010, EUR J MED CHEM, V45, P1976, DOI 10.1016/j.ejmech.2010.01.042.
   Achutha L, 2013, J CHEM-NY, DOI 10.1155/2013/578438.
   Ajani OO, 2014, EUR J MED CHEM, V85, P688, DOI 10.1016/j.ejmech.2014.08.034.
   Ancizu S, 2010, BIOORGAN MED CHEM, V18, P2713, DOI 10.1016/j.bmc.2010.02.024.
   {[}Anonymous], 2016, WHOHTMTB201610.
   Bansal R. K., 2013, HETEROCYCLIC CHEM.
   BARBER RS, 1979, ANIM FEED SCI TECH, V4, P117, DOI 10.1016/0377-8401(79)90036-1.
   Tarallo MB, 2010, J INORG BIOCHEM, V104, P1164, DOI 10.1016/j.jinorgbio.2010.07.005.
   Brown ED, 2005, CHEM REV, V105, P759, DOI 10.1021/cr030116o.
   Burguete A, 2007, BIOORG MED CHEM LETT, V17, P6439, DOI 10.1016/j.bmcl.2007.10.002.
   Campaigne E., 1984, COMPREHENSIVE HETERO.
   Campiani G, 1999, J MED CHEM, V42, P4362, DOI 10.1021/jm990151g.
   Carta A, 2002, EUR J MED CHEM, V37, P355, DOI 10.1016/S0223-5234(02)01346-6.
   Cogo J, 2015, EUR J MED CHEM, V90, P107, DOI 10.1016/j.ejmech.2014.11.018.
   D'Ambrosio L., 2015, ERJ OPEN RES, V1, P00010, DOI DOI 10.1183/23120541.00010-2015.
   Daniel VS, 1999, CLIN INFECT DIS, V29, P1557, DOI 10.1086/313562.
   Das U, 2010, EUR J MED CHEM, V45, P4682, DOI 10.1016/j.ejmech.2010.07.030.
   Desai V, 2017, BIOORG MED CHEM LETT, V27, P2174, DOI 10.1016/j.bmcl.2017.03.059.
   Diaz FR, 2006, POLYM BULL, V56, P155, DOI 10.1007/s00289-005-0484-0.
   Fernandes GFD, 2017, J MED CHEM, V60, P8647, DOI 10.1021/acs.jmedchem.7b01332.
   Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677.
   El-Helby AGA, 2017, MED CHEM RES, V26, P2967, DOI 10.1007/s00044-017-1996-5.
   Galar SA, 2013, EUR J MED CHEM, V69, P115, DOI 10.1016/j.ejmech.2013.07.049.
   Ganapaty S, 2008, ASIAN J CHEM, V20, P3353.
   Ganapaty S, 2007, INDIAN J HETEROCY CH, V16, P283.
   Ganihigama DU, 2015, EUR J MED CHEM, V89, P1, DOI 10.1016/j.ejmech.2014.10.026.
   Gao HL, 2000, CANCER RES, V60, P5937.
   Grange J. M., 2009, TUBERCULOSIS COMPREH.
   Guillon J, 2004, J ENZYM INHIB MED CH, V19, P489, DOI 10.1080/14756360412331280464.
   Hajri M, 2016, EUR J MED CHEM, V124, P959, DOI 10.1016/j.ejmech.2016.10.025.
   Huang WH, 2011, BIOORGAN MED CHEM, V19, P7158, DOI 10.1016/j.bmc.2011.09.061.
   Hui X, 2006, BIOORG MED CHEM LETT, V16, P815, DOI 10.1016/j.bmcl.2005.11.025.
   Ibrahim MK, 2017, BIOORGAN MED CHEM, V25, P1496, DOI 10.1016/j.bmc.2017.01.015.
   Ingle R, 2013, EUR J MED CHEM, V65, P168, DOI 10.1016/j.ejmech.2013.04.028.
   Jaso A, 2005, J MED CHEM, V48, P2019, DOI 10.1021/jm049952w.
   Jaso A, 2003, EUR J MED CHEM, V38, P791, DOI 10.1016/S0223-5234(03)00137-5.
   Kakodkar NC, 2011, PEDIATR BLOOD CANCER, V56, P164, DOI 10.1002/pbc.22639.
   Kamble AA, 2016, MED CHEM RES, V25, P1163, DOI 10.1007/s00044-016-1558-2.
   Katritzky A. R., 1996, COMPREHENSIVE HETERO, VII.
   Kawasaki-Yatsugi S, 1998, N-S ARCH PHARMACOL, V358, P586, DOI 10.1007/PL00005297.
   Keri RS, 2014, BIOMED PHARMACOTHER, V68, P1161, DOI 10.1016/j.biopha.2014.10.007.
   Khattab SN, 2010, EUR J MED CHEM, V45, P4479, DOI 10.1016/j.ejmech.2010.07.008.
   Kikuchi K, 2000, J MED CHEM, V43, P409, DOI 10.1021/jm990063w.
   Konstantinos A, 2010, AUST PRESCR, V33, P12.
   Kumar S, 2017, ORIENT J CHEM, V33, P821, DOI 10.13005/ojc/330230.
   Liu Z, 2017, J MATER CHEM C, V5, P6798, DOI 10.1039/c7tc01329a.
   Loch-Neckel G, 2015, EUR J MED CHEM, V90, P93, DOI 10.1016/j.ejmech.2014.11.014.
   Loughran HM, 2016, BIOORG MED CHEM LETT, V26, P3429, DOI 10.1016/j.bmcl.2016.06.053.
   Montoya ME, 1998, FARMACO, V53, P570, DOI 10.1016/S0014-827X(98)00067-6.
   Moreno E, 2010, EUR J MED CHEM, V45, P4418, DOI 10.1016/j.ejmech.2010.06.036.
   Neres J, 2015, ACS CHEM BIOL, V10, P705, DOI 10.1021/cb5007163.
   Noolvi MN, 2011, EUR J MED CHEM, V46, P2327, DOI 10.1016/j.ejmech.2011.03.015.
   Olayiwola G, 2007, AFR J BIOTECHNOL, V6, P777.
   Ortega MA, 2002, ARZNEIMITTEL-FORSCH, V52, P113.
   Ortega MA, 2001, PHARMAZIE, V56, P205.
   Pan YH, 2016, BIOORG MED CHEM LETT, V26, P4146, DOI 10.1016/j.bmcl.2016.01.066.
   Patel SB, 2016, EUR J MED CHEM, V117, P230, DOI 10.1016/j.ejmech.2016.04.019.
   Patinote C, 2017, EUR J MED CHEM, V138, P909, DOI 10.1016/j.ejmech.2017.07.021.
   Pedersen OS, 1999, ANTIVIR CHEM CHEMOTH, V10, P285, DOI 10.1177/095632029901000601.
   Pelletier JC, 2009, J MED CHEM, V52, P2148, DOI 10.1021/jm801572m.
   Peraman R, 2015, BIOORG MED CHEM LETT, V25, P4314, DOI 10.1016/j.bmcl.2015.07.071.
   Pereira JA, 2015, EUR J MED CHEM, V97, P664, DOI 10.1016/j.ejmech.2014.06.058.
   Pissot-Soldermann C, 2010, BIOORG MED CHEM LETT, V20, P2609, DOI 10.1016/j.bmcl.2010.02.056.
   Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555.
   Porter J, 2009, BIOORG MED CHEM LETT, V19, P397, DOI 10.1016/j.bmcl.2008.11.062.
   Primas N, 2014, EUR J MED CHEM, V83, P26, DOI 10.1016/j.ejmech.2014.06.014.
   Puratchikody A, 2011, CHEM BIOL DRUG DES, V78, P988, DOI 10.1111/j.1747-0285.2011.01246.x.
   Qi JG, 2018, EUR J MED CHEM, V143, P8, DOI 10.1016/j.ejmech.2017.08.018.
   Ramalingam P, 2008, ASIAN J CHEM, V20, P4132.
   Ramalingam P, 2010, BIOORG MED CHEM LETT, V20, P406, DOI 10.1016/j.bmcl.2009.10.026.
   Rao G. K., 2010, J CHEM PHARM RES, V2, P368.
   RICHARD HC, 1963, NATURE, V199, P354, DOI 10.1038/199354a0.
   Rogawski MA, 2006, EPILEPSY RES, V69, P273, DOI 10.1016/j.eplepsyres.2006.02.004.
   Rong F, 2007, BIOORG MED CHEM LETT, V17, P1663, DOI 10.1016/j.bmcl.2006.12.103.
   Sainz Y, 1999, ARZNEIMITTEL-FORSCH, V49, P55.
   Santivanez-Veliz M, 2016, BIOORG MED CHEM LETT, V26, P2188, DOI 10.1016/j.bmcl.2016.03.066.
   Santivañez-Veliz Mery, 2013, Rev. Soc. Quím. Perú, V79, P272.
   Sasaki T, 1996, VISION RES, V36, P787, DOI 10.1016/0042-6989(95)00176-X.
   Sato M, 2013, CURR OPIN CHEM BIOL, V17, P537, DOI 10.1016/j.cbpa.2013.06.022.
   Seeler AO, 1944, J PHARMACOL EXP THER, V82, P357.
   Seitz LE, 2002, J MED CHEM, V45, P5604, DOI 10.1021/jm020310n.
   Shekhar AC, 2014, EUR J MED CHEM, V77, P280, DOI 10.1016/j.ejmech.2014.03.010.
   Shibinskaya MO, 2010, EUR J MED CHEM, V45, P1237, DOI 10.1016/j.ejmech.2009.12.014.
   Shintre S, 2017, MED CHEM RES, V26, P2141, DOI 10.1007/s00044-017-1922-x.
   Szekelyhidi Z, 2005, BIOORG MED CHEM LETT, V15, P3241, DOI 10.1016/j.bmcl.2005.04.064.
   Tarallo MB, 2009, J ARGENT CHEM SOC, V97, P80.
   Torres E, 2013, EUR J MED CHEM, V66, P324, DOI 10.1016/j.ejmech.2013.04.065.
   Torres E, 2011, BIOORG MED CHEM LETT, V21, P3699, DOI 10.1016/j.bmcl.2011.04.072.
   Udilova N, 2003, BIOCHEM PHARMACOL, V65, P59, DOI 10.1016/S0006-2952(02)01452-1.
   Vicente E, 2008, ANTIMICROB AGENTS CH, V52, P3321, DOI 10.1128/AAC.00379-08.
   Vicente E, 2009, BIOORGAN MED CHEM, V17, P385, DOI 10.1016/j.bmc.2008.10.086.
   Villar R, 2008, J ANTIMICROB CHEMOTH, V62, P547, DOI 10.1093/jac/dkn214.
   Waring MJ, 2002, MOLECULES, V7, P641, DOI 10.3390/70800641.
   Wu P, 2012, BIOORGAN MED CHEM, V20, P2837, DOI 10.1016/j.bmc.2012.03.026.
   You L, 2011, BIOORG MED CHEM LETT, V21, P3007, DOI 10.1016/j.bmcl.2011.03.042.
   Zhang Y, 2006, DRUG DISCOV TODAY, V11, P21, DOI 10.1016/S1359-6446(05)03626-3.
   2010, TREATM TUB GUID, P1.}},
Number-of-Cited-References = {{98}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{8}},
Usage-Count-Since-2013 = {{8}},
Journal-ISO = {{Arch. Pharm.}},
Doc-Delivery-Number = {{GE8NS}},
Unique-ID = {{ISI:000431489000002}},
DA = {{2018-08-13}},
}

@article{ ISI:000429877200011,
Author = {Zheng, Ji and Zhou, Zhenchao and Wei, Yuanyuan and Chen, Tao and Feng,
   Wanqiu and Chen, Hong},
Title = {{High-throughput profiling of seasonal variations of antibiotic
   resistance gene transport in a peri-urban river}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2018}},
Volume = {{114}},
Pages = {{87-94}},
Month = {{MAY}},
Abstract = {{The rapid expansion of human activity in a region can exacerbate human
   health risks induced by antibiotic resistance genes (ARGs). Peri-urban
   ecosystems serve at the symbiotic interface between urban and rural
   ecosystems, and investigations into the dissemination of ARGs in
   peri-urban areas provide a basic framework for tracking the spread of
   ARGs and potential mitigations. In this study, through the use of
   high-throughput quantitative PCR and 16S rRNA gene high-throughput
   sequencing, seasonal and geographical distributions of ARGs and their
   host bacterial communities were characterized in a peri-urban river. The
   abundance of ARGs in downstream was 5.2-33.9 times higher than upstream,
   which indicated distinct antibiotic resistance pollution in the areas
   where human lives. With the comparison classified based on land use
   nearby, the abundance of ARGs in samples near farmland and villages was
   higher than in the background (3.47-5.58 times), pointing to the high
   load in the river caused by farming and other human activities in the
   peri-urban areas. With the co-occurrence pattern revealed by network
   analysis, blaVEB and tetM were proposed to be indicators of ARGs which
   get together in the same module. Furthermore, seasonal variations in
   ARGs and the transport of bacterial communities were observed. The
   effects of seasonal temperature on the dissemination of ARGs along the
   watershed was also evaluated. The highest absolute abundance of ARGs
   occurred in summer (2.81 x 10(9) copies/L on average), the trends of ARG
   abundances in four seasons were similar with local air temperature. The
   Linear discriminant analysis effect size (LEfSe) suggested that nine
   bacterial genera were implicated as biomarkers for the corresponding
   season. Mobile genetic elements (MGEs) showed significant positive
   correlation with ARGs (P < 0.01) and MGEs were also identified as the
   key-contributing factor driving ARG alteration. This study provides an
   overview of seasonal and geographical variations in ARGs distribution in
   a peri-urban river and draws attention to controlling pollutants in
   peri-urban ecosystems.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chen, H (Reprint Author), Zhejiang Univ, Dept Environm Engn, Coll Environm \& Resource Sci, Hangzhou 310058, Zhejiang, Peoples R China.
   Zheng, Ji; Zhou, Zhenchao; Wei, Yuanyuan; Chen, Tao; Feng, Wanqiu; Chen, Hong, Zhejiang Univ, Dept Environm Engn, Coll Environm \& Resource Sci, Hangzhou 310058, Zhejiang, Peoples R China.}},
DOI = {{10.1016/j.envint.2018.02.039}},
ISSN = {{0160-4120}},
EISSN = {{1873-6750}},
Keywords = {{Antibiotic resistance genes; Peri-urban river; Bacteria community;
   Network analysis}},
Keywords-Plus = {{MUNICIPAL WASTE-WATER; BACTERIAL COMMUNITIES; SEWAGE-SLUDGE; TREATMENT
   SYSTEMS; TREATMENT PLANT; CHINA; SOIL; PATHOGENS; RESISTOME; NETWORKS}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{chen\_hong@zju.edu.cn}},
Funding-Acknowledgement = {{Natural Science Foundation of China {[}41571130064, 21677121]}},
Funding-Text = {{This work was supported by Natural Science Foundation of China
   (41571130064 and 21677121).}},
Cited-References = {{Ahammad ZS, 2014, ENVIRON SCI TECHNOL, V48, P3014, DOI 10.1021/es405348h.
   Amos GCA, 2014, VET MICROBIOL, V171, P441, DOI 10.1016/j.vetmic.2014.02.017.
   Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2.
   Bertolini V, 2013, APPL MICROBIOL BIOT, V97, P6561, DOI 10.1007/s00253-012-4450-0.
   Bondarczuk K, 2016, ENVIRON INT, V87, P49, DOI 10.1016/j.envint.2015.11.011.
   Brooks JP, 2014, WATER RES, V57, P96, DOI 10.1016/j.watres.2014.03.017.
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303.
   Chen H, 2013, ENVIRON INT, V55, P9, DOI 10.1016/j.envint.2013.01.019.
   Chen QL, 2016, ENVIRON INT, V92-93, P1, DOI 10.1016/j.envint.2016.03.026.
   Comte J, 2017, ENVIRON MICROBIOL, V19, P2391, DOI 10.1111/1462-2920.13749.
   Cui EP, 2016, BIORESOURCE TECHNOL, V203, P11, DOI 10.1016/j.biortech.2015.12.030.
   Fang H, 2015, ENVIRON SCI TECHNOL, V49, P1095, DOI 10.1021/es504157v.
   Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761.
   Graham DW, 2011, ENVIRON SCI TECHNOL, V45, P418, DOI 10.1021/es102473z.
   Gyles C, 2014, VET PATHOL, V51, P328, DOI 10.1177/0300985813511131.
   He LY, 2016, ENVIRON INT, V92-93, P210, DOI 10.1016/j.envint.2016.03.023.
   Huang LP, 2015, ENVIRON SCI TECHNOL, V49, P9914, DOI 10.1021/acs.est.5b00191.
   Huerta B, 2013, SCI TOTAL ENVIRON, V456, P161, DOI 10.1016/j.scitotenv.2013.03.071.
   Jia SY, 2015, ENVIRON SCI TECHNOL, V49, P12271, DOI 10.1021/acs.est.5b03521.
   Jiao YN, 2017, CHEMOSPHERE, V184, P53, DOI 10.1016/j.chemosphere.2017.05.149.
   Kim TG, 2014, APPL MICROBIOL BIOT, V98, P1417, DOI 10.1007/s00253-013-5057-9.
   Li B, 2015, ISME J, V9, P2490, DOI 10.1038/ismej.2015.59.
   Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109.
   Luo Y, 2010, ENVIRON SCI TECHNOL, V44, P7220, DOI 10.1021/es100233w.
   Ma LP, 2017, ENVIRON SCI TECHNOL, V51, P5721, DOI 10.1021/acs.est.6b05887.
   Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103.
   Ouyang WY, 2015, APPL MICROBIOL BIOT, V99, P5697, DOI 10.1007/s00253-015-6416-5.
   Pehrsson EC, 2016, NATURE, V533, P212, DOI 10.1038/nature17672.
   Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es0604131.
   Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r.
   Rodriguez-Mozaz S, 2015, WATER RES, V69, P234, DOI 10.1016/j.watres.2014.11.021.
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73.
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60.
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303.
   Steele JA, 2011, ISME J, V5, P1414, DOI 10.1038/ismej.2011.24.
   Su JQ, 2015, ENVIRON SCI TECHNOL, V49, P7356, DOI 10.1021/acs.est.5b01012.
   Threedeach S, 2012, BIORESOURCE TECHNOL, V113, P253, DOI 10.1016/j.biortech.2012.01.086.
   Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x.
   Vaz-Moreira I, 2014, FEMS MICROBIOL REV, V38, P761, DOI 10.1111/1574-6976.12062.
   Wang FH, 2014, ENVIRON SCI TECHNOL, V48, P9079, DOI 10.1021/es502615e.
   Wu Y, 2016, BIORESOURCE TECHNOL, V211, P414, DOI 10.1016/j.biortech.2016.03.086.
   Xiao EZ, 2017, ENVIRON POLLUT, V221, P244, DOI 10.1016/j.envpol.2016.11.071.
   Xie WY, 2016, ENVIRON SCI TECHNOL, V50, P12602, DOI 10.1021/acs.est.6b02138.
   Xu L., 2016, ENVIRON SCI POLLUT R, V23, P1.
   Xu Y, 2016, ENVIRON POLLUT, V213, P833, DOI 10.1016/j.envpol.2016.03.054.
   Yang Y, 2014, WATER RES, V62, P97, DOI 10.1016/j.watres.2014.05.019.
   Zhang SY, 2017, ENVIRON MICROBIOL, V19, P2468, DOI 10.1111/1462-2920.13775.
   Zheng J, 2017, ENVIRON POLLUT, V230, P648, DOI 10.1016/j.envpol.2017.07.025.
   Zhou Z. C., 2017, ENVIRON SCI POLLUT R, V3, P1.
   Zhu YG, 2017, SCI TOTAL ENVIRON, V586, P1085, DOI 10.1016/j.scitotenv.2017.02.094.
   Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110.}},
Number-of-Cited-References = {{51}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{39}},
Usage-Count-Since-2013 = {{39}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{GC6CH}},
Unique-ID = {{ISI:000429877200011}},
DA = {{2018-08-13}},
}

@article{ ISI:000429877200021,
Author = {Jensen, John and Kyvsgaard, Niels Christian and Battisti, Antonio and
   Baptiste, Keith Edward},
Title = {{Environmental and public health related risk of veterinary zinc in pig
   production - Using Denmark as an example}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2018}},
Volume = {{114}},
Pages = {{181-190}},
Month = {{MAY}},
Abstract = {{At great economic cost, important steps have been taken over the last
   many decades to reduce and control emissions of heavy metals in order to
   protect the environment and public health. Monitoring has confirmed the
   success of these policies with progressive declines of heavy metals in
   for example air, sewage sludge and environmental samples. For zinc, such
   improvements may nevertheless be counter-acted by its widely usage as a
   feed additive and veterinary medicinal product to piglets in the
   post-weaning period resulting in reduced occurrence of diarrhea and
   improvement of daily weight gain. This review therefore focuses on two
   major concerns associated with veterinary use of zinc, namely the
   quantifiable risks to the environment and promotion of (multi) resistant
   bacteria like LA-MRSA in pig farms. Denmark is used as an informed and
   realistic worst-case scenario, representing the largest pig production
   per capita in Europe. It is furthermore, one of the countries where most
   recent information can be found regarding soil monitoring data and zinc
   consumption within the pig production. An average increase in soil
   concentration by > 45\% was recently reported within the period
   1998-2014. In order to predict future risk, this review presents new and
   simplified model predictions using current soil concentrations, annual
   load rates and predicted accumulation rates. In conclusion, it is
   estimated that within 25 years, continued agricultural practice of
   current zinc loads may result in a situation where almost all soils
   receiving manure from intensive piglet production may be at risk, but
   also other pig production types may result in scenarios with predicted
   risk to soil dwelling species, especially in sandy soils. Besides the
   quantifiable risks to soil ecosystems, high levels of zinc furthermore
   co-select for the persistence of LA-MRSA CC398 and other resistant
   bacteria on pig farms.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Jensen, J (Reprint Author), Aarhus Univ, Dept Biosci, Vejlsovej 25, DK-8600 Silkeborg, Denmark.
   Jensen, John, Aarhus Univ, Dept Biosci, Vejlsovej 25, DK-8600 Silkeborg, Denmark.
   Kyvsgaard, Niels Christian; Baptiste, Keith Edward, Danish Med Agcy, Axel Heides Gade 1, DK-2300 Copenhagen S, Denmark.
   Battisti, Antonio, Ist Zooprofilatt Sperimentale Lazio \& Toscana, Rome, Italy.}},
DOI = {{10.1016/j.envint.2018.02.007}},
ISSN = {{0160-4120}},
EISSN = {{1873-6750}},
Keywords-Plus = {{RESISTANT STAPHYLOCOCCUS-AUREUS; SOIL MICROBIAL COMMUNITIES; HEAVY-METAL
   CONTAMINATION; WEANED PIGS; LONG-TERM; DIETARY ZINC;
   MULTIDRUG-RESISTANT; ECOSYSTEM SERVICES; AGRICULTURAL SOILS; MANURE
   APPLICATION}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{jje@bios.au.dk}},
ORCID-Numbers = {{Battisti, Antonio/0000-0003-1308-199X}},
Cited-References = {{Alba P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137143.
   Amachawadi RG, 2015, FOODBORNE PATHOG DIS, V12, P159, DOI 10.1089/fpd.2014.1851.
   Aminov RI, 2007, FEMS MICROBIOL LETT, V271, P147, DOI 10.1111/j.1574-6968.2007.00757.x.
   Argudin MA, 2016, VET MICROBIOL, V191, P88, DOI 10.1016/j.vetmic.2016.06.004.
   Asada K, 2010, J ENVIRON SCI HEAL B, V45, P285, DOI 10.1080/03601231003704580.
   Bak J, 1997, SCI TOTAL ENVIRON, V207, P179, DOI 10.1016/S0048-9697(97)00262-3.
   Ballhausen B, 2017, VET MICROBIOL, V200, P39, DOI 10.1016/j.vetmic.2016.05.006.
   Barrios E, 2007, ECOL ECON, V64, P269, DOI 10.1016/j.ecolecon.2007.03.004.
   Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008.
   Bednorz C, 2013, INT J MED MICROBIOL, V303, P396, DOI 10.1016/j.ijmm.2013.06.004.
   Berenguer P, 2008, AGRON J, V100, P1056, DOI 10.2134/agronj2007.0321.
   Bos MEH, 2012, PREV VET MED, V105, P155, DOI 10.1016/j.prevetmed.2012.01.002.
   Brock EH, 2006, SOIL SCI, V171, P388, DOI 10.1097/01.ss.0000209360.62945.95.
   Brussaard L, 2007, AGR ECOSYST ENVIRON, V121, P233, DOI 10.1016/j.agee.2006.12.013.
   Carlson D, 2004, COMP BIOCHEM PHYS A, V137, P757, DOI 10.1016/j.cbpb.2004.02.011.
   Cavaco LM, 2010, ANTIMICROB AGENTS CH, V54, P3605, DOI 10.1128/AAC.00058-10.
   Cavaco LM, 2011, VET MICROBIOL, V150, P344, DOI 10.1016/j.vetmic.2011.02.014.
   DANMAP, 2016, US ANT AG OCC ANT RE.
   De Vries W., 2004, 1030 ALT.
   Ellermann T., 2016, 204 NOVANA DCE AARH, P70.
   EMA, 2007, EMEACVMPERA418282200.
   EU, 2010, 24587EN2010 EUR.
   FAO, 2016, DRIV DYN EP ANT RES.
   Feltrin F, 2016, APPL ENVIRON MICROB, V82, P816, DOI 10.1128/AEM.02854-15.
   Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990.
   Guardabassi L, 2013, J GLOB ANTIMICROB RE, V1, P55, DOI 10.1016/j.jgar.2013.03.011.
   Han FX, 2000, SOIL SCI, V165, P260, DOI 10.1097/00010694-200003000-00008.
   Hasman H, 2002, ANTIMICROB AGENTS CH, V46, P1410, DOI 10.1128/AAC.46.5.1410-1416.2002.
   Hau S.J., 2017, APPL ENVIRON MICROB, V83, P1.
   Heo JM, 2013, J ANIM PHYSIOL AN N, V97, P207, DOI 10.1111/j.1439-0396.2012.01284.x.
   Jensen J., 2018, ZINK KOBBER VANDMILJ.
   Jensen J, 2016, ENVIRON POLLUT, V214, P334, DOI 10.1016/j.envpol.2016.03.034.
   Jensen-Waern M, 1998, RES VET SCI, V64, P225, DOI 10.1016/S0034-5288(98)90130-8.
   Kandeler E, 1996, BIOL FERT SOILS, V23, P299, DOI 10.1007/s003740050174.
   Katouli M, 1999, J APPL MICROBIOL, V87, P564, DOI 10.1046/j.1365-2672.1999.00853.x.
   Larsen J, 2016, CLIN INFECT DIS, V63, P1349, DOI 10.1093/cid/ciw532.
   Larsen J, 2016, ANTIMICROB AGENTS CH, V60, P4401, DOI 10.1128/AAC.00426-16.
   Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002.
   Li XQ, 2017, ENVIRON POLLUT, V231, P908, DOI 10.1016/j.envpol.2017.08.057.
   Li XL, 2006, J NUTR, V136, P1786.
   Li ZY, 2014, SCI TOTAL ENVIRON, V468, P843, DOI 10.1016/j.scitotenv.2013.08.090.
   Lin J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00033.
   Liu HY, 2005, SCI TOTAL ENVIRON, V339, P153, DOI 10.1016/j.scitotenv.2004.07.030.
   Lock K, 2003, ENVIRON POLLUT, V126, P371, DOI 10.1016/S0269-7491(03)00232-X.
   Lofts S, 2013, ENVIRON POLLUT, V180, P236, DOI 10.1016/j.envpol.2013.05.030.
   Macklin MG, 2003, APPL GEOCHEM, V18, P241, DOI 10.1016/S0883-2927(02)00123-3.
   Mantovi P, 2003, PLANT SOIL, V250, P249, DOI 10.1023/A:1022848131043.
   McBride MB, 2003, ADV ENVIRON RES, V8, P5, DOI 10.1016/S1093-0191(02)00141-7.
   Medardus JJ, 2014, APPL ENVIRON MICROB, V80, P2317, DOI 10.1128/AEM.04283-13.
   Migliorini M, 2004, ENVIRON POLLUT, V129, P331, DOI 10.1016/j.envpol.2003.09.025.
   Miljostyrelsen, 2009, ORIENTERING MILJOSTY.
   Monteiro S.C., 2010, NPFEEDAP200801.
   Nicholson FA, 2003, SCI TOTAL ENVIRON, V311, P205, DOI 10.1016/S0048-9697(03)00139-6.
   Nicholson FA, 1999, BIORESOURCE TECHNOL, V70, P23, DOI 10.1016/S0960-8524(99)00017-6.
   Novak JM, 2004, T ASAE, V47, P1513.
   Ogiyama S, 2005, SOIL SCI PLANT NUTR, V51, P801, DOI 10.1111/j.1747-0765.2005.tb00114.x.
   Osek J, 1999, VET MICROBIOL, V68, P209, DOI 10.1016/S0378-1135(99)00109-1.
   Posch M, 2009, ENVIRON MODELL SOFTW, V24, P86, DOI 10.1016/j.envsoft.2008.05.007.
   POULSEN HD, 1995, ACTA AGR SCAND A-AN, V45, P159, DOI 10.1080/09064709509415847.
   Sauve S, 2000, ENVIRON SCI TECHNOL, V34, P1125, DOI 10.1021/es9907764.
   Shi JC, 2011, J ENVIRON QUAL, V40, P1695, DOI 10.2134/jeq2010.0316.
   Singh RP, 2008, WASTE MANAGE, V28, P347, DOI 10.1016/j.wasman.2006.12.010.
   SKINNER S, 1988, MOL MICROBIOL, V2, P289, DOI 10.1111/j.1365-2958.1988.tb00030.x.
   Slifierz MJ, 2015, ZOONOSES PUBLIC HLTH, V62, P301, DOI 10.1111/zph.12150.
   Slifierz MJ, 2014, CAN VET J, V55, P489.
   Smith JW, 1997, J ANIM SCI, V75, P1861.
   Smolders E, 2003, ENVIRON TOXICOL CHEM, V22, P2592, DOI 10.1897/02-503.
   Vahjen W, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0071-3.
   van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384.
   Wang YZ, 2004, ASIAN AUSTRAL J ANIM, V17, P1635, DOI 10.5713/ajas.2004.1635.
   Werner G, 2013, INT J MED MICROBIOL, V303, P360, DOI 10.1016/j.ijmm.2013.03.001.
   Xu Y, 2013, PLANT SOIL ENVIRON, V59, P492, DOI 10.17221/121/2013-PSE.
   You YQ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00284.}},
Number-of-Cited-References = {{73}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{15}},
Usage-Count-Since-2013 = {{15}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{GC6CH}},
Unique-ID = {{ISI:000429877200021}},
DA = {{2018-08-13}},
}

@article{ ISI:000429877200030,
Author = {Zhang, Ye and Gu, April Z. and Cen, Tianyu and Li, Xiangyang and Li, Dan
   and Chen, Jianmin},
Title = {{Petrol and diesel exhaust particles accelerate the horizontal transfer
   of plasmid-mediated antimicrobial resistance genes}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2018}},
Volume = {{114}},
Pages = {{280-287}},
Month = {{MAY}},
Abstract = {{Particles exhausted from petrol and diesel consumptions are major
   components of urban air pollution that can be exposed to human via
   direct inhalation or other routes due to atmospheric deposition into
   water and soil. Antimicrobial resistance is one of the most serious
   threats to modern health care. However, how the petrol and diesel
   exhaust particles affect the development and spread of antimicrobial
   resistance genes (ARGs) in various environments remain largely unknown.
   This study investigated the effects and potential mechanisms of four
   representative petrol and diesel exhaust particles, namely 97 octane
   petrol, 93 octane petrol, light diesel oil, and marine heavy diesel oil,
   on the horizontal transfer of ARGs between two opportunistic Escherichia
   coli (E. coli) strains, E. coli S17-1 (donor) and E. coli K12
   (recipient). The results demonstrated that these four representative
   types of nano-scale particles induced concentration-dependent increases
   in conjugative transfer rates compared with the controls. The underlying
   mechanisms involved in the accelerated transfer of ARGs were also
   identified, including the generation of intracellular reactive oxygen
   species (ROS) and the consequent induction of oxidative stress, SOS
   response, changes in cell morphology, and the altered mRNA expression of
   membrane protein genes and those involved in the promotion of
   conjugative transfer. The findings provide new evidences and mechanistic
   insights into the antimicrobial resistance risks posed by petrol and
   diesel exhaust particles, and highlight the implications and need for
   stringent strategies on alternative fuels to mitigate air pollution and
   health risks.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Li, D (Reprint Author), Fudan Univ, Dept Environm Sci \& Engn, Shanghai Key Lab Atmospher Particle Pollut \& Prev, Shanghai 200433, Peoples R China.
   Zhang, Ye; Cen, Tianyu; Li, Xiangyang; Li, Dan; Chen, Jianmin, Fudan Univ, Dept Environm Sci \& Engn, Shanghai Key Lab Atmospher Particle Pollut \& Prev, Shanghai 200433, Peoples R China.
   Gu, April Z., Cornell Univ, Sch Civil \& Environm Engn, Ithaca, NY 14853 USA.}},
DOI = {{10.1016/j.envint.2018.02.038}},
ISSN = {{0160-4120}},
EISSN = {{1873-6750}},
Keywords = {{Petrol and diesel exhaust particles; Antimicrobial resistance;
   Conjugative transfer; ROS formation}},
Keywords-Plus = {{OXYGEN SPECIES ROS; ANTIBIOTIC-RESISTANCE; PARTICULATE MATTER;
   ESCHERICHIA-COLI; AIR-POLLUTION; MULTIDRUG-RESISTANCE; CONJUGATIVE
   TRANSFER; OXIDATIVE DAMAGE; HEALTH; COMBUSTION}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{lidanfudan@fudan.edu.cn}},
ORCID-Numbers = {{Chen, Jianmin/0000-0001-5859-3070}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}91643106, 21477024,
   21527814, 21507012]; United States National Science Foundation (NSF)
   {[}CBET-1437257, CBET-1810769, IIS-1546428]; National Institute of
   Environmental Health Sciences (NIEHS) {[}PROTECT 3P42ES017109, CRECE
   1P50ES026049]; Environmental Protection Agency (EPA) {[}CRECE 83615501]}},
Funding-Text = {{The content is solely the responsibility of the authors. This work was
   supported by grants from the National Natural Science Foundation of
   China (No. 91643106, 21477024, 21527814, and 21507012), United States
   National Science Foundation (NSF, CBET-1437257, CBET-1810769,
   IIS-1546428), National Institute of Environmental Health Sciences
   (NIEHS, PROTECT 3P42ES017109 and CRECE 1P50ES026049) and Environmental
   Protection Agency (EPA, CRECE 83615501).}},
Cited-References = {{Aguilera I, 2013, ENVIRON HEALTH PERSP, V121, P387, DOI 10.1289/ehp.1205281.
   Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004.
   Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270.
   Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241.
   Bengtsson-Palme J, 2015, NAT REV MICROBIOL, V13, DOI 10.1038/nrmicro3399-c1.
   Borras E, 2009, ATMOS ENVIRON, V43, P5944, DOI 10.1016/j.atmosenv.2009.08.010.
   Burton B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000406.
   Cambray G, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-6.
   Chang MCO, 2004, J AIR WASTE MANAGE, V54, P1494, DOI 10.1080/10473289.2004.10471010.
   Chen F, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/431047.
   Chen QL, 2016, ENVIRON INT, V92-93, P1, DOI 10.1016/j.envint.2016.03.026.
   Chen Q, 2015, BIOSENS BIOELECTRON, V73, P251, DOI 10.1016/j.bios.2015.06.011.
   CHMIELARCZYK A, 2014, BMC PEDIAT, V14.
   Choudhary A, 2016, TRANSPORT RES D-TR E, V43, P59, DOI 10.1016/j.trd.2015.12.006.
   Giusti MD, 2012, PLASMID, V67, P199, DOI 10.1016/j.plasmid.2011.12.010.
   Durga M, 2014, ENVIRON TOXICOL PHAR, V38, P518, DOI 10.1016/j.etap.2014.08.003.
   Fu H, 2012, ATMOS CHEM PHYS, V12, P693, DOI 10.5194/acp-12-693-2012.
   Gandolfi I, 2011, J APPL MICROBIOL, V110, P1612, DOI 10.1111/j.1365-2672.2011.05018.x.
   Gerlofs-Nijland ME, 2013, ENVIRON SCI TECHNOL, V47, P5931, DOI 10.1021/es305330y.
   Goel R, 2015, ATMOS ENVIRON, V105, P78, DOI 10.1016/j.atmosenv.2015.01.045.
   Grahn AM, 2000, J BACTERIOL, V182, P1564, DOI 10.1128/JB.182.6.1564-1574.2000.
   He C, 2014, ENVIRON INT, V69, P9, DOI 10.1016/j.envint.2014.04.001.
   Hesterberg TW, 2010, INHAL TOXICOL, V22, P679, DOI 10.3109/08958371003758823.
   Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938.
   Jin L, 2017, NATL SCI REV, V4, P593, DOI 10.1093/nsr/nww079.
   Jutkina J, 2018, SCI TOTAL ENVIRON, V616, P172, DOI 10.1016/j.scitotenv.2017.10.312.
   Kabir MM, 2006, BIOCHEM ENG J, V30, P39, DOI 10.1016/j.bej.2006.01.015.
   Katouli Mohammad, 2010, Iran J Microbiol, V2, P59.
   Knuckles TL, 2007, J TOXICOL ENV HEAL A, V70, P1824, DOI 10.1080/15287390701459213.
   Lv L, 2014, ENVIRON SCI TECHNOL, V48, P8188, DOI 10.1021/es501646n.
   MacIntyre EA, 2014, ENVIRON HEALTH PERSP, V122, P107, DOI 10.1289/ehp.1306755.
   McCool JD, 2004, MOL MICROBIOL, V53, P1343, DOI 10.1111/j.1365-2958.2004.04225.x.
   McEachran AD, 2015, ENVIRON HEALTH PERSP, V123, P337, DOI 10.1289/ehp.1408555.
   O'Neill J., 2014, REV ANTIMICROBIAL RE, V2014, P1.
   Pal C, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0199-5.
   Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0.
   Qiu ZG, 2012, P NATL ACAD SCI USA, V109, P4944, DOI 10.1073/pnas.1107254109.
   Riddle SG, 2007, ATMOS ENVIRON, V41, P8658, DOI 10.1016/j.atmosenv.2007.07.023.
   Samuels AL, 2000, J BACTERIOL, V182, P2709, DOI 10.1128/JB.182.10.2709-2715.2000.
   Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304.
   Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538.
   Verma V, 2015, ENVIRON SCI TECHNOL, V49, P4646, DOI 10.1021/es505577w.
   Wang Q, 2015, ENVIRON SCI TECHNOL, V49, P8731, DOI 10.1021/acs.est.5b01129.
   World Health Organization, 2014, ANT RES GLOB REP SUR.
   Wu D, 2017, SCI TOTAL ENVIRON, V605, P172, DOI 10.1016/j.scitotenv.2017.06.058.
   Xu P., 2014, COMPUT INTEL NEUROSC, V2014.
   Xu P, 2013, LANCET, V382, P2067, DOI 10.1016/S0140-6736(13)62693-8.
   Yadav VK, 2010, ENVIRON MONIT ASSESS, V168, P173, DOI 10.1007/s10661-009-1101-8.
   Zhang Y, 2017, ENVIRON SCI TECHNOL, V51, P570, DOI 10.1021/acs.est.6b03132.
   Zhang YZ, 2015, ATMOS ENVIRON, V122, P885, DOI 10.1016/j.atmosenv.2015.07.014.
   Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110.
   ZIEGELIN G, 1989, J BIOL CHEM, V264, P11989.}},
Number-of-Cited-References = {{52}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{31}},
Usage-Count-Since-2013 = {{31}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{GC6CH}},
Unique-ID = {{ISI:000429877200030}},
DA = {{2018-08-13}},
}

@article{ ISI:000429500300011,
Author = {Davis, Meghan F. and Pisanic, Nora and Rhodes, Sarah M. and Brown,
   Alexis and Keller, Haley and Nadimpalli, Maya and Christ, Andrea and
   Ludwig, Shanna and Ordak, Carly and Spicer, Kristoffer and Love, David
   C. and Larsen, Jesper and Wright, Asher and Blacklin, Sarah and Flowers,
   Billy and Stewart, Jill and Sexton, Kenneth G. and Rule, Ana M. and
   Heaney, Christopher D.},
Title = {{Occurrence of Staphylococcus aureus in swine and swine workplace
   environments on industrial and antibiotic-free hog operations in North
   Carolina, USA: A One Health pilot study}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2018}},
Volume = {{163}},
Pages = {{88-96}},
Month = {{MAY}},
Abstract = {{Occupational exposure to swine has been associated with increased
   Staphylococcus aureus carriage, including antimicrobial-resistant
   strains, and increased risk of infections. To characterize animal and
   environmental routes of worker exposure, we optimized methods to
   identify S. aureus on operations that raise swine in confinement with
   antibiotics (industrial hog operation: IHO) versus on pasture without
   antibiotics (antibiotic-free hog operation: AFHO). We associated
   findings from tested swine and environmental samples with those from
   personal inhalable air samplers on worker surrogates at one IHO and
   three AFHOs in North Carolina using a new One Health approach. We
   determined swine S. aureus carriage status by collecting swab samples
   from multiple anatomical sites, and we determined environmental
   positivity for airborne bioaerosols with inhalable and impinger samplers
   and a single-stage impactor (ambient air) cross-sectionally. All samples
   were analyzed for S. aureus, and isolates were tested for antimicrobial
   susceptibility, absence of scn (livestock marker), and spa type.
   Seventeen of twenty (85\%) swine sampled at the one IHO carried S.
   aureus at > 1 anatomical sites compared to none of 30 (0\%) swine
   sampled at the three AFHOs. All S. aureus isolates recovered from IHO
   swine and air samples were scn negative and spa type t337; almost all
   isolates (62/63) were multidrug resistant. S. aureus was recovered from
   eight of 14 (67\%) ambient air and two (100\%) worker surrogate personal
   air samples at the one IHO, whereas no S. aureus isolates were recovered
   from 19 ambient and six personal air samples at the three AFHOs.
   Personal worker surrogate inhalable sample findings were consistent with
   both swine and ambient air data, indicating the potential for workplace
   exposure. IHO swine and the one IHO environment could be a source of
   potential pathogen exposure to workers, as supported by the detection of
   multidrug-resistant S. aureus (MDRSA) with livestock-associated spa type
   t337 among swine, worker surrogate personal air samplers and
   environmental air samples at the one IHO but none of the three AFHOs
   sampled in this study. Concurrent sampling of swine, personal swine
   worker surrogate air, and ambient airborne dust demonstrated that IHO
   workers may be exposed through both direct (animal contact) and indirect
   (airborne) routes of transmission. Investigation of the effectiveness of
   contact and respiratory protections is warranted to prevent IHO worker
   exposure to multidrug-resistant livestock-associated S. aureus and other
   pathogens.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Davis, MF; Heaney, CD (Reprint Author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth \& Engn, 615 N Wolfe St, Baltimore, MD 21205 USA.
   Heaney, CD (Reprint Author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.
   Heaney, CD (Reprint Author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.
   Davis, Meghan F.; Pisanic, Nora; Brown, Alexis; Christ, Andrea; Ludwig, Shanna; Ordak, Carly; Spicer, Kristoffer; Love, David C.; Rule, Ana M.; Heaney, Christopher D., Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth \& Engn, 615 N Wolfe St, Baltimore, MD 21205 USA.
   Rhodes, Sarah M.; Nadimpalli, Maya; Stewart, Jill; Sexton, Kenneth G., Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Environm Sci \& Engn, Chapel Hill, NC USA.
   Keller, Haley; Flowers, Billy, North Carolina State Univ, Raleigh, NC USA.
   Larsen, Jesper, Statens Serum Inst, Dept Bacteria Parasites \& Fungi, Copenhagen, Denmark.
   Wright, Asher; Blacklin, Sarah, North Carolina State Univ Cooperat Extens, NC Choices, Raleigh, NC USA.
   Wright, Asher; Blacklin, Sarah, NC A\&T State Univ, Greensboro, NC USA.
   Davis, Meghan F., Johns Hopkins Sch Med, Dept Mol \& Comparat Pathobiol, Baltimore, MD USA.
   Love, David C., Johns Hopkins Ctr Livable Future, Baltimore, MD USA.
   Heaney, Christopher D., Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.
   Heaney, Christopher D., Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.}},
DOI = {{10.1016/j.envres.2017.12.010}},
ISSN = {{0013-9351}},
EISSN = {{1096-0953}},
Keywords = {{Staphylococcus aureus; Occupational health; One Health; Swine;
   Antimicrobial resistance}},
Keywords-Plus = {{LIVESTOCK-ASSOCIATED METHICILLIN; PIG FARMERS; NASAL CARRIAGE; MECA
   HOMOLOG; RESISTANT; HUMANS; COLONIZATION; WORKERS; MRSA; IDENTIFICATION}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{mdavis65@jhu.edu
   cheaney1@jhu.edu}},
Funding-Acknowledgement = {{Thrasher Research Fund {[}10287]; National Science Foundation as part of
   the joint NSF-National Institutes of Health (NIH)-US Department of
   Agriculture (USDA) Ecology and Evolution of Infectious Diseases program
   {[}1316318]; Johns Hopkins NIOSH ERC; Thrasher Award {[}10287]; NIOSH
   Grant {[}1K01OH010193-01A1]; NIH ORIP grant {[}1K01OD019918]; National
   Institute of Environmental Health Sciences (NIEHS) {[}5T32ES007141-32];
   NSF {[}1316318]; Johns Hopkins Center for a Livable Future}},
Funding-Text = {{Funding for this study was provided by E.W. ``Al{''} Thrasher Award
   10287 from the Thrasher Research Fund and National Science Foundation
   grant 1316318 as part of the joint NSF-National Institutes of Health
   (NIH)-US Department of Agriculture (USDA) Ecology and Evolution of
   Infectious Diseases program. The Johns Hopkins NIOSH ERC also provided
   support for portions of this work. CDH was supported by Thrasher Award
   10287 and NIOSH Grant 1K01OH010193-01A1. MFD was supported by NIH ORIP
   grant 1K01OD019918. NP and AB were supported by the National Institute
   of Environmental Health Sciences (NIEHS) award 5T32ES007141-32. SMR was
   supported by NSF award 1316318. DCL was supported by the Johns Hopkins
   Center for a Livable Future with a gift from the GRACE Communication
   Foundation. The funders had no role in study design, data collection and
   interpretation, or the decision to submit the work for publication.}},
Cited-References = {{Agerso Y, 2014, EPIDEMIOL INFECT, V142, P1727, DOI 10.1017/S095026881300280X.
   Bos MEH, 2016, J EXPO SCI ENV EPID, V26, P263, DOI 10.1038/jes.2014.85.
   Broens EM, 2011, VET MICROBIOL, V147, P440, DOI 10.1016/j.vetmic.2010.07.021.
   CLSI, 2014, M100S25 CLSI.
   CLSI, 2012, M100S21 CLSI.
   Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275.
   Davis MF, 2017, ONE HEALTH, V4, P14, DOI 10.1016/j.onehlt.2017.07.001.
   Davis MF, 2016, J CLIN MICROBIOL, V54, P1907, DOI 10.1128/JCM.00132-16.
   Davis MF, 2012, APPL ENVIRON MICROB, V78, P2474, DOI 10.1128/AEM.06886-11.
   Denis O, 2009, EMERG INFECT DIS, V15, P1098, DOI 10.3201/eid1507.080652.
   Dorado-Garcia A, 2015, EMERG INFECT DIS, V21, P950, DOI 10.3201/eid2106.140706.
   DTU, 2009, PROT SPA TYP COMM RE.
   EFSA, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.229r.
   Espinosa-Gongora C, 2015, APPL ENVIRON MICROB, V81, P1251, DOI 10.1128/AEM.03392-14.
   FDA (Food and Drug Administration), 2016, 2015 SUMM REP ANT SO.
   Ferguson D. D., 2016, J AGROMED.
   Friese A, 2012, VET MICROBIOL, V158, P129, DOI 10.1016/j.vetmic.2012.01.019.
   Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8.
   Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910.
   Grontvedt CA, 2016, CLIN INFECT DIS, V63, P1431, DOI 10.1093/cid/ciw552.
   Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025.
   Hatcher SM, 2017, ENVIRON HEALTH PERSP, V125, P560, DOI 10.1289/EHP35.
   Hau SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142832.
   Iverson SA, 2015, VET MICROBIOL, V176, P202, DOI 10.1016/j.vetmic.2015.01.003.
   Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006.
   Larsen J., 2017, EUR SURVEILL, V22.
   Larsen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031976.
   Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576.
   Linhares LL, 2015, J VET DIAGN INVEST, V27, P55, DOI 10.1177/1040638714559598.
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x.
   Nadimpalli M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165713.
   Nadimpalli M, 2015, OCCUP ENVIRON MED, V72, P90, DOI 10.1136/oemed-2014-102095.
   NASS, 2015, OV US HOG IND.
   Oppliger A, 2012, APPL ENVIRON MICROB, V78, P8010, DOI 10.1128/AEM.01902-12.
   Paule SM, 2003, J MOL DIAGN, V6, P191, DOI 10.1016/S1525-1578(10)60509-0.
   Peterson AE, 2012, VET MICROBIOL, V160, P539, DOI 10.1016/j.vetmic.2012.06.032.
   Pletinckx LJ, 2013, PREV VET MED, V109, P293, DOI 10.1016/j.prevetmed.2012.10.019.
   Price L. B., 2011, MBIO, V3.
   Reischl U, 2000, J CLIN MICROBIOL, V38, P2429.
   Rinsky JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067641.
   Sasaki T, 2010, J CLIN MICROBIOL, V48, P765, DOI 10.1128/JCM.01232-09.
   Schmithausen KM., 2015, PLOS ONE, V10.
   Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12.
   Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556.
   Sinlapasorn S, 2015, J MED MICROBIOL, V64, P1087, DOI 10.1099/jmm.0.000119.
   SKC, GEL FILT OP INSTR.
   Smith Tara C, 2015, Curr Environ Health Rep, V2, P41, DOI 10.1007/s40572-014-0034-8.
   Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258.
   Stegger M, 2012, CLIN MICROBIOL INFEC, V18, P395, DOI 10.1111/j.1469-0691.2011.03715.x.
   Steward CD, 2005, J CLIN MICROBIOL, V43, P1716, DOI 10.1128/JCM.43.4.1716-1721.2005.
   Sun J., 2016, THESIS.
   van Cleef BAGL, 2014, CLIN MICROBIOL INFEC, V20, pO764, DOI 10.1111/1469-0691.12582.
   van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10.
   Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507.
   van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384.
   van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006.
   Wardyn SE, 2015, CLIN INFECT DIS, V61, P59, DOI 10.1093/cid/civ234.
   Ye XH, 2016, APPL ENVIRON MICROB, V82, P3892, DOI 10.1128/AEM.00091-16.
   Ye XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19184.}},
Number-of-Cited-References = {{59}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{10}},
Usage-Count-Since-2013 = {{10}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{GC0XD}},
Unique-ID = {{ISI:000429500300011}},
DA = {{2018-08-13}},
}

@article{ ISI:000434978700177,
Author = {Usui, Tatsuya and Sakurai, Masashi and Umata, Koji and Elbadawy, Mohamed
   and Ohama, Takashi and Yamawaki, Hideyuki and Hazama, Shoichi and
   Takenouchi, Hiroko and Nakajima, Masao and Tsunedomi, Ryouichi and
   Suzuki, Nobuaki and Nagano, Hiroaki and Sato, Koichi and Kaneda,
   Masahiro and Sasaki, Kazuaki},
Title = {{Hedgehog Signals Mediate Anti-Cancer Drug Resistance in
   Three-Dimensional Primary Colorectal Cancer Organoid Culture}},
Journal = {{INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES}},
Year = {{2018}},
Volume = {{19}},
Number = {{4}},
Month = {{APR}},
Abstract = {{Colorectal cancer is one of the most common causes of cancer death
   worldwide. In patients with metastatic colorectal cancer, combination
   treatment with several anti-cancer drugs is employed and improves
   overall survival in some patients. Nevertheless, most patients with
   metastatic disease are not cured owing to the drug resistance. Cancer
   stem cells are known to regulate resistance to chemotherapy. In the
   previous study, we established a novel three-dimensional organoid
   culture model from tumor colorectal tissues of human patients using an
   air-liquid interface (ALI) method, which contained numerous cancer stem
   cells and showed resistance to 5-fluorouracil (5-FU) and Irinotecan.
   Here, we investigate which inhibitor for stem cell-related signal
   improves the sensitivity for anti-cancer drug treatment in tumor ALI
   organoids. Treatment with Hedgehog signal inhibitors (AY9944, GANT61)
   decreases the cell viability of organoids compared with Notch (YO-01027,
   DAPT) and Wnt (WAV939, Wnt-C59) signal inhibitors. Combination treatment
   of AY9944 or GANT61 with 5-FU, Irinotecan or Oxaliplatin decreases the
   cell viability of tumor organoids compared with each anti-cancer drug
   alone treatment. Treatment with AY9944 or GANT61 inhibits expression of
   stem cell markers c-Myc, CD44 and Nanog, likely through the decrease of
   their transcription factor, GLI-1 expression. Combination treatment of
   AY9944 or GANT61 with 5-FU or Irinotecan also prevents colony formation
   of colorectal cancer cell lines HCT116 and SW480. These findings suggest
   that Hedgehog signals mediate anti-cancer drug resistance in colorectal
   tumor patient-derived ALI organoids and that the inhibitors are useful
   as a combinational therapeutic strategy against colorectal cancer.}},
Publisher = {{MDPI}},
Address = {{ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Usui, T (Reprint Author), Tokyo Univ Agr \& Technol, Fac Agr, Dept Vet Med, Lab Vet Pharmacol, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.
   Usui, Tatsuya; Elbadawy, Mohamed; Sasaki, Kazuaki, Tokyo Univ Agr \& Technol, Fac Agr, Dept Vet Med, Lab Vet Pharmacol, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.
   Sakurai, Masashi, Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pathol, 1677-1 Yoshida, Yamaguchi 7538515, Japan.
   Umata, Koji; Ohama, Takashi; Sato, Koichi, Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pharmacol, 1677-1 Yoshida, Yamaguchi 7538515, Japan.
   Elbadawy, Mohamed, Benha Univ, Fac Vet Med, Dept Pharmacol, Toukh 13736, Elqaliobiya, Egypt.
   Yamawaki, Hideyuki, Kitasato Univ, Sch Vet Med, Lab Vet Pharmacol, Higashi 23 Bancho 35-1, Towada, Aomori 0348628, Japan.
   Hazama, Shoichi, Yamaguchi Univ, Sch Med, Dept Translat Res \& Dev Therapeut Canc, 1-1-1 Ogushi, Ube, Yamaguchi 7558505, Japan.
   Hazama, Shoichi; Takenouchi, Hiroko; Nakajima, Masao; Tsunedomi, Ryouichi; Suzuki, Nobuaki; Nagano, Hiroaki, Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol Breast \& Endocrine Surg, 1-1-1 Ogushi, Ube, Yamaguchi 7558505, Japan.
   Kaneda, Masahiro, Tokyo Univ Agr \& Technol, Fac Agr, Dept Vet Med, Lab Vet Anat, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.}},
DOI = {{10.3390/ijms19041098}},
Article-Number = {{1098}},
ISSN = {{1422-0067}},
Keywords = {{colorectal cancer; Hedgehog signal; chemoresistance; organoid; stem cell}},
Keywords-Plus = {{HUMAN COLON-CANCER; STEM-CELLS; PANCREATIC-CANCER; TUMOR-GROWTH;
   PATHWAY; INHIBITION; THERAPY; CARCINOGENESIS; CHEMOTHERAPY; PROGRESSION}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Chemistry, Multidisciplinary}},
Author-Email = {{fu7085@go.tuat.ac.jp
   sakurai@yamaguchi-u.ac.jp
   t007tb@yamaguchi-u.ac.jp
   mohamed.elbadawy@fvtm.bu.edu.eg
   t.ohama@yamaguchi-u.ac.jp
   yamawaki@vmas.kitasato-u.ac.jp
   hazama@yamaguchi-u.ac.jp
   h-take@yamaguchi-u.ac.jp
   masao-y@yamaguchi-u.ac.jp
   tsune-r@yamaguchi-u.ac.jp
   nobusuzu@yamaguchi-u.ac.jp
   hnagano@yamaguchi-u.ac.jp
   k-sato@yamaguchi-u.ac.jp
   kanedam@cc.tuat.ac.jp
   skazuaki@cc.tuat.ac.jp}},
ORCID-Numbers = {{Elbadawy, Mohamed/0000-0001-9368-1535}},
Cited-References = {{Agyeman A, 2012, ONCOTARGET, V3, P854.
   Batsaikhan BE, 2014, ANTICANCER RES, V34, P6339.
   Buller NVJA, 2015, GASTROENTEROLOGY, V148, P170, DOI 10.1053/j.gastro.2014.10.006.
   Croker AK, 2008, J CELL MOL MED, V12, P374, DOI 10.1111/j.1582-4934.2007.00211.x.
   Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516.
   Fujiwara N, 2016, J BIOL CHEM, V291, P10858, DOI 10.1074/jbc.M115.704908.
   Galimberti F, 2012, INT J ONCOL, V41, P1751, DOI 10.3892/ijo.2012.1599.
   Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pans.0400067101.
   Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019.
   Huang EH, 2008, TRENDS MOL MED, V14, P503, DOI 10.1016/j.molmed.2008.09.005.
   Hwang RF, 2012, MOL CANCER RES, V10, P1147, DOI 10.1158/1541-7786.MCR-12-0022.
   Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601.
   Kake S, 2017, ONCOL REP, V37, P1100, DOI 10.3892/or.2017.5359.
   Lenz HJ, 2008, CANCER TREAT REV, V34, pS3, DOI 10.1016/S0305-7372(08)70002-1.
   Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9.
   Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585.
   Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943.
   McMillan R, 2012, CLIN CANCER RES, V18, P4883, DOI 10.1158/1078-0432.CCR-11-2509.
   Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053.
   Nagare RP, 2017, CURR STEM CELL RES T, V12, P37, DOI 10.2174/1574888X11666160607211436.
   Nordlinger B, 2002, J CLIN ONCOL, V20, P1442, DOI 10.1200/JCO.2002.20.6.1442.
   Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362.
   Ong BA, 2014, WORLD J GASTROENTERO, V20, P1898, DOI 10.3748/wjg.v20.i8.1898.
   Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951.
   Palle K, 2015, CANCERS, V7, P2330, DOI 10.3390/cancers7040894.
   Pan TH, 2017, INT J MOL MED, V39, P9, DOI 10.3892/ijmm.2016.2815.
   Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895.
   Stockler M, 2000, CANCER TREAT REV, V26, P151, DOI 10.1053/ctrv.1999.0161.
   Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106.
   Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063.
   Tolba MF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15239.
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262.
   Usui T., 2016, STEM CELLS INT, V2016.
   Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039.
   Yabe R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145226.
   Yang ZT, 2017, J CANCER RES CLIN, V143, P243, DOI 10.1007/s00432-016-2273-6.
   Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386.
   Zhang CJ, 2011, J CANCER RES CLIN, V137, P1679, DOI 10.1007/s00432-011-1038-5.
   Zhang L., 2017, MICROSYST TECHNOL, V5, P1.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{Int. J. Mol. Sci.}},
Doc-Delivery-Number = {{GJ0XU}},
Unique-ID = {{ISI:000434978700177}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000427254400006,
Author = {Schwarz, Carsten and Vandeputte, Patrick and Rougeron, Amandine and
   Giraud, Sandrine and de Bernonville, Thomas Duge and Duvaux, Ludovic and
   Gastebois, Amandine and Alastruey-Izquierdo, Ana and Teresa
   Martin-Gomez, Maria and Martin Mazuelos, Estrella and Sole, Amparo and
   Cano, Josep and Peman, Javier and Quindos, Guillermo and Botterel,
   Francoise and Bougnoux, Marie-Elisabeth and Chen, Sharon and Delhaes,
   Laurence and Favennec, Loic and Ranque, Stephane and Sedlacek, Ludwig
   and Steinmann, Joerg and Vazquez, Jose and Williams, Craig and Meyer,
   Wieland and Le Gal, Solene and Nevez, Gilles and Fleury, Maxime and
   Papon, Nicolas and Symoens, Francoise and Bouchara, Jean-Philippe and
   ECMM ISHAM Working Grp and Fungal Resp Infections Cystic Fibr},
Title = {{Developing collaborative works for faster progress on fungal respiratory
   infections in cystic fibrosis}},
Journal = {{MEDICAL MYCOLOGY}},
Year = {{2018}},
Volume = {{56}},
Number = {{1}},
Pages = {{S42-S59}},
Month = {{APR}},
Abstract = {{Cystic fibrosis (CF) is the major genetic inherited disease in Caucasian
   populations. The respiratory tract of CF patients displays a sticky
   viscous mucus, which allows for the entrapment of airborne bacteria and
   fungal spores and provides a suitable environment for growth of
   microorganisms, including numerous yeast and filamentous fungal species.
   As a consequence, respiratory infections are the major cause of
   morbidity and mortality in this clinical context. Although bacteria
   remain the most common agents of these infections, fungal respiratory
   infections have emerged as an important cause of disease. Therefore, the
   International Society for Human and Animal Mycology (ISHAM) has launched
   a working group on Fungal respiratory infections in Cystic Fibrosis
   (Fri-CF) in October 2006, which was subsequently approved by the
   European Confederation of Medical Mycology (ECMM). Meetings of this
   working group, comprising both clinicians and mycologists involved in
   the follow-up of CF patients, as well as basic scientists interested in
   the fungal species involved, provided the opportunity to initiate
   collaborative works aimed to improve our knowledge on these infections
   to assist clinicians in patient management. The current review
   highlights the outcomes of some of these collaborative works in clinical
   surveillance, pathogenesis and treatment, giving special emphasis to
   standardization of culture procedures, improvement of species
   identification methods including the development of nonculture-based
   diagnostic methods, microbiome studies and identification of new
   biological markers, and the description of genotyping studies aiming to
   differentiate transient carriage and chronic colonization of the
   airways. The review also reports on the breakthrough in sequencing the
   genomes of the main Scedosporium species as basis for a better
   understanding of the pathogenic mechanisms of these fungi, and discusses
   treatment options of infections caused by multidrug resistant
   microorganisms, such as Scedosporium and Lomentospora species and
   members of the Rasamsonia argillacea species complex.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Bouchara, JP (Reprint Author), CHU Angers, Inst Biol Sante IRIS, Host Pathogen Interact Study Grp EA 3142, 4 Rue Larrey, F-49933 Angers 9, France.
   Schwarz, Carsten, Charite, Cyst Fibrosis Ctr Berlin, Dept Pediat Pneumol \& Immunol, Berlin, Germany.
   Vandeputte, Patrick; Giraud, Sandrine; Duvaux, Ludovic; Gastebois, Amandine; Fleury, Maxime; Papon, Nicolas; Symoens, Francoise; Bouchara, Jean-Philippe, Univ Bretagne Loire, UNIV Brest, UNIV Angers, Host Pathogen Interact Study Grp EA 3142, Angers, France.
   Vandeputte, Patrick; Bouchara, Jean-Philippe, CHU Angers, Lab Parasitol Mycol, Angers, France.
   Rougeron, Amandine, Univ Bordeaux, Microbiol Fondamentale \& Pathogenicite UMR 5234, Bordeaux, France.
   Rougeron, Amandine, CNRS, Microbiol Fondamentale \& Pathogenicite, UMR 5234, Bordeaux, France.
   Rougeron, Amandine, CHU Bordeaux, Lab Parasitol Mycol, Bordeaux, France.
   de Bernonville, Thomas Duge, Univ Tours, UFR Sci \& Techn, Dept Biol \& Physiol Vegetales, Biomol \& Biotechnol Vegetales EA 2106, Tours, France.
   Duvaux, Ludovic, IRHS, UMR INRA 1345, Beaucouze, France.
   Alastruey-Izquierdo, Ana, Inst Salud Carlos III, Natl Ctr Microbiol, Mycol Reference Lab, Madrid, Spain.
   Teresa Martin-Gomez, Maria, Univ Autonoma Barcelona, Vall DHebron Univ Hosp, Dept Microbiol, Resp Bacteriol Unit, Barcelona, Spain.
   Teresa Martin-Gomez, Maria, Univ Autonoma Barcelona, Vall DHebron Univ Hosp, Dept Microbiol, Clin Mycol Unit, Barcelona, Spain.
   Martin Mazuelos, Estrella, Hosp Univ Valme, Dept Microbiol, Seville, Spain.
   Sole, Amparo, Hosp Univ La Fe, Unidad Trasplante Pulmonar \& Fibrosis Quist, Valencia, Spain.
   Cano, Josep, Univ Rovira \& Virgili, Med Sch, Oenol Sch, Mycol Unit, Reus, Spain.
   Peman, Javier, Univ La Fe, Serv Microbiol, Unidad Micol, Valencia, Spain.
   Quindos, Guillermo, Univ Basque Country, Fac Med \& Enfermeria, Dept Inmunol Microbiol \& Parasitol, Lab Micol Med, Bilbao, Spain.
   Botterel, Francoise, CHU Henri Mondor, Lab Parasitol Mycol, Creteil, France.
   Bougnoux, Marie-Elisabeth, Hop Necker Enfants Malad, Lab Microbiol, Paris, France.
   Chen, Sharon, Westmead Hosp, ICPMR Pathol West, Ctr Infect Dis \& Microbiol Lab Serv, Westmead, NSW, Australia.
   Delhaes, Laurence, INSERM, U1045, Ctr Cardiothorac Res Bordeaux, Bordeaux, France.
   Favennec, Loic, CHU Charles Nicolle, EA 3800, Lab Parasitol Mycol, Rouen, France.
   Favennec, Loic, Univ Rouen, Rouen, France.
   Ranque, Stephane, AP HM Timone, Lab Parasitol Mycol, Marseille, France.
   Sedlacek, Ludwig, Med Sch Hannover, Inst Med Microbiol \& Hosp Epidemiol, Hannover, Germany.
   Steinmann, Joerg, Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany.
   Vazquez, Jose, Georgia Regents Univ, Dept Med, Div Infect Dis, Augusta, GA USA.
   Williams, Craig, Univ West Scotland, Univ Hosp Crosshouse, Inst Healthcare Associated Infect, Kilmarnock, Scotland.
   Meyer, Wieland, Univ Sydney, Westmead Hosp,Mol Mycol Res Lab, Westmead Inst Med Res,Ctr Infect Dis \& Microbiol, Sydney Med Sch,Westmead Clin Sch,Marie Bashir Ins, Westmead, NSW, Australia.
   Le Gal, Solene; Nevez, Gilles, Univ Bretagne Loire, UNIV Brest, UNIV Angers, Host Pathogen Interact Study Grp EA 3142, Brest, France.
   Le Gal, Solene; Nevez, Gilles, CHU Brest, Lab Parasitol Mycol, Brest, France.}},
DOI = {{10.1093/mmy/myx106}},
ISSN = {{1369-3786}},
EISSN = {{1460-2709}},
Keywords = {{cystic fibrosis; fungal respiratory infections; biological diagnosis;
   pathogenic mechanisms; treatment; Scedosporium species}},
Keywords-Plus = {{ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; DESORPTION-IONIZATION-TIME;
   FLIGHT MASS-SPECTROMETRY; SCEDOSPORIUM-PROLIFICANS INFECTION; IN-VITRO
   ACTIVITIES; PSEUDALLESCHERIA-BOYDII COMPLEX; CONVENTIONAL ANTIFUNGAL
   AGENTS; CHRONIC GRANULOMATOUS-DISEASE; CHRONIC AIRWAY COLONIZATION;
   RENAL-TRANSPLANT RECIPIENT}},
Research-Areas = {{Infectious Diseases; Mycology; Veterinary Sciences}},
Web-of-Science-Categories  = {{Infectious Diseases; Mycology; Veterinary Sciences}},
Author-Email = {{jean-philippe.bouchara@univ-angers.fr}},
ResearcherID-Numbers = {{Duvaux, Ludovic/F-4479-2011
   }},
ORCID-Numbers = {{Duvaux, Ludovic/0000-0003-0960-0312
   Peman, Javier/0000-0003-3222-5653
   Martin Gomez, M. Teresa/0000-0001-8119-8749
   Quindos Andres, Guillermo/0000-0003-0438-2248}},
Funding-Acknowledgement = {{National Health and Medical Research Council (NH\&MRC) grant from
   Australia {[}APP1031943]; French association Vaincre la Mucoviscidose
   {[}RF20120600725/1/1/110]; Angers University; Vaincre la Mucoviscidose
   {[}2010/IC1003, RC20120600707/1/2/110, RF20130500840]}},
Funding-Text = {{The genomic studies have been supported by a National Health and Medical
   Research Council (NH\&MRC) grant from Australia APP1031943 to WM for S.
   aurantiacum, by the French association Vaincre la Mucoviscidose
   (RF20120600725/1/1/110) to JPB for S. apiospermum and by Angers
   University (Appel a projets internes 2014) to AG for S. boydii. Some of
   the works performed regarding improvement of the biological diagnosis of
   fungal respiratory infections in CF were supported by grants from
   Vaincre la Mucoviscidose to JPB (2010/IC1003), MEB
   (RC20120600707/1/2/110) or MF (RF20130500840).}},
Cited-References = {{Accurso FJ, 2006, AM J RESP CRIT CARE, V173, P944, DOI 10.1164/rccm.2601006.
   Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004.
   Al-Laaeiby A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040444.
   Alastruey-Izquierdo A, 2013, ANTIMICROB AGENTS CH, V57, P3380, DOI 10.1128/AAC.00383-13.
   Ananda-Rajah MR, 2008, MYCOPATHOLOGIA, V166, P83, DOI 10.1007/s11046-008-9131-2.
   Bakare N, 2003, MYCOSES, V46, P19, DOI 10.1046/j.1439-0507.2003.00830.x.
   Balandin B, 2016, MED MYCOL CASE REP, V11, P53, DOI 10.1016/j.mmcr.2016.04.006.
   Barrera C, 2016, CLIN VACCINE IMMUNOL, V23, P196, DOI 10.1128/CVI.00498-15.
   Barton RC, 2010, J CLIN MICROBIOL, V48, P2615, DOI 10.1128/JCM.00184-10.
   BAUERNFEIND A, 1987, INFECTION, V15, P270, DOI 10.1007/BF01644137.
   Baxter CG, 2013, J ALLERGY CLIN IMMUN, V132, P560, DOI 10.1016/j.jaci.2013.04.007.
   Bernhardt A, 2013, J CYST FIBROS, V12, P592, DOI 10.1016/j.jcf.2013.05.007.
   Bertrand S, 2010, MED MYCOL, V48, pS98, DOI 10.3109/13693786.2010.503972.
   Bertrand S, 2009, BIOMETALS, V22, P1019, DOI 10.1007/s10534-009-9253-0.
   Bhat SV, 2007, SCAND J INFECT DIS, V39, P87, DOI 10.1080/00365540600786564.
   Biswas C, 2013, J ANTIMICROB CHEMOTH, V68, P2842, DOI 10.1093/jac/dkt282.
   Blyth CC, 2010, J CLIN MICROBIOL, V48, P314, DOI 10.1128/JCM.01470-09.
   Borghi E, 2010, MED MYCOL, V48, pS108, DOI 10.3109/13693786.2010.504239.
   Borman AM, 2010, MED MYCOL, V48, pS88, DOI 10.3109/13693786.2010.511287.
   Bouchara JP, 2009, J CLIN MICROBIOL, V47, P142, DOI 10.1128/JCM.01668-08.
   Brouard J, 2005, J INFECT DIS, V191, P1988, DOI 10.1086/429964.
   Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075.
   Cairns TC, 2016, TRENDS MICROBIOL, V24, P35, DOI 10.1016/j.tim.2015.09.008.
   Carrillo AJ, 2001, ANTIMICROB AGENTS CH, V45, P2151, DOI 10.1128/AAC.45.7.2151-2153.2001.
   Casaulta C, 2005, PEDIATR ALLERGY IMMU, V16, P217, DOI 10.1111/j.1399-3038.2005.00262.x.
   Cassagne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028425.
   Castanheira M, 2012, ANTIMICROB AGENTS CH, V56, P352, DOI 10.1128/AAC.05414-11.
   Castellani C, 2017, CELL MOL LIFE SCI, V74, P129, DOI 10.1007/s00018-016-2393-9.
   Cerqueira LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092851.
   CHABASSE D, 1991, Journal de Mycologie Medicale, V1, P152.
   Chambers ST, 2009, MED MYCOL, V47, P468, DOI 10.1080/13693780802475212.
   Chauhan B, 2000, J ALLERGY CLIN IMMUN, V106, P723, DOI 10.1067/mai.2000.109913.
   Chotirmall SH, 2014, INT J BIOCHEM CELL B, V52, P161, DOI {[}10.1016/j.bioce1.2014.03.001, 10.1016/j.biocel.2014.03.001].
   Cimon B, 1999, MED MYCOL, V37, P291, DOI 10.1046/j.1365-280X.1999.00232.x.
   Cimon B, 2000, EUR J CLIN MICROBIOL, V19, P53, DOI 10.1007/s100960050011.
   Cohen-Cymberknoh M, 2011, AM J RESP CRIT CARE, V183, P1463, DOI 10.1164/rccm.201009-1478CI.
   Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07.
   Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x.
   Cuenca-Estrella M, 1999, J ANTIMICROB CHEMOTH, V43, P149, DOI 10.1093/jac/43.1.149.
   Cuenca-Estrella M, 2008, ANTIMICROB AGENTS CH, V52, P1136, DOI 10.1128/AAC.01160-07.
   De Carolis E, 2012, CLIN MICROBIOL INFEC, V18, P475, DOI 10.1111/j.1469-0691.2011.03599.x.
   De Ravin SS, 2011, CLIN INFECT DIS, V52, pE136, DOI 10.1093/cid/ciq250.
   Defontaine A, 2002, J CLIN MICROBIOL, V40, P2108, DOI 10.1128/JCM.40.6.2108-2114.2002.
   Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313.
   Delhaes L, 2010, MED MYCOL, V48, pS77, DOI 10.3109/13693786.2010.514301.
   Denning DW, 2015, SCIENCE, V347, P1414, DOI 10.1126/science.aaa6097.
   Denton EJ, 2016, MED MYCOL CASE REP, V12, P14, DOI 10.1016/j.mmcr.2016.07.001.
   Doring G, 2012, J CYST FIBROS, V11, P461, DOI 10.1016/j.jcf.2012.10.004.
   Doligalski CT, 2014, AM J TRANSPLANT, V14, P1328, DOI 10.1111/ajt.12691.
   Domingo MP, 2012, DIAGN MICR INFEC DIS, V73, P57, DOI 10.1016/j.diagmicrobio.2012.01.012.
   Downes F. P., 2001, COMPENDIUM METHODS M.
   Doyon JB, 2013, J CLIN MICROBIOL, V51, P719, DOI 10.1128/JCM.02884-12.
   Dumollard C, 2016, J CLIN MICROBIOL, V54, P1236, DOI 10.1128/JCM.03261-15.
   Duvaux L, 2017, GENOME ANNO IN PRESS.
   Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631.
   Ferroni A, 2010, J CLIN MICROBIOL, V48, P1542, DOI 10.1128/JCM.02485-09.
   Fricker-Hidalgo H, 2010, CLIN VACCINE IMMUNOL, V17, P1330, DOI 10.1128/CVI.00200-10.
   George AM, 2009, FEMS MICROBIOL LETT, V300, P153, DOI 10.1111/j.1574-6968.2009.01704.x.
   Gernez Y, 2016, EUR RESPIR J, V47, P177, DOI 10.1183/13993003.01068-2015.
   Ghamrawi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128680.
   Ghamrawi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100290.
   Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO.
   Gilgado F, 2005, J CLIN MICROBIOL, V43, P4930, DOI 10.1128/JCM.43.10.4930-4942.2005.
   Gilgado F, 2006, ANTIMICROB AGENTS CH, V50, P4211, DOI 10.1128/AAC.00981-06.
   Giraud S, 2010, J CLIN MICROBIOL, V48, P2381, DOI 10.1128/JCM.00047-10.
   Gosbell IB, 2003, MYCOSES, V46, P233, DOI 10.1046/j.1439-0507.2003.00878.x.
   Guignard S, 2008, J CYST FIBROS, V7, P89, DOI 10.1016/j.jcf.2007.05.003.
   Guinea J, 2008, ANTIMICROB AGENTS CH, V52, P1396, DOI 10.1128/AAC.01512-07.
   Hamutcu R, 2002, AM J RESP CRIT CARE, V165, P1172, DOI 10.1164/rccm.2104090.
   Harun A, 2009, MED MYCOL, V47, P406, DOI 10.1080/13693780802510240.
   Hettick JM, 2008, RAPID COMMUN MASS SP, V22, P2555, DOI 10.1002/rcm.3649.
   HOCKING AD, 1980, APPL ENVIRON MICROB, V39, P488.
   Holle J, 2014, J CYST FIBROS, V13, P400, DOI 10.1016/j.jcf.2013.10.014.
   Homa M, 2016, MED MYCOL, V54, P776, DOI 10.1093/mmy/myw029.
   Homa M, 2015, MED MYCOL, V53, P890, DOI 10.1093/mmy/myv064.
   Hong Gina, 2017, J Cyst Fibros, V16, pe3, DOI 10.1016/j.jcf.2017.01.005.
   Horre R, 2011, MYCOSES, V54, P514, DOI 10.1111/j.1439-0507.2010.01897.x.
   Horre R, 2009, RESPIRATION, V77, P320, DOI 10.1159/000167419.
   Horre R, 2010, MED MYCOL, V48, pS1, DOI 10.3109/13693786.2010.529304.
   Houbraken J, 2013, J CLIN MICROBIOL, V51, P22, DOI 10.1128/JCM.02147-12.
   Howden BP, 2003, EUR J CLIN MICROBIOL, V22, P111, DOI 10.1007/s10096-002-0877-z.
   JARVIS B, 1973, J APPL BACTERIOL, V36, P723, DOI 10.1111/j.1365-2672.1973.tb04157.x.
   Jat KR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010288.pub2.
   Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031.
   Katelari A, 2016, J CYST FIBROS, V15, P587, DOI 10.1016/j.jcf.2016.02.004.
   Kaur J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122354.
   Kegel A, 2006, NUCLEIC ACIDS RES, V34, P1633, DOI 10.1093/nar/gkl064.
   Kesson AM, 2009, CLIN INFECT DIS, V48, P1257, DOI 10.1086/597772.
   KING AD, 1979, APPL ENVIRON MICROB, V37, P959.
   Knutsen Alan P, 2006, Clin Mol Allergy, V4, P3, DOI 10.1186/1476-7961-4-3.
   Kramer R, 2015, J CLIN MICROBIOL, V53, P2900, DOI 10.1128/JCM.01094-15.
   Krappmann S, 2014, APPL MICROBIOL BIOT, V98, P1971, DOI 10.1007/s00253-013-5480-y.
   Lackner M, 2011, MYCOSES, V54, P12, DOI 10.1111/j.1439-0507.2011.02110.x.
   Lackner M, 2012, ANTIMICROB AGENTS CH, V56, P2635, DOI 10.1128/AAC.05910-11.
   Langan KM, 2015, CURR OPIN INFECT DIS, V28, P547, DOI 10.1097/QCO.0000000000000217.
   Larcher G, 1996, BIOCHEM J, V315, P119, DOI 10.1042/bj3150119.
   Latzin P, 2008, EUR RESPIR J, V31, P36, DOI 10.1183/09031936.00078107.
   Lau AF, 2013, J CLIN MICROBIOL, V51, P828, DOI 10.1128/JCM.02852-12.
   Li JYZ, 2008, TRANSPL INFECT DIS, V10, P63, DOI 10.1111/j.1399-3062.2007.00240.x.
   Lima OC, 2007, MICROBES INFECT, V9, P558, DOI 10.1016/j.micinf.2007.01.027.
   Lujik B, 2011, CASE REP INFECT DIS, V2011.
   Machouart M, 2011, J CLIN MICROBIOL, V49, P1681, DOI 10.1128/JCM.02456-10.
   Rodriguez MM, 2009, ANTIMICROB AGENTS CH, V53, P2153, DOI 10.1128/AAC.01477-08.
   Marguet C, 2012, MED MYCOL CASE REP, V1, P79, DOI 10.1016/j.mmcr.2012.08.004.
   Martin-Vicente A, 2017, INT J ANTIMICROB AG, V49, P422, DOI 10.1016/j.ijantimicag.2016.12.015.
   Maskarinec Stacey A, 2016, Curr Clin Microbiol Rep, V3, P81.
   Masoud-Landgraf L, 2014, MED MYCOL, V52, P179, DOI 10.3109/13693786.2013.792438.
   Matray O, 2016, MED MYCOL, V54, P409, DOI 10.1093/mmy/myv080.
   Meletiadis J, 2000, CLIN MICROBIOL INFEC, V6, P336, DOI 10.1046/j.1469-0691.2000.00089.x.
   Meletiadis J, 2002, ANTIMICROB AGENTS CH, V46, P62, DOI 10.1128/AAC.46.1.62-68.2002.
   Meletiadis J, 2003, ANTIMICROB AGENTS CH, V47, P106, DOI 10.1128/AAC.47.1.106-117.2003.
   Middleton PG, 2013, CURR OPIN PULM MED, V19, P670, DOI 10.1097/MCP.0b013e328365ab74.
   Mina S, 2015, FUNGAL BIOL-UK, V119, P1322, DOI 10.1016/j.funbio.2015.09.007.
   Mina S, 2015, CLIN VACCINE IMMUNOL, V22, P37, DOI 10.1128/CVI.00482-14.
   Moran O, 2017, CELL MOL LIFE SCI, V74, P1, DOI 10.1007/s00018-016-2384-x.
   Morrissey BM, 2003, CLIN REV ALLERG IMMU, V25, P275, DOI 10.1385/CRIAI:25:3:275.
   Mouhajir A, 2016, J CLIN MICROBIOL, V54, P2804, DOI 10.1128/JCM.01462-16.
   Mounier J, 2014, J MICROBIOL, V52, P307, DOI 10.1007/s12275-014-3425-5.
   Muller FMC, 2010, EXPERT REV ANTI-INFE, V8, P957, DOI {[}10.1586/eri.10.72, 10.1586/ERI.10.72].
   Muro M, 2013, MICROBIOL IMMUNOL, V57, P193, DOI 10.1111/1348-0421.12020.
   Nagano Y, 2010, MED MYCOL, V48, P166, DOI 10.3109/13693780903127506.
   Nagano Y, 2008, J CYST FIBROS, V7, P566, DOI 10.1016/j.jcf.2008.06.007.
   Neerincx AH, 2016, J BREATH RES, V10, DOI 10.1088/1752-7155/10/1/016002.
   Nishimori Makoto, 2014, Med Mycol J, V55, pE63, DOI 10.3314/mmj.55.E63.
   Ochi Y, 2015, INT J HEMATOL, V101, P620, DOI 10.1007/s12185-015-1752-x.
   Ohashi Rina, 2011, Med Mycol J, V52, P33.
   Osherov N, 2017, MED MYCOL, V55, P118, DOI 10.1093/mmy/myw060.
   Overton NLD, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0152-y.
   Padoan R, 2016, PEDIATR INFECT DIS J, V35, P701, DOI 10.1097/INF.0000000000001130.
   Papon N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004179.
   Parize P, 2014, J CYST FIBROS, V13, P667, DOI 10.1016/j.jcf.2014.01.011.
   Pashley CH, 2012, MED MYCOL, V50, P433, DOI 10.3109/13693786.2011.615762.
   Pellon A, 2016, J PROTEOME RES, V15, P595, DOI 10.1021/acs.jproteome.5b00978.
   Pereira M, 2009, MYCOPATHOLOGIA, V167, P25, DOI 10.1007/s11046-008-9147-7.
   Perez-Bercoff A, 2015, GENOME ANNOUNC, V3.
   Perfect JR, 2017, NAT REV DRUG DISCOV, V16, P603, DOI 10.1038/nrd.2017.46.
   Pihet M, 2009, MED MYCOL, V47, P387, DOI 10.1080/13693780802609604.
   Plesiat P, 2015, SOC FRANCAISE MICROB, V5, P193.
   Posterard B, 2013, EXPERT REV PROTEOMIC, V10, P151, DOI {[}10.1586/EPR.13.8, 10.1586/epr.13.8].
   Rainer J, 2008, ANTON LEEUW INT J G, V93, P315, DOI 10.1007/s10482-007-9206-y.
   Ramirez-Garcia A, 2018, MYCOPATHOLOGIA, V183, P273, DOI 10.1007/s11046-017-0139-3.
   Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532.
   Rolfe NE, 2013, MED MYCOL CASE REP, V2, P37, DOI 10.1016/j.mmcr.2013.01.002.
   Rougeron A, 2014, CLIN MICROBIOL INFEC, V20, P327, DOI 10.1111/1469-0691.12323.
   Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109.
   Schwarz C, 2015, JMM CASE REP, P2, DOI {[}10.1099/jmmcr.0.000061, DOI 10.1099/JMMCR.0.000061].
   Schwarz C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171485.
   Sedlacek L, 2015, J CYST FIBROS, V14, P237, DOI 10.1016/j.jcf.2014.12.014.
   Silva BA, 2006, RES MICROBIOL, V157, P425, DOI 10.1016/j.resmic.2005.11.010.
   Sitterle E, 2014, CLIN MICROBIOL INFEC, V20, P929, DOI 10.1111/1469-0691.12574.
   Sleiman S, 2016, J CLIN MICROBIOL, V54, P2182, DOI 10.1128/JCM.00906-16.
   Steinbach WJ, 2003, J CLIN MICROBIOL, V41, P3981, DOI 10.1128/JCM.41.8.3981-3985.2003.
   Steinmann J, 2016, ANTIMICROB AGENTS CH, V60, P6890, DOI 10.1128/AAC.00742-16.
   Steinmann J, 2014, New Microbes New Infect, V2, P72, DOI 10.1002/nmi2.44.
   Studahl M, 2003, ACTA PAEDIATR, V92, P980, DOI 10.1080/08035250310004595.
   Sudfeld CR, 2010, J CYST FIBROS, V9, P110, DOI 10.1016/j.jcf.2009.11.010.
   SUMMERBELL RC, 1993, J CLIN MICROBIOL, V31, P572.
   Syhre M, 2008, MED MYCOL, V46, P209, DOI 10.1080/13693780701753800.
   Symoens F, 2006, J HEART LUNG TRANSPL, V25, P603, DOI 10.1016/j.healun.2005.12.011.
   Tong S Y C, 2007, Transpl Infect Dis, V9, P241, DOI 10.1111/j.1399-3062.2007.00203.x.
   Tortorano AM, 2014, CLIN MICROBIOL INFEC, V20, P27, DOI 10.1111/1469-0691.12465.
   Triest D, 2015, J CLIN MICROBIOL, V53, P465, DOI 10.1128/JCM.02213-14.
   Uno K, 2014, J INFECT CHEMOTHER, V20, P131, DOI 10.1016/j.jiac.2013.09.006.
   Vagefi MR, 2005, AM J OPHTHALMOL, V139, P370, DOI 10.1016/j.ajo.2004.08.005.
   Vandeputte P, 2014, GENOME ANNOUNC, V2.
   Vanhee LME, 2008, EUR J CLIN MICROBIOL, V27, P1005, DOI 10.1007/s10096-008-0527-1.
   Vanhee LME, 2010, MED MYCOL, V48, pS60, DOI 10.3109/13693786.2010.484816.
   Vidal-Garcia M, 2016, APPL MICROBIOL BIOT, V100, P2327, DOI 10.1007/s00253-015-7209-6.
   Wanka F, 2016, FUNGAL GENET BIOL, V89, P72, DOI 10.1016/j.fgb.2015.11.003.
   Wiederhold NP, 2017, J ANTIMICROB CHEMOTH, V72, P1977, DOI 10.1093/jac/dkx065.
   Willger SD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-40.
   Williams C, 2016, CURR FUNGAL INFECT R, V10, P163, DOI 10.1007/s12281-016-0268-z.}},
Number-of-Cited-References = {{172}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{5}},
Usage-Count-Since-2013 = {{5}},
Journal-ISO = {{Med. Mycol.}},
Doc-Delivery-Number = {{FZ0JI}},
Unique-ID = {{ISI:000427254400006}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000426530100057,
Author = {Wei, K. and Li, Y.},
Title = {{Global genetic variation and transmission dynamics of H9N2 avian
   influenza virus}},
Journal = {{TRANSBOUNDARY AND EMERGING DISEASES}},
Year = {{2018}},
Volume = {{65}},
Number = {{2}},
Pages = {{504-517}},
Month = {{APR}},
Abstract = {{The H9N2 influenza viruses are extensively circulating in the poultry
   population, and variable genotypes can be generated through mutation,
   recombination and reassortment, which may be better adapted to infect a
   new host, resist drug treatment or escape immune pressure. The LPAI H9N2
   viruses have the potential to evolve towards high levels of virulence in
   human. Some studies about the regional dispersal were reported, but
   global dissemination and the drivers of the virus are poorly understood,
   particularly at the genome scale. Here, we have analysed all eight gene
   segments of 168 H9N2 genomes sampled randomly aiming to provide a
   panoramic framework for better understanding the genesis and genetic
   variation of the viruses, and utilized phylogeography and spatial
   epidemiology approaches to uncover the effects of the genetic variation,
   predictors and spread of H9N2 viruses. We found that more frequent
   reassortment events involve segments PA, NP and NS, and 21 isolates have
   possible mosaic structure resulting from recombination events. Estimates
   of gene-specific global dN/dS ratios showed that all genes were subject
   to purifying selection. However, a total of 13 sites were detected under
   positive selection by at least two of three methods, which located
   within segments HA, NA, M2, NS1 and PA. Additionally, we inferred that
   NA segment has the highest rate of nucleotide substitution, and its
   tMRCA estimate is the youngest than the remaining segments' inference.
   About the spatial history, air transportation of human was identified as
   the predominant driver of global viral migration using GLM analysis, and
   economic factors and geographical distance were the modest predictors.
   Higher migration rates were estimated between five pairs of regions
   (>0.01) indicating the frequent migration of the viruses between
   discrete geographical locations. Further, our Markov jumps analysis
   showed that viral migration is more frequent between Southern China and
   Northern China, and high rate of gene flow was observed between America
   and East Asia. Moreover, the America together with Southeast Asia acted
   as the primary hubs of global transmission, forming the trunk of
   evolutionary tree. These findings suggested a complex interaction
   between virus evolution, epidemiology and human behaviour.}},
Publisher = {{WILEY}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wei, K (Reprint Author), Minnan Normal Univ, Sch Biol Sci \& Biotechnol, Zhangzhou, Peoples R China.
   Wei, K.; Li, Y., Minnan Normal Univ, Sch Biol Sci \& Biotechnol, Zhangzhou, Peoples R China.}},
DOI = {{10.1111/tbed.12733}},
ISSN = {{1865-1674}},
EISSN = {{1865-1682}},
Keywords = {{genetic variation; H9N2 avian influenza virus; phylogenetics;
   reassortment; viral migration}},
Keywords-Plus = {{A VIRUSES; INTERNAL GENES; RECOMBINATION DETECTION; SOUTHEASTERN CHINA;
   HUMAN INFECTION; HONG-KONG; POULTRY; EVOLUTION; MODEL; PHYLOGEOGRAPHY}},
Research-Areas = {{Infectious Diseases; Veterinary Sciences}},
Web-of-Science-Categories  = {{Infectious Diseases; Veterinary Sciences}},
Author-Email = {{kaifa-wei@163.com}},
Cited-References = {{Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100.
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084.
   Boni MF, 2008, J VIROL, V82, P4807, DOI 10.1128/JVI.02683-07.
   Boni MF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010434.
   Brockmann D., 2009, REV NONLINEAR DYNAMI, V2, P1.
   Brown IH, 2006, DEV BIOLOGICALS, V124, P45.
   Dalby AR, 2014, PEERJ, V2, DOI 10.7717/peerj.655.
   De Antara, 2016, BMC Res Notes, V9, P222, DOI 10.1186/s13104-016-2017-3.
   Dong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017212.
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075.
   Fusaro A, 2011, J VIROL, V85, P8413, DOI 10.1128/JVI.00219-11.
   Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000.
   Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363.
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520.
   Heidari A, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0472-z.
   HOMME P J, 1970, Avian Diseases, V14, P66, DOI 10.2307/1588557.
   Huang YW, 2015, J MED VIROL, V87, P1641, DOI 10.1002/jmv.24231.
   Iqbal M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005788.
   Jin Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1110.
   Kimble JB, 2011, P NATL ACAD SCI USA, V108, P12084, DOI 10.1073/pnas.1108058108.
   Lau EHY, 2007, EMERG INFECT DIS, V13, P1340, DOI 10.3201/eid1309.061549.
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932.
   Lemey P, 2012, BIOINFORMATICS, V28, P3248, DOI 10.1093/bioinformatics/bts580.
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520.
   Li XB, 2014, EMERG INFECT DIS, V20, P1287, DOI 10.3201/eid2008.130910.
   Lole KS, 1999, J VIROL, V73, P152.
   Marshall N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003421.
   Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490.
   Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799.
   Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8.
   O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003.
   Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001.
   Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5.
   Peiris M, 1999, J CLIN MICROBIOL, V37, P3426.
   Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474.
   Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320.
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083.
   Qiao CL, 2012, J GEN VIROL, V93, P2337, DOI 10.1099/vir.0.044040-0.
   Ramey AM, 2015, VIROLOGY, V482, P79, DOI 10.1016/j.virol.2015.03.028.
   Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137.
   Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106.
   Sun YP, 2010, VET MICROBIOL, V146, P215, DOI 10.1016/j.vetmic.2010.05.010.
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197.
   Vandegrift KJ, 2010, ANN NY ACAD SCI, V1195, P113, DOI 10.1111/j.1749-6632.2010.05451.x.
   Wang J, 2016, J VIROL, V90, P3506, DOI 10.1128/JVI.02605-15.
   Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06.
   Ye G, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00057.
   Young SG, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090886.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{18}},
Usage-Count-Since-2013 = {{18}},
Journal-ISO = {{Transbound. Emerg. Dis.}},
Doc-Delivery-Number = {{FY0VH}},
Unique-ID = {{ISI:000426530100057}},
DA = {{2018-08-13}},
}

@article{ ISI:000428625300001,
Author = {Steinberg, Nitai and Rosenberg, Gili and Keren-Paz, Alona and
   Kolodkin-Gal, Ilana},
Title = {{Collective Vortex-Like Movement of Bacillus subtilis Facilitates the
   Generation of Floating Biofilms}},
Journal = {{FRONTIERS IN MICROBIOLOGY}},
Year = {{2018}},
Volume = {{9}},
Month = {{MAR 29}},
Abstract = {{Bacteria in nature are usually found in complex multicellular
   structures, called biofilms. One common form of a biofilm is pellicle-a
   floating mat of bacteria formed in the water-air interphase. So far, our
   knowledge on the basic mechanisms underlying the formation of biofilms
   at air-liquid interfaces is not complete. In particular, the
   co-occurrence of motile cells and extracellular matrix producers has not
   been studied. In addition, the potential involvement of chemical
   communication in pellicle formation remained largely undefined. Our
   results indicate that vortex-like collective motility by aggregates of
   motile cells and EPS producers accelerate the formation of floating
   biofilms. Successful aggregation and migration to the water-air
   interphase depend on the chemical communication signal autoinducer 2
   (AI-2). This ability of bacteria to form a biofilm in a preferable niche
   ahead of their potential rivals would provide a fitness advantage in the
   context of inter-species competition.}},
Publisher = {{FRONTIERS MEDIA SA}},
Address = {{AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kolodkin-Gal, I (Reprint Author), Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel.
   Steinberg, Nitai; Rosenberg, Gili; Keren-Paz, Alona; Kolodkin-Gal, Ilana, Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel.}},
DOI = {{10.3389/fmicb.2018.00590}},
Article-Number = {{590}},
ISSN = {{1664-302X}},
Keywords = {{pellicles; biofilms; collective behavior; cell-cell communication;
   flagellar motility}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE; BACTERIAL BIOFILMS; MOTILITY; GENE; COMPETENCE;
   MECHANISMS; STRATEGIES; FLAGELLA; SYSTEM}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{ilana.kolodkin-gal@weizmann.ac.il}},
Funding-Acknowledgement = {{Israeli Science Foundation {[}119/16]; Kekst Family Institute for
   Medical Genetics; ISF I-CORE grant {[}152/1]; Rowland and Sylvia Career
   Development Chair;  {[}3-13021]}},
Funding-Text = {{We thank Ohad Herches, Research Services Division, Weizmann Institute of
   Science, for designing and conducting the time-lapse photography. We
   thank Prof. Michael Meijler (Ben-Gurion University of the Negev) for
   providing us with synthesized DPD. The Kolodkin-Gal lab is supported by
   the Israeli Science Foundation grant number 119/16, France-Israel grant
   number 3-13021, The Kekst Family Institute for Medical Genetics, and the
   ISF I-CORE grant 152/1. IK-G is a recipient of Rowland and Sylvia Career
   Development Chair.}},
Cited-References = {{Aguilar C, 2007, CURR OPIN MICROBIOL, V10, P638, DOI 10.1016/j.mib.2007.09.006.
   Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001.
   Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004.
   Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198.
   Cairns LS, 2013, MOL MICROBIOL, V90, P6, DOI 10.1111/mmi.12342.
   Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357.
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318.
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002.
   Dragos A, 2017, TRENDS MICROBIOL, V25, P257, DOI 10.1016/j.tim.2016.12.010.
   Elias S, 2012, FEMS MICROBIOL REV, V36, P990, DOI 10.1111/j.1574-6976.2012.00325.x.
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010.
   Guttenplan SB, 2013, MOL MICROBIOL, V87, P211, DOI 10.1111/mmi.12103.
   He ZY, 2015, J MOL MICROB BIOTECH, V25, P60, DOI 10.1159/000371816.
   Holscher T, 2015, J MOL BIOL, V427, P3695, DOI 10.1016/j.jmb.2015.06.014.
   Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405.
   Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905.
   Kobayashi K, 2007, J BACTERIOL, V189, P4920, DOI 10.1128/JB.00157-07.
   Kolodkin-Gal D, 2007, VIROLOGY, V357, P91, DOI 10.1016/j.virol.2006.07.048.
   Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a.
   Kovacs AT, 2016, CURR GENET, V62, P125, DOI 10.1007/s00294-015-0524-8.
   LAVALLIE ER, 1989, J BACTERIOL, V171, P3085, DOI 10.1128/jb.171.6.3085-3094.1989.
   Lombardia E, 2006, J BACTERIOL, V188, P4442, DOI 10.1128/JB.00165-06.
   Mah TF, 2003, NATURE, V426, P306, DOI 10.1038/nature02122.
   McLoon AL, 2011, J BACTERIOL, V193, P2027, DOI 10.1128/JB.01542-10.
   Mendelson NH, 1999, ENVIRON MICROBIOL, V1, P471, DOI 10.1046/j.1462-2920.1999.00066.x.
   Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165.
   MIREL DB, 1992, J BACTERIOL, V174, P4197.
   Mukherjee S, 2014, ANNU REV GENET, V48, P319, DOI 10.1146/annurev-genet-120213-092406.
   Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304.
   STEWART PS, 1994, ANTIMICROB AGENTS CH, V38, P1052, DOI 10.1128/AAC.38.5.1052.
   Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196.
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1.
   Trappetti C, 2011, INFECT IMMUN, V79, P4550, DOI 10.1128/IAI.05644-11.
   van Gestel J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002141.
   Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008.
   Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960.
   Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C.
   WILSON GA, 1968, J BACTERIOL, V95, P1439.
   Yuan J, 2011, J BACTERIOL, V193, P611, DOI 10.1128/JB.01185-10.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{Front. Microbiol.}},
Doc-Delivery-Number = {{GA8XO}},
Unique-ID = {{ISI:000428625300001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000428292500001,
Author = {Basnyat, Buddha and Caws, Maxine and Udwadia, Zarir},
Title = {{Tuberculosis in South Asia: a tide in the affairs of men}},
Journal = {{MULTIDISCIPLINARY RESPIRATORY MEDICINE}},
Year = {{2018}},
Volume = {{13}},
Month = {{MAR 22}},
Abstract = {{Background: Tuberculosis (TB) remains the most common cause of
   infectious disease deaths worldwide. What is perhaps less appreciated is
   that the caseload of tuberculosis patients in South Asia is staggering.
   South Asia has almost 40\% of the global TB burden with 4,028,165 cases
   in 2015. This region also has a disproportionate share of TB deaths
   (681,975 deaths, 38\% of the global burden). Worldwide just 12.5\% of TB
   cases are in HIV positive individuals, but much research and investment
   has focused on HIV-associated TB. Only 3.5\% of patients with
   tuberculosis in South Asia have HIV co-infection. Not surprisingly with
   such a huge burden of disease, this region has an estimated 184,336
   multi drug resistant (MDR) cases among notified TB cases which accounts
   for a third of global MDR burden. Crucially, at least 70\% of the
   estimated MDR cases remain untreated in this region and MDR treatment
   success ranged from only 46\% for India to 88\% for Sri Lanka in the
   2012 cohort that received treatment. This region represents many of the
   drivers of the modern TB epidemic: rapid urbanization and high density
   populations with dramatically rising incidence of diabetes, a burgeoning
   and largely unregulated private sector with escalating drug resistance
   and high air pollution both outdoor and household.
   Conclusion: From bacterial biochemistry to policy implementation, we
   suggest ways in which South Asia can seize the opportunity lead global
   TB elimination by demonstrating feasibility in some of the world's most
   densely populated cities and remotest reaches of the Himalayas. Clearly
   political will is essential, but we cannot defeat TB without
   understanding how to eliminate it in South Asia.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Basnyat, B (Reprint Author), Univ Oxford, Ctr Trop Med \& Global Hlth, Oxford, England.
   Basnyat, B (Reprint Author), Patan Acad Hlth Sci, Oxford Univ Clin Res Unit, Lalitpur, Nepal.
   Basnyat, Buddha, Univ Oxford, Ctr Trop Med \& Global Hlth, Oxford, England.
   Basnyat, Buddha, Patan Acad Hlth Sci, Oxford Univ Clin Res Unit, Lalitpur, Nepal.
   Basnyat, Buddha, Global Antibiot Resistance Partnership, Kathmandu, Nepal.
   Caws, Maxine, Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.
   Caws, Maxine, British Nepal Med Trust, Kathmandu, Nepal.
   Udwadia, Zarir, Hinduja Hosp \& Res Ctr, Bombay, Maharashtra, India.}},
DOI = {{10.1186/s40248-018-0122-y}},
Article-Number = {{10}},
ISSN = {{2049-6958}},
Keywords = {{Infectious disease; LMICs; Equity; Tuberculosis; Research priorities}},
Keywords-Plus = {{DRUG-RESISTANT TUBERCULOSIS; STOPPING TUBERCULOSIS; INDIA; IMPACT;
   TRANSMISSION; DIAGNOSIS; MEDICINE}},
Research-Areas = {{Respiratory System}},
Web-of-Science-Categories  = {{Respiratory System}},
Author-Email = {{Buddha.basnyat@ndm.ox.ac.uk}},
Cited-References = {{Akhtar S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-70.
   {[}Anonymous], 2017, OUT STEP TB POL 29 C.
   Arinaminpathy N, 2016, LANCET INFECT DIS, V16, P1255, DOI 10.1016/S1473-3099(16)30259-6.
   Basnyat B, 2015, LANCET GLOB HEALTH, V3, pE731, DOI 10.1016/S2214-109X(15)00211-9.
   D'souza DTB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-211.
   Dheda K, 2016, LANCET, V387, P1211, DOI 10.1016/S0140-6736(15)00151-8.
   Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8.
   Golub JE, 2006, INT J TUBERC LUNG D, V10, P24.
   Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907.
   Houben RMGJ, 2016, LANCET GLOB HEALTH, V4, pE806, DOI 10.1016/S2214-109X(16)30199-1.
   Houben RMGJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002152.
   Hwang SS, 2014, KOREAN J INTERN MED, V29, P183, DOI 10.3904/kjim.2014.29.2.183.
   Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429.
   Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0.
   Lakshmi PVM, 2012, J EPIDEMIOL COMMUN H, V66, P457, DOI 10.1136/jech.2010.115840.
   Maheshwari P, 2016, INT J TUBERC LUNG D, V20, P304, DOI 10.5588/ijtld.15.0571.
   Mondal S, 2015, CLIN TRIALS IND INDI.
   Nguyen TD, 2015, LANCET GLOB HEALTH, V3, pE758, DOI 10.1016/S2214-109X(15)00162-X.
   Ortblad KF, 2015, LANCET, V386, P2354, DOI 10.1016/S0140-6736(15)00324-4.
   Pai M, 2011, NATL MED J INDIA, V24, P198.
   Rangaka MX, 2015, LANCET, V386, P1, DOI 10.1016/S0140-6736(15)00323-2.
   Sachdeva KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126065.
   Sanghani RN, 2013, THORAX, V68, P202, DOI 10.1136/thoraxjnl-2012-202976.
   Satyanarayana S, 2016, LANCET INFECT DIS, V16, P1261, DOI 10.1016/S1473-3099(16)30215-8.
   Shaikh BT, 2005, EVID-BASED COMPL ALT, V2, P139, DOI 10.1093/ecam/neh088.
   Steingart KR, 2012, INDIAN J MED RES, V135, P695.
   Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062.
   Thomas BE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147579.
   Treatment Action Group Pipeline Report, 2017, HIV TB HCV DRUGS DIA.
   Tuberculosis Chemotherapy Centre, 1959, B WORLD HEALTH ORGAN, V21, P51.
   Udwadia ZF, 2014, INT J TUBERC LUNG D, V18, P1315, DOI 10.5588/ijtld.14.0284.
   Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023.
   Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889.
   Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC.
   World Health Organisation, MON GENEXPERT ROLL O.
   World Health Organisation, 2012, TOT DRUG RES TUB WHO.
   World Health Organization, GLOB TUB REP 2017.
   Yuen CM, 2015, LANCET, V386, P2334, DOI 10.1016/S0140-6736(15)00322-0.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{Multidscip. Respir. Med.}},
Doc-Delivery-Number = {{GA4IG}},
Unique-ID = {{ISI:000428292500001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000435539900568,
Author = {Xie, Jiawen and Jin, Ling and Luo, Xiaosan and Li, Xiangdong},
Title = {{Airborne bacteria and antibiotic resistance genes in PM2.5 of Nanjing,
   China: Spatial-temporal variability and human inhalation risk}},
Journal = {{ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY}},
Year = {{2018}},
Volume = {{255}},
Meeting = {{13}},
Month = {{MAR 18}},
Note = {{255th National Meeting and Exposition of the American-Chemical-Society
   (ACS) - Nexus of Food, Energy, and Water, New Orleans, LA, MAR 18-22,
   2018}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Meeting Abstract}},
Language = {{English}},
Affiliation = {{Li, Xiangdong, Hong Kong PolyU, Civil \& Environm Engn, Kowloon, Hong Kong, Peoples R China.
   Xie, Jiawen; Jin, Ling, Hong Kong Polytech Univ, Civil \& Environm Engn, Kowloon, Hong Kong, Peoples R China.
   Luo, Xiaosan, Nanjing Univ Informat Sci \& Technol, Int Ctr Ecol Meteorol \& Environm, Nanjing, Jiangsu, Peoples R China.}},
ISSN = {{0065-7727}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Multidisciplinary}},
Author-Email = {{cexdli@polyu.edu.hk}},
Number-of-Cited-References = {{0}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Abstr. Pap. Am. Chem. Soc.}},
Doc-Delivery-Number = {{GJ7BN}},
Unique-ID = {{ISI:000435539900568}},
DA = {{2018-08-13}},
}

@article{ ISI:000435527600017,
Author = {Falzon, Laura C. and Lechner, Isabel and Chantziaras, Ilias and
   Collineau, Lucie and Courcoul, Aurelie and Filippitzi, Maria-Eleni and
   Laukkanen-Ninios, Riikka and Peroz, Carole and Ferreira, Jorge Pinto and
   Postma, Merel and Prestmo, Pia G. and Phythian, Clare J. and Sarno,
   Eleonora and Vanantwerpen, Gerty and Vergne, Timothee and Grindlay,
   Douglas J. C. and Brennan, Marnie L.},
Title = {{Quantitative Outcomes of a One Health approach to Study Global Health
   Challenges}},
Journal = {{ECOHEALTH}},
Year = {{2018}},
Volume = {{15}},
Number = {{1}},
Pages = {{209-227}},
Month = {{MAR}},
Abstract = {{Having gained momentum in the last decade, the One Health initiative
   promotes a holistic approach to address complex global health issues.
   Before recommending its adoption to stakeholders, however, it is
   paramount to first compile quantitative evidence of the benefit of such
   an approach. The aim of this scoping review was to identify and
   summarize primary research that describes monetary and non-monetary
   outcomes following adoption of a One Health approach. An extensive
   literature search yielded a total of 42,167 references, of which 85 were
   included in the final analysis. The top two biotic health issues
   addressed in these studies were rabies and malaria; the top abiotic
   health issue was air pollution. Most studies described collaborations
   between human and animal (n = 42), or human and environmental
   disciplines (n = 41); commonly reported interventions included vector
   control and animal vaccination. Monetary outcomes were commonly
   expressed as cost-benefit or cost-utility ratios; non-monetary outcomes
   were described using disease frequency or disease burden measurements.
   The majority of the studies reported positive or partially positive
   outcomes. This paper illustrates the variety of health challenges that
   can be addressed using a One Health approach, and provides tangible
   quantitative measures that can be used to evaluate future
   implementations of the One Health approach.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Falzon, LC (Reprint Author), Univ Bern, Vet Publ Hlth Inst, Schwarzenburgstr 155, CH-3097 Liebefeld, Switzerland.
   Falzon, LC (Reprint Author), Univ Liverpool, Inst Infect \& Global Hlth, 8 West Derby St, Liverpool L69 7BE, Merseyside, England.
   Falzon, Laura C.; Lechner, Isabel, Univ Bern, Vet Publ Hlth Inst, Schwarzenburgstr 155, CH-3097 Liebefeld, Switzerland.
   Falzon, Laura C., Univ Liverpool, Inst Infect \& Global Hlth, 8 West Derby St, Liverpool L69 7BE, Merseyside, England.
   Chantziaras, Ilias; Filippitzi, Maria-Eleni; Postma, Merel, Univ Ghent, Vet Epidemiol Unit, Dept Reprod Obstet \& Herd Hlth, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium.
   Collineau, Lucie; Ferreira, Jorge Pinto, SAFOSO, Waldeggstr 1, CH-3097 Liebefeld, Switzerland.
   Courcoul, Aurelie, Univ Paris Est, Epidemiol Unit, Lab Anim Hlth, Anses, 23 Ave Gen Gaulle, F-94706 Maisons Alfort, France.
   Laukkanen-Ninios, Riikka, Univ Helsinki, Fac Vet Med, Dept Food Hyg \& Environm Hlth, POB 66, FIN-00014 Helsinki, Finland.
   Peroz, Carole, Oniris, INRA, BIOEPAR, F-44307 Nantes, France.
   Prestmo, Pia G., Univ Bristol, Sch Vet Sci, Langford House, Bristol BS40 5DU, Avon, England.
   Phythian, Clare J., Norwegian Univ Life Sci, Inst Prod Anim Clin Sci, Fac Vet Med, Sect Small Ruminant Res, N-4325 Sandnes, Norway.
   Sarno, Eleonora, Univ Zurich, Inst Food Safety \& Hyg, Winterthurerstr 272, CH-8057 Zurich, Switzerland.
   Vanantwerpen, Gerty, Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth \& Food Safety, Merelbeke, Belgium.
   Vergne, Timothee, Royal Vet Coll, Vet Epidemiol Econ \& Publ Hlth Grp, London, England.
   Vergne, Timothee, Inst Rech Dev, MIVEGEC Grp, Montpellier, France.
   Vergne, Timothee, Univ Toulouse, IHAP, INRA, UMR,ENVT, Toulouse, France.
   Grindlay, Douglas J. C., Univ Nottingham, Ctr Evidence Based Dermatol, Kings Meadow Campus, Nottingham NG7 2NR, England.
   Brennan, Marnie L., Univ Nottingham, Ctr Evidence Based Vet Med, Sch Vet Med \& Sci, Sutton Bonington Campus, Loughborough LE12 5RD, Leics, England.}},
DOI = {{10.1007/s10393-017-1310-5}},
ISSN = {{1612-9202}},
EISSN = {{1612-9210}},
Keywords = {{One Medicine; Transdisciplinarity; Endemic and emerging infectious
   diseases; Zoonoses; Non-communicable diseases; Systematic evidence;
   Scoping review}},
Keywords-Plus = {{COST-EFFECTIVENESS; RABIES CONTROL; MALARIA CONTROL; ONE MEDICINE;
   ANTIMICROBIAL RESISTANCE; CONTROL CAMPYLOBACTER; SALMONELLA CONTROL;
   CONTROL PROGRAMS; CANINE RABIES; POULTRY MEAT}},
Research-Areas = {{Biodiversity \& Conservation; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Biodiversity Conservation; Ecology; Environmental Sciences}},
Author-Email = {{laura.falzon@liverpool.ac.uk}},
Cited-References = {{Aikins MK, 1998, SOC SCI MED, V46, P181, DOI 10.1016/S0277-9536(97)00145-7.
   Akhavan D, 1999, SOC SCI MED, V49, P1385, DOI 10.1016/S0277-9536(99)00214-2.
   {[}Anonymous], 2010, VET REC, V167, P847.
   Aubert MFA, 1999, REV SCI TECH OIE, V18, P533, DOI 10.20506/rst.18.2.1174.
   Barrett MA, 2015, ECOHEALTH, V12, P212, DOI 10.1007/s10393-014-0964-5.
   Baum SE, 2017, ONE HEALTH, V3, P5, DOI 10.1016/j.onehlt.2016.10.004.
   Bauman AE, 2001, MED J AUSTRALIA, V175, P632.
   Boden L, 2014, VET REC, V174, P165, DOI 10.1136/vr.g1430.
   BOGEL K, 1990, B WORLD HEALTH ORGAN, V68, P281.
   Centre for Reviews and Dissemination, 2009, SYSTEMATIC REV CRDS.
   Chan M, 2014, LANCET, V384, P1910, DOI 10.1016/S0140-6736(14)62037-7.
   Cleaveland S, 2014, VET REC, V175, P188, DOI 10.1136/vr.g4996.
   Davis MF, 2017, ONE HEALTH, V4, P14, DOI 10.1016/j.onehlt.2017.07.001.
   Diaz C, 2012, INSIGHT INNOV INT DE, P163, DOI 10.1007/978-1-4614-0517-7\_15.
   Dixon MA, 2014, VET REC, V174, P546, DOI 10.1136/vr.g3263.
   European Union Scientific Steering Committee, 2015, ROL RES GLOB FOOD NU.
   FISHBEIN DB, 1991, VACCINE, V9, P581, DOI 10.1016/0264-410X(91)90246-3.
   Fitzpatrick MC, 2014, ANN INTERN MED, V160, P91, DOI 10.7326/M13-0542.
   Gatton ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015149.
   Gellynck X, 2008, J FOOD PROTECT, V71, P479, DOI 10.4315/0362-028X-71.3.479.
   Gibbs EPJ, 2014, VET REC, V174, P85, DOI 10.1136/vr.g143.
   Global Burden Disease, 2015, LANCET, V388, P1603.
   Goldbach SG, 2006, PREV VET MED, V77, P1, DOI 10.1016/j.prevetmed.2005.10.008.
   Goodman CA, 1999, LANCET, V354, P378, DOI 10.1016/S0140-6736(99)02141-8.
   Goodman CA, 2001, TROP MED INT HEALTH, V6, P280, DOI 10.1046/j.1365-3156.2001.00700.x.
   Greter H, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i2.726.
   Hasler B, 2014, REV SCI TECH OIE, V33, P453, DOI 10.20506/rst.33.2.2294.
   Hasler B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003270.
   Hasler B, 2013, CURR TOP MICROBIOL, V365, P127, DOI 10.1007/82\_2012\_239.
   Hanoi Declaration, 2015, SUST DEV GOALS TURN.
   Havelaar AH, 2007, RISK ANAL, V27, P831, DOI 10.1111/j.1539-6924.2007.00926.x.
   Higgins JPT, 2008, COCHRANE HDB SYSTEMA.
   Hodgson K, 2011, CAN VET J, V52, P189.
   Jensen HG, 2013, FOOD EC, DOI {[}10.1080/2164828X.2013.859142, DOI 10.1080/2164828X.2013.859142].
   Kangas S, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-35.
   Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X.
   Korsgaard H, 2009, EPIDEMIOL INFECT, V137, P828, DOI 10.1017/S0950268808000903.
   Kushner RF, 2006, OBESITY, V14, P1762, DOI 10.1038/oby.2006.203.
   Lake RJ, 2013, J FOOD PROTECT, V76, P1161, DOI 10.4315/0362-028X.JFP-12-481.
   Mangen MJJ, 2007, RISK ANAL, V27, P815, DOI 10.1111/j.1539-6924.2007.00925.x.
   Manlove KR, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002448.
   McConnell K. John, 2003, Rev Panam Salud Publica, V14, P9, DOI 10.1590/S1020-49892003000600003.
   Miller GY, 2005, J FOOD PROTECT, V68, P1788, DOI 10.4315/0362-028X-68.9.1788.
   Mills D, 2014, VET REC, V174, P269, DOI 10.1136/vr.g1929.
   Min B, 2013, PREV VET MED, V112, P222, DOI 10.1016/j.prevetmed.2013.09.010.
   Ministere de la Sante et de la Protection Sociale Francaise, 1989, B EPIDEMIOLOGIQUE HE, V36, P145.
   Minutes of the expert workshop (Leverhulme Centre for Integrative Research on Agriculture and Health Royal Veterinary College SOAS University of London London School of Hygiene and Tropical Medicine), 2013, EXP WORKSH LEV CTR I.
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097.
   Mueller DH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-73.
   Mulligan JA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-32.
   Murray M, 2014, VET REC, V174, P227, DOI 10.1136/vr.g1801.
   Ocampo CB, 2014, ACTA TROP, V132, P15, DOI 10.1016/j.actatropica.2013.12.019.
   Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002.
   Orellano PW, 2008, REV PANAM SALUD PUBL, V24, P113.
   Oura C, 2014, VET REC, V174, P398, DOI 10.1136/vr.g2539.
   PERSSON U, 1992, INT J FOOD MICROBIOL, V15, P207, DOI 10.1016/0168-1605(92)90050-D.
   Pinto HDBF, 2011, ARQUIVO BRASILEIRO M, V18, P112.
   Pulkki-Brannstrom Anni-Maria, 2012, Cost Eff Resour Alloc, V10, P5, DOI 10.1186/1478-7547-10-5.
   Queenan K, 2016, INT J ANTIMICROB AG, V48, P422, DOI 10.1016/j.ijantimicag.2016.06.014.
   Rabinowitz PM, 2008, ECOHEALTH, V5, P224, DOI 10.1007/s10393-008-0170-4.
   Riedel N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-37.
   Roberts RJ, 2014, VET REC, V174, P283, DOI 10.1136/vr.g2064.
   Romero-Barrios P, 2013, FOOD CONTROL, V29, P343, DOI 10.1016/j.foodcont.2012.05.043.
   Roth F, 2003, B WORLD HEALTH ORGAN, V81, P867.
   Rushton J, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i2.461.
   Rusthon J, 2009, EC ANIMAL HLTH PRODU.
   Schelling E, 2007, EMERG INFECT DIS, V13, P373, DOI 10.3201/eid1303.060391.
   Shaw APM, 2015, PREV VET MED, V122, P406, DOI 10.1016/j.prevetmed.2015.06.013.
   Sherman DM, 2010, ILAR J, V51, P281, DOI 10.1093/ilar.51.3.281.
   Shwiff S, 2013, TRANSBOUND EMERG DIS, V60, P330, DOI 10.1111/j.1865-1682.2012.01351.x.
   Shwiff SA, 2011, ZOONOSES PUBLIC HLTH, V58, P169, DOI 10.1111/j.1863-2378.2010.01335.x.
   Singh P, 2017, BMJ-BRIT MED J, V358, P1, DOI 10.1136/bmj.j3625.
   Smithuis FM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-363.
   Stark KDC, 2015, PREV VET MED, V120, P124, DOI 10.1016/j.prevetmed.2015.01.019.
   Suaya JA, 2007, TROP MED INT HEALTH, V12, P1026, DOI 10.1111/j.1365-3156.2007.01889.x.
   Sundstrom K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096446.
   Tenzin, 2012, VACCINE, V31, P260, DOI 10.1016/j.vaccine.2012.05.023.
   The American Veterinary Medical Association, 2008, ON HLTH NEW PROF IMP.
   The FAO-OIE-WHO Collaboration, 2010, SHAR RESP COORD GLOB.
   Townsend SE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002372.
   Tschopp R, 2013, CURR TOP MICROBIOL, V365, P249, DOI 10.1007/82\_2012\_245.
   Tsunoda T, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-6.
   UHAA IJ, 1992, J AM VET MED ASSOC, V201, P1873.
   United Nations, 2015, SUST DEV GOALS.
   United Nations, 2014, WORLD EC SIT PROSP.
   Van Noorden R, 2015, NATURE, V525, P306, DOI 10.1038/525306a.
   Wall P, 2014, VET REC, V174, P189, DOI 10.1136/vr.g1512.
   Wegener HC, 2003, EMERG INFECT DIS, V9, P774.
   Woods A, 2014, VET REC, V174, P650, DOI 10.1136/vr.g3678.
   World Bank, 2012, PEOPL PATH OUR PLAN, V2.
   World Conservation Society, 2004, MANH PRINC.
   World Health Organisation, 2017, ANT RES.
   World Health Organization, 2014, CONTR NEGL ZOON DIS.
   World Health Organization, 2007, WHO REL NEW GUID INS.
   World Health Organization, 2016, EST 2000 2012.
   World Health Organization, 2015, GLOB BURD FOODB DIS.
   World Health Organization (WHO), 2016, WHO DIR GEN SUMM OUT.
   YHDEGO M, 1988, ENVIRON INT, V14, P479, DOI 10.1016/0160-4120(88)90408-4.
   Young I, 2014, PREV VET MED, V113, P339, DOI 10.1016/j.prevetmed.2013.11.009.
   Zinsstag J, 2011, PREV VET MED, V101, P148, DOI 10.1016/j.prevetmed.2010.07.003.
   Zinsstag J, 2009, P NATL ACAD SCI USA, V106, P14996, DOI 10.1073/pnas.0904740106.
   Zinsstag J, 2007, EMERG INFECT DIS, V13, P527, DOI 10.3201/eid1304.060381.}},
Number-of-Cited-References = {{102}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{EcoHealth}},
Doc-Delivery-Number = {{GJ6XL}},
Unique-ID = {{ISI:000435527600017}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000428228300011,
Author = {Khan, Farmanullah and Ahmad, Bashir and Ahmed, Jawad and Yoo, Han Sang
   and Bashir, Shumaila},
Title = {{Investigation of Staphylococcus aureus, prevailing in the environment of
   Khyber Teaching Hospital, Peshawar, Pakistan}},
Journal = {{PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES}},
Year = {{2018}},
Volume = {{31}},
Number = {{2}},
Pages = {{429-437}},
Month = {{MAR}},
Abstract = {{The hospital environment plays an important role in the spread of
   microorganisms, including multi drug resistant (MDR) strains. Patients
   can acquire Methicillin-Resistant Staphylococcus aureus (MRSA) which can
   reside in the clinical setup that are not cleaned and can spread through
   air droplets, bed clothing, and healthcare workers. The purpose of this
   study was to investigate the prevalence of S. aureus in the Khyber
   Teaching Hospital (KTH). A total of 200 samples were collected from the
   floor, walls, air and inanimate objects in different wards of the KTH,
   during May 2012 to September 2012. These samples were screened for the
   recovery of S. aureus. Recovered organisms were subjected to
   susceptibility testing and investigated for the detection of various
   toxin and antibiotic resistance genes by Polymerase Chain Reaction
   (PCR). A total of 64 samples yielded S. aureus, out of which 37
   (57.81\%) were proved as MRSA. No isolate was found resistant to
   Vancomycin, however 81.25\% of the isolates were found susceptible to
   Linezolid and Amikacin. The susceptibility to Fusidic acid,
   Chloramphenicol, Rifampicin, Doxycycline and Meropenem was observed as
   79.69\%, 76.56\%, 75.00, 73.44\% and 68.75\% respectively. The frequency
   of sea, seb and sec genes were 56.25\%, 43.75\% and 12.5\% in the
   recovered isolates. Erm C was more prevalent (28.12 \%) than the ermA
   and ermB. The prevalence of pvl in MRSA was 21.62 \% which is less than
   33.33\% in the MSSA isolates. S. aureus and especially MRSA are
   frequently prevalent in the KTH. Therefore, every immune-compromised
   patient is prone to infections caused by S. aureus. This will lead to
   high morbidity/mortality rate, prolong hospital stay and add extra cost
   to the health system.}},
Publisher = {{UNIV KARACHI}},
Address = {{UNIV CAMPUS, FAC PHARMACY, KARACHI, 75270, PAKISTAN}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ahmad, B (Reprint Author), Univ Peshawar, Ctr Biotechnol \& Microbiol, Peshawar, Pakistan.
   Khan, Farmanullah; Ahmad, Bashir, Univ Peshawar, Ctr Biotechnol \& Microbiol, Peshawar, Pakistan.
   Khan, Farmanullah, Kohat Univ Sci \& Technol, Dept Pharm, Peshawar, Pakistan.
   Ahmed, Jawad, Khyber Med Univ, Inst Basic Med Sci, Peshawar, Pakistan.
   Yoo, Han Sang, Seoul Natl Univ, Coll Vet Med, Dept Infect Dis, Seoul 151742, South Korea.
   Bashir, Shumaila, Univ Peshawar, Dept Pharm, Peshawar, Pakistan.}},
ISSN = {{1011-601X}},
Keywords = {{Staphylococcus aureus; multi drug resistant; antibiotic resistance genes
   by polymerase chain reaction}},
Keywords-Plus = {{SHOCK-SYNDROME TOXIN; INFECTION-CONTROL; RISK-FACTORS; BURN UNIT;
   RESISTANT; LINCOSAMIDE; MACROLIDE; AIRBORNE; CONTAMINATION; EPIDEMIOLOGY}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy}},
Author-Email = {{bashirdr2015@yahoo.com}},
Funding-Acknowledgement = {{Higher Education Commission Islamabad Pakistan, under the International
   Research Support Initiative Program (IRSIP); Research Institute for
   Veterinary Science, Seoul National University, Seoul Korea}},
Funding-Text = {{The study was sponsored and supported by the Higher Education Commission
   Islamabad Pakistan, under the International Research Support Initiative
   Program (IRSIP), and the Research Institute for Veterinary Science,
   Seoul National University, Seoul Korea.}},
Cited-References = {{Ahmad B, 2014, TROP J PHARM RES, V13, P2091, DOI 10.4314/tjpr.v13i12.21.
   Andrade C, 2009, AM J INFECT CONTROL, V37, P515, DOI 10.1016/j.ajic.2008.10.026.
   Bignardi GE, 1996, J ANTIMICROB CHEMOTH, V37, P53, DOI 10.1093/jac/37.1.53.
   Bischoff WE, 2006, J INFECT DIS, V194, P1119, DOI 10.1086/507908.
   Boyce JM, 1997, INFECT CONT HOSP EP, V18, P622.
   BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654.
   Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204.
   Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006.
   El-Ghodban A, 2006, J MED MICROBIOL, V55, P179, DOI 10.1099/jmm.0.46162-0.
   Erol S, 2004, BURNS, V30, P357, DOI 10.1016/j.burns.2003.12.013.
   Garbacz Katarzyna, 2007, Medycyna Doswiadczalna i Mikrobiologia, V59, P201.
   Gehanno JF, 2009, J HOSP INFECT, V71, P256, DOI 10.1016/j.jhin.2008.11.015.
   Hacek DM, 1999, AM J CLIN PATHOL, V111, P647.
   Jones RN, 2010, J CLIN MICROBIOL, V48, P972, DOI 10.1128/JCM.01829-09.
   Kaiser ML, 2011, J BURN CARE RES, V32, P429, DOI 10.1097/BCR.0b013e318217f92d.
   Kim HB, 2004, MICROB DRUG RESIST, V10, P248.
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130.
   Kumari DNP, 1997, J CLIN MICROBIOL, V35, P881.
   LECLERCQ R, 1989, PATHOL BIOL, V37, P568.
   LIDWELL OM, 1975, J HYG-CAMBRIDGE, V75, P445, DOI 10.1017/S0022172400024505.
   Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461.
   Mehtar S, 2008, J HOSP INFECT, V68, P45, DOI 10.1016/j.jhin.2007.10.009.
   MORTIMER EA, 1966, BMJ-BRIT MED J, V1, P319, DOI 10.1136/bmj.1.5483.319.
   Naeem M, 2013, J POSTGRAD MED I, V27, P42.
   Naimi TS, 2003, PAK J PHARM SCI, V31, P429.
   Nashev D, 2004, FEMS MICROBIOL LETT, V233, P45, DOI 10.1016/j.femsle.2004.01.032.
   Otsuka T, 2007, CLIN MICROBIOL INFEC, V13, P325, DOI 10.1111/j.1469-0691.2006.01632.x.
   PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237.
   Rafla K, 2011, BURNS, V37, P5, DOI 10.1016/j.burns.2009.06.198.
   Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102.
   RUTALA WA, 1983, J CLIN MICROBIOL, V18, P683.
   Sander C, 2011, C P 21 ECCMID 27 ICC, P1035.
   Saribas Z, 2006, CLIN MICROBIOL INFEC, V12, P797, DOI 10.1111/j.1469-0691.2006.01486.x.
   Schreckenberger PC, 2004, J CLIN MICROBIOL, V42, P2777, DOI 10.1128/JCM.42.6.2777-2779.2004.
   Seguin JC, 1999, J CLIN MICROBIOL, V37, P1459.
   Shiomori T, 2002, J HOSP INFECT, V50, P30, DOI 10.1053/jhin.2001.1136.
   Solberg CO, 2000, SCAND J INFECT DIS, V32, P587, DOI 10.1080/003655400459478.
   Taj Y, 2010, JCPSP-J COLL PHYSICI, V20, P728, DOI 11.2010/JCPSP.728732.
   Olivo TET, 2009, BURNS, V35, P1104, DOI 10.1016/j.burns.2009.02.008.
   TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P3660, DOI 10.1093/nar/18.12.3660.
   Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1.
   Wayne P, 2011, M100S21 CLSI.
   Wibbenmeyer L, 2010, J BURN CARE RES, V31, P269, DOI 10.1097/BCR.0b013e3181d0f479.
   Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521.
   WILLIAMS RE, 1966, BACTERIOL REV, V30, P660.
   Zafar A, 2011, J MED MICROBIOL, V60, P56, DOI 10.1099/jmm.0.022707-0.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{Pak. J. Pharm. Sci.}},
Doc-Delivery-Number = {{GA3KU}},
Unique-ID = {{ISI:000428228300011}},
DA = {{2018-08-13}},
}

@article{ ISI:000426822400019,
Author = {Marfina, Galina Yu and Vladimirov, Kirill B. and Avetisian, Armen O. and
   Starshinova, Anna A. and Kudriashov, Grigorii G. and Sokolovich, Evgenii
   G. and Yablonskii, Piotr K.},
Title = {{Bilateral cavitary multidrug- or extensively drug-resistant
   tuberculosis: role of surgery}},
Journal = {{EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY}},
Year = {{2018}},
Volume = {{53}},
Number = {{3}},
Pages = {{618-624}},
Month = {{MAR}},
Note = {{24th European Conference on General Thoracic Surgery of the
   European-Society-of-Thoracic-Surgeons (ESTS), Naples, ITALY, MAY 29-JUN
   01, 2016}},
Organization = {{European Soc Thorac Surg}},
Abstract = {{Cavitary disease and bilateral lesions are among the risk factors for
   poor outcome of pulmonary tuberculosis (TB). Our aim was to explore the
   value and limits of surgery in patients with advanced TB.
   A retrospective study of 57 consecutive patients who underwent thoracic
   surgery for culture-positive bilateral cavitary pulmonary TB was
   performed. Forty-four (77.2\%) patients were men and 13 (22.8\%)
   patients were women; their ages were in the range of 18-61 years.
   Twenty-two (38.6\%) patients had multidrug-resistant (MDR) TB and 35
   (61.4\%) patients had extensively drug-resistant (XDR) TB confirmed with
   cultures. On admission, 49 (86.0\%) patients had sputum smear microscopy
   positive for acid-fast bacilli. The main indication for surgery was
   treatment failure manifested as contagious persisting cavities despite
   best available therapy. The surgical procedures included combinations of
   pulmonary resections of different levels, selective thoracoplasties
   and/or endobronchial valve treatment. The operations were performed
   consecutively, starting with the most affected side. TB therapy preceded
   the operation for a minimum of 6 months and was continued after the
   operation on the basis of the patient's susceptibility to drugs for
   Mycobacterium tuberculosis.
   We performed 121 operations: 42 in 22 patients with MDR TB (1.9
   operations per patient) and 79 procedures in 35 patients with XDR TB
   (2.3 operations per patient). No deaths occurred in the 1st year. Two
   late deaths followed, 1 unrelated to and 1 due to TB progression. Ten
   major complications (1 complication per patient) developed: main
   bronchus stump fistula (n = 4), prolonged air leak (n = 3), respiratory
   failure (n = 2) and wound seroma (n = 1). At the 1-month follow-up
   visit, sputum smear conversion was observed in 11 (68.8\%) patients with
   MDR and in 15 (45.5\%) patients with XDR TB. At the late (20-36 months)
   follow-up visit, culture negativity was achieved in 21 (95.5\%) patients
   with MDR TB and in 23 (65.7\%) patients with XDR TB (P = 0.015).
   Thoracic surgery may significantly improve patients' outcomes and even
   result in a cure in a good portion of patients with bilateral cavitary
   MDR and XDR TB and should be considered as the essential element of
   multimodality treatment for MDR and XDR TB, even in patients with
   bilateral cavitary disease and borderline respiratory reserves.}},
Publisher = {{OXFORD UNIV PRESS INC}},
Address = {{JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Vladimirov, KB (Reprint Author), II Mechnikov North West State Med Univ, Zhukovskogo St St 5-23, St Petersburg 191104, Russia.
   Marfina, Galina Yu; Avetisian, Armen O.; Starshinova, Anna A.; Kudriashov, Grigorii G.; Sokolovich, Evgenii G.; Yablonskii, Piotr K., St Petersburg State Sci \& Res Inst Phthisiopulmon, Dept Pulm TB Thorac Surg, St Petersburg, Russia.
   Vladimirov, Kirill B., II Mechnikov North West State Med Univ, Dept Phthisiopulmonol \& Thorac Surg, St Petersburg, Russia.
   Yablonskii, Piotr K., St Petersburg State Univ, Fac Med, St Petersburg, Russia.}},
DOI = {{10.1093/ejcts/ezx350}},
ISSN = {{1010-7940}},
EISSN = {{1873-734X}},
Keywords = {{Tuberculosis; Cavitary; Surgery; Multidrug-resistant tuberculosis;
   Extensively drug-resistant tuberculosis}},
Keywords-Plus = {{PULMONARY TUBERCULOSIS; TREATMENT OUTCOMES; SURGICAL-TREATMENT;
   RESECTION; CURE}},
Research-Areas = {{Cardiovascular System \& Cardiology; Respiratory System; Surgery}},
Web-of-Science-Categories  = {{Cardiac \& Cardiovascular Systems; Respiratory System; Surgery}},
Author-Email = {{kv2001@bk.ru}},
ResearcherID-Numbers = {{Yablonskiy, Petr/T-8804-2017}},
ORCID-Numbers = {{Yablonskiy, Petr/0000-0003-4385-9643}},
Cited-References = {{{[}Anonymous], 2013, NAT CLIN REC APPL SU, P48.
   Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-11590C.
   Dravniece G, 2009, EUR RESPIR J, V34, P180, DOI 10.1183/09031936.00047208.
   Gegia M, 2012, INT J INFECT DIS, V16, pE391, DOI 10.1016/j.ijid.2011.12.018.
   Iddriss A, 2012, ANN THORAC SURG, V94, P381, DOI 10.1016/j.athoracsur.2012.03.072.
   Jeon DS, 2009, INT J TUBERC LUNG D, V13, P594.
   Kang MW, 2010, ANN THORAC SURG, V89, P1597, DOI 10.1016/j.athoracsur.2010.02.020.
   Kim HJ, 2006, EUR RESPIR J, V28, P576, DOI 10.1183/09031936.06.00023006.
   Kir A, 2006, J THORAC CARDIOV SUR, V131, P693, DOI 10.1016/j.jtcvs.2005.09.033.
   Krasnov D, 2017, THORAC SURG CLIN, V27, P99, DOI 10.1016/j.thorsurg.2017.01.003.
   Kwon YS, 2008, CLIN INFECT DIS, V47, P496, DOI 10.1086/590005.
   Lange C, 2014, EUR RESPIR J, V44, P23, DOI 10.1183/09031936.00188313.
   Levin A, 2016, INT J TUBERC LUNG D, V20, P1539, DOI 10.5588/ijtld.16.0033.
   Marrone MT, 2013, INT J TUBERC LUNG D, V17, P6, DOI 10.5588/ijtld.12.0198.
   Migliori GB, 2007, EUR RESPIR J, V30, P623, DOI 10.1183/09031936.00077307.
   Mohsen T, 2007, J THORAC CARDIOV SUR, V134, P194, DOI 10.1016/j.jtcvs.2007.03.022.
   Park SK, 2002, INT J TUBERC LUNG D, V6, P143.
   Pomerantz BJ, 2001, J THORAC CARDIOV SUR, V121, P448, DOI 10.1067/mtc.2001.112339.
   Porkhanov VA, 2002, PROBL TUBER, V3, P22.
   Shiraishi Yuji, 2008, Interact Cardiovasc Thorac Surg, V7, P1075, DOI 10.1510/icvts.2008.185124.
   Shiraishi Y, 2009, J THORAC CARDIOV SUR, V138, P1180, DOI 10.1016/j.jtcvs.2009.07.018.
   Somocurcio JG, 2007, THORAX, V62, P416, DOI 10.1136/thx.2005.051961.
   Subotic D, 2016, J THORAC DIS, V8, pE474, DOI 10.21037/jtd.2016.05.59.
   Sung SW, 1999, EUR J CARDIO-THORAC, V16, P187, DOI 10.1016/S1010-7940(99)00158-X.
   Takeda S, 2005, ANN THORAC SURG, V79, P959, DOI 10.1016/j.athoracsur.2004.09.007.
   Wang HF, 2008, ANN THORAC SURG, V86, P1640, DOI 10.1016/j.athoracsur.2008.07.056.
   WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016, WHOHTMTB201604.}},
Number-of-Cited-References = {{27}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Eur. J. Cardio-Thorac. Surg.}},
Doc-Delivery-Number = {{FY4UP}},
Unique-ID = {{ISI:000426822400019}},
DA = {{2018-08-13}},
}

@article{ ISI:000425813000004,
Author = {Scott, Andrew and Tien, Yuan-Ching and Drury, Craig F. and Reynolds, W.
   Daniel and Topp, Edward},
Title = {{Enrichment of antibiotic resistance genes in soil receiving composts
   derived from swine manure, yard wastes, or food wastes, and evidence for
   multiyear persistence of swine Clostridium spp.}},
Journal = {{CANADIAN JOURNAL OF MICROBIOLOGY}},
Year = {{2018}},
Volume = {{64}},
Number = {{3}},
Pages = {{201-208}},
Month = {{MAR}},
Abstract = {{The impact of amendment with swine manure compost (SMC), yard waste
   compost (YWC), or food waste compost (FWC) on the abundance of
   antibiotic resistance genes in soil was evaluated. Following a
   commercial-scale application of the composts in a field experiment,
   soils were sampled periodically for a decade, and archived air-dried.
   Soil DNA was extracted and gene targets quantified by qPCR. Compared
   with untreated control soil, all 3 amendment types increased the
   abundance of gene targets for up to 4 years postapplication. The
   abundance of several gene targets was much higher in soil amended with
   SMC than in soil receiving either YWC or FWC. The gene target ermB
   remained higher in the SMC treatment for a decade postapplication.
   Clostridia were significantly more abundant in the SMC-amended soil
   throughout the decade following application. Eight percent of
   Clostridium spp. isolates from the SMC treatment carried ermB. Overall,
   addition of organic amendments to soils has the potential to increase
   the abundance of antibiotic resistance genes. Amendments of fecal
   origin, such as SMC, will in addition entrain bacteria carrying
   antibiotic resistance genes. Environmentally recalcitrant clostridia,
   and the antibiotic resistance genes that they carry, will persist for
   many years under field conditions following the application of SMC.}},
Publisher = {{CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS}},
Address = {{65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Topp, E (Reprint Author), Agr \& Agri Food Canada, 1391 Sandford St, London, ON N5V 4T3, Canada.
   Topp, E (Reprint Author), Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.
   Scott, Andrew; Tien, Yuan-Ching; Topp, Edward, Agr \& Agri Food Canada, 1391 Sandford St, London, ON N5V 4T3, Canada.
   Drury, Craig F.; Reynolds, W. Daniel, Agr \& Agri Food Canada, 2585 Cty Rd 20, Harrow, ON N0R 1G0, Canada.
   Topp, Edward, Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.}},
DOI = {{10.1139/cjm-2017-0642}},
ISSN = {{0008-4166}},
EISSN = {{1480-3275}},
Keywords = {{antibiotic resistance; agriculture; soil amendment; Clostridium spp.}},
Keywords-Plus = {{BACTERIAL COMMUNITY TOLERANCE; LAND APPLICATION; BETA-LACTAMASES; CU
   EXPOSURE; ABUNDANCE; PERFRINGENS; VEGETABLES; HARVEST; IMPACT; WATER}},
Research-Areas = {{Biochemistry \& Molecular Biology; Biotechnology \& Applied
   Microbiology; Immunology; Microbiology}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Biotechnology \& Applied
   Microbiology; Immunology; Microbiology}},
Author-Email = {{ed.topp@agr.gc.ca}},
Funding-Acknowledgement = {{Agriculture and Agri-Food Canada's Growing Forward 2 program}},
Funding-Text = {{This work was supported by competitive financing through Agriculture and
   Agri-Food Canada's Growing Forward 2 program.}},
Cited-References = {{Albini S, 2008, VET MICROBIOL, V127, P179, DOI 10.1016/j.vetmic.2007.07.024.
   Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312.
   Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86.
   Bengtsson-Palme J, 2016, ENVIRON INT, V86, P140, DOI 10.1016/j.envint.2015.10.015.
   Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439.
   Berg J, 2012, APPL ENVIRON MICROB, V78, P7438, DOI 10.1128/AEM.01071-12.
   Berg J, 2010, ENVIRON SCI TECHNOL, V44, P8724, DOI 10.1021/es101798r.
   BISSON JW, 1979, APPL ENVIRON MICROB, V37, P55.
   Braga LPP, 2017, BIODATA MIN, V10, DOI 10.1186/s13040-017-0138-4.
   Brandt KK, 2009, ENVIRON SCI TECHNOL, V43, P2963, DOI 10.1021/es803546y.
   CLEWELL DB, 1990, EUR J CLIN MICROBIOL, V9, P90, DOI 10.1007/BF01963632.
   Coleman BL, 2013, WATER RES, V47, P3026, DOI 10.1016/j.watres.2013.03.008.
   Cook KL, 2014, J ENVIRON QUAL, V43, P1546, DOI 10.2134/jeq2013.10.0432.
   Cytryn E, 2013, SOIL BIOL BIOCHEM, V63, P18, DOI 10.1016/j.soilbio.2013.03.017.
   Dai L, 2010, ANTIMICROB AGENTS CH, V54, P3953, DOI 10.1128/AAC.00169-10.
   Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10.
   Drury CF, 2014, CAN J SOIL SCI, V94, P347, DOI {[}10.4141/CJSS2013-077, 10.4141/cjss2013-077].
   Durso LM, 2014, CURR OPIN MICROBIOL, V19, P37, DOI 10.1016/j.mib.2014.05.019.
   European Centre for Disease Prevention and Control, 2015, ANT RES STRAT ACT PL.
   Galan JC, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00009.
   Gaze W.H., 2013, EMERG INFECT DIS, V19, DOI {[}10.3201/eid1907.120871, DOI 10.3201/EID1907.120871].
   Government of Canada, 2015, FED ACT PLAN ANT RES.
   Gudeta DD, 2016, ANTIMICROB AGENTS CH, V60, P151, DOI 10.1128/AAC.01424-15.
   Gupta A, 2003, APPL ENVIRON MICROB, V69, P6455, DOI 10.1128/AEM.69.11.6455-6463.2003.
   Hoelzer K, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1131-3.
   Jechalke S, 2013, APPL ENVIRON MICROB, V79, P1704, DOI 10.1128/AEM.03172-12.
   Kather EJ, 2006, VET MICROBIOL, V113, P97, DOI 10.1016/j.vetmic.2005.10.021.
   Larney FJ, 2011, ACSESS PUBL, P247, DOI 10.2136/2011.soilmanagement.c16.
   Lau CHF, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00989-17.
   Lau CHF, 2017, SCI TOTAL ENVIRON, V587, P214, DOI 10.1016/j.scitotenv.2017.02.123.
   Liu JX, 2016, ENVIRON MICROBIOL, V18, P557, DOI 10.1111/1462-2920.13097.
   Marti R, 2014, APPL ENVIRON MICROB, V80, P3258, DOI 10.1128/AEM.00231-14.
   Marti R, 2013, APPL ENVIRON MICROB, V79, P5701, DOI 10.1128/AEM.01682-13.
   Mathews Burwell S., 2015, OUR PLAN COMBAT PREV.
   Michael I, 2013, WATER RES, V47, P957, DOI 10.1016/j.watres.2012.11.027.
   Monot M, 2011, J MED MICROBIOL, V60, P1193, DOI 10.1099/jmm.0.030452-0.
   Nolvak H, 2016, SCI TOTAL ENVIRON, V562, P678, DOI 10.1016/j.scitotenv.2016.04.035.
   Perry JA, 2014, BIOESSAYS, V36, P1179, DOI 10.1002/bies.201400128.
   Pope L., 2009, VET MED ENV, P129.
   Pourcher AM, 2014, SCI TOTAL ENVIRON, V482, P269, DOI {[}10.1016/j.scitotenv.2014.02.136, 10.1016/j.].
   Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es0604131.
   Pruden A, 2013, ENVIRON HEALTH PERSP, V121, P878, DOI 10.1289/ehp.1206446.
   Rahube TO, 2014, APPL ENVIRON MICROB, V80, P6898, DOI 10.1128/AEM.02389-14.
   Review on Antimicrobial Resistance, 2016, TACKLING DRUG RESIST.
   Reynolds WD, 2015, CAN J SOIL SCI, V95, P251, DOI {[}10.4141/CJSS-2014-114, 10.4141/cjss-2014-114].
   Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x.
   Ryzinska-Paier G, 2011, J MICROBIOL METH, V87, P189, DOI 10.1016/j.mimet.2011.08.006.
   Shoemaker NB, 2001, APPL ENVIRON MICROB, V67, P561, DOI 10.1128/AEM.67.2.561-568.2001.
   TOMICH PK, 1980, J BACTERIOL, V141, P1366.
   Udikovic-Kolic N, 2014, P NATL ACAD SCI USA, V111, P15202, DOI 10.1073/pnas.1409836111.
   Wang FH, 2015, J HAZARD MATER, V299, P215, DOI 10.1016/j.jhazmat.2015.05.028.
   Wang FH, 2014, ENVIRON SCI TECHNOL, V48, P9079, DOI 10.1021/es502615e.
   Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1.
   Williams-Nguyen J, 2016, J ENVIRON QUAL, V45, P394, DOI 10.2134/jeq2015.07.0336.
   Yang XM, 2014, CAN J SOIL SCI, V94, P357, DOI {[}10.4141/CJSS2013-076, 10.4141/cjss2013-076].
   Zhou X, 2017, ENVIRON SCI POLLUT R, V24, P701, DOI 10.1007/s11356-016-7854-z.
   Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110.}},
Number-of-Cited-References = {{57}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{25}},
Usage-Count-Since-2013 = {{25}},
Journal-ISO = {{Can. J. Microbiol.}},
Doc-Delivery-Number = {{FX1LO}},
Unique-ID = {{ISI:000425813000004}},
DA = {{2018-08-13}},
}

@article{ ISI:000425604300026,
Author = {Ponnaiya, Brian and Buonanno, Manuela and Welch, David and Shuryak, Igor
   and Randers-Pehrson, Gerhard and Brenner, David J.},
Title = {{Far-UVC light prevents MRSA infection of superficial wounds in vivo}},
Journal = {{PLOS ONE}},
Year = {{2018}},
Volume = {{13}},
Number = {{2}},
Month = {{FEB 21}},
Abstract = {{Background
   Prevention of superficial surgical wound infections from drug-resistant
   bacteria such as methicillin resistant Staphylococcus aureus (MRSA)
   currently present major health care challenges. The majority of surgical
   site infections (SSI) are believed to be caused by airborne transmission
   of bacteria alighting onto the wound during surgical procedures. We have
   previously shown that far-ultraviolet C light in the wavelength range of
   207-222 nm is significantly harmful to bacteria, but without damaging
   mammalian cells and tissues. It is important that the lamp be fitted
   with a filter to remove light emitted at wavelengths longer than 230 nm
   which are harmful.
   Aims
   Using a hairless mouse model of infection of superficial wounds, here we
   tested the hypothesis that 222-nm light kills MRSA alighting onto a
   superficial skin incisions as efficiently as typical germicidal light
   (254 nm), but without inducing skin damage.
   Methods
   To simulate the scenario wherein incisions are infected during surgical
   procedures as pathogens in the room alight on a wound, MRSA was spread
   on a defined area of the mouse dorsal skin; the infected skin was then
   exposed to UVC light (222 nm or 254 nm) followed by a superficial
   incision within the defined area, which was immediately sutured. Two and
   seven days post procedure, bactericidal efficacy was measured as MRSA
   colony formation unit (CFU) per gram of harvested skin whereas fixed
   samples were used to assess skin damage measured in terms of epidermal
   thickness and DNA photodamage.
   Results
   In the circumstance of superficial incisions infected with bacteria
   alighting onto the wound, 222-nm light showed the same bactericidal
   properties of 254-nm light but without the associated skin damage.
   Conclusions
   Being safe for patient and hospital staff, our results suggested that
   far-UVC light (222 nm) might be a convenient approach to prevent
   transmission of drug-resistant infectious agents in the clinical
   setting.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ponnaiya, B (Reprint Author), Columbia Univ, Dept Radiat Oncol, Ctr Radiol Res, Med Ctr, New York, NY 10027 USA.
   Ponnaiya, Brian; Buonanno, Manuela; Welch, David; Shuryak, Igor; Randers-Pehrson, Gerhard; Brenner, David J., Columbia Univ, Dept Radiat Oncol, Ctr Radiol Res, Med Ctr, New York, NY 10027 USA.}},
DOI = {{10.1371/journal.pone.0192053}},
Article-Number = {{e0192053}},
ISSN = {{1932-6203}},
Keywords-Plus = {{SURGICAL-SITE INFECTIONS; LAMINAR AIR-FLOW; ULTRAVIOLET-RADIATION;
   ORTHOPEDIC-SURGERY; CONTAMINATION; DISINFECTION; IRRADIATION; GUIDELINE;
   ROOM; SKIN}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{bp156@cumc.columbia.edu}},
Funding-Acknowledgement = {{Shostack Foundation; USHIO Inc. {[}PG006603-02-USHIO CU15-1452]}},
Funding-Text = {{This work was supported by Shostack Foundation and USHIO Inc., grant
   number PG006603-02-USHIO CU15-1452 to DJB. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.}},
Cited-References = {{Anderson DJ, 2011, INFECT DIS CLIN N AM, V25, P135, DOI 10.1016/j.idc.2010.11.004.
   Balasubramanian D, 2000, J OCUL PHARMACOL TH, V16, P285, DOI 10.1089/jop.2000.16.285.
   BASFORD JR, 1986, ARCH PHYS MED REHAB, V67, P151, DOI 10.1016/0003-9993(86)90053-5.
   Bratzler DW, 2013, SURG INFECT, V14, P73, DOI 10.1089/sur.2013.9999.
   Buonanno M., 2013, PLOS ONE.
   Buonanno M, 2017, RAD RES.
   Buonanno M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0138418.
   Buonanno M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076968.
   Chauveaux D, 2015, ORTHOP TRAUMATOL-SUR, V101, pS77, DOI 10.1016/j.otsr.2014.07.028.
   Diab-Elschahawi M, 2011, AM J INFECT CONTROL, V39, pE25, DOI 10.1016/j.ajic.2010.10.035.
   Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043.
   Gosden PE, 1998, J HOSP INFECT, V39, P173, DOI 10.1016/S0195-6701(98)90255-9.
   Gupta A, 2013, ADV WOUND CARE, V2, P422, DOI 10.1089/wound.2012.0366.
   HOWORTH FH, 1985, LANCET, V1, P386.
   JAMES LC, 1991, SKIN PHARMACOL, V4, P61.
   Kraissl CJ, 1940, ANN SURG, V111, P161, DOI 10.1097/00000658-194002000-00001.
   LIDWELL OM, 1983, J HOSP INFECT, V4, P111, DOI 10.1016/0195-6701(83)90041-5.
   Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620.
   Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X.
   McHugh SM, 2015, SURG-J R COLL SURG E, V13, P52, DOI 10.1016/j.surge.2014.10.003.
   Michael Carolyn Anne, 2014, Front Public Health, V2, P145, DOI 10.3389/fpubh.2014.00145.
   Nardell E, 2013, PHOTOCHEM PHOTOBIOL, V89, P764, DOI 10.1111/php.12098.
   Narita K, 2017, J PHOTOCH PHOTOBIO B, V178, P10.
   Noguchi C, 2017, BMC SURG, V17, DOI 10.1186/s12893-017-0275-1.
   Overholt RH, 1940, J THOR SURG, V9, P520.
   Ritter MA, 2007, J BONE JOINT SURG AM, V89A, P1935, DOI 10.2106/JBJS.F.01037.
   SETLOW RB, 1993, P NATL ACAD SCI USA, V90, P6666, DOI 10.1073/pnas.90.14.6666.
   Siegel J. D., 2007, GUIDELINE ISOLATION.
   Stocks GW, 2011, J ARTHROPLASTY, V26, P771, DOI 10.1016/j.arth.2010.07.001.
   TAYLOR GJS, 1995, J HOSP INFECT, V30, P85, DOI 10.1016/0195-6701(95)90148-5.
   Uhlemann AC, 2014, INFECT GENET EVOL, V21, P563, DOI 10.1016/j.meegid.2013.04.030.
   Woods JA, 2015, PHOTODERMATOL PHOTO, V31, P159, DOI 10.1111/phpp.12156.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{FW8RO}},
Unique-ID = {{ISI:000425604300026}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000414922600137,
Author = {Hu, Jialin and Zhao, Fuzheng and Zhang, Xu-Xiang and Li, Kan and Li,
   Chaoran and Ye, Lin and Li, Mei},
Title = {{Metagenomic profiling of ARGs in airborne particulate matters during a
   severe smog event}},
Journal = {{SCIENCE OF THE TOTAL ENVIRONMENT}},
Year = {{2018}},
Volume = {{615}},
Pages = {{1332-1340}},
Month = {{FEB 15}},
Abstract = {{Information is currently limited regarding the distribution of
   antibiotic resistance genes (ARGs) in smog and their correlations with
   airborne bacteria. This study characterized the diversity and abundance
   of ARGs in the particulate matters (PMs) of severe smog based on
   publicly available metagenomic data, and revealed the occurrence of 205
   airborne ARG subtypes, including 31 dominant ones encoding resistance to
   11 antibiotic types. Among the detectable ARGs, tetracycline,
   beta-lactam and aminoglycoside resistance genes had the highest
   abundance, and smog and soil had similar composition characteristics of
   ARGs. During the smog event, the total abundance of airborne ARGs ranged
   from 4.90 to 38.07 ppm in PM2.5 samples, and from 7.61 to 38.49 ppm in
   PM10 samples, which were 1.6-7.7 times and 2.1-5.1 times of those in the
   non-smog day, respectively. The airborne ARGs showed complicated
   co-occurrence patterns, which were heavily influenced by the interaction
   of bacterial community, and physicochemical and meteorological factors.
   Lactobacillus and sulfonamide resistance gene sul1 were determined as
   keystones in the co-occurrence network of microbial taxa and airborne
   ARGs. The results may help to understand the distribution patterns of
   ARGs in smog for the potential health risk evaluation. (C) 2017 Elsevier
   B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Zhang, XX; Li, M (Reprint Author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control \& Resource Reuse, 163 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.
   Hu, Jialin; Zhao, Fuzheng; Zhang, Xu-Xiang; Li, Kan; Li, Chaoran; Ye, Lin; Li, Mei, Nanjing Univ, Sch Environm, Environm Hlth Res Ctr, State Key Lab Pollut Control \& Resource Reuse, Nanjing 210023, Jiangsu, Peoples R China.}},
DOI = {{10.1016/j.scitotenv.2017.09.222}},
ISSN = {{0048-9697}},
EISSN = {{1879-1026}},
Keywords = {{Antibiotic resistance genes; Antibiotic resistant bacteria; Network
   analysis; Metagenome; Particulate matters; Smog air}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE GENES; WATER TREATMENT-PLANT; WASTE-WATER;
   BACTERIAL COMMUNITIES; MICROBIAL COMMUNITIES; ACTIVATED-SLUDGE; METAL
   RESISTANCE; DRINKING-WATER; SOIL; TETRACYCLINE}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{zhangxx@nju.edu.cn
   meili@nju.edu.cn}},
ORCID-Numbers = {{Ye, Lin/0000-0002-4682-8917}},
Funding-Acknowledgement = {{National Science \& Technology Pillar Program of China {[}2014BAC08B04];
   Six Talent Peaks Project in Jiangsu Province of China {[}2015JNHB-001]}},
Funding-Text = {{This study was financially supported by National Science \& Technology
   Pillar Program of China (2014BAC08B04) and Six Talent Peaks Project in
   Jiangsu Province of China (2015JNHB-001). We would like to thank Chen
   Cao, Wenjun Jiang, Buying Wang, Jianhuo Fang, Jidong Lang, Geng Tian,
   Jingkun Jiang, and Ting F. Zhu for providing free online access to their
   metagenome sequencing data of PM samples, and the High Performance
   Computing Center (HPCC) of Nanjing University for the help of
   computation.}},
Cited-References = {{Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006.
   Bastian M., 2009, ICWSM, V1, P2, DOI DOI 10.13140/2.1.1341.1520.
   Behzad H, 2015, GENOME BIOL EVOL, V7, P1216, DOI 10.1093/gbe/evv064.
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289.
   Bennett PM, 2008, BRIT J PHARMACOL, V153, pS347, DOI 10.1038/sj.bjp.0707607.
   Bertolini V, 2013, APPL MICROBIOL BIOT, V97, P6561, DOI 10.1007/s00253-012-4450-0.
   Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380.
   Blanco P, 2016, MICROORGANISMS, V4, P14, DOI DOI 10.3390/MICR00RGANISMS4010014.
   Bowers RM, 2013, ENVIRON SCI TECHNOL, V47, P12097, DOI 10.1021/es402970s.
   Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167.
   Brooks B, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-1.
   Cao C, 2014, ENVIRON SCI TECHNOL, V48, P1499, DOI 10.1021/es4048472.
   Chapin A, 2005, ENVIRON HEALTH PERSP, V113, P137, DOI 10.1289/ehp.7473.
   Chen BW, 2013, ENVIRON SCI TECHNOL, V47, P12753, DOI 10.1021/es403818e.
   Chen YF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-753.
   Cromwell GL, 2002, ANIM BIOTECHNOL, V13, P7, DOI 10.1081/ABIO-120005767.
   Deletoile A, 2009, J CLIN MICROBIOL, V47, P300, DOI 10.1128/JCM.01916-08.
   Desmarais TR, 2002, APPL ENVIRON MICROB, V68, P1165, DOI 10.1128/AEM.68.3.1165-1172.2002.
   Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634.
   Donato JJ, 2010, APPL ENVIRON MICROB, V76, P4396, DOI 10.1128/AEM.01763-09.
   Dong WeiChao, 2012, Chinese Journal of Zoonoses, V28, P1130.
   Fang H, 2015, ENVIRON SCI TECHNOL, V49, P1095, DOI 10.1021/es504157v.
   {[}方治国 Fang Zhiguo], 2004, {[}生态学报, Acta Ecologica Sinica], V24, P315.
   Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110.
   Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377.
   Gandolfi I, 2015, APPL MICROBIOL BIOT, V99, P4867, DOI 10.1007/s00253-014-6348-5.
   Gao M, 2017, ENVIRON POLLUT, V220, P1342, DOI 10.1016/j.envpol.2016.10.101.
   Gao P, 2015, APPL MICROBIOL BIOT, V99, P3971, DOI 10.1007/s00253-015-6404-9.
   Gerasopoulos E., 2014, GEOPH RES ABSTR, V16.
   Harrell F. E., 2008, HMISC HARRELL MISCEL.
   Hellweger FL, 2011, INT J ENV RES PUB HE, V8, P480, DOI 10.3390/ijerph8020480.
   Hernando MD, 2006, TALANTA, V69, P334, DOI 10.1016/j.talanta.2005.09.037.
   Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387.
   Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679.
   Jia SY, 2015, ENVIRON SCI TECHNOL, V49, P12271, DOI 10.1021/acs.est.5b03521.
   Kan HF, 2015, ENVIRON SCI TECHNOL, V49, P11894, DOI 10.1021/acs.est.5b02990.
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198.
   Kemper N, 2008, ECOL INDIC, V8, P1, DOI 10.1016/j.ecolind.2007.06.002.
   Knapp CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027300.
   Li B, 2015, ISME J, V9, P2490, DOI 10.1038/ismej.2015.59.
   Li J, 2016, ATMOS ENVIRON, V124, P404, DOI 10.1016/j.atmosenv.2015.06.030.
   Li LG, 2017, ISME J, V11, P651, DOI 10.1038/ismej.2016.155.
   Li WJ, 2006, INT J SYST EVOL MICR, V56, P733, DOI 10.1099/ijs.0.63876-0.
   Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656.
   Luo CW, 2014, APPL ENVIRON MICROB, V80, P1777, DOI 10.1128/AEM.03712-13.
   Ma JZ, 2012, ADV ATMOS SCI, V29, P1006, DOI 10.1007/s00376-012-1188-7.
   Mathur S, 2005, INT J FOOD MICROBIOL, V105, P281, DOI 10.1016/j.ijfoodmicro.2005.03.008.
   Mazar Y, 2016, ENVIRON SCI TECHNOL, V50, P4194, DOI 10.1021/acs.est.5b06348.
   McEachran AD, 2015, ENVIRON HEALTH PERSP, V123, P337, DOI 10.1289/ehp.1408555.
   Miao Y, 2015, WATER RES, V76, P43, DOI 10.1016/j.watres.2015.02.042.
   Munck C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9452.
   Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103.
   Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480.
   Pal C, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0199-5.
   Pal C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2153-5.
   Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483.
   Poole K, 2017, TRENDS MICROBIOL, V25, P820, DOI 10.1016/j.tim.2017.04.010.
   Pu XY, 2013, WORLD J MICROB BIOT, V29, P365, DOI 10.1007/s11274-012-1190-3.
   Roychowdhury R, 2016, B ENVIRON CONTAM TOX, V96, P210, DOI 10.1007/s00128-015-1692-4.
   Rubner Y, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P59, DOI 10.1109/ICCV.1998.710701.
   Sharma P, 2016, J FOOD SAFETY, V36, P38, DOI 10.1111/jfs.12211.
   Shen XJ, 2015, ATMOS ENVIRON, V120, P307, DOI 10.1016/j.atmosenv.2015.09.011.
   Shi P, 2013, WATER RES, V47, P111, DOI 10.1016/j.watres.2012.09.046.
   Soler L, 2016, ELECTROPHORESIS, V37, P1277, DOI 10.1002/elps.201500529.
   Stanier CO, 2004, AEROSOL SCI TECH, V38, P215, DOI 10.1080/02786820390229525.
   Su JQ, 2015, ENVIRON SCI TECHNOL, V49, P7356, DOI 10.1021/acs.est.5b01012.
   van Hoek AHAM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00203.
   Wang L, 2015, LETT APPL MICROBIOL, V61, P245, DOI 10.1111/lam.12450.
   Woodford N, 2007, CLIN MICROBIOL INFEC, V13, P5, DOI 10.1111/j.1469-0691.2006.01492.x.
   Xiao KQ, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw023.
   Yang Y, 2013, ENVIRON SCI TECHNOL, V47, P10197, DOI 10.1021/es4017365.
   Zhang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026041.
   Zhang T, 2009, ENVIRON SCI TECHNOL, V43, P3455, DOI 10.1021/es803309m.
   Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x.}},
Number-of-Cited-References = {{74}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{32}},
Usage-Count-Since-2013 = {{105}},
Journal-ISO = {{Sci. Total Environ.}},
Doc-Delivery-Number = {{FM3QQ}},
Unique-ID = {{ISI:000414922600137}},
DA = {{2018-08-13}},
}

@article{ ISI:000428576300004,
Author = {Kim, Chung-Jong and Yi, Jeong-Eun and Kim, Yookyung and Choi, Hee Jung},
Title = {{Emphysematous endocarditis caused by AmpC beta-lactamase-producing
   Escherichia coli A case report}},
Journal = {{MEDICINE}},
Year = {{2018}},
Volume = {{97}},
Number = {{6}},
Month = {{FEB}},
Abstract = {{Rationale: Infective endocarditis (IE) is a life-threatening disease,
   mostly caused by gram-positive bacteria. Gram-negative bacteria were
   identified as a causative organism in relatively small number of cases.
   Although, antibiotic-resistant Escherichia coli is common cause of
   gram-negative endocarditis, AmpC beta-lactamase (BL)-harboring E coli is
   very rare cause of IE. Furthermore, emphysematous endocarditis is also a
   very rare manifestation of E coli infection.
   Patientconcerns: We report a case of 80-year-old female patient
   presenting with dizziness, fever, and altered mental status, who was
   finally diagnosed with emphysematous endocarditis caused by E coli
   harboring an AmpC BL gene.
   Diagnosis: Her chest computed tomography revealed air bubbles
   surrounding the annulus of a mitral valve and a transesophageal
   echocardiogram revealed a hyperechogenic mass fixed on the posteromedial
   side of the mitral annulus with 2 eccentric mitral regurgitation jets.
   Blood cultures grew E coli which harbored the DHA-type AmpC BL. The
   organism belonged to a B2 phylogenic group, and multilocus sequence
   typing analyses revealed that the strains were of ST-95.
   Interventions: She was treated with meropenem following the resistant
   profiles, and surgery was recommended by the healthcare professional,
   but denied by the patient's guardians. She was transferred to another
   hospital due to a refusal for further treatment.
   Lessons: Emphysematous endocarditis is an uncommon complication of E
   coli bacteremia. Certain phylogenetic groups may be associated with
   development of E coli endocarditis.}},
Publisher = {{LIPPINCOTT WILLIAMS \& WILKINS}},
Address = {{TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Choi, HJ (Reprint Author), Ewha Womans Univ, Sch Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea.
   Kim, Chung-Jong; Yi, Jeong-Eun; Choi, Hee Jung, Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   Kim, Yookyung, Ewha Womans Univ, Coll Med, Dept Radiol, Seoul, South Korea.}},
DOI = {{10.1097/MD.0000000000009620}},
Article-Number = {{e9620}},
ISSN = {{0025-7974}},
EISSN = {{1536-5964}},
Keywords = {{AmpC beta-lactamases; case report; endocarditis; Escherichia coli}},
Keywords-Plus = {{VALVE ENDOCARDITIS; ENTEROBACTERIACEAE; INFECTIONS; RESISTANCE; ADULTS}},
Research-Areas = {{General \& Internal Medicine}},
Web-of-Science-Categories  = {{Medicine, General \& Internal}},
Author-Email = {{heechoi@ewha.ac.kr}},
Cited-References = {{Aherne Andrew, 2017, J Emerg Trauma Shock, V10, P85, DOI 10.4103/JETS.JETS\_75\_16.
   Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296.
   Bennett JE, 2014, PRINCIPLES PRACTICE.
   Branger S, 2005, EUR J CLIN MICROBIOL, V24, P537, DOI 10.1007/s10096-005-1379-6.
   Chen MY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005367.
   Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000.
   Gaillot O, 1997, J ANTIMICROB CHEMOTH, V39, P85, DOI 10.1093/jac/39.1.85.
   George S, 2013, WORLD J HEPATOL, V5, P296, DOI 10.4254/wjh.v5.i5.296.
   Lee CH, 2015, J MICROBIOL IMMUNOL, V48, P269, DOI 10.1016/j.jmii.2013.08.010.
   Lupse M, 2012, J GASTROINTEST LIVER, V21, P219.
   Micol R, 2006, CLIN MICROBIOL INFEC, V12, P401, DOI 10.1111/j.1469-0691.2006.01375.x.
   Misgar Raiz Ahmad, 2016, Indian J Endocrinol Metab, V20, P475, DOI 10.4103/2230-8210.183475.
   Modi HH, 2011, J GLOB INFECT DIS, V3, P99, DOI 10.4103/0974-777X.77310.
   Morpeth S, 2007, ANN INTERN MED, V147, P829, DOI 10.7326/0003-4819-147-12-200712180-00002.
   Park YS, 2009, INT J ANTIMICROB AG, V34, P38, DOI 10.1016/j.ijantimicag.2009.01.009.
   Pekarkova M, 2008, J SMALL ANIM PRACT, V49, P44, DOI 10.1111/j.1748-5827.2007.00425.x.
   PEREZLLARENA FJ, 2014, J ANTIMICROB CHEMOTH, V58, P6544, DOI DOI 10.1128/AAC.03144-14.
   Sheng WH, 2013, ANTIMICROB AGENTS CH, V57, P2981, DOI 10.1128/AAC.00971-12.
   Song W, 2006, DIAGN MICR INFEC DIS, V55, P219, DOI 10.1016/j.diagmicrobio.2006.01.012.
   Takano Yuichi, 2017, BMC Res Notes, V10, P117, DOI 10.1186/s13104-017-2445-8.
   Yong D, 2005, DIAGN MICR INFEC DIS, V53, P65, DOI 10.1016/j.diagmicrobio.2005.03.008.}},
Number-of-Cited-References = {{21}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Medicine (Baltimore)}},
Doc-Delivery-Number = {{GA8GI}},
Unique-ID = {{ISI:000428576300004}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000426436300141,
Author = {Bello-Vieda, Nestor J. and Pastrana, Homero F. and Garavito, Manuel F.
   and Avila, Alba G. and Celis, Adriana M. and Munoz-Castro, Alvaro and
   Restrepo, Silvia and Hurtado, John J.},
Title = {{Antibacterial Activities of Azole Complexes Combined with Silver
   Nanoparticles}},
Journal = {{MOLECULES}},
Year = {{2018}},
Volume = {{23}},
Number = {{2}},
Month = {{FEB}},
Abstract = {{Growing antimicrobial resistance is considered a potential threat for
   human health security by health organizations, such as the WHO, CDC and
   FDA, pointing to MRSA as an example. New antibacterial drugs and complex
   derivatives are needed to combat the development of bacterial
   resistance. Six new copper and cobalt complexes of azole derivatives
   were synthesized and isolated as air-stable solids and characterized by
   melting point analyses, elemental analyses, thermogravimetric analyses
   (TGA), and infrared and ultraviolet/visible spectroscopy. The analyses
   and spectral data showed that the complexes had 1:1 (M:L)
   stoichiometries and tetrahedral geometries, the latter being supported
   by DFT calculations. The antibacterial activities of the metal complexes
   by themselves and combined with silver nanoparticles (AgNPs; 2 mu g
   mL(-1)) were assessed in vitro by broth microdilution assays against
   eight bacterial strains of clinical relevance. The results showed that
   the complexes alone exhibited moderate antibacterial activities.
   However, when the metal complexes were combined with AgNPs, their
   antibacterial activities increased (up to 10-fold in the case of complex
   5), while human cell viabilities were maintained. The minimum inhibitory
   concentration (MIC50) values were in the range of 25-500 mu g mL(-1).
   This study thus presents novel approaches for the design of materials
   for fighting bacterial resistance. The use of azole complexes combined
   with AgNPs provides a new alternative against bacterial infections,
   especially when current treatments are associated with the rapid
   development of antibiotic resistance.}},
Publisher = {{MDPI}},
Address = {{ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hurtado, JJ (Reprint Author), Univ Los Andes, Dept Chem, Carrera 1 18A-12, Bogota 111711, Colombia.
   Bello-Vieda, Nestor J.; Hurtado, John J., Univ Los Andes, Dept Chem, Carrera 1 18A-12, Bogota 111711, Colombia.
   Pastrana, Homero F.; Avila, Alba G., Univ Los Andes, Ctr Microelect, Elect \& Elect, Carrera 1 18A-12, Bogota 111711, Colombia.
   Garavito, Manuel F.; Celis, Adriana M.; Restrepo, Silvia, Univ Los Andes, Dept Ciencias Biol, Lab Micol \& Fitopatol, Carrera 1 18A-12, Bogota 111711, Colombia.
   Munoz-Castro, Alvaro, Univ Autonoma Chile, Grp Quim Inorgan \& Mat Mol, El Llano Subercaseaux 2801, Santiago, Chile.}},
DOI = {{10.3390/molecules23020361}},
Article-Number = {{361}},
ISSN = {{1420-3049}},
Keywords = {{azole ligands; copper and cobalt complexes; silver nanoparticles;
   antibacterial resistance; antibacterial activity; cytotoxicity}},
Keywords-Plus = {{BIOLOGICAL EVALUATION; CRYSTAL-STRUCTURE; COBALT COMPLEXES; AGENTS;
   LIGAND; COPPER; ANTIFUNGAL; IMIDAZOLES; RESISTANCE; ZN(II)}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Chemistry, Multidisciplinary}},
Author-Email = {{nj.bello1211@uniandes.edu.co
   hf.pastrana122@uniandes.edu.co
   manuel.garavitodiago@yale.edu
   a-avila@uniandes.edu.co
   acelis@uniandes.edu.co
   alvaro.munoz@uautonoma.cl
   srestrep@uniandes.edu.co
   jj.hurtado@uniandes.edu.co}},
ORCID-Numbers = {{Hurtado, John/0000-0002-0511-9719
   Pastrana, Homero/0000-0001-6077-6263}},
Funding-Acknowledgement = {{Universidad de los Andes; Vicerrectoria de Investigaciones Universidad
   de los Andes; Colciencias Beca Francisco Jose de Caldas}},
Funding-Text = {{The authors express their thanks to the Universidad de los Andes for
   financial support from the Interfaculty project and the Faculty of
   Sciences. Thanks to Vicerrectoria de Investigaciones Universidad de los
   Andes and Colciencias Beca Francisco Jose de Caldas 547 for providing
   financial support to the PhD candidate Fernando Pastrana. We acknowledge
   the human genetics laboratory Human Genetics Laboratory at Andes
   University for all their support during the cytotoxicity assays.}},
Cited-References = {{Agnihotri S, 2014, RSC ADV, V4, P3974, DOI 10.1039/c3ra44507k.
   Allahverdiyev AM, 2011, EXPERT REV ANTI-INFE, V9, P1035, DOI {[}10.1586/eri.11.121, 10.1586/ERI.11.121].
   Arab Ahmadi R., 2013, ISRN INORG CHEM, V2013, P1.
   Atkins P, 2010, SHRIVER ATKINS INORG.
   Bayrak H, 2009, EUR J MED CHEM, V44, P4362, DOI 10.1016/j.ejmech.2009.05.022.
   Boni A, 2006, J ORGANOMET CHEM, V691, P5602, DOI 10.1016/j.jorganchem.2006.09.006.
   Castillo KF, 2016, J BRAZIL CHEM SOC, V27, P2334, DOI 10.5935/0103-5053.20160130.
   Chandra S, 2007, BIOINORG CHEM APPL, DOI 10.1155/2007/51483.
   Collin F, 2011, APPL MICROBIOL BIOT, V92, P479, DOI 10.1007/s00253-011-3557-z.
   Cotton FA, 1999, ADV INORGANIC CHEM.
   Elechiguerra J. L., 2005, J NANOBIOTECHNOL, V6, P3, DOI DOI 10.1186/1477-3155-3-6.
   Fang B, 2010, EUR J MED CHEM, V45, P4388, DOI 10.1016/j.ejmech.2010.06.012.
   Franci G, 2015, MOLECULES, V20, P8856, DOI 10.3390/molecules20058856.
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7.
   Heerding DA, 2001, BIOORG MED CHEM LETT, V11, P2061, DOI 10.1016/S0960-894X(01)00404-8.
   Herbrecht Raoul, 2004, Expert Rev Anti Infect Ther, V2, P485, DOI 10.1586/14787210.2.4.485.
   Honary S, 2013, TROP J PHARM RES, V12, P265, DOI 10.4314/tjpr.v12i2.20.
   Hurtado J, 2013, J CHIL CHEM SOC, V58, P1534, DOI 10.4067/S0717-97072013000100007.
   Hurtado J, 2009, J COORD CHEM, V62, P2772, DOI 10.1080/00958970902929344.
   JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370.
   JULIA S, 1982, J HETEROCYCLIC CHEM, V19, P1141, DOI 10.1002/jhet.5570190531.
   Kabbani AT, 2007, CHEM PHARM BULL, V55, P446, DOI 10.1248/cpb.55.446.
   Khabnadideh S, 2003, BIOORG MED CHEM LETT, V13, P2863, DOI 10.1016/S0960-894X(03)00591-2.
   Kljun J, 2014, ORGANOMETALLICS, V33, P1594, DOI 10.1021/om401096y.
   Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z.
   Atria AM, 2011, J CHIL CHEM SOC, V56, P786, DOI 10.4067/S0717-97072011000300015.
   Montazerozohori M, 2015, SPECTROCHIM ACTA A, V138, P517, DOI 10.1016/j.saa.2014.11.055.
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4.
   Nair LS, 2007, J BIOMED NANOTECHNOL, V3, P301, DOI 10.1166/jbn.2007.041.
   Naqvi SZH, 2013, INT J NANOMED, V8, DOI 10.2147/IJN.S49284.
   NAVARRORANNINGER MC, 1987, INORG CHIM ACTA, V132, P7, DOI 10.1016/S0020-1693(00)83982-1.
   Pahontu E, 2013, MOLECULES, V18, P8812, DOI 10.3390/molecules18088812.
   Pelgrift RY, 2013, ADV DRUG DELIVER REV, V65, P1803, DOI 10.1016/j.addr.2013.07.011.
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002.
   Sass J, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0188-y.
   Shelke S, 2010, BIOORG MED CHEM LETT, V20, P7200, DOI 10.1016/j.bmcl.2010.10.111.
   Silver S, 1996, GENE, V179, P9, DOI 10.1016/S0378-1119(96)00323-X.
   Singh K, 2012, EUR J MED CHEM, V52, P313, DOI 10.1016/j.ejmech.2012.02.053.
   VANDENBOSSCHE H, 1983, BIOCHEM SOC T, V11, P665, DOI 10.1042/bst0110665.
   Yousef TA, 2014, SPECTROCHIM ACTA A, V129, P163, DOI 10.1016/j.saa.2014.02.184.
   Zhang XF, 2015, INT J NANOMED, V10, P1335, DOI 10.2147/IJN.S76062.
   Zhang Y, 2008, BIOMED MICRODEVICES, V10, P321, DOI 10.1007/s10544-007-9139-2.
   Zhou Y, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-19.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Molecules}},
Doc-Delivery-Number = {{FX9PK}},
Unique-ID = {{ISI:000426436300141}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000426003200005,
Author = {He, Meng-Han and Li, Dong-Liang and Zhu, Wen and Wu, E-Jiao and Yang,
   Li-Na and Wang, Yan-Ping and Waheed, Abdul and Zhan, Jiasui},
Title = {{Slow and temperature-mediated pathogen adaptation to a nonspecific
   fungicide in agricultural ecosystem}},
Journal = {{EVOLUTIONARY APPLICATIONS}},
Year = {{2018}},
Volume = {{11}},
Number = {{2}},
Pages = {{182-192}},
Month = {{FEB}},
Abstract = {{The spread of antimicrobial resistance and global change in air
   temperature represent two major phenomena that are exerting a disastrous
   impact on natural and social issues but investigation of the interaction
   between these phenomena in an evolutionary context is limited. In this
   study, a statistical genetic approach was used to investigate the
   evolution of antimicrobial resistance in agricultural ecosystem and its
   association with local air temperature, precipitation, and UV radiation.
   We found no resistance to mancozeb, a nonspecific fungicide widely used
   in agriculture for more than half a century, in 215 Alternaria alternata
   isolates sampled from geographic locations along a climatic gradient and
   cropping system representing diverse ecotypes in China, consistent with
   low resistance risk in many nonspecific fungicides. Genetic variance
   accounts for similar to 35\% of phenotypic variation, while
   genotype-environment interaction is negligible, suggesting that
   heritability plays a more important role in the evolution of resistance
   to mancozeb in plant pathogens than phenotypic plasticity. We also found
   that tolerance to mancozeb in agricultural ecosystem is under
   constraining selection and significantly associated with local air
   temperature, possibly resulting from a pleiotropic effect of resistance
   with thermal and other ecological adaptations. The implication of these
   results for fungicide and other antimicrobial management in the context
   of global warming is discussed.}},
Publisher = {{WILEY}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Zhan, JS (Reprint Author), Fujian Agr \& Forestry Univ, Inst Plant Virol, Fujian Key Lab Plant Virol, Fuzhou, Fujian, Peoples R China.
   He, Meng-Han; Li, Dong-Liang; Zhu, Wen; Wu, E-Jiao; Yang, Li-Na; Wang, Yan-Ping; Waheed, Abdul, Fujian Agr \& Forestry Univ, State Key Lab Ecol Pest Control Fujian \& Taiwan C, Fuzhou, Fujian, Peoples R China.
   He, Meng-Han; Li, Dong-Liang; Zhu, Wen; Wu, E-Jiao; Yang, Li-Na; Wang, Yan-Ping; Waheed, Abdul, Fujian Agr \& Forestry Univ, Inst Plant Virol, Fujian Key Lab Plant Virol, Fuzhou, Fujian, Peoples R China.
   Zhan, Jiasui, Fujian Agr \& Forestry Univ, Minist Educ, Key Lab Biopesticide \& Chem Biol, Fuzhou, Fujian, Peoples R China.}},
DOI = {{10.1111/eva.12526}},
ISSN = {{1752-4571}},
Keywords = {{Alternaria alternata; epistasis; evolution of antimicrobial resistance;
   negative pleiotropy; population genetics}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE; MYCOSPHAERELLA-GRAMINICOLA; ANTIMICROBIAL
   RESISTANCE; PHYTOPHTHORA-INFESTANS; DRUG-RESISTANCE;
   RHYNCHOSPORIUM-COMMUNE; ALTERNARIA-ALTERNATA; THERMAL ADAPTATION;
   NATURAL-SELECTION; ESCHERICHIA-COLI}},
Research-Areas = {{Evolutionary Biology}},
Web-of-Science-Categories  = {{Evolutionary Biology}},
Author-Email = {{jiasui.zhan@fafu.edu.cn}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}31,371,901, U1405213];
   China Agriculture Research System {[}CARS-10-P11]}},
Funding-Text = {{National Natural Science Foundation of China, Grant/Award Number:
   31,371,901 and U1405213; China Agriculture Research System, Grant/Award
   Number: No. CARS-10-P11}},
Cited-References = {{Abang MM, 2006, PHYTOPATHOLOGY, V96, P1214, DOI 10.1094/PHYTO-96-1214.
   Aguayo J, 2014, GLOBAL CHANGE BIOL, V20, P3209, DOI 10.1111/gcb.12601.
   Auger P, 2005, EXP APPL ACAROL, V37, P83, DOI 10.1007/s10493-005-1020-5.
   Benichou S, 2009, MOL ECOL RESOUR, V9, P390, DOI 10.1111/j.1755-0998.2008.02237.x.
   Blumthaler M, 1997, J PHOTOCH PHOTOBIO B, V39, P130, DOI 10.1016/S1011-1344(96)00018-8.
   Boerlin P, 2005, APPL ENVIRON MICROB, V71, P6753, DOI 10.1128/AEM.71.11.6753-6761.2005.
   BOITEUX LS, 1994, PLANT DIS, V78, P101.
   Brunner PC, 2016, PHYTOPATHOLOGY, V106, P355, DOI 10.1094/PHYTO-07-15-0158-R.
   Chen CJ, 2009, PHYTOPATHOLOGY, V99, P1403, DOI 10.1094/PHYTO-99-12-1403.
   Chen J, 2015, MOL BIOL EVOL, V32, P2393, DOI 10.1093/molbev/msv120.
   Cooper TF, 2007, EVOLUTION, V61, P1495, DOI 10.1111/j.1558-5646.2007.00109.x.
   Courvalin P, 2005, EMERG INFECT DIS, V11, P1503, DOI 10.3201/eid1110.051014.
   Darmency H, 2015, EVOLUTION, V69, P271, DOI 10.1111/evo.12531.
   Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681.
   Elena K, 2006, EUR J PLANT PATHOL, V115, P259, DOI 10.1007/s10658-006-9005-8.
   Elliott M, 2015, CROP PROT, V67, P136, DOI 10.1016/j.cropro.2014.10.008.
   Ferenci T, 2003, TRENDS MICROBIOL, V11, P457, DOI 10.1016/j.tim.2003.08.003.
   Gelband H, 2015, TRENDS MICROBIOL, V23, P524, DOI 10.1016/j.tim.2015.06.005.
   Gent DH, 2003, PLANT DIS, V87, P78, DOI 10.1094/PDIS.2003.87.1.78.
   Gisi U, 2000, CROP PROT, V19, P863, DOI 10.1016/S0261-2194(00)00114-9.
   Gisi U, 2008, EUR J PLANT PATHOL, V122, P157, DOI 10.1007/s10658-008-9290-5.
   Gould IM, 2010, INT J ANTIMICROB AG, V36, pS1, DOI 10.1016/S0924-8579(10)00497-8.
   Gullino ML, 2010, PLANT DIS, V94, P1076, DOI 10.1094/PDIS-94-9-1076.
   Hall AR, 2015, EVOL APPL, V8, P261, DOI 10.1111/eva.12187.
   Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006.
   Handel A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3051.
   Henriquez JL, 2011, CHIL J AGR RES, V71, P39, DOI 10.4067/S0718-58392011000100005.
   Hiltunen T, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0039.
   Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R.
   Iorio R, 2015, TOXICOL IN VITRO, V30, P438, DOI 10.1016/j.tiv.2015.09.018.
   Khan HAA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095636.
   Knies JL, 2010, AM NAT, V176, P227, DOI 10.1086/653662.
   Kniskern JM, 2007, EVOLUTION, V61, P377, DOI 10.1111/j.1558-5646.2007.00032.x.
   Kokalis-Burelle N, 2013, J NEMATOL, V45, P272.
   Lamari L., 2002, ASSESS IMAGE ANAL SO.
   Leiminger JH, 2012, PLANT DIS, V96, P124, DOI 10.1094/PDIS-05-11-0431.
   Li HX, 2008, PHYTOPATHOLOGY, V98, P427, DOI 10.1094/PHYTO-98-4-0427.
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051.
   MacLean RC, 2010, NAT REV GENET, V11, P405, DOI 10.1038/nrg2778.
   Malandrakis AA, 2015, EUR J PLANT PATHOL, V142, P489, DOI 10.1007/s10658-015-0628-5.
   Markoglou AN, 2006, EUR J PLANT PATHOL, V115, P149, DOI 10.1007/s10658-006-0008-2.
   McGann P, 2007, APPL ENVIRON MICROB, V73, P2806, DOI 10.1128/AEM.02923-06.
   Melnyk AH, 2015, EVOL APPL, V8, P273, DOI 10.1111/eva.12196.
   Meng JW, 2015, PLANT PATHOL, V64, P434, DOI 10.1111/ppa.12275.
   Meng JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep18250.
   Mohd-Assaad N, 2016, MOL ECOL, V25, P6124, DOI 10.1111/mec.13916.
   Neff T, 2005, BLOOD, V105, P997, DOI 10.1182/blood-2004-08-3169.
   NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321.
   Perron GG, 2015, EVOL APPL, V8, P211, DOI 10.1111/eva.12254.
   Qin CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep20483.
   Reis RF, 2006, PLANT DIS, V90, P1051, DOI 10.1094/PD-90-1051.
   Rekanovic E, 2012, J ENVIRON SCI HEAL B, V47, P403, DOI 10.1080/03601234.2012.657043.
   Rodriguez-Verdugo A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-50.
   Rotem J., 1994, GENUS ALTERNARIA BIO.
   Santos PM, 2009, PROTEOMICS, V9, P657, DOI 10.1002/pmic.200800452.
   Schenk MF, 2015, EVOL APPL, V8, P248, DOI 10.1111/eva.12200.
   Schenk MF, 2013, MOL BIOL EVOL, V30, P1779, DOI 10.1093/molbev/mst096.
   Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426.
   SHAW MW, 1989, PLANT PATHOL, V38, P44, DOI 10.1111/j.1365-3059.1989.tb01426.x.
   Siepielski AM, 2017, SCIENCE, V355, P959, DOI 10.1126/science.aag2773.
   Singaravelan N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002993.
   Solomon S, 2007, CONTRIBUTION WORKING.
   Sornmerhalder RJ, 2010, PHYTOPATHOLOGY, V100, P855, DOI 10.1094/PHYTO-100-9-0855.
   Stefansson TS, 2014, PLANT PATHOL, V63, P405, DOI 10.1111/ppa.12111.
   Tenover FC, 2006, AM J INFECT CONTROL, V34, pS3, DOI 10.1016/j.ajic.2006.05.219.
   Tonsor SJ, 2013, EVOLUTION, V67, P2923, DOI 10.1111/evo.12175.
   Torres-Calzada C, 2015, PLANT DIS, V99, P1590, DOI 10.1094/PDIS-11-14-1183-RE.
   Valencia-Botin AJ, 2013, PLANT DIS, V97, P1491, DOI 10.1094/PDIS-03-13-0272-RE.
   Vittoz P, 2013, J NAT CONSERV, V21, P154, DOI 10.1016/j.jnc.2012.12.002.
   Vogwill T, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0151.
   Weir TL, 1998, MYCOLOGIA, V90, P813, DOI 10.2307/3761323.
   Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026.
   Woudenberg JHC, 2015, STUD MYCOL, P1, DOI 10.1016/j.simyco.2015.07.001.
   Woudenberg JHC, 2013, STUD MYCOL, P171, DOI 10.3114/sim0015.
   Wu EJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26182.
   Yang LN, 2016, MOL ECOL, V25, P4047, DOI 10.1111/mec.13727.
   Yeh F., 1999, POPGENE32 MICROSOFT.
   Zhan J, 2006, MOL PLANT PATHOL, V7, P259, DOI {[}10.1111/j.1364-3703.2006.00336.x, 10.1111/J.1364-3703.2006.00336.X].
   Zhan J, 2005, MOL ECOL, V14, P2683, DOI 10.1111/j.1365-294X.2005.02638.x.
   Zhan JS, 2011, MOL ECOL, V20, P1689, DOI 10.1111/j.1365-294X.2011.05023.x.
   Zhang T, 2015, APPL MICROBIOL BIOT, V99, P7771, DOI 10.1007/s00253-015-6688-9.
   Zheng HH, 2015, PLANT PATHOL, V64, P425, DOI 10.1111/ppa.12274.}},
Number-of-Cited-References = {{82}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{8}},
Usage-Count-Since-2013 = {{8}},
Journal-ISO = {{Evol. Appl.}},
Doc-Delivery-Number = {{FX3WN}},
Unique-ID = {{ISI:000426003200005}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000425880400010,
Author = {Wolny-Koladka, Katarzyna},
Title = {{Resistance to Antibiotics and the Occurrence of Genes Responsible for
   the Development of Methicillin Resistance in Staphylococcus Bacteria
   Isolated From the Environment of Horse Riding Centers}},
Journal = {{JOURNAL OF EQUINE VETERINARY SCIENCE}},
Year = {{2018}},
Volume = {{61}},
Pages = {{65-71}},
Month = {{FEB}},
Abstract = {{The purpose of the study was to identify species, to determine the drug
   resistance profile, and to evaluate the occurrence of genes responsible
   for the development of methicillin resistance in Staphylococcus bacteria
   isolated from the environment of horse riding centers. Staphylococci
   were isolated from air, manure, and nostrils of horses located in three
   horse riding centers, differing in horse stabling systemd-box stall
   stabling (OJK Pegaz and KJK Szary) and free-range stabling (SKH
   Nielepice). The dominant species was Staphylococcus vitulinus. A large
   variation in the frequency of occurrence of individual species between
   horse riding centers was determined. Resistance to antibiotics was
   determined by means of disc diffusion method and polymerase chain
   reaction technique to detect mecA genes responsible for methicillin
   resistance. In total, 408 strains were collected, most from SKH
   Nielepice, and least from OJK Pegaz. The highest resistance was found to
   gentamicin and tetracycline. Multidrug-resistant isolates were also
   detected in KJK Szary (10), in SKH Nielepice (5), and in OJK Pegaz (4).
   Methicillin resistance determined by disk diffusion assay was found in
   23 strains, while the mecA gene was detected in 142 isolates. A total of
   137 strains holding the mecA gene are coagulase-negative staphylococci
   (CNS), which, as shown by our own studies, may be a reservoir of
   methicillin resistance. Most commonly, the mecA gene was found in
   staphylococci isolated in KJK Szary (61.70\%). The mecA gene was
   detected in five strains that belonged to Staphylococcus aureus species
   and came from horses in SKH Nielepice, indicating the presence of
   methicillin-resistant Staphylococcus aureus strains in these animals.
   (C) 2017 Elsevier Inc. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE INC}},
Address = {{360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wolny-Koladka, K (Reprint Author), Agr Univ Krakow, Dept Microbiol, Mickiewicza Ave 24-28, PL-30059 Krakow, Poland.
   Wolny-Koladka, Katarzyna, Agr Univ Krakow, Dept Microbiol, Mickiewicza Ave 24-28, PL-30059 Krakow, Poland.}},
DOI = {{10.1016/j.jevs.2017.11.010}},
ISSN = {{0737-0806}},
EISSN = {{1542-7412}},
Keywords = {{Staphylococcus spp.; Drug resistance; mecA gene; Methicillin resistance;
   Horse}},
Keywords-Plus = {{COAGULASE-NEGATIVE STAPHYLOCOCCI; TOF-MASS-SPECTROMETRY; ANTIMICROBIAL
   RESISTANCE; HEALTHY HORSES; NASAL CAVITY; AUREUS; PATHOGENS;
   IDENTIFICATION; MICROBIOLOGY; PREVALENCE}},
Research-Areas = {{Veterinary Sciences}},
Web-of-Science-Categories  = {{Veterinary Sciences}},
Author-Email = {{katarzyna.wolny@urk.edu.pl}},
Funding-Acknowledgement = {{Department of Microbiology, University of Agriculture in Cracow, Poland}},
Funding-Text = {{The authors would like to sincerely thank Mr Marian Mikolajewicz (The
   Hutsul Pony Stud Farm in Nielepice), Mr Bogdan German (The Horse Riding
   Center Pegaz in Krakow), and Mrs Anna Szary-Zie. bicka (The Horse Riding
   Club Szary in Michalowice) for allowing this research and valuable help
   during the study. This study was supported by the statutory measures of
   the Department of Microbiology, University of Agriculture in Cracow,
   Poland.}},
Cited-References = {{Ahmed MO, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-12.
   Angulo FJ, 2004, REV SCI TECH OIE, V23, P485.
   Anzai Toru, 1996, Journal of Equine Science, V7, P7, DOI 10.1294/jes.7.7.
   Bagcigil FA, 2007, VET MICROBIOL, V121, P307, DOI 10.1016/j.vetmic.2006.12.007.
   Benko T, 2015, VET MED-CZECH, V60, P613, DOI 10.17221/8529-VETMED.
   Bhargava K, 2012, J APPL MICROBIOL, V113, P1027, DOI 10.1111/j.1365-2672.2012.05410.x.
   Bohme K, 2010, J PROTEOME RES, V9, P3169, DOI 10.1021/pr100047q.
   Bryan J, 2010, IRISH VET J, V63, P373, DOI 10.1186/2046-0481-63-6-373.
   Busscher JF, 2006, VET MICROBIOL, V113, P131, DOI 10.1016/j.vetmic.2005.10.028.
   Casanova C, 2011, J CLIN MICROBIOL, V49, P4377, DOI 10.1128/JCM.05645-11.
   Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x.
   De Martino L, 2010, J VET DIAGN INVEST, V22, P77, DOI 10.1177/104063871002200114.
   European Committee on Antimicrobial Susceptibility Testing, 2017, CLIN BREAKP BACT V 7.
   Fiebelkorn KR, 2003, J CLIN MICROBIOL, V41, P4740, DOI 10.1128/JCM.41.10.4740-4744.2003.
   GEHA DJ, 1994, J CLIN MICROBIOL, V32, P1768.
   Guardabassi L, 2012, VET MICROBIOL, V159, P351, DOI 10.1016/j.vetmic.2012.04.004.
   Hanssen AM, 2006, FEMS IMMUNOL MED MIC, V46, P8, DOI 10.1111/j.1574-695X.2005.00009.x.
   Hiramatsu K, 2002, INT J MED MICROBIOL, V292, P67, DOI 10.1078/1438-4221-00192.
   Huber H, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-6.
   Karakulska J, 2012, J MICROBIOL, V50, P444, DOI 10.1007/s12275-012-1550-6.
   Kern A, 2013, J ANTIMICROB CHEMOTH, V68, P1256, DOI 10.1093/jac/dkt020.
   Kosikowska U., 2015, DIAGN LAB, V51, P23.
   Layer F, 2007, J MICROBIOL METH, V70, P542, DOI 10.1016/j.mimet.2007.06.015.
   Leclercq R, 2002, CLIN INFECT DIS, V34, P482, DOI 10.1086/324626.
   Lenart-Boron A, 2017, AEROBIOLOGIA, V33, P435, DOI 10.1007/s10453-017-9481-7.
   Maddox TW, 2012, EQUINE VET J, V44, P289, DOI 10.1111/j.2042-3306.2011.00441.x.
   Moodley A, 2009, VET MICROBIOL, V137, P397, DOI 10.1016/j.vetmic.2009.01.034.
   Podkowik M, 2013, INT J FOOD MICROBIOL, V163, P34, DOI 10.1016/j.ijfoodmicro.2013.02.005.
   Saputra S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176379.
   Seng P, 2010, FUTURE MICROBIOL, V5, P1733, DOI {[}10.2217/fmb.10.127, 10.2217/FMB.10.127].
   Stull J. W., 2014, CANADA EMERG INFECT, V20, P3.
   van Duijkeren E, 2010, VET MICROBIOL, V141, P96, DOI 10.1016/j.vetmic.2009.08.009.
   Venglovsky J, 2009, BIORESOURCE TECHNOL, V100, P5386, DOI 10.1016/j.biortech.2009.03.068.
   Wang L, 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1007/S12035-014-8848-9.
   Waran N, 2002, WELFARE OF HORSES, P79.
   Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4.
   Wolny-Koladka K, 2014, POL J MICROBIOL, V63, P363.
   Wolny-Koladka KA, 2017, MICRO NANO LETT, V12, P772, DOI 10.1049/mnl.2017.0129.
   Wroblewski Z., 2015, Zycie Weterynaryjne, V90, P298.
   Yasuda R, 2002, J VET MED SCI, V64, P821, DOI 10.1292/jvms.64.821.
   Zhou F, 2013, INT J ENV RES PUB HE, V10, P2412, DOI 10.3390/ijerph10062412.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{7}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{J. Equine Vet. Sci.}},
Doc-Delivery-Number = {{FX2HN}},
Unique-ID = {{ISI:000425880400010}},
DA = {{2018-08-13}},
}

@article{ ISI:000425474600001,
Author = {Zhou, Hao and Wang, Xiaolong and Li, Zhaohuan and Kuang, Yu and Mao,
   Daqing and Luo, Yi},
Title = {{Occurrence and Distribution of Urban Dust-Associated Bacterial
   Antibiotic Resistance in Northern China}},
Journal = {{ENVIRONMENTAL SCIENCE \& TECHNOLOGY LETTERS}},
Year = {{2018}},
Volume = {{5}},
Number = {{2}},
Pages = {{50-55}},
Month = {{FEB}},
Abstract = {{The occurrence and distribution of 20 subtypes of antibiotic resistance
   genes (ARGs), conferring sulfonamide, tetracycline, macrolide,
   beta-lactam, aminoglycoside, or quinolone antibiotic resistance, were
   investigated in urban dust samples collected from the surfaces of three
   megacities (Beijing, Tianjin, and Shijiazhuang) of northern China.
   Real-time polymerase chain reaction indicated that the abundance of ARGs
   and 16S rRNA genes was significantly higher in the summer than in the
   winter. A total of 80 antibiotic-resistant bacteria were isolated and
   identified, and 12 of those species were identified as opportunistic
   pathogens. An isolated pathogen Acinetobacter sp. was proven to be able
   to transfer antibiotic resistance, which highlights the potential risk
   that an urban dust-associated ARG poses to public health. Deep 16S rRNA
   sequencing indicated high heterogeneity of bacterial communities among
   cities in the summer, but great homogeneity in the winter. In the
   summer, Enterococcus, Massilia, and Anthrobacter were the most prevalent
   genera in Tianjin, Beijing, and Shijiazhuang, respectively. However, the
   most prevalent bacterial genera were Bacillus and Lactococcus in the
   winter. This is the first study of the occurrence and distribution of
   the urban dust-associated bacterial community and its associated
   bacterial antibiotic resistance in northern China. This study highlights
   the risk of dust-associated antibiotic resistance to public health.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Luo, Y (Reprint Author), Nankai Univ, Coll Environm Sci \& Engn, Minist Educ, Key Lab Pollut Proc \& Environm Criteria, Tianjin 300071, Peoples R China.
   Mao, DQ (Reprint Author), Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.
   Zhou, Hao; Wang, Xiaolong; Li, Zhaohuan; Kuang, Yu; Luo, Yi, Nankai Univ, Coll Environm Sci \& Engn, Minist Educ, Key Lab Pollut Proc \& Environm Criteria, Tianjin 300071, Peoples R China.
   Mao, Daqing, Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.
   Zhou, Hao, Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.}},
DOI = {{10.1021/acs.estlett.7b00571}},
ISSN = {{2328-8930}},
Keywords-Plus = {{SWINE-FEEDING OPERATION; WATER TREATMENT-PLANT; BETA-LACTAMASE GENES;
   KOSA ASIAN DUST; AIRBORNE BACTERIA; RECEIVING RIVER; SOIL; AIR;
   TRANSPORT; ENTEROCOCCUS}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences}},
Author-Email = {{daqingm@126.com
   luoy@nankai.edu.cn}},
Funding-Acknowledgement = {{National Science Fund for Distinguished Young Scholars {[}41525013];
   National Natural Science Foundation of China {[}41473085, 31470440,
   31670509]}},
Funding-Text = {{This study was financially supported by the National Science Fund for
   Distinguished Young Scholars (41525013) and the National Natural Science
   Foundation of China (41473085, 31470440, and 31670509).}},
Cited-References = {{Afshinnekoo E, 2015, CELL SYST, V1, P72, DOI 10.1016/j.cels.2015.01.001.
   {[}Anonymous], 2015, M100S22 CLIN LAB STA.
   Arifuzzaman M, 2010, AFR J BIOTECHNOL, V9, P4615.
   Barberan A, 2015, P NATL ACAD SCI USA, V112, P5756, DOI 10.1073/pnas.1420815112.
   Braga TM, 2013, VET MICROBIOL, V161, P344, DOI 10.1016/j.vetmic.2012.07.034.
   Burch TR, 2014, ENVIRON SCI TECHNOL, V48, P5620, DOI 10.1021/es501098g.
   Cao C, 2014, ENVIRON SCI TECHNOL, V48, P1499, DOI 10.1021/es4048472.
   Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8.
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303.
   Chapin A, 2005, ENVIRON HEALTH PERSP, V113, P137, DOI 10.1289/ehp.7473.
   Chin M, 2007, ATMOS CHEM PHYS, V7, P5501, DOI 10.5194/acp-7-5501-2007.
   Christman GD, 2011, APPL ENVIRON MICROB, V77, P2026, DOI 10.1128/AEM.01907-10.
   CLARK S, 1983, AM IND HYG ASSOC J, V44, P537, DOI 10.1080/15298668391405265.
   CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x.
   Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038.
   Cottrell MT, 2009, APPL ENVIRON MICROB, V75, P4958, DOI 10.1128/AEM.00117-09.
   Coulibaly Souleymane, 2015, Genes Environ, V37, P25, DOI 10.1186/s41021-015-0025-5.
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05.
   Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x.
   Drudge CN, 2012, AEROBIOLOGIA, V28, P285, DOI 10.1007/s10453-011-9219-x.
   Echeverria-Palencia CM, 2017, ACS OMEGA, V2, P2255, DOI 10.1021/acsomega.7b00118.
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461.
   Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192.
   Franz CMAP, 1999, INT J FOOD MICROBIOL, V47, P1, DOI 10.1016/S0168-1605(99)00007-0.
   Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910.
   Gilbert Y, 2010, AEROBIOLOGIA, V26, P185, DOI 10.1007/s10453-010-9155-1.
   Griffin D.W., 2001, GLOBAL CHANGE HUMAN, V2, P20, DOI DOI 10.1023/A:1011910224374.
   Guardabassi L, 2005, ANTIMICROB AGENTS CH, V49, P4227, DOI 10.1128/AAC.49.10.4227-4233.2005.
   Han Y, 2017, ENVIRON SCI TECHNOL, V51, P10850, DOI 10.1021/acs.est.7b02875.
   Hartmann EM, 2016, ENVIRON SCI TECHNOL, V50, P9807, DOI 10.1021/acs.est.6b00262.
   He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x.
   Honda A, 2014, J APPL TOXICOL, V34, P250, DOI 10.1002/jat.2871.
   Huang RJ, 2014, NATURE, V514, P218, DOI 10.1038/nature13774.
   Hujer KM, 2006, ANTIMICROB AGENTS CH, V50, P4114, DOI 10.1128/AAC.00778-06.
   Jennison AV, 2004, FEMS MICROBIOL REV, V28, P43, DOI 10.1016/j.femsre.2003.07.002.
   Jie OY, 2008, ANN CLIN LAB SCI, V38, P393.
   Kim KY, 2007, BUILD ENVIRON, V42, P2188, DOI 10.1016/j.buildenv.2006.04.013.
   Kim SB, 2004, INT J SYST EVOL MICR, V54, P1617, DOI 10.1099/ijs.0.02742-0.
   KLIJN N, 1995, APPL ENVIRON MICROB, V61, P788.
   Kobayashi F, 2015, J BIOSCI BIOENG, V119, P570, DOI 10.1016/j.jbiosc.2014.10.015.
   Lee JY, 2009, J CLIN MICROBIOL, V47, P3376, DOI 10.1128/JCM.00847-09.
   Li D, 2009, ENVIRON MICROBIOL, V11, P1506, DOI 10.1111/j.1462-2920.2009.01878.x.
   Li SQ, 2016, PEDOSPHERE, V26, P374, DOI 10.1016/S1002-0160(15)60050-9.
   Luo Y, 2014, ENVIRON SCI TECH LET, V1, P26, DOI 10.1021/ez400152e.
   Mahgoub S, 2015, DESALIN WATER TREAT, V54, P2059, DOI 10.1080/19443994.2014.933627.
   Manaia CM, 2017, TRENDS MICROBIOL, V25, P173, DOI 10.1016/j.tim.2016.11.014.
   Mazar Y, 2016, ENVIRON SCI TECHNOL, V50, P4194, DOI 10.1021/acs.est.5b06348.
   McEachran AD, 2015, ENVIRON HEALTH PERSP, V123, P337, DOI 10.1289/ehp.1408555.
   Mori I, 2003, ATMOS ENVIRON, V37, P4253, DOI 10.1016/S1352-2310(03)00535-1.
   Mukherjee N, 2014, INT J ENV RES PUB HE, V11, P12544, DOI 10.3390/ijerph111212544.
   Neuhauser MM, 2003, JAMA-J AM MED ASSOC, V289, P885, DOI 10.1001/jama.289.7.885.
   Novais C, 2013, J ANTIMICROB CHEMOTH, V68, P2746, DOI 10.1093/jac/dkt289.
   Onishi K, 2012, ATMOS ENVIRON, V49, P94, DOI 10.1016/j.atmosenv.2011.12.018.
   Pal C, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0199-5.
   Phan TPH, 2011, SCI TOTAL ENVIRON, V409, P2894, DOI 10.1016/j.scitotenv.2011.04.030.
   Prussin AJ, 2015, ENVIRON SCI TECH LET, V2, P84, DOI 10.1021/acs.estlett.5b00050.
   Purty S, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.71.
   Racine JS, 2012, J APPL ECONOMET, V27, P167, DOI 10.1002/jae.1278.
   Sapkota AR, 2006, LETT APPL MICROBIOL, V43, P534, DOI 10.1111/j.1472-765X.2006.01996.x.
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09.
   Seltenrich N, 2015, ENVIRON HEALTH PERSP, V123, pA96, DOI 10.1289/ehp.123-A96.
   Theron J, 2001, WATER RES, V35, P869, DOI 10.1016/S0043-1354(00)00348-1.
   Uno I, 2009, NAT GEOSCI, V2, P557, DOI 10.1038/NGEO583.
   Vokou D, 2012, MICROB ECOL, V64, P714, DOI 10.1007/s00248-012-0053-7.
   Wickham H., 2016, GGPLOT2 ELEGANT GRAP.
   Yamaguchi N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00525.
   Yang FX, 2016, ENVIRON SCI TECH LET, V3, P138, DOI 10.1021/acs.estlett.6b00036.
   Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y.
   Zhang YQ, 2006, INT J SYST EVOL MICR, V56, P459, DOI 10.1099/ijs.0.64083-0.}},
Number-of-Cited-References = {{69}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{24}},
Usage-Count-Since-2013 = {{24}},
Journal-ISO = {{Environ. Sci. Technol. Lett.}},
Doc-Delivery-Number = {{FW7BQ}},
Unique-ID = {{ISI:000425474600001}},
DA = {{2018-08-13}},
}

@article{ ISI:000425474600005,
Author = {Xie, Jiawen and Jin, Ling and Luo, Xiaosan and Zhao, Zhen and Li,
   Xiangdong},
Title = {{Seasonal Disparities in Airborne Bacteria and Associated Antibiotic
   Resistance Genes in PM2.5 between Urban and Rural Sites}},
Journal = {{ENVIRONMENTAL SCIENCE \& TECHNOLOGY LETTERS}},
Year = {{2018}},
Volume = {{5}},
Number = {{2}},
Pages = {{74-79}},
Month = {{FEB}},
Abstract = {{The atmosphere represents an unappreciated compartment for the
   environmental dissemination of antibiotic resistance genes (ARGs),
   particularly via airborne fine particles (PM2.5), with strong
   implications for the inhalational exposure of the general population. We
   examined the seasonal variations in airborne bacteria and several ARGs
   in PM2.5 across an industrial urban rural transect in a megacity of
   China over an annual cycle. Seasonality was most apparent at the rural
   site with a remarkable wintertime reduction in the total level of
   bacteria and an enrichment of certain ARGs in winter but dilution in
   spring. This contrasted with the relative consistency across seasons at
   urban and industrial sites. The statistical correlation between ARGs and
   the mobile genetic element (MGE), intI1, weakened from rural to urban
   and industrial sites, which hints at the diluting role of intI1 in
   horizontal gene transfers across the land use gradient. Differing
   mechanisms may regulate site-specific population exposure to
   transferable ARGs, and the identification of additional MGEs is
   warranted. Compared to drinking water and the accidental ingestion of
   agricultural soil, airborne PM2.5 contributes to a similar extent to the
   human daily intake of certain ARGs and intI1. Collectively, this study
   highlights the importance of PM2.5 in the dissemination of, and pathways
   of human exposure to, common environmental ARGs.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Li, XD (Reprint Author), Hong Kong Polytech Univ, Dept Civil \& Environm Engn, Kowloon, Hong Kong, Peoples R China.
   Xie, Jiawen; Jin, Ling; Li, Xiangdong, Hong Kong Polytech Univ, Dept Civil \& Environm Engn, Kowloon, Hong Kong, Peoples R China.
   Luo, Xiaosan; Zhao, Zhen, Nanjing Univ Informat Sci \& Technol, Sch Appl Meteorol, Int Ctr Ecol Meteorol \& Environm, Nanjing 210044, Jiangsu, Peoples R China.}},
DOI = {{10.1021/acs.estlett.7b00561}},
ISSN = {{2328-8930}},
Keywords-Plus = {{WATER TREATMENT-PLANT; TETRACYCLINE RESISTANCE; DRINKING-WATER;
   ATMOSPHERIC MICROBIOME; METEOROLOGICAL FACTORS; DUST STORMS; RIVER
   DELTA; CHINA; RESISTOME; ENVIRONMENT}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences}},
Author-Email = {{cexdli@polyu.edu.hk}},
ResearcherID-Numbers = {{Li, Xiangdong/B-2211-2008
   LUO, Xiao-San/D-9374-2011
   }},
ORCID-Numbers = {{Li, Xiangdong/0000-0002-4044-2888
   LUO, Xiao-San/0000-0003-4314-7216
   Jin, Ling/0000-0003-1267-7396}},
Funding-Acknowledgement = {{National Natural Science Foundation of China (NSFC) {[}91543205,
   41471418]; Research Grants Council of Hong Kong {[}PolyU 152095/14E];
   Hong Kong Polytechnic University}},
Funding-Text = {{This study was supported by the National Natural Science Foundation of
   China (NSFC 91543205 and 41471418), the Research Grants Council of Hong
   Kong (PolyU 152095/14E), and the Hong Kong Polytechnic University
   (Project of Strategic Importance, and PolyU Postdoctoral Fellowship).
   The authors thank Y. Chen, Q. Chen, L. C. Wu, and C. Suo of Nanjing
   University of Information Science and Technology and L. Cang of the CAS
   Institute of Soil Science for their valuable assistance in field
   sampling. The authors are also obliged to P. Shi and X. X. Zhang of
   Nanjing University for kindly sharing their raw data on ARG
   concentrations in drinking water from Nanjing.}},
Cited-References = {{Behzad H, 2015, GENOME BIOL EVOL, V7, P1216, DOI 10.1093/gbe/evv064.
   Bowers RM, 2013, ENVIRON SCI TECHNOL, V47, P12097, DOI 10.1021/es402970s.
   Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167.
   Cao C, 2014, ENVIRON SCI TECHNOL, V48, P1499, DOI 10.1021/es4048472.
   Cao JJ, 2003, ATMOS ENVIRON, V37, P1451, DOI 10.1016/S1352-2310(02)01002-6.
   Chen BW, 2016, ENVIRON SCI TECHNOL, V50, P6670, DOI 10.1021/acs.est.6b00619.
   Chen QL, 2017, ENVIRON SCI TECHNOL, V51, P8149, DOI 10.1021/acs.est.7b01420.
   Cheng CL, 2013, ATMOS ENVIRON, V81, P443, DOI 10.1016/j.atmosenv.2013.09.013.
   Frohlich-Nowoisky J, 2016, ATMOS RES, V182, P346, DOI 10.1016/j.atmosres.2016.07.018.
   Gao M, 2017, ENVIRON POLLUT, V220, P1342, DOI 10.1016/j.envpol.2016.10.101.
   Gat D, 2017, ENVIRON SCI TECHNOL, V51, P6709, DOI 10.1021/acs.est.7b00362.
   Gillings MR, 2015, ISME J, V9, P1269, DOI 10.1038/ismej.2014.226.
   Hartmann EM, 2016, ENVIRON SCI TECHNOL, V50, P9807, DOI 10.1021/acs.est.6b00262.
   Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867.
   Jia SY, 2015, ENVIRON SCI TECHNOL, V49, P12271, DOI 10.1021/acs.est.5b03521.
   Jiang WJ, 2015, NAT PROTOC, V10, P768, DOI 10.1038/nprot.2015.046.
   Jin L, 2017, NATL SCI REV, V4, P593, DOI 10.1093/nsr/nww079.
   Jones AM, 2004, SCI TOTAL ENVIRON, V326, P151, DOI 10.1016/j.scitotenv.2003.11.021.
   Li J, 2016, ATMOS ENVIRON, V124, P404, DOI 10.1016/j.atmosenv.2015.06.030.
   Ling AL, 2013, ENVIRON SCI TECHNOL, V47, P4046, DOI 10.1021/es400238g.
   Luo Y, 2010, ENVIRON SCI TECHNOL, V44, P7220, DOI 10.1021/es100233w.
   Ma LP, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0369-0.
   Ma LP, 2016, ENVIRON SCI TECHNOL, V50, P420, DOI 10.1021/acs.est.5b03522.
   Mazar Y, 2016, ENVIRON SCI TECHNOL, V50, P4194, DOI 10.1021/acs.est.5b06348.
   McEachran AD, 2015, ENVIRON HEALTH PERSP, V123, P337, DOI 10.1289/ehp.1408555.
   Ming LL, 2017, ENVIRON POLLUT, V223, P200, DOI 10.1016/j.envpol.2017.01.013.
   Munck C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9452.
   Pal C, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0199-5.
   Peng S, 2015, SCI TOTAL ENVIRON, V506, P279, DOI 10.1016/j.scitotenv.2014.11.010.
   Pruden A, 2013, ENVIRON HEALTH PERSP, V121, P878, DOI 10.1289/ehp.1206446.
   Schaeffer JW, 2017, ENVIRON SCI TECHNOL, V51, P6430, DOI 10.1021/acs.est.7b00882.
   Shi P, 2013, WATER RES, V47, P111, DOI 10.1016/j.watres.2012.09.046.
   Smets W, 2016, ATMOS ENVIRON, V139, P214, DOI 10.1016/j.atmosenv.2016.05.038.
   Tong YY, 1997, PHOTOCHEM PHOTOBIOL, V65, P103, DOI 10.1111/j.1751-1097.1997.tb01884.x.
   United Nations Environment Programme. Frontiers, 2017, FRONT 2017 EM ISS EN.
   Vikesland PJ, 2017, ENVIRON SCI TECHNOL, V51, P13061, DOI 10.1021/acs.est.7b03623.
   Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7.
   Wang FH, 2014, ENVIRON SCI TECHNOL, V48, P9079, DOI 10.1021/es502615e.
   Wei M, 2017, ATMOS CHEM PHYS, V17, P5253, DOI 10.5194/acp-17-5253-2017.
   Xie WY, 2016, ENVIRON SCI TECHNOL, V50, P12602, DOI 10.1021/acs.est.6b02138.
   Xiong WG, 2015, MICROB ECOL, V70, P425, DOI 10.1007/s00248-015-0583-x.
   Yang Y, 2013, ENVIRON SCI TECHNOL, V47, P10197, DOI 10.1021/es4017365.
   Yue SY, 2017, ACS EARTH SPACE CHEM, V1, P493, DOI 10.1021/acsearthspacechem.7b00062.
   Zhang T, 2011, ATMOS RES, V102, P110, DOI 10.1016/j.atmosres.2011.06.014.
   Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x.
   Zhen Q, 2017, SCI TOTAL ENVIRON, V601, P703, DOI 10.1016/j.scitotenv.2017.05.049.
   Zhu YG, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.270.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{43}},
Usage-Count-Since-2013 = {{43}},
Journal-ISO = {{Environ. Sci. Technol. Lett.}},
Doc-Delivery-Number = {{FW7BQ}},
Unique-ID = {{ISI:000425474600005}},
DA = {{2018-08-13}},
}

@article{ ISI:000415769700020,
Author = {Tansawai, Uttapoln and Sanguansermsri, Donruedee and Na-udom, Anamai and
   Walsh, Timothy R. and Niumsup, Pannika R.},
Title = {{Occurrence of extended spectrum beta-lactamase and AmpC genes among
   multidrug-resistant Escherichia coli and emergence of ST131 from poultry
   meat in Thailand}},
Journal = {{FOOD CONTROL}},
Year = {{2018}},
Volume = {{84}},
Pages = {{159-164}},
Month = {{FEB}},
Abstract = {{This study investigated the prevalence of antibiotic-resistant
   Escherichia coli using extended-spectrum beta-lactamase (ESBL) and AmpC
   beta-lactamase as exemplars of multidrug-resistant phenotypes in poultry
   meat samples taken from open-air and supermarkets in Phitsanulok
   province, Northern Thailand. Two hundred and fifty poultry meat samples
   from open-air (n = 147) and supermarkets (n = 103) were analyzed. In
   total, 143 cefotaxime-resistant E. coli isolates comprising 78 isolates
   (53.1\%) from open-air markets and 65 isolates (63.1\%) from
   supermarkets were obtained. No significant difference could be observed
   in the prevalence of ESBL-positive E. coli between samples taken from
   open-air (70.5\%) and supermarkets (69.2\%). ESBL genotypes comprised of
   bla(CTX-M-group 1) (69\%), bla(CTX-M-group 9) (13\%), bla(TEM-116)
   (1\%), bla(SHV-2a) (1\%) and bla(SHV-12) (1\%) were detected. 39.5\% of
   the ESBL-negative E. coli possessed bla(CMY-2). The bla(CTX-M-group 1),
   bla(CTX-M-group 9) and bla(CMY-2) were successfully transferred into E.
   coli by conjugation at high frequencies. Repetitive palindromic-PCR of
   some bla(CTX-M) and bla(CMY-2)-positive E. coli isolates revealed
   identical DNA patterns suggesting clonal spread. Phylogenetic grouping
   and MLST analysis revealed that 3 isolates were E. coli ST131. Of these,
   2 isolates were ESBL-negative and carried bla(CMY-2). The other isolate
   was ESBL-positive and carried bla(TEM-116). This is the first study to
   demonstrate ESBL and AmpC genotypes in E. coli and the first discovery
   of human pathogen ST131 from Thai poultry meat. Our data raises serious
   concerns for food safety and biosecurity in the Thai food industry.
   Crown Copyright (C) 2017 Published by Elsevier Ltd. All rights reserved.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Niumsup, PR (Reprint Author), Naresuan Univ, Fac Med Sci, Dept Microbiol \& Parasitol, Phitsanulok 65000, Thailand.
   Tansawai, Uttapoln; Sanguansermsri, Donruedee; Niumsup, Pannika R., Naresuan Univ, Fac Med Sci, Dept Microbiol \& Parasitol, Phitsanulok 65000, Thailand.
   Sanguansermsri, Donruedee; Niumsup, Pannika R., Naresuan Univ, Fac Med Sci, Ctr Excellence Med Biotechnol, Phitsanulok 65000, Thailand.
   Na-udom, Anamai, Naresuan Univ, Dept Math, Fac Sci, Phitsanulok 65000, Thailand.
   Walsh, Timothy R., Heath Pk Hosp, Inst Infect \& Immun, Dept Med Microbiol \& Infect Dis, UHW Main Bldg, Cardiff CF14 4XN, S Glam, Wales.}},
DOI = {{10.1016/j.foodcont.2017.07.028}},
ISSN = {{0956-7135}},
EISSN = {{1873-7129}},
Keywords = {{Poultry; Meat; ESBL; CTX-M; AmpC; CMY-2; E. coli; ST131}},
Keywords-Plus = {{CHICKEN MEAT; MOLECULAR CHARACTERIZATION; RAPID DETECTION; MULTIPLEX
   PCR; CTX-M; RETAIL; ENTEROBACTERIACEAE; COMMUNITY; EPIDEMIOLOGY;
   PREVALENCE}},
Research-Areas = {{Food Science \& Technology}},
Web-of-Science-Categories  = {{Food Science \& Technology}},
Author-Email = {{pannikan@nu.ac.th}},
Funding-Acknowledgement = {{Naresuan University {[}R2558B072]; Royal Golden Jubilee-PhD Program from
   Thailand Research Fund; Rajamangala University of Technology Lanna
   {[}PHD/0054/2555]}},
Funding-Text = {{This work was funded by Naresuan University (R2558B072). U. Tansawai was
   supported by the Royal Golden Jubilee-PhD Program from Thailand Research
   Fund and Rajamangala University of Technology Lanna (PHD/0054/2555). We
   would like to thank staffs at the Department of Microbiology and
   Parasitology, Faculty of Medical Science, Naresuan University for their
   technical assistance.}},
Cited-References = {{Apisarnthanarak A, 2007, AM J INFECT CONTROL, V35, P606, DOI 10.1016/j.ajic.2007.05.008.
   Boonyasiri A, 2014, PATHOG GLOB HEALTH, V108, P235, DOI 10.1179/2047773214Y.0000000148.
   Chaisatit C, 2012, JPN J INFECT DIS, V65, P527, DOI 10.7883/yoken.65.527.
   Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000.
   Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194.
   Clinical and Laboratory Standards Institute (CLSI), 2013, M100S23 CLSI.
   Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498.
   Nguyen DP, 2016, BIOMED RES INT, DOI 10.1155/2016/8182096.
   Egea P, 2012, INT J FOOD MICROBIOL, V159, P69, DOI {[}10.1016/j.ijfoodmicro.2O12.08.002, 10.1016/j.ijfoodmicro.2012.08.002].
   Ghodousi A, 2015, FOODBORNE PATHOG DIS, V12, P619, DOI 10.1089/fpd.2015.1936.
   Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08.
   Kawamura K, 2014, FOODBORNE PATHOG DIS, V11, P104, DOI 10.1089/fpd.2013.1608.
   Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929.
   Lane D.J., 1991, NUCL ACID TECHNIQUES, P115.
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x.
   Netikul T, 2014, J ANTIMICROB CHEMOTH, V69, P3161, DOI 10.1093/jac/dku275.
   Nicolas-Chanoine MH, 2014, CLIN MICROBIOL REV, V27, P543, DOI 10.1128/CMR.00125-13.
   Oteo J, 2010, DIAGN MICR INFEC DIS, V67, P270, DOI 10.1016/j.diagmicrobio.2010.02.008.
   Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209.
   Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002.
   Pitout JDD, 2013, CURR PHARM DESIGN, V19, P257, DOI 10.2174/138161213804070348.
   Poirel L, 2012, INFECT GENET EVOL, V12, P883, DOI 10.1016/j.meegid.2012.02.008.
   Schwaiger K, 2012, INT J FOOD MICROBIOL, V154, P206, DOI 10.1016/j.ijfoodmicro.2011.12.014.
   Sidjabat HE, 2014, INT J ANTIMICROB AG, V44, P203, DOI 10.1016/j.ijantimicag.2014.04.016.
   Stuart JC, 2012, INT J FOOD MICROBIOL, V154, P212, DOI 10.1016/j.ijfoodmicro.2011.12.034.
   Tamang MD, 2012, ANTIMICROB AGENTS CH, V56, P2705, DOI 10.1128/AAC.05598-11.
   Trongjit S, 2016, MICROBIOL IMMUNOL, V60, P575, DOI 10.1111/1348-0421.12407.
   VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823.
   Vincent C, 2010, EMERG INFECT DIS, V16, P88, DOI 10.3201/eid1601.091118.
   Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13.
   Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{9}},
Usage-Count-Since-2013 = {{28}},
Journal-ISO = {{Food Control}},
Doc-Delivery-Number = {{FN1RU}},
Unique-ID = {{ISI:000415769700020}},
DA = {{2018-08-13}},
}

@article{ ISI:000416616100002,
Author = {Sandoz, Melissa A. and Wooten, Kimberly J. and Clendening, Sheree L. and
   Hensley, Loren L. and Smith, Lucas R. and Smith, Philip N.},
Title = {{Transport mechanisms for veterinary pharmaceuticals from beef cattle
   feedyards to wetlands: Is aerial deposition a contributing source?}},
Journal = {{AGRICULTURE ECOSYSTEMS \& ENVIRONMENT}},
Year = {{2018}},
Volume = {{252}},
Pages = {{14-21}},
Month = {{JAN 15}},
Abstract = {{Veterinary pharmaceuticals from beef cattle feedyards have, with
   increasing frequency; been identified as contaminants in aquatic
   systems. Transport of these pharmaceuticals has generally been assumed
   to be via manure land application, surface runoff, or groundwater
   percolation. However, veterinary pharmaceuticals in airborne particulate
   matter downwind of beef cattle feedyards have recently been documented,
   indicating that aerial transport and deposition are a potential
   transport mechanism in arid and semi-arid environments. In this study,
   35 hydrologically discrete playa wetlands within 15 km of beef cattle
   feedyards were examined for occurrence of six steroid hormones and eight
   antibiotics. 17 alpha-trenbolone, estrone, estradiol, tetracycline,
   chlortetracycline, oxytetracycline, tylosin, and monensin were all
   detected in either water or sediment samples. Concentrations for the
   majority of analytes were < 15 ng/g in sediment and < 70 ng/L in water.
   Tylosin and monensin were detected at highest concentrations in water,
   at 3 and 84 mu g/L, respectively. A correlation between distance from
   the nearest beef cattle feedyard and concentration of monensin in playa
   water was observed, similar to correlations observed between
   pharmaceutical concentrations and distance from feedyard among air
   samples collected downwind of feedyards. This study suggests that
   airborne transport and deposition of pharmaceutical-laden particulate
   matter are a possible contributor to pharmaceutical concentrations in
   aquatic systems. Aerial deposition of pharmaceutical-laden particulate
   matter, not typically included in risk assessments, is of yet poorly
   characterized but may play a significant role in pharmaceutical
   transport in arid and semi-arid locations and deserves further
   investigation.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Smith, PN (Reprint Author), Texas Tech Univ, Dept Environm Toxicol, POB 41163, Lubbock, TX 79409 USA.
   Sandoz, Melissa A.; Wooten, Kimberly J.; Clendening, Sheree L.; Hensley, Loren L.; Smith, Lucas R.; Smith, Philip N., Texas Tech Univ, Dept Environm Toxicol, POB 41163, Lubbock, TX 79409 USA.}},
DOI = {{10.1016/j.agee.2017.09.016}},
ISSN = {{0167-8809}},
EISSN = {{1873-2305}},
Keywords = {{Veterinary pharmaceuticals; Aerial transport; Playa wetlands;
   Environmental analytical chemistry; Agrochemical runoff}},
Keywords-Plus = {{ANTIMICROBIAL RESISTANCE GENES; ANTIBIOTIC-RESISTANCE; PARTICULATE
   MATTER; XENOPUS-LAEVIS; IN-VITRO; REPRODUCTIVE ENDOCRINOLOGY; IONOPHORE
   ANTIBIOTICS; ESTROGENIC ACTIVITY; TRENBOLONE ACETATE; LAND APPLICATION}},
Research-Areas = {{Agriculture; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Agriculture, Multidisciplinary; Ecology; Environmental Sciences}},
Author-Email = {{phil.smith@ttu.edu}},
Cited-References = {{Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI 10.1897/1551-5028(2003)022<1350:EOTAGP>2.0.CO;2.
   {[}Anonymous], 2009, EFSA J, V1041, P1.
   Bak SA, 2014, ANTIBIOTICS-BASEL, V3, P564, DOI 10.3390/antibiotics3040564.
   Bartelt-Hunt S, 2011, J CONTAM HYDROL, V123, P94, DOI 10.1016/j.jconhyd.2010.12.010.
   Bartelt-Hunt SL, 2012, ENVIRON SCI TECHNOL, V46, P1352, DOI 10.1021/es202680q.
   Baumann L, 2014, ENVIRON TOXICOL CHEM, V33, P2488, DOI 10.1002/etc.2698.
   Bialk-Bielinska A, 2017, CHEMOSPHERE, V173, P542, DOI 10.1016/j.chemosphere.2017.01.035.
   Blackwell BR, 2015, ENVIRON SCI TECHNOL, V49, P8796, DOI 10.1021/acs.est.5b01881.
   Blackwell BR, 2014, ENVIRON TOXICOL CHEM, V33, P2850, DOI 10.1002/etc.2757.
   Bona MD, 2014, CHEMOSPHERE, V115, P67, DOI 10.1016/j.chemosphere.2014.02.003.
   Bonifacio HF, 2015, ATMOS ENVIRON, V101, P49, DOI 10.1016/j.atmosenv.2014.11.017.
   Bradford SA, 2008, J ENVIRON QUAL, V37, pS97, DOI 10.2134/jeq2007.0393.
   Brown D, 2015, J ENVIRON QUAL, V44, P299, DOI 10.2134/jeq2014.08.0334.
   Caldwell DJ, 2012, ENVIRON TOXICOL CHEM, V31, P1396, DOI 10.1002/etc.1825.
   Callaway T R, 2003, Curr Issues Intest Microbiol, V4, P43.
   Cavallin JE, 2014, ENVIRON TOXICOL CHEM, V33, P1849, DOI 10.1002/etc.2627.
   Chee-Sanford JC, 2009, J ENVIRON QUAL, V38, P1086, DOI 10.2134/jeq2008.0128.
   Chen K, 2014, CHEMOSPHERE, V95, P604, DOI 10.1016/j.chemosphere.2013.09.119.
   Cheng DM, 2014, SCI TOTAL ENVIRON, V476, P266, DOI 10.1016/j.scitotenv.2014.01.010.
   Durhan EJ, 2006, ENVIRON HEALTH PERSP, V114, P65, DOI 10.1289/ehp.8055.
   Eguchi K, 2004, CHEMOSPHERE, V57, P1733, DOI 10.1016/j.chemosphere.2004.07.017.
   Elanco Animal Health, 2012, ENV ASS US TYL TARTR.
   Finch BE, 2013, ENVIRON SCI POLLUT R, V20, P1151, DOI 10.1007/s11356-012-1118-3.
   Gall HE, 2014, HYDROL PROCESS, V28, P1318, DOI 10.1002/hyp.9664.
   Gurdak J. J., 2009, RECHARGE RATES CHEM.
   Hafner SC, 2016, J ENVIRON QUAL, V45, P480, DOI 10.2134/jeq2015.05.0251.
   Hansen M, 2009, TRAC-TREND ANAL CHEM, V28, P534, DOI 10.1016/j.trac.2009.02.015.
   Hu F, 2008, GEN COMP ENDOCR, V155, P190, DOI 10.1016/j.ygcen.2007.04.015.
   Intervet Inc, 2007, NEW AN DRUG APPL 141.
   Jackson CR, 2004, APPL ENVIRON MICROB, V70, P4205, DOI 10.1128/AEM.70.7.4205-4210.2004.
   Jaimes-Correa JC, 2015, ENVIRON POLLUT, V205, P87, DOI 10.1016/j.envpol.2015.05.023.
   Jeffries MKS, 2011, AQUAT TOXICOL, V105, P189, DOI 10.1016/j.aquatox.2011.04.008.
   Jensen KM, 2006, ENVIRON SCI TECHNOL, V40, P3112, DOI 10.1021/es052174s.
   Jessick AM, 2014, AQUAT TOXICOL, V148, P48, DOI 10.1016/j.aquatox.2013.12.025.
   Joy SR, 2013, ENVIRON SCI TECHNOL, V47, P12081, DOI 10.1021/es4026358.
   Khan B, 2008, ENVIRON SCI TECHNOL, V42, P3570, DOI 10.1021/es702690P.
   Khan SJ, 2008, ENVIRON INT, V34, P839, DOI 10.1016/j.envint.2007.10.007.
   Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104.
   Kim SC, 2006, WATER RES, V40, P2549, DOI 10.1016/j.watres.2006.04.036.
   Kolok AS, 2007, SCI TOTAL ENVIRON, V388, P104, DOI 10.1016/j.scitotenv.2007.08.001.
   Kolok AS, 2014, J AM WATER RESOUR AS, V50, P266, DOI 10.1111/jawr.12158.
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j.
   Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103.
   Leet JK, 2015, AQUAT TOXICOL, V158, P98, DOI 10.1016/j.aquatox.2014.10.022.
   Li YY, 2015, AQUAT TOXICOL, V158, P230, DOI 10.1016/j.aquatox.2014.11.017.
   Lissemore L, 2006, CHEMOSPHERE, V64, P717, DOI 10.1016/j.chemosphere.2005.11.015.
   Lone KP, 1997, CRIT REV FOOD SCI, V37, P93, DOI 10.1080/10408399709527771.
   Matthiessen P, 2006, SCI TOTAL ENVIRON, V367, P616, DOI 10.1016/j.dcitotenv.2006.02.007.
   McEachran AD, 2015, ENVIRON HEALTH PERSP, V123, P337, DOI 10.1289/ehp.1408555.
   Mersmann HJ, 1998, J ANIM SCI, V76, P160.
   O'Neill Jim, 2015, ANTIMICROBIALS AGR E.
   Peterson EM, 2017, ENVIRON SCI TECH LET, V4, P216, DOI 10.1021/acs.estlett.7b00123.
   Pharmacia \& Upjohn Company, 1994, NEW AN DRUG APPL 046.
   Robinson JA, 2017, ENVIRON TOXICOL CHEM, V36, P636, DOI 10.1002/etc.3526.
   Robinson JA, 2017, ENVIRON TOXICOL CHEM, V36, P630, DOI 10.1002/etc.3381.
   Samuelson KL, 2016, J ANIM SCI, V94, P2648, DOI {[}10.2527/jas.2016-0282, 10.2527/jas2016-0282].
   Sangster JL, 2014, SCI TOTAL ENVIRON, V496, P576, DOI 10.1016/j.scitotenv.2014.07.040.
   Sassman SA, 2007, ENVIRON TOXICOL CHEM, V26, P1614, DOI 10.1897/07-073R.1.
   Sellin MK, 2009, AQUAT TOXICOL, V92, P221, DOI 10.1016/j.aquatox.2009.02.004.
   Smith L. M., 2003, PLAYAS GREAT PLAINS.
   Sone K, 2004, GEN COMP ENDOCR, V138, P228, DOI 10.1016/j.ygcen.2004.06.011.
   Soto AM, 2004, ENVIRON HEALTH PERSP, V112, P346, DOI 10.1289/ehp.6590.
   Sweeten J., 1990, CATTLE FEEDLOT WASTE.
   United States Food and Drug Administration, 2015, SUMM REP ANT SOLD DI.
   US Environmental Protection Agency, 2007, 1694 US EPA HPLC MS.
   US Environmental Protection Agency, 2017, EC DAT.
   USDA National Agricultural Statistics Service, 2012, CENS AGR.
   USDA National Agriculture Statistics Service, 2017, CATTL ON FEED.
   USDA National Animal Health Monitoring System, 2000, BAS REF FEEDL MAN PR.
   USFDA Center for Veterinary Medicine, 2003, GUID IND 152 EV SAF.
   Williams-Nguyen J, 2016, J ENVIRON QUAL, V45, P394, DOI 10.2134/jeq2015.07.0336.
   Wooten K.J., PERSISTENCE EL UNPUB.
   Wooten K.J., RACTOPAMINE PA UNPUB.
   Wooten KJ, 2015, AGR ECOSYST ENVIRON, V203, P29, DOI 10.1016/j.agee.2015.01.016.
   Xu J, 2014, SCI TOTAL ENVIRON, V497, P267, DOI 10.1016/j.scitotenv.2014.07.114.
   Zhang YP, 2013, SCI TOTAL ENVIRON, V463, P631, DOI 10.1016/j.scitotenv.2013.06.016.}},
Number-of-Cited-References = {{76}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{25}},
Usage-Count-Since-2013 = {{31}},
Journal-ISO = {{Agric. Ecosyst. Environ.}},
Doc-Delivery-Number = {{FO2NN}},
Unique-ID = {{ISI:000416616100002}},
DA = {{2018-08-13}},
}

@article{ ISI:000440030400001,
Author = {Dietl, Anna-Maria and Meir, Zohar and Shadkchan, Yona and Osherov, Nir
   and Haas, Hubertus},
Title = {{Riboflavin and pantothenic acid biosynthesis are crucial for iron
   homeostasis and virulence in the pathogenic mold Aspergillus fumigatus}},
Journal = {{VIRULENCE}},
Year = {{2018}},
Volume = {{9}},
Number = {{1}},
Pages = {{1036-1049}},
Abstract = {{Background: Aspergillus fumigatus is the most prevalent airborne fungal
   pathogen, causing invasive fungal infections mainly in immunosuppressed
   individuals. Death rates from invasive aspergillosis remain high because
   of limited treatment options and increasing antifungal resistance. The
   aim of this study was to identify key fungal-specific genes
   participating in vitamin B biosynthesis in A. fumigatus. Because these
   genes are absent in humans they can serve as possible novel targets for
   antifungal drug development.
   Methods: By sequence homology we identified, deleted and analysed four
   key A. fumigatus genes (riboB, panA, pyroA, thiB) involved respectively
   in the biosynthesis of riboflavin (vitamin B2), pantothenic acid
   (vitamin B5), pyridoxine (vitamin B6) and thiamine (vitamin B1).
   Results: Deletion of riboB, panA, pyroA or thiB resulted in respective
   vitamin auxotrophy. Lack of riboflavin and pantothenic acid biosynthesis
   perturbed many cellular processes including iron homeostasis. Virulence
   in murine pulmonary and systemic models of infection was severely
   attenuated following deletion of riboB and panA, strongly reduced after
   pyroA deletion and weakly attenuated after thiB deletion.
   Conclusions: This study reveals the biosynthetic pathways of the
   vitamins riboflavin and pantothenic acid as attractive targets for novel
   antifungal therapy. Moreover, the virulence studies with auxotrophic
   mutants serve to identify the availability of nutrients to pathogens in
   host niches.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Haas, H (Reprint Author), Med Univ Innsbruck, Div Mol Biol, Bioctr, Innsbruck, Austria.
   Osherov, N (Reprint Author), Sackler Sch Med Ramat Aviv, Dept Clin Microbiol \& Immunol, Tel Aviv, Israel.
   Dietl, Anna-Maria; Haas, Hubertus, Med Univ Innsbruck, Div Mol Biol, Bioctr, Innsbruck, Austria.
   Meir, Zohar; Shadkchan, Yona; Osherov, Nir, Sackler Sch Med Ramat Aviv, Dept Clin Microbiol \& Immunol, Tel Aviv, Israel.}},
DOI = {{10.1080/21505594.2018.1482181}},
ISSN = {{2150-5594}},
EISSN = {{2150-5608}},
Keywords = {{Aspergillus fumigatus virulence; vitamin B biosynthesis; auxotrophy;
   iron metabolism; antifungal drug target}},
Keywords-Plus = {{MYCOBACTERIUM-TUBERCULOSIS; SYNTHASE INHIBITORS; LYSINE BIOSYNTHESIS;
   INFECTION MODEL; DRUG TARGETS; NIDULANS; SYNTHETASE; RECOMBINATION;
   ASSIMILATION; METABOLISM}},
Research-Areas = {{Immunology; Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Immunology; Infectious Diseases; Microbiology}},
Author-Email = {{nosherov@post.tau.ac.il
   hubertus.haas@i-med.ac.at}},
Funding-Acknowledgement = {{Austrian Science Fund/Infect-ERA program {[}I1616]; Israel Ministry of
   Health Infect-ERA {[}3-0000-11080]}},
Funding-Text = {{This work was supported by the Austrian Science Fund/Infect-ERA program
   {[}I1616]; Israel Ministry of Health Infect-ERA {[}3-0000-11080].}},
Cited-References = {{Amich J, 2016, INFECT IMMUN, V84, P917, DOI 10.1128/IAI.01124-15.
   Balloy V, 2005, INFECT IMMUN, V73, P494, DOI 10.1128/IAI.73.1.494-503.2005.
   Becker JM, 2010, P NATL ACAD SCI USA, V107, P22044, DOI 10.1073/pnas.1009845107.
   Ben Yaakov D, 2017, J ANTIMICROB CHEMOTH, V72, P2263, DOI 10.1093/jac/dkx117.
   Bonamore A, 2008, IUBMB LIFE, V60, P19, DOI 10.1002/iub.9.
   Bongomin F, 2017, J FUNGI, V3, P57, DOI DOI 10.3390/J0F3040057.
   Bourne CR, 2014, ANTIBIOTICS-BASEL, V3, P1, DOI 10.3390/antibiotics3010001.
   Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236.
   Brown JS, 2000, MOL MICROBIOL, V36, P1371, DOI 10.1046/j.1365-2958.2000.01953.x.
   Calder RB, 1999, J BIOL CHEM, V274, P2014, DOI 10.1074/jbc.274.4.2014.
   Cerqueira GC, 2014, NUCLEIC ACIDS RES, V42, pD705, DOI 10.1093/nar/gkt1029.
   Chen JH, 2005, ANAL BIOCHEM, V338, P124, DOI 10.1016/j.ab.2004.11.033.
   Dick T, 2010, MOL MICROBIOL, V78, P980, DOI 10.1111/j.1365-2958.2010.07381.x.
   Dietl AM, 2016, VIRULENCE, V7, P465, DOI 10.1080/21505594.2016.1146848.
   Eisendle M, 2003, MOL MICROBIOL, V49, P359, DOI 10.1046/j.1365-2958.2003.03586.x.
   Fischer GJ, 2016, J MICROBIOL, V54, P254, DOI 10.1007/s12275-016-5620-z.
   Garfoot AL, 2014, INFECT IMMUN, V82, P393, DOI 10.1128/IAI.00824-13.
   Grahl N, 2012, EUKARYOT CELL, V11, P560, DOI 10.1128/EC.00031-12.
   Gudipati V, 2014, BBA-PROTEINS PROTEOM, V1844, P535, DOI 10.1016/j.bbapap.2013.12.015.
   HAAS H, 2012, FRONT MICROBIOL, V3.
   Haas H, 2014, NAT PROD REP, V31, P1266, DOI 10.1039/c4np00071d.
   Hartmann T, 2010, APPL ENVIRON MICROB, V76, P6313, DOI 10.1128/AEM.00882-10.
   Hung AW, 2016, CHEMMEDCHEM, V11, P38, DOI 10.1002/cmdc.201500414.
   Ianiri G, 2015, MBIO, V6, DOI 10.1128/mBio.02334-14.
   Johns A, 2017, MBIO, V8, DOI {[}10.1128/mBio.01504-16, 10.1128/mbio.01504-16].
   Kaltdorf Martin, 2016, Front Mol Biosci, V3, P22, DOI 10.3389/fmolb.2016.00022.
   Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006.
   Lapp K, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00469.
   Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001.
   Liebmann B, 2004, ARCH MICROBIOL, V181, P378, DOI 10.1007/s00203-004-0667-3.
   Long QX, 2010, CHEM BIOL DRUG DES, V75, P339, DOI 10.1111/j.1747-0285.2010.00946.x.
   Lu Y, 2014, COMPUT BIOL CHEM, V50, P29, DOI 10.1016/j.compbiolchem.2014.01.011.
   Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332.
   Oberegger H, 2003, CURR GENET, V44, P211, DOI 10.1007/s00294-003-0434-z.
   Perfect JR, 2017, NAT REV DRUG DISCOV, V16, P603, DOI 10.1038/nrd.2017.46.
   PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3.
   PURNELL DM, 1973, MYCOPATH MYCOL APPL, V50, P195, DOI 10.1007/BF02053368.
   Reidling JC, 2010, GASTROENTEROLOGY, V138, P1802, DOI 10.1053/j.gastro.2009.10.042.
   Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765.
   Sasse A, 2016, VIRULENCE, V7, P56, DOI 10.1080/21505594.2015.1109766.
   Schinko T, 2010, MOL MICROBIOL, V78, P720, DOI 10.1111/j.1365-2958.2010.07363.x.
   Schobel F, 2010, EUKARYOT CELL, V9, P878, DOI 10.1128/EC.00020-10.
   Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128.
   Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124.
   Spry C, 2008, FEMS MICROBIOL REV, V32, P56, DOI 10.1111/j.1574-6976.2007.00093.x.
   Tao L, 2010, CURR GENET, V56, P283, DOI 10.1007/s00294-010-0300-8.
   Thykaer J, 2009, MED MYCOL, V47, pS80, DOI 10.1080/13693780802455305.
   Yekutiel A, 2004, ANTIMICROB AGENTS CH, V48, P3279, DOI 10.1128/AAC.48.9.3279-3283.2004.
   Zhao YJJ, 2009, J ORG CHEM, V74, P5297, DOI 10.1021/jo900768c.}},
Number-of-Cited-References = {{49}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Virulence}},
Doc-Delivery-Number = {{GO5AQ}},
Unique-ID = {{ISI:000440030400001}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000433428300010,
Author = {Li, Yan and Pi, Qing-meng and You, Hui-hui and Li, Jin-quan and Wang,
   Peng-cheng and Yang, Xu and Wu, Yang},
Title = {{A smart multi-functional coating based on anti-pathogen micelles
   tethered with copper nanoparticles via a biosynthesis method using
   l-vitamin C}},
Journal = {{RSC ADVANCES}},
Year = {{2018}},
Volume = {{8}},
Number = {{33}},
Pages = {{18272-18283}},
Abstract = {{A multi-functional anti-pathogen coating with release-killing,
   contact-killing and anti-adhesion properties was prepared from
   biocompatible polymer encapsulated chlorine dioxide (ClO2) which
   protected the active ingredient from the outside environment. A slow
   sustained-release of ClO2 from micelles over fifteen days was detected
   for long-term release-killing. Micelles only release ClO2 on demand in
   minimum inhibitory concentrations. We prepared nanoparticles which were
   covalently clustered on micelle surfaces to improve contact-killing as
   well as to improve the stability of the micelle. Copper nanoparticles
   were generated using the biosynthesis method including l-vitamin C,
   which avoids the toxicity and allows for the preparation of copper
   nanoparticles in a green environment. Synergistic anti-pathogen activity
   could be generated by a combination of micelle released ClO2 and
   ascorbic acid. In addition to release-killing and contact-killing, a
   pluronic polymer coated surface also provides an additional
   anti-adhesion property through its protein-repelling ability. In this
   research, the designed coating demonstrated a broad-spectrum of activity
   to kill drug-resistant bacteria, viruses and spores in short period of
   time. Based on scanning electron microscopy (SEM), transmission electron
   microscopy (TEM) and anti-oxidase assays, we found that the designed
   coatings killed the pathogens via bio-oxidation. We also carried out
   acute respiratory toxicity tests in this research. Analysis of blood
   samples, lung function and histopathological slices indicated that the
   synthesized micelles allowed a controlled and sustained release of ClO2
   to kill pathogens while maintaining an overall ClO2 concentration in the
   air within a safe range.}},
Publisher = {{ROYAL SOC CHEMISTRY}},
Address = {{THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wu, Y (Reprint Author), Wuhan Polytech Univ, Key Lab Deep Proc Major Grain \& Oil, Minist Educ, Coll Food Sci \& Engn, Wuhan 430023, Hubei, Peoples R China.
   Wu, Y (Reprint Author), Wuhan Polytech Univ, Hubei Key Lab Proc \& Transformat Agr Prod, Coll Food Sci \& Engn, Wuhan 430023, Hubei, Peoples R China.
   Li, Yan; Wang, Peng-cheng; Wu, Yang, Wuhan Polytech Univ, Key Lab Deep Proc Major Grain \& Oil, Minist Educ, Coll Food Sci \& Engn, Wuhan 430023, Hubei, Peoples R China.
   Wu, Yang, Wuhan Polytech Univ, Hubei Key Lab Proc \& Transformat Agr Prod, Coll Food Sci \& Engn, Wuhan 430023, Hubei, Peoples R China.
   Pi, Qing-meng, Shanghai Jiao Tong Univ, Renji Hosp, Dept Plast \& Reconstruct Surg, Sch Med, Shanghai 200129, Peoples R China.
   Pi, Qing-meng, MIT, Harvard MIT Div Hlth Sci \& Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   You, Hui-hui; Yang, Xu, Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat \& Integrat Biol, Wuhan 430079, Hubei, Peoples R China.
   Li, Jin-quan, Wuhan Univ Sci \& Technol, Sch Med, Brain \& Cognit Dysfunct Res Ctr, Wuhan 430081, Hubei, Peoples R China.}},
DOI = {{10.1039/c8ra01985a}},
ISSN = {{2046-2069}},
Keywords-Plus = {{ASCORBIC-ACID; SILVER NANOPARTICLES; CHLORINE DIOXIDE; INFLUENZA-VIRUS;
   BACTERIAL ADHESION; CONTROLLED-RELEASE; RESISTANCE; WATER; INACTIVATION;
   BIOFILM}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Multidisciplinary}},
Author-Email = {{wuyangwhpu@163.com}},
Funding-Acknowledgement = {{Foundation of Excellent Young Scholar of Wuhan Polytechnic University
   {[}2018RZ01]; National Natural Science Foundation of China {[}21577045,
   21607117]}},
Funding-Text = {{This work was supported by the National Natural Science Foundation of
   China (No. 21607117), the National Natural Science Foundation of China
   (No. 21577045) and the Foundation of Excellent Young Scholar of Wuhan
   Polytechnic University (No. 2018RZ01).}},
Cited-References = {{Aksenov AA, 2012, CHEMBIOCHEM, V13, P1053, DOI 10.1002/cbic.201200011.
   Alabi Z O, 1994, Afr J Med Med Sci, V23, P143.
   AMABILECUEVAS CF, 1991, MUTAT RES, V264, P119, DOI 10.1016/0165-7992(91)90128-Q.
   Bae KH, 2006, LANGMUIR, V22, P6380, DOI 10.1021/la0606704.
   Bai ZF, 2016, J AGR FOOD CHEM, V64, P8647, DOI 10.1021/acs.jafc.6b03875.
   Bouzianas DG, 2009, TRENDS MICROBIOL, V17, P522, DOI 10.1016/j.tim.2009.08.006.
   BRAWN K, 1980, ACTA PHYSIOL SCAND, P9.
   Byers KE, 1998, INFECT CONT HOSP EP, V19, P261.
   Chen CL, 2013, INT BIODETER BIODEGR, V83, P71, DOI 10.1016/j.ibiod.2013.04.012.
   Chen M, 2013, INT J MOL SCI, V14, P18488, DOI 10.3390/ijms140918488.
   COLOBERT L, 1962, Rev Pathol Gen Physiol Clin, V62, P551.
   Cowling BJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2922.
   Cross JB, 2003, APPL ENVIRON MICROB, V69, P2245, DOI 10.1128/AEM.69.4.2245-2252.2003.
   D'Agnillo F, 1998, NAT BIOTECHNOL, V16, P667, DOI 10.1038/nbt0798-667.
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002.
   Ficheux MF, 1998, LANGMUIR, V14, P2702, DOI 10.1021/la971271z.
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013.
   GAUSH CR, 1968, APPL MICROBIOL, V16, P588.
   Gkana EN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01295.
   Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010.
   Israelachvili J, 1997, P NATL ACAD SCI USA, V94, P8378, DOI 10.1073/pnas.94.16.8378.
   Jansson PJ, 2005, FREE RADICAL RES, V39, P1233, DOI 10.1080/10715760500249861.
   Jasovsky D, 2016, UPSALA J MED SCI, V121, P159, DOI 10.1080/03009734.2016.1195900.
   Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005.
   Rivero PJ, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-305.
   Khan A, 2016, INT NANO LETT, V6, P21, DOI 10.1007/s40089-015-0163-6.
   Kolsi RBA, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0643-y.
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130.
   Laloyaux X, 2010, ADV MATER, V22, P5024, DOI 10.1002/adma.201002538.
   Li Y, 2009, LANGMUIR, V25, P13472, DOI 10.1021/la901974d.
   Li YQ, 2015, ANGEW CHEM INT EDIT, V54, P11073, DOI 10.1002/anie.201505232.
   Li YQ, 2014, CHEM-EUR J, V20, P6027, DOI 10.1002/chem.201304689.
   Li Z, 2006, LANGMUIR, V22, P9820, DOI 10.1021/la0622166.
   Lih E, 2015, PROG POLYM SCI, V44, P28, DOI 10.1016/j.progpolymsci.2014.10.004.
   Lin ZF, 2017, RSC ADV, V7, P742, DOI 10.1039/c6ra25010f.
   Liu XD, 2014, INT J NANOMED, V9, P823, DOI 10.2147/IJN.S56339.
   Loukili N. H., 2017, Journal of Infection Prevention, V18, P78, DOI 10.1177/1757177416679879.
   Madhusudana SN, 2004, INT J INFECT DIS, V8, P21, DOI 10.1016/j.ijid.2003.09.002.
   MAGDASSI S, 1986, Journal of Controlled Release, V3, P273, DOI 10.1016/0168-3659(86)90098-2.
   Mccoy CP, 2012, BIOMATERIALS, V33, P7952, DOI 10.1016/j.biomaterials.2012.07.052.
   McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147.
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059.
   Muszanska AK, 2011, BIOMATERIALS, V32, P6333, DOI 10.1016/j.biomaterials.2011.05.016.
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014.
   Nejadnik MR, 2009, LANGMUIR, V25, P6245, DOI 10.1021/la9001169.
   Nimse SB, 2015, RSC ADV, V5, P27986, DOI 10.1039/c4ra13315c.
   Ogata N, 2016, PHARMACOLOGY, V97, P301, DOI 10.1159/000444503.
   Ogata N, 2012, J GEN VIROL, V93, P2558, DOI 10.1099/vir.0.044263-0.
   Orr RV, 2000, J FOOD PROTECT, V63, P1117, DOI 10.4315/0362-028X-63.8.1117.
   Peddireddy KR, 2016, ACS MACRO LETT, V5, P283, DOI 10.1021/acsmacrolett.5b00953.
   RAGABDEPRE NJ, 1982, APPL ENVIRON MICROB, V44, P555.
   Ranu Harpreet, 2011, Ulster Med J, V80, P84.
   Rappuoli R, 2014, P NATL ACAD SCI USA, V111, P12288, DOI 10.1073/pnas.1402981111.
   Read JM, 2003, P ROY SOC B-BIOL SCI, V270, P699, DOI 10.1098/rspb.2002.2305.
   Reithofer MR, 2014, BIOMATERIALS, V35, P7535, DOI 10.1016/j.biomaterials.2014.04.102.
   REYNOLDS HY, 1977, J CLIN INVEST, V59, P165, DOI 10.1172/JCI108615.
   Rodriguez-Lazaro D, 2012, FEMS MICROBIOL REV, V36, P786, DOI 10.1111/j.1574-6976.2011.00306.x.
   Sagripanti JL, 1997, ANTIMICROB AGENTS CH, V41, P812.
   Acevedo MS, 2013, INT BIODETER BIODEGR, V83, P97, DOI 10.1016/j.ibiod.2013.05.002.
   Schmitz FJ, 2002, EUR J CLIN MICROBIOL, V21, P647, DOI 10.1007/s10096-002-0788-z.
   SELA Y, 1995, J CONTROL RELEASE, V33, P1, DOI 10.1016/0168-3659(94)00029-T.
   Tamanna T, 2015, RSC ADV, V5, P107839, DOI 10.1039/c5ra22976f.
   TAYLOR GR, 1982, J HYG-CAMBRIDGE, V89, P321, DOI 10.1017/S0022172400070856.
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X.
   Vijayalakshmi K, 2016, RSC ADV, V6, P9663, DOI 10.1039/c5ra28125c.
   White Carl W, 2010, Proc Am Thorac Soc, V7, P257, DOI 10.1513/pats.201001-008SM.
   Wu Y, 2017, RSC ADV, V7, P18917, DOI 10.1039/c7ra01464c.
   Xu KD, 2000, MICROBIOL-UK, V146, P547, DOI 10.1099/00221287-146-3-547.
   Yang JS, 2015, RSC ADV, V5, P2378, DOI 10.1039/c4ra12836b.
   Yeap JW, 2016, APPL ENVIRON MICROB, V82, P116, DOI 10.1128/AEM.02489-15.
   Zain NM, 2014, CARBOHYD POLYM, V112, P195, DOI 10.1016/j.carbpol.2014.05.081.
   Zhou J, 2011, LANGMUIR, V27, P3308, DOI 10.1021/la1036844.
   ZIMMERMAN L, 1966, J BACTERIOL, V91, P1537.}},
Number-of-Cited-References = {{73}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{RSC Adv.}},
Doc-Delivery-Number = {{GH5AN}},
Unique-ID = {{ISI:000433428300010}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000429485200002,
Author = {Ngozika, Wokem Gloria and Obioma, Azuonwu and Appollus, Josiah
   Nkereawaji},
Title = {{Investigation of Rifampicin Resistance Outcome among Tuberculosis
   Patients Visiting Two Major Health Facilities in Port Harcourt in Niger
   Delta}},
Journal = {{INTERNATIONAL JOURNAL OF MEDICAL RESEARCH \& HEALTH SCIENCES}},
Year = {{2018}},
Volume = {{7}},
Number = {{3}},
Pages = {{8-14}},
Abstract = {{Background: Tuberculosis is caused by Mycobacterium tuberculosis and is
   spread mainly through contact with air droplets and respiratory fluid
   from an infected person. Drug of choice for its treatment are rifampicin
   and isoniazid respectively. However, in recent times, resistance to
   these drugs as with other antibiotics has been observed across the
   globe. This study was thus aimed at determining the prevalence of
   rifampicin resistance strain among TB patients attending two major
   hospitals (Braithwaite Memorial Hospital and University of Port Harcourt
   Teaching Hospital) in Port Harcourt. Method: Sputum of patients was
   collected, tested for the presence of TB and rifampicin resistance of
   the isolates were determined using GeneXpert assay approach. Result: A
   total of 158 isolates from patients who were TB positive were tested for
   rifampicin resistance. 13.3\% of these were resistant to rifampicin
   drug. 8.9\% was from UPTH while 4.4\% was from BUSH. 9.5\% were less
   than age 45 while 3.8\% were greater than or equal to age 45 (>= 45).
   Males made up 8.2\% of the total prevalence while females made up 5.1\%
   of the total prevalence. Alternative drugs to rifampicin and isoniazid
   drug should however, be prescribed in confirmed cases of resistance
   outcome in our health facilities especially in the rural communities.
   Conclusion: Nonetheless, the use of antibiotics indiscriminately without
   the effective laboratory assay and physician's prescription should be
   discouraged at all levels and patients receiving treatment should be
   monitored to adhere strictly to the desired dosage as non-adhering to
   the gold standard option may lead to drug resistance outcome among
   vulnerable patients who are literally exposed to lack of health
   education and functional health facilities in the remote communities
   which are also hard to reach area due to the environmental terrine.}},
Publisher = {{SUAMTHI PUBLICATIONS}},
Address = {{SUAMTHI PUBLICATIONS, AHMEDNAGAR, 00000, INDIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Obioma, A (Reprint Author), Rivers State Univ Sci \& Technol, Dept Med Lab Sci, Fac Sci, Nkpolu, Orowhorukwo Por, Nigeria.
   Ngozika, Wokem Gloria; Obioma, Azuonwu, Rivers State Univ Sci \& Technol, Dept Med Lab Sci, Fac Sci, Nkpolu, Orowhorukwo Por, Nigeria.
   Appollus, Josiah Nkereawaji, Univ Port Harcourt Teaching Hosp Choba, Dept Med Microbiol, East West Rd, Port Harcourt, Nigeria.}},
ISSN = {{2319-5886}},
Keywords = {{Rifampicin; Tuberculosis; Resistance strain; Public health; Port
   Harcourt; Niger Delta; Health facility}},
Keywords-Plus = {{MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; DRUG-RESISTANCE;
   GENEXPERT}},
Research-Areas = {{Research \& Experimental Medicine}},
Web-of-Science-Categories  = {{Medicine, Research \& Experimental}},
Author-Email = {{bimajacobs@yahoo.co.uk}},
Cited-References = {{Azuonwu O., 2016, J CLIN LAB MED, V1.
   Azuonwu O., 2017, J CLIN LAB MED, V2.
   Azuonwu Obioma, 2017, TRANSLATIONAL BIOMED, V8.
   Boakye-Appiah JK, 2016, INT J MYCOBACT, V5, P226, DOI 10.1016/j.ijmyco.2016.02.004.
   Drobniewski F, 2002, THORAX, V57, P810, DOI 10.1136/thorax.57.9.810.
   Glynn JR, 2005, EMERG INFECT DIS, V11, P150, DOI 10.3201/eid1101.040869.
   Kapata N, 2011, TROP MED INT HEALTH, V16, P1404, DOI 10.1111/j.1365-3156.2011.02849.x.
   Kuaban C, 2000, INT J TUBERC LUNG D, V4, P356.
   Lin J, 2004, INT J TUBERC LUNG D, V8, P568.
   Masenga SK, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2750-9.
   Nair SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150054.
   Palomino JC, 2014, ANTIBIOTICS-BASEL, V3, P317, DOI 10.3390/antibiotics3030317.
   Park SK, 1998, INT J TUBERC LUNG D, V2, P877.
   Park WG, 2002, J CLIN MICROBIOL, V40, P4750, DOI 10.1128/JCM.40.12.4740-4752.2002.
   Seyoum Berhanu, 2014, TUBERCULOSIS RES TRE, V2014.
   Shinnick Thomas M., 2005, Morbidity and Mortality Weekly Report, V54, P1.
   SNIDER DE, 1984, AM REV RESPIR DIS, V129, P573.
   Tuberculosis Section Health Protection Agency Centre for Infections, 2005, UK MYC SURV NETW REP.
   Uzoewulu NG, 2014, J MED MICROB DIAGN, V3, P2.
   World Health Organization, 2012, REP 1 NAT TB PREV SU.
   World Health Organization, 2004, ANT TUB DRUG RES WOR.
   World Health Organization, 2013, GLOB TUB REP.}},
Number-of-Cited-References = {{22}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Int. J. Med. Res. Health Sci.}},
Doc-Delivery-Number = {{GC0RK}},
Unique-ID = {{ISI:000429485200002}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000428835600009,
Author = {Torun, Selda Hancerli and Acar, Emine Manolya and Somer, Ayper and
   Erkose, Gonca and Satana, Dilek and Bayramoglu, Zuhal and Caliskan,
   Emine and Kilicaslan, Zeki},
Title = {{Management and Treatment Difficulties of Multi-drug Resistant Pulmonary
   Tuberculosis in a Pediatric Case}},
Journal = {{MIKROBIYOLOJI BULTENI}},
Year = {{2018}},
Volume = {{52}},
Number = {{1}},
Pages = {{89-95}},
Month = {{JAN}},
Abstract = {{Tuberculosis continues to be a major health problem worldwide. Multidrug
   resistant tuberculosis (MDR-TB) infection that occurs in childhood is
   caused by adult MDR-TB agents which are in circulation and resistant to
   primary drugs. In this case report a 17-month-old child with MDR-TB who
   was cured after a 24-month therapy regimen was presented. Physical
   examination of a 17-month-old girl admitted to the hospital with the
   cause of recurrent pneumonia revealed a rubbery lymphadenopathy less
   than 2 cm in the right upper cervical region. Crepitant rales were
   detected in the right basal on auscultation of the lung. Interferon
   gamma release assay (IGRA) and tuberculin skin (TST) tests were
   negative. Computed tomography (CT) scan of the chest showed mediastinal
   conglomerate pathologic lymphadenopathy and air bronchograms were
   detected near the lower lobe of the left lung. Treatment of isoniazid,
   rifampicin, pyrazinamide with the diagnosis of epituberculosis was
   started by taking a sample of gastric aspirate culture sample. In the
   sixth month of the treatment patient was admitted to our clinic with
   enlarged cervical rubbery lymphadenopathy. It was determined that
   microbiological test of gastric aspirate culture specimen was positive
   for M.tuberculosis complex resistant to isoniazid, rifampin, ethambutol,
   streptomycin, ethionamide and rifabutin. Control CT showed residual
   peribronchial infiltrations and hilar calcific lymph nodes. Hearing
   test, vision control and, thyroid function tests were performed and
   treatment of moxifloxacin, amikacin, para-amino salicylic acid,
   protionamide and pyrazinamide was started based on minor drug
   susceptibility results of M.tuberculosis isolate which was still growing
   in gastric aspirate culture. Gastric aspirate culture for M.tuberculosis
   was still positive after 3 months of treatment and the current treatment
   was continued. Amikacin was stopped after 6 months. Therapy regimen was
   stopped after 24-months. Over the course of a follow-up period of more
   than 3 years, the clinical and radiological resultsof the patient has
   improved significantly. The clinical presentation of TB in children is
   often nonspecific and differs from the patterns seen in adults. MDR-TB
   cases can be seen in this age group since tuberculosis in children is
   mainly caused by transmission of drug-resistant strains from adults.
   This situation is particularly problematic due to the long-term
   treatment and the lack of specific drug formulations for children.}},
Publisher = {{ANKARA MICROBIOLOGY SOC}},
Address = {{HACETLEPE UNIV FACULTY MEDICINE DEPT MICROBIOLOGY, 06100 ANKARA, TURKEY}},
Type = {{Article}},
Language = {{Turkish}},
Affiliation = {{Torun, SH (Reprint Author), Istanbul Univ, Fac Med, Dept Pediat Infect Dis, Istanbul, Turkey.
   Torun, Selda Hancerli; Acar, Emine Manolya; Somer, Ayper, Istanbul Univ, Fac Med, Dept Pediat Infect Dis, Istanbul, Turkey.
   Erkose, Gonca; Satana, Dilek, Istanbul Univ, Fac Med, Dept Med Microbiol, Istanbul, Turkey.
   Bayramoglu, Zuhal; Caliskan, Emine, Istanbul Univ, Fac Med, Dept Radiol, Istanbul, Turkey.
   Kilicaslan, Zeki, Istanbul Univ, Fac Med, Dept Chest Dis, Istanbul, Turkey.}},
DOI = {{10.5578/mb.61937}},
ISSN = {{0374-9096}},
Keywords = {{Child; multidrug-resistance; pulmonary tuberculosis}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{seldahancerli@hotmail.com}},
Cited-References = {{Bakanligi T. C. Saglik, 2011, TUBERKULOZ TANI VE T.
   HOLDEN M, 1971, NEW ENGL J MED, V285, P1506, DOI 10.1056/NEJM197112302852704.
   Jenkins HE, 2016, PNEUMONIA, V8, DOI 10.1186/s41479-016-0018-6.
   Kampmann B, 2015, HDB CHILD ADOLESCENT, P33.
   Schaaf HS, 2012, CLIN PRACT, V9, P701.
   Starke JR, 2014, PEDIATRICS, V134, pE1763, DOI 10.1542/peds.2014-2983.
   Tuberkuloz Kilicarslan Z., 2010, TORAKS KITAPLARI TUB, P25.
   WHO, 2016, TREATM GUID DRUG RES.
   World Health Organization, 2015, GLOB TUB REP.
   Yalcin Gunes E, 2016, TURKIYE KLIN J PEDIA, V12, P14.}},
Number-of-Cited-References = {{10}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Mikrobiyol. Bul.}},
Doc-Delivery-Number = {{GB1UL}},
Unique-ID = {{ISI:000428835600009}},
DA = {{2018-08-13}},
}

@article{ ISI:000428835600010,
Author = {Surucuoglu, Suheyla},
Title = {{Risk of Travel Associated Tuberculosis}},
Journal = {{MIKROBIYOLOJI BULTENI}},
Year = {{2018}},
Volume = {{52}},
Number = {{1}},
Pages = {{96-107}},
Month = {{JAN}},
Abstract = {{Tuberculosis has spread by human movements throughout history. There
   have been reports indicating tuberculosis transmission on all travel
   vehicles, including aircrafts, ground vehicles and vessels until today.
   However, due to the ever increasing of air transportation and air
   travelling among countries with low and high tuberculosis incidence,
   transmission risk especially in aircrafts has become an important issue
   worldwide. But in many of the studies conducted in this regard,
   transmission of tuberculosis in aircrafts was found very low. The case
   of active tuberculosis has not yet been reported. This is due to the
   fact that in modern aircrafts, there are ventilation systems that
   provide hepa filtered laminar air flow and change the air 15-20 times
   per hour. The guidelines for the prevention of tuberculosis infection in
   aircrafts published by the World Health Organization ``Tuberculosis and
   Air Travel, 2008{''} and European Centre for Disease Prevention and
   Control ``RAGIDA-TB, 2014{''} confirm each other. According to these
   guidelines, air travelling of patients with active pulmonary
   tuberculosis should be prohibited until smears of two consecutive sputum
   samples become negative for drug susceptible cases, and cultures of two
   consecutive of sputum samples become negative for multidrug or
   extensively drug resistant cases. When it is reported that a
   tuberculosis patient has travelled by the aircraft, it is recommended
   that the exposed passengers should be investigated for tuberculosis
   infection if the flight duration equal to or exceeding eight hours
   including ground delays and the time elapsed between flight and
   diagnosis of the case is no longer than three months. Contact screening
   is only recommended for passengers sitting in the same row, two rows
   ahead and two rows behind the index case. Tuberculin skin test or
   interferon gamma release assay can be used for investigation. It is very
   difficult to determine the risk of tuberculosis transmission in ground
   vehicles like buses, subways and trains. The reason is that it is often
   not possible to access the information of the passengers travelling in
   these vehicles. Because the ventilation systems in ground vehicles are
   not as reliable as in aircrafts and the crowded environment in the
   ground vehicles, the risk of tuberculosis transmission is theoretically
   higher. In modelling studies, the transmission risk in the buses was
   found to be higher than the trains. In the case of regular travelling
   with an index case such as school bus riders, the risk increases
   significantly. The increased human population travelling all over the
   world nowadays has also raised concerns about travel-related
   tuberculosis risk. However, because of the limited evidence, it may be
   more efficient to spend time and resources for the other actions in
   order to prevent tuberculosis. In this review article, the transmission
   risk of tuberculosis in vehicles has been discussed.}},
Publisher = {{ANKARA MICROBIOLOGY SOC}},
Address = {{HACETLEPE UNIV FACULTY MEDICINE DEPT MICROBIOLOGY, 06100 ANKARA, TURKEY}},
Type = {{Review}},
Language = {{Turkish}},
Affiliation = {{Surucuoglu, S (Reprint Author), Manisa Celal Bayar Univ, Fac Med, Dept Med Microbiol, Manisa, Turkey.
   Surucuoglu, Suheyla, Manisa Celal Bayar Univ, Fac Med, Dept Med Microbiol, Manisa, Turkey.}},
DOI = {{10.5578/mb.66237}},
ISSN = {{0374-9096}},
Keywords = {{Tuberculosis; travel; transmission; infection; tuberculin skin test}},
Keywords-Plus = {{PUBLIC TRANSPORTATION; AIR-TRAVEL; TRANSMISSION; ABOARD; LIMA; PERU}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{suheylasurucuoglu@yahoo.com}},
Cited-References = {{Abubakar I, 2010, LANCET INFECT DIS, V10, P176, DOI 10.1016/S1473-3099(10)70028-1.
   Al-Jahdali H, 2003, INT J ANTIMICROB AG, V21, P125, DOI 10.1016/S0924-8579(02)00283-2.
   An der Heiden M, 2017, EURO SURVEILL, V22.
   Andrews JR, 2013, AM J EPIDEMIOL, V177, P556, DOI 10.1093/aje/kws331.
   {[}Anonymous], 2014, RISK ASS GUID INF DI.
   {[}Anonymous], 2008, TUB AIR TRAV GUID PR.
   {[}Anonymous], 2016, WHO GLOBAL TUBERCULO.
   Edelson PJ, 2011, TRAVEL MED INFECT DI, V9, P27, DOI 10.1016/j.tmaid.2010.11.001.
   Feske ML, 2011, TUBERCULOSIS, V91, pS16, DOI 10.1016/j.tube.2011.10.005.
   Flanagan P, 2016, EUROSURVEILLANCE, V6, P21.
   Grout A, 2017, LANCET INFECT DIS, V17, pE118, DOI 10.1016/S1473-3099(16)30476-5.
   HARDY MA, 1968, J AMER MED ASSOC, V203, P175, DOI 10.1001/jama.203.3.175.
   Hertzberg VS, 2016, ANN GLOB HEALTH, V82, P819, DOI 10.1016/j.aogh.2016.06.003.
   Horna-Campos OJ, 2010, INT J TUBERC LUNG D, V14, P714.
   Horna-Campos OJ, 2007, EMERG INFECT DIS, V13, P1491, DOI 10.3201/eid1310.060793.
   International Transport Forum, 2015, TOUR FAC PART TRANSP.
   Jackson C, 2017, EURO SURVEILL, V22.
   Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501.
   Kotila SM, 2016, EURO SURVEILL, V21.
   Leder K, 2005, INTERN MED J, V35, P50, DOI 10.1111/j.1445-5994.2004.00696.x.
   Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8.
   Marienau KJ, 2010, TRAVEL MED INFECT DI, V8, P104, DOI 10.1016/j.tmaid.2010.02.003.
   Mohr O, 2015, EXPERT REV ANTI-INFE, V13, P1, DOI 10.1586/14787210.2015.985656.
   Mohr O, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002939.
   MOSER MR, 1979, AM J EPIDEMIOL, V110, P1.
   Nasir ZA, 2016, ENVIRON SCI POLLUT R, V23, P15757, DOI 10.1007/s11356-016-7064-8.
   Ota M, 2017, EUROSURVEILLANCE, V22, P29, DOI 10.2807/1560-7917.ES.2017.22.12.30492.
   The World Bank Data United Nations World Tourism Organization, 1995, YB TOUR STAT COMP TO.
   Thibeault C, 2012, AVIAT SPACE ENVIR MD, V83, P61, DOI 10.3357/ASEM.3135.2012.
   Turkiye Seyahat Acentalari Birligi Turizm Verileri Istatistikleri, 2014, MILL GOR GEL YAB ZIY.
   United Nations World Tourism Organization, 2016, UNWTO ELIBRARY TURK.
   Zuckerman JN, 2010, TRAVEL MED INFECT DI, V8, P81, DOI 10.1016/j.tmaid.2010.04.001.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Mikrobiyol. Bul.}},
Doc-Delivery-Number = {{GB1UL}},
Unique-ID = {{ISI:000428835600010}},
DA = {{2018-08-13}},
}

@article{ ISI:000426339000002,
Author = {Singla, Rupak and Mallick, Manashree and Mrigpuri, Parul and Singla,
   Neeta and Gupta, Amitesh},
Title = {{Sequelae of pulmonary multidrug-resistant tuberculosis at the completion
   of treatment}},
Journal = {{LUNG INDIA}},
Year = {{2018}},
Volume = {{35}},
Number = {{1}},
Pages = {{4-8}},
Month = {{JAN-FEB}},
Abstract = {{Background: Treatment of multidrug-resistant (MDR-TB) mainly focuses on
   bacteriological cure. However, only limited studies have evaluated the
   sequelae left after the completion of treatment among MDR-TB patients.
   Objective: To assess the persistent symptoms, radiological sequelae,
   pulmonary function impairment and quality of life at the completion of
   treatment among MDR-TB patients. Methods: Forty six MDR-TB patients were
   enrolled, who completed two years of treatment under programmatic
   management of Drug Resistant tuberculosis at a tertiary referral
   institute in Delhi, India. Detailed clinical history was taken. X-ray
   chest, 6 Minute Walk Test and pulmonary function tests were attempted in
   all patients. Quality of life was evaluated using Seattle obstructive
   lung disease questionnaire. Results: At the completion of MDR-TB
   treatment 95.7\% patients had residual symptoms; 100\% patients had
   residual bilateral chest x-ray abnormality with 82.6\% patients showing
   far advanced disease. PFT was abnormal in 97.6\% patients with mixed
   pattern being the commonest abnormality. Quality of Life was impaired
   with mean physical function of 46\%. Conclusion: At the completion of
   MDR-TB treatment, significant numbers of patients are left with post
   treatment sequelae. The medical management and social support for these
   patients should be incorporated in the national programs.}},
Publisher = {{MEDKNOW PUBLICATIONS \& MEDIA PVT LTD}},
Address = {{B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Singla, R (Reprint Author), Natl Inst TB \& Resp Dis, Dept TB \& Resp Dis, New Delhi 110030, India.
   Singla, Rupak; Mallick, Manashree; Mrigpuri, Parul; Gupta, Amitesh, Natl Inst TB \& Resp Dis, Dept TB \& Resp Dis, New Delhi 110030, India.
   Singla, Neeta, Natl Inst TB \& Resp Dis, Dept Epidemiol, New Delhi, India.}},
DOI = {{10.4103/lungindia.lungindia\_269\_16}},
ISSN = {{0970-2113}},
EISSN = {{0974-598X}},
Keywords = {{Multidrug-resistant; sequelae; tuberculosis}},
Keywords-Plus = {{AIR-FLOW OBSTRUCTION; QUALITY-OF-LIFE; LUNG-FUNCTION; RISK-FACTORS;
   DISEASE; THROMBOEMBOLISM; IMPAIRMENT}},
Research-Areas = {{Respiratory System}},
Web-of-Science-Categories  = {{Respiratory System}},
Author-Email = {{drrupaksingla@yahoo.com}},
Cited-References = {{Ambrosetti M, 2006, RESPIRATION, V73, P396, DOI 10.1159/000091188.
   Atif M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-19.
   Bairwa Mohan, 2013, Indian J Community Med, V38, P185, DOI 10.4103/0970-0218.116358.
   BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92.
   Brown J, 2015, INT J INFECT DIS, V32, P68, DOI 10.1016/j.ijid.2014.12.045.
   Byrne AL, 2015, INT J INFECT DIS, V32, P138, DOI 10.1016/j.ijid.2014.12.016.
   Chakaya J, 2016, J CLIN TUBERC OTHER, V3, P10.
   Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111.
   de Valliere S, 2004, INT J TUBERC LUNG D, V8, P767.
   Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545.
   Dhuria Meera, 2008, Indian J Community Med, V33, P58, DOI 10.4103/0970-0218.39249.
   Di Naso FC, 2011, REV PORT PNEUMOL, V17, P216, DOI 10.1016/j.rppneu.2011.06.010.
   Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086.
   Godoy MDP, 2012, RESP CARE, V57, P1949, DOI 10.4187/respcare.01532.
   Guo N, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-14.
   Heit JA, 2002, ARCH INTERN MED, V162, P1245, DOI 10.1001/archinte.162.11.1245.
   Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32.
   Kim HY, 2001, RADIOGRAPHICS, V21, P839, DOI 10.1148/radiographics.21.4.g01jl06839.
   Lam KBH, 2010, CHEST, V137, P593, DOI 10.1378/chest.09-1435.
   Lee JH, 2003, RESP MED, V97, P1237, DOI 10.1016/S0954-6111(03)00255-5.
   Marjani M, 2012, ARCH CLIN INFECT DIS, V7, P56, DOI 10.5812/archcid.13950.
   Medical Research Council Committee on Research into Chronic Bronchitis, 1966, INSTR US QUEST RESP.
   Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507.
   Menon B, 2015, LUNG INDIA, V32, P241, DOI 10.4103/0970-2113.156233.
   Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805.
   Muniyandi M, 2007, INT J TUBERC LUNG D, V11, P887.
   Panda A, 2016, LUNG INDIA, V33, P592, DOI 10.4103/0970-2113.192871.
   Pasipanodya JG, 2007, CHEST, V131, P1817, DOI 10.1378/chest.06-2949.
   Pefura-Yone EW, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005361.
   Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205.
   QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693.
   Ralph AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080302.
   Ramos Lucia Maria Macedo, 2006, J. bras. pneumol., V32, P43, DOI 10.1590/S1806-37132006000100010.
   Singla Neeta, 2009, Indian J Tuberc, V56, P206.
   Sivaranjini S, 2010, Cardiopulm Phys Ther J, V21, P5.
   SNIDER GL, 1971, AM REV RESPIR DIS, V103, P625.
   Tu SP, 1997, CHEST, V112, P614, DOI 10.1378/chest.112.3.614.
   Vecino Mauricio, 2011, J Infect Public Health, V4, P244, DOI 10.1016/j.jiph.2011.08.005.
   WILLCOX PA, 1989, RESP MED, V83, P195, DOI 10.1016/S0954-6111(89)80031-9.
   World Health Organization, 2014, REP TUB EP.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Lung India}},
Doc-Delivery-Number = {{FX8JT}},
Unique-ID = {{ISI:000426339000002}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000417548600029,
Author = {Madsen, Anne Mette and Moslehi-Jenabian, Saloomeh and Islam, Md Zohorul
   and Frankel, Mika and Spilak, Michal and Frederiksen, Margit W.},
Title = {{Concentrations of Staphylococcus species in indoor air as associated
   with other bacteria, season, relative humidity, air change rate, and S.
   aureus-positive occupants}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2018}},
Volume = {{160}},
Pages = {{282-291}},
Month = {{JAN}},
Abstract = {{The aim of this study was to obtain knowledge about concentrations of
   Staphylococcus aureus, MRSA (methicillin-resistant S. aureus), and other
   Staphylococcus species in indoor air in Greater Copenhagen and about
   factors affecting the concentrations. The effects of season,
   temperature, relative humidity, air change rate (ACR), other bacterial
   genera, area per occupant, and presence of S. aureus-positive occupants
   were studied. In samples from 67 living rooms, S. hominis, S. warneri,
   S. epidermidis, and S. capitis were found in 13-25\%; S. saprophyticus,
   S. cohnii, and S. pasteuri in 5-10\%; and S. lugdunensis, S.
   haemolyticus, S. caprae, S. equorum, S. kloosii, S. pettenkoferi, S.
   simulans, and S. xylosus in less than 3\%. Staphylococcus aureus were
   found in two of 67 living rooms: spa type t034 (an MRSA) was recovered
   from a farmhouse, while spa type t509 was found in an urban home. Two
   species, S. equorum and S. kloosii, were found only in the farmhouse.
   Staphylococcus was significantly associated with season with lowest
   concentration and richness in winter. Genera composition was associated
   with ACR with smaller fractions of Staphylococcus at higher ACR, while
   richness was significantly and negatively associated with area per
   occupant. Concentration of Staphylococcus correlated positively with the
   total concentration of bacteria, but negatively with the total
   concentration of other bacteria. The concentration of Staphylococcus was
   not significantly associated with concentrations of the other abundant
   genera Bacillus, Kocuria, and Micrococcus. In offices with S.
   aureus-positive occupants, airborne S. aureus was not found. In
   conclusion, Staphylococcus species constitute a considerable proportion
   of the airborne bacteria in the studied homes and offices. However, both
   S. aureus and MRSA had very low prevalence during all seasons. Thus,
   transmission of S. aureus and MRSA through the air in living rooms in
   Copenhagen is expected to be limited. The negative associations between
   ACR and the fraction Staphylococcus constituted out of total bacteria,
   and between area per occupant and Staphylococcus richness indicate that
   it might be possible to affect the presence of airborne Staphylococcus
   in homes.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Madsen, AM (Reprint Author), Natl Res Ctr Working Environm, Lerso Pk Alle 105, DK-2100 Copenhagen O, Denmark.
   Madsen, Anne Mette; Moslehi-Jenabian, Saloomeh; Frankel, Mika; Frederiksen, Margit W., Natl Res Ctr Working Environm, Lerso Pk Alle 105, DK-2100 Copenhagen O, Denmark.
   Islam, Md Zohorul, Statens Serum Inst, Microbiol \& Infect Control, Artillerivej 5, DK-2300 Copenhagen S, Denmark.
   Spilak, Michal, Aalborg Univ, Danish Bldg Res Inst, Dept Construct \& Hlth, Copenhagen, Denmark.}},
DOI = {{10.1016/j.envres.2017.10.001}},
ISSN = {{0013-9351}},
EISSN = {{1096-0953}},
Keywords = {{CoNS; Indoor air; MALDI-TOF; MRSA; Staphylococcus aureus}},
Keywords-Plus = {{COAGULASE-NEGATIVE STAPHYLOCOCCI; ANTIBIOTIC-RESISTANCE; NASAL CARRIAGE;
   MRSA; EXPOSURE; BIOAEROSOLS; INFECTIONS; ENDOTOXIN; SURVIVAL; DUST}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{amm@nrcwe.dk}},
ORCID-Numbers = {{Islam, Md Zohorul/0000-0002-2015-5195}},
Funding-Acknowledgement = {{Helsefonden {[}16-B-0239]; Torben and Alice Frimodt's Fun; Danish
   Government}},
Funding-Text = {{This study was funded by Helsefonden (16-B-0239), the Torben and Alice
   Frimodt's Fund, and by the Danish Government through a grant to the
   FOR-SOSU program (SATS 2004) at the National Research Centre for the
   Working Environment, Denmark, and The Realdania Foundation.}},
Cited-References = {{Adhikari A, 2010, SCI TOTAL ENVIRON, V408, P5489, DOI 10.1016/j.scitotenv.2010.07.087.
   Amorim ML, 2007, J CLIN MICROBIOL, V45, P2881, DOI 10.1128/JCM.00603-07.
   Aydogdu H, 2010, ENVIRON MONIT ASSESS, V164, P53, DOI 10.1007/s10661-009-0874-0.
   Balasubramanian R, 2012, AEROBIOLOGIA, V28, P375, DOI 10.1007/s10453-011-9242-y.
   Bartlett K. H., 2002, ANN OCCUP HYG, V46, P113.
   Bartlett KH, 2004, ANN OCCUP HYG, V48, P547, DOI 10.1093/annhyg/meh051.
   Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13.
   Bonetta S, 2010, ENVIRON MONIT ASSESS, V161, P473, DOI 10.1007/s10661-009-0761-8.
   Creamer E, 2014, J HOSP INFECT, V86, P201, DOI 10.1016/j.jhin.2013.12.005.
   Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002.
   Davis MF, 2012, LANCET INFECT DIS, V12, P703, DOI 10.1016/S1473-3099(12)70156-1.
   de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027.
   de Sousa MA, 2004, FEMS IMMUNOL MED MIC, V40, P101, DOI 10.1016/S0928-8244(03)00370-5.
   Dietze B, 2001, J HOSP INFECT, V49, P255, DOI 10.1053/jhin.2001.1094.
   Dorado-Garcia A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003272.
   Fox K, 2010, J ENVIRON MONITOR, V12, P917, DOI 10.1039/b925250a.
   Frankel M, 2012, INDOOR AIR, V22, P405, DOI 10.1111/j.1600-0668.2012.00770.x.
   Frankel M, 2012, APPL ENVIRON MICROB, V78, P8289, DOI 10.1128/AEM.02069-12.
   Fredheim EGA, 2015, EUR J CLIN MICROBIOL, V34, P123, DOI 10.1007/s10096-014-2197-5.
   Gandara A, 2006, ENVIRON HEALTH PERSP, V114, P1859, DOI 10.1289/ehp.9585.
   Gilbert MJ, 2012, OCCUP ENVIRON MED, V69, P472, DOI 10.1136/oemed-2011-100069.
   Gorny RL, 1999, ANN AGR ENV MED, V6, P105.
   Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006.
   Gupta AK, 2015, INT J DERMATOL, V54, P1226, DOI 10.1111/ijd.13010.
   Hanninen OO, 2011, FUNDAMENTALS OF MOLD GROWTH IN INDOOR ENVIRONMENTS AND STRATEGIES FOR HEALTHY LIVING, P277.
   Karottki DG, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-116.
   Kim KY, 2007, BUILD ENVIRON, V42, P2188, DOI 10.1016/j.buildenv.2006.04.013.
   KLOOS WE, 1975, APPL MICROBIOL, V30, P381.
   Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505.
   Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4.
   Lai YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139044.
   Larsen J, 2015, EUROSURVEILLANCE, V20, P5, DOI 10.2807/1560-7917.ES.2015.20.37.30021.
   Lee JH, 2006, ENVIRON RES, V101, P11, DOI 10.1016/j.envres.2005.08.009.
   Leekha S, 2012, CLIN MICROBIOL INFEC, V18, P927, DOI 10.1111/j.1469-0691.2012.03955.x.
   Lin JL, 2016, ENVIRON RES, V150, P528, DOI 10.1016/j.envres.2016.06.040.
   Madsen AM, 2016, APPL ENVIRON MICROB, V82, P2479, DOI 10.1128/AEM.04063-15.
   Madsen AM, 2015, ENVIRON RES, V140, P255, DOI 10.1016/j.envres.2015.03.027.
   Madsen AM, 2012, J ENVIRON MONITOR, V14, P3230, DOI 10.1039/c2em30699a.
   Masclaux FG, 2013, ANN OCCUP HYG, V57, P550, DOI 10.1093/annhyg/mes098.
   Mkrtchyan HV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054223.
   Moon KW, 2014, ENVIRON MONIT ASSESS, V186, P2111, DOI 10.1007/s10661-013-3521-8.
   Neely AN, 2000, J CLIN MICROBIOL, V38, P724.
   Oie S, 1996, J HOSP INFECT, V34, P145, DOI 10.1016/S0195-6701(96)90140-1.
   Otter JA, 2010, LANCET INFECT DIS, V10, P227, DOI 10.1016/S1473-3099(10)70053-0.
   Otto M, 2013, BIOESSAYS, V35, P4, DOI 10.1002/bies.201200112.
   Pastuszka JS, 2000, ATMOS ENVIRON, V34, P3833, DOI 10.1016/S1352-2310(99)00527-0.
   Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059.
   Perez HR, 2011, J OCCUP ENVIRON HYG, V8, P80, DOI 10.1080/15459624.2010.515552.
   Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x.
   Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001.
   Rosenstein R, 2013, CURR TOP MICROBIOL, V358, P33, DOI 10.1007/82\_2012\_286.
   SCHABERG DR, 1991, AM J MED, V91, pS72, DOI 10.1016/0002-9343(91)90346-Y.
   Schnellmann C, 2006, J CLIN MICROBIOL, V44, P4444, DOI 10.1128/JCM.00868-06.
   Skow A, 2005, J CLIN MICROBIOL, V43, P2876, DOI 10.1128/JCM.43.6.2876-2880.2005.
   Spilak MP, 2015, BUILD ENVIRON, V93, P64, DOI 10.1016/j.buildenv.2015.03.031.
   Taubel M, 2009, J ALLERGY CLIN IMMUN, V124, P834, DOI 10.1016/j.jaci.2009.07.045.
   Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P1324, DOI 10.1128/AAC.05804-11.
   Thorne PS, 2005, AM J RESP CRIT CARE, V172, P1371, DOI 10.1164/rccm.200505-758OC.
   van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119.
   van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036.
   Wang Z, 2001, J AEROSOL SCI, V32, P661, DOI 10.1016/S0021-8502(00)00108-7.
   Wertheim HFL, 2005, ANTIMICROB AGENTS CH, V49, P1465, DOI 10.1128/AAC.49.4.1465-1467.2005.
   Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924.
   Wos-Oxley ML, 2010, ISME J, V4, P839, DOI 10.1038/ismej.2010.15.
   Xu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041137.}},
Number-of-Cited-References = {{65}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{6}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{FP3WL}},
Unique-ID = {{ISI:000417548600029}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000414881600035,
Author = {Philip, Jeeva M. and Aravind, Usha K. and Aravindakumar, Charuvila T.},
Title = {{Emerging contaminants in Indian environmental matrices - A review}},
Journal = {{CHEMOSPHERE}},
Year = {{2018}},
Volume = {{190}},
Pages = {{307-326}},
Month = {{JAN}},
Abstract = {{The emergence of issues related to environment from ECs is a topic under
   serious discussions worldwide in recent years. Indian scenario is not an
   exception as it is tremendously growing in its rate of production and
   consumption of compounds belongs to ECs categories. However, a
   comprehensive documentation on the occurrence of ECs and consequent ARGs
   as well as their toxic effects on vertebrates on Indian context is still
   lacking. In the present study, an extensive literature survey was
   carried out to get an idea on the geographical distribution of ECs in
   various environmental matrices (water, air, soil, sediment and sludge)
   and biological samples by dividing the entire subcontinent into six
   zones based on climatic, geographical and cultural features. A
   comprehensive assessment of the toxicological effects of ECs and the
   consequent antibiotic resistant genes has been included. It is found
   that studies on the screening of ECs are scarce and concentrated in
   certain geological locations. A total of 166 individual compounds
   belonging to 36 categories have been reported so far. Pharmaceuticals
   and drugs occupy the major share in these compounds followed by PFASs,
   EDCs, PCPs, ASW5 and flame retardants. This review throws light on the
   alarming situation in India where the highest ever reported values of
   concentrations of some of these compounds are from India. This
   necessitates a national level monitoring system for ECs in order to
   assess the magnitude of environmental risks posed by these compounds.
   (C) 2017 Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Aravindakumar, CT (Reprint Author), Mahatma Gandhi Univ, Sch Environm Sci, Kottayam 686560, Kerala, India.
   Aravindakumar, CT (Reprint Author), Mahatma Gandhi Univ, Inter Univ, Instrumentat Ctr, Kottayam 686560, Kerala, India.
   Philip, Jeeva M.; Aravindakumar, Charuvila T., Mahatma Gandhi Univ, Sch Environm Sci, Kottayam 686560, Kerala, India.
   Aravind, Usha K., Mahatma Gandhi Univ, Adv Ctr Environm Studies \& Sustainable Dev, Kottayam 686560, Kerala, India.
   Aravindakumar, Charuvila T., Mahatma Gandhi Univ, Inter Univ, Instrumentat Ctr, Kottayam 686560, Kerala, India.}},
DOI = {{10.1016/j.chemosphere.2017.09.120}},
ISSN = {{0045-6535}},
EISSN = {{1879-1298}},
Keywords = {{Emerging contaminants; Pharmaceuticals; Antibiotic resistance genes;
   Toxicity; India}},
Keywords-Plus = {{PERSONAL CARE PRODUCTS; ANTIBIOTIC-RESISTANCE GENES; SEWAGE-TREATMENT
   PLANTS; WATER TREATMENT PLANTS; PERFLUOROALKYL SUBSTANCES PFASS; TANDEM
   MASS-SPECTROMETRY; SOLID-PHASE EXTRACTION; TRACE-LEVEL DETERMINATION;
   URBAN WASTE-WATER; DRINKING-WATER}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{cta@mgu.ac.in}},
Funding-Acknowledgement = {{DST- INSPIRE program {[}IF140973]}},
Funding-Text = {{We acknowledge the financial support from DST- INSPIRE program
   (IF140973) for the preparation of this critical review.}},
Cited-References = {{Akiba M, 2015, ECOTOX ENVIRON SAFE, V115, P203, DOI 10.1016/j.ecoenv.2015.02.018.
   Alavandi SV, 1999, INDIAN J MED RES, V110, P50.
   Ambili T.R, 2012, ARCH ENV CONTAM TOXI, V64, P494.
   Anumol T, 2016, ENVIRON INT, V92-93, P33, DOI 10.1016/j.envint.2016.03.022.
   Archana G, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5510-1.
   Archer E, 2017, CHEMOSPHERE, V174, P437, DOI {[}10.1016/j.chemosphere.2017.01.1010045-6535, 10.1016/j.chemosphere.2017.01.101].
   Banzhaf S, 2017, AMBIO, V46, P335, DOI 10.1007/s13280-016-0848-8.
   Beijer K, 2013, CHEMOSPHERE, V90, P1149, DOI 10.1016/j.chemosphere.2012.09.023.
   Bengtsson-Palme J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00648.
   Berglund Bjorn, 2015, Infection Ecology \& Epidemiology, V5, P28564, DOI 10.3402/iee.v5.28564.
   Berglund B, 2015, ENVIRON TOXICOL CHEM, V34, P192, DOI 10.1002/etc.2784.
   BIS, 2012, IND STAND DRINK WAT.
   BISARYA SC, 1993, RES IND, V38, P170.
   Blair BD, 2013, CHEMOSPHERE, V93, P2116, DOI 10.1016/j.chemosphere.2013.07.057.
   Bo LL, 2015, J ENVIRON CHEM ENG, V3, P2203, DOI 10.1016/j.jece.2015.08.001.
   Borkar RM, 2012, BIOMED CHROMATOGR, V26, P720, DOI 10.1002/bmc.1721.
   Buerge IJ, 2003, ENVIRON SCI TECHNOL, V37, P691, DOI 10.1021/es02015z.
   Cardoso O, 2014, CHEMOSPHERE, V115, P20, DOI 10.1016/j.chemosphere.2014.02.004.
   Carlsson G, 2009, ENVIRON TOXICOL CHEM, V28, P2656, DOI 10.1897/08-524.1.
   Carvalho ARM, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4374-0.
   CCI, 2015, BRIEF REP PHARM IND, P1.
   Chen H, 2017, ENVIRON POLLUT, V221, P234, DOI 10.1016/j.envpol.2016.11.070.
   Chitanand MP, 2010, INDIAN J MICROBIOL, V50, P216, DOI 10.1007/s12088-010-0042-9.
   Choi K, 2008, SCI TOTAL ENVIRON, V405, P120, DOI 10.1016/j.scitotenv.2008.06.038.
   Corsolini S, 2012, MAR POLLUT BULL, V64, P2829, DOI 10.1016/j.marpolbul.2012.09.019.
   Coutinho F.H., 2013, PERSPECTIVES WATER P, P114.
   Cowell Whitney J., 2017, Emerging Contaminants, V3, P32, DOI 10.1016/j.emcon.2017.01.001.
   CPCB, 2016, IND SPEC STAND EFFL.
   CSE, 2016, QUEST RAIS LOK SABH.
   Czekalski N, 2014, ISME J, V8, P1381, DOI 10.1038/ismej.2014.8.
   Das MT, 2014, ENVIRON POLLUT, V189, P118, DOI 10.1016/j.envpol.2014.02.021.
   Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10.
   Diwan V, 2009, CURR SCI, V97, P1752.
   Diwan V, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-414.
   DoD, 2009, EM CONT ECS.
   Fatta-Kassinos D, 2013, ENVIRON SCI POLLUT R, V20, P3493, DOI 10.1007/s11356-013-1699-5.
   Feitosa-Felizzola J, 2007, J CHROMATOGR A, V1164, P95, DOI 10.1016/j.chroma.2007.06.071.
   Fick J, 2009, ENVIRON TOXICOL CHEM, V28, P2522, DOI 10.1897/09-073.1.
   Fuertes I, 2017, CHEMOSPHERE, V168, P399, DOI 10.1016/j.chemosphere.2016.10.072.
   Gani KM, 2016, ENVIRON SCI-PROC IMP, V18, P406, DOI {[}10.1039/C5EM00583C, 10.1039/c5em00583c].
   Ghafur A, 2013, INDIAN J CANCER, V50, P71, DOI 10.4103/0019-509X.104065.
   Ghafur A, 2014, INDIAN J MED MICROBI, V32, P221, DOI 10.4103/0255-0857.129053.
   Giger W, 2003, CHIMIA, V57, P485, DOI 10.2533/000942903777679064.
   Glassmeyer ST, 2017, SCI TOTAL ENVIRON, V581, P909, DOI 10.1016/j.scitotenv.2016.12.004.
   Gobel A, 2004, ANAL CHEM, V76, P4756, DOI 10.1021/ac0496603.
   Gothwal R., 2016, J HAZARD TOXIC RADIO, V1-8.
   Green RE, 2004, J APPL ECOL, V41, P793, DOI 10.1111/j.0021-8901.2004.00954.x.
   Gros M, 2008, J CHROMATOGR A, V1189, P374, DOI 10.1016/j.chroma.2007.10.052.
   Gros M, 2006, TALANTA, V70, P678, DOI 10.1016/j.talanta.2006.05.024.
   Gros M, 2017, J HAZARD MATER, V328, P37, DOI 10.1016/j.jhazmat.2016.12.055.
   Guedes-Alonso R, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-24.
   Gunnarsson L, 2009, ENVIRON TOXICOL CHEM, V28, P2639, DOI 10.1897/09-120.1.
   HIGNITE C, 1977, LIFE SCI, V20, P337, DOI 10.1016/0024-3205(77)90329-0.
   IBEF, 2017, PHARM IND BRAND EQ F, P1.
   Igbinosa E. O., 2015, BATTLE MICROBIAL PAT, V2, P858.
   Jindal K, 2015, J PHARMACEUT BIOMED, V108, P86, DOI 10.1016/j.jpba.2015.02.003.
   Johnning A, 2013, APPL ENVIRON MICROB, V79, P7256, DOI 10.1128/AEM.02141-13.
   Kalotra A., 2014, J DRUG DELIV THER, V4, P64.
   Kamaraj M., 2013, Advances in Bio Research, V4, P59.
   Kannan K, 2004, ENVIRON SCI TECHNOL, V38, P4489, DOI 10.1021/es0493446.
   Kapil A, 2013, INDIAN J MED MICROBI, V31, P111, DOI 10.4103/0255-0857.115212.
   Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038.
   Kulkarni P, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060668.
   Kumar S.G., 2014, J NAT SCI BIOL MED, V4, P286.
   Kurunthachalam S.K., 2012, J WASTE WATER TREAT, V3.
   Kwok KY, 2010, ENVIRON SCI TECHNOL, V44, P7043, DOI 10.1021/es101170c.
   Lai Webber Wei-Po, 2016, Emerging Contaminants, V2, P135, DOI 10.1016/j.emcon.2016.05.001.
   Larsson DGJ, 2007, J HAZARD MATER, V148, P751, DOI 10.1016/j.jhazmat.2007.07.008.
   Larsson DGJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0571.
   Larsson DGJ, 2009, REGUL TOXICOL PHARM, V53, P161, DOI 10.1016/j.yrtph.2009.01.008.
   Lata P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-140.
   Laxminarayan R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001974.
   Li JA, 2015, ENVIRON SCI POLLUT R, V22, P4587, DOI 10.1007/s11356-014-3665-2.
   Li J, 2011, ENVIRON SCI TECHNOL, V45, P7241, DOI 10.1021/es201739t.
   Lorenzo M, 2016, SCI TOTAL ENVIRON, V540, P191, DOI 10.1016/j.scitotenv.2015.07.045.
   Lubick N, 2009, NATURE, V457, P640, DOI 10.1038/457640a.
   Lubbert C, 2017, INFECTION, V45, P479, DOI 10.1007/s15010-017-1007-2.
   Martinez JL, 2009, ENVIRON POLLUT, V157, P2893, DOI 10.1016/j.envpol.2009.05.051.
   Malarvizhi Annamalai, 2012, Journal of King Saud University Science, V24, P179, DOI 10.1016/j.jksus.2011.01.001.
   Maloo A., 2014, INDIA ENV EXP BIOL, V12, P43.
   Mandal SM, 2015, AM J INFECT CONTROL, V43, pE87, DOI 10.1016/j.ajic.2015.08.015.
   Mandal Shyamapada, 2011, OPEN ANTIMICROBIAL A, V3, P45, DOI DOI 10.2174/1876518101103010045.
   Manjusha S., 2005, American Journal of Biochemistry and Biotechnology, V1, P201.
   Mapsoflndia.com, 2015, ZON MAP IND.
   Marathe NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077310.
   Marti E, 2014, TRENDS MICROBIOL, V22, P36, DOI 10.1016/j.tim.2013.11.001.
   McArdell CS, 2003, ENVIRON SCI TECHNOL, V37, P5479, DOI 10.1021/es034368i.
   McEachran AD, 2015, ENVIRON HEALTH PERSP, V123, P337, DOI 10.1289/ehp.1408555.
   McGrath Thomas J., 2017, Emerging Contaminants, V3, P23, DOI 10.1016/j.emcon.2017.01.002.
   Mohapatra S, 2016, CHEMOSPHERE, V159, P526, DOI 10.1016/j.chemosphere.2016.06.047.
   MoHFW, 2017, NAT ACT PLAN ANT RES, P1.
   Murakami M, 2011, ARCH ENVIRON CON TOX, V61, P631, DOI 10.1007/s00244-011-9660-4.
   Mutiyar P.K., 2012, NONSTEROID ANTIINFLA.
   Mutiyar P.K., 2012, CONTAMINANTS EMERGIN.
   Mutiyar PK, 2014, ENVIRON SCI POLLUT R, V21, P7723, DOI 10.1007/s11356-014-2702-5.
   Mutiyar PK, 2014, ENVIRON MONIT ASSESS, V186, P541, DOI 10.1007/s10661-013-3398-6.
   Mutiyar PK, 2013, DESALIN WATER TREAT, V51, P6158, DOI 10.1080/19443994.2013.770199.
   Nguyen MA, 2017, ENVIRON POLLUT, V220, P1438, DOI 10.1016/j.envpol.2016.10.089.
   Nielsen E., 2000, TOXICOLOGICAL EVALUA, P1.
   NPPA, 2007, DIR NAT PHARM MAN UN, P1.
   Oberle K, 2012, ENVIRON SCI TECHNOL, V46, P1859, DOI 10.1021/es203399h.
   Padhye LP, 2014, WATER RES, V51, P266, DOI 10.1016/j.watres.2013.10.070.
   Pan CG, 2016, WATER RES, V106, P562, DOI 10.1016/j.watres.2016.10.045.
   Panda SK, 2012, ENVIRON MONIT ASSESS, V184, P193, DOI 10.1007/s10661-011-1958-1.
   PATHAK SP, 1993, J ENVIRON SCI HEAL A, VA28, P73, DOI 10.1080/10934529309375863.
   Patoli AA, 2010, GOMAL J MED SCI, V8, P23.
   Pedrouzo M, 2011, WATER AIR SOIL POLL, V217, P267, DOI 10.1007/s11270-010-0585-8.
   Pedrouzo M, 2009, TALANTA, V78, P1327, DOI 10.1016/j.talanta.2009.02.005.
   Petrie B, 2015, WATER RES, V72, P3, DOI 10.1016/j.watres.2014.08.053.
   Petrovic M, 2003, TRAC-TREND ANAL CHEM, V22, P685, DOI 10.1016/S0165-9936(03)01105-1.
   Phillips PJ, 2010, ENVIRON SCI TECHNOL, V44, P4910, DOI 10.1021/es100356f.
   PIB, 2015, ANT POL.
   Pitarch E, 2010, ANAL BIOANAL CHEM, V397, P2763, DOI 10.1007/s00216-010-3692-x.
   Planning Commission, 2014, DRUGS AND PHARM, P1.
   Poonia Shubra, 2014, Indian J Community Med, V39, P156, DOI 10.4103/0970-0218.137152.
   Prabhasankar VP, 2016, ENVIRON SCI POLLUT R, V23, P8679, DOI 10.1007/s11356-015-5968-3.
   Prakash V, 2003, BIOL CONSERV, V109, P381, DOI 10.1016/S0006-3207(02)00164-7.
   PRAKASH V, 2007, J BOMBAY NAT HIST SO, V104, P129.
   Prakash Vibhu, 1999, Journal of the Bombay Natural History Society, V96, P365.
   Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es0604131.
   Pruden A, 2013, ENVIRON HEALTH PERSP, V121, P878, DOI 10.1289/ehp.1206446.
   Pugajeva I, 2017, J PHARMACEUT BIOMED, V133, P64, DOI 10.1016/j.jpba.2016.11.008.
   Ram S, 2008, J APPL MICROBIOL, V105, P1899, DOI 10.1111/j.1365-2672.2008.03879.x.
   Ram S, 2005, B ENVIRON CONTAM TOX, V75, P623, DOI 10.1007/s00128-005-0798-5.
   Ram S, 2008, ENVIRON HEALTH PERSP, V116, P448, DOI 10.1289/ehp.10809.
   Ram S, 2007, ENVIRON SCI TECHNOL, V41, P7383, DOI 10.1021/es0712266.
   Ramaswamy BR, 2011, J HAZARD MATER, V186, P1586, DOI 10.1016/j.jhazmat.2010.12.037.
   Rao RN, 2008, J CHROMATOGR A, V1187, P151, DOI 10.1016/j.chroma.2008.02.021.
   Rayaroth MP, 2015, CLEAN-SOIL AIR WATER, V43, P1338, DOI 10.1002/clen.201400508.
   Reinholds I, 2017, WATER SCI TECHNOL, V75, P387, DOI 10.2166/wst.2016.528.
   Risebrough R, 2004, NATURE, V427, P596, DOI 10.1038/nature02365.
   Risebrough Robert W., 2004, P197.
   Ritesh J, 2012, IJEP, V2, P28.
   Rodayan A, 2016, ENVIRON TOXICOL CHEM, V35, P843, DOI 10.1002/etc.3085.
   RUBAN P, 2011, ENVIRON EXP BIOL, V9, P133.
   Rutgersson C, 2014, ENVIRON SCI TECHNOL, V48, P7825, DOI 10.1021/es501452a.
   Rutgersson C, 2013, ENVIRON TOXICOL CHEM, V32, P577, DOI 10.1002/etc.2105.
   Sahoo KC, 2012, INT J ENV RES PUB HE, V9, P746, DOI 10.3390/ijerph9030746.
   Sanderson H, 2016, ENVIRON REV, V24, P205, DOI 10.1139/er-2015-0069.
   Saptadeepa Roy, 2011, International Journal of ChemTech Research, V3, P1840.
   Saravanan M, 2013, CHEMOSPHERE, V93, P388, DOI 10.1016/j.chemosphere.2013.05.015.
   Saravanan M, 2014, ENVIRON TOXICOL PHAR, V38, P948, DOI 10.1016/j.etap.2014.10.013.
   Saravanan M, 2011, J HAZARD MATER, V195, P188, DOI 10.1016/j.jhazmat.2011.08.029.
   Sauve S, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-15.
   Selvaraj KK, 2015, ENVIRON GEOCHEM HLTH, V37, P83, DOI 10.1007/s10653-014-9632-5.
   Selvaraj KK, 2014, ECOTOX ENVIRON SAFE, V99, P13, DOI 10.1016/j.ecoenv.2013.09.006.
   Sengupta N, 2011, INFECT GENET EVOL, V11, P64, DOI 10.1016/j.meegid.2010.10.009.
   Shanmugam G, 2014, ENVIRON FORENSICS, V15, P207, DOI 10.1080/15275922.2014.930940.
   Shanmugam G, 2014, ENVIRON SCI POLLUT R, V21, P921, DOI 10.1007/s11356-013-1957-6.
   Shao MH, 2016, ENVIRON POLLUT, V216, P675, DOI 10.1016/j.envpol.2016.06.031.
   Sharma A., 2007, ASIAN J EXP SCI, V21, P435.
   Sharma BM, 2016, ENVIRON POLLUT, V208, P704, DOI 10.1016/j.envpol.2015.10.050.
   Singh KP, 2014, ENVIRON MONIT ASSESS, V186, P6663, DOI 10.1007/s10661-014-3881-8.
   Singh N.V., 2011, ASIAN J EXP BIOL SCI, V2, P697.
   Sneha KG, 2016, REG STUD MAR SCI, V3, P242, DOI 10.1016/j.rsma.2015.11.004.
   Srivastava A, 2010, ENVIRON MONIT ASSESS, V169, P397, DOI 10.1007/s10661-009-1182-4.
   Srivastava R.K., 2011, NATL POLICY CONTAINM, P1.
   Stackelberg PE, 2004, SCI TOTAL ENVIRON, V329, P99, DOI 10.1016/j.scitotenv.2004.03.015.
   Subedi B, 2017, CHEMOSPHERE, V167, P429, DOI 10.1016/j.chemosphere.2016.10.026.
   Subedi B, 2015, J ENVIRON CHEM ENG, V3, P2882, DOI 10.1016/j.jece.2015.09.031.
   Sunantha G, 2016, MAR POLLUT BULL, V109, P612, DOI 10.1016/j.marpolbul.2016.05.023.
   Suter MJF, 2000, CHIMIA, V54, P13.
   Taggart MA, 2009, ENVIRON SCI TECHNOL, V43, P4561, DOI 10.1021/es9002026.
   Tanner WD, 2015, SYST APPL MICROBIOL, V38, P351, DOI 10.1016/j.syapm.2015.03.010.
   Ur Rehman MS, 2015, CHEMOSPHERE, V138, P1045, DOI 10.1016/j.chemosphere.2013.02.036.
   USEPA, 2014, EXT PEER REV DRAFT A, P1.
   USGS, 2017, CONT EM CONC ENV.
   Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7.
   Venkatesh P., 2013, Journal of Pharmacy Research, V6, P48.
   Vignesh S, 2012, MAR POLLUT BULL, V64, P790, DOI 10.1016/j.marpolbul.2012.01.015.
   Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7.
   Watanabe MX, 2010, ENVIRON TOXICOL CHEM, V29, P1551, DOI 10.1002/etc.189.
   Westerhoff P, 2005, ENVIRON SCI TECHNOL, V39, P6649, DOI 10.1021/es0484799.
   Westhof Lena, 2016, Emerging Contaminants, V2, P178, DOI 10.1016/j.emcon.2016.10.001.
   Willhite CC, 2008, J TOXICOL ENV HEAL B, V11, P69, DOI 10.1080/10937400701724303.
   Yan Q, 2014, SCI TOTAL ENVIRON, V470, P618, DOI 10.1016/j.scitotenv.2013.09.032.
   Yang YY, 2017, SCI TOTAL ENVIRON, V590, P611, DOI 10.1016/j.scitotenv.2017.03.001.
   Yeung LWY, 2009, CHEMOSPHERE, V76, P55, DOI 10.1016/j.chemosphere.2009.02.055.
   Yin Q, 2013, MICROBES ENVIRON, V28, P479, DOI 10.1264/jsme2.ME13098.}},
Number-of-Cited-References = {{179}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{43}},
Usage-Count-Since-2013 = {{78}},
Journal-ISO = {{Chemosphere}},
Doc-Delivery-Number = {{FM3CJ}},
Unique-ID = {{ISI:000414881600035}},
DA = {{2018-08-13}},
}

@article{ ISI:000419146000002,
Author = {Kapesa, Anthony and Kweka, Eliningaya J. and Atieli, Harrysone and
   Kamugisha, Erasmus and Zhou, Guofa and Githeko, Andrew K. and Yan,
   Guiyun},
Title = {{Why some sites are responding better to anti-malarial interventions? A
   case study from western Kenya}},
Journal = {{MALARIA JOURNAL}},
Year = {{2017}},
Volume = {{16}},
Month = {{DEC 29}},
Abstract = {{Background: In sub-Saharan Africa, malaria interventions over the last
   decades have been successful in reducing both mortality and morbidity.
   In western Kenya however some areas experience contrasting outcomes of
   the ongoing interventions while the causes for this observation remains
   not yet clearly known.
   Methods: The WHO insecticide (deltamethrin) susceptibility test of the
   common malaria vectors was studied. Multiple surveys on household use
   and hospital prescriptions of antimalarial drugs from 2003 to 2015 were
   done. Along with this, cross sectional surveys on their availability in
   the local drug dispensing outlets were also done in 2015. Monthly
   precipitations and air temperature data was collected along with
   systematic review on abundance and composition of common malaria vectors
   in the study area before and during interventions. The above factors
   were used to explain the possible causes of contrasting outcome of
   malaria interventions between the three study sites.
   Results: Areas with malaria resurgence or sustained high transmission
   (Kombewa and Marani) showed higher composition of Anopheles funestus
   sensu lato (s.l.) than the previously abundant Anopheles gambiae sensu
   stricto (s.s.) and the later had higher composition to an area with a
   sustained infection decline (Iguhu). Anopheles gambiae s.l. from Kombewa
   showed highest resistance (50\% mortality) upon exposure to WHO
   deltamethrin discriminating dosage of 0.75\% while those from Marani and
   Iguhu had reduced resistance status (both had a mean mortality of 91\%).
   Sampled An. funestus s.l. from Marani were also highly resistant to
   deltamethrin as 57\% of the exposed vectors survived. An increasing of
   mean air temperature by 2 degrees C was noted for Marani and Iguhu from
   2013 to 2015 and was accompanied by an increased rainfall at Marani.
   Community drug use and availability in selling outlets along with
   prescription in hospitals were not linked to the struggling control of
   the disease.
   Conclusions: The malaria vector species composition shift, insecticide
   resistance and climatic warming were the likely cause of the contrasting
   outcome of malaria intervention in western Kenya. Surveillance of
   malaria parasite and vector dynamics along with insecticide resistance
   and vector biting behaviour monitoring are highly recommended in these
   areas.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Yan, GY (Reprint Author), Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92697 USA.
   Kapesa, Anthony; Atieli, Harrysone; Githeko, Andrew K., Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Climate \& Hlth Lab, POB 1578, Kisumu, Kenya.
   Kapesa, Anthony; Kweka, Eliningaya J.; Kamugisha, Erasmus, Catholic Univ Hlth \& Allied Sci, POB 1464, Mwanza, Tanzania.
   Kweka, Eliningaya J., Trop Pesticides Res Inst, Div Livestock \& Human Hlth Dis Vector, POB 3024, Arusha, Tanzania.
   Zhou, Guofa; Yan, Guiyun, Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92697 USA.}},
DOI = {{10.1186/s12936-017-2145-9}},
Article-Number = {{498}},
ISSN = {{1475-2875}},
Keywords = {{Malaria intervention; Species shift; Climate variability; Insecticide
   resistance; Western Kenya}},
Keywords-Plus = {{EAST-AFRICAN HIGHLANDS; PLASMODIUM-FALCIPARUM; POPULATION-DYNAMICS;
   ANOPHELES-FUNESTUS; DRUG-RESISTANCE; MALARIA VECTORS; NETS;
   SURVEILLANCE; COMMUNITY; MOSQUITOS}},
Research-Areas = {{Infectious Diseases; Parasitology; Tropical Medicine}},
Web-of-Science-Categories  = {{Infectious Diseases; Parasitology; Tropical Medicine}},
Author-Email = {{guiyuny@uci.edu}},
Funding-Acknowledgement = {{National Institute of Health {[}RO1 AI050243, U19 AI129326, D43
   TW001505]}},
Funding-Text = {{Authors are grateful to everybody who participated in this study in the
   households for their time and patience. We also acknowledge the Kombewa,
   Iguhu and Marani Hospital administrations and for the kind support
   during data collection. We also appreciate the contribution of all field
   assistants throughout the time of data collection. This study was
   supported by grants from the National Institute of Health (RO1 AI050243,
   U19 AI129326 and D43 TW001505).}},
Cited-References = {{Afrane YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054305.
   Afrane YA, 2012, ANN NY ACAD SCI, V1249, P204, DOI 10.1111/j.1749-6632.2011.06432.x.
   Bayoh MN, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-380.
   Beck-Johnson LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079276.
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535.
   Centre for disease control (CDC) Department of state health and human service, 2016, PRES MAL IN KEN MAL.
   Centre for Disease Control (CDC) USAID Department of Health and Human Service, 2016, DEC PROGR PRES MAL I.
   Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122.
   Cooke MK, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0766-4.
   Gimnig JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145282.
   Himeidan YE, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00315.
   Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435.
   Juma DW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-250.
   Juma EA, 2008, MALARIA J, V7, P190.
   Koenraadt CJM, 2006, TROP MED INT HEALTH, V11, P1195, DOI 10.1111/j.1365-3156.2006.01675.x.
   Kweka EJ, 2013, ACTA TROP, V128, P158, DOI 10.1016/j.actatropica.2013.06.006.
   Kweka EJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-110.
   Larsen DA, 2014, AM J TROP MED HYG, V91, P950, DOI 10.4269/ajtmh.14-0318.
   Lucchi NW, 2015, ANTIMICROB AGENTS CH, V59, P7540, DOI 10.1128/AAC.01894-15.
   Lwetoijera DW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-331.
   McCann RS, 2014, AM J TROP MED HYG, V90, P597, DOI 10.4269/ajtmh.13-0614.
   Mends-Brew E, 2016, SCI J APPL MATH STAT, V4, P12.
   Ministry of Health, 2011, 2010 MAL IND SURV.
   Ministry of Health, 2006, NAT MAL TREATM GUID.
   Minstry of Health, 2014, KEN MAL MON EV PLAN.
   Mulamba C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110058.
   Mulamba C, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-71.
   Mzilahowa T, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1610-1.
   National Malaria Control Programme (NMCP) Kenya National Beural of Statistics (KNBS) ICF International, 2016, KEN MAL IND SURV 201.
   Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043{[}0200:PDOMVI]2.0.CO;2.
   Ngalah BS, 2015, SCI REP, V5, P8306.
   Odhiambo F, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2018-2.
   Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226.
   Okombo J, 2014, INT J PARASITOL-DRUG, V4, P152, DOI 10.1016/j.ijpddr.2014.07.003.
   Olanga EA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0860-z.
   Omukunda E, 2013, J VECTOR DIS, V50, P85.
   Ototo EN, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0763-7.
   Roca-Feltrer A, 2012, EMERG INFECT DIS, V18, P272, DOI {[}10.3201/eid1802.111108, 10.3201/eid1802.111008].
   Shah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026746.
   Stevenson JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077641.
   Teklehaimanot A, 2008, ANN NY ACAD SCI, V1136, P32, DOI 10.1196/annals.1425.037.
   Trape JF, 2014, LANCET INFECT DIS, V14, P476, DOI 10.1016/S1473-3099(14)70712-1.
   Wamae PM, 2015, ACTA TROP, V150, P136, DOI 10.1016/j.actatropica.2015.07.008.
   Wanjala CL, 2015, EMERG INFECT DIS, V21, P2178, DOI 10.3201/eid2112.150814.
   WHO, 2017, WORLD MAL REP 2016.
   WHO, 2013, TEST PROC INREMO.
   Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100.
   Zhou G, 2011, PLOS ONE, V6, P20318, DOI DOI 10.1371/J0URNAL.P0NE.0020318.
   Zhou GF, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00153.
   Zhou GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-351.}},
Number-of-Cited-References = {{50}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Malar. J.}},
Doc-Delivery-Number = {{FR5ZV}},
Unique-ID = {{ISI:000419146000002}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000418832800007,
Author = {Huang, Kai-Yao and Chang, Tzu-Hao and Jhong, Jhih-Hua and Chi, Yu-Hsiang
   and Li, Wen-Chi and Chan, Chien-Lung and Lai, K. Robert and Lee,
   Tzong-Yi},
Title = {{Identification of natural antimicrobial peptides from bacteria through
   metagenomic and metatranscriptomic analysis of high-throughput
   transcriptome data of Taiwanese oolong teas}},
Journal = {{BMC SYSTEMS BIOLOGY}},
Year = {{2017}},
Volume = {{11}},
Number = {{7}},
Month = {{DEC 21}},
Note = {{16th International Conference on Bioinformatics (InCoB) - Systems
   Biology, Shenzhen, PEOPLES R CHINA, SEP 20-22, 2017}},
Abstract = {{Background: Anti-microbial peptides (AMPs), naturally encoded by genes
   and generally containing 12-100 amino acids, are crucial components of
   the innate immune system and can protect the host from various
   pathogenic bacteria and viruses. In recent years, the widespread use of
   antibiotics has resulted in the rapid growth of antibiotic-resistant
   microorganisms that often induce critical infection and pathogenesis.
   Recently, the advent of high-throughput technologies has led molecular
   biology into a data surge in both the amount and scope of data. For
   instance, next-generation sequencing technology has been applied to
   generate large-scale sequencing reads from foods, water, soil, air, and
   specimens to identify microbiota and their functions based on
   metagenomics and metatranscriptomics, respectively. In addition, oolong
   tea is partially fermented and is the most widely produced tea in
   Taiwan. Many studies have shown the benefits of oolong tea in inhibiting
   obesity, reducing dental plaque deposition, antagonizing allergic immune
   responses, and alleviating the effects of aging. However, the microbes
   and their functions present in oolong tea remain unknown.
   Results: To understand the relationship between Taiwanese oolong teas
   and bacterial communities, we designed a novel bioinformatics scheme to
   identify AMPs and their functional types based on metagenomics and
   metatranscriptomic analysis of high-throughput transcriptome data. Four
   types of oolong teas (Dayuling tea, Alishan tea, Jinxuan tea, and
   Oriental Beauty tea) were subjected to 16S ribosomal DNA and total RNA
   extraction and sequencing. Metagenomics analysis results revealed that
   Oriental Beauty tea exhibited greater bacterial diversity than other
   teas. The most common bacterial families across all tea types were
   Bacteroidaceae (21.7\%), Veillonellaceae (22\%), and Fusobacteriaceae
   (12.3\%). Metatranscriptomics analysis results revealed that the
   dominant bacteria species across all tea types were Escherichia coli,
   Bacillus subtilis, and Chryseobacterium sp. StRB126, which were
   subjected to further functional analysis. A total of 8194 (6.5\%),
   26,220 (6.1\%), 5703 (5.8\%), and 106,183 (7.8\%) reads could be mapped
   to AMPs.
   Conclusion: We found that the distribution of anti-gram-positive and
   anti-gram-negative AMPs is highly correlated with the distribution of
   gram-positive and gram-negative bacteria in Taiwanese oolong tea
   samples.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Lee, TY (Reprint Author), Yuan Ze Univ, Dept Comp Sci \& Engn, Taoyuan 320, Taiwan.
   Lee, TY (Reprint Author), Yuan Ze Univ, Innovat Ctr Big Data \& Digital Convergence, Taoyuan 320, Taiwan.
   Huang, Kai-Yao; Jhong, Jhih-Hua; Chi, Yu-Hsiang; Li, Wen-Chi; Lai, K. Robert; Lee, Tzong-Yi, Yuan Ze Univ, Dept Comp Sci \& Engn, Taoyuan 320, Taiwan.
   Huang, Kai-Yao, Hsinchu Mackay Mem Hosp, Dept Med Res, Hsinchu 300, Taiwan.
   Chang, Tzu-Hao, Taipei Med Univ, Grad Inst Biomed Informat, Taipei 110, Taiwan.
   Chan, Chien-Lung, Yuan Ze Univ, Dept Informat Management, Taoyuan 320, Taiwan.
   Chan, Chien-Lung; Lai, K. Robert; Lee, Tzong-Yi, Yuan Ze Univ, Innovat Ctr Big Data \& Digital Convergence, Taoyuan 320, Taiwan.}},
DOI = {{10.1186/s12918-017-0503-4}},
Article-Number = {{131}},
ISSN = {{1752-0509}},
Keywords = {{Antimicrobial peptide; Amp; Next-generation sequencing; Metagenomics;
   Metatranscriptomics; Oolong teas}},
Keywords-Plus = {{HUMAN GUT MICROBIOME; GENE-EXPRESSION; MANUFACTURING PROCESS; PUER TEA;
   RNA-SEQ; FERMENTATION; POLYPHENOLS; SEQUENCES; DISEASE; TOOL}},
Research-Areas = {{Mathematical \& Computational Biology}},
Web-of-Science-Categories  = {{Mathematical \& Computational Biology}},
Author-Email = {{francis@saturn.yzu.edu.tw}},
Funding-Acknowledgement = {{Ministry of Science and Technology (MOST) of Taiwan
   {[}MOST106-2221-E-155-063]}},
Funding-Text = {{Publication charge for this work was funded by the Ministry of Science
   and Technology (MOST) of Taiwan under contract number of
   MOST106-2221-E-155-063 to TYL.}},
Cited-References = {{Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944.
   Cho JY, 2007, BIOSCI BIOTECH BIOCH, V71, P1476, DOI 10.1271/bbb.60708.
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107.
   De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5.
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI {[}10.1038/nmeth.2604, 10.1038/NMETH.2604].
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863.
   Gordon A., 2010, AGJH FASTX TOOLKIT F.
   Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084.
   Han LK, 1999, INT J OBESITY, V23, P98, DOI 10.1038/sj.ijo.0800766.
   Hsieh F. C, 2003, Plant Protection Bulletin (Taichung), V45, P155.
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211.
   Jung JY, 2013, INT J FOOD MICROBIOL, V163, P171, DOI 10.1016/j.ijfoodmicro.2013.02.022.
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882.
   Keegan KP, 2016, METHODS MOL BIOL, V1399, P207, DOI 10.1007/978-1-4939-3369-3\_13.
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111.
   Kuczynski J, 2011, CURR PROTOC BIOINFOR.
   La Ragione RM, 2003, VET MICROBIOL, V94, P245, DOI 10.1016/S0378-1135(03)00077-4.
   Langmead B, 2012, NAT METHODS, V9, P357, DOI {[}10.1038/NMETH.1923, 10.1038/nmeth.1923].
   Lee HT, 2015, BIOMED RES INT, DOI 10.1155/2015/475062.
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/nature4441022a.
   Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323.
   Lyu CY, 2013, J SCI FOOD AGR, V93, P3165, DOI 10.1002/jsfa.6149.
   Marchandin H, 2004, ANTIMICROB AGENTS CH, V48, P3207, DOI 10.1128/AAC.48.8.3207-3208.2004.
   Marchetti A, 2012, P NATL ACAD SCI USA, V109, pE317, DOI 10.1073/pnas.1118408109.
   Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108.
   Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59.
   Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052.
   Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050.
   Mitra S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S21.
   Negishi H, 2004, J NUTR, V134, P38.
   OHMORI Y, 1995, BIOL PHARM BULL, V18, P683.
   OOSHIMA T, 1994, CARIES RES, V28, P146, DOI 10.1159/000261636.
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821.
   Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069.
   Shannon CE, 1997, M D COMPUT, V14, P306.
   Sutcliffe IC, 2010, TRENDS MICROBIOL, V18, P464, DOI 10.1016/j.tim.2010.06.005.
   Taguri T, 2004, BIOL PHARM BULL, V27, P1965, DOI 10.1248/bpb.27.1965.
   Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33.
   Waghu FH, 2016, NUCLEIC ACIDS RES, V44, pD1094, DOI 10.1093/nar/gkv1051.
   Wan MLY, 2016, MOL NUTR FOOD RES, V60, P1048, DOI 10.1002/mnfr.201500992.
   Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278.
   Wen Q, 1991, J TEA SCI, V11, P10.
   Xu X, 2005, ENG LIFE SCI, V5, P382, DOI 10.1002/elsc.200520083.
   Yamamoto T., 1997, CHEM APPL GREEN TEA.
   Zhang GL, 2000, VET RES, V31, P277, DOI 10.1051/vetres:2000121.
   Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557.
   Zhou HongJie, 2004, Journal of Tea Science, V24, P212.
   Zhu QY, 2002, J AGR FOOD CHEM, V50, P6929, DOI 10.1021/jf0206163.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{12}},
Usage-Count-Since-2013 = {{13}},
Journal-ISO = {{BMC Syst. Biol.}},
Doc-Delivery-Number = {{FR1MZ}},
Unique-ID = {{ISI:000418832800007}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000418625900025,
Author = {Burch, Tucker R. and Sadowsky, Michael J. and LaPara, Timothy M.},
Title = {{Effect of Different Treatment Technologies on the Fate of Antibiotic
   Resistance Genes and Class 1 Integrons when Residual Municipal
   Wastewater Solids are Applied to Soil}},
Journal = {{ENVIRONMENTAL SCIENCE \& TECHNOLOGY}},
Year = {{2017}},
Volume = {{51}},
Number = {{24}},
Pages = {{14225-14232}},
Month = {{DEC 19}},
Abstract = {{Residual wastewater solids are a significant reservoir of antibiotic
   resistance genes (ARGs). While treatment technologies can reduce ARG
   level's in residual wastewater solids, the effects of these technologies
   on ARGs in soil during subsequent land-application are unknown. In this
   study we investigated the use of numerous treatment technologies (air
   drying, aerobic digestion; mesophilic anaerobic digestion, thermophilic
   anaerobic digestion, pasteurization, and alkaline stabilization) on the
   fate of ARGs and class 1 integrons in wastewater solids-amended soil
   microcosms. Six ARGs {[}erm(B), qnrA, sul1, tet(A), tet(W), and tet(X)],
   the integrase gene of class 1 integrons (intl1); and 16S rRNA genes were
   quantified using quantitative polymerase chain reaction. The quantities
   of ARGs and intl1 decreased in all microcosms, but thermophilic
   anaerobic digestion, alkaline stabilization, and pasteurization led to
   the most extensive decay of ARGs and intl1, often to levels similar to
   that of the control microcosms to which no wastewater solids had been
   applied. In contrast, the rates by which ARGs and intl1 declined using
   the other treatment technologies were generally similar, typically
   varying by less than 2 fold. These results demonstrate that wastewater
   solids treatment technologies can be used to decrease the persistence of
   ARGs and intll during their subsequent application to soil.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{LaPara, TM (Reprint Author), Univ Minnesota, Dept Civil Environm \& Geoengn, 500 Pillsbury Dr SE, Minneapolis, MN 55455 USA.
   Burch, Tucker R.; LaPara, Timothy M., Univ Minnesota, Dept Civil Environm \& Geoengn, 500 Pillsbury Dr SE, Minneapolis, MN 55455 USA.
   Sadowsky, Michael J.; LaPara, Timothy M., Univ Minnesota, Biotechnol Inst, St Paul, MN 55108 USA.
   Sadowsky, Michael J., Univ Minnesota, Dept Soil Water \& Climate, St Paul, MN 55108 USA.
   Sadowsky, Michael J., Univ Minnesota, Dept Plant \& Microbial Biol, St Paul, MN 55108 USA.
   Burch, Tucker R., USDA ARS, Environmentally Integrated Dairy Management Res U, Marshfield, WI 54449 USA.}},
DOI = {{10.1021/acs.est.7b04760}},
ISSN = {{0013-936X}},
EISSN = {{1520-5851}},
Keywords-Plus = {{SEWAGE-TREATMENT PLANTS; TETRACYCLINE RESISTANCE; ACTIVATED-SLUDGE;
   BACTERIA; SWINE; ENVIRONMENTS; ENTEROBACTERIACEAE; DIVERSITY; BIOSOLIDS;
   EVOLUTION}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences}},
Author-Email = {{lapar001@umn.edu}},
ORCID-Numbers = {{Sadowsky, Michael/0000-0001-8779-2781}},
Funding-Acknowledgement = {{National Science Foundation {[}0967176]}},
Funding-Text = {{This work was supported by National Science Foundation Grant 0967176.}},
Cited-References = {{Alekshun M.N., 2004, DRUG DISCOV TODAY, V1, P483.
   Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312.
   Aminov RI, 2009, ENVIRON MICROBIOL, V11, P2970, DOI 10.1111/j.1462-2920.2009.01972.x.
   Arnold S, 2004, PHARMACOEPIDEM DR S, V13, P323, DOI 10.1002/pds.874.
   Auerbach EA, 2007, WATER RES, V41, P1143, DOI 10.1016/j.watres.2006.11.045.
   Bae SW, 2009, APPL ENVIRON MICROB, V75, P2940, DOI 10.1128/AEM.01333-08.
   Baertsch C, 2007, APPL ENVIRON MICROB, V73, P4522, DOI 10.1128/AEM.02387-06.
   Beecher N., 2007, FINAL REPORT NATL BI.
   Bengtsson-Palme J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00648.
   Bondarczuk K, 2016, ENVIRON INT, V87, P49, DOI 10.1016/j.envint.2015.11.011.
   Borjesson S, 2009, INT J ENVIRON HEAL R, V19, P219, DOI 10.1080/09603120802449593.
   Borjesson S, 2009, WATER RES, V43, P925, DOI 10.1016/j.watres.2008.11.036.
   Burch TR, 2016, APPL MICROBIOL BIOT, V100, P1437, DOI 10.1007/s00253-015-7043-x.
   Burch TR, 2014, ENVIRON SCI TECHNOL, V48, P5620, DOI 10.1021/es501098g.
   Burch TR, 2013, ENVIRON SCI TECHNOL, V47, P9965, DOI 10.1021/es4024749.
   Burch TR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00017.
   Centers for Disease Control and Prevention, 2013, ANT RES THREATS US.
   Chee-Sanford JC, 2001, APPL ENVIRON MICROB, V67, P1494, DOI 10.1128/AEM.67.4.1494-1502.2001.
   Chen J, 2012, ENVIRON SCI TECHNOL, V46, P13448, DOI 10.1021/es302760s.
   Crittenden JC, 2005, WATER TREATMENT PRIN.
   Cummings DE, 2011, ENVIRON SCI TECHNOL, V45, P447, DOI 10.1021/es1029206.
   Diehl DL, 2010, ENVIRON SCI TECHNOL, V44, P9128, DOI 10.1021/es102765a.
   Edgar R, 2012, APPL ENVIRON MICROB, V78, P744, DOI 10.1128/AEM.05741-11.
   Gatica J, 2016, ENVIRON SCI TECHNOL, V50, P11825, DOI 10.1021/acs.est.6b03188.
   Ghosh S, 2007, ISME J, V1, P191, DOI 10.1038/ismej.2007.31.
   Ghosh S, 2009, APPL MICROBIOL BIOT, V84, P791, DOI 10.1007/s00253-009-2125-2.
   Gillings MR, 2015, GENES-BASEL, V6, P841, DOI 10.3390/genes6030841.
   Gillings MR, 2015, ISME J, V9, P1269, DOI 10.1038/ismej.2014.226.
   Graham DW, 2011, ENVIRON SCI TECHNOL, V45, P418, DOI 10.1021/es102473z.
   Guo X, 2011, LETT APPL MICROBIOL, V52, P667, DOI 10.1111/j.1472-765X.2011.03059.x.
   Jabes D, 2011, CURR OPIN MICROBIOL, V14, P564, DOI 10.1016/j.mib.2011.08.002.
   Kim S, 2010, CHEMOSPHERE, V78, P1071, DOI 10.1016/j.chemosphere.2009.12.068.
   Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333.
   Lachmayr KL, 2009, APPL ENVIRON MICROB, V75, P203, DOI 10.1128/AEM.01254-08.
   LaPara TM, 2011, ENVIRON SCI TECHNOL, V45, P9543, DOI 10.1021/es202775r.
   Li J, 2013, ENVIRON SCI TECHNOL, V47, P2892, DOI 10.1021/es304616c.
   Ling AL, 2013, ENVIRON SCI TECHNOL, V47, P4046, DOI 10.1021/es400238g.
   Ma LP, 2017, ENVIRON SCI TECHNOL, V51, P5721, DOI 10.1021/acs.est.6b05887.
   Ma YJ, 2011, ENVIRON SCI TECHNOL, V45, P7855, DOI 10.1021/es200827t.
   Mao DQ, 2014, ENVIRON SCI TECHNOL, V48, P71, DOI 10.1021/es404280v.
   Marti R, 2014, APPL ENVIRON MICROB, V80, P3258, DOI 10.1128/AEM.00231-14.
   Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462.
   Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111.
   Munir M, 2011, WATER RES, V45, P681, DOI 10.1016/j.watres.2010.08.033.
   Nesme J, 2014, CURR BIOL, V24, P1096, DOI 10.1016/j.cub.2014.03.036.
   Peak N, 2007, ENVIRON MICROBIOL, V9, P143, DOI 10.1111/j.1462-2920.2006.01123.x.
   Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017.
   Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es0604131.
   Pruden A, 2013, ENVIRON HEALTH PERSP, V121, P878, DOI 10.1289/ehp.1206446.
   Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r.
   Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630.
   Sandberg KD, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw001.
   Sanderson H, 2016, ENVIRON REV, V24, P205, DOI 10.1139/er-2015-0069.
   Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x.
   SELLECK RE, 1978, J ENV ENG DIV-ASCE, V104, P1197.
   Seyfried EE, 2010, MICROB ECOL, V59, P799, DOI 10.1007/s00248-009-9624-7.
   Stalder T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00119.
   Storteboom H, 2010, ENVIRON SCI TECHNOL, V44, P7397, DOI 10.1021/es101657s.
   Tamminen M, 2011, ENVIRON SCI TECHNOL, V45, P386, DOI 10.1021/es102725n.
   Tchobanoglous G., 2003, WASTEWATER ENG TREAT.
   Uyaguari MI, 2011, APPL ENVIRON MICROB, V77, P8226, DOI 10.1128/AEM.02732-10.
   Volkmann H, 2004, J MICROBIOL METH, V56, P277, DOI 10.1016/j.mimet.2003.10.014.
   Williams-Nguyen J, 2016, J ENVIRON QUAL, V45, P394, DOI 10.2134/jeq2015.07.0336.
   Xie WY, 2016, ENVIRON SCI TECHNOL, V50, P12602, DOI 10.1021/acs.est.6b02138.
   Zhang T, 2009, ENVIRON SCI TECHNOL, V43, P3455, DOI 10.1021/es803309m.
   Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x.
   Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y.
   Zhang YP, 2013, ENVIRON SCI TECHNOL, V47, P10206, DOI 10.1021/es401964s.
   Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110.}},
Number-of-Cited-References = {{69}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{33}},
Usage-Count-Since-2013 = {{40}},
Journal-ISO = {{Environ. Sci. Technol.}},
Doc-Delivery-Number = {{FQ8PR}},
Unique-ID = {{ISI:000418625900025}},
DA = {{2018-08-13}},
}

@article{ ISI:000405981500042,
Author = {Kraemer, Julia G. and Pires, Joao and Kueffer, Marianne and Semaani,
   Eulalia and Endimiani, Andrea and Hilty, Markus and Oppliger, Anne},
Title = {{Prevalence of extended-spectrum beta-lactamase-producing
   Enterobacteriaceae and Methicillin-Resistant Staphylococcus aureus in
   pig farms in Switzerland}},
Journal = {{SCIENCE OF THE TOTAL ENVIRONMENT}},
Year = {{2017}},
Volume = {{603}},
Pages = {{401-405}},
Month = {{DEC 15}},
Abstract = {{The presence of Methicillin-Resistant Staphylococcus aureus (MRSA) in
   pig farms has been widely reported, and the emergence of
   extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E)
   has been documented in several countries. However, data for Switzerland
   are very scarce. This study aimed to compare changes in the prevalence
   of MRSA in Swiss pig farms between 2008 and 2015 and make the first ever
   estimates of the presence of ESBL-E and carbapenemase producers in pigs
   and pig farm workers. Results showed that ESBL-E was present in both
   pigs and farm workers and that the proportion of farms with MRSA had
   increased fourfold in seven years (from 7\% to 31\%). Associations
   between antibiotic use and resistant bacteria carriage were shown. (C)
   2017 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Oppliger, A (Reprint Author), Univ Lausanne, Inst Work \& Hlth, Inst Univ Romand Sante Travail, CH-1066 Epalinges, Switzerland.
   Oppliger, A (Reprint Author), Univ Geneva, Inst Work \& Hlth, Inst Univ Romand Sante Travail, CH-1066 Epalinges, Switzerland.
   Kraemer, Julia G.; Oppliger, Anne, Univ Lausanne, Inst Work \& Hlth, Inst Univ Romand Sante Travail, CH-1066 Epalinges, Switzerland.
   Kraemer, Julia G.; Oppliger, Anne, Univ Geneva, Inst Work \& Hlth, Inst Univ Romand Sante Travail, CH-1066 Epalinges, Switzerland.
   Kraemer, Julia G.; Pires, Joao; Kueffer, Marianne; Endimiani, Andrea; Hilty, Markus, Univ Bern, Inst Infect Dis, CH-3001 Bern, Switzerland.
   Semaani, Eulalia, SUISAG, SGD, SSP Berne Suisse Romande, CH-1350 Orbe, Switzerland.
   Pires, Joao, Univ Bern, Grad Sch Cellular \& Biomed Sci, CH-3001 Bern, Switzerland.}},
DOI = {{10.1016/j.scitotenv.2017.06.110}},
ISSN = {{0048-9697}},
EISSN = {{1879-1026}},
Keywords = {{Antibiotic resistance; Bioaerosols; ESBL; MRSA; One health; Occupational
   health}},
Keywords-Plus = {{ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; ANIMAL FARMS; RISK-FACTORS;
   E. COLI; LIVESTOCK; CARRIAGE; MRSA; HUMANS; SLAUGHTER}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{Anne.Oppliger@hospvd.ch}},
ORCID-Numbers = {{Hilty, Markus/0000-0002-2418-6474
   Endimiani, Andrea/0000-0003-3186-5421}},
Funding-Acknowledgement = {{Swiss National Science Foundation (SNF) grant {[}310030\_152880]; SNF
   grant {[}153377]}},
Funding-Text = {{This work was supported by Swiss National Science Foundation (SNF) grant
   310030\_152880 to AO and MH. It was also partially supported by SNF
   grant 153377 to AE.}},
Cited-References = {{Anresis, 2016, US ANT OCC ANT RES B.
   Bos MEH, 2016, J EXPO SCI ENV EPID, V26, P263, DOI 10.1038/jes.2014.85.
   Burow E, 2014, PREV VET MED, V113, P364, DOI 10.1016/j.prevetmed.2013.12.007.
   Cuny C, 2015, ANTIBIOTICS-BASEL, V4, P521, DOI 10.3390/antibiotics4040521.
   Dahms C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143326.
   DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1.
   Dohmen W, 2015, CLIN MICROBIOL INFEC, V21, P917, DOI 10.1016/j.cmi.2015.05.032.
   Endimiani A, 2012, ANTIMICROB AGENTS CH, V56, P4556, DOI 10.1128/AAC.00389-12.
   Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x.
   Fenner L, 2008, J MED MICROBIOL, V57, P612, DOI 10.1099/jmm.0.47757-0.
   Fischer J, 2017, VET MICROBIOL, V200, P107, DOI 10.1016/j.vetmic.2016.05.021.
   Friese A, 2013, BERL MUNCH TIERARZTL, V126, P175, DOI 10.2376/0005-9366-126-175.
   Friese A, 2012, VET MICROBIOL, V158, P129, DOI 10.1016/j.vetmic.2012.01.019.
   Garcia-Graells C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065512.
   Hammerum AM, 2014, J ANTIMICROB CHEMOTH, V69, P2650, DOI 10.1093/jac/dku180.
   Hansen KH, 2013, APPL ENVIRON MICROB, V79, P794, DOI 10.1128/AEM.02399-12.
   Hering J, 2014, PREV VET MED, V116, P129, DOI 10.1016/j.prevetmed.2014.06.014.
   Jakobsen L, 2015, J GLOB ANTIMICROB RE, V3, P132, DOI 10.1016/j.jgar.2015.03.009.
   Karanika S, 2016, CLIN INFECT DIS, V63, P195, DOI 10.1093/cid/ciw240.
   Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x.
   Liu WD, 2015, AM J INFECT CONTROL, V43, P469, DOI 10.1016/j.ajic.2014.12.009.
   Madec JY, 2017, CLIN MICROBIOL INFEC.
   Masclaux FG, 2013, ANN OCCUP HYG, V57, P550, DOI 10.1093/annhyg/mes098.
   Mesa RJ, 2006, J ANTIMICROB CHEMOTH, V58, P211, DOI 10.1093/jac/dkl211.
   Moodley A, 2009, ANTIMICROB AGENTS CH, V53, P1709, DOI 10.1128/AAC.01014-08.
   Nadimpalli M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165713.
   Oppliger A, 2012, APPL ENVIRON MICROB, V78, P8010, DOI 10.1128/AEM.01902-12.
   Overesch G, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-30.
   Pires J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01069.
   Randall LP, 2014, J ANTIMICROB CHEMOTH, V69, P2947, DOI 10.1093/jac/dku258.
   Rodrigues C, 2013, J ANTIMICROB CHEMOTH, V68, P2245, DOI 10.1093/jac/dkt187.
   Schmithausen RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138173.
   Seiffert SN, 2013, DRUG RESIST UPDATE, V16, P22, DOI 10.1016/j.drup.2012.12.001.
   Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556.
   Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112.
   van Cleef BAGL, 2014, CLIN MICROBIOL INFEC, V20, pO764, DOI 10.1111/1469-0691.12582.
   van Cleef BAGL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127190.
   von Salviati C, 2015, VET MICROBIOL, V175, P77, DOI 10.1016/j.vetmic.2014.10.010.
   von Salviati C, 2014, BERL MUNCH TIERARZTL, V127, P412, DOI 10.2376/0005-9366-127-412.
   Wardyn SE, 2015, CLIN INFECT DIS, V61, P59, DOI 10.1093/cid/civ234.
   World Health Organization (WHO), 2015, GLOB ACT PLAN ANT RE.
   Xu GF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01103.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{5}},
Usage-Count-Since-2013 = {{80}},
Journal-ISO = {{Sci. Total Environ.}},
Doc-Delivery-Number = {{FB2NW}},
Unique-ID = {{ISI:000405981500042}},
DA = {{2018-08-13}},
}

@article{ ISI:000422990500057,
Author = {Wang, Lin and Xia, Fan and Li, Feng and Qian, Xueqin and Zhu, Yijun and
   Chen, Hui and Bian, Aoao and Wang, Jun and Zhang, Min and Li, Hongwei
   and Han, Jiafu and Jiang, Nan and Xu, Ning and Song, Yanzheng},
Title = {{Pulmonary resection in the treatment of multidrug-resistant tuberculosis
   A case series}},
Journal = {{MEDICINE}},
Year = {{2017}},
Volume = {{96}},
Number = {{50}},
Month = {{DEC}},
Abstract = {{Multidrug-resistant (MDR) and extensive drug-resistant (XDR)
   tuberculosis (TB) are significant health problems throughout the world.
   Although the main treatment is medical, adjunctive surgical resection
   may increase the chance of cure in selected patients with MDR-TB or
   XDR-TB. This study aimed to present a case series of patients who
   underwent surgical resection for MDR-TB.
   Between March 2008 and November 2011, surgical resection was performed
   on 54 patients including 34 with MDR-TB and 20 with XDR-TB at the
   Departments of Surgery of Shanghai Public Health Clinical Center
   (Shanghai), Henan Chest Hospital (Henan), and Anhui Chest Hospital
   (Henan). Preoperative sputum smear samples were positive for 28 patients
   and sputum quantitative polymerase chain reaction was positive for 32.
   Patients were treated according to a standard therapy protocol for a
   mean of 4.2 months before the operation. The variables that affected
   treatment outcomes were identified through multivariate regression
   analysis.
   Fifty-four patients were operated for MDR-TB with localized disease
   usually complicated by cavity formation or destroyed lung. Thirty-seven
   were males and 17 were females. Median age was 37.8 (range, 20-75)
   years. Lobectomy was performed in 46 patients and pneumonectomy in 8.
   Muscle flaps were used in 36 of the patients with lobectomy and 8 with
   pneumonectomy. Various complications occurred in 6 (11.1\%) patients,
   including bronchopleural fistula in 1 patient, bleeding in 2 patients,
   and prolonged air leak in 2 patients. A favorable outcome was achieved
   in 47 patients (87\%) who underwent surgical resection. Higher body mass
   index (BMI) was associated with better outcome (odds ratio= 0.537, 95\%
   confidence interval: 0.310-0.928, P=.026).
   Patients with MDR-TB had good treatment outcomes after adjunctive
   pulmonary resection, and with few complications. Higher BMI was related
   to a favorable outcome.}},
Publisher = {{LIPPINCOTT WILLIAMS \& WILKINS}},
Address = {{TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Song, YZ (Reprint Author), Fudan Univ, Dept Thorac Surg, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.
   Wang, Lin; Zhu, Yijun; Chen, Hui; Wang, Jun; Li, Hongwei; Han, Jiafu; Song, Yanzheng, Shanghai Publ Hlth Clin Ctr, Dept Thorac Surg, Shanghai, Peoples R China.
   Xia, Fan, Eighty Fifth Hosp PLA, Dept TB, Shanghai, Peoples R China.
   Li, Feng, Shanghai Publ Hlth Clin Ctr, Sci Res, Shanghai, Peoples R China.
   Qian, Xueqin; Zhang, Min, Shanghai Publ Hlth Clin Ctr, Dept Clin Lab, Shanghai, Peoples R China.
   Bian, Aoao, Suzhou Fifth Peoples Hosp, Dept Surg, Suzhou, Peoples R China.
   Jiang, Nan, Anhui Chest Hosp Henan, Dept Surg, Zhengzhou, Henan, Peoples R China.
   Xu, Ning, Anhui Chest Hosp Anhui, Dept Surg, Hefei, Anhui, Peoples R China.}},
DOI = {{10.1097/MD.0000000000009109}},
Article-Number = {{e9109}},
ISSN = {{0025-7974}},
EISSN = {{1536-5964}},
Keywords = {{multidrug resistant; operative; surgical procedures; therapeutic use;
   treatment outcome; tuberculosis}},
Keywords-Plus = {{SURGICAL INTERVENTION; TREATMENT OUTCOMES; INFECTION-CONTROL; SURGERY;
   PNEUMONECTOMY; METAANALYSIS; MANAGEMENT; EMERGENCY; CHINA}},
Research-Areas = {{General \& Internal Medicine}},
Web-of-Science-Categories  = {{Medicine, General \& Internal}},
Author-Email = {{yanzhengsong@163.com}},
Funding-Acknowledgement = {{Clinical study of association between quantitative detection of
   Mycobacterium tuberculosis and surgical-assisted pulmonary resection for
   the treatment of MDR-TB patients (Project of Technology Commission of
   Shanghai Municipality) {[}KSF0546]}},
Funding-Text = {{This study was support by a grant: Clinical study of association between
   quantitative detection of Mycobacterium tuberculosis and
   surgical-assisted pulmonary resection for the treatment of MDR-TB
   patients (Project of Technology Commission of Shanghai Municipality
   KSF0546).}},
Cited-References = {{{[}Anonymous], 2012, Drug Ther Bull, V50, P21, DOI 10.1136/dtb.2012.02.0087.
   {[}Anonymous], 2009, PEARSON SCHWEIZ AG, V63, P307.
   Ashour M, 1997, EUR J CARDIO-THORAC, V12, P209, DOI 10.1016/S1010-7940(97)00155-3.
   Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-11590C.
   Chiang CY, 2009, INT J TUBERC LUNG D, V13, P304.
   Dravniece G, 2009, EUR RESPIR J, V34, P180, DOI 10.1183/09031936.00047208.
   Duan QH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148041.
   Gegia M, 2012, INT J INFECT DIS, V16, pE391, DOI 10.1016/j.ijid.2011.12.018.
   ISEMAN MD, 1990, AM REV RESPIR DIS, V141, P623, DOI 10.1164/ajrccm/141.3.623.
   Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3.
   Kim HJ, 2006, EUR RESPIR J, V28, P576, DOI 10.1183/09031936.06.00023006.
   Lalloo UG, 2006, CURR OPIN PULM MED, V12, P179, DOI 10.1097/01.mcp.0000219266.27439.52.
   Man MA, 2012, EUR J CARDIO-THORAC, V42, pe9, DOI 10.1093/ejcts/ezs215.
   Michael JS, 2012, INDIAN J MED RES, V136, P599.
   Mohsen T, 2007, J THORAC CARDIOV SUR, V134, P194, DOI 10.1016/j.jtcvs.2007.03.022.
   MORAN GJ, 1995, ANN EMERG MED, V26, P283, DOI 10.1016/S0196-0644(95)70073-0.
   MORAN GJ, 1995, ANN EMERG MED, V26, P290, DOI 10.1016/S0196-0644(95)70074-9.
   Morris MI, 2012, AM J TRANSPLANT, V12, P2288, DOI 10.1111/j.1600-6143.2012.04205.x.
   Naidoo Rishendran, 2007, Asian Cardiovasc Thorac Ann, V15, P134.
   Olcmen Aysun, 2006, Asian Cardiovasc Thorac Ann, V14, P363.
   Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6.
   Orki A, 2009, THORAC CARDIOV SURG, V57, P222, DOI 10.1055/s-0029-1185458.
   PAIROLERO PC, 1983, J THORAC CARDIOV SUR, V86, P809.
   Park SK, 2009, INT J INFECT DIS, V13, P170, DOI 10.1016/j.ijid.2008.06.001.
   Pomerantz BJ, 2001, J THORAC CARDIOV SUR, V121, P448, DOI 10.1067/mtc.2001.112339.
   Pomerantz M, 2000, Chest Surg Clin N Am, V10, P131.
   Pomerantz M, 1995, Semin Thorac Cardiovasc Surg, V7, P108.
   Shiraishi Y, 2004, J THORAC CARDIOV SUR, V128, P523, DOI 10.1016/j.jtcvs.2004.06.012.
   Somocurcio JG, 2007, THORAX, V62, P416, DOI 10.1136/thx.2005.051961.
   Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008.
   Takeda S, 2005, ANN THORAC SURG, V79, P959, DOI 10.1016/j.athoracsur.2004.09.007.
   Torun T, 2007, INT J TUBERC LUNG D, V11, P979.
   VanLeuven M, 1997, ANN THORAC SURG, V63, P1368.
   Vashakidze S, 2013, ANN THORAC SURG, V95, P1892, DOI 10.1016/j.athoracsur.2013.03.067.
   Xie BX, 2013, INTERACT CARDIOV TH, V17, P455, DOI 10.1093/icvts/ivt251.
   Yew WW, 2008, AM J RESP CRIT CARE, V177, P479, DOI 10.1164/rccm.200710-1561UP.
   Zhang JY, 2016, AM J INFECT CONTROL, V44, P671, DOI 10.1016/j.ajic.2015.12.042.
   Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Medicine (Baltimore)}},
Doc-Delivery-Number = {{FT2QG}},
Unique-ID = {{ISI:000422990500057}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000418438200007,
Author = {Malecka-Adamowicz, Marta and Kubera, Lukasz and Donderski, Wojciech and
   Kolet, Katarzyna},
Title = {{Microbial air contamination on the premises of the sewage treatment
   plant in Bydgoszcz (Poland) and antibiotic resistance of Staphylococcus
   spp.}},
Journal = {{ARCHIVES OF ENVIRONMENTAL PROTECTION}},
Year = {{2017}},
Volume = {{43}},
Number = {{4}},
Pages = {{58-65}},
Month = {{DEC}},
Abstract = {{The study was aimed at evaluating microbial contamination on the
   premises of the sewage treatment plant by determining the concentrations
   of selected groups of airborne microorganisms. Another objective was to
   determine the antibiotic sensitivity patterns of isolated strains of
   staphylococci. The research was conducted in a seasonal cycle, by the
   impaction method using Merck MAS-100 air sampler. Samples were collected
   at six sites, each representing a different stage of sewage treatment.
   The susceptibility of isolated staphylococci was assessed with the
   disc-diffusion method, following the recommendations of the EUCAST. The
   results indicate that the microbial population in the air of the
   investigated area was dominated by mold fungi, whose highest average
   concentration was recorded at site IV located near the final clarifier
   (7672 CFU.m(-3)). Heterotrophic bacteria and mannitol-positive
   staphylococci were the most numerous at locations where sewage undergoes
   primary treatment. In each subseuqent stage the number of microorganisms
   emitted into the air from the sewage was lower. Antibiograms show that
   more than 50\% of Staphylococcus spp. exhibited resistance to penicillin
   and 20\% to rifampicin. In addition, 90\% of the analyzed strains were
   sensitive to other antibiotics. The fungal community included the
   following genera: Cladosporium, Fusarium, Alternaria, Penicillium,
   Aspergillus, Aureobasidium, and Acremonium. The highest air
   contamination with all studied groups of microorganisms was recorded at
   the locations where mechanical sewage treatment was performed. During
   the subsequent stages lower numbers of heterotrophic bacteria were
   emitted into the air.
   The air in the investigated sewage treatment plant did not contain
   multidrug-resistant staphylococci.}},
Publisher = {{POLSKA AKAD NAUK, POLISH ACAD SCIENCES, INST ENVIRON ENG PAS}},
Address = {{PL DEFILAD 1, WARSZAWA, 00-901, POLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Malecka-Adamowicz, M (Reprint Author), Kazimierz Wielki Univ Bydgoszcz, Fac Nat Sci, Inst Expt Biol, Dept Microbiol, Bydgoszcz, Poland.
   Malecka-Adamowicz, Marta; Kubera, Lukasz; Donderski, Wojciech; Kolet, Katarzyna, Kazimierz Wielki Univ Bydgoszcz, Fac Nat Sci, Inst Expt Biol, Dept Microbiol, Bydgoszcz, Poland.}},
DOI = {{10.1515/aep-2017-0040}},
ISSN = {{2083-4772}},
EISSN = {{2083-4810}},
Keywords = {{bioaerosols; treatment plant; Antimicrobial resistance; air
   contamination}},
Keywords-Plus = {{WATER TREATMENT PLANTS; POLLUTION; MICROORGANISMS; AREA}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{marmal@ukw.edu.pl}},
Cited-References = {{Barberan A., 2015, P ROYAL SOC B, V282.
   Brandi G, 2000, J APPL MICROBIOL, V88, P845, DOI 10.1046/j.1365-2672.2000.01024.x.
   Breza-Boruta B., 2010, WODA SRODOWISKO OBSZ, V10, P49.
   Breza-Boruta B., 2016, ATMOSPHERIC POLLUTIO, P1.
   Breza-Boruta Barbara, 2007, Medycyna Weterynaryjna, V63, P717.
   Budzinska K, 2011, ROCZ OCHR SR, V13, P1543.
   Chmiel M. J., 2015, WODA SRODOWISKO OBSZ, V1, P17.
   EUCAST, 2015, BREAKP TABL INT MICS.
   Filipkowska Z., 2009, POLISH J ENV STUDIES, V11, P639.
   Fraczek K, 2016, AEROBIOLOGIA, V32, P499, DOI 10.1007/s10453-016-9423-9.
   Gandara A, 2006, ENVIRON HEALTH PERSP, V114, P1859, DOI 10.1289/ehp.9585.
   Haas D, 2013, ATMOS ENVIRON, V65, P215, DOI 10.1016/j.atmosenv.2012.10.031.
   Hameed AAA, 2015, AEROBIOLOGIA, V31, P283, DOI 10.1007/s10453-015-9364-8.
   Hrynkiewicz W., 2005, POSTEP MIKROBIOL, V44, P175.
   Kalwasinska A, 2014, CLEAN-SOIL AIR WATER, V42, P1337, DOI 10.1002/clen.201300385.
   Kermani M., 2016, J AIR POLLUTION HLTH, V1, P161.
   Kim KH, 2013, ENVIRON INT, V59, P41, DOI 10.1016/j.envint.2013.05.007.
   Kolwzan B., 2005, BASIC MICROBIOLOGY E.
   Kolwzan B, 2012, OCHR SR, V34, P9.
   Lebkowska M., 2001, INZYMIERIA OCHRONA S, V4, P3.
   Li L, 2011, PROCESS BIOCHEM, V46, P910, DOI 10.1016/j.procbio.2010.12.016.
   Miaskiewicz-Peska E, 2015, ARCH ENVIRON PROT, V41, P41, DOI 10.1515/aep-2015-0017.
   Michalak A., 2012, MEDYCYNA SRODOWISKOW, V15, P116.
   Michalkiewicz M., 2015, TECHNOLOGIA WODY 2, V4, P44.
   Michalkiewicz M., 2009, MONOGRAFIE KOMITET I, V2, P135.
   Michalkiewicz M, 2011, POL J ENVIRON STUD, V20, P1243.
   Nahaei MR, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.19945v2.
   Samson R.A., 2000, INTRO FOOD AIRBORNE.
   Schlosser O, 2016, INT J HYG ENVIR HEAL, V219, P239, DOI 10.1016/j.ijheh.2016.02.003.
   Sivri N, 2016, ARCH ENVIRON PROT, V42, P77, DOI 10.1515/aep-2016-0034.
   Viegas C., 2014, J TOXICOL ENV HEAL A, V77, P77.
   Vitezova M., 2012, ACTA U AGR SILVICULT, V3, P233.
   Zhou F, 2013, INT J ENV RES PUB HE, V10, P2412, DOI 10.3390/ijerph10062412.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{Arch. Environ. Prot.}},
Doc-Delivery-Number = {{FQ5YS}},
Unique-ID = {{ISI:000418438200007}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000418390000004,
Author = {Nickel, Sabrina and Selo, Mohammed Ali and Fallack, Juliane and Clerkin,
   Caoimhe G. and Huwer, Hanno and Schneider-Daum, Nicole and Lehr,
   Claus-Michael and Ehrhardt, Carsten},
Title = {{Expression and Activity of Breast Cancer Resistance Protein (BCRP/ABCG2)
   in Human Distal Lung Epithelial Cells In Vitro}},
Journal = {{PHARMACEUTICAL RESEARCH}},
Year = {{2017}},
Volume = {{34}},
Number = {{12}},
Pages = {{2477-2487}},
Month = {{DEC}},
Abstract = {{Breast cancer resistance protein (BCRP/ABCG2) has previously been
   identified with high expression levels in human lung. The subcellular
   localisation and functional activity of the transporter in lung
   epithelia, however, remains poorly investigated. The aim of this project
   was to study BCRP expression and activity in freshly isolated human
   alveolar epithelial type 2 (AT2) and type 1-like (AT1-like) cells in
   primary culture, and to compare these findings with data obtained from
   the NCI-H441 cell line.
   BCRP expression levels in AT2 and AT1-like cells and in different
   passages of NCI-H441 cells were determined using q-PCR and immunoblot.
   Transporter localisation was confirmed by confocal laser scanning
   microscopy. Efflux and transport studies using the BCRP substrate BODIPY
   FL prazosin and the inhibitor Ko143 were carried out to assess BCRP
   activity in the different cell models.
   BCRP expression decreased during transdifferentiation from AT2 to
   AT1-like phenotype. Culturing NCI-H441 cells at an air-liquid interface
   or submersed did not change BCRP abundance, however, BCRP levels
   increased with passage number. BCRP was localised to the apical membrane
   and cytosol in NCI-H441 cells. In primary cells, the protein was found
   predominantly in the nucleus. Functional studies were consistent with
   expression data.
   BCRP is differently expressed in AT2 and AT1-like cells with lower
   abundance and activity in the latter ones. Nuclear BCRP might play a
   transcriptional role in distal lung epithelium. In NCI-H441 cells, BCRP
   is expressed in apical cell membranes and its activity is consistent
   with the localisation pattern.}},
Publisher = {{SPRINGER/PLENUM PUBLISHERS}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ehrhardt, C (Reprint Author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Pharm \& Pharmaceut Sci, Dublin, Ireland.
   Nickel, Sabrina; Selo, Mohammed Ali; Fallack, Juliane; Clerkin, Caoimhe G.; Ehrhardt, Carsten, Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Pharm \& Pharmaceut Sci, Dublin, Ireland.
   Selo, Mohammed Ali, Univ Kufa, Fac Pharm, Al Najaf, Iraq.
   Huwer, Hanno, Volklingen Heart Ctr, Dept Cardiothorac Surg, Volklingen, Germany.
   Schneider-Daum, Nicole; Lehr, Claus-Michael, Helmholtz Inst Pharmaceut Res Saarland HIPS, Helmholtz Ctr Infect Res, Drug Delivery, Saarbrucken, Germany.}},
DOI = {{10.1007/s11095-017-2172-9}},
ISSN = {{0724-8741}},
EISSN = {{1573-904X}},
Keywords = {{ABC transporter; drug absorption; inhalation biopharmaceutics; NCI-H441
   cells; pulmonary drug disposition}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; MULTIDRUG-RESISTANCE; FUNCTIONAL EXPRESSION;
   DRUG-DELIVERY; LINE NCL-H441; TRANSPORTER; A549; INVOLVEMENT; ABCG2;
   INHIBITION}},
Research-Areas = {{Chemistry; Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Chemistry, Multidisciplinary; Pharmacology \& Pharmacy}},
Author-Email = {{ehrhardc@tcd.ie}},
ResearcherID-Numbers = {{Ehrhardt, Carsten/B-1259-2010}},
ORCID-Numbers = {{Ehrhardt, Carsten/0000-0003-0730-1829}},
Funding-Acknowledgement = {{Clinical Investigator Awards from the Flight Attendant Medical Research
   Institute {[}FAMRI CIA 130016]; Iraqi Ministry of Higher Education and
   Scientific Research (MOHESR); Trinity College Research Studentship Award}},
Funding-Text = {{This work has been financially supported by a Clinical Investigator
   Awards from the Flight Attendant Medical Research Institute (FAMRI CIA
   130016). M.A.S. is the recipient of a PhD bursary from the Iraqi
   Ministry of Higher Education and Scientific Research (MOHESR) and C.G.C.
   is supported by a Trinity College Research Studentship Award. The
   authors would like to acknowledge the contribution of the COST Actions
   BM1201 and MP1404.}},
Cited-References = {{AlDamluji S, 1996, BRIT J PHARMACOL, V117, P811, DOI 10.1111/j.1476-5381.1996.tb15265.x.
   Alfaras I, 2010, J AGR FOOD CHEM, V58, P4523, DOI 10.1021/jf9042858.
   Ando T, 2007, DRUG METAB DISPOS, V35, P1873, DOI 10.1124/dmd.107.014969.
   Bhatia P, 2012, XENOBIOTICA, V42, P748, DOI 10.3109/00498254.2012.662726.
   Bleasby K, 2006, XENOBIOTICA, V36, P963, DOI 10.1080/00498250600861751.
   Chen JS, 2006, LARYNGOSCOPE, V116, P401, DOI 10.1097/01.mlg.0000195075.14093.fb.
   Cooray HC, 2006, EUR J PHARMACOL, V531, P25, DOI 10.1016/j.ejphar.2005.12.010.
   Daum N, 2012, METHODS MOL BIOL, V806, P31, DOI 10.1007/978-1-61779-367-7\_3.
   Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0.
   Doring B, 2014, DRUG METAB REV, V46, P261, DOI 10.3109/03602532.2014.882353.
   Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665.
   Endter S, 2009, J PHARM PHARMACOL, V61, P583, DOI 10.1211/jpp/61.05.0006.
   Forbes B, 2005, EUR J PHARM BIOPHARM, V60, P193, DOI 10.1016/j.ejpb.2005.02.010.
   Galetti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141795.
   Kage K, 2002, INT J CANCER, V97, P626, DOI 10.1002/ijc.10100.
   Kawabata S, 2003, CLIN CANCER RES, V9, P3052.
   Lee CA, 2015, DRUG METAB DISPOS, V43, P490, DOI 10.1124/dmd.114.062174.
   Liang S., 2015, ELECT J DIFFERENTIAL, V2015, P1.
   Nakanishi T, 2012, CHIN J CANCER, V31, P73, DOI 10.5732/cjc.011.10320.
   Nickel S, 2016, EXPERT OPIN DRUG DEL, V13, P667, DOI 10.1517/17425247.2016.1140144.
   Ohbayashi M, 2013, J TOXICOL SCI, V38, P103, DOI 10.2131/jts.38.103.
   Paturi DK, 2010, INT J PHARMACEUT, V384, P32, DOI 10.1016/j.ijpharm.2009.09.037.
   Ren H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165225.
   Sakamoto A, 2015, J PHARM SCI-US, V104, P3029, DOI 10.1002/jps.24381.
   Sakamoto A, 2013, J PHARM SCI-US, V102, P3395, DOI 10.1002/jps.23606.
   Salomon JJ, 2015, EUR J PHARM SCI, V80, P82, DOI 10.1016/j.ejps.2015.08.007.
   Salomon JJ, 2014, MOL PHARMACEUT, V11, P995, DOI 10.1021/mp4006535.
   Salomon JJ, 2014, DRUG METAB PHARMACOK, V29, P101, DOI 10.2133/dmpk.DMPK-13-SH-026.
   Scheffer GL, 2002, J CLIN PATHOL, V55, P332, DOI 10.1136/jcp.55.5.332.
   Schwagerus E, 2015, PFLUG ARCH EUR J PHY, V467, P2257, DOI 10.1007/s00424-015-1693-5.
   Suzuki M, 2003, J BIOL CHEM, V278, P22644, DOI 10.1074/jbc.M212399200.
   Takano M, 2015, PHARM RES-DORDR, V32, P3916, DOI 10.1007/s11095-015-1751-x.
   Tega Y, 2016, DRUG METAB PHARMACOK, V31, P99, DOI 10.1016/j.dmpk.2015.11.006.
   Tian Y, 2015, CURR DRUG METAB, V16, P877, DOI 10.2174/138920021610151210184205.
   Togami K, 2017, J PHARMACOL TOX MET, V86, P19, DOI 10.1016/j.vascn.2017.02.023.
   van der Deen M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-59.
   Yeboah D, 2008, REPROD FERT DEVELOP, V20, P328, DOI 10.1071/RD07133.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Pharm. Res.}},
Doc-Delivery-Number = {{FQ5HR}},
Unique-ID = {{ISI:000418390000004}},
DA = {{2018-08-13}},
}

@article{ ISI:000415937600003,
Author = {Iyer, Rupa and Iken, Brian and Damania, Ashish},
Title = {{Whole genome of Klebsiella aerogenes PX01 isolated from San Jacinto
   River sediment west of Baytown, Texas reveals the presence of multiple
   antibiotic resistance determinants and mobile genetic elements}},
Journal = {{GENOMICS DATA}},
Year = {{2017}},
Volume = {{14}},
Pages = {{7-9}},
Month = {{DEC}},
Abstract = {{Klebsiella aerogenes is a Gram-negative bacterium of the family
   Enterobacteriaceae which is widely distributed in water, air and soil.
   It also forms part of the normal microbiota found in human and animal
   gastrointestinal tracts. Here we report the draft genome sequence
   (chromosome and 1 plasmid) of K. aerogenes strain PX01 compiled at the
   scaffold level from 97 contigs totaling 5,262,952 bp. K. aerogenes PX01
   was isolated from sediment along the northern face of Burnet Bay west of
   Baytown, Texas. The nucleotide sequence of this genome was deposited
   into NCBI GenBank under the accession NJBB00000000.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Iyer, R (Reprint Author), Univ Houston, Ctr Life Sci Technol, Dept Engn Technol, Houston, TX 77004 USA.
   Iyer, Rupa; Iken, Brian, Univ Houston, Ctr Life Sci Technol, Dept Engn Technol, Houston, TX 77004 USA.
   Damania, Ashish, Baylor Coll Med, Dept Trop Med Pediat, Houston, TX 77030 USA.}},
DOI = {{10.1016/j.gdata.2017.07.012}},
ISSN = {{2213-5960}},
Keywords-Plus = {{PATHOGENS; DATABASE}},
Research-Areas = {{Genetics \& Heredity}},
Web-of-Science-Categories  = {{Genetics \& Heredity}},
Author-Email = {{riyer@uh.edu}},
Funding-Acknowledgement = {{NIST {[}G110008 58106]}},
Funding-Text = {{Whole genome sequencing of Enterobacter aerogenes PX01 was funded
   through NIST (G110008 58106).}},
Cited-References = {{Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75.
   B. Bioinformatics, 2011, FASTQC QUALITY CONTR.
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021.
   Bushnell B., 2016, BBMAP SHORT READ ALI.
   Davin-Regli A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00392.
   Iyer R, 2015, NEW BIOTECHNOL, V32, P403, DOI 10.1016/j.nbt.2015.03.010.
   McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13.
   Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI {[}10.1586/eri.13.12, 10.1586/ERI.13.12].
   Tatusova T., 2013, NCBI HDB.
   Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099.}},
Number-of-Cited-References = {{10}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{17}},
Journal-ISO = {{Genom. Data}},
Doc-Delivery-Number = {{FN3YB}},
Unique-ID = {{ISI:000415937600003}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000414516500001,
Author = {Paytubi, Sonia and Cansado, Cintia and Madrid, Cristina and Balsalobre,
   Carlos},
Title = {{Nutrient Composition Promotes Switching between Pellicle and Bottom
   Biofilm in Salmonella}},
Journal = {{FRONTIERS IN MICROBIOLOGY}},
Year = {{2017}},
Volume = {{8}},
Month = {{NOV 7}},
Abstract = {{Salmonella is one of the most frequently reported causes of foodborne
   illness worldwide. Non-typhoidal serovars cause gastroenteritis in
   humans. Salmonella can grow on surfaces forming biofilms, contributing
   to its persistence since biofilms are difficult to eradicate due to the
   high resistance to antimicrobials and disinfectants. It has been
   described that there are two crucial biofilm promoting factors in
   Salmonella: curli and cellulose. The expression of both factors is
   coordinately regulated by the transcriptional regulator CsgD. Most
   biofilm studies of Salmonella have been performed by growing bacteria in
   low osmolarity rich medium and low temperature (25 degrees C). In such
   conditions, the biofilm is formed at the air-liquid interface (pellicle
   biofilm). Remarkably, when Salmonella grow in minimal medium, biofilm
   formation switches from the air-liquid interface to the solid-liquid
   interface (bottom biofilm). In this report, the switching between
   pellicle and bottom biofilm has been characterized. Our data indicate
   that curli, but not cellulose, is crucial for the formation of both
   kinds of biofilms. In minimal medium, conditions promoting formation of
   bottom biofilm, a high transcriptional expression of csgD and
   consequently of the genes involved in the synthesis of curli and
   cellulose was detected. The nutritional status of the cells seems to be
   pivotal for the spatial distribution of the biofilms formed. When
   bacteria is growing in minimal medium the addition of amino acids
   downregulates the expression of csgB and causes the switch between
   bottom and pellicle biofilm. The crosstalk between general metabolism
   and biofilm formation is also highlighted by the fact that the metabolic
   sensor cAMP modulates the type of biofilm generated by Salmonella.
   Moreover, cAMP regulates transcriptional expression of csgD and
   stimulates pellicle biofilm formation, suggesting that the physiological
   conditions define the type of biofilm formed by Salmonella. The
   consequences of the switching between pellicle and bottom biofilm during
   either infection or survival in natural environments remain undercover.}},
Publisher = {{FRONTIERS MEDIA SA}},
Address = {{PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Madrid, C; Balsalobre, C (Reprint Author), Univ Barcelona, Dept Genet Microbiol \& Stat, Sect Microbiol Virol \& Biotechnol, Barcelona, Spain.
   Paytubi, Sonia; Cansado, Cintia; Madrid, Cristina; Balsalobre, Carlos, Univ Barcelona, Dept Genet Microbiol \& Stat, Sect Microbiol Virol \& Biotechnol, Barcelona, Spain.}},
DOI = {{10.3389/fmicb.2017.02160}},
Article-Number = {{2160}},
ISSN = {{1664-302X}},
Keywords = {{biofilm; Salmonella; adenylate cyclase; amino acids; nutrient
   composition studies; curli; cellulose}},
Keywords-Plus = {{ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; RECEPTOR PROTEIN;
   EXTRACELLULAR-MATRIX; GENE-EXPRESSION; CSGD; CELLULOSE; BEHAVIOR;
   BIOSYNTHESIS; DETERMINANTS}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{cmadrid@ub.edu
   cbalsalobre@ub.edu}},
ORCID-Numbers = {{Balsalobre, Carlos/0000-0002-4147-219X}},
Funding-Acknowledgement = {{Spanish Ministry of Economy, Industry and Competitiveness Innovation
   {[}AGL2013-45339-R]; RecerCaixa program {[}2012/ACUP/00048]; Government
   of Catalonia {[}2014SGR1260]}},
Funding-Text = {{This work was supported by grants from the Spanish Ministry of Economy,
   Industry and Competitiveness Innovation (AGL2013-45339-R), RecerCaixa
   program (2012/ACUP/00048), and the Government of Catalonia
   (2014SGR1260).}},
Cited-References = {{Balsalobre C, 2006, J BACTERIOL, V188, P5935, DOI 10.1128/JB.00235-06.
   Bridier A, 2011, BIOFOULING, V27, P1017, DOI 10.1080/08927014.2011.626899.
   Brombacher E, 2006, J BACTERIOL, V188, P2027, DOI 10.1128/JB.188.6.2027-2037.2006.
   Brown PK, 2001, MOL MICROBIOL, V41, P349, DOI 10.1046/j.1365-2958.2001.02529.x.
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297.
   Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000.
   DUGUID JP, 1966, J PATHOL BACTERIOL, V92, P107, DOI 10.1002/path.1700920113.
   Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6.
   Fong JCN, 2008, J BACTERIOL, V190, P6646, DOI 10.1128/JB.00466-08.
   Frank JF, 2001, J FOOD PROTECT, V64, P1178, DOI 10.4315/0362-028X-64.8.1178.
   Gerstel U, 2001, ENVIRON MICROBIOL, V3, P638, DOI 10.1046/j.1462-2920.2001.00235.x.
   Hamilton S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-599.
   Heaton JC, 2008, J APPL MICROBIOL, V104, P613, DOI 10.1111/j.1365-2672.2007.03587.x.
   HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0.
   Hufnagel DA, 2016, J BACTERIOL, V198, P3329, DOI 10.1128/JB.00652-16.
   Jain S, 2007, J FOOD PROTECT, V70, P2473, DOI 10.4315/0362-028X-70.11.2473.
   Kalivoda EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071267.
   KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533.
   Malcova M, 2009, FEMS MICROBIOL LETT, V291, P44, DOI 10.1111/j.1574-6968.2008.01433.x.
   Maloy SR, 1996, GENETIC ANAL PATHOGE.
   Matange N, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv183.
   Miller J. H., 1992, SHORT COURSE BACTERI.
   Muller CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000303.
   NEIDHARDT FC, 1977, J BACTERIOL, V129, P378.
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49.
   OBYRNE CP, 1994, J BACTERIOL, V176, P905, DOI 10.1128/jb.176.3.905-912.1994.
   Paytubi S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00326.
   Perez-Mendoza D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091645.
   Prigent-Combaret C, 2001, J BACTERIOL, V183, P7213, DOI 10.1128/JB.183.24.7213-7223.2001.
   Romling U, 1998, J BACTERIOL, V180, P722.
   Romling U, 2000, MOL MICROBIOL, V36, P10, DOI 10.1046/j.1365-2958.2000.01822.x.
   Romling U, 1999, FEMS MICROBIOL LETT, V180, P91.
   SAIER MH, 1976, J BIOL CHEM, V251, P883.
   Sambrook J, 2001, MOL CLONING LAB MANU.
   Savery NJ, 1998, EMBO J, V17, P3439, DOI 10.1093/emboj/17.12.3439.
   Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101.
   Shi XM, 2009, TRENDS FOOD SCI TECH, V20, P407, DOI 10.1016/j.tifs.2009.01.054.
   Steenackers H, 2012, FOOD RES INT, V45, P502, DOI 10.1016/j.foodres.2011.01.038.
   Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6.
   Stepanovic S, 2004, LETT APPL MICROBIOL, V38, P428, DOI 10.1111/j.1472-765X.2004.01513.x.
   STERNBERG NL, 1991, METHOD ENZYMOL, V204, P18.
   Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002.
   ULLMANN A, 1968, Febs Letters, V2, P57, DOI 10.1016/0014-5793(68)80100-0.
   Vidal O, 1998, J BACTERIOL, V180, P2442.
   Vivero A, 2008, J BACTERIOL, V190, P1152, DOI 10.1128/JB.01206-07.
   VOGEL HJ, 1956, J BIOL CHEM, V218, P97.
   White AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011814.
   Zakikhany K, 2010, MOL MICROBIOL, V77, P771, DOI 10.1111/j.1365-2958.2010.07247.x.
   Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x.}},
Number-of-Cited-References = {{49}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Front. Microbiol.}},
Doc-Delivery-Number = {{FL8RA}},
Unique-ID = {{ISI:000414516500001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000414482400001,
Author = {Akshaya, Kibballi Madhukeshwar and Shewade, Hemant Deepak and Aslesh,
   Ottapura Prabhakaran and Nagaraja, Sharath Burugina and Nirgude, Abhay
   Subashrao and Singarajipura, Anil and Jacob, Anil G.},
Title = {{``Who has to do it at the end of the day? Programme officials or
   hospital authorities?{''} Airborne infection control at drug resistant
   tuberculosis (DR-TB) centres of Karnataka, India: a mixed-methods study}},
Journal = {{ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL}},
Year = {{2017}},
Volume = {{6}},
Month = {{NOV 6}},
Abstract = {{Background: Drug resistant tuberculosis (DR-TB) centers admit patients
   with DR-TB for initiation of treatment and thereby concentrate the
   patients under one setting. It becomes imperative to assess the
   compliance of DR-TB centres to national airborne infection control (AIC)
   guidelines and explore the provider perspectives into reasons for
   unsatisfactory compliance.
   Methods: This mixed methods study (triangulation design) was carried out
   across all the six DR-TB centers of Karnataka state, India, between
   November 2016 and April 2017. Non-participant observation using a
   structured format was carried out at the DR-TB wards (n = 6), outpatient
   departments (n = 6), patient waiting areas outside outpatient
   departments (n = 6) and culture and drug susceptibility testing
   laboratories (n = 3). Structured interviews of admitted patients (n =
   30) were done to assess the knowledge on cough hygiene and sputum
   disposal. Key informant interviews (KIIs) of health care providers (n =
   20) were done. Manual descriptive content analysis was done to analyse
   the transcripts of KIIs.
   Results: The findings related to compliance in non-participant
   observation were corroborated by KIIs. All the laboratories were
   consistently implementing the AIC guidelines. Compliance to hand
   hygiene, wet mopping and ventilation measures were satisfactory in four
   or more DR-TB wards. The non-availability of N95 masks in wards as well
   as outpatient departments was staggering. Sputum disposal without prior
   disinfection and the lack of display materials on cough hygiene and
   patient education was common. Patient fast tracking in outpatient
   department waiting areas and visitor restrictions in wards were lacking.
   Trainings on AIC measures were uncommon. About half and one-third of
   patients admitted had satisfactory knowledge regarding sputum disposal
   and situations demanding mask respectively. The reasons for
   unsatisfactory compliance to AIC guidelines were poor coordination
   between programme and hospital authorities leading to lack of ownership;
   ineffective or non-existent infection control committees; vacant posts
   of medical officers; and attitudes of health care delivery staff.
   Conclusion: Compliance with AIC guidelines in DR-TB centers of Karnataka
   was sub-optimal. The reasons identified require urgent attention of the
   programme managers and hospital authorities.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Akshaya, KM (Reprint Author), Yenepoya Univ, Dept Community Med, Yenepoya Med Coll, Mangaluru 575018, India.
   Akshaya, Kibballi Madhukeshwar; Nirgude, Abhay Subashrao, Yenepoya Univ, Dept Community Med, Yenepoya Med Coll, Mangaluru 575018, India.
   Shewade, Hemant Deepak; Jacob, Anil G., South East Asia Off, Int Union TB \& Lung Dis, New Delhi, India.
   Aslesh, Ottapura Prabhakaran, Govt Med Coll, Dept Community Med, Trichur, India.
   Nagaraja, Sharath Burugina, ESIC Med Coll, Dept Community Med, Bengaluru, India.
   Nagaraja, Sharath Burugina, PGIMSR, Bengaluru, India.
   Singarajipura, Anil, Govt Karnataka, Dept Hlth \& Family Welf, Bengaluru, India.}},
DOI = {{10.1186/s13756-017-0270-4}},
Article-Number = {{111}},
ISSN = {{2047-2994}},
Keywords = {{Infection control; Drug-resistant tuberculosis; MDR tuberculosis;
   Hospital infections; SORT IT}},
Keywords-Plus = {{HEALTH-CARE WORKERS; SOUTH-AFRICA; NOSOCOMIAL TRANSMISSION}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases;
   Microbiology}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases;
   Microbiology}},
Author-Email = {{docakshay@gmail.com}},
ORCID-Numbers = {{Shewade, Hemant Deepak/0000-0002-8242-1911}},
Funding-Acknowledgement = {{Department for International Development (DFID), UK; La Fondation Veuve
   Emile Metz-Tesch (Luxembourg)}},
Funding-Text = {{The training programme and open access publications costs were funded by
   the Department for International Development (DFID), UK and La Fondation
   Veuve Emile Metz-Tesch (Luxembourg). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.}},
Cited-References = {{Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300.
   Bantubani N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090868.
   Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5.
   Central TB Division Directorate General of Health Services Ministry of Health and Family Welfare, 2017, TB IND 2017.
   Central TB Division Directorate General of Health Services Ministry of Health \& Family Welfare Government of India, 2012, GUID PROGR MAN DRUG.
   Creswell J. W., 2007, DESIGNING CONDUCTING.
   Directorate General of Health Services Ministry of Health and Family Welfare Government of India, 2010, GUID AIRB INF CONTR.
   Farley JE, 2012, INT J TUBERC LUNG D, V16, P82, DOI 10.5588/ijtld.10.0791.
   Gandhi NR, 2013, J INFECT DIS, V207, P9, DOI 10.1093/infdis/jis631.
   Jarand J, 2010, TROP MED INT HEALTH, V15, P1179, DOI 10.1111/j.1365-3156.2010.02590.x.
   Kvale S., 2007, DOING INTERVIEWS.
   Lincoln Y. S., 1985, NATURALISTIC INQUIRY.
   Parmar Malik M, 2015, Indian J Tuberc, V62, P211, DOI 10.1016/j.ijtb.2015.11.006.
   Saldana Johnny, 2010, CODING MANUAL QUALIT.
   The Tuberculosis Coalition for Technical Asssistance (TBCTA), 2009, IMPL WHO POL TB INF.
   Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042.
   Waheed Y, 2017, ACTION, V7, P26.
   WHO, 2016, GLOB TB REP 2016.
   Williams OM, 2015, EMERG INFECT DIS, V21, P1082, DOI 10.3201/eid2106.141903.
   World Health Organization, 2009, WHO POL TB INF CONTR.
   Zelnick JR, 2013, J PUBLIC HEALTH POL, V34, P388, DOI 10.1057/jphp.2013.20.}},
Number-of-Cited-References = {{21}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{Antimicrob. Resist. Infect. Control}},
Doc-Delivery-Number = {{FL8EF}},
Unique-ID = {{ISI:000414482400001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000415056400020,
Author = {Jose, Diana and Lekshmi, N. and Goel, A. K. and Kumar, R. Ajay and
   Thomas, Sabu},
Title = {{Development of a Novel Herbal Formulation To Inhibit Biofilm Formation
   in Toxigenic Vibrio cholerae}},
Journal = {{JOURNAL OF FOOD PROTECTION}},
Year = {{2017}},
Volume = {{80}},
Number = {{11}},
Pages = {{1933-1940}},
Month = {{NOV}},
Abstract = {{Vibrio cholerae, a causative agent of the waterborne disease cholera,
   still threatens a large proportion of world's population. The role of
   biofilm formation in V. cholerae pathogenesis is well established, as it
   provides the bacterium enhanced tolerance to antimicrobial agents and
   increased transmission. In the present study, four medicinal plants used
   in traditional medicines with antidiarrheal properties were evaluated
   for its antibiofilm activity. Methanol extracts of these plants
   (Centella asiatica, Elephantopus scaber, Camellia sinensis, and
   Holarrhena antidysenterica) showed promising antibiofilm activity
   against V. cholerae with crystal violet and air-liquid interface
   coverslip assays. Results revealed that C. asiatica, E. scaber, C.
   sinensis, and H. antidysenterica extracts significantly inhibited
   biofilm formation by approximately 75, 76, 78, and 55\% at
   concentrations of 3, 2, 1, and 0.6 mg/mL, respectively. A promising
   antibiofilm activity of similar to 89\% inhibition at 1.5 mg/mL
   concentration was observed when a combination of E. scaber and C.
   sinensis was used. The herbal extracts were thermostable at a
   temperature range of 40 to 100 degrees C. The
   3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay
   revealed that the viability of bacteria was not affected by treatment
   with these plant extracts. Gene expression studies revealed that
   extracts of H. antidysenterica leaf, H. antidysenterica bark, and the
   whole plant of E. scaber and C. asiatica down-regulate aphA or aphB, the
   major regulator genes modulating both virulence and biofilm formation.
   Hence, we propose that these herbal combinations could serve as a
   multifaceted approach to combat the pathogen and also, in turn, reduce
   antimicrobial resistance development.}},
Publisher = {{INT ASSOC FOOD PROTECTION}},
Address = {{6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Thomas, S (Reprint Author), Rajiv Gandhi Ctr Biotechnol, Cholera \& Biofilm Res Lab, Thiruvananthapuram 695014, Kerala, India.
   Jose, Diana; Lekshmi, N.; Thomas, Sabu, Rajiv Gandhi Ctr Biotechnol, Cholera \& Biofilm Res Lab, Thiruvananthapuram 695014, Kerala, India.
   Kumar, R. Ajay, Rajiv Gandhi Ctr Biotechnol, Mycobacterium Res Grp, Thiruvananthapuram 695014, Kerala, India.
   Lekshmi, N., Univ Kerala, Thiruvananthapuram 695034, Kerala, India.
   Goel, A. K., Def Res \& Dev Estab, Gwalior 474002, Madhya Pradesh, India.}},
DOI = {{10.4315/0362-028X.JFP-17-091}},
ISSN = {{0362-028X}},
EISSN = {{1944-9097}},
Keywords = {{Antibiofilm; aphB gene; MIC; Vibrio cholerae}},
Keywords-Plus = {{MEDICINAL-PLANTS; ANTIBACTERIAL ACTIVITY; VIRULENCE; KERALA; INDIA;
   PATHOGENS; KNOWLEDGE; DISTRICT; TRIBE; COLI}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Food Science \& Technology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Food Science \& Technology}},
Author-Email = {{sabu@rgcb.res.in}},
Funding-Acknowledgement = {{Defence Research and Development Organisation, Ministry of Defence,
   Government of India, New Delhi {[}ERIP/ER/1102209/M/01/1419]; Department
   of Science \& Technology, Government of India {[}IF 140851]}},
Funding-Text = {{This research was supported by a grant from the Defence Research and
   Development Organisation, Ministry of Defence, Government of India, New
   Delhi (grant ERIP/ER/1102209/M/01/1419). The authors thank the Ayurveda
   Research Institute, Trivandrum, for providing the plant samples used in
   the study. N. Lekshmi thanks the Department of Science \& Technology,
   Government of India, for providing the Innovation in Science Pursuit for
   Inspired Research (INSPIRE) fellowship (IF 140851). The authors thank M.
   Radhakrishna Pillai, director of the Rajiv Gandhi Centre for
   Biotechnology, for the facilities provided.}},
Cited-References = {{Ahmad I, 2001, J ETHNOPHARMACOL, V74, P113, DOI 10.1016/S0378-8741(00)00335-4.
   Ankri S, 1997, ANTIMICROB AGENTS CH, V41, P2286.
   {[}Anonymous], 2014, Wkly Epidemiol Rec, V89, P345.
   Avani K., 2005, Indian Journal of Pharmacology, V37, P126.
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493.
   Centers for Disease Control and Prevention, 2012, GLOB HLTH HAIT.
   Chakraborty A, 1999, J ETHNOPHARMACOL, V68, P339, DOI 10.1016/S0378-8741(99)00119-1.
   Dey A, 2012, J ETHNOPHARMACOL, V143, P68, DOI 10.1016/j.jep.2012.05.064.
   Faraz N., 2012, BIOMEDICA, V28, P171.
   Geeta, 2001, Indian J Med Sci, V55, P434.
   GROSVENOR PW, 1995, J ETHNOPHARMACOL, V45, P97, DOI 10.1016/0378-8741(94)01210-Q.
   Huang CC, 2013, J NUTR BIOCHEM, V24, P516, DOI 10.1016/j.jnutbio.2012.01.013.
   Kamruzzaman M, 2013, ASIAN PAC J TROP MED, V6, P352, DOI 10.1016/S1995-7645(13)60038-3.
   Kavitha D., 2004, Indian Journal of Experimental Biology, V42, P589.
   Kierek K, 2003, APPL ENVIRON MICROB, V69, P5079, DOI 10.1128/AEM.69.9.5079-5088.2003.
   Kirtikar KR, 1975, INDIAN MED PLANTS, VII, P894.
   Kovacikova G, 1999, J BACTERIOL, V181, P4250.
   Kumar P, 2010, FEMS MICROBIOL LETT, V303, P132, DOI 10.1111/j.1574-6968.2009.01868.x.
   Mamtha B., 2004, Indian Journal of Pharmacology, V36, P41.
   Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00.
   Mitra R, 2007, ASIA PAC BIOTECH NEW, V11, P105.
   Mshana RN, 1998, J CLIN MICROBIOL, V36, P1214.
   Nimri LF, 1999, PHARM BIOL, V37, P196, DOI 10.1076/phbi.37.3.196.6308.
   OTOOLE GA, 2011, JOVE J VIS EXP JAN.
   Pathmanathan M K, 2010, INT J PHARM BIOL ARC, V1, P291.
   Rahim N, 2010, JPN J INFECT DIS, V63, P271.
   Rajith N. P., 2010, Indian Journal of Natural Products and Resources, V1, P249.
   Raju V. S., 2005, Indian Journal of Traditional Knowledge, V4, P443.
   Rath S, 2015, J INTEGR MED-JIM, V13, P45, DOI 10.1016/S2095-4964(15)60154-6.
   Ratnakar P, 1995, INDIAN J CLIN BIOCH, V10, P34.
   Ravichandiran V, 2013, MED CHEM, V9, P819, DOI 10.2174/1573406411309060006.
   Saxena VK, 1999, FITOTERAPIA, V70, P328, DOI 10.1016/S0367-326X(99)00036-2.
   Silja VP, 2008, INDIAN J TRADIT KNOW, V7, P604.
   Silva AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004330.
   Silva O, 1996, J ETHNOPHARMACOL, V50, P55, DOI 10.1016/0378-8741(95)01323-7.
   Thakur P, 2016, MICROB PATHOGENESIS, V92, P76, DOI 10.1016/j.micpath.2016.01.001.
   TODA M, 1992, MICROBIOL IMMUNOL, V36, P999, DOI 10.1111/j.1348-0421.1992.tb02103.x.
   Union Nation Office for the Coordination of Humanitarian Affairs, 2013, BUILD BRIDG EM REL R.
   VANDELLEN KL, 2006, DRUG DISCOV TODAY DI, V3, P261.
   Xavier TF, 2014, J ETHNOPHARMACOL, V152, P78, DOI 10.1016/j.jep.2013.12.016.
   Yamasaki S, 2011, INDIAN J MED RES, V133, P232.
   Yesodharan K, 2007, INDIAN J TRADIT KNOW, V6, P481.
   Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{J. Food Prot.}},
Doc-Delivery-Number = {{FM5FI}},
Unique-ID = {{ISI:000415056400020}},
DA = {{2018-08-13}},
}

@article{ ISI:000414696900051,
Author = {Kumar, Arvind and Asaf, Belal B. and Lingaraju, Vijay C. and Yendamuri,
   Sai and Pulle, Mohan V. and Sood, Jayashree},
Title = {{Thoracoscopic Decortication of Stage III Tuberculous Empyema Is
   Effective and Safe in Selected Cases}},
Journal = {{ANNALS OF THORACIC SURGERY}},
Year = {{2017}},
Volume = {{104}},
Number = {{5}},
Pages = {{1688-1694}},
Month = {{NOV}},
Abstract = {{Background. Open decortication of advanced tuberculous empyema remains
   standard of care. As with other aspects of thoracic surgery, minimally
   invasive approaches are making inroads into procedures traditionally
   performed open. In this retrospective analysis, we sought to examine
   feasibility, efficacy, and outcomes of thoracoscopic decortication of
   stage III tuberculous empyema in our experience.\& para;\& para;Methods.
   The records of all patients in whom thoracoscopic decortication of stage
   III tuberculous empyema was performed between March 2012 and December
   2015 were examined. Demographic and perioperative data were analyzed to
   assess the surgical outcomes of this study group. To assess long-term
   efficacy, patients were followed for a minimum of 6 months.\& para;\&
   para;Results. One hundred patients fit the study criteria, of these 67
   were men. Ninety cases were successfully completed thoracoscopically.
   Mean operative time was 204 +/- 34.2 minutes with mean blood loss of 384
   +/- 28 mL. Median chest drain duration and hospital stay was 7 days.
   There was no perioperative deaths. Morbidity rate was 33\%, composed
   mostly of prolonged air leak (29\%). Six-month follow-up revealed
   completely expanded lung in all patients except one with small apical
   asymptomatic air space. Intraoperative cultures were positive for
   mycobacteria in 25\% patients. Six (6\%) of these patients had
   multidrug-resistant tuberculosis and required a modification in their
   antituberculous therapy.\& para;\& para;Conclusions. Thoracoscopic
   decortication of advanced tuberculous empyema is feasible, safe, and
   effective with good short- and long-term results in selected patients.
   In a substantial portion of patients, operative cultures required
   modifying drug treatment to treat underlying tuberculosis. (C) 2017 by
   The Society of Thoracic Surgeons}},
Publisher = {{ELSEVIER SCIENCE INC}},
Address = {{360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kumar, A (Reprint Author), Sir Ganga Ram Hosp, Dept Thorac Surg, Ctr Chest Surg \& Lung Transplantat, SSRB, Rm 2328,3rd Flr, New Delhi 110060, India.
   Sir Ganga Ram Hosp, Dept Thorac Surg, New Delhi, India.
   Roswell Pk Canc Inst, Dept Thorac Surg, Buffalo, NY 14263 USA.
   Sir Ganga Ram Hosp, Dept Anesthesiol Pain \& Perioperat Management, New Delhi, India.}},
DOI = {{10.1016/j.athoracsur.2017.06.038}},
ISSN = {{0003-4975}},
EISSN = {{1552-6259}},
Keywords-Plus = {{SURGICAL-TREATMENT; SURGERY; MANAGEMENT; OUTCOMES}},
Research-Areas = {{Cardiovascular System \& Cardiology; Respiratory System; Surgery}},
Web-of-Science-Categories  = {{Cardiac \& Cardiovascular Systems; Respiratory System; Surgery}},
Author-Email = {{arvindreena@gmail.com}},
Cited-References = {{Acharya Preetam Rajgopal, 2007, Ann Thorac Med, V2, P14, DOI 10.4103/1817-1737.30356.
   ANDREWS NC, 1962, AM REV RESPIR DIS, V85, P935.
   Bagheri Reza, 2016, Asian Cardiovasc Thorac Ann, V24, P245, DOI 10.1177/0218492316629281.
   Cardillo G, 2009, EUR J CARDIO-THORAC, V36, P914, DOI 10.1016/j.ejcts.2009.06.017.
   Chan DTL, 2007, ANN THORAC SURG, V84, P225, DOI 10.1016/j.athoracsur.2007.03.019.
   Chen BF, 2015, ANN THORAC CARDIOVAS, V21, P223, DOI 10.5761/atcs.oa.14-00185.
   Goyal SP, 1976, INDIAN J TUBERC, V23, P103.
   Kruijshaar ME, 2009, THORAX, V64, P1090, DOI 10.1136/thx.2009.118133.
   Liu Z, 2015, ANN THORAC CARDIOVAS, V21, P523, DOI 10.5761/atcs.oa.15-00158.
   Luh SP, 2005, CHEST, V127, P1427, DOI 10.1378/chest.127.4.1427.
   Molnar TF, 2007, EUR J CARDIO-THORAC, V32, P422, DOI 10.1016/j.ejcts.2007.05.028.
   Shahin Y, 2010, INTERACT CARDIOV TH, V10, P565, DOI 10.1510/icvts.2009.215004.
   Sharma SK, 2004, INDIAN J MED RES, V120, P316.
   Tong BC, 2010, ANN THORAC SURG, V89, P220, DOI 10.1016/j.athoracsur.2009.09.021.}},
Number-of-Cited-References = {{14}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Ann. Thorac. Surg.}},
Doc-Delivery-Number = {{FM0ZC}},
Unique-ID = {{ISI:000414696900051}},
DA = {{2018-08-13}},
}

@article{ ISI:000413589400001,
Author = {Solomon, Fithamlak Bisetegen and Wadilo, Fiseha and Tufa, Efrata Girma
   and Mitiku, Meseret},
Title = {{Extended spectrum and metalo beta-lactamase producing airborne
   Pseudomonas aeruginosa and Acinetobacter baumanii in restricted settings
   of a referral hospital: a neglected condition}},
Journal = {{ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL}},
Year = {{2017}},
Volume = {{6}},
Month = {{OCT 23}},
Abstract = {{Background: Frequently encountered multidrug-resistant bacterial
   isolates of P. aeruginosa and A. baumannii are common and prevalent in a
   hospital environment. The aim of this study was to determine the
   prevalence and pattern of antibiotic resistance, extended spectrum and
   metallo beta-lactamase producing P. aeruginosa and A. baumannii isolates
   from restricted settings of indoor air hospital environment.
   Methods: A hospital-based cross-sectional study was conducted in Wolaita
   Sodo University Teaching and referral Hospital, Ethiopia from December
   1/2015 to April 30/2015. The Air samples were collected from delivery
   room, intensive care unit and operation theatre of the hospital by
   active, Anderson six slate sampler technique during the first week of
   the months, twice a week during Monday's and Friday's. Standard
   microbiological procedures were followed to isolate P. aeruginosa and A.
   baumannii. Susceptibility testing was performed on isolates using the
   Kirby-Bauer disk diffusion technique. Extended spectrum beta lactamase
   production was detected by double disc synergy test and
   Imipenem-resistant isolates were screened for producing Metallo-beta
   lactamase.
   Results: A total number of 216 indoor air samples were collected from
   the delivery room, intensive care unit, and operation room.
   Correspondingly, 43 A. baumannii isolates were identified (13 from
   delivery room, 21 from intensive care unit and 9 from operation room).
   Likewise 24 P. aeruginosa isolates were obtained (4 from delivery room,
   13 from intensive care unit and 7 from operation room). Extended
   spectrum beta lactamase and metalo-beta lactamase production were
   observed in 24 (55.8\%) and 13 (30.2\%) isolates of A. baumannii
   respectively, whereas P. aeruginosa showed 15 (62.5\%) extended spectrum
   beta lactamase and 9 (37.5\%) metallo-beta lactamase production.
   Conclusions: Extended spectrum beta lactamase and metallo-beta lactamase
   producing bacteria in hospital air is a new dimension for specific
   setting of the study area where antimicrobial resistance is increasing
   and surgical site infection is prevalent. So, identification of these
   microorganisms has a great role in reducing the burden of antibiotic
   resistance and could also provide a significant input for framing
   hospital infection control policies.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Solomon, FB (Reprint Author), Wolaita Sodo Univ, Sch Med, POB 138, Sodo, Ethiopia.
   Solomon, Fithamlak Bisetegen, Wolaita Sodo Univ, Sch Med, POB 138, Sodo, Ethiopia.
   Wadilo, Fiseha, Wolaita Sodo Univ, Sch Med, Sodo, Ethiopia.
   Tufa, Efrata Girma, Wolaita Sodo Univ, Dept Med Lab, Sodo, Ethiopia.
   Mitiku, Meseret, MaddaWalabu Univ, Sch Med, Coll Hlth Sci \& Med, Bale Goba, Ethiopia.}},
DOI = {{10.1186/s13756-017-0266-0}},
Article-Number = {{106}},
ISSN = {{2047-2994}},
Keywords = {{Antibiotic resistance; ESBL; MBL; P. aeruginosa; A. Baumannii; MDR;
   Airborne}},
Keywords-Plus = {{ANTIMICROBIAL SUSCEPTIBILITY; DISK METHOD; INFECTIONS; PREVALENCE;
   STRAINS; AIR}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases;
   Microbiology}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases;
   Microbiology}},
Author-Email = {{fitha2007@yahoo.com}},
Funding-Acknowledgement = {{Wolaita Sodo University {[}239/2015WSU]}},
Funding-Text = {{The research budget is funded by Wolaita Sodo University. Grant number
   239/2015WSU.}},
Cited-References = {{Aktas O, 2003, J INT MED RES, V31, P272, DOI 10.1177/147323000303100404.
   Alemu A, 2015, BIOMEDICINE BIOTECHN, V3, P1.
   Alireza A, 2012, IRAN J PATHOL, V7, P168.
   Alisha A, 2015, JUNDISHAPUR J MICROB, V8.
   ANDERSEN AA, 1958, J BACTERIOL, V76, P471.
   Asghar AH, 2009, SAUDI MED J, V30, P1017.
   Azizun N, 2012, BANGLADESH J MED MIC, V06.
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493.
   Behrooozi A, 2010, AFR J MICROBIOL RES, V4, P881.
   BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148.
   CDC, 2013, ANTIBIOTIC RESISTANC.
   Chemaly RF, 2014, THER ADV INFECT DIS, V2, P79, DOI 10.1177/2049936114543287.
   Clinical and Laboratory Standards Institute, 2014, M100524 CLIN LAB STA.
   Clinical and Laboratory Standards Institute, 2007, M100S16 CLIN LAB STA.
   Constantiniu Sofia, 2004, J PREVENTIVE MED, V12, P35.
   Daef E. A., 2013, J AM SCI, V9, P67.
   Eyo AA, 2015, J PHARM BIOL SCI, V10.
   Gad GF, 2007, J ANTIMICROB CHEMOTH, V60, P1010, DOI 10.1093/jac/dkm348.
   Gaikwad V., 2015, TERIARY CARE CTR, V4, P3126.
   Goel v, 2013, J SCI SOC, V40, P28.
   Gorny RL, 2004, ANN AGR ENV MED, V11, P185.
   Govan JR, 2006, MACKIE MCCARTNEY PRA, P413.
   Guardabassi L, 1998, APPL ENVIRON MICROB, V64, P3499.
   Haketni-Vala M, 2013, ARCH HYG SCI, V2, P1.
   Hirsch EB, 2010, EXPERT REV PHARM OUT, V10, P441, DOI {[}10.1586/erp.10.49, 10.1586/ERP.10.49].
   Huang PY, 2013, AEROSOL AIR QUAL RES, V13, P1060, DOI 10.4209/aaqr.2012.08.0217.
   Inacio HSM, 2014, CHEMOTHERAPY, V60, P54, DOI 10.1159/000365726.
   Indu B, 2014, J CLIN DIAGNOSTIC RE, V8, P26.
   Jones AM, 2003, THORAX, V58, P525, DOI 10.1136/thorax.58.6.525.
   Kritu P, 2012, NEPAL J SCI TECHNOL, V13, P203.
   Lee TB, 1998, AM J INFECT CONTROL, V26, P277, DOI 10.1016/S0196-6553(98)80013-8.
   Manchanda V, 2010, J GLOB INFECT DIS, V2, P291, DOI 10.4103/0974-777X.68538.
   Medeiros M, 2013, BRAZ J PATHOL LAB ME, V49, P391.
   Mirnejad R, 2013, J GENES MICROBES IMM, V2013, P1, DOI DOI 10.5899/2013/JGMI-00002.
   Mitiku M, 2014, AM J BIOMEDICAL LIFE, V2, P40.
   Nasreen M., 2015, ADV MICROBIOL, V5, P74, DOI DOI 10.4236/AIM.2015.51008.
   Owlia Parviz, 2012, Infez Med, V20, P182.
   Pasquarella C, 2000, J HOSP INFECT, V46, P241, DOI 10.1053/jhin.2000.0820.
   Sinha M, 2007, INDIAN J MED RES, V126, P63.
   Sivaraj S, 2012, INT J PHARM PHARMSCI, V4, P103.
   Teklu S, 2016, INT J INFECT CONTROL, V12, P1.
   Vahdani M, 2012, Ann Burns Fire Disasters, V25, P78.
   Varaiya A, 2008, INDIAN J MED RES, V127, P398.
   Vila J, 2008, EXPERT OPIN PHARMACO, V9, P587, DOI 10.1517/14656566.9.4.587.
   WHO, 2012, EV THREATS ANT RES O.
   Yong DE, 2002, J CLIN MICROBIOL, V40, P3798, DOI 10.1128/JCM.40.10.3798-3801.2002.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Antimicrob. Resist. Infect. Control}},
Doc-Delivery-Number = {{FK6BZ}},
Unique-ID = {{ISI:000413589400001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000412191500003,
Author = {Shamarina, Daria and Stoyantcheva, Iana and Mason, Christopher E. and
   Bibby, Kyle and Elhaik, Eran},
Title = {{Communicating the promise, risks, and ethics of large-scale, open space
   microbiome and metagenome research}},
Journal = {{MICROBIOME}},
Year = {{2017}},
Volume = {{5}},
Month = {{OCT 4}},
Abstract = {{The public commonly associates microorganisms with pathogens. This
   suspicion of microorganisms is understandable, as historically
   microorganisms have killed more humans than any other agent while
   remaining largely unknown until the late seventeenth century with the
   works of van Leeuwenhoek and Kircher. Despite our improved understanding
   regarding microorganisms, the general public are apt to think of
   diseases rather than of the majority of harmless or beneficial species
   that inhabit our bodies and the built and natural environment. As long
   as microbiome research was confined to labs, the public's exposure to
   microbiology was limited. The recent launch of global microbiome
   surveys, such as the Earth Microbiome Project and MetaSUB (Metagenomics
   and Metadesign of Subways and Urban Biomes) project, has raised ethical,
   financial, feasibility, and sustainability concerns as to the public's
   level of understanding and potential reaction to the findings, which,
   done improperly, risk negative implications for ongoing and future
   investigations, but done correctly, can facilitate a new vision of
   ``smart cities.{''} To facilitate improved future research, we describe
   here the major concerns that our discussions with ethics committees,
   community leaders, and government officials have raised, and we expound
   on how to address them. We further discuss ethical considerations of
   microbiome surveys and provide practical recommendations for public
   engagement.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mason, CE (Reprint Author), Weill Cornell Med, Dept Physiol \& Biophys, New York, NY 10021 USA.
   Mason, CE (Reprint Author), HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA.
   Mason, CE (Reprint Author), Weill Cornell Med, Feil Family Brain \& Mind Res Inst, New York, NY 10021 USA.
   Elhaik, E (Reprint Author), Univ Sheffield, Dept Anim \& Plant Sci, Sheffield S10 2TN, S Yorkshire, England.
   Shamarina, Daria; Stoyantcheva, Iana, Univ Sheffield, Dept Mol Biol \& Biotechnol, Sheffield S10 2TN, S Yorkshire, England.
   Mason, Christopher E., Weill Cornell Med, Dept Physiol \& Biophys, New York, NY 10021 USA.
   Mason, Christopher E., HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA.
   Mason, Christopher E., Weill Cornell Med, Feil Family Brain \& Mind Res Inst, New York, NY 10021 USA.
   Bibby, Kyle, Univ Notre Dame, Dept Civil \& Environm Engn, Notre Dame, IN 46556 USA.
   Elhaik, Eran, Univ Sheffield, Dept Anim \& Plant Sci, Sheffield S10 2TN, S Yorkshire, England.}},
DOI = {{10.1186/s40168-017-0349-4}},
Article-Number = {{132}},
ISSN = {{2049-2618}},
Keywords = {{Microbiome; Metagenome; Built environment; Public; MetaSUB; Concerns;
   Ethics}},
Keywords-Plus = {{HUMAN FECAL POLLUTION; INDOOR ENVIRONMENT; STAPHYLOCOCCUS-AUREUS;
   ANTIBIOTIC-RESISTANCE; PATHOGEN DIVERSITY; PUBLIC ENGAGEMENT; HEALTH;
   AIR; CONTAMINATION; ACQUISITION}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{chm2042@med.cornell.edu
   e.elhaik@sheffield.ac.uk}},
ORCID-Numbers = {{Elhaik, Eran/0000-0003-4795-1084}},
Funding-Acknowledgement = {{DNA Diagnostics Center; Bert L and N Kuggie Vallee Foundation;
   WorldQuant Foundation; Pershing Square Sohn Cancer Research Alliance;
   National Institutes of Health {[}R25EB020393, R01ES021006]; National
   Science Foundation {[}1510925, 1748019]; Bill and Melinda Gates
   Foundation {[}OPP1151054]; Alfred P. Sloan Foundation {[}G-2015-13964]}},
Funding-Text = {{We wish to thank the University of Sheffield's Research Ethics Committee
   (UREC) for helpful discussions. We would like to thank funding from the
   DNA Diagnostics Center, Bert L and N Kuggie Vallee Foundation, the
   WorldQuant Foundation, The Pershing Square Sohn Cancer Research
   Alliance, the National Institutes of Health (R25EB020393, R01ES021006),
   National Science Foundation (1510925, 1748019), the Bill and Melinda
   Gates Foundation (OPP1151054), and the Alfred P. Sloan Foundation
   (G-2015-13964).}},
Cited-References = {{Adams RI, 2016, BUILD ENVIRON, V109, P224, DOI 10.1016/j.buildenv.2016.09.001.
   Adams RI, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0108-3.
   Afshinnekoo E, 2015, CELL SYST, V1, P72, DOI 10.1016/j.cels.2015.01.001.
   Agg J., 2015, CLEAN ARE YOUR HANDS.
   Albala Ilene, 2010, IRB, V32, P7.
   Alfred P, MICROBIOLOGY BUILT E.
   {[}Anonymous], 2020, HORIZON 2020 RESPONS.
   Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012.
   Bashford A, 2001, CONTAGION HIST CULTU, P129.
   Beskow LM, 2001, JAMA-J AM MED ASSOC, V286, P2315, DOI 10.1001/jama.286.18.2315.
   Bialik C., 2009, KILLS 99 9 GERMS UND.
   Bibby K, 2013, ENVIRON SCI TECHNOL, V47, P1945, DOI 10.1021/es305181x.
   Bibby K, 2010, WATER RES, V44, P4252, DOI 10.1016/j.watres.2010.05.039.
   Bik HM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00226-16.
   Borland S, 2017, SHOCKING PHOTOS REVE.
   Brody H, 2000, LANCET, V356, P64, DOI 10.1016/S0140-6736(00)02442-9.
   Brown C., 2014, AIRPORT EXIT ENTRY S.
   Cai L, 2014, APPL MICROBIOL BIOT, V98, P3317, DOI 10.1007/s00253-013-5402-z.
   Callahan A., 2017, NEW TYPE BABY MONITO.
   Camossi LG, 2014, EXP PARASITOL, V145, P157, DOI 10.1016/j.exppara.2014.08.012.
   Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50.
   Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182.
   Chosewood LC, 1999, PUBLIC HLTH SERV, V5, P1.
   Clucas DB, 2008, B WORLD HEALTH ORGAN, V86, P275, DOI 10.2471/BLT.07.043034.
   Coil DA, 2016, PEERJ, V4, P1.
   Dancer SJ, 2008, LANCET INFECT DIS, V8, P101, DOI 10.1016/S1473-3099(07)70241-4.
   Department of Health, 2005, HEALTH SOC CARE COMM, V10, P1.
   Di Bella JM, 2013, J MICROBIOL METH, V95, P401, DOI 10.1016/j.mimet.2013.08.011.
   Doria Miguel F., 2006, Journal of Water and Health, V4, P271, DOI 10.2166/wh.2006.008.
   Dufour A, 2003, WHO DRINKING WATER Q, P1.
   Edelsberg J, 2014, DIAGN MICR INFEC DIS, V78, P255, DOI 10.1016/j.diagmicrobio.2013.11.011.
   Elhaik E, 2013, GENOME BIOL EVOL, V5, P1021, DOI 10.1093/gbe/evt066.
   Fall T, 2015, JAMA PEDIAT, V169, P219.
   Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107.
   Findley K, 2016, TRENDS MICROBIOL, V24, P847, DOI 10.1016/j.tim.2016.08.001.
   Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036.
   FOX A, 1993, APPL ENVIRON MICROB, V59, P4354.
   Franzosa EA, 2015, P NATL ACAD SCI USA, V112, pE2930, DOI 10.1073/pnas.1423854112.
   Garbarino Jeanne, 2016, J Microbiol Biol Educ, V17, P7, DOI 10.1128/jmbe.v17i1.1052.
   Gibbons SM, 2015, APPL ENVIRON MICROB, V81, P765, DOI 10.1128/AEM.03117-14.
   Gilbert JA, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002020.
   Gilbert MTP, 2017, MOL ECOL, V26, P969, DOI 10.1111/mec.13944.
   Green J, 1998, J HOSP INFECT, V39, P39, DOI 10.1016/S0195-6701(98)90241-9.
   Guggenbichler J., 2011, GMS KRANKENHAUSHYG I, V6, P1, DOI DOI 10.3205/DGKH000175.
   Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566.
   Hampton-Marcell JT, 2017, MICROB BIOTECHNOL, V10, P228, DOI 10.1111/1751-7915.12699.
   Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68.
   Hodgekiss A., 2015, ANTIBIOTIC RESISTANC.
   Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867.
   Hsu T, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00018-16.
   Jacobson SH, 2016, PREV MED, V88, P33, DOI 10.1016/j.ypmed.2016.03.018.
   KAATZ GW, 1988, AM J EPIDEMIOL, V127, P1289, DOI 10.1093/oxfordjournals.aje.a114921.
   Kaufman DJ, 2009, AM J HUM GENET, V85, P643, DOI 10.1016/j.ajhg.2009.10.002.
   Kelley ST, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-202.
   Knight Jenny, 2011, Nurs Stand, V25, P20.
   Konya T, 2014, CURR SUSTAIN ENERGY, V1, P35, DOI DOI 10.1007/S40518-014-0007-4.
   Kuske CR, 2006, J FORENSIC SCI, V51, P548, DOI 10.1111/j.1556-4029.2006.00131.x.
   Lai KM, 2009, ENV HLTH, V8, P593.
   Lax S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6500.
   Lee CR, 2013, INT J ENV RES PUB HE, V10, P4274, DOI 10.3390/ijerph10094274.
   Lee RLT, 2014, RES DEV DISABIL, V35, P3014, DOI 10.1016/j.ridd.2014.07.016.
   Leshner AI, 2003, SCIENCE, V299, P977, DOI 10.1126/science.299.5609.977.
   Leung MHY, 2014, APPL ENVIRON MICROB, V80, P6760, DOI 10.1128/AEM.02244-14.
   Leuwenhoek V., 1693, PHIL T, V17, P646, DOI DOI 10.1098/RSTL.
   Li Y, 2015, J ANTIBIOT, V68, P496, DOI 10.1038/ja.2015.25.
   Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004.
   Lowe C, 2012, EMERG INFECT DIS, V18, P1242, DOI 10.3201/eid1808.111268.
   Madigan M. T., 2010, BROCK BIOL MICROORGA.
   Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801.
   Manfredi P., 2013, MODELING INTERPLAY H, P329.
   Martinez JA, 2003, ARCH INTERN MED, V163, P1905, DOI 10.1001/archinte.163.16.1905.
   Mason Christopher E, 2017, J Biomol Tech, V28, P8, DOI 10.7171/jbt.17-2801-006.
   Mathur Purva, 2011, Indian J Med Res, V134, P611, DOI 10.4103/0971-5916.90985.
   McClure JA, 2017, J CLIN MICROBIOL, V55, P1857, DOI 10.1128/JCM.02488-16.
   McGuire AL, 2012, J EMPIR RES HUM RES, V7, P1, DOI 10.1525/jer.2012.7.3.1.
   McIntyre ABR, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.35.
   Meadow JF, 2015, PEERJ, V3, DOI 10.7717/peerj.1258.
   Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028.
   Mensah-Attipoe J, 2017, INDOOR AIR, V27, P3, DOI 10.1111/ina.12344.
   Metro News Reporter, 2017, METRO NEWS REPORTER.
   MIESNER EA, 1989, JAPCA J AIR WASTE MA, V39, P1577, DOI 10.1080/08940630.1989.10466652.
   Moritz A., 2008, HOSP ARE MAJOR HLTH.
   MTA, 2016, HIGH FIG 1948.
   Murphy A, 2006, SCH CAN BE HOTBED BA.
   National Institutes of Health, 2013, HUM MICR PROJ.
   NERC, 2014, UKS 7 RES COUNC UN F.
   NIH, 2013, REQ INF RFI INV COMM, P1.
   NIH, 2007, IMPL GUID INSTR APPL, P1.
   O'Hara NB, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0339-6.
   Ormond KE, 2009, AM J MED GENET A, V149A, P188, DOI 10.1002/ajmg.a.32635.
   Osborne S., 2016, MAP SHOWS BRITAINS D.
   Otter JA, 2009, LETT APPL MICROBIOL, V49, P803, DOI 10.1111/j.1472-765X.2009.02728.x.
   Pemberton B., 2016, DAILY MAIL.
   Plague Yuhas A., 2015, PLAGUE ANTHRAX CHEES.
   Posa D, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0697-y.
   Priest N, 2010, J EPIDEMIOL COMMUNIT, V66, P440.
   Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x.
   Quach C, 2012, CAN MED ASSOC J, V184, pE232, DOI 10.1503/cmaj.110372.
   Robertson CE, 2013, APPL ENVIRON MICROB, V79, P3485, DOI 10.1128/AEM.00331-13.
   Schmidt C, 2017, NAT BIOTECHNOL, V35, P401, DOI 10.1038/nbt.3868.
   Shao M, 2006, FRONT ECOL ENVIRON, V4, P353, DOI 10.1890/1540-9295(2006)004{[}0353:CCICAA]2.0.CO;2.
   Sharma N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088443.
   Sharma S, 2017, FOLIA MICROBIOL, V62, P17, DOI 10.1007/s12223-016-0471-x.
   Stachler E, 2017, ENVIRON SCI TECHNOL, V51, P9146, DOI 10.1021/acs.est.7b02703.
   Stachlert E, 2014, ENVIRON SCI TECH LET, V1, P405, DOI 10.1021/ez500266s.
   Stanley NJ, 2008, J ENVIRON MONITOR, V10, P474, DOI 10.1039/b719316e.
   SteelFisher GK, 2015, INFLUENZA OTHER RESP, V9, P131, DOI 10.1111/irv.12306.
   Stephens B, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00083-16.
   Stilgoe J, 2014, PUBLIC UNDERST SCI, V23, P4, DOI 10.1177/0963662513518154.
   Tighe Scott, 2017, J Biomol Tech, V28, P31, DOI 10.7171/jbt.17-2801-004.
   Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862.
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244.
   U. S. Department of Health and Human Services, PERS PROT EQ INF CON.
   Ursell LK, 2012, NUTR REV, V70, pS38, DOI 10.1111/j.1753-4887.2012.00493.x.
   Vuong HE, 2017, ANNU REV NEUROSCI, V40, P21, DOI 10.1146/annurev-neuro-072116-031347.
   Wagner J, 2016, BIOINFORMATICS, V32, P1873, DOI 10.1093/bioinformatics/btw073.
   Waldor MK, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002050.
   Wang H, 2013, ENVIRON SCI TECHNOL, V47, P10117, DOI 10.1021/es402455r.
   Wassenaar M., 2002, BACTERIA MORE PATHOG.
   White P, 2012, IDENTITY STUD SOC SC, P143.
   Wilensky J., 2017, COLLABORATIVE STARTU.
   Wolfson R., 2017, USING BIG DATA NEXT.
   Wolinsky H, 2011, EMBO REP, V12, P1102, DOI 10.1038/embor.2011.201.
   World Bank, 2014, EC IMP 2014 EB EP SH.
   World Health Organisation, 2014, WHO INT GUID EB VIR.
   World Health Organization, 2016, AMB AIR POLL GLOB AS.
   Yarygin KS, 2017, BIOINFORMATICS, V33, P2205, DOI 10.1093/bioinformatics/btx134.
   Zheng P, 2016, MOL PSYCHIATR, V21, P786, DOI 10.1038/mp.2016.44.}},
Number-of-Cited-References = {{128}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{5}},
Usage-Count-Since-2013 = {{17}},
Journal-ISO = {{Microbiome}},
Doc-Delivery-Number = {{FI7QF}},
Unique-ID = {{ISI:000412191500003}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000423952900009,
Author = {Ansaril, Reda and Nawani, Kapeel and Nusrat, Hafsa},
Title = {{COMMON FACTORS INFLUENCING DISEASE RECURRENCE RELAPSE AND RE-INFECTION
   IN TREATED PATIENTS OF TUBERCULOSIS}},
Journal = {{INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES}},
Year = {{2017}},
Volume = {{4}},
Number = {{10}},
Pages = {{3416-3422}},
Month = {{OCT}},
Abstract = {{Background: Tuberculosis is a potentially life-threatening, airborne
   bacterial infection that can be found worldwide. The treatment regimen
   is a lengthy one, but if you stick with it and take medications the way
   you should, you can beat the disease. Even with treatment, however, you
   can get tuberculosis infection again.
   Objective: TB recurrence, relapse and re-infection are becoming more
   common every day in successfully treated patients of tuberculosis. This
   study aims to determine the common factors influencing T.B recurrence,
   relapse and re-infection.
   Methods: This multi-center, cross-sectional study comprised of 200
   patients (64.8\% males and 35.2\% females) chosen via simple random
   sampling and undergoing treatment for recurrent, relapsed or reinfection
   of tuberculosis at different T.B centers namely: Government T.B
   Sanatorium Kotri, Bhittai Hospital Hyderabad, Civil Hospital Hyderabad
   and Civil Hospital Mirpurkhas, from 1st December 2014 to 10th February
   2015. Verbal informed consent was obtained before administering
   structured self-administered questionnaires. The data obtained was
   analyzed using SPSS v. 19.0 and Microsoft Excel 2013.
   Results: The study shows that males are more prone (27.3\%) to get a
   relapse within 2 years while females are less prone 15\%. According to
   social economic status, there is 74.9\% chance of low economic class for
   TB relapse, 19.6 \% in case of middle class and 5.5\% in case of high
   economic class. TB is 55.3\% more common in those patients whose family
   members are suffering from same disease. Among cases of relapse within 5
   years, 95.6\% took medicine without supervision, 86.6\% were supervised
   by the family and 84\% by the health professional. Urban areas are less
   affected with TB relapse within 5 years than the rural areas.
   Non-smokers are more affected within 5 years while smokers are
   comparably less affected with TB.
   Conclusion:My study concluded that secondary TB relapse cases gender
   variation , social economic status , medical monitoring , TB regimen
   coarse , family history, smoking all are the common factors which
   influence TB relapse within 5 years or above 5 years.}},
Publisher = {{SSJ COLL PHARMACY-SSJCP}},
Address = {{125B-125 SANTRANJIPURA, TLIPHONE EXCHANGE RD, NAGPUR, 440001, INDIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ansaril, R (Reprint Author), LUMHS Res Forum, Jamshoro, Pakistan.
   Ansaril, R (Reprint Author), Liaquat Univ Med \& Hlth Sci, Jamshoro, Pakistan.
   Ansaril, Reda; Nawani, Kapeel; Nusrat, Hafsa, LUMHS Res Forum, Jamshoro, Pakistan.
   Ansaril, Reda; Nawani, Kapeel; Nusrat, Hafsa, Liaquat Univ Med \& Hlth Sci, Jamshoro, Pakistan.}},
DOI = {{10.5281/zenodo.1001120}},
ISSN = {{2349-7750}},
Keywords = {{Tuberculosis; Tuberculosis relapse; Tuberculosis Recurrence and
   Tuberculosis Recurrence}},
Keywords-Plus = {{SHORT-COURSE CHEMOTHERAPY; DRUG-RESISTANT TUBERCULOSIS; STANDARD
   RETREATMENT REGIMEN; PULMONARY TUBERCULOSIS; EXOGENOUS REINFECTION;
   MYCOBACTERIUM-TUBERCULOSIS; MADRAS; INDIA; AREA}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Chemistry, Medicinal}},
Author-Email = {{reda.ansaari@gmail.com}},
Cited-References = {{Bandera A, 2001, J CLIN MICROBIOL, V39, P2213, DOI 10.1128/JCM.39.6.2213-2218.2001.
   Cacho J, 2007, EUR RESPIR J, V30, P333, DOI 10.1183/09031936.00005107.
   Caminero JA, 2001, AM J RESP CRIT CARE, V163, P717, DOI 10.1164/ajrccm.163.3.2003070.
   Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009.
   Crofts JP, 2010, THORAX, V65, P310, DOI 10.1136/thx.2009.124677.
   DAS S, 1993, TUBERCLE LUNG DIS, V74, P47, DOI 10.1016/0962-8479(93)90068-9.
   Das S, 1995, TUBERCLE LUNG DIS, V76, P550, DOI 10.1016/0962-8479(95)90533-2.
   DeRiemer K, 2005, LANCET, V365, P1239, DOI 10.1016/S0140-6736(05)74812-1.
   Dobler CC, 2009, EUR RESPIR J, V33, P160, DOI 10.1183/09031936.00104108.
   Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537.
   Garcia de Viedma D, 2002, ARCH INTERN MED, V162, P1873.
   Garcia-Garcia MD, 2000, ARCH INTERN MED, V160, P630, DOI 10.1001/archinte.160.5.630.
   Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-10810C.
   Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9.
   Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8.
   Lan NTN, 2001, INT J TUBERC LUNG D, V5, P575.
   Migliori GB, 2002, INT J TUBERC LUNG D, V6, P858.
   Millet JP, 2009, J EPIDEMIOL COMMUN H, V63, P799, DOI 10.1136/jech.2008.077560.
   MITCHISON DA, 1986, AM REV RESPIR DIS, V133, P423.
   Quy HTW, 2003, INT J TUBERC LUNG D, V7, P631.
   SAHADEVAN R, 1995, J CLIN MICROBIOL, V33, P3037.
   Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005.
   Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5.
   Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602.
   Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC.
   WHO, 2008, GLOB TUB CONTR SURV.
   World Health Organization, 2004, ANT DRUG RES WORLD 3.
   World Health Organization (WHO), 2006, WHOHTMTB2006362.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Indo Am. J. Pharm. Sci.}},
Doc-Delivery-Number = {{FU6HQ}},
Unique-ID = {{ISI:000423952900009}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000425196700010,
Author = {Mietke, H. and Keck, S. and Jaeckel, U.},
Title = {{Investigations of bioaerosols from emissions of a turkey farm - Part 2:
   Characterization of the bacterial composition}},
Journal = {{GEFAHRSTOFFE REINHALTUNG DER LUFT}},
Year = {{2017}},
Volume = {{77}},
Number = {{10}},
Pages = {{451-457}},
Month = {{OCT}},
Abstract = {{The bacterial composition of bioaerosol emissions from a turkey poultry
   house harbouring 1,700 animals was intensively investigated. Employing
   different agar based media bacteria were isolated from emission samples
   and subsequently identified by MALDI-TOF MS analyses. Furthermore, 16S
   rRNA gene compositions in samples were investigated at four different
   time points within a fattening period by the generation and analyses of
   clone libraries. The identified bacterial species reflect the turkeys'
   skin-associated bacterial community. Species of the genera
   Staphylococcus/Jeotgalicoccus as well as Coryne-bacterium stationis were
   predominantly detected. The clone libraries' sequences were predominated
   by those who were most closely related to species known as members of
   turkeys' microaerophilic and obligate anaerobic intestinal community.
   Results of investigated clone libraries show as well that species of the
   genera Lactobacillus, Staphylococcus, Romboutsia, Streptococcus,
   Aerococcus, Megamonas, Jeotgalicoccus, Blautia, Faecalibacterium,
   Ruminococcus and Clostridium seems to be emitted at each time point
   during fattening. A lot of sequences could not be assigned to any of jet
   cultured bacterial species. This demonstrates a big gap in our
   knowledge. Aerococcus viridans deserves special attention for health
   risk assessments in future. In context to measuring strategies the
   implementations of potentially new indicator-micorganisms is part of the
   discussion.}},
Publisher = {{SPRINGER-V D I VERLAG GMBH \& CO KG}},
Address = {{VDI-PLATZ 1, D-40468 DUSSELDORF, GERMANY}},
Type = {{Article}},
Language = {{German}},
Affiliation = {{Mietke, H (Reprint Author), Staatliche Betriebsgesell Umwelt \& Landwirtschaft, Nossen, Germany.
   Mietke, H., Staatliche Betriebsgesell Umwelt \& Landwirtschaft, Nossen, Germany.
   Keck, S.; Jaeckel, U., Bundesanstalt Arbeitsschutz \& Arbeitsmed, Berlin, Germany.}},
ISSN = {{0949-8036}},
EISSN = {{1436-4891}},
Keywords-Plus = {{HIGHLY CONTAMINATED WORKPLACES; WORK-RELATED CONTACT; COAGULASE-NEGATIVE
   STAPHYLOCOCCI; GRAM-POSITIVE COCCI; MICROBIOLOGICAL METHODS; BIOLOGICAL
   AGENTS; EXPOSURE ANALYSES; COMB-NOV; ANTIBIOTIC-RESISTANCE; AIRBORNE
   BACTERIA}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Engineering, Civil; Environmental Sciences}},
Cited-References = {{{[}Anonymous], 2011, 4257 VDI.
   {[}Anonymous], 2013, 4253 VDI.
   {[}Anonymous], 2016, 4255 VDI.
   {[}Anonymous], 2017, 4253 VDI.
   {[}Anonymous], 2017, 215281 DIN EN ISO.
   {[}Anonymous], 2000, 78992 DIN EN ISO.
   {[}Anonymous], 2008, 4253 VDI.
   {[}Anonymous], 2016, 4250 VDI.
   Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13.
   Bernard KA, 2010, INT J SYST EVOL MICR, V60, P874, DOI 10.1099/ijs.0.012641-0.
   Collins M. D., 2006, GENUS BREVIBACTERIUM, V3.
   Danzeisen JL, 2013, PEERJ, V1, DOI 10.7717/peerj.237.
   DEVRIESE LA, 1978, INT J SYST BACTERIOL, V28, P482, DOI 10.1099/00207713-28-4-482.
   DEVRIESE LA, 1985, J APPL BACTERIOL, V58, P45, DOI 10.1111/j.1365-2672.1985.tb01428.x.
   EURL-AMR, 2012, EFSA J, V19, P2897.
   FACKLAM R, 1995, CLIN MICROBIOL REV, V8, P479.
   Fallschissel K, 2010, ANN OCCUP HYG, V54, P934, DOI 10.1093/annhyg/meq054.
   FUJISAWA T, 1984, SYST APPL MICROBIOL, V5, P414, DOI 10.1016/S0723-2020(84)80042-9.
   Gartner A, 2016, GEFAHRST REINHALT L, V76, P31.
   Gartner A, 2014, GEFAHRST REINHALT L, V74, P377.
   Haas D, 2005, AEROBIOLOGIA, V21, P193, DOI 10.1007/s10453-005-9003-x.
   HAJEK V, 1986, SYST APPL MICROBIOL, V8, P169, DOI 10.1016/S0723-2020(86)80071-6.
   Jackel U, 2013, GEFAHRST REINHALT L, V73, P358.
   Li Y, 2006, INT J SYST EVOL MICR, V56, P2397, DOI 10.1099/ijs.0.64426-0.
   Lippmann J, 2016, GEFAHRST REINHALT L, V76, P359.
   Martin E, 2013, GEFAHRST REINHALT L, V73, P361.
   Martin E, 2012, GEFAHRST REINHALT L, V72, P99.
   Martin E, 2010, SYST APPL MICROBIOL, V33, P188, DOI 10.1016/j.syapm.2010.03.008.
   Mohan B., 2017, J CLIN DIAGN RES, V11.
   Rasmussen M, 2013, J INFECTION, V66, P467, DOI 10.1016/j.jinf.2012.12.006.
   Schafer J, 2013, GEFAHRST REINHALT L, V73, P423.
   SCHLEIFER KH, 1984, SYST APPL MICROBIOL, V5, P501, DOI 10.1016/S0723-2020(84)80007-7.
   SCHLEIFER KH, 1983, SYST APPL MICROBIOL, V4, P382, DOI 10.1016/S0723-2020(83)80022-8.
   Schneider D, 2015, GEFAHRST REINHALT L, V75, P340.
   Schwaiger K, 2010, LETT APPL MICROBIOL, V50, P441, DOI 10.1111/j.1472-765X.2010.02811.x.
   Scupham AJ, 2008, MICROB ECOL, V56, P322, DOI 10.1007/s00248-007-9349-4.
   Technische Regeln fur Biologische Arbeitsstoffe (TRBA), 2015, GMBI, P910.
   TURTURA GC, 1994, MICROBIOL RES, V149, P203, DOI 10.1016/S0944-5013(11)80120-5.
   Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822.
   WILLIAMS REO, 1953, J GEN MICROBIOL, V8, P475, DOI 10.1099/00221287-8-3-475.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Gefahrst. Reinhalt. Luft}},
Doc-Delivery-Number = {{FW3HF}},
Unique-ID = {{ISI:000425196700010}},
DA = {{2018-08-13}},
}

@article{ ISI:000417400700012,
Author = {Hui, David S. C. and Lee, Nelson and Chan, Paul K. S.},
Title = {{A clinical approach to the threat of emerging influenza viruses in the
   Asia-Pacific region}},
Journal = {{RESPIROLOGY}},
Year = {{2017}},
Volume = {{22}},
Number = {{7}},
Pages = {{1300-1312}},
Month = {{OCT}},
Abstract = {{Seasonal influenza epidemics and periodic pandemics are important causes
   of morbidity and mortality. Patients with chronic co-morbid illness,
   those at the extremes of age and pregnant women are at higher risks of
   complications requiring hospitalization, whereas young adults and obese
   individuals were also at increased risk during the A(H1N1) pandemic in
   2009. Avian influenza A(H5N1) and A(H7N9) viruses have continued to
   circulate widely in some poultry populations and infect humans
   sporadically since 1997 and 2013, respectively. The recent upsurge in
   human cases of A(H7N9) infections in Mainland China is of great concern.
   Sporadic human cases of avian A(H5N6), A (H10N8) and A(H6N1) have also
   emerged in recent years while there are also widespread poultry
   outbreaks due to A(H5N8) in many countries. Observational studies have
   shown that treatment with a neuraminidase inhibitor (NAI) for adults
   hospitalized with severe influenza is associated with lower mortality
   and better clinical outcomes, especially when administered early in the
   course of illness. Whether higher than standard doses of NAI would
   provide greater antiviral effects in such patients will require further
   investigation. High-dose systemic corticosteroids were associated with
   worse outcomes in patients with severe influenza. There is an urgent
   need for developing more effective antiviral therapies for treatment of
   influenza infections.}},
Publisher = {{WILEY}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Hui, DSC (Reprint Author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med \& Therapeut, Shatin, Hong Kong, Peoples R China.
   Hui, David S. C.; Lee, Nelson, Chinese Univ Hong Kong, Dept Med \& Therapeut, Shatin, Hong Kong, Peoples R China.
   Hui, David S. C.; Lee, Nelson; Chan, Paul K. S., Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China.
   Chan, Paul K. S., Chinese Univ Hong Kong, Dept Microbiol, Shatin, Hong Kong, Peoples R China.}},
DOI = {{10.1111/resp.13114}},
ISSN = {{1323-7799}},
EISSN = {{1440-1843}},
Keywords = {{avian influenza; respiratory tract infections; seasonal; treatment;
   viral}},
Keywords-Plus = {{A H7N9 VIRUS; RESPIRATORY-TRACT INFECTIONS; EXHALED AIR DISPERSION;
   TO-HUMAN TRANSMISSION; AVIAN-INFLUENZA; H5N1 VIRUS; INTRAVENOUS
   ZANAMIVIR; ANTIVIRAL RESISTANCE; NEURAMINIDASE INHIBITORS; NONINVASIVE
   VENTILATION}},
Research-Areas = {{Respiratory System}},
Web-of-Science-Categories  = {{Respiratory System}},
Author-Email = {{dschui@cuhk.edu.hk}},
ResearcherID-Numbers = {{Lee, Nelson/B-6418-2008
   Hui, David/O-2754-2015
   }},
ORCID-Numbers = {{Hui, David/0000-0003-4382-2445
   Lee, Nelson/0000-0002-0783-6607}},
Funding-Acknowledgement = {{Health \& Medical Research Fund {[}12110392]; Research Grants Council of
   the Hong Kong Special Administrative Region, China {[}T11-705/14N]; Food
   \& Health Bureau, HKSAR}},
Funding-Text = {{This project was partially supported by the Health \& Medical Research
   Fund (\#12110392), Research Grants Council of the Hong Kong Special
   Administrative Region, China (Project No. T11-705/14N), Food \& Health
   Bureau, HKSAR.}},
Cited-References = {{Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279.
   Adisasmito W, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-571.
   Adisasmito W, 2010, J INFECT DIS, V202, P1154, DOI 10.1086/656316.
   {[}Anonymous], 2017, DIS OUTBREAK NE 0208.
   {[}Anonymous], 2014, WHO CHINA STATEMENT.
   Avian Influenza Report. Centre for Health Protection, 2017, HONG KONG SAR GOV, V13, P15.
   Bai T, 2013, NEW ENGL J MED, V368, P2339, DOI 10.1056/NEJMc1305865.
   Cao B, 2016, CRIT CARE MED, V44, pE318, DOI 10.1097/CCM.0000000000001616.
   Centers for Disease Control and Prevention, 2003, MMWR RECOMM REP, V52, P1.
   Chan MCW, 2014, J CLIN MICROBIOL, V52, P497, DOI 10.1128/JCM.02316-13.
   Chan PKS, 2013, CLIN INFECT DIS, V56, P677, DOI 10.1093/cid/cis885.
   Chan PKS, 2012, J INFECT DIS, V206, P1359, DOI 10.1093/infdis/jis509.
   Chan PKS, 2009, J MED VIROL, V81, P1797, DOI 10.1002/jmv.21551.
   CHAN PKS, 2015, MEDICINE, V94, DOI DOI 10.1097/MD.0000000000002024.
   Chan-Tack KM, 2013, J INFECT DIS, V207, P196, DOI 10.1093/infdis/jis637.
   Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2.
   Chen HZ, 2016, EMERG INFECT DIS, V22, P598, DOI 10.3201/eid2204.151561.
   Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4.
   Chi Y, 2013, J INFECT DIS, V208, P1962, DOI 10.1093/infdis/jit440.
   Conti G, 2009, ROLE NONINVASIVE VEN.
   Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X.
   Davey RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057121.
   de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307.
   Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1.
   ECDC, 2017, REC UPS A H7N9 CAS C.
   Fang CF, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5765.
   Feng L., 2014, Eurosurveillance, V19, P20984, DOI 10.2807/1560-7917.ES2014.19.49.20984.
   Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1.
   Food \& Agricultural Organization of the United Nations, 2017, H5N8 HPAI GLOB SIT U.
   Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584.
   Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459.
   Govorkova EA, 2013, ANTIVIR RES, V98, P297, DOI 10.1016/j.antiviral.2013.02.013.
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520.
   Haviari S, 2015, HUM VACC IMMUNOTHER, V11, P2522, DOI 10.1080/21645515.2015.1082014.
   Ho PL, 2014, EUR RESPIR J, V44, P535, DOI 10.1183/09031936.00006414.
   Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3.
   Hui DS, 2006, CHEST, V130, P730, DOI 10.1378/chest.130.3.730.
   Hui DS, 2015, CHEST, V147, P1336, DOI 10.1378/chest.14-1934.
   Hui DS, 2013, ANTIVIR RES, V98, P410, DOI 10.1016/j.antiviral.2013.03.019.
   Hui DS, 2010, CHEST, V137, P916, DOI 10.1378/chest.09-2344.
   Hui DS, 2009, CHEST, V136, P998, DOI 10.1378/chest.09-0434.
   Hui DSC, 2008, RESPIROLOGY, V13, pS10, DOI 10.1111/j.1440-1843.2008.01247.x.
   Hung IFN, 2017, CHEST, V151, P1069, DOI 10.1016/j.chest.2016.11.012.
   Hurt AC, 2015, INFLUENZA OTHER RESP, V9, P20, DOI 10.1111/irv.12293.
   Jefferson T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008965.pub4.
   Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930.
   Kang SM, 2011, VIRUS RES, V162, P31, DOI 10.1016/j.virusres.2011.09.037.
   Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224.
   KAWAOKA Y, 1989, J VIROL, V63, P4603.
   Keh D, 2016, JAMA-J AM MED ASSOC, V316, P1775, DOI 10.1001/jama.2016.14799.
   Kumar A, 2013, 53 INT C ANT AG CHEM.
   Lai SJ, 2016, LANCET INFECT DIS, V16, pE108, DOI 10.1016/S1473-3099(16)00153-5.
   Latham T, 2001, J VIROL, V75, P6154, DOI 10.1128/JVI.75.13.6154-6165.2001.
   Lee N, 2016, INT J ANTIMICROB AG, V48, P215, DOI 10.1016/j.ijantimicag.2016.05.003.
   Lee N, 2013, CLIN INFECT DIS, V57, P1511, DOI 10.1093/cid/cit597.
   Lee N, 2010, THORAX, V65, P510, DOI 10.1136/thx.2009.130799.
   Lee N, 2007, ANTIVIR THER, V12, P501.
   Lee N, 2015, EUR RESPIR J, V45, P1642, DOI 10.1183/09031936.00169714.
   Lee N, 2011, J INFECT DIS, V203, P1739, DOI 10.1093/infdis/jir187.
   Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722.
   Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617.
   Li TCM, 2015, VIRUSES-BASEL, V7, P4929, DOI 10.3390/v7092850.
   Lim WS, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19160.
   Liu T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-98.
   Mair-Jenkins J, 2015, J INFECT DIS, V211, P80, DOI 10.1093/infdis/jiu396.
   Marty FM, 2014, J INFECT DIS, V209, P542, DOI 10.1093/infdis/jit467.
   Mertz D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089697.
   Morens DM, 2013, NEW ENGL J MED, V368, P2345, DOI 10.1056/NEJMp1307009.
   Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4.
   Pabbaraju K, 2014, EMERG INFECT DIS, V20, P887, DOI 10.3201/eid2005.140164.
   Patel RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091630.
   Peiris JSM, 2016, LANCET INFECT DIS, V16, P252, DOI {[}10.1016/S1473-3099(15)00502-2, 10.1016/S1473-3099(15)70191-X].
   Public Health England, 2016, PHE GUID US ANT AG T.
   Pushko P, 2005, VACCINE, V23, P5751, DOI 10.1016/j.vaccine.2005.07.098.
   Pushko P, 2011, VACCINE, V29, P5911, DOI 10.1016/j.vaccine.2011.06.068.
   Qi X, 2014, GENOME ANNOUNC, V2.
   Rodrigo C, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010406.pub2.
   SCHULTZ U, 1991, VIROLOGY, V183, P61, DOI 10.1016/0042-6822(91)90118-U.
   Self WH, 2016, CHEST, V150, P819, DOI 10.1016/j.chest.2016.04.010.
   Seto WH, 2013, E MEDITERR HEALTH J, V19, pS39.
   South East Asia Infectious Disease Clinical Research Network, 2013, BMJ, V346, pf3039, DOI 10.1136/bmj.f3039.
   Takashita E, 2016, ANTIVIR RES, V132, P170, DOI 10.1016/j.antiviral.2016.06.007.
   Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230.
   Taylor G, 2014, INFECT CONT HOSP EP, V35, P169, DOI 10.1086/674858.
   Thomas RE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005187.pub5.
   Thompson KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056278.
   Torres A, 2016, EUR RESPIR J, V48, P1764, DOI 10.1183/13993003.01144-2016.
   Wang CH, 2014, CRIT CARE MED, V42, P313, DOI 10.1097/CCM.0b013e3182a2727d.
   Wang TT, 2012, SCIENCE, V335, P1463, DOI 10.1126/science.1218888.
   Wei SH, 2013, LANCET RESP MED, V1, P771, DOI 10.1016/S2213-2600(13)70221-2.
   WHO, 2009, WHO GUID NAT VENT IN.
   WHO, 2014, AV INFL A H7N9 VIR P.
   WHO, 2016, ASS RISK ASS INFL A.
   WHO, 2003, CUM NUMB CONF HUM CA.
   WHO West Pacific Region, 2017, AVIAN INFLUENZA WEEK.
   Wong BCK, 2010, CLIN INFECT DIS, V51, P1176, DOI 10.1086/656743.
   WONG MCS, 2016, MEDICINE, V95, DOI DOI 10.1097/MD.0000000000003359.
   World Health Organization, 2014, DIS OUTBREAK NE 0208.
   Yamashita M, 2009, ANTIMICROB AGENTS CH, V53, P186, DOI 10.1128/AAC.00333-08.
   Yang Y, 2007, EMERG INFECT DIS, V13, P1348, DOI 10.3201/eid1309.070111.
   Yi LN, 2015, J CLIN MICROBIOL, V53, P22, DOI 10.1128/JCM.02322-14.
   Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2.
   Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9.
   Zhang T, 2014, EMERG INFECT DIS, V20, P2076, DOI 10.3201/eid2012.140911.
   Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379.
   Zumla A, 2014, LANCET INFECT DIS, V14, P1136, DOI 10.1016/S1473-3099(14)70828-X.}},
Number-of-Cited-References = {{106}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{6}},
Journal-ISO = {{Respirology}},
Doc-Delivery-Number = {{FP1UR}},
Unique-ID = {{ISI:000417400700012}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000412355000004,
Author = {Gowda, Tanuja K. G. M. and Latha, C. and Sunil, B. and Van Damme, Inge},
Title = {{Occurrence and Antibiotic Susceptibility of Listeria Species and
   Staphylococcus aureus in Cattle Slaughterhouses of Kerala, South India}},
Journal = {{FOODBORNE PATHOGENS AND DISEASE}},
Year = {{2017}},
Volume = {{14}},
Number = {{10}},
Pages = {{573-579}},
Month = {{OCT}},
Abstract = {{A total of 765 samples were collected from beef carcasses, knives,
   cutting table surfaces, beef, hands, air, and water from four cattle
   slaughterhouses of Kerala, South India, to determine the occurrence and
   antibiotic susceptibility of Listeria species and Staphylococcus aureus.
   Listeria spp. were isolated from beef carcasses (2.0\%), knives (3.7\%),
   cutting table surfaces (1.9\%), beef (0.7\%), and water (1.3\%). The
   identified species were Listeria monocytogenes (0.1\%), Listeria innocua
   (0.9\%), and Listeria ivanovii (0.4\%). Most of the Listeria spp. were
   susceptible to majority of the antibiotics tested. The virulence genes
   were not detected in Listeria spp. However, all the L. innocua isolates
   were found to harbor the iap gene. The overall occurrence of S. aureus
   in slaughterhouses was 50.8\%. The highest occurrence was observed on
   hands of abattoir workers (79.6\%) and beef carcasses (59.9\%). The
   isolates were commonly resistant to penicillin (38.0\%), followed by
   ceftriaxone (31.9\%), ampicillin (29.0\%), amoxicillin (28.8\%),
   tetracycline (24.4\%), and chloramphenicol (23.9\%). Overall, 53.0\% of
   S. aureus isolates were resistant to three or more antibiotics.
   Vancomycin and methicillin resistance were observed in 8.5\% and 5.4\%
   of S. aureus isolates, respectively. Eight methicillin-resistant S.
   aureus isolates were found to harbor the mecA gene. In conclusion,
   Listeria spp. was only rarely found in the slaughterhouse environment
   and on beef. Nevertheless, the recovery of L. monocytogenes from a water
   reservoir containing sea water that was used to wash carcasses indicates
   the potential risk of contamination of the carcasses with L.
   monocytogenes when using sea water. S. aureus was frequently isolated
   from abattoir workers and beef carcasses, and the occurrence of S.
   aureus differed significantly between slaughterhouses. The high
   occurrence of S. aureus, which were often resistant toward different
   antibiotics, represents a significant public health concern.}},
Publisher = {{MARY ANN LIEBERT, INC}},
Address = {{140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Gowda, TKGM (Reprint Author), Kerala Vet \& Anim Sci Univ, Coll Vet \& Anim Sci, Dept Vet Publ Hlth, Wayanad 673576, Kerala, India.
   Gowda, Tanuja K. G. M.; Latha, C., Kerala Vet \& Anim Sci Univ, Coll Vet \& Anim Sci, Dept Vet Publ Hlth, Wayanad 673576, Kerala, India.
   Gowda, Tanuja K. G. M.; Van Damme, Inge, Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth \& Food Safety, Merelbeke, Belgium.
   Sunil, B., Kerala Vet \& Anim Sci Univ, Coll Vet \& Anim Sci, Dept Vet Publ Hlth, Wayanad, Kerala, India.}},
DOI = {{10.1089/fpd.2017.2293}},
ISSN = {{1535-3141}},
EISSN = {{1556-7125}},
Keywords = {{cattle slaughterhouses; Listeria spp.; Staphylococcus aureus; antibiotic
   susceptibility}},
Keywords-Plus = {{PROCESSING PLANTS; MONOCYTOGENES; PREVALENCE; MEAT; CONTAMINATION;
   RESISTANCE; BEEF; IDENTIFICATION; POULTRY; MILK}},
Research-Areas = {{Food Science \& Technology}},
Web-of-Science-Categories  = {{Food Science \& Technology}},
Author-Email = {{tanu.gowda@gmail.com}},
ResearcherID-Numbers = {{Amoako, Daniel Gyamfi/I-4223-2018}},
Funding-Acknowledgement = {{Kerala State Council for Science and Technology and Environment (KSCSTE)}},
Funding-Text = {{We would like to thank Kerala Veterinary and Animal Sciences University
   (KVASU) for providing necessary infrastructure and facilities for
   conducting the study, also, Kerala State Council for Science and
   Technology and Environment (KSCSTE) for the financial support.}},
Cited-References = {{AjayKumar VJ, 2014, THESIS, P92.
   Alarcon B, 2006, J APPL MICROBIOL, V100, P352, DOI 10.1111/j.1365-2672.2005.02768.x.
   {[}Anonymous], 2011, STAT DAT AN STAT SOF.
   Aznar R, 2003, J APPL MICROBIOL, V95, P958, DOI 10.1046/j.1365-2672.2003.02066.x.
   Barros MAF, 2007, MEAT SCI, V76, P591, DOI 10.1016/j.meatsci.2007.01.016.
   Barrow C. J., 1993, COWAN STEELS MANUAL.
   Bhandare SG, 2007, FOOD CONTROL, V18, P854, DOI 10.1016/j.foodcont.2006.04.012.
   Bhargava K, 2011, EMERG INFECT DIS, V17, P1135, DOI {[}10.3201/eid/1706.101905, 10.3201/eid1706.101095].
   Caplan ME, 2014, ROM REV LAB MED, V22, P2.
   Charpentier E, 1999, ANTIMICROB AGENTS CH, V43, P2103.
   Clinical Laboratory Standard Institute {[}CLSI], 2010, M100S20 CLSI, P30.
   Dan SD, 2015, J INFECT DEV COUNTR, V9, P35, DOI 10.3855/jidc.4958.
   Dhama K, 2015, VET QUART, V35, P211, DOI 10.1080/01652176.2015.1063023.
   Dhanashree B, 2003, INDIAN J MED RES, V117, P19.
   Evancho G. M., 2001, COMPENDIUM METHODS M, P25.
   Frey Y, 2013, J DAIRY SCI, V96, P2247, DOI 10.3168/jds.2012-6091.
   Hiroi M, 2012, J FOOD PROTECT, V75, P1774, DOI 10.4315/0362-028X.JFP-11-479.
   Jackson CR, 2013, J CLIN MICROBIOL, V51, P1199, DOI 10.1128/JCM.03166-12.
   Kalorey DR, 2005, 17 EUR S QUAL POULTR.
   Kelman A, 2011, J FOOD PROTECT, V74, P1625, DOI 10.4315/0362-028X.JFP-10-571.
   Lancette GA, 2001, COMPENDIUM METHODS M, P403.
   LECHEVALLIER MW, 1980, APPL ENVIRON MICROB, V39, P739.
   Lipsitcht M, 2002, P NATL ACAD SCI USA, V99, P5752, DOI 10.1073/pnas.09214299.
   Nightingale KK, 2004, APPL ENVIRON MICROB, V70, P4458, DOI 10.1128/AEM.70.8.4458-4467.2004.
   Pesavento G, 2010, FOOD CONTROL, V21, P708, DOI 10.1016/j.foodcont.2009.10.012.
   Phillips D, 2001, FOOD CONTROL, V25, P778.
   Rawool DB, 2007, INT J FOOD MICROBIOL, V113, P201, DOI 10.1016/j.ijfoodmicro.2006.06.029.
   Ryser ET, 2001, COMPENDIUM METHODS M, P580.
   Schlegelova J, 2004, MEAT SCI, V66, P557, DOI 10.1016/S0309-1740(03)00159-1.
   Thaker HC, 2013, VET WORLD, V6, P10, DOI 10.5455/vetworld.2013.10-13.
   Waters AE, 2011, CLIN INFECT DIS, V52, P1227, DOI 10.1093/cid/cir181.
   WHO, 2012, WHO TECH REP SER, V969, P1.
   WU S., 2015, PLOS ONE, V10.
   Zhu LX, 2012, FOODBORNE PATHOG DIS, V9, P556, DOI 10.1089/fpd.2011.1088.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{6}},
Usage-Count-Since-2013 = {{38}},
Journal-ISO = {{Foodborne Pathog. Dis.}},
Doc-Delivery-Number = {{FI9UO}},
Unique-ID = {{ISI:000412355000004}},
DA = {{2018-08-13}},
}

@article{ ISI:000414451900002,
Author = {Churchyard, Gavin and Kim, Peter and Shah, N. Sarita and Rustomjee,
   Roxana and Gandhi, Neel and Mathema, Barun and Dowdy, David and Kasmar,
   Anne and Cardenas, Vicky},
Title = {{What We Know About Tuberculosis Transmission: An Overview}},
Journal = {{JOURNAL OF INFECTIOUS DISEASES}},
Year = {{2017}},
Volume = {{216}},
Number = {{6}},
Pages = {{S629-S635}},
Month = {{OCT 1}},
Abstract = {{Tuberculosis remains a global health problem with an enormous burden of
   disease, estimated at 10.4 million new cases in 2015. To stop the
   tuberculosis epidemic, it is critical that we interrupt tuberculosis
   transmission. Further, the interventions required to interrupt
   tuberculosis transmission must be targeted to high-risk groups and
   settings. A simple cascade for tuberculosis transmission has been
   proposed in which (1) a source case of tuberculosis (2) generates
   infectious particles (3) that survive in the air and (4) are inhaled by
   a susceptible individual (5) who may become infected and (6) then has
   the potential to develop tuberculosis. Interventions that target these
   events will interrupt tuberculosis transmission and accelerate the
   decline in tuberculosis incidence and mortality. The purpose of this
   article is to provide a high-level overview of what is known about
   tuberculosis transmission, using the tuberculosis transmission cascade
   as a framework, and to set the scene for the articles in this series,
   which address specific aspects of tuberculosis transmission.}},
Publisher = {{OXFORD UNIV PRESS INC}},
Address = {{JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Cardenas, V (Reprint Author), Aurum Inst, Aurum House,29 Queens Rd, ZA-2193 Johannesburg, South Africa.
   Churchyard, Gavin; Cardenas, Vicky, Aurum Inst, Aurum House,29 Queens Rd, ZA-2193 Johannesburg, South Africa.
   Churchyard, Gavin, Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.
   Churchyard, Gavin, Advancing Care \& Treatment TB HIV, Johannesburg, South Africa.
   Churchyard, Gavin, South African Med Res Council, Johannesburg, South Africa.
   Kim, Peter; Rustomjee, Roxana, NIH, Div AIDS, Bldg 10, Bethesda, MD 20892 USA.
   Dowdy, David, Johns Hopkins Univ, Baltimore, MD USA.
   Shah, N. Sarita, Ctr Dis Control \& Prevent, Div Global HIV \& TB, Atlanta, GA USA.
   Gandhi, Neel, Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
   Gandhi, Neel, Emory Univ, Emory Sch Med, Atlanta, GA 30322 USA.
   Mathema, Barun, Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA.
   Kasmar, Anne, Bill \& Melinda Gates Fdn, Seattle, WA USA.}},
DOI = {{10.1093/infdis/jix362}},
ISSN = {{0022-1899}},
EISSN = {{1537-6613}},
Keywords = {{Tuberculosis; transmission}},
Keywords-Plus = {{ISONIAZID PREVENTIVE THERAPY; CLUSTER-RANDOMIZED TRIAL;
   MULTIDRUG-RESISTANT TUBERCULOSIS; RIO-DE-JANEIRO; SOUTH-AFRICA;
   MYCOBACTERIUM-TUBERCULOSIS; SOCIAL CONTACT; XPERT MTB/RIF; GOLD MINERS;
   COMMUNITY}},
Research-Areas = {{Immunology; Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Immunology; Infectious Diseases; Microbiology}},
Author-Email = {{vcardenas@auruminstitute.org}},
Funding-Acknowledgement = {{Division of AIDS, National Institute of Allergy and Infectious Diseases
   (NIAID), US National Institutes of Health (NIH), Department of Health
   and Human Services {[}HHSN272201100001G]; NIH {[}NIAID R01AI089349,
   NIAID R01AI087465, NIAIDK24AI114444, Emory CFAR P30AI050409, NHLBI T32
   HL116271]; Bill \& Melinda Gates Foundation}},
Funding-Text = {{This publication and workshop have been funded in whole or in part with
   Federal Funds from the Division of AIDS, National Institute of Allergy
   and Infectious Diseases (NIAID), US National Institutes of Health (NIH),
   Department of Health and Human Services under contract number
   HHSN272201100001G - Research Support Services for the Division of AIDS.
   Funding support was alsoprovided in part by NIH grants: NIAID
   R01AI089349 (PI Gandhi), NIAID R01AI087465 (PI Gandhi), NIAIDK24AI114444
   (PI Gandhi), Emory CFAR P30AI050409 (PI JW Curran), and NHLBI T32
   HL116271 (PI DM Guidot). The Bill \& Melinda Gates Foundation provided
   funding for participant travel to the workshop. TheCenters for Disease
   Control and Prevention (CDC) and the South African Medical Research
   Council co-hostedthe event.}},
Cited-References = {{Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106.
   Andrews JR, 2014, J INFECT DIS, V210, P597, DOI 10.1093/infdis/jiu138.
   Andrews JR, 2013, AM J EPIDEMIOL, V177, P556, DOI 10.1093/aje/kws331.
   Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9.
   Barnagarwala T., 2014, TB HOSP STAFF LIVE S.
   Barrera E, 2015, INT J TUBERC LUNG D, V19, P381, DOI 10.5588/ijtld.14.0680.
   Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847.
   Cavalcante SC, 2010, INT J TUBERC LUNG D, V14, P203.
   Cegielski JP, 2013, AM J PUBLIC HEALTH, V103, P1292, DOI 10.2105/AJPH.2012.300781.
   CHAPMAN JS, 1964, AM REV RESPIR DIS, V90, P48.
   Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X.
   Churchyard GJ, 2014, NEW ENGL J MED, V370, P301, DOI 10.1056/NEJMoa1214289.
   COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P827.
   COMSTOCK GW, 1967, AM REV RESPIR DIS, V95, P935.
   Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022.
   Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0.
   Cowie RL, 1996, TUBERCLE LUNG DIS, V77, P239, DOI 10.1016/S0962-8479(96)90007-6.
   Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834.
   Dobbs TE, 2008, AIDS THERAPY E BOOK.
   Dodd PJ, 2016, AM J EPIDEMIOL, V183, P156, DOI 10.1093/aje/kwv160.
   Dowdy DW, 2014, CLIN INFECT DIS, V59, P1123, DOI 10.1093/cid/ciu506.
   Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7.
   Escombe AR, 2010, INT J TUBERC LUNG D, V14, P1120.
   Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043.
   FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28.
   Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812.
   Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166.
   Hanifa Y, 2009, INT J TUBERC LUNG D, V13, P39.
   Hermans S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135179.
   HORWITZ O, 1966, B WORLD HEALTH ORGAN, V35, P509.
   HORWITZ O, 1974, AM J EPIDEMIOL, V99, P333, DOI 10.1093/oxfordjournals.aje.a121618.
   Houben RMGJ, 2016, LANCET GLOB HEALTH, V4, pE806, DOI 10.1016/S2214-109X(16)30199-1.
   Houben RMGJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002152.
   Huang CC, 2014, CLIN INFECT DIS, V58, P765, DOI 10.1093/cid/cit948.
   Johnstone-Robertson S, 2011, SAMJ S AFR MED J, V101, P809.
   Kendall EA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002202.
   Knight GM, 2014, P NATL ACAD SCI USA, V111, P15520, DOI 10.1073/pnas.1404386111.
   Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743.
   Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5.
   Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797.
   Nyboe J, 1963, REPORT CHEMOTHERAPY.
   Rangaka MX, 2015, LANCET, V386, P1, DOI 10.1016/S0140-6736(15)00323-2.
   Rendleman NJ, 1999, AM J PREV MED, V17, P108, DOI 10.1016/S0749-3797(99)00052-5.
   RILEY RL, 1962, AM REV RESPIR DIS, V85, P511.
   RILEY RL, 1959, AM J HYG, V70, P185, DOI 10.1093/oxfordjournals.aje.a120069.
   Riley RL, 1961, AIRBORNE INFECT TRAN.
   Shah NS, 2014, CLIN INFECT DIS, V58, P381, DOI 10.1093/cid/cit643.
   Shanaube K, 2014, THESIS.
   Small PM, 2010, NEW ENGL J MED, V363, P1070, DOI 10.1056/NEJMe1008496.
   Telisinghe L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087262.
   Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5.
   Turner RD, 2015, J INFECT DIS, V211, P1367, DOI 10.1093/infdis/jiu625.
   Wells WF, 1934, AM J HYG, V20, P611, DOI 10.1093/oxfordjournals.aje.a118097.
   WHO, 2016, WHOHTMTB201613.
   Yates TA, 2016, LANCET INFECT DIS, V16, P227, DOI 10.1016/S1473-3099(15)00499-5.
   Zachariah R, 2011, INT J TUBERC LUNG D, V15, P933, DOI 10.5588/ijtld.10.0666.
   Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1.
   Zelner JL, 2016, J INFECT DIS, V213, P287, DOI 10.1093/infdis/jiv387.
   Zelner JL, 2014, AM J EPIDEMIOL, V180, P853, DOI 10.1093/aje/kwu192.}},
Number-of-Cited-References = {{59}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{J. Infect. Dis.}},
Doc-Delivery-Number = {{FL7SY}},
Unique-ID = {{ISI:000414451900002}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000414451900005,
Author = {Dowdy, David W. and Grant, Alison D. and Dheda, Keertan and Nardell,
   Edward and Fielding, Katherine and Moore, David A. J.},
Title = {{Designing and Evaluating Interventions to Halt the Transmission of
   Tuberculosis}},
Journal = {{JOURNAL OF INFECTIOUS DISEASES}},
Year = {{2017}},
Volume = {{216}},
Number = {{6}},
Pages = {{S654-S661}},
Month = {{OCT 1}},
Abstract = {{To reduce the incidence of tuberculosis, it is insufficient to simply
   understand the dynamics of tuberculosis transmission. Rather, we must
   design and rigorously evaluate interventions to halt transmission,
   prioritizing those interventions most likely to achieve population-level
   impact. Synergy in reducing tuberculosis transmission may be attainable
   by combining interventions that shrink the reservoir of latent
   Mycobacterium tuberculosis infection (preventive therapy), shorten the
   time between disease onset and treatment initiation (case finding and
   diagnosis), and prevent transmission in key settings, such as the built
   environment (infection control). In evaluating efficacy and estimating
   population-level impact, cluster-randomized trials and mechanistic
   models play particularly prominent roles. Historical and contemporary
   evidence suggests that effective public health interventions can halt
   tuberculosis transmission, but an evidence-based approach based on
   knowledge of local epidemiology is necessary for success. We provide a
   roadmap for designing, evaluating, and modeling interventions to
   interrupt the process of transmission that fuels a diverse array of
   tuberculosis epidemics worldwide.}},
Publisher = {{OXFORD UNIV PRESS INC}},
Address = {{JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dowdy, DW (Reprint Author), 615 N Wolfe St,Ste E6531, Baltimore, MD 21205 USA.
   Dowdy, David W., Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   Nardell, Edward, Harvard Med Sch, Brigham \& Womens Hosp, Div Global Hlth Equ, Boston, MA USA.
   Grant, Alison D.; Moore, David A. J., London Sch Hyg \& Trop Med, TB Ctr, London, England.
   Fielding, Katherine, London Sch Hyg \& Trop Med, Dept Infect Dis Epidemiol, London, England.
   Grant, Alison D., Univ KwaZulu Natal, Sch Nursing \& Publ Hlth, Africa Hlth Res Inst, Durban, South Africa.
   Grant, Alison D., Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.
   Dheda, Keertan, Univ Cape Town, Dept Med, Div Pulmonol, Cape Town, South Africa.}},
DOI = {{10.1093/infdis/jix320}},
ISSN = {{0022-1899}},
EISSN = {{1537-6613}},
Keywords = {{Tuberculosis; disease transmission; infectious; public health;
   prevention and control; diagnosis; infection control}},
Keywords-Plus = {{MULTIDRUG-RESISTANT TUBERCULOSIS; ISONIAZID PREVENTIVE THERAPY;
   CLUSTER-RANDOMIZED TRIAL; HIGH-BURDEN SETTINGS; XPERT MTB/RIF TEST;
   MYCOBACTERIUM-TUBERCULOSIS; TREATMENT INITIATION; AIR DISINFECTION;
   COUGH AEROSOLS; CARE SETTINGS}},
Research-Areas = {{Immunology; Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Immunology; Infectious Diseases; Microbiology}},
Author-Email = {{ddowdy1@jhmi.edu}},
Funding-Acknowledgement = {{Division of AIDS, National Institute of Allergy and Infectious Diseases,
   National Institutes of Health, Department of Health and Human Services
   {[}HHSN272201100001G]; Bill and Melinda Gates Foundation}},
Funding-Text = {{This work was supported by the Division of AIDS, National Institute of
   Allergy and Infectious Diseases, National Institutes of Health,
   Department of Health and Human Services (contract HHSN272201100001G);
   and the Bill and Melinda Gates Foundation.}},
Cited-References = {{Accinelli RA, 2015, AM J RESP CRIT CARE, V191, P1202, DOI 10.1164/rccm.201412-2173LE.
   Alland D, 2015, C RETR OPP INF SEATT.
   Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9.
   Barrera E, 2015, INT J TUBERC LUNG D, V19, P381, DOI 10.5588/ijtld.14.0680.
   Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0.
   Bernal J Lopez, 2016, INT J EPIDEMIOL.
   Bonell CP, 2011, J EPIDEMIOL COMMUN H, V65, P582, DOI 10.1136/jech.2008.082602.
   Calligaro GL, 2017, LANCET INFECT DIS, V17, P441, DOI 10.1016/S1473-3099(16)30384-X.
   Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X.
   Churchyard GJ, 2014, NEW ENGL J MED, V370, P301, DOI 10.1056/NEJMoa1214289.
   Cobelens F, 2017, LANCET RESP MED, V5, P243, DOI 10.1016/S2213-2600(16)30419-2.
   Cobelens F, 2014, LANCET, V383, P213, DOI 10.1016/S0140-6736(14)60065-9.
   COMSTOCK GW, 1961, PUBLIC HEALTH REP, V76, P19, DOI 10.2307/4591052.
   COMSTOCK GW, 1967, AM REV RESPIR DIS, V95, P935.
   Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0.
   Cox HS, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv014.
   Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834.
   Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC.
   Dheda K, 2016, LANCET, V387, P1211, DOI 10.1016/S0140-6736(15)00151-8.
   Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC.
   Escombe AR, 2007, PLOS MED, V4, P309, DOI 10.1371/journal.pmed.0040068.
   Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043.
   Esmail H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0437.
   FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28.
   Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X.
   Hargreaves JR, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0841-8.
   Hayes RJ, 2009, INTERD STAT, P3.
   HORWITZ O, 1966, B WORLD HEALTH ORGAN, V35, P509.
   HORWITZ O, 1974, AM J EPIDEMIOL, V99, P333, DOI 10.1093/oxfordjournals.aje.a121618.
   Houben RMGJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002152.
   Houben RMGJ, 2014, P NATL ACAD SCI USA, V111, P5325, DOI 10.1073/pnas.1317660111.
   International Union Against Tuberculosis Committee on Prophylaxis, 1982, B WORLD HEALTH ORGAN, V60, P555.
   Iruedo J, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2200-8.
   Jones-Lopez EC, 2016, CLIN INFECT DIS, V63, P10, DOI 10.1093/cid/ciw199.
   Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC.
   Kendall EA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002202.
   Kendall EA, 2015, LANCET RESP MED, V3, P963, DOI 10.1016/S2213-2600(15)00458-0.
   MacPherson P, 2014, B WORLD HEALTH ORGAN, V92, P126, DOI 10.2471/BLT.13.124800.
   Middelkoop K, 2010, AM J RESP CRIT CARE, V182, P1080, DOI 10.1164/rccm.201004-0598OC.
   Miller C, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00364-2017.
   Miller SL, 2013, PHOTOCHEM PHOTOBIOL, V89, P777, DOI 10.1111/php.12080.
   Mphaphlele M, 2015, AM J RESP CRIT CARE, V192, P477, DOI 10.1164/rccm.201501-0060OC.
   Nyboe J, 1963, TUNISIA, V9.
   Onozaki I, 2015, TROP MED INT HEALTH, V20, P1128, DOI 10.1111/tmi.12534.
   Reid A, 2015, INT J TUBERC LUNG D, V19, P5, DOI 10.5588/ijtld.14.0078.
   Salje H, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001674.
   Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007.
   Smieja MJ, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001363.
   Stagg HR, 2016, EMERG INFECT DIS, V22, P482, DOI 10.3201/eid2203.151227.
   SULTAN L, 1960, AM REV RESPIR DIS, V82, P358.
   Sun AY, 2013, AM J EPIDEMIOL, V178, P1740, DOI 10.1093/aje/kwt210.
   Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5.
   Vynnycky E, 2015, AM J EPIDEMIOL, V181, P619, DOI 10.1093/aje/kwu320.
   WENGER PN, 1995, LANCET, V345, P235, DOI 10.1016/S0140-6736(95)90228-7.
   WHO, 2009, NATURAL VENTILATION.
   Wilkinson D, 1998, BRIT MED J, V317, P625, DOI 10.1136/bmj.317.7159.625.
   World Health Organization, 2013, SYST SCREEN ACT TUB.
   World Health Organization, 2016, GLOB TUB REP 2016.
   Yates TA, 2016, LANCET INFECT DIS, V16, P227, DOI 10.1016/S1473-3099(15)00499-5.
   Yuen CM, 2015, LANCET, V386, P2334, DOI 10.1016/S0140-6736(15)00322-0.}},
Number-of-Cited-References = {{60}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{J. Infect. Dis.}},
Doc-Delivery-Number = {{FL7SY}},
Unique-ID = {{ISI:000414451900005}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000414451900003,
Author = {Turner, Richard D. and Chiu, Christopher and Churchyard, Gavin J. and
   Esmail, Hanif and Lewinsohn, David M. and Gandhi, Neel R. and Fennelly,
   Kevin P.},
Title = {{Tuberculosis Infectiousness and Host Susceptibility}},
Journal = {{JOURNAL OF INFECTIOUS DISEASES}},
Year = {{2017}},
Volume = {{216}},
Number = {{6}},
Pages = {{S636-S643}},
Month = {{OCT 1}},
Abstract = {{The transmission of tuberculosis is complex. Necessary factors include a
   source case with respiratory disease that has developed sufficiently for
   Mycobacterium tuberculosis to be present in the airways. Viable bacilli
   must then be released as an aerosol via the respiratory tract of the
   source case. This is presumed to occur predominantly by coughing but may
   also happen by other means. Airborne bacilli must be capable of
   surviving in the external environment before inhalation into a new
   potential host-steps influenced by ambient conditions and crowding and
   by M. tuberculosis itself. Innate and adaptive host defenses will then
   influence whether new infection results; a process that is difficult to
   study owing to a paucity of animal models and an inability to measure
   infection directly. This review offers an overview of these steps and
   highlights the many gaps in knowledge that remain.}},
Publisher = {{OXFORD UNIV PRESS INC}},
Address = {{JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Turner, RD (Reprint Author), Kings Coll Hosp London, Dept Resp Med, London SE5 9RS, England.
   Turner, Richard D., Kings Coll Hosp London, Dept Resp Med, London SE5 9RS, England.
   Chiu, Christopher, Imperial Coll London, Sect Infect Dis \& Immun, London, England.
   Churchyard, Gavin J., Aurum Inst, Johannesburg, South Africa.
   Churchyard, Gavin J., Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.
   Esmail, Hanif, Univ Oxford, Radcliffe Dept Med, Oxford, England.
   Esmail, Hanif, Univ Cape Town, Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa.
   Lewinsohn, David M., Oregon Hlth \& Sci Univ, Dept Mol Microbiol \& Immunol, Portland, OR 97201 USA.
   Gandhi, Neel R., Emory Univ, Sch Med, Atlanta, GA USA.
   Gandhi, Neel R., Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA USA.
   Fennelly, Kevin P., NHLBI, Pulm Clin Med Sect, Cardiovasc Pulm Branch, Div Intramural Res,NIH, Bldg 10, Bethesda, MD 20892 USA.}},
DOI = {{10.1093/infdis/jix361}},
ISSN = {{0022-1899}},
EISSN = {{1537-6613}},
Keywords = {{Tuberculosis; transmission; infectiousness; susceptibility}},
Keywords-Plus = {{MULTIDRUG-RESISTANT TUBERCULOSIS; ISONIAZID PREVENTIVE THERAPY;
   HEALTH-CARE WORKERS; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS;
   COUGH FREQUENCY; AIRBORNE TRANSMISSION; HOUSEHOLD CONTACTS;
   TUBERCLE-BACILLI; CONTROLLED-TRIAL}},
Research-Areas = {{Immunology; Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Immunology; Infectious Diseases; Microbiology}},
Author-Email = {{richard.turner17@nhs.net}},
ORCID-Numbers = {{Esmail, Hanif/0000-0002-4278-9316}},
Funding-Acknowledgement = {{Division of AIDS, National Institute of Allergy and Infectious Disease,
   National Institute of Health, Department of Health and Human Services
   {[}HHSN272201100001G]; Bill and Melinda Gates Foundation; Centers for
   Disease Control and Prevention; South African Medical Research Council}},
Funding-Text = {{This work was supported by the Division of AIDS, National Institute of
   Allergy and Infectious Disease, National Institute of Health, Department
   of Health and Human Services (contract HHSN272201100001G {[}Research
   Support Services for the Division of AIDS]), the Bill and Melinda Gates
   Foundation, the Centers for Disease Control and Prevention, and the
   South African Medical Research Council.}},
Cited-References = {{Achkar JM, 2015, IMMUNOL REV, V264, P167, DOI 10.1111/imr.12276.
   Balcells ME, 2006, EMERG INFECT DIS, V12, P744.
   Barria MI, 2013, J INFECT DIS, V207, P115, DOI 10.1093/infdis/jis641.
   Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236.
   Beggs CB, 2003, INT J TUBERC LUNG D, V7, P1015.
   Bhatt K, 2015, CLIN VACCINE IMMUNOL, V22, P258, DOI 10.1128/CVI.00721-14.
   Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4.
   Cadena AM, 2016, MBIO, V7, DOI 10.1128/mBio.00342-16.
   Chamie G, 2010, INT J TUBERC LUNG D, V14, P1295.
   Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788.
   Cobat A, 2015, J INFECT DIS, V211, P317, DOI 10.1093/infdis/jiu446.
   Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744.
   Cruciani M, 2001, CLIN INFECT DIS, V33, P1922, DOI 10.1086/324352.
   Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014.
   Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834.
   Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC.
   Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002.
   Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC.
   Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC.
   DYE JA, 1994, THORAX, V49, P825, DOI 10.1136/thx.49.8.825.
   Ellman P, 1939, BMJ-BRIT MED J, V1.
   Escombe AR, 2007, PLOS MED, V4, P309, DOI 10.1371/journal.pmed.0040068.
   Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043.
   Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188.
   Esmail H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0437.
   Esmail H, 2016, NAT MED, V22, P1090, DOI 10.1038/nm.4161.
   Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691.
   Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061.
   Fennelly KP, 2012, AM J RESP CRIT CARE, V186, P450, DOI 10.1164/rccm.201203-0444OC.
   Fennelly KP, 1998, INFECT CONT HOSP EP, V19, P754.
   Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC.
   Fennelly KP, 2015, FRONT IMMUNOL, V6, P1.
   FEREBEE SH, 1962, AM REV RESPIR DIS, V85, P490.
   Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410.
   Grandjean L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001843.
   Habibi MS, 2015, AM J RESP CRIT CARE, V191, P1040, DOI 10.1164/rccm.201412-2256OC.
   Hanifa Y, 2009, INT J TUBERC LUNG D, V13, P39.
   Huang CC, 2014, CLIN INFECT DIS, V58, P765, DOI 10.1093/cid/cit948.
   Hunter RL, 2011, TUBERCULOSIS, V91, P497, DOI 10.1016/j.tube.2011.03.007.
   Jiamjarasrangsi W, 2009, INT J TUBERC LUNG D, V13, P454.
   Jones-Lopez EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100984.
   Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC.
   Jozwik A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10224.
   Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003.
   Killingley B, 2012, J INFECT DIS, V205, P35, DOI 10.1093/infdis/jir701.
   Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109.
   Knibbs LD, 2014, THORAX, V69, P740, DOI 10.1136/thoraxjnl-2014-205213.
   Kwon SB, 2012, CHEMOSPHERE, V87, P1260, DOI 10.1016/j.chemosphere.2012.01.032.
   Lai KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023269.
   Li H, 2017, P NATL ACAD SCI USA, V114.
   Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC.
   Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020.
   Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412.
   LOUDON RG, 1967, AM REV RESPIR DIS, V96, P1137.
   LOUDON RG, 1968, AM REV RESPIR DIS, V98, P297.
   Lurie MB, 1944, J EXP MED, V79, P573, DOI 10.1084/jem.79.6.573.
   MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243.
   Marakalala MJ, 2016, NAT MED, V22, P531, DOI 10.1038/nm.4073.
   Martinez L, 2016, AM J RESP CRIT CARE, V194, P1152, DOI 10.1164/rccm.201511-2146OC.
   Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474.
   Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002.
   Muller B, 2013, EMERG INFECT DIS, V19, P899, DOI 10.3201/eid1906.120543.
   Nardell EA, 2016, AM J RESP CRIT CARE, V193.
   NOBLE RC, 1981, AM J INFECT CONTROL, V9, P6, DOI 10.1016/S0196-6553(81)80003-X.
   Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT.
   Pereira M, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150686.
   Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559.
   Plotkin SA, 2013, CLIN INFECT DIS, V56, P1458, DOI 10.1093/cid/cit048.
   Proano A, 2017, CLIN INFECT DIS, V64, P1174, DOI 10.1093/cid/cix039.
   RILEY RL, 1962, AM REV RESPIR DIS, V85, P511.
   RILEY RL, 1959, AM J HYG, V70, P185, DOI 10.1093/oxfordjournals.aje.a120069.
   ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2.
   Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051.
   Satti I, 2014, LANCET INFECT DIS, V14, P939, DOI 10.1016/S1473-3099(14)70845-X.
   STEINBRUECK P, 1972, Bulletin of the International Union Against Tuberculosis, V47, P135.
   Subbian S, 2012, AM J PATHOL, V181, P1711, DOI 10.1016/j.ajpath.2012.07.019.
   Turner RD, 2016, AM J RESP CRIT CARE, V193.
   Turner RD, 2015, J INFECT DIS, V211, P1367, DOI 10.1093/infdis/jiu625.
   van Rie A, 2013, SAMJ S AFR MED J, V103, P853, DOI {[}10.7196/SAMJ.7092, 10.7196/samj.7092].
   Vynnycky E, 2015, AM J EPIDEMIOL, V181, P619, DOI 10.1093/aje/kwu320.
   Wainwright CE, 2009, THORAX, V64, P926, DOI 10.1136/thx.2008.112466.
   Welsh KJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/307631.
   WHO, 2016, GLOB TUB REP.
   WHO, 2009, NATURAL VENTILATION.
   Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC.
   Wood R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146658.
   Wu H, 2015, P NATL ACAD SCI USA, V112, pE340, DOI 10.1073/pnas.1424013112.
   Wurie FB, 2016, THORAX, V71, P549, DOI 10.1136/thoraxjnl-2015-207295.
   Yang CG, 2012, CLIN INFECT DIS, V55, P1179, DOI 10.1093/cid/cis670.
   Zayas Gustavo, 2005, BMC Pulm Med, V5, P11, DOI 10.1186/1471-2466-5-11.}},
Number-of-Cited-References = {{90}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{6}},
Usage-Count-Since-2013 = {{10}},
Journal-ISO = {{J. Infect. Dis.}},
Doc-Delivery-Number = {{FL7SY}},
Unique-ID = {{ISI:000414451900003}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000411419000001,
Author = {Daear, Weiam and Mahadeo, Mark and Prenner, Elmar J.},
Title = {{Applications of Brewster angle microscopy from biological materials to
   biological systems}},
Journal = {{BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES}},
Year = {{2017}},
Volume = {{1859}},
Number = {{10}},
Pages = {{1749-1766}},
Month = {{OCT}},
Abstract = {{Brewster angle microscopy (BAM) is a powerful technique that allows for
   real-time visualization of Langmuir monolayers. The lateral organization
   of these films can be investigated, including phase separation and the
   formation of domains, which may be of different sizes and shapes
   depending on the properties of the monolayer. Different molecules or
   small changes within a molecule such as the molecule's length or
   presence of a double bond can alter the monolayer's lateral organization
   that is usually undetected using surface pressure-area isotherms. The
   effect of such changes can be clearly observed using BAM in real-time,
   under full hydration, which is an experimental advantage in many cases.
   While previous BAM reviews focused more on selected compounds or
   compared the impact of structural variations on the lateral domain
   formation, this review provided a broader overview of BAM application
   using biological materials and systems including the visualization of
   amphiphilic molecules, proteins, drugs, extracts, DNA, and nanoparticles
   at the air-water interface. (C) 2017 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Prenner, EJ (Reprint Author), Univ Calgary, Dept Biol Sci, Fac Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.
   Daear, Weiam; Mahadeo, Mark; Prenner, Elmar J., Univ Calgary, Dept Biol Sci, Fac Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.}},
DOI = {{10.1016/j.bbamem.2017.06.016}},
ISSN = {{0005-2736}},
EISSN = {{0006-3002}},
Keywords = {{Brewster angle microscopy; Monolayers; Lipid-protein; Drugs;
   Nanoparticles; Biological extracts}},
Keywords-Plus = {{AIR-WATER-INTERFACE; X-RAY-DIFFRACTION; MULTIDRUG-RESISTANCE PROTEIN;
   HUMAN ERYTHROCYTE-MEMBRANE; ACID-BASED SURFACTANTS; LIPID DOMAIN
   ORGANIZATION; LANGMUIR-BLODGETT-FILMS; PULMONARY SURFACTANT; AIR/WATER
   INTERFACE; LUNG SURFACTANT}},
Research-Areas = {{Biochemistry \& Molecular Biology; Biophysics}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Biophysics}},
Author-Email = {{eprenner@ucalgary.ca}},
Funding-Acknowledgement = {{NSERC; Queen Elizabeth II scholarships}},
Funding-Text = {{This work was funded by a NSERC Discovery grant to EIP and Queen
   Elizabeth II scholarships to WD and MM.}},
Cited-References = {{ADDADI L, 1986, MOL CRYST LIQ CRYST, V134, P305, DOI 10.1080/00268948608079592.
   ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110.
   Agassandian M, 2013, BBA-MOL CELL BIOL L, V1831, P612, DOI 10.1016/j.bbalip.2012.09.010.
   Albalat R, 2003, LANGMUIR, V19, P10878, DOI 10.1021/la035281d.
   Alonso C, 2004, BIOPHYS J, V87, P4188, DOI 10.1529/biophysj.104.051201.
   Aloulou A, 2012, METHODS MOL BIOL, V861, P63, DOI 10.1007/978-1-61779-600-5\_4.
   Angelova A, 1996, J PHYS CHEM-US, V100, P10710, DOI 10.1021/jp960417k.
   Baoukina S, 2008, P NATL ACAD SCI USA, V105, P10803, DOI 10.1073/pnas.0711563105.
   Barenholz Y., 1982, NEW COMPREHENSIVE BI, V4, P129.
   Bay DC, 2008, BBA-BIOMEMBRANES, V1778, P1814, DOI 10.1016/j.bbamem.2007.08.015.
   Bay DC, 2013, BBA-BIOMEMBRANES, V1828, P260, DOI 10.1016/j.bbamem.2012.09.003.
   Bay DC, 2012, J BACTERIOL, V194, P5941, DOI 10.1128/JB.00666-12.
   Bay DC, 2010, BBA-BIOMEMBRANES, V1798, P526, DOI 10.1016/j.bbamem.2009.12.017.
   Bay DC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-140.
   Beketskaia MS, 2014, J BACTERIOL, V196, P1908, DOI 10.1128/JB.01483-14.
   Benamara H, 2011, BBA-BIOMEMBRANES, V1808, P98, DOI 10.1016/j.bbamem.2010.09.004.
   Bernardini C, 2013, CHEM SOC REV, V42, P2100, DOI 10.1039/c2cs35269a.
   Brezesinski G, 2003, ADV COLLOID INTERFAC, V100, P563, DOI 10.1016/S0001-8686(02)00071-4.
   Broniatowski M, 2017, BBA-BIOMEMBRANES, V1859, P155, DOI 10.1016/j.bbamem.2016.11.008.
   Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111.
   Cardenas M, 2005, J COLLOID INTERF SCI, V286, P166, DOI 10.1016/j.jcis.2005.01.008.
   Ale EC, 2012, BBA-BIOMEMBRANES, V1818, P2767, DOI 10.1016/j.bbamem.2012.06.017.
   Castano S, 2005, BBA-BIOMEMBRANES, V1715, P81, DOI 10.1016/j.bbamem.2005.07.008.
   CESAR JM, 1993, EUR J HAEMATOL, V50, P234.
   Cha HG, 2010, J PHYS CHEM C, V114, P9802, DOI 10.1021/jp912166b.
   Chao KP, 2012, J COLLOID INTERF SCI, V378, P58, DOI 10.1016/j.jcis.2012.04.028.
   Chapman KD, 2000, CHEM PHYS LIPIDS, V108, P221, DOI 10.1016/S0009-3084(00)00198-5.
   Cheng Q, 1997, ADV MATER, V9, P481, DOI 10.1002/adma.19970090605.
   Clapes P, 2002, BIOCATAL BIOTRANSFOR, V20, P215, DOI 10.1080/10242420290004947.
   Creuwels LAJM, 1997, LUNG, V175, P1, DOI 10.1007/PL00007554.
   Cristofolini L, 2007, BIOMACROMOLECULES, V8, P2270, DOI 10.1021/bm070322w.
   Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851.
   Cruz A, 2005, LANGMUIR, V21, P5349, DOI 10.1021/la046759w.
   Dabkowska AP, 2012, BIOMACROMOLECULES, V13, P2391, DOI 10.1021/bm300639n.
   Dabkowska AP, 2014, SOFT MATTER, V10, P1685, DOI 10.1039/c3sm52747f.
   Daear W, 2015, J PHYS CHEM B, V119, P5356, DOI 10.1021/jp5122239.
   De Jong WH, 2008, INT J NANOMED, V3, P133.
   Degen P, 2008, LANGMUIR, V24, P12958, DOI 10.1021/la802394a.
   Degen P, 2010, COLLOID POLYM SCI, V288, P643, DOI 10.1007/s00396-010-2191-0.
   DeWolf C, 1998, J PHYS CHEM B, V102, P3238, DOI 10.1021/jp9802174.
   Dickenson NE, 2010, ANAL BIOANAL CHEM, V396, P31, DOI 10.1007/s00216-009-3040-1.
   Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0.
   Ding JQ, 2003, LANGMUIR, V19, P1539, DOI 10.1021/la0261794.
   Discher BM, 1996, BIOPHYS J, V71, P2583, DOI 10.1016/S0006-3495(96)79450-X.
   DOMINGO JC, 1993, BIOCHIM BIOPHYS ACTA, V1148, P308, DOI 10.1016/0005-2736(93)90144-O.
   Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199.
   Dupuy F, 2011, LANGMUIR, V27, P3783, DOI 10.1021/la105011x.
   Dynarowicz-Latka P, 2001, ADV COLLOID INTERFAC, V91, P221, DOI 10.1016/S0001-8686(99)00034-2.
   Dynarowicz-Latka P, 2013, COLLOID SURFACE B, V107, P43, DOI 10.1016/j.colsurfb.2013.01.044.
   El Kirat K, 2004, BBA-BIOMEMBRANES, V1661, P144, DOI 10.1016/j.bbamem.2003.12.010.
   Fahmi AW, 2003, MACROMOL RAPID COMM, V24, P625, DOI 10.1002/marc.200350005.
   Fanani ML, 2011, J PHYS CHEM B, V115, P41, DOI 10.1021/jp107344t.
   Feldherr CM, 1999, J CELL SCI, V112, P2043.
   FISCHER B, 1994, J PHYS CHEM-US, V98, P7430, DOI 10.1021/j100082a005.
   Flasinski M, 2015, LANGMUIR, V31, P7364, DOI 10.1021/acs.langmuir.5b00896.
   Flasinski M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1103.
   Flasinski M, 2013, COLLOID SURFACE B, V111, P43, DOI 10.1016/j.colsurfb.2013.05.024.
   Flasinski M, 2012, J PHYS CHEM B, V116, P10842, DOI 10.1021/jp302907e.
   Georgiev GA, 2011, INVEST OPHTH VIS SCI, V52, P4645, DOI 10.1167/iovs.10-6271.
   Groger T, 2012, CHEM PHYS LIPIDS, V165, P216, DOI 10.1016/j.chemphyslip.2011.12.012.
   Gromelski S, 2006, LANGMUIR, V22, P6293, DOI 10.1021/la0531796.
   Guzman E, 2013, COLLOID SURFACE B, V105, P284, DOI 10.1016/j.colsurfb.2013.01.020.
   Guzman E, 2012, COLLOID SURFACE A, V413, P174, DOI 10.1016/j.colsurfa.2011.12.059.
   Guzman E, 2012, COLLOID SURFACE A, V413, P280, DOI 10.1016/j.colsurfa.2011.11.023.
   Guzman E, 2011, J PHYS CHEM C, V115, P21715, DOI 10.1021/jp207713x.
   Hac-Wydro K, 2013, BBA-BIOMEMBRANES, V1828, P2460, DOI 10.1016/j.bbamem.2013.06.030.
   Hac-Wydro K, 2013, COLLOID SURFACE B, V102, P178, DOI 10.1016/j.colsurfb.2012.07.048.
   Hac-Wydro K, 2012, BBA-BIOMEMBRANES, V1818, P2184, DOI 10.1016/j.bbamem.2012.05.010.
   Hac-Wydro K, 2011, COLLOID SURFACE B, V88, P635, DOI 10.1016/j.colsurfb.2011.07.055.
   Han YC, 2007, J PHYS CHEM C, V111, P6275, DOI 10.1021/jp0686285.
   He Q, 2004, J PHYS CHEM B, V108, P473, DOI 10.1021/jp036071c.
   He Q, 2003, BIOCHEM BIOPH RES CO, V300, P541, DOI 10.1016/S0006-291X(02)02893-0.
   HENON S, 1991, REV SCI INSTRUM, V62, P936, DOI 10.1063/1.1142032.
   Heredia V, 2015, BBA-BIOMEMBRANES, V1848, P2163, DOI 10.1016/j.bbamem.2015.06.022.
   HONIG D, 1992, THIN SOLID FILMS, V210, P64, DOI 10.1016/0040-6090(92)90169-C.
   HONIG D, 1991, J PHYS CHEM-US, V95, P4590, DOI 10.1021/j100165a003.
   Ivanova S, 2015, INT J MOL SCI, V16, P21813, DOI 10.3390/ijms160921813.
   Jebrail M, 2008, COLLOID SURFACE A, V321, P168, DOI 10.1016/j.colsurfa.2008.02.049.
   Johann R, 2000, J PHYS CHEM B, V104, P8512, DOI 10.1021/jp001293l.
   Johann R, 2001, LANGMUIR, V17, P4569, DOI 10.1021/la001781k.
   Johann R, 2001, J PHYS CHEM B, V105, P2957, DOI 10.1021/jp003870b.
   Johann R, 1999, MAT SCI ENG C-BIO S, V8-9, P35, DOI 10.1016/S0928-4931(99)00086-7.
   Jones PJH, 2009, CURR OPIN CLIN NUTR, V12, P147, DOI 10.1097/MCO.0b013e328326770f.
   Jurak M, 2016, BBA-BIOMEMBRANES, V1858, P1821, DOI 10.1016/j.bbamem.2016.04.012.
   Jurak M, 2013, BBA-BIOMEMBRANES, V1828, P2410, DOI 10.1016/j.bbamem.2013.07.005.
   KAERCHER T, 1993, INT OPHTHALMOL, V17, P341.
   Kaganer VM, 1999, REV MOD PHYS, V71, P779, DOI 10.1103/RevModPhys.71.779.
   Kamlekar RK, 2009, BIOPHYS CHEM, V139, P63, DOI 10.1016/j.bpc.2008.10.004.
   Kang YS, 1996, LANGMUIR, V12, P4345, DOI 10.1021/la960148p.
   Keating E, 2012, BBA-BIOMEMBRANES, V1818, P1225, DOI 10.1016/j.bbamem.2011.12.007.
   Khalifat N, 2011, BBA-BIOMEMBRANES, V1808, P2724, DOI 10.1016/j.bbamem.2011.07.013.
   KNOBLER CM, 1992, ANNU REV PHYS CHEM, V43, P207, DOI 10.1146/annurev.pc.43.100192.001231.
   Korchowiec B, 2011, BBA-BIOMEMBRANES, V1808, P2466, DOI 10.1016/j.bbamem.2011.06.027.
   Korchowiec B, 2006, CHEM PHYS LIPIDS, V144, P127, DOI 10.1016/j.chemphyslip.2006.08.005.
   Krasteva N, 2000, COLLOID SURFACE A, V171, P49, DOI 10.1016/S0927-7757(99)00566-X.
   Lai P, 2010, J BIOMED NANOTECHNOL, V6, P145, DOI 10.1166/jbn.2010.1114.
   Lee KYC, 2008, ANNU REV PHYS CHEM, V59, P771, DOI 10.1146/annurev.physchem.58.032806.104619.
   Lipp MM, 1997, BIOPHYS J, V72, P2783, DOI 10.1016/S0006-3495(97)78921-5.
   Lopes-Costa T, 2011, J COLLOID INTERF SCI, V354, P733, DOI 10.1016/j.jcis.2010.11.048.
   Loste E, 2003, LANGMUIR, V19, P2830, DOI 10.1021/la026837k.
   Lystvet SM, 2011, NANOSCALE, V3, P1788, DOI 10.1039/c0nr00948b.
   Maggio B, 2006, BBA-BIOMEMBRANES, V1758, P1922, DOI 10.1016/j.bbamem.2006.04.020.
   Mahadeo M, 2015, CHEM PHYS LIPIDS, V191, P153, DOI 10.1016/j.chemphyslip.2015.09.004.
   Mahadeo M, 2015, BBA-BIOMEMBRANES, V1848, P1165, DOI 10.1016/j.bbamem.2015.02.005.
   Maniti O, 2011, BBA-BIOMEMBRANES, V1808, P1129, DOI 10.1016/j.bbamem.2011.01.005.
   Maniti O, 2009, MOL MEMBR BIOL, V26, P171, DOI 10.1080/09687680802698639.
   Mariani ME, 2016, CHEM PHYS LIPIDS, V198, P39, DOI 10.1016/j.chemphyslip.2016.05.002.
   Martin-Garcia B, 2014, LANGMUIR, V30, P509, DOI 10.1021/la404834b.
   Mate SM, 2014, BBA-BIOMEMBRANES, V1838, P1832, DOI 10.1016/j.bbamem.2014.02.022.
   MCCONNELL HM, 1991, ANNU REV PHYS CHEM, V42, P171, DOI 10.1146/annurev.pc.42.100191.001131.
   McLoughlin D, 2005, LANGMUIR, V21, P1900, DOI 10.1021/la047700s.
   MCMICHAEL RD, 1992, J MAGN MAGN MATER, V111, P29, DOI 10.1016/0304-8853(92)91049-Y.
   MERCADAL M, 1995, BBA-BIOMEMBRANES, V1235, P281, DOI 10.1016/0005-2736(95)80015-8.
   Miller R, 2000, ADV COLLOID INTERFAC, V86, P39, DOI 10.1016/S0001-8686(00)00032-4.
   Minones J, 2002, COLLOID SURFACE A, V203, P273, DOI 10.1016/S0927-7757(01)01107-4.
   Minones J, 2009, BIOPHYS CHEM, V140, P69, DOI 10.1016/j.bpc.2008.11.011.
   Mobius D, 1998, CURR OPIN COLLOID IN, V3, P137.
   MOHWALD H, 1990, ANNU REV PHYS CHEM, V41, P441, DOI 10.1146/annurev.pc.41.100190.002301.
   Moran MC, 2004, GREEN CHEM, V6, P233, DOI 10.1039/b400293h.
   Nag K, 1998, BIOPHYS J, V74, P2983, DOI 10.1016/S0006-3495(98)78005-1.
   Nag K, 2007, LANGMUIR, V23, P4421, DOI 10.1021/la062513a.
   Nathoo S, 2013, CHEM PHYS LIPIDS, V167, P33, DOI 10.1016/j.chemphyslip.2013.01.007.
   Nobre TM, 2015, THIN SOLID FILMS, V593, P158, DOI 10.1016/j.tsf.2015.09.047.
   Park JW, 2002, BREAST CANCER RES, V4, P93.
   Patino JMR, 1999, LANGMUIR, V15, P2484.
   Patterson M, 2016, BBA-BIOMEMBRANES, V1858, P403, DOI 10.1016/j.bbamem.2015.11.025.
   Penalva DA, 2014, BBA-BIOMEMBRANES, V1838, P731, DOI 10.1016/j.bbamem.2013.11.018.
   Pinheiro M, 2013, BBA-BIOMEMBRANES, V1828, P896, DOI 10.1016/j.bbamem.2012.09.015.
   Possmayer F, 2010, RESP PHYSIOL NEUROBI, V173, pS55, DOI 10.1016/j.resp.2010.02.014.
   Prenner E, 2007, CHEM PHYS LIPIDS, V145, P106, DOI 10.1016/j.chemphyslip.2006.11.002.
   Rawat M, 2006, BIOL PHARM BULL, V29, P1790, DOI 10.1248/bpb.29.1790.
   Rebaud S, 2014, BBA-BIOMEMBRANES, V1838, P2698, DOI 10.1016/j.bbamem.2014.06.021.
   Rehman ZU, 2013, J CONTROL RELEASE, V166, P46, DOI 10.1016/j.jconrel.2012.12.014.
   Roldan-Carmona C, 2012, ADV COLLOID INTERFAC, V173, P12, DOI 10.1016/j.cis.2012.02.002.
   Rosetti CM, 2008, BBA-BIOMEMBRANES, V1778, P1665, DOI 10.1016/j.bbamem.2008.02.007.
   Rosetti CM, 2007, BIOPHYS J, V93, P4254, DOI 10.1529/biophysj.107.112441.
   Rosetti CM, 2005, BBA-BIOMEMBRANES, V1668, P75, DOI 10.1016/j.bbamem.2004.11.009.
   Ross M, 2002, EUR BIOPHYS J BIOPHY, V31, P52, DOI 10.1007/s002490100181.
   Ryan JA, 2007, ANAL CHEM, V79, P9150, DOI 10.1021/ac0715524.
   Saunders BR, 2008, ADV COLLOID INTERFAC, V138, P1, DOI 10.1016/j.cis.2007.09.001.
   Schief WR, 2003, BIOPHYS J, V84, P3792, DOI 10.1016/S0006-3495(03)75107-8.
   Schmidt R, 2004, LANGMUIR, V20, P3284, DOI 10.1021/la036099f.
   Schug ZT, 2012, ACTA ONCOL, V51, P301, DOI 10.3109/0284186X.2011.643823.
   SCHURCH S, 1976, P NATL ACAD SCI USA, V73, P4698, DOI 10.1073/pnas.73.12.4698.
   Siegel S, 2005, COLLOID SURFACE A, V256, P9, DOI 10.1016/j.colsurfa.2004.09.040.
   SOMMER A, 1992, J BIOL CHEM, V267, P24217.
   Stefaniu C, 2012, SOFT MATTER, V8, P7952, DOI 10.1039/c2sm25773d.
   Subczynski WK, 2003, BBA-BIOMEMBRANES, V1610, P231, DOI 10.1016/S0005-2736(03)00021-X.
   Taeusch HW, 2005, BIOPHYS J, V89, P1769, DOI 10.1529/biophysj.105.062620.
   Tatur S, 2012, LANGMUIR, V28, P628, DOI 10.1021/la203439u.
   Teixeira ACT, 2008, CHEM PHYS LIPIDS, V153, P98, DOI 10.1016/j.chemphyslip.2008.03.006.
   Tkachenko AG, 2003, J AM CHEM SOC, V125, P4700, DOI 10.1021/ja0296935.
   Tsanova A., 2014, BIOTECHNOL BIOTECHNO, V26, P185.
   Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1.
   VERGER R, 1976, J BIOL CHEM, V251, P3128.
   Volinsky R, 2002, J PHYS CHEM B, V106, P9231, DOI 10.1021/jp020393j.
   Vollhardt A, 2004, J PHYS CHEM B, V108, P3781, DOI 10.1021/jp0361677.
   Vollhardt D, 2005, ADV COLLOID INTERFAC, V116, P63, DOI 10.1016/j.cis.2005.03.008.
   Vollhardt D, 2007, J PHYS CHEM C, V111, P6805, DOI 10.1021/jp0704822.
   Vollhardt D, 2006, ADV COLLOID INTERFAC, V127, P83, DOI 10.1016/j.cis.2006.11.006.
   Vollhardt D, 2016, LANGMUIR, V32, P7316, DOI 10.1021/acs.langmuir.6b01379.
   Vollhardt D, 2004, J PHYS CHEM B, V108, P17448, DOI 10.1021/jp0483041.
   Vollhardt D, 2015, ADV COLLOID INTERFAC, V222, P728, DOI 10.1016/j.cis.2014.07.014.
   Vollhardt D, 2004, LANGMUIR, V20, P7670, DOI 10.1021/la049345b.
   Vollhardt D, 2014, CURR OPIN COLLOID IN, V19, P183, DOI 10.1016/j.cocis.2014.02.001.
   Vollhardt D, 2010, ADV COLLOID INTERFAC, V154, P1, DOI 10.1016/j.cis.2010.01.003.
   Vollhardt D, 2015, J PHYS CHEM C, V119, P9934, DOI 10.1021/acs.jpcc.5b01766.
   Wang L, 2007, LANGMUIR, V23, P4950, DOI 10.1021/la063139h.
   WEIDEMANN G, 1995, THIN SOLID FILMS, V264, P94, DOI 10.1016/0040-6090(95)06613-6.
   Winsel K, 2003, EUR BIOPHYS J BIOPHY, V32, P544, DOI 10.1007/s00249-003-0290-2.
   Worthman LAD, 2000, BIOPHYS J, V79, P2657, DOI 10.1016/S0006-3495(00)76504-0.
   Wustneck R, 2005, ADV COLLOID INTERFAC, V117, P33, DOI 10.1016/j.cis.2005.05.001.
   Wydro P, 2013, BBA-BIOMEMBRANES, V1828, P1415, DOI 10.1016/j.bbamem.2013.01.023.
   Wydro P, 2013, COLLOID SURFACE B, V106, P217, DOI 10.1016/j.colsurfb.2013.01.053.
   Wydro P, 2013, J COLLOID INTERF SCI, V397, P122, DOI 10.1016/j.jcis.2013.01.060.
   Wydro P, 2013, COLLOID SURFACE B, V103, P67, DOI 10.1016/j.colsurfb.2012.10.020.
   Wydro P, 2012, COLLOID SURFACE B, V93, P174, DOI 10.1016/j.colsurfb.2011.12.035.
   Zerrouk Z, 2008, COLLOID SURFACE B, V63, P306, DOI 10.1016/j.colsurfb.2007.12.016.}},
Number-of-Cited-References = {{178}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{7}},
Usage-Count-Since-2013 = {{16}},
Journal-ISO = {{Biochim. Biophys. Acta-Biomembr.}},
Doc-Delivery-Number = {{FH8CI}},
Unique-ID = {{ISI:000411419000001}},
DA = {{2018-08-13}},
}

@article{ ISI:000410751800011,
Author = {Kowalski, M. and Wolany, J. and Pastuszka, J. S. and Plaza, G. and
   Wlazlo, A. and Ulfig, K. and Malina, A.},
Title = {{Characteristics of airborne bacteria and fungi in some Polish wastewater
   treatment plants}},
Journal = {{INTERNATIONAL JOURNAL OF ENVIRONMENTAL SCIENCE AND TECHNOLOGY}},
Year = {{2017}},
Volume = {{14}},
Number = {{10}},
Pages = {{2181-2192}},
Month = {{OCT}},
Abstract = {{The aim of this study was to characterize both the viable airborne
   bacteria and fungi collected in different types of wastewater treatment
   plants in Poland. Bacterial and fungal aerosols in five different
   wastewater treatment plants in Poland were studied, including the
   pioneering antibiotic resistance testing of airborne bacteria.
   Concentration level was measured using the six-stage Andersen impactor.
   After incubation, bioaerosol particles captured on nutrient media on
   Petri dishes were quantitatively evaluated and qualitatively identified.
   It was found that the concentration levels of both airborne bacteria and
   fungi ranged from 10A(2) to 10A(3) colony-forming units/mA(3), in all
   stages of the wastewater treatment plants. The patterns of size
   distributions of airborne bacteria and fungi were very similar, showing
   dominant peaks typically in the size range between 3.3 and 4.7 mu m. The
   majority fraction of small bacterial and fungal particles (less than 4.7
   mu m) in the studied areas indicates that the bioaerosol is relatively
   fresh, and mostly of local origin. The Gram-positive cocci and
   nonsporing Gram-positive rods were the dominating forms in the studied
   wastewater treatment plants environment. The existing differences in the
   concentration levels between sampling sites enabled identification of
   the main bioaerosol sources. The highest concentration of bacterial
   aerosol appeared in sections, where activated sludge post-processing and
   mechanical purifying are conducted. The most frequently occurring
   species in the sampled bacterial aerosol were Gram-positive cocci and
   nonsporing Gram-positive rods. Multi-antibiotic resistance testing
   showed that among the isolated airborne bacteria, the most
   antibiotic-resistant features were present among Bacillus species
   (especially Bacillus mycoides).}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kowalski, M (Reprint Author), Silesian Tech Univ, Fac Energy \& Environm Engn, Dept Air Protect, 22B Konarskiego St, PL-44100 Gliwice, Poland.
   Kowalski, M.; Wolany, J.; Pastuszka, J. S.; Malina, A., Silesian Tech Univ, Fac Energy \& Environm Engn, Dept Air Protect, 22B Konarskiego St, PL-44100 Gliwice, Poland.
   Plaza, G., Inst Ecol Ind Areas, 6 Kossutha St, PL-40832 Katowice, Poland.
   Wlazlo, A., Inst Occupat Med \& Environm Hlth, 13 Koscielna St, PL-41200 Sosnowiec, Poland.
   Ulfig, K., Cent Min Inst, Dept Postind Sites \& Waste Management, 1 Plac Gwarkow, PL-40166 Katowice, Poland.}},
DOI = {{10.1007/s13762-017-1314-2}},
ISSN = {{1735-1472}},
EISSN = {{1735-2630}},
Keywords = {{Wastewater plants; Bioaerosols; Airborne bacteria; Airborne fungi;
   Antibiotic resistance}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANT BACTERIA; BIOAEROSOL EMISSIONS; ESCHERICHIA-COLI;
   SEWAGE; GENES; ENVIRONMENT; MICROORGANISMS; AEROSOL; SITE}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{michal.kowalski@polsl.pl}},
Funding-Acknowledgement = {{Ministry of Science and Higher Education, Poland {[}BKM/510/RIE-2/2015
   (08/020/BKM15/0009)]; DoktoRIS-Scholarship Program for Innovative
   Silesia; European Union under the European Social Fund}},
Funding-Text = {{This publication was done under Grant BKM/510/RIE-2/2015
   (08/020/BKM15/0009), funded by Ministry of Science and Higher Education,
   Poland. The first author was supported by the DoktoRIS-Scholarship
   Program for Innovative Silesia, cofinanced by the European Union under
   the European Social Fund. We acknowledge Ewa Bra. goszewska, PhD,
   Silesian University of Technology, for her help in the laboratory work.}},
Cited-References = {{ACGIH, 1989, AM C GOV IND HTG CIN.
   Bauer H, 2002, WATER RES, V36, P3965, DOI 10.1016/S0043-1354(02)00121-5.
   Bouki C, 2013, ECOTOX ENVIRON SAFE, V91, P1, DOI 10.1016/j.ecoenv.2013.01.016.
   Chen H, 2013, ENVIRON INT, V55, P9, DOI 10.1016/j.envint.2013.01.019.
   Di Giulio M, 2010, ENVIRON MONIT ASSESS, V170, P509, DOI 10.1007/s10661-009-1252-7.
   Fracchia L, 2006, WATER RES, V40, P1985, DOI 10.1016/j.watres.2006.03.016.
   Gao P, 2012, SCI TOTAL ENVIRON, V421, P173, DOI 10.1016/j.scitotenv.2012.01.061.
   Haas D, 2010, WATER AIR SOIL POLL, V207, P49, DOI 10.1007/s11270-009-0118-5.
   Karra S, 2007, WATER RES, V41, P1355, DOI 10.1016/j.watres.2006.12.014.
   Korzeniewska E, 2009, WATER RES, V43, P2841, DOI 10.1016/j.watres.2009.03.050.
   Korzeniewska E, 2013, ECOTOX ENVIRON SAFE, V91, P96, DOI 10.1016/j.ecoenv.2013.01.014.
   LAITINEN S, 1994, AM IND HYG ASSOC J, V55, P1055.
   Li J, 2016, ATMOS ENVIRON, V124, P404, DOI 10.1016/j.atmosenv.2015.06.030.
   Michael I, 2013, WATER RES, V47, P957, DOI 10.1016/j.watres.2012.11.027.
   NEVALAINEN A, 1992, ATMOS ENVIRON A-GEN, V26, P531, DOI 10.1016/0960-1686(92)90166-I.
   Novo A, 2013, WATER RES, V47, P1875, DOI 10.1016/j.watres.2013.01.010.
   Pascual Leonor, 2003, Aerobiologia, V19, P261, DOI 10.1023/B:AERO.0000006598.45757.7f.
   Pastuszka JS, 2005, POL J ENVIRON STUD, V14, P883.
   Pastuszka JS, 2000, ATMOS ENVIRON, V34, P3833, DOI 10.1016/S1352-2310(99)00527-0.
   Plaza G, 2013, INT J ENVIRON RES, V2, P67.
   Reinthaler FF, 2003, WATER RES, V37, P1685, DOI 10.1016/S0043-1354(02)00569-9.
   Sanchez-Monedero MA, 2008, WATER RES, V42, P3739, DOI 10.1016/j.watres.2008.06.028.
   Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x.
   Szylak-Szydlowski M, 2016, INT BIODETER BIODEGR, V115, P11, DOI 10.1016/j.ibiod.2016.07.008.
   Thorn J, 2001, AM J IND MED, V40, P170, DOI 10.1002/ajim.1085.abs.
   Wlazlo Agnieszka, 2002, Medycyna Pracy, V53, P109.
   Yadav J, 2015, J FORMOS MED ASSOC, V114, P639, DOI 10.1016/j.jfma.2013.04.006.
   Zhang YL, 2009, SCI TOTAL ENVIRON, V407, P3702, DOI 10.1016/j.scitotenv.2009.02.013.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{19}},
Journal-ISO = {{Int. J. Environ. Sci. Technol.}},
Doc-Delivery-Number = {{FG9II}},
Unique-ID = {{ISI:000410751800011}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000407490900013,
Author = {Hu, Yuanan and Cheng, Hefa and Tao, Shu},
Title = {{Environmental and human health challenges of industrial livestock and
   poultry farming in China and their mitigation}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2017}},
Volume = {{107}},
Pages = {{111-130}},
Month = {{OCT}},
Abstract = {{Driven by the growing demand for food products of animal origin,
   industrial livestock and poultry production has become increasingly
   popular and is on the track of becoming an important source of
   environmental pollution in China. Although concentrated animal feeding
   operations (CAFOs) have higher production efficiency and profitability
   with less resource consumption compared to the traditional family-based
   and ``free range{''} farming, they bring significant environmental
   pollution concerns and pose public health risks. Gaseous pollutants and
   bioaerosols are emitted directly from CAFOs, which have health
   implications on animal producers and neighboring communities. A range of
   pollutants are excreted with the animal waste, including nutrients,
   pathogens, natural and synthetic hormones, veterinary antimicrobials,
   and heavy metals, which can enter local farmland soils, surface water,
   and groundwater, during the storage and disposal of animal waste, and
   pose direct and indirect human health risks. The extensive use of
   antimicrobials in CAFOs also contributes to the global public health
   concern of antimicrobial resistance (AMR). Efforts on treating the large
   volumes of manure generated in CAFOs should be enhanced (e.g., by biogas
   digesters and integrated farm systems) to minimize their impacts on the
   environment and human health. Furthermore, the use of veterinary drugs
   and feed additives in industrial livestock and poultry farming should be
   controlled, which will not only make the animal food products much safer
   to the consumers, but also render the manure more benign for treatment
   and disposal on farmlands. While improving the sustainability of animal
   farming, China also needs to promote healthy food consumption, which not
   only improves public health from avoiding high-meat diets, but also
   slows down the expansion of industrial animal farming, and thus reduces
   the associated environmental and public health risks.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Cheng, HF (Reprint Author), Peking Univ, Coll Urban \& Environm Sci, MOE Key Lab Earth Surface Proc, Beijing 100871, Peoples R China.
   Hu, Yuanan, China Univ Geosci Beijing, Sch Water Resources \& Environm, Beijing 100083, Peoples R China.
   Cheng, Hefa; Tao, Shu, Peking Univ, Coll Urban \& Environm Sci, MOE Key Lab Earth Surface Proc, Beijing 100871, Peoples R China.}},
DOI = {{10.1016/j.envint.2017.07.003}},
ISSN = {{0160-4120}},
EISSN = {{1873-6750}},
Keywords = {{Concentrated animal feeding operations (CAFOs); Environmental pollution;
   Human health risk; Manure disposal; Sustainable animal farming; Healthy
   diets}},
Keywords-Plus = {{ANIMAL FEEDING OPERATIONS; ANTIBIOTIC-RESISTANCE GENES; NITROUS-OXIDE
   EMISSIONS; SPECIAL TOPICS-MITIGATION; INTENSIVE VEGETABLE CULTIVATION;
   SOIL MICROBIAL ACTIVITY; FOOD-PRODUCING ANIMALS; SWINE WASTE-WATER;
   PUBLIC-HEALTH; PIG-MANURE}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{hefac@umich.edu}},
ResearcherID-Numbers = {{Hu, Yuanan/F-3830-2012
   Cheng, Hefa/A-1193-2007}},
ORCID-Numbers = {{Hu, Yuanan/0000-0001-7103-8119
   Cheng, Hefa/0000-0003-4911-6971}},
Funding-Acknowledgement = {{Natural Science Foundation of China {[}41673089, 41472324]; National Key
   Research and Development Program of China {[}2016YFD0800302]; National
   Program for Support of Top-notch Young Professionals}},
Funding-Text = {{The authors thank the anonymous reviewers for their valuable insights
   and advice, as well as helpful suggestions for improvement on an earlier
   version of this manuscript. This work was supported in parts by the
   Natural Science Foundation of China (Grant Nos. 41673089 and 41472324),
   the National Key Research and Development Program of China
   (2016YFD0800302), and the National Program for Support of Top-notch
   Young Professionals.}},
Cited-References = {{Akhtar AZ, 2009, AM J PREV MED, V36, P182, DOI 10.1016/j.amepre.2008.09.043.
   Aneja VP, 2000, J GEOPHYS RES-ATMOS, V105, P11535, DOI 10.1029/2000JD900066.
   Aneja VP, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002271.
   Arnon S, 2008, ENVIRON SCI TECHNOL, V42, P5521, DOI 10.1021/es800784m.
   Athar R, 2002, WATER AIR SOIL POLL, V138, P165, DOI 10.1023/A:1015594815016.
   Avery LM, 2012, SCI TOTAL ENVIRON, V431, P128, DOI 10.1016/j.scitotenv.2012.05.020.
   Baker LR, 2011, APPL SOIL ECOL, V48, P1, DOI {[}10.1016/j.apsoi1.2011.02.007, 10.1016/j.apsoil.2011.02.007].
   Barrett JR, 2005, ENVIRON HEALTH PERSP, V113, pA116, DOI 10.1289/ehp.113-a116b.
   Bartikova H, 2016, CHEMOSPHERE, V144, P2290, DOI 10.1016/j.chemosphere.2015.10.137.
   Barza M, 2002, CLIN INFECT DIS, V34, pS123, DOI 10.1086/340249.
   Ben WW, 2013, ENVIRON SCI-PROC IMP, V15, P870, DOI 10.1039/c3em30845f.
   Borlee F., 2017, AM J RESP CRIT CARE.
   Borlee F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171494.
   Brooks JP, 2014, WATER RES, V57, P96, DOI 10.1016/j.watres.2014.03.017.
   Burkholder JM, 1997, J ENVIRON QUAL, V26, P1451, DOI 10.2134/jeq1997.00472425002600060003x.
   Burkholder J, 2007, ENVIRON HEALTH PERSP, V115, P308, DOI 10.1289/ehp.8839.
   Carmichael WW, 2001, ENVIRON HEALTH PERSP, V109, P663, DOI 10.2307/3454781.
   Centner TJ, 2010, ENVIRON INT, V36, P237, DOI 10.1016/j.envint.2009.11.007.
   Centner TJ, 2006, ENVIRON MANAGE, V37, P745, DOI 10.1007/s00267-005-0130-5.
   Chander Y, 2005, J ENVIRON QUAL, V34, P1952, DOI 10.2134/jeq2005.0017.
   CHANGCLAUDE J, 1992, EPIDEMIOLOGY, V3, P395, DOI 10.1097/00001648-199209000-00003.
   Chapin A, 2005, ENVIRON HEALTH PERSP, V113, P137, DOI 10.1289/ehp.7473.
   Chen B, 2011, APPL ENVIRON MICROB, V77, P148, DOI 10.1128/AEM.01676-10.
   Cheng HF, 2009, ENVIRON SCI TECHNOL, V43, P240, DOI 10.1021/es801934a.
   Cheng HF, 2007, ECOL ENG, V29, P96, DOI 10.1016/j.ecoleng.2006.08.005.
   Cheng HF, 2012, CLIMATIC CHANGE, V112, P253, DOI 10.1007/s10584-011-0042-8.
   Cheng HF, 2010, ENVIRON POLLUT, V158, P2809, DOI 10.1016/j.envpol.2010.06.014.
   Clark S, 2012, J ANIM SCI, V90, P2861, DOI 10.2527/jas.2011-4739.
   Cole D, 2000, ENVIRON HEALTH PERSP, V108, P685, DOI 10.2307/3434721.
   Coman A, 2013, J INFECT PUBLIC HEAL, V6, P438, DOI 10.1016/j.jiph.2013.05.003.
   Cordova-Kreylos AL, 2007, ISME J, V1, P585, DOI 10.1038/ismej.2007.71.
   Cortinas I, 2006, ENVIRON SCI TECHNOL, V40, P2951, DOI 10.1021/es051981o.
   Costanza JK, 2008, SCI TOTAL ENVIRON, V398, P76, DOI 10.1016/j.scitotenv.2008.02.024.
   Csavas I., 1992, INTEGRATED LIVESTOCK.
   CULLEY JLB, 1982, J ENVIRON QUAL, V11, P155, DOI 10.2134/jeq1982.00472425001100010034x.
   Ding C, 2010, APPL MICROBIOL BIOT, V87, P925, DOI 10.1007/s00253-010-2649-5.
   Dolliver H, 2007, J ENVIRON QUAL, V36, P1224, DOI 10.2134/jeq2006.0266.
   Dong HongMin, 2011, Transactions of the Chinese Society of Agricultural Engineering, V27, P303.
   Donham KJ, 2007, ENVIRON HEALTH PERSP, V115, P317, DOI 10.1289/ehp.8836.
   Donham Kelley J, 2006, J Agromedicine, V11, P15, DOI 10.1300/J096v11n03\_03.
   Duan GL, 2012, SOIL SCI PLANT NUTR, V58, P637, DOI 10.1080/00380768.2012.726597.
   Ellis LJ, 2007, CHINA ENV SER, V9, P19.
   European Commissions (EC), 1999, ASS POT RISKS HUM HL.
   Fan JL, 2013, COMMUN SOIL SCI PLAN, V44, P1224, DOI 10.1080/00103624.2012.756002.
   FAO, 2012, STAT FOOD INS WORLD.
   FAO (Food and Agriculture Organization of the United Nations), 2009, STAT FOOD AGR 2009 L.
   Flavel TC, 2006, J ENVIRON QUAL, V35, P183, DOI 10.2134/jeq2005.0022.
   Food and Agriculture Organization (FAO), 2010, PROD SYST MAN LIV EN.
   Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113.
   Gagliardi JV, 2000, APPL ENVIRON MICROB, V66, P877, DOI 10.1128/AEM.66.3.877-883.2000.
   Garbarino JR, 2003, ENVIRON SCI TECHNOL, V37, P1509, DOI 10.1021/es026219q.
   Gentry-Shields J, 2015, SCI TOTAL ENVIRON, V505, P487, DOI 10.1016/j.scitotenv.2014.10.004.
   Gerba CP, 2005, J ENVIRON QUAL, V34, P42.
   Gibbs SG, 2004, J OCCUP ENVIRON HYG, V1, P699, DOI 10.1080/15459620490515824.
   Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837.
   Greger M, 2010, FAM COMMUNITY HEALTH, V33, P11, DOI 10.1097/FCH.0b013e3181c4e22a.
   Guan TY, 2003, J ENVIRON QUAL, V32, P383, DOI 10.2134/jeq2003.0383.
   Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158.
   Gurian-Sherman D., 2008, CAFOS UNCOVERED UNTO.
   Hanselman TA, 2003, ENVIRON SCI TECHNOL, V37, P5471, DOI 10.1021/es034410+.
   HANSEN PK, 1992, CAN J MICROBIOL, V38, P1307, DOI 10.1139/m92-215.
   HARLOW SD, 1989, AM J EPIDEMIOL, V129, P233, DOI 10.1093/oxfordjournals.aje.a115129.
   Harper LA, 2004, J ENVIRON QUAL, V33, P1189, DOI 10.2134/jeq2004.1189.
   He LY, 2016, ENVIRON INT, V92-93, P210, DOI 10.1016/j.envint.2016.03.023.
   He LY, 2014, ENVIRON SCI TECHNOL, V48, P13120, DOI 10.1021/es5041267.
   Heaney CD, 2015, SCI TOTAL ENVIRON, V511, P676, DOI 10.1016/j.scitotenv.2014.12.062.
   Heederik D, 2007, ENVIRON HEALTH PERSP, V115, P298, DOI 10.1289/ehp.8835.
   Hoff SJ, 2006, J AIR WASTE MANAGE, V56, P581, DOI 10.1080/10473289.2006.10464472.
   Hollenbeck JE, 2016, INFECT GENET EVOL, V38, P44, DOI {[}10.1016/j.meegid.2015.12.002, 10.].
   Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0.
   Hooiveld M, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0123-2.
   Hristov AN, 2013, J ANIM SCI, V91, P5045, DOI 10.2527/jas.2013-6583.
   Hristov AN, 2013, J ANIM SCI, V91, P5095, DOI 10.2527/jas.2013-6585.
   Hu XG, 2010, ENVIRON POLLUT, V158, P2992, DOI 10.1016/j.envpol.2010.05.023.
   Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151.
   Hu YN, 2017, ENVIRON SCI TECHNOL, V51, P3508, DOI 10.1021/acs.est.6b06258.
   Hu YN, 2016, ENVIRON POLLUT, V219, P993, DOI 10.1016/j.envpol.2016.04.099.
   Hu YN, 2016, ENVIRON INT, V92-93, P515, DOI 10.1016/j.envint.2016.04.042.
   Hu YN, 2015, J GLOB ANTIMICROB RE, V3, P144, DOI 10.1016/j.jgar.2015.03.003.
   Hu YN, 2014, ENVIRON SCI TECHNOL, V48, P5364, DOI 10.1021/es502032c.
   Hu YA, 2013, ENVIRON DEV, V8, P57, DOI 10.1016/j.envdev.2013.06.001.
   Hu YA, 2013, ENVIRON SCI TECHNOL, V47, P3044, DOI 10.1021/es303146q.
   Hutchins SR, 2007, ENVIRON SCI TECHNOL, V41, P738, DOI 10.1021/es062234+.
   Hvistendahl M, 2012, SCIENCE, V336, P795, DOI 10.1126/science.336.6083.795.
   Irwin LK, 2001, AQUAT TOXICOL, V55, P49, DOI 10.1016/S0166-445X(01)00159-X.
   JANZEN JJ, 1974, J DAIRY SCI, V57, P260, DOI 10.3168/jds.S0022-0302(74)84869-1.
   Jensen VF, 2004, J ANTIMICROB CHEMOTH, V54, P274, DOI 10.1093/jac/dkh264.
   Jiang XB, 2013, FOOD CONTROL, V30, P30, DOI 10.1016/j.foodcont.2012.06.042.
   Johnsen PJ, 2011, J ANTIMICROB CHEMOTH, V66, P608, DOI 10.1093/jac/dkq512.
   Johnson R., 2015, R40449 CRS.
   Jordan CF, 2013, ECOSYSTEM APPROACH S.
   Khanal SK, 2006, ENVIRON SCI TECHNOL, V40, P6537, DOI 10.1021/es0607739.
   Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006.
   Kim KR, 2011, WATER AIR SOIL POLL, V214, P163, DOI 10.1007/s11270-010-0412-2.
   KLAVER AL, 1994, AQUACULTURE, V123, P237, DOI 10.1016/0044-8486(94)90062-0.
   Knapp JR, 2014, J DAIRY SCI, V97, P3231, DOI 10.3168/jds.2013-7234.
   Kolok AS, 2008, REV ENVIRON CONTAM T, V195, P1, DOI 10.1007/978-0-387-77030-7\_1.
   Koneswaran G, 2008, ENVIRON HEALTH PERSP, V116, P578, DOI 10.1289/ehp.11034.
   Kotzerke A, 2008, ENVIRON POLLUT, V153, P315, DOI 10.1016/j.envpol.2007.08.020.
   Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0.
   Krishnasamy V, 2015, ANTIMICROB RESIST IN, V4.
   Kumar K, 2005, J ENVIRON QUAL, V34, P2082, DOI 10.2134/jeq2005.0026.
   Lai J, 2014, INT J FOOD MICROBIOL, V180, P30, DOI 10.1016/j.ijfoodmicro.2014.03.030.
   Larson C, 2015, SCIENCE, V347, P704, DOI 10.1126/science.347.6223.704.
   Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145.
   Li K., 2006, BIOGAS CHINA.
   Li XW, 2014, SCI TOTAL ENVIRON, V468, P258, DOI 10.1016/j.scitotenv.2013.08.057.
   Li YW, 2011, J AGR FOOD CHEM, V59, P7268, DOI 10.1021/jf1047578.
   Li YX, 2012, ENVIRON MONIT ASSESS, V184, P5035, DOI 10.1007/s10661-011-2319-9.
   Li YX, 2005, RESOUR CONSERV RECY, V45, P356, DOI 10.1016/j.resconrec.2005.03.002.
   Lipsitch M, 2002, P NATL ACAD SCI USA, V99, pS572.
   Liu CY, 2013, LANCET, V381, P1539, DOI 10.1016/S0140-6736(13)60768-0.
   Liu S, 2012, ENVIRON POLLUT, V170, P190, DOI 10.1016/j.envpol.2012.07.016.
   Liu XH, 2016, MAR POLLUT BULL, V109, P597, DOI 10.1016/j.marpolbul.2016.05.033.
   Liu XP, 2015, CHEMOSPHERE, V119, P273, DOI 10.1016/j.chemosphere.2014.06.067.
   Liu XP, 2013, MICROCHEM J, V108, P38, DOI 10.1016/j.microc.2012.12.005.
   Liu Z., 2013, CHINA ANIMAL IND YB.
   Llonch P, 2017, ANIMAL, V11, P274, DOI 10.1017/S1751731116001440.
   Macauley JJ, 2006, WATER RES, V40, P2017, DOI 10.1016/j.watres.2006.03.021.
   Mallin MA, 2000, AM SCI, V88, P26, DOI 10.1511/2000.15.762.
   Mangalgiri KP, 2015, ENVIRON INT, V75, P68, DOI 10.1016/j.envint.2014.10.022.
   Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11.
   Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483.
   Mathers JJ, 2011, ENVIRON INT, V37, P991, DOI 10.1016/j.envint.2011.01.014.
   Mawdsley JL, 1996, BIOL FERT SOILS, V23, P215.
   McKinney CW, 2012, ENVIRON SCI TECHNOL, V46, P13393, DOI 10.1021/es303652q.
   McKinney CW, 2010, ENVIRON SCI TECHNOL, V44, P6102, DOI 10.1021/es9038165.
   McLaughlin MR, 2012, WATER RES, V46, P4949, DOI 10.1016/j.watres.2012.06.023.
   {[}MEP Ministry of Environmental Protection(MEP).], 2009, 4972009 MEP HJ.
   MEP (Ministry of environmental protection of the People's Republic of China), 2012, 12 5 YEAR PLAN PREV.
   Merchant JA, 2005, ENVIRON HEALTH PERSP, V113, P350, DOI 10.1289/ehp.7240.
   Min S., 2013, ZHONGGUO ZHAOQI, V31, P33.
   Ministry of Agriculture, 2013, ADM MEAS VET PRESCR.
   Ministry of Agriculture, 2013, VET PRESCR VET DRUG.
   Ministry of Environmental Protection (MEP), 2003, 185962001 MEP GB.
   Ministry of Environmental Protection (MEP), 2017, YB ENV STAT 2015.
   Ministry of Environmental Protection (MEP), 2010, 1 NAT CENS POLL SOUR.
   Mirabelli MC, 2006, ENVIRON HEALTH PERSP, V114, P591, DOI 10.1289/ehp.8586.
   Mohangoo AD, 2006, EUR J PUBLIC HEALTH, V16, P101, DOI 10.1093/eurpub/cki043.
   Mohring SAI, 2009, ENVIRON SCI TECHNOL, V43, P2569, DOI 10.1021/es802042d.
   Mole B, 2013, NATURE, V499, P398, DOI 10.1038/499398a.
   Montes F, 2013, J ANIM SCI, V91, P5070, DOI 10.2527/jas.2013-6584.
   Nachman KE, 2005, ENVIRON HEALTH PERSP, V113, P1123, DOI 10.1289/ehp.7834.
   Nachman KE, 2013, ENVIRON HEALTH PERSP, V121, P818, DOI 10.1289/ehp.1206245.
   Naslund J, 2008, AQUAT TOXICOL, V90, P223, DOI 10.1016/j.aquatox.2008.09.002.
   Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8.
   Network of Aquaculture Centres in Asia-Pacific (NACA), 1989, NACA TECHN MAN, V7.
   Nicholson FA, 2005, BIORESOURCE TECHNOL, V96, P135, DOI {[}10.1016/j.biortech.2004.02.030, 10.1016/j.biotech.2004.02.030].
   NRC, 2003, AIR EM AN FEED OP CU.
   Ornish D, 1998, JAMA-J AM MED ASSOC, V280, P2001, DOI 10.1001/jama.280.23.2001.
   Panter GH, 1998, AQUAT TOXICOL, V42, P243, DOI 10.1016/S0166-445X(98)00038-1.
   Pavilonis BT, 2013, ENVIRON SCI-PROC IMP, V15, P1271, DOI 10.1039/c3em00082f.
   Pei R, 2007, ENVIRON SCI TECHNOL, V41, P5108, DOI 10.1021/es070051x.
   Peng FJ, 2014, ENVIRON TOXICOL CHEM, V33, P776, DOI 10.1002/etc.2513.
   Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483.
   Place SE, 2010, J DAIRY SCI, V93, P3407, DOI 10.3168/jds.2009-2719.
   Pohl HR, 2017, REGUL TOXICOL PHARM, V84, P18, DOI 10.1016/j.yrtph.2016.11.005.
   Popkin BM, 2003, J NUTR, V133, p3898S, DOI 10.1093/jn/133.11.3898S.
   Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es0604131.
   Pruden A, 2013, ENVIRON HEALTH PERSP, V121, P878, DOI 10.1289/ehp.1206446.
   Radl V, 2005, ENVIRON POLLUT, V137, P345, DOI 10.1016/j.envpol.2004.12.035.
   Radon K, 2007, EPIDEMIOLOGY, V18, P300, DOI 10.1097/01.ede.0000259966.62137.84.
   Raman DR, 2004, ENVIRON SCI TECHNOL, V38, P3567, DOI 10.1021/es0353208.
   Rao PVL, 2002, J ENVIRON BIOL, V23, P215.
   Reeve KA, 2013, J OCCUP ENVIRON HYG, V10, P287, DOI 10.1080/15459624.2013.777303.
   Richards JD, 2010, ASIAN AUSTRAL J ANIM, V23, P1527, DOI 10.5713/ajas.2010.r.07.
   Saenz RA, 2006, VECTOR-BORNE ZOONOT, V6, P338, DOI 10.1089/vbz.2006.6.338.
   Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026.
   Schinasi L, 2011, EPIDEMIOLOGY, V22, P208, DOI 10.1097/EDE.0b013e3182093c8b.
   Schultz Mark, 2010, UNDERSTANDING CONCEN.
   Schulze A, 2011, ARCH ENVIRON OCCUP H, V66, P146, DOI 10.1080/19338244.2010.539635.
   Shan J., 2014, CHINA DAILY.
   Sharma R, 2009, J ENVIRON QUAL, V38, P567, DOI 10.2134/jeq2007.0638.
   Shen QiRong, 1997, Pedosphere, V7, P225.
   Shi JC, 2011, J ENVIRON QUAL, V40, P1695, DOI 10.2134/jeq2010.0316.
   Shore LS, 2003, PURE APPL CHEM, V75, P1859, DOI 10.1351/pac200375111859.
   Smith B, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-37.
   Smith DL, 2005, PLOS MED, V2, P731, DOI 10.1371/journal.pmed.0020232.
   Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258.
   Sneeringer S, 2009, AM J AGR ECON, V91, P124, DOI 10.1111/j.1467-8276.2008.01161.x.
   Standing Committee of the National People's Congress (NPCSC), 1997, AN EP PREV LAW PEOPL.
   Standing Committee of the National People's Congress (NPCSC), 2005, AN HUSB LAW PEOPL RE.
   State Council (SC), 2013, REG PREV CONTR POLL.
   State Environmental Protection Administration (SEPA),, 2001, LIV POULTR IND POLL.
   Steinfeld H, 2006, LIVESTOCKS LONG SHAD.
   Stephany RW, 2001, APMIS, V109, pS357.
   Stolz JF, 2007, ENVIRON SCI TECHNOL, V41, P818, DOI 10.1021/es061802i.
   Storteboom HN, 2007, J ENVIRON QUAL, V36, P1695, DOI 10.2134/jeq2007.0006.
   Teuber M, 2001, CURR OPIN MICROBIOL, V4, P493, DOI 10.1016/S1369-5274(00)00241-1.
   Thiele-Bruhn S, 2005, CHEMOSPHERE, V59, P457, DOI 10.1016/j.chemosphere.2005.01.023.
   Thorne PS, 2009, J OCCUP ENVIRON HYG, V6, P211, DOI 10.1080/15459620902729184.
   THOROGOOD M, 1994, BRIT MED J, V308, P1667, DOI 10.1136/bmj.308.6945.1667.
   Thorpe KL, 2003, ENVIRON SCI TECHNOL, V37, P1142, DOI 10.1021/es0201348.
   Thu K M, 2002, J Agric Saf Health, V8, P175.
   Tiquia SM, 1998, BIORESOURCE TECHNOL, V63, P193, DOI 10.1016/S0960-8524(97)00113-2.
   Turner C, 2002, BIORESOURCE TECHNOL, V84, P57, DOI 10.1016/S0960-8524(02)00069-X.
   {[}USEPA] United States Environmental Protection Agency, 2017, 430P17001 USEPA.
   van Bunnik BAD, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.161067.
   Villeneuve PJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-330.
   Von Essen Susanna G, 2005, J Agromedicine, V10, P55, DOI 10.1300/J096v10n04\_08.
   Walker P, 2005, PUBLIC HEALTH NUTR, V8, P348, DOI 10.1079/PHN2005727.
   WALKER PJ, 1985, J APPL BACTERIOL, V58, P139, DOI 10.1111/j.1365-2672.1985.tb01440.x.
   Wang FangHao, 2006, China Environmental Science, V26, P614.
   Wang LL, 2015, ENVIRON SCI TECHNOL, V49, P3473, DOI 10.1021/es505358c.
   Wang LL, 2012, MICROB ECOL, V63, P32, DOI 10.1007/s00248-011-9921-9.
   Wang X., 2003, DIFF POLL C DUBL IR.
   Ward MH, 2005, ENVIRON HEALTH PERSP, V113, P1607, DOI 10.1289/ehp.8043.
   Webb S, 2003, TOXICOL LETT, V142, P157, DOI 10.1016/S0378-4274(03)00071-7.
   Wei H, 2011, B ENVIRON CONTAM TOX, V86, P465, DOI 10.1007/s00128-011-0247-6.
   Wei RC, 2011, CHEMOSPHERE, V82, P1408, DOI 10.1016/j.chemosphere.2010.11.067.
   Wei XJ, 2015, FOOD POLICY, V54, P52, DOI 10.1016/j.foodpol.2015.04.005.
   Wing S, 2000, ENVIRON HEALTH PERSP, V108, P233, DOI 10.2307/3454439.
   Wu LH, 2012, GEODERMA, V173, P224, DOI 10.1016/j.geoderma.2011.12.003.
   Wu N, 2010, ENVIRON SCI TECHNOL, V44, P6933, DOI 10.1021/es1007802.
   Wu XL, 2014, SCI TOTAL ENVIRON, V487, P399, DOI 10.1016/j.scitotenv.2014.04.015.
   Xiang L, 2016, ENVIRON SCI POLLUT R, V23, P13984, DOI 10.1007/s11356-016-6493-8.
   Xie XD, 2016, WATER RES, V96, P136, DOI 10.1016/j.watres.2016.03.053.
   Yang CM, 2004, AGR WATER MANAGE, V70, P67, DOI 10.1016/j.agwat.2004.05.003.
   Yang H, 2007, SEP PURIF TECHNOL, V56, P392, DOI 10.1016/j.seppur.2007.05.036.
   Zhang B, 2015, ECOL INFORM, V26, P101, DOI 10.1016/j.ecoinf.2014.01.009.
   Zhang FS, 2015, SCI TOTAL ENVIRON, V538, P423, DOI 10.1016/j.scitotenv.2015.08.067.
   Zhang HB, 2016, CHEMOSPHERE, V152, P229, DOI 10.1016/j.chemosphere.2016.02.111.
   Zhang H, 2014, ENVIRON SCI POLLUT R, V21, P9939, DOI 10.1007/s11356-014-3002-9.
   Zhang QQ, 2015, ENVIRON SCI TECHNOL, V49, P6772, DOI 10.1021/acs.est.5b00729.
   Zhang Tian, 2012, Shengtaixue Zazhi, V31, P1241.
   Zhang XL, 2014, ECOTOX ENVIRON SAFE, V107, P313, DOI 10.1016/j.ecoenv.2014.06.010.
   Zhang Y, 2014, ENVIRON MONIT ASSESS, V186, P5297, DOI 10.1007/s10661-014-3778-6.
   Zhang ZC, 2017, CRIT REV ANAL CHEM, V47, P223, DOI 10.1080/10408347.2016.1266924.
   Zhao S, 2010, CHEMOSPHERE, V79, P420, DOI 10.1016/j.chemosphere.2010.01.060.
   Zheng W, 2013, J HAZARD MATER, V258, P109, DOI 10.1016/j.jhazmat.2013.04.038.
   Zhou DM, 2005, CHEMOSPHERE, V59, P167, DOI 10.1016/j.chemosphere.2004.11.008.
   Zhou LJ, 2011, ENVIRON POLLUT, V159, P1877, DOI 10.1016/j.envpol.2011.03.034.
   Zhou Z., 2012, FOOD CONSUMPTI UNPUB.
   {[}朱建春 Zhu Jianchun], 2014, {[}农业环境科学学报, Journal of Agro-Environment Science], V33, P435.
   Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110.
   Zhuang FF, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0379-0.}},
Number-of-Cited-References = {{236}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{49}},
Usage-Count-Since-2013 = {{176}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{FD4GZ}},
Unique-ID = {{ISI:000407490900013}},
DA = {{2018-08-13}},
}

@article{ ISI:000404697300016,
Author = {Conzatti, G. and Faucon, D. and Castel, M. and Ayadi, F. and Cavalie, S.
   and Tourrette, A.},
Title = {{Alginate/chitosan polyelectrolyte complexes: A comparative study of the
   influence of the drying step on physicochemical properties}},
Journal = {{CARBOHYDRATE POLYMERS}},
Year = {{2017}},
Volume = {{172}},
Pages = {{142-151}},
Month = {{SEP 15}},
Abstract = {{Polyelectrolyte complexes (PECs) based on Alginate and Chitosan were
   prepared for biomedical application. These two biopolymers are valuable
   resources for biomedical applications. In the present work, three PECs
   materials were produced using three different drying techniques: hot air
   drying, lyophilization and supercritical CO2 drying. The choice of the
   drying technique allowed producing different type of structures, with
   different porosity scale. In order to evaluate their potential as
   intra-abdominal wound dressings, swelling ability in various media,
   enzymatic resistance and drug release behavior of the resulting
   materials was studied. It was shown that the increase of the porosity
   improved the swelling ability, without altering the resistance of the
   materials, whereas drug release studies revealed that the majority of
   the drug was released within the first 24h whatever the drying process.
   (C) 2017 Published by Elsevier Ltd.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Tourrette, A (Reprint Author), Univ Toulouse, CIRIMAT, UMR UPS INPT CNRS 5085, Fac Sci Pharmaceut, 118 Route Narbonne, F-31062 Toulouse 4, France.
   Conzatti, G.; Faucon, D.; Castel, M.; Ayadi, F.; Cavalie, S.; Tourrette, A., Univ Toulouse, CIRIMAT, UMR UPS INPT CNRS 5085, Fac Sci Pharmaceut, 118 Route Narbonne, F-31062 Toulouse 4, France.}},
DOI = {{10.1016/j.carbpol.2017.05.023}},
ISSN = {{0144-8617}},
EISSN = {{1879-1344}},
Keywords = {{Alginate; Chitosan; Freeze drying; Supercritical CO2 drying; Hot air
   drying; Physical-chemistry}},
Keywords-Plus = {{BIOMEDICAL APPLICATIONS; ALGINATE; CHITOSAN; HYDROGELS; SCAFFOLDS;
   DELIVERY; SYSTEM; CHITIN}},
Research-Areas = {{Chemistry; Polymer Science}},
Web-of-Science-Categories  = {{Chemistry, Applied; Chemistry, Organic; Polymer Science}},
Author-Email = {{audrey.tourrette@univ-tlse3.fr}},
ResearcherID-Numbers = {{Tourrette, Audrey/R-2763-2017}},
ORCID-Numbers = {{Tourrette, Audrey/0000-0003-1107-2176}},
Funding-Acknowledgement = {{French National Research Agency {[}ANR-14-CE17-0002-01]}},
Funding-Text = {{Authors would like to thank the French National Research Agency for its
   financial support (ANR-14-CE17-0002-01, FP-BioPrev project).}},
Cited-References = {{Aarstad OA, 2012, BIOMACROMOLECULES, V13, P106, DOI 10.1021/bm2013026.
   Andersen Therese, 2015, Microarrays (Basel), V4, P133, DOI 10.3390/microarrays4020133.
   Anjum S, 2016, INT J PHARMACEUT, V508, P92, DOI 10.1016/j.ijpharm.2016.05.013.
   Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI 10.1089/ten.TEB.2009.0639.
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069.
   Bellich B, 2016, MAR DRUGS, V14, DOI 10.3390/md14050099.
   Bueno CZ, 2016, J SUPERCRIT FLUID, V112, P128, DOI 10.1016/j.supflu.2015.10.001.
   Cardea S, 2013, CHEM ENGINEER TRANS, V32, P1123, DOI 10.3303/CET1332188.
   Castel M., 2017, J MED BIOL IN PRESS.
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1.
   Cuadros TR, 2015, J MECH BEHAV BIOMED, V46, P331, DOI 10.1016/j.jmbbm.2014.08.026.
   Dash S., 2001, ACTA POL PHARM, V67, P217.
   Garg T., 2015, ARTIF CELL NANOMED B, V1401, P1.
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI {[}10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590].
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6.
   Kasaai MR, 2007, CARBOHYD POLYM, V68, P477, DOI 10.1016/j.carbpol.2006.11.006.
   Kasper JC, 2011, EUR J PHARM BIOPHARM, V78, P248, DOI 10.1016/j.ejpb.2011.03.010.
   Kassem M. A. A., 2014, AAPS PHARMSCITECH, V16.
   Kidoaki A, 2008, J BIOTECHNOL, V133, P225, DOI 10.1016/j.jbiotec.2007.08.015.
   Kim MY, 2011, CARBOHYD POLYM, V84, P1329, DOI 10.1016/j.carbpol.2011.01.029.
   KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9.
   Lawrie G, 2007, BIOMACROMOLECULES, V8, P2533, DOI 10.1021/bm070014y.
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003.
   Leofanti G, 1998, CATAL TODAY, V41, P207, DOI 10.1016/S0920-5861(98)00050-9.
   Levi-Polyachenko N, 2016, COLLOID SURFACE B, V142, P315, DOI 10.1016/j.colsurfb.2016.02.038.
   Li XX, 2009, POLYM DEGRAD STABIL, V94, P1, DOI 10.1016/j.polymdegradstab.2008.10.017.
   Li XY, 2016, APPL CLAY SCI, V126, P306, DOI 10.1016/j.clay.2016.03.035.
   MARTINSEN A, 1991, CARBOHYD POLYM, V15, P171, DOI 10.1016/0144-8617(91)90031-7.
   Meng SJ, 2013, WATER RES, V47, P6618, DOI 10.1016/j.watres.2013.08.037.
   Momoh FU, 2015, INT J BIOL MACROMOL, V81, P137, DOI 10.1016/j.ijbiomac.2015.07.037.
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001.
   Pongjanyakul T., 2015, PHARM DEV TECHNOLOGY, V7450, P1.
   Quraishi S, 2015, J SUPERCRIT FLUID, V105, P1, DOI 10.1016/j.supflu.2014.12.026.
   Raman SP, 2015, J SUPERCRIT FLUID, V106, P23, DOI 10.1016/j.supflu.2015.05.003.
   Rezvanian M, 2016, CARBOHYD POLYM, V137, P295, DOI 10.1016/j.carbpol.2015.10.091.
   Rio D. A. D. H., 2012, SYNTHESIS CHARACTERI, V2012, P485.
   Robitzer M, 2011, CARBOHYD POLYM, V85, P44, DOI 10.1016/j.carbpol.2011.01.040.
   Robitzer M, 2008, MACROMOL SYMP, V273, P80, DOI 10.1002/masy.200851311.
   Sahoo D., 2011, BIOPOLYMERS BIOMEDIC, P129.
   Shigemasa Y, 1996, INT J BIOL MACROMOL, V18, P237, DOI 10.1016/0141-8130(95)01079-3.
   Trisunaryanti W., 2009, J MAT SCI ENG, V3, P40.
   Vilen EM, 2011, MAGN RESON CHEM, V49, P584, DOI 10.1002/mrc.2789.
   Worthington Biochemical Corporation W. D., 1972, MANUAL CLIN ENZYME M.
   Yan XL, 2000, CHEM PHARM BULL, V48, P941.
   Zhao LQ, 2015, CARBOHYD POLYM, V126, P150, DOI 10.1016/j.carbpol.2015.02.050.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{5}},
Usage-Count-Since-2013 = {{51}},
Journal-ISO = {{Carbohydr. Polym.}},
Doc-Delivery-Number = {{EZ4QJ}},
Unique-ID = {{ISI:000404697300016}},
DA = {{2018-08-13}},
}

@article{ ISI:000411156100006,
Author = {Das, Bibhuti and Basumatari, Surajeet},
Title = {{MICROBIOLOGICAL PROFILE OF EAR DISCHARGE IN CHRONIC SUPPURATIVE OTITIS
   MEDIA}},
Journal = {{JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS}},
Year = {{2017}},
Volume = {{6}},
Number = {{71}},
Pages = {{5040-5044}},
Month = {{SEP 9}},
Abstract = {{BACKGROUND
   Chronic suppurative otitis media (CSOM) is defined as the inflammation
   of the mucous membrane of the middle ear cleft which includes the middle
   ear cavity, mastoid antrum, the mastoid air cells and the Eustachian
   tube. Complex interactions between the environment, microbes, and host
   are thought to lead to the development of this multifactorial disease.
   Understanding of the microbiology of chronic otitis media is important
   for efficient and effective treatment, and prevention of complications
   and antibiotic resistance. Thus, the study was conducted with the aim to
   determine the bacteriological agents implicated in discharging ears of
   the patients of CSOM and to determine the associated
   clinco-epidemiological factors among the patients of CSOM.
   MATERIALS AND METHODS
   This hospital-based descriptive study was conducted in 100 patients
   attending the ENT OPD in Fakhruddin Ali Ahmed Medical College, Barpeta,
   Assam from July 2016 to June 2017. Detailed clinical history and
   demographic data were collected and analysed. Ear discharge was
   collected and microbiological profile was evaluated.
   RESULTS
   One hundred patients after fulfilling the inclusion and exclusion
   criteria were chosen for the study. 31-40 years age group was most
   commonly involved with male preponderance. Microbiological analysis of
   ear discharge showed that Gram-negative bacteria accounted for 76\% and
   Gram-positive bacteria were found in 34\% cases. Gram-negative bacteria
   included Pseudomonas aeruginosa 24\%, Klebsiella spp. 19\%, Proteus spp.
   12\% and Escherichia coli 10\%. The Gram-positive aerobes identified
   included Staphylococcus spp. 15\%. The most common anaerobes identified
   were Bacteroides spp. in 1\%, Peptostreptococcus spp. in 1\% cases.
   Fungal growth was seen in 5\% cases. Diphtheroids were seen in 3\%
   cases.
   CONCLUSION
   Continuous and periodic evaluation of microbiological pattern and
   antibiotic sensitivity of isolates is necessary to decrease the
   potential risk of complications by early institution of appropriate
   treatment. Our study emphasised the need of proper identification of
   microbiological profile of the cases of CSOM in order to facilitate
   early institution of proper treatment.}},
Publisher = {{JOURNAL EVOLUTION MEDICAL \& DENTAL SCIENCES}},
Address = {{C/O AKSHANTALA ENTERPRISES, NO 65, 1ST FL, SAHUKAR CHENNIAH RD, MYSORE,
   KARNATAKA, 570 009, INDIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Das, B (Reprint Author), House 143, Gauhati 781028, Assam, India.
   Das, Bibhuti; Basumatari, Surajeet, FAAMCH, Dept ENT, Barpeta, Assam, India.}},
DOI = {{10.14260/jemds/2017/1096}},
ISSN = {{2278-4748}},
EISSN = {{2278-4802}},
Keywords = {{Chronic Suppurative Otitis Media; Bacterial Isolates}},
Keywords-Plus = {{MIDDLE-EAR; PSEUDOMONAS-AERUGINOSA; BACTERIAL CULTURE; CHILDREN; MUCOSA;
   MALAWI; MODEL}},
Research-Areas = {{General \& Internal Medicine}},
Web-of-Science-Categories  = {{Medicine, General \& Internal}},
Author-Email = {{drbibhutidas9@gmail.com}},
Cited-References = {{Acuin J., 2007, BMJ CLIN EVID, V2007, P05.
   Afolabi OA, 2012, AFR HEALTH SCI, V12, P362, DOI 10.4314/ahs.v12i3.18.
   Ahn JH, 2012, OTOL NEUROTOL, V33, P54, DOI 10.1097/MAO.0b013e31823dbc70.
   Albert RRA, 2005, J LARYNGOL OTOL, V119, P774.
   Baron S., 1996, MED MICROBIOLOGY.
   BERMAN S, 1995, PEDIATRICS, V96, P126.
   Bluestone CD, 1996, WHO CIBA FDN WORKSH, P14.
   Brook I, 1996, J PEDIATR-US, V128, P237, DOI 10.1016/S0022-3476(96)70397-9.
   Byrd MS, 2011, INFECT IMMUN, V79, P3087, DOI 10.1128/IAI.00057-11.
   Chang J, 2011, CLIN EXP OTORHINOLAR, V4, P122, DOI 10.3342/ceo.2011.4.3.122.
   Chirwa M, 2015, MALAWI MED J, V27, P120, DOI 10.4314/mmj.v27i4.1.
   Chowdhury M A, 2002, Bangladesh Med Res Counc Bull, V28, P36.
   COTICCHIA JM, 2013, FRONT PEDIATR, V1.
   Dohar JE, 2005, LARYNGOSCOPE, V115, P1469, DOI 10.1097/01.mlg.0000172036.82897.d4.
   Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202.
   Ibekwe AO, 1997, ANN OTO RHINOL LARYN, V106, P649, DOI 10.1177/000348949710600806.
   Indudharan R, 1999, ANN OTO RHINOL LARYN, V108, P440, DOI 10.1177/000348949910800504.
   Jose A., 2004, CHILD ADOLESCENT HLT.
   Kumar H, 2011, J CLIN DIAGN RES, V5, P1224.
   Lee SK, 2010, OTOLARYNG HEAD NECK, V143, P500, DOI 10.1016/j.otohns.2010.06.906.
   Levi J, 2016, CHRONIC SUPPURATIVE.
   Lieberthal AS, 2004, PEDIATRICS, V113, P1451.
   Maji PK, 2007, INDIAN J OTOLARYNGOL, V59, P128, DOI 10.1007/s12070-007-0038-x.
   Mansoor Tahira, 2009, J Ayub Med Coll Abbottabad, V21, P120.
   Melaku A, 1999, ETHIOPIAN MED J, V37, P237.
   Mittal R, 2015, J MED MICROBIOL, V64, P1103, DOI 10.1099/jmm.0.000155.
   Ologe F E, 2002, Niger Postgrad Med J, V9, P63.
   Osazuwa F, 2011, N AM J MED SCI, V3, P95, DOI 10.4297/najms.2011.395.
   Poorey V K, 2002, Indian J Otolaryngol Head Neck Surg, V54, P91, DOI 10.1007/BF02968724.
   Prakash Rajat, 2013, N Am J Med Sci, V5, P282, DOI 10.4103/1947-2714.110436.
   Shyamla R, 2012, J MICROBIOL BIOTECHN, V2, P152.
   Smith AW, 1996, LANCET, V348, P1128, DOI 10.1016/S0140-6736(96)09388-9.
   van Hasselt P, 2002, INT J PEDIATR OTORHI, V63, P49, DOI 10.1016/S0165-5876(01)00648-6.
   Westerberg BD, 2009, OTOL NEUROTOL, V30, P174, DOI 10.1097/MAO.0b013e31819225a0.
   Yang JA, 2008, J KOREAN MED SCI, V23, P762, DOI 10.3346/jkms.2008.23.5.762.}},
Number-of-Cited-References = {{35}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{J. Evol. Med. Dent. Sci.-JEMDS}},
Doc-Delivery-Number = {{FH4TX}},
Unique-ID = {{ISI:000411156100006}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000409954600012,
Author = {Lenart-Boron, Anna and Wolny-Koladka, Katarzyna and Juraszek, Katarzyna
   and Kasprowicz, Andrzej},
Title = {{Phenotypic and molecular assessment of antimicrobial resistance profile
   of airborne Staphylococcus spp. isolated from flats in Krakw}},
Journal = {{AEROBIOLOGIA}},
Year = {{2017}},
Volume = {{33}},
Number = {{3}},
Pages = {{435-444}},
Month = {{SEP}},
Abstract = {{Bacteria of the genus Staphylococcus were isolated from air sampled from
   living spaces in Krakw (Poland). In total, 55 strains belonging to the
   genus Staphylococcus were isolated from 45 sites, and 13 species of
   coagulase-negative staphylococci were identified. The species
   composition of studied airborne microbiota contains Staphylococcus
   species that are rarely infectious to humans. Most commonly isolated
   species comprised S. hominis and S. warneri. The disk-diffusion tests
   showed that the collected isolates were most frequently resistant to
   erythromycin. The PCR technique was employed to search for genes
   conferring the resistance in staphylococci to antibiotics from the group
   of macrolides, lincosamides and streptogramins. The analyzed
   Staphylococcus isolates possessed simultaneously 4 different resistance
   genes. The molecular analysis with the use of specific primers allowed
   to determine the most prevalent gene which is mphC, responsible for the
   resistance to macrolides and for the enzymatic inactivation of the drug
   by phosphotransferase. The second most often detected gene was msrA1,
   which confers the resistance of staphylococci to macrolides and is
   responsible for active pumping of antimicrobial particles out of
   bacterial cells.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lenart-Boron, A (Reprint Author), Univ Agr, Dept Microbiol, Mickiewicza Ave 24-28, PL-31059 Krakow, Poland.
   Lenart-Boron, Anna; Wolny-Koladka, Katarzyna, Univ Agr, Dept Microbiol, Mickiewicza Ave 24-28, PL-31059 Krakow, Poland.
   Juraszek, Katarzyna, Univ Agr, Fac Biotechnol \& Hort, 29 Listopada Ave 54, PL-31425 Krakow, Poland.
   Kasprowicz, Andrzej, Ctr Microbiol Res \& Autovaccines, Slawkowska 17, PL-31016 Krakow, Poland.}},
DOI = {{10.1007/s10453-017-9481-7}},
ISSN = {{0393-5965}},
EISSN = {{1573-3025}},
Keywords = {{Antibiotics; Bacteria; Molecular characterization; Polymerase chain
   reaction (PCR); Resistance}},
Keywords-Plus = {{COAGULASE-NEGATIVE STAPHYLOCOCCI; INDOOR ENVIRONMENT; AUREUS;
   STREPTOGRAMIN; INFECTIONS; BACTERIAL; WARNERI; HOMINIS; SKIN}},
Research-Areas = {{Life Sciences \& Biomedicine - Other Topics; Environmental Sciences \&
   Ecology}},
Web-of-Science-Categories  = {{Biology; Environmental Sciences}},
Author-Email = {{a.lenart-boron@ur.krakow.pl
   a.kasprowicz@cbm.com.pl}},
Funding-Acknowledgement = {{University of Agriculture {[}DS 3158/KM/2014]}},
Funding-Text = {{This study was funded by the statutory measures of the University of
   Agriculture-Grant No. DS 3158/KM/2014 and by measures of the Centre for
   Microbiological Research and Autovaccines in Krakow.}},
Cited-References = {{{[}Anonymous], 1989, PNZ0400808 POL COMM.
   Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1.
   Bartoszewicz-Potyrala M, 2002, POSTEP MIKROBIOL, V41, P351.
   Butarewicz A., 2005, ANN NATL I HYGIENE, V56, P199.
   Campoccia D, 2010, INT J ARTIF ORGANS, V33, P575.
   Castro-Alarcon N, 2011, J MED MICROBIOL, V60, P730, DOI 10.1099/jmm.0.027847-0.
   Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P565.
   Chesneau O, 2005, ANTIMICROB AGENTS CH, V49, P973, DOI 10.1128/AAC.49.3.973-980.2005.
   Dakic I, 2005, J CLIN MICROBIOL, V43, P2782, DOI 10.1128/JCM.43.6.2782-2785.2005.
   Gaillot O, 2000, J CLIN MICROBIOL, V38, P1587.
   Gaska-Jedruch U., 2009, POLISH ENV ENG 5 YEA, V2, P31.
   Gorny RL, 2002, ANN AGR ENV MED, V9, P17.
   Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867.
   Hryniewicz W., 2014, BREAKPOINT TABLES IN.
   Hu XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081813.
   Irving W., 2008, MED MICROBIOLOGY SHO.
   Jiang SP, 2012, J BACTERIOL, V194, P4761, DOI 10.1128/JB.00991-12.
   Jo WK, 2006, CHEMOSPHERE, V65, P1755, DOI 10.1016/j.chemosphere.2006.04.068.
   KLOOS WE, 1975, INT J SYST BACTERIOL, V25, P62, DOI 10.1099/00207713-25-1-62.
   KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117.
   Leclercq R, 2002, CLIN INFECT DIS, V34, P482, DOI 10.1086/324626.
   Lenart-Boron A, 2016, MICROB DRUG RESIST, V22, P515, DOI 10.1089/mdr.2015.0271.
   Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461.
   Liu C, 2009, BIOMED ENVIRON SCI, V22, P401, DOI 10.1016/S0895-3988(10)60018-9.
   Luthje P, 2006, J ANTIMICROB CHEMOTH, V57, P966, DOI 10.1093/jac/dk1061.
   Marciniak P., 2008, PHARM NEWSPAPER, V12, P31.
   Markiewicz Z., 2012, BACTERIA ANTIBIOTICS.
   Botelho AMN, 2012, J MED MICROBIOL, V61, P1136, DOI 10.1099/jmm.0.035931-0.
   Pastuszka JS, 2000, ATMOS ENVIRON, V34, P3833, DOI 10.1016/S1352-2310(99)00527-0.
   Schmitz FJ, 2000, J ANTIMICROB CHEMOTH, V45, P891, DOI 10.1093/jac/45.6.891.
   Stogios PJ, 2014, ANTIMICROB AGENTS CH, V58, P7083, DOI 10.1128/AAC.03743-14.
   Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562.
   The European Commission, 2001, COM33 EUR COMM, V1.
   Zabicka D., 2010, RECOMMENDATIONS SELE.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Aerobiologia}},
Doc-Delivery-Number = {{FG2PA}},
Unique-ID = {{ISI:000409954600012}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000410532400004,
Author = {Datta, Sumona and Sherman, Jonathan M. and Tovar, Marco A. and Bravard,
   Marjory A. and Valencia, Teresa and Montoya, Rosario and Quino, Willi
   and D'Arcy, Nikki and Ramos, Eric S. and Gilman, Robert H. and Evans,
   Carlton A.},
Title = {{Sputum Microscopy With Fluorescein Diacetate Predicts Tuberculosis
   Infectiousness}},
Journal = {{JOURNAL OF INFECTIOUS DISEASES}},
Year = {{2017}},
Volume = {{216}},
Number = {{5}},
Pages = {{514-524}},
Month = {{SEP 1}},
Abstract = {{Background. Sputum from patients with tuberculosis contains
   subpopulations of metabolically active and inactive Mycobacterium
   tuberculosis with unknown implications for infectiousness.
   Methods. We assessed sputum microscopy with fluorescein diacetate (FDA,
   evaluating M. tuberculosis metabolic activity) for predicting
   infectiousness. Mycobacterium tuberculosis was quantified in
   pretreatment sputum of patients with pulmonary tuberculosis using FDA
   microscopy, culture, and acid-fast microscopy. These 35 patients' 209
   household contacts were followed with prevalence surveys for
   tuberculosis disease for 6 years.
   Results. FDA microscopy was positive for a median of 119 (interquartile
   range {[}IQR], 47-386) bacteria/mu L sputum, which was 5.1\% (IQR,
   2.4\%-11\%) the concentration of acid-fast microscopy-positive bacteria
   (2069 {[}IQR, 1358-3734] bacteria/mu L). Tuberculosis was diagnosed
   during follow-up in 6.4\% (13/209) of contacts. For patients with lower
   than median concentration of FDA microscopy-positive M. tuberculosis,
   10\% of their contacts developed tuberculosis. This was significantly
   more than 2.7\% of the contacts of patients with higher than median FDA
   microscopy results (crude hazard ratio {[}HR], 3.8; P = .03). This
   association maintained statistical significance after adjusting for
   disease severity, chemoprophylaxis, drug resistance, and social
   determinants (adjusted HR, 3.9; P = .02).
   Conclusions. Mycobacterium tuberculosis that was FDA microscopy negative
   was paradoxically associated with greater infectiousness. FDA
   microscopy-negative bacteria in these pretreatment samples may be a
   nonstaining, slowly metabolizing phenotype better adapted to airborne
   transmission.}},
Publisher = {{OXFORD UNIV PRESS INC}},
Address = {{JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Datta, S (Reprint Author), Imperial Coll London, Sect Infect Dis \& Immun, Hammersmith Hosp Campus,Commonwealth Bldg Level 8, London W12 0NN, England.
   Datta, Sumona; Sherman, Jonathan M.; Tovar, Marco A.; Bravard, Marjory A.; Valencia, Teresa; Quino, Willi; D'Arcy, Nikki; Ramos, Eric S.; Evans, Carlton A., Univ Peruana Cayetano Heredia, Lab Res \& Dev, Innovat Hlth \& Dev IFHAD, Lima, Peru.
   Datta, Sumona; Evans, Carlton A., Imperial Coll London, Infect Dis \& Immun, London, England.
   Datta, Sumona; Evans, Carlton A., Imperial Coll London, Wellcome Trust Ctr Global Hlth Res, London, England.
   Datta, Sumona; Tovar, Marco A.; Montoya, Rosario; Quino, Willi; D'Arcy, Nikki; Evans, Carlton A., Asociac Benef Prisma, Innovac Salud \& Desarollo IPSYD, Lima, Peru.
   Gilman, Robert H., Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   Bravard, Marjory A., Massachusetts Gen Hosp, Dept Gen Internal Med, Boston, MA 02114 USA.}},
DOI = {{10.1093/infdis/jix229}},
ISSN = {{0022-1899}},
EISSN = {{1537-6613}},
Keywords = {{fluorescein diacetate; infectiousness; microscopy; tuberculosis; TB}},
Keywords-Plus = {{MYCOBACTERIUM-TUBERCULOSIS; SEEKING BEHAVIOR; PERUVIAN AMAZON;
   VIABILITY; CULTURE; CELLS; HIV; DECONTAMINATION; RESISTANCE; DIAGNOSIS}},
Research-Areas = {{Immunology; Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Immunology; Infectious Diseases; Microbiology}},
Author-Email = {{sumona.datta@ifhad.org}},
ORCID-Numbers = {{Tovar, Marco/0000-0002-8474-4319}},
Funding-Acknowledgement = {{Wellcome Trust Fellowship {[}105788/Z/14/Z]; Wellcome Trust
   {[}057434/Z/99/Z, 070005/Z/02/Z, 078340/Z/05/Z, MR/K007467/1]; Joint
   Global Health Trials Consortium of the Medical Research Council, UK;
   UK-AID; Bill \& Melinda Gates Foundation {[}OPP1118545]; Imperial
   College Biomedical Research Centre; World Health Organization; charity
   Innovation for Health and Development (IFHAD)}},
Funding-Text = {{This work was supported principally by the Wellcome Trust Fellowship
   105788/Z/14/Z. Specific activities and researchers were also supported
   by the Wellcome Trust (award numbers 057434/Z/99/Z, 070005/Z/02/Z, and
   078340/Z/05/Z); the Joint Global Health Trials Consortium of the Medical
   Research Council, UK; UK-AID and the Wellcome Trust (award number
   MR/K007467/1); the Bill \& Melinda Gates Foundation (award number
   OPP1118545); the Imperial College Biomedical Research Centre; the World
   Health Organization; and the charity Innovation for Health and
   Development (IFHAD).}},
Cited-References = {{Ashiru OT, 2012, ANAEROBE, V18, P471, DOI 10.1016/j.anaerobe.2012.04.010.
   Bacon J, 2004, TUBERCULOSIS, V84, P205, DOI 10.1016/j.tube.2003.12.011.
   Baldwin MR, 2004, INT J TUBERC LUNG D, V8, P1484.
   Bravard M, 2010, P 41 WORLD ANN UN TU, V13, pS85.
   Brooks-Pollock E, 2011, J INFECT DIS, V203, P1582, DOI 10.1093/infdis/jir162.
   Burdz TVN, 2003, DIAGN MICR INFEC DIS, V47, P503, DOI 10.1016/S0732-8893(03)00138-X.
   Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203.
   Chew RS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-269.
   Datta S, 2015, CLIN INFECT DIS, V60, P1186, DOI 10.1093/cid/ciu1153.
   Dhillon J, 2014, J ANTIMICROB CHEMOTH, V69, P437, DOI 10.1093/jac/dkt357.
   Dietrich J, 2015, INFECT IMMUN, V83, P4731, DOI 10.1128/IAI.01055-15.
   Escombe AR, 2007, CLIN INFECT DIS, V44, P1349, DOI 10.1086/515397.
   Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188.
   Ford CM, 2009, AM J TROP MED HYG, V81, P1097, DOI 10.4269/ajtmh.2009.08-0627.
   Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075.
   Grandjean L, 2008, J CLIN MICROBIOL, V46, P2339, DOI 10.1128/JCM.02476-07.
   Harada S, 1992, Kekkaku, V67, P113.
   Kawai V, 2006, AM J TROP MED HYG, V75, P1027.
   Kent PT, 1985, PUBLIC HLTH MYCOBACT.
   Kinomoto M, 1999, Kekkaku, V74, P599.
   KVACH JT, 1982, INT J LEPROSY, V50, P183.
   Lawn SD, 2015, CLIN INFECT DIS, V60, P1196, DOI 10.1093/cid/ciu1156.
   Li YJ, 2002, INFECT IMMUN, V70, P6223, DOI 10.1128/IAI.70.11.6223-6230.2002.
   Lumb R, 2013, LAB DIAGNOSIS TUBERC.
   Martinez L, 2013, AM J TROP MED HYG, V89, P507, DOI 10.4269/ajtmh.13-0005.
   MEDZON EL, 1969, J BACTERIOL, V97, P402.
   Ministry of Health, 2006, NORM TECN SALUD CONT.
   Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524.
   Mukamolova GV, 2010, AM J RESP CRIT CARE, V181, P174, DOI 10.1164/rccm.200905-0661OC.
   Nahid P, 2012, J INFECT DIS, V205, pS159, DOI 10.1093/infdis/jis194.
   Nava-Aguilera E, 2009, INT J TUBERC LUNG D, V13, P17.
   Oberhelman RA, 2006, PEDIATRICS, V118, pE100, DOI 10.1542/peds.2005-2623.
   Onifade DA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-381.
   Pelly TF, 2005, INT J TUBERC LUNG D, V9, P977.
   Proano A, 2017, CLIN INFECT DIS, V64, P1174, DOI 10.1093/cid/cix039.
   Ramos E, 2010, AM J TROP MED HYG, V83, P896, DOI 10.4269/ajtmh.2010.09-0566.
   Rao VB, 2007, EMERG INFECT DIS, V13, P1101, DOI 10.3201/eid1307.070227.
   Rocha C., 2011, International Journal of Tuberculosis and Lung Disease, V15, pS50.
   Ryan GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011108.
   Saito M, 2004, INT J TUBERC LUNG D, V8, P842.
   Sandhu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038080.
   Saunders MJ, 2016, AM J RESP CRIT CARE, V194, P1049, DOI 10.1164/rccm.201605-1007ED.
   Sharma S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173508.
   Sherman JM, 2007, MONTORING ANTITUBERC.
   Sun ZH, 1999, J BACTERIOL, V181, P7626.
   Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139.
   Wingfield T, 2014, J INFECT DIS, V210, P774, DOI 10.1093/infdis/jiu121.
   Zevallos K, 2009, 40 INT UN TB LUNG DI, P3.
   Zevallos K, 2010, AM J TROP MED HYG, V83, P319, DOI 10.4269/ajtmh.2010.10-0073.
   Zhang Y, 2012, ANTIMICROB AGENTS CH, V56, P2223, DOI 10.1128/AAC.06288-11.}},
Number-of-Cited-References = {{50}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{J. Infect. Dis.}},
Doc-Delivery-Number = {{FG6UY}},
Unique-ID = {{ISI:000410532400004}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000408179300013,
Author = {van de lagemaat, Marieke and Grotenhuis, Arjen and van de Belt-Gritter,
   Betsy and Roest, Steven and Loontjens, Ton J. A. and Busscher, Henk J.
   and van der Mei, Henny C. and Ren, Yijin},
Title = {{Comparison of methods to evaluate bacterial contact-killing materials}},
Journal = {{ACTA BIOMATERIALIA}},
Year = {{2017}},
Volume = {{59}},
Pages = {{139-147}},
Month = {{SEP 1}},
Abstract = {{Cationic surfaces with alkylated quaternary-ammonium groups kill
   adhering bacteria upon contact by membrane disruption and are considered
   increasingly promising as a non-antibiotic based way to eradicate
   bacteria adhering to surfaces. However, reliable in vitro evaluation
   methods for bacterial contact-killing surfaces do not yet exist. More
   importantly, results of different evaluation methods are often
   conflicting. Therefore, we compared five methods to evaluate
   contact-killing surfaces. To this end, we have copolymerized
   quaternary-ammonium groups into diurethane dimethacrylate/glycerol
   dimethacrylate (UDMA/GDMA) and determined contact-killing efficacies
   against five different Gram-positive and Gram-negative strains.
   Spray-coating bacteria from an aerosol onto contact-killing surfaces
   followed by air-drying as well as ASTM E2149-13a (American Society for
   Testing and Materials) were found unsuitable, while the Petrifilm (R)
   system and JIS Z 2801 (Japanese Industrial Standards) were found to be
   excellent methods to evaluate bacterial contact-killing surfaces. It is
   recommended however, that these methods be used in combination with a
   zone of inhibition on agar assay to exclude that leakage of
   antimicrobials from the material interferes with the contact-killing
   ability of the surface.
   Statement of Significance
   Bacterial adhesion to surfaces of biomaterials implants can be
   life-threatening. Antimicrobials to treat biomaterial-associated
   infections often fail due to the bacterial biofilm-mode-of-growth or are
   ineffective due to antibiotic-resistance of causative organisms.
   Positively-charged, quaternized surfaces can kill bacteria upon contact
   and are promising as a non-antibiotic-based treatment of
   biomaterial-associated infections. Reliable methods to determine
   efficacies of contact-killing surfaces are lacking, however. Here, we
   show that three out of five methods compared, including an established
   ASTM, are unsuitable. Methods found suitable should be used in
   combination with a zone-of-inhibition-assay to establish absence of
   antimicrobial leaching, potentially interfering with contact-killing.
   Identification of suitable assays for evaluating bacterial
   contact-killing will greatly assist this emerging field as an
   alternative for antibiotic-based treatment of
   biomaterial-associated-infections. (C) 2017 Acta Materialia Inc.
   Published by Elsevier Ltd. All rights reserved.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{van der Mei, HC (Reprint Author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, FB40,POB 196, NL-9700 AD Groningen, Netherlands.
   van de lagemaat, Marieke; Grotenhuis, Arjen; Ren, Yijin, Univ Groningen, Univ Med Ctr Groningen, Dept Orthodont, Hanzepl 1, NL-9700 RB Groningen, Netherlands.
   van de Belt-Gritter, Betsy; Roest, Steven; Busscher, Henk J.; van der Mei, Henny C., Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
   Loontjens, Ton J. A., Univ Groningen, Zernike Inst Adv Mat, Dept Polymer Chem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.}},
DOI = {{10.1016/j.actbio.2017.06.042}},
ISSN = {{1742-7061}},
EISSN = {{1878-7568}},
Keywords = {{Quaternary ammonium compounds; Positively-charged surface; JIS Z 2801;
   Leaching coating; Bacterial contact-killing surface; Antibiotic
   resistance}},
Keywords-Plus = {{ANTIBACTERIAL SURFACES; CATIONIC SURFACES; COATINGS; POLYMERS; DENSITY;
   FILMS; PREVENTION; PERMANENT; SYSTEMS; CELLS}},
Research-Areas = {{Engineering; Materials Science}},
Web-of-Science-Categories  = {{Engineering, Biomedical; Materials Science, Biomaterials}},
Author-Email = {{h.c.van.der.mei@umcg.nl}},
Funding-Acknowledgement = {{UMCG, Groningen, The Netherlands}},
Funding-Text = {{This study was entirely funded by UMCG, Groningen, The Netherlands.
   H.J.B. is also director of a consulting company SASA BV. The authors
   declare no potential conflicts of interest with respect to authorship
   and/or publication of this article. Opinions and assertions contained
   herein are those of the authors and are not construed as necessarily
   representing views of the funding organization or their respective
   employer(s). The authors would like to thank Dr. P. Zhao and Dr. J. Yue
   for their expertise in the polymers.}},
Cited-References = {{Andresen M, 2007, BIOMACROMOLECULES, V8, P2149, DOI 10.1021/bm070304e.
   {[}Anonymous], PETRIFILM AEROBIC CO.
   {[}Anonymous], 2013, E214913A ASTM.
   Asri LATW, 2014, ADV FUNCT MATER, V24, P346, DOI 10.1002/adfm.201301686.
   BRADY R.F, 2000, J COATING TECHNOL, V72, P45.
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528.
   Cado G, 2013, ADV FUNCT MATER, V23, P4801, DOI 10.1002/adfm.201300416.
   Cleophas RTC, 2014, BIOMACROMOLECULES, V15, P3390, DOI 10.1021/bm500899r.
   Dalsin JL, 2005, MATER TODAY, V8, P38, DOI 10.1016/S1369-7021(05)71079-8.
   Fears R., 2013, LANCET GLOB HEALTH, V2, pe11.
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034.
   Gottenbos B, 2003, BIOMATERIALS, V24, P2707, DOI 10.1016/S0142-9612(03)00083-8.
   Haldar J, 2007, NAT PROTOC, V2, P2412, DOI 10.1038/nprot.2007.353.
   Haldar J, 2006, P NATL ACAD SCI USA, V103, P17667, DOI 10.1073/pnas.0608803103.
   Hammes F, 2011, ADV BIOCHEM ENG BIOT, V124, P123, DOI 10.1007/10\_2010\_95.
   Hammond S. M., 2001, BACTERIAL CELL SURFA.
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017.
   Imazato S, 2003, BIOMATERIALS, V24, P3605, DOI 10.1016/S0142-9612(03)00217-5.
   Irikura H, 2003, J PHOTOPOLYM SCI TEC, V16, P273, DOI 10.2494/photopolymer.16.273.
   JANSEN B, 1995, J IND MICROBIOL, V15, P391, DOI 10.1007/BF01569996.
   Japanese Industrial Standard, 2010, Z2801 JIS JAP STAND.
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035.
   Klink CD, 2012, J BIOMED MATER RES A, V100A, P1195, DOI 10.1002/jbm.a.34066.
   Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0.
   Lenoir S., 2005, E-POLYMERS, V5, P783.
   MELLOUKI A, 1989, MAR POLLUT BULL, V20, P612, DOI 10.1016/0025-326X(89)90398-6.
   Milovic NM, 2005, BIOTECHNOL BIOENG, V90, P715, DOI 10.1002/bit.20454.
   Montali A, 2006, INJURY, V37, P81, DOI 10.1016/j.injury.2006.04.013.
   Murata H, 2007, BIOMATERIALS, V28, P4870, DOI 10.1016/j.biomaterials.2007.06.012.
   Necula BS, 2009, ACTA BIOMATER, V5, P3573, DOI 10.1016/j.actbio.2009.05.010.
   Neut D, 2003, BIOMATERIALS, V24, P1829, DOI 10.1016/S0142-9612(02)00614-2.
   Norde W, 2004, LANGMUIR, V20, P4162, DOI 10.1021/la030417t.
   Pasquier N, 2007, BIOMACROMOLECULES, V8, P2874, DOI 10.1021/bm070353r.
   Rouxhet PG, 2011, SURF INTERFACE ANAL, V43, P1453, DOI 10.1002/sia.3831.
   Schaer TP, 2012, BIOMATERIALS, V33, P1245, DOI 10.1016/j.biomaterials.2011.10.038.
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046.
   Taheri S, 2014, BIOMATERIALS, V35, P4601, DOI 10.1016/j.biomaterials.2014.02.033.
   Thoma LM, 2014, BIOMACROMOLECULES, V15, P2933, DOI 10.1021/bm500557d.
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098.
   van de Belt H, 1999, NAT MED, V5, P358, DOI 10.1038/7330.
   van der Mei HC, 2012, CLIN ORAL INVEST, V16, P109, DOI 10.1007/s00784-011-0514-2.
   Xue Y, 2012, J BIOMAT SCI-POLYM E, V23, P1115, DOI 10.1163/092050611X576639.
   Yao X, 2013, BIOMATERIALS, V34, P9001, DOI 10.1016/j.biomaterials.2013.08.013.
   Yue J, 2015, ADV FUNCT MATER, V25, P6756, DOI 10.1002/adfm.201502384.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{8}},
Usage-Count-Last-180-days = {{12}},
Usage-Count-Since-2013 = {{28}},
Journal-ISO = {{Acta Biomater.}},
Doc-Delivery-Number = {{FE4JD}},
Unique-ID = {{ISI:000408179300013}},
DA = {{2018-08-13}},
}

@article{ ISI:000404321400003,
Author = {Raghavendra, Gownolla Malegowd and Jung, Jeyoung and Kim, Dowan and Seo,
   Jongchul},
Title = {{Effect of chitosan silver nanoparticle coating on functional properties
   of Korean traditional paper}},
Journal = {{PROGRESS IN ORGANIC COATINGS}},
Year = {{2017}},
Volume = {{110}},
Pages = {{16-23}},
Month = {{SEP}},
Abstract = {{The effect of chitosan silver nanoparticle (CSN) coatings on functional
   properties of Korean traditional paper (Hanji) was investigated as a
   function of dilution. In a typical process, CSN solution was prepared
   from AgNO3 and chitosan via microwave irradiation. The as-prepared CSN
   solution was diluted to several concentrations (10, 1, 0.1 v/v\% of
   undiluted CSN solution) and also used as prepared for coating Hanji by a
   dip coating method. The mechanical, oil resistance (TAPPI T559 pm-96),
   air resistance (TAPPI T 460), and antibacterial properties (JIS Z 2801)
   against Escherichia coil were investigated. Among the various
   concentrations, the minimum concentration that can positively influence
   the mechanical, air resistance, oil resistance and antibacterial
   properties of Hanji was identified as 1, 1, 10, 0.1\% of the pure CSN
   solution, respectively. These findings are significant, since an
   improvement for a specific property of Hanji can be achieved by coating
   respective concentration.}},
Publisher = {{ELSEVIER SCIENCE SA}},
Address = {{PO BOX 564, 1001 LAUSANNE, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Seo, J (Reprint Author), Yonsei Univ, Dept Packaging, Kangwondo 220710, South Korea.
   Raghavendra, Gownolla Malegowd; Jung, Jeyoung; Kim, Dowan; Seo, Jongchul, Yonsei Univ, Dept Packaging, Kangwondo 220710, South Korea.}},
DOI = {{10.1016/j.porgcoat.2017.04.040}},
ISSN = {{0300-9440}},
Keywords = {{Korean traditional paper; Chitosan; Silver nanoparticles; Functional
   properties}},
Keywords-Plus = {{ESCHERICHIA-COLI; NANOCOMPOSITE HYDROGELS; INACTIVATION; BACTERIA;
   FIBERS; HANJI}},
Research-Areas = {{Chemistry; Materials Science}},
Web-of-Science-Categories  = {{Chemistry, Applied; Materials Science, Coatings \& Films}},
Author-Email = {{jcseo@yonsei.ac.kr}},
Funding-Acknowledgement = {{Korea Institute of Planning and Evaluation for Technology in the
   Ministry of Food, Agriculture, Forestry, and Fisheries of the Korean
   Government {[}IPET314050-3]; Yonsei University Research Fund}},
Funding-Text = {{This work was supported by the Korea Institute of Planning and
   Evaluation for Technology in the Ministry of Food, Agriculture,
   Forestry, and Fisheries of the Korean Government (No. IPET314050-3) and
   also supported (in part) by the Yonsei University Research Fund of 2016.}},
Cited-References = {{Amro NA, 2000, LANGMUIR, V16, P2789, DOI 10.1021/la991013x.
   {[}Anonymous], 2000, Z2801 JIS.
   Ashori A., 2016, FIBER POLYM, V6, P174.
   Danilczuk M, 2006, SPECTROCHIM ACTA A, V63, P189, DOI 10.1016/j.saa.2005.05.002.
   Dankovich TA, 2016, ENVIRON SCI-WAT RES, V2, P85, DOI {[}10.1039/c5ew00188a, 10.1039/C5EW00188A].
   Dankovich TA, 2014, ENVIRON-SCI NANO, V1, P367, DOI {[}10.1039/c4en00067f, 10.1039/C4EN00067F].
   Dankovich TA, 2011, ENVIRON SCI TECHNOL, V45, P1992, DOI 10.1021/es103302t.
   Goy RC, 2016, REV BRAS FARMACOGN, V26, P122, DOI 10.1016/j.bjp.2015.09.010.
   Guazzotti V, 2014, FOOD ADDIT CONTAM A, V31, P402, DOI 10.1080/19440049.2013.869360.
   Ham-Pichavant F, 2005, CARBOHYD POLYM, V61, P259, DOI 10.1016/j.carbpol.2005.01.020.
   Huang HZ, 2004, COLLOID SURFACE B, V39, P31, DOI 10.1016/j.colsurfb.2004.08.014.
   Jang YS, 2015, CERAM INT, V41, P6274, DOI 10.1016/j.ceramint.2015.01.050.
   Jayaramudu T., 2016, J APPL POLYM SCI, V133.
   Jayaramudu T, 2013, CARBOHYD POLYM, V95, P188, DOI 10.1016/j.carbpol.2013.02.075.
   Jeong MJ, 2014, CARBOHYD POLYM, V101, P1249, DOI 10.1016/j.carbpol.2013.10.033.
   Jung J, 2016, INT J BIOL MACROMOL, V93, P933, DOI 10.1016/j.ijbiomac.2016.09.067.
   Khwaldia K, 2014, CARBOHYD POLYM, V99, P508, DOI 10.1016/j.carbpol.2013.08.086.
   Laleg M, 1991, NORD PULP PAP RES J, V6, P99.
   Lara HH, 2010, WORLD J MICROB BIOT, V26, P615, DOI 10.1007/s11274-009-0211-3.
   Li S, 2011, BIOMACROMOLECULES, V12, P2864, DOI 10.1021/bm2001439.
   Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5.
   Ling YZ, 2013, IND CROP PROD, V51, P470, DOI 10.1016/j.indcrop.2013.09.040.
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m.
   Raghavendra GM, 2016, CARBOHYD POLYM, V152, P558, DOI 10.1016/j.carbpol.2016.07.045.
   Raghavendra GM, 2016, INT J BIOL MACROMOL, V86, P126, DOI 10.1016/j.ijbiomac.2016.01.057.
   Raghavendra GM, 2016, INT J BIOL MACROMOL, V84, P281, DOI 10.1016/j.ijbiomac.2015.12.026.
   Raghavendra GM, 2015, RSC ADV, V5, P14351, DOI 10.1039/c4ra15995k.
   Raghavendra GM, 2014, RSC ADV, V4, P3494, DOI 10.1039/c3ra46429f.
   Raghavendra GM, 2013, CARBOHYD POLYM, V93, P553, DOI 10.1016/j.carbpol.2012.12.035.
   Retulainen E., 1993, EFFECTS SODIUM CHLOR, P499.
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012.
   Tang Y., 2016, CARBOHYDR POLYM, V161.
   Vogt RL, 2005, PUBLIC HEALTH REP, V120, P174, DOI 10.1177/003335490512000211.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{14}},
Journal-ISO = {{Prog. Org. Coat.}},
Doc-Delivery-Number = {{EY9LZ}},
Unique-ID = {{ISI:000404321400003}},
DA = {{2018-08-13}},
}

@article{ ISI:000406944300059,
Author = {Vasseur, Maleck V. and Lacroix, Marlene Z. and Toutain, Pierre-Louis and
   Bousquet-Melou, Alain and Ferran, Aude A.},
Title = {{Infection-stage adjusted dose of beta-lactams for parsimonious and
   efficient antibiotic treatments: A Pasteurella multocida experimental
   pneumonia in mice}},
Journal = {{PLOS ONE}},
Year = {{2017}},
Volume = {{12}},
Number = {{8}},
Month = {{AUG 4}},
Abstract = {{In this study, the impact of infection stage on clinically and
   microbiologically efficacious doses and on antibiotic consumption was
   assessed during a naturally evolving infectious disease, using an
   original mouse model of pulmonary infection produced by air-borne
   contamination. When Pasteurella multocida was administered as pathogenic
   agent to immunocompetent mice, 60\% of the animals exhibited clinical
   symptoms of pneumonia 2 to 4 days after bacterial contamination of the
   lungs. Two beta-lactam antibiotics were evaluated: amoxicillin and
   cefquinome, a fourth generation cephalosporin developed for food
   animals. First, a pharmacokinetic study was performed in infected mice
   to determine the exposure to amoxicillin or cefquinome required to treat
   clinically affected animals, based on the targeted values of PK/PD
   indices for beta-lactams. We then confirmed that these doses resulted in
   a 100\% clinical cure rate in animals exhibiting clinical signs of
   infection and harboring a high pathogenic inoculum. More interestingly,
   we also showed that the same 100\% clinical cure could be obtained in
   our model with 10-fold lower doses in animals at pre-patent stages of
   infection i.e. when harboring a low pathogenic inoculum. At the group
   level, antimicrobial drug consumption was reduced by treating animals at
   an early stage of the infection course with a pre-patent tailored dose.
   These results suggest that early treatment with a dose suitably adjusted
   to the stage of infection might help to reduce both overall antibiotic
   consumption and resistance selection pressure in the animals and in the
   environment.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ferran, AA (Reprint Author), Univ Toulouse, INRA, UPS, Toxalim Res Ctr Food Toxicol,ENVT,INP Purpan, Toulouse, France.
   Vasseur, Maleck V.; Lacroix, Marlene Z.; Toutain, Pierre-Louis; Bousquet-Melou, Alain; Ferran, Aude A., Univ Toulouse, INRA, UPS, Toxalim Res Ctr Food Toxicol,ENVT,INP Purpan, Toulouse, France.}},
DOI = {{10.1371/journal.pone.0182863}},
Article-Number = {{e0182863}},
ISSN = {{1932-6203}},
Keywords-Plus = {{BOVINE RESPIRATORY-DISEASE; INOCULUM SIZE; KLEBSIELLA-PNEUMONIAE;
   ESCHERICHIA-COLI; RESISTANCE; MODEL; EMERGENCE; SELECTION; EFFICACY;
   THERAPY}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{a.ferran@envt.fr}},
ResearcherID-Numbers = {{BOUSQUET-MELOU, Alain/O-5357-2017
   Ferran, Aude/J-6344-2013
   Toutain, Pierre-Louis/G-4540-2011
   }},
ORCID-Numbers = {{Toutain, Pierre-Louis/0000-0002-8846-8892
   Ferran, Aude A/0000-0002-6629-1088
   BOUSQUET-MELOU, Alain/0000-0002-7661-4311}},
Cited-References = {{Ackermann MR, 2000, MICROBES INFECT, V2, P1079, DOI 10.1016/S1286-4579(00)01262-4.
   Andremont A, 2003, ASM NEWS, V69, P601.
   Canton R, 2011, FEMS MICROBIOL REV, V35, P977, DOI 10.1111/j.1574-6976.2011.00295.x.
   Cockerill F, 2015, METHODS DILUTION ANT.
   Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284.
   Craig WA, 2003, INFECT DIS CLIN N AM, V17, P479, DOI 10.1016/S0891-5520(03)00065-5.
   Dagleish MP, 2010, J COMP PATHOL, V142, P157, DOI 10.1016/j.jcpa.2009.10.015.
   Dudley MN, 2001, ANTIMICROBIAL PHARMA, P67.
   EAGLE H, 1949, J EXP MED, V90, P595, DOI 10.1084/jem.90.6.595.
   Ferran A, 2007, ANTIMICROB AGENTS CH, V51, P4163, DOI 10.1128/AAC.00156-07.
   Ferran AA, 2011, VET MICROBIOL, V148, P292, DOI 10.1016/j.vetmic.2010.09.005.
   Ferran AA, 2009, ANTIMICROB AGENTS CH, V53, P3384, DOI 10.1128/AAC.01347-08.
   Forbes AB, 2011, ANTIMICROB AGENTS CH, V55, P831, DOI 10.1128/AAC.00552-10.
   Jumbe N, 2003, J CLIN INVEST, V112, P275, DOI 10.1172/JCI200316814.
   Kesteman AS, 2010, ANTIMICROB AGENTS CH, V54, P2960, DOI 10.1128/AAC.01612-09.
   Kesteman AS, 2009, ANTIMICROB AGENTS CH, V53, P4740, DOI 10.1128/AAC.00608-09.
   Martinez MN, 2012, ANTIMICROB AGENTS CH, V56, P2795, DOI 10.1128/AAC.05360-11.
   Mizunaga S, 2005, J ANTIMICROB CHEMOTH, V56, P91, DOI 10.1093/jac/dki163.
   Morrissey I, 1999, J ANTIMICROB CHEMOTH, V43, P423.
   Nickell JS, 2010, VET CLIN N AM-FOOD A, V26, P285, DOI 10.1016/j.cvfa.2010.04.006.
   Sanderson MW, 2008, CAN VET J, V49, P373.
   Timsit E, 2011, VET J, V190, P136, DOI 10.1016/j.tvjl.2010.09.012.
   Toutain PL, 2002, RES VET SCI, V73, P105, DOI 10.1016/S0034-5288(02)00039-5.
   Udekwu KI, 2009, J ANTIMICROB CHEMOTH, V63, P745, DOI 10.1093/jac/dkn554.
   United State Department of Agriculture, 2013, TYP COSTS RESP DIS T.
   Vasseur MV, 2014, ANTIMICROB AGENTS CH, V58, P1744, DOI 10.1128/AAC.02135-13.}},
Number-of-Cited-References = {{26}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{12}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{FC6IS}},
Unique-ID = {{ISI:000406944300059}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000426432800006,
Author = {Nie Ting-ting and Li Xiao-ying and Tian Lin-hai and Dong Han-shan},
Title = {{Wear and Antibacterial Properties of Ag-N Co-alloyed AISI 316 Stainless
   Steel}},
Journal = {{CHINA SURFACE ENGINEERING}},
Year = {{2017}},
Volume = {{30}},
Number = {{4}},
Pages = {{36-44}},
Month = {{AUG}},
Abstract = {{In order to improve the hardness, wear resistance and antibacterial
   properties of AISI316 austenite stainless steel (ASS), Ag-N co-alloyed
   layers were prepared on AISI316 ASS by a modified active screen plasma
   nitriding (ASPN) technology. The composition and microstructure of the
   Ag-N co-alloyed layers were characterized using SEM, EDS, XRD, TEM and
   glow discharge optical emission spectroscope (GDOES). Microhardness,
   wear performance in dry air and artificial simulation of body fluids
   (SBF), corrosion resisitance in SBF and antibacterial efficiency to S.
   aureus of the untreated and Ag-N co-alloyed ASS were evaluated. Results
   show that a continuous and compact Ag-N co-alloyed surface case, with a
   nanostructure Ag doped S-phase deposition layer on an S-phase diffusion
   layer, is obtained on 316 ASS. Hardness of the ASS is improved by 3 to 4
   times after Ag-N co-alloying treatment. Comparing with the ASS
   substrate, the dry wear loss of the Ag-N co-alloyed samples is reduced
   by about 84.6\%, while the wear rate decreases by about 35\% in SBF. The
   corrosion resistance of Ag-N co-alloyed layer is slightly lower than
   that of ASS in SBF. Antibacterial tests show that Ag-N co-alloyed layer
   presents a bactericide rate of 100\% after contacting with S. aureus for
   12 h.}},
Publisher = {{CHINESE ASSOC SCIENCE \& TECHNOLOGY-CAST}},
Address = {{21, DUJIAKAN, CHANGXINDIAN, BEIJ, 100072, PEOPLES R CHINA}},
Type = {{Article}},
Language = {{Chinese}},
Affiliation = {{Nie, TT (Reprint Author), Taiyuan Univ Technol, Res Inst Surface Engn, Taiyuan 030024, Peoples R China.
   Nie Ting-ting; Tian Lin-hai, Taiyuan Univ Technol, Res Inst Surface Engn, Taiyuan 030024, Peoples R China.
   Li Xiao-ying; Dong Han-shan, Univ Birmingham, Sch Met \& Mat, Birmingham B15 2TT, W Midlands, England.}},
DOI = {{10.11933/j.issn.1007-9289.20170310001}},
ISSN = {{1007-9289}},
Keywords = {{stainless steel; ASPN; Ag-N co-alloyed; wear resistance; antibacterial
   property}},
Keywords-Plus = {{MECHANICAL-PROPERTIES; CORROSION-RESISTANCE; LOW-TEMPERATURE; SCREEN;
   MICROSTRUCTURE; SURFACES; CR}},
Research-Areas = {{Materials Science}},
Web-of-Science-Categories  = {{Materials Science, Coatings \& Films}},
Author-Email = {{tianlinhai@tyut.edu.cn}},
Funding-Acknowledgement = {{EC Marie Curie International Incoming Fellowship
   {[}PIIF-GA-2012-327750]; Shanxi Scholarship Council of China
   {[}2016-025]}},
Funding-Text = {{Supported by EC Marie Curie International Incoming Fellowship
   (PIIF-GA-2012-327750) and Shanxi Scholarship Council of China (2016-025)}},
Cited-References = {{Baranowska J, 2004, SURF COAT TECH, V180, P145, DOI 10.1016/j.surfcoat.2003.10.056.
   Chen SH, 2004, ACTA METALL SIN, V40, P314.
   Czerwiec T, 2000, SURF COAT TECH, V131, P267, DOI 10.1016/S0257-8972(00)00792-1.
   Dong H, 2010, INT MATER REV, V55, P65, DOI 10.1179/095066009X12572530170589.
   Dong Y, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/054105.
   Dong YC, 2010, J BIOMED MATER RES B, V93B, P185, DOI 10.1002/jbm.b.31573.
   Gallo SC, 2009, VACUUM, V84, P321, DOI 10.1016/j.vacuum.2009.07.002.
   Gontijo LC, 2006, MAT SCI ENG A-STRUCT, V431, P315, DOI 10.1016/j.msea.2006.06.023.
   Hong IT, 2005, MAT SCI ENG A-STRUCT, V393, P213, DOI 10.1016/j.msea.2004.10.032.
   Li CX, 2004, WEAR, V256, P1144, DOI 10.1016/j.wear.2003.07.006.
   Li CX, 2002, SURF ENG, V18, P174, DOI 10.1179/026708401225005250.
   {[}李东 Li Dong], 2005, {[}金属热处理, Heat treatment of metals], V30, P8.
   {[}李小英 Li Xiaoying], 2015, {[}中国表面工程, China Surface Engineering], V28, P1.
   Liao KH, 2010, APPL SURF SCI, V256, P3642, DOI 10.1016/j.apsusc.2010.01.001.
   LIU C F., 2007, SPECIAL STEEL TECHNO, V13, P4.
   {[}马涛 Ma Tao], 2015, {[}材料导报, Materials Review], V29, P98.
   Nishimoto A, 2010, SURF COAT TECH, V205, pS365, DOI 10.1016/j.surfcoat.2010.08.034.
   Pan F, 2014, MAT SCI ENG R, V83, P1, DOI {[}10.1016/j.mser.2014.10.001, 10.1016/j.mser.2014.06.002].
   Tian LH, 2008, MAT SCI ENG A-STRUCT, V483-84, P751, DOI 10.1016/j.msea.2006.09.157.
   Xi T, 2017, MAT SCI ENG C-MATER, V71, P1079, DOI 10.1016/j.msec.2016.11.022.
   {[}杨化娟 Yang Huajuan], 2005, {[}材料导报, Materials Review], V19, P56.
   Zhang XY, 2012, APPL SURF SCI, V258, P10058, DOI 10.1016/j.apsusc.2012.06.074.
   ZHANG Z L, 1984, SURFACE ENG, V1, P131.
   Zhao C, 2006, SURF COAT TECH, V201, P2320, DOI 10.1016/j.surfcoat.2006.03.045.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{China Surf. Eng.}},
Doc-Delivery-Number = {{FX9OQ}},
Unique-ID = {{ISI:000426432800006}},
DA = {{2018-08-13}},
}

@article{ ISI:000419928700025,
Author = {Zinsstag, J. and Crump, L. and Winkler, M. S.},
Title = {{Biological threats from a `One Health' perspective}},
Journal = {{REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES}},
Year = {{2017}},
Volume = {{36}},
Number = {{2}},
Pages = {{671-680}},
Month = {{AUG}},
Abstract = {{Biological threats are a prime example of an issue that needs the `One
   Health' approach. Such an approach would facilitate the prevention and
   mitigation of these threats. `One Health' is defined as any added value
   in terms of the health of humans and animals, financial savings or
   environmental services achievable through the cooperation of human and
   veterinary medicines when compared to the two disciplines working,
   separately. This principle also applies to the involvement of other
   disciplines from the natural sciences and humanities. This paper is not
   an exhaustive survey of integrated approaches but discusses concepts and
   methods and provides key examples of the benefits of a `One Health'
   approach when applied to biological threats. Zoonoses and vector-borne
   diseases (i.e. diseases transmitted between animals and humans and by
   insect or acarian vectors) remain central biological threats in highly
   dynamic social and environmental conditions. Such diseases are not
   always directly transmitted. Contaminated food, water, air and soil
   represent important sources of transmission for foodborne and
   environmentally related diseases. Therefore, this paper treats
   environmental sanitation separately because of the importance of the
   excreta management of humans and animals. Integrated syndromic
   surveillance and antimicrobial resistance surveillance link the above
   aspects and are showcases for a `One Health' approach to biological
   threat reduction. Biological threats are not only related to natural
   conditions but may also be exacerbated by large development projects
   such as dams, mining and infrastructure. Consequently, it is recommended
   that the health impact assessment (HIA) approach be implemented as early
   as the planning stage of any large infrastructure project located in a
   complex socioecological system. This paper extends the HIA approach to
   an integrated `One Health' impact assessment approach.}},
Publisher = {{OFFICE INT EPIZOOTIES}},
Address = {{12 RUE DE PRONY, 75017 PARIS, FRANCE}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Zinsstag, J (Reprint Author), Swiss Trop \& Publ Hlth Inst, CH-4002 Basel, Switzerland.
   Zinsstag, J (Reprint Author), Univ Basel, Peterspl 1, CH-4001 Basel, Switzerland.
   Zinsstag, J.; Crump, L.; Winkler, M. S., Swiss Trop \& Publ Hlth Inst, CH-4002 Basel, Switzerland.
   Zinsstag, J.; Crump, L.; Winkler, M. S., Univ Basel, Peterspl 1, CH-4001 Basel, Switzerland.}},
DOI = {{10.20506/rst.36.2.2684}},
ISSN = {{0253-1933}},
Keywords = {{Antimicrobial resistance; Biological threat; Foodborne; Health impact
   assessment; One Health; Syndromic surveillance; Vector-borne; Zoonosis}},
Keywords-Plus = {{RIFT-VALLEY FEVER; IMPACT ASSESSMENT; LIVESTOCK; PASTORALISTS; AFRICA;
   CHAD; SEROPREVALENCES; VISUALIZATION; EPIDEMIOLOGY; BRUCELLOSIS}},
Research-Areas = {{Veterinary Sciences}},
Web-of-Science-Categories  = {{Veterinary Sciences}},
Author-Email = {{jakob.zinsstag@unibas.ch}},
Cited-References = {{Abakar MF, 2016, REV SCI TECH OIE, V35, P683, DOI 10.20506/rst.35.2.2549.
   Anyamba A, 2010, AM J TROP MED HYG, V83, P43, DOI 10.4269/ajtmh.2010.09-0289.
   Bonfoh B, 2012, ECOHEALTH, V9, P132, DOI 10.1007/s10393-011-0722-x.
   Bresalier M, 2015, ONE HEALTH: THE THEORY AND PRACTICE OF INTEGRATED HEALTH APPROACHES, P1, DOI 10.1079/9781780643410.0001.
   Chan M, 2014, NEW ENGL J MED, V371, P1183, DOI 10.1056/NEJMp1409859.
   Charron DF, 2012, ECOHEALTH, V9, P256, DOI 10.1007/s10393-012-0791-5.
   Coffin JL, 2015, SOC SCI MED, V129, P44, DOI 10.1016/j.socscimed.2014.07.037.
   Digoutte JP, 1999, B SOC PATHOL EXOT, V92, P343.
   Drewry J, 2017, INT J PUBLIC HEALTH, V62, P253, DOI 10.1007/s00038-016-0860-6.
   Enserink M, 2010, SCIENCE, V327, P266, DOI {[}10.1126/science.327.5963.266-a, 10.1126/science.327.5963.266-b].
   Erlanger TE, 2008, ENVIRON IMPACT ASSES, V28, P349, DOI 10.1016/j.eiar.2007.07.003.
   Fluckiger Y, 2016, NATURE, V531, P448, DOI 10.1038/531448c.
   Fuhrimann S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1809-6.
   Fuhrimann S, 2014, GEOSPATIAL HEALTH, V9, P251.
   Greter H, 2017, ACTA TROP, V175, P91, DOI 10.1016/j.actatropica.2016.05.012.
   Hattendorf J, 2017, ACTA TROP, V165, P268, DOI 10.1016/j.actatropica.2016.10.009.
   Jean-Richard V, 2015, GEOSPATIAL HEALTH, V10, P6, DOI 10.4081/gh.2015.307.
   Kasymbekov J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002047.
   Kayali U, 2003, PREV VET MED, V61, P227, DOI 10.1016/j.prevetmed.2003.07.002.
   Kimani Tabitha, 2016, Infection Ecology \& Epidemiology, V6, P31191, DOI 10.3402/iee.v6.31191.
   Knoblauch AM, 2014, INT J ENV RES PUB HE, V11, P12997, DOI 10.3390/ijerph111212997.
   Mwachui MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003843.
   Nguyen-Viet H, 2009, ECOHEALTH, V6, P180, DOI 10.1007/s10393-009-0249-6.
   Osofsky S. A., 2005, CONSERVATION DEV INT, DOI {[}10.2305/IUCN.CH.2005.SSC-OP.3O.en, DOI 10.2305/IUCN.CH.2005.SSC-OP.3O.EN].
   Pereira CAR, 2017, ENVIRON IMPACT ASSES, V65, P175, DOI 10.1016/j.eiar.2016.09.005.
   Quigley RL, 2006, HLTH IMPACT ASSESSME.
   Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004.
   Viliani F, 2017, EXTRACT IND SOC, V4, P251, DOI 10.1016/j.exis.2016.08.009.
   WHO, 2015, SAN SAF PLANN MAN SA.
   Winkler MS, 2013, B WORLD HEALTH ORGAN, V91, P298, DOI 10.2471/BLT.12.112318.
   Winkler MS, 2012, GEOSPATIAL HEALTH, V6, P299, DOI 10.4081/gh.2012.148.
   Winkler MS, 2010, ENVIRON IMPACT ASSES, V30, P52, DOI 10.1016/j.eiar.2009.05.005.
   World Bank, 2010, 50833GLB56 WORLD BAN, V1, P56.
   Zinsstag J, 2005, LANCET, V366, P2142, DOI 10.1016/S0140-6736(05)67731-8.
   Zinsstag J, 2011, PREV VET MED, V101, P148, DOI 10.1016/j.prevetmed.2010.07.003.
   Zinsstag J, 2015, ONE HLTH THEORY PRAC.
   Zinsstag J, 2007, EMERG INFECT DIS, V13, P527, DOI 10.3201/eid1304.060381.
   Zolzaya B, 2014, ECOHEALTH, V11, P356, DOI 10.1007/s10393-014-0962-7.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{6}},
Usage-Count-Since-2013 = {{6}},
Journal-ISO = {{Rev. Sci. Tech. Off. Int. Epizoot.}},
Doc-Delivery-Number = {{FS6SZ}},
Unique-ID = {{ISI:000419928700025}},
DA = {{2018-08-13}},
}

@article{ ISI:000407535900005,
Author = {Druckenmueller, Katharina and Gartner, Andrea and Jaeckel, Udo and Klug,
   Kerstin and Schiffels, Johannes and Guenther, Klaus and Elbers, Gereon},
Title = {{Development of a methodological approach for the characterization of
   bioaerosols in exhaust air from pig fattening farms with MALDI-TOF mass
   spectrometry}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2017}},
Volume = {{220}},
Number = {{6}},
Pages = {{974-983}},
Month = {{AUG}},
Abstract = {{In this paper, we evaluated matrix-assisted laser desorption/ionization
   time-of-flight mass spectrometry (MALDI-TOF MS) as a
   cultivation-independent, routinely applicable approach to identify
   microbial fractions in bioaerosol emission samples. We developed a
   streamlined protocol in line with the German state-of-the-art
   impingement sampling guideline. Following isokinetic sampling, a fast
   and reliable pretreatment methodology involving a series of cascade
   filtration steps was implemented, which produced fractions for
   spectrometric measurement devoid of interfering substances. We sampled
   the exhaust air from eight pig fattening farms around western Germany,
   which yielded two sets of samples for both method development and
   validation. For method development, in total 65 bacterial isolates were
   produced directly from the exhaust air samples, taxonomically classified
   by 16S rRNA-Gene sequencing, and subjected to MALDI-TOF analysis. In
   this way, we could assign fingerprint biomarkers to classified bacterial
   genera or even species to build up a preliminary reference database. For
   verification of the novel methodology and application of the reference
   database, we subjected the second set of exhaust air samples to the
   developed protocol. Here, 18 out of 21 bacterial species deposited in
   the database were successfully retrieved, including organisms classified
   in risk group 2, which might be used to evaluate the pathogenic
   potential of sampled exhaust air. Overall, this study pursues an
   entirely new approach to rapidly analyze airborne microbial fractions.
   (C) 2017 The Authors. Published by Elsevier GmbH.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Elbers, G (Reprint Author), FH Aachen Univ Appl Sci, Fac Chem \& Biotechnol, Campus Mich, Julich, Germany.
   Druckenmueller, Katharina; Gartner, Andrea; Jaeckel, Udo; Klug, Kerstin; Schiffels, Johannes; Guenther, Klaus; Elbers, Gereon, FH Aachen Univ Appl Sci, Fac Chem \& Biotechnol, Campus Mich, Julich, Germany.}},
DOI = {{10.1016/j.ijheh.2017.05.003}},
ISSN = {{1438-4639}},
EISSN = {{1618-131X}},
Keywords = {{Bioaerosol; Emission; MALDI; Bacteria; Livestock facility; Rapid
   identification}},
Keywords-Plus = {{LASER-DESORPTION/IONIZATION-TIME; SWINE CONFINEMENT BUILDINGS;
   DESORPTION IONIZATION-TIME; BLOOD CULTURE PELLETS; BACTERIAL
   IDENTIFICATION; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; MICROBIAL
   DIVERSITY; EXPOSURE ASSESSMENT; RISK-ASSESSMENT}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{elbers@fh-aachen.de}},
ResearcherID-Numbers = {{Guenther, Klaus/B-3283-2010}},
ORCID-Numbers = {{Guenther, Klaus/0000-0003-0541-6980}},
Funding-Acknowledgement = {{North Rhine-Westphalia State Agency for Nature, Environment and Consumer
   Protection (LANUV NRW), Essen, Germany; Aachen University of Applied
   Sciences, Campus Juelich, Germany; Society for Chemical Engineering and
   Biotechnology e.V. (DECHEMA), Frankfurt, Germany}},
Funding-Text = {{This work was supported by the North Rhine-Westphalia State Agency for
   Nature, Environment and Consumer Protection (LANUV NRW), Essen, Germany,
   the Aachen University of Applied Sciences, Campus Juelich, Germany, and
   the Society for Chemical Engineering and Biotechnology e.V. (DECHEMA),
   Frankfurt, Germany. Further, we thank Andreas Gessner, Sandra Knust and
   her team (LANUV-NRW, Germany) for the organization and execution of the
   bioaerosol emission impinger sampling. Finally, we thank Mechthild Prinz
   and Catherine Kelly for editorial support.}},
Cited-References = {{Adell E, 2012, WORLD RABBIT SCI, V20, P241, DOI 10.4995/wrs.2012.1211.
   Angelakis Emmanouil, 2014, BMC Res Notes, V7, P892, DOI 10.1186/1756-0500-7-892.
   {[}Anonymous], 2015, 466 TRBA COMM BIOL A, P65.
   {[}Anonymous], 2011, 4257 VDI 2, P1.
   Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI {[}10.1093/nar/gkh131, 10.1093/nar/gkw1099].
   Arnold RJ, 1999, ANAL BIOCHEM, V269, P105, DOI 10.1006/abio.1998.3077.
   Barreiro JR, 2012, PROTEOMICS, V12, P2739, DOI 10.1002/pmic.201200053.
   Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI 10.1093/nar/gks1195.
   Bizzini A, 2010, J CLIN MICROBIOL, V48, P1549, DOI 10.1128/JCM.01794-09.
   Chapin A, 2005, ENVIRON HEALTH PERSP, V113, P137, DOI 10.1289/ehp.7473.
   Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244.
   CURTIS SE, 1975, J ANIM SCI, V41, P1512.
   DeMarco ML, 2014, AM J CLIN PATHOL, V141, P204, DOI 10.1309/AJCPQYW3B6JLKILC.
   DONHAM K, 1989, BRIT J IND MED, V46, P31.
   Donohue MJ, 2006, J MICROBIOL METH, V65, P380, DOI 10.1016/j.mimet.2005.08.005.
   Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032.
   Gartner A, 2008, GEFAHRST REINHALT L, V68, P357.
   Gartner A, 2008, GEFAHRST REINHALT L, V68, P351.
   Gartner A, 2016, GEFAHRST REINHALT L, V76, P31.
   Gartner A, 2014, GEFAHRST REINHALT L, V74, P377.
   Gao LL, 2015, INT J ENV RES PUB HE, V12, P4203, DOI 10.3390/ijerph120404203.
   Gartner A., 1885, EMISSIONSMESSUNGEN M.
   Ghosh B, 2015, ENVIRON INT, V85, P254, DOI 10.1016/j.envint.2015.09.018.
   Hausdorf L, 2013, FOOD MICROBIOL, V34, P406, DOI 10.1016/j.fm.2012.10.008.
   Jahne MA, 2016, J ENVIRON QUAL, V45, P666, DOI 10.2134/jeq2015.04.0187.
   Jahne MA, 2015, ENVIRON SCI TECHNOL, V49, P9842, DOI 10.1021/acs.est.5b01981.
   Kim HB, 2015, VET MICROBIOL, V177, P242, DOI 10.1016/j.vetmic.2015.03.014.
   Lighthart B., 1994, ATMOSPHERIC MICROBIA, P5.
   Madsen AM, 2016, ANN OCCUP HYG, V60, P651, DOI 10.1093/annhyg/mew021.
   Madsen AM, 2016, APPL ENVIRON MICROB, V82, P2479, DOI 10.1128/AEM.04063-15.
   Madsen AM, 2015, ENVIRON RES, V140, P255, DOI 10.1016/j.envres.2015.03.027.
   Marti R, 2009, APPL ENVIRON MICROB, V75, P4967, DOI 10.1128/AEM.02791-08.
   Martin E, 2009, GEFAHRST REINHALT L, V69, P97.
   Martin E, 2015, J OCCUP ENVIRON HYG, V12, P77, DOI {[}10.1080/15459624.2014.946514, 10.1080/15459624.2015.946514].
   Masclaux FG, 2013, ANN OCCUP HYG, V57, P550, DOI 10.1093/annhyg/mes098.
   Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x.
   Ngbede EO, 2017, TROP ANIM HEALTH PRO, V49, P451, DOI 10.1007/s11250-016-1212-5.
   Nishikaze Takashi, 2012, Mass Spectrom (Tokyo), V1, pA0006, DOI 10.5702/massspectrometry.A0006.
   Pineda FJ, 2003, ANAL CHEM, V75, P3817, DOI 10.1021/ac034069b.
   Pisanic N, 2015, ENVIRON RES, V143, P93, DOI 10.1016/j.envres.2015.09.026.
   Prod'hom G, 2010, J CLIN MICROBIOL, V48, P1481, DOI 10.1128/JCM.01780-09.
   Pundir Sangya, 2015, Curr Protoc Bioinformatics, V50, DOI 10.1002/0471250953.bi0127s50.
   Ryzhov V, 2001, ANAL CHEM, V73, P746, DOI 10.1021/ac0008791.
   Sala-Comorera L, 2016, INT J HYG ENVIR HEAL, V219, P577, DOI 10.1016/j.ijheh.2016.01.001.
   Sedo O, 2011, MASS SPECTROM REV, V30, P417, DOI 10.1002/mas.20287.
   Seedorf J, 1998, J AGR ENG RES, V70, P97, DOI 10.1006/jaer.1997.0281.
   Stetzenbach LD, 2004, CURR OPIN BIOTECH, V15, P170, DOI 10.1016/j.copbio.2004.04.009.
   The UniProt Consortium, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI {[}10.1093/nar/gkw1099, DOI 10.1093/NAR/GKW1099].
   Thomin J, 2015, J MICROBIOL METH, V115, P54, DOI 10.1016/j.mimet.2015.05.010.
   Toh-Boyo GM, 2012, ANAL CHEM, V84, P9971, DOI 10.1021/ac302375e.
   VDI, 2008, 4253 VDI 3, P1.
   Walser SM, 2015, INT J HYG ENVIR HEAL, V218, P577, DOI 10.1016/j.ijheh.2015.07.004.
   Wang H., 2016, FRONT MICROBIOL, V7.
   Wang ZP, 1998, RAPID COMMUN MASS SP, V12, P456, DOI 10.1002/(SICI)1097-0231(19980430)12:8<456::AID-RCM177>3.3.CO;2-L.
   Wattal C, 2016, EUR J CLIN MICROBIOL, V35, P75, DOI 10.1007/s10096-015-2510-y.
   WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/jb.173.2.697-703.1991.
   Wielders CC., 2017, CLIN MICROBIOL INFEC, V23.}},
Number-of-Cited-References = {{57}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{6}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{FD4XQ}},
Unique-ID = {{ISI:000407535900005}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000405725400001,
Author = {Be, Nicholas A. and Avila-Herrera, Aram and Allen, Jonathan E. and
   Singh, Nitin and Sielaff, Aleksandra Checinska and Jaing, Crystal and
   Venkateswaran, Kasthuri},
Title = {{Whole metagenome profiles of particulates collected from the
   International Space Station}},
Journal = {{MICROBIOME}},
Year = {{2017}},
Volume = {{5}},
Month = {{JUL 17}},
Abstract = {{Background: The built environment of the International Space Station
   (ISS) is a highly specialized space in terms of both physical
   characteristics and habitation requirements. It is unique with respect
   to conditions of microgravity, exposure to space radiation, and
   increased carbon dioxide concentrations. Additionally, astronauts
   inhabit a large proportion of this environment. The microbial
   composition of ISS particulates has been reported; however, its
   functional genomics, which are pertinent due to potential impact of its
   constituents on human health and operational mission success, are not
   yet characterized.
   Methods: This study examined the whole metagenome of ISS microbes at
   both species-and gene-level resolution. Air filter and dust samples from
   the ISS were analyzed and compared to samples collected in a terrestrial
   cleanroom environment. Furthermore, metagenome mining was carried out to
   characterize dominant, virulent, and novel microorganisms. The whole
   genome sequences of select cultivable strains isolated from these
   samples were extracted from the metagenome and compared.
   Results: Species-level composition in the ISS was found to be largely
   dominated by Corynebacterium ihumii GD7, with overall microbial
   diversity being lower in the ISS relative to the cleanroom samples. When
   examining detection of microbial genes relevant to human health such as
   antimicrobial resistance and virulence genes, it was found that a larger
   number of relevant gene categories were observed in the ISS relative to
   the cleanroom. Strain-level cross-sample comparisons were made for
   Corynebacterium, Bacillus, and Aspergillus showing possible distinctions
   in the dominant strain between samples.
   Conclusion: Species-level analyses demonstrated distinct differences
   between the ISS and cleanroom samples, indicating that the cleanroom
   population is not necessarily reflective of space habitation
   environments. The overall population of viable microorganisms and the
   functional diversity inherent to this unique closed environment are of
   critical interest with respect to future space habitation. Observations
   and studies such as these will be important to evaluating the conditions
   required for long-term health of human occupants in such environments.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Venkateswaran, K (Reprint Author), CALTECH, Jet Prop Lab, Biotechnol \& Planetary Protect Grp, M-S 89-2,4800 Oak Grove Dr, Pasadena, CA 91109 USA.
   Be, Nicholas A.; Jaing, Crystal, Lawrence Livermore Natl Lab, Phys \& Life Sci Directorate, Livermore, CA USA.
   Avila-Herrera, Aram; Allen, Jonathan E., Lawrence Livermore Natl Lab, Computat Directorate, Livermore, CA USA.
   Singh, Nitin; Sielaff, Aleksandra Checinska; Venkateswaran, Kasthuri, CALTECH, Jet Prop Lab, Biotechnol \& Planetary Protect Grp, M-S 89-2,4800 Oak Grove Dr, Pasadena, CA 91109 USA.
   Sielaff, Aleksandra Checinska, Iowa State Univ, Dept Ecol Evolut \& Organismal Biol, Ames, IA USA.}},
DOI = {{10.1186/s40168-017-0292-4}},
Article-Number = {{81}},
ISSN = {{2049-2618}},
Keywords = {{International Space Station; Microbiome; Functional metagenomics; Built
   environment; Cleanroom; Propidium monoazide}},
Keywords-Plus = {{STREPTOCOCCUS-AGALACTIAE; ACINETOBACTER-BAUMANNII;
   ANTIBIOTIC-RESISTANCE; BUILT ENVIRONMENT; VIRULENCE FACTOR; MODULE KIBO;
   INFECTION; DNA; PROTEIN; GENES}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{kjvenkat@jpl.nasa.gov}},
Funding-Acknowledgement = {{U.S. Department of Energy by the Lawrence Livermore National Laboratory
   {[}DE-AC52-07NA27344];  {[}NNH12ZTT001N];  {[}19-12829-26]; 
   {[}NNN13D111T];  {[}1506453];  {[}NNH14ZTT002N];  {[}NNX15AJ29G]}},
Funding-Text = {{This research was funded by a 2012 Space Biology NNH12ZTT001N grant no.
   19-12829-26 under Task Order NNN13D111T award to KV which also funded
   post-doctoral fellowship for AC and a JPL subcontract 1506453 to GEF.
   This work was performed under the auspices of the U.S. Department of
   Energy by the Lawrence Livermore National Laboratory under Contract
   DE-AC52-07NA27344. In addition, the research carried out at the Lawrence
   Livermore National Laboratory was funded by a 2014 Space Biology
   NNH14ZTT002N grant no. NNX15AJ29G award to CJ which also funded JA, NB,
   and AAH.}},
Cited-References = {{Ames SK, 2013, BIOINFORMATICS, V29, P2253, DOI 10.1093/bioinformatics/btt389.
   {[}Anonymous], 2017, VEGAN COMMUNITY ECOL.
   Aponte VM, 2006, LIFE SCI, V79, P1317, DOI 10.1016/j.lfs.2006.04.007.
   Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287.
   Bashir M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01321.
   Baylay AJ, 2015, ANTIMICROB AGENTS CH, V59, P3098, DOI 10.1128/AAC.04858-14.
   Beceiro A, 2013, CLIN MICROBIOL REV, V26, P185, DOI 10.1128/CMR.00059-12.
   Boch T, 2016, CLIN MICROBIOL INFEC, V22, P862, DOI 10.1016/j.cmi.2016.06.021.
   Borchers AT, 2002, NUTRITION, V18, P889, DOI 10.1016/S0899-9007(02)00913-9.
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176.
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303.
   Cathcart GRA, 2011, ANTIMICROB AGENTS CH, V55, P2670, DOI 10.1128/AAC.00776-10.
   Checinska A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0116-3.
   Chen LH, 2016, NUCLEIC ACIDS RES, V44, pD694, DOI 10.1093/nar/gkv1239.
   Dawson TL, 2007, J INVEST DERM SYMP P, V12, P15, DOI 10.1038/sj.jidsymp.5650049.
   Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789.
   Flechard M, 2014, MICROBIOL-SGM, V160, P1298, DOI 10.1099/mic.0.077628-0.
   Freihofer P, 2016, RNA, V22, P1836, DOI 10.1261/rna.057257.116.
   Garcia-Del Portillo F, 1999, P NATL ACAD SCI USA, V96, P11578, DOI 10.1073/pnas.96.20.11578.
   Garrison E, 2012, GENOMICS, V1207, P3907.
   Garrison E., VCFLIB SIMPLE C LIB.
   Han T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-217.
   Hartmann EM, 2016, ENVIRON SCI TECHNOL, V50, P9807, DOI 10.1021/acs.est.6b00262.
   Hoisington AJ, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0127-0.
   Hu WY, 2015, MYCOPATHOLOGIA, V179, P147, DOI 10.1007/s11046-014-9822-9.
   Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111.
   Ichijo T, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.7.
   Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004.
   Kaya A, 2015, ANTIOXID REDOX SIGN, V23, P814, DOI 10.1089/ars.2015.6385.
   King GM, 2014, J MICROBIOL, V52, P721, DOI 10.1007/s12275-014-4364-x.
   Knox BP, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00227-16.
   Krappmann S, 2016, CURR OPIN MICROBIOL, V34, P136, DOI 10.1016/j.mib.2016.10.002.
   Kwan K, 2011, APPL ENVIRON MICROB, V77, P2943, DOI 10.1128/AEM.02978-10.
   Kyuma T, 2015, FEBS J, V282, P2570, DOI 10.1111/febs.13302.
   La Duc Myron T., 2004, Habitation, V10, P39, DOI 10.3727/154296604774808883.
   Lan JH, 2015, HUM IMMUNOL, V76, P166, DOI 10.1016/j.humimm.2014.12.016.
   Lax S, 2015, TRENDS MOL MED, V21, P427, DOI 10.1016/j.molmed.2015.03.005.
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324.
   Lo Seynabou, 2015, J Med Case Rep, V9, P156, DOI 10.1186/s13256-015-0638-0.
   Lopez-Rojas R, 2016, INT J ANTIMICROB AG, V47, P473, DOI 10.1016/j.ijantimicag.2016.03.010.
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8.
   Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001.
   Martin LJ, 2015, TRENDS ECOL EVOL, V30, P223, DOI 10.1016/j.tree.2015.02.001.
   Mayer T, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0167-0.
   McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531.
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217.
   Mora M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01573.
   Moric I, 2010, J MED BIOCHEM, V29, P165, DOI 10.2478/v10011-010-0030-y.
   Morris HC, 2012, ASTROBIOLOGY, V12, P830, DOI 10.1089/ast.2012.0863.
   National Research Council (NRC), 2011, REC FUT SPAC EXPL LI.
   Nayfach S, 2016, GENOME RES, V26, P1612, DOI 10.1101/gr.201863.115.
   Nishino K, 2006, MOL MICROBIOL, V59, P126, DOI 10.1111/j.1365-2958.2005.04940.x.
   Nocker A, 2010, INT MICROBIOL, V13, P59, DOI 10.2436/20.1501.01.111.
   Novikova N, 2006, RES MICROBIOL, V157, P5, DOI 10.1016/j.resmic.2005.07.010.
   Oliveira DS, 2013, REV SOC BRAS MED TRO, V46, P654, DOI 10.1590/0037-8682-1486-2013.
   Ongley SE, 2016, J APPL PHYCOL, V28, P2793, DOI 10.1007/s10811-016-0816-5.
   Padmanabhan Roshan, 2014, Stand Genomic Sci, V9, P1128, DOI 10.4056/sigs.5149006.
   Perrone G, 2017, METHODS MOL BIOL, V1542, P107, DOI 10.1007/978-1-4939-6707-0\_5.
   PULKKINEN WS, 1991, J BACTERIOL, V173, P86, DOI 10.1128/jb.173.1.86-93.1991.
   Rawsthorne H, 2009, APPL ENVIRON MICROB, V75, P2936, DOI 10.1128/AEM.02524-08.
   Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032.
   Rojo-Bezares B, 2016, EPIDEMIOL INFECT, V144, P3205, DOI 10.1017/S0950268816001692.
   Salem N, 2015, INFECT DRUG RESIST, V8, DOI 10.2147/IDR.S74795.
   Satoh K, 2011, MICROBIOL IMMUNOL, V55, P823, DOI 10.1111/j.1348-0421.2011.00386.x.
   Scholz M, 2016, NAT METHODS, V13, P435, DOI {[}10.1038/NMETH.3802, 10.1038/nmeth.3802].
   Seemann T., 2015, SNIPPY RAPID BACTERI.
   Seng P, 2014, CLIN MICROBIOL INFEC, V20, pO1052, DOI 10.1111/1469-0691.12743.
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303.
   Singh Nitin Kumar, 2016, Genome Announc, V4, DOI 10.1128/genomeA.00553-16.
   Song SH, 2009, J MED MICROBIOL, V58, P270, DOI 10.1099/jmm.0.004697-0.
   Sosnik A, 2013, ADV DRUG DELIVER REV, V65, P1828, DOI 10.1016/j.addr.2013.09.002.
   Sudagidan M, 2013, FOODBORNE PATHOG DIS, V10, P555, DOI 10.1089/fpd.2012.1424.
   Sugita T, 2016, MED MYCOL, V54, P232, DOI {[}10.1093/mmy/myv121, 10.109].
   TAMURA Y, 1992, MICROB PATHOGENESIS, V12, P237, DOI 10.1016/0882-4010(92)90058-V.
   Tongeren SP, 2014, PLOS ONE, V9.
   Vaishampayan P, 2013, ISME J, V7, P312, DOI 10.1038/ismej.2012.114.
   Van Houdt R, 2012, PLANET SPACE SCI, V60, P115, DOI 10.1016/j.pss.2011.09.001.
   Vedel G, 2006, EMERG INFECT DIS, V12, P355, DOI 10.3201/eid1202.050950.
   Venkateswaran K, 2017, MSYSTEMS, V2.
   Venkateswaran K, 2014, APPL MICROBIOL BIOT, V98, P6453, DOI 10.1007/s00253-014-5650-6.
   Vesper SJ, 2008, RES MICROBIOL, V159, P432, DOI 10.1016/j.resmic.2008.06.001.
   Wang J, 2011, APPL ENVIRON MICROB, V77, P4241, DOI 10.1128/AEM.01834-10.
   Wassenaar TM, 2015, EUR J MICROBIOL IMMU, V5, P44, DOI {[}10.1556/EuJMI-D-14-00038, 10.1556/EUJMI-D-14-00038].
   Wessolossky Mireya, 2013, Infect Drug Resist, V6, P33, DOI 10.2147/IDR.S43069.
   Yamaguchi N, 2014, MICROBES ENVIRON, V29, P250, DOI 10.1264/jsme2.ME14031.}},
Number-of-Cited-References = {{85}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{14}},
Journal-ISO = {{Microbiome}},
Doc-Delivery-Number = {{FA8VV}},
Unique-ID = {{ISI:000405725400001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000405464200031,
Author = {Chen, Yih-Yuan and Chang, Jia-Ru and Wu, Chih-Da and Yeh, Yen-Po and
   Yang, Shiu-Ju and Hsu, Chih-Hao and Lin, Ming-Ching and Tsai, Ching-Fang
   and Lin, Ming-Shian and Su, Ih-Jen and Dou, Horng-Yunn},
Title = {{Combining molecular typing and spatial pattern analysis to identify
   areas of high tuberculosis transmission in a moderateincidence county in
   Taiwan}},
Journal = {{SCIENTIFIC REPORTS}},
Year = {{2017}},
Volume = {{7}},
Month = {{JUL 14}},
Abstract = {{In total, 303 randomly selected clinical Mycobacterium tuberculosis
   (MTB) isolates from 303 patients (collected January to December 2012) in
   central Taiwan were examined. The major lineages found were Beijing (N =
   114, 37.62\%), Haarlem (N = 76, 25.08\%) and East African-Indian (EAI)
   (N = 42, 13.86\%). Notably, younger persons (<= 30 years old) were 6.58
   times more likely to be infected with a Beijing genotype compared to
   older persons (>70 years) (p < 0.05). Combining molecular typing methods
   and geographical information system (GIS) analysis, we uncovered a
   twofold higher incidence of Beijing strains in a hotspot area (33\%)
   compared to non-hotspot areas (17\%). By 24 MIRU-VNTR typing, persons in
   clustered groups were 1.96 times more likely to be infected with a
   Beijing strain compared with non-clustered persons, suggesting recent
   spread and emergence of MTB. Finally, we observed a trend in which TB
   incidence increased as the density / concentration of analyzed
   environmental factors increased, suggesting that environmental factors
   are associated with TB transmission; however, only population density
   was found to be significantly associated with increased risk of TB (p <
   0.05). Molecular typing methods combined with spatial analysis suggest
   possible TB transmission. Early intervention to interrupt transmission
   may be most effective if targeted to hot zones of TB.}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dou, HY (Reprint Author), Natl Hlth Res Inst, Natl Inst Infect Dis \& Vaccinol, Miaoli, Taiwan.
   Chen, Yih-Yuan, Natl Chiayi Univ, Dept Biochem Sci \& Technol, Chiai Yi, Taiwan.
   Chang, Jia-Ru; Yang, Shiu-Ju; Hsu, Chih-Hao; Lin, Ming-Ching; Su, Ih-Jen; Dou, Horng-Yunn, Natl Hlth Res Inst, Natl Inst Infect Dis \& Vaccinol, Miaoli, Taiwan.
   Wu, Chih-Da, Natl Chiayi Univ, Dept Forestry \& Nat Resources, Chiayi, Taiwan.
   Wu, Chih-Da, Harvard TH Chan Sch Publ Hlth, Ctr Hlth \& Global Environm, Boston, MA USA.
   Tsai, Ching-Fang, Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Med Res, Chiayi, Taiwan.
   Lin, Ming-Shian, Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Chiayi, Taiwan.
   Yeh, Yen-Po, Chang Hua Cty Publ Hlth Bur, Changhua, Taiwan.}},
DOI = {{10.1038/s41598-017-05674-6}},
Article-Number = {{5394}},
ISSN = {{2045-2322}},
Keywords-Plus = {{MULTIDRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; GENETIC
   DIVERSITY; BEIJING GENOTYPE; AIR-POLLUTION; EPIDEMIOLOGY;
   PHYLOGEOGRAPHY; PULMONARY; DATABASE}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{hydou@nhri.org.tw}},
ORCID-Numbers = {{Yeh, Yen-Po/0000-0002-1091-387X}},
Funding-Acknowledgement = {{National Health Research Institutes (Zhunan, Taiwan) {[}IV-103-SP-06,
   PH103-PP-05]; National Science Council (Taipei, Taiwan) {[}NSC
   102-2320-B-400-006]}},
Funding-Text = {{We thank the mycobacteriology laboratories of Changhua Christian
   Hospital for providing bacterial isolates and Chang-Hua County Public
   Health Bureau for its timely collection of data. All participants of
   this consortium are acknowledged for valuable discussions. This work was
   supported by grants from the National Health Research Institutes
   (IV-103-SP-06 and PH103-PP-05) (Zhunan, Taiwan) and the National Science
   Council (NSC 102-2320-B-400-006) (Taipei, Taiwan).}},
Cited-References = {{{[}Anonymous], 2016, CENT EUR J PUBLIC HL.
   Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23.
   Buu TN, 2009, INT J TUBERC LUNG D, V13, P900.
   Chang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043018.
   Chen Y. Y, 2013, J INFECT.
   Chen YY, 2017, J MICROBIOL IMMUNOL, V50, P886, DOI 10.1016/j.jmii.2015.10.012.
   Chen YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117061.
   Chen YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112633.
   Chen YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039792.
   Ribeiro FKC, 2015, CLIN INFECT DIS, V61, P758, DOI 10.1093/cid/civ365.
   Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004.
   Dou HY, 2015, J FORMOS MED ASSOC, V114, P484, DOI 10.1016/j.jfma.2014.07.006.
   Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170.
   Environmental Systems Research Institute (ESRI), 2014, ARCGIS DESKT HELP 10.
   KOLK AHJ, 1992, J CLIN MICROBIOL, V30, P2567.
   Kurepina N. E., 1998, Tubercle and Lung Disease, V79, P31, DOI 10.1054/tuld.1998.0003.
   Lai TC, 2016, OCCUP ENVIRON MED, V73, P56, DOI 10.1136/oemed-2015-102995.
   Lim LKY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084487.
   Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605.
   Mokrousov I, 2015, TUBERCULOSIS, V95, pS167, DOI 10.1016/j.tube.2015.02.031.
   NGUYEN VAT, 2012, PLOS ONE, V0007.
   PA W, 2000, SUSCEPTIBILITY TESTI.
   Pan WC, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv341.
   Phyu S, 2009, J CLIN MICROBIOL, V47, P335, DOI 10.1128/JCM.01812-08.
   Rivas-Santiago CE, 2015, INFECT IMMUN, V83, P2507, DOI 10.1128/IAI.03018-14.
   Shamputa IC, 2010, J CLIN MICROBIOL, V48, P387, DOI 10.1128/JCM.02167-09.
   Smith GS, 2014, INT J ENVIRON HEAL R, V24, P103, DOI 10.1080/09603123.2013.800959.
   Srilohasin P, 2014, J CLIN MICROBIOL, V52, P4267, DOI 10.1128/JCM.01467-14.
   Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06.
   Nguyen VAT, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0784-6.
   VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406.
   Wada T, 2009, FEMS MICROBIOL LETT, V291, P35, DOI 10.1111/j.1574-6968.2008.01431.x.
   Wan KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029190.
   Zelner JL, 2016, J INFECT DIS, V213, P287, DOI 10.1093/infdis/jiv387.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{6}},
Journal-ISO = {{Sci Rep}},
Doc-Delivery-Number = {{FA5EA}},
Unique-ID = {{ISI:000405464200031}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000405425000027,
Author = {van Duuren, Jozef B. J. H. and Muesken, Mathias and Karge, Bianka and
   Tomasch, Juergen and Wittmann, Christoph and Haeussler, Susanne and
   Broenstrup, Mark},
Title = {{Use of Single-Frequency Impedance Spectroscopy to Characterize the
   Growth Dynamics of Biofilm Formation in Pseudomonas aeruginosa}},
Journal = {{SCIENTIFIC REPORTS}},
Year = {{2017}},
Volume = {{7}},
Month = {{JUL 12}},
Abstract = {{Impedance spectroscopy has been applied in prokaryotic and eukaryotic
   cytometry as a label-free method for the investigation of adherent
   cells. In this paper, its use for characterizing the growth dynamics of
   P. aeruginosa biofilms is described and compared to crystal violet
   staining and confocal microscopy. The method allows monitoring the
   growth of biofilm-forming P. aeruginosa in a continuous and label-free
   manner over a period of 72 h in a 96 well plate format. Impedance curves
   obtained for P. aeruginosa PA14 wild type and mutant strains with a
   transposon insertion in pqsA and pelA genes exhibited distinct phases.
   We propose that the slope of the declining curve following a maximum at
   ca. 35-40 h is a measure of biofilm formation. Transplant experiments
   with P. aeruginosa biofilms and paraffin suggest that the impedance also
   reflects pellicle formation at the liquid-air interface, a barely
   considered contributor to impedance. Finally, the impairment of biofilm
   formation upon treatment of cultures with L-arginine and with
   ciprofloxacin, tobramycin and meropenem was studied by single frequency
   impedance spectroscopy. We suggest that these findings qualify impedance
   spectroscopy as an additional technique to characterize biofilm
   formation and its modulation by small molecule drugs.}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Bronstrup, M (Reprint Author), Helmholtz Ctr Infect Res, Dept Chem Biol, Braunschweig, Germany.
   Bronstrup, M (Reprint Author), German Ctr Infect Res DZIF, Site Hannover Braunschweig, Braunschweig, Germany.
   van Duuren, Jozef B. J. H.; Karge, Bianka; Broenstrup, Mark, Helmholtz Ctr Infect Res, Dept Chem Biol, Braunschweig, Germany.
   van Duuren, Jozef B. J. H.; Wittmann, Christoph, Saarland Univ, Inst Syst Biotechnol, Saarbrucken, Germany.
   Muesken, Mathias; Haeussler, Susanne, Helmholtz Ctr Infect Res, Dept Mol Bacteriol, Braunschweig, Germany.
   Muesken, Mathias; Haeussler, Susanne, Ctr Expt \& Clin Infect Res, TWINCORE, Inst Mol Bacteriol, Hannover, Germany.
   Tomasch, Juergen, Helmholtz Ctr Infect Res, Grp Microbial Commun, Braunschweig, Germany.
   Broenstrup, Mark, German Ctr Infect Res DZIF, Site Hannover Braunschweig, Braunschweig, Germany.}},
DOI = {{10.1038/s41598-017-05273-5}},
Article-Number = {{5223}},
ISSN = {{2045-2322}},
Keywords-Plus = {{CANDIDA-ALBICANS BIOFILMS; REAL-TIME; BACTERIAL BIOFILMS;
   ANTIBIOTIC-RESISTANCE; IN-VITRO; MAMMALIAN-CELLS; LABEL-FREE;
   SUSCEPTIBILITY; ASSAY; INFECTIONS}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{mark.broenstrup@helmholtz-hzi.de}},
ResearcherID-Numbers = {{Haussler, Susanne/I-2605-2014
   }},
ORCID-Numbers = {{Haussler, Susanne/0000-0001-6141-9102
   Bronstrup, Mark/0000-0002-8971-7045
   Musken, Mathias/0000-0002-5624-1378
   Wittmann, Christoph/0000-0002-7952-985X}},
Cited-References = {{Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011.
   Ahn SJ, 2008, INFECT IMMUN, V76, P4259, DOI 10.1128/IAI.00422-08.
   Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x.
   Arndt S, 2004, BIOSENS BIOELECTRON, V19, P583, DOI 10.1016/S0956-5663(03)00269-0.
   Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/108705710527635.
   Atienza JM, 2006, J BIOMOL SCREEN, V11, P634, DOI 10.1177/1087057106289334.
   Benson K, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-5.
   Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000.
   Blazquez J, 2012, CURR OPIN MICROBIOL, V15, P561, DOI 10.1016/j.mib.2012.07.007.
   Borriello G, 2006, ANTIMICROB AGENTS CH, V50, P382, DOI 10.1128/AAC.50.1.382-384.2006.
   Bronstrup M., 2015, PCTEP2015080540.
   Brooun A, 2000, ANTIMICROB AGENTS CH, V44, P640, DOI 10.1128/AAC.44.3.640-646.2000.
   Bruchmann J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117300.
   Cady P., 1975, NEW APPROACHES IDENT, P74.
   Ceri H, 1999, J CLIN MICROBIOL, V37, P1771.
   Chavant P, 2007, J MICROBIOL METH, V68, P605, DOI 10.1016/j.mimet.2006.11.010.
   Chow L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00803.
   Coenye T, 2014, PATHOG DIS, V70, P203, DOI 10.1111/2049-632X.12169.
   Colvin KM, 2013, J BACTERIOL, V195, P2329, DOI 10.1128/JB.02150-12.
   Colvin KM, 2012, ENVIRON MICROBIOL, V14, P1913, DOI 10.1111/j.1462-2920.2011.02657.x.
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318.
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008.
   DAVIES DG, 1993, APPL ENVIRON MICROB, V59, P1181.
   De Kievit TR, 2001, ANTIMICROB AGENTS CH, V45, P1761, DOI 10.1128/AAC.45.6.1761-1770.2001.
   Dheilly A, 2008, APPL MICROBIOL BIOT, V79, P157, DOI 10.1007/s00253-008-1404-7.
   di Blasio L, 2015, J CELL SCI, V128, P863, DOI 10.1242/jcs.149294.
   Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x.
   Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760.
   European Centre for Disease prevention and Control/ European Medicines Agencies (ECDPC/ EMA) ECDC/EMEA, 2009, BACT CHALL TIM REACT.
   Firstenberg-Eden R., 1984, IMPEDANCE MICROBIOLO.
   Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x.
   Gagliardi PA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10206.
   GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761.
   GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0.
   GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896.
   Gilbert P, 2001, AM J INFECT CONTROL, V29, P252, DOI 10.1067/mic.2001.115673.
   Gilbert Peter, 2002, Adv Microb Physiol, V46, P202.
   Gottschamel J, 2009, ANAL CHEM, V81, P8503, DOI 10.1021/ac901420u.
   Haussler S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000166.
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821.
   Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x.
   Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912.
   HUANG CT, 1995, APPL ENVIRON MICROB, V61, P2252.
   Jennings LK, 2015, P NATL ACAD SCI USA, V112, P11353, DOI 10.1073/pnas.1503058112.
   Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08.
   Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6\_6.
   Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.030758810.
   Kim S, 2012, ELECTROCHIM ACTA, V82, P126, DOI 10.1016/j.electacta.2012.05.131.
   Kim T, 2011, WATER RES, V45, P4615, DOI 10.1016/j.watres.2011.06.010.
   Kolderman E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121835.
   Komor U, 2012, MICROBES INFECT, V14, P951, DOI 10.1016/j.micinf.2012.04.002.
   Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103.
   Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4.
   Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002.
   Morita Y, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00422.
   Musken M, 2010, NAT PROTOC, V5, P1460, DOI 10.1038/nprot.2010.110.
   Musken M, 2010, MICROBIOL-SGM, V156, P431, DOI 10.1099/mic.0.033290-0.
   Olson ME, 2002, CAN J VET RES, V66, P86.
   Paredes J, 2014, SENSOR ACTUAT B-CHEM, V195, P667, DOI 10.1016/j.snb.2014.01.098.
   Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI {[}10.1038/nport.2008.141, 10.1038/nprot.2008.141].
   Pietrosimone KM, 2012, JOVE-J VIS EXP, DOI 10.3791/3840.
   Pitts B, 2003, J MICROBIOL METH, V54, P269, DOI 10.1016/S0167-7012(03)00034-4.
   Rahim S, 2011, JOVE-J VIS EXP, DOI 10.3791/2792.
   Ramage G, 2001, ANTIMICROB AGENTS CH, V45, P2475, DOI 10.1128/AAC.45.9.2475-2479.2001.
   Repp KK, 2007, MED MYCOL, V45, P603, DOI 10.1080/13693780701581458.
   Sandoe JAT, 2006, J ANTIMICROB CHEMOTH, V57, P767, DOI 10.1093/jac/dkl013.
   Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363.
   TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919.
   Tre-Hardy M, 2008, INT J ANTIMICROB AG, V31, P329, DOI 10.1016/j.ijantimicag.2007.12.005.
   Varshney M, 2009, BIOSENS BIOELECTRON, V24, P2951, DOI 10.1016/j.bios.2008.10.001.
   Wang Xiaobo, 2017, COMMUNICATION.
   Ward AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091732.
   Xi ZK, 2014, COMPUT BIOL CHEM, V49, P23, DOI 10.1016/j.compbiolchem.2013.12.004.
   Zhang L, 2011, J BACTERIOL, V193, P5510, DOI 10.1128/JB.00268-11.}},
Number-of-Cited-References = {{74}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{12}},
Journal-ISO = {{Sci Rep}},
Doc-Delivery-Number = {{FA4PJ}},
Unique-ID = {{ISI:000405425000027}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000411693900007,
Author = {Fuka, Mirna Mrkonjic and Maksimovic, Ana Zgomba and Tanuwidjaja, Irina
   and Hulak, Natasa and Schloter, Michael},
Title = {{Characterization of Enterococcal Community Isolated from an Artisan
   Istrian Raw Milk Cheese: Biotechnological and Safety Aspects}},
Journal = {{FOOD TECHNOLOGY AND BIOTECHNOLOGY}},
Year = {{2017}},
Volume = {{55}},
Number = {{3}},
Pages = {{368-380}},
Month = {{JUL-SEP}},
Abstract = {{In this study, prevalence, biotechnological and safety profi les of 588
   Enterococcus isolates isolated from raw milk and Istrian cheese during
   diff erent stages of ripening were analyzed. Despite the low and
   variable presence of enterococci in milk ((3.65 +/- 2.93) log CFU/mL),
   highly comparable enterococcal populations were established aft er 30
   days of cheese ripening ((7.96 +/- 0.80) log CFU/g), confirming
   Enterococcus spp. as a major part of the core microbiota of Istrian
   cheese. The dominant species were E. faecium (53.8 \%) and E. faecalis
   (42.4 \%), while minor groups, consisting of E. durans (2.84 \%) and E.
   casselifl avus (0.95 \%), also occurred. A pronounced intraspecies
   variability was noticed based on molecular fi ngerprinting, with 35
   strains (genotypes) detected. Most of the genotypes were farm- specifi c
   with one third being shared between the farms. This genotype variability
   refl ected particular diff erences of Istrian cheese production, mainly
   variable salt concentration, ripening temperature and air humidity as
   well as microclimatic or vegetation conditions. There was considerable
   variation between the strains of the same species regarding wide range
   of biotechnologically important traits as well as their ability to
   survive in simulated gastrointestinal conditions. A considerable number
   of strains were resistant to critically important antibiotics such as
   tetracycline (43.56 \%), erythromycin (35.79 \%) and vancomycin (23.48
   \%). Polymerase chain reaction- based detection did not identify any of
   the common genetic determinants for vancomycin and erythromycin
   resistance; for tetracycline tetM gene was detected. The presence of
   virulence genes including agg, efaAfs, gelE, cylM, cylB, cylA, esp,
   efaAfm, cob and cpd was frequently recorded, especially among E.
   faecalis strains.}},
Publisher = {{FACULTY FOOD TECHNOLOGY BIOTECHNOLOGY}},
Address = {{UNIV ZAGREB, KACIECEVA 23, 41000 ZAGREB, CROATIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fuka, MM (Reprint Author), Univ Zagreb, Fac Agr, Dept Microbiol, Svetosimunska 25, HR-10000 Zagreb, Croatia.
   Fuka, Mirna Mrkonjic; Maksimovic, Ana Zgomba; Tanuwidjaja, Irina; Hulak, Natasa, Univ Zagreb, Fac Agr, Dept Microbiol, Svetosimunska 25, HR-10000 Zagreb, Croatia.
   Schloter, Michael, Helmholtz Zentrum Munchen, Res Unit Environm Genom, Ingolstaedter Landstr 1, DE-85758 Neuherberg, Germany.}},
DOI = {{10.17113/ftb.55.03.17.5118}},
ISSN = {{1330-9862}},
EISSN = {{1334-2606}},
Keywords = {{cheese; spontaneous fermentation; Enterococcus spp.; molecular fi
   ngerprinting; antibiotic resistance; virulence genes}},
Keywords-Plus = {{VIRULENCE FACTORS; ANTIMICROBIAL RESISTANCE; BIFIDOBACTERIUM-LONGUM;
   ANTIBIOTIC-RESISTANCE; DAIRY-PRODUCTS; FERMENTED MEAT; FOOD; PCR;
   ORIGIN; GENES}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Food Science \& Technology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Food Science \& Technology}},
Author-Email = {{mfuka@agr.hr}},
Funding-Acknowledgement = {{German Academic Exchange Service (DAAD); Ministry of Science and
   Education of the Republic of Croatia (MZO)}},
Funding-Text = {{This study was partially funded by the German Academic Exchange Service
   (DAAD) and the Ministry of Science and Education of the Republic of
   Croatia (MZO).}},
Cited-References = {{Aberna RA, 2011, INT J BIOL MED RES, V2, P523.
   Agerso Y, 2006, J ANTIMICROB CHEMOTH, V57, P832, DOI 10.1093/jac/dkl069.
   AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137.
   {[}Anonymous], 2002, R PROJ STAT COMP R S.
   {[}Anonymous], 2016, APPL MATHS NV.
   Aslam M, 2012, INT J FOOD MICROBIOL, V156, P222, DOI 10.1016/j.ijfoodmicro.2012.03.026.
   Barbosa J, 2010, FOOD CONTROL, V21, P651, DOI 10.1016/j.foodcont.2009.10.002.
   Basbulbul Ozdemir G, 2011, INDIAN J MICROBIOL, V51, P182, DOI 10.1007/s12088-011-0143-0.
   Clinical and Laboratory Standard Institute (CLSI), 2005, M100S15 CLSI.
   de Giori GS, 2001, METH BIOTEC, V14, P197.
   Deasy BM, 2000, SYST APPL MICROBIOL, V23, P510, DOI 10.1016/S0723-2020(00)80025-9.
   Del Re B, 2000, LETT APPL MICROBIOL, V31, P438, DOI 10.1046/j.1365-2672.2000.00845.x.
   Doleyres Y, 2004, J APPL MICROBIOL, V97, P527, DOI 10.1111/j.1365-2672.2004.02326.x.
   Domann E, 2007, INT J MED MICROBIOL, V297, P533, DOI 10.1016/j.ijmm.2007.02.008.
   DUTKAMALEN S, 1995, J CLIN MICROBIOL, V33, P24.
   Eaton TJ, 2001, APPL ENVIRON MICROB, V67, P1628, DOI 10.1128/AEM.67.4.1628-1635.2001.
   Fortina MG, 2008, INT J FOOD MICROBIOL, V123, P204, DOI 10.1016/j.ijfoodmicro.2008.01.014.
   Franz CMAP, 1999, INT J FOOD MICROBIOL, V47, P1, DOI 10.1016/S0168-1605(99)00007-0.
   Fuka MM, 2008, BIOL FERT SOILS, V45, P185, DOI 10.1007/s00374-008-0319-x.
   Fuka MM, 2010, INT J FOOD MICROBIOL, V142, P19, DOI 10.1016/j.ijfoodmicro.2010.05.008.
   Giraffa G, 2003, INT J FOOD MICROBIOL, V88, P215, DOI 10.1016/S0168-1605(03)00183-1.
   Giraffa G, 2002, FEMS MICROBIOL REV, V26, P163, DOI 10.1016/S0168-6445(02)00094-3.
   Heaton MP, 1995, MICROB DRUG RESIST, V1, P177, DOI 10.1089/mdr.1995.1.177.
   Hosseini SV, 2009, J APPL MICROBIOL, V107, P1392, DOI 10.1111/j.1365-2672.2009.04327.x.
   HUEY B, 1989, J BACTERIOL, V171, P2528, DOI 10.1128/jb.171.5.2528-2532.1989.
   Huycke MM, 1998, EMERG INFECT DIS, V4, P239, DOI 10.3201/eid0402.980211.
   International Commission on Microbiological Specifi cations for Foods (ICMSF), 1978, MICR FOODS 1 THEIR S.
   Jahan M, 2014, INT J FOOD MICROBIOL, V170, P65, DOI 10.1016/j.ijfoodmicro.2013.11.002.
   Jamaly N, 2010, AFR J MICROBIOL RES, V4, P1768.
   Jamet E, 2012, FOOD MICROBIOL, V31, P191, DOI 10.1016/j.fm.2012.03.009.
   Klibi N, 2013, MEAT SCI, V93, P675, DOI 10.1016/j.meatsci.2012.11.020.
   Krizova J, 2008, FOLIA MICROBIOL, V53, P99, DOI 10.1007/s12223-008-0014-1.
   Lane D.J., 1991, NUCL ACID TECHNIQUES, P115.
   Magdic V, 2013, MLJEKARSTVO, V63, P55.
   Majhenic AC, 2005, INT J FOOD MICROBIOL, V102, P239, DOI 10.1016/j.ijfoodmicro.2004.12.021.
   Morandi S, 2013, ANTON LEEUW INT J G, V103, P239, DOI 10.1007/s10482-012-9806-z.
   Moreno MRF, 2006, INT J FOOD MICROBIOL, V106, P1, DOI 10.1016/j.ijfoodmicro.2005.06.026.
   Mrkonjic Fuka M, 2013, PLOS ONE, V8.
   Mundy LM, 2000, CLIN MICROBIOL REV, V13, P513, DOI 10.1128/CMR.13.4.513-522.2000.
   MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46.
   Ng LK, 2001, MOL CELL PROBE, V15, P209, DOI 10.1006/mcpr.2001.0363.
   Nubel U, 1996, J BACTERIOL, V178, P5636.
   Nueno-Palop C, 2011, INT J FOOD MICROBIOL, V145, P390, DOI 10.1016/j.ijfoodmicro.2010.12.029.
   Olsen RH, 2012, ZOONOSES PUBLIC HLTH, V59, P256, DOI 10.1111/j.1863-2378.2011.01442.x.
   Rehaiem A, 2016, FOOD CONTROL, V63, P259, DOI 10.1016/j.foodcont.2015.11.034.
   Sarantinopoulos P, 2001, INT DAIRY J, V11, P621, DOI 10.1016/S0958-6946(01)00087-5.
   Schreiner K, 2010, APPL ENVIRON MICROB, V76, P4703, DOI 10.1128/AEM.00481-10.
   Semedo T, 2003, SYST APPL MICROBIOL, V26, P13, DOI {[}10.1078/072320203322337263, 10.1078/0723202022528942].
   Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562.
   TEUBER M, 1996, LEBENSMITTEL TECHNOL, V29, P182.
   Togay SO, 2010, J APPL MICROBIOL, V109, P1084, DOI 10.1111/j.1365-2672.2010.04763.x.
   VAUTERIN L, 1992, EUROPEAN MICROBIOLOG, V1, P37.
   Wang JS, 2014, INT J INFECT DIS, V25, P26, DOI 10.1016/j.ijid.2014.01.009.
   Warsa UC, 1996, J ANTIBIOT, V49, P1127, DOI 10.7164/antibiotics.49.1127.
   Yilmaz ES, 2016, LWT-FOOD SCI TECHNOL, V66, P20, DOI 10.1016/j.lwt.2015.10.009.}},
Number-of-Cited-References = {{55}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{Food Technol. Biotechnol.}},
Doc-Delivery-Number = {{FI1LA}},
Unique-ID = {{ISI:000411693900007}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000411025800005,
Author = {Jungerman, M. Robynne and Vonnahme, Laura A. and Washburn, Faith and
   Alvarado-Ramy, Francisco},
Title = {{Federal travel restrictions to prevent disease transmission in the
   United States: An analysis of requested travel restrictions}},
Journal = {{TRAVEL MEDICINE AND INFECTIOUS DISEASE}},
Year = {{2017}},
Volume = {{18}},
Pages = {{30-35}},
Month = {{JUL-AUG}},
Abstract = {{Background: Individuals with certain communicable diseases may pose
   risks to the health of the traveling public; there has been documented
   transmission on commercial aircraft of tuberculosis (TB), measles, and
   severe acute respiratory syndrome (SARS). Federal public health travel
   restrictions (PHTR) prevent commercial air or international travel of
   persons with communicable diseases that pose a public health threat.
   Methods: We described demographics and clinical characteristics of all
   cases considered for PHTR because of suspected or confirmed communicable
   disease from May 22, 2007, to December 31, 2015.
   Results: We reviewed 682 requests for PHTR; 414 (61\%) actions were
   completed to place 396 individuals on PHTR. The majority (>99\%) had
   suspected (n = 27) or confirmed (n = 367) infectious pulmonary TB; 58
   (16\%) had multidrug-resistant-TB. There were 128 (85\%) interceptions
   that prevented the initiation or continuation of travel. PHTR were
   removed for 310 (78\%) individuals after attaining noninfectious status
   and 86 (22\%) remained on PHTR at the end of the analysis period.
   Conclusions: PHTR effectively prevent exposure during commercial air
   travel to persons with potentially infectious diseases. In addition,
   they are effective tools available to public health agencies to prevent
   commercial travel of individuals with certain communicable diseases and
   possibly reconnect them with public health authorities. Published by
   Elsevier Ltd.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Vonnahme, LA (Reprint Author), US Ctr Dis Control \& Prevent, Quarantine \& Border Hlth Serv Branch, Div Global Migrat \& Quarantine, 701 5th Ave,Rm 1630, Seattle, WA 98104 USA.
   Jungerman, M. Robynne; Vonnahme, Laura A.; Washburn, Faith; Alvarado-Ramy, Francisco, US Ctr Dis Control \& Prevent, Quarantine \& Border Hlth Serv, Div Global Migrat \& Quarantine, Atlanta, GA USA.
   Vonnahme, Laura A.; Alvarado-Ramy, Francisco, US PHS, Washington, DC USA.
   Jungerman, M. Robynne, US Ctr Dis Control \& Prevent, Quarantine \& Border Hlth Serv Branch, Div Global Migrat \& Quarantine, 12379 Sunrise Valley Dr Ste C, Reston, VA 20191 USA.
   Washburn, Faith; Alvarado-Ramy, Francisco, US Ctr Dis Control \& Prevent, Quarantine \& Border Hlth Serv Branch, Div Global Migrat \& Quarantine, 1825 Century Ctr Blvd NE, Atlanta, GA 30345 USA.}},
DOI = {{10.1016/j.tmaid.2017.06.007}},
ISSN = {{1477-8939}},
EISSN = {{1873-0442}},
Keywords = {{Travel; Restrictions; Tuberculosis}},
Keywords-Plus = {{AIR-TRAVEL; TUBERCULOSIS; MEASLES}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{Guk8@cdc.gov
   kdy1@cdc.gov
   Wlz5@cdc.gov
   Fba8@cdc.gov}},
ORCID-Numbers = {{Vonnahme, Laura/0000-0001-9781-5748}},
Funding-Acknowledgement = {{Intramural CDC HHS {[}CC999999]}},
Cited-References = {{CDC, 2015, FED REG, P16400.
   Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P1009.
   DeSisto C, 2015, AM J TROP MED HYG, V93, P747, DOI 10.4269/ajtmh.15-0300.
   DRIVER CR, 1994, JAMA-J AM MED ASSOC, V272, P1031, DOI 10.1001/jama.272.13.1031.
   Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376.
   Glaziou P, 2013, SEMIN RESP CRIT CARE, V34, P3, DOI 10.1055/s-0032-1333467.
   Hagmann SHF, 2015, TRAVEL MED INFECT DI, V13, P1, DOI 10.1016/j.tmaid.2014.12.017.
   Huizer YL, 2015, TRAVEL MED INFECT DI, V13, P19, DOI 10.1016/j.tmaid.2014.11.008.
   Jost M, 2015, TRAVEL MED INFECT DI, V13, P10, DOI 10.1016/j.tmaid.2014.10.022.
   Krishnamurthy R, 2006, AMIA ANN S P, V2006, P990.
   Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8.
   Nelson K, 2013, TRAVEL MED INFECT DI, V11, P81, DOI 10.1016/j.tmaid.2013.03.007.
   TSA, 2014, SEC FLIGHT PROGR.
   Winston C., 2010, Morbidity and Mortality Weekly Report, V59, P289.}},
Number-of-Cited-References = {{14}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{Travel Med. Infect. Dis.}},
Doc-Delivery-Number = {{FH3DT}},
Unique-ID = {{ISI:000411025800005}},
DA = {{2018-08-13}},
}

@article{ ISI:000408618500019,
Author = {Mullen, Nathan and Raposo, Hugo and Gudis, Polyxeni and Barker, Linsey
   and Humphries, Romney M. and Schmitt, Bryan H. and Relich, Ryan F. and
   May, Meghan},
Title = {{Induction of beta-Lactamase Activity and Decreased beta-Lactam
   Susceptibility by CO2 in Clinical Bacterial Isolates}},
Journal = {{MSPHERE}},
Year = {{2017}},
Volume = {{2}},
Number = {{4}},
Month = {{JUL-AUG}},
Abstract = {{Antimicrobial susceptibility testing of clinical isolates is a crucial
   step toward appropriate treatment of infectious diseases. The clinical
   isolate Francisella philomiragia 14IUHPL001, recently isolated from a
   63-year-old woman with atypical pneumonia, featured decreased
   susceptibility to beta-lactam antibiotics when cultivated in 5\% CO2.
   Quantitative beta-lactamase assays demonstrated a significant (P <
   0.0001) increase in enzymatic activity between bacteria cultivated in
   5\% CO2 over those incubated in ambient air. The presence of
   beta-lactamase genes bla(TEM) and bla(SHV) was detected in the clinical
   isolate F. philomiragia 14IUHPL001 by PCR, and the genes were positively
   identified by nucleotide sequencing. Expression of bla(TEM) and bla(SHV)
   was detected by reverse transcription-PCR during growth at 5\% CO2 but
   not during growth in ambient air. A statistically significant alkaline
   shift was observed following cultivation of F. philomiragia 14IUHPL001
   in both ambient air and 5\% CO2, allowing desegregation of the
   previously reported effects of acidic pH from the currently reported
   effect of 5\% CO2 on bla(TEM) and blaSHV beta-lactamases. To ensure that
   the observed phenomenon was not unique to F. philomiragia, we evaluated
   a clinical isolate of bla(TEM)-carrying Haemophilus influenzae and found
   parallel induction of bla(TEM) gene expression and beta-lactamase
   activity at 5\% CO2 relative to ambient air.
   IMPORTANCE beta-Lactamase induction and concurrent beta-lactam
   resistance in respiratory tract pathogens as a consequence of growth in
   a physiologically relevant level of CO2 are of clinical significance,
   particularly given the ubiquity of TEM and SHV beta-lactamase genes in
   diverse bacterial pathogens. This is the first report of beta-lactamase
   induction by 5\% CO2.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{May, M (Reprint Author), Univ New England, Coll Osteopath Med, Dept Biomed Sci, Biddeford, ME 04005 USA.
   Mullen, Nathan; Raposo, Hugo; Gudis, Polyxeni; Barker, Linsey; May, Meghan, Univ New England, Coll Osteopath Med, Dept Biomed Sci, Biddeford, ME 04005 USA.
   Humphries, Romney M., Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol \& Lab Med, Los Angeles, CA 90095 USA.
   Schmitt, Bryan H.; Relich, Ryan F., Indiana Univ Sch Med, Dept Pathol \& Lab Med, Indianapolis, IN 46202 USA.}},
DOI = {{10.1128/mSphere.00266-17}},
Article-Number = {{e00266-17}},
ISSN = {{2379-5042}},
Keywords = {{BLA; Francisella; Haemophilus; SHV; TEM; antimicrobial resistance;
   beta-lactamases; carbon dioxide}},
Keywords-Plus = {{FORMERLY YERSINIA-PHILOMIRAGIA; ESCHERICHIA-COLI; PH;
   ENTEROBACTERIACEAE; DISEASE}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{mmay3@une.edu}},
Funding-Acknowledgement = {{University of New England; University of California, Los Angeles}},
Funding-Text = {{This work was supported by institutional funds from the University of
   New England (M.M.) and the University of California, Los Angeles
   (R.M.H.).}},
Cited-References = {{Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389.
   Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216.
   Cole MJ, 2015, J ANTIMICROB CHEMOTH, V70, P3238, DOI 10.1093/jac/dkv260.
   HOLLIS DG, 1989, J CLIN MICROBIOL, V27, P1601.
   JENSEN WI, 1969, J BACTERIOL, V100, P1237.
   KEMAL C, 1981, BIOCHEMISTRY-US, V20, P3688, DOI 10.1021/bi00516a004.
   Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808.
   KONIG C, 1995, J ANTIMICROB CHEMOTH, V36, P513, DOI 10.1093/jac/36.3.513.
   Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI 10.1093/nar/gkr201.
   Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008.
   LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557.
   LIVERMORE DM, 1992, ANTIMICROB AGENTS CH, V36, P1870, DOI 10.1128/AAC.36.9.1870.
   Relich RF, 2015, J CLIN MICROBIOL, V53, P3947, DOI 10.1128/JCM.01762-15.
   Sharma J, 2010, INDIAN J MED RES, V132, P332.
   Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7\_6.
   Ulu-Kilic A, 2014, TRAVEL MED INFECT DI, V12, P609, DOI 10.1016/j.tmaid.2014.10.007.
   Waley S. G., 1992, CHEM BETA LACTAMS, P198.
   WENGER JD, 1989, ANN INTERN MED, V110, P888, DOI 10.7326/0003-4819-110-11-888.
   Zeytun A, 2012, J BACTERIOL, V194, P3266, DOI 10.1128/JB.00413-12.}},
Number-of-Cited-References = {{19}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{mSphere}},
Doc-Delivery-Number = {{FF0VF}},
Unique-ID = {{ISI:000408618500019}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000415365900011,
Author = {Dugani, Sagar and Kissoon, Niranjan},
Title = {{Global advocacy needed for sepsis in children}},
Journal = {{JOURNAL OF INFECTION}},
Year = {{2017}},
Volume = {{74}},
Number = {{1}},
Pages = {{S61-S65}},
Month = {{JUN}},
Abstract = {{Sepsis in children is a complex syndrome that develops from various
   infections and results in 15-30\% mortality in high-income countries and
   up to 50\% or higher in low-income countries. Worldwide, this represents
   an annual burden of 30 million cases resulting in 8 million deaths. Not
   surprisingly, there is a significantly higher burden in low-income
   countries with children there being 18 times more likely to die before
   the age of 5 years compared to high-income countries. Factors such as
   commercial air travel, climate change, and unchecked population growth
   have contributed to the growing burden of infectious diseases and
   ensuing sepsis. In this article, we review the important role of global
   advocacy to improve public awareness of sepsis; increase access to
   essential medicines and vaccines; improve use of evidence-based
   treatment guidelines; raise awareness of antimicrobial resistance and
   encourage antibiotic stewardship; and, develop resilient health systems
   that can cope with health crises. Advocacy in these areas can assist
   nations in reaching the United Nations sustainable development goals (UN
   SDGs) of low rates of neonatal and under-5 mortality. (C) 2017 The
   British Infection Association. Published by Elsevier Ltd. All rights
   reserved.}},
Publisher = {{W B SAUNDERS CO LTD}},
Address = {{32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kissoon, N (Reprint Author), British Columbia Childrens Hosp, 4480 Oak St,Room B245, Vancouver, BC V6H 3V4, Canada.
   Dugani, Sagar, Univ Toronto, St Michaels Hosp, Div Internal Med, Toronto, ON, Canada.
   Kissoon, Niranjan, Univ British Columbia, Vancouver, BC, Canada.
   Kissoon, Niranjan, British Columbia Childrens Hosp, 4480 Oak St,Room B245, Vancouver, BC V6H 3V4, Canada.}},
ISSN = {{0163-4453}},
EISSN = {{1532-2742}},
Keywords = {{Sepsis; Global health; Infection; Morbidity; Mortality; Pediatric
   infection; Global sepsis alliance}},
Keywords-Plus = {{PEDIATRIC SEVERE SEPSIS; CHEST CONSENSUS STATEMENT; ORGAN DYSFUNCTION;
   CRITICALLY-ILL; HAND HYGIENE; HEALTH; EPIDEMIOLOGY; INFECTION; CARE;
   ANTIMICROBIALS}},
Research-Areas = {{Infectious Diseases}},
Web-of-Science-Categories  = {{Infectious Diseases}},
Author-Email = {{sagar.dugani@utoronto.ca
   nkissoon@cw.bc.ca}},
ORCID-Numbers = {{Kissoon, Niranjan/0000-0001-8847-9973}},
Cited-References = {{Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI 10.1056/NEJMra1208623.
   Aspesberro F, IMPROVING LONG TERM.
   Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6.
   Carter JH, 2016, INFECT CONT HOSP EP, V37, P939, DOI 10.1017/ice.2016.83.
   Chan M, 2012, LANCET, V379, P2119, DOI 10.1016/S0140-6736(12)60908-8.
   Das JK, 2016, J ADOLESCENT HEALTH, V59, pS40, DOI 10.1016/j.jadohealth.2016.07.005.
   de Souza DC, 2017, SHOCK, V47, P2, DOI 10.1097/SHK.0000000000000699.
   Dugani S, 2017, CAN MED ASSOC J, V189, pE2, DOI 10.1503/cmaj.160798.
   Dugani S, 2016, CAN MED ASSOC J, V188, pE213, DOI 10.1503/cmaj.151241.
   Farris RWD, 2013, PEDIATR CRIT CARE ME, V14, P835, DOI 10.1097/PCC.0b013e3182a551c8.
   Favin M, 2012, INT HEALTH, V4, P229, DOI 10.1016/j.inhe.2012.07.004.
   Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC.
   Foppa IM, 2015, VACCINE, V33, P3003, DOI 10.1016/j.vaccine.2015.02.042.
   Ford N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043953.
   Geiling J, 2014, CHEST, V146, pE156S, DOI 10.1378/chest.14-0744.
   Geiling J, 2014, CHEST, V146, pE168S, DOI 10.1378/chest.14-0745.
   Geldsetzer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093427.
   Goldstein B, 2006, PEDIATR CRIT CARE ME, V7, P200, DOI 10.1097/01.PCC.0000217470.68764.36.
   Hartman ME, 2013, PEDIATR CRIT CARE ME, V14, P686, DOI 10.1097/PCC.0b013e3182917fad.
   Jacob ST, 2009, PLOS ONE, V4, pA115, DOI 10.1371/journal.pone.0007782.
   Jorgensen PS, 2016, NATURE, V537, P159, DOI 10.1038/537159a.
   Kaufman DA, 2014, JAMA PEDIATR, V168, P909, DOI 10.1001/jamapediatrics.2014.953.
   Kissoon N, 2016, JAMA PEDIATR, V170, P107, DOI 10.1001/jamapediatrics.2015.3241.
   Kissoon N, 2015, J INFECTION, V71, pS21, DOI 10.1016/j.jinf.2015.04.016.
   Kruk ME, 2015, LANCET, V385, P1910, DOI 10.1016/S0140-6736(15)60755-3.
   Kwizera Arthur, 2012, BMC Res Notes, V5, P475, DOI 10.1186/1756-0500-5-475.
   Laxminarayan R, 2016, LANCET, V388, P218, DOI 10.1016/S0140-6736(16)31079-0.
   Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2.
   Lee ACC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001741.
   Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549.
   Maredza M, 2016, COST EFFECT RESOUR A, V14, DOI 10.1186/s12962-015-0049-5.
   Marston HD, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009872.
   Moore MR, 2016, LANCET RESP MED, V4, P399, DOI 10.1016/S2213-2600(16)00052-7.
   Muhumuza C, 2015, INT J EVID-BASED HEA, V13, P19, DOI 10.1097/XEB.0000000000000013.
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2.
   Ng YY, 2015, SINGAP MED J, V56, P506, DOI 10.11622/smedj.2015135.
   Novosad SA, 2016, MMWR-MORBID MORTAL W, V65, P864, DOI 10.15585/mmwr.mm6533e1.
   Reinhart Konrad, 2013, Rev. bras. ter. intensiva, V25, P3, DOI 10.1590/S0103-507X2013000100002.
   Reinhart K, 2012, J CRIT CARE, V27, P410, DOI 10.1016/j.jcrc.2012.06.010.
   Saokaew S, 2016, PHARMACOECONOMICS, V34, P1211, DOI 10.1007/s40273-016-0439-3.
   Thompson GC, 2014, CLIN EPIDEMIOL, V6, P461, DOI 10.2147/CLEP.S72282.
   Weiss SL, 2015, AM J RESP CRIT CARE, V191, P1147, DOI 10.1164/rccm.201412-2323OC.
   Wiens MO, 2016, PEDIATR CRIT CARE ME, V17, P400, DOI 10.1097/PCC.0000000000000708.
   Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057.
   Wulff K, 2015, ANNU REV PUBL HEALTH, V36, P361, DOI 10.1146/annurev-publhealth-031914-122829.
   Zhan QL, 2009, PEDIATR INFECT DIS J, V28, P182, DOI 10.1097/INF.0b013e31818a65d2.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{J. Infect.}},
Doc-Delivery-Number = {{FM8UO}},
Unique-ID = {{ISI:000415365900011}},
DA = {{2018-08-13}},
}

@article{ ISI:000405542500021,
Author = {Gurgulova, Kalinka I. and Orozova, Petya S. and Panayotov, Mihail V. and
   Zhelyazkova, Ivanka Z. and Takova, Sonya B. and Guncheva, Radostina P.},
Title = {{Isolation and Identification of Some Gram-positive Bacteria Causing
   Infections in Silkworm Bombyx mori L. (Lepidoptera)}},
Journal = {{ACTA ZOOLOGICA BULGARICA}},
Year = {{2017}},
Number = {{8}},
Pages = {{139-144}},
Month = {{JUN}},
Note = {{2nd International Conference on Zoology and Zoonoses, Hissar, BULGARIA,
   OCT 26-28, 2016}},
Abstract = {{Totally, 82 samples from air and various surfaces of shelves (wood),
   grids (metal), wall (wallpaper) and floor (linoleum) in a silkworm
   rearing room were taken and analysed. Twenty two bacterial isolates were
   identified as Gram-positive: spore-forming microorganisms, staphylococci
   and streptococci. According to biochemical identification of isolates by
   Micronaut-Scan, we confirmed isolates as Paenibacillus macerans,
   Bacillus sphaericus, Bacillus circulans, Bacillus cereus, Staphylococcus
   aureus, Staphylococcus epidermidis and Streptococcus spp. Susceptibility
   of some selected isolates to various drugs was tested. Resistance to
   important groups of antibacterials (penicillin, chloramphenicol,
   quinolones, macrolides, tetracyclines and sulfonamides) was detected.
   Contamination of various surfaces with these bacteria is a potential
   risk of infection in silkworm.}},
Publisher = {{INST ZOOLOGY, BAS}},
Address = {{1000 SOFIA, 1, TSAR OSVOBODITEL BLVD, SOFIA, 00000, BULGARIA}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Gurgulova, KI (Reprint Author), Natl Diagnost \& Res Vet Med Inst, Sofia, Bulgaria.
   Gurgulova, Kalinka I.; Orozova, Petya S.; Takova, Sonya B., Natl Diagnost \& Res Vet Med Inst, Sofia, Bulgaria.
   Panayotov, Mihail V.; Zhelyazkova, Ivanka Z.; Guncheva, Radostina P., Trakia Univ, Agr Fac, Stara Zagora, Bulgaria.}},
ISSN = {{0324-0770}},
Keywords = {{silkworm; Bombyx mori; bacteria; drug resistance}},
Research-Areas = {{Zoology}},
Web-of-Science-Categories  = {{Zoology}},
Author-Email = {{kalinkag@abv.bg
   panayotov\_m@abv.bg}},
Cited-References = {{Adel A. A., 2015, INT J CURR RES BIOSC, V2, P69.
   ANANDAKUMAR MD, 2012, INT J ENVIRON RES, V1, P1.
   ANITHA T, 1994, SERICOLOGIA, V34, P97.
   Dong XZ, 2001, COMMON MANUAL SYSTEM, P353.
   Gurgulova K., 1998, J ANIMAL SCI S, P57.
   Hamamoto H, 2005, RES ADV ANTIMICROB A, V5, P1.
   Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494.
   Karthikairaj K., 2013, International Journal of Microbiological Research (IJMR), V4, P158.
   Kim Gilho, 2002, Korean Journal of Applied Entomology, V41, P279.
   Mahmoud S. M., 2012, Egyptian Academic Journal of Biological Sciences: Entomology, V5, P55.
   NAHAR A, 1995, B SERICUL RES, V6, P79.
   NATARAJU B, 1991, Indian Journal of Sericulture, V30, P56.
   Nataraju B., 2005, CENTRAL SILK BOARD, P61.
   PATIL CS, 1994, SERICOLOGIA, V34, P54.
   Priyadharshini P., 2008, Current Biotica, V2, P181.
   Sahay D. N., 2000, INT LESSONS TROPICAL.
   SAKTHIVEL S, 2012, ADV APPL SCI RES, V3, P4066.
   SHEEBHA A, 2008, J BASIC APPL BIOL, V2, P19.
   Singh G. P., 2011, J MICROBIOL, V6, P891.
   Subramanian S., 2009, Karnataka Journal of Agricultural Sciences, V22, P499.
   Vasileva I., 1998, J ANIMAL SCI S, P60.
   ZHANG J, 2013, GLOBAL J BACTERIOL C, V1, P49.}},
Number-of-Cited-References = {{22}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Acta Zool. Bulg.}},
Doc-Delivery-Number = {{FA6GY}},
Unique-ID = {{ISI:000405542500021}},
DA = {{2018-08-13}},
}

@article{ ISI:000402866300016,
Author = {Naz, Sehar Afshan and Yaseen, Muhammad and Jabeen, Nusrat and Shafique,
   Maryam},
Title = {{Isolation of potentially pathogenic fungi from selected pigeons' feeding
   sites in Karachi: A new dimension to health hazard}},
Journal = {{JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION}},
Year = {{2017}},
Volume = {{67}},
Number = {{6}},
Pages = {{901-906}},
Month = {{JUN}},
Abstract = {{Objective: To determine the presence of pathogenic fungal strains in
   areas where pigeons are present in a large number.
   Methods: This study was conducted at the Federal Urdu University of
   Arts, Science and Technology, Karachi, from February 2015 to March2016,
   and comprised samples of soil contaminated with pigeons' excreta. The
   samples were collected from 20 different pigeon-feeding places in the
   city. These samples were processed for the isolation and identification
   of fungi by using standard conventional methods. The fungal strains
   isolated were also tested for their susceptibility to commonly used
   antifungal agents by disc diffusion technique.
   Results: There were 105 samples. A wide variety of fungal strains
   belonging to different genera of Aspergillus, Rhizopus, Penicillium,
   Fusarium and Candida were isolated and identified by using conventional
   methods. The antifungal resistance pattern of these strains also depicts
   emergence of resistance against commonly used antifungal agents such as
   amphotericin B and fluconazole.
   Conclusion: The soil and air of places densely populated with pigeons
   were found to be loaded with fungal spores and many of them were
   potential pathogens.}},
Publisher = {{PAKISTAN MEDICAL ASSOC}},
Address = {{PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Naz, SA (Reprint Author), Fed Urdu Univ Arts Sci \& Technol, Dept Microbiol, Karachi, Pakistan.
   Naz, Sehar Afshan; Yaseen, Muhammad; Jabeen, Nusrat; Shafique, Maryam, Fed Urdu Univ Arts Sci \& Technol, Dept Microbiol, Karachi, Pakistan.}},
ISSN = {{0030-9982}},
Keywords = {{Feral pigeons; Fungal infections; Antifungal resistance}},
Keywords-Plus = {{VORICONAZOLE; ASPERGILLUS; INFECTION}},
Research-Areas = {{General \& Internal Medicine; Research \& Experimental Medicine}},
Web-of-Science-Categories  = {{Medicine, General \& Internal; Medicine, Research \& Experimental}},
Author-Email = {{seharafshan@fuuast.edu.pk}},
Funding-Acknowledgement = {{FUUAST}},
Funding-Text = {{The study was partially funded by Dean, Research Grant, FUUAST.}},
Cited-References = {{Anastasi A, 2005, MYCOLOGIA, V97, P33, DOI 10.3852/mycologia.97.1.33.
   {[}Anonymous], 2002, CRYPTOCOCCOSIS.
   Costa AKF, 2010, MYCOPATHOLOGIA, V169, P207, DOI 10.1007/s11046-009-9245-1.
   DEAN AG, 1978, AM J EPIDEMIOL, V108, P36.
   Diekema DJ, 2003, J CLIN MICROBIOL, V41, P3623, DOI 10.1128/JCM.41.8.3623-3626.2003.
   Gallo MG, 1989, PARASSITOLOGIA, V31, P201.
   Geigenfeind I, 2012, J MED MICROBIOL, V61, P261, DOI 10.1099/jmm.0.034025-0.
   Haag-Wackernagel D, 2004, J INFECTION, V48, P307, DOI 10.1016/j.jinf.2003.11.001.
   Haag-Wackernagel D, 2010, DERMATOLOGY, V220, P82, DOI 10.1159/000266039.
   Kerr C, 2004, J MED ETHICS, V30, P80, DOI 10.1136/jme.2002.001123.
   Lam C L, 2001, Respirology, V6, P351, DOI 10.1046/j.1440-1843.2001.00345.x.
   Larone D. H., 1995, MED IMPORTANT FUNGI.
   Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7.
   Pfaller MA, 1996, CLIN INFECT DIS, V22, pS89, DOI 10.1093/clinids/22.Supplement\_2.S89.
   QUINN P.J., 1994, CLIN VET MICROBIOLOG, P648.
   RAMIREZ R, 1976, Journal of Wildlife Diseases, V12, P83.
   Richardson M, 2008, CLIN MICROBIOL INFEC, V14, P5, DOI 10.1111/j.1469-0691.2008.01978.x.
   Serrano MC, 2004, J ANTIMICROB CHEMOTH, V53, P739, DOI 10.1093/jac/dkh172.
   Smith KA, 2005, JAVMA-J AM VET MED A, V226, P532, DOI 10.2460/javma.2005.226.532.
   Spellberg B, 2005, CLIN MICROBIOL REV, V18, P556, DOI 10.1128/CMR.18.3.556-569.2005.
   Suankratay C, 2015, MYCOSES, V58, P1, DOI 10.1111/myc.12270.
   Taylor ML, 2005, FEMS IMMUNOL MED MIC, V45, P451, DOI 10.1016/j.femsim.2005.05.019.
   VIDOTTO V, 1985, Parassitologia (Rome), V27, P313.
   ZareiMahmoudabadi A, 2012, JUNDISHAPUR J MICROB, V6, P24.
   Ziokowska G, 2014, POULTRY SCI, V93, P1106.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{J. Pak. Med. Assoc.}},
Doc-Delivery-Number = {{EW9VA}},
Unique-ID = {{ISI:000402866300016}},
DA = {{2018-08-13}},
}

@article{ ISI:000401441600002,
Author = {Mottet, A. and Tempio, G.},
Title = {{Global poultry production: current state and future outlook and
   challenges}},
Journal = {{WORLDS POULTRY SCIENCE JOURNAL}},
Year = {{2017}},
Volume = {{73}},
Number = {{2}},
Pages = {{245-256}},
Month = {{JUN}},
Abstract = {{This paper presents the current situation of the global poultry sector
   and future trends, and discusses the challenges the sector is facing,
   with particular emphasis on four areas: food security, social challenges
   (poverty alleviation and equity), health (animal and human) and
   environment (natural resources and climate change). Poultry makes a
   substantial contribution to food security and nutrition, providing
   energy, protein, and essential micro-nutrients to humans, with short
   production cycles and the ability to convert a wide range of agri-food
   by-products and wastes into meat and eggs edible by humans. Poultry is
   the fastest growing agricultural sub-sector, especially in developing
   countries. The global poultry sector is expected to continue to grow as
   demand for meat and eggs is driven by growing populations, rising
   incomes and urbanisation. In this context, the sector is facing
   unprecedented challenges. Particularly for small holders and the poor,
   both in rural and urban areas, poultry is a major asset and key to
   poverty alleviation, providing income and market participation. Birds
   can be sold in times of crisis and act as household insurance. But the
   growing market is essentially benefiting large scale operations and
   access to market is critical for small holders. However, poultry
   represent a threat to human health, especially as a vector of infectious
   diseases and because of its role in antimicrobial resistance.
   Furthermore, poultry has a significant impact on the environment and is
   a large consumer of natural resources. While the sector is usually seen
   as efficient in converting natural resources into edible products, it
   uses large amounts of land, water and nutrients for the production of
   feed materials and contributes to climate change, mainly through feed
   production, and air and water pollution.}},
Publisher = {{CAMBRIDGE UNIV PRESS}},
Address = {{EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Mottet, A (Reprint Author), UN, Anim Prod \& Hlth Div, FAO, Rome, Italy.
   Mottet, A.; Tempio, G., UN, Anim Prod \& Hlth Div, FAO, Rome, Italy.}},
DOI = {{10.1017/S0043933917000071}},
ISSN = {{0043-9339}},
EISSN = {{1743-4777}},
Keywords = {{trends; livelihoods; health; natural resources}},
Keywords-Plus = {{FAMILY POULTRY; FOOD SECURITY; FOOTPRINT; DYNAMICS; IMPACT}},
Research-Areas = {{Agriculture}},
Web-of-Science-Categories  = {{Agriculture, Dairy \& Animal Science}},
Author-Email = {{anne.mottet@fao.org}},
Cited-References = {{ALDERS R., 1996, P 20 WORLDS POULTR C, V3, P441.
   Alexandratos N, 2012, 20121203 ESA, P12, DOI DOI 10.1016/S0264-8377(03)00047-4.
   AROGO J., 2001, P AM SOC AGR BIOL EN.
   ARUNA M. B., 2007, J CENTRAL EUROPEAN A, V7, P753.
   DOBROWOLSKA A., 2016, EC IMPACT 2015 AVIAN.
   EGG INDUSTRY CENTER, 2015, IMP REP.
   EUROPEAN COMMISSION, 2012, AGR ENV IND GROSS NI.
   FAO (Food and Agriculture Organization of the United Nations), 2009, STAT FOOD AGR 2009 L.
   FAO-AGAL, 2016, SYNTH LIV SUST DEV G.
   FAOSTAT, 2016, FAO STAT DAT.
   Farrell D., 2013, POULTRY DEV REV.
   Gasparri NI, 2013, GLOBAL ENVIRON CHANG, V23, P1605, DOI 10.1016/j.gloenvcha.2013.09.007.
   GERBER P. J., 2013, TACKLING CLIMATE CAH.
   Gerber PJ, 2015, MEAT SCI, V109, P2, DOI 10.1016/j.meatsci.2015.05.013.
   GLEAM 2.0, 2016, GLOB LIV ENV ASS MOD.
   GUEYE E. F., 1998, WORLD POULTRY, V14, P14.
   Gueye EF, 2000, OUTLOOK AGR, V29, P129, DOI 10.5367/000000000101293130.
   Hoffmann I, 2005, WORLD POULTRY SCI J, V61, P57, DOI 10.1079/WPS200449.
   IFAH, 2012, COST AN DIS REP PROD.
   ILRI, 2008, ILRI ANN REP 2007 MA.
   Mekonnen MM, 2012, ECOSYSTEMS, V15, P401, DOI 10.1007/s10021-011-9517-8.
   Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103.
   MOTTET A., 2017, GLOBAL FOOD IN PRESS.
   Murphy SP, 2003, J NUTR, V133, p3932S, DOI 10.1093/jn/133.11.3932S.
   NARROD CLARE A, 2012, GLOBAL POULTRY SECTO.
   OECD/FAO, 2016, OECD FAO AGR OUTL 20.
   Pelletier N, 2014, POULTRY SCI, V93, P241, DOI 10.3382/ps.2013-03390.
   PICA-CIAMARRA U., 2010, SMALL SCALE POULTRY.
   Sonaiya EB, 2007, WORLD POULTRY SCI J, V63, P132, DOI 10.1079/WPS2006135.
   STEINFELD H., 2007, ANIMAL PRODUCTION HL.
   Steinfeld H, 2006, LIVESTOCKS LONG SHAD.
   Van Horne PLM, 2008, WORLD POULTRY SCI J, V64, P40, DOI 10.1017/S0043933907001705.
   WINDHORST H. W., 2015, P IEC 2015 BUS C LIS.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{12}},
Usage-Count-Since-2013 = {{38}},
Journal-ISO = {{Worlds Poult. Sci. J.}},
Doc-Delivery-Number = {{EV0OU}},
Unique-ID = {{ISI:000401441600002}},
DA = {{2018-08-13}},
}

@article{ ISI:000399471500002,
Author = {Skipityte, Raminta and Masalaite, Agne and Garbaras, Andrius and
   Mickiene, Ruta and Ragazinskiene, Ona and Baliukoniene, Violeta and
   Bakutis, Bronius and Siugzdaite, Jurate and Petkevicius, Saulius and
   Maruska, Audrius Sigitas and Remeikis, Vidmantas},
Title = {{Stable isotope ratio method for the characterisation of the poultry
   house environment}},
Journal = {{ISOTOPES IN ENVIRONMENTAL AND HEALTH STUDIES}},
Year = {{2017}},
Volume = {{53}},
Number = {{3}},
Pages = {{243-260}},
Month = {{JUN}},
Abstract = {{Stable isotope analysis was applied to describe the poultry house
   environment. The poultry house indoor environment was selected for this
   study due to the relevant health problems in animals and their
   caretakers. Air quality parameters including temperature, relative
   humidity, airflow rate, NH3, CO2 and total suspended particles, as well
   as mean levels of total airborne bacteria and fungi count, were
   measured. Carbon isotope ratios (C-13/C-12) were obtained in
   size-segregated aerosol particles. The carbon (C-13/C-12) and nitrogen
   (N-15/N-14) isotope ratios were measured in feed, litter, scrapings from
   the ventilation system, feathers and eggs. Additionally, the
   distribution of C-13 and N-15 values in different tissues of the chicken
   was examined. The airborne bacteria and fungi extracted from the air
   filters collected from poultry farms were grown in the laboratory in
   media with known isotope values and measured for stable isotope ratios.
   Analysis of isotope fractionation between microorganisms and their media
   indicated the applicability of stable isotope analysis in bulk samples
   for the identification of source material. The analysed examples imply
   that stable isotope analysis can be used to examine the indoor
   environment along with its biology and ecology, and serve as an
   informative bioanalytical tool.}},
Publisher = {{TAYLOR \& FRANCIS LTD}},
Address = {{2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Skipityte, R (Reprint Author), Ctr Phys Sci \& Technol, Inst Phys, Vilnius, Lithuania.
   Skipityte, Raminta; Masalaite, Agne; Garbaras, Andrius; Remeikis, Vidmantas, Ctr Phys Sci \& Technol, Inst Phys, Vilnius, Lithuania.
   Mickiene, Ruta; Maruska, Audrius Sigitas, Vytautas Magnus Univ, Dept Biol, Ctr Environm Res, Fac Nat Sci, Kaunas, Lithuania.
   Ragazinskiene, Ona, Vytautas Magnus Univ, Sect Med Plants, Kaunas Bot Garden, Kaunas, Lithuania.
   Baliukoniene, Violeta; Bakutis, Bronius, Lithuanian Univ Hlth Sci, Vet Acad, Dept Food Safety \& Qual, Fac Vet Med, Kaunas, Lithuania.
   Siugzdaite, Jurate; Petkevicius, Saulius, Lithuanian Univ Hlth Sci, Vet Acad, Dept Infect Dis, Fac Vet Med, Kaunas, Lithuania.}},
DOI = {{10.1080/10256016.2016.1230609}},
ISSN = {{1025-6016}},
EISSN = {{1477-2639}},
Keywords = {{Aerosol particles; carbon-13; isotope ecology; isotope fractionation;
   microorganisms; nitrogen-15; poultry house environment}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE; MASS-SPECTROMETRY; ESCHERICHIA-COLI; TROPHIC
   POSITION; CARBON ISOTOPES; DUST; NITROGEN; DIET; ENDOTOXINS; BACTERIA}},
Research-Areas = {{Chemistry; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Chemistry, Inorganic \& Nuclear; Environmental Sciences}},
Author-Email = {{raminta.skipityte@ftmc.lt}},
ORCID-Numbers = {{Maruska, Audrius/0000-0002-9267-3805}},
Cited-References = {{Bakutis B, 2004, ACTA VET BRNO, V73, P283, DOI 10.2754/avb200473020283.
   Balciauskas L, 2016, SCI TOTAL ENVIRON, V565, P376, DOI 10.1016/j.scitotenv.2016.04.185.
   Banhazi TM, 2008, BIOSYST ENG, V101, P100, DOI 10.1016/j.biosystemseng.2008.06.007.
   Berg C, 2001, ACTA VET SCAND, P37.
   Bogaard A, 2007, J ARCHAEOL SCI, V34, P335, DOI 10.1016/j.jas.2006.04.009.
   Calvet S, 2009, POULTRY SCI, V88, P2504, DOI 10.3382/ps.2009-00255.
   Ceburnis D, 2011, ATMOS CHEM PHYS, V11, P8593, DOI 10.5194/acp-11-8593-2011.
   CHOW JC, 1995, J AIR WASTE MANAGE, V45, P320, DOI 10.1080/10473289.1995.10467369.
   COLLINS M, 1986, VET RES COMMUN, V10, P415, DOI 10.1007/BF02214005.
   Czarick M, 2012, POULTRY HOUSING TIPS.
   Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0.
   Dawkins MS, 2004, NATURE, V427, P342, DOI 10.1038/nature02226.
   Dawkins MS, 2014, SCI PARLIAM, V71, P14.
   Domsch KH, 1980, COMPENDIUM SOIL FUNG.
   Ehleringer JR, 2002, C3 C4 PHOTOSYNTHESIS, V2, P186.
   Eller P, 1994, NATL I OCCUPATIONAL.
   Garbaras A, 2008, LITH J PHYS, V48, P259, DOI 10.3952/lithjphys.48309.
   Garbaras A, 2009, LITH J PHYS, V49, P229, DOI 10.3952/lithjphys.49202.
   Gerlach W, 1982, MITTEILUNGEN BIOL BU, V209.
   Guarino M, 1999, T ASAE, V42, P1127.
   HAGMAR L, 1990, INT ARCH OCC ENV HEA, V62, P159, DOI 10.1007/BF00383592.
   Hawksworth D. L., 1995, AINSWORTH BISBYS DIC.
   Healy DA, 2014, ATMOS CHEM PHYS, V14, P8055, DOI 10.5194/acp-14-8055-2014.
   Herrmann AM, 2007, SOIL BIOL BIOCHEM, V39, P1835, DOI 10.1016/j.soilbio.2007.03.011.
   HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807.
   HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808.
   HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361.
   Jones AM, 2004, SCI TOTAL ENVIRON, V326, P151, DOI 10.1016/j.scitotenv.2003.11.021.
   Karlson AML, 2015, AMBIO, V44, pS413, DOI 10.1007/s13280-015-0660-x.
   Kudrin AA, 2015, SOIL BIOL BIOCHEM, V86, P193, DOI 10.1016/j.soilbio.2015.03.017.
   Kulkarni P., 2011, AEROSOL MEASUREMENT.
   Lai H. T. L., 2014, Agricultural Engineering International: CIGR Journal, V16, P28.
   Lai HTL, 2009, POULTRY SCI, V88, P1838, DOI 10.3382/ps.2009-00129.
   Lawniczek-Walczyk A, 2013, ANN AGR ENV MED, V20, P259.
   Li JR, 2003, APPL ENVIRON MICROB, V69, P901, DOI 10.1128/AEM.69.2.901-908.2003.
   Lugauskas A, 2002, PATOGENIKI IR TOKSIK.
   Masalaite A, 2015, ATMOS RES, V158, P1, DOI 10.1016/j.atmosres.2015.01.014.
   Masalaite A, 2012, LITH J PHYS, V52, P261, DOI 10.3952/physics.v52i3.2478.
   McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x.
   Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9.
   Nandi S, 2004, P NATL ACAD SCI USA, V101, P7118, DOI 10.1073/pnas.0306466101.
   Nelson PE, 1983, FUSARIUM SPECIES ILL.
   OLEARY MH, 1992, PLANT CELL ENVIRON, V15, P1099, DOI 10.1111/j.1365-3040.1992.tb01660.x.
   Oppel S, 2010, AUK, V127, P72, DOI 10.1525/auk.2009.09153.
   Philp RP, 2007, ENVIRON CHEM LETT, V5, P57, DOI 10.1007/s10311-006-0081-y.
   Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083{[}0703:USITET]2.0.CO;2.
   Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820.
   Saleh M, 2003, DEUT TIERARZTL WOCH, V110, P394.
   Samson R. A., 2002, INTRO FOOD AIRBORNE.
   SAMSON RA, 1988, INTRO FOOD BORNE FUN.
   Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734.
   TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558.
   Trakimas G, 2011, HYDROBIOLOGIA, V675, P87, DOI 10.1007/s10750-011-0804-3.
   van den Bogaard AE, 2001, J ANTIMICROB CHEMOTH, V47, P763, DOI 10.1093/jac/47.6.763.
   Vucemilo M, 2008, CZECH J ANIM SCI, V53, P83, DOI 10.17221/329-CJAS.
   Vucemilo M, 2007, CZECH J ANIM SCI, V52, P170, DOI 10.17221/2318-CJAS.
   Yohannes A, 2014, J VET SCI MED DIAGN, V3, P2, DOI {[}10.4172/2325-9590.1000133, DOI 10.4172/2325-9590.1000133.].}},
Number-of-Cited-References = {{57}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{12}},
Journal-ISO = {{Isot. Environ. Health Stud.}},
Doc-Delivery-Number = {{ES4AN}},
Unique-ID = {{ISI:000399471500002}},
DA = {{2018-08-13}},
}

@article{ ISI:000402244400001,
Author = {Zhang, Nan and Wu, Yuzhi and Huang, Zilong and Yao, Lihua and Zhang,
   Longfei and Cai, Qinren and Shen, Xiangguang and Jiang, Hongxia and
   Ding, Huanzhong},
Title = {{The PK-PD Relationship and Resistance Development of Danofloxacin
   against Mycoplasma gallisepticum in An In Vivo Infection Model}},
Journal = {{FRONTIERS IN MICROBIOLOGY}},
Year = {{2017}},
Volume = {{8}},
Month = {{MAY 30}},
Abstract = {{Mycoplasma gallisepticum is the causative agent of chronic respiratory
   disease (CRD), a prevalent disease of poultry, which is responsible for
   significant economic losses in farms. Although several antimicrobial
   agents are currently recommended for the treatment and prevention of M.
   gallisepticum infections, investigations of M. gallisepticum have been
   hampered by their fastidious growth requirements and slow growth rate.
   As such, little work has been conducted concerning the PK/PD
   relationship and mechanisms of antibiotic resistance between
   antimicrobials against M. gallisepticum. In the present study,
   danofloxacin was orally administrated to the infected chickens once
   daily for 3 days by an established in vivo M. gallisepticum infection
   model. Not only the concentrations of danofloxacin in plasma and lung
   tissues were analyzed, but also the counting of viable cells and changes
   in antimicrobial susceptibility in air sac and lung were determined. The
   PK and PD data were fitted by WinNonlin to evaluate the PK/PD
   interactions of danofloxacin against M. gallisepticum. PCR amplification
   of quinolone resistance-determining regions (QRDRs) and DNA sequencing
   were performed to identify point mutations in gyrA, gyrB, parC, and parE
   of the selected resistant mutant strains. In addition, susceptibility of
   enrofloxacin, ofloxacin, levofloxacin, gatifloxacin, and norfloxacin
   against these mutant strains were also determined. The PK profiles
   indicated that danofloxacin concentration in the lung tissues was higher
   than plasma. Mycoplasmacidal activity was achieved when infected
   chickens were exposed to danofloxacin at the dose group above 2.5 mg/kg.
   The ratios of AUC(24)/MIC (the area under the concentration-time curve
   over 24 h divided by the MIC) for 2 log(10) (CFU) and 3 log(10) (CFU)
   reduction were 31.97 and 97.98 L h/kg, respectively. Substitutions of
   Ser-83 -> Arg or Glu-87 -> Gly in gyrA; Glu-84 -> Lys in parC were
   observed in the resistant mutant strains that were selected from the
   dose group of 1 and 2.5 mg/kg. MICs of danofloxacin, enrofloxacin,
   ofloxacin, levofloxacin, gatifloxacin, and norfloxacin against the
   resistant mutant strains with a single mutation in position-83 were
   higher than that with a single mutation in position-87. These findings
   suggested that danofloxacin may be therapeutically effective to treat M.
   gallisepticum infection in chickens if administered at a dosage of 5.5
   mg/kg once daily for 3 days.}},
Publisher = {{FRONTIERS MEDIA SA}},
Address = {{PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ding, HZ (Reprint Author), South China Agr Univ, Guangdong Key Lab Vet Drug Dev \& Safety Evaluat, Guangzhou, Guangdong, Peoples R China.
   Zhang, Nan; Wu, Yuzhi; Huang, Zilong; Yao, Lihua; Zhang, Longfei; Shen, Xiangguang; Jiang, Hongxia; Ding, Huanzhong, South China Agr Univ, Guangdong Key Lab Vet Drug Dev \& Safety Evaluat, Guangzhou, Guangdong, Peoples R China.
   Cai, Qinren, Zhuhai Entry Exit Inspect \& Quarantine Bur, Tech Ctr Inspect \& Quarantine, Zhuhai, Peoples R China.}},
DOI = {{10.3389/fmicb.2017.00926}},
Article-Number = {{926}},
ISSN = {{1664-302X}},
Keywords = {{Mycoplasma gallisepticum; danofloxacin; in vivo infection model;
   mutation; killing}},
Keywords-Plus = {{QUINOLONE-RESISTANCE; ESCHERICHIA-COLI; DNA GYRASE; MOLECULAR
   CHARACTERIZATION; INHIBITORY CONCENTRATION; TOPOISOMERASE-IV; MUTATIONS;
   PHARMACOKINETICS; ENROFLOXACIN; CHICKENS}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{hzding@sacu.edu.cn}},
Funding-Acknowledgement = {{National Key Research and Development Program of China
   {[}2016YFD0501300/2016 YFD0501310]; Special Program for Science and
   Technology Development of Guangdong Province {[}2015AD20 209130]}},
Funding-Text = {{This study is supported financially by National Key Research and
   Development Program of China (2016YFD0501300/2016 YFD0501310) and
   Special Program for Science and Technology Development of Guangdong
   Province (2015AD20 209130).}},
Cited-References = {{ADLER HE, 1958, AM J VET RES, V19, P440.
   Bagel S, 1999, ANTIMICROB AGENTS CH, V43, P868.
   Bailey CC, 1996, GENE, V168, P77, DOI 10.1016/0378-1119(95)00718-0.
   Benskin CMH, 2009, BIOL REV, V84, P349, DOI 10.1111/j.1469-185X.2008.00076.x.
   FRIIS C, 1993, AM J VET RES, V54, P1122.
   Gerchman I, 2008, VET MICROBIOL, V131, P266, DOI 10.1016/j.vetmic.2008.04.006.
   GILES CJ, 1991, J VET PHARMACOL THER, V14, P400, DOI 10.1111/j.1365-2885.1991.tb00854.x.
   Giraud E, 1999, ANTIMICROB AGENTS CH, V43, P2131.
   GREENBERGOFRATH N, 1993, APPL ENVIRON MICROB, V59, P547.
   Gruson D, 2005, ANTIMICROB AGENTS CH, V49, P1190, DOI 10.1128/AAC.49.3.1190-1193.2005.
   Hannan PCT, 2000, VET RES, V31, P373, DOI 10.1051/vetres:2000100.
   Hopkins KL, 2005, INT J ANTIMICROB AG, V25, P358, DOI 10.1016/j.ijantimicag.2005.02.006.
   JORDAN FTW, 1993, J VET PHARMACOL THER, V16, P79, DOI 10.1111/j.1365-2885.1993.tb00292.x.
   KLEVEN S, 1990, AVIAN PATHOL, V19, P795, DOI 10.1080/03079459008418732.
   Knoll U, 1999, J VET PHARMACOL THER, V22, P239, DOI 10.1046/j.1365-2885.1999.00217.x.
   Levisohn S, 2000, REV SCI TECH OIE, V19, P425, DOI 10.20506/rst.19.2.1232.
   Ley DH, 1997, EMERG INFECT DIS, V3, P375, DOI 10.3201/eid0303.970318.
   Liebana E, 2002, J CLIN MICROBIOL, V40, P1481, DOI 10.1128/JCM.40.4.1481-1486.2002.
   LYNCH MJ, 1994, J AGR FOOD CHEM, V42, P289, DOI 10.1021/jf00038a012.
   Lysnyansky I, 2008, AVIAN DIS, V52, P685, DOI 10.1637/8386-063008-RESNOTE.1.
   Lysnyansky I, 2012, VET MICROBIOL, V160, P222, DOI 10.1016/j.vetmic.2012.05.002.
   McKellar QA, 1998, BIOPHARM DRUG DISPOS, V19, P123, DOI 10.1002/(SICI)1099-081X(199803)19:2<123::AID-BDD89>3.0.CO;2-G.
   Ozeki S, 1997, J CLIN MICROBIOL, V35, P2315.
   Pakpinyo S, 2007, VET MICROBIOL, V125, P59, DOI 10.1016/j.vetmic.2007.05.011.
   RAZIN S, 1970, J BACTERIOL, V102, P306.
   Reinhardt AK, 2002, J ANTIMICROB CHEMOTH, V50, P589, DOI 10.1093/jac/dkf158.
   Reinhardt AK, 2002, ANTIMICROB AGENTS CH, V46, P590, DOI 10.1128/AAC.46.2.590-593.2002.
   Toutain PL, 2007, J ANTIMICROB CHEMOTH, V60, P1185, DOI 10.1093/jac/dkm360.
   Vinks A, 2014, FUNDAMENTALS ANTIMIC.
   WILLMOTT CJR, 1993, ANTIMICROB AGENTS CH, V37, P126, DOI 10.1128/AAC.37.1.126.
   Xiao X, 2015, ANTIMICROB AGENTS CH, V59, P3754, DOI 10.1128/AAC.00200-15.
   Xiao X, 2015, VET J, V204, P54, DOI 10.1016/j.tvjl.2015.01.020.
   Xie XY, 2006, FEMS MICROBIOL LETT, V259, P181, DOI 10.1111/j.1574-6968.2006.00239.x.
   Zeng Z, 2011, J VET PHARMACOL THER, V34, P101, DOI 10.1111/j.1365-2885.2010.01223.x.
   Zhang N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169134.
   Zhang N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00653.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{10}},
Journal-ISO = {{Front. Microbiol.}},
Doc-Delivery-Number = {{EW1IV}},
Unique-ID = {{ISI:000402244400001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000400281800018,
Author = {Apisarnthanarak, Anucha and Ratz, David and Khawcharoenporn, Thana and
   Patel, Payal K. and Weber, David J. and Saint, Sanjay and Greene, M.
   Todd},
Title = {{National Survey of Practices to Prevent Methicillin-Resistant
   Staphylococcus aureus and Multidrug-Resistant Acinetobacter baumannii in
   Thailand}},
Journal = {{CLINICAL INFECTIOUS DISEASES}},
Year = {{2017}},
Volume = {{64}},
Number = {{2}},
Pages = {{S161-S166}},
Month = {{MAY 15}},
Abstract = {{Background. We evaluated the extent to which hospital characteristics,
   infection control practices, and compliance with prevention bundles
   impacted multidrug-resistant organism (MDRO) infections in Thai
   hospitals.
   Methods. From 1 January 2014 to 30 November 2014, we surveyed all Thai
   hospitals with an intensive care unit and >= 250 beds. Infection control
   practices for methicillin-resistant Staphylococcus aureus (MRSA) and
   multidrug-resistant Acinetobacter baumannii (MDR-AB) were assessed.
   Linear regression was used to examine associations between hospital
   characteristics and prevention bundle compliance and changes in MDRO
   infection rates.
   Results. A total of 212 of 245 (86.5\%) eligible hospitals responded.
   Most hospitals regularly used several fundamental infection control
   practices for MRSA and MDR-AB (ie, contact precautions, private
   room/cohorting, hand hygiene, environmental cleaning, and antibiotic
   stewardship); advanced infection control practices (ie, active
   surveillance, chlorhexidine bathing, decolonization for MRSA, and
   hydrogen peroxide vaporizer for MDR-AB) were used less commonly.
   Facilities with >= 75\% compliance with the MRSA prevention bundle
   experienced a 17.4\% reduction in MRSA rates (P =.03). Although the
   presence of environmental cleaning services (41.3\% reduction, P =.01)
   and a microbiology laboratory (82.8\% reduction, P =.02) were among
   characteristics associated with decreases in MDR-AB rates, greater
   compliance with the MDR-AB prevention bundle did not lead to reductions
   in MDR-AB rates.
   Conclusions. Although fundamental MRSA and MDR-AB control practices are
   used regularly in most Thai hospitals, compliance with more
   comprehensive bundled prevention approaches is suboptimal. Improving
   compliance with bundled infection prevention approaches and promoting
   the integration of certain hospital factors into infection control
   efforts may help reduce MDRO infections in Thai hospitals.}},
Publisher = {{OXFORD UNIV PRESS INC}},
Address = {{JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Apisarnthanarak, A (Reprint Author), Thammasat Univ Hosp, Div Infect Dis, Pathum Thani 12120, Thailand.
   Apisarnthanarak, Anucha; Khawcharoenporn, Thana, Thammasat Univ, Pathum Thani, Thailand.
   Ratz, David; Patel, Payal K.; Saint, Sanjay; Greene, M. Todd, Vet Affairs Ann Arbor Healthcare Syst, Ctr Clin Management Res, Ann Arbor, MI USA.
   Patel, Payal K., Univ Michigan, Div Infect Dis, Ann Arbor, MI 48109 USA.
   Saint, Sanjay; Greene, M. Todd, Univ Michigan, Div Gen Med, Ann Arbor, MI 48109 USA.
   Weber, David J., Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA.}},
DOI = {{10.1093/cid/cix045}},
ISSN = {{1058-4838}},
EISSN = {{1537-6591}},
Keywords = {{national survey; multidrug-resistant; MRSA; Acinetobacter baumannii;
   Thailand}},
Keywords-Plus = {{VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE UNITS;
   INFECTION-CONTROL; SOUTHEAST-ASIA; CONTAMINATION; EPIDEMIOLOGY;
   PHYSICIANS; STATES; AIR}},
Research-Areas = {{Immunology; Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Immunology; Infectious Diseases; Microbiology}},
Author-Email = {{anapisarn@yahoo.com}},
Funding-Acknowledgement = {{National Research University Project of the Thailand Office of Higher
   Education Commission; National Research University Project of the
   Thailand Office of Higher Education Commission}},
Funding-Text = {{This study was supported by the National Research University Project of
   the Thailand Office of Higher Education Commission (to A. A.).}},
Cited-References = {{Apisarnthanarak A, 2009, J MED ASSOC THAI, V92, pS91.
   Apisarnthanarak A, 2016, INFECT CONT HOSP EP, V37, P489, DOI 10.1017/ice.2015.343.
   Apisarnthanarak A, 2013, AM J INFECT CONTROL, V41, P416, DOI 10.1016/j.ajic.2012.05.011.
   Buppajarntham A, 2016, INFECT CONT HOSP EP, V37, P61, DOI 10.1017/ice.2015.240.
   Calfee David P, 2014, Infect Control Hosp Epidemiol, V35 Suppl 2, pS108, DOI 10.1086/676534.
   Cheon S, 2016, KOREAN J INTERN MED, V31, P367, DOI 10.3904/kjim.2015.178.
   Cohen AL, 2008, INFECT CONT HOSP EP, V29, P901, DOI 10.1086/591741.
   Dejsirilert Surang, 2009, J Med Assoc Thai, V92 Suppl 4, pS34.
   Durante-Mangoni E, 2011, FUTURE MICROBIOL, V6, P407, DOI {[}10.2217/fmb.11.23, 10.2217/FMB.11.23].
   Furuya EY, 2016, INFECT CONT HOSP EP, V37, P805, DOI 10.1017/ice.2016.67.
   Furuya EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015452.
   Ho J, 2010, CURR OPIN INFECT DIS, V23, P546, DOI 10.1097/QCO.0b013e32833f0d3e.
   Kanamori H, 2016, CLIN INFECT DIS, V62, P1423, DOI 10.1093/cid/ciw122.
   Kaye KS, 2015, INFECT CONT HOSP EP, V36, P369, DOI 10.1017/ice.2014.79.
   Krein SL, 2008, INFECT CONT HOSP EP, V29, P933, DOI 10.1086/591455.
   Krein SL, 2007, MAYO CLIN PROC, V82, P672.
   Ling ML, 2015, CLIN INFECT DIS, V60, P1690, DOI 10.1093/cid/civ095.
   Mootsikapun Piroon, 2009, J Med Assoc Thai, V92 Suppl 4, pS87.
   Munoz-Price LS, 2013, CRIT CARE MED, V41, P1915, DOI 10.1097/CCM.0b013e31828a39c0.
   Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07.
   Rock C, 2015, INFECT CONT HOSP EP, V36, P830, DOI 10.1017/ice.2015.68.
   Rossolini GM, 2010, CURR OPIN MICROBIOL, V13, P582, DOI 10.1016/j.mib.2010.08.006.
   Saint S, 2008, CLIN INFECT DIS, V46, P243, DOI 10.1086/524662.
   Shimose LA, 2015, J CLIN MICROBIOL, V53, P2346, DOI 10.1128/JCM.00198-15.
   Suwantarat N, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0115-6.
   Tacconelli E, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12427.
   Tishyadhigama Prapawadee, 2009, J Med Assoc Thai, V92 Suppl 4, pS8.}},
Number-of-Cited-References = {{27}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{11}},
Journal-ISO = {{Clin. Infect. Dis.}},
Doc-Delivery-Number = {{ET4UZ}},
Unique-ID = {{ISI:000400281800018}},
DA = {{2018-08-13}},
}

@article{ ISI:000404727800058,
Author = {Echeverria-Palencia, Cristina M. and Thulsiraj, Vanessa and Tran, Nghi
   and Ericksen, Cody A. and Melendez, Isabel and Sanchez, Michael G. and
   Walpert, Devin and Yuan, Tony and Ficara, Elizabeth and Senthilkumar,
   Niru and Sun, Fangfang and Li, Renjie and Hernandez-Cira, Marisol and
   Gamboa, Demi and Haro, Heather and Paulson, Suzanne E. and Zhu, Yifang
   and Jay, Jennifer A.},
Title = {{Disparate Antibiotic Resistance Gene Quantities Revealed across 4 Major
   Cities in California: A Survey in Drinking Water, Air, and Soil at 24
   Public Parks}},
Journal = {{ACS OMEGA}},
Year = {{2017}},
Volume = {{2}},
Number = {{5}},
Pages = {{2255-2263}},
Month = {{MAY}},
Abstract = {{Widespread prevalence of multidrug and pandrug-resistant bacteria has
   prompted substantial concern over the global dissemination of antibiotic
   resistance genes (ARGs). Environmental compartments can behave as
   genetic reservoirs and hotspots, wherein resistance genes can accumulate
   and be laterally transferred to clinically relevant pathogens. In this
   work, we explore the ARG copy quantities in three environmental media
   distributed across four cities in California and demonstrate that there
   exist city-to-city disparities in soil and drinking water ARGs.
   Statistically significant differences in ARGs were identified in soil,
   where differences in bla(SHV) gene copies were the most striking; the
   highest copy numbers were observed in Bakersfield (6.0 x 10(-2)
   copies/16S-rRNA gene copies and 2.6 x 10(6) copies/g of soil), followed
   by San Diego (1.8 x 10(-3) copies/16S-rRNA gene copies and 3.0 x 10(4)
   copies/g of soil), Fresno (1.8 x 10(-5) copies/16S-rRNA gene copies and
   8.5 x 10(2) copies/g of soil), and Los Angeles (5.8 x 10(-6)
   copies/16S-rRNA gene copies and 5.6 x 10(2) copies/g of soil). In
   addition, ARG copy numbers in the air, water, and soil of each city are
   contextualized in relation to globally reported quantities and
   illustrate that individual genes are not necessarily predictors for the
   environmental resistome as a whole.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Jay, JA (Reprint Author), Univ Calif Los Angeles, Civil \& Environm Engn Dept, 420 Westwood Plaza, Los Angeles, CA 90095 USA.
   Jay, JA (Reprint Author), Univ Calif Los Angeles, Inst Environm \& Sustainabil, LaKretz Bldg, Los Angeles, CA 90095 USA.
   Echeverria-Palencia, Cristina M.; Thulsiraj, Vanessa; Sun, Fangfang; Li, Renjie; Hernandez-Cira, Marisol; Gamboa, Demi; Haro, Heather; Jay, Jennifer A., Univ Calif Los Angeles, Civil \& Environm Engn Dept, 420 Westwood Plaza, Los Angeles, CA 90095 USA.
   Thulsiraj, Vanessa, Mt St Marys Univ, Dept Biol, 12001 Chalon Rd, Los Angeles, CA 90049 USA.
   Tran, Nghi; Ericksen, Cody A.; Melendez, Isabel; Sanchez, Michael G.; Walpert, Devin; Yuan, Tony; Ficara, Elizabeth; Paulson, Suzanne E.; Zhu, Yifang; Jay, Jennifer A., Univ Calif Los Angeles, Inst Environm \& Sustainabil, LaKretz Bldg, Los Angeles, CA 90095 USA.}},
DOI = {{10.1021/acsomega.7b00118}},
ISSN = {{2470-1343}},
Keywords-Plus = {{WASTE-WATER; TETRACYCLINE RESISTANCE; TREATMENT PLANTS; EMERGING
   CONTAMINANTS; BACTERIA; CHINA; ENVIRONMENT; ADJACENT; MANURE; RIVER}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Multidisciplinary}},
Author-Email = {{jjay@seas.ucla.edu}},
Funding-Acknowledgement = {{UCLA Institute of the Environment and Sustainability; Natural Resources
   Defense Council; UCLA Institute for the Environment and Sustainability;
   National Science Foundation {[}0963183]; American Recovery and
   Reinvestment Act of 2009 (ARRA)}},
Funding-Text = {{We thank N. Garrison and C. Cordova for assistance in planning the study
   and the UCLA Institute of the Environment and Sustainability for
   supporting this work as a Senior Practicum Project. Funding was provided
   by the Natural Resources Defense Council and the UCLA Institute for the
   Environment and Sustainability. This material is based upon research
   performed in a collaboratory renovated by the National Science
   Foundation under Grant No. 0963183, which is an award funded under the
   American Recovery and Reinvestment Act of 2009 (ARRA).}},
Cited-References = {{Auerbach EA, 2007, WATER RES, V41, P1143, DOI 10.1016/j.watres.2006.11.045.
   Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006.
   Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439.
   Binh CTT, 2009, RES MICROBIOL, V160, P427, DOI 10.1016/j.resmic.2009.06.005.
   Brooks JP, 2010, SCI TOTAL ENVIRON, V408, P4770, DOI 10.1016/j.scitotenv.2010.06.038.
   Chapin A, 2005, ENVIRON HEALTH PERSP, V113, P137, DOI 10.1289/ehp.7473.
   Chee-Sanford JC, 2009, J ENVIRON QUAL, V38, P1086, DOI 10.2134/jeq2008.0128.
   Chen CQ, 2014, ENVIRON POLLUT, V193, P94, DOI 10.1016/j.envpol.2014.06.005.
   Czekalski N, 2015, ENVIRON INT, V81, P45, DOI 10.1016/j.envint.2015.04.005.
   Czekalski N, 2014, ISME J, V8, P1381, DOI 10.1038/ismej.2014.8.
   Dalkmann P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045397.
   Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421.
   Dodd MC, 2012, J ENVIRON MONITOR, V14, P1754, DOI 10.1039/c2em00006g.
   Enne VI, 2001, LANCET, V357, P1325, DOI 10.1016/S0140-6736(00)04519-0.
   Fahrenfeld N, 2014, ENVIRON SCI TECHNOL, V48, P2643, DOI 10.1021/es404988k.
   Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355.
   Gomez-Alvarez V, 2012, APPL ENVIRON MICROB, V78, P6095, DOI 10.1128/AEM.01018-12.
   Guo XP, 2014, SCI TOTAL ENVIRON, V493, P626, DOI 10.1016/j.scitotenv.2014.06.035.
   Han XM, 2016, ENVIRON POLLUT, V211, P48, DOI 10.1016/j.envpol.2015.12.033.
   Heuer H, 2011, APPL ENVIRON MICROB, V77, P2527, DOI 10.1128/AEM.02577-10.
   Ji XL, 2012, J HAZARD MATER, V235, P178, DOI 10.1016/j.jhazmat.2012.07.040.
   Khan S, 2016, ENV PROCESS, V3, P541, DOI {[}DOI 10.1007/S40710-016-0149-Z, 10.1007/s40710-016-0149-z].
   Knapp CW, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00396.
   Knapp CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027300.
   Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x.
   Koike S, 2007, APPL ENVIRON MICROB, V73, P4813, DOI 10.1128/AEM.00665-07.
   Li J, 2012, ENVIRON HEALTH PERSP, V120, P1144, DOI 10.1289/ehp.1104776.
   Ling AL, 2013, ENVIRON SCI TECHNOL, V47, P4046, DOI 10.1021/es400238g.
   Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7.
   Luo Y, 2010, ENVIRON SCI TECHNOL, V44, P7220, DOI 10.1021/es100233w.
   Martinez JL, 2015, NAT REV MICROBIOL, V13, P116, DOI 10.1038/nrmicro3399.
   McEachran AD, 2015, ENVIRON HEALTH PERSP, V123, P337, DOI 10.1289/ehp.1408555.
   Munir M, 2011, WATER RES, V45, P681, DOI 10.1016/j.watres.2010.08.033.
   Nardelli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039223.
   Niu ZG, 2016, MAR POLLUT BULL, V107, P245, DOI 10.1016/j.marpolbul.2016.03.064.
   O'Neill J., 2014, ANTIMICROBIAL RESIST, P1.
   Olaitan A. O., 2015, J ANTIMICROB CHEMOTH, P1.
   ONeill J., 2016, TACKLING DRUG RESIST.
   Pehrsson E., 2016, NATURE, V61, P5985.
   Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es0604131.
   Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r.
   Ravva SV, 2012, J ENVIRON MONITOR, V14, P473, DOI 10.1039/c1em10753d.
   Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032.
   Rodriguez-Mozaz S, 2015, WATER RES, V69, P234, DOI 10.1016/j.watres.2014.11.021.
   Sanchez HM, 2016, WATER AIR SOIL POLL, V227, DOI 10.1007/s11270-016-3072-z.
   Sanderson H, 2016, ENVIRON REV, V24, P205, DOI 10.1139/er-2015-0069.
   Schnoor JL, 2014, ENVIRON SCI TECHNOL, V48, P11019, DOI {[}10.1021/es5042S6j, 10.1021/es504256j].
   Seiler C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00399.
   Simmons K., 2014, SOIL SAMPLING SESD O, P1.
   Suzuki S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00796.
   Suzuki S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00102.
   Tiirik K, 2014, BIOTECHNOL APPL BIOC, V61, P23, DOI 10.1002/bab.1144.
   Walia S., 2016, CURR MED RES PRACT, V6, P149.
   Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005.}},
Number-of-Cited-References = {{54}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{10}},
Journal-ISO = {{ACS Omega}},
Doc-Delivery-Number = {{EZ5BW}},
Unique-ID = {{ISI:000404727800058}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000401984900007,
Author = {Mansson, Emeli and Hellmark, Bengt and Stegger, Marc and Andersen, Paal
   Skytt and Sundqvist, Martin and Soderquist, Bo},
Title = {{Genomic relatedness of Staphylococcus pettenkoferi isolates of different
   origins}},
Journal = {{JOURNAL OF MEDICAL MICROBIOLOGY}},
Year = {{2017}},
Volume = {{66}},
Number = {{5}},
Pages = {{601-608}},
Month = {{MAY}},
Abstract = {{Purpose. The aim of the study was to characterize clinical and
   environmental Staphylococcus pettenkoferi isolates with regard to
   genomic diversity and antibiotic susceptibility pattern.
   Repetitive-sequence-based PCR and core genome phylogenetic analysis of
   whole-genome sequencing (WGS) data verified the presence of distinct
   clades comprising closely related S. pettenkoferi isolates from
   different geographical locations and origins.
   Methodology. Phylogenetic relationships between 25 S. pettenkoferi
   isolates collected from blood cultures and intra-operative air sampling
   were determined by repetitive-sequence-based PCR typing and analysis of
   similar to 157 000 SNPs identified in the core genome after WGS.
   Antibiotic susceptibility testing and tests for biofilm production
   (microtitre plate assay) were performed.
   Results. Repetitive-sequence-based PCR as well as WGS data demonstrated
   the close relatedness of clinically significant blood culture isolates
   to probable contaminants, as well as to environmental isolates.
   Antibiotic-susceptibility testing demonstrated a low level of
   antimicrobial resistance. The mecA gene was present in two
   cefoxitin-resistant isolates. No isolates were found to produce biofilm.
   Conclusion. Close genomic relatedness of S. pettenkoferi isolates from
   different geographical locations and origins were found within clades,
   but with substantial genomic difference between the two major clades.
   The ecological niche of S. pettenkoferi remains unconfirmed, but the
   presence of S. pettenkoferi in the air of the operating field favours
   the suggestion of a role in skin flora. Identification of S.
   pettenkoferi in clinical samples should, in a majority of cases, most
   likely be regarded as a probable contamination, and its role as a
   possible pathogen in immunocompromised hosts remains to be clarified.}},
Publisher = {{MICROBIOLOGY SOC}},
Address = {{CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mansson, E (Reprint Author), Orebro Univ, Sch Med Sci, Fac Med \& Hlth, SE-70182 Orebro, Sweden.
   Mansson, E (Reprint Author), Hosp Vastmanland Vasteras, Ctr Clin Res, SE-72189 Vasteras, Sweden.
   Mansson, Emeli; Soderquist, Bo, Orebro Univ, Sch Med Sci, Fac Med \& Hlth, SE-70182 Orebro, Sweden.
   Mansson, Emeli, Hosp Vastmanland Vasteras, Ctr Clin Res, SE-72189 Vasteras, Sweden.
   Hellmark, Bengt; Sundqvist, Martin, Orebro Univ, Fac Med \& Hlth, Dept Lab Med, SE-70182 Orebro, Sweden.
   Stegger, Marc; Andersen, Paal Skytt, Statens Serum Inst, Artillerivej 5, DK-2300 Copenhagen S, Denmark.}},
DOI = {{10.1099/jmm.0.000472}},
ISSN = {{0022-2615}},
EISSN = {{1473-5644}},
Keywords = {{Staphylococcus pettenkoferi; genotypic relatedness; repetitive-sequence
   based PCR typing; whole-genome sequencing}},
Keywords-Plus = {{COAGULASE-NEGATIVE STAPHYLOCOCCI; PROSTHETIC JOINT INFECTIONS; CLINICAL
   SPECIMENS; EPIDERMIDIS; SUSCEPTIBILITY; IMPLEMENTATION; IDENTIFICATION;
   LABORATORIES; AUREUS}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{emeli.mansson@regionvastmanland.se}},
Funding-Acknowledgement = {{Orebro County Council Research Committee, Orebro, Sweden, Centre for
   Clinical Research, Vasteras; County Council of Vastmanland Research Fund}},
Funding-Text = {{The study was funded by Orebro County Council Research Committee,
   Orebro, Sweden, Centre for Clinical Research, Vasteras and the County
   Council of Vastmanland Research Fund. The funders played no role in
   study design, data collection and interpretation, or the decision to
   submit the work for publication.}},
Cited-References = {{Argemi X, 2015, J CLIN MICROBIOL, V53, P2030, DOI 10.1128/JCM.00177-15.
   Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13.
   Berglund C, 2005, CLIN MICROBIOL INFEC, V11, P447, DOI 10.1111/j.1469-0691.2005.01150.x.
   Cornaglia G., 2012, EUROPEAN MANUAL CLIN.
   d'Azevedo PA, 2010, REV SOC BRAS MED TRO, V43, P331, DOI 10.1590/S0037-86822010000300023.
   Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537.
   Hellmark B, 2013, INT J MED MICROBIOL, V303, P32, DOI 10.1016/j.ijmm.2012.11.001.
   Loiez C, 2007, J CLIN MICROBIOL, V45, P1069, DOI 10.1128/JCM.02328-06.
   Mammina C, 2011, CASE REP CRIT CARE, V2011, P1.
   Mansson E, 2015, APMIS, V123, P589, DOI 10.1111/apm.12392.
   Matuschek E, 2014, CLIN MICROBIOL INFEC, V20, pO255, DOI 10.1111/1469-0691.12373.
   Mihaila L, 2012, INT J ANTIMICROB AG, V40, P472, DOI 10.1016/j.ijantimicag.2012.06.014.
   Mkrtchyan HV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054223.
   Morfin-Otero R, 2012, ANN CLIN LAB SCI, V42, P182.
   Park S, 2015, ANN LAB MED, V35, P250, DOI 10.3343/alm.2015.35.2.250.
   Song SH, 2009, J MED MICROBIOL, V58, P270, DOI 10.1099/jmm.0.004697-0.
   Trulzsch K, 2007, INT J SYST EVOL MICR, V57, P1543, DOI 10.1099/ijs.0.64381-0.
   Trulzsch K, 2002, DIAGN MICR INFEC DIS, V43, P175, DOI 10.1016/S0732-8893(02)00399-1.
   Weiss S, 2013, VET MICROBIOL, V167, P680, DOI 10.1016/j.vetmic.2013.07.036.}},
Number-of-Cited-References = {{19}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{J. Med. Microbiol.}},
Doc-Delivery-Number = {{EV7TQ}},
Unique-ID = {{ISI:000401984900007}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000399377100005,
Author = {Proano, Alvaro and Bravard, Marjory A. and Lopez, Jose W. and Lee,
   Gwenyth O. and Bui, David and Datta, Sumona and Comina, German and
   Zimic, Mirko and Coronel, Jorge and Caviedes, Luz and Cabrera, Jose L.
   and Salas, Antonio and Ticona, Eduardo and Vu, Nancy M. and Kirwan,
   Daniela E. and Loader, Maria-Cristina I. and Friedland, Jon S. and
   Moore, David A. J. and Evans, Carlton A. and Tracey, Brian H. and
   Gilman, Robert H. and TB Working Grp Peru},
Title = {{Dynamics of Cough Frequency in Adults Undergoing Treatment for Pulmonary
   Tuberculosis}},
Journal = {{CLINICAL INFECTIOUS DISEASES}},
Year = {{2017}},
Volume = {{64}},
Number = {{9}},
Pages = {{1174-1181}},
Month = {{MAY 1}},
Abstract = {{Background. Cough is the major determinant of tuberculosis transmission.
   Despite this, there is a paucity of information regarding
   characteristics of cough frequency throughout the day and in response to
   tuberculosis therapy. Here we evaluate the circadian cycle of cough,
   cough frequency risk factors, and the impact of appropriate treatment on
   cough and bacillary load.
   Methods. We prospectively evaluated human immunodeficiency
   virus-negative adults (n = 64) with a new diagnosis of culture-proven,
   drug-susceptible pulmonary tuberculosis immediately prior to treatment
   and repeatedly until treatment day 62. At each time point, participant
   cough was recorded (n = 670) and analyzed using the Cayetano Cough
   Monitor. Consecutive coughs at least 2 seconds apart were counted as
   separate cough episodes. Sputum samples (n = 426) were tested with
   microscopic-observation drug susceptibility broth culture, and in
   culture-positive samples (n = 252), the time to culture positivity was
   used to estimate bacillary load.
   Results. The highest cough frequency occurred from 1 pm to 2 pm, and the
   lowest from 1 am to 2 am (2.4 vs 1.1 cough episodes/hour, respectively).
   Cough frequency was higher among participants who had higher sputum
   bacillary load (P < .01). Pretreatment median cough episodes/hour was
   2.3 (interquartile range {[}IQR], 1.2-4.1), which at 14 treatment days
   decreased to 0.48 (IQR, 0.01.4) and at the end of the study decreased to
   0.18 (IQR, 0.0-0.59) (both reductions P < .001). By 14 treatment days,
   the probability of culture conversion was 29\% (95\% confidence
   interval, 19\%-41\%).
   Conclusions. Coughs were most frequent during daytime. Two weeks of
   appropriate treatment significantly reduced cough frequency and resulted
   in one-third of participants achieving culture conversion. Thus,
   treatment by 2 weeks considerably diminishes, but does not eliminate,
   the potential for airborne tuberculosis transmission.}},
Publisher = {{OXFORD UNIV PRESS INC}},
Address = {{JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Proano, A (Reprint Author), Escuela Profes Med, Fac Med Alberto Hurtado, Lima, Peru.
   Proano, Alvaro; Cabrera, Jose L.; Vu, Nancy M.; Loader, Maria-Cristina I.; Gilman, Robert H., Escuela Profes Med, Fac Med Alberto Hurtado, Lima, Peru.
   Proano, Alvaro; Comina, German; Cabrera, Jose L.; Loader, Maria-Cristina I.; Friedland, Jon S., Univ Peruana Cayetano Heredia, Fac Ciencias Filosof, Lab Invest Enfermedades Infecciosa, Lab Invest Desarrollo, Lima, Peru.
   Asociac Ben PRISMA, Lima, Peru.
   Lee, Gwenyth O.; Datta, Sumona; Salas, Antonio; Loader, Maria-Cristina I.; TB Working Grp Peru, Massachusetts Gen Hosp, Dept Gen Internal Med, Boston, MA USA.
   Univ Peruana Cayetano Heredia, Fac Ciencias Filosof, Lab Bioinformat Biolog Mol, Perm, Russia.
   Tulane Univ, Dept Global Community Hlth \& Behav Sci, New Orleans, LA USA.
   Univ Arizona, Div Epidemiol \& Biostat, Mel \& Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA.
   Comina, German; Cabrera, Jose L.; Loader, Maria-Cristina I.; Tracey, Brian H., Imperial Coll London, Infect Dis \& Immun \& Wellcome Trust Imperial Coll, London, England.}},
DOI = {{10.1093/cid/cix039}},
ISSN = {{1058-4838}},
EISSN = {{1537-6591}},
Keywords = {{tuberculosis; airborne transmission; infectiousness; cough; Peru}},
Keywords-Plus = {{MULTIDRUG-RESISTANT TUBERCULOSIS; EARLY BACTERICIDAL ACTIVITY;
   DRUG-SUSCEPTIBILITY ASSAY; MYCOBACTERIUM-TUBERCULOSIS;
   MICROSCOPIC-OBSERVATION; ANTITUBERCULOSIS DRUGS; TREATMENT RESPONSE;
   TRANSMISSION; SYMPTOMS; DISEASE}},
Research-Areas = {{Immunology; Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Immunology; Infectious Diseases; Microbiology}},
Author-Email = {{alvaro.proano.f@upch.pe}},
ResearcherID-Numbers = {{Proano, Alvaro/M-4288-2014
   }},
ORCID-Numbers = {{Proano, Alvaro/0000-0002-4057-7686
   Bui, David/0000-0003-0861-0850
   Comina, German/0000-0003-2114-0486
   Kirwan, Daniela/0000-0003-3989-0795
   Coronel, Jorge/0000-0002-4580-6716
   Ticona, Eduardo/0000-0002-6556-1082}},
Funding-Acknowledgement = {{NIH {[}5D43TW006581, 5R21AI094143-02, 5D43TW009349-03]; Grand Challenges
   Canada {[}0539-01-10]; Wellcome Trust {[}078067/Z/05/Z, 105788/Z/14/Z,
   201251/Z/16/Z]; Imperial College Biomedical Research Centre; Joint
   Global Health Trials {[}MR/K007467/1]; Bill \& Melinda Gates Foundation
   {[}OPP1118545]; Innovation for Health And Development funding; Bill \&
   Melinda Gates Foundation - Grand Challenges Explorations Initiative
   {[}OPP1118545]; Medical Research Council {[}MR/K007467/1]}},
Funding-Text = {{This work was supported by the NIH (5D43TW006581, 5R21AI094143-02, and
   5D43TW009349-03) and Grand Challenges Canada (0539-01-10). Contributions
   by coauthors were funded as follows: Wellcome Trust (award numbers
   078067/Z/05/Z to D. A. J. M., 105788/Z/14/Z and 201251/Z/16/Z to S. D.
   and C. A. E.); Imperial College Biomedical Research Centre to S. D., J.
   S. F., and C. A. E.; Joint Global Health Trials (award number
   MR/K007467/1 to S. D., C. A. E., and R. H. G.); Bill \& Melinda Gates
   Foundation (OPP1118545 to S. D. and C. A. E.); Innovation for Health And
   Development funding (to C. A. E.).}},
Cited-References = {{{*}AM THOR SOC, 2005, AM J RESP CRIT CARE, V172, P1169, DOI DOI 10.1164/RCCM.2508001.CI.
   Bark CM, 2011, TUBERCULOSIS, V91, P601, DOI 10.1016/j.tube.2011.05.007.
   Barry Samantha J, 2006, Cough, V2, P8, DOI 10.1186/1745-9974-2-8.
   Boulet LP, 2015, CHEST, V147, P804, DOI 10.1378/chest.14-2506.
   Breen RAM, 2008, INT J TUBERC LUNG D, V12, P44.
   Carroll NM, 2008, TUBERCULOSIS, V88, P624, DOI 10.1016/j.tube.2008.03.003.
   Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203.
   Datta S, 2015, CLIN INFECT DIS, V60, P1186, DOI 10.1093/cid/ciu1153.
   Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834.
   Diacon AH, 2014, EXPERT REV ANTI-INFE, V12, P223, DOI 10.1586/14787210.2014.870884.
   Diacon AH, 2014, TUBERCULOSIS, V94, P148, DOI 10.1016/j.tube.2013.12.002.
   Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188.
   Fan J, 2014, J ACOUST SOC AM, V135, P2268.
   Fitzwater SP, 2010, CLIN INFECT DIS, V51, P371, DOI 10.1086/655127.
   Hales Craig M, 2013, Ann Am Thorac Soc, V10, P18, DOI 10.1513/AnnalsATS.201207-038OC.
   JINDANI A, 1980, AM REV RESPIR DIS, V121, P939.
   Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC.
   Jones-Lopez EC, 2016, CLIN INFECT DIS, V63, P10, DOI 10.1093/cid/ciw199.
   Larson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046229.
   Lee KK, 2012, CHEST, V142, P1237, DOI 10.1378/chest.11-3309.
   Lee KK, 2010, LUNG, V188, pS91, DOI 10.1007/s00408-009-9176-0.
   LOUDON RG, 1969, AM REV RESPIR DIS, V99, P109.
   LOUDON RG, 1968, AM REV RESPIR DIS, V98, P297.
   Matos S, 2006, IEEE T BIO-MED ENG, V53, P1078, DOI 10.1109/TBME.2006.873548.
   Moore DAJ, 2004, J CLIN MICROBIOL, V42, P4432, DOI 10.1128/JCM.42.10.4432-4437.2004.
   Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524.
   National Institute for Health and Clinical Excellence, 2011, TUB CLIN DIAGN MAN T.
   Panlilio Adelisa L., 2005, Morbidity and Mortality Weekly Report, V54, P1.
   Proano A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010365.
   Ramos ES, 2016, 47 WORLD C LUNG HLTH, pS351.
   RILEY RL, 1989, AM REV RESPIR DIS, V139, P1286, DOI 10.1164/ajrccm/139.5.1286.
   ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2.
   Sumner H, 2013, AM J RESP CRIT CARE, V187, P943, DOI 10.1164/rccm.201211-2000OC.
   Ticona E, 2016, EUR RESPIR J, V47, P330, DOI 10.1183/13993003.00877-2015.
   Tracey BH, 2011, IEEE ENG MED BIO, P6017, DOI 10.1109/IEMBS.2011.6091487.
   Turner RD, 2015, J INFECT DIS, V211, P1367, DOI 10.1093/infdis/jiu625.
   Vizel Eldad, 2010, Cough, V6, P3, DOI 10.1186/1745-9974-6-3.
   World Health Organization, 2016, GLOB TUB REP 2016.
   World Health Organization, 2001, INT J TUBERC LUNG D, V5, P213.
   Yousaf N, 2013, EUR RESPIR J, V41, P241, DOI 10.1183/09031936.00089312.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{8}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{Clin. Infect. Dis.}},
Doc-Delivery-Number = {{ES2SB}},
Unique-ID = {{ISI:000399377100005}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000398651000043,
Author = {Dohmen, Wietske and Schmitt, Heike and Bonten, Marc and Heederik, Dick},
Title = {{Air exposure as a possible route for ESBL in pig farmers}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2017}},
Volume = {{155}},
Pages = {{359-364}},
Month = {{MAY}},
Abstract = {{Livestock can carry extended-spectrum beta-lactamase (ESBL)-producing
   Enterobacteriaceae, with blac being most prevalent. ESBL carriage in
   farmers is associated with ESBL carriage in animals, with direct animal
   human contact considered as the dominant route of transmission. However,
   inhalation of stable air might represent another route of transmission.
   We, therefore, quantified presence of bla(CTX-M) group 1 genes
   (CTX-Mgrl) in dust and the association with CTX-M-grl carriage in pig
   farmers, family members and employees. We included 131 people living
   and/or working on 32 conventional Dutch pig production farms (farmers,
   family members and employees) during two sampling moments over a 12
   -month interval. Human stool samples, rectal swabs from 60 pigs per
   farm, and 2-5 dust samples collected using an electrostatic dust
   collector (EDC) (as a proxy for presence of viable CTX-M-grl carrying
   bacteria in air) were obtained per farm. Presence of ESBLproducing
   Escherichia Coli (E. colt) in stool samples and rectal swabs was
   determined by selective plating and CTX-M-grl was identified by PCR.
   Dust samples were analyzed directly by PCR for presence of CTX-M-grl.
   Questionnaires were used to collect information on nature, intensity and
   duration of animal contact. Overall human prevalence of CIX-M-grl
   carriage was 3.6\%. CTX-M-grl was detected in dust on 26\% of the farms
   and in pigs on 35\% of the farms, on at least one sampling moment. Human
   CTX-M-grl carriage and presence of CIX-M-grl in dust were associated
   univariately (OR=12.4, 95\% CI=2.7-57.1). In multivariate analysis human
   CTX-M-grl carriage was associated with the number of working hours per
   week (OR=1.03, 95\% CI=1.00-1.06), presence of CTX-M-grl carrying pigs
   on the farm (OR=7.4, 95\% CI=1.1-49.7) and presence of CTX-M-grl in dust
   (OR=3.5, 95\% CI=0.6-20.9). These results leave open the possibility of
   airborne CTX-M-grl transmission from animals to humans next to direct
   contact.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dohmen, W (Reprint Author), Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands.
   Dohmen, Wietske; Schmitt, Heike; Heederik, Dick, Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands.
   Bonten, Marc, Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.}},
DOI = {{10.1016/j.envres.2017.03.002}},
ISSN = {{0013-9351}},
EISSN = {{1096-0953}},
Keywords = {{Antimicrobial resistance; Airborne transmission; Pig farmers;
   Extended-spectrum beta-lactamase; Zoonosis}},
Keywords-Plus = {{ESCHERICHIA-COLI; RISK-FACTORS; ENTEROBACTERIACEAE; ENDOTOXINS;
   PREVALENCE; RESISTANCE; LIVESTOCK; CARRIAGE; DUST}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{w.dohmen@uu.nl}},
Funding-Acknowledgement = {{Senter Novem {[}FND07003]; Product Boards for Livestock and Meat
   {[}13.31.001]; Netherlands Organization for Research and Development
   ZonMw {[}50-51700-98-053]}},
Funding-Text = {{This work was supported by Senter Novem (Contract no. FND07003); Product
   Boards for Livestock and Meat (Contract no. 13.31.001); Netherlands
   Organization for Research and Development ZonMw (Contract no.
   50-51700-98-053)., Funding sources had no involvement other than
   financial support of this research.}},
Cited-References = {{Bos MEH, 2016, J EXPO SCI ENV EPID, V26, P263, DOI 10.1038/jes.2014.85.
   Dahms C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143326.
   de Been M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004776.
   Dohmen W, 2015, CLIN MICROBIOL INFEC, V21, P917, DOI 10.1016/j.cmi.2015.05.032.
   Dorado-Garcia A, 2015, EMERG INFECT DIS, V21, P950, DOI 10.3201/eid2106.140706.
   Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x.
   Fischer J, 2016, EPIDEMIOL INFECT, V144, P686, DOI 10.1017/S0950268815001776.
   Garcia-Cobos S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134533.
   Hammerum AM, 2014, J ANTIMICROB CHEMOTH, V69, P2650, DOI 10.1093/jac/dku180.
   Hering J, 2014, PREV VET MED, V116, P129, DOI 10.1016/j.prevetmed.2014.06.014.
   Mesa RJ, 2006, J ANTIMICROB CHEMOTH, V58, P211, DOI 10.1093/jac/dkl211.
   Moodley A, 2009, ANTIMICROB AGENTS CH, V53, P1709, DOI 10.1128/AAC.01014-08.
   Noss I, 2008, APPL ENVIRON MICROB, V74, P5621, DOI 10.1128/AEM.00619-08.
   Paauw A, 2006, EMERG INFECT DIS, V12, P807.
   PRELLER L, 1995, OCCUP ENVIRON MED, V52, P654, DOI 10.1136/oem.52.10.654.
   Reuland EA, 2016, J ANTIMICROB CHEMOTH, V71, P1076, DOI 10.1093/jac/dkv441.
   Schmithausen RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138173.
   Spaan S, 2006, J ENVIRON MONITOR, V8, P63, DOI 10.1039/b509838f.
   von Salviati C, 2015, VET MICROBIOL, V175, P77, DOI 10.1016/j.vetmic.2014.10.010.
   Wielders CCH, 2017, CLIN MICROBIOL INFEC, V23.
   Xu L, 2005, J MED MICROBIOL, V54, P1183, DOI 10.1099/jmm.0.46160-0.}},
Number-of-Cited-References = {{21}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{5}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{ER2VD}},
Unique-ID = {{ISI:000398651000043}},
DA = {{2018-08-13}},
}

@article{ ISI:000399070000001,
Author = {Solomon, Fithamlak Bisetegen and Wadilo, Fiseha Wada and Arota, Amsalu
   Amache and Abraham, Yishak Leka},
Title = {{Antibiotic resistant airborne bacteria and their multidrug resistance
   pattern at University teaching referral Hospital in South Ethiopia}},
Journal = {{ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS}},
Year = {{2017}},
Volume = {{16}},
Month = {{APR 12}},
Abstract = {{Background: Hospitals provide a reservoir of microorganisms, many of
   which are multi-resistant to antibiotics. Emergence of multi-drug
   resistant strains in a hospital environment, particularly in developing
   countries is an increasing problem to infection treatment. This study
   aims at assessing antibiotic resistant airborne bacterial isolates.
   Methods: A cross-sectional study was conducted at Wolaita Sodo
   university teaching and referral Hospital. Indoor air samples were
   collected by using passive air sampling method. Sample processing and
   antimicrobial susceptibility testing were done following standard
   bacteriological techniques. The data was analyzed using SPSS version 20.
   Results: Medically important bacterial pathogens, Coagulase negative
   staphylococci (29.6\%), Staphylococcus aureus (26.3\%), Enterococci
   species, Enterococcus faecalis and Enterococcus faecium (16.5\%),
   Acinetobacter species (9.5\%), Escherichia coli (5.8\%) and Pseudomonas
   aeruginosa (5.3\%) were isolated. Antibiotic resistance rate ranging
   from 7.5 to 87.5\% was detected for all isolates. Acinetobacter species
   showed a high rate of resistance for trimethoprim-sulfamethoxazole,
   gentamicin (78.2\%) and ciprofloxacin (82.6\%), 28 (38.9\%) of S. aureus
   isolates were meticillin resistant, and 7.5\% Enterococci isolates of
   were vancomycin resistant. 75.3\% of all bacterial pathogen were
   multi-drug resistant. Among them, 74.6\% were gram positive and 84\%
   were gram negative. Multi-drug resistance were observed among 84.6\% of
   P. aeruginosa, of 82.5\% Enterococcii, E. coli 78.6\%, S. aureus 76.6\%,
   and Coagulase negative staphylococci of 73.6\%.
   Conclusions: Indoor environment of the hospital was contaminated with
   airborne microbiotas, which are common cause of post-surgical site
   infection in the study area. Bacterial isolates were highly resistant to
   commonly used antibiotics with high multi-drug resistance percentage. So
   air quality of hospital environment, in restricted settings deserves
   attention, and requires long-term surveillance to protect both patients
   and healthcare workers.}},
Publisher = {{BMC}},
Address = {{CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Solomon, FB (Reprint Author), Wolaita Sodo Univ, Coll Hlth Sci, Sch Med, POB 138, Wolaita Sodo, Ethiopia.
   Solomon, Fithamlak Bisetegen; Wadilo, Fiseha Wada; Arota, Amsalu Amache; Abraham, Yishak Leka, Wolaita Sodo Univ, Coll Hlth Sci, Sch Med, POB 138, Wolaita Sodo, Ethiopia.}},
DOI = {{10.1186/s12941-017-0204-2}},
Article-Number = {{29}},
ISSN = {{1476-0711}},
Keywords = {{Airborne; Bacteria; Antibiotic; Resistance; Multi-drug resistance}},
Keywords-Plus = {{INFECTIONS; AIR}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{fitha2007@yahoo.com}},
Funding-Acknowledgement = {{Wolaita Sodo University}},
Funding-Text = {{The funding for this study was granted by Wolaita Sodo University. The
   funding body had no influence on study design, data collection, analysis
   and interpretation of data, writing of the manuscript and in the
   decision to submit the manuscript for publication.}},
Cited-References = {{Alireza A, 2012, IRAN J PATHOL, V7, P168.
   Anguzu J R, 2007, Afr Health Sci, V7, P148.
   {[}Anonymous], 2012, GUID PREV CONTR MULT.
   Asghar AH, 2009, SAUDI MED J, V30, P1017.
   Awoke D., 2011, LONGITUDINAL BACTERI, P1.
   Awosika S. A., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P465, DOI 10.1016/S2221-1691(12)60077-X.
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493.
   Bergey, 2014, MANUAL SYSTEMATIC BA, V1.
   CDC, ANTIBIOTIC RESISTANC.
   Centers for Disease Control and Prevention, 2003, GUID ENV INF CONTR H.
   Chemaly RF, 2014, THER ADV INFECT DIS, V2, P79, DOI 10.1177/2049936114543287.
   CLSI, 2014, M100S24 CLSI.
   Collee JG, 1989, PRACTICAL MED MICROB, P432.
   Davane M, 2014, J MICROBIOL INFECT D, V4, P42, DOI DOI 10.5799/AHINJS.02.2014.01.0124.
   Edosa K., 2015, BACTERIAL PROFILE AN, P1.
   Ekhaise F. O., 2010, World Journal of Agricultural Sciences, V6, P166.
   Frieden T., 2013, ANTIBIOTIC RESISTANC.
   Genet C, 2011, ETHIOP J HEALTH SCI, V21, P9.
   Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861.
   Huang PY, 2013, AEROSOL AIR QUAL RES, V13, P1060, DOI 10.4209/aaqr.2012.08.0217.
   Kirecci E, 2010, ETHIOP J HEALTH DEV, V24, P57.
   Lee TB, 1998, AM J INFECT CONTROL, V26, P277, DOI 10.1016/S0196-6553(98)80013-8.
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x.
   Mitiku M, 2015, AM J BIOMED LIFE SCI, V2, P40.
   Muhammad U. K., 2013, Journal of Microbiology and Biotechnology Research, V3, P139.
   Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007.
   Nunes ZG, 2005, MEM I OSWALDO CRUZ, V100, P351, DOI 10.1590/S0074-02762005000400003.
   Osaro EF, 2008, WJMS, V3, P34.
   Pasquarella C, 2000, J HOSP INFECT, V46, P241, DOI 10.1053/jhin.2000.0820.
   Pradhan SB, 2012, INT J INFECT MICROBI, V1, P76.
   Shiferaw T, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-39.
   Singh K, 2013, INNOV J MED HLTH SCI, V3, P62.
   SUZUKI A, 1984, J HYG-CAMBRIDGE, V93, P559, DOI 10.1017/S002217240006513X.
   Tayh G, 2011, RISK FACTORS ANTIMIC.
   Tewelde T, 2015, INT J PHARM SCI RES, V6, P1264.
   WHO, 2012, EV THREATS ANT RES O.
   Yagoub Sanaa O, 2010, Journal of Applied Sciences, V10, P1011.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{11}},
Journal-ISO = {{Ann. Clin. Microbiol. Antimicrob.}},
Doc-Delivery-Number = {{ER8LC}},
Unique-ID = {{ISI:000399070000001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000398903200003,
Author = {Bahi, Gnogbo Alexis and Boyvin, Lydie and Meite, Souleymane and M'Boh,
   Gervais Melaine and Yeo, Kadjowely and N'Guessan, Kouassi Raymond and
   Bidie, Alain Dit Philippe and Djaman, Allico Joseph},
Title = {{Assessments of serum copper and zinc concentration, and the Cu/Zn ratio
   determination in patients with multidrug resistant pulmonary
   tuberculosis (MDR-TB) in Cote d'Ivoire}},
Journal = {{BMC INFECTIOUS DISEASES}},
Year = {{2017}},
Volume = {{17}},
Month = {{APR 11}},
Abstract = {{Background: In Cote d'Ivoire, multidrug-resistant tuberculosis (MDR-TB)
   is a serious public health problem with a prevalence estimated at 2.5\%
   in 2006. Zinc and copper are essential Trace element needed to
   strengthen the immune system and also useful in the fight against
   tuberculosis. The Cu / Zn ratio is a good indicator of oxidative stress.
   The principal aim of this study was to evaluate the serum concentration
   of some trace element and determine the Cu / Zn ratio in patients with
   multidrug resistant pulmonary tuberculosis (MDR-TB) before and after
   second line treatment of TB.
   Methods: Blood samples were obtained from 100 MDR-TB patients after
   confirmation of their status through the microscopic and molecular
   diagnosis of resistance to Isoniazid and Rifampicin by GeneXpert. The
   concentration level of zinc and copper were determined using flame air /
   acetylene atomic absorption spectrometer (AAS) Type Varian Spectr AA-20
   Victoria, Australlia.
   Results: A significant decrease in zinc levels (P < 0.05) and an
   increased Cu / Zn ratio (P < 0.05) was observed in MDR-TB patients
   compared to controls TB free. During treatment a significant reduction
   in Cu / Zn ratio (P < 0.05) was observed compared to the initial result.
   Conclusions: The decrease in serum zinc level and the high Cu / Zn ratio
   could explain the immune system dysfunction and the high level of
   oxidative stress in patients with MDR-TB. Therefore the evaluation of
   the zinc and copper status could represent essential parameters in
   monitoring of TB second line treatment for better treatment management.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Meite, S (Reprint Author), Pasteur Inst Cote Ivoire IPCI, Dept Clin \& Fondamental Biochem, 01 BP 490, Abidjan 01, Cote Ivoire.
   Bahi, Gnogbo Alexis; Boyvin, Lydie; Meite, Souleymane; M'Boh, Gervais Melaine; Yeo, Kadjowely; N'Guessan, Kouassi Raymond; Djaman, Allico Joseph, Pasteur Inst Cote Ivoire IPCI, Dept Clin \& Fondamental Biochem, 01 BP 490, Abidjan 01, Cote Ivoire.
   Bahi, Gnogbo Alexis; Yeo, Kadjowely; Bidie, Alain Dit Philippe; Djaman, Allico Joseph, Univ FelixHouphouet Boigny UFHB, Pharmacodynam Lab Biochem, 01 BP V34, Abidjan 01, Cote Ivoire.}},
DOI = {{10.1186/s12879-017-2343-7}},
Article-Number = {{257}},
ISSN = {{1471-2334}},
Keywords = {{Abidjan; Trace elements; Cu/Zn Ratio; MDR-TB; Second-line anti-TB drugs}},
Keywords-Plus = {{TRACE-ELEMENTS}},
Research-Areas = {{Infectious Diseases}},
Web-of-Science-Categories  = {{Infectious Diseases}},
Author-Email = {{Souley\_ci@yahoo.fr}},
Funding-Acknowledgement = {{Pasteur Institute of Cote d'Ivoire}},
Funding-Text = {{The Pasteur Institute of Cote d'Ivoire financed this research project.}},
Cited-References = {{Ananda SP, 2009, CLIN NUTR METABOLIC, V12, P646.
   Anonyme, 2012, PROGRAMME NATL LUTTE, P65.
   Anuraj HS, 1998, AM J CLIN NUTR, V68, P447.
   Aouam K, 2007, MED MALADIES INFECT, V37, P253, DOI 10.1016/j.medmal.2006.12.006.
   Banjoko SO, IRON STATUS HIV 1 IN.
   Chan TYK, 1997, CALCIFIED TISSUE INT, V60, P91, DOI 10.1007/s002239900192.
   Ciftci TU, 2003, BIOL TRACE ELEM RES, V95, P65, DOI 10.1385/BTER:95:1:65.
   Edem VF, 2016, EGYPT J CHEST DIS TU, V65, P441, DOI 10.1016/j.ejcdt.2016.02.001.
   Edem VF, 2015, EGYPT J CHEST DIS TU, V64, P675, DOI 10.1016/j.ejcdt.2015.03.031.
   Gupta A, 2012, IMMUNOBIOLOGY, V217, P363, DOI 10.1016/j.imbio.2011.07.008.
   Karyadi E, 2002, AM J CLIN NUTR, V75, P720.
   Kassu A, 2006, EUR J CLIN NUTR, V60, P580, DOI 10.1038/sj.ejcn.1602352.
   Kolia KI, 2014, INT J BIOCH REREV, V4, P527.
   M'boh GM, 2012, INT J CHILD HLTH NUT, V2, P29.
   Mobaien A, 2012, IRAN J CLIN INFECT D, V5, P96.
   Munoz C, 2007, BRIT J NUTR, V98, pS24, DOI 10.1017/S0007114507833046.
   Pinta M., 1980, SPECTROMETRY ABSOPTI, P696.
   Rajendra P, 2012, KUWAIT MED J, V44, P183.
   Wintergerst ES, 2007, ANN NUTR METAB, V51, P301, DOI 10.1159/000107673.
   World Health Organization, 2015, GLOB TUB REP.
   World Health Organization, 2011, POL STAT AUT REAL TI.}},
Number-of-Cited-References = {{21}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{8}},
Journal-ISO = {{BMC Infect. Dis.}},
Doc-Delivery-Number = {{ER6GK}},
Unique-ID = {{ISI:000398903200003}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000430569100795,
Author = {Palencia, Cristina Echeverria and Jay, Jennifer and Thulsiraj, Vanessa
   and Nghi Tran and Ericksen, Cody and Melendez, Isabel and Sanchez,
   Michael and Walpert, Devin and Yuan, Tony and Ficara, Elizabeth and
   Senthilkumar, Niru and Hernandez-Cira, Marisol and Gamboa, Demi and
   Haro, Heather and Paulson, Suzanne and Zhu, Yifang},
Title = {{Disparate antibiotic resistance gene levels revealed across four major
   cities in California: A survey in drinking water, air, and soil at 24
   public parks}},
Journal = {{ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY}},
Year = {{2017}},
Volume = {{253}},
Meeting = {{343}},
Month = {{APR 2}},
Note = {{253rd National Meeting of the American-Chemical-Society (ACS) on
   Advanced Materials, Technologies, Systems, and Processes, San Francisco,
   CA, APR 02-06, 2017}},
Organization = {{Amer Chem Soc}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Meeting Abstract}},
Language = {{English}},
Affiliation = {{Palencia, Cristina Echeverria; Thulsiraj, Vanessa; Senthilkumar, Niru; Hernandez-Cira, Marisol; Gamboa, Demi; Haro, Heather, Univ Calif Los Angeles, Civil \& Environm Engn, Los Angeles, CA USA.
   Nghi Tran; Ericksen, Cody; Melendez, Isabel; Sanchez, Michael; Walpert, Devin; Yuan, Tony; Ficara, Elizabeth; Paulson, Suzanne; Zhu, Yifang, Univ Calif Los Angeles, Inst Environm \& Sustainabil, Los Angeles, CA USA.}},
ISSN = {{0065-7727}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Multidisciplinary}},
Author-Email = {{criseche113@gmail.com}},
Number-of-Cited-References = {{0}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Abstr. Pap. Am. Chem. Soc.}},
Doc-Delivery-Number = {{GD5TH}},
Unique-ID = {{ISI:000430569100795}},
DA = {{2018-08-13}},
}

@article{ ISI:000414813000007,
Author = {Sarkar, Chinmoy and Webster, Chris},
Title = {{Urban environments and human health: current trends and future
   directions}},
Journal = {{CURRENT OPINION IN ENVIRONMENTAL SUSTAINABILITY}},
Year = {{2017}},
Volume = {{25}},
Pages = {{33-44}},
Month = {{APR}},
Abstract = {{In an era of rapid urbanization and significant demographic shifts,
   human health has emerged as a primary focus of sustainable development.
   According to the environmental model of public health, the environment
   is one of the first causes of disease, injury and mortality. In this
   paper we discuss the complexities involved in urban environment-human
   health interactions; provide an overview of the environmental
   determinants of health; and highlight future directions and challenges.
   A deeper understanding of the relationships between urban environment
   and human health will help devise effective preventive interventions
   towards minimizing/offsetting environmental risk exposures reducing
   resulting health burdens, lead to healthy lifestyle and behaviour and
   thereby fulfil the goals of sustainable development.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Sarkar, C (Reprint Author), Univ Hong Kong, Hlth High Dens Cities Lab, HKUrbanLab, Knowles Bldg,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.
   Sarkar, Chinmoy; Webster, Chris, Univ Hong Kong, Hlth High Dens Cities Lab, HKUrbanLab, Knowles Bldg,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.
   Webster, Chris, Univ Cambridge, Dept Land Econ, 19 Silver St, Cambridge CB3 9EP, England.}},
DOI = {{10.1016/j.cosust.2017.06.001}},
ISSN = {{1877-3435}},
EISSN = {{1877-3443}},
Keywords-Plus = {{LONG-TERM EXPOSURE; SUSTAINABLE DEVELOPMENT GOALS; PARTICULATE
   AIR-POLLUTION; BODY-MASS INDEX; BUILT ENVIRONMENT; PHYSICAL-ACTIVITY;
   MENTAL-HEALTH; PUBLIC-HEALTH; LAND-USE; ANTIMICROBIAL RESISTANCE}},
Research-Areas = {{Science \& Technology - Other Topics; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{GREEN \& SUSTAINABLE SCIENCE \& TECHNOLOGY; Environmental Sciences}},
Author-Email = {{csarkar@hku.hk}},
Funding-Acknowledgement = {{University of Hong Kong's URC PDF/RAP grant; HKUrbanLab, The University
   of Hong Kong's University Development Fund; UK Economic \& Social
   Research Council's Transformative Research grant {[}ES/L003201/1]; UK
   Biobank seed grant}},
Funding-Text = {{The study was funded by The University of Hong Kong's URC PDF/RAP grant;
   HKUrbanLab, The University of Hong Kong's University Development Fund;
   UK Economic \& Social Research Council's Transformative Research grant
   {[}ES/L003201/1]; and UK Biobank seed grant.}},
Cited-References = {{Allen N, 2012, HEALTH POLICY TECHN, V1, P123, DOI 10.1016/j.hlpt.2012.07.003.
   Almedom AM, 2005, SOC SCI MED, V61, P943, DOI 10.1016/j.socscimed.2004.12.025.
   Araya R, 2007, BRIT J PSYCHIAT, V190, P394, DOI 10.1192/bjp.bp.106.024596.
   Auchincloss AH, 2008, AM J EPIDEMIOL, V168, P1, DOI 10.1093/aje/kwn118.
   Babisch W, 2014, ENVIRON HEALTH PERSP, V122, P492, DOI 10.1289/ehp.1306981.
   Badland H, 2017, HEALTH PLACE, V43, P17, DOI 10.1016/j.healthplace.2016.11.003.
   Banks S, 2007, J CLIN SLEEP MED, V3, P519.
   Barrett AE, 2005, J HEALTH SOC BEHAV, V46, P156, DOI 10.1177/002214650504600203.
   Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367.
   Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X.
   Bayer-Oglesby L, 2006, AM J EPIDEMIOL, V164, P1190, DOI 10.1093/aje/kwj338.
   Bernard P, 2007, SOC SCI MED, V65, P1839, DOI 10.1016/j.socscimed.2007.05.037.
   Brownson RC, 2006, ANNU REV PUBL HEALTH, V27, P341, DOI 10.1146/annurev.publhealth.27.021405.102137.
   Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005.
   Campbell CA, 2009, AM J PREV MED, V37, P556, DOI 10.1016/j.amepre.2009.09.028.
   Chokshi DA, 2012, NEW ENGL J MED, V367, P295, DOI 10.1056/NEJMp1206268.
   Cobb LK, 2015, OBESITY, V23, P1331, DOI 10.1002/oby.21118.
   Coburn D, 2004, SOC SCI MED, V58, P41, DOI 10.1016/S0277-9536(03)00159-X.
   Cohen DA, 2006, SOC SCI MED, V62, P769, DOI 10.1016/j.socscimed.2005.06.033.
   Cohen DA, 2003, AM J PUBLIC HEALTH, V93, P467, DOI 10.2105/AJPH.93.3.467.
   Cohen DA, 2008, HEALTH PLACE, V14, P198, DOI 10.1016/j.healthplace.2007.06.001.
   Corburn J, 2009, URBAN STUD, V46, P413, DOI 10.1177/0042098008099361.
   Craig P, 2012, J EPIDEMIOL COMMUN H.
   Cummins S, 2007, SOC SCI MED, V65, P1825, DOI 10.1016/j.socscimed.2007.05.036.
   Dales R, 2008, CAN MED ASSOC J, V179, P147, DOI {[}10.1503/cmaj.070359, 10.1053/cmaj.070359].
   Darby S, 2005, BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63.
   Dora C, 2015, LANCET, V385, P380, DOI 10.1016/S0140-6736(14)60605-X.
   Dumbaugh E, 2009, J AM PLANN ASSOC, V75, P309, DOI 10.1080/01944360902950349.
   Dye C, 2008, SCIENCE, V319, P766, DOI 10.1126/science.1150198.
   Elliott P, 2009, OCCUP ENVIRON MED, V66, P81, DOI 10.1136/oem.2007.038497.
   EU, 2007, TOG HLTH STRAT APPR.
   Evans GW, 2003, J URBAN HEALTH, V80, P536, DOI 10.1093/jurban/jtg063.
   Ewing R, 2003, AM J HEALTH PROMOT, V18, P47, DOI 10.4278/0890-1171-18.1.47.
   Ewing R, 2001, TRANSPORT RES REC, P87.
   Ewing R, 2009, J PLAN LIT, V23, P347, DOI 10.1177/0885412209335553.
   Feychting M, 2005, ANNU REV PUBL HEALTH, V26, P165, DOI 10.1146/annurev.publhealth.26.021304.144445.
   Forastiere Francesco, 2009, ENV HLTH, V8, P1.
   Frank LD, 2006, J AM PLANN ASSOC, V72, P75, DOI 10.1080/01944360608976725.
   Frumkin H., 2004, URBAN SPRAWL PUBLIC.
   Fullerton DG, 2008, T ROY SOC TROP MED H, V102, P843, DOI 10.1016/j.trstmh.2008.05.028.
   Galea S, 2005, J EPIDEMIOL COMMUN H, V59, P822, DOI 10.1136/jech.2005.033084.
   Galea S, 2010, INT J EPIDEMIOL, V39, P97, DOI 10.1093/ije/dyp296.
   Galea S, 2009, INT J DRUG POLICY, V20, P209, DOI 10.1016/j.drugpo.2008.08.005.
   Gascon M, 2015, INT J ENV RES PUB HE, V12, P4354, DOI 10.3390/ijerph120404354.
   Giles-Corti B, 2016, LANCET, V388, P2912, DOI 10.1016/S0140-6736(16)30066-6.
   Glouberman S, 2006, J URBAN HEALTH, V83, P325, DOI 10.1007/s11524-006-9034-9.
   Goggins WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038551.
   Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058.
   Grahn Patrik, 2003, Urban Forestry \& Urban Greening, V2, P001, DOI 10.1078/1618-8667-00019.
   Griggs D, 2013, NATURE, V495, P305, DOI 10.1038/495305a.
   Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0.
   Gundersen H, 2013, ARCH ENVIRON OCCUP H, V68, P153, DOI 10.1080/19338244.2012.676103.
   Halonen JI, 2015, PREV MED, V73, P10, DOI 10.1016/j.ypmed.2015.01.012.
   Halpern D, 1995, MENTAL HLTH BUILT EN.
   Harris MH, 2015, ENVIRON HEALTH PERSP, V123, P1072, DOI 10.1289/ehp.1408803.
   Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3.
   Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443.
   Haskell WL, 2007, CIRCULATION, V116, P1081, DOI 10.1161/CIRCULATIONAHA.107.185649.
   Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2.
   Hoek G, 2013, ENV HLTH, V12, P1, DOI DOI 10.1186/1476-069X-12-43.
   Howden-Chapman P, 2004, J EPIDEMIOL COMMUN H, V58, P162, DOI 10.1136/jech.2003.011569.
   Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578.
   ICSU, 2012, REP ICSU PLANN GROUP.
   {[}ISSC ICSU], 2015, REV LARG SUST DEV GO.
   Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032.
   Jerrett M, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-49.
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536.
   Kaczynski AT, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0146-4.
   Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012.
   Kawachi I, 2002, J EPIDEMIOL COMMUN H, V56, P647, DOI 10.1136/jech.56.9.647.
   Kawachi I, 2000, SOCIAL EPIDEMIOLOGY, P174.
   Kettleson EM, 2015, ENVIRON RES, V138, P130, DOI 10.1016/j.envres.2015.02.003.
   Kim D, 2006, SOC SCI MED, V63, P1045, DOI 10.1016/j.socscimed.2006.02.017.
   Kim KH, 2013, ENVIRON INT, V59, P41, DOI 10.1016/j.envint.2013.05.007.
   Knittel CR, 2016, REV ECON STAT, V98, P350, DOI 10.1162/REST\_a\_00548.
   Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843.
   Kovats S, 2014, LANCET, V383, P757, DOI 10.1016/S0140-6736(13)62700-2.
   KRIEGER N, 1994, SOC SCI MED, V39, P887, DOI 10.1016/0277-9536(94)90202-X.
   Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668.
   Kuh D, 2004, LIFE COURSE APPROACH.
   Kweon BS, 1998, ENVIRON BEHAV, V30, P832, DOI 10.1177/001391659803000605.
   Lawlor DA, 2005, AM J PUBLIC HEALTH, V95, P91, DOI 10.2105/AJPH.2003.035592.
   Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529.
   Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9.
   Leal C, 2011, OBES REV, V12, P217, DOI 10.1111/j.1467-789X.2010.00726.x.
   Leaning J, 2013, NEW ENGL J MED, V369, P1836, DOI 10.1056/NEJMra1109877.
   Lee ACK, 2011, J PUBLIC HEALTH-UK, V33, P212, DOI 10.1093/pubmed/fdq068.
   Lee C, 2006, TRANSPORT RES D-TR E, V11, P204, DOI 10.1016/j.trd.2006.02.003.
   Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371.
   Leyden KM, 2003, AM J PUBLIC HEALTH, V93, P1546, DOI 10.2105/AJPH.93.9.1546.
   Lim YH, 2012, ENVIRON HEALTH PERSP, V120, P1023, DOI 10.1289/ehp.1104100.
   Lin RT, 2007, LANCET, V369, P844, DOI 10.1016/S0140-6736(07)60412-7.
   Liu L, 2008, CURR ISSUES MOL BIOL, V10, P25.
   Lorenc T, 2012, HEALTH PLACE, V18, P757, DOI 10.1016/j.healthplace.2012.04.001.
   Lovasi GS, 2008, J EPIDEMIOL COMMUN H, V62, P647, DOI 10.1136/jech.2007.071894.
   Lovasi GS, 2011, J URBAN HEALTH, V88, P1143, DOI 10.1007/s11524-011-9604-3.
   Lovasi GS, 2009, EPIDEMIOL REV.
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(10)61257-3.
   Lu Y, 2016, J TRANSPORT HLTH.
   Lund H, 2002, J PLAN EDUC RES, V21, P301, DOI 10.1177/0739456X0202100307.
   Macintyre S, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/14795868-4-32.
   Manolio TA, 2012, AM J EPIDEMIOL, V175, P859, DOI 10.1093/aje/kwr453.
   Materia E, 2005, J EPIDEMIOL COMMUN H, V59, P534, DOI 10.1136/jech.2004.030619.
   McCarthy MP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042845.
   McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125.
   McMichael AJ, 1999, AM J EPIDEMIOL, V149, P887.
   McMichael C, 2012, ENVIRON HEALTH PERSP, V120, P646, DOI 10.1289/ehp.1104375.
   Mitchell R, 2008, LANCET, V372, P1655, DOI 10.1016/S0140-6736(08)61689-X.
   Mobley LR, 2006, AM J PREV MED, V30, P327, DOI 10.1016/j.amepre.2005.12.001.
   Monrad M, 2017, ENVIRON HEALTH PERSP, V125, P422, DOI 10.1289/EHP392.
   Moonen P, 2012, FRONT ARCHIT RES, V1, P197, DOI 10.1016/j.foar.2012.05.002.
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759.
   Mueller N, 2017, ENVIRON HEALTH PERSP, V125, P89, DOI 10.1289/EHP220.
   Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931.
   Naujokas MF, 2013, ENVIRON HEALTH PERSP, V121, P295, DOI 10.1289/ehp.1205875.
   Ozsvath David L., 2009, Reviews in Environmental Science and Bio/Technology, V8, P59, DOI 10.1007/s11157-008-9136-9.
   Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009.
   Paravantis J, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9040606.
   Park M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128460.
   Pearce N, 2006, INT J EPIDEMIOL, V35, P515, DOI 10.1093/ije/dyi322.
   Pereira G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-49.
   Pereira G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-466.
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132.
   Popova S, 2009, ALCOHOL ALCOHOLISM, V44, P500, DOI 10.1093/alcalc/agp054.
   Prince M, 2015, INT ASD WORLD ALZHEI.
   Pruss-ustun A., 2016, PREVENTING DIS HLTH.
   Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7.
   Roca I., 2015, New Microbes and New Infections, V6, P22, DOI 10.1016/j.nmni.2015.02.007.
   ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32.
   Rothon C, 2012, SOC PSYCH PSYCH EPID, V47, P697, DOI 10.1007/s00127-011-0391-7.
   Rundle A, 2007, AM J HEALTH PROMOT, V21, P326, DOI 10.4278/0890-1171-21.4s.326.
   Rydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8.
   Sachs JD, 2012, LANCET, V379, P2206, DOI 10.1016/S0140-6736(12)60685-0.
   Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI {[}10.1249/MSS.0b013e31817e67a4, 10.1249/MSS.0b013e31817c67a4].
   Sallis JF, 2016, LANCET, V388, P2936, DOI 10.1016/S0140-6736(16)30068-X.
   Sallis JF, 2012, CIRCULATION, V125, P729, DOI 10.1161/CIRCULATIONAHA.110.969022.
   Sarkar C., 2014, HLTH CITIES PUBLIC H.
   Sarkar C., 2015, ANN GIS, V21, P135.
   Sarkar C, 2017, ENVIRON INT, V106, P1, DOI 10.1016/j.envint.2017.05.016.
   Sarkar C, 2017, J URBAN HEALTH, V94, P4, DOI 10.1007/s11524-016-0122-1.
   Sarkar C, 2015, LANDSCAPE URBAN PLAN, V143, P112, DOI 10.1016/j.landurbplan.2015.06.013.
   Sarkar C, 2013, HEALTH PLACE, V19, P33, DOI 10.1016/j.healthplace.2012.10.001.
   Schwarzenbach RP, 2010, ANNU REV ENV RESOUR, V35, P109, DOI 10.1146/annurev-environ-100809-125342.
   Sclar ED, 2005, LANCET, V365, P901, DOI 10.1016/S0140-6736(05)71049-7.
   Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904.
   Soltero EG, 2015, PREV MED, V72, P44, DOI 10.1016/j.ypmed.2014.12.030.
   Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050.
   Stevenson M, 2016, LANCET, V388, P2925, DOI 10.1016/S0140-6736(16)30067-8.
   Sullivan WC, 2004, ENVIRON BEHAV, V36, P678, DOI 10.1177/0193841x04264945.
   Susser M, 1996, AM J PUBLIC HEALTH, V86, P674, DOI 10.2105/AJPH.86.5.674.
   Takano T, 2002, J EPIDEMIOL COMMUN H, V56, P913, DOI 10.1136/jech.56.12.913.
   Tan JG, 2010, INT J BIOMETEOROL, V54, P75, DOI 10.1007/s00484-009-0256-x.
   Theorell T, 2016, EUR J PUBLIC HEALTH.
   Thompson CW, 2012, LANDSCAPE URBAN PLAN, V105, P221, DOI 10.1016/j.landurbplan.2011.12.015.
   Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003.
   US Department of Health, 2006, HLTH CONS INV EXP TO.
   US Department of Health and Human Services, 2014, HLTH CONSMOK 50 YE.
   van Kempen E, 2012, J HYPERTENS, V30, P1075, DOI 10.1097/HJH.0b013e328352ac54.
   Vineis P, 2005, CARCINOGENESIS, V26, P1846, DOI 10.1093/carcin/bgi216.
   Vlahov D, 2007, J URBAN HEALTH, V84, pI16, DOI 10.1007/s11524-007-9169-3.
   Volker S, 2011, INT J HYG ENVIR HEAL, V214, P449, DOI 10.1016/j.ijheh.2011.05.001.
   Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539.
   Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6.
   Wheeler BW, 2012, HEALTH PLACE, V18, P1198, DOI 10.1016/j.healthplace.2012.06.015.
   White M, 2007, OBES REV, V8, P99, DOI 10.1111/j.1467-789X.2007.00327.x.
   White M, 2010, J ENVIRON PSYCHOL, V30, P482, DOI 10.1016/j.jenvp.2010.04.004.
   WHO, 1997, HLTH ENV SUST DEV 5.
   WHO, 2003, DIET NUTR PREV CHRON.
   Woo J, 2009, LANCET, V373, P299, DOI 10.1016/S0140-6736(09)60094-5.
   Zauderer C, 2015, MENTAL HLTH PRACTICE, V18, P21.
   Zhang JF, 2003, BRIT MED BULL, V68, P209, DOI 10.1093/bmb/ldg029.
   Zhang K, 2013, SCI TOTAL ENVIRON, V450, P307, DOI 10.1016/j.scitotenv.2013.01.074.
   Zimring C, 2005, AM J PREV MED, V28, P186, DOI 10.1016/j.amepre.2004.10.025.}},
Number-of-Cited-References = {{173}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{8}},
Usage-Count-Since-2013 = {{22}},
Journal-ISO = {{Curr. Opin. Environ. Sustain.}},
Doc-Delivery-Number = {{FM2KG}},
Unique-ID = {{ISI:000414813000007}},
DA = {{2018-08-13}},
}

@article{ ISI:000411474500034,
Author = {Muhammad, Amir and Kaleemullah and Shafee, Muhammad and Khan, Shireen
   and Hajira, Bibi and Ashraf, Mohammad and Nabi, Sajid and Tahira, Bibi
   and Umar, Muhammad},
Title = {{FREQUENCY OF RIFAMPICIN RESISTANCE AND SMEAR CONVERSION IN CATEGORY 11
   TUBERCULOSIS PATIENTS USING GENEXPERT ASSAY IN QUETTA, PAKISTAN}},
Journal = {{INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES}},
Year = {{2017}},
Volume = {{4}},
Number = {{4}},
Pages = {{1004-1008}},
Month = {{APR}},
Abstract = {{Background: Pulmonary tuberculosis is highly contagious disease commonly
   transmitted through air droplets and is a global public health concern.
   Almost one third of world population is infected tuberculosis and in
   last 2-3 decades the resurgence of drug resistance have posed serious
   threat over the globe. This study was aimed to evaluate RIF resistance
   in category II TB patients. Methods: A total of 100 sputum samples were
   collected from category ii (relapse, loss of follow up, failure,
   interrupted) TB patients visiting Fatima Jinnah Chest Hospital Brewery
   Road Quetta. All the samples were examined through GeneXpert MTB/RIF
   assay and other relevant information were collected from patients using
   predesigned questionnaire.
   Results: About 23 patients were found RIF resistant with 7/23 (30 \%)
   male and 16/23 (70\%) female. While, 5 (21.7 \%) patients from 15-34
   year age group converted to smear negative in first month of treatment.
   Likewise, in second month 3/23(13\%) patients in 15-54 years, followed
   by 5/23 (21.7\%) in third month in 15-64 years and in fourth month 3/23
   (13\%) patients were seroconverted in 15-24 years age group. Similarly,
   in fifth month 4/23 (17.4\%) patients were converted in the age 35-65
   Years followed by seventh month 1/23 (4.3\%) in, 15-24 years age group.
   while 2 (8.7\%) in the age 25-34 were died.
   Conclusion: Higher prevalence of RIF resistance in category II TB
   patients and sero-conversion was found in 1534 years age group.}},
Publisher = {{SSJ COLL PHARMACY-SSJCP}},
Address = {{125B-125 SANTRANJIPURA, TLIPHONE EXCHANGE RD, NAGPUR, 440001, INDIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kaleemullah (Reprint Author), Univ Balochistan, Dept Microbiol, Quetta, Pakistan.
   Muhammad, Amir; Kaleemullah; Hajira, Bibi; Nabi, Sajid; Tahira, Bibi, Univ Balochistan, Dept Microbiol, Quetta, Pakistan.
   Khan, Shireen; Ashraf, Mohammad; Umar, Muhammad, Fatima Jinnah TB Hosp, Quetta, Pakistan.
   Shafee, Muhammad, Univ Balochistan, Ctr Adv Studies Vaccinol \& Biotechnol, Quetta, Pakistan.}},
DOI = {{10.5281/zenodo.572351}},
ISSN = {{2349-7750}},
Keywords = {{Tuberculosis; geneXpert MTB/RIF; rpoB gene; Sputum smear conversion}},
Keywords-Plus = {{POSITIVE PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS;
   IDENTIFICATION}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Chemistry, Medicinal}},
Author-Email = {{kaleemullah@um.uob.edu.pk}},
Cited-References = {{Alix E, 2006, J CLIN MICROBIOL, V44, P2093, DOI 10.1128/JCM.00278-06.
   Bawri S, 2008, LUNG INDIA, V25, P118, DOI 10.4103/0970-2113.44122.
   Bouti K, 2013, ISRN PULMONOL, P1, DOI {[}10.1155/2013/486507, DOI 10.1155/2013/486507].
   Ejaz M, 2010, T ROY SOC TROP MED H, V104, P511, DOI 10.1016/j.trstmh.2010.03.005.
   El-Hajj HH, 2001, J CLIN MICROBIOL, V39, P4131, DOI 10.1128/JCM.39.11.4131-4137.2001.
   Ganguly J, 2015, J EVOL MED DENT SCI-, V4, P4762, DOI 10.14260/jemds/2015/692.
   Harkin TJ, 1995, TUBERCULOSIS, P843.
   Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426.
   Ibrahim M. K., 2002, CROAT MED J, V43, P245.
   Jawetz Melnick, 2010, TXB MED MICROBIOLOGY.
   Shafee M, 2014, PAK J MED SCI, V30, P36, DOI 10.12669/pjms.301.4129.
   Taimur S., 2009, JPMA, V89, P107.
   Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614.}},
Number-of-Cited-References = {{13}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Indo Am. J. Pharm. Sci.}},
Doc-Delivery-Number = {{FH8TM}},
Unique-ID = {{ISI:000411474500034}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000406871700016,
Author = {Park, Da-Eon and Yoon, In-Soo and Kim, Jung-Eun and Seo, Ji-Hye and Yoo,
   Jin-Cheol and Bae, Chun-Sik and Lee, Chang-Dai and Park, Dae-Hun and
   Cho, Seung-Sik},
Title = {{Antimicrobial and Anti-Inflammatory Effects of Ethanol Extract of
   Corylopsis coreana Uyeki Flos}},
Journal = {{PHARMACOGNOSY MAGAZINE}},
Year = {{2017}},
Volume = {{13}},
Number = {{50}},
Pages = {{286-292}},
Month = {{APR-JUN}},
Abstract = {{Background: Corylopsis coreana Uyeki (Hamamelidaceae) is a medicinal
   plant cultivated in Northeast Asia. Previously, we have reported that an
   ethanol extract of Corylopsis coreana Uyeki flos (ECCF) contains four
   active compounds with antioxidant activity. Objective: The aim of this
   study was to investigate the antimicrobial spectrum against infectious
   bacteria and anti-inflammatory effect of ECCF in a mouse model of acute
   local inflammation. Materials and Methods: In vitro antimicrobial
   susceptibility was evaluated using standard plate assay technique.
   Antimicrobial activities (minimum inhibitory concentration, MIC; mu
   g/mL) were determined with the serial dilution method. In vivo
   anti-inflammatory activity was studied using a mouse model of
   carrageenan-induced air pouch inflammation. Results: The ECCF showed
   antimicrobial activities against general bacteria and drug-resistant
   bacteria including Staphylococcus aureus, Micrococcus luteus ATCC 9341,
   Mycrobacterium smegmatis ATCC 9341, Mycrobacterium smegmatis ATCC 9341,
   Salmonella typhimrium KCTC 1925, and nine methicillin-resistant
   Staphylococcus aureus strains, with MIC values ranging from 250 to 1000
   mu g/mL. In in vivo mouse model, inflammatory morphologic changes
   observed in the air pouch membrane were restored to its normal condition
   by the ECCF treatment. Moreover, the ECCF significantly reduced exudate
   volumes, protein contents, inflammatory cell counts, and proinflammatory
   cytokine levels in the exudates recovered from air pouches of the mouse
   model. Flavonoids in the ECCF were found to contain bergenin,
   quercitrin, and quercetin with reported anti-inflammatory activity via
   suppressing tumornecrosis factor-alpha production. Conclusion: To the
   best of our knowledge, this is the first report to demonstrate the
   antimicrobial and anti-inflammatory activities of ECCF. Our results
   suggest that the ECCF might potentially serve as an alternative or
   complementary medicine for treating inflammatory diseases caused by
   microbial infection.}},
Publisher = {{MEDKNOW PUBLICATIONS \& MEDIA PVT LTD}},
Address = {{B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Cho, SS (Reprint Author), Mokpo Natl Univ, Coll Pharm, Dept Pharm, Jeonnam, South Korea.
   Park, DH (Reprint Author), Dongshin Univ, Dept Oriental Med Mat, Naju, Jeonnam, South Korea.
   Park, Da-Eon; Kim, Jung-Eun; Cho, Seung-Sik, Mokpo Natl Univ, Coll Pharm, Dept Pharm, Jeonnam, South Korea.
   Yoon, In-Soo, Pusan Natl Univ, Coll Pharm, Busan, South Korea.
   Seo, Ji-Hye; Park, Dae-Hun, Dongshin Univ, Dept Oriental Med Mat, Naju, Jeonnam, South Korea.
   Yoo, Jin-Cheol, Chosun Univ, Coll Pharm, Dept Pharm, Gwangju, South Korea.
   Bae, Chun-Sik, Chonnam Natl Univ, Coll Vet Med, Gwangju, South Korea.
   Lee, Chang-Dai, Mokpo Natl Univ, Dept Business Adm, Jeonnam, South Korea.}},
DOI = {{10.4103/0973-1296.204554}},
ISSN = {{0973-1296}},
EISSN = {{0976-4062}},
Keywords = {{Antimicrobial activity; Corylopsis coreana Uyeki flos; inflammation;
   TNF-alpha}},
Keywords-Plus = {{NITRIC-OXIDE SYNTHASE; QUERCITRIN GALLATE; TNF-ALPHA; INFLAMMATION;
   ARTHRITIS; BERGENIN; ANTIOXIDANT; LIPOPOLYSACCHARIDE; ANTIBIOTICS;
   MACROPHAGES}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Chemistry, Medicinal}},
Author-Email = {{dhj1221@hanmail.net
   sscho@mokpo.ac.kr}},
Cited-References = {{Chen BQ, 2006, FITOTERAPIA, V77, P262, DOI 10.1016/j.fitote.2006.03.019.
   Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10.
   Gao XJ, 2015, INFLAMMATION, V38, P1142, DOI 10.1007/s10753-014-0079-8.
   Garcia-Mediavilla V, 2007, EUR J PHARMACOL, V557, P221, DOI 10.1016/j.ejphar.2006.11.014.
   Gibbons S, 2004, NAT PROD REP, V21, P263, DOI 10.1039/b212695h.
   Guardia T, 2001, FARMACO, V56, P683, DOI 10.1016/S0014-827X(01)01111-9.
   Hollman PCH, 1999, FOOD CHEM TOXICOL, V37, P937, DOI 10.1016/S0278-6915(99)00079-4.
   Ianaro A, 2000, J PHARMACOL EXP THER, V292, P156.
   IWASA T, 1971, J ANTIBIOT, V24, P114, DOI 10.7164/antibiotics.24.114.
   Jan S, 2016, J ETHNOPHARMACOL, V182, P90, DOI 10.1016/j.jep.2016.02.020.
   Jo HY, 2008, J VET SCI, V9, P267, DOI 10.4142/jvs.2008.9.3.267.
   Kim BH, 2005, BIOCHEM PHARMACOL, V69, P1577, DOI 10.1016/j.bcp.2005.03.014.
   Kim MH, 2013, MOLECULES, V18, P4876, DOI 10.3390/molecules18054876.
   Kim WS, 2015, KOREAN J PHYSIOL PHA, V19, P21, DOI 10.4196/kjpp.2015.19.1.21.
   KLOPPENBURG M, 1995, BAILLIERE CLIN RHEUM, V9, P759, DOI 10.1016/S0950-3579(05)80312-7.
   Musumeci R, 2003, INT J ANTIMICROB AG, V22, P48, DOI 10.1016/S0924-8579(03)00085-2.
   Nazir N, 2007, J ETHNOPHARMACOL, V112, P401, DOI 10.1016/j.jep.2007.02.023.
   Nazir N, 2011, EUR J MED CHEM, V46, P2415, DOI 10.1016/j.ejmech.2011.03.025.
   Pang LH, 1997, BIOCHEM PHARMACOL, V53, P773, DOI 10.1016/S0006-2952(96)00817-9.
   Ritchlin CT, 2003, J CLIN INVEST, V111, P821, DOI 10.1172/JCI200316069.
   Romano M, 1997, MEDIAT INFLAMM, V6, P32, DOI 10.1080/09629359791901.
   Sandoval M, 2002, PHYTOMEDICINE, V9, P325, DOI 10.1078/0944-7113-00117.
   Seo JH, 2016, MOLECULES, V21, DOI 10.3390/molecules21010094.
   Shah MR, 2012, BIOORG MED CHEM LETT, V22, P2744, DOI 10.1016/j.bmcl.2012.02.096.
   Shin S, 2009, EXP ANIM TOKYO, V58, P431, DOI 10.1538/expanim.58.431.
   Silva LR, 2015, ASIAN PAC J TROP MED, V8, P870, DOI 10.1016/j.apjtm.2015.10.013.
   Silva RR, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-107.
   Sohng JK, 2008, ARCH PHARM RES, V31, P1339, DOI 10.1007/s12272-001-2115-0.
   Wang HF, 2003, J PHARMACEUT BIOMED, V33, P539, DOI 10.1016/S0731-7085(03)00303-0.
   White M, 1999, J ALLERGY CLIN IMMUN, V103, pS378, DOI 10.1016/S0091-6749(99)70215-0.
   Yoon IS, 2015, BIOL PHARM BULL, V38, P1732, DOI 10.1248/bpb.b15-00356.
   Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{Pharmacogn. Mag.}},
Doc-Delivery-Number = {{FC5HE}},
Unique-ID = {{ISI:000406871700016}},
OA = {{green\_published}},
DA = {{2018-08-13}},
}

@article{ ISI:000401215300013,
Author = {Brauner, Paul and Gromoeller, Silvana and Pfeifer, Yvonne and Wilharm,
   Gottfried and Jaeckel, Udo},
Title = {{Hatchery workers' IgG antibody profiles to airborne bacteria}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2017}},
Volume = {{220}},
Number = {{2, B}},
Pages = {{431-439}},
Month = {{APR}},
Abstract = {{Occupational exposure to high concentrations of airborne bacteria in
   poultry production is related to an increased risk of respiratory
   disorders. However, etiology and in particular microorganisms' potential
   role in pathogenesis still needs to be elucidated. Thus, detection of
   specific antibodies against occupational microbial antigens may lead to
   identification of potentially harmful species. For the purpose of IgG
   titer determination, indirect immunofluorescence on various bacterial
   isolates from duck hatchery air was combined with image-based
   quantification of fluorescence intensity. Moreover, in addition to
   established assays with pure bacterial cultures, a new approach utilized
   complex bioaerosol samples for detection of anti-microbial antibodies in
   human sera by determination of percentages of antibody bound cells in
   different serum dilutions. Mean titers in sera from hatchery workers and
   a non-exposed control group did not display significant differences for
   most tested isolates and application of comprehensive cluster analysis
   to entire titer data revealed no structure reflecting workers and
   controls group. Furthermore, determination of immunoreactivity to the
   complete microbial community in workplace air displayed similar
   proportions of antibody-bound cells in both groups. Although no general
   differences in immunoreaction patterns were observed, mean titers to a
   Proteus mirabilis isolate and to 3 of 4 distinct Acinetobacter baumannii
   isolates were higher in the group of hatchery workers than in the
   reference group indicating a potential applicability as exposure
   markers. We conclude, despite long term bioaerosol exposure, hatchery
   workers' IgG antibody profiles to tested antigens did not differ
   substantially from those of the control group. However, increased
   workers' titers to A. baumannii and clinical relevance of this species
   should lead to further investigations regarding potential involvement in
   pathogenesis of occupational respiratory disorders. (C) 2017 Elsevier
   GmbH. All rights reserved.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Jackel, U (Reprint Author), Fed Inst Occupat Safety \& Hlth, Naldnerstr 40-42, D-10317 Berlin, Germany.
   Brauner, Paul; Gromoeller, Silvana; Jaeckel, Udo, Fed Inst Occupat Safety \& Hlth, Naldnerstr 40-42, D-10317 Berlin, Germany.
   Pfeifer, Yvonne; Wilharm, Gottfried, Robert Koch Inst, Burgstr 37, D-38855 Wernigerode, Germany.}},
DOI = {{10.1016/j.ijheh.2016.12.008}},
ISSN = {{1438-4639}},
EISSN = {{1618-131X}},
Keywords = {{Indirect immunofluorescence; Image analysis; Bioaerosol; Acinetobacter
   baumannii; Proteus mirabilis; Occupational health}},
Keywords-Plus = {{INDIRECT IMMUNOFLUORESCENCE ASSAY; ACINETOBACTER-BAUMANNII STRAINS;
   PROTEUS-MIRABILIS; ESCHERICHIA-COLI; CAPSULAR POLYSACCHARIDES;
   ANTIBIOTIC-RESISTANCE; EFFICIENT ALGORITHM; POULTRY WORKERS;
   LYME-DISEASE; SP NOV.}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{jaeckel.udo@baua.bund.de}},
Cited-References = {{Amerein MP, 1996, CLIN DIAGN LAB IMMUN, V3, P200.
   Anstey NM, 2002, J CLIN MICROBIOL, V40, P685, DOI 10.1128/JCM.40.2.685-686.2002.
   BAKKEN LL, 1992, JAMA-J AM MED ASSOC, V268, P891, DOI 10.1001/jama.268.7.891.
   Barbour EK, 2012, PATHOG GLOB HEALTH, V106, P352, DOI 10.1179/2047773212Y.0000000042.
   Baud D, 2010, EUR J CLIN MICROBIOL, V29, P669, DOI 10.1007/s10096-010-0912-4.
   BENSON RF, 1983, J CLIN MICROBIOL, V17, P909.
   Bjerrum L, 2006, POULTRY SCI, V85, P1151, DOI 10.1093/ps/85.7.1151.
   Brauner P, 2016, ANN OCCUP HYG, V60, P643, DOI 10.1093/annhyg/mew014.
   Brodka K, 2012, INT J OCCUP MED ENV, V25, P281, DOI 10.2478/S13382-012-0032-8.
   Bunger J, 2000, OCCUP ENVIRON MED, V57, P458, DOI 10.1136/oem.57.7.458.
   Chiaro TR, 2011, CLIN CHIM ACTA, V412, P1076, DOI 10.1016/j.cca.2011.02.025.
   Chmielowiec-Korzeniowska A, 2007, ANN AGR ENV MED, V14, P141.
   Choi J., 2014, POULTRY SCI.
   CORDES LG, 1981, ANN INTERN MED, V95, P688, DOI 10.7326/0003-4819-95-6-688.
   de Beer H, 2005, INT J SYST EVOL MICR, V55, P2149, DOI 10.1099/ijs.0.63746-0.
   DEFAYS D, 1977, COMPUT J, V20, P364, DOI 10.1093/comjnl/20.4.364.
   DEVRIESE LA, 1991, J APPL BACTERIOL, V71, P46.
   Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789.
   Doekes G, 2004, AM J IND MED, V46, P404, DOI 10.1002/ajim.20086.
   Donham KJ, 2000, J OCCUP ENVIRON MED, V42, P260, DOI 10.1097/00043764-200003000-00006.
   Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032.
   Eliopoulos G. M., 2008, CLIN INFECT DIS, V46, P1254.
   Everitt B, 2001, CLUSTER ANAL.
   Florek K., 1951, I MATH POL ACAD SCI, P282.
   Forsgren A, 1970, Infect Immun, V2, P387.
   FORSGREN A, 1966, J IMMUNOL, V97, P822.
   Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202.
   Fung Frederick, 2003, Appl Occup Environ Hyg, V18, P535, DOI 10.1080/10473220301451.
   Gehan Z. M., 2009, International Journal of Poultry Science, V8, P1047.
   Giraffa G, 2002, FEMS MICROBIOL REV, V26, P163, DOI 10.1016/S0168-6445(02)00094-3.
   Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591.
   Hufnagel M, 2005, INFECTION, V33, P373, DOI 10.1007/S15010-005-5062-8.
   Hufnagel M, 2005, CLIN DIAGN LAB IMMUN, V12, P930, DOI 10.1128/CDLI.12.8.930-934.2005.
   Jenzora A, 2008, FEMS IMMUNOL MED MIC, V53, P183, DOI 10.1111/j.1574-695X.2008.00408.x.
   Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505.
   Kolar M, 2005, ACTA VET BRNO, V74, P249, DOI 10.2754/avb200574020249.
   LACEY J, 1994, J AEROSOL SCI, V25, P1371, DOI 10.1016/0021-8502(94)90215-1.
   Laitinen S, 1999, INT ARCH OCC ENV HEA, V72, P443, DOI 10.1007/s004200050397.
   LENHART SW, 1984, AM J IND MED, V6, P89, DOI 10.1002/ajim.4700060203.
   Liu D, 2016, VET MICROBIOL, V186, P126, DOI 10.1016/j.vetmic.2016.02.018.
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806.
   Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003.
   LUGER SW, 1990, ARCH INTERN MED, V150, P761, DOI 10.1001/archinte.150.4.761.
   Lupo A, 2014, J FOOD PROTECT, V77, P1976, DOI 10.4315/0362-028X.JFP-14-073.
   Luttmann W, 2014, EXPERIMENTATOR, P1, DOI 10.1007/978-3-642-41899-0.
   Mahalanobis P. C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302.
   Manges AR, 2016, CLIN MICROBIOL INFEC, V22, P122, DOI 10.1016/j.cmi.2015.11.010.
   Martin E, 2013, ENVIRON SCI-PROC IMP, V15, P478, DOI 10.1039/c2em30758h.
   Martin E, 2011, J ENVIRON MONITOR, V13, P464, DOI 10.1039/c0em00272k.
   Mellata M, 2013, FOODBORNE PATHOG DIS, V10, P916, DOI 10.1089/fpd.2013.1533.
   Moodley A, 2008, SCAND J WORK ENV HEA, V34, P151, DOI 10.5271/sjweh.1219.
   Nemec A, 2009, INT J SYST EVOL MICR, V59, P118, DOI 10.1099/ijs.0.001230-0.
   O'Hara CM, 2000, CLIN MICROBIOL REV, V13, P534, DOI 10.1128/CMR.13.4.534-546.2000.
   Olsen RH, 2014, AVIAN PATHOL, V43, P199, DOI 10.1080/03079457.2014.907866.
   Pantophlet R, 2001, J CLIN MICROBIOL, V39, P2576, DOI 10.1128/JCM.39.7.2576-2580.2001.
   Papadopoulou C, 1997, COMP IMMUNOL MICROB, V20, P35, DOI 10.1016/S0147-9571(96)00024-0.
   Park G.-S., 2014, GENOME ANNOUNC, V2.
   Peeling RW, 2000, J INFECT DIS, V181, pS426, DOI 10.1086/315603.
   Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07.
   Poh CH, 2006, J INFECTION, V52, P383, DOI 10.1016/j.jinf.2005.07.011.
   Porsch-Ozcurumez M, 2004, CLIN DIAGN LAB IMMUN, V11, P1008, DOI 10.1128/CDLI.11.6.1008-1015.2004.
   Radon K, 2001, EUR RESPIR J, V17, P747, DOI 10.1183/09031936.01.17407470.
   Rees D, 1998, S AFR MED J, V88, P1110.
   Rimac D, 2010, INT ARCH OCC ENV HEA, V83, P9, DOI 10.1007/s00420-009-0487-5.
   RODBARD D, 1970, ACTA ENDOCRINOL-COP, P79.
   Rodbard D., 1974, RADIOIMMUNOASSAY REL, V165, P192.
   Rylander R, 2006, INT ARCH OCC ENV HEA, V79, P487, DOI 10.1007/s00420-005-0072-5.
   Savigny D.d., 1980, J IMMUNOASSAY, V1, P105.
   Scalabrin DMF, 1999, J ALLERGY CLIN IMMUN, V104, P1273, DOI 10.1016/S0091-6749(99)70024-2.
   Seiffert SN, 2013, ANTIMICROB AGENTS CH, V57, P6406, DOI 10.1128/AAC.01773-13.
   SIBSON R, 1973, COMPUT J, V16, P30, DOI 10.1093/comjnl/16.1.30.
   Skorska C, 2007, ANN AGR ENV MED, V14, P341.
   Sorensen T., 1948, BIOL SKR, V5, P1.
   TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233.
   Thanh T.Q.T., 2016, NOVA J MED BIOL SCI, V3.
   Tillie-Leblond I, 2011, EUR RESPIR J, V37, P640, DOI 10.1183/09031936.00195009.
   TRAUB WH, 1989, J CLIN MICROBIOL, V27, P2713.
   Turton JF, 2007, CLIN MICROBIOL INFEC, V13, P807, DOI 10.1111/j.1469-0691.2007.01759.x.
   van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10.
   WEERNINK A, 1995, J HOSP INFECT, V29, P189, DOI 10.1016/0195-6701(95)90328-3.
   Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822.
   WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/jb.173.2.697-703.1991.
   WERGELAND HI, 1989, J CLIN MICROBIOL, V27, P1286.
   WILKINSON HW, 1979, J CLIN MICROBIOL, V9, P379.
   Wilkinson M.H.F., 2003, GRONINGEN REDUCTION.
   Witte W, 2003, BUNDESGESUNDHEITSBLA, V10, P881.
   Zander E, 2012, J CLIN MICROBIOL, V50, P1900, DOI 10.1128/JCM.06462-11.
   ZUSKIN E, 1994, INT ARCH OCC ENV HEA, V66, P317, DOI 10.1007/BF00378364.}},
Number-of-Cited-References = {{88}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{EU7LC}},
Unique-ID = {{ISI:000401215300013}},
DA = {{2018-08-13}},
}

@article{ ISI:000392791000002,
Author = {Du, Xin-jun and Zhang, Xiang and Wang, Xiao-yi and Su, Yu-lan and Li,
   Ping and Wang, Shuo},
Title = {{Isolation and characterization of Listeria monocytogenes in Chinese food
   obtained from the central area of China}},
Journal = {{FOOD CONTROL}},
Year = {{2017}},
Volume = {{74}},
Pages = {{9-16}},
Month = {{APR}},
Abstract = {{The objective of this study was to investigate the prevalence and
   characteristics of Listeria mbnocytogenes isolated from Chinese food,
   including frozen dumplings, flavored raw meat, roasted meat, braised
   meat, and a cold vegetable dish with sauce. A total of 900 food samples
   were collected from supermarkets, open-air markets, and delicatessens in
   three large cities in the central area of China to examine the presence
   of L monocytogenes; 21 (2.3\%) of the samples were positive for this
   pathogen. Among the different samples, braised meat showed the highest
   L. monocytogenes detection rate (4.4\%). Samples obtained from
   delicatessens showed a much higher L monocytogenes contamination rate
   (83\%) than those from open-air markets (6.7\%) or supermarkets (0\%).
   Multilocus sequence typing (MLST) analysis indicated that the 21
   bacterial isolates belonged to 12 ST subgroups. ST5 was the largest and
   contained 7 isolates (333\%); it was followed by ST474, ST121 and ST9
   (each containing 2 isolates {[}10.5\%]). Antibiotic susceptibility
   analysis showed that the 21 L monocytogenes isolates were thoroughly
   resistant to cefoxitin but highly susceptible to doxycycline and
   ciprofloxacin. The presence of 10 virulence genes was evaluated by PCR,
   which showed that inlA, iniC, iniJ, prfA, hlyA, and plcH were present in
   all isolates and that iniB, actA, plcA and iap were present in
   71.4-90.5\% of the isolates. This study provides a useful reference for
   risk assessment and control of L. monocytogenes contamination in Chinese
   food and for the treatment of clinical listeriosis. (C) 2016 Elsevier
   Ltd. All rights reserved.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wang, S (Reprint Author), Tianjin Univ Sci \& Technol, Key Lab Food Nutr \& Safety, Tianjin 300457, Peoples R China.
   Du, Xin-jun; Zhang, Xiang; Wang, Xiao-yi; Su, Yu-lan; Li, Ping; Wang, Shuo, Tianjin Univ Sci \& Technol, Key Lab Food Nutr \& Safety, Minist Educ, Tianjin 300457, Peoples R China.
   Wang, Shuo, BTBU, Beijing Adv Innovat Ctr Food Nutr \& Human Hlth, Beijing 100048, Peoples R China.}},
DOI = {{10.1016/j.foodcont.2016.11.024}},
ISSN = {{0956-7135}},
EISSN = {{1873-7129}},
Keywords = {{Chinese food; Listeria monocytogenes; Antimicrobial susceptibility; MLST
   typing; Virulence genes}},
Keywords-Plus = {{TO-EAT FOODS; FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL RESISTANCE;
   MEAT-PRODUCTS; ANTIBIOTIC-RESISTANCE; GENETIC DIVERSITY; MULTIPLEX PCR;
   RETAIL FOODS; VIRULENCE GENES; CHILLED PORK}},
Research-Areas = {{Food Science \& Technology}},
Web-of-Science-Categories  = {{Food Science \& Technology}},
Author-Email = {{s.wang@tust.edu.cn}},
Funding-Acknowledgement = {{Ministry of Science and Technology of the People's Republic of China
   {[}2014BAD04B03]; International Science and Technology Cooperation
   Program of China {[}2014DFR30350]}},
Funding-Text = {{This study received financial support from a project of the Ministry of
   Science and Technology of the People's Republic of China (Project No.
   2014BAD04B03) and International Science and Technology Cooperation
   Program of China (Project No. 2014DFR30350).}},
Cited-References = {{Bonazzi M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003087.
   Bouayad L, 2015, FOODBORNE PATHOG DIS, V12, P606, DOI 10.1089/fpd.2014.1904.
   Bubert A, 1999, MOL GEN GENET, V261, P323, DOI 10.1007/s004380050973.
   Burall LS, 2011, J FOOD PROTECT, V74, P403, DOI 10.4315/0362-028X.JFP-10-355.
   Chao GX, 2007, FOODBORNE PATHOG DIS, V4, P277, DOI 10.1089/fpd.2007.0088.
   Charpentier E, 1999, ANTIMICROB AGENTS CH, V43, P2103.
   Chen MT, 2014, FOOD CONTROL, V38, P1, DOI 10.1016/j.foodcont.2013.09.061.
   Cockerill FR, 2012, PERFORMANCE STANDARD.
   Cocolin L, 2005, INT J FOOD MICROBIOL, V103, P167, DOI 10.1016/j.ijfoodmicro.2004.12.027.
   Conter M, 2009, INT J FOOD MICROBIOL, V128, P497, DOI 10.1016/j.ijfoodmicro.2008.10.018.
   Coroneo V, 2016, J FOOD SCI, V81, pM114, DOI 10.1111/1750-3841.13173.
   Di Pinto A, 2010, NEW MICROBIOL, V33, P249.
   Dornenech E., 2015, FOOD CONTROL, V47, P120.
   Ebner R, 2015, FOOD CONTROL, V57, P321, DOI 10.1016/j.foodcont.2015.04.030.
   Elmali M, 2015, FOOD SCI TECH-BRAZIL, V35, P672, DOI 10.1590/1678-457X.6808.
   European Food Safety Authority (EFSA) European Centre for Disease Prevention and Control (ECDC), 2014, EFSA J, V12, P3547, DOI DOI 10.2903/J.EFSA.2014.3547.
   Fallah AA, 2013, FOOD CONTROL, V34, P630, DOI 10.1016/j.foodcont.2013.06.015.
   Fang C, 2016, FOODBORNE PATHOG DIS, V13, P8, DOI 10.1089/fpd.2015.2023.
   Granier SA, 2011, APPL ENVIRON MICROB, V77, P2788, DOI 10.1128/AEM.01381-10.
   Graves LM, 2001, INT J FOOD MICROBIOL, V65, P55, DOI 10.1016/S0168-1605(00)00501-8.
   Harakeh S, 2009, SCI TOTAL ENVIRON, V407, P4022, DOI 10.1016/j.scitotenv.2009.04.010.
   Henri C, 2016, APPL ENVIRON MICROB, V82, P5720, DOI 10.1128/AEM.00583-16.
   Iannetti L, 2016, FOOD CONTROL, V68, P55, DOI {[}10.1016/j.foodcont.2016.03.036, 10.1016/j.foodcont.2016].
   Jacquet C, 2004, J INFECT DIS, V189, P2094, DOI 10.1086/420853.
   Jadhav S, 2012, J MICROBIOL METH, V88, P327, DOI 10.1016/j.mimet.2012.01.002.
   Jamali H, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0476-7.
   Jamali H, 2013, FOOD CONTROL, V34, P121, DOI 10.1016/j.foodcont.2013.04.023.
   Jersek B, 1999, J CLIN MICROBIOL, V37, P103.
   Jonquieres R, 1998, INFECT IMMUN, V66, P3420.
   Kaur S, 2007, J APPL MICROBIOL, V103, P1889, DOI 10.1111/j.1365-2672.2007.03414.x.
   KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I.
   Korsak D, 2012, INT J FOOD MICROBIOL, V158, P203, DOI 10.1016/j.ijfoodmicro.2012.07.016.
   Kovacevic J, 2013, FOOD MICROBIOL, V34, P319, DOI 10.1016/j.fm.2013.01.002.
   Kovacevic J, 2012, FOOD MICROBIOL, V30, P372, DOI 10.1016/j.fm.2011.12.015.
   Li LL, 2016, FOODBORNE PATHOG DIS, V13, P262, DOI 10.1089/fpd.2015.2087.
   Liu D, 2007, J MICROBIOL METH, V71, P133, DOI 10.1016/j.mimet.2007.08.007.
   Lomonaco S, 2012, INT J FOOD MICROBIOL, V160, P76, DOI 10.1016/j.ijfoodmicro.2012.09.011.
   Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140.
   Martin B, 2014, FOOD MICROBIOL, V44, P119, DOI 10.1016/j.fm.2014.05.014.
   Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502.
   Olaniran AO, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0570-x.
   Ooi ST, 2005, CLIN INFECT DIS, V40, P1327, DOI 10.1086/429324.
   Orsi RH, 2016, APPL MICROBIOL BIOT, V100, P5273, DOI 10.1007/s00253-016-7552-2.
   Osaili TM, 2014, J FOOD PROTECT, V77, P106, DOI 10.4315/0362-028X.JFP-13-049.
   Parisi A, 2010, FOOD MICROBIOL, V27, P101, DOI 10.1016/j.fm.2009.09.001.
   Pesavento G, 2010, FOOD CONTROL, V21, P708, DOI 10.1016/j.foodcont.2009.10.012.
   Ristori CA, 2014, FOODBORNE PATHOG DIS, V11, P969, DOI 10.1089/fpd.2014.1809.
   Shen JL, 2013, FOOD MICROBIOL, V35, P58, DOI 10.1016/j.fm.2013.02.014.
   Shimojima Y, 2016, J VET MED SCI, V78, P1183, DOI 10.1292/jvms.15-0708.
   Todd ECD, 2011, FOOD CONTROL, V22, P1484, DOI 10.1016/j.foodcont.2010.07.021.
   Wang GY, 2015, FOOD CONTROL, V50, P202, DOI 10.1016/j.foodcont.2014.07.057.
   Wang K, 2015, LWT-FOOD SCI TECHNOL, V64, P905, DOI 10.1016/j.lwt.2015.06.015.
   Ward TJ, 2008, APPL ENVIRON MICROB, V74, P7629, DOI 10.1128/AEM.01127-08.
   Wehner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108639.
   Wu S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00168.
   Wu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136682.
   Wu S, 2015, FOOD CONTROL, V47, P340, DOI 10.1016/j.foodcont.2014.07.028.
   Wu SJ, 2004, J MICROBIOL METH, V56, P395, DOI 10.1016/j.mimet.2003.11.005.
   Yan H, 2010, INT J FOOD MICROBIOL, V144, P310, DOI 10.1016/j.ijfoodmicro.2010.10.015.
   Yu T, 2014, FOOD CONTROL, V37, P228, DOI 10.1016/j.foodcont.2013.09.047.
   Zhang WS, 2013, FOODBORNE PATHOG DIS, V10, P867, DOI 10.1089/fpd.2013.1528.}},
Number-of-Cited-References = {{61}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{5}},
Usage-Count-Since-2013 = {{50}},
Journal-ISO = {{Food Control}},
Doc-Delivery-Number = {{EI8XH}},
Unique-ID = {{ISI:000392791000002}},
DA = {{2018-08-13}},
}

@article{ ISI:000405537400039,
Author = {Wang, Wenkai and Zhou, Xiujuan and Suo, Yujuan and Deng, Xiangyu and
   Cheng, Mengya and Shi, Chunlei and Shi, Xianming},
Title = {{Prevalence, serotype diversity, biofilm-forming ability and eradication
   of Listeria monocytogenes isolated from diverse foods in Shanghai, China}},
Journal = {{FOOD CONTROL}},
Year = {{2017}},
Volume = {{73}},
Number = {{B}},
Pages = {{1068-1073}},
Month = {{MAR}},
Abstract = {{Listeria monocytogenes is a major foodborne pathogen that is well known
   for its high mortality rate in humans upon infection. This study aimed
   to investigate the prevalence and serotype diversity of L. monocytogenes
   isolates in various foods. From July 2013 to June 2014, a total of 648
   food samples, originating from raw milk, quick-frozen food, vegetables,
   raw meats, cooked meats, aquatic products, dairy products and bean
   products, were collected from open-air markets, large supermarkets,
   delis and dairy farms, in Shanghai, China. Forty samples (6.2\%) tested
   positive for L. monocytogenes, confirmed by both bacteriological and
   molecular methods. Among the food categories surveyed, the highest
   prevalence was observed in raw meat samples at 16.0\% (15/94), followed
   by 9.9\% (10/101) in quick-frozen food samples and 73\% (4/55) in cooked
   meat samples. Serotyping showed that majority of the isolates (67.5\%)
   belonged to serotype 1/2a, followed by 1/2b (22.5\%),112c (7.5\%) and 3c
   (2.5\%). Isolates were assessed for their ability to form biofilms.
   Significant differences in biofilm forming abilities were observed
   between storage temperatures and serotypes. Anti-biofilm efficacy of
   industrial disinfectants, chlorine dioxide (ClO2) and hydrogen peroxide
   (H2O2), was examined by measuring minimal effective concentration (MEC)
   on L. monocytogenes in biofilm. A positive correlation was observed
   among the biofilm's resistance to H2O2 and the biomass of biofilms. ClO2
   was found to be more effective against biofilm and inactivated all the
   listerial cells in the biofilm state, whereas H2O2 was not able to kill
   all the cells in biofilms at the recommended concentrations according to
   National Food Safety Standard of China. Our study suggests that there is
   potential public health risk of L. monocytogenes infection in Shanghai.
   Efficacy against L. monocytogenes biofilm should be considered when
   evaluating disinfectants. (C) 2016 Published by Elsevier Ltd.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Shi, XM (Reprint Author), Shanghai Jiao Tong Univ, Sch Agr \& Biol, State Key Lab Microbial Metab, MOST USDA Joint Res Ctr Food Safety, Shanghai 200240, Peoples R China.
   Wang, Wenkai; Zhou, Xiujuan; Cheng, Mengya; Shi, Chunlei; Shi, Xianming, Shanghai Jiao Tong Univ, Sch Agr \& Biol, State Key Lab Microbial Metab, MOST USDA Joint Res Ctr Food Safety, Shanghai 200240, Peoples R China.
   Suo, Yujuan, Shanghai Acad Agr Sci, Inst Agri Food Stand \& Testing Technol, Shanghai 201403, Peoples R China.
   Deng, Xiangyu, Univ Georgia, Dept Food Sci \& Technol, Ctr Food Safety, 1109 Expt St, Griffin, GA 30223 USA.}},
DOI = {{10.1016/j.foodcont.2016.10.025}},
ISSN = {{0956-7135}},
EISSN = {{1873-7129}},
Keywords = {{Listeria monocytogenes; Food isolates; Serotypes; Biofilm; Disinfectants}},
Keywords-Plus = {{ANTIMICROBIAL RESISTANCE; ANTIBIOTIC SUSCEPTIBILITY; GENETIC DIVERSITY;
   STRAIN ORIGIN; PRODUCTS; MEAT; CONSUMPTION; SANITIZERS; SAFETY; MILK}},
Research-Areas = {{Food Science \& Technology}},
Web-of-Science-Categories  = {{Food Science \& Technology}},
Author-Email = {{xmshi@sjtu.edu.cn}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}31230058]; Science and
   Technology Commission of Shanghai Municipality {[}14390711900]; Youth
   Development Project of Shanghai Agriculture Commission {[}1-32]}},
Funding-Text = {{This study was supported by the National Natural Science Foundation of
   China (31230058), the Science and Technology Commission of Shanghai
   Municipality (14390711900) and Youth Development Project of Shanghai
   Agriculture Commission (2015, NO. 1-32).}},
Cited-References = {{Borucki MK, 2003, APPL ENVIRON MICROB, V69, P7336, DOI 10.1128/AEM.69.12.7336-7342.2003.
   Chae MS, 2006, FOOD MICROBIOL, V23, P250, DOI 10.1016/j.fm.2005.04.004.
   Chavant P, 2004, FEMS MICROBIOL LETT, V236, P241, DOI 10.1016/j.femsle.2004.05.040.
   Chen MT, 2014, FOOD CONTROL, V38, P1, DOI 10.1016/j.foodcont.2013.09.061.
   Cruz CD, 2012, FOOD CONTROL, V26, P194, DOI 10.1016/j.foodcont.2012.01.041.
   Dofiad S. P, 2015, PLOS ONE, V10.
   Fallah AA, 2012, FOOD CONTROL, V28, P327, DOI 10.1016/j.foodcont.2012.05.014.
   FRETZ R, 2010, EUROSURVEILLANCE, V15, P2.
   Fugett EB, 2007, J CLIN MICROBIOL, V45, P865, DOI 10.1128/JCM.01285-06.
   Harvey J, 2007, FOOD MICROBIOL, V24, P380, DOI 10.1016/j.fm.2006.06.006.
   Indrawattana N, 2011, J HEALTH POPUL NUTR, V29, P26.
   Jacquet C, 2002, APPL ENVIRON MICROB, V68, P616, DOI 10.1128/AEM.68.2.616-622.2002.
   Jahid IK, 2012, FOOD SCI BIOTECHNOL, V21, P299, DOI 10.1007/s10068-012-0041-1.
   Jalali M, 2008, INT J FOOD MICROBIOL, V122, P336, DOI 10.1016/j.ijfoodmicro.2007.11.082.
   Jamali H, 2013, FOOD CONTROL, V34, P121, DOI 10.1016/j.foodcont.2013.04.023.
   Kadam SR, 2013, INT J FOOD MICROBIOL, V165, P259, DOI 10.1016/j.ijfoodmicro.2013.05.025.
   Kramarenko T, 2013, FOOD CONTROL, V30, P24, DOI 10.1016/j.foodcont.2012.06.047.
   Miladi H, 2013, ARCH MICROBIOL, V195, P705, DOI 10.1007/s00203-013-0921-7.
   Nam H, 2014, INT J FOOD MICROBIOL, V188, P122, DOI 10.1016/j.ijfoodmicro.2014.07.009.
   Nilsson RE, 2011, INT J FOOD MICROBIOL, V150, P14, DOI 10.1016/j.ijfoodmicro.2011.07.012.
   Oliver SP, 2009, FOODBORNE PATHOG DIS, V6, P793, DOI 10.1089/fpd.2009.0302.
   Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002.
   Osaili TM, 2011, FOOD CONTROL, V22, P586, DOI 10.1016/j.foodcont.2010.10.008.
   Pan J., 2008, CHINESE J PUBLIC HLT, V24, P107.
   Pan Y, 2006, APPL ENVIRON MICROB, V72, P7711, DOI 10.1128/AEM.01065-06.
   Parihar VS, 2008, FOODBORNE PATHOG DIS, V5, P755, DOI 10.1089/fpd.2008.0123.
   Pesavento G, 2010, FOOD CONTROL, V21, P708, DOI 10.1016/j.foodcont.2009.10.012.
   Rahimi E, 2010, FOOD CONTROL, V21, P1448, DOI 10.1016/j.foodcont.2010.03.014.
   Silva EPd, 2013, APPL MICROBIOL BIOT, V97, P957.
   SIMPSON GD, 2005, PRACTICAL CHLORINE D, V1.
   Vaid R, 2010, FOOD MICROBIOL, V27, P979, DOI 10.1016/j.fm.2010.05.024.
   Vanegas MC, 2009, FOOD CONTROL, V20, P430, DOI 10.1016/j.foodcont.2008.07.007.
   Vazquez-Sanchez D, 2014, FOOD CONTROL, V39, P8, DOI 10.1016/j.foodcont.2013.09.029.
   Wang GY, 2015, FOOD CONTROL, V50, P202, DOI 10.1016/j.foodcont.2014.07.057.
   Wang P, 2012, J FOOD SCI, V77, pM212, DOI 10.1111/j.1750-3841.2011.02596.x.
   Wang XM, 2013, FOOD CONTROL, V32, P153, DOI 10.1016/j.foodcont.2012.11.032.
   Wieczorek K, 2012, FOODBORNE PATHOG DIS, V9, P681, DOI 10.1089/fpd.2012.1137.
   Wu S, 2015, FOOD CONTROL, V47, P340, DOI 10.1016/j.foodcont.2014.07.028.
   Yan H. S., 2012, BIOSCIENCE BIOTECHNO, V76, P2008.
   Yan H, 2010, INT J FOOD MICROBIOL, V144, P310, DOI 10.1016/j.ijfoodmicro.2010.10.015.
   Yu T, 2014, FOOD CONTROL, V37, P228, DOI 10.1016/j.foodcont.2013.09.047.
   Zhang DD, 2010, J FOOD SAFETY, V30, P832, DOI 10.1111/j.1745-4565.2010.00245.x.
   Zhu XN, 2008, APPL ENVIRON MICROB, V74, P7675, DOI 10.1128/AEM.01229-08.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{11}},
Usage-Count-Since-2013 = {{33}},
Journal-ISO = {{Food Control}},
Doc-Delivery-Number = {{FA6EZ}},
Unique-ID = {{ISI:000405537400039}},
DA = {{2018-08-13}},
}

@article{ ISI:000404543200010,
Author = {Hassan, H. A. and Mostfa, M. I.},
Title = {{Monitoring the Quality of Mineral Bottled Water Concerning to Potential
   Pathogenic Bacteria and Nitrate Levels}},
Journal = {{JOURNAL OF WATER CHEMISTRY AND TECHNOLOGY}},
Year = {{2017}},
Volume = {{39}},
Number = {{2}},
Pages = {{116-124}},
Month = {{MAR}},
Abstract = {{The diversity of cultured pathogenic bacteria in the bottled mineral
   water (BMW) was investigated using selective media. The pure isolates
   from these selective media, which showed hemolytic activity on the blood
   agar media and antibiotic resistance, were identified by 16S rRNA gene
   technique. The seven obtained strains were belonged to the genus
   Pseudomonas, Bacillus, Acinetobacter, Stenotrophomonas, and
   Exiguobacterium, and were mostly closed to the pathogenic strains. The
   increasing of ozone concentration from air-fed ozone generators
   eliminate the growth of bacteria included the pathogenic bacteria, but
   in other side it increases the amount of nitrates and nitrites in the
   final product of the BMW. These findings revealed that the BMW either
   has potential pathogenic bacteria or high levels of nitrates and all
   these products may effect on the health of the end user.}},
Publisher = {{ALLERTON PRESS INC}},
Address = {{18 WEST 27TH ST, NEW YORK, NY 10001 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hassan, HA (Reprint Author), Sadat City Univ, Genet Engn \& Biotechnol Res Inst, Environm Biotechnol Dept, Sadat City, Egypt.
   Hassan, H. A.; Mostfa, M. I., Sadat City Univ, Genet Engn \& Biotechnol Res Inst, Environm Biotechnol Dept, Sadat City, Egypt.}},
DOI = {{10.3103/S1063455X17020102}},
ISSN = {{1063-455X}},
EISSN = {{1934-936X}},
Keywords = {{bottled mineral water; pathogenic bacteria; 16S rRNA gene sequence;
   ozone and nitrates}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANT BACTERIA; DRINKING-WATER; PSEUDOMONAS-AERUGINOSA;
   WASTE-WATER; OUTBREAK; STRAINS; ACINETOBACTER; MICROBIOLOGY;
   MALTOPHILIA; INFECTION}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Applied; Chemistry, Analytical; Chemistry, Physical}},
Author-Email = {{hamdy.hassan@gebri.usc.edu.eg}},
Cited-References = {{APHA American Public Health Association, 1998, STANDARD METHODS EXA.
   ARAGONE MD, 1992, J CLIN MICROBIOL, V30, P1583.
   ARMSTRONG JL, 1981, APPL ENVIRON MICROB, V42, P277.
   Aumeran C, 2007, J HOSP INFECT, V65, P47, DOI 10.1016/j.jhin.2006.08.009.
   Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006.
   BLAKE PA, 1977, AM J EPIDEMIOL, V105, P337, DOI 10.1093/oxfordjournals.aje.a112391.
   Burge SH, 1990, RIV ITAL IG, V50, P401.
   CAMPER AK, 1986, APPL ENVIRON MICROB, V52, P434.
   Carraro Elisabetta, 2004, Ann Ist Super Sanita, V40, P117.
   Chang YJ, 2000, J MICROBIOL METH, V40, P19, DOI 10.1016/S0167-7012(99)00134-7.
   Cooke M. D., 1975, FRESHWATER RES, V10, P391.
   Craun GF, 2002, J ENVIRON HEALTH, V65, P16.
   Cruickshank R., 1975, MED MICROBIOLOGY.
   Daood N., 2009, J BASIC SCI, V25, P1.
   Dibua U. E., 2006, ANIMAL RES INT, V3, P439.
   Eckmanns T, 2008, CLIN MICROBIOL INFEC, V14, P454, DOI 10.1111/j.1469-0691.2008.01949.x.
   Eliasson B., 1987, P 8 INT S PLASM CHEM, P736.
   FERREIRA AC, 1994, CAN J MICROBIOL, V40, P72, DOI 10.1139/m94-012.
   From C, 2007, INT J FOOD MICROBIOL, V115, P319, DOI 10.1016/j.ijfoodmicro.2006.11.005.
   Funke G, 1997, CLIN MICROBIOL REV, V10, P125.
   GOYAL SM, 1979, WATER RES, V13, P349, DOI 10.1016/0043-1354(79)90022-8.
   Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879.
   HUNTER PR, 1993, J APPL BACTERIOL, V74, P345, DOI 10.1111/j.1365-2672.1993.tb05137.x.
   Klare I, 1995, MICROB DRUG RESIST, V1, P265, DOI 10.1089/mdr.1995.1.265.
   KOGELSCHATZ U, 1987, OZONE-SCI ENG, V9, P195.
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150.
   Kummerer K., 2004, ANTIMICROB CHEMOTHER, V54, P311.
   Leclerc H, 2002, CRIT REV MICROBIOL, V28, P371, DOI 10.1080/1040-840291046768.
   Leclerc H, 1998, TECHNOLOGY BOTTLED W, P223.
   Levi I., 1996, ACINETOBACTER MICROB, P101.
   Magda M. M., 2008, J EGYPT PUBLIC HLTH, V83, P468.
   Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483.
   Nithya V, 2012, INT J TOXICOL, V31, P228, DOI 10.1177/1091581812443388.
   Oggioni MR, 1998, J CLIN MICROBIOL, V36, P325.
   PALLERONI NJ, 1970, J GEN MICROBIOL, V60, P215, DOI 10.1099/00221287-60-2-215.
   Palmer KL, 2007, J BACTERIOL, V189, P4449, DOI 10.1128/JB.00162-07.
   Palmera-Suarez R., 2007, EUROSURVEILLANCE, V12, P3235.
   Papapetropoulou M, 1997, CAN J MICROBIOL, V43, P499, DOI 10.1139/m97-071.
   Pepe O, 2003, APPL ENVIRON MICROB, V69, P2321, DOI 10.1128/AEM.69.4.2321-2329.2003.
   Raphael S. S., 1983, LYNCH MED LAB TECHNO.
   Ronald M., 2010, ATLAS HAND BOOK MICR.
   Ronald M., 1997, ATLAS PRINCIPLES MSI.
   Sakhnini E, 2002, AM J MED SCI, V323, P269, DOI 10.1097/00000441-200205000-00008.
   Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x.
   Snydman DR, 2008, CLIN INFECT DIS, V46, pS104, DOI 10.1086/523331.
   SPENCER RC, 1995, J HOSP INFECT, V30, P453, DOI 10.1016/0195-6701(95)90049-7.
   Suarez-Varela Maria Morales, 1993, Journal of Environmental Pathology Toxicology and Oncology, V12, P229.
   Tena D, 2007, CLIN INFECT DIS, V44, pE40, DOI 10.1086/511077.
   Todar K., PSEUDOMONAS AERUGINO.
   Towner KJ, 1997, J MED MICROBIOL, V46, P721, DOI 10.1099/00222615-46-9-721.
   Trautmann M, 2005, AM J INFECT CONTROL, V33, pS41, DOI 10.1016/j.ajic.2005.03.006.
   Vander Mauven C., LYNCH MED LAB TECHNO, V160, P928.
   WARBURTON DW, 1993, CAN J MICROBIOL, V39, P158, DOI 10.1139/m93-022.
   WHO, 1997, DIV EM CIOMM DES SUR.
   Zhang YL, 2009, SCI TOTAL ENVIRON, V407, P3702, DOI 10.1016/j.scitotenv.2009.02.013.
   Zobell CE, 1936, BIOL BULL-US, V71, P324, DOI 10.2307/1537438.}},
Number-of-Cited-References = {{56}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{J. Water. Chem. Technol.}},
Doc-Delivery-Number = {{EZ2MK}},
Unique-ID = {{ISI:000404543200010}},
DA = {{2018-08-13}},
}

@article{ ISI:000399163700042,
Author = {Rodrigues-Silva, Caio and Miranda, Sandra M. and Lopes, Filipe V. S. and
   Silva, Mario and Dezotti, Marcia and Silva, Adrian M. T. and Faria,
   Joaquim L. and Boaventura, Rui A. R. and Vilar, Vitor J. P. and Pinto,
   Eugenia},
Title = {{Bacteria and fungi inactivation by photocatalysis under UVA irradiation:
   liquid and gas phase}},
Journal = {{ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH}},
Year = {{2017}},
Volume = {{24}},
Number = {{7}},
Pages = {{6372-6381}},
Month = {{MAR}},
Abstract = {{In the last decade, environmental risks associated with wastewater
   treatment plants (WWTPs) have become a concern in the scientific
   community due to the absence of specific legislation governing the
   occupational exposure limits (OEL) for microorganisms present in indoor
   air. Thus, it is necessary to develop techniques to effectively
   inactivate microorganisms present in the air of WWTPs facilities. In the
   present work, ultraviolet light A radiation was used as inactivation
   tool. The microbial population was not visibly reduced in the bioaerosol
   by ultraviolet light A (UVA) photolysis. The UVA photocatalytic process
   for the inactivation of microorganisms (bacteria and fungi, ATCC strains
   and isolates from indoor air samples of a WWTP) using titanium dioxide
   (TiO2 P25) and zinc oxide (ZnO) was tested in both liquid-phase and
   airborne conditions. In the slurry conditions at liquid phase, P25
   showed a better performance in inactivation. For this reason, gas-phase
   assays were performed in a tubular photoreactor packed with cellulose
   acetate monolithic structures coated with P25. The survival rate of
   microorganisms under study decreased with the catalyst load and the UVA
   exposure time. Inactivation of fungi was slower than resistant bacteria,
   followed by Gram-positive bacteria and Gram-negative bacteria.}},
Publisher = {{SPRINGER HEIDELBERG}},
Address = {{TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Rodrigues-Silva, C (Reprint Author), Univ Porto, Fac Engn, Lab Separat \& React Engn, Lab Catalysis \& Mat LSRE LCM, Rua Dr Roberto Frias, P-4200465 Oporto, Portugal.
   Rodrigues-Silva, C (Reprint Author), Univ Estadual Campinas, Inst Chem, Dept Analyt Chem, POB 6154, BR-13083970 Campinas, SP, Brazil.
   Rodrigues-Silva, Caio; Miranda, Sandra M.; Lopes, Filipe V. S.; Silva, Adrian M. T.; Faria, Joaquim L.; Boaventura, Rui A. R.; Vilar, Vitor J. P., Univ Porto, Fac Engn, Lab Separat \& React Engn, Lab Catalysis \& Mat LSRE LCM, Rua Dr Roberto Frias, P-4200465 Oporto, Portugal.
   Rodrigues-Silva, Caio, Univ Estadual Campinas, Inst Chem, Dept Analyt Chem, POB 6154, BR-13083970 Campinas, SP, Brazil.
   Silva, Mario; Pinto, Eugenia, Univ Porto, Fac Pharm, Dept Biol Sci, Microbiol Serv, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.
   Dezotti, Marcia, Univ Fed Rio de Janeiro, Chem Engn Program COPPE, POB 68 502, BR-21941972 Rio De Janeiro, RJ, Brazil.
   Pinto, Eugenia, Univ Porto, Interdisciplinary Ctr Marine \& Environm Res CIIMA, Rua Bragas 289, P-4050123 Oporto, Portugal.}},
DOI = {{10.1007/s11356-016-7137-8}},
ISSN = {{0944-1344}},
EISSN = {{1614-7499}},
Keywords = {{Photocatalysis; Air disinfection; Water disinfection; Monolithic
   structures}},
Keywords-Plus = {{TITANIUM-DIOXIDE; ANTIBIOTIC-RESISTANCE; TREATMENT PLANTS; TIO2 FILMS;
   INDOOR AIR; N-DECANE; DISINFECTION; WATER; CONTAMINATION; DEGRADATION}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{caio.rodrigues@iqm.unicamp.br
   vilar@fe.up.pt}},
ResearcherID-Numbers = {{Scientific output, CIIMAR/E-5122-2012
   Scientific Productivity, CIIMAR/N-6498-2017
   }},
ORCID-Numbers = {{Scientific output, CIIMAR/0000-0001-6270-2153
   Scientific Productivity, CIIMAR/0000-0002-3703-4402
   Faria, Joaquim/0000-0002-6531-3978
   Vilar, Vitor/0000-0003-0943-2144
   Pinto, Eugenia/0000-0003-2948-5809
   Miranda, Sandra/0000-0003-2614-059X
   Silva, Adrian/0000-0001-8551-6353}},
Funding-Acknowledgement = {{Associate Laboratory LSRE-LC - FEDER funds through COMPETE2020 -
   Programa Operacional Competitividade e Internacionalizacao (POCI)
   {[}PTDC/EQU-EQU/100554/2008, POCI-01-0145-FEDER-006984]; national funds
   through FCT Fundacao para a Ciencia e a Tecnologia; CAPES
   {[}2013:8674/13-2]; FAPESP {[}2014:2014/16622-3]; project CAPES/FCT
   {[}308/11]; FCT {[}SFRH/BPD/73894/2010]; FCT Investigator Programme
   {[}IF/00273/2013, IF/01501/2013]; national funds
   {[}UID/Multi/04423/2013]; European Regional Development Fund (ERDF)}},
Funding-Text = {{Financial support was partially provided by PTDC/EQU-EQU/100554/2008
   (AIRPHOTOXI) and POCI-01-0145-FEDER-006984 Associate Laboratory LSRE-LCM
   funded by FEDER funds through COMPETE2020 - Programa Operacional
   Competitividade e Internacionalizacao (POCI)-and by national funds
   through FCT Fundacao para a Ciencia e a Tecnologia. Caio Rodrigues-Silva
   acknowledges CAPES (2013:8674/13-2) and FAPESP (2014:2014/16622-3)
   research scholarship and the project CAPES/FCT 308/11 for the financial
   support. F.V.S. Lopes gratefully acknowledge FCT for his post-doc
   research fellowship, SFRH/BPD/73894/2010. V.J.P. Vilar and A.M.T. Silva
   acknowledge the FCT Investigator 2013 Programme (IF/00273/2013 and
   IF/01501/2013, respectively). This research was partially supported by
   the Strategic Funding UID/Multi/04423/2013 through national funds
   provided by FCT - Foundation for Science and Technology and European
   Regional Development Fund (ERDF), in the framework of the programme
   PT2020.}},
Cited-References = {{Blake DM, 1999, SEPAR PURIF METHOD, V28, P1, DOI 10.1080/03602549909351643.
   Foster HA, 2011, APPL MICROBIOL BIOT, V90, P1847, DOI 10.1007/s00253-011-3213-7.
   FOX BC, 1990, AM J INFECT CONTROL, V18, P300, DOI 10.1016/0196-6553(90)90229-L.
   Fracchia L, 2006, J APPL MICROBIOL, V100, P973, DOI 10.1111/j.1365-2672.2006.02846.x.
   Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2.
   Gerardi MH, 2005, WASTEWATER MICROBIOL, V1.
   Guo MZ, 2013, CEMENT CONCRETE COMP, V36, P101, DOI 10.1016/j.cemconcomp.2012.08.006.
   Harakeh S, 2006, MAR POLLUT B, V52, P8.
   Hung HF, 2010, J HAZARD MATER, V175, P866, DOI 10.1016/j.jhazmat.2009.10.090.
   Kuhn KP, 2003, CHEMOSPHERE, V53, P71, DOI 10.1016/S0045-6535(03)00362-X.
   Lonnen J, 2005, WATER RES, V39, P877, DOI 10.1016/j.watres.2004.11.023.
   Lopes FVS, 2013, APPL CATAL B-ENVIRON, V140, P444, DOI 10.1016/j.apcatb.2013.04.034.
   Markowska-Szczupak A, 2011, CATAL TODAY, V169, P249, DOI 10.1016/j.cattod.2010.11.055.
   Matsumoto M, 2012, INT J ANTIMICROB AG, V40, P440, DOI 10.1016/j.ijantimicag.2012.06.021.
   MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211.
   Miranda SM, 2015, ENVIRON SCI POLLUT R, V22, P820, DOI 10.1007/s11356-014-2952-2.
   Monteiro RAR, 2015, APPL CATAL B-ENVIRON, V165, P306, DOI 10.1016/j.apcatb.2014.10.026.
   Monteiro RAR, 2015, APPL CATAL B-ENVIRON, V162, P66, DOI 10.1016/j.apcatb.2014.06.017.
   Oppliger A, 2005, ANN OCCUP HYG, V49, P393, DOI {[}10.1093/annhyg/meh108, 10.1093/annhyg/mch108].
   Pulgarin C, 2012, APPL CATAL B-ENVIRON, V128, P179, DOI 10.1016/j.apcatb.2012.01.036.
   Sanchez B, 2012, CHEMOSPHERE, V87, P625, DOI 10.1016/j.chemosphere.2012.01.050.
   Schluter A, 2007, FEMS MICROBIOL REV, V31, P449, DOI 10.1111/j.1574-6976.2007.00074.x.
   Sichel C, 2007, J PHOTOCH PHOTOBIO A, V189, P239, DOI 10.1016/j.jphotochem.2007.02.004.
   Teixeira JV, 2013, ENVIRON MONIT ASSESS, V185, P59, DOI 10.1007/s10661-012-2533-0.
   Vijay M, 2013, CURR APPL PHYS, V13, P510, DOI 10.1016/j.cap.2012.09.014.
   Vohra A, 2006, APPL CATAL B-ENVIRON, V64, P57, DOI 10.1016/j.apcatb.2005.10.025.
   Wang WJ, 2015, J ENVIRON SCI-CHINA, V34, P232, DOI 10.1016/j.jes.2015.05.003.
   WHO, 2002, COMM DIS PROGR REP.
   Zhang YL, 2009, SCI TOTAL ENVIRON, V407, P3702, DOI 10.1016/j.scitotenv.2009.02.013.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{13}},
Usage-Count-Since-2013 = {{29}},
Journal-ISO = {{Environ. Sci. Pollut. Res.}},
Doc-Delivery-Number = {{ER9RI}},
Unique-ID = {{ISI:000399163700042}},
DA = {{2018-08-13}},
}

@article{ ISI:000396341700035,
Author = {Marks, Florian and von Kalckreuth, Vera and Aaby, Peter and
   Adu-Sarkodie, Yaw and El Tayeb, Muna Ahmed and Ali, Mohammad and Aseffa,
   Abraham and Baker, Stephen and Biggs, Holly M. and Bjerregaard-Andersen,
   Morten and Breiman, Robert F. and Campbell, James I. and Cosmas, Leonard
   and Crump, John A. and Espinoza, Maria Cruz and Deerin, Jessica Fung and
   Dekker, Denise Myriam and Fields, Barry S. and Gasmelseed, Nagla and
   Hertz, Julian T. and Nguyen Van Minh Hoang and Jaeger, Justin Im Anna
   and Jeon, Hyon Jin and Kabore, Leon Parfait and Keddy, Karen H. and
   Konings, Frank and Krumkamp, Ralf and Ley, Benedikt and Erg, Sandra
   Valborg Lofb and May, Juergen and Meyer, Christian G. and Mintz, Eric D.
   and Montgomery, Joel M. and Niang, Aissatou Ahmet and Nichols, Chelsea
   and Olack, Beatrice and Pak, Gi Deok and Panzner, Ursula and Park, Jin
   Kyung and Park, Se Eun and Rabezanahary, Henintsoa and
   Rakotozandrindrainy, Raphael and Raminosoa, Tiana Mirana and
   Razafindrabe, Tsiriniaina Jean Luco and Sampo, Emmanuel and
   Schutt-Gerowitt, Heidi and Sow, Amy Gassama and Sarpong, Nimako and Seo,
   Hye Jin and Sooka, Arvinda and Soura, Abdramane Bassiahi and Tall, Adama
   and Teferi, Mekonnen and Thriemer, Kamala and Warren, Michelle R. and
   Yeshitela, Biruk and Clemens, John D. and Wierzba, Thomas F.},
Title = {{Incidence of invasive salmonella disease in sub-Saharan Africa: a
   multicentre population-based surveillance study}},
Journal = {{LANCET GLOBAL HEALTH}},
Year = {{2017}},
Volume = {{5}},
Number = {{3}},
Pages = {{E310-E323}},
Month = {{MAR}},
Abstract = {{Background Available incidence data for invasive salmonella disease in
   sub-Saharan Africa are scarce. Standardised, multicountry data are
   required to better understand the nature and burden of disease in
   Africa. We aimed to measure the adjusted incidence estimates of typhoid
   fever and invasive non-typhoidal salmonella (iNTS) disease in
   sub-Saharan Africa, and the antimicrobial susceptibility profiles of the
   causative agents.
   Methods We established a systematic, standardised surveillance of blood
   culture-based febrile illness in 13 African sentinel sites with previous
   reports of typhoid fever: Burkina Faso (two sites), Ethiopia, Ghana,
   Guinea-Bissau, Kenya, Madagascar (two sites), Senegal, South Africa,
   Sudan, and Tanzania (two sites). We used census data and health-care
   records to define study catchment areas and populations. Eligible
   participants were either inpatients or outpatients who resided within
   the catchment area and presented with tympanic (>= 38.0 degrees C) or
   axillary temperature (>= 37.5 degrees C). Inpatients with a reported
   history of fever for 72 h or longer were excluded. We also implemented a
   health-care utilisation survey in a sample of households randomly
   selected from each study area to investigate health-seeking behaviour in
   cases of self-reported fever lasting less than 3 days. Typhoid fever and
   iNTS disease incidences were corrected for health-care-seeking behaviour
   and recruitment.
   Findings Between March 1, 2010, and Jan 31, 2014, 135 Salmonella
   enterica serotype Typhi (S Typhi) and 94 iNTS isolates were cultured
   from the blood of 13 431 febrile patients. Salmonella spp accounted for
   33\% or more of all bacterial pathogens at nine sites. The adjusted
   incidence rate (AIR) of S Typhi per 100 000 person-years of observation
   ranged from 0 (95\% CI 0-0) in Sudan to 383 (274-535) at one site in
   Burkina Faso; the AIR of iNTS ranged from 0 in Sudan, Ethiopia,
   Madagascar (Isotry site), and South Africa to 237 (178-316) at the
   second site in Burkina Faso. The AIR of iNTS and typhoid fever in
   individuals younger than 15 years old was typically higher than in those
   aged 15 years or older. Multidrug-resistant S Typhi was isolated in
   Ghana, Kenya, and Tanzania (both sites combined), and
   multidrug-resistant iNTS was isolated in Burkina Faso (both sites
   combined), Ghana, Kenya, and Guinea-Bissau.
   Interpretation Typhoid fever and iNTS disease are major causes of
   invasive bacterial febrile illness in the sampled locations, most
   commonly affecting children in both low and high population density
   settings. The development of iNTS vaccines and the introduction of S
   Typhi conjugate vaccines should be considered for high-incidence
   settings, such as those identified in this study. Copyright (C) The
   Author(s). Published by Elsevier Ltd. This is an Open Access article
   under the CC BY license.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Marks, F (Reprint Author), Int Vaccine Inst, SNU Res Pk,1 Gwanak Ro, Seoul 08826, South Korea.
   Marks, Florian; von Kalckreuth, Vera; Espinoza, Maria Cruz; Deerin, Jessica Fung; Jeon, Hyon Jin; Konings, Frank; Ley, Benedikt; Nichols, Chelsea; Pak, Gi Deok; Panzner, Ursula; Park, Jin Kyung; Park, Se Eun; Schutt-Gerowitt, Heidi; Seo, Hye Jin; Thriemer, Kamala; Warren, Michelle R.; Clemens, John D.; Wierzba, Thomas F., Int Vaccine Inst, SNU Res Pk,1 Gwanak Ro, Seoul 08826, South Korea.
   Aaby, Peter; Bjerregaard-Andersen, Morten; Erg, Sandra Valborg Lofb, Bandim Hlth Project, Bissau, Guinea Bissau.
   Aaby, Peter; Bjerregaard-Andersen, Morten; Erg, Sandra Valborg Lofb, Res Ctr Vitamins \& Vaccines, Copenhagen, Denmark.
   Adu-Sarkodie, Yaw; Sarpong, Nimako, Kwame Nkrumah Univ Sci \& Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana.
   El Tayeb, Muna Ahmed; Gasmelseed, Nagla, Univ Gezira, Fac Med, Wad Madani, Sudan.
   Ali, Mohammad, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   Aseffa, Abraham; Teferi, Mekonnen; Yeshitela, Biruk, Armauer Hansen Res Inst, Addis Ababa, Ethiopia.
   Baker, Stephen; Campbell, James I.; Nguyen Van Minh Hoang, Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam.
   Biggs, Holly M.; Crump, John A.; Hertz, Julian T., Kilimanjaro Christian Med Ctr, Moshi, Tanzania.
   Biggs, Holly M.; Crump, John A.; Hertz, Julian T., Duke Univ, Med Ctr, Div Infect Dis \& Int Hlth, Durham, NC USA.
   Breiman, Robert F.; Cosmas, Leonard; Fields, Barry S.; Montgomery, Joel M., Ctr Dis Control \& Prevent, Nairobi, Kenya.
   Cosmas, Leonard, WHO Kenya Country Off, Nairobi, Kenya.
   Breiman, Robert F., Emory Univ, Global Hlth Inst, Atlanta, GA 30322 USA.
   Crump, John A., Duke Univ, Duke Global Hlth Inst, Durham, NC USA.
   Crump, John A., Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   Dekker, Denise Myriam; Jaeger, Justin Im Anna; Krumkamp, Ralf; May, Juergen, Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   Dekker, Denise Myriam; Krumkamp, Ralf; May, Juergen; Sarpong, Nimako, German Ctr Infect Res, Hamburg, Germany.
   Gasmelseed, Nagla, Univ Hafr Al Batin, Fac Sci, Hafar al Batin, Saudi Arabia.
   Kabore, Leon Parfait; Sampo, Emmanuel, Schiphra Hosp, Ouagadougou, Burkina Faso.
   Keddy, Karen H.; Sooka, Arvinda, Natl Inst Communicable Dis, Johannesburg, South Africa.
   Keddy, Karen H., Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa.
   Ley, Benedikt; Thriemer, Kamala, Charles Darwin Univ, Menzies Sch Hlth Res, Global \& Trop Hlth Div, Darwin, NT, Australia.
   Meyer, Christian G., Eberhard Karls Univ Tubingen, Inst Trop Med, Tubingen, Germany.
   Meyer, Christian G., Duy Tan Univ, Da Nang, Vietnam.
   Mintz, Eric D., Ctr Dis Control \& Prevent, Natl Ctr Emerging \& Zoonot Infect Dis, Atlanta, GA USA.
   Niang, Aissatou Ahmet; Sow, Amy Gassama; Tall, Adama, Inst Pasteur, Dakar, Senegal.
   Olack, Beatrice, Kenya Govt Med Res Ctr, Clin Res Ctr, Nairobi, Kenya.
   Rabezanahary, Henintsoa; Rakotozandrindrainy, Raphael; Raminosoa, Tiana Mirana; Razafindrabe, Tsiriniaina Jean Luco, Univ Antananarivo, Microbiol Lab, Antananarivo, Madagascar.
   Soura, Abdramane Bassiahi, Univ Ouagadougou, Inst Super Sci Populat, Ouagadougou, Burkina Faso.
   Schutt-Gerowitt, Heidi, Univ Cologne, Inst Med Microbiol, Cologne, Germany.
   Sow, Amy Gassama, Univ Cheikh Anta Diop Dakar, Dakar, Senegal.
   Clemens, John D., Int Ctr Diarrheal Dis Res Bangladesh, Dhaka, Bangladesh.
   Clemens, John D., Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA.}},
DOI = {{10.1016/S2214-109X(17)30022-0}},
ISSN = {{2214-109X}},
Keywords-Plus = {{ENTERICA SEROVAR TYPHI; LABORATORY DIAGNOSIS; FEVER; KENYA; COUNTRIES;
   CHILDREN; BURDEN; BLOOD; SENSITIVITY; INFECTIONS}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{fmarks@ivi.int}},
ResearcherID-Numbers = {{Ali, Mohammad/E-2365-2017
   }},
ORCID-Numbers = {{Ali, Mohammad/0000-0003-1410-388X
   Aseffa, Abraham/0000-0002-8028-1150
   Hertz, Julian/0000-0002-7396-4789
   Aaby, Peter/0000-0001-8331-1389}},
Funding-Acknowledgement = {{Bill \& Melinda Gates Foundation}},
Funding-Text = {{Bill \& Melinda Gates Foundation.}},
Cited-References = {{AKOH JA, 1991, TROP DOCT, V21, P174, DOI 10.1177/004947559102100415.
   {[}Anonymous], 2008, WKLY EPIDEMIOL REC, V83, P49.
   Ao TT, 2015, EMERG INFECT DIS, V21, P941, DOI 10.3201/eid2106.140999.
   Baker S, 2005, J CLIN MICROBIOL, V43, P4418, DOI {[}10.1128/JCM.43.9.4418-4425.2005, 10.1128/JCM.43.9.4418-4425].
   Baker S, 2015, SCIENCE, V347, P1064, DOI 10.1126/science.aaa2868.
   Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016.
   Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119.
   Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401.
   Burton DC, 2011, J HEALTH POPUL NUTR, V29, P61, DOI 10.3329/jhpn.v29i1.7567.
   Clemens John D, 2009, Emerg Infect Dis, V15, pe2, DOI 10.3201/eid1507.090416.
   Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA.
   Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346.
   Dougan G, 2014, ANNU REV MICROBIOL, V68, P317, DOI 10.1146/annurev-micro-091313-103739.
   Espinoza LMC, 2016, CLIN INFECT DIS, V62, pS17, DOI 10.1093/cid/civ787.
   Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2.
   Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09.
   Kaur J, 2013, J CLIN DIAGN RES, V7, P576, DOI 10.7860/JCDR/2013/4765.2831.
   Keddy KH, 2011, B WORLD HEALTH ORGAN, V89, P640, DOI 10.2471/BLT.11.087627.
   Koirala KD, 2012, ANTIMICROB AGENTS CH, V56, P2761, DOI 10.1128/AAC.06414-11.
   Langridge GC, 2009, J INFECT DIS, V199, P602, DOI 10.1086/596208.
   Marks F, 2010, EMERG INFECT DIS, V16, P1796, DOI 10.3201/eid1611.100388.
   Mengo DM, 2010, J INFECT DEV COUNTR, V4, P393.
   Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8.
   Murray P, 2007, MANUAL CLIN MICROBIO, P649.
   Mweu E, 2008, TROP MED INT HEALTH, V13, P532, DOI 10.1111/j.1365-3156.2008.02031.x.
   Nielsen MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044063.
   Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818.
   Owais A, 2010, PEDIATR INFECT DIS J, V29, P1035, DOI 10.1097/INF.0b013e3181e39f8b.
   Panzner U, 2016, CLIN INFECT DIS, V62, pS56, DOI 10.1093/cid/civ891.
   Park SE, 2016, CLIN INFECT DIS, V62, pS23, DOI 10.1093/cid/civ893.
   Parry CM, 2011, EXPERT REV ANTI-INFE, V9, P711, DOI {[}10.1586/eri.11.47, 10.1586/ERI.11.47].
   Sankoh O, 2012, INT J EPIDEMIOL, V41, P579, DOI 10.1093/ije/dys081.
   Tabu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031237.
   Takem EN, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-400.
   Verma R, 2011, HUM VACCINES, V7, P883, DOI 10.4161/hv.7.8.16282.
   Vlieghe ER, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001933.
   von Kalckreuth V, 2016, CLIN INFECT DIS, V62, pS9, DOI 10.1093/cid/civ693.
   Wain J, 2008, J INFECT DEV COUNTR, V2, P421.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{19}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{18}},
Journal-ISO = {{Lancet Glob. Health}},
Doc-Delivery-Number = {{EN9TE}},
Unique-ID = {{ISI:000396341700035}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000438857100001,
Author = {O'Mullan, Gregory D. and Dueker, M. Elias and Juhl, Andrew R.},
Title = {{Challenges to Managing Microbial Fecal Pollution in Coastal
   Environments: Extra-Enteric Ecology and Microbial Exchange Among Water,
   Sediment, and Air}},
Journal = {{CURRENT POLLUTION REPORTS}},
Year = {{2017}},
Volume = {{3}},
Number = {{1}},
Pages = {{1-16}},
Month = {{MAR}},
Abstract = {{Human population growth, especially in coastal urban cities, increases
   the potential for fecal pollution of adjacent waterways, requiring
   continued advances in pollution monitoring and management. Infections
   remain the largest health risk from contact with fecal- and
   sewage-polluted waters, and a small number of fecal indicator bacteria
   (FIB) are used as primary pollution assessment tools. While FIB continue
   to be useful tools, some of the assumptions about the behavior of FIB in
   the environment, and the associated pathways for pathogen exposure, have
   come into question. Research into the extra-enteric ecology of these
   indicators has identified management-relevant complexities including
   particle association, prolonged environmental persistence, and
   multidirectional microbial exchange among water, sediment, and air.
   These complexities provide opportunities for improving current
   monitoring and modeling strategies and to better understand exposure
   pathways for sewage-related infections.}},
Publisher = {{SPRINGER HEIDELBERG}},
Address = {{TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{O'Mullan, GD (Reprint Author), CUNY Queens Coll, Sch Earth \& Environm Sci, Flushing, NY 11367 USA.
   O'Mullan, GD (Reprint Author), CUNY, Grad Ctr, Earth \& Environm Sci, New York, NY 10017 USA.
   O'Mullan, GD (Reprint Author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.
   O'Mullan, Gregory D., CUNY Queens Coll, Sch Earth \& Environm Sci, Flushing, NY 11367 USA.
   O'Mullan, Gregory D., CUNY, Grad Ctr, Earth \& Environm Sci, New York, NY 10017 USA.
   O'Mullan, Gregory D.; Juhl, Andrew R., Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.
   Dueker, M. Elias, Bard Coll, Environm \& Urban Studies Program, Annandale On Hudson, NY 12504 USA.
   Dueker, M. Elias, Bard Coll, Biol Program, Annandale On Hudson, NY 12504 USA.}},
DOI = {{10.1007/s40726-016-0047-z}},
ISSN = {{2198-6592}},
Keywords = {{Fecal indicator bacteria; Water quality; Microbial exchange; Sewage
   pollution; Coastal; Enterococci}},
Keywords-Plus = {{NEUSE RIVER ESTUARY; ANTIBIOTIC-RESISTANT BACTERIA;
   AMYOTROPHIC-LATERAL-SCLEROSIS; ESCHERICHIA-COLI SURVIVAL; INDICATOR
   BACTERIA; BEACH SAND; RECREATIONAL WATER; SURFACE WATERS; LAKE-MICHIGAN;
   E. COLI}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{gomullan@qc.cuny.edu}},
Funding-Acknowledgement = {{Riverkeeper; Hudson River Foundation}},
Funding-Text = {{The authors would like to thank Ms. Anju Singh for her assistance in
   producing the conceptual figures for this review. Support for writing
   this review was partly provided by grants from Riverkeeper and the
   Hudson River Foundation.}},
Cited-References = {{Ahn JH, 2005, ENVIRON SCI TECHNOL, V39, P5940, DOI 10.1021/es0501464.
   Alderisio KA, 1999, APPL ENVIRON MICROB, V65, P5628.
   Aller JY, 2005, J AEROSOL SCI, V36, P801, DOI 10.1016/j.jaerosci.2004.10.012.
   Anderson ML, 2005, APPL ENVIRON MICROB, V71, P3041, DOI 10.1128/AEM.71.6.3041-3048.2005.
   {[}Anonymous], 2016, SCIENCE, V352, P906.
   Anumol T, 2016, ENVIRON INT, V92-93, P33, DOI 10.1016/j.envint.2016.03.022.
   Arana I, 2003, MICROB ECOL, V45, P29, DOI 10.1007/s00248-002-1029-9.
   Arnold BF, 2016, AM J PUBLIC HEALTH, V106, P1690, DOI 10.2105/AJPH.2016.303279.
   Atwill R, 2007, CHARACTERIZING FRESH.
   AUER MT, 1993, WATER RES, V27, P693, DOI 10.1016/0043-1354(93)90179-L.
   Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747.
   Banack SA, 2015, TOXINS, V7, P322, DOI 10.3390/toxins7020322.
   Benami M, 2016, SCI TOTAL ENVIRON, V562, P344, DOI 10.1016/j.scitotenv.2016.03.200.
   Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P4571, DOI 10.1128/AEM.66.10.4571-4574.2000.
   Beversdorf LJ, 2007, J APPL MICROBIOL, V102, P1372, DOI 10.1111/j.1365-2672.2006.03177.x.
   BIDLE KD, 1995, APPL ENVIRON MICROB, V61, P944.
   BLANCHARD DC, 1982, APPL ENVIRON MICROB, V43, P1001.
   Boehm AB, 2005, WATER RES, V39, P3565, DOI 10.1016/j.watres.2005.06.026.
   Boehm AB, 2002, ENVIRON SCI TECHNOL, V36, P3885, DOI 10.1021/es020524u.
   Boehm AB, 2009, J WATER HEALTH, V7, P9, DOI 10.2166/wh.2009.122.
   Bolster CH, 2005, ENVIRON SCI TECHNOL, V39, P3083, DOI 10.1021/es048643s.
   Bonilla TD, 2007, MAR POLLUT BULL, V54, P1472, DOI 10.1016/j.marpolbul.2007.04.016.
   Bordalo AA, 2002, J APPL MICROBIOL, V93, P864, DOI 10.1046/j.1365-2672.2002.01760.x.
   Boualam M, 2002, WATER RES, V36, P2618, DOI 10.1016/S0043-1354(01)00460-2.
   Bouvier TC, 2002, LIMNOL OCEANOGR, V47, P453, DOI 10.4319/lo.2002.47.2.0453.
   Brennan FP, 2010, APPL ENVIRON MICROB, V76, P1449, DOI 10.1128/AEM.02335-09.
   Brinkmeyer R, 2015, SCI TOTAL ENVIRON, V502, P650, DOI 10.1016/j.scitotenv.2014.09.071.
   Byappanahalli MN, 1998, WATER SCI TECHNOL, V38, P171, DOI 10.1016/S0273-1223(98)00820-8.
   Byappanahalli MN, 2012, MICROBES ENVIRON, V27, P164, DOI 10.1264/jsme2.ME11305.
   CABELLI VJ, 1982, AM J EPIDEMIOL, V115, P606, DOI 10.1093/oxfordjournals.aje.a113342.
   Campbell BJ, 2013, ISME J, V7, P210, DOI 10.1038/ismej.2012.93.
   Campos CJA, 2013, ESTUAR COAST, V36, P834, DOI 10.1007/s12237-013-9599-y.
   Cantwell MG, 2016, MAR POLLUT B.
   CARON DA, 1982, SCIENCE, V218, P795, DOI 10.1126/science.218.4574.795.
   Characklis GW, 2005, WATER RES, V39, P1773, DOI 10.1016/j.watres.2005.03.004.
   Cho KH, 2010, WATER RES, V44, P2189, DOI 10.1016/j.watres.2009.12.051.
   Chudoba EA, 2013, WATER RES, V47, P3455, DOI 10.1016/j.watres.2013.03.047.
   Cizek AR, 2008, WATER RES, V42, P4421, DOI 10.1016/j.watres.2008.06.020.
   Craig DL, 2004, J APPL MICROBIOL, V96, P922, DOI 10.1111/j.1365-2672.2004.02243.x.
   Crump BC, 1998, AQUAT MICROB ECOL, V14, P7, DOI 10.3354/ame014007.
   Davies CM, 2000, J APPL MICROBIOL, V89, P349, DOI 10.1046/j.1365-2672.2000.01118.x.
   DAVIES CM, 1991, J APPL BACTERIOL, V70, P265, DOI 10.1111/j.1365-2672.1991.tb02935.x.
   DAVIES CM, 1995, APPL ENVIRON MICROB, V61, P1888.
   de Brauwere A, 2014, CRIT REV ENV SCI TEC, V44, P2380, DOI 10.1080/10643389.2013.829978.
   de Leeuw G, 2000, J GEOPHYS RES-ATMOS, V105, P29397, DOI 10.1029/2000JD900549.
   De Man H, 2016, EPIDEMIOL INFECT, V144, P1445, DOI 10.1017/S0950268815002654.
   de Man H, 2014, WATER RES, V48, P90, DOI 10.1016/j.watres.2013.09.022.
   DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924.
   Desmarais TR, 2002, APPL ENVIRON MICROB, V68, P1165, DOI 10.1128/AEM.68.3.1165-1172.2002.
   Domingo JWS, 2007, WATER RES, V41, P3539, DOI 10.1016/j.watres.2007.06.001.
   Donaldson AI, 2002, REV SCI TECH OIE, V21, P569, DOI 10.20506/rst.21.3.1362.
   Donovan EP, 2008, APPL ENVIRON MICROB, V74, P1004, DOI 10.1128/AEM.01203-07.
   Dorevitch S, 2010, ENVIRON HEALTH PERSP, V118, P871, DOI 10.1289/ehp.0901627.
   Dorfman MH, 2009, TESTING WATERS GUIDE.
   Dueker ME, 2012, BIOGEOSCIENCES, V9, P803, DOI 10.5194/bg-9-803-2012.
   Dueker ME, 2014, SCI TOTAL ENVIRON, V478, P184, DOI 10.1016/j.scitotenv.2014.01.092.
   Dueker ME, 2012, ENVIRON SCI TECHNOL, V46, P10926, DOI 10.1021/es301870t.
   Dueker ME, 2011, ENVIRON SCI TECHNOL, V45, P3386, DOI 10.1021/es1035128.
   Dufour A, 2007, STAT FRAMEWORK RECRE, V65.
   Eaton T. T., 2013, Annals of Environmental Science, V7, P79.
   Eisenberg SWF, 2010, VET MICROBIOL, V143, P284, DOI 10.1016/j.vetmic.2009.11.033.
   ERKENBRECHER CW, 1981, APPL ENVIRON MICROB, V42, P484.
   EVISON LM, 1988, WATER SCI TECHNOL, V20, P309.
   Farnham DJ, 2015, WATER RES, V76, P143, DOI 10.1016/j.watres.2015.02.040.
   Feng F, 2010, FEMS MICROBIOL ECOL, V74, P214, DOI 10.1111/j.1574-6941.2010.00921.x.
   Feng ZX, 2016, MAR POLLUT BULL, V104, P54, DOI 10.1016/j.marpolbul.2016.02.011.
   Feng ZX, 2015, MAR POLLUT BULL, V94, P37, DOI 10.1016/j.marpolbul.2015.03.019.
   Fisher JC, 2015, APPL ENVIRON MICROB, V81, P7023, DOI 10.1128/AEM.01524-15.
   Fleisher JM, 1996, AM J PUBLIC HEALTH, V86, P1228, DOI 10.2105/AJPH.86.9.1228.
   FLINT KP, 1987, J APPL BACTERIOL, V63, P261, DOI 10.1111/j.1365-2672.1987.tb04945.x.
   Fries JS, 2008, WATER RES, V42, P941, DOI 10.1016/j.watres.2007.09.006.
   Fries JS, 2007, ESTUAR COAST, V30, P359, DOI 10.1007/BF02700178.
   Fries JS, 2006, J ENVIRON ENG-ASCE, V132, P1338, DOI 10.1061/(ASCE)0733-9372(2006)132:10(1338).
   Fugate DC, 2003, ESTUAR COAST SHELF S, V58, P389, DOI 10.1016/S0272-7714(03)00107-0.
   Fujioka R, 1999, J APPL MICROBIOL, V85, p83S.
   Fujioka RS, 2015, INT J ENV RES PUB HE, V12, P7752, DOI 10.3390/ijerph120707752.
   Garcia-Armisen T, 2009, WATER ENVIRON RES, V81, P21.
   Garzio A, 2009, THESIS.
   GERBA CP, 1976, APPL ENVIRON MICROB, V32, P114.
   GONZALEZ JM, 1992, APPL ENVIRON MICROB, V58, P998.
   GOYAL SM, 1977, APPL ENVIRON MICROB, V34, P139.
   Grant SB, 2001, ENVIRON SCI TECHNOL, V35, P2407, DOI 10.1021/es0018163.
   GREENBERG AE, 1956, PUBLIC HEALTH REP, V71, P77, DOI 10.2307/4589366.
   GRIFFITH P, 1994, MAR ECOL PROG SER, V108, P1, DOI 10.3354/meps108001.
   Guber AK, 2015, APPL ENVIRON MICROB, V81, P1168, DOI 10.1128/AEM.03295-14.
   Gutierrez-Cacciabue D, 2016, SCI TOTAL ENVIRON, V539, P494, DOI 10.1016/j.scitotenv.2015.07.138.
   Haas D, 2010, WATER AIR SOIL POLL, V207, P49, DOI 10.1007/s11270-009-0118-5.
   Haller L, 2009, WATER AIR SOIL POLL, V203, P217, DOI 10.1007/s11270-009-0005-0.
   Haller L, 2009, ECOL INDIC, V9, P540, DOI 10.1016/j.ecolind.2008.08.001.
   Halliday E, 2015, ENVIRON SCI TECHNOL, V49, P451, DOI 10.1021/es504908h.
   Halliday E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090815.
   Halliday E, 2011, ENVIRON SCI TECHNOL, V45, P370, DOI 10.1021/es102747s.
   Hammond MJ, 2015, URBAN WATER J, V12, P14, DOI 10.1080/1573062X.2013.857421.
   HARDINA CM, 1991, ENVIRON TOXIC WATER, V6, P185, DOI 10.1002/tox.2530060208.
   Hartz A, 2008, J ENVIRON QUAL, V37, P898, DOI 10.2134/jeq2007.0312.
   Hawker J I, 1998, Commun Dis Public Health, V1, P180.
   Heaney CD, 2012, EPIDEMIOLOGY, V23, P95, DOI 10.1097/EDE.0b013e31823b504c.
   Heaney CD, 2009, AM J EPIDEMIOL, V170, P164, DOI 10.1093/aje/kwp152.
   Hess-Erga OK, 2008, AQUAT BIOL, V4, P147, DOI 10.3354/ab00105.
   Hetling LJ, 2003, WATER ENVIRON RES, V75, P30, DOI 10.2175/106143003X140809.
   Jamieson R, 2005, WATER RES, V39, P2665, DOI 10.1016/j.watres.2005.04.040.
   Jamieson R, 2004, AGR WATER MANAGE, V70, P1, DOI 10.1016/j.agwat.2004.05.006.
   Jamieson RC, 2005, J ENVIRON QUAL, V34, P581, DOI 10.2134/jeq2005.0581.
   Jeng HWC, 2005, J ENVIRON SCI HEAL A, V40, P779, DOI 10.1081/ESE-20048264.
   Juhr AR, 2014, ESTUAR COAST SHELF S, V151, P45, DOI 10.1016/j.ecss.2014.09.020.
   Kay D, 2007, ENVIRON POLLUT, V147, P138, DOI 10.1016/j.envpol.2006.08.019.
   Kay D, 2005, WATER RES, V39, P655, DOI 10.1016/j.watres.2004.11.014.
   Kim JW, 2010, ECOL MODEL, V221, P1592, DOI 10.1016/j.ecolmodel.2010.03.005.
   Kinzelman J. L., 2004, Aquatic Ecosystem Health \& Management, V7, P425, DOI 10.1080/14634980490483953.
   Kinzelman JL, 2003, LAKE RESERV MANAGE, V19, P349, DOI 10.1080/07438140309353944.
   Korajkic A, 2013, APPL ENVIRON MICROB, V79, P5329, DOI 10.1128/AEM.01362-13.
   Korzeniewska E, 2012, WATER AIR SOIL POLL, V223, P4039, DOI 10.1007/s11270-012-1171-z.
   Krometis LAH, 2007, WATER RES, V41, P506, DOI 10.1016/j.watres.2006.09.029.
   LALIBERTE P, 1982, APPL ENVIRON MICROB, V43, P623.
   Lamparelli CC, 2015, WATER RES, V87, P59, DOI 10.1016/j.watres.2015.09.001.
   Le Fevre NM, 2003, WATER SCI TECHNOL, V47, P205.
   Leclerc H, 1996, J APPL BACTERIOL, V81, P459.
   Leclerc H, 2002, CRIT REV MICROBIOL, V28, P371, DOI 10.1080/1040-840291046768.
   Lee CM, 2006, WATER RES, V40, P2593, DOI 10.1016/j.watres.2006.04.032.
   Lee C, 2015, J PHYS CHEM A, V119, P8860, DOI 10.1021/acs.jpca.5b03488.
   Leonard AFC, 2015, ENVIRON INT, V82, P92, DOI 10.1016/j.envint.2015.02.013.
   LIM CH, 1989, J APPL BACTERIOL, V66, P559, DOI 10.1111/j.1365-2672.1989.tb04578.x.
   LITSKY W, 1953, APPL MICROBIOL, V1, P247.
   Liu L, 2006, ENVIRON SCI TECHNOL, V40, P5022, DOI 10.1021/es060438k.
   Loos R, 2009, J CHROMATOGR A, V1216, P1126, DOI 10.1016/j.chroma.2008.12.048.
   Lyons MM, 2010, AQUAT MICROB ECOL, V60, P1, DOI 10.3354/ame01417.
   Mailhot A, 2015, J HYDROL, V523, P602, DOI 10.1016/j.jhydrol.2015.01.063.
   Mallin MA, 2007, MAR POLLUT BULL, V54, P81, DOI 10.1016/j.marpolbul.2006.09.003.
   McLellan SL, 2010, ENVIRON MICROBIOL, V12, P378, DOI 10.1111/j.1462-2920.2009.02075.x.
   McLellan SL, 2014, TRENDS MICROBIOL, V22, P697, DOI 10.1016/j.tim.2014.08.002.
   Mitch AA, 2010, WATER RES, V44, P4776, DOI 10.1016/j.watres.2010.05.060.
   MITCHELL R, 1968, WATER RES, V2, P535, DOI 10.1016/0043-1354(68)90002-X.
   MONAHAN EC, 1983, Q J ROY METEOR SOC, V109, P379, DOI 10.1256/smsqj.46009.
   Montero A, 2016, PEERJ, V4, DOI 10.7717/peerj.2827.
   Mote BL, 2012, APPL ENVIRON MICROB, V78, P2569, DOI 10.1128/AEM.06902-11.
   Murby AL, AEROBIOLOGIA, P1.
   Newton RJ, 2013, MICROB ECOL, V65, P1011, DOI 10.1007/s00248-013-0200-9.
   Tran NH, 2014, ENVIRON SCI POLLUT R, V21, P4727, DOI 10.1007/s11356-013-2428-9.
   Nguyen TMN, 2006, J INFECT DIS, V193, P102.
   Noble RT, 2004, J APPL MICROBIOL, V96, P464, DOI 10.1111/j.1365-2672.2004.02155.x.
   ORLOB GT, 1956, SEWAGE IND WASTES, V28, P1147.
   Pachepsky YA, 2011, CRIT REV ENV SCI TEC, V41, P1067, DOI 10.1080/10643380903392718.
   Pandey PK, 2016, J AM WATER RESOUR AS, V52, P184, DOI 10.1111/1752-1688.12373.
   Pandey PK, 2013, J AM WATER RESOUR AS, V49, P1261, DOI 10.1111/jawr.12079.
   Pandey PK, 2012, WATER RES, V46, P115, DOI 10.1016/j.watres.2011.10.019.
   Passerat J, 2011, WATER RES, V45, P893, DOI 10.1016/j.watres.2010.09.024.
   Perkins TL, 2016, SCI TOTAL ENV.
   Perkins TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112951.
   Pettibone GW, 1996, WATER RES, V30, P2517, DOI 10.1016/0043-1354(96)00135-2.
   Phillip DAT, 2009, J ENVIRON MONITOR, V11, P1192, DOI 10.1039/b817452k.
   Phillips MC, 2014, MAR POLLUT BULL, V79, P114, DOI 10.1016/j.marpolbul.2013.12.029.
   Phillips MC, 2011, WATER RES, V45, P6763, DOI 10.1016/j.watres.2011.10.028.
   Pickup RW, 2005, APPL ENVIRON MICROB, V71, P2130, DOI 10.1128/AEM.71.4.2130-2139.2005.
   PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943.
   Pruss A, 1998, INT J EPIDEMIOL, V27, P1, DOI 10.1093/ije/27.1.1.
   Rehmann CR, 2009, WATER RES, V43, P4579, DOI 10.1016/j.watres.2009.06.049.
   RHODES MW, 1988, APPL ENVIRON MICROB, V54, P2902.
   Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000.
   Riverkeeper, 2015, HOWS THE WAT.
   Roslev P, 2008, WATER AIR SOIL POLL, V194, P13, DOI 10.1007/s11270-008-9715-y.
   Rozen Y, 2001, FEMS MICROBIOL REV, V25, P513, DOI 10.1016/S0168-6445(01)00065-1.
   Sabino R, 2014, SCI TOTAL ENVIRON, V472, P1062, DOI 10.1016/j.scitotenv.2013.11.091.
   Sabino R, 2011, MAR POLLUT BULL, V62, P1506, DOI 10.1016/j.marpolbul.2011.04.008.
   SCHILLINGER JE, 1985, J WATER POLLUT CON F, V57, P384.
   Schoen ME, 2010, ENVIRON SCI TECHNOL, V44, P2286, DOI 10.1021/es903523q.
   Shaffer BT, 1997, MICROBIAL ECOL, V34, P167, DOI 10.1007/s002489900046.
   SHANKS AL, 1993, MAR ECOL PROG SER, V96, P43, DOI 10.3354/meps096043.
   Shanks OC, 2013, APPL ENVIRON MICROB, V79, P2906, DOI 10.1128/AEM.03448-12.
   SHIARIS MP, 1987, APPL ENVIRON MICROB, V53, P1756.
   Shuval Hillel, 2003, Journal of Water and Health, V1, P53.
   Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175.
   Sinton LW, 1999, APPL ENVIRON MICROB, V65, P3605.
   Sinton LW, 2002, APPL ENVIRON MICROB, V68, P1122, DOI 10.1128/AEM.68.3.1122-1131.2002.
   Sinton LW, 2005, BIOTIC ABIOTIC EFFEC, P69.
   Solo-Gabriele HM, 2016, J MAR BIOL ASSOC UK, V96, P101, DOI 10.1017/S0025315415000843.
   Solo-Gabriele HM, 2000, APPL ENVIRON MICROB, V66, P230, DOI 10.1128/AEM.66.1.230-237.2000.
   Spoelstra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082706.
   Stewart JR, 2008, ENV HLTH, V7, P1, DOI {[}10.1186/1476-069x-7-s2-s3, DOI 10.1186/1476-069X-7-S2-S3].
   Stommel EW, 2013, MED HYPOTHESES, V80, P142, DOI 10.1016/j.mehy.2012.11.012.
   Surbeck CQ, 2009, ECOHYDROLOGY, V2, P399, DOI 10.1002/eco.98.
   Suter E., 2011, Journal of Water Resource and Protection, V3, P715, DOI 10.4236/jwarp.2011.310082.
   Tandlich R., 2016, Journal of Disaster Research, V11, P732.
   Tassoula E.A., 1997, INT J ENVIRON STUD, V52, P67.
   Taylor J, 2013, INT J HYG ENVIR HEAL, V216, P91, DOI 10.1016/j.ijheh.2012.03.010.
   ten Veldhuis JAE, 2010, WATER RES, V44, P2910, DOI 10.1016/j.watres.2010.02.009.
   Topp E, 2009, BIORESOURCE TECHNOL, V100, P5395, DOI 10.1016/j.biortech.2008.11.001.
   TORBICK N, 2014, INT J HLTH GEOGR, V13.
   Troussellier M, 1998, OCEANOL ACTA, V21, P965, DOI 10.1016/S0399-1784(99)80019-X.
   Urbano R, 2011, BIOGEOSCIENCES, V8, P301, DOI 10.5194/bg-8-301-2011.
   US-EPA, 2012, 820F12058 USEPA.
   VandeWalle JL, 2012, ENVIRON MICROBIOL, V14, P2538, DOI 10.1111/j.1462-2920.2012.02757.x.
   VANDONSEL DJ, 1971, WATER RES, V5, P1079, DOI 10.1016/0043-1354(71)90040-6.
   Vermeulen LC, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/9/094017.
   Vogel LJ, 2016, ENVIRON SCI TECHNOL, V50, P5676, DOI 10.1021/acs.est.6b00707.
   Wade T.J., 2010, ENV HLTH, V9, P1.
   Wade TJ, 2008, EPIDEMIOLOGY, V19, P375, DOI 10.1097/EDE.0b013e318169cc87.
   Wade TJ, 2003, ENVIRON HEALTH PERSP, V111, P1102, DOI 10.1289/ehp.6241.
   Walters E, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-013-1822-8.
   Wang JD, 2010, MAR POLLUT BULL, V60, P1270, DOI 10.1016/j.marpolbul.2010.03.016.
   Whitlock JE, 2002, WATER RES, V36, P4273, DOI 10.1016/S0043-1354(02)00139-2.
   Whitman RL, 2006, APPL ENVIRON MICROB, V72, P7301, DOI 10.1128/AEM.00454-06.
   Whitman RL, 2014, REV ENVIRON SCI BIO, V13, P329, DOI 10.1007/s11157-014-9340-8.
   Whitman RL, 2009, J WATER HEALTH, V7, P623, DOI 10.2166/wh.2009.115.
   Whitman RL, 2003, APPL ENVIRON MICROB, V69, P5555, DOI 10.1128/AEM.69.9.5555-5562.2003.
   Wohl E, 2015, EARTH-SCI REV, V147, P30, DOI 10.1016/j.earscirev.2015.05.001.
   World Health Organization, 2003, GUID SAF RECR WAT EN.
   Wright ME, 2009, MAR POLLUT BULL, V58, P1649, DOI 10.1016/j.marpolbul.2009.07.003.
   Yamahara KM, 2007, ENVIRON SCI TECHNOL, V41, P4515, DOI 10.1021/es062822n.
   Yamamoto N, 2012, ISME J, V6, P1801, DOI 10.1038/ismej.2012.30.
   Yan T, 2007, ENVIRON MONIT ASSESS, V129, P97, DOI 10.1007/s10661-006-9426-z.
   Yau V, 2009, WATER QUAL EXPOS HEA, V1, P79, DOI 10.1007/s12403-009-0012-9.
   Young S, 2013, J WATER HEALTH, V11, P297, DOI 10.2166/wh.2013.131.
   Zhang Q, 2015, ENVIRON SCI TECHNOL, V49, P8531, DOI 10.1021/acs.est.5b01879.}},
Number-of-Cited-References = {{213}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Curr. Pollut. Rep.}},
Doc-Delivery-Number = {{GN2UQ}},
Unique-ID = {{ISI:000438857100001}},
DA = {{2018-08-13}},
}

@article{ ISI:000393700100042,
Author = {Vaze, Nachiket D. and Park, Sin and Brooks, Ari D. and Fridman,
   Alexander and Joshi, Suresh G.},
Title = {{Involvement of multiple stressors induced by non-thermal plasma-charged
   aerosols during inactivation of airborne bacteria}},
Journal = {{PLOS ONE}},
Year = {{2017}},
Volume = {{12}},
Number = {{2}},
Month = {{FEB 6}},
Abstract = {{A lab-scale, tunable, single-filament, point-to-point nonthermal
   dieletric-barrier discharge (DBD) plasma device was built to study the
   mechanisms of inactivation of aerosolized bacterial pathogens. The
   system inactivates airborne antibiotic-resistant pathogens efficiently.
   Nebulization mediated pre-optimized (4 log and 7 log) bacterial loads
   were challenged to plasma-charged aerosols, and lethal and sublethal
   doses determined using colony assay, and cell viability assay; and the
   loss of membrane potential and cellular respiration were determined
   using cell membrane potential assay and XTT assay. Using the strategies
   of Escherichia coli wildtype, over-expression mutant, deletion mutants,
   and peroxide and heat stress scavenging, we analyzed activation of
   intracellular reactive oxygen species (ROS) and heat shock protein (hsp)
   chaperons. Superoxide dismutase deletion mutants (Delta sodA, Delta
   sodB, Delta sodA Delta sodB) and catalase mutants Delta katG and Delta
   katE Delta katG did not show significant difference from wildtype
   strain, and Delta katE and Delta ahpC was found significantly more
   susceptible to cell death than wildtype. The oxyR regulon was found to
   mediate plasma-charged aerosol-induced oxidative stress in bacteria. Hsp
   deficient E. coli (Delta htpG, Delta groEL, Delta cIpX, Delta grpE)
   showed complete inactivation of cells at ambient temperature, and the
   treatment at cold temperature (4 degrees C) significantly protected hsp
   deletion mutants and wildtype cells, and indicate a direct involvement
   of hsp in plasma-charged aerosol mediated E. coli cell death.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Joshi, SG (Reprint Author), Drexel Univ, Coll Med, Ctr Surg Infect \& Biofilm, Philadelphia, PA 19104 USA.
   Joshi, SG (Reprint Author), Drexel Univ, Sch Biomed Engn Sci \& Hlth Syst, Philadelphia, PA 19104 USA.
   Joshi, SG (Reprint Author), Drexel Univ, AJ Drexel Plasma Inst, Philadelphia, PA 19104 USA.
   Vaze, Nachiket D.; Brooks, Ari D.; Fridman, Alexander; Joshi, Suresh G., Drexel Univ, Coll Med, Ctr Surg Infect \& Biofilm, Philadelphia, PA 19104 USA.
   Vaze, Nachiket D.; Joshi, Suresh G., Drexel Univ, Sch Biomed Engn Sci \& Hlth Syst, Philadelphia, PA 19104 USA.
   Park, Sin; Fridman, Alexander; Joshi, Suresh G., Drexel Univ, AJ Drexel Plasma Inst, Philadelphia, PA 19104 USA.
   Vaze, Nachiket D., Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
   Brooks, Ari D., Univ Penn Hlth Syst, Dept Surg, Philadelphia, PA USA.}},
DOI = {{10.1371/journal.pone.0171434}},
Article-Number = {{e0171434}},
ISSN = {{1932-6203}},
Keywords-Plus = {{RESISTANT STAPHYLOCOCCUS-AUREUS; BARRIER DISCHARGE PLASMA;
   ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; SUPEROXIDE-DISMUTASE; OXIDATIVE
   DAMAGE; MOLECULAR EPIDEMIOLOGY; RAPID INACTIVATION; HYPOCHLOROUS ACID;
   OXYR}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{suresh.joshi@drexelmed.edu}},
Funding-Acknowledgement = {{Drexel University College of Medicine for Surgical Infection Control
   Research}},
Funding-Text = {{This research was carried out through intramural research support from
   the Drexel University College of Medicine for Surgical Infection Control
   Research. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.}},
Cited-References = {{Alexopoulos J, 2013, MOL MICROBIOL, V90, P167, DOI 10.1111/mmi.12356.
   AMBROSIO G, 1992, CARDIOVASC DRUG THER, V6, P623, DOI 10.1007/BF00052564.
   Arjunan KP, 2011, IEEE ENG MED BIO, P2447, DOI 10.1109/IEMBS.2011.6090680.
   Asad NR, 1998, MUTAT RES-DNA REPAIR, V407, P253, DOI 10.1016/S0921-8777(98)00010-X.
   Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161.
   Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050.
   Baharoglu Z, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003421.
   Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104.
   BUKAU B, 1993, MOL MICROBIOL, V9, P671, DOI 10.1111/j.1365-2958.1993.tb01727.x.
   CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484.
   COOMBS AML, 1987, INT J RADIAT BIOL, V51, P493, DOI 10.1080/09553008714550971.
   Cooper M, 2010, J APPL MICROBIOL, V109, P2039, DOI 10.1111/j.1365-2672.2010.04834.x.
   D'Agata EMC, 2009, CLIN INFECT DIS, V48, P274, DOI 10.1086/595844.
   Dukan S, 1996, J BACTERIOL, V178, P6145, DOI 10.1128/jb.178.21.6145-6150.1996.
   Eduard W, 1998, AM IND HYG ASSOC J, V59, P113, DOI 10.1202/0002-8894(1998)059<0113:MFQAOA>2.0.CO;2.
   Gallagher MJ, 2007, IEEE T PLASMA SCI, V35, P1501, DOI 10.1109/TPS.2007.905209.
   Genest O, 2011, P NATL ACAD SCI USA, V108, P8206, DOI 10.1073/pnas.1104703108.
   Goswami M, 2006, ANTIMICROB AGENTS CH, V50, P949, DOI 10.1128/AAC.50.3.949-954.2006.
   Guan TJ, 2010, J AEROSOL SCI, V41, P611, DOI 10.1016/j.jaerosci.2010.03.002.
   Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07.
   Hwang D, 2015, SCI REP-UK, V5, DOI 10.1038/srep10029.
   Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10.
   Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002.
   JUOZAITIS A, 1994, APPL ENVIRON MICROB, V60, P861.
   Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688.
   Kim NH, 2006, J BIOCHEM MOL BIOL, V39, P452.
   Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049.
   Kvam E, 2012, ANTIMICROB AGENTS CH, V56, P2028, DOI 10.1128/AAC.05642-11.
   Liang JL, 2012, J AEROSOL SCI, V54, P103, DOI 10.1016/j.jaerosci.2012.07.009.
   Liang YD, 2012, ENVIRON SCI TECHNOL, V46, P3360, DOI {[}10.1021/es203770q, 10.1021/es203770g].
   McCormick ML, 1998, J BACTERIOL, V180, P622.
   McDonald KF, 2002, IEEE T PLASMA SCI, V30, P1986, DOI 10.1109/TPS.2002.805378.
   Moreau M, 2008, BIOTECHNOL ADV, V26, P610, DOI 10.1016/j.biotechadv.2008.08.001.
   Moritz M, 2001, INT J HYG ENVIR HEAL, V203, P401, DOI 10.1078/1438-4639-00054.
   Nair N, 2011, INFECT CONT HOSP EP, V32, P1057, DOI 10.1086/662178.
   Noor R, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1415-7.
   OGG JE, 1956, J BACTERIOL, V72, P494.
   Panek HR, 2004, J BACTERIOL, V186, P7874, DOI {[}10.1128/JB.186.23.7874-7880.2004, 10.1028/JB.186.23.7874-7880.2004].
   Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010.
   Schmid S, 2013, J HAZARD MATER, V256, P76, DOI 10.1016/j.jhazmat.2013.04.021.
   SCHWARTZ CE, 1983, J BIOL CHEM, V258, P6277.
   Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001.
   Shi Xing-min, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P2033.
   Theodore A, 2013, GENETICS.
   TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995.
   Uhlich GA, 2009, MICROBIOL-SGM, V155, P3589, DOI {[}10.1099/mic.0.1331435-0, 10.1099/mic.0.031435-0].
   Van Droogenbroeck C, 2009, VET MICROBIOL, V135, P31, DOI 10.1016/j.vetmic.2008.09.042.
   VANDERHEIDE RS, 1987, J MOL CELL CARDIOL, V19, P615, DOI 10.1016/S0022-2828(87)80367-X.
   Vaze ND, 2010, IEEE T PLASMA SCI, V38, P3234, DOI 10.1109/TPS.2010.2072788.
   Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08.
   Warnes SL, 2012, ENVIRON MICROBIOL, V14, P1730, DOI 10.1111/j.1462-2920.2011.02677.x.
   WASIL M, 1987, BIOCHEM J, V243, P867, DOI 10.1042/bj2430867.
   Weir SK, 2012, J CLIN MICROBIOL, V50, P3283, DOI 10.1128/JCM.01143-12.
   Yamazaki H, 2011, DENT MATER J, V30, P384, DOI 10.4012/dmj.2010-190.
   Yao M, 2005, ENVIRON SCI TECHNOL, V39, P3338, DOI 10.1021/es048808x.
   Yoon SJ, 2002, J BIOCHEM MOL BIOL, V35, P297.
   Yost AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139903.
   Zerrouki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116083.
   Zhang Q, 2010, J AEROSOL SCI, V41, P880, DOI 10.1016/j.jaerosci.2010.06.001.}},
Number-of-Cited-References = {{59}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{9}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{EK1QH}},
Unique-ID = {{ISI:000393700100042}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000393227000001,
Author = {Bunalema, Lydia and Fotso, Ghislain Wabo and Waako, Paul and Tabuti,
   John and Yeboah, Samuel O.},
Title = {{Potential of Zanthoxylum leprieurii as a source of active compounds
   against drug resistant Mycobacterium tuberculosis}},
Journal = {{BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE}},
Year = {{2017}},
Volume = {{17}},
Month = {{FEB 2}},
Abstract = {{Background: Tuberculosis (TB) is still a global health problem mainly
   due to development of resistance and co-infection with the Human immune
   Virus (HIV). Treatment of multi and extensively drug resistant TB
   requires use of second line drugs which are less efficacious, expensive
   and very toxic. This has necessitated a need to search for new treatment
   regimens especially from medicinal plants. Zanthoxylum leprieurii, a
   plant species from Rutace is used locally in the treatment of
   tuberculosis in Uganda. The aim of the study was to isolate, identify
   and characterize bio active compounds from Z. leprieurii stem bark with
   antimycobacterial activity.
   Methods: Crude extracts, fractions and compounds from air dried stem
   bark of Z. leprieurii were tested against pan sensitive (H37rv),
   isoniazid resistant (TMC 301) and rifampicin resistant (TMC 331) strains
   of M. tuberculosis using micro plate alamar blue assay. Isolation of
   active compounds was done by using column chromatography and thin layer
   chromatography. They were analysed using nuclear magnetic resonance
   spectroscopy and mass spectroscopy.
   Results: The methanol extract had minimum inhibitory concentrations
   (MIC) of 47.5, 75.3 and 125.0 mu g/ml on the pan sensitive strain,
   rifampicin resistant and isozianid resistant strains of M. tuberculosis
   respectively. The chloroform extract had MIC values of 260 mu g/ml
   agnaist the pan sensitive strain and 156 mu g/ml on the rifampicin
   resistant strain. Of the sixteen fractions from the methanol extract,
   fraction Za(4) (MIC = 6.3 mu g/mL, 23.0 mu g/mL, 11.7 mu g/mL) and Za(6)
   (MIC = 11.7 mu g/mL 31.2 mu g/ml, 31.2 mu g/ml) were the most active.
   Three acridone alkaloids; hydroxy-1, 3-dimethoxy-10-methyl-9-acridone
   (1), 1 hydroxy 3 methoxy 10 methyl 9 acridone (2) and 3 hydroxy 1, 5, 6
   trimethoxy 9 acridone (3) were isolated from Za(4) and Za(6). The MIC of
   compound 3 was found to be 5.1 mu g/ml, 4.5 mu g/ml and 3.9 mu g/ml on
   H37rv, TMC 331 and TMC 301 while that of 1 was found to be 1.5 mu g/ml,
   8.3 mu g/ml and 3.5 mu g/ml respectively.
   Conclusion: The results of this study suggest that Z. leprieurii is
   active on resistant strains of M. tuberculosis and could be a potential
   source of new leads against resistant tuberculosis. It also verifies the
   local use of the plant in treatment of tuberculosis.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Bunalema, L (Reprint Author), Makerere Univ, Dept Pharmacol \& Therapeut, Coll Hlth Sci, POB 7072, Kampala, Uganda.
   Bunalema, Lydia; Waako, Paul, Makerere Univ, Dept Pharmacol \& Therapeut, Coll Hlth Sci, POB 7072, Kampala, Uganda.
   Fotso, Ghislain Wabo, Univ Yaounde I, Dept Organ Chem, Fac Sci, POB 812, Yaounde, Cameroon.
   Tabuti, John, Makerere Univ, Dept Environm management, POB 7062, Kampala, Uganda.
   Yeboah, Samuel O., Univ Botswana, Dept Chem, Fac Sci, Private Bag UB00704, Gaborone, Botswana.}},
DOI = {{10.1186/s12906-017-1602-x}},
Article-Number = {{89}},
ISSN = {{1472-6882}},
Keywords = {{Zanthoxylum leprieurii; Tuberculosis; Isolation; Acridone alkaloids;
   Antimycobacterial activity}},
Keywords-Plus = {{IN-VITRO; ANTIOXIDANT ACTIVITY; MEDICINAL-PLANTS; CONSTITUENTS;
   MANAGEMENT; PRODUCTS; EXTRACTS; AGENTS; TB}},
Research-Areas = {{Integrative \& Complementary Medicine}},
Web-of-Science-Categories  = {{Integrative \& Complementary Medicine}},
Author-Email = {{blydia@chs.mak.ac.ug}},
ORCID-Numbers = {{Yeboah, Samuel/0000-0002-8070-7967}},
Funding-Acknowledgement = {{Carnegie cooperation through Next Generation of African Academics1
   (NGAA1); Carnegie cooperation through Regional Initiative in Science and
   Education -African Natural products Network (RISE-AFNNET); Commonwealth
   University Young Career award; Network for Analytical Bioassay Services
   in Africa (NABSA)}},
Funding-Text = {{We acknowledge Carnegie cooperation through Next Generation of African
   Academics1 (NGAA1) and Regional Initiative in Science and Education
   -African Natural products Network (RISE-AFNNET), Commonwealth University
   Young Career award and Network for Analytical Bioassay Services in
   Africa (NABSA) for funding this work.}},
Cited-References = {{Akintola A O, 2013, Niger J Physiol Sci, V28, P135.
   Bunalema L, 2014, J ETHNOPHARMACOL, V151, P999, DOI 10.1016/j.jep.2013.12.020.
   Chatha SAS, 2006, GRASAS ACEITES, V57, P328.
   Chin YW, 2006, AAPS J, V8, pE239.
   Cos P, 2006, J ETHNOPHARMACOL, V106, P290, DOI 10.1016/j.jep.2006.04.003.
   Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564.
   Cox E, 2014, NEW ENGL J MED, V371, P689, DOI 10.1056/NEJMp1314385.
   Do QD, 2014, J FOOD DRUG ANAL, V22, P296, DOI 10.1016/j.jfda.2013.11.001.
   Gautam R, 2007, J ETHNOPHARMACOL, V110, P200, DOI 10.1016/j.jep.2006.12.031.
   Harmill HM., 1997, USEFUL PLANTS W TROP.
   HUGHES GK, 1949, AUST J SCI RES SER A, V2, P429, DOI 10.1071/CH9490429.
   Kishore N, 2009, FITOTERAPIA, V80, P149, DOI 10.1016/j.fitote.2009.01.002.
   Lamorde M, 2010, J ETHNOPHARMACOL, V130, P43, DOI 10.1016/j.jep.2010.04.004.
   Lawal T. O., 2011, African Journal of Biomedical Research, V14, P17.
   Luo X, 2013, J ETHNOPHARMACOL, V146, P417, DOI 10.1016/j.jep.2013.01.013.
   Matasyoh JC, 2011, J NAT PRODUCTS, V1, P121.
   Migliori GB, 2013, EUR RESPIR J, V42, P169, DOI 10.1183/09031936.00136312.
   Ngoumfo RM, 2010, BIOORGAN MED CHEM, V18, P3601, DOI 10.1016/j.bmc.2010.03.040.
   Ladino OJP, 2010, QUIM NOVA, V33, P1019, DOI 10.1590/S0100-40422010000500002.
   Phillips L, 2013, NATURE, V493, P14, DOI 10.1038/493014a.
   Sarathy JP, ROLE TRANSPORT MECHA.
   Sloan DJ, 2016, T ROY SOC TROP MED H, V110, P163, DOI 10.1093/trstmh/trv107.
   Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008.
   Tabuti JRS, 2010, J ETHNOPHARMACOL, V127, P130, DOI 10.1016/j.jep.2009.09.035.
   Tekwu EM, 2012, J ETHNOPHARMACOL, V142, P374, DOI 10.1016/j.jep.2012.05.003.
   Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889.
   World Health Organisation, T1B FACT SHEET.
   World Health Organization, 2015, GLOB TUB REP.
   Wouatsa VNA, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-125.
   Wynne A, 2014, INT J AFRICA NURSING, V1, P6.
   Yadav AK, 2013, MED CHEM RES, V22, P2706, DOI 10.1007/s00044-012-0268-7.
   Zia-u1-Haq M, 2016, ANTHOCYANINS HUMAN H.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{9}},
Journal-ISO = {{BMC Complement. Altern. Med.}},
Doc-Delivery-Number = {{EJ4ZT}},
Unique-ID = {{ISI:000393227000001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000395955000018,
Author = {Bumah, Violet V. and Aboualizadeh, Ebrahim and Masson-Meyers, Daniela S.
   and Eells, Janis T. and Enwemeka, Chukuka S. and Hirschmugl, Carol J.},
Title = {{Spectrally resolved infrared microscopy and chemometric tools to reveal
   the interaction between blue light (470 nm) and methicillin-resistant
   Staphylococcus aureus}},
Journal = {{JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY}},
Year = {{2017}},
Volume = {{167}},
Pages = {{150-157}},
Month = {{FEB}},
Abstract = {{Blue light inactivates methicillin-resistant Staphylococcus aureus
   (MRSA), a Gram-positive antibiotic resistant bacterium that leads to
   fatal infections; however, the mechanism of bacterial death remains
   unclear. In this paper, to uncover the mechanism underlying the
   bactericidal effect of blue light, a combination of Fourier transform
   infrared (FTIR) spectroscopy and chemometric tools is employed to detect
   the photoreactivity of MRSA and its distinctive pathway toward apoptosis
   after treatment. The mechanism of action of UV light and vancomycin
   against MRSA is also investigated to support the findings. Principal
   component analysis followed by linear discriminant analysis (PCA-LDA) is
   employed to reveal clustering of five groups of MRSA samples, namely
   untreated (control I), untreated and incubated at ambient air (control
   II), irradiated with 470 nm blue light, irradiated with 253.5 UV light,
   and vancomycin-treated MRSA. Loadings plot from PCA-LDA analysis reveals
   important functional groups in proteins (1683, 1656, 1596, 1542 cm(-1)),
   lipids (1743, 1409 cm(-1)), and nucleic acids region of the spectrum
   (1060, 1087 cm(-1)) that are responsible for the classification of blue
   light irradiated spectra and control spectra. Cluster vector plots and
   scores plot reveals that UV light-irradiated spectra are the most
   biochemically similar to blue light-irradiated spectra; however, some
   wavenumbers experience a shift. The shifts between blue light and UV
   light irradiated loadings plot at nu(asym) PO2- band (from 1228 to 1238
   cm(-1)), DNA backbone (from 970 to 966 cm(-1)) and base pairing
   vibration of DNA (from 1717 to 1712 cm(-1)) suggest distinctive changes
   in DNA conformation in response to irradiation. Our findings indicate
   that irradiation of MRSA with 470 nm light induces A-DNA cleavage and
   that B-DNA is more resistant to damage by blue light. Blue light and UV
   light treatment of MRSA are complementary and distinct from the known
   antimicrobial effect of vancomycin. Moreover, it is known that
   UV-induced cleavage of DNA predominantly targets B-DNA, which is in
   agreement with the FTIR findings. Overall the results suggest that the
   combination of light and vancomycin could be a more robust approach in
   treating MRSA infections}},
Publisher = {{ELSEVIER SCIENCE SA}},
Address = {{PO BOX 564, 1001 LAUSANNE, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hirschmugl, CJ (Reprint Author), Univ Wisconsin, Coll Letters \& Sci, Dept Phys, 3135 North Maryland Ave, Milwaukee, WI 53211 USA.
   Bumah, Violet V.; Masson-Meyers, Daniela S.; Eells, Janis T., Univ Wisconsin, Dept Biomed Sci, Milwaukee, WI 53201 USA.
   Aboualizadeh, Ebrahim; Hirschmugl, Carol J., Univ Wisconsin, Dept Phys, Milwaukee, WI USA.
   Enwemeka, Chukuka S., San Diego State Univ, San Diego, CA 92182 USA.}},
DOI = {{10.1016/j.jphotobiol.2016.12.030}},
ISSN = {{1011-1344}},
Keywords = {{FTIR spectromicroscopy; Blue light (470 nm); Mechanism of action;
   PCA-LDA; DNA; MRSA; Vancomycin}},
Keywords-Plus = {{MRSA IN-VITRO; FTIR SPECTROSCOPY; PHOTODYNAMIC THERAPY;
   RAMAN-SPECTROSCOPY; NUCLEIC-ACIDS; DNA-DAMAGE; IDENTIFICATION;
   BACTERIAL; DISCRIMINATION; RADIATION}},
Research-Areas = {{Biochemistry \& Molecular Biology; Biophysics}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Biophysics}},
Author-Email = {{cjhirsch@uwm.edu}},
Funding-Acknowledgement = {{Stimulus Program to Accelerate Research Clusters (SPARC) of College of
   Health Sciences; University of Wisconsin-Milwaukee {[}PRJ73CL]; NSF
   {[}CHE-1508240, CHE-1112433]}},
Funding-Text = {{Financial support was received from the Stimulus Program to Accelerate
   Research Clusters (SPARC) of College of Health Sciences, University of
   Wisconsin-Milwaukee (Grant No. PRJ73CL to J.E and V.V.B), NSF grants
   CHE-1508240 and CHE-1112433 to CJ.H.}},
Cited-References = {{Baker MJ, 2014, NAT PROTOC, V9, P1771, DOI 10.1038/nprot.2014.110.
   Banfi S, 2006, J PHOTOCH PHOTOBIO B, V85, P28, DOI 10.1016/j.jphotobiol.2006.04.003.
   Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8.
   BECKER MM, 1989, J MOL BIOL, V210, P429, DOI 10.1016/0022-2836(89)90120-4.
   Bernardo K, 2002, PROTEOMICS, V2, P740, DOI 10.1002/1615-9861(200206)2:6<740::AID-PROT740>3.0.CO;2-M.
   Bumah VV, 2013, PHOTOMED LASER SURG, V31, P547, DOI 10.1089/pho.2012.3461.
   Bumah VV, 2015, LASER MED SCI, V30, P1153, DOI 10.1007/s10103-015-1722-9.
   Buonanno M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076968.
   Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012.
   Dai TH, 2013, LASER SURG MED, V45, P41.
   Dai TH, 2010, LASER SURG MED, V42, P38, DOI 10.1002/lsm.20887.
   Dastgheyb SS, 2013, J PHOTOCH PHOTOBIO B, V129, P27, DOI 10.1016/j.jphotobiol.2013.09.006.
   Di Giambattista L, 2010, EUR BIOPHYS J BIOPHY, V39, P929, DOI 10.1007/s00249-009-0446-9.
   Enwemeka CS, 2009, PHOTOMED LASER SURG, V27, P221, DOI 10.1089/pho.2008.2413.
   Enwemeka CS, 2008, LASER SURG MED, V40, P734, DOI 10.1002/lsm.20724.
   Erukhimovitch V, 2005, J PHARMACEUT BIOMED, V37, P1105, DOI 10.1016/j.jpba.2004.08.010.
   FRANKLIN RE, 1953, ACTA CRYSTALLOGR, V6, P673, DOI 10.1107/S0365110X53001939.
   Fu XJ, 2014, J PHOTOCH PHOTOBIO B, V136, P72, DOI 10.1016/j.jphotobiol.2014.04.016.
   Gault N, 2003, RADIAT RES, V160, P238, DOI 10.1667/RR3020.1.
   Grinhoic M, 2008, J PHOTOCH PHOTOBIO B, V90, P57, DOI 10.1016/j.jphotobiol.2007.11.002.
   HAMMES WP, 1974, ANTIMICROB AGENTS CH, V6, P722, DOI 10.1128/AAC.6.6.722.
   HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69.
   Hidayat LK, 2006, ARCH INTERN MED, V166, P2138, DOI 10.1001/archinte.166.19.2138.
   Howell-Jones RS, 2005, J ANTIMICROB CHEMOTH, V55, P143, DOI 10.1093/jac/dkh513.
   Jarvis RM, 2008, CHEM SOC REV, V37, P931, DOI 10.1039/b705973f.
   Kansiz M, 1999, PHYTOCHEMISTRY, V52, P407, DOI 10.1016/S0031-9422(99)00212-5.
   Lambert PA, 2002, J APPL MICROBIOL, V92, p46S, DOI 10.1046/j.1365-2672.92.5s1.7.x.
   Lamprell H, 2006, INT J FOOD MICROBIOL, V108, P125, DOI 10.1016/j.ijfoodmicro.2005.10.015.
   LANGRIDGE R, 1960, J MOL BIOL, V2, P19, DOI 10.1016/S0022-2836(60)80004-6.
   Lee KS, 2008, P NATL ACAD SCI USA, V105, P2806, DOI 10.1073/pnas.0708244105.
   Lipiec E, 2014, J MOL STRUCT, V1073, P134, DOI 10.1016/j.molstruc.2014.04.056.
   Lipiec E, 2014, ANALYST, V139, P4200, DOI 10.1039/c4an00838c.
   Lipovsky A, 2009, PHOTOCHEM PHOTOBIOL, V85, P255, DOI 10.1111/j.1751-1097.2008.00429.x.
   Liu HH, 1999, ADV EXP MED BIOL, V455, P387.
   Maclean M, 2009, APPL ENVIRON MICROB, V75, P1932, DOI 10.1128/AEM.01892-08.
   Mariey L, 2001, VIB SPECTROSC, V26, P151, DOI 10.1016/S0924-2031(01)00113-8.
   Martin FL, 2007, J COMPUT BIOL, V14, P1176, DOI 10.1089/cmb.2007.0057.
   Mattson EC, 2013, INT J MOL SCI, V14, P22753, DOI 10.3390/ijms141122753.
   Mignolet A, 2016, BBA-PROTEINS PROTEOM, V1864, P85, DOI 10.1016/j.bbapap.2015.08.010.
   Mone MJ, 2001, EMBO REP, V2, P1013, DOI 10.1093/embo-reports/kve224.
   Mueller P., 2013, PLOS ONE, V8.
   Otto CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064068.
   Pilling M, 2016, CHEM SOC REV, V45, P1935, DOI 10.1039/c5cs00846h.
   Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8.
   Sakoulas G, 2004, J CLIN MICROBIOL, V42, P2398, DOI 10.1128/JCM.42.6.2398-2402.2004.
   Trevisan J, 2012, ANALYST, V137, P3202, DOI 10.1039/c2an16300d.
   TSUBOI M, 1969, APPL SPECTROSC REV, V3, P45.
   Tsuboi M., 1961, APPL SPECTROSC PRO S, V17, P99.
   Turhan V, 2009, J SURG RES, V155, P111, DOI 10.1016/j.jss.2008.08.031.
   Wenning M, 2013, APPL MICROBIOL BIOT, V97, P7111, DOI 10.1007/s00253-013-5087-3.
   Whelan DR, 2011, NUCLEIC ACIDS RES, V39, P5439, DOI 10.1093/nar/gkr175.
   Willemse-Erix DFM, 2009, J CLIN MICROBIOL, V47, P652, DOI 10.1128/JCM.01900-08.
   Wood BR, 2016, CHEM SOC REV, V45, P1980, DOI 10.1039/c5cs00511f.
   Wood BR, 2000, APPL SPECTROSC, V54, P353, DOI 10.1366/0003702001949627.
   Wulf MWH, 2012, CLIN MICROBIOL INFEC, V18, P147, DOI 10.1111/j.1469-0691.2011.03517.x.}},
Number-of-Cited-References = {{55}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{12}},
Journal-ISO = {{J. Photochem. Photobiol. B-Biol.}},
Doc-Delivery-Number = {{EN4CI}},
Unique-ID = {{ISI:000395955000018}},
DA = {{2018-08-13}},
}

@article{ ISI:000394102500061,
Author = {Collins, Samuel A. and Kelso, Michael J. and Rineh, Ardeshir and Yepuri,
   Nageshwar R. and Coles, Janice and Jackson, Claire L. and Halladay,
   Georgia D. and Walker, Woolf T. and Webb, Jeremy S. and Hall-Stoodley,
   Luanne and Connett, Gary J. and Feelisch, Martin and Faust, Saul N. and
   Lucas, Jane S. A. and Allan, Raymond N.},
Title = {{Cephalosporin-3 `-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances
   Azithromycin Susceptibility of Nontypeable Haemophilus influenzae
   Biofilms}},
Journal = {{ANTIMICROBIAL AGENTS AND CHEMOTHERAPY}},
Year = {{2017}},
Volume = {{61}},
Number = {{2}},
Month = {{FEB}},
Abstract = {{PYRRO-C3D is a cephalosporin-3-diazeniumdiolate nitric oxide (NO) donor
   prodrug designed to selectively deliver NO to bacterial infection sites.
   The objective of this study was to assess the activity of PYRRO-C3D
   against nontypeable Haemophilus influenzae (NTHi) biofilms and examine
   the role of NO in reducing biofilm-associated antibiotic tolerance. The
   activity of PYRRO-C3D on in vitro NTHi biofilms was assessed through CFU
   enumeration and confocal microscopy. NO release measurements were
   performed using an ISO-NO probe. NTHi biofilms grown on primary ciliated
   respiratory epithelia at an air-liquid interface were used to
   investigate the effects of PYRRO-C3D in the presence of host tissue.
   Label-free liquid chromatography-mass spectrometry (LC/MS) proteomic
   analyses were performed to identify differentially expressed proteins
   following NO treatment. PYRRO-C3D specifically released NO in the
   presence of NTHi, while no evidence of spontaneous NO release was
   observed when the compound was exposed to primary epithelial cells. NTHi
   lacking beta-lactamase activity failed to trigger NO release. Treatment
   significantly increased the susceptibility of in vitro NTHi biofilms to
   azithromycin, causing a log fold reduction (10-fold reduction or
   1-log-unit reduction) in viability (P < 0.05) relative to azithromycin
   alone. The response was more pronounced for biofilms grown on primary
   respiratory epithelia, where a 2-log-unit reduction was observed (P <
   0.01). Label-free proteomics showed that NO increased expression of 16
   proteins involved in metabolic and transcriptional/translational
   functions. NO release from PYRRO-C3D enhances the efficacy of
   azithromycin against NTHi biofilms, putatively via modulation of NTHi
   metabolic activity. Adjunctive therapy with NO mediated through
   PYRRO-C3D represents a promising approach for reducing
   biofilm-associated antibiotic tolerance.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lucas, JSA (Reprint Author), Univ Southampton, Clin \& Expt Sci, Fac Med, Southampton, Hants, England.
   Lucas, JSA (Reprint Author), Univ Southampton, Clin \& Expt Sci, Inst Life Sci, Southampton, Hants, England.
   Lucas, JSA (Reprint Author), Univ Hosp Southampton NHS Fdn Trust, Southampton NIHR Resp Biomed Res Unit, Southampton, Hants, England.
   Collins, Samuel A.; Coles, Janice; Jackson, Claire L.; Halladay, Georgia D.; Walker, Woolf T.; Connett, Gary J.; Feelisch, Martin; Faust, Saul N.; Lucas, Jane S. A.; Allan, Raymond N., Univ Southampton, Clin \& Expt Sci, Fac Med, Southampton, Hants, England.
   Collins, Samuel A.; Coles, Janice; Jackson, Claire L.; Halladay, Georgia D.; Walker, Woolf T.; Connett, Gary J.; Feelisch, Martin; Faust, Saul N.; Lucas, Jane S. A.; Allan, Raymond N., Univ Southampton, Clin \& Expt Sci, Inst Life Sci, Southampton, Hants, England.
   Collins, Samuel A.; Walker, Woolf T.; Connett, Gary J.; Feelisch, Martin; Faust, Saul N.; Lucas, Jane S. A., Univ Hosp Southampton NHS Fdn Trust, Southampton NIHR Resp Biomed Res Unit, Southampton, Hants, England.
   Kelso, Michael J.; Rineh, Ardeshir; Yepuri, Nageshwar R., Univ Wollongong, Illawarra Hlth \& Med Res Inst, Sch Chem, Wollongong, NSW, Australia.
   Webb, Jeremy S., Univ Southampton, Ctr Biol Sci, Southampton, Hants, England.
   Hall-Stoodley, Luanne, Ohio State Univ, Coll Med, Dept Microbial Infect \& Immun, Ctr Microbial Interface Biol, Columbus, OH 43210 USA.
   Faust, Saul N.; Allan, Raymond N., Univ Hosp Southampton NHS Fdn Trust, Southampton NIHR Wellcome Trust Clin Res Facil, Southampton, Hants, England.}},
DOI = {{10.1128/AAC.02086-16}},
Article-Number = {{e02086-16}},
ISSN = {{0066-4804}},
EISSN = {{1098-6596}},
Keywords = {{Haemophilus influenzae; biofilms; antibiotic resistance; nitric oxide;
   proteomics}},
Keywords-Plus = {{PRIMARY CILIARY DYSKINESIA; NITRIC-OXIDE; PSEUDOMONAS-AERUGINOSA;
   CYSTIC-FIBROSIS; STAPHYLOCOCCUS-AUREUS; BACTERIAL BIOFILMS; DISPERSAL;
   PHOSPHODIESTERASE; INFECTIONS; DOMAIN}},
Research-Areas = {{Microbiology; Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Microbiology; Pharmacology \& Pharmacy}},
Author-Email = {{jlucas1@soton.ac.uk}},
ResearcherID-Numbers = {{Rineh, Ardeshir/B-7481-2018
   Allan, Raymond/K-2494-2017
   Feelisch, Martin/C-3042-2008
   }},
ORCID-Numbers = {{Rineh, Ardeshir/0000-0003-2975-591X
   Allan, Raymond/0000-0001-7764-4849
   Feelisch, Martin/0000-0003-2320-1158
   Faust, Saul/0000-0003-3410-7642
   Connett, Gary/0000-0003-1310-3239
   Lucas, Jane/0000-0001-8701-9975}},
Funding-Acknowledgement = {{Southampton Biomedical Imaging Unit; Australian Cystic Fibrosis Research
   Trust (ACFRT)}},
Funding-Text = {{We thank the Southampton Biomedical Imaging Unit for their support in
   biofilm imaging and Paul Skipp at the Southampton Centre for Proteomic
   Research for his support in the proteomic analyses. We also thank Stuart
   Clarke at the University of Southampton, Department of Clinical \&
   Experimental Sciences, for provision of the nontypeable Haemophilus
   influenzae strains used in this study.; M.J.K. acknowledges funding from
   Australian Cystic Fibrosis Research Trust (ACFRT, 2014).}},
Cited-References = {{Alanin MC, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.08.020.
   Allan RN, 2016, ANTIMICROB AGENTS CH, V60, P2456, DOI 10.1128/AAC.02432-15.
   Allan RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107015.
   An SW, 2010, APPL ENVIRON MICROB, V76, P8160, DOI 10.1128/AEM.01233-10.
   Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06.
   Barraud N, 2015, CURR PHARM DESIGN, V21, P31, DOI 10.2174/1381612820666140905112822.
   Barraud N, 2012, ANGEW CHEM INT EDIT, V51, P9057, DOI 10.1002/anie.201202414.
   Barraud N, 2009, MICROB BIOTECHNOL, V2, P370, DOI 10.1111/j.1751-7915.2009.00098.x.
   Caly DL, 2015, CURR PHARM DESIGN, V21, P12.
   Chou SH, 2016, J BACTERIOL, V198, P32, DOI 10.1128/JB.00333-15.
   CLUTTONBROCK J, 1967, BRIT J ANAESTH, V39, P388, DOI 10.1093/bja/39.5.388.
   Collins SA, 2014, EUR RESPIR J, V44, P1589, DOI 10.1183/09031936.00088614.
   D'Autreaux B, 2002, P NATL ACAD SCI USA, V99, P16619, DOI 10.1073/pnas.252591299.
   Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1.
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010.
   Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605.
   Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202.
   Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x.
   Harrison A, 2013, INFECT IMMUN, V81, P1221, DOI 10.1128/IAI.01227-12.
   Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409.
   Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102.
   Hirst RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089675.
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011.
   Jardeleza C, 2015, TRANSL RES, V166, P683, DOI 10.1016/j.trsl.2015.06.009.
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27.
   Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x.
   Li Y, 2013, J BACTERIOL, V195, P3531, DOI 10.1128/JB.01156-12.
   Murphy TF, 2005, FEMS IMMUNOL MED MIC, V44, P81, DOI 10.1016/j.femsim.2004.12.008.
   Musk DJ, 2005, CHEM BIOL, V12, P789, DOI 10.1016/j.chembiol.2005.05.007.
   Obaid NA, 2015, CAN J MICROBIOL, V61, P243, DOI 10.1139/cjm-2014-0763.
   Post DMB, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0329-9.
   Ramon-Perez ML, 2014, J MED MICROBIOL, V63, P1369, DOI 10.1099/jmm.0.075796-0.
   Ramsey KA, 2014, AM J RESP CRIT CARE, V190, P1111, DOI 10.1164/rccm.201407-1277OC.
   Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08.
   Ridnour LA, 2004, BIOL CHEM, V385, P1, DOI 10.1515/BC.2004.001.
   Rogers GB, 2013, J CLIN MICROBIOL, V51, P4029, DOI 10.1128/JCM.02164-13.
   Sanchez CJ, 2014, ANTIMICROB AGENTS CH, V58, P4353, DOI 10.1128/AAC.02468-14.
   Schlag S, 2007, J BACTERIOL, V189, P7911, DOI 10.1128/JB.00598-07.
   Sriramulu DD, 2005, J MED MICROBIOL, V54, P667, DOI 10.1099/jmm.0.45969-0.
   Starner TD, 2006, AM J RESP CRIT CARE, V174, P213, DOI 10.1164/rccm.200509-1459OC.
   Swords WE, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00097.
   Unal CM, 2012, INT J MED MICROBIOL, V302, P261, DOI 10.1016/j.ijmm.2012.07.013.
   Vogel AR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00042.
   Walker WT, 2014, CHEST, V145, P668, DOI 10.1378/chest.13-2398.
   Wu SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090107.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{11}},
Journal-ISO = {{Antimicrob. Agents Chemother.}},
Doc-Delivery-Number = {{EK7JQ}},
Unique-ID = {{ISI:000394102500061}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000394159800019,
Author = {Lapid-Gortzak, Ruth and Traversari, Roberto and van der Linden, Jan
   Willem and Oberstein, Sarit Y. Lesnik and Lapid, Oren and Schlingemann,
   Reinier O.},
Title = {{Mobile ultra-clean unidirectional airflow screen reduces air
   contamination in a simulated setting for intra-vitreal injection}},
Journal = {{INTERNATIONAL OPHTHALMOLOGY}},
Year = {{2017}},
Volume = {{37}},
Number = {{1}},
Pages = {{131-137}},
Month = {{FEB}},
Abstract = {{The aim of this study is to determine whether the use of a mobile
   ultra-clean laminar airflow screen reduces the air-borne particle counts
   in the setting of a simulated procedure of an intra-vitreal injection. A
   mobile ultra-clean unidirectional airflow (UDF) screen was tested in a
   simulated procedure for intra-vitreal injections in a treatment room
   without mechanical ventilation. One UDF was passed over the instrument
   tray and the surgical area. The concentration of particles was measured
   in the background, over the instrument table, and next to the ocular
   area. The degree of protection was calculated at the instrument table
   and at the surgical site. Use of the UDF mobile screen reduced the mean
   particle concentration (particles > 0.3 microns) on the instrument table
   by a factor of at least 100.000 (p < 0.05), and over the patient's eye
   by at least a factor of 436 (p < 0.05), which in clinical practice
   translates into significantly reduced air contamination. Mobile UDF
   screen reduces the mean particle concentration substantially. The mobile
   UDF screen may therefore allow for a safer procedural environment for
   ambulatory care procedures such as intra-vitreal injections in treatment
   rooms.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lapid-Gortzak, R (Reprint Author), Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Meibergdreef 9, NL-1100 AZ Amsterdam, Netherlands.
   Lapid-Gortzak, R (Reprint Author), Retina Total Eye Care, Driebergen, Netherlands.
   Lapid-Gortzak, Ruth; Oberstein, Sarit Y. Lesnik; Schlingemann, Reinier O., Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Meibergdreef 9, NL-1100 AZ Amsterdam, Netherlands.
   Lapid-Gortzak, Ruth; van der Linden, Jan Willem, Retina Total Eye Care, Driebergen, Netherlands.
   Traversari, Roberto, Dutch Ctr Hlth Assets, TNO, Soesterberg, Netherlands.
   Lapid, Oren, Univ Amsterdam, Acad Med Ctr, Dept Plast \& Reconstruct Surg, Amsterdam, Netherlands.}},
DOI = {{10.1007/s10792-016-0236-1}},
ISSN = {{0165-5701}},
EISSN = {{1573-2630}},
Keywords = {{Unidirectional ultra-clean laminar airflow; Intra-vitreal injections;
   Endophthalmitis prevention; HEPA filters; Contamination}},
Keywords-Plus = {{OPERATING-ROOM VENTILATION; INTRAVITREAL INJECTION;
   ANTIBIOTIC-RESISTANCE; QUALITY; THEATERS}},
Research-Areas = {{Ophthalmology}},
Web-of-Science-Categories  = {{Ophthalmology}},
Author-Email = {{r.lapid@amc.nl}},
Funding-Acknowledgement = {{Alcon; Hanita lenses; Santen; LUWA}},
Funding-Text = {{Ruth Lapid-Gortzak has received speaker fees from Alcon, Hanita lenses,
   and Santen, and is a clinical investigator for Alcon. Roberto Traversari
   has received fees from LUWA.}},
Cited-References = {{{[}Anonymous], 19464 DIN.
   Brohus H, 2006, INDOOR AIR, V16, P356, DOI 10.1111/j.1600-0668.2006.00454.x.
   Brown R., 1828, PHILOS MAG, V4, P161, DOI DOI 10.1080/14786442808674769.
   Bugajny A, 2005, POL J ENVIRON STUD, V14, P287.
   Dharan S, 2002, J HOSP INFECT, V51, P79, DOI 10.1053/jhin.2002.1217.
   Friberg B, 1998, AORN J, V67, P5.
   Friberg BEE, 1996, ACTA ORTHOP SCAND, V67, P578, DOI 10.3109/17453679608997760.
   Friberg S, 2003, J HOSP INFECT, V55, P92, DOI 10.1016/S0195-6701(03)00143-9.
   Honnart-Thomas M, 2004, J FR OPHTALMOL, V27, P424, DOI 10.1016/S0181-5512(04)96156-6.
   International Organisation for Standardization, 2013, 146441 ISO.
   Jager RD, 2004, RETINA-J RET VIT DIS, V24, P676, DOI 10.1097/00006982-200410000-00002.
   Milder E, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.016.
   MURAKAMI S, 1992, ASHRAE TRAN, V98, P82.
   Nilsson KG, 2010, J HOSP INFECT, V76, P243, DOI 10.1016/j.jhin.2010.05.016.
   Pilu S, 2008, AM J OPHTHALMOL, V145, P879, DOI 10.1016/j.ajo.2007.12.036.
   SEAL DV, 1990, J APPL BACTERIOL, V68, P225, DOI 10.1111/j.1365-2672.1990.tb02568.x.
   Ta CN, 2004, RETINA-J RET VIT DIS, V24, P699, DOI 10.1097/00006982-200410000-00003.
   Tammelin A, 2012, PATIENT SAF SURG, V6, DOI 10.1186/1754-9493-6-23.
   Traversari AAL, 2013, J HOSP INFECT, V85, P125, DOI 10.1016/j.jhin.2013.06.006.
   Yin VT, 2013, JAMA OPHTHALMOL, V131, P456, DOI 10.1001/jamaophthalmol.2013.2379.}},
Number-of-Cited-References = {{20}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Int. Ophthalmol.}},
Doc-Delivery-Number = {{EK8FR}},
Unique-ID = {{ISI:000394159800019}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000393863900006,
Author = {Bridgeman, Victoria L. and Vermeulen, Peter B. and Foo, Shane and
   Bilecz, Agnes and Daley, Frances and Kostaras, Eleftherios and Nathan,
   Mark R. and Wan, Elaine and Frentzas, Sophia and Schweiger, Thomas and
   Hegedus, Balazs and Hoetzenecker, Konrad and Renyi-Vamos, Ferenc and
   Kuczynski, Elizabeth A. and Vasudev, Naveen S. and Larkin, James and
   Gore, Martin and Dvorak, Harold F. and Paku, Sandor and Kerbel, Robert
   S. and Dome, Balazs and Reynolds, Andrew R.},
Title = {{Vessel co-option is common in human lung metastases and mediates
   resistance to anti-angiogenic therapy in preclinical lung metastasis
   models}},
Journal = {{JOURNAL OF PATHOLOGY}},
Year = {{2017}},
Volume = {{241}},
Number = {{3}},
Pages = {{362-374}},
Month = {{FEB}},
Abstract = {{Anti-angiogenic therapies have shown limited efficacy in the clinical
   management of metastatic disease, including lung metastases. Moreover,
   the mechanisms via which tumours resist anti-angiogenic therapies are
   poorly understood. Importantly, rather than utilizing angiogenesis, some
   metastases may instead incorporate pre-existing vessels from surrounding
   tissue (vessel co-option). As anti-angiogenic therapies were designed to
   target only new blood vessel growth, vessel co-option has been proposed
   as a mechanism that could drive resistance to anti-angiogenic therapy.
   However, vessel co-option has not been extensively studied in lung
   metastases, and its potential to mediate resistance to anti-angiogenic
   therapy in lung metastases is not established. Here, we examined the
   mechanism of tumour vascularization in 164 human lung metastasis
   specimens (composed of breast, colorectal and renal cancer lung
   metastasis cases). We identified four distinct histopathological growth
   patterns (HGPs) of lung metastasis (alveolar, interstitial, perivascular
   cuffing, and pushing), each of which vascularized via a different
   mechanism. In the alveolar HGP, cancer cells invaded the alveolar air
   spaces, facilitating the co-option of alveolar capillaries. In the
   interstitial HGP, cancer cells invaded the alveolar walls to co-opt
   alveolar capillaries. In the perivascular cuffing HGP, cancer cells grew
   by co-opting larger vessels of the lung. Only in the pushing HGP did the
   tumours vascularize by angiogenesis. Importantly, vessel co-option
   occurred with high frequency, being present in >80\% of the cases
   examined. Moreover, we provide evidence that vessel co-option mediates
   resistance to the anti-angiogenic drug sunitinib in preclinical lung
   metastasis models. Assuming that our interpretation of the data is
   correct, we conclude that vessel co-option in lung metastases occurs
   through at least three distinct mechanisms, that vessel co-option occurs
   frequently in lung metastases, and that vessel co-option could mediate
   resistance to anti-angiogenic therapy in lung metastases. Novel
   therapies designed to target both angiogenesis and vessel co-option are
   therefore warranted. (c) 2016 The Authors. The Journal of Pathology
   published by John Wiley \& Sons Ltd on behalf of Pathological Society of
   Great Britain and Ireland.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Reynolds, AR (Reprint Author), Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, Tumour Biol Team, London SW3 6JB, England.
   Dome, B (Reprint Author), Med Univ Vienna, Dept Thorac Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
   Bridgeman, Victoria L.; Vermeulen, Peter B.; Foo, Shane; Kostaras, Eleftherios; Nathan, Mark R.; Wan, Elaine; Frentzas, Sophia; Vasudev, Naveen S.; Reynolds, Andrew R., Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, Tumour Biol Team, London SW3 6JB, England.
   Vermeulen, Peter B., GZA Hosp St Augustinus, TCRU, Antwerp, Belgium.
   Bilecz, Agnes, Semmelweis Univ, Inst Pathol 2, Budapest, Hungary.
   Daley, Frances, Royal Marsden, Breast Canc Now Histopathol Core Facil, London, England.
   Wan, Elaine; Frentzas, Sophia; Vasudev, Naveen S.; Larkin, James; Gore, Martin, Royal Marsden, London, England.
   Schweiger, Thomas; Hoetzenecker, Konrad; Dome, Balazs, Med Univ Vienna, Dept Thorac Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
   Hegedus, Balazs, Univ Hosp Univ Duisburg Essen, Dept Thorac Surg, Ruhrlandklin Essen, Duisburg, Germany.
   Hegedus, Balazs, Hungarian Acad Sci, MTA SE Mol Oncol Res Grp, Budapest, Hungary.
   Renyi-Vamos, Ferenc; Dome, Balazs, Semmelweis Univ, Dept Thorac Surg, Natl Inst Oncol, Budapest, Hungary.
   Kuczynski, Elizabeth A.; Kerbel, Robert S., Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.
   Vasudev, Naveen S., St James Univ Hosp, Leeds Inst Canc \& Pathol, Canc Res UK Ctr, Leeds, W Yorkshire, England.
   Dvorak, Harold F., Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   Paku, Sandor, Semmelweis Univ, Dept Pathol \& Expt Canc Res 1, Budapest, Hungary.
   Paku, Sandor, Semmelweis Univ, Tumour Progress Res Grp, Hungarian Acad Sci, Budapest, Hungary.
   Kerbel, Robert S., Sunnybrook Res Inst, Biol Sci Platform, Toronto, ON, Canada.
   Dome, Balazs, Natl Koranyi Inst Pulmonol, Budapest, Hungary.
   Dome, Balazs, Med Univ Vienna, Dept Biomed Imaging \& Image Guided Therapy, Vienna, Austria.}},
DOI = {{10.1002/path.4845}},
ISSN = {{0022-3417}},
EISSN = {{1096-9896}},
Keywords = {{lung metastasis; angiogenesis; vessel co-option; anti-angiogenic
   therapy; sunitinib; drug resistance}},
Keywords-Plus = {{RENAL-CELL CARCINOMA; ADVANCED BREAST-CANCER; PHASE-III; CLINICAL
   ONCOLOGY/COLLEGE; ANTIANGIOGENIC THERAPY; 1ST-LINE TREATMENT; AMERICAN
   SOCIETY; LIVER METASTASES; BRAIN METASTASIS; INTERFERON-ALPHA}},
Research-Areas = {{Oncology; Pathology}},
Web-of-Science-Categories  = {{Oncology; Pathology}},
Author-Email = {{balazs.dome@meduniwien.ac.at
   andrew.reynolds@icr.ac.uk}},
ResearcherID-Numbers = {{Hegedus, Balazs/B-6076-2008}},
ORCID-Numbers = {{Hegedus, Balazs/0000-0002-4341-4153}},
Funding-Acknowledgement = {{Breakthrough Breast Cancer; NHS; Hungarian Scientific Research Fund
   {[}SNN114490, K109626, K108465]; Semmelweis University Start-Up grant
   {[}40148-11658]; ONB Jubilaumsfondsprojekt {[}14043]; Vienna Fund for
   Innovative Interdisciplinary Cancer Research}},
Funding-Text = {{ARR acknowledges funding from Breakthrough Breast Cancer (recently
   merged with Breast Cancer Campaign forming Breast Cancer Now) and NHS
   funding to the NIHR Biomedical Research Centre at RM/ICR. BD was
   supported by a Hungarian Scientific Research Fund (SNN114490, K109626,
   K108465), a Semmelweis University Start-Up grant (40148-11658), ONB
   Jubilaumsfondsprojekt No. 14043, and the Vienna Fund for Innovative
   Interdisciplinary Cancer Research. We thank the staff of the Biological
   Services Unit at the ICR and the staff of the Breast Cancer Now
   Histopathology Core Facility for technical assistance.}},
Cited-References = {{Adighibe O, 2006, BRIT J CANCER, V94, P1176, DOI 10.1038/sj.bjc.6603039.
   {[}Anonymous], 2000, LANCET, V355, P1787.
   Barrios CH, 2010, BREAST CANCER RES TR, V121, P121, DOI 10.1007/s10549-010-0788-0.
   Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442.
   Bergh J, 2012, J CLIN ONCOL, V30, P921, DOI 10.1200/JCO.2011.35.7376.
   BROERS JLV, 1989, DIFFERENTIATION, V40, P119, DOI 10.1111/j.1432-0436.1989.tb00821.x.
   Bugyik E, 2011, J NEUROPATH EXP NEUR, V70, P979, DOI 10.1097/NEN.0b013e318233afd7.
   Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857.
   Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144.
   Colpaert CG, 2003, HISTOPATHOLOGY, V42, P530, DOI 10.1046/j.1365-2559.2003.01629.x.
   Crown JP, 2013, J CLIN ONCOL, V31, P2870, DOI 10.1200/JCO.2012.43.3391.
   de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027.
   disTomaso E, 2011, CANCER RES, V71, P19.
   Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302.
   Donnem T, 2013, CANCER MED-US, V2, P427, DOI 10.1002/cam4.105.
   Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21.
   Frentzas S, 2016, NAT MED, V22, P1294, DOI 10.1038/nm.4197.
   Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303.
   Guerin E, 2013, CANCER RES, V73, P2743, DOI 10.1158/0008-5472.CAN-12-4183.
   Haas NB, 2016, LANCET, V387, P2008, DOI 10.1016/S0140-6736(16)00559-6.
   Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48.
   Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994.
   Jeong HS, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv155.
   Kuczynski EA, 2016, JNCI-J NATL CANCER I, V108, P30.
   Kusters B, 2002, CANCER RES, V62, P341.
   Leenders WPJ, 2004, CLIN CANCER RES, V10, P6222, DOI 10.1158/1078-0432.CCR-04-0823.
   Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044.
   Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293.
   Naresh KN, 2001, HISTOPATHOLOGY, V38, P466, DOI 10.1046/j.1365-2559.2001.01061.x.
   Passalidou E, 2002, BRIT J CANCER, V86, P244, DOI 10.1038/sj/bjc/6600015.
   Pezzella F, 1996, EUR J CANCER, V32A, P2494, DOI 10.1016/S0959-8049(96)00377-2.
   Pezzella F, 1997, AM J PATHOL, V151, P1417.
   Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2.
   Robert NJ, 2011, CLIN BREAST CANCER, V11, P82, DOI 10.1016/j.clbc.2011.03.005.
   Rubenstein JL, 2000, NEOPLASIA, V2, P306, DOI 10.1038/sj.neo.7900102.
   Sardari N. P., 2008, ANN THORAC SURG, V85, P395.
   Sardari N. P., 2007, HISTOPATHOLOGY, V51, P354, DOI DOI 10.1111/J.1365-2559.2007.02800.X.
   Sennino B, 2012, NAT REV CANCER, V12, P699, DOI 10.1038/nrc3366.
   Stahlman MT, 1996, J HISTOCHEM CYTOCHEM, V44, P673, DOI 10.1177/44.7.8675988.
   Stessels F, 2004, BRIT J CANCER, V90, P1429, DOI 10.1038/sj.bjc.6601727.
   Szabo V, 2015, J PATHOL, V235, P384, DOI 10.1002/path.4464.
   Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040.
   Vasudev NS, 2013, BRIT J CANCER, V109, P1230, DOI 10.1038/bjc.2013.429.
   Vasudev NS, 2014, ANGIOGENESIS, V17, P471, DOI 10.1007/s10456-014-9420-y.
   Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984.
   Yousem SA, 2009, HUM PATHOL, V40, P861, DOI 10.1016/j.humpath.2008.11.008.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{26}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{17}},
Journal-ISO = {{J. Pathol.}},
Doc-Delivery-Number = {{EK3YI}},
Unique-ID = {{ISI:000393863900006}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000387349900047,
Author = {Victor Navajas-Benito, Enrique and Andrea Alonso, Carla and Sanz, Susana
   and Olarte, Carmen and Martinez-Olarte, Roberto and Hidalgo-Sanz, Sara
   and Somalo, Sergio and Torres, Carmen},
Title = {{Molecular characterization of antibiotic resistance in Escherichia coli
   strains from a dairy cattle farm and its surroundings}},
Journal = {{JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE}},
Year = {{2017}},
Volume = {{97}},
Number = {{1}},
Pages = {{362-365}},
Month = {{JAN 15}},
Abstract = {{BACKGROUNDThis study describes the phenotypic and genotypic
   characteristics of 78 genetically different Escherichia coli recovered
   from air and exudate samples of a dairy cattle farm and its surroundings
   in Spain, in order to gain insight into the flow of antimicrobial
   resistance through the environment and food supply.
   RESULTSAntimicrobial resistance was detected in 21.8\% of the 78 E. coli
   isolates analyzed (resistance for at least one of the 14 agents tested).
   The highest resistance rates were recorded for ampicillin, nalidixic
   acid, trimethoprim/sulfamethoxazole and tetracycline. The resistance
   genes detected were as follows (antibiotic (number of resistant
   strains), gene (number of strains)): ampicillin (9), bla(TEM-1) (6);
   tetracycline (15), tet(A) (7), tet(B) (4), tet(A)+tet(B) (1);
   chloramphenicol (5), cmlA (2), floR (2); trimethoprim/sulfamethoxazole
   (10), sul2 (4), sul1 (3), sul3 (2), sul1 + sul2 (1);
   gentamicin-tobramycin (1), ant(2) (1). About 14\% of strains showed a
   multidrug-resistant phenotype and, of them, seven strains carried class
   1 integrons containing predominantly the dfrA1-aadA1 array. One
   multidrug-resistant strain was found in both inside and outside air,
   suggesting that the airborne spread of multidrug-resistant bacteria from
   the animal housing facilities to the surroundings is feasible.
   CONCLUSIONSThis study gives a genetic background of the antimicrobial
   resistance problem in a dairy cattle farm and shows that air can act as
   a source for dissemination of antimicrobial-resistant bacteria. (c) 2016
   Society of Chemical Industry}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Torres, C (Reprint Author), Univ La Rioja, Dept Agr \& Alimentac, Area Bioquim \& Biol Mol, Madre Dios 51, E-26006 Logrono, Spain.
   Victor Navajas-Benito, Enrique; Andrea Alonso, Carla; Sanz, Susana; Olarte, Carmen; Martinez-Olarte, Roberto; Somalo, Sergio; Torres, Carmen, Univ La Rioja, Dept Agr \& Alimentac, Logrono, Spain.
   Hidalgo-Sanz, Sara, CINFA, Pamplona, Spain.}},
DOI = {{10.1002/jsfa.7709}},
ISSN = {{0022-5142}},
EISSN = {{1097-0010}},
Keywords = {{resistance genes; air; cattle; farm environment}},
Keywords-Plus = {{ANTIMICROBIAL RESISTANCE; PREVALENCE; SWINE; ENTEROBACTERIACEAE;
   ENVIRONMENT; VEGETABLES; INTEGRONS; BACTERIA; ANIMALS; HUMANS}},
Research-Areas = {{Agriculture; Chemistry; Food Science \& Technology}},
Web-of-Science-Categories  = {{Agriculture, Multidisciplinary; Chemistry, Applied; Food Science \&
   Technology}},
Author-Email = {{carmen.torres@unirioja.es}},
ResearcherID-Numbers = {{Torres, Carmen/C-9027-2013
   }},
ORCID-Numbers = {{Torres, Carmen/0000-0003-3709-1690
   Olarte Martinez, Carmen/0000-0002-0624-9275
   Alonso, Carla Andrea/0000-0002-9497-8573
   Sanz Cervera, Susana/0000-0001-6873-1940}},
Cited-References = {{Ben Said L, 2015, INT J FOOD MICROBIOL, V203, P86, DOI 10.1016/j.ijfoodmicro.2015.02.023.
   Changkaew K, 2015, J FOOD PROTECT, V78, P1442, DOI 10.4315/0362-028X.JFP-14-445.
   Chantziaras I, 2014, J ANTIMICROB CHEMOTH, V69, P827, DOI 10.1093/jac/dkt443.
   Clinical and Laboratory Standards Institute, 2015, M100S25 CLSI.
   Enne VI, 2008, FEMS MICROBIOL LETT, V278, P193, DOI 10.1111/j.1574-6968.2007.00991.x.
   Guerra B, 2003, J ANTIMICROB CHEMOTH, V52, P489, DOI 10.1093/jac/dkg362.
   Jiang HX, 2011, VET J, V187, P99, DOI 10.1016/j.tvjl.2009.10.017.
   Karczmarczyk M, 2011, APPL ENVIRON MICROB, V77, P7121, DOI 10.1128/AEM.00601-11.
   Laube H, 2014, VET MICROBIOL, V172, P519, DOI 10.1016/j.vetmic.2014.06.008.
   McEachran AD, 2015, ENVIRON HEALTH PERSP, V123, P337, DOI 10.1289/ehp.1408555.
   Reuland EA, 2014, EUR J CLIN MICROBIOL, V33, P1843, DOI 10.1007/s10096-014-2142-7.
   Sanz S, 2015, INT J FOOD MICROBIOL, V197, P40, DOI 10.1016/j.ijfoodmicro.2014.12.010.
   Sawant AA, 2007, APPL ENVIRON MICROB, V73, P156, DOI 10.1128/AEM.01551-06.
   Szmolka A, 2012, VET MICROBIOL, V156, P110, DOI 10.1016/j.vetmic.2011.09.030.
   Vinue L, 2008, J ANTIMICROB CHEMOTH, V62, P934, DOI 10.1093/jac/dkn331.
   Zhou LJ, 2013, SCI TOTAL ENVIRON, V444, P183, DOI 10.1016/j.scitotenv.2012.11.087.}},
Number-of-Cited-References = {{16}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{7}},
Usage-Count-Since-2013 = {{148}},
Journal-ISO = {{J. Sci. Food Agric.}},
Doc-Delivery-Number = {{EB4NZ}},
Unique-ID = {{ISI:000387349900047}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@inproceedings{ ISI:000430609800032,
Author = {Banciu, Alina Roxana and Nita-Lazar, Mihai and Niculescu, Liliana
   Daniela},
Editor = {{Pascu, LF and Lehr, CB and Tiron, O and Vasile, GG}},
Title = {{ENVIRONMENTAL FACTORS - POTENTIAL RESERVOIRS OF NOSOCOMIAL INFECTIONS}},
Booktitle = {{20TH INTERNATIONAL SYMPOSIUM - THE ENVIRONMENT AND THE INDUSTRY (SIMI
   2017)}},
Year = {{2017}},
Pages = {{248-254}},
Note = {{20th International Symposium on The Environment and the Industry (SIMI),
   Bucharest, ROMANIA, SEP 28-29, 2017}},
Organization = {{Romanian Acad; Natl Res \& Dev Inst Ind Ecol; Romanian Soc Chem;
   Romanian Water Assoc; Romanian Environm Assoc; Acad Econ Studies, Fac
   Agro Food Econ \& Environm; BCRS; Agilrom Sci; Tehno Instrument;
   Mediclim; Total Spectrum SRL; AMS 2000; ProAnalysis; Thermo Sci; REDOX;
   SARTOROM; ROMTECH; RONEXPRIM}},
Abstract = {{All infections follow the basic epidemiological pattern that if
   recognized early helps to apply the measures to prevent and control
   pathologies. The epidemiological process cannot be triggered in the
   absence of the microorganism's reservoir and therefore it is very
   important to control the potential reservoirs involved in nosocomial
   infections. The etiological structure of nosocomial infections varies
   and includes a wide variety of potentially or strictly pathogenic
   bacteria that have native or acquired proprieties of virulence and
   antibiotic resistance. The aim of this project was to monitor the
   potential role of the environmental risk factors involved in outbreak
   nosocomial infections. The microbiological studies from an emergency
   hospital from Bucharest have been started in January 2016 and samples
   were quarterly collected from drilling and tap water, waste water, air
   and surfaces. There were performed quantitative analyzes of
   microbiological contamination level and qualitative analyzes for
   pathogenic and resistant bacteria detection. Some pathogenic bacteria
   have been identified in the waste water and drilling water, indicating
   their interference. The antibiotic resistance properties were observed
   especially in bacteria from waste waters. Bacteria from vegetables from
   food preparation were detected in air samples and surfaces tests from
   kitchen. The results indicated that environmental factors from a medical
   unit could constitute a reservoir of microorganisms that can trigger
   nosocomial infections.}},
Publisher = {{NATL RESEARCH \& DEVELOPMENT INST INDUSTRIAL ECOLOGY ECOIND}},
Address = {{DRUMUL PODU DAMBOVITEI ST NO 71-73, DISTRICT 6, BUCHAREST, 00000,
   ROMANIA}},
Type = {{Proceedings Paper}},
Language = {{English}},
Affiliation = {{Banciu, AR (Reprint Author), Natl Reasearch \& Dev Inst Ind Ecol ECOIND, 71-73 Drumul Podu Dambovitei, Bucharest 060652, Romania.
   Banciu, Alina Roxana; Nita-Lazar, Mihai; Niculescu, Liliana Daniela, Natl Reasearch \& Dev Inst Ind Ecol ECOIND, 71-73 Drumul Podu Dambovitei, Bucharest 060652, Romania.}},
DOI = {{10.21698/simi.2017.0032}},
Keywords = {{antibiotic resistance; infection pathogenic bacteria}},
Keywords-Plus = {{HOSPITAL WASTE-WATER}},
Research-Areas = {{Science \& Technology - Other Topics; Engineering}},
Web-of-Science-Categories  = {{GREEN \& SUSTAINABLE SCIENCE \& TECHNOLOGY; Engineering, Environmental;
   Engineering, Chemical}},
Author-Email = {{alina.banciu@incdecoind.ro}},
ResearcherID-Numbers = {{Nita-Lazar, Mihai/Q-2206-2016
   Catrangiu / Banciu, Alina Roxana/K-3016-2018}},
ORCID-Numbers = {{Nita-Lazar, Mihai/0000-0002-5099-1311
   }},
Funding-Acknowledgement = {{CORE Program {[}PN 16 25 01 05]}},
Funding-Text = {{CORE Program PN 16 25 01 05 - Investigation of the pathogenic profile
   and antibiotic resistance of microorganisms potentially involved in
   causing nosocomial infections.}},
Cited-References = {{Anaissie EJ, 2002, ARCH INTERN MED, V162, P1483, DOI 10.1001/archinte.162.13.1483.
   {[}Anonymous], 2000, 78992 ISO.
   {[}Anonymous], 2006, 19458 ISO.
   {[}Anonymous], 2012, 93082 ISO.
   {[}Anonymous], 2014, 93081 ISO.
   Banciu A, 2016, INT S ENV IND, P105.
   Chagas TPG, 2011, J APPL MICROBIOL, V111, P572, DOI 10.1111/j.1365-2672.2011.05072.x.
   CLSI, 2015, M100S CLSI.
   Decker BK, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0432-y.
   Emmanuel E, 2005, J HAZARD MATER, V117, P1, DOI 10.1016/j.jhazmat.2004.08.032.
   Emmanuel E, 2009, ENVIRON INT, V35, P718, DOI 10.1016/j.envint.2009.01.011.
   ISO, 1999, 6222 ISO.
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130.
   Wingender J, 2011, INT J HYG ENVIR HEAL, V214, P417, DOI 10.1016/j.ijheh.2011.05.009.
   World Health Organization, 2002, PREV HOSP ACQ INF PR.}},
Number-of-Cited-References = {{15}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Doc-Delivery-Number = {{BK0JF}},
Unique-ID = {{ISI:000430609800032}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000428427400001,
Author = {Olasunkanmi, Oluwaseun Oyetunji and Akinpelu, David Ayinde and Adeniyi,
   Paul Opeyemi and Ajayi, Oludare Femi and Omololu-Aso, Joseph and
   Olorunmola, Felix Oluwasola},
Title = {{Investigations into Antibacterial, Phytochemical and Antioxidant
   Properties of Vitellaria paradoxa (Gaertn.) Stem Bark Extracts}},
Journal = {{BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH}},
Year = {{2017}},
Volume = {{20}},
Number = {{5}},
Abstract = {{This study investigated the antibacterial potentials and mechanisms of
   action of crude extract and fractions from stem bark of Vitellaria
   paradoxa on susceptible bacterial isolates. It also assessed the
   phytochemical constituents and antioxidant properties of the plant. This
   was with a view to tackling problem of multidrug resistance development
   by microorganisms.
   The stem bark of V. paradoxa was harvested from Ijagbo, Kwara State,
   Nigeria, in the month of April, 2016. The plant sample was oven dried at
   40 degrees C using hot-air oven and ground into fine powder. The
   powdered sample was cold extracted using methanol and sterile distilled
   water in ratio 3:2 (v/v). The mixture obtained was concentrated in vacuo
   using a rotary evaporator and then lyophilized. The crude extract
   collected was screened for antimicrobial, phytochemical and antioxidant
   properties. The crude extract was later partitioned into fractions using
   different organic solvents in the order of their polarity. The
   antimicrobial potentials of the various solvent fractions were
   determined using agar-well diffusion method. The active fractions were
   further partially purified by combination of thin layer and column
   chromatography. The rate of killing, protein, nucleotide and potassium
   ions leakages of the active fractions were determined using
   Staphylococcus aureus and Escherichia coli as representatives of Gram
   positive and Gram negative bacteria respectively. The most active
   partially purified fraction was analysed using GC-MS.
   Phytochemical screening of the extract revealed the presence of
   alkaloids, flavonoids, saponins, tannins, reducing sugar and cardiac
   glycosides. The minimum inhibitory concentrations of the crude extract
   ranged between 0.545 mg/mL and 2.187 mg/mL while those of aqueous,
   butanol and ethylacetate fractions ranged between 0.31 mg/mL and 5.00
   mg/mL, 0.31 mg/mL and 2.50 mg/mL and 0.31 mg/mL and 2.50 mg/mL
   respectively. The time kill assay showed that the percentage of the
   cells killed increased with increasing concentrations of the fractions,
   as well as, contact time intervals. Leakages of protein, potassium ions
   and nucleotides followed the same trend observed for killing rate.
   Vitellaria paradoxa extract exhibited 50\% inhibition of DPPH free
   radicals at 0.008777 mg/mL, whereas ascorbic acid used as standard had
   IC50 of 0.078777 mg/mL. The major active constituent of the purified
   sample was identified as 14-methylhexadecanoic acid. The study concluded
   that V. paradoxa stem bark extract possessed antioxidant properties and
   exhibited appreciable antimicrobial activities against the test
   pathogens.}},
Publisher = {{SCIENCEDOMAIN INT}},
Address = {{SCIENCEDOMAIN INT, GURGAON, 00000, INDIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Akinpelu, DA (Reprint Author), Obafemi Awolowo Univ, Dept Microbiol, Ife, Osun State, Nigeria.
   Akinpelu, DA (Reprint Author), Univ Free State, Dept Plant Sci, Qwaqwa Campus, Bloemfontein, South Africa.
   Olasunkanmi, Oluwaseun Oyetunji; Akinpelu, David Ayinde; Adeniyi, Paul Opeyemi; Ajayi, Oludare Femi; Omololu-Aso, Joseph, Obafemi Awolowo Univ, Dept Microbiol, Ife, Osun State, Nigeria.
   Akinpelu, David Ayinde, Univ Free State, Dept Plant Sci, Qwaqwa Campus, Bloemfontein, South Africa.
   Olorunmola, Felix Oluwasola, Obafemi Awolowo Univ, Fac Pharm, Drug Res \& Prod Unit, Ife, Osun State, Nigeria.}},
DOI = {{10.9734/JPRI/2017/38749}},
Article-Number = {{38749}},
ISSN = {{2231-2919}},
Keywords = {{Vitellaria paradoxa; antioxidant; antimicrobial; antibacterial;
   phytochemicals; killing rate}},
Keywords-Plus = {{FREE-RADICAL METHOD; MEDICINAL-PLANTS; PATHOGENS; PHENOL}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy}},
Author-Email = {{dakinpel@yahoo.com}},
Cited-References = {{Achinto Saha, 2009, Pakistan Journal of Pharmaceutical Sciences, V22, P74.
   Adamu HM, 2013, INT J MODERN BIOL ME, V3, P50.
   Ahmed RN, 2009, ETHNOBOTANICAL LEAFL, V13, P679.
   Akinpelu D.A., 2004, SCI FOCUS, V7, P64.
   Akinpelu DA, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1080-6.
   Atawodi SE, 2005, AFR J BIOTECHNOL, V4, P128.
   Ayankunle A. A., 2012, Journal of Pharmacology and Toxicology, V7, P298.
   Blazzy M, 1998, INT J FOOD MICROBIOL, V39, P175.
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3.
   BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25.
   Doughari JH, 2010, AFR J MICROBIOL RES, V4, P1836.
   European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), 2006, DET MIN INH CONC MIC, V509, P15.
   Harborne J. B., 1998, PHYTOCHEMICAL METHOD, V3, P60.
   HEIPIEPER HJ, 1992, APPL ENVIRON MICROB, V58, P1847.
   Hong TD, 1996, HDB GENEBANKS, V4, P1.
   Keay RWJ, 1960, TREES NIGERIA REVISE, P389.
   Mensor LL, 2001, PHYTOTHER RES, V15, P127, DOI 10.1002/ptr.687.
   Ndukwe IG, 2007, AFR J BIOTECHNOL, V6, P1905.
   Odenholt I, 2001, ANTIMICROB AGENTS CH, V45, P23, DOI 10.1128/AAC.45.1.23-29.2001.
   Okore VC, 2005, PHARM MICROBIOL, V55, P120.
   Parekh J, 2007, AFR J BIOTECHNOL, V6, P1905.
   Parr AJ, 2000, J SCI FOOD AGR, V80, P985, DOI 10.1002/(SICI)1097-0010(20000515)80:7<985::AID-JSFA572>3.0.CO;2-7.
   Pourmorad F, 2006, AFR J BIOTECHNOL, V5, P1142.
   RACCACH M, 1984, J FOOD SAFETY, V6, P141, DOI 10.1111/j.1745-4565.1984.tb00479.x.
   Shanmughapriya S, 2008, ANN MICROBIOL, V58, P535, DOI 10.1007/BF03175554.
   Soladoye MO, 1989, BIENN C EC SOC NIG 1, P13.
   Stojkovic DS, 2013, FOOD CHEM TOXICOL, V55, P209, DOI 10.1016/j.fct.2013.01.005.
   Trease GE, 2002, TXB PHARMACOGNOSY, V42, P214.
   Verma N., 2012, J COMPL INTEGR MED, V9, P1.
   Ziba L, 2002, P WORKSH ORG FOOD AG, P80.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Brit. J. Pharm. Res.}},
Doc-Delivery-Number = {{GA6FC}},
Unique-ID = {{ISI:000428427400001}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000416800500002,
Author = {Yang, Benqin and Hao, Zongdi and Jahng, Deokjin},
Title = {{Advances in biodrying technologies for converting organic wastes into
   solid fuel}},
Journal = {{DRYING TECHNOLOGY}},
Year = {{2017}},
Volume = {{35}},
Number = {{16}},
Pages = {{1950-1969}},
Abstract = {{Biodrying has emerged recently as an energy-effective technology for
   converting organic wastes into solid recovered fuel (SRF). In biodrying,
   water removal is achieved using metabolic heat produced from
   microbiological degradation of organics and forced airflow to promote
   heat and mass transfer. Factors affecting biodrying include moisture
   content (MC) and free air space (FAS) of the wastes, use of bulking
   agents, aeration rate, mechanical turning as well as microbial
   activities. These factors independently or collectively determine water
   removal capacities of various biodrying processes. In this review
   article, studies on these factors are surveyed extensively and reviewed.
   Additionally, details of reactor configurations, operation modes, and
   modeling studies on biodrying are summarized. Finally, health and
   environmental risks and their management associated with off-gases and
   final products of biodrying processes are discussed.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Jahng, D (Reprint Author), Myongji Univ, Dept Environm Engn \& Energy, 116 Myongjiro, Yonginshi 17508, Gyeonggido, South Korea.
   Yang, Benqin, Kunming Univ Sci \& Technol, Fac Environm Sci \& Engn, Kunming, Yunnan, Peoples R China.
   Hao, Zongdi; Jahng, Deokjin, Myongji Univ, Dept Environm Engn \& Energy, 116 Myongjiro, Yonginshi 17508, Gyeonggido, South Korea.}},
DOI = {{10.1080/07373937.2017.1322100}},
ISSN = {{0737-3937}},
EISSN = {{1532-2300}},
Keywords = {{Biodrying; environmental risk; organic wastes; solid recovered fuel}},
Keywords-Plus = {{MECHANICAL-BIOLOGICAL TREATMENT; ANTIBIOTIC-RESISTANCE GENES; INITIAL
   MOISTURE-CONTENT; AIR-FLOW RATE; SEWAGE-SLUDGE; BULKING AGENT;
   HEAVY-METALS; PIG-MANURE; BACTERIAL COMMUNITIES; TRANSPORT PHENOMENA}},
Research-Areas = {{Engineering}},
Web-of-Science-Categories  = {{Engineering, Chemical; Engineering, Mechanical}},
Author-Email = {{djahng@mju.ac.kr}},
Funding-Acknowledgement = {{National Research Foundation of Korea (NRF) {[}2015R1D1A1A01059073]}},
Funding-Text = {{This study was supported by the National Research Foundation of Korea
   (NRF) (2015R1D1A1A01059073).}},
Cited-References = {{Adani F, 2004, WASTE MANAGE, V24, P775, DOI 10.1016/j.wasman.2004.03.007.
   Adani F, 2002, BIORESOURCE TECHNOL, V83, P173, DOI 10.1016/S0960-8524(01)00231-0.
   Ahn HK, 2008, WASTE MANAGE, V28, P1411, DOI 10.1016/j.wasman.2007.05.022.
   Ahn HK, 2007, PROCESS BIOCHEM, V42, P215, DOI 10.1016/j.procbio.2006.08.005.
   Al-Khashman OA, 2004, ATMOS ENVIRON, V38, P6803, DOI 10.1016/j.atmosenv.2004.09.011.
   AlChalabi AS, 1997, SCI TOTAL ENVIRON, V206, P195.
   Archer E., 2005, MECH BIOL TREATMENT.
   Atkinson B, 1991, BIOCH ENG BIOTECHNOL.
   Baldwin R. L., 1995, MODELING RUMINANT DI.
   Banegas V, 2007, WASTE MANAGE, V27, P1317, DOI 10.1016/j.wasman.2006.098.008.
   Benesova L., 2015, P 30 INT C SOL WAST.
   Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027.
   Bernal MP, 1998, BIORESOURCE TECHNOL, V63, P91, DOI 10.1016/S0960-8524(97)00084-9.
   BISHOP PL, 1983, BIOCYCLE, V24, P34.
   Cai L, 2017, DRY TECHNOL, V35, P108, DOI 10.1080/07373937.2016.1162169.
   Cai L, 2016, WATER RES, V90, P44, DOI 10.1016/j.watres.2015.12.026.
   Cai L, 2015, DRY TECHNOL, V33, P1151, DOI 10.1080/07373937.2015.1016574.
   Cai L, 2013, WATER RES, V47, P4767, DOI 10.1016/j.watres.2013.03.048.
   Chang JI, 2010, BIORESOURCE TECHNOL, V101, P5917, DOI 10.1016/j.biortech.2010.02.042.
   Choi HL, 2001, COMPOST SCI UTIL, V9, P303.
   Colomer-Mendoza EJ, 2013, J ENVIRON SCI-CHINA, V25, P865, DOI 10.1016/S1001-0742(12)60123-5.
   Cronje AL, 2004, COMPOST SCI UTIL, V12, P119.
   de Guardia A, 2008, WASTE MANAGE, V28, P73, DOI 10.1016/j.wasman.2006.10.019.
   Deshusses MA, 1997, CURR OPIN BIOTECH, V8, P335, DOI 10.1016/S0958-1669(97)80013-4.
   Di Lonardo MC, 2016, WASTE MANAGE, V47, P195, DOI 10.1016/j.wasman.2015.07.018.
   Di Maria F, 2008, WASTE MANAGE, V28, P805, DOI 10.1016/j.wasman.2007.03.021.
   Dinis MJ, 2009, BIORESOURCE TECHNOL, V100, P4829, DOI 10.1016/j.biortech.2009.04.036.
   Dominczyk A, 2014, DRY TECHNOL, V32, P1297, DOI 10.1080/07373937.2014.901349.
   Fehrenbach H., 2003, REFUSE DERIVED FUEL.
   Frei KM, 2004, DRY TECHNOL, V22, P1191, DOI {[}10.1081/DRT-120038587, 10.1081/drt-120038587].
   Fricke K, 2005, WASTE MANAGE, V25, P799, DOI 10.1016/j.wasman.2004.12.018.
   Fugere M, 2007, CAN J CHEM ENG, V85, P360.
   Garg A., 2007, P 11 INT WAST MAN LA.
   Garg A, 2007, ENVIRON SCI TECHNOL, V41, P4868, DOI 10.1021/es062163e.
   Goyal S, 2005, BIORESOURCE TECHNOL, V96, P1584, DOI 10.1016/j.biortech.2004.12.012.
   Grammelis P., 2011, REPORT RDF SRF UTILI.
   GRIFFIN DM, 1981, ADV MICROB ECOL, V5, P91.
   Hamidian A, 2017, DRY TECHNOL, V35, P300, DOI 10.1080/07373937.2016.1164182.
   Haug R. T., 1993, PRACTICAL HDB COMPOS.
   Havukainen J, 2017, J CLEAN PROD, V141, P453, DOI 10.1016/j.jclepro.2016.09.146.
   He PJ, 2013, DRY TECHNOL, V31, P132, DOI 10.1080/07373937.2012.693143.
   Hernandez-Atonal FD, 2007, CHEM ENG SCI, V62, P627, DOI 10.1016/j.ces.2006.09.025.
   HIGGINS AJ, 1986, WASTE MANAGE RES, V4, P367, DOI 10.1177/0734242X8600400156.
   Hilber T, 2007, FUEL, V86, P1935, DOI 10.1016/j.fuel.2006.12.014.
   Huilinir C, 2017, DRY TECHNOL, V35, P651, DOI 10.1080/07373937.2016.1212063.
   Huilinir C, 2017, DRY TECHNOL, V35, P666, DOI 10.1080/07373937.2016.1206124.
   Huilinir C, 2015, WATER RES, V82, P118, DOI 10.1016/j.watres.2015.04.046.
   Huilinir C, 2014, BIORESOURCE TECHNOL, V157, P206, DOI 10.1016/j.biortech.2014.01.109.
   Hurka M., 2014, INFRASTRUKTURA EKOLO.
   Imbeah M, 1998, BIORESOURCE TECHNOL, V63, P197, DOI 10.1016/S0960-8524(97)00165-X.
   Iqbal MK, 2010, BIORESOURCE TECHNOL, V101, P1913, DOI 10.1016/j.biortech.2009.10.030.
   Jewell W.J., 1984, 61615168 SEACR USDA.
   JEWELL WJ, 1984, J FOOD SCI, V49, P407, DOI 10.1111/j.1365-2621.1984.tb12433.x.
   Kaiser J, 1996, ECOL MODEL, V91, P25, DOI 10.1016/0304-3800(95)00157-3.
   Kalamdhad AS, 2009, CHEMOSPHERE, V74, P1327, DOI 10.1016/j.chemosphere.2008.11.058.
   Kasinski S, 2016, WASTE MANAGE, V50, P31, DOI 10.1016/j.wasman.2016.02.012.
   KRAFT DL, 1993, TAPPI J, V76, P175.
   Kudra T, 2002, DRY TECHNOL, V20, P917, DOI 10.1081/DRT-120003769.
   Leonard A, 2008, WATER RES, V42, P2671, DOI 10.1016/j.watres.2008.01.020.
   LESON G, 1991, J AIR WASTE MANAGE, V41, P1045, DOI 10.1080/10473289.1991.10466898.
   Li XW, 2015, BIORESOURCE TECHNOL, V175, P245, DOI 10.1016/j.biortech.2014.10.078.
   Liang XH, 2015, J BIOBASED MATER BIO, V9, P66, DOI 10.1166/jbmb.2015.1484.
   LIAO PH, 1993, J ENVIRON SCI HEAL A, V28, P1889.
   Liu HT, 2017, J AIR WASTE MANAGE, V67, P212, DOI 10.1080/10962247.2016.1227282.
   Luo W, 2008, RESOUR CONSERV RECY, V52, P635, DOI 10.1016/j.resconrec.2007.08.004.
   Ma J, 2016, WASTE MANAGE, V56, P411, DOI 10.1016/j.wasman.2016.06.007.
   Madejon E, 2002, BIORESOURCE TECHNOL, V85, P73, DOI 10.1016/S0960-8524(02)00030-5.
   Madigan M. T., 2012, BROCK BIOL MICROORGA.
   Maeda K, 2010, BIORESOURCE TECHNOL, V101, P9631, DOI 10.1016/j.biortech.2010.07.057.
   Mason IG, 2009, WASTE MANAGE, V29, P559, DOI 10.1016/j.wasman.2008.05.001.
   Mason IG, 2006, WASTE MANAGE, V26, P3, DOI 10.1016/j.wasman.2005.01.021.
   Mason IG, 2005, WASTE MANAGE, V25, P481, DOI 10.1016/j.wasman.2005.01.015.
   Miller F. C., 1991, BIOL DEGRADATION WAS, P1.
   MILLER FC, 1989, MICROBIAL ECOL, V18, P59, DOI 10.1007/BF02011696.
   Molla A, 2004, WATER RES, V38, P4143, DOI 10.1016/j.watres.2004.08.002.
   NAKASAKI K, 1985, APPL ENVIRON MICROB, V50, P1526.
   NAKASAKI K, 1985, APPL ENVIRON MICROB, V49, P37.
   NAKASAKI K, 1985, APPL ENVIRON MICROB, V49, P724.
   Navaee-Ardeh S, 2006, DRY TECHNOL, V24, P863, DOI 10.1080/07373930600734026.
   Navaee-Ardeh S, 2011, DRY TECHNOL, V29, P135, DOI 10.1080/07373937.2010.482723.
   Navaee-Ardeh S, 2011, DRY TECHNOL, V29, P153, DOI 10.1080/07373937.2010.482724.
   Navaee-Ardeh S, 2010, BIORESOURCE TECHNOL, V101, P3379, DOI 10.1016/j.biortech.2009.12.037.
   Negoi RM, 2009, UNIV POLIT BUCHAR S, V71, P193.
   Nicolai RE, 2001, WATER SCI TECHNOL, V44, P261.
   Ogunwande GA, 2008, BIORESOURCE TECHNOL, V99, P7495, DOI 10.1016/j.biortech.2008.02.020.
   Pagans E, 2005, CHEM ENG J, V113, P105, DOI 10.1016/j.cej.2005.03.004.
   Pagans E, 2006, J HAZARD MATER, V131, P179, DOI 10.1016/j.jhazmat.2005.09.017.
   Psomopoulos CS, 2014, AIMS ENERGY, V2, P321, DOI 10.3934/energy.2014.3.321.
   Rada EC, 2007, ENVIRON TECHNOL, V28, P463, DOI 10.1080/09593332808618807.
   Rada EC, 2007, CHEMOSPHERE, V68, P1669, DOI 10.1016/j.chemosphere.2007.03.075.
   Rada EC, 2010, WASTE BIOMASS VALORI, V1, P271, DOI 10.1007/s12649-010-9023-9.
   Rada EC, 2011, CHEMOSPHERE, V84, P289, DOI 10.1016/j.chemosphere.2011.04.019.
   Rada Elena Cristina, 2009, University ``Politehnica{''} of Bucharest, Scientific Bulletin Series D: Mechanical Engineering, V71, P113.
   Rada E. C., 2005, University ``Politehnica{''} of Bucharest, Scientific Bulletin Series C: Electrical Engineering, V67, P69.
   Rada EC, 2009, WATER SCI TECHNOL, V60, P1065, DOI 10.2166/wst.2009.559.
   Rada E.C., 2007, P 2 INT S MBT 2007 M, P440.
   Rada E.C., 2005, P INT C INT URB SOL, P6.
   Rada EC, 2006, CHEMOSPHERE, V62, P404, DOI 10.1016/j.chemosphere.2005.04.065.
   Ragazzi M, 2011, WASTE MANAGE, V31, P2085, DOI 10.1016/j.wasman.2011.02.024.
   Ragazzi M., 2012, WIT T ECOL ENV, V163, P199.
   Richard TL, 2004, BIOTECHNOL PROGR, V20, P1372, DOI 10.1021/bp0499505.
   Richard TL, 2002, COMPOST SCI UTIL, V10, P286.
   Ruggieri L, 2009, BIORESOURCE TECHNOL, V100, P2655, DOI 10.1016/j.biortech.2008.12.049.
   Ryckeboer J, 2003, ANN MICROBIOL, V53, P349.
   Ryu HW, 2011, BIORESOURCE TECHNOL, V102, P4654, DOI 10.1016/j.biortech.2011.01.021.
   Sen R, 2015, INT J ENVIRON TECHNO, V18, P9, DOI 10.1504/IJETM.2015.068414.
   Shah MM, 2012, ENERG BUILDINGS, V49, P306, DOI 10.1016/j.enbuild.2012.02.026.
   Shao LM, 2010, WASTE MANAGE, V30, P1165, DOI 10.1016/j.wasman.2010.01.011.
   Sharara MA, 2012, APPL ENG AGRIC, V28, P407.
   Smet E, 2000, WATER AIR SOIL POLL, V119, P177, DOI 10.1023/A:1005186327201.
   Song X, 2015, MATH PROBL ENG, V2015, P1.
   Staley BF, 2006, ENVIRON SCI TECHNOL, V40, P5984, DOI 10.1021/es060786m.
   Stanford K, 2009, BIORESOURCE TECHNOL, V100, P4417, DOI 10.1016/j.biortech.2008.11.061.
   Sugni M, 2005, BIORESOURCE TECHNOL, V96, P1331, DOI 10.1016/j.biortech.2004.11.016.
   Swan JRM, 2002, ISS ENVIR SCI TECHN, V18, P73.
   Taha MPM, 2006, ATMOS ENVIRON, V40, P1159, DOI 10.1016/j.atmosenv.2005.11.010.
   Tambone F, 2011, BIORESOURCE TECHNOL, V102, P7443, DOI 10.1016/j.biortech.2011.05.010.
   Tiquia SM, 1997, BIORESOURCE TECHNOL, V62, P37, DOI 10.1016/S0960-8524(97)00080-1.
   Tita G., 2007, P 11 INT WAST MAN LA, P1085.
   Tom AP, 2016, WASTE MANAGE, V49, P64, DOI 10.1016/j.wasman.2016.01.004.
   TSANG KR, 1990, WATER SCI TECHNOL, V22, P135.
   Velis CA, 2010, CRIT REV ENV SCI TEC, V40, P979, DOI 10.1080/10643380802586980.
   Velis CA, 2009, BIORESOURCE TECHNOL, V100, P2747, DOI 10.1016/j.biortech.2008.12.026.
   Velis C.A., 2009, P 3 INT C HELL SOL W.
   Velis C, 2012, ENVIRON SCI TECHNOL, V46, P1923, DOI 10.1021/es2035653.
   Velis CA, 2013, ENVIRON SCI TECHNOL, V47, P2957, DOI 10.1021/es3021815.
   Villegas M, 2014, BIORESOURCE TECHNOL, V174, P33, DOI 10.1016/j.biortech.2014.09.136.
   Wagland ST, 2011, WASTE MANAGE, V31, P1176, DOI 10.1016/j.wasman.2011.01.001.
   Wang K, 2011, BIORESOURCE TECHNOL, V102, P5528, DOI 10.1016/j.biortech.2011.01.083.
   Wang XM, 2008, ENVIRON SCI TECHNOL, V42, P3265, DOI 10.1021/es702999j.
   Wani AH, 1997, J ENVIRON SCI HEAL A, V32, P2027, DOI 10.1080/10934529709376664.
   Wheeler P.A., 2001, P1315TR ENV AG.
   Yang BQ, 2016, DRY TECHNOL, V34, P76, DOI 10.1080/07373937.2015.1009536.
   Yang BQ, 2015, DRY TECHNOL, V33, P1188, DOI 10.1080/07373937.2014.943235.
   Yang B, 2014, DRY TECHNOL, V32, P135, DOI 10.1080/07373937.2013.795586.
   Yang B, 2013, WATER RES, V47, P5678, DOI 10.1016/j.watres.2013.06.044.
   YANG YH, 1994, J AIR WASTE MANAGE, V44, P863, DOI 10.1080/1073161X.1994.10467287.
   Yao J, 2010, FUEL, V89, P616, DOI 10.1016/j.fuel.2009.06.016.
   You SJ, 2006, J ENVIRON SCI HEAL A, V41, P2721, DOI 10.1080/10934520600966284.
   Youngquist CP, 2016, J ENVIRON QUAL, V45, P537, DOI 10.2134/jeq2015.05.0256.
   Yuan HR, 2014, BIOTECHNOL BIOPROC E, V19, P668, DOI 10.1007/s12257-013-0575-y.
   Zawadzka A, 2010, DRY TECHNOL, V28, P1220, DOI 10.1080/07373937.2010.483034.
   Zhang DQ, 2008, BIORESOURCE TECHNOL, V99, P8796, DOI 10.1016/j.biortech.2008.04.046.
   Zhang DQ, 2011, WASTE MANAGE, V31, P1790, DOI 10.1016/j.wasman.2011.04.006.
   Zhang DQ, 2009, J HAZARD MATER, V168, P1497, DOI 10.1016/j.jhazmat.2009.03.035.
   Zhang DQ, 2009, BIORESOURCE TECHNOL, V100, P3848, DOI 10.1016/j.biortech.2009.03.017.
   Zhang DQ, 2009, BIORESOURCE TECHNOL, V100, P1087, DOI 10.1016/j.biortech.2008.07.059.
   Zhang G, 2013, ENVIRON SCI TECHNOL, V47, P2123, DOI 10.1021/es304127k.
   Zhang H, 2008, J HAZARD MATER, V156, P365, DOI 10.1016/j.jhazmat.2007.12.025.
   Zhang JN, 2008, WATER SCI TECHNOL, V57, P1017, DOI 10.2166/wst.2008.063.
   Zhang JY, 2016, WATER RES, V106, P62, DOI 10.1016/j.watres.2016.09.055.
   Zhang JY, 2016, WATER RES, V91, P339, DOI 10.1016/j.watres.2016.01.010.
   Zhang JY, 2015, APPL MICROBIOL BIOT, V99, P7321, DOI 10.1007/s00253-015-6640-z.
   Zhao L, 2012, DRY TECHNOL, V30, P1037, DOI 10.1080/07373937.2012.665113.
   Zhao L, 2011, WATER RES, V45, P2322, DOI 10.1016/j.watres.2011.01.014.
   Zhao L, 2010, WATER RES, V44, P6144, DOI 10.1016/j.watres.2010.07.002.
   Zhou HB, 2014, BIORESOURCE TECHNOL, V171, P452, DOI 10.1016/j.biortech.2014.07.006.
   Zumdahl S, 2014, INTRO CHEM FDN.}},
Number-of-Cited-References = {{158}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{9}},
Usage-Count-Since-2013 = {{13}},
Journal-ISO = {{Dry. Technol.}},
Doc-Delivery-Number = {{FO4GR}},
Unique-ID = {{ISI:000416800500002}},
DA = {{2018-08-13}},
}

@article{ ISI:000416502000008,
Author = {Vital, Pierangeli G. and Caballes, Marie Bernadine D. and Rivera,
   Windell L.},
Title = {{Antimicrobial resistance in Escherichia coli and Salmonella spp.
   isolates from fresh produce and the impact to food safety}},
Journal = {{JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART B-PESTICIDES FOOD
   CONTAMINANTS AND AGRICULTURAL WASTES}},
Year = {{2017}},
Volume = {{52}},
Number = {{9}},
Pages = {{683-689}},
Abstract = {{Foodborne diseases associated with fresh produce consumption have
   escalated worldwide, causing microbial safety of produce of critical
   importance. Bacteria that have increasingly been detected in fresh
   produce are Escherichia coli and Salmonella spp., both of which have
   been shown to progressively display antimicrobial resistance. The study
   focused on the assessment of antimicrobial resistance of these enteric
   bacteria from different kinds of fresh produce from various open air
   markets and supermarkets in the Philippines. Using the disk diffusion
   assay on a total of 50 bacterial isolates obtained from 410 fresh
   produce surveyed, monoresistance to tetracycline was observed to be the
   most prevalent (38\%), followed by multidrug resistance to tetracycline,
   chloramphenicol, ciprofloxacin, and nalidixic acid (4\%), and lastly by
   dual resistance to tetracycline and chloramphenicol (2\%). Using
   multiplex and simplex polymerase chain reaction (PCR) assays, tetA
   (75\%) and tetB (9\%) were found in tetracycline resistant isolates,
   whereas catI (67\%) and catIII (33\%) were detected in chloramphenicol
   resistant isolates. Sequence analysis of gyr and par genes from the
   ciprofloxacin and nalidixic acid resistant isolates revealed different
   mutations. Based on the results, fresh produce act as a reservoir of
   these antibiotic resistant bacteria whichmay pose health threat to
   consumers.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Vital, PG (Reprint Author), Univ Philippines Diliman, Coll Sci, Inst Biol, Quezon City 1101, Philippines.
   Vital, Pierangeli G.; Caballes, Marie Bernadine D.; Rivera, Windell L., Univ Philippines Diliman, Coll Sci, Inst Biol, Quezon City 1101, Philippines.
   Vital, Pierangeli G.; Rivera, Windell L., Univ Philippines Diliman, Nat Sci Res Inst, Quezon City, Philippines.}},
DOI = {{10.1080/03601234.2017.1331676}},
ISSN = {{0360-1234}},
EISSN = {{1532-4109}},
Keywords = {{Antibiotic resistance; contamination; Escherichia coli; food safety;
   fresh produce; Salmonella}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE; QUINOLONE RESISTANCE; IRRIGATION WATER; VIRULENCE
   GENES; E. COLI; PREVALENCE; ENTERICA; STRAINS; QUALITY;
   ENTEROBACTERIACEAE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{piervital@hotmail.com}},
Funding-Acknowledgement = {{Department of Agriculture - Bureau of Agricultural Research (DA-BAR) of
   the Philippine Government; Commission on Higher Education (CHED) K to 12
   Transition Program Postdoctoral Research Grant}},
Funding-Text = {{This work was funded by the Department of Agriculture - Bureau of
   Agricultural Research (DA-BAR) of the Philippine Government and the
   Commission on Higher Education (CHED) K to 12 Transition Program
   Postdoctoral Research Grant.}},
Cited-References = {{Abadias M, 2008, INT J FOOD MICROBIOL, V123, P121, DOI 10.1016/j.ijfoodmicro.2007.12.013.
   Abakpa G. O., 2015, Environmental Nanotechnology, Monitoring and Management, V3, P38, DOI 10.1016/j.enmm.2014.11.004.
   Brenner D., 2005, BERGEYS MANUAL SYSTE, V2, P926.
   Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001.
   Clinical and Laboratory Standards Institute, 2012, PERFORMANCE STANDARD, P188.
   Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498.
   Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P4012, DOI 10.1128/AAC.48.10.4012-4015.2004.
   Esiobu N, 2002, INT J ENVIRON HEAL R, V12, P133, DOI 10.1080/09603120220129292.
   Gabriel AA, 2007, FOOD CONTROL, V18, P1307, DOI 10.1016/j.foodcont.2006.09.004.
   Garcia BCB, 2015, J ENVIRON SCI HEAL B, V50, P734, DOI 10.1080/03601234.2015.1048107.
   Golberg D, 2011, INT J FOOD MICROBIOL, V145, P250, DOI {[}10.1016/j.ijfoodmicro.2010.12.031, 10.1016/j.jfoodmicro.2010.12.031].
   Hall T. A., 1999, NUCL ACIDS S SER, P95, DOI DOI 10.1021/BK-1999-0734.CH008.
   Hirose K, 2002, ANTIMICROB AGENTS CH, V46, P3249, DOI 10.1128/AAC.46.10.3249-3252.2002.
   Holvoet K, 2013, APPL ENVIRON MICROB, V79, P6677, DOI 10.1128/AEM.01995-13.
   Hopkins KL, 2005, INT J ANTIMICROB AG, V25, P358, DOI 10.1016/j.ijantimicag.2005.02.006.
   Khachatourians GG, 1998, CAN MED ASSOC J, V159, P1129.
   Kim KY, 2011, INT J FOOD MICROBIOL, V146, P52, DOI 10.1016/j.ijfoodmicro.2011.01.037.
   Malorny B, 2003, APPL ENVIRON MICROB, V69, P290, DOI 10.1128/AEM.69.1.290-296.2003.
   Masters N, 2011, WATER RES, V45, P6321, DOI 10.1016/j.watres.2011.09.018.
   Ng K.H., 2013, INT FOOD RES J, V21, P1321.
   Olaimat AN, 2012, FOOD MICROBIOL, V32, P1, DOI 10.1016/j.fm.2012.04.016.
   Pasquali F, 2004, VET MICROBIOL, V103, P71, DOI 10.1016/j.vetmic.2004.07.007.
   Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es0604131.
   Robicsek A, 2006, ANTIMICROB AGENTS CH, V50, P2872, DOI 10.1128/AAC.01647-05.
   Saenz Y, 2004, ANTIMICROB AGENTS CH, V48, P3996, DOI 10.1128/AAC.48.10.3996-4001.2004.
   Saxena T, 2015, DIAGN MICR INFEC DIS, V82, P249, DOI 10.1016/j.diagmicrobio.2015.03.015.
   Shanahan PMA, 1998, J CLIN MICROBIOL, V36, P1595.
   Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09.
   Tacao M, 2014, WATER RES, V48, P100, DOI 10.1016/j.watres.2013.09.021.
   Takahashi H, 2009, J MICROBIOL METH, V79, P124, DOI 10.1016/j.mimet.2009.08.002.
   Teplitski M, 2012, FOOD RES INT, V45, P576, DOI 10.1016/j.foodres.2011.06.020.
   Van TTH, 2008, INT J FOOD MICROBIOL, V124, P217, DOI 10.1016/j.ijfoodmicro.2008.03.029.
   Vital PG, 2014, SCI WORLD J, DOI 10.1155/2014/219534.
   Yoo MH, 2003, AQUACULTURE, V217, P11, DOI 10.1016/S0044-8486(02)00169-2.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{6}},
Usage-Count-Since-2013 = {{6}},
Journal-ISO = {{J. Environ. Sci. Health Part B-Pestic. Contam. Agric. Wastes}},
Doc-Delivery-Number = {{FO1FL}},
Unique-ID = {{ISI:000416502000008}},
DA = {{2018-08-13}},
}

@article{ ISI:000412037300001,
Author = {Liu, Huizhong and Xiao, Yujie and Nie, Hailing and Huang, Qiaoyun and
   Chen, Wenli},
Title = {{Influence of (p)ppGpp on biofilm regulation in Pseudomonas putida KT2440}},
Journal = {{MICROBIOLOGICAL RESEARCH}},
Year = {{2017}},
Volume = {{204}},
Pages = {{1-8}},
Abstract = {{The global regulatory molecule (p)ppGpp is synthesized under limited
   nutrition conditions and involves in many cellular processes in
   bacteria. (p)ppGpp has been reported to affect biofilm formation in
   several bacterial species. Here, we found that deletion of (p)ppGpp
   synthase genes of Pseudomonas putida KT2440 led to enhanced biofilm
   formation in polystyrene microtitre plates. Besides, the pellicle of
   this mutant formed at the air -liquid interface lost the robust
   structure and became frail. The biofilm formation and its structure are
   mainly determined by exopolysaccharides (EPSs) and adhesins.
   Transcriptional analysis of four EPS operons designated as pea, peb, alg
   and bcs and two adhesin genes nominated as lapA and lapF showed that the
   deletion of (p)ppGpp synthase genes increased the expression of peb, bcs
   and lapA but repressed the expression of pea and lapF. Furthermore,
   expression of the regulation factor FleQ was significantly augmented in
   (p)ppGpp-synthase mutants while the expression of sigma factor RpoS was
   reduced. Since FleQ and RpoS play important roles in regulating
   expression of EPS and adhesin genes, (p)ppGpp may mediate the synthesis
   of biofilm matrix via influencing these regulators to control the
   biofilm formation and pellicle structure.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chen, WL (Reprint Author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.
   Liu, Huizhong; Xiao, Yujie; Nie, Hailing; Huang, Qiaoyun; Chen, Wenli, Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.
   Huang, Qiaoyun, Huazhong Agr Univ, Key Lab Arable Land Conservat Middle \& Lower Reac, Minist Agr, Coll Resources \& Environm, Wuhan 430070, Hubei, Peoples R China.}},
DOI = {{10.1016/j.micres.2017.07.003}},
ISSN = {{0944-5013}},
Keywords = {{(P)PPGPP; Biofilm; Extracellular matrix; fieQ; rpoS}},
Keywords-Plus = {{C-DI-GMP; WATER-LIMITING CONDITIONS; ESCHERICHIA-COLI; STRINGENT
   RESPONSE; RNA-POLYMERASE; ANTIBIOTIC-RESISTANCE; MOLECULAR-MECHANISMS;
   SIGMA(S) SUBUNIT; GENE-EXPRESSION; AERUGINOSA}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{wlchen@mail.hzau.edu.cn}},
ResearcherID-Numbers = {{Huang, Qiaoyun/A-8418-2012}},
Funding-Acknowledgement = {{National Key Research and Development Program of China
   {[}2016YFD0800206]; National Natural Science Foundation of China
   {[}41571230, 41230854]; Fundamental Research Funds for the Central
   Universities {[}2662015PY016, 2662015PY116]}},
Funding-Text = {{The research was financially supported by The National Key Research and
   Development Program of China (2016YFD0800206); The National Natural
   Science Foundation of China (41571230, 41230854), and The Fundamental
   Research Funds for the Central Universities (2662015PY016,
   2662015PY116). We thank Professor Victoria Shingler from Umea.
   University for providing plasmids pVI681 and pVI682.}},
Cited-References = {{Balzer GJ, 2002, CAN J MICROBIOL, V48, P675, DOI 10.1139/W02-060.
   Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x.
   Bougdour A, 2007, P NATL ACAD SCI USA, V104, P12896, DOI 10.1073/pnas.0705561104.
   Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720.
   Dasgupta N, 2002, J BACTERIOL, V184, P5240, DOI 10.1128/JB.184.19.5240-5250.2002.
   de Paz LEC, 2012, APPL ENVIRON MICROB, V78, P1627, DOI 10.1128/AEM.07036-11.
   Dean SN, 2015, APPL ENVIRON MICROB, V81, P7057, DOI 10.1128/AEM.02165-15.
   Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07.
   Fernandez-Pinar R, 2011, ENV MICROBIOL REP, V3, P79, DOI 10.1111/j.1758-2229.2010.00190.x.
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415.
   GENTRY DR, 1993, J BACTERIOL, V175, P7982.
   Ghafoor A, 2011, APPL ENVIRON MICROB, V77, P5238, DOI 10.1128/AEM.00637-11.
   Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x.
   Griffith KL, 2002, BIOCHEM BIOPH RES CO, V290, P397, DOI 10.1006/bbrc.2001.6152.
   Hall CW, 2017, FEMS MICROBIOL REV, V41, P276, DOI {[}10.1093/femsre/fux010, 10.1093/femsre/f].
   Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912.
   He HJ, 2012, J BACTERIOL, V194, P2962, DOI 10.1128/JB.00014-12.
   HERNANDEZ VJ, 1991, J BIOL CHEM, V266, P5991.
   Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x.
   Irie Y, 2012, P NATL ACAD SCI USA, V109, P20632, DOI 10.1073/pnas.1217993109.
   Jimenez-Fernandez A, 2015, ENV MICROBIOL REP, V7, P78, DOI 10.1111/1758-2229.12153.
   Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902.
   JUSTESEN J, 1986, BIOCHIMIE, V68, P715, DOI 10.1016/S0300-9084(86)80165-1.
   Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k.
   Keith LMW, 1999, J BACTERIOL, V181, P7176.
   Khakimova M, 2013, J BACTERIOL, V195, P2011, DOI 10.1128/JB.02061-12.
   KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1.
   LANGE R, 1995, J BACTERIOL, V177, P4676, DOI 10.1128/jb.177.16.4676-4680.1995.
   LANGE R, 1994, GENE DEV, V8, P1600, DOI 10.1101/gad.8.13.1600.
   Li G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141501.
   Li XH, 2010, ENVIRON MICROBIOL, V12, P1578, DOI 10.1111/j.1462-2920.2010.02186.x.
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262.
   Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048.
   Martinez-Gil M, 2014, J BACTERIOL, V196, P1484, DOI 10.1128/JB.01287-13.
   Martinez-Gil M, 2010, MOL MICROBIOL, V77, P549, DOI 10.1111/j.1365-2958.2010.07249.x.
   Matilla MA, 2011, ENVIRON MICROBIOL, V13, P1745, DOI 10.1111/j.1462-2920.2011.02499.x.
   Moor H, 2014, MICROBIOL-SGM, V160, P2681, DOI 10.1099/mic.0.082503-0.
   Nakazawa T, 2002, ENVIRON MICROBIOL, V4, P782, DOI 10.1046/j.1462-2920.2002.00310.x.
   Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x.
   Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587.
   Nielsen L, 2011, ENVIRON MICROBIOL, V13, P1342, DOI 10.1111/j.1462-2920.2011.02432.x.
   Nilsson M, 2011, ENVIRON MICROBIOL, V13, P1357, DOI 10.1111/j.1462-2920.2011.02447.x.
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49.
   O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x.
   Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903.
   SARUBBI E, 1988, MOL GEN GENET, V213, P214, DOI 10.1007/BF00339584.
   Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705.
   Sugisaki K, 2013, MICROBIOL-SGM, V159, P1379, DOI 10.1099/mic.0.066597-0.
   SUTRINA SL, 2015, MOL MICROBIOL BIOTEC, V25, P209.
   Sze CC, 2002, J BACTERIOL, V184, P760, DOI 10.1128/JB.184.3.760-770.2002.
   Teitzel GM, 2003, APPL ENVIRON MICROB, V69, P2313, DOI 10.1128/AEM.69.4.2313-2320.2003.
   Van Delden C, 2001, J BACTERIOL, V183, P5376, DOI 10.1128/JB.183.18.5376-5384.2001.
   Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003.
   Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x.
   Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1.
   XIAO H, 1991, J BIOL CHEM, V266, P5980.
   Xiao YJ, 2016, ENV MICROBIOL REP, V8, P659, DOI 10.1111/1758-2229.12419.
   Xie ZD, 1996, J BACTERIOL, V178, P4990, DOI 10.1128/jb.178.16.4990-4996.1996.
   Yousef-Coronado F, 2008, FEMS MICROBIOL LETT, V288, P118, DOI 10.1111/j.1574-6968.2008.01339.x.
   Zhang SR, 2013, J BACTERIOL, V195, P4536, DOI 10.1128/JB.00724-13.}},
Number-of-Cited-References = {{60}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{7}},
Usage-Count-Since-2013 = {{10}},
Journal-ISO = {{Microbiol. Res.}},
Doc-Delivery-Number = {{FI5PW}},
Unique-ID = {{ISI:000412037300001}},
DA = {{2018-08-13}},
}

@article{ ISI:000412451500045,
Author = {Subjalearndee, Nakarin and Intasanta, Varol},
Title = {{Mechanically robust, multifunctional and nanofibrous membranes for
   tuberculosis elimination}},
Journal = {{RSC ADVANCES}},
Year = {{2017}},
Volume = {{7}},
Number = {{74}},
Pages = {{46906-46915}},
Abstract = {{M. tuberculosis H37Ra is one of the most virulent microbes in the world;
   it causes endemic and neglected disease that is highly drug resistant,
   and no vaccine has yet been created for it. In this present study,
   mechanically robust and potent antibacterial membranes were fabricated
   for total elimination of water and airborne tuberculosis (TB) bacteria.
   Via simple electrospinning, a multi-component, water-based solution
   containing nanofunctional and antibacterial materials led to a thermally
   and chemically stable nanofibrous membrane with water-repellent,
   UV-resistant, and antibacterial properties. The liquid-and air-permeable
   multifunctional nanofibrous membrane contains distributed fibers with
   two distinct characteristic sizes, proven to be unique physical origins
   of its exceptional sharp tensile strength and elongation percentage.
   Concerns over the unfavorable release of nanosilver into the environment
   and human respiratory systems were palliated by a unique approach for in
   situ formation of a chemical network that trapped the concerned
   entities. The nanomembrane not only could effectively filter the M.
   tuberculosis H37Ra bacteria, but could also completely exterminate them
   by a process involving cell membrane destabilization via direct contact
   of the inherently intact lipid-protein bilayers with the nanofibrous
   network with embedded lethal nanosilver. Finally, the persistent
   physical integrity of the membrane after harsh simulated weathering
   indicates its potential and extended usage as a nanofilter in remote
   areas where TB is endemic.}},
Publisher = {{ROYAL SOC CHEMISTRY}},
Address = {{THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Intasanta, V (Reprint Author), Natl Sci \& Technol Dev Agcy, Natl Nanotechnol Ctr, Nano Funct Text Lab, 111 Phahonyothin Rd, Klongluang 12120, Pathumthani, Thailand.
   Subjalearndee, Nakarin; Intasanta, Varol, Natl Sci \& Technol Dev Agcy, Natl Nanotechnol Ctr, Nano Funct Text Lab, 111 Phahonyothin Rd, Klongluang 12120, Pathumthani, Thailand.}},
DOI = {{10.1039/c7ra08762d}},
ISSN = {{2046-2069}},
Keywords-Plus = {{MULTIDRUG-RESISTANT TUBERCULOSIS; FILTER METHOD; SILVER NANOPARTICLES;
   DRUG REGIMENS; FABRICATION; AIR; MICROSCOPY; FILTRATION; MAT}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Multidisciplinary}},
Author-Email = {{varol@nanotec.or.th}},
Funding-Acknowledgement = {{Grand Challenge Canada {[}S7 0683-01-10]; National Nanotechnology Center}},
Funding-Text = {{The authors would like to thank the Grand Challenge Canada (Grant Number
   S7 0683-01-10) and National Nanotechnology Center for financial support.}},
Cited-References = {{Ahmed FE, 2015, DESALINATION, V356, P15, DOI 10.1016/j.desal.2014.09.033.
   Al-Saleh MH, 2011, COMPOS PART A-APPL S, V42, P2126, DOI 10.1016/j.compositesa.2011.08.005.
   Barhate RS, 2007, J MEMBRANE SCI, V296, P1, DOI 10.1016/j.memsci.2007.03.038.
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004.
   Bolto B, 2009, PROG POLYM SCI, V34, P969, DOI 10.1016/j.progpolymsci.2009.05.003.
   Chen PS, 2005, AEROSOL SCI TECH, V39, P371, DOI 10.1080/027868290945767.
   Cheng N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096348.
   DAVIES CM, 1991, LETT APPL MICROBIOL, V13, P58, DOI 10.1111/j.1472-765X.1991.tb00570.x.
   Destaye AG, 2013, ACS APPL MATER INTER, V5, P4745, DOI 10.1021/am401730x.
   Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC.
   Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449.
   Fajzulin I, 2015, J COAT TECHNOL RES, V12, P617, DOI 10.1007/s11998-015-9683-2.
   Fennelly KP, 2012, J CLIN MICROBIOL, V50, P2096, DOI 10.1128/JCM.00572-12.
   Gopal R, 2007, J MEMBRANE SCI, V289, P210, DOI 10.1016/j.memsci.2006.11.056.
   Kwon YS, 2016, EXPERT OPIN INV DRUG, V25, P183, DOI 10.1517/13543784.2016.1121993.
   Kwon YS, 2014, CURR OPIN PULM MED, V20, P280, DOI 10.1097/MCP.0000000000000045.
   Lala NL, 2007, BIOTECHNOL BIOENG, V97, P1357, DOI 10.1002/bit.21351.
   Li ZW, 2017, J BIOMED NANOTECHNOL, V13, P17, DOI 10.1166/jbn.2017.2324.
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021.
   Ma WJ, 2016, RSC ADV, V6, P12868, DOI 10.1039/c5ra27309a.
   Mao XW, 2014, NANO TODAY, V9, P405, DOI 10.1016/j.nantod.2014.06.011.
   Marra F, 2007, INT J TUBERC LUNG D, V11, P868.
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059.
   Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238.
   Patel RV, 2014, CURR TOP MED CHEM, V14, P1866, DOI 10.2174/1568026614666140929114822.
   Qian YF, 2016, MATERIALS, V9, DOI 10.3390/ma9070504.
   Quinco P, 2013, J CLIN MICROBIOL, V51, P2921, DOI 10.1128/JCM.00683-13.
   Ramakrishna S, 2006, MATER TODAY, V9, P40, DOI 10.1016/S1369-7021(06)71389-X.
   Sousa AMM, 2015, CARBOHYD POLYM, V115, P348, DOI 10.1016/j.carbpol.2014.08.074.
   Souzandeh H, 2016, ACS APPL MATER INTER, V8, P20023, DOI 10.1021/acsami.6b05339.
   Tan EPS, 2006, COMPOS SCI TECHNOL, V66, P1102, DOI 10.1016/j.compscitech.2005.10.003.
   Tang C, 2010, MACROMOLECULES, V43, P630, DOI 10.1021/ma902269p.
   Watanabe A, 2007, BIOMACROMOLECULES, V8, P2969, DOI 10.1021/bm700678u.
   Wood R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160123.
   Yuan CG, 2017, RSC ADV, V7, P4830, DOI 10.1039/c6ra26770j.
   Zhu MM, 2017, MACROMOL MATER ENG, V302, DOI 10.1002/mame.201600353.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{6}},
Usage-Count-Since-2013 = {{8}},
Journal-ISO = {{RSC Adv.}},
Doc-Delivery-Number = {{FJ1DA}},
Unique-ID = {{ISI:000412451500045}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000409539500005,
Author = {Fahmy, H. M. and Aly, A. A. and Amr, A. and Sayed, Sh. M. and Rabie, A.
   M.},
Title = {{Effect of Phenolic Compounds and Water Repellents Combination on
   Performance Properties of Cotton/polyester Blended Fabric}},
Journal = {{EGYPTIAN JOURNAL OF CHEMISTRY}},
Year = {{2017}},
Volume = {{60}},
Number = {{1}},
Pages = {{68-83}},
Month = {{JAN-FEB}},
Abstract = {{A NEWLY prepared stearyl alcohol / poly (N-vinyl-2-pyrrolidone) (SA/PVP)
   hybrid emulsion was used, as a water repellent finish, alone or in
   combination with some phenolic compounds namely tertiary butyl
   hydroquinone (TBHQ), curcumin and vanillin, in easy care finishing
   formulations. The results obtained reveal that: i) finishing fabric
   samples with different concentrations of the hybrid emulsion in absence
   of the aforementioned phenolic compounds, significantly enhances fabric
   weight, tensile strength, stiffness, water repellency, antibacterial,
   water vapor resistance and thermal resistance properties along with a
   gradual decrease in the resilience, surface roughness and air
   permeability of treated fabric, ii) using the hybrid emulsion with the
   above phenolic compounds efficiently enhances the storage life of the
   emulsion and upgrades the antibacterial properties of treated fabric,
   iii) addition of vanillin provides the finished fabric with pleasant
   scent, curcumin upgrades the UV protection property of treated fabric
   and TBHQ slightly enhances tensile strength, surface roughness, air
   permeability, water vapor resistance and thermal resistance along with a
   reduction in the resilience of treated fabric, and iv) the prepared
   hybrid emulsion, whether in absence or presence of TBHQ, can be used as
   extender for fluorocarbon textile finishes.}},
Publisher = {{NAT INFORM \& DOCUMENT CENTRE}},
Address = {{NIDOC DOKKI, CAIRO, EGYPT}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Aly, AA (Reprint Author), Natl Res Ctr, Text Res Div, Giza, Egypt.
   Fahmy, H. M.; Aly, A. A.; Amr, A.; Sayed, Sh. M., Natl Res Ctr, Text Res Div, Giza, Egypt.
   Rabie, A. M., Ain Shams Univ, Fac Sci, Cairo, Egypt.}},
DOI = {{10.21608/ejchem.2017.671.1013}},
ISSN = {{0449-2285}},
EISSN = {{2357-0245}},
Keywords = {{Phenolic compounds; Hybrid emulsion; Cotton/polyester blend; Textile
   finishing; Functional finishes}},
Keywords-Plus = {{ANTIBACTERIAL ACTIVITY; COTTON FABRICS; UV PROTECTION; CROSS-LINKING;
   CURCUMIN; ESTER; ANTIOXIDANT; OXIDATION; ALCOHOLS; ENHANCE}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Multidisciplinary}},
Author-Email = {{amalahmedali@yahoo.com}},
ORCID-Numbers = {{Aly, Amal/0000-0002-0897-1341}},
Cited-References = {{Abdel-Wahab BF, 2009, J APPL POLYM SCI, V112, P2221, DOI 10.1002/app.29768.
   Abo-Shosha MH, 2008, J IND TEXT, V37, P315, DOI 10.1177/1528083707083793.
   Abo-Shosha MH, 2009, AATCC REV, V9, P38.
   Abo-Shosha M. H., 1995, AM DYEST REP, V84, P44.
   Akram M., 2010, ROMANIAN J BIOL PLAN, V55, P65.
   Asouri M, 2013, ASIAN J CHEM, V25, P7593.
   Audenaert F, 1999, J TEXT I, V90, P76, DOI 10.1080/00405009908659480.
   BLECHER L, 1980, HDB WATER SOLUBLE GU.
   Buck D. F., 1997, FOOD TECHNOLOGY INT, V2, P29.
   Eid RAA, 2015, EGYPT J CHEM, V58, P203.
   Fahmy HM, 2015, EGYPT J CHEM, V58, P447.
   Fahmy HM, 2017, PROG ORG COAT, V105, P176, DOI 10.1016/j.porgcoat.2016.11.014.
   Fahmy HM, 2013, CARBOHYD POLYM, V92, P1539, DOI 10.1016/j.carbpol.2012.11.008.
   Fahmy HM, 2010, J IND TEXT, V40, P109, DOI 10.1177/1528083709350185.
   Fahmy HM, 2009, J IND TEXT, V39, P109, DOI 10.1177/1528083709102932.
   Fahmy HM, 2009, CARBOHYD POLYM, V77, P845, DOI 10.1016/j.carbpol.2009.03.003.
   Fahmy H. M., 2016, INT J CHEM TECH RES, V9, P96.
   Fahmy H. M., 2004, EGYPT J CHEM, V47, P627.
   Fahmy HM, 2004, POLYM-PLAST TECHNOL, V43, P445, DOI 10.1081/PPT-120029973.
   Fahmy M. H., 2016, PROGR ORGANIC COATIN, V99, P166.
   Fahmy M. H., 2016, INT J CHEMTECH RES, V9, P215.
   Fehmy HM, 2004, TINCTORIA, V10, P22.
   Fouda MMG, 2011, CARBOHYD POLYM, V86, P625, DOI 10.1016/j.carbpol.2011.04.086.
   Gaffer H. E., 2013, J APPL SCI RES, V9, P4059.
   Han SY, 2005, DYES PIGMENTS, V64, P157, DOI 10.1016/j.dyepig.2004.05.008.
   Hashem M, 2011, CARBOHYD POLYM, V86, P1692, DOI 10.1016/j.carbpol.2011.06.085.
   Havenith G., 2003, EXOGENOUS DERMATOLOG, V1, P221, DOI DOI 10.1159/000068802.
   Ibrahim NA, 2008, J MATER PROCESS TECH, V200, P385, DOI 10.1016/j.jmatprotec.2007.09.021.
   Ibrahim NA, 2012, CARBOHYD POLYM, V89, P648, DOI 10.1016/j.carbpol.2012.03.068.
   Ibrahim NA, 2011, J IND TEXT, V41, P41, DOI 10.1177/1528083710390966.
   Ibrahim NA, 2010, POLYM-PLAST TECHNOL, V49, P1297, DOI 10.1080/03602551003773114.
   Ibrahim NA, 2013, RJTA, V17, P58.
   Jagannathan R, 2012, J PHYS CHEM B, V116, P14533, DOI 10.1021/jp3050516.
   KUBO I, 1993, BIOORG MED CHEM LETT, V3, P1305, DOI 10.1016/S0960-894X(00)80336-4.
   Mourtzinos I, 2009, FOOD CHEM, V114, P791, DOI 10.1016/j.foodchem.2008.10.014.
   Ooi N, 2013, J ANTIMICROB CHEMOTH, V68, P1297, DOI 10.1093/jac/dkt030.
   Rakchoy S., 2009, J FOOD AG IND, V2, P138.
   Schindler W. D., 2004, CHEM FINISHING TEXTI, P74, DOI 10.1533/9781845690373.74.
   Shahidi F, 2000, NAHRUNG, V44, P158, DOI 10.1002/1521-3803(20000501)44:3<158::AID-FOOD158>3.0.CO;2-L.
   Simoncic B, 2010, TEXT RES J, V80, P1721, DOI 10.1177/0040517510363193.
   Tai A, 2011, BBA-GEN SUBJECTS, V1810, P170, DOI 10.1016/j.bbagen.2010.11.004.
   Togashi N, 2007, MOLECULES, V12, P139, DOI 10.3390/12020139.
   Tzanov T, 1999, INT J CLOTH SCI TECH, V11, p{[}4, 189].
   Zhou YY, 2015, IND CROP PROD, V64, P224, DOI 10.1016/j.indcrop.2014.09.041.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Egypt. J. Chem.}},
Doc-Delivery-Number = {{FG1FG}},
Unique-ID = {{ISI:000409539500005}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000408161700001,
Author = {Encarnacion-Medina, Jarline and Rodriguez-Cotto, Rosa I. and
   Bloom-Oquendo, Joseph and Ortiz-Martinez, Mario G. and Duconge, Jorge
   and Jimenez-Velez, Braulio},
Title = {{Selective ATP-Binding Cassette Subfamily C Gene Expression and
   Proinflammatory Mediators Released by BEAS-2B after PM2.5, Budesonide,
   and Cotreated Exposures}},
Journal = {{MEDIATORS OF INFLAMMATION}},
Year = {{2017}},
Abstract = {{ATP-binding cassette subfamily C (ABCC) genes code for phase III
   metabolism proteins that translocate xenobiotic (e.g., particulate
   matter 2.5 (PM2.5)) and drug metabolites outside the cells. IL-6
   secretion is related with the activation of the ABCC transporters. This
   study assesses ABCC1-4 gene expression changes and proinflammatory
   cytokine (IL-6, IL-8) release in human bronchial epithelial cells
   (BEAS-2B) exposed to PM2.5 organic extract, budesonide ( BUD, used to
   control inflammation in asthmatic patients), and a cotreatment (Co-T:
   PM2.5 and BUD). A real-time PCR assay shows that ABCC1 was upregulated
   in BEAS-2B exposed after 6 and 7hr to PM2.5 extract or BUD but
   downregulated after 6hr of the Co-T. ABCC3 was downregulated after 6hr
   of BUD and upregulated after 6hr of the Co-T exposures. ABCC4 was
   upregulated after 5hr of PM2.5 extract, BUD, and the Co-T exposures. The
   cytokine assay revealed an increase in IL-6 release by BEAS-2B exposed
   after 5hr to PM2.5 extract, BUD, and the Co-T. At 7hr, the Co-T
   decreases IL-6 release and IL-8 at 6hr. In conclusion, the cotreatment
   showed an opposite effect on exposed BEAS-2B as compared with BUD. The
   results suggest an interference of the BUD therapeutic potential by
   PM2.5.}},
Publisher = {{HINDAWI LTD}},
Address = {{ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Jimenez-Velez, B (Reprint Author), Ctr Environm \& Toxicol Res, San Juan, PR USA.
   Jimenez-Velez, B (Reprint Author), Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA.
   Encarnacion-Medina, Jarline; Bloom-Oquendo, Joseph; Duconge, Jorge, Univ Puerto Rico, Sch Pharm, Med Sci Campus, San Juan, PR 00936 USA.
   Encarnacion-Medina, Jarline; Rodriguez-Cotto, Rosa I.; Ortiz-Martinez, Mario G.; Jimenez-Velez, Braulio, Ctr Environm \& Toxicol Res, San Juan, PR USA.
   Rodriguez-Cotto, Rosa I.; Ortiz-Martinez, Mario G.; Jimenez-Velez, Braulio, Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA.
   Rodriguez-Cotto, Rosa I.; Ortiz-Martinez, Mario G., Inst Biomed \& Forens Sci Res Puerto Rico Inc IBFS, San Juan, PR USA.}},
DOI = {{10.1155/2017/6827194}},
Article-Number = {{6827194}},
ISSN = {{0962-9351}},
EISSN = {{1466-1861}},
Keywords-Plus = {{BRONCHIAL EPITHELIAL-CELLS; MULTIDRUG-RESISTANT PROTEIN-3; AIR-POLLUTION
   PARTICLES; LONG-TERM EXPOSURE; HUMAN LUNG-CELLS; NF-KAPPA-B; PARTICULATE
   MATTER; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; ANTIOXIDANT DEFENSE}},
Research-Areas = {{Cell Biology; Immunology}},
Web-of-Science-Categories  = {{Cell Biology; Immunology}},
Author-Email = {{braulio.jimenez@upr.edu}},
Funding-Acknowledgement = {{National Center for Research Resources {[}2G12RR003051]; National
   Institute on Minority Health and Health Disparities {[}8G12-MD007600];
   National Institutes of Health}},
Funding-Text = {{The study was supported by grants from the National Center for Research
   Resources (2G12RR003051) and National Institute on Minority Health and
   Health Disparities (8G12-MD007600) and from the National Institutes of
   Health. The authors want to acknowledge Dr. Carmen M. Ortiz Sanchez for
   the manuscript review.}},
Cited-References = {{Akhtar US, 2014, TOXICOL REP, V1, P145, DOI 10.1016/j.toxrep.2014.05.002.
   Alvarez-Aviles O, 2007, ANAL CHIM ACTA, V597, P273, DOI 10.1016/j.aca.2007.07.004.
   Bandi N, 2002, EUR J PHARMACOL, V437, P9, DOI 10.1016/S0014-2999(02)01267-0.
   Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x.
   Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3.
   Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557.
   Baxter LK, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-016-0208-y.
   Becker S, 2005, TOXICOL APPL PHARM, V203, P45, DOI 10.1016/j.taap.2004.07.007.
   Becker S, 2002, AM J RESP CELL MOL, V27, P611, DOI 10.1165/rcmb.4868.
   Bekele RT, 2016, SCI REP-UK, V6, DOI 10.1038/srep21164.
   Bulek K, 2010, IMMUNOL CELL BIOL, V88, P257, DOI 10.1038/icb.2009.113.
   Cassee FR, 2013, INHAL TOXICOL, V25, P802, DOI 10.3109/08958378.2013.850127.
   Celli BR, 2012, AM J RESP CRIT CARE, V185, P1065, DOI 10.1164/rccm.201110-1792OC.
   Che WC, 2014, AM J RESP CELL MOL, V50, P358, DOI 10.1165/rcmb.2013-0208OC.
   Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76.
   Cnubben NHP, 2001, ENVIRON TOXICOL PHAR, V10, P141, DOI 10.1016/S1382-6689(01)00077-1.
   Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8.
   Dittrich A, 2012, HEPATOLOGY, V55, P256, DOI 10.1002/hep.24655.
   Dreuw A, 2005, J INVEST DERMATOL, V124, P28, DOI 10.1111/j.0022-202X.2004.23499.x.
   Fletcher JI, 2016, DRUG RESIST UPDATE, V26, P1, DOI 10.1016/j.drup.2016.03.001.
   Fredin MF, 2005, PHARMACOL RES, V52, P422, DOI 10.1016/j.phrs.2005.06.003.
   Fuentes-Mattei E, 2010, TOXICOL APPL PHARM, V243, P381, DOI 10.1016/j.taap.2009.12.009.
   Fuzzi S, 2015, ATMOS CHEM PHYS, V15, P8217, DOI 10.5194/acp-15-8217-2015.
   Gao B, 2014, CLIN PHARMACOL-ADV A, V6, P19, DOI 10.2147/CPAA.S35078.
   Gelhaus SL, 2012, TOXICOL LETT, V209, P58, DOI 10.1016/j.toxlet.2011.11.021.
   Gerk PM, 2002, J PHARMACOL EXP THER, V302, P407, DOI 10.1124/jpet.102.035014.
   Gioda A, 2011, INT J ENVIRON HEAL R, V21, P106, DOI 10.1080/09603123.2010.515668.
   Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200.
   Hara Y, 2011, J CLIN INVEST, V121, P2888, DOI 10.1172/JCI45023.
   Huang YC, 2005, ANN ALLERG ASTHMA IM, V95, P443, DOI 10.1016/S1081-1206(10)61170-2.
   Janssen NAH, 2011, ENVIRON HEALTH PERSP, V119, P1691, DOI 10.1289/ehp.1003369.
   Ji LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063404.
   Jia D, 2006, ENDOCRINOLOGY, V147, P5592, DOI 10.1210/en.2006-0459.
   Jiang X.-Q., 2015, J THORAC DIS, V8, pE31.
   Kielar D, 2003, J INVEST DERMATOL, V121, P465, DOI 10.1046/j.1523-1747.2003.12404.x.
   Kopriva F, 2009, J ASTHMA, V46, P366, DOI 10.1080/02770900902777767.
   Korn SH, 2001, EUR RESPIR J, V17, P1070, DOI 10.1183/09031936.01.00073301.
   Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467.
   Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017.
   Li YJ, 2013, PULM PHARMACOL THER, V26, P318, DOI 10.1016/j.pupt.2012.12.010.
   Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002.
   Mahaffey CM, 2012, J THORAC ONCOL, V7, P34, DOI 10.1097/JTO.0b013e318233d753.
   Mahaffey CM, 2009, FREE RADICAL BIO MED, V46, P1650, DOI 10.1016/j.freeradbiomed.2009.03.023.
   Martin Todd M, 2002, AAPS PharmSciTech, V3, pE18, DOI 10.1208/pt030318.
   Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409.
   Molinelli AR, 2006, ENVIRON RES, V102, P314, DOI 10.1016/j.envres.2006.04.010.
   Ortiz-Martinez MG, 2015, MEDIAT INFLAMM, DOI 10.1155/2015/784212.
   Panni T, 2016, ENVIRON HEALTH PERSP, V124, P983, DOI 10.1289/ehp.1509966.
   Persdotter S, 2007, INT ARCH ALLERGY IMM, V143, P201, DOI 10.1159/000099463.
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132.
   Provost EB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127014.
   Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541.
   Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874.
   Rodriguez-Cotto RI, 2015, ENVIRON TOXICOL PHAR, V39, P845, DOI 10.1016/j.etap.2015.02.015.
   Rodriguez-Cotto RI, 2014, ENVIRON POLLUT, V194, P112, DOI 10.1016/j.envpol.2014.07.010.
   Rodriguez-Cotto Rosa I, 2013, Health (Irvine Calif), V5, P14.
   Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006.
   Sanchez-Guerra M, 2015, EPIGENETICS-US, V10, P633, DOI 10.1080/15592294.2015.1050174.
   Scheffer GL, 2000, CANCER RES, V60, P5269.
   Scheffer GL, 2002, LAB INVEST, V82, P193, DOI 10.1038/labinvest.3780411.
   Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034.
   Schwarze PE, 2006, HUM EXP TOXICOL, V25, P559, DOI 10.1177/096032706072520.
   Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401.
   Vagaggini B, 2001, AM J RESP CRIT CARE, V164, P2172, DOI 10.1164/rccm2009090.
   van der Deen M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-59.
   van der Deen M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-49.
   van der Deen M, 2007, J BIOCHEM MOL TOXIC, V21, P243, DOI 10.1002/jbt.20187.
   van der Deen M, 2006, VIRCHOWS ARCH, V449, P682, DOI 10.1007/s00428-006-0240-3.
   van der Deen Margaretha, 2008, Int J Chron Obstruct Pulmon Dis, V3, P469.
   Veldenvander V. H., 1998, MEDIAT INFLAMM, V7, P229.
   Wang JM, 2000, J IMMUNOL, V165, P4051, DOI 10.4049/jimmunol.165.7.4051.
   Wang S, 2015, OXID MED CELL LONGEV, V2015, P8, DOI {[}10.1155/2015/659750, DOI 10.1186/S13071-015-1282-7].
   Wang Y, 2017, EPIDEMIOLOGY, V28, P207, DOI 10.1097/EDE.0000000000000614.
   Wu FY, 2015, SCI TOTAL ENVIRON, V512, P194, DOI 10.1016/j.scitotenv.2015.01.041.
   Xing YF, 2016, J THORAC DIS, V8, pE69, DOI 10.3978/j.issn.2072-1439.2016.01.19.
   Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886.
   Zhang T, 2016, SURF INTERFACES, V5, P15, DOI 10.1016/j.surfin.2016.08.004.
   Zhang XL, 2005, EUR J IMMUNOL, V35, P3258, DOI 10.1002/eji.200526116.
   Zhang YK, 2015, AAPS J, V17, P802, DOI 10.1208/s12248-015-9757-1.
   Zhou Z., 2015, PLOS ONE, V10.}},
Number-of-Cited-References = {{80}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Mediat. Inflamm.}},
Doc-Delivery-Number = {{FE4CJ}},
Unique-ID = {{ISI:000408161700001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000407594000008,
Author = {Callaghan, Chris William},
Title = {{Scientific real-time research problem-solving and pharmaceutical
   innovation}},
Journal = {{AFRICAN JOURNAL OF SCIENCE TECHNOLOGY INNOVATION \& DEVELOPMENT}},
Year = {{2017}},
Volume = {{9}},
Number = {{4}},
Pages = {{425-435}},
Abstract = {{Despite dramatic advances on a global scale in the scientific fields
   that underlie pharmaceutical innovation, the literature suggests that
   returns on investment in pharmaceutical R\&D have not kept pace.
   Further, some argue that for the last 50 years advances in drug and
   vaccine development have plateaued. In the face of serious challenges,
   such as increasing antibiotic resistance, the threat of global pandemics
   such as Ebola, aging populations, increasing healthcare costs, and a
   general lack of access to medicines by many in developing regions, this
   paper argues that the current paradigm of pharmaceutical R\&D is not
   able to address these problems adequately. Probabilistic innovation
   theory predicts how the convergence of technologies and methods such as
   expert crowdsourced R\&D may ultimately contribute to real-time
   problem-solving. These potentialities are described as a new paradigm in
   R\&D. Such a paradigm might be uniquely suited to an industry that has
   perhaps moved beyond small molecule R\&D into a new era of complex
   protein-based R\&D associated with an almost infinite problem space'
   that is dependent on economies of scale in R\&D efforts. This paper
   therefore offers a perspective on these challenges, and provides certain
   arguments in support of novel, technologically enabled approaches to
   scientific problem-solving.}},
Publisher = {{TAYLOR \& FRANCIS LTD}},
Address = {{2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Callaghan, CW (Reprint Author), Univ Witwatersrand, Sch Econ \& Business Sci, Braamfontein, South Africa.
   Callaghan, Chris William, Univ Witwatersrand, Sch Econ \& Business Sci, Braamfontein, South Africa.}},
DOI = {{10.1080/20421338.2017.1341093}},
ISSN = {{2042-1338}},
EISSN = {{2042-1346}},
Keywords = {{innovation; knowledge management; probabilistic innovation; crowdsourced
   research and development}},
Keywords-Plus = {{RESEARCH-AND-DEVELOPMENT; DEVELOPMENT TAX CREDITS; DRUG DEVELOPMENT;
   AIR-TRAVEL; MARKET; TRANSMISSION; INCENTIVES; DISCOVERY; KNOWLEDGE;
   DISEASES}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{chris.callaghan@wits.ac.za}},
Cited-References = {{Adams SA, 2011, SOC SCI MED, V72, P1069, DOI 10.1016/j.socscimed.2011.02.001.
   Almirall E, 2010, ACAD MANAGE REV, V35, P27, DOI 10.5465/AMR.2010.45577790.
   Armstrong April W., 2012, DERMATOLOGY ONLINE J, V18, P15.
   Berndt ER, 2015, HEALTH AFFAIR, V34, P245, DOI 10.1377/hlthaff.2014.1029.
   Bloom N, 2002, J PUBLIC ECON, V85, P1, DOI 10.1016/S0047-2727(01)00086-X.
   Bonabeau E, 2000, SCI AM, V282, P72, DOI 10.1038/scientificamerican0300-72.
   Bryan L., 2005, J SOCIAL STUDIES RES, V29, P3.
   Callaghan CW, 2016, SOUTH AFR BUS REV, V20, P1.
   Callaghan C. W., 2014, AM J HLTH SCI, V5, P165.
   Callaghan Chris William, 2014, INT BUSINESS EC RES, V13, P1499.
   Callaghan CW, 2015, BRIT MED BULL, V115, P67, DOI 10.1093/bmb/ldv035.
   Chesbrough H., 2011, FORBES.
   Czarnitzki D, 2011, RES POLICY, V40, P217, DOI 10.1016/j.respol.2010.09.017.
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13.
   DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1.
   Dorigo M, 2000, FUTURE GENER COMP SY, V16, P851, DOI 10.1016/S0167-739X(00)00042-X.
   Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401.
   FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486.
   Fama Eugene F., 1995, FINANCIAL ANAL J, V51, P75, DOI DOI 10.2469/FAJ.V51.N1.1861.
   Gans JS, 2000, J ECON MANAGE STRAT, V9, P485, DOI 10.1162/105864000567945.
   Garnier Simon, 2007, Swarm Intelligence, V1, P3, DOI 10.1007/s11721-007-0004-y.
   Gassmann O., 2005, CREATIVITY INNOVATIO, V14, P233, DOI DOI 10.1111/J.1467-8691.2005.00344.X.
   Gassmann O, 2010, R\&D MANAGE, V40, P213, DOI 10.1111/j.1467-9310.2010.00605.x.
   Gleadle P, 2014, CRIT PERSPECT ACCOUN, V25, P67, DOI 10.1016/j.cpa.2012.10.003.
   Grasela TH, 2014, CLIN PHARMACOL THER, V95, P521, DOI 10.1038/clpt.2013.242.
   Hayden EC, 2014, NATURE, V507, P294, DOI 10.1038/507294a.
   Hayek FA, 1945, AM ECON REV, V35, P519.
   Horrobin DF, 2000, J ROY SOC MED, V93, P341, DOI 10.1177/014107680009300702.
   Hottenrott H, 2016, ECON INNOV NEW TECH, V25, P197, DOI 10.1080/10438599.2015.1076200.
   Howe J, 2006, WIRED MAGAZINE, V14, P1, DOI DOI 10.1086/599595.
   Kaitin KI, 2010, CLIN PHARMACOL THER, V87, P356, DOI 10.1038/clpt.2009.293.
   Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501.
   Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470.
   Kuhn T., 1970, STRUCTURE SCI REVOLU.
   Li AP, 2001, DRUG DISCOV TODAY, V6, P357, DOI 10.1016/S1359-6446(01)01712-3.
   Lim S, 2015, J PHARM INNOV, V10, P156, DOI 10.1007/s12247-015-9214-9.
   Malone T. W., 2007, INNOVATIONS TECHNOLO, V2, P15, DOI DOI 10.1162/ITGG.2007.2.3.15.
   Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8.
   Martin S, 2000, RES POLICY, V29, P437, DOI 10.1016/S0048-7333(99)00084-0.
   Mashonganyika C. H., 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481.
   Molokanova E, 2017, DRUG DISCOV TODAY, V22, P1045, DOI 10.1016/j.drudis.2017.01.015.
   Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961.
   Nathan C, 2007, NAT MED, V13, P304, DOI 10.1038/nm0307-309.
   Niederer S, 2010, NEW MEDIA SOC, V12, P1368, DOI 10.1177/1461444810365297.
   Parekh A, 2015, CLIN PHARMACOL THER, V97, P221, DOI 10.1002/cpt.42.
   Prainsack B, 2010, PHARMACOGENOMICS, V11, P651, DOI 10.2217/PGS.10.33.
   Prowell TM, 2016, NEW ENGL J MED, V374, P2001, DOI 10.1056/NEJMp1603747.
   Rodriguez A. Foncubierta, 2012, P ACM MULT 2012 WORK, P9, DOI DOI 10.1145/2390803.2390808.
   Sause WE, 2016, TRENDS PHARMACOL SCI, V37, P231, DOI 10.1016/j.tips.2015.11.008.
   Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681.
   Sims MH, 2014, J HOSP MED, V9, P451, DOI 10.1002/jhm.2204.
   Smith A., 1776, WEALTH NATIONS.
   SMITH VL, 1962, J POLIT ECON, V70, P111, DOI 10.1086/258609.
   Traitler H, 2011, J FOOD SCI, V76, pR62, DOI 10.1111/j.1750-3841.2010.01998.x.
   Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7.
   VONHIPPEL E, 1994, MANAGE SCI, V40, P429, DOI 10.1287/mnsc.40.4.429.
   WHO Ebola Response Team, 2014, NEW ENGL J MED, DOI {[}DOI 10.1056/NEJMOA1411100, 10.1056/NEJMoa1411100].
   Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147.
   World Health Organization (WHO), 2015, AG LIF COURS.
   Yin W, 2008, J HEALTH ECON, V27, P1060, DOI 10.1016/j.jhealeco.2008.01.002.
   Yu B, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2513.
   Yu L., 2011, P 29 SIGCHI C HUM FA, P1393, DOI DOI 10.1145/1978942.1979147].
   Zook M, 2010, WORLD MED HEALTH POL, V2, P7, DOI 10.2202/1948-4682.1069.}},
Number-of-Cited-References = {{63}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{Afr. J. Sci. Technol. Innov. Dev.}},
Doc-Delivery-Number = {{FD5TZ}},
Unique-ID = {{ISI:000407594000008}},
DA = {{2018-08-13}},
}

@article{ ISI:000405392400001,
Author = {Chin, Kai Ling and Anis, Fadhilah Zulkipli and Sarmiento, Maria E. and
   Norazmi, Mohd Nor and Acosta, Armando},
Title = {{Role of Interferons in the Development of Diagnostics, Vaccines, and
   Therapy for Tuberculosis}},
Journal = {{JOURNAL OF IMMUNOLOGY RESEARCH}},
Year = {{2017}},
Abstract = {{Tuberculosis (TB) is an airborne infection caused by Mycobacterium
   tuberculosis (Mtb). About one-third of the world's population is
   latently infected with TB and 5-15\% of them will develop active TB in
   their lifetime. It is estimated that each case of active TB may cause
   10-20 new infections. Host immune response to Mtb is influenced by
   interferon- (IFN-) signaling pathways, particularly by type I and type
   II interferons (IFNs). The latter that consists of IFN-gamma has been
   associated with the promotion of Th1 immune response which is associated
   with protection against TB. Although this aspect remains controversial
   at present due to the lack of established correlates of protection,
   currently, there are different prophylactic, diagnostic, and
   immunotherapeutic approaches in which IFNs play an important role. This
   review summarizes the main aspects related with the biology of IFNs,
   mainly associated with TB, as well as presents the main applications of
   these cytokines related to prophylaxis, diagnosis, and immunotherapy of
   TB.}},
Publisher = {{HINDAWI LTD}},
Address = {{ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Norazmi, MN; Acosta, A (Reprint Author), Univ Sains Malaysia, Sch Hlth Sci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.
   Chin, Kai Ling; Anis, Fadhilah Zulkipli; Sarmiento, Maria E.; Norazmi, Mohd Nor; Acosta, Armando, Univ Sains Malaysia, Sch Hlth Sci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.}},
DOI = {{10.1155/2017/5212910}},
Article-Number = {{5212910}},
ISSN = {{2314-8861}},
EISSN = {{2314-7156}},
Keywords-Plus = {{RESISTANT PULMONARY TUBERCULOSIS; GAMMA RELEASE ASSAYS;
   MYCOBACTERIUM-BOVIS BCG; CALMETTE-GUERIN VACCINE; DNA VACCINE;
   MULTIDRUG-RESISTANT; IFN-GAMMA; PROTECTIVE EFFICACY; IMMUNE-RESPONSE; I
   INTERFERONS}},
Research-Areas = {{Immunology}},
Web-of-Science-Categories  = {{Immunology}},
Author-Email = {{norazmimn@usm.my
   armando@usm.my}},
ORCID-Numbers = {{Norazmi, Mohd Nor/0000-0002-2817-6441
   CHIN, KAI LING/0000-0003-4362-1731}},
Funding-Acknowledgement = {{LRGS Grant, Department of Higher Education, Ministry of Education,
   Malaysia {[}203.PPSK.67212002]}},
Funding-Text = {{The authors acknowledge the financial contribution by the LRGS Grant,
   Department of Higher Education, Ministry of Education, Malaysia
   (203.PPSK.67212002).}},
Cited-References = {{Abdel-Samea SA, 2013, EGYPT J CHEST DIS TU, V62, P137, DOI 10.1016/j.ejcdt.2013.02.003.
   Abebe F, 2012, CLIN EXP IMMUNOL, V169, P213, DOI 10.1111/j.1365-2249.2012.04614.x.
   Alteri CJ, 2007, P NATL ACAD SCI USA, V104, P5145, DOI 10.1073/pnas.0602304104.
   Andersen P, 2015, CURR OPIN IMMUNOL, V35, P55, DOI 10.1016/j.coi.2015.06.001.
   Arlehamn CSL, 2012, J IMMUNOL, V188, P5020, DOI 10.4049/jimmunol.1103556.
   Badell E, 2009, VACCINE, V27, P28, DOI 10.1016/j.vaccine.2008.10.034.
   Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3.
   Belkahla N, 2010, Rev Med Interne, V31, pe1, DOI 10.1016/j.revmed.2009.11.017.
   Bhatt K, 2015, CLIN VACCINE IMMUNOL, V22, P258, DOI 10.1128/CVI.00721-14.
   Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080.
   Booty MG, 2016, SCI REP-UK, V6, DOI 10.1038/srep36720.
   Bradfute SB, 2013, CURR OPIN MICROBIOL, V16, P355, DOI 10.1016/j.mib.2013.05.003.
   CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395.
   CDC, 2013, COR CURR TUB WHAT CL.
   CDC,, 2013, GUID PRIM HLTH CAR P.
   CDC, 2013, TEST TUB INF DIS CTR, P45.
   Cheallaigh CN, 2011, CLIN EXP IMMUNOL, V164, P291, DOI 10.1111/j.1365-2249.2011.04381.x.
   Chee CBE, 2008, J CLIN MICROBIOL, V46, P1935, DOI 10.1128/JCM.02403-07.
   Condos R, 1997, LANCET, V349, P1513, DOI 10.1016/S0140-6736(96)12273-X.
   Coulter C, 2012, AUST FAM PHYSICIAN, V41, P489.
   De Andrea Marco, 2002, Eur J Paediatr Neurol, V6 Suppl A, pA41, DOI 10.1053/ejpn.2002.0573.
   De Keyser E, 2014, ACTA CLIN BELG, V69, P358, DOI 10.1179/2295333714Y.0000000043.
   Desvignes L, 2012, J IMMUNOL, V188, P6205, DOI 10.4049/jimmunol.1200255.
   Divangahi M, 2013, ADV EXP MED BIOL, V783, P103, DOI 10.1007/978-1-4614-6111-1\_6.
   Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078.
   Dou J, 2012, INT J IMMUNOGENET, V39, P183, DOI 10.1111/j.1744-313X.2011.01066.x.
   Dussurget O, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00050.
   Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x.
   Farinacci M, 2012, VACCINE, V30, P7608, DOI 10.1016/j.vaccine.2012.10.031.
   FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035.
   Freidag BL, 2000, INFECT IMMUN, V68, P2948, DOI 10.1128/IAI.68.5.2948-2953.2000.
   Gao XF, 2011, INT J INFECT DIS, V15, pE594, DOI 10.1016/j.ijid.2011.05.002.
   Gartner T, 2008, VACCINE, V26, P1458, DOI 10.1016/j.vaccine.2007.12.056.
   Ge L, 2014, CLIN PEDIATR, V53, P1255, DOI 10.1177/0009922814540040.
   Ghadimi D, 2010, INT IMMUNOPHARMACOL, V10, P694, DOI 10.1016/j.intimp.2010.03.014.
   Gideon HP, 2011, IMMUNOL RES, V50, P202, DOI 10.1007/s12026-011-8229-7.
   Giosue S, 1998, AM J RESP CRIT CARE, V158, P1156, DOI 10.1164/ajrccm.158.4.9803065.
   Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133.
   Guardigni V., 2013, J INFECT DIS THERAPE, V1, P3.
   Hermansen TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093986.
   Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068.
   Hovav AH, 2005, INFECT IMMUN, V73, P250, DOI 10.1128/IAI.73.1.250-257.2005.
   Hovav AH, 2003, INFECT IMMUN, V71, P3146, DOI 10.1128/IAI.71.6.3146-3154.2003.
   Hu D, 2014, VACCINE, V32, P2308, DOI 10.1016/j.vaccine.2014.02.069.
   Hu XD, 2009, DNA CELL BIOL, V28, P191, DOI 10.1089/dna.2008.0790.
   Jamwal SV, 2016, SCI REP-UK, V6, DOI 10.1038/srep23089.
   Jeon BY, 2011, YONSEI MED J, V52, P1008, DOI 10.3349/ymj.2011.52.6.1008.
   Kang YA, 2007, CHEST, V132, P959, DOI 10.1378/chest.06-2805.
   Kativhu CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162148.
   Klimpel G. R., 1996, MEDICAL MICROBIOLOGY.
   Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054961.
   Kolibab K, 2010, CLIN VACCINE IMMUNOL, V17, P793, DOI 10.1128/CVI.00006-10.
   Lalvani A, 2010, ENFERM INFEC MICR CL, V28, P245, DOI 10.1016/j.eimc.2009.05.012.
   Lankford CSR, 2003, J LEUKOCYTE BIOL, V73, P49, DOI 10.1189/jlb.0602326.
   Laraque F, 2009, CLIN INFECT DIS, V49, P46, DOI 10.1086/599037.
   Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1.
   Lerner B. W., 2003, WORLD MICROBIOLOGY I, P313.
   Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001.
   Li G, 2015, MOL IMMUNOL, V66, P346, DOI 10.1016/j.molimm.2015.04.003.
   Li H, 2006, VACCINE, V24, P1315, DOI 10.1016/j.vaccine.2005.09.025.
   Lin CW, 2012, APMIS, V120, P72, DOI 10.1111/j.1600-0463.2011.02815.x.
   Lousberg EL, 2010, J VIROL, V84, P6549, DOI 10.1128/JVI.02618-09.
   Madariaga MG, 2007, J AM BOARD FAM MED, V20, P540, DOI 10.3122/jabfm.2007.06.070109.
   Marchant A, 2001, AM J RESP CELL MOL, V24, P187, DOI 10.1165/ajrcmb.24.2.4274.
   McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787.
   Meerak J, 2013, VACCINE, V31, P784, DOI 10.1016/j.vaccine.2012.11.075.
   Mendez-Samperio P, 2010, INT J INFECT DIS, V14, pE366, DOI 10.1016/j.ijid.2009.06.022.
   Migliori GB, 2010, TROP MED INT HEALTH, V15, P1052, DOI 10.1111/j.1365-3156.2010.02581.x.
   Moraco AH, 2014, SEMIN IMMUNOL, V26, P497, DOI 10.1016/j.smim.2014.10.001.
   Moreira-Teixeira L, 2016, J IMMUNOL, V197, P4714, DOI 10.4049/jimmunol.1600584.
   Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2.
   Nayak Surajit, 2012, Indian Dermatol Online J, V3, P2, DOI 10.4103/2229-5178.93479.
   O'Brien TR, 2014, J INTERF CYTOK RES, V34, P829, DOI 10.1089/jir.2013.0136.
   Orr MT, 2015, J INFECT DIS, V212, P495, DOI 10.1093/infdis/jiv055.
   Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839.
   Park SK, 2007, INT J INFECT DIS, V11, P434, DOI 10.1016/j.ijid.2006.12.004.
   Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7.
   Pepponi I, 2014, PLANT BIOTECHNOL J, V12, P840, DOI 10.1111/pbi.12185.
   Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309.
   Pfyffer GE, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P543.
   Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001.
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604.
   Raad I, 1996, CLIN INFECT DIS, V22, P572, DOI 10.1093/clinids/22.3.572.
   Ranganathan UDK, 2009, VACCINE, V28, P152, DOI 10.1016/j.vaccine.2009.09.087.
   Revere R., 2002, EUR J PAEDIAT NEU SA, V6, pA55.
   Roya-Pabon CL, 2016, PNEUMONIA, V8, DOI 10.1186/s41479-016-0023-9.
   Soleimanpour S, 2015, APPL MICROBIOL BIOT, V99, P10467, DOI 10.1007/s00253-015-6952-z.
   Starke JR, 2014, PEDIATRICS, V134, pE1763, DOI 10.1542/peds.2014-2983.
   Suarez-Mendez R, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-44.
   Sun E, 2015, GENET MOL RES, V14, P3436, DOI 10.4238/2015.April.15.7.
   Tang C, 2008, J INFECT DIS, V197, P1263, DOI 10.1086/586902.
   Tau G, 1999, ALLERGY, V54, P1233, DOI 10.1034/j.1398-9995.1999.00099.x.
   Telesca C., 2007, J INFECTION, V54, pe233.
   Travar M, 2014, SCAND J IMMUNOL, V80, P43, DOI 10.1111/sji.12178.
   Travar M, 2016, ARCH IMMUNOL THER EX, V64, P19, DOI 10.1007/s00005-015-0365-7.
   Vilaplana C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100830.
   Walker NF, 2013, FUTURE VIROL, V8, P57, DOI 10.2217/FVL.12.123.
   Watson RO, 2015, CELL HOST MICROBE, V17, P811, DOI 10.1016/j.chom.2015.05.004.
   WHO, 2016, TUB FACT SHEET.
   WHO, 2015, LAT TUB INF.
   World Health Organization, 2015, GLOB TUB REP.
   World Health Organization, 2001, GLOB TUB CONTR WHO R.
   Wozniak TM, 2006, INFECT IMMUN, V74, P557, DOI 10.1128/IAI.74.1.557-565.2006.
   Xu GH, 2014, PROTEIN CELL, V5, P728, DOI 10.1007/s13238-014-0077-5.
   Xu Y, 2007, FEMS IMMUNOL MED MIC, V51, P480, DOI 10.1111/j.1574-695X.2007.00322.x.
   Yang HL, 2012, FEMS IMMUNOL MED MIC, V66, P273, DOI 10.1111/j.1574-695X.2012.01002.x.
   YE JP, 1995, J LEUKOCYTE BIOL, V58, P225.
   Yu DH, 2007, VACCINE, V25, P6744, DOI 10.1016/j.vaccine.2007.06.061.
   Yu FL, 2012, NANOMED-NANOTECHNOL, V8, P1337, DOI 10.1016/j.nano.2012.02.015.
   Zarogoulidis P, 2012, J CHEMOTHERAPY, V24, P173, DOI 10.1179/1973947812Y.0000000005.
   Zhao SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031908.
   Zhukova E M, 2009, Tuberk Biolezni Legkih, P58.
   Zuniga J., 2012, CLIN DEV IMMUNOL, V2012.}},
Number-of-Cited-References = {{113}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{J Immunol. Res.}},
Doc-Delivery-Number = {{FA4CW}},
Unique-ID = {{ISI:000405392400001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000404998700009,
Author = {Neundorf, Ines},
Title = {{Metal Complex-Peptide Conjugates: How to Modulate Bioactivity of
   Metal-Containing Compounds by the Attachment to Peptides}},
Journal = {{CURRENT MEDICINAL CHEMISTRY}},
Year = {{2017}},
Volume = {{24}},
Number = {{17}},
Pages = {{1853-1861}},
Abstract = {{During the last years, the interest in combining the features of
   metal-containing molecules with biomolecules, particularly peptides, has
   been increased. Large series of new innovative organometallic compounds,
   as well as potent coordination complexes have been designed and,
   especially in medicinal chemistry, the library of bioactive compounds
   was excessively expanded by the introduction of metal complexes. The
   research foci are divers and not limited to e.g. the development of
   therapeutics with anti-proliferative or antibacterial activity, or the
   design of novel biosensors useful for pharmaceutical applications. By
   introduction of a metal centre, new attributes might be added that could
   help to overcome the problems of difficult to treat diseases, as well as
   to combat issues with arising drug resistances. However, the application
   of a number of very potent metal complexes is restricted owing to their
   poor water-solubility, air-stability and only poor uptake when in
   contact with cells. In this context, one possibility to optimize
   promising lead structures is to couple them to bioactive peptides.
   Within this review, an overview on metal complex-peptide conjugates used
   for drug design and future pharmaceutical application is presented.}},
Publisher = {{BENTHAM SCIENCE PUBL LTD}},
Address = {{EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Neundorf, I (Reprint Author), Univ Cologne, Inst Biochem, Dept Chem, Cologne, Germany.
   Neundorf, Ines, Univ Cologne, Inst Biochem, Dept Chem, Cologne, Germany.}},
DOI = {{10.2174/0929867324666170505112836}},
ISSN = {{0929-8673}},
EISSN = {{1875-533X}},
Keywords = {{Cell-penetrating peptides; antimicrobial peptides; solid phase peptide
   synthesis; organometallic complexes; anti-cancer therapy; biosensor}},
Keywords-Plus = {{CELL-PENETRATING PEPTIDES; SOLID-PHASE SYNTHESIS; ANTIMICROBIAL PEPTIDE;
   MAMMALIAN-CELLS; DRUG-DELIVERY; LIVING CELLS; AMINO-ACID;
   IDENTIFICATION; MECHANISMS; TRYPTOPHAN}},
Research-Areas = {{Biochemistry \& Molecular Biology; Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Chemistry, Medicinal; Pharmacology \&
   Pharmacy}},
Author-Email = {{ines.neundorf@uni-koeln.de}},
Funding-Acknowledgement = {{Deutsche Forschungsgemeinschaft (DFG) within the research group FOR 630
   ``Biological Function of Organometallic Compounds'' {[}NE 1419/2-2]}},
Funding-Text = {{Financial support by the Deutsche Forschungsgemeinschaft (DFG) within
   the research group FOR 630 ``Biological Function of Organometallic
   Compounds'' (NE 1419/2-2) is gratefully acknowledged.}},
Cited-References = {{Abramkin S, 2012, DALTON T, V41, P3001, DOI 10.1039/c2dt12024k.
   Adhikari B, 2015, CHEM-EUR J, V21, P11560, DOI 10.1002/chem.201501395.
   Adhikari B, 2014, CHEM COMMUN, V50, P5551, DOI 10.1039/c3cc49268k.
   Afrasiabi R, 2013, CHEM-EUR J, V19, P17296, DOI 10.1002/chem.201302450.
   Albada HB, 2012, BEILSTEIN J ORG CHEM, V8, P1753, DOI 10.3762/bjoc.8.200.
   Bandow JE, 2009, CHEMBIOCHEM, V10, P2847, DOI 10.1002/cbic.200900628.
   Bihari Z, 2016, J INORG BIOCHEM, V160, P189, DOI 10.1016/j.jinorgbio.2016.02.011.
   Blackmore L, 2013, CHEM COMMUN, V49, P2658, DOI 10.1039/c3cc40453f.
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098.
   Brogden NK, 2011, INT J ANTIMICROB AG, V38, P217, DOI 10.1016/j.ijantimicag.2011.05.004.
   Chantson JT, 2006, CHEMMEDCHEM, V1, P1268, DOI 10.1002/cmdc.200600117.
   Cosgrave L, 2010, CHEM COMMUN, V46, P103, DOI 10.1039/b918611e.
   Dang Q, 2016, ANAL BIOANAL CHEM, V408, P7067, DOI 10.1007/s00216-016-9360-z.
   Dong MM, 2016, ANAL CHIM ACTA, V906, P72, DOI 10.1016/j.aca.2015.11.047.
   Epand RM, 2016, BBA-BIOMEMBRANES, V1858, P980, DOI 10.1016/j.bbamem.2015.10.018.
   Franzel B, 2010, J BIOL INORG CHEM, V15, P1293, DOI 10.1007/s00775-010-0689-z.
   Gasser G, 2012, CURR OPIN CHEM BIOL, V16, P84, DOI 10.1016/j.cbpa.2012.01.013.
   Geldmacher Y, 2012, J BIOL INORG CHEM, V17, P631, DOI 10.1007/s00775-012-0883-2.
   Gross A, 2015, METALLOMICS, V7, P371, DOI 10.1039/c4mt00255e.
   Gross A, 2013, CHEMBIOCHEM, V14, P2472, DOI 10.1002/cbic.201300450.
   Hoffknecht BC, 2016, J INORG BIOCHEM, V160, P246, DOI 10.1016/j.jinorgbio.2016.02.036.
   Hoyer J, 2012, BEILSTEIN J ORG CHEM, V8, P1788, DOI 10.3762/bjoc.8.204.
   Hoyer J, 2012, DALTON T, V41, P6396, DOI 10.1039/c2dt12211a.
   Hu WN, 2012, J BIOL INORG CHEM, V17, P175, DOI 10.1007/s00775-011-0840-5.
   Hunold A, 2009, EUR J ORG CHEM, P4429, DOI 10.1002/ejoc.200900552.
   Hyvonen M, 2015, METHODS MOL BIOL, V1324, P205, DOI 10.1007/978-1-4939-2806-4\_14.
   Kang SJ, 2014, EXPERT REV ANTI-INFE, V12, P1477, DOI 10.1586/14787210.2014.976613.
   Li YX, 2014, BIOSENS BIOELECTRON, V58, P193, DOI 10.1016/j.bios.2014.02.045.
   Martin A, 2014, J AM CHEM SOC, V136, P15300, DOI 10.1021/ja508043q.
   Maschke M, 2015, CHEMBIOCHEM, V16, P1333, DOI 10.1002/cbic.201500060.
   Matson JB, 2012, SOFT MATTER, V8, P6689, DOI 10.1039/c2sm25785h.
   Meier SM, 2013, CHEM-EUR J, V19, P9297, DOI 10.1002/chem.201300889.
   Monney A, 2013, COORDIN CHEM REV, V257, P2420, DOI 10.1016/j.ccr.2012.12.015.
   Neugebauer U, 2008, CHEM COMMUN, P5307, DOI 10.1039/b810403d.
   Neundorf I, 2008, CHEM COMMUN, P5604, DOI 10.1039/b812799a.
   Neundorf Ines, 2009, Pharmaceuticals (Basel), V2, P49.
   Perekalin DS, 2015, CHEM-EUR J, V21, P4923, DOI 10.1002/chem.201406510.
   Philip AT, 2015, J PEPT SCI, V21, P887, DOI 10.1002/psc.2831.
   Reinhardt A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050701.
   Reissmann S, 2014, J PEPT SCI, V20, P760, DOI 10.1002/psc.2672.
   Rennert R, 2008, ADV DRUG DELIVER REV, V60, P485, DOI 10.1016/j.addr.2007.09.008.
   Rijt S. H., 2011, BIOCONJUG CHEM, V22, P218.
   Splith K, 2011, EUR BIOPHYS J BIOPHY, V40, P387, DOI 10.1007/s00249-011-0682-7.
   Splith K, 2010, BIOCONJUGATE CHEM, V21, P1288, DOI 10.1021/bc100089z.
   Splith K, 2010, DALTON T, V39, P2536, DOI 10.1039/b916907e.
   Wenzel M, 2016, BBA-BIOMEMBRANES, V1858, P1004, DOI 10.1016/j.bbamem.2015.11.009.
   Wieberneit F, 2013, DALTON T, V42, P9799, DOI 10.1039/c3dt50635e.
   Yao VJ, 2016, J CONTROL RELEASE, V240, P267, DOI 10.1016/j.jconrel.2016.01.002.
   Zhang DD, 2016, J CONTROL RELEASE, V229, P130, DOI 10.1016/j.jconrel.2016.03.020.
   Zhang L, 2013, ANAL BIOCHEM, V434, P292, DOI 10.1016/j.ab.2012.11.025.}},
Number-of-Cited-References = {{50}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{14}},
Journal-ISO = {{Curr. Med. Chem.}},
Doc-Delivery-Number = {{EZ8ST}},
Unique-ID = {{ISI:000404998700009}},
DA = {{2018-08-13}},
}

@article{ ISI:000404445900008,
Author = {Bielawska-Drozd, Agata and Cleslik, Piotr and Wlizlo-Skowronek, Bozena
   and Winnicka, Izabela and Kubiak, Leszek and Jaroszuk-Scisel, Jolanta
   and Depczynska, Daria and Bohacz, Justyna and Kornillowicz-Kowalska,
   Teresa and Skopinska-Rozewska, Ewa and Kocik, Janusz},
Title = {{IDENTIFICATION AND CHARACTERISTICS OF BIOLOGICAL AGENTS IN WORK
   ENVIRONMENT OF MEDICAL EMERGENCY SERVICES IN SELECTED AMBULANCES}},
Journal = {{INTERNATIONAL JOURNAL OF OCCUPATIONAL MEDICINE AND ENVIRONMENTAL HEALTH}},
Year = {{2017}},
Volume = {{30}},
Number = {{4}},
Pages = {{617-627}},
Abstract = {{Objectives: Assessment of microbial air quality and surface
   contamination in ambulances and administration offices as a control
   place without occupational exposure to biological agents; based on
   quantitative and qualitative analysis of bacteria, yeasts and
   filamentous fungi found in collected samples. Material and Methods: The
   sampling was done by wet cyclone technology using the Coriolis recon
   apparatus, imprint and swab methods, respectively. In total, 280 samples
   from 28 ambulances and 10 offices in Warszawa were tested. Data was
   analyzed using Shapiro-Wilk normality test, Kruskal-Wallis test with
   alpha = 0.05. Pvalue <= 0.05 was considered as significant. Results: The
   levels of air contamination were from 0 to 2.3 x 10(1) colony-forming
   unit (CFU)/m(3) for bacteria and for yeast and filamentous fungi were
   from 0 to 1.8 x 10(1) CFU/m(3). The assessment of office space air
   samples has shown the following numbers of microorganisms: bacteria from
   3.0 x 10(1) to 4.2 X 10(1) CFU/m(3) and yeast and filamentous fungi from
   0 to 1.9 x 10(1) CFU/m3. For surface contamination the mean bacterial
   count in ambulances has been between 1.0 x 10(1) and 1.3 x 10(2) CFU/25
   cm(2) and in offices-between 1.1 X 10(1) and 8.5 x 10(1) CFU/25 cm(2).
   Mean fungal count has reached the level from 2.8 x 10(0) 4.2 x 10(1)
   CFU/25 cm(2) in ambulances and 1.3 x 10(1) to 5.8 x 10(1) CFU/25 cm(2)
   in offices. The qualitative analysis has revealed the presence of
   Acinetobacter spp. (surfaces), coagulase - negative Staphylococci (air
   and surfaces), Aspergillus and Penicillium genera (air and surfaces).
   Conclusions: The study has revealed a satisfactory microbiological
   quantity of analyzed air and surface samples in both study and control
   environments. However, the presence of potentially pathogenic
   microorganisms in the air and on surfaces in ambulances may endanger the
   medical emergency staff and patients with infection. Disinfection and
   cleaning techniques therefore should be constantly developed and
   implemented. Int J Occup Med Environ Health 2017; 30(4): 617-627}},
Publisher = {{NOFER INST OCCUPATIONAL MEDICINE, SW}},
Address = {{TERESY 8, LODZ, 91-348, POLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Bielawska-Drozd, A (Reprint Author), Mil Inst Hyg \& Epidemiol, Biol Threats Identificat \& Countermeasure Ctr, Lubelska 2, PL-24100 Pulawy, Poland.
   Bielawska-Drozd, Agata; Cleslik, Piotr; Wlizlo-Skowronek, Bozena, Mil Inst Hyg \& Epidemiol, Biol Threats Identificat \& Countermeasure Ctr, Lubelska 2, PL-24100 Pulawy, Poland.
   Winnicka, Izabela; Kubiak, Leszek; Depczynska, Daria; Skopinska-Rozewska, Ewa; Kocik, Janusz, Mil Inst Hyg \& Epidemiol, Lab Epidemiol, Warsaw, Poland.
   Jaroszuk-Scisel, Jolanta, Marie Curie Sklodowska Univ, Fac Biol \& Biotechnol, Dept Environm Microbiol, Lublin, Poland.
   Bohacz, Justyna; Kornillowicz-Kowalska, Teresa, Univ Life Sci Lublin, Lab Mycol, Dept Environm Microbiol, Fac Agrobioengn, Lublin, Poland.
   Skopinska-Rozewska, Ewa, Med Univ Warsaw, Pathol Dept, Biostruct Ctr, Warsaw, Poland.}},
DOI = {{10.13075/ijomeh.1896.00816}},
ISSN = {{1232-1087}},
EISSN = {{1896-494X}},
Keywords = {{Bacteria; Fungi; Work environment; Harmful biological agents;
   Antimicrobial resistance; Ambulances}},
Keywords-Plus = {{BACTERIAL-CONTAMINATION; INFECTIONS; PERSONNEL; RISK}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{abielawska@wihe.pulawy.pl}},
Cited-References = {{Alves DW, 2008, PREHOSP EMERG CARE, V12, P218, DOI 10.1080/10903120801906721.
   Barnett H., 1998, ILLUSTRATED GENERA I.
   Beasley V. R., 1989, TRICHOTHECENE MYCOTO.
   Buczynska Alina, 2007, Medycyna Pracy, V58, P521.
   Charkowska A, 2008, BEZPIECZ PR, V10, P16.
   Chwala K, 2013, J GLOB INFECT DIS, V5, P144.
   Domsch K. H., 1980, COMPENDIUM SOIL FUNG, V1.
   Eibicht SJ, 2011, J HOSP INFECT, V78, P221, DOI 10.1016/j.jhin.2011.01.015.
   European Committee on Antimicrobial Susceptibility Testing, 2016, EUR COMM ANT SUSC TE.
   Eveillard M, 2001, INFECT CONT HOSP EP, V22, P693, DOI 10.1086/501847.
   Golofit-Szymczak M, 2015, MED PR, V66, P779, DOI 10.13075/mp.5893.00349.
   Gorny R.L., 2004, PODSTAWY METODY OCEN, V3, P17.
   Gorny RL, 2016, INT J OCCUP MED ENV, V29, P255, DOI 10.13075/ijomeh.1896.00630.
   Hajduga M, 2014, AKTUAL PROBL BIOMECH, V8, P39.
   Hajduga MA, 2013, AKTUAL PROBL BIOMECH, V7, P69.
   Harkawy A, 2011, ANN AGR ENV MED, V18, P323.
   Krogulski Adam, 2008, Rocz Panstw Zakl Hig, V59, P97.
   Lis D. O., 1997, ANN POL RELAT HYG, V48, P59.
   Luksamijarulkul Pipat, 2015, Oman Med J, V30, P104, DOI 10.5001/omj.2015.23.
   Luksamijarulkul P, 2014, SE ASIAN J TROP MED, V45, P940.
   Mahomed O, 2007, EMERG MED J, V24, P497, DOI 10.1136/emj.2006.045575.
   Makarowski T, 2009, MED MYCOL, V16, P148.
   National Sanitary Inspectorate, 2010, COUNTR SAN COND REP.
   National Sanitary Inspectorate, 2011, COUNTR SAN COND REP.
   National Sanitary Inspectorate, 2009, COUNTR SAN COND REP.
   Nigam Y, 2003, EMERG MED J, V20, P479, DOI 10.1136/emj.20.5.479.
   Noh H, 2011, J KOREAN MED SCI, V26, P124, DOI 10.3346/jkms.2011.26.1.124.
   OGOREK R., 2011, MIKOL LEK, V., 18, P79.
   Plaskowska E, 2012, PART II MIKOL LEK, V19, P27.
   Regulation of Polish Ministry of Health, 2011, J LAWS.
   RHODES JC, 1992, J MED VET MYCOL, V30, P51.
   Robbins C A, 2000, Appl Occup Environ Hyg, V15, P773.
   Skowron K, 2014, EKOL TECH, V22, P155.
   Slesiona S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031223.
   Speers D., 2003, J EMERG PRIM HEALTH, V1, P1, DOI DOI 10.1140/EPJCD/S2003-03-0121-6.
   Steinka I., 2013, ANN ACAD MED GEDAN, V43, P165.
   Vikke Heidi Storm, 2015, BMC Res Notes, V8, P95, DOI 10.1186/s13104-015-1057-4.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{Int. J. Occup. Med. Environ. Health}},
Doc-Delivery-Number = {{EZ1CK}},
Unique-ID = {{ISI:000404445900008}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000401410700031,
Author = {Shamsizadeh, Zahra and Nikaeen, Mahnaz and Esfahani, Bahram Nasr and
   Mirhoseini, Seyed Hamed and Hatamzadeh, Maryam and Hassanzadeh, Akbar},
Title = {{Detection of antibiotic resistant Acinetobacter baumannii in various
   hospital environments: potential sources for transmission of
   Acinetobacter infections}},
Journal = {{ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE}},
Year = {{2017}},
Volume = {{22}},
Number = {{1}},
Abstract = {{Background: Antibiotic resistant Acinetobacter baumannii has emerged as
   one of the most problematic hospital acquired pathogens around the
   world. This study was designed to investigate the presence of antibiotic
   resistant A. baumannii in various hospital environments.
   Methods: Air, water and inanimate surface samples were taken in
   different wards of four hospitals and analyzed for the presence of A.
   baumannii. Confirmed A. baumannii isolates were analyzed for
   antimicrobial susceptibility and also screened for the presence of three
   most common OXA- type carbapenemase-encoding genes.
   Results: A. baumannii was detected in 11\% (7/64) of air samples with
   the highest recovery in intensive care units (ICUs). A. baumannii was
   also detected in 17\% (7/42) and 2\% (1/42) of surface and water
   samples, respectively. A total of 40 A. baumannii isolates were
   recovered and analysis of antimicrobial susceptibility showed the
   highest resistance towards ceftazidime (92.5\%, 37/40). 85\% (34/40) and
   80\% (32/40) of the isolates were also resistant to imipenem and
   gentamicin, respectively. Resistance genes analysis showed that 77.5\%
   (31/40) strains contained OXA-23 and 5\% (2/40) strains contained
   OXA-24, but OXA-58 was not detected in any of the strains.
   Conclusion: Detection of antibiotic resistant A. baumannii in various
   samples revealed that hospital environments could act as a potential
   source for transmission of A. baumannii infections especially in ICUs.
   These results emphasize the importance of early detection and
   implementation of control measures to prevent the spread of A. baumannii
   in hospital environments.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Nikaeen, M (Reprint Author), Isfahan Univ Med Sci, Sch Hlth, Dept Environm Hlth Engn, Hezar Jerib Ave, Esfahan, Iran.
   Shamsizadeh, Zahra; Nikaeen, Mahnaz; Hatamzadeh, Maryam, Isfahan Univ Med Sci, Sch Hlth, Dept Environm Hlth Engn, Hezar Jerib Ave, Esfahan, Iran.
   Esfahani, Bahram Nasr, Isfahan Univ Med Sci, Sch Med, Dept Microbiol, Esfahan, Iran.
   Mirhoseini, Seyed Hamed, Arak Univ Med Sci, Sch Hlth, Dept Environm Hlth Engn, Arak, Iran.
   Hassanzadeh, Akbar, Isfahan Univ Med Sci, Sch Hlth, Dept Stat \& Epidemiol, Esfahan, Iran.}},
DOI = {{10.1186/s12199-017-0653-4}},
Article-Number = {{UNSP 44}},
ISSN = {{1342-078X}},
EISSN = {{1347-4715}},
Keywords = {{Acinetobacter baumannii; Hospital; Antibiotic resistance; Air; Water;
   Surface}},
Keywords-Plus = {{INTENSIVE-CARE-UNIT; CARBAPENEM RESISTANCE; NOSOCOMIAL OUTBREAK;
   WATER-SYSTEMS; TURKEY; PCR; EPIDEMIOLOGY; MECHANISMS; WORLDWIDE;
   PRIORITY}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{nikaeen@hlth.mui.ac.ir}},
ResearcherID-Numbers = {{Hassanzadeh, Akbar/V-5970-2017
   Nikaeen, Mahnaz/W-5007-2017}},
ORCID-Numbers = {{Hassanzadeh, Akbar/0000-0002-4555-0992
   Nikaeen, Mahnaz/0000-0002-1852-1547}},
Funding-Acknowledgement = {{vice chancellery for research of Isfahan University of Medical Sciences}},
Funding-Text = {{This research was conducted with funding from the vice chancellery for
   research of Isfahan University of Medical Sciences only for collection
   of samples and analyses.}},
Cited-References = {{Akalin H, 2006, INFECT CONT HOSP EP, V27, P404, DOI 10.1086/503349.
   {[}Anonymous], 2012, M100S22 CLSI.
   Asghari FB, 2013, J WATER HEALTH, V11, P713, DOI 10.2166/wh.2013.064.
   Asghari FB, 2013, FEMS MICROBIOL LETT, V343, P77, DOI 10.1111/1574-6968.12132.
   Aygun G, 2002, J HOSP INFECT, V52, P259, DOI 10.1053/jhin.2002.1300.
   Beggs CB, 2003, INDOOR BUILT ENVIRON, V12, P9, DOI 10.1177/142032603032201.
   Benedetta L, 2007, ANN I SUPER SANITA, V43, P83.
   BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148.
   Bernards AT, 1998, AM J INFECT CONTROL, V26, P544, DOI 10.1053/ic.1998.v26.a84555.
   Bou G, 2000, CLIN MICROBIOL INFEC, V6, P635, DOI 10.1046/j.1469-0691.2000.00181.x.
   Cai Y, 2012, J ANTIMICROB CHEMOTH, V67, P1607, DOI 10.1093/jac/dks084.
   Cicek AC, 2013, JPN J INFECT DIS, V66, P245, DOI 10.7883/yoken.66.245.
   Custovic Amer, 2014, Med Arch, V68, P402, DOI 10.5455/medarh.2014.68.402-406.
   D'Arezzo S, 2011, J ANTIMICROB CHEMOTH, V66, P54, DOI 10.1093/jac/dkq407.
   Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202.
   Gao J, 2014, BURNS, V40, P295, DOI 10.1016/j.burns.2013.06.003.
   Kilic A, 2008, J CLIN MICROBIOL, V46, P902, DOI 10.1128/JCM.01876-07.
   Lautenbach E, 2009, INFECT CONT HOSP EP, V30, P1186, DOI 10.1086/648450.
   Lemos EV, 2014, CLIN MICROBIOL INFEC, V20, P416, DOI 10.1111/1469-0691.12363.
   Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145.
   Munoz-Price LS, 2013, CRIT CARE MED, V41, P1915, DOI 10.1097/CCM.0b013e31828a39c0.
   Murray G, 2015, SEMINARS RESP CRITIC.
   Pajand O, 2013, BURNS, V39, P1414, DOI 10.1016/j.burns.2013.03.024.
   Pittet D, 2005, LANCET, V366, P1246, DOI 10.1016/S0140-6736(05)67506-X.
   Sarica S, 2002, INDOOR BUILT ENVIRON, V11, P285, DOI 10.1159/000066523.
   Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022.
   Tena D, 2013, JPN J INFECT DIS, V66, P323, DOI 10.7883/yoken.66.323.
   Vanbroekhoven K, 2004, FEMS MICROBIOL ECOL, V50, P37, DOI 10.1016/j.femsec.2004.05.007.
   Wang SH, 2003, J HOSP INFECT, V53, P97, DOI 10.1053/jhin.2002.1348.
   Weinstein RA, 2004, CLIN INFECT DIS, V39, P1182.
   Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{134}},
Journal-ISO = {{Environ. Health Prev.}},
Doc-Delivery-Number = {{EV0EH}},
Unique-ID = {{ISI:000401410700031}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000401014400004,
Author = {Velazquez-Guadarrama, Norma and Olivares-Cervantes, Alma L. and Salinas,
   Eva and Martinez, Leticia and Escorcia, Magdalena and Oropeza, Ricardo
   and Rosas, Irma},
Title = {{Presence of environmental coagulase-positive staphylococci, their clonal
   relationship, resistance factors and ability to form biofilm}},
Journal = {{REVISTA ARGENTINA DE MICROBIOLOGIA}},
Year = {{2017}},
Volume = {{49}},
Number = {{1}},
Pages = {{15-23}},
Month = {{JAN-MAR}},
Abstract = {{Coagulase-positive staphylococci (CoPS) are opportunistic pathogens
   carrying various mechanisms of resistance that have a large number of
   virulence factors, and whose ability to induce illness is associated
   with the host. This study aimed to investigate the presence of
   environmental coagulase-positive staphylococci, their susceptibility
   profile, clonal relationship and ability to form biofilm. The 16S rRNA
   genes from CoPS isolates were analyzed, and their antibiotic
   susceptibility was evaluated using the agar dilution method in
   accordance with Clinical and Laboratory Standards Institute guidelines.
   The clonal profile was obtained by pulsed-field gel electrophoresis
   (PFGE) and biofilm formation was measured by a crystal violet retention
   assay. A total of 72 Staphylococcus spp. strains were isolated from air,
   metal surfaces, and nostrils from humans, dogs, cats, and birds. Three
   species were identified: Staphylococcus aureus (17\%), Staphylococcus
   intermedius (63\%), and Staphylococcus pseudintermedius (21\%). Ninety
   three percent (93\%) of the strains were resistant to at least one of 13
   tested antibiotics. S. pseudintermedius strains were the only resistant
   ones to methicillin while most of these isolates were
   multidrug-resistant, had significantly higher ability to form biofilm
   and PFGE grouped into seven different patterns, without showing clonal
   dispersion among animals and environmental isolates. This study suggests
   that dogs, cat, and air are environmental sources potentially carrying
   multidrug-resistant S. pseudintermedius, which survives in different
   environments through biofilm formation and multidrug resistance,
   characteristics that can be transmitted horizontally to other bacteria
   andexacerbate the problem of antibiotic resistance in humans. (C) 2016
   Asociacion Argentina de Microbiologia. Published by Elsevier Espana,
   S.L.U. This is an open access article under the CC BY-NC-ND license}},
Publisher = {{ASOCIACION ARGENTINA MICROBIOLOGIA}},
Address = {{BULNES 44  PB   B, BUENOS AIRES, 00000, ARGENTINA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Velazquez-Guadarrama, N (Reprint Author), Hosp Infantil Mexico Feder Gomez, Lab Infectol, Mexico City 06720, DF, Mexico.
   Rosas, I (Reprint Author), Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Mexico City 04510, DF, Mexico.
   Velazquez-Guadarrama, Norma; Olivares-Cervantes, Alma L., Hosp Infantil Mexico Feder Gomez, Lab Infectol, Mexico City 06720, DF, Mexico.
   Salinas, Eva; Martinez, Leticia; Rosas, Irma, Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Mexico City 04510, DF, Mexico.
   Escorcia, Magdalena, Univ Nacl Autonoma Mexico, Fac Med Vet \& Zootecn, Mexico City 04510, DF, Mexico.
   Oropeza, Ricardo, Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico.}},
DOI = {{10.1016/j.ram.2016.08.006}},
ISSN = {{0325-7541}},
EISSN = {{1851-7617}},
Keywords = {{Multidrug-resistant; Biofilm; Pulsed-field gel electrophoresis;
   Coagulase-positive Staphylococci; Environmental}},
Keywords-Plus = {{UNITED-STATES; NORTH-AMERICA; PSEUDINTERMEDIUS; AUREUS; VANCOMYCIN;
   SUSCEPTIBILITY; EPIDERMIDIS; HUMANS; EUROPE}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{normave@himfg.edu.mx
   iarp@atmosfera.unam.mx}},
ORCID-Numbers = {{Martinez Romero, Leticia/0000-0002-9608-4178
   velazquez-guadarrama, norma/0000-0002-3620-7260
   Rosas Perez, Irma Aurora/0000-0003-0149-8931}},
Funding-Acknowledgement = {{Federal Resources from SSA {[}HIM/2013/ 009 SSA 1081]}},
Funding-Text = {{The authors thank Juan Carlos Vigueras Galindo for review of the
   manuscript. This work was supported by Federal Resources (HIM/2013/ 009
   SSA 1081) from SSA.}},
Cited-References = {{Ben Zakour NL, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00044.
   BIBERSTEIN EL, 1984, J CLIN MICROBIOL, V19, P610.
   Borjesson S, 2015, EUR J CLIN MICROBIOL, V34, P839, DOI 10.1007/s10096-014-2300-y.
   Clinical and Laboratory Standards Institute, 2014, PERF STAND SUSC TE S, V34.
   Errecalde L, 2013, REV ARGENT MICROBIOL, V45, P99, DOI 10.1016/S0325-7541(13)70007-5.
   Fitzgerald J. Ross, 2008, P255.
   Freney J, 1999, INT J SYST BACTERIOL, V49, P489, DOI 10.1099/00207713-49-2-489.
   Gronthal T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110084.
   Hanselman BA, 2009, CAN VET J, V50, P954.
   Kadlec K, 2010, J ANTIMICROB CHEMOTH, V65, P1826, DOI 10.1093/jac/dkq203.
   Kelesidis T, 2010, INT J INFECT DIS, V14, pE838, DOI 10.1016/j.ijid.2010.02.2249.
   Lindsay JA, 2010, INT J MED MICROBIOL, V300, P98, DOI 10.1016/j.ijmm.2009.08.013.
   Manly B., 1997, RANDOMIZATION BOOTST.
   McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003.
   Niba ETE, 2007, DNA RES, V14, P237, DOI 10.1093/dnares/dsm024.
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182.
   Paul NC, 2011, ZOONOSES PUBLIC HLTH, V58, P533, DOI 10.1111/j.1863-2378.2011.01398.x.
   Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078.
   Pinheiro L, 2014, MEM I OSWALDO CRUZ, V109, P871, DOI 10.1590/0074-0276140120.
   Quitoco Isidorio Mebinda Zuco, 2013, BMC Res Notes, V6, P336, DOI 10.1186/1756-0500-6-336.
   Richter SS, 2011, J CLIN MICROBIOL, V49, P4203, DOI 10.1128/JCM.01152-11.
   Rohlf JF., 2004, APPL BIOSTAT.
   Ruscher C, 2010, VET MICROBIOL, V144, P340, DOI 10.1016/j.vetmic.2010.01.008.
   Stegmann R, 2010, J ANTIMICROB CHEMOTH, V65, P2047, DOI 10.1093/jac/dkq241.
   Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6.
   Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P1324, DOI 10.1128/AAC.05804-11.
   Van Hoovels L, 2006, J CLIN MICROBIOL, V44, P4609, DOI 10.1128/JCM.01308-06.
   Vigo GB, 2015, REV ARGENT MICROBIOL, V47, P206, DOI 10.1016/j.ram.2015.06.002.
   Walther B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035197.
   Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005.
   Zhou S, 2013, BMC INFECT DIS, V13, P747.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{Rev. Argent. Microbiol.}},
Doc-Delivery-Number = {{EU4QG}},
Unique-ID = {{ISI:000401014400004}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000396687400014,
Author = {Rahimzadeh, Golnar and Gill, Pooria and Rezai, Mohammad Sadegh},
Title = {{Characterization of Methicillin-Resistant Staphylococcus aureus (MRSA)
   Phages From Sewage at a Tertiary Pediatric Hospital}},
Journal = {{ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES}},
Year = {{2017}},
Volume = {{5}},
Number = {{1}},
Month = {{JAN}},
Abstract = {{Background: The methicillin-resistant Staphylococcus aureus (MRSA)
   strain is now the most commonly reported antibiotic-resistant bacterium
   in clinical settings. Therefore, there is an urgent need to develop
   novel antibacterial agents to control this pathogen. Bacteriophages are
   a potential alternative treatment for MRSA infections.
   Objectives: The objective of this study was the isolation and
   characterization of MRSA phages from the sewage at a tertiary pediatric
   hospital.
   Methods: Two MRSA strains were isolated from patient blood. The isolated
   strains were confirmed as MRSA through the conventional methods. Phages
   were then isolated from the sewage at the tertiary pediatric hospital.
   Lytic activity was determined with a spot test, while the titers of
   phage lysates were measured using the DLA technique. The morphology was
   assessed using electron microscopy, and the latent period time and burst
   size were determined.
   Results: Electron microscopy showed MRSA phages' resemblance to members
   of the family Siphoviridae, serogroups A and F. They exhibited a latent
   period of 70 minutes and a relatively burst size of 2,400 plaque-forming
   units (PFU)/infected cell. The titer of the phages was determined to be
   3 x 10(9) PFU/mL using the by DLA technique.
   Conclusions: In this study, two phages from the family Siphoviridae were
   isolated and characterized from sewage at a tertiary pediatric hospital;
   these phages specifically target MRSA. Their presence may be one reason
   for the transfer of antibiotic resistance or virulence factors,
   resulting in transduction and the conversion of nonvirulent strains of
   Staphylococcus to virulent strains. Considering that phages through can
   be transferred to wards in an air-born manner, it is better to create
   negative pressure in the sewage pipes at hospitals until the phages can
   no longer transfer to the wards via aerosols.}},
Publisher = {{KOWSAR CORP}},
Address = {{PO BOX 14155-3651, TEHRAN, 14155, IRAN}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Rezai, MS (Reprint Author), Mazandaran Univ Med Sci, Bouali Sina Hosp, Infect Dis Res Ctr Focus Nosocomial Infect, Sari, Iran.
   Rahimzadeh, Golnar; Rezai, Mohammad Sadegh, Mazandaran Univ Med Sci, Bouali Sina Hosp, Infect Dis Res Ctr Focus Nosocomial Infect, Sari, Iran.
   Rahimzadeh, Golnar, Mazandaran Univ Med Sci, Student Res Comm, Sari, Iran.
   Gill, Pooria, Mazandaran Univ Med Sci, Nanomed Grp, Immunogenet Res Ctr, Sari, Iran.}},
DOI = {{10.5812/pedinfect.39615}},
Article-Number = {{e39615}},
ISSN = {{2322-1828}},
EISSN = {{2322-1836}},
Keywords = {{Bacteriophage; Methicillin-Resistant Staphylococcus aureus (MRSA);
   Hospital Sewage; Siphoviridae}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE; LYTIC ACTIVITY; BACTERIOPHAGES; INFECTIONS;
   EVOLUTION; OUTBREAK; BACTERIA; CATTLE}},
Research-Areas = {{Pediatrics}},
Web-of-Science-Categories  = {{Pediatrics}},
Author-Email = {{drmsrezaii@yahoo.com}},
ResearcherID-Numbers = {{Gill, Pooria/E-7614-2017
   }},
ORCID-Numbers = {{Gill, Pooria/0000-0002-9020-4263
   rezai, mohammad sadegh/0000-0003-4585-9954}},
Cited-References = {{Behzadnia S, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.14562.
   Berglund C, 2008, CLIN MICROBIOL INFEC, V14, P1048, DOI 10.1111/j.1469-0691.2008.02090.x.
   Bin S, 2007, J MED COLL PLA, V22, P261, DOI {[}10.1016/S1000-1948(07)60054-9, DOI 10.1016/S1000-1948(07)60054-9].
   Brown DFJ, 2005, J ANTIMICROB CHEMOTH, V56, P1000, DOI 10.1093/jac/dki372.
   Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004.
   Chang Y, 2015, VIRUSES-BASEL, V7, P5225, DOI 10.3390/v7102870.
   Chen CR, 2007, ARCH MICROBIOL, V188, P191, DOI 10.1007/s00203-007-0238-5.
   Chhibber S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056022.
   COHEN S, 1970, J BACTERIOL, V104, P1158.
   Colomer-Lluch M, 2011, ANTIMICROB AGENTS CH, V55, P4908, DOI 10.1128/AAC.00535-11.
   Dane J.H., 2002, METHODS SOIL ANAL, V5.
   Deghorain M, 2012, VIRUSES-BASEL, V4, P3316, DOI 10.3390/v4123316.
   Diekema DJ, 2004, CLIN INFECT DIS, V38, P78, DOI 10.1086/380457.
   Feiner R, 2015, NAT REV MICROBIOL, V13, P641, DOI 10.1038/nrmicro3527.
   Feng Y, 2008, FEMS MICROBIOL REV, V32, P23, DOI 10.1111/j.1574-6976.2007.00086.x.
   Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002.
   Ghasemian A, 2016, INFECT EPIDEMIOL MED, V2, P31.
   Gupta R, 2011, CURR MICROBIOL, V62, P255, DOI 10.1007/s00284-010-9699-x.
   JEVONS MP, 1963, LANCET, V1, P904.
   Kahankova J, 2010, ENVIRON MICROBIOL, V12, P2527, DOI 10.1111/j.1462-2920.2010.02226.x.
   Kraushaar B, 2013, ARCH VIROL, V158, P2341, DOI 10.1007/s00705-013-1707-6.
   Kwiatek M, 2012, ARCH VIROL, V157, P225, DOI 10.1007/s00705-011-1160-3.
   Li LP, 2014, MOL BIOL REP, V41, P5829, DOI 10.1007/s11033-014-3457-2.
   Li XY, 2014, VIRUS GENES, V49, P145, DOI 10.1007/s11262-014-1079-3.
   Martha RJC, 2009, BACTERIOPHAGES METHO.
   Matsuzaki Shigenobu, 2005, Journal of Infection and Chemotherapy, V11, P211, DOI 10.1007/s10156-005-0408-9.
   Mattila S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01271.
   Navidinia M, 2015, J PARAMED SCI, V6, P91.
   Navidinia M, 2015, ARCH PEDIAT INFECT D, V3, P16458, DOI DOI 10.5812/PEDINFECT.16458.
   PATHAK SP, 1993, J ENVIRON SCI HEAL A, VA28, P73, DOI 10.1080/10934529309375863.
   Pinto AN, 2013, CLIN MICROBIOL INFEC, V19, P620, DOI 10.1111/j.1469-0691.2012.03987.x.
   Pirnay JP, 2011, PHARM RES-DORDR, V28, P934, DOI 10.1007/s11095-010-0313-5.
   Rahimzadeh G, 2016, AUSTRALAS MED J, V9, P169, DOI 10.4066/AMJ.2016.2642.
   Rezaei M, 2013, ARCH PEDIATR INFECT, V1, P53, DOI 10.5812/pedinfect.8969.
   Rezai MS, 2015, J PEDIAT REV, V3, DOI 10.17795/jpr-680.
   Rezai MS, 2016, CASP J INTERN MED, V7, P114.
   Shen GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046537.
   Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001.
   Synnott AJ, 2009, APPL ENVIRON MICROB, V75, P4483, DOI 10.1128/AEM.02641-08.
   Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000.
   Yang CM, 2009, LETT APPL MICROBIOL, V48, P560, DOI 10.1111/j.1472-765X.2009.02572.x.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{Arch. Pediatr. Infect. Dis.}},
Doc-Delivery-Number = {{EO4TO}},
Unique-ID = {{ISI:000396687400014}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000393758100017,
Author = {Rashid, T. and Vonville, H. and Hasan, I. and Garey, K. W.},
Title = {{Mechanisms for floor surfaces or environmental ground contamination to
   cause human infection: a systematic review}},
Journal = {{EPIDEMIOLOGY AND INFECTION}},
Year = {{2017}},
Volume = {{145}},
Number = {{2}},
Pages = {{347-357}},
Month = {{JAN}},
Abstract = {{Shoe soles have been shown to transfer infectious microorganisms to
   floor and ground surfaces. However, the possible modes of transmission
   of infectious agents from floors or ground surfaces to human contact for
   infection have not been systematically reviewed. A systematic review was
   performed on articles indexed in medical databases (Medline, EMBASE,
   PubMed) using a pre-defined search strategy and MeSH terms (date of last
   search: 15 March 2016). Only primary research studies in English that
   investigated the transmission dynamics of infectious microorganisms from
   floor or ground surfaces to human infection were included. Extraction of
   articles was performed two independent reviewers using pre-defined data
   fields in an Excel sheet. Disagreements were resolved by consensus.
   Thirty studies met the inclusion criteria. Almost all
   hospital-associated microorganisms including methicillin-resistant
   Staphylococcus aureus, Clostridium difficile, and multidrug-resistant
   Gram-negative species were identified on floor or ground surfaces.
   Several modes of transmission dynamics, most commonly direct contact or
   aerosolization, were identified. In conclusion, interventions such as
   efficient cleaning of floor surfaces and vectors that transfer
   infectious organisms to floors such as shoe soles could be an effective
   infection control strategy to prevent human disease.}},
Publisher = {{CAMBRIDGE UNIV PRESS}},
Address = {{32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Garey, KW (Reprint Author), Univ Houston, Coll Pharm, 1441 Moursund St, Houston, TX 77030 USA.
   Rashid, T.; Garey, K. W., Univ Houston, Coll Pharm, 1441 Moursund St, Houston, TX 77030 USA.
   Rashid, T.; Vonville, H.; Garey, K. W., UTHlth Sch Publ Hlth, Houston, TX USA.
   Hasan, I., Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland.}},
DOI = {{10.1017/S0950268816002193}},
ISSN = {{0950-2688}},
EISSN = {{1469-4409}},
Keywords = {{Bacterial infections; Clostridium difficile; disinfection methods;
   epidemiology; infectious disease transmission; Staphylococcus aureus}},
Keywords-Plus = {{AIRBORNE BACTERIA; OPERATING-ROOM; AIR-QUALITY; DISSEMINATION;
   TRANSMISSION; VECTORS; SPORES; BOOTS; OFFICE; FUNGI}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{kgarey@uh.edu}},
ORCID-Numbers = {{VonVille, Helena/0000-0001-5193-2391
   Garey, Kevin/0000-0003-2063-7503}},
Funding-Acknowledgement = {{Healthy Sole LLC}},
Funding-Text = {{This work was supported by a research grant from Healthy Sole LLC.}},
Cited-References = {{Agarwal M, 2002, AM J INFECT CONTROL, V30, P179, DOI 10.1067/mic.2002.119513.
   Alam MJ, 2014, ANAEROBE, V27, P31, DOI 10.1016/j.anaerobe.2014.03.002.
   Amass SF, 2006, JAVMA-J AM VET MED A, V228, P1391, DOI 10.2460/javma.228.9.1391.
   Amirfeyz R, 2007, ANN ROY COLL SURG, V89, P607, DOI 10.1308/003588407X205440.
   ANDERSON RL, 1982, J CLIN MICROBIOL, V15, P408.
   Andersson AE, 2012, AM J INFECT CONTROL, V40, P750, DOI 10.1016/j.ajic.2011.09.015.
   Aquino RSS, 2013, J HOSP INFECT, V83, P200, DOI 10.1016/j.jhin.2012.11.022.
   AYLIFFE GAJ, 1966, BRIT MED J, V2, P442, DOI 10.1136/bmj.2.5511.442.
   Brodka K, 2012, INT J OCCUP MED ENV, V25, P281, DOI 10.2478/S13382-012-0032-8.
   Buttner Mark P., 2002, Aerobiologia, V18, P1, DOI 10.1023/A:1014977900352.
   Caselli E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148857.
   Chambers MK, 2009, J ENVIRON MANAGE, V90, P961, DOI 10.1016/j.jenvnman.2008.03.008.
   Chao HJ, 2002, MYCOPATHOLOGIA, V154, P93, DOI 10.1023/A:1015592224368.
   Curry CH, 2002, J TRAVEL MED, V9, P190.
   DiCaprio E, 2015, APPL ENVIRON MICROB, V81, P2727, DOI 10.1128/AEM.03867-14.
   Eisenberg T, 2013, J DAIRY RES, V80, P485, DOI 10.1017/S002202991300040X.
   FOTEDAR R, 1993, J HOSP INFECT, V23, P55, DOI 10.1016/0195-6701(93)90131-I.
   Gagniere S, 2006, J FOOD PROTECT, V69, P2692, DOI 10.4315/0362-028X-69.11.2692.
   Gorny RL, 2002, ANN AGR ENV MED, V9, P17.
   Gorny RL, 2003, ENVIRON RES, V91, P45, DOI 10.1016/S0013-9351(02)00006-3.
   GWALTNEY JM, 1982, AM J EPIDEMIOL, V116, P828, DOI 10.1093/oxfordjournals.aje.a113473.
   HAMBRAEUS A, 1978, J HYG-CAMBRIDGE, V80, P169, DOI 10.1017/S0022172400053511.
   Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867.
   Jonges M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125401.
   Koganti S, 2016, INFECT CONT HOSP EP, V37, P1374, DOI 10.1017/ice.2016.181.
   Limmathurotsakul D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002072.
   Lues JFR, 2006, INT J ENVIRON HEAL R, V16, P419, DOI 10.1080/09603120601093600.
   Mathew JI, 2016, AM J INFECT CONTROL, V44, P724, DOI 10.1016/j.ajic.2015.12.043.
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135.
   Monaghan JM, 2012, J APPL MICROBIOL, V112, P1007, DOI 10.1111/j.1365-2672.2012.05269.x.
   Nieuwenhuijsen MJ, 1999, ANN OCCUP HYG, V43, P35, DOI 10.1016/S0003-4878(98)00068-4.
   O'Connor BA, 2015, EPIDEMIOL INFECT, V143, P391, DOI 10.1017/S0950268814001083.
   Pai HH, 2004, INFECT CONT HOSP EP, V25, P979, DOI 10.1086/502330.
   Paton S, 2015, APPL ENVIRON MICROB, V81, P4914, DOI 10.1128/AEM.00412-15.
   Penet L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115757.
   Rashid T, 2016, J APPL MICROBIOL, V121, P1223, DOI 10.1111/jam.13250.
   Roberts K, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-7.
   Sola-Gines M, 2015, APPL ENVIRON MICROB, V81, P3604, DOI 10.1128/AEM.04252-14.
   SRAMOVA H, 1992, J HOSP INFECT, V20, P281, DOI 10.1016/0195-6701(92)90006-8.
   Strassle P, 2012, AM J INFECT CONTROL, V40, P1005, DOI 10.1016/j.ajic.2012.05.027.
   UTHealth, 2016, EXC WORKB SYST REV.
   Verde SC, 2015, RES MICROBIOL, V166, P557, DOI 10.1016/j.resmic.2015.03.004.
   Weis CP, 2002, JAMA-J AM MED ASSOC, V288, P2853, DOI 10.1001/jama.288.22.2853.
   Whyte W, 2013, INT J VENT, V12, P271.
   WRIGHT DN, 1968, AM IND HYG ASSOC J, V29, P574, DOI 10.1080/00028896809343058.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{5}},
Usage-Count-Since-2013 = {{16}},
Journal-ISO = {{Epidemiol. Infect.}},
Doc-Delivery-Number = {{EK2LF}},
Unique-ID = {{ISI:000393758100017}},
DA = {{2018-08-13}},
}

@article{ ISI:000393205400009,
Author = {Projahn, Michaela and Daehre, Katrin and Roesler, Uwe and Friese, Anika},
Title = {{Extended-Spectrum-Beta-Lactamase- and Plasmid-Encoded
   Cephamycinase-Producing Enterobacteria in the Broiler Hatchery as a
   Potential Mode of Pseudo-Vertical Transmission}},
Journal = {{APPLIED AND ENVIRONMENTAL MICROBIOLOGY}},
Year = {{2017}},
Volume = {{83}},
Number = {{1}},
Month = {{JAN}},
Abstract = {{Antimicrobial resistance through extended-spectrum beta-lactamases
   (ESBLs) and transferable (plasmid-encoded) cephamycinases (pAmpCs)
   represents an increasing problem in human and veterinary medicine. The
   presence of ESBL-/pAmpC-producing commensal enterobacteria in farm
   animals, such as broiler chickens, is considered one possible source of
   food contamination and could therefore also be relevant for human
   colonization. Studies on transmission routes along the broiler
   production chain showed that 1-day-old hatchlings are already affected.
   In this study, ESBL-/pAmpC-positive broiler parent flocks and their
   corresponding eggs, as well as various environmental and air samples
   from the hatchery, were analyzed. The eggs were investigated concerning
   ESBL-/pAmpC-producing enterobacteria on the outer eggshell surface
   (before/after disinfection), the inner eggshell surface, and the egg
   content. Isolates were analyzed concerning their species, their
   phylogroup in the case of Escherichia coli strains, the respective
   resistance genes, and the phenotypical antibiotic resistance. Of the
   tested eggs, 0.9\% (n = 560) were contaminated on their outer shell
   surface. Further analyses using pulsed-field gel electrophoresis showed
   a relationship of these strains to those isolated from the corresponding
   parent flocks, which demonstrates a pseudo-vertical transfer of
   ESBL-/pAmpC-producing enterobacteria into the hatchery. Resistant
   enterobacteria were also found in environmental samples from the
   hatchery, such as dust or surfaces which could pose as a possible
   contamination source for the hatchlings. All 1-day-old chicks tested
   negative directly after hatching. The results show a possible entry of
   ESBL-/pAmpC-producing enterobacteria from the parent flocks into the
   hatchery; however, the impact of the hatchery on colonization of the
   hatchlings seems to be low.
   IMPORTANCE ESBL-/pAmpC-producing enterobacteria occur frequently in
   broiler-fattening farms. Recent studies investigated the prevalence and
   possible transmission route of these bacteria in the broiler production
   chain. It seemed very likely that the hatcheries play an important role
   in transmission and/or contamination events. There are only few data on
   transmission investigations from a grandparent or parent flock to their
   offspring. However, reliable data on direct or indirect vertical
   transmission events in the hatchery are not available. Therefore, we
   conducted our study and intensively investigated the broiler hatching
   eggs from ESBL-/pAmpC-positive broiler parent flocks as well as the
   hatchlings and the environment of the hatchery.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Projahn, M (Reprint Author), Free Univ Berlin, Inst Anim Hyg \& Environm Hlth, Berlin, Germany.
   Projahn, Michaela; Daehre, Katrin; Roesler, Uwe; Friese, Anika, Free Univ Berlin, Inst Anim Hyg \& Environm Hlth, Berlin, Germany.}},
DOI = {{10.1128/AEM.02364-16}},
Article-Number = {{UNSP e02364-16}},
ISSN = {{0099-2240}},
EISSN = {{1098-5336}},
Keywords = {{antibiotic resistance; Enterobacteriaceae; broiler chicken; hatchery;
   ESBL; pAmpC; AmpC}},
Keywords-Plus = {{RESISTANT ESCHERICHIA-COLI; POULTRY PRODUCTION CHAIN;
   SALMONELLA-ENTERICA; COMPANION ANIMALS; PUBLIC-HEALTH; ANTIMICROBIAL
   RESISTANCE; HATCHING EGGS; PENETRATION; CHICKEN; FARMS}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Microbiology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Microbiology}},
Author-Email = {{michaela.projahn@fu-berlin.de}},
ResearcherID-Numbers = {{Projahn, Michaela/O-7430-2018}},
ORCID-Numbers = {{Projahn, Michaela/0000-0002-3896-3561}},
Funding-Acknowledgement = {{Federal Ministry of Education and Research {[}01KI1313C]}},
Funding-Text = {{This project was funded by the Federal Ministry of Education and
   Research (grant 01KI1313C) and is part of the RESET research consortium
   (http://www.resetverbund.de/index.htm).}},
Cited-References = {{Bauernfeind A, 1998, YONSEI MED J, V39, P520, DOI 10.3349/ymj.1998.39.6.520.
   Blaak H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135402.
   Blanc V, 2006, VET MICROBIOL, V118, P299, DOI 10.1016/j.vetmic.2006.08.002.
   Borjesson S, 2016, EMERG INFECT DIS, V22, P634, DOI 10.3201/eid2204.151142.
   Brinas L, 2003, ANTIMICROB AGENTS CH, V47, P2056, DOI 10.1128/AAC.47.6.2056-2058.2003.
   Cadirci S, 2009, ARCH GEFLUGELKD, V73, P116.
   Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019.
   Cox NA, 2000, POULTRY SCI, V79, P1571, DOI 10.1093/ps/79.11.1571.
   De Reu K, 2006, INT J FOOD MICROBIOL, V112, P253, DOI 10.1016/j.ijfoodmicro.2006.04.011.
   Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049.
   Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349.
   Dierikx C, 2010, VET MICROBIOL, V145, P273, DOI 10.1016/j.vetmic.2010.03.019.
   Dierikx CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079005.
   European Committee on Antimicrobial Susceptibility Testing, 2016, BREAKP TABL INT MICS.
   Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x.
   Forgetta V, 2012, POULTRY SCI, V91, P512, DOI 10.3382/ps.2011-01738.
   Giovanardi D, 2005, AVIAN PATHOL, V34, P313, DOI 10.1080/03079450500179046.
   HOPKINS JM, 1990, J ANTIMICROB CHEMOTH, V25, P49, DOI 10.1093/jac/25.1.49.
   Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005.
   Kaesbohrer A, 2012, ZOONOSES PUBLIC HLTH, V59, P158, DOI 10.1111/j.1863-2378.2011.01451.x.
   Laube H, 2014, VET MICROBIOL, V172, P519, DOI 10.1016/j.vetmic.2014.06.008.
   Laube H, 2013, APPL ENVIRON MICROB, V79, P4815, DOI 10.1128/AEM.00856-13.
   Matuschek E, 2014, CLIN MICROBIOL INFEC, V20, pO255, DOI 10.1111/1469-0691.12373.
   Messens W, 2005, BRIT POULTRY SCI, V46, P694, DOI 10.1080/00071660500395582.
   Mevius D.J., 2009, MONITORING ANTIMICRO.
   Mezhoud H, 2016, AVIAN PATHOL, V45, P493, DOI 10.1080/03079457.2016.1167837.
   Michael GB, 2015, FUTURE MICROBIOL, V10, P427, DOI {[}10.2217/fmb.14.93, 10.2217/FMB.14.93].
   Musgrove MT, 2005, POULTRY SCI, V84, P1955, DOI 10.1093/ps/84.12.1955.
   Nilsson O, 2014, J ANTIMICROB CHEMOTH, V69, P1497, DOI 10.1093/jac/dku030.
   Pasquali F, 2015, VET MICROBIOL, V178, P230, DOI 10.1016/j.vetmic.2015.05.007.
   Petersen A, 2006, VET MICROBIOL, V116, P120, DOI 10.1016/j.vetmic.2006.03.015.
   Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005.
   Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0.
   Rathgeber BM, 2013, POULTRY SCI, V92, P2457, DOI 10.3382/ps.2013-03139.
   Reich F, 2013, EMERG INFECT DIS, V19, P1253, DOI 10.3201/eid1908.120879.
   Rodriguez I, 2009, J ANTIMICROB CHEMOTH, V64, P301, DOI 10.1093/jac/dkp195.
   Roschanski N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100956.
   Schaufler K, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv155.
   Schmiedel J, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-187.
   Schwaiger K, 2013, MICROB DRUG RESIST, V19, P498, DOI 10.1089/mdr.2012.0257.
   Smet A, 2008, ANTIMICROB AGENTS CH, V52, P1238, DOI 10.1128/AAC.01285-07.
   Valentin L, 2014, INT J MED MICROBIOL, V304, P805, DOI 10.1016/j.ijmm.2014.07.015.
   Valenza G, 2014, ANTIMICROB AGENTS CH, V58, P1228, DOI 10.1128/AAC.01993-13.
   Wellman-Labadie O, 2008, BRIT POULTRY SCI, V49, P133, DOI 10.1080/00071660802001722.
   Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x.
   Wu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075392.
   Zurfluh K, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00519.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{5}},
Journal-ISO = {{Appl. Environ. Microbiol.}},
Doc-Delivery-Number = {{EJ4RV}},
Unique-ID = {{ISI:000393205400009}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000393017100009,
Author = {Joubert, Lydia-Marie and Ferreira, Jose A. G. and Stevens, David A. and
   Nazik, Hasan and Cegelski, Lynette},
Title = {{Visualization of Aspergillus fumigatus biofilms with Scanning Electron
   Microscopy and Variable Pressure-Scanning Electron Microscopy: A
   comparison of processing techniques}},
Journal = {{JOURNAL OF MICROBIOLOGICAL METHODS}},
Year = {{2017}},
Volume = {{132}},
Pages = {{46-55}},
Month = {{JAN}},
Abstract = {{Aspergillus fumigatus biofilms consist of a three-dimensional network of
   cellular hyphae and extracellular matrix. They are involved in
   infections of immune-compromised individuals, particularly those with
   cystic fibrosis. These structures are associated with persistence of
   infection, resistance to host immunity, and antimicrobial resistance.
   Thorough understanding of structure and function is imperative in the
   design of therapeutic drugs. Optimization of processing parameters,
   including aldehyde fixation, heavy metal contrasting, drying techniques
   and Ionic Liquid treatment, was undertaken for an ultrastructural
   approach to understand cellular and extracellular biofilm components.
   Conventional and Variable Pressure Scanning Electron Microscopy were
   applied to analyze the structure of biofilms attached to plastic and
   formed at an air-liquid interface. (C) 2016 Elsevier B.V. All rights
   reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Joubert, LM (Reprint Author), Stanford Univ, Sch Med, Cell Sci Imaging Facil, Stanford, CA 94305 USA.
   Joubert, Lydia-Marie, Stanford Univ, Sch Med, Cell Sci Imaging Facil, Stanford, CA 94305 USA.
   Ferreira, Jose A. G.; Stevens, David A.; Nazik, Hasan, Stanford Univ, Div Infect Dis \& Geog Med, Stanford, CA 94305 USA.
   Ferreira, Jose A. G.; Stevens, David A.; Nazik, Hasan, Calif Inst Med Res, San Jose, CA 95128 USA.
   Cegelski, Lynette, Stanford Univ, Dept Chem, Stanford, CA 94305 USA.
   Ferreira, Jose A. G., Fac Saude \& Ecol Humana FASEH, Sch Med, Vespasiano, Brazil.
   Nazik, Hasan, Istanbul Univ, Dept Med Microbiol, Istanbul, Turkey.}},
DOI = {{10.1016/j.mimet.2016.11.002}},
ISSN = {{0167-7012}},
EISSN = {{1872-8359}},
Keywords = {{Aspergillus fumigatus; Biofilms; Scanning Electron Microscopy; Variable
   Pressure-SEM; Processing techniques}},
Keywords-Plus = {{STREPTOCOCCUS-MUTANS BIOFILM; EXTRACELLULAR-MATRIX; RUTHENIUM RED;
   MICROBIAL BIOFILMS; CYSTIC-FIBROSIS; LUNG-FUNCTION; FIXATIVES; CELLS;
   COLONIZATION; INFECTIONS}},
Research-Areas = {{Biochemistry \& Molecular Biology; Microbiology}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Microbiology}},
Author-Email = {{lydiaj@stanford.edu}},
Funding-Acknowledgement = {{Child Health Research Institute, Stanford Transdisciplinary Initiatives
   Program; Beckman Foundation; Technology Innovation mini-grant; Brazilian
   National Council for Scientific and Technological Development (CNPq);
   National Science Foundation CAREER Award {[}1453247]}},
Funding-Text = {{These studies were partially supported (D.A.S.) by a grant from the
   Child Health Research Institute, Stanford Transdisciplinary Initiatives
   Program, and a gift from John Flatley. L-M.J. was partially supported by
   the Beckman Foundation and a Technology Innovation mini-grant and J.A.F.
   by a grant from the Brazilian National Council for Scientific and
   Technological Development (CNPq). The material is based in part upon
   work supported (L.C.) by the National Science Foundation CAREER Award
   (1453247). Hitachi High Technologies is thanked for providing HILEM (TM)
   IL. Kent McDonald is gratefully acknowledged for fruitful discussions.}},
Cited-References = {{Alhede M, 2012, FEMS IMMUNOL MED MIC, V65, P335, DOI 10.1111/j.1574-695X.2012.00956.x.
   ANNIKO M, 1977, ARCH OTO-RHINO-LARYN, V218, P67, DOI 10.1007/BF00469735.
   Arimoto S, 2008, ELECTROCHIM ACTA, V53, P6228, DOI 10.1016/j.electacta.2008.01.001.
   Asahi Y, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0097-4.
   Beauvais A, 2007, CELL MICROBIOL, V9, P1588, DOI 10.1111/j.1462-5822.2007.00895.x.
   Beauvais A, 2014, MYCOPATHOLOGIA, V178, P371, DOI 10.1007/s11046-014-9766-0.
   Beauvais A, 2009, FEMS YEAST RES, V9, P411, DOI 10.1111/j.1567-1364.2009.00482.x.
   BONE Q, 1971, J CELL BIOL, V49, P571, DOI 10.1083/jcb.49.3.571.
   Bozzola JJ, 1999, ELECT MICROSCOPY PRI.
   BRAY DF, 1993, MICROSC RES TECHNIQ, V26, P489, DOI 10.1002/jemt.1070260603.
   Cegelski L, 2015, J MAGN RESON, V253, P91, DOI 10.1016/j.jmr.2015.01.014.
   Chotirmall SH, 2014, MYCOPATHOLOGIA, V178, P363, DOI 10.1007/s11046-014-9768-y.
   COETZEE J, 1984, J MICROSC-OXFORD, V135, P147, DOI 10.1111/j.1365-2818.1984.tb00515.x.
   COETZEE J, 1986, J MICROSC-OXFORD, V141, P111, DOI 10.1111/j.1365-2818.1986.tb02705.x.
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431.
   de Vrankrijker AMM, 2011, CLIN MICROBIOL INFEC, V17, P1381, DOI 10.1111/j.1469-0691.2010.03429.x.
   DIERICHS R, 1979, HISTOCHEMISTRY, V64, P171, DOI 10.1007/BF00490097.
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063.
   Ferreira JAG, 2009, ANTIMICROB AGENTS CH, V53, P4377, DOI 10.1128/AAC.00316-09.
   Ferreira JAG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134692.
   Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07.
   Flemming HC, 2016, NAT REV MICROBIOL, V14, P563, DOI 10.1038/nrmicro.2016.94.
   Fox Emily P, 2012, Transcription, V3, P315, DOI 10.4161/trns.22281.
   GAYLARDE P, 1968, SCIENCE, V161, P1157, DOI 10.1126/science.161.3846.1157.
   Hayat M. A., 2000, PRINCIPLES TECHNIQUE.
   Joubert L.-M., 2016, MICROSC MICROANAL, V22, P1170.
   Joubert L.-M., 2012, IMAGING MICROSC, P1.
   Joubert L-M., 2015, MICROSC MICROANAL, V21, P935, DOI DOI 10.1017/S1431927615005474.
   Joubert LM, 2009, MICROSC MICROANAL, V15, P1308, DOI 10.1017/S1431927609096263.
   Kaur S, 2014, MED MYCOL, V52, P2, DOI 10.3109/13693786.2013.819592.
   Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004.
   Lappin-Scott H, 2014, NAT REV MICROBIOL, V12, P781, DOI 10.1038/nrmicro3343.
   LUFT JH, 1971, ANAT REC, V171, P347, DOI 10.1002/ar.1091710302.
   Manavathu EK, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-53.
   Mowat E, 2007, J MED MICROBIOL, V56, P1205, DOI 10.1099/jmm.0.47247-0.
   Muller FMC, 2011, MED MYCOL, V49, pS96, DOI 10.3109/13693786.2010.502190.
   Nobile CJ, 2015, ANNU REV MICROBIOL, V69, P71, DOI 10.1146/annurev-micro-091014-104330.
   Polke M, 2015, ADV APPL MICROBIOL, V91, P139, DOI 10.1016/bs.aambs.2014.12.002.
   PORTER KR, 1953, EXP CELL RES, V4, P127, DOI 10.1016/0014-4827(53)90195-5.
   Priester JH, 2007, J MICROBIOL METH, V68, P577, DOI 10.1016/j.mimet.2006.10.018.
   Reichhardt C, 2016, FUTURE MED CHEM, V8, P1455, DOI 10.4155/fmc-2016-0049.
   Reichhardt C, 2015, EUKARYOT CELL, V14, P1064, DOI 10.1128/EC.00050-15.
   REIMANN B, 1961, Mikroskopie, V16, P224.
   Sakaue M., 2014, MICROSC MICROANAL, V20, P1012.
   Santos ALS, 2015, J ANTIMICROBIAL AGEN, V1, pe101, DOI DOI 10.4172/ANTIMICR0.1000E101.
   Speirs JJ, 2012, CURR OPIN PULM MED, V18, P632, DOI 10.1097/MCP.0b013e328358d50b.
   TRENT JS, 1983, MACROMOLECULES, V16, P589, DOI 10.1021/ma00238a021.
   Villena GK, 2010, BIORESOURCE TECHNOL, V101, P1920, DOI 10.1016/j.biortech.2009.10.036.
   Voelker D, 1996, BIOPHYS J, V70, P818, DOI 10.1016/S0006-3495(96)79621-2.
   Weber K, 2014, FEMS MICROBIOL LETT, V350, P175, DOI 10.1111/1574-6968.12334.
   Weimer PJ, 2006, APPL ENVIRON MICROB, V72, P7559, DOI 10.1128/AEM.01632-06.
   Wu Y, 2014, MICROSC MICROANAL, V20, P1348, DOI 10.1017/S143192761401277X.
   Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623.
   Yousif A, 2015, ADV EXP MED BIOL, V830, P157, DOI 10.1007/978-3-319-11038-7\_10.}},
Number-of-Cited-References = {{54}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{J. Microbiol. Methods}},
Doc-Delivery-Number = {{EJ2CI}},
Unique-ID = {{ISI:000393017100009}},
DA = {{2018-08-13}},
}

@article{ ISI:000392337000054,
Author = {Badea, Mihaela and Bucur, Cristina and Chifiriuc, Mariana Carmen and
   Bleotu, Coralia and Grecu, Maria-Nicoleta and Lazar, Veronica and
   Marinescu, Dana and Olar, Rodica},
Title = {{Insight on thermal behaviour of new complexes of Ni(II), Cu(II) and
   Zn(II) with a bismacrocyclic ligand developed as biologically active
   species}},
Journal = {{JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY}},
Year = {{2017}},
Volume = {{127}},
Number = {{1}},
Pages = {{487-497}},
Month = {{JAN}},
Abstract = {{A multi-component reaction involving metal ion, amines and formaldehyde
   has been used for a series of decaaza bismacrocyclic complexes
   M2L(CH3COO)(4)center dot nH(2)O {[}(1) M: Ni, n = 2.5; (2) M:Cu, n = 1;
   (3) M:Zn, n = 10;
   L:1,3-bis(N,N-1,3,6,9,12-pentaazacyclotridecane)-benzene] preparation.
   Elemental analyses, ESI-MS, IR, UV-Vis-NIR, NMR and EPR spectra,
   magnetic susceptibility at room temperature, molar conductivities, as
   well as thermogravimetric analysis, provided data concerning complexes
   features. The macrocyclic ligand behaves as bischelate, resulting in
   either a square planar or an octahedral stereochemistry. The in vitro
   screening of the antimicrobial activity was performed against both
   reference and clinical isolates multi-drug-resistant strains. The
   overall antimicrobial potency of complexes was enhanced in comparison
   with the free ligand, against both planktonic and biofilm-embedded
   pathogenic strains. Complexes exhibit no cytotoxicity on the HCT 8
   tumour cells. Thermogravimetric curves (TG, DTG and DTA) evidenced in
   air processes as water elimination, acetate into carbonate
   transformation as well as oxidative degradation of the bismacrocyclic
   ligand. The powder X-ray diffraction data indicate MO (M: Ni, Cu, Zn) as
   final product.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Olar, R (Reprint Author), Univ Bucharest, Dept Inorgan Chem, Fac Chem, 90-92 Panduri Str,Sect 5, Bucharest 050663, Romania.
   Badea, Mihaela; Bucur, Cristina; Marinescu, Dana; Olar, Rodica, Univ Bucharest, Dept Inorgan Chem, Fac Chem, 90-92 Panduri Str,Sect 5, Bucharest 050663, Romania.
   Bucur, Cristina, Inst Control Biol Prod \& Vet Med, 39 Dudului Str,Sect 6, Bucharest, Romania.
   Chifiriuc, Mariana Carmen; Lazar, Veronica, Univ Bucharest, Dept Microbiol, Fac Biol, 1-3 Aleea Portocalilor St, Bucharest, Romania.
   Chifiriuc, Mariana Carmen; Lazar, Veronica, Univ Bucharest, Res Inst, Spl Independentei 91-95, Bucharest, Romania.
   Bleotu, Coralia, Stefan S Nicolau Inst Virol, 285 Mihai Bravu Ave, Bucharest, Romania.
   Grecu, Maria-Nicoleta, Natl Inst Mat Phys, POB MG-7, Bucharest, Romania.}},
DOI = {{10.1007/s10973-016-5502-y}},
ISSN = {{1388-6150}},
EISSN = {{1588-2926}},
Keywords = {{Complexes; Bismacrocycle; One-pot condensation; Antimicrobial; Thermal
   behaviour}},
Keywords-Plus = {{NITROGEN-NITROGEN LINKERS; CXCR4 RECEPTOR ANTAGONISTS; COPPER(II)
   COMPLEXES; CATALYTIC-OXIDATION; METAL-COMPLEXES; COORDINATION;
   MACROCYCLES; REDUCTION; TETRAHYDROFURAN; TRANSITION}},
Research-Areas = {{Thermodynamics; Chemistry}},
Web-of-Science-Categories  = {{Thermodynamics; Chemistry, Analytical; Chemistry, Physical}},
Author-Email = {{rodica\_m\_olar@yahoo.com}},
ORCID-Numbers = {{Grecu, Maria Nicoleta/0000-0001-8725-6997}},
Cited-References = {{Bernhardt PV, 2005, CR CHIM, V8, P211, DOI 10.1016/j.crci.2004.10.024.
   Bucur C, 2014, J THERM ANAL CALORIM, V115, P2179, DOI 10.1007/s10973-013-3460-1.
   Bucur C, 2013, J THERM ANAL CALORIM, V113, P1287, DOI 10.1007/s10973-012-2912-3.
   Bucur C, 2012, J THERM ANAL CALORIM, V110, P235, DOI 10.1007/s10973-012-2199-4.
   Chartres JD, 2001, COORDIN CHEM REV, V216, P249, DOI 10.1016/S0010-8545(01)00313-7.
   COLLIN JP, 1988, INORG CHEM, V27, P1986, DOI 10.1021/ic00284a030.
   Dametto PR, 2014, J THERM ANAL CALORIM, V115, P161, DOI 10.1007/s10973-013-3276-z.
   de Alwis C, 2000, ELECTROCHIM ACTA, V45, P2061, DOI 10.1016/S0013-4686(99)00427-2.
   De Clercq E, 2002, BBA-MOL BASIS DIS, V1587, P258, DOI 10.1016/S0925-4439(02)00089-3.
   DE CLERCQ E, 1994, ANTIMICROB AGENTS CH, V38, P668, DOI 10.1128/AAC.38.4.668.
   DEACON GB, 1980, COORDIN CHEM REV, V33, P227, DOI 10.1016/S0010-8545(00)80455-5.
   Drewry JA, 2011, COORDIN CHEM REV, V255, P459, DOI 10.1016/j.ccr.2010.10.018.
   Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110.
   GEARY WJ, 1971, COORDIN CHEM REV, V7, P81, DOI 10.1016/S0010-8545(00)80009-0.
   Gerlach LO, 2003, BIOCHEMISTRY-US, V42, P710, DOI 10.1021/bi0264770.
   HATHAWAY BJ, 1970, COORDIN CHEM REV, V5, P143, DOI 10.1016/S0010-8545(00)80135-6.
   Hunter TM, 2007, CHEM-EUR J, V13, P40, DOI 10.1002/chem.200601334.
   Kaden TA, 1999, COORDIN CHEM REV, V190, P371, DOI 10.1016/S0010-8545(99)00095-8.
   Khan A, 2009, J AM CHEM SOC, V131, P3416, DOI 10.1021/ja807921k.
   Kharadi GJ, 2014, J THERM ANAL CALORIM, V117, P333, DOI 10.1007/s10973-014-3720-8.
   McRobbie G, 2007, DALTON T, P5008, DOI 10.1039/b705800d.
   Mewis RE, 2010, COORDIN CHEM REV, V254, P1686, DOI 10.1016/j.ccr.2010.02.025.
   Mochizuki K, 1996, INORG CHEM, V35, P5132, DOI 10.1021/ic960208e.
   Nakamoto K, 2009, INFRARED RAMAN SPE B.
   Olar R, 2011, J THERM ANAL CALORIM, V105, P571, DOI 10.1007/s10973-010-1226-6.
   Rastogi A, 2009, J COORD CHEM, V62, P3366, DOI 10.1080/00958970903062046.
   Ribas Gispert J, 2008, COORDINATION CHEM.
   Ross A, 2010, INORG CHEM, V49, P1122, DOI 10.1021/ic9020614.
   Salavati-Niasari M, 2006, INORG CHEM COMMUN, V9, P332, DOI 10.1016/j.inoche.2005.12.011.
   Salavati-Niasari M, 2005, J MOL CATAL A-CHEM, V235, P114, DOI 10.1016/j.molcata.2005.03.016.
   Salavati-Niasari M, 2007, J INCL PHENOM MACRO, V59, P223, DOI 10.1007/s10847-007-9316-1.
   Salavati-Niasari M, 2007, J MOL CATAL A-CHEM, V272, P207, DOI 10.1016/j.molcan.2007.03.053.
   Schols D, 1997, ANTIVIR RES, V35, P147, DOI 10.1016/S0166-3542(97)00025-9.
   Singh K, 2012, EUR J MED CHEM, V52, P313, DOI 10.1016/j.ejmech.2012.02.053.
   Solomon E. I., 2006, INORGANIC ELECT STRU.
   Valks GC, 2006, J MED CHEM, V49, P6162, DOI 10.1021/jm0607810.
   Yousef TA, 2012, J MOL STRUCT, V1029, P149, DOI 10.1016/j.molstruc.2012.06.050.
   Zelenak V, 2005, J THERM ANAL CALORIM, V82, P747, DOI 10.1007/s10973-005-0959-0.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{J. Therm. Anal. Calorim.}},
Doc-Delivery-Number = {{EI2RZ}},
Unique-ID = {{ISI:000392337000054}},
DA = {{2018-08-13}},
}

@article{ ISI:000392205300008,
Author = {Kentache, Takfarinas and Ben Abdelkrim, Ahmed and Jouenne, Thierry and
   De, Emmanuelle and Hardouin, Julie},
Title = {{Global Dynamic Proteome Study of a Pellicle-forming Acinetobacter
   baumannii Strain}},
Journal = {{MOLECULAR \& CELLULAR PROTEOMICS}},
Year = {{2017}},
Volume = {{16}},
Number = {{1}},
Pages = {{100-112}},
Month = {{JAN}},
Abstract = {{For several decades, many bacteria, among which A. baumannii, have shown
   their ability to colonize the upper surface of static liquids, forming a
   biofilm at the air-liquid interface named pellicle. Despite the ubiquity
   of these pellicles in both natural and artificial environments, few
   studies have investigated this biofilm type. The present data set
   provides the first description of the whole proteome of A. baumannii
   cells grown as pellicle, using a label-free mass spectrometry approach.
   Results are in accord with the general findings reporting that sessile
   bacteria are far more resistant to detrimental conditions than their
   planktonic counterparts, by the accumulation of stress proteins. The
   present investigation also confirmed previous studies suggesting a
   correlation between the pellicle forming ability and the bacterial
   virulence. Indeed, we showed the up-regulation of numerous virulence
   factors during the pellicle growth, e.g. phospholipases, adhesion
   factors, as well as those of the GacAS Two-Component System (TCS) and
   Type 6 Secretion System (T6SS). We also highlighted that Bam and Tam
   systems, both related to the OM insertion machinery, play a critical
   role during pellicle biogenesis. Moreover, sessile bacteria activate
   several pathways, e.g. iron, magnesium, phosphate pathways, which allows
   for increasing the panel of nutrient sources.}},
Publisher = {{AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC}},
Address = {{9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hardouin, J (Reprint Author), Univ Rouen, UMR CNRS 6270, Lab Polymeres, Biopolymeres,Surfaces, F-76821 Mont St Aignan, France.
   Kentache, Takfarinas; Ben Abdelkrim, Ahmed; Jouenne, Thierry; De, Emmanuelle; Hardouin, Julie, CNRS, UMR Polymeres 6270, Biopolymeres, Surfaces Lab, F-76821 Mont St Aignan, France.
   Kentache, Takfarinas; Ben Abdelkrim, Ahmed; Jouenne, Thierry; De, Emmanuelle; Hardouin, Julie, Normandie Univ, UR, Caen, France.
   Jouenne, Thierry; De, Emmanuelle; Hardouin, Julie, IRIB, PISSARO Prote Facil, F-76821 Mont St Aignan, France.}},
DOI = {{10.1074/mcp.M116.061044}},
ISSN = {{1535-9476}},
EISSN = {{1535-9484}},
Keywords-Plus = {{PSEUDOMONAS-AERUGINOSA BIOFILMS; IRON ACQUISITION FUNCTIONS; BACTERIAL
   OUTER MEMBRANES; ACID CATABOLIC PATHWAY; VI SECRETION; ESCHERICHIA-COLI;
   ANTIBIOTIC-RESISTANCE; MICROBIAL BIOFILMS; LYSINE ACETYLATION;
   REGULATORY SYSTEM}},
Research-Areas = {{Biochemistry \& Molecular Biology}},
Web-of-Science-Categories  = {{Biochemical Research Methods}},
Author-Email = {{julie.hardouin@univ-rouen.fr}},
ORCID-Numbers = {{jouenne, thierry/0000-0003-0994-9944}},
Funding-Acknowledgement = {{Region Haute-Normandie; IRIB institute}},
Funding-Text = {{T.K. thanks the Region Haute-Normandie for and the IRIB institute for
   the PhD financial support.}},
Cited-References = {{Amini S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000432.
   Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674.
   Antunes LCS, 2011, RES MICROBIOL, V162, P279, DOI 10.1016/j.resmic.2010.10.010.
   Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI {[}10.1128/JB.186.15.5062-5077.2004, 10.1128/jb.186.15.5062-5077.2004].
   Armitano J, 2014, ENV MICROBIOL REP, V6, P534, DOI 10.1111/1758-2229.12171.
   Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102.
   BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148.
   Bernier SP, 2011, RES MICROBIOL, V162, P680, DOI 10.1016/j.resmic.2011.04.014.
   Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651.
   Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269.
   Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011.
   Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006.
   Cabral MP, 2011, J PROTEOME RES, V10, P3399, DOI 10.1021/pr101299j.
   CARPENTIER B, 1993, J APPL BACTERIOL, V75, P499, DOI 10.1111/j.1365-2672.1993.tb01587.x.
   Carruthers MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059388.
   Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2.
   Catel-Ferreira M, 2012, ANTIMICROB AGENTS CH, V56, P3826, DOI 10.1128/AAC.06022-11.
   Cerqueira GM, 2014, J INFECT DIS, V210, P46, DOI 10.1093/infdis/jiu024.
   Chabane YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111660.
   Chang KC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-815.
   Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09.
   Clemmer KM, 2011, MICROBIOL-SGM, V157, P2534, DOI 10.1099/mic.0.049791-0.
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431.
   Dallo S. F., 2010, ETHN DIS S1, V20.
   Danhorn T, 2004, J BACTERIOL, V186, P4492, DOI 10.1128/JB.186.14.4492-4501.2004.
   Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718.
   Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000.
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295.
   De Gregorio E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2136-6.
   De Kievit TR, 2001, APPL ENVIRON MICROB, V67, P1865, DOI 10.1128/AEM.67.4.1865-1873.2001.
   Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789.
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063.
   Downer R, 2002, J BIOL CHEM, V277, P243, DOI 10.1074/jbc.M107621200.
   Eijkelkamp BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-126.
   Fernandez C, 2014, ENV MICROBIOL REP, V6, P239, DOI 10.1111/1758-2229.12117.
   Fernandez FJ, 2004, J BIOL CHEM, V279, P21478, DOI 10.1074/jbc.M400291200.
   Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0.
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415.
   Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094.
   Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11.
   Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09.
   Gaddy JA, 2009, FUTURE MICROBIOL, V4, P273, DOI 10.2217/FMB.09.5.
   Gayoso CM, 2014, J PROTEOME RES, V13, P460, DOI 10.1021/pr400603f.
   Geisinger E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004691.
   Gentile V, 2014, PATHOGENS, V3, P704, DOI 10.3390/pathogens3030704.
   Giles SK, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0440-6.
   Goh S.-N., 2013, J BIOL LIFE SCI, V4.
   GOLDSTEIN R, 1995, J BACTERIOL, V177, P1039, DOI 10.1128/jb.177.4.1039-1052.1995.
   Greene C, 2016, AM J INFECT CONTROL, V44, pE65, DOI 10.1016/j.ajic.2015.12.012.
   Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x.
   Hamlin JNR, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-222.
   Hasan Tank, 2015, Genomics \& Informatics, V13, P2, DOI 10.5808/GI.2015.13.1.2.
   Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7.
   Heilmann C, 2003, MICROBIOL-SGM, V149, P2769, DOI 10.1099/mic.0.26527-0.
   Heilmann C, 2005, INFECT IMMUN, V73, P4793, DOI 10.1128/IAI.73..8.4793-4802.2005.
   Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09.
   Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08.
   Kapatral V, 2004, MICROBIOL-SGM, V150, P2289, DOI 10.1099/mic.0.26814-0.
   King T, 2010, APPL ENVIRON MICROB, V76, P6514, DOI 10.1128/AEM.02392-09.
   Koza A, 2009, MICROBIOL-SGM, V155, P1397, DOI 10.1099/mic.0.025064-0.
   Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x.
   Li H, 2012, INT J MED MICROBIOL, V302, P63, DOI 10.1016/j.ijmm.2011.10.001.
   Liu FY, 2014, MOL CELL PROTEOMICS, V13, P3352, DOI 10.1074/mcp.M114.041962.
   Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07.
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2.
   MARCUS H, 1989, INFECT IMMUN, V57, P1050.
   Marti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026030.
   Marti Sara, 2011, BMC Res Notes, V4, P5, DOI 10.1186/1756-0500-4-5.
   Mihara K, 2004, MICROBIOL-SGM, V150, P2587, DOI 10.1099/mic.0.27141-0.
   Miller RM, 2008, J BACTERIOL, V190, P4038, DOI 10.1128/JB.00129-08.
   Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243.
   Modarresi F, 2015, APMIS, V123, P959, DOI 10.1111/apm.12455.
   Modarresi F, 2015, VIRULENCE, V6, P152, DOI 10.1080/21505594.2014.1003001.
   Monds RD, 2001, MOL MICROBIOL, V42, P415, DOI 10.1046/j.1365-2958.2001.02641.x.
   Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001.
   Mussi MA, 2005, ANTIMICROB AGENTS CH, V49, P1432, DOI 10.1128/AAC.49.4.1432-1440.2005.
   Mussi MA, 2007, FEBS LETT, V581, P5573, DOI 10.1016/j.febslet.2007.10.063.
   NESTER EW, 1976, J BACTERIOL, V126, P699.
   Niu C, 2008, J BACTERIOL, V190, P3386, DOI 10.1128/JB.01929-07.
   Nwugo CC, 2011, J PROTEOMICS, V74, P44, DOI 10.1016/j.jprot.2010.07.010.
   O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x.
   Obry P. C., 2014, ANN RHEUM DIS, V72, pA834.
   Ofori-Darko E, 2000, INFECT IMMUN, V68, P3657, DOI 10.1128/IAI.68.6.3657-3666.2000.
   Olivera ER, 1998, P NATL ACAD SCI USA, V95, P6419, DOI 10.1073/pnas.95.11.6419.
   Ouidir T, 2016, PROTEOMICS, V16, P301, DOI 10.1002/pmic.201500258.
   Ouidir T, 2015, J PROTEOMICS, V114, P214, DOI 10.1016/j.jprot.2014.11.006.
   Palaniyandi S, 2013, VET MICROBIOL, V166, P567, DOI 10.1016/j.vetmic.2013.07.009.
   Park AJ, 2014, MOL CELL PROTEOMICS, V13, P1095, DOI 10.1074/mcp.M113.033985.
   Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07.
   Pimenta AD, 2003, MICROBES INFECT, V5, P1177, DOI 10.1016/j.micinf.2003.09.002.
   Rao RS, 2008, INDIAN J MED MICROBI, V26, P333.
   Repizo GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138265.
   Rhodes ER, 2007, BIOMETALS, V20, P365, DOI 10.1007/s10534-006-9058-3.
   Rodriguez-Bano J, 2008, CLIN MICROBIOL INFEC, V14, P276, DOI 10.1111/j.1469-0691.2007.01916.x.
   Ruiz FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129691.
   Rumbo-Feal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072968.
   Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002.
   Selkrig J, 2014, BBA-MOL CELL RES, V1843, P1542, DOI 10.1016/j.bbamcr.2013.10.009.
   Selkrig J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/nsmb.2261.
   Sengstock DM, 2010, CLIN INFECT DIS, V50, P1611, DOI 10.1086/652759.
   Shin JH, 2009, J MICROBIOL, V47, P728, DOI 10.1007/s12275-009-0158-y.
   Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619.
   Simoni SF, 2000, ENVIRON SCI TECHNOL, V34, P1011, DOI 10.1021/es990476m.
   Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307.
   Soares NC, 2010, J PROTEOME RES, V9, P1951, DOI 10.1021/pr901116r.
   Song B, 2006, MICROBIOL RES, V161, P355, DOI 10.1016/j.micres.2006.01.004.
   Stahl J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138360.
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1.
   Sutton KA, 2016, ACTA CRYSTALLOGR F, V72, P179, DOI 10.1107/S2053230X16001114.
   Tian YL, 2015, MOL PLANT PATHOL, V16, P38, DOI 10.1111/mpp.12159.
   Tien HC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-95.
   Tomaras AP, 2008, MICROBIOL-SGM, V154, P3398, DOI 10.1099/mic.0.2008/019471-0.
   Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0.
   Umland TC, 2012, MBIO, V3, DOI 10.1128/mBio.00113-12.
   Uppu DSSM, 2016, BIOMACROMOLECULES, V17, P862, DOI 10.1021/acs.biomac.5b01567.
   Vallenet D, 2013, NUCLEIC ACIDS RES, V41, pE636, DOI 10.1093/nar/gks1194.
   van den Berg B, 2010, CHEMBIOCHEM, V11, P1339, DOI 10.1002/cbic.201000105.
   Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973.
   Wang HB, 2015, ACS APPL MATER INTER, V7, P13007, DOI 10.1021/acsami.5b03041.
   Weber BS, 2015, P NATL ACAD SCI USA, V112, P9442, DOI 10.1073/pnas.1502966112.
   Weber BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055142.
   Yoon EJ, 2015, MBIO, V6, DOI 10.1128/mBio.00309-15.
   Zhang L, 2011, J BACTERIOL, V193, P5510, DOI 10.1128/JB.00268-11.
   Zimbler D, 2009, BIOMETALS, V22, P23, DOI 10.1007/s10534-008-9202-3.}},
Number-of-Cited-References = {{124}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{Mol. Cell. Proteomics}},
Doc-Delivery-Number = {{EI0ZU}},
Unique-ID = {{ISI:000392205300008}},
OA = {{green\_published}},
DA = {{2018-08-13}},
}

@article{ ISI:000390732300062,
Author = {Gao, Min and Jia, Ruizhi and Qiu, Tianlei and Han, Meilin and Wang,
   Xuming},
Title = {{Size-related bacterial diversity and tetracycline resistance gene
   abundance in the air of concentrated poultry feeding operations}},
Journal = {{ENVIRONMENTAL POLLUTION}},
Year = {{2017}},
Volume = {{220}},
Number = {{B}},
Pages = {{1342-1348}},
Month = {{JAN}},
Abstract = {{Concentrated animal-feeding operations (CAFOs) are considered a source
   of airborne human pathogens and antibiotic resistance genes. Although
   bacterial abundance and diversity have been well studied, limited
   information on the size distribution of bioaerosols has prevented a
   clear understanding of the health effects of exposure to bioaerosols
   from CAFOs. Here, different sizes of particles were sampled from the
   inside and outside of atmospheric environments of layer and broiler
   feeding operations using 8-stage Andersen samplers. The quantitative
   real-time polymerase chain reaction (qPCR) and 16S rDNA-based sequencing
   were used to analyze the characteristics of biological abundance and
   diversity, respectively, according to size. The results indicated that
   size-related differences occurred in terms of airborne bacterial
   richness, diversity, and concentration at poultry-feeding operations.
   The richness of biological genera in the urban atmospheric environment
   was lower than in concentrated poultry-feeding operations. The
   biological diversity of airborne bacterial genera, including genera
   associated with potential pathogens, varied according to size. The
   bacterial lineages of bioaerosols present in the 7 size stages for
   layers clustered apart from those for broilers, suggesting that the type
   of poultry house is a more important factor than the particle size in
   shaping the microbial communities. In most cases, the concentrations of
   the 16S rDNA, Escherichia coli, tetW, and tetL genes increased as the
   particle size increased, with the geometric mean diameters varying from
   4.7 to 5.8 mu m. These results regarding the size-related differences in
   the diversity and abundance of bioaerosols will facilitate a better
   understanding of the potential health impact on both poultry and humans
   working in such environments. (C) 2016 Elsevier Ltd. All rights
   reserved.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wang, XM (Reprint Author), Beijing Acad Agr \& Forestry Sci, Beijing Agrobiotechnol Res Ctr, 9 Shuguang Middle Rd, Beijing 100097, Peoples R China.
   Gao, Min; Jia, Ruizhi; Qiu, Tianlei; Han, Meilin; Wang, Xuming, Beijing Acad Agr \& Forestry Sci, Beijing Key Lab Agr Genet Resources \& Biotechnol, Beijing Agrobiotechnol Res Ctr, Beijing 100097, Peoples R China.}},
DOI = {{10.1016/j.envpol.2016.10.101}},
ISSN = {{0269-7491}},
EISSN = {{1873-6424}},
Keywords = {{Size distribution; Tetracycline resistance gene; Biological diversity;
   Airborne bacteria; Poultry operation}},
Keywords-Plus = {{SWINE CONFINEMENT BUILDINGS; CULTURE-INDEPENDENT CHARACTERIZATION;
   ANTIBIOTIC-RESISTANCE; RIBOSOMAL-RNA; BIOAEROSOLS; FARMS;
   MICROORGANISMS; DISTRIBUTIONS; CONTAMINANTS; POLLUTANTS}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{wangxuming@baafs.net.cn}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}51308047]; Beijing Nova
   Program {[}Z151100000315058]; Beijing Agriculture Innovation Consortium
   {[}BAIC04-2016]; Special Program for Creative Ability of Beijing Academy
   of Agriculture and Forestry Sciences {[}KJCX 2014302, 20151204]}},
Funding-Text = {{The authors are grateful to the National Natural Science Foundation of
   China (Grant No. 51308047), the Beijing Nova Program (Grant No.
   Z151100000315058), the Beijing Agriculture Innovation Consortium (Grant
   No. BAIC04-2016), and the Special Program for Creative Ability of
   Beijing Academy of Agriculture and Forestry Sciences (Grant No. KJCX
   2014302, 20151204).}},
Cited-References = {{Aminov RI, 2001, APPL ENVIRON MICROB, V67, P22, DOI 10.1128/AEM.67.1.22-32.2001.
   Brooks JP, 2010, SCI TOTAL ENVIRON, V408, P4770, DOI 10.1016/j.scitotenv.2010.06.038.
   Cao C, 2014, ENVIRON SCI TECHNOL, V48, P1499, DOI 10.1021/es4048472.
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303.
   CORMIER Y, 1990, AM IND HYG ASSOC J, V51, P304, DOI 10.1202/0002-8894(1990)051<0304:AMCITT>2.0.CO;2.
   Dungan RS, 2010, J ANIM SCI, V88, P3693, DOI 10.2527/jas.2010-3094.
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI {[}10.1038/nmeth.2604, 10.1038/NMETH.2604].
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381.
   Fang ZG, 2008, AEROSOL SCI TECH, V42, P325, DOI 10.1080/02786820802068657.
   {[}高敏 Gao Min], 2015, {[}农业环境科学学报, Journal of Agro-Environment Science], V34, P787.
   Herron S. L., 2015, Journal of Environmental Protection, V6, P1257, DOI 10.4236/jep.2015.611110.
   Hinds W. C., 1999, AEROSOL TECHNOLOGY P, P72.
   Hong PY, 2012, ENVIRON MICROBIOL, V14, P1420, DOI 10.1111/j.1462-2920.2012.02726.x.
   Jiang WX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134142.
   Just N, 2013, CAN J MICROBIOL, V59, P46, DOI 10.1139/cjm-2012-0305.
   Just N, 2011, ENVIRON RES, V111, P492, DOI 10.1016/j.envres.2011.01.009.
   Kawanaka Y, 2009, ENVIRON SCI TECHNOL, V43, P6851, DOI 10.1021/es900033u.
   Ko G, 2008, ENVIRON SCI TECHNOL, V42, P8849, DOI 10.1021/es801091t.
   Lecours PB, 2012, APPL ENVIRON MICROB, V78, P3242, DOI 10.1128/AEM.07661-11.
   Letourneau V, 2010, INT J HYG ENVIR HEAL, V213, P444, DOI 10.1016/j.ijheh.2010.09.008.
   Leung MHY, 2014, APPL ENVIRON MICROB, V80, P6760, DOI 10.1128/AEM.02244-14.
   Lin WH, 1996, AEROSOL SCI TECH, V25, P93, DOI 10.1080/02786829608965382.
   Malinen E, 2003, MICROBIOL-SGM, V149, P269, DOI 10.1099/mic.0.25975-0.
   McEachran AD, 2015, ENVIRON HEALTH PERSP, V123, P337, DOI 10.1289/ehp.1408555.
   Meklin T, 2002, ATMOS ENVIRON, V36, P6031, DOI 10.1016/S1352-2310(02)00769-0.
   MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695.
   Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x.
   Nehme B, 2009, APPL ENVIRON MICROB, V75, P5445, DOI 10.1128/AEM.00726-09.
   Nonnenmann MW, 2010, J OCCUP ENVIRON HYG, V7, P693, DOI 10.1080/15459624.2010.526893.
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219.
   Skora J, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020192.
   Wang FH, 2014, ENVIRON POLLUT, V184, P247, DOI 10.1016/j.envpol.2013.08.038.
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07.
   WHYTE RT, 1993, WORLD POULTRY SCI J, V49, P139, DOI 10.1079/WPS19930012.
   Yamamoto N, 2012, ISME J, V6, P1801, DOI 10.1038/ismej.2012.30.
   Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{8}},
Usage-Count-Last-180-days = {{17}},
Usage-Count-Since-2013 = {{54}},
Journal-ISO = {{Environ. Pollut.}},
Doc-Delivery-Number = {{EG0OO}},
Unique-ID = {{ISI:000390732300062}},
DA = {{2018-08-13}},
}

@article{ ISI:000389864700040,
Author = {Tatem, Andrew J. and Jia, Peng and Ordanovich, Dariya and Falkner,
   Michael and Huang, Zhuojie and Howes, Rosalind and Hay, Simon I. and
   Gething, Peter W. and Smith, David L.},
Title = {{The geography of imported malaria to non-endemic countries: a
   meta-analysis of nationally reported statistics}},
Journal = {{LANCET INFECTIOUS DISEASES}},
Year = {{2017}},
Volume = {{17}},
Number = {{1}},
Pages = {{98-107}},
Month = {{JAN}},
Abstract = {{Background Malaria remains a problem for many countries classified as
   malaria free through cases imported from endemic regions. Imported cases
   to non-endemic countries often result in delays in diagnosis, are
   expensive to treat, and can sometimes cause secondary local
   transmission. The movement of malaria in endemic countries has also
   contributed to the spread of drug resistance and threatens long-term
   eradication goals. Here we focused on quantifying the international
   movements of malaria to improve our understanding of these phenomena and
   facilitate the design of mitigation strategies.
   Methods In this meta-analysis, we studied the database of publicly
   available nationally reported statistics on imported malaria in the past
   10 years, covering more than 50 000 individual cases. We obtained data
   from 40 non-endemic countries and recorded the geographical variations.
   Findings Infection movements were strongly skewed towards a small number
   of high-traffic routes between 2005 and 2015, with the west Africa
   region accounting for 56\% (13 947/24 941) of all imported cases to
   non-endemic countries with a reported travel destination, and France and
   the UK receiving the highest number of cases, with more than 4000
   reported cases per year on average. Countries strongly linked by
   movements of imported cases are grouped by historical, language, and
   travel ties. There is strong spatial clustering of plasmodium species
   types.
   Interpretation The architecture of the air network, historical ties,
   demographics of travellers, and malaria endemicity contribute to highly
   heterogeneous patterns of numbers, routes, and species compositions of
   parasites transported. With global malaria eradication on the
   international agenda, malaria control altering local transmission, and
   the threat of drug resistance, understanding these patterns and their
   drivers is increasing in importance. Copyright (C) The Author(s).
   Published by Elsevier Ltd. This is an Open Access article under the CC
   BY license.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Tatem, AJ (Reprint Author), Univ Southampton, Dept Geog \& Environm, Southampton SO17 1BJ, Hants, England.
   Tatem, Andrew J.; Ordanovich, Dariya, Univ Southampton, Dept Geog \& Environm, Southampton SO17 1BJ, Hants, England.
   Tatem, Andrew J., Flowminder Fdn, Stockholm, Sweden.
   Jia, Peng, Univ Twente, Fac Geoinformat Sci \& Earth Observat ITC, Enschede, Netherlands.
   Falkner, Michael, Univ Florida, Dept Geog, Gainesville, FL 32611 USA.
   Huang, Zhuojie, Chinese Ctr Dis Control \& Prevent, Div Infect Dis, Key Lab Surveillance \& Early Warning Infect Dis, Beijing, Peoples R China.
   Howes, Rosalind, Univ Oxford, Dept Zool, Spatial Ecol \& Epidemiol Grp, Oxford, England.
   Howes, Rosalind, Case Western Reserve Univ, Ctr Global Hlth \& Dis, Cleveland, OH 44106 USA.
   Hay, Simon I.; Smith, David L., Univ Washington, Inst Hlth Metr \& Evaluat, Seattle, WA 98195 USA.
   Hay, Simon I.; Gething, Peter W., Univ Oxford, Li Ka Shing Ctr Hlth Informat \& Discovery, Oxford Big Data Inst, Oxford, England.}},
DOI = {{10.1016/S1473-3099(16)30326-7}},
ISSN = {{1473-3099}},
EISSN = {{1474-4457}},
Keywords-Plus = {{AIR-TRAVEL; GEOSENTINEL SURVEILLANCE; PLASMODIUM-FALCIPARUM; RETURNED
   TRAVELERS; UNITED-KINGDOM; VIVAX MALARIA; RISK-FACTORS; DISEASE;
   INFECTION; EUROPE}},
Research-Areas = {{Infectious Diseases}},
Web-of-Science-Categories  = {{Infectious Diseases}},
Author-Email = {{a.j.tatem@soton.ac.uk}},
ResearcherID-Numbers = {{Jia, Peng/K-1446-2017
   Hay, Simon/F-8967-2015
   }},
ORCID-Numbers = {{Jia, Peng/0000-0003-0110-3637
   Hay, Simon/0000-0002-0611-7272
   Smith, David/0000-0003-4367-3849
   Gething, Peter/0000-0001-6759-5449}},
Funding-Acknowledgement = {{Bill \& Melinda Gates Foundation; National Institutes of Health; UK
   Medical Research Council; UK Department for International Development;
   Wellcome Trust; Medical Research Council {[}MR/K00669X/1]}},
Funding-Text = {{Bill \& Melinda Gates Foundation, National Institutes of Health, UK
   Medical Research Council, UK Department for International Development,
   Wellcome Trust.}},
Cited-References = {{Abel GJ, 2014, SCIENCE, V343, P1520, DOI 10.1126/science.1248676.
   Andriopoulos P, 2013, INT J INFECT DIS, V17, pE125, DOI 10.1016/j.ijid.2012.09.009.
   Askling HH, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-328.
   Behrens RH, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-461.
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535.
   Broderick C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1703.
   Checkley AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2116.
   Cibulskis RE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001142.
   Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111.
   Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122.
   Collins WE, 2005, CLIN MICROBIOL REV, V18, P570, DOI 10.1128/CMR.18.3.570-581.2005.
   Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331.
   Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814.
   Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378.
   Hanscheid T, 2003, CLIN MICROBIOL INFEC, V9, P497, DOI 10.1046/j.1469-0691.2003.00640.x.
   Huang ZJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-269.
   Huang ZJ, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-33.
   Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616.
   Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893.
   Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005.
   Li ZJ, 2015, EMERG INFECT DIS, V21, P864, DOI {[}10.3201/eid2105.141712, 10.3201/2105.141712].
   Mao L, 2015, J TRANSP GEOGR, V48, P52, DOI 10.1016/j.jtrangeo.2015.08.017.
   Muentener P, 1999, B WORLD HEALTH ORGAN, V77, P560.
   Musa IR, 2014, TRAVEL MED INFECT DI, V12, P733, DOI 10.1016/j.tmaid.2014.04.006.
   Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026113.
   Pavli A, 2010, TRAVEL MED INFECT DI, V8, P161, DOI 10.1016/j.tmaid.2010.01.003.
   Reiner RC, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0849-2.
   SCHELLENBERG JRMA, 1994, PARASITOL TODAY, V10, P439, DOI 10.1016/0169-4758(94)90179-1.
   Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X.
   Smith DL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0145.
   Stager K, 2009, EMERG INFECT DIS.
   Svihrova V, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-1.
   Talisuna A, 2012, LANCET INFECT DIS, V12, P888, DOI 10.1016/S1473-3099(12)70241-4.
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352.
   Tatem AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-133.
   Tusting LS, 2013, LANCET, V382, P963, DOI 10.1016/S0140-6736(13)60851-X.
   van Genderen PJJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-179.
   Warne B, 2014, J TRAVEL MED, V21, P248, DOI 10.1111/jtm.12120.
   WHO, 2015, GLOB TECHN STRAT MAL.
   Wieten RW, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-360.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{22}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{38}},
Journal-ISO = {{Lancet Infect. Dis.}},
Doc-Delivery-Number = {{EE8GW}},
Unique-ID = {{ISI:000389864700040}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000393108700003,
Author = {Bamaiyi, Pwaveno Huladeino and Izreen, Mohd Sani Nani and Mohamad,
   Khatijah and Eizzati, Badrul Hisham Nur and Siti-Bainum, Che Rostman and
   Farhana, Mat Kamir Norsyamimi and Norfaizull, Mohd Nor Mohd and
   Kadkhodaei, Saeid and Khan, Goriman Khan Mohd Azam},
Title = {{Isolation and polymerase chain reaction identification of bacteria from
   the 2014-2015 flood of Kota Bharu, Kelantan, Malaysia}},
Journal = {{ASIAN BIOMEDICINE}},
Year = {{2016}},
Volume = {{10}},
Number = {{6}},
Pages = {{549-565}},
Month = {{DEC}},
Abstract = {{Background: The transmission of waterborne, foodborne, and airborne
   infections following flooding is common around the world. There is a
   need to study and understand the bacterial biodiversity of flood water
   during massive floods.
   Objectives: To determine the 16S rRNA bacterial biodiversity of flood
   water that affected parts of Kota Bharu, Kelantan, Malaysia from
   December 2014 to January 2015.
   Methods: We collected 31 water samples in 50 mL sterile containers from
   6 different locations. Bacteria were cultured by inoculating into blood
   and nutrient agar using sterile swabs. Various bacteria were identified
   from the cultures that grew within 24-48 h, using colony morphology,
   differential/selective media, and biochemical tests. The isolated
   bacteria were identified using DNA Sanger sequencing and comparing with
   sequences at NCBI BLAST and SepsiTest BLAST up to species level, and
   sequences were deposited at GenBank. A 16S rRNA biodiversity chart was
   obtained. Sequences with low trace score (<20) were removed, sequences
   were trimmed, capped (pair-wise assembled) and the 16S biodiversity was
   analyzed using a 16S biodiversity tool (Geneious version R8.1).
   Results: The 16S biodiversity tool results revealed 22 genera of
   bacteria belonging to 12 families: Moraxellaceae (10\%), Aeromonadaceae
   (8\%), Comamonadaceae (13\%), Neisseriaceae (2\%), Bacillaceae 1 (16\%),
   Staphylococcaceae (8\%), Bacillales Incertae Sedis XII (3\%),
   Bacillaceae 2 (3\%), Streptococcaceae (2\%), Flavobacteriaceae (2\%),
   Enterobacteriaceae (25\%), and Pseudomonadaceae (10\%). Antibiotic
   susceptibility tests revealed Klebsiella pneumoniae of the family
   Enterobacteriaceae as the most resistant (71.4\%) to all 7 antibiotics
   tested.
   Conclusions: The isolation of some relatively new species of bacteria in
   the floodwater in Malaysia needs to be taken into consideration for
   epidemiological study of flood pathogens to determine future public
   health implications. Antibiotic resistance of bacteria should support
   choice of therapy.}},
Publisher = {{WALTER DE GRUYTER GMBH}},
Address = {{GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Bamaiyi, PH (Reprint Author), Univ Malaysia Kelantan, Fac Vet Med, Kota Baharu 16100, Kelantan, Malaysia.
   Bamaiyi, PH (Reprint Author), Kampala Int Univ, Sch Allied Hlth Sci, Dept Publ Hlth, Kampala, Uganda.
   Bamaiyi, Pwaveno Huladeino; Izreen, Mohd Sani Nani; Mohamad, Khatijah; Eizzati, Badrul Hisham Nur; Siti-Bainum, Che Rostman; Farhana, Mat Kamir Norsyamimi; Norfaizull, Mohd Nor Mohd; Khan, Goriman Khan Mohd Azam, Univ Malaysia Kelantan, Fac Vet Med, Kota Baharu 16100, Kelantan, Malaysia.
   Kadkhodaei, Saeid, Univ Putra Malaysia, Dept Agr Technol, Serdang 43400, Malaysia.
   Bamaiyi, Pwaveno Huladeino, Kampala Int Univ, Sch Allied Hlth Sci, Dept Publ Hlth, Kampala, Uganda.}},
DOI = {{10.5372/1905-7415.1006.525}},
ISSN = {{1905-7415}},
EISSN = {{1875-855X}},
Keywords = {{Bacteria; biodiversity; flood; isolation; Malaysia; PCR; 16S rRNA}},
Keywords-Plus = {{KLEBSIELLA-PNEUMONIAE CARBAPENEMASES; RIBOSOMAL-RNA SEQUENCES; SP-NOV.;
   ANTIBIOTIC-RESISTANCE; WASTE-WATER; SOIL; EXIGUOBACTERIUM; THAILAND;
   EVENTS; TOOLS}},
Research-Areas = {{Research \& Experimental Medicine}},
Web-of-Science-Categories  = {{Medicine, Research \& Experimental}},
Author-Email = {{pwaveno.hb@umk.edu.my}},
ResearcherID-Numbers = {{Kadkhodaei, Saeid/F-7868-2010}},
ORCID-Numbers = {{Kadkhodaei, Saeid/0000-0002-5528-0738}},
Funding-Acknowledgement = {{Faculty of Veterinary Medicine Universiti Malaysia Kelantan}},
Funding-Text = {{The authors wish to thank the Faculty of Veterinary Medicine Universiti
   Malaysia Kelantan for providing emergency funds for this study.}},
Cited-References = {{Apisarnthanarak A, 2012, INT J INFECT DIS, V16, pE409, DOI 10.1016/j.ijid.2012.01.013.
   Baharuddin KA, 2015, MALAYS J MED SCI, V22, P1.
   Balkhair KS, 2016, SAUDI J BIOL SCI, V23, pS83, DOI 10.1016/j.sjbs.2015.10.029.
   Basri Z, 2015, ISFRAM 2014 SE 16, P185, DOI {[}10.1007/978-981-287-365-1\_16, DOI 10.1007/978-981-287-365-1\_16].
   Benedict KM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-216.
   Bernama, 2014, THE MALAY MAIL.
   Brown MG, 2009, MICROB ECOL, V57, P484, DOI 10.1007/s00248-008-9431-6.
   Cann KF, 2013, EPIDEMIOL INFECT, V141, P671, DOI 10.1017/S0950268812001653.
   Chaturongkasumrit Y, 2013, SCI TOTAL ENVIRON, V463, P959, DOI 10.1016/j.scitotenv.2013.06.071.
   Cohen J, 1988, STAT POWER ANAL BEHA.
   Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244.
   Coutinho FH, 2014, MICROB ECOL, V68, P441, DOI 10.1007/s00248-014-0422-5.
   Ding LX, 2004, INT J SYST EVOL MICR, V54, P2223, DOI 10.1099/ijs.0.02975-0.
   Estrada-de los Santos P, 2012, SYST APPL MICROBIOL, V35, P310, DOI 10.1016/j.syapm.2012.05.005.
   Golebiewski M, 2014, MICROB ECOL, V67, P635, DOI 10.1007/s00248-013-0344-7.
   Hakim LS., 2015, CPRC STRATEGY SUPPOR.
   HAMMOUDA O, 1995, ECOTOX ENVIRON SAFE, V31, P205, DOI 10.1006/eesa.1995.1064.
   Hirsch EB, 2010, J ANTIMICROB CHEMOTH, V65, P1119, DOI 10.1093/jac/dkq108.
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199.
   Ko KS, 2006, INT J SYST EVOL MICR, V56, P2541, DOI 10.1099/ijs.0.64213-0.
   Lau C, 2010, TRAVEL MED INFECT DI, V8, P33, DOI 10.1016/j.tmaid.2009.12.002.
   Logan NA, 2004, INT J SYST EVOL MICR, V54, P373, DOI 10.1099/ijs.0.02661-0.
   Lopez-Cortes A, 2006, SYST APPL MICROBIOL, V29, P183, DOI 10.1016/j.syapm.2005.09.007.
   Mhuantong W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128043.
   Muirhead RW, 2004, WATER RES, V38, P1215, DOI 10.1016/j.watres.2003.12.010.
   Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7.
   Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385.
   Raichand R, 2012, INT J SYST EVOL MICR, V62, P2150, DOI 10.1099/ijs.0.035790-0.
   Sauer Pavel, 2005, Biomedical Papers (Olomouc), V149, P285.
   Scholz HC, 2005, FEMS MICROBIOL LETT, V244, P347, DOI 10.1016/j.femsle.02.005.
   Shrivastava P, 2015, SAUDI J BIOL SCI, V22, P123, DOI 10.1016/j.sjbs.2014.12.001.
   Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129.
   ten Veldhuis JAE, 2010, WATER RES, V44, P2910, DOI 10.1016/j.watres.2010.02.009.
   Reguero MT, 2013, ENFERM INFEC MICR CL, V31, P142, DOI 10.1016/j.eimc.2012.07.013.
   Trouillet JL, 1998, AM J RESP CRIT CARE, V157, P531, DOI 10.1164/ajrccm.157.2.9705064.
   Tvrzova L, 2006, INT J SYST EVOL MICR, V56, P2657, DOI 10.1099/ijs.0.63988-0.
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07.
   Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{Asian Biomed.}},
Doc-Delivery-Number = {{EJ3JP}},
Unique-ID = {{ISI:000393108700003}},
DA = {{2018-08-13}},
}

@article{ ISI:000391146000018,
Author = {Castillo, Keshia F. and Bello-Vieda, Nestor J. and Nunez-Dallos, Nelson
   G. and Pastrana, Homero F. and Celis, Adriana M. and Restrepo, Silvia
   and Hurtado, John J. and Avila, Alba G.},
Title = {{Metal Complex Derivatives of Azole: a Study on Their Synthesis,
   Characterization, and Antibacterial and Antifungal Activities}},
Journal = {{JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY}},
Year = {{2016}},
Volume = {{27}},
Number = {{12}},
Pages = {{2334-2347}},
Month = {{DEC}},
Abstract = {{Four new zinc complex derivatives of azoles and ligands were synthesized
   and isolated as white air-stable solids and characterized by elemental
   analyses, thermogravimetric analysis (TGA), infrared spectroscopy,
   nuclear magnetic resonance (NMR) and mass spectra. The elemental
   analysis, theoretical calculations and NMR show that the complexes
   likely have a 1: 1 (M: L) stoichiometry and tetrahedral geometry. To
   evaluate the biological activity of the complexes and to discuss the
   role of metal ions and structural properties, the ligands and their
   metal complexes have been studied. Their antimicrobial activity was
   determined in vitro by agar-well diffusion and broth microdilution
   against nine bacterial strains and seven fungal strains with clinical
   relevance. In vitro assays showed that the complexes exhibited moderate
   antibacterial and/or antifungal activities. The antimicrobial activity
   was found to be more active for the metal complexes than the ligands.
   The metal complexes that contained copper and cobalt, respectively,
   displayed notable antibacterial and antifungal effects against all the
   tested bacterial strains. The minimum inhibitory concentration 50
   (MIC50) values were in the range 2454-0.7 mu g mL(-1). Metal complexes
   were more effective at inhibiting bacteria than fungi. The results could
   provide a high-potential solution for antimicrobial growth resistance,
   for both bacteria and fungi.}},
Publisher = {{SOC BRASILEIRA QUIMICA}},
Address = {{CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hurtado, JJ (Reprint Author), Univ Los Andes, Dept Quim, Grp Invest Quim Inorgan Catalisis \& Bioinorgan, Bogota, DC, Colombia.
   Castillo, Keshia F.; Celis, Adriana M.; Restrepo, Silvia, Univ Los Andes, Dept Ciencias Biol, Lab Micol \& Fitopatol, Bogota, DC, Colombia.
   Bello-Vieda, Nestor J.; Nunez-Dallos, Nelson G.; Hurtado, John J., Univ Los Andes, Dept Quim, Grp Invest Quim Inorgan Catalisis \& Bioinorgan, Bogota, DC, Colombia.
   Pastrana, Homero F., Univ Los Andes, Ctr Microelect, Dept Ingn Elect \& Elect, Bogota, DC, Colombia.}},
DOI = {{10.5935/0103-5053.20160130}},
ISSN = {{0103-5053}},
EISSN = {{1678-4790}},
Keywords = {{zinc; copper; cobalt; azole ligands; antibacterial activity; antifungal
   activity}},
Keywords-Plus = {{COBALT(II) COMPLEXES; SCHIFF-BASES; ZN(II); CU(II); RESISTANCE;
   INDUCTION; CHEMISTRY; DISCOVERY; MEMBRANES; PYRAZOLE}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Multidisciplinary}},
Author-Email = {{jj.hurtado@uniandes.edu.co}},
ORCID-Numbers = {{Hurtado, John/0000-0002-0511-9719
   Bello, Nestor/0000-0001-8336-0893
   Nunez-Dallos, Nelson/0000-0003-4437-3928}},
Funding-Acknowledgement = {{Universidad de los Andes; Vicerrectoria de Investigaciones Universidad
   de los Andes; Colciencias Beca Francisco Jose de Caldas {[}547]}},
Funding-Text = {{The authors express their thanks to the Universidad de los Andes for
   financial support from the Interfaculty project, and J. H. acknowledges
   the FAPA and Semilla projects at the Faculty of Sciences. Thanks to
   Vicerrectoria de Investigaciones Universidad de los Andes and
   Colciencias Beca Francisco Jose de Caldas 547 for providing financial
   support to the PhD candidate Fernando Pastrana.}},
Cited-References = {{Abd El-Halim HF, 2011, SPECTROCHIM ACTA A, V78, P36, DOI 10.1016/j.saa.2010.06.003.
   Alcazar-Fuoli L, 2014, BRIT J HAEMATOL, V166, P471, DOI 10.1111/bjh.12896.
   Allouche AR, 2011, J COMPUT CHEM, V32, P174, DOI 10.1002/jcc.21600.
   Amich J, 2010, EUKARYOT CELL, V9, P424, DOI 10.1128/EC.00348-09.
   An CX, 2008, TRANSIT METAL CHEM, V33, P835, DOI 10.1007/s11243-008-9119-2.
   Baker MV, 2004, J ORG CHEM, V69, P7640, DOI 10.1021/jo049097o.
   Banfi E, 2006, J ANTIMICROB CHEMOTH, V58, P76, DOI 10.1093/jac/dkl182.
   Maia JDC, 2012, J CHEM THEORY COMPUT, V8, P3072, DOI 10.1021/ct3004645.
   Clinical and Laboratory Standards Institute (CLSI), 2004, M44A2 CLSI NCCLS.
   Clinical and Laboratory Standards Institute (CLSI), 2012, M07A9 CLSI NCCLS.
   Clinical and Laboratory Standards Institute (CLSI), 2010, M51A CLSI NCCLS.
   Clinical and Laboratory Standards Institute (CLSI), 2002, M38A CLSI NCCLS.
   Clinical and Laboratory Standards Institute (CLSI), 2012, M02A11 CLSI NCCLS.
   Denyer SP, 2002, J APPL MICROBIOL, V92, p35S, DOI 10.1046/j.1365-2672.92.5s1.19.x.
   Dharmaraj N, 2001, TRANSIT METAL CHEM, V26, P105, DOI 10.1023/A:1007132408648.
   Fang B, 2010, EUR J MED CHEM, V45, P4388, DOI 10.1016/j.ejmech.2010.06.012.
   Ghannoum MA, 2002, EUR J MED RES, V7, P242.
   HEIPIEPER HJ, 1994, APPL ENVIRON MICROB, V60, P4440.
   Hurtado J, 2009, J ORGANOMET CHEM, V694, P2636, DOI 10.1016/j.jorganchem.2009.04.014.
   Jeeva J., 2013, RES J PHARM SCI, V2, P1.
   JULIA S, 1982, J HETEROCYCLIC CHEM, V19, P1141, DOI 10.1002/jhet.5570190531.
   Kaim W., 2013, BIOINORGANIC CHEM IN.
   LOBBIA GG, 1988, SYN REACT INORG MET, V18, P551, DOI 10.1080/00945718808060811.
   Luo GL, 2006, J ORG CHEM, V71, P5392, DOI 10.1021/jo060607j.
   MacDiarmid CW, 2003, J BIOL CHEM, V278, P15065, DOI 10.1074/jbc.M300568200.
   MESUBI MA, 1991, TRANSIT METAL CHEM, V16, P348.
   MISHRA L, 1993, INDIAN J CHEM A, V32, P446.
   Munoz P, 2015, MYCOSES, V58, P1, DOI 10.1111/myc.12332.
   {[}NCCLS Laboratory Standarts Institute (CLSI)], 2002, M27A2 CLSI NCCLS.
   Pahontu E, 2013, MOLECULES, V18, P8812, DOI 10.3390/molecules18088812.
   Patel P, 2010, INT J CHEM TECH RES, V2, P1147.
   Pore VS, 2012, MEDCHEMCOMM, V3, P484, DOI 10.1039/c2md00205a.
   REEDIJK J, 1979, TRANSIT METAL CHEM, V4, P239.
   Sheng CQ, 2011, CURR MED CHEM, V18, P733, DOI 10.2174/092986711794480113.
   Sheng CQ, 2006, J MED CHEM, V49, P2512, DOI 10.1021/jm051211n.
   SIKKEMA J, 1994, J BIOL CHEM, V269, P8022.
   Silverstein RM, 2014, SPECTROMETRIC IDENTI.
   Singh K, 2012, EUR J MED CHEM, V52, P313, DOI 10.1016/j.ejmech.2012.02.053.
   Singh NK, 2003, INDIAN J CHEM A, V42, P2767.
   Socrates G., 2004, INFRARED RAMAN CHARA.
   Stewart J.J.P., 2012, MOPAC2012.
   Sudhir M. S., 2013, DRUG INVENTION TODAY, V5, P126.
   Sundaraganesan N, 2009, SPECTROCHIM ACTA A, V74, P788, DOI 10.1016/j.saa.2009.08.019.
   Szecsenyi KM, 2001, J THERM ANAL CALORIM, V66, P573.
   Tanwar J., 2014, INTERDISCIP PERSPECT, V2014, P1.
   THIMMAIAH KN, 1985, INORG CHIM A-BIOINOR, V107, P1, DOI 10.1016/S0020-1693(00)80680-5.
   Thomas M, 2012, INT J CHEMTECH RES, V4, P257.
   Tu T, 2008, ANGEW CHEM INT EDIT, V47, P7127, DOI 10.1002/anie.200801628.
   Wang WY, 2011, MEDCHEMCOMM, V2, P1066, DOI 10.1039/c1md00103e.
   Wang X, 2004, CARBOHYD POLYM, V56, P21, DOI 10.1016/j.carbpol.2003.11.007.
   Wang XL, 2010, EUR J MED CHEM, V45, P4631, DOI 10.1016/j.ejmech.2010.07.031.
   Wang Y, 2012, BIOORG MED CHEM LETT, V22, P5363, DOI 10.1016/j.bmcl.2012.07.064.
   Woolhouse M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0083.
   Yousef TA, 2014, SPECTROCHIM ACTA A, V129, P163, DOI 10.1016/j.saa.2014.02.184.
   Yu R., 2014, MED CHEM, V4, P640.
   Zelenak V, 2002, Met Based Drugs, V8, P269, DOI 10.1155/MBD.2002.269.
   Zhang SS, 2008, EUR J PHARMACOL, V584, P144, DOI 10.1016/j.ejphar.2008.01.041.
   Zhang YY, 2011, EUR J MED CHEM, V46, P4391, DOI 10.1016/j.ejmech.2011.07.010.}},
Number-of-Cited-References = {{58}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{6}},
Journal-ISO = {{J. Braz. Chem. Soc.}},
Doc-Delivery-Number = {{EG6HR}},
Unique-ID = {{ISI:000391146000018}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000388910800009,
Author = {Mason, Paul H. and Sweetland, Annika C. and Fox, Greg J. and Halovic,
   Shaun and Thu Anh Nguyen and Marks, Guy B.},
Title = {{Tuberculosis and mental health in the Asia-Pacific}},
Journal = {{AUSTRALASIAN PSYCHIATRY}},
Year = {{2016}},
Volume = {{24}},
Number = {{6}},
Pages = {{553-555}},
Month = {{DEC}},
Abstract = {{Objective: This opinion piece encourages mental health researchers and
   clinicians to engage with mental health issues among tuberculosis
   patients in the Asia-Pacific region in a culturally appropriate and
   ethical manner. The diversity of cultural contexts and the high burden
   of tuberculosis throughout the Asia-Pacific presents significant
   challenges. Research into tuberculosis and mental illness in this region
   is an opportunity to develop more nuanced models of mental illness and
   treatment, while simultaneously contributing meaningfully to regional
   tuberculosis care and prevention.
   Conclusions: We overview key issues in tuberculosis and mental illness
   co-morbidity, highlight ethical concerns and advocate for a regional
   approach to tuberculosis and mental health that is consistent with the
   transnational challenges presented by this airborne infectious disease.
   Integrating tuberculosis and mental health services will go a long way
   to addressing the needs of vulnerable populations and stopping the
   transmission of one of the world's biggest infectious killers.}},
Publisher = {{SAGE PUBLICATIONS LTD}},
Address = {{1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mason, PH (Reprint Author), Univ Sydney, Woolcock Inst Med Res, 431 Glebe Point Rd, Glebe, NSW 2037, Australia.
   Mason, Paul H., Univ Sydney, Ctr Values Eth \& Law Med, Sydney, NSW, Australia.
   Mason, Paul H.; Fox, Greg J.; Marks, Guy B., Woolcock Inst Med Res, Glebe, NSW, Australia.
   Mason, Paul H., Macquarie Univ, Dept Anthropol, Sydney, NSW, Australia.
   Sweetland, Annika C., Columbia Univ Coll Phys \& Surg, Dept Psychiat, 722 W 168th St, New York, NY 10032 USA.
   Fox, Greg J., Univ Sydney, Cent Clin Sch, Med, Sydney, NSW, Australia.
   Halovic, Shaun, Westmead Psychotherapy Program, Westmead, NSW, Australia.
   Halovic, Shaun, Univ Sydney, Sydney, NSW, Australia.
   Thu Anh Nguyen, Woolcock Inst Med Res, Hanoi, Vietnam.
   Marks, Guy B., Univ Sydney, Cent Clin Sch, Fac Med, Sydney, NSW, Australia.
   Marks, Guy B., Univ New South Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia.}},
DOI = {{10.1177/1039856216649770}},
ISSN = {{1039-8562}},
EISSN = {{1440-1665}},
Keywords = {{tuberculosis; mental illness; mental health; depression; psychosis;
   Asia-Pacific}},
Keywords-Plus = {{DRUG-RESISTANT TUBERCULOSIS; PSYCHODYNAMIC PSYCHOTHERAPY; DEPRESSION;
   METAANALYSIS; EFFICACY; CULTURE; ANXIETY}},
Research-Areas = {{Psychiatry}},
Web-of-Science-Categories  = {{Psychiatry}},
Author-Email = {{paul.mason@woolcock.org.au}},
ORCID-Numbers = {{Mason, Paul/0000-0002-5488-1056
   Nguyen, Thu Anh/0000-0002-2089-2902}},
Funding-Acknowledgement = {{Australian NHMRC Center of Research Excellence in Tuberculosis Control;
   US Global Mental Health Research Fellowship {[}NIMH T32 MH096724]}},
Funding-Text = {{The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: Support was
   received from the Australian NHMRC Center of Research Excellence in
   Tuberculosis Control and the US Global Mental Health Research
   Fellowship. NIMH T32 MH096724.}},
Cited-References = {{Acha J, 2007, INT J RES POLICY PRA, V2, P404.
   Alarcon RD, 2009, WORLD PSYCHIATRY, V8, P131.
   Ambrose CT, 2014, J MED BIOGR, V22, P35, DOI 10.1177/0967772013479756.
   Aydin IO, 2001, GEN HOSP PSYCHIAT, V23, P77.
   Becker A, 2013, CALIF SER PUB ANTHR, V26, P212.
   Demissie M, 2003, SOC SCI MED, V56, P2009, DOI 10.1016/S0277-9536(02)00182-X.
   Doherty AM, 2013, GEN HOSP PSYCHIAT, V35, P398, DOI 10.1016/j.genhosppsych.2013.03.018.
   Hall J., 2001, J MENTAL HLTH POLICY, V4, P3.
   Harper I, 2014, DEV PUBLIC HLTH HIMA.
   Hollon SD, 2015, EPIDEMIOL PSYCHIAT S.
   Hwang TJ, 2013, INT J TUBERC LUNG D, V17, P1257, DOI 10.5588/ijtld.12.0863.
   Janmeja AK, 2005, RESPIRATION, V72, P375, DOI 10.1159/000086251.
   Kessler RC, 2012, PSYCHIAT CLIN N AM, V35, P1, DOI 10.1016/j.psc.2011.11.005.
   Kisely SR, 1999, AUST NZ J PSYCHIAT, V33, P207, DOI 10.1046/j.1440-1614.1999.00548.x.
   Leichsenring F, 2004, ARCH GEN PSYCHIAT, V61, P1208, DOI 10.1001/archpsyc.61.12.1208.
   Lumb R, 2011, COMMUN DIS INTELL, V35, P154.
   Majumdar SS, 2014, MED J AUSTRALIA, V200, P241, DOI 10.5694/mja13.00239.
   Pachi A, 2013, TUBERC RES TREAT, V2013, DOI {[}DOI 10.1155/2013/489865, 10.1155/2013/489865].
   Pratt JE, 1906, BOSTON MED SURG J, V154, P210, DOI 10.1056/NEJM190602221540803.
   Schwartzman K, 2005, NEW ENGL J MED, V353, P1008, DOI 10.1056/NEJMsa043194.
   Shedler J, 2010, AM PSYCHOL, V65, P98, DOI 10.1037/a0018378.
   Sweetland A, 2014, WORLD PSYCHIATRY, V13, P325, DOI 10.1002/wps.20134.
   Sweetland AC, 2014, DEPRESS ANXIETY, V31, P223, DOI 10.1002/da.22142.
   Sweetland J., 2002, WORLD MENTAL HLTH CA, P51.
   Timimi S., 2012, ETHNICITY INEQUALITI, V4, P154.
   Toms C, 2015, COMM DIS INTELL, V39, P217.
   Wainberg ML, 2007, AIDS BEHAV, V11, P872, DOI 10.1007/s10461-006-9181-8.
   Watters E., 2010, CRAZY UGLOBALIZATI.
   Whitaker R., 2010, ANATOMY EPIDEMIC.
   WHO, 2010, MHGAP INT GUID MENT.
   World Health Organization, 2014, GLOB TUB REP.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{Australas. Psychiatry}},
Doc-Delivery-Number = {{ED5RU}},
Unique-ID = {{ISI:000388910800009}},
OA = {{green\_accepted}},
DA = {{2018-08-13}},
}

@article{ ISI:000388580200067,
Author = {Pandey, Pramod K. and Cao, Wenlong and Wang, Yi and Vaddella, Venkata
   and Castillo, Alejandro R. and Souza, Alex and del Rio, Noelia Silva},
Title = {{Simulating the effects of mesophilic anaerobic and aerobic digestions,
   lagoon system, and composting on pathogen inactivation}},
Journal = {{ECOLOGICAL ENGINEERING}},
Year = {{2016}},
Volume = {{97}},
Pages = {{633-641}},
Month = {{DEC}},
Abstract = {{To improve understanding of pathogen inactivation in flushed dairy
   manure during anaerobic digestion, lagoon systems, and mesophilic
   composting, we assessed pathogen inactivation in batch-scale anaerobic
   digesters, aerobic lagoons, and manure piles. Further, we assessed the
   impact of air injection in lagoon systems on pathogen inactivation. The
   inactivation of Salmonella and E. coli was studied for more than 70
   days. The change in pH, total solids, total carbon, and total nitrogen
   during manure treatment was determined. The results showed that the
   lagoon system with air injection to be more effective in pathogen
   removal compared to the lagoon system with no air injection, anaerobic
   digestion, and mesophilic composting. Both types of lagoon systems (with
   and without air injection) were found to be more effective in
   eliminating pathogens than anaerobic digester systems. Mesophilic manure
   pile extended the survival of both Salmonella and E. coli. In the
   anaerobic system, E. coli was detected beyond 60 days of incubation,
   while in the aerobic system; it was eliminated in 30-35 days. In
   anaerobic system, Salmonella reached to non-detectable level in 30-35
   days, while in aerobic system it took 4-12 days. In the mesophilic
   manure pile, however, E. coli survival was extended beyond 78 days. Less
   than one log reduction was obtained in 78 days of mesophilic composting.
   Salmonella survival was also extended in mesophilic composting pile. (C)
   2016 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Pandey, PK (Reprint Author), Univ Calif Davis, 1089 Vet Med Dr, Davis, CA 95616 USA.
   Pandey, Pramod K.; Cao, Wenlong; Wang, Yi; Vaddella, Venkata, Univ Calif Davis, Sch Vet Med, Dept Populat Hlth \& Reprod, Davis, CA 95616 USA.
   Pandey, Pramod K., Univ Calif Cooperat Extens, Div Agr \& Nat Resources, Davis, CA 95616 USA.
   Pandey, Pramod K.; Cao, Wenlong; Wang, Yi, Univ Calif Davis, Dept Biol \& Agr Engn, Davis, CA 95616 USA.
   Pandey, Pramod K., Univ Calif Davis, Dept Land Air \& Water Resources, Davis, CA 95616 USA.
   Castillo, Alejandro R., Univ Calif Cooperat Extens, Merced, CA 95341 USA.
   Souza, Alex; del Rio, Noelia Silva, Univ Calif Cooperat Extens, Vet Med Teaching \& Res Ctr, Tulare, CA 93274 USA.}},
DOI = {{10.1016/j.ecoleng.2016.10.047}},
ISSN = {{0925-8574}},
EISSN = {{1872-6992}},
Keywords = {{Animal waste; Anaerobic digestion; Lagoon system; Composting; Pathogens}},
Keywords-Plus = {{ESCHERICHIA-COLI STRAINS; VOLATILE FATTY-ACIDS; DAIRY MANURE; SWINE
   MANURE; ANTIBIOTIC-RESISTANT; METHANE PRODUCTION; PIG MANURE;
   MICROORGANISMS; PERSISTENCE; SURVIVAL}},
Research-Areas = {{Environmental Sciences \& Ecology; Engineering}},
Web-of-Science-Categories  = {{Ecology; Engineering, Environmental; Environmental Sciences}},
Author-Email = {{pkpandey@ucdavis.edu}},
Funding-Acknowledgement = {{Division of Agriculture and Natural Resources (ANR); School of
   Veterinary Medicine Extension, University of California, Davis}},
Funding-Text = {{The authors thank to Division of Agriculture and Natural Resources (ANR)
   and School of Veterinary Medicine Extension, University of California,
   Davis for supporting this work.}},
Cited-References = {{ABDUL P, 1985, APPL MICROBIOL BIOT, V22, P373, DOI 10.1007/BF00582423.
   APHA American Public Health Association, 1998, STANDARD METHODS EXA.
   Arikan OA, 2015, WASTE MANAGE, V43, P108, DOI 10.1016/j.wasman.2015.06.005.
   Armstrong SD, 2010, J ENVIRON QUAL, V39, P345, DOI 10.2134/jeq2009.0234.
   Belle AJ, 2015, BIORESOURCE TECHNOL, V178, P230, DOI 10.1016/j.biortech.2014.09.036.
   Cole K.J., 2015, BACTERIAL COUNTS COM.
   El-Mashad HM, 2011, T ASABE, V54, P599.
   Erickson M. C., 2014, AGR FOOD ANAL BACTER, V4, P96.
   Erickson MC, 2014, J FOOD PROTECT, V77, P1911, DOI 10.4315/0362-028X.JFP-14-194.
   ERICKSON MC, 2004, FOOD PROT, V67, P685.
   Faverial J, 2014, J CLEAN PROD, V83, P238, DOI 10.1016/j.jclepro.2014.07.068.
   Grewal SK, 2006, APPL ENVIRON MICROB, V72, P565, DOI 10.1128/AEM.72.1.565-574.2006.
   Heinonen-Tanski H, 2006, LIVEST SCI, V102, P248, DOI 10.1016/j.livsci.2006.03.024.
   Jiang JS, 2015, WASTE MANAGE, V39, P78, DOI 10.1016/j.wasman.2015.02.025.
   Koivunen J, 2005, WATER RES, V39, P1519, DOI 10.1016/j.watres.2005.01.021.
   Lovanh N, 2009, BIORESOURCE TECHNOL, V100, P3706, DOI 10.1016/j.biortech.2008.09.024.
   Lukicheva I, 2012, WATER ENVIRON RES, V84, P17, DOI 10.2175/106143011X13184214855975.
   MATEU A, 1992, APPL MICROBIOL BIOT, V38, P291.
   McLaughlin MR, 2009, J ENVIRON QUAL, V38, P2422, DOI 10.2134/jeq2008.0468.
   MEZRIOUI N, 1994, WATER RES, V28, P2399, DOI 10.1016/0043-1354(94)90056-6.
   Page LH, 2015, J ENVIRON MANAGE, V152, P91, DOI 10.1016/j.jenvman.2015.01.024.
   Pandey PK, 2016, J CLEAN PROD, V139, P407, DOI 10.1016/j.jclepro.2016.08.034.
   Pandey PK, 2016, J CLEAN PROD, V133, P1252, DOI 10.1016/j.jclepro.2016.05.114.
   Pandey PK, 2015, BIOPROC BIOSYST ENG, V38, P457, DOI 10.1007/s00449-014-1285-3.
   Ravva SV, 2006, J APPL MICROBIOL, V101, P891, DOI 10.1111/j.1365-2672.2006.02956.x.
   Ravva SV, 2014, INT J ENV RES PUB HE, V11, P11249, DOI 10.3390/ijerph111111249.
   Resende JA, 2014, BIORESOURCE TECHNOL, V153, P284, DOI 10.1016/j.biortech.2013.12.007.
   Rumburg B, 2004, ATMOS ENVIRON, V38, P1523, DOI 10.1016/j.atmosenv.2003.11.036.
   Saady NMC, 2015, BIORESOURCE TECHNOL, V182, P50, DOI 10.1016/j.biortech.2015.01.065.
   Toth JD, 2013, J DAIRY SCI, V96, P5756, DOI 10.3168/jds.2012-6499.
   Turner C, 2002, BIORESOURCE TECHNOL, V84, P57, DOI 10.1016/S0960-8524(02)00069-X.
   United States Environmental Protection Agency (USEPA), 2015, AN WAST.
   United States Food and Drug Administration (USFDA), 2014, CTR FOOD SAF APPL NU.
   Vanotti MB, 2005, BIORESOURCE TECHNOL, V96, P209, DOI {[}10.1016/j.biortech.2004.05.010, 10.1016/j.biotech.2004.05.010].
   Viancelli A, 2013, CHEMOSPHERE, V90, P1539, DOI 10.1016/j.chemosphere.2012.08.055.
   Witarsa F, 2015, ECOL ENG, V78, P95, DOI 10.1016/j.ecoleng.2014.05.031.
   Zhou C, 2015, WASTE MANAGE, V40, P38, DOI 10.1016/j.wasman.2015.03.016.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{8}},
Usage-Count-Since-2013 = {{47}},
Journal-ISO = {{Ecol. Eng.}},
Doc-Delivery-Number = {{ED1CA}},
Unique-ID = {{ISI:000388580200067}},
DA = {{2018-08-13}},
}

@article{ ISI:000387808200004,
Author = {Fouquier, J. and Schwartz, T. and Kelley, S. T.},
Title = {{Rapid assemblage of diverse environmental fungal communities on public
   restroom floors}},
Journal = {{INDOOR AIR}},
Year = {{2016}},
Volume = {{26}},
Number = {{6}},
Pages = {{869-879}},
Month = {{DEC}},
Abstract = {{An increasing proportion of humanity lives in urban environments where
   they spend most of their lives indoors. Recent molecular studies have
   shown that bacterial assemblages in built environments (BEs) are
   extremely diverse, but BE fungal diversity remains poorly understood. We
   applied culture-independent methods based on next-generation sequencing
   (NGS) of the fungal internal transcribed spacer to investigate the
   diversity and temporal dynamics of fungi in restrooms. Swab samples were
   collected weekly from three different surfaces in two public restrooms
   (male and female) in San Diego, CA, USA, over an 8-week period. DNA
   amplification and culturing methods both found that the floor samples
   had significantly higher fungal loads than other surfaces. NGS
   sequencing of floor fungal assemblages identified a total of 2550 unique
   phylotypes (similar to 800 per sample), less than half of which were
   identifiable. Of the known fungi, the majority came from environmental
   sources and we found little evidence of known human skin fungi. Fungal
   assemblages reformed rapidly in a highly consistent manner, and the
   variance in the species diversity among samples was low. Overall, our
   study contributes to a better understanding of public restroom floor
   fungal communities.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kelley, ST (Reprint Author), San Diego State Univ, Dept Biol, 5500 Campanile Dr, San Diego, CA 92182 USA.
   Fouquier, J.; Kelley, S. T., San Diego State Univ, Grad Program Bioinformat \& Med Informat, San Diego, CA 92182 USA.
   Schwartz, T.; Kelley, S. T., San Diego State Univ, Dept Biol, 5500 Campanile Dr, San Diego, CA 92182 USA.}},
DOI = {{10.1111/ina.12279}},
ISSN = {{0905-6947}},
EISSN = {{1600-0668}},
Keywords = {{Built environment; Indoor microbial ecology; Fungal diversity; ITS-1;
   Culture-independent methods; Next-generation sequencing}},
Keywords-Plus = {{SICK BUILDING SYNDROME; RIBOSOMAL-RNA GENE; ANTIBIOTIC-RESISTANCE;
   INDOOR ENVIRONMENT; DAMAGED BUILDINGS; IDENTIFICATION; WATER; MICROBES;
   AIR; PREVALENCE}},
Research-Areas = {{Construction \& Building Technology; Engineering; Public, Environmental
   \& Occupational Health}},
Web-of-Science-Categories  = {{Construction \& Building Technology; Engineering, Environmental; Public,
   Environmental \& Occupational Health}},
Author-Email = {{skelley@mail.sdsu.edu}},
ORCID-Numbers = {{Kelley, Scott/0000-0001-9547-4169}},
Funding-Acknowledgement = {{Alfred P. Sloan Foundation's Microbiology of the Built Environment
   program}},
Funding-Text = {{The support for this project was provided by the Alfred P. Sloan
   Foundation's Microbiology of the Built Environment program, which has
   been an exceptional resource for learning and collaboration. We would
   like to thank James Harper for help with editing, the core facility at
   The Scripps Research Institute for their help with sequencing, John
   Thompson for his help with speeding up the clustering method
   comparisons, and the members of Jennifer Fouquier's graduate committee,
   Elizabeth Waters, and Richard W. Bizzoco. We also thank current and
   previous Kelley laboratory members for help and support, especially
   Pedro Torres, Karen Schwarzberg, Rosalin Le, and Michelle Mitchell.}},
Cited-References = {{Adams RI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078866.
   Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28.
   Allermann L, 2006, TOXICOL IN VITRO, V20, P1522, DOI 10.1016/j.tiv.2006.06.004.
   Andersen B, 2011, APPL ENVIRON MICROB, V77, P4180, DOI 10.1128/AEM.02513-10.
   Bokulich NA, 2013, J CLIN MICROBIOL, V51, P2617, DOI 10.1128/JCM.00898-13.
   BRAY JR, 1957, ECOL MONOGR, V27, P326.
   Brooks B, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-1.
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303.
   CDC, 2009, CDC FUNG DIS WHY AR.
   Cooley JD, 1998, OCCUP ENVIRON MED, V55, P579, DOI 10.1136/oem.55.9.579.
   Crook Brian, 2010, Fungal Biology Reviews, V24, P106, DOI 10.1016/j.fbr.2010.05.001.
   Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x.
   Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x.
   Dollive S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r60.
   Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133.
   Dupuy AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090899.
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461.
   Faganello J, 2009, MED MYCOL, V47, P584, DOI 10.1080/13693780802272148.
   Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105.
   Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171.
   Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132.
   Foto M, 2005, INDOOR AIR, V15, P257, DOI 10.1111/j.1600-0668.2005.00370.x.
   GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x.
   Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713.
   Gibbons SM, 2015, APPL ENVIRON MICROB, V81, P765, DOI 10.1128/AEM.03117-14.
   Gueidan C, 2011, FUNGAL BIOL-UK, V115, P987, DOI 10.1016/j.funbio.2011.04.002.
   Hageskal G, 2009, MYCOL RES, V113, P165, DOI 10.1016/j.mycres.2008.10.002.
   Hewitt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054703.
   Hewitt KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037849.
   HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338.
   Hoppe P, 1998, INT J BIOMETEOROL, V42, P1, DOI 10.1007/s004840050075.
   Hospodsky D, 2015, INDOOR AIR, V25, P641, DOI 10.1111/ina.12172.
   Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867.
   Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI DOI 10.1111/J.1469-8137.1912.TB05611.X.
   Karathia H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016015.
   Karpouzas DG, 2009, FEMS MICROBIOL ECOL, V70, P388, DOI 10.1111/j.1574-6941.2009.00779.x.
   Kelley ST, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-202.
   Kellogg CA, 2006, TRENDS ECOL EVOL, V21, P638, DOI 10.1016/j.tree.2006.07.004.
   Kendrick B., 2011, FUNGI ECOLOGICAL IMP.
   Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650.
   Kodsueb R, 2006, MYCOLOGIA, V98, P571, DOI 10.3852/mycologia.98.4.571.
   Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x.
   Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085.
   Low Chian-Yong, 2011, F1000 Med Rep, V3, P14, DOI 10.3410/M3-14.
   Mortimer RK, 2000, GENOME RES, V10, P403, DOI 10.1101/gr.10.4.403.
   Narciso-da-Rocha C, 2014, SCI TOTAL ENVIRON, V466, P127, DOI 10.1016/j.scitotenv.2013.06.109.
   Perez CA, 2013, FUNGAL BIOL-UK, V117, P94, DOI 10.1016/j.funbio.2012.12.002.
   Pitkaranta M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-235.
   Schmidt O, 2007, MYCOL PROG, V6, P261, DOI 10.1007/s11557-007-0534-0.
   Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109.
   Shoemaker RC, 2005, NEUROTOXICOL TERATOL, V27, P29, DOI 10.1016/j.ntt.2004.07.005.
   Soeria-Atmadja D, 2010, J ALLERGY CLIN IMMUN, V125, P1379, DOI 10.1016/j.jaci.2010.02.028.
   SOLOMON WR, 1978, J ALLERGY CLIN IMMUN, V62, P56, DOI 10.1016/0091-6749(78)90073-8.
   SOLOMON WR, 1975, J ALLERGY CLIN IMMUN, V56, P235, DOI 10.1016/0091-6749(75)90095-0.
   Stanford L. G., 1970, J SAN DIEGO HIST, V16, P15.
   Tonge DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106021.
   Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011.
   Vaz-Moreira I, 2011, APPL ENVIRON MICROB, V77, P5697, DOI 10.1128/AEM.00579-11.
   Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16.
   White T. J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1.
   Yamamoto N, 2010, J BIOSCI BIOENG, V109, P83, DOI 10.1016/j.jbiosc.2009.06.015.}},
Number-of-Cited-References = {{61}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{15}},
Journal-ISO = {{Indoor Air}},
Doc-Delivery-Number = {{EC0RK}},
Unique-ID = {{ISI:000387808200004}},
DA = {{2018-08-13}},
}

@article{ ISI:000388248500051,
Author = {Barbosa, Simone C. and Nobre, Thatyane M. and Volpati, Diogo and
   Ciancaglini, Pietro and Cilli, Eduardo M. and Lorenzon, Esteban N. and
   Oliveira, Jr., Osvaldo N.},
Title = {{The importance of cyclic structure for Labaditin on its antimicrobial
   activity against Staphylococcus aureus}},
Journal = {{COLLOIDS AND SURFACES B-BIOINTERFACES}},
Year = {{2016}},
Volume = {{148}},
Pages = {{453-459}},
Month = {{DEC 1}},
Abstract = {{Antimicrobial resistance has reached alarming levels in many countries,
   thus leading to a search for new classes of antibiotics, such as
   antimicrobial peptides whose activity is exerted by interacting
   specifically with the microorganism membrane. In this study, we
   investigate the molecular-level mechanism of action for Labaditin (Lo),
   a 10-amino acid residue cyclic peptide from Jatropha multifida with
   known bactericidal activity against Streptococcus mutans. We show that
   Lo is also effective against Staphylococcus aureus (S. aureus) but this
   does not apply to its linear analogue (L-1). Using
   polarization-modulated infrared reflection absorption spectroscopy
   (PM-IRRAS), we observed with that the secondary structure of Lo was
   preserved upon interacting with Langmuir monolayers from a phospholipid
   mixture mimicking S. aureus membrane, in contrast to L-1. This structure
   preservation for the rigid, cyclic Lo is key for the self-assembly of
   peptide nanotubes that induce pore formation in large unilamellar
   vesicles (LUVs), according to permeability assays and dynamic light
   scattering measurements. In summary, the comparison between Labaditin
   (Lo) and its linear analogue L-1 allowed us to infer that the
   bactericidal activity of Lo is more related to its interaction with the
   membrane. It does not require specific metabolic targets, which makes
   cyclic peptides promising for antibiotics without bacteria resistance.
   (C) 2016 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Barbosa, SC (Reprint Author), Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil.
   Barbosa, Simone C.; Nobre, Thatyane M.; Oliveira, Osvaldo N., Jr., Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil.
   Volpati, Diogo, Mid Sweden Univ, Dept Nat Sci, SE-85170 Sundsvall, Sweden.
   Ciancaglini, Pietro, Univ Sao Paulo, Fac Filosofia Ciencias \& Letras Ribeirao Preto, Dept Quim, Ribeirao Preto, SP, Brazil.
   Cilli, Eduardo M., Univ Estadual Paulista, Inst Quim, Araraquara, SP, Brazil.
   Lorenzon, Esteban N., Univ Fed Goias, Inst Ciencias Biol, Dept Bioquim \& Biol Mol, Goiania, Go, Brazil.}},
DOI = {{10.1016/j.colsurfb.2016.09.017}},
ISSN = {{0927-7765}},
EISSN = {{1873-4367}},
Keywords = {{Antimicrobial peptide; Cyclic peptides; Peptide nanotubes; Labaditin;
   Langmuir monolayers; PM-IRRAS; Large unilamellar vesicles;
   Staphylococcus aureus}},
Keywords-Plus = {{AMINO-ACID-COMPOSITION; AIR-WATER-INTERFACE; LIPID-COMPOSITION;
   TACHYPLESIN-I; PM-IRRAS; PEPTIDES; MEMBRANES; PHOSPHOLIPIDS;
   ORIENTATION; NANOTUBES}},
Research-Areas = {{Biophysics; Chemistry; Materials Science}},
Web-of-Science-Categories  = {{Biophysics; Chemistry, Physical; Materials Science, Biomaterials}},
Author-Email = {{simonebarbsa@gmail.com}},
ResearcherID-Numbers = {{Sao Carlos Institute of Physics, IFSC/USP/M-2664-2016
   CEPID-FAPESP, CIBFar/J-2382-2015
   Oliveira, Osvaldo/A-1714-2008
   Ciancaglini, Pietro/C-4842-2012}},
ORCID-Numbers = {{CEPID-FAPESP, CIBFar/0000-0003-2719-0302
   Oliveira, Osvaldo/0000-0002-5399-5860
   Ciancaglini, Pietro/0000-0002-2785-1345}},
Funding-Acknowledgement = {{CNPq; FAPESP {[}2014/03748-9]; CAPES; nBioNet network (Brazil)}},
Funding-Text = {{The authors are grateful to CNPq, FAPESP (2014/03748-9), CAPES and
   nBioNet network (Brazil) for financial support.}},
Cited-References = {{Banc A, 2007, LANGMUIR, V23, P13066, DOI 10.1021/la702037k.
   Barbosa SC, 2015, J COLLOID INTERF SCI, V438, P39, DOI 10.1016/j.jcis.2014.09.059.
   Barbosa SC, 2011, AMINO ACIDS, V40, P135, DOI 10.1007/s00726-010-0648-6.
   BEINING PR, 1975, J BACTERIOL, V121, P137.
   Bellet-Amalric E, 2000, BBA-BIOMEMBRANES, V1467, P131, DOI 10.1016/S0005-2736(00)00218-2.
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098.
   Buffeteau T, 2000, J PHYS CHEM B, V104, P4537, DOI 10.1021/jp9939524.
   Castano S, 1999, BBA-BIOMEMBRANES, V1416, P176, DOI 10.1016/S0005-2736(98)00220-X.
   Cirac AD, 2011, BIOPHYS J, V100, P2422, DOI 10.1016/j.bpj.2011.03.057.
   da Costa JP, 2015, APPL MICROBIOL BIOT, V99, P2023, DOI 10.1007/s00253-015-6375-x.
   Danial M, 2015, ORG BIOMOL CHEM, V13, P2464, DOI 10.1039/c4ob02041c.
   Devapriya F., 2013, GULF MED J, V2, P6.
   Epand RF, 2007, BBA-BIOMEMBRANES, V1768, P2500, DOI 10.1016/j.bbamem.2007.05.023.
   Epand RF, 2011, CELL MOL LIFE SCI, V68, P2177, DOI 10.1007/s00018-011-0711-9.
   Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591.
   GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0.
   Hancock R E, 2001, Lancet Infect Dis, V1, P156, DOI 10.1016/S1473-3099(01)00092-5.
   Hartgerink JD, 1996, J AM CHEM SOC, V118, P43, DOI 10.1021/ja953070s.
   JOYCE GH, 1970, J BACTERIOL, V104, P323.
   Khandelia H, 2008, BBA-BIOMEMBRANES, V1778, P1528, DOI 10.1016/j.bbamem.2008.02.009.
   Lhor M, 2014, ADV COLLOID INTERFAC, V207, P223, DOI 10.1016/j.cis.2014.01.015.
   Lorenzon EN, 2013, AMINO ACIDS, V44, P1521, DOI 10.1007/s00726-013-1475-3.
   Maltseva E, 2005, CHEMBIOCHEM, V6, P1817, DOI 10.1002/cbic.200500116.
   Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8.
   MATSUZAKI K, 1991, BIOCHIM BIOPHYS ACTA, V1070, P259, DOI 10.1016/0005-2736(91)90173-6.
   Mattei B, 2014, LANGMUIR, V30, P3513, DOI 10.1021/la500146j.
   Mishra B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00221.
   Mitchell NJ, 2016, BBA-BIOMEMBRANES, V1858, P988, DOI 10.1016/j.bbamem.2015.10.014.
   Naber CK, 2009, CLIN INFECT DIS, V48, pS231, DOI 10.1086/598189.
   Paiva AD, 2012, ANTIMICROB AGENTS CH, V56, P4586, DOI 10.1128/AAC.00295-12.
   Roscia G, 2013, CURR PROTEIN PEPT SC, V14, P641, DOI 10.2174/138920371408131227155308.
   ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316.
   Roxin A, 2012, FUTURE MED CHEM, V4, P1601, DOI {[}10.4155/fmc.12.75, 10.4155/FMC.12.75].
   Russell AL, 2010, CHEM PHYS LIPIDS, V163, P488, DOI 10.1016/j.chemphyslip.2010.03.009.
   Sani MA, 2012, BBA-BIOMEMBRANES, V1818, P205, DOI 10.1016/j.bbamem.2011.07.015.
   TAMAMURA H, 1993, BIOCHIM BIOPHYS ACTA, V1163, P209, DOI 10.1016/0167-4838(93)90183-R.
   Xiao Q, 2007, J MED CHEM, V50, P3132, DOI 10.1021/jm070282e.
   Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{23}},
Journal-ISO = {{Colloid Surf. B-Biointerfaces}},
Doc-Delivery-Number = {{EC6LV}},
Unique-ID = {{ISI:000388248500051}},
DA = {{2018-08-13}},
}

@article{ ISI:000387807200066,
Author = {Gao, Xin-Lei and Shao, Ming-Fei and Luo, Yi and Dong, Yu-Fang and
   Ouyang, Feng and Dong, Wen-Yi and Li, Ji},
Title = {{Airborne bacterial contaminations in typical Chinese wet market with
   live poultry trade}},
Journal = {{SCIENCE OF THE TOTAL ENVIRONMENT}},
Year = {{2016}},
Volume = {{572}},
Pages = {{681-687}},
Month = {{DEC 1}},
Abstract = {{Chinese wet markets with live poultry trade have been considered as
   major sources of pathogen dissemination, and sites for horizontal
   transfer of bacterial and viral pathogens. In this study, the pathogenic
   bacteria and antibiotic resistant genes (ARGs) in air samples collected
   at a typical Chinese wet market had been analysis and quantified.
   Corynebacterium minutissimum and other pathogenic bacteria accounted for
   0.81-8.02\% of the whole microbial community in different air samples.
   The four ARGs quantified in this study showed a comparable relative
   concentration (copies/ng\_DNA) with municipal wastewater. Poultry
   manures were demonstrated to be important microbial contamination source
   in wet market, which was supported by both microbial composition based
   source tracking and the quantification of airborne microbial density. A
   series of Firmicutes and Bacteroidetes indicators of poultry area
   contamination were successfully screened, which will be useful for the
   more convenient monitoring of airborne poultry area contamination. Our
   results indicate bioaerosols acted as important route for the
   transmissions of pathogens and ARGs. Continued surveillance of airborne
   microbial contamination is required in poultry trade wet market.
   Practical implications: Urban live poultry markets are important sources
   of pathogen dissemination, and sites for horizontal transfer of viral
   and bacterial pathogens. In the present field-study, pathogenic bacteria
   and antibiotic resistance genes were focused to provide quantitative
   information on the levels of microbial contaminations at the indoor air
   of wet markets. Results demonstrated that poultry manures were important
   microbial contamination source in wet market, and in the meanwhile
   bioaerosols were identified as important route for the transmissions of
   microbial contaminants. A series of Firmicutes and Bacteroidetes
   indicators of poultry area contamination were successfully screened,
   which will be useful for the more convenient monitoring of airborne
   poultry area contamination. (C) 2016 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Shao, MF; Li, J (Reprint Author), Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen Key Lab Water Resource Utilizat \& Enviro, Shenzhen 518055, Peoples R China.
   Gao, Xin-Lei; Shao, Ming-Fei; Dong, Yu-Fang; Ouyang, Feng; Dong, Wen-Yi; Li, Ji, Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen Key Lab Water Resource Utilizat \& Enviro, Shenzhen 518055, Peoples R China.
   Luo, Yi, Nankai Univ, Coll Environm Sci \& Engn, Minist Educ, Key Lab Pollut Proc \& Environm Criteria, Tianjin 300071, Peoples R China.}},
DOI = {{10.1016/j.scitotenv.2016.06.208}},
ISSN = {{0048-9697}},
EISSN = {{1879-1026}},
Keywords = {{Pathogenic bacteria; Bioaerosol; Antibiotic resistance gene; Wet market;
   Live poultry trade; Microbial contaminant}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE GENES; SEWAGE-TREATMENT PLANTS; ANTIMICROBIAL
   RESISTANCE; PATHOGENIC BACTERIA; SWINE; ENVIRONMENT; INFLUENZA; LAGOONS;
   FARMS}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{mfshao@hitsz.edu.cn
   Liji99@hitsz.edu.cn}},
ResearcherID-Numbers = {{Luo, Yi/C-2451-2018
   }},
ORCID-Numbers = {{Gao, Xin-Lei/0000-0002-7767-1457}},
Funding-Acknowledgement = {{State Environmental Protection Commonweal Project of China
   {[}201309031]; National Natural Science Foundation of China {[}31200104,
   21306049]; Shenzhen Basic Research Foundation {[}20120531134448140];
   Fundamental Research Funds for the Central Universities, the higher
   school specialized research fund for the doctoral program
   {[}222201314029]}},
Funding-Text = {{Financial support from the State Environmental Protection Commonweal
   Project of China (201309031), National Natural Science Foundation of
   China (31200104, 21306049), Shenzhen Basic Research Foundation
   (20120531134448140), and the Fundamental Research Funds for the Central
   Universities, the higher school specialized research fund for the
   doctoral program (222201314029) are gratefully acknowledged.}},
Cited-References = {{Albertsen M, 2012, ISME J, V6, P1094, DOI 10.1038/ismej.2011.176.
   DAVISON RL, 1974, ENVIRON SCI TECHNOL, V8, P1107, DOI 10.1021/es60098a003.
   Gao GF, 2014, SCIENCE, V344, P235, DOI 10.1126/science.1254664.
   Gao PP, 2012, WATER RES, V46, P2355, DOI 10.1016/j.watres.2012.02.004.
   Hospodsky D, 2010, APPL ENVIRON MICROB, V76, P7004, DOI 10.1128/AEM.01240-10.
   Husman T, 1996, SCAND J WORK ENV HEA, V22, P5, DOI 10.5271/sjweh.103.
   Just NA, 2012, ANN OCCUP HYG, V56, P440, DOI 10.1093/annhyg/mer105.
   Kash JC, 2015, AM J PATHOL, V185, P1528, DOI 10.1016/j.ajpath.2014.08.030.
   Kaushik R, 2013, SCI TOTAL ENVIRON, V449, P237, DOI 10.1016/j.scitotenv.2013.01.065.
   Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7.
   McKinney CW, 2010, ENVIRON SCI TECHNOL, V44, P6102, DOI 10.1021/es9038165.
   McLellan SL, 2010, ENVIRON MICROBIOL, V12, P1376, DOI 10.1111/j.1462-2920.2010.02204.x.
   Penton P.K., 2015, GENOME ANNOUNCEMENTS, V3.
   Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es0604131.
   Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864.
   Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916.
   Rusinol M, 2013, SCI TOTAL ENVIRON, V458, P355, DOI 10.1016/j.scitotenv.2013.04.028.
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09.
   Wu D.L., 2015, SCI REP, V5.
   Ye L, 2011, ENVIRON SCI TECHNOL, V45, P7173, DOI 10.1021/es201045e.
   Zhang QQ, 2015, ENVIRON SCI TECHNOL, V49, P6772, DOI 10.1021/acs.est.5b00729.
   Zhang T, 2009, ENVIRON SCI TECHNOL, V43, P3455, DOI 10.1021/es803309m.
   Zhang X, 2009, J NATURAL DISASTERS, V18, P1.
   Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x.
   Zhang YP, 2013, SCI TOTAL ENVIRON, V463, P631, DOI 10.1016/j.scitotenv.2013.06.016.
   Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160.
   Zhou LJ, 2013, SCI TOTAL ENVIRON, V444, P183, DOI 10.1016/j.scitotenv.2012.11.087.
   Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{14}},
Usage-Count-Since-2013 = {{72}},
Journal-ISO = {{Sci. Total Environ.}},
Doc-Delivery-Number = {{EC0RA}},
Unique-ID = {{ISI:000387807200066}},
DA = {{2018-08-13}},
}

@article{ ISI:000383523800014,
Author = {Edelblute, C. M. and Malik, M. A. and Heller, L. C.},
Title = {{Antibacterial efficacy of a novel plasma reactor without an applied gas
   flow against methicillin resistant Staphylococcus aureus on diverse
   surfaces}},
Journal = {{BIOELECTROCHEMISTRY}},
Year = {{2016}},
Volume = {{112}},
Pages = {{106-111}},
Month = {{DEC}},
Abstract = {{The use of nonthermal plasma in the clinic has gained recent interest,
   as the need for alternative or supplementary strategies are necessary
   for preventing multi-drug resistant infections. The purpose of this
   study was to evaluate the antibacterial efficacy of a novel plasma
   reactor based on a high current version of sliding discharge and
   operated by nanosecond voltage pulses without an applied gas flow. This
   modification is advantageous for both portability and convenience.
   Bacterial inactivation was determined within a chamber by direct
   quantification of colony Jing units. Plasma exposure significantly
   inhibited the growth of Escherichia coli and Staphylococcus epidermidis
   following a 1-min application (p < 0.001). S. epidermidis was more
   susceptible to the plasma after a 5-min exposure compared to E. coli.
   Temperature and pH measurements taken immediately before and after
   plasma exposure determined neither heat nor pH changes play a role in
   bacterial inactivation. Because of the notable effect on S. epidermidis,
   the effect of plasma exposure on several isolates and strains of the
   related opportunistic pathogen Staphylococcus aureus was quantified.
   While S. aureus isolates and strains were efficiently inactivated on an
   agar surface, subsequent testing on other clinically relevant surfaces
   demonstrated that the inactivation level, although significant, was
   reduced. This reduction appeared to depend on both the surface texture
   and the surface moisture content. These findings suggest this novel
   plasma source lacking an applied gas flow has potential application for
   surface bacterial decontamination. (C) 2016 Elsevier B.V. All rights
   reserved.}},
Publisher = {{ELSEVIER SCIENCE SA}},
Address = {{PO BOX 564, 1001 LAUSANNE, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Heller, LC (Reprint Author), Old Dominion Univ, Frank Reidy Res Ctr Bioelect, 4211 Monarch Way,Suite 300, Norfolk, VA 23508 USA.
   Edelblute, C. M.; Malik, M. A.; Heller, L. C., Old Dominion Univ, Frank Reidy Res Ctr Bioelect, 4211 Monarch Way,Suite 300, Norfolk, VA 23508 USA.
   Heller, L. C., Old Dominion Univ, Coll Hlth Sci, Sch Med Diagnost \& Translat Sci, Norfolk, VA 23529 USA.}},
DOI = {{10.1016/j.bioelechem.2016.04.001}},
ISSN = {{1567-5394}},
EISSN = {{1878-562X}},
Keywords = {{Nonthermal plasma; Bacterial decontamination; Plasma medicine; Sliding
   discharge; Escherichia coli; Staphylococcus epidermidis; Staphylococcus
   aureus}},
Keywords-Plus = {{ATMOSPHERIC-PRESSURE PLASMA; BARRIER DISCHARGE PLASMA; NONTHERMAL
   PLASMA; IN-VITRO; ESCHERICHIA-COLI; FRESH PRODUCE; ARGON PLASMA;
   NITRIC-OXIDE; AIR PLASMA; INACTIVATION}},
Research-Areas = {{Biochemistry \& Molecular Biology; Life Sciences \& Biomedicine - Other
   Topics; Biophysics; Electrochemistry}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Biology; Biophysics; Electrochemistry}},
Author-Email = {{lheller@odu.edu}},
Cited-References = {{Ardhaoui M, 2013, BIOELECTROCHEMISTRY, V91, P52, DOI 10.1016/j.bioelechem.2012.12.005.
   Baier M, 2014, INNOV FOOD SCI EMERG, V22, P147, DOI 10.1016/j.ifset.2014.01.011.
   Barbero AM, 2009, TOXICOL IN VITRO, V23, P1, DOI 10.1016/j.tiv.2008.10.008.
   Caspers PJ, 2001, J INVEST DERMATOL, V116, P434, DOI 10.1046/j.1523-1747.2001.01258.x.
   Connolly RJ, 2015, BIOELECTROCHEMISTRY, V103, P15, DOI 10.1016/j.bioelechem.2014.09.003.
   Connolly RJ, 2010, INT J PHARMACEUT, V389, P53, DOI 10.1016/j.ijpharm.2010.01.016.
   Connolly RJ, 2009, BIOTECHNOL BIOENG, V104, P1034, DOI 10.1002/bit.22451.
   Daeschlein G, 2012, J HOSP INFECT, V81, P177, DOI 10.1016/j.jhin.2012.02.012.
   Daeschlein G, 2015, J DTSCH DERMATOL GES, V13, P143, DOI {[}10.1111/ddg.12559, 10.1111/ddg.12559\_suppl].
   Edelblute C.M., 2015, BIOTECHNOL BIOENG.
   Edelblute CM, 2015, BIOELECTROCHEMISTRY, V103, P22, DOI 10.1016/j.bioelechem.2014.08.013.
   El-Sayed WS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01098.
   Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0.
   Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154.
   Fridman G, 2007, PLASMA PROCESS POLYM, V4, P370, DOI 10.1002/ppap.200600217.
   Galvin S, 2013, LETT APPL MICROBIOL, V57, P83, DOI 10.1111/lam.12091.
   Hammann A, 2010, SKIN PHARMACOL PHYS, V23, P328, DOI 10.1159/000314724.
   Heinlin J, 2011, J EUR ACAD DERMATOL.
   Heller LC, 2012, LETT APPL MICROBIOL, V54, P126, DOI 10.1111/j.1472-765X.2011.03186.x.
   Homma T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.036201.
   Isbary G, 2010, BRIT J DERMATOL, V163, P78, DOI 10.1111/j.1365-2133.2010.09744.x.
   Jiang CQ, 2009, IEEE T PLASMA SCI, V37, P1190, DOI 10.1109/TPS.2009.2014870.
   Jones ML, 2010, APPL MICROBIOL BIOT, V88, P401, DOI 10.1007/s00253-010-2733-x.
   Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002.
   Kelly-Wintenberg K, 1998, J IND MICROBIOL BIOT, V20, P69, DOI 10.1038/sj.jim.2900482.
   Kolb JF, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2940325.
   Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012.
   Laroussi M, 1996, IEEE T PLASMA SCI, V24, P1188, DOI 10.1109/27.533129.
   Lu X, 2008, J APPL PHYS, V104, DOI 10.1063/1.2977674.
   Maisch T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034610.
   Malik M.A., NITRIC OXIDE.
   Malik MA, 2016, CHEM ENG J, V283, P631, DOI 10.1016/j.cej.2015.07.092.
   Malik MA, 2015, PLASMA CHEM PLASMA P, V35, P697, DOI 10.1007/s11090-015-9611-3.
   Malik MA, 2014, PLASMA CHEM PLASMA P, V34, P871, DOI 10.1007/s11090-014-9528-2.
   Malik MA, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/13/132001.
   Malik MA, 2012, J HAZARD MATER, V209, P293, DOI 10.1016/j.jhazmat.2012.01.024.
   Merbahi N, 2012, IEEE T PLASMA SCI, V40, P1167, DOI 10.1109/TPS.2012.2184804.
   Montenegro J, 2002, J FOOD SCI, V67, P646, DOI 10.1111/j.1365-2621.2002.tb10653.x.
   Moreau E, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/11/115204.
   Napartovich A. P., 2001, Plasmas and Polymers, V6, P1.
   Nasruddin, 2014, CLIN PLASMA MED, V2, P28, DOI 10.1016/j.cpme.2014.01.001.
   O'Connor N, 2014, J HOSP INFECT, V88, P59, DOI 10.1016/j.jhin.2014.06.015.
   Otter JA, 2011, INFECT CONT HOSP EP, V32, P687, DOI 10.1086/660363.
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182.
   Pan J, 2010, IEEE T PLASMA SCI, V38, P3143, DOI 10.1109/TPS.2010.2066291.
   Pankaj SK, 2014, TRENDS FOOD SCI TECH, V35, P5, DOI 10.1016/j.tifs.2013.10.009.
   QORONFLEH MW, 1990, ANTON LEEUW INT J G, V58, P79.
   Rupf S, 2010, J MED MICROBIOL, V59, P206, DOI 10.1099/jmm.0.013714-0.
   Scholtz V, 2015, BIOTECHNOL ADV, V33, P1108, DOI 10.1016/j.biotechadv.2015.01.002.
   Sekimoto K, 2015, J PHYS D APPL PHYS, V48, DOI 10.1088/0022-3727/48/30/305401.
   Sung SJ, 2013, J ADV PROSTHODONT, V5, P2, DOI 10.4047/jap.2013.5.1.2.
   Sysolyatina E, 2014, PLASMA PROCESS POLYM, V11, P315, DOI 10.1002/ppap.201300041.
   Vleugels M, 2005, IEEE T PLASMA SCI, V33, P824, DOI 10.1109/TPS.2005.844524.
   Weber DJ, 2013, CURR OPIN INFECT DIS, V26, P338, DOI 10.1097/QCO.0b013e3283630f04.
   Yang Y, 2015, BIOSURF BIOTRIBOL, V1, P177.
   Yu QS, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2161807.
   Zhang Q, 2012, J APPL PHYS, V111, DOI 10.1063/1.4730627.
   Ziuzina D, 2014, FOOD MICROBIOL, V42, P109, DOI 10.1016/j.fm.2014.02.007.}},
Number-of-Cited-References = {{58}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{33}},
Journal-ISO = {{Bioelectrochemistry}},
Doc-Delivery-Number = {{DW3EB}},
Unique-ID = {{ISI:000383523800014}},
DA = {{2018-08-13}},
}

@article{ ISI:000409539300011,
Author = {Fahmy, H. M. and Aly, A. A. and Amr, A. and Sayed, Sh. M. and Rabie, A.
   M.},
Title = {{Evaluation of Functional and Comfort Properties of SA/TDI/PEG1000 Adduct
   Treated Cotton/Polyester Blended Fabric}},
Journal = {{EGYPTIAN JOURNAL OF CHEMISTRY}},
Year = {{2016}},
Volume = {{59}},
Number = {{6}},
Pages = {{1095-1112}},
Month = {{NOV-DEC}},
Abstract = {{THE SA/TDI/PEG1000 adduct was synthesized by reacting a mixture of
   stearyl alcohol (SA) and polyethylene glycol (PEG) of molecular weight
   400, 1000, 2000, or 6000 Dalton with 2,4-toluene diisocyanate (TDI). The
   prepared adduct emulsion was incorporated in different easy care
   finishing formulations to illustrate the impact of that adduct emulsion
   on the performance, functional and comfort properties of treated
   cotton/polyester fabric. Among five salts namely ammonium sulphate,
   magnesium chloride, zinc sulphate, copper sulphate and ammonium chloride
   examined as catalysts for the aforementioned finishing formulations,
   ammonium sulphate with a concentration of 6 g/l was the unique catalyst
   that imparts treated fabric with significant durable functional
   properties. Furthermore, increasing of the adduct concentration in the
   finishing bath results in an increase in fabric weight, tensile
   strength, softness, stiffness, water repellency, antibacterial, water
   vapor resistance and thermal resistance properties of treated fabric
   along with a reduction in resiliency and air permeability properties of
   that fabric. On the other hand, inclusion Ag or TiO2 nano-particles
   (NPs) in easy care finishing baths containing the SA/TDI/PEG1000 adduct
   emulsion effectively upgrades the antibacterial properties along with a
   slight reduction in the water repellency of treated fabric. Furthermore,
   the morphology of prepared Ag-or TiO2-NPs was characterized via their
   TEM images. Meanwhile, fabric samples treated with SA/TDI/PEG1000
   composites containing such NPs were characterized via their SEM and EDX
   images as well as TGA analysis.}},
Publisher = {{NAT INFORM \& DOCUMENT CENTRE}},
Address = {{NIDOC DOKKI, CAIRO, EGYPT}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fahmy, HM (Reprint Author), Natl Res Ctr, Text Res Div, 33 Bohouth St,PO 12622,Scopus Affiliat ID, Giza, Egypt.
   Fahmy, H. M.; Aly, A. A.; Amr, A.; Sayed, Sh. M., Natl Res Ctr, Text Res Div, 33 Bohouth St,PO 12622,Scopus Affiliat ID, Giza, Egypt.
   Rabie, A. M., Ain Shams Univ, Fac Sci, Cairo, Egypt.}},
ISSN = {{0449-2285}},
EISSN = {{2357-0245}},
Keywords-Plus = {{ANTIBACTERIAL PROPERTIES; COTTON FABRICS; WATER REPELLENT; STEARYL
   ALCOHOL; UV PROTECTION; CROSS-LINKING; ESTER; PERFORMANCE; FINISHES;
   ENHANCE}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Multidisciplinary}},
ORCID-Numbers = {{Aly, Amal/0000-0002-0897-1341}},
Cited-References = {{Abdel-Wahab BF, 2009, J APPL POLYM SCI, V112, P2221, DOI 10.1002/app.29768.
   Abo-Shosha MH, 2008, J IND TEXT, V37, P315, DOI 10.1177/1528083707083793.
   Abo-Shosha MH, 2009, AATCC REV, V9, P38.
   Abo-Shosha M. H., 1995, AM DYEST REP, V84, P44.
   Abo-Shosha M. H., 2005, 2 INT C TEX RES DIV.
   Abo-Shosha MH, 2005, POLYM-PLAST TECHNOL, V44, P1189, DOI 10.1081/PTE-200065283.
   Arora S., 2013, INT J PHARM SCI REV, V23, P279.
   Bozzi A, 2005, J PHOTOCH PHOTOBIO A, V172, P27, DOI 10.1016/j.jphotochem.2004.11.010.
   Fahmy HM, 2015, EGYPT J CHEM, V58, P447.
   Fahmy HM, 2017, PROG ORG COAT, V105, P176, DOI 10.1016/j.porgcoat.2016.11.014.
   Fahmy HM, 2016, PROG ORG COAT, V99, P166, DOI 10.1016/j.porgcoat.2016.05.020.
   Fahmy HM, 2010, J IND TEXT, V40, P109, DOI 10.1177/1528083709350185.
   Fahmy HM, 2009, J IND TEXT, V39, P109, DOI 10.1177/1528083709102932.
   Fahmy HM, 2009, CARBOHYD POLYM, V77, P845, DOI 10.1016/j.carbpol.2009.03.003.
   Fahmy H. M., CARBOHYDRATE POLYM, V92, P1539.
   Fahmy H. M., 2016, INT J CHEM TECH RES, V9, P96.
   Fahmy H. M., 2004, EGYPT J CHEM, V47, P627.
   Fahmy H.M., 2016, INT J CHEMTECH RES, V9, P215.
   Fahmy HM, 2004, POLYM-PLAST TECHNOL, V43, P445, DOI 10.1081/PPT-120029973.
   Fehmy HM, 2004, TINCTORIA, V10, P22.
   Fouda MMG, 2011, CARBOHYD POLYM, V86, P625, DOI 10.1016/j.carbpol.2011.04.086.
   Gaffer H. E., 2013, J APPL SCI RES, V9, P4059.
   Hashem M, 2011, CARBOHYD POLYM, V86, P1692, DOI 10.1016/j.carbpol.2011.06.085.
   Holmes D.A., 2000, HDB TECHNICAL TEXTIL, P282.
   Hu J, 2007, WOODHEAD PUBL SER TE, P1, DOI 10.1533/9781845693060.
   Ibrahim NA, 2008, J MATER PROCESS TECH, V200, P385, DOI 10.1016/j.jmatprotec.2007.09.021.
   Ibrahim NA, 2012, CARBOHYD POLYM, V89, P648, DOI 10.1016/j.carbpol.2012.03.068.
   Ibrahim NA, 2011, J IND TEXT, V41, P41, DOI 10.1177/1528083710390966.
   Ibrahim NA, 2010, POLYM-PLAST TECHNOL, V49, P1297, DOI 10.1080/03602551003773114.
   Ibrahim NA, 2006, POLYM-PLAST TECHNOL, V45, P719, DOI 10.1080/03602550600611198.
   Ibrahim NA, 2013, RJTA, V17, P58.
   KUBO I, 1993, BIOORG MED CHEM LETT, V3, P1305, DOI 10.1016/S0960-894X(00)80336-4.
   Nalawade TM, 2015, J INT SOC PREV COMMU, V5, P114, DOI 10.4103/2231-0762.155736.
   Save N. S., 2005, J IND TEXT, V34, P139.
   Schindler W. D., 2004, CHEM FINISHING TEXTI, P74, DOI 10.1533/9781845690373.74.
   Sen A. K., 2008, COATED TEXTILES PRIN, P22.
   Sileikaite A., 2006, Materials Science, V12, P287.
   Togashi N, 2007, MOLECULES, V12, P139, DOI 10.3390/12020139.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Egypt. J. Chem.}},
Doc-Delivery-Number = {{FG1FF}},
Unique-ID = {{ISI:000409539300011}},
DA = {{2018-08-13}},
}

@article{ ISI:000409058600018,
Author = {Rychen, Guido and Aquilina, Gabriele and Azimonti, Giovanna and
   Bampidis, Vasileios and Bastos, Maria De Lourdes and Bories, Georges and
   Chesson, Andrew and Cocconcelli, Pier Sandro and Flachowsky, Gerhard and
   Gropp, Jurgen and Kolar, Boris and Kouba, Maryline and Puente, Secundino
   Lopez and Lopez-Alonso, Marta and Mantovani, Alberto and Mayo, Baltasar
   and Ramos, Fernando and Villa, Roberto Edoardo and Wallace, Robert John
   and Wester, Pieter and Brozzi, Rosella and Saarela, Maria and EFSA Panel
   Additives Prod Subst},
Title = {{Safety and efficacy of Lactobacillus brevis NCIMB 42149 as a silage
   additive for all animal species}},
Journal = {{EFSA JOURNAL}},
Year = {{2016}},
Volume = {{14}},
Number = {{11}},
Month = {{NOV}},
Abstract = {{Lactobacillus brevis is a technological additive intended to improve the
   ensiling process at a minimum proposed dose of 1 x 10(8) colony-forming
   units (CFU)/kg fresh material. The species L. brevis is considered by
   EFSA to be suitable for the qualified presumption of safety approach to
   safety assessment and not to require specific demonstration of safety
   other than the susceptibility to antibiotics of human and veterinary
   significance. Although identity was established, the strain was found
   resistant to ampicillin and clindamycin and may pose a risk for the
   spread of genes coding for resistance to these antibiotics. Therefore,
   the use of this strain as a silage additive is not considered safe for
   target animals, and consumers of products from animals fed the treated
   silage. In the absence of data, no conclusion can be drawn on the skin
   and eye irritancy or skin sensitisation of the additive. The additive
   should be considered as a potential respiratory sensitiser. Although L.
   brevis is ubiquitous in the environment, due to its antibiotic
   resistance, the FEEDAP Panel cannot conclude on the extent of the risk
   of horizontal gene transfer to other bacteria in the environment. Six
   studies with laboratory-scale silos were made using forage of differing
   water-soluble carbohydrate content. Replicate silos containing forages
   treated at the proposed application rate were compared to identical
   silos containing the same but untreated forage. After opening and
   exposure to air, an increase of 3 degrees C over ambient was taken to
   indicate aerobic deterioration. The additive showed a potential to
   significantly improve the aerobic stability of silage produced from
   easy, moderately difficult and difficult to ensile forage at a minimum
   application rate of 1 x 10(8) CFU/kg plant material. (C) 2016 European
   Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd
   on behalf of European Food Safety Authority.}},
Publisher = {{EUROPEAN FOOD SAFETY AUTHORITY-EFSA}},
Address = {{EUROPEAN FOOD SAFETY AUTHORITY-EFSA, PARMA, 00000, ITALY}},
Type = {{Article}},
Language = {{English}},
DOI = {{10.2903/j.efsa.2016.4616}},
Article-Number = {{UNSP 4616}},
ISSN = {{1831-4732}},
Keywords = {{Lactobacillus brevis; silage; safety; QPS; efficacy; aerobic stability}},
Research-Areas = {{Food Science \& Technology}},
Web-of-Science-Categories  = {{Food Science \& Technology}},
Cited-References = {{{[}Anonymous], 2007, EFSA J, V587, P1, DOI DOI 10.2903/J.EFSA.2007.587.
   Aquilina G, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2528.
   EFSA, 2013, EFSA J, V11, P3449, DOI DOI 10.2903/J.EFSA.2013.3449.
   EFSA FEEDAP Panel (EFSA Panelon Additives and Products or Substances used in Animal Feed), 2011, EFSA J, V9, P2175, DOI {[}10. 2903/j. efsa. 2011. 2175, DOI 10.2903/J.EFSA.2011.2175].
   EFSA FEEDAP Panel (EFSA Panelon Additives and Products or Substances used in Animal Feed), 2012, EFSA J, V10, P2539, DOI {[}10. 2903/j. efsa. 2012. 2539, DOI 10.2903/J.EFSA.2012.2539].
   European Food Safety Authority (EFSA), 2008, EFSA J, V6, P732, DOI DOI 10.2903/J.EFSA.2008.732.
   Kim HJ, 2001, MOL CELLS, V12, P112.}},
Number-of-Cited-References = {{7}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{EFSA J.}},
Doc-Delivery-Number = {{FF5TC}},
Unique-ID = {{ISI:000409058600018}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000390180500016,
Author = {Memon, Badaruddin Allah Dino and Bhutto, Gul Hassan and Rizvi, Wajid
   Hussain},
Title = {{Measurement of air contamination in different wards of public sector
   hospital, Sukkur}},
Journal = {{PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES}},
Year = {{2016}},
Volume = {{29}},
Number = {{6}},
Pages = {{2015-2021}},
Month = {{NOV}},
Abstract = {{The aim of this study was to evaluate and assess the index of bacterial
   contamination in different wards of the Public Sector Hospital of Sukkur
   (Teaching) Pakistan; whether or not the air contamination was
   statistically different from the acceptable level using active and
   passive sampling. In addition to this main hypothesis, other
   investigations included: occurrence of the most common bacteria, whether
   or not the bacterial contamination in the wards was a persistent problem
   and identification of the effective antibiotics against the identified
   bacteria. The evidence sought based on the One Sample T test suggests
   that there is a (statistically) significant difference between the
   observed (higher) than the acceptance level (p<0.01), the result based
   on One-Way ANOVA suggests that the contamination problem was persistent
   as there was no significant difference among observed contamination of
   all three visits at (p>0.01) and the result of antibiotic susceptibility
   test highlights sensitivity and resistance level of antibiotics for the
   identified bacteria.}},
Publisher = {{UNIV KARACHI}},
Address = {{UNIV CAMPUS, FAC PHARMACY, KARACHI, 75270, PAKISTAN}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Memon, BAD (Reprint Author), Shah Abdul Latif Univ, Dept Microbiol, Khairpur, Sindh, Pakistan.
   Memon, Badaruddin Allah Dino; Bhutto, Gul Hassan, Shah Abdul Latif Univ, Dept Microbiol, Khairpur, Sindh, Pakistan.
   Rizvi, Wajid Hussain, Inst Business Adm, Dept Mkt, Karachi, Pakistan.}},
ISSN = {{1011-601X}},
Keywords = {{Airborne bacteria; air contamination; antibiotic sensitivity; active
   sampling; passive sampling}},
Keywords-Plus = {{AIRBORNE BACTERIA; ENVIRONMENT; SURVIVAL; FUNGI}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy}},
Author-Email = {{doctor\_badar@yahoo.com}},
Funding-Acknowledgement = {{Higher Education Commission Islamabad}},
Funding-Text = {{Thanks to Higher Education Commission Islamabad for providing the funds
   for this project. We are also grateful to Medical Superintendent,
   Doctors and all Paramedical staff of Public Sector Hospital (Taluka
   Hospital Sukkur) Sukkur for facilitating the air sampling. We are most
   grateful to Professor Dr T. Harry Birkbeck, Institute of Biomedical
   Sciences, University of Glasgow (UK) for constant encouragement.}},
Cited-References = {{AYLIFFE GAJ, 1988, J HOSP INFECT, V11, P226, DOI 10.1016/0195-6701(88)90101-6.
   Blessing-Moore J, 1979, MUCOSAL DROPLET SPRE.
   Brachman P. S., 1970, P INT C NOS INF AM H, P189.
   Butkevich VS, 1938, MICROBIOLOGY, V7, P1005.
   Chessbrough M, 2002, DISTRICT LAB PRACT 2, V2, P132.
   Cunha BA, 1997, J ANTIMICROB CHEMOTH, V39, P29, DOI 10.1093/jac/39.suppl\_2.29.
   Daniel YC, 2009, BIOSCIENCE WORLD, V8, P1.
   de Kaspar HM, 2005, AM J OPHTHALMOL, V139, P730.
   Drago L, 2001, J ANTIMICROB CHEMOTH, V48, P37, DOI 10.1093/jac/48.1.37.
   EMMERSON AM, 1995, J HOSP INFECT, V30, P421, DOI 10.1016/0195-6701(95)90047-0.
   Fisher G, 1972, Z GES HYG, V18, P729.
   Gaynes RP, 1996, PEDIATRICS, V98, P357.
   GOULD JC, 1970, AEROBIOLOGY, P62.
   Greene VW, 1960, MOD HOSP, P1.
   GRIEBLE HG, 1974, J INFECT DIS, V130, P602, DOI 10.1093/infdis/130.6.602.
   Herman L G, 1980, Ann N Y Acad Sci, V353, P140, DOI 10.1111/j.1749-6632.1980.tb18916.x.
   Jaffal AA, 1997, ENVIRON INT, V23, P167, DOI 10.1016/S0160-4120(97)00003-2.
   Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P47.
   Kaur N, 2007, J CLIN DIAGN RES, V2, P87.
   Kelsen S G, 1980, Ann N Y Acad Sci, V353, P218, DOI 10.1111/j.1749-6632.1980.tb18925.x.
   Kim KY, 2011, IND HEALTH, V49, P242, DOI 10.2486/indhealth.MS1199.
   Li CS, 2003, SCI TOTAL ENVIRON, V305, P169, DOI 10.1016/S0048-9697(02)00500-4.
   Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047.
   Nevalainen A., 1993, BIOAEROSOL SAMPLING, p{[}471, 492].
   NOVITSKY JA, 1977, APPL ENVIRON MICROB, V33, P635.
   Pasquarella C, 2000, J HOSP INFECT, V46, P241, DOI 10.1053/jhin.2000.0820.
   Rainer J, 2001, MYCOPATHOLOGIA, V149, P87, DOI 10.1023/A:1007273131130.
   ROSZAK DB, 1987, MICROBIOL REV, V51, P365.
   Sands KEF, 1998, J HOSP INFECT, P3.
   Setlhare G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-100.
   Tambekar D. H., 2007, Journal of Medical Sciences (Pakistan), V7, P67.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{Pak. J. Pharm. Sci.}},
Doc-Delivery-Number = {{EF2UG}},
Unique-ID = {{ISI:000390180500016}},
DA = {{2018-08-13}},
}

@article{ ISI:000389640700009,
Author = {Danyal, Karamatullah and de Jong, Willem and O'Brien, Edmund and Bauer,
   Robert A. and Heppner, David E. and Little, Andrew C. and Hristova,
   Milena and Habibovic, Aida and van der Vliet, Albert},
Title = {{Acrolein and thiol-reactive electrophiles suppress allergen-induced
   innate airway epithelial responses by inhibition of DUOX1 and EGFR}},
Journal = {{AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY}},
Year = {{2016}},
Volume = {{311}},
Number = {{5}},
Pages = {{L913-L923}},
Month = {{NOV 1}},
Abstract = {{Acrolein is a major thiol-reactive component of cigarette smoke (CS)
   that is thought to contribute to increased asthma incidence associated
   with smoking. Here, we explored the effects of acute acrolein exposure
   on innate airway responses to two common airborne allergens, house dust
   mite and Alternaria alternata, and observed that acrolein exposure of
   C57BL/6 mice (5 ppm, 4 h) dramatically inhibited innate airway responses
   to subsequent allergen challenge, demonstrated by attenuated release of
   the epithelial-derived cytokines IL-33, IL-25, and IL-1 alpha. Acrolein
   and other anti-inflammatory thiol-reactive electrophiles,
   cinnamaldehyde, curcumin, and sulforaphane, similarly inhibited
   allergen-induced production of these cytokines from human or murine
   airway epithelial cells in vitro. Based on our previous observations
   indicating the importance of Ca2+-dependent signaling, activation of the
   NADPH oxidase DUOX1, and Src/EGFR-dependent signaling in
   allergen-induced epithelial secretion of these cytokines, we explored
   the impact of acrolein on these pathways. Acrolein and other
   thiol-reactive electrophiles were found to dramatically prevent
   allergen-induced activation of DUOX1 as well as EGFR, and acrolein was
   capable of inhibiting EGFR tyrosine kinase activity via modification of
   C797. Biotin-labeling strategies indicated increased cysteine
   modification and carbonylation of Src, EGFR, as well as DUOX1, in
   response to acrolein exposure in vitro and in vivo, suggesting that
   direct alkylation of these proteins on accessible cysteine residues may
   be responsible for their inhibition. Collectively, our findings indicate
   a novel anti-inflammatory mechanism of CS-derived acrolein and other
   thiol-reactive electrophiles, by directly inhibiting DUOX1- and
   EGFR-mediated airway epithelial responses to airborne allergens.}},
Publisher = {{AMER PHYSIOLOGICAL SOC}},
Address = {{9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{van der Vliet, A (Reprint Author), Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA.
   Danyal, Karamatullah; de Jong, Willem; O'Brien, Edmund; Bauer, Robert A.; Heppner, David E.; Little, Andrew C.; Hristova, Milena; Habibovic, Aida; van der Vliet, Albert, Univ Vermont, Coll Med, Dept Pathol \& Lab Med, Burlington, VT USA.}},
DOI = {{10.1152/ajplung.00276.2016}},
ISSN = {{1040-0605}},
EISSN = {{1522-1504}},
Keywords = {{asthma; dual oxidase 1; IL-33; airway epithelium; cysteine oxidation;
   cigarette smoke}},
Keywords-Plus = {{GROWTH-FACTOR RECEPTOR; OBSTRUCTIVE PULMONARY-DISEASE; CIGARETTE-SMOKE;
   MESENCHYMAL TRANSITION; DRUG-RESISTANCE; C-SRC; ASTHMA; INFLAMMATION;
   ACTIVATION; CELLS}},
Research-Areas = {{Physiology; Respiratory System}},
Web-of-Science-Categories  = {{Physiology; Respiratory System}},
Author-Email = {{albert.van-der-vliet@uvm.edu}},
ORCID-Numbers = {{Little, Andrew/0000-0003-0135-1032}},
Funding-Acknowledgement = {{NIH {[}R01 ES021476, HL085646, T32 HL076122, F32 HL129706]}},
Funding-Text = {{This work was supported by research grants from the NIH to A. van der
   Vliet (R01 ES021476 and HL085646) and fellowship support to A. C. Little
   (T32 HL076122) and D. E. Heppner (F32 HL129706).}},
Cited-References = {{Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010.
   Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455.
   Bein K, 2011, MOL NUTR FOOD RES, V55, P1342, DOI 10.1002/mnfr.201100279.
   Botelho FM, 2011, AM J RESP CELL MOL, V45, P753, DOI 10.1165/rcmb.2010-0404OC.
   Cai J, 2009, CHEM RES TOXICOL, V22, P708, DOI 10.1021/tx800465m.
   Carre A, 2015, ANTIOXID REDOX SIGN, V23, P724, DOI 10.1089/ars.2015.6265.
   Chao LK, 2008, FOOD CHEM TOXICOL, V46, P220, DOI 10.1016/j.fct.2007.07.016.
   Chauhan PS, 2014, INT IMMUNOPHARMACOL, V21, P63, DOI 10.1016/j.intimp.2014.03.021.
   Coogan PF, 2015, AM J RESP CRIT CARE, V191, P168, DOI 10.1164/rccm.201406-1108OC.
   De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200.
   Deshmukh HS, 2005, AM J RESP CRIT CARE, V171, P305, DOI 10.1164/rccm.200408-1003OC.
   Engel J, 2015, J MED CHEM, V58, P6844, DOI 10.1021/acs.jmedchem.5b01082.
   Erle DJ, 2014, J CELL BIOL, V205, P621, DOI 10.1083/jcb.201401050.
   Fanga S. H, 2004, INT J APPL SCI ENG, V2, P136.
   Geraghty P, 2014, AM J RESP CELL MOL, V50, P559, DOI 10.1165/rcmb.2013-0258OC.
   Giannoni E, 2014, ANTIOXID REDOX SIGN, V20, P2011, DOI 10.1089/ars.2013.5525.
   Gilliland FD, 2006, AM J RESP CRIT CARE, V174, P1092, DOI 10.1164/rccm.200605-722OC.
   Gras D, 2013, PHARMACOL THERAPEUT, V140, P290, DOI 10.1016/j.pharmthera.2013.07.008.
   Holtzman MJ, 2014, NAT REV IMMUNOL, V14, P686, DOI 10.1038/nri3739.
   Hristova M, 2016, J ALLERGY CLIN IMMUN, V137, P1545, DOI 10.1016/j.jaci.2015.10.003.
   Jia Y, 2016, NATURE, V534, P129, DOI 10.1038/nature17960.
   Kasahara DI, 2008, J IMMUNOL, V181, P736, DOI 10.4049/jimmunol.181.1.736.
   Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6.
   Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020.
   Kwarcinski FE, 2012, ACS CHEM BIOL, V7, P1910, DOI 10.1021/cb300337u.
   Lambert C, 2007, J BIOL CHEM, V282, P19666, DOI 10.1074/jbc.M611527200.
   Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036.
   Lanckacker EA, 2013, EUR RESPIR J, V41, P1189, DOI 10.1183/09031936.00096612.
   Li L, 1997, REV ENV HLTH, V13, P99.
   Liew FY, 2015, IMMUNITY, V42, P401, DOI 10.1016/j.immuni.2015.02.014.
   LoPachin RM, 2014, CHEM RES TOXICOL, V27, P1081, DOI 10.1021/tx5001046.
   Meitzler JL, 2013, J BIOL CHEM, V288, P7147, DOI 10.1074/jbc.M112.414797.
   Molofsky AB, 2015, IMMUNITY, V42, P1005, DOI 10.1016/j.immuni.2015.06.006.
   Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112.
   O'Brien E, 2016, J IMMUNOTOXICOL, V13, P191, DOI 10.3109/1547691X.2015.1033571.
   Pace E, 2014, BBA-MOL BASIS DIS, V1842, P1630, DOI 10.1016/j.bbadis.2014.06.009.
   Park JH, 2012, BMB REP, V45, P311, DOI 10.5483/BMBRep.2012.45.5.311.
   Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736.
   Polosa R, 2013, EUR RESPIR J, V41, P716, DOI 10.1183/09031936.00073312.
   Qiu CA, 2013, IMMUNOLOGY, V138, P76, DOI 10.1111/imm.12020.
   Rahman I, 1996, THORAX, V51, P348, DOI 10.1136/thx.51.4.348.
   Randall MJ, 2013, FEBS LETT, V587, P3808, DOI 10.1016/j.febslet.2013.10.006.
   Robbins CS, 2005, J IMMUNOL, V175, P2834, DOI 10.4049/jimmunol.175.5.2834.
   RUBY AJ, 1995, CANCER LETT, V94, P79, DOI 10.1016/0304-3835(95)03827-J.
   Schwartz PA, 2014, P NATL ACAD SCI USA, V111, P173, DOI 10.1073/pnas.1313733111.
   Sham D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054391.
   Spiess PC, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-107.
   Spiess PC, 2011, J PROTEOMICS, V74, P2380, DOI 10.1016/j.jprot.2011.05.039.
   Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530.
   Takeuchi K, 2001, J CELL BIOCHEM, V81, P679, DOI 10.1002/jcb.1105.
   Tang MS, 2011, MOL NUTR FOOD RES, V55, P1291, DOI 10.1002/mnfr.201100148.
   Thatcher TH, 2008, AM J PHYSIOL-LUNG C, V295, pL412, DOI 10.1152/ajplung.00392.2007.
   Trimble NJ, 2009, AM J RESP CELL MOL, V40, P38, DOI 10.1165/rcmb.2008-0107OC.
   Vasil'ev YV, 2014, MASS SPECTROM REV, V33, P157, DOI 10.1002/mas.21389.
   Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200.
   Woodruff PG, 2010, AM J RESP CRIT CARE, V181, P438, DOI {[}10.1164/rccm.200909-14150OC, 10.1164/rccm.200909-1415OC].
   WU R, 1982, IN VITRO CELL DEV B, V18, P800.
   Yadav IS, 2014, GENE, V539, P82, DOI 10.1016/j.gene.2014.01.056.
   Zhang HQ, 2012, FREE RADICAL BIO MED, V52, P1437, DOI 10.1016/j.freeradbiomed.2012.01.024.
   ZHANG YS, 1994, P NATL ACAD SCI USA, V91, P3147, DOI 10.1073/pnas.91.8.3147.}},
Number-of-Cited-References = {{60}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{10}},
Journal-ISO = {{Am. J. Physiol.-Lung Cell. Mol. Physiol.}},
Doc-Delivery-Number = {{EE5IS}},
Unique-ID = {{ISI:000389640700009}},
OA = {{green\_published}},
DA = {{2018-08-13}},
}

@article{ ISI:000389735200071,
Author = {Herzog, A. L. and Wanner, C. and Lopau, K.},
Title = {{Successful Short-Term Intravenous Treatment of Disseminated Nocardia
   farcinica Infection with Severe Hyponatremia After Kidney
   Transplantation: A Case Report}},
Journal = {{TRANSPLANTATION PROCEEDINGS}},
Year = {{2016}},
Volume = {{48}},
Number = {{9}},
Pages = {{3115-3119}},
Month = {{NOV}},
Note = {{4th National Congress of the Spanish-Society-of-Transplantation,
   Santander, SPAIN, MAY 06-08, 2016}},
Organization = {{Spanish Soc Transplantat}},
Abstract = {{Background. Nocardia is a genus of gram-positive Actinomycetes that are
   ubiquitous in decaying organic material, soil, and water. Some Nocardia
   species can infect humans, mainly by airborne transmission. Several
   reports describe disseminated infections, which are rare and mostly
   affect strongly immunocompromised patients because intact T-cell
   mediated immunity is the major protective mechanism.
   Case Report. We report a case of disseminated pulmonary, cerebral, and
   cutaneous infection with Nocardia farcinica in a 66-year-old kidney
   transplant recipient treated with low-dose triple immunosuppression. The
   patient was initially admitted because of severe hyponatremia and
   pneumonia with radiologic signs of pleural effusion. The infectious
   agent was isolated when cutaneous lesions developed. Oral
   trimethoprim/sulfamethoxazole treatment led to severe hyponatremia;
   therefore, long-term treatment with parenteral amikacin and minocycline
   was initiated. After 7 months of consistent intravenous treatment, the
   lesions completely resolved and treatment was stopped, against some
   expert suggestions. The patient had remained free of relapse at the time
   of writing.
   Conclusions. Disseminated Nocardia infection in immunocompromised
   patients is a rare but life-threatening disease. Owing to its
   infrequency, the variety of clinical patterns, antimicrobial resistance,
   and often fatal complications of standardized therapy, the diagnosis and
   treatment of this infection remain challenging and protracted.}},
Publisher = {{ELSEVIER SCIENCE INC}},
Address = {{360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Herzog, AL (Reprint Author), Transplantat Zentrum, Dept Med 1, Div Nephrol, Oberdurrbacherstr 6, D-97080 Wurzburg, Germany.
   Herzog, A. L.; Wanner, C.; Lopau, K., Univ Wurzburg, Med Klin 1, Div Nephrol, Wurzburg, Germany.}},
DOI = {{10.1016/j.transproceed.2016.04.004}},
ISSN = {{0041-1345}},
EISSN = {{1873-2623}},
Keywords-Plus = {{RECIPIENTS}},
Research-Areas = {{Immunology; Surgery; Transplantation}},
Web-of-Science-Categories  = {{Immunology; Surgery; Transplantation}},
Author-Email = {{herzog\_a1@ukw.de}},
Cited-References = {{Abreu C, 2015, WORLD J GASTROENTERO.
   Baldawa Sachin, 2014, Asian J Neurosurg, V9, P245, DOI 10.4103/1793-5482.146661.
   BEAMAN BL, 1994, CLIN MICROBIOL REV, V7, P213.
   Bruno P, 2011, EUR REV MED PHARMACO, V15, P401.
   Dunn Rebecca L, 2011, Consult Pharm, V26, P754, DOI 10.4140/TCP.n.2011.754.
   Leli C, 2013, CASE REP MED, V2013.
   Lerner PI, 1996, CLIN INFECT DIS, V22, P891, DOI 10.1093/clinids/22.6.891.
   Mori H, 2003, INTERNAL MED, V42, P665, DOI 10.2169/internalmedicine.42.665.
   Peleg AY, 2007, CLIN INFECT DIS, V44, P1307, DOI 10.1086/514340.
   Scharfen J, 2010, EPIDEMIOL MIKROBI IM, V59, P13.
   Simpson RS, 2014, MEDICINE, V42, P23, DOI DOI 10.1016/J.MPMED.2013.10.012.
   Sorrell TC, 2005, PRINCIPLES PRACTICE, V2.
   Valdezate S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00376.
   Verma Rishi, 2015, W V Med J, V111, P36.
   WILSON JP, 1989, MEDICINE, V68, P38, DOI 10.1097/00005792-198901000-00003.
   Xu QS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000848.
   Yokota Sho, 2010, Nihon Ishinkin Gakkai Zasshi, V51, P93.
   Condas LAZ, 2015, REV INST MED TROP SP, V57, P251, DOI 10.1590/S0036-46652015000300012.}},
Number-of-Cited-References = {{18}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Transplant. Proc.}},
Doc-Delivery-Number = {{EE6PR}},
Unique-ID = {{ISI:000389735200071}},
DA = {{2018-08-13}},
}

@article{ ISI:000384776800065,
Author = {Ribeiro, Joaquim de Paula and Kalb, Ana Cristina and Campos, Paula
   Peixoto and Huaman De la Cruz, Alex Ruben and Martinez, Pablo Elias and
   Gioda, Adriana and de Souza, Marta Marques and Gioda, Carolina Rosa},
Title = {{Toxicological effects of particulate matter (PM2.5) on rats:
   Bioaccumulation, antioxidant alterations, lipid damage, and ABC
   transporter activity}},
Journal = {{CHEMOSPHERE}},
Year = {{2016}},
Volume = {{163}},
Pages = {{569-577}},
Month = {{NOV}},
Abstract = {{Previous studies have demonstrated the harmful effects of atmospheric
   pollutants on cardiac systems because of the presence of particulate
   matter (PM), a complex mixture of numerous substances including trace
   metals. In this study, the toxicity of PM2.5 from two regions, rural
   (PM2.5 level of 8.5 +/- 4.0 mu g m(-3)) and industrial (PM2.5 level of
   14.4 +/- 4.1 mu g m(-3)) in Brazil, was investigated through in vivo
   experiments in rats. Metal accumulation and biochemical responses were
   evaluated after rats were exposed to three different concentrations of
   PM2.5 in saline extract (10x dilution, 5x dilution, and concentrated).
   The experimental data showed the bioaccumulation of diverse trace metals
   in the hearts of groups exposed to PM2.5 from both regions. Furthermore,
   mobilization of the antioxidant defenses and an increase in lipid
   peroxidation of the cardiac tissue was observed in response to the
   industrial and rural area PM2.5. Glutathione-S-transferase activity was
   increased in groups exposed to the 5x and concentrated rural PM2.5.
   Additionally, ATP-binding cassette (ABC) transporter activity in the
   cardiac tissue exposed to PM2.5 was reduced in response to the 5x
   dilution of the rural and industrial region PM2.5. Histological analysis
   showed a decrease in the percentage of cardiac cells in the heart at all
   tested concentrations. The results indicate that exposure to different
   concentrations of PM2.5 from both sources causes biochemical and}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Gioda, CR (Reprint Author), Univ Fed Rio Grande, Inst Ciencias Biol, Ave Italia Km 8,Campus Carreiros,Caixa Postal 474, BR-96203900 Rio Grande, RS, Brazil.
   Ribeiro, Joaquim de Paula; Kalb, Ana Cristina; Martinez, Pablo Elias; de Souza, Marta Marques; Gioda, Carolina Rosa, Univ Fed Rio Grande, Inst Ciencias Biol, FURG, Rio Grande, RS, Brazil.
   Ribeiro, Joaquim de Paula; Kalb, Ana Cristina; Martinez, Pablo Elias; de Souza, Marta Marques; Gioda, Carolina Rosa, Fundacao Univ Fed Rio Grande, Inst Ciencias Biol, Programa Pos Grad Ciencias Fisiol, Rio Grande, RS, Brazil.
   Campos, Paula Peixoto, Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Farmacol, Belo Horizonte, MG, Brazil.
   Huaman De la Cruz, Alex Ruben; Gioda, Adriana, Pontificia Univ Catolica Rio de Janeiro PUC Rio, Dept Quim, Rio De Janeiro, RJ, Brazil.}},
DOI = {{10.1016/j.chemosphere.2016.07.094}},
ISSN = {{0045-6535}},
EISSN = {{1879-1298}},
Keywords = {{Antioxidant capacity; Bioaccumulation; Heart; ABC transporters}},
Keywords-Plus = {{OXIDATIVE STRESS; AIR-POLLUTION; MULTIDRUG-RESISTANCE;
   CARDIOVASCULAR-DISEASE; CARDIAC FIBROBLASTS; CYSTEINE LIGASE;
   LEAD-EXPOSURE; HEAVY-METALS; DNA-DAMAGE; CADMIUM}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{carolinagioda@furg.br}},
ResearcherID-Numbers = {{Souza, Marta/E-4974-2013}},
Funding-Acknowledgement = {{Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES, Brazil); Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ, RJ, Brazil)}},
Funding-Text = {{The authors are grateful to Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq, Brazil), Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES, Brazil), and Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ, RJ, Brazil) for financial
   support and to Institute Estadual do Ambiente (INEA, RJ, Brazil) for
   providing PM<INF>2.5</INF> samples. We specially thank Dr Jose Maria
   Monserrat for his important assistance and contribution in reviewing
   this study.}},
Cited-References = {{Amado LL, 2009, SCI TOTAL ENVIRON, V407, P2115, DOI 10.1016/j.scitotenv.2008.11.038.
   Araujo JA, 2008, CIRC RES, V102, P589, DOI 10.1161/CIRCRESAHA.107.164970.
   Bai N, 2007, PHARMACOL THERAPEUT, V113, P16, DOI 10.1016/j.pharmthera.2006.06.005.
   Barison A., 2015, HEART FAIL REV, V30, P1.
   Byrd JB, 2016, J AM SOC HYPERTENS, V10, P133, DOI 10.1016/j.jash.2015.11.015.
   Cabral M, 2015, ENVIRON POLLUT, V206, P247, DOI 10.1016/j.envpol.2015.06.032.
   Carson F. L, 2009, HISTOTECHNOLOGY SELF.
   Casalino E, 2004, TOXICOLOGY, V200, P29, DOI 10.1016/j.tox.2004.03.004.
   Deng J, 2015, J PHARMACOL EXP THER, V355, P272, DOI 10.1124/jpet.115.225490.
   Dewanjee S, 2013, FOOD CHEM TOXICOL, V55, P78, DOI 10.1016/j.fct.2012.12.040.
   Donaldson K, 2003, FREE RADICAL BIO MED, V34, P1369, DOI 10.1016/S0891-5849(03)00150-3.
   Donaldson K, 2001, INT J HYG ENVIR HEAL, V203, P411, DOI 10.1078/1438-4639-00059.
   Flens MJ, 1996, AM J PATHOL, V148, P1237.
   Fuentes-Mattei E, 2010, TOXICOL APPL PHARM, V243, P381, DOI 10.1016/j.taap.2009.12.009.
   Garcia T, 2016, FOOD CHEM TOXICOL, V92, P177, DOI 10.1016/j.fct.2016.04.010.
   Gill EA, 2011, PROG CARDIOVASC DIS, V53, P353, DOI 10.1016/j.pcad.2011.02.001.
   Gilmour PS, 1996, OCCUP ENVIRON MED, V53, P817, DOI 10.1136/oem.53.12.817.
   Gioda A, 2011, J ENVIRON MONITOR, V13, P2134, DOI 10.1039/c1em10240k.
   Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706.
   Guerrero-Castilla A, 2014, MUTAT RES-GEN TOX EN, V762, P24, DOI 10.1016/j.mrgentox.2013.12.005.
   Habig W H, 1981, Methods Enzymol, V77, P218.
   Haider S, 2015, METAB BRAIN DIS, V30, P83, DOI 10.1007/s11011-014-9578-4.
   Hu Y., 2003, ARSEN EXPO HLTH EF 5, V13, P167.
   Huttunen K, 2012, ENVIRON RES, V116, P44, DOI 10.1016/j.envres.2012.04.004.
   Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001.
   Kai H, 2006, HYPERTENS RES, V29, P711, DOI 10.1291/hypres.29.711.
   Kato T., 2011, ENVIRON TOXICOL, V28, P588.
   Kim JB, 2012, TOXICOL APPL PHARM, V259, P66, DOI 10.1016/j.taap.2011.12.007.
   Kim KH, 2015, ENVIRON INT, V74, P136, DOI 10.1016/j.envint.2014.10.005.
   Kurelec B, 2000, ECOTOXICOLOGY, V9, P307, DOI 10.1023/A:1026560922731.
   Marchini T, 2013, BBA-GEN SUBJECTS, V1830, P2545, DOI 10.1016/j.bbagen.2012.11.012.
   Martinelli N, 2013, EUR J INTERN MED, V24, P295, DOI 10.1016/j.ejim.2013.04.001.
   Mateus VL, 2013, SPECTROCHIM ACTA B, V86, P131, DOI 10.1016/j.sab.2013.03.003.
   Mendez-Armenta M, 2011, ENVIRON TOXICOL PHAR, V32, P107, DOI 10.1016/j.etap.2011.03.001.
   Nair PMG, 2013, ENVIRON TOXICOL PHAR, V36, P265, DOI 10.1016/j.etap.2013.04.001.
   Nascarella MA, 2012, DOSE-RESPONSE, V10, P344, DOI 10.2203/dose-response.10-025.Nascarella.
   Oakes KD, 2003, AQUAT TOXICOL, V63, P447, DOI 10.1016/S0166-445X(02)00204-7.
   Peters A, 2001, CIRCULATION, V103, P2810.
   Pope CA, 2008, AM J CARDIOL, V102, P1230, DOI 10.1016/j.amjcard.2008.06.044.
   Pope III C. A., 2000, ENV HLTH PERSP, V108, P713, DOI DOI 10.1289/EHP.00108S4713.
   Pulido MD, 2003, MUTAT RES-FUND MOL M, V533, P227, DOI 10.1016/j.mrfmmm.2003.07.015.
   Quig D, 1998, Altern Med Rev, V3, P262.
   Risom L, 2005, MUTAT RES-FUND MOL M, V592, P119, DOI 10.1016/j.mrfmmm.2005.06.012.
   Rivero DHRF, 2005, TOXICOL SCI, V85, P898, DOI 10.1093/toxsci/kfi137.
   Rodriguez-Cotto RI, 2014, ENVIRON POLLUT, V194, P112, DOI 10.1016/j.envpol.2014.07.010.
   Schuetze KB, 2014, J MOL CELL CARDIOL, V70, P100, DOI 10.1016/j.yjmcc.2014.02.015.
   Shi HL, 2004, FREE RADICAL BIO MED, V37, P582, DOI 10.1016/j.freeradbiomed.2004.03.012.
   STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H.
   Valko M, 2016, ARCH TOXICOL, V90, P1, DOI 10.1007/s00204-015-1579-5.
   Wallenborn JG, 2009, TOXICOL APPL PHARM, V241, P71, DOI 10.1016/j.taap.2009.08.003.
   Wang XZ, 2014, BIOL TRACE ELEM RES, V159, P312, DOI 10.1007/s12011-014-9970-2.
   White CC, 2003, ANAL BIOCHEM, V318, P175, DOI 10.1016/S0003-2697(03)00143-X.
   Zhang W, 2016, TOXICOL SCI, V151, P44, DOI 10.1093/toxsci/kfw021.
   Zhang Y, 2009, ENVIRON POLLUT, V157, P3064, DOI 10.1016/j.envpol.2009.05.039.}},
Number-of-Cited-References = {{54}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{8}},
Usage-Count-Since-2013 = {{51}},
Journal-ISO = {{Chemosphere}},
Doc-Delivery-Number = {{DY0HB}},
Unique-ID = {{ISI:000384776800065}},
DA = {{2018-08-13}},
}

@article{ ISI:000397866600001,
Author = {Pai, Madhukar and Behr, Marcel A. and Dowdy, David and Dheda, Keertan
   and Divangahi, Maziar and Boehme, Catharina C. and Ginsberg, Ann and
   Swaminathan, Soumya and Spigelman, Melvin and Getahun, Haileyesus and
   Menzies, Dick and Raviglione, Mario},
Title = {{Tuberculosis}},
Journal = {{NATURE REVIEWS DISEASE PRIMERS}},
Year = {{2016}},
Volume = {{2}},
Month = {{OCT 27}},
Abstract = {{Tuberculosis (TB) is an airborne infectious disease caused by organisms
   of the Mycobacterium tuberculosis complex. Although primarily a
   pulmonary pathogen, M. tuberculosis can cause disease in almost any part
   of the body. Infection with M. tuberculosis can evolve from containment
   in the host, in which the bacteria are isolated within granulomas
   (latent TB infection), to a contagious state, in which the patient will
   show symptoms that can include cough, fever, night sweats and weight
   loss. Only active pulmonary TB is contagious. In many low-income and
   middle-income countries, TB continues to be a major cause of morbidity
   and mortality, and drug-resistant TB is a major concern in many
   settings. Although several new TB diagnostics have been developed,
   including rapid molecular tests, there is a need for simpler
   point-of-care tests. Treatment usually requires a prolonged course of
   multiple antimicrobials, stimulating efforts to develop shorter drug
   regimens. Although the Bacillus Calmette-Guerin (BCG) vaccine is used
   worldwide, mainly to prevent life-threatening TB in infants and young
   children, it has been ineffective in controlling the global TB epidemic.
   Thus, efforts are underway to develop newer vaccines with improved
   efficacy. New tools as well as improved programme implementation and
   financing are necessary to end the global TB epidemic by 2035.}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Pai, M (Reprint Author), McGill Univ, McGill Int TB Ctr, 1020 Pine Ave West, Quebec City, PQ H3A 1A2, Canada.
   Pai, Madhukar; Behr, Marcel A.; Divangahi, Maziar, McGill Univ, McGill Int TB Ctr, 1020 Pine Ave West, Quebec City, PQ H3A 1A2, Canada.
   Pai, Madhukar, Manipal Univ, Manipal McGill Ctr Infect Dis, Manipal, India.
   Dowdy, David, Univ Cape Town, Div Pulmonol, UCT Lung Inst, Cape Town, South Africa.
   Dheda, Keertan, Fdn Innovat New Diagnost FIND, Geneva, Switzerland.
   Boehme, Catharina C., Aeras, Rockville, MD USA.
   Ginsberg, Ann, Indian Council Med Res, New Delhi, India.
   Swaminathan, Soumya, Global Alliance TB Drug Dev, New York, NY USA.
   Spigelman, Melvin, Global TB Programme, WHO, Geneva, Switzerland.}},
DOI = {{10.1038/nrdp.2016.76}},
Article-Number = {{UNSP 16076}},
ISSN = {{2056-676X}},
Keywords-Plus = {{DRUG-RESISTANT TUBERCULOSIS; DIAGNOSED PULMONARY TUBERCULOSIS;
   HUMAN-IMMUNODEFICIENCY-VIRUS; CLUSTER-RANDOMIZED TRIAL;
   PLACEBO-CONTROLLED TRIAL; MIDDLE-INCOME COUNTRIES; GAMMA RELEASE ASSAYS;
   HIV-INFECTED ADULTS; XPERT MTB/RIF ASSAY; SUB-SAHARAN AFRICA}},
Research-Areas = {{General \& Internal Medicine}},
Web-of-Science-Categories  = {{Medicine, General \& Internal}},
Author-Email = {{madhukar.pai@mcgill.ca}},
ORCID-Numbers = {{RAVIGLIONE, Mario/0000-0002-9331-2067}},
Funding-Acknowledgement = {{Canada Research Chair award from the Canadian Institutes of Health
   Research (CIHR); CIHR; Bill \& Melinda Gates Foundation; TMA Pai
   Endowment Chair from Manipal University, India; Public Health Agency of
   Canada; US National Institutes of Health (NIH); NIH; US Centers for
   Disease Control and Prevention; US Agency for International Development;
   European Developing Clinical Trials Partnership; South African Medical
   Research Council; South African National Research Foundation; CIHR
   Foundation {[}FDN-143273]; Foundation for Innovative New Diagnostics
   (FIND) (Australia); Foundation for Innovative New Diagnostics (FIND)
   (the Netherlands); Foundation for Innovative New Diagnostics (FIND)
   (United Kingdom); Foundation for Innovative New Diagnostics (FIND)
   (Switzerland); UK Department for International Development (DFID); Dutch
   Ministry of Foreign Affairs (DGIS); Australian Agency for International
   Development (AusAID); Global Health Innovative Technology (GHIT) Fund;
   US FDA; US National Institute of Allergy and Infectious Diseases (NIAID)
   of the NIH; AusAID; DFID; DGIS; European Commission (EC); GHIT;
   Indonesia Health Fund; NIAID/NIH; UNITAID; US Agency for International
   Development (USAID); FDA}},
Funding-Text = {{M.P. is a recipient of a Canada Research Chair award from the Canadian
   Institutes of Health Research (CIHR), and acknowledges grant support
   from the CIHR and the Bill \& Melinda Gates Foundation. He also holds a
   TMA Pai Endowment Chair from Manipal University, India. M.A.B.
   acknowledges grant support from the CIHR, the Public Health Agency of
   Canada and the US National Institutes of Health (NIH). D.D. acknowledges
   grant support from the NIH, CIHR, US Centers for Disease Control and
   Prevention, US Agency for International Development and the Bill \&
   Melinda Gates Foundation. K.D. acknowledges grant support from the
   European Developing Clinical Trials Partnership, the South African
   Medical Research Council and the South African National Research
   Foundation. M.D. is supported by the CIHR Foundation Grant (FDN-143273)
   as well as a CIHR New Investigator Award. C.C.B. acknowledges grant
   support for Foundation for Innovative New Diagnostics (FIND) from
   several governments (Australia, the Netherlands, the United Kingdom and
   Switzerland), the Bill \& Melinda Gates Foundation and the NIH. A.G. is
   a full-time employee of Aeras, which has received current or past grant
   support from the Bill \& Melinda Gates Foundation, the UK Department for
   International Development (DFID), the Dutch Ministry of Foreign Affairs
   (DGIS), the Australian Agency for International Development (AusAID),
   the Global Health Innovative Technology (GHIT) Fund, the US FDA and the
   US National Institute of Allergy and Infectious Diseases (NIAID) of the
   NIH. S.S. is a full-time employee of the Indian Council of Medical
   Research (ICMR), a Government of India agency. M.S. is a full-time
   employee of TB Alliance, which has received current or past grant
   support from AusAID, the Bill \& Melinda Gates Foundation, DFID, DGIS,
   the European Commission (EC), GHIT, the Indonesia Health Fund,
   NIAID/NIH, UNITAID, the US Agency for International Development (USAID)
   and the FDA. D.M. acknowledges grant support from CIHR.}},
Cited-References = {{Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773.
   Abel L, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0428.
   Abubakar I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17370.
   AERAS, 2014, TB VACC RES DEV BUS.
   Albanna AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025075.
   Albert H, 2016, EUR RESPIR J, V48, P516, DOI 10.1183/13993003.00543-2016.
   Alsultan A, 2014, DRUGS, V74, P839, DOI 10.1007/s40265-014-0222-8.
   Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2.
   Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951.
   Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753.
   {[}Anonymous], 2014, INT STAND TUB CAR.
   Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817.
   Arend SM, 2002, J INFECT DIS, V186, P1797, DOI 10.1086/345760.
   Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304.
   Barreto ML, 2011, VACCINE, V29, P4875, DOI 10.1016/j.vaccine.2011.05.023.
   Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236.
   Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335.
   Bauer M, 2013, QUAL LIFE RES, V22, P2213, DOI 10.1007/s11136-012-0329-x.
   Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387.
   Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520.
   Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247.
   Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911.
   Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8.
   Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847.
   Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591.
   Bradley P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10063.
   Brigden G, 2014, B WORLD HEALTH ORGAN, V92, P68, DOI 10.2471/BLT.13.122028.
   Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008.
   Calligaro GL, 2014, J THORAC DIS, V6, P186, DOI 10.3978/j.issn.2072-1439.2013.11.11.
   Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002.
   Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X.
   Cobat A, 2009, J EXP MED, V206, P2583, DOI 10.1084/jem.20090892.
   Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744.
   Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590.
   COMSTOCK GW, 1961, PUBLIC HEALTH REP, V76, P19, DOI 10.2307/4591052.
   Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9.
   Cox E, 2014, NEW ENGL J MED, V371, P689, DOI 10.1056/NEJMp1314385.
   Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2.
   Cruciani M, 2004, J CLIN MICROBIOL, V42, P2321, DOI 10.1128/JCM.42.5.2321-2325.2004.
   Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198.
   DANIELS M, 1952, BRIT MED J, V1, P1162, DOI 10.1136/bmj.1.4769.1162.
   Das J, 2015, LANCET INFECT DIS, V15, P1305, DOI 10.1016/S1473-3099(15)00077-8.
   Datta M, 1999, INDIAN J MED RES, V110, P56.
   Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814.
   Denkinger CM, 2013, EXPERT REV MOL DIAGN, V13, P763, DOI 10.1586/14737159.2013.850034.
   Denkinger CM, 2013, EUR RESPIR J, V42, P544, DOI 10.1183/09031936.00081113.
   Detjen AK, 2015, LANCET RESP MED, V3, P451, DOI 10.1016/S2213-2600(15)00095-8.
   Dheda K, 2016, LANCET, V387, P1211, DOI 10.1016/S0140-6736(15)00151-8.
   Dheda K, 2014, LANCET RESP MED, V2, P321, DOI 10.1016/S2213-2600(14)70031-1.
   Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8.
   Divangahi M, 2015, TRENDS IMMUNOL, V36, P307, DOI 10.1016/j.it.2015.03.005.
   Dodd PJ, 2016, LANCET INFECT DIS, V16, P1193, DOI 10.1016/S1473-3099(16)30132-3.
   Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1.
   Dominguez J, 2016, INT J TUBERC LUNG D, V20, P24, DOI 10.5588/ijtld.15.0221.
   Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC.
   Dowdy DW, 2014, CLIN INFECT DIS, V59, P1123, DOI 10.1093/cid/ciu506.
   Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC.
   Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109.
   Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0.
   Ellis RD, 2015, TUBERCULOSIS, V95, P352, DOI 10.1016/j.tube.2015.02.036.
   Esmail H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0437.
   Esmail H, 2016, NAT MED, V22, P1090, DOI 10.1038/nm.4161.
   Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192.
   Fenner L, 2012, J CLIN MICROBIOL, V50, P388, DOI 10.1128/JCM.05392-11.
   Ferguson JS, 1999, J IMMUNOL, V163, P312.
   Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256.
   Fletcher HA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11290.
   Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X.
   Fox GJ, 2016, CLIN INFECT DIS, V62, P887, DOI 10.1093/cid/ciw002.
   FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406.
   Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103.
   Gardiner JL, 2015, J EXP MED, V212, P1759, DOI 10.1084/jem.20151468.
   Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0.
   Getahun H, 2015, EUR RESPIR J, V46, P1563, DOI 10.1183/13993003.01245-2015.
   Getahun H, 2015, NEW ENGL J MED, V373, P1179.
   Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391.
   Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492.
   Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426.
   Gupta RK, 2013, INT J TUBERC LUNG D, V17, P1014, DOI 10.5588/ijtld.13.0032.
   Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423.
   Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607.
   Hawn TR, 2014, MICROBIOL MOL BIOL R, V78, P650, DOI 10.1128/MMBR.00021-14.
   Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x.
   IFPMA, 2012, TB DRUG ACC PROGR.
   Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC.
   Jenkins HE, 2013, EUR RESPIR J, V42, P1291, DOI 10.1183/09031936.00111812.
   Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152.
   Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210.
   Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181.
   Karumbi J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003343.pub4.
   Kaufmann SHE, 2016, IMMUNITY, V44, P476, DOI 10.1016/j.immuni.2016.02.014.
   Kendall EA, 2015, LANCET RESP MED, V3, P963, DOI 10.1016/S2213-2600(15)00458-0.
   Kik SV, 2014, EUR RESPIR J, V43, P1793, DOI 10.1183/09031936.00217313.
   Knight GM, 2014, P NATL ACAD SCI USA, V111, P15520, DOI 10.1073/pnas.1404386111.
   Lalvani A, 2012, CELL, V148, P389, DOI 10.1016/j.cell.2012.01.026.
   Landry J, 2008, INT J TUBERC LUNG D, V12, P1352.
   Lawn SD, 2012, AIDS, V26, P2121, DOI 10.1097/QAD.0b013e3283565dd1.
   Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d.
   Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107.
   Lee M, 2012, NEW ENGL J MED, V367, P1508, DOI 10.1056/NEJMoa1201964.
   Lee RS, 2015, P NATL ACAD SCI USA, V112, P13609, DOI 10.1073/pnas.1507071112.
   Lessem E, 2016, TUBERCULOSIS DIAGNOS.
   Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862.
   Lienhardt C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001965.
   Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797.
   Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412.
   Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808.
   Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7.
   Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996.
   Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998.
   Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790.
   Manosuthi W, 2012, JAIDS-J ACQ IMM DEF, V60, P377, DOI 10.1097/QAI.0b013e31825b5e06.
   Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007.
   Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO.
   Marakalala MJ, 2016, NAT MED, V22, P531, DOI 10.1038/nm.4073.
   Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466.
   Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489.
   McDowell A, 2016, INT J TUBERC LUNG D, V20, P536, DOI 10.5588/ijtld.15.0562.
   Menzies D, 2008, INT J TUBERC LUNG D, V12, P498.
   Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817.
   Mfinanga SG, 2014, LANCET INFECT DIS, V14, P563, DOI 10.1016/S1473-3099(14)70733-9.
   Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9.
   Nahid P, 2016, CLIN INFECT DIS, V63, pe147, DOI 10.1093/cid/ciw376.
   Nebenzahl-Guimaraes H, 2014, J ANTIMICROB CHEMOTH, V69, P331, DOI 10.1093/jac/dkt358.
   Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801.
   O'Donnell MR, 2016, INT J TUBERC LUNG D, V20, P430, DOI 10.5588/ijtld.15.0360.
   Onozaki I, 2015, TROP MED INT HEALTH, V20, P1128, DOI 10.1111/tmi.12534.
   Orme IM, 2015, NAT IMMUNOL, V16, P57, DOI 10.1038/ni.3048.
   Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X.
   Pai M, 2016, EUR RESPIR J, V47, P704, DOI 10.1183/13993003.01910-2015.
   Pai M, 2015, J INFECT DIS, V211, pS21, DOI 10.1093/infdis/jiu803.
   Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13.
   Pande T, 2015, EUR RESPIR J, V46, P1816, DOI 10.1183/13993003.01064-2015.
   Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500.
   Pankhurst LJ, 2016, LANCET RESP MED, V4, P49, DOI 10.1016/S2213-2600(15)00466-X.
   Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049.
   Peter JG, 2016, LANCET, V387, P1187, DOI 10.1016/S0140-6736(15)01092-2.
   Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6.
   Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3.
   Raizada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105346.
   Raizada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089301.
   Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9.
   Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837.
   Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08.
   Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450.
   Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643.
   Russell DG, 2016, CELL MICROBIOL, V18, P1065, DOI 10.1111/cmi.12623.
   Russell DG, 2011, IMMUNOL REV, V240, P252, DOI 10.1111/j.1600-065X.2010.00984.x.
   Sachdeva KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131438.
   Sachdeva KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126065.
   Salamon H, 2015, J INFECT DIS, V211, pS50, DOI 10.1093/infdis/jiu816.
   Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3.
   Samstein M, 2013, ELIFE, V2, DOI 10.7554/eLife.01086.
   Satyanarayana S, 2015, INT J TUBERC LUNG D, V19, P751, DOI 10.5588/ijtld.15.0186.
   Satyanarayana S, 2016, LANCET INFECT DIS.
   Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST.
   Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906.
   Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810.
   Simeone R, 2016, CELL MICROBIOL, V18, P1070, DOI 10.1111/cmi.12622.
   Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507.
   Singla Neeta, 2009, Indian J Tuberc, V56, P206.
   Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827.
   SORENSEN AL, 1995, INFECT IMMUN, V63, P1710.
   Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143.
   Steingart KR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub3.
   Stop TB Partnership's Working Group on New Drugs, 2016, DRUG PIP.
   Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777.
   Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270.
   Swaminathan S, 2015, CLIN PHARMACOL THER, V98, P240, DOI 10.1002/cpt.175.
   Swaminathan S, 2010, CLIN INFECT DIS, V50, pS184, DOI 10.1086/651490.
   Sweeney TE, 2016, LANCET RESP MED, V4, P213, DOI 10.1016/S2213-2600(16)00048-5.
   Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4.
   Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5.
   Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573.
   Tiberi S, 2016, EUR RESPIR J, V47, P333, DOI 10.1183/13993003.01278-2015.
   Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601.
   Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023.
   Torok ME, 2011, CLIN INFECT DIS, V52, P1374, DOI 10.1093/cid/cir230.
   Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3.
   Udwadia ZF, 2012, THORAX, V67, P286, DOI 10.1136/thoraxjnl-2012-201663.
   Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889.
   UNITAID, 2015, TUB DIAGN TECHN MARK.
   Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0.
   Uthman OA, 2015, ANN INTERN MED, V163, P32, DOI 10.7326/M14-2979.
   van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059.
   Van Leth F, 2008, B WORLD HEALTH ORGAN, V86, P20, DOI 10.2471/BLT.06.037804.
   Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917.
   Walker TM, 2015, LANCET INFECT DIS, V15, P1193, DOI 10.1016/S1473-3099(15)00062-6.
   Wang J, 2015, GENOME BIOL EVOL, V7, P856, DOI 10.1093/gbe/evv035.
   Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2.
   Warner DF, 2015, TRENDS MICROBIOL, V23, P14, DOI 10.1016/j.tim.2014.10.005.
   Watford WT, 2001, J IMMUNOL, V167, P6593, DOI 10.4049/jimmunol.167.11.6593.
   Wells WA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001842.
   Wells WA, 2013, LANCET INFECT DIS, V13, P449, DOI 10.1016/S1473-3099(13)70025-2.
   WHO, 2014, DRUG RES TB SURV RES.
   WHO, 2015, GLOB TUB REP 2015.
   WHO, 2016, SHORT MDR TB REG.
   WHO, 2015, US LAT FLOW UR LIP A.
   WHO, 2016, CONS GUID US ANT DRU.
   WHO, 2014, GUID MAN LAT TUB INF.
   WHO, 2014, GUID NAT TUB PROGR M.
   WHO, 2010, GUID INT TUB CAS FIN.
   WHO Geneva, 2010, GUID TREATM TUB.
   Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367.
   World Health Organization, 2011, GUID PROGR MAN DRUG.
   World Health Organization, 2016, US MOL LIN PROB ASS.
   World Health Organization, 2008, MOL LIN PROB ASS RAP.
   World Health Organization, 2015, END TB STRAT GLOB ST.
   World Health Organization, 2016, US LOOPM IS AMPL TB.
   World Health Organization, 2013, SYST SCREEN ACT TUB.
   World Health Organization, 2015, WHO MON XPERT MTB RI.
   World Health Organization, 2013, POL UPD AUT REAL TIM.
   World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P617.
   Xie HX, 2012, NAT CHEM, V4, P802, DOI {[}10.1038/NCHEM.1435, 10.1038/nchem.1435].
   Yan SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127645.
   Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1.
   Zelner JL, 2016, J INFECT DIS, V213, P287, DOI 10.1093/infdis/jiv387.
   Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789.
   Zumla A, 2015, LANCET RESP MED, V3, P220, DOI 10.1016/S2213-2600(15)00063-6.
   Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012.}},
Number-of-Cited-References = {{220}},
Times-Cited = {{87}},
Usage-Count-Last-180-days = {{28}},
Usage-Count-Since-2013 = {{46}},
Journal-ISO = {{Nat. Rev. Dis. Primers}},
Doc-Delivery-Number = {{EQ1YX}},
Unique-ID = {{ISI:000397866600001}},
DA = {{2018-08-13}},
}

@article{ ISI:000386376300001,
Author = {Chakravarty, Ipsita and Kundu, Subir},
Title = {{Improved production of Daptomycin in an airlift bioreactor by
   morphologically modified and immobilized cells of Streptomyces
   roseosporus}},
Journal = {{AMB EXPRESS}},
Year = {{2016}},
Volume = {{6}},
Month = {{OCT 22}},
Abstract = {{The increased threat of drug resistance has challenged the existence of
   several conventional and non-conventional antibiotics in the recent
   times. Daptomycin is a novel cyclic-lipopeptide antibiotic produced by
   Streptomyces roseosporus that has progressed as a significant anti-MRSA
   (methicillin-resistant Staphylococcus aureus) antibiotic. But, the
   economic practicality of this highly valued secondary metabolite is
   deterred by its poor production and tedious processing methodology. The
   present study aims at strategic improvement of Daptomycin production
   through morphological variations of S. roseosporus cells. Free cells,
   pelletized cells and immobilized cells on ultra porous refractory brick
   and silk sachets were investigated for the production of Daptomycin in a
   lab-scale 2.0 l air-lift bioreactor. The effect(s) of nitrogen source,
   inoculum size and oxygen stress were analyzed for pellet formation of S.
   roseosporus. Interestingly, free cells produced 750 mg/l of Daptomycin
   in a single batch. But, the three phase broth viscosity increased due to
   vigorous growth of free cells which hampered the oxygen transfer rate.
   The cell degeneration over the time deterred pellet reusability. 1430
   mg/l Daptomycin was produced using pellets for 2 batches. On the
   contrary, mechanical stability, buoyancy and reusability of refractory
   bricks and silk sachets were beneficial. Daptomycin production was
   recorded for 6-8 batches. Immobilized cells on refractory bricks and
   silk sachets led to 4895 mg/l and 3623 mg/l Daptomycin production
   respectively. Cell immobilization improved the three phase broth
   rheology and hence, the hydrodynamics within the reactor. Therefore,
   whole-cell immobilization could contribute to the ameliorated production
   of this life-saving drug.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kundu, S (Reprint Author), Banaras Hindu Univ, Indian Inst Technol, Sch Biochem Engn, Varanasi 221005, Uttar Pradesh, India.
   Chakravarty, Ipsita; Kundu, Subir, Banaras Hindu Univ, Indian Inst Technol, Sch Biochem Engn, Varanasi 221005, Uttar Pradesh, India.}},
DOI = {{10.1186/s13568-016-0274-0}},
Article-Number = {{101}},
ISSN = {{2191-0855}},
Keywords = {{Antibiotics; Drug resistance; Morphological variation; Immobilization;
   Daptomycin}},
Keywords-Plus = {{CEPHALOSPORIN-C PRODUCTION; PENICILLIUM-CHRYSOGENUM; SUBMERGED CULTURES;
   BROTH VISCOSITY; ACREMONIUM; MODES}},
Research-Areas = {{Biotechnology \& Applied Microbiology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology}},
Author-Email = {{subirbhu@gmail.com}},
Cited-References = {{Chakravarty I, 2015, BATTLE MICROBIAL PAT, V2, P895.
   Choi DB, 2000, BIOTECHNOL PROGR, V16, P525, DOI 10.1021/bp000056x.
   DSOUZA SF, 1986, BIOTECHNOL LETT, V8, P643, DOI 10.1007/BF01025974.
   Du LX, 2003, PROCESS BIOCHEM, V38, P1643, DOI 10.1016/S0032-9592(02)00089-4.
   Eisenstein BI, 2010, CLIN INFECT DIS, V50, pS10, DOI 10.1086/647938.
   Fluit AC, 2001, J CLIN MICROBIOL, V39, P3727, DOI 10.1128/JCM.39.10.3727-3732.2001.
   Huang D, 2012, APPL MICROBIOL BIOT, V94, P637, DOI 10.1007/s00253-011-3773-6.
   KUNDU S, 1992, PROCESS BIOCHEM, V27, P347, DOI 10.1016/0032-9592(92)87013-7.
   Kundu S., 2000, INDIAN J MICROBIOL, V40, P141.
   MAHAPATRA AC, 2002, INDIAN J MICROBIOL, V42, P319.
   Mishra P, 2005, WORLD J MICROB BIOT, V21, P525, DOI 10.1007/s11274-004-3489-1.
   MORIKAWA Y, 1979, BIOTECHNOL BIOENG, V21, P261, DOI 10.1002/bit.260210211.
   NIELSEN J, 1995, BIOTECHNOL PROGR, V11, P93, DOI 10.1021/bp00031a013.
   O'Cleirigh C, 2005, APPL MICROBIOL BIOT, V68, P305, DOI 10.1007/s00253-004-1883-0.
   Papagianni M, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-5.
   Ramakrishna SV, 1999, CURR SCI INDIA, V77, P87.
   Robbel L, 2010, J BIOL CHEM, V285, P27501, DOI 10.1074/jbc.R110.128181.
   RUCHTI G, 1981, BIOTECHNOL BIOENG, V23, P277, DOI 10.1002/bit.260230204.
   Srivastava P, 1998, J GEN APPL MICROBIOL, V44, P113, DOI 10.2323/jgam.44.113.
   Tally FP, 2000, J ANTIMICROB CHEMOTH, V46, P523, DOI 10.1093/jac/46.4.523.
   Yu GH, 2011, WORLD J MICROB BIOT, V27, P1859, DOI 10.1007/s11274-010-0644-8.}},
Number-of-Cited-References = {{21}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{16}},
Journal-ISO = {{AMB Express}},
Doc-Delivery-Number = {{EA1UB}},
Unique-ID = {{ISI:000386376300001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000388524300001,
Author = {Mora, Maximilian and Mahnert, Alexander and Koskinen, Kaisa and Pausan,
   Manuela R. and Oberauner-Wappis, Lisa and Krause, Robert and Perras,
   Alexandra K. and Gorkiewicz, Gregor and Berg, Gabriele and
   Moissi-Eichinger, Christine},
Title = {{Microorganisms in Confined Habitats: Microbial Monitoring and Control of
   Intensive Care Units, Operating Rooms, Cleanrooms and the International
   Space Station}},
Journal = {{FRONTIERS IN MICROBIOLOGY}},
Year = {{2016}},
Volume = {{7}},
Month = {{OCT 13}},
Abstract = {{Indoor environments, where people spend most of their time, are
   characterized by a specific microbial community, the indoor microbiome.
   Most indoor environments are connected to the natural environment by
   high ventilation, but some habitats are more confined: intensive care
   units, operating rooms, cleanrooms and the international space station
   (ISS) are extraordinary living and working areas for humans, with a
   limited exchange with the environment. The purposes for confinement are
   different: a patient has to be protected from infections (intensive care
   unit, operating room), product quality has to be assured (cleanrooms),
   or confinement is necessary due to extreme, health threatening outer
   conditions, as on the ISS. The ISS represents the most secluded man-made
   habitat, constantly inhabited by humans since November 2000 - and,
   inevitably, also by microorganisms. All of these man-made confined
   habitats need to be microbiologically monitored and controlled, by e.g.,
   microbial cleaning and disinfection. However, these measures apply
   constant selective pressures, which support microbes with resistance
   capacities against antibiotics or chemical and physical stresses and
   thus facilitate the rise of survival specialists and multi-resistant
   strains. In this article, we summarize the available data on the
   microbiome of aforementioned confined habitats. By comparing the
   different operating, maintenance and monitoring procedures as well as
   microbial communities therein, we emphasize the importance to properly
   understand the effects of confinement on the microbial diversity, the
   possible risks represented by some of these microorganisms and by the
   evolution of (antibiotic) resistances in such environments - and the
   need to reassess the current hygiene standards.}},
Publisher = {{FRONTIERS MEDIA SA}},
Address = {{PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Moissi-Eichinger, C (Reprint Author), Med Univ Graz, Dept Internal Med, Graz, Austria.
   Moissi-Eichinger, C (Reprint Author), BioTechMed Graz, Graz, Austria.
   Mora, Maximilian; Koskinen, Kaisa; Pausan, Manuela R.; Krause, Robert; Perras, Alexandra K.; Moissi-Eichinger, Christine, Med Univ Graz, Dept Internal Med, Graz, Austria.
   Mahnert, Alexander; Berg, Gabriele, Graz Univ Technol, Inst Environm Biotechnol, Graz, Austria.
   Koskinen, Kaisa; Gorkiewicz, Gregor; Moissi-Eichinger, Christine, BioTechMed Graz, Graz, Austria.
   Oberauner-Wappis, Lisa; Gorkiewicz, Gregor, Med Univ Graz, Dept Pathol, Graz, Austria.
   Perras, Alexandra K., Univ Regensburg, Dept Microbiol, Regensburg, Germany.}},
DOI = {{10.3389/fmicb.2016.01573}},
Article-Number = {{1573}},
ISSN = {{1664-302X}},
Keywords = {{microbiome; built environment; indoor; confined habitat; microorganisms}},
Keywords-Plus = {{RESISTANT STAPHYLOCOCCUS-AUREUS; HOSPITAL-ACQUIRED INFECTION;
   BACTERIAL-CONTAMINATION; NOSOCOMIAL INFECTIONS; ENVIRONMENTAL SURFACES;
   CLOSTRIDIUM-DIFFICILE; INANIMATE SURFACES; AIR CONTAMINATION; RISK;
   DIVERSITY}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{eichinger@medunigraz.at}},
ResearcherID-Numbers = {{Koskinen, Kaisa/T-9905-2017
   }},
ORCID-Numbers = {{Koskinen, Kaisa/0000-0001-5727-8415
   Pausan, Manuela-Raluca/0000-0001-6741-4521
   Berg, Gabriele/0000-0001-9423-3101}},
Funding-Acknowledgement = {{FFG {[}847977]}},
Funding-Text = {{We thank all colleagues that provided information. This work was
   supported by FFG No. 847977. MM and NW were trained within the frame of
   the Ph.D. Program Molecular Medicine of the Medical University of Graz.}},
Cited-References = {{Adler A, 2005, J INFECTION, V51, P390, DOI 10.1016/j.jinf.2004.12.006.
   Agodi A, 2007, INTENS CARE MED, V33, P1155, DOI 10.1007/s00134-007-0671-6.
   Al Laham Nahed A, 2012, J Infect Public Health, V5, P43, DOI 10.1016/j.jiph.2011.10.006.
   Alekhova TA, 2015, DOKL BIOCHEM BIOPHYS, V465, P347, DOI 10.1134/S1607672915060010.
   Alekhova TA, 2005, APPL BIOCHEM MICRO+, V41, P382, DOI 10.1007/s10438-005-0065-x.
   AMANN RI, 1995, MICROBIOL REV, V59, P143.
   Amirfeyz R, 2007, ANN ROY COLL SURG, V89, P607, DOI 10.1308/003588407X205440.
   Anderson DJ, 2007, INFECT CONT HOSP EP, V28, P1047, DOI 10.1086/520731.
   Anderson RN, 2005, NATL VITAL STAT REPO, P53.
   Anusha Venkatesan, 2015, International Journal of Biomedical and Advance Research, V6, P435.
   Aponte VM, 2006, LIFE SCI, V79, P1317, DOI 10.1016/j.lfs.2006.04.007.
   Arnold C, 2014, ENVIRON HEALTH PERSP, V122, pA182, DOI 10.1289/ehp.122-A182.
   Beceiro A, 2013, CLIN MICROBIOL REV, V26, P185, DOI 10.1128/CMR.00059-12.
   Bekatorou A, 2006, FOOD TECHNOL BIOTECH, V44, P407.
   Berg G., 2015, FRONT MICROBIOL, V5, P15.
   Beswick A. J., 2011, J APPL BIOSAFETY, V16, P139, DOI DOI 10.1177/153567601101600303.
   Birgand G, 2015, AM J INFECT CONTROL, V43, P516, DOI 10.1016/j.ajic.2015.01.026.
   Birgand G, 2015, INFECT CONT HOSP EP, V36, P93, DOI 10.1017/ice.2014.9.
   Blazejewski Caroline, 2011, Infectious Disorders - Drug Targets, V11, P365.
   Bonora MG, 2004, MICROB DRUG RESIST, V10, P114, DOI 10.1089/1076629041310046.
   Boyce JM, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0111-x.
   Brooks B, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-1.
   Bruce R. J., 2005, SAE T, V114, P283.
   Buffet-Bataillon S, 2009, J HOSP INFECT, V72, P17, DOI 10.1016/j.jhin.2009.01.010.
   Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05.
   Califf K, 2014, MICROBE, V9, P410.
   Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8.
   Carling P, 2013, AM J INFECT CONTROL, V41, pS20, DOI 10.1016/j.ajic.2013.01.003.
   Castro VA, 2004, MICROBIAL ECOL, V47, P119, DOI 10.1007/s00248-003-1030-y.
   Centers for Disease and Prevention, 2010, 57 CTR DIS PREV.
   Centers for Disease and Prevention, 2002, 49 CTR DIS PERV.
   Centers for Disease Control and Prevention, 2003, MMWR RECOMM REP, V52, P1.
   Chauveaux D, 2015, ORTHOP TRAUMATOL-SUR, V101, pS77, DOI 10.1016/j.otsr.2014.07.028.
   Checinska A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0116-3.
   Coil DA, 2016, PEERJ, V4, DOI 10.7717/peerj.1842.
   Couto RC, 2007, AM J INFECT CONTROL, V35, P183, DOI 10.1016/j.ajic.2006.06.013.
   Cristina ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052809.
   Czupalla M, 2005, ADV SPACE RES, V35, P1609, DOI 10.1016/j.asr.2005.06.010.
   Dai CY, 2015, AM J INFECT CONTROL, V43, P78, DOI 10.1016/j.ajic.2014.10.004.
   Dancer SJ, 2008, LANCET INFECT DIS, V8, P101, DOI 10.1016/S1473-3099(07)70241-4.
   Daniels C, 2009, CLIN MICROBIOL INFEC, V15, P32, DOI 10.1111/j.1469-0691.2008.02693.x.
   Daxboeck F, 2006, J HOSP INFECT, V62, P214, DOI 10.1016/j.jhin.2005.07.009.
   Dharan S, 2002, J HOSP INFECT, V51, P79, DOI 10.1053/jhin.2002.1217.
   DINEEN P, 1973, LANCET, V2, P1157.
   Directorate N. M. O, 2000, INT SPACE STATION IN.
   Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107.
   DONOWITZ LG, 1982, CRIT CARE MED, V10, P355, DOI 10.1097/00003246-198206000-00001.
   Duane P., 2011, P 41 INT C ENV SYST.
   Edmiston CE, 2005, SURGERY, V138, P573, DOI 10.1016/j.surg.2005.06.045.
   FAVERO MS, 1966, APPL MICROBIOL, V14, P539.
   FAVERO MS, 1968, APPL MICROBIOL, V16, P480.
   Fijan S, 2012, INT J ENV RES PUB HE, V9, P3330, DOI 10.3390/ijerph9093330.
   Friberg B, 1999, J HOSP INFECT, V42, P287, DOI 10.1053/jhin.1998.0598.
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010.
   Gaci N, 2014, WORLD J GASTROENTERO, V20, P16062, DOI 10.3748/wjg.v20.i43.16062.
   Gastmeier P, 2007, AM J INFECT CONTROL, V35, P172, DOI 10.1016/j.ajic.2006.07.007.
   Genet C, 2011, ETHIOP J HEALTH SCI, V21, P9.
   Goodman ER, 2008, INFECT CONT HOSP EP, V29, P593, DOI 10.1086/588566.
   Griffith CJ, 2000, J HOSP INFECT, V45, P19, DOI 10.1053/jhin.1999.0717.
   Guh A., 2015, OPTIONS EVALUATING E.
   Gupta C., 2015, OFFICIAL SCI J DELHI, V25, P190, DOI {[}10.1089/sur.2014.097, DOI 10.1089/SUR.2014.097].
   Habib M.A.B., 2008, REV CULTURE PRODUCTI.
   Hammond TG, 2013, ASTROBIOLOGY, V13, P1081, DOI 10.1089/ast.2013.0986.
   Handorean A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0132-3.
   Harsoor SS, 2007, INDIAN J ANAESTH, V51, P193.
   Hee HI, 2014, ANAESTHESIA, V69, P816, DOI 10.1111/anae.12633.
   HEEG P, 1994, ZBL HYG UMWELTMED, V195, P282.
   Hewitt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054703.
   Hoppe P, 1998, INT J BIOMETEOROL, V42, P1, DOI 10.1007/s004840050075.
   Hortig H.-P., 2002, REINRAUMTECHNIK, P1.
   Howard JL, 2007, J ARTHROPLASTY, V22, P6, DOI 10.1016/j.artli.2007.05.013.
   Hu H, 2015, J HOSP INFECT, V91, P35, DOI 10.1016/j.jhin.2015.05.016.
   Huang SS, 2006, ARCH INTERN MED, V166, P1945, DOI 10.1001/archinte.166.18.1945.
   Humphreys H, 2009, J HOSP INFECT, V73, P316, DOI 10.1016/j.jhin.2009.03.028.
   Hussong D., 2004, PHARM TECHNOL, V28, P10.
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234.
   Ichijo T, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.7.
   KIM KH, 1981, J INFECT DIS, V143, P42, DOI 10.1093/infdis/143.1.42.
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205.
   Kminek G, 2015, SPACE RES TODAY, V193, P7.
   Knobben BAS, 2006, J HOSP INFECT, V62, P174, DOI 10.1016/j.jhin.2005.08.007.
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130.
   Kulpmann R, 2016, GMS HYG INFECT CONTR, V11, DOI 10.3205/dgkh000263.
   La Duc MT, 2004, MICROB ECOL, V47, P150, DOI 10.1007/s00248-003-1012-0.
   La Duc MT, 2003, ENVIRON MICROBIOL, V5, P977, DOI 10.1046/j.1462-2920.2003.00496.x.
   La Duc MT, 2007, APPL ENVIRON MICROB, V73, P2600, DOI 10.1128/AEM.03007-06.
   La Duc MT, 2009, APPL ENVIRON MICROB, V75, P6559, DOI 10.1128/AEM.01073-09.
   LaDuc M. T., 2003, HABITATION ELMSFORD, V10, P39, DOI {[}10.3727/154296604774808883, DOI 10.3727/154296604774808883].
   Landrin A, 2005, J HOSP INFECT, V61, P27, DOI 10.1016/j.jhin.2005.03.002.
   Li CS, 2003, SCI TOTAL ENVIRON, V305, P169, DOI 10.1016/S0048-9697(02)00500-4.
   Lives S. S. S., 2009, WHO GUIDELINES SAFE.
   LIVORNESE LL, 1992, ANN INTERN MED, V117, P112, DOI 10.7326/0003-4819-117-2-112.
   Lynch RJ, 2009, AM J MED QUAL, V24, P45, DOI 10.1177/1062860608326419.
   Mahnert A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00887.
   Mahnert A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134848.
   Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X.
   Marinella MA, 1997, ARCH INTERN MED, V157, P786, DOI 10.1001/archinte.157.7.786.
   McLeod V., 2010, BIOSAFETY LEVELS 1 2.
   Meadow JF, 2015, PEERJ, V3, DOI 10.7717/peerj.1258.
   Moissl C, 2008, ISME J, V2, P115, DOI 10.1038/ismej.2007.98.
   Moissl C, 2007, FEMS MICROBIOL ECOL, V61, P509, DOI 10.1111/j.1574-6941.2007.00360.x.
   Moissl-Eichinger C, 2016, FEMS MICROBIOL REV, V40, P722, DOI 10.1093/femsre/fuw015.
   Moissl-Eichinger C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09156.
   Moissl-Eichinger C, 2013, ASTROBIOLOGY, V13, P1125, DOI 10.1089/ast.2013.1024.
   Moissl-Eichinger C, 2012, ASTROBIOLOGY, V12, P1024, DOI 10.1089/ast.2012.0906.
   Moissl-Eichinger C, 2011, ISME J, V5, P209, DOI 10.1038/ismej.2010.124.
   Mord I. S. S., 2009, HOUSTON, V307, P22.
   MYERS MG, 1978, PEDIATRICS, V61, P42.
   Naesens R, 2009, J HOSP INFECT, V71, P197, DOI 10.1016/j.jhin.2008.10.018.
   Napoli C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-594.
   Nicholson WL, 2009, TRENDS MICROBIOL, V17, P389, DOI 10.1016/j.tim.2009.07.001.
   Nitta K, 1999, ADV SPACE RES, V24, P343, DOI 10.1016/S0273-1177(99)00322-1.
   Novikova N, 2006, RES MICROBIOL, V157, P5, DOI 10.1016/j.resmic.2005.07.010.
   Novikova N. D., 2001, RES MICROBILOGICAL R.
   Novikova ND, 2004, MICROBIAL ECOL, V47, P127, DOI 10.1007/s00248-003-1035-2.
   Nseir S, 2011, CLIN MICROBIOL INFEC, V17, P1201, DOI 10.1111/j.1469-0691.2010.03420.x.
   Oberauner L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01413.
   Ott M, 2014, MICROBES ENVIRON, V29, P239, DOI 10.1264/jsme2.ME2903rh.
   Parfrey LW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00153.
   Pasquarella C, 2000, J HOSP INFECT, V46, P241, DOI 10.1053/jhin.2000.0820.
   Passaretti CL, 2013, CLIN INFECT DIS, V56, P27, DOI 10.1093/cid/cis839.
   Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124.
   Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824.
   Perez E, 2014, J CLIN MICROBIOL, V52, P823, DOI 10.1128/JCM.02220-13.
   Pham TAN, 2014, CURR OPIN MICROBIOL, V17, P67, DOI 10.1016/j.mib.2013.12.002.
   Pierson D L, 2001, Gravit Space Biol Bull, V14, P1.
   Pittet D, 2006, LANCET INFECT DIS, V6, P641, DOI 10.1016/S1473-3099(06)70600-4.
   Powers E. M., 1965, TECHNICAL REPORT.
   Poza M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044105.
   Probst A, 2010, APPL ENVIRON MICROB, V76, P2837, DOI 10.1128/AEM.02167-09.
   Probst AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065388.
   PULEO JR, 1977, APPL ENVIRON MICROB, V33, P379.
   Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x.
   Raschka S, 2013, AM J INFECT CONTROL, V41, P773, DOI 10.1016/j.ajic.2012.10.026.
   Richmond Y. S., 1999, BIOSAFETY MICROBIOLO.
   Ruiz-Calderon JF, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501061.
   Russotto V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0120-5.
   Rutala WA, 2008, GUIDELINE DISINFECTI.
   Safdar N, 2012, INT J INFECT CONTROL, V8, P10, DOI DOI 10.3396/IJIC.V8I2.012.12.
   Salassa TE, 2014, J BONE JOINT SURG AM, V96A, P1485, DOI 10.2106/JBJS.M.01133.
   Salgado CD, 2013, INFECT CONT HOSP EP, V34, P479, DOI 10.1086/670207.
   Satoh K, 2011, MICROBIOL IMMUNOL, V55, P823, DOI 10.1111/j.1348-0421.2011.00386.x.
   Scaltriti S, 2007, J HOSP INFECT, V66, P320, DOI 10.1016/j.jhin.2007.05.019.
   Schabrun S, 2006, PHYSIOTHER RES INT, V11, P61, DOI 10.1002/pri.329.
   Schmidt MG, 2016, AM J INFECT CONTROL, V44, P203, DOI 10.1016/j.ajic.2015.09.008.
   Schroder C, 2015, INT J MED MICROBIOL, V305, P799, DOI 10.1016/j.ijmm.2015.08.034.
   SEAL DV, 1990, J APPL BACTERIOL, V68, P225, DOI 10.1111/j.1365-2672.1990.tb02568.x.
   Semmelweis I., 1988, CHALLENGE EPIDEMIOLO, P46.
   Shin HD, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0126-1.
   Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007.
   Singh N, 2005, INFECT CONT HOSP EP, V26, P646, DOI 10.1086/502595.
   Sonnenfeld G, 2002, NUTRITION, V18, P899, DOI 10.1016/S0899-9007(02)00903-6.
   Spagnolo A M, 2013, J Prev Med Hyg, V54, P131.
   Stieglmeier M, 2012, ASTROBIOLOGY, V12, P572, DOI 10.1089/ast.2011.0735.
   Stieglmeier M, 2009, APPL ENVIRON MICROB, V75, P3484, DOI 10.1128/AEM.02565-08.
   Stocks GW, 2010, AM J INFECT CONTROL, V38, P199, DOI 10.1016/j.ajic.2009.07.006.
   Stover BH, 2001, AM J INFECT CONTROL, V29, P152, DOI 10.1067/mic.2001.115407.
   Sun Y, 2016, ECOL ENG, V88, P165, DOI 10.1016/j.ecoleng.2015.12.013.
   Taylor PW, 2015, INFECT DRUG RESIST, V8, P249, DOI 10.2147/IDR.S67275.
   Thomas M, 2005, AM J HEALTH-SYST PH, V62, P2386, DOI 10.2146/ajhp050078.
   Touati A, 2009, ANN EPIDEMIOL, V19, P372, DOI 10.1016/j.annepidem.2009.03.010.
   Triassi M, 2006, J HOSP INFECT, V62, P494, DOI 10.1016/j.jhin.2005.09.029.
   Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011.
   U. S. Department of Health and Human Services Public Health Service Centers for Disease Control and Prevention National Institutes of Health. Biosafety in microbiological and biomedical laboratories (BMBL), 2009, HHS PUBL.
   Unahalekhaka A., 2011, IFIC BASIC CONCEPTS, P27.
   Urrea M, 2003, PEDIATR INFECT DIS J, V22, P490, DOI 10.1097/00006454-200306000-00002.
   Vaishampayan P, 2013, ISME J, V7, P312, DOI 10.1038/ismej.2012.114.
   van den Berg RWA, 2000, J HOSP INFECT, V45, P29, DOI 10.1053/jhin.1999.0657.
   van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109.
   Van Houdt R, 2012, PLANET SPACE SCI, V60, P115, DOI 10.1016/j.pss.2011.09.001.
   Venkateswaran K, 2014, MICROBES ENVIRON, V29, P243, DOI 10.1264/jsme2.ME14032.
   Venkateswaran K, 2014, APPL MICROBIOL BIOT, V98, P6453, DOI 10.1007/s00253-014-5650-6.
   Venkateswaran K, 2014, ASTROBIOLOGY, V14, P24, DOI 10.1089/ast.2013.0978.
   Verde SC, 2015, RES MICROBIOL, V166, P557, DOI 10.1016/j.resmic.2015.03.004.
   VESLEY D, 1966, APPL MICROBIOL, V14, P203.
   Vesper SJ, 2008, RES MICROBIOL, V159, P432, DOI 10.1016/j.resmic.2008.06.001.
   Vickery K, 2012, J HOSP INFECT, V80, P52, DOI 10.1016/j.jhin.2011.07.007.
   VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639.
   Wan GH, 2011, AM J INFECT CONTROL, V39, P302, DOI 10.1016/j.ajic.2010.07.006.
   Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196.
   Weinmaier T, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0129-y.
   Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4.
   Whitfield W., 1964, Patent No. {[}US3158457A, 3158457A].
   Whyte W., 2010, CLEANROOM TECHNOLOGY.
   Whyte W, 2004, EUR J PHARM SCI, V9, P11.
   Whyte W., 2004, EUROPEAN J PARENTERA, V9, P16, DOI {[}10.5731/pdajpst.2011.00693, DOI 10.5731/PDAJPST.2011.00693].
   Whyte W., 1999, CLEANROOM DESIGN.
   WHYTE W, 2007, EUR J PARENTER PHARM, V12, P39.
   Whyte W., 2001, CLEANROOM TECHNOLOGY.
   WILSON DE, 2007, BIOSAFETY MICROBIOLO.
   Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104.
   Wolcott R D, 2009, J Wound Care, V18, P317.
   Wu Gen-fu, 2007, Journal of Zhejiang University-Science B, V8, P666, DOI 10.1631/jzus.2007.B0666.
   Yamaguchi N., 2016, T JPN SOC AERONAUT S, V14, p{[}1, 4], DOI {[}10.2322/tastj.14.Pp\_1, DOI 10.2322/TASTJ.14.PP\_1].}},
Number-of-Cited-References = {{194}},
Times-Cited = {{10}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{54}},
Journal-ISO = {{Front. Microbiol.}},
Doc-Delivery-Number = {{ED0HT}},
Unique-ID = {{ISI:000388524300001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000385047800002,
Author = {Pal, Chandan and Bengtsson-Palme, Johan and Kristiansson, Erik and
   Larsson, D. G. Joakim},
Title = {{The structure and diversity of human, animal and environmental
   resistomes}},
Journal = {{MICROBIOME}},
Year = {{2016}},
Volume = {{4}},
Month = {{OCT 7}},
Abstract = {{Background: Antibiotic resistance genes (ARGs) are widespread but cause
   problems only when present in pathogens. Environments where selection
   and transmission of antibiotic resistance frequently take place are
   likely to be characterized by high abundance and diversity of
   horizontally transferable ARGs. Large-scale quantitative data on ARGs
   is, however, lacking for most types of environments, including humans
   and animals, as is data on resistance genes to potential co-selective
   agents, such as biocides and metals. This paucity prevents efficient
   identification of risk environments.
   Results: We provide a comprehensive characterization of resistance
   genes, mobile genetic elements (MGEs) and bacterial taxonomic
   compositions for 864 metagenomes from humans (n = 350), animals (n =
   145) and external environments (n = 369), all deeply sequenced using
   Illumina technology. Environment types showed clear differences in both
   resistance profiles and bacterial community compositions. Human and
   animal microbial communities were characterized by limited taxonomic
   diversity and low abundance and diversity of biocide/metal resistance
   genes and MGEs but a relatively high abundance of ARGs. In contrast,
   external environments showed consistently high taxonomic diversity which
   in turn was linked to high diversity of both biocide/metal resistance
   genes and MGEs. Water, sediment and soil generally carried low relative
   abundance and few varieties of known ARGs, whereas wastewater/sludge was
   on par with the human gut. The environments with the largest relative
   abundance and/or diversity of ARGs, including genes encoding resistance
   to last resort antibiotics, were those subjected to industrial
   antibiotic pollution and a limited set of deeply sequenced air samples
   from a Beijing smog event.
   Conclusions: Our study identifies air and antibiotic-polluted
   environments as under-investigated transmission routes and reservoirs
   for antibiotic resistance. The high taxonomic and genetic diversity of
   external environments supports the hypothesis that these also form vast
   sources of unknown resistance genes, with potential to be transferred to
   pathogens in the future.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Larsson, DGJ (Reprint Author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, SE-41346 Gothenburg, Sweden.
   Larsson, DGJ (Reprint Author), Univ Gothenburg, Ctr Antibiot Resistance Res CARe, Gothenburg, Sweden.
   Pal, Chandan; Bengtsson-Palme, Johan; Larsson, D. G. Joakim, Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, SE-41346 Gothenburg, Sweden.
   Pal, Chandan; Bengtsson-Palme, Johan; Kristiansson, Erik; Larsson, D. G. Joakim, Univ Gothenburg, Ctr Antibiot Resistance Res CARe, Gothenburg, Sweden.
   Kristiansson, Erik, Chalmers Univ Technol, Dept Math Sci, SE-41296 Gothenburg, Sweden.}},
DOI = {{10.1186/s40168-016-0199-5}},
Article-Number = {{54}},
ISSN = {{2049-2618}},
Keywords = {{Antibiotic resistance; Biocide resistance; Metal resistance; Resistome;
   Metagenomics; Human microbiome; Environmental microbiome}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE GENES; WATER TREATMENT-PLANT; AVERAGE GENOME SIZE;
   COMPARATIVE METAGENOMICS; HUMAN MICROBIOME; ESCHERICHIA-COLI;
   BETA-LACTAMASES; GLOBAL SPREAD; RIBOSOMAL-RNA; BACTERIA}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{joakim.larsson@fysiologi.gu.se}},
ORCID-Numbers = {{Pal, Chandan/0000-0002-0503-8804
   Bengtsson-Palme, Johan/0000-0002-6528-3158}},
Funding-Acknowledgement = {{Swedish Research Council for Environment, Agriculture and Spatial
   Planning (FORMAS) {[}2012-86]; Swedish Research Council (VR); Life
   Science Area of Advance at Chalmers University of Technology; Wallenberg
   Foundation; Wilhelm \& Martina Lundgrens Foundation {[}2015-0493];
   Centre for Sea and Society at the University of Gothenburg; Centre for
   Antibiotic Resistance Research (CARe) at University of Gothenburg}},
Funding-Text = {{This work was funded by the Swedish Research Council for Environment,
   Agriculture and Spatial Planning (FORMAS) (2012-86 to DGJL); the Swedish
   Research Council (VR); the Life Science Area of Advance at Chalmers
   University of Technology; the Wallenberg Foundation; The Wilhelm \&
   Martina Lundgrens Foundation (2015-0493 to CP); the Centre for Sea and
   Society at the University of Gothenburg; and the Centre for Antibiotic
   Resistance Research (CARe) at University of Gothenburg.}},
Cited-References = {{Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86.
   Ashbolt NJ, 2013, ENVIRON HEALTH PERSP, V121, P993, DOI 10.1289/ehp.1206316.
   Baquero F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00015.
   Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x.
   Bengtsson-Palme J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00648.
   Bengtsson-Palme J, 2016, SCI TOTAL ENVIRON, V572, P697, DOI 10.1016/j.scitotenv.2016.06.228.
   Bengtsson-Palme J, 2016, ENVIRON INT, V86, P140, DOI 10.1016/j.envint.2015.10.015.
   Bengtsson-Palme J, 2015, MOL ECOL RESOUR, V15, P1403, DOI 10.1111/1755-0998.12399.
   Bengtsson-Palme J, 2015, NAT REV MICROBIOL, V13, DOI 10.1038/nrmicro3399-c1.
   Beszteri B, 2010, ISME J, V4, P1075, DOI 10.1038/ismej.2010.29.
   Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953.
   Cao C, 2014, ENVIRON SCI TECHNOL, V48, P1499, DOI 10.1021/es4048472.
   Chapin A, 2005, ENVIRON HEALTH PERSP, V113, P137, DOI 10.1289/ehp.7473.
   Cheng Z, 2016, ENVIRON INT, V89-90, P212, DOI 10.1016/j.envint.2016.02.003.
   D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388.
   Dantas G, 2012, CURR OPIN MICROBIOL, V15, P577, DOI 10.1016/j.mib.2012.07.004.
   de Been M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004776.
   de Meo PD, 2012, NUCLEIC ACIDS RES, V40, pD1168, DOI 10.1093/nar/gkr1144.
   Durso LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048325.
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461.
   Fitzpatrick D, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv168.
   Flach CF, 2015, J ANTIMICROB CHEMOTH, V70, P2709, DOI 10.1093/jac/dkv167.
   Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377.
   Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761.
   Grace D., 2015, REV EVIDENCE ANTIMIC.
   Graham DW, 2016, SCI REP-UK, V6, DOI 10.1038/srep21550.
   Grave K, 2014, J ANTIMICROB CHEMOTH, V69, P2284, DOI 10.1093/jac/dku106.
   Gregova G, 2012, ANN AGR ENV MED, V19, P75.
   Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202.
   Hatosy SM, 2015, APPL ENVIRON MICROB, V81, P7593, DOI 10.1128/AEM.00736-15.
   Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151.
   HUGHES VM, 1983, NATURE, V302, P725, DOI 10.1038/302725a0.
   Humeniuk C, 2002, ANTIMICROB AGENTS CH, V46, P3045, DOI 10.1128/AAC.46.9.3045-3049.2002.
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234.
   Johnson AP, 2013, J MED MICROBIOL, V62, P499, DOI 10.1099/jmm.0.052555-0.
   JONES C, 1992, J GEN MICROBIOL, V138, P189, DOI 10.1099/00221287-138-1-189.
   Jonsson V, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2386-y.
   Ju F, 2016, WATER RES, V91, P1, DOI 10.1016/j.watres.2015.11.071.
   Kim S, 2015, COMMUN STAT APPL MET, V22, P665, DOI 10.5351/CSAM.2015.22.6.665.
   Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x.
   Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038.
   Larsson DGJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0571.
   Laxminarayan R, 2014, SCIENCE, V345, P1299, DOI 10.1126/science.1254163.
   Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9.
   Li B, 2015, ISME J, V9, P2490, DOI 10.1038/ismej.2015.59.
   Li H, 2012, SEQTK TOOLKIT PROCES.
   Lundstrom SV, 2016, SCI TOTAL ENVIRON, V553, P587, DOI 10.1016/j.scitotenv.2016.02.103.
   Manor O, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0610-8.
   Marathe NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077310.
   Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483.
   McEachran AD, 2015, ENVIRON HEALTH PERSP, V123, P337, DOI 10.1289/ehp.1408555.
   McLellan SL, 2010, ENVIRON MICROBIOL, V12, P378, DOI 10.1111/j.1462-2920.2009.02075.x.
   Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386.
   Munck C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9452.
   Nayfach S, 2016, CELL, V166, P1103, DOI 10.1016/j.cell.2016.08.007.
   Nayfach S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0611-7.
   Nesme J, 2014, CURR BIOL, V24, P1096, DOI 10.1016/j.cub.2014.03.036.
   Newton RJ, 2015, MBIO, V6, DOI 10.1128/mBio.02574-14.
   Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655.
   O'Neill Jim, 2014, ANTIMICROBIAL RESIST.
   Oksanen AJ, 2015, VEGAN COMMUNITY ECOL.
   ONeill J., 2016, TACKLING DRUG RESIST.
   Osterblad M, 2001, NATURE, V409, P37, DOI 10.1038/35051173.
   Pal C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2153-5.
   Pal C, 2014, NUCLEIC ACIDS RES, V42, pD737, DOI 10.1093/nar/gkt1252.
   Pehrsson EC, 2016, NATURE, V533, P212, DOI 10.1038/nature17672.
   Perron GG, 2007, P R SOC B, V274, P2351, DOI 10.1098/rspb.2007.0640.
   Perron GG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0069533.
   Petersen TN, 2015, SCI REP-UK, V5, DOI 10.1038/srep11444.
   Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109.
   Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P3593, DOI 10.1128/AAC.49.8.3593-3597.2005.
   Port JA, 2014, ENVIRON HEALTH PERSP, V122, P222, DOI 10.1289/ehp.1307009.
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219.
   R Development Core Team, 2013, R LANG ENV STAT COMP.
   Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032.
   SCENIHR, 2009, ASS ANT RES EFF BIOC.
   Segawa T, 2013, ENV MICROBIOL REP, V5, P127, DOI 10.1111/1758-2229.12011.
   Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571.
   Spencer SJ, 2016, ISME J, V10, P427, DOI 10.1038/ismej.2015.124.
   Su JY, 2006, FEMS MICROBIOL LETT, V254, P75, DOI 10.1111/j.1574-6968.2005.00025.x.
   Swedish Government, 2016, NAT PHARM STRAT 2016.
   Tang JY, 2016, ECOTOX ENVIRON SAFE, V132, P260, DOI 10.1016/j.ecoenv.2016.06.016.
   Teixeira JV, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5382-4.
   Thaller MC, 2011, PLOS ONE, V5, pe8989.
   Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05.
   van Hoek AHAM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00203.
   Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923.
   Warnes G. R., 2011, GPLOTS VARIOUS R PRO.
   WHO, 2014, ANT RES GLOB ANT RES.
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3\_1.
   World Health Organization (WHO), 2015, GLOB ACT PLAN ANT RE.
   Yooseph S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081862.
   Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110.}},
Number-of-Cited-References = {{93}},
Times-Cited = {{51}},
Usage-Count-Last-180-days = {{20}},
Usage-Count-Since-2013 = {{151}},
Journal-ISO = {{Microbiome}},
Doc-Delivery-Number = {{DY4CY}},
Unique-ID = {{ISI:000385047800002}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000406830200004,
Author = {Lee, Ji Yeon},
Title = {{Tuberculosis Infection Control in Health-Care Facilities: Environmental
   Control and Personal Protection}},
Journal = {{TUBERCULOSIS AND RESPIRATORY DISEASES}},
Year = {{2016}},
Volume = {{79}},
Number = {{4}},
Pages = {{234-240}},
Month = {{OCT}},
Abstract = {{Transmission of tuberculosis (TB) is a recognized risk to patients and
   healthcare workers in healthcare settings. The literature review
   suggests that implementation of combination control measures reduces the
   risk of TB transmission. Guidelines suggest a three-level hierarchy of
   controls including administrative, environmental, and respiratory
   protection. Among environmental controls, installation of ventilation
   systems is a priority because ventilation reduces the number of
   infectious particles in the air. Natural ventilation is cost-effective
   but depends on climatic conditions. Supplemented intervention such as
   air-cleaning methods including high efficiency particulate air
   filtration and ultraviolet germicidal irradiation should be considered
   in areas where adequate ventilation is difficult to achieve. Personal
   protective equipment including particulate respirators provides
   additional benefit when administrative and environmental controls cannot
   assure protection.}},
Publisher = {{TAEHAN KYORHAEK HYOPHOE-KOREAN ACAD TUBERCULOSIS \& RESPIRATORY DISEASES}},
Address = {{101-605 SEOCHO ART XI 1583-10 SEOCHO 3-DONG, SEOCHO-GU, SEOUL, 137-875,
   SOUTH KOREA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Lee, JY (Reprint Author), Natl Med Ctr, Dept Internal Med, Div Pulm \& Crit Care Med, 245 Eulji Ro, Seoul 04564, South Korea.
   Lee, Ji Yeon, Natl Med Ctr, Dept Internal Med, Div Pulm \& Crit Care Med, 245 Eulji Ro, Seoul 04564, South Korea.}},
DOI = {{10.4046/trd.2016.79.4.234}},
ISSN = {{1738-3536}},
EISSN = {{2005-6184}},
Keywords = {{Tuberculosis; Infection Control; Environment; Controlled; Ventilation;
   Personal Protective Equipment}},
Keywords-Plus = {{FILTERING-FACEPIECE RESPIRATORS; MULTIDRUG-RESISTANT TUBERCULOSIS; USER
   SEAL CHECK; MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION; OUTBREAK; FIT;
   PREVENTION; WORKERS; RISK}},
Research-Areas = {{Respiratory System}},
Web-of-Science-Categories  = {{Respiratory System}},
Author-Email = {{jedidiah125@gmail.com}},
Cited-References = {{American Institute of Architects, 2006, GUID DES CONSTR HLTH.
   American Society of Heating Refrigerating and Air-Conditioning Engineers, 2003, 2003 ASHRAE HDB HVAC.
   Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5.
   Brubacher J, 1996, CHEST, V109, P582, DOI 10.1378/chest.109.2.582-a.
   Clayton M, 2005, ANN OCCUP HYG, V49, P545, DOI 10.1093/annhyg/mei046.
   Coffey CC, 2004, J OCCUP ENVIRON HYG, V1, P262, DOI 10.1080/15459620490433799.
   Curry International Tuberculosis Center, 2011, TUB INF CONTR PRACT.
   Curtis AB, 2000, INT J TUBERC LUNG D, V4, P308.
   Danyluk Q, 2011, J OCCUP ENVIRON HYG, V8, P267, DOI 10.1080/15459624.2011.566016.
   Department of Health and Human Services Centers for Disease Control and Prevention, 2009, DHHS NIOSH PUBL.
   EDLIN BR, 1992, NEW ENGL J MED, V326, P1514, DOI 10.1056/NEJM199206043262302.
   EHRENKRA.NJ, 1972, ANN INTERN MED, V77, P377, DOI 10.7326/0003-4819-77-3-377.
   Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068.
   Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043.
   Fennelly KP, 1997, CLIN CHEST MED, V18, P1, DOI 10.1016/S0272-5231(05)70352-X.
   Lam SC, 2011, J HOSP INFECT, V77, P252, DOI 10.1016/j.jhin.2010.09.034.
   Lam SC, 2016, AM J INFECT CONTROL, V44, P579, DOI 10.1016/j.ajic.2015.12.013.
   Lee K, 2004, J OCCUP ENVIRON HYG, V1, P22, DOI 10.1080/15459620490250026.
   McMahon E, 2008, AM J INFECT CONTROL, V36, P298, DOI 10.1016/j.ajic.2007.10.014.
   Mehta AC, 2005, CHEST, V128, P1742, DOI 10.1378/chest.128.3.1742.
   Menzies D, 2000, ANN INTERN MED, V133, P779, DOI 10.7326/0003-4819-133-10-200011210-00010.
   Mohle-Boetani JC, 2002, CLIN INFECT DIS, V34, P668, DOI 10.1086/338815.
   Mphaphlele M, 2015, AM J RESP CRIT CARE, V192, P477, DOI 10.1164/rccm.201501-0060OC.
   National hospitalization (isolation) wards and operating management {[}Internet], 2011, NAT HOSP IS WARDS OP.
   National Institute for Occupational Safety and Health, 2015, RESP TRUST SOURC INF.
   Occupational Safety and Health Administration, 2003, 315112R OSHA.
   Or P, 2012, WORKPLACE HEALTH SAF, V60, P511, DOI 10.3928/21650799-20121128-76.
   RILEY RL, 1976, AM REV RESPIR DIS, V113, P413.
   Sacks LV, 1999, CLIN INFECT DIS, V29, P96, DOI 10.1086/520189.
   Shaffer RE, 2015, AM J INFECT CONTROL, V43, P127, DOI 10.1016/j.ajic.2014.10.021.
   Talbot EA, 2002, INT J TUBERC LUNG D, V6, P738.
   Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1.
   World Health Organization, 2009, CONGR SETT HOUS HOLD.
   Yu YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085299.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Tuberc. Respir. Dis.}},
Doc-Delivery-Number = {{FC4SF}},
Unique-ID = {{ISI:000406830200004}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000398362000002,
Author = {Mileva, Sevda and Gospodinova, Margarita and Todorov, Ilian},
Title = {{Salmonella enteritidis primary bacteremia in previously healthy patient
   from Taiwan: case report}},
Journal = {{THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE}},
Year = {{2016}},
Volume = {{3}},
Number = {{5}},
Pages = {{128-132}},
Month = {{OCT}},
Abstract = {{Background: Diseases caused by invasive nontyphoidal Salmonella strains
   present with various extraintestinal manifestations, including
   bacteremia. Factors affecting the incidence include Salmonella serotype,
   geographic location, and host factors.
   Case: We present an unusual case of Salmonella enteritidis primary
   bacteremia in a patient without any risk factors and originating from a
   region with the lowest burden of invasive nontyphoidal Salmonella
   infections. We observed an incomplete clinical response to the treatment
   with a third-generation cephalosporin, despite the in vitro
   susceptibility of the strain.
   Discussion: The diagnosis of Salmonella bacteremia was far from expected
   in our previously healthy patient from Taiwan, without any preceding
   diarrhea and the lack of marked response to therapy with ceftriaxone.
   Making the diagnosis was a challenge, requiring wide range of
   laboratory, imaging, and consultative work to rule out alternative
   diagnoses and complications.
   Conclusion: Invasive Salmonella infections are uncommon in our clinical
   practice at the present. Air transportation, intensive migration
   processes, and changes in climate are able to change the burden of
   infectious diseases dramatically in the near future. That fact along
   with the raising antibacterial resistance among invasive nontyphoidal
   Salmonella strains make imperative the profound understanding of the
   epidemiology and pathophysiology of those infections.}},
Publisher = {{SAGE PUBLICATIONS LTD}},
Address = {{1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mileva, S (Reprint Author), Med Univ Varna, Dept Infect Dis, Varna 9000, Bulgaria.
   Mileva, Sevda; Gospodinova, Margarita; Todorov, Ilian, Med Univ Varna, Dept Infect Dis, Varna 9000, Bulgaria.}},
DOI = {{10.1177/2049936116661949}},
ISSN = {{2049-9361}},
EISSN = {{2049-937X}},
Keywords = {{antibacterial treatment response; bacteremia; nontyphoidal invasive
   Salmonella}},
Keywords-Plus = {{NONTYPHOID SALMONELLA; DISEASE}},
Research-Areas = {{Infectious Diseases}},
Web-of-Science-Categories  = {{Infectious Diseases}},
Author-Email = {{sevdamileva@mail.bg}},
Cited-References = {{Ao TT, 2015, EMERG INFECT DIS, V21, P941, DOI 10.3201/eid2106.140999.
   Brenner FW, 2000, J CLIN MICROBIOL, V38, P2465.
   Cao X T, 1999, Pediatr Infect Dis J, V18, P245.
   Chiou C., 2015, TAIWAN EPIDEMIOL B, V31, P235.
   Chiu CH, 1999, INT J ANTIMICROB AG, V12, P47, DOI 10.1016/S0924-8579(99)00038-2.
   Dhanoa A, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-15.
   Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2.
   GALOFRE J, 1994, CLIN INFECT DIS, V18, P873, DOI 10.1093/clinids/18.6.873.
   Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012.
   Gorecki B, 2008, KARDIOL POL, V66, P664.
   Hibbert B, 2010, CAN J CARDIOL, V26, pE323, DOI 10.1016/S0828-282X(10)70444-X.
   Hohmann EL, 2001, CLIN INFECT DIS, V32, P263.
   Hsu RB, 2005, QJM-INT J MED, V98, P821, DOI 10.1093/qjmed/hci126.
   Jean Shio-Shin, 2006, Journal of Microbiology Immunology and Infection, V39, P358.
   Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259.
   Ortiz D, 2014, TEX HEART I J, V41, P401, DOI 10.14503/THIJ-13-3722.
   Papamichalis P., 2011, CARDIOL RES PRACT, V4, P1.}},
Number-of-Cited-References = {{17}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Ther. Adv. Infect. Dis.}},
Doc-Delivery-Number = {{EQ8UW}},
Unique-ID = {{ISI:000398362000002}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000389034200008,
Author = {Jensen, Rasmus Hare},
Title = {{Resistance in human pathogenic yeasts and filamentous fungi: prevalence,
   underlying molecular mechanisms and link to the use of antifungals in
   humans and the environment}},
Journal = {{DANISH MEDICAL JOURNAL}},
Year = {{2016}},
Volume = {{63}},
Number = {{10}},
Month = {{OCT}},
Abstract = {{Antifungal drug resistance is a multifaceted clinical challenge, and
   when present, a primary cause of treatment failure in patients with
   severe fungal infections. Changing epidemiology, increasing resistance
   rates and a narrow antifungal armamentarium may further underline the
   required attention on resistance particularly within the most prevalent
   invasive fungal infections caused by Candida yeasts and Aspergillus
   moulds. In Denmark, the resistance epidemiology remains to be fully
   elucidated. This thesis sought to address this demand as well as provide
   insight into the landscape of underlying molecular resistance
   mechanisms. Paper I and II both contributed to the understanding of FKS
   (beta-glucan synthase) mediated echinocandin resistance in Candida
   species. Paper I covered a unique stepwise acquisition of a homozygous
   mutation in FKS1 of Candida tropicalis leading to an amino acid change
   corresponding to a well-known S645P in Candida albicans. Paper II
   presented a failure case due to Candida krusei displaying high-level
   echinocandin resistance likely attributable to an acquired D662Y amino
   acid substitution in FKS1. Intrinsic differences in FKS1 among Candida
   species may explain why the level of resistance both depends on the
   mutation as well as the species and cannot be easily translated to the
   level of clinical resistance. Intrinsic fluconazole resistance in C.
   krusei further substantiated the clinical implications of acquired
   echinocandin resistance.
   Paper III presented a rare multidrug resistance case in a series of
   isogenic C. albicans isolates, almost covering the entire spectrum of
   known resistance mechanisms in Candida and involved the proposal of
   novel resistance mutations. An A61E change in ERG11 was potentially
   involved in reduced susceptibility to long-structured azoles. Increased
   expression levels of azole efflux pumps were probably accredited to
   novel gain-of-function variants in the transcription factor TAC1 (R688Q
   and R673L). Echinocandin resistance was induced by the well-known S645P
   variant of FKS1 and polyene resistance was likely inflicted by a
   frameshift mutation in ERG2 leading to loss of function of the encoded
   protein and subsequent ergosterol depletion.
   The number of acquired resistance cases is increasing in our settings
   and Paper IV sought to illuminate whether antifungal resistance is
   overlooked in the current fungaemia programme. This involved the
   acquisition of post-treatment oral isolates from 193 Candidaemia
   patients among which 114 received azoles (primarily fluconazole) and 85
   received an echinocandin (and some both). Azole exposed patients carried
   a significantly higher proportion of species less susceptible to
   fluconazole (primarily Candida glabrata) among colonising Candida
   compared to baseline blood isolates (P<0.001). A similar trend was seen
   for echinocandin treated patients although not statistically
   significant. Interestingly, there was a high frequency of acquired
   resistance, 29.4\% to fluconazole and 21.6\% to echinocandins, among
   colonising C. glabrata isolates post treatment. These figures were both
   significantly higher compared to baseline blood isolates as well as oral
   isolates from patients with no or minimal exposure to either drug class.
   In contrast, acquired resistance among C. albicans oral isolates was
   rare (<5\%). Thus, the oral cavity may be an unrecognized reservoir of
   resistant Candida species, especially C. glabrata following azole or
   echinocandin treatment. This underlines the care of which therapeutic
   stewardship must be taken both for antifungal naive patients, to avoid
   resistance development, as well as for patients previously exposed to
   antifungals.
   Paper VI was a retrospective laboratory based study and aimed to
   elucidate the prevalence of azole resistance in A. fumigatus isolates
   from 2010-2014 in Denmark. This study also sought to uncover the
   underlying resistance mechanisms, primarily attributable to CYP51A
   mutations, and finally to assess the accumulated genotyping data. Among
   1162 A. fumigatus isolates, 94.5\% were screened for azole resistance
   and a significant increasing trend was observed for the number of azole
   resistant isolates to approximately 6\% in 2014 (P<0.001) and 4\% in
   corresponding patients (P<0.05). The underlying resistance mutations
   were diverse but still dominated by the TR34/L98H resistance mechanism
   responsible for >50\% of all our azole resistant isolates. The
   genotyping data of resistant and a selection of susceptible A. fumigatus
   showed high identity to foreign isolates (>15\%). This could argue for
   the hypothesis on clonal expansion, which has previously been suggested
   for TR34/L98H clones in the Netherlands and India, but could also
   indicate an insufficient discriminatory power of such analysis. Still, a
   proposed A. fumigatus outbreak in a haematology ward was unresolved
   since no genetically identical isolates were recovered from patients and
   air samples, illustrating the ubiquitous nature of this organism.
   Overall, the main concerns are a changing Candida epidemiology towards
   species less susceptible to fluconazole combined with the rapid
   acquisition of echinocandin resistance, especially among C. glabrata
   isolates. For A. fumigatus, the concern is the emergence of azole
   resistant strains in the environment, displaying cross-resistance to
   clinical azoles, and thus posing unforeseen clinical challenges in the
   management of invasive aspergillosis. Collectively, these findings call
   for an increased awareness especially at clinical microbiology
   laboratories, which ideally would lead to susceptibility testing of all
   clinically relevant isolates by reference or validated methods.
   Moreover, novel diagnostic approaches for non-culturable pathogens are
   warranted and especially DNA based detection by PCR may serve as a solid
   complimentary tool for improved diagnostics of invasive fungal
   infections.}},
Publisher = {{DANISH MEDICAL ASSOC}},
Address = {{TRONDHJEMSGADE 9, DK-2100 COPENHAGEN, DENMARK}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Jensen, RH (Reprint Author), Statens Serum Inst, Dept Microbiol \& Infect Control, Off 43-316,Artillerivej 5, DK-2300 Copenhagen S, Denmark.
   Jensen, Rasmus Hare, Statens Serum Inst, Dept Microbiol \& Infect Control, Off 43-316,Artillerivej 5, DK-2300 Copenhagen S, Denmark.}},
Article-Number = {{B5288}},
ISSN = {{2245-1919}},
Keywords-Plus = {{ACQUIRED ECHINOCANDIN RESISTANCE; CANDIDA-ALBICANS ERG11; AMINO-ACID
   SUBSTITUTIONS; MINIMUM INHIBITORY CONCENTRATIONS; CLINICAL-PRACTICE
   GUIDELINES; INFECTIOUS-DISEASES SOCIETY; TRANSCRIPTION FACTOR UPC2P; ABC
   TRANSPORTER GENE; INTENSIVE-CARE-UNIT; OF-THE-LITERATURE}},
Research-Areas = {{General \& Internal Medicine}},
Web-of-Science-Categories  = {{Medicine, General \& Internal}},
Author-Email = {{RMJ@ssi.dk}},
Cited-References = {{Abdolrasouli A, 2015, MBIO, V6, DOI 10.1128/mBio.00939-15.
   Ahmad S, 2014, ENVIRON RES, V133, P20, DOI 10.1016/j.envres.2014.05.009.
   Alanio A, 2011, J ANTIMICROB CHEMOTH, V66, P371, DOI 10.1093/jac/dkq450.
   Alastruey-Izquierdo A, 2009, ANTIMICROB AGENTS CH, V53, P1686, DOI 10.1128/AAC.01467-08.
   Albertson GD, 1996, ANTIMICROB AGENTS CH, V40, P2835.
   Alexander BD, 2013, CLIN INFECT DIS, V56, P1724, DOI 10.1093/cid/cit136.
   Alvarez A, 2015, TRENDS MED MYCOLOGY.
   Arendrup M, 2002, INFECTION, V30, P286, DOI 10.1007/s15010-002-2131-0.
   Arendrup MC, 2013, CLIN MICROBIOL INFEC, V19, pE343, DOI 10.1111/1469-0691.12212.
   Arendrup MC, 2014, CURR OPIN INFECT DIS, V27, P484, DOI 10.1097/QCO.0000000000000111.
   Arendrup MC, 2012, J INFECT DIS, V206, P981, DOI 10.1093/infdis/jis442.
   Arendrup MC, 2012, CLIN MICROBIOL INFEC, V18, pE246, DOI 10.1111/j.1469-0691.2012.03880.x.
   Arendrup MC, 2013, DAN MED J, V60.
   Arendrup MC, 2012, ANTIMICROB AGENTS CH, V56, P2435, DOI 10.1128/AAC.06369-11.
   Arendrup MC, 2011, J CLIN MICROBIOL, V49, P3300, DOI 10.1128/JCM.00179-11.
   Arendrup MC, 2011, J CLIN MICROBIOL, V49, P325, DOI 10.1128/JCM.01811-10.
   Arendrup MC, 2010, ANTIMICROB AGENTS CH, V54, P426, DOI 10.1128/AAC.01256-09.
   Arendrup MC, 2009, ANTIMICROB AGENTS CH, V53, P1185, DOI 10.1128/AAC.01292-08.
   Arendrup MC, 2009, CLIN MICROBIOL INFEC, V15, P103.
   Astvad KMT, 2014, ANTIMICROB AGENTS CH, V58, P5096, DOI 10.1128/AAC.02855-14.
   Axner-Elings M, 2011, J CLIN MICROBIOL, V49, P2516, DOI 10.1128/JCM.00201-11.
   Ayoub MJ, 2006, J APPL MICROBIOL, V100, P699, DOI 10.1111/j.1365-2672.2006.02817.x.
   Badali H, 2013, MYCOSES, V56, P659, DOI 10.1111/myc.12089.
   Bader O, 2015, ANTIMICROB AGENTS CH, V59, P4356, DOI 10.1128/AAC.00100-15.
   Baixench MT, 2007, J ANTIMICROB CHEMOTH, V59, P1076, DOI 10.1093/jac/dkm095.
   Balajee SA, 2008, J MICROBIOL METH, V73, P252, DOI 10.1016/j.mimet.2008.02.011.
   Balashov SV, 2006, ANTIMICROB AGENTS CH, V50, P2058, DOI 10.1128/AAC.01653-05.
   Basso LR, 2010, EUKARYOT CELL, V9, P960, DOI 10.1128/EC.00355-09.
   Ben-Ami R, 2011, J INFECT DIS, V204, P626, DOI 10.1093/infdis/jir351.
   Bennett JW, 2009, MED MYCOL, V47, pS5, DOI 10.1080/13693780802712515.
   Berdal JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103916.
   Blanchard E, 2011, ANTIMICROB AGENTS CH, V55, P5358, DOI 10.1128/AAC.00690-11.
   Bougnoux ME, 2002, J CLIN MICROBIOL, V40, P1290, DOI 10.1128/JCM.40.4.1290-1297.2002.
   Bowyer Paul, 2011, Curr Infect Dis Rep, V13, P485, DOI 10.1007/s11908-011-0218-4.
   Brillowska-Dabrowska A, 2009, SCAND J INFECT DIS, V41, P135, DOI 10.1080/00365540802585301.
   Brillowska-Dabrowska A, 2010, SCAND J INFECT DIS, V42, P109, DOI 10.3109/00365540903348336.
   Bromley MJ, 2014, J GLOB ANTIMICROB RE, V2, P276, DOI 10.1016/j.jgar.2014.05.004.
   BROUGHTON MC, 1991, MYCOSES, V34, P75.
   Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404.
   Camps SMT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050034.
   Camps SMT, 2012, J CLIN MICROBIOL, V50, P2674, DOI 10.1128/JCM.00335-12.
   Camps SMT, 2012, ANTIMICROB AGENTS CH, V56, P10, DOI 10.1128/AAC.05088-11.
   Canuto MM, 2002, LANCET INFECT DIS, V2, P550, DOI 10.1016/S1473-3099(02)00371-7.
   Carvalho VO, 2013, REV IBEROAM MICOL, V30, P209, DOI 10.1016/j.riam.2013.01.001.
   Chapeland-Leclerc F, 2010, ANTIMICROB AGENTS CH, V54, P1360, DOI 10.1128/AAC.01138-09.
   Chau AS, 2004, ANTIMICROB AGENTS CH, V48, P2124, DOI 10.1128/AAC.48.6.2124-2131.2004.
   Chen Y, 2015, ANTIMICROB AGENTS CH.
   Cho EJ, 2015, J ANTIMICROB CHEMOTH, V70, P1268, DOI 10.1093/jac/dku518.
   Chowdhary A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00428.
   Chowdhary A, 2014, J ANTIMICROB CHEMOTH, V69, P2979, DOI 10.1093/jac/dku259.
   Chowdhary A, 2014, J ANTIMICROB CHEMOTH, V69, P555, DOI 10.1093/jac/dkt397.
   Chowdhary A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052871.
   Clinical Laboratory Standards Institute (CLSI), 2008, REF METH BROTH DIL A.
   Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07.
   Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370.
   Crump KR, 2004, 44 INT C ANT AG CHEM.
   Daneman N, 2006, CLIN MICROBIOL INFEC, V12, pP1204.
   Dannaoui E, 2012, EMERG INFECT DIS, V18, P86, DOI 10.3201/eid1801.110556.
   Darwin C, 1859, ORIGIN SPECIES MEANS.
   De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660.
   de Valk HA, 2005, J CLIN MICROBIOL, V43, P4112, DOI 10.1128/JCM.43.8.4112-4120.2005.
   Debnath S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-660.
   Denning DW, 2011, CLIN INFECT DIS, V52, P1123, DOI 10.1093/cid/cir179.
   Denning DW, 2002, LANCET INFECT DIS, V2, P251, DOI 10.1016/S1473-3099(02)00243-8.
   Denning DW, 1996, INT J ANTIMICROB AG, V6, P161, DOI 10.1016/0924-8579(95)00042-9.
   Desnos-Ollivier M, 2008, ANTIMICROB AGENTS CH, V52, P3092, DOI 10.1128/AAC.00088-08.
   Desnos-Ollivier M, 2011, J CLIN MICROBIOL, V49, P2304, DOI 10.1128/JCM.00325-11.
   Diab-Elschahawi M, 2012, J CLIN MICROBIOL, V50, P3422, DOI 10.1128/JCM.01179-12.
   Dodgson AR, 2003, J CLIN MICROBIOL, V41, P5709, DOI 10.1128/JCM.41.12.5709-5717.2003.
   Dodgson KJ, 2005, CLIN MICROBIOL INFEC, V11, pP1158.
   Douglas CM, 1997, ANTIMICROB AGENTS CH, V41, P2471.
   Dudiuk C, 2015, J CLIN MICROBIOL, V53, P2037, DOI 10.1128/JCM.00398-15.
   ECDC, 2013, RISK ASS IMP ENV US.
   Edlind TD, 2010, ANTIMICROB AGENTS CH, V54, P4733, DOI 10.1128/AAC.00605-10.
   Ellis D, 2002, J ANTIMICROB CHEMOTH, V49, P7, DOI 10.1093/jac/49.suppl\_1.7.
   Escribano P, 2011, ANTIMICROB AGENTS CH, V55, P2460, DOI 10.1128/AAC.01358-10.
   Farmakiotis D, 2014, EMERG INFECT DIS, V20, P1833, DOI 10.3201/eid2011.140685.
   Fekkar A, 2013, ANTIMICROB AGENTS CH, V57, P2380, DOI 10.1128/AAC.02037-12.
   Finkel JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002525.
   Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475.
   Fischer J, 2014, J ANTIMICROB CHEMOTH, V69, P1533, DOI 10.1093/jac/dku009.
   Flowers SA, 2015, ANTIMICROB AGENTS CH, V59, P450, DOI 10.1128/AAC.03470-14.
   Flowers SA, 2012, EUKARYOT CELL, V11, P1289, DOI 10.1128/EC.00215-12.
   Forastiero A, 2015, ANTIMICROB AGENTS CH.
   Fraczek MG, 2011, ANTIMICROB AGENTS CH, V55, P2483, DOI 10.1128/AAC.01651-10.
   Gammelsrud KW, 2011, CLIN MICROBIOL INFEC, V17, P1875, DOI 10.1111/j.1469-0691.2011.03528.x.
   Gammelsrud KW, 2012, MED MYCOL, V50, P619, DOI 10.3109/13693786.2012.675088.
   Garcia-Effron G, 2008, ANTIMICROB AGENTS CH, V52, P4181, DOI 10.1128/AAC.00802-08.
   Garcia-Effron G, 2008, ANTIMICROB AGENTS CH, V52, P2305, DOI 10.1128/AAC.00262-08.
   Garcia-Effron G, 2010, ANTIMICROB AGENTS CH, V54, P2225, DOI 10.1128/AAC.00998-09.
   Garcia-Effron G, 2009, ANTIMICROB AGENTS CH, V53, P3690, DOI 10.1128/AAC.00443-09.
   Garcia-Effron G, 2009, ANTIMICROB AGENTS CH, V53, P112, DOI 10.1128/AAC.01162-08.
   Garcia-Rodriguez J, 2015, TRENDS MED MYCOLOGY.
   Garnaud C, 2015, J ANTIMICROB CHEMOTH, V70, P2556, DOI 10.1093/jac/dkv139.
   Gerstein AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4819.
   Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501.
   Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109.
   Hakki M, 2006, ANTIMICROB AGENTS CH, V50, P2522, DOI 10.1128/AAC.00148-06.
   Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191.
   Hernandez S, 2004, ANTIMICROB AGENTS CH, V48, P1382, DOI 10.1128/AAC.48.4.1382-1383.2004.
   Hill JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003390.
   Hodiamont CJ, 2009, MED MYCOL, V47, P217, DOI 10.1080/13693780802545600.
   Hoot SJ, 2011, ANTIMICROB AGENTS CH, V55, P940, DOI 10.1128/AAC.00995-10.
   Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043.
   Hull CM, 2012, ANTIMICROB AGENTS CH, V56, P6417, DOI 10.1128/AAC.01145-12.
   Jacobsen MD, 2007, J CLIN MICROBIOL, V45, P317, DOI 10.1128/JCM.01549-06.
   Jensen RH, 2015, J ANTIMICROB CHEMOTH, V70, P2551, DOI 10.1093/jac/dkv140.
   Jensen RH, 2014, ANTIMICROB AGENTS CH, V58, P3550, DOI 10.1128/AAC.02367-14.
   Jensen RH, 2013, ANTIMICROB AGENTS CH, V57, P614, DOI 10.1128/AAC.01193-12.
   Jensen RH, 2015, AZOLE RESISTANT ASPE.
   Jensen RH, 2015, POSTTREATMENT UNPUB.
   Johnson ME, 2012, EUKARYOT CELL, V11, P952, DOI 10.1128/EC.00082-12.
   Johnson ME, 2011, ANTIMICROB AGENTS CH, V55, P3774, DOI 10.1128/AAC.01811-10.
   Kahn JN, 2007, ANTIMICROB AGENTS CH, V51, P1876, DOI 10.1128/AAC.00067-07.
   Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071.
   Kartsonis NA, 2003, DRUG RESIST UPDATE, V6, P197, DOI 10.1016/S1368-7646(03)00064-5.
   Kathuria S, 2015, J CLIN MICROBIOL, V53, P1823, DOI 10.1128/JCM.00367-15.
   Katiyar S, 2006, ANTIMICROB AGENTS CH, V50, P2892, DOI 10.1128/AAC.00349-06.
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2.
   Kelly SL, 1996, LANCET, V348, P1523, DOI 10.1016/S0140-6736(05)65949-1.
   Kelly SL, 1997, FEBS LETT, V400, P80, DOI 10.1016/S0014-5793(96)01360-9.
   Kidd SE, 2015, MYCOSES, V58, P350, DOI 10.1111/myc.12324.
   Klaassen CHW, 2012, MOL ECOL, V21, P57, DOI 10.1111/j.1365-294X.2011.05364.x.
   Koga-Ito CY, 2011, MYCOSES, V54, pE278, DOI 10.1111/j.1439-0507.2010.01899.x.
   Kosmidis C, 2015, THORAX, V70, P270, DOI 10.1136/thoraxjnl-2014-206291.
   Krogh-Madsen M, 2006, CLIN INFECT DIS, V42, P938, DOI 10.1086/500939.
   Kumar R, 2010, FUNGAL BIOL-UK, V114, P189, DOI 10.1016/j.funbio.2009.12.003.
   Lackner M, 2014, ANTIMICROB AGENTS CH, V58, P3626, DOI 10.1128/AAC.00123-14.
   Lau A, 2008, J CLIN MICROBIOL, V46, P3021, DOI 10.1128/JCM.00689-08.
   Lau AF, 2015, J CLIN MICROBIOL, V53, P1324, DOI 10.1128/JCM.03239-14.
   Laverdiere M, 2006, J ANTIMICROB CHEMOTH, V57, P705, DOI 10.1093/jac/dkl022.
   Lescar J, 2014, J ANTIMICROB CHEMOTH, V69, P3244, DOI 10.1093/jac/dku316.
   Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576.
   Lewis James S 2nd, 2013, Antimicrob Agents Chemother, V57, P4559, DOI 10.1128/AAC.01144-13.
   Liu MS, 2015, ANTIMICROB AGENTS CH, V59, P4321, DOI 10.1128/AAC.00003-15.
   Lockhart SR, 2011, ANTIMICROB AGENTS CH, V55, P4465, DOI 10.1128/AAC.00185-11.
   LOCKHART SR, 1995, J CLIN MICROBIOL, V33, P1501.
   Lohberger A, 2014, EUKARYOT CELL, V13, P127, DOI 10.1128/EC.00245-13.
   Lortholary O, 2011, ANTIMICROB AGENTS CH, V55, P532, DOI 10.1128/AAC.01128-10.
   Maertens J, 2011, BONE MARROW TRANSPL, V46, P709, DOI 10.1038/bmt.2010.175.
   Mann PA, 2009, ANTIMICROB AGENTS CH, V53, P5026, DOI 10.1128/AAC.01031-09.
   Marchesi JR, 2015, GUT, P1.
   Martel CM, 2010, ANTIMICROB AGENTS CH, V54, P3578, DOI 10.1128/AAC.00303-10.
   Maubon D, 2014, INTENS CARE MED, V40, P1241, DOI 10.1007/s00134-014-3404-7.
   MAZUR P, 1995, MOL CELL BIOL, V15, P5671.
   McManus BA, 2008, J CLIN MICROBIOL, V46, P652, DOI 10.1128/JCM.01574-07.
   Mellado E, 2013, REV IBEROAM MICOL, V30, P64, DOI 10.1016/j.riam.2012.09.002.
   Miyazaki Y, 1999, GENE, V236, P43, DOI 10.1016/S0378-1119(99)00263-2.
   Monk BC, 2014, P NATL ACAD SCI USA, V111, P3865, DOI 10.1073/pnas.1324245111.
   Montesinos I, 2014, J ANTIMICROB CHEMOTH, V69, P3439, DOI 10.1093/jac/dku289.
   Moran GP, 2011, EUKARYOT CELL, V10, P34, DOI 10.1128/EC.00242-10.
   Morio F, 2013, INT J ANTIMICROB AG, V42, P410, DOI 10.1016/j.ijantimicag.2013.07.013.
   Morio F, 2012, J ANTIMICROB CHEMOTH, V67, P2131, DOI 10.1093/jac/dks186.
   Morio F, 2010, DIAGN MICR INFEC DIS, V66, P373, DOI 10.1016/j.diagmicrobio.2009.11.006.
   Morschhauser J, 2002, BBA-MOL BASIS DIS, V1587, P240, DOI 10.1016/S0925-4439(02)00087-X.
   Mortensen KL, 2011, EUR J CLIN MICROBIOL, V30, P1355, DOI 10.1007/s10096-011-1229-7.
   Mortensen KL, 2011, J CLIN MICROBIOL, V49, P2243, DOI 10.1128/JCM.00213-11.
   Mortensen KL, 2010, ANTIMICROB AGENTS CH, V54, P4545, DOI 10.1128/AAC.00692-10.
   Mukherjee PK, 2015, NAT REV GASTRO HEPAT, V12, P77, DOI 10.1038/nrgastro.2014.188.
   Muller FMC, 2007, ANTIMICROB AGENTS CH, V51, P3014, DOI 10.1128/AAC.00459-07.
   Nawrot U, 2015, TRENDS MEDICAL MYCOL, pP006.
   Niimi K, 2010, J ANTIMICROB CHEMOTH, V65, P842, DOI 10.1093/jac/dkq073.
   Nolte FS, 1997, ANTIMICROB AGENTS CH, V41, P196.
   Odds FC, 2008, EUKARYOT CELL, V7, P1075, DOI 10.1128/EC.00062-08.
   Oliver BG, 2007, EUKARYOT CELL, V6, P2231, DOI 10.1128/EC.00331-06.
   Ostrosky-Zeichner L, 2013, CLIN INFECT DIS, V56, P1733, DOI 10.1093/cid/cit140.
   Ozmerdiven GE, 2015, J INFECT CHEMOTHER, V21, P581, DOI 10.1016/j.jiac.2015.04.012.
   Panackal AA, 2006, J CLIN MICROBIOL, V44, P1740, DOI 10.1128/JCM.44.5.1740-1743.2006.
   Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757.
   Park S, 2005, ANTIMICROB AGENTS CH, V49, P3264, DOI 10.1128/AAC.49.8.3264-3273.2005.
   Pelaez T., 2015, New Microbes and New Infections, V6, P33, DOI 10.1016/j.nmni.2015.04.005.
   Pelaez T, 2012, CLIN INFECT DIS, V54, pE24, DOI 10.1093/cid/cir771.
   Pelaez T, 2012, J CLIN MICROBIOL, V50, P2531, DOI 10.1128/JCM.00329-12.
   Perlin DS, 2007, DRUG RESIST UPDATE, V10, P121, DOI 10.1016/j.drup.2007.04.002.
   Perlin David S, 2015, Curr Clin Microbiol Rep, V2, P84.
   Perlin DS, 2011, FUTURE MICROBIOL, V6, P441, DOI {[}10.2217/fmb.11.19, 10.2217/FMB.11.19].
   Perlin DS, 2009, CURR OPIN INFECT DIS, V22, P568, DOI 10.1097/QCO.0b013e3283321ce5.
   Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001.
   Pham CD, 2014, EMERG INFECT DIS, V20, P1498, DOI 10.3201/eid2009.140142.
   PIERCE AM, 1978, CAN J BIOCHEM CELL B, V56, P135, DOI 10.1139/o78-023.
   Pierson CA, 2004, MED MYCOL, V42, P385, DOI 10.1080/13693780410001712016.
   Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11.
   Prigitano A, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.12.20747.
   Prigitano A, 2014, NEW MICROBIOL, V37, P237.
   Puig-Asensio M, 2014, CRIT CARE MED, V42, P1423, DOI 10.1097/CCM.0000000000000221.
   Quindos G, 2014, REV IBEROAM MICOL, V31, P42, DOI 10.1016/j.riam.2013.10.001.
   Reiss E, 2012, INFECT GENET EVOL, V12, P1654, DOI 10.1016/j.meegid.2012.06.012.
   Rodrigues CF, 2014, EUR J CLIN MICROBIOL, V33, P673, DOI 10.1007/s10096-013-2009-3.
   Sanglard D, 2003, ANTIMICROB AGENTS CH, V47, P2404, DOI 10.1128/AAC.47.8.2404-2412.2003.
   Sanglard D, 1998, ANTIMICROB AGENTS CH, V42, P241.
   Sanglard D, 2002, LANCET INFECT DIS, V2, P73, DOI 10.1016/S1473-3099(02)00181-0.
   Sanglard D, 1997, MICROBIOL-UK, V143, P405, DOI 10.1099/00221287-143-2-405.
   Alonso MAS, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01602.x.
   Scorzoni L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060047.
   Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242.
   Seyedmousavi S, 2013, EMERG INFECT DIS, V19, P832, DOI 10.3201/eid1905.130075.
   Shields RK, 2014, ANTIMICROB AGENTS CH, V58, P7601, DOI 10.1128/AAC.04134-14.
   Shields RK, 2012, ANTIMICROB AGENTS CH, V56, P4862, DOI 10.1128/AAC.00027-12.
   Shor E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004668.
   Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x.
   Silver PM, 2004, EUKARYOT CELL, V3, P1391, DOI 10.1128/EC.3.6.1391-1397.2004.
   Singh-Babak SD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002718.
   Sipsas NV, 2009, CANCER, V115, P4745, DOI 10.1002/cncr.24507.
   Slaven JW, 2002, FUNGAL GENET BIOL, V36, P199, DOI 10.1016/S1087-1845(02)00016-6.
   Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219.
   Snelders E, 2015, FUNGAL GENET BIOL, V82, P129, DOI 10.1016/j.fgb.2015.06.001.
   Snelders E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031801.
   Snelders E, 2011, FUNGAL GENET BIOL, V48, P1062, DOI 10.1016/j.fgb.2011.08.002.
   Snelders E, 2010, ANTIMICROB AGENTS CH, V54, P2425, DOI 10.1128/AAC.01599-09.
   Spampinato C, 2013, BIOMED RES INT, DOI 10.1155/2013/204237.
   Staab JF, 2014, ANTIMICROB AGENTS CH, V58, P5421, DOI 10.1128/AAC.00096-14.
   Steier Z, 2013, ANTIMICROB AGENTS CH, V57, P5543, DOI 10.1128/AAC.02394-12.
   Stensvold CR, 2012, CURR FUNGAL INFECT R, V6, P178, DOI 10.1007/s12281-012-0097-7.
   Tashiro M, 2012, ANTIMICROB AGENTS CH, V56, P584, DOI 10.1128/AAC.05394-11.
   Tavanti A, 2005, J CLIN MICROBIOL, V43, P5593, DOI 10.1128/JCM.43.11.5593-5600.2005.
   Tavanti A, 2003, J CLIN MICROBIOL, V41, P3765, DOI 10.1128/JCM.41.8.3765-3776.2003.
   Duran-Valle MT, 2012, ANTIMICROB AGENTS CH, V56, P3417, DOI 10.1128/AAC.06100-11.
   van Asbeck EC, 2007, MYCOPATHOLOGIA, V164, P287, DOI 10.1007/s11046-007-9054-3.
   van der Linden JWM, 2013, CLIN INFECT DIS, V57, P513, DOI 10.1093/cid/cit320.
   van der Linden JWM, 2011, EMERG INFECT DIS, V17, P1846, DOI 10.3201/eid1710.110226.
   van Ingen J, 2015, J ANTIMICROB CHEMOTH, V70, P178, DOI 10.1093/jac/dku364.
   Van Waeyenberghe L, 2011, AVIAN PATHOL, V40, P73, DOI 10.1080/03079457.2010.540229.
   Vasicek EM, 2014, EUKARYOT CELL, V13, P933, DOI 10.1128/EC.00221-13.
   Vermeulen E, 2012, EUROSURVEILLANCE, V17, P11.
   Vermeulen E, 2013, CURR OPIN INFECT DIS, V26, P493, DOI 10.1097/QCO.0000000000000005.
   Verweij PE, 2015, DRUG RESIST UPDATE, V21-22, P30, DOI 10.1016/j.drup.2015.08.001.
   Verweij PE, 2009, DRUG RESIST UPDATE, V12, P141, DOI 10.1016/j.drup.2009.09.002.
   Verweij PE, 2009, LANCET INFECT DIS, V9, P789, DOI 10.1016/S1473-3099(09)70265-8.
   Walker LA, 2010, FUNGAL GENET BIOL, V47, P117, DOI 10.1016/j.fgb.2009.09.003.
   Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258.
   Warris A, 2003, J CLIN MICROBIOL, V41, P4101, DOI 10.1128/JCM.41.9.4101-4106.2003.
   Weber DJ, 2009, MED MYCOL, V47, pS199, DOI 10.1080/13693780802709073.
   Wiederhold NP, 2008, ANTIMICROB AGENTS CH, V52, P4145, DOI 10.1128/AAC.00959-08.
   Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946.
   Wu CJ, 2015, MYCOSES, V58, P544, DOI 10.1111/myc.12354.
   Xiang MJ, 2013, FEMS YEAST RES, V13, P386, DOI 10.1111/1567-1364.12042.
   Young LY, 2003, ANTIMICROB AGENTS CH, V47, P2717, DOI 10.1128/AAC.47.9.2717-2724.2003.
   Zhao J, 2013, MYCOSES, V56, P315, DOI 10.1111/myc.12027.
   Zhao YA, 2013, J ANTIMICROB CHEMOTH, V68, P1497, DOI 10.1093/jac/dkt071.}},
Number-of-Cited-References = {{239}},
Times-Cited = {{8}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{12}},
Journal-ISO = {{Dan. Med. J.}},
Doc-Delivery-Number = {{ED7HT}},
Unique-ID = {{ISI:000389034200008}},
DA = {{2018-08-13}},
}

@article{ ISI:000385864800002,
Author = {Lenart-Boron, Anna and Wolny-Koladka, Katarzyna and Stec, Joanna and
   Kasprowic, Andrzej},
Title = {{Phenotypic and Molecular Antibiotic Resistance Determination of Airborne
   Coagulase Negative Staphylococcus spp. Strains from Healthcare
   Facilities in Southern Poland}},
Journal = {{MICROBIAL DRUG RESISTANCE}},
Year = {{2016}},
Volume = {{22}},
Number = {{7}},
Pages = {{515-522}},
Month = {{OCT}},
Abstract = {{This study assessed the antimicrobial resistance of airborne
   Staphylococcus spp. strains isolated from healthcare facilities in
   southern Poland. A total of 55 isolates, belonging to 10
   coagulase-negative staphylococci (CoNS) species, isolated from 10
   healthcare facilities (including hospitals and outpatient units) were
   included in the analysis. The most frequently identified species were
   Staphylococcus saprophyticus and Staphylococcus warneri, which belong to
   normal human skin flora, but can also be the cause of common and even
   severe nosocomial infections. Disk diffusion tests showed that the
   bacterial strains were most frequently resistant to erythromycin and
   tetracycline and only 18\% of strains were susceptible to all tested
   antimicrobials. Polymerase chain reaction amplification of specific gene
   regions was used to determine the presence of the
   Macrolide-Lincosamide-Streptogramin resistance mechanisms in CoNS. The
   molecular analysis, conducted using specific primer pairs, identified
   the msrA1 gene, encoding active efflux pumps in bacterial cells, as the
   most frequent resistance gene. As many as seven antibiotic resistance
   genes were found in one isolate, whereas the most common number of
   resistance genes per isolate was five (n=17). It may be concluded that
   drug resistance was widely spread among the tested strains, but the
   resulting antimicrobial resistance profile indicates that in the case of
   infection, the use of antibiotics from the basic antibiogram group will
   be effective in therapy. However, before administering treatment,
   determination of the specific antimicrobial resistance should be
   conducted, particularly in the case of hospitalized patients.}},
Publisher = {{MARY ANN LIEBERT, INC}},
Address = {{140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lenart-Boron, A (Reprint Author), Univ Agr, Dept Microbiol, Mickiewicza Ave 24-28, PL-31059 Krakow, Poland.
   Lenart-Boron, Anna; Wolny-Koladka, Katarzyna; Stec, Joanna, Univ Agr, Dept Microbiol, Mickiewicza Ave 24-28, PL-31059 Krakow, Poland.
   Kasprowic, Andrzej, Ctr Microbiol Res \& Autovaccines, Krakow, Poland.}},
DOI = {{10.1089/mdr.2015.0271}},
ISSN = {{1076-6294}},
EISSN = {{1931-8448}},
Keywords = {{antimicrobial resistance; coagulase-negative staphylococci; nosocomial
   infections; resistance genes}},
Keywords-Plus = {{URINARY-TRACT-INFECTION; WARNERI; AUREUS; IDENTIFICATION; LINCOSAMIDES;
   MACROLIDES; GENES}},
Research-Areas = {{Infectious Diseases; Microbiology; Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Infectious Diseases; Microbiology; Pharmacology \& Pharmacy}},
Author-Email = {{a.lenart-boron@ur.krakow.pl}},
Funding-Acknowledgement = {{University of Agriculture {[}DS 3102/KM/2014]; Centre for
   Microbiological Research and Autovaccines in Krakow}},
Funding-Text = {{This study was funded by the statutory measures of the University of
   Agriculture-Grant No. DS 3102/KM/2014 and by measures of the Centre for
   Microbiological Research and Autovaccines in Krakow.}},
Cited-References = {{{[}Anonymous], PNZ04008081989.
   Augustowska M, 2006, ANN AGR ENV MED, V13, P99.
   Barbier F, 2010, J INFECT DIS, V202, P270, DOI 10.1086/653483.
   Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1.
   Carlet J, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-11.
   Castro-Alarcon N, 2011, J MED MICROBIOL, V60, P730, DOI 10.1099/jmm.0.027847-0.
   {*}CDCP, 2002, MMWR-MORBID MORTAL W, V51, P565.
   Ferreira AM, 2012, J MICROBIOL METH, V91, P406, DOI 10.1016/j.mimet.2012.09.024.
   Gaillot O, 2000, J CLIN MICROBIOL, V38, P1587.
   Henry D, 1998, ANTIMICROB AGENTS CH, V42, P2262.
   Hryniewicz W., 2014, BREAKPOINT TABLES IN.
   Irving W., 2008, MIKROBIOLOGIA MEDYCZ.
   Ivic I, 2013, CENT EUR J MED, V8, P45, DOI 10.2478/s11536-012-0066-0.
   KLOOS WE, 1975, INT J SYST BACTERIOL, V25, P62, DOI 10.1099/00207713-25-1-62.
   KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117.
   Leclercq R, 2002, CLIN INFECT DIS, V34, P482, DOI 10.1086/324626.
   Lina G, 1999, ANTIMICROB AGENTS CH, V43, P1062.
   Liu C, 2009, BIOMED ENVIRON SCI, V22, P401, DOI 10.1016/S0895-3988(10)60018-9.
   Luthje P, 2006, J ANTIMICROB CHEMOTH, V57, P966, DOI 10.1093/jac/dk1061.
   Markiewicz Z., 2012, BACTERIA ANTIBIOTICS.
   Martinez-Lage JF, 2010, CHILD NERV SYST, V26, P1795, DOI 10.1007/s00381-009-1050-0.
   Mkrtchyan HV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054223.
   Reynolds E, 2003, INT J ANTIMICROB AG, V22, P228, DOI 10.1016/S0924-8579(03)00218-8.
   Sadowska B, 2010, POSTEP MIKROBIOL, V49, P173.
   Schmitz FJ, 2000, J ANTIMICROB CHEMOTH, V45, P891, DOI 10.1093/jac/45.6.891.
   Social Science Statistics, CHI SQUAR CALC.
   Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562.
   Szewczyk E.M., 2013, BACTERIOLOGICAL DIAG, P19.
   Widerstrom M, 2012, EUR J CLIN MICROBIOL, V31, P7, DOI 10.1007/s10096-011-1270-6.
   Zabicka D., 2010, RECOMMENDATIONS TEST.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{8}},
Journal-ISO = {{Microb. Drug Resist.}},
Doc-Delivery-Number = {{DZ4XL}},
Unique-ID = {{ISI:000385864800002}},
DA = {{2018-08-13}},
}

@article{ ISI:000385636300017,
Author = {Qin, Yong and Roszik, Jason and Chattopadhyay, Chandrani and Hashimoto,
   Yuuri and Liu, Chengwen and Cooper, Zachary A. and Wargo, Jennifer A.
   and Hwu, Patrick and Ekmekcioglu, Suhendan and Grimm, Elizabeth A.},
Title = {{Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma}},
Journal = {{MOLECULAR CANCER THERAPEUTICS}},
Year = {{2016}},
Volume = {{15}},
Number = {{10}},
Pages = {{2442-2454}},
Month = {{OCT 1}},
Abstract = {{Melanoma is molecularly and structurally heterogeneous, with some tumor
   cells existing under hypoxic conditions. Our cell growth assays showed
   that under controlled hypoxic conditions, BRAF(V600E) melanoma cells
   rapidly became resistant to vemurafenib. By employing both a
   three-dimensional (3D) spheroid model and a two-dimensional (2D) hypoxic
   culture system to model hypoxia in vivo, we identified upregulation of
   HGF/MET signaling as a major mechanism associated with vemurafenib
   resistance as compared with 2D standard tissue culture in ambient air.
   We further confirmed that the upregulation of HGF/MET signaling was
   evident in drug-resistant melanoma patient tissues and mouse xenografts.
   Pharmacologic inhibition of the c-Met/Akt pathway restored the
   sensitivity of melanoma spheroids or 2D hypoxic cultures to vemurafenib.
   (C) 2016 AACR.}},
Publisher = {{AMER ASSOC CANCER RESEARCH}},
Address = {{615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Grimm, EA (Reprint Author), Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Ave,Unit 421,Room FC11-2048, Houston, TX 77030 USA.
   Qin, Yong; Roszik, Jason; Chattopadhyay, Chandrani; Hashimoto, Yuuri; Liu, Chengwen; Cooper, Zachary A.; Wargo, Jennifer A.; Hwu, Patrick; Ekmekcioglu, Suhendan; Grimm, Elizabeth A., Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA.}},
DOI = {{10.1158/1535-7163.MCT-15-0963}},
ISSN = {{1535-7163}},
EISSN = {{1538-8514}},
Keywords-Plus = {{CELL LUNG-CANCER; C-MET; TUMOR MICROENVIRONMENT; NECK-CANCER; KINASE;
   INHIBITION; EXPRESSION; BRAF; CULTURE; IMPACT}},
Research-Areas = {{Oncology}},
Web-of-Science-Categories  = {{Oncology}},
Author-Email = {{egrimm@mdanderson.org}},
ORCID-Numbers = {{Roszik, Jason/0000-0002-4561-6170
   Cooper, Zachary/0000-0003-1059-0940}},
Funding-Acknowledgement = {{UT MD Anderson Cancer Center SPORE in Melanoma (NCI) {[}P50 CA093459];
   Aim at Melanoma Foundation; Miriam \& Jim Mulva Research Funds; Dr.
   Miriam and Sheldon G. Adelson Medical Research Foundation; CCSG grant
   (NCI) {[}P30 CA016672]}},
Funding-Text = {{This work was supported by The UT MD Anderson Cancer Center SPORE in
   Melanoma (NCI, P50 CA093459), Aim at Melanoma Foundation, the Miriam \&
   Jim Mulva Research Funds, and the Dr. Miriam and Sheldon G. Adelson
   Medical Research Foundation all to E.A. Grimm as PI; and CCSG grant
   (NCI, P30 CA016672; DePinho, PI).}},
Cited-References = {{Arai K, 2013, PROTEOMICS, V13, P2351, DOI 10.1002/pmic.201300053.
   Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003.
   Briest F, 2014, THERANOSTICS, V4, P336, DOI 10.7150/thno.7851.
   Brizel DM, 1999, RADIOTHER ONCOL, V53, P113, DOI 10.1016/S0167-8140(99)00102-4.
   Casazza A, 2014, ONCOGENE, V33, P1743, DOI 10.1038/onc.2013.121.
   Chattopadhyay C, 2012, INT J CANCER, V131, pE56, DOI 10.1002/ijc.26487.
   Chu SH, 2009, MOL BIOL REP, V36, P1967, DOI 10.1007/s11033-008-9406-1.
   Corso S, 2013, CANCER DISCOV, V3, P978, DOI 10.1158/2159-8290.CD-13-0040.
   Cruz J, 2003, ONCOLOGY-BASEL, V65, P72, DOI 10.1159/000071207.
   Cuvillier O, 2013, ADV CANCER RES, V117, P117, DOI 10.1016/B978-0-12-394274-6.00005-4.
   Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766.
   Eckerich C, 2007, INT J CANCER, V121, P276, DOI 10.1002/ijc.22679.
   Ekmekcioglu S, 2006, INT J CANCER, V119, P861, DOI 10.1002/ijc.21767.
   Evans SM, 2003, CANCER LETT, V195, P1, DOI 10.1016/S0304-3835(03)00012-0.
   Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011.
   Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200.
   Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0\_1.
   Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266.
   Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627.
   Jubb AM, 2013, HISTOPATHOLOGY, V63, P351, DOI 10.1111/his.12169.
   Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868.
   Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650.
   Malik SM, 2014, CLIN CANCER RES, V20, P2029, DOI 10.1158/1078-0432.CCR-13-3077.
   Matteucci E, 2009, CARCINOGENESIS, V30, P937, DOI 10.1093/carcin/bgp080.
   Mayer A, 2013, ADV EXP MED BIOL, V789, P203, DOI 10.1007/978-1-4614-7411-1\_28.
   Moschetta M, 2013, CLIN CANCER RES, V19, P4371, DOI 10.1158/1078-0432.CCR-13-0039.
   Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626.
   Nordsmark M, 2004, ACTA ONCOL, V43, P396, DOI 10.1080/02841860410026189.
   O'Connell MP, 2013, CANCER DISCOV, V3, P1378, DOI 10.1158/2159-8290.CD-13-0005.
   Parmenter TJ, 2014, CANCER DISCOV, V4, P423, DOI 10.1158/2159-8290.CD-13-0440.
   Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0.
   Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662.
   Pucciarelli D, 2016, MOL MED REP, V13, P3281, DOI 10.3892/mmr.2016.4888.
   Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690.
   Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085.
   Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183.
   Takahashi R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02474.
   Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105.
   Usatyuk PV, 2014, J BIOL CHEM, V289, P13476, DOI 10.1074/jbc.M113.527556.
   Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1.
   Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132.
   Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312.
   Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249.
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006.
   Yoshii Y, 2011, BIOMATERIALS, V32, P6052, DOI 10.1016/j.biomaterials.2011.04.076.
   Yu F, 2015, CELL BIOL INT, V39, P310, DOI 10.1002/cbin.10397.
   Zhang C, 2014, ONCOTARGET, V5, P5535, DOI 10.18632/oncotarget.2137.
   Zhang SJ, 2010, CANCER RES, V70, P4490, DOI 10.1158/0008-5472.CAN-09-3948.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{8}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Mol. Cancer Ther.}},
Doc-Delivery-Number = {{DZ1XV}},
Unique-ID = {{ISI:000385636300017}},
OA = {{green\_accepted}},
DA = {{2018-08-13}},
}

@article{ ISI:000385419200012,
Author = {Sanchez, Helen M. and Echeverria, Cristina and Thulsiraj, Vanessa and
   Zimmer-Faust, Amy and Flores, Ariel and Laitz, Madeleine and Healy,
   Gregory and Mahendra, Shaily and Paulson, Suzanne E. and Zhu, Yifang and
   Jay, Jennifer A.},
Title = {{Antibiotic Resistance in Airborne Bacteria Near Conventional and Organic
   Beef Cattle Farms in California, USA (vol 227, pg 369, 2016)}},
Journal = {{WATER AIR AND SOIL POLLUTION}},
Year = {{2016}},
Volume = {{227}},
Number = {{10}},
Month = {{OCT}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Correction}},
Language = {{English}},
Affiliation = {{Jay, JA (Reprint Author), Univ Calif Los Angeles, Dept Civil \& Environm Engn, Los Angeles, CA 90095 USA.
   Sanchez, Helen M.; Echeverria, Cristina; Thulsiraj, Vanessa; Zimmer-Faust, Amy; Flores, Ariel; Laitz, Madeleine; Healy, Gregory; Mahendra, Shaily; Paulson, Suzanne E.; Zhu, Yifang; Jay, Jennifer A., Univ Calif Los Angeles, Dept Civil \& Environm Engn, Los Angeles, CA 90095 USA.}},
DOI = {{10.1007/s11270-016-3072-z}},
Article-Number = {{369}},
ISSN = {{0049-6979}},
EISSN = {{1573-2932}},
Research-Areas = {{Environmental Sciences \& Ecology; Meteorology \& Atmospheric Sciences;
   Water Resources}},
Web-of-Science-Categories  = {{Environmental Sciences; Meteorology \& Atmospheric Sciences; Water
   Resources}},
Author-Email = {{cecheverria@ucla.edu
   vthulsiraj@msmu.edu
   amityzf@ucla.edu
   Ariel@smithemerylabs.com
   mlaitz@mit.edu
   ghealy@andrew.cmu.edu
   mahendra@seas.ucla.edu
   Paulson@atmos.ucla.edu
   yifang@ucla.edu
   jjay@seas.ucla.edu}},
ResearcherID-Numbers = {{Mahendra, Shaily/F-2759-2012}},
ORCID-Numbers = {{Mahendra, Shaily/0000-0003-3298-9602}},
Cited-References = {{Sancheza HM, 2016, WATER AIR SOIL POLL, V227, DOI 10.1007/s11270-016-2979-8.}},
Number-of-Cited-References = {{1}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{18}},
Journal-ISO = {{Water Air Soil Pollut.}},
Doc-Delivery-Number = {{DY8YT}},
Unique-ID = {{ISI:000385419200012}},
DA = {{2018-08-13}},
}

@article{ ISI:000384420900011,
Author = {Bean, Thomas G. and Bergstrom, Ed and Thomas-Oates, Jane and Wolff, Amy
   and Bartl, Peter and Eaton, Bob and Boxall, Alistair B. A.},
Title = {{Evaluation of a Novel Approach for Reducing Emissions of Pharmaceuticals
   to the Environment}},
Journal = {{ENVIRONMENTAL MANAGEMENT}},
Year = {{2016}},
Volume = {{58}},
Number = {{4}},
Pages = {{707-720}},
Month = {{OCT}},
Abstract = {{Increased interest over the levels of pharmaceuticals detected in the
   environment has led to the need for new approaches to manage their
   emissions. Inappropriate disposal of unused and waste medicines and
   release from manufacturing plants are believed to be important pathways
   for pharmaceuticals entering the environment. In situ treatment
   technologies, which can be used on-site in pharmacies, hospitals,
   clinics, and at manufacturing plants, might provide a solution. In this
   study we explored the use of Pyropure, a microscale combined pyrolysis
   and gasification in situ treatment system for destroying pharmaceutical
   wastes. This involved selecting 17 pharmaceuticals, including 14 of the
   most thermally stable compounds currently in use and three of high
   environmental concern to determine the technology's success in waste
   destruction. Treatment simulation studies were done on three different
   waste types and liquid, solid, and gaseous emissions from the process
   were analyzed for parent pharmaceutical and known active transformation
   products. Gaseous emissions were also analyzed for NOx, particulates,
   dioxins, furans, and metals. Results suggest that Pyropure is an
   effective treatment process for pharmaceutical wastes: over 99 \% of
   each study pharmaceutical was destroyed by the system without known
   active transformation products being formed during the treatment
   process. Emissions of the other gaseous air pollutants were within
   acceptable levels. Future uptake of the system, or similar in situ
   treatment approaches, by clinics, pharmacists, and manufacturers could
   help to reduce the levels of pharmaceuticals in the environment and
   reduce the economic and environmental costs of current waste management
   practices.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Bean, TG (Reprint Author), Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England.
   Bean, TG (Reprint Author), Univ Maryland, Dept Environm Sci \& Technol, College Pk, MD 20742 USA.
   Bean, Thomas G.; Boxall, Alistair B. A., Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England.
   Bergstrom, Ed; Thomas-Oates, Jane, Univ York, Ctr Excellence Mass Spectrometry, York YO10 5DD, N Yorkshire, England.
   Bergstrom, Ed; Thomas-Oates, Jane, Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England.
   Wolff, Amy; Bartl, Peter; Eaton, Bob, PyroPure Ltd, Unit 58 Woolmer Trading Estate, Bordon GU35 9QF, Hants, England.
   Bean, Thomas G., Univ Maryland, Dept Environm Sci \& Technol, College Pk, MD 20742 USA.}},
DOI = {{10.1007/s00267-016-0728-9}},
ISSN = {{0364-152X}},
EISSN = {{1432-1009}},
Keywords = {{Pharmaceutical waste; Thermal decomposition; Pyrolysis-gasification;
   Stewardship; Take-back strategy; Antimicrobial resistance}},
Keywords-Plus = {{PERSONAL CARE PRODUCTS; THERMAL-DECOMPOSITION; DISPOSAL PRACTICES;
   SEWAGE-SLUDGE; DRUGS; WASTE; MEDICATIONS; LANDFILL; WATER; CONTAMINATION}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{tbean@umd.edu}},
Funding-Acknowledgement = {{Innovate UK {[}sKTP 1007668]}},
Funding-Text = {{Phase 1 was funded as a short Knowledge Transfer Partnership (sKTP) by
   Innovate UK (formerly the Technology Strategy Board), partnership ID
   sKTP 1007668.}},
Cited-References = {{Abahussain EA, 2006, MED PRIN PRACT, V15, P7.
   Abahussain EA, 2007, PHARM WORLD SCI, V29, P368, DOI 10.1007/s11096-006-9082-y.
   Barnes KK, 2004, GROUND WATER MONIT R, V24, P119, DOI 10.1111/j.1745-6592.2004.tb00720.x.
   Boehringer SK, 2004, PHARMACISTS LETT, V20.
   Bound JP, 2005, ENVIRON HEALTH PERSP, V113, P1705, DOI 10.1289/ehp.8315.
   Boxall ABA, 2014, ENVIRON INT, V73, P176, DOI 10.1016/j.envint.2014.07.018.
   Boxall ABA, 2004, ENVIRON SCI TECHNOL, V38, p368A, DOI 10.1021/es040624v.
   Braund R, 2009, ENVIRON INT, V35, P952, DOI 10.1016/j.envint.2009.04.003.
   Bumpass JB, 2014, CLIN INFECT DIS, V59, pS108, DOI 10.1093/cid/ciu545.
   Cameron S, 1996, CAN MED ASSOC J, V155, P1596.
   Chartier Y., 2014, SAFE MANAGEMENT WAST.
   COTTER ML, 1978, TETRAHEDRON LETT, P1939.
   Daughton CG, 2003, ENVIRON HEALTH PERSP, V111, P775, DOI 10.1289/ehp.5948.
   Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573.
   Daughton CG, 2013, SCI TOTAL ENVIRON, V443, P324, DOI 10.1016/j.scitotenv.2012.10.092.
   Daughton CG, 2009, ENVIRON TOXICOL CHEM, V28, P2495, DOI 10.1897/08-382.1.
   DEFRA, 2013, INC MUN SOL WAST.
   ECKEL WP, 1993, GROUND WATER, V31, P801, DOI 10.1111/j.1745-6584.1993.tb00853.x.
   Environment Agency (EA), 2011, CLIN WAST EPR 5 07 V.
   Environment Agency (EA), 2011, COMPL YOUR ENV PERM, P81.
   Environment Agency (EA), 2014, HOR GUID ENV PERM.
   EU, 2015, NO PILLS IN WAT.
   Fernandes NS, 1999, J BRAZIL CHEM SOC, V10, P459, DOI 10.1590/S0103-50531999000600007.
   Glassmeyer ST, 2009, ENVIRON INT, V35, P566, DOI 10.1016/j.envint.2008.10.007.
   Guo JH, 2016, ENVIRON TOXICOL CHEM, V35, P1550, DOI 10.1002/etc.3319.
   Heim S, 2004, ENVIRON CHEM LETT, V2, P21, DOI 10.1007/s10311-003-0054-3.
   HOLM JV, 1995, ENVIRON SCI TECHNOL, V29, P1415, DOI 10.1021/es00005a039.
   Isacson D, 1999, PHARM WORLD SCI, V21, P96, DOI 10.1023/A:1008626306770.
   Karayildirim T, 2006, FUEL, V85, P1498, DOI 10.1016/j.fuel.2005.12.002.
   Kasprzyk-Hordern B, 2010, WATER RES, V44, P2076, DOI 10.1016/j.watres.2009.06.026.
   Kern S, 2010, J ENVIRON MONITOR, V12, P2100, DOI 10.1039/c0em00238k.
   Kotchen M, 2009, J ENVIRON MANAGE, V90, P1476, DOI 10.1016/j.jenvman.2008.10.002.
   Kotsanas D, 2013, MED J AUSTRALIA, V198, P267, DOI 10.5694/mja12.11757.
   Krupiene J, 2007, ENV RES ENG MANAG, V41, P9.
   Langelier K.M., 1993, P231.
   Larsson DGJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0571.
   Lewis R Sr, 2007, HAWLEYS CONDENSED CH, P1400.
   Lide DR, 1994, HDB DATA ORGANIC COM, V1, P2660.
   Lubick N, 2010, ENVIRON HEALTH PERSP, V118, pA211.
   Lyons G, 2014, CHEM TRUST REPORT.
   Macedo RO, 1999, J THERM ANAL CALORIM, V56, P1323, DOI 10.1023/A:1010102422381.
   Mackridge AJ, 2005, THESIS.
   Malkow T, 2004, WASTE MANAGE, V24, P53, DOI 10.1016/S0956-053X(03)00038-2.
   MARTIN HF, 1962, BIOCHIM BIOPHYS ACTA, V60, P25, DOI 10.1016/0006-3002(62)90367-0.
   Martin J, 2010, J SEP SCI, V33, P1760, DOI 10.1002/jssc.200900873.
   Matuo R, 2009, J APPL TOXICOL, V29, P308, DOI 10.1002/jat.1411.
   McClellan K, 2010, WATER RES, V44, P658, DOI 10.1016/j.watres.2009.12.032.
   McGregor C, 2004, THERMOCHIM ACTA, V417, P231, DOI 10.1016/j.tca.2003.09.031.
   Monteiro SC, 2010, REV ENVIRON CONTAM T, V202, P53, DOI 10.1007/978-1-4419-1157-5\_2.
   Musson SE, 2007, J AIR WASTE MANAGE, V57, P828, DOI 10.3155/1047-3289.57.7.828.
   Musson SE, 2009, J HAZARD MATER, V162, P730, DOI 10.1016/j.jhazmat.2008.05.089.
   National Health Service (NHS), 2013, PRESCR COST AN ENGL.
   Ort C, 2010, WATER RES, V44, P605, DOI 10.1016/j.watres.2009.08.002.
   Pereira RN, 2007, LAT AM J PHARM, V26, P382.
   Persson M, 2009, ENVIRON INT, V35, P771, DOI 10.1016/j.envint.2008.10.002.
   Ribeiro YA, 1996, THERMOCHIM ACTA, V279, P177, DOI 10.1016/0040-6031(96)90082-9.
   Rich CR, 2013, SUSTAINABILITY HEALT, P205.
   Rodriguez-Navas C, 2013, ARCH ENVIRON CON TOX, V65, P56, DOI 10.1007/s00244-013-9880-x.
   Royal Society of Chemistry (RSC), 2013, AM HYDR MERCK IND.
   Russell RE, 2014, WILDLIFE SOC B, V38, P697, DOI 10.1002/wsb.469.
   Samy AM, 2010, DRUG DISCOV THER, V4, P77.
   Schwarzbauer J, 2002, WATER RES, V36, P2275, DOI 10.1016/S0043-1354(01)00452-3.
   Seehusen DA, 2006, J AM BOARD FAM MED, V19, P542, DOI 10.3122/jabfm.19.6.542.
   Silva MAS, 2007, J THERM ANAL CALORIM, V87, P463, DOI 10.1007/s10973-005-7471-4.
   Smith C. A., 2002, J PHARM SOC WISC NOV, P17.
   Starlander G, 2012, J HOSP INFECT, V82, P122, DOI 10.1016/j.jhin.2012.07.004.
   Thach AV, 2013, J ENVIRON MANAGE, V127, P23, DOI 10.1016/j.jenvman.2013.04.025.
   Thomas NJ, 1999, BARBITUATES, P349.
   Tita B, 2011, REV CHIM-BUCHAREST, V62, P1060.
   Tita B, 2010, REV CHIM-BUCHAREST, V61, P1037.
   Tita D, 2011, J THERM ANAL CALORIM, V105, P501, DOI 10.1007/s10973-010-1187-9.
   Tong AYC, 2011, ENVIRON INT, V37, P292, DOI 10.1016/j.envint.2010.10.002.
   Tudja P, 2001, CHEM PHARM BULL, V49, P1245, DOI 10.1248/cpb.49.1245.
   United States Geological Survey (USGS), 2014, PHARM OTH CONT COMM.
   Vellinga A, 2014, SCI TOTAL ENVIRON, V478, P98, DOI 10.1016/j.scitotenv.2014.01.085.
   Zayed MA, 2010, J THERM ANAL CALORIM, V102, P305, DOI 10.1007/s10973-010-0734-8.}},
Number-of-Cited-References = {{76}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{25}},
Journal-ISO = {{Environ. Manage.}},
Doc-Delivery-Number = {{DX5KW}},
Unique-ID = {{ISI:000384420900011}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000381836200001,
Author = {Chojnacka, Magdalena and Antosik-Wojcinska, Anna Z. and Dominiak, Monika
   and Bzinkowska, Dorota and Borzym, Agnieszka and Sokol-Szawlowska,
   Marlena and Bodzak-Opolska, Gabriela and Antoniak, Dorota and Swiecicki,
   Lukasz},
Title = {{A sham-controlled randomized trial of adjunctive light therapy for
   non-seasonal depression}},
Journal = {{JOURNAL OF AFFECTIVE DISORDERS}},
Year = {{2016}},
Volume = {{203}},
Pages = {{1-8}},
Month = {{OCT}},
Abstract = {{Background: The aim of the study was to examine the efficacy and safety
   of morning bright light therapy (BLT) in the treatment of patients with
   a current major depressive episode (MDE) in bipolar and unipolar
   disorder without a seasonal pattern. It was a randomized,
   sham-controlled trial.
   Methods: Adults, ages 18-70 years were randomized to treatment either
   with BLT or a sham negative ion generator (as a placebo control). The
   subjects were required to be on a stable and therapeutic dose of
   psychotropic medication for at least 4 weeks prior to enrollment and
   their treatment had to be insufficiently effective. Their clinical state
   was monitored at the baseline and at the end of treatment. The Hamilton
   Depression Rating Scale-21 items (HDRS-21), Montgomery-Asberg Depression
   Rating Scale (MADRS), Beck Depression Inventory (BDI-II), Clinical
   Global Impression-Severity (CGI-S) and Patient Global Impression (PGI)
   were used. The results were analyzed with an intention-to-treat (ITT)
   analysis.
   Results: Ninety-five patients were enrolled (50 diagnosed with bipolar
   disorder and 45 with unipolar depression). Fifty-two patients were
   randomized to treatment with BLT and forty-three were in the placebo
   group (ITT population). Eighty-three subjects completed the study. There
   were 12 dropouts (5 in the light group and 7 in the placebo group).
   After 14 days of treatment, a significant improvement was found in all
   groups (p<0.001). The subjects treated with BLT did not significantly
   differ in terms of improvement in HDRS-21 scores at the endpoint when
   compared to patients treated with placebo (p=02). However, further
   analysis demonstrated significantly higher response (50\% v. 27.9\%,
   p=0.02) and remission rates (28.8\% v. 11.6\%, p=0.04) among patients
   treated with morning BLT when compared to placebo group. It should be
   noted that in the population of drug-resistant patients, BLT was more
   efficacious than placebo. There were no statistically significant
   differences between unipolar and bipolar disorders (p=0.4).
   Conclusion: Although overall improvement in HDRS-21 scores were not
   superior in the BLT group, both response and remission rates were
   significantly higher among patients treated with BLT relative to those
   receiving the sham intervention. BLT was also more efficacious than
   placebo in the population of patients with drug-resistant depression.
   Further studies to define the subpopulation of patients with
   non-seasonal depression who may benefit the most from BLT are needed.
   (C) 2016 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chojnacka, M (Reprint Author), Inst Psychiat \& Neurol, Dept Affect Disorders, Sobieskiego St 9, PL-02957 Warsaw, Poland.
   Chojnacka, Magdalena; Antosik-Wojcinska, Anna Z.; Bzinkowska, Dorota; Swiecicki, Lukasz, Inst Psychiat \& Neurol, Dept Affect Disorders, Sobieskiego St 9, PL-02957 Warsaw, Poland.
   Dominiak, Monika; Borzym, Agnieszka; Sokol-Szawlowska, Marlena; Bodzak-Opolska, Gabriela; Antoniak, Dorota, Inst Psychiat \& Neurol, Warsaw, Poland.}},
DOI = {{10.1016/j.jad.2016.05.062}},
ISSN = {{0165-0327}},
EISSN = {{1573-2517}},
Keywords-Plus = {{SEASONAL AFFECTIVE-DISORDER; TREATMENT-RESISTANT DEPRESSION; NEGATIVE
   AIR IONS; BRIGHT LIGHT; BIPOLAR DEPRESSION; SLEEP-DEPRIVATION; MAJOR
   DEPRESSION; CLINICAL-TRIAL; ANTEPARTUM DEPRESSION; TREATMENT DURATION}},
Research-Areas = {{Neurosciences \& Neurology; Psychiatry}},
Web-of-Science-Categories  = {{Clinical Neurology; Psychiatry}},
Author-Email = {{mchojnacka1@gmail.com}},
Cited-References = {{Andrews G, 2001, BRIT J PSYCHIAT, V178, P192, DOI 10.1192/bjp.178.3.192.
   Babel P., 2008, ROCZ PSYCHOL, V11, P59.
   Beauchemin KM, 1997, ACTA PSYCHIAT SCAND, V95, P424, DOI 10.1111/j.1600-0447.1997.tb09656.x.
   Beck AT, 1996, BDI 2 BECK DEPRESSIO.
   Benedetti F, 2005, J CLIN PSYCHIAT, V66, P1535, DOI 10.4088/JCP.v66n1207.
   Benedetti F, 2003, J CLIN PSYCHIAT, V64, P648, DOI 10.4088/JCP.v64n0605.
   Benedetti F, 2001, J AFFECT DISORDERS, V62, P221, DOI 10.1016/S0165-0327(00)00149-X.
   Benedetti F, 2014, J CLIN PSYCHIAT, V75, P133, DOI 10.4088/JCP.13m08455.
   Cohen J, 1988, STAT POWER ANAL BEHA.
   Crown WH, 2002, J CLIN PSYCHIAT, V63, P963, DOI 10.4088/JCP.v63n1102.
   Dallaspezia S, 2012, J AFFECT DISORDERS, V138, P337, DOI 10.1016/j.jad.2012.01.019.
   Dauphinais DR, 2012, PSYCHIAT RES, V196, P57, DOI 10.1016/j.psychres.2012.01.015.
   DELTITO JA, 1991, J AFFECT DISORDERS, V23, P231, DOI 10.1016/0165-0327(91)90105-2.
   EASTMAN CI, 1990, PSYCHOPHARMACOL BULL, V26, P495.
   ECDEU W., 1976, ASS MAN PSYCHPH, P223.
   Epperson CN, 2004, J CLIN PSYCHIAT, V65, P421.
   Even C, 2008, J AFFECT DISORDERS, V108, P11, DOI 10.1016/j.jad.2007.09.008.
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149.
   Fava M, 1996, PSYCHIAT CLIN N AM, V19, P179, DOI 10.1016/S0193-953X(05)70283-5.
   Fawcett J, 1997, J CLIN PSYCHIAT, V58, P32.
   Gaynes BN, 2009, PSYCHIAT SERV, V60, P1439, DOI 10.1176/ps.2009.60.11.1439.
   Goel N, 2005, PSYCHOL MED, V35, P945, DOI 10.1017/S0033291705005027.
   Golden RN, 2005, AM J PSYCHIAT, V162, P656, DOI 10.1176/appi.ajp.162.4.656.
   Guducu F, 2005, TURK PSIKIYATR DERG, V16, P245.
   Guy W, 1976, ECDEU ASSESSMENT MAN, P217.
   Haffmans P.M.J., 2009, SOC LIGHT TREATM BIO.
   HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56.
   HOLSBOERTRACHSLER E, 1994, J PSYCHIAT RES, V28, P381, DOI 10.1016/0022-3956(94)90020-5.
   LABBATE LA, 1995, BIOL PSYCHIAT, V38, P747, DOI 10.1016/0006-3223(95)00069-0.
   LABBATE LA, 1994, J CLIN PSYCHIAT, V55, P189.
   Lam RW, 2016, JAMA PSYCHIAT, V73, P56, DOI 10.1001/jamapsychiatry.2015.2235.
   Leibenluft E, 1995, PSYCHOPHARMACOL BULL, V31, P705.
   Loving RT, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-41.
   Martensson B, 2015, J AFFECT DISORDERS, V182, P1, DOI 10.1016/j.jad.2015.04.013.
   Martiny K, 2005, ACTA PSYCHIAT SCAND, V112, P117, DOI 10.1111/j.1600-0447.2005.00574.x.
   Meissner K, 2011, PHILOS T R SOC B, V366, P1783, DOI 10.1098/rstb.2010.0414.
   MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382.
   NAGAYAMA H, 1991, J AFFECT DISORDERS, V23, P185, DOI 10.1016/0165-0327(91)90099-E.
   Naus T, 2013, J AFFECT DISORDERS, V151, P1135, DOI 10.1016/j.jad.2013.07.017.
   Niederhofer H, 2012, INT J PSYCHIAT CLIN, V16, P233, DOI 10.3109/13651501.2011.625123.
   PAPATHEODOROU G, 1995, J PSYCHIATR NEUROSCI, V20, P226.
   Partonen T, 2001, SEASONAL AFFECTIVE D.
   Poon SH, 2012, BIPOLAR DISORD, V14, P573, DOI 10.1111/j.1399-5618.2012.01042.x.
   Prasko J, 2002, NEUROENDOCRINOL LETT, V23, P109.
   Prasko J, 2010, BIOMED PAP, V154, P355, DOI 10.5507/bp.2010.053.
   Rubin DB, 1987, MULTIPLE IMPUTATION.
   Ruhe HG, 2005, COMPR PSYCHIAT, V46, P417, DOI 10.1016/j.comppsych.2005.03.001.
   Rutherford BR, 2009, PSYCHOTHER PSYCHOSOM, V78, P172, DOI 10.1159/000209348.
   Sit D, 2007, BIPOLAR DISORD, V9, P918, DOI 10.1111/j.1399-5618.2007.00451.x.
   Sondergaard MP, 2006, PSYCHOTHER PSYCHOSOM, V75, P244, DOI 10.1159/000092895.
   Sumaya IC, 2001, J GERONTOL A-BIOL, V56, pM356, DOI 10.1093/gerona/56.6.M356.
   Swiecicki L., 2008, POST PSYCHIAT NEUROL, V17, P347.
   Terman M, 1996, AM J PSYCHIAT, V153, P1423.
   Terman M, 2005, CNS SPECTRUMS, V10, P647, DOI 10.1017/S1092852900019611.
   Thompson C, 2001, J AFFECT DISORDERS, V64, P89, DOI 10.1016/S0165-0327(00)00208-1.
   Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840.
   Wirz-Justice A, 1999, J AFFECT DISORDERS, V52, P291.
   Wirz-Justice A, 2011, J CLIN PSYCHIAT, V72, P986, DOI 10.4088/JCP.10m06188blu.}},
Number-of-Cited-References = {{58}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{23}},
Journal-ISO = {{J. Affect. Disord.}},
Doc-Delivery-Number = {{DT9QA}},
Unique-ID = {{ISI:000381836200001}},
DA = {{2018-08-13}},
}

@article{ ISI:000383840800002,
Author = {Fong, Siat Yee and Piva, Terrence and Dekiwadia, Chaitali and Urban,
   Sylvia and Huynh, Tien},
Title = {{Comparison of cytotoxicity between extracts of Clinacanthus nutans
   (Burm. f.) Lindau leaves from different locations and the induction of
   apoptosis by the crude methanol leaf extract in D24 human melanoma cells}},
Journal = {{BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE}},
Year = {{2016}},
Volume = {{16}},
Month = {{SEP 20}},
Abstract = {{Background: Clinacanthus nutans (Burm. f.) Lindau leaves are widely used
   by cancer patients and the leaf extracts possess cytotoxic and
   antiproliferative effects on several human cancer cell lines. However,
   the effect of C. nutans leaf extract on human melanoma, which is the
   least common but most fatal form of skin cancer and one of the most
   common cancers diagnosed in both sexes worldwide, is unknown. There is
   also limited information on whether the bioactivity of extracts differs
   between C. nutans leaves grown in different geographical locations with
   varying environmental conditions.
   Methods: The present study, for the first time, compared and
   demonstrated the cytotoxicity of the crude methanol extracts of C.
   nutans leaves from 11 different locations in Malaysia, Thailand and
   Vietnam, with diverse environmental conditions against D24 melanoma
   cells through WST-8 assay. The percentage of apoptotic cells following
   treatment with the most active extract was determined in a dose-and
   time-dependent manner by a cytofluorometric double staining technique.
   Biochemical and morphological changes in the treated and untreated cells
   were examined by fluorescence and transmission electron microscopy
   techniques, respectively, to further affirm the induction of apoptosis.
   Results: The leaves of plants grown at higher elevations and lower air
   temperatures were more cytotoxic to the D24 melanoma cells than those
   grown at lower elevations and higher air temperatures, with the leaf
   extract from Chiang Dao, Chiang Mai, Thailand exhibited the highest
   cytotoxicity (24 h EC50: 0.95 mg/mL and 72 h EC50: 0. 77 mg/mL). This
   most active crude extract induced apoptotic cell death in the D24 cells
   in a dose-and time-dependent manner. Typical biochemical and
   morphological characteristics of apoptosis were also observed in the
   treated D24 cells.
   Conclusions: The results, showing the cytotoxicity of C. nutans and the
   induction of apoptosis in D24 cells, are significant and useful to
   facilitate the development of C. nutans as a potential novel
   chemotherapeutic agent for the management of skin melanoma.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fong, SY (Reprint Author), Univ Malaysia Sabah, Fac Med \& Hlth Sci, Jalan UMS, Kota Kinabalu 88400, Sabah, Malaysia.
   Fong, SY (Reprint Author), RMIT Univ, Sch Sci, POB 71, Bundoora, Vic 3083, Australia.
   Fong, Siat Yee, Univ Malaysia Sabah, Fac Med \& Hlth Sci, Jalan UMS, Kota Kinabalu 88400, Sabah, Malaysia.
   Piva, Terrence, RMIT Univ, Sch Hlth \& Biomed Sci, POB 71, Bundoora, Vic 3083, Australia.
   Dekiwadia, Chaitali, RMIT Univ, RMIT Microscopy \& Microanal Facil, GPO Box 2476, Melbourne, Vic 3001, Australia.
   Urban, Sylvia, RMIT Univ, Sch Sci, GPO Box 2476, Melbourne, Vic 3001, Australia.
   Fong, Siat Yee; Huynh, Tien, RMIT Univ, Sch Sci, POB 71, Bundoora, Vic 3083, Australia.}},
DOI = {{10.1186/s12906-016-1348-x}},
Article-Number = {{368}},
ISSN = {{1472-6882}},
Keywords = {{Clinacanthus nutans; Melanoma; Anticancer; Cytotoxic; Apoptosis}},
Keywords-Plus = {{HUMAN KERATINOCYTE HACAT; JUSTICIA-SPICIGERA; DRUG-RESISTANCE; CANCER;
   MITOCHONDRIA; DEATH; NANOMEDICINE; CONSTITUENTS; ANTIOXIDANT;
   ACANTHACEAE}},
Research-Areas = {{Integrative \& Complementary Medicine}},
Web-of-Science-Categories  = {{Integrative \& Complementary Medicine}},
Author-Email = {{siatyee@ums.edu.my}},
ResearcherID-Numbers = {{Urban, Sylvia/L-6418-2017}},
ORCID-Numbers = {{Urban, Sylvia/0000-0002-2376-4260}},
Funding-Acknowledgement = {{Ministry of Education Malaysia}},
Funding-Text = {{The authors acknowledge the facilities, and the scientific and technical
   assistance, of the Australian Microscopy \& Microanalysis Research
   Facility at RMIT University. We thank the Ministry of Education Malaysia
   for the provision of scholarship to the first author.}},
Cited-References = {{Ahmad Nor Hazwani, 2010, Trop Life Sci Res, V21, P101.
   Arullappan S, 2014, TROP J PHARM RES, V13, P1455, DOI 10.4314/tjpr.v13i9.11.
   Ayob Z, 2014, EVIDENCE COMPLEMENT, V2014, P1.
   Basar N, 2015, PHYTOTHER RES, V29, P944, DOI 10.1002/ptr.5329.
   Batus M, 2013, AM J CLIN DERMATOL, V14, P179, DOI 10.1007/s40257-013-0025-9.
   Bhatia S, 2009, ONCOLOGY-NY, V23, P488.
   Brauchle E, 2014, SCI REP-UK, V4, DOI 10.1038/srep04698.
   Caceres-Cortes JR, 2001, PHYTOTHER RES, V15, P691, DOI 10.1002/ptr.791.abs.
   Chen YY, 2001, FEBS LETT, V509, P191, DOI 10.1016/S0014-5793(01)03062-9.
   Chinembiri TN, 2014, MOLECULES, V19, P11679, DOI 10.3390/molecules190811679.
   Cifola I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063597.
   Cock I. E., 2011, Pharmacognosy Communications, V1, P52, DOI 10.5530/pc.2011.1.3.
   Dey S, 2013, INT J PHARM PHARM SC, V5, P854.
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337.
   Ferlay J, 2013, GLOBOCAN 2012 V1 0 C.
   Forman D., 2014, WORLD CANC REPORT 20, P16.
   Hijmans R. J., 2012, DIVA GIS.
   Hirsch T, 1997, ONCOGENE, V15, P1573, DOI 10.1038/sj.onc.1201324.
   Iyer AK, 2013, ADV DRUG DELIVER REV, V65, P1784, DOI 10.1016/j.addr.2013.07.012.
   Johnson IT, 2007, P NUTR SOC, V66, P207, DOI 10.1017/S0029665107005459.
   Alonso-Castro AJ, 2012, J ETHNOPHARMACOL, V141, P888, DOI 10.1016/j.jep.2012.03.036.
   Konur A, 2005, BRIT J DERMATOL, V152, P1134, DOI 10.1111/j.1365-2133.2005.06508.x.
   Kunjachan S, 2013, ADV DRUG DELIVER REV, V65, P1852, DOI 10.1016/j.addr.2013.09.018.
   Kunsorn Paween, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P284, DOI 10.1016/S2221-1691(13)60064-7.
   Li YX, 2011, 2011 INT S IT MED ED.
   Liu TZ, 2007, MOL CANCER THER, V6, P1814, DOI 10.1158/1535-7163.MCT-06-0279.
   Markman JL, 2013, ADV DRUG DELIVER REV, V65, P1866, DOI 10.1016/j.addr.2013.09.019.
   McLachlan A, 2005, APOPTOSIS, V10, P619, DOI 10.1007/s10495-005-1896-x.
   Minitab, 2013, MIN STAT SOFTW.
   Pannangpetch P., 2007, SONGKLANAKARIN J SCI, V29, P1.
   Piva TJ, 1998, J CELL BIOCHEM, V68, P213, DOI 10.1002/(SICI)1097-4644(19980201)68:2<213::AID-JCB8>3.0.CO;2-Y.
   Pratheeshkumar P, 2012, ANTI-CANCER AGENT ME, V12, P1159, DOI 10.2174/187152012803833035.
   Radusiene Jolita, 2012, Botanica Lithuanica, V18, P101, DOI 10.2478/v10279-012-0012-8.
   Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613.
   Rodrigues MF, 2016, BIOCHEM J, V473, P703, DOI 10.1042/BJ20150645.
   Saengkhae C, 2009, THAI J PHYSL SCI, V21, P40.
   Sakdarat S, 2009, BIOORGAN MED CHEM, V17, P1857, DOI 10.1016/j.bmc.2009.01.059.
   Sookmai W, 2011, SRINAGARIND MED J, V26, P240.
   Svejda B, 2010, ANTICANCER RES, V30, P55.
   Thawaranantha D., 1992, SIRIRAJ HOSP GAZ, V44, P285.
   Thongchai S, 2008, J SCI TECHNOL MAHASA, V27, P318.
   Thongrakard V, 2010, AFR J BIOTECHNOL, V9, P4999.
   Tiew W.P., 2014, J APPL PHARM, V6, P77.
   Tu SF, 2014, MOLECULES, V19, P20382, DOI 10.3390/molecules191220382.
   Uong A, 2010, J CELL PHYSIOL, V222, P38, DOI 10.1002/jcp.21935.
   Vachirayonstien T, 2010, NAT PROD RES, V24, P236, DOI 10.1080/14786410802393548.
   Wanikiat P, 2008, J ETHNOPHARMACOL, V116, P234, DOI 10.1016/j.jep.2007.11.035.
   Wong FC, 2014, IRAN J PHARM RES, V13, P1409.
   Yong Y. K., 2013, ALTERNATIVE MED, V2013, P1.
   Zeiss CJ, 2003, VET PATHOL, V40, P481, DOI 10.1354/vp.40-5-481.
   Zhang Yang, 2015, Zhongguo Zhong Yao Za Zhi, V40, P1543.
   Ziegler U, 2004, NEWS PHYSIOL SCI, V19, P124, DOI 10.1152/nips.01519.2004.}},
Number-of-Cited-References = {{52}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{16}},
Journal-ISO = {{BMC Complement. Altern. Med.}},
Doc-Delivery-Number = {{DW7OO}},
Unique-ID = {{ISI:000383840800002}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000383198400001,
Author = {Lee, Robert J. and Workman, Alan D. and Carey, Ryan M. and Chen, Bei and
   Rosen, Phillip L. and Doghramji, Laurel and Adappa, Nithin D. and
   Palmer, James N. and Kennedy, David W. and Cohen, Noam A.},
Title = {{Fungal Aflatoxins Reduce Respiratory Mucosal Ciliary Function}},
Journal = {{SCIENTIFIC REPORTS}},
Year = {{2016}},
Volume = {{6}},
Month = {{SEP 14}},
Abstract = {{Aflatoxins are mycotoxins secreted by Aspergillus flavus, which can
   colonize the respiratory tract and cause fungal rhinosinusitis or
   bronchopulmonary aspergillosis. A. flavus is the second leading cause of
   invasive aspergillosis worldwide. Because many respiratory pathogens
   secrete toxins to impair mucociliary immunity, we examined the effects
   of acute exposure to aflatoxins on airway cell physiology. Using
   air-liquid interface cultures of primary human sinonasal and bronchial
   cells, we imaged ciliary beat frequency (CBF), intracellular calcium,
   and nitric oxide (NO). Exposure to aflatoxins (0.1 to 10 mu M; 5 to 10
   minutes) reduced baseline (similar to 6-12\%) and agonist-stimulated
   CBF. Conditioned media (CM) from A. fumigatus, A. niger, and A. flavus
   cultures also reduced CBF by similar to 10\% after 60 min exposure, but
   effects were blocked by an anti-aflatoxin antibody only with A. flavus
   CM. CBF reduction required protein kinase C but was not associated with
   changes in calcium or NO. However, AFB(2) reduced NO production by
   similar to 50\% during stimulation of the ciliary-localized T2R38
   receptor. Using a fluorescent reporter construct expressed in A549
   cells, we directly observed activation of PKC activity by AFB2.
   Aflatoxins secreted by respiratory A. flavus may impair motile and
   chemosensory functions of airway cilia, contributing to pathogenesis of
   fungal airway diseases.}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Cohen, NA (Reprint Author), Univ Penn, Dept Otorhinolaryngol Head \& Neck Surg, Perelman Sch Med, Philadelphia, PA 19104 USA.
   Cohen, NA (Reprint Author), Philadelphia VA Med Ctr Surg Serv, Philadelphia, PA 19104 USA.
   Cohen, NA (Reprint Author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.
   Lee, Robert J.; Workman, Alan D.; Carey, Ryan M.; Chen, Bei; Rosen, Phillip L.; Doghramji, Laurel; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Cohen, Noam A., Univ Penn, Dept Otorhinolaryngol Head \& Neck Surg, Perelman Sch Med, Philadelphia, PA 19104 USA.
   Lee, Robert J., Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA.
   Cohen, Noam A., Philadelphia VA Med Ctr Surg Serv, Philadelphia, PA 19104 USA.
   Cohen, Noam A., Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.}},
DOI = {{10.1038/srep33221}},
Article-Number = {{33221}},
ISSN = {{2045-2322}},
Keywords-Plus = {{PROTEIN-KINASE-C; TASTE RECEPTOR T2R38; BRONCHIAL EPITHELIAL-CELLS;
   NITRIC-OXIDE SYNTHASE; CHRONIC RHINOSINUSITIS; ASPERGILLUS-FUMIGATUS;
   IN-VITRO; ANTIBIOTIC-RESISTANCE; CYTOCHROME-P450 2A13; CULTURE MATERIAL}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{cohenn@uphs.upenn.edu}},
ResearcherID-Numbers = {{Lee, Robert/L-4397-2017
   }},
ORCID-Numbers = {{Lee, Robert/0000-0001-5826-6686
   Cohen, Noam/0000-0002-9462-3932}},
Funding-Acknowledgement = {{National Institutes of Health {[}R01DC013588, R03DC013862]; Department
   of Otorhinolaryngology at the University of Pennsylvania}},
Funding-Text = {{The authors wish to thank Dr. L. Chandler and the Philadelphia V.A.
   Medical Center microbiology laboratory for help with Aspergillus
   culture. This study was supported by grants from National Institutes of
   Health (R01DC013588 to N.A.C., R03DC013862 to R.J.L.), a charitable
   donation from the RLG Foundation, Inc (to N.A.C.), and funding from the
   Department of Otorhinolaryngology at the University of Pennsylvania (to
   R.J.L.).}},
Cited-References = {{Abad A, 2010, REV IBEROAM MICOL, V27, P155, DOI 10.1016/j.riam.2010.10.003.
   Adappa ND, 2015, INT FORUM ALLERGY RH.
   Adappa ND, 2014, INT FORUM ALLERGY RH, V4, P3, DOI 10.1002/alr.21253.
   Adappa ND, 2013, INT FORUM ALLERGY RH, V3, P184, DOI 10.1002/alr.21140.
   AMITANI R, 1995, EUR RESPIR J, V8, P1681, DOI 10.1183/09031936.95.08101681.
   AMITANI R, 1995, INFECT IMMUN, V63, P3266.
   AMITANI R, 1991, AM J RESP CELL MOL, V4, P26, DOI 10.1165/ajrcmb/4.1.26.
   Antunes MB, 2009, IMMUNOL ALLERGY CLIN, V29, P631, DOI 10.1016/j.iac.2009.07.004.
   Bedard LL, 2006, CANCER LETT, V241, P174, DOI 10.1016/j.canlet.2005.11.018.
   Bhattacharyya N, 2012, OTOLARYNG HEAD NECK, V146, P307, DOI 10.1177/0194599811426089.
   BLACKWELL DL, 2002, VITAL HLTH STAT, V10, P1.
   BUTLER WH, 1969, CANCER RES, V29, P2206.
   Chaudhary Neelkamal, 2011, Clin Transl Allergy, V1, P4, DOI 10.1186/2045-7022-1-4.
   Cherry Donald K, 2002, Adv Data, P1.
   Cohen M, 2009, AM J RHINOL ALLERGY, V23, P255, DOI 10.2500/ajra.2009.23.3319.
   Cui A, 2015, TUMOR BIOL, V36, P6507, DOI 10.1007/s13277-015-3341-2.
   Dalgorf DM, 2013, AM J RHINOL ALLERGY, V27, pS3, DOI 10.2500/ajra.2013.27.3888.
   Diaz-Meco MT, 2012, IMMUNOL REV, V246, P154, DOI 10.1111/j.1600-065X.2012.01093.x.
   Dilkin P, 2003, FOOD CHEM TOXICOL, V41, P1345, DOI 10.1016/S0278-6915(03)00137-6.
   DVORACKOVA I, 1981, J CANCER RES CLIN, V100, P221, DOI 10.1007/BF00403368.
   Economou V, 2015, INFECT DRUG RESIST, V8, P49, DOI 10.2147/IDR.S55778.
   Gallegos LL, 2011, METHODS MOL BIOL, V756, P295, DOI 10.1007/978-1-61779-160-4\_17.
   HARVEY RB, 1995, AM J VET RES, V56, P1668.
   He XY, 2006, INT J CANCER, V118, P2665, DOI 10.1002/ijc.21665.
   Hens G, 2006, RHINOLOGY, V44, P179.
   Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07.
   Hutcheson PS, 2010, AM J RHINOL ALLERGY, V24, P405, DOI 10.2500/ajra.2010.24.3533.
   Jacob A, 2006, LARYNGOSCOPE, V116, P558, DOI 10.1097/01.MLG.0000202085.23454.2F.
   Jones DA, 1997, GEN PHARMACOL-VASC S, V28, P183, DOI 10.1016/S0306-3623(96)00189-9.
   KANTHAKUMAR K, 1993, INFECT IMMUN, V61, P2848.
   Kelly JD, 1997, TOXICOL APPL PHARM, V144, P88, DOI 10.1006/taap.1997.8117.
   Krishnan S, 2009, MYCOSES, V52, P206, DOI 10.1111/j.1439-0507.2008.01642.x.
   Lai YY, 2011, J ALLERGY CLIN IMMUN, V128, P1207, DOI 10.1016/j.jaci.2011.09.001.
   Larsson P, 2003, RES VET SCI, V74, P227, DOI 10.1016/S0034-5288(02)00191-1.
   Lee RJ, 2015, CELL MOL LIFE SCI, V72, P217, DOI 10.1007/s00018-014-1736-7.
   Lee RJ, 2015, CURR OPIN ALLERGY CL, V15, P14, DOI 10.1097/ACI.0000000000000120.
   Lee RJ, 2014, INNATE IMMUN-LONDON, V20, P606, DOI 10.1177/1753425913503386.
   Lee RJ, 2014, CELL CALCIUM, V55, P325, DOI 10.1016/j.ceca.2014.02.001.
   Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094.
   Lee RJ, 2013, FASEB J, V27, P5094, DOI 10.1096/fj.13-234476.
   Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240.
   Leung MCK, 2006, J AGR FOOD CHEM, V54, P9623, DOI 10.1021/jf062363+.
   Lorico A, 2002, TOXICOLOGY, V171, P201, DOI 10.1016/S0300-483X(01)00584-4.
   MAHGOUB ES, 1972, THORAX, V27, P33, DOI 10.1136/thx.27.1.33.
   Manes RP, 2012, FACIAL PLAST SURG CL, V20, P87, DOI 10.1016/j.fsc.2011.10.010.
   Marcinkiewicz J, 2013, POL ARCH MED WEWN, V123, P309.
   Massey TE, 2000, EXP LUNG RES, V26, P673, DOI 10.1080/01902140150216756.
   Matsubara M, 2003, J BIOCHEM, V133, P773, DOI 10.1093/jb/mvg099.
   Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200.
   Mistry KJ, 1996, CHEM-BIOL INTERACT, V100, P177, DOI 10.1016/0009-2797(96)03698-8.
   Mistry KJ, 2001, INDIAN J BIOCHEM BIO, V38, P270.
   Mistry KJ, 1997, CANCER LETT, V121, P99, DOI 10.1016/S0304-3835(97)00337-6.
   Mulder JE, 2015, MUTAT RES-FUND MOL M, V773, P63, DOI 10.1016/j.mrfmmm.2015.01.015.
   Mulder JE, 2014, TOXICOL APPL PHARM, V275, P96, DOI 10.1016/j.taap.2013.12.016.
   Paget V, 2008, MUTAT RES-GEN TOX EN, V656, P55, DOI 10.1016/j.mrgentox.2008.07.009.
   Pasqualotto A. C., 2009, MED MYCOLOGY OFFI S1, V407, pS261.
   READ RC, 1992, J APPL PHYSIOL, V72, P2271.
   SALATHE M, 1993, J CELL SCI, V106, P1211.
   Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253.
   Schwab JA, 1998, LARYNGOSCOPE, V108, P120, DOI 10.1097/00005537-199801000-00023.
   Shen HT, 2013, FOOD CHEM TOXICOL, V62, P661, DOI 10.1016/j.fct.2013.09.030.
   Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x.
   Soler ZM, 2012, AM J RHINOL ALLERGY, V26, P351, DOI 10.2500/ajra.2012.26.3807.
   STEINFORT C, 1989, INFECT IMMUN, V57, P2006.
   Streit E, 2013, J SCI FOOD AGR, V93, P2892, DOI 10.1002/jsfa.6225.
   Streit E, 2012, TOXINS, V4, P788, DOI 10.3390/toxins4100788.
   Sutandyo Noorwati, 2010, Acta Med Indones, V42, P36.
   Van Vleet TR, 2006, TOXICOL SCI, V89, P399, DOI 10.1093/toxsci/kfj039.
   Van Vleet TR, 2002, CANCER RES, V62, P105.
   Van Vleet TR, 2001, J TOXICOL ENV HEAL A, V63, P525, DOI 10.1080/15287390152410156.
   VANDENHEEVER LH, 1991, INT J BIOCHEM, V23, P839, DOI 10.1016/0020-711X(91)90068-X.
   Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125.
   WONG JJ, 1976, P NATL ACAD SCI USA, V73, P2241, DOI 10.1073/pnas.73.7.2241.
   Wong LB, 1998, AM J PHYSIOL-CELL PH, V275, pC440, DOI 10.1152/ajpcell.1998.275.2.C440.
   Wu-Zhang AX, 2013, BIOCHEM J, V452, P195, DOI 10.1042/BJ20130220.
   Zhang Z, 2014, INT J CANCER, V134, P1539, DOI 10.1002/ijc.28489.
   Zhao KQ, 2012, FASEB J, V26, P3178, DOI 10.1096/fj.11-202184.
   Zhao M, 2012, ARCH IMMUNOL THER EX, V60, P361, DOI 10.1007/s00005-012-0188-8.}},
Number-of-Cited-References = {{78}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{16}},
Journal-ISO = {{Sci Rep}},
Doc-Delivery-Number = {{DV8PH}},
Unique-ID = {{ISI:000383198400001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000385787300013,
Author = {Munoz-Torrico, Marcela and Rendon, Adrian and Centis, Rosetta and
   D'Ambrosio, Lia and Fuentes, Zhenia and Torres-Duque, Carlos and Mello,
   Fernanda and Dalcolmo, Margareth and Perez-Padilla, Rogelio and
   Spanevellom, Antonio and Migliori, Giovanni Battista},
Title = {{Is there a rationale for pulmonary rehabilitation following successful
   chemotherapy for tuberculosis?}},
Journal = {{JORNAL BRASILEIRO DE PNEUMOLOGIA}},
Year = {{2016}},
Volume = {{42}},
Number = {{5}},
Pages = {{374-385}},
Month = {{SEP-OCT}},
Publisher = {{SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA}},
Address = {{SEPS 714-719, BLOCO E ASA SUL, SALAS 220-223, BRASILIA DF, CEP70390-145,
   BRAZIL}},
Type = {{Article}},
Language = {{Portuguese}},
Affiliation = {{Migliori, GB (Reprint Author), Fdn Salvatore Maugeri, IRCCS, WHO Collaborating Ctr TB \& Lung Dis, Via Roncaccio 16, I-21049 Tradate, Italy.
   Munoz-Torrico, Marcela, INER, Clin TB, Mexico City, DF, Mexico.
   Rendon, Adrian, Univ Monterrey, Univ Hosp, Ctr Invest Prevenc \& Tratamiento Infecc Resp, Monterrey, Mexico.
   Centis, Rosetta; D'Ambrosio, Lia; Migliori, Giovanni Battista, Fdn Salvatore Maugeri, IRCCS, WHO Collaborating Ctr TB \& Lung Dis, Via Roncaccio 16, I-21049 Tradate, Italy.
   D'Ambrosio, Lia, Publ Hlth Consulting Grp SAGL, Lugano, Switzerland.
   Fuentes, Zhenia, Hosp Gen Dr Jose Ignacio Baldo, Serv Neumol, Caracas, Venezuela.
   Torres-Duque, Carlos, Univ La Sabana, Fdn Neumol Colombiana, Bogota, Colombia.
   Mello, Fernanda, Univ Fed Rio de Janeiro, Inst Doencas Torax, Rio De Janeiro, RJ, Brazil.
   Dalcolmo, Margareth, Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Ctr Referencia Helio Fraga, Rio De Janeiro, RJ, Brazil.
   Perez-Padilla, Rogelio, INER, Clin Sueno, Mexico City, DF, Mexico.
   Spanevellom, Antonio, Fdn Salvatore Maugeri, IRCCS, Unita Pneumol, Tradate, Italy.
   Spanevellom, Antonio, Univ Insubria, Dipartimento Med Clin \& Sperimentale, Varese, Italy.}},
DOI = {{10.1590/S1806-37562016000000226}},
ISSN = {{1806-3713}},
EISSN = {{1806-3756}},
Keywords-Plus = {{AIR-FLOW OBSTRUCTION; MULTIDRUG-RESISTANT TUBERCULOSIS; FUNCTION
   IMPAIRMENT; AIRWAYS DISEASE; DESTROYED LUNG; TB; ELIMINATION; SEQUELAE;
   EUROPE}},
Research-Areas = {{Respiratory System}},
Web-of-Science-Categories  = {{Respiratory System}},
Author-Email = {{giovannibattista.migliori@fsm.it}},
ResearcherID-Numbers = {{Mello, Fernanda/I-2957-2013
   Centis, Rosella/E-8882-2018
   }},
ORCID-Numbers = {{Centis, Rosella/0000-0002-8551-3598
   Migliori, Giovanni Battista/0000-0002-2597-574X
   SPANEVELLO, ANTONIO/0000-0002-3595-9903}},
Cited-References = {{Abdool-Gaffar M S, 2011, SAMJ, S. Afr. med. j., V101, P63.
   Amaral AFS, 2015, EUR RESPIR J, V46, P1104, DOI 10.1183/13993003.02325-2014.
   Ando M, 2003, CHEST, V123, P1988, DOI 10.1378/chest.123.6.1988.
   Baez-Saldana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078926.
   Baig IM, 2010, JCPSP-J COLL PHYSICI, V20, P542, DOI 08.2010/JCPSP.542544.
   Bansal Vishal, 2014, Indian J Chest Dis Allied Sci, V56, P147.
   Wilches EC, 2009, COLOMB MEDICA, V40, P436.
   CHAPMAN C E, 1964, Calif Med, V100, P88.
   Chung KP, 2011, CLINICS, V66, P549, DOI 10.1590/S1807-59322011000400005.
   D'Ambrosio L, 2014, EUR RESPIR J, V43, P1410, DOI 10.1183/09031936.00198813.
   DANIELS M, 1949, BMJ-BRIT MED J, V2, P1135, DOI 10.1136/bmj.2.4637.1135.
   de Grass Donna, 2014, Afr Health Sci, V14, P866, DOI 10.4314/ahs.v14i4.14.
   de la Mora IL, 2015, INT J TUBERC LUNG D, V19, P808, DOI 10.5588/ijtld.14.0983.
   de Valliere S, 2004, INT J TUBERC LUNG D, V8, P767.
   Di Naso FC, 2011, REV PORT PNEUMOL, V17, P216, DOI 10.1016/j.rppneu.2011.06.010.
   Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611.
   Godoy MDP, 2012, RESP CARE, V57, P1949, DOI 10.4187/respcare.01532.
   HALLETT WY, 1961, ANN INTERN MED, V54, P1146, DOI 10.7326/0003-4819-54-6-1146.
   Hassan IS, 2005, SAUDI MED J, V26, P1155.
   Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32.
   Jordan TS, 2010, RESPIROLOGY, V15, P623, DOI 10.1111/j.1440-1843.2010.01749.x.
   Jung JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141230.
   Kida Kozui, 2013, Pneumonol Alergol Pol, V81, P468.
   Lam KBH, 2010, CHEST, V137, P593, DOI 10.1378/chest.09-1435.
   Lee JH, 2003, RESP MED, V97, P1237, DOI 10.1016/S0954-6111(03)00255-5.
   Lee SW, 2011, J KOREAN MED SCI, V26, P268, DOI 10.3346/jkms.2011.26.2.268.
   Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014.
   Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507.
   Migliori GB, 2012, EUR RESPIR J, V39, P807, DOI 10.1183/09031936.00203811.
   Migliori GB, 2013, EUR RESPIR J, V42, P169, DOI 10.1183/09031936.00136312.
   Mohan Alladi, 2006, BMC Pulm Med, V6, P27, DOI 10.1186/1471-2466-6-27.
   Pasipanodya JG, 2007, CHEST, V131, P1817, DOI 10.1378/chest.06-2949.
   Pefura-Yone EW, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005361.
   Pontali E, 2016, EUR RESPIR J, V47, P394, DOI 10.1183/13993003.01891-2015.
   Ralph AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080302.
   Rhee CK, 2013, INT J TUBERC LUNG D, V17, P67, DOI 10.5588/ijtld.12.0351.
   Rivera JA, 2015, PHYSIOTHERAPY S1, V101, pe1288.
   Motta JAR, 2016, AM J RESP CRIT CARE, V193.
   Sailaja K, 2015, J EVOL MED DENT SCI-, V4, P7365, DOI 10.14260/jemds/2015/1068.
   Schito M, 2015, CLIN INFECT DIS, V61, pS102, DOI 10.1093/cid/civ609.
   Shah M, 2014, CURR OPIN INFECT DIS, V27, P403, DOI 10.1097/QCO.0000000000000090.
   Singla Neeta, 2009, Indian J Tuberc, V56, P206.
   Sotgiu G., 2016, EUR RESP J.
   Sotgiu G, 2016, LANCET, V387, P2486, DOI 10.1016/S0140-6736(16)30729-2.
   Sotgiu G, 2014, EUR RESPIR J, V43, P1563, DOI 10.1183/09031936.00064314.
   Spruit MA, 2013, AM J RESP CRIT CARE, V188, pE13, DOI 10.1164/rccm.201309-1634ST.
   Strelis A A, 2004, Probl Tuberk Bolezn Legk, P29.
   Subotic D, 2016, J THORAC DIS, V8, pE474, DOI 10.21037/jtd.2016.05.59.
   Tada Atsuhiko, 2002, Nihon Kokyuki Gakkai Zasshi, V40, P275.
   Tsuboi T, 1997, CHEST, V112, P1000, DOI 10.1378/chest.112.4.1000.
   Vecino Mauricio, 2011, J Infect Public Health, V4, P244, DOI 10.1016/j.jiph.2011.08.005.
   Weyer K, 2013, EUR RESPIR J, V42, P252, DOI 10.1183/09031936.00157212.
   WHO, 2015, WHOHTMTB201522.
   WILLCOX PA, 1989, RESP MED, V83, P195, DOI 10.1016/S0954-6111(89)80031-9.
   World Health Organization, 2016, WHOHTMTB201604.
   YANG GFW, 1984, ARCH PHYS MED REHAB, V65, P556.
   Zhuk N A, 2007, Probl Tuberk Bolezn Legk, P25.}},
Number-of-Cited-References = {{57}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{J. Bras. Pneumol.}},
Doc-Delivery-Number = {{DZ3ZB}},
Unique-ID = {{ISI:000385787300013}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000383829700011,
Author = {Sivri, Nuket and Bagcigil, Arzu Funda and Metiner, Kemal and Seker,
   Dursun Zafer and Orak, Selin and Durak, Sevgi Gunes and Sonmez, Vildan
   Zulal},
Title = {{Culturable airborne bacteria and isolation of methicillin-resistant
   coagulase-negative staphylococci from outdoor environments on European
   side of Istanbul, Turkey}},
Journal = {{ARCHIVES OF ENVIRONMENTAL PROTECTION}},
Year = {{2016}},
Volume = {{42}},
Number = {{3}},
Pages = {{77-86}},
Month = {{SEP}},
Abstract = {{This study is aimed to investigate culturable airborne bacteria
   concentrations and the composition of methicillin-resistant
   staphylococci in eleven different locations on the basis of specific
   activities conducted within different parts of the European side of
   Istanbul. The highest bacterial levels were observed at the Bakirkoy
   station (1 100 CFU/m(3)) while the second highest levels were found at
   the Bahcelievler station (1 040 CFU/m(3)) in October; the lowest levels
   (10 CFU/m(3)) were measured at other different stations (Atakoy,
   Yesilkoy). Fifteen methicillin- resistant isolates {[}Staphylococcus
   hominis (n=11), S. cohnii spp. cohnii (n=2), S. sciuri (n=1), S. capitis
   spp. capitis (n=1)] were identified. The disc diffusion method was used
   to identify the antimicrobial resistance of these isolates, it was
   observed that the most common resistance was to penicillin (P) (n=11),
   doxycycline (DO) (n=4) and tetracycline (T) (n=5). None of the isolates
   was resistant to imipenem, amoxicillin/clavulanic acid, vancomycin (IPM,
   AMC, VA). However, multiple antimicrobial resistance was found to be
   26.7\%. The results of this study revealed the importance of isolated
   methicillin-resistant staphylococci in the stations with densely active
   human population and traffic, for public health. As a result, the
   importance of resting along known shorelines, where culturable airborne
   bacteria concentrations are much lower, and its importance for human
   health have been emphasized.}},
Publisher = {{POLSKA AKAD NAUK, POLISH ACAD SCIENCES, INST ENVIRON ENG PAS}},
Address = {{PL DEFILAD 1, WARSZAWA, 00-901, POLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Sivri, N (Reprint Author), Istanbul Univ, Dept Environm Engn, Fac Engn, Istanbul, Turkey.
   Sivri, Nuket; Sonmez, Vildan Zulal, Istanbul Univ, Dept Environm Engn, Fac Engn, Istanbul, Turkey.
   Bagcigil, Arzu Funda; Metiner, Kemal, Istanbul Univ, Dept Microbiol, Fac Vet Med, Istanbul, Turkey.
   Seker, Dursun Zafer, Istanbul Tech Univ, Dept Geomat Engn, Fac Civil Engn, Istanbul, Turkey.
   Orak, Selin, Istanbul Tech Univ, Cevre Yapi Aritma Sistemleri, Nilufer Ticaret Merkezi Yaylali Sok, 7 Nilufer, Bursa, Turkey.
   Durak, Sevgi Gunes, Yildiz Tech Univ, Dept Environm Engn, Fac Civil Engn, Istanbul, Turkey.}},
DOI = {{10.1515/aep-2016-0034}},
ISSN = {{2083-4772}},
EISSN = {{2083-4810}},
Keywords = {{Antimicrobial resistance; Culturable airborne bacteria; European side of
   Istanbul; GIS; Staphylococcus sp}},
Keywords-Plus = {{DAY-CARE-CENTERS; EDIRNE CITY; ANTIBIOTIC-RESISTANCE; INDOOR; URBAN;
   AIR; FUNGI; CONTAMINATION; MICROORGANISMS; HUMIDITY}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{sivrin@gmail.com}},
Funding-Acknowledgement = {{University of Istanbul {[}2917/2008, UDP-35903]}},
Funding-Text = {{This study was supported by the Research Fund of The University of
   Istanbul (Project Number: 2917/2008 and UDP-35903). Special thanks to
   the IUCEMIK Group for their assistance with the field work. We
   gratefully acknowledge Dr. N. Linda FRAIM and Armagan OZER for critical
   reading of the manuscript.}},
Cited-References = {{Abulreesh H. H., 2011, Research Journal of Microbiology, V6, P510, DOI 10.3923/jm.2011.510.523.
   {[}Anonymous], 2003, 146981 ISOFDIS.
   {[}Anonymous], 2014, IST METR MUN ANN REP.
   {[}Anonymous], 2013, IST METR MUN ANN REP.
   Aydogdu H, 2005, INDOOR BUILT ENVIRON, V14, P411, DOI 10.1177/1420326X05057539.
   Aydogdu H, 2010, ENVIRON MONIT ASSESS, V164, P53, DOI 10.1007/s10661-009-0874-0.
   Aydogdu H, 2008, ENVIRON MONIT ASSESS, V147, P423, DOI 10.1007/s10661-007-0130-4.
   BAGCIGIL AF, 2012, ISTANB UNIV VET FAK, V38, P151.
   Bhowmick B. K., 2004, Pakistan Journal of Biological Sciences, V7, P1616.
   BOVALLIUS A, 1978, APPL ENVIRON MICROB, V35, P847.
   Bowers RM, 2011, APPL ENVIRON MICROB, V77, P6350, DOI 10.1128/AEM.05498-11.
   Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167.
   Bowers RM, 2009, APPL ENVIRON MICROB, V75, P5121, DOI 10.1128/AEM.00447-09.
   Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104.
   Chitanand MP, 2010, INDIAN J MICROBIOL, V50, P216, DOI 10.1007/s12088-010-0042-9.
   Clinical and Laboratory Standards Institute (CLSI), 2013, M100S23 CLSI.
   Fang ZG, 2008, AEROSOL SCI TECH, V42, P325, DOI 10.1080/02786820802068657.
   Fang ZG, 2007, MICROB ECOL, V54, P487, DOI 10.1007/s00248-007-9216-3.
   Gandolfi I, 2011, J APPL MICROBIOL, V110, P1612, DOI 10.1111/j.1365-2672.2011.05018.x.
   GEHA DJ, 1994, J CLIN MICROBIOL, V32, P1768.
   Giorgio C.D., 1996, ATMOS ENVIRON, V30, P155.
   Gunes S., 2009, THESIS.
   Huebner J, 1999, ANNU REV MED, V50, P223.
   Karwowska E, 2013, ARCH ENVIRON PROT, V39, P51, DOI 10.2478/aep-2013-0034.
   Koneman EW, 1997, COLOR ATLAS TXB DIAG, P539.
   Lis DO, 2009, AM J INFECT CONTROL, V37, P177, DOI 10.1016/j.ajic.2008.09.013.
   Ly S, 2011, HYDROL EARTH SYST SC, V15, P2259, DOI 10.5194/hess-15-2259-2011.
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x.
   Mandal J., 2011, Open Environmental \& Biological Monitoring Journal, V4, P83, DOI 10.2174/1875040001104010083.
   Mentese S, 2012, INDOOR BUILT ENVIRON, V21, P797, DOI 10.1177/1420326X11425965.
   Mentese S, 2009, EKOLOJI, V19, P21, DOI 10.5053/ekoloji.2009.733.
   Mohr AJ, 2002, MANUAL ENV MICROBIOL, P827.
   Mooi E, 2011, CONCISE GUIDE TO MARKET RESEARCH: THE PROCESS, DATA, AND METHODS USING IBM SPSS STATISTICS, P285, DOI 10.1007/978-3-642-12541-6\_10.
   {*}NCCLS, 1997, M7A4 NCCLS.
   NCCLS National Committee for Clinical Laboratory Standards, 2004, M31S1 NCCLS.
   PASANEN AL, 1991, ATMOS ENVIRON A-GEN, V25, P459, DOI 10.1016/0960-1686(91)90316-Y.
   Roberts RB, 1998, J INFECT DIS, V178, P164, DOI 10.1086/515610.
   Rogula-Kozlowska W, 2013, ARCH ENVIRON PROT, V39, P53, DOI 10.2478/aep-2013-0002.
   Sanchez-Monedero MA, 2008, WATER RES, V42, P3739, DOI 10.1016/j.watres.2008.06.028.
   Sarica S, 2002, INDOOR BUILT ENVIRON, V11, P285, DOI 10.1159/000066523.
   Say ANO, 2010, FRESEN ENVIRON BULL, V19, P2116.
   Klaric MS, 2006, ANN AGR ENV MED, V13, P55.
   Seino K, 2005, ATMOS ENVIRON, V39, P337, DOI 10.1016/j.atmosenv.2004.09.030.
   Shaffer BT, 1997, MICROBIAL ECOL, V34, P167, DOI 10.1007/s002489900046.
   Shiomori T, 2002, J HOSP INFECT, V50, P30, DOI 10.1053/jhin.2001.1136.
   Simor AE, 2002, J INFECT DIS, V186, P652, DOI 10.1086/342292.
   Skoog J, 2006, INDOOR BUILT ENVIRON, V15, P93, DOI 10.1177/1420326X06062100.
   Szewczyk Eligia M., 2003, Microbial Ecology in Health and Disease, V15, P51, DOI 10.1080/08910600310014908.
   Szewczyk EM, 2004, FOLIA MICROBIOL, V49, P123, DOI 10.1007/BF02931385.
   Yassin MF, 2010, INT J ENVIRON SCI TE, V7, P535, DOI 10.1007/BF03326162.
   Zhu Hong, 2003, Aerobiologia, V19, P201, DOI 10.1023/B:AERO.0000006571.23160.8a.
   Zmyslowska I., 2005, ARCH ENVIRON PROT, V31, P13.}},
Number-of-Cited-References = {{52}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{15}},
Journal-ISO = {{Arch. Environ. Prot.}},
Doc-Delivery-Number = {{DW7KN}},
Unique-ID = {{ISI:000383829700011}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000381382100057,
Author = {Meghji, Jamilah and Simpson, Hope and Squire, S. Bertel and Mortimer,
   Kevin},
Title = {{A Systematic Review of the Prevalence and Pattern of Imaging Defined
   Post-TB Lung Disease}},
Journal = {{PLOS ONE}},
Year = {{2016}},
Volume = {{11}},
Number = {{8}},
Month = {{AUG 12}},
Abstract = {{Background
   Tuberculosis is an important risk factor for chronic respiratory disease
   in resource poor settings. The persistence of abnormal spirometry and
   symptoms after treatment are well described, but the structural
   abnormalities underlying these changes remain poorly defined, limiting
   our ability to phenotype post-TB lung disease in to meaningful
   categories for clinical management, prognostication, and ongoing
   research. The relationship between post-TB lung damage and
   patient-centred outcomes including functional impairment, respiratory
   symptoms, and health related quality of life also remains unclear.
   Methods
   We performed a systematic literature review to determine the prevalence
   and pattern of imaging-defined lung pathology in adults after medical
   treatment for pleural, miliary, or pulmonary TB disease. Data were
   collected on study characteristics, and the modality, timing, and
   findings of thoracic imaging. The proportion of studies relating imaging
   findings to spirometry results and patient morbidity was recorded. Study
   quality was assessed using a modified Newcastle-Ottowa score. (Prospero
   Registration number CRD42015027958)
   Results
   We identified 37 eligible studies. The principle features seen on CXR
   were cavitation (8.383.7\%), bronchiectasis (4.3-11.2\%), and fibrosis
   (25.0-70.4\%), but prevalence was highly variable. CT imaging identified
   a wider range of residual abnormalities than CXR, including nodules
   (25.0-55.8\%), consolidation (3.7-19.2\%), and emphysema (15.0-45.0\%).
   The prevalence of cavitation was generally lower (7.4-34.6\%) and
   bronchiectasis higher (35.086.0\%) on CT vs. CXR imaging. A paucity of
   prospective data, and data from HIV-infected adults and sub-Saharan
   Africa (sSA) was noted. Few studies related structural damage to
   physiological impairment, respiratory symptoms, or patient morbidity.
   Conclusions Post-TB structural lung pathology is common. Prospective
   data are required to determine the evolution of this lung damage and its
   associated morbidity over time. Further data are required from
   HIV-infected groups and those living in sSA.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Meghji, J (Reprint Author), Malawi Liverpool Wellcome Clin Res Programme, Blantyre, Malawi.
   Meghji, J (Reprint Author), Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.
   Meghji, Jamilah, Malawi Liverpool Wellcome Clin Res Programme, Blantyre, Malawi.
   Meghji, Jamilah; Simpson, Hope; Squire, S. Bertel; Mortimer, Kevin, Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.}},
DOI = {{10.1371/journal.pone.0161176}},
Article-Number = {{e0161176}},
ISSN = {{1932-6203}},
Keywords-Plus = {{OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION;
   HUMAN-IMMUNODEFICIENCY-VIRUS; MULTIDRUG-RESISTANT TUBERCULOSIS; CHRONIC
   RESPIRATORY-DISEASE; RESOLUTION CHEST CT; QUALITY-OF-LIFE; RADIOLOGICAL
   SEQUELAE; SOUTH-AFRICAN; RISK-FACTOR}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{jmeghji@doctors.org.uk}},
Funding-Acknowledgement = {{Wellcome Trust Clinical PhD Fellowship Grant {[}106065/Z/14/A]}},
Funding-Text = {{This study was supported by a Wellcome Trust Clinical PhD Fellowship
   Grant, awarded to Dr Jamilah Meghji (106065/Z/14/A). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.}},
Cited-References = {{Al-Hajjaj MS, 2000, ACTA RADIOL, V41, P533, DOI 10.1034/j.1600-0455.2000.041006533.x.
   Allwood BW, 2013, RESPIRATION, V86, P76, DOI 10.1159/000350917.
   Angthong W, 2011, JPN J RADIOL, V29, P554, DOI 10.1007/s11604-011-0597-3.
   Baez-Saldana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078926.
   BARBAS CSV, 1991, CHEST, V100, P1264, DOI 10.1378/chest.100.5.1264.
   Beran D, 2015, LANCET RESP MED, V3, P159, DOI 10.1016/S2213-2600(15)00004-1.
   Bishwakarma R, 2015, RESPIROLOGY, V20, P556, DOI 10.1111/resp.12515.
   Bombarda Sidney, 2003, Sao Paulo Med. J., V121, P198, DOI 10.1590/S1516-31802003000500004.
   Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4.
   Buyukoglan H, 2007, MEDIAT INFLAMM, DOI 10.1155/2007/64859.
   Byrne AL, 2015, INT J INFECT DIS, V32, P138, DOI 10.1016/j.ijid.2014.12.016.
   Caballero A, 2008, CHEST, V133, P343, DOI 10.1378/chest.07-1361.
   Chen YC, 2011, DIS MARKERS, V31, P101, DOI 10.3233/DMA-2011-0808.
   Chung KP, 2011, CLINICS, V66, P549, DOI 10.1590/S1807-59322011000400005.
   Cohen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117716.
   Corlan E, 1997, RESP MED, V91, P21, DOI 10.1016/S0954-6111(97)90133-5.
   Crothers K, 2007, CLIN CHEST MED, V28, P575, DOI 10.1016/j.ccm.2007.06.004.
   de la Mora IL, 2015, INT J TUBERC LUNG D, V19, P808, DOI 10.5588/ijtld.14.0983.
   de Valliere S, 2004, INT J TUBERC LUNG D, V8, P767.
   dePablo A, 1997, CHEST, V112, P1293, DOI 10.1378/chest.112.5.1293.
   Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545.
   Dickson RP, 2014, LANCET, V384, P691, DOI 10.1016/S0140-6736(14)61136-3.
   Drummond MB, 2014, LANCET RESP MED, V2, P583, DOI 10.1016/S2213-2600(14)70017-7.
   Drummond MB, 2010, QUAL LIFE RES, V19, P1295, DOI 10.1007/s11136-010-9701-x.
   Ehrlich RI, 2011, INT J TUBERC LUNG D, V15, P886, DOI 10.5588/ijtld.10.0526.
   Ehrlich RI, 2004, INT J TUBERC LUNG D, V8, P369.
   Elkington PTG, 2006, THORAX, V61, P259, DOI 10.1136/thx.2005.051979.
   Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656.
   Finney LJ, 2013, INT J TUBERC LUNG D, V17, P583, DOI 10.5588/ijtld.12.0619.
   Fitzpatrick M, 2013, CLIN CHEST MED, V34, P325, DOI 10.1016/j.ccm.2013.01.010.
   Frye MD, 1997, CHEST, V112, P393, DOI 10.1378/chest.112.2.393.
   GALARZA I, 1995, THORAX, V50, P1305, DOI 10.1136/thx.50.12.1305.
   Godoy MDP, 2012, RESP CARE, V57, P1949, DOI 10.4187/respcare.01532.
   Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1.
   Hamilton CD, 2008, INT J TUBERC LUNG D, V12, P1059.
   Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC.
   How SH, 2014, MALAY J PATHOL, V36, P91.
   KALLAN B M, 1988, Indian Journal of Medical Sciences, V42, P4.
   Kenangalem E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076077.
   Kunter E, 2002, INT J TUBERC LUNG D, V6, P516.
   Lam KBH, 2010, CHEST, V137, P593, DOI 10.1378/chest.09-1435.
   Lee JJ, 2008, EUR J RADIOL, V67, P100, DOI 10.1016/j.ejrad.2007.07.009.
   Lin HH, 2014, INT J TUBERC LUNG D, V18, P613, DOI 10.5588/ijtld.13.0765.
   Lisha P V, 2012, Indian J Tuberc, V59, P83.
   Long R, 1998, CHEST, V113, P933, DOI 10.1378/chest.113.4.933.
   Marks GB, 2014, INT J TUBERC LUNG D, V18, P1261, DOI 10.5588/ijtld.14.0707.
   Meghji J, 2016, AM J RESP CRIT CARE, V194, P67, DOI 10.1164/rccm.201509-1807OC.
   Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507.
   Menon B, 2015, LUNG INDIA, V32, P241, DOI 10.4103/0970-2113.156233.
   Munthali L, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-107.
   National Tuberculosis Association of the USA, 1961, DIAGN STAND CLASS TU.
   Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120.
   Poey C, 1997, J COMPUT ASSIST TOMO, V21, P601, DOI 10.1097/00004728-199707000-00014.
   Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242.
   Ramachandran R, 2009, INDIAN J TUBERC, V56, P132.
   Rufino RL, 2015, AM J RESP CRIT CARE, V191.
   Ryu YJ, 2011, INT J TUBERC LUNG D, V15, P246.
   Salvi S, 2010, CHEST, V138, P3, DOI 10.1378/chest.10-0645.
   Seiscento M, 2007, RESPIROLOGY, V12, P660, DOI 10.1111/j.1440-1843.2007.01135.x.
   Singla Neeta, 2009, Indian J Tuberc, V56, P206.
   Small P M, 1994, J Thorac Imaging, V9, P74, DOI 10.1097/00005382-199421000-00003.
   Stocks J, 2013, LANCET RESP MED, V1, P728, DOI 10.1016/S2213-2600(13)70118-8.
   Swaminathan S, 2007, J POSTGRAD MED, V53, P228, DOI 10.4103/0022-3859.37509.
   {*}TUB CHEM CTR, 1973, BMJ-BRIT MED J, V2, P7.
   Uskul B, 2005, Monaldi Arch Chest Dis, V63, P101.
   Wang CH, 2010, INT J TUBERC LUNG D, V14, P627.
   Wardlaw AJ, 2005, CLIN EXP ALLERGY, V35, P1254, DOI 10.1111/j.1365-2222.2005.02344.x.
   Wells GA, NEWCASTLE OTTOWA SCA.
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1.
   {*}WHO, 2013, GLOBAL ACTION PLAN F.
   WILLCOX PA, 1989, RESP MED, V83, P195, DOI 10.1016/S0954-6111(89)80031-9.
   Wong CF, 2005, RESPIROLOGY, V10, P515, DOI 10.1111/j.1440-1843.2005.00743.x.
   World Health Organisation, 2013, GLOB TUB REP POST 20.
   World Health Organization, 2015, GLOB TUB REP.
   Wyser C, 1996, CHEST, V110, P333, DOI 10.1378/chest.110.2.333.
   YU CT, 1995, THORAX, V50, P869, DOI 10.1136/thx.50.8.869.
   Zhou YM, 2013, J INT MED, V52, P379.}},
Number-of-Cited-References = {{77}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{DT3LI}},
Unique-ID = {{ISI:000381382100057}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000381110700024,
Author = {King, Paula and Pham, Long K. and Waltz, Shannon and Sphar, Dan and
   Yamamoto, Robert T. and Conrad, Douglas and Taplitz, Randy and Torriani,
   Francesca and Forsyth, R. Allyn},
Title = {{Longitudinal Metagenomic Analysis of Hospital Air Identifies Clinically
   Relevant Microbes}},
Journal = {{PLOS ONE}},
Year = {{2016}},
Volume = {{11}},
Number = {{8}},
Month = {{AUG 2}},
Abstract = {{We describe the sampling of sixty-three uncultured hospital air samples
   collected over a six-month period and analysis using shotgun metagenomic
   sequencing. Our primary goals were to determine the longitudinal
   metagenomic variability of this environment, identify and characterize
   genomes of potential pathogens and determine whether they are atypical
   to the hospital airborne metagenome. Air samples were collected from
   eight locations which included patient wards, the main lobby and
   outside. The resulting DNA libraries produced 972 million sequences
   representing 51 gigabases. Hierarchical clustering of samples by the
   most abundant 50 microbial orders generated three major nodes which
   primarily clustered by type of location. Because the indoor locations
   were longitudinally consistent, episodic relative increases in microbial
   genomic signatures related to the opportunistic pathogens Aspergillus,
   Penicillium and Stenotrophomonas were identified as outliers at specific
   locations. Further analysis of microbial reads specific for
   Stenotrophomonas maltophilia indicated homology to a sequenced
   multi-drug resistant clinical strain and we observed broad sequence
   coverage of resistance genes. We demonstrate that a shotgun metagenomic
   sequencing approach can be used to characterize the resistance
   determinants of pathogen genomes that are uncharacteristic for an
   otherwise consistent hospital air microbial metagenomic profile.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Forsyth, RA (Reprint Author), FLIR Syst Inc, La Jolla, CA 92037 USA.
   Forsyth, RA (Reprint Author), Singlera Genom Inc, La Jolla, CA 92037 USA.
   Forsyth, RA (Reprint Author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.
   King, Paula; Pham, Long K.; Waltz, Shannon; Sphar, Dan; Forsyth, R. Allyn, FLIR Syst Inc, La Jolla, CA 92037 USA.
   King, Paula; Forsyth, R. Allyn, Singlera Genom Inc, La Jolla, CA 92037 USA.
   Forsyth, R. Allyn, San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.
   Yamamoto, Robert T., Zova Syst LLC, San Diego, CA USA.
   Conrad, Douglas, UC San Diego Hlth Syst, Div Pulm Med, Dept Med, San Diego, CA USA.
   Taplitz, Randy; Torriani, Francesca, UC San Diego Hlth Syst, Div Infect Dis, Dept Med, San Diego, CA USA.
   Taplitz, Randy; Torriani, Francesca, UC San Diego Hlth Syst, Infect Prevent \& Clin Epidemiol Unit, San Diego, CA USA.}},
DOI = {{10.1371/journal.pone.0160124}},
Article-Number = {{e0160124}},
ISSN = {{1932-6203}},
Keywords-Plus = {{STENOTROPHOMONAS-MALTOPHILIA; HEMATOLOGIC MALIGNANCIES; ENVIRONMENT;
   MICROORGANISMS; COMMUNITIES; DIVERSITY; GENOME; MICROBIOLOGY;
   COLONIZATION; TRANSMISSION}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{rforsyth@mail.sdsu.edu}},
Funding-Acknowledgement = {{Department of Homeland Security (DHS), Science and Technology
   Directorate (ST) {[}HSHQDC-10-C-00019]; FLIR Systems, Inc.; Singlera
   Genomics Inc.; Zova Systems, LLC}},
Funding-Text = {{Funding for this research was provided in full through contract
   HSHQDC-10-C-00019 to FLIR Systems, Inc., by the Department of Homeland
   Security (DHS), Science and Technology Directorate (S\&T),
   http://www.dhs.gov/science-and-technology. DHS S\&T reviewed and
   approved the manuscript for publication. DHS S\&T had no additional
   roles in the study design, data collection and analysis or preparation
   of the manuscript. FLIR Systems, Inc., Singlera Genomics Inc. and Zova
   Systems, LLC, provided support in the form of salaries for authors PK,
   LKP, SW, DS, RTY, and RAF, but did not have any additional role in the
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript. The specific roles of these authors are
   articulated in the `author contributions' section.}},
Cited-References = {{Afshinnekoo E, 2015, CELL SYST, V1, P72, DOI 10.1016/j.cels.2015.01.001.
   Alburty DS, 2013, M AM ASS AER RES POR.
   Amato P, 2007, FEMS MICROBIOL ECOL, V59, P242, DOI 10.1111/j.1574-6941.2006.00199.x.
   Anaissie EJ, 2003, BLOOD, V101, P2542, DOI 10.1182/blood-2002-02-0530.
   Barnes HE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109061.
   Barrett LW, 1998, AM IND HYG ASSOC J, V59, P532, DOI 10.1202/0002-8894(1998)059<0532:ALPOEF>2.0.CO;2.
   Beggs C, 2015, INDOOR AIR, V25, P462, DOI 10.1111/ina.12170.
   Benson DA, 2009, NUCLEIC ACIDS RES, V37, pD26, DOI 10.1093/nar/gkn723.
   Blaser MJ, 2014, J CLIN INVEST, V124, P4162, DOI 10.1172/JCI78366.
   Caggiano G, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0595-z.
   Cao C, 2014, ENVIRON SCI TECHNOL, V48, P1499, DOI 10.1021/es4048472.
   Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74.
   de Abreu PM, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-118.
   de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078.
   Di Bella JM, 2013, J MICROBIOL METH, V95, P401, DOI 10.1016/j.mimet.2013.08.011.
   Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226.
   Feehery GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076096.
   Fernstrom A, 2013, J PATHOG, DOI {[}10.1155/013/493960, 10.1155/2013/493960].
   Gibbons HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017836.
   Hahn T, 2002, INFECT CONT HOSP EP, V23, P525, DOI 10.1086/502101.
   Halachev MR, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0070-x.
   Harrison EM, 2013, EMBO MOL MED, V5, P509, DOI 10.1002/emmm.201202413.
   Hasan NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097699.
   Hewitt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054703.
   Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867.
   Jalali S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128711.
   Jiang WJ, 2015, NAT PROTOC, V10, P768, DOI 10.1038/nprot.2015.046.
   Katra I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05265.
   Kembel SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087093.
   Kievet O, 1999, ELECTRET FILTERS PRO.
   Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529.
   Layshock JA, 2012, BIOSECUR BIOTERROR, V10, P299, DOI 10.1089/bsp.2012.0026.
   Leung MHY, 2014, APPL ENVIRON MICROB, V80, P6760, DOI 10.1128/AEM.02244-14.
   Li Y, 2007, INDOOR AIR, V17, P2, DOI 10.1111/j.1600-0668.2006.00445.x.
   Liu GH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146064.
   Loman NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/jama.2013.3231.
   Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801.
   Matouskova I, 2014, INT J ENV RES PUB HE, V11, P9480, DOI 10.3390/ijerph110909480.
   Oberauner L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01413.
   Ortiz G, 2009, CURR MICROBIOL, V59, P53, DOI 10.1007/s00284-009-9398-7.
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357.
   Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341.
   Robertson CE, 2013, APPL ENVIRON MICROB, V79, P3485, DOI 10.1128/AEM.00331-13.
   Romay RJ, 1998, AEROSOL SCI TECH, V28, P224.
   Sanchez MB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00658.
   Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkn741.
   Sghaier H, 2016, ISME J, V10, P21, DOI 10.1038/ismej.2015.108.
   Sharon I, 2013, SCIENCE, V342, P1057, DOI 10.1126/science.1247023.
   Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112.
   Smith DJ, 2012, MICROB ECOL, V64, P973, DOI 10.1007/s00248-012-0088-9.
   Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862.
   Verde SC, 2015, RES MICROBIOL, V166, P557, DOI 10.1016/j.resmic.2015.03.004.
   Weber DJ, 1999, AM J INFECT CONTROL, V27, P59, DOI 10.1016/S0196-6553(99)70077-5.
   Yooseph S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081862.}},
Number-of-Cited-References = {{54}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{19}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{DS9NS}},
Unique-ID = {{ISI:000381110700024}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000383677500010,
Author = {Luo, Ting and Ou-Yang, Xue-Qing and Yang, Li-Tao and Li, Yang-Rui and
   Song, Xiu-Peng and Zhang, Ge-Min and Gao, Yi-Jing and Duan, Wei-Xing and
   An, Qianli},
Title = {{Raoultella sp strain L03 fixes N-2 in association with micropropagated
   sugarcane plants}},
Journal = {{JOURNAL OF BASIC MICROBIOLOGY}},
Year = {{2016}},
Volume = {{56}},
Number = {{8}},
Pages = {{934-940}},
Month = {{AUG}},
Abstract = {{N-2-fixing bacteria belonging to the genus Raoultella of the family
   Enterobacteriaceae are widely associated with plants. Raoultella sp.
   strain L03 was isolated from surface-sterilized sugarcane roots. In this
   study, we inoculated the strain L03 to microbe-free micropropagated
   plantlets of the main sugarcane cultivar ROC22 grown in Guangxi, China
   and determined z-fixation and association between strain L03 and
   sugarcane plants. Inoculation of strain L03 increased plant biomass,
   total N, N concentration and chlorophyll, and relieved N-deficiency
   symptoms of plants under an N-limiting condition. An 15N isotope
   dilution assay revealed 15N isotope dilution in the inoculated sugarcane
   plants and incorporation of the fixed 14N from air into chlorophyll.
   Moreover, a gfp-tagged and antibiotic-resistant L03 strain was
   reisolated from surface-sterilized sugarcane plants and was detected in
   plant tissues by fluorescent microscopy. This study for the first time
   demonstrates that a Raoultella bacterium is able to fix N-2 in
   association with the plant host.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Li, YR (Reprint Author), Chinese Acad Agr Sci, Key Lab Sugarcane Biotechnol \& Genet Improvement, Guangxi Key Lab Sugarcane Genet Improvement,Sugar, Sugarcane Res Inst,Guangxi Acad Agr Sci,Minist Ag, Nanning, Peoples R China.
   Li, YR (Reprint Author), Guangxi Univ, State Key Lab Conservat \& Utilizat Subtrop Agrobi, Coll Agr, Nanning, Peoples R China.
   Yang, LT (Reprint Author), Guangxi Univ, Coll Agr, Nanning 530004, Peoples R China.
   Luo, Ting; Yang, Li-Tao; Li, Yang-Rui; Zhang, Ge-Min; Gao, Yi-Jing; Duan, Wei-Xing, Chinese Acad Agr Sci, Key Lab Sugarcane Biotechnol \& Genet Improvement, Guangxi Key Lab Sugarcane Genet Improvement,Sugar, Sugarcane Res Inst,Guangxi Acad Agr Sci,Minist Ag, Nanning, Peoples R China.
   Luo, Ting; Ou-Yang, Xue-Qing; Yang, Li-Tao; Li, Yang-Rui; Song, Xiu-Peng, Guangxi Univ, State Key Lab Conservat \& Utilizat Subtrop Agrobi, Coll Agr, Nanning, Peoples R China.
   Ou-Yang, Xue-Qing, Vegetable Res Inst Nanning City, Nanning, Peoples R China.
   An, Qianli, Zhejiang Univ, Inst Biotechnol, Hangzhou, Zhejiang, Peoples R China.}},
DOI = {{10.1002/jobm.201500738}},
ISSN = {{0233-111X}},
EISSN = {{1521-4028}},
Keywords = {{Endophytic bacteria; Nitrogen fixation; Plant growth; promoting
   bacteria; Raoultella; Sugarcane}},
Keywords-Plus = {{ENTEROBACTER-CLOACAE; RICE; KLEBSIELLA; BACTERIA; RHIZOSPHERE; FIXATION;
   GROWTH; MAIZE; SOILS; NOV}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{litao61@hotmail.com
   liyr@gxaas.net
   an@zju.edu.cn}},
Funding-Acknowledgement = {{National High Technology Research and Development Program of China
   {[}2013AA102604]; National Natural Science Foundation of China
   {[}30860150, 30971837, 31171504]; Guangxi Provincial Natural Science
   Foundation of China {[}2011GXNSFF018002, 2012GXNSFDA053011,
   2013NXNSFAA019082]; Guangxi Special Fund for Bagui Scholars and
   Distinguished Visiting Scientists; Guangxi Academy of Agricultural
   Sciences {[}GNK2011YT01, GNK 2012YZ16]}},
Funding-Text = {{We thank Prof. Bo Wu at Guangxi University for providing the pFAJ1819
   plasmid. This work was supported by the National High Technology
   Research and Development Program of China (2013AA102604), the National
   Natural Science Foundation of China (30860150, 30971837, and 31171504),
   Guangxi Provincial Natural Science Foundation of China
   (2011GXNSFF018002, 2012GXNSFDA053011, and 2013NXNSFAA019082), Guangxi
   Special Fund for Bagui Scholars and Distinguished Visiting Scientists
   and Guangxi Academy of Agricultural Sciences (GNK2011YT01 and GNK
   2012YZ16).}},
Cited-References = {{BERGE O, 1991, BIOL FERT SOILS, V11, P210, DOI 10.1007/BF00335769.
   Bradstreet RB, 1965, KJELDAHL METHOD ORGA.
   Drancourt M, 2001, INT J SYST EVOL MICR, V51, P925, DOI 10.1099/00207713-51-3-925.
   FUJII T, 1987, PLANT SOIL, V103, P221, DOI 10.1007/BF02370392.
   Habibi S, 2014, PLANT SOIL, V379, P51, DOI 10.1007/s11104-014-2035-7.
   Hardoim PR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-164.
   Iniguez AL, 2004, MOL PLANT MICROBE IN, V17, P1078, DOI 10.1094/MPMI.2004.17.10.1078.
   Kahn ML, 2002, ANAL BIOCHEM, V307, P219, DOI 10.1016/S0003-2697(02)00046-5.
   LADHA JK, 1983, CAN J MICROBIOL, V29, P1301, DOI 10.1139/m83-203.
   Li Jiu-Di, 1994, Acta Botanica Sinica, V36, P265.
   Lin L, 2012, MICROBES ENVIRON, V27, P391, DOI 10.1264/jsme2.ME11275.
   {[}罗霆 Luo Ting], 2010, {[}热带作物学报, Chinese Journal of Tropical Crops], V31, P972.
   Ormeno- Orrillo E, 2013, PROKARYOTES PROKARYO, P427, DOI DOI 10.1007/978-3-642-30141-4\_72.
   Ouma S.O., 2014, INT J SCI TECHNOL, V2, P156.
   Pawlicki-Jullian N, 2010, RES MICROBIOL, V161, P101, DOI 10.1016/j.resmic.2009.12.009.
   Reis VM, 1999, PLANT SOIL, V206, P205.
   Rodriguez-Blanco A, 2015, BIOL FERT SOILS, V51, P391, DOI 10.1007/s00374-014-0986-8.
   Roesch LFW, 2008, PLANT SOIL, V302, P91, DOI 10.1007/s11104-007-9458-3.
   Sarathambal C, 2015, APPL SOIL ECOL, V87, P1, DOI 10.1016/j.apsoil.2014.11.004.
   Schicklberger M., 2015, GENOME ANNOUNC, V3.
   Verma SC, 2001, J BIOTECHNOL, V91, P127, DOI 10.1016/S0168-1656(01)00333-9.
   {[}王伦旺 WANG LunWang], 2007, {[}植物生理学通讯, Plant Physiology Communications], V43, P65.
   Wei CY, 2014, BIOL FERT SOILS, V50, P657, DOI 10.1007/s00374-013-0878-3.
   Xi CW, 1999, J MICROBIOL METH, V35, P85, DOI 10.1016/S0167-7012(98)00103-1.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{8}},
Journal-ISO = {{J. Basic Microbiol.}},
Doc-Delivery-Number = {{DW5IM}},
Unique-ID = {{ISI:000383677500010}},
DA = {{2018-08-13}},
}

@article{ ISI:000383824200005,
Author = {Gautier, M. and Normand, A. -C. and Ranque, S.},
Title = {{Previously unknown species of Aspergillus}},
Journal = {{CLINICAL MICROBIOLOGY AND INFECTION}},
Year = {{2016}},
Volume = {{22}},
Number = {{8}},
Pages = {{662-669}},
Month = {{AUG}},
Abstract = {{The use of multi-locus DNA sequence analysis has led to the description
   of previously unknown `cryptic' Aspergillus species, whereas classical
   morphology-based identification of Aspergillus remains limited to the
   section or species-complex level. The current literature highlights two
   main features concerning these `cryptic' Aspergillus species. First, the
   prevalence of such species in clinical samples is relatively high
   compared with emergent filamentous fungal taxa such as Mucorales,
   Scedosporium or Fusarium. Second, it is clearly important to identify
   these species in the clinical laboratory because of the high frequency
   of antifungal drug-resistant isolates of such Aspergillus species.
   Matrix-assisted laser desorption/ionization-time of flight mass
   spectrometry (MALDI-TOF MS) has recently been shown to enable the
   identification of filamentous fungi with an accuracy similar to that of
   DNA sequence-based methods. As MALDI-TOF MS is well suited to the
   routine clinical laboratory workflow, it facilitates the identification
   of these `cryptic' Aspergillus species at the routine mycology bench.
   The rapid establishment of enhanced filamentous fungi identification
   facilities will lead to a better understanding of the epidemiology and
   clinical importance of these emerging Aspergillus species. Based on
   routine MALDI-TOF MS-based identification results; we provide original
   insights into the key interpretation issues of a positive Aspergillus
   culture from a clinical sample. Which ubiquitous species that are
   frequently isolated from air samples are rarely involved in human
   invasive disease? Can both the species and the type of biological sample
   indicate Aspergillus carriage, colonization or infection in a patient?
   Highly accurate routine filamentous fungi identification is central to
   enhance the understanding of these previously unknown Aspergillus
   species, with a vital impact on further improved patient care. M.
   Gautier, (C) 2016 European Society of Clinical Microbiology and
   Infectious Diseases. Published by Elsevier Ltd. All rights reserved.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Ranque, S (Reprint Author), CHU Timone, APHM, Lab Parasitol Mycol, 264 Rue St Pierre, F-13385 Marseille 5, France.
   Gautier, M.; Ranque, S., Univ Montpellier I, IRBA, IP TPT, Aix Marseille Univ, Marseille, France.
   Gautier, M.; Normand, A. -C.; Ranque, S., Hop La Timone, Assistance Publ Hop Marseille, Parasitol \& Mycol, Marseille, France.}},
DOI = {{10.1016/j.cmi.2016.05.013}},
ISSN = {{1198-743X}},
EISSN = {{1469-0691}},
Keywords = {{Cryptic species; Environmental samples; Fungal identification; Human
   aspergillosis; MALDI-TOF MS; Multi-locus sequencing}},
Keywords-Plus = {{FLIGHT MASS-SPECTROMETRY; DESORPTION IONIZATION-TIME; INVASIVE
   ASPERGILLOSIS; FILAMENTOUS FUNGI; ROUTINE IDENTIFICATION; ANTIFUNGAL
   RESISTANCE; NEOSARTORYA-UDAGAWAE; CLINICAL-PRACTICE; AZOLE RESISTANCE;
   CAUSATIVE AGENT}},
Research-Areas = {{Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Infectious Diseases; Microbiology}},
Author-Email = {{stephane.ranque@ap-hm.fr}},
ORCID-Numbers = {{Normand, Anne-Cecile/0000-0002-9589-4603}},
Cited-References = {{Accoceberry I, 2015, E MALDI TOF SPECTRA.
   Alanio A, 2011, CLIN MICROBIOL INFEC, V17, P750, DOI 10.1111/j.1469-0691.2010.03323.x.
   Alastruey-Izquierdo A, 2013, ANTIMICROB AGENTS CH, V57, P3380, DOI 10.1128/AAC.00383-13.
   Alastruey-Izquierdo A, 2014, MYCOPATHOLOGIA, V178, P427, DOI 10.1007/s11046-014-9775-z.
   Alastruey-Izquierdo A, 2010, MED MYCOL, V48, P97, DOI 10.3109/13693780902803040.
   Alcazar-Fuoli L, 2014, BRIT J HAEMATOL, V166, P471, DOI 10.1111/bjh.12896.
   Badali H, 2015, MYCOPATHOLOGIA.
   Baddley JW, 2009, J CLIN MICROBIOL, V47, P3271, DOI 10.1128/JCM.00854-09.
   Balajee SA, 2006, EUKARYOT CELL, V5, P1705, DOI 10.1128/EC.00162-06.
   Balajee SA, 2009, J CLIN MICROBIOL, V47, P3138, DOI 10.1128/JCM.01070-09.
   Balajee SA, 2009, EUKARYOT CELL, V8, P713, DOI 10.1128/EC.00272-08.
   Balajee SA, 2009, MED MYCOL, V47, pS42, DOI 10.1080/13693780802562092.
   Balajee SA, 2005, J CLIN MICROBIOL, V43, P5996, DOI 10.1128/JCM.43.12.5996-5999.2005.
   Balajee SA, 2005, EUKARYOT CELL, V4, P625, DOI 10.1128/EC.4.3.625-632.2005.
   Barrs VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064871.
   Becker PT, 2014, MED MYCOL, V52, P826, DOI 10.1093/mmy/myu064.
   Cassagne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028425.
   Damek DM, 2008, CLIN NEUROPATHOL, V27, P400.
   Ellenbogen JR, 2016, BRIT J NEUROSURG, P1.
   Escribano P, 2013, ANTIMICROB AGENTS CH, V57, P2815, DOI 10.1128/AAC.02487-12.
   Espinel-Ingroff A, 2010, J CLIN MICROBIOL, V48, P3251, DOI 10.1128/JCM.00536-10.
   Fuller J, 2010, J CLIN MICROBIOL, V48, P479, DOI 10.1128/JCM.01677-09.
   Garber G, 2001, DRUGS, V61, P1, DOI 10.2165/00003495-200161001-00001.
   Gautier M, 2014, CLIN MICROBIOL INFEC, V20, P1366, DOI 10.1111/1469-0691.12750.
   Gautier M, 2016, MED MYCOL.
   Gheith S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-19.
   Guarro J, 2000, ATLAS CLIN FUNGI.
   Gupta K, 2015, PEDIAT DEV PATHOL OF.
   Hadrich I, 2012, MED MYCOL, V50, P829, DOI 10.3109/13693786.2012.684154.
   Hall WA, 2014, WORLD NEUROSURG, V82, pE139, DOI 10.1016/j.wneu.2014.03.007.
   Houbraken J, 2007, STUD MYCOL, P107, DOI 10.3114/sim.2007.59.12.
   Houbraken J, 2014, ADV APPL MICROBIOL, V86, P199, DOI 10.1016/B978-0-12-800262-9.00004-4.
   Howard SJ, 2014, MYCOPATHOLOGIA, V178, P435, DOI 10.1007/s11046-014-9774-0.
   Hubka V, 2012, PERSOONIA, V29, P1, DOI 10.3767/003158512X658123.
   Hubka V, 2015, MYCOLOGIA, V107, P169, DOI 10.3852/14-059.
   Hubka V, 2012, MED MYCOL, V50, P601, DOI 10.3109/13693786.2012.667578.
   Irinyi L, 2015, MED MYCOL, V53, P313, DOI 10.1093/mmy/myv008.
   Kathuria S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118997.
   Kullberg BJ, 2002, EUR J MED RES, V7, P183.
   Lau AF, 2013, J CLIN MICROBIOL, V51, P828, DOI 10.1128/JCM.02852-12.
   Lockhart SR, 2011, ANTIMICROB AGENTS CH, V55, P3944, DOI 10.1128/AAC.00428-11.
   Martiny D, 2014, EUR J CLIN MICROBIOL, V33, P745, DOI 10.1007/s10096-013-2006-6.
   McNeill J, 2012, REGNUM VEG, V154, P1.
   Muraoka S, 2016, WORLD NEUROSURG.
   Nedel WL, 2014, MYCOPATHOLOGIA, V178, P441, DOI 10.1007/s11046-014-9811-z.
   Normand AC, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-76.
   Norvell LL, 2011, MYCOTAXON, V116, P481, DOI 10.5248/116.481.
   Oz Y, 2015, MYCOPATHOLOGIA.
   Pavie J, 2005, J CLIN MICROBIOL, V43, P4902, DOI 10.1128/JCM.43.9.4902-4904.2005.
   Pelaez T, 2013, J MED MICROBIOL, V62, P474, DOI 10.1099/jmm.0.044867-0.
   Posteraro B, 2011, J CLIN MICROBIOL, V49, P2357, DOI 10.1128/JCM.00134-11.
   Ranque S, 2014, MYCOSES, V57, P135, DOI 10.1111/myc.12115.
   Samson RA, 2014, STUD MYCOL, P141, DOI 10.1016/j.simyco.2014.07.004.
   Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109.
   Schulthess B, 2014, J CLIN MICROBIOL, V52, P2797, DOI 10.1128/JCM.00049-14.
   Sutton DA, 2009, J CLIN MICROBIOL, V47, P3386, DOI 10.1128/JCM.00588-09.
   The Fungal Infection Trust, 2011, FUNG RES TRUST 20 AN.
   Van Der Linden JWM, 2011, MED MYCOL, V49, pS82, DOI 10.3109/13693786.2010.499916.
   Varga J, 2008, EUKARYOT CELL, V7, P630, DOI 10.1128/EC.00425-07.
   Verweij PE, 2008, EMERG INFECT DIS, V14, P566, DOI 10.3201/eid1404.071157.
   Verweij PE, 2016, CLIN INFECT DIS, V62, P362, DOI 10.1093/cid/civ885.
   Vinh DC, 2009, CLIN INFECT DIS, V49, P102, DOI 10.1086/599345.
   Vinh DC, 2009, EMERG INFECT DIS, V15, P1292, DOI 10.3201/eid1508.090251.
   Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258.
   Zotti M, 2010, MED MYCOL, V48, P656, DOI 10.3109/13693780903420641.}},
Number-of-Cited-References = {{65}},
Times-Cited = {{11}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{8}},
Journal-ISO = {{Clin. Microbiol. Infect.}},
Doc-Delivery-Number = {{DW7IK}},
Unique-ID = {{ISI:000383824200005}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000382578100012,
Author = {Mirhoseini, Seyed Hamed and Nikaeen, Mahnaz and Shamsizadeh, Zahra and
   Khanahmad, Hossein},
Title = {{Hospital air: A potential route for transmission of infections caused by
   beta-lactam-resistant bacteria}},
Journal = {{AMERICAN JOURNAL OF INFECTION CONTROL}},
Year = {{2016}},
Volume = {{44}},
Number = {{8}},
Pages = {{898-904}},
Month = {{AUG 1}},
Abstract = {{Background: The emergence of bacterial resistance to beta-lactam
   antibiotics seriously challenges the treatment of various nosocomial
   infections. This study was designed to investigate the presence of
   beta-lactam-resistant bacteria (BLRB) in hospital air.
   Methods: A total of 64 air samples were collected in 4 hospital wards.
   Detection of airborne bacteria was carried out using culture plates with
   and without beta-lactams. BLRB isolates were screened for the presence
   of 5 common beta-lactamase-encoding genes. Sequence analysis of
   predominant BLRB was also performed.
   Results: The prevalence of BLRB ranged between 3\% and 34\%.
   Oxacillin-resistant bacteria had the highest prevalence, followed by
   ceftazidime-and cefazolin-resistant bacteria. The frequency of
   beta-lactamaseencoding genes in isolated BLRB ranged between 0\% and
   47\%, with the highest and lowest detection for OXA-23 and CTX-m-32,
   respectively. MecA had a relatively high frequency in surgery wards and
   operating theaters, whereas the frequency of blaTEM was higher in
   intensive care units and internal medicine wards. OXA-51 was detected in
   4 wards. Acinetobacter spp, Acinetobacter baumannii, and Staphylococcus
   spp were the most predominant BLRB.
   Conclusions: The results revealed that hospital air is a potential route
   of transmission of BLRB, such as Acinetobacter and Staphylococcus, 2
   important causative agents of nosocomial infections. Therefore,
   improvement of control measures against the spreading of airborne
   bacteria in hospital environments is warranted. (C) 2016 Published by
   Elsevier Inc. on behalf of Association for Professionals in Infection
   Control and Epidemiology, Inc.}},
Publisher = {{MOSBY-ELSEVIER}},
Address = {{360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Nikaeen, M (Reprint Author), Isfahan Univ Med Sci, Sch Hlth, Dept Environm Hlth Engn, Hezar Jerib Ave, Esfahan 8174673461, Iran.
   Mirhoseini, Seyed Hamed; Nikaeen, Mahnaz; Shamsizadeh, Zahra, Isfahan Univ Med Sci, Sch Hlth, Dept Environm Hlth Engn, Esfahan, Iran.
   Mirhoseini, Seyed Hamed; Shamsizadeh, Zahra, Isfahan Univ Med Sci, Student Res Ctr, Esfahan, Iran.
   Mirhoseini, Seyed Hamed, Arak Univ Med Sci, Sch Hlth, Dept Environm Hlth Engn, Arak, Iran.
   Khanahmad, Hossein, Isfahan Univ Med Sci, Sch Med, Dept Genet \& Mol Biol, Esfahan, Iran.}},
DOI = {{10.1016/j.ajic.2016.01.041}},
ISSN = {{0196-6553}},
EISSN = {{1527-3296}},
Keywords = {{Airborne; hospital; antibiotic-resistant bacteria; nosocomial infection;
   beta-lactam}},
Keywords-Plus = {{STAPHYLOCOCCUS-AUREUS; ACINETOBACTER-BAUMANNII; DIFFERENT AREAS;
   METHICILLIN; CARE; PATHOGEN; SEQUENCE; HEALTH; SPREAD; UNIT}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{nikaeen@hlth.mui.ac.ir}},
ResearcherID-Numbers = {{Khanahmad, Hossein/W-1688-2017
   Nikaeen, Mahnaz/W-5007-2017
   }},
ORCID-Numbers = {{Nikaeen, Mahnaz/0000-0002-1852-1547
   Mirhoseini, Seyed Hamed/0000-0001-7821-4824}},
Funding-Acknowledgement = {{vice chancellery for research of Isfahan University of Medical Sciences
   {[}392542]}},
Funding-Text = {{Supported with funding from the vice chancellery for research of Isfahan
   University of Medical Sciences (research project no. 392542) as a PhD
   dissertation thesis.}},
Cited-References = {{{[}Anonymous], 2012, M100S22 CLSI.
   Augustowska M, 2006, ANN AGR ENV MED, V13, P99.
   Barbut F, 2013, BURNS, V39, P395, DOI 10.1016/j.burns.2012.07.007.
   Barros EM, 2012, J CLIN MICROBIOL, V50, P166, DOI 10.1128/JCM.05563-11.
   Beggs CB, 2003, INDOOR BUILT ENVIRON, V12, P9, DOI 10.1177/142032603032201.
   BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148.
   Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11.
   Curtis LT, 2008, J HOSP INFECT, V69, P204, DOI 10.1016/j.jhin.2008.03.018.
   Drudge CN, 2012, AEROBIOLOGIA, V28, P285, DOI 10.1007/s10453-011-9219-x.
   Dubois V, 2002, ANTIMICROB AGENTS CH, V46, P3624, DOI 10.1128/AAC.46.11.3624-3626.2002.
   Fernandez A, 2007, J ANTIMICROB CHEMOTH, V59, P841, DOI 10.1093/jac/dkm030.
   Gilbert Y, 2010, AEROBIOLOGIA, V26, P185, DOI 10.1007/s10453-010-9155-1.
   Haddadin AS, 2002, POSTGRAD MED J, V78, P385, DOI 10.1136/pmj.78.921.385.
   Kim KY, 2010, IND HEALTH, V48, P236, DOI 10.2486/indhealth.48.236.
   Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086.
   Kuroda M, 2005, P NATL ACAD SCI USA, V102, P13272, DOI 10.1073/pnas.0502950102.
   Lee MR, 2011, EUR J CLIN MICROBIOL, V30, P1185, DOI 10.1007/s10096-011-1210-5.
   Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145.
   Olender A, 2012, ANTIBIOTIC RESISTANT BACTERIA - A CONTINUOUS CHALLENGE IN THE NEW MILLENNIUM, P387.
   Omenn GS, 2010, P NATL ACAD SCI USA, V107, P1702, DOI 10.1073/pnas.0906198106.
   Ortiz G, 2009, CURR MICROBIOL, V59, P53, DOI 10.1007/s00284-009-9398-7.
   Pajand O, 2013, BURNS, V39, P1414, DOI 10.1016/j.burns.2013.03.024.
   Pittet D, 2005, LANCET, V366, P1246, DOI 10.1016/S0140-6736(05)67506-X.
   Quinteros M, 2003, ANTIMICROB AGENTS CH, V47, P2864, DOI 10.1128/AAC.47.9.2864-2867.2003.
   Roux V, 2004, INT J SYST EVOL MICR, V54, P1049, DOI 10.1099/ijs.0.02954-0.
   Sarica S, 2002, INDOOR BUILT ENVIRON, V11, P285, DOI 10.1159/000066523.
   Stocks GW, 2010, AM J INFECT CONTROL, V38, P199, DOI 10.1016/j.ajic.2009.07.006.
   Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022.
   Yadav J, 2013, J FORMOS MED ASSOC, V114, P639.
   Zhang KY, 2004, J CLIN MICROBIOL, V42, P4947, DOI 10.1128/JCM.42.11.4947-4955.2004.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{6}},
Usage-Count-Since-2013 = {{20}},
Journal-ISO = {{Am. J. Infect. Control}},
Doc-Delivery-Number = {{DU9ZY}},
Unique-ID = {{ISI:000382578100012}},
DA = {{2018-08-13}},
}

@article{ ISI:000381092800029,
Author = {Sancheza, Helen M. and Echeverria, Cristina and Thulsiraj, Vanessa and
   Zimmer-Faust, Amy and Flores, Ariel and Laitz, Madeleine and Healy,
   Gregory and Mahendra, Shaily and Paulson, Suzanne E. and Zhu, Yifang and
   Jay, Jennifer A.},
Title = {{Antibiotic Resistance in Airborne Bacteria Near Conventional and Organic
   Beef Cattle Farms in California, USA}},
Journal = {{WATER AIR AND SOIL POLLUTION}},
Year = {{2016}},
Volume = {{227}},
Number = {{8}},
Month = {{AUG}},
Abstract = {{Levels of antibiotic resistance genes (ARGs) and the fractions of
   antibiotic resistant bacteria (ARB) among culturable heterotrophic
   bacteria were compared in outdoor air near conventional (n = 3) and
   organic (n = 3) cattle rearing facilities. DNA extracts from filters
   taken from 18 locations were analyzed by quantitative polymerase chain
   reaction (qPCR) for five ARGs. At the reference (non-agricultural) site,
   all genes were below detection. ARGs sul1, bla(SHV), erm(B), and
   bla(TEM) were more frequently detected and at higher levels (up to 870
   copies m(-3) for bla(SHV) and 750 copies m(-3) for sul1) near
   conventional farms compared to organic locations while the opposite was
   observed for erm(F) (up to 210 copies m(-3)). Isolates of airborne
   heterotrophic bacteria (n = 1295) collected from the sites were tested
   for growth in the presence of six antibiotics. By disk diffusion on a
   subset of isolates, the fractions of ARB were higher for conventional
   sites compared to organic farms for penicillin (0.9 versus 0.63),
   cloxacillin (0.74 versus 0.23), cefoperazone (0.58 versus 0.14), and
   sulfamethazine (0.50 versus 0.33) for isolates on nutrient agar. All
   isolates' Delta A600(pres)/Delta A600(abs) were measured for each of the
   six tested antibiotics; isolates from farms downwind of organic sites
   had a lower average Delta A600(pres)/Delta A600(abs) for most
   antibiotics. In general, all three analyses used to indicate microbial
   resistance to to 210 copies m(-3)). Isolates of airborne heterotrophic
   bacteria (n = 1295) collected from the sites were tested for growth in
   the presence of six antibiotics. By disk diffusion on a subset of
   isolates, the fractions of ARB were higher for conventional sites
   compared to organic farms for penicillin (0.9 versus 0.63), cloxacillin
   (0.74 versus 0.23), cefoperazone (0.58 versus 0.14), and sulfamethazine
   (0.50 versus 0.33) for isolates on nutrient agar. All isolates' Delta
   600(pres)/Delta A600(abs) were measured for each of the six tested
   antibiotics; isolates from farms downwind of organic sites had a lower
   average Delta 600(pres)/Delta A600(abs) for most antibiotics. In
   general, all three analyses used to indicate microbial resistance to
   antibiotics showed increases in air samples nearby conventional versus
   organic cattle rearing facilities. Regular surveillance of airborne ARB
   and ARGs near conventional and organic beef cattle farms is suggested.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Jay, JA (Reprint Author), Univ Calif Los Angeles, Dept Civil \& Environm Engn, Los Angeles, CA 90095 USA.
   Echeverria, Cristina; Thulsiraj, Vanessa; Zimmer-Faust, Amy; Flores, Ariel; Laitz, Madeleine; Healy, Gregory; Mahendra, Shaily; Paulson, Suzanne E.; Zhu, Yifang; Jay, Jennifer A., Univ Calif Los Angeles, Dept Civil \& Environm Engn, Los Angeles, CA 90095 USA.}},
DOI = {{10.1007/s11270-016-2979-8}},
Article-Number = {{280}},
ISSN = {{0049-6979}},
EISSN = {{1573-2932}},
Keywords = {{Antibiotic resistance; Organic; Conventional; Air; ARGs; Cattle}},
Keywords-Plus = {{RECEIVING SWINE MANURE; FOOD ANIMAL PRODUCTION; ANTIMICROBIAL
   SUSCEPTIBILITY; ESCHERICHIA-COLI; WASTE-WATER; EMERGING CONTAMINANTS;
   POULTRY SLAUGHTERERS; FEEDING OPERATION; SURFACE-WATER; DAIRY FARMS}},
Research-Areas = {{Environmental Sciences \& Ecology; Meteorology \& Atmospheric Sciences;
   Water Resources}},
Web-of-Science-Categories  = {{Environmental Sciences; Meteorology \& Atmospheric Sciences; Water
   Resources}},
Author-Email = {{cecheverria@ucla.edu
   vthulsiraj@msmu.edu
   amityzf@ucla.edu
   Ariel@smithemerylabs.com
   mlaitz@mit.edu
   ghealy@andrew.cmu.edu
   mahendra@seas.ucla.edu
   Paulson@atmos.ucla.edu
   yifang@ucla.edu
   jjay@seas.ucla.edu}},
ResearcherID-Numbers = {{Mahendra, Shaily/F-2759-2012}},
ORCID-Numbers = {{Mahendra, Shaily/0000-0003-3298-9602}},
Funding-Acknowledgement = {{National Science Foundation under the American Recovery and Reinvestment
   Act (ARRA) {[}0963183]; Natural Resources Defense Fund; Institute of the
   Environment and Sustainability at UCLA}},
Funding-Text = {{This material is based upon research performed in a renovated
   collaboratory by the National Science Foundation under Grant No.
   0963183, which is an award funded under the American Recovery and
   Reinvestment Act of 2009 (ARRA). We are grateful to Winston Lee, Karmina
   Padgett, Elizabeth Roswell, Cindy Xiong, and Alicia Amundson. Funding
   was provided by the Natural Resources Defense Fund and the Institute of
   the Environment and Sustainability at UCLA.}},
Cited-References = {{Alali WQ, 2010, FOODBORNE PATHOG DIS, V7, P1363, DOI 10.1089/fpd.2010.0566.
   Brown MG, 2009, MICROB ECOL, V57, P484, DOI 10.1007/s00248-008-9431-6.
   Bunner CA, 2007, JAVMA-J AM VET MED A, V231, P275, DOI 10.2460/javma.231.2.275.
   BURROWS GE, 1989, J VET PHARMACOL THER, V12, P289, DOI 10.1111/j.1365-2885.1989.tb00673.x.
   Centers for Disease Control and Prevention. Website on the Internet, 2013, ANTIBIOTIC RESISTANC.
   Chapin A, 2005, ENVIRON HEALTH PERSP, V113, P137, DOI 10.1289/ehp.7473.
   Cho Seung-Hak, 2012, Osong Public Health Res Perspect, V3, P151, DOI 10.1016/j.phrp.2012.07.002.
   Czekalski N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00106.
   Fahrenfeld N, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00130.
   Garder JL, 2014, J ENVIRON QUAL, V43, P1484, DOI 10.2134/jeq2013.09.0379.
   Gebreyes WA, 2005, J ANTIMICROB CHEMOTH, V56, P765, DOI 10.1093/jac/dki305.
   Ghosh S, 2007, ISME J, V1, P191, DOI 10.1038/ismej.2007.31.
   Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910.
   Graham DW, 2011, ENVIRON SCI TECHNOL, V45, P418, DOI 10.1021/es102473z.
   Graham JP, 2008, PUBLIC HEALTH REP, V123, P282, DOI 10.1177/003335490812300309.
   Green CF, 2006, J OCCUP ENVIRON HYG, V3, P9, DOI 10.1080/15459620500430615.
   Halbert LW, 2006, JAVMA-J AM VET MED A, V228, P1074, DOI 10.2460/javma.228.7.1074.
   Heuer H, 2011, APPL ENVIRON MICROB, V77, P2527, DOI 10.1128/AEM.02577-10.
   Heuer OE, 2001, LETT APPL MICROBIOL, V33, P269, DOI 10.1046/j.1472-765X.2001.00994.x.
   Huang JJ, 2011, WATER RES, V45, P2775, DOI 10.1016/j.watres.2011.02.026.
   Huijbers P.M., 2015, ENV SCI TECHNOL.
   Knapp CW, 2010, ENVIRON POLLUT, V158, P1506, DOI 10.1016/j.envpol.2009.12.020.
   Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x.
   Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145.
   LEVY SB, 1978, J INFECT DIS, V137, P688, DOI 10.1093/infdis/137.5.688.
   Ling AL, 2013, ENVIRON SCI TECHNOL, V47, P4046, DOI 10.1021/es400238g.
   Luangtongkum T, 2006, APPL ENVIRON MICROB, V72, P3600, DOI 10.1128/AEM.72.5.3600-3607.2006.
   Mathew AG, 2001, J SWINE HEALTH PROD, V9, P125.
   McEachran AD, 2015, ENVIRON HEALTH PERSP, V123, P337, DOI 10.1289/ehp.1408555.
   Mellon M., 2001, HOGGING IT ESTIMATES.
   Millman Jack M, 2013, F1000Res, V2, P155, DOI 10.12688/f1000research.2-155.v1.
   Miranda JM, 2009, MEAT SCI, V82, P284, DOI 10.1016/j.meatsci.2009.01.020.
   Negreanu Y, 2012, ENVIRON SCI TECHNOL, V46, P4800, DOI 10.1021/es204665b.
   Olmstead J., 2012, FDA FAILS REGULATE A.
   Price LB, 2007, ENVIRON HEALTH PERSP, V115, P1035, DOI 10.1289/ehp.10050.
   Price LB, 2005, ENVIRON HEALTH PERSP, V113, P557, DOI 10.1289/ehp.7647.
   Pruden A., 2013, ENV HLTH PERSPECT, V121, P1.
   Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es0604131.
   Pruden A, 2014, ENVIRON SCI TECHNOL, V48, P5, DOI 10.1021/es403883p.
   Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r.
   Ramsden SJ, 2010, J APPL MICROBIOL, V109, P1609, DOI 10.1111/j.1365-2672.2010.04787.x.
   Ray KA, 2006, J DAIRY SCI, V89, P2038, DOI 10.3168/jds.S0022-0302(06)72271-8.
   Reinstein S, 2009, APPL ENVIRON MICROB, V75, P5421, DOI 10.1128/AEM.00459-09.
   Rule Ana M, 2008, J Infect Public Health, V1, P33, DOI 10.1016/j.jiph.2008.08.001.
   Sanderson H, 2016, ENVIRON REV, V24, P205, DOI 10.1139/er-2015-0069.
   Sato K, 2005, JAVMA-J AM VET MED A, V226, P589, DOI 10.2460/javma.2005.226.589.
   Schnoor JL, 2014, ENVIRON SCI TECHNOL, V48, P11019, DOI {[}10.1021/es5042S6j, 10.1021/es504256j].
   Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x.
   Shanks OC, 2012, ENVIRON SCI TECHNOL, V46, P945, DOI 10.1021/es2031455.
   Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904.
   Stoll C, 2012, ENVIRON SCI TECHNOL, V46, P9716, DOI 10.1021/es302020s.
   Storteboom H, 2010, ENVIRON SCI TECHNOL, V44, P7397, DOI 10.1021/es101657s.
   Su HC, 2014, SCI TOTAL ENVIRON, V490, P708, DOI 10.1016/j.scitotenv.2014.05.060.
   USDA National Organic Program; National Archives and Records Administration, 2012, AGR.
   van den Bogaard AE, 2002, J ANTIMICROB CHEMOTH, V49, P497, DOI 10.1093/jac/49.3.497.
   van den Bogaard AE, 2001, J ANTIMICROB CHEMOTH, V47, P763, DOI 10.1093/jac/47.6.763.
   Wittwer M, 2005, APPL ENVIRON MICROB, V71, P2840, DOI 10.1128/AEM.71.6.2840-2847.2005.
   Woolhouse M, 2014, NATURE, V509, P555, DOI 10.1038/509555a.
   World Health Organization, 2014, ANT RES GLOB REP SUR.
   Xu YG, 2015, SCI TOTAL ENVIRON, V530, P191, DOI 10.1016/j.scitotenv.2015.04.046.}},
Number-of-Cited-References = {{60}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{8}},
Usage-Count-Since-2013 = {{47}},
Journal-ISO = {{Water Air Soil Pollut.}},
Doc-Delivery-Number = {{DS9HE}},
Unique-ID = {{ISI:000381092800029}},
DA = {{2018-08-13}},
}

@article{ ISI:000381804000056,
Author = {Orme, Ian M. and Ordway, Diane J.},
Title = {{Mouse and Guinea Pig Models of Tuberculosis}},
Journal = {{MICROBIOLOGY SPECTRUM}},
Year = {{2016}},
Volume = {{4}},
Number = {{4}},
Month = {{AUG}},
Abstract = {{This article describes the nature of the host response to Mycobacterium
   tuberculosis in the mouse and guinea pig models of infection. It
   describes the great wealth of information obtained from the mouse model,
   reflecting the general availability of immunological reagents, as well
   as genetic manipulations of the mouse strains themselves. This has led
   to a good understanding of the nature of the T-cell response to the
   infection, as well as an appreciation of the complexity of the response
   involving multiple cytokine- and chemokine-mediated systems. As
   described here and elsewhere, we have a growing understanding of how
   multiple CD4-positive T-cell subsets are involved, including regulatory
   T cells, TH17 cells, as well as the subsequent emergence of effector and
   central memory T-cell subsets. While, in contrast, our understanding of
   the host response in the guinea pig model is less advanced, considerable
   strides have been made in the past decade in terms of defining the basis
   of the immune response, as well as a better understanding of the
   immunopathologic process. This model has long been the gold standard for
   vaccine testing, and more recently is being revisited as a model for
   testing new drug regimens (bedaquiline being the latest example).}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Orme, IM (Reprint Author), Colorado State Univ, Ft Collins, CO 80523 USA.
   Orme, Ian M.; Ordway, Diane J., Colorado State Univ, Ft Collins, CO 80523 USA.}},
DOI = {{10.1128/microbiolspec.TBTB2-0002-2015}},
Article-Number = {{UNSP TBTB2-0002-2015}},
EISSN = {{2165-0497}},
Keywords-Plus = {{VIRULENT MYCOBACTERIUM-TUBERCULOSIS; EXPERIMENTAL AIRBORNE TUBERCULOSIS;
   BACILLUS-CALMETTE-GUERIN; CHRONIC PULMONARY TUBERCULOSIS; TOLL-LIKE
   RECEPTORS; ANTIMICROBIAL RESISTANCE GENE; ACQUIRED CELLULAR-RESISTANCE;
   HOST-PARASITE RELATIONSHIPS; BOVIS BCG VACCINE; W-BEIJING STRAINS}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{ian.orme@colostate.edu}},
ResearcherID-Numbers = {{Ordway, Diane/H-9732-2017}},
ORCID-Numbers = {{Ordway, Diane/0000-0003-0003-326X}},
Cited-References = {{Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155.
   Ackart DF, 2014, PATHOG DIS, V70, P359, DOI 10.1111/2049-632X.12144.
   Ackart DF, 2014, PATHOG DIS, V70, P370, DOI 10.1111/2049-632X.12143.
   Adams LB, 1997, TUBERCLE LUNG DIS, V78, P237, DOI 10.1016/S0962-8479(97)90004-6.
   Aiyaz M, 2014, TUBERCULOSIS, V94, P606, DOI 10.1016/j.tube.2014.10.001.
   Allen SS, 2004, INFECT IMMUN, V72, P1358, DOI 10.1128/IAI.72.3.1358-1363.2004.
   ANDERSEN P, 1993, INFECT IMMUN, V61, P844.
   Arbues A, 2013, VACCINE, V31, P4867, DOI 10.1016/j.vaccine.2013.07.051.
   Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1081/jem.20051782.
   Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236.
   Basaraba RJ, 2008, TUBERCULOSIS, V88, P69, DOI 10.1016/j.tube.2007.09.002.
   Basaraba RJ, 2006, TUBERCULOSIS, V86, P386, DOI 10.1016/j.tube.2005.11.003.
   Basaraba RJ, 2006, INFECT IMMUN, V74, P5397, DOI 10.1128/IAI.00332-06.
   Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545.
   Beamer GL, 2005, ARCH IMMUNOL THER EX, V53, P469.
   Behar SM, 2014, SEMIN IMMUNOL, V26, P559, DOI 10.1016/j.smim.2014.09.003.
   Bertholet S, 2010, SCI TRANSL MED, V2.
   BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0.
   Brandt L, 2004, INFECT IMMUN, V72, P6622, DOI 10.1128/IAI.72.11.6622-6632.2004.
   Branger J, 2004, INT IMMUNOL, V16, P509, DOI 10.1093/intimm/dxh052.
   Brighenti S, 2012, J INFECT DIS, V205, pS316, DOI 10.1093/infdis/jis043.
   Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732.
   Buu N, 2000, CLIN INFECT DIS, V31, pS81, DOI 10.1086/314067.
   Cardona PJ, 2009, VACCINE, V27, P2499, DOI 10.1016/j.vaccine.2009.02.060.
   Chackerian AA, 2003, TUBERCULOSIS, V83, P279, DOI 10.1016/S1472-9792(03)00017-9.
   Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002.
   Chackerian AA, 2001, INFECT IMMUN, V69, P2666, DOI 10.1128/IAI.69.4.2666-2674.2001.
   Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2.
   COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243.
   COOPER AM, 1995, IMMUNOLOGY, V84, P423.
   Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39.
   Cooper AM, 2007, CURR OPIN IMMUNOL, V19, P441, DOI 10.1016/j.coi.2007.07.004.
   Cyktor JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058612.
   Cyktor JC, 2013, J IMMUNOL, V190, P2778, DOI 10.4049/jimmunol.1202722.
   Desvignes L, 2012, J IMMUNOL, V188, P6205, DOI 10.4049/jimmunol.1200255.
   Dey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018773.
   Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002.
   Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157.
   Dorhoi A, 2014, EUR J IMMUNOL, V44, P2380, DOI 10.1002/eji.201344219.
   Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7.
   DSouza CD, 1997, J IMMUNOL, V158, P1217.
   Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259.
   Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043.
   Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188.
   Fennelly KP, 2007, CLIN INFECT DIS, V44, P1358, DOI 10.1086/516617.
   Ferwerda G, 2007, J LEUKOCYTE BIOL, V82, P1011, DOI 10.1189/jlb.0307147.
   Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034.
   FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249.
   Flynn JL, 1998, J IMMUNOL, V160, P1796.
   FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013.
   FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2.
   Gandotra S, 2007, INFECT IMMUN, V75, P5127, DOI 10.1128/IAI.00458-07.
   Geluk A, 2000, J IMMUNOL, V165, P6463, DOI 10.4049/jimmunol.165.11.6463.
   Geluk A, 1998, P NATL ACAD SCI USA, V95, P10797, DOI 10.1073/pnas.95.18.10797.
   Gonzalez-Juarrero M, 2005, J LEUKOCYTE BIOL, V77, P914, DOI 10.1189/jlb.1204723.
   Gonzalez-Juarrero M, 2001, INFECT IMMUN, V69, P1722, DOI 10.1128/IAI.69.3.1722-1728.2001.
   GROSSET J, 1980, CLIN CHEST MED, V1, P231.
   Gruppo V, 2002, MICROBIOL-SGM, V148, P2959, DOI 10.1099/00221287-148-10-2959.
   Gupta UD, 2005, TUBERCULOSIS, V85, P277, DOI 10.1016/j.tube.2005.08.008.
   Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC.
   Henao-Tamayo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136500.
   Henao-Tamayo M, 2014, TUBERCULOSIS, V94, P455, DOI 10.1016/j.tube.2014.05.001.
   Henao-Tamayo M, 2012, TUBERCULOSIS, V92, P211, DOI 10.1016/j.tube.2012.02.008.
   Henao-Tamayo M, 2009, TUBERCULOSIS, V89, P142, DOI 10.1016/j.tube.2009.01.002.
   Henao-Tamayo MI, 2010, CLIN VACCINE IMMUNOL, V17, P618, DOI 10.1128/CVI.00368-09.
   Higgins DM, 2009, TUBERCULOSIS, V89, P149, DOI 10.1016/j.tube.2009.01.001.
   Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947.
   Hoff DR, 2008, ANTIMICROB AGENTS CH, V52, P4137, DOI 10.1128/AAC.00196-08.
   Hoff DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017550.
   Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397.
   Horwitz MA, 2003, INFECT IMMUN, V71, P1672, DOI 10.1128/IAI.71.4.1672-1679.2003.
   HORWITZ MA, 1995, P NATL ACAD SCI USA, V92, P1530, DOI 10.1073/pnas.92.5.1530.
   Kamath AB, 2003, INFECT IMMUN, V71, P4112, DOI 10.1128/IAI.71.7.4112-4118.2003.
   Kato-Maeda M, 2012, CLIN VACCINE IMMUNOL, V19, P1227, DOI 10.1128/CVI.00250-12.
   Kaveh DA, 2014, VACCINE, V32, P6911, DOI 10.1016/j.vaccine.2014.10.041.
   Keller C, 2006, INFECT IMMUN, V74, P4295, DOI 10.1128/IAI.00057-06.
   Kelly BP, 1996, ANTIMICROB AGENTS CH, V40, P2809.
   Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022.
   Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449.
   Khader SA, 2010, CYTOKINE GROWTH F R, V21, P403, DOI 10.1016/j.cytogfr.2010.10.008.
   Kincaid EZ, 2007, J IMMUNOL, V179, P3187, DOI 10.4049/jimmunol.179.5.3187.
   Klinkenberg LG, 2008, J INFECT DIS, V198, P275, DOI 10.1086/589515.
   Kraft SL, 2004, INFECT IMMUN, V72, P5963, DOI 10.1128/IAI.72.10.5963-5971.2004.
   Kramnik I, 1998, NOVART FDN SYMP, V217, P120, DOI 10.1002/0470846526.ch9.
   Kramnik I, 2000, P NATL ACAD SCI USA, V97, P8560, DOI 10.1073/pnas.150227197.
   LADEL CH, 1995, EUR J IMMUNOL, V25, P838, DOI 10.1002/eji.1830250331.
   Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07.
   Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662.
   Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393.
   Ly LH, 2008, AM J RESP CELL MOL, V38, P455, DOI 10.1165/rcmb.2007-0326OC.
   Lyons MJ, 2004, TUBERCULOSIS, V84, P283, DOI 10.1016/j.tube.2003.09.003.
   MACKANESS GB, 1967, BRIT MED BULL, V23, P52, DOI 10.1093/oxfordjournals.bmb.a070516.
   MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105.
   Majorov KB, 2003, INFECT IMMUN, V71, P697, DOI 10.1128/IAI.71.2.697-707.2003.
   Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694.
   Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489.
   McBride A, 2011, INFECT IMMUN, V79, P1118, DOI 10.1128/IAI.01076-10.
   McMurray D. N., 1999, Tubercle and Lung Disease, V79, P261, DOI 10.1054/tuld.1998.0207.
   MCMURRAY DN, 1986, AM REV RESPIR DIS, V133, P1081.
   McMurray DN, 2001, TUBERCULOSIS, V81, P141, DOI 10.1054/tube.2000.0265.
   MCMURRAY DN, 1986, TUBERCLE, V67, P31, DOI 10.1016/0041-3879(86)90029-2.
   McMurray DN, 2001, SCAND J INFECT DIS, V33, P175, DOI 10.1080/00365540151060743.
   MCMURRAY DN, 1985, INFECT IMMUN, V50, P555.
   McShane H, TUBERCULOSI IN PRESS.
   McShane H, 2014, TUBERCULOSIS, V94, P105, DOI 10.1016/j.tube.2013.11.003.
   Medina E, 1996, IMMUNOLOGY, V88, P479, DOI 10.1046/j.1365-2567.1996.d01-700.x.
   North RJ, 1996, RES IMMUNOL, V147, P493, DOI 10.1016/S0923-2494(97)85213-3.
   NORTH RJ, 1973, CELL IMMUNOL, V7, P166, DOI 10.1016/0008-8749(73)90193-7.
   Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910.
   Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x.
   Olsen AW, 2004, INFECT IMMUN, V72, P6148, DOI 10.1128/IAI.72.10.6148-6150.2004.
   Ordway D, 2007, J LEUKOCYTE BIOL, V82, P1221, DOI 10.1189/jlb.0607426.
   Ordway D, 2007, J IMMUNOL, V179, P2532, DOI 10.4049/jimmunol.179.4.2532.
   Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522.
   Ordway DJ, 2010, METHOD MICROBIOL, V37, P271, DOI 10.1016/S0580-9517(10)37012-7.
   Ordway DJ, 2010, ANTIMICROB AGENTS CH, V54, P1820, DOI 10.1128/AAC.01521-09.
   Ordway DJ, 2011, CURR PROTOC IMMUNOL, DOI DOI 10.1002/0471142735.IM1905S94.
   Orme IA, 1985, PROG LEUK BIOL, V3, P285.
   Orme IM, 2015, NAT IMMUNOL, V16, P57, DOI 10.1038/ni.3048.
   Orme IM, 2014, SEMIN IMMUNOL, V26, P601, DOI 10.1016/j.smim.2014.09.009.
   Orme IM, 2014, TUBERCULOSIS, V94, P8, DOI 10.1016/j.tube.2013.07.004.
   Orme IM, 2010, TUBERCULOSIS, V90, P329, DOI 10.1016/j.tube.2010.06.002.
   ORME IM, 1987, J IMMUNOL, V138, P293.
   ORME IM, 1988, J IMMUNOL, V140, P3589.
   ORME IM, 1983, J EXP MED, V158, P74, DOI 10.1084/jem.158.1.74.
   ORME IM, 1986, INFECT IMMUN, V54, P56.
   Ottenhoff TH, 2010, HUM VACCINES, V6, P1007, DOI 10.4161/hv.6.12.13143.
   PAL PG, 1992, INFECT IMMUN, V60, P4781.
   Palanisamy GS, 2008, TUBERCULOSIS, V88, P295, DOI 10.1016/j.tube.2007.12.003.
   Palanisamy GS, 2009, TUBERCULOSIS, V89, P203, DOI 10.1016/j.tube.2009.01.005.
   Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500.
   Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468.
   Pichugin AV, 2009, AM J PATHOL, V174, P2190, DOI 10.2353/ajpath.2009.081075.
   Pitt JM, 2012, J IMMUNOL, V189, P4079, DOI 10.4049/jimmunol.1201061.
   Podell BK, 2014, AM J PATHOL, V184, P1104, DOI 10.1016/j.ajpath.2013.12.015.
   Reiley WW, 2008, P NATL ACAD SCI USA, V105, P10961, DOI 10.1073/pnas.0801496105.
   Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480.
   Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2.
   Richardson ET, 2015, INFECT IMMUN, V83, P2242, DOI 10.1128/IAI.00135-15.
   Ryan GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011108.
   Sampson SL, 2004, INFECT IMMUN, V72, P3031, DOI 10.1128/IAI.72.5.3031-3037.2004.
   Sanchez F, 2003, INFECT IMMUN, V71, P126, DOI 10.1128/IAI.71.1.126-131.2003.
   Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105.
   Shang SB, 2012, VACCINE, V30, P1572, DOI 10.1016/j.vaccine.2011.12.114.
   Shang SB, 2011, TUBERCULOSIS, V91, P378, DOI 10.1016/j.tube.2011.06.001.
   Shang SB, 2011, ANTIMICROB AGENTS CH, V55, P124, DOI 10.1128/AAC.00978-10.
   Shanley CA, 2014, TUBERCULOSIS, V94, P140, DOI 10.1016/j.tube.2013.08.010.
   Shim TS, 2003, TUBERCULOSIS, V83, P367, DOI 10.1016/S1472-9792(03)00071-4.
   SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C.
   SKAMENE E, 1994, IMMUNOBIOLOGY, V191, P451, DOI 10.1016/S0171-2985(11)80451-1.
   SKAMENE E, 1982, NATURE, V297, P506, DOI 10.1038/297506a0.
   Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618.
   Skwor TA, 2004, J LEUKOCYTE BIOL, V76, P1229, DOI 10.1189/jlb.0704414.
   SMITH DW, 1975, J HYG EPID MICROB IM, V19, P407.
   SMITH DW, 1966, J BACTERIOL, V91, P718.
   SMITH DW, 1977, AM J PATHOL, V89, P273.
   SMITH DW, 1970, AM REV RESPIR DIS, V102, P937.
   SMITH DW, 1989, REV INFECT DIS, V11, pS385.
   Somashekar BS, 2011, J PROTEOME RES, V10, P4186, DOI 10.1021/pr2003352.
   Somashekar BS, 2012, J PROTEOME RES, V11, P4873, DOI 10.1021/pr300345x.
   Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143.
   Stenger S, 2002, CURR OPIN IMMUNOL, V14, P452, DOI 10.1016/S0952-7915(02)00355-2.
   Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4.
   Tobian AAR, 2003, J IMMUNOL, V171, P1413, DOI 10.4049/jimmunol.171.3.1413.
   Turner J, 2004, INFECT IMMUN, V72, P3759, DOI 10.1128/IAI.72.7.3759-3768.2004.
   Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343.
   Turner J, 2001, AM J RESP CELL MOL, V24, P203, DOI 10.1165/ajrcmb.24.2.4370.
   Turner J, 2001, INFECT IMMUN, V69, P3264, DOI 10.1128/IAI.69.5.3264-3270.2001.
   Turner OC, 2003, GRANULOMATOUS INFECTIONS AND INFLAMMATIONS: CELLULAR AND MOLECULAR MECHANISMS, P65.
   Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003.
   VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655.
   Vilaplana C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020404.
   Vogelzang A, 2014, J INFECT DIS, V210, P1928, DOI 10.1093/infdis/jiu347.
   Wang BL, 2007, CLIN VACCINE IMMUNOL, V14, P902, DOI 10.1128/CDLI.00077-07.
   Ward SK, 2010, MOL MICROBIOL, V77, P1096, DOI 10.1111/j.1365-2958.2010.07273.x.
   Wozniak TM, 2010, INFECT IMMUN, V78, P4187, DOI 10.1128/IAI.01392-09.
   Yamamoto T, 2007, TUBERCULOSIS, V87, P155, DOI 10.1016/j.tube.2006.07.002.
   Yan BS, 2007, J IMMUNOL, V179, P6919, DOI 10.4049/jimmunol.179.10.6919.}},
Number-of-Cited-References = {{178}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{5}},
Journal-ISO = {{Microbiol. Spectr.}},
Doc-Delivery-Number = {{DT9GI}},
Unique-ID = {{ISI:000381804000056}},
DA = {{2018-08-13}},
}

@article{ ISI:000378542300030,
Author = {Rogalsky, Sergiy and Bardeau, Jean-Francois and Wu, Hao and Lyoshina,
   Lyudmila and Bulko, Olga and Tarasyuk, Oksana and Makhno, Stanislav and
   Cherniavska, Tetiana and Kyselov, Yuriy and Koo, Joseph H.},
Title = {{Structural, thermal and antibacterial properties of polyamide
   11/polymeric biocide polyhexamethylene guanidine dodecylbenzenesulfonate
   composites}},
Journal = {{JOURNAL OF MATERIALS SCIENCE}},
Year = {{2016}},
Volume = {{51}},
Number = {{16}},
Pages = {{7716-7730}},
Month = {{AUG}},
Abstract = {{Antimicrobial polyamide 11 (PA-11) films containing low-cost, thermally
   stable and water resistant polymeric biocide polyhexamethylene guanidine
   dodecylbenzenesulfonate (PHMG-DBS) have been obtained by compression
   moulding. The structure of the modified PA-11 films containing from 3 to
   10 wt\% of PHMG-DBS was characterized using Raman and FTIR spectroscopy
   and atomic force microscopy (AFM). The surface properties were evaluated
   both by contact angle and contactless inductive method. The introduction
   of PHMG-DBS into PA-11 films was found to increase positive surface
   charge density to 5.5.10(-11) C/cm(2) for 10 wt\% of PHMG-DBS.
   Antibacterial activity of PA-11/PHMG-DBS films against both
   Gram-positive (Escherichia coli) and Gram-negative (Bacillus subtilis)
   bacteria was demonstrated for films containing from 5 to 7 wt\% of
   polymeric biocide. According to thermal investigations data,
   PA-11/PHMG-DBS composite has excellent thermal stability to at least 390
   degrees C both in air and in argon atmosphere which indicates on its
   availability for the melt processing by common methods. It has also been
   found that polymeric biocide is highly resistant to leaching from PA-11
   film.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Rogalsky, S (Reprint Author), Natl Acad Sci Ukraine, Inst Bioorgan Chem \& Petrochem, 50 Kharkivske Schose, UA-02160 Kiev, Ukraine.
   Rogalsky, Sergiy; Tarasyuk, Oksana; Kyselov, Yuriy, Natl Acad Sci Ukraine, Inst Bioorgan Chem \& Petrochem, 50 Kharkivske Schose, UA-02160 Kiev, Ukraine.
   Bardeau, Jean-Francois, Univ Maine, Inst Mol \& Materiaux Mans, UMR CNRS 6283, Ave Olivier Messiaen, F-72085 Le Mans 9, France.
   Wu, Hao; Koo, Joseph H., Univ Texas Austin, Texas Mat Inst, Ctr Nano \& Mol Sci \& Technol, 204 E Dean Keeton St,C2200, Austin, TX 78712 USA.
   Lyoshina, Lyudmila; Bulko, Olga, Natl Acad Sci Ukraine, Inst Cell Biol \& Genet Engn, 148 Acad Zabolotnoho Str, UA-03143 Kiev, Ukraine.
   Makhno, Stanislav; Cherniavska, Tetiana, Natl Acad Sci Ukraine, Chuiko Inst Surface Chem, 17 Gen Naumov Str, UA-03680 Kiev, Ukraine.}},
DOI = {{10.1007/s10853-016-0054-x}},
ISSN = {{0022-2461}},
EISSN = {{1573-4803}},
Keywords-Plus = {{HYDROCHLORIDE-BASED DISINFECTANT; ESCHERICHIA-COLI; ANTIMICROBIAL
   POLYMERS; STAPHYLOCOCCUS-AUREUS; SURFACES; SILVER; DEGRADATION;
   ADHESION; CHARGE}},
Research-Areas = {{Materials Science}},
Web-of-Science-Categories  = {{Materials Science, Multidisciplinary}},
Author-Email = {{sergey.rogalsky@gmail.com}},
ResearcherID-Numbers = {{Wu, Hao/M-9303-2018
   }},
ORCID-Numbers = {{Tarasyuk, Oksana/0000-0002-7825-9720
   Rogalsky, Sergiy/0000-0002-5200-5247}},
Cited-References = {{ALGELAWI MH, 2013, J BIOL SCI, V13, P555, DOI DOI 10.3923/jbs.2013.555.558.
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B.
   Arkema, 2010, FIN POWD DUR COAT DU.
   Arkema, 2005, RILSAN PA11 CREAT RE.
   Carmona-Ribeiro AM, 2013, INT J MOL SCI, V14, P9906, DOI 10.3390/ijms14059906.
   Chonde Sonal G, 2013, IJETCAS, V4, P362.
   Damm C, 2008, MATER CHEM PHYS, V108, P61, DOI 10.1016/j.matchemphys.2007.09.002.
   Damm C, 2007, J MATER SCI, V42, P6067, DOI 10.1007/s10853-006-1158-5.
   Dawans FA, 1986, P OFFSH TECHN C HOUS.
   Faille C, 2002, CAN J MICROBIOL, V48, P728, DOI 10.1139/W02-063.
   Fatyeyeva K, 2011, MATER CHEM PHYS, V130, P760, DOI 10.1016/j.matchemphys.2011.07.057.
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3.
   Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x.
   Guo N, 2013, POLYM BULL, V70, P3031, DOI 10.1007/s00289-013-1005-1.
   Haghi AK, 2013, MULTICOMPONENT POLYM, P169.
   Izmaylov B, 2015, REACT FUNCT POLYM, V87, P22, DOI 10.1016/j.reactfunctpolym.2014.12.007.
   Kaali P, 2011, BIOMEDICAL ENGINEERING, TRENDS IN MATERIALS SCIENCE, P513.
   Klun U, 2003, POLYM DEGRAD STABIL, V79, P99, DOI 10.1016/S0141-3910(02)00260-4.
   Kohan M., 1995, NYLON PLASTICS HDB.
   Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0.
   Kukharenko O, 2014, EUR POLYM J, V60, P247, DOI 10.1016/j.eurpolymj.2014.09.014.
   Kumar R, 2005, BIOMATERIALS, V26, P2081, DOI 10.1016/j.biomaterials.2004.05.030.
   Kuratsuji T, 2003, US Patent, Patent No. 20030171452.
   Lapeyre A, 2005, US Patent, Patent No. 8303970.
   Lee JC, 2009, 41 AIAA THERM C SAN.
   Lewis K, 2005, TRENDS BIOTECHNOL, V23, P343, DOI 10.1016/j.tibtech.2005.05.004.
   Lyon RE, 2002, DOTFAAAR01117 NTIS.
   Marmur A, 2006, SOFT MATTER, V2, P12, DOI 10.1039/b514811c.
   Mason JF, 1998, MATER PERFORMANCE, V37, P34.
   Mathurin YK, 2012, J FOOD PROTECT, V75, P1167, DOI 10.4315/0362-028X.JFP-11-361.
   Mohee R, 2007, WASTE MANAGE, V27, P1486, DOI 10.1016/j.wasman.2006.07.023.
   Nichols D, 2005, RAPRA REV REPORTS.
   Nigmatullin R, 2009, MACROMOL MATER ENG, V294, P795, DOI 10.1002/mame.200900166.
   Oule MK, 2008, J MED MICROBIOL, V57, P1523, DOI 10.1099/jmm.0.2008/003350-0.
   Qian LY, 2008, POLYMER, V49, P2471, DOI 10.1016/j.polymer.2008.03.042.
   Rajendran R., 2004, IE I J TX, V84, P42.
   Rogalskyy S, 2012, POLYM INT, V61, P686, DOI 10.1002/pi.4168.
   Russell AD, 1994, PROGR MED CHEM, V31, P351, DOI DOI 10.1016/S0079-6468(08)70024-9.
   SEDIN VA, 1971, MEAS TECH-USSR, V14, P439, DOI 10.1007/BF00980286.
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046.
   Tomita K, 2003, BIOTECHNOL LETT, V25, P1743, DOI 10.1023/A:1026091711130.
   Walczak M, 2014, J IND MICROBIOL BIOT, V41, P1719, DOI 10.1007/s10295-014-1505-5.
   WILLIAMS RL, 1989, CRIT REV BIOCOMPAT, V5, P221.
   Zhou ZX, 2010, J APPL MICROBIOL, V108, P898, DOI 10.1111/j.1365-2672.2009.04482.x.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{32}},
Journal-ISO = {{J. Mater. Sci.}},
Doc-Delivery-Number = {{DP5MS}},
Unique-ID = {{ISI:000378542300030}},
DA = {{2018-08-13}},
}

@article{ ISI:000379836200001,
Author = {Frise, Rebecca and Bradley, Konrad and van Doremalen, Neeltje and
   Galiano, Monica and Elderfield, Ruth A. and Stilwell, Peter and
   Ashcroft, Jonathan W. and Fernandez-Alonso, Mirian and Miah, Shahjahan
   and Lackenby, Angie and Roberts, Kim L. and Donnelly, Christl A. and
   Barclay, Wendy S.},
Title = {{Contact transmission of influenza virus between ferrets imposes a looser
   bottleneck than respiratory droplet transmission allowing propagation of
   antiviral resistance}},
Journal = {{SCIENTIFIC REPORTS}},
Year = {{2016}},
Volume = {{6}},
Month = {{JUL 19}},
Abstract = {{Influenza viruses cause annual seasonal epidemics and occasional
   pandemics. It is important to elucidate the stringency of bottlenecks
   during transmission to shed light on mechanisms that underlie the
   evolution and propagation of antigenic drift, host range switching or
   drug resistance. The virus spreads between people by different routes,
   including through the air in droplets and aerosols, and by direct
   contact. By housing ferrets under different conditions, it is possible
   to mimic various routes of transmission. Here, we inoculated donor
   animals with a mixture of two viruses whose genomes differed by one or
   two reverse engineered synonymous mutations, and measured the
   transmission of the mixture to exposed sentinel animals. Transmission
   through the air imposed a tight bottleneck since most recipient animals
   became infected by only one virus. In contrast, a direct contact
   transmission chain propagated a mixture of viruses suggesting the dose
   transferred by this route was higher. From animals with a mixed
   infection of viruses that were resistant and sensitive to the antiviral
   drug oseltamivir, resistance was propagated through contact transmission
   but not by air. These data imply that transmission events with a looser
   bottleneck can propagate minority variants and may be an important route
   for influenza evolution.}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Barclay, WS (Reprint Author), Imperial Coll London, Fac Med, Div Infect Dis, Norfolk Pl, London W2 1PG, England.
   Frise, Rebecca; Bradley, Konrad; van Doremalen, Neeltje; Elderfield, Ruth A.; Stilwell, Peter; Ashcroft, Jonathan W.; Roberts, Kim L.; Barclay, Wendy S., Imperial Coll London, Fac Med, Div Infect Dis, Norfolk Pl, London W2 1PG, England.
   Galiano, Monica; Fernandez-Alonso, Mirian; Miah, Shahjahan; Lackenby, Angie, Publ Hlth England, London, England.
   Donnelly, Christl A., Imperial Coll London, Fac Med, Sch Publ Hlth, MRC Ctr Outbreak Anal \& Modelling,Dept Infect Dis, London, England.
   van Doremalen, Neeltje, NIAID, Virus Ecol Unit, Virol Lab, Rocky Mt Labs,NIH, 903 South 4th St, Hamilton, MT 59840 USA.
   Stilwell, Peter, Univ Exeter, Environm \& Sustainabil Inst, Penryn, England.
   Ashcroft, Jonathan W., Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Gastroenterol \& Hepatol, Cambridge, England.
   Fernandez-Alonso, Mirian, Univ Navarra, Sch Med, E-31080 Pamplona, Spain.
   Roberts, Kim L., Trinity Coll Dublin, Sch Genet \& Microbiol, Moyne Inst Prevent Med, Dept Microbiol, Dublin, Ireland.}},
DOI = {{10.1038/srep29793}},
Article-Number = {{29793}},
ISSN = {{2045-2322}},
Keywords-Plus = {{A VIRUS; MAMMALIAN ADAPTATION; AEROSOL TRANSMISSION; IN-VIVO; INFECTION;
   MUTATIONS; DIVERSITY; SELECTION; HUMANS; MODEL}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{w.barclay@imperial.ac.uk}},
ResearcherID-Numbers = {{Fernandez-Alonso, Mirian/Q-4471-2016
   }},
ORCID-Numbers = {{Fernandez-Alonso, Mirian/0000-0001-8047-2734
   Ashcroft, Jonathan/0000-0002-6224-4233
   Bradley, Konrad/0000-0001-8761-6219}},
Funding-Acknowledgement = {{Wellcome Trust {[}087039/Z/08Z]; Medical Research Council UK
   {[}G0600504]; NC3Rs grant {[}NC/K00042X/1]; UK Medical Research Council;
   European Union Seventh Framework Programme {[}FP7]
   {[}nu278433-PREDEMICS]; National Institute for Health Research Health
   Protection Research Unit (NIHR HPRU)) in Modelling Methodology at
   Imperial College London; Public Health England (PHE); Medical Research
   Council {[}G0600504, MR/K010174/1, MR/K010174/1B]; National Centre for
   the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)
   {[}NC/K00042X/1]}},
Funding-Text = {{Jason Long for critical reviews of the manuscript. The authors thank
   staff at Imperial College Central Biological Services for their expert
   help. Aisling Vaughan for help with plaque picking. KB, JA, RF, NvD and
   KR were supported by Wellcome Trust programme grant (087039/Z/08Z), and
   Medical Research Council UK grant G0600504. RE was supported by NC3Rs
   grant NC/K00042X/1. CAD thanks the UK Medical Research Council for
   Centre funding and the European Union Seventh Framework Programme
   {[}FP7/2007-2013] for funding under Grant Agreement nu278433-PREDEMICS.
   The research was funded by the National Institute for Health Research
   Health Protection Research Unit (NIHR HPRU)) in Modelling Methodology at
   Imperial College London in partnership with Public Health England (PHE).
   The views expressed are those of the author(s) and not necessarily those
   of the NHS, the NIHR, the Department of Health or Public Health England.}},
Cited-References = {{Abel S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004823.
   Aditama TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029971.
   ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800.
   Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823.
   Belser JA, 2011, J VIROL, V85, P1563, DOI 10.1128/JVI.02231-10.
   Blumenkrantz D, 2013, J VIROL, V87, P10539, DOI 10.1128/JVI.00967-13.
   Boeras DI, 2011, P NATL ACAD SCI USA, V108, pE1156, DOI 10.1073/pnas.1103764108.
   Buhnerkempe MG, 2015, ELIFE, V4, DOI 10.7554/eLife.07969.
   Bull RA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002243.
   Butler J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004065.
   Cowling BJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2922.
   Elderfield RA, 2014, J VIROL, V88, P13269, DOI 10.1128/JVI.01636-14.
   Forrester NL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002897.
   Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101.
   Gustin KM, 2013, J VIROL, V87, P7864, DOI 10.1128/JVI.00719-13.
   Gustin KM, 2011, P NATL ACAD SCI USA, V108, P8432, DOI 10.1073/pnas.1100768108.
   Hamelin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001015.
   Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572.
   Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831.
   Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260.
   Jayaraman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027517.
   Jia N, 2014, J BIOL CHEM, V289, P28489, DOI 10.1074/jbc.M114.588541.
   Killingley B, 2013, INFLUENZA OTHER RESP, V7, P42, DOI 10.1111/irv.12080.
   Koster F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033118.
   Lakdawala SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002443.
   Laurie KL, 2015, J INFECT DIS, V212, P1701, DOI 10.1093/infdis/jiv260.
   Linster M, 2014, CELL, V157, DOI 10.1016/j.cell.2014.02.040.
   LITTLE JW, 1979, J MED VIROL, V3, P177, DOI 10.1002/jmv.1890030303.
   Luk GSM, 2015, J VIROL, V89, P9939, DOI 10.1128/JVI.01444-15.
   MacInnes H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024448.
   Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103.
   Marriott AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094090.
   Mccaw JM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002026.
   Moncla LH, 2016, CELL HOST MICROBE, V19, P169, DOI 10.1016/j.chom.2016.01.011.
   Murcia PR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002730.
   Park AW, 2009, SCIENCE, V326, P726, DOI 10.1126/science.1175980.
   Poon LLM, 2016, NAT GENET, V48, P195, DOI 10.1038/ng.3479.
   Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947.
   Roberts KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043303.
   Roberts KL, 2011, J GEN VIROL, V92, P1822, DOI 10.1099/vir.0.031203-0.
   Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526.
   Stack JC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2173.
   Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426.
   van Doremalen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025755.
   Varble A., 2014, INFLUENZA VIRUS TRAN, P691, DOI {[}10.1016/j.chom.2014.09.020, DOI 10.1016/J.CH0M.2014.09.020].
   Varble A, 2014, CELL HOST MICROBE, V16, P691, DOI 10.1016/j.chom.2014.09.020.
   Wilker PR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3636.
   Yen HL, 2011, P NATL ACAD SCI USA, V108, P14264, DOI 10.1073/pnas.1111000108.
   Zaraket H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7553.}},
Number-of-Cited-References = {{49}},
Times-Cited = {{10}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{12}},
Journal-ISO = {{Sci Rep}},
Doc-Delivery-Number = {{DR3XO}},
Unique-ID = {{ISI:000379836200001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000377532100003,
Author = {Dolberg, Anne M. and Reichl, Stephan},
Title = {{Expression of P-glycoprotein in excised human nasal mucosa and optimized
   models of RPMI 2650 cells}},
Journal = {{INTERNATIONAL JOURNAL OF PHARMACEUTICS}},
Year = {{2016}},
Volume = {{508}},
Number = {{1-2}},
Pages = {{22-33}},
Month = {{JUL 11}},
Abstract = {{To assess the transmucosal drug transport in the development of
   medications for intranasal administration, cellular in vitro models are
   preferred over the use of animal tissues due to interspecies variations
   and ethical concerns. With regard to the distribution of active agents
   and multidrug resistance, the ABC transporter P-glycoprotein plays a
   major role in several mammalian tissues. The present study compares the
   expression of this efflux pump in optimized in vitro models based on the
   human RPMI 2650 cell line with specimens of human turbinate mucosa. The
   presence of the ABCB1 gene was investigated at the mRNA and protein
   levels using RT-PCR and Western blot analysis in differently cultured
   RPMI 2650 cells and excised human nasal epithelium. Furthermore, the
   localization and activity of P-gp was examined by immunohistochemical
   staining and functionality assays using different substrates in both in
   vitro and ex vivo models. Both mRNA and protein expression of P-gp was
   found in all studied models. Furthermore, transporter functionality was
   detected in both RPMI 2650 cell culture models and excised human mucosa.
   The results demonstrated a highly promising comparability between RPMI
   2650 models and explants of human nasal tissue concerning the influence
   of MDR1 on drug disposition. The RPMI 2650 cell line might become a
   useful tool in preclinical trials to improve reproducibility and achieve
   greater applicability to humans of experimental data regarding passive
   diffusion and active efflux of drug candidates. (C) 2016 Elsevier B.V.
   All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Reichl, S (Reprint Author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmazeut Technol, Mendelssohnstr 1, D-38106 Braunschweig, Germany.
   Dolberg, Anne M.; Reichl, Stephan, Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmazeut Technol, Mendelssohnstr 1, D-38106 Braunschweig, Germany.
   Reichl, Stephan, Tech Univ Carolo Wilhelmina Braunschweig, Zentrum Pharmaverfahrenstech, D-38106 Braunschweig, Germany.}},
DOI = {{10.1016/j.ijpharm.2016.05.010}},
ISSN = {{0378-5173}},
EISSN = {{1873-3476}},
Keywords = {{RPMI 2650 cell line; Human nasal mucosa; ABC transporter;
   P-glycoprotein; Active efflux; In vitro model; Drug delivery}},
Keywords-Plus = {{IN-VITRO MODEL; AIR-LIQUID INTERFACE; DRUG TRANSPORT;
   MULTIDRUG-RESISTANCE; CHRONIC RHINOSINUSITIS; FUNCTIONAL-ACTIVITY;
   CULTURE-CONDITIONS; DIPLOID KARYOTYPE; GENE-EXPRESSION; CACO-2 CELLS}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy}},
Author-Email = {{S.Reichl@tu-bs.de}},
Funding-Acknowledgement = {{German Federal Institute for Risk Assessment (BfR), Berlin, Germany
   {[}3-1329-469, 3-1328-508]}},
Funding-Text = {{We are grateful to the German Federal Institute for Risk Assessment
   (BfR), Berlin, Germany, which funded this work under grant numbers
   3-1329-469 and 3-1328-508. Furthermore, the authors would like to thank
   Prof. Schroeder and Dr. Schmidt, Stadtisches Klinikum Braunschweig,
   Germany, as well as Dr. Reintjes and Dr. Kollisch, HNO Praxis
   Schlosscarree Braunschweig, Germany, for the friendly supply of human
   nasal tissue specimens. We further gratefully acknowledge the Institute
   of Pharmacology and Toxicology, University Braunschweig, Germany, for
   the confocal laser scanning microscope.}},
Cited-References = {{Al-Ghabeish M, 2015, MOL PHARMACEUT, V12, P2742, DOI 10.1021/acs.molpharmaceut.5b00103.
   Anand U, 2014, FUTURE MED CHEM, V6, P1381, DOI 10.4155/fmc.14.77.
   Artursson P, 2012, ADV DRUG DELIVER REV, V64, P280, DOI 10.1016/j.addr.2012.09.005.
   Bai S, 2008, J PHARM SCI-US, V97, P1165, DOI 10.1002/jps.21031.
   Beule AG, 2010, LARYNGORHINOOTOLO S1, V89, P15.
   Bleier BS, 2012, INT FORUM ALLERGY RH, V2, P122, DOI 10.1002/alr.21004.
   Boucher R C, 1987, Eur J Respir Dis Suppl, V153, P59.
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3.
   Cho HJ, 2011, J PHARM PHARMACOL, V63, P385, DOI 10.1111/j.2042-7158.2010.01221.x.
   Chu XY, 2007, J PHARMACOL EXP THER, V321, P673, DOI 10.1124/jpct.106.116517.
   COTTON CU, 1987, J CLIN INVEST, V79, P80, DOI 10.1172/JCI112812.
   CREMASCHI D, 1991, PFLUG ARCH EUR J PHY, V419, P425, DOI 10.1007/BF00370784.
   Daoud R, 2000, BIOCHEMISTRY-US, V39, P15344, DOI 10.1021/bi0020574.
   De Fraissinette A., 1995, Rhinology (Utrecht), V33, P194.
   {[}丁国强 DING Guo-qiang], 2009, {[}中华耳鼻咽喉头颈外科杂志, Chinese Journal of Otorhinolaryngology Head and Neck Surgery], V44, P203.
   Endter S, 2007, CELL TISSUE RES, V328, P77, DOI 10.1007/s00441-006-0346-6.
   Feldman RE, 2013, INT FORUM ALLERGY RH, V3, P684, DOI 10.1002/alr.21176.
   Fogh J, 1975, HUMAN TUMOR CELLS IN, P115.
   Forster S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033253.
   Graff CL, 2005, PHARM RES, V22, P86, DOI 10.1007/s11095-004-9013-3.
   Grassin-Delyle S, 2012, PHARMACOL THERAPEUT, V134, P366, DOI 10.1016/j.pharmthera.2012.03.003.
   Harikarnpakdee S, 2006, AAPS PHARMSCITECH, V7, DOI 10.1208/pt070112.
   Hayeshi R, 2008, EUR J PHARM SCI, V35, P383, DOI 10.1016/j.ejps.2008.08.004.
   Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009.
   Henriksson G, 1997, AM J RHINOL, V11, P317, DOI 10.2500/105065897781446603.
   Hung C. Y., 2013, EVIDENCED BASED COMP, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0059419.
   Jouan E, 2012, FUND CLIN PHARM, V28, P65, DOI DOI 10.1111/J.1472-8206.2012.01071.X.
   JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7.
   Kandimalla KK, 2005, PHARM RES, V22, P1121, DOI 10.1007/s11095-005-5420-3.
   Kimoto E, 2011, DRUG METAB DISPOS, V39, P47, DOI 10.1124/dmd.110.034298.
   Kocharyan A, 2014, INT FORUM ALLERGY RH, V4, P734, DOI 10.1002/alr.21361.
   Kreft ME, 2015, PHARM RES-DORDR, V32, P665, DOI 10.1007/s11095-014-1494-0.
   Kurti L, 2013, EUR J PHARM SCI, V50, P86, DOI 10.1016/j.ejps.2013.03.012.
   Kurti L, 2013, CYTOTECHNOLOGY, V65, P395, DOI 10.1007/s10616-012-9493-7.
   Kurti L, 2012, TOXICOL IN VITRO, V26, P445, DOI 10.1016/j.tiv.2012.01.015.
   Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176.
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0.
   Lage H, 2008, CELL MOL LIFE SCI, V65, P3145, DOI 10.1007/s00018-008-8111-5.
   Landis MS, 2012, THER DELIV, V3, P195, DOI 10.4155/TDE.11.149.
   Lang S, 1998, PEPTIDES, V19, P599, DOI 10.1016/S0196-9781(97)00470-1.
   Li Y, 2010, CURR MED CHEM, V17, P786, DOI 10.2174/092986710790514507.
   Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006.
   Mallants R, 2009, J PHARM PHARMACOL, V61, P883, DOI 10.1211/jpp/61.07.0007.
   Mikkaichi T, 2004, P NATL ACAD SCI USA, V101, P3569, DOI 10.1073/pnas.0304987101.
   MOORE GE, 1964, CANCER, V17, P170, DOI 10.1002/1097-0142(196402)17:2<170::AID-CNCR2820170206>3.0.CO;2-N.
   MOORHEAD PS, 1965, EXP CELL RES, V39, P190, DOI 10.1016/0014-4827(65)90022-4.
   Nader AM, 2014, J CLIN PHARMACOL, V54, P3, DOI 10.1002/jcph.200.
   Osth K, 2002, J PHARM SCI, V91, P1259, DOI 10.1002/jps.10123.
   Ozsoy Y, 2011, EXPERT OPIN DRUG DEL, V8, P1439, DOI 10.1517/17425247.2011.607437.
   Patel D, 2012, J PHARM SCI-US, V101, P690, DOI 10.1002/jps.22780.
   Peter H. G., 1996, THESIS.
   Reichl S, 2012, J PHARM PHARMACOL, V64, P1621, DOI 10.1111/j.2042-7158.2012.01540.x.
   Russell WMS, 1959, THE PRINCIPLES OF HU.
   Salib RJ, 2005, CLIN EXP ALLERGY, V35, P811, DOI 10.1111/j.1365-2222.2005.02258.x.
   Schmidt MC, 1998, ADV DRUG DELIVER REV, V29, P51, DOI 10.1016/S0169-409X(97)00061-6.
   Taub ME, 2011, DRUG METAB DISPOS, V39, P2093, DOI 10.1124/dmd.111.040816.
   Thiebaud N, 2011, NEUROSCI LETT, V505, P180, DOI 10.1016/j.neulet.2011.10.018.
   Troutman MD, 2003, PHARMACEUT RES, V20, P1192, DOI 10.1023/A:1025096930604.
   Vasiliou Vasilis, 2009, Human Genomics, V3, P281.
   Verstraelen J, 2015, J PHARM PHARMACOL, V67, P605, DOI 10.1111/jphp.12357.
   Verstraelen J, 2013, INT J PHARMACEUT, V441, P765, DOI 10.1016/j.ijpharm.2012.10.007.
   Wadell C, 1999, EUR J PHARM SCI, V7, P197, DOI 10.1016/S0928-0987(98)00023-2.
   Wang YL, 2006, BBA-BIOMEMBRANES, V1758, P1671, DOI 10.1016/j.bbamem.2006.06.004.
   Wengst A, 2010, EUR J PHARM BIOPHARM, V74, P290, DOI 10.1016/j.ejpb.2009.08.008.
   Werner U, 1996, PHARMACEUT RES, V13, P978, DOI 10.1023/A:1016038119909.
   Wioland MA, 2000, J HISTOCHEM CYTOCHEM, V48, P1215, DOI 10.1177/002215540004800905.
   Yamaguchi H, 2010, DRUG METAB PHARMACOK, V25, P314, DOI 10.2133/dmpk.25.314.
   Yoo JW, 2003, PHARMACEUT RES, V20, P1690, DOI 10.1023/A:1026112107100.
   Zhang HF, 2011, J PHARM SCI-US, V100, P2717, DOI 10.1002/jps.22499.
   Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI {[}10.1080/00498250701867889, 10.1080/00498250701867889 ].}},
Number-of-Cited-References = {{70}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{13}},
Journal-ISO = {{Int. J. Pharm.}},
Doc-Delivery-Number = {{DO1IQ}},
Unique-ID = {{ISI:000377532100003}},
DA = {{2018-08-13}},
}

@article{ ISI:000379687700007,
Author = {Kroll, Kristin and Shekhova, Elena and Mattern, Derek J. and Thywissen,
   Andreas and Jacobsen, Ilse D. and Strassburger, Maria and Heinekamp,
   Thorsten and Shelest, Ekaterina and Brakhage, Axel A. and Kniemeyer,
   Olaf},
Title = {{The hypoxia-induced dehydrogenase HorA is required for coenzyme Q10
   biosynthesis, azole sensitivity and virulence of Aspergillus fumigatus}},
Journal = {{MOLECULAR MICROBIOLOGY}},
Year = {{2016}},
Volume = {{101}},
Number = {{1}},
Pages = {{92-108}},
Month = {{JUL}},
Abstract = {{Aspergillus fumigatus is the predominant airborne pathogenic fungus
   causing invasive aspergillosis in immunocompromised patients. During
   infection A.fumigatus has to adapt to oxygen-limiting conditions in
   inflammatory or necrotic tissue. Previously, we identified a
   mitochondrial protein to be highly up-regulated during hypoxic
   adaptation. Here, this protein was found to represent the novel
   oxidoreductase HorA. In Saccharomyces cerevisiae a homologue was shown
   to play a role in biosynthesis of coenzyme Q. Consistently, reduced
   coenzyme Q content in the generated horA mutant indicated a respective
   function in A. fumigatus. Since coenzyme Q is involved in cellular
   respiration and maintaining cellular redox homeostasis, the strain horA
   displayed an impaired response to both oxidative and reductive stress, a
   delay in germination and an accumulation of NADH. Moreover, an increased
   resistance against antifungal drugs was observed. All phenotypes were
   completely reversed by the addition of the synthetic electron carrier
   menadione. The deletion strain horA showed significantly attenuated
   virulence in two murine infection models of invasive pulmonary
   aspergillosis. Therefore, the biosynthesis of coenzyme Q and,
   particularly, the fungal-specific protein HorA play a crucial role in
   virulence of A. fumigatus. Due to its absence in mammals, HorA might
   represent a novel therapeutic target against fungal infections.}},
Publisher = {{WILEY}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Brakhage, AA; Kniemeyer, O (Reprint Author), HKI, Leibniz Inst Nat Prod Res \& Infect Biol, Dept Mol \& Appl Microbiol, Jena, Germany.
   Kroll, Kristin; Shekhova, Elena; Mattern, Derek J.; Thywissen, Andreas; Strassburger, Maria; Heinekamp, Thorsten; Brakhage, Axel A.; Kniemeyer, Olaf, HKI, Leibniz Inst Nat Prod Res \& Infect Biol, Dept Mol \& Appl Microbiol, Jena, Germany.
   Jacobsen, Ilse D., HKI, Leibniz Inst Nat Prod Res \& Infect Biol, Res Grp Microbial Immunol, Jena, Germany.
   Strassburger, Maria, Leibniz Inst Nat Prod Res \& Infect Biol HKI, Transfer Grp Antiinfect, Jena, Germany.
   Heinekamp, Thorsten; Brakhage, Axel A.; Kniemeyer, Olaf, Univ Jena, Inst Microbiol, Dept Microbiol \& Mol Biol, Jena, Germany.
   Shelest, Ekaterina, HKI, Leibniz Inst Nat Prod Res \& Infect Biol, Res Grp Syst Biol \& Bioinformat, Jena, Germany.
   Shelest, Ekaterina, Univ Jena, Jena, Germany.}},
DOI = {{10.1111/mmi.13377}},
ISSN = {{0950-382X}},
EISSN = {{1365-2958}},
Keywords-Plus = {{MITOCHONDRIAL COMPLEX-I; SACCHAROMYCES-CEREVISIAE; FUNGAL PATHOGENESIS;
   INFECTION MODEL; PROTEIN; OXYGEN; IDENTIFICATION; HOMEOSTASIS; BINDING;
   GENES}},
Research-Areas = {{Biochemistry \& Molecular Biology; Microbiology}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Microbiology}},
Author-Email = {{axel.brakhage@leibniz-hki.de
   olaf.knie-meyer@leibniz-hki.de}},
ResearcherID-Numbers = {{Shelest, Ekaterina/H-3069-2018
   Kniemeyer, Olaf/K-1253-2013
   }},
ORCID-Numbers = {{Shelest, Ekaterina/0000-0002-9751-6702
   Kniemeyer, Olaf/0000-0002-9493-6402
   Heinekamp, Thorsten/0000-0001-9503-9634
   Jacobsen, Ilse/0000-0002-6033-9984}},
Funding-Acknowledgement = {{Collaborative Research Center/Transregio `Human-pathogenic fungi and
   their human host: Networks of interaction (FungiNet) {[}Z1, A1];
   International Leibniz Research School for Microbial and Biomolecular
   Interactions Jena - ILRS Jena}},
Funding-Text = {{We thank Maria Potsch for mass spectrometric analysis and Silke
   Steinbach for technical assistance. This work was supported by the
   Collaborative Research Center/Transregio `Human-pathogenic fungi and
   their human host: Networks of interaction (FungiNet) (project Z1, A1)
   and the International Leibniz Research School for Microbial and
   Biomolecular Interactions Jena - ILRS Jena.}},
Cited-References = {{Aichinger C, 2003, MOL GENET GENOMICS, V270, P303, DOI 10.1007/s00438-003-0926-z.
   Allan CM, 2015, J BIOL CHEM, V290, P7517, DOI 10.1074/jbc.M114.633131.
   Barker BM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-62.
   Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374.
   Bowyer P, 2012, FEMS MICROBIOL LETT, V332, P10, DOI 10.1111/j.1574-6968.2012.02575.x.
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3.
   Brakhage AA, 2005, CURR DRUG TARGETS, V6, P875, DOI 10.2174/138945005774912717.
   Brakhage AA, 2002, ANNU REV MICROBIOL, V56, P433, DOI 10.1146/annurev.micro.56.012302.160625.
   BRAKHAGE AA, 1995, J BACTERIOL, V177, P2781, DOI 10.1128/jb.177.10.2781-2788.1995.
   BRIVETCHEVILLOTTE P, 1989, FEBS LETT, V255, P5, DOI 10.1016/0014-5793(89)81050-6.
   Monteiro MC, 2012, J BIOMOL SCREEN, V17, P542, DOI 10.1177/1087057111433459.
   Canuto MM, 2002, LANCET INFECT DIS, V2, P550, DOI 10.1016/S1473-3099(02)00371-7.
   Chatre L, 2014, CURR OPIN MICROBIOL, V20, P49, DOI 10.1016/j.mib.2014.05.001.
   Chung D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004576.
   de Jesus-Berrios M, 2003, CURR BIOL, V13, P1963, DOI 10.1016/j.cub.2003.10.029.
   Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019.
   Featherstone C, 1999, MUTAT RES-DNA REPAIR, V434, P3, DOI 10.1016/S0921-8777(99)00006-3.
   Fernandez-Ortuno D, 2008, INT MICROBIOL, V11, P1, DOI 10.2436/20.1501.01.38.
   Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006.
   Gonzalez-Mariscal I, 2014, IUBMB LIFE, V66, P63, DOI 10.1002/iub.1243.
   Grahl N, 2012, MOL MICROBIOL, V84, P383, DOI 10.1111/j.1365-2958.2012.08034.x.
   Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145.
   Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013.
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010.
   Haefeli RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017963.
   Hillmann F, 2014, MOL MICROBIOL, V93, P539, DOI 10.1111/mmi.12679.
   Ingavale SS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000155.
   Jacobsen ID, 2010, INFECT IMMUN, V78, P2995, DOI 10.1128/IAI.00268-10.
   Jain Manu, 2005, Proc Am Thorac Soc, V2, P202, DOI 10.1513/pats.200501-006AC.
   Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013.
   Kniemeyer O, 2006, CURR GENET, V49, P178, DOI 10.1007/s00294-005-0047-9.
   Kupfahl C, 2006, MOL MICROBIOL, V62, P292, DOI 10.1111/j.1365-2958.2006.05373.x.
   Lang EGE, 2011, PLANT CELL REP, V30, P205, DOI 10.1007/s00299-010-0935-4.
   Lapp K, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00469.
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404.
   Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889.
   Liebmann B, 2004, INFECT IMMUN, V72, P5193, DOI 10.1128/IAI.72.9.5193-5203.2004.
   Linde J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-6.
   Ma Y, 2008, INFECT IMMUN, V76, P1695, DOI 10.1128/IAI.01507-07.
   Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5.
   Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200.
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386.
   Neubauer M, 2015, MOL MICROBIOL, V98, P930, DOI 10.1111/mmi.13167.
   NOSOH Y, 1968, ARCH BIOCHEM BIOPHYS, V127, P1, DOI 10.1016/0003-9861(68)90193-8.
   Peng YB, 2012, FEMS YEAST RES, V12, P719, DOI 10.1111/j.1567-1364.2012.00821.x.
   Post MJ, 2007, TRANSPL INFECT DIS, V9, P189, DOI 10.1111/j.1399-3062.2007.00219.x.
   Priebe S, 2011, FUNGAL GENET BIOL, V48, P353, DOI 10.1016/j.fgb.2010.11.001.
   Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258.
   Rosenfeld E, 2003, YEAST, V20, P1115, DOI 10.1002/yea.1026.
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h.
   Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11.
   Shneyvays V, 2005, J MOL CELL CARDIOL, V39, P149, DOI 10.1016/j.yjmcc.2005.03.017.
   SHORE GC, 1995, EUR J BIOCHEM, V227, P9, DOI 10.1111/j.1432-1033.1995.tb20354.x.
   Singh A., 2012, PLOS ONE, V7, P27.
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058.
   Szewczyk E, 2010, EUKARYOT CELL, V9, P774, DOI 10.1128/EC.00375-09.
   Teutschbein J, 2010, J PROTEOME RES, V9, P3427, DOI 10.1021/pr9010684.
   Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006.
   Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007.
   Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97.
   Ushakova AV, 2005, J MOL BIOL, V351, P327, DOI 10.1016/j.jmb.2005.06.006.
   Valiante V, 2008, FUNGAL GENET BIOL, V45, P618, DOI 10.1016/j.fgb.2007.09.006.
   Vodisch M, 2011, J PROTEOME RES, V10, P2508, DOI 10.1021/pr1012812.
   Vodisch M, 2009, PROTEOMICS, V9, P1407, DOI 10.1002/pmic.200800394.
   WALTNER M, 1995, J BIOL CHEM, V270, P26311, DOI 10.1074/jbc.270.44.26311.
   Weidner G, 1998, CURR GENET, V33, P378, DOI 10.1007/s002940050350.
   Zu YG, 2006, J SEP SCI, V29, P1607, DOI 10.1002/jssc.200600047.}},
Number-of-Cited-References = {{67}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{10}},
Journal-ISO = {{Mol. Microbiol.}},
Doc-Delivery-Number = {{DR1TL}},
Unique-ID = {{ISI:000379687700007}},
DA = {{2018-08-13}},
}

@article{ ISI:000378967500009,
Author = {Rojo-Gimeno, Cristina and Postma, Merel and Dewulf, Jeroen and Hogeveen,
   Henk and Lauwers, Ludwig and Wauters, Erwin},
Title = {{Farm-economic analysis of reducing antimicrobial use whilst adopting
   improved management strategies on farrow-to-finish pig farms}},
Journal = {{PREVENTIVE VETERINARY MEDICINE}},
Year = {{2016}},
Volume = {{129}},
Pages = {{74-87}},
Month = {{JUL 1}},
Abstract = {{Due to increasing public health concerns that food animals could be
   reservoirs for antibiotic resistant organisms, calls for reduced current
   antibiotic use on farms are growing. Nevertheless, it is challenging for
   farmers to perform this reduction without negatively affecting technical
   and economic performance. As an alternative, improved management
   practices based on biosecurity and vaccinations have been proven useful
   to reduce antimicrobial use without lowering productivity, but issues
   with insufficient experimental design possibilities have hindered
   economic analysis. In the present study a quasi-experimental approach
   was used for assessing the economic impact of reduction of antimicrobial
   use coupled with improved management strategies, particularly
   biosecurity strategies. The research was performed on farrow-to-finish
   pig farms in Flanders (northern region of Belgium). First, to account
   for technological progress and to avoid selection bias, propensity score
   analysis was used to compare data on technical parameters. The treatment
   group (n = 48) participated in an intervention study whose aim was to
   improve management practices to reduce the need for use of
   antimicrobials. Before and after the change in management, data were
   collected on the technical parameters, biosecurity status, antimicrobial
   use, and vaccinations. Treated farms were matched without replacement
   with control farms (n = 69), obtained from the Farm Accountancy Data
   Network, to estimate the difference in differences (DID) of the
   technical parameters. Second, the technical parameters' DID, together
   with the estimated costs of the management intervention and the price
   volatility of the feed, meat of the finisher pigs, and piglets served as
   a basis for modelling the profit of 11 virtual farrow-to-finish pig
   farms representative of the Flemish sector. Costs incurred by new
   biosecurity measures (median +(sic)3.96/sow/year), and new vaccinations
   (median (sic)0.00/sow/year) did not exceed the cost reduction achieved
   by lowering the use of antimicrobials (median -(sic)7.68/sow/year). No
   negative effect on technical parameters was observed and mortality of
   the finishers was significantly reduced by -1.1\%. Even after a
   substantial reduction of the antimicrobial treatments, the difference of
   the enterprise profit increased by +(sic)2.67/finisher pig/year after
   implementing the interventions. This result proved to be robust after
   stochastic modelling of input and output price volatility. The results
   of this study can be used by veterinarians and other stakeholders to
   incentivise managers of farrow-to-finish operations to use biosecurity
   practices as a cost-effective way to reduce antimicrobial use. (C) 2016
   Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Rojo-Gimeno, C (Reprint Author), Inst Agr \& Fisheries Res, Social Sci Unit, Burg Van Gansberghelaan 115 Box 2, B-9820 Merelbeke, Belgium.
   Rojo-Gimeno, Cristina; Lauwers, Ludwig; Wauters, Erwin, Inst Agr \& Fisheries Res, Social Sci Unit, Burg Van Gansberghelaan 115 Box 2, B-9820 Merelbeke, Belgium.
   Rojo-Gimeno, Cristina; Postma, Merel; Dewulf, Jeroen, Univ Ghent, Fac Vet Med, Dept Reprod Obstet \& Herd Hlth, Vet Epidemiol Unit, Salisburylaan 133, B-9820 Merelbeke, Belgium.
   Hogeveen, Henk, Wageningen Univ, Business Econ Grp, Hollandseweg 1, NL-6706 KN Wageningen, Netherlands.
   Lauwers, Ludwig, Univ Ghent, Fac Biosci Engn, Dept Agr Econ, Coupure Links 653, B-9000 Ghent, Belgium.
   Wauters, Erwin, Univ Antwerp, Dept Vet Sci, Univ Pl 1, B-2610 Antwerp, Belgium.}},
DOI = {{10.1016/j.prevetmed.2016.05.001}},
ISSN = {{0167-5877}},
EISSN = {{1873-1716}},
Keywords = {{Antimicrobial usage; Biosecurity; Farrow-to-finish pig farms;
   Farm-economic analysis; Propensity score matching; Longitudinal design}},
Keywords-Plus = {{AGRICULTURAL TECHNOLOGY ADOPTION; SCORE MATCHING ANALYSIS; AIR
   FILTRATION SYSTEMS; FOOD ANIMAL PRODUCTION; LARGE SOW HERDS;
   PROPENSITY-SCORE; FINANCIAL IMPLICATIONS; DISEASE PREVENTION; PRRSV
   INFECTION; FEED-EFFICIENCY}},
Research-Areas = {{Veterinary Sciences}},
Web-of-Science-Categories  = {{Veterinary Sciences}},
Author-Email = {{cristina.rojogimeno@ilvo.vlaanderen.be}},
ORCID-Numbers = {{Dewulf, jeroen/0000-0001-9843-5990
   Postma, Merel/0000-0003-3628-2014
   Wauters, Erwin/0000-0002-1054-0487}},
Funding-Acknowledgement = {{Boerenbond; Certus}},
Funding-Text = {{CRG would like to express her gratitude to Jef Van Meensel (Institute of
   Agriculture and Fisheries Research, Social Sciences Unit) for his useful
   insights on the economic model and discussions. CRG would also like to
   thank Dakerlia Claeys (Institute of Agriculture and Fisheries Research,
   Social Sciences Unit) for her help with the FADN data. CRG and MP wish
   to thank Els De Fre (Veterinary support from the Large Animal Practice
   of the University of Ghent, Department of Obstetrics, Reproduction and
   Herd Health) for her help obtaining the prices of antimicrobials. CRG
   and MP would like to acknowledge both veterinarians active in pig
   veterinary medicine for replying to the questionnaires about the
   vaccination prices. MP wishes to thank the farmers, herd veterinarians,
   and herd advisors who participated in the study. MP would like to thank
   Boerenbond and Certus for financing the `reduction of antimicrobials
   project'.}},
Cited-References = {{Aarestrup F.M., 2015, PHILOS T R SOC B, V370.
   Aarestrup FM, 2005, BASIC CLIN PHARMACOL, V96, P271, DOI 10.1111/j.1742-7843.2005.pto960401.x.
   Aarestrup FM, 2010, AM J VET RES, V71, P726, DOI 10.2460/ajvr.71.7.726.
   Alarcon P, 2014, PREV VET MED, V116, P223, DOI 10.1016/j.prevetmed.2013.08.004.
   Alarcon P, 2013, PREV VET MED, V110, P103, DOI 10.1016/j.prevetmed.2012.12.006.
   Alban L, 2013, PREV VET MED, V108, P334, DOI 10.1016/j.prevetmed.2012.11.010.
   Alonso C, 2013, PREV VET MED, V112, P109, DOI 10.1016/j.prevetmed.2013.06.001.
   Alonso C, 2013, PREV VET MED, V111, P268, DOI 10.1016/j.prevetmed.2013.05.001.
   {[}Anonymous], 2011, MARKTPRIJZEN 2011.
   {[}Anonymous], 2012, MARKTPRIJZEN 2012 VL.
   {[}Anonymous], 2015, ACTUALISATIE STUDIE.
   {[}Anonymous], 2010, MARKTPRIJZEN 2010.
   Austin PC, 2007, STAT MED, V26, P754, DOI 10.1002/sim.2618.
   Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786.
   BelVet-SAC, 2014, BELGIAN VET SURVEILL.
   BelVet-SAC, 2012, BELGIAN VET SURVEILL.
   BelVet-SAC, 2013, BELGIAN VET SURVEILL.
   BelVet-SAC, 2011, BELGIAN VET SURVELIL.
   Boehlje M.D., 1983, LABOR ACQUIS MANAG, P498.
   Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149.
   Callens B, 2012, PREV VET MED, V106, P53, DOI 10.1016/j.prevetmed.2012.03.001.
   Chantziaras I, 2014, J ANTIMICROB CHEMOTH, V69, P827, DOI 10.1093/jac/dkt443.
   COATES ME, 1951, NATURE, V168, P332, DOI 10.1038/168332a0.
   Coelli T. J., 2005, INTRO EFFICIENCY PRO.
   Correge I., 2012, Journees de la Recherche Porcine en France, V44, P101.
   Correge I., 2011, P 15 INT C INT SOC A, V2, p{[}Vienna, 689].
   DANMAP, 2013, US ANT AG OCC ANT RE.
   Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982.
   Diamond A, 2013, REV ECON STAT, V95, P932, DOI 10.1162/REST\_a\_00318.
   Dohoo I., 2009, VET EPIDEMIOLOGIC RE, P271.
   Dritz SS, 2002, J AM VET MED ASSOC, V220, P1690, DOI 10.2460/javma.2002.220.1690.
   Dunlop RH, 1998, CAN VET J, V39, P87.
   Earle CC, 2001, J CLIN ONCOL, V19, P1064, DOI 10.1200/JCO.2001.19.4.1064.
   European Medicines Agency, 2014, SAL VET ANT AG 26EU.
   European Medicines Agency, 2013, EMA2365012013.
   Filippitzi ME, 2014, VLAAMS DIERGEN TIJDS, V83, P215.
   Fraser RW, 2010, ZOONOSES PUBLIC HLTH, V57, pE109, DOI 10.1111/j.1863-2378.2009.01295.x.
   Graham JP, 2007, PUBLIC HEALTH REP, V122, P79, DOI 10.1177/003335490712200111.
   Gunn GJ, 2008, PREV VET MED, V84, P310, DOI 10.1016/j.prevetmed.2007.12.003.
   Hadley GL, 2002, J DAIRY SCI, V85, P2053, DOI 10.3168/jds.S0022-0302(02)74283-5.
   Harris AD, 2006, J AM MED INFORM ASSN, V13, P16, DOI 10.1197/jamia.M1749.
   Hays V.W., 1977, EFECTIVENESS FEED AD.
   HILL DC, 1953, POULTRY SCI, V32, P462, DOI 10.3382/ps.0320462.
   Key N, 2014, AM J AGR ECON, V96, P831, DOI 10.1093/ajae/aat091.
   Laanen M, 2014, PREV VET MED, V115, P1, DOI 10.1016/j.prevetmed.2014.03.015.
   Laanen M, 2013, VET J, V198, P508, DOI 10.1016/j.tvjl.2013.08.029.
   Laanen M, 2010, VLAAMS DIERGEN TIJDS, V79, P302.
   LALONDE RJ, 1986, AM ECON REV, V76, P604.
   LILLIE RJ, 1953, POULTRY SCI, V32, P466, DOI 10.3382/ps.0320466.
   MARAN, 2014, CONS ANT AG ANT RES, P1.
   Mendola M, 2007, FOOD POLICY, V32, P372, DOI 10.1016/j.foodpol.2006.07.003.
   Miller G. Y., 2003, Journal of Agricultural and Applied Economics, V35, P469.
   Niemi J.K., 2011, PRICE VOLATILITY RET.
   Nuthall P, 2009, AUST J AGR RESOUR EC, V53, P413, DOI 10.1111/j.1467-8489.2009.00459.x.
   Postma M., 2015, ANIMAL, V16, P12.
   Postma M., 2013, FLEISCHWIRTSCHAFT IN, V2, P104.
   Postma M., 2016, ZOONOSES PU IN PRESS.
   Postma M, 2015, PREV VET MED, V118, P457, DOI 10.1016/j.prevetmed.2015.01.010.
   Postma M, 2015, J ANTIMICROB CHEMOTH, V70, P294, DOI 10.1093/jac/dku347.
   Racicot M, 2012, PREV VET MED, V103, P201, DOI 10.1016/j.prevetmed.2011.08.011.
   Ramirez CR, 2015, PREV VET MED, V121, P176, DOI 10.1016/j.prevetmed.2015.06.002.
   Rosen G. D., 1995, Biotechnology in animal feeds and animal feeding., P143, DOI 10.1002/9783527615353.ch8.
   ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.2307/2335942.
   Rushton J, 2015, ZOONOSES PUBLIC HLTH, V62, P10, DOI 10.1111/zph.12193.
   Rushton J, 2009, ECONOMICS OF ANIMAL HEALTH AND PRODUCTION, P1.
   Rushton J., 2014, ANTIMICROBIAL RESIST.
   Schwarz S, 2001, INT J ANTIMICROB AG, V17, P431, DOI 10.1016/S0924-8579(01)00297-7.
   Sekhon JS, 2011, J STAT SOFTW, V42, P1.
   Siekkinen KM, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-12.
   {*}SOU, 1997, ANTIMICROBIAL FEED A.
   Speksnijder DC, 2015, ZOONOSES PUBLIC HLTH, V62, P39, DOI 10.1111/zph.12168.
   Teillant A., 2015, ANN REV RESOURC EC.
   Thomke S, 1998, ANN ZOOTECH, V47, P85, DOI 10.1051/animres:19980201.
   Timmerman T, 2006, PREV VET MED, V74, P251, DOI 10.1016/j.prevetmed.2005.10.003.
   van der Voort M., 2015, THESIS.
   Van Meensel J, 2010, VET MED-CZECH, V55, P483.
   Visschers VHM, 2015, PREV VET MED, V119, P10, DOI 10.1016/j.prevetmed.2015.01.018.
   Vrints G., 2014, TECHNISCHE EC RESULT.
   WHO, 2003, IMP ANT GROWTH PROM.
   Wierup M, 2001, MICROB DRUG RESIST, V7, P183, DOI 10.1089/10766290152045066.
   Wu HT, 2010, ASIAN ECON J, V24, P141, DOI 10.1111/j.1467-8381.2010.02033.x.
   ZIMMERMAN DR, 1986, J ANIM SCI S3, V62, P6.}},
Number-of-Cited-References = {{82}},
Times-Cited = {{8}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{35}},
Journal-ISO = {{Prev. Vet. Med.}},
Doc-Delivery-Number = {{DQ1NK}},
Unique-ID = {{ISI:000378967500009}},
DA = {{2018-08-13}},
}

@article{ ISI:000378840300005,
Author = {Teixeira, Juliana V. and Cecilio, Pedro and Goncalves, Daniela and
   Vilar, Vitor J. P. and Pinto, Eugenia and Ferreira, Helena N.},
Title = {{Multidrug-resistant Enterobacteriaceae from indoor air of an urban
   wastewater treatment plant}},
Journal = {{ENVIRONMENTAL MONITORING AND ASSESSMENT}},
Year = {{2016}},
Volume = {{188}},
Number = {{7}},
Month = {{JUL}},
Abstract = {{Wastewater treatment plants (WWTPs) have been recognized as sources of
   bioaerosols that may act as vehicles for dissemination of pathogens and
   multidrug-resistant (MDR) bacteria. The occurrence of MDR
   Enterobacteriaceae in indoor air of an urban WWTP was investigated. A
   possible airborne contamination with extended-spectrum beta-lactamase
   (ESBL) and carbapenemase-producing Enterobacteriaceae was also explored.
   Fourteen of 39 Enterobacteriaceae isolates were MDR. These isolates were
   found at all sampling sites, mainly at the secondary sedimentation
   settings. The highest levels of resistance were detected in three
   different species: Enterobacter cloacae, Escherichia coli, and
   Citrobacter freundii. Furthermore, one of the airborne E. coli isolates
   was phenotypically characterized as an ESBL producer. Additionally, five
   isolates showed non-susceptibility to at least one carbapenem tested.
   The presence of genes encoding relevant beta-lactamase types in these
   ESBL-producing and carbapenem-resistant Enterobacteriaceae isolates was
   investigated by PCR. Results showed amplification for bla(CTX-M) and
   bla(OXA). These findings are relevant both in terms of
   occupational/public health and of environmental dissemination of MDR
   bacteria.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ferreira, HN (Reprint Author), Univ Porto, REQUIMTE, Microbiol Serv, Biol Sci Dept,Fac Pharm, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.
   Teixeira, Juliana V.; Pinto, Eugenia, Univ Porto, CEQUIMED, Microbiol Serv, Biol Sci Dept,Fac Pharm, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.
   Cecilio, Pedro; Goncalves, Daniela; Ferreira, Helena N., Univ Porto, REQUIMTE, Microbiol Serv, Biol Sci Dept,Fac Pharm, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.
   Vilar, Vitor J. P., Univ Porto, LSRE Lab Separat \& React Engn, Associate Lab LSRE LCM, Fac Engn, Rua Dr Roberto Frias, P-4200465 Oporto, Portugal.
   Pinto, Eugenia, Univ Porto, CIIMAR CIMAR Interdisciplinary Ctr Marine \& Envir, Rua Bragas 289, P-4050123 Oporto, Portugal.}},
DOI = {{10.1007/s10661-016-5382-4}},
Article-Number = {{388}},
ISSN = {{0167-6369}},
EISSN = {{1573-2959}},
Keywords = {{Airborne Enterobacteriaceae; Multidrug-resistant; ESBL; Carbapenemase;
   Wastewater treatment plant}},
Keywords-Plus = {{SWINE-FEEDING OPERATION; ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL
   RESISTANCE; BACTERIA; GENES; COLI; BIOAEROSOLS; SEWAGE}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{hferr@ff.up.pt}},
ResearcherID-Numbers = {{Scientific Productivity, CIIMAR/N-6498-2017
   Scientific output, CIIMAR/E-5122-2012
   }},
ORCID-Numbers = {{Scientific Productivity, CIIMAR/0000-0002-3703-4402
   Scientific output, CIIMAR/0000-0001-6270-2153
   Vilar, Vitor/0000-0003-0943-2144
   Ferreira, Helena/0000-0001-8465-6346
   Goncalves, Daniela/0000-0002-1652-7494
   Cecilio, Pedro/0000-0001-5945-5040
   Pinto, Eugenia/0000-0003-2948-5809}},
Funding-Acknowledgement = {{FCT (Fundacao para a Ciencia e a Tecnologia)
   {[}PTDC/EQU-EQU/100554/2008, CEQUIMED-PEst-OE/SAU/UI4040/2014]; FCT
   {[}SFRH/BD/78477/2011]}},
Funding-Text = {{Financial support for this work was mainly provided by FCT (Fundacao
   para a Ciencia e a Tecnologia) under the projects
   PTDC/EQU-EQU/100554/2008 and CEQUIMED-PEst-OE/SAU/UI4040/2014. J.V.
   Teixeira would like to acknowledge her fellowship (SFRH/BD/78477/2011)
   supported by FCT}},
Cited-References = {{Chagas TPG, 2011, J APPL MICROBIOL, V111, P572, DOI 10.1111/j.1365-2672.2011.05072.x.
   Chapin A, 2005, ENVIRON HEALTH PERSP, V113, P137, DOI 10.1289/ehp.7473.
   CLSI, 2011, 21 INFORM S, P31.
   Coque T. M., 2008, EURO SURVEILLANCE, V13.
   Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498.
   ECDC, 2011, RISK ASS SPREAD CARB.
   European Centre for Disease Prevention and Control (ECDC) and European Medicines Agency (EMEA), 2009, BACT CHALL TIM REACT.
   Figueira V, 2012, J WATER HEALTH, V10, P1, DOI 10.2166/wh.2011.002.
   Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910.
   Gregova G, 2012, ANN AGR ENV MED, V19, P75.
   Heinonen-Tanski H, 2009, WATER RES, V43, P2558, DOI 10.1016/j.watres.2009.03.006.
   Just NA, 2012, ANN OCCUP HYG, V56, P440, DOI 10.1093/annhyg/mer105.
   Korzeniewska E, 2009, WATER RES, V43, P2841, DOI 10.1016/j.watres.2009.03.050.
   Korzeniewska E, 2013, ECOTOX ENVIRON SAFE, V91, P96, DOI 10.1016/j.ecoenv.2013.01.014.
   Letourneau V, 2010, INT J HYG ENVIR HEAL, V213, P444, DOI 10.1016/j.ijheh.2010.09.008.
   Li L, 2011, PROCESS BIOCHEM, V46, P910, DOI 10.1016/j.procbio.2010.12.016.
   Li S, 2013, AEROBIOLOGIA, V29, P315, DOI 10.1007/s10453-012-9273-z.
   Luczkiewicz A, 2010, WATER RES, V44, P5089, DOI 10.1016/j.watres.2010.08.007.
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x.
   Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655.
   Paterson DL, 2006, AM J MED, V119, pS20, DOI 10.1016/j.amjmed.2006.03.013.
   Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0.
   Reinthaler FF, 2010, WATER RES, V44, P1981, DOI 10.1016/j.watres.2009.11.052.
   Sapkota AR, 2006, LETT APPL MICROBIOL, V43, P534, DOI 10.1111/j.1472-765X.2006.01996.x.
   Tao R, 2010, ENVIRON POLLUT, V158, P2101, DOI 10.1016/j.envpol.2010.03.004.
   Teixeira JV, 2013, ENVIRON MONIT ASSESS, V185, P59, DOI 10.1007/s10661-012-2533-0.}},
Number-of-Cited-References = {{26}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{7}},
Usage-Count-Since-2013 = {{42}},
Journal-ISO = {{Environ. Monit. Assess.}},
Doc-Delivery-Number = {{DP9TM}},
Unique-ID = {{ISI:000378840300005}},
DA = {{2018-08-13}},
}

@article{ ISI:000378432900012,
Author = {Libbrecht, Clara and Goutagny, Marie-Pierre and Bacchetta, Justine and
   Ploton, Christine and Bienvenu, Anne-Lise and Bleyzac, Nathalie and
   Mialou, Valerie and Bertrand, Yves and Domenech, Carine},
Title = {{Impact of a change in protected environment on the occurrence of severe
   bacterial and fungal infections in children undergoing hematopoietic
   stem cell transplantation}},
Journal = {{EUROPEAN JOURNAL OF HAEMATOLOGY}},
Year = {{2016}},
Volume = {{97}},
Number = {{1}},
Pages = {{70-77}},
Month = {{JUL}},
Abstract = {{Background: Allogeneic hematopoietic stem cell transplantation
   (alloHSCT) is a procedure with a high infection risk. Strict isolation
   of patients is the rule to prevent such condition. Objective: We
   compared the occurrence of severe infections (bacteremia and invasive
   fungal infection, IFI) in children undergoing alloHSCT before and after
   the move to a new protected unit with decreases in isolation methods.
   Methods: The study was conducted over a 10-year period. Unit 1
   (2002-2007) consisted of laminar airflow rooms where caregivers were
   required to wear a sterile outfit (gown, gloves, hat, and mask). Unit 2
   (2008-2012) included spacious positive air pressure rooms with HEPA
   filters where only a clean gown and mask were required to be worn.
   Results: Two hundred eighty-six alloHSCTs were performed (144 in Unit 1
   and 142 in Unit 2). We reported a total incidence of 4.78
   infections/1000 hospital-days including 4.4 episodes of bacteremia and
   0.38 episodes of IFI. There was no statistical difference in the
   incidence of infections: n = 4.98/1000 hospital-days in Unit 1 vs. n =
   4.6/1000 in Unit 2 (P = 0.63). Conclusion: The lack of difference in the
   occurrence of severe infection supports our decision to decrease
   unnecessary high protection in alloHSCT units to improve children's
   daily life.}},
Publisher = {{WILEY}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Libbrecht, C (Reprint Author), Inst Hematol \& Oncol Pediat, 1 Pl Joseph Renaut, F-69008 Lyon, France.
   Libbrecht, Clara; Goutagny, Marie-Pierre; Bleyzac, Nathalie; Bertrand, Yves; Domenech, Carine, Univ Lyon 1, Hosp Civils Lyon, Inst Pediat Hematol \& Oncol, F-69365 Lyon, France.
   Bacchetta, Justine, Univ Lyon 1, Hosp Civils Lyon, Women Mother \& Child Hosp, Pediat Nephrol Unit, F-69365 Lyon, France.
   Ploton, Christine, Hosp Civils Lyon, Women Mother \& Child Hosp, Bacteriol Unit, Lyon, France.
   Bienvenu, Anne-Lise, Hosp Civils Lyon, Med Mycol \& Parasitol Unit, IP2M, Lyon, France.
   Bienvenu, Anne-Lise, Univ Lyon 1, Malaria Res Unit, CNRS UMR 5246, ICBMS, F-69365 Lyon, France.
   Mialou, Valerie, Hosp Civils Lyon, Edouard Herriot Hosp, Tissue \& Cell Bank, Lyon, France.}},
DOI = {{10.1111/ejh.12685}},
ISSN = {{0902-4441}},
EISSN = {{1600-0609}},
Keywords = {{allogeneic HSCT; infections; pediatrics; protected environment}},
Keywords-Plus = {{BLOOD-STREAM INFECTIONS; SINGLE-CENTER EXPERIENCE; ACUTE
   MYELOID-LEUKEMIA; MARROW TRANSPLANTATION; PEDIATRIC-PATIENTS;
   RISK-FACTORS; ANTIBIOTIC-RESISTANCE; ANTIFUNGAL THERAPY; RECIPIENTS;
   EPIDEMIOLOGY}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Author-Email = {{libbrecht.clara@gmail.com}},
ORCID-Numbers = {{Bacchetta, Justine/0000-0002-0578-2529}},
Cited-References = {{Benjamin DK, 2002, PEDIATR INFECT DIS J, V21, P227, DOI 10.1097/00006454-200203000-00013.
   Bernaudin F, 2007, BLOOD, V110, P2749, DOI 10.1182/blood-2007-03-079665.
   Bock AM, 2013, BIOL BLOOD MARROW TR, V19, P102, DOI 10.1016/j.bbmt.2012.08.016.
   Brunet AS, 2006, PEDIATR BLOOD CANCER, V47, P765, DOI 10.1002/pbc.20706.
   Burroughs LM, 2012, BRIT J HAEMATOL, V158, P120, DOI 10.1111/j.1365-2141.2012.09130.x.
   Busca A, 2012, TRANSPL INFECT DIS, V14, P40, DOI 10.1111/j.1399-3062.2011.00650.x.
   Buzyn A, 1999, CLIN MICROBIOL INFEC, V5, P449.
   Cappellano P, 2007, NEW MICROBIOL, V30, P89.
   Castagnola E, 2008, BONE MARROW TRANSPL, V41, P339, DOI 10.1038/sj.bmt.1705921.
   Centers for Disease Control and Prevention, 2000, MMWR RECOMM REP, V49, pCE1.
   Centers for Disease Control and Prevention, 2000, MMWR-MORBID MORTAL W, V49, P1.
   Collin BA, 2001, CLIN INFECT DIS, V33, P947, DOI 10.1086/322604.
   De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660.
   Dvorak CC, 2005, BONE MARROW TRANSPL, V36, P621, DOI 10.1038/sj.bmt.1705113.
   Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015.
   Groll AH, 2014, LANCET ONCOL, V15, pE327, DOI 10.1016/S1470-2045(14)70017-8.
   Hicheri Y, 2013, TRANSPL INFECT DIS, V15, P251, DOI 10.1111/tid.12064.
   Kersun LS, 2005, PEDIATR BLOOD CANCER, V45, P162, DOI 10.1002/pbc.20277.
   Lee SJ, 2008, BIOL BLOOD MARROW TR, V14, P1231, DOI 10.1016/j.bbmt.2008.08.008.
   Leung W, 2011, BLOOD, V118, P223, DOI 10.1182/blood-2011-01-333070.
   Lucarelli G, 2008, BLOOD REV, V22, P53, DOI 10.1016/j.blre.2007.10.001.
   Maertens JA, 2010, PEDIATR INFECT DIS J, V29, P415, DOI 10.1097/INF.0b013e3181da2171.
   Mikulska M, 2012, INFECTION, V40, P271, DOI 10.1007/s15010-011-0229-y.
   Mikulska M, 2009, BIOL BLOOD MARROW TR, V15, P47, DOI 10.1016/j.bbmt.2008.10.024.
   Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846.
   Ninin E, 2001, CLIN INFECT DIS, V33, P41, DOI 10.1086/320871.
   Ortega M, 2005, ANN HEMATOL, V84, P40, DOI 10.1007/s00277-004-0909-0.
   Pession A, 2013, BLOOD, V122, P170, DOI 10.1182/blood-2013-03-491621.
   Poutsiaka DD, 2007, BONE MARROW TRANSPL, V40, P63, DOI 10.1038/sj.bmt.1705690.
   Poutsiaka DD, 2011, BONE MARROW TRANSPL, V46, P300, DOI 10.1038/bmt.2010.112.
   PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825.
   Srinivasan A, 2013, BIOL BLOOD MARROW TR, V19, P94, DOI 10.1016/j.bbmt.2012.08.012.
   Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580.
   Zhang P, 2009, BONE MARROW TRANSPL, V43, P533, DOI 10.1038/bmt.2008.356.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{5}},
Journal-ISO = {{Eur. J. Haematol.}},
Doc-Delivery-Number = {{DP3YT}},
Unique-ID = {{ISI:000378432900012}},
DA = {{2018-08-13}},
}

@article{ ISI:000377597600001,
Author = {Schulz, Jochen and Ruddat, Inga and Hartung, Joerg and Hamscher, Gerd
   and Kemper, Nicole and Ewers, Christa},
Title = {{Antimicrobial-Resistant Escherichia coil Survived in Dust Samples for
   More than 20 Years}},
Journal = {{FRONTIERS IN MICROBIOLOGY}},
Year = {{2016}},
Volume = {{7}},
Month = {{JUN 10}},
Abstract = {{In a retrospective study, 119 sedimentation dust samples stored between
   five and 35 years from various barns of intensive livestock farming were
   evaluated for the occurrence of cultivatable Escherichia coli. Growth of
   E. coll. occurred in 54 samples. Successful cultivation was achieved in
   samples from as early as 1994. The frequency of detection increased from
   earlier to later time periods, but the concentrations, which ranged
   between 3.4 x 10(2) and 1.1 x 10(5) colony-forming units per gram, did
   not correlate with sample age (Spearman rank correlation; p > 0.05). We
   hypothesize that E. coil cells survived in dust samples without cell
   division because of the storage conditions. Dry material (dust) with low
   water activities (arithmetic mean 0.6) and storage at 40 degrees C in
   the dark likely facilitated long-term survival. E. coil were isolated on
   MacConkey agar with and without ciprofloxacin supplementation. For 110
   isolates (79 from non-supplemented media and 31 from supplemented
   media), we determined the E. coil phylotype and antimicrobial
   resistance. Six phylogenetic groups were identified. Phylogroups A and
   B1 predominated. Compared to group A. phylogroup B1 was significantly
   associated with growth on ciprofloxacin-supplemented media (chi-square
   test, p = 0.003). Furthermore, the antibiotic resistance profiles
   determined by a microdilution method revealed that isolates were
   phenotypically resistant to at least one antimicrobial substance and
   that more than 50\% were resistant to a minimum of five out of 10
   antibiotics tested. A linear mixed model was used to identify factors
   associated with the number of phenotypic resistances of individual
   isolates. Younger isolates and isolates from fattening poultry barns
   tended to be resistant to significantly more antibiotics than older
   isolates and those from laying-hen houses (p = 0.01 and p = 0.02,
   respectively). Sample origin and storage conditions may have influenced
   the number of antimicrobial resistances. Overall, we found that under
   particular conditions, dust from farm animal houses can be reservoirs
   for antimicrobial-resistant E. coil for at least 20 years. The survival
   strategies that allow E. coil to survive such long periods in
   environmental samples are not fully understood and could be an
   interesting research topic for future studies.}},
Publisher = {{FRONTIERS MEDIA SA}},
Address = {{AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Schulz, J (Reprint Author), Univ Vet Med Hannover, Inst Anim Hyg Anim Welf \& Farm Anim Behav, Hannover, Germany.
   Schulz, Jochen; Hartung, Joerg; Kemper, Nicole, Univ Vet Med Hannover, Inst Anim Hyg Anim Welf \& Farm Anim Behav, Hannover, Germany.
   Ruddat, Inga, Univ Vet Med Hannover, Dept Biometry Epidemiol \& Informat Proc, Hannover, Germany.
   Hamscher, Gerd, Univ Giessen, Inst Food Chem \& Food Biotechnol, D-35390 Giessen, Germany.
   Ewers, Christa, Univ Giessen, Inst Hyg \& Infect Dis Anim, D-35390 Giessen, Germany.}},
DOI = {{10.3389/fmicb.2016.00866}},
Article-Number = {{866}},
ISSN = {{1664-302X}},
Keywords = {{survival; Escherichia coil; dust; livestock; antibiotic; resistance;
   fluoroquinolones; ciprofloxacin}},
Keywords-Plus = {{LIVESTOCK BUILDINGS; WATER ACTIVITY; COLI STRAINS; POULTRY;
   MICROORGANISMS; BACTERIA; STORAGE; SWINE; AIR; TETRACYCLINE}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{jochen.schulz@tiho-hannover.de}},
ResearcherID-Numbers = {{Hamscher, Gerd/B-2100-2012}},
Cited-References = {{BREESE MD, 1980, J APPL BACTERIOL, V48, P63, DOI 10.1111/j.1365-2672.1980.tb05207.x.
   CARPENTER GA, 1986, J AGR ENG RES, V33, P227, DOI 10.1016/S0021-8634(86)80038-5.
   Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019.
   CLSI, 2014, M100S24 CLSI.
   Cortes P, 2010, APPL ENVIRON MICROB, V76, P2799, DOI 10.1128/AEM.02421-09.
   ENDTZ HP, 1991, J ANTIMICROB CHEMOTH, V27, P199, DOI 10.1093/jac/27.2.199.
   Engberg J, 2001, EMERG INFECT DIS, V7, P24, DOI 10.3201/eid0701.010104.
   FLINT KP, 1987, J APPL BACTERIOL, V63, P261, DOI 10.1111/j.1365-2672.1987.tb04945.x.
   Freye J. G., 2013, FRONT MICROBIOL, V4, P135, DOI {[}10.3389/fmicb.2013.00135, DOI 10.3389/FMICB.2013.00135].
   Friese A, 2012, VET MICROBIOL, V158, P129, DOI 10.1016/j.vetmic.2012.01.019.
   Guerra B, 2003, J ANTIMICROB CHEMOTH, V52, P489, DOI 10.1093/jac/dkg362.
   GUNDERMANN KO, 1972, ZBL BAKT MIK HYG B, V156, P422.
   Harry E. G., 1964, VET REC, V76, P466.
   Hartung J., 2007, LANDBAUFORSCH VOLK, V308, P111.
   Kaesbohrer A, 2012, ZOONOSES PUBLIC HLTH, V59, P158, DOI 10.1111/j.1863-2378.2011.01451.x.
   Karcher S. J, 1995, MOL BIOL PROJECT APP, P231.
   Khanna R, 2008, NEPHROL DIAL TRANSPL, V23, P1819, DOI 10.1093/ndt/gfn125.
   Kim JG, 1999, J FOOD PROTECT, V62, P1071, DOI 10.4315/0362-028X-62.9.1071.
   Koenig GL, 2003, APPL ENVIRON MICROB, V69, P6605, DOI 10.1128/AEM.69.11.6605-6609.2003.
   Laube H, 2014, VET MICROBIOL, V172, P519, DOI 10.1016/j.vetmic.2014.06.008.
   Letourneau V, 2010, INT J HYG ENVIR HEAL, V213, P444, DOI 10.1016/j.ijheh.2010.09.008.
   Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000.
   Li CS, 1999, AEROSOL SCI TECH, V30, P100, DOI 10.1080/027868299304705.
   Liss MA, 2013, J CLIN MICROBIOL, V51, P249, DOI 10.1128/JCM.02158-12.
   LOUIS P, 1994, APPL MICROBIOL BIOT, V41, P684.
   Marston CK, 2005, APPL ENVIRON MICROB, V71, P7778, DOI 10.1128/AEM.71.12.7778-7780.2005.
   Normand AC, 2011, OCCUP ENVIRON MED, V68, P849, DOI 10.1136/oem.2010.061879.
   Pahl O, 1997, J AEROSOL SCI, V28, P427, DOI 10.1016/S0021-8502(96)00445-4.
   Ponizovskaya VB, 2011, MICROBIOLOGY+, V80, P378, DOI 10.1134/S0026261711030179.
   POTTS M, 1994, MICROBIOL REV, V58, P755.
   Presser KA, 1998, APPL ENVIRON MICROB, V64, P1773.
   Redgrave LS, 2014, TRENDS MICROBIOL, V22, P438, DOI 10.1016/j.tim.2014.04.007.
   Rylander R, 2006, INT ARCH OCC ENV HEA, V79, P487, DOI 10.1007/s00420-005-0072-5.
   Sampson Reynee W., 2006, Journal of Water and Health, V4, P389, DOI 10.2166/wh.2006.024.
   Scherz G, 2014, BERL MUNCH TIERARZTL, V127, P478, DOI 10.2376/0005-9366-127-478.
   Schulz J, 2013, BERL MUNCH TIERARZTL, V126, P143, DOI 10.2376/0005-9366-126-143.
   Seedorf J, 1998, J AGR ENG RES, V70, P97, DOI 10.1006/jaer.1997.0281.
   Seedorf J., 2001, LANDBAUFORSCH VOLK, V226, P15.
   SPEER BS, 1992, CLIN MICROBIOL REV, V5, P387.
   STEWART SL, 1995, APPL ENVIRON MICROB, V61, P1232.
   Szmolka A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00258.
   Tadesse DA, 2012, EMERG INFECT DIS, V18, P741, DOI 10.3201/eid1805.111153.
   THORNE PS, 1992, APPL ENVIRON MICROB, V58, P2543.
   van den Bogaard AE, 2001, J ANTIMICROB CHEMOTH, V47, P763, DOI 10.1093/jac/47.6.763.
   van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80.
   Van Hoorebeke S, 2011, EPIDEMIOL INFECT, V139, P1610, DOI 10.1017/S0950268810002700.
   Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x.
   Zhao JY, 2000, J BACTERIOL, V182, P5025, DOI 10.1128/JB.182.17.5025-5028.2000.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{17}},
Journal-ISO = {{Front. Microbiol.}},
Doc-Delivery-Number = {{DO2GI}},
Unique-ID = {{ISI:000377597600001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000378620100001,
Author = {Chernomoretz, Ariel and Stolovitzky, Gustavo and Labaj, Pawel P. and
   Graf, Alexandra B. and Darling, Aaron and Burke, Catherine and
   Noushmehr, Houtan and Moraes, Milton Ozorio and Dias-Neto, Emmanuel and
   Guo, Yongli and Xie, Zhi and Lee, Patrick and Shi, Leming and
   Ruiz-Perez, Carlos A. and Mercedes Zambrano, Maria and Siam, Rania and
   Ouf, Amged and Richard, Hugues and Lafontaine, Ingrid and Wieler, Lothar
   H. and Semmler, Torsten and Ahmed, Niyaz and Prithi-viraj, Bharath and
   Nedunuri, Narasimha and Mehr, Shaadi and Banihashemi, Kambiz and Lista,
   Florigio and Anselmo, Anna and Suzuki, Haruo and Kuroda, Makoto and
   Yamashita, Riu and Sato, Yukoto and Kaminuma, Eli and Alpuche Aranda,
   Celia M. and Martinez, Jesus and Dada, Christopher and Dybwad, Marius
   and Oliveira, Manuela and Schuster, Stephan and Siwo, Geoffrey H. and
   Jang, Soojin and Seo, Sung Chul and Hwang, Sung Ho and Ossowski, Stephan
   and Bezdan, Daniela and Chaker, Salama and Chatziefthimiou, Aspassia D.
   and Udekwu, Klas and Liungdahl, Per and Sezerman, Ugur and Meydan, Cem
   and Elhaik, Eran and Gonnet, Gaston and Schriml, Lynn M. and Mongodin,
   Emmanuel and Huttenhower, Curtis and Gilbert, Jack and Mason,
   Christopher E. and Eisen, Jonathan and Hirschberg, David and Hernandez,
   Mark and MetaSUB Int Consortium},
Title = {{The Metagenomics and Metadesign of the Subways and Urban Biomes
   (MetaSUB) International Consortium inaugural meeting report}},
Journal = {{MICROBIOME}},
Year = {{2016}},
Volume = {{4}},
Month = {{JUN 3}},
Abstract = {{The Metagenomics and Metadesign of the Subways and Urban Biomes
   (MetaSUB) International Consortium is a novel, interdisciplinary
   initiative comprised of experts across many fields, including genomics,
   data analysis, engineering, public health, and architecture. The
   ultimate goal of the MetaSUB Consortium is to improve city utilization
   and planning through the detection, measurement, and design of
   metagenomics within urban environments. Although continual measures
   occur for temperature, air pressure, weather, and human activity,
   including longitudinal, cross-kingdom ecosystem dynamics can alter and
   improve the design of cities. The MetaSUB Consortium is aiding these
   efforts by developing and testing metagenomic methods and standards,
   including optimized methods for sample collection, DNA/RNA isolation,
   taxa characterization, and data visualization. The data produced by the
   consortium can aid city planners, public health officials, and
   architectural designers. In addition, the study will continue to lead to
   the discovery of new species, global maps of antimicrobial resistance
   (AMR) markers, and novel biosynthetic gene clusters (BGCs). Finally, we
   note that engineered metagenomic ecosystems can help enable more
   responsive, safer, and quantified cities.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mason, CE (Reprint Author), Weill Cornell Med, Physiol \& Biophys, New York, NY USA.
   Stolovitzky, Gustavo, Icahn Sch Med Mt Sinai, Genet \& Genom Sci, New York, NY USA.
   Chernomoretz, Ariel, Univ Buenos Aires, Dept Fis, Buenos Aires, DF, Argentina.
   Darling, Aaron; Burke, Catherine, Univ Technol Sydney, Computat Metagen, Sydney, NSW, Australia.
   Labaj, Pawel P., Boku Univ Vienna, Bioinformat, Vienna, Austria.
   Graf, Alexandra B., Univ Appl Sci, Bioinformat, Vienna, Austria.
   Moraes, Milton Ozorio, Univ Sao Paulo, Dept Genet, Lab Epigen \& Bioinformat, BR-14049 Ribeirao Preto, Brazil.
   Dias-Neto, Emmanuel, AC Camargo Canc Ctr, Med Genom, Sao Paulo, Brazil.
   Guo, Yongli, Capital Med Univ, Beijing Childrens Hospital, Beijing, Peoples R China.
   Guo, Yongli; Xie, Zhi, Capitalbio Corp, Translat Bioinformat Res Inst, Beijing, Peoples R China.
   Xie, Zhi, Sun Yat Sen Univ, Guangdong Prov Key Lab Ophthalmol \& Visual Sci, State Key Lab Ophthalmol,Sch Public Hlth, Zhognshan Ophthalm Ctr,Ctr Precis Med, Guangzhou, Guangdong, Peoples R China.
   Lee, Patrick, City Univ Hong Kong, Sch Energy \& Environm, Hong Kong, Hong Kong, Peoples R China.
   Shi, Leming, Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China.
   Ruiz-Perez, Carlos A.; Mercedes Zambrano, Maria, Corp Corpogen, Bogota, Colombia.
   Siam, Rania, Amer Univ Cairo, Dept Biol, Cairo, Egypt.
   Richard, Hugues; Lafontaine, Ingrid, Univ Paris 06, Sorbonne Univ, Inst Biol Paris Seine, CNRS,Lab Computat \& Quantitat Biol, Paris, France.
   Wieler, Lothar H.; Semmler, Torsten, Robert Koch Inst, Publ Hlth, Berlin, Germany.
   Ahmed, Niyaz, Univ Hyderabad, Dept Biotechnol \& Bioinformat, Hyderabad 500134, Andhra Pradesh, India.
   Prithi-viraj, Bharath, Noble Foundation, Dept Biotechnol \& Bioinformat, Hyderabad, Andhra Pradesh, India.
   Nedunuri, Narasimha, ClonzBio Tech, Dept Biotechnol \& Bioinformat, Hyderabad, Andhra Pradesh, India.
   Mehr, Shaadi, Amer Museum Nat Hist, Ecol, Tehran, Iran.
   Banihashemi, Kambiz, Minist Sci, Med Sci, Tehran, Iran.
   Lista, Florigio; Anselmo, Anna, Army Med \& Vet Res Ctr, Mol Biol Sect, Rome, Italy.
   Suzuki, Haruo, Keio Univ, Inst Adv Biosci, Sendai, Miyagi, Japan.
   Suzuki, Haruo, Keio Univ, Inst Adv Biosci, Tokyo, Japan.
   Alpuche Aranda, Celia M.; Martinez, Jesus, IANPHI Mexico Secretariat, Natl Inst Publ Hlth, Mexico City, DF, Mexico.
   Dada, Christopher, Univ Waikato, Environm Res Inst, Auckland, New Zealand.
   Dybwad, Marius, Norwegian Def Res Estab FFI, Protect \& Societal Secur Div, Oslo, Norway.
   Oliveira, Manuela, Univ Porto, Dept Biol, Populat Genet \& Evolut Grp i3S, Lisbon, Portugal.
   Oliveira, Manuela, Univ Porto, Dept Biol, Populat Genet \& Evolut Grp i3S, Rua Campo Alegre 823, P-4100 Porto, Portugal.
   Chaker, Salama; Chatziefthimiou, Aspassia D., Weill Cornell Med Coll Qatar, Ecology, Doha, Qatar.
   Chaker, Salama; Chatziefthimiou, Aspassia D., Weill Cornell Med Coll Qatar, Med, Doha, Qatar.
   Schuster, Stephan, Penn State Univ, Biochem \& Mol Biol, Singapore, Singapore.
   Siwo, Geoffrey H., IBM Corp, Watson Res, Johannesburg, South Africa.
   Jang, Soojin, Inst Pasteur Korea, Microbiol, Seoul, South Korea.
   Seo, Sung Chul, Korea Univ, Coll Med, Inst Allergy \& Immunol, Seoul 136705, South Korea.
   Hwang, Sung Ho, Natl Canc Ctr, Canc Risk Appraisal \& Prevent Branch, Seoul, South Korea.
   Ossowski, Stephan; Bezdan, Daniela, Ctr Genom Regulat CRG, Barcelona Inst Sci \& Technol, Genom \& Epigen Variat, Dr Aiguader 88, Barcelona 08003, Spain.
   Bezdan, Daniela, Univ Pompeu Fabra, Genom \& Epigen Variat, Barcelona, Spain.
   Udekwu, Klas; Liungdahl, Per, Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden.
   Sezerman, Ugur, Acibadem Univ, Dept Biostat \& Med Informat, Izmir, Turkey.
   Elhaik, Eran, Univ Sheffield, Dept Anim \& Plant Sci, Sheffield S10 2TN, S Yorkshire, England.
   Gonnet, Gaston, Swiss Fed Inst Technol, Genet, Montevideo, Uruguay.
   Mongodin, Emmanuel, Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.
   Huttenhower, Curtis, Harvard TH Chan Sch Publ Hlth, Biostat, Boston, MA USA.
   Gilbert, Jack, Argonne Natl Lab, Microbial Ecol, Chicago, IL USA.
   Hernandez, Mark, Univ Colorado, Mech Engn, Denver, CO 80202 USA.
   Mason, Christopher E., Weill Cornell Med, Physiol \& Biophys, New York, NY USA.
   Eisen, Jonathan, Univ Calif Davis, Dept Interdisciplinary Arts \& Sci, Sacramento, CA USA.
   Hirschberg, David, Univ Washington, Dept Genet \& Genom, Seattle, WA 98195 USA.
   Schriml, Lynn M., Univ Maryland, Sch Med, Inst Genome Sci, Washington, DC USA.
   Stolovitzky, Gustavo, Icahn Sch Med Mt Sinai, Genet \& Genom Sci, New York, NY USA.}},
DOI = {{10.1186/s40168-016-0168-z}},
Article-Number = {{UNSP 24}},
ISSN = {{2049-2618}},
Keywords = {{Microbiome; Biosynthetic gene clusters; Built environment;
   Next-generation sequencing; Antimicrobial resistance markers}},
Keywords-Plus = {{MICROBIOME; GENOME; BIOSYNTHESIS; SYSTEM}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{gustavo@us.ibm.com
   pawel.labaj@boku.ac.at
   alexandra.graf@fh-campuswien.ac.at
   aaron.darling@uts.edu.au
   Catherine.Burke@uts.edu.au
   houtan@usp.br
   milton.moraes@fiocruz.br
   emmanuel@cipe.accamargo.org.br
   ylgyongliguo@163.com
   xiezhi@gmail.com
   patrick.kh.lee@cityu.edu.hk
   lemingshi@fudan.edu.cn
   cruiz\_perez@hotmail.com
   mzambrano@corpogen.org
   rsiam@aucegypt.edu
   hugues.richard@upmc.fr
   ingrid.lafontaine@upmc.fr
   wielerlh@rki.de
   SemmlerT@rki.de
   ahmed.nizi@gmail.com
   bharath.prithiviraj@gmail.com
   narasimha.nedunuri@clonzbio.com
   smehr@amnh.org
   kbanihashemi@yahoo.com
   romano.lista@gmail.com
   annanselm@gmail.com
   haruo@sfc.keio.ac.jp
   celia.alpuche@insp.mx
   jmbarnet@insp.mx
   marius.dybwad@ffi.no
   manuelao@ipatimup.pt
   scschuster@ntu.edu.sg
   ghsiwo@us.ibm.com
   soojin.jang@ip-korea.org
   sungchul\_seo@korea.ac.kr
   9954074@daum.net
   Stephan.Ossowski@crg.eu
   bezdan.daniela@googlemail.com
   salamab.chaker@gmail.com
   asc2006@qatar-med.cornell.edu
   klas.udekwu@su.se
   per.ljungdahl@su.se
   sezermanu@gmail.com
   e.elhaik@sheffield.ac.uk
   gonnet@ethz.ch
   lschriml@som.umaryland.edu
   emongodin@som.umaryland.edu
   chuttenh@hsph.harvard.edu
   gilbertjack@uchicago.edu
   chm2042@med.cornell.edu
   jonathan.eisen@gmail.com
   dhberg@uw.edu
   mark.hernandez@colorado.edu}},
ResearcherID-Numbers = {{Dias-Neto, Emmanuel/A-5869-2008
   Darling, Aaron/G-8119-2017
   }},
ORCID-Numbers = {{Dias-Neto, Emmanuel/0000-0001-5670-8559
   Pasolli, Edoardo/0000-0003-0799-3490
   Burke, Catherine/0000-0002-8917-0019
   Vayndorf, Elena/0000-0001-9416-3350
   Osuolale, Olayinka/0000-0001-6525-8502
   Rascovan, Nicolas/0000-0002-2129-5878
   Ossowski, Stephan/0000-0002-7416-9568
   Darling, Aaron/0000-0003-2397-7925
   Bowler, Chris/0000-0003-3835-6187
   Levy, Shawn/0000-0002-1369-5740
   Lafontaine, Ingrid/0000-0003-4544-8055}},
Funding-Acknowledgement = {{Alfred P. Sloan Foundation {[}2015-13964]; National Institutes of Health
   {[}F31GM111053, R01NS076465, R25EB020393]; Promega; CosmosID; Illumina;
   Copan; QIAGEN}},
Funding-Text = {{We would like to thank the Alfred P. Sloan Foundation (2015-13964) and
   in particular, Paula Olsiewski, for her insightful guidance during the
   founding of the Consortium, and for the Alfred P. Sloan Foundation's
   generous support in funding the MetaSUB planning meetings and
   conferences. Moreover, the Bill and Melinda Gates Foundation's Grand
   Challenges Exploration grant helped generate the sequence data for the
   first global city sampling day (CSD). We also wanted to thank Jeff Zhu
   and the Clinical and Translational Science Center (CTSC). We would also
   like to thank the Irma T. Hirschl and Monique Weill-Caulier Charitable
   Trusts, the WorldQuant Foundation, the Bert L and N Kuggie Vallee
   Foundation, the STARR Consortium (I7-A765, I9-A9-071), and support from
   the National Institutes of Health (F31GM111053, R01NS076465, and
   R25EB020393). We also would like to thank Promega, CosmosID, Illumina,
   Copan, and QIAGEN that sponsored the inaugural MetaSUB 2015 meeting,
   including travel grants for many of the participants. We would like to
   thank Diana Stern for her dedication and immeasurable help planning and
   organizing the inaugural conference as well as the New York Genome
   Center (Nathan Pearson and Jennifer Busuttil-Doran) for hosting the
   conference. We also want to thank the eXtreme Mcirobiome Project (XMP),
   the Association of Biomolecular Resource Facilities (ABRF) Metagenomics
   Research Group (MGRG), and George Yeh.}},
Cited-References = {{Afshinnekoo E, 2015, CELL SYST, V1, P72, DOI 10.1016/j.cels.2015.01.001.
   Alivisatos AP, 2015, SCIENCE, V350, P507, DOI 10.1126/science.aac8480.
   Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365.
   Cameron P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-134.
   Cao C, 2014, ENVIRON SCI TECHNOL, V48, P1499, DOI 10.1021/es4048472.
   Conceicao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077812.
   Dimise EJ, 2008, P NATL ACAD SCI USA, V105, P15311, DOI 10.1073/pnas.0805451105.
   Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032.
   Dubilier N, 2015, NATURE, V526, P631, DOI 10.1038/526631a.
   Dudley JT, 2010, NAT BIOTECHNOL, V28, P1181, DOI 10.1038/nbt1110-1181.
   Ehrenberg R, 2015, NATURE, V522, P399, DOI 10.1038/522399a.
   Felczykowska A, 2015, ACTA BIOCHIM POL, V62, P151, DOI 10.18388/abp.2014\_916.
   Filippidou S, 2015, COMPUT STRUCT BIOTEC, V13, P299, DOI 10.1016/j.csbj.2015.04.002.
   Firth C, 2014, MBIO, V5, DOI 10.1128/mBio.01933-14.
   Fisch KM, 2015, BIOINFORMATICS, V31, P1724, DOI 10.1093/bioinformatics/btv061.
   Garbarino Jeanne, 2016, J Microbiol Biol Educ, V17, P7, DOI 10.1128/jmbe.v17i1.1052.
   Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1.
   Hsu T, URBAN TRANS IN PRESS.
   Hu Y, 2007, CHEM BIOL, V14, P691, DOI 10.1016/j.chembiol.2007.05.009.
   Ji P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141087.
   Jones MB, 2015, P NATL ACAD SCI USA, V112, P14024, DOI 10.1073/pnas.1519288112.
   Kopf A, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0066-5.
   La Rosa PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052078.
   Lappalainen I, 2015, NAT GENET, V47, P692, DOI 10.1038/ng.3312.
   Leung MHY, 2014, APPL ENVIRON MICROB, V80, P6760, DOI 10.1128/AEM.02244-14.
   Li S, 2014, NAT BIOTECHNOL, V32, P888, DOI 10.1038/nbt.3000.
   Li S, 2014, NAT BIOTECHNOL, V32, P915, DOI 10.1038/nbt.2972.
   Li S, 2014, ANNU REV GENOM HUM G, V15, P127, DOI 10.1146/annurev-genom-090413-025405.
   Mason CE, 2014, NAT BIOTECHNOL, V32, P903.
   Mason CE, 2014, ADV EXP MED BIOL, V799, P15, DOI 10.1007/978-1-4614-8778-4\_2.
   Patel R., 2015, SCI ARE STUDYING SUB.
   Pendleton M, 2015, NAT METHODS, P29.
   Piwowar HA, 2011, NATURE, V473, P285, DOI 10.1038/473285a.
   Reese AT, 2016, ISME J, V10, P751, DOI 10.1038/ismej.2015.152.
   Robertson CE, 2013, APPL ENVIRON MICROB, V79, P3485, DOI 10.1128/AEM.00331-13.
   Rosenfeld J, 2013, GENOME MED, V5, DOI 10.1186/gm431.
   Rosenfeld JA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10164.
   Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394.
   Schatz MC, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-4.
   Slavin K, HOLOBIONT URBANISM B.
   The United Nations (UN), STUD 2014 WORLD URB.
   Traxler MF, 2015, NAT PROD REP, V32, P956, DOI 10.1039/c5np00013k.
   Vieira-Silva S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000808.
   Yooseph S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081862.
   Zook J, 2016, BIORXIV, DOI {[}10.1101/026468, DOI 10.1101/026468].}},
Number-of-Cited-References = {{45}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{31}},
Journal-ISO = {{Microbiome}},
Doc-Delivery-Number = {{DP6PR}},
Unique-ID = {{ISI:000378620100001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000377173500001,
Author = {Ahmed, Marwa Fawzy El Metwaly and El-Adawy, Hosny and Hotzel, Helmut and
   Tomaso, Herbert and Neubauer, Heinrich and Kemper, Nicole and Hartung,
   Joerg and Hafez, Hafez Mohamed},
Title = {{Prevalence, genotyping and risk factors of thermophilic Campylobacter
   spreading in organic turkey farms in Germany}},
Journal = {{GUT PATHOGENS}},
Year = {{2016}},
Volume = {{8}},
Month = {{JUN 2}},
Abstract = {{Background: The need for organic food of animal origin has increased
   rapidly in recent years. However, effects of organic animal husbandry on
   food safety have not been rigorously tested especially in meat turkey
   flocks. This study provides for the first time an overview on the
   prevalence and genetic diversity of Campylobacter species (spp.) in five
   organic meat turkey farms located in different regions in Germany, as
   well as on potential risk factors of bacterial spreading. Thirty cloacal
   swabs as well as water samples and darkling beetles were collected from
   each flock and examined for the presence of Campylobacter by
   conventional and molecular biological methods. The isolates were
   genotyped by flaA-RFLP.
   Results: Campylobacter spp. were detected in cloacal swabs in all 5
   turkey flocks with prevalence ranged from 90.0 to 100 \%. 13 cloacal
   swabs collected from birds in farm III and IV were harboured mixed
   population of thermophilic campylobacters. In total, from 158
   Campylobacter isolated from turkeys 89 (56.33 \%) were identified as C.
   coli and 69 (43.76 \%) as C. jejuni. Three Campylobacter (2 C. jejuni
   and 1 C. coli) were detected in drinkers of two farms and 3 C. coli were
   isolated from darkling beetles of one farm. No Campylobacter were
   isolated from main water tanks. flaA-RFLP assay showed that turkey farms
   can harbour more than one genotype. In a single turkey two different
   genotypes could be detected. The genotypes of campylobacters isolated
   from water samples or beetles were identical with those isolated from
   turkeys. No effect was found of some environmental parameters {[}ammonia
   concentration (NH3), carbon dioxide concentration (CO2), relative
   humidity (RH) and air temperature)] on Campylobacter prevalence in
   organic turkey farms. Additionally, drinking water and darkling beetles
   might be considered as risk factors for the spreading of Campylobacter
   in turkey flocks.
   Conclusions: This study highlights the high prevalence and genotypic
   diversity of Campylobacter spp. isolated from organic turkey flocks.
   Further research is needed to assess other potential risk factors
   responsible for bacteria spreading in order to mitigate the spread of
   Campylobacter in organic turkey flocks by improving biosecurity control
   measures.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ahmed, MFE (Reprint Author), Univ Vet Med Hannover, Inst Anim Hyg Anim Welf \& Farm Anim Behav, Fdn, Hannover, Germany.
   Ahmed, MFE (Reprint Author), Mansoura Univ, Fac Vet Med, Dept Hyg \& Zoonoses, Mansoura, Egypt.
   Ahmed, Marwa Fawzy El Metwaly; Kemper, Nicole; Hartung, Joerg, Univ Vet Med Hannover, Inst Anim Hyg Anim Welf \& Farm Anim Behav, Fdn, Hannover, Germany.
   El-Adawy, Hosny; Hotzel, Helmut; Tomaso, Herbert; Neubauer, Heinrich, Friedrich Loeffler Inst, Inst Bacterial Infect \& Zoonoses, Jena, Germany.
   Hafez, Hafez Mohamed, Free Univ Berlin, Inst Poultry Dis, Berlin, Germany.
   Ahmed, Marwa Fawzy El Metwaly, Mansoura Univ, Fac Vet Med, Dept Hyg \& Zoonoses, Mansoura, Egypt.
   El-Adawy, Hosny, Kafrelsheikh Univ, Fac Vet Med, Dept Poultry Dis, Kafr Al Sheikh, Egypt.}},
DOI = {{10.1186/s13099-016-0108-2}},
Article-Number = {{28}},
ISSN = {{1757-4749}},
Keywords = {{Thermophilic Campylobacter; Organic turkey; Genotyping; Water; Beetles}},
Keywords-Plus = {{BEETLES ALPHITOBIUS-DIAPERINUS; BROILER-CHICKENS; GENETIC DIVERSITY;
   DARKLING BEETLES; FREE-RANGE; ANTIMICROBIAL RESISTANCE; FOOD SAFETY;
   JEJUNI; SPP.; FLOCKS}},
Research-Areas = {{Gastroenterology \& Hepatology; Microbiology}},
Web-of-Science-Categories  = {{Gastroenterology \& Hepatology; Microbiology}},
Author-Email = {{mrw\_fwzy@yahoo.com}},
ORCID-Numbers = {{El-Adawy, Hosny/0000-0002-8585-4237}},
Funding-Acknowledgement = {{Institute for Animal Hygiene, Animal Welfare and Farm Animal Behaviour,
   University of Veterinary Medicine Hannover, Foundation, Germany;
   Friedrich-Loeffler-Institut, Institute of Bacterial Infections and
   Zoonoses, Germany}},
Funding-Text = {{The project was funded from Institute for Animal Hygiene, Animal Welfare
   and Farm Animal Behaviour, University of Veterinary Medicine Hannover,
   Foundation, Germany and Friedrich-Loeffler-Institut, Institute of
   Bacterial Infections and Zoonoses, Germany.}},
Cited-References = {{Agunos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104905.
   Ahmed MFE, 2013, ANN AGR ENV MED, V20, P16.
   Anderson J, 2012, ZOONOSES PUBLIC HLTH, V59, P52, DOI 10.1111/j.1863-2378.2011.01418.x.
   Bates C, 2004, AVIAN DIS, V48, P138, DOI 10.1637/7082.
   Bokkers EAM, 2009, BRIT POULTRY SCI, V50, P546, DOI 10.1080/00071660903140999.
   Bronowski C, 2014, FEMS MICROBIOL LETT, V356, P8, DOI 10.1111/1574-6968.12488.
   Bull SA, 2006, APPL ENVIRON MICROB, V72, P645, DOI 10.1128/AEM.72.1.645-652.2006.
   Colles FM, 2008, ENVIRON MICROBIOL, V10, P2042, DOI 10.1111/j.1462-2920.2008.01623.x.
   EFSA, 2015, EFSA J, V12, P3547.
   El-Adawy H, 2012, POULTRY SCI, V91, P454, DOI 10.3382/ps.2010-01810.
   El-Adawy H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051582.
   European Commission, 2010, AN EU ORG SECT.
   Gregory E, 1997, AVIAN DIS, V41, P890, DOI 10.2307/1592343.
   Guerin M, 2007, ACTA VET SCAND, V49, P1.
   Hagstrum D, 2009, ATLAS STORED PRODUCT, P3.
   Hald B, 2001, APPL ENVIRON MICROB, V67, P2388, DOI 10.1128/AEM.67.5.2388-2392.2001.
   Hazeleger WC, 2008, APPL ENVIRON MICROB, V74, P6887, DOI 10.1128/AEM.00451-08.
   Heuer OE, 2001, LETT APPL MICROBIOL, V33, P269, DOI 10.1046/j.1472-765X.2001.00994.x.
   HUMPHREY TJ, 1993, EPIDEMIOL INFECT, V110, P601, DOI 10.1017/S0950268800051025.
   ISO, 2006, 1027212006 ISO.
   JACOBSREITSMA WF, 1995, EPIDEMIOL INFECT, V114, P413, DOI 10.1017/S0950268800052122.
   Kashoma IP, 2014, FOODBORNE PATHOG DIS, V11, P850, DOI 10.1089/fpd.2014.1794.
   Kijlstra A, 2009, J FOOD PROTECT, V72, P2629, DOI 10.4315/0362-028X-72.12.2629.
   Luangtongkum T, 2006, APPL ENVIRON MICROB, V72, P3600, DOI 10.1128/AEM.72.5.3600-3607.2006.
   MATHEWSON JJ, 1983, APPL ENVIRON MICROB, V46, P985.
   Miflin J, 2001, P AUST POULT SCI S, V13, P140.
   Neubauer C, 2005, WIEN TIERARZTL MONAT, V92, P4.
   Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003.
   Noormohamed Aneesa, 2014, Open Microbiol J, V8, P130, DOI 10.2174/1874285801408010130.
   Patriarchi A, 2009, LETT APPL MICROBIOL, V49, P305, DOI 10.1111/j.1472-765X.2009.02658.x.
   Perez-Boto D, 2010, AVIAN PATHOL, V39, P483, DOI 10.1080/03079457.2010.518138.
   Petersen L, 2001, J APPL MICROBIOL, V91, P217, DOI 10.1046/j.1365-2672.2001.01383.x.
   Ridley AM, 2008, APPL ENVIRON MICROB, V74, P2492, DOI 10.1128/AEM.01242-07.
   Rivoal K, 1999, LETT APPL MICROBIOL, V29, P370, DOI 10.1046/j.1472-765X.1999.00645.x.
   Rodenburg TB, 2004, NJAS-WAGEN J LIFE SC, V52, P101, DOI 10.1016/S1573-5214(04)80006-X.
   Sasaki Y, 2011, ZOONOSES PUBLIC HLTH, V58, P350, DOI 10.1111/j.1863-2378.2010.01370.x.
   Smith K, 2004, J FOOD PROTECT, V67, P1463, DOI 10.4315/0362-028X-67.7.1463.
   Strother KO, 2005, J MED ENTOMOL, V42, P42, DOI 10.1603/0022-2585(2005)042{[}0042:RCOLMC]2.0.CO;2.
   Templeton JM, 2006, APPL ENVIRON MICROB, V72, P7909, DOI 10.1128/AEM.01471-06.
   Tuyttens F, 2008, LIVEST SCI, V113, P123, DOI 10.1010/j.livsci.2007.02.019.
   Van Overbeke I, 2006, AVIAN DIS, V50, P196, DOI 10.1637/7448-093005R.1.
   Vandeplas S, 2010, BIOTECHNOL AGRON SOC, V14, P279.
   Wieczorek K, 2015, INT J FOOD MICROBIOL, V210, P24, DOI 10.1016/j.ijfoodmicro.2015.06.006.
   Wilson DL, 2010, MICROBIOL-SGM, V156, P2046, DOI 10.1099/mic.0.035717-0.
   Wittwer M, 2005, APPL ENVIRON MICROB, V71, P2840, DOI 10.1128/AEM.71.6.2840-2847.2005.
   Wright SL, 2008, J FOOD PROTECT, V71, P1791, DOI 10.4315/0362-028X-71.9.1791.
   Zimmer M, 2003, AVIAN DIS, V47, P101, DOI 10.1637/0005-2086(2003)047{[}0101:DOCJSI]2.0.CO;2.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{11}},
Journal-ISO = {{Gut Pathogens}},
Doc-Delivery-Number = {{DN6HF}},
Unique-ID = {{ISI:000377173500001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000388325500016,
Author = {Zumla, Alimuddin and Bin Saeed, Abdulaziz and Alotaibi, Badriah and
   Yezli, Saber and Dar, Osman and Bieh, Kingsley and Bates, Matthew and
   Tayeb, Tamara and Mwaba, Peter and Shafi, Shuja and McCloskey, Brian and
   Petersen, Eskild and Azhar, Esam I.},
Title = {{Tuberculosis and mass gatherings-opportunities for defining burden,
   transmission risk, and the optimal surveillance, prevention, and control
   measures at the annual Hajj pilgrimage}},
Journal = {{INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES}},
Year = {{2016}},
Volume = {{47}},
Pages = {{86-91}},
Month = {{JUN}},
Abstract = {{Tuberculosis (TB) is now the most common infectious cause of death
   worldwide. In 2014, an estimated 9.6 million people developed active TB.
   There were an estimated three million people with active TB including
   360 000 with multidrug-resistant TB (MDR-TB) who were not diagnosed, and
   such people continue to fuel TB transmission in the community. Accurate
   data on the actual burden of TB and the transmission risk associated
   with mass gatherings are scarce and unreliable due to the small numbers
   studied and methodological issues. Every year, an estimated 10 million
   pilgrims from 184 countries travel to the Kingdom of Saudi Arabia (KSA)
   to perform the Hajj and Umrah pilgrimages. A large majority of pilgrims
   come from high TB burden and MDR-TB endemic areas and thus many may have
   undiagnosed active TB, sub-clinical TB, and latent TB infection. The
   Hajj pilgrimage provides unique opportunities for the KSA and the 184
   countries from which pilgrims originate, to conduct high quality
   priority research studies on TB under the remit of the Global Centre for
   Mass Gatherings Medicine. Research opportunities are discussed,
   including those related to the definition of the TB burden, transmission
   risk, and the optimal surveillance, prevention, and control measures at
   the annual Hajj pilgrimage. The associated data are required to develop
   international recommendations and guidelines for TB management and
   control at mass gathering events. (C) 2016 The Authors. Published by
   Elsevier Ltd on behalf of International Society for Infectious Diseases.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Azhar, EI (Reprint Author), Minist Hlth, Global Ctr Mass Gatherings, Riyadh, Saudi Arabia.
   Azhar, EI (Reprint Author), King Abdulaziz Univ, Fac Appl Med Sci, King Fahd Med Res Ctr, Special Infect Agents Unit, Jeddah, Saudi Arabia.
   Azhar, EI (Reprint Author), King Abdulaziz Univ, Fac Appl Med Sci, Dept Technol, Med Lab, Jeddah, Saudi Arabia.
   Zumla, Alimuddin; Bates, Matthew, UCL, Div Infect \& Immun, London, England.
   Zumla, Alimuddin; Bates, Matthew, UCL Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.
   Bin Saeed, Abdulaziz, King Saud Univ, Coll Med, Dept Family \& Community Med, Riyadh, Saudi Arabia.
   Zumla, Alimuddin; Bin Saeed, Abdulaziz; Alotaibi, Badriah; Yezli, Saber; Bieh, Kingsley; Tayeb, Tamara; Shafi, Shuja; McCloskey, Brian; Petersen, Eskild; Azhar, Esam I., Minist Hlth, Global Ctr Mass Gatherings, Riyadh, Saudi Arabia.
   Zumla, Alimuddin; McCloskey, Brian, Publ Hlth England, Global Hlth Dept, London, England.
   Zumla, Alimuddin; Bates, Matthew, Univ Zambia, Univ Coll London, Univ Teaching Hosp, Sch Med,Res \& Training Project, Lusaka, Zambia.
   Zumla, Alimuddin; Azhar, Esam I., King Abdulaziz Univ, Fac Appl Med Sci, King Fahd Med Res Ctr, Special Infect Agents Unit, Jeddah, Saudi Arabia.
   Zumla, Alimuddin; Azhar, Esam I., King Abdulaziz Univ, Fac Appl Med Sci, Dept Technol, Med Lab, Jeddah, Saudi Arabia.
   Shafi, Shuja, Muslim Council Great Britain, London, England.
   Petersen, Eskild, Royal Hosp, Muscat, Oman.
   Petersen, Eskild, Aarhus Univ, Aarhus, Denmark.}},
DOI = {{10.1016/j.ijid.2016.02.003}},
ISSN = {{1201-9712}},
EISSN = {{1878-3511}},
Keywords = {{Tuberculosis; Hajj; Mass gatherings; Transmission}},
Keywords-Plus = {{RESPIRATORY-TRACT INFECTIONS; MYCOBACTERIUM-TUBERCULOSIS; SAUDI-ARABIA;
   FUTURE-PROSPECTS; AIR-TRAVEL; HOSPITALIZATION; EPIDEMIOLOGY;
   DIAGNOSTICS; RESISTANCE; MEDICINE}},
Research-Areas = {{Infectious Diseases}},
Web-of-Science-Categories  = {{Infectious Diseases}},
Author-Email = {{eazhar@kau.edu.sa}},
ORCID-Numbers = {{Bates, Matthew/0000-0003-0464-1529
   Yezli, Saber/0000-0002-3380-7092
   Zumla, Alimuddin/0000-0002-5111-5735}},
Cited-References = {{A-Asmary S, 2007, INT J INFECT DIS, V11, P268, DOI 10.1016/j.ijid.2006.04.008.
   Abouzeid MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039478.
   Abubakar I, 2010, LANCET INFECT DIS, V10, P176, DOI 10.1016/S1473-3099(10)70028-1.
   Al Rabeeah A, 2012, LANCET, V380, P3, DOI 10.1016/S0140-6736(12)61073-3.
   Al-Bishri Jamal, 2014, Ger Med Sci, V12, pDoc02, DOI 10.3205/000187.
   Al-Hajoj S, 2015, J INFECT DEV COUNTR, V9, P222, DOI 10.3855/jidc.5296.
   Al-Hajoj S, 2013, ANTIMICROB AGENTS CH, V57, P2161, DOI 10.1128/AAC.02403-12.
   Al-Hajoj SA, 2007, SAUDI MED J, V28, P268.
   Al-Jahdali H, 2003, INT J ANTIMICROB AG, V21, P125, DOI 10.1016/S0924-8579(02)00283-2.
   Al-Orainey IO, 2013, SAUDI MED J, V34, P676.
   Al-Tawfiq JA, 2015, CLIN MICROBIOL INFEC, V21, P109, DOI 10.1016/j.cmi.2014.11.013.
   Al-Tawfiq JA, 2015, J CHEMOTHERAPY, V27, P378, DOI 10.1179/1973947815Y.0000000058.
   Al-Tawfiq JA, 2013, CURR OPIN PULM MED, V19, P192, DOI 10.1097/MCP.0b013e32835f1ae8.
   ALKASSIMI FA, 1993, TUBERCLE LUNG DIS, V74, P254, DOI 10.1016/0962-8479(93)90051-X.
   Alzeer A, 1998, J INFECTION, V36, P303, DOI 10.1016/S0163-4453(98)94315-8.
   Alzeer AH, 2009, ANN THORAC MED, V4, P50, DOI 10.4103/1817-1737.49412.
   Balkhy HH, 2004, J TRAVEL MED, V11, P82, DOI 10.2310/7060.2004.17027.
   Bates M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040774.
   Benkouiten S, 2013, CLIN INFECT DIS, V57, P992, DOI 10.1093/cid/cit446.
   Colijn C, 2016, LANCET RESP MED, V4, P6, DOI 10.1016/S2213-2600(15)00510-X.
   DRIVER CR, 1994, JAMA-J AM MED ASSOC, V272, P1031, DOI 10.1001/jama.272.13.1031.
   Gautret P, 2013, TRAVEL MED INFECT DI, p{[}11, 9].
   Gautret P, 2015, TRAVEL MED INFECT DI, V13, P485, DOI 10.1016/j.tmaid.2015.09.008.
   Khan NA, 2006, SAUDI MED J, V27, P1373.
   Kholeidi A, 2001, SAUDI EPIDEMIOL B, V8, P27.
   Lai KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023269.
   Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2.
   Madani TA, 2006, ANN SAUDI MED, V26, P346, DOI 10.5144/0256-4947.2006.346.
   Mandourah Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-117.
   Mantero J, 2014, EUROSURVEILLANCE, V19, P27, DOI 10.2807/1560-7917.ES2014.19.18.20796.
   McCloskey B, 2014, LANCET, V383, P2083, DOI 10.1016/S0140-6736(13)62342-9.
   Memish ZA, 2014, LANCET, V383, P2030, DOI 10.1016/S0140-6736(14)60225-7.
   Memish ZA, 2014, LANCET, V383, P2073, DOI 10.1016/S0140-6736(14)60381-0.
   Pankhurst LJ, 2016, LANCET RESP MED, V4, P49, DOI 10.1016/S2213-2600(15)00466-X.
   Rashid H, 2008, Emerg Health Threats J, V1, pe2, DOI 10.3134/ehtj.08.002.
   Rashid H, 2008, CLIN MICROBIOL INFEC, V14, P569, DOI 10.1111/j.1469-0691.2008.01987.x.
   Schito M, 2015, CLIN INFECT DIS, V61, pS102, DOI 10.1093/cid/civ609.
   Smallwood CAH, 2014, LANCET, V383, P2090, DOI 10.1016/S0140-6736(13)62384-3.
   Varghese B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055598.
   WHO TB, 1994, WHOTB94177.
   Wilder-Smith A, 2005, TROP MED INT HEALTH, V10, P336, DOI 10.1111/j.1365-3156.2005.01395.x.
   World Health Organization, 2015, WHO GLOB STRAT TARG.
   World Health Organization, 2015, WHO GLOB REP TUB 201.
   Zumla A, 2014, LANCET INFECT DIS, V14, P1123, DOI 10.1016/S1473-3099(14)70827-8.
   Zumla A, 2014, LANCET INFECT DIS, V14, P1136, DOI 10.1016/S1473-3099(14)70828-X.
   Zumla A, 2014, LANCET INFECT DIS, V14, P910, DOI 10.1016/S1473-3099(14)70899-0.
   Zumla A, 2011, TROP MED INT HEALTH, V16, P79, DOI 10.1111/j.1365-3156.2010.02665.x.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Int. J. Infect. Dis.}},
Doc-Delivery-Number = {{EC7NC}},
Unique-ID = {{ISI:000388325500016}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000381057700003,
Author = {Williams-Nguyen, Jessica and Bueno, Irene and Sargeant, Jan M. and
   Nault, Andre J. and Singer, Randall S.},
Title = {{What is the evidence that point sources of anthropogenic effluent
   increase antibiotic resistance in the environment? Protocol for a
   systematic review}},
Journal = {{ANIMAL HEALTH RESEARCH REVIEWS}},
Year = {{2016}},
Volume = {{17}},
Number = {{1, SI}},
Pages = {{9-15}},
Month = {{JUN}},
Abstract = {{Herein we describe a protocol for a systematic review of the evidence on
   whether point sources of anthropogenic effluent are associated with an
   increase in antibiotic resistance in the adjacent environment. The
   review question was based on the Population, Exposure, Comparator,
   Outcome, Study Design (PECOS) framework as follows: Is the prevalence or
   concentration of antibiotic resistant bacteria or resistance genes (O)
   in soil, water, air or free-living wildlife (P) higher in close
   proximity to, or downstream from, known or suspected sources of
   anthropogenic effluent (E) compared to areas more distant from or
   upstream from these sources (C)? A comprehensive search strategy was
   created to capture all relevant, published literature. Criteria for two
   stages of eligibility screening were developed to exclude publications
   that were not relevant to the question, and determine if the study used
   a design that permitted estimation of an association between a source
   and levels of resistance. A decision matrix was created for assessment
   of risk of bias to internal validity due to sample selection bias,
   information bias, and confounding. The goal of this protocol is to
   provide a method for determining the state of knowledge about the effect
   of point sources on antibiotic resistance in the environment.}},
Publisher = {{CAMBRIDGE UNIV PRESS}},
Address = {{EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Williams-Nguyen, J (Reprint Author), Univ Washington, Dept Epidemiol, 1959 NE Pacific St,Hlth Sci Bldg F-262, Seattle, WA 98195 USA.
   Williams-Nguyen, J (Reprint Author), Univ Minnesota, Dept Vet \& Biomed Sci, 1971 Commonwealth Ave, St Paul, MN 55108 USA.
   Williams-Nguyen, Jessica, Univ Washington, Dept Epidemiol, 1959 NE Pacific St,Hlth Sci Bldg F-262, Seattle, WA 98195 USA.
   Williams-Nguyen, Jessica; Singer, Randall S., Univ Minnesota, Dept Vet \& Biomed Sci, 1971 Commonwealth Ave, St Paul, MN 55108 USA.
   Bueno, Irene, Univ Minnesota, Dept Vet Populat Med, 1988 Fitch Ave, St Paul, MN 55108 USA.
   Sargeant, Jan M., Univ Guelph, Ontario Vet Coll, Dept Populat Med, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.
   Sargeant, Jan M., Univ Guelph, Ontario Vet Coll, Ctr Publ Hlth \& Zoonoses, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.
   Nault, Andre J., Univ Minnesota, Vet Med Lib, 1971 Commonwealth Ave, St Paul, MN 55108 USA.
   Singer, Randall S., Univ Austral Chile, Fac Ciencias Vet, Inst Med Prevent Vet, Valdivia, Chile.}},
DOI = {{10.1017/S1466252316000037}},
ISSN = {{1466-2523}},
EISSN = {{1475-2654}},
Keywords = {{antibiotic resistance; environment; systematic review protocol; point
   source}},
Keywords-Plus = {{MANAGEMENT; BACTERIA; GENES; RISK}},
Research-Areas = {{Veterinary Sciences}},
Web-of-Science-Categories  = {{Veterinary Sciences}},
Author-Email = {{jswn@uw.edu}},
ORCID-Numbers = {{Williams-Nguyen, Jessica/0000-0003-0643-7433
   Nault, Andre/0000-0002-6698-1476}},
Funding-Acknowledgement = {{National Pork Board {[}13-260]}},
Funding-Text = {{The authors would like to thank Annette M. O'Connor for her helpful
   comments during the development of this protocol. This work is funded by
   the National Pork Board (Agreement no. 13-260) who requested a
   systematic review of the topic. The funding organization has been
   advised of the study question, but will play no role designating
   eligibility criteria, evaluating evidence or interpreting findings.}},
Cited-References = {{Amaya E, 2012, CLIN MICROBIOL INFEC, V18, pE347, DOI 10.1111/j.1469-0691.2012.03930.x.
   Ashbolt NJ, 2013, ENVIRON HEALTH PERSP, V121, P993, DOI 10.1289/ehp.1206316.
   Best M, 2013, IMPACT NATL INT ASSE.
   Birnbaum LS, 2013, ENVIRON HEALTH PERSP, V121, pA108, DOI 10.1289/ehp.1306711.
   Cook CN, 2013, CONSERV BIOL, V27, P902, DOI 10.1111/cobi.12114.
   Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355.
   Higgins JP, 2011, COCHRANE COLLABORATI, DOI DOI 10.1002/9780470712184.
   Hong PY, 2013, APPL ENVIRON MICROB, V79, P2620, DOI 10.1128/AEM.03760-12.
   Irwin CK, 2011, APPL ENVIRON MICROB, V77, P1049, DOI 10.1128/AEM.02733-09.
   Larsson DGJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0571.
   Moher David, 2015, Syst Rev, V4, P1, DOI 10.1186/2046-4053-4-1.
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097.
   Perry JA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00138.
   Pullin AS, 2006, CONSERV BIOL, V20, P1647, DOI 10.1111/j.1523-1739.2006.00485.x.
   Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032.
   Sargeant JM, 2014, ZOONOSES PUBLIC HLTH, V61, P39, DOI 10.1111/zph.12124.
   Sargeant JM, 2014, ZOONOSES PUBLIC HLTH, V61, P3, DOI 10.1111/zph.12128.
   Singer RS, 2014, CURR OPIN MICROBIOL, V19, P1, DOI 10.1016/j.mib.2014.05.014.
   Varela AR, 2013, ENVIRON SCI POLLUT R, V20, P3550, DOI 10.1007/s11356-013-1594-0.
   Williams-Nguyen J, 2016, J ENVIRON QUAL, V45, P394, DOI 10.2134/jeq2015.07.0336.
   Wooldridge M, 2012, REV SCI TECH OIE, V31, P231.
   Woolhouse M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0083.}},
Number-of-Cited-References = {{22}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{26}},
Journal-ISO = {{Anim. Health Res. Rev.}},
Doc-Delivery-Number = {{DS8UE}},
Unique-ID = {{ISI:000381057700003}},
DA = {{2018-08-13}},
}

@article{ ISI:000376935700006,
Author = {Hwang, John H. and Lyes, Matthew and Sladewski, Katherine and Enany,
   Shymaa and McEachern, Elisa and Mathew, Denzil P. and Das, Soumita and
   Moshensky, Alexander and Bapat, Sagar and Pride, David T. and Ongkeko,
   Weg M. and Alexander, Laura E. Crotty},
Title = {{Electronic cigarette inhalation alters innate immunity and airway
   cytokines while increasing the virulence of colonizing bacteria}},
Journal = {{JOURNAL OF MOLECULAR MEDICINE-JMM}},
Year = {{2016}},
Volume = {{94}},
Number = {{6}},
Pages = {{667-679}},
Month = {{JUN}},
Abstract = {{Electronic (e)-cigarette use is rapidly rising, with 20 \% of Americans
   ages 25-44 now using these drug delivery devices. E-cigarette users
   expose their airways, cells of host defense, and colonizing bacteria to
   e-cigarette vapor (EV). Here, we report that exposure of human
   epithelial cells at the air-liquid interface to fresh EV (vaped from an
   e-cigarette device) resulted in dose-dependent cell death. After
   exposure to EV, cells of host defense-epithelial cells, alveolar
   macrophages, and neutrophils-had reduced antimicrobial activity against
   Staphylococcus aureus (SA). Mouse inhalation of EV for 1 h daily for 4
   weeks led to alterations in inflammatory markers within the airways and
   elevation of an acute phase reactant in serum. Upon exposure to
   e-cigarette vapor extract (EVE), airway colonizer SA had increased
   biofilm formation, adherence and invasion of epithelial cells,
   resistance to human antimicrobial peptide LL-37, and up-regulation of
   virulence genes. EVE-exposed SA were more virulent in a mouse model of
   pneumonia. These data suggest that e-cigarettes may be toxic to airway
   cells, suppress host defenses, and promote inflammation over time, while
   also promoting virulence of colonizing bacteria.
   Acute exposure to e-cigarette vapor (EV) is cytotoxic to airway cells in
   vitro.
   Acute exposure to EV decreases macrophage and neutrophil antimicrobial
   function.
   Inhalation of EV alters immunomodulating cytokines in the airways of
   mice.
   Inhalation of EV leads to increased markers of inflammation in BAL and
   serum.
   Staphylococcus aureus become more virulent when exposed to EV.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Alexander, LEC (Reprint Author), VA San Diego Healthcare Syst, Pulm \& Crit Care Sect, 3350 La Jolla Village Dr,MC 111J, San Diego, CA 92161 USA.
   Alexander, LEC (Reprint Author), Univ Calif San Diego, Div Pulm \& Crit Care, Dept Med, San Diego, CA 92093 USA.
   Hwang, John H.; Lyes, Matthew; Sladewski, Katherine; Enany, Shymaa; McEachern, Elisa; Mathew, Denzil P.; Moshensky, Alexander; Alexander, Laura E. Crotty, VA San Diego Healthcare Syst, Pulm \& Crit Care Sect, 3350 La Jolla Village Dr,MC 111J, San Diego, CA 92161 USA.
   Hwang, John H.; Alexander, Laura E. Crotty, Univ Calif San Diego, Div Pulm \& Crit Care, Dept Med, San Diego, CA 92093 USA.
   Enany, Shymaa, Suez Canal Univ, Fac Pharm, Dept Microbiol \& Immunol, Ismailia, Egypt.
   Das, Soumita; Pride, David T., Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.
   Das, Soumita; Pride, David T., Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   Bapat, Sagar, Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.
   Ongkeko, Weg M., Univ Calif San Diego, Dept Surg, Div Head \& Neck Surg, La Jolla, CA 92093 USA.
   McEachern, Elisa, Weill Cornell Med Coll, New York, NY USA.
   Lyes, Matthew, Duke Univ, Sch Med, Durham, NC USA.}},
DOI = {{10.1007/s00109-016-1378-3}},
ISSN = {{0946-2716}},
EISSN = {{1432-1440}},
Keywords = {{E-cigarette vapor; Staphylococcal virulence; Cytotoxicity; Inflammatory
   lung disease; Antimicrobial peptide LL-37; MRSA pneumonia}},
Keywords-Plus = {{RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL PEPTIDE LL-37;
   PANTON-VALENTINE LEUKOCIDIN; CARDIOVASCULAR RISK-FACTORS; C-REACTIVE
   PROTEIN; RHEUMATOID-ARTHRITIS; SMOKE EXTRACT; LUNG-CANCER; IN-VITRO;
   ACETYLCHOLINE}},
Research-Areas = {{Genetics \& Heredity; Research \& Experimental Medicine}},
Web-of-Science-Categories  = {{Genetics \& Heredity; Medicine, Research \& Experimental}},
Author-Email = {{lcrotty@ucsd.edu}},
ResearcherID-Numbers = {{Enany, Shymaa/F-2053-2010
   }},
ORCID-Numbers = {{Enany, Shymaa/0000-0002-7827-6504
   Crotty Alexander, Laura/0000-0002-5091-2660}},
Funding-Acknowledgement = {{VA Career Development Award (CDA)-2, {[}1IK2BX001313]; U.S. Department
   of Veterans Affairs, Biomedical Laboratory Research and Development
   (BLRD) Program}},
Funding-Text = {{This work was supported by the VA Career Development Award (CDA)-2,
   award no. 1IK2BX001313, PI Crotty Alexander, from the U.S. Department of
   Veterans Affairs, Biomedical Laboratory Research and Development
   (BLR\&D) Program. Thank you to Drs. Ross Corriden and Simon Dohrmann for
   their technical support. Thank you to Dr. Atul Malhotra for his guidance
   and support.}},
Cited-References = {{Alexander LEC, 2015, CHEST, V148, P1307, DOI 10.1378/chest.15-0409.
   Alexander LEC, 2010, J MOL MED, V88, P371, DOI 10.1007/s00109-009-0566-9.
   Askarian F, 2014, PATHOG DIS, V70, P158, DOI 10.1111/2049-632X.12099.
   Bauguess AJ, 2014, MAKE YOUR OWN E LIQU.
   Bermudez EA, 2002, ARTERIOSCL THROM VAS, V22, P1668, DOI 10.1161/01.ATV.0000029781.31325.66.
   Bermudez Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020487.
   Bostean G, 2015, AM J PUBLIC HEALTH, V105, P2423, DOI 10.2105/AJPH.2015.302899.
   Brown J, 2014, ADDICT BEHAV, V39, P1120, DOI 10.1016/j.addbeh.2014.03.009.
   Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036.
   Comer DM, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-32.
   Condliffe AM, 1998, CLIN SCI, V94, P461, DOI 10.1042/cs0940461.
   Czoli CD, 2014, CAN J PUBLIC HEALTH, V105, pE97.
   DAHLBACK B, 1981, ARCH MICROBIOL, V128, P267, DOI 10.1007/BF00422527.
   Dawkins L, 2013, ADDICTION, V108, P1115, DOI 10.1111/add.12150.
   El Mezayen R, 2007, IMMUNOL LETT, V111, P36, DOI 10.1016/j.imlet.2007.04.011.
   Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P5146, DOI 10.3390/ijerph10105146.
   Flouris AD, 2013, INHAL TOXICOL, V25, P91, DOI 10.3109/08958378.2012.758197.
   Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172.
   Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7.
   Grando SA, 2008, J PHARMACOL SCI, V106, P174, DOI 10.1254/jphs.FM0070087.
   Hamilton SM, 2007, CLIN INFECT DIS, V45, P1550, DOI 10.1086/523581.
   Herzog E, 2007, TOXICOL LETT, V174, P49, DOI 10.1016/j.toxlet.2007.08.009.
   Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003.
   King BA, 2013, 2011 2012 MORBIDITY, P729.
   Kinnunen JM, 2015, TOB CONTROL, V24, pE264, DOI 10.1136/tobaccocontrol-2013-051512.
   Lee S, 2014, J ADOLESCENT HEALTH, V54, P684, DOI 10.1016/j.jadohealth.2013.11.003.
   Liu GY, 2009, PEDIATR RES, V65, p71R, DOI 10.1203/PDR.0b013e31819dc44d.
   Ma XL, 2014, TOXICOL APPL PHARM, V278, P172, DOI 10.1016/j.taap.2014.04.023.
   MAGNUSSON KE, 1982, SCAND J INFECT DIS, P32.
   McEachern EK, 2015, INFECT IMMUN, V83, P2443, DOI 10.1128/IAI.00303-15.
   Molad Y, 2015, EUR J CLIN INVEST, V45, P557, DOI 10.1111/eci.12442.
   Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157.
   Neville F, 2006, BIOPHYS J, V90, P1275, DOI 10.1529/biophysj.105.067595.
   Neville F, 2007, BIOELECTROCHEMISTRY, V70, P205, DOI 10.1016/j.bioelechem.2006.07.006.
   Papanikolaou IC, 2015, IMMUNOL LETT, V163, P179, DOI 10.1016/j.imlet.2014.12.004.
   Park EJ, 2016, J APPL TOXICOL, V36, P424, DOI 10.1002/jat.3233.
   Pegtel DM, 2005, J VIROL, V79, P15430, DOI 10.1128/JVI.79.24.15430-15442.2005.
   Radsak MP, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/52040.
   Regan AK, 2013, TOB CONTROL, V22, P19, DOI 10.1136/tobaccocontrol-2011-050044.
   Reynolds PR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-175.
   Rohde LEP, 1999, AM J CARDIOL, V84, P1018, DOI 10.1016/S0002-9149(99)00491-9.
   Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957.
   Schweitzer KS, 2015, AM J PHYSIOL-LUNG C, V309, pL175, DOI 10.1152/ajplung.00411.2014.
   Streck E, 2010, J INVEST ALLERG CLIN, V20, P324.
   Sussan TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116861.
   Sutfin EL, 2013, DRUG ALCOHOL DEPEN, V131, P214, DOI 10.1016/j.drugalcdep.2013.05.001.
   Thunnissen FB, 2009, J THORAC ONCOL, V4, P943, DOI 10.1097/JTO.0b013e3181ad83fc.
   Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490.
   Wang GS, 2008, J BIOL CHEM, V283, P32637, DOI 10.1074/jbc.M805533200.
   Wu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108342.
   Yang ES, 2010, CLIN MICROBIOL INFEC, V16, P425, DOI 10.1111/j.1469-0691.2009.02836.x.}},
Number-of-Cited-References = {{51}},
Times-Cited = {{31}},
Usage-Count-Last-180-days = {{5}},
Usage-Count-Since-2013 = {{37}},
Journal-ISO = {{J. Mol. Med.}},
Doc-Delivery-Number = {{DN3AX}},
Unique-ID = {{ISI:000376935700006}},
DA = {{2018-08-13}},
}

@article{ ISI:000377233700004,
Author = {Zhang, Changsheng and Berra, Lorenzo and Klompas, Michael},
Title = {{Should Aerosolized Antibiotics Be Used to Treat Ventilator-Associated
   Pneumonia?}},
Journal = {{RESPIRATORY CARE}},
Year = {{2016}},
Volume = {{61}},
Number = {{6, SI}},
Pages = {{737-746}},
Month = {{JUN}},
Note = {{54th Respiratory Care Journal Conference on Respiratory Care
   Controversies III, St Petersburg, FL, JUN 05-06, 2015}},
Abstract = {{In patients with ventilator-associated pneumonia, systemic use of
   antibiotics is the cornerstone of medical management. Supplemental use
   of aerosolized antibiotics with intravenous antibiotics in both
   experimental and clinical studies has been shown to have the following
   pharmacologic benefits: (1) aerosolized antibiotics reach the infected
   lung parenchyma without crossing the pulmonary alveolar capillary
   barrier; (2) aerosolized antibiotics increase anti-bacterial efficacy
   through increased local antibiotic concentration; and (3) aerosolized
   antibiotics decrease systemic toxicity. These benefits may be
   particularly beneficial to treat pneumonia caused by multidrug-resistant
   pathogens. Clinical data on the benefits of aerosolized antibiotics are
   more limited. Studies to date have not clearly shown improvements in
   time to extubation, mortality, or other patient-centered outcomes. At
   present, amikacin, colistin, and ceftazidime are the most frequently
   used and studied aerosolized antibiotics. This review summarizes the
   characteristics of aerosolized antibiotics, reviews the advantages and
   disadvantages of using aerosolized antibiotics, and calls for future
   investigations based on animal study data. (C) 2016 Daedalus Enterprises}},
Publisher = {{DAEDALUS ENTERPRISES INC}},
Address = {{9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Berra, L (Reprint Author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care \& Pain Med, White 434B,55 Fruit St, Boston, MA 02114 USA.
   Zhang, Changsheng; Berra, Lorenzo, Massachusetts Gen Hosp, Dept Anesthesia Crit Care \& Pain Med, White 434B,55 Fruit St, Boston, MA 02114 USA.
   Klompas, Michael, Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA.
   Klompas, Michael, Harvard Pilgrim Hlth Care Inst, Boston, MA USA.
   Klompas, Michael, Brigham \& Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.}},
DOI = {{10.4187/respcare.04748}},
ISSN = {{0020-1324}},
EISSN = {{1943-3654}},
Keywords = {{ventilator-associated pneumonia; aerosol; antibiotics; delivery device;
   mechanical ventilation}},
Keywords-Plus = {{INTENSIVE-CARE-UNIT; GRAM-NEGATIVE PNEUMONIA; AIR-SPACE ENLARGEMENT;
   MECHANICAL VENTILATION; CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA;
   NEBULIZED CEFTAZIDIME; INTRAVENOUS COLISTIN; ADJUNCTIVE THERAPY;
   RESPIRATORY-TRACT}},
Research-Areas = {{General \& Internal Medicine; Respiratory System}},
Web-of-Science-Categories  = {{Critical Care Medicine; Respiratory System}},
Author-Email = {{lberra@partners.org}},
Cited-References = {{{[}Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST.
   Barbier F, 2013, CURR OPIN PULM MED, V19, P216, DOI 10.1097/MCP.0b013e32835f27be.
   Bergmans DCJJ, 1997, J ANTIMICROB CHEMOTH, V39, P527, DOI 10.1093/jac/39.4.527.
   Bhaysar T, 2011, EXP LUNG RES, V37, P536.
   Boe J, 2001, EUR RESPIR J, V18, P228.
   BRAIN JD, 1979, AM REV RESPIR DIS, V120, P1325.
   BYRON PR, 1986, J PHARM SCI-US, V75, P433, DOI 10.1002/jps.2600750502.
   Chalmers JD, 2012, AM J RESP CRIT CARE, V186, P657, DOI 10.1164/rccm.201203-0487OC.
   Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/rccm.2105078.
   Dolovich M A, 2000, Respir Care, V45, P597.
   Doshi NM, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-45.
   Dubus JC, 2005, PEDIATR RES, V58, P10, DOI 10.1203/01.PDR.0000156244.84422.55.
   Elman M, 2002, ANESTHESIOLOGY, V97, P199, DOI 10.1097/00000542-200207000-00028.
   Fagon JY, 2007, CRIT CARE, V11, DOI 10.1186/cc5724.
   Ferrari F, 2009, INTENS CARE MED, V35, P1792, DOI 10.1007/s00134-009-1605-2.
   Fink J, 2013, EXPERT OPIN DRUG DEL, V10, P1077, DOI 10.1517/17425247.2013.790362.
   Flume P, 2002, PHARMACOTHERAPY, V22, p71S, DOI 10.1592/phco.22.6.71S.33909.
   FULLER HD, 1990, AM REV RESPIR DIS, V141, P440, DOI 10.1164/ajrccm/141.2.440.
   Ghannam DE, 2009, EUR J CLIN MICROBIOL, V28, P253, DOI 10.1007/s10096-008-0620-5.
   Goldstein I, 2002, AM J RESP CRIT CARE, V166, P1375, DOI 10.1164/rccm.200204-363OC.
   Goldstein I, 2002, AM J RESP CRIT CARE, V165, P171, DOI 10.1164/ajrccm.165.2.2107025.
   Goldstein I, 2001, AM J RESP CRIT CARE, V163, P958, DOI 10.1164/ajrccm.163.4.2006072.
   Hallal Ali, 2007, Surg Infect (Larchmt), V8, P73, DOI 10.1089/sur.2006.051.
   Harvey CJ, 1997, EUR RESPIR J, V10, P905.
   Hess DR, 2003, INTENS CARE MED, V29, P1145, DOI 10.1007/s00134-003-1792-1.
   Imberti R, 2010, CHEST, V138, P1333, DOI {[}10.1378/chest.10-0463, 10.1378/chest.10.0463].
   INGOLD A, 1975, BRIT J DIS CHEST, V69, P211, DOI 10.1016/0007-0971(75)90082-0.
   Kiem S, 2008, ANTIMICROB AGENTS CH, V52, P24, DOI 10.1128/AAC.00133-06.
   Kleinstreuer C, 2008, RESP PHYSIOL NEUROBI, V163, P128, DOI 10.1016/j.resp.2008.07.002.
   Klompas M, 2007, JAMA-J AM MED ASSOC, V297, P1583, DOI 10.1001/jama.297.14.1583.
   Klompas M, 2010, AM J INFECT CONTROL, V38, P237, DOI 10.1016/j.ajic.2009.10.003.
   Klompas M, 2009, CRIT CARE, V13, DOI 10.1186/cc8036.
   Kofteridis DP, 2010, CLIN INFECT DIS, V51, P1238, DOI 10.1086/657242.
   Korbila IP, 2010, CLIN MICROBIOL INFEC, V16, P1230, DOI 10.1111/j.1469-0691.2009.03040.x.
   Labiris NR, 2013, ENCY PHARM SCI TECHN.
   Le Conte P, 2000, PRESSE MED, V29, P76.
   Lu Q, 2011, AM J RESP CRIT CARE, V184, P106, DOI 10.1164/rccm.201011-1894OC.
   Lu Q, 2010, INTENS CARE MED, V36, P1147, DOI 10.1007/s00134-010-1879-4.
   Maesen F P, 1976, J Antimicrob Chemother, V2, P279, DOI 10.1093/jac/2.3.279.
   MAKHOUL IR, 1993, J INFECT DIS, V168, P1296, DOI 10.1093/infdis/168.5.1296.
   Mccoy KS, 2008, AM J RESP CRIT CARE, V178, P921, DOI 10.1164/rccm.200712-1804OC.
   Miller DD, 2003, AM J RESP CRIT CARE, V168, P1205, DOI 10.1164/rccm.200210-1167OC.
   Moore RH, 1998, CHEST, V113, P1095, DOI 10.1378/chest.113.4.1095.
   Myers TR, 2015, RESP CARE, V60, P1190, DOI 10.4187/respcare.04224.
   Neuhauser MM, 2003, JAMA-J AM MED ASSOC, V289, P885, DOI 10.1001/jama.289.7.885.
   Niederman MS, 2012, INTENS CARE MED, V38, P263, DOI 10.1007/s00134-011-2420-0.
   Nseir S, 2008, CRIT CARE MED, V36, P2191, DOI 10.1097/CCM.0b013e31817c0a28.
   ORIORDAN TG, 1994, AM J RESP CRIT CARE, V149, P214, DOI 10.1164/ajrccm.149.1.8111585.
   Palmer LB, 2008, CRIT CARE MED, V36, P2008, DOI 10.1097/CCM.0b013e31817c0f9e.
   Palmer LB, 2014, AM J RESP CRIT CARE, V189, P1225, DOI 10.1164/rccm.201312-2161OC.
   Pelkonen AS, 1997, PEDIATR PULM, V24, P282, DOI 10.1002/(SICI)1099-0496(199710)24:4<282::AID-PPUL7>3.0.CO;2-M.
   Ramsey BW, 1999, NEW ENGL J MED, V340, P23, DOI 10.1056/NEJM199901073400104.
   Ratjen F, 2006, J ANTIMICROB CHEMOTH, V57, P306, DOI 10.1093/jac/dki461.
   Rattanaumpawan P, 2010, J ANTIMICROB CHEMOTH, V65, P2645, DOI 10.1093/jac/dkq360.
   Roberts MC, 2002, PERIODONTOL 2000, V28, P280, DOI 10.1034/j.1600-0757.2002.280112.x.
   Rose LM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001634.
   Rottboll LA, 2015, J PHARMACOL TOX MET, V78, P58.
   Rouby JJ, 2012, ANESTHESIOLOGY, V117, P1364, DOI 10.1097/ALN.0b013e3182755d7a.
   Sagalla RB, 2014, J AEROSOL MED PULM D, V27, P341, DOI 10.1089/jamp.2014.1152.
   Sartorius A, 2007, CRIT CARE, V11, DOI 10.1186/cc5680.
   SEGAL MS, 1947, JAMA-J AM MED ASSOC, V134, P762, DOI 10.1001/jama.1947.02880260020005.
   SPIER R, 1961, JAMA-J AM MED ASSOC, V178, P878, DOI 10.1001/jama.1961.03040480008003.
   Steckel H, 2003, EUR J PHARM SCI, V19, P443, DOI 10.1016/S0928-0987(03)00148-9.
   STEWART SM, 1974, THORAX, V29, P110, DOI 10.1136/thx.29.1.110.
   Tejerina E, 2010, J CRIT CARE, V25, P62, DOI 10.1016/j.jcrc.2009.05.008.
   Tonnellier M, 2005, ANESTHESIOLOGY, V102, P995, DOI 10.1097/00000542-200505000-00019.
   Tumbarello M, 2013, CHEST, V144, P1768, DOI 10.1378/chest.13-1018.
   Valachis A, 2015, CRIT CARE MED, V43, P527, DOI 10.1097/CCM.0000000000000771.
   VALCKE Y, 1990, EUR RESPIR J, V3, P715.
   Warren DK, 2003, CRIT CARE MED, V31, P1312, DOI 10.1097/01.CCM.0000063087.93157.06.
   Zampieri FG, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0868-y.}},
Number-of-Cited-References = {{71}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{5}},
Journal-ISO = {{Respir. Care}},
Doc-Delivery-Number = {{DN7CU}},
Unique-ID = {{ISI:000377233700004}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000376404600003,
Author = {Guadalupe Frias-De Leon, Maria and Duarte-Escalante, Esperanza and del
   Carmen Calderon-Ezquerro, Maria and del Carmen Jimenez-Martinez, Maria
   and Acosta-Altamirano, Gustavo and Adan Moreno-Eutimio, Mario and
   Zuniga, Gerardo and Garcia-Gonzalez, Rafael and Ramirez-Perez, Maritona
   and del Rocio Reyes-Montes, Maria},
Title = {{Diversity and characterization of airborne bacteria at two health
   institutions}},
Journal = {{AEROBIOLOGIA}},
Year = {{2016}},
Volume = {{32}},
Number = {{2}},
Pages = {{187-198}},
Month = {{JUN}},
Abstract = {{The aim of this study was to identify the types and abundance of
   airborne bacteria of two health institutions (1 and 2) and to determine
   the genetic association between environmental and clinical isolates of
   Staphylococcus spp. Environmental sampling in institutions 1 and 2 was
   conducted for 1 year (dry and rainy seasons) using M Air T sampler. The
   bacteria and their susceptibility to antibiotics were identified. The
   colony-forming units per cubic meter (CFU/m(3)) of air were quantified
   for all the isolates, and the diversity and abundance of species were
   calculated. The genetic relationship between the clinical and
   environmental isolates of S. aureus obtained from institution 1 was
   established by the UPGMA based on RAPD markers. At both of the
   institutions, the genera most frequently isolated were Staphylococcus
   and Bacillus, and the greater concentration of airborne bacteria was
   detected during the dry season than the rainy season. The lowest
   diversity and highest dominance was found in the institution 2. On the
   other hand, at institution 1, the genus that was resistant to
   antibiotics was Staphylococcus, whereas at institution 2, no isolate was
   found to be resistant to antibiotics. Furthermore, no association
   between the clinical and environmental isolates of S. aureus was found.
   However, one clone was found in different areas of the institution 1.
   The presence of airborne pathogenic bacteria in institutions 1 and 2 is
   important to establish the measures for the prevention and control of
   nosocomial outbreaks.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Reyes-Montes, MD (Reprint Author), Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol \& Parasitol, Col Copilco Univ, Ciudad Univ 3000, Mexico City 04510, DF, Mexico.
   Guadalupe Frias-De Leon, Maria; Acosta-Altamirano, Gustavo; Adan Moreno-Eutimio, Mario, Hosp Juarez Mexico, Div Invest, Av Inst Politecn Nacl 5160, Mexico City 07760, DF, Mexico.
   Duarte-Escalante, Esperanza; Garcia-Gonzalez, Rafael; Ramirez-Perez, Maritona; del Rocio Reyes-Montes, Maria, Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol \& Parasitol, Col Copilco Univ, Ciudad Univ 3000, Mexico City 04510, DF, Mexico.
   del Carmen Calderon-Ezquerro, Maria, Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Col Copilco Univ, Ciudad Univ 3000, Mexico City 04510, DF, Mexico.
   del Carmen Jimenez-Martinez, Maria, Fdn Asistencia Privada Conde Valenciana IAP, Inst Oftalmol, Unidad Invest, Mexico City, DF, Mexico.
   del Carmen Jimenez-Martinez, Maria, Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Col Copilco Univ, Ciudad Univ 3000, Mexico City 04510, DF, Mexico.
   Zuniga, Gerardo, Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Zool, Prol Carpio \& Plan Ayala S-N Col Sto Tomas, Mexico City 11340, DF, Mexico.}},
DOI = {{10.1007/s10453-015-9389-z}},
ISSN = {{0393-5965}},
EISSN = {{1573-3025}},
Keywords = {{HAIs; Staphylococcus aureus; Environmental sampling; Abundance; Genetic
   diversity; Airborne bacteria}},
Keywords-Plus = {{VANCOMYCIN-RESISTANT ENTEROCOCCUS; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   INTENSIVE-CARE-UNIT; ENVIRONMENTAL CONTAMINATION; NOSOCOMIAL INFECTION;
   INDOOR AIR; RISK; ACQUISITION; AUREUS; DISINFECTION}},
Research-Areas = {{Life Sciences \& Biomedicine - Other Topics; Environmental Sciences \&
   Ecology}},
Web-of-Science-Categories  = {{Biology; Environmental Sciences}},
Author-Email = {{remoa@unam.mx}},
ORCID-Numbers = {{Moreno-Eutimio, Mario Adan/0000-0002-9955-8498
   JIMENEZ-MARTINEZ, MARIA C/0000-0003-3982-9097
   Calderon Ezquerro, Maria del Carmen Leticia/0000-0002-3175-6762}},
Funding-Acknowledgement = {{PAPIIT-DGAPA, UNAM {[}IN219212]; Direccion de Investigacion, Hospital
   Juarez de Mexico}},
Funding-Text = {{This project was supported by PAPIIT-DGAPA (IN219212), UNAM. Additional
   support for this study was provided by Direccion de Investigacion,
   Hospital Juarez de Mexico.}},
Cited-References = {{Augustowska M, 2006, ANN AGR ENV MED, V13, P99.
   Aydin C.N., 2013, ANN AGR ENV, V20, P106.
   Beggs CB, 2003, INDOOR BUILT ENVIRON, V12, P9, DOI 10.1177/142032603032201.
   Benet T, 2009, J HOSP INFECT, V73, P217, DOI 10.1016/j.jhin.2009.07.018.
   Coates ARM, 2011, BRIT J PHARMACOL, V163, P184, DOI 10.1111/j.1476-5381.2011.01250.x.
   Collee J. G., 1999, MACKIE MCCARTNEY PRA, P135.
   DiGiorgio C, 1996, ATMOS ENVIRON, V30, P155, DOI 10.1016/1352-2310(95)00143-M.
   Dotis J, 2012, PERITON DIALYSIS INT, V32, P577, DOI 10.3747/pdi.2011.00300.
   Drees M, 2008, CLIN INFECT DIS, V46, P678, DOI 10.1086/527394.
   DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324.
   Ekhaise F.O., 2008, WORLD J MED SCI, V3, P19.
   Farinas-Alvarez C, 2010, MEDICINE, V10, P3293.
   Griffin D. W., 2001, AEROBIOLOGIA, V17, P203, DOI DOI 10.1023/A:1011868218901.
   Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025.
   Hardy KJ, 2006, INFECT CONT HOSP EP, V27, P127, DOI 10.1086/500622.
   Hayden MK, 2008, INFECT CONT HOSP EP, V29, P149, DOI 10.1086/524331.
   Hayden MK, 2006, CLIN INFECT DIS, V42, P1552, DOI 10.1086/503845.
   Ho J, 2010, CURR OPIN INFECT DIS, V23, P546, DOI 10.1097/QCO.0b013e32833f0d3e.
   Hota B, 2004, CLIN INFECT DIS, V39, P1182, DOI 10.1086/424667.
   Huang SS, 2006, ARCH INTERN MED, V166, P1945, DOI 10.1001/archinte.166.18.1945.
   Hubad B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082186.
   Inweregbu K, 2005, BJA EDUC, V5, P14, DOI 10.1093/bjaceaccp/mki006.
   Ishida T, 2006, SURG TODAY, V36, P504, DOI 10.1007/s00595-006-3178-9.
   Jaffal AA, 1997, ENVIRON INT, V23, P167, DOI 10.1016/S0160-4120(97)00003-2.
   Jensen PA, 1998, SAMPLING CHARACTERIZ, P82.
   Jones AP, 1999, ATMOS ENVIRON, V33, P4535, DOI 10.1016/S1352-2310(99)00272-1.
   Kayabas U, 2008, AM J INFECT CONTROL, V36, P33, DOI 10.1016/i.ajic.2007.03.003.
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130.
   Li CS, 2003, SCI TOTAL ENVIRON, V305, P169, DOI 10.1016/S0048-9697(02)00500-4.
   Liakopoulos V, 2008, NEPHROL DIAL TRANSPL, V23, P2599, DOI 10.1093/ndt/gfn101.
   Maragakis LL, 2004, JAMA-J AM MED ASSOC, V292, P3006, DOI 10.1001/jama.292.24.3006.
   Martinez JA, 2003, ARCH INTERN MED, V163, P1905, DOI 10.1001/archinte.163.16.1905.
   Martinez-Martinez L, 2010, ENFERM INFEC MICR CL, V28, P25, DOI 10.1016/S0213-005X(10)70027-6.
   Martins-Diniz JN, 2005, REV SAUDE PUBL, V39, P398, DOI 10.1590/S0034-89102005000300010.
   Mongkolrattanothai K, 2003, CLIN INFECT DIS, V37, P1050, DOI 10.1086/378277.
   Newman Mercy J, 2002, West Afr J Med, V21, P310.
   Botelho AMN, 2012, J MED MICROBIOL, V61, P1136, DOI 10.1099/jmm.0.035931-0.
   Okten S, 2012, ENVIRON MONIT ASSESS, V184, P1739, DOI 10.1007/s10661-011-2075-x.
   Palma S, 2007, INFECT CONT HOSP EP, V28, P489, DOI 10.1086/513026.
   Real R, 1996, SYST BIOL, V45, P380, DOI 10.2307/2413572.
   Rohlf F. J., 1998, NUMERICAL TAXONOMY M.
   ROLANDI L, 1998, TOXICOL LETT, V95, P226.
   Rosa M., 2002, OBSERVATORIO MEDIOAM, V5, P375.
   Rosas I., 1994, AEROBIOLOGIA, V10, P39.
   Ross C, 2004, BRAZ ARCH BIOL TECHN, V47, P827, DOI 10.1590/S1516-89132004000500020.
   SCHABERG DR, 1991, AM J MED, V91, pS72, DOI 10.1016/0002-9343(91)90346-Y.
   Sexton T, 2006, J HOSP INFECT, V62, P187, DOI 10.1016/j.jhin.2005.07.017.
   SNEATH PHA, 1973, NUMERICAL TAXONOMY, P188.
   Solberg CO, 2000, SCAND J INFECT DIS, V32, P587, DOI 10.1080/003655400459478.
   Talbot GH, 2010, INFECT CONT HOSP EP, V31, pS55, DOI 10.1086/655988.
   Ternes YM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-572.
   Thanos M, 1996, J CLIN MICROBIOL, V34, P615.
   Tong YY, 1997, PHOTOCHEM PHOTOBIOL, V65, P103, DOI 10.1111/j.1751-1097.1997.tb01884.x.
   Vila J, 2008, ENFERM INFEC MICR CL, V26, P48, DOI 10.1157/13114395.
   Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x.}},
Number-of-Cited-References = {{55}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{15}},
Journal-ISO = {{Aerobiologia}},
Doc-Delivery-Number = {{DM5QH}},
Unique-ID = {{ISI:000376404600003}},
DA = {{2018-08-13}},
}

@article{ ISI:000376688000020,
Author = {Ofori, Afua and Steinmetz, Alexis R. and Akaasi, John and Frimpong,
   George A. Asafu Adjaye and Norman, Betty R. and Obeng-Baah, Joseph and
   Bedu-Addo, George and Phillips, Richard O.},
Title = {{Pulmonary aspergilloma: An evasive disease}},
Journal = {{INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY}},
Year = {{2016}},
Volume = {{5}},
Number = {{2}},
Pages = {{235-239}},
Month = {{JUN}},
Abstract = {{Aspergillomas are often misdiagnosed as tuberculosis (TB) in developing
   countries where the prevalence of TB is high, hemoptysis is often
   equated with TB, and most patients are diagnosed clinically. This report
   describes the case of a patient being treated for smear-negative TB who
   presented with hemoptysis and was found to have an aspergilloma. (C)
   2016 Asian-African Society for Mycobacteriology. Production and hosting
   by Elsevier Ltd. All rights reserved.}},
Publisher = {{WOLTERS KLUWER MEDKNOW PUBLICATIONS}},
Address = {{WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Steinmetz, AR (Reprint Author), Loyola Univ Chicago, Stritch Sch Med, Dept Med, 2160 S First Ave, Maywood, IL 60153 USA.
   Phillips, RO (Reprint Author), Kwame Nkrumah Univ Sci \& Technol, Sch Med Sci, Private Mail Bag,Univ PO, Kumasi, Ghana.
   Ofori, Afua; Norman, Betty R.; Obeng-Baah, Joseph; Phillips, Richard O., Komfo Anokye Teaching Hosp, Dept Med, Kumasi, Ghana.
   Steinmetz, Alexis R., Loyola Univ Chicago, Stritch Sch Med, Dept Med, 2160 S First Ave, Maywood, IL 60153 USA.
   Akaasi, John; Frimpong, George A. Asafu Adjaye; Norman, Betty R.; Bedu-Addo, George; Phillips, Richard O., Kwame Nkrumah Univ Sci \& Technol, Sch Med Sci, Private Mail Bag,Univ PO, Kumasi, Ghana.}},
DOI = {{10.1016/j.ijmyco.2016.03.002}},
ISSN = {{2212-5531}},
Keywords = {{Air crescent sign; Drug-resistant tuberculosis; Massive hemoptysis;
   Pulmonary tuberculosis; Smear-negative tuberculosis}},
Keywords-Plus = {{SURGICAL-TREATMENT; FUNGAL-INFECTIONS; DIAGNOSIS; GUIDELINES; MANAGEMENT}},
Research-Areas = {{Mycology}},
Web-of-Science-Categories  = {{Mycology}},
Author-Email = {{alexis.steinmetz@gmail.com
   rodamephillips@gmail.com}},
ORCID-Numbers = {{Phillips, Richard/0000-0001-8992-0222}},
Funding-Acknowledgement = {{Ghana National TB control program; Medical Research Council
   {[}MR/J01477X/1]}},
Funding-Text = {{We are grateful to the patient for providing permission to publish this
   case report. The Ghana National TB control program partly funded the
   microbiological testing. This work was not supported by any external
   funding.}},
Cited-References = {{ADEYEMO AO, 1984, THORAX, V39, P862, DOI 10.1136/thx.39.11.862.
   Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236.
   CAMPBELL JH, 1991, THORAX, V46, P839, DOI 10.1136/thx.46.11.839.
   Chakrabarti A., 2005, Journal of Postgraduate Medicine, V51, P16.
   Chen JC, 1997, THORAX, V52, P810, DOI 10.1136/thx.52.9.810.
   Denning DW, 2016, EUR RESPIR J, V47, P45, DOI 10.1183/13993003.00583-2015.
   Denning DW, 2011, B WORLD HEALTH ORGAN, V89, P864, DOI 10.2471/BLT.11.089441.
   Enoch DA, 2006, J MED MICROBIOL, V55, P809, DOI 10.1099/jmm.0.46548-0.
   Fishman A., 2008, FISHMANS PULMONARY D.
   Godet C, 2014, RESPIRATION, V88, P162, DOI 10.1159/000362674.
   Hassan M.Y., 2004, E CENTRAL AFR J SURG, V9, P72.
   Kant S., 2007, INTERNET J PULM MED, V10, pe1.
   Kawamura S., 2002, INT MED, V39, P209.
   Kim YT, 2005, ANN THORAC SURG, V79, P294, DOI 10.1016/j.athoraesur.2004.05.050.
   Lachanas E, 2005, RESPIRATION, V72, P657, DOI 10.1159/000087183.
   Longo L.D., 2012, HARRISONS PRINCIPLES.
   Martinez R, 2009, REV I MED TROP, V51, P49, DOI 10.1590/S0036-46652009000100009.
   Moodley L, 2014, J THORAC DIS, V6, P202, DOI 10.3978/j.issn.2072-1439.2013.12.40.
   Nguyen MH, 2007, J CLIN MICROBIOL, V45, P2787, DOI 10.1128/JCM.00716-07.
   Park SY, 2011, CLIN INFECT DIS, V52, pE149, DOI 10.1093/cid/cir027.
   Pohl C., 2013, PLOS NEGLECT TROP D, V7, P2352.
   Sagan D, 2010, ANN THORAC SURG, V89, P1603, DOI 10.1016/j.athoracsur.2010.02.037.
   Sharma S., 2013, BMJ CASE REP, V2013.
   Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Int. J. Mycobact.}},
Doc-Delivery-Number = {{DM9LO}},
Unique-ID = {{ISI:000376688000020}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000374916800038,
Author = {Rouhani, Parvaneh and Govindaraju, Nirmal and Iyer, Janaki K. and Kaul,
   Rashmi and Kaul, Anil and Singh, Raj N.},
Title = {{Purification and functionalization of nanodiamond to serve as a platform
   for amoxicillin delivery}},
Journal = {{MATERIALS SCIENCE \& ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS}},
Year = {{2016}},
Volume = {{63}},
Pages = {{323-332}},
Month = {{JUN 1}},
Abstract = {{Urinary tract infections (UTIs) cost \$0.4-0.5 billion a year in the US
   and is the second most common disease affecting millions of people. As
   resistance to antibiotics becomes more common, a greater need for
   alternative treatments is needed. Nanodiamond particles (NDPs) are
   actively researched as drug delivery platforms due to their
   biocompatibility, particle size, and stable inert core. This research is
   aimed at developing NDPs as antibiotic drug delivery platforms for
   treating UTIs. To this end, 100 nm, 75 nm, 25 nm and 6 nm size NDPs are
   purified with acid and heat treatment techniques. Raman spectra of the
   NDPs showed that the acid treatment method resulted in higher diamond
   yield. Fourier transform infrared spectroscopy (FTIR) studies showed
   that both purification techniques result in oxygen terminated surface
   groups. Efficiency of loading amoxicillin on 25 nm NDPs based on
   electrostatic interaction of NDPs, functionalizing surfaces of NDPs with
   hydrogen, and polyethylenimine (PEI) are investigated. It it found that
   the electrostatic and surface hydrogenation approaches are not efficient
   in loading amoxicillin on the NDPs. On the other hand, PEI
   functionalized NDPs produced successful loading with amoxicillin as
   indicated by the presence of the beta-lactam peak at 1770 cm(-1), amide
   peak at 1680 cm(-1), and bond between PEI NH stretching and amoxicillin
   -COOH group at 3650 cm(-1) by the FTIR spectra. These results are
   expected to lay the foundation for developing NDP based targeted drug
   delivery treatment techniques for treating UTIs and other infectious
   diseases. (C) 2016 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Singh, RN (Reprint Author), Oklahoma State Univ, 700 N Greenwood Ave, Tulsa, OK 74106 USA.
   Rouhani, Parvaneh; Govindaraju, Nirmal; Singh, Raj N., Oklahoma State Univ, Sch Mat Sci \& Engn, Helmerich Res Ctr, Tulsa, OK 74106 USA.
   Iyer, Janaki K.; Kaul, Rashmi; Kaul, Anil, Oklahoma State Univ, Dept Biochem \& Microbiol, Ctr Hlth Sci, Tulsa, OK 74107 USA.}},
DOI = {{10.1016/j.msec.2016.02.075}},
ISSN = {{0928-4931}},
EISSN = {{1873-0191}},
Keywords = {{Nanodiamond; Targeted drug delivery; Antibiotics; Polyethylenimine;
   Amoxicillin}},
Keywords-Plus = {{DIAMOND THIN-FILMS; TEMPERATURE SYNTHESIS; DRUG-DELIVERY;
   NANOCRYSTALLINE; MICROCRYSTALLINE; NANOPARTICLES; CHEMISTRY; SURFACES;
   HYDROGEN; AIR}},
Research-Areas = {{Materials Science}},
Web-of-Science-Categories  = {{Materials Science, Biomaterials}},
Funding-Acknowledgement = {{Oklahoma Center for the Advancement of Science and Technology (OCAST)
   {[}HR14-065]; Oklahoma State University through Williams Companies Chair
   funds}},
Funding-Text = {{This project was partially supported through a grant HR14-065 from
   Oklahoma Center for the Advancement of Science and Technology (OCAST)
   and Oklahoma State University through Williams Companies Chair funds of
   Professor Raj Singh.}},
Cited-References = {{{[}Anonymous], 2013, BRAZ J CHEM ENG, V30, P45.
   Bennett PM, 2008, BRIT J PHARMACOL, V153, pS347, DOI 10.1038/sj.bjp.0707607.
   Chang YR, 2008, NAT NANOTECHNOL, V3, P284, DOI 10.1038/nnano.2008.99.
   Chatterjee A., 2014, BIOMEDO, V20.
   Chen M, 2010, J PHYS CHEM LETT, V1, P3167, DOI 10.1021/jz1013278.
   Chow EK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001713.
   Das D, 2007, INT MATER REV, V52, P29, DOI 10.1179/174328007X160245.
   Das D, 2006, DIAM RELAT MATER, V15, P1336, DOI 10.1016/j.diamond.2005.10.016.
   Faraji AH, 2009, BIOORGAN MED CHEM, V17, P2950, DOI 10.1016/j.bmc.2009.02.043.
   Govindaraju N, 2008, J MATER RES, V23, P2774, DOI 10.1557/JMR.2008.0330.
   Govindaraju N, 2011, MATER SCI ENG B-ADV, V176, P1058, DOI 10.1016/j.mseb.2011.05.042.
   Govindaraju N, 2010, ECS TRANSACTIONS, V33, P155, DOI 10.1149/1.3485615.
   Govindaraju N, 2011, J MATER RES, V26, P3072, DOI 10.1557/jmr.2011.396.
   Jiang TL, 1996, J CHEM SOC FARADAY T, V92, P3401, DOI 10.1039/ft9969203401.
   Lee DK, 2015, ACS NANO, V9, P11490, DOI 10.1021/acsnano.5b05718.
   Maier F, 2000, PHYS REV LETT, V85, P3472, DOI 10.1103/PhysRevLett.85.3472.
   Mochalin VN, 2012, NAT NANOTECHNOL, V7, P11, DOI {[}10.1038/NNANO.2011.209, 10.1038/nnano.2011.209].
   Mochalin VN, 2009, J AM CHEM SOC, V131, P4594, DOI 10.1021/ja9004514.
   Myshakina NS, 2008, J PHYS CHEM B, V112, P11873, DOI 10.1021/jp8057355.
   Narayan RJ, 2006, DIAM RELAT MATER, V15, P1935, DOI 10.1016/j.diamond.2006.08.024.
   Osawa E., 2012, J MED ALLIED SCI.
   Osswald S, 2006, J AM CHEM SOC, V128, P11635, DOI 10.1021/ja063303n.
   Rezek B, 2006, DIAM RELAT MATER, V15, P1374, DOI 10.1016/j.diamond.2005.10.002.
   Rezek B, 2003, APPL PHYS LETT, V82, P3336, DOI 10.1063/1.1576507.
   Schrand A. M., 2009, SAFETY NANOPARTICLES.
   Schrand AM, 2007, J PHYS CHEM B, V111, P2, DOI 10.1021/jp066387v.
   Shimkunas RA, 2009, BIOMATERIALS, V30, P5720, DOI 10.1016/j.biomaterials.2009.07.004.
   Thanh NTK, 2010, NANO TODAY, V5, P213, DOI 10.1016/j.nantod.2010.05.003.
   Turcheniuk V., 2014, DIAM RELAT MAT.
   Ushizawa K, 2002, CHEM PHYS LETT, V351, P105, DOI 10.1016/S0009-2614(01)01362-8.
   Zaitsev A. M., 2001, OPTICAL PROPERTIES D.
   Zhang XQ, 2009, ACS NANO, V3, P2609, DOI 10.1021/nn900865g.
   Zhu Y, 2012, THERANOSTICS, V2, P302, DOI 10.7150/thno.3627.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{5}},
Usage-Count-Since-2013 = {{34}},
Journal-ISO = {{Mater. Sci. Eng. C-Mater. Biol. Appl.}},
Doc-Delivery-Number = {{DK4UW}},
Unique-ID = {{ISI:000374916800038}},
DA = {{2018-08-13}},
}

@article{ ISI:000376689700001,
Author = {Cuperus, Tryntsje and van Dijk, Albert and Matthijs, Mieke G. R. and
   Veldhuizen, Edwin J. A. and Haagsman, Henk P.},
Title = {{Protective effect of in ovo treatment with the chicken cathelicidin
   analog D-CATH-2 against avian pathogenic E. coli}},
Journal = {{SCIENTIFIC REPORTS}},
Year = {{2016}},
Volume = {{6}},
Month = {{MAY 27}},
Abstract = {{Increasing antibiotic resistance and ever stricter control on antibiotic
   use are a driving force to develop alternatives to antibiotics. One such
   strategy is the use of multifunctional Host Defense Peptides. Here we
   examined the protective effect of prophylactic treatment with the D
   analog of chicken cathelicidin-2 (D-CATH-2) against a respiratory E.
   coli infection. Chickens were treated with D-CATH-2 in ovo at day 18 of
   embryonic development or intramuscularly at days 1 and 4 after hatch. At
   7 days of age, birds were challenged intratracheally with avian
   pathogenic E. coli. Protection was evaluated by recording mortality,
   morbidity (Mean Lesion Score) and bacterial swabs of air sacs at 7 days
   post-infection. In ovo D-CATH-2 treatment significantly reduced
   morbidity (63\%) and respiratory bacterial load (>90\%), while
   intramuscular treatment was less effective. D-CATH-2 increased the
   percentage of peripheral blood lymphocytes and heterophils by both
   administration routes. E. coli specific IgM levels were lower in in ovo
   treated animals compared to intramuscular D-CATH-2 treatment. In short,
   in ovo treatment with the Host Defense Peptide derived D-CATH-2 can
   partially protect chickens from E. coli infection, making this peptide
   an interesting starting point to develop alternatives to antibiotics for
   use in the poultry sector.}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{van Dijk, A (Reprint Author), Univ Utrecht, Fac Vet Med, Dept Infect Dis \& Immunol, Div Mol Host Def, Utrecht, Netherlands.
   Cuperus, Tryntsje; van Dijk, Albert; Veldhuizen, Edwin J. A.; Haagsman, Henk P., Univ Utrecht, Fac Vet Med, Dept Infect Dis \& Immunol, Div Mol Host Def, Utrecht, Netherlands.
   Matthijs, Mieke G. R., Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Div Poultry Hlth, Utrecht, Netherlands.}},
DOI = {{10.1038/srep26622}},
Article-Number = {{26622}},
ISSN = {{2045-2322}},
Keywords-Plus = {{HOST-DEFENSE PEPTIDES; INFECTIOUS-BRONCHITIS VIRUS; ESCHERICHIA-COLI;
   RESPIRATORY-TRACT; BROILER-CHICKENS; IMMUNE-RESPONSE; RESISTANCE; CELLS;
   DNA; DIFFERENTIATION}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{h.p.haagsman@uu.nl}},
Funding-Acknowledgement = {{Immuno Valley ALTernatives to ANTibiotics (ALTANT) Animal Specific
   Immunomodulatory Antimicrobials (ASIA) 2 program of the Dutch Ministry
   of Economic Affairs}},
Funding-Text = {{We would like to thank Hanne Tjeerdsma-van Bokhoven for performing the
   antibody measurements. Marius Dwars, Robbert van Sambeek, Freek Weites
   and Marc Kranenburg of the Department of Farm Animal Health, Faculty of
   Veterinary Medicine, Utrecht University are thanked for their help with
   the animal work. We are grateful to Richard Wubbolts from the Center for
   Cell Imaging, Faculty of Veterinary Medicine, Utrecht University for his
   help designing an Image J plugin to quantify TUNEL results. This work
   was supported by the Immuno Valley ALTernatives to ANTibiotics (ALTANT)
   Animal Specific Immunomodulatory Antimicrobials (ASIA) 2 program of the
   Dutch Ministry of Economic Affairs.}},
Cited-References = {{Annamalai T, 2012, POULTRY SCI, V91, P1326, DOI 10.3382/ps.2011-02026.
   Ariaans MP, 2008, VET IMMUNOL IMMUNOP, V123, P240, DOI 10.1016/j.vetimm.2008.02.003.
   Barnes JH, 2008, DIS POULTRY, P691.
   Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466.
   Bommineni YR, 2014, MOL IMMUNOL, V59, P55, DOI 10.1016/j.molimm.2014.01.004.
   Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271.
   Choi KY, 2012, J INNATE IMMUN, V4, P361, DOI 10.1159/000336630.
   Coorens M, 2015, J IMMUNOL, V195, P3970, DOI 10.4049/jimmunol.1501242.
   Cuperus T, 2013, DEV COMP IMMUNOL, V41, P352, DOI 10.1016/j.dci.2013.04.019.
   Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146.
   De Brucker K, 2014, ANTIMICROB AGENTS CH, V58, P5395, DOI 10.1128/AAC.03045-14.
   Dwars RM, 2009, VET IMMUNOL IMMUNOP, V127, P65, DOI 10.1016/j.vetimm.2008.09.019.
   Gomis S, 2004, AVIAN DIS, V48, P813, DOI 10.1637/7194-041204R.
   Gyles Carlton L., 2008, Animal Health Research Reviews, V9, P149, DOI 10.1017/S1466252308001552.
   Horn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041031.
   Iseri V. J., 2013, DEV COMP IMMUNOL, V40, P257.
   Jochemsen P, 2002, POULTRY SCI, V81, P1811, DOI 10.1093/ps/81.12.1811.
   Kariyawasam S, 2004, VET MICROBIOL, V98, P273, DOI 10.1016/j.vetmic.2003.10.022.
   Kin NW, 2011, EUR J IMMUNOL, V41, P3006, DOI 10.1002/eji.201141606.
   Kindrachuk J, 2011, BIOPOLYMERS, V96, P14, DOI 10.1002/bip.21441.
   Kurosaka K, 2005, J IMMUNOL, V174, P6257, DOI 10.4049/jimmunol.174.10.6257.
   LARRICK JW, 1995, IMMUNOTECHNOLOGY, V1, P65, DOI 10.1016/1380-2933(95)00006-2.
   Lee SH, 2014, POULTRY SCI, V93, P1113, DOI 10.3382/ps.2013-03770.
   LEITNER G, 1990, AVIAN DIS, V34, P58, DOI 10.2307/1591334.
   Bedran TBL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106766.
   Molhoek EM, 2011, PEPTIDES, V32, P875, DOI 10.1016/j.peptides.2011.02.017.
   Molhoek EM, 2010, INT J ANTIMICROB AG, V36, P271, DOI 10.1016/j.ijantimicag.2010.06.001.
   NAKAMURA K, 1986, VET PATHOL, V23, P712, DOI 10.1177/030098588602300610.
   Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813.
   Olsen RH, 2012, AVIAN DIS, V56, P51, DOI 10.1637/9777-051011-Reg.1.
   Ricks CA, 1999, ADV VET MED-ACAD PR, V41, P495.
   ROMANOFF AL, 1952, ANN NY ACAD SCI, V55, P288, DOI 10.1111/j.1749-6632.1952.tb26545.x.
   Sang YM, 2009, DEV COMP IMMUNOL, V33, P334, DOI 10.1016/j.dci.2008.05.006.
   Schneider VAF, 2016, DEV COMP IMMUNOL, V60, P108, DOI 10.1016/j.dci.2016.02.023.
   Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288.
   SHARMA JM, 1982, AVIAN DIS, V26, P134, DOI 10.2307/1590032.
   SHARMA JM, 1984, AM J VET RES, V45, P1619.
   Taghavi A, 2008, AVIAN DIS, V52, P398, DOI 10.1637/8196-121907-Reg.
   Tomasinsig L, 2010, INFECT IMMUN, V78, P1781, DOI 10.1128/IAI.01090-09.
   van der Does AM, 2010, J IMMUNOL, V185, P1442, DOI 10.4049/jimmunol.1000376.
   van Dijk A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147919.
   van Dijk A, 2009, MOL IMMUNOL, V46, P2465, DOI 10.1016/j.molimm.2009.05.019.
   Van Dijk A, 2009, MOL IMMUNOL, V46, P1517, DOI 10.1016/j.molimm.2008.12.015.
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034.
   VANECK JHH, 1991, AVIAN PATHOL, V20, P497, DOI 10.1080/03079459108418787.
   Veldhuizen EJA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061964.
   Wang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022120.
   Wu W, 2012, LEUKEMIA, V26, P736, DOI 10.1038/leu.2011.252.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{6}},
Journal-ISO = {{Sci Rep}},
Doc-Delivery-Number = {{DM9MF}},
Unique-ID = {{ISI:000376689700001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000382551900001,
Author = {Takeuti, Karine Ludwig and Malgarin, Carolina Maciel and Amaral, Amanda
   Figueiredo and Santos Neves de Barcellos, David Emilio},
Title = {{Frequency of Methicillin-Resistant Staphylococcus aureus (MRSA) in
   Fattening Pigs in the State of Rio Grande do Sul, Brazil}},
Journal = {{ACTA SCIENTIAE VETERINARIAE}},
Year = {{2016}},
Volume = {{44}},
Month = {{MAY 23}},
Abstract = {{Background: Staphylococcus (S.) aureus is an important nosocomial
   pathogen in humans and animals worldwide. The commonest class of
   antibiotics used to treat staphylococcal infections is the beta-lactams.
   Frequently, S. aureus strains show high resistance to methicillin and
   other beta-lactam antibiotics, called ``Methicillin-resistant
   Staphylococcus aureus{''} (MRSA). Although MRSA has emerged at slower
   rate in domestic animals, it has frequently been found in the nasal
   cavity of healthy piglets and its transmission between pigs and swine
   handlers has already been studied. The aim of this work was to assess
   the presence of MRSA in finishing pigs in the state of Rio Grande do
   Sul, Brazil.
   Materials, Methods \& Results: A total of 350 nasal swabs were collected
   from 10 to 20 week old finishing pigs. Sampling was performed in five
   pig farms in northeast Rio Grande do Sul State, Brazil. Swabs were
   stored in tubes without transport medium and carried to the laboratory
   under refrigeration. The specimens were cultured in selective and
   differential Agar (Baird Parker) and then were incubated at 37 degrees C
   for 48 h. After isolation of typical colonies of S. aureus, they were
   inoculated in BHI (Brain Heart Infusion) broth at 37 degrees C for 24 h
   and tested for tube coagulase activity. Coagulase positive samples were
   selected for growth in Oxacillin Resistant Screening Agar (ORSA)
   supplemented with 2 mg/ L of oxacillin. This media contains aniline blue
   to demonstrate mannitol fermentation. Oxacillin and 5.5\% NaCl have the
   capacity to reduce the growth of non-staphylococcal bacteria, selecting
   for MRSA. Blue colonies growth after 24 to 48 h of incubation at 37
   degrees C indicate the presence of positive MRSA strains. Specimens with
   at least one colony growing in ORSA within 48 h were considered
   resistant. Linear regression was performed in order to identify the
   association between herd size and MRSA frequency (SAS 9.4, 2012). Growth
   of S. aureus occurred on 18.0\% of the samples and differences among
   farms were found. However, after incubation in ORSA only 18 (5.1\%) were
   MRSA positive, ranging from zero to 12.5\% among farms. Significant
   correlation between herd size and MRSA frequency (adjusted r(2) = 0.978;
   P = 0.001) was observed.
   Discussion: In a previous study in pig herds in Brazil examining swine
   nasal swabs, 22.5\% was positive for S. aureus and none for MRSA. One of
   5 farms tested in our work also had no positive animals and 4 of them
   showed low frequencies, ranging from 1.7\% to 12.5\% with an average of
   5.1\%. Our results were similar to those found in Asian countries, but
   were very different from European data. Some factors can be associated
   with MRSA frequency in pig farms, such as dust, air contamination, poor
   hygiene, age, herd size, replacement rate and number of sources. In the
   present work we found a strong positive correlation (r(2) adjusted =
   0.978; P = 0.001) between herd size and MRSA frequency, such as detected
   by previous authors. It might occur due to a higher risk of bacterial
   introduction and higher pressure of infection, easing dissemination of
   MRSA. Herd size may be a crucial factor to explain the frequencies
   found, since farms had very similar facilities and handling practices.
   Although the average frequency has been low in this work when compared
   to other countries, MRSA was present in almost all farms. This bacteria
   is able to transmit mecA gene to S. aureus susceptible populations,
   increasing MRSA frequencies over time.}},
Publisher = {{UNIV FED RIO GRANDE DO SUL}},
Address = {{FAC VET, CAIXA POSTAL 15017, PORTO ALEGRE RS, 91501-570, BRAZIL}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Takeuti, KL (Reprint Author), Ave Bento Goncalves 9090, BR-91540000 Porto Alegre, RS, Brazil.
   Takeuti, Karine Ludwig; Malgarin, Carolina Maciel; Amaral, Amanda Figueiredo; Santos Neves de Barcellos, David Emilio, Univ Fed Rio Grande do Sul, Fac Vet, Setor Suinos, Porto Alegre, RS, Brazil.}},
Article-Number = {{1358}},
ISSN = {{1678-0345}},
EISSN = {{1679-9216}},
Keywords = {{swine; MRSA; resistance; nasal swabs}},
Keywords-Plus = {{OXACILLIN RESISTANCE; PREVALENCE; SWINE}},
Research-Areas = {{Veterinary Sciences}},
Web-of-Science-Categories  = {{Veterinary Sciences}},
Author-Email = {{karinelt87@yahoo.com.br}},
Cited-References = {{Alt K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-69.
   Aquino GD, 2012, ZOONOSES PUBLIC HLTH, V59, P1, DOI 10.1111/j.1863-2378.2011.01413.x.
   Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866.
   Broens EM, 2011, PREV VET MED, V102, P41, DOI 10.1016/j.prevetmed.2011.06.005.
   Caddick JM, 2006, J MICROBIOL METH, V65, P87, DOI 10.1016/j.mimet.2005.06.017.
   Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275.
   de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027.
   EFSA, 2010, EFSA J, V8, P1, DOI DOI 10.2903/J.EFSA.2010.1637.
   Gibbs SG, 2004, J OCCUP ENVIRON HYG, V1, P699, DOI 10.1080/15459620490515824.
   Huijsdens X. W., 2006, ANN CLIN MICROB ANTI, V10, P5.
   Karthy E. S., 2009, Modern Applied Science, V3, P51.
   Kluytmans J, 2002, J CLIN MICROBIOL, V40, P2480, DOI 10.1128/JCM.40.7.2480-2482.2002.
   Lim SK, 2012, VET MICROBIOL, V155, P88, DOI 10.1016/j.vetmic.2011.08.011.
   Markey B., 2013, STAPHYLOCOCCUS SPECI, P105.
   Masson G. C. I. H., 2012, Archives of Veterinary Science, V17, P1.
   Meemken D, 2010, ZOONOSES PUBLIC HLTH, V57, pE143, DOI 10.1111/j.1863-2378.2009.01313.x.
   van der Wolf PJ, 2012, VET MICROBIOL, V158, P136, DOI 10.1016/j.vetmic.2012.01.025.
   van Duijkeren E, 2007, EMERG INFECT DIS, V13, P1408, DOI 10.3201/eid1309.061268.
   Velasco D, 2005, J ANTIMICROB CHEMOTH, V55, P379, DOI 10.1093/jac/dki017.
   Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428.
   Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039.}},
Number-of-Cited-References = {{21}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{9}},
Journal-ISO = {{Acta Sci. Vet.}},
Doc-Delivery-Number = {{DU9QG}},
Unique-ID = {{ISI:000382551900001}},
DA = {{2018-08-13}},
}

@article{ ISI:000378436500002,
Author = {Verkuijl, Sabine and Middelkoop, Keren},
Title = {{Protecting Our Front-liners: Occupational Tuberculosis Prevention
   Through Infection Control Strategies}},
Journal = {{CLINICAL INFECTIOUS DISEASES}},
Year = {{2016}},
Volume = {{62}},
Number = {{3}},
Pages = {{S231-S237}},
Month = {{MAY 15}},
Abstract = {{Healthcare workers (HCWs) in low- and middle-income countries with high
   tuberculosis prevalence are at increased risk of tuberculosis infection;
   however, tuberculosis infection control (TBIC) measures are often poorly
   implemented. The World Health Organization recommends 4 levels of TBIC:
   managerial (establishment and oversight of TBIC policies),
   administrative controls (reducing HCWs' exposure to tuberculosis),
   environmental controls (reducing the concentration of infectious
   respiratory aerosols in the air), and personal respiratory protection.
   This article will discuss each of these levels of TBIC, and review the
   available data on the implementation of each in sub-Saharan African
   countries. In addition, we review the attitudes and motivation of HCWs
   regarding TBIC measures, and the impact of stigma on infection control
   practices and implementation. After summarizing the challenges facing
   effective TBIC implementation, we will discuss possible solutions and
   recommendations. Last, we present a case study of how a clinic
   effectively addressed some of the challenges of TBIC implementation.}},
Publisher = {{OXFORD UNIV PRESS INC}},
Address = {{JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Verkuijl, S (Reprint Author), Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care \& Treatment Programs, Dreve Rembucher 93, B-1170 Watermael Boitsfort, Belgium.
   Verkuijl, Sabine, Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care \& Treatment Programs, Dreve Rembucher 93, B-1170 Watermael Boitsfort, Belgium.
   Middelkoop, Keren, Univ Cape Town, Desmond Tutu HIV Ctr, Dept Med, ZA-7700 Rondebosch, South Africa.
   Middelkoop, Keren, Univ Cape Town, Inst Infect Dis \& Mol Med, ZA-7700 Rondebosch, South Africa.}},
DOI = {{10.1093/cid/civ1184}},
ISSN = {{1058-4838}},
EISSN = {{1537-6591}},
Keywords = {{tuberculosis; infection control; healthcare workers; occupational health}},
Keywords-Plus = {{DRUG-RESISTANT TUBERCULOSIS; HEALTH-CARE WORKERS; RESOURCE-LIMITED
   SETTINGS; SUB-SAHARAN AFRICA; SOUTH-AFRICA; HIV CARE; IMPLEMENTATION;
   FACILITIES; TB; TRANSMISSION}},
Research-Areas = {{Immunology; Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Immunology; Infectious Diseases; Microbiology}},
Author-Email = {{sv2221@cumc.columbia.edu}},
Funding-Acknowledgement = {{US President's Emergency Plan for AIDS Relief (PEPFAR) through the
   Centers for Disease Control and Prevention (CDC) {[}5U2GGH000388]; Hasso
   Plattner Foundation award via University of Cape Town; Bill \& Melinda
   Gates Foundation {[}OPP1116641]}},
Funding-Text = {{S. V. and K. M. are supported by the US President's Emergency Plan for
   AIDS Relief (PEPFAR) through the Centers for Disease Control and
   Prevention (CDC) (cooperative agreement number 5U2GGH000388). K. M. is
   also supported by the Hasso Plattner Foundation award via University of
   Cape Town and the Bill \& Melinda Gates Foundation (OPP1116641).}},
Cited-References = {{Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5.
   Bock NN, 2007, J INFECT DIS, V196, pS108, DOI 10.1086/518661.
   Brouwer M, 2015, INT J TUBERC LUNG D, V19, P44, DOI 10.5588/ijtld.14.0337.
   Brouwer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114364.
   Buregyeya E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-360.
   Christodoulou M, 2011, LANCET INFECT DIS, V11, P663, DOI 10.1016/S1473-3099(11)70228-6.
   Claassens MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076272.
   Cox H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029589.
   Dharmadhikari A, 2010, AM J RESP CRIT CARE, V181.
   Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043.
   Farley JE, 2012, INT J TUBERC LUNG D, V16, P82, DOI 10.5588/ijtld.10.0791.
   Gupta S, 2014, INT J TUBERC LUNG D, V18, P1149, DOI 10.5588/ijtld.13.0889.
   Howard AA, 2010, CLIN INFECT DIS, V50, pS238, DOI 10.1086/651497.
   Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494.
   Kanjee Z, 2012, J Infect Public Health, V5, P67, DOI 10.1016/j.jiph.2011.10.008.
   Kanjee Z, 2011, J HOSP INFECT, V79, P333, DOI 10.1016/j.jhin.2011.06.017.
   Naidoo S, 2012, INT J TUBERC LUNG D, V16, P1600, DOI 10.5588/ijtld.12.0041.
   Nardell E, 2010, INT J TUBERC LUNG D, V14, P1233.
   Nardell E, 2013, PHOTOCHEM PHOTOBIOL, V89, P764, DOI 10.1111/php.12098.
   O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008.
   Ogbonnaya LU, 2011, NIGER J CLIN PRACT, V14, P270, DOI 10.4103/1119-3077.86765.
   Reid MJA, 2012, INT J TUBERC LUNG D, V16, P1605, DOI 10.5588/ijtld.12.0033.
   Robert J, 2013, INFECT CONT HOSP EP, V34, P190, DOI 10.1086/669085.
   Shenoi SV, 2010, CLIN INFECT DIS, V50, pS231, DOI 10.1086/651496.
   Sissolak D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-262.
   Somma D, 2008, INT J TUBERC LUNG D, V12, P856.
   TBCTA, 2010, IMPL WHO POL TB INF.
   Tudor C, 2013, Int J Tuberc Lung Dis, V17, P22, DOI 10.5588/ijtld.13.0109.
   Tudor C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-891.
   van Rie A, 2013, SAMJ S AFR MED J, V103, P853, DOI {[}10.7196/SAMJ.7092, 10.7196/samj.7092].
   Verkuijl S, 2010, 2 S AFR TB C DURB S.
   VERKUIJL S, 2009, 4 S AFR AIDS C DURB.
   Von Delft A, 2015, INT J INFECT DIS, V32, P147, DOI 10.1016/j.ijid.2014.12.003.
   World Health Organization, 2009, WHO POL TB INF CONTR.
   World Health Organization, 2012, WHO POL COLL TB HIV.
   Zelnick JR, 2013, J PUBLIC HEALTH POL, V34, P388, DOI 10.1057/jphp.2013.20.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{12}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Clin. Infect. Dis.}},
Doc-Delivery-Number = {{DP4AA}},
Unique-ID = {{ISI:000378436500002}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000378633000009,
Author = {Fondi, Marco and Karkman, Antti and Tamminen, Manu V. and Bosi, Emanuele
   and Virta, Marko and Fani, Renato and Alm, Eric and McInerney, James O.},
Title = {{``Every Gene Is Everywhere but the Environment Selects{''}: Global
   Geolocalization of Gene Sharing in Environmental Samples through Network
   Analysis}},
Journal = {{GENOME BIOLOGY AND EVOLUTION}},
Year = {{2016}},
Volume = {{8}},
Number = {{5}},
Pages = {{1388-1400}},
Month = {{MAY}},
Abstract = {{The spatial distribution of microbes on our planet is famously
   formulated in the Baas Becking hypothesis as everything is everywhere
   but the environment selects.{''} While this hypothesis does not strictly
   rule out patterns caused by geographical effects on ecology and
   historical founder effects, it does propose that the remarkable
   dispersal potential of microbes leads to distributions generally shaped
   by environmental factors rather than geographical distance. By
   constructing sequence similarity networks from uncultured environmental
   samples, we show that microbial gene pool distributions are not
   influenced nearly as much by geography as ecology, thus extending the
   Bass Becking hypothesis from whole organisms to microbial genes. We find
   that gene pools are shaped by their broad ecological niche (such as sea
   water, fresh water, host, and airborne). We find that freshwater
   habitats act as a gene exchange bridge between otherwise disconnected
   habitats. Finally, certain antibiotic resistance genes deviate from the
   general trend of habitat specificity by exhibiting a high degree of
   cross-habitat mobility. The strong cross-habitat mobility of antibiotic
   resistance genes is a cause for concern and provides a paradigmatic
   example of the rate by which genes colonize new habitats when new
   selective forces emerge.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{McInerney, JO (Reprint Author), Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland.
   McInerney, JO (Reprint Author), Univ Manchester, Fac Life Sci, Computat Evolutionary Biol, Manchester M13 9PL, Lancs, England.
   Fondi, Marco; Bosi, Emanuele; Fani, Renato, Univ Florence, Dept Biol, Lab Microbial \& Mol Evolut, I-50121 Florence, Italy.
   Fondi, Marco; Bosi, Emanuele; Fani, Renato, Univ Florence, Computat Biol Grp, I-50121 Florence, Italy.
   Karkman, Antti; Virta, Marko, Univ Helsinki, Dept Food \& Environm Sci, FIN-00014 Helsinki, Finland.
   Tamminen, Manu V., Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland.
   Tamminen, Manu V., Eawag, Dept Aquat Ecol, Dubendorf, Switzerland.
   Alm, Eric, MIT, Dept Civil \& Environm Engn, Cambridge, MA 02139 USA.
   McInerney, James O., Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland.
   McInerney, James O., Univ Manchester, Fac Life Sci, Computat Evolutionary Biol, Manchester M13 9PL, Lancs, England.}},
DOI = {{10.1093/gbe/evw077}},
ISSN = {{1759-6653}},
Keywords = {{biogeography; horizontal gene transfer; antibiotic resistance}},
Keywords-Plus = {{MULTIPLE SEQUENCE ALIGNMENT; CHLORAMPHENICOL-RESISTANCE;
   ANTIBIOTIC-RESISTANCE; SIMILARITY NETWORKS; TRANSPOSABLE ELEMENT;
   DATABASE; ECOLOGY; MICROORGANISMS; BIOGEOGRAPHY; FRAGMENTS}},
Research-Areas = {{Evolutionary Biology; Genetics \& Heredity}},
Web-of-Science-Categories  = {{Evolutionary Biology; Genetics \& Heredity}},
Author-Email = {{james.mcinerney@manchester.ac.uk}},
ResearcherID-Numbers = {{Virta, Marko/B-4292-2010
   }},
ORCID-Numbers = {{Virta, Marko/0000-0001-5981-7566
   /0000-0003-1885-2503
   Karkman, Antti/0000-0003-0983-3319
   /0000-0001-5891-7653
   Bosi, Emanuele/0000-0002-4769-8667}},
Funding-Acknowledgement = {{SFI Incoming STTF Programme {[}09/RFP/EOB2510 - ISTTF 1]; Academy of
   Finland; Science Foundation Ireland {[}09/RFP/EOB2510 - ISTTF 1]}},
Funding-Text = {{This work was supported by a grant under the SFI Incoming STTF Programme
   (09/RFP/EOB2510 - ISTTF 1) and a grant from Academy of Finland. This
   work was supported by a grant under the Science Foundation Ireland
   Incoming STTF Programme (09/RFP/EOB2510 - ISTTF 1) and a grant from
   Academy of Finland.}},
Cited-References = {{Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389.
   Alvarez-Ponce D, 2013, P NATL ACAD SCI USA, V110, pE1594, DOI 10.1073/pnas.1211371110.
   Aravind L, 1998, TRENDS GENET, V14, P442, DOI 10.1016/S0168-9525(98)01553-4.
   Baas Becking LGM, 1934, GEOBIOLOGIE INLEIDIN.
   Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006.
   Bastian M, 2009, INT AAAI C WEBL SOC.
   Bosi E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-403.
   Boucher Y, 2011, MBIO, V2, DOI 10.1128/mBio.00335-10.
   Caro-Quintero A, 2011, ISME J, V5, P131, DOI 10.1038/ismej.2010.93.
   CLEWELL DB, 1995, TRENDS MICROBIOL, V3, P229, DOI 10.1016/S0966-842X(00)88930-1.
   Dagan T, 2011, TRENDS MICROBIOL, V19, P483, DOI 10.1016/j.tim.2011.07.001.
   De Luca G, 1998, ZBL HYG UMWELTMED, V201, P269.
   Dishaw LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093386.
   DUNNY GM, 1995, J BACTERIOL, V177, P871, DOI 10.1128/jb.177.4.871-876.1995.
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113.
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340.
   Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI 10.1093/nar/gkt1223.
   Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367.
   Fondi M, 2010, ENVIRON MICROBIOL, V12, P3228, DOI 10.1111/j.1462-2920.2010.02295.x.
   Forster D, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0125-5.
   Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058.
   Halary S, 2010, P NATL ACAD SCI USA, V107, P127, DOI 10.1073/pnas.0908978107.
   Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795.
   Hooper SD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002607.
   Hooper SD, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r45.
   JONES PW, 1980, VET REC, V106, P4, DOI 10.1136/vr.106.1.4.
   JUKES TH, 1969, MAMMALIAN PROTEIN ME, V3, P21.
   Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1\_18.
   Li J, 2013, ENVIRON SCI TECHNOL, V47, P2892, DOI 10.1021/es304616c.
   Lima-Mendez G, 2008, MOL BIOL EVOL, V25, P762, DOI 10.1093/molbev/msn023.
   Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656.
   Machado Moara, 2011, Investig Genet, V2, P3, DOI 10.1186/2041-2223-2-3.
   Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341.
   McInerney JO, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-41.
   Nalbantoglu OU, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-41.
   Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126.
   Popa O, 2011, CURR OPIN MICROBIOL, V14, P615, DOI 10.1016/j.mib.2011.07.027.
   Raes J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.6.
   Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106.
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2.
   Schluter A, 2007, FEMS MICROBIOL REV, V31, P449, DOI 10.1111/j.1574-6976.2007.00074.x.
   Schmieder R, 2012, BIOINFORMATICS, V28, P433, DOI 10.1093/bioinformatics/btr669.
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026.
   SERMONTI G, 1978, MOL GEN GENET, V164, P99, DOI 10.1007/BF00267604.
   Shanahan EF, 2010, INT J ENV RES PUB HE, V7, P565, DOI 10.3390/ijerph7020565.
   Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571.
   STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541.
   Sul WJ, 2013, P NATL ACAD SCI USA, V110, P2342, DOI 10.1073/pnas.1212424110.
   Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102.
   Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI {[}10.1038/nmeth.2693, 10.1038/NMETH.2693].
   Takamatsu D, 2003, PLASMID, V49, P143, DOI 10.1016/S0147-619X(02)00149-X.
   Talavera G, 2007, SYSTEMATIC BIOL, V56, P564, DOI 10.1080/10635150701472164.
   Tamminen M, 2012, MOL BIOL EVOL, V29, P1225, DOI 10.1093/molbev/msr292.
   Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x.
   Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862.
   van Dongen S, 2012, METHODS MOL BIOL, V804, P281, DOI 10.1007/978-1-61779-361-5\_15.
   Zhang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026041.
   Zhou FF, 2010, BIOINFORMATICS, V26, P2051, DOI 10.1093/bioinformatics/btq299.}},
Number-of-Cited-References = {{58}},
Times-Cited = {{12}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{37}},
Journal-ISO = {{Genome Biol. Evol.}},
Doc-Delivery-Number = {{DP6TY}},
Unique-ID = {{ISI:000378633000009}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000374275700042,
Author = {Carey, Stephanie Ann and Goldstein, Rachel E. Rosenberg and Gibbs, Shawn
   G. and Claye, Emma and He, Xin and Sapkota, Amy R.},
Title = {{Occurrence of vancomycin-resistant and -susceptible Enterococcus spp. in
   reclaimed water used for spray irrigation}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2016}},
Volume = {{147}},
Pages = {{350-355}},
Month = {{MAY}},
Abstract = {{Reclaiming municipal wastewater for agricultural, environmental, and
   industrial purposes is increasing in the United States to combat
   dwindling freshwater supplies. However, there is a lack of data
   regarding the microbial quality of reclaimed water. In particular, no
   previous studies have evaluated the occurrence of vancomycin-resistant
   enterococci (VRE) in reclaimed water used at spray irrigation sites in
   the United States. To address this knowledge gap, we investigated the
   occurrence, concentration, and antimicrobial resistance patterns of VRE
   and vancomycin-susceptible enterococci at three U.S. spray irrigation
   sites that use reclaimed water. We collected 48 reclaimed water samples
   from one Mid-Atlantic and two Midwest spray irrigation sites, as well as
   their respective wastewater treatment plants, in 2009 and 2010. Samples
   were analyzed for total enterococci and VRE using standard membrane
   filtration. Isolates were purified and then confirmed using biochemical
   tests and PCR. Antimicrobial susceptibility testing was conducted using
   the Sensititre microbroth dilution system. Data were analyzed by
   two-sample proportion tests and one-way analysis of variance. We
   detected total enterococci and VRE in 71\% (34/48) and 4\% (2/48) of
   reclaimed water samples, respectively. Enterococcus faecalis was the
   most common species identified. At the Mid-Atlantic spray irrigation
   site, UV radiation decreased total enterococci to undetectable levels;
   however, subsequent storage in an. open-air pond at this site resulted
   in increased concentrations of enterococci. E. faecalis isolates
   recovered from the Mid-Atlantic spray irrigation site expressed
   intrinsic resistance to quinupristin/dalfopristin; however, non-E.
   faecalis isolates expressed resistance to quinupristin/dalfopristin
   (52\% of isolates), vancomycin (4\%), tetracycline (13\%), penicillin
   (4\%) and ciprofloxacin (17\%). Our findings show that VRE are present
   in low numbers in reclaimed water at point-of-use at the sampled spray
   irrigation sites; however, resistance to other antimicrobial classes is
   more prevalent, particularly among non-E. faecalis isolates. (C) 2016
   Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Sapkota, AR (Reprint Author), Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, Sch Publ Hlth Bldg 255,4273 Wellness Way, College Pk, MD 20742 USA.
   Carey, Stephanie Ann; Goldstein, Rachel E. Rosenberg; Claye, Emma; Sapkota, Amy R., Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, Sch Publ Hlth Bldg 255,4273 Wellness Way, College Pk, MD 20742 USA.
   Gibbs, Shawn G., Indiana Univ, Sch Publ Hlth Bloomington, Dept Environm Hlth, Bloomington, IN USA.
   He, Xin, Univ Maryland, Sch Publ Hlth, Dept Epidemiol \& Biostat, College Pk, MD 20742 USA.}},
DOI = {{10.1016/j.envres.2016.02.030}},
ISSN = {{0013-9351}},
EISSN = {{1096-0953}},
Keywords = {{Antibiotic-resistant bacteria; Enterococci; Vancomycin-resistant
   enterococci; Wastewater; Reclaimed water; Spray irrigation}},
Keywords-Plus = {{WASTE-WATER; TREATMENT-PLANT; ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL
   RESISTANCE; EFFLUENT; BACTERIA; INFECTIONS; INDICATORS; DIVERSITY;
   FAECIUM}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{ars@umd.edu}},
ResearcherID-Numbers = {{He, Xin/N-6742-2016
   Sapkota, Amy/A-6046-2011}},
Funding-Acknowledgement = {{National Institute for Occupational Safety and Health, Centers for
   Disease Control and Prevention (CDC) {[}1-R03-OH009598-01]}},
Funding-Text = {{We thank the operators of the wastewater treatment plants and spray
   irrigation sites for their participation and assistance. This work was
   supported by the R03 Small Grants Program, Grant \#1-R03-OH009598-01,
   from the National Institute for Occupational Safety and Health, Centers
   for Disease Control and Prevention (CDC). Its contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of CDC.}},
Cited-References = {{Abreu-Acosta N, 2011, ECOL ENG, V37, P496, DOI 10.1016/j.ecoleng.2010.12.014.
   Arias CA, 2012, CLIN INFECT DIS, V54, pS233, DOI 10.1093/cid/cir924.
   Bahri A, 2001, WATER SCI TECHNOL, V43, P117.
   Banerjee T, 2015, J PATHOG, V2015, DOI DOI 10.1155/2015/692612.
   Beier RC, 2008, B ENVIRON CONTAM TOX, V80, P188, DOI 10.1007/s00128-007-9342-0.
   Ben Said L, 2015, SCI TOTAL ENVIRON, V530, P11, DOI 10.1016/j.scitotenv.2015.05.091.
   Caplin JL, 2008, ENVIRON MICROBIOL, V10, P885, DOI 10.1111/j.1462-2920.2007.01507.x.
   Castillo-Rojas G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059491.
   CDC, 2009, DIS ORG HEALTHC SETT.
   CLSI, 2012, PERF STAND ANT SUSC, V32.
   Conner-Kerr T A, 1998, Ostomy Wound Manage, V44, P50.
   da Silva MF, 2006, FEMS MICROBIOL ECOL, V55, P322, DOI 10.1111/j.1574-6941.2005.00032.x.
   EPA, 2002, METH 1600 ENT WAT ME.
   EPA, 2012, GUID WAT REUS.
   Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0.
   Garcia S, 2007, WATER ENVIRON RES, V79, P2387, DOI 10.2175/106143007X183826.
   Goldstein RER, 2014, SCI TOTAL ENVIRON, V466, P404, DOI 10.1016/j.scitotenv.2013.07.039.
   Goldstein RER, 2012, ENVIRON HEALTH PERSP, V120, P1551, DOI 10.1289/ehp.1205436.
   Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861.
   Huang JJ, 2012, ENVIRON INT, V42, P31, DOI 10.1016/j.envint.2011.03.001.
   Levantesi C, 2010, SCI TOTAL ENVIRON, V408, P4923, DOI 10.1016/j.scitotenv.2010.07.042.
   Lleo MM, 2001, J APPL MICROBIOL, V91, P1095, DOI 10.1046/j.1365-2672.2001.01476.x.
   Luczkiewicz A, 2011, WATER SCI TECHNOL, V64, P2352, DOI 10.2166/wst.2011.769.
   da Costa PM, 2006, WATER RES, V40, P1735, DOI 10.1016/j.watres.2006.02.025.
   Micallef SA, 2013, FOOD MICROBIOL, V36, P465, DOI 10.1016/j.fm.2013.04.016.
   MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46.
   Nagulapally SR, 2009, WATER ENVIRON RES, V81, P82, DOI 10.2175/106143008X304596.
   Ryu H, 2005, ENVIRON SCI TECHNOL, V39, P8600, DOI 10.1021/es0506071.
   Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770.
   Silva N, 2012, ANN MICROBIOL, V62, P449, DOI 10.1007/s13213-011-0308-4.
   Varela AR, 2013, SCI TOTAL ENVIRON, V450, P155, DOI 10.1016/j.scitotenv.2013.02.015.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{5}},
Usage-Count-Since-2013 = {{32}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{DJ5UN}},
Unique-ID = {{ISI:000374275700042}},
DA = {{2018-08-13}},
}

@article{ ISI:000375735200016,
Author = {van Winkelhoff, Arie J. and Rurenga, Patrick and Wekema-Mulder, Gepke J.
   and Singadji, Zadrach M. and Rams, Thomas E.},
Title = {{Non-oral gram-negative facultative rods in chronic periodontitis
   microbiota}},
Journal = {{MICROBIAL PATHOGENESIS}},
Year = {{2016}},
Volume = {{94}},
Pages = {{117-122}},
Month = {{MAY}},
Abstract = {{Objective: The subgingival prevalence of gram-negative facultative rods
   not usually inhabiting or indigenous to the oral cavity (non-oral GNFR),
   as well as selected periodontal bacterial pathogens, were evaluated by
   culture in untreated and treated chronic periodontitis patients.
   Methods: Subgingival biofilm specimens from 102 untreated and 101
   recently treated adults with chronic periodontitis in the Netherlands
   were plated onto MacConkey III and Dentaid selective media with air-5\%
   CO2 incubation for isolation of non-oral GNFR, and onto enriched Oxoid
   blood agar with anaerobic incubation for recovery of selected
   periodontal bacterial pathogens. Suspected non-oral GNFR clinical
   isolates were identified to a species level with the VITEK 2 automated
   system.
   Results: A total of 87 (42.9\%) out of 203 patients yielded subgingival
   non-oral GNFR. Patients recently treated with periodontal mechanical
   debridement therapy demonstrated a greater prevalence of non oral GNFR
   (57.4\% vs 28.4\%, P < 0.0001), and a greater number of different
   non-oral GNFR species (23 vs 14 different species), than untreated
   patients. Sphingomonas paucimobilis was the most frequently isolated
   subgingival non-oral GNFR species. Several GNFR species normally found
   in animals and human zoonotic infections, and not previously detected in
   human subgingival biofilms, were recovered from some patients, including
   Bordetella bronchispetica, Pasteurella canis, Pasteurella pneumotropica
   and Neisseria zoodegmatis. Porphyromonas gingivalis and Tannerella
   forsythia were significantly associated with the presence of subgingival
   non-oral GNFR.
   Conclusions: A surprisingly high proportion of Dutch chronic
   periodontitis patients yielded cultivable non-oral GNFR in periodontal
   pockets, particularly among those recently treated with periodontal
   mechanical debridement therapy. Since non-oral GNFR species may resist
   mechanical debridement from periodontal pockets, and are often not
   susceptible to many antibiotics frequently used in periodontal practice,
   their subgingival presence may complicate periodontal treatment in
   species-positive patients and increase risk of potentially dangerous
   GNFR infections developing at other body sites. (C) 2016 Elsevier Ltd.
   All rights reserved.}},
Publisher = {{ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD}},
Address = {{24-28 OVAL RD, LONDON NW1 7DX, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Rams, TE (Reprint Author), Temple Univ, Sch Dent, Dept Periodontol \& Oral Implantol, 3223 North Broad St, Philadelphia, PA 19140 USA.
   van Winkelhoff, Arie J.; Rurenga, Patrick; Wekema-Mulder, Gepke J.; Singadji, Zadrach M., Univ Groningen, Univ Med Ctr Groningen, Sch Med, Dept Med Microbiol, Groningen, Netherlands.
   van Winkelhoff, Arie J., Univ Groningen, Univ Med Ctr Groningen, Sch Med, Ctr Dent \& Oral Hyg, Groningen, Netherlands.
   Rams, Thomas E., Temple Univ, Sch Dent, Dept Periodontol \& Oral Implantol, 3223 North Broad St, Philadelphia, PA 19140 USA.
   Rams, Thomas E., Temple Univ, Sch Dent, Oral Microbiol Testing Serv Lab, Philadelphia, PA 19140 USA.
   Rams, Thomas E., Temple Univ, Sch Med, Dept Microbiol \& Immunol, Philadelphia, PA 19140 USA.}},
DOI = {{10.1016/j.micpath.2016.01.020}},
ISSN = {{0882-4010}},
Keywords = {{Chronic periodontitis; Gram-negative facultatively anaerobic rods;
   Periodontal pocket; Humans}},
Keywords-Plus = {{ENTERIC RODS; ANTIMICROBIAL SUSCEPTIBILITY; ANTIBIOTIC-RESISTANCE;
   ORAL-CAVITY; REFRACTORY PERIODONTITIS; AGGRESSIVE PERIODONTITIS;
   SUBGINGIVAL MICROFLORA; ADULT PERIODONTITIS; HUMAN INFECTIONS; PLAQUE}},
Research-Areas = {{Immunology; Microbiology}},
Web-of-Science-Categories  = {{Immunology; Microbiology}},
Author-Email = {{trams@temple.edu}},
ORCID-Numbers = {{Rurenga, Patrick/0000-0001-7681-8878}},
Funding-Acknowledgement = {{University Medical Center Groningen}},
Funding-Text = {{This study was supported with internal funds from the University Medical
   Center Groningen. Arie J. van Winkelhoff is co-owner of LabOral
   Diagnostics (Houten, The Netherlands), a company that provides dental
   professionals with diagnostic microbiology services. All other authors
   declare no conflicts of interest, and all authors report no financial
   relationships related to any products involved in this study.}},
Cited-References = {{Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174.
   ALI RW, 1994, J PERIODONTOL, V65, P1046, DOI 10.1902/jop.1994.65.11.1046.
   Ardila Carlos M, 2012, J Indian Soc Periodontol, V16, P65, DOI 10.4103/0972-124X.94607.
   Ardila Carlos M, 2011, Acta odontol. latinoam., V24, P15.
   Ardila CM, 2010, J PERIODONTOL, V81, P292, DOI 10.1902/jop.2009.090464.
   Barbosa FCB, 2001, ORAL MICROBIOL IMMUN, V16, P306, DOI 10.1034/j.1399-302x.2001.016005306.x.
   Booij-Vrieling HE, 2010, VET MICROBIOL, V144, P147, DOI 10.1016/j.vetmic.2009.12.046.
   Botero Javier Enrique, 2007, J Int Acad Periodontol, V9, P13.
   Boutaga K, 2005, FEMS IMMUNOL MED MIC, V45, P191, DOI 10.1016/j.femsim.2005.03.011.
   Chen C, 1996, ORAL MICROBIOL IMMUN, V11, P425, DOI 10.1111/j.1399-302X.1996.tb00206.x.
   Coenen S, 2007, QUAL SAF HEALTH CARE, V16, P440, DOI 10.1136/qshc.2006.021121.
   Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185.
   DAHLEN G, 1995, ORAL MICROBIOL IMMUN, V10, P42, DOI 10.1111/j.1399-302X.1995.tb00116.x.
   Botero JE, 2007, J PERIODONTOL, V78, P696, DOI 10.1902/jop.2007.060129.
   ESCANDE F, 1993, ZBL BAKT-INT J MED M, V279, P131, DOI 10.1016/S0934-8840(11)80499-8.
   Gaetti-Jardim EC, 2010, J APPL ORAL SCI, V18, P551, DOI 10.1590/S1678-77572010000600004.
   Gautam V, 2011, INDIAN J MED MICROBI, V29, P4, DOI 10.4103/0255-0857.76516.
   Gavin PJ, 2002, EUR J CLIN MICROBIOL, V21, P869, DOI 10.1007/s10096-002-0826-x.
   Gendron R, 2000, MICROBES INFECT, V2, P897, DOI 10.1016/S1286-4579(00)00391-9.
   Goncalves MO, 2007, LETT APPL MICROBIOL, V44, P488, DOI 10.1111/j.1472-765X.2007.02111.x.
   HAFFAJEE AD, 1992, ORAL MICROBIOL IMMUN, V7, P57, DOI 10.1111/j.1399-302X.1992.tb00022.x.
   Handal T, 2003, ANTIMICROB AGENTS CH, V47, P1443, DOI 10.1128/AAC.47.4.1443-1446.2003.
   HELOVUO H, 1993, ORAL MICROBIOL IMMUN, V8, P75, DOI 10.1111/j.1399-302X.1993.tb00548.x.
   Listgarten MA, 1999, J PERIODONTOL, V70, P431, DOI 10.1902/jop.1999.70.4.431.
   LISTGARTEN MA, 1993, J PERIODONTOL, V64, P155, DOI 10.1902/jop.1993.64.3.155.
   MACHTEI EE, 1993, J CLIN PERIODONTOL, V20, P81, DOI 10.1111/j.1600-051X.1993.tb00334.x.
   Martinez-Pabon MC, 2010, ARCH ORAL BIOL, V55, P728, DOI 10.1016/j.archoralbio.2010.07.008.
   MINAH GE, 1986, J CLIN MICROBIOL, V24, P210.
   Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x.
   Paster BJ, 2009, PERIODONTOL 2000, V51, P38, DOI 10.1111/j.1600-0757.2009.00316.x.
   Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8.
   RAMS TE, 1991, J PERIODONTOL, V62, P74, DOI 10.1902/jop.1991.62.1.74.
   Rams TE, 1997, CLIN INFECT DIS, V25, pS224, DOI 10.1086/516248.
   RAMS TE, 1990, ORAL MICROBIOL IMMUN, V5, P166, DOI 10.1111/j.1399-302X.1990.tb00416.x.
   Rams TE, 2014, J PERIODONTOL, V85, P160, DOI 10.1902/jop.2013.130142.
   Rhemrev GE, 2006, J CLIN PERIODONTOL, V33, P42, DOI 10.1111/j.1600-051X.2005.000871.x.
   Rurenga P, 2013, J PERIODONTAL RES, V48, P549, DOI 10.1111/jre.12037.
   Ryan MP, 2010, J HOSP INFECT, V75, P153, DOI 10.1016/j.jhin.2010.03.007.
   Silva-Boghossian C. M., 2011, ARCH ORAL BIOL, V56, P899.
   Silva-Boghossian CM, 2013, J PERIODONTOL, V84, pE9, DOI 10.1902/jop.2013.120639.
   SLOTS J, 1991, J PERIODONTOL, V62, P543, DOI 10.1902/jop.1991.62.9.543.
   SLOTS J, 1990, ORAL MICROBIOL IMMUN, V5, P149, DOI 10.1111/j.1399-302X.1990.tb00413.x.
   SLOTS J, 1991, ORAL MICROBIOL IMMUN, V6, P62, DOI 10.1111/j.1399-302X.1991.tb00452.x.
   SLOTS J, 1988, Oral Microbiology and Immunology, V3, P47, DOI 10.1111/j.1399-302X.1988.tb00080.x.
   SLOTS J, 1982, J CLIN MICROBIOL, V15, P606.
   SLOTS J, 1990, ORAL MICROBIOL IMMUN, V5, P298.
   Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x.
   SYED SA, 1972, APPL MICROBIOL, V24, P638.
   VanWinkelhoff AJ, 1996, PERIODONTOL 2000, V10, P45.
   WOOLFREY BF, 1991, CLIN MICROBIOL REV, V4, P243.}},
Number-of-Cited-References = {{50}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{Microb. Pathog.}},
Doc-Delivery-Number = {{DL6FN}},
Unique-ID = {{ISI:000375735200016}},
DA = {{2018-08-13}},
}

@article{ ISI:000374377700002,
Author = {Noyes, Noelle R. and Yang, Xiang and Linke, Lyndsey M. and Magnuson,
   Roberta J. and Cook, Shaun R. and Zaheer, Rahat and Yang, Hua and
   Woerner, Dale R. and Geornaras, Ifigenia and McArt, Jessica A. and Gow,
   Sheryl P. and Ruiz, Jaime and Jones, Kenneth L. and Boucher, Christina
   A. and McAllister, Tim A. and Belk, Keith E. and Morley, Paul S.},
Title = {{Characterization of the resistome in manure, soil and wastewater from
   dairy and beef production systems}},
Journal = {{SCIENTIFIC REPORTS}},
Year = {{2016}},
Volume = {{6}},
Month = {{APR 20}},
Abstract = {{It has been proposed that livestock production effluents such as
   wastewater, airborne dust and manure increase the density of
   antimicrobial resistant bacteria and genes in the environment. The
   public health risk posed by this proposed outcome has been difficult to
   quantify using traditional microbiological approaches. We utilized
   shotgun metagenomics to provide a first description of the resistome of
   North American dairy and beef production effluents, and identify factors
   that significantly impact this resistome. We identified 34 mechanisms of
   antimicrobial drug resistance within 34 soil, manure and wastewater
   samples from feedlot, ranch and dairy operations. The majority of
   resistance-associated sequences found in all samples belonged to
   tetracycline resistance mechanisms. We found that the ranch samples
   contained significantly fewer resistance mechanisms than dairy and
   feedlot samples, and that the resistome of dairy operations differed
   significantly from that of feedlots. The resistome in soil, manure and
   wastewater differed, suggesting that management of these effluents
   should be tailored appropriately. By providing a baseline of the cattle
   production waste resistome, this study represents a solid foundation for
   future efforts to characterize and quantify the public health risk posed
   by livestock effluents.}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Morley, PS (Reprint Author), Colorado State Univ, Coll Vet Med \& Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA.
   Noyes, Noelle R.; Linke, Lyndsey M.; Magnuson, Roberta J.; Morley, Paul S., Colorado State Univ, Coll Vet Med \& Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA.
   Yang, Xiang; Yang, Hua; Woerner, Dale R.; Geornaras, Ifigenia; Belk, Keith E., Colorado State Univ, Dept Anim Sci, Coll Agr Sci, Ft Collins, CO 80523 USA.
   Cook, Shaun R.; Zaheer, Rahat; McAllister, Tim A., Agr \& Agri Food Canada, Res Ctr, Lethbridge, AB, Canada.
   McArt, Jessica A., Cornell Univ, Dept Populat Med \& Diagnost Sci, Ithaca, NY USA.
   Gow, Sheryl P., Univ Saskatoon, Publ Hlth Agcy Canada, Ctr Foodborne, Environm Zoonot Infect Dis, Saskatoon, SK, Canada.
   Ruiz, Jaime; Boucher, Christina A., Colorado State Univ, Coll Nat Sci, Dept Comp Sci, Ft Collins, CO 80523 USA.
   Jones, Kenneth L., Univ Colorado, Sch Med, Dept Biochem \& Mol Genet, Denver, CO USA.}},
DOI = {{10.1038/srep24645}},
Article-Number = {{24645}},
ISSN = {{2045-2322}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE GENES; FECAL ESCHERICHIA-COLI; COW-CALF HERDS;
   ANTIMICROBIAL RESISTANCE; TETRACYCLINE RESISTANCE;
   ENTEROCOCCUS-FAECALIS; BACTERIA; CATTLE; LAGOONS; CALVES}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{paul.morley@colostate.edu}},
ResearcherID-Numbers = {{Morley, Paul/C-9960-2009
   }},
ORCID-Numbers = {{Morley, Paul/0000-0001-8138-2714
   McAllister, Tim A./0000-0002-8266-6513
   Noyes, Noelle/0000-0001-6149-1008}},
Funding-Acknowledgement = {{Colorado State University Infectious Disease Supercluster; NIH
   {[}T32OD012201]}},
Funding-Text = {{The authors thank all of the livestock operations that allowed us access
   to their facilities to obtain samples. The authors also acknowledge Erin
   Petrilli and the Colorado State University Next Generation Sequencing
   Core for their assistance. This project was supported by a grant from
   the Colorado State University Infectious Disease Supercluster. N.N. was
   supported by NIH T32OD012201.}},
Cited-References = {{Alexander TW, 2009, APPL ENVIRON MICROB, V75, P7125, DOI 10.1128/AEM.00944-09.
   Barlow RS, 2009, J APPL MICROBIOL, V107, P540, DOI 10.1111/j.1365-2672.2009.04240.x.
   Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241.
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289.
   Berge A. C., 2006, APPL ENVIRON MICROB, V72, P3872.
   Berge ACB, 2005, PREV VET MED, V69, P25, DOI 10.1016/j.prevetmed.2005.01.013.
   Berge AC, 2010, JAVMA-J AM VET MED A, V236, P1338, DOI 10.2460/javma.236.12.1338.
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170.
   Carson CA, 2008, CAN J VET RES, V72, P119.
   Chen BW, 2013, ENVIRON SCI TECHNOL, V47, P12753, DOI 10.1021/es403818e.
   CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x.
   Conlan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009845.
   Cytryn E, 2013, SOIL BIOL BIOCHEM, V63, P18, DOI 10.1016/j.soilbio.2013.03.017.
   DOUCETPOPULAIRE F, 1991, ANTIMICROB AGENTS CH, V35, P185, DOI 10.1128/AAC.35.1.185.
   Durso LM, 2012, LETT APPL MICROBIOL, V55, P109, DOI 10.1111/j.1472-765X.2012.03265.x.
   Durso LM, 2011, J MICROBIOL METH, V84, P278, DOI 10.1016/j.mimet.2010.12.008.
   Fuentes MAF, 2014, FOOD CONTROL, V37, P9, DOI 10.1016/j.foodcont.2013.08.041.
   Food and Drug Administration, 2013, GUID IND 213 NEW AN.
   Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377.
   Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761.
   Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113.
   Fouhy F., 2014, PLOS ONE, V9, P1.
   Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565.
   Ghosh S, 2007, ISME J, V1, P191, DOI 10.1038/ismej.2007.31.
   Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106.
   Gow SP, 2008, APPL ENVIRON MICROB, V74, P3658, DOI 10.1128/AEM.02505-07.
   Gow SP, 2008, CAN J VET RES, V72, P82.
   Gow SP, 2008, CAN J VET RES, V72, P91.
   Gow SP, 2009, PREV VET MED, V90, P55, DOI 10.1016/j.prevetmed.2009.03.010.
   Guerin E, 2009, SCIENCE, V324, P1034, DOI 10.1126/science.1172914.
   Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13.
   Hall RM, 2016, J ANTIMICROB CHEMOTH, V71, P569, DOI 10.1093/jac/dkv351.
   Ham JM, 2000, J ENVIRON QUAL, V29, P1721, DOI 10.2134/jeq2000.00472425002900060001x.
   Herrick JB, 2014, J APPL MICROBIOL, V117, P380, DOI 10.1111/jam.12538.
   Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151.
   Klein-Jobstl D., 2014, FRONT MICROBIOL, V5, P1.
   Kyselkova M, 2013, CHEMOSPHERE, V93, P2413, DOI 10.1016/j.chemosphere.2013.08.058.
   Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716.
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324.
   Mach N, 2015, ENV MICROBIOL REP, V7, P554, DOI 10.1111/1758-2229.12285.
   Martinez JL, 2015, NAT REV MICROBIOL, V13, P116, DOI 10.1038/nrmicro3399.
   McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13.
   McEachran AD, 2015, ENVIRON HEALTH PERSP, V123, P337, DOI 10.1289/ehp.1408555.
   McKinney CW, 2010, ENVIRON SCI TECHNOL, V44, P6102, DOI 10.1021/es9038165.
   McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531.
   Mcnab WW, 2007, ENVIRON SCI TECHNOL, V41, P753, DOI 10.1021/es061490j.
   Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666.
   Mitchell SM, 2014, SCI TOTAL ENVIRON, V466, P547, DOI 10.1016/j.scitotenv.2013.06.027.
   Noyes NR, 2016, ELIFE, V5, DOI 10.7554/eLife.13195.
   Oikonomou G., 2013, PLOS ONE, V8, P1.
   Paulson JN, 2013, NAT METHODS, V10, P1200, DOI {[}10.1038/NMETH.2658, 10.1038/nmeth.2658].
   Peabody MA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0788-5.
   Peak N, 2007, ENVIRON MICROBIOL, V9, P143, DOI 10.1111/j.1462-2920.2006.01123.x.
   Pehrsson E. C., 2013, FRONT MICROBIOL, V4.
   Pereira RV, 2014, J DAIRY SCI, V97, P7644, DOI 10.3168/jds.2014-8521.
   Pereira RVV, 2011, J DAIRY SCI, V94, P4556, DOI 10.3168/jds.2011-4337.
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007.
   Schmitt H, 2006, MICROB ECOL, V51, P267, DOI 10.1007/s00248-006-9035-y.
   Shanks OC, 2011, APPL ENVIRON MICROB, V77, P2992, DOI 10.1128/AEM.02988-10.
   Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234.
   Smorawinska M, 2012, FEMS MICROBIOL LETT, V326, P76, DOI 10.1111/j.1574-6968.2011.02432.x.
   Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109.
   Sura S, 2015, SCI TOTAL ENVIRON, V521, P191, DOI 10.1016/j.scitotenv.2015.03.080.
   Tian BY, 2012, MBIO, V3, DOI 10.1128/mBio.00377-12.
   Tremblay CL, 2012, J FOOD PROTECT, V75, P1595, DOI 10.4315/0362-028X.JFP-12-047.
   Udikovic-Kolic N, 2014, P NATL ACAD SCI USA, V111, P15202, DOI 10.1073/pnas.1409836111.
   Umu OCO, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0078-5.
   USDA, 2009, DAIR 2007 5.
   USDA-APHIS-VS-CEAH-NAHMS, 2013, FEEDL 2011 4.
   USDA-APHIS-VS-CEAH-NAHMS, 2009, DAIR 2007 5.
   USDA-APHIS-VS-CEAH-NAHMS. USDA, 2012, BEEF 2007 08 ANT DRU.
   Walsh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065567.
   Wichmann F, 2014, MBIO, V5, DOI 10.1128/mBio.01017-13.
   World Health Organization, 2011, CRIT IMP ANT HUM MED.
   Xiong W., 2015, FRONT MICROBIOL, V6, P1.
   Yang X, 2016, APPL ENVIRON MICROB, V82, P2433, DOI 10.1128/AEM.00078-16.
   Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261.
   Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P397, DOI 10.1007/s00253-008-1829-z.
   Zhang YP, 2013, SCI TOTAL ENVIRON, V463, P631, DOI 10.1016/j.scitotenv.2013.06.016.
   Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110.}},
Number-of-Cited-References = {{80}},
Times-Cited = {{16}},
Usage-Count-Last-180-days = {{9}},
Usage-Count-Since-2013 = {{78}},
Journal-ISO = {{Sci Rep}},
Doc-Delivery-Number = {{DJ7FQ}},
Unique-ID = {{ISI:000374377700002}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000374707100007,
Author = {Mazar, Yinon and Cytryn, Eddie and Ere, Yigal and Rudich, Yinon},
Title = {{Effect of Dust Storms on the Atmospheric Microbiome in the Eastern
   Mediterranean}},
Journal = {{ENVIRONMENTAL SCIENCE \& TECHNOLOGY}},
Year = {{2016}},
Volume = {{50}},
Number = {{8}},
Pages = {{4194-4202}},
Month = {{APR 19}},
Abstract = {{We evaluated the impact of Saharan dust storms on the local airborne
   microbiome in a city in the Eastern Mediterranean area. Samples of
   particles with diameter less than 10 mu m were collected during two
   spring seasons on both dusty and nondusty days. DNA was extracted, and
   partial 16S rRNA gene amplicons were sequenced using the Illumina
   platform. Bioinformatic analysis showed the effect of dust events on the
   diversity of the atmospheric microbiome. The relative abundance of
   desert soil-associated bacteria increased during dust events, while the
   relative abundance of anthropogenic-influenced taxa decreased.
   Quantitative polymerase chain reaction measurements of selected
   clinically significant antibiotic resistance genes (ARGs) showed that
   their relative abundance decreased during dust events. The ARG profiles
   on dust-free days were similar to those in aerosol collected in a
   poultry house, suggesting a strong agricultural influence on the local
   ambient profiles. We conclude that dust storms enrich the ambient
   airborne microbiome with new soil-derived bacteria that disappear as the
   dust settles, suggesting that the bacteria are transported attached to
   the dust particles. Dust storms do not seem to be an important vector
   for transport of probed ARGs.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Rudich, Y (Reprint Author), Weizmann Inst Sci, Dept Earth \& Planetary Sci, IL-76100 Rehovot, Israel.
   Mazar, Yinon; Rudich, Yinon, Weizmann Inst Sci, Dept Earth \& Planetary Sci, IL-76100 Rehovot, Israel.
   Cytryn, Eddie, Agr Res Org, Volcani Ctr, Inst Soil Water \& Environm Sci, IL-50250 Bet Dagan, Israel.
   Ere, Yigal, Hebrew Univ Jerusalem, Fredy \& Nadine Herrmann Inst Earth Sci, IL-91904 Jerusalem, Israel.}},
DOI = {{10.1021/acs.est.5b06348}},
ISSN = {{0013-936X}},
EISSN = {{1520-5851}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE GENES; REAL-TIME PCR; AIRBORNE BACTERIAL
   COMMUNITIES; ASIAN-DUST; SP-NOV.; STAPHYLOCOCCUS-AUREUS; SEASONAL
   VARIABILITY; GLOBAL DISPERSION; DOWNWIND AREA; WATER SAMPLES}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences}},
Author-Email = {{Yinon.rudich@weizmann.ac.il}},
ResearcherID-Numbers = {{Rudich, Yinon/K-1498-2012
   Amoako, Daniel Gyamfi/I-4223-2018}},
ORCID-Numbers = {{Rudich, Yinon/0000-0003-3149-0201
   }},
Funding-Acknowledgement = {{Israel Science Foundation {[}913/12]; Dollond Charitable Trust}},
Funding-Text = {{This study was supported by the Israel Science Foundation (grant 913/12)
   and the Dollond Charitable Trust. We acknowledge Dr. Stefan Green for
   the Illumina sequencing, Dr. Shelly Druyan for access to the poultry
   site, Dr. Naama Lang-Yona and Dr. Yoav Barak for assistance in the
   biological analyses, and Prof. Arnon Karnieli for establishing and
   maintaining Aeronet's Nes-Ziona and Sede Boker sites.}},
Cited-References = {{Aarestrup FM, 1998, MICROB DRUG RESIST, V4, P137, DOI 10.1089/mdr.1998.4.137.
   An S, 2015, HEREDITY, V114, P460, DOI 10.1038/hdy.2014.102.
   Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x.
   Barberan A, 2015, P NATL ACAD SCI USA, V112, P5756, DOI 10.1073/pnas.1420815112.
   Barberan A, 2014, SCI TOTAL ENVIRON, V487, P187, DOI 10.1016/j.scitotenv.2014.04.030.
   Barraud O, 2010, J ANTIMICROB CHEMOTH, V65, P1642, DOI 10.1093/jac/dkq167.
   Bennett PM, 1999, J ANTIMICROB CHEMOTH, V43, P1, DOI 10.1093/jac/43.1.1.
   Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942.
   Blais-Lecours P, 2015, ATMOS ENVIRON, V110, P45, DOI 10.1016/j.atmosenv.2015.03.039.
   Bowers RM, 2013, ENVIRON SCI TECHNOL, V47, P12097, DOI 10.1021/es402970s.
   Brauer SL, 2011, ENVIRON MICROBIOL, V13, P589, DOI 10.1111/j.1462-2920.2010.02360.x.
   Burton NC, 2005, J ENVIRON MONITOR, V7, P475, DOI 10.1039/b500056d.
   Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8.
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303.
   Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636.
   CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x.
   Colomer-Lluch M, 2014, J ANTIMICROB CHEMOTH, V69, P1265, DOI 10.1093/jac/dkt528.
   Cummings DE, 2011, ENVIRON SCI TECHNOL, V45, P447, DOI 10.1021/es1029206.
   De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003.
   DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11.
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05.
   Despres V. R., 2012, TELLUS B, V64, P15598, DOI DOI 10.3402/TELLUSB.V64I0.15598.
   Draxler R. R., HYSPLIT HYBRID SINGL.
   Dybwad M, 2014, AEROSOL SCI TECH, V48, P282, DOI 10.1080/02786826.2013.871501.
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381.
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461.
   Erel Y, 2006, ENVIRON SCI TECHNOL, V40, P2996, DOI 10.1021/es051502l.
   Falkovich AH, 2001, J GEOPHYS RES-ATMOS, V106, P18029, DOI 10.1029/2000JD900430.
   Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110.
   Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377.
   Garrison VH, 2003, BIOSCIENCE, V53, P469, DOI 10.1641/0006-3568(2003)053{[}0469:AAADFD]2.0.CO;2.
   Gillings MR, 2015, ISME J, V9, P1269, DOI 10.1038/ismej.2014.226.
   Gonzalez-Martin C, 2014, ADV AGRON, V127, P1, DOI 10.1016/B978-0-12-800131-8.00001-7.
   Hoisington AJ, 2014, BUILD ENVIRON, V80, P274, DOI 10.1016/j.buildenv.2014.04.021.
   Holmes AJ, 2000, FEMS MICROBIOL ECOL, V33, P111, DOI 10.1016/S0168-6496(00)00051-9.
   Katra I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05265.
   Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650.
   LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185.
   Li KJ, 2011, SCI TOTAL ENVIRON, V409, P5493, DOI 10.1016/j.scitotenv.2011.09.010.
   Lin YK, 2016, J EXPO SCI ENV EPID, V26, P189, DOI 10.1038/jes.2015.70.
   Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005.
   Maki T, 2015, ATMOS ENVIRON, V119, P282, DOI 10.1016/j.atmosenv.2015.08.052.
   Maki T, 2014, SCI TOTAL ENVIRON, V488, P75, DOI 10.1016/j.scitotenv.2014.04.044.
   Marti E, 2013, APPL ENVIRON MICROB, V79, P1743, DOI 10.1128/AEM.03409-12.
   Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483.
   Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386.
   Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715.
   Molesworth AM, 2003, EMERG INFECT DIS, V9, P1287.
   Montero-Calasanz M. C., 2013, ARCH MICROBIOL, V195, P153.
   Montero-Calasanz Mdel C., 2013, SYST APPL MICROBIOL, V36, P177.
   Montero-Calasanz Mdel C., 2013, ANTON LEEUW INT J G, V104, P207.
   Montero-Calasanz Mdel C., 2013, INT J SYST EVOL MI 9, V63, P3437.
   Musovic S, 2014, ENV MICROBIOL REP, V6, P125, DOI 10.1111/1758-2229.12138.
   Nilsson O., 2012, INFECT ECOL EPIDEMIO, V2, DOI {[}10.3402/iee.v2i0.16959, DOI 10.3402/IEE.V2I0.16959].
   Normand P, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P669, DOI 10.1007/0-387-30743-5\_26.
   Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017.
   Perry KD, 1997, J GEOPHYS RES-ATMOS, V102, P11225, DOI 10.1029/97JD00260.
   Polymenakou P. N., 2007, ENV HLTH PERSPECT, V116, P292, DOI {[}DOI 10.1289/EHP.10684, 10.1289/ehp.10684].
   Sabet NS, 2007, J MICROBIOL METH, V68, P157, DOI 10.1016/j.mimet.2006.07.008.
   de la Campa AS, 2013, ENVIRON SCI TECHNOL, V47, P3630, DOI 10.1021/es3051235.
   Smith DJ, 2013, APPL ENVIRON MICROB, V79, P1134, DOI 10.1128/AEM.03029-12.
   Stalder T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00119.
   Subhash Y, 2014, INT J SYST EVOL MICR, V64, P1006, DOI 10.1099/ijs.0.058842-0.
   SUZUKI K, 1988, FEMS MICROBIOL LETT, V52, P33, DOI 10.1111/j.1574-6968.1988.tb02568.x.
   Szczepanowski R, 2009, MICROBIOL-SGM, V155, P2306, DOI 10.1099/mic.0.028233-0.
   Taylor S. R., 1985, CONTINENTAL CRUST IT.
   Udikovic-Kolic N, 2014, P NATL ACAD SCI USA, V111, P15202, DOI 10.1073/pnas.1409836111.
   Wales AD, 2015, ANTIBIOTICS-BASEL, V4, P567, DOI 10.3390/antibiotics4040567.
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07.
   Weller R, 2008, TELLUS B, V60, P742, DOI 10.1111/j.1600-0889.2008.00372.x.
   Yadav S, 2007, ATMOS ENVIRON, V41, P6063, DOI 10.1016/j.atmosenv.2007.03.050.
   Yamaguchi N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00525.
   Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593.
   Zhang L, 2008, INT J SYST EVOL MICR, V58, P1210, DOI 10.1099/ijs.0.65667-0.
   Zhou Y, 2007, INT J SYST EVOL MICR, V57, P321, DOI 10.1099/ijs.0.64716-0.}},
Number-of-Cited-References = {{75}},
Times-Cited = {{13}},
Usage-Count-Last-180-days = {{10}},
Usage-Count-Since-2013 = {{63}},
Journal-ISO = {{Environ. Sci. Technol.}},
Doc-Delivery-Number = {{DK1WZ}},
Unique-ID = {{ISI:000374707100007}},
DA = {{2018-08-13}},
}

@article{ ISI:000373555900001,
Author = {Matyszewska, Dorota},
Title = {{Comparison of the interactions of daunorubicin in a free form and
   attached to single-walled carbon nanotubes with model lipid membranes}},
Journal = {{BEILSTEIN JOURNAL OF NANOTECHNOLOGY}},
Year = {{2016}},
Volume = {{7}},
Pages = {{524-532}},
Month = {{APR 8}},
Abstract = {{In this work the interactions of an anticancer drug daunorubicin (DNR)
   with model thiolipid layers composed of
   1,2-dipalmitoyl-sn-glycero-3-phosphothioethanol (DPPTE) were
   investigated using Langmuir technique. The results obtained for a free
   drug were compared with the results recorded for DNR attached to SWCNTs
   as potential drug carrier. Langmuir studies of mixed DPPTE-SWCNTs-DNR
   monolayers showed that even at the highest investigated content of the
   nanotubes in the monolayer, the changes in the properties of DPPTE model
   membranes were not as significant as in case of the incorporation of a
   free drug, which resulted in a significant increase in the area per
   molecule and fluidization of the thiolipid layer. The presence of
   SWCNTs-DNR in the DPPTE monolayer at the air-water interface did not
   change the organization of the lipid molecules to such extent as the
   free drug, which may be explained by different types of interactions
   playing crucial role in these two types of systems. In the case of the
   interactions of free DNR the electrostatic attraction between positively
   charged drug and negatively charged DPPTE monolayer play the most
   important role, while in the case of SWCNTs-DNR adducts the hydrophobic
   interactions between nanotubes and acyl chains of the lipid seem to be
   prevailing. Electrochemical studies performed for supported model
   membranes containing the drug delivered in the two investigated forms
   revealed that the surface concentration of the drug-nanotube adduct in
   supported monolayers is comparable to the reported surface concentration
   of the free DNR incorporated into DPPTE monolayers on gold electrodes.
   Therefore, it may be concluded that the application of carbon nanotubes
   as potential DNR carrier allows for the incorporation of comparable
   amount of the drug into model membranes with simultaneous decrease in
   the negative changes in the membrane structure and organization, which
   is an important aspect in terms of side effects of the drug.}},
Publisher = {{BEILSTEIN-INSTITUT}},
Address = {{TRAKEHNER STRASSE 7-9, FRANKFURT AM MAIN, 60487, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Matyszewska, D (Reprint Author), Univ Warsaw, Fac Chem, Biol \& Chem Res Ctr, Zwirki \& Wigury 101, PL-02089 Warsaw, Poland.
   Matyszewska, Dorota, Univ Warsaw, Fac Chem, Biol \& Chem Res Ctr, Zwirki \& Wigury 101, PL-02089 Warsaw, Poland.}},
DOI = {{10.3762/bjnano.7.46}},
ISSN = {{2190-4286}},
Keywords = {{daunorubicin (DNR); 1,2-dipalmitoyl-sn-glycero-3-phosphothioethanol
   (DPPTE); drug carriers; model lipid membranes; single-walled carbon
   nanotubes (SWCNTs)}},
Keywords-Plus = {{OVERCOME MULTIDRUG-RESISTANCE; CONTROLLED-RELEASE DELIVERY;
   DRUG-DELIVERY; NANOPARTICLES; TOXICITY; CELL; PH; ANTHRAQUINONE;
   ADRIAMYCIN; MONOLAYERS}},
Research-Areas = {{Science \& Technology - Other Topics; Materials Science; Physics}},
Web-of-Science-Categories  = {{Nanoscience \& Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied}},
Author-Email = {{dorota.matyszewska@chem.uw.edu.pl}},
Funding-Acknowledgement = {{Foundation for Polish Science; European Union, Regional Development Fund
   {[}POMOST/2011-3/6]}},
Funding-Text = {{Prof. Jan Biernat is acknowledged for providing CNTs-DNR conjugates.
   This work was supported by the Foundation for Polish Science with the
   POMOST/2011-3/6 project co-financed by the European Union, Regional
   Development Fund.}},
Cited-References = {{Banks CE, 2005, J IRAN CHEM SOC, V2, P60, DOI 10.1007/BF03245781.
   Cancino J, 2013, NANOTOXICOLOGY, V7, P61, DOI 10.3109/17435390.2011.629748.
   Chen BA, 2009, INT J NANOMED, V4, P201.
   Danesh NM, 2015, INT J PHARMACEUT, V489, P311, DOI 10.1016/j.ijpharm.2015.04.072.
   Fernandez-Fernandez A, 2011, APPL BIOCHEM BIOTECH, V165, P1628, DOI 10.1007/s12010-011-9383-z.
   Gaines G., 1966, INSOLUBLE MONOLAYERS.
   Gallois L, 1998, BBA-BIOMEMBRANES, V1370, P31, DOI 10.1016/S0005-2736(97)00241-1.
   Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4.
   GUAGLIANONE P, 1994, INVEST NEW DRUG, V12, P103, DOI 10.1007/BF00874439.
   Harkins W. D., 1952, PHYS CHEM SURFACE FI.
   Jablonowska E, 2011, J ELECTROANAL CHEM, V660, P360, DOI 10.1016/j.jelechem.2011.03.018.
   Jadhav SR, 2013, J COLLOID INTERF SCI, V390, P211, DOI 10.1016/j.jcis.2012.09.031.
   Komorsky-Lovric S, 2006, BIOELECTROCHEMISTRY, V69, P82, DOI 10.1016/j.bioelechem.2005.10.006.
   Liu Z, 2007, ACS NANO, V1, P50, DOI 10.1021/nn700040t.
   Ma P, 2013, NANO TODAY, V8, P313, DOI 10.1016/j.nantod.2013.04.006.
   Matyszewska D, 2015, COLLOID SURFACE B, V134, P295, DOI 10.1016/j.colsurfb.2015.07.001.
   Matyszewska D, 2015, ELECTROCHIM ACTA, V162, P45, DOI 10.1016/j.electacta.2015.01.032.
   Matyszewska D, 2012, LANGMUIR, V28, P5182, DOI 10.1021/la2044027.
   Mehra NK, 2015, DRUG DISCOV TODAY, V20, P750, DOI 10.1016/j.drudis.2015.01.006.
   Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6.
   Myhren L, 2014, EUR J PHARM BIOPHARM, V88, P186, DOI 10.1016/j.ejpb.2014.04.002.
   Nazaruk E, 2010, ANAL BIOANAL CHEM, V398, P1651, DOI 10.1007/s00216-010-4012-1.
   Patel AG, 2012, ELIFE, V1, DOI 10.7554/eLife.00387.
   Peretz S, 2012, CURR OPIN COLLOID IN, V17, P360, DOI 10.1016/j.cocis.2012.09.001.
   Ren YY, 2012, INT J NANOMED, V7, P2261, DOI 10.2147/IJN.S29357.
   Sadowska K, 2010, BIOELECTROCHEMISTRY, V80, P73, DOI 10.1016/j.bioelechem.2010.06.003.
   Sadowska K, 2009, CARBON, V47, P1501, DOI 10.1016/j.carbon.2009.01.044.
   Taghdisi SM, 2011, EUR J PHARM BIOPHARM, V77, P200, DOI 10.1016/j.ejpb.2010.12.005.
   Wong BS, 2013, ADV DRUG DELIVER REV, V65, P1964, DOI 10.1016/j.addr.2013.08.005.
   Xiao HH, 2012, J CONTROL RELEASE, V163, P304, DOI 10.1016/j.jconrel.2012.06.004.
   Yang ST, 2012, THERANOSTICS, V2, P271, DOI 10.7150/thno.3618.
   Yang XL, 1999, PHARMACOL THERAPEUT, V83, P181, DOI 10.1016/S0163-7258(99)00020-0.
   Ying X, 2010, J CONTROL RELEASE, V141, P183, DOI 10.1016/j.jconrel.2009.09.020.
   Yu SJ, 2013, SOFT MATTER, V9, P2637, DOI 10.1039/c2sm27616j.
   Zhang HJ, 2012, INT J NANOMED, V7, P235, DOI 10.2147/IJN.S27722.
   Zhang HJ, 2011, BIOSENS BIOELECTRON, V26, P3361, DOI 10.1016/j.bios.2011.01.020.
   Zhao XC, 2012, ENVIRON INT, V40, P244, DOI 10.1016/j.envint.2011.12.003.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{13}},
Journal-ISO = {{Beilstein J. Nanotechnol.}},
Doc-Delivery-Number = {{DI5RI}},
Unique-ID = {{ISI:000373555900001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000373787100005,
Author = {Ferguson, Dwight D. and Smith, Tara C. and Hanson, Blake M. and Wardyn,
   Shylo E. and Donham, Kelley J.},
Title = {{Detection of Airborne Methicillin-Resistant Staphylococcus aureus Inside
   and Downwind of a Swine Building, and in Animal Feed: Potential
   Occupational, Animal Health, and Environmental Implications}},
Journal = {{JOURNAL OF AGROMEDICINE}},
Year = {{2016}},
Volume = {{21}},
Number = {{2}},
Pages = {{149-153}},
Month = {{APR 2}},
Abstract = {{Aerosolized methicillin-resistant Staphylococcus aureus (MRSA) was
   sampled inside and downwind of a swine facility. Animal feed was sampled
   before and after entry into the swine facility. Aerosolized particles
   were detected using an optical particle counter for real-time
   measurement and with an Andersen sampler to detect viable MRSA.
   Molecular typing and antimicrobial susceptibility testing were performed
   on samples collected. Viable MRSA organisms isolated inside the swine
   facility were primarily associated with particles >5 mu m, and those
   isolated downwind from the swine facility were associated with particles
   <5 mu m. MRSA isolates included spa types t008, t034, and t5706 and were
   resistant to methicillin, tetracycline, clindamycin, and erythromycin.
   Animal feed both before and after entry into the swine facility tested
   positive for viable MRSA. These isolates were of similar spa types as
   the airborne MRSA organisms. Air samples collected after power washing
   with a biocide inside the swine facility resulted in no viable MRSA
   organisms detected. This pilot study showed that the ecology of MRSA is
   complex. Additional studies are warranted on the maximum distance that
   viable MRSA can be emitted outside the facility, and the possibility
   that animal feed may be a source of contamination.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ferguson, DD (Reprint Author), Univ Iowa, Dept Occupat Environm Hlth, 105 River St,CPHB Suite 329, Iowa City, IA 52242 USA.
   Ferguson, Dwight D.; Donham, Kelley J., Univ Iowa, Dept Occupat Environm Hlth, 105 River St,CPHB Suite 329, Iowa City, IA 52242 USA.
   Smith, Tara C.; Hanson, Blake M.; Wardyn, Shylo E., Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA.
   Smith, Tara C., Kent State Univ, Dept Biostat Environm Hlth Sci \& Epidemiol, Kent, OH 44242 USA.}},
DOI = {{10.1080/1059924X.2016.1142917}},
ISSN = {{1059-924X}},
EISSN = {{1545-0813}},
Keywords = {{Agriculture; air sampling; animal feeding operation; bioaerosol;
   confined; MRSA; swine; zoonosis}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANT; RISK; AIR; INFECTIONS; OPERATIONS; BACTERIA;
   ST398; PIGS}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{dwightdeonferguson@gmail.com}},
Funding-Acknowledgement = {{National Institute for Environmental Health Sciences through the
   University of Iowa Environmental Health Sciences Research Center,
   NIEHS/NIH {[}P30 ES005605]}},
Funding-Text = {{This research was funded by the National Institute for Environmental
   Health Sciences through the University of Iowa Environmental Health
   Sciences Research Center, NIEHS/NIH P30 ES005605.}},
Cited-References = {{BARBER M, 1961, J CLIN PATHOL, V14, P385, DOI 10.1136/jcp.14.4.385.
   Bogelmez-Tnaz G, 2006, EUROPEAN J CLIN MICR, V25, P410.
   Broens EM, 2011, PREV VET MED, V102, P41, DOI 10.1016/j.prevetmed.2011.06.005.
   Cavaco LM, 2011, VET MICROBIOL, V150, P344, DOI 10.1016/j.vetmic.2011.02.014.
   Donham KJ, 2010, J ANIM SCI, V88, pE102, DOI 10.2527/jas.2009-2554.
   DONHAM KJ, 1986, AM IND HYG ASSOC J, V47, P404, DOI 10.1202/0002-8894(1986)047<0404:CODCFS>2.3.CO;2.
   Fessler AT, 2011, ANTIMICROB AGENTS CH, V55, P373, DOI 10.1128/AAC.01124-10.
   Gibbs SG, 2004, J OCCUP ENVIRON HYG, V1, P699, DOI 10.1080/15459620490515824.
   Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910.
   Graffunder EM, 2002, J ANTIMICROB CHEMOTH, V49, P999, DOI 10.1093/jac/dkf009.
   Green CF, 2006, J OCCUP ENVIRON HYG, V3, P9, DOI 10.1080/15459620500430615.
   Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025.
   Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001.
   Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006.
   Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461.
   Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109.
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806.
   Moodley A, 2008, SCAND J WORK ENV HEA, V34, P151, DOI 10.5271/sjweh.1219.
   O'Brien AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030092.
   O'Shaughnessy PT, 2010, J OCCUP ENVIRON HYG, V7, P7, DOI 10.1080/15459620903327970.
   Osadebe LU, 2013, ZOONOSES PUBLIC HLTH, V60, P234, DOI 10.1111/j.1863-2378.2012.01527.x.
   Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12.
   Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556.
   Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258.
   Springer B, 2009, WIEN KLIN WOCHENSCHR, V121, P86, DOI 10.1007/s00508-008-1126-y.
   Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507.
   van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384.
   Wagenaar JA, 2009, VET MICROBIOL, V139, P405, DOI 10.1016/j.vetmic.2009.06.014.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{18}},
Journal-ISO = {{J. Agromedicine}},
Doc-Delivery-Number = {{DI8XZ}},
Unique-ID = {{ISI:000373787100005}},
OA = {{green\_accepted}},
DA = {{2018-08-13}},
}

@article{ ISI:000373300000005,
Author = {de Breij, A. and Karnaoukh, T. G. and Schrumpf, J. and Hiemstra, P. S.
   and Nibbering, P. H. and van Dissel, J. T. and de Visser, P. C.},
Title = {{The licorice pentacyclic triterpenoid component 18 beta-glycyrrhetinic
   acid enhances the activity of antibiotics against strains of
   methicillin-resistant Staphylococcus aureus}},
Journal = {{EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY \& INFECTIOUS DISEASES}},
Year = {{2016}},
Volume = {{35}},
Number = {{4}},
Pages = {{555-562}},
Month = {{APR}},
Abstract = {{This study aimed to identify compounds that enhance the activity of
   current antibiotics against multidrug-resistant bacteria. Screening of a
   350+ compound proprietary small molecules library revealed that the
   Glycyrrhiza glabra (licorice)-derived triterpenoid 18
   beta-glycyrrhetinic acid (18 beta-GA) potentiated the antibacterial
   activity of certain antibiotics against Staphylococcus aureus. Here, we
   evaluated the ability of pentacyclic triterpenoids to potentiate the
   activity of antibiotics against strains of methicillin-resistant S.
   aureus (MRSA). Checkerboard assays were used to assess the minimum
   inhibitory concentration (MIC) of tobramycin and ten pentacyclic
   triterpenoids against S. aureus. The effect of 18 beta-GA on the MIC of
   different antibiotics against MRSA was also determined in an in vitro
   airway MRSA infection model. 18 beta-GA enhanced the bactericidal
   activity of the aminoglycosides tobramycin, gentamicin and amikacin, and
   of polymyxin B against two MRSA strains, reducing the MIC of these
   antibiotics 32-64-fold {[}fractional inhibitory concentration index
   (FICI) of 0.12-0.13]. Other beta-amyrin triterpenoids and alpha-amyrin
   triterpenoids did not exert such synergistic effects. 18 beta-GA did not
   enhance the activity of antibiotics from other structural classes
   against the MRSA strains. In an air-exposed airway epithelial cell
   culture, 18 beta-GA enhanced the bactericidal activity of tobramycin and
   polymyxin B against the MRSA strain. These data demonstrate the
   potential of 18 beta-GA to synergise with certain types of antibiotics
   to eliminate strains of MRSA.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{de Visser, PC (Reprint Author), BioMarin Nederland BV, JH Oortweg 21, NL-2333 CH Leiden, Netherlands.
   de Breij, A.; Nibbering, P. H.; van Dissel, J. T., Leiden Univ, Med Ctr, Dept Infect Dis, Albinusdreef 2, NL-2333 AL Leiden, Netherlands.
   Karnaoukh, T. G.; de Visser, P. C., BioMarin Nederland BV, JH Oortweg 21, NL-2333 CH Leiden, Netherlands.
   Schrumpf, J.; Hiemstra, P. S., Leiden Univ, Med Ctr, Dept Pulmonol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.}},
DOI = {{10.1007/s10096-015-2570-z}},
ISSN = {{0934-9723}},
EISSN = {{1435-4373}},
Keywords-Plus = {{BRONCHIAL EPITHELIAL-CELLS; VIRULENCE GENE-EXPRESSION; ANTIMICROBIAL
   ACTIVITY; ATOPIC-DERMATITIS; MODIFYING AGENTS; DERIVATIVES; INHIBITION;
   TOMATIDINE; PNEUMONIA; PATHOGENS}},
Research-Areas = {{Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Infectious Diseases; Microbiology}},
Author-Email = {{peter.devisser@bmrn.com}},
ResearcherID-Numbers = {{Hiemstra, Pieter/K-8587-2018}},
ORCID-Numbers = {{Hiemstra, Pieter/0000-0002-0238-5982}},
Funding-Acknowledgement = {{Dutch Top Institute Pharma {[}T4-211]}},
Funding-Text = {{This research was funded, in part, by the Dutch Top Institute Pharma
   under project T4-211.}},
Cited-References = {{Abreu AC, 2012, NAT PROD REP, V29, P1007, DOI 10.1039/c2np20035j.
   Allen HB, 2014, JAMA DERMATOL, V150, P260, DOI 10.1001/jamadermatol.2013.8627.
   Beseda I, 2010, BIOORGAN MED CHEM, V18, P433, DOI 10.1016/j.bmc.2009.10.036.
   Centers for Disease Control and Prevention, 2014, ANT RES THREATS US 2.
   Chagnon F, 2014, EUR J MED CHEM, V80, P605, DOI 10.1016/j.ejmech.2013.11.019.
   Chintharlapalli S, 2007, MOL CANCER THER, V6, P1588, DOI 10.1158/1535-7163.MCT-07-0022.
   Chung PY, 2014, FITOTERAPIA, V94, P48, DOI 10.1016/j.fitote.2014.01.026.
   Classen-Houben D, 2009, J STEROID BIOCHEM, V113, P248, DOI 10.1016/j.jsbmb.2009.01.009.
   {*}COSM INGR REV EXP, 2007, INT J TOXICOL S2, V26, P79.
   Croes S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-229.
   David MZ, 2012, INFECT CONT HOSP EP, V33, P782, DOI 10.1086/666640.
   de Leon L, 2005, PLANTA MED, V71, P313, DOI 10.1055/s-2005-864096.
   Dwivedi GR, 2015, CHEM BIOL DRUG DES, V86, P272, DOI 10.1111/cbdd.12491.
   Gibbons S, 2003, PHYTOCHEMISTRY, V62, P83, DOI 10.1016/S0031-9422(02)00446-6.
   Gill EE, 2015, CHEM BIOL DRUG DES, V85, P56, DOI 10.1111/cbdd.12478.
   Haisma EM, 2014, ANTIMICROB AGENTS CH, V58, P4411, DOI 10.1128/AAC.02554-14.
   Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011.
   Li HE, 2012, FITOTERAPIA, V83, P241, DOI 10.1016/j.fitote.2011.10.018.
   Long DR, 2013, ANTIMICROB AGENTS CH, V57, P241, DOI 10.1128/AAC.01023-12.
   Marquez B, 2005, PHYTOCHEMISTRY, V66, P1804, DOI 10.1016/j.phytochem.2005.06.008.
   Matchkov VV, 2004, BRIT J PHARMACOL, V142, P961, DOI 10.1038/sj.bjp.0705870.
   Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09.
   Mitchell G, 2012, J ANTIMICROB CHEMOTH, V67, P559, DOI 10.1093/jac/dkr510.
   Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301.
   Oluwatuyi M, 2004, PHYTOCHEMISTRY, V65, P3249, DOI 10.1016/j.phytochem.2004.10.009.
   Podoll JD, 2013, P NATL ACAD SCI USA, V110, P15573, DOI 10.1073/pnas.1310459110.
   Schrumpf JA, 2012, INFECT IMMUN, V80, P4485, DOI 10.1128/IAI.06224-11.
   Shibata H, 2005, ANTIMICROB AGENTS CH, V49, P549, DOI 10.1128/AAC.49.2.549-555.2005.
   Stapleton PD, 2004, INT J ANTIMICROB AG, V23, P462, DOI 10.1016/j.ijantimicag.2003.09.027.
   Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003.
   Welte T, 2010, INT J ANTIMICROB AG, V36, P391, DOI 10.1016/j.ijantimicag.2010.06.045.
   Wichmann K, 2009, BRIT J DERMATOL, V161, P300, DOI 10.1111/j.1365-2133.2009.09229.x.
   ZANI F, 1993, PLANTA MED, V59, P502, DOI 10.1055/s-2006-959748.
   Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357.
   Zhou XZ, 2012, PHYTOTHER RES, V26, P253, DOI 10.1002/ptr.3536.
   Zuyderduyn S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-59.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{16}},
Journal-ISO = {{Eur. J. Clin. Microbiol. Infect. Dis.}},
Doc-Delivery-Number = {{DI2BF}},
Unique-ID = {{ISI:000373300000005}},
DA = {{2018-08-13}},
}

@article{ ISI:000372567100041,
Author = {Meenach, Samantha A. and Tsoras, Alexandra N. and McGarry, Ronald C. and
   Mansour, Heidi M. and Hilt, J. Zach and Anderson, Kimberly W.},
Title = {{Development of three-dimensional lung multicellular spheroids in air-
   and liquid-interface culture for the evaluation of anticancer
   therapeutics}},
Journal = {{INTERNATIONAL JOURNAL OF ONCOLOGY}},
Year = {{2016}},
Volume = {{48}},
Number = {{4}},
Pages = {{1701-1709}},
Month = {{APR}},
Abstract = {{Three-dimensional (3D) lung multicellular spheroids (MCS) in
   liquid-covered culture (LCC) and air-interface culture (AIC) conditions
   have both been developed for the evaluation of aerosol anticancer
   therapeutics in solution and aerosols, respectively. The MCS were formed
   by seeding lung cancer cells on top of collagen where they formed
   spheroids due to the prevalence of cell-to-cell interactions. LCC MCS
   were exposed to paclitaxel (PTX) in media whereas AIC MCS were exposed
   to dry powder PEGylated phospholipid aerosol microparticles containing
   paclitaxel. The difference in viability for 2D versus 3D culture for
   both LCC and AIC was evaluated along with the effects of the particles
   on lung epithelium via transepithelial electrical resistance (TEER)
   measurements. For LCC and AIC conditions, the 3D spheroids were more
   resistant to treatment with higher IC50 values for A549 and H358 cell
   lines. TEER results initially indicated a decrease in resistance upon
   drug or particle exposure, however, these values increased over the
   course of several days indicating the ability of the cells to recover.
   Overall, these studies offer a comprehensive in vitro evaluation of
   aerosol particles used in the treatment of lung cancer while introducing
   a new method for culturing lung cancer MCS in both LCC and AIC
   conditions.}},
Publisher = {{SPANDIDOS PUBL LTD}},
Address = {{POB 18179, ATHENS, 116 10, GREECE}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Meenach, SA (Reprint Author), Univ Kentucky, Dept Pharmaceut Sci, Drug Dev Div, Lexington, KY 40536 USA.
   Meenach, SA (Reprint Author), Univ Kentucky, Dept Chem \& Mat Engn, Coll Engn, Lexington, KY 40506 USA.
   Meenach, SA (Reprint Author), Univ Rhode Isl, Dept Chem Engn, 205 Crawford Hall,16 Greenhouse Rd, Kingston, RI 02881 USA.
   Meenach, Samantha A.; Mansour, Heidi M., Univ Kentucky, Dept Pharmaceut Sci, Drug Dev Div, Lexington, KY 40536 USA.
   Meenach, Samantha A.; Tsoras, Alexandra N.; Hilt, J. Zach; Anderson, Kimberly W., Univ Kentucky, Dept Chem \& Mat Engn, Coll Engn, Lexington, KY 40506 USA.
   McGarry, Ronald C., Univ Kentucky, Dept Radiat Med, Lexington, KY 40536 USA.
   Meenach, Samantha A., Univ Rhode Isl, Dept Chem Engn, 205 Crawford Hall,16 Greenhouse Rd, Kingston, RI 02881 USA.
   Mansour, Heidi M., Univ Arizona, Dept Pharm Practice \& Sci, Tucson, AZ 85721 USA.}},
DOI = {{10.3892/ijo.2016.3376}},
ISSN = {{1019-6439}},
EISSN = {{1791-2423}},
Keywords = {{multicellular spheroids; air interface culture; paclitaxel;
   three-dimensional cell culture; lung cancer}},
Keywords-Plus = {{TUMOR SPHEROIDS; CANCER BIOLOGY; DRUG-DELIVERY; CELL-CULTURE; MODEL;
   AEROSOL; THERAPY}},
Research-Areas = {{Oncology}},
Web-of-Science-Categories  = {{Oncology}},
Author-Email = {{smeenach@uri.edu}},
ORCID-Numbers = {{Meenach, Samantha/0000-0002-3833-2110}},
Funding-Acknowledgement = {{National Cancer Institute (NCI) {[}R25CA153954]; National Cancer
   Institute Cancer Nanotechnology Training Center (NCI-CNTC) Postdoctoral
   Traineeship}},
Funding-Text = {{The authors gratefully acknowledge financial support from the National
   Cancer Institute (NCI) grant no. R25CA153954 and a National Cancer
   Institute Cancer Nanotechnology Training Center (NCI-CNTC) Postdoctoral
   Traineeship awarded to S. A. M. The content is solely the responsibility
   of the authors and does not necessarily represent the official views of
   the National Cancer Institute or the National Institutes of Health.}},
Cited-References = {{Alipour S, 2010, COLLOID SURFACE B, V81, P521, DOI 10.1016/j.colsurfb.2010.07.050.
   Burdett E, 2010, TISSUE ENG PART B-RE, V16, P351, DOI {[}10.1089/ten.teb.2009.0676, 10.1089/ten.TEB.2009.0676].
   FJELLBIRKELAND L, 1995, VIRCHOWS ARCH, V426, P169.
   Forbes B, 2005, EUR J PHARM BIOPHARM, V60, P193, DOI 10.1016/j.ejpb.2005.02.010.
   Forbes B, 2000, J AEROSOL MED, V13, P281, DOI 10.1089/jam.2000.13.281.
   Foster KA, 2000, INT J PHARM, V208, P1, DOI 10.1016/S0378-5173(00)00452-X.
   Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531.
   Goodman TT, 2008, BIOTECHNOL BIOENG, V101, P388, DOI 10.1002/bit.21910.
   Goodman TT, 2007, INT J NANOMED, V2, P265.
   Grainger CI, 2009, EUR J PHARM BIOPHARM, V71, P318, DOI 10.1016/j.ejpb.2008.09.006.
   Grainger CI, 2006, PHARM RES, V23, P1482, DOI 10.1007/s11095-006-0255-0.
   Haghi M, 2010, DRUG DEV IND PHARM, V36, P1207, DOI 10.3109/03639041003695113.
   Hehlgans S, 2009, RADIOTHER ONCOL, V92, P371, DOI 10.1016/j.radonc.2009.08.001.
   Hendricks P, 2012, FUND CLIN PHARMACOL, V26, P632, DOI 10.1111/j.1472-8206.2011.00964.x.
   Ingram M, 2010, BIOTECH HISTOCHEM, V85, P213, DOI 10.3109/10520295.2010.483655.
   Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763.
   Jin HJ, 2011, LAB CHIP, V11, P115, DOI {[}10.1039/c0lc00134a, 10.1039/c01c00134a].
   Kelly K, 2001, J CLIN ONCOL, V19, P3210, DOI 10.1200/JCO.2001.19.13.3210.
   Koshkina NV, 2004, J AEROSOL MED, V17, P7, DOI 10.1089/089426804322994415.
   Koshkina NV, 2001, CLIN CANCER RES, V7, P3258.
   Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228.
   Meenach SA, 2013, EUR J PHARM SCI, V49, P699, DOI 10.1016/j.ejps.2013.05.012.
   Meenach SA, 2013, INT J NANOMED, V8, P275, DOI 10.2147/IJN.S30724.
   Nirmalanandhan VS, 2010, ASSAY DRUG DEV TECHN, V8, P581, DOI 10.1089/adt.2010.0276.
   Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053.
   Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954.
   Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242.
   Society AC, 2013, CANC FACTS FIG 2013, P4.
   Tazzyman S, 2011, INT J CANCER, V129, P847, DOI 10.1002/ijc.25987.
   Vertrees RA, 2009, CANCER BIOL THER, V8, P356, DOI 10.4161/cbt.8.4.7432.
   Wisnivesky JP, 2005, CHEST, V128, P1461, DOI 10.1378/chest.128.3.1461.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{14}},
Journal-ISO = {{Int. J. Oncol.}},
Doc-Delivery-Number = {{DH1TF}},
Unique-ID = {{ISI:000372567100041}},
OA = {{green\_published}},
DA = {{2018-08-13}},
}

@article{ ISI:000373275900001,
Author = {Kondakova, Tatiana and Catovic, Chloe and Barreau, Magalie and Nusser,
   Michael and Brenner-Weiss, Gerald and Chevalier, Sylvie and Dionnet,
   Frederic and Orange, Nicole and Poc, Cecile Duclairoir},
Title = {{Response to Gaseous NO2 Air Pollutant of P. fluorescens Airborne Strain
   MFAF76a and Clinical Strain MFN1032}},
Journal = {{FRONTIERS IN MICROBIOLOGY}},
Year = {{2016}},
Volume = {{7}},
Month = {{MAR 31}},
Abstract = {{Human exposure to nitrogen dioxide (NO2), an air pollutant of increasing
   interest in biology, results in several toxic effects to human health
   and also to the air microbiota. The aim of this study was to investigate
   the bacterial response to gaseous NO2. Two Pseudomonas fluorescens
   strains, namely the airborne strain MFAF76a and the clinical strain
   MFN1032 were exposed to 0.1, 5, or 45 ppm concentrations of NO2, and
   their effects on bacteria were evaluated in terms of motility, biofilm
   formation, antibiotic resistance, as well as expression of several
   chosen target genes. While 0.1 and 5 ppm of NO2did not lead to any
   detectable modification in the studied phenotypes of the two bacteria,
   several alterations were observed when the bacteria were exposed to 45
   ppm of gaseous NO2. We thus chose to focus on this high concentration.
   NO2-exposed P. fluorescens strains showed reduced swimming motility, and
   decreased swarming in case of the strain MFN1032. Biofilm formed by
   NO2-treated airborne strain MFAF76a showed increased maximum thickness
   compared to non-treated cells, while NO2 had no apparent effect on the
   clinical MFN1032 biofilm structure. It is well known that biofilm and
   motility are inversely regulated by intracellular c-di-GMP level. The
   c-di-GMP level was however not affected in response to NO2 treatment.
   Finally, NO2-exposed P fluorescens strains were found to be more
   resistant to ciprofloxacin and chloramphenicol. Accordingly, the
   resistance nodulation cell division (RND) MexEF-OprN efflux pump
   encoding genes were highly upregulated in the two P fluorescens strains.
   Noticeably, similar phenotypes had been previously observed following a
   NO treatment. Interestingly, an hmp-homolog gene in P. fluorescens
   strains MFAF76a and MFN1032 encodes a NO dioxygenase that is involved in
   NO detoxification into nitrites. Its expression was upregulated in
   response to NO2, suggesting a possible common pathway between NO and NO2
   detoxification. Taken together, our study provides evidences for the
   bacterial response to NO2 toxicity.}},
Publisher = {{FRONTIERS MEDIA SA}},
Address = {{PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Poc, CD (Reprint Author), Univ Rouen, Normandy Univ, Lab Microbiol Signals \& Microenvironm EA 4312, SeSa,IRIB, Evreux, France.
   Kondakova, Tatiana; Catovic, Chloe; Barreau, Magalie; Chevalier, Sylvie; Orange, Nicole; Poc, Cecile Duclairoir, Univ Rouen, Normandy Univ, Lab Microbiol Signals \& Microenvironm EA 4312, SeSa,IRIB, Evreux, France.
   Kondakova, Tatiana; Dionnet, Frederic, Aerotherm \& Internal Combust Engine Technol Res C, St Etienne, France.
   Nusser, Michael; Brenner-Weiss, Gerald, Karlsruhe Inst Technol, Inst Funct Interfaces, D-76021 Karlsruhe, Germany.}},
DOI = {{10.3389/fmicb.2016.00379}},
Article-Number = {{379}},
ISSN = {{1664-302X}},
Keywords = {{airborne; Pseudomonas fluorescens; nitrogen dioxide; biofilm; antibiotic
   sensitivity; motility; air pollution}},
Keywords-Plus = {{PSEUDOMONAS-AERUGINOSA PA14; NITRIC-OXIDE; BIOFILM FORMATION;
   ESCHERICHIA-COLI; SWARMING MOTILITY; FLAVOHEMOGLOBIN GENE; DIFFERENT
   ECOSYSTEMS; GLOBAL ATMOSPHERE; OXIDATIVE STRESS; NITROGEN-DIOXIDE}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{cecile.poc@univ-rouen.fr}},
ResearcherID-Numbers = {{Brenner-Weiss, Gerald/H-2868-2013}},
ORCID-Numbers = {{Brenner-Weiss, Gerald/0000-0002-6728-5907}},
Funding-Acknowledgement = {{GRR SESA (Research Network of Sanitary Safety); Europe, French
   Government (FEDER); Regional Council of Haute-Normandie; Conseil General
   de I'Eure; Grand Evreux Agglomeration (France)}},
Funding-Text = {{We thank Marc Feuilloley for his constructive comments and Yoan
   Konto-Ghiorghi for his advices in English editing and academic writing.
   kNre are grateful to Anne Groboillot for help with development of gas
   delivery system. We thank Audrey Garreau and Olivier Maillot for
   technical assistance. This study was supported by a PhD grant from the
   GRR SESA (Research Network of Sanitary Safety) and was financially
   supported by Europe, French Government (FEDER), Regional Council of
   Haute-Normandie, the Conseil General de I'Eure and the Grand Evreux
   Agglomeration (France).}},
Cited-References = {{Ahern HE, 2007, BIOGEOSCIENCES, V4, P115, DOI 10.5194/bg-4-115-2007.
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389.
   {[}Anonymous], 2015, ACC EUR UN LAW.
   Arai H, 2005, J BACTERIOL, V187, P3960, DOI 10.1128/JB.187.12.3960-3968.2005.
   Auger C, 2015, BBA-GEN SUBJECTS, V1850, P43, DOI 10.1016/j.bbagen.2014.09.028.
   Auger C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028469.
   Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4.
   Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06.
   Barraud N, 2009, MICROB BIOTECHNOL, V2, P370, DOI 10.1111/j.1751-7915.2009.00098.x.
   Bauer H, 2002, ATMOS RES, V64, P109, DOI 10.1016/S0169-8095(02)00084-4.
   Bernagaud C., 2014, POLLUTION ATMOSPHERI.
   Bodilis J, 2004, SYST APPL MICROBIOL, V27, P93, DOI 10.1078/0723-2020-00253.
   Bouffartigues E, 2012, J BACTERIOL, V194, P4301, DOI 10.1128/JB.00509-12.
   Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8.
   Burrows SM, 2009, ATMOS CHEM PHYS, V9, P9263, DOI 10.5194/acp-9-9263-2009.
   Burrows SM, 2009, ATMOS CHEM PHYS, V9, P9281, DOI 10.5194/acp-9-9281-2009.
   Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005.
   Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06.
   Chaloulakou A, 2008, ATMOS ENVIRON, V42, P454, DOI 10.1016/j.atmosenv.2007.09.067.
   Chapalain A, 2008, CAN J MICROBIOL, V54, P19, DOI 10.1139/w07-110.
   Chauhan A. J., 1998, Reviews on Environmental Health, V13, P73.
   Corker H, 2003, J BIOL CHEM, V278, P31584, DOI 10.1074/jbc.M303282200.
   Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339.
   Cutruzzola F, 2016, J BACTERIOL, V198, P55, DOI 10.1128/JB.00371-15.
   Despres VR, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.15598.
   Deziel E, 2001, J BACTERIOL, V183, P1195, DOI 10.1128/JB.183.4.1195-1204.2001.
   Duclairoir-Poc C., 2011, J BACTERIOLOGY PARAS, pS1, DOI {[}10.4172/2155-9597.S1-002, DOI 10.4172/2155-9597.S1-002].
   Dybwad M, 2012, APPL ENVIRON MICROB, V78, P1917, DOI 10.1128/AEM.07212-11.
   Fang ZG, 2007, MICROB ECOL, V54, P487, DOI 10.1007/s00248-007-9216-3.
   Fetar H, 2011, ANTIMICROB AGENTS CH, V55, P508, DOI 10.1128/AAC.00830-10.
   Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200.
   Ghaffari A, 2005, NITRIC OXIDE-BIOL CH, V12, P129, DOI 10.1016/j.niox.2005.01.006.
   Gicquel G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080407.
   Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439.
   Guttenplan SB, 2013, FEMS MICROBIOL REV, V37, P849, DOI 10.1111/1574-6976.12018.
   Ha DG, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0003-2014.
   Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395.
   Husain M, 2008, J BIOL CHEM, V283, P7682, DOI 10.1074/jbc.M708845200.
   INERIS, 2011, PORTAIL SUBST CHIM.
   JETER RM, 1984, J BACTERIOL, V157, P673.
   Kohler T, 1997, MOL MICROBIOL, V23, P345, DOI 10.1046/j.1365-2958.1997.2281594.x.
   Laver JR, 2013, ANTIOXID REDOX SIGN, V18, P309, DOI 10.1089/ars.2012.4767.
   Li Y, 2013, J BACTERIOL, V195, P3531, DOI 10.1128/JB.01156-12.
   Liu PL, 2012, CAN J MICROBIOL, V58, P336, DOI {[}10.1139/W11-141, 10.1139/w11-141].
   Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354.
   McCollister BD, 2011, ANTIMICROB AGENTS CH, V55, P2189, DOI 10.1128/AAC.01203-10.
   McLean S, 2010, J BIOL CHEM, V285, P20724, DOI 10.1074/jbc.M109.085506.
   Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573.
   Morin J.-P., 2013, POLLUT ATMOS.
   Morita Y, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00008.
   Pearce DA, 2010, EXTREMOPHILES, V14, P145, DOI 10.1007/s00792-009-0293-8.
   Pershagen G, 1995, INT J EPIDEMIOL, V24, P1147, DOI 10.1093/ije/24.6.1147.
   Petrova OE, 2014, J BACTERIOL, V196, P2827, DOI 10.1128/JB.01628-14.
   Petrova OE, 2012, J BACTERIOL, V194, P5817, DOI 10.1128/JB.00780-12.
   Poc C. D., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P708.
   Poole RK, 1996, J BACTERIOL, V178, P5487, DOI 10.1128/jb.178.18.5487-5492.1996.
   Redondo-Nieto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-54.
   Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102.
   Rossignol G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-189.
   Roy AB, 2012, J BACTERIOL, V194, P2904, DOI 10.1128/JB.05346-11.
   Santl-Temkiv T, 2015, ATMOS ENVIRON, V109, P105, DOI 10.1016/j.atmosenv.2015.02.060.
   Sastalla I, 2009, APPL ENVIRON MICROB, V75, P2099, DOI 10.1128/AEM.02066-08.
   Scales BS, 2014, CLIN MICROBIOL REV, V27, P927, DOI 10.1128/CMR.00044-14.
   Sher E., 1998, HDB AIR POLLUTION IN.
   Shiro Y, 2012, BBA-BIOENERGETICS, V1817, P1907, DOI 10.1016/j.bbabio.2012.03.001.
   Skalska K, 2010, SCI TOTAL ENVIRON, V408, P3976, DOI 10.1016/j.scitotenv.2010.06.001.
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7.
   Sobel ML, 2005, J BACTERIOL, V187, P1246, DOI 10.1128/JB.187.4.1246-1253.2005.
   Sobel ML, 2003, ANTIMICROB AGENTS CH, V47, P3202, DOI 10.1128/AAC.47.10.3202-3207.2003.
   Spangler C, 2010, J MICROBIOL METH, V81, P226, DOI 10.1016/j.mimet.2010.03.020.
   Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x.
   Strehmel J, 2015, APPL ENVIRON MICROB, V81, P1274, DOI 10.1128/AEM.02832-14.
   Tamir S, 1996, CHEM RES TOXICOL, V9, P821, DOI 10.1021/tx9600311.
   van Sorge NM, 2013, J BIOL CHEM, V288, P6417, DOI 10.1074/jbc.M112.448738.
   Varivarn K, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-92.}},
Number-of-Cited-References = {{75}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{9}},
Journal-ISO = {{Front. Microbiol.}},
Doc-Delivery-Number = {{DI1SK}},
Unique-ID = {{ISI:000373275900001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000373395700008,
Author = {Svanberg, Sune and Zhao, Guangyu and Zhang, Hao and Huang, Jing and
   Lian, Ming and Li, Tianqi and Zhu, Shiming and Li, Yiyun and Duan, Zheng
   and Lin, Huiying and Svanberg, Katarina},
Title = {{Laser spectroscopy applied to environmental, ecological, food safety,
   and biomedical research}},
Journal = {{OPTICS EXPRESS}},
Year = {{2016}},
Volume = {{24}},
Number = {{6}},
Pages = {{A515-A527}},
Month = {{MAR 21}},
Abstract = {{Laser spectroscopy provides many possibilities for multidisciplinary
   applications in environmental monitoring, in the ecological field, for
   food safety investigations, and in biomedicine. The paper gives several
   examples of the power of multi-disciplinary applications of laser
   spectroscopy as pursued in our research group. The studies utilize
   mostly similar and widely applicable spectroscopic approaches. Air
   pollution and vegetation monitoring by lidar techniques, as well as
   agricultural pest insect monitoring and classification by elastic
   scattering and fluorescence spectroscopy are described. Biomedical
   aspects include food safety applications and medical diagnostics of
   sinusitis and otitis, with strong connection to the abatement of
   antibiotics resistance development. (C) 2016 Optical Society of America}},
Publisher = {{OPTICAL SOC AMER}},
Address = {{2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Svanberg, S (Reprint Author), S China Normal Univ, Ctr Opt \& Electromagnet Res, Univ City Campus, Guangzhou 510006, Guangdong, Peoples R China.
   Svanberg, S (Reprint Author), Lund Univ, Lund Laser Ctr, POB 118, SE-22100 Lund, Sweden.
   Svanberg, Sune; Zhao, Guangyu; Zhang, Hao; Huang, Jing; Lian, Ming; Li, Tianqi; Zhu, Shiming; Li, Yiyun; Duan, Zheng; Lin, Huiying; Svanberg, Katarina, S China Normal Univ, Ctr Opt \& Electromagnet Res, Univ City Campus, Guangzhou 510006, Guangdong, Peoples R China.
   Svanberg, Sune; Svanberg, Katarina, Lund Univ, Lund Laser Ctr, POB 118, SE-22100 Lund, Sweden.}},
DOI = {{10.1364/OE.24.00A515}},
ISSN = {{1094-4087}},
Keywords-Plus = {{MEDIA ABSORPTION-SPECTROSCOPY; SCATTERING MEDIA; ATOMIC MERCURY; INDUCED
   FLUORESCENCE; GAS-SPECTROSCOPY; LIDAR SYSTEM; LAND MINES;
   CLASSIFICATION; DIAGNOSTICS; CAVITY}},
Research-Areas = {{Optics}},
Web-of-Science-Categories  = {{Optics}},
Author-Email = {{sune.svanberg@fysik.lth.se}},
Funding-Acknowledgement = {{Guangdong Province Innovation Research Team Program
   {[}201001D0104799318]; Swedish Research Council; Knut and Alice
   Wallenberg Foundation}},
Funding-Text = {{The authors are grateful for a fruitful collaboration with Lund
   University, Sweden, and with Chinese partners, including Henan
   Agricultural University, Zhengzhou, as mediated by Prof. Jiandong Hu.
   The kind and persistent support by Prof. Sailing He is much appreciated.
   This work was financially supported by a Guangdong Province Innovation
   Research Team Program (No. 201001D0104799318), the Swedish Research
   Council and the Knut and Alice Wallenberg Foundation.}},
Cited-References = {{Anderson T. W., 2013, INTRO MULTIVARIATE S.
   Andersson M, 2007, LASER PHYS, V17, P893, DOI 10.1134/S1054660X07070018.
   ANKERST J, 1984, APPL SPECTROSC, V38, P890, DOI 10.1366/0003702844554738.
   Baudelet M., 2013, LASER SPECTROSCOPY S.
   Boas DA, 2011, HDB BIOMEDICAL OPTIC.
   Brydegaard M, 2016, APPL SPECTROSC, V70, P372, DOI 10.1177/0003702815620564.
   Brydegaard M, 2014, PROG ELECTROMAGN RES, V147, P141, DOI 10.2528/PIER14101001.
   Brydegaard M, 2013, APPL SPECTROSC, V67, P477, DOI 10.1366/12-06860.
   BUCK AL, 1981, J APPL METEOROL, V20, P1527, DOI 10.1175/1520-0450(1981)020<1527:NEFCVP>2.0.CO;2.
   Carlsten ES, 2011, APPL OPTICS, V50, P2112, DOI 10.1364/AO.50.002112.
   CHURCH IJ, 1995, J SCI FOOD AGR, V67, P143, DOI 10.1002/jsfa.2740670202.
   Cui XJ, 2012, J QUANT SPECTROSC RA, V113, P1300, DOI 10.1016/j.jqsrt.2011.11.008.
   Dimish U. S., 2015, FRONTIERS BIOPHOTONI.
   Drake VA, 2012, RADAR ENTOMOLOGY: OBSERVING INSECT FLIGHT AND MIGRATION, P1, DOI 10.1079/9781845935566.0000.
   EDNER H, 1993, APPL OPTICS, V32, P327, DOI 10.1364/AO.32.000327.
   Ennis C. A., 2014, 55 WMO.
   Fujii Takashi, 2005, LASER REMOTE SENSING.
   Fujimoto J. G., 2009, BIOMEDICAL OPTICAL I.
   Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0.
   Guan ZG, 2010, APPL PHYS B-LASERS O, V101, P465, DOI 10.1007/s00340-010-4166-8.
   Guan ZG, 2010, APPL OPTICS, V49, P5133, DOI 10.1364/AO.49.005133.
   Hodgkinson J, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/1/012004.
   Huang J, 2014, PR ELECTROMAGN RES S, P1251.
   Huang J, 2015, J BIOPHOTONICS, V8, P985, DOI 10.1002/jbio.201500110.
   Jelinkova H, 2013, WOODH PUB SER ELECT, P1, DOI 10.1533/9780857097545.
   Lackner M, 2007, REV CHEM ENG, V23, P65.
   Lewander M, 2008, APPL PHYS B-LASERS O, V93, P619, DOI 10.1007/s00340-008-3192-2.
   Lewander M, 2011, PACKAG TECHNOL SCI, V24, P271, DOI 10.1002/pts.934.
   Lewander M, 2009, OPT EXPRESS, V17, P10849, DOI 10.1364/OE.17.010849.
   Lewander M, 2012, RHINOLOGY, V50, P26, DOI 10.4193/Rhino10.231.
   LICHTENTHALER HK, 1988, CRC CR REV ANAL CHEM, V19, pS29, DOI 10.1080/15476510.1988.10401466.
   Lindberg S, 2012, ANN OTO RHINOL LARYN, V121, P217, DOI 10.1177/000348941212100406.
   Liu C, 2014, ATMOS CHEM PHYS, V14, P1717, DOI 10.5194/acp-14-1717-2014.
   Liu W. Q., 2015, CURRENT AIR QUALITY, P251.
   Lundin P, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.127005.
   Lundin P, 2011, APPL OPTICS, V50, P3396, DOI 10.1364/AO.50.003396.
   McCarthy Jr J. H., 1969, 609 US GEOL SURV, V609.
   McDowell NG, 2015, TRENDS PLANT SCI, V20, P114, DOI 10.1016/j.tplants.2014.10.008.
   Mei L., 2011, APPL PHYS B, V106, P733, DOI {[}10.1007/s00340-011-4785-8, DOI 10.1007/S00340-011-4785-8].
   Mei L, 2015, APPL OPTICS, V54, P2234, DOI 10.1364/AO.54.002234.
   Mei L, 2014, SENSORS-BASEL, V14, P3871, DOI 10.3390/s140303871.
   Mei L, 2014, OPT LASER ENG, V55, P128, DOI 10.1016/j.optlaseng.2013.10.028.
   Mei L, 2012, PROC SPIE, V8531, DOI 10.1117/12.974562.
   Molina M. J., 1997, NOBEL LECT CHEM 1991.
   MONTAN S, 1985, OPT LETT, V10, P56, DOI 10.1364/OL.10.000056.
   Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659.
   Persson L, 2006, APPL PHYS B-LASERS O, V82, P313, DOI 10.1007/s00340-005-1968-1.
   Persson L, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2777189.
   Platt U, 2008, PHYS EARTH SPACE ENV, P1, DOI 10.1007/978-3-540-75776-4\_1.
   Popp J., 2011, HDB BIOPOTONICS, V1-3.
   Raimondi V, 2009, INT BIODETER BIODEGR, V63, P823, DOI 10.1016/j.ibiod.2009.03.006.
   Randeberg LL, 2004, P SOC PHOTO-OPT INS, V5312, P54, DOI 10.1117/12.538045.
   Rechner A. C., 2002, METHODS MULTIVARIATE.
   Runemark A., 2011, IEEE J SEL TOP QUANT, V18, P1573.
   Shaw JA, 2005, OPT EXPRESS, V13, P5853, DOI 10.1364/OPEX.13.005853.
   Sigrist M. W., 1994, AIR MONITORING SPECT.
   Sjoholm M, 2001, OPT LETT, V26, P16, DOI 10.1364/OL.26.000016.
   Svanberg EK, 2016, PEDIATR RES, V79, P621, DOI 10.1038/pr.2015.267.
   SVANBERG K, 1994, BRIT J DERMATOL, V130, P743, DOI 10.1111/j.1365-2133.1994.tb03412.x.
   Svanberg K, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3466579.
   SVANBERG S, 1988, APPL PHYS B-PHOTO, V46, P271, DOI 10.1007/BF00692885.
   Svanberg S, 2008, APPL PHYS B-LASERS O, V92, P351, DOI 10.1007/s00340-008-3092-5.
   Svanberg S, 2002, OPT LASER ENG, V37, P245, DOI 10.1016/S0143-8166(01)00098-7.
   Svanberg S., 2014, ENCY ANAL CHEM.
   Svanberg S., 2012, SPRINGER HDB LASERS, P1146.
   Svanberg S., 2004, ATOMIC MOL SPECTROSC.
   Svanberg S., 2015, OPT PHOT EN ENV SUZH.
   Svanberg S, 2013, LASER PHOTONICS REV, V7, P779, DOI 10.1002/lpor.201200073.
   Thompson A. K., 2010, CONTROLLED ATMOSPHER.
   VanEmden HF, 2013, HANDBOOK OF AGRICULTURAL ENTOMOLOGY, P1, DOI 10.1002/9781118469347.
   Waynant RW, 2002, LASERS MED.
   Weibring P, 2003, APPL OPTICS, V42, P3583, DOI 10.1364/AO.42.003583.
   Werle P., 2008, LASERS CHEM.
   Wu BF, 2015, REMOTE SENS-BASEL, V7, P3907, DOI 10.3390/rs70403907.
   Zhang H., OPT EXPRESS IN PRESS.
   Zhang H., 2016, ACTA OPT SINICA, V36.
   Zhang H, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.5.057001.
   Zhang H, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.6.067001.
   Zhao GY, 2014, PR ELECTROMAGN RES S, P2711.}},
Number-of-Cited-References = {{79}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{7}},
Usage-Count-Since-2013 = {{24}},
Journal-ISO = {{Opt. Express}},
Doc-Delivery-Number = {{DI3JU}},
Unique-ID = {{ISI:000373395700008}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000374832600012,
Author = {Parrilli, Ermenegilda and Ricciardelli, Annarita and Casillo, Angela and
   Sannino, Filomena and Papa, Rosanna and Tilotta, Marco and Artini, Marco
   and Selan, Laura and Corsaro, Maria Michela and Tutino, Maria Luisa},
Title = {{Large-scale biofilm cultivation of Antarctic bacterium Pseudoalteromonas
   haloplanktis TAC125 for physiologic studies and drug discovery}},
Journal = {{EXTREMOPHILES}},
Year = {{2016}},
Volume = {{20}},
Number = {{2}},
Pages = {{227-234}},
Month = {{MAR}},
Abstract = {{Microbial biofilms are mainly studied due to detrimental effects on
   human health but they are also well established in industrial
   biotechnology for the production of chemicals. Moreover, biofilm can be
   considered as a source of novel drugs since the conditions prevailing
   within biofilm can allow the production of specific metabolites.
   Antarctic bacterium Pseudoalteromonas haloplanktis TAC125 when grown in
   biofilm condition produces an anti-biofilm molecule able to inhibit the
   biofilm of the opportunistic pathogen Staphylococcus epidermidis. In
   this paper we set up a P. haloplanktis TAC125 biofilm cultivation
   methodology in automatic bioreactor. The biofilm cultivation was
   designated to obtain two goals: (1) the scale up of cell-free
   supernatant production in an amount necessary for the anti-biofilm
   molecule/s purification; (2) the recovery of P. haloplanktis TAC125
   cells grown in biofilm for physiological studies. We set up a
   fluidized-bed reactor fermentation in which floating polystyrene
   supports were homogeneously mixed, exposing an optimal air-liquid
   interface to let bacterium biofilm formation. The proposed methodology
   allowed a large-scale production of anti-biofilm molecule and paved the
   way to study differences between P. haloplanktis TAC125 cells grown in
   biofilm and in planktonic conditions. In particular, the modifications
   occurring in the lipopolysaccharide of cells grown in biofilm were
   investigated.}},
Publisher = {{SPRINGER JAPAN KK}},
Address = {{CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Parrilli, E (Reprint Author), Univ Naples Federico II, Complesso Univ Monte St Angelo, Dept Chem Sci, Via Cintia 4, I-80126 Naples, Italy.
   Parrilli, Ermenegilda; Ricciardelli, Annarita; Casillo, Angela; Sannino, Filomena; Corsaro, Maria Michela; Tutino, Maria Luisa, Univ Naples Federico II, Complesso Univ Monte St Angelo, Dept Chem Sci, Via Cintia 4, I-80126 Naples, Italy.
   Papa, Rosanna; Tilotta, Marco; Artini, Marco; Selan, Laura, Univ Roma La Sapienza, Dept Publ Hlth \& Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.}},
DOI = {{10.1007/s00792-016-0813-2}},
ISSN = {{1431-0651}},
EISSN = {{1433-4909}},
Keywords = {{Biofilm cultivation; Pseudoalteromonas haloplanktis TAC125;
   Anti-biofilm; Bacterial biofilm phenotype}},
Keywords-Plus = {{STAPHYLOCOCCUS-EPIDERMIDIS; ANTIBIOTIC-RESISTANCE; LIPOPOLYSACCHARIDES;
   POLYSACCHARIDE; PRODUCTS; PROTEINS; REACTORS; GENOME; COLD; LIFE}},
Research-Areas = {{Biochemistry \& Molecular Biology; Microbiology}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Microbiology}},
Author-Email = {{erparril@unina.it}},
ResearcherID-Numbers = {{parrilli, ermenegilda/K-4616-2016
   }},
ORCID-Numbers = {{parrilli, ermenegilda/0000-0002-9002-5409
   CORSARO, Maria Michela/0000-0002-6834-8682
   Tutino, Maria Luisa/0000-0002-4978-6839}},
Funding-Acknowledgement = {{Programma Nazionale di Ricerche in Antartide {[}2013/B1.04]; Programma
   Operativo Nazionale Ricerca e Competitivita {[}01/Ric.-PON01\_01802]}},
Funding-Text = {{This work was supported by Programma Nazionale di Ricerche in Antartide
   2013/B1.04 Tutino and Programma Operativo Nazionale Ricerca e
   Competitivita 2007-2013 (D. D. Prot. n. 01/Ric. del
   18.1.2010)-PON01\_01802.}},
Cited-References = {{Artini M, 2013, J APPL MICROBIOL, V114, P266, DOI 10.1111/jam.12038.
   Bowman JP, 2005, MICROBIAL ECOL, V49, P451, DOI 10.1007/s00248-004-0070-2.
   Carillo S, 2015, J AM CHEM SOC, V137, P179, DOI 10.1021/ja5075954.
   Chalabaev S, 2014, MBIO, V19.
   Cheng KC, 2010, APPL MICROBIOL BIOT, V87, P445, DOI 10.1007/s00253-010-2622-3.
   Ciornei CD, 2010, INNATE IMMUN-LONDON, V16, P288, DOI 10.1177/1753425909341807.
   Corsaro MM, 2001, EUR J BIOCHEM, V268, P5092, DOI 10.1046/j.0014-2956.2001.02435.x.
   de la Fuente-Nunez C, 2013, CURR OPIN MICROBIOL, V16, P580, DOI 10.1016/j.mib.2013.06.013.
   Fondi M, 2015, ENVIRON MICROBIOL, V17, P751, DOI 10.1111/1462-2920.12513.
   GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x.
   Giuliani M, 2011, PROCESS BIOCHEM, V46, P953, DOI 10.1016/j.procbio.2011.01.011.
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821.
   Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514.
   Heilmann C, 1996, INFECT IMMUN, V64, P277.
   Kiran GS, 2010, FEMS IMMUNOL MED MIC, V59, P432, DOI 10.1111/j.1574-695X.2010.00698.x.
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0.
   Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905.
   Ni NT, 2009, MED RES REV, V29, P65, DOI 10.1002/med.20145.
   Papa R, 2006, EXTREMOPHILES, V10, P483, DOI 10.1007/s00792-006-0525-0.
   Papa R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01333.
   Papa R, 2013, MICROB PATHOGENESIS, V63, P44, DOI 10.1016/j.micpath.2013.05.003.
   Papa R, 2013, RES MICROBIOL, V164, P450, DOI 10.1016/j.resmic.2013.01.010.
   Parrilli E, 2015, INT J IMMUNOPATH PH, V28, P104, DOI 10.1177/0394632015572751.
   Percival SL, 2015, J MED MICROBIOL, V64, P323, DOI 10.1099/jmm.0.000032.
   Piette F, 2011, APPL ENVIRON MICROB, V77, P3881, DOI 10.1128/AEM.02757-10.
   Piette F, 2010, MOL MICROBIOL, V76, P120, DOI 10.1111/j.1365-2958.2010.07084.x.
   Pongtharangku T, 2007, APPL MICROBIOL BIOT, V74, P555, DOI 10.1007/s00253-006-0697-7.
   Qin ZQ, 2009, MICROBIOL-SGM, V155, P2148, DOI 10.1099/mic.0.028001-0.
   Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414.
   Rosche B, 2009, TRENDS BIOTECHNOL, V27, P636, DOI 10.1016/j.tibtech.2009.08.001.
   Szilagyi N, 2013, WATER SCI TECHNOL, V68, P1391, DOI 10.2166/wst.2013.385.
   TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X.
   Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103.
   Wilmes B, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-72.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{19}},
Journal-ISO = {{Extremophiles}},
Doc-Delivery-Number = {{DK3QN}},
Unique-ID = {{ISI:000374832600012}},
DA = {{2018-08-13}},
}

@article{ ISI:000373217700015,
Author = {Taylor, Matthew and McCollister, Bruce and Park, Daewon},
Title = {{Highly Bactericidal Polyurethane Effective Against Both Normal and
   Drug-Resistant Bacteria: Potential Use as an Air Filter Coating}},
Journal = {{APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY}},
Year = {{2016}},
Volume = {{178}},
Number = {{5}},
Pages = {{1053-1067}},
Month = {{MAR}},
Abstract = {{The battle against the prevalence of hospital-acquired infections has
   underscored the importance of identifying and maintaining the
   cleanliness of possible infection transmission sources in the patient's
   environment. One of the most crucial lines of defense for mitigating the
   spread of pathogens in a healthcare facility is the removal of
   microorganisms from the environment by air filtration systems. After
   removing the pathogenic microorganisms, the filters used in these
   systems can serve as reservoirs for the pathogens and pose a risk for
   secondary infection. This threat, combined with the ever-growing
   prevalence of drug-resistant bacterial strains, substantiates the need
   for an effective bactericidal air filter. To this end, a broad-spectrum
   bactericidal polyurethane incorporating immobilized quaternary ammonium
   groups was developed for use as an air filter coating. In this study,
   the bactericidal activity of the polymer coating on high-efficiency
   particulate air (HEPA) filter samples was quantified against eight
   bacterial strains commonly responsible for nosocomial
   infection-including drug-resistant strains, and confirmed when applied
   as a filter coating in conditions mimicking those of its intended
   application. The coated HEPA filter samples exhibited high bactericidal
   activity against all eight strains, and the polyurethane was concluded
   to be an effective coating in rendering HEPA filters bactericidal.}},
Publisher = {{HUMANA PRESS INC}},
Address = {{999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Park, D (Reprint Author), Univ Colorado, Dept Bioengn, Denver, CO 80206 USA.
   Taylor, Matthew; Park, Daewon, Univ Colorado, Dept Bioengn, Denver, CO 80206 USA.
   McCollister, Bruce, Univ Colorado, Univ Colorado Hosp, Microbiol Lab, Aurora, CO 80045 USA.}},
DOI = {{10.1007/s12010-015-1928-0}},
ISSN = {{0273-2289}},
EISSN = {{1559-0291}},
Keywords = {{Pathogens; Antibacterial; Air filtration system; Drug-resistant strains;
   Coating}},
Keywords-Plus = {{QUATERNARY AMMONIUM-COMPOUNDS; BLOOD-STREAM INFECTIONS;
   PROVIDENCIA-STUARTII; MOLECULAR-WEIGHT; ANTIBACTERIAL; POLYMER;
   SURFACES; SURVIVAL; DISINFECTANTS; PREVALENCE}},
Research-Areas = {{Biochemistry \& Molecular Biology; Biotechnology \& Applied Microbiology}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Biotechnology \& Applied Microbiology}},
Author-Email = {{daewon.park@ucdenver.edu}},
Funding-Acknowledgement = {{State Bioscience Proof of Concept Grant {[}CU3460D]; University of
   Colorado Denver}},
Funding-Text = {{This work was financially supported in part by State Bioscience Proof of
   Concept Grant (CU3460D) and University of Colorado Denver Start-up
   funding.}},
Cited-References = {{Abraham G., 1998, J AM BIOL SAFETY ASS, V3, P134.
   Ahmad N., 2010, SHERRIS MED MICROBIO.
   Albert M, 2003, BIOMACROMOLECULES, V4, P1811, DOI 10.1021/bm0342180.
   {[}Anonymous], 2011, BASIC INFECTION CONT.
   Cao ZB, 2009, ACS APPL MATER INTER, V1, P494, DOI 10.1021/am800157a.
   Cetinkaya Y, 2000, CLIN MICROBIOL REV, V13, P686, DOI 10.1128/CMR.13.4.686-707.2000.
   Chattopadhyay DK, 2007, PROG POLYM SCI, V32, P352, DOI 10.1016/j.progpolymsci.2006.05.003.
   Chuaybamroong P, 2010, INDOOR AIR, V20, P246, DOI 10.1111/j.1600-0668.2010.00651.x.
   Cooper A, 2013, CARBOHYD POLYM, V92, P254, DOI 10.1016/j.carbpol.2012.08.114.
   Denyer SP, 1998, INT BIODETER BIODEGR, V41, P261, DOI 10.1016/S0964-8305(98)00023-7.
   Ding X, 2012, BIOMATERIALS, V33, P6593, DOI 10.1016/j.biomaterials.2012.06.001.
   Ducel G., 2002, PREVENTION HOSP ACQU.
   Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192.
   First M. W., 1998, J AM BIOL SAFETY ASS, V3, P33.
   Fraise A. P., 2012, RUSSELL HUGO AYLIFFE.
   Gabriel GJ, 2007, MAT SCI ENG R, V57, P28, DOI 10.1016/j.mser.2007.03.002.
   Garcia-Fernandez L, 2013, ADV MATER, V25, P529, DOI 10.1002/adma.201203362.
   Haenle M, 2011, J MATER SCI-MATER M, V22, P381, DOI 10.1007/s10856-010-4204-4.
   Hayakawa K, 2012, INT J INFECT DIS, V16, pE646, DOI 10.1016/j.ijid.2012.05.1029.
   Himanshu Mittal S. R. P., 2011, APPL BIOSAFETY, V16, P163.
   Hsu BB, 2011, BIOTECHNOL LETT, V33, P411, DOI 10.1007/s10529-010-0419-1.
   IKEDA T, 1986, ANTIMICROB AGENTS CH, V30, P132, DOI 10.1128/AAC.30.1.132.
   JARVIS WR, 1992, J ANTIMICROB CHEMOTH, V29, P19, DOI 10.1093/jac/29.suppl\_A.19.
   Kampf G, 1998, ANTIMICROB AGENTS CH, V42, P2440.
   Khajavi R, 2013, J IND TEXT, V42, P219, DOI 10.1177/1528083711434653.
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130.
   Laxminarayan R., 2007, EXTENDING CURE POLIC.
   Li J, 2005, INT J ANTIMICROB AG, V25, P11, DOI 10.1016/j.ijantimicag.2004.10.001.
   Li Y, 2012, LANGMUIR, V28, P12134, DOI 10.1021/la302732w.
   Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801.
   Mansur-Azzarn N, 2014, COLLOID SURFACE B, V117, P383, DOI 10.1016/j.colsurfb.2014.03.011.
   Maus R, 2001, ATMOS ENVIRON, V35, P105, DOI 10.1016/S1352-2310(00)00280-6.
   McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147.
   Medlin J, 1997, ENVIRON HEALTH PERSP, V105, P290, DOI 10.2307/3433265.
   Melo LD, 2011, ACS APPL MATER INTER, V3, P1933, DOI 10.1021/am200150t.
   Miaskiewicz-Peska E, 2011, FIBRES TEXT EAST EUR, V19, P73.
   NOHR RS, 1994, J BIOMAT SCI-POLYM E, V5, P607, DOI 10.1163/156856294X00239.
   Park D, 2013, APPL BIOCHEM BIOTECH, V169, P1134, DOI 10.1007/s12010-012-9999-7.
   Park D, 2010, ACS APPL MATER INTER, V2, P703, DOI 10.1021/am900748v.
   Shearer AEH, 2000, BIOTECHNOL BIOENG, V67, P141.
   Sinclair KD, 2012, J BIOMED MATER RES A, V100A, P2732, DOI 10.1002/jbm.a.34209.
   SLEIGH JD, 1983, BRIT MED J, V287, P1651, DOI 10.1136/bmj.287.6406.1651.
   Stock I, 1998, J MED MICROBIOL, V47, P629, DOI 10.1099/00222615-47-7-629.
   Tashiro T, 2001, MACROMOL MATER ENG, V286, P63.
   Thorsteinsson T, 2003, J MED CHEM, V46, P4173, DOI 10.1021/jm030829z.
   Tiller JC, 2002, BIOTECHNOL BIOENG, V79, P465, DOI 10.1002/bit.10299.
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098.
   Timofeeva L, 2011, APPL MICROBIOL BIOT, V89, P475, DOI 10.1007/s00253-010-2920-9.
   Vyhnalkova R., 2012, 10 MILLION FOLD REDU, P4096.
   Weinstein RA, 1998, EMERG INFECT DIS, V4, P416, DOI 10.3201/eid0403.980320.
   Wenzel RP, 2001, EMERG INFECT DIS, V7, P174, DOI 10.3201/eid0702.010203.
   WENZEL RP, 1995, J HOSP INFECT, V31, P79, DOI 10.1016/0195-6701(95)90162-0.
   Wynne JH, 2011, ACS APPL MATER INTER, V3, P2005, DOI 10.1021/am200250d.}},
Number-of-Cited-References = {{53}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{18}},
Journal-ISO = {{Appl. Biochem. Biotechnol.}},
Doc-Delivery-Number = {{DI0WJ}},
Unique-ID = {{ISI:000373217700015}},
DA = {{2018-08-13}},
}

@article{ ISI:000370721800002,
Author = {Wang, G. M. and Sun, P. P. and Pan, H. and Ye, G. P. and Sun, K. and
   Zhang, J. and Pan, J. and Fang, J.},
Title = {{Inactivation of Candida albicans Biofilms on Polymethyl Methacrylate and
   Enhancement of the Drug Susceptibility by Cold Ar/O-2 Plasma Jet}},
Journal = {{PLASMA CHEMISTRY AND PLASMA PROCESSING}},
Year = {{2016}},
Volume = {{36}},
Number = {{2}},
Pages = {{383-396}},
Month = {{MAR}},
Abstract = {{The antimicrobial effects of the cold plasma for the dental pathogenic
   microorganism propose a promising approach to the Denture Stomatitis
   (DS) treatment. However, it is crucial to understand that the complexity
   of the biofilm microenvironment may compromise the efficiency of the
   therapy. As one of the major issue for DS, Candida albicans biofilms
   (ATCC10231) formed on denture base resins were treated by cold Ar/O-2 (2
   \%) plasma jet. Spatial viability of the biofilms was investigated with
   confocal scanning laser microscopy through evaluating their inside
   cross-section properties. Results showed Candida albicans biofilms with
   thickness of similar to 100 A mu m was completely inactivated by 8 min
   plasma treatment. Morphology change of the fungi was also observed by
   the scanning electron microscopy. Drug susceptibilities, the sessile
   minimum inhibitory concentration (SMIC50) of the biofilm for
   amphotericin B and fluconazole were decreased from > 32 and > 256 A mu
   g/mL to 8 and 64 A mu g/mL after 1 min's plasma treatment, respectively.
   The reactive species produced from plasma were monitored by optical
   emission spectroscopy. The successfully inactivation of Candida albicans
   biofilms and the significant enhancement of its drug susceptibilities
   induced by the plasma released reactive species propose a promising
   strategy for the treatment of DS caused by drug-resistant Candida
   albicans biofilms.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Pan, J (Reprint Author), Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.
   Pan, J (Reprint Author), Peking Univ, Sch Stomatol, Dept Gen Dent, Beijing 100871, Peoples R China.
   Wang, G. M.; Pan, H.; Ye, G. P.; Sun, K.; Zhang, J.; Pan, J.; Fang, J., Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.
   Pan, H.; Ye, G. P., Lan Zhou Univ, Sch Stomatol, Lanzhou, Gansu, Peoples R China.
   Sun, P. P.; Zhang, J.; Fang, J., Peking Univ, Coll Engn, Beijing 100871, Peoples R China.
   Pan, J., Peking Univ, Sch Stomatol, Dept Gen Dent, Beijing 100871, Peoples R China.}},
DOI = {{10.1007/s11090-015-9656-3}},
ISSN = {{0272-4324}},
EISSN = {{1572-8986}},
Keywords = {{Candida albicans biofilms; PMMA; Cold plasma; Inactivation; Drug
   susceptibility}},
Keywords-Plus = {{ATMOSPHERIC-PRESSURE AIR; IN-VITRO; ANTIFUNGAL SUSCEPTIBILITY;
   NONTHERMAL PLASMA; RESISTANCE; CHLORHEXIDINE; INHIBITION; MICROJET;
   ADHESION; EFFICACY}},
Research-Areas = {{Engineering; Physics}},
Web-of-Science-Categories  = {{Engineering, Chemical; Physics, Applied; Physics, Fluids \& Plasmas}},
Author-Email = {{panjie72@sina.com}},
ORCID-Numbers = {{Sun, Peter/0000-0001-5681-6621}},
Funding-Acknowledgement = {{Natural Science Foundation (China) {[}81200821]; Bioelectrics. Inc (USA)}},
Funding-Text = {{This research was supported by Natural Science Foundation No. 81200821
   (China) and Bioelectrics. Inc (USA).}},
Cited-References = {{Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0.
   Bayliss DL, 2012, PLASMA PROCESS POLYM, V9, P597, DOI 10.1002/ppap.201100104.
   Bc W, 1998, AUST DENT J, V43, P160.
   Bueno M, 2013, ORAL DIS, V21, P57.
   Bulacio L, 2012, J MYCOL MED, V22, P348, DOI 10.1016/j.mycmed.2012.08.002.
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001.
   Dong XQ, 2013, EUR J ORAL SCI, V121, P355, DOI 10.1111/eos.12052.
   Du TF, 2013, J ENDODONT, V39, P1438, DOI 10.1016/j.joen.2013.06.027.
   Duarte S, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3606486.
   Duday D, 2013, PLASMA PROCESS POLYM, V10, P864, DOI 10.1002/ppap.201200173.
   Duyck J, 2013, J DENT, V41, P1281, DOI 10.1016/j.jdent.2013.08.002.
   Emami E, 2014, J DENT, V42, P99, DOI 10.1016/j.jdent.2013.11.021.
   Feng HQ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3491180.
   Fothergill AW, 2014, J CLIN MICROBIOL, V52, P994, DOI 10.1128/JCM.03044-13.
   Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001.
   Jiang CQ, 2009, PLASMA PROCESS POLYM, V6, P479, DOI 10.1002/ppap.200800133.
   Jin Y, 2004, ARCH ORAL BIOL, V49, P789, DOI 10.1016/j.archoralbio.2004.04.011.
   Kim G., 2011, PLASMA MED, V1, P45, DOI DOI 10.1615/PLASMAMED.V1.I1.40.
   Koban I, 2011, J CLIN PERIODONTOL, V38, P956, DOI 10.1111/j.1600-051X.2011.01740.x.
   Koban I, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/073039.
   Kobayashi D, 2002, ANTIMICROB AGENTS CH, V46, P3113, DOI 10.1128/AAC.46.10.3113-3117.2002.
   Kunze KL, 1996, DRUG METAB DISPOS, V24, P414.
   Lazarin AA, 2013, ARCH ORAL BIOL, V58, P1, DOI 10.1016/j.archoralbio.2012.10.005.
   Lee HW, 2010, PLASMA PROCESS POLYM, V7, P274, DOI 10.1002/ppap.200900083.
   Liebermann A, 2013, DENT MATER, V29, P935, DOI 10.1016/j.dental.2013.06.004.
   Maisch T, 2012, APPL ENVIRON MICROB, V78, P4242, DOI 10.1128/AEM.07235-11.
   Pan J, 2013, IEEE T PLASMA SCI, V41, P325, DOI 10.1109/TPS.2012.2233753.
   Pan J, 2013, J ENDODONT, V39, P105, DOI 10.1016/j.joen.2012.08.017.
   Pan J, 2010, IEEE T PLASMA SCI, V38, P3143, DOI 10.1109/TPS.2010.2066291.
   Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI {[}10.1038/nport.2008.141, 10.1038/nprot.2008.141].
   Radford DR, 1998, J DENT, V26, P577, DOI 10.1016/S0300-5712(97)00034-1.
   Ramage Gordon, 2001, Revista Iberoamericana de Micologia, V18, P163.
   Rautemaa R, 2011, CRIT REV MICROBIOL, V37, P328, DOI 10.3109/1040841X.2011.585606.
   Reich MS, 2013, CELL TISSUE BANK, V14, P381, DOI 10.1007/s10561-012-9335-z.
   Sanglard D, 2002, LANCET INFECT DIS, V2, P507.
   Sun P, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3530434.
   Sun P, 2010, IEEE T PLASMA SCI, V38, P1892, DOI 10.1109/TPS.2009.2039585.
   Sun Y, 2012, PLOS ONE, V7, P40629.
   Valverde GB, 2013, J DENT, V41, P51, DOI 10.1016/j.jdent.2012.10.002.
   von Woedtke T, 2013, PHYS REP, V530, P291, DOI 10.1016/j.physrep.2013.05.005.
   Wang J, 2012, IEEE T PLASMA SCI, V40, P2157, DOI 10.1109/TPS.2012.2204779.
   Wang RX, 2011, PLASMA MED, V1, P143.
   WINK DA, 1993, ARCH BIOCHEM BIOPHYS, V300, P115, DOI 10.1006/abbi.1993.1016.
   Wu HY, 2012, PLASMA PROCESS POLYM, V9, P417, DOI 10.1002/ppap.201100065.
   Xiong Z, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3597622.
   Yamazaki H, 2011, DENT MATER J, V30, P384, DOI 10.4012/dmj.2010-190.
   Yang B, 2011, J DENT, V39, P48, DOI 10.1016/j.jdent.2010.10.002.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{30}},
Journal-ISO = {{Plasma Chem. Plasma Process.}},
Doc-Delivery-Number = {{DE6CU}},
Unique-ID = {{ISI:000370721800002}},
DA = {{2018-08-13}},
}

@article{ ISI:000430594400001,
Author = {Cai, Zhendong and Chail, Yanfei and Zhang, Caiyun and Fengl, Ruoyun and
   Sang, Hong and Lu, Ling},
Title = {{Molecular Characterization of G beta-Like Protein CpcB Involved in
   Antifungal Drug Susceptibility and Virulence in A. fumigatus}},
Journal = {{FRONTIERS IN MICROBIOLOGY}},
Year = {{2016}},
Volume = {{7}},
Month = {{FEB 9}},
Abstract = {{Aspergillus fumigatus is an airborne human fungal pathogen that can
   survive in a wide range of environmental condition. G protein complex
   transduces external signals from a variety of stimuli outside a cell to
   its interior effectors in all eukaryotes. G beta-like CpcB (cross
   pathway control B) belongs to a WD40 repeat protein family with the
   conserved G-H and W-D residues. Previous studies have demonstrated that
   G beta-like proteins cooperate with related signal transduction proteins
   to function during many important developmental processes in A.
   fumigatus. However, the molecular characteristics of G beta-like CpcB
   have not yet been identified. In this study, we demonstrated that the
   G-H residues in WD repeat 1, 2, 3, and the W-D residue in WD repeat 2 of
   CpcB are required not only to control normal hyphal growth and
   conidiation but also to affect antifungal drug susceptibility. The
   enhanced drug resistance might be due to reduced intracellular drug
   accumulation and altered ergosterol component. Moreover, we find that
   the first G-H residue of CpcB plays an important role in the virulence
   of A. fumigatus. To our knowledge, this is the first report for finding
   the importance of the conserved G-H and W-D residues for a G beta-like
   protein in understanding of G protein functions.}},
Publisher = {{FRONTIERS MEDIA SA}},
Address = {{AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lu, L (Reprint Author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Microbes \& Funct Genom, Jiangsu Engn \& Technol Res Ctr Microbiol, Nanjing, Jiangsu, Peoples R China.
   Cai, Zhendong; Chail, Yanfei; Fengl, Ruoyun; Lu, Ling, Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Microbes \& Funct Genom, Jiangsu Engn \& Technol Res Ctr Microbiol, Nanjing, Jiangsu, Peoples R China.
   Zhang, Caiyun; Sang, Hong, Nanjing Univ, Sch Med, Jinling Hosp, Dept Dermatol, Nanjing, Jiangsu, Peoples R China.}},
DOI = {{10.3389/fmicb.2016.00106}},
Article-Number = {{106}},
ISSN = {{1664-302X}},
Keywords = {{G beta-like CpcB; Gprotein; drugsusceptibility; virulence; Aspergillus
   fumigatus}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{linglu@njnu.edu.cn}},
ORCID-Numbers = {{Lu, Ling/0000-0002-2891-7326}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}NSFC81330035]; Special
   Fund for the Doctoral Program of Higher Education of China
   {[}20123207110012]; Priority Academic Program Development (PAPD) of
   Jiangsu Higher Education Institutions}},
Funding-Text = {{This work was financially supported by the National Natural Science
   Foundation of China (NSFC81330035) to LL, and the Special Fund for the
   Doctoral Program of Higher Education of China (No. 20123207110012) to
   LL; the Priority Academic Program Development (PAPD) of Jiangsu Higher
   Education Institutions.}},
Cited-References = {{Abad A, 2010, REV IBEROAM MICOL, V27, P155, DOI 10.1016/j.riam.2010.10.003.
   Alcazar-Fuoli L, 2008, STEROIDS, V73, P339, DOI 10.1016/j.steroids.2007.11.005.
   Alcazar-Fuoli L, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00439.
   Alcazar-Fuoli L, 2011, INT J ANTIMICROB AG, V38, P426, DOI 10.1016/j.ijantimicag.2011.06.005.
   Bramucci E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S2.
   Brookman JL, 2000, CURR OPIN MICROBIOL, V3, P468, DOI 10.1016/S1369-5274(00)00124-7.
   Cai ZD, 2015, FUNGAL GENET BIOL, V81, P120, DOI 10.1016/j.fgb.2015.04.007.
   Chamilos G, 2005, DRUG RESIST UPDATE, V8, P344, DOI 10.1016/j.drup.2006.01.001.
   Chen SH, 2004, J MOL CELL CARDIOL, V37, P399, DOI 10.1016/j.yjmcc.2004.04.019.
   Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08.
   Dohlman HG, 2015, J BIOL CHEM, V290, P6679, DOI 10.1074/jbc.R114.631093.
   Downes GB, 1999, GENOMICS, V62, P544, DOI 10.1006/geno.1999.5992.
   Ero R, 2015, SCI REP-UK, V5, DOI 10.1038/srep08688.
   Ferreira MED, 2006, CURR GENET, V50, P32, DOI 10.1007/s00294-006-0073-2.
   Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501.
   Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109.
   HAINES J, 1995, BIOCYCLE, V36, P32.
   Hill JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003390.
   Hillmann F, 2015, ENVIRON MICROBIOL, V17, P2858, DOI 10.1111/1462-2920.12808.
   Jain P, 2003, ANTIMICROB AGENTS CH, V47, P3195, DOI 10.1128/AAC.47.10.3195-3201.2003.
   Jiang HC, 2014, FUNGAL GENET BIOL, V62, P62, DOI 10.1016/j.fgb.2013.11.003.
   Kelly SL, 1997, FEBS LETT, V400, P80, DOI 10.1016/S0014-5793(96)01360-9.
   Kong Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070355.
   Kontoyiannis DP, 2000, ANTIMICROB AGENTS CH, V44, P1743, DOI 10.1128/AAC.44.6.1743-1744.2000.
   LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069.
   Lapp K, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00469.
   Latge JP, 1999, CLIN MICROBIOL REV, V12, P310.
   Liu W, 2004, ANTIMICROB AGENTS CH, V48, P2490, DOI 10.1128/AAC.48.7.2490-2496.2004.
   Maesaki S, 1999, J ANTIMICROB CHEMOTH, V44, P27, DOI 10.1093/jac/44.1.27.
   Mailloux S, 2014, BIOMATER SCI-UK, V2, P184, DOI 10.1039/c3bm60197h.
   Martel CM, 2010, ANTIMICROB AGENTS CH, V54, P4920, DOI 10.1128/AAC.00349-10.
   MAY GS, 1989, J CELL BIOL, V109, P2267, DOI 10.1083/jcb.109.5.2267.
   Morio F, 2012, J ANTIMICROB CHEMOTH, V67, P2131, DOI 10.1093/jac/dks186.
   NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0.
   OSMANI SA, 1988, CELL, V53, P237, DOI 10.1016/0092-8674(88)90385-6.
   Prasad R, 2005, INT REV CYTOL, V242, P215.
   PRASAD R, 1995, CURR GENET, V27, P320, DOI 10.1007/BF00352101.
   Priebe S, 2011, FUNGAL GENET BIOL, V48, P353, DOI 10.1016/j.fgb.2010.11.001.
   Ruckenstuhl C, 2007, ANTIMICROB AGENTS CH, V51, P275, DOI 10.1128/AAC.00988-06.
   Sanglard D, 2002, CURR OPIN MICROBIOL, V5, P379, DOI 10.1016/S1369-5274(02)00344-2.
   Sanglard D, 2002, LANCET INFECT DIS, V2, P73, DOI 10.1016/S1473-3099(02)00181-0.
   SANGLARD D, 1995, ANTIMICROB AGENTS CH, V39, P2378, DOI 10.1128/AAC.39.11.2378.
   Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08.
   Seyedmousavi S, 2015, MED MYCOL, V53, P765, DOI 10.1093/mmy/myv067.
   Shim WB, 2006, MOL PLANT MICROBE IN, V19, P725, DOI 10.1094/MPMI-19-0725.
   Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430.
   Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5.
   Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0.
   Tekaia F, 2005, CURR OPIN MICROBIOL, V8, P385, DOI 10.1016/j.mib.2005.06.017.
   Throckmorton K, 2016, ENVIRON MICROBIOL, V18, P246, DOI 10.1111/1462-2920.13007.
   Valerius O, 2007, MOL CELL PROTEOMICS, V6, P1968, DOI 10.1074/mcp.M700184-MCP200.
   Walther C, 2015, MOL ENDOCRINOL, V29, P814, DOI 10.1210/me.2015-1091.
   Wang L, 2011, MOL MICROBIOL, V81, P1484, DOI 10.1111/j.1365-2958.2011.07783.x.
   White TC, 1997, ANTIMICROB AGENTS CH, V41, P1482.
   WHITEWAY M, 1989, CELL, V56, P467, DOI 10.1016/0092-8674(89)90249-3.
   Zavrel M, 2015, FUTURE MICROBIOL, V10, P1355, DOI 10.2217/FMB.15.47.
   Zhong GW, 2014, EUKARYOT CELL, V13, P1494, DOI 10.1128/EC.00201-14.}},
Number-of-Cited-References = {{57}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Front. Microbiol.}},
Doc-Delivery-Number = {{VC1OE}},
Unique-ID = {{ISI:000430594400001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000369097000001,
Author = {Ercan, Utku K. and Smith, Josh and Ji, Hai-Feng and Brooks, Ari D. and
   Joshi, Suresh G.},
Title = {{Chemical Changes in Nonthermal Plasma-Treated N-Acetylcysteine (NAC)
   Solution and Their Contribution to Bacterial Inactivation}},
Journal = {{SCIENTIFIC REPORTS}},
Year = {{2016}},
Volume = {{6}},
Month = {{FEB 2}},
Abstract = {{In continuation of our previous reports on the broad-spectrum
   antimicrobial activity of atmospheric non-thermal dielectric barrier
   discharge (DBD) plasma treated N-Acetylcysteine (NAC) solution against
   planktonic and biofilm forms of different multidrug resistant
   microorganisms, we present here the chemical changes that mediate
   inactivation of Escherichia coli. In this study, the mechanism and
   products of the chemical reactions in plasma-treated NAC solution are
   shown. UV-visible spectrometry, FT-IR, NMR, and colorimetric assays were
   utilized for chemical characterization of plasma treated NAC solution.
   The characterization results were correlated with the antimicrobial
   assays using determined chemical species in solution in order to confirm
   the major species that are responsible for antimicrobial inactivation.
   Our results have revealed that plasma treatment of NAC solution creates
   predominantly reactive nitrogen species versus reactive oxygen species,
   and the generated peroxynitrite is responsible for significant bacterial
   inactivation.}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Joshi, SG (Reprint Author), Drexel Univ, Dept Surg, Ctr Surg Infect \& Biofilm, Philadelphia, PA 19102 USA.
   Joshi, SG (Reprint Author), Drexel Univ, Dept Microbiol \& Immunol, Ctr Surg Infect \& Biofilm, Philadelphia, PA 19102 USA.
   Ercan, Utku K.; Brooks, Ari D.; Joshi, Suresh G., Drexel Univ, Dept Surg, Ctr Surg Infect \& Biofilm, Philadelphia, PA 19102 USA.
   Smith, Josh; Ji, Hai-Feng, Drexel Univ, Dept Chem, Ctr Surg Infect \& Biofilm, Philadelphia, PA 19102 USA.
   Joshi, Suresh G., Drexel Univ, Dept Microbiol \& Immunol, Ctr Surg Infect \& Biofilm, Philadelphia, PA 19102 USA.
   Ercan, Utku K., Izmir Katip Celebi Univ, TR-35620 Izmir, Turkey.
   Brooks, Ari D., Hosp Univ Penn, Dept Surg, Philadelphia, PA 19107 USA.}},
DOI = {{10.1038/srep20365}},
Article-Number = {{20365}},
ISSN = {{2045-2322}},
Keywords-Plus = {{ATMOSPHERIC-PRESSURE PLASMA; GLIDING-ARC DISCHARGES; NITRIC-OXIDE; RAPID
   INACTIVATION; HYDROGEN-PEROXIDE; S-NITROSOTHIOLS; IN-VITRO;
   PEROXYNITRITE; WATER; AIR}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{Suresh.Joshi@Drexelmed.edu}},
ResearcherID-Numbers = {{Ercan, Utku/A-1658-2012}},
ORCID-Numbers = {{Ercan, Utku/0000-0002-9762-2265}},
Funding-Acknowledgement = {{Ministry of National Education, Government of Turkey; Department of
   Surgery, Drexel University College of Medicine}},
Funding-Text = {{Utku K. Ercan had a research fellowship from the Ministry of National
   Education, Government of Turkey. Ercan was a graduate student of the
   biomedical engineering graduate program. Authors thank the members of
   A.J. Drexel Plasma Institute, Drexel University for their suggestions
   and scientific criticisms. This work was supported with research funds
   from the Department of Surgery, Drexel University College of Medicine.
   Solution component separation schema in Fig. 5(A) is drawn by Master's
   student, Ms. Betul Aldemir of Izmir Katip Celebi University, Institute
   of Natural and Applied Sciences, Department of Biomedical Engineering,
   as per author's suggestion. Authors thank Betul.}},
Cited-References = {{ABEDINZADEH Z, 1994, CAN J CHEM, V72, P2102, DOI 10.1139/v94-267.
   Anber M., 1954, J AM CHEM SOC, V76, P6243.
   BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0.
   Burlica R, 2006, J ELECTROSTAT, V64, P35, DOI 10.1016/j.elstat.2004.12.007.
   Burlica R, 2008, IEEE T IND APPL, V44, P482, DOI 10.1109/TIA.2008.916603.
   CASTELLANI AG, 1955, APPL MICROBIOL, V3, P154.
   Chen CW, 2008, IEEE T PLASMA SCI, V36, P215, DOI 10.1109/TPS.2007.913928.
   Chen CW, 2009, J ELECTROSTAT, V67, P703, DOI 10.1016/j.elstat.2009.03.008.
   Cooper M, 2010, J APPL MICROBIOL, V109, P2039, DOI 10.1111/j.1365-2672.2010.04834.x.
   Coupe PJ, 1999, J CHEM SOC PERK T 2, P1057, DOI 10.1039/a902420d.
   Duncan C, 1997, COMP BIOCHEM PHYS A, V118, P939, DOI 10.1016/S0300-9629(97)00023-6.
   Dykhuizen RS, 1998, GUT, V42, P334, DOI 10.1136/gut.42.3.334.
   Elmoualij B, 2012, PLASMA PROCESS POLYM, V9, P612, DOI 10.1002/ppap.201100194.
   Ercan UK, 2013, PLASMA PROCESS POLYM, V10, P544, DOI 10.1002/ppap.201200104.
   Gallagher MJ, 2007, IEEE T PLASMA SCI, V35, P1501, DOI 10.1109/TPS.2007.905209.
   Gow AJ, 1997, J BIOL CHEM, V272, P2841, DOI 10.1074/jbc.272.5.2841.
   Holthoff JH, 2010, BIOCHEM PHARMACOL, V80, P1260, DOI 10.1016/j.bcp.2010.06.027.
   Hu TM, 2006, AAPS J, V8, pE485, DOI 10.1208/aapsj080357.
   Hughes MN, 1999, BBA-BIOENERGETICS, V1411, P263, DOI 10.1016/S0005-2728(99)00019-5.
   Ikawa S, 2010, PLASMA PROCESS POLYM, V7, P33, DOI 10.1002/ppap.200900090.
   Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10.
   Julak J, 2012, PHYS MEDICA, V28, P230, DOI 10.1016/j.ejmp.2011.08.001.
   Kamgang-Youbi G, 2009, LETT APPL MICROBIOL, V49, P292.
   KHARITONOV VG, 1995, J BIOL CHEM, V270, P28158.
   Koval IV, 2007, RUSS J ORG CHEM+, V43, P319, DOI 10.1134/S1070428007030013.
   Kuhn DM, 1999, J NEUROSCI, V19, P10289.
   Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016.
   Liang YD, 2012, ENVIRON SCI TECHNOL, V46, P3360, DOI {[}10.1021/es203770q, 10.1021/es203770g].
   Liu FX, 2010, PLASMA PROCESS POLYM, V7, P231, DOI 10.1002/ppap.200900070.
   Lobysheva I. I., 1999, BIOCHEMNISTRY MOSCOW, V24, P194.
   Lukes P., 2014, PLASMA SOURCES SCI T, V23.
   Machala Z, 2013, PLASMA PROCESS POLYM, V10, P649, DOI 10.1002/ppap.201200113.
   Marla SS, 1997, P NATL ACAD SCI USA, V94, P14243, DOI 10.1073/pnas.94.26.14243.
   McDonnell GE, 2007, ANTISEPSIS DISINFECT.
   McLean S, 2010, FEBS LETT, V584, P1628, DOI 10.1016/j.febslet.2010.03.029.
   Naitali M, 2010, APPL ENVIRON MICROB, V76, P7662, DOI 10.1128/AEM.01615-10.
   Oehmigen K, 2010, PLASMA PROCESS POLYM, V7, P250, DOI 10.1002/ppap.200900077.
   Oehmigen K, 2011, PLASMA PROCESS POLYM, V8, P904, DOI 10.1002/ppap.201000099.
   Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006.
   Traylor M. J., 2011, J PHYS D, V44.
   Tsikas D, 2001, BBA-PROTEIN STRUCT M, V1546, P422, DOI 10.1016/S0167-4838(01)00166-2.
   Voetsch B, 2004, HISTOCHEM CELL BIOL, V122, P353, DOI 10.1007/s00418-004-0675-z.
   Von Woedtke T, 2011, NATO SCI PEACE SEC A.
   Wang PG, 2002, CHEM REV, V102, P1091, DOI 10.1021/cr000040l.
   Weller R, 2001, J APPL MICROBIOL, V90, P648, DOI 10.1046/j.1365-2672.2001.01291.x.
   Whiteman M, 1999, BRIT J PHARMACOL, V126, P1646, DOI 10.1038/sj.bjp.0702465.
   Xia DS, 2006, CHINESE MED J-PEKING, V119, P1904.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{35}},
Journal-ISO = {{Sci Rep}},
Doc-Delivery-Number = {{DC3CN}},
Unique-ID = {{ISI:000369097000001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000373208600006,
Author = {Nardell, E. A.},
Title = {{Indoor environmental control of tuberculosis and other airborne
   infections}},
Journal = {{INDOOR AIR}},
Year = {{2016}},
Volume = {{26}},
Number = {{1, SI}},
Pages = {{79-87}},
Month = {{FEB}},
Note = {{Indoor Air Conference, Hong Kong, PEOPLES R CHINA, 2014}},
Abstract = {{Tuberculosis (TB) remains the airborne infection of global importance,
   although many environmental interventions to control TB apply to
   influenza and other infections with airborne potential. This review
   focuses on the global problem and the current state of available
   environmental interventions. TB transmission is facilitated in
   overcrowded, poorly ventilated congregate settings, such as hospitals,
   clinics, prisons, jails, and refugee camps. The best means of TB
   transmission control is source control-to identify unsuspected
   infectious cases and to promptly begin effective therapy. However, even
   with active case finding and rapid diagnostics, not every unsuspected
   case will be identified, and environmental control measures remain the
   next intervention of choice. Natural ventilation is the main means of
   air disinfection and has the advantage of wide availability, low cost,
   and high efficacy-under optimal conditions. It is usually not applicable
   all year in colder climates and may not be effective when windows are
   closed on cold nights in warm climates, for security, and for pest
   control. In warm climates, windows may be closed when air conditioning
   is installed for thermal comfort. Although mechanical ventilation, if
   properly installed and maintained, can provide adequate air
   disinfection, it is expensive to install, maintain, and operate. The
   most cost-effective way to achieve high levels of air disinfection is
   upper room germicidal irradiation. The safe and effective application of
   this poorly defined intervention is now well understood, and recently
   published evidence-based application guidelines will make implementation
   easier.}},
Publisher = {{WILEY}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Nardell, EA (Reprint Author), Harvard Univ, Sch Med, Harvard Sch Publ Hlth, Brigham \& Womens Hosp, 641 Huntington Ave,3A-03, Boston, MA 02115 USA.
   Nardell, E. A., Harvard Univ, Sch Med, Harvard Sch Publ Hlth, Brigham \& Womens Hosp, 641 Huntington Ave,3A-03, Boston, MA 02115 USA.}},
DOI = {{10.1111/ina.12232}},
ISSN = {{0905-6947}},
EISSN = {{1600-0668}},
Keywords = {{Tuberculosis; Airborne Infection; Environmental Control; Ultraviolet air
   disinfection}},
Keywords-Plus = {{MULTIDRUG-RESISTANT TUBERCULOSIS; ULTRAVIOLET AIR DISINFECTION;
   PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; AERIAL
   DISSEMINATION; TUBERCLE-BACILLI; TRANSMISSION; IRRADIATION; VENTILATION;
   WARD}},
Research-Areas = {{Construction \& Building Technology; Engineering; Public, Environmental
   \& Occupational Health}},
Web-of-Science-Categories  = {{Construction \& Building Technology; Engineering, Environmental; Public,
   Environmental \& Occupational Health}},
Author-Email = {{endardell@gmail.com}},
Cited-References = {{Accinelli R, 2002, AM THOR SOC ANN M AT.
   Barrera E, 2015, INT J TUBERC LUNG D, V19, P381, DOI 10.5588/ijtld.14.0680.
   Bates M, 2013, TROP MED INT HEALTH, V18, P1134, DOI 10.1111/tmi.12145.
   Bates M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040774.
   Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847.
   CATANZARO A, 1982, AM REV RESPIR DIS, V125, P559, DOI 10.1164/arrd.1982.125.5.559.
   Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834.
   Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC.
   Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068.
   Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043.
   Fennelly KP, 2007, CLIN INFECT DIS, V44, P1358, DOI 10.1086/516617.
   Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC.
   Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331.
   Lalvani A, 2006, LANCET, V367, P391, DOI 10.1016/S0140-6736(06)68129-4.
   Linnes JC, 2014, INDOOR AIR, V24, P116, DOI 10.1111/ina.12063.
   LOUDON RG, 1969, AM REV RESPIR DIS, V99, P109.
   Miller S.L., 2002, 200972602 CDCNIOSH.
   MillerLeiden S, 1996, J AIR WASTE MANAGE, V46, P869, DOI 10.1080/10473289.1996.10467523.
   Mphaphlele M, 2015, AM J RESP CRIT CARE, V192, P477, DOI 10.1164/rccm.201501-0060OC.
   NARDELL EA, 1993, INFECT CONT HOSP EP, V14, P681.
   NARDELL EA, 1991, AM REV RESPIR DIS, V144, P302, DOI 10.1164/ajrccm/144.2.302.
   Nardell EA, 1999, CHEST, V116, P1143, DOI 10.1378/chest.116.4.1143.
   Nightingale F., 1859, NOTES ON HOSP.
   NIOSH, 2009, NIOSH PUBL, V2009-125.
   Richardson ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096334.
   RILEY EC, 1978, AM J EPIDEMIOL, V107, P421, DOI 10.1093/oxfordjournals.aje.a112560.
   Riley R., 1961, AIRBORNE INFECT.
   RILEY RL, 1976, AM REV RESPIR DIS, V113, P413.
   RILEY RL, 1989, AM REV RESPIR DIS, V139, P1286, DOI 10.1164/ajrccm/139.5.1286.
   RILEY RL, 1995, AM J EPIDEMIOL, V142, P3, DOI 10.1093/oxfordjournals.aje.a117542.
   RILEY RL, 1957, AM REV TUBERC PULM, V76, P931.
   RILEY RL, 1962, AM REV RESPIR DIS, V85, P511.
   ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2.
   Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643.
   Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051.
   Rudnick SN, 2003, INDOOR AIR, V13, P237, DOI 10.1034/j.1600-0668.2003.00189.x.
   Rudnick SN, 2012, HVAC\&R RES, V18, P774, DOI 10.1080/10789669.2012.667863.
   Seaworth Barbara J, 2014, Ann Am Thorac Soc, V11, P286, DOI 10.1513/AnnalsATS.201309-312PS.
   Stevenson C., 2000, MED MAGNIFICENCE BRI, P155.
   SULTAN L, 1960, AM REV RESPIR DIS, V82, P358.
   Wells W.F., 1955, AIRBORNE CONTAGION A.
   Wells WF, 1934, AM J HYG, V20, P611, DOI 10.1093/oxfordjournals.aje.a118097.
   WHO, 2009, NAT VENT INF CONTR H.
   Willingham FF, 2001, EMERG INFECT DIS, V7, P123, DOI 10.3201/eid0701.010117.
   World Health Organization, 2009, WHOHTMTB2009419.
   World Health Organization, 2013, WHOHTMTB201311.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{9}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{16}},
Journal-ISO = {{Indoor Air}},
Doc-Delivery-Number = {{DI0SY}},
Unique-ID = {{ISI:000373208600006}},
DA = {{2018-08-13}},
}

@article{ ISI:000371847300004,
Author = {Moriceau, G. and Gagneux-Brunon, A. and Gagnaire, J. and Mariat, C. and
   Lucht, F. and Berthelot, P. and Botelho-Nevers, E.},
Title = {{Preventing healthcare-associated infections: Residents and attending
   physicians need better training in advanced isolation precautions}},
Journal = {{MEDECINE ET MALADIES INFECTIEUSES}},
Year = {{2016}},
Volume = {{46}},
Number = {{1}},
Pages = {{14-19}},
Month = {{FEB}},
Abstract = {{Objective. - Compliance with advanced isolation precautions (IPs) is
   crucial to reduce healthcare-associated infections. Our aim was to
   evaluate physician's knowledge and attitudes related to IPs.
   Methods. - An online questionnaire was sent to our hospital's physicians
   (attending physicians and residents).
   Results. - A total of 111 physicians completed the questionnaire: 60
   (54\%) attending physicians and 51 (46\%) residents. Overall,
   respondents had a poor knowledge of the three types of IPs, especially
   droplet precautions (13 correct answers, 11.7\%) and airborne IP (17
   correct answers, 16.3\%). We observed a statistically significant
   difference between attending physicians and residents for the type of IP
   to prescribe to a patient presenting with multidrug-resistant urinary
   infection: 44 residents (86\%) gave the correct answer vs 42 attending
   physicians (70\%), P = 0.04. Physicians (both residents and attending
   physicians) who were already familiar with the dedicated webpage
   available on the hospital's intranet (n = 40) obtained a score of
   4.75/10 (+/- 2.0) compared with 4.03/10 (+/- 1.7) for those who had
   never used that tool (n = 71). The difference was statistically
   significant (P = 0.04). The average score for both residents and
   attending physicians was 4.3/10 (+/- 1.9, range: 1-10). Attending
   physicians' and residents' scores were 4/10 (+/- 1.8) and 4.5/10 (+/-
   1.9), respectively, but the difference was not statistically significant
   (P = 0.14).
   Conclusion. - Physicians' knowledge of IPs was insufficient. Improvement
   in medical training is needed. The use of a dedicated webpage on
   hospitals' intranet could help physicians acquire better knowledge on
   that matter. (C) 2015 Elsevier Masson SAS. All rights reserved.}},
Publisher = {{ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER}},
Address = {{23 RUE LINOIS, 75724 PARIS, FRANCE}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Gagneux-Brunon, A (Reprint Author), CHU St Etienne, Serv Malad Infect \& Trop, F-42055 St Etienne 02, France.
   Gagneux-Brunon, A (Reprint Author), Univ Lyon, EA 3064, GIMAP, F-42023 St Etienne, France.
   Moriceau, G.; Gagneux-Brunon, A.; Gagnaire, J.; Lucht, F.; Berthelot, P.; Botelho-Nevers, E., CHU St Etienne, Serv Malad Infect \& Trop, F-42055 St Etienne 02, France.
   Gagneux-Brunon, A.; Mariat, C.; Lucht, F.; Botelho-Nevers, E., Univ Lyon, EA 3064, GIMAP, F-42023 St Etienne, France.
   Gagnaire, J.; Berthelot, P., CHU St Etienne, Unite Hyg Interhosp, Serv Malad Infect \& Trop, F-42055 St Etienne 2, France.
   Mariat, C., CHU St Etienne, Serv Nephrol, Dialyse, Transplantat, F-42055 St Etienne 2, France.}},
DOI = {{10.1016/j.medmal.2015.11.001}},
ISSN = {{0399-077X}},
Keywords = {{Isolation precautions; Healthcare-associated infections}},
Keywords-Plus = {{HAND HYGIENE; CROSS-TRANSMISSION; CONTROL KNOWLEDGE; GUIDELINE;
   STUDENTS; WORKERS; RECOMMENDATIONS; INFORMATION; SETTINGS; ATTITUDE}},
Research-Areas = {{Infectious Diseases}},
Web-of-Science-Categories  = {{Infectious Diseases}},
Author-Email = {{amandine.gagneux-brunon@chu-st-etienne.fr}},
Cited-References = {{Al-Hussami M, 2013, AM J INFECT CONTROL, V41, P332, DOI 10.1016/j.ajic.2012.03.029.
   Barikani Ameneh, 2012, Glob J Health Sci, V4, P142, DOI 10.5539/gjhs.v4n2p142.
   Berthelot P, 2007, INFECT CONT HOSP EP, V28, P633, DOI 10.1086/513536.
   Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391.
   Brady RRW, 2008, ANN ROY COLL SURG, V90, P647, DOI 10.1308/003588408X321756.
   Clock SA, 2010, AM J INFECT CONTROL, V38, P105, DOI 10.1016/j.ajic.2009.08.008.
   Eveillard M, 2007, J HOSP INFECT, V65, P81, DOI 10.1016/j.jhin.2006.09.023.
   Fakih MG, 2006, INFECT CONT HOSP EP, V27, P704, DOI 10.1086/505920.
   Ghabrah TM, 2007, SCAND J INFECT DIS, V39, P1018, DOI 10.1080/00365540701466173.
   Girou E, 2004, J HOSP INFECT, V57, P162, DOI 10.1016/j.jhin.2004.03.010.
   Gould D, 2013, AM J INFECT CONTROL, V41, P760, DOI 10.1016/j.ajic.2013.01.025.
   Huang YC, 2013, J INFECT DEV COUNTR, V7, P144, DOI 10.3855/jidc.3099.
   Jain M, 2010, MED ORAL PATOL ORAL, pe957.
   Larson EL, 2007, AM J INFECT CONTROL, V35, P666, DOI 10.1016/j.ajic.2006.10.006.
   Lepelletier D, 2015, J HOSP INFECT, V90, P186, DOI 10.1016/j.jhin.2015.04.002.
   Organization WH, 2009, WHO PAT SAF CURR GUI.
   Paudyal P, 2008, AM J INFECT CONTROL, V36, P595, DOI 10.1016/j.ajic.2007.10.026.
   Robert J, 2006, J HOSP INFECT, V62, P163, DOI 10.1016/j.jhin.2005.07.003.
   Saint S, 2003, AM J INFECT CONTROL, V31, P354, DOI 10.1067/mic.2003.50.
   Seibert DJ, 2014, AM J INFECT CONTROL, V42, P405, DOI 10.1016/j.ajic.2013.10.008.
   Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007.
   Tavolacci MP, 2008, INFECT CONT HOSP EP, V29, P642, DOI 10.1086/588683.
   van Gemert-Pijnen J, 2005, AM J INFECT CONTROL, V33, P377, DOI 10.1016/j.ajic.2004.10.009.
   Weber DJ, 2007, INFECT CONT HOSP EP, V28, P358, DOI 10.1086/510871.
   Zhou YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105838.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{10}},
Journal-ISO = {{Med. Mal. Infect.}},
Doc-Delivery-Number = {{DG1SH}},
Unique-ID = {{ISI:000371847300004}},
DA = {{2018-08-13}},
}

@article{ ISI:000371174800004,
Author = {Nardell, Edward A.},
Title = {{Transmission and Institutional Infection Control of Tuberculosis}},
Journal = {{COLD SPRING HARBOR PERSPECTIVES IN MEDICINE}},
Year = {{2016}},
Volume = {{6}},
Number = {{2}},
Month = {{FEB}},
Abstract = {{Tuberculosis (TB) transmission control in institutions is evolving with
   increased awareness of the rapid impact of treatment on transmission,
   the importance of the unsuspected, untreated case of transmission, and
   the advent of rapid molecular diagnostics. With active case finding
   based on cough surveillance and rapid drug susceptibility testing, in
   theory, it is possible to be reasonably sure that no patient enters a
   facility with undiagnosed TB or drug resistance. Droplet nuclei
   transmission of TB is reviewed with an emphasis on risk factors relevant
   to control. Among environmental controls, natural ventilation and
   upper-room ultraviolet germicidal ultraviolet air disinfection are the
   most cost-effective choices, although high-volume mechanical ventilation
   can also be used. Room air cleaners are generally not recommended.
   Maintenance is required for all engineering solutions. Finally, personal
   protection with fit-tested respirators is used in many situations where
   administrative and engineering methods cannot assure protection.}},
Publisher = {{COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT}},
Address = {{1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Nardell, EA (Reprint Author), Brigham \& Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.
   Nardell, Edward A., Brigham \& Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.}},
DOI = {{10.1101/cshperspect.a018192}},
Article-Number = {{a018192}},
ISSN = {{2157-1422}},
Keywords-Plus = {{MULTIDRUG-RESISTANT TUBERCULOSIS; ULTRAVIOLET GERMICIDAL IRRADIATION;
   SOUTH-AFRICAN TOWNSHIP; PULMONARY TUBERCULOSIS;
   MYCOBACTERIUM-TUBERCULOSIS; NOSOCOMIAL TRANSMISSION; AERIAL
   DISSEMINATION; AIRBORNE INFECTION; COST-EFFECTIVENESS; TUBERCLE-BACILLI}},
Research-Areas = {{Research \& Experimental Medicine}},
Web-of-Science-Categories  = {{Medicine, Research \& Experimental}},
Author-Email = {{ean@hsph.harvard.edu}},
Cited-References = {{ACGIH, 1999, DOC THRESH LIM VAL B.
   Advisory Committee on Immunization Practices, 2000, MMWR Recomm Rep, V49, P1.
   ANDREWS R H, 1960, Bull World Health Organ, V23, P463.
   {[}Anonymous], 1992, NEHW HLTH WATCH, V12, P8.
   Atkinson J, 2009, NATURAL VENTILATION FOR INFECTION CONTROL IN HEALTH-CARE SETTINGS, P1.
   Bacaer N, 2008, J MATH BIOL, V57, P557, DOI 10.1007/s00285-008-0177-z.
   Bates M, 2013, TROP MED INT HEALTH, V18, P1134, DOI 10.1111/tmi.12145.
   Bates M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040774.
   Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847.
   CATANZARO A, 1982, AM REV RESPIR DIS, V125, P559, DOI 10.1164/arrd.1982.125.5.559.
   Coffey CC, 2004, J OCCUP ENVIRON HYG, V1, P262, DOI 10.1080/15459620490433799.
   Coffey CC, 1998, AM IND HYG ASSOC J, V59, P862, DOI 10.1202/0002-8894(1998)059<0862:COSRFM>2.0.CO;2.
   Coffey Christopher C, 2002, Appl Occup Environ Hyg, V17, P723, DOI 10.1080/10473220290107002.
   Crofton J., 1962, B INT UNION TUBERC, V32, P643.
   Cummings KJ, 2009, INFECT CONT HOSP EP, V30, P1123, DOI 10.1086/644754.
   de Perio MA, 2009, ARCH INTERN MED, V169, P179, DOI 10.1001/archinternmed.2008.524.
   Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834.
   Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC.
   Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002.
   Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068.
   Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043.
   Fennelly KP, 2007, CLIN INFECT DIS, V44, P1358, DOI 10.1086/516617.
   Fennelly KP, 1998, INFECT CONT HOSP EP, V19, P754.
   Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC.
   First M., 1999, ASHRAE T, V105, P877.
   First M, 2007, J OCCUP ENVIRON HYG, V4, P321, DOI 10.1080/15459620701271693.
   First MW, 2005, J OCCUP ENVIRON HYG, V2, P285, DOI 10.1080/1545962059095224.
   FIRST MW, 1999, ASHRAE T, V105, P869.
   Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000.
   Friedman LN, 2006, INFECT CONT HOSP EP, V27, P436, DOI 10.1086/503690.
   Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075.
   GILPIN TP, 1987, S AFR MED J, V72, P260.
   Gounder CR, 2011, JAIDS-J ACQ IMM DEF, V57, pE77, DOI 10.1097/QAI.0b013e31821ac9c1.
   GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90.
   Hoek KGP, 2011, MOL DIAGN THER, V15, P189, DOI 10.2165/11593780-000000000-00000.
   HOUK VN, 1968, ARCH ENVIRON HEALTH, V16, P4, DOI 10.1080/00039896.1968.10665007.
   HUTTON MD, 1990, J INFECT DIS, V161, P286, DOI 10.1093/infdis/161.2.286.
   Johnstone-Robertson S, 2011, SAMJ S AFR MED J, V101, P809.
   Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251.
   Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494.
   Ko G, 1998, APPL BIOSAF, V3, P65.
   Lever MS, 2000, LETT APPL MICROBIOL, V31, P238, DOI 10.1046/j.1365-2672.2000.00807.x.
   Lorent N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092754.
   LOUDON RG, 1969, AM REV RESPIR DIS, V100, P172.
   LOUDON RG, 1969, AM REV RESPIR DIS, V99, P109.
   LOUDON RG, 1969, AM REV RESPIR DIS, V100, P165.
   Menzies D, 2007, INT J TUBERC LUNG D, V11, P593.
   Middelkoop K, 2008, CLIN INFECT DIS, V47, P349, DOI 10.1086/589750.
   MillerLeiden S, 1996, J AIR WASTE MANAGE, V46, P869, DOI 10.1080/10473289.1996.10467523.
   Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928.
   Nardell E, 2010, INT J TUBERC LUNG D, V14, P1233.
   NARDELL EA, 1993, INFECT CONT HOSP EP, V14, P681.
   NARDELL EA, 1991, AM REV RESPIR DIS, V144, P302, DOI 10.1164/ajrccm/144.2.302.
   Nardell EA, 1999, CHEST, V116, P1143, DOI 10.1378/chest.116.4.1143.
   NARDELL EA, 1993, MED CLIN N AM, V77, P1315, DOI 10.1016/S0025-7125(16)30196-1.
   Nardell E, 2013, PHOTOCHEM PHOTOBIOL, V89, P764, DOI 10.1111/php.12098.
   Nardell EA, 2008, PUBLIC HEALTH REP, V123, P52, DOI 10.1177/003335490812300108.
   Nardell EA, 2006, AM J RESP CRIT CARE, V174, P734, DOI 10.1164/rccm.200607-923ED.
   Ordway D, 2006, J IMMUNOL, V176, P4931, DOI 10.4049/jimmunol.176.8.4931.
   Orme IM, 2014, TUBERCULOSIS, V94, P8, DOI 10.1016/j.tube.2013.07.004.
   Puisis M, 1996, PUBLIC HEALTH REP, V111, P330.
   RILEY EC, 1978, AM J EPIDEMIOL, V107, P421, DOI 10.1093/oxfordjournals.aje.a112560.
   RILEY RL, 1974, AM J MED, V57, P466, DOI 10.1016/0002-9343(74)90140-5.
   RILEY RL, 1995, AM J EPIDEMIOL, V142, P3, DOI 10.1093/oxfordjournals.aje.a117542.
   RILEY RL, 1957, AM REV TUBERC PULM, V76, P931.
   RILEY RL, 1962, AM REV RESPIR DIS, V85, P511.
   ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2.
   Rudnick SN, 2003, INDOOR AIR, V13, P237, DOI 10.1034/j.1600-0668.2003.00189.x.
   Rudnick SN, 2001, AIHAJ, V62, P434, DOI 10.1080/15298660108984645.
   Rudnick SN, 2007, J OCCUP ENVIRON HYG, V4, P352, DOI 10.1080/15459620701298167.
   Silva VMC, 2000, INT J TUBERC LUNG D, V4, P420.
   SMITH DW, 1970, AM REV RESPIR DIS, V102, P937.
   SMITH DW, 1989, REV INFECT DIS, V11, pS385.
   SULTAN L, 1960, AM REV RESPIR DIS, V82, P358.
   Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1.
   Wells W.F., 1955, AIRBORNE CONTAGION A.
   Willingham FF, 2001, EMERG INFECT DIS, V7, P123, DOI 10.3201/eid0701.010117.
   World Health Organization, 2009, WHO POL TB INF CONTR.
   Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033.
   Zhu SW, 2014, BUILD ENVIRON, V72, P116, DOI 10.1016/j.buildenv.2013.10.019.
   Zhu SW, 2013, PHOTOCHEM PHOTOBIOL, V89, P782, DOI 10.1111/php.12039.}},
Number-of-Cited-References = {{81}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{Cold Spring Harb. Perspect. Med.}},
Doc-Delivery-Number = {{DF2LN}},
Unique-ID = {{ISI:000371174800004}},
OA = {{green\_published}},
DA = {{2018-08-13}},
}

@article{ ISI:000371249600020,
Author = {Ibekwe, A. M. and Murinda, Shelton E. and DebRoy, Chitrita and Reddy,
   Gudigopura B.},
Title = {{Potential pathogens, antimicrobial patterns and genotypic diversity of
   Escherichia coli isolates in constructed wetlands treating swine
   wastewater}},
Journal = {{FEMS MICROBIOLOGY ECOLOGY}},
Year = {{2016}},
Volume = {{92}},
Number = {{2}},
Month = {{FEB}},
Abstract = {{Escherichia coli populations originating from swine houses through
   constructed wetlands were analyzed for potential pathogens,
   antimicrobial susceptibility patterns, and genotypic diversity.
   Escherichia coli isolates (n = 493) were screened for the presence of
   the following virulence genes: stx1, stx2 and eae (Shiga toxin-producing
   E. coli {[}STEC]), heat-labile enterotoxin (LT) genes and heat stable
   toxin STa and STb (enterotoxigenic E. coli (ETEC), cytotoxin necrotizing
   factors 1 and 2 (cnf1 and cnf2 {[}necrotoxigenic E. coli-NTEC]), as well
   as O and H antigens, and the presence of the antibiotic resistance genes
   bla(TEM), bla(SHV), bla(CMY-2), tet A, tet B, tet C, mph(A), aadA,
   StrA/B, sul1, sul2 and sul3. The commensal strains were further screened
   for 16 antimicrobials and characterized by BOX AIR-1 PCR for unique
   genotypes. The highest antibiotic resistance prevalence was for
   tetracycline, followed by erythromycin, ampicillin, streptomycin,
   sulfisoxazole and kanamycin. Our data showed that most of the isolates
   had high distribution of single or multidrug-resistant (MDR) genotypes.
   Therefore, the occurrence of MDR E. coli in the wetland is a matter of
   great concern due to possible transfer of resistance genes from
   nonpathogenic to pathogenic strains or vice versa in the environment.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ibekwe, AM (Reprint Author), USDA ARS, US Salin Lab, 450 W Big Springs Rd, Riverside, CA 92507 USA.
   Ibekwe, A. M., USDA ARS, US Salin Lab, 450 W Big Springs Rd, Riverside, CA 92507 USA.
   Murinda, Shelton E., Calif State Polytech Univ Pomona, Dept Vet \& Anim Sci, Pomona, CA 91768 USA.
   DebRoy, Chitrita, Penn State Univ, E Coli Reference Ctr, State Coll, PA 16802 USA.
   Reddy, Gudigopura B., N Carolina Agr \& Tech State Univ, Dept Nat Resources \& Environm Design, Greensboro, NC 27411 USA.}},
DOI = {{10.1093/femsec/fiw006}},
Article-Number = {{fiw006}},
ISSN = {{0168-6496}},
EISSN = {{1574-6941}},
Keywords = {{constructed wetland; contaminants; E. coli; BOX AIR-1; antimicrobial}},
Keywords-Plus = {{MARSH-POND-MARSH; ANTIBIOTIC-RESISTANCE GENES; MOLECULAR SIGNATURES;
   POPULATION-STRUCTURE; FECAL CONTAMINATION; UNITED-STATES; SURFACE-WATER;
   FOOD ANIMALS; BACTERIA; CANADA}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{Mark.Ibekwe@ars.usda.gov}},
Funding-Acknowledgement = {{214 Manure and Byproduct Utilization Project of the USDA-ARS}},
Funding-Text = {{This research was supported by the 214 Manure and Byproduct Utilization
   Project of the USDA-ARS. Mention of trademark or proprietary products in
   this manuscript does not constitute a guarantee or warranty of the
   product by the USDA and does not imply its approval to the exclusion of
   other products that may also be suitable.}},
Cited-References = {{Aarestrup FM, 2000, MICROB DRUG RESIST, V6, P63, DOI 10.1089/mdr.2000.6.63.
   Anderson AD, 2003, MICROB DRUG RESIST, V9, P373, DOI 10.1089/107662903322762815.
   Baquero F, 2008, CURR OPIN BIOTECH, V9, P260.
   Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439.
   Brichta-Harhay DM, 2011, APPL ENVIRON MICROB, V77, P1783, DOI 10.1128/AEM.01885-10.
   Call DR, 2003, J MICROBIOL METH, V53, P235, DOI 10.1016/S0167-7012(03)00027-7.
   Casteel MJ, 2006, J ENVIRON SCI HEAL A, V41, P173, DOI 10.1080/10934520500351884.
   Chandran A, 2015, APPL ENVIRON MICROB, V81, P1779, DOI 10.1128/AEM.03738-14.
   Chapman TA, 2006, APPL ENVIRON MICROB, V72, P4782, DOI 10.1128/AEM.02885-05.
   Clinical and Laboratory Standard Institute, 2006, M02A9 CLIN LAB STAND.
   DebRoy C, 2001, ANIM HLTH RES REV, V1, P129.
   Dombek PE, 2000, APPL ENVIRON MICROB, V66, P2572, DOI 10.1128/AEM.66.6.2572-2577.2000.
   Duriez P, 2007, APPL ENVIRON MICROB, V73, P5486, DOI 10.1128/AEM.00218-07.
   Durso LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048325.
   Eaton A.D., 1998, STANDARD METHOD EXAM.
   Fatta-Kassinos D, 2011, ANAL BIOANAL CHEM, V399, P251, DOI 10.1007/s00216-010-4300-9.
   Food and Drug Administration, 2003, GUID IND 152 EV SAF.
   Forbes DA, 2010, J ENVIRON SCI HEAL A, V45, P803, DOI 10.1080/10934521003708927.
   Frigon D, 2013, APPL ENVIRON MICROB, V79, P835, DOI 10.1128/AEM.02789-12.
   Gow SP, 2008, APPL ENVIRON MICROB, V74, P3658, DOI 10.1128/AEM.02505-07.
   Graves AK, 2007, WATER RES, V41, P3729, DOI 10.1016/j.watres.2007.04.020.
   Graves AK, 2010, J APPL MICROBIOL, V108, P1226, DOI 10.1111/j.1365-2672.2009.04516.x.
   Graves AK, 2002, J ENVIRON QUAL, V31, P1300, DOI 10.2134/jeq2002.1300.
   Haley CA, 2012, J FOOD PROTECT, V75, P428, DOI 10.4315/0362-028X.JFP-11-363.
   Ibekwe AM, 2007, J APPL MICROBIOL, V102, P921, DOI 10.1111/j.1365-2672.2006.03181.x.
   Ibekwe AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020819.
   Ibekwe AM, 2012, FEMS MICROBIOL ECOL, V79, P155, DOI 10.1111/j.1574-6941.2011.01205.x.
   Ibekwe AM, 2003, APPL ENVIRON MICROB, V69, P5060, DOI 10.1128/AEM.69.9.5060-5069.2003.
   Ishii S, 2008, MICROBES ENVIRON, V23, P101, DOI 10.1264/jsme2.23.101.
   Jacoby George A., 1994, Trends in Microbiology, V2, P357, DOI 10.1016/0966-842X(94)90611-4.
   Kadlec RH, 1996, TREATMENT WETLANDS.
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j.
   Kozak GK, 2009, APPL ENVIRON MICROB, V75, P559, DOI 10.1128/AEM.01821-08.
   Kummerer K, 2009, CHEMOSPHERE, V75, P435, DOI 10.1016/j.chemosphere.2008.12.006.
   Lyautey E, 2010, APPL ENVIRON MICROB, V76, P1486, DOI 10.1128/AEM.02288-09.
   Mathew AG, 2007, FOODBORNE PATHOG DIS, V4, P115, DOI 10.1089/fpd.2006.0066.
   McKinney CW, 2012, ENVIRON SCI TECHNOL, V44, P6102.
   Michael I, 2013, WATER RES, V47, P957, DOI 10.1016/j.watres.2012.11.027.
   Murinda SE, 2005, FOODBORNE PATHOG DIS, V2, P348, DOI 10.1089/fpd.2005.2.348.
   Nguyen MCP, 2009, EMERG INFECT DIS, V15, P1648, DOI 10.3201/eid1510.090696.
   Normark BH, 2002, J INTERN MED, V252, P91, DOI 10.1046/j.1365-2796.2002.01026.x.
   Paton JC, 1998, CLIN MICROBIOL REV, V11, P450.
   Pereira A, 2013, SCI TOTAL ENVIRON, V461, P65, DOI 10.1016/j.scitotenv.2013.04.067.
   Poach ME, 2004, ECOL ENG, V23, P165, DOI 10.1016/j.ecoleng.2004.09.001.
   Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P6102.
   Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es0604131.
   Rademaker JLW, 1997, DNA MARKERS, P151.
   Reddy GB, 2001, WATER SCI TECHNOL, V44, P545.
   Reddy GB, 2010, BIORESOURCE TECHNOL, V101, P11541.
   Russell JB, 2000, J DAIRY SCI, V83, P863, DOI 10.3168/jds.S0022-0302(00)74950-2.
   Sapkota AR, 2007, ENVIRON HEALTH PERSP, V115, P1040, DOI 10.1289/ehp.9770.
   SAS INSTITUTE INC, 2009, SAS STAT US GUID REL.
   Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x.
   Servais P, 2009, SCI TOTAL ENVIRON, V408, P365, DOI 10.1016/j.scitotenv.2009.09.042.
   Sharma R, 2008, APPL ENVIRON MICROB, V74, P6178, DOI 10.1128/AEM.00704-08.
   Sidrach-Cardona R, 2013, ECOL ENG, V50, P107, DOI 10.1016/j.ecoleng.2012.01.001.
   Smith DL, 2002, P NATL ACAD SCI USA, V99, P6434, DOI 10.1073/pnas.082188899.
   Steer D, 2002, ECOL ENG, V18, P429, DOI 10.1016/S0925-8574(01)00104-5.
   Storteboom H, 2010, ENVIRON SCI TECHNOL, V44, P1947, DOI 10.1021/es902893f.
   Storteboom H, 2010, ENVIRON SCI TECHNOL, V44, P7397, DOI 10.1021/es101657s.
   Tenover F.C., 1998, MANUAL CLIN MICROBIO, P1578.
   Versalovic J, 1998, BACTERIAL GENOMES, P437.
   Vymazal J., 2008, WASTEWATER TREATMENT.
   Whitman RL, 2008, SCI TOTAL ENVIRON, V390, P448, DOI 10.1016/j.scitotenv.2007.10.014.
   Yan T, 2011, APPL ENVIRON MICROB, V77, P3988.}},
Number-of-Cited-References = {{65}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{35}},
Journal-ISO = {{FEMS Microbiol. Ecol.}},
Doc-Delivery-Number = {{DF3MX}},
Unique-ID = {{ISI:000371249600020}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000368567000035,
Author = {Yates, Tom A. and Khan, Palwasha Y. and Knight, Gwenan M. and Taylor,
   Jonathon G. and McHugh, Timothy D. and Lipman, Marc and White, Richard
   G. and Cohen, Ted and Cobelens, Frank G. and Wood, Robin and Moore,
   David A. J. and Abubakar, Ibrahim},
Title = {{The transmission of Mycobacterium tuberculosis in high burden settings}},
Journal = {{LANCET INFECTIOUS DISEASES}},
Year = {{2016}},
Volume = {{16}},
Number = {{2}},
Pages = {{227-238}},
Month = {{FEB}},
Abstract = {{Unacceptable levels of Mycobacterium tuberculosis transmission are noted
   in high burden settings and a renewed focus on reducing person-to-person
   transmission in these communities is needed. We review recent
   developments in the understanding of airborne transmission. We outline
   approaches to measure transmission in populations and trials and
   describe the Wells-Riley equation, which is used to estimate
   transmission risk in indoor spaces. Present research priorities include
   the identification of effective strategies for tuberculosis infection
   control, improved understanding of where transmission occurs and the
   transmissibility of drug-resistant strains, and estimates of the effect
   of HIV and antiretroviral therapy on transmission dynamics. When
   research is planned and interventions are designed to interrupt
   transmission, resource constraints that are common in high burden
   settings-including shortages of health-care workers-must be considered.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Yates, TA (Reprint Author), UCL, Ctr Infect Dis Epidemiol, Res Dept Infect \& Populat Hlth, London WC1E 6JB, England.
   Yates, Tom A.; Abubakar, Ibrahim, UCL, Ctr Infect Dis Epidemiol, Res Dept Infect \& Populat Hlth, London WC1E 6JB, England.
   Yates, Tom A., Wellcome Trust Africa Ctr Populat Hlth, Mtubatuba, South Africa.
   Khan, Palwasha Y.; Wood, Robin, London Sch Hyg \& Trop Med, Fac Epidemiol \& Populat Hlth, Dept Infect Dis Epidemiol, London WC1, England.
   Khan, Palwasha Y.; Knight, Gwenan M.; White, Richard G.; Wood, Robin; Moore, David A. J., London Sch Hyg \& Trop Med, TB Ctr, London WC1, England.
   Knight, Gwenan M.; White, Richard G., London Sch Hyg \& Trop Med, TB Modelling Grp, London WC1, England.
   Moore, David A. J., London Sch Hyg \& Trop Med, Dept Clin Res, London WC1, England.
   Khan, Palwasha Y., Karonga Prevent Study, Chilumba, Malawi.
   Knight, Gwenan M., Univ London Imperial Coll Sci Technol \& Med, Natl Inst Hlth Res Hlth Protect Res Unit Healthca, London, England.
   Taylor, Jonathon G., UCL, UCL Inst Environm Design \& Engn, Bartlett Sch Environm Energy \& Resources, London WC1E 6JB, England.
   McHugh, Timothy D., UCL, Ctr Clin Microbiol, London WC1E 6JB, England.
   Lipman, Marc, UCL, Div Med, London WC1E 6JB, England.
   Abubakar, Ibrahim, UCL, MRC Clin Trials Unit, London WC1E 6JB, England.
   Cohen, Ted, Yale Univ, Dept Epidemiol Microbial Dis, Sch Publ Hlth, New Haven, CT USA.
   Cobelens, Frank G., Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
   Cobelens, Frank G., KNCV TB Fdn, The Hague, Netherlands.
   Wood, Robin, Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis \& Mol Med, ZA-7925 Cape Town, South Africa.}},
DOI = {{10.1016/S1473-3099(15)00499-5}},
ISSN = {{1473-3099}},
EISSN = {{1474-4457}},
Keywords-Plus = {{DRUG-RESISTANT TUBERCULOSIS; ISONIAZID PREVENTIVE THERAPY;
   HUMAN-IMMUNODEFICIENCY-VIRUS; SOUTH-AFRICAN TOWNSHIP; HIV-ASSOCIATED
   TUBERCULOSIS; POLYMERASE-CHAIN-REACTION; MOLECULAR EPIDEMIOLOGY;
   ANTIRETROVIRAL THERAPY; PULMONARY TUBERCULOSIS; ANNUAL RISK}},
Research-Areas = {{Infectious Diseases}},
Web-of-Science-Categories  = {{Infectious Diseases}},
Author-Email = {{tyates@ucl.ac.uk}},
ResearcherID-Numbers = {{White, Richard/D-5407-2009
   Taylor, Jonathon/B-1558-2018
   }},
ORCID-Numbers = {{White, Richard/0000-0003-4410-6635
   Taylor, Jonathon/0000-0003-3485-1404
   Yates, Tom/0000-0002-6081-1767}},
Funding-Acknowledgement = {{TB Modelling and Analysis Consortium {[}OPP1084276]; University College
   of London Population Health Domain; TB Centre at the London School of
   Hygiene \& Tropical Medicine; Medical Research Council (UK); Wellcome
   Trust; Bill and Melinda Gates Foundation; Centres for Disease
   Control/President's Emergency Plan for AIDS Relief through the Aurum
   Institute; US Agency for International Development/International Union
   Against Tuberculosis and Lung Disease/The Union North America; National
   Institutes of Health Research Project Grant {[}R01 AI112438-01]; UK
   Medical Research Council; National Institute for Health Research; Public
   Health England; Medical Research Council {[}MR/J005088/1]; National
   Institute for Health Research {[}SRF-2011-04-001]}},
Funding-Text = {{This Review was written after the M tuberculosis transmission meeting,
   held in London in November, 2014, which was funded by the TB Modelling
   and Analysis Consortium (OPP1084276), University College of London
   Population Health Domain, and the TB Centre at the London School of
   Hygiene \& Tropical Medicine. TAY is funded with a studentship from the
   Medical Research Council (UK). PYK is funded by the Wellcome Trust
   clinical research training fellowship. RGW is funded by the Medical
   Research Council (UK), the Bill and Melinda Gates Foundation, Centres
   for Disease Control/President's Emergency Plan for AIDS Relief through
   the Aurum Institute, and the US Agency for International
   Development/International Union Against Tuberculosis and Lung
   Disease/The Union North America. TC is funded by a National Institutes
   of Health Research Project Grant (R01 AI112438-01). IA is funded by the
   UK Medical Research Council, National Institute for Health Research, and
   Public Health England.}},
Cited-References = {{Addo KK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-35.
   Aggerbeck H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064215.
   Anderson R. M., 1991, INFECT DIS HUMANS DY.
   Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657.
   Andrews JR, 2015, AM J RESP CRIT CARE, V191, P584, DOI 10.1164/rccm.201409-1704OC.
   Andrews JR, 2014, J INFECT DIS, V210, P597, DOI 10.1093/infdis/jiu138.
   {[}Anonymous], 2013, TB CARE 2 FAST TUB I.
   Ayles H, 2014, LANCET, V383, P214, DOI 10.1016/S0140-6736(14)60067-2.
   Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9.
   Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236.
   Beggs CB, 2003, INT J TUBERC LUNG D, V7, P1015.
   Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247.
   Blower SM, 1998, J MOL MED-JMM, V76, P624, DOI 10.1007/s001090050260.
   Borgdorff MW, 2013, CLIN MICROBIOL INFEC, V19, P889, DOI 10.1111/1469-0691.12253.
   Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P501.
   Brooks-Pollock E, 2011, J INFECT DIS, V203, P1582, DOI 10.1093/infdis/jir162.
   Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110.
   Buu TN, 2010, EMERG INFECT DIS, V16, P1466, DOI 10.3201/eid1609.100281.
   Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878.
   Churchyard GJ, 2014, NEW ENGL J MED, V370, P301, DOI 10.1056/NEJMoa1214289.
   Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499.
   Cobelens F, 2014, LANCET, V383, P213, DOI 10.1016/S0140-6736(14)60065-9.
   Cohen T, 2003, LANCET INFECT DIS, V3, P13, DOI 10.1016/S1473-3099(03)00483-3.
   Cohen T, 2012, CLIN MICROBIOL REV, V25, P708, DOI 10.1128/CMR.00021-12.
   Cohen Ted, 2009, Expert Rev Respir Med, V3, P67, DOI 10.1586/17476348.3.1.67.
   Colangeli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091024.
   Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038.
   Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC.
   Corbett EL, 2003, J INFECT DIS, V188, P1156, DOI 10.1086/378519.
   Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022.
   Cox H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029589.
   Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198.
   de Vos M, 2013, ANTIMICROB AGENTS CH, V57, P827, DOI 10.1128/AAC.01541-12.
   Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834.
   Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC.
   Dharmadhikari AS, 2011, CLIN INFECT DIS, V52, P554, DOI 10.1093/cid/ciq182.
   Didelot X, 2014, MOL BIOL EVOL, V31, P1869, DOI 10.1093/molbev/msu121.
   Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1.
   Dodd PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075466.
   Doocy Shannon C, 2008, World Health Popul, V10, P44.
   Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109.
   Dowdy DW, 2009, B WORLD HEALTH ORGAN, V87, P296, DOI 10.2471/BLT.08.054510.
   du Plessis DG, 2001, TUBERCULOSIS, V81, P211, DOI 10.1054/tube.2000.0278.
   Dye C, 2008, LANCET INFECT DIS, V8, P233, DOI 10.1016/S1473-3099(07)70291-8.
   Dye C, 2001, P ROY SOC B-BIOL SCI, V268, P45, DOI 10.1098/rspb.2000.1328.
   Egwaga SA, 2006, AIDS, V20, P915, DOI 10.1097/01.aids.0000218557.44284.83.
   Escombe AR, 2010, INT J TUBERC LUNG D, V14, P1120.
   Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068.
   Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043.
   Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188.
   Esmail H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0437.
   Fennelly KP, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00313.
   Fennelly KP, 2012, AM J RESP CRIT CARE, V186, P450, DOI 10.1164/rccm.201203-0444OC.
   Field N, 2014, LANCET INFECT DIS, V14, P341, DOI 10.1016/S1473-3099(13)70324-4.
   Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962.
   Fitzwater SP, 2010, CLIN INFECT DIS, V51, P371, DOI 10.1086/655127.
   Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811.
   Gandhi NR, 2013, J INFECT DIS, V207, P9, DOI 10.1093/infdis/jis631.
   Getahun H, 2015, EUR RESPIR J, V46, P1563, DOI 10.1183/13993003.01245-2015.
   Glaziou P, 2013, SEMIN RESP CRIT CARE, V34, P3, DOI 10.1055/s-0032-1333467.
   Glynn JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132840.
   Godfrey-Faussett P, 2000, LANCET, V356, P1066, DOI 10.1016/S0140-6736(00)02730-6.
   Godfrey-Faussett P., 2014, 21 C RETR OPP INF BO.
   Gopi PG, 2006, INDIAN J MED RES, V124, P71.
   Grandjean L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001843.
   Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166.
   GUNNELS JJ, 1974, AM REV RESPIR DIS, V109, P323.
   Hawn TR, 2014, MICROBIOL MOL BIOL R, V78, P650, DOI 10.1128/MMBR.00021-14.
   Hoa NB, 2013, INT J TUBERC LUNG D, V17, P738, DOI 10.5588/ijtld.12.0200.
   Houben RMGJ, 2011, INT J TUBERC LUNG D, V15, P24.
   Houben RMGJ, 2014, P NATL ACAD SCI USA, V111, P5325, DOI 10.1073/pnas.1317660111.
   Houben RMGJ, 2009, TROP MED INT HEALTH, V14, P892, DOI 10.1111/j.1365-3156.2009.02316.x.
   Huang CC, 2014, CLIN INFECT DIS, V58, P765, DOI 10.1093/cid/cit948.
   Ioerger TR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-670.
   Horna-Campos OJ, 2011, OCCUP ENVIRON MED, V68, P163, DOI 10.1136/oem.2009.051128.
   Jenkins HE, 2014, EURO SURVEILL, V19.
   Jenkins HE, 2014, LANCET, V383, P1572, DOI 10.1016/S0140-6736(14)60195-1.
   Johnstone-Robertson S, 2011, SAMJ S AFR MED J, V101, P809.
   Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251.
   Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC.
   Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538.
   KAMAT SR, 1966, B WORLD HEALTH ORGAN, V34, P517.
   Kasaie P, 2014, AM J RESP CRIT CARE, V189, P845, DOI 10.1164/rccm.201310-1846OC.
   Khan MAI, 2012, BUILD SIMUL-CHINA, V5, P39, DOI 10.1007/s12273-012-0058-7.
   Kim SH, 2013, BUILD ENVIRON, V60, P305, DOI 10.1016/j.buildenv.2012.09.005.
   Knight GM, 2015, CLIN INFECT DIS, V61, pS147, DOI 10.1093/cid/civ579.
   Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743.
   Kritzinger FE, 2009, TROP MED INT HEALTH, V14, P136, DOI 10.1111/j.1365-3156.2008.02213.x.
   Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483.
   Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5.
   Li Y, 2007, INDOOR AIR, V17, P2, DOI 10.1111/j.1600-0668.2006.00445.x.
   LOUDON RG, 1967, AM REV RESPIR DIS, V95, P435.
   LOUDON RG, 1969, AM REV RESPIR DIS, V99, P109.
   LOUDON RG, 1968, AM REV RESPIR DIS, V98, P297.
   Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816.
   LURIE MB, 1950, AM REV TUBERC PULM, V61, P765.
   Mastorides SM, 1999, CHEST, V115, P19, DOI 10.1378/chest.115.1.19.
   Matuka O, 2015, J HOSP INFECT, V89, P192, DOI 10.1016/j.jhin.2014.11.013.
   Menzies D, 2000, ANN INTERN MED, V133, P779, DOI 10.7326/0003-4819-133-10-200011210-00010.
   Menzies D, 1997, INFECT CONT HOSP EP, V18, P582.
   Middelkoop K, 2015, J INFECT DIS, V211, P53, DOI 10.1093/infdis/jiu403.
   Middelkoop K, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-221.
   Middelkoop K, 2011, INT J TUBERC LUNG D, V15, P1714, DOI 10.5588/ijtld.11.0545.
   Munim A., 2008, Eastern Mediterranean Health Journal, V14, P518.
   Munthali L, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-107.
   Murray M, 2002, AM J EPIDEMIOL, V155, P565, DOI 10.1093/aje/155.6.565.
   NARAIN R, 1966, B WORLD HEALTH ORGAN, V34, P639.
   NARDELL EA, 1991, AM REV RESPIR DIS, V144, P302, DOI 10.1164/ajrccm/144.2.302.
   Nardell EA, 2008, PUBLIC HEALTH REP, V123, P52, DOI 10.1177/003335490812300108.
   National Institute for Health and Care Excellence, 2011, TEB CLIN DIAGN MAN T.
   Neuenschwander BF., 2007, BAYES MIXT AN TUB IN.
   Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439.
   Pretorius C, 2014, AIDS, V28, pS25, DOI 10.1097/QAD.0000000000000085.
   Rieder H, 2005, EUR RESPIR J, V25, P181, DOI 10.1183/09031936.04.00103804.
   Rieder HL, 1999, EPIDEMIOLOGICAL BASI.
   RILEY EC, 1978, AM J EPIDEMIOL, V107, P421, DOI 10.1093/oxfordjournals.aje.a112560.
   RILEY RL, 1989, AM REV RESPIR DIS, V139, P1286, DOI 10.1164/ajrccm/139.5.1286.
   RILEY RL, 1962, AM REV RESPIR DIS, V85, P511.
   Riley RL, 1959, AM J HYG, P70.
   Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387.
   Rudnick SN, 2003, INDOOR AIR, V13, P237, DOI 10.1034/j.1600-0668.2003.00189.x.
   Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3.
   Shah S., 2015, 22 C RETR OPP INF SE.
   Shenoi SV, 2010, CLIN INFECT DIS, V50, pS231, DOI 10.1086/651496.
   SULTAN L, 1960, AM REV RESPIR DIS, V82, P358.
   Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x.
   Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001.
   Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270.
   Turner RD, 2015, J INFECT DIS, V211, P1367, DOI 10.1093/infdis/jiu625.
   van Halsema CL, 2015, JAIDS-J ACQ IMM DEF, V70, P104, DOI 10.1097/QAI.0000000000000684.
   Van Leth F, 2008, B WORLD HEALTH ORGAN, V86, P20, DOI 10.2471/BLT.06.037804.
   van Soolingen D, 1999, J INFECT DIS, V180, P726, DOI 10.1086/314930.
   VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406.
   Verrall AJ, 2014, IMMUNOLOGY, V141, P506, DOI 10.1111/imm.12223.
   Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9.
   Vynnycky E, 2015, AM J EPIDEMIOL, V181, P619, DOI 10.1093/aje/kwu320.
   Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3.
   Wan GH, 2004, AM J INFECT CONTROL, V32, P17, DOI 10.1016/S0196-6553(03)00090-7.
   Wells WF, 1934, AM J HYG, V20, P611, DOI 10.1093/oxfordjournals.aje.a118097.
   WELLS WF, 1948, AM J HYG, V47, P11, DOI 10.1093/oxfordjournals.aje.a119179.
   WHO, 2014, WORLD HLTH ASS.
   WHO, 2015, GUID START ANT THER.
   WHO, 2009, WHO GUID IND AIR QUA.
   Williams BG, 2010, P NATL ACAD SCI USA, V107, P19485, DOI 10.1073/pnas.1005660107.
   Wood R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106622.
   Wood R, 2011, SAMJ S AFR MED J, V101, P111, DOI 10.7196/SAMJ.4587.
   Wood R, 2010, CLIN INFECT DIS, V51, P401, DOI 10.1086/655129.
   World Health Organization, 2009, WHO POL TB INF CONTR.
   World Health Organization, 2006, STOP TB STRAT BUILD.
   World Health Organization Geneva, 2014, GLOB TUB CONTR WHO R.
   Yates TA, 2016, INT J TUBERC LUNG D, V20, P5, DOI 10.5588/ijtld.15.0494.
   Yates TA, 2015, J INFECT DIS, V211, P1510, DOI 10.1093/infdis/jiu628.
   Ypma RJF, 2013, EPIDEMIOLOGY, V24, P395, DOI 10.1097/EDE.0b013e3182878e19.
   Zachariah R, 2011, INT J TUBERC LUNG D, V15, P933, DOI 10.5588/ijtld.10.0666.
   Zelner JL, 2016, J INFECT DIS, V213, P287, DOI 10.1093/infdis/jiv387.
   Zelner JL, 2014, AM J EPIDEMIOL, V180, P853, DOI 10.1093/aje/kwu192.}},
Number-of-Cited-References = {{156}},
Times-Cited = {{32}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{26}},
Journal-ISO = {{Lancet Infect. Dis.}},
Doc-Delivery-Number = {{DB5PV}},
Unique-ID = {{ISI:000368567000035}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000367704100001,
Author = {Heimbuch, Brian K. and Wallace, William H. and Balzli, Charles L. and
   Laning, Michelle L. and Harnish, Delbert A. and Wander, Joseph D.},
Title = {{Bioaerosol exposure to personnel in a clinical environment absent
   patients}},
Journal = {{JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE}},
Year = {{2016}},
Volume = {{13}},
Number = {{2}},
Pages = {{D11-D15}},
Month = {{FEB 1}},
Abstract = {{Nosocomial infections pose a significant and escalating threat to both
   patients and healthcare workers (HCWs). By their nature, hospitals
   induce antibiotic resistance in virulent and commensal strains, leading
   to increasingly severe hospital-acquired infections. This study measured
   environmental exposure experienced by domestic staff cleaning vacated
   patient rooms of a community hospital to bacteria in ambient
   bioaerosols. While they cleaned the room, participants wore an N95
   filtering facepiece respirator (FFR), from which coupons were cut and
   bacteria were extracted, cultured and enumerated. Extrapolation to the
   full area of the respirator yielded measured exposures of 0.2-1.4 x
   10(4) colony-forming units/ hour, of which similar to 97\% collected on
   the front layer of the N95, suggesting a possible role for minimal
   respiratory protection in nonpatient environments. Random resistance
   testing of 1.6\% of the isolates showed that similar to 70\% of both
   Gram-positive and Gram-negative organisms exhibited resistance to
   oxacillin and similar to 9\% of the Gram-positives displayed resistance
   to vancomycin. These data provide an estimate formask bioaerosol loading
   that can be used in risk modeling and to refine strategies for reuse of
   FFRs during critical shortages.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wander, JD (Reprint Author), Air Force Civil Engineer Ctr Readiness, Tyndall AFB, FL 32403 USA.
   Heimbuch, Brian K.; Wallace, William H.; Harnish, Delbert A., Appl Res Associates, Engn Sci Div, Panama City, FL USA.
   Balzli, Charles L., Universal Technol Corp, Mat \& Mfg Div, Dayton, OH USA.
   Laning, Michelle L., Air Force Res Lab, Tyndall AFB, FL USA.
   Wander, Joseph D., Air Force Civil Engineer Ctr, Tyndall AFB, FL USA.}},
DOI = {{10.1080/15459624.2015.1091966}},
ISSN = {{1545-9624}},
EISSN = {{1545-9632}},
Keywords = {{Antibiotic resistance; background; hospital; infection; nosocomial; N95
   respirator}},
Keywords-Plus = {{FILTERING FACEPIECE RESPIRATORS; INFECTION; AIR; STAPHYLOCOCCI;
   CONTAMINATION; DISPERSAL; BACTERIA; AEROSOLS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{joseph.wander@us.af.mil}},
Funding-Acknowledgement = {{FDA, Centers for Devices and Radiologic Health; Air Force Research
   Laboratory}},
Funding-Text = {{This work was funded by the FDA, Centers for Devices and Radiologic
   Health, through an interagency agreement with the Air Force Research
   Laboratory.}},
Cited-References = {{Agvald-Ohman C, 2004, CRIT CARE, V8, pR42, DOI 10.1186/cc2422.
   Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl\_1.5.
   Bergman MS, 2010, J ENG FIBER FABR, V5, P33.
   Burden M, 2011, J HOSP MED, V6, P177, DOI 10.1002/jhm.864.
   CHARNLEY J, 1969, BRIT J SURG, V56, P641, DOI 10.1002/bjs.1800560902.
   Davies M.W., 2012, PEDIATRICS, V106, P1.
   Dzidic S, 2003, ACTA PHARMACOL SIN, V24, P519.
   Gosch ME, 2013, AM J INFECT CONTROL, V41, P1224, DOI 10.1016/j.ajic.2013.03.293.
   GREENE VW, 1962, APPL MICROBIOL, V10, P561.
   Harnish DA, 2013, INFECT CONT HOSP EP, V34, P494, DOI 10.1086/670225.
   Heimbuch B.K., 2010, AM J INFECT CONTROL, V38, P3.
   Heimbuch BK, 2014, AM J INFECT CONTROL, V42, P265, DOI 10.1016/j.ajic.2013.09.014.
   Krein SL, 2012, J GEN INTERN MED, V27, P773, DOI 10.1007/s11606-011-1935-y.
   Lemmen SW, 2004, J HOSP INFECT, V56, P191, DOI 10.1016/j.jhin.2003.12.004.
   LIDWELL OM, 1988, J HOSP INFECT, V11, P18, DOI 10.1016/0195-6701(88)90020-5.
   LIDWELL OM, 1975, J HYG-CAMBRIDGE, V75, P445, DOI 10.1017/S0022172400024505.
   MAKI DG, 1982, NEW ENGL J MED, V307, P1562, DOI 10.1056/NEJM198212163072507.
   Neely AN, 2000, J CLIN MICROBIOL, V38, P724.
   NOBLE WC, 1965, J CLIN PATHOL, V18, P16, DOI 10.1136/jcp.18.1.16.
   Occupational Safety and Health Administration (OSHA), 2007, OSHA PUB.
   Radonovich L.J., BETTER RESP PROTECTI.
   Rautemaa R, 2006, J HOSP INFECT, V64, P76, DOI 10.1016/j.jhin.2006.04.011.
   Siegel JD, GUIDELINE ISOLATION.
   SUZUKI A, 1984, J HYG-CAMBRIDGE, V93, P559, DOI 10.1017/S002217240006513X.
   Viscusi DJ, 2011, J OCCUP ENVIRON HYG, V8, P426, DOI 10.1080/15459624.2011.585927.
   Young JM, 2005, AM J INFECT CONTROL, V33, P170, DOI 10.1016/j.ajic.2004.11.005.}},
Number-of-Cited-References = {{26}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{18}},
Journal-ISO = {{J. Occup. Environ. Hyg.}},
Doc-Delivery-Number = {{DA3NJ}},
Unique-ID = {{ISI:000367704100001}},
DA = {{2018-08-13}},
}

@article{ ISI:000391646200010,
Author = {Bielawska-Drozd, Agata and Wlizlo-Skowronek, Bozena and Cieslik, Piotr
   and Winnicka, Izabela and Skopinska-Rozewska, Ewa and Kubiak, Leszek and
   Zakowska, Dorota and Brewczynska, Aleksandra and Kocik, Janusz},
Title = {{Evaluation of the Levels and Quality of Microbial Contamination in
   Medical Emergency Departments in Comparison to Other Workplaces}},
Journal = {{POLISH JOURNAL OF MICROBIOLOGY}},
Year = {{2016}},
Volume = {{65}},
Number = {{4}},
Pages = {{465-469}},
Abstract = {{Work in Hospital Emergency Departments (HEDs) exposes both the emergency
   ward staff and patients to infectious and in other way harmful
   biological agents. The results of this study shows the presence of
   pathogenic bacteria isolated by three different methods. It revealed
   9.8\% of pathogens detected by imprint method, 10.5\% of pathogens by
   swabbing method, 17.6\% and 22\% in HEDs corridors and rooms,
   respectively, by air sampling method. In control workplaces (offices)
   pathogenic bacteria reached the level of 6.5\% and 14.7\% by imprint
   method and swabbing, respectively. The relatively low level of
   contamination by bacteria in HEDs may depend on the effectiveness of
   Standard Protective Precautions in the studied hospitals.}},
Publisher = {{POLSKIE TOWARZYSTWO MIKROBIOLOGOW-POLISH SOCIETY OF MICROBIOLOGISTS}},
Address = {{CHELMSKA STR 30-34, WARSAW, 00-725, POLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Bielawska-Drozd, A (Reprint Author), Mil Inst Hyg \& Epidemiol, Biol Threats Identificat \& Countermeasure Ctr, Warsaw, Poland.
   Bielawska-Drozd, Agata; Wlizlo-Skowronek, Bozena; Cieslik, Piotr; Zakowska, Dorota, Mil Inst Hyg \& Epidemiol, Biol Threats Identificat \& Countermeasure Ctr, Warsaw, Poland.
   Winnicka, Izabela; Skopinska-Rozewska, Ewa; Kubiak, Leszek; Brewczynska, Aleksandra; Kocik, Janusz, Mil Inst Hyg \& Epidemiol, Lab Epidemiol, Warsaw, Poland.
   Skopinska-Rozewska, Ewa, Med Univ Warsaw, Dept Pathol, Biostruct Ctr, Warsaw, Poland.}},
ISSN = {{1733-1331}},
Keywords = {{harmful biological agents; Hospital Emergency Department; antimicrobial
   resistance; microbiological monitoring surface and air samples}},
Keywords-Plus = {{BACTERIAL-CONTAMINATION; SUSCEPTIBILITY; ENVIRONMENT; SURFACES}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{abielawska@wihe.pulawy.pl}},
Funding-Acknowledgement = {{ {[}42/2014/PW-PB];  {[}II.P.19]}},
Funding-Text = {{This article was funded by the project number II.P.19 (contract number
   42/2014/PW-PB) named ``Identification of biological hazards in rescue
   operations and their impact on the competence of the immune system, in
   the perspective of health consequences{''} and carried out under the
   program ``Improving safety and working conditions{''} conducted by
   Central Institute for Labour Protection - National Research Institute.}},
Cited-References = {{Augustowska M, 2006, ANN AGR ENV MED, V13, P99.
   Charkowska A., 2003, CONTAMINATION AIR CO, P1.
   Dancer SJ, 2004, J HOSP INFECT, V56, P10, DOI 10.1016/j.jhin.2003.09.017.
   Ekhaise F.O., 2008, WORLD J MED SCI, V3, P19.
   Fiedotow Maja, 2006, Pol Merkur Lekarski, V21, P484.
   Golofit-Szymczak M., 2013, PODST MET OCENY SROD, V2, P5.
   Gorny R.L., 2004, PODSTAWY METODY OCEN, V3, P17.
   Guzek A, 2013, ADV EXP MED BIOL, V788, P125, DOI 10.1007/978-94-007-6627-3\_19.
   Heczko P. B., 2009, NOSOCOMIAL INFECT, P61.
   Hoseinzadeh E, 2013, JUNDISHAPUR J MICROB, V6, DOI 10.5812/jjm.10704.
   ISAP, 2011, ORD POL MIN HLTH.
   Kepa M., 2012, ANN ACAD MED SILES, V66, P7.
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130.
   Maszkiewicz W., 2007, ZDR PUBL, V117, P260.
   Mirzaei R, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.11688.
   National Sanitary Inspectorate (NSI), 2011, COUNTR SAN COND REP.
   National Sanitary Inspectorate (NSI), 2010, COUNTR SAN COND REP.
   National Sanitary Inspectorate (NSI), 2009, COUNTR SAN COND REP.
   Nourmoradi H., 2012, INT J ENV HLTH ENG, V1, P47.
   Paluchowska Paulina, 2012, Medycyna Doswiadczalna i Mikrobiologia, V64, P45.
   Paluchowska Paulina, 2012, Medycyna Doswiadczalna i Mikrobiologia, V64, P35.
   Park DU, 2013, INT J ENV RES PUB HE, V10, P541, DOI 10.3390/ijerph10020541.
   Garcia-Cruz CP, 2012, JUNDISHAPUR J MICROB, V5, P460, DOI 10.5812/jjm.2625.
   Rubino F. M., 1995, P HLTH BUILD, V95, P1389.
   Seweryn M., 2014, PRZEGL EPIDEMIOL, V68, P549.
   Shiferaw T, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-39.
   The European Committee on Antimicrobial Susceptibility Testing, BREAKP TABL INT MICS.
   Weber DJ, 2013, CURR OPIN INFECT DIS, V26, P338, DOI 10.1097/QCO.0b013e3283630f04.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Pol. J. Microbiol.}},
Doc-Delivery-Number = {{EH3CH}},
Unique-ID = {{ISI:000391646200010}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000391980400001,
Author = {Usui, Tatsuya and Sakurai, Masashi and Enjoji, Shuhei and Kawasaki,
   Hideyoshi and Umata, Koji and Ohama, Takashi and Fujiwara, Nobuyuki and
   Yabe, Ryotaro and Tsuji, Shunya and Yamawaki, Hideyuki and Hazama,
   Shoichi and Takenouchi, Hiroko and Nakajima, Masao and Tsunedomi,
   Ryouichi and Suzuki, Nobuaki and Nagano, Hiroaki and Sato, Koichi},
Title = {{Establishment of a Novel Model for Anticancer Drug Resistance in
   Three-Dimensional Primary Culture of Tumor Microenvironment}},
Journal = {{STEM CELLS INTERNATIONAL}},
Year = {{2016}},
Abstract = {{Tumor microenvironment has been implicated in tumor development and
   progression. As a three-dimensional tumor microenvironment model, air
   liquid interface (ALI) organoid culture from oncogene transgenic mouse
   gastrointestinal tissues was recently produced. However, ALI organoid
   culture system from tissues of colorectal cancer patients has not been
   established. Here, we developed an ALI organoid model from normal and
   tumor colorectal tissues of human patients. Both organoids were
   successfully generated and showed cystic structures containing an
   epithelial layer and surrounding mesenchymal stromal cells. Structures
   of tumor organoids closely resembled primary tumor epithelium.
   Expression of an epithelial cell marker, E-cadherin, a goblet cell
   marker, MUC2, and a fibroblast marker, vimentin, but not a myofibroblast
   marker, alpha-smooth muscle actin (SMA), was observed in normal
   organoids. Expression of E-cadherin, MUC2, vimentin, and alpha-SMA was
   observed in tumor organoids. Expression of a cancer stem cell marker,
   LGR5 in tumor organoids, was higher than that in primary tumor tissues.
   Tumor organoids were more resistant to toxicity of 5-fluorouracil and
   Irinotecan than colorectal cancer cell lines, SW480, SW620, and HCT116.
   These findings indicate that ALI organoid culture fromcolorectal cancer
   patients may become a novelmodel that is useful for examining resistance
   to chemotherapy in tumor microenvironment.}},
Publisher = {{HINDAWI PUBLISHING CORP}},
Address = {{315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Usui, T (Reprint Author), Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Toxicol, 1677-1 Yoshida, Yamaguchi 7538515, Japan.
   Usui, Tatsuya, Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Toxicol, 1677-1 Yoshida, Yamaguchi 7538515, Japan.
   Sakurai, Masashi, Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pathol, 1677-1 Yoshida, Yamaguchi 7538515, Japan.
   Enjoji, Shuhei; Kawasaki, Hideyoshi; Umata, Koji; Ohama, Takashi; Fujiwara, Nobuyuki; Yabe, Ryotaro; Tsuji, Shunya; Sato, Koichi, Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pharmacol, 1677-1 Yoshida, Yamaguchi 7538515, Japan.
   Yamawaki, Hideyuki, Kitasato Univ, Sch Vet Med, Lab Vet Pharmacol, Higashi 23 Bancho 35-1, Towada, Aomori 0348628, Japan.
   Hazama, Shoichi, Yamaguchi Univ, Sch Med, Dept Translat Res \& Dev Therapeut Canc, 1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.
   Hazama, Shoichi; Takenouchi, Hiroko; Nakajima, Masao; Tsunedomi, Ryouichi; Suzuki, Nobuaki; Nagano, Hiroaki, Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol Breast \& Endocrine Surg, 1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.}},
DOI = {{10.1155/2016/7053872}},
Article-Number = {{7053872}},
ISSN = {{1687-966X}},
EISSN = {{1687-9678}},
Keywords-Plus = {{STEM-CELL NICHE; COLORECTAL-CANCER; MYOFIBROBLASTS; INFLAMMATION;
   FIBROBLASTS; MIGRATION; GROWTH}},
Research-Areas = {{Cell Biology}},
Web-of-Science-Categories  = {{Cell \& Tissue Engineering}},
Author-Email = {{usui@yamaguchi-u.ac.jp}},
ResearcherID-Numbers = {{Usui, Tatsuya/Q-5170-2017}},
ORCID-Numbers = {{Usui, Tatsuya/0000-0002-1818-2127}},
Cited-References = {{Andoh A, 2007, PHARMACOL THERAPEUT, V114, P94, DOI 10.1016/j.pharmthera.2006.12.004.
   Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002.
   Brenmoehl J, 2009, WORLD J GASTROENTERO, V15, P1431, DOI 10.3748/wjg.15.1431.
   Brown KM, 2016, ONCOTARGET.
   Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840.
   De Greef K, 2016, WORLD J GASTROENTERO, V22, P7215, DOI 10.3748/wjg.v22.i32.7215.
   De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925.
   Dotse E, 2016, CYTOTECHNOLOGY, V68, P609, DOI 10.1007/s10616-014-9806-0.
   Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023.
   Hsu HC, 2013, INT J COLORECTAL DIS, V28, P1535, DOI 10.1007/s00384-013-1721-x.
   Hynds RE, 2013, STEM CELLS, V31, P417, DOI 10.1002/stem.1290.
   Katano T, 2013, BIOCHEM BIOPH RES CO, V432, P558, DOI 10.1016/j.bbrc.2013.02.051.
   Kobayashi S, 2012, STEM CELLS, V30, P2631, DOI 10.1002/stem.1257.
   Kozovska Z, 2014, BIOMED PHARMACOTHER, V68, P911, DOI 10.1016/j.biopha.2014.10.019.
   Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585.
   Mathonnet M, 2014, WORLD J GASTROENTERO, V20, P4189, DOI 10.3748/wjg.v20.i15.4189.
   Ong BA, 2014, WORLD J GASTROENTERO, V20, P1898, DOI 10.3748/wjg.v20.i8.1898.
   Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951.
   POSTLETHWAITE AE, 1987, J EXP MED, V165, P251, DOI 10.1084/jem.165.1.251.
   Roulis M, 2016, DIFFERENTIATION, V92, P116, DOI 10.1016/j.diff.2016.05.002.
   SATO T, 2011, YGAST, V141, P1762, DOI DOI 10.1053/J.GASTR0.2011.07.050.
   Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852.
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957.
   Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332.
   Tanase CP, 2014, WORLD J GASTROENTERO, V20, P10790, DOI 10.3748/wjg.v20.i31.10790.
   Tschumperlin DJ, 2013, CURR OPIN RHEUMATOL, V25, P92, DOI 10.1097/BOR.0b013e32835b13cd.
   Usui T, 2012, HYPERTENSION, V60, P1031, DOI 10.1161/HYPERTENSIONAHA.112.200337.
   van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{Stem Cells Int.}},
Doc-Delivery-Number = {{EH7VJ}},
Unique-ID = {{ISI:000391980400001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000387059800006,
Author = {Farshad, Ali Asghar and Enferadi, Mojtaba and Bakand, Shahnaz and Orak,
   Rouhangiz Jamshidi and Mirkazemi, Roksana},
Title = {{Penicillin dust exposure and penicillin resistance among pharmaceutical
   workers in Tehran, Iran}},
Journal = {{INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH}},
Year = {{2016}},
Volume = {{22}},
Number = {{3}},
Pages = {{218-223}},
Abstract = {{Background: Antimicrobial resistance (AMR) adversely impacts the
   prevention and treatment of a wide range of infections and is considered
   as a serious threat to global public health. Occupational-related AMR is
   a neglected area of research.
   Objective: To assess exposure to penicillin dust, penicillin active
   materials, and to report the frequency of penicillin resistance among
   pharmaceutical workers in Tehran, Iran.
   Methods: A quasi-experimental study was conducted among workers on a
   penicillin production line in a pharmaceutical company (n = 60) and
   workers in a food producing company (n = 60). Data were collected via
   survey, air sampling, and throat swab.
   Results: The mean overall concentrations of penicillin dust and
   penicillin active material were 6.6 and 4.3 mg/m(3), respectively, in
   the pharmaceutical industry. Streptococcus pneumoniae (S. pneumoniae)
   was detected in 45\% (27) individuals in the exposed group, 92.6\% of
   which showed penicillin resistance. Resistance was significantly higher
   among workers in penicillin production line (p = 0.014).
   Conclusions: High level of AMR among workers in penicillin production
   line is a health risk for the workers as well as society as a whole
   through the spread of drug resistant micro-organisms.}},
Publisher = {{TAYLOR \& FRANCIS LTD}},
Address = {{2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Farshad, AA (Reprint Author), Iran Univ Med Sci, OHRC, Tehran, Iran.
   Farshad, Ali Asghar; Enferadi, Mojtaba; Bakand, Shahnaz; Orak, Rouhangiz Jamshidi, Iran Univ Med Sci, OHRC, Tehran, Iran.
   Mirkazemi, Roksana, Hooman Res Collaborators Inst, Tehran, Iran.}},
DOI = {{10.1080/10773525.2016.1201238}},
ISSN = {{1077-3525}},
EISSN = {{2049-3967}},
Keywords = {{Penicillin dust; Antimicrobial resistance; Pharmaceutical industry; Iran}},
Keywords-Plus = {{OCCUPATIONAL-EXPOSURE; FACTORY-WORKERS; ALLERGY}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{fdgir@yahoo.com}},
ORCID-Numbers = {{Mirkazemi, Roksana/0000-0001-7749-1096}},
Cited-References = {{Angulo S. Diaz, 2011, J ALLERGY, V2011, P1.
   Binks SP, 2003, OCCUP MED-OXFORD, V53, P363, DOI 10.1093/occmed/kqg1.
   BOISON JO, 1992, J CHROMATOGR, V624, P171, DOI 10.1016/0021-9673(92)85678-M.
   Cardoso MRA, 2008, ARCH DIS CHILD, V93, P221, DOI 10.1136/adc.2006.111625.
   Cockerill FR, 2012, PERFORMANCE STANDARD, V32.
   Corey S V, 1992, Clin Podiatr Med Surg, V9, P385.
   de Sande-Bruinsma NV, 2008, EMERG INFECT DIS, V14, P1722, DOI 10.3201/eid1411.070467.
   Eller P. M., 1994, NIOSH MANUAL ANAL ME, P1.
   Food and Drug Administration, 2001, GUID IND Q7A GOOD MA.
   Haddadin RN, 2013, INT J OCCUP ENV HEAL, V19, P207, DOI 10.1179/2049396713Y.0000000035.
   Hanke W, 1983, 801691300 GHE US NAT.
   Kirk R. E., 1985, KIRK OTHMER CONCISE.
   Kumari N, 2008, J NEPAL MED ASSOC, V47, P53.
   MOLLER NE, 1990, CONTACT DERMATITIS, V22, P106, DOI 10.1111/j.1600-0536.1990.tb01528.x.
   MOLLER NE, 1992, CONTACT DERMATITIS, V26, P351, DOI 10.1111/j.1600-0536.1992.tb00134.x.
   Moore GA, 2004, PENICILLINS.
   Rembadel P, 1990, Pol Tyg Lek, V45, P82.
   RUDZKI E, 1965, ACTA ALLERGOL, V20, P206, DOI 10.1111/j.1398-9995.1965.tb03371.x.
   RUDZKI E, 1986, Medycyna Pracy, V37, P383.
   Sarker MMR, 2014, J OCCUP HEALTH, V56, P260, DOI 10.1539/joh.14-0012-OA.
   SHMUNES E, 1976, ANN ALLERGY, V36, P313.
   STEJSKAL VDM, 1987, INT ARCH ALLER A IMM, V82, P461, DOI 10.1159/000234254.
   Tiwari Hare Krishna, 2008, Infect Drug Resist, V1, P57.
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{Int. J. Occup. Environ. Health}},
Doc-Delivery-Number = {{EB0TW}},
Unique-ID = {{ISI:000387059800006}},
OA = {{green\_published}},
DA = {{2018-08-13}},
}

@article{ ISI:000386390000006,
Author = {Brauner, Paul and Klug, Kerstin and Jaeckel, Udo},
Title = {{Eggshells as a source for occupational exposure to airborne bacteria in
   hatcheries}},
Journal = {{JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE}},
Year = {{2016}},
Volume = {{13}},
Number = {{12}},
Pages = {{950-959}},
Abstract = {{Occupational exposure to high concentrations of airborne bacteria in
   poultry production is related to an increased risk of respiratory
   disorders. However, potential sources and formation of hatchery
   bioaerosols are rarely characterized. In this study, bacterial
   multiplication on fresh shell fragments from turkey hatching eggs under
   conditions present in a hatcher incubator was investigated. A 10(5)-fold
   amplification was observed both by colony count and total cell count
   gaining 4x10(7) cfu/cells per gram eggshell within 30 hr of incubation.
   Furthermore, the bacterial community present on eggshells was analyzed
   by generation of 16S rRNA gene clone libraries and identification of
   eight isolates. RFLP analysis revealed no shift in community composition
   during incubation and Enterococcus faecalis and Enterococcus gallinarum
   were found as the predominant species on turkey eggshells, both have
   been classified as risk group 2 microorganisms (German TRBA 466). Since
   Enterococcus spp. were found as predominant species on turkey eggshells,
   contribution of this genus to bioaerosol formation was demonstrated.
   During different work activities with poult and eggshell handling
   concentrations of airborne enterococci up to 1.3x10(4) cfu m(-3) were
   detected. In contrast, no enterococci were identified at a day without
   poult or eggshell processing. In conclusion, turkey hatching eggs carry
   a viable specific microflora from breeder flocks to hatcheries. After
   hatching of turkey poults, hatcher incubators and eggshell fragments
   provide appropriate conditions for excessive bacterial growth. Thus,
   high bacterial loads on eggshell fragments are a source of potential
   harmful bioaersols caused by air flows, poult activity, and handling of
   equipment.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Brauner, P (Reprint Author), Fed Inst Occupat Safety \& Hlth, Noldnerstr 40-42, D-10317 Berlin, Germany.
   Brauner, Paul; Klug, Kerstin; Jaeckel, Udo, Fed Inst Occupat Safety \& Hlth, Noldnerstr 40-42, D-10317 Berlin, Germany.}},
DOI = {{10.1080/15459624.2016.1200192}},
ISSN = {{1545-9624}},
EISSN = {{1545-9632}},
Keywords = {{16S rRNA; bacteria; bioaerosols; clone library; eggshell; hatchery;
   occupational health; respiratory disorder; RFLP; turkey}},
Keywords-Plus = {{SPACE-CHARGE SYSTEM; ENTEROCOCCUS-GALLINARUM; ANTIBIOTIC-RESISTANCE;
   ANTIMICROBIAL RESISTANCE; HATCHING CABINETS; BROILER-CHICKENS; HENS
   EGGS; SP NOV.; POULTRY; DUST}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{brauner.paul@baua.bund.de}},
Cited-References = {{Aarestrup FM, 2000, DIAGN MICR INFEC DIS, V37, P127, DOI 10.1016/S0732-8893(00)00130-9.
   Anderson JF, 2008, APPL ENVIRON MICROB, V74, P1726, DOI 10.1128/AEM.02164-07.
   BAILEY J S, 1992, Poultry Science, V71, P6.
   Bailey JS, 1996, POULTRY SCI, V75, P191, DOI 10.3382/ps.0750191.
   Berrang ME, 2000, J APPL POULTRY RES, V9, P279, DOI 10.1093/japr/9.2.279.
   Berrang ME, 1999, J APPL POULTRY RES, V8, P499, DOI 10.1093/japr/8.4.499.
   Bjerrum L, 2006, POULTRY SCI, V85, P1151, DOI 10.1093/ps/85.7.1151.
   Board R. G., 1995, EGG SCI TECHNOLOGY, P81104.
   BRAY JR, 1957, ECOL MONOGR, V27, P326.
   Bruce J., 1994, P63.
   CASON JA, 1994, AVIAN DIS, V38, P583, DOI 10.2307/1592082.
   Chmielowiec-Korzeniowska A, 2007, ANN AGR ENV MED, V14, P141.
   Choi J., 2014, POULTRY SCI.
   Choi SH, 2004, CLIN INFECT DIS, V38, P53, DOI 10.1086/380452.
   COLLINS MD, 1988, INT J SYST BACTERIOL, V38, P45, DOI 10.1099/00207713-38-1-45.
   Cox NA, 2007, J APPL POULTRY RES, V16, P623, DOI 10.3382/japr.2007-00039.
   Crecchio C, 2004, SOIL BIOL BIOCHEM, V36, P1595, DOI 10.1016/j.soilbio.2004.07.016.
   Dargere S, 2002, J CLIN MICROBIOL, V40, P2308, DOI 10.1128/JCM.40.6.2308-2310.2002.
   DEVRIESE LA, 1991, J APPL BACTERIOL, V71, P46.
   DEVRIESE LA, 1987, INT J SYST BACTERIOL, V37, P257, DOI 10.1099/00207713-37-3-257.
   Diarra MS, 2010, APPL ENVIRON MICROB, V76, P8033, DOI 10.1128/AEM.01545-10.
   Donham KJ, 2000, J OCCUP ENVIRON MED, V42, P260, DOI 10.1097/00043764-200003000-00006.
   Dosman JA, 2000, CHEST, V118, P852, DOI 10.1378/chest.118.3.852.
   Elliott L., 1957, J FOOD SCI, V22, P241.
   Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0.
   Fracalanzza Suely Aparecida Pimenta, 2007, Mem Inst Oswaldo Cruz, V102, P853, DOI 10.1590/S0074-02762007005000120.
   Gambarotto K, 2001, J CLIN MICROBIOL, V39, P2354, DOI 10.1128/JCM.39.6.2354-2355.2001.
   Garibaldi J., 1958, J FOOD SCI, V23, P283.
   GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344.
   HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716.
   HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145.
   Kemp PF, 2004, FEMS MICROBIOL ECOL, V47, P161, DOI 10.1016/S0168-6496(03)00257-5.
   Krakat N, 2010, APPL ENVIRON MICROB, V76, P1842, DOI 10.1128/AEM.02397-09.
   LACEY J, 1994, J AEROSOL SCI, V25, P1371, DOI 10.1016/0021-8502(94)90215-1.
   Lee SA, 2005, J OCCUP ENVIRON HYG, V2, P577, DOI 10.1080/15459620500330583.
   Lemcke R, 2000, INT J FOOD MICROBIOL, V60, P185, DOI 10.1016/S0168-1605(00)00310-X.
   LENHART SW, 1984, AM J IND MED, V6, P89, DOI 10.1002/ajim.4700060203.
   LEYER I., 2007, MULTIVARIATE STAT OK.
   LIFSHITZ A, 1965, J FOOD SCI, V30, P516, DOI 10.1111/j.1365-2621.1965.tb01795.x.
   Liu WY, 2011, INT J SYST EVOL MICR, V61, P1720, DOI 10.1099/ijs.0.022251-0.
   LOCK JL, 1992, FEMS MICROBIOL LETT, V100, P71, DOI 10.1016/0378-1097(92)90190-Y.
   Lu JR, 2008, J MICROBIOL, V46, P469, DOI 10.1007/s12275-008-0117-z.
   Martin E, 2013, ENVIRON SCI-PROC IMP, V15, P478, DOI 10.1039/c2em30758h.
   Martin E, 2011, J ENVIRON MONITOR, V13, P464, DOI 10.1039/c0em00272k.
   Martin E, 2010, ANN OCCUP HYG, V54, P217, DOI 10.1093/annhyg/mep088.
   Mitchell BW, 2002, POULTRY SCI, V81, P49, DOI 10.1093/ps/81.1.49.
   Mitchell BW, 2003, AVIAN DIS, V47, P247, DOI 10.1637/0005-2086(2003)047{[}0247:RAPADI]2.0.CO;2.
   Nuutinen J., 1986, EUR J RESP DIS S, V152, P212.
   Onishi JC, 2012, VET MICROBIOL, V158, P329, DOI 10.1016/j.vetmic.2012.02.024.
   Oravecz O, 2004, FOLIA MICROBIOL, V49, P83, DOI 10.1007/BF02931652.
   Palmberg L, 2004, AM J IND MED, V46, P363, DOI 10.1002/ajim.20079.
   Papadopoulou C, 1997, COMP IMMUNOL MICROB, V20, P35, DOI 10.1016/S0147-9571(96)00024-0.
   PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943.
   Radon K, 2001, EUR RESPIR J, V17, P747, DOI 10.1183/09031936.01.17407470.
   Reid KC, 2001, CLIN INFECT DIS, V32, P1540, DOI 10.1086/320542.
   Rosch C, 2005, APPL ENVIRON MICROB, V71, P2026, DOI 10.1128/AEM.71.4.2026-2035.2005.
   Rylander R, 2006, INT ARCH OCC ENV HEA, V79, P487, DOI 10.1007/s00420-005-0072-5.
   SANDER JE, 1995, AVIAN DIS, V39, P420, DOI 10.2307/1591888.
   Senthilselvan A, 1997, AM J RESP CRIT CARE, V156, P410, DOI 10.1164/ajrccm.156.2.9612069.
   Seputiene V, 2012, POL J VET SCI, V15, P431, DOI 10.2478/v10181-012-0067-6.
   Simberloff D.S., 1978, BIOL DATA WATER POLL, V652, P150.
   Skorska C, 2007, ANN AGR ENV MED, V14, P341.
   SLOVAK AJM, 1985, AM IND HYG ASSOC J, V46, P411, DOI 10.1202/0002-8894(1985)046<0411:EOTHRI>2.3.CO;2.
   SPARKS NHC, 1985, AUST VET J, V62, P169, DOI 10.1111/j.1751-0813.1985.tb07281.x.
   Stokes J., 1956, J FOOD SCI, V21, P264.
   Stucky Brian J, 2012, J Biomol Tech, V23, P90, DOI 10.7171/jbt.12-2303-004.
   Taivainen AI, 1998, SCAND J WORK ENV HEA, V24, P503, DOI 10.5271/sjweh.375.
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092.
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121.
   Tremblay CL, 2011, J FOOD PROTECT, V74, P1639, DOI 10.4315/0362-028X.JFP-10-451.
   Tvrzova L, 2005, INT J SYST EVOL MICR, V55, P139, DOI 10.1099/ijs.0.63304-0.
   Tymczyna L, 2007, POULTRY SCI, V86, P2095, DOI 10.1093/ps/86.10.2095.
   Wauters G, 2003, INT J SYST EVOL MICR, V53, P1321, DOI 10.1099/ijs.0.02513-0.
   Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822.
   WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/jb.173.2.697-703.1991.
   Willinghan EM, 1996, AVIAN DIS, V40, P510, DOI 10.2307/1592258.}},
Number-of-Cited-References = {{76}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{8}},
Journal-ISO = {{J. Occup. Environ. Hyg.}},
Doc-Delivery-Number = {{EA1ZE}},
Unique-ID = {{ISI:000386390000006}},
DA = {{2018-08-13}},
}

@article{ ISI:000385513900006,
Author = {Kuehn, Anna and Kletting, Stephanie and Carvalho-Wodarz, Cristiane de
   Souza and Repnik, Urska and Griffiths, Gareth and Fischer, Ulrike and
   Meese, Eckart and Huwer, Hanno and Wirth, Dagmar and May, Tobias and
   Schneider-Daum, Nicole and Lehr, Claus-Michael},
Title = {{Human Alveolar Epithelial Cells Expressing Tight Junctions to Model the
   Air-Blood Barrier}},
Journal = {{ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION}},
Year = {{2016}},
Volume = {{33}},
Number = {{3}},
Pages = {{251-260}},
Abstract = {{This paper describes a new human alveolar epithelial cell line (hAELVi -
   human Alveolar Epithelial Lentivirus immortalized) with type I-like
   characteristics and functional tight junctions, suitable to model the
   air-blood barrier of the peripheral lung. Primary human alveolar
   epithelial cells were immortalized by a novel regimen, grown as
   monolayers on permeable filter supports and characterized
   morphologically, biochemically and biophysically. hAELVi cells maintain
   the capacity to form tight intercellular junctions, with high
   trans-epithelial electrical resistance (> 1000 Omega(star)cm(2)). The
   cells could be kept in culture over several days, up to passage 75,
   under liquid-liquid as well as air-liquid conditions. Ultrastructural
   analysis and real-time PCR revealed type I-like cell properties, such as
   the presence of caveolae, expression of caveolin-1, and absence of
   surfactant protein C. Accounting for the barrier properties,
   inter-digitations sealed with tight junctions and desmosomes were also
   observed. Low permeability of the hydrophilic marker sodium fluorescein
   confirmed the suitability of hAELVi cells for in vitro transport studies
   across the alveolar epithelium. These results suggest that hAELVi cells
   reflect the essential features of the air-blood barrier, as needed for
   an alternative to animal testing to study absorption and toxicity of
   inhaled drugs, chemicals and nanomaterials.}},
Publisher = {{SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH}},
Address = {{TIERGARTENSTRASSE 17, HEILDEBERG, 69121, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Schneider-Daum, N (Reprint Author), Helmholtz Inst Pharmaceut Res Saarland, Dept Drug Delivery, Univ Campus,Bldg E8-1, D-66123 Saarbrucken, Germany.
   Kuehn, Anna; Kletting, Stephanie; Carvalho-Wodarz, Cristiane de Souza; Schneider-Daum, Nicole; Lehr, Claus-Michael, Helmholtz Inst Pharmaceut Res Saarland HIPS, Drug Delivery DDEL, Saarbrucken, Germany.
   Lehr, Claus-Michael, Univ Saarland, Dept Pharm, Saarbrucken, Germany.
   Repnik, Urska; Griffiths, Gareth, Univ Oslo, Dept Biosci, Oslo, Norway.
   Fischer, Ulrike; Meese, Eckart, Univ Saarland, Univ Hosp, Inst Human Genet, Homburg, Germany.
   Huwer, Hanno, Volklingen Heart Ctr, Dept Cardiothorac Surg, SHG Clin, Volklingen, Germany.
   Wirth, Dagmar, Helmholtz Ctr Infect Res HZI, Model Syst Infect \& Immun, Braunschweig, Germany.
   May, Tobias, InSCREENeX GmbH, Braunschweig, Germany.
   Wirth, Dagmar, Hannover Med Sch, Expt Hematol, Hannover, Germany.}},
DOI = {{10.14573/altex.1511131}},
ISSN = {{1868-596X}},
EISSN = {{1868-8551}},
Keywords = {{lentivirus immortalization; ATI cells; pulmonary drug delivery;
   inhalation toxicology}},
Keywords-Plus = {{IN-VITRO; MULTIDRUG-RESISTANCE; PRIMARY CULTURE; P-GLYCOPROTEIN;
   HUMAN-LUNG; TRANSPORT; LINE; CAVEOLIN-1; COCULTURE; PROTEINS}},
Research-Areas = {{Research \& Experimental Medicine}},
Web-of-Science-Categories  = {{Medicine, Research \& Experimental}},
Author-Email = {{Nicole.Daum@helmholtz-hzi.de}},
Funding-Acknowledgement = {{Innovative Medicines Initiative Joint Undertaking {[}115363]; European
   Union's Seventh Framework Program (FP7)}},
Funding-Text = {{The authors thank Marijas Jurisic for the histological data. SK has
   received support from the Innovative Medicines Initiative Joint
   Undertaking under grant agreement No 115363, resources which are
   composed of financial contribution from the European Union's Seventh
   Framework Program (FP7/2007-2013) and EFPIA companies' in kind
   contribution. We also thank the EM laboratory at the Department of
   Biosciences, University of Oslo, for access to the instruments.}},
Cited-References = {{Blank F, 2011, IMMUNOBIOLOGY, V216, P86, DOI 10.1016/j.imbio.2010.02.006.
   Bur M, 2006, EUR J PHARM SCI, V28, P196, DOI 10.1016/j.ejps.2006.02.002.
   Camerlingo R, 2011, LUNG CANCER, V72, P23, DOI 10.1016/j.lungcan.2010.07.009.
   Campbell L, 1999, BIOCHEM BIOPH RES CO, V262, P744, DOI 10.1006/bbrc.1999.1280.
   Carvalho CD, 2011, CELL MICROBIOL, V13, P1234, DOI 10.1111/j.1462-5822.2011.01615.x.
   Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135.
   CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900.
   Crandall ED, 2001, AM J RESP CRIT CARE, V163, P1021, DOI 10.1164/ajrccm.163.4.2006116.
   CRAPO JD, 1982, AM REV RESPIR DIS, V126, P332.
   Daum N, 2012, METHODS MOL BIOL, V806, P31, DOI 10.1007/978-1-61779-367-7\_3.
   Daum Nicole, 2009, V480, P151, DOI 10.1007/978-1-59745-429-2\_11.
   Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0.
   Ehrhardt C, 2003, PHARMACEUT RES, V20, P545, DOI 10.1023/A:1023230328687.
   Ejendal KFK, 2002, CURR PROTEIN PEPT SC, V3, P503, DOI 10.2174/1389203023380521.
   Elbert KJ, 1999, PHARMACEUT RES, V16, P601, DOI 10.1023/A:1018887501927.
   Endter S, 2009, J PHARM PHARMACOL, V61, P583, DOI 10.1211/jpp/61.05.0006.
   Forbes B, 2003, INT J PHARM, V257, P161, DOI 10.1016/S0378-5173(03)00129-7.
   Forbes B, 2005, EUR J PHARM BIOPHARM, V60, P193, DOI 10.1016/j.ejpb.2005.02.010.
   Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172.
   Fuchs S, 2003, CELL TISSUE RES, V311, P31, DOI 10.1007/s00441-002-0653-5.
   Godfrey RWA, 1997, MICROSC RES TECHNIQ, V38, P488, DOI 10.1002/(SICI)1097-0029(19970901)38:5<488::AID-JEMT5>3.0.CO;2-E.
   Grainger CI, 2006, PHARM RES, V23, P1482, DOI 10.1007/s11095-006-0255-0.
   Groneberg DA, 2001, AM J PATHOL, V158, P707, DOI 10.1016/S0002-9440(10)64013-8.
   Gumbleton M, 2001, ADV DRUG DELIVER REV, V49, P281, DOI 10.1016/S0169-409X(01)00142-9.
   Hein S, 2011, EUR J PHARM BIOPHARM, V77, P132, DOI 10.1016/j.ejpb.2010.10.003.
   Hermanns MI, 2009, CELL TISSUE RES, V336, P91, DOI 10.1007/s00441-008-0750-1.
   Hermanns MI, 2004, LAB INVEST, V84, P736, DOI 10.1038/labinvest.3700081.
   Horalkova L, 2009, EUR J PHARM SCI, V36, P444, DOI 10.1016/j.ejps.2008.11.010.
   King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155.
   Lehmann AD, 2011, EUR J PHARM BIOPHARM, V77, P398, DOI 10.1016/j.ejpb.2010.10.014.
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262.
   McElroy MC, 2004, EUR RESPIR J, V24, P664, DOI 10.1183/09031936.04.00096003.
   Mennecier G, 2014, MOL CARCINOGEN, V53, P392, DOI 10.1002/mc.21987.
   Newman GR, 1999, CELL TISSUE RES, V295, P111, DOI 10.1007/s004410051217.
   Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549, DOI 10.1152/ajpcell.1997.273.5.C1549.
   PHELPS DS, 1991, EXP LUNG RES, V17, P985, DOI 10.3109/01902149109064330.
   Roggen EL, 2006, TOXICOL IN VITRO, V20, P1249, DOI 10.1016/j.tiv.2006.03.009.
   Rosenberger CM, 2014, J GEN VIROL, V95, P350, DOI 10.1099/vir.0.058438-0.
   Salomon JJ, 2012, THER DELIV, V3, P735, DOI 10.4155/TDE.12.51.
   SHAPIRO DL, 1978, BIOCHIM BIOPHYS ACTA, V530, P197, DOI 10.1016/0005-2760(78)90005-X.
   Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025.
   Susewind J, 2016, NANOTOXICOLOGY, V10, P53, DOI 10.3109/17435390.2015.1008065.
   van den Bogaard EHJ, 2009, PHARM RES-DORD, V26, P1172, DOI 10.1007/s11095-009-9838-x.
   Vermeer PD, 2009, AM J PHYSIOL-LUNG C, V296, pL751, DOI 10.1152/ajplung.90578.2008.
   Wang ZY, 2004, INT J PHARM, V269, P451, DOI 10.1016/j.ijpharm.2003.09.033.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{12}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{ALTEX-Altern. Anim. Exp.}},
Doc-Delivery-Number = {{DZ0FW}},
Unique-ID = {{ISI:000385513900006}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000379022900009,
Author = {Ugur, Sule and Sariisik, Merih and Turkoglu, Gizem and Erkan, Gokhan and
   Erden, Emre},
Title = {{Layer by layer assembly of antibacterial inclusion complexes}},
Journal = {{INTERNATIONAL JOURNAL OF CLOTHING SCIENCE AND TECHNOLOGY}},
Year = {{2016}},
Volume = {{28}},
Number = {{3}},
Pages = {{368-377}},
Abstract = {{Purpose - The purpose of this paper is to create a textile material
   which shows antibacterial activity with resistance to environmental
   conditions by using volatile active agent inclusion complex and
   self-assembly method.
   Design/methodology/approach - An inclusion complex of carvacrol and
   beta-CD is generated by kneading method and deposited on the cotton
   fabrics by using a nanofabrication method named as layer-by-layer (LbL)
   deposition method. Three different concentration of CD and CD: Car
   aqueous solutions were deposited on cotton fabrics. Attenuated total
   reflectance Fourier transform infrared spectroscopy (FTIR-ATR), scanning
   electron microscopy (SEM), antimicrobial efficacy test of fabrics
   against washing and some physical tests (water vapor permeability, air
   permeability) were performed on the fabrics before and after the
   treatment with CD to evaluate the effect of the LbL process on cotton
   fabric properties.
   Findings - The results showed that the coated fabrics with CD/CD: Car
   multilayer films enhanced the antimicrobial efficacy of cotton fabrics
   against to Klebsiella pneumonia and Staphylococus aureus bacteria. Air
   and water vapor permeability properties of the cotton fabric effected
   after the LbL deposition process sure enough. With SEM and FTIR-ATR
   analysis the CD: Car complex presence were verified. The durability of
   antibacterial properties were analyzed after one and ten washing (40
   degrees C and 30 min) cycles.
   Originality/value - This work provides a novel and simple method for CD
   and inclusion complex of carvacrol film deposition by self-assembly
   method on cotton fabrics and their application onto cotton fabrics to
   gain antibacterial property.}},
Publisher = {{EMERALD GROUP PUBLISHING LTD}},
Address = {{HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ugur, S (Reprint Author), Suleyman Demirel Univ, Dept Text Engn, Isparta, Turkey.
   Ugur, Sule, Suleyman Demirel Univ, Dept Text Engn, Isparta, Turkey.
   Sariisik, Merih; Turkoglu, Gizem; Erkan, Gokhan, Dokuz Eylul Univ, Dept Text Engn, Izmir, Turkey.
   Erden, Emre, Ege Univ, Dept Biochem, Izmir, Turkmenistan.}},
DOI = {{10.1108/IJCST-03-2016-0032}},
ISSN = {{0955-6222}},
EISSN = {{1758-5953}},
Keywords = {{Antimicrobial textiles; Carvacrol; Inclusion complex; Layer-by-layer
   deposition; beta-cyclodextrin}},
Keywords-Plus = {{DEPOSITION METHOD; MULTILAYER FILMS; NANOPARTICLES; CYCLODEXTRIN; FIBERS}},
Research-Areas = {{Materials Science}},
Web-of-Science-Categories  = {{Materials Science, Textiles}},
Author-Email = {{suleugur@sdu.edu.tr}},
Cited-References = {{{[}Anonymous], 1998, 100 AATCC, P142.
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7.
   Cao HN, 2009, APPL SURF SCI, V255, P7974, DOI 10.1016/j.apsusc.2009.04.199.
   Crespo-Biel O, 2005, J AM CHEM SOC, V127, P7594, DOI 10.1021/ja051093t.
   Dastjerdi R, 2010, COLLOID SURFACE B, V79, P5, DOI 10.1016/j.colsurfb.2010.03.029.
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232.
   Dodziuk H., 2006, CYCLODEXTRINS THEIR.
   Dubas ST, 2006, COLLOID SURFACE A, V289, P105, DOI 10.1016/j.colsurfa.2006.04.012.
   Dubas ST, 2006, J APPL POLYM SCI, V101, P3286, DOI 10.1002/app.23826.
   Keawchaoon L, 2011, COLLOID SURFACE B, V84, P163, DOI 10.1016/j.colsurfb.2010.12.031.
   Lvov Y, 2002, COLLOID SURFACE A, V198, P375, DOI 10.1016/S0927-7757(01)00970-0.
   Lvov Y, 1997, LANGMUIR, V13, P6195, DOI 10.1021/la970517x.
   Rubilar JF, 2013, J FOOD ENG, V115, P466, DOI 10.1016/j.jfoodeng.2012.07.009.
   Sato K, 2003, LANGMUIR, V19, P7406, DOI 10.1021/la030163b.
   Smith RC, 2009, CHEM MATER, V21, P1108, DOI 10.1021/cm802972d.
   Szejtli J., 1988, TOPICS INCLUSION SCI, P186.
   Turkoglu G.C., 2013, ICPC INT CLEAN PERS, P92.
   Ugur SS, 2011, MATER RES BULL, V46, P1202, DOI 10.1016/j.materresbull.2011.04.005.
   Ugur SS, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/32/325603.
   Ugur SS, 2010, NANOSCALE RES LETT, V5, P1204, DOI 10.1007/s11671-010-9627-9.}},
Number-of-Cited-References = {{20}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{22}},
Journal-ISO = {{Int. J. Cloth. Sci. Technol.}},
Doc-Delivery-Number = {{DQ2HH}},
Unique-ID = {{ISI:000379022900009}},
DA = {{2018-08-13}},
}

@article{ ISI:000378414700021,
Author = {Zetola, N. M. and Modongo, C. and Moonan, P. K. and Click, E. and
   Oeltmann, J. E. and Shepherd, J. and Finlay, A.},
Title = {{Protocol for a population-based molecular epidemiology study of
   tuberculosis transmission in a high HIV-burden setting: the Botswana
   Kopanyo study}},
Journal = {{BMJ OPEN}},
Year = {{2016}},
Volume = {{6}},
Number = {{5}},
Abstract = {{IntroductionMycobacterium tuberculosis (Mtb) is transmitted from person
   to person via airborne droplet nuclei. At the community level, Mtb
   transmission depends on the exposure venue, infectiousness of the
   tuberculosis (TB) index case and the susceptibility of the index case's
   social network. People living with HIV infection are at high risk of TB,
   yet the factors associated with TB transmission within communities with
   high rates of TB and HIV are largely undocumented. The primary aim of
   the Kopanyo study is to better understand the demographic, clinical,
   social and geospatial factors associated with TB and multidrug-resistant
   TB transmission in 2 communities in Botswana, a country where 60\% of
   all patients with TB are also infected with HIV. This manuscript
   describes the methods used in the Kopanyo study.
   Methods and analysis The study will be conducted in greater Gaborone,
   which has high rates of HIV and a mobile population; and in Ghanzi, a
   rural community with lower prevalence of HIV infection and home to the
   native San population. Kopanyo aims to enrol all persons diagnosed with
   TB during a 4-year study period. From each participant, sputum will be
   cultured, and for all Mtb isolates, molecular genotyping (24-locus
   mycobacterial interspersed repetitive units-variable number of tandem
   repeats) will be performed. Patients with matching genotype results will
   be considered members of a genotype cluster, a proxy for recent
   transmission. Demographic, behavioural, clinical and social information
   will be collected by interview. Participant residence, work place,
   healthcare facilities visited and social gathering venues will be
   geocoded. We will assess relationships between these factors and cluster
   involvement to better plan interventions for reducing TB transmission.
   Ethics Ethical approval from the Independent Review Boards at the
   University of Pennsylvania, US Centers for Disease Control and
   Prevention, Botswana Ministry of Health and University of Botswana has
   been obtained.}},
Publisher = {{BMJ PUBLISHING GROUP}},
Address = {{BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Zetola, NM (Reprint Author), Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA.
   Zetola, N. M., Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA.
   Modongo, C., Univ Penn, Dept Med, Philadelphia, PA 19104 USA.
   Modongo, C., Univ Pennsylvania Gaborone, Dept Med, Botswana UPenn Partnership, Gaborone, Botswana.
   Moonan, P. K.; Click, E.; Oeltmann, J. E.; Finlay, A., Ctr Dis Control \& Prevent, Div TB Eliminat, Atlanta, GA USA.
   Shepherd, J., Yale Univ, Div Infect Dis, Dept Med, New Heaven, CT USA.}},
DOI = {{10.1136/bmjopen-2015-010046}},
Article-Number = {{e010046}},
ISSN = {{2044-6055}},
Keywords = {{Transmission; Molecular Epidemiology; Multi-Drug Resistant Tuberculosis}},
Keywords-Plus = {{INTERSPERSED REPETITIVE UNITS; MYCOBACTERIUM-TUBERCULOSIS; INFECTION;
   DIAGNOSIS; RESISTANT; RISK; BIAS; TB}},
Research-Areas = {{General \& Internal Medicine}},
Web-of-Science-Categories  = {{Medicine, General \& Internal}},
Author-Email = {{nzetola@gmail.com}},
Funding-Acknowledgement = {{US National Institute of Health {[}R01AI097045]}},
Funding-Text = {{This work was supported by the US National Institute of Health grant
   number R01AI097045.}},
Cited-References = {{Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964.
   Bock NN, 2007, J INFECT DIS, V196, pS108, DOI 10.1086/518661.
   Borgdorff MW, 2011, AM J EPIDEMIOL, V174, P243, DOI 10.1093/aje/kwr061.
   Botswana Tuberculosis National Programme, 2009, BOTSW TUB NAT PROGR.
   Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105.
   Field N, 2014, LANCET INFECT DIS, V14, P341, DOI 10.1016/S1473-3099(13)70324-4.
   Gomes MGM, 2004, J THEOR BIOL, V228, P539, DOI 10.1016/j.jtbi.2004.02.015.
   Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166.
   Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907.
   Ma NN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-352.
   Mears J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005636.
   Middelkoop K, 2009, J INFECT DIS, V200, P1207, DOI 10.1086/605930.
   Moonan PK, 2013, LANCET INFECT DIS, V13, P777, DOI 10.1016/S1473-3099(13)70128-2.
   Moonan PK, 2012, EMERG INFECT DIS, V18, P458, DOI 10.3201/eid1803.111107.
   Moonan PK, 2004, INT J HEALTH GEOGR, V3, P23, DOI DOI 10.1186/1476-072X-3-23.
   Murray M, 2002, EMERG INFECT DIS, V8, P363, DOI 10.3201/eid0804.000444.
   Plazzotta G, 2015, J THEOR BIOL, V368, P67, DOI 10.1016/j.jtbi.2014.12.009.
   Roeger LIW, 2009, MATH BIOSCI ENG, V6, P815, DOI 10.3934/mbe.2009.6.815.
   Sharomi O, 2008, MATH BIOSCI ENG, V5, P145.
   Sloot R, 2014, AM J RESP CRIT CARE, V190, P1044, DOI 10.1164/rccm.201406-1159OC.
   Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001.
   Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06.
   The National AIDS Coordinating Agency (NACA), 2014, BOTSW AIDS IMP SURV, VIV.
   Touray K, 2010, TROP MED INT HEALTH, V15, P664, DOI 10.1111/j.1365-3156.2010.02533.x.
   Varma-Basil M, 2011, MEM I OSWALDO CRUZ, V106, P524, DOI 10.1590/S0074-02762011000500002.
   WHO, 2008, GLOB TUB CONTR SURV.
   WHO, 2014, GLOB TUB CONTR SURV.
   World Health Organization Stop TB Partnership, 2004, WHOHTMTB2004330.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{BMJ Open}},
Doc-Delivery-Number = {{DP3SF}},
Unique-ID = {{ISI:000378414700021}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000378679300001,
Author = {Callaghan, C. W.},
Title = {{A new paradigm of knowledge management: Crowdsourcing as emergent
   research and development}},
Journal = {{SOUTHERN AFRICAN BUSINESS REVIEW}},
Year = {{2016}},
Volume = {{20}},
Pages = {{1-28}},
Abstract = {{Drawing from knowledge management theory, this paper argues that the
   knowledge aggregation problem poses a fundamental constraint to
   knowledge creation and innovation, and offers a potential solution to
   this problem. Specific consequences of innovation failure include the
   failure of research and development to deliver new medicines to address
   threats such as widespread and increasing antibiotic resistance, the
   rise of airborne multidrug-resistant or totally drug-resistant
   tuberculosis, as well as a lack of new drugs to deal with emerging
   threats such as Ebola. Persistent constraints to knowledge creation
   exist in the form of market failure, or the failure of profit-seeking
   models of innovation to internalise the positive externalities
   associated with innovations, as well as academic failure, or the failure
   of academic research to provide much-needed innovations to address
   societal problems. However, a lack of theory exists as to how to
   transcend these constraints to knowledge aggregation. This paper
   presents a probabilistic theoretical framework of innovation, suggesting
   that the `wisdom of the crowd', or emergent properties of
   problem-solving, may emerge as a function of scale when crowdsourcing
   principles are applied to research and development. It is argued in this
   paper that the consequences of a lack of knowledge of innovation failure
   are already upon us, and that a radical new approach to knowledge
   management and innovation is needed.}},
Publisher = {{UNISA PRESS}},
Address = {{PO BOX 392, PRETORIA, 0003, SOUTH AFRICA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Callaghan, CW (Reprint Author), Univ Witwatersrand, Sch Econ \& Business Sci, ZA-2050 Johannesburg, South Africa.
   Callaghan, C. W., Univ Witwatersrand, Sch Econ \& Business Sci, ZA-2050 Johannesburg, South Africa.}},
ISSN = {{1998-8125}},
Keywords = {{probabilistic innovation; knowledge management; innovation;
   crowdsourcing; crowdsourced R\&D}},
Keywords-Plus = {{INNOVATION; INFORMATION; STATE}},
Research-Areas = {{Government \& Law}},
Web-of-Science-Categories  = {{Law}},
Author-Email = {{chris.callaghan@wits.ac.za}},
Cited-References = {{Adair JG, 2003, AM PSYCHOL, V58, P15, DOI 10.1037/0003-066X.58.1.15.
   Ajumobi K., 2014, WAR POLIO NIGERIA RE.
   Bornmann L, 2011, ANNU REV INFORM SCI, V45, P199, DOI 10.1002/aris.2011.1440450112.
   Bornmann L, 2010, IETE TECH REV, V27, P93, DOI 10.4103/0256-4602.60162.
   Callaghan C. W., 2014, AM J HLTH SCI, V5, P165.
   Callaghan C. W., 2013, THESIS.
   CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016.
   DELONG JB, 1992, J POLIT ECON, V100, P1257, DOI 10.1086/261860.
   DEWALD WG, 1986, AM ECON REV, V76, P587.
   Epstein J. M., 1999, Complexity, V4, P41, DOI 10.1002/(SICI)1099-0526(199905/06)4:5<41::AID-CPLX9>3.0.CO;2-F.
   FORREST S, 1990, PHYSICA D, V42, P1, DOI 10.1016/0167-2789(90)90063-U.
   Halifax J., 2013, SUPERBUGS IMMUNE ANT.
   Hanson R, 2003, INFORM SYST FRONT, V5, P107, DOI 10.1023/A:1022058209073.
   Hanson R., 1990, COULD GAMBLING SAVE.
   Hanson R., 2000, SHALL WE VOTE VALUES.
   Hayek FA, 1945, AM ECON REV, V35, P519.
   Hayek F. A., 1973, LAW LEGISLATION LIBE.
   HENRION M, 1986, AM J PHYS, V54, P791, DOI 10.1119/1.14447.
   Horrobin DF, 2000, J ROY SOC MED, V93, P341, DOI 10.1177/014107680009300702.
   HOWE J, 2006, WIRED MAG, V14, P14.
   Jay J, 2013, ACAD MANAGE J, V56, P137, DOI 10.5465/amj.2010.0772.
   Johnson N. L., 1998, LAUR982227 LOS AL NA.
   Kochugovindan S., 1998, INDEP REV, V3, P53.
   Krishnan J., 2014, PANIC DEADLY EBOLA V.
   Lakhani K. R., 2007, INNOVATIONS TECHNOLO, V2, P97, DOI DOI 10.1162/ITGG.2007.2.3.97.
   Le Bon G, 1896, CROWD STUDY POPULAR.
   Maher K., 2013, TIME MAGAZINE.
   Mahoney M.J., 1977, COGNITIVE THERAPY RE, V1, P161, DOI {[}10.1007/BF01173636, DOI 10.1007/BF01173636].
   McKenna M., 2014, SNEAK PEEK WHAT WHIT.
   Campanario JM, 2009, SCIENTOMETRICS, V81, P549, DOI 10.1007/s11192-008-2141-5.
   Mitchell M., 1996, INTRO GENETIC ALGORI.
   Mitchell Melanie, 1994, Artificial Life, V1, P267, DOI 10.1162/artl.1994.1.3.267.
   Murray F, 2010, AM J SOCIOL, V116, P341, DOI 10.1086/653599.
   NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14.
   PETERS DP, 1982, BEHAV BRAIN SCI, V5, P187, DOI 10.1017/S0140525X00011183.
   PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565.
   Polanyi M., 1973, PERSONAL KNOWLEDGE P.
   SIMON HA, 1971, AM PSYCHOL, V26, P145, DOI 10.1037/h0030806.
   SMITH A., 2003, WEALTH NATIONS.
   Surowiecki J., 2004, WISDOM CROWDS.
   VONHIPPEL E, 1994, MANAGE SCI, V40, P429, DOI 10.1287/mnsc.40.4.429.
   Zia A., 2014, NEWLY DIAGNOSED CHIL.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{24}},
Journal-ISO = {{South. Afr. Bus. Rev.}},
Doc-Delivery-Number = {{DP7KY}},
Unique-ID = {{ISI:000378679300001}},
DA = {{2018-08-13}},
}

@article{ ISI:000372691600006,
Author = {Gaertner, A. and Gessner, A. and Gromoeller, S. and Klug, K. and Knust,
   S. and Jaeckel, U.},
Title = {{Emissions from pig barns - Investigation on the composition of bacterial
   community and antibiotic resistance}},
Journal = {{GEFAHRSTOFFE REINHALTUNG DER LUFT}},
Year = {{2016}},
Volume = {{76}},
Number = {{1-2}},
Pages = {{31-38}},
Month = {{JAN-FEB}},
Abstract = {{The goal of the joint project of the North Rhine-Westphalian State
   Agency for Nature, Environment and Consumer Protection (LANUV NRW) and
   the Federal Institute for Occupational Safety and Health (BAuA) was the
   determination of antibiotic resistant bacteria in the exhaust air of pig
   barns. Methicillin-resistant Staphylococcus aureus strains were detected
   in five of the ten investigated stables. Trimethoprim/Sulfamethoxazole
   resistant Enterococcus faecalis could be found in two samples in
   concentrations below the determination limit, whereas
   Trimethoprim/Sulfamethoxazole resistant E. faecium, Erythromycine
   resistant Streptococcus spp. und ESBL forming species of the family
   Enterobacteriaceae (e.g. Escherichia coli) were not present on the basis
   of cultivation. Based on molecular biological analyses the composition
   of bacterial communities has been detected in more detail. It seems that
   bacterial species of the genera Clostridium and Lactobacillus dominate
   the bacterial composition in pig barns' emissions. Furthermore, the
   suitability of commercially available selective nutrition media was
   tested for the qualification and quantification of bacterial species and
   genera and cultivation independent analyses regarding the airborne
   bacteria were made.}},
Publisher = {{SPRINGER-V D I VERLAG GMBH \& CO KG}},
Address = {{VDI-PLATZ 1, D-40468 DUSSELDORF, GERMANY}},
Type = {{Article}},
Language = {{German}},
Affiliation = {{Gartner, A (Reprint Author), Landesamt Natur Umwelt \& Verbraucherschutz Nordrh, Dienstort Essen, Germany.
   Gaertner, A.; Gessner, A.; Knust, S., Landesamt Natur Umwelt \& Verbraucherschutz Nordrh, Dienstort Essen, Germany.
   Gromoeller, S.; Klug, K.; Jaeckel, U., Bundesanstalt Arbeitsschutz \& Arbeitsmed, Berlin, Germany.}},
ISSN = {{0949-8036}},
EISSN = {{1436-4891}},
Keywords-Plus = {{SWINE CONFINEMENT BUILDINGS; STAPHYLOCOCCUS-AUREUS MRSA;
   ESCHERICHIA-COLI; MOLECULAR CHARACTERISTICS; MICROORGANISM EMISSIONS;
   SURROUNDING AREAS; POULTRY HOUSES; FARMS; PREVALENCE; BIOAEROSOLS}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Engineering, Civil; Environmental Sciences}},
ResearcherID-Numbers = {{Amoako, Daniel Gyamfi/I-4223-2018}},
Cited-References = {{Alt K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-69.
   {[}Anonymous], 2013, 4253 VDI.
   {[}Anonymous], 2010, TECHNISCHE REGELN BI, P380.
   {[}Anonymous], 2011, 4257 VDI.
   Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866.
   Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI 10.1093/nar/gks1195.
   Bisdorff B, 2012, EPIDEMIOL INFECT, V140, P1800, DOI 10.1017/S0950268811002378.
   Bonifait L, 2014, APPL ENVIRON MICROB, V80, P3296, DOI {[}10.1128/AEM.04167, 10.1128/AEM.04167-13].
   Broens EM, 2011, PREV VET MED, V102, P41, DOI 10.1016/j.prevetmed.2011.06.005.
   Chapin A, 2005, ENVIRON HEALTH PERSP, V113, P137, DOI 10.1289/ehp.7473.
   Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244.
   de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027.
   Denis O, 2009, EMERG INFECT DIS, V15, P1098, DOI 10.3201/eid1507.080652.
   Friese A, 2012, VET MICROBIOL, V158, P129, DOI 10.1016/j.vetmic.2012.01.019.
   Gartner A, 2014, GEFAHRST REINHALT L, V74, P505.
   Gartner A, 2014, GEFAHRST REINHALT L, V74, P377.
   Gartner A, 2011, GEFAHRST REINHALT L, V71, P362.
   Gao LL, 2015, INT J ENV RES PUB HE, V12, P4203, DOI 10.3390/ijerph120404203.
   Kim HB, 2015, VET MICROBIOL, V177, P242, DOI 10.1016/j.vetmic.2015.03.014.
   Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4.
   Kumari P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112897.
   Laube H, 2014, VET MICROBIOL, V172, P519, DOI 10.1016/j.vetmic.2014.06.008.
   Letourneau V, 2010, J OCCUP ENVIRON HYG, V7, P94, DOI 10.1080/15459620903425642.
   Li S, 2013, AEROBIOLOGIA, V29, P315, DOI 10.1007/s10453-012-9273-z.
   Marti R, 2009, APPL ENVIRON MICROB, V75, P4967, DOI 10.1128/AEM.02791-08.
   Martin E, 2012, GEFAHRST REINHALT L, V72, P99.
   Martin E, 2009, GEFAHRST REINHALT L, V69, P97.
   Masclaux FG, 2013, ANN OCCUP HYG, V57, P550, DOI 10.1093/annhyg/mes098.
   Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x.
   Nehme B, 2009, APPL ENVIRON MICROB, V75, P5445, DOI 10.1128/AEM.00726-09.
   Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12.
   van de Vijver LPL, 2014, ZOONOSES PUBLIC HLTH, V61, P338, DOI 10.1111/zph.12076.
   Verreault D., 2010, VET MICROBIOL, V14, P224.
   von Salviati C, 2015, VET MICROBIOL, V175, P77, DOI 10.1016/j.vetmic.2014.10.010.
   WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/jb.173.2.697-703.1991.}},
Number-of-Cited-References = {{35}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{8}},
Journal-ISO = {{Gefahrst. Reinhalt. Luft}},
Doc-Delivery-Number = {{DH3MR}},
Unique-ID = {{ISI:000372691600006}},
DA = {{2018-08-13}},
}

@article{ ISI:000370101700008,
Author = {Beehan, David P. and Paccamonti, Dale and Lyle, Sarah K.},
Title = {{Equine endometritis and biofilm forming Escherichia coli}},
Journal = {{PFERDEHEILKUNDE}},
Year = {{2016}},
Volume = {{32}},
Number = {{1}},
Pages = {{46-48}},
Month = {{JAN-FEB}},
Abstract = {{A common cause of chronic equine endometritis is Escherichia coli (E.
   coli), and its ability to form a biofilm within the uterus is a
   potential cause of persistent endometrial infections. Bacterial biofilm
   is defined as a community of microorganisms irreversibly attached to a
   surface, producing extracellular polymeric substance (EPS), exhibiting
   an altered phenotype and having increased resistance to innate immune
   responses and antibiotics. Our study objectives were to screen uterine
   E. coli for their biofilm forming potential (BFP) and to investigate
   antibiotic resistance of any identified BFP-E.coli isolates against
   commonly used equine intra-uterine antibiotics. The BFP of uterine E.
   coli isolates (n = 52) was evaluated using the Crystal Violet (CV)
   assay. E. coli were grown in Luria enrichment broth (LB) for 24 h at 37
   degrees C, bacterial suspensions were diluted 1:100 with fresh LB, and
   100- L aliquots were incubated in 96-well plates for 24 h. Plates were
   washed to remove free bacteria, air dried, 125 mu L 0.5\% CV stain was
   added to each well for 10 min, followed by washing to remove excess
   stain. Acetic acid (30\%) was used to solubilize any remaining stain and
   the optical density OD570 of each well was measured. Based on the OD
   value, isolates are categorized as strong (OD > 0.4) moderate (0.4 >= OD
   >= 0.2) or weak (OD < 0.2) BFP isolates. The minimum inhibitory
   concentrations of strong BFP isolates (n = 9) for timentin, ceftiofur,
   gentamicin and amikacin (0.25, 0.5, 1, 2, 4, 8, 16, 32, 64, 128, 256,
   and 5121,tg/mL) in their planktonic state (PlankMIC) and in their
   biofilm state (BioMIC) was measured using the resazurin assay. Resazurin
   is a blue reagent that fluoresces red when reduced by metabolically
   active viable cells. The PlankMIC was measured by adding antibiotics and
   diluted bacterial suspensions to 96-well plates, incubating for 24 h at
   37 degrees C, followed by the addition of 10 mu l of resazurin,
   incubation at 37 degrees C for an additional 90 min, and the absorbance
   of each well was read at 590 nm. The BioMIC was determined by first
   allowing biofilm formation within wells for 24 h, followed by washing to
   remove free bacteria. Antibiotics and fresh LB was added to the
   biofilm-coated wells and the BioMIC evaluated as described for PlankMIC
   using the resazurin assay. Evaluated E. coli were classified as having
   strong (31\%; 16/52), moderate (8\%; 4/52), or weak (61.5\%; 32/52) BFP.
   The combined median fold increase of BioMIC over PlankMIC for timentin,
   ceftiofur, gentamicin and amikacin was 8, 10, 8 and 7 respectively.
   These results show that 31\% of uterine E. coli isolates demonstrate
   strong BFP in vitro and that strong biofilm-forming isolates in a
   biofilm state exhibit a large increase in antibiotic resistance in
   comparison to the isolate's planktonic state. In conclusion, by
   combining clinical history and evaluating E. coli BFP, we believe
   treatment strategies can be better optimized for mares with chronic
   endometritis.}},
Publisher = {{HIPPIATRIKA VERLAG MBH}},
Address = {{POSTFACH 102251, 70018 STUTTGART, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Beehan, DP (Reprint Author), Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA.
   Beehan, David P.; Paccamonti, Dale; Lyle, Sarah K., Louisiana State Univ, Dept Vet Clin Sci, Baton Rouge, LA 70803 USA.}},
DOI = {{10.21836/PEM20160108}},
ISSN = {{0177-7726}},
Keywords = {{mare; reproduction; uterus; biofilm; equine; endometritis; Escherichia
   coli}},
Keywords-Plus = {{RESISTANCE}},
Research-Areas = {{Veterinary Sciences}},
Web-of-Science-Categories  = {{Veterinary Sciences}},
Author-Email = {{dbeehan@lsu.edu}},
Funding-Acknowledgement = {{Equine Health Studies Program, School of Veterinary Medicine, Louisiana
   State University}},
Funding-Text = {{The authors would like to acknowledge Dr. William Doerrler for his
   advice and technical support. The authors would like to gratefully
   acknowledge the Equine Health Studies Program, School of Veterinary
   Medicine, Louisiana State University for project funding.}},
Cited-References = {{Ferris RA, 2014, J EQUINE VET SCI, V34, P121.
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010.
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2.
   Soto SM, 2007, J UROLOGY, V177, P365, DOI 10.1016/j.juro.2006.08.081.
   Soto SM, 2006, CLIN MICROBIOL INFEC, V12, P1034, DOI 10.1111/j.1469-0691.2006.01543.x.
   Westgate SJ, 2011, VET MICROBIOL, V150, P152, DOI 10.1016/j.vetmic.2011.01.003.}},
Number-of-Cited-References = {{6}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{17}},
Journal-ISO = {{Pferdeheilkunde}},
Doc-Delivery-Number = {{DD7JX}},
Unique-ID = {{ISI:000370101700008}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000368363300009,
Author = {Hussain, Afzal and Singh, Sandeep Kumar},
Title = {{Evidences for anti-mycobacterium activities of lipids and surfactants}},
Journal = {{WORLD JOURNAL OF MICROBIOLOGY \& BIOTECHNOLOGY}},
Year = {{2016}},
Volume = {{32}},
Number = {{1}},
Month = {{JAN}},
Abstract = {{Tuberculosis is the most widespread and deadly airborne disease caused
   by Mycobacterium tuberculosis. The two-pronged lethal effect on the
   bacteria using lipids/surfactants and anti-tubercular drugs may render
   the miniaturization of dose owing to synergistic and tandem effect of
   both. The current research has been focused on screening and evaluating
   various lipids/surfactants possessing inherent anti-mycobacterium
   activity that can ferry the anti-tubercular drugs. In vitro
   anti-mycobacterium activity was evaluated using agar well diffusion
   method. Furthermore, time-concentration dependent killing and DNA/RNA
   content release studies were performed to correlate the findings. The
   exact mechanism of bacterial killing was further elucidated by
   electron/atomic force microscopy studies. Finally, to negate any
   toxicity, in vitro hemolysis and toxicity studies were performed. The
   study revealed that capmul MCM C-8, labrasol and acconon C-80 possessed
   highest in vitro anti-mycobacterium activity. Electron/atomic force
   microscopy results confirmed in vitro studies and verified the killing
   of Mycobacterium owing to the release of cytoplasmic content after cell
   wall fragmentation and disruption. Moreover, the least hemolysis and
   hundred percent survivals rate of mice using the excipients demonstrated
   the safety aspects of explored excipients that can ferry the
   anti-tubercular drugs. The present study concluded the safe, efficient
   and synergistic activity of the explored excipients and anti-tubercular
   drugs in controlling the menace of tuberculosis.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Singh, SK (Reprint Author), Birla Inst Technol, Dept Pharmaceut Sci \& Technol, Ranchi 835215, Jharkhand, India.
   Hussain, Afzal; Singh, Sandeep Kumar, Birla Inst Technol, Dept Pharmaceut Sci \& Technol, Ranchi 835215, Jharkhand, India.}},
DOI = {{10.1007/s11274-015-1965-4}},
Article-Number = {{7}},
ISSN = {{0959-3993}},
EISSN = {{1573-0972}},
Keywords = {{Mycobacterium tuberculosis H-37 R-v; Mycobacterium smegmatis;
   Transmission electron microscopy; Atomic force microscopy;
   Histopathology}},
Keywords-Plus = {{P-GLYCOPROTEIN SUBSTRATE; DRUG-DELIVERY; MULTIDRUG-RESISTANCE;
   HEMOLYTIC-ACTIVITY; SMEGMATIS; EXCIPIENTS; ABSORPTION; MEMBRANE; RATS;
   REVERSAL}},
Research-Areas = {{Biotechnology \& Applied Microbiology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology}},
Author-Email = {{dr.sandeep\_pharmaceutics@yahoo.com}},
ResearcherID-Numbers = {{BIT MESRA, Pharmaceutical Scien/M-6865-2017
   }},
ORCID-Numbers = {{Singh, Sandeep Kumar/0000-0001-5702-4554}},
Funding-Acknowledgement = {{Department of Biotechnology (DBT), New Delhi under DBT Project
   {[}BT/PR5653/MED/29/561/2012]}},
Funding-Text = {{The authors thank the Birla Institute of Technology, Mesra, Ranchi and
   Government of Jharkhand, for providing the facilities and encouragement.
   We are also grateful to Mr. Babar Iqbal, formulation and development
   officer, Unicure India Pvt Ltd., New Delhi for providing drugs as gift
   samples. Authors are highly thankful to Department of Biotechnology
   (DBT), New Delhi to provide Senior Research Fellow under DBT Project No.
   BT/PR5653/MED/29/561/2012) for financial assistance for carrying out
   this work. The constructive comments and suggestion of anonymous
   reviewers is gratefully acknowledged.}},
Cited-References = {{Arnold YE, 2012, DRUG DEV IND PHARM, V38, P1262, DOI 10.3109/03639045.2011.645834.
   Barry III, 2001, TRENDS MICROBIOL, V9, P472.
   Beg S, 2013, COLLOID SURFACE B, V101, P414, DOI 10.1016/j.colsurfb.2012.06.031.
   Bleck CKE, 2010, J MICROSC-OXFORD, V237, P23, DOI 10.1111/j.1365-2818.2009.03299.x.
   Chang T, 1996, CLIN PHARMACOL THER, V59, P297, DOI 10.1016/S0009-9236(96)80007-5.
   Dahl JL, 2005, CAN J MICROBIOL, V51, P277, DOI 10.1139/W05-001.
   DUDEJA PK, 1995, ARCH BIOCHEM BIOPHYS, V319, P309, DOI 10.1006/abbi.1995.1298.
   Etienne G, 2005, MICROBIOL-SGM, V151, P2075, DOI 10.1099/mic.0.27869-0.
   Falamarzian A, 2010, MACROMOL BIOSCI, V10, P648, DOI 10.1002/mabi.200900387.
   Fujiwara N, 2012, TUBERCULOSIS, V92, P187, DOI 10.1016/j.tube.2011.10.001.
   Gopalaswamy R, 2008, FEMS MICROBIOL LETT, V278, P121, DOI 10.1111/j.1574-6968.2007.00989.x.
   Gupta R, 2010, INDIAN J MED RES, V131, P809.
   Hanh ND, 2015, DRUG DEV IND PHARM, V41, P207, DOI 10.3109/03639045.2013.858732.
   Hassan A, 2014, J APPL ENV MICROBIOL, V2, P65.
   Hussain A, 2013, DRUG DEV IND PHARM, V40, P527.
   Immanuel G, 2011, AQUACULT INT, V19, P91, DOI 10.1007/s10499-010-9343-6.
   Jain S, 2003, DRUG DEV IND PHARM, V29, P1013, DOI 10.1081/DDC-120025458.
   Jain S, 2010, EUR J MED CHEM, V45, P4997, DOI 10.1016/j.ejmech.2010.08.006.
   Jiang T, 2011, MICROB PATHOGENESIS, V51, P156, DOI 10.1016/j.micpath.2011.04.005.
   Kamdem SS, 2011, INT J FOOD MICROBIOL, V128, P122.
   Kang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061589.
   Lin YL, 2007, BIOL PHARM BULL, V30, P1301, DOI 10.1248/bpb.30.1301.
   Malik M, 2005, ANTIMICROB AGENTS CH, V49, P2008, DOI 10.1128/AAC.49.5.2008-2014.2005.
   Mukherjee K, 2013, FEMS MICROBIOL LETT, V338, P177, DOI 10.1111/1574-6968.12043.
   Nasr M, 2013, DRUG DELIV, V20, P311, DOI 10.3109/10717544.2013.835160.
   Pandey Rajesh, 2006, Indian Journal of Experimental Biology, V44, P459.
   Perkins WR, 1997, BBA-BIOMEMBRANES, V1327, P61, DOI 10.1016/S0005-2736(97)00043-6.
   Rahman MA, 2013, DRUG DEV IND PHARM, V39, P1, DOI 10.3109/03639045.2012.660949.
   Rege BD, 2002, EUR J PHARM SCI, V16, P237, DOI 10.1016/S0928-0987(02)00055-6.
   SCHNEIDER WC, 1957, METHOD ENZYMOL, V3, P680, DOI 10.1016/S0076-6879(57)03442-4.
   Shen Y, 2011, DRUG DEV IND PHARM, V37, P1415, DOI 10.3109/03639045.2011.582874.
   Singh N, 2013, J EXP NANOSCI, V10, P381.
   Singh N, 2013, J EXP NANOSCI, V10, P299.
   Singh N., 2014, MATER RES EXPRESS, V1, P1, DOI DOI 10.1088/2053-1591/1/2/025401.
   Singh N, 2015, ANTON LEEUW INT J G, V107, P1555, DOI 10.1007/s10482-015-0449-8.
   Su HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045818.
   Verma S, 2014, DRUG DEV IND PHARM, V40, P1.
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1.
   WOODCOCK DM, 1992, BRIT J CANCER, V66, P62, DOI 10.1038/bjc.1992.217.
   World Health Organization, 2013, GLOB TUB REP.
   World Health Organization, 2014, GLOB TUB REP.
   Yang SF, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-174.
   Zhang HJ, 2003, ARCH PHARM RES, V26, P768, DOI 10.1007/BF02976689.
   Zhang H, 2010, INT J PHARMACEUT, V395, P154, DOI 10.1016/j.ijpharm.2010.05.022.
   Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{World J. Microbiol. Biotechnol.}},
Doc-Delivery-Number = {{DB2TT}},
Unique-ID = {{ISI:000368363300009}},
DA = {{2018-08-13}},
}

@article{ ISI:000367860100028,
Author = {Li, Jing and Zhou, Liantong and Zhang, Xiangyu and Xu, Caijia and Dong,
   Liming and Yao, Maosheng},
Title = {{Bioaerosol emissions and detection of airborne antibiotic resistance
   genes from a wastewater treatment plant}},
Journal = {{ATMOSPHERIC ENVIRONMENT}},
Year = {{2016}},
Volume = {{124}},
Number = {{B}},
Pages = {{404-412}},
Month = {{JAN}},
Abstract = {{Air samples from twelve sampling sites (including seven intra-plant
   sites, one upwind site and four downwind sites) from a wastewater
   treatment plant (WWTP) in Beijing were collected using a Reuter
   Centrifugal Sampler High Flow (RCS); and their microbial fractions were
   studied using culturing and high throughput gene sequence. In addition,
   the viable (fluorescent) bioaerosol concentrations for 7 intra-plant
   sites were also monitored for 30 min each using an ultraviolet
   aerodynamic particle sizer (UV-APS). Both air and water samples
   collected from the plant were investigated for possible bacterial
   antibiotic resistance genes and integrons using polymerase chain
   reaction (PCR) coupled with gel electrophoresis.
   The results showed that the air near sludge thickening basin was
   detected to have the highest level of culturable bacterial aerosols (up
   to 1697 CFU/m(3)) and fungal aerosols (up to 930 CFU/m(3)). For most
   sampling sites, fluorescent peaks were observed at around 3-4 mu m,
   except the office building with a peak at 1.5 mu m, with a number
   concentration level up to 1233-6533 Particles/m(3). About 300 unique
   bacterial species, including human opportunistic pathogens, such as
   Comamonas Testosteroni and Moraxella Osloensis, were detected from the
   air samples collected over the biological reaction basin. In addition,
   we have detected the sul2 gene resistant to cotrimoxazole (also known as
   septra, bactrim and TMP-SMX) and class 1 integrase gene from the air
   samples collected from the screen room and the biological reaction
   basin. Overall, the screen room, sludge thickening basin and biological
   reaction basin imposed significant microbial exposure risks, including
   those from airborne antibiotic resistance genes. (C) 2015 Elsevier Ltd.
   All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Yao, MS (Reprint Author), Peking Univ, State Key Joint Lab Environm Simulat \& Pollut Con, Coll Environm Sci \& Engn, Beijing 100871, Peoples R China.
   Li, Jing; Zhang, Xiangyu; Xu, Caijia; Yao, Maosheng, Peking Univ, State Key Joint Lab Environm Simulat \& Pollut Con, Coll Environm Sci \& Engn, Beijing 100871, Peoples R China.
   Zhou, Liantong; Dong, Liming, Beijing Technol \& Business Univ, Dept Environm Sci \& Engn, Beijing 100048, Peoples R China.}},
DOI = {{10.1016/j.atmosenv.2015.06.030}},
ISSN = {{1352-2310}},
EISSN = {{1873-2844}},
Keywords = {{Wastewater treatment plant; Bioaerosols; Airborne antibiotic resistance
   genes; Bacterial aerosols; Fungal aerosols; Bacterial pathogens}},
Keywords-Plus = {{WORK-RELATED SYMPTOMS; SULFONAMIDE RESISTANCE; TREATMENT SYSTEMS;
   ESCHERICHIA-COLI; ACTIVATED-SLUDGE; SEWAGE; TETRACYCLINE; ENVIRONMENT;
   BACTERIA; CHINA}},
Research-Areas = {{Environmental Sciences \& Ecology; Meteorology \& Atmospheric Sciences}},
Web-of-Science-Categories  = {{Environmental Sciences; Meteorology \& Atmospheric Sciences}},
Author-Email = {{donglm@btbu.edu.cn
   yao@pku.edu.cn}},
ResearcherID-Numbers = {{DONG, LIMING/J-3434-2016}},
ORCID-Numbers = {{DONG, LIMING/0000-0003-2922-1045}},
Funding-Acknowledgement = {{NSF of China {[}21277007, 21477003, 41121004]; MOST {[}2015CB553401];
   International Science \& Technology Cooperation Program of China
   {[}2015DFG92040]; State Key Joint Laboratory of Environment Simulation
   and Pollution Control {[}14K02ESPCP]}},
Funding-Text = {{This study was supported by the NSF of China grants (21277007, 21477003
   and 41121004), MOST grant (2015CB553401), International Science \&
   Technology Cooperation Program of China (2015DFG92040), and Special fund
   of State Key Joint Laboratory of Environment Simulation and Pollution
   Control (14K02ESPCP). The results only represent the authors' opinions
   for academic communication only.}},
Cited-References = {{Agranovski V, 2005, J AEROSOL SCI, V36, P665, DOI 10.1016/j.jaerosci.2004.12.005.
   Aminov RI, 2001, APPL ENVIRON MICROB, V67, P22, DOI 10.1128/AEM.67.1.22-32.2001.
   Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319.
   Boerjesson S., 2010, J WATER HEALTH, V8, P247.
   Boxall ABA, 2003, TOXICOL LETT, V142, P207, DOI 10.1016/S0378-4274(03)00067-5.
   Brooks JP, 2007, CAN J MICROBIOL, V53, P616, DOI 10.1139/W07-021.
   Byrne-Bailey KG, 2009, ANTIMICROB AGENTS CH, V53, P696, DOI 10.1128/AAC.00652-07.
   Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x.
   Chan PL, 2009, J ENVIRON SCI-CHINA, V21, P1148, DOI 10.1016/S1001-0742(08)62395-5.
   Chen H, 2010, ENVIRON POLLUT, V158, P2459, DOI 10.1016/j.envpol.2010.03.023.
   Chen H, 2013, ENVIRON SCI TECHNOL, V47, P8157, DOI 10.1021/es401091y.
   Chen H, 2013, ENVIRON INT, V55, P9, DOI 10.1016/j.envint.2013.01.019.
   Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001.
   Cox CS., 1995, BIOAEROSOLS HDB.
   Douwes J, 2001, ANN AGR ENV MED, V8, P39.
   ECCMID, 2011, SPOTL NDM 1 SUP HIGH.
   Enne VI, 2002, ANTIMICROB AGENTS CH, V46, P1934, DOI 10.1128/AAC.46.6.1934-1939.2002.
   Farshad S, 2012, J INFECT DEV COUNTR, V6, P521.
   Gao P, 2012, SCI TOTAL ENVIRON, V421, P173, DOI 10.1016/j.scitotenv.2012.01.061.
   Gotkowska-Plachta A, 2013, CLEAN-SOIL AIR WATER, V41, P429, DOI 10.1002/clen.201100466.
   Hadano Y, 2012, INT J GEN MED, V5, P875, DOI 10.2147/IJGM.S36919.
   Kerrn MB, 2002, J ANTIMICROB CHEMOTH, V50, P513, DOI 10.1093/jac/dkf164.
   {[}孔秀琴 KONG Xiuqin], 2007, {[}武汉理工大学学报, Journal of wuhan university of technology], V29, P47.
   Korean Ministry of Environment, 2004, AIR QUAL PUBL BUILD.
   Li L, 2013, ENVIRON MONIT ASSESS, V185, P603, DOI 10.1007/s10661-012-2578-0.
   Li L, 2011, PROCESS BIOCHEM, V46, P910, DOI 10.1016/j.procbio.2010.12.016.
   {[}刘建伟 Liu Jianwei], 2013, {[}环境污染与防治, Environmental Pollution \& Control], V35, P1.
   Luo Y, 2014, ENVIRON SCI TECH LET, V1, P26, DOI 10.1021/ez400152e.
   Malakootian M, 2013, DESALIN WATER TREAT, V51, P4478, DOI 10.1080/19443994.2013.769668.
   Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483.
   Mauldin P.D., 2010, ANTIMICROB AGENTS CH, V54, P109.
   Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462.
   Munir M, 2011, J ENVIRON QUAL, V40, P248, DOI 10.2134/jeq2010.0209.
   Ng LK, 2001, MOL CELL PROBE, V15, P209, DOI 10.1006/mcpr.2001.0363.
   Pastor-Navarro N, 2009, ANAL BIOANAL CHEM, V395, P907, DOI 10.1007/s00216-009-2901-y.
   Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017.
   Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es0604131.
   Reinthaler FF, 2003, WATER RES, V37, P1685, DOI 10.1016/S0043-1354(02)00569-9.
   Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032.
   Rylander R, 1999, OCCUP ENVIRON MED, V56, P354, DOI 10.1136/oem.56.5.354.
   Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026.
   Scheff P A, 2000, Appl Occup Environ Hyg, V15, P835.
   Shlaes DM, 2013, ANTIMICROB AGENTS CH, V57, P4605, DOI 10.1128/AAC.01277-13.
   Stalder T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00119.
   Su HC, 2014, ENVIRON SCI-PROC IMP, V16, P324, DOI 10.1039/c3em00555k.
   Szczepanowski R., 2009, MICROBIOLOGY, V155, P2306.
   Thorn J, 2004, INT J OCCUP ENV HEAL, V10, P84, DOI 10.1179/oeh.2004.10.1.84.
   Thorn J, 2002, OCCUP ENVIRON MED, V59, P562, DOI 10.1136/oem.59.8.562.
   Viegas C, 2014, J TOXICOL ENV HEAL A, V77, P90, DOI 10.1080/15287394.2014.866925.
   Viegas C, 2011, ITAL J OCCUP ENV HYG, V2, P15.
   Vitezova M., 2012, ACTA U AGR SILVIC ME, VLX, P233.
   Wang Z., 2013, PLOS ONE, V8.
   WHO, 1988, REG PUBL EUR SER, V31.
   WHO, 2014, ANT RES.
   WHO, 2013, MULT RES TUB MDR TB.
   Yang Y, 2013, ENVIRON SCI TECHNOL, V47, P10197, DOI 10.1021/es4017365.
   Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09.
   Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P397, DOI 10.1007/s00253-008-1829-z.
   Ziembinska A, 2009, J GEN APPL MICROBIOL, V55, P373, DOI 10.2323/jgam.55.373.}},
Number-of-Cited-References = {{59}},
Times-Cited = {{15}},
Usage-Count-Last-180-days = {{12}},
Usage-Count-Since-2013 = {{116}},
Journal-ISO = {{Atmos. Environ.}},
Doc-Delivery-Number = {{DA5RL}},
Unique-ID = {{ISI:000367860100028}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000367000600001,
Author = {Audrain, Bianca and Letoffe, Sylvie and Ghigo, Jean-Marc},
Title = {{Airborne Bacterial Interactions: Functions Out of Thin Air?}},
Journal = {{FRONTIERS IN MICROBIOLOGY}},
Year = {{2015}},
Volume = {{6}},
Month = {{DEC 22}},
Abstract = {{Bacteria produce and release a large diversity of small molecules
   including organic and inorganic volatile compounds, hereafter referred
   to as bacterial volatile compounds (BVCs). Whereas BVCs were often only
   considered as wasted metabolic by-product sometimes perceived by animal
   olfactory systems, it is increasingly clear that they can also mediate
   cross-kingdom interactions with fungi, plants and animals. Recently, in
   vitro studies also reported the impact of BVCs on bacterial biology
   through modulation of antibiotic resistance, biofilm formation and
   virulence. Here, we review BVCs influence on bacterial adaptation to
   their environment and discuss the biological relevance of recently
   reported inter- and intra-species bacterial interactions mediated by
   BVGs.}},
Publisher = {{FRONTIERS MEDIA SA}},
Address = {{AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ghigo, JM (Reprint Author), Inst Pasteur, Dept Microbiol, Genet Biofilms Lab, Paris, France.
   Audrain, Bianca; Letoffe, Sylvie; Ghigo, Jean-Marc, Inst Pasteur, Dept Microbiol, Genet Biofilms Lab, Paris, France.}},
DOI = {{10.3389/fmicb.2015.01476}},
Article-Number = {{1476}},
ISSN = {{1664-302X}},
Keywords = {{bacterial volatile compounds; metabolism; signaling; bacterial
   interactions; biofilm; antibiotic resistance}},
Keywords-Plus = {{METABOLIC BY-PRODUCTS; CHAIN FATTY-ACIDS; NITRIC-OXIDE;
   PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; INDOLE;
   GROWTH; VOLATILES; MICROORGANISMS}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{jmghigo@pasteur.fr}},
Funding-Acknowledgement = {{Institut Pasteur; French government's Investissement d'Avenir Program,
   Laboratoire d'Excellence ``Integrative Biology of Emerging Infectious
   Diseases{''} {[}ANR-10-LABX-62-IBEID]; Fondation pour la Recherche
   Medicale {[}Equipe FRM DEQ20140329508]}},
Funding-Text = {{BA, SL, and I-MG are supported by grants from Institut Pasteur, the
   French government's Investissement d'Avenir Program, Laboratoire
   d'Excellence ``Integrative Biology of Emerging Infectious Diseases{''}
   (grant No : ANR-10-LABX-62-IBEID) and by Fondation pour la Recherche
   Medicale (grant No : Equipe FRM DEQ20140329508).}},
Cited-References = {{Audrain B, 2015, FEMS MICROBIOL REV, V39, P222, DOI 10.1093/femsre/fuu013.
   Barraud N, 2015, CURR PHARM DESIGN, V21, P31, DOI 10.2174/1381612820666140905112822.
   Barraud N, 2009, J BACTERIOL, V191, P7333, DOI 10.1128/JB.00975-09.
   Barraud N, 2009, MICROB BIOTECHNOL, V2, P370, DOI 10.1111/j.1751-7915.2009.00098.x.
   BARRETT EL, 1985, ANNU REV MICROBIOL, V39, P131, DOI 10.1146/annurev.mi.39.100185.001023.
   Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7.
   Bernier SP, 2011, MOL MICROBIOL, V81, P705, DOI 10.1111/j.1365-2958.2011.07724.x.
   Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311.
   Cepl J, 2014, FEMS MICROBIOL LETT, V354, P126, DOI 10.1111/1574-6968.12442.
   Chen Y, 2015, MBIO, V6, DOI 10.1128/mBio.00392-15.
   Dandurishvili N, 2011, J APPL MICROBIOL, V110, P341, DOI 10.1111/j.1365-2672.2010.04891.x.
   Effmert U, 2012, J CHEM ECOL, V38, P665, DOI 10.1007/s10886-012-0135-5.
   Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001.
   Garbeva P, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00289.
   GURTLER H, 1994, J ANTIBIOT, V47, P434.
   Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439.
   Heal RD, 2002, J APPL MICROBIOL, V92, P1116, DOI 10.1046/j.1365-2672.2002.01647.x.
   Henares BM, 2013, INT J MOL SCI, V14, P16473, DOI 10.3390/ijms140816473.
   HINTON A, 1995, ANAEROBE, V1, P121, DOI 10.1006/anae.1995.1007.
   Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x.
   Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3.
   Kai M, 2008, PLANT SIGNAL BEHAV, V3, P482, DOI 10.1128/AEM.01078-07.
   Kim KS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2789.
   KURITAOCHIAI T, 1995, J DENT RES, V74, P1367, DOI 10.1177/00220345950740070801.
   Lee J, 2008, ISME J, V2, P1007, DOI 10.1038/ismej.2008.54.
   Lee J, 2009, MICROB BIOTECHNOL, V2, P75, DOI 10.1111/j.1751-7915.2008.00061.x.
   Letoffe S, 2014, MBIO, V5, DOI 10.1128/mBio.00944-13.
   Liu N, 2012, BIOCHEMISTRY-US, V51, P2087, DOI 10.1021/bi201753f.
   Marvasi M, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0042-y.
   Molina-Santiago C, 2014, ENVIRON MICROBIOL, V16, P1267, DOI 10.1111/1462-2920.12368.
   Nijland R, 2010, BIOTECHNOL J, V5, P974, DOI 10.1002/biot.201000174.
   Nikaido E, 2008, J BIOL CHEM, V283, P24245, DOI 10.1074/jbc.M804544200.
   Niu QH, 2010, P NATL ACAD SCI USA, V107, P16631, DOI 10.1073/pnas.1007276107.
   Pieterse CMJ, 2014, ANNU REV PHYTOPATHOL, V52, P347, DOI 10.1146/annurev-phyto-082712-102340.
   Potter AJ, 2009, J INFECT DIS, V199, P227, DOI 10.1086/595737.
   Probert CSJ, 2009, J GASTROINTEST LIVER, V18, P337.
   Que YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080140.
   Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100.
   Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h.
   Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165.
   Venkataraman A, 2014, ISME J, V8, P1210, DOI 10.1038/ismej.2013.232.
   Venkataraman A, 2011, ENERG ENVIRON SCI, V4, P4550, DOI 10.1039/c1ee01377g.
   Whiteson KL, 2014, ISME J, V8, P1247, DOI 10.1038/ismej.2013.229.
   Wrigley DM, 2004, ANAEROBE, V10, P295, DOI 10.1016/j.anaerobe.2004.05.006.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{17}},
Journal-ISO = {{Front. Microbiol.}},
Doc-Delivery-Number = {{CZ3JO}},
Unique-ID = {{ISI:000367000600001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000366640600012,
Author = {Nobre, Thatyane M. and Martynowycz, Michael W. and Andreev, Konstantin
   and Kuzmenko, Ivan and Nikaido, Hiroshi and Gidalevitz, David},
Title = {{Modification of Salmonella Lipopolysaccharides Prevents the Outer
   Membrane Penetration of Novobiocin}},
Journal = {{BIOPHYSICAL JOURNAL}},
Year = {{2015}},
Volume = {{109}},
Number = {{12}},
Pages = {{2537-2545}},
Month = {{DEC 15}},
Abstract = {{Small hydrophilic antibiotics traverse the outer membrane of
   Gram-negative bacteria through porin channels. Large lipophilic agents
   traverse the outer membrane through its bilayer, containing a majority
   of lipopolysaccharides in its outer leaflet. Genes controlled by the
   two-component regulatory system PhoPQ modify lipopolysaccharides. We
   isolate lipopolysaccharides from isogenic mutants of Salmonella sp., one
   lacking the modification, the other fully modified. These
   lipopolysaccharides were reconstituted asmonolayers at the air-water
   interface, and their properties, as well as their interaction with a
   large lipophilic drug, novobiocin, was studied. X-ray reflectivity
   showed that the drug penetrated the monolayer of the unmodified
   lipopolysaccharides reaching the hydrophobic region, but was prevented
   from this penetration into the modified lipopolysaccharides. Results
   correlate with behavior of bacterial cells, which become resistant to
   antibiotics after PhoPQ-regulated modifications. Grazing incidence x-ray
   diffraction showed that novobiocin produced a striking increase in
   crystalline coherence length, and the size of the near-crystalline
   domains.}},
Publisher = {{CELL PRESS}},
Address = {{600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Gidalevitz, D (Reprint Author), IIT, Ctr Mol Study Condensed Soft Matter, Chicago, IL 60616 USA.
   Nobre, Thatyane M.; Nikaido, Hiroshi, Univ Calif Berkeley, Dept Mol \& Cell Biol, Berkeley, CA 94720 USA.
   Nobre, Thatyane M., Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA.
   Martynowycz, Michael W.; Andreev, Konstantin; Gidalevitz, David, IIT, Ctr Mol Study Condensed Soft Matter, Chicago, IL 60616 USA.
   Martynowycz, Michael W.; Andreev, Konstantin; Gidalevitz, David, IIT, Dept Phys, Chicago, IL 60616 USA.
   Martynowycz, Michael W.; Kuzmenko, Ivan, Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Lemont, IL USA.}},
DOI = {{10.1016/j.bpj.2015.10.013}},
ISSN = {{0006-3495}},
EISSN = {{1542-0086}},
Keywords-Plus = {{GRAM-NEGATIVE BACTERIA; X-RAY; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI;
   LIPID MONOLAYERS; NEUTRON REFLECTIVITY; PORIN CHANNELS; PERMEABILITY;
   TYPHIMURIUM; RESISTANCE}},
Research-Areas = {{Biophysics}},
Web-of-Science-Categories  = {{Biophysics}},
Author-Email = {{thatty@ursa.ifsc.usp.br
   gidalevitz@iit.edu}},
ResearcherID-Numbers = {{Sao Carlos Institute of Physics, IFSC/USP/M-2664-2016
   }},
ORCID-Numbers = {{Andreev, Konstantin/0000-0002-1757-4532}},
Funding-Acknowledgement = {{National Institutes of Health (NIH) {[}AI009644, AI073892]; Defense
   Advanced Research Projects Agency (DARPA) {[}W911NF-09-1-378]; Brazilian
   funding agency Coordination for the Improvement of Higher Education
   Personnel (CAPES) {[}BEX 4058/11 -9]; U.S. Department of Energy (DOE)
   {[}W-31-109-Eng-38]; Illinois Institute of Technology Dean's fellowship;
   National Science Foundation (NSF) fellowship grant under the Adler
   Planetarium and Astronomy Museum; Argonne National Laboratory's X-ray
   science division (XSD), under the inelastic X-ray nuclear scattering
   group (IXN)}},
Funding-Text = {{This work was supported by funds from the National Institutes of Health
   (NIH) (AI009644 to H.N., AI073892 to D.G.), and Defense Advanced
   Research Projects Agency (DARPA) (W911NF-09-1-378, D.G.). T.M.N. was
   supported by a fellowship from the Brazilian funding agency Coordination
   for the Improvement of Higher Education Personnel (CAPES) (Proc \# BEX
   4058/11 -9). Use of the Advanced Photon Source (APS) was supported by
   the U.S. Department of Energy (DOE) under contract No. W-31-109-Eng-38.
   M.W.M. was supported in part by the Illinois Institute of Technology
   Dean's fellowship, the National Science Foundation (NSF) fellowship
   grant under the Adler Planetarium and Astronomy Museum, and Argonne
   National Laboratory's X-ray science division (XSD), under the inelastic
   X-ray nuclear scattering group (IXN).}},
Cited-References = {{Abuillan W, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012705.
   Andreev K, 2014, BBA-BIOMEMBRANES, V1838, P2492, DOI 10.1016/j.bbamem.2014.05.022.
   Bonomo RA, 2006, CLIN INFECT DIS, V43, pS49, DOI 10.1086/504477.
   BRANDENBURG K, 1988, EUR BIOPHYS J BIOPHY, V16, P83.
   Danauskas SM, 2008, J APPL CRYSTALLOGR, V41, P1187, DOI 10.1107/S0021889808032445.
   Davies JT, 1961, INTERFACIAL PHENOMEN.
   GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x.
   Gidalevitz D, 2003, P NATL ACAD SCI USA, V100, P6302, DOI 10.1073/pnas.0934731100.
   Groisman EA, 1997, J BACTERIOL, V179, P7040, DOI 10.1128/jb.179.22.7040-7045.1997.
   GRUNDY MJ, 1988, THIN SOLID FILMS, V159, P43, DOI 10.1016/0040-6090(88)90615-3.
   Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X.
   Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250.
   Ivankin A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.238103.
   Ivankin A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.108101.
   KJAER K, 1988, THIN SOLID FILMS, V159, P17, DOI 10.1016/0040-6090(88)90613-X.
   KJAER K, 1994, PHYSICA B, V198, P100, DOI 10.1016/0921-4526(94)90137-6.
   Konovalov OV, 1996, KRISTALLOGRAFIYA+, V41, P640.
   Le Brun AP, 2013, BIOMACROMOLECULES, V14, P2014, DOI 10.1021/bm400356m.
   Livermore DM, 2003, ANN MED, V35, P226, DOI 10.1080/07853890310001609.
   Martin-Orozco N, 2006, MOL BIOL CELL, V17, P498, DOI 10.1091/mbc.E04-12-1096.
   Murata T, 2007, J BACTERIOL, V189, P7213, DOI 10.1128/JB.00973-07.
   Neonakis IK, 2011, INT J ANTIMICROB AG, V37, P102, DOI 10.1016/j.ijantimicag.2010.10.014.
   Neville F, 2008, SOFT MATTER, V4, P1665, DOI 10.1039/b718295c.
   Neville F, 2010, BBA-BIOMEMBRANES, V1798, P851, DOI 10.1016/j.bbamem.2009.09.017.
   NIKAIDO H, 1983, J BACTERIOL, V153, P232.
   Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003.
   Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996.
   NUMMILA K, 1995, MOL MICROBIOL, V16, P271, DOI 10.1111/j.1365-2958.1995.tb02299.x.
   Plesiat P, 1997, J BACTERIOL, V179, P7004, DOI 10.1128/jb.179.22.7004-7010.1997.
   PLESIAT P, 1992, MOL MICROBIOL, V6, P1323, DOI 10.1111/j.1365-2958.1992.tb00853.x.
   Prost LR, 2008, CELL MICROBIOL, V10, P576, DOI 10.1111/j.1462-5822.2007.01111.x.
   QURESHI N, 1984, REV INFECT DIS, V6, P576.
   Snyder DS, 2000, BIOCHEMISTRY-US, V39, P11777, DOI 10.1021/bi000810n.
   Sugawara E, 2006, J BIOL CHEM, V281, P16220, DOI 10.1074/jbc.M600680200.
   Sugawara E, 2012, J BACTERIOL, V194, P4089, DOI 10.1128/JB.00435-12.
   TRIAS J, 1990, ANTIMICROB AGENTS CH, V34, P52, DOI 10.1128/AAC.34.1.52.
   VAARA M, 1992, MICROBIOL REV, V56, P395.
   VAARA M, 1993, ANTIMICROB AGENTS CH, V37, P2255, DOI 10.1128/AAC.37.11.2255.
   YOSHIMURA F, 1985, ANTIMICROB AGENTS CH, V27, P84, DOI 10.1128/AAC.27.1.84.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{18}},
Journal-ISO = {{Biophys. J.}},
Doc-Delivery-Number = {{CY8EC}},
Unique-ID = {{ISI:000366640600012}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000363348900090,
Author = {Suraju, Mohammed O. and Lalinde-Barnes, Sloan and Sanamvenkata,
   Sachindra and Esmaeili, Mahsa and Shishodia, Shishir and Rosenzweig,
   Jason A.},
Title = {{The effects of indoor and outdoor dust exposure on the growth,
   sensitivity to oxidative-stress, and biofilm production of three
   opportunistic bacterial pathogens}},
Journal = {{SCIENCE OF THE TOTAL ENVIRONMENT}},
Year = {{2015}},
Volume = {{538}},
Pages = {{949-958}},
Month = {{DEC 15}},
Abstract = {{Within the last decade, many studies have highlighted the radical
   changes in the components of indoor and outdoor dust. For example,
   agents like automobile emitted platinum group elements and different
   kinds of organic phthalates and esters have been reported to be
   accumulating in the biosphere. Humans consistently face dermal,
   respiratory, and dietary exposures to these particles while indoors and
   outdoors. In fact, dust particulate matter has been associated with
   close to 500,000 deaths per year in Europe and about 200,000 deaths per
   year in the United States. To date, there has been limited examination
   of the physiological impact of indoor and outdoor dust exposure on
   normal flora microbes. In this study, the effect of indoor- and
   outdoor-dust exposure on three opportunistic bacterial species
   (Escherichia coli, Enterococcus faecalis, and Pseudomonas aeruginosa)
   was assessed. Specifically, bacterial growth, oxidative stress
   resistance, and biofilm production were measured following indoor- and
   outdoor-dust exposures. Studies were conducted in nutritionally-rich and
   -poor environments typically encountered by bacteria. Surprisingly,
   indoor-dust (200 mu g/mL), enhanced the growth of all three bacterial
   species in nutrient-poor conditions, but slowed growth in nutrient-rich
   conditions. In nutrient-rich medium, 100 mu g/mL exposure of either
   indoor- or outdoor-dust resulted in significantly reduced oxidative
   stress resistance in E. coli. Most interestingly, dust (indoor and
   outdoor), either in nutrient-rich or -poor conditions, significantly
   increased biofilm production in all three bacterial species. These data
   suggest that indoor and outdoor dust, can modify opportunistic bacteria
   through altering growth, sensitivity to oxidative stress, and their
   virulence potential through enhanced biofilm formation. (C) 2015
   Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Rosenzweig, JA (Reprint Author), Texas So Univ, Dept Biol, 3100 Cleburne St, Houston, TX 77099 USA.
   Suraju, Mohammed O.; Shishodia, Shishir; Rosenzweig, Jason A., Texas So Univ, Dept Biol, Houston, TX 77099 USA.
   Esmaeili, Mahsa; Rosenzweig, Jason A., Texas So Univ, Dept Environm \& Interdisciplinaty Sci, Houston, TX 77099 USA.
   Lalinde-Barnes, Sloan; Sanamvenkata, Sachindra, DeBakey High Sch Hlth Profess, Houston, TX 77021 USA.}},
DOI = {{10.1016/j.scitotenv.2015.08.063}},
ISSN = {{0048-9697}},
EISSN = {{1879-1026}},
Keywords = {{Platinum group elements; House dust; Road dust; Bacterial pathogenesis}},
Keywords-Plus = {{VEHICLE EXHAUST CATALYSTS; PLATINUM-GROUP ELEMENTS; ROAD DUST; HUMAN
   HEALTH; ANTIBIOTIC-RESISTANCE; ENTEROCOCCUS-FAECALIS; PARTICULATE
   MATTER; AIRBORNE PLATINUM; PALLADIUM; RHODIUM}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{rosenzweigja@tsu.edu}},
Funding-Acknowledgement = {{National Science Foundation RISE {[}HRD-1345173]; National Aeronautic
   and Space Administration Cooperative Agreement {[}NNXO8B4A47A]}},
Funding-Text = {{We would like to acknowledge Daniel Vrinceanu, Hyun-Min-Hwang, Sandeel
   Ahmed, John Eunson, Kelvin Obimah, and Mariam Konate for their insight
   and valuable comments. This work was supported by the National Science
   Foundation RISE (HRD-1345173) JR, and National Aeronautic and Space
   Administration Cooperative Agreement (NNXO8B4A47A) JR.}},
Cited-References = {{Bjerg A, 2015, ALLERGY, V70, P604, DOI 10.1111/all.12584.
   Cao S, 2014, FEBS LETT.
   Colombo C, 2008, ECOTOX ENVIRON SAFE, V71, P722, DOI 10.1016/j.ecoenv.2007.11.011.
   Colombo C, 2008, SCI TOTAL ENVIRON, V389, P46, DOI 10.1016/j.scitotenv.2007.08.022.
   Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430.
   Djoric D, 2015, ANTIMICROB AGENTS CH, V59, P159, DOI 10.1128/AAC.03984-14.
   Fann N, 2012, RISK ANAL, V32, P81, DOI 10.1111/j.1539-6924.2011.01630.x.
   Farago ME, 1998, ANALYST, V123, P451, DOI 10.1039/a705920e.
   Ferreira CM, 2014, J IMMUNOL RES, V2014, DOI DOI 10.1155/2014/689492.
   Garrison VH, 2014, SCI TOTAL ENVIRON, V500, P383, DOI 10.1016/j.scitotenv.2014.08.106.
   Geuking Markus B, 2014, Gut Microbes, V5, P411, DOI 10.4161/gmic.29330.
   Green LK, 2014, J MICROBIOL, V52, P771, DOI 10.1007/s12275-014-4208-8.
   Happo MS, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0060-6.
   Happo MS, 2008, INHAL TOXICOL, V20, P1215, DOI {[}10.1080/08958370802147282, 10.1080/08958370802147282 ].
   Hogervorst J, 2007, ENVIRON RES, V103, P30, DOI 10.1016/j.envres.2006.05.009.
   Iavicoli I, 2004, OCCUP ENVIRON MED, V61, P636, DOI 10.1136/oem.2003.010744.
   Iavicoli I, 2007, INT ARCH OCC ENV HEA, V81, P109, DOI 10.1007/s00420-007-0195-y.
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527.
   Jalava PI, 2009, INHAL TOXICOL, V21, P994, DOI 10.1080/08958370802695710.
   Kamal A, 2015, ENVIRON SCI POLLUT R, V22, P12644, DOI 10.1007/s11356-015-4444-4.
   Karottki DG, 2014, ENVIRON INT, V73, P372, DOI 10.1016/j.envint.2014.08.019.
   Khan I, 2014, CNS NEUROL DISORD-DR, V13, P1325, DOI 10.2174/1871527313666141023153506.
   Kotzampassi Katerina, 2014, ISRN Obes, V2014, P651895, DOI 10.1155/2014/651895.
   Lee KN, 2014, WORLD J GASTROENTERO, V20, P8886, DOI 10.3748/wjg.v20.i27.8886.
   Lippmann Morton, 2013, Res Rep Health Eff Inst, P5.
   Marks A.R., 2012, ENV HLTH PERSPECT, V118, P1768.
   MOORE W, 1975, Environmental Health Perspectives, V10, P63, DOI 10.2307/3428410.
   Nygren O, 1997, INT ARCH OCC ENV HEA, V70, P209, DOI 10.1007/s004200050209.
   O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437.
   Palacios M, 2000, SCI TOTAL ENVIRON, V257, P1, DOI 10.1016/S0048-9697(00)00464-2.
   Petrucci F, 2005, OCCUP ENVIRON MED, V62, P27, DOI 10.1136/oem.2004.016022.
   Poster DL, 2007, ENVIRON SCI TECHNOL, V41, P2861, DOI 10.1021/es061966z.
   Ravindra K, 2004, SCI TOTAL ENVIRON, V318, P1, DOI 10.1016/S0048-9697(03)00372-3.
   Robles Alonso V., 2013, BR J NUTR S2, V109, pS21, DOI DOI 10.1017/S0007114512005235.
   Rossolini GM, 2014, CURR OPIN PHARMACOL, V18, P56, DOI 10.1016/j.coph.2014.09.006.
   Sahlstrom LMO, 2015, INT J HYG ENVIR HEAL, V218, P422, DOI 10.1016/j.ijheh.2015.03.011.
   Schierl R, 1998, OCCUP ENVIRON MED, V55, P138, DOI 10.1136/oem.55.2.138.
   Schramel P, 2000, J ENVIRON MONITOR, V2, P443, DOI 10.1039/b003668o.
   Sha J, 2013, MICROBIOL-SGM, V159, P1120, DOI 10.1099/mic.0.063495-0.
   Shiue I., 2014, ENV SCI POLLUT RES I.
   Soltani N, 2015, SCI TOTAL ENVIRON, V505, P712, DOI 10.1016/j.scitotenv.2014.09.097.
   Stapleton HM, 2006, ANAL BIOANAL CHEM, V384, P791, DOI 10.1007/s00216-005-0227-y.
   Subhani M, 2015, ECOTOX ENVIRON SAFE, V115, P187, DOI 10.1016/j.ecoenv.2015.02.019.
   Taylor PK, 2014, J BIOTECHNOL, V191, P121, DOI 10.1016/j.jbiotec.2014.09.003.
   Vesic D, 2013, J BACTERIOL, V195, P1815, DOI 10.1128/JB.02135-12.
   Viaud S, 2014, CANCER RES, V74, P4217, DOI 10.1158/0008-5472.CAN-14-0987.
   Viaud S, 2014, CELL DEATH DIFFER.
   Weyrich L.S., 2015, AUSTRALAS J DERMATOL.
   WOOLF AD, 1991, J TOXICOL-CLIN TOXIC, V29, P467, DOI 10.3109/15563659109025742.
   Zereini F, 2007, ENVIRON SCI TECHNOL, V41, P451, DOI 10.1021/es061453s.}},
Number-of-Cited-References = {{50}},
Times-Cited = {{7}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{48}},
Journal-ISO = {{Sci. Total Environ.}},
Doc-Delivery-Number = {{CU2JD}},
Unique-ID = {{ISI:000363348900090}},
DA = {{2018-08-13}},
}

@article{ ISI:000368132800023,
Author = {Park, Hyun-Jung and Chon, Jung-Whan and Lim, Jong-Soo and Seo, Kun-Ho
   and Kim, Young-Jo and Heo, Eun-Jeong and Wee, Sung-Hwan and Sung, Kidon
   and Moon, Jin-San},
Title = {{Prevalence Analysis and Molecular Characterization of Salmonella at
   Different Processing Steps in Broiler Slaughter Plants in South Korea}},
Journal = {{JOURNAL OF FOOD SCIENCE}},
Year = {{2015}},
Volume = {{80}},
Number = {{12}},
Pages = {{M2822-M2826}},
Month = {{DEC}},
Abstract = {{In this study, changes in the prevalence of Salmonella during the
   processing of broiler chicken carcasses were investigated. A total of
   1040 fecal swabs and chicken carcasses samples were collected from 2
   processing plants at the 4 stages of broiler processing, which included
   live birds in slaughter line, postevisceration/prewashing,
   postwashing/prechilling, and postchilling, respectively. The
   intraspecific biodiversity of the Salmonella isolates was determined
   using a DiversiLab automated repetitive sequence-based PCR (rep-PCR)
   system. In both plants, the prevalence of Salmonella increased
   considerably after evisceration (from 4.6\% to 30.8\%, P < 0.05) and
   decreased after washing (from 30.8\% to 25.4\%, P < 0.05). However, the
   chilling step had little effect on Salmonella prevalence (from 25.4\% to
   22.7\%, P > 0.05). The most frequent Salmonella serovar in plant A was
   Infantis (35.8\%), followed by Enteritidis (26.2\%) and Montevideo
   (15.0\%), while Montevideo (43.6\%) and Enteritidis (35.9\%) were most
   prevalent in plant B. A difference in the rep-PCR banding pattern was
   found to be related to the processing plant origin and serovar rather
   than sampling point or sampling day, although there were some
   exceptional strains.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Moon, JS (Reprint Author), Anim \& Plant Quarantine Agcy, Anyang, South Korea.
   Park, Hyun-Jung; Kim, Young-Jo; Heo, Eun-Jeong, Minist Food \& Drug Safety, Cheongju, South Korea.
   Chon, Jung-Whan; Sung, Kidon, US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR USA.
   Lim, Jong-Soo; Seo, Kun-Ho, Konkuk Univ, Coll Vet Med, KU Ctr Food Safety, Seoul, South Korea.
   Wee, Sung-Hwan; Moon, Jin-San, Anim \& Plant Quarantine Agcy, Anyang, South Korea.}},
DOI = {{10.1111/1750-3841.13106}},
ISSN = {{0022-1147}},
EISSN = {{1750-3841}},
Keywords = {{contamination; poultry processing; salmonella; subtyping}},
Keywords-Plus = {{CAMPYLOBACTER-SPP.; ANTIBIOTIC SUSCEPTIBILITY; ANTIMICROBIAL RESISTANCE;
   POULTRY SLAUGHTERHOUSES; MICROBIOLOGICAL QUALITY; CROSS-CONTAMINATION;
   CHICKEN CARCASSES; WATER IMMERSION; AIR; OPERATION}},
Research-Areas = {{Food Science \& Technology}},
Web-of-Science-Categories  = {{Food Science \& Technology}},
Author-Email = {{moonjs727@korea.kr}},
Funding-Acknowledgement = {{Animal, Plant and Fisheries Quarantine and Inspection Agency
   {[}B-FS03-2011-12-01]}},
Funding-Text = {{This work was supported by the Animal, Plant and Fisheries Quarantine
   and Inspection Agency (No. B-FS03-2011-12-01).}},
Cited-References = {{Bae DH, 2013, J VET MED SCI, V75, P1193, DOI 10.1292/jvms.13-0093.
   Berrang ME, 2008, POULTRY SCI, V87, P992, DOI 10.3382/ps.2007-00406.
   Carciofi BAM, 2007, CHEM ENG PROCESS, V46, P444, DOI 10.1016/j.cep.2006.05.020.
   Carroll CD, 2008, POULTRY SCI, V87, P368, DOI 10.3382/ps.2007-00213.
   Choi SW, 2014, POULTRY SCI, V93, P1251, DOI 10.3382/ps.2013-03558.
   Chung YH, 2003, J FOOD PROTECT, V66, P1154, DOI 10.4315/0362-028X-66.7.1154.
   Demirok E, 2013, POULTRY SCI, V92, P1117, DOI 10.3382/ps.2012-02493.
   Ellerbroek LI, 2010, ZOONOSES PUBLIC HLTH, V57, pE81, DOI 10.1111/j.1863-2378.2009.01267.x.
   Figueroa G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-94.
   Fluckey WM, 2003, J FOOD PROTECT, V66, P272, DOI 10.4315/0362-028X-66.2.272.
   Grimont P. A. D, 2007, ANTIGENIC FORMULAE S.
   Guerin MT, 2010, POULTRY SCI, V89, P1070, DOI 10.3382/ps.2009-00213.
   Hue O, 2010, FOOD MICROBIOL, V27, P992, DOI 10.1016/j.fm.2010.06.004.
   Huezo R, 2007, J APPL POULTRY RES, V16, P438, DOI 10.1093/japr/16.3.438.
   Hyeon Ji-Yeon, 2013, Osong Public Health Res Perspect, V4, P27, DOI 10.1016/j.phrp.2012.12.005.
   Hyeon JY, 2011, J FOOD PROTECT, V74, P161, DOI 10.4315/0362-028X.JFP-10-327.
   Kidie DH, 2013, JPN J VET RES, V61, P129.
   Kim A, 2007, J VET SCI, V8, P155, DOI 10.4142/jvs.2007.8.2.155.
   Kim MS, 2012, POULTRY SCI, V91, P2370, DOI 10.3382/ps.2012-02357.
   Lee YJ, 2007, J VET MED SCI, V69, P399, DOI 10.1292/jvms.69.399.
   McCrea BA, 2006, POULTRY SCI, V85, P136, DOI 10.1093/ps/85.1.136.
   MEAD GC, 1994, BRIT POULTRY SCI, V35, P345, DOI NO\_DOI.
   Mead GC, 1995, EPIDEMIOL INFECT, V115, P495, DOI 10.1017/S0950268800058659.
   Sanchez MX, 2002, J FOOD PROTECT, V65, P948, DOI 10.4315/0362-028X-65.6.948.
   Wise MG, 2009, J MICROBIOL METH, V76, P18, DOI 10.1016/j.mimet.2008.09.006.
   Woo YK, 2007, KOREAN J MICROBIOL, V43, P186.
   Zhang L, 2011, J FOOD PROTECT, V74, P1531, DOI 10.4315/0362-028X.JFP-11-032.}},
Number-of-Cited-References = {{27}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{8}},
Journal-ISO = {{J. Food Sci.}},
Doc-Delivery-Number = {{DA9MI}},
Unique-ID = {{ISI:000368132800023}},
DA = {{2018-08-13}},
}

@article{ ISI:000366807800003,
Author = {Dallaspezia, Sara and Suzuki, Masahiro and Benedetti, Francesco},
Title = {{Chronobiological Therapy for Mood Disorders}},
Journal = {{CURRENT PSYCHIATRY REPORTS}},
Year = {{2015}},
Volume = {{17}},
Number = {{12}},
Month = {{DEC}},
Abstract = {{Chronobiological therapies for mood disorders include manipulations of
   the sleep-wake cycle such as sleep deprivation and sleep phase advance
   and the controlled exposure to light and darkness. Their antidepressant
   efficacy can overcome drug resistance and targets the core depressive
   symptoms including suicide, thus making them treatment options to be
   tried either alone or as adjunctive treatments combined with common
   psychopharmacological interventions. The specific pattern of mood change
   observed with chronobiological therapies is characterized by rapid and
   sustained effects, when used among themselves or combined with drugs.
   Effects sizes are the same reported for the most effective psychiatric
   treatments, but side effects are usually marginal or absent. New
   treatment protocols are developed to adapt them in different clinical
   settings. This review deals with the general principles of clinical
   chronobiology and the latest findings in this rapidly developing field.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Dallaspezia, S (Reprint Author), Ist Sci Univ Osped San Raffaele, Dipartimento Neurosci Clin, San Raffaele Turro, Via Stamira Ancona 20, I-20127 Milan, Italy.
   Dallaspezia, Sara; Benedetti, Francesco, Ist Sci Univ Osped San Raffaele, Dipartimento Neurosci Clin, San Raffaele Turro, I-20127 Milan, Italy.
   Suzuki, Masahiro, Nihon Univ, Sch Med, Dept Psychiat, Tokyo, Japan.}},
DOI = {{10.1007/s11920-015-0633-6}},
Article-Number = {{95}},
ISSN = {{1523-3812}},
EISSN = {{1535-1645}},
Keywords = {{Mood disorder; Bipolar disorder; Chronotherapeutics; Sleep deprivation;
   Light therapy; Sleep phase advance; Dark therapy; Depression}},
Keywords-Plus = {{SEASONAL AFFECTIVE-DISORDER; TOTAL SLEEP-DEPRIVATION; BRIGHT LIGHT
   THERAPY; PLACEBO-CONTROLLED-TRIAL; HYPERSOMNIC WINTER DEPRESSION;
   RESISTANT BIPOLAR DEPRESSION; NEGATIVE AIR IONIZATION; RETINAL
   GANGLION-CELLS; PHASE ADVANCE THERAPY; ANTIDEPRESSANT RESPONSE}},
Research-Areas = {{Psychiatry}},
Web-of-Science-Categories  = {{Psychiatry}},
Author-Email = {{dallaspezia.sara@hsr.it}},
ResearcherID-Numbers = {{Benedetti, Francesco/A-4124-2015
   }},
ORCID-Numbers = {{Benedetti, Francesco/0000-0003-4949-856X
   Dallaspezia, Sara/0000-0003-3115-1808}},
Cited-References = {{Akiskal HS, 2006, J AFFECT DISORDERS, V94, P105, DOI 10.1016/j.jad.2006.04.002.
   Albert R, 1998, NERVENARZT, V69, P66, DOI 10.1007/s001150050240.
   Altshuler L, 2001, J CLIN PSYCHIAT, V62, P612, DOI 10.4088/JCP.v62n0807.
   Avery DH, 2002, J AFFECT DISORDERS, V69, P231, DOI 10.1016/S0165-0327(00)00360-8.
   Avery DH, 2001, BIOL PSYCHIAT, V50, P205, DOI 10.1016/S0006-3223(01)01200-8.
   Avery DH, 1997, BIOL PSYCHIAT, V41, P1109, DOI 10.1016/S0006-3223(96)00210-7.
   Barbini B, 1998, PSYCHIAT RES, V79, P43, DOI 10.1016/S0165-1781(98)00020-1.
   Barbini B, 2005, BIPOLAR DISORD, V7, P98, DOI 10.1111/j.1399-5618.2004.00166.x.
   Barbini B, 1996, PSYCHIAT RES, V65, P121, DOI 10.1016/S0165-1781(96)02909-5.
   Benedetti F, 2007, INT J PSYCHIAT CLIN, V11, P316.
   Benedetti F, 1999, AM J PSYCHIAT, V156, P1450.
   Benedetti F, 2005, J CLIN PSYCHIAT, V66, P1535, DOI 10.4088/JCP.v66n1207.
   Benedetti F, 1999, J CLIN PSYCHOPHARM, V19, P240, DOI 10.1097/00004714-199906000-00007.
   Benedetti F, 2003, J CLIN PSYCHIAT, V64, P648, DOI 10.4088/JCP.v64n0605.
   Benedetti F, 1999, J PSYCHIAT RES, V33, P69, DOI 10.1016/S0022-3956(98)00053-3.
   Benedetti F, 1997, EUR ARCH PSY CLIN N, V247, P100, DOI 10.1007/BF02900200.
   Benedetti F, 2001, J PSYCHIAT RES, V35, P323, DOI 10.1016/S0022-3956(01)00034-6.
   Benedetti F, 2012, DIALOGUES CLIN NEURO, V14.
   Benedetti F, 2008, J CLIN PSYCHOPHARM, V28, P249, DOI 10.1097/JCP.0b013e318167461e.
   Benedetti F, 2007, SLEEP MED REV, V11, P509, DOI 10.1016/j.smrv.2007.06.004.
   Benedetti F, 2007, CHRONOBIOL INT, V24, P921, DOI 10.1080/07420520701649455.
   Benedetti F, 2007, AM J MED GENET B, V144B, P631, DOI 10.1002/ajmg.b.30475.
   Benedetti F, 2007, ARCH GEN PSYCHIAT, V64, P179, DOI 10.1001/archpsyc.64.2.179.
   Benedetti F, 2014, J CLIN PSYCHIAT, V75, P133, DOI 10.4088/JCP.13m08455.
   Benedetti F, 2011, NEUROPSYCHOBIOLOGY, V64, P141, DOI 10.1159/000328947.
   Benedetti F, 2009, PSYCHIAT RES-NEUROIM, V173, P238, DOI 10.1016/j.pscychresns.2008.08.004.
   Benedetti F, 2009, CURR PHARM DESIGN, V15, P2637, DOI 10.2174/138161209788957447.
   Benedetti F, 2008, PROG NEURO-PSYCHOPH, V32, P1863, DOI 10.1016/j.pnpbp.2008.08.017.
   Berger M, 1997, AM J PSYCHIAT, V154, P870.
   Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262.
   Bhattacharjee Y, 2007, SCIENCE, V317, P1488, DOI 10.1126/science.317.5844.1488.
   Boyce P, 2013, ACTA PSYCHIAT SCAND, V128, P16, DOI 10.1111/acps.12175.
   Braun DL, 1999, COMPR PSYCHIAT, V40, P442, DOI 10.1016/S0010-440X(99)90088-3.
   Bump G M, 1997, Depress Anxiety, V6, P113, DOI 10.1002/(SICI)1520-6394(1997)6:3<113::AID-DA4>3.3.CO;2-K.
   Bunney BG, 2012, BIOL PSYCHIAT.
   Burkhart K, 2009, CHRONOBIOL INT, V26, P1602, DOI 10.3109/07420520903523719.
   Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839.
   Caliyurt O, 2005, J AFFECT DISORDERS, V88, P75, DOI 10.1016/j.jad.2005.04.008.
   Canali P, 2014, BIPOLAR DISORD, V16, P809, DOI 10.1111/bdi.12249.
   CHRISTODOULOU GN, 1978, AM J PSYCHIAT, V135, P375.
   Colombo C, 1999, PSYCHIAT RES, V86, P267, DOI 10.1016/S0165-1781(99)00036-0.
   Colombo C, 2000, PSYCHIAT RES, V95, P43, DOI 10.1016/S0165-1781(00)00164-5.
   Crown WH, 2002, J CLIN PSYCHIAT, V63, P963, DOI 10.4088/JCP.v63n1102.
   Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387.
   DAHL K, 1993, ACTA PSYCHIAT SCAND, V88, P60, DOI 10.1111/j.1600-0447.1993.tb03414.x.
   Danilenko KV, 2015, J AFFECT DISORDERS, V180, P87, DOI 10.1016/j.jad.2015.03.055.
   Dauphinais DR, 2012, PSYCHIAT RES, V196, P57, DOI 10.1016/j.psychres.2012.01.015.
   DAVID MM, 1991, ACTA PSYCHIAT SCAND, V84, P33, DOI 10.1111/j.1600-0447.1991.tb01418.x.
   Eastman CI, 1998, ARCH GEN PSYCHIAT, V55, P883, DOI 10.1001/archpsyc.55.10.883.
   EBERT D, 1994, BIOL PSYCHIAT, V35, P880, DOI 10.1016/0006-3223(94)90024-8.
   Ebert D, 1998, PSYCHOPHARMACOLOGY, V140, P1, DOI 10.1007/s002130050732.
   Echizenya M, 2012, J AFFECT DISORD.
   Echizenya M, 2013, J AFFECT DISORDERS, V144, P28, DOI 10.1016/j.jad.2012.06.022.
   Elliott R, 2002, ARCH GEN PSYCHIAT, V59, P597, DOI 10.1001/archpsyc.59.7.597.
   ELSENGA S, 1983, J PSYCHIAT RES, V17, P361, DOI 10.1016/0022-3956(82)90041-3.
   FAHNDRICH E, 1982, NERVENARZT, V53, P279.
   FAHNDRICH E, 1981, PSYCHIAT RES, V5, P277, DOI 10.1016/0165-1781(81)90074-3.
   Frye MA, 2009, AM J PSYCHIAT, V166, P164, DOI 10.1176/appi.ajp.2008.08030322.
   Gangwisch JE, 2010, SLEEP, V33, P97, DOI 10.1093/sleep/33.1.97.
   Gao KM, 2008, BIPOLAR DISORD, V10, P907, DOI 10.1111/j.1399-5618.2008.00637.x.
   Gasio PF, 2003, EXP GERONTOL, V38, P207, DOI 10.1016/S0531-5565(02)00164-X.
   GERNER RH, 1979, J PSYCHIAT RES, V15, P21, DOI 10.1016/0022-3956(79)90004-9.
   Giedke H, 2002, SLEEP MED REV, V6, P361, DOI 10.1053/smrv.2002.0235.
   GIEDKE H, 1992, J AFFECT DISORDERS, V25, P117, DOI 10.1016/0165-0327(92)90074-G.
   GIEDKE H, 1990, PROG NEURO-PSYCHOPH, V14, P37, DOI 10.1016/0278-5846(90)90062-L.
   Gillin JC, 2001, DEPRESS ANXIETY, V14, P37, DOI 10.1002/da.1045.
   GILLIN JC, 1989, PSYCHIAT RES, V27, P253, DOI 10.1016/0165-1781(89)90141-8.
   Goel N, 2005, PSYCHOL MED, V35, P945, DOI 10.1017/S0033291705005027.
   Goel N, 2003, PSYCHIAT RES, V119, P89, DOI 10.1016/S0165-1781(03)00106-9.
   Golden RN, 2005, AM J PSYCHIAT, V162, P656, DOI 10.1176/appi.ajp.162.4.656.
   Hanley GE, 2015, PEDIATR RES, V78, P174, DOI 10.1038/pr.2015.77.
   Hannibal J, 2002, J NEUROSCI, V22.
   Harrison SJ, 2015, ACTA PSYCHIAT SCAND.
   Harvey AG, 2008, AM J PSYCHIAT, V165, P820, DOI 10.1176/appi.ajp.2008.08010098.
   Heim M, 1988, Psychiatr Neurol Med Psychol (Leipz), V40, P269.
   Hemmeter U, 1998, BIOL PSYCHIAT, V43, P829, DOI 10.1016/S0006-3223(97)00297-7.
   Holden C, 2003, SCIENCE, V302, P810, DOI 10.1126/science.302.5646.810.
   HORNE J A, 1976, International Journal of Chronobiology, V4, P97.
   JAUHAR P, 1982, BRIT J PSYCHIAT, V140, P231, DOI 10.1192/bjp.140.3.231.
   Kripke D., 1981, BIOL PSYCHIAT, P1249.
   Kripke DF, 1998, J AFFECT DISORDERS, V49, P109, DOI 10.1016/S0165-0327(98)00005-6.
   KRIPKE DF, 1983, PSYCHIAT RES, V10, P105, DOI 10.1016/0165-1781(83)90109-9.
   Kuhs H, 1996, J AFFECT DISORDERS, V37, P31, DOI 10.1016/0165-0327(95)00074-7.
   KUHS H, 1991, BIOL PSYCHIAT, V29, P1129, DOI 10.1016/0006-3223(91)90255-K.
   KVIST J, 1980, ACTA PSYCHIAT SCAND, V62, P494, DOI 10.1111/j.1600-0447.1980.tb00638.x.
   LABBATE LA, 1994, J CLIN PSYCHIAT, V55, P189.
   Lam RW, 1996, ARCH GEN PSYCHIAT, V53, P41.
   Lam RW, 1999, PSYCHIAT RES, V86, P185, DOI 10.1016/S0165-1781(99)00043-8.
   LAM RW, 1994, AM J PSYCHIAT, V151, P744.
   LEIBENLUFT E, 1992, AM J PSYCHIAT, V149, P159.
   Leibenluft E, 1995, PSYCHOPHARMACOL BULL, V31, P705.
   LEWY AJ, 1982, AM J PSYCHIAT, V139, P1496.
   LEWY AJ, 1985, AM J PSYCHIAT, V142, P725.
   Lewy AJ, 2006, P NATL ACAD SCI USA, V103, P7414, DOI 10.1073/pnas.0602425103.
   Lewy AJ, 1998, ARCH GEN PSYCHIAT, V55, P890, DOI 10.1001/archpsyc.55.10.890.
   Lewy AJ, 2009, SLEEP MED CLIN, V4, P285, DOI 10.1016/j.jsmc.2009.02.003.
   Lieverse R, 2011, ARCH GEN PSYCHIAT, V68, P61, DOI 10.1001/archgenpsychiatry.2010.183.
   Lingjaerde O, 1998, ACTA PSYCHIAT SCAND, V98, P73, DOI 10.1111/j.1600-0447.1998.tb10045.x.
   Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570.
   Martiny K, 2005, ACTA PSYCHIAT SCAND, V112, P117, DOI 10.1111/j.1600-0447.2005.00574.x.
   Meesters Y, 2011, BMC PSYCHIAT, V11.
   Millan MJ, 2006, PHARMACOL THERAPEUT, V110, P135, DOI 10.1016/j.pharmthera.2005.11.006.
   Mongrain V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026622.
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4.
   Nakken KO, 2005, EPILEPSY BEHAV, V6, P85, DOI 10.1016/j.yebeh.2004.11.003.
   Nemeroff CB, 2003, J CLIN PSYCHIAT, V64, P25.
   Neumeister A, 1997, ARCH GEN PSYCHIAT, V54, P133.
   Neumeister A, 1998, ARCH GEN PSYCHIAT, V55, P524, DOI 10.1001/archpsyc.55.6.524.
   Neumeister A, 1996, BIOL PSYCHIAT, V39, P16, DOI 10.1016/0006-3223(95)00086-0.
   Oren DA, 2002, AM J PSYCHIAT, V159, P666, DOI 10.1176/appi.ajp.159.4.666.
   PAPADIMITRIOU GN, 1993, J AFFECT DISORDERS, V27, P107, DOI 10.1016/0165-0327(93)90083-V.
   PAPATHEODOROU G, 1995, J PSYCHIATR NEUROSCI, V20, P226.
   Pearlstein T, 2008, J PSYCHIATR NEUROSCI, V33, P302.
   Pflug B, 1971, Nervenarzt, V42, P117.
   PFLUG B, 1971, INT PHARMACOPSYCHIAT, V6, P187, DOI 10.1159/000468269.
   Prasko J, 2010, BIOMED PAP, V154, P355, DOI 10.5507/bp.2010.053.
   Preskorn S, 2006, NEUROPSYCHOPHARMACOL, V31, P1605, DOI 10.1038/sj.npp.1301070.
   Riemann D, 1999, EUR ARCH PSY CLIN N, V249, P231, DOI 10.1007/s004060050092.
   RIEMANN D, 1993, PSYCHIAT RES, V49, P109, DOI 10.1016/0165-1781(93)90099-3.
   Robillard R, 2013, EUR PSYCHIAT, V28, P412, DOI 10.1016/j.eurpsy.2013.04.001.
   Robillard R, 2013, J AFFECT DISORDERS, V145, P260, DOI 10.1016/j.jad.2012.06.006.
   ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72.
   Roy-Byrne PP, 1984, NEUROBIOLOGY MOOD DI, P817.
   Rybak YE, 2006, J CLIN PSYCHIAT, V67, P1527, DOI 10.4088/JCP.v67n1006.
   SACK DA, 1985, AM J PSYCHIAT, V142, P606.
   SCHILGEN B, 1980, ARCH GEN PSYCHIAT, V37, P267.
   SCHULTE W, 1959, Med Klin, V54, P969.
   SHELTON RC, 1993, PROG NEURO-PSYCHOPH, V17, P113, DOI 10.1016/0278-5846(93)90036-R.
   Sit D, 2007, BIPOLAR DISORD, V9, P918, DOI 10.1111/j.1399-5618.2007.00451.x.
   Skjerve A, 2004, INT J GERIATR PSYCH, V19, P516, DOI 10.1002/gps.1087.
   Steinberg H, 2014, SLEEP MED, V15, P1159, DOI 10.1016/j.sleep.2014.03.027.
   Strong RE, 2009, DEPRESS ANXIETY, V26, P273, DOI 10.1002/da.20538.
   SURRIDGEDAVID M, 1987, PSYCHIAT RES, V22, P149, DOI 10.1016/0165-1781(87)90102-8.
   SZUBA MP, 1994, PSYCHIAT RES, V51, P283, DOI 10.1016/0165-1781(94)90015-9.
   TERMAN JS, 1990, PSYCHOPHARMACOL BULL, V26, P3.
   Terman JS, 2001, ARCH GEN PSYCHIAT, V58, P69, DOI 10.1001/archpsyc.58.1.69.
   TERMAN M, 1989, BIOL PSYCHIAT, V25, P966, DOI 10.1016/0006-3223(89)90276-X.
   Terman M, 2005, CNS SPECTRUMS, V10, P647, DOI 10.1017/S1092852900019611.
   TERMAN M, 1989, NEUROPSYCHOPHARMACOL, V2, P1, DOI 10.1016/0893-133X(89)90002-X.
   Terman M, 1998, ARCH GEN PSYCHIAT, V55, P875, DOI 10.1001/archpsyc.55.10.875.
   Terman M, 1999, J CLIN PSYCHIAT, V60, P799.
   Terman M, 2007, SLEEP MED REV, V11, P497, DOI 10.1016/j.smrv.2007.06.003.
   Terman M, 2006, AM J PSYCHIAT, V163, P2126, DOI 10.1176/appi.ajp.163.12.2126.
   Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002.
   Voderholzer U, 2003, EUR ARCH PSY CLIN N, V253, P68, DOI 10.1007/s00406-003-0408-7.
   VOGEL GW, 1975, ARCH GEN PSYCHIAT, V32, P765.
   VOLLMANN J, 1993, BIOL PSYCHIAT, V33, P54, DOI 10.1016/0006-3223(93)90280-Q.
   Wehr T, 1981, INTERNAL COINCIDENCE, P26.
   WEHR TA, 1979, SCIENCE, V206, P710, DOI 10.1126/science.227056.
   WEHR TA, 1987, AM J PSYCHIAT, V144, P201.
   Wehr TA, 1998, BIOL PSYCHIAT, V43, P822, DOI 10.1016/S0006-3223(97)00542-8.
   Winkler Dietmar, 2006, Expert Rev Neurother, V6, P1039, DOI 10.1586/14737175.6.7.1039.
   Wirz-Justice A, 2005, PSYCHOL MED, V35, P939, DOI 10.1017/S003329170500437X.
   Wirz-Justice A, 2004, SCIENCE, V303, P467.
   Wirz-Justice A, 1999, BIOL PSYCHIAT, V46, P445, DOI 10.1016/S0006-3223(99)00125-0.
   Wirz-Justice A, 1999, BIOL PSYCHIAT, V45, P1075, DOI 10.1016/S0006-3223(98)00289-3.
   Wirz-Justice A, 2011, J CLIN PSYCHIAT, V72, P986, DOI 10.4088/JCP.10m06188blu.
   Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018.
   Wood B, 2013, APPL ERGON, V44, P237, DOI 10.1016/j.apergo.2012.07.008.
   Wu JC, 2008, J AFFECT DISORDERS, V107, P181, DOI 10.1016/j.jad.2007.07.030.
   Wu JC, 2009, BIOL PSYCHIAT, V66, P298, DOI 10.1016/j.biopsych.2009.02.018.}},
Number-of-Cited-References = {{161}},
Times-Cited = {{12}},
Usage-Count-Last-180-days = {{7}},
Usage-Count-Since-2013 = {{34}},
Journal-ISO = {{Curr. Psychiatry Rep.}},
Doc-Delivery-Number = {{CZ0PI}},
Unique-ID = {{ISI:000366807800003}},
DA = {{2018-08-13}},
}

@article{ ISI:000366066900011,
Author = {Van Meervenne, Eva and Van Coillie, Els and Van Weyenberg, Stephanie and
   Boon, Nico and Berman, Lieve and Devlieghere, Frank},
Title = {{Low Temperature and Modified Atmosphere: Hurdles for Antibiotic
   Resistance Transfer?}},
Journal = {{JOURNAL OF FOOD PROTECTION}},
Year = {{2015}},
Volume = {{78}},
Number = {{12}},
Pages = {{2191-2199}},
Month = {{DEC}},
Abstract = {{Food is an important dissemination route for antibiotic-resistant
   bacteria. Factors used during food production and preservation may
   contribute to the transfer of antibiotic resistance genes, but research
   on this subject is scarce. In this study, the effect of temperature (7
   to 37 degrees C) and modified atmosphere packaging (air, 50\% CO2-50\%
   N-2, and 100\% N-2) on antibiotic resistance transfer from Lactobacillus
   sakei subsp. sakei to Listeria monocyto genes was evaluated. Filter
   mating was performed on nonselective agar plates with high-density
   inocula. A more realistic setup was created by performing modified
   atmosphere experiments on cooked ham using high-density and low-density
   inocula. Plasmid transfer was observed between 10 and 37 degrees C, with
   plasmid transfer also observed at 7 degrees C during a prolonged
   incubation period. When high-density inocula were used, transconjugants
   were detected, both on agar plates and cooked ham, under the three
   atmospheres (air, 50\% CO2-50\% N-2, and 100\% N-2) at 7 degrees C. This
   yielded a median transfer ratio (number of transconjugants/number of
   recipients) with an order of magnitude of 10(-4) to 10(-6). With
   low-density inocula, transfer was only detected under the 100\% N-2
   atmosphere after 10-day incubation at 7 degrees C,-yielding a transfer
   ratio of 10(-5). Under this condition, the highest bacterial density was
   obtained. The results indicate that low temperature and modified
   atmosphere packaging, two important hurdles in the food industry, do not
   necessarily prevent plasmid transfer from Lactobacillus sakei subsp.
   sakei to Listeria monocytogenes.}},
Publisher = {{INT ASSOC FOOD PROTECTION}},
Address = {{6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Van Meervenne, E (Reprint Author), Inst Agr \& Fisheries Res, Technol \& Food Sci Unit, Brusselsesteenweg 370, B-9090 Melle, Belgium.
   Van Meervenne, Eva; Van Coillie, Els; Van Weyenberg, Stephanie; Berman, Lieve, Inst Agr \& Fisheries Res, Technol \& Food Sci Unit, B-9090 Melle, Belgium.
   Van Meervenne, Eva; Devlieghere, Frank, Univ Ghent, Lab Food Microbiol \& Food Preservat, B-9000 Ghent, Belgium.
   Boon, Nico, Univ Ghent, Lab Microbial Ecol \& Technol, B-9000 Ghent, Belgium.}},
DOI = {{10.4315/0362-028X.JFP-15-105}},
ISSN = {{0362-028X}},
EISSN = {{1944-9097}},
Keywords-Plus = {{COOKED MEAT-PRODUCTS; ANTIMICROBIAL RESISTANCE; LISTERIA-MONOCYTOGENES;
   CONJUGAL TRANSFER; ESCHERICHIA-COLI; PLASMID TRANSFER; SALT STRESS;
   FOOD; BACTERIA; TRANSMISSION}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Food Science \& Technology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Food Science \& Technology}},
Author-Email = {{eva.vanmeervenne@ilvo.vlaanderen.be}},
ResearcherID-Numbers = {{Boon, Nico/B-4083-2011}},
ORCID-Numbers = {{Boon, Nico/0000-0002-7734-3103}},
Funding-Acknowledgement = {{Federal Public Service of Health, Food Chain Safety and Environment
   {[}RF 09/6219]}},
Funding-Text = {{This study was funded by the Federal Public Service of Health, Food
   Chain Safety and Environment (contract RF 09/6219). We thank Ann Van Hee
   for technical assistance.}},
Cited-References = {{Al-Nabulsi AA, 2011, INT J FOOD MICROBIOL, V146, P137, DOI 10.1016/j.ijfoodmicro.2011.02.013.
   {[}Anonymous], 2013, EFSA J, V11, P3129, DOI DOI 10.2903/J.EFSA.2013.3129.
   Beuls E, 2012, APPL ENVIRON MICROB, V78, P7128, DOI 10.1128/AEM.01105-12.
   Boerlin Patrick, 2008, Animal Health Research Reviews, V9, P115, DOI 10.1017/S146625230800159X.
   Capita R, 2013, CRIT REV FOOD SCI, V53, P11, DOI 10.1080/10408398.2010.519837.
   Cocconcelli PS, 2003, INT J FOOD MICROBIOL, V88, P315, DOI 10.1016/S0168-1605(03)00194-6.
   European Food Safety Authority, 2013, EFSA J, V11, P3241, DOI {[}10.2903/j.efsa.2013.3241, DOI 10.2903/J.EFSA.2013.3241].
   FARBER JM, 1991, J FOOD PROTECT, V54, P58, DOI 10.4315/0362-028X-54.1.58.
   FERNANDEZASTORGA A, 1992, APPL ENVIRON MICROB, V58, P392.
   Ganjian H, 2012, JUNDISHAPUR J MICROB, V5, P328, DOI 10.5812/kowsar.20083645.2375.
   Gevers D, 2003, APPL ENVIRON MICROB, V69, P1270, DOI 10.1128/AEM.69.2.1270-1275.2003.
   Gevers D, 2003, FEMS MICROBIOL LETT, V225, P125, DOI 10.1016/S0378-1097(03)00505-6.
   GOODMAN AE, 1993, APPL ENVIRON MICROB, V59, P1035.
   Hachler H., 2013, EURO SURVEILL, V18, P20469.
   Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256.
   Kutner MH, 2005, APPL LINEAR STAT MOD.
   Mc Mahon MAS, 2007, J APPL MICROBIOL, V103, P1883, DOI 10.1111/j.1365-2672.2007.03412.x.
   McMahon MAS, 2007, APPL ENVIRON MICROB, V73, P211, DOI 10.1128/AEM.00578-06.
   OHLSSON T, 1994, TRENDS FOOD SCI TECH, V5, P341, DOI 10.1016/0924-2244(94)90210-0.
   Phillips CA, 1996, INT J FOOD SCI TECH, V31, P463, DOI 10.1046/j.1365-2621.1996.00369.x.
   Rice LB, 1998, ANTIMICROB AGENTS CH, V42, P1871.
   Rizzotti L, 2009, ANTON LEEUW INT J G, V96, P43, DOI 10.1007/s10482-009-9334-7.
   Samelis J, 1998, J APPL MICROBIOL, V84, P649, DOI 10.1046/j.1365-2672.1998.00392.x.
   Silk BJ, 2013, MMWR-MORBID MORTAL W, V62, P448.
   SINGLETON P, 1981, APPL ENVIRON MICROB, V42, P789.
   Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232.
   Toomey N, 2009, FOODBORNE PATHOG DIS, V6, P925, DOI 10.1089/fpd.2009.0278.
   Toomey N, 2009, J MICROBIOL METH, V77, P23, DOI 10.1016/j.mimet.2008.12.002.
   Uyttendaele M, 2009, INT J FOOD MICROBIOL, V133, P94, DOI 10.1016/j.ijfoodmicro.2009.05.002.
   Uyttendaele M, 1999, INT J FOOD MICROBIOL, V53, P75, DOI 10.1016/S0168-1605(99)00155-5.
   Uyttendaele M., 2010, MICROBIOLOGISCHE RIC.
   Van Coillie E, 2004, J FOOD PROTECT, V67, P2480, DOI 10.4315/0362-028X-67.11.2480.
   van Elsas JD, 2002, FEMS MICROBIOL ECOL, V42, P187, DOI 10.1111/j.1574-6941.2002.tb01008.x.
   Vermeiren L, 2004, INT J FOOD MICROBIOL, V96, P149, DOI 10.1016/j.ijfoodmicro.2004.03.016.
   Verraes C, 2013, INT J ENV RES PUB HE, V10, P2643, DOI 10.3390/ijerph10072643.
   Walsh C, 2008, LETT APPL MICROBIOL, V46, P210, DOI 10.1111/j.1472-765X.2007.02288.x.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{8}},
Usage-Count-Since-2013 = {{41}},
Journal-ISO = {{J. Food Prot.}},
Doc-Delivery-Number = {{CY0AB}},
Unique-ID = {{ISI:000366066900011}},
DA = {{2018-08-13}},
}

@article{ ISI:000360773500056,
Author = {Wang, Kai and Ye, Keping and Zhu, Yepei and Huang, Yan and Wang, Guangyu
   and Wang, Huhu and Zhou, Guanghong},
Title = {{Prevalence, antimicrobial resistance and genetic diversity of Listeria
   monocytogenes isolated from chilled pork in Nanjing, China}},
Journal = {{LWT-FOOD SCIENCE AND TECHNOLOGY}},
Year = {{2015}},
Volume = {{64}},
Number = {{2}},
Pages = {{905-910}},
Month = {{DEC}},
Abstract = {{The objective of this study was to investigate the prevalence of
   Listeria monocytogenes isolated from chilled pork from open-air markets
   and supermarkets in Nanjing and to characterize the isolates by
   serotyping, antibiotic resistance, and MLST subtyping analyses. The
   results showed that 26 of 476 samples (5.5\%) were positive for L.
   monocytogenes. All the isolates belonged to three serotypes, with
   serotype 1/2a being dominant (53.8\%), followed by serotype 1/2b
   (23.1\%) and serotype 1/2c (23.1\%). The antimicrobial susceptibility
   tests revealed that 5 isolates (19.2\%) were susceptible to all
   antimicrobials used; the remaining strains were resistant to 1 (19.2\%),
   2 (34.6\%), 3 (11.5\%), 6 (3.85\%) or even 9 (3.85\%) different
   antimicrobials. All the isolates were susceptible to penicillin and
   vancomycin. Most of the isolates were susceptible to rifampicin and
   gentamicin (96.2\%), cefotaxime (92.3\%), streptomycin (92.3\%) and
   trimethoprim/sulfamethoxazole (92.3\%). MLST subtyping analyses revealed
   that 26 isolates were grouped into 10 sequence types (STs). Therefore,
   this study indicates the high percentage of serotypes 1/2a and 4b, which
   are associated with human listeriosis; and the high level of
   multi-resistance could be a public health hazard. (C) 2015 Elsevier Ltd.
   All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Zhou, GH (Reprint Author), Nanjing Agr Univ, Coll Food Sci \& Technol, Collaborat Innovat Ctr Food Safety \& Nutr, Minist Educ,Minist Educ \& Finance,Key Lab Meat Pr, Nanjing 210095, Jiangsu, Peoples R China.
   Wang, Kai; Ye, Keping; Zhu, Yepei; Huang, Yan; Wang, Guangyu; Wang, Huhu; Zhou, Guanghong, Nanjing Agr Univ, Coll Food Sci \& Technol, Collaborat Innovat Ctr Food Safety \& Nutr, Minist Educ,Minist Educ \& Finance,Key Lab Meat Pr, Nanjing 210095, Jiangsu, Peoples R China.}},
DOI = {{10.1016/j.lwt.2015.06.015}},
ISSN = {{0023-6438}},
EISSN = {{1096-1127}},
Keywords = {{Listeria monocytogenes; Chilled pork; Contamination; Antibiotic
   resistance}},
Keywords-Plus = {{TO-EAT FOODS; ANTIBIOTIC-RESISTANCE; MEAT-PRODUCTS; RETAIL FOODS; RAW;
   SUSCEPTIBILITY; PCR; IDENTIFICATION; EPIDEMIOLOGY; MALAYSIA}},
Research-Areas = {{Food Science \& Technology}},
Web-of-Science-Categories  = {{Food Science \& Technology}},
Author-Email = {{guanghong.zhou@hotmail.com}},
ORCID-Numbers = {{Wang, Huhu/0000-0003-1688-7948}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}31071614]; National
   ``Twelfth Five-Year{''} Plan for Science and Technology of China
   {[}2012BAD28B02-03]}},
Funding-Text = {{We are very grateful to Prof. Ron Tume from CSIRO, Animal, Food and
   Health Sciences, Australia for his valuable advice and assistance with
   language. This work was supported by National Natural Science Foundation
   of China (Project 31071614) and National ``Twelfth Five-Year{''} Plan
   for Science and Technology of China (grant no. 2012BAD28B02-03).}},
Cited-References = {{Alonso-Hernando A, 2012, FOOD CONTROL, V23, P37, DOI 10.1016/j.foodcont.2011.06.006.
   Arslan S, 2008, FOOD CONTROL, V19, P360, DOI 10.1016/j.foodcont.2007.04.009.
   Aziz A., 2013, FOOD CONTROL, V34, P630.
   Aziz A. F., 2012, FOOD CONTROL, V28, P327.
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493.
   Bucrieser C., 2003, FEMS IMMUNOLOGY MED, V35, P207.
   Chao G., 2005, CHINESE J HLTH LAB T, V15, P519.
   Charpentier E, 1999, ANTIMICROB AGENTS CH, V43, P2103.
   Chen MT, 2014, FOOD CONTROL, V38, P1, DOI 10.1016/j.foodcont.2013.09.061.
   Clinical and Laboratory Standards Institute (CLSI), 2011, M1A9 CLSI.
   Conter M, 2009, INT J FOOD MICROBIOL, V128, P497, DOI 10.1016/j.ijfoodmicro.2008.10.018.
   Domenech E, 2015, FOOD CONTROL, V47, P120, DOI 10.1016/j.foodcont.2014.06.043.
   Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI {[}10.1128/JCM.42.8.3819-3822.2004, 10.1128/JCM.42.3819-3822.2004].
   {[}European Centre for Disease Prevention and Control (ECDC) European Food Safety Authority (ESFA)], 2014, EFSA J, V12, P3457.
   European Union, 2007, OFF J EUR UNION L, V322, P12.
   Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904.
   Feng YF, 2013, TROP MED INT HEALTH, V18, P1248, DOI 10.1111/tmi.12173.
   Filiousis G, 2009, FOOD CONTROL, V20, P314, DOI 10.1016/j.foodcont.2008.05.018.
   Fugett EB, 2007, J CLIN MICROBIOL, V45, P865, DOI 10.1128/JCM.01285-06.
   Granier SA, 2011, APPL ENVIRON MICROB, V77, P2788, DOI 10.1128/AEM.01381-10.
   Harakeh S, 2009, SCI TOTAL ENVIRON, V407, P4022, DOI 10.1016/j.scitotenv.2009.04.010.
   Hitchins A. D., 2003, FDA BAM ONLINE DETEC.
   Indrawattana N, 2011, J HEALTH POPUL NUTR, V29, P26.
   Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230.
   Kinga W., 2012, APPL ENVIRON MICROB, V78, P2043.
   Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140.
   Marian MN, 2012, FOOD CONTROL, V28, P309, DOI 10.1016/j.foodcont.2012.05.030.
   Mayrhofer S, 2004, INT J FOOD MICROBIOL, V97, P23, DOI 10.1016/j.ijfoodmicro.2004.04.006.
   Nadon CA, 2001, J CLIN MICROBIOL, V39, P2704, DOI 10.1128/JCM.39.7.2704-2707.2001.
   Ngapo TM, 2012, MEAT SCI, V92, P338, DOI 10.1016/j.meatsci.2012.04.031.
   Ngapo TM, 2012, MEAT SCI, V92, P330, DOI 10.1016/j.meatsci.2012.04.032.
   Pan J., 2008, CHINESE J PUBLIC HLT, V24, P107.
   Pesavento G, 2010, FOOD CONTROL, V21, P708, DOI 10.1016/j.foodcont.2009.10.012.
   Ponniah J, 2010, FOOD CONTROL, V21, P774, DOI 10.1016/j.foodcont.2009.09.008.
   Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146.
   Rahimi E, 2010, FOOD CONTROL, V21, P1448, DOI 10.1016/j.foodcont.2010.03.014.
   Ryser E. T., 2007, LISTERIA LISTERIOSIS.
   Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI 10.3201/eid1701.091101p2.
   Seeliger H. P., 1979, METHOD MICROBIOL, V13, P31, DOI DOI 10.1016/S0580-9517(08)70372-6.
   Shaw J.W., 2004, J MICROBIOL MET, V58, P395.
   Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011.
   Tang XY, 2013, FOOD CONTROL, V32, P334, DOI 10.1016/j.foodcont.2012.12.010.
   Todd ECD, 2011, FOOD CONTROL, V22, P1484, DOI 10.1016/j.foodcont.2010.07.021.
   Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006.
   Wang GY, 2015, FOOD CONTROL, V50, P202, DOI 10.1016/j.foodcont.2014.07.057.
   Wang P, 2012, J FOOD SCI, V77, pM212, DOI 10.1111/j.1750-3841.2011.02596.x.
   Wang XM, 2013, FOOD CONTROL, V32, P153, DOI 10.1016/j.foodcont.2012.11.032.
   Ward TJ, 2004, J BACTERIOL, V186, P4994, DOI 10.1128/jb.186.15.4994-5002.2004.
   Warriner K, 2009, TRENDS FOOD SCI TECH, V20, P245, DOI 10.1016/j.tifs.2009.03.008.
   Wong W. C., 2012, International Food Research Journal, V19, P1751.
   Wu S, 2015, FOOD CONTROL, V47, P340, DOI 10.1016/j.foodcont.2014.07.028.
   Yan H, 2010, INT J FOOD MICROBIOL, V144, P310, DOI 10.1016/j.ijfoodmicro.2010.10.015.
   Ye KP, 2013, FOOD CONTROL, V32, P246, DOI 10.1016/j.foodcont.2012.11.017.
   Ye KP, 2012, FOOD CONTROL, V25, P117, DOI 10.1016/j.foodcont.2011.10.025.
   Yu T, 2014, FOOD CONTROL, V37, P228, DOI 10.1016/j.foodcont.2013.09.047.
   Yucel N, 2005, FOOD MICROBIOL, V22, P241, DOI 10.1016/j.fm.2004.03.007.
   Zhang W, 2004, APPL ENVIRON MICROB, V70, P913, DOI 10.1128/AEM.70.2.913-920.2004.
   Zhang YF, 2007, INT J FOOD MICROBIOL, V113, P47, DOI 10.1016/j.ijfoodmicro.2006.07.010.}},
Number-of-Cited-References = {{58}},
Times-Cited = {{13}},
Usage-Count-Last-180-days = {{6}},
Usage-Count-Since-2013 = {{66}},
Journal-ISO = {{LWT-Food Sci. Technol.}},
Doc-Delivery-Number = {{CQ7HL}},
Unique-ID = {{ISI:000360773500056}},
DA = {{2018-08-13}},
}

@article{ ISI:000364317500015,
Author = {Huang, Jing and Zhang, Hao and Li, Tianqi and Lin, Huiying and Svanberg,
   Katarina and Svanberg, Sune},
Title = {{Assessment of human sinus cavity air volume using tunable diode laser
   spectroscopy, with application to sinusitis diagnostics}},
Journal = {{Journal of Biophotonics}},
Year = {{2015}},
Volume = {{8}},
Number = {{11-12}},
Pages = {{985-992}},
Month = {{NOV}},
Abstract = {{Sinusitis is a very common disease and improved diagnostic tools are
   desirable also in view of reducing over-prescription of antibiotics. A
   non-intrusive optical technique called GASMAS (GAs in Scattering Media
   Absorption Spectroscopy), which has a true potential of being developed
   into an important complement to other means of detection, was utilized
   in this work. Water vapor in the frontal sinuses, related to the free
   gas volume, was studied at around 937 nm in healthy volunteers. The
   results show a good stability of the GASMAS signals over extended times
   for the frontal sinuses for all volunteers, showing promising
   applicability to detect anomalies due to sinusitis. Measurements were
   also performed following the application of a decongestion spray. No
   noticeable signal change was observed, which is consistent with the fact
   that the water vapor concentration is given by the temperature only, and
   is not influenced by changes in cavity ventilation.}},
Publisher = {{WILEY-V C H VERLAG GMBH}},
Address = {{POSTFACH 101161, 69451 WEINHEIM, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Svanberg, S (Reprint Author), S China Normal Univ, Ctr Opt \& Electromagnet Res, Univ City Campus, Guangzhou 510006, Guangdong, Peoples R China.
   Huang, Jing; Zhang, Hao; Li, Tianqi; Lin, Huiying; Svanberg, Katarina; Svanberg, Sune, S China Normal Univ, Ctr Opt \& Electromagnet Res, Guangzhou 510006, Guangdong, Peoples R China.
   Svanberg, Katarina; Svanberg, Sune, Lund Univ, Lund Laser Ctr, SE-22100 Lund, Sweden.}},
DOI = {{10.1002/jbio.201500110}},
ISSN = {{1864-063X}},
EISSN = {{1864-0648}},
Keywords = {{paranasal cavities; frontal sinus; GASMAS; water vapor; sinusitis;
   antibiotic resistance}},
Keywords-Plus = {{PARANASAL SINUSES; SCATTERING MEDIA; GAS; VAPOR}},
Research-Areas = {{Biochemistry \& Molecular Biology; Biophysics; Optics}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Biophysics; Optics}},
Author-Email = {{sune.svanberg@fysik.lth.se}},
Funding-Acknowledgement = {{Guangdong Province Innovation Research Team Program
   {[}201001D0104799318]}},
Funding-Text = {{The authors are grateful for the participation of volunteers outside the
   group of authors. We are further thankful to Liang Mei and Yuan Fu for
   their assistance in setting up the GASMAS system. We thank Prof. Sailing
   He for his kind support. This work was supported by a Guangdong Province
   Innovation Research Team Program (No. 201001D0104799318).}},
Cited-References = {{Ahovuo-Saloranta A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000243.pub3.
   Boyles S., ANTIBIOTICS OVERUSED.
   BUCK AL, 1981, J APPL METEOROL, V20, P1527, DOI 10.1175/1520-0450(1981)020<1527:NEFCVP>2.0.CO;2.
   DUVOISIN B, 1991, NEURORADIOLOGY, V33, P403, DOI 10.1007/BF00598612.
   EVANS KL, 1994, BRIT MED J, V309, P1415, DOI 10.1136/bmj.309.6966.1415.
   Fatterpekar GM, 2008, ANAT REC, V291, P1564, DOI 10.1002/ar.20773.
   Lewander M, 2012, RHINOLOGY, V50, P26, DOI 10.4193/Rhino10.231.
   Lundberg JO, 2008, ANAT REC, V291, P1479, DOI 10.1002/ar.20782.
   Maroldi R., 2005, IMAGING TREATMENT PL, P9.
   Persson L, 2008, APPL OPTICS, V47, P2028, DOI 10.1364/AO.47.002028.
   Persson L, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2777189.
   Raut A. A., 2009, RHINOLOGY FACIAL PLA, P35.
   Schilt S, 2003, APPL OPTICS, V42, P6728, DOI 10.1364/AO.42.006728.
   Sjoholm M, 2001, OPT LETT, V26, P16, DOI 10.1364/OL.26.000016.
   Svanberg S, 2013, WOODH PUB SER ELECT, P286, DOI 10.1533/9780857097545.3.286.
   Svanberg S, 2010, LASER PHYS, V20, P68, DOI 10.1134/S1054660X09170198.
   Svanberg S, 2013, LASER PHOTONICS REV, V7, P779, DOI 10.1002/lpor.201200073.
   Watelet JB, 1999, ALLERGY, V54, P14, DOI 10.1111/j.1398-9995.1999.tb04402.x.
   Werle P, 1998, SPECTROCHIM ACTA A, V54, P197, DOI 10.1016/S1386-1425(97)00227-8.
   Wise R., 2002, J ANTIMICROB CHEMOTH, V49, P585.
   Zhang H., 2015, J BIOMEDICA IN PRESS.}},
Number-of-Cited-References = {{21}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{9}},
Journal-ISO = {{J. Biophotonics}},
Doc-Delivery-Number = {{CV5NL}},
Unique-ID = {{ISI:000364317500015}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000363348700002,
Author = {Huijbers, Patricia M. C. and Blaak, Hetty and de Jong, Mart C. M. and
   Graat, Elisabeth A. M. and Vandenbroucke-Grauls, Christina M. J. E. and
   Husman, Ana Maria de Roda},
Title = {{Role of the Environment in the Transmission of Antimicrobial Resistance
   to Humans: A Review}},
Journal = {{ENVIRONMENTAL SCIENCE \& TECHNOLOGY}},
Year = {{2015}},
Volume = {{49}},
Number = {{20}},
Pages = {{11993-12004}},
Month = {{OCT 20}},
Abstract = {{To establish a possible role for the natural environment in the
   transmission of clinically relevant AMR bacteria to humans, a literature
   review was conducted to systematically collect and categorize evidence
   for human exposure to extended-spectrum beta-lactamase-producing
   Enterobacteriaceae, methicillin-resistant Staphylococcus aureus, and
   vancomycin-resistant Enterococcus spp. in the environment. In total, 239
   datasets adhered to inclusion criteria. AMR bacteria were detected at
   exposure-relevant sites (35/38), including recreational areas, drinking
   water, ambient air, and shellfish, and in fresh produce (8/16). More
   datasets were available for environmental compartments (139/157),
   including wildlife, water, soil, and air/dust. Quantitative data from
   exposure-relevant sites (6/35) and environmental compartments (11/139)
   were scarce. AMR bacteria were detected in the contamination sources
   (66/66) wastewater and manure, and molecular data supporting their
   transmission from wastewater to the environment (1/66) were found. The
   abundance of AMR bacteria at exposure-relevant sites suggests risk for
   human exposure. Of publications pertaining to both environmental and
   human isolates, however, only one compared isolates from samples that
   had a clear spatial and temporal relationship, and no direct evidence
   was found for transmission to humans through the environment. To what
   extent the environment, compared to the clinical and veterinary domains,
   contributes to human exposure needs to be quantified. AMR bacteria in
   the environment, including sites relevant for human exposure, originate
   from contamination sources. Intervention strategies targeted at these
   sources could therefore limit emission of AMR bacteria to the
   environment.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Blaak, H (Reprint Author), Natl Inst Publ Hlth \& Environm RIVM, Ctr Zoonoses \& Environm Microbiol, Ctr Infect Dis Control CIb, POB 1, NL-3720 BA Bilthoven, Netherlands.
   Huijbers, Patricia M. C.; de Jong, Mart C. M.; Graat, Elisabeth A. M., Wageningen Univ, Wageningen Inst Anim Sci, Quantitat Vet Epidemiol Grp, NL-6700 AH Wageningen, Netherlands.
   Huijbers, Patricia M. C.; Blaak, Hetty; Husman, Ana Maria de Roda, Natl Inst Publ Hlth \& Environm RIVM, Ctr Zoonoses \& Environm Microbiol, Ctr Infect Dis Control CIb, NL-3720 BA Bilthoven, Netherlands.
   Vandenbroucke-Grauls, Christina M. J. E., Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol \& Infect Control, NL-1007 MB Amsterdam, Netherlands.
   Husman, Ana Maria de Roda, Univ Utrecht, Fac Vet Med, Inst Risk Assessment Sci, NL-3508 TD Utrecht, Netherlands.}},
DOI = {{10.1021/acs.est.5b02566}},
ISSN = {{0013-936X}},
EISSN = {{1520-5851}},
Keywords-Plus = {{SPECTRUM BETA-LACTAMASE; WATER TREATMENT-PLANT; VANCOMYCIN-RESISTANT;
   STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; WASTE-WATER;
   ANTIBIOTIC-RESISTANCE; SPORADIC INFECTIONS; SOURCE ATTRIBUTION;
   MUNICIPAL SEWAGE}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences}},
Author-Email = {{hetty.blaak@rivm.nl}},
ORCID-Numbers = {{de Jong, Mart/0000-0002-5339-1995}},
Funding-Acknowledgement = {{Netherlands Organization for Health Research and Development (ZonMw);
   Dutch Ministry of Health, Welfare and Sport (VWS)}},
Funding-Text = {{This work was financially supported by The Netherlands Organization for
   Health Research and Development (ZonMw) and the Dutch Ministry of
   Health, Welfare and Sport (VWS). We thank drs. A. M. P. Kersten for her
   valuable assistance with the literature search, and Prof. Dr. J. W. M.
   van der Meer and Prof. Dr. T. J. M. Verheij for their helpful
   suggestions on the manuscript.}},
Cited-References = {{Alouache S, 2014, MICROB DRUG RESIST, V20, P30, DOI 10.1089/mdr.2012.0264.
   Ashbolt NJ, 2013, ENVIRON HEALTH PERSP, V121, P993, DOI 10.1289/ehp.1206316.
   BATES J, 1994, J ANTIMICROB CHEMOTH, V34, P507, DOI 10.1093/jac/34.4.507.
   Blaak H, 2014, VET MICROBIOL, V171, P448, DOI 10.1016/j.vetmic.2014.03.007.
   Blaak H, 2014, APPL ENVIRON MICROB, V80, P239, DOI 10.1128/AEM.02616-13.
   Blanch AR, 2003, J APPL MICROBIOL, V94, P994, DOI 10.1046/j.1365-2672.2003.01919.x.
   Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482.
   Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55, P1.
   Centers for Disease Control and Prevention (CDC), 2010, VANC RES ENT VRE CLI.
   Chee-Sanford JC, 2009, J ENVIRON QUAL, V38, P1086, DOI 10.2134/jeq2008.0128.
   Clauss M, 2013, BERL MUNCH TIERARZTL, V126, P137, DOI 10.2376/0005-9366-126-137.
   Clinical Laboratory Standards Institute (CLSI), 2010, 20 INF SUPPL M100 20.
   Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10.
   de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104.
   Dolejska M, 2009, J APPL MICROBIOL, V106, P1941, DOI 10.1111/j.1365-2672.2009.04155.x.
   Domingues AR, 2012, EPIDEMIOL INFECT, V140, P970, DOI 10.1017/S0950268811002676.
   Domingues AR, 2012, EPIDEMIOL INFECT, V140, P959, DOI 10.1017/S0950268811002172.
   Droge M, 1999, BIOL FERT SOILS, V29, P221, DOI 10.1007/s003740050548.
   Evers E G, 2008, International Journal of Risk Assessment \& Management, V8, P174, DOI 10.1504/IJRAM.2008.016151.
   Fahrenfeld N, 2014, ENVIRON SCI TECHNOL, V48, P2643, DOI 10.1021/es404988k.
   Foley C, 2013, MMWR-MORBID MORTAL W, V62, P1029.
   Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483.
   Franz E, 2008, CRIT REV MICROBIOL, V34, P143, DOI {[}10.1080/10408410802357432, 10.1080/10408410802357432 ].
   Friese A, 2013, APPL ENVIRON MICROB, V79, P2759, DOI 10.1128/AEM.03939-12.
   Friese A, 2013, BERL MUNCH TIERARZTL, V126, P175, DOI 10.2376/0005-9366-126-175.
   Goldstein RER, 2014, INT J ENV RES PUB HE, V11, P4340, DOI 10.3390/ijerph110404340.
   Goldstein RER, 2014, SCI TOTAL ENVIRON, V466, P404, DOI 10.1016/j.scitotenv.2013.07.039.
   Gomez M, 2010, WIT TRANS ECOL ENVIR, V135, P83, DOI 10.2495/WP100081.
   Goodwin KD, 2012, WATER RES, V46, P4195, DOI 10.1016/j.watres.2012.04.001.
   Guardabassi L, 2004, APPL ENVIRON MICROB, V70, P984, DOI 10.1128/AEM.70.2.984-990.2004.
   Guardabassi L, 2002, MICROB DRUG RESIST, V8, P401, DOI 10.1089/10766290260469688.
   Hartmann A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00083.
   Harwood VJ, 2014, FEMS MICROBIOL REV, V38, P1, DOI 10.1111/1574-6976.12031.
   Hasan B, 2012, EMERG INFECT DIS, V18, P2055, DOI 10.3201/eid1812.120513.
   Hernandez J, 2012, APPL ENVIRON MICROB, V78, P2056, DOI 10.1128/AEM.07320-11.
   Hower S, 2013, MICROB ECOL, V65, P1024, DOI 10.1007/s00248-013-0178-3.
   Huijbers PMC, 2013, CLIN MICROBIOL INFEC, V19, pE256, DOI 10.1111/1469-0691.12150.
   Hunter PR, 2008, APPL ENVIRON MICROB, V74, P6085, DOI 10.1128/AEM.01036-08.
   Korzeniewska E, 2013, J ENVIRON MANAGE, V128, P904, DOI 10.1016/j.jenvman.2013.06.051.
   Korzeniewska E, 2013, J ENVIRON MANAGE, V123, P1, DOI 10.1016/j.jenvman.2013.03.024.
   Korzeniewska E, 2013, ECOTOX ENVIRON SAFE, V91, P96, DOI 10.1016/j.ecoenv.2013.01.014.
   Kruger U, 2000, Schriftenr Ver Wasser Boden Lufthyg, V105, P319.
   Kuhn I, 2005, APPL ENVIRON MICROB, V71, P5383, DOI 10.1128/AEM.71.9.5383-5390.2005.
   Levin-Edens E, 2012, FEMS MICROBIOL ECOL, V79, P412, DOI 10.1111/j.1574-6941.2011.01229.x.
   Ma JY, 2012, APPL ENVIRON MICROB, V78, P3668, DOI 10.1128/AEM.07507-11.
   Manero A, 2006, ENVIRON MICROBIOL, V8, P667, DOI 10.1111/j.1462-2920.2005.00945.x.
   Monier JM, 2011, CURR OPIN MICROBIOL, V14, P229, DOI 10.1016/j.mib.2011.04.010.
   Nagulapally SR, 2009, WATER ENVIRON RES, V81, P82, DOI 10.2175/106143008X304596.
   Novais C, 2005, APPL ENVIRON MICROB, V71, P3364, DOI 10.1128/AEM.71.63364-3368.2005.
   Pires SM, 2009, FOODBORNE PATHOG DIS, V6, P417, DOI 10.1089/fpd.2008.0208.
   Plano LRW, 2013, MICROB ECOL, V65, P1039, DOI 10.1007/s00248-013-0216-1.
   Pruden A, 2013, ENVIRON HEALTH PERSP, V121, P878, DOI 10.1289/ehp.1206446.
   Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739.
   Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17.
   Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x.
   Shuval Hillel, 2003, Journal of Water and Health, V1, P53.
   Soraas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069581.
   Varela AR, 2013, SCI TOTAL ENVIRON, V450, P155, DOI 10.1016/j.scitotenv.2013.02.015.
   World Health Organization, 2014, ANT RES GLOB REP SUR.}},
Number-of-Cited-References = {{59}},
Times-Cited = {{51}},
Usage-Count-Last-180-days = {{16}},
Usage-Count-Since-2013 = {{191}},
Journal-ISO = {{Environ. Sci. Technol.}},
Doc-Delivery-Number = {{CU2JB}},
Unique-ID = {{ISI:000363348700002}},
DA = {{2018-08-13}},
}

@article{ ISI:000362811600003,
Author = {Beyer, Anne and Baumann, Sven and Scherz, Gesine and Stahl, Jessica and
   von Bergen, Martin and Friese, Anika and Roesler, Uwe and Kietzmann,
   Manfred and Honscha, Walther},
Title = {{Effects of ceftiofur treatment on the susceptibility of commensal
   porcine E.coli - comparison between treated and untreated animals housed
   in the same stable}},
Journal = {{BMC VETERINARY RESEARCH}},
Year = {{2015}},
Volume = {{11}},
Month = {{OCT 15}},
Abstract = {{Background: Healthy farm animals have been found to act as a reservoir
   of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli
   (E. coli). Therefore, the objective of the study was to determine the
   input of antimicrobial active ceftiofur metabolites in the stable via
   faeces and urine after intramuscular administration of the drug to pigs
   and the elucidation of the Escherichia coli ESBL resistance pattern of
   treated and untreated pigs housed in the same barn during therapy.
   Methods: For determination of the minimal inhibitory concentration (MIC)
   the method of microdilutionaccording to the recommended procedure of the
   Clinical and Laboratory Standards Institute was used. Inaddition to
   that, a qualitative determination was performed by agar dilution.
   Unsusceptible E. coli speciesselected via agar dilution with cefotaxime
   were confirmed by MALDI-TOF and ESBL encoding genes wereidentified by
   PCR. The amounts of ceftiofur measured as desfuroylceftiofur (DFC) in
   the different probes (plasma, urine, faeces and dust) were analysed by
   UPLC-MS/MS.
   Results: In a first experiment two groups of pigs (6 animals per group)
   were housed in the same barn in two separated boxes. One group (group B)
   were treated with ceftiofur according to the licence (3 mg/kg
   administered intramuscularly (i.m.) on three consecutive days, day 1-3).
   During a second treatment period (day 29-31) an increased rate of ESBL
   resistant E. coli was detectable in these treated pigs and in the air of
   the stable. Moreover, the second group of animals (group A) formerly
   untreated but housed for the whole period in the same stable as the
   treated animals revealed increased resistance rates during their first
   treatment (day 45-47) with ceftiofur. In order to investigate the
   environmental input of ceftiofur during therapy and to simulate oral
   uptake of ceftiofur residues from the air of the stable a second set of
   experiments were performed. Pigs (6 animals) were treated with an
   interval of 2 weeks for 3 days with different doses of ceftiofur (3
   mg/kg, 1 mg/kg and 0.3 mg/kg i.m.) as well as with 3 mg/kg per os) and
   the renal and biliary excretion of ceftiofur as its active metabolite
   were measured in comparison to the plasma levels. In addition to that,
   probes of the sedimentation dust and the air of the stable were analysed
   for drug residues.
   Conclusion: The present study shows that treatment of several animals in
   a stable with ceftiofur influences the resistance pattern of intestinal
   Escherichia coli of the treated as well as untreated animals housed in
   the same stable. During therapy with the drug which was administered by
   injection according to the licence we detected nameable amounts of
   ceftiofur and its active metabolites in the dust and air of the stable.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Honscha, W (Reprint Author), Univ Leipzig, Fac Vet Med, Inst Pharmacol Pharm \& Toxicol, D-04109 Leipzig, Germany.
   Beyer, Anne; Honscha, Walther, Univ Leipzig, Fac Vet Med, Inst Pharmacol Pharm \& Toxicol, D-04109 Leipzig, Germany.
   Baumann, Sven; von Bergen, Martin, UFZ Helmholtz Ctr Environm Res, Dept Metabol, Leipzig, Germany.
   Baumann, Sven, Univ Leipzig, Fac Biosci Pharm \& Psychol, Inst Pharm, D-04109 Leipzig, Germany.
   Scherz, Gesine; Stahl, Jessica; Kietzmann, Manfred, Univ Vet Med Hannover, Inst Pharmacol Toxicol \& Pharm, Hannover, Germany.
   von Bergen, Martin, UFZ Helmholtz Ctr Environm Res, Dept Prote, Leipzig, Germany.
   von Bergen, Martin, Aalborg Univ, Chem \& Environm Engn, Dept Biotechnol, Aalborg, Denmark.
   Friese, Anika; Roesler, Uwe, Free Univ Berlin, Inst Anim Hyg \& Environm Hlth, Berlin, Germany.}},
DOI = {{10.1186/s12917-015-0578-3}},
Article-Number = {{265}},
ISSN = {{1746-6148}},
Keywords = {{Cephalosporins; ESBLs; Swine; Stable dust; Aerosol}},
Keywords-Plus = {{SPECTRUM BETA-LACTAMASES; ESCHERICHIA-COLI; CTX-M;
   ANTIBIOTIC-RESISTANCE; PIGS; CEFTRIAXONE; PREVALENCE; METABOLISM;
   CHICKENS; TISSUES}},
Research-Areas = {{Veterinary Sciences}},
Web-of-Science-Categories  = {{Veterinary Sciences}},
Author-Email = {{honscha@vetmed.uni-leipzig.de}},
ResearcherID-Numbers = {{von Bergen, Martin/D-7960-2011
   }},
ORCID-Numbers = {{von Bergen, Martin/0000-0003-2732-2977
   Baumann, Sven/0000-0002-3453-5308}},
Funding-Acknowledgement = {{German Federal Ministry for Education and Research {[}FKZ: 01KI1013 A]}},
Funding-Text = {{This project was supported by the German Federal Ministry for Education
   and Research (FKZ: 01KI1013 A).}},
Cited-References = {{Babic M, 2006, DRUG RESIST UPDATE, V9, P142, DOI 10.1016/j.drup.2006.05.005.
   BAUERNFEIND A, 1990, INFECTION, V18, P294, DOI 10.1007/BF01647010.
   BECONIBARKER MG, 1995, J CHROMATOGR B, V673, P231, DOI 10.1016/0378-4347(95)00258-1.
   BeconiBarker MG, 1996, J VET PHARMACOL THER, V19, P192, DOI 10.1111/j.1365-2885.1996.tb00038.x.
   BECONIBARKER MG, 1995, J AGR FOOD CHEM, V43, P1589, DOI 10.1021/jf00054a033.
   Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x.
   Cavaco LM, 2008, ANTIMICROB AGENTS CH, V52, P3612, DOI 10.1128/AAC.00354-08.
   CLSI, 2002, M31 A2 PERF STAND AN, V22.
   Costa D, 2004, J ANTIMICROB CHEMOTH, V54, P960, DOI 10.1093/jac/dkh444.
   Council of the European Union, COUNC CONCL IMP ANT.
   DVG, 2002, NCCLS M31 A2.
   EUCAST, 2012, EUCAST MIC DISTR REF.
   European Commission, COMM COMM EUR PARL C.
   Fecteau ME, 2003, AM J VET RES, V64, P918, DOI 10.2460/ajvr.2003.64.918.
   Friese A, 2014, BERL MUNCH TIERARZTL, V127, P412.
   Frye JG, 2011, FOODBORNE PATHOG DIS, V8, P663, DOI 10.1089/fpd.2010.0695.
   GILBERTSON TJ, 1990, J AGR FOOD CHEM, V38, P890, DOI 10.1021/jf00093a064.
   Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158.
   Hall BG, 2004, DRUG RESIST UPDATE, V7, P111, DOI 10.1016/j.drup.2004.02.003.
   Hamscher G, 2003, ENVIRON HEALTH PERSP, V111, P1590, DOI 10.1289/ehp.6288.
   Hornish Rex E., 2002, Current Topics in Medicinal Chemistry, V2, P717, DOI 10.2174/1568026023393679.
   Horton RA, 2011, APPL ENVIRON MICROB, V77, P3715, DOI 10.1128/AEM.02831-10.
   JACOBY GA, 1991, ANTIMICROB AGENTS CH, V35, P1697, DOI 10.1128/AAC.35.9.1697.
   Jiang XP, 2006, FOODBORNE PATHOG DIS, V3, P355, DOI 10.1089/fpd.2006.3.355.
   Jorgensen CJ, 2007, J ANTIMICROB CHEMOTH, V59, P1040, DOI 10.1093/jac/dkm075.
   Kietzmann M, 1995, DEUT TIERARZTL WOCH, V102, P441.
   Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483.
   Lowrance TC, 2007, AM J VET RES, V68, P501, DOI 10.2460/ajvr.68.5.501.
   Lutz EA, 2011, FOODBORNE PATHOG DIS, V8, P1229, DOI 10.1089/fpd.2011.0925.
   Mathew AG, 2001, J SWINE HEALTH PROD, V9, P154.
   Melzer M, 2007, J INFECTION, V55, P254, DOI 10.1016/j.jinf.2007.04.007.
   Mshana S, 2009, BMC INFECT DIS, V17, P97.
   MUELLER W, 1986, Zentralblatt fuer Bakteriologie Mikrobiologie und Hygiene Series A, V262, P304.
   Olson SC, 1998, J VET PHARMACOL THER, V21, P112, DOI 10.1046/j.1365-2885.1998.00118.x.
   Randall LP, 2014, J ANTIMICROB CHEMOTH, V69, P2947, DOI 10.1093/jac/dku258.
   Randall LP, 2011, J ANTIMICROB CHEMOTH, V66, P86, DOI 10.1093/jac/dkq396.
   Rodriguez-Bano J, 2006, CLIN INFECT DIS, V43, P1407, DOI 10.1086/508877.
   Roschanski N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100956.
   Salviati C, 2015, VET MICROBIOL, V175, P77.
   Scherz G, 2014, BERL MUNCH TIERARZTL, V127, P478, DOI 10.2376/0005-9366-127-478.
   Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178.
   Shallcross LJ, 2014, J ANTIMICROB CHEMOTH, V69, P2883, DOI 10.1093/jac/dku346.
   Snow LC, 2012, PREV VET MED, V106, P225, DOI 10.1016/j.prevetmed.2012.03.009.
   Tragesser LA, 2006, AM J VET RES, V67, P1696, DOI 10.2460/ajvr.67.10.1696.
   Varga C, 2009, PREV VET MED, V88, P185, DOI 10.1016/j.prevetmed.2008.10.002.
   Vetidata, 2013, VET INF ARZN TOX ARZ.
   World Health Organization, 2001, WHO GLOB STRAT CONT.
   Zessel K, 2012, THESIS TIERARZTL HOC.
   Zucker BA, 2002, BERL MUNCH TIERARZTL, V115, P30.}},
Number-of-Cited-References = {{49}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{17}},
Journal-ISO = {{BMC Vet. Res.}},
Doc-Delivery-Number = {{CT4XU}},
Unique-ID = {{ISI:000362811600003}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000360411300082,
Author = {Kotecka, K. and Krysinski, P.},
Title = {{Effect of tetracycline antibiotic on the monolayers of
   phosphatidylcholines at the air-water interface}},
Journal = {{COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS}},
Year = {{2015}},
Volume = {{482}},
Pages = {{678-686}},
Month = {{OCT 5}},
Abstract = {{Tetracycline is a broad-spectrum antibiotic belonging to the polyketide
   class. It is widely used against bacterial infections as well as food
   additive to a live-stock. Since tetracycline is resistant against
   degradation, it accumulates in the environment, leading also to
   antibiotic residues in animal and food products, which is now considered
   to be an important health risk because of increasing antibiotic
   resistance of pathogenic microorganisms. In this work we studied the
   interactions of tetracycline with phospholipid monolayers at the
   air/water interface in order to elucidate the mechanism of its action on
   cell membrane biomimetic system. We selected three phosphatidylcholines,
   having the same head-group structure, differing with respect to their
   hydrophobic chain length, the presence of unsaturated bonds between
   carbon atoms and, consequently, the phase transition temperature.
   Analysis of the results presented here suggests that tetracycline
   interacts with the three phosphatidylcholines mainly through the
   electrostatic interactions with hydrophilic groups of these lipids. On
   the other hand, the shape of presented pressure-area isotherms and their
   compressibility moduli show the synergistic effect of hydrophobic
   interactions that are larger for longer alkyl chains, promoting easier
   ordering of monolayer molecules with increased surface pressure when
   drug is present in the subphase, particularly for saturated DPPC. Based
   on our contact potential data we think that positively charged tertiary
   amino group of TC is facing negatively charged phosphate groups of
   phosphatidylcholines, penetrating only the hydrophilic head group region
   but not the hydrophobic moiety of these monolayers. However, the
   observed differences in CPD values for the case of DMPC point toward the
   drug disordering influence also on the organization of the hydrophobic
   region of this monolayer. This is because the drug penetration disturbs
   the van der Waals ordering interactions between its shorter hydrophobic
   chains to a greater extent comparing to DPPC and DOPC molecules. (C)
   2015 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Krysinski, P (Reprint Author), Univ Warsaw, Fac Chem, PL-02093 Warsaw, Poland.
   Kotecka, K.; Krysinski, P., Univ Warsaw, Fac Chem, PL-02093 Warsaw, Poland.}},
DOI = {{10.1016/j.colsurfa.2015.05.055}},
ISSN = {{0927-7757}},
EISSN = {{1873-4359}},
Keywords = {{Tetracycline; Langmuir films; Interaction}},
Keywords-Plus = {{LANGMUIR MONOLAYERS; DOXORUBICIN; MODEL; HYDROCHLORIDE; ENVIRONMENT;
   RESISTANCE; SYSTEMS; QUARTZ; FILMS}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Physical}},
Author-Email = {{pakrys@chem.uw.edu.pl}},
Funding-Acknowledgement = {{Switzerland through the Swiss Contribution to the enlarged European
   Union {[}PSPB-079/2010]}},
Funding-Text = {{This work was supported by Project PSPB-079/2010 - grant from
   Switzerland through the Swiss Contribution to the enlarged European
   Union.}},
Cited-References = {{Batt AL, 2007, CHEMOSPHERE, V68, P428, DOI 10.1016/j.chemosphere.2007.01.008.
   Butaye P, 2001, ANTIMICROB AGENTS CH, V45, P1374, DOI 10.1128/AAC.45.5.1374-1378.2001.
   Chen TS, 2014, INT J ELECTROCHEM SC, V9, P8422.
   Daghrir R, 2013, ENVIRON CHEM LETT, V11, P209, DOI 10.1007/s10311-013-0404-8.
   DEWOLF FA, 1993, BIOCHEMISTRY-US, V32, P6688, DOI 10.1021/bi00077a023.
   Dynarowicz-Latka P, 2001, ADV COLLOID INTERFAC, V91, P221, DOI 10.1016/S0001-8686(99)00034-2.
   Gaber MH, 1998, BIOPHYS CHEM, V70, P223, DOI 10.1016/S0301-4622(97)00125-7.
   Gambinossi F, 2004, BIOPHYS CHEM, V110, P101, DOI 10.1016/j.bpc.2004.01.008.
   Goto TE, 2014, J COLLOID INTERF SCI, V431, P24, DOI 10.1016/j.jcis.2014.05.050.
   Ha TH, 2000, LANGMUIR, V16, P871, DOI 10.1021/la981752y.
   Harkins W. D., 1952, PHYS CHEM SURFACE FI, P107.
   Kang J, 2010, J COLLOID INTERF SCI, V344, P117, DOI 10.1016/j.jcis.2009.11.049.
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j.
   Mangiarotti A, 2014, BBA-BIOMEMBRANES, V1838, P1823, DOI 10.1016/j.bbamem.2014.02.012.
   Martins AC, 2015, CHEM ENG J, V260, P291, DOI 10.1016/j.cej.2014.09.017.
   Mecheri B, 2004, BIOPHYS CHEM, V111, P15, DOI 10.1016/j.bpc.2004.03.008.
   Michalova E, 2004, VET MED-CZECH, V49, P79, DOI 10.17221/5681-VETMED.
   Nieciecka D, 2015, ELECTROCHIM ACTA, V165, P430, DOI 10.1016/j.electacta.2015.02.223.
   Nieciecka D, 2013, LANGMUIR, V29, P14560, DOI 10.1021/la403765w.
   Nieciecka D, 2013, LANGMUIR, V29, P14570, DOI 10.1021/la4037666.
   Oliveira ON, 1997, LANGMUIR, V13, P5920, DOI 10.1021/la970272o.
   Qin JY, 2015, FOOD CHEM, V170, P415, DOI 10.1016/j.foodchem.2014.08.050.
   Risovic D, 2012, J COLLOID INTERF SCI, V373, P116, DOI 10.1016/j.jcis.2011.12.009.
   Risovic D, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3522646.
   Sczesny S, 2003, J AGR FOOD CHEM, V51, P697, DOI 10.1021/jf0258407.
   Shanmukh S, 2004, VIB SPECTROSC, V36, P167, DOI 10.1016/j.vibspec.2004.05.002.
   Tanis E, 2008, COLLOID SURFACE A, V327, P57, DOI 10.1016/j.colsurfa.2008.06.013.
   Mercado FV, 2011, CHEM PHYS LIPIDS, V164, P386, DOI 10.1016/j.chemphyslip.2011.05.004.
   Warschawski DE, 2011, BBA-BIOMEMBRANES, V1808, P1957, DOI 10.1016/j.bbamem.2011.03.016.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{8}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{63}},
Journal-ISO = {{Colloid Surf. A-Physicochem. Eng. Asp.}},
Doc-Delivery-Number = {{CQ2ED}},
Unique-ID = {{ISI:000360411300082}},
DA = {{2018-08-13}},
}

@article{ ISI:000362848000003,
Author = {Tseng, C. -C. and Hsiao, P. -K. and Chang, K. -C. and Cheng, C. -C. and
   Yiin, L. -M. and Hsieh, C. -J.},
Title = {{Detection of viable antibiotic-resistant/sensitive Acinetobacter
   baumannii in indoor air by propidium monoazide quantitative polymerase
   chain reaction}},
Journal = {{INDOOR AIR}},
Year = {{2015}},
Volume = {{25}},
Number = {{5}},
Pages = {{475-487}},
Month = {{OCT}},
Abstract = {{Acinetobacter baumannii represents a significant cause of nosocomial
   infections. Therefore, we combined real-time quantitative polymerase
   chain reaction (PCR) with the propidium monoazide (PMA-qPCR) to assess
   the feasibility of detecting viable, airborne A. baumannii. The
   biological collection efficiencies of three samplers for collecting
   airborne A. baumannii were evaluated by PMA-qPCR in a chamber study.
   After sampling, the effects of storage in collection fluid on A.
   baumannii were evaluated. The results showed that the culturable ratio
   of A. baumannii measured using the culture method was significantly
   correlated with the viable ratio measured using PMA-qPCR, but was not
   significantly correlated with the qPCR results. It was indicated that
   the AGI-30 impinger and the BioSampler were much more effective than the
   Nuclepore filter sampler for collecting airborne A. baumannii. The
   storage temperature was critical for aerosol samples, as the loss of
   viable A. baumannii was minimized when the PMA-bound DNA was stored at
   -20 degrees C or if the collected cells were stored at 4 degrees C and
   subsequently processed by PMA-qPCR within 1 month. The PMA-qPCR method
   was also to distinguish between colistin-sensitive and
   colistin-resistant A. baumannii, and no colistin-sensitive A. baumannii
   was detected by PMA-qPCR upon treatment of the BioSampler collection
   medium with 2 mu g/ml colistin for 5 min.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Tseng, CC (Reprint Author), Tzu Chi Univ, Dept \& Grad Inst Publ Hlth, Hualien, Taiwan.
   Tseng, C. -C.; Cheng, C. -C.; Yiin, L. -M.; Hsieh, C. -J., Tzu Chi Univ, Dept \& Grad Inst Publ Hlth, Hualien, Taiwan.
   Hsiao, P. -K., Natl Taiwan Univ, Inst Environm Hlth, Taipei 10764, Taiwan.
   Chang, K. -C., Tzu Chi Univ, Dept Lab Med \& Biotechnol, Hualien, Taiwan.}},
DOI = {{10.1111/ina.12165}},
ISSN = {{0905-6947}},
EISSN = {{1600-0668}},
Keywords = {{Acinetobacter baumannii; Propidium monoazide; Colistin; Bioaerosol}},
Keywords-Plus = {{BIOAEROSOL SAMPLING TECHNIQUES; ETHIDIUM-BROMIDE MONOAZIDE; DEAD
   STAPHYLOCOCCUS-AUREUS; REAL-TIME PCR; FLOW-CYTOMETRY;
   LEGIONELLA-PNEUMOPHILA; PREFERENTIAL DETECTION; AIRBORNE BACTERIA;
   RESISTANT; FLUOROCHROME}},
Research-Areas = {{Construction \& Building Technology; Engineering; Public, Environmental
   \& Occupational Health}},
Web-of-Science-Categories  = {{Construction \& Building Technology; Engineering, Environmental; Public,
   Environmental \& Occupational Health}},
Author-Email = {{tsengcc@mail.tcu.edu.tw}},
ORCID-Numbers = {{Yiin, Lih-Ming/0000-0001-7732-9291
   HSIAO, PAO-KUEI/0000-0003-1212-6535}},
Funding-Acknowledgement = {{Ministry of Science and Technology, Republic of China {[}MOST
   102-2314-B-320-005]; Tzu Chi University, Hualien, Taiwan
   {[}TCMRC-P-101011-01]}},
Funding-Text = {{This work was supported by grant MOST 102-2314-B-320-005 from the
   Ministry of Science and Technology, Republic of China and grant
   TCMRC-P-101011-01 from Tzu Chi University, Hualien, Taiwan.}},
Cited-References = {{Akalin H, 2006, INFECT CONT HOSP EP, V27, P404, DOI 10.1086/503349.
   Cai Y, 2012, J ANTIMICROB CHEMOTH, V67, P1607, DOI 10.1093/jac/dks084.
   Cawthorn DM, 2008, J APPL MICROBIOL, V105, P1178, DOI 10.1111/j.1365-2672.2008.03851.x.
   Center for Disease Control Taiwan, 2012, ANN REP NOS INF SURV.
   Chang CW, 2015, INDOOR AIR, V25, P59, DOI 10.1111/ina.12124.
   Chang CW, 2011, INDOOR AIR, V21, P291, DOI 10.1111/j.1600-0668.2010.00701.x.
   Chang CW, 2011, AEROSOL SCI TECH, V45, P343, DOI 10.1080/02786826.2010.537400.
   Chang CW, 2010, J AEROSOL SCI, V41, P1055, DOI 10.1016/j.jaerosci.2010.09.002.
   Chang HL, 2009, INFECT CONT HOSP EP, V30, P34, DOI 10.1086/592704.
   Chen NT, 2010, J APPL MICROBIOL, V109, P623, DOI 10.1111/j.1365-2672.2010.04678.x.
   Chen PS, 2008, AEROSOL SCI TECH, V42, P194, DOI 10.1080/02786820801922953.
   Chen PS, 2005, AEROSOL SCI TECH, V39, P231, DOI 10.1080/027868290925534.
   Chen PS, 2005, J ENVIRON MONITOR, V7, P257, DOI 10.1039/b415250f.
   Chen PS, 2005, J ENVIRON MONITOR, V7, P950, DOI 10.1039/b505224f.
   Chi MC, 2005, AEROSOL SCI TECH, V39, P1101, DOI 10.1080/02786820500421539.
   Chuang YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014133.
   Clifford RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048558.
   Clinical and Laboratory Standards Institute, 2005, PERF STAND ANT SUS S.
   Coudray-Meunier C., 2013, BMC MICROBIOL, V1, P216.
   Fittipaldi M, 2012, J MICROBIOL METH, V91, P276, DOI 10.1016/j.mimet.2012.08.007.
   Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007.
   Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803.
   Hilton CL, 2001, J APPL MICROBIOL, V91, P929, DOI 10.1046/j.1365-2672.2001.01457.x.
   Hospodsky D, 2010, APPL ENVIRON MICROB, V76, P7004, DOI 10.1128/AEM.01240-10.
   Hsiao PK, 2014, AEROSOL SCI TECH, V48, P173, DOI 10.1080/02786826.2013.865833.
   Hsiao PK, 2012, AEROSOL SCI TECH, V46, P297, DOI 10.1080/02786826.2011.626001.
   Jawad A, 1996, J CLIN MICROBIOL, V34, P2881.
   Karumathil DP, 2014, INT J ENV RES PUB HE, V11, P1844, DOI 10.3390/ijerph110201844.
   Kobayashi H, 2009, LETT APPL MICROBIOL, V48, P633, DOI 10.1111/j.1472-765X.2009.02585.x.
   Kobayashi H, 2010, J ORTHOP RES, V28, P1245, DOI 10.1002/jor.21108.
   Kobayashi H, 2009, J ORTHOP RES, V27, P1243, DOI 10.1002/jor.20872.
   Li CS, 2001, SCI TOTAL ENVIRON, V278, P231, DOI 10.1016/S0048-9697(01)00654-4.
   Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1.
   Li J, 2006, ANTIMICROB AGENTS CH, V50, P2946, DOI 10.1128/AAC.00103-06.
   Liang YD, 2012, ENVIRON SCI TECHNOL, V46, P3360, DOI {[}10.1021/es203770q, 10.1021/es203770g].
   Lin WH, 1999, AEROSOL SCI TECH, V30, P109, DOI 10.1080/027868299304714.
   Lin XJ, 2000, AEROSOL SCI TECH, V32, P184, DOI 10.1080/027868200303722.
   Lin XJ, 1999, ATMOS ENVIRON, V33, P4291, DOI 10.1016/S1352-2310(99)00169-7.
   Liu YR, 2014, INT J FOOD MICROBIOL, V170, P48, DOI 10.1016/j.ijfoodmicro.2013.10.026.
   Macher J, 1999, AM C GOV IND HYG.
   Masters CI, 1998, LETT APPL MICROBIOL, V27, P279, DOI 10.1046/j.1472-765X.1998.t01-14-00449.x.
   MCGANN LE, 1978, CRYOBIOLOGY, V15, P382, DOI 10.1016/0011-2240(78)90056-1.
   Meric M, 2008, FEMS MICROBIOL LETT, V282, P214, DOI 10.1111/j.1574-6968.2008.01129.x.
   Munoz-Price LS, 2013, CRIT CARE MED, V41, P1915, DOI 10.1097/CCM.0b013e31828a39c0.
   Napoli C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-594.
   Nocker A, 2009, FEMS MICROBIOL LETT, V291, P137, DOI 10.1111/j.1574-6968.2008.01429.x.
   Nocker A, 2007, J MICROBIOL METH, V70, P252, DOI 10.1016/j.mimet.2007.04.014.
   Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015.
   OKPARA AU, 1994, AM J HOSP PHARM, V51, P2671.
   Parshionikar S, 2010, APPL ENVIRON MICROB, V76, P4318, DOI 10.1128/AEM.02800-09.
   Rastogi VK, 2007, MIL MED, V172, P1166, DOI 10.7205/MILMED.172.11.1166.
   Sanchez G, 2012, FOOD ENVIRON VIROL, V4, P21, DOI 10.1007/s12560-011-9074-5.
   Sengstock DM, 2010, CLIN INFECT DIS, V50, P1611, DOI 10.1086/652759.
   THORNE PS, 1992, APPL ENVIRON MICROB, V58, P2543.
   Tseng CC, 2005, J AEROSOL SCI, V36, P593, DOI 10.1016/j.jaerosci.2004.12.004.
   Tseng CC, 2010, J ENVIRON HEALTH, V73, P22.
   Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06.
   Villegas MV, 2003, INFECT CONT HOSP EP, V24, P284, DOI 10.1086/502205.
   Wang SH, 2003, J HOSP INFECT, V53, P97, DOI 10.1053/jhin.2002.1348.}},
Number-of-Cited-References = {{59}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{31}},
Journal-ISO = {{Indoor Air}},
Doc-Delivery-Number = {{CT5KH}},
Unique-ID = {{ISI:000362848000003}},
DA = {{2018-08-13}},
}

@article{ ISI:000362558600011,
Author = {Betteken, Michael I. and Rocha, Edson R. and Smith, C. Jeffrey},
Title = {{Dps and DpsL Mediate Survival In Vitro and In Vivo during the Prolonged
   Oxidative Stress Response in Bacteroides fragilis}},
Journal = {{JOURNAL OF BACTERIOLOGY}},
Year = {{2015}},
Volume = {{197}},
Number = {{20}},
Pages = {{3329-3338}},
Month = {{OCT}},
Abstract = {{Bacteroides fragilis is a Gram-negative anaerobe and member of the human
   intestinal tract microbiome, where it plays many beneficial roles.
   However, translocation of the organism to the peritoneal cavity can lead
   to peritonitis, intra-abdominal abscess formation, bacteremia, and
   sepsis. During translocation, B. fragilis is exposed to increased
   oxidative stress from the oxygenated tissues of the peritoneal cavity
   and the immune response. In order to survive, B. fragilis mounts a
   robust oxidative stress response consisting of an acute and a prolonged
   oxidative stress (POST) response. This report demonstrates that the
   ability to induce high levels of resistance to tert-butyl hydroperoxide
   (tBOOH) after extended exposure to air can be linked to the POST
   response. Disk diffusion assays comparing the wild type to a Delta dps
   mutant and a Delta dps Delta bfr mutant showed greater sensitivity of
   the mutants to tBOOH after exposure to air, suggesting that Dps and DpsL
   play a role in the resistance phenotype. Complementation studies with
   dps or bfr (encoding DpsL) restored tBOOH resistance, suggesting a role
   for both of these ferritin-family proteins in the response.
   Additionally, cultures treated with the iron chelator dipyridyl were not
   killed by tBOOH, indicating Dps and DpsL function by sequestering iron
   to prevent cellular damage. An in vivo animal model showed that the
   Delta dps Delta bfr mutant was attenuated, indicating that management of
   iron is important for survival within the abscess. Together, these data
   demonstrate a role for Dps and DpsL in the POST response which mediates
   survival in vitro and in vivo.
   IMPORTANCE
   B. fragilis is the anaerobe most frequently isolated from
   extraintestinal opportunistic infections, but there is a paucity of
   information about the factors that allow this organism to survive
   outside its normal intestinal environment. This report demonstrates that
   the iron storage proteins Dps and DpsL protect against oxidative stress
   and that they contribute to survival both in vitro and in vivo.
   Additionally, this work demonstrates an important role for the POST
   response in B. fragilis survival and provides insight into the complex
   regulation of this response.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Smith, CJ (Reprint Author), E Carolina Univ, Dept Microbiol \& Immunol, Brody Sch Med, Greenville, NC 27858 USA.
   Betteken, Michael I.; Rocha, Edson R.; Smith, C. Jeffrey, E Carolina Univ, Dept Microbiol \& Immunol, Brody Sch Med, Greenville, NC 27858 USA.}},
DOI = {{10.1128/JB.00342-15}},
ISSN = {{0021-9193}},
EISSN = {{1098-5530}},
Keywords-Plus = {{DNA-BINDING PROTEIN; ESCHERICHIA-COLI; HYDROGEN-PEROXIDE;
   ANTIBIOTIC-RESISTANCE; GENETIC-ANALYSIS; MURINE MODEL; HUMAN FECES;
   ANAEROBE; IRON; VIRULENCE}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{smithcha@ecu.edu}},
ORCID-Numbers = {{Rocha, Edson R./0000-0002-3472-8951}},
Funding-Acknowledgement = {{NIH {[}AI40588]}},
Funding-Text = {{This work was supported by NIH grant AI40588 (to C.J.S.).}},
Cited-References = {{ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x.
   Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010.
   Bamberger DM, 2002, ANTIMICROB AGENTS CH, V46, P2878, DOI 10.1128/AAC.46.9.2878-2884.2002.
   Bellapadrona G, 2010, FREE RADICAL BIO MED, V48, P292, DOI 10.1016/j.freeradbiomed.2009.10.053.
   Bjerke GA, 2011, APPL ENVIRON MICROB, V77, P8318, DOI 10.1128/AEM.05293-11.
   Brenot A, 2005, MOL MICROBIOL, V55, P221, DOI 10.1111/j.1365-2958.2004.04370.x.
   Calhoun LN, 2011, J APPL MICROBIOL, V110, P375, DOI 10.1111/j.1365-2672.2010.04890.x.
   Cao YL, 2014, P NATL ACAD SCI USA, V111, P12901, DOI 10.1073/pnas.1407344111.
   Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013.
   Chiancone E, 2008, REND LINCEI-SCI FIS, V19, P261, DOI 10.1007/s12210-008-0018-4.
   Chung HC, 2010, CURR OPIN IMMUNOL, V22, P455, DOI 10.1016/j.coi.2010.06.008.
   Comstock L.E., 2000, PERSISTENT BACTERIOL, P397.
   Drahota Z, 2005, PHYSIOL RES, V54, P67.
   Eggerth AH, 1933, J BACTERIOL, V25, P389.
   Espey MG, 2013, FREE RADICAL BIO MED, V55, P130, DOI 10.1016/j.freeradbiomed.2012.10.554.
   Faulkner MJ, 2011, ANTIOXID REDOX SIGN, V15, P175, DOI 10.1089/ars.2010.3682.
   Finlay-Jones JJ, 1999, J LEUKOCYTE BIOL, V66, P583.
   Gauss GH, 2006, BIOCHEMISTRY-US, V45, P10815, DOI 10.1021/bi060728u.
   Gauss GH, 2012, J BACTERIOL, V194, P15, DOI 10.1128/JB.05260-11.
   Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108.
   GUINEY DG, 1984, P NATL ACAD SCI-BIOL, V81, P7203, DOI 10.1073/pnas.81.22.7203.
   Gundogdu O, 2011, J BACTERIOL, V193, P4238, DOI 10.1128/JB.05189-11.
   Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004.
   Herren CD, 2003, GENE, V316, P167, DOI 10.1016/S0378-1119(03)00759-5.
   Hix S, 1999, CHEM-BIOL INTERACT, V118, P141, DOI 10.1016/S0009-2797(99)00079-4.
   HIX S, 1995, FREE RADICAL BIO MED, V19, P293, DOI 10.1016/0891-5849(95)00026-T.
   Housseau F, 2010, CELL CYCLE, V9, P3, DOI 10.4161/cc.9.1.10352.
   JACOBS MR, 1990, J ANTIMICROB CHEMOTH, V26, P361, DOI 10.1093/jac/26.3.361.
   JOHNSON JL, 1978, INT J SYST BACTERIOL, V28, P245, DOI 10.1099/00207713-28-2-245.
   JOHNSON JL, 1986, INT J SYST BACTERIOL, V36, P499, DOI 10.1099/00207713-36-4-499.
   Lee SM, 2013, NATURE, V501, P426, DOI 10.1038/nature12447.
   Lobo LA, 2003, MICROBIOLOGYOPEN, V2, P326.
   Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007.
   Mazuski JE, 2009, SURG CLIN N AM, V89, P421, DOI 10.1016/j.suc.2008.12.001.
   MCCLEAN KL, 1994, CLIN INFECT DIS, V19, P100, DOI 10.1093/clinids/19.1.100.
   NAMAVAR F, 1989, J MED MICROBIOL, V29, P171, DOI 10.1099/00222615-29-3-171.
   National Research Council, 2011, GUIDE CARE USE LAB A.
   Pang B, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00058.
   Peshenko IV, 2001, FREE RADICAL BIO MED, V31, P292, DOI 10.1016/S0891-5849(01)00579-2.
   PRIVITERA G, 1979, J INFECT DIS, V139, P97, DOI 10.1093/infdis/139.1.97.
   RENVALL S, 1975, AM J SURG, V130, P286, DOI 10.1016/0002-9610(75)90387-6.
   Rocha ER, 2007, J BACTERIOL, V189, P8015, DOI 10.1128/JB.00714-07.
   Rocha Edson R., 2004, Microbiology (Reading), V150, P2125, DOI 10.1099/mic.0.26948-0.
   Rocha ER, 2013, BIOMETALS, V26, P577, DOI 10.1007/s10534-013-9650-2.
   Rocha ER, 1999, J BACTERIOL, V181, P5701.
   Rocha ER, 2000, J BACTERIOL, V182, P5059, DOI 10.1128/JB.182.18.5059-5069.2000.
   Rocha ER, 1996, J BACTERIOL, V178, P6895, DOI 10.1128/jb.178.23.6895-6903.1996.
   SAWYER RG, 1991, ANN SURG, V213, P253, DOI 10.1097/00000658-199103000-00013.
   Sears CL, 2014, J CLIN INVEST, V124, P4166, DOI 10.1172/JCI72334.
   SEVINC MS, 1995, EUR J BIOCHEM, V230, P127, DOI 10.1111/j.1432-1033.1995.0127i.x.
   Smith C.J., 2006, PROKARYOTES, V7, P381.
   Smith CJ, 1995, PLASMID, V34, P211, DOI 10.1006/plas.1995.0007.
   SMITH CJ, 1987, J BACTERIOL, V169, P3450, DOI 10.1128/jb.169.8.3450-3457.1987.
   Sund CJ, 2008, MOL MICROBIOL, V67, P129, DOI 10.1111/j.1365-2958.2007.06031.x.
   Sund CJ, 2006, FEMS MICROBIOL LETT, V261, P211, DOI 10.1111/j.1574-6968.00353.x.
   van Till JWO, 2007, SHOCK, V28, P504, DOI 10.1097/shk.0b013e318063e6ca.
   Velayudhan J, 2007, MOL MICROBIOL, V63, P1495, DOI 10.1111/j.1365-2958.2007.05600.x.
   Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07.
   Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200.}},
Number-of-Cited-References = {{59}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{13}},
Journal-ISO = {{J. Bacteriol.}},
Doc-Delivery-Number = {{CT1LA}},
Unique-ID = {{ISI:000362558600011}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000361919700012,
Author = {Chitnis, Amit S. and Davis, J. Lucian and Schecter, Gisela F. and Barry,
   Pennan M. and Flood, Jennifer M.},
Title = {{Review of Nucleic Acid Amplification Tests and Clinical Prediction Rules
   for Diagnosis of Tuberculosis in Acute Care Facilities}},
Journal = {{INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY}},
Year = {{2015}},
Volume = {{36}},
Number = {{10}},
Pages = {{1215-1225}},
Month = {{OCT}},
Abstract = {{Tuberculosis (TB) remains an important cause of hospitalization and
   mortality in the United States. Prevention of TB transmission in acute
   care facilities relies on prompt identification and implementation of
   airborne isolation, rapid diagnosis, and treatment of presumptive
   pulmonary TB patients. In areas with low TB burden, this strategy may
   result in inefficient utilization of airborne infection isolation rooms
   (AIIRs). We reviewed TB epidemiology and diagnostic approaches to inform
   optimal TB detection in low-burden settings. Published clinical
   prediction rules for individual studies have a sensitivity ranging from
   81\% to 100\% and specificity ranging from 14\% to 63\% for detection of
   culture-positive pulmonary TB patients admitted to acute care
   facilities. Nucleic acid amplification tests (NAATs) have a specificity
   of >98\%, and the sensitivity of NAATs varies by acid-fast bacilli
   sputum smear status (positive smear, >= 95\%; negative smear,
   50\%-70\%). We propose an infection prevention strategy using a clinical
   prediction rule to identify patients who warrant diagnostic evaluation
   for TB in an AIIR with an NAAT. Future studies are needed to evaluate
   whether use of clinical prediction rules and NAATs results in optimized
   utilization of AIIRs and improved detection and treatment of presumptive
   pulmonary TB patients.}},
Publisher = {{CAMBRIDGE UNIV PRESS}},
Address = {{32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Chitnis, AS (Reprint Author), 850 Marina Bay Pkwy,Bldg P,2nd Floor, Richmond, CA 94804 USA.
   Chitnis, Amit S.; Schecter, Gisela F.; Barry, Pennan M.; Flood, Jennifer M., Calif Dept Publ Hlth, Ctr Infect Dis, Div Communicable Dis Control, TB Control Branch, Richmond, CA USA.
   Davis, J. Lucian, Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   Davis, J. Lucian, Yale Univ, Sch Med, Div Pulm Crit Care \& Sleep Med, New Haven, CT USA.}},
DOI = {{10.1017/ice.2015.145}},
ISSN = {{0899-823X}},
EISSN = {{1559-6834}},
Keywords-Plus = {{SUSPECTED PULMONARY TUBERCULOSIS; XPERT MTB/RIF ASSAY; DETECTING
   MYCOBACTERIUM-TUBERCULOSIS; SPUTUM SMEAR MICROSCOPY; UNITED-STATES;
   RESPIRATORY ISOLATION; NOSOCOMIAL TRANSMISSION; RESISTANT TUBERCULOSIS;
   ISOLATING INPATIENTS; MULTIDRUG-RESISTANT}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{amitschitnis@gmail.com}},
ORCID-Numbers = {{Davis, J. Lucian/0000-0002-8629-9992}},
Cited-References = {{Aguilar J, 2009, INFECT DIS CLIN PRAC, V17, P317, DOI {[}10. 1097/IPC. 0b013e3181a6535c, DOI 10.1097/IPC.0B013E3181A6535C].
   {[}Anonymous], 2008, TUB STAYS US HOSP 20.
   {[}Anonymous], 2015, XPERT MTB RIF ASSAY.
   {[}Anonymous], 2013, AMPL MYC TUB DIR TES.
   Banerjee R, 2010, J CLIN MICROBIOL, V48, P3779, DOI 10.1128/JCM.01236-10.
   Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0.
   BLUMBERG HM, 1995, ANN INTERN MED, V122, P658, DOI 10.7326/0003-4819-122-9-199505010-00003.
   Bock NN, 1996, AM J RESP CRIT CARE, V154, P1468, DOI 10.1164/ajrccm.154.5.8912766.
   Boyles TH, 2014, INT J TUBERC LUNG D, V18, P876, DOI 10.5588/ijtld.13.0853.
   Campos M, 2008, AM J RESP CRIT CARE, V178, P300, DOI 10.1164/rccm.200803-381OC.
   Catanzaro A, 2000, JAMA-J AM MED ASSOC, V283, P639, DOI 10.1001/jama.283.5.639.
   Centers for Disease Control and Prevention, 2014, REP TUB US 2013.
   Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P7.
   Chaisson LH, 2014, CLIN INFECT DIS, V59, P1353, DOI 10.1093/cid/ciu620.
   Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012.
   Chitnis AS, 2014, AM J NEPHROL, V39, P314, DOI 10.1159/000360183.
   Cookson ST, 1997, INFECT DIS CLIN N AM, V11, P385, DOI 10.1016/S0891-5520(05)70362-7.
   Cordeiro-Santos M, 2014, INFECT CONT HOSP EP, V35, P1206, DOI 10.1086/677643.
   Davis JL, 2014, AM J RESP CRIT CARE, V189, P1551, DOI 10.1164/rccm.201311-1974OC.
   Demlow SE, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1600-1.
   El Sahly HM, 2001, J INFECT DIS, V183, P461.
   ElSolh A, 1997, AM J RESP CRIT CARE, V155, P1711, DOI 10.1164/ajrccm.155.5.9154881.
   Friedrich SO, 2013, LANCET RESP MED, V1, P462, DOI 10.1016/S2213-2600(13)70119-X.
   Gaeta TJ, 1997, ACAD EMERG MED, V4, P138, DOI 10.1111/j.1553-2712.1997.tb03721.x.
   Gitterman S, 2015, MMWR-MORBID MORTAL W, V64, P193.
   Goncalves BD, 2015, INFECT CONT HOSP EP, V36, P204, DOI 10.1017/ice.2014.29.
   Greco S, 2006, THORAX, V61, P783, DOI 10.1136/thx.2005.054908.
   Greco S, 2009, J CLIN MICROBIOL, V47, P569, DOI 10.1128/JCM.02051-08.
   Hansel NN, 2004, CHEST, V126, P1079, DOI 10.1378/chest.126.4.1079.
   Horne DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-258.
   Iademarco MF, 2013, MMWR-MORBID MORTAL W, V62, P821.
   Kattan JA, 2012, INT J TUBERC LUNG D, V16, P1657, DOI 10.5588/ijtld.12.0169.
   Lim TK, 2003, CHEST, V124, P902, DOI 10.1378/chest.124.3.902.
   Lim TK, 2000, CHEST, V118, P641, DOI 10.1378/chest.118.3.641.
   Lin SYG, 2014, J CLIN MICROBIOL, V52, P475, DOI 10.1128/JCM.01821-13.
   Lippincott CK, 2014, CLIN INFECT DIS, V59, DOI 10.1093/cid/ciu212.
   LoBue PA, 1998, CHEST, V113, P1184, DOI 10.1378/chest.113.5.1184.
   Luetkemeyer A, 2015, C RETR OPP INF FEBR.
   Manangan L, 2009, INT J TUBERC LUNG D, V13, P1077.
   Marks SM, 2011, INT J TUBERC LUNG D, V15, P465, DOI 10.5588/ijtld.10.0259.
   Marks SM, 2014, EMERG INFECT DIS, V20, P812, DOI 10.3201/eid2005.131037.
   Marks SM, 2013, CLIN INFECT DIS, V57, P532, DOI 10.1093/cid/cit336.
   Millman AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079669.
   Moran GJ, 2009, ANN EMERG MED, V53, P625, DOI 10.1016/j.annemergmed.2008.07.027.
   Mylotte JM, 1997, INFECT CONT HOSP EP, V18, P554.
   Nahid Payam, 2006, Proc Am Thorac Soc, V3, P103, DOI 10.1513/pats.200511-119JH.
   Nahid P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-1.
   Nguyen LT, 2011, INT J TUBERC LUNG D, V15, P257.
   Pascopella L, 2004, J CLIN MICROBIOL, V42, P4209, DOI 10.1128/JCM.42.9.4209-4213.2004.
   Pascopella L, 2014, OPEN FORUM INFECT DI, V1, P1, DOI DOI 10.1093/0FID/0FU090.
   Pegues CF, 1996, INFECT CONT HOSP EP, V17, P412.
   Piersimoni C, 2005, DIAGN MICR INFEC DIS, V53, P195, DOI 10.1016/j.diagmicrobio.2005.06.005.
   Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3.
   Rakoczy KS, 2008, INFECT CONT HOSP EP, V29, P927, DOI 10.1086/590667.
   Sarmiento OL, 2003, J CLIN MICROBIOL, V41, P3233, DOI 10.1128/JCM.41.7.3233-3240.2003.
   SCOTT B, 1994, ARCH INTERN MED, V154, P326, DOI 10.1001/archinte.154.3.326.
   Shah NS, 2012, INT J TUBERC LUNG D, V16, P1234, DOI 10.5588/ijtld.11.0794.
   Steingart KR, 2007, EXPERT REV ANTI-INFE, V5, P327, DOI 10.1586/14787210.5.3.327.
   Steingart KR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub3.
   Taegtmeyer M, 2008, THORAX, V63, P317, DOI 10.1136/thx.2007.083816.
   Taylor Z, 2000, INT J TUBERC LUNG D, V4, P931.
   Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1.
   Thomas JA, 2010, INT J TUBERC LUNG D, V14, P1603.
   Tuberculosis Control Branch, 2013, TUB CONTR BRANCH REP.
   van der Heijden YF, 2012, INT J TUBERC LUNG D, V16, P1162, DOI 10.5588/ijtld.12.0046.
   Wisnivesky JP, 2000, ARCH INTERN MED, V160, P2471, DOI 10.1001/archinte.160.16.2471.
   Wisnivesky JP, 2005, J GEN INTERN MED, V20, P947, DOI 10.1111/j.1525-1497.2005.0185.x.
   Wisnivesky JP, 2005, ARCH INTERN MED, V165, P453, DOI 10.1001/archinte.165.4.453.
   World Health Organization, 2011, RAP IMPL XPERT MTB R.}},
Number-of-Cited-References = {{69}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{6}},
Journal-ISO = {{Infect. Control Hosp. Epidemiol.}},
Doc-Delivery-Number = {{CS2RV}},
Unique-ID = {{ISI:000361919700012}},
DA = {{2018-08-13}},
}

@article{ ISI:000362175700033,
Author = {Schmithausen, Ricarda Maria and Schulze-Geisthoevel, Sophia Vernika and
   Stemmer, Franziska and El-Jade, Mohamed and Reif, Marion and Hack,
   Sylvia and Meilaender, Alina and Montabauer, Gabriele and Fimmers, Rolf
   and Parcina, Marijo and Hoerauf, Achim and Exner, Martin and Petersen,
   Brigitte and Bierbaum, Gabriele and Bekeredjian-Ding, Isabelle},
Title = {{Analysis of Transmission of MRSA and ESBL-E among Pigs and Farm
   Personnel}},
Journal = {{PLOS ONE}},
Year = {{2015}},
Volume = {{10}},
Number = {{9}},
Month = {{SEP 30}},
Abstract = {{Livestock-associated bacteria with resistance to two or more antibiotic
   drug classes have heightened our awareness for the consequences of
   antibiotic consumption and spread of resistant bacterial strains in the
   veterinary field. In this study we assessed the prevalence of
   concomitant colonization with livestock-associated methicillin-resistant
   Staphylococcus aureus (LA-MRSA) and enterobacteriaceae expressing
   extended-spectrum betalactamases (ESBL-E) in farms at the German-Dutch
   border region. Nasal colonization of pigs with MRSA (113/547 (20.7\%))
   was less frequent than rectal colonization with ESBL-E (163/540
   (30.2\%)). On the individual farm level MRSA correlated with ESBL-E
   recovery. The data further provide information on prevalence at
   different stages of pig production, including abattoirs, as well as in
   air samples and humans living and working on the farms. Notably, MRSA
   was detected in stable air samples of 34 out of 35 pig farms,
   highlighting air as an important MRSA transmission reservoir. The
   majority of MRSA isolates, including those from humans, displayed
   tetracycline resistance and spa types t011 and t034 characteristic for
   LA-MRSA, demonstrating transmission from pigs to humans. ESBL-E positive
   air samples were detected on 6 out of 35 farms but no pig-to-human
   transmission was found. Detection of ESBL-E, e.g. mostly Escherichia
   coli with CTX-M-type ESBL, was limited to these six farms. Molecular
   typing revealed transmission of ESBL-E within the pig compartments;
   however, related strains were also found on unrelated farms. Although
   our data suggest that acquisition of MRSA and ESBL-E might occur among
   pigs in the abattoirs, MRSA and ESBL-E were not detected on the
   carcasses. Altogether, our data define stable air (MRSA), pig
   compartments (ESBL-E) and abattoir waiting areas (MRSA and ESBL-E) as
   major hot spots for transmission of MRSA and/or ESBL-E along the pig
   production chain.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Bekeredjian-Ding, I (Reprint Author), Univ Hosp Bonn, Inst Med Microbiol Immunol \& Parasitol, Bonn, Germany.
   Schmithausen, Ricarda Maria; El-Jade, Mohamed; Reif, Marion; Meilaender, Alina; Montabauer, Gabriele; Parcina, Marijo; Hoerauf, Achim; Bierbaum, Gabriele, Univ Hosp Bonn, Inst Med Microbiol Immunol \& Parasitol, Bonn, Germany.
   Schmithausen, Ricarda Maria; Schulze-Geisthoevel, Sophia Vernika; Stemmer, Franziska; Petersen, Brigitte, Univ Bonn, Prevent Hlth Management Grp, Inst Anim Sci, Bonn, Germany.
   Fimmers, Rolf, Univ Hosp Bonn, Inst Med Biometry Epidemiol \& Comp Sci, Bonn, Germany.
   Hack, Sylvia; Exner, Martin, Univ Hosp Bonn, Inst Hyg \& Publ Hlth, Bonn, Germany.
   Bekeredjian-Ding, Isabelle, Paul Ehrlich Inst, Div EU Cooperat Microbiol, Langen, Germany.}},
DOI = {{10.1371/journal.pone.0138173}},
Article-Number = {{e0138173}},
ISSN = {{1932-6203}},
Keywords-Plus = {{RESISTANT STAPHYLOCOCCUS-AUREUS; SPECTRUM-BETA-LACTAMASE;
   LIVESTOCK-ASSOCIATED MRSA; PORK PRODUCTION CHAIN; ESCHERICHIA-COLI;
   ANTIBIOTIC-RESISTANCE; FOOD ANIMALS; ANTIMICROBIAL RESISTANCE; NASAL
   COLONIZATION; GENETIC DIVERSITY}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{isabelle.bekeredjian-ding@pei.de}},
Funding-Acknowledgement = {{FIN-Q NRW research network; European Union; state of North Rhine
   Westfalia, Germany {[}005-NA01-030]; LeanIX GmbH}},
Funding-Text = {{The project was financed by the FIN-Q NRW research network funded by the
   European Union and the state of North Rhine Westfalia, Germany.
   Reference number: 005-NA01-030
   (http://giqs.org/projekte/abgeschlossene-projekte/fin-qnrw/). LeanIX
   GmbH provided support in the form of salaries for author Andre Christ,
   but did not have any additional role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. The specific roles of this author are articulated in the
   `author contributions' section.}},
Cited-References = {{Aarestrup FM, 1999, MICROBES INFECT, V1, P639, DOI 10.1016/S1286-4579(99)80064-1.
   Aarestrup FM, 2001, ANTIMICROB AGENTS CH, V45, P2054, DOI 10.1128/AAC.45.7.2054-2059.2001.
   Adell E, 2014, ANN AGR ENV MED, V21, P15.
   Agerso Y, 2014, EPIDEMIOL INFECT, V142, P1727, DOI 10.1017/S095026881300280X.
   Agerso Y, 2013, J ANTIMICROB CHEMOTH, V68, P569, DOI 10.1093/jac/dks427.
   Anwar Muhammad Saeed, 2004, J Coll Physicians Surg Pak, V14, P661.
   Beneke B, 2011, J FOOD PROTECT, V74, P126, DOI 10.4315/0362-028X.JFP-10-250.
   Blanc V, 2006, VET MICROBIOL, V118, P299, DOI 10.1016/j.vetmic.2006.08.002.
   Boerlin P, 2001, J CLIN MICROBIOL, V39, P4193, DOI 10.1128/JCM.39.11.4193-4195.2001.
   Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349.
   Broens EM, 2011, PREV VET MED, V98, P182, DOI 10.1016/j.prevetmed.2010.10.010.
   Broens EM, 2012, VET MICROBIOL, V155, P381, DOI 10.1016/j.vetmic.2011.09.010.
   Broens EM, 2011, VET J, V189, P302, DOI 10.1016/j.tvjl.2010.08.003.
   Brolund A, 2010, J MICROBIOL METH, V83, P224, DOI 10.1016/j.mimet.2010.09.004.
   Callens B, 2012, PREV VET MED, V106, P53, DOI 10.1016/j.prevetmed.2012.03.001.
   Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x.
   Cavaco LM, 2008, ANTIMICROB AGENTS CH, V52, P3612, DOI 10.1128/AAC.00354-08.
   Cormican MG, 1997, DIAGN MICR INFEC DIS, V29, P241, DOI 10.1016/S0732-8893(97)00134-X.
   Cuny C, 2013, INT J MED MICROBIOL, V303, P331, DOI 10.1016/j.ijmm.2013.02.010.
   Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800.
   de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027.
   Deplano A, 2011, J CLIN MICROBIOL, V49, P3616, DOI 10.1128/JCM.00528-11.
   Escudero E, 2010, RES VET SCI, V88, P83, DOI 10.1016/j.rvsc.2009.05.021.
   EUCAST ECoAST, 2013, CLIN BREAKP BACT V3.
   FELLER W, 1948, ANN MATH STAT, V19, P177, DOI 10.1214/aoms/1177730243.
   Friese A, 2013, BERL MUNCH TIERARZTL, V126, P175, DOI 10.2376/0005-9366-126-175.
   Friese A, 2012, VET MICROBIOL, V158, P129, DOI 10.1016/j.vetmic.2012.01.019.
   Geser N, 2011, J FOOD PROTECT, V74, P446, DOI 10.4315/0362-028X.JFP-10-372.
   Geser N, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-21.
   Geser N, 2012, ANTIMICROB AGENTS CH, V56, P1609, DOI 10.1128/AAC.05539-11.
   Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837.
   Goncalves A, 2010, FOODBORNE PATHOG DIS, V7, P1569, DOI 10.1089/fpd.2010.0598.
   Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004.
   Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830.
   Grohs P, 2013, J CLIN MICROBIOL, V51, P2713, DOI 10.1128/JCM.00077-13.
   Hammerum AM, 2007, INT J ANTIMICROB AG, V30, P466, DOI 10.1016/j.ijantimicag.2007.07.012.
   Hammerum AM, 2014, J ANTIMICROB CHEMOTH, V69, P2650, DOI 10.1093/jac/dku180.
   Hansen KH, 2013, APPL ENVIRON MICROB, V79, P794, DOI 10.1128/AEM.02399-12.
   Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003.
   HARRIS D. L., 2000, MULTISITE PIG PRODUC.
   Harrison EM, 2013, EMBO MOL MED, V5, P509, DOI 10.1002/emmm.201202413.
   Hiramatsu K, 2002, CURR OPIN INFECT DIS, V15, P407, DOI 10.1097/00001432-200208000-00009.
   Horton RA, 2011, APPL ENVIRON MICROB, V77, P3715, DOI 10.1128/AEM.02831-10.
   Hu YY, 2013, APPL ENVIRON MICROB, V79, P5988, DOI 10.1128/AEM.01740-13.
   Huletsky A, 2005, CLIN INFECT DIS, V40, P976, DOI 10.1086/428579.
   Hurd HS, 2002, APPL ENVIRON MICROB, V68, P2376, DOI 10.1128/AEM.68.5.2376-2381.2002.
   Hurd HS, 2001, AM J VET RES, V62, P1194, DOI 10.2460/ajvr.2001.62.1194.
   Jakobsen L, 2010, FOODBORNE PATHOG DIS, V7, P537, DOI 10.1089/fpd.2009.0409.
   Kastrup GN, 2011, PREVALENCE METICILLI.
   Kennedy K, 2010, EUR J CLIN MICROBIOL, V29, P1501, DOI 10.1007/s10096-010-1031-y.
   Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006.
   Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4.
   Kock R, 2012, APPL ENVIRON MICROB, V78, P4046, DOI 10.1128/AEM.00212-12.
   Kock R, 2011, DTSCH ARZTEBL INT, V108, P761, DOI 10.3238/arztebl.2011.0761.
   Lassok B, 2013, J FOOD PROTECT, V76, P1095, DOI 10.4315/0362-028X.JFP-12-341.
   LEELAPORN A, 1994, J MED MICROBIOL, V40, P214, DOI 10.1099/00222615-40-3-214.
   Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x.
   Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145.
   LITTLEJOHN TG, 1992, FEMS MICROBIOL LETT, V95, P259.
   Liu BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073947.
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x.
   MARAN, 2009, MARAN 2009 MON ANT R.
   Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11.
   Mathew AG, 2007, FOODBORNE PATHOG DIS, V4, P115, DOI 10.1089/fpd.2006.0066.
   Meeniken D, 2008, DEUT TIERARZTL WOCH, V115, P132, DOI 10.2377/0341-6593-115-132.
   Monaco M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-258.
   Moodley A, 2009, ANTIMICROB AGENTS CH, V53, P1709, DOI 10.1128/AAC.01014-08.
   Nadimpalli M, 2015, OCCUP ENVIRON MED, V72, P90, DOI 10.1136/oemed-2014-102095.
   Naseer U, 2011, MICROB DRUG RESIST, V17, P83, DOI 10.1089/mdr.2010.0132.
   Nedbalcova K, 2014, VET MICROBIOL, V171, P328, DOI 10.1016/j.vetmic.2014.02.004.
   Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855.
   Pitout JDD, 1997, AM J MED, V103, P51, DOI 10.1016/S0002-9343(97)00044-2.
   Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11.
   Rinsky JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067641.
   Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12.
   Seiler C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00399.
   Smith DL, 2002, P NATL ACAD SCI USA, V99, P6434, DOI 10.1073/pnas.082188899.
   Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258.
   Strommenger B, 2003, J CLIN MICROBIOL, V41, P4089, DOI 10.1128/JCM.41.9.4089-4094.2003.
   Strommenger B, 2014, J ANTIMICROB CHEMOTH, V69, P616, DOI 10.1093/jac/dkt413.
   Tenhagen BA, 2009, VET REC, V165, P589, DOI 10.1136/vr.165.20.589.
   Teuber M, 2001, CURR OPIN MICROBIOL, V4, P493, DOI 10.1016/S1369-5274(00)00241-1.
   Tian GB, 2009, FOODBORNE PATHOG DIS, V6, P297, DOI 10.1089/fpd.2008.0164.
   van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385.
   Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507.
   van der Fels-Klerx HJ, 2011, J ANIM SCI, V89, P1922, DOI 10.2527/jas.2010-3046.
   van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021.
   van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384.
   Vandendriessche S, 2014, J ANTIMICROB CHEMOTH, V69, P355, DOI 10.1093/jac/dkt366.
   Vandendriessche S, 2013, J ANTIMICROB CHEMOTH, V68, P1510, DOI 10.1093/jac/dkt047.
   Voets GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052102.
   Wagenaar JA, 2009, VET MICROBIOL, V139, P405, DOI 10.1016/j.vetmic.2009.06.014.
   Wegener HC, 2003, CURR OPIN MICROBIOL, V6, P439, DOI 10.1016/j.mib.2003.09.009.
   Wulf MWH, 2012, EUR J CLIN MICROBIOL, V31, P61, DOI 10.1007/s10096-011-1269-z.}},
Number-of-Cited-References = {{94}},
Times-Cited = {{21}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{26}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{CS6GF}},
Unique-ID = {{ISI:000362175700033}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000361800700077,
Author = {Lee, Seungeun and Xu, Siyu and Bivila, Chemmeri Padasseri and Lee,
   Hyeyoung and Park, Myung Soo and Lim, Young Woon and Yamamoto, Naomichi},
Title = {{Triazole Susceptibilities in Thermotolerant Fungal Isolates from Outdoor
   Air in the Seoul Capital Area in South Korea}},
Journal = {{PLOS ONE}},
Year = {{2015}},
Volume = {{10}},
Number = {{9}},
Month = {{SEP 25}},
Abstract = {{Emerging fungi resistant to triazoles are a concern because of the
   increased use of medical triazoles and exposure to agricultural
   triazoles. However, little is known about the levels of triazole
   susceptibility in outdoor airborne fungi making it difficult to assess
   the risks of inhalation exposure to airborne, antifungal-resistant
   fungi. This study examined triazole susceptibilities of the airborne
   thermotolerant fungi isolated from the ambient air of the Seoul Capital
   Area of South Korea. We used impactor air sampling with
   triazole-containing nutrient agar plates as the collection substrates to
   screen for airborne fungal isolates based on their triazole
   susceptibilities. This study estimated that 0.17\% of all the culturable
   fungi belong to the pathogenic thermotolerant taxa, among which each
   isolate of Aspergillus niger and Aspergillus tubingensis showed a
   minimum inhibitory concentration (MIC) of 2 mu g/mL or greater for
   itraconazole. Their concentration in air was 0.4 CFU/m(3). Seven human
   pathogenic Paecilomyces variotii isolates had MICs of 32 mu g/mL or
   greater and lower than 2 mu g/mL for the agricultural fungicide
   tebuconazole and the medical triazole itraconazole, respectively. Though
   the concentration was low, our results confirm the presence of airborne
   fungi with high MICs for itraconazole in ambient air. Inhalation is an
   important exposure route because people inhale more than 10 m(3) of air
   each day. Vigilance is preferred over monitoring for the emergence of
   triazole-resistant fungal pathogens in ambient outdoor air.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Yamamoto, N (Reprint Author), Seoul Natl Univ, Grad Sch Publ Hlth, Dept Environm Hlth Sci, Seoul 151742, South Korea.
   Lee, Seungeun; Xu, Siyu; Bivila, Chemmeri Padasseri; Lee, Hyeyoung; Yamamoto, Naomichi, Seoul Natl Univ, Grad Sch Publ Hlth, Dept Environm Hlth Sci, Seoul 151742, South Korea.
   Park, Myung Soo; Lim, Young Woon, Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea.}},
DOI = {{10.1371/journal.pone.0138725}},
Article-Number = {{e0138725}},
ISSN = {{1932-6203}},
Keywords-Plus = {{RESISTANT ASPERGILLUS-FUMIGATUS; AZOLE RESISTANCE; ANTIFUNGAL AGENTS;
   AIRBORNE FUNGI; CYP51A; ITRACONAZOLE; VORICONAZOLE; DIVERSITY;
   MECHANISM; PCR}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{nyamamoto@snu.ac.kr}},
ResearcherID-Numbers = {{Yamamoto, Naomichi/D-4099-2014}},
ORCID-Numbers = {{Yamamoto, Naomichi/0000-0002-5969-5500}},
Funding-Acknowledgement = {{National Research Foundation of Korea - Ministry of Education, Science
   and Technology {[}2013R1A1A1004497]}},
Funding-Text = {{This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea
   (http://www.nrf.re.kr/) funded by the Ministry of Education, Science and
   Technology (2013R1A1A1004497) (N.Y.). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.}},
Cited-References = {{Aguilar C, 1998, ANTIMICROB AGENTS CH, V42, P1601.
   Ahmad S, 2014, ENVIRON RES, V133, P20, DOI 10.1016/j.envres.2014.05.009.
   Alcazar-Fuoli L, 2009, ANTIMICROB AGENTS CH, V53, P4514, DOI 10.1128/AAC.00585-09.
   AlDoory Y., 1984, MOULD ALLERGY, P66.
   Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107.
   Audenaert K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-112.
   Balajee SA, 2009, J CLIN MICROBIOL, V47, P3138, DOI 10.1128/JCM.01070-09.
   Bartlett KH, 2004, ANN OCCUP HYG, V48, P547, DOI 10.1093/annhyg/meh051.
   Brochu P, 2006, HUM ECOL RISK ASSESS, V12, P675, DOI 10.1080/10807030600801550.
   Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x.
   Chowdhary A, 2014, J ANTIMICROB CHEMOTH, V69, P2979, DOI 10.1093/jac/dku259.
   Chowdhary A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052871.
   CLSI, 2008, APPROVED STANDARD M3.
   Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x.
   Diaz-Guerra TM, 2003, ANTIMICROB AGENTS CH, V47, P1120, DOI 10.1128/AAC.47.3.1120-1124.2003.
   Espinel-Ingroff A, 2010, J CLIN MICROBIOL, V48, P3251, DOI 10.1128/JCM.00536-10.
   Espinel-Ingroff A, 2001, MYCOPATHOLOGIA, V150, P101, DOI 10.1023/A:1010954803886.
   Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171.
   Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106.
   Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501.
   Gheith S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-19.
   GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323.
   Gutierrez F, 2005, EUR J CLIN MICROBIOL, V24, P607, DOI 10.1007/s10096-005-0013-y.
   Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043.
   Kahle M, 2008, ENVIRON SCI TECHNOL, V42, P7193, DOI 10.1021/es8009309.
   Kousha M, 2011, EUR RESPIR REV, V20, P156, DOI 10.1183/09059180.00001011.
   KWOK IMY, 1993, PESTIC SCI, V39, P1, DOI 10.1002/ps.2780390102.
   Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483.
   MACHER JM, 1989, AM IND HYG ASSOC J, V50, P561, DOI 10.1202/0002-8894(1989)050<0561:PCOMIF>2.0.CO;2.
   MADELIN TM, 1992, J APPL BACTERIOL, V72, P400, DOI 10.1111/j.1365-2672.1992.tb01853.x.
   McGrath JJ, 1999, CURR MICROBIOL, V38, P33, DOI 10.1007/PL00006768.
   Mellado E, 2007, ANTIMICROB AGENTS CH, V51, P1897, DOI 10.1128/AAC.01092-06.
   Mellado E, 2001, J CLIN MICROBIOL, V39, P2431, DOI 10.1128/JCM.39.7.2431-2438.2001.
   MORRING KL, 1983, AM IND HYG ASSOC J, V44, P662, DOI 10.1202/0002-8894(1983)044<0662:SFAFAS>2.3.CO;2.
   Mortensen KL, 2010, ANTIMICROB AGENTS CH, V54, P4545, DOI 10.1128/AAC.00692-10.
   Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332.
   O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005.
   Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3.
   Pitman SK, 2011, EXPERT OPIN EMERG DR, V16, P559, DOI 10.1517/14728214.2011.607811.
   Reponen T, 1996, ATMOS ENVIRON, V30, P3967, DOI 10.1016/1352-2310(96)00128-8.
   Rial-Otero R, 2005, J AGR FOOD CHEM, V53, P4471, DOI 10.1021/jf047848h.
   Seo YH, 2013, PREV NUTR FOOD SCI, V18, P145, DOI {[}10.3746/pnf.2013.18.2.145, DOI 10.3746/PNF.2013.18.2.145].
   Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002.
   Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219.
   Snelders E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031801.
   Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09.
   Spiess B, 2012, ANTIMICROB AGENTS CH, V56, P3905, DOI 10.1128/AAC.05902-11.
   Spolti P, 2014, PLANT DIS, V98, P607, DOI 10.1094/PDIS-10-13-1051-RE.
   Steiner B, 2013, CASE REP INFECT DIS, DOI 10.1155/2013/273848.
   STREIFEL AJ, 1983, APPL ENVIRON MICROB, V46, P375.
   Tedersoo L, 2014, SCIENCE, V28, P6213, DOI DOI 10.1126/SCIENCE.1256688.
   van der Linden JWM, 2013, CLIN INFECT DIS, V57, P513, DOI 10.1093/cid/cit320.
   VANDENBOSSCHE H, 1993, ANTIMICROB AGENTS CH, V37, P2101, DOI 10.1128/AAC.37.10.2101.
   Vermeulen E, 2013, CURR OPIN INFECT DIS, V26, P493, DOI 10.1097/QCO.0000000000000005.
   Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720.
   Verweij PE, 2009, LANCET INFECT DIS, V9, P789, DOI 10.1016/S1473-3099(09)70265-8.
   Wei XL, 2015, J MICROBIOL, V53, P91, DOI 10.1007/s12275-015-5014-7.
   White T. J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1.
   Yamamoto N, 2011, INDOOR AIR, V21, P521, DOI 10.1111/j.1600-0668.2011.00732.x.
   Yamamoto N, 2015, ENVIRON SCI TECHNOL, V49, P5098, DOI 10.1021/es506165z.
   Yamamoto N, 2012, ISME J, V6, P1801, DOI 10.1038/ismej.2012.30.
   Yoshida T, 1997, ANTIMICROB AGENTS CH, V41, P1349.}},
Number-of-Cited-References = {{62}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{9}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{CS1CR}},
Unique-ID = {{ISI:000361800700077}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000367369800001,
Author = {Dramowski, Angela and Cotton, Mark F. and Whitelaw, Andrew},
Title = {{Utilization of paediatric isolation facilities in a TB-endemic setting}},
Journal = {{ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL}},
Year = {{2015}},
Volume = {{4}},
Month = {{SEP 21}},
Abstract = {{Introduction: In hospital settings, patient isolation is used to limit
   transmission of certain pathogens (e.g. M. tuberculosis {[}TB],
   antibiotic-resistant bacteria and viruses causing respiratory and
   enteric infection). Data is lacking on utilization of paediatric
   isolation facilities in low-resource, TB-endemic settings.
   Methods: Prospective weekday observation of 18 paediatric isolation
   rooms at Tygerberg Children's Hospital, Cape Town, South Africa, was
   conducted between 1 May 2014 and 31 October 2014 documenting: occupancy
   rate; indication for isolation; duration of isolation; application of
   transmission-based precautions and infection prevention (IPC) behaviour
   of personnel. Potential under-utilization of isolation rooms was
   determined by cross-referencing isolation room occupancy with laboratory
   isolates of antibiotic-resistant bacteria, M. tuberculosis and selected
   viral pathogens.
   Results: Six percent (335/5906) of hospitalized children were isolated:
   78 \% (260/335) for IPC purposes. Most IPC-isolated patients had
   community-acquired infections (213/260; 82 \%), including tuberculosis
   (130/260; 50 \%) and suspected viral infections (75/260; 29 \%).
   Children (median age 17 months {[}IQR 6-50]) spent 4 days (IQR 2-8) in
   isolation. Isolation occupancy was 66 \% (2172/3294 occupied bed days),
   but varied significantly by month. Laboratory data identified an
   additional 135 patients warranting isolation with 2054 extra bed-days
   required. Forty patients with 171 patient days of inappropriate
   isolation were identified. During 1223 weekday visits to IPC-isolated
   patient rooms: alcohol-based handrub was available (89 \%);
   transmission-based precautions were appropriately implemented (71 \%);
   and personal protective equipment was provided (74 \%). Of 358 observed
   interactions between paediatric staff and isolated patients, hand
   hygiene compliance was 65 \% and adherence to transmission-based
   precautions was 58 \%.
   Conclusion: Patients isolated for TB (under airborne precautions)
   accounted for more than half of all isolation episodes. Missed
   opportunities for patient isolation were common but could be reduced by
   implementation of syndromic isolation. Demand for isolation facilities
   was seasonal, with projected demand exceeding available isolation beds
   over winter months.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dramowski, A (Reprint Author), Univ Stellenbosch, Div Paediat Infect Dis, Dept Paediat \& Child Hlth, Fac Med \& Hlth Sci, POB 241, ZA-8000 Cape Town, South Africa.
   Dramowski, Angela; Cotton, Mark F., Univ Stellenbosch, Div Paediat Infect Dis, Dept Paediat \& Child Hlth, Fac Med \& Hlth Sci, ZA-8000 Cape Town, South Africa.
   Whitelaw, Andrew, Univ Stellenbosch, Dept Med Microbiol, ZA-8000 Cape Town, South Africa.
   Whitelaw, Andrew, NHLS, Cape Town, South Africa.}},
DOI = {{10.1186/s13756-015-0078-z}},
Article-Number = {{36}},
ISSN = {{2047-2994}},
Keywords = {{Paediatrics; Healthcare-associated infection; Nosocomial infection;
   Infection control; Patient isolation; Transmission-based precautions;
   Tuberculosis}},
Keywords-Plus = {{CARE-ASSOCIATED INFECTIONS; NOSOCOMIAL TRANSMISSION;
   MYCOBACTERIUM-TUBERCULOSIS; CHILDREN; AFRICA}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases;
   Microbiology}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases;
   Microbiology}},
Author-Email = {{dramowski@sun.ac.za}},
Funding-Acknowledgement = {{South African Medical Research Council's (MRC) Clinician Researcher
   Programme; Discovery Foundation Academic Fellowship}},
Funding-Text = {{The primary author (AD) is supported by the South African Medical
   Research Council's (MRC) Clinician Researcher Programme and the
   Discovery Foundation Academic Fellowship (but these funding bodies
   played no role in the design, data collection, data analysis and
   interpretation, or writing of the manuscript). The authors wish to thank
   Mr Hewitt de Jager from the Unit for IPC for assistance with database
   management, Mr Jean-Marie Vianney Namohoro for assistance with data
   collection, Mr Darryl Visagie from the hospital IT department, Dr Jean
   Maritz for access to virology laboratory data and the staff and patients
   of the Tygerberg Children's Hospital.}},
Cited-References = {{Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4.
   Dramowski A, 2015, PAEDIAT INT CHILD HL.
   Foster CB, 2011, JAMA-J AM MED ASSOC, V305, P1480, DOI 10.1001/jama.2011.449.
   Heyns L, 2006, ACTA PAEDIATR, V95, P535, DOI 10.1080/089035250600636560.
   KIM MHM, 1987, INFECT CONT HOSP EP, V8, P195, DOI 10.1017/S0195941700065930.
   LANGLEY JM, 1994, AM J INFECT CONTROL, V22, P207, DOI 10.1016/0196-6553(94)90069-8.
   Lee EH, 2005, INT J TUBERC LUNG D, V9, P689.
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x.
   Melendo S, 2011, AN PEDIATR, V75, P21, DOI 10.1016/j.anpedi.2011.02.006.
   Munoz FM, 2002, INFECT CONT HOSP EP, V23, P568, DOI 10.1086/501972.
   Rothe C, 2013, J HOSP INFECT, V85, P257, DOI 10.1016/j.jhin.2013.09.008.
   Saulnier FF, 2001, INFECT CONT HOSP EP, V22, P273, DOI 10.1086/501899.
   SCHAAF HS, 1991, J TROP PEDIATRICS, V37, P223, DOI 10.1093/tropej/37.5.223.
   Sherman GG, 2014, SAMJ S AFR MED J, V104, P235, DOI {[}10.7196/SAMJ.7598, 10.7196/samj.7598].
   Vayalumkal JV, 2007, AM J INFECT CONTROL, V35, P207, DOI 10.1016/j.ajic.2006.03.012.
   WEINSTEIN JW, 1995, PEDIATR INFECT DIS J, V14, P232, DOI 10.1097/00006454-199503000-00011.
   Western Cape Government Provincial Treasury, MUN EC REV OUTL CAP.
   WHO, GLOB TUB REP 2014.}},
Number-of-Cited-References = {{18}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Antimicrob. Resist. Infect. Control}},
Doc-Delivery-Number = {{CZ8SQ}},
Unique-ID = {{ISI:000367369800001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000360866500001,
Author = {Azevedo, Maria-Manuel and Faria-Ramos, Isabel and Costa Cruz, Luisa and
   Pina-Vaz, Cidalia and Goncalves Rodrigues, Acacio},
Title = {{Genesis of Azole Antifungal Resistance from Agriculture to Clinical
   Settings}},
Journal = {{JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY}},
Year = {{2015}},
Volume = {{63}},
Number = {{34}},
Pages = {{7463-7468}},
Month = {{SEP 2}},
Abstract = {{Azole fungal resistance is becoming a major public health problem in
   medicine in recent years. However, it was known in agriculture since
   several decades; the extensive use of these compounds results in
   contamination of air, plants, and soil. The increasing frequency of
   life-threatening fungal infections and the increase of prophylactical
   use of azoles in high-risk patients, taken together with the
   evolutionary biology evidence that drug selection pressure is an
   important factor for the emergence and spread of drug resistance, can
   result in a dramatic scenario. This study reviews the azole use in
   agricultural and medical contexts and discusses the hypothetical link
   between its extensive use and the emergence of azole resistance among
   human fungal pathogens.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Azevedo, MM (Reprint Author), Univ Porto, Fac Med, Dept Microbiol, P-4200319 Oporto, Portugal.
   Azevedo, Maria-Manuel; Faria-Ramos, Isabel; Costa Cruz, Luisa; Pina-Vaz, Cidalia; Goncalves Rodrigues, Acacio, Univ Porto, Fac Med, Dept Microbiol, P-4200319 Oporto, Portugal.
   Azevedo, Maria-Manuel; Faria-Ramos, Isabel; Pina-Vaz, Cidalia; Goncalves Rodrigues, Acacio, Univ Porto, Fac Med, Ctr Res Hlth Technol \& Informat Syst, P-4200319 Oporto, Portugal.
   Azevedo, Maria-Manuel, Sch D Maria II, Vila Nova De Famalicao, Portugal.
   Pina-Vaz, Cidalia, Cent Hosp Sao Joao, Dept Clin Pathol, P-4200319 Oporto, Portugal.}},
DOI = {{10.1021/acs.jafc.5b02728}},
ISSN = {{0021-8561}},
EISSN = {{1520-5118}},
Keywords = {{antifungals; azoles; fungal resistance; Candida; Aspergillus fumigatus;
   Portuguese agriculture}},
Keywords-Plus = {{ASPERGILLUS-FUMIGATUS; CROSS-RESISTANCE; MEDICAL AZOLES; SUSCEPTIBILITY;
   STRAINS; RISK; ITRACONAZOLE; MECHANISMS; PROTECTION; VEGETABLES}},
Research-Areas = {{Agriculture; Chemistry; Food Science \& Technology}},
Web-of-Science-Categories  = {{Agriculture, Multidisciplinary; Chemistry, Applied; Food Science \&
   Technology}},
Author-Email = {{maria.manuel.azevedo2011@gmail.com}},
ResearcherID-Numbers = {{Rodrigues, Acacio/K-1467-2013
   FMUP, CINTESIS/C-6631-2014
   Pina-Vaz, Cidalia/K-1835-2013}},
ORCID-Numbers = {{Rodrigues, Acacio/0000-0003-4246-5212
   FMUP, CINTESIS/0000-0001-7248-2086
   Pina-Vaz, Cidalia/0000-0003-4936-1301}},
Funding-Acknowledgement = {{Fundacao para a Ciencia e Tecnologia (FCT) {[}SERH/BD/91155/2012]}},
Funding-Text = {{Isabel Faria-Ramos is supported by Fundacao para a Ciencia e Tecnologia
   (FCT) Ph.D. Grant SERH/BD/91155/2012.}},
Cited-References = {{Araujo R, 2007, INT J ANTIMICROB AG, V29, P108, DOI 10.1016/j.ijantimicag.2006.09.019.
   Arendrup MC, 2008, ANTIMICROB AGENTS CH, V52, P3504, DOI 10.1128/AAC.00190-08.
   Barth M, 2009, FOOD MICROBIOL FOOD, P135, DOI 10.1007/978-1-4419-0826-1\_6.
   Chambers JE, 2014, CRIT REV TOXICOL, V44, P176, DOI 10.3109/10408444.2013.855163.
   Chowdhary A, 2012, J ANTIMICROB CHEMOTH, V67, P362, DOI 10.1093/jac/dkr443.
   Chryssanthou E, 1997, SCAND J INFECT DIS, V29, P509, DOI 10.3109/00365549709011864.
   Costa-de-Oliveira S, 2008, EUR J CLIN MICROBIOL, V27, P365, DOI 10.1007/s10096-007-0448-4.
   Dannaoui E, 2001, J ANTIMICROB CHEMOTH, V47, P333, DOI 10.1093/jac/47.3.333.
   Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10.
   Dijksterhuis J., 2013, MYCOTA AGR APPL, V11, P35.
   Direcao Geral de Agricultura e Desenvolvimento Rural (DGADR), VEND PROD FIT PORT 2.
   Direccao-Geral de Alimentacao e Veterinaria (DGAV), 2013, PLAN AC NAC US SUST, V1.
   Direccao-Geral de Alimentacao e Veterinaria (DGAV), 2013, PLAN AC NAC US SUST, V2.
   European Commision, 2002, OP AZ ANT RES AD SCI.
   Eurostat, 2012, AGR CENS REP PORT.
   Faria-Ramos I, 2014, EUR J CLIN MICROBIOL, V33, P2241, DOI 10.1007/s10096-014-2194-8.
   Faria-Ramos I, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-155.
   Garland SM, 1999, J AGR FOOD CHEM, V47, P294, DOI 10.1021/jf980120e.
   Hamey PY, 1999, REGUL TOXICOL PHARM, V30, pS34, DOI 10.1006/rtph.1999.1324.
   Hof H, 2001, ANTIMICROB AGENTS CH, V45, P2987, DOI 10.1128/AAC.45.11.2987-2990.2001.
   Hof H, 2008, DRUG RESIST UPDATE, V11, P25, DOI 10.1016/j.drup.2008.01.001.
   Lago M, 2014, ENVIRON MONIT ASSESS, V186, P5581, DOI 10.1007/s10661-014-3804-8.
   Lagrou K., 2008, P 3 ADV ASP MIAM BEA.
   Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7.
   Lelievre L, 2013, Med Mal Infect, V43, P139, DOI 10.1016/j.medmal.2013.02.010.
   Lucas J., 2003, Pesticide Outlook, V14, P268, DOI 10.1039/b314850p.
   Matthews G., 2000, PESTICIDE APPL METHO.
   Mellado E, 2007, ANTIMICROB AGENTS CH, V51, P1897, DOI 10.1128/AAC.01092-06.
   Perea S, 2001, ANTIMICROB AGENTS CH, V45, P2676, DOI 10.1128/AAC.45.10.2676-2684.2001.
   Price CL, 2015, PEST MANAG SCI, V71, P1054, DOI 10.1002/ps.4029.
   Rocchi S, 2014, J CLIN MICROBIOL, V52, P1724, DOI 10.1128/JCM.03182-13.
   RUSSELL PE, 1995, J AGR SCI, V124, P317, DOI 10.1017/S0021859600073275.
   Serfling A, 2007, ANTIMICROB AGENTS CH, V51, P3672, DOI 10.1128/AAC.00654-07.
   Snelders E., 2008, PLOS MED, V5, pe219, DOI DOI 10.1371/J0URNAL.PMED.
   Snelders E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031801.
   Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09.
   STEVA H, 1990, Mededelingen van de Faculteit Landbouwwetenschappen Universiteit Gent, V55, P983.
   Tomlim C. D. S, 1997, PESTICIDE MANUAL.
   Trosken ER, 2005, J CHROMATOGR A, V1083, P113, DOI 10.1016/j.chroma.2005.06.020.
   Verweij PE, 2009, DRUG RESIST UPDATE, V12, P141, DOI 10.1016/j.drup.2009.09.002.
   Verweij PE, 2009, LANCET INFECT DIS, V9, P789, DOI 10.1016/S1473-3099(09)70265-8.
   White TC, 1998, CLIN MICROBIOL REV, V11, P382.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{17}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{40}},
Journal-ISO = {{J. Agric. Food Chem.}},
Doc-Delivery-Number = {{CQ8OA}},
Unique-ID = {{ISI:000360866500001}},
DA = {{2018-08-13}},
}

@article{ ISI:000360704400010,
Author = {Fonville, Judith M.},
Title = {{Expected Effect of Deleterious Mutations on Within-Host Adaptation of
   Pathogens}},
Journal = {{JOURNAL OF VIROLOGY}},
Year = {{2015}},
Volume = {{89}},
Number = {{18}},
Pages = {{9242-9251}},
Month = {{SEP}},
Abstract = {{Adaptation is a common theme in both pathogen emergence, for example, in
   zoonotic cross-species transmission, and pathogen control, where
   adaptation might limit the effect of the immune response and antiviral
   treatment. When such evolution requires deleterious intermediate
   mutations, fitness ridges and valleys arise in the pathogen's fitness
   landscape. The effect of deleterious intermediate mutations on
   within-host pathogen adaptation is examined with deterministic
   calculations, appropriate for pathogens replicating in large populations
   with high error rates. The effect of deleterious intermediate mutations
   on pathogen adaptation is smaller than their name might suggest: when
   two mutations are required and each individual single mutation is fully
   deleterious, the pathogen can jump across the fitness valley by
   obtaining two mutations at once, leading to a proportion of adapted
   mutants that is 20-fold lower than that in the situation where the
   fitness of all mutants is neutral. The negative effects of deleterious
   intermediates are typically substantially smaller and outweighed by the
   fitness advantages of the adapted mutant. Moreover, requiring a specific
   mutation order has a substantially smaller effect on pathogen adaptation
   than the effect of all intermediates being deleterious. These results
   can be rationalized when the number of routes of mutation available to
   the pathogen is calculated, providing a simple approach to estimate the
   effect of deleterious mutations. The calculations discussed here are
   applicable when the effect of deleterious mutations on the within-host
   adaptation of pathogens is assessed, for example, in the context of
   zoonotic emergence, antigenic escape, and drug resistance.
   IMPORTANCE
   Adaptation is critical for pathogens after zoonotic transmission into a
   new host species or to achieve antigenic immune escape and drug
   resistance. Using a deterministic approach, the effects of deleterious
   intermediate mutations on pathogen adaptation were calculated while
   avoiding commonly made simplifications that do not apply to large
   pathogen populations replicating with high mutation rates. Perhaps
   unexpectedly, pathogen adaptation does not halt when the intermediate
   mutations are fully deleterious. The negative effects of deleterious
   mutations are substantially outweighed by the fitness gains of
   adaptation. To gain an understanding of the effect of deleterious
   mutations on pathogen adaptation, a simple approach that counts the
   number of routes available to the pathogen with and without deleterious
   intermediate mutations is introduced. This methodology enables a
   straightforward calculation of the proportion of the pathogen population
   that will cross a fitness valley or traverse a fitness ridge, without
   reverting to more complicated mathematical models.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fonville, JM (Reprint Author), Univ Cambridge, Dept Zool, Ctr Pathogen Evolut, Cambridge, England.
   Fonville, Judith M., Univ Cambridge, Dept Zool, Ctr Pathogen Evolut, Cambridge, England.
   Fonville, Judith M., WHO Collaborating Ctr Modelling Evolut \& Control, Cambridge, England.
   Fonville, Judith M., Erasmus MC, Dept Virosci, Rotterdam, Netherlands.}},
DOI = {{10.1128/JVI.00832-15}},
ISSN = {{0022-538X}},
EISSN = {{1098-5514}},
Keywords-Plus = {{EMPIRICAL FITNESS LANDSCAPES; INFLUENZA-A VIRUS;
   MYCOBACTERIUM-TUBERCULOSIS; ANTIBIOTIC-RESISTANCE; AIRBORNE
   TRANSMISSION; ADAPTIVE EVOLUTION; ANTIVIRAL THERAPY; NATURAL-SELECTION;
   A/H5N1 VIRUS; RNA VIRUSES}},
Research-Areas = {{Virology}},
Web-of-Science-Categories  = {{Virology}},
Author-Email = {{jmf77@cam.ac.uk}},
Funding-Acknowledgement = {{award of a fellowship in biomedical informatics from the Medical
   Research Council of the United Kingdom {[}MR/K021885/1]; junior research
   fellowship from Homerton College Cambridge; NIAID Centres of Excellence
   for Influenza Research and Surveillance {[}HHSN272201400008C]; Medical
   Research Council {[}MR/K021885/1]}},
Funding-Text = {{This work was supported by the award of a fellowship in biomedical
   informatics from the Medical Research Council of the United Kingdom
   (MR/K021885/1) and a junior research fellowship from Homerton College
   Cambridge to J.M.F. and the award of HHSN272201400008C (NIAID Centres of
   Excellence for Influenza Research and Surveillance) to the Center for
   Pathogen Evolution.}},
Cited-References = {{Alexander HK, 2010, J R SOC INTERFACE, V7, P1455, DOI 10.1098/rsif.2010.0123.
   Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816.
   Butler J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004065.
   COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947.
   Covert AW, 2013, P NATL ACAD SCI USA, V110, pE3171, DOI 10.1073/pnas.1313424110.
   Cowperthwaite MC, 2006, PLOS COMPUT BIOL, V2, P1292, DOI 10.1371/journal.pcbi.0020141.
   da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458.
   Das SR, 2011, P NATL ACAD SCI USA, V108, pE1417, DOI 10.1073/pnas.1108754108.
   de Visser JAGM, 2014, NAT REV GENET, V15, P480, DOI 10.1038/nrg3744.
   Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160.
   Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678.
   DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171.
   Duan S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6029.
   Fan SF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6021.
   Fan SF, 2013, J VIROL, V87, P4861, DOI 10.1128/JVI.02608-12.
   Fonville JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076047.
   Franke J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002134.
   Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410.
   Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551.
   GILLESPIE JH, 1983, AM NAT, V121, P691, DOI 10.1086/284095.
   Gokhale CS, 2009, J THEOR BIOL, V259, P613, DOI 10.1016/j.jtbi.2009.04.011.
   Gong LI, 2013, ELIFE, V2, DOI 10.7554/eLife.00631.
   Hensley SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015190.
   Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362.
   Holmes EC, 2013, CURR OPIN VIROL, V3, P180, DOI 10.1016/j.coviro.2012.12.003.
   Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831.
   Iwasa Y, 2004, GENETICS, V166, P1571, DOI 10.1534/genetics.166.3.1571.
   Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105.
   Komarova NL, 2003, J THEOR BIOL, V223, P433, DOI 10.1016/S0022-5193(03)00120-6.
   Kryazhimskiy S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001301.
   Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818.
   Linster M, 2014, CELL, V157, DOI 10.1016/j.cell.2014.02.040.
   LOEB LA, 1991, CANCER RES, V51, P3075.
   Loverdo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068179.
   Lozovsky ER, 2009, P NATL ACAD SCI USA, V106, P12025, DOI 10.1073/pnas.0905922106.
   Maisnier-Patin S, 2004, RES MICROBIOL, V155, P360, DOI 10.1016/j.resmic.2004.01.019.
   Mansky LM, 2000, TRENDS GENET, V16, P512, DOI 10.1016/S0168-9525(00)02125-9.
   Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013.
   Muller B, 2013, TRENDS GENET, V29, P160, DOI 10.1016/j.tig.2012.11.005.
   Myers JL, 2013, J VIROL, V87, P11168, DOI 10.1128/JVI.01414-13.
   Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523.
   Orr HA, 1998, EVOLUTION, V52, P935, DOI 10.1111/j.1558-5646.1998.tb01823.x.
   Park M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0333.
   Paulson JC, 2013, VIRUS RES, V178, P99, DOI 10.1016/j.virusres.2013.02.015.
   Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440.
   Perelson AS, 2012, J INFECT DIS, V205, P1642, DOI 10.1093/infdis/jis265.
   Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451.
   Ribeiro RM, 1998, AIDS, V12, P461, DOI 10.1097/00002030-199805000-00006.
   Ribeiro RM, 1999, AIDS, V13, P351, DOI 10.1097/00002030-199902250-00007.
   Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805.
   Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526.
   Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10.
   Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178.
   Simon P, 2011, J CLIN MICROBIOL, V49, P715, DOI 10.1128/JCM.01732-10.
   SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0.
   SUAREZ P, 1992, J VIROL, V66, P2491.
   VALCARCEL J, 1989, J VIROL, V63, P4107.
   Varble A, 2014, CELL HOST MICROBE, V16, P691, DOI 10.1016/j.chom.2014.09.020.
   Wang GP, 2010, J VIROL, V84, P6218, DOI 10.1128/JVI.02271-09.
   Webby R, 2004, NAT MED, V10, pS77, DOI 10.1038/nm1151.
   Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539.
   Weinreich DM, 2005, EVOLUTION, V59, P1165.
   Weinreich DM, 2005, EVOLUTION, V59, P1175.
   Weissman DB, 2009, THEOR POPUL BIOL, V75, P286, DOI 10.1016/j.tpb.2009.02.006.
   WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125.
   Wilke CO, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-3.
   Wilke CO, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-11.
   Wilker PR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3636.}},
Number-of-Cited-References = {{68}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{13}},
Journal-ISO = {{J. Virol.}},
Doc-Delivery-Number = {{CQ6HE}},
Unique-ID = {{ISI:000360704400010}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000360667200009,
Author = {Messi, Patrizia and Sabia, Carla and Anacarso, Immacolata and Condo,
   Carla and Iseppi, Ramona and Stefani, Sara and de Niederhausern, Simona
   and Bondi, Moreno},
Title = {{Prevalence of multi-drug-resistant (MDR) bacteria in air samples from
   indoor and outdoor environments}},
Journal = {{AEROBIOLOGIA}},
Year = {{2015}},
Volume = {{31}},
Number = {{3}},
Pages = {{381-387}},
Month = {{SEP}},
Abstract = {{The prevalence of multi-drug-resistant (MDR) bacteria in 48 air samples
   from indoor environments, surgical rooms, dental surgery and waste
   management plants has been investigated. A total of 280 bacterial
   strains belonging to different genera were isolated, and the operating
   rooms were the most contaminated ones (107 isolates), with all the
   isolates belonging to Gram-positive cocci (51.5 \% Micrococcus spp.,
   48.5 \% Staphylococcus spp.). Only 5 \% of the isolates was sensitive to
   all the antibiotics tested, while the remaining strains resulted
   resistant to three (13 \%), four (14 \%), five (9 \%) and six (10 \%)
   antibiotics. Correlation between the resistance patterns and the
   environmental source of MDR bacteria isolates also emerged from the
   present investigation. This study confirms the high presence of
   antibiotic-resistant bacteria in air samples, finding that represents a
   threat for the possible transfer of resistance genes to pathogenic
   bacteria.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Messi, P (Reprint Author), Univ Modena \& Reggio Emilia, Dept Biomed Sci, Via Giuseppe Campi 287, I-41125 Modena, Italy.
   Messi, Patrizia; Sabia, Carla; Anacarso, Immacolata; Condo, Carla; Iseppi, Ramona; Stefani, Sara; de Niederhausern, Simona; Bondi, Moreno, Univ Modena \& Reggio Emilia, Dept Life Sci, I-41125 Modena, Italy.
   Messi, Patrizia, Univ Modena \& Reggio Emilia, Dept Biomed Sci, I-41125 Modena, Italy.}},
DOI = {{10.1007/s10453-015-9371-9}},
ISSN = {{0393-5965}},
EISSN = {{1573-3025}},
Keywords = {{Air; Multi-drug-resistant bacteria; Operating room; Public environments;
   Waste management plants}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE; STAPHYLOCOCCUS-AUREUS; INFECTION; GENES;
   ENTEROBACTERIACEAE; CONTAMINATION; CONSEQUENCES; BIOAEROSOL; SURFACES}},
Research-Areas = {{Life Sciences \& Biomedicine - Other Topics; Environmental Sciences \&
   Ecology}},
Web-of-Science-Categories  = {{Biology; Environmental Sciences}},
Author-Email = {{patrizia.messi@unimore.it}},
ResearcherID-Numbers = {{Bondi, Moreno/C-7416-2015
   }},
ORCID-Numbers = {{Bondi, Moreno/0000-0002-6652-9148
   sabia, carla/0000-0003-3221-5172
   Iseppi, Ramona/0000-0003-3071-3258
   Messi, Patrizia/0000-0002-2452-5763}},
Cited-References = {{Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312.
   Barza M, 2002, CLIN INFECT DIS, V34, pS71, DOI 10.1086/340241.
   Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713.
   Bernard MC, 2012, INFECT CONT HOSP EP, V33, P949, DOI 10.1086/667373.
   CLSI, 2012, PERF STAND ANT SUSC.
   David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09.
   Davies JE, 1997, CIBA F SYMP, V207, P15.
   Gandara A, 2006, ENVIRON HEALTH PERSP, V114, P1859, DOI 10.1289/ehp.9585.
   Gilbert Y, 2010, AEROBIOLOGIA, V26, P185, DOI 10.1007/s10453-010-9155-1.
   Hota B, 2004, CLIN INFECT DIS, V39, P1182, DOI 10.1086/424667.
   Icgen B, 2002, MICROBIOL RES, V157, P233, DOI 10.1078/0944-5013-00155.
   Lai K., 2009, ENV HLTH S1, V8, P1.
   Levy S. B., 2004, NATURE MED S, V10, P5122, DOI DOI 10.1038/NM1145.
   Li CS, 2003, SCI TOTAL ENVIRON, V305, P169, DOI 10.1016/S0048-9697(02)00500-4.
   Ling AL, 2013, ENVIRON SCI TECHNOL, V47, P4046, DOI 10.1021/es400238g.
   Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255.
   Livermore DM, 2005, LANCET INFECT DIS, V5, P450, DOI 10.1016/S1473-3099(05)70166-3.
   Martinez JL, 2009, ENVIRON POLLUT, V157, P2893, DOI 10.1016/j.envpol.2009.05.051.
   MACRINA FL, 1978, PLASMID, V1, P417, DOI 10.1016/0147-619X(78)90056-2.
   OSULLIVAN DJ, 1993, APPL ENVIRON MICROB, V59, P2730.
   Reynolds KA, 2005, INT J ENVIRON HEAL R, V15, P225, DOI 10.1080/09603120500115298.
   Septimus EJ, 2009, CLIN PHARMACOL THER, V86, P336, DOI 10.1038/clpt.2009.122.
   Strommenger B, 2003, J CLIN MICROBIOL, V41, P4089, DOI 10.1128/JCM.41.9.4089-4094.2003.
   Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022.
   Teuber M, 2001, CURR OPIN MICROBIOL, V4, P493, DOI 10.1016/S1369-5274(00)00241-1.
   Vela J, 2012, POULTRY SCI, V91, P3003, DOI 10.3382/ps.2012-02302.
   Zhou F, 2013, INT J ENV RES PUB HE, V10, P2412, DOI 10.3390/ijerph10062412.}},
Number-of-Cited-References = {{27}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{5}},
Usage-Count-Since-2013 = {{27}},
Journal-ISO = {{Aerobiologia}},
Doc-Delivery-Number = {{CQ5SY}},
Unique-ID = {{ISI:000360667200009}},
DA = {{2018-08-13}},
}

@article{ ISI:000359172600043,
Author = {Jin, Yiguang and Wang, Shan and Yao, Weishang and Du, Lina},
Title = {{Molecular self-assembly of amphiphilic cyclic phosphoryl gemcitabine
   with different N-fatty acyl tails and enhanced anticancer effects of the
   self-assembled nanostructures}},
Journal = {{COLLOIDS AND SURFACES B-BIOINTERFACES}},
Year = {{2015}},
Volume = {{133}},
Pages = {{356-361}},
Month = {{SEP 1}},
Abstract = {{Molecular self-assembly of nucleosides is important, and the
   self-assembled nanostructures may be used for drug delivery and
   targeting. Gemcitabine (GEM) is an important anticancer nucleoside
   analog though deactivation and multi-drug resistance frequently happen.
   Four N-fatty acyl derivatives of cyclic phosphoryl GEM were prepared
   based on the theory of self-assembled drug delivery systems and the
   HepDirect prodrug technique wherein the prodrug could be degraded by the
   cytochrome P-450 isozymes in hepatocytes to release active drugs. They
   are cyclic phosphoryl N-octyl gemcitabine (CPOG), cyclic phosphoryl
   N-dodecanoyl gemcitabine (CPDG), cyclic phosphoryl N-hexadecanoyl
   gemcitabine (CPHG), and cyclic phosphoryl N-octadecanoyl gemcitabine
   (CPODG). Their amphiphilicity and self-assembling property were
   explored. The self-assembled nanostructures of them were prepared and
   simulated. The in vitro anticancer activities of the nanostructures were
   investigated. The derivatives formed the Langmuir monolayers at the
   air/water interface, though their surface pressure-molecular area
   isotherms were different with dependency of the length of lipid chains.
   The derivatives self-assembled into the vesicular or rice-like
   nanostructures based on the hydrophobic interaction between lipid chains
   when injected into water, in accordance with the results of computer
   simulation. The nanostructures showed higher anticancer effects on HepG2
   cells than GEM. The nanostructures are promising anticancer
   nanomedicines. (C) 2015 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Jin, YG (Reprint Author), Beijing Inst Radiat Med, Dept Pharmaceut Sci, 27 Taiping Rd, Beijing 100850, Peoples R China.
   Jin, Yiguang; Wang, Shan; Du, Lina, Beijing Inst Radiat Med, Dept Pharmaceut Sci, Beijing 100850, Peoples R China.
   Jin, Yiguang; Wang, Shan, Henan Univ, Pharmaceut Coll, Inst Pharm, Kaifeng 475004, Peoples R China.
   Yao, Weishang, Beijing Inst Technol, Beijing 100081, Peoples R China.}},
DOI = {{10.1016/j.colsurfb.2015.06.033}},
ISSN = {{0927-7765}},
EISSN = {{1873-4367}},
Keywords = {{Gemcitabine; Langmuir monolayers; Molecular self-assembly;
   Nanostructure; Phosphorylation; Simulation}},
Keywords-Plus = {{LANGMUIR MONOLAYERS; HEPDIRECT PRODRUGS; VITRO/IN-VIVO; DELIVERY;
   NANOASSEMBLIES; NUCLEOSIDES; DERIVATIVES; SIMULATION; ADEFOVIR; RELEASE}},
Research-Areas = {{Biophysics; Chemistry; Materials Science}},
Web-of-Science-Categories  = {{Biophysics; Chemistry, Physical; Materials Science, Biomaterials}},
Author-Email = {{jinyg@bmi.ac.cn}},
ORCID-Numbers = {{Jin, Yiguang/0000-0002-3528-1397}},
Funding-Acknowledgement = {{National Key Technologies R\&D Program for New Drugs of China
   {[}2012ZX09301003-001-009]; National Natural Science Foundation of China
   {[}81202464, 81373340]}},
Funding-Text = {{This work was supported by the National Key Technologies R\&D Program
   for New Drugs of China (No. 2012ZX09301003-001-009) and the National
   Natural Science Foundation of China (Nos. 81202464, 81373340).}},
Cited-References = {{Aime C, 2007, LANGMUIR, V23, P12875, DOI 10.1021/la702105s.
   Araki K, 2005, TOP CURR CHEM, V256, P133, DOI 10.1007/b107173.
   Bonaccio S, 1996, LANGMUIR, V12, P4976, DOI 10.1021/la960315l.
   Bookser BC, 2009, NUCLEOS NUCLEOT NUCL, V28, P969, DOI 10.1080/15257770903307151.
   Campins N, 2007, NEW J CHEM, V31, P1928, DOI 10.1039/b704884j.
   Chabaud P, 2006, BIOCONJUGATE CHEM, V17, P466, DOI 10.1021/bc050162q.
   CIGNARELLA G, 1995, EUR J MED CHEM, V30, P721, DOI 10.1016/0223-5234(96)88290-0.
   Du LN, 2014, INT J PHARMACEUT, V472, P1, DOI 10.1016/j.ijpharm.2014.06.020.
   Dynarowicz-Latka P, 2001, ADV COLLOID INTERFAC, V91, P221, DOI 10.1016/S0001-8686(99)00034-2.
   Erion MD, 2004, J AM CHEM SOC, V126, P5154, DOI 10.1021/ja031818y.
   Jin YG, 2012, INT J PHARMACEUT, V430, P276, DOI 10.1016/j.ijpharm.2012.03.046.
   Jin YG, 2009, INT J PHARMACEUT, V381, P40, DOI 10.1016/j.ijpharm.2009.07.024.
   Lepeltier E, 2014, LANGMUIR, V30, P6348, DOI 10.1021/la5007132.
   Lepeltier E, 2013, LANGMUIR, V29, P14795, DOI 10.1021/la403338y.
   Li M, 2015, INT J PHARMACEUT, V478, P124, DOI 10.1016/j.ijpharm.2014.11.033.
   Li MA, 2014, COLLOID SURFACE B, V123, P852, DOI 10.1016/j.colsurfb.2014.10.035.
   Moreau L, 2005, TETRAHEDRON LETT, V46, P1593, DOI 10.1016/j.tetlet.2005.01.095.
   Moysan E, 2013, MOL PHARMACEUT, V10, P430, DOI 10.1021/mp300370t.
   Reddy KR, 2008, J MED CHEM, V51, P666, DOI 10.1021/jm7012216.
   Serdjebi C, 2013, PHARMACOGENOMICS, V14, P1047, DOI {[}10.2217/PGS.13.93, 10.2217/pgs.13.93].
   Sloat BR, 2011, INT J PHARMACEUT, V409, P278, DOI 10.1016/j.ijpharm.2011.02.037.
   Sreenivasachary N, 2008, CHEM-ASIAN J, V3, P134, DOI 10.1002/asia.200700041.
   Velichko YS, 2008, J PHYS CHEM B, V112, P2326, DOI 10.1021/jp074420n.
   Wang YZ, 2014, MOL PHARMACEUT, V11, P1140, DOI 10.1021/mp4005904.
   Wang Z., 2009, MOL SIMULAT, V8, P638.
   Wydro P, 2007, J PHYS CHEM B, V111, P2495, DOI 10.1021/jp066950+.}},
Number-of-Cited-References = {{26}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{25}},
Journal-ISO = {{Colloid Surf. B-Biointerfaces}},
Doc-Delivery-Number = {{CO5AS}},
Unique-ID = {{ISI:000359172600043}},
DA = {{2018-08-13}},
}

@article{ ISI:000413509700107,
Author = {Moghimipour, Eskandar and Ameri, Abdulghani and Handali, Somayeh and
   Ramezani, Zahra and Azemi, Mohammad Ebrahim and Sadaghi-Nejad, Batool},
Title = {{In-vitro Evaluation of Antibacterial Activity of Glycyrrhiza glabra and
   Acanthopyllum squarrusom Total Saponins}},
Journal = {{RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES}},
Year = {{2015}},
Volume = {{6}},
Number = {{5}},
Pages = {{764-768}},
Month = {{SEP-OCT}},
Abstract = {{In recent years, with increasing prevalence of antibiotic resistant
   bacteria, there is an urgency to develop new antimicrobial compounds
   from various sources such as medicinal plants. Saponins are secondary
   metabolites that are found in various plant species. The aim of this
   study was to evaluate antibacterial activity of saponins extracted from
   the Glycyrrhiza glabra and Acanthopyllum squarrusom against E. coli,
   Staphylococcus aureus, Pseudomonas aeruginosa and Proteus mirabilis. The
   results were compared to data of Quillaja saponaria as a commercial
   saponin. The roots of the plants were dried, powdered and def-fatted
   with petroleum ether in a soxhlet apparatus. The air dried powder was
   successively extracted with methanol, n-butanol and diethyl ether. The
   antibacterial activity of the saponins was determined using well
   diffusion method and also the value of minimum inhibitory concentrations
   (MIC) was evaluated by 96-well microtiter plates. Ampicillin and
   gentamicin were used as positive controls to determine the sensitivity
   of the strains. According to the results, the best growth inhibitory
   activity was observed with saponin of G. glabra, while saponin fraction
   of A. squarrusom and Q. saponaria showed less activity against bacteria.
   The zone inhibition of the saponin extract from G. glabra was
   40.00+/-0.00 mm for E. coli, 35.00+/-0.00 for S. aureus, 34.00+/-0.05
   for P. aeruginosa and 30.00+/-0.00 for P. mirabilis. The value of MIC of
   saponin of G. glabra against E. coli, S. aureus and P. aeruginosa was
   3.12 mg/ml, and against P. mirabilis was 25 mg/ml, whereas saponins of
   A. squarrusom and Q. saponaria were found comparatively less effective
   against bacterial pathogens. The results of the study indicated that
   saponin of G. glabra has a broad spectrum of antimicrobial activity and
   can be used as a natural antimicrobial agent.}},
Publisher = {{RJPBCS RESEARCH JOURNAL PHARMACEUTICAL, BIOLOGICAL \& CHEMICAL SCIENCES}},
Address = {{RJPBCS RESEARCH JOURNAL PHARMACEUTICAL, BIOLOGICAL \& CHEMICAL SCIENCES,
   PRODDATUR, 00000, INDIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Handali, S (Reprint Author), Ahvaz Junclishapur Univ Med Sci, Nanotechnol Res Ctr, Ahwaz, Iran.
   Moghimipour, Eskandar, Ahvaz Jundishapur Univ Med Sci, Med Plant Res Ctr, Ahwaz, Iran.
   Ameri, Abdulghani, Ahvaz Jundishapur Univ Med Sci, Fac Pharm, Dept Drug \& Food Control, Ahwaz, Iran.
   Handali, Somayeh; Ramezani, Zahra, Ahvaz Junclishapur Univ Med Sci, Nanotechnol Res Ctr, Ahwaz, Iran.
   Azemi, Mohammad Ebrahim, Ahvaz Jundishapur Univ Med Sci, Fac Pharm, Dept Pharmacognosy, Ahwaz, Iran.
   Sadaghi-Nejad, Batool, Ahvaz Jundishapur Univ Med Sci, Abadan Fac Med, Cellular \& Mol Res Ctr, Ahwaz, Iran.}},
ISSN = {{0975-8585}},
Keywords = {{Saponin; Glycyrrhiza glabra; Acanthopyllum squarrusom; Quillaja
   saponaria; antibacterial activity}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
ORCID-Numbers = {{ameri, abdulghani/0000-0002-9034-2287
   Ramezani, Zahra/0000-0001-7404-2105
   moghimipour, eskandar/0000-0002-6686-2485}},
Funding-Acknowledgement = {{Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran}},
Funding-Text = {{The authors are grateful to Ahvaz Jundishapur University of Medical
   Sciences, Ahvaz, Iran for providing financial support and also
   gratefully thank Farabi and Daroupakhsh Pharmaceutical Co., for donating
   of antibiotics.}},
Cited-References = {{Aghel N, 2007, IRAN J PHARM RES, V6, P167.
   Alcaraz L., 2012, PHARM ONLINE, V3, P158.
   Aqel H, 2012, PHARM SINICA, V3, P349.
   CHAIEB I., 2010, TUNISIAN J PLANT PRO, V5, P39.
   Francis G, 2002, BRIT J NUTR, V88, P587, DOI 10.1079/BJN2002725.
   Hassan SM, 2010, FOOD CHEM, V119, P600, DOI 10.1016/j.foodchem.2009.06.066.
   Hassawi D., 2006, J BIOL SCI, V6, P109.
   Iwalokun BA, 2004, J MED FOOD, V7, P327, DOI 10.1089/1096620041938669.
   Kalaigandhi V, 2011, INT J CURRENT PHARM, V3, P93.
   Khalil A, 2009, J FOOD AGRIC ENVIRON, V7, P103.
   Khanna VG, 2008, WORLD J MICROB BIOT, V24, P2737, DOI 10.1007/s11274-008-9758-7.
   Langfield RD, 2004, J ETHNOPHARMACOL, V94, P279, DOI 10.1016/j.jep.2004.06.013.
   Maatalah MB, 2012, J BIOTECH PHARM RES, V3, P54.
   Maleki S, 2008, Pak J Biol Sci, V11, P1286.
   Moghimipour E, 2003, IRAN J BASIC MED SCI, V6, P9.
   Nascimento GGF, 2000, BRAZ J MICROBIOL, V31, P247.
   Nitalikar MM, 2010, INT J PHARMTECH RES, V2, P899.
   Soetan KO, 2006, AFR J BIOTECHNOL, V5, P2405.
   Tajkarimi MM, 2010, FOOD CONTROL, V21, P1199, DOI 10.1016/j.foodcont.2010.02.003.
   Tsao SM, 2001, J MED MICROBIOL, V50, P646, DOI 10.1099/0022-1317-50-7-646.
   Zhao B., 2012, ASIAN J TRADITIONAL, V7, P14.}},
Number-of-Cited-References = {{21}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Res. J. Pharm. Biol. Chem. Sci.}},
Doc-Delivery-Number = {{VB1FV}},
Unique-ID = {{ISI:000413509700107}},
DA = {{2018-08-13}},
}

@article{ ISI:000360299100146,
Author = {Fertner, Mette and Sanchez, Javier and Boklund, Anette and Stryhn,
   Henrik and Dupont, Nana and Toft, Nils},
Title = {{Persistent Spatial Clusters of Prescribed Antimicrobials among Danish
   Pig Farms - A Register-Based Study}},
Journal = {{PLOS ONE}},
Year = {{2015}},
Volume = {{10}},
Number = {{8}},
Month = {{AUG 28}},
Abstract = {{The emergence of pathogens resistant to antimicrobials has prompted
   political initiatives targeting a reduction in the use of veterinary
   antimicrobials in Denmark, especially for pigs. This study elucidates
   the tendency of pig farms with a significantly higher antimicrobial use
   to remain in clusters in certain geographical regions of Denmark. Animal
   Daily Doses/100 pigs/day were calculated for all three age groups of
   pigs (weaners, finishers and sows) for each quarter during 2012-13 in
   6,143 commercial indoor pig producing farms. The data were split into
   four time periods of six months. Repeated spatial cluster analyses were
   performed to identify persistent clusters, i.e. areas included in a
   significant cluster throughout all four time periods. Antimicrobials
   prescribed for weaners did not result in any persistent clusters. In
   contrast, antimicrobial use in finishers clustered persistently in two
   areas (157 farms), while those issued for sows clustered in one area (51
   farms). A multivariate analysis including data on antimicrobial use for
   weaners, finishers and sows as three separate outcomes resulted in three
   persistent clusters (551 farms). Compared to farms outside the clusters
   during this period, weaners, finishers and sows on farms within these
   clusters had 19\%, 104\% and 4\% higher use of antimicrobials,
   respectively. Production type, farm type and farm size seemed to have
   some bearing on the clustering effect. Adding these factors as
   categorical covariates one at a time in the multivariate analysis
   reduced the persistent clusters by 24.3\%, 30.5\% and 34.1\%,
   respectively.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fertner, M (Reprint Author), Tech Univ Denmark, Natl Vet Inst, Epidemiol Sect, Frederiksberg, Denmark.
   Fertner, Mette; Boklund, Anette; Toft, Nils, Tech Univ Denmark, Natl Vet Inst, Epidemiol Sect, Frederiksberg, Denmark.
   Sanchez, Javier; Stryhn, Henrik, Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Ctr Vet Epidemiol Res, Charlottetown, PE C1A 4P3, Canada.
   Dupont, Nana, Univ Copenhagen, Dept Large Anim Sci, Frederiksberg, Denmark.}},
DOI = {{10.1371/journal.pone.0136834}},
Article-Number = {{e0136834}},
ISSN = {{1932-6203}},
Keywords-Plus = {{AIRBORNE TRANSMISSION; PRRS VIRUS; HERDS; EPIDEMIOLOGY; SURVEILLANCE;
   CONSUMPTION; STATISTICS; INFECTION; BACTERIA; ANIMALS}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{memun@vet.dtu.dk}},
ORCID-Numbers = {{Toft, Nils/0000-0002-0265-3764
   Fertner, Mette Ely/0000-0001-6697-5327}},
Cited-References = {{Aarestrup FM, 1999, INT J ANTIMICROB AG, V12, P279, DOI 10.1016/S0924-8579(99)90059-6.
   {[}Anonymous], 2014, DK5342014.
   {[}Anonymous], 2014, DK5332014.
   {[}Anonymous], 2015, SPF HLTH REGULATIONS.
   {[}Anonymous], 2010, DK13192010.
   {[}Anonymous], 2014, STAT ANAL SYSTEM SOF.
   {[}Anonymous], 2011, DK10852011.
   {[}Anonymous], 2014, DK1782014.
   Baekbo P, 2012, TRANSBOUND EMERG DIS, V59, P60, DOI 10.1111/j.1865-1682.2011.01288.x.
   Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4.
   Christiansen JP, 2011, HLTH PIGS BIOSECURIT, V5, P25.
   Danmap 2012, 2013, US ANT AG OCC ANT.
   Dunlop RH, 1998, PREV VET MED, V34, P247, DOI 10.1016/S0167-5877(97)00093-7.
   Dupont N, 2014, DANSK VETTIDSSKRI, V97, P33.
   Elvstrom Anders, 2015, COMMUNICATION.
   Garcia-Migura L, 2014, VET MICROBIOL, V170, P1, DOI 10.1016/j.vetmic.2014.01.013.
   Hybschmann GK, 2011, PREV VET MED, V98, P190, DOI 10.1016/j.prevetmed.2010.10.005.
   Jensen VF, 2012, J VET PHARMACOL THER, V35, P33, DOI 10.1111/j.1365-2885.2011.01291.x.
   Jensen VF, 2004, PREV VET MED, V64, P201, DOI 10.1016/j.prevetmed.2004.04.001.
   Kristensen CS, 2004, VET MICROBIOL, V98, P243, DOI 10.1016/j.vetmic.2003.10.026.
   Kristensen CS, 2004, VET MICROBIOL, V99, P197, DOI 10.1016/j.vetmic.2004.01.005.
   KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809.
   Kulldorff M, 2014, INFORM MANAGEMENT SE.
   Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818.
   Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490.
   Kulldorff M, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-58.
   Maes D, 2000, VET RES, V31, P313, DOI 10.1051/vetres:2000122.
   Moore JE, 2012, PREV VET MED, V107, P286, DOI 10.1016/j.prevetmed.2012.09.006.
   Mortensen S, 2002, PREV VET MED, V53, P83, DOI 10.1016/S0167-5877(01)00260-4.
   Nielsen E. O., 2002, Dansk Veterinartidsskrift, V85, P6.
   Patanasatienkul T, 2015, PREV VET MED, V120, P219, DOI 10.1016/j.prevetmed.2015.03.006.
   R Core Team R, 2014, LANG ENV STAT COMP.
   Sibila M, 2009, VET J, V181, P221, DOI 10.1016/j.tvjl.2008.02.020.
   Stege H, 2003, PREV VET MED, V57, P105, DOI 10.1016/S0167-5877(02)00233-7.
   Taylor D. J., 2006, PIG DIS.
   van der Fels-Klerx HJ, 2011, J ANIM SCI, V89, P1922, DOI 10.2527/jas.2010-3046.
   Vigre H, 2010, PREV VET MED, V93, P98, DOI 10.1016/j.prevetmed.2009.10.010.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{CQ0PO}},
Unique-ID = {{ISI:000360299100146}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000360186700014,
Author = {Mphaphlele, Matsie and Dharmadhikari, Ashwin S. and Jensen, Paul A. and
   Rudnick, Stephen N. and van Reenen, Tobias H. and Pagano, Marcello A.
   and Leuschner, Wilhelm and Sears, Tim A. and Milonova, Sonya P. and van
   der Walt, Martie and Stoltz, Anton C. and Weyer, Karin and Nardell,
   Edward A.},
Title = {{Institutional Tuberculosis Transmission Controlled Trial of Upper Room
   Ultraviolet Air Disinfection: A Basis for New Dosing Guidelines}},
Journal = {{AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE}},
Year = {{2015}},
Volume = {{192}},
Number = {{4}},
Pages = {{477-484}},
Month = {{AUG 15}},
Abstract = {{Rationale: Transmission is driving the global tuberculosis epidemic,
   especially in congregate settings. Worldwide, natural ventilation is the
   most common means of air disinfection, but it is inherently unreliable
   and of limited use in cold climates. Upper room germicidal ultraviolet
   (UV) air disinfection with air mixing has been shown to be highly
   effective, but improved evidence-based dosing guidelines are needed.
   Objectives: To test the efficacy of upper room germicidal air
   disinfection with air mixing to reduce tuberculosis transmission under
   real hospital conditions, and to define the application parameters
   responsible as a basis for proposed new dosing guidelines.
   Methods: Over an exposure period of 7 months, 90 guinea pigs breathed
   only untreated exhaust ward air, and another 90 guinea pigs breathed
   only air from the same six-bed tuberculosis ward on alternate days when
   upper room germicidal air disinfection was turned on throughout the
   ward.
   Measurements and Main Results: The tuberculin skin test conversion rates
   (>6 mm) of the two chambers were compared. The hazard ratio for guinea
   pigs in the control chamber converting their skin test to positive was
   4.9 (95\% confidence interval, 2.8-8.6), with an efficacy of
   approximately 80\%.
   Conclusions: Upper room germicidal UV air disinfection with air mixing
   was highly effective in reducing tuberculosis transmission under
   hospital conditions. These data support using either a total fixture
   output (rather than electrical or UV lamp wattage) of 15-20 mW/m(3)
   total room volume, or an average whole-room UV irradiance (fluence rate)
   of 5-7 p6W/cm(2), calculated by a lighting computer-assisted design
   program modified for UV use.}},
Publisher = {{AMER THORACIC SOC}},
Address = {{25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Nardell, EA (Reprint Author), Brigham \& Womens Hosp, Div Global Hlth Equity, 641 Huntington Ave,3A-03, Boston, MA 02115 USA.
   Mphaphlele, Matsie, JHPIEGO, MDR TB Program, Pretoria, South Africa.
   Dharmadhikari, Ashwin S.; Nardell, Edward A., Brigham \& Womens Hosp, Div Pulm \& Crit Care Med, Boston, MA 02115 USA.
   Nardell, Edward A., Brigham \& Womens Hosp, Div Global Hlth Equity, Dept Med, Boston, MA 02115 USA.
   Jensen, Paul A., Natl Ctr HIV AIDS Viral Hepatitis STD \& TB Preven, CDC Div TB Eliminat, Atlanta, GA USA.
   Rudnick, Stephen N.; Milonova, Sonya P., Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   van Reenen, Tobias H., CSIR, Pretoria, South Africa.
   Pagano, Marcello A., Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA.
   Leuschner, Wilhelm, Univ Pretoria, Dept Elect \& Comp Engn, ZA-0002 Pretoria, South Africa.
   Sears, Tim A., Acuity Brands Lighting, Connors, GA USA.
   van der Walt, Martie, MRC, Pretoria, South Africa.
   Stoltz, Anton C., Univ Pretoria, Sch Med, Div Infect Dis, Internal Med, ZA-0002 Pretoria, South Africa.
   Weyer, Karin, WHO, Global TB Programme, CH-1211 Geneva, Switzerland.}},
DOI = {{10.1164/rccm.201501-0060OC}},
ISSN = {{1073-449X}},
EISSN = {{1535-4970}},
Keywords = {{tuberculosis transmission; infection control; air disinfection;
   ultraviolet irradiation; tuberculosis prevention}},
Keywords-Plus = {{GERMICIDAL IRRADIATION SYSTEM; DRUG-RESISTANT TUBERCULOSIS; WARD;
   MICROORGANISMS; INFECTIVITY; ENVIRONMENT; LIGHT}},
Research-Areas = {{General \& Internal Medicine; Respiratory System}},
Web-of-Science-Categories  = {{Critical Care Medicine; Respiratory System}},
Author-Email = {{enardell@partners.org}},
Funding-Acknowledgement = {{CDC/National Institute for Occupational Safety and Health {[}1RO1
   OH009050]; National Institutes of Health/Fogarty International
   {[}1D43TW009379]}},
Funding-Text = {{Supported by CDC/National Institute for Occupational Safety and Health
   grant 1RO1 OH009050 and National Institutes of Health/Fogarty
   International grant 1D43TW009379.}},
Cited-References = {{Coker I, 2000, GUIDELINES UTILISATI.
   Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC.
   Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002.
   EPA, 2011, EN STAR LAB GUID MAN.
   Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043.
   First M., 1999, ASHRAE T, V105, P877.
   First M, 2007, J OCCUP ENVIRON HYG, V4, P321, DOI 10.1080/15459620701271693.
   FIRST MW, 1999, ASHRAE T, V105, P869.
   Ko G, 2002, ENVIRON HEALTH PERSP, V110, P95.
   Linnes JC, 2014, INDOOR AIR, V24, P116, DOI 10.1111/ina.12063.
   MACHER JM, 1989, AM IND HYG ASSOC J, V50, P561, DOI 10.1202/0002-8894(1989)050<0561:PCOMIF>2.0.CO;2.
   McDevitt JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003186.
   Miller SLHM, 2002, EFFICACY ULTRAVIOLET.
   Mphahlele M, 2009, INT UN TUB LUNG DIS.
   Nardell E, 2010, INT J TUBERC LUNG D, V14, P1233.
   Nardell E, 1992, WORLD C TUB NOV BETH.
   NARDELL EA, 1993, INFECT CONT HOSP EP, V14, P681.
   Nardell EA, 1999, CHEST, V116, P1143, DOI 10.1378/chest.116.4.1143.
   Nardell EA, 2008, PUBLIC HEALTH REP, V123, P52, DOI 10.1177/003335490812300108.
   National Institute for Occupational Safety and Health, 2009, ENV CONTR TUB BAS UP.
   Peng X, 2003, ATMOS ENVIRON, V37, P405.
   RILEY RL, 1971, ARCH ENVIRON HEALTH, V22, P208, DOI 10.1080/00039896.1971.10665834.
   RILEY RL, 1976, AM REV RESPIR DIS, V113, P413.
   RILEY RL, 1957, AM REV TUBERC PULM, V75, P420.
   RILEY RL, 1989, AM REV RESPIR DIS, V139, P1286, DOI 10.1164/ajrccm/139.5.1286.
   RILEY RL, 1971, ARCH ENVIRON HEALTH, V22, P200, DOI 10.1080/00039896.1971.10665833.
   RILEY RL, 1995, AM J EPIDEMIOL, V142, P3, DOI 10.1093/oxfordjournals.aje.a117542.
   RILEY RL, 1962, AM REV RESPIR DIS, V85, P511.
   Riley RL, 2001, AM J RESP CRIT CARE, V163, P7, DOI 10.1164/ajrccm.163.1.hh11-00.
   RILEY RL, 1971, ARCH ENVIRON HEALTH, V23, P35, DOI 10.1080/00039896.1971.10665951.
   Rudnick SN, 2015, BUILD ENVIRON, V92, P756, DOI 10.1016/j.buildenv.2014.03.025.
   Rudnick SN, 2001, AIHAJ, V62, P434, DOI 10.1080/15298660108984645.
   Rudnick SN, 2007, J OCCUP ENVIRON HYG, V4, P352, DOI 10.1080/15459620701298167.
   Rudnick SN, 2012, HVAC\&R RES, V18, P774, DOI 10.1080/10789669.2012.667863.
   van Geuns H A, 1989, Bull Int Union Tuberc Lung Dis, V64, P31.
   van Reenen T, 2013, INTERNAL REPORT.
   WHO, 2009, NAT VENT INF CONTR H.
   Zhu SW, 2014, BUILD ENVIRON, V72, P116, DOI 10.1016/j.buildenv.2013.10.019.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{13}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{Am. J. Respir. Crit. Care Med.}},
Doc-Delivery-Number = {{CP9AS}},
Unique-ID = {{ISI:000360186700014}},
OA = {{green\_published}},
DA = {{2018-08-13}},
}

@article{ ISI:000360514500012,
Author = {Huff, G. R. and Huff, W. E. and Rath, N. C.},
Title = {{Effect of dexamethasone on bacteriostatic activity of turkey monocytes
   and implications for food safety}},
Journal = {{VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY}},
Year = {{2015}},
Volume = {{166}},
Number = {{3-4}},
Pages = {{151-158}},
Month = {{AUG 15}},
Abstract = {{Stress has been shown to affect the immune system of turkeys making them
   more susceptible to bacterial infections. Five-week-old male and female
   turkeys were treated with 3 intra-muscular injections of dexamethasone
   (Dex) at 0, 0.5 and 2.0 mg/kg body weight. Twenty-four hours after the
   third injection birds were bled and white blood cell (WBC) differentials
   and bacteriostatic activity of monocytes were measured. Dex at both 0.5
   and 2.0 mg/kg decreased phagocytic activity in females only.
   Bacteriostatic activity was decreased at both concentrations of Dex at 8
   and 16 h post-infection in both sexes and was lower in males as compared
   to females. Total WBC counts were increased in females at both
   concentrations of Dex whereas male total WBC counts were unaffected.
   Both males and females had an increase in the heterophil to lymphocyte
   ratio. Within the same study, replicate pens of turkeys were challenged
   with intra-air sac inoculation of 100 cfu of Escherichia coli. Isolation
   of E. coli was significantly increased by both Dex and E. con challenge,
   but there were no differences between sexes. These results suggest that
   stress can compromise the bacteriostatic activity of turkey monocytes
   and increase bacterial colonization of blood and tissues, potentially
   affecting food safety. Published by Elsevier B.V.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Huff, GR (Reprint Author), Univ Arkansas, USDA, Agr Res Serv, Poultry Prod \& Prod Safety Res,Poultry Sci Ctr, Fayetteville, AR 72701 USA.
   Huff, G. R.; Huff, W. E.; Rath, N. C., Univ Arkansas, USDA, Agr Res Serv, Poultry Prod \& Prod Safety Res,Poultry Sci Ctr, Fayetteville, AR 72701 USA.}},
DOI = {{10.1016/j.vetimm.2015.05.006}},
ISSN = {{0165-2427}},
EISSN = {{1873-2534}},
Keywords = {{Turkeys; Dexamethasone; Stress; Sex; Monocytes; Escherichia coli}},
Keywords-Plus = {{PATHOGENIC ESCHERICHIA-COLI; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS;
   GREEN LIVER DISCOLORATION; SALMONELLA-ENTERITIDIS; OSTEOMYELITIS
   COMPLEX; BROILER-CHICKENS; CLOSTRIDIAL DERMATITIS;
   ANTIBIOTIC-RESISTANCE; SEX-DIFFERENCES; STRESS}},
Research-Areas = {{Immunology; Veterinary Sciences}},
Web-of-Science-Categories  = {{Immunology; Veterinary Sciences}},
Author-Email = {{grhuff@uark.edu}},
Funding-Acknowledgement = {{USDA Agricultural Research Service}},
Funding-Text = {{This study was funded by the USDA Agricultural Research Service. We
   acknowledge the excellent technical assistance of Dana Bassi, Sonia
   Tsai, Scott Zornes, and Wally McDonner (USDA, Agricultural Research
   Service, Poultry Production and Product Safety Research Unit). The U.S.
   Department of Agriculture (USDA) prohibits discrimination in all its
   programs and activities on the basis of race, color, national origin,
   age, disability, and where applicable, sex, marital status, familial
   status, parental status, religion, sexual orientation, genetic
   information, political beliefs, reprisal, or because all or part of an
   individual's income is derived from any public assistance program.}},
Cited-References = {{ANDERSON RJ, 1973, AM J MED, V54, P453, DOI 10.1016/0002-9343(73)90041-7.
   BAYYARI GR, 1994, AVIAN DIS, V38, P744, DOI 10.2307/1592110.
   Behnsen J, 2015, TRENDS IMMUNOL, V36, P112, DOI 10.1016/j.it.2014.12.003.
   Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001.
   Carr D, 1996, AVIAN DIS, V40, P736, DOI 10.2307/1592289.
   CLARK SR, 1991, AVIAN DIS, V35, P139, DOI 10.2307/1591306.
   Clark S, 2010, AVIAN DIS, V54, P788, DOI 10.1637/9147-111309-Review.1.
   Dutta V, 2008, AVIAN DIS, V52, P581, DOI 10.1637/8299-032808-Reg.1.
   Gomes AVS, 2014, AVIAN PATHOL, V43, P82, DOI 10.1080/03079457.2013.874006.
   GRAHAM BS, 1984, ANN INTERN MED, V101, P334, DOI 10.7326/0003-4819-101-3-334.
   Gross W. G., 1994, P237.
   GROSS WB, 1980, POULTRY SCI, V59, P516, DOI 10.3382/ps.0590516.
   GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198.
   Guerra B, 2014, VET MICROBIOL, V171, P290, DOI 10.1016/j.vetmic.2014.02.001.
   GUSTAFSON TL, 1983, J INFECT DIS, V148, P230, DOI 10.1093/infdis/148.2.230.
   Hebishima T, 2010, J VET MED SCI, V72, P435, DOI 10.1292/jvms.09-0398.
   HOMODELARCHE F, 1991, J STEROID BIOCHEM, V40, P619, DOI 10.1016/0960-0760(91)90285-D.
   Huff G, 2006, POULTRY SCI, V85, P266, DOI 10.1093/ps/85.2.266.
   Huff GR, 2014, AVIAN DIS, V58, P572, DOI 10.1637/10865-051614-Reg.1.
   Huff GR, 2013, AVIAN DIS, V57, P730, DOI 10.1637/10522-030113-Reg.1.
   Huff GR, 1998, POULTRY SCI, V77, P654, DOI 10.1093/ps/77.5.654.
   Huff GR, 2000, POULTRY SCI, V79, P1050, DOI 10.1093/ps/79.7.1050.
   Huff GR, 1999, POULTRY SCI, V78, P38, DOI 10.1093/ps/78.1.38.
   Johnson TJ, 2010, INFECT IMMUN, V78, P1931, DOI 10.1128/IAI.01174-09.
   Kallapura G, 2014, AVIAN PATHOL, V43, P305, DOI 10.1080/03079457.2014.923554.
   Kallapura G, 2014, POULTRY SCI, V93, P340, DOI 10.3382/ps.2013-03602.
   LEITNER G, 1992, AVIAN DIS, V36, P211, DOI 10.2307/1591493.
   LEITNER G, 1989, VET IMMUNOL IMMUNOP, V21, P249, DOI 10.1016/0165-2427(89)90035-4.
   Manges AR, 2012, CLIN INFECT DIS, V55, P712, DOI 10.1093/cid/cis502.
   Marin RH, 2002, POULTRY SCI, V81, P261, DOI 10.1093/ps/81.2.261.
   Markland S. M., 2015, ZOONOSES PUBLIC HLTH.
   MASON D, 1990, IMMUNOLOGY, V70, P1.
   MASON D, 1991, IMMUNOL TODAY, V12, P57, DOI 10.1016/0167-5699(91)90158-P.
   Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372.
   McDermott PF, 2002, ANIM BIOTECHNOL, V13, P71, DOI 10.1081/ABIO-120005771.
   Mellata M, 2013, FOODBORNE PATHOG DIS, V10, P916, DOI 10.1089/fpd.2013.1533.
   Mitchell NM, 2015, APPL ENVIRON MICROB, V81, P1177, DOI 10.1128/AEM.03524-14.
   Mora A, 2013, VET MICROBIOL, V167, P506, DOI 10.1016/j.vetmic.2013.08.007.
   Mutalib A, 1996, AVIAN DIS, V40, P661, DOI 10.2307/1592278.
   NAIRN ME, 1973, AVIAN DIS, V17, P504, DOI 10.2307/1589148.
   NRC - National Research Council, 1994, NUTR REQ POULTR.
   Platell JL, 2011, VET MICROBIOL, V153, P99, DOI 10.1016/j.vetmic.2011.05.007.
   Quinteiro WM, 2012, AVIAN PATHOL, V41, P421, DOI 10.1080/03079457.2012.709315.
   REDIG PT, 1985, AVIAN DIS, V29, P373, DOI 10.2307/1590498.
   Rostagno MH, 2009, FOODBORNE PATHOG DIS, V6, P767, DOI 10.1089/fpd.2009.0315.
   SAS, 2008, US GUID.
   SCHAFFNER A, 1985, J CLIN INVEST, V76, P1755, DOI 10.1172/JCI112166.
   Schaffner A., 1988, PERSPECTIVES BACTERI, P212.
   SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283.
   Seiffert SN, 2013, DRUG RESIST UPDATE, V16, P22, DOI 10.1016/j.drup.2012.12.001.
   SIEGEL HS, 1980, BIOSCIENCE, V30, P529, DOI 10.2307/1307973.
   Taube R. V., 2002, INT J FOOD MICROBIOL, V78, P31.
   Wei J, 2014, MOL PSYCHIATR, V19, P588, DOI 10.1038/mp.2013.83.
   Wideman RF, 2013, POULTRY SCI, V92, P64, DOI 10.3382/ps.2012-02745.
   Wideman RF, 2000, POULTRY SCI, V79, P396, DOI 10.1093/ps/79.3.396.
   Yamamoto Y., 1996, PSYCHONEUROIMMUNOLOG, P173.}},
Number-of-Cited-References = {{56}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{9}},
Journal-ISO = {{Vet. Immunol. Immunopathol.}},
Doc-Delivery-Number = {{CQ3PJ}},
Unique-ID = {{ISI:000360514500012}},
DA = {{2018-08-13}},
}

@article{ ISI:000359344900003,
Author = {Pasipanodya, Jotam G. and Nuermberger, Eric and Romero, Klaus and Hanna,
   Debra and Gumbo, Tawanda},
Title = {{Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments}},
Journal = {{CLINICAL INFECTIOUS DISEASES}},
Year = {{2015}},
Volume = {{61}},
Number = {{1}},
Pages = {{S10-S17}},
Month = {{AUG 15}},
Abstract = {{Background. The in vitro hollow fiber system model of tuberculosis
   (HFS-TB), in tandem with Monte Carlo experiments, was introduced more
   than a decade ago. Since then, it has been used to perform a large
   number of tuberculosis pharmacokinetics/pharmacodynamics (PK/PD) studies
   that have not been subjected to systematic analysis.
   Methods. We performed a literature search to identify all HFS-TB
   experiments published between 1 January 2000 and 31 December 2012. There
   was no exclusion of articles by language. Bias minimization was
   according to Preferred Reporting Items for Systematic Reviews and
   Meta-Analyses (PRISMA). Steps for reporting systematic reviews were
   followed.
   Results. There were 22 HFS-TB studies published, of which 12 were
   combination therapy studies and 10 were monotherapy studies. There were
   4 stand-alone Monte Carlo experiments that utilized quantitative output
   from the HFS-TB. All experiments reported drug pharmacokinetics, which
   recapitulated those encountered in humans. HFS-TB studies included
   log-phase growth studies under ambient air, semidormant bacteria at pH
   5.8, and nonreplicating persisters at low oxygen tension of <= 10 parts
   per billion. The studies identified antibiotic exposures associated with
   optimal kill of Mycobacterium tuberculosis and suppression of acquired
   drug resistance (ADR) and informed predictions about optimal clinical
   doses, expected performance of standard doses and regimens in patients,
   and expected rates of ADR, as well as a proposal of new susceptibility
   breakpoints.
   Conclusions. The HFS-TB model offers the ability to perform PK/PD
   studies including humanlike drug exposures, to identify bactericidal and
   sterilizing effect rates, and to identify exposures associated with
   suppression of drug resistance. Because of the ability to perform
   repetitive sampling from the same unit over time, the HFS-TB vastly
   improves statistical power and facilitates the execution of
   time-to-event analyses and repeated event analyses, as well as dynamic
   system pharmacology mathematical models.}},
Publisher = {{OXFORD UNIV PRESS INC}},
Address = {{JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Gumbo, T (Reprint Author), Baylor Res Inst, 3434 Live Oak St, Dallas, TX 75204 USA.
   Pasipanodya, Jotam G.; Gumbo, Tawanda, Baylor Univ Med Ctr, Baylor Res Inst, Ctr Infect Dis Res \& Expt Therapeut, Dallas, TX USA.
   Nuermberger, Eric, Johns Hopkins Univ, Sch Med, Div Infect Dis, Ctr TB Res, Baltimore, MD 21205 USA.
   Romero, Klaus; Hanna, Debra, Crit Path Inst, Tucson, AZ USA.
   Gumbo, Tawanda, Univ Cape Town, Dept Med, Observatory, South Africa.}},
DOI = {{10.1093/cid/civ425}},
ISSN = {{1058-4838}},
EISSN = {{1537-6591}},
Keywords = {{tuberculosis; PK/PD; hollow fiber system; quantitative drug development
   tool; Monte Carlo experiments}},
Keywords-Plus = {{MULTIDRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS;
   ANTITUBERCULOSIS DRUGS; IN-VITRO; PHARMACOKINETICS-PHARMACODYNAMICS;
   BACTERICIDAL ACTIVITY; RAPID EMERGENCE; RIFAMPIN; MOXIFLOXACIN;
   VARIABILITY}},
Research-Areas = {{Immunology; Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Immunology; Infectious Diseases; Microbiology}},
Author-Email = {{tawanda.gumbo@baylorhealth.edu}},
ORCID-Numbers = {{Gumbo, Tawanda/0000-0001-7592-8012}},
Funding-Acknowledgement = {{Critical Path to TB Drug Regimens (CPTR) Initiative}},
Funding-Text = {{This article was published as part of a supplement entitled ``An
   Evidence-Based Drug Development Tool for TB Regimens: The Hollow Fiber
   System Model,{''} initiated and sponsored by the Critical Path to TB
   Drug Regimens (CPTR) Initiative.}},
Cited-References = {{Chigutsa E, 2015, ANTIMICROB AGENTS CH, V59, P38, DOI 10.1128/AAC.03931-14.
   Chigutsa E, 2013, ANTIMICROB AGENTS CH, V57, P789, DOI 10.1128/AAC.01876-12.
   Dheda K, 2014, LANCET RESP MED, V2, P321, DOI 10.1016/S2213-2600(14)70031-1.
   Diacon AH, 2012, CLIN MICROBIOL INFEC, V18, P711, DOI 10.1111/j.1469-0691.2011.03626.x.
   Drusano GL, 2006, CLIN INFECT DIS, V42, P525, DOI 10.1086/499046.
   Drusano GL, 2011, MBIO, V2.
   Drusano GL, 2010, MBIO, V1.
   Drusano GL, 2012, 52 INT C ANT AG CHEM.
   Ginsburg AS, 2005, ANTIMICROB AGENTS CH, V49, P853, DOI 10.1128/AAC.49.2.853-856.2005.
   Goutelle S, 2011, J THEOR BIOL, V282, P80, DOI 10.1016/j.jtbi.2011.05.013.
   Goutelle S, 2009, ANTIMICROB AGENTS CH, V53, P2974, DOI 10.1128/AAC.01520-08.
   Gumbo T, 2005, ANTIMICROB AGENTS CH, V49, P3178, DOI 10.1128/AAC.49.8.3178-3181.2005.
   Gumbo T, 2004, J INFECT DIS, V190, P1642, DOI 10.1086/424849.
   Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P3781, DOI 10.1128/AAC.01533-06.
   Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P2329, DOI 10.1128/AAC.00185-07.
   Gumbo T, 2007, J INFECT DIS, V195, P194, DOI 10.1086/510247.
   Gumbo T, 2015, CLIN INFECT DIS, V61, pS25, DOI 10.1093/cid/civ427.
   Gumbo T, 2015, J INFECT DIS, V211, pS83, DOI 10.1093/infdis/jiv183.
   Gumbo T, 2015, J INFECT DIS, V211, pS96, DOI 10.1093/infdis/jiu610.
   Gumbo T, 2013, NAT GENET, V45, P720, DOI 10.1038/ng.2675.
   Gumbo T, 2010, ANTIMICROB AGENTS CH, V54, P1484, DOI 10.1128/AAC.01474-09.
   Gumbo T, 2009, ANTIMICROB AGENTS CH, V53, P3197, DOI 10.1128/AAC.01681-08.
   Jeena PM, 2011, ANTIMICROB AGENTS CH, V55, P539, DOI 10.1128/AAC.00763-10.
   Louie A, 2012, 52ND INTERSCIENCE CO.
   Louie A, 2012, ANTIMICROBIAL AGENTS.
   Louie A, 2012, 52 INT C ANT AG CHEM.
   METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232.
   Metropolis N, 1987, THE BEGINNING OF THE.
   Musuka S, 2013, ANTIMICROB AGENTS CH, V57, P5870, DOI 10.1128/AAC.00829-13.
   National Science Foundation Blue Ribbon Panel on Simulation-Based Engineering, 2006, SIMULATION BASED ENG.
   Okusanya OO, 2012, 52 INT C ANT AG CHEM.
   Pasipanodya J, 2011, ANTIMICROB AGENTS CH, V55, P24, DOI 10.1128/AAC.00749-10.
   Pasipanodya JG, 2013, J INFECT DIS, V208, P1464, DOI 10.1093/infdis/jit352.
   Pasipanodya JG, 2011, CURR OPIN PHARMACOL, V11, P457, DOI 10.1016/j.coph.2011.07.001.
   Schmalstieg AM, 2012, ANTIMICROB AGENTS CH, V56, P4806, DOI 10.1128/AAC.05546-11.
   Sorger PK, 2011, QSP WORKSHOP GROUP.
   Srivastava S, 2012, 52 INT C ANT AG CHEM.
   Srivastava S, 2011, J INFECT DIS, V204, P1951, DOI 10.1093/infdis/jir658.
   Srivastava S, 2011, CURR PHARM DESIGN, V17, P2881, DOI 10.2174/138161211797470192.
   Srivastava S, 2011, ANTIMICROB AGENTS CH, V55, P5085, DOI 10.1128/AAC.00269-11.
   Srivastava S, 2010, J INFECT DIS, V201, P1225, DOI 10.1086/651377.
   Stass H, 1998, ANTIMICROB AGENTS CH, V42, P2060.
   World Health Organization, 2011, GUID PROGR MAN DRUG.
   Xue B, 2012, 52 INT C ANT AG CHEM.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{24}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{14}},
Journal-ISO = {{Clin. Infect. Dis.}},
Doc-Delivery-Number = {{CO7NA}},
Unique-ID = {{ISI:000359344900003}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000359492800065,
Author = {Blaak, Hetty and van Hoek, Angela H. A. M. and Hamidjaja, Raditijo A.
   and van der Plaats, Rozemarijn Q. J. and Kerkhof-de Heer, Lianne and
   Husman, Ana Maria de Roda and Schets, Franciska M.},
Title = {{Distribution, Numbers, and Diversity of ESBL-Producing E. coli in the
   Poultry Farm Environment}},
Journal = {{PLOS ONE}},
Year = {{2015}},
Volume = {{10}},
Number = {{8}},
Month = {{AUG 13}},
Abstract = {{This study aimed to discern the contribution of poultry farms to the
   contamination of the environment with ESBL-producing Escherichia coli
   and therewith, potentially to the spread of these bacteria to humans and
   other animals. ESBL-producing E. coli were detected at all investigated
   laying hen farms (n = 5) and broiler farms (n = 3) in 65\% (46/71) and
   81\% (57/70) of poultry faeces samples, respectively. They were detected
   in rinse water and runoff water (21/26; 81\%), other farm animals
   (11/14; 79\%), dust (21/35; 60\%), surface water adjacent to farms
   (20/35; 57\%), soil (48/87; 55\%), on flies (11/73; 15\%), and in barn
   air (2/33; 6\%). The highest prevalence and concentrations in the
   outdoor environment were observed in soil of free-range areas at laying
   hen farms (100\% of samples positive, geometric mean concentration
   2.4x10(4) cfu/kg), and surface waters adjacent to broiler farms during,
   or shortly after, cleaning between production rounds (91\% of samples
   positive, geometric mean concentration 1.9x10(2) cfu/l). The diversity
   of ESBL-producing E. coli variants with respect to sequence type,
   phylogenetic group, ESBL-genotype and antibiotic resistance profile was
   high, especially on broiler farms where on average 16 different variants
   were detected, and the average Simpson's Indices of diversity (SID; 1-D)
   were 0.93 and 0.94 among flock and environmental isolates respectively.
   At laying hen farms on average nine variants were detected, with SIDs of
   0.63 (flock isolates) and 0.77 (environmental isolates). Sixty percent
   of environmental isolates were identical to flock isolates at the same
   farm. The highest proportions of `flock variants' were observed in dust
   (94\%), run-off gullies (82\%), and barn air (67\%), followed by surface
   water (57\%), soil (56\%), flies (50\%) and other farm animals (35\%).
   The introduction of ESBL-producing E. coli from poultry farms to the
   environment may pose a health risk if these bacteria reach places where
   people may become exposed.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Blaak, H (Reprint Author), Natl Inst Publ Hlth \& Environm RIVM, Ctr Zoonoses \& Environm Microbiol, Bilthoven, Netherlands.
   Blaak, Hetty; van Hoek, Angela H. A. M.; Hamidjaja, Raditijo A.; van der Plaats, Rozemarijn Q. J.; Kerkhof-de Heer, Lianne; Husman, Ana Maria de Roda; Schets, Franciska M., Natl Inst Publ Hlth \& Environm RIVM, Ctr Zoonoses \& Environm Microbiol, Bilthoven, Netherlands.
   Husman, Ana Maria de Roda, Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands.}},
DOI = {{10.1371/journal.pone.0135402}},
Article-Number = {{e0135402}},
ISSN = {{1932-6203}},
Keywords-Plus = {{SPECTRUM-BETA-LACTAMASE; COMMENSAL ESCHERICHIA-COLI; R-PLASMID TRANSFER;
   EXTENDED-SPECTRUM; ANTIBIOTIC-RESISTANCE; SPORADIC INFECTIONS; SOURCE
   ATTRIBUTION; SURROUNDING AREAS; GENETIC EXCHANGE; BROILER FARMS}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{hetty.blaak@rivm.nl}},
ORCID-Numbers = {{Hamidjaja, Raditijo/0000-0002-5655-2299}},
Funding-Acknowledgement = {{Netherlands Food and Consumer Product Safety Authority (nVWA)
   {[}V/092326]}},
Funding-Text = {{The study was financed by the Netherlands Food and Consumer Product
   Safety Authority (nVWA). Grant number V/092326. The funding was granted
   to Ana Maria de Roda Husman.}},
Cited-References = {{{[}Anonymous], 2014, ANT PLUIMV 2013 TREN.
   Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006.
   Blaak H, 2014, VET MICROBIOL, V171, P448, DOI 10.1016/j.vetmic.2014.03.007.
   Blaak H, 2014, APPL ENVIRON MICROB, V80, P239, DOI 10.1128/AEM.02616-13.
   Canton R, 2008, CLIN MICROBIOL INFEC, V14, P144, DOI 10.1111/j.1469-0691.2007.01850.x.
   Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x.
   Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018.
   Chen H, 2010, ENVIRON POLLUT, V158, P2459, DOI 10.1016/j.envpol.2010.03.023.
   Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000.
   Clinical and Laboratory Standards Institute, 2010, M100S20 CLIN LAB S S.
   Clinical and Laboratory Standards Institute, 2015, M100S25 CLSI S.
   COUGHTER JP, 1989, A VAN LEEUW J MICROB, V55, P15, DOI 10.1007/BF02309615.
   CRANE SR, 1986, WATER AIR SOIL POLL, V27, P411, DOI 10.1007/BF00649422.
   Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498.
   Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421.
   de Been M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004776.
   den Heijer CDJ, 2010, J ANTIMICROB CHEMOTH, V65, P2128, DOI 10.1093/jac/dkq286.
   Dhanji H, 2011, J ANTIMICROB CHEMOTH, V66, P512, DOI 10.1093/jac/dkq472.
   Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049.
   Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349.
   Dierikx C, 2010, VET MICROBIOL, V145, P273, DOI 10.1016/j.vetmic.2010.03.019.
   Dierikx CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079005.
   Domingues AR, 2012, EPIDEMIOL INFECT, V140, P970, DOI 10.1017/S0950268811002676.
   Domingues AR, 2012, EPIDEMIOL INFECT, V140, P959, DOI 10.1017/S0950268811002172.
   EARSNet, 2011, ANN REP EUR ANT RES.
   Escobar-Paramo P, 2006, ENVIRON MICROBIOL, V8, P1975, DOI 10.1111/j.1462-2920.2006.01077.x.
   Evers EG, 2015, RISK ANAL IN PRESS.
   Frahm E, 2003, J MICROBIOL METH, V52, P123, DOI 10.1016/S0167-7012(02)00150-1.
   Franz E, 2014, ENVIRON SCI TECHNOL, V48, P6763, DOI 10.1021/es501677c.
   Gao LL, 2015, INT J ENV RES PUB HE, V12, P4203, DOI 10.3390/ijerph120404203.
   Greenberg B, 1973, FLIES DIS, V2.
   Hartmann A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00083.
   Hong HG, 2004, MICROB DRUG RESIST, V10, P184, DOI 10.1089/1076629041310145.
   Huijbers PMC, 2014, J ANTIMICROB CHEMOTH, V69, P2669, DOI 10.1093/jac/dku178.
   Huijbers PMC, 2013, CLIN MICROBIOL INFEC, V19, pE256, DOI 10.1111/1469-0691.12150.
   Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325.
   Laube H, 2014, VET MICROBIOL, V172, P519, DOI 10.1016/j.vetmic.2014.06.008.
   Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x.
   Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483.
   LYSYK TJ, 1986, J ECON ENTOMOL, V79, P993, DOI 10.1093/jee/79.4.993.
   Ma JY, 2012, APPL ENVIRON MICROB, V78, P3668, DOI 10.1128/AEM.07507-11.
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x.
   Nazni W.A., 2005, Tropical Biomedicine, V22, P53.
   Njage PMK, 2015, MICROB BIOTECHNOL, V8, P462, DOI 10.1111/1751-7915.12234.
   Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209.
   Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005.
   Poirel L, 2008, CLIN MICROBIOL INFEC, V14, P75, DOI 10.1111/j.1469-0691.2007.01865.x.
   Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739.
   Reuland EA, 2013, CLIN MICROBIOL INFEC, V19, P542, DOI 10.1111/j.1469-0691.2012.03947.x.
   Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004.
   SMITH HW, 1969, LANCET, V1, P1174.
   Sola-Gines M, 2015, APPL ENVIRON MICROB, V81, P3604, DOI 10.1128/AEM.04252-14.
   Soraas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069581.
   TREVORS JT, 1987, SYST APPL MICROBIOL, V9, P312.
   TREVORS JT, 1987, CAN J MICROBIOL, V33, P191, DOI 10.1139/m87-033.
   TREVORS JT, 1987, WATER AIR SOIL POLL, V34, P409.
   TREVORS JT, 1986, CAN J MICROBIOL, V32, P610, DOI 10.1139/m86-114.
   Usui M, 2013, MICROB DRUG RESIST, V15, P415, DOI DOI 10.1089/MDR.2012.0251.
   von Salviati C, 2015, VET MICROBIOL, V175, P77, DOI 10.1016/j.vetmic.2014.10.010.
   Wang J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00188.
   Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x.
   Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005.
   Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P397, DOI 10.1007/s00253-008-1829-z.
   Zurfluh K, 2013, APPL ENVIRON MICROB, V79, P3021, DOI 10.1128/AEM.00054-13.
   2001, 166492 ISO.}},
Number-of-Cited-References = {{65}},
Times-Cited = {{18}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{34}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{CO9JX}},
Unique-ID = {{ISI:000359492800065}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000358100500002,
Author = {O'Leary, Denis and McCabe, Evonne M. and McCusker, Matthew P. and
   Martins, Marta and Fanning, Seamus and Duffy, Geraldine},
Title = {{Acid environments affect biofilm formation and gene expression in
   isolates of Salmonella enterica Typhimurium DT104}},
Journal = {{INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY}},
Year = {{2015}},
Volume = {{206}},
Pages = {{7-16}},
Month = {{AUG 3}},
Abstract = {{The aim of this study was to examine the survival and potential
   virulence of biofilm-forming Salmonella Typhimurium DT104 under mild
   acid conditions. Salmonella Typhimurium 01104 employs an acid tolerance
   response (AIR) allowing it to adapt to acidic environments. The threat
   that these acid adapted cells pose to food safety could be enhanced if
   they also produce biofilms in acidic conditions. The cells were
   add-adapted by culturing them in 1\% glucose and their ability to form
   biofilms on stainless steel and on the surface of Luria Bertani (LB)
   broth at pH 7 and pH 5 was examined. Plate counts were performed to
   examine cell survival. RNA was isolated from cells to examine changes in
   the expression of genes associated with virulence, invasion, biofilm
   formation and global gene regulation in response to acid stress. Of the
   4 isolates that were examined only one (1481) that produced a rigid
   biofilm in LB broth at pH 7 also formed this same structure at pH 5.
   This indicated that the lactic acid severely impeded the biofilm
   producing capabilities of the other isolates examined under these
   conditions. Isolate 1481 also had higher expression of genes associated
   with virulence (hilA) and invasion (invA) with a 24.34-fold and
   13.68-fold increase in relative gene expression respectively at pH 5
   compared to pH 7. Although genes associated with biofilm formation had
   increased expression in response to acid stress for all the isolates
   this only resulted in the formation of a biofilm by isolate 1481. This
   suggests that in addition to the range of genes associated with biofilm
   production at neutral pH, there are genes whose protein products
   specifically aid in biofilm production in acidic environments.
   Furthermore, it highlights the potential for the use of lactic acid for
   the inhibition of Salmonella biofilms. (C) 2015 Elsevier B.V. All rights
   reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{McCabe, EM (Reprint Author), Teagasc Food Res Ctr, Food Safety Dept, Ashtown Dublin 15, Ireland.
   O'Leary, Denis; McCabe, Evonne M.; Duffy, Geraldine, Teagasc Food Res Ctr, Food Safety Dept, Ashtown Dublin 15, Ireland.
   O'Leary, Denis; McCabe, Evonne M.; McCusker, Matthew P.; Martins, Marta; Fanning, Seamus, Univ Coll Dublin, UCD Ctr Food Safety, UCD Sch Publ Hlth Physiotherapy \& Populat Sci, Belfield Dublin 4, Ireland.}},
DOI = {{10.1016/j.ijfoodmicro.2015.03.030}},
ISSN = {{0168-1605}},
EISSN = {{1879-3460}},
Keywords = {{Biofilm; Gene expression; Antibiotic resistance; Salmonella enterica}},
Keywords-Plus = {{ESCHERICHIA-COLI O157-H7; SEROVAR TYPHIMURIUM; TOLERANCE RESPONSE;
   MICROBIAL BIOFILMS; FOOD-INDUSTRY; SURVIVAL; STRESS; RESISTANCE;
   ADAPTATION; SYSTEM}},
Research-Areas = {{Food Science \& Technology; Microbiology}},
Web-of-Science-Categories  = {{Food Science \& Technology; Microbiology}},
Author-Email = {{evonne.mccabe@teagasc.ie}},
ORCID-Numbers = {{Martins, Marta/0000-0002-0323-2857
   Fanning, Seamus/0000-0002-1922-8836}},
Funding-Acknowledgement = {{Food Institute Research Measure (FIRM) {[}06/TNI/UCD/10]}},
Funding-Text = {{We acknowledge with gratitude funding from the Food Institute Research
   Measure (FIRM) administrated by the Department of Agriculture, Fisheries
   and Food (DAFF), Ireland, Project no.: 06/TNI/UCD/10.}},
Cited-References = {{Arnold CN, 2001, J BACTERIOL, V183, P2178, DOI 10.1128/JB.183.7.2178-2186.2001.
   Audia JP, 2001, INT J MED MICROBIOL, V291, P97, DOI 10.1078/1438-4221-00106.
   Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x.
   Bang IS, 2000, J BACTERIOL, V182, P2245, DOI 10.1128/JB.182.8.2245-2252.2000.
   Bang IS, 2002, MOL MICROBIOL, V44, P1235, DOI 10.1046/j.1365-2958.2002.02937.x.
   Bertrand S, 2006, J CLIN MICROBIOL, V44, P2897, DOI 10.1128/JCM.02549-05.
   Bouchrif B, 2008, MED MALADIES INFECT, V38, P615, DOI 10.1016/j.medmal.2008.09.014.
   Buchanan RL, 1999, J FOOD PROTECT, V62, P219, DOI 10.4315/0362-028X-62.3.219.
   Cardona-Castro N, 2002, MEM I OSWALDO CRUZ, V97, P1153, DOI 10.1590/S0074-02762002000800016.
   CARPENTIER B, 1993, J APPL BACTERIOL, V75, P499, DOI 10.1111/j.1365-2672.1993.tb01587.x.
   Chen CX, 2010, ENVIRON TOXICOL PHAR, V30, P5, DOI 10.1016/j.etap.2010.03.004.
   Clark MA, 1996, INFECT IMMUN, V64, P4363.
   CLOUSER CS, 1995, POULTRY SCI, V74, P732, DOI 10.3382/ps.0740732.
   Cooke FJ, 2007, J CLIN MICROBIOL, V45, P2590, DOI 10.1128/JCM.00729-07.
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431.
   Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000.
   Finlay JA, 1997, BIOFOULING, V11, P19, DOI 10.1080/08927019709378318.
   FOSTER JW, 1995, CRIT REV MICROBIOL, V21, P215, DOI 10.3109/10408419509113541.
   FOSTER JW, 1991, J BACTERIOL, V173, P6896, DOI 10.1128/jb.173.21.6896-6902.1991.
   Fricks-Lima J, 2011, INT J ANTIMICROB AG, V37, P309, DOI 10.1016/j.ijantimicag.2010.12.017.
   Garcia B, 2004, MOL MICROBIOL, V54, P264, DOI 10.1111/j.1365-2958.2004.04269.x.
   Gilbert P, 2001, J APPL MICROBIOL, V91, P248, DOI 10.1046/j.1365-2672.2001.01385.x.
   Grantcharova N, 2010, J BACTERIOL, V192, P456, DOI 10.1128/JB.01826-08.
   Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi\_18040661.x.
   Kapfhammer D, 2005, APPL ENVIRON MICROB, V71, P3840, DOI 10.1128/AEM.71.7.3840-3847.2005.
   Kint G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-276.
   Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000.
   LEYER GJ, 1995, APPL ENVIRON MICROB, V61, P3752.
   LEYER GJ, 1992, APPL ENVIRON MICROB, V58, P2075.
   Mikolajczyk A., 2002, Polish Journal of Veterinary Sciences, V5, P139.
   O'Leary D, 2013, INT J FOOD MICROBIOL, V161, P36, DOI 10.1016/j.ijfoodmicro.2012.11.021.
   Poppe C, 1998, CAN VET J, V39, P559.
   Raffatellu M., 2007, INTESTINAL PHASE SAL.
   RAHN K, 1992, MOL CELL PROBE, V6, P271, DOI 10.1016/0890-8508(92)90002-F.
   Romling U, 2000, MOL MICROBIOL, V36, P10, DOI 10.1046/j.1365-2958.2000.01822.x.
   Rychlik I, 2005, FEMS MICROBIOL REV, V29, P1021, DOI 10.1016/j.femsre.2005.03.005.
   Samelis J, 2005, APPL ENVIRON MICROB, V71, P6228, DOI 10.1128/AEM.71.10.6228-6234.2005.
   Scher K, 2005, APPL ENVIRON MICROB, V71, P1163, DOI 10.1128/AEM.71.3.1163-1168.2005.
   Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3.
   Skandamis PN, 2009, FOOD MICROBIOL, V26, P112, DOI 10.1016/j.fm.2008.09.001.
   Stafford GP, 2007, MICROBIOL-SGM, V153, P541, DOI 10.1099/mic.0.2006/002576-0.
   Taormina PJ, 2002, J APPL MICROBIOL, V92, P71, DOI 10.1046/j.1365-2672.2002.01488.x.
   Teplitski M, 2006, MICROBIOL-SGM, V152, P3411, DOI 10.1099/mic.0.29118-0.
   Trevejo RT, 2003, AM J EPIDEMIOL, V157, P48, DOI 10.1093/aje/kwf155.
   Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x.
   White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.3219-3227.2006.
   Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003.
   Zhao BY, 2010, BIOCHEM CELL BIOL, V88, P301, DOI {[}10.1139/o09-182, 10.1139/O09-182].}},
Number-of-Cited-References = {{48}},
Times-Cited = {{10}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{46}},
Journal-ISO = {{Int. J. Food Microbiol.}},
Doc-Delivery-Number = {{CN0JS}},
Unique-ID = {{ISI:000358100500002}},
DA = {{2018-08-13}},
}

@article{ ISI:000358782300056,
Author = {Kumari, Priyanka and Choi, Hong Lim},
Title = {{Manure removal system influences the abundance and composition of
   airborne biotic contaminants in swine confinement buildings}},
Journal = {{ENVIRONMENTAL MONITORING AND ASSESSMENT}},
Year = {{2015}},
Volume = {{187}},
Number = {{8}},
Month = {{AUG}},
Abstract = {{Little is known about the factors influencing the abundance and
   community composition of airborne biotic contaminants in swine
   confinement buildings (SCBs). Microbial air samples were collected from
   three different SCBs equipped with three different types of manure
   removal systems (deep-pit manure removal with slats, scraper removal
   system, and deep-litter bed system). The abundance and composition of
   airborne biotic contaminants of all the collected air samples were
   analyzed using cultivation-independent methods. The V1V3 region of the
   16S rRNA gene was amplified from the extracted DNA and sequenced using
   454-pyrosequencing. The abundances of 16S rRNA genes and six
   tetracycline resistance genes (tetB, tetH, tetZ, tetO, tetQ, and tetW)
   were quantified using real-time PCR. The abundance of 16S rRNA gene and
   tetracycline resistance genes were significantly higher in SCBs equipped
   with a deep-pit manure removal system with slats, except for tetB gene.
   This contrasts with the opposite trend found previously by culture-based
   studies. The aerial bacterial community composition, as measured by
   pairwise Bray-Curtis distances, varied significantly according to the
   manure removal system. 16S rRNA-based pyrosequencing revealed Firmicutes
   (72.4 \%) as the dominant group with Lactobacillus as the major genus,
   while Actinobacteria constituted 10.7 \% of the detectable bacteria.
   Firmicutes were more abundant in SCBs with deep pit with slats, whereas
   Actinobacteria were highly abundant in SCBs with a deep-litter bed
   system. Overall, the results of this study suggest that the manure
   removal system plays a key role in structuring the abundance and
   composition of airborne biotic contaminants in SCBs.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Choi, HL (Reprint Author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.
   Kumari, Priyanka; Choi, Hong Lim, Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.
   Kumari, Priyanka; Choi, Hong Lim, Seoul Natl Univ, Res Inst Agr \& Life Sci, Seoul 151921, South Korea.}},
DOI = {{10.1007/s10661-015-4759-0}},
Article-Number = {{537}},
ISSN = {{0167-6369}},
EISSN = {{1573-2959}},
Keywords = {{Bacterial bioaerosol; Manure removal system; Pyrosequencing; Swine
   confinement buildings (SCBs)}},
Keywords-Plus = {{CULTURE-INDEPENDENT CHARACTERIZATION; ANTIBIOTIC-RESISTANCE; AERIAL
   POLLUTANTS; POULTRY LITTER; BACTERIA; EXPOSURE; HEALTH; HOUSES; DUST;
   PIG}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{ulsoo8@snu.ac.kr}},
Funding-Acknowledgement = {{Korea Institute of Planning and Evaluation for Technology in Food,
   Agriculture, Forestry, and Fisheries (IPET) from the Ministry of
   Agriculture, Food, and Rural Affairs (MAFRA) {[}312036-03-2-HD030];
   Korea Institute of Energy Technology Evaluation and Planning (KETEP)
   from Ministry of Trade, Industry and Energy (MOTIE) {[}2012-3020090040];
   BK21 Plus Program}},
Funding-Text = {{This work was supported by the Korea Institute of Planning and
   Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries
   (IPET) from the Ministry of Agriculture, Food, and Rural Affairs (MAFRA)
   through project no. 312036-03-2-HD030 and in part by the Korea Institute
   of Energy Technology Evaluation and Planning (KETEP) from the Ministry
   of Trade, Industry and Energy (MOTIE) through project no.
   2012-3020090040. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. Priyanka Kumari was supported by a scholarship from the BK21
   Plus Program.}},
Cited-References = {{Blake DP, 2003, J APPL MICROBIOL, V95, P428, DOI 10.1046/j.1365-2672.2003.01988.x.
   Chang CW, 2001, APPL ENVIRON MICROB, V67, P155, DOI 10.1128/AEM.67.1.155-161.2001.
   Clarke K. R., 2006, PRIMER V6 USER MANUA.
   Cole D, 2000, ENVIRON HEALTH PERSP, V108, P685, DOI 10.2307/3434721.
   DONHAM KJ, 1990, AM J IND MED, V18, P241, DOI 10.1002/ajim.4700180303.
   Duan HY, 2009, ENVIRON RES, V109, P511, DOI 10.1016/j.envres.2009.02.014.
   Dumas MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024785.
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381.
   Fries R, 2005, BRIT POULTRY SCI, V46, P668, DOI 10.1080/00071660500395483.
   Heuer H, 2002, FEMS MICROBIOL ECOL, V42, P289, DOI {[}10.1111/j.1574-6941.2002.tb01019.x, 10.1016/S0168-6496(02)00342-2].
   Hong PY, 2012, ENVIRON MICROBIOL, V14, P1420, DOI 10.1111/j.1462-2920.2012.02726.x.
   KFDA (Korean Food and Drug Administration), 2006, EST CONTR SYST ANT L, P19.
   Kim KY, 2007, ENVIRON MONIT ASSESS, V133, P255, DOI 10.1007/s10661-006-9578-x.
   Kristiansen A, 2012, FEMS MICROBIOL ECOL, V80, P390, DOI 10.1111/j.1574-6941.2012.01305.x.
   Kumari P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112897.
   Lee SA, 2006, J OCCUP ENVIRON HYG, V3, P118, DOI 10.1080/15459620500524607.
   Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002.
   Levy SB, 1999, ANTIMICROB AGENTS CH, V43, P1523.
   Martin SA, 1998, J APPL POULTRY RES, V7, P90, DOI 10.1093/japr/7.1.90.
   Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x.
   Nehme B, 2009, APPL ENVIRON MICROB, V75, P5445, DOI 10.1128/AEM.00726-09.
   Nonnenmann MW, 2010, J OCCUP ENVIRON HYG, V7, P693, DOI 10.1080/15459624.2010.526893.
   Olson D K, 1996, AAOHN J, V44, P198.
   PEARSON CC, 1995, J AGR ENG RES, V60, P145, DOI 10.1006/jaer.1995.1008.
   Predicala BZ, 2002, CURR MICROBIOL, V44, P136, DOI 10.1007/s00284-001-0064-y.
   Robbins C A, 2000, Appl Occup Environ Hyg, V15, P773.
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09.
   Smalla K, 2000, APPL ENVIRON MICROB, V66, P4854, DOI 10.1128/AEM.66.11.4854-4862.2000.
   Unno T, 2010, ENVIRON SCI TECHNOL, V44, P7777, DOI 10.1021/es101500z.
   WHYTE RT, 1993, WORLD POULTRY SCI J, V49, P139, DOI 10.1079/WPS19930012.
   Yao HQ, 2011, ATMOS ENVIRON, V45, P2577, DOI 10.1016/j.atmosenv.2011.01.058.
   Yao HQ, 2010, J ANIM SCI, V88, P3707, DOI 10.2527/jas.2009-2399.
   ZEJDA JE, 1994, J OCCUP ENVIRON MED, V36, P49.
   Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{23}},
Journal-ISO = {{Environ. Monit. Assess.}},
Doc-Delivery-Number = {{CN9PW}},
Unique-ID = {{ISI:000358782300056}},
DA = {{2018-08-13}},
}

@article{ ISI:000357618300015,
Author = {Torre, Antonina and Bacconi, Marta and Sammicheli, Chiara and Galletti,
   Bruno and Laera, Donatello and Fontana, Maria Rita and Grandi, Guido and
   De Gregorio, Ennio and Bagnoli, Fabio and Nuti, Sandra and Bertholet,
   Sylvie and Bensi, Giuliano},
Title = {{Four-Component Staphylococcus aureus Vaccine 4C-Staph Enhances Fc gamma
   Receptor Expression in Neutrophils and Monocytes and Mitigates S-aureus
   Infection in Neutropenic Mice}},
Journal = {{INFECTION AND IMMUNITY}},
Year = {{2015}},
Volume = {{83}},
Number = {{8}},
Pages = {{3157-3163}},
Month = {{AUG}},
Abstract = {{Staphylococcus aureus is a human bacterial pathogen causing a variety of
   diseases. The occurrence of multidrug-resistant strains of
   Staphylococcus aureus underlines the need for a vaccine. Defining immune
   correlates of protection may support the design of an effective vaccine.
   We used a murine Staphylococcus aureus infection model, in which
   bacteria were inoculated in an air pouch generated on the back of the
   animal. Analysis of the air-pouch content in mice immunized or not with
   an adjuvanted multiantigen vaccine formulation, four-component S. aureus
   vaccine (4C-Staph), prior to infection allowed us to measure bacteria,
   cytokines, and 4C-Staph-specific antibodies and to analyze host immune
   cells recruited to the infection site. Immunization with 4C-Staph
   resulted in accumulation of antigen-specific antibodies in the pouch and
   mitigated the infection. Neutrophils were the most abundant cells in the
   pouch, and they showed the upregulation of Fc gamma receptor ( Fc gamma
   R) following immunization with 4C-Staph. Reduction of the infection was
   also obtained in mice immunized with 4C-Staph and depleted of
   neutrophils; these mice showed an increase in monocytes and macrophages.
   Upregulation of the Fc gamma R and the presence of antigen-specific
   antibodies induced by immunization with 4C-Staph may contribute to
   increase bacterial opsonophagocytosis. Protection in neutropenic mice
   indicated that an effective vaccine could activate alternative
   protection mechanisms compensating for neutropenia, a condition often
   occurring in S. aureus-infected patients.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Bensi, G (Reprint Author), Novartis Vaccines \& Diagnost Srl, Siena, Italy.
   Torre, Antonina; Bacconi, Marta; Sammicheli, Chiara; Galletti, Bruno; Laera, Donatello; Fontana, Maria Rita; Grandi, Guido; De Gregorio, Ennio; Bagnoli, Fabio; Nuti, Sandra; Bertholet, Sylvie; Bensi, Giuliano, Novartis Vaccines \& Diagnost Srl, Siena, Italy.}},
DOI = {{10.1128/IAI.00258-15}},
ISSN = {{0019-9567}},
EISSN = {{1098-5522}},
Keywords-Plus = {{PSEUDOMONAS-AERUGINOSA PNEUMONIA; SURFACE DETERMINANT B; ACTIVITY
   IN-VITRO; IMMUNE EVASION; ANTIBODY; INFLAMMATION; MODELS; MACROPHAGES;
   PROTECTION; CELLS}},
Research-Areas = {{Immunology; Infectious Diseases}},
Web-of-Science-Categories  = {{Immunology; Infectious Diseases}},
Author-Email = {{giuliano.x.bensi@gsk.com}},
Funding-Acknowledgement = {{Novartis Vaccines and Diagnostics, s.r.l.}},
Funding-Text = {{This study was supported by internal funding from Novartis Vaccines and
   Diagnostics, s.r.l.}},
Cited-References = {{Bagnoli F, 2015, P NATL ACAD SCI USA, V112, P3680, DOI 10.1073/pnas.1424924112.
   BENSI G, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/mcp.M111.015693.
   Botelho-Nevers E, 2013, EXPERT REV VACCINES, V12, P1249, DOI 10.1586/14760584.2013.840091.
   Boxer LA, 2012, HEMATOL-AM SOC HEMAT, P174, DOI 10.1182/asheducation-2012.1.174.
   Brown AE, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00507.
   Brown M, 2009, CLIN VACCINE IMMUNOL, V16, P1095, DOI 10.1128/CVI.00085-09.
   Chiappini N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040411.
   Chiarot E, 2013, MBIO, V4, DOI 10.1128/mBio.00387-12.
   Colville-Nash Paul, 2003, Methods Mol Biol, V225, P181.
   Delano DL, 2005, ARTHRITIS RHEUM, V52, P2567, DOI 10.1002/art.21208.
   DeLeo FR, 2004, APOPTOSIS, V9, P399, DOI 10.1023/B:APPT.0000031448.64969.fa.
   DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1.
   Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.
   Ebert Tim, 2010, Human Antibodies, V19, P113, DOI 10.3233/HAB-2010-0235.
   Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161.
   Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289.
   Fritz SA, 2013, CLIN INFECT DIS, V56, P1554, DOI 10.1093/cid/cit123.
   Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582.
   Holtfreter S, 2010, INT J MED MICROBIOL, V300, P176, DOI 10.1016/j.ijmm.2009.10.002.
   Kamei A, 2013, J INFECT DIS, V207, P39, DOI 10.1093/infdis/jis657.
   Kim HK, 2014, J IMMUNOL METHODS, V410, P88, DOI 10.1016/j.jim.2014.04.007.
   Kim HK, 2012, CURR OPIN MICROBIOL, V15, P92, DOI 10.1016/j.mib.2011.10.012.
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806.
   Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010.
   Moellering RC, 2010, J ANTIMICROB CHEMOTH, V65, piv3, DOI 10.1093/jac/dkq250.
   Molne L, 2000, INFECT IMMUN, V68, P6162, DOI 10.1128/IAI.68.11.6162-6167.2000.
   Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x.
   NickersonNutter CL, 1996, ARTHRITIS RHEUM, V39, P515, DOI 10.1002/art.1780390320.
   Pancari G, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00036.
   Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3.
   Rothfork JM, 2003, J IMMUNOL, V171, P5389, DOI 10.4049/jimmunol.171.10.5389.
   Scarff JM, 2008, CLIN VACCINE IMMUNOL, V15, P367, DOI 10.1128/CVI.00419-07.
   Scully IL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00109.
   Selvaraj P, 2004, IMMUNOL RES, V29, P219, DOI 10.1385/IR:29:1-3:219.
   Verdrengh M, 1997, INFECT IMMUN, V65, P2517.
   Wood P, 2007, CLIN EXP IMMUNOL, V149, P410, DOI 10.1111/j.1365-2249.2007.03432.x.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{12}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{Infect. Immun.}},
Doc-Delivery-Number = {{CM3XI}},
Unique-ID = {{ISI:000357618300015}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000358482100002,
Author = {Jamali, Hossein and Paydar, Mohammadjavad and Ismail, Salmah and Looi,
   Chung Yeng and Wong, Won Fen and Radmehr, Behrad and Abedini, Atefeh},
Title = {{Prevalence, antimicrobial susceptibility and virulotyping of Listeria
   species and Listeria monocytogenes isolated from open-air fish markets}},
Journal = {{BMC MICROBIOLOGY}},
Year = {{2015}},
Volume = {{15}},
Month = {{JUL 25}},
Abstract = {{Background: The aim of this study was to investigate the prevalence and
   characterization of Listeria species and Listeria monocytogenes isolated
   from raw fish and open-air fish market environments. Eight hundred and
   sixty two samples including raw fish and fish market environments
   (samples from workers' hands, workers' knives, containers and work
   surface) were collected from the open-air fish markets in the Northern
   region of Iran.
   Results: Listeria spp. was isolated from 104/488 (21.3 \%) raw fish and
   29/374 (7.8 \%) of samples from open-air fish market environment. The
   isolates of Listeria spp. included L. innocua (35.3 \%), L.
   monocytogenes (32.3 \%), L. seeligeri (18 \%), and L. ivanovii (14.3
   \%). Of the 43 L. monocytogenes isolates, 31 (72.1 \%), 10 (23.3 \%) and
   2 (4.7 \%) belonged to serovars 1/2a, 4b, and 1/2b, respectively. The
   inlA, inlB, inlC, inlJ, actA, hlyA, iap, plcA, and prfA
   virulence-associated genes were detected in almost all of the L.
   monocytogenes isolates. The Listeria spp. isolates showed high
   resistance against tetracycline (23.3 \%), penicillin G, and cephalothin
   (each 16.5 \%). Besides, we observed significant resistance level to
   tetracycline (27.9 \%), ampicillin (20.9 \%), cephalothin, penicillin G,
   and streptomycin (each 16.3 \%) in the L. monocytogenes isolates. All of
   the isolates were susceptible to cefotaxime, gentamicin, kanamycin, and
   pefloxacin. We found that tetM (25.6 \%), tetA (23.3 \%), ampC (14 \%),
   and penA (11.6 \%) were the most prevalent antibiotic resistance genes
   in the L. monocytogenes isolates.
   Conclusions: Recovery of potentially pathogenic L. monocytogenes from
   raw fish and environment of open-air fish market samples in this study
   is a convincing evidence for the zoonotic potential of listeriosis.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Jamali, H (Reprint Author), Univ Malaya, Fac Sci, Inst Biol Sci, Biohlth Sci Program, Kuala Lumpur 50603, Malaysia.
   Jamali, Hossein; Ismail, Salmah, Univ Malaya, Fac Sci, Inst Biol Sci, Biohlth Sci Program, Kuala Lumpur 50603, Malaysia.
   Paydar, Mohammadjavad; Looi, Chung Yeng, Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.
   Wong, Won Fen, Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.
   Radmehr, Behrad, Islamic Azad Univ, Dept Food Hyg \& Qual Control, Karaj Branch, Karaj 31485313, Iran.
   Abedini, Atefeh, Univ Montreal, Ctr Rech Reprod Anim, St Hyacinthe, PQ, Canada.}},
DOI = {{10.1186/s12866-015-0476-7}},
Article-Number = {{144}},
ISSN = {{1471-2180}},
Keywords = {{Listeria; Seafood; Virulence genes; Serotyping; Antibiotic resistance;
   Resistance gene}},
Keywords-Plus = {{TETRACYCLINE-RESISTANCE; MOLECULAR CHARACTERIZATION; ESCHERICHIA-COLI;
   UNITED-STATES; PCR DETECTION; WASTE-WATER; GENES; DETERMINANTS;
   VIRULENCE; FOODS}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{mordabenilofari@gmail.com}},
ResearcherID-Numbers = {{Looi, Chung Yeng/A-2623-2013
   wong, wonfen/D-3087-2012}},
ORCID-Numbers = {{Looi, Chung Yeng/0000-0002-4830-3495
   wong, wonfen/0000-0003-1082-1956}},
Funding-Acknowledgement = {{Islamic Azad University-Karaj Branch; University of Malaya
   {[}RG525-13HTM]}},
Funding-Text = {{This study was supported by funding from Islamic Azad University-Karaj
   Branch and a research grant from University of Malaya (RG525-13HTM).}},
Cited-References = {{Aznar R, 2003, J APPL MICROBIOL, V95, P958, DOI 10.1046/j.1365-2672.2003.02066.x.
   Basti AA, 2006, FOOD CONTROL, V17, P183, DOI 10.1016/j.foodcont.2004.10.001.
   Cartwright EJ, 2013, EMERG INFECT DIS, V19, P1, DOI 10.3201/eid1901.120393.
   CHARPENTIER E, 1993, GENE, V131, P27, DOI 10.1016/0378-1119(93)90665-P.
   Clermont D, 1997, ANTIMICROB AGENTS CH, V41, P112.
   Clinical and Laboratory Standards Institute, 2010, METH ANT DIL DISK SU.
   Cocolin L, 2005, INT J FOOD MICROBIOL, V103, P167, DOI 10.1016/j.ijfoodmicro.2004.12.027.
   Conter M, 2009, INT J FOOD MICROBIOL, V128, P497, DOI 10.1016/j.ijfoodmicro.2008.10.018.
   Das S, 2013, ANN MICROBIOL, V63, P1093, DOI 10.1007/s13213-012-0566-9.
   Fallah AA, 2013, FOOD CONTROL, V34, P630, DOI 10.1016/j.foodcont.2013.06.015.
   FAO, 1999, EXP CONS TRAD IMP LI.
   FARBER JM, 1991, MICROBIOL REV, V55, P476.
   FARMER S, 1992, J ANTIMICROB CHEMOTH, V29, P27, DOI 10.1093/jac/29.1.27.
   Gebreyes WA, 2002, J CLIN MICROBIOL, V40, P2813, DOI 10.1128/JCM.40.8.2813-2822.2002.
   Gelbicova I, 2012, CZECH J FOOD SCI, V30, P83.
   Gevers D, 2003, APPL ENVIRON MICROB, V69, P1270, DOI 10.1128/AEM.69.2.1270-1275.2003.
   Guillaume G, 2000, FEMS MICROBIOL ECOL, V32, P77, DOI 10.1111/j.1574-6941.2000.tb00701.x.
   Harakeh S, 2009, SCI TOTAL ENVIRON, V407, P4022, DOI 10.1016/j.scitotenv.2009.04.010.
   ISO, 1996, 112901 ISO.
   Jamali H, 2014, FOOD CONTROL, V44, P1, DOI 10.1016/j.foodcont.2014.03.038.
   Jamali H, 2013, VET J, V198, P541, DOI 10.1016/j.tvjl.2013.06.012.
   Jamali H, 2013, FOOD CONTROL, V34, P121, DOI 10.1016/j.foodcont.2013.04.023.
   Johansson T, 1999, INT J FOOD MICROBIOL, V47, P111, DOI 10.1016/S0168-1605(99)00019-7.
   Kalorey DR, 2006, COMP IMMUNOL MICROB, V29, P295, DOI 10.1016/j.cimid.2006.07.002.
   Kasper S, 2009, WIEN KLIN WOCHENSCHR, V121, P113, DOI 10.1007/s00508-008-1130-2.
   Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811.
   Keyes K, 2000, ANTIMICROB AGENTS CH, V44, P421, DOI 10.1128/AAC.44.2.421-424.2000.
   Kramarenko T, 2013, FOOD CONTROL, V30, P24, DOI 10.1016/j.foodcont.2012.06.047.
   Lanz R, 2003, VET MICROBIOL, V91, P73, DOI 10.1016/S0378-1135(02)00263-8.
   Li Q, 2007, LETT APPL MICROBIOL, V44, P86, DOI 10.1111/j.1472-765X.2006.02027.x.
   Liu D, 2007, J MICROBIOL METH, V71, P133, DOI 10.1016/j.mimet.2007.08.007.
   Liu Donyou, 2008, P27, DOI 10.1201/9781420051414.ch2.
   Maktabi S., 2011, World Journal of Fish and Marine Sciences, V3, P206.
   Mammina C, 2009, J CLIN MICROBIOL, V47, P2925, DOI 10.1128/JCM.00102-09.
   Marian MN, 2012, FOOD CONTROL, V28, P309, DOI 10.1016/j.foodcont.2012.05.030.
   McGann P, 2008, FOODBORNE PATHOG DIS, V5, P417, DOI 10.1089/fpd.2008.0085.
   Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502.
   Modaresi R, 2011, AFR J MICROBIOL RES, V5, P5398, DOI 10.5897/AJMR11.888.
   Momtaz H, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-149.
   Okamoto K, 2002, ANTIMICROB AGENTS CH, V46, P2696, DOI 10.1128/AAC.46.8.2696-2699.2002.
   Orsi RH, 2007, MICROBIOL-SGM, V153, P2666, DOI 10.1099/mic.0.2007/007310-0.
   Parihar VS, 2008, FOOD CONTROL, V19, P566, DOI 10.1016/j.foodcont.2007.06.009.
   POYARTSALMERON C, 1992, ANTIMICROB AGENTS CH, V36, P463, DOI 10.1128/AAC.36.2.463.
   Rahimi E, 2012, ANN MICROBIOL, V62, P37, DOI 10.1007/s13213-011-0222-9.
   Rodas-Suarez OR, 2006, APPL ENVIRON MICROB, V72, P7410, DOI 10.1128/AEM.00956-06.
   Safdar A, 2003, J CLIN MICROBIOL, V41, P483, DOI 10.1128/JCM.41.1.483-485.2003.
   Sant'Ana AS, 2012, INT J FOOD MICROBIOL, V155, P1, DOI 10.1016/j.ijfoodmicro.2011.12.036.
   Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x.
   Siriken B, 2013, J AQUAT FOOD PROD T, V22, P77, DOI 10.1080/10498850.2011.625594.
   Soultos N, 2007, FOOD CONTROL, V18, P554, DOI 10.1016/j.foodcont.2006.01.006.
   Srinivasan V, 2005, FOODBORNE PATHOG DIS, V2, P201, DOI 10.1089/fpd.2005.2.201.
   Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817.
   Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011.
   Tham W, 2000, INT J FOOD MICROBIOL, V62, P173, DOI 10.1016/S0168-1605(00)00332-9.
   Vasilev V, 2010, FOOD CONTROL, V21, P1179, DOI 10.1016/j.foodcont.2010.01.015.
   Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001.
   Wang XM, 2013, FOOD CONTROL, V32, P153, DOI 10.1016/j.foodcont.2012.11.032.
   YAN W, 1991, ANTIMICROB AGENTS CH, V35, P1989, DOI 10.1128/AAC.35.10.1989.
   Zhang YF, 2007, INT J FOOD MICROBIOL, V113, P47, DOI 10.1016/j.ijfoodmicro.2006.07.010.}},
Number-of-Cited-References = {{59}},
Times-Cited = {{23}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{32}},
Journal-ISO = {{BMC Microbiol.}},
Doc-Delivery-Number = {{CN5PU}},
Unique-ID = {{ISI:000358482100002}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000357252100007,
Author = {Harper, Sherilee L. and Edge, Victoria L. and Ford, James and Willox,
   Ashlee Cunsolo and Wood, Michele and McEwen, Scott A. and IHACC Res Team
   and RICG},
Title = {{Climate-sensitive health priorities in Nunatsiavut, Canada}},
Journal = {{BMC PUBLIC HEALTH}},
Year = {{2015}},
Volume = {{15}},
Month = {{JUL 2}},
Abstract = {{Background: This exploratory study used participatory methods to
   identify, characterize, and rank climate-sensitive health priorities in
   Nunatsiavut, Labrador, Canada.
   Methods: A mixed method study design was used and involved collecting
   both qualitative and quantitative data at regional, community, and
   individual levels. In-depth interviews with regional health
   representatives were conducted throughout Nunatsiavut (n = 11). In
   addition, three PhotoVoice workshops were held with Rigolet community
   members (n = 11), where participants took photos of areas, items, or
   concepts that expressed how climate change is impacting their health.
   The workshop groups shared their photographs, discussed the stories and
   messages behind them, and then grouped photos into re-occurring themes.
   Two community surveys were administered in Rigolet to capture data on
   observed climatic and environmental changes in the area, and perceived
   impacts on health, wellbeing, and lifestyles (n = 187).
   Results: Climate-sensitive health pathways were described in terms of
   inter-relationships between environmental and social determinants of
   Inuit health. The climate-sensitive health priorities for the region
   included food security, water security, mental health and wellbeing, new
   hazards and safety concerns, and health services and delivery.
   Conclusions: The results highlight several climate-sensitive health
   priorities that are specific to the Nunatsiavut region, and suggest
   approaching health research and adaptation planning from an EcoHealth
   perspective.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Harper, SL (Reprint Author), Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada.
   Harper, Sherilee L.; Edge, Victoria L.; McEwen, Scott A., Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada.
   Harper, Sherilee L.; Edge, Victoria L.; Ford, James; IHACC Res Team, Indigenous Hlth Adaptat Climate Change Res Team, Montreal, PQ, Canada.
   Ford, James, McGill Univ, Dept Geog, Montreal, PQ, Canada.
   Willox, Ashlee Cunsolo, Cape Breton Univ, Cross Appointed Indigenous Studies, Dept Nursing, Sydney, NS, Canada.
   Wood, Michele, Nunatsiavut Govt, Dept Hlth \& Social Dev, Labrador City, ON, Canada.
   RICG, Rigolet, Rigolet Inuit Community Govt, Labrador City, ON, Canada.}},
DOI = {{10.1186/s12889-015-1874-3}},
Article-Number = {{605}},
ISSN = {{1471-2458}},
Keywords = {{Canada; Climate change; Health; Inuit; Nunatsiavut; EcoHealth}},
Keywords-Plus = {{2 INUIT COMMUNITIES; NOTIFIABLE GASTROINTESTINAL ILLNESS;
   RESPIRATORY-TRACT INFECTIONS; INDOOR AIR-QUALITY; INDIGENOUS HEALTH;
   ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; NORTHWEST-TERRITORIES;
   ENVIRONMENTAL-CHANGE; CAMPYLOBACTER SPP.}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{harpers@uoguelph.ca}},
ResearcherID-Numbers = {{Ford, James/A-4284-2013
   Harper, Sherilee/L-4996-2013
   }},
ORCID-Numbers = {{Ford, James/0000-0002-2066-3456
   Harper, Sherilee/0000-0001-7298-8765
   Edge, Victoria/0000-0002-2830-8395
   Lwasa, Shuaib/0000-0003-4312-2836}},
Funding-Acknowledgement = {{Vanier Canada Graduate Scholarship (CIHR); Canada Graduate Scholarship
   (SSHRC); IRIACC initiative (IDRC); ArcticNet; CIHR Applied Public Health
   Chairs program; Nasivvik Centre; Inuit Health Branch; IRIACC initiative
   (CIHR); IRIACC initiative (NSERC); IRIACC initiative (SSHRC)}},
Funding-Text = {{Foremost, we would like to thank the residents of Rigolet for welcoming
   us into their community. Sincerest thanks to the dedicated community
   research coordinators, including Inez Shiwak, Marilyn Baikie, Ashley
   Shiwak, Candice Elson, Dinah Wolfrey, Tanya Pottle, and Barbara Pottle.
   Thanks to Bryn Wood for creating the map. All aspects of all authors'
   work were independent of the funding source. This project was funded by
   the Vanier Canada Graduate Scholarship (CIHR to SLH), Canada Graduate
   Scholarship (SSHRC to ACW), IRIACC initiative to JF (funded by IDRC,
   CIHR, NSERC, SSHRC), ArcticNet and the CIHR Applied Public Health Chairs
   program to JF, Nasivvik Centre to SLH, JF, VLE, SM, and Health Canada's
   First Nations and Inuit Health Branch to RICG.}},
Cited-References = {{Adger N, 2007, CLIMATE CHANGE 2007.
   ALLEY R, 2007, CLIMATE CHANGE 2007.
   Austin SE, 2015, INT J ENV RES PUB HE, V12, P623, DOI 10.3390/ijerph120100623.
   Bates B., 2008, TECHNICAL PAPER INTE.
   Beaumier MC, 2010, CAN J PUBLIC HEALTH, V101, P196.
   Berrang-Ford L, 2012, SOC SCI MED, V75, P1067, DOI 10.1016/j.socscimed.2012.04.016.
   Berrang-Ford L, 2011, GLOBAL ENVIRON CHANG, V21, P25, DOI 10.1016/j.gloenvcha.2010.09.012.
   Blashki G, 2011, ASIA-PAC J PUBLIC HE, V23, p133S, DOI 10.1177/1010539510395121.
   Bohaychuk VM, 2006, J FOOD PROTECT, V69, P2176, DOI 10.4315/0362-028X-69.9.2176.
   Braun V., 2007, QUALITATIVE RES PSYC, V3, P77, DOI DOI 10.1191/1478088706QP0630A.
   Brinkmann S., 2009, INTERVIEWS LEARNING.
   Brubaker M, 2011, GLOB HLTH ACTION, V4, P1.
   Burgess CP, 2009, MED J AUSTRALIA, V190, P567.
   Burton I, 2002, CLIM POLICY, V2, P145, DOI 10.1016/S1469-3062(02)00038-4.
   Canas A. J., 2004, CONCEPT MAPS THEORY, P7.
   Casteldon H., 2012, CAN GEOGR-GEOGR CAN, V56, P160, DOI DOI 10.1111/J.1541-0064.2012.00432.X.
   Castleden H, 2008, SOC SCI MED, V66, P1393, DOI 10.1016/j.socscimed.2007.11.031.
   Castleden H, 2012, CAN GEOGR-GEOGR CAN, V56, P155, DOI 10.1111/j.1541-0064.2012.00430.x.
   Catto N., 2010, REV ACAD LIT RELATED.
   Charmaz K., 2006, CONSTRUCTING GROUNDE.
   Charron DF, 2012, INSIGHT INNOV INT DE, P1, DOI 10.1007/978-1-4614-0517-7.
   Coker R, 2011, LANCET INFECT DIS, V11, P326, DOI 10.1016/S1473-3099(10)70312-1.
   CONFALONIERI U, 2007, CLIMATE CHANGE 2007, P391.
   Cook A, 2009, J FOOD PROTECT, V72, P473, DOI 10.4315/0362-028X-72.3.473.
   Creswell J., 2008, RES DESIGN QUALITATI.
   Creswell J. W., 2007, DESIGNING CONDUCTING.
   Deckert A, 2010, J FOOD PROTECT, V73, P1317, DOI 10.4315/0362-028X-73.7.1317.
   DeCuir-Gunby J. T., 2010, FIELD METHOD, V23, P136.
   Downing A, 2011, INDIAN J TRADIT KNOW, V10, P57.
   Dowsley M, 2010, INUIT STUD, V34, P151.
   Driscoll D, 2007, ECOLOG ENV ANTHR, V3, P19.
   Driscoll DL, 2013, INT J CIRCUMPOL HEAL, V72, P1.
   Durkalec A, 2012, UNDERSTANDING ROLE E.
   Ebi KL, 2008, AM J PREV MED, V35, P501, DOI 10.1016/j.amepre.2008.08.018.
   Ebi KL, 2008, ENVIRON SCI POLICY, V11, P359, DOI 10.1016/j.envsci.2008.02.001.
   Ebi KL, 2007, PEDIATR CLIN N AM, V54, P213, DOI 10.1016/j.pcl.2007.01.004.
   Ebi KL, 2006, ENVIRON HEALTH PERSP, V114, P1930, DOI 10.1289/ehp.8430.
   Fereday J, 2006, INT J QUAL METH, V5, P1, DOI DOI 10.1063/1.2011295.
   Findlay LC, 2011, HLTH REP, V22, P1.
   Ford J., 2007, INT PUBLIC POLICY RE, V3, P5.
   Ford JD, 2009, CLIM RES, V38, P137, DOI 10.3354/cr00777.
   Ford J, 2007, ARCTIC, V60, P150.
   Ford JD, 2008, GEOGR J, V174, P45, DOI 10.1111/j.1475-4959.2007.00249.x.
   Ford JD, 2014, AM J PUBLIC HEALTH, V104, pE9, DOI 10.2105/AJPH.2013.301724.
   Ford JD, 2013, ANN ASSOC AM GEOGR, V103, P1193, DOI 10.1080/00045608.2013.776880.
   Ford JD, 2012, AM J PUBLIC HEALTH, V102, P1260, DOI 10.2105/AJPH.2012.300752.
   Ford JD, 2010, GLOBAL ENVIRON CHANG, V20, P668, DOI 10.1016/j.gloenvcha.2010.05.003.
   Ford JD, 2010, GLOBAL ENVIRON CHANG, V20, P177, DOI 10.1016/j.gloenvcha.2009.10.008.
   Ford JD, 2006, POLAR REC, V42, P127, DOI 10.1017/S0032247406005122.
   Ford JD, 2006, GLOBAL ENVIRON CHANG, V16, P145, DOI 10.1016/j.gloenvcha.2005.11.007.
   Ford JD, 2004, ARCTIC, V57, P389, DOI 10.14430/arctic516.
   Fordl JD, 2008, ARCT ANTARCT ALP RES, V40, P647, DOI 10.1657/1523-0430(07-040){[}FORD]2.0.CO;2.
   Frumkin H, 2008, AM J PUBLIC HEALTH, V98, P435, DOI 10.2105/AJPH.2007.119362.
   Fussel HM, 2009, CLIMATIC CHANGE, V97, P469, DOI 10.1007/s10584-009-9648-5.
   Furgal C, 2006, ENVIRON HEALTH PERSP, V114, P1964, DOI 10.1289/ehp.8433.
   Goldhar C, 2010, INT J CIRCUMPOL HEAL, V69, P285, DOI 10.3402/ijch.v69i3.17616.
   Green D, 2009, MED J AUSTRALIA, V190, P4.
   Hall D. C., 2013, Journal of Public Health and Epidemiology, V5, P336.
   Hancock T., 2011, HEALTH PROMOT INT, V26, pii168, DOI DOI 10.1093/HEAPRO/DAR064.
   Harper SL, 2012, ECOHEALTH, V9, P89, DOI 10.1007/s10393-012-0762-x.
   Harper SL, 2011, ECOHEALTH, V8, P93, DOI 10.1007/s10393-011-0690-1.
   Healey GK, 2011, ARCTIC, V64, P89, DOI 10.14430/arctic4082.
   Henry M, 2011, ENVIROSTATS SERV B, V5, P3.
   Hess JJ, 2008, AM J PREV MED, V35, P468, DOI 10.1016/j.amepre.2008.08.024.
   Hess JJ, 2012, ENVIRON HEALTH PERSP, V120, P171, DOI 10.1289/ehp.1103515.
   Hofmeijer I, 2012, MITIG ADAPT STRAT GL, V18, P957.
   Hopping BN, 2010, J HUM NUTR DIET, V23, P110, DOI 10.1111/j.1365-277X.2010.01096.x.
   IPCC, 2013, CLIM CHANG 2013 PHY.
   Johnston DW, 2005, CLIMATE RES, V29, P209, DOI 10.3354/cr029209.
   Khamsi R, 2005, NAT NEWS, DOI 10.103.
   Kirmayer LJ, 2008, HEALING TRADITIONS M, P289.
   Knotsch K, 2011, NOT NOW ADDRESSING O.
   Kone B, 2011, ECOHEALTH, V8, P413, DOI 10.1007/s10393-012-0740-3.
   Kovesi T, 2006, INDOOR AIR, V16, P266, DOI 10.1111/j.1600-0668.2006.00423.x.
   Kovesi T, 2007, CAN MED ASSOC J, V177, P155, DOI {[}10.1503/cmaj.061574, 10.1503/CMAJ.061574].
   Kuhnlein HV, 2004, J NUTR, V134, P1447.
   Kuhnlein HV, 1996, J AM DIET ASSOC, V96, P155, DOI 10.1016/S0002-8223(96)00045-4.
   Lardeau MP, 2011, RURAL REMOTE HEALTH, V11.
   Leung Z, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-358.
   MacDonald JP, 2013, GLOBAL ENVIRON CHANG, V23, P360, DOI 10.1016/j.gloenvcha.2012.07.010.
   Manyong V., 2012, GLOB HEAL CHALL INTE.
   Martin D, 2008, EPIDEMIOLOGY, V19, pS217.
   Martin D, 2007, ARCTIC, V60, P195.
   Maynard NG, 2011, EURASIAN ARCTIC LAND COVER AND LAND USE IN A CHANGING CLIMATE, P177, DOI 10.1007/978-90-481-9118-5\_8.
   McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3.
   McMichael AJ, 2013, NEW ENGL J MED, V368, P1335, DOI 10.1056/NEJMra1109341.
   Mendez I, 2013, INT J CIRCUMPOL HEAL, V72, P1, DOI DOI 10.3402/IJCH.V72I0.21112].
   Minich K, 2011, INT J CIRCUMPOL HEAL, V70, P520, DOI 10.3402/ijch.v70i5.17858.
   Myers SS, 2009, ANNU REV ENV RESOUR, V34, P223, DOI 10.1146/annurev.environ.033108.102650.
   Nickels S., 2005, UNIKKAAQATIGIIT PUTT.
   Pardhan-Ali A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000732.
   Pardhan-Ali A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-63.
   Pardhan-Ali A, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-17.
   Parkes MW, 2009, ECOHEALTH ABORIGINAL.
   Parkinson Alan J, 2005, Int J Circumpolar Health, V64, P478.
   Parmley J, 2012, IMPROV FOOD SAF ONE, P176.
   Patz JA, 2002, BRIT MED J, V325, P1094, DOI 10.1136/bmj.325.7372.1094.
   Pearce T, 2011, HUM ECOL, V39, P271, DOI 10.1007/s10745-011-9403-1.
   Pearce TD, 2009, POLAR RES, V28, P10, DOI 10.1111/j.1751-8369.2008.00094.x.
   Richmond CAM, 2008, SOC SCI MED, V67, P1423, DOI 10.1016/j.socscimed.2008.06.028.
   Rodriguez-Palacios A, 2009, EMERG INFECT DIS, V15, P802, DOI 10.3201/eid1505.081084.
   Samadpour M, 2006, J FOOD PROTECT, V69, P441, DOI 10.4315/0362-028X-69.2.441.
   Sharma S, 2010, J HUM NUTR DIET, V23, P5, DOI 10.1111/j.1365-277X.2010.01093.x.
   Sharma S, 2009, GLOBAL CHANGE BIOL, V15, P2549, DOI 10.1111/j.1365-2486.2009.01945.x.
   Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008.
   Waldram J. B., 2006, ABORIGINAL HLTH CANA.
   Waleckx E, 2015, T ROY SOC TROP MED H, V109, P143, DOI 10.1093/trstmh/tru200.
   Waltner-Toews D, 2009, CAN VET J, V50, P519.
   Warren John A, 2005, Int J Circumpolar Health, V64, P487.
   Weinhold B, 2010, ENV HLTH PERSPECT, V118, P64.
   Weladji RB, 2006, CLIMATE RES, V32, P119, DOI 10.3354/cr032119.
   Wheeldon J., 2009, INT J QUAL METH, V8, P68, DOI DOI 10.1177/160940690900800307.
   Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402.
   WHO, 2012, SOC DET HLTH SECT BR.
   Willox AC, 2013, EMOT SPACE SOC, V6, P14, DOI 10.1016/j.emospa.2011.08.005.
   Willox AC, 2013, CLIMATIC CHANGE, V121, P255, DOI 10.1007/s10584-013-0875-4.
   Willox AC, 2012, SOC SCI MED, V75, P538, DOI 10.1016/j.socscimed.2012.03.043.
   Young K, 2011, CMAJ, V183, P209.
   Young TK, 2003, BRIT MED J, V327, P419, DOI 10.1136/bmj.327.7412.419.
   Young TK, 1996, SOC SCI MED, V43, P1665, DOI 10.1016/S0277-9536(96)00075-5.
   Zhao CW, 2001, APPL ENVIRON MICROB, V67, P5431, DOI 10.1128/AEM.67.12.5431-5436.2001.
   Zinsstag J, 2007, EMERG INFECT DIS, V13, P527, DOI 10.3201/eid1304.060381.}},
Number-of-Cited-References = {{122}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{5}},
Usage-Count-Since-2013 = {{40}},
Journal-ISO = {{BMC Public Health}},
Doc-Delivery-Number = {{CL8VL}},
Unique-ID = {{ISI:000357252100007}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000360443300005,
Author = {MacFadden, Derek R. and Bogoch, Isaac I. and Brownstein, John S. and
   Daneman, Nick and Fisman, David and German, Matthew and Khan, Kamran},
Title = {{A passage from India: Association between air traffic and reported cases
   of New Delhi Metallo-beta-lactamase 1 from 2007 to 2012}},
Journal = {{TRAVEL MEDICINE AND INFECTIOUS DISEASE}},
Year = {{2015}},
Volume = {{13}},
Number = {{4}},
Pages = {{295-299}},
Month = {{JUL-AUG}},
Abstract = {{Background: Highly transmissible genes encoding resistance to
   carbapenems have demonstrated global spread. The New Delhi
   Metallo-beta-lactamase 1 gene is hypothesized to have originated in
   India, with subsequent dissemination by colonized or infected travelers.
   Method: We conducted an ecological study evaluating the association
   between the cumulative air traffic departing India between 2007 and 2012
   and published cases of NDM-1. Receiver operator characteristic curves
   were generated as well as multivariate logistic regression models. 193
   countries with complete flight and World Bank data were included in the
   analysis.
   Results: Receiver operator characteristic curves (ROC) of the
   dichotomous outcome of a published case of NDM-1 were generated,
   yielding an unadjusted area under the curve (AUC) of 0.88 and adjusted
   AUC of 0.85. The unadjusted odds ratio of having a reported case of
   NDM-1, for every percentage increase in cumulative air traffic departing
   India, was 2.3 (95\% CI 1.4 to 3.7) and adjusted was 2.0 (95\% CI 1.2 to
   3.4).
   Conclusions: We demonstrate that flows of international travelers
   departing India by air is associated with published NDM-1 cases,
   globally. Countries with high passenger flight traffic from India with
   no reported cases of NDM-1 may be at increased risk of having unreported
   transmission of NDM-1. (C) 2015 Elsevier Ltd. All rights reserved.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{MacFadden, DR (Reprint Author), Toronto Gen Hosp, 200 Elizabeth St,13EN-213, Toronto, ON M5G 2C4, Canada.
   MacFadden, Derek R.; Bogoch, Isaac I.; Daneman, Nick; Fisman, David; Khan, Kamran, Univ Toronto, Div Infect Dis, Toronto, ON, Canada.
   Brownstein, John S., Boston Childrens Hosp, Boston, MA USA.
   German, Matthew; Khan, Kamran, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada.}},
DOI = {{10.1016/j.tmaid.2015.06.003}},
ISSN = {{1477-8939}},
EISSN = {{1873-0442}},
Keywords = {{Antimicrobial resistance; New Delhi Metallo-beta-lactamase; Air travel}},
Keywords-Plus = {{RESISTANCE; EMERGENCE; SPREAD}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{derek.macfadden@mail.utoronto.ca}},
Funding-Acknowledgement = {{Canadian Institute of Health Research; NIH/NLM grant {[}R01LM010812]}},
Funding-Text = {{KK is supported by a grant from the Canadian Institute of Health
   Research.; JB is supported by an NIH/NLM grant (R01LM010812).}},
Cited-References = {{Bathoorn E., 2013, EURO SURVEILL, V18.
   Berrazeg M, 2014, EUROSURVEILLANCE, V19, P2.
   Bogoch I, 2014, LANCET, V385, P29.
   Bonomo RA, 2011, CLIN INFECT DIS, V52, P485, DOI 10.1093/cid/ciq179.
   Cappell MS, 2009, DIGEST DIS SCI, V54, P1609, DOI 10.1007/s10620-008-0696-x.
   Dash N, 2014, MICROB DRUG RESIST, V20, P52, DOI 10.1089/mdr.2013.0040.
   Khan Kamran, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.2134a0a7bf37fd8d388181539fea2da5.
   Khan Kamran, 2013, PLoS Curr, V5, DOI 10.1371/currents.outbreaks.a7b70897ac2fa4f79b59f90d24c860b8.
   Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2.
   Molton JS, 2013, CLIN INFECT DIS, V56, P1310, DOI 10.1093/cid/cit020.
   Norazah Ahmad, 2013, Journal of Medical Microbiology, V62, P804.
   Population of Overseas Indians, POP OV IND.
   Rogers BA, 2011, CLIN INFECT DIS, V53, P49, DOI 10.1093/cid/cir273.
   Ruppe E, 2014, EURO SURVEILL, V19.
   Shibl A, 2013, INT J INFECT DIS, V17.
   Sonnevend A, 2013, J MED MICROBIOL, V62, P1044, DOI 10.1099/jmm.0.059014-0.
   World Bank, 2012, WORLD DEV IND POP DY.
   World Health Organization, 2014, ANT RES GLOB REP SUR.
   Zowawi HM, 2014, ANTIMICROB AGENTS CH, V58, P3085, DOI {[}10.1128/AAC.02050-13, 10.1128/AAC.].}},
Number-of-Cited-References = {{19}},
Times-Cited = {{7}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Travel Med. Infect. Dis.}},
Doc-Delivery-Number = {{CQ2PL}},
Unique-ID = {{ISI:000360443300005}},
DA = {{2018-08-13}},
}

@article{ ISI:000359953100008,
Author = {Ferguson, Stephanie L.},
Title = {{The World Health Organization's Sixty-Eighth World Health Assembly:
   Updates and Opportunities}},
Journal = {{NURSING ECONOMICS}},
Year = {{2015}},
Volume = {{33}},
Number = {{4}},
Pages = {{236-238}},
Month = {{JUL-AUG}},
Abstract = {{The World Health Assembly (WHA) is the decision-making body of the World
   Health Organization.
   Delegates attending the Sixty-Eighth WHA, May 2015, covered a wide range
   of global challenges and agreed on several key resolutions of importance
   to nurse leaders.
   Some of the resolutions adopted relevant for nurse leaders and nursing
   care such as air pollution, strategies to strengthen epilepsy care,
   antimicrobial drug resistance, and strategies to strengthen surgical
   care, are highlighted.
   Nurse leaders should consider attending the World Health Assembly, as
   the topics discussed are critical for the future directions of
   strengthening human resources for health worldwide and, in particular,
   nursing and midwifery services.}},
Publisher = {{JANNETTI PUBLICATIONS, INC}},
Address = {{EAST HOLLY AVENUE, BOX 56, PITMAN, NJ 08071-0056 USA}},
Type = {{Editorial Material}},
Language = {{English}},
Affiliation = {{Ferguson, SL (Reprint Author), Stephanie L Ferguson \& Associates LLC, Amherst, VA 24521 USA.
   Ferguson, Stephanie L., Stephanie L Ferguson \& Associates LLC, Amherst, VA 24521 USA.
   Ferguson, Stephanie L., ICN Burdett Global Nursing Leadership Inst, Geneva, Switzerland.
   Ferguson, Stephanie L., ICN Leadership Change Programme, Geneva, Switzerland.}},
ISSN = {{0746-1739}},
Research-Areas = {{Nursing}},
Web-of-Science-Categories  = {{Nursing}},
Cited-References = {{Ferguson SL, 2015, NURS ECON, V33, P113.
   World Health Organization, 2015, ANT RES DRAFT GLOB A.
   World Health Organization, 2015, HLTH ENV ADDR HLTH I.
   World Health Organization Executive Board 136th Session, 2015, GLOB BURD EP NEED CO.
   World Health Organization (WHO), 2015, EX BOARD ITS 135 136.
   World Health Organization (WHO), MAIN PAG.
   World Health Organization (WHO), 2015, FOLL UP 2014 HIGH LE.
   World Health Organization (WHO), 2015, WORLD HLTH ASS WORKS.
   World Health Organization (WHO), 2015, PUBL CONS GLOB STRAT.
   World Health Organization (WHO), 2015, DOC WHA 68 REP RES.}},
Number-of-Cited-References = {{10}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Nurs. Econ.}},
Doc-Delivery-Number = {{CP5VM}},
Unique-ID = {{ISI:000359953100008}},
DA = {{2018-08-13}},
}

@article{ ISI:000359029700012,
Author = {Yadav, Jayprakash and Kumar, Awanish and Mahor, Pawan and Goel, Ajay
   Kumar and Chaudhary, Hotam Singh and Yadava, Pramod Kumar and Yadav,
   Hariom and Kumar, Pramod},
Title = {{Distribution of airborne microbes and antibiotic susceptibility pattern
   of bacteria during Gwalior trade fair, Central India}},
Journal = {{JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION}},
Year = {{2015}},
Volume = {{114}},
Number = {{7}},
Pages = {{639-646}},
Month = {{JUL}},
Abstract = {{Background/Purpose: Research into the distribution of bioaerosols during
   events associated with huge groups of people is lacking, especially in
   developing countries. The purpose of this study was to understand the
   distribution pattern of bioaerosols during an annual trade fair in the
   historical city of Gwalior, central India, a very important historical
   fair that was started by the King of Gwalior Maharaja Madho Rao in 1905.
   Methods: Air samples were collected from six different sites at the fair
   ground and three different sites in a residential area
   before/during/after the fair using an impactor sampler on microbial
   content test agar and rose bengal agar for total bacteria and fungi,
   respectively. The representative strains of bacteria and fungi were
   further identified and selected bacterial strains were subjected to
   antibiotic susceptibility testing according to US Clinical and
   Laboratory Standards Institute (CLSI) guidelines.
   Results: The bacterial bioaerosol count {[}colony-forming units
   (CFU)/m(3)] at fair sites was found to be 9.0 x 10(3), 4.0 x 10(4), and
   1.0 x 10(4) before the start of the fair, during the fair, and after the
   fair, respectively. The fungal bioaerosol count at fair sites was 2.6 x
   10(3) CFU / m(3), 6.3 x 10(3) CFU/m(3), and 1.7 x 10(3) CFU/m(3) before
   the fair, during the fair, and after the fair, respectively.
   Bacterial/fungal bioaerosols during-fair were increased significantly
   from the bacterial/fungal bioaerosols of the before-fair period (p <
   0.05); they were also significantly higher than the bacterial/fungal
   bioaerosols at non-fair sites during the event (p < 0.0001). The
   proportion of antibiotic-resistant bacteria over the fair ground was
   significantly increased during-fair and was still higher in the
   after-fair period. Methicillin-resistant staphylococci (MRS) were also
   reported at the fair ground.
   Conclusion: The study indicates significantly higher bacterial and
   fungal bioaerosols during the fair event. Therefore, further research is
   needed to explore the health aspects and guidelines to control microbial
   load during such types of events. Copyright (C) 2013, Elsevier Taiwan
   LLC \& Formosan Medical Association. All rights reserved.}},
Publisher = {{ELSEVIER TAIWAN}},
Address = {{RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kumar, P (Reprint Author), Jawaharlal Nehru Univ, Sch Life Sci, Appl Mol Biol Lab, New Mehrauli Rd, New Delhi 110067, India.
   Yadav, Jayprakash; Mahor, Pawan; Chaudhary, Hotam Singh, Madhav Inst Sci \& Technol, Dept Biotechnol, Gwalior 474005, India.
   Kumar, Awanish; Yadava, Pramod Kumar; Kumar, Pramod, Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.
   Goel, Ajay Kumar; Kumar, Pramod, Def Res \& Dev Estab, Div Biotechnol, Gwalior 474002, India.
   Yadav, Hariom, Natl Agrifood Biotechnol Inst, Mohali 160071, India.}},
DOI = {{10.1016/j.jfma.2013.04.006}},
ISSN = {{0929-6646}},
EISSN = {{1876-0821}},
Keywords = {{antibiotic-resistant bacteria; bacterial bioaerosol; fair; fungal
   bioaerosol}},
Keywords-Plus = {{RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; METEOROLOGICAL
   FACTORS; OUTDOOR ENVIRONMENTS; FEEDING OPERATION; INFECTION;
   MICROORGANISMS; TRANSMISSION; ATMOSPHERE; FUNGI}},
Research-Areas = {{General \& Internal Medicine}},
Web-of-Science-Categories  = {{Medicine, General \& Internal}},
Author-Email = {{pramodjnu1@gmail.com}},
ResearcherID-Numbers = {{Kumar, Awanish/B-2646-2018
   }},
ORCID-Numbers = {{Kumar, Awanish/0000-0001-8735-479X
   Yadav, Hariom/0000-0003-4504-1597}},
Funding-Acknowledgement = {{MITS, Gwalior, India}},
Funding-Text = {{The authors thank the Director of MITS, Gwalior, India for providing
   necessary facilities and financial support for the work. We greatly
   acknowledge the University Grant Commission (UGC), New Delhi, India.}},
Cited-References = {{Abramson MA, 1999, INFECT CONT HOSP EP, V20, P408, DOI 10.1086/501641.
   Adhikari A, 2004, SCI TOTAL ENVIRON, V326, P121.
   Anderson DJ, 2007, INFECT CONT HOSP EP, V28, P1047, DOI 10.1086/520731.
   Beggs CB, 2003, INDOOR BUILT ENVIRON, V12, P9, DOI 10.1177/142032603032201.
   Burch M, 2002, INT J BIOMETEOROL, V46, P107, DOI 10.1007/s00484-002-0127-1.
   Burge HA, 2000, ENVIRON HEALTH PERSP, V108, P653, DOI 10.2307/3454401.
   Centers for Disease Control and Prevention, 2009, STAPH AUR MRSA SURV.
   Chapin A, 2005, ENVIRON HEALTH PERSP, V113, P137, DOI 10.1289/ehp.7473.
   Clinical and Laboratory Standards Institute, 2007, M100S17 CLSI.
   Dales RE, 2004, J ALLERGY CLIN IMMUN, V113, P303, DOI 10.1016/j.jaci.2003.11.016.
   DAVIES RR, 1963, LANCET, V1, P1111.
   Fang ZG, 2005, SCI TOTAL ENVIRON, V350, P47, DOI 10.1016/j.scitotenv.2005.01.032.
   Fang ZG, 2007, MICROB ECOL, V54, P487, DOI 10.1007/s00248-007-9216-3.
   Fierer N, 2008, APPL ENVIRON MICROB, V74, P200, DOI 10.1128/AEM.01467-07.
   Gandara A, 2006, ENVIRON HEALTH PERSP, V114, P1859, DOI 10.1289/ehp.9585.
   Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910.
   Gorbushina A. A., 1999, AEROBIOLOGIA, V15, P183, DOI DOI 10.1023/A:1007616614172.
   Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06.
   Hameed AAA, 2009, SCI TOTAL ENVIRON, V407, P6217, DOI 10.1016/j.scitotenv.2009.08.028.
   Harrison RM, 2005, INT J BIOMETEOROL, V49, P167, DOI 10.1007/s00484-004-0225-3.
   HELDMAN DR, 1974, J FOOD SCI, V39, P962, DOI 10.1111/j.1365-2621.1974.tb07287.x.
   Homer W. E., 1995, CLIN MICROBIOL REV, V8, P161.
   Jones AM, 2004, SCI TOTAL ENVIRON, V326, P151, DOI 10.1016/j.scitotenv.2003.11.021.
   Kumari DNP, 1998, J HOSP INFECT, V39, P127, DOI 10.1016/S0195-6701(98)90326-7.
   Lighthart B, 1997, FEMS MICROBIOL ECOL, V23, P263, DOI 10.1016/S0168-6496(97)00036-6.
   Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341.
   Mason WJ, 2001, J CLIN MICROBIOL, V39, P3332, DOI 10.1128/JCM.39.9.3332-3338.2001.
   MORTIMER EA, 1966, BMJ-BRIT MED J, V1, P319, DOI 10.1136/bmj.1.5483.319.
   Mouli P. Chandra, 2005, Applied Ecology and Environmental Research, V3, P139.
   Peternel R, 2004, ANN AGR ENV MED, V11, P303.
   Roberts K, 2006, INDOOR BUILT ENVIRON, V15, P135.
   Tenover FC, 2008, J CLIN MICROBIOL, V46, P2837, DOI 10.1128/JCM.00480-08.
   Tham KW, 2005, INDOOR AIR, V15, P48, DOI 10.1111/j.1600-0668.2005.00303.x.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{13}},
Journal-ISO = {{J. Formos. Med. Assoc.}},
Doc-Delivery-Number = {{CO3AW}},
Unique-ID = {{ISI:000359029700012}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000356972400007,
Author = {Mansson, Emeli and Hellmark, Bengt and Sundqvist, Martin and Soderquist,
   Bo},
Title = {{Sequence types of Staphylococcus epidermidis associated with prosthetic
   joint infections are not present in the laminar airflow during
   prosthetic joint surgery}},
Journal = {{APMIS}},
Year = {{2015}},
Volume = {{123}},
Number = {{7}},
Pages = {{589-595}},
Month = {{JUL}},
Abstract = {{Molecular characterization of Staphylococcus epidermidis isolates from
   prosthetic joint infections (PJIs) has demonstrated a predominance of
   healthcare-associated multi-drug resistant sequence types (ST2 and
   ST215). How, and when, patients acquire these nosocomial STs is not
   known. The aim was to investigate if sequence types of S.epidermidis
   associated with PJIs are found in the air during prosthetic joint
   surgery. Air sampling was undertaken during 17 hip/knee arthroplasties
   performed in operating theaters equipped with mobile laminar airflow
   units in a 500-bed hospital in central Sweden. Species identification
   was performed using MALDI-TOF MS and 16S rRNA gene analysis. Isolates
   identified as S.epidermidis were further characterized by MLST and
   antibiotic susceptibility testing. Seven hundred and thirty-five
   isolates were available for species identification. Micrococcus spp.
   (n=303) and coagulase-negative staphylococci (n=217) constituted the
   majority of the isolates. Thirty-two isolates of S.epidermidis were
   found. S.epidermidis isolates demonstrated a high level of allelic
   diversity with 18 different sequence types, but neither ST2 nor ST215
   was found. Commensals with low pathogenic potential dominated among the
   airborne microorganisms in the operating field during prosthetic joint
   surgery. Nosocomial sequence types of S.epidermidis associated with PJIs
   were not found, and other routes of inoculation are therefore of
   interest in future studies.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mansson, E (Reprint Author), Cty Hosp Vasteras, Clin Res Ctr, SE-72189 Vasteras, Sweden.
   Mansson, Emeli; Sundqvist, Martin; Soderquist, Bo, Univ Orebro, Fac Med \& Hlth, SE-70182 Orebro, Sweden.
   Mansson, Emeli, Uppsala Univ, Cty Hosp, Clin Res Ctr, Vasteras, Sweden.
   Hellmark, Bengt, Orebro Univ Hosp, Dept Lab Med, Clin Microbiol, Orebro, Sweden.}},
DOI = {{10.1111/apm.12392}},
ISSN = {{0903-4641}},
EISSN = {{1600-0463}},
Keywords = {{Staphylococcus epidermidis; ST2; ST215; prosthetic joint infections;
   airborne transmission}},
Keywords-Plus = {{FOREIGN-BODY INFECTION; KNEE REPLACEMENT; TOTAL HIP; ANTIBIOTIC
   SUSCEPTIBILITY; DEEP INFECTION; CONTAMINATION; PATHOGENESIS;
   COLONIZATION; DISINFECTION; IMPACT}},
Research-Areas = {{Immunology; Microbiology; Pathology}},
Web-of-Science-Categories  = {{Immunology; Microbiology; Pathology}},
Author-Email = {{emeli.mansson@ltv.se}},
Funding-Acknowledgement = {{Orebro County Council Research Committee, Orebro Sweden; Centre for
   Clinical Research, Vasteras; County Council of Vastmanland Research Fund}},
Funding-Text = {{The authors thank Christer Haggstrom, RD, for the indispensable help
   with air sampling and Asa Johansson for technical assistance and advice.
   The study was funded by Orebro County Council Research Committee, Orebro
   Sweden and the Centre for Clinical Research, Vasteras and the County
   Council of Vastmanland Research Fund.}},
Cited-References = {{Alijanipour Pouya, 2014, J Arthroplasty, V29, P49, DOI 10.1016/j.arth.2013.09.031.
   Breier AC, 2011, INFECT CONT HOSP EP, V32, P1097, DOI 10.1086/662182.
   BYRNE DJ, 1991, J HOSP INFECT, V17, P217, DOI 10.1016/0195-6701(91)90233-X.
   Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623.
   GARIBALDI RA, 1988, INFECT CONT HOSP EP, V9, P109.
   Gastmeier P, 2012, J HOSP INFECT, V81, P73, DOI 10.1016/j.jhin.2012.04.008.
   Gosden PE, 1998, J HOSP INFECT, V39, P173, DOI 10.1016/S0195-6701(98)90255-9.
   Hellmark B, 2009, CLIN MICROBIOL INFEC, V15, P238, DOI 10.1111/j.1469-0691.2008.02663.x.
   Hellmark B, 2013, INT J MED MICROBIOL, V303, P32, DOI 10.1016/j.ijmm.2012.11.001.
   Hooper GJ, 2011, J BONE JOINT SURG BR, V93B, P85, DOI 10.1302/0301-620X.93B1.24862.
   Jonsson EO, 2014, ACTA ORTHOP, V85, P159, DOI 10.3109/17453674.2014.899848.
   Knobben BAS, 2006, CLIN ORTHOP RELAT R, P236, DOI 10.1097/01.blo.0000229339.11351.ea.
   Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022.
   LEVY MF, 1990, J CLIN MICROBIOL, V28, P664.
   LIDWELL OM, 1982, BRIT MED J, V285, P10, DOI 10.1136/bmj.285.6334.10.
   Lindgren V, 2014, INFECT CONT HOSP EP, V35, P1491, DOI 10.1086/678600.
   Matuschek E, 2014, CLIN MICROBIOL INFEC, V20, pO255, DOI 10.1111/1469-0691.12373.
   Molina-Manso D, 2013, INT J ANTIMICROB AG, V41, P521, DOI 10.1016/j.ijantimicag.2013.02.018.
   Botelho AMN, 2012, J MED MICROBIOL, V61, P1136, DOI 10.1099/jmm.0.035931-0.
   Ritter MA, 1999, CLIN ORTHOP RELAT R, P103.
   Sivadon V, 2005, J CLIN MICROBIOL, V43, P2952, DOI 10.1128/JCM.43.6.2952-2954.2005.
   SOUTHWOOD RT, 1985, J BONE JOINT SURG BR, V67, P229.
   Stefansdottir A, 2013, ACTA ORTHOP, V84, P87, DOI 10.3109/17453674.2013.773120.
   Tande AJ, 2014, CLIN MICROBIOL REV, V27, P302, DOI 10.1128/CMR.00111-13.
   Thomas JC, 2007, J CLIN MICROBIOL, V45, P616, DOI 10.1128/JCM.01934-06.
   Wang XM, 2003, J MED MICROBIOL, V52, P989, DOI 10.1099/jmm.0.05360-0.
   Webster J, 2012, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.
   Wisplinghoff H, 2003, ANTIMICROB AGENTS CH, V47, P3574, DOI 10.1128/AAC.47.11.3574-3579.2003.
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305.
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487.
   Zimmerli W, 2012, FEMS IMMUNOL MED MIC, V65, P158, DOI 10.1111/j.1574-695X.2012.00938.x.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{9}},
Journal-ISO = {{APMIS}},
Doc-Delivery-Number = {{CL5AU}},
Unique-ID = {{ISI:000356972400007}},
DA = {{2018-08-13}},
}

@article{ ISI:000356642800005,
Author = {Pardon, Bart and Alliet, Jeroen and Boone, Randy and Roelandt, Sophie
   and Valgaeren, Bonnie and Deprez, Piet},
Title = {{Prediction of respiratory disease and diarrhea in veal calves based on
   immunoglobulin levels and the serostatus for respiratory pathogens
   measured at arrival}},
Journal = {{PREVENTIVE VETERINARY MEDICINE}},
Year = {{2015}},
Volume = {{120}},
Number = {{2}},
Pages = {{169-176}},
Month = {{JUN 15}},
Abstract = {{Failure of passive transfer is a common problem in calves destined for
   veal production. At present it is unknown whether the risk for
   respiratory disease (BRD) or neonatal calf diarrhea (NCD) in the veal
   herd is associated with total immunoglobulin (Ig) and/or on the
   serostatus for respiratory pathogens measured at arrival. Therefore, the
   first objective of this prospective longitudinal cohort study was to
   determine associations between serum protein fractions as determined by
   routine electrophoresis (total protein, albumin, alpha-1 and -2
   globulins, beta-globulins and Ig's) at arrival and BRD and NCD in the
   first 3 weeks of the production cycle. The second objective was to
   determine whether the serostatus (seropositive/seronegative) of seven
   respiratory pathogens (bovine respiratory syncytial virus (BRSV),
   parainfluenzavirus-3, bovine coronavirus (BCV), bovine herpesvirus-1,
   bovine viral diarrhea virus, Mannheimia haemolytica and Mycoplasma
   bovis) of these arrival serum samples could be associated with the risk
   of having BRD. The third objective was to determine which of the
   electrophoresis proteins and respiratory serostatuses were associated
   with average daily gain (ADG) in the study period. The study population
   consisted of 150 rose veal calves housed in a single air-space. The
   study period ended at day 18 post arrival, when BRD incidence was judged
   to be too high to further postpone a group treatment. A Cox regression
   model was used to determine the effect of the studied protein fractions
   and antibodies on the time to BRD and NCD occurrence. The effect of the
   studied predictors on ADG was determined by linear regression. Calves
   with Ig levels under 7.5 g/L had an increased BRD hazard (hazard ratio
   (HR) = 1.9 (95\% confidence interval (CI) = 1.2-3.0)). NCD was only
   positively associated with the alpha-2 globulin concentration. Calves
   with a negative serostatus for BCV (HR = 1.7 (95\% CI = 1.0-2.8)) or
   BRSV (HR = 2.0 (95\% CI = 1.0-3.9)) had an increased BRD hazard. Average
   daily gain (ADG) was 0.242 kg/day (SD = 0.142) and was not related to
   the occurrence of BRD or NCD. Calves with Ig's below 7.5 g/L and with
   increased levels of alpha-2 globulins showed a decrease in ADG. This
   study showed the importance of providing sufficient colostrum to veal
   calves and the potential benefit of the presence of BCV and BRSV
   antibodies at arrival to reduce the BRD hazard in the first 3 weeks. (C)
   2015 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Pardon, B (Reprint Author), Univ Ghent, Fac Vet Med, Dept Large Anim Internal Med, Salisburylaan 133, B-9820 Merelbeke, Belgium.
   Pardon, Bart; Alliet, Jeroen; Valgaeren, Bonnie; Deprez, Piet, Univ Ghent, Fac Vet Med, Dept Large Anim Internal Med, B-9820 Merelbeke, Belgium.
   Boone, Randy, Vet Practice Venhei, B-2460 Kasterlee, Belgium.
   Roelandt, Sophie, Vet \& Agrochem Res Ctr VAR CODA CERVA, Unit Coordinat Vet Diag Epidemiol \& Risk Assessme, Brussels, Belgium.}},
DOI = {{10.1016/j.prevetmed.2015.04.009}},
ISSN = {{0167-5877}},
EISSN = {{1873-1716}},
Keywords = {{Bovine respiratory disease; Failure of passive transfer; Immunoglobulin;
   Neonatal diarrhea; Average daily gain; Veal calves}},
Keywords-Plus = {{ANTIMICROBIAL RESISTANCE; PASSIVE TRANSFER; DAIRY CALVES; ENTERIC
   PATHOGENS; PREWEANED CALVES; RISK-FACTORS; BEEF-CALVES; SERUM; HEALTH;
   PREVALENCE}},
Research-Areas = {{Veterinary Sciences}},
Web-of-Science-Categories  = {{Veterinary Sciences}},
Author-Email = {{Bart.Pardon@UGent.be
   Jeroen.Alliet@UGent.be
   Dapdeboskant@Gmail.com
   Sophie.Roelandt@coda-cerva.be
   Bonnie.Valgaeren@UGent.be
   Piet.Deprez@UGent.be}},
Cited-References = {{Barnes DM, 2002, AMINO ACIDS, V22, P15, DOI 10.1007/s726-002-8198-6.
   BCFI, 2013, COMM DRUG REP VET US.
   Berge ACB, 2009, J DAIRY SCI, V92, P286, DOI 10.3168/jds.2008-1433.
   Berge ACB, 2005, J DAIRY SCI, V88, P2166, DOI 10.3168/jds.S0022-0302(05)72892-7.
   Bosman A.B., 2013, EPIDEMIOL INFECT, P1.
   Brscic M, 2012, J DAIRY SCI, V95, P2753, DOI 10.3168/jds.2011-4699.
   BURTON JL, 1989, J DAIRY SCI, V72, P135, DOI 10.3168/jds.S0022-0302(89)79089-5.
   Catry B, 2005, MICROB DRUG RESIST, V11, P387, DOI 10.1089/mdr.2005.11.387.
   Cook A, 2011, J FOOD PROTECT, V74, P1328, DOI 10.4315/0362-028X.JFP-10-495.
   Di Labio E, 2007, ZOONOSES PUBLIC HLTH, V54, P344, DOI 10.1111/j.1863-2378.2007.01071.x.
   Furman-Fratczak K, 2011, J DAIRY SCI, V94, P5536, DOI 10.3168/jds.2010-3253.
   Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990.
   Gulliksen SM, 2009, J DAIRY SCI, V92, P5139, DOI 10.3168/jds.2009-2224.
   Hassig M, 2007, VET REC, V160, P234, DOI 10.1136/vr.160.7.234.
   Hoet AE, 2003, J VET DIAGN INVEST, V15, P205, DOI 10.1177/104063870301500301.
   MCDONOUGH SP, 1994, AM J VET RES, V55, P1516.
   Mevius D, 2012, MONITORING ANTIMICRO.
   Mevius D.J., 2011, MONITORING ANTIMICRO.
   Mohri M, 2007, RES VET SCI, V83, P30, DOI 10.1016/j.rvsc.2006.10.017.
   NRC, 2001, NUTR REQ DAIR CATTL, P214.
   Pardon B, 2011, VET REC, V169, P278, DOI 10.1136/vr.d4406.
   Pardon B., 2012, THESIS GHENT U, pp316.
   Pardon B, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-79.
   Pardon B, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-26.
   Pardon B, 2012, J ANTIMICROB CHEMOTH, V67, P1027, DOI 10.1093/jac/dkr570.
   POSTEMA HJ, 1984, ZBL VET MED A, V31, P751.
   POSTEMA HJ, 1987, TIJDSCHR DIERGENEESK, V112, P665.
   Rerat M, 2012, PREV VET MED, V103, P265, DOI 10.1016/j.prevetmed.2011.09.003.
   ROBISON JD, 1988, J DAIRY SCI, V71, P1283, DOI 10.3168/jds.S0022-0302(88)79684-8.
   SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.2307/2335876.
   Stilwell G, 2011, CAN VET J, V52, P524.
   Thrusfield M, 2001, VET REC, V148, P567, DOI 10.1136/vr.148.18.567.
   Vandendriessche S, 2013, J ANTIMICROB CHEMOTH, V68, P1510, DOI 10.1093/jac/dkt047.
   Virtala AMK, 1996, J DAIRY SCI, V79, P1040, DOI 10.3168/jds.S0022-0302(96)76457-3.
   Waldner CL, 2009, CAN VET J, V50, P275.
   Weaver DM, 2000, J VET INTERN MED, V14, P569, DOI 10.1892/0891-6640(2000)014<0569:PTOCII>2.3.CO;2.
   Wilson LL, 2000, J DAIRY SCI, V83, P843, DOI 10.3168/jds.S0022-0302(00)74948-4.
   WITTUM TE, 1994, PREV VET MED, V19, P15, DOI 10.1016/0167-5877(94)90011-6.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{16}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{36}},
Journal-ISO = {{Prev. Vet. Med.}},
Doc-Delivery-Number = {{CL0OU}},
Unique-ID = {{ISI:000356642800005}},
DA = {{2018-08-13}},
}

@article{ ISI:000210237300001,
Author = {Jroundi, Imane and Mahraoui, Chafiq and Benmessaoud, Rachid and
   Moraleda, Cinta and Benjelloun, BadrSououd and Bassat, Quique},
Title = {{Knowledge gaps on paediatric respiratory infections in Morocco, Northern
   Africa}},
Journal = {{ARCHIVES OF PUBLIC HEALTH}},
Year = {{2015}},
Volume = {{73}},
Month = {{JUN 15}},
Abstract = {{Background: The burden of acute respiratory infections (ARI) among
   Moroccan children remains significant. However, scarce information is
   available regarding trends in its epidemiology and etiology, or
   regarding its associated prognostic factors. The purpose of this work
   was to review available data on the burden of ARI among children under
   five years of age in Morocco.
   Methods: A systematic review was conducted for the period 1997-2014
   using the PRISMA proposed methodology. Various online databases were
   screened, in addition to physical libraries of Moroccan medical schools,
   and official reports of the Moroccan Ministry of Health. Search queries
   in English and French languages included: Respiratory Tract Infections,
   pneumonia, epidemiology, etiology, microbiology, mortality and Morocco.
   The documents were included for analysis when they reported original
   data on the incidence, distribution, or a clinical description of the
   diseases or their etiology or described clinical management or national
   preventive strategies.
   Results: Thirty-two documents were included in the final analysis. 21 of
   which had been published. In 2012, ARI caused 13\% of paediatric deaths,
   half of the consultations at health facilities and third of the
   paediatric admissions. The microorganisms more frequently identified
   among hospitalized children were Streptococcus pneumoniae (38\%) and
   Haemophilus influenza type b (Hib) (15\%). The MOH introduced Hib
   vaccines into the national immunization program (PNI) in 2007and the
   13-valent vaccine against pneumococcus in 2010. The national first line
   antibiotics recommended for non-severe ambulatory treatment is
   Amoxicillin. Studies of antibiotic resistance showed from 1998 to 2008 a
   22\% increase in the rate of penicillin non-susceptibility among
   Streptococcus pneumoniae isolates. Viral respiratory infections and the
   role attributed to air pollution in the incidence of ARI have been
   poorly characterized.
   Conclusions: Further efforts should be made towards the development of
   adequate surveillance programs to better clarify the epidemiology,
   etiology, antimicrobial susceptibility patterns and the effectiveness of
   the preventives and curatives strategies in place against paediatric
   ARIs in Morocco. Additionally, a holistical approach should be used to
   identify the heath determinants of ARIs among children.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Jroundi, I (Reprint Author), Univ Barcelona, ISGlobal, Ctr Int Hlth Res CRESIB, Hosp Clin, Calle Rossello 132,4 PC, E-08036 Barcelona, Spain.
   Jroundi, Imane; Benmessaoud, Rachid; Moraleda, Cinta; Bassat, Quique, Univ Barcelona, ISGlobal, Ctr Int Hlth Res CRESIB, Hosp Clin, Calle Rossello 132,4 PC, E-08036 Barcelona, Spain.
   Jroundi, Imane, Univ Mohammed 5, Lab Sante Publ \& Med Communautaire, Fac Med \& Pharm Rabat, Rabat, Morocco.
   Mahraoui, Chafiq; Benjelloun, BadrSououd, Ctr Hosp Univ Ibn Sina, HER, Rabat, Morocco.}},
DOI = {{10.1186/s13690-015-0076-x}},
Article-Number = {{28}},
ISSN = {{0778-7367}},
EISSN = {{2049-3258}},
Keywords = {{Acute respiratory infection; Pneumonia; Morocco; Children under five;
   Burden; Epidemiology; Respiratory syncytial virus; Bacteria}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{imane.jroundi.fmpr@gmail.com}},
ORCID-Numbers = {{Moraleda, Cinta/0000-0002-8335-903X
   Bassat, Quique/0000-0003-0875-7596}},
Funding-Acknowledgement = {{program Miguel Servet of the ISCIII (Plan Nacional de I+D+I)
   {[}CP11/00269]; People Program (Marie Curie Actions) of the European
   Union's seventh Framework Program FP7 under REA grant {[}621216]}},
Funding-Text = {{Authors are also thankful for the principal investigators (PI) of the
   different research studies who were happy to share their data and
   respond to questions. QB has a fellowship from the program Miguel Servet
   of the ISCIII (Plan Nacional de I+D+I 2008-2011, grant number
   CP11/00269). The research leading to these results has received funding
   from the People Program (Marie Curie Actions) of the European Union's
   seventh Framework Program FP7/2007-2013 under REA grant agreement n
   621216.}},
Cited-References = {{Adegbola RA, 2011, EXPERT REV RESP MED, V5, P731, DOI {[}10.1586/ers.11.74, 10.1586/ERS.11.74].
   Barakat A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024579.
   Belabbes H, 2010, CLIN MICROBIOL INFEC, V16, P468.
   Belabbes H, 2000, MAROC MED, V22, P265.
   Benbachir M, 2001, ANTIMICROB AGENTS CH, V45, P627, DOI 10.1128/AAC.45.2.627-629.2001.
   Benbachir M, 2009, RFL S, VS416, P32.
   Benouda A, 2009, J CHEMOTHERAPY, V21, P627, DOI 10.1179/joc.2009.21.6.627.
   Bircher J, 2014, J PUBLIC HEALTH POL, V35, P363, DOI 10.1057/jphp.2014.19.
   BLAND CJ, 1995, ACAD MED, V70, P642, DOI 10.1097/00001888-199507000-00014.
   Borg MA, 2009, CLIN MICROBIOL INFEC, V15, P232, DOI 10.1111/j.1469-0691.2008.02651.x.
   Center for Diseases Control and Prevention, 2010, MMWR-MORBID MORTAL W, V59, pRR.
   Direction de l'Epidemiologie et de Lutte contre les Maladies Ministere de la Sante Maroc, 2000, ESPERANCE MED, V7, P532.
   El Idrissi-Raja L, 2011, REV PNEUMOL CLIN, V67, P289, DOI 10.1016/j.pneumo.2010.11.001.
   Hassani A., 2001, PEDIATR PULM S, VS23, P153.
   Houssaini ASS, 2007, INT J ENVIRON HEAL R, V17, P243, DOI 10.1080/09603120701372086.
   Jackson S, 2013, CROAT MED J, V54, P110, DOI 10.3325/cmj.2013.54.110.
   Joseph F., 2006, INT J QUAL HEALTH C, V18, P134.
   Jroundi I, 2014, INT J INFECT DIS, V14.
   Jroundi I, 2014, J TROP PEDIATRICS, V60, P270, DOI 10.1093/tropej/fmu010.
   Jroundi I, 2013, ANTIBIOTICS-BASEL, V2, P450, DOI 10.3390/antibiotics2040450.
   Lahlou A, 2011, EUROSURVEILLANCE, V16, P15.
   Lahrach J, 2010, ARCH PEDIATR, V17, P168.
   Liu L, 2014, LANCET, V375, P1969.
   Louriz, 2010, INT ARCH MED, V3, P26.
   Maynard-Tucker G, 1998, J TROP PEDIATRICS, V44, P59, DOI 10.1093/tropej/44.1.59.
   Ministry of Health Morocco, 2006, ENQ NAT IND MULT SAN.
   Ministry of Health Morocco, 2012, PROGR LUTT INF RESP, P128.
   Moustaoui N, 2000, CLIN MICROBIOL INFEC, V6, P48, DOI 10.1046/j.1469-0691.2000.00015-3.x.
   Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1.
   Seffar M, 2002, MED MALADIES INFECT, V32, P529.
   Warda K, 2013, J INFECT PUBLIC HEAL, V6, P473, DOI 10.1016/j.jiph.2013.06.003.
   World Health Organisation, 2013, WHO REP GLOB TOB EP.
   Zar HJ, 2013, THORAX, V68, P1052, DOI 10.1136/thoraxjnl-2013-204247.
   Zar HJ, 2014, PEDIATR PULM, V49, P430, DOI 10.1002/ppul.23030.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{0}},
Journal-ISO = {{Arch. Public Health}},
Doc-Delivery-Number = {{V51QS}},
Unique-ID = {{ISI:000210237300001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000356325100001,
Author = {Giles, Sarah K. and Stroeher, Uwe H. and Eijkelkamp, Bart A. and Brown,
   Melissa H.},
Title = {{Identification of genes essential for pellicle formation in
   Acinetobacter baumannii}},
Journal = {{BMC MICROBIOLOGY}},
Year = {{2015}},
Volume = {{15}},
Month = {{JUN 6}},
Abstract = {{Background: Acinetobacter baumannii is an opportunistic pathogen, which
   has the ability to persist in the clinical environment, causing acute
   and chronic infections. A possible mechanism contributing to survival of
   Acinetobacter baumannii is its ability to form a biofilm-like structure
   at the air/liquid interface, known as a pellicle. This study aimed to
   identify and characterise the molecular mechanisms required for pellicle
   formation in Acinetobacter baumannii and to assess a broad range of
   clinical Acinetobacter baumannii strains for their ability to form these
   multicellular structures.
   Results: Random transposon mutagenesis was undertaken on a previously
   identified hyper-motile variant of Acinetobacter baumannii ATCC 17978
   designated 17978hm. In total three genes critical for pellicle formation
   were identified; cpdA, a phosphodiesterase required for degradation of
   cyclic adenosine monophosphate (cAMP), and A1S\_0112 and A1S\_0115 which
   are involved in the production of a secondary metabolite. While motility
   of the A1S\_0112::Tn and A1S\_0115::Tn mutant strains was abolished, the
   cpdA::Tn mutant strain displayed a minor alteration in its motility
   pattern. Determination of cAMP levels in the cpdA::Tn strain revealed a
   similar to 24-fold increase in cellular cAMP, confirming the role CpdA
   plays in catabolising this secondary messenger molecule. Interestingly,
   transcriptional analysis of the cpdA::Tn strain showed significant
   down-regulation of the operon harboring the A1S\_0112 and A1S\_0115
   genes, revealing a link between these three genes and pellicle
   formation. Examination of our collection of 54 clinical Acinetobacter
   baumannii strains revealed that eight formed a measurable pellicle; all
   of these strains were motile.
   Conclusions: This study shows that pellicle formation is a rare trait in
   Acinetobacter baumannii and that a limited number of genes are essential
   for the expression of this phenotype. Additionally, an association
   between pellicle formation and motility was identified. The level of the
   signalling molecule cAMP was found to be controlled, in part, by the
   cpdA gene product, in addition to playing a critical role in pellicle
   formation, cellular hydrophobicity and motility. Furthermore, cAMP was
   identified as a novel regulator of the operon A1S\_0112-0118.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Brown, MH (Reprint Author), Flinders Univ S Australia, Sch Biol Sci, GPO Box 21005001, Adelaide, SA, Australia.
   Giles, Sarah K.; Stroeher, Uwe H.; Eijkelkamp, Bart A.; Brown, Melissa H., Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA, Australia.
   Eijkelkamp, Bart A., Univ Adelaide, Sch Biol Sci, Res Ctr Infect Dis, Adelaide, SA, Australia.}},
DOI = {{10.1186/s12866-015-0440-6}},
Article-Number = {{116}},
ISSN = {{1471-2180}},
Keywords = {{Cyclic AMP; Motility; Virulence; Biofilm; Hydrophobicity}},
Keywords-Plus = {{CELL-SURFACE HYDROPHOBICITY; GRAM-NEGATIVE BACTERIA;
   PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; MULTIDRUG-RESISTANT;
   ESCHERICHIA-COLI; CYCLIC-AMP; MOTILITY; EXPRESSION; VIRULENCE}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{melissa.brown@flinders.edu.au}},
ResearcherID-Numbers = {{Eijkelkamp, Bart/G-7109-2015}},
ORCID-Numbers = {{Eijkelkamp, Bart/0000-0003-0179-8977}},
Funding-Acknowledgement = {{National Health and Medical Research Council Australia Project Grant
   {[}535053]; Flinders Medical Research Foundation Grant; Flinders
   University Research Scholarship (FURS)}},
Funding-Text = {{This project was financially supported by the National Health and
   Medical Research Council Australia Project Grant 535053 and a Flinders
   Medical Research Foundation Grant. SKG is the recipient of a Flinders
   University Research Scholarship (FURS).}},
Cited-References = {{Bergogne-Berezin E, 1997, Expert Opin Investig Drugs, V6, P119, DOI 10.1517/13543784.6.2.119.
   Brazma A, 2001, MICROBES INFECT, V3, P823, DOI 10.1016/S1286-4579(01)01440-X.
   Carruthers M. D., 2013, GENOME ANNOUNC, V1, DOI DOI 10.1128/GENOMEA.00906-13.
   Chabane YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111660.
   Chiku K, 2013, BIOSCI BIOTECH BIOCH, V77, P505, DOI 10.1271/bbb.120736.
   Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09.
   Clemmer KM, 2011, MICROBIOL-SGM, V157, P2534, DOI 10.1099/mic.0.049791-0.
   Costa Gislaine Franco de Moura, 2006, Braz J Infect Dis, V10, P346, DOI 10.1590/S1413-86702006000500009.
   de Kievit TR, 2009, ENVIRON MICROBIOL, V11, P279, DOI 10.1111/j.1462-2920.2008.01792.x.
   Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005.
   Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789.
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002.
   Eijkelkamp BA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1020.
   Eijkelkamp BA, 2013, INFECT IMMUN, V81, P2574, DOI 10.1128/IAI.00065-13.
   Eijkelkamp BA, 2011, FEMS MICROBIOL LETT, V323, P44, DOI 10.1111/j.1574-6968.2011.02362.x.
   Eijkelkamp BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-126.
   Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013.
   Fuchs EL, 2010, J BACTERIOL, V192, P3553, DOI 10.1128/JB.00363-10.
   Fuchs EL, 2010, J BACTERIOL, V192, P2779, DOI 10.1128/JB.00168-10.
   Furuhata K, 2009, J GEN APPL MICROBIOL, V55, P69, DOI 10.2323/jgam.55.69.
   Golic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055059.
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8.
   HENRICHSEN J, 1975, ACTA PATH MICRO IM B, V83, P179.
   HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C.
   Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11.
   Kalivoda EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071267.
   Kanchanarach W, 2010, BIOSCI BIOTECH BIOCH, V74, P1591, DOI 10.1271/bbb.100183.
   Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-2.
   Karaiskos I, 2013, INT J ANTIMICROB AG, V41, P499, DOI 10.1016/j.ijantimicag.2013.02.006.
   Kobayashi K, 2007, J BACTERIOL, V189, P4920, DOI 10.1128/JB.00157-07.
   Kouidhi B, 2010, MICROB PATHOGENESIS, V49, P14, DOI 10.1016/j.micpath.2010.03.007.
   Lazar V, 2011, ANAEROBE, V17, P280, DOI 10.1016/j.anaerobe.2011.03.023.
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262.
   Longo F, 2014, NEW MICROBIOL, V37, P119.
   Marti S., 2011, BIO MED CENTRAL, V4, P1.
   Marti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026030.
   Matthysse AG, 1996, FEMS MICROBIOL LETT, V145, P87, DOI 10.1111/j.1574-6968.1996.tb08561.x.
   McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688.
   McQueary CN, 2011, J MICROBIOL, V49, P243, DOI 10.1007/s12275-011-0343-7.
   Moonmangmee S, 2002, J BIOSCI BIOENG, V93, P192, DOI 10.1263/jbb.93.192.
   Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10.
   Neely AN, 1999, CLIN INFECT DIS, V29, P1358, DOI 10.1086/313463.
   Ono K, 2014, MICROBES ENVIRON, V29, P104, DOI 10.1264/jsme2.ME13151.
   Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07.
   Pour NK, 2011, FEMS IMMUNOL MED MIC, V62, P328, DOI 10.1111/j.1574-695X.2011.00818.x.
   Raut Jayant, 2010, Nihon Ishinkin Gakkai Zasshi, V51, P131.
   Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148.
   ROSENBERG E, 1983, INFECT IMMUN, V39, P1024.
   Rumbo-Feal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072968.
   Sambandan D, 2013, MBIO, V4, DOI {[}10.1128/mBio.00222-13, DOI 10.1128/MBIO.00222-13].
   Saroj SD, 2013, ANTIMICROB AGENTS CH, V57, P1926, DOI 10.1128/AAC.02161-12.
   Shemarova IV, 2009, CRIT REV MICROBIOL, V35, P23, DOI 10.1080/10408410802645646.
   Shin JA, 2012, YONSEI MED J, V53, P974, DOI 10.3349/ymj.2012.53.5.974.
   SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784.
   Skiebe E, 2012, INT J MED MICROBIOL, V302, P117, DOI 10.1016/j.ijmm.2012.03.003.
   Skorupski K, 1997, P NATL ACAD SCI USA, V94, P265, DOI 10.1073/pnas.94.1.265.
   Ramirez MS, 2010, J CLIN MICROBIOL, V48, P1488, DOI 10.1128/JCM.01264-09.
   Stewart CR, 2009, J BACTERIOL, V191, P1537, DOI 10.1128/JB.01531-08.
   Strassle P, 2012, AM J INFECT CONTROL, V40, P1005, DOI 10.1016/j.ajic.2012.05.027.
   Stretton S, 1998, APPL ENVIRON MICROB, V64, P2554.
   Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0.
   Vallet I, 2001, P NATL ACAD SCI USA, V98, P6911, DOI 10.1073/pnas.111551898.
   Wada A, 2000, J BACTERIOL, V182, P2893, DOI 10.1128/JB.182.10.2893-2899.2000.
   Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4.
   Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899.
   Yamamoto K, 2012, MICROBES ENVIRON, V27, P320, DOI 10.1264/jsme2.ME11322.
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9.
   Yuan J, 2013, BBA-GEN SUBJECTS, V1830, P5248, DOI 10.1016/j.bbagen.2013.07.023.}},
Number-of-Cited-References = {{68}},
Times-Cited = {{15}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{BMC Microbiol.}},
Doc-Delivery-Number = {{CK6FY}},
Unique-ID = {{ISI:000356325100001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000351977000005,
Author = {Edelblute, Chelsea M. and Malik, Muhammad A. and Heller, Loree C.},
Title = {{Surface-dependent inactivation of model microorganisms with shielded
   sliding plasma discharges and applied air flow}},
Journal = {{BIOELECTROCHEMISTRY}},
Year = {{2015}},
Volume = {{103}},
Number = {{SI}},
Pages = {{22-27}},
Month = {{JUN}},
Abstract = {{Cold atmospheric plasma inactivates bacteria through reactive species
   produced from the applied gas. The use of cold plasma clinically has
   gained recent interest, as the need for alternative or supplementary
   strategies are necessary for preventing multi-drug resistant infections.
   The purpose of this study was to evaluate the antibacterial efficacy of
   a novel shielded sliding discharge based cold plasma reactor operated by
   nanosecond voltage pulses in atmospheric air on both biotic and
   inanimate surfaces. Bacterial inactivation was determined by direct
   quantification of colony forming units. The plasma activated air
   (afterglow) was bactericidal against Escherichia coli and Staphylococcus
   epidermidis seeded on culture media, laminate, and linoleum vinyl. In
   general, E. coli was more susceptible to plasma exposure. A bacterial
   reduction was observed with the application of air alone on a laminate
   surface. Whole-cell real-time PCR revealed a decrease in the presence of
   E. coli genomic DNA on exposed samples. These findings suggest that
   plasma-induced bacterial inactivation is surface-dependent. (C) 2014
   Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE SA}},
Address = {{PO BOX 564, 1001 LAUSANNE, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Heller, LC (Reprint Author), Old Dominion Univ, Frank Reidy Res Ctr Bioelect, 4211 Monarch Way,Suite 300, Norfolk, VA 23508 USA.
   Edelblute, Chelsea M.; Malik, Muhammad A.; Heller, Loree C., Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23508 USA.
   Heller, Loree C., Old Dominion Univ, Coll Hlth Sci, Sch Med Diagnost \&Translat Sci, Norfolk, VA 23529 USA.}},
DOI = {{10.1016/j.bioelechem.2014.08.013}},
ISSN = {{1567-5394}},
EISSN = {{1521-186X}},
Keywords = {{Nonthermal plasma; Shielded sliding discharge; Bacterial inactivation;
   Plasma medicine}},
Keywords-Plus = {{REAL-TIME PCR; ESCHERICHIA-COLI; NOSOCOMIAL PATHOGENS; PROPIDIUM
   MONOAZIDE; NONTHERMAL PLASMA; ELECTRON-TRANSFER; BACTERIA;
   STERILIZATION; TRANSMISSION; CONVERSION}},
Research-Areas = {{Biochemistry \& Molecular Biology; Life Sciences \& Biomedicine - Other
   Topics; Biophysics; Electrochemistry}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Biology; Biophysics; Electrochemistry}},
Author-Email = {{lheller@odu.edu}},
ORCID-Numbers = {{Malik, Muhammad Arif/0000-0002-1986-5974}},
Funding-Acknowledgement = {{U.S. Army Medical Research and Materiel Command; Telemedicine and
   Advanced Technology Research Center, at Fort Detrick, MD
   {[}W81XWH-10-1-0376]}},
Funding-Text = {{This research and development project is being conducted by Old Dominion
   University and is made possible by a research grant that was awarded and
   administered by the U.S. Army Medical Research and Materiel Command and
   the Telemedicine and Advanced Technology Research Center, at Fort
   Detrick, MD under contract number W81XWH-10-1-0376. The views, opinions
   and/or findings contained in this research are those of the authors and
   do not necessarily reflect the views of the Department of Defense and
   should not be construed as an official DoD/Army position, policy or
   decision unless so designated by other documentation. No official
   endorsement should be made.}},
Cited-References = {{Ardhaoui M, 2013, BIOELECTROCHEMISTRY, V91, P52, DOI 10.1016/j.bioelechem.2012.12.005.
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797.
   Daeschlein G, 2012, J HOSP INFECT, V81, P177, DOI 10.1016/j.jhin.2012.02.012.
   Deng SB, 2007, J FOOD SCI, V72, pM62, DOI 10.1111/j.1750-3841.2007.00275.x.
   Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020.
   Ermolaeva SA, 2012, J MED MICROBIOL, V61, P793, DOI 10.1099/jmm.0.038117-0.
   Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154.
   Heinlin J, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2010.03702.x.
   Heller LC, 2012, LETT APPL MICROBIOL, V54, P126, DOI 10.1111/j.1472-765X.2011.03186.x.
   Hoshino T, 2012, BIOELECTROCHEMISTRY, V84, P1, DOI 10.1016/j.bioelechem.2011.09.001.
   Jiang CQ, 2009, IEEE T PLASMA SCI, V37, P1190, DOI 10.1109/TPS.2009.2014870.
   JOSEPHSON KL, 1993, APPL ENVIRON MICROB, V59, P3513.
   Kelly-Wintenberg K, 1998, J IND MICROBIOL BIOT, V20, P69, DOI 10.1038/sj.jim.2900482.
   Kim JG, 1999, J FOOD PROTECT, V62, P1071, DOI 10.4315/0362-028X-62.9.1071.
   Kobayashi H, 2010, J ORTHOP RES, V28, P1245, DOI 10.1002/jor.21108.
   Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333.
   Kolb J.F., 2012, COLD DC OPERATED AIR.
   Kolb J. F., 2008, APPL PHYS LETT, V92.
   Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012.
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130.
   Laroussi M., 2005, APPL PHYS LETT, V87.
   Liang YD, 2012, ENVIRON SCI TECHNOL, V46, P3360, DOI {[}10.1021/es203770q, 10.1021/es203770g].
   Malik MA, 2014, PLASMA CHEM PLASMA P, V34, P93, DOI 10.1007/s11090-013-9497-x.
   Malik MA, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/13/132001.
   Malik MA, 2012, J HAZARD MATER, V209, P293, DOI 10.1016/j.jhazmat.2012.01.024.
   Napartovich A., 2001, PLASMAS POLYM, V6, P1, DOI {[}10.1023/A:1011313322430, DOI 10.1023/A:1011313322430].
   Niemira BA, 2008, J FOOD PROTECT, V71, P1357, DOI 10.4315/0362-028X-71.7.1357.
   Nocker A, 2007, J MICROBIOL METH, V70, P252, DOI 10.1016/j.mimet.2007.04.014.
   Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015.
   Nogva HK, 2003, BIOTECHNIQUES, V34, P804.
   Oliver JD, 2005, J MICROBIOL, V43, P93.
   Otter JA, 2011, INFECT CONT HOSP EP, V32, P687, DOI 10.1086/660363.
   Pan J, 2010, IEEE T PLASMA SCI, V38, P3143, DOI 10.1109/TPS.2010.2066291.
   Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2.
   Schmidlin M., 2010, APPL BIOSAF, V15, P180, DOI DOI 10.1177/153567601001500404.
   Scholle K., 2013, P IEEE INT C MULT EX, P1.
   Shashurin A., 2008, APPL PHYS LETT, V93, DOI {[}10.1063/13020223, DOI 10.1063/13020223].
   Shiraishi H, 2007, BIOELECTROCHEMISTRY, V70, P481, DOI 10.1016/j.bioelechem.2006.07.011.
   Sung SJ, 2013, J ADV PROSTHODONT, V5, P2, DOI 10.4047/jap.2013.5.1.2.
   Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196.
   Weltmann KD, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/194008.
   Wenzel R. P., 1997, PREVENTION CONTROL N.
   Wenzel RP, 2001, EMERG INFECT DIS, V7, P174, DOI 10.3201/eid0702.010203.
   Wood A. J. J., 1996, NEW ENGL J MED, V335, P1445, DOI DOI 10.1056/NEJM199611073351907.
   Yu Q., 2006, APPL PHYS LETT, V88.
   Zhang Q., 2012, J APPL PHYS, V111.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{11}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{36}},
Journal-ISO = {{Bioelectrochemistry}},
Doc-Delivery-Number = {{CE6VT}},
Unique-ID = {{ISI:000351977000005}},
DA = {{2018-08-13}},
}

@article{ ISI:000355631400050,
Author = {Xu, Zimu and Wei, Jun and Shen, Jie and Liu, Yuan and Ma, Ronghua and
   Zhang, Zelong and Qian, Shulou and Ma, Jie and Lan, Yan and Zhang, Hao
   and Zhao, Ying and Xia, Weidong and Sun, Qiang and Cheng, Cheng and Chu,
   Paul K.},
Title = {{Genetic effects of an air discharge plasma on Staphylococcus aureus at
   the gene transcription level}},
Journal = {{APPLIED PHYSICS LETTERS}},
Year = {{2015}},
Volume = {{106}},
Number = {{21}},
Month = {{MAY 25}},
Abstract = {{The dynamics of gene expression regulation (at transcription level) in
   Staphylococcus aureus after different doses of atmospheric-pressure
   room-temperature air plasma treatments are investigated by monitoring
   the quantitative real-time polymerase chain reaction. The plasma
   treatment influences the transcription of genes which are associated
   with several important bio-molecular processes related to the
   environmental stress resistance of the bacteria, including oxidative
   stress response, biofilm formation, antibiotics resistance, and DNA
   damage protection/repair. The reactive species generated by the plasma
   discharge in the gas phase and/or induced in the liquid phase may
   account for these gene expression changes. (C) 2015 AIP Publishing LLC.}},
Publisher = {{AMER INST PHYSICS}},
Address = {{1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Xia, WD (Reprint Author), Univ Sci \& Technol China, Dept Thermal Sci \& Energy Engn, Hefei 230026, Anhui, Peoples R China.
   Xu, Zimu; Wei, Jun; Zhang, Zelong; Qian, Shulou; Xia, Weidong; Sun, Qiang, Univ Sci \& Technol China, Dept Thermal Sci \& Energy Engn, Hefei 230026, Anhui, Peoples R China.
   Xu, Zimu; Liu, Yuan; Ma, Ronghua; Zhang, Hao; Xia, Weidong, Univ Sci \& Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.
   Lan, Yan; Zhao, Ying; Cheng, Cheng, Chinese Acad Sci, Inst Plasma Phys, Hefei 230031, Peoples R China.
   Shen, Jie; Ma, Jie; Lan, Yan; Cheng, Cheng, Chinese Acad Sci, Hefei Inst Phys Sci, Ctr Med Phys \& Technol, Hefei 230031, Peoples R China.
   Cheng, Cheng; Chu, Paul K., City Univ Hong Kong, Dept Phys \& Mat Sci, Kowloon, Hong Kong, Peoples R China.}},
DOI = {{10.1063/1.4921754}},
Article-Number = {{213701}},
ISSN = {{0003-6951}},
EISSN = {{1077-3118}},
Keywords-Plus = {{PRESSURE COLD-PLASMA; HYDROGEN-PEROXIDE; BIOFILM FORMATION; EXPRESSION;
   RESPONSES; SHOCK}},
Research-Areas = {{Physics}},
Web-of-Science-Categories  = {{Physics, Applied}},
Author-Email = {{xiawd@ustc.edu.cn
   chengcheng@ipp.ac.cn
   paul.chu@cityu.edu.hk}},
ResearcherID-Numbers = {{Chu, Paul/B-5923-2013
   }},
ORCID-Numbers = {{Chu, Paul/0000-0002-5581-4883
   Cheng, Cheng/0000-0002-5007-4695}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}11035005, 11005126,
   50876101]; Hefei Institutes of Physical Science, Chinese Academy of
   Sciences (CASHIPS) Dean Funds {[}YZJJ201331]; City University of Hong
   Kong Strategic Research Grant (SRG) {[}7004188]; Hong Kong Research
   Grants Council (RGC) General Research Funds (GRF) {[}CityU 112212]}},
Funding-Text = {{This work was supported by the National Natural Science Foundation of
   China under Grant Nos. 11035005, 11005126, and 50876101, Hefei
   Institutes of Physical Science, Chinese Academy of Sciences (CASHIPS)
   Dean Funds No. YZJJ201331, City University of Hong Kong Strategic
   Research Grant (SRG) No. 7004188, as well as Hong Kong Research Grants
   Council (RGC) General Research Funds (GRF) No. CityU 112212.}},
Cited-References = {{Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06.
   Arjunan KP, 2011, PLASMA PROCESS POLYM, V8, P1154, DOI 10.1002/ppap.201100078.
   Bore E, 2007, MICROBIOL-SGM, V153, P2289, DOI 10.1099/mic.0.2007/005942-0.
   Cabiscol Elisa, 2000, International Microbiology, V3, P3.
   Chang W, 2006, J BACTERIOL, V188, P1648, DOI 10.1128/JB.188.4.1648-1659.2006.
   Cheng C, 2006, CHINESE PHYS, V15, P1544, DOI 10.1088/1009-1963/15/7/028.
   Cheng C, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/7/075204.
   Deng XT, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2103394.
   Hashizume H, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824892.
   Karavolos MH, 2003, MICROBIOL-SGM, V149, P2749, DOI 10.1099/mic.0.26353-0.
   Kim GJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3292206.
   Kolb JF, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2940325.
   Laroussi M, 2002, APPL PHYS LETT, V81, P772, DOI 10.1063/1.1494863.
   Laverty G, 2013, FUTURE MICROBIOL, V8, P509, DOI {[}10.2217/FMB.13.7, 10.2217/fmb.13.7].
   Leduc M, 2010, PLASMA PROCESS POLYM, V7, P899, DOI 10.1002/ppap.201000032.
   Lu X, 2014, PHYS REP, V540, P123, DOI 10.1016/j.physrep.2014.02.006.
   Lu X, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/3/034005.
   Lu X, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3258071.
   Lukes P, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/1/015019.
   Palmer HJ, 1997, NUTR REV, V55, P353.
   Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0.
   Shen J, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.036201.
   TARTAGLIA LA, 1990, J BIOL CHEM, V265, P10535.
   Turpaev KT, 2002, BIOCHEMISTRY-MOSCOW+, V67, P281, DOI 10.1023/A:1014819832003.
   Valderas MW, 2001, J BACTERIOL, V183, P3399, DOI 10.1128/JB.183.11.3399-3407.2001.
   Walsh JL, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3623487.
   Yasuda H, 2010, PLASMA PROCESS POLYM, V7, P301, DOI 10.1002/ppap.200900088.
   You YB, 2014, INT J MED MICROBIOL, V304, P603, DOI {[}10.1016/j.fimm.2014.04.003, 10.1016/j.ijmm.2014.04.003].
   Zhang Q, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807133.
   Zhao Y, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3588036.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{10}},
Usage-Count-Last-180-days = {{5}},
Usage-Count-Since-2013 = {{42}},
Journal-ISO = {{Appl. Phys. Lett.}},
Doc-Delivery-Number = {{CJ6UX}},
Unique-ID = {{ISI:000355631400050}},
DA = {{2018-08-13}},
}

@article{ ISI:000355198800003,
Author = {Sotgiu, Giovanni and Centis, Rosella and D'ambrosio, Lia and Migliori,
   Giovanni Battista},
Title = {{Tuberculosis Treatment and Drug Regimens}},
Journal = {{COLD SPRING HARBOR PERSPECTIVES IN MEDICINE}},
Year = {{2015}},
Volume = {{5}},
Number = {{5}},
Month = {{MAY}},
Abstract = {{Tuberculosis is an airborne infectious disease treated with combination
   therapeutic regimens. Adherence to long-term antituberculosis therapy is
   crucial for maintaining adequate blood drug level. The emergence and
   spread of drug-resistant Mycobacterium tuberculosis strains are mainly
   favored by the inadequate medical management of the patients. The
   therapeutic approach for drug-resistant tuberculosis is cumbersome,
   because of the poor, expensive, less-effective, and toxic alternatives
   to the first-line drugs. New antituberculosis drugs (bedaquiline and
   delamanid) have been recently approved by the health authorities, but
   they cannot represent the definitive solution to the clinical management
   of drug-resistant tuberculosis forms, particularly in intermediate
   economy settings where the prevalence of drug resistance is high (China,
   India, and former Soviet Union countries). New research and development
   activities are urgently needed. Public health policies are required to
   preserve the new and old therapeutic options.}},
Publisher = {{COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT}},
Address = {{1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Migliori, GB (Reprint Author), Fdn S Maugeri, WHO, Collaborating Ctr TB \& Lung Dis, Care \& Res Inst, I-21049 Tradate, Italy.
   Sotgiu, Giovanni, Univ Sassari, Dept Biomed Sci, Clin Epidemiol \& Med Stat Unit, Res Med Educ \& Profess Dev Unit, I-07100 Aou Sassari, Italy.
   Centis, Rosella; D'ambrosio, Lia; Migliori, Giovanni Battista, Fdn S Maugeri, WHO, Collaborating Ctr TB \& Lung Dis, Care \& Res Inst, I-21049 Tradate, Italy.}},
DOI = {{10.1101/cshperspect.a017822}},
Article-Number = {{a017822}},
ISSN = {{2157-1422}},
Keywords-Plus = {{MULTIDRUG-RESISTANT TUBERCULOSIS; EARLY BACTERICIDAL ACTIVITY; POSITIVE
   PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; BEDAQUILINE TMC207;
   RANDOMIZED-TRIAL; TOLERABILITY; DELAMANID; EFFICACY; SAFETY}},
Research-Areas = {{Research \& Experimental Medicine}},
Web-of-Science-Categories  = {{Medicine, Research \& Experimental}},
Author-Email = {{gbmigliori@fsm.it}},
ResearcherID-Numbers = {{Centis, Rosella/E-8882-2018
   }},
ORCID-Numbers = {{Centis, Rosella/0000-0002-8551-3598
   Migliori, Giovanni Battista/0000-0002-2597-574X
   Sotgiu, Giovanni/0000-0002-1600-4474}},
Cited-References = {{Alffenaar JWC, 2010, CLIN PHARMACOKINET, V49, P559, DOI 10.2165/11532080-000000000-00000.
   {[}Anonymous], 2013, US BED TREATM MULT R.
   Arentz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047370.
   B.M.R. Councils, 1974, LANCET, V304, P237.
   Barry V. C., 1964, CHEMOTHERAPY TUBERCU.
   Crofton J, 2006, J ROY SOC MED, V99, P531, DOI 10.1258/jrsm.99.10.531.
   CROFTON J, 1960, Br Med J, V2, P679.
   CROFTON J, 1969, BRIT MED J, V2, P137, DOI 10.1136/bmj.2.5650.137.
   Daniel TM, 2006, RESP MED, V100, P1862, DOI 10.1016/j.rmed.2006.08.006.
   DAWSON JJY, 1966, B WORLD HEALTH ORGAN, V34, P533.
   De Lorenzo S, 2013, EUR RESPIR J, V41, P1386, DOI 10.1183/09031936.00124312.
   Dheda K, 2012, LANCET, V379, P773, DOI 10.1016/S0140-6736(11)61062-3.
   Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3271, DOI 10.1128/AAC.06126-11.
   Diacon AH, 2011, INT J TUBERC LUNG D, V15, P949, DOI 10.5588/ijtld.10.0616.
   Diacon AH, 2013, ANTIMICROB AGENTS CH, V57, P2199, DOI 10.1128/AAC.02243-12.
   Diacon AH, 2012, LANCET, V380, P986, DOI 10.1016/S0140-6736(12)61080-0.
   Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3027, DOI 10.1128/AAC.06125-11.
   Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427.
   Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611.
   Forgacs P, 2009, ANTIMICROB AGENTS CH, V53, P4789, DOI 10.1128/AAC.01658-08.
   Fox W, 1999, INT J TUBERC LUNG D, V3, pS231.
   Fox W, 1954, QJM, V91, P347.
   Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433.
   Goldsworthy PD, 2002, MED J AUSTRALIA, V176, P176.
   Grosset JH, 2012, INT J TUBERC LUNG D, V16, P1005, DOI 10.5588/ijtld.12.0277.
   HINSHAW HC, 1945, P STAFF M MAYO CLIN, V20, P313.
   Huang TS, 2012, J ANTIMICROB CHEMOTH, V67, P633, DOI 10.1093/jac/dkr501.
   Koh WJ, 2012, J ANTIMICROB CHEMOTH, V67, P1503, DOI 10.1093/jac/dks078.
   Mahajan Rajiv, 2013, Int J Appl Basic Med Res, V3, P1, DOI 10.4103/2229-516X.112228.
   Migliori GB, 2009, EUR RESPIR J, V34, P387, DOI 10.1183/09031936.00009509.
   Migliori GB, 2011, CURRENT EMERGING DIA, P42.
   Migliori GB, 2012, LANCET, V380, P955, DOI 10.1016/S0140-6736(12)61183-0.
   Pontali E, 2013, CURR OPIN PULM MED, V19, P266, DOI 10.1097/MCP.0b013e32835f1bf3.
   ROSENBLATT MB, 1973, B NEW YORK ACAD MED, V49, P163.
   SAKULA A, 1983, THORAX, V38, P326, DOI 10.1136/thx.38.5.326.
   Schatz A, 1944, P SOC EXP BIOL MED, V55, P66.
   SENSI P, 1983, REV INFECT DIS, V5, pS402.
   Shaw KJ, 2011, ANN NY ACAD SCI, V1241, P48, DOI 10.1111/j.1749-6632.2011.06330.x.
   Skripconoka V, 2013, EUR RESPIR J, V41, P1393, DOI 10.1183/09031936.00125812.
   Sotgiu G, 2013, EUR RESPIR MONOGR, P11, DOI 10.1183/1025448x.10040212.
   Sotgiu G, 2012, EUR RESPIR J, V40, P1430, DOI 10.1183/09031936.00022912.
   Sotgiu G, 2009, J ANTIMICROB CHEMOTH, V64, P879, DOI 10.1093/jac/dkp265.
   Srivastava S, 2013, EUR RESPIR J, V42, P1449, DOI 10.1183/09031936.00073213.
   Tuberculosis Coalition for Technical Assistance, 2009, INT STAND TUB CAR IS.
   Vilcheze C, 2012, ANTIMICROB AGENTS CH, V56, P5142, DOI 10.1128/AAC.00832-12.
   Wallis RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030479.
   WASSERSUG JD, 1946, NEW ENGL J MED, V235, P220, DOI 10.1056/NEJM194608152350704.
   {*}WHO, 2004, TOM TUB CAS DET TREA.
   Willyard C, 2012, NAT MED, V18, P1157, DOI 10.1038/nm0812-1157.
   World Health Organization, 2011, WHOHTMTB20114.
   World Health Organization, 2011, WHOHTMTB20116.
   World Health Organization, 2008, WHOHTMTB2008402.
   World Health Organization, 2010, WHOHTMTB2009420.
   World Health Organization, 2013, WHOHTMTB201311.}},
Number-of-Cited-References = {{54}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{8}},
Journal-ISO = {{Cold Spring Harb. Perspect. Med.}},
Doc-Delivery-Number = {{CJ0WB}},
Unique-ID = {{ISI:000355198800003}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000355369100019,
Author = {Arfken, Ann M. and Song, Bongkeun and Sung, Jung-Suk},
Title = {{Comparison of Airborne Bacterial Communities from a Hog Farm and Spray
   Field}},
Journal = {{JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY}},
Year = {{2015}},
Volume = {{25}},
Number = {{5}},
Pages = {{709-717}},
Month = {{MAY}},
Abstract = {{Airborne bacteria from hog farms may have detrimental impacts on human
   health, particularly in terms of antibiotic resistance and pathogen
   zoonosis. Despite human health risks, very little is known about the
   composition and diversity of airborne bacteria from hog farms and
   hog-related spray fields. We used pyrosequencing analysis of 16S rRNA
   genes to compare airborne bacterial communities in a North Carolina hog
   farm and lagoon spray field. In addition, we isolated and identified
   antibiotic-resistant bacteria from both air samples. Based on 16S rRNA
   gene,pyrosequene analysis, Actinobacteria, Bacteroidetes, Firmicutes,
   and Proteobacteria were the dominant phyla in airborne bacterial
   communities from both hog farm and spray field sites. Within the
   Firmicutes genera, Clostridium spp. were more abundant in the hog farm,
   whereas Staphylococcus spp. were higher in the spray field. The presence
   of opportunitic pathogens, including several Staphylococcus species and
   Propionibacterium acnes, was detected in both bioaerosol communities
   based on phylogenetic analysis. The isolation and identification of
   antibiotic-resistant bacteria from air samples also showed similar
   results with dominance of Actinobacteria and Proteobacteria in both hog
   farm and spray field air. Thus, the existence of opportunistic pathogens
   and antibiotic resistant bacteria in airborne communities evidences
   potential health risks to farmers and other residents from swine
   bioaerosol exposure.}},
Publisher = {{KOREAN SOC MICROBIOLOGY \& BIOTECHNOLOGY}},
Address = {{KOREA SCI TECHNOL CENTER \#507,  635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Song, B (Reprint Author), Univ N Carolina, Dept Biol \& Marine Biol, Wilmington, NC 28403 USA.
   Arfken, Ann M.; Song, Bongkeun, Univ N Carolina, Dept Biol \& Marine Biol, Wilmington, NC 28403 USA.
   Arfken, Ann M.; Song, Bongkeun, Virginia Inst Marine Sci, Dept Biol Sci, Gloucester Point, VA 23062 USA.
   Song, Bongkeun; Sung, Jung-Suk, Dongguk Univ, Dept Life Sci, Seoul, South Korea.}},
DOI = {{10.4014/jmb.1408.08005}},
ISSN = {{1017-7825}},
EISSN = {{1738-8872}},
Keywords = {{Hog; swine; antibiotic resistance; bioaerosol; airborne bacteria}},
Keywords-Plus = {{SWINE CONFINEMENT BUILDINGS; ANIMAL FEEDING OPERATIONS;
   ENTEROCOCCUS-FAECIUM; PROPIONIBACTERIUM-ACNES; ANTIBIOTIC-RESISTANCE;
   INDOOR ENVIRONMENT; MOLECULAR ANALYSIS; HEALTH; PIG; BIOAEROSOLS}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Microbiology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Microbiology}},
Author-Email = {{songb@vims.edu}},
Funding-Acknowledgement = {{US Department of Agriculture {[}2014-67019-21614]; UNCW Cahill Award;
   North Carolina Pork Council; IPET Technology Commercialization Support
   Program of Ministry of Agriculture, Food and Rural Affairs, Korea
   {[}812001-3]}},
Funding-Text = {{This research was supported by a US Department of Agriculture grant
   (2014-67019-21614), the UNCW Cahill Award, and the North Carolina Pork
   Council, as well as IPET Technology Commercialization Support Program
   (812001-3) of Ministry of Agriculture, Food and Rural Affairs, Korea. We
   thank Dr. Lawrence Cahoon for his assistance in sampling North Carolina
   hog lagoon and spray field bioaerosols.}},
Cited-References = {{Aarestrup FM, 2000, MICROB DRUG RESIST, V6, P63, DOI 10.1089/mdr.2000.6.63.
   Aarestrup FM, 2000, DIAGN MICR INFEC DIS, V37, P127, DOI 10.1016/S0732-8893(00)00130-9.
   AMANN RI, 1995, MICROBIOL REV, V59, P143.
   Angenent LT, 2005, P NATL ACAD SCI USA, V102, P4860, DOI 10.1073/pnas.0501235102.
   Bager F, 1997, PREV VET MED, V31, P95, DOI 10.1016/S0167-5877(96)01119-1.
   Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167.
   Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990.
   Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330.
   Capiraso JG, NAT METHODS, V7, P335.
   Chapin A, 2005, ENVIRON HEALTH PERSP, V113, P137, DOI 10.1289/ehp.7473.
   Chee-Sanford JC, 2009, J ENVIRON QUAL, V38, P1086, DOI 10.2134/jeq2008.0128.
   Chien YC, 2011, J AIR WASTE MANAGE, V61, P882, DOI 10.3155/1047-3289.61.8.882.
   CLARK S, 1983, AM IND HYG ASSOC J, V44, P537, DOI 10.1080/15298668391405265.
   Cole D, 2000, ENVIRON HEALTH PERSP, V108, P685, DOI 10.2307/3434721.
   CORMIER Y, 1990, AM IND HYG ASSOC J, V51, P304, DOI 10.1202/0002-8894(1990)051<0304:AMCITT>2.0.CO;2.
   CROOK B, 1991, AM IND HYG ASSOC J, V52, P271, DOI 10.1202/0002-8894(1991)052<0271:ADAMAA>2.0.CO;2.
   Cruz AT, 2007, J CLIN MICROBIOL, V45, P1989, DOI 10.1128/JCM.00632-07.
   de Evgrafov MR, 2013, AEROSOL SCI TECH, V47, P755, DOI 10.1080/02786826.2013.789477.
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05.
   DONHAM K, 1989, BRIT J IND MED, V46, P31.
   Duchaine C, 2000, AM IND HYG ASSOC J, V61, P56, DOI 10.1202/0002-8894(2000)061<0056:IOBMEF>2.0.CO;2.
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381.
   FDA (Food and Drug Administration), 2004, FDA APPR AN DRUG PRO.
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x.
   Franzetti A, 2011, APPL MICROBIOL BIOT, V90, P745, DOI 10.1007/s00253-010-3048-7.
   Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910.
   Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837.
   HOLNESS DL, 1987, AM J IND MED, V11, P571, DOI 10.1002/ajim.4700110509.
   Hong PY, 2012, ENVIRON MICROBIOL, V14, P1420, DOI 10.1111/j.1462-2920.2012.02726.x.
   Jensen LB, 2002, MICROB DRUG RESIST, V8, P369, DOI 10.1089/10766290260469642.
   KELLY WJ, 1987, ARCH MICROBIOL, V147, P169, DOI 10.1007/BF00415279.
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581.
   Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002.
   Leung K, 2001, FEMS MICROBIOL ECOL, V38, P169, DOI 10.1016/S0168-6496(01)00181-7.
   Millner PD, 2009, BIORESOURCE TECHNOL, V100, P5379, DOI 10.1016/j.biortech.2009.03.026.
   Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x.
   Predicala BZ, 2002, CURR MICROBIOL, V44, P136, DOI 10.1007/s00284-001-0064-y.
   Ravva SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017281.
   Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56.
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406.
   Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P1225, DOI 10.1089/vbz.2010.0182.
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121.
   Von Essen SG, 1998, J TOXICOL-CLIN TOXIC, V36, P557, DOI 10.3109/15563659809028049.
   WEBSTER GF, 1981, APPL ENVIRON MICROB, V41, P1269.
   Wegener HC, 1999, EMERG INFECT DIS, V5, P329, DOI 10.3201/eid0503.990303.
   Wing S, 2000, ENVIRON HEALTH PERSP, V108, P233, DOI 10.2307/3454439.
   Zedja JE, 1994, J OCCUP MED, V36, P49.
   Zedja JE, 1993, CHEST, V103, P702.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{15}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{36}},
Journal-ISO = {{J. Microbiol. Biotechnol.}},
Doc-Delivery-Number = {{CJ3FP}},
Unique-ID = {{ISI:000355369100019}},
DA = {{2018-08-13}},
}

@article{ ISI:000354722000003,
Author = {Turner, Richard D. and Bothamley, Graham H.},
Title = {{Cough and the Transmission of Tuberculosis}},
Journal = {{JOURNAL OF INFECTIOUS DISEASES}},
Year = {{2015}},
Volume = {{211}},
Number = {{9}},
Pages = {{1367-1372}},
Month = {{MAY 1}},
Abstract = {{Cough is a predominant feature of respiratory infection and, in
   tuberculosis, is of prime importance for transmitting infection.
   Tuberculosis is transmitted by the air, yet the process by which bacilli
   are aerosolized has received little attention. Features of cough may
   account for differences in transmission rates from source cases of
   pulmonary disease. We review the literature on the mechanisms and
   characteristics of cough in tuberculosis in the context of the
   dissemination of infection. Coughing is probably more important than
   other respiratory maneuvers, and characteristics of mucus may have an
   important role but data are scarce. Direct mechanisms of cough in
   tuberculosis are unknown, as are temporal and other patterns that
   correlate with the release of viable airborne bacilli. Other than
   antituberculous chemotherapy and masks, there are few methods of
   modulating cough in tuberculosis. This is an increasingly important area
   for research.}},
Publisher = {{OXFORD UNIV PRESS INC}},
Address = {{JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Turner, RD (Reprint Author), Homerton Univ Hosp NHS Trust, Dept Resp Med, London E9 6SR, England.
   Turner, Richard D.; Bothamley, Graham H., Homerton Univ Hosp NHS Trust, Dept Resp Med, London E9 6SR, England.}},
DOI = {{10.1093/infdis/jiu625}},
ISSN = {{0022-1899}},
EISSN = {{1537-6613}},
Keywords = {{tuberculosis; cough; airborne transmission; infectiousness}},
Keywords-Plus = {{MULTIDRUG-RESISTANT TUBERCULOSIS; PULMONARY TUBERCULOSIS;
   MYCOBACTERIUM-TUBERCULOSIS; AIRBORNE TRANSMISSION; AUTOMATED COUGH;
   DROPLET NUCLEI; INFECTION; RECEPTOR; AIR; VARIABILITY}},
Research-Areas = {{Immunology; Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Immunology; Infectious Diseases; Microbiology}},
Author-Email = {{richard.turner@homerton.nhs.uk}},
Cited-References = {{Abdullah H, 2014, THORAX, V69, P46, DOI 10.1136/thoraxjnl-2013-203894.
   BATES JH, 1965, NEW ENGL J MED, V272, P714, DOI 10.1056/NEJM196504082721403.
   Birring SS, 2008, EUR RESPIR J, V31, P1013, DOI 10.1183/09031936.00057407.
   Bothamley GH, 2005, THORAX, V60, P527, DOI 10.1136/thx.2004.036012.
   Carr MJ, 2002, AM J RESP CRIT CARE, V165, P1071, DOI 10.1164/rccm.2108065.
   Chung KF, 2008, LANCET, V371, P1364, DOI 10.1016/S0140-6736(08)60595-4.
   Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834.
   Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC.
   Dicpinigaitis PV, 2014, PHARMACOL REV, V66, P468, DOI 10.1124/pr.111.005116.
   Earis J, 2005, ACUTE CHRONIC COUGH, P143.
   Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101.
   Escombe AR, 2007, CLIN INFECT DIS, V44, P1349, DOI 10.1086/515397.
   Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061.
   Fennelly KP, 2007, CLIN INFECT DIS, V44, P1358, DOI 10.1086/516617.
   Fennelly KP, 2012, AM J RESP CRIT CARE, V186, P450, DOI 10.1164/rccm.201203-0444OC.
   Gralton J, 2011, J INFECTION, V62, P1, DOI 10.1016/j.jinf.2010.11.010.
   HATCH TF, 1961, BACTERIOL REV, V25, P237.
   Huang CC, 2014, INT J TUBERC LUNG D, V18, P1285, DOI 10.5588/ijtld.14.0309.
   Jones-Lopez EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100984.
   Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC.
   Kelsall A, 2008, EUR RESPIR J, V32, P175, DOI 10.1183/09031936.00101307.
   Khalid S, 2014, J ALLERGY CLIN IMMUN, V134, P56, DOI 10.1016/j.jaci.2014.01.038.
   Kwon SB, 2012, CHEMOSPHERE, V87, P1260, DOI 10.1016/j.chemosphere.2012.01.032.
   Leith DE, 1979, HDB PHYSL RESP SYSTE, P315.
   LOUDON RG, 1969, AM REV RESPIR DIS, V99, P109.
   Marion E, 2014, CELL, V157, P1565, DOI 10.1016/j.cell.2014.04.040.
   McGarvey L, 2014, LUNG, V192, P459, DOI 10.1007/s00408-014-9581-x.
   McGuinness K, 2012, THORAX, V67, pA131, DOI 10.1136/thoraxjnl-2012-202678.220.
   Morawska L, 2006, INDOOR AIR, V16, P335, DOI 10.1111/j.1600-0668.2006.00432.x.
   Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002.
   Morice AH, 2007, EUR RESPIR J, V29, P1256, DOI 10.1183/09031936.00101006.
   Morice AH, 2007, AM J RESP CRIT CARE, V175, P312, DOI 10.1164/rccm.200607-892OC.
   Nardell EA, 2004, AM J RESP CRIT CARE, V169, P553, DOI 10.1164/rccm.2401003.
   OConnell F, 1996, RESP MED, V90, P279, DOI 10.1016/S0954-6111(96)90099-2.
   Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5.
   Rangel MJ, 2002, IMMUNOLOGY, V106, P257, DOI DOI 10.1046/J.1365-2567.2002.01403.X.
   RILEY RL, 1974, AM J MED, V57, P466, DOI 10.1016/0002-9343(74)90140-5.
   RILEY RL, 1959, AM J HYG, V70, P185, DOI 10.1093/oxfordjournals.aje.a120069.
   ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2.
   Sepkowitz KA, 1996, CLIN INFECT DIS, V23, P954, DOI 10.1093/clinids/23.5.954.
   Smit LAM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-26.
   Smith JA, 2012, J PHYSIOL-LONDON, V590, P563, DOI 10.1113/jphysiol.2011.213157.
   SULTAN L, 1960, AM REV RESPIR DIS, V82, P358.
   Tang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034818.
   Turner RD, 2014, THORAX, V69, pA43, DOI 10.1136/thoraxjnl-2014-206260.85.
   Turner RD, 2014, RESP MED, V108, P1808, DOI 10.1016/j.rmed.2014.10.003.
   Wells WF, 1934, AM J HYG, V20, P611, DOI 10.1093/oxfordjournals.aje.a118097.
   Yousaf N, 2013, EUR RESPIR J, V41, P241, DOI 10.1183/09031936.00089312.
   Zayas Gustavo, 2005, BMC Pulm Med, V5, P11, DOI 10.1186/1471-2466-5-11.
   Zayas G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-811.}},
Number-of-Cited-References = {{50}},
Times-Cited = {{20}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{17}},
Journal-ISO = {{J. Infect. Dis.}},
Doc-Delivery-Number = {{CI4LZ}},
Unique-ID = {{ISI:000354722000003}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000352999700004,
Author = {Saadoun, Ismail and Jaradat, Ziad W. and Al Tayyar, Ibraheem Ali and El
   Nasser, Ziad and Ababneh, Qotaibah},
Title = {{Airborne methicillin-resistant Staphylococcus aureus in the indoor
   environment of King Abdullah University Hospital, Jordan}},
Journal = {{INDOOR AND BUILT ENVIRONMENT}},
Year = {{2015}},
Volume = {{24}},
Number = {{3}},
Pages = {{315-323}},
Month = {{MAY}},
Abstract = {{Methicillin-resistant Staphylococcus aureus (MRSA) is seen with
   increasing frequency in hospitals and is considered as a major cause of
   hospital-acquired infection. The objectives of this study were to
   isolate and characterize the airborne MRSA in different wards of a
   referral university hospital. Thirty-four air samples of 100 litres
   volume/min were collected by a microbiological air sampler, then
   impacted on trypticase soy agar (TSA) and incubated at 37? for 48h.
   Recovered colonies were identified by standard methods. From all S.
   aureus, 9.3\% was identified as MRSA which comprised 4.2\%, 3.1\% and
   2\% in the adult and nursery intensive care units, and operating
   theatres (ICU, NICU and OT, respectively). MRSA isolates were remarkably
   susceptible (87.1\%) to each of amikacin, chloramphenicol, imipenem and
   rifampin. MRSA isolates were shown in all units with minimum inhibitory
   concentration value of >256, 32 and 6 mu g/l in ICU, OT and NICU,
   respectively. Polymerase chain reaction analysis of all MRSA isolates
   indicated the amplification of the mec A gene. It is concluded that MRSA
   was isolated from all units making eradication of MRSA a target hard to
   achieve. However, the antibiotic resistance profile of the MRSA isolates
   looks promising leaving a room to combat nosocomial infections.}},
Publisher = {{SAGE PUBLICATIONS LTD}},
Address = {{1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Saadoun, I (Reprint Author), Univ Sharjah, Dept Appl Biol, Coll Sci, POB 27272, Sharjah, U Arab Emirates.
   Saadoun, Ismail, Univ Sharjah, Dept Appl Biol, Coll Sci, Sharjah, U Arab Emirates.
   Saadoun, Ismail; Jaradat, Ziad W.; Al Tayyar, Ibraheem Ali; Ababneh, Qotaibah, Jordan Univ Sci \& Technol, Fac Sci \& Arts, Dept Biotechnol \& Genet Engn, Irbid, Jordan.
   El Nasser, Ziad, Jordan Univ Sci \& Technol, Dept Pathol \& Microbiol, Irbid, Jordan.}},
DOI = {{10.1177/1420326X14526604}},
ISSN = {{1420-326X}},
EISSN = {{1423-0070}},
Keywords = {{Airborne; Antibiotic resistance; MRSA; mec A gene}},
Keywords-Plus = {{INTENSIVE-CARE-UNIT; ANTIMICROBIAL RESISTANCE; MRSA; CONTAMINATION;
   EPIDEMIOLOGY; TRANSMISSION; MANAGEMENT; POLLUTION; BACTERIA; SPREAD}},
Research-Areas = {{Construction \& Building Technology; Engineering; Public, Environmental
   \& Occupational Health}},
Web-of-Science-Categories  = {{Construction \& Building Technology; Engineering, Environmental; Public,
   Environmental \& Occupational Health}},
Author-Email = {{isaadoun@sharjah.ac.ae}},
Funding-Acknowledgement = {{Deanship of Scientific Research at Jordan University of Science and
   Technology {[}37/2005]}},
Funding-Text = {{Deanship of Scientific Research at Jordan University of Science and
   Technology funded this research (Grant No. 37/2005).}},
Cited-References = {{Abdel-Haq N, 2009, EUR J CLIN MICROBIOL, V28, P547, DOI 10.1007/s10096-008-0658-4.
   Ahmad S, 2003, MED MYCOL, V41, P487, DOI 10.1080/1369378031000147458.
   Andersen BM, 2002, J HOSP INFECT, V50, P18, DOI 10.1053/jhin.2001.1128.
   Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P3, DOI 10.1111/j.1469-0691.2006.01402.x.
   Archibald L, 1997, CLIN INFECT DIS, V24, P211, DOI 10.1093/clinids/24.2.211.
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493.
   Beggs CB, 2003, INDOOR BUILT ENVIRON, V12, P9, DOI 10.1177/142032603032201.
   Buemi M, 2000, J NEPHROL, V13, P433.
   Carolyn NB, 1994, DIAGN MICROBIOL INFE, V19, P167.
   Cavalcanti Silvana M.M., 2005, Braz J Infect Dis, V9, P56, DOI 10.1590/S1413-86702005000100010.
   Chandrashekar M R, 1997, J Indian Med Assoc, V95, P72.
   Clinical and Laboratory Standards Institute (CLSI), 2007, M100S17 CLSI, V27.
   Dancer SJ., 2008, LANCET INFECT DIS, V8, P111.
   Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003.
   Elliott B, 2007, INTERN MED J, V37, P561, DOI 10.1111/j.1445-5994.2007.01403.x.
   Fernandes CJ, 2005, J ANTIMICROB CHEMOTH, V55, P506, DOI 10.1093/jac/dki052.
   Fridkin SK, 1999, CLIN INFECT DIS, V29, P245, DOI 10.1086/520193.
   Gammage RB, 1985, INDOOR HUMAN HLTH.
   Gehanno JF, 2009, J HOSP INFECT, V71, P256, DOI 10.1016/j.jhin.2008.11.015.
   Gilbert Y, 2010, AEROBIOLOGIA, V26, P185, DOI 10.1007/s10453-010-9155-1.
   Haddadin AS, 2002, POSTGRAD MED J, V78, P385, DOI 10.1136/pmj.78.921.385.
   Hardy KJ, 2006, INFECT CONT HOSP EP, V27, P127, DOI 10.1086/500622.
   Hewitt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054703.
   Jaffal AA, 1997, ENVIRON INT, V23, P167, DOI 10.1016/S0160-4120(97)00003-2.
   Kalliokoski P, 2003, INDOOR BUILT ENVIRON, V12, P41, DOI {[}10.1177/1420326X03012001007, 10.1177/142032603032676].
   Kilic A, 2007, JPN J INFECT DIS, V60, P394.
   Koneman EW, 1997, COLOR ATLAS TXB DIAG.
   Leung M, 2006, MED SCI MONITOR, V12, pSR17.
   Lugauskas A, 2004, INDOOR BUILT ENVIRON, V13, P101, DOI 10.1177/1420326X04040936.
   Merlino J, 2002, J ANTIMICROB CHEMOTH, V49, P793, DOI 10.1093/jac/dkf021.
   Newman Mercy J, 2002, West Afr J Med, V21, P310.
   Njoku-Obi A N, 1993, Afr J Med Med Sci, V22, P19.
   Obbard JP, 2003, WATER AIR SOIL POLL, V144, P333, DOI 10.1023/A:1022973402453.
   Omori A, 1992, Kansenshogaku Zasshi, V66, P1396.
   Saad SG, 2003, INDOOR BUILT ENVIRON, V12, P93, DOI {[}10.1177/1420326X03012001015, 10.1177/142032603033012].
   Sambrook J, 1989, MOL CLONING LAB MANU, P150.
   Sarica S, 2002, INDOOR BUILT ENVIRON, V11, P285, DOI 10.1159/000066523.
   Sessa R, 2002, MICROBIOLOGICA, V25, P51.
   Shehabi AA IB, 1996, E MEDITERR HEALTH J, V2, P515.
   Shiomori T, 2002, J HOSP INFECT, V50, P30, DOI 10.1053/jhin.2001.1136.
   Shiomori T, 2001, ARCH OTOLARYNGOL, V127, P644, DOI 10.1001/archotol.127.6.644.
   Smyth RW, 2001, J HOSP INFECT, V48, P103, DOI 10.1053/jhin.2001.0933.
   Solberg CO, 2000, SCAND J INFECT DIS, V32, P587, DOI 10.1080/003655400459478.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{18}},
Journal-ISO = {{Indoor Built Environ.}},
Doc-Delivery-Number = {{CG0YJ}},
Unique-ID = {{ISI:000352999700004}},
DA = {{2018-08-13}},
}

@article{ ISI:000354037400008,
Author = {Matyszewska, Dorota and Bilewicz, Renata},
Title = {{Interactions of daunorubicin with Langmuir-Blodgett thiolipid monolayers}},
Journal = {{ELECTROCHIMICA ACTA}},
Year = {{2015}},
Volume = {{162}},
Pages = {{45-52}},
Month = {{APR 20}},
Note = {{15th Topical Meeting of the International-Society-of-Electrochemistry
   (ISE), Niagara Falls, CANADA, APR 27-30, 2014}},
Organization = {{Int Soc Electrochemistry; Lakehead Univ, Fac Sci \& Environm Studies;
   GAMRY Instruments; IVIUM Technologies; Metrohm Autolab B V; Pine Res
   Instrumentat; ZAHNER Messsysteme}},
Abstract = {{Interactions of daunorubicin (DNR) with thiolipid membranes composed of
   1,2-Dipalmitoyl-sn-Glycero-3-Phosphothioethanol (DPPTE) formed both at
   the air-water interface and transferred onto gold electrodes were
   investigated. The drug incorporates into the DPPTE layers during their
   formation increasing the area per molecule and causing the fluidization
   of the layers. The interactions of DNR with preformed layers depend on
   the membrane organization and therefore the dominating type of the
   driving forces. For less organized layers both electrostatic and
   hydrophobic interactions take place, while for more condensed layers
   precompressed to higher surface pressures, electrostatic interactions
   seem to be prevailing. The drug adsorbs at the layer formed at the
   air-water interface, which prevents from its further penetration. The
   DPPTE layers were transferred onto gold electrodes by means of
   Langmuir-Blodgett and self-assembly method. Cyclic voltammetry
   experiments revealed that DNR is more easily incorporated into LB layers
   supported on solid substrate than into SAMs, since the former tend to be
   less compact and hydrophobic interactions between the acyl chains of the
   thiolipid and hydrophobic anthraquinone part of DNR is facilitated. The
   influence of pH changes of the supporting electrolyte on the electrode
   processes of DNR incorporated into the layers was also investigated in
   order to verify if the lipid environment affects the mechanism of
   electron transfer. (C) 2015 Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Bilewicz, R (Reprint Author), Univ Warsaw, Fac Chem, Ul Pasteura 1, PL-02093 Warsaw, Poland.
   Matyszewska, Dorota, Univ Warsaw, Biol \& Chem Res Ctr, PL-02089 Warsaw, Poland.
   Matyszewska, Dorota; Bilewicz, Renata, Univ Warsaw, Fac Chem, PL-02093 Warsaw, Poland.}},
DOI = {{10.1016/j.electacta.2015.01.032}},
ISSN = {{0013-4686}},
EISSN = {{1873-3859}},
Keywords = {{daunorubicin (DNR); 1,2-Dipalmitoyl-sn-Glycero-3-Phosphothioethanol
   (DPPTE); model lipid membranes; Langmuir monolayer; cyclic voltammetry}},
Keywords-Plus = {{BILAYER-LIPID MEMBRANE; AIR-WATER-INTERFACE; CLASS-II PORIN;
   DRUG-RESISTANCE; CANCER-CELLS; ANIONIC PHOSPHOLIPIDS; IN-VIVO;
   ANTHRACYCLINES; DOXORUBICIN; SURFACE}},
Research-Areas = {{Electrochemistry}},
Web-of-Science-Categories  = {{Electrochemistry}},
Author-Email = {{bilewicz@chem.uw.edu.pl}},
Funding-Acknowledgement = {{Foundation for Polish Science; European Union, Regional Development
   Fund; European Union from the European Regional Development Fund; 
   {[}POMOST/2011-3/6]}},
Funding-Text = {{This work was supported by the Foundation for Polish Science with the
   POMOST/2011-3/6 project co-financed by the European Union, Regional
   Development Fund.; Part of this study was carried out at the Biological
   and Chemical Research Centre, University of Warsaw, established within
   the project co-financed by European Union from the European Regional
   Development Fund under the Operational Programme Innovative Economy,
   2007-2013.}},
Cited-References = {{Bordi F, 1999, BIOELECTROCH BIOENER, V49, P51, DOI 10.1016/S0302-4598(99)00063-X.
   DEWOLF FA, 1993, BIOCHEMISTRY-US, V32, P6688, DOI 10.1021/bi00077a023.
   Duoou- Cezanne L., 1989, EUR J BIOCHEM, V81, P695.
   ESCRIBA PV, 1990, BIOCHEMISTRY-US, V29, P7275, DOI 10.1021/bi00483a017.
   Gaines Jr G. L, 1966, INSOLUBLE MONOLAYERS, P24.
   Gallois L, 1996, EUR J BIOCHEM, V241, P879, DOI 10.1111/j.1432-1033.1996.00879.x.
   Geraldo VPN, 2013, CHEM PHYS LETT, V559, P99, DOI 10.1016/j.cplett.2012.12.064.
   Gevritz D. A., 1999, BIOCHEM PHARMACOL, V57, P727.
   Hahn YH, 2004, ARCH PHARM RES, V27, P31, DOI 10.1007/BF02980041.
   Harkins W. D., 1952, PHYS CHEM SURFACE FI, P107.
   Heywang C, 1998, BIOPHYS J, V75, P2368, DOI 10.1016/S0006-3495(98)77681-7.
   Jablonowska E, 2011, J ELECTROANAL CHEM, V660, P360, DOI 10.1016/j.jelechem.2011.03.018.
   Jadhav SR, 2013, J COLLOID INTERF SCI, V390, P211, DOI 10.1016/j.jcis.2012.09.031.
   Jadhav SR, 2008, BIOSENS BIOELECTRON, V24, P831, DOI 10.1016/j.bios.2008.07.010.
   Janmey PA, 2006, TRENDS CELL BIOL, V16, P538, DOI 10.1016/j.tcb.2006.08.009.
   Komorsky-Lovric S, 2006, BIOELECTROCHEMISTRY, V69, P82, DOI 10.1016/j.bioelechem.2005.10.006.
   Kunze J, 2006, LANGMUIR, V22, P5509, DOI 10.1021/la0535274.
   Li MH, 2014, J MATER CHEM B, V2, P1619, DOI 10.1039/c3tb21423k.
   Liu Y, 2014, BBA-BIOMEMBRANES, V1838, P429, DOI 10.1016/j.bbamem.2013.09.007.
   Ma P, 2013, NANO TODAY, V8, P313, DOI 10.1016/j.nantod.2013.04.006.
   Matyszewska D, 2012, LANGMUIR, V28, P5182, DOI 10.1021/la2044027.
   Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6.
   Mohamadi S, 2014, ANAL CHIM ACTA, V813, P83, DOI 10.1016/j.aca.2014.01.009.
   Nascimento JM, 2012, CHEM PHYS LIPIDS, V165, P537, DOI 10.1016/j.chemphyslip.2012.05.002.
   Nieciecka D, 2013, J ELECTROANAL CHEM, V710, P59, DOI 10.1016/j.jelechem.2013.03.004.
   Nieciecka D, 2011, LANGMUIR, V27, P1100, DOI 10.1021/la103583g.
   Peetla C, 2010, MOL PHARMACEUT, V7, P2334, DOI 10.1021/mp100308n.
   Ringstad L, 2008, LANGMUIR, V24, P208, DOI 10.1021/la702538k.
   Romao RIS, 2013, THIN SOLID FILMS, V534, P584, DOI 10.1016/j.tsf.2013.02.052.
   Sarpietro MG, 2010, INT J PHARMACEUT, V395, P167, DOI 10.1016/j.ijpharm.2010.05.035.
   Schnoller D, 2011, PROG COLL POL SCI S, V138, P131, DOI 10.1007/978-3-642-19038-4\_23.
   Steinkopf S, 2010, BIOPHYS CHEM, V152, P65, DOI 10.1016/j.bpc.2010.08.001.
   Taghdisi SM, 2011, EUR J PHARM BIOPHARM, V77, P200, DOI 10.1016/j.ejpb.2010.12.005.
   Wieckowska A., 2011, PHYS CHEM CHEM PHYS, V13, P9716.
   Yang XL, 1999, PHARMACOL THERAPEUT, V83, P181, DOI 10.1016/S0163-7258(99)00020-0.
   Yue Y, 2012, ARCH PHARM RES, V35, P343, DOI 10.1007/s12272-012-0215-7.
   Zhang G, 2011, NANOMED-NANOTECHNOL, V7, P595, DOI 10.1016/j.nano.2011.01.013.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{7}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{15}},
Journal-ISO = {{Electrochim. Acta}},
Doc-Delivery-Number = {{CH4XQ}},
Unique-ID = {{ISI:000354037400008}},
DA = {{2018-08-13}},
}

@article{ ISI:000352914700001,
Author = {Maclntyre, C. Raina and Chughtai, Abrar Ahmad},
Title = {{Facemasks for the prevention of infection in healthcare and community
   settings}},
Journal = {{BMJ-BRITISH MEDICAL JOURNAL}},
Year = {{2015}},
Volume = {{350}},
Month = {{APR 9}},
Abstract = {{Facemasks are recommended for diseases transmitted through droplets and
   respirators for respiratory aerosols, yet recommendations and
   terminology vary between guidelines. The concepts of droplet and
   airborne transmission that are entrenched in clinical practice have
   recently been shown to be more complex than previously thought. Several
   randomised clinical trials of facemasks have been conducted in community
   and healthcare settings, using widely varying interventions, including
   mixed interventions (such as masks and handwashing), and diverse
   outcomes. Of the nine trials of facemasks identified in community
   settings, in all but one, facemasks were used for respiratory protection
   of well people. They found that facemasks and facemasks plus hand
   hygiene may prevent infection in community settings, subject to early
   use and compliance. Two trials in healthcare workers favoured
   respirators for clinical respiratory illness. The use of reusable cloth
   masks is widespread globally, particularly in Asia, which is an
   important region for emerging infections, but there is no clinical
   research to inform their use and most policies offer no guidance on
   them. Health economic analyses of facemasks are scarce and the few
   published cost effectiveness models do not use clinical efficacy data.
   The lack of research on facemasks and respirators is reflected in varied
   and sometimes conflicting policies and guidelines. Further research
   should focus on examining the efficacy of facemasks against specific
   infectious threats such as influenza and tuberculosis, assessing the
   efficacy of cloth masks, investigating common practices such as reuse of
   masks, assessing compliance, filling in policy gaps, and obtaining cost
   effectiveness data using clinical efficacy estimates.}},
Publisher = {{BMJ PUBLISHING GROUP}},
Address = {{BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Maclntyre, CR (Reprint Author), Univ New S Wales, Sch Publ Hlth \& Community Med, Fac Med, Sydney, NSW 2052, Australia.
   Maclntyre, C. Raina; Chughtai, Abrar Ahmad, Univ New S Wales, Sch Publ Hlth \& Community Med, Fac Med, Sydney, NSW 2052, Australia.}},
DOI = {{10.1136/bmj.h694}},
Article-Number = {{h694}},
ISSN = {{1756-1833}},
Keywords-Plus = {{ACUTE RESPIRATORY SYNDROME; SURGICAL FACE MASKS; MULTIDRUG-RESISTANT
   TUBERCULOSIS; PERSONAL PROTECTIVE EQUIPMENT; RANDOMIZED
   CONTROLLED-TRIAL; HAND HYGIENE; INFLUENZA TRANSMISSION; PANDEMIC
   INFLUENZA; SARS TRANSMISSION; HONG-KONG}},
Research-Areas = {{General \& Internal Medicine}},
Web-of-Science-Categories  = {{Medicine, General \& Internal}},
Author-Email = {{r.macintyre@unsw.edu.au}},
ORCID-Numbers = {{Chughtai, Abrar/0000-0003-4203-7891}},
Funding-Acknowledgement = {{3M; GSK; Merck; BioCSL; Pfizer; 3M Australia}},
Funding-Text = {{We have read and understood BMJ policy on declaration of interests and
   declare the following interests: CRM has received funding for
   investigator driven research on facemasks from 3M in the form of an
   Australian Research Council Industry Linkage grant (where 3M was the
   industry partner) and supply of masks for clinical research. She also
   has received funding or in-kind support from GSK, Merck, BioCSL, and
   Pfizer for investigator driven research on infectious diseases. 3M
   Australia provided support to AAC for facemask testing as part of his
   PhD thesis.}},
Cited-References = {{A-Asmary S, 2007, INT J INFECT DIS, V11, P268, DOI 10.1016/j.ijid.2006.04.008.
   Aiello AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029744.
   Aiello AE, 2010, J INFECT DIS, V201, P491, DOI 10.1086/650396.
   Albano L, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-208.
   Aledort JE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-208.
   Ang B, 2010, CLIN INFECT DIS, V50, P1011, DOI 10.1086/651159.
   Association for Professionals in Infection Control and Epidemiology (APIC), 2009, APIC POS PAP EXT US.
   Atkins D, 2004, BMJ-BRIT MED J, V328, P1490.
   Balazy A, 2006, AM J INFECT CONTROL, V34, P51, DOI 10.1016/j.ajic.2005.08.018.
   Barker J, 2004, J HOSP INFECT, V58, P42, DOI 10.1016/j.jhin.2004.04.021.
   Beckman S, 2013, AM J INFECT CONTROL, V41, P1024, DOI 10.1016/j.ajic.2013.05.006.
   Belkin NL, 2002, J HOSP INFECT, V50, P233, DOI 10.1053/jhin.2001.1166.
   Belkin NL, 1997, INFECT CONT HOSP EP, V18, P49.
   Bell D, 2006, EMERG INFECT DIS, V12, P88.
   bin-Reza F, 2012, INFLUENZA OTHER RESP, V6, P257, DOI 10.1111/j.1750-2659.2011.00307.x.
   Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478.
   BLUMBERG HM, 1995, ANN INTERN MED, V122, P658, DOI 10.7326/0003-4819-122-9-199505010-00003.
   Booth C. M., 2013, Journal of Hospital Infection, V84, P22, DOI 10.1016/j.jhin.2013.02.007.
   Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4.
   Brienen NCJ, 2010, RISK ANAL, V30, P1210, DOI 10.1111/j.1539-6924.2010.01428.x.
   Brosseau LM, 2014, HLTH WORKERS NEED OP.
   Bryce E, 2008, J HOSP INFECT, V68, P241, DOI 10.1016/j.jhin.2007.12.007.
   Canini L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013998.
   Caplan A, 2013, JAMA-J AM MED ASSOC, V310, P1797, DOI 10.1001/jama.2013.280633.
   Capps JA, 1918, J AMER MED ASSOC, V71, P448, DOI 10.1001/jama.1918.26020320008010a.
   Center for Disease Control and Prevention (CDC), 2014, PREV STRAT SEAS INFL.
   Centers for Disease Control and Prevention, 2010, INT GUID INF CONTR M.
   Centers for Disease Control and Prevention, 2014, INT INF PREV CONTR R.
   Centers for Disease Control and Prevention, 2014, GUID PERS PROT EQ US.
   Centers for Disease Control and Prevention, 2009, INT REC FAC RESP US.
   CHAMBERLAIN GV, 1984, ANN ROY COLL SURG, V66, P432.
   Chen MIC, 2006, ANN ACAD MED SINGAP, V35, P317.
   CHEN SK, 1994, AM J INFECT CONTROL, V22, P65, DOI 10.1016/0196-6553(94)90116-3.
   Chen WQ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-81.
   Chen YC, 2004, EMERG INFECT DIS, V10, P895, DOI 10.3201/eid1005.030777.
   CHRISTIE CDC, 1995, INFECT CONT HOSP EP, V16, P556.
   Chughtai AA, 2013, INT J INFECT CONTROL, V9, P1.
   Chughtai Abrar Ahmad, 2015, J Infect Prev, V16, P68, DOI 10.1177/1757177414560251.
   Chughtai AA, 2015, AM J INFECT CONTROL, V43, P72, DOI 10.1016/j.ajic.2014.10.009.
   Chughtai Abrar Ahmad, 2013, BMC Res Notes, V6, P216, DOI 10.1186/1756-0500-6-216.
   Cohen J, 2014, SCIENCE, V346, P17, DOI 10.1126/science.346.6205.17.
   Cowling BJ, 2010, EPIDEMIOL INFECT, V138, P449, DOI 10.1017/S0950268809991658.
   Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142.
   Cowling BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002101.
   Danyluk Q, 2011, J OCCUP ENVIRON HYG, V8, P267, DOI 10.1080/15459624.2011.566016.
   DAVIES KJ, 1994, BRIT DENT J, V176, P262, DOI 10.1038/sj.bdj.4808430.
   Derrick JL, 2005, J HOSP INFECT, V59, P365, DOI 10.1016/j.jhin.2004.10.013.
   Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC.
   Elder AG, 1996, BRIT MED J, V313, P1241, DOI 10.1136/bmj.313.7067.1241.
   European Centre for Disease Prevention and Control, 2014, Q A SEAS INFL.
   Fella P, 1995, AM J INFECT CONTROL, V23, P352, DOI 10.1016/0196-6553(95)90265-1.
   Gamage B, 2005, AM J INFECT CONTROL, V33, P114, DOI 10.1016/j.ajic.2004.12.002.
   Gammon J, 2008, J CLIN NURS, V17, P157, DOI 10.1111/j.1365-2702.2006.01852.x.
   Gershon Robyn R M, 2010, Am J Disaster Med, V5, P15.
   GERSHON RRM, 1995, AM J INFECT CONTROL, V23, P225, DOI 10.1016/0196-6553(95)90067-5.
   Gralton J, 2010, CRIT CARE MED, V38, P657, DOI 10.1097/CCM.0b013e3181b9e8b3.
   HALL CB, 1981, AM J DIS CHILD, V135, P512, DOI 10.1001/archpedi.1981.02130300012006.
   Institute of Medicine, 2006, REUC FAC INFL PAND F.
   Institute of Medicine (IOM) National Academy of Sciences, 2010, PREV TRANSM PAND INF.
   Jacobs JL, 2009, AM J INFECT CONTROL, V37, P417, DOI 10.1016/j.ajic.2008.11.002.
   Jefferson T., 2011, COCHRANE DB SYST REV, V7.
   Jefferson T, 2008, BRIT MED J, V336, P77, DOI 10.1136/bmj.39393.510347.BE.
   Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3675.
   Johnson DF, 2009, CLIN INFECT DIS, V49, P275, DOI 10.1086/600041.
   Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797.
   KISER JC, 1958, SURGERY, V44, P936.
   La Torre G, 2011, HUM VACCINES, V7, P728, DOI 10.4161/hv.7.7.15413.
   Larson EL, 2010, PUBLIC HEALTH REP, V125, P178, DOI 10.1177/003335491012500206.
   Lau JTF, 2004, EMERG INFECT DIS, V10, P587, DOI 10.3201/eid1004.030628.
   Lau JTF, 2004, EMERG INFECT DIS, V10, P280, DOI 10.3201/eid1002.030534.
   Lautenbach E, 2010, CLIN INFECT DIS, V50, P523, DOI 10.1086/650169.
   Lee KM, 2011, PHYS INTERVENTIONS I.
   Leung TF, 2004, J HOSP INFECT, V56, P215, DOI 10.1016/j.jhin.2003.11.004.
   Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100.
   Liu JW, 2006, INFECT CONT HOSP EP, V27, P466, DOI 10.1086/504501.
   Lo JYC, 2005, EMERG INFECT DIS, V11, P1738, DOI 10.3201/eid1111.050729.
   Loeb M, 2004, EMERG INFECT DIS, V10, P251, DOI 10.3201/eid1002.030838.
   Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466.
   Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7.
   MacIntyre CR, 2014, EPIDEMIOL INFECT, V142, P1802, DOI 10.1017/S095026881300304X.
   MacIntyre CR, 2014, INT J NURS STUD, V51, P1421, DOI 10.1016/j.ijnurstu.2014.09.002.
   MacIntyre CR, 2014, PREV MED, V62, P1, DOI 10.1016/j.ypmed.2014.01.015.
   MacIntyre CR, 2013, AM J RESP CRIT CARE, V187, P960, DOI 10.1164/rccm.201207-1164OC.
   MacIntyre CR, 2011, INFLUENZA OTHER RESP, V5, P170, DOI 10.1111/j.1750-2659.2011.00198.x.
   MacIntyre CR, 2014, ANZCTR.
   Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167.
   MADSEN PO, 1967, AM J SURG, V114, P431, DOI 10.1016/0002-9610(67)90168-7.
   MALONEY SA, 1995, ANN INTERN MED, V122, P90, DOI 10.7326/0003-4819-122-2-199501150-00002.
   Manangan LP, 1999, INFECT CONT HOSP EP, V20, P337, DOI 10.1086/501627.
   Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620.
   Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P79.
   Marks PJ, 2003, EPIDEMIOL INFECT, V131, P727, DOI 10.1017/S0950268803008689.
   McKinney K. R, 2006, J ENV HLTH, V68, P51.
   McKinney KR, 2006, J ENVIRON HEALTH, V68, P26.
   McNett EH, 1949, AM J NURS, V49, P32, DOI 10.2307/3458307.
   Migliori GB, 2012, EUR RESPIR J, V39, P807, DOI 10.1183/09031936.00203811.
   Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205.
   MITCHELL NJ, 1991, J HOSP INFECT, V18, P239, DOI 10.1016/0195-6701(91)90148-2.
   Moore D, 2005, AM J INFECT CONTROL, V33, P88, DOI 10.1016/j.ajic.2004.11.003.
   MURPHY D, 1981, J PEDIATR-US, V99, P746, DOI 10.1016/S0022-3476(81)80401-5.
   National Institute for Occupational Safety and Health (NIOSH), 1995, NIOSH GUID SEL US PA.
   New South Wales Department of Public Health, REP INFL EP NEW S 1.
   Ng TC, 2009, INFECT CONT HOSP EP, V30, P292, DOI 10.1086/595690.
   Nichol K, 2013, AM J INFECT CONTROL, V41, P8, DOI 10.1016/j.ajic.2011.12.018.
   Nickell LA, 2004, CAN MED ASSOC J, V170, P793, DOI 10.1503/cmaj.1031077.
   Nishiura H, 2005, AM J TROP MED HYG, V73, P17.
   Nishiyama A, 2008, JPN J INFECT DIS, V61, P388.
   Noti JD, 2012, CLIN INFECT DIS, V54, P1569, DOI 10.1093/cid/cis237.
   Occupational Safety and Health Administration (OSHA) U.S. Department of Labor, 2002, 3079 OSHA.
   Occupational Safety and Health Administration (OSHA). US Department of Labor, 1994, RESP FIT TEST.
   Occupational Safety and Health Administration (OSHA). US Department of Labor, PROP GUID WORKPL STO.
   Ofner M, 2003, JAMA-J AM MED ASSOC, V289, P2788.
   ORR N, 1982, ANN ROY COLL SURG, V64, P205.
   Park BJ, 2004, EMERG INFECT DIS, V10, P244.
   Perl TM, 2014, INCIDENCE RESPITATOR.
   Phin NF, 2009, J HOSP INFECT, V71, P15, DOI 10.1016/j.jhin.2008.09.005.
   Pittet D, 2001, EMERG INFECT DIS, V7, P234, DOI 10.3201/eid0702.010217.
   QUESNEL LB, 1975, BRIT J SURG, V62, P936, DOI 10.1002/bjs.1800621203.
   Rabie T, 2006, TROP MED INT HEALTH, V11, P258, DOI 10.1111/j.1365-3156.2006.01568.x.
   Rashid H., 2013, CLUSTER RANDOMISED C.
   Rebmann T, 2009, AM J INFECT CONTROL, V37, pE5, DOI 10.1016/j.ajic.2009.09.003.
   Rengasamy S, 2008, J OCCUP ENVIRON HYG, V5, P556, DOI 10.1080/15459620802275387.
   Rengasamy S, 2010, ANN OCCUP HYG, V54, P789, DOI 10.1093/annhyg/meq044.
   Salgado CD, 2002, LANCET INFECT DIS, V2, P145, DOI 10.1016/S1473-3099(02)00221-9.
   Seale H, 2009, INFECT CONT HOSP EP, V30, P710, DOI 10.1086/599254.
   Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6.
   Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007.
   Simmerman JM, 2011, INFLUENZA OTHER RESP, V5, P256, DOI 10.1111/j.1750-2659.2011.00205.x.
   Simon A, 2006, INT J HYG ENVIR HEAL, V209, P317, DOI 10.1016/j.ijheh.2006.02.003.
   Society for Healthcare Epidemiology of America (SHEA), 2009, SHEA POS STAT INT GU.
   Standards Australia Limited/Standards New Zealand, 2012, 1716 ASNZS.
   Suess T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-26.
   Swaminathan A, 2007, EMERG INFECT DIS, V13, P1541, DOI 10.3201/eid1310.070033.
   Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1.
   Teleman MD, 2004, EPIDEMIOL INFECT, V132, P797, DOI 10.1017/s0950268804002766.
   Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus.
   TUNEVALL TG, 1991, WORLD J SURG, V15, P383, DOI 10.1007/BF01658736.
   Ulmer BC, 2008, AORN J, V87, P35.
   Ulmer Brenda C, 2008, AORN J, V87, P721, DOI 10.1016/j.aorn.2007.10.012.
   van der Sande M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002618.
   Weaver GH, 1918, J AMER MED ASSOC, V70, P76, DOI 10.1001/jama.1918.02600020010005.
   Weaver GH, 1919, J INFECT DIS, V24, P218, DOI 10.1093/infdis/24.3.218.
   White C, 2003, AM J INFECT CONTROL, V31, P364, DOI 10.1067/mic.2003.76.
   Whitelaw TH, 1919, CAN MED ASSOC J, V9, P1070.
   WHO, 2014, INF PREV CONTR GUID.
   WHO, 2003, PRACT GUID INF CONTR.
   Wilder-Smith A, 2005, EMERG INFECT DIS, V11, P1142, DOI 10.3201/eid1107.041165.
   Winter S, 2010, CRIT CARE RESUSC, V12, P24.
   Wise ME, 2011, CLIN INFECT DIS, V52, pS198, DOI 10.1093/cid/ciq038.
   World Health Organization, 2009, WHO POL TB INF CONTR.
   World Health Organization, 2013, INF PREV CONTR HLTH.
   World Health Organization, 2003, CONS DOC EP SEV AC R.
   World Health Organization (WHO), 2014, INF PREV CONTR EP PA.
   Wu J, 2004, EMERG INFECT DIS, V10, P210, DOI 10.3201/eid1002.030730.
   Wu Lien-Teh, 1926, TREATISE PNEUMONIC P.
   {[}殷文武 Yin Wenwu], 2004, {[}中华流行病学杂志, Chinese Journal of Epidemiology], V25, P18.
   Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867.}},
Number-of-Cited-References = {{157}},
Times-Cited = {{18}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{16}},
Journal-ISO = {{BMJ-British Medical Journal}},
Doc-Delivery-Number = {{CF9VG}},
Unique-ID = {{ISI:000352914700001}},
DA = {{2018-08-13}},
}

@article{ ISI:000353488500051,
Author = {Gao, Lili and Tan, Yeke and Zhang, Xiaodan and Hu, Jiaqing and Miao,
   Zengmin and Wei, Liangmeng and Chai, Tongjie},
Title = {{Emissions of Escherichia coli Carrying Extended-Spectrum beta-Lactamase
   Resistance from Pig Farms to the Surrounding Environment}},
Journal = {{INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH}},
Year = {{2015}},
Volume = {{12}},
Number = {{4}},
Pages = {{4203-4213}},
Month = {{APR}},
Abstract = {{The dissemination of extended-spectrum beta-lactamase (ESBL)-producing
   Escherichia coli (E. coli) from food-producing animals to the
   surrounding environment has attracted much attention. To determine the
   emissions of ESBL-producing E. coli from pig farms to the surrounding
   environment, fecal and environmental samples from six pig farms were
   collected. In total, 119 ESBL-producing E. coli were isolated from
   feces, air samples, water, sludge and soil samples. Antibiotic
   susceptibility testing showed that the ESBL-producing isolates were
   resistant to multiple antibiotics and isolates of different origin
   within the same farm showed similar resistance phenotypes. Both CTX-M
   and TEM ESBL-encoding genes were detected in these isolates. CTX-M-14
   and CTX-M-15 were the predominant ESBL genes identified. ESBL producers
   from feces and environmental samples within the same farm carried
   similar CTX-M types. The results indicated that the ESBL-producing E.
   coli carrying multidrug resistance could readily disseminate to the
   surrounding environment.}},
Publisher = {{MDPI AG}},
Address = {{POSTFACH, CH-4005 BASEL, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wei, LM (Reprint Author), Shandong Agr Univ, Coll Vet Med, Tai An 271000, Shandong, Peoples R China.
   Gao, Lili; Zhang, Xiaodan; Hu, Jiaqing; Wei, Liangmeng; Chai, Tongjie, Shandong Agr Univ, Coll Vet Med, Tai An 271000, Shandong, Peoples R China.
   Gao, Lili; Zhang, Xiaodan; Wei, Liangmeng; Chai, Tongjie, Sino German Cooperat Res Ctr Zoonosis Anim Origin, Tai An 271000, Shandong, Peoples R China.
   Gao, Lili; Zhang, Xiaodan; Wei, Liangmeng; Chai, Tongjie, Key Lab Anim Biotechnol \& Dis Control \& Prevent S, Tai An 271000, Shandong, Peoples R China.
   Tan, Yeke, Taian City Cent Hosp, Tai An 271000, Shandong, Peoples R China.
   Miao, Zengmin, Taishan Med Univ, Coll Life Sci, Tai An 271000, Shandong, Peoples R China.}},
DOI = {{10.3390/ijerph120404203}},
ISSN = {{1660-4601}},
Keywords-Plus = {{KLEBSIELLA-PNEUMONIAE; CLINICAL-UPDATE; PUBLIC-HEALTH; MULTIPLEX PCR;
   FOOD ANIMALS; ENTEROBACTERIACEAE; PREVALENCE; GENES; BACTERIA; HOUSE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{abigheart@163.com
   tykaaa@163.com
   zhangxiaodan89@126.com
   hujiaqing0609@126.com
   Zengminmiao@163.com
   lmwei@sdau.edu.cn
   chaitj117@163.com}},
Funding-Acknowledgement = {{NSFC {[}31270172, 31470258]; National Science and Technology Support
   Project {[}2012BAD39B0205]; State Key Laboratory for Environmental
   Protection, Using of Environmental Microbiology and Security Controls
   {[}SMARC2013D001]}},
Funding-Text = {{This study was sponsored by the NSFC project (31270172) and (31470258);
   The National Science and Technology Support Project (2012BAD39B0205);
   Open Fund 2013 of the State Key Laboratory for Environmental Protection,
   Using of Environmental Microbiology and Security Controls
   (SMARC2013D001).}},
Cited-References = {{Aliabadi A. A., 2011, ADV PREV MED, V2011, DOI {[}10.4061/2011/12406421991436, DOI 10.4061/2011/12406421991436].
   ANDERSEN AA, 1958, J BACTERIOL, V76, P471.
   Batchelor M, 2005, ANTIMICROB AGENTS CH, V49, P1319, DOI 10.1128/AAC.49.4.1319-1322.2005.
   BAUERNFEIND A, 1990, INFECTION, V18, P294, DOI 10.1007/BF01647010.
   Blaak H, 2014, VET MICROBIOL, V171, P448, DOI 10.1016/j.vetmic.2014.03.007.
   Blanc V, 2006, VET MICROBIOL, V118, P299, DOI 10.1016/j.vetmic.2006.08.002.
   Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011.
   Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x.
   Clinical and Laboratory Standards Institute, 2011, M100S18 CLSI.
   Dolejska M, 2011, J ANTIMICROB CHEMOTH, V66, P2784, DOI 10.1093/jac/dkr363.
   Ewers C, 2014, J ANTIMICROB CHEMOTH, V69, P2676, DOI 10.1093/jac/dku217.
   Fallschissel K, 2010, ANN OCCUP HYG, V54, P934, DOI 10.1093/annhyg/meq054.
   Guo YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096738.
   Hartmann A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00083.
   Horton RA, 2011, APPL ENVIRON MICROB, V77, P3715, DOI 10.1128/AEM.02831-10.
   Jang J, 2013, ENVIRON SCI TECHNOL, V47, P1128, DOI 10.1021/es303577u.
   KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355.
   Laube H, 2014, VET MICROBIOL, V172, P519, DOI 10.1016/j.vetmic.2014.06.008.
   Li S, 2013, AEROBIOLOGIA, V29, P315, DOI 10.1007/s10453-012-9273-z.
   Liu BT, 2014, MICROB DRUG RESIST, V20, P641, DOI 10.1089/mdr.2014.0022.
   Lu SY, 2010, APPL ENVIRON MICROB, V76, P5972, DOI 10.1128/AEM.00711-10.
   Malloy AMW, 2011, PEDIATR INFECT DIS J, V30, P1092, DOI 10.1097/INF.0b013e31823c0e9d.
   Monstein HJ, 2007, APMIS, V115, P1400, DOI 10.1111/j.1600-0463.2007.00722.x.
   Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334.
   Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005.
   Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0.
   Poeta P, 2010, ZOONOSES PUBLIC HLTH, V57, P162, DOI 10.1111/j.1863-2378.2008.01221.x.
   Reinthaler FF, 2010, WATER RES, V44, P1981, DOI 10.1016/j.watres.2009.11.052.
   Smet A, 2010, FEMS MICROBIOL REV, V34, P295, DOI 10.1111/j.1574-6976.2009.00198.x.
   Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412.
   Yuan W, 2010, SCI TOTAL ENVIRON, V408, P1446, DOI 10.1016/j.scitotenv.2009.12.019.
   Zheng HQ, 2012, INT J ANTIMICROB AG, V39, P305, DOI 10.1016/j.ijantimicag.2011.12.001.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{10}},
Usage-Count-Last-180-days = {{5}},
Usage-Count-Since-2013 = {{19}},
Journal-ISO = {{Int. J. Environ. Res. Public Health}},
Doc-Delivery-Number = {{CG7MT}},
Unique-ID = {{ISI:000353488500051}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000353184300010,
Author = {Cegelski, Lynette},
Title = {{Bottom-up and top-down solid-state NMR approaches for bacterial biofilm
   matrix composition}},
Journal = {{JOURNAL OF MAGNETIC RESONANCE}},
Year = {{2015}},
Volume = {{253}},
Number = {{SI}},
Pages = {{91-97}},
Month = {{APR}},
Abstract = {{The genomics and proteomics revolutions have been enormously successful
   in providing crucial ``parts lists{''} for biological systems. Yet,
   formidable challenges exist in generating complete descriptions of how
   the parts function and assemble into macromolecular complexes and
   whole-cell assemblies. Bacterial biofilms are complex multicellular
   bacterial communities protected by a slime-like extracellular matrix
   that confers protection to environmental stress and enhances resistance
   to antibiotics and host defenses. As a non-crystalline, insoluble,
   heterogeneous assembly, the biofilm extracellular matrix poses a
   challenge to compositional analysis by conventional methods. In this
   perspective, bottom-up and topdown solid-state NMR approaches are
   described for defining chemical composition in complex macrosystems. The
   ``sum-of-the-parts{''} bottom-up approach was introduced to examine the
   amyloid-integrated biofilms formed by Escherichia coli and permitted the
   first determination of the composition of the intact extracellular
   matrix from a bacterial biofilm. An alternative top-down approach was
   developed to define composition in Vibrio cholerae biofilms and relied
   on an extensive panel of NMR measurements to tease out specific carbon
   pools from a single sample of the intact extracellular matrix. These two
   approaches are widely applicable to other heterogeneous assemblies. For
   bacterial biofilms, quantitative parameters of matrix composition are
   needed to understand how biofilms are assembled, to improve the
   development of biofilm inhibitors, and to dissect inhibitor modes of
   action. Solid-state NMR approaches will also be invaluable in obtaining
   parameters of matrix architecture. (C) 2015 Elsevier Inc. All rights
   reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Cegelski, L (Reprint Author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.
   Stanford Univ, Dept Chem, Stanford, CA 94305 USA.}},
DOI = {{10.1016/j.jmr.2015.01.014}},
ISSN = {{1090-7807}},
EISSN = {{1096-0856}},
Keywords = {{Bacterial biofilms; Extracellular matrix; Solid-state NMR; CPMAS; REDOR;
   E. coli; V. cholerae}},
Keywords-Plus = {{3-DIMENSIONAL FOURIER SYNTHESIS; RUGOSE COLONY MORPHOLOGY;
   OUTER-MEMBRANE VESICLES; AIR-LIQUID INTERFACE; ESCHERICHIA-COLI;
   VIBRIO-CHOLERAE; EXTRACELLULAR-MATRIX; AMYLOID BIOGENESIS;
   MASS-SPECTROMETRY; IDENTIFICATION}},
Research-Areas = {{Biochemistry \& Molecular Biology; Physics; Spectroscopy}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Physics, Atomic, Molecular \& Chemical;
   Spectroscopy}},
Author-Email = {{cegelski@stanford.edu}},
Funding-Acknowledgement = {{NIH Director's New Innovator Award; Stanford University; Stanford Terman
   Fellowship}},
Funding-Text = {{Electron microscopy images in Fig. 1B and C were kindly provided by Dr.
   Ji Youn Lim, and assistance from the Stanford Cell Sciences Imaging
   Facility is acknowledged. L.C. gratefully acknowledges support from the
   NIH Director's New Innovator Award, Stanford University, and the
   Stanford Terman Fellowship.}},
Cited-References = {{Allison DG, 2003, BIOFOULING, V19, P139, DOI 10.1080/0892701031000072190.
   Altindis E, 2014, P NATL ACAD SCI USA, V111, pE1548, DOI 10.1073/pnas.1403683111.
   Beloin C, 2008, CURR TOP MICROBIOL, V322, P249.
   Berk V, 2012, SCIENCE, V337, P236, DOI 10.1126/science.1222981.
   BLOCH F, 1946, PHYS REV, V70, P474, DOI 10.1103/PhysRev.70.474.
   Cegelski L, 2009, ENCY MICROBIOLOGY, P1.
   Cegelski L, 2009, NAT CHEM BIOL, V5, P913, DOI 10.1038/nchembio.242.
   Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484.
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318.
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002.
   Duperthuy M., 2013, PLOS PATHOG, V9.
   Fang JS, 2014, CURR OPIN MICROBIOL, V19, P120, DOI 10.1016/j.mib.2014.06.014.
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415.
   Fong JCN, 2006, J BACTERIOL, V188, P1049, DOI 10.1128/JB.188.3.1049-1059.2006.
   Fong JCN, 2007, J BACTERIOL, V189, P2319, DOI 10.1128/JB.01569-06.
   Fong JCN, 2010, MICROBIOL-SGM, V156, P2757, DOI 10.1099/mic.0.040196-0.
   GULLION T, 1989, J MAGN RESON, V81, P196, DOI 10.1016/0022-2364(89)90280-1.
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821.
   Hollenbeck Emily C., 2014, BIOPHYS J, V107, P2245.
   Jiao YQ, 2010, APPL ENVIRON MICROB, V76, P2916, DOI 10.1128/AEM.02289-09.
   Karunakaran E, 2011, APPL MICROBIOL BIOT, V90, P1869, DOI 10.1007/s00253-011-3293-4.
   KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0.
   Leitner DR, 2013, INFECT IMMUN, V81, P2379, DOI 10.1128/IAI.01382-12.
   Lim JY, 2012, APPL ENVIRON MICROB, V78, P3369, DOI 10.1128/AEM.07743-11.
   Lim Y., 2014, BIOCHEM BIOPH RES CO, V443, P345.
   McCrate OA, 2013, J MOL BIOL, V425, P4286, DOI 10.1016/j.jmb.2013.06.022.
   OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0.
   PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0.
   PURCELL EM, 1946, PHYS REV, V69, P37, DOI 10.1103/PhysRev.69.37.
   Reichhardt C, 2015, BBA-BIOMEMBRANES, V1848, P378, DOI 10.1016/j.bbamem.2014.05.030.
   Reichhardt C, 2014, MOL PHYS, V112, P887, DOI 10.1080/00268976.2013.837983.
   Romling U, 2003, INT J MED MICROBIOL, V293, P273, DOI 10.1078/1438-4221-00268.
   Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3.
   Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000.
   Watrous JD, 2011, NAT REV MICROBIOL, V9, P683, DOI 10.1038/nrmicro2634.
   Wu C, 2013, LANGMUIR, V29, P920, DOI 10.1021/la304710k.
   Wu C, 2012, BIOPHYS J, V103, P464, DOI 10.1016/j.bpj.2012.06.049.
   Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028.
   Zhang B, 2012, FUTURE MED CHEM, V4, P1764.
   Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{9}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{29}},
Journal-ISO = {{J. Magn. Reson.}},
Doc-Delivery-Number = {{CG3MM}},
Unique-ID = {{ISI:000353184300010}},
OA = {{green\_accepted}},
DA = {{2018-08-13}},
}

@article{ ISI:000352168000019,
Author = {McEachran, Andrew D. and Blackwell, Brett R. and Hanson, J. Delton and
   Wooten, Kimberly J. and Mayer, Gregory D. and Cox, Stephen B. and Smith,
   Philip N.},
Title = {{Antibiotics, Bacteria, and Antibiotic Resistance Genes: Aerial Transport
   from Cattle Feed Yards via Particulate Matter}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2015}},
Volume = {{123}},
Number = {{4}},
Pages = {{337-343}},
Month = {{APR}},
Abstract = {{Background: Emergence and spread of antibiotic resistance has become a
   global health threat and is often linked with overuse and misuse of
   clinical and veterinary chemotherapeutic agents. Modern industrial-scale
   animal feeding operations rely extensively on veterinary
   pharmaceuticals, including antibiotics, to augment animal growth.
   Following excretion, antibiotics are transported through the environment
   via runoff, leaching, and land application of manure; however, airborne
   transport from feed yards has not been characterized.
   Objectives: The goal of this study was to determine the extent to which
   antibiotics, antibiotic resistance genes (ARG), and ruminant-associated
   microbes are aerially dispersed via particulate matter (PM) derived from
   large-scale beef cattle feed yards.
   Methods: PM was collected downwind and upwind of 10 beef cattle feed
   yards. After extraction from PM, five veterinary anti-biotics were
   quantified via high-performance liquid chromatography with tandem mass
   spectrometry, ARG were quantified via targeted quantitative polymerase
   chain reaction, and microbial community diversity was analyzed via 16S
   rRNA amplification and sequencing.
   Results: Airborne PM derived from feed yards facilitated dispersal of
   several veterinary antibiotics, as well as microbial communities
   containing ARG. Concentrations of several antibiotics in airborne PM
   immediately downwind of feed yards ranged from 0.5 to 4.6 mu g/g of PM.
   Microbial communities of PM collected downwind of feed yards were
   enriched with ruminant-associated taxa and were distinct when compared
   to upwind PM assemblages. Furthermore, genes encoding resistance to
   tetracycline antibiotics were significantly more abundant in PM
   collected downwind of feed yards as compared to upwind.
   Conclusions: Wind-dispersed PM from feed yards harbors antibiotics,
   bacteria, and ARGs.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Smith, PN (Reprint Author), Texas Tech Univ, Dept Environm Toxicol, Box 41163, Lubbock, TX 79409 USA.
   McEachran, Andrew D.; Blackwell, Brett R.; Wooten, Kimberly J.; Mayer, Gregory D.; Smith, Philip N., Texas Tech Univ, Dept Environm Toxicol, Lubbock, TX 79409 USA.
   Hanson, J. Delton; Cox, Stephen B., Res \& Testing Lab, Lubbock, TX USA.}},
DOI = {{10.1289/ehp.1408555}},
ISSN = {{0091-6765}},
EISSN = {{1552-9924}},
Keywords-Plus = {{PERFORMANCE LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; SOLID-PHASE
   EXTRACTION; SOUTHERN HIGH-PLAINS; HUMAN HEALTH; VETERINARY ANTIBIOTICS;
   UPPER ATMOSPHERE; NORTH-AMERICA; MANURE; TETRACYCLINE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology}},
Author-Email = {{phil.smith@ttu.edu}},
ResearcherID-Numbers = {{Mayer, Gregory/A-8459-2017
   }},
ORCID-Numbers = {{Mayer, Gregory/0000-0002-2652-9856
   Smith, Philip/0000-0002-7557-7563
   Blackwell, Brett/0000-0003-1296-4539
   McEachran, Andrew/0000-0003-1423-330X}},
Funding-Acknowledgement = {{Texas Tech University College of Arts and Sciences; AT\&T Chancellor's
   Fellowship (Texas Tech University)}},
Funding-Text = {{This research was supported by a grant from the Texas Tech University
   College of Arts and Sciences to P.N.S., G.D.M., and S.B.C. (Next-Gen
   Sequencing Enhancement); and by the AT\&T Chancellor's Fellowship (Texas
   Tech University) to A.D.M.}},
Cited-References = {{Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084{[}0511:CAOPCA]2.0.CO;2.
   Aust MO, 2008, ENVIRON POLLUT, V156, P1243, DOI 10.1016/j.envpol.2008.03.011.
   Bonifacio HF, 2012, J AIR WASTE MANAGE, V62, P350, DOI 10.1080/10473289.2011.651557.
   Boxall ABA, 2006, J AGR FOOD CHEM, V54, P2288, DOI 10.1021/jf053041t.
   Chee-Sanford JC, 2009, J ENVIRON QUAL, V38, P1086, DOI 10.2134/jeq2008.0128.
   Christian T, 2003, ACTA HYDROCH HYDROB, V31, P36, DOI 10.1002/aheh.200390014.
   Cole N. A., 2008, Professional Animal Scientist, V24, P1.
   DONOHO AL, 1984, J ANIM SCI, V58, P1528.
   Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-125.
   Dungan RS, 2010, J ANIM SCI, V88, P3693, DOI 10.2527/jas.2010-3094.
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381.
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461.
   Franzetti A, 2010, APPL MICROBIOL BIOT, V90, P745.
   FULTON JD, 1966, APPL MICROBIOL, V14, P245.
   FULTON JD, 1966, APPL MICROBIOL, V14, P237.
   Galyean M. L., 2011, Animal Frontiers, V1, P29.
   Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837.
   Griffin D.W., 2001, GLOBAL CHANGE HUMAN, V2, P20, DOI DOI 10.1023/A:1011910224374.
   Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06.
   Hamscher G, 2003, ENVIRON HEALTH PERSP, V111, P1590, DOI 10.1289/ehp.6288.
   Hamscher G, 2002, ANAL CHEM, V74, P1509, DOI 10.1021/ac015588m.
   Hiranuma N, 2011, ATMOS CHEM PHYS, V11, P8809, DOI 10.5194/acp-11-8809-2011.
   Hirsch R, 1998, J CHROMATOGR A, V815, P213, DOI 10.1016/S0021-9673(98)00335-5.
   Jones AM, 2004, SCI TOTAL ENVIRON, V326, P151, DOI 10.1016/j.scitotenv.2003.11.021.
   Kemper N, 2008, ECOL INDIC, V8, P1, DOI 10.1016/j.ecolind.2007.06.002.
   Khan SJ, 2008, ENVIRON INT, V34, P839, DOI 10.1016/j.envint.2007.10.007.
   Kim SC, 2007, ANAL BIOANAL CHEM, V387, P1301, DOI 10.1007/s00216-006-0613-0.
   Kim SC, 2006, WATER RES, V40, P2549, DOI 10.1016/j.watres.2006.04.036.
   Kuhne M, 2000, J VET MED A, V47, P379, DOI 10.1046/j.1439-0442.2000.00300.x.
   Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145.
   Lindsey ME, 2001, ANAL CHEM, V73, P4640, DOI 10.1021/ac010514w.
   Loke ML, 2000, CHEMOSPHERE, V40, P759, DOI 10.1016/S0045-6535(99)00450-6.
   Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371.
   Luo WH, 2000, J AOAC INT, V83, P20.
   McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139.
   McGinn SM, 2010, J ENVIRON QUAL, V39, P791, DOI 10.2134/jeq2009.0240.
   Mellon M., 2001, HOGGING IT ESTIMATES.
   NASS (National Agricultural Statistics Service), 2013, CATTL ON FEED FEBR 2.
   NASS (National Agricultural Statistics Service), 2014, CATTL ON FEED MARCH.
   ORGILL MM, 1976, ATMOS ENVIRON, V10, P813, DOI 10.1016/0004-6981(76)90136-0.
   Ouwerkerk D, 2001, ANAEROBE, V7, P59, DOI 10.1006/anae.2001.0373.
   Parnell SE, 1994, THESIS TEXAS A M U C.
   Peak N, 2007, ENVIRON MICROBIOL, V9, P143, DOI 10.1111/j.1462-2920.2006.01123.x.
   Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017.
   Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483.
   Purdy CW, 2007, AEROSOL SCI TECH, V41, P497, DOI 10.1080/02786820701225838.
   Research and Testing Laboratory, 2014, DAT AN METH.
   Rice WC, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-25.
   Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026.
   Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601.
   Shuford JA, 2005, REV MED MICROBIOL, V16, P17.
   Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904.
   Smith MS, 2004, APPL ENVIRON MICROB, V70, P7372, DOI 10.1128/AEM.70.12.7372-7377.2004.
   Stout JE, 2001, J ARID ENVIRON, V47, P425, DOI 10.1006/jare.2000.0732.
   Sweeten JM, 1998, T ASAE, V41, P1477.
   Von Essen Susanna G, 2005, J Agromedicine, V10, P55, DOI 10.1300/J096v10n04\_08.
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07.
   Wegener HC, 2003, CURR OPIN MICROBIOL, V6, P439, DOI 10.1016/j.mib.2003.09.009.
   Wilson SC, 2002, APPL ENVIRON MICROB, V68, P3238, DOI 10.1128/AEM.68.7.3238-3242.2002.
   Wu N, 2010, ENVIRON SCI TECHNOL, V44, P6933, DOI 10.1021/es1007802.
   Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110.}},
Number-of-Cited-References = {{61}},
Times-Cited = {{52}},
Usage-Count-Last-180-days = {{9}},
Usage-Count-Since-2013 = {{129}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{CE9ML}},
Unique-ID = {{ISI:000352168000019}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000351692100001,
Author = {Zumla, A. and Rao, M. and Parida, S. K. and Keshavjee, S. and Cassell,
   G. and Wallis, R. and Axelsson-Robertsson, R. and Doherty, M. and
   Andersson, J. and Maeurer, M.},
Title = {{Inflammation and tuberculosis: host-directed therapies}},
Journal = {{JOURNAL OF INTERNAL MEDICINE}},
Year = {{2015}},
Volume = {{277}},
Number = {{4}},
Pages = {{373-387}},
Month = {{APR}},
Abstract = {{Tuberculosis (TB) is an airborne infectious disease that kills almost
   two million individuals every year. Multidrug-resistant (MDR) TB is
   caused by strains of Mycobacterium tuberculosis (M.tb) resistant to
   isoniazid and rifampin, the backbone of first-line antitubercular
   treatment. MDR TB affects an estimated 500000 new patients annually.
   Genetic analysis of drug-resistant MDR-TB showed that airborne
   transmission of undetected and untreated strains played a major role in
   disease outbreaks. The need for new TB vaccines and faster diagnostics,
   as well as the development of new drugs, has recently been highlighted.
   The major problem in terms of current TB research and clinical demands
   is the increasing number of cases of extensively drug-resistant and
   treatment-refractory' TB. An emerging scenario of adjunct host-directed
   therapies is intended to target pulmonary TB where inflammatory
   processes can be deleterious and lead to immune exhaustion.
   Target-organ-saving' strategies may be warranted to prevent damage to
   infected tissues and achieve focused, clinically relevant and
   long-lasting anti-M.tb cellular immune responses. Candidates for such
   interventions may be biological agents or already approved drugs that
   can be re-purposed' to interfere with biologically relevant cellular
   checkpoints. Here, we review current concepts of inflammation in TB
   disease and discuss candidate pathways for host-directed therapies to
   achieve better clinical outcomes.}},
Publisher = {{WILEY}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Maeurer, M (Reprint Author), Karolinska Univ Hosp Huddinge, TIM, F79 Halsovagen, SE-14186 Stockholm, Sweden.
   Zumla, A., UCL, Univ Coll London Hosp NHS Fdn Trust, London, England.
   Rao, M.; Parida, S. K.; Maeurer, M., Karolinska Inst, Dept Lab Med, Therapeut Immunol TIM, Stockholm, Sweden.
   Keshavjee, S.; Cassell, G., Harvard Univ, Sch Med, Dept Global Hlth \& Social Med, Boston, MA USA.
   Wallis, R., Case Western Reserve Univ, Madison, NJ USA.
   Wallis, R., Univ Med \& Dent New Jersey, Pfizer, Madison, NJ USA.
   Axelsson-Robertsson, R.; Maeurer, M., Karolinska Univ Hosp Huddinge Campus, Ctr Allogene Stem Cell Transplantat CAST, Stockholm, Sweden.
   Axelsson-Robertsson, R., Karolinska Inst, Dept Microbiol Tumor \& Cell Biol MTC, Stockholm, Sweden.
   Doherty, M., GlaxoSmithKline, Copenhagen, Denmark.
   Andersson, J., Karolinska Inst, Dept Med, Stockholm, Sweden.}},
DOI = {{10.1111/joim.12256}},
ISSN = {{0954-6820}},
EISSN = {{1365-2796}},
Keywords = {{drug-resistant tuberculosis; host-directed therapy; inflammation; M;
   tuberculosis; multidrug-resistant tuberculosis; tuberculosis}},
Keywords-Plus = {{HISTONE DEACETYLASE INHIBITORS; DRUG-RESISTANT TUBERCULOSIS;
   SYSTEMIC-LUPUS-ERYTHEMATOSUS; T-CELL RESPONSES;
   MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; IFN-GAMMA; ACTIVE
   TUBERCULOSIS; ADJUNCTIVE THERAPY; NLRP3 INFLAMMASOME}},
Research-Areas = {{General \& Internal Medicine}},
Web-of-Science-Categories  = {{Medicine, General \& Internal}},
Author-Email = {{markus.maeurer@ki.se}},
ORCID-Numbers = {{Zumla, Alimuddin/0000-0002-5111-5735
   Parida, Shreemanta K/0000-0003-2129-6691
   Maeurer, Markus/0000-0002-8436-8077}},
Funding-Acknowledgement = {{HLF, Sweden; Vinnova, Sweden; VR, Sweden; SIDA, Sweden; EDCTP (TBNeat);
   UK Medical Research Council; European Union 7th Framework project
   Rid-RTI; European Developing Countries Clinical Trials Partnership
   (EDCTP); UBS Optimus Foundation, Switzerland; NIHR Biomedical Research
   Centre, University College Hospitals, London, UK}},
Funding-Text = {{This work was funded by HLF, Vinnova, VR, SIDA, Sweden and EDCTP
   (TBNeat) (to MM), and the UK Medical Research Council, European Union
   7th Framework project Rid-RTI, European Developing Countries Clinical
   Trials Partnership (EDCTP), UBS Optimus Foundation, Switzerland, and the
   NIHR Biomedical Research Centre, University College Hospitals, London,
   UK (to AZ).}},
Cited-References = {{Archin NM, 2009, AIDS, V23, P1799, DOI 10.1097/QAD.0b013e32832ec1dc.
   Ashenafi S, 2013, THORAX, V68, P269, DOI 10.1136/thoraxjnl-2012-201817.
   Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081.
   Austin JF, 2004, INT J TUBERC LUNG D, V8, P435.
   Axelsson-Robertson R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058309.
   Axelsson-Robertson R, 2012, J INFECT DIS, V205, pS301, DOI 10.1093/infdis/jis198.
   Azzurri A, 2006, INT J IMMUNOPATH PH, V19, P199.
   Bang D, 2010, INT J TUBERC LUNG D, V14, P447.
   Barnes PF, 2003, AM J RESP CRIT CARE, V168, P142, DOI 10.1164/rccm.2305001.
   Basile JI, 2011, J INFECT DIS, V204, P1054, DOI 10.1093/infdis/jir460.
   Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3.
   Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070.
   Bermudez LE, 1996, INFECT IMMUN, V64, P1400.
   Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247.
   Bilaceroglu S, 1999, INT J TUBERC LUNG D, V3, P47.
   Bradfute SB, 2013, CURR OPIN MICROBIOL, V16, P355, DOI 10.1016/j.mib.2013.05.003.
   Briken V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00062.
   Brodin P, 2013, EXPERT REV CLIN IMMU, V9, P307, DOI {[}10.1586/eci.13.9, 10.1586/ECI.13.9].
   Brooks JV, 1999, ANTIMICROB AGENTS CH, V43, P1285.
   Byrne ST, 2007, ANTIMICROB AGENTS CH, V51, P794, DOI 10.1128/AAC.01145-06.
   Castillo EF, 2012, P NATL ACAD SCI USA, V109, pE3168, DOI 10.1073/pnas.1210500109.
   Chiu YW, 2012, INFORM HEALTH SOC CA, V37, P230, DOI 10.3109/17538157.2012.654842.
   Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI {[}10.1056/NEJMc1303158, 10.1056/NEJMra1205406].
   Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499.
   Coetzee WA, 2013, PHARMACOL THERAPEUT, V140, P167, DOI 10.1016/j.pharmthera.2013.06.007.
   Corral LG, 1996, MOL MED, V2, P506.
   Critchley JA, 2013, LANCET INFECT DIS, V13, P223, DOI 10.1016/S1473-3099(12)70321-3.
   Cross AH, 2012, THER ADV NEUROL DISO, V5, P311, DOI 10.1177/1756285612461165.
   Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265.
   Das B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004912.
   Desai C R, 1989, J Assoc Physicians India, V37, P694.
   Dey T, 2013, J ANTIMICROB CHEMOTH, V68, P284, DOI 10.1093/jac/dks389.
   Diel R, 2014, EUR RESPIR J, V43, P554, DOI 10.1183/09031936.00079413.
   Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678.
   Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741.
   Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548.
   Dorhoi A, 2010, J EXP MED, V207, P777, DOI 10.1084/jem.20090067.
   Dowdell KC, 2009, EXP HEMATOL, V37, P487, DOI 10.1016/j.exphem.2008.12.002.
   Dranoff G, 2013, NAT MED, V19, P1100, DOI 10.1038/nm.3335.
   Eichelmann K, 2013, ACTAS DERMO-SIFILOGR, V104, P554, DOI {[}10.1016/j.ad.2012.03.003, 10.1016/j.adengl.2012.03.028].
   Eilertsen GO, 2011, RHEUMATOLOGY, V50, P2197, DOI 10.1093/rheumatology/ker282.
   Fu J, 2010, NEURO-ONCOLOGY, V12, P328, DOI 10.1093/neuonc/nop005.
   Fukutomi Y, 2011, ANTIMICROB AGENTS CH, V55, P4000, DOI 10.1128/AAC.00434-11.
   Gaseitsiwe S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003840.
   Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x.
   Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6.
   Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777.
   Gomes MGM, 2012, P ROY SOC B-BIOL SCI, V279, P2473, DOI 10.1098/rspb.2011.2712.
   Gomes MGM, 2004, P ROY SOC B-BIOL SCI, V271, P617, DOI 10.1098/rspb.2003.2606.
   Grahmann PR, 2008, INT J TUBERC LUNG D, V12, P636.
   Grosset JH, 2013, AM J RESP CRIT CARE, V188, P608, DOI 10.1164/rccm.201304-0753OC.
   Gupta S, 2014, ANTIMICROB AGENTS CH, V58, P574, DOI 10.1128/AAC.01462-13.
   Gupta S, 2013, AM J RESP CRIT CARE, V188, P600, DOI 10.1164/rccm.201304-0650OC.
   Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133.
   Han BR, 2013, ONCOL REP, V30, P2999, DOI 10.3892/or.2013.2747.
   Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299.
   Henter JI, 2010, LANCET, V376, P2116, DOI 10.1016/S0140-6736(10)61345-1.
   Hideshima T, 2013, INT J HEMATOL, V97, P324, DOI 10.1007/s12185-013-1290-3.
   Hoal EG, 2004, INT J TUBERC LUNG D, V8, P1464.
   Hogdal LJ, 2013, CELL STEM CELL, V12, P269, DOI 10.1016/j.stem.2013.02.006.
   Jacobsen M, 2011, CLIN MICROBIOL INFEC, V17, P1323, DOI 10.1111/j.1469-0691.2010.03326.x.
   Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-10810C.
   Johnson BJ, 1997, TUBERCLE LUNG DIS, V78, P195, DOI 10.1016/S0962-8479(97)90026-5.
   Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449.
   Kumar D, 2011, MICROBES INFECT, V13, P121, DOI 10.1016/j.micinf.2010.10.009.
   Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013.
   Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559.
   Lawn SD, 2011, EXPERT REV ANTI-INFE, V9, P415, DOI {[}10.1586/eri.11.21, 10.1586/ERI.11.21].
   LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0.
   Lin PL, 2012, P NATL ACAD SCI USA, V109, P14188, DOI 10.1073/pnas.1121497109.
   Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856.
   Liu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038429.
   Maeurer MJ, 2000, INFECT IMMUN, V68, P2962, DOI 10.1128/IAI.68.5.2962-2970.2000.
   Magalhaes I, 2010, IMMUNOLOGY, V131, P128, DOI 10.1111/j.1365-2567.2010.03284.x.
   Manca C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074082.
   Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X.
   Marais BJ, 2013, LANCET INFECT DIS, V13, P287, DOI 10.1016/S1473-3099(13)70031-8.
   Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185.
   Marks PA, 2004, ADV CANCER RES, V91, P137, DOI 10.1016/S0065-230X(04)91004-4.
   Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272.
   Masood KI, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-13.
   Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003.
   Mattos AMM, 2010, INT IMMUNOL, V22, P775, DOI 10.1093/intimm/dxq429.
   Mayanja-Kizza H, 2005, J INFECT DIS, V191, P856, DOI 10.1086/427995.
   Meintjes G, 2012, AM J RESP CRIT CARE, V186, P369, DOI 10.1164/rccm.201201-0094OC.
   Messmer UK, 1996, J BIOL CHEM, V271, P20192, DOI 10.1074/jbc.271.33.20192.
   Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474.
   Misra UK, 2010, J NEUROL SCI, V293, P12, DOI 10.1016/j.jns.2010.03.025.
   Mudenda V, 2012, J INFECT DIS, V205, pS340, DOI 10.1093/infdis/jir859.
   Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016.
   MUTHUSWAMY P, 1995, CHEST, V107, P1621, DOI 10.1378/chest.107.6.1621.
   Napier RJ, 2011, CELL HOST MICROBE, V10, P475, DOI 10.1016/j.chom.2011.09.010.
   Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043.
   Omar H, 2011, J IMMUNOTHER, V34, P390, DOI 10.1097/CJI.0b013e318215e31b.
   Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006.
   Rane L, 2011, GENES IMMUN, V12, P513, DOI 10.1038/gene.2011.29.
   Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335.
   Rasmussen TA, 2013, HUM VACC IMMUNOTHER, V9, P790, DOI 10.4161/hv.23202.
   Schleicher GK, 2005, EUR RESPIR J, V25, P688, DOI 10.1183/09031936.05.00067604.
   Seitzer U, 2001, IMMUNOLOGY, V104, P269, DOI 10.1046/j.1365-2567.2001.01323.x.
   Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9.
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110.
   Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014.
   Shirakawa K, 2013, TRENDS MICROBIOL, V21, P277, DOI 10.1016/j.tim.2013.02.005.
   Siawaya JFD, 2008, J INFECTION, V56, P340, DOI 10.1016/j.jinf.2008.02.007.
   Skrahin A, 2014, LANCET RESP MED, V2, P108, DOI 10.1016/S2213-2600(13)70234-0.
   Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5.
   Spellberg B, 2013, NEW ENGL J MED, V368, P299, DOI 10.1056/NEJMp1215093.
   Sutherland JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025230.
   Sutherland JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012365.
   Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x.
   Tobin DM, 2013, CURR OPIN PHARMACOL, V13, P641, DOI 10.1016/j.coph.2013.06.007.
   Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023.
   Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013.
   Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004.
   TRAMONTANA JM, 1995, MOL MED, V1, P384.
   Tsenova L, 2002, ANTIMICROB AGENTS CH, V46, P1887, DOI 10.1128/AAC.46.6.1887-1895.2002.
   Uhlin M, 2012, J INFECT DIS, V205, pS325, DOI 10.1093/infdis/jis197.
   Valentini D, 2010, TRENDS IMMUNOL, V31, P399, DOI 10.1016/j.it.2010.08.007.
   Veenstra H, 2007, CLIN IMMUNOL, V124, P336, DOI 10.1016/j.clim.2007.05.014.
   Verway M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003407.
   Vilaplana C, 2013, J INFECT DIS, V208, P199, DOI 10.1093/infdis/jit152.
   Vladimer GI, 2013, CURR OPIN MICROBIOL, V16, P23, DOI 10.1016/j.mib.2012.11.008.
   Vudattu NK, 2009, GENES IMMUN, V10, P132, DOI 10.1038/gene.2008.90.
   Vudattu NK, 2007, INT J CANCER, V121, P1512, DOI 10.1002/ijc.22854.
   Wallis RS, 2004, AIDS, V18, P257, DOI 10.1097/01.aids.0000104367.21567.d8.
   Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960.
   Wayne LG, 1996, INFECT IMMUN, V64, P2062.
   Whiteside TL, 2010, J ALLERGY CLIN IMMUN, V125, pS272, DOI 10.1016/j.jaci.2009.09.045.
   Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509.
   Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x.
   Yamada G, 2000, AM J RESP CRIT CARE, V161, P1786, DOI 10.1164/ajrccm.161.6.9911054.
   Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199.
   Yew WW, 2005, AM J RESP CRIT CARE, V171, P1324, DOI 10.1164/rccm.2502005.
   Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/01.aids.0000125940.58195.dc.
   Yoo JW, 2013, INT J TUBERC LUNG D, V17, P1243, DOI 10.5588/ijtld.13.0312.
   Zhang JL, 2005, MICROBIOL IMMUNOL, V49, P845, DOI 10.1111/j.1348-0421.2005.tb03673.x.
   Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6.
   Zumla A, 2012, J INFECT DIS, V205, pS335, DOI 10.1093/infdis/jir881.}},
Number-of-Cited-References = {{139}},
Times-Cited = {{31}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{12}},
Journal-ISO = {{J. Intern. Med.}},
Doc-Delivery-Number = {{CE2ZK}},
Unique-ID = {{ISI:000351692100001}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000347581100028,
Author = {Wang, Guangyu and Qian, Wenjuan and Zhang, Xinxiao and Wang, Huhu and
   Ye, Keping and Bai, Yun and Zhou, Guanghong},
Title = {{Prevalence, genetic diversity and antimicrobial resistance of Listeria
   monocytogenes isolated from ready-to-eat meat products in Nanjing, China}},
Journal = {{FOOD CONTROL}},
Year = {{2015}},
Volume = {{50}},
Pages = {{202-208}},
Month = {{APR}},
Abstract = {{The prevalence of Listeria monocytogenes were investigated in a total of
   628 ready-to-eat (RTE) meat products collected from different
   supermarkets and open-air markets in Nanjing, China. All isolates were
   further examined for the serogroup, virulence marker gene, genotype and
   antibiotic resistance. Thirty-three out of 628 samples (5.3\%) were
   positive confirmed by the bacteriological method and PCR including 7.2\%
   (17/236) of sauce pickled products, 4.2\% (11/260) of cured products and
   5.6\% (5/90) of smoked and roasted products. Fifteen isolates (45.5\%)
   belonged to serogroup 1/2a, 3a; 16 (48.5\%) belonged to serogroup 1/2b,
   3b and 2 (6.1\%) belonged to serogroup 1/2c, 3c. All of them were
   positive for the virulence marker genes-lap, inlA, inlC, inlJ and
   lmo2672. Thirty-three isolates were grouped into 11 sequence types (STs)
   by multilocus sequence typing (MLST). The results of the antimicrobial
   susceptibility revealed that the isolates were sensitive to most of the
   antimicrobials used in the study except trimethoprim sulfamethoxazole
   (100\%), chloramphenicol (33.3\%), ciprofloxacin (30.3\%) and
   tetracycline (12.1\%). Our findings indicated high prevalence of L
   monocytogenes especially in sauce pickled products and from open-air
   markets, high prevalence of serogroups 1/2a, 3a and 1/2b, 3b that
   involved in the majority of foodborne outbreaks could be a public health
   concern. In addition, resistance of the isolates to the antimicrobials
   was also a potential health hazard for consumers. (C) 2014 Published by
   Elsevier Ltd.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Zhou, GH (Reprint Author), Nanjing Agr Univ, Coll Food Sci \& Technol, Minist Educ \& Finance, Key Lab Meat Proc \& Qual Control,Minist Educ,Coll, Nanjing 210095, Jiangsu, Peoples R China.
   Wang, Guangyu; Qian, Wenjuan; Zhang, Xinxiao; Wang, Huhu; Ye, Keping; Bai, Yun; Zhou, Guanghong, Nanjing Agr Univ, Coll Food Sci \& Technol, Minist Educ \& Finance, Key Lab Meat Proc \& Qual Control,Minist Educ,Coll, Nanjing 210095, Jiangsu, Peoples R China.}},
DOI = {{10.1016/j.foodcont.2014.07.057}},
ISSN = {{0956-7135}},
EISSN = {{1873-7129}},
Keywords = {{Listeria monocytogenes; Ready-to-eat meat products; MLST; Antimicrobial
   resistance}},
Keywords-Plus = {{FOOD-PRODUCTS; PROCESSING ENVIRONMENTS; ANTIBIOTIC-RESISTANCE; MULTIPLEX
   PCR; VIRULENCE; SUSCEPTIBILITY; CONTAMINATION; STRAINS; SPP.; POULTRY}},
Research-Areas = {{Food Science \& Technology}},
Web-of-Science-Categories  = {{Food Science \& Technology}},
Author-Email = {{ghzhou@njau.edu.cn}},
ORCID-Numbers = {{Wang, Huhu/0000-0003-1688-7948}},
Funding-Acknowledgement = {{National ``Twelfth Five-Year{''} Plan for Science and Technology of
   China {[}2012BAD28B02-03]; Science and Technology Innovation Foundation
   of College of Food Science and Technology {[}80900225]}},
Funding-Text = {{We are very grateful to Prof. Ron Tume from CSIRO, Animal, Food and
   Health Sciences, Australia for his valuable advice and for assistance
   with language. This work was supported by National ``Twelfth
   Five-Year{''} Plan for Science and Technology of China (grant no.
   2012BAD28B02-03) and Science and Technology Innovation Foundation of
   College of Food Science and Technology (grant no. 80900225).}},
Cited-References = {{Acciari VA, 2011, VET ITAL, V47, P15.
   Arslan S, 2008, FOOD CONTROL, V19, P360, DOI 10.1016/j.foodcont.2007.04.009.
   Baek SY, 2000, J FOOD PROTECT, V63, P186, DOI 10.4315/0362-028X-63.2.186.
   Charpentier E, 1999, ANTIMICROB AGENTS CH, V43, P2103.
   Chen MT, 2014, FOOD CONTROL, V38, P1, DOI 10.1016/j.foodcont.2013.09.061.
   Chenal-Francisque V, 2011, EMERG INFECT DIS, V17, P1110, DOI {[}10.3201/eid1706.101778, 10.3201/eid/1706.101778].
   Clinical and Laboratory Standards Institute (CLSI), 2011, M2A9 CLSI.
   Conter M, 2009, INT J FOOD MICROBIOL, V128, P497, DOI 10.1016/j.ijfoodmicro.2008.10.018.
   Cooper JE, 2004, TRENDS MICROBIOL, V12, P373, DOI 10.1016/j.tim.2004.06.003.
   Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI {[}10.1128/JCM.42.8.3819-3822.2004, 10.1128/JCM.42.3819-3822.2004].
   Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1.
   Fallah AA, 2012, FOOD CONTROL, V28, P327, DOI 10.1016/j.foodcont.2012.05.014.
   FARBER JM, 1991, MICROBIOL REV, V55, P476.
   Filiousis G, 2009, FOOD CONTROL, V20, P314, DOI 10.1016/j.foodcont.2008.05.018.
   FURRER B, 1991, J APPL BACTERIOL, V70, P372, DOI 10.1111/j.1365-2672.1991.tb02951.x.
   GAILLARD JL, 1986, INFECT IMMUN, V52, P50.
   Gandhi M, 2007, INT J FOOD MICROBIOL, V113, P1, DOI 10.1016/j.ijfoodmicro.2006.07.008.
   Gottlieb SL, 2006, CLIN INFECT DIS, V42, P29, DOI 10.1086/498113.
   Granier SA, 2011, APPL ENVIRON MICROB, V77, P2788, DOI 10.1128/AEM.01381-10.
   Graves L. M., 2007, FOOD SCI TECHNOLOGY, V161, P283.
   Hansen CH, 2006, J FOOD PROTECT, V69, P2113, DOI 10.4315/0362-028X-69.9.2113.
   Harakeh S, 2009, SCI TOTAL ENVIRON, V407, P4022, DOI 10.1016/j.scitotenv.2009.04.010.
   Indrawattana N, 2011, J HEALTH POPUL NUTR, V29, P26.
   Jalali M, 2008, INT J FOOD MICROBIOL, V122, P336, DOI 10.1016/j.ijfoodmicro.2007.11.082.
   Jamali H, 2013, FOOD CONTROL, V34, P121, DOI 10.1016/j.foodcont.2013.04.023.
   Jiang LL, 2008, INT J FOOD MICROBIOL, V121, P53, DOI 10.1016/j.ijfoodmicro.2007.10.007.
   Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230.
   Jorgensen LV, 1998, INT J FOOD MICROBIOL, V42, P127, DOI 10.1016/S0168-1605(98)00071-3.
   Kramarenko T, 2013, FOOD CONTROL, V30, P24, DOI 10.1016/j.foodcont.2012.06.047.
   Liu D, 2007, J MICROBIOL METH, V71, P133, DOI 10.1016/j.mimet.2007.08.007.
   Liu DY, 2003, J MED MICROBIOL, V52, P1065, DOI 10.1099/jmm.0.05358-0.
   Lomonaco S, 2012, INT J FOOD MICROBIOL, V160, P76, DOI 10.1016/j.ijfoodmicro.2012.09.011.
   Loura CAC, 2005, J FOOD SAFETY, V25, P19, DOI 10.1111/j.0149-6085.2005.25551.x.
   Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140.
   Mayrhofer S, 2004, INT J FOOD MICROBIOL, V97, P23, DOI 10.1016/j.ijfoodmicro.2004.04.006.
   Mena C, 2004, FOOD MICROBIOL, V21, P213, DOI 10.1016/S0740-0020(03)00057-1.
   O'Connor L, 2010, LETT APPL MICROBIOL, V51, P490, DOI 10.1111/j.1472-765X.2010.02928.x.
   Osaili TM, 2011, FOOD CONTROL, V22, P586, DOI 10.1016/j.foodcont.2010.10.008.
   Painter J., 2007, LISTERIA LISTERIOSIS, V85.
   Parihar VS, 2008, FOODBORNE PATHOG DIS, V5, P755, DOI 10.1089/fpd.2008.0123.
   Porog-Gluchowska J. O. A. N. N. A., 2003, POLSKIE TOWARZYSTWO, V52, P113.
   Prencipe VA, 2012, FOOD CONTROL, V25, P150, DOI 10.1016/j.foodcont.2011.10.018.
   Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146.
   Rahimi E, 2010, FOOD CONTROL, V21, P1448, DOI 10.1016/j.foodcont.2010.03.014.
   Revazishvili T, 2004, J CLIN MICROBIOL, V42, P276, DOI 10.1128/JCM.42.1.276-285.2004.
   Rouquette Corinne, 1996, Microbiologia (Madrid), V12, P245.
   Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17.
   Salcedo C, 2003, J CLIN MICROBIOL, V41, P757, DOI 10.1128/JCM.41.2.757-762.2003.
   Samelis J, 1999, FOOD MICROBIOL, V16, P465, DOI 10.1006/fmic.1998.0263.
   Samelis J, 2002, J FOOD PROTECT, V65, P299, DOI 10.4315/0362-028X-65.2.299.
   Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x.
   Stonsaovapak S, 2010, J FOOD SAFETY, V30, P154, DOI 10.1111/j.1745-4565.2009.00197.x.
   Uyttendaele M, 1999, INT J FOOD MICROBIOL, V53, P75, DOI 10.1016/S0168-1605(99)00155-5.
   Vela AI, 2001, INT J ANTIMICROB AG, V17, P215, DOI 10.1016/S0924-8579(00)00318-6.
   Vitas AI, 2004, INT J FOOD MICROBIOL, V90, P349, DOI 10.1016/S0168-1605(03)00314-3.
   Wang HH, 2006, FEMS MICROBIOL LETT, V254, P226, DOI 10.1111/j.1574-6968.2005.00030.x.
   Wang P, 2012, J FOOD SCI, V77, pM212, DOI 10.1111/j.1750-3841.2011.02596.x.
   Wang XM, 2013, FOOD CONTROL, V32, P153, DOI 10.1016/j.foodcont.2012.11.032.
   Warriner K, 2009, TRENDS FOOD SCI TECH, V20, P245, DOI 10.1016/j.tifs.2009.03.008.
   Wieczorek K, 2012, FOODBORNE PATHOG DIS, V9, P681, DOI 10.1089/fpd.2012.1137.
   Wu SJ, 2004, J MICROBIOL METH, V56, P395, DOI 10.1016/j.mimet.2003.11.005.
   Yan H, 2010, INT J FOOD MICROBIOL, V144, P310, DOI 10.1016/j.ijfoodmicro.2010.10.015.
   {[}杨洋 YANG Yang], 2008, {[}卫生研究, Journal of Hygiene Research], V37, P183.
   Yu T, 2014, FOOD CONTROL, V37, P228, DOI 10.1016/j.foodcont.2013.09.047.
   Yuan Y., 2009, J FOOD SCI, V74, pM446.
   Zhang W, 2004, APPL ENVIRON MICROB, V70, P913, DOI 10.1128/AEM.70.2.913-920.2004.
   Zhang YF, 2007, INT J FOOD MICROBIOL, V113, P47, DOI 10.1016/j.ijfoodmicro.2006.07.010.}},
Number-of-Cited-References = {{67}},
Times-Cited = {{21}},
Usage-Count-Last-180-days = {{6}},
Usage-Count-Since-2013 = {{63}},
Journal-ISO = {{Food Control}},
Doc-Delivery-Number = {{AY4YO}},
Unique-ID = {{ISI:000347581100028}},
DA = {{2018-08-13}},
}

@article{ ISI:000353889600140,
Author = {Le Vee, Marc and Jouan, Elodie and Stieger, Bruno and Lecureur, Valerie
   and Fardel, Olivier},
Title = {{Regulation of Human Hepatic Drug Transporter Activity and Expression by
   Diesel Exhaust Particle Extract}},
Journal = {{PLOS ONE}},
Year = {{2015}},
Volume = {{10}},
Number = {{3}},
Month = {{MAR 24}},
Abstract = {{Diesel exhaust particles (DEPs) are common environmental air pollutants
   primarily affecting the lung. DEPs or chemicals adsorbed on DEPs also
   exert extra-pulmonary effects, including alteration of hepatic drug
   detoxifying enzyme expression. The present study was designed to
   determine whether organic DEP extract (DEPe) may target hepatic drug
   transporters that contribute in a major way to drug detoxification.
   Using primary human hepatocytes and transporter-overexpressing cells,
   DEPe was first shown to strongly inhibit activities of the sinusoidal
   solute carrier (SLC) uptake transporters organic anion-transporting
   polypeptides (OATP) 1B1, 1B3 and 2B1 and of the canalicular ATP-binding
   cassette (ABC) efflux pump multidrug resistance-associated protein 2,
   with IC50 values ranging from approximately 1 to 20 mu g/mL and relevant
   to environmental exposure situations. By contrast, 25 mu g/mL DEPe
   failed to alter activities of the SLC transporter organic cation
   transporter (OCT) 1 and of the ABC efflux pumps P-glycoprotein and bile
   salt export pump (BSEP), whereas it only moderately inhibited those of
   sodium taurocholate co-transporting polypeptide and of breast cancer
   resistance protein (BCRP). Treatment by 25 mu g/mL DEPe was next
   demonstrated to induce expression of BCRP at both mRNA and protein level
   in cultured human hepatic cells, whereas it concomitantly repressed mRNA
   expression of various transporters, including OATP1B3, OATP2B1, OCT1 and
   BSEP. Such changes in transporter expression were found to be highly
   correlated to those caused by 2,3,7,8-tetrachlorodi-benzo-p-dioxin
   (TCDD), a reference activator of the aryl hydrocarbon receptor (AhR)
   pathway. This suggests that DEPe, which is enriched in known ligands of
   AhR like polycyclic aromatic hydrocarbons, alters drug transporter
   expression via activation of the AhR cascade. Taken together, these data
   established human hepatic transporters as targets of organic chemicals
   containing in DEPs, which may contribute to their systemic effects
   through impairing hepatic transport of endogenous compound or drug
   substrates of these transporters.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fardel, O (Reprint Author), Fac Pharm, IRSET, UMR INSERM U1085, 2 Ave Pr Leon Bernard, F-35043 Rennes, France.
   Le Vee, Marc; Jouan, Elodie; Lecureur, Valerie; Fardel, Olivier, Fac Pharm, IRSET, UMR INSERM U1085, F-35043 Rennes, France.
   Stieger, Bruno, Univ Zurich Hosp, Dept Clin Pharmacol \& Toxicol, CH-8091 Zurich, Switzerland.
   Fardel, Olivier, Ctr Hosp Univ, Pole Biol, F-35033 Rennes, France.}},
DOI = {{10.1371/journal.pone.0121232}},
Article-Number = {{e0121232}},
ISSN = {{1932-6203}},
Keywords-Plus = {{ARYL-HYDROCARBON RECEPTOR; BLOOD-BRAIN-BARRIER; PRIMARY HUMAN
   HEPATOCYTES; CANCER RESISTANCE PROTEIN; MULTIDRUG-RESISTANCE; OXIDATIVE
   STRESS; RAT HEPATOCYTES; ORGANIC EXTRACT; GENE-EXPRESSION;
   BILIARY-EXCRETION}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{olivier.fardel@univ-rennes1.fr}},
ResearcherID-Numbers = {{Stieger, Bruno/U-6323-2017
   Fardel, Olivier/J-8560-2015
   LECUREUR, Valerie/J-9095-2015}},
ORCID-Numbers = {{Stieger, Bruno/0000-0002-7190-5785
   }},
Cited-References = {{Annaert PP, 2001, DRUG METAB DISPOS, V29, P1277.
   Antherieu S, 2012, TOXICOL IN VITRO, V26, P1278, DOI 10.1016/j.tiv.2012.05.008.
   Anwer MS, 2014, PFLUG ARCH EUR J PHY, V466, P77, DOI 10.1007/s00424-013-1367-0.
   Bellamy WT, 1996, ANNU REV PHARMACOL, V36, P161, DOI 10.1146/annurev.pa.36.040196.001113.
   Bock KW, 2009, BIOL CHEM, V390, P1225, DOI 10.1515/BC.2009.138.
   Bosquillon C, 2010, J PHARM SCI-US, V99, P2240, DOI 10.1002/jps.21995.
   Boxberger KH, 2014, DRUG METAB DISPOS, V42, P990, DOI 10.1124/dmd.113.055095.
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3.
   Bronger H, 2005, CANCER RES, V65, P11419, DOI 10.1158/0008-5472.CAN-05-1271.
   Chuang HC, 2013, TOXICOL APPL PHARM, V266, P329, DOI 10.1016/j.taap.2012.12.004.
   De Bruyn T, 2013, MOL PHARMACOL, V83, P1257, DOI 10.1124/mol.112.084152.
   De Bruyn T, 2011, J PHARM SCI-US, V100, P5018, DOI 10.1002/jps.22694.
   Doring B, 2014, DRUG METAB REV, V46, P261, DOI 10.3109/03602532.2014.882353.
   DRENOU B, 1993, LEUKEMIA RES, V17, P1031, DOI 10.1016/0145-2126(93)90159-I.
   Ebert B, 2005, CARCINOGENESIS, V26, P1754, DOI 10.1093/carcin/bgi139.
   FARDEL O, 1993, CARCINOGENESIS, V14, P781, DOI 10.1093/carcin/14.4.781.
   Fardel O., 1996, PHARMACOLOGY, V51, P1427.
   Fardel O, 2012, EXPERT OPIN DRUG MET, V8, P29, DOI 10.1517/17425255.2012.637918.
   Fardel O, 2009, EXPERT OPIN DRUG MET, V5, P1469, DOI 10.1517/17425250903304056.
   Fenner KS, 2012, XENOBIOTICA, V42, P28, DOI 10.3109/00498254.2011.626464.
   Funk C, 2008, EXPERT OPIN DRUG MET, V4, P363, DOI 10.1517/17425255.4.4.363 .
   Gerde P, 2001, CARCINOGENESIS, V22, P741, DOI 10.1093/carcin/22.5.741.
   Gouge B, 2010, ENVIRON SCI TECHNOL, V44, P7163, DOI 10.1021/es101391r.
   Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699.
   Gui C, 2008, EUR J PHARMACOL, V584, P57, DOI 10.1016/j.ejphar.2008.01.042.
   Hartz AMS, 2008, FASEB J, V22, P2723, DOI 10.1096/fj.08-106997.
   Hatanaka N, 2001, CARCINOGENESIS, V22, P2033, DOI 10.1093/carcin/22.12.2033.
   Hessel S, 2013, ARCH TOXICOL, V87, P269, DOI 10.1007/s00204-012-0917-0.
   Hesterberg TW, 2012, INHAL TOXICOL, V24, P1, DOI 10.3109/08958378.2012.691913.
   Hooijberg JH, 2004, NUCLEOS NUCLEOT NUCL, V23, P1451, DOI 10.1081/NCN-200027672.
   Huber RD, 2007, AM J PHYSIOL-CELL PH, V292, pC795, DOI 10.1152/ajpcell.00597.2005.
   Hughes TJ, 1997, MUTAT RES-GEN TOX EN, V391, P243, DOI 10.1016/S1383-5718(97)00075-2.
   Izumi S, 2013, DRUG METAB DISPOS, V41, P1859, DOI 10.1124/dmd.113.052290.
   Jacob A, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-23.
   Jigorel E, 2005, DRUG METAB DISPOS, V33, P1418, DOI 10.1124/dmd.105.004762.
   Jigorel E, 2006, DRUG METAB DISPOS, V34, P1756, DOI 10.1124/dmd.106.010033.
   Keppler D, 1999, FREE RADICAL BIO MED, V27, P985, DOI 10.1016/S0891-5849(99)00171-9.
   Konig J, 2011, HANDB EXP PHARMACOL, V201, P1, DOI 10.1007/978-3-642-14541-4\_1.
   Koike E, 2002, TOXICOL SCI, V67, P241, DOI 10.1093/toxsci/67.2.241.
   Kroon LA, 2007, AM J HEALTH-SYST PH, V64, P1917, DOI 10.2146/ajhp060414.
   Landvik NE, 2007, TOXICOLOGY, V231, P159, DOI 10.1016/j.tox.2006.12.009.
   Le Vee M, 2008, DRUG METAB DISPOS, V36, P217, DOI 10.1124/dmd.107.016907.
   Le Vee M, 2013, TOXICOL IN VITRO, V27, P1979, DOI 10.1016/j.tiv.2013.07.003.
   Le Vee M, 2010, TOXICOL IN VITRO, V24, P1775, DOI 10.1016/j.tiv.2010.07.001.
   Le Vee M, 2009, DRUG METAB DISPOS, V37, P2228, DOI 10.1124/dmd.109.028035.
   Le Vee M, 2009, DRUG METAB DISPOS, V37, P685, DOI 10.1124/dmd.108.023630.
   Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006.
   Li Ying-Ji, 2010, Inflammation \& Allergy Drug Targets, V9, P300.
   Liu XR, 1999, AM J PHYSIOL-GASTR L, V277, pG12, DOI 10.1152/ajpgi.1999.277.1.G12.
   Meek MD, 1998, ENVIRON RES, V79, P114, DOI 10.1006/enrs.1998.3870.
   Miller MR, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-61.
   Misaki K, 2007, ENVIRON TOXICOL CHEM, V26, P1370, DOI 10.1897/06-465R.1.
   Moreau A, 2011, FUND CLIN PHARMACOL, V25, P743, DOI 10.1111/j.1472-8206.2010.00913.x.
   Morjani H, 2001, INT J CANCER, V94, P157, DOI 10.1002/ijc.1449.
   National Institute of Standards \& Technology, 2008, CERT AN STAND RES MA.
   Nejad SH, 2015, J APPL TOXICOL, V35, P41, DOI 10.1002/jat.2985.
   Nemmar A, 2004, TOXICOL LETT, V149, P243, DOI 10.1016/j.toxlet.2003.12.061.
   Oh SM, 2008, ARCH PHARM RES, V31, P75, DOI 10.1007/s12272-008-1123-8.
   Olsavsky KM, 2007, TOXICOL APPL PHARM, V222, P42, DOI 10.1016/j.taap.2007.03.032.
   Pan WC, 2009, TOXICOL LETT, V185, P116, DOI 10.1016/j.toxlet.2008.12.007.
   Payen L, 2000, BIOCHEM PHARMACOL, V60, P1967, DOI 10.1016/S0006-2952(00)00496-2.
   Payen L, 1999, BIOCHEM BIOPH RES CO, V258, P513, DOI 10.1006/bbrc.1999.0671.
   Pedersen JM, 2008, J MED CHEM, V51, P3275, DOI 10.1021/jm7015683.
   Potschka H, 2003, J PHARMACOL EXP THER, V306, P124, DOI 10.1124/jpet.103.049858.
   Rabindran SK, 2000, CANCER RES, V60, P47.
   Rahi MM, 2009, EUR J PHARM SCI, V37, P588, DOI 10.1016/j.ejps.2009.05.005.
   Riedl M, 2005, J ALLERGY CLIN IMMUN, V115, P221, DOI 10.1016/j.jaci.2004.11.047.
   Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036.
   Santos KT, 2014, ARCH TOXICOL, V88, P1589, DOI 10.1007/s00204-014-1212-z.
   Shvedova AA, 2013, J TOXICOL ENV HEAL A, V76, P907, DOI 10.1080/15287394.2013.825217.
   Sugihara N, 2006, TOXICOLOGY, V223, P156, DOI 10.1016/j.tox.2006.03.011.
   Sydbom A, 2001, EUR RESPIR J, V17, P733, DOI 10.1183/09031936.01.17407330.
   Takano H, 2002, ARCH TOXICOL, V76, P146, DOI 10.1007/s00204-002-0323-0.
   TEEPE AG, 1992, ENVIRON MOL MUTAGEN, V20, P134, DOI 10.1002/em.2850200209.
   Tompkins LM, 2010, BIOCHEM PHARMACOL, V80, P1754, DOI 10.1016/j.bcp.2010.08.016.
   Tornqvist H, 2007, AM J RESP CRIT CARE, V176, P395, DOI 10.1164/rccm.200606-872OC.
   Totlandsdal AI, 2012, TOXICOL LETT, V208, P262, DOI 10.1016/j.toxlet.2011.10.025.
   Tournier N, 2010, INT J NEUROPSYCHOPH, V13, P905, DOI 10.1017/S1461145709990848.
   Wang XQ, 2011, FASEB J, V25, P644, DOI 10.1096/fj.10-169227.
   Washio I, 2011, DRUG METAB DISPOS, V39, P1, DOI 10.1124/dmd.110.034504.
   Wichmann HE, 2007, INHAL TOXICOL, V19, P241, DOI 10.1080/08958370701498075.
   Xu YY, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-60.
   Xu Y, 2013, MOL PHARMACEUT, V10, P4611, DOI 10.1021/mp400423g.
   Yin F, 2013, ARTERIOSCL THROM VAS, V33, P1153, DOI 10.1161/ATVBAHA.112.300552.
   Zielinska B, 2004, J AIR WASTE MANAGE, V54, P1138, DOI 10.1080/10473289.2004.10470973.}},
Number-of-Cited-References = {{85}},
Times-Cited = {{10}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{11}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{CH2XV}},
Unique-ID = {{ISI:000353889600140}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000411186500423,
Author = {Sanchez, Helen and Jay, Jennifer},
Title = {{Airborne antibiotic resistant genes upwind and downwind of poultry
   concentrated animal feeding operation}},
Journal = {{ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY}},
Year = {{2015}},
Volume = {{249}},
Meeting = {{430}},
Month = {{MAR 22}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Meeting Abstract}},
Language = {{English}},
Affiliation = {{Sanchez, Helen; Jay, Jennifer, Univ Calif Los Angeles, Civil \& Environm Engn, Stanton, CA USA.}},
ISSN = {{0065-7727}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Multidisciplinary}},
Author-Email = {{helensnchz21@gmail.com}},
Number-of-Cited-References = {{0}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Abstr. Pap. Am. Chem. Soc.}},
Doc-Delivery-Number = {{VA9RR}},
Unique-ID = {{ISI:000411186500423}},
DA = {{2018-08-13}},
}

@article{ ISI:000352401500024,
Author = {Byrne, Anthony L. and Marais, Ben J. and Mitnick, Carole D. and Lecca,
   Leonid and Marks, Guy B.},
Title = {{Tuberculosis and chronic respiratory disease: a systematic review}},
Journal = {{INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES}},
Year = {{2015}},
Volume = {{32}},
Number = {{SI}},
Pages = {{138-146}},
Month = {{MAR}},
Abstract = {{Background: Chronic respiratory disease causes substantial global
   morbidity and mortality. The contribution of pulmonary tuberculosis to
   the aetiology of chronic respiratory disease is rarely considered, but
   may be important in tuberculosis-endemic areas.
   Methods: We performed a systematic literature review to assess the
   association between a history of tuberculosis and the presence of
   chronic obstructive pulmonary disease (COPD) or chronic suppurative lung
   disease (bronchiectasis). Study quality was evaluated using the National
   Heart Lung and Blood Institute quality assessment tool. Meta-analysis
   was performed using the DerSimonian and Laird random effects model.
   Results: We identified 9 eligible studies for COPD and 2 for
   bronchiectasis. Overall, there was a significant association between a
   history of tuberculosis and the presence of COPD in adults aged over 40
   years (pooled odds ratio 3.05 (95\% confidence interval 2.42, 3.85).
   Among individual COPD studies the strongest associations were found in
   countries with a high incidence of tuberculosis, as well as among never
   smokers and younger people.
   Conclusion: In tuberculosis endemic areas, tuberculosis is strongly
   associated with the presence of chronic respiratory disease in adults.
   Efforts to improve long-term lung health should be part of tuberculosis
   care. (c) 2014 The Authors. Published by Elsevier Ltd on behalf of
   International Society for Infectious Diseases.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Byrne, AL (Reprint Author), Socios Salud Sucursal Peru Jr Emeterio Perez, 310 San Marti Porres, Lima, Peru.
   Byrne, Anthony L.; Marais, Ben J.; Marks, Guy B., Univ Sydney, Sydney, NSW 2006, Australia.
   Byrne, Anthony L.; Mitnick, Carole D.; Lecca, Leonid, Socios Salud Sucursal Partners Hlth, Lima, Peru.
   Byrne, Anthony L.; Marais, Ben J.; Marks, Guy B., Ctr Res Excellence TB TB CRE, Sydney, NSW, Australia.
   Marais, Ben J., Univ Sydney, Marie Bashir Inst Infect Dis \& Biosecur MBI, Sydney, NSW 2006, Australia.
   Lecca, Leonid, Harvard Univ, Sch Med, Boston, MA 02115 USA.
   Marks, Guy B., Woolcock Inst Med Res, Sydney, NSW, Australia.}},
DOI = {{10.1016/j.ijid.2014.12.016}},
ISSN = {{1201-9712}},
EISSN = {{1878-3511}},
Keywords = {{Tuberculosis; Chronic Respiratory Disease; Chronic Obstructive Pulmonary
   Disease; Bronchiectasis; Systematic Review}},
Keywords-Plus = {{OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; MULTIDRUG-RESISTANT
   TUBERCULOSIS; COMPUTED-TOMOGRAPHY FEATURES; INHALED CORTICOSTEROIDS;
   LUNG-DISEASE; NEVER SMOKERS; GLOBAL BURDEN; BRONCHIECTASIS; RISK}},
Research-Areas = {{Infectious Diseases}},
Web-of-Science-Categories  = {{Infectious Diseases}},
Author-Email = {{abyrne@med.usyd.edu.au}},
Cited-References = {{Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1.
   Akkara SA, 2013, INT J TUBERC LUNG D, V17, P810, DOI 10.5588/ijtld.12.0317.
   Apostu Marius, 2013, Pneumologia, V62, P148.
   Baig IM, JCPSP, V20, P542.
   Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519.
   Bhatta N, 2008, Kathmandu Univ Med J (KUMJ), V6, P195.
   Bousquet J, 2007, EUR RESPIR J, V29, P233, DOI 10.1183/09031936.00138606.
   Brassard P, 2011, AM J RESP CRIT CARE, V183, P675, DOI 10.1164/rccm.201007-1099OC.
   Buist AS, 2008, INT J TUBERC LUNG D, V12, P703.
   Buist A Sonia, 2005, COPD, V2, P277, DOI 10.1081/COPD-200057610.
   Burney P, 2014, THORAX, V69, DOI 10.1136/thoraxjnl-2013-204460.
   Bygbjerg IC, 2012, SCIENCE, V337, P1499, DOI 10.1126/science.1223466.
   Caballero A, 2008, CHEST, V133, P343, DOI 10.1378/chest.07-1361.
   Clark KD, 1998, EUR RESPIR J, V12, P395, DOI 10.1183/09031936.98.12020395.
   Crae T, 1926, OSLERS PRINCIPLES PR, P628.
   Cruz RS, 1992, REV ASSOCICAO MED BR, V54, P406.
   de Valliere S, 2004, INT J TUBERC LUNG D, V8, P767.
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2.
   Ehrlich RI, 2004, INT J TUBERC LUNG D, V8, P369.
   Gan Q, 2007, TOB CONTROL, V16, P417, DOI 10.1136/tc.2007.021477.
   Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2014, GLOBAL STRATEGY DIAG.
   Grancher JJ, 1878, GAZZMEDDE PARIS  APR.
   Hansell DM, 1998, RADIOL CLIN N AM, V36, P107, DOI 10.1016/S0033-8389(05)70009-9.
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186.
   Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32.
   Hooper R, 2012, EUR RESPIR J, V39, P1343, DOI 10.1183/09031936.00002711.
   Huang CC, 2014, INT J TUBERC LUNG D, V18, P1285, DOI 10.5588/ijtld.14.0309.
   Idolor LF, 2011, RESPIROLOGY, V16, P1111, DOI 10.1111/j.1440-1843.2011.02027.x.
   Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152.
   Jiang YA, 2010, TOB CONTROL, V19, DOI 10.1136/tc.2009.031179.
   Kim JH, 2013, CHEST, V143, P1018, DOI 10.1378/chest.12-1225.
   Kwak HJ, 2010, TOHOKU J EXP MED, V222, P237, DOI 10.1620/tjem.222.237.
   Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253.
   Lee CH, 2012, PLOS ONE, P7.
   Lee CH, 2013, THORAX, V68, P1105, DOI 10.1136/thoraxjnl-2012-203175.
   Lee ES, 2010, J COMPUT ASSIST TOMO, V34, P559, DOI 10.1097/RCT.0b013e3181d472bc.
   Lee SW, 2011, J KOREAN MED SCI, V26, P268, DOI 10.3346/jkms.2011.26.2.268.
   Leung CC, 2007, EUR RESPIR J, V29, P745, DOI 10.1183/09031936.00134706.
   Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807.
   Lokke A, 2006, THORAX, V61, P935, DOI 10.1136/thx.2006.062802.
   Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4.
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(10)61257-3.
   Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4.
   Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X.
   Martinez-Garcia MA, 2005, CHEST, V128, P739, DOI 10.1378/chest.128.2.739.
   Martinez-Garcia MA, 2007, CHEST, V132, P1565, DOI 10.1378/chest.07-0490.
   Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507.
   Menezes Ana M B, 2004, BMC Med Res Methodol, V4, P15, DOI 10.1186/1471-2288-4-15.
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535.
   Morrissey BM, 2003, CLIN REV ALLERG IMMU, V25, P233, DOI 10.1385/CRIAI:25:3:233.
   Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534.
   National Heart Lung and Blood Institute website, 2014, DEV US QUAL ASS TOOL.
   Perez-Padilla R, 2012, ARCH MED RES, V43, P159, DOI 10.1016/j.arcmed.2012.03.007.
   Plit ML, 1998, EUR RESPIR J, V12, P351, DOI 10.1183/09031936.98.12020351.
   Rhee CK, 2013, INT J TUBERC LUNG D, V17, P67, DOI 10.5588/ijtld.12.0351.
   Roberts HR, 2000, THORAX, V55, P198, DOI 10.1136/thorax.55.3.198.
   Rosen MJ, 2006, CHEST, V129, p122S, DOI 10.1378/chest.129.1\_suppl.122S.
   SALKIN D, 1950, Calif Med, V73, P577.
   Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9.
   Scarselli A, 2011, OCCUP MED-OXFORD, V61, P422, DOI 10.1093/occmed/kqr060.
   Senn S, 2011, STAT PROBABIL LETT, V81, P842, DOI 10.1016/j.spl.2011.02.010.
   Shu CC, 2010, MEDICINE, V89, P53, DOI 10.1097/MD.0b013e3181cafcd3.
   Smit RNV, 2010, EUR RESPIR J, V35, P27, DOI 10.1183/09031936.00072909.
   Tsuboi Tomomasa, 2006, Nihon Kokyuki Gakkai Zasshi, V44, P160.
   United States Library of Medicine website, 2014, INTRO MED SUBJ HEAD.
   Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029.
   World Health Organisation, 2014, WHO GLOBAL TUBERCULO.
   Yeom JA, 2009, J COMPUT ASSIST TOMO, V33, P956, DOI 10.1097/RCT.0b013e31819877ab.
   Zhou Yu-min, 2013, Zhonghua Nei Ke Za Zhi, V52, P379.
   Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894.}},
Number-of-Cited-References = {{70}},
Times-Cited = {{37}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{12}},
Journal-ISO = {{Int. J. Infect. Dis.}},
Doc-Delivery-Number = {{CF2TW}},
Unique-ID = {{ISI:000352401500024}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000350273900007,
Author = {Espeso, D. R. and Carpio, A. and Einarsson, B.},
Title = {{Differential growth of wrinkled biofilms}},
Journal = {{PHYSICAL REVIEW E}},
Year = {{2015}},
Volume = {{91}},
Number = {{2}},
Month = {{FEB 18}},
Abstract = {{Biofilms are antibiotic-resistant bacterial aggregates that grow on
   moist surfaces and can trigger hospital-acquired infections. They
   provide a classical example in biology where the dynamics of cellular
   communities may be observed and studied. Gene expression regulates cell
   division and differentiation, which affect the biofilm architecture.
   Mechanical and chemical processes shape the resulting structure. We gain
   insight into the interplay between cellular and mechanical processes
   during biofilm development on air-agar interfaces by means of a hybrid
   model. Cellular behavior is governed by stochastic rules informed by a
   cascade of concentration fields for nutrients, waste, and autoinducers.
   Cellular differentiation and death alter the structure and the
   mechanical properties of the biofilm, which is deformed according to
   Foppl-Von Karman equations informed by cellular processes and the
   interaction with the substratum. Stiffness gradients due to growth and
   swelling produce wrinkle branching. We are able to reproduce wrinkled
   structures often formed by biofilms on air-agar interfaces, as well as
   spatial distributions of differentiated cells commonly observed with B.
   subtilis.}},
Publisher = {{AMER PHYSICAL SOC}},
Address = {{ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Carpio, A (Reprint Author), Univ Complutense, Dept Matemat Aplicada, E-28040 Madrid, Spain.
   Espeso, D. R., CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain.
   Carpio, A., Univ Complutense, Dept Matemat Aplicada, E-28040 Madrid, Spain.
   Einarsson, B., Univ Calif Santa Barbara, Ctr Complex \& Nonlinear Sci, Santa Barbara, CA 93106 USA.}},
DOI = {{10.1103/PhysRevE.91.022710}},
Article-Number = {{022710}},
ISSN = {{2470-0045}},
EISSN = {{2470-0053}},
Keywords-Plus = {{BACILLUS-SUBTILIS BIOFILMS; BACTERIAL BIOFILMS; MECHANICAL-PROPERTIES;
   VIBRIO-HARVEYI; MODEL; FLOW; HYDROGELS; MATRIX; TISSUE; CELLS}},
Research-Areas = {{Physics}},
Web-of-Science-Categories  = {{Physics, Fluids \& Plasmas; Physics, Mathematical}},
Author-Email = {{carpio@mat.ucm.es}},
ResearcherID-Numbers = {{RODRIGUEZ ESPESO, DAVID/N-1590-2016
   }},
ORCID-Numbers = {{RODRIGUEZ ESPESO, DAVID/0000-0002-5329-815X
   carpio, ana/0000-0001-8623-6521}},
Funding-Acknowledgement = {{Comunidad de Madrid; spanish MICINN {[}S2009/DPI-1572,
   FIS2011-28838-C02-02, FIS2010-22438-E]; Fundacion Caja Madrid; NILS
   Mobility project (European Economic Area-EEA grant); MECD; MICINN; 
   {[}FIS2008-04921-C02-01]}},
Funding-Text = {{A.C. and D.R.E. thank M.P. Brenner for hospitality while visiting
   Harvard University. D.R.E. and A.C. were supported by Comunidad de
   Madrid and the spanish MICINN through Grants No. S2009/DPI-1572, No.
   FIS2011-28838-C02-02, and No. FIS2010-22438-E. A.C. was also supported
   by a mobility grant of Fundacion Caja Madrid. B.E. was supported by the
   NILS Mobility project (European Economic Area-EEA grant) and Project No.
   FIS2008-04921-C02-01. Part of the computations of this work were
   performed in EOLO, the HPC of Climate Change of the International Campus
   of Excellence of Moncloa, funded by MECD and MICINN. This is a
   contribution to CEI Moncloa.}},
Cited-References = {{Ahearne M, 2005, J R SOC INTERFACE, V2, P455, DOI 10.1098/rsif.2005.0065.
   Alber MS, 2003, IMA VOL MATH APPL, V134, P1.
   Alpkvist E, 2006, BIOTECHNOL BIOENG, V94, P961, DOI 10.1002/bit.20917.
   Amar MB, 2014, EPL-EUROPHYS LETT, V108, DOI 10.1209/0295-5075/108/38003.
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7.
   Asally M, 2012, P NATL ACAD SCI USA, V109, P18891, DOI 10.1073/pnas.1212429109.
   Autrusson N, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3601446.
   Chai LR, 2011, MRS BULL, V36, P374, DOI 10.1557/mrs.2011.68.
   Coen E, 2004, P NATL ACAD SCI USA, V101, P4728, DOI {[}10.1073/pnas.0306308101, 10.1073/pnas.030608101].
   Cogan NG, 2010, HFSP J, V4, P11, DOI 10.2976/1.3291142.
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318.
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130.
   de Carvalho Carla C C R, 2007, Recent Pat Biotechnol, V1, P49.
   Dechesne A, 2010, P NATL ACAD SCI USA, V107, P14369, DOI 10.1073/pnas.1008392107.
   Dervaux J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.068101.
   Dervaux J, 2009, J MECH PHYS SOLIDS, V57, P458, DOI 10.1016/j.jmps.2008.11.011.
   Drescher K, 2013, P NATL ACAD SCI USA, V110, P4345, DOI 10.1073/pnas.1300321110.
   Dupin HJ, 2001, WATER RESOUR RES, V37, P2965, DOI 10.1029/2001WR000306.
   Eguia E, 2008, INT BIODETER BIODEGR, V62, P79, DOI 10.1016/j.ibiod.2007.12.004.
   Fernandez E, 2008, J POLYM SCI POL PHYS, V46, P322, DOI 10.1002/polb.21370.
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415.
   FUQUA WC, 1994, J BACTERIOL, V176, P269.
   Glozman T, 2010, J ULTRAS MED, V29, P387, DOI 10.7863/jum.2010.29.3.387.
   Grant MAA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0400.
   HEJNOWICZ Z, 1984, J THEOR BIOL, V110, P93, DOI 10.1016/S0022-5193(84)80017-X.
   Hendrata M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061902.
   Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600.
   Hermanowicz SW, 2001, MATH BIOSCI, V169, P1, DOI 10.1016/S0025-5564(00)00049-3.
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011.
   Hou T., 1995, ACTA NUMER, V4, P335.
   Huang R, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.026214.
   ISTINI SO, 1994, B MARINE SCI FISHERI, V14, P49.
   Kapellos GE, 2007, ADV WATER RESOUR, V30, P1648, DOI 10.1016/j.advwatres.2006.05.030.
   Kapellos GE, 2012, INT J ENG SCI, V51, P241, DOI 10.1016/j.ijengsci.2011.09.010.
   Kapellos GE, 2010, MATH BIOSCI, V225, P83, DOI 10.1016/j.mbs.2010.03.003.
   Klapper I, 2010, SIAM REV, V52, P221, DOI 10.1137/080739720.
   Landau L, 1986, THEORY ELASTICITY.
   Lardon LA, 2011, ENVIRON MICROBIOL, V13, P2416, DOI 10.1111/j.1462-2920.2011.02414.x.
   Laspidou CS, 2014, MATH BIOSCI, V251, P11, DOI 10.1016/j.mbs.2014.02.007.
   Laspidou CS, 2004, WATER RES, V38, P3349, DOI 10.1016/j.watres.2004.04.037.
   Liu ZS, 2013, SOFT MATTER, V9, P577, DOI 10.1039/c2sm26642c.
   Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068.
   Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166.
   Mehta P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.79.
   Mehta P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026005.
   Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001.
   Mora T, 2006, EUR PHYS J E, V20, P119, DOI 10.1140/epje/i2005-10124-5.
   Nadell CD, 2008, PLOS BIOL, V6, P171, DOI 10.1371/journal.pbio.0060014.
   Ni Y, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031604.
   Poplawski NJ, 2008, MATH BIOSCI ENG, V5, P355.
   Purevdorj B, 2002, APPL ENVIRON MICROB, V68, P4457, DOI 10.1128/AEM.68.9.4457-4464.2002.
   Rodriguez D, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.061914.
   Ross KA, 1999, J TEXTURE STUD, V30, P17, DOI 10.1111/j.1745-4603.1999.tb00199.x.
   Schachter B, 2003, NAT BIOTECHNOL, V21, P361, DOI 10.1038/nbt0403-361.
   Seminara A, 2012, P NATL ACAD SCI USA, V109, P1116, DOI 10.1073/pnas.1109261108.
   Shaw T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098102.
   Singh R, 2006, TRENDS MICROBIOL, V14, P389, DOI 10.1016/j.tim.2006.07.001.
   Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838.
   Storck T, 2014, BIOPHYS J, V106, P2037, DOI 10.1016/j.bpj.2014.03.015.
   Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8.
   Swem LR, 2008, CELL, V134, P461, DOI 10.1016/j.cell.2008.06.023.
   Taherzadeh D, 2010, BIOTECHNOL BIOENG, V105, P600, DOI 10.1002/bit.22551.
   Teng SW, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.30.
   Torres A, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.084029.
   Trejo M, 2013, P NATL ACAD SCI USA, V110, P2011, DOI 10.1073/pnas.1217178110.
   Wanner O., 2006, MATH MODELING BIOFIL.
   Wilking JN, 2013, P NATL ACAD SCI USA, V110, P848, DOI 10.1073/pnas.1216376110.
   Wilking JN, 2011, MRS BULL, V36, P385, DOI 10.1557/mrs.2011.71.
   Wuertz S., 2003, BIOFILMS WASTEWATER.
   Xavier JB, 2007, P NATL ACAD SCI USA, V104, P876, DOI 10.1073/pnas.0607651104.
   Xavier JB, 2009, AM NAT, V174, P1, DOI 10.1086/599297.
   Xiong YH, 2010, APPL MICROBIOL BIOT, V86, P825, DOI 10.1007/s00253-010-2463-0.
   Zhang WB, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/1/015028.}},
Number-of-Cited-References = {{73}},
Times-Cited = {{15}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{34}},
Journal-ISO = {{Phys. Rev. E}},
Doc-Delivery-Number = {{CC3TV}},
Unique-ID = {{ISI:000350273900007}},
OA = {{green\_published}},
DA = {{2018-08-13}},
}

@article{ ISI:000348083100010,
Author = {von Salviati, Christina and Laube, Henriette and Guerra, Beatriz and
   Roesler, Uwe and Friese, Anika},
Title = {{Emission of ESBL/AmpC-producing Escherichia coli from pig fattening
   farms to surrounding areas}},
Journal = {{VETERINARY MICROBIOLOGY}},
Year = {{2015}},
Volume = {{175}},
Number = {{1}},
Pages = {{77-84}},
Month = {{JAN 30}},
Abstract = {{The presence of ESBL/AmpC-producing Escherichia coli in livestock such
   as pigs has been known for some time. However, to date there is little
   information about the transmission of these resistant bacteria between
   pig farms and their surroundings. Thus, the aim of this study was to
   explore this topic by investigating seven German pig fattening farms.
   Samples from outside (including ground surfaces, ambient air, slurry and
   digestate from biogas plants) and, in parallel, from inside the pig
   barns (including pig feces, dust, barn air, flies and mice feces) were
   examined for ESBL/AmpC-producing E. coli and selected isolates were
   compared by pulsed-field gel electrophoresis (PFGE) analysis. 14/17
   (82.4\%) slurry samples and three of four samples of digestate from
   biogas plants tested positive for ESBL/ AmpC-producing E. coli. In the
   vicinity of the pig barns these resistant bacteria were detected in
   14/87(16.1\%) boot swabs taken from various ground surfaces and in
   2/36(6\%) ambient air samples. Inside the pig barns, 6/63 (9.5\%) barn
   air samples and a small proportion of flies and mice feces samples were
   ESBL/AmpC-positive. PFGE analysis proved fecal emission as well as a
   possible spread via flies, as identical ESBL-E. coli isolates were
   detected in slurry and on fertilized fields, as well as in flies and
   pooled feces from inside the barn and slurry. Contaminated slurry
   presented the major emission source for ESBL/AmpC-producing E. cob in
   the pig fattening farms, but a spread via the airborne route or via
   different vectors also seems possible. (C) 2014 Elsevier B.V. All rights
   reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{von Salviati, C (Reprint Author), Free Univ Berlin, Inst Anim Hyg \& Environm Hlth, Robert von Ostertag Str 7-13, D-14163 Berlin, Germany.
   von Salviati, Christina; Laube, Henriette; Roesler, Uwe; Friese, Anika, Free Univ Berlin, Inst Anim Hyg \& Environm Hlth, D-14163 Berlin, Germany.
   Guerra, Beatriz, Fed Inst Risk Assessment, Dept Biol Safety, D-10589 Berlin, Germany.}},
DOI = {{10.1016/j.vetmic.2014.10.010}},
ISSN = {{0378-1135}},
EISSN = {{1873-2542}},
Keywords = {{Pig husbandry; Antimicrobial resistance; Environment; Slurry; ESBL;
   Emission}},
Keywords-Plus = {{SPECTRUM BETA-LACTAMASES; FIELD GEL-ELECTROPHORESIS; RESISTANT
   STAPHYLOCOCCUS-AUREUS; FOOD ANIMALS; CTX-M; SALMONELLA; LIVESTOCK;
   PREVALENCE; CATTLE; ENTEROBACTERIACEAE}},
Research-Areas = {{Microbiology; Veterinary Sciences}},
Web-of-Science-Categories  = {{Microbiology; Veterinary Sciences}},
Author-Email = {{Christinavon.Salviati@fu-berlin.de}},
Funding-Acknowledgement = {{German Federal Ministry of Education and Research {[}01K11013C]}},
Funding-Text = {{This study was part of the research consortium RESET
   (http://www.reset-verbund.de) and was financially supported by the
   German Federal Ministry of Education and Research (funding number
   01K11013C).}},
Cited-References = {{Batchelor M, 2005, ANTIMICROB AGENTS CH, V49, P1319, DOI 10.1128/AAC.49.4.1319-1322.2005.
   BENBOUGH JE, 1967, J GEN MICROBIOL, V47, P325, DOI 10.1099/00221287-47-3-325.
   Carattoli A, 2008, J CLIN MICROBIOL, V46, P103, DOI 10.1128/JCM.01542-07.
   Carrico JA, 2005, J CLIN MICROBIOL, V43, P5483, DOI 10.1128/JCM.43.11.5483-5490.2005.
   Chinivasagam HN, 2009, APPL ENVIRON MICROB, V75, P7417, DOI 10.1128/AEM.01380-09.
   Chmelnitsky I, 2005, ANTIMICROB AGENTS CH, V49, P4745, DOI 10.1128/AAC.49.11.4745-4750.2005.
   Costa D, 2006, J ANTIMICROB CHEMOTH, V58, P1311, DOI 10.1093/jac/dkl415.
   Friese A, 2013, APPL ENVIRON MICROB, V79, P2759, DOI 10.1128/AEM.03939-12.
   Friese A, 2013, BERL MUNCH TIERARZTL, V126, P175, DOI 10.2376/0005-9366-126-175.
   Guenther S, 2010, J ANTIMICROB CHEMOTH, V65, P582, DOI 10.1093/jac/dkp496.
   Guerra B, 2001, ANTIMICROB AGENTS CH, V45, P1305, DOI 10.1128/AAC.45.4.1305-1308.2001.
   HANDLEY BA, 1995, J APPL BACTERIOL, V79, P368, DOI 10.1111/j.1365-2672.1995.tb03150.x.
   Hartmann A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00083.
   Hopkins KL, 2006, INT J ANTIMICROB AG, V27, P572, DOI 10.1016/j.ijantimicag.2006.03.003.
   Hordijk J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00242.
   KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355.
   Korzeniewska E, 2013, J ENVIRON MANAGE, V128, P904, DOI 10.1016/j.jenvman.2013.06.051.
   Kozak GK, 2009, APPL ENVIRON MICROB, V75, P559, DOI 10.1128/AEM.01821-08.
   Laube H, 2014, VET MICROBIOL, V172, P519, DOI 10.1016/j.vetmic.2014.06.008.
   Laube H, 2013, APPL ENVIRON MICROB, V79, P4815, DOI 10.1128/AEM.00856-13.
   Muller W, 1977, Berl Munch Tierarztl Wochenschr, V90, P6.
   Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334.
   PEARSON CC, 1995, J AGR ENG RES, V60, P145, DOI 10.1006/jaer.1995.1008.
   Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59.
   del Castillo BR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-84.
   Schmid A, 2013, APPL ENVIRON MICROB, V79, P3027, DOI 10.1128/AEM.00204-13.
   Seedorf J., 2002, KTBL SCHRIFT, V393.
   Seiffert SN, 2013, DRUG RESIST UPDATE, V16, P22, DOI 10.1016/j.drup.2012.12.001.
   TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233.
   Usui M, 2013, MICROB DRUG RESIST, V19, P415, DOI 10.1089/mdr.2012.0251.
   von Salviati C, 2014, BERL MUNCH TIERARZTL, V127, P412, DOI 10.2376/0005-9366-127-412.
   Weill FX, 2004, J CLIN MICROBIOL, V42, P2432, DOI 10.1128/JCM.42.6.2432-2437.2004.
   Yuan W, 2010, SCI TOTAL ENVIRON, V408, P1446, DOI 10.1016/j.scitotenv.2009.12.019.
   Zhang TX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081178.
   Zhao SH, 2001, ANTIMICROB AGENTS CH, V45, P3647, DOI 10.1128/AAC.45.12.3647-3650.2001.}},
Number-of-Cited-References = {{35}},
Times-Cited = {{30}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{32}},
Journal-ISO = {{Vet. Microbiol.}},
Doc-Delivery-Number = {{AZ2SQ}},
Unique-ID = {{ISI:000348083100010}},
DA = {{2018-08-13}},
}

@article{ ISI:000367669800151,
Author = {Huang, Chao-Lin and Zhang, Wei and Ni, Zheng-Yi and Zuo, Tao and Zhou,
   Mi and Xu, Jun and Yang, Zhi-Feng and Li, Lei and Xiao, Jun and Zhang,
   Ding-Yu},
Title = {{Efficacy of video-assisted thoracoscopic surgery for 29 patients with
   tuberculosis-destroyed lung}},
Journal = {{INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE}},
Year = {{2015}},
Volume = {{8}},
Number = {{10}},
Pages = {{18391-18398}},
Abstract = {{Background: Incompleteness of interlobar fissures and pleural adhesions,
   common in tuberculous destroyed lung (TDL), are among ``technical
   contraindications{''} for video-assisted thoracoscopic surgery (VATS).
   The efficacy and safety of VATS in the treatment of TDL, has not yet
   been detailed in. Objective: The objective of the present study is to
   observe the efficacy and safety of VATS in the management of TDL.
   Methods: A retrospective review of anatomic lobectomy by VATS on 29
   cases of TDL was performed in the Department of Thoracic Surgery of
   Wuhan Medical Treatment Center between October 2010 and October 2013.
   Results: All the 29 surgeries by VATS were successfully completed. No
   death case was reported. Operative duration of VATS was 75 similar to
   400 min, with an average of 185.4 min; intraoperative amount of bleeding
   ranged 50 to 2300 ml, with an average of 575.6 ml; the incidence of
   postoperative complication was 21.4\% (6/28). Postoperative
   complications occurred in 6 cases, among which there were 2 cases of
   persistent postoperative pulmonary air leak, 2 cases of pleural
   effusion, one case of thoracic hemorrhage and one case of arrhythmia
   complicated with left heart failure. There was one patient who was
   converted from VATS to open thoracic surgery half-way. Conclusion: Our
   results have shown the efficacy, safety and a breakthrough in the
   ``technical contraindications{''} of VATS in the management of TDL.}},
Publisher = {{E-CENTURY PUBLISHING CORP}},
Address = {{40 WHITE OAKS LN, MADISON, WI 53711 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Zhang, DY (Reprint Author), Wuhan Med Treatment Ctr, Intens Care Unit, 1 Yintan Rd, Wuhan 430023, Hubei Province, Peoples R China.
   Huang, Chao-Lin; Ni, Zheng-Yi; Zuo, Tao; Zhou, Mi; Xu, Jun; Yang, Zhi-Feng; Li, Lei; Xiao, Jun, Wuhan Med Treatment Ctr, Dept Thorac Surg, Wuhan 430023, Hubei Province, Peoples R China.
   Zhang, Wei; Zhang, Ding-Yu, Wuhan Med Treatment Ctr, Intens Care Unit, 1 Yintan Rd, Wuhan 430023, Hubei Province, Peoples R China.}},
ISSN = {{1940-5901}},
Keywords = {{Video-assisted thoracoscopic surgery; anatomic lobectomy; tuberculous
   destroyed lung}},
Keywords-Plus = {{MULTIDRUG-RESISTANT TUBERCULOSIS; PULMONARY TUBERCULOSIS; NEUROMUSCULAR
   BLOCKADE; BISPECTRAL INDEX; LOBECTOMY; RESECTION; EXPERIENCE; RECOVERY}},
Research-Areas = {{Research \& Experimental Medicine}},
Web-of-Science-Categories  = {{Medicine, Research \& Experimental}},
Author-Email = {{zhangdy63@hotmail.com}},
Cited-References = {{Bai LQ, 2012, EUR J CARDIO-THORAC, V41, P335, DOI 10.1016/j.ejcts.2011.05.028.
   Eikermann M, 2003, ANESTHESIOLOGY, V98, P1333, DOI 10.1097/00000542-200306000-00006.
   Feng MX, 2014, J THORAC DIS, V6, P1751, DOI 10.3978/j.issn.2072-1439.2014.11.20.
   Girgirah K, 2015, BRIT J ANAESTH, V114, P530, DOI 10.1093/bja/aev018.
   Ikeda M, 2012, INTERACT CARDIOV TH, V14, P652, DOI 10.1093/icvts/ivs054.
   Iwasaki H, 2013, CAN J ANESTH, V60, P1222, DOI 10.1007/s12630-013-0042-4.
   Kim H, 2013, J NEUROSURG ANESTH, V25, P217, DOI 10.1097/ANA.0b013e31827e1842.
   Lee EJ, 2012, SCI WORLD J, DOI 10.1100/2012/835031.
   Massard G, 2012, THORAC SURG CLIN, V22, P287, DOI 10.1016/j.thorsurg.2012.05.006.
   Mohsen T, 2007, J THORAC CARDIOV SUR, V134, P194, DOI 10.1016/j.jtcvs.2007.03.022.
   Park JH, 2001, INT J TUBERC LUNG D, V5, P963.
   Pischik VG, 2014, J THORAC DIS, V6, pS623, DOI 10.3978/j.issn.2072-1439.2014.10.11.
   Sagawa M, 2004, ANN THORAC SURG, V78, P2165, DOI 10.1016/S0003-4975(03)01451-6.
   Shields TW, 2005, GEN THORACIC SURG.
   Shiraishi Y, 2004, J THORAC CARDIOV SUR, V128, P523, DOI 10.1016/j.jtcvs.2004.06.012.
   Wang HF, 2008, ANN THORAC SURG, V86, P1640, DOI 10.1016/j.athoracsur.2008.07.056.
   Weber A, 2001, EUR J CARDIO-THORAC, V20, P443, DOI 10.1016/S1010-7940(01)00689-3.
   WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1.
   Witkowska M, 2012, ANAESTH INTENSIVE TH, V44, P138.
   Yen YT, 2013, ANN THORAC SURG, V95, P257, DOI 10.1016/j.athoracsur.2012.09.034.
   Yen YT, 2011, ANN THORAC SURG, V92, P290, DOI 10.1016/j.athoracsur.2011.02.039.
   Yim APC, 1999, WORLD J SURG, V23, P1114, DOI 10.1007/s002689900633.
   Yim APC, 1996, CHEST, V109, P13, DOI 10.1378/chest.109.1.13.
   Yim APC, 1996, CHEST, V109, P554, DOI 10.1378/chest.109.2.554.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Int. J. Clin. Exp. Med.}},
Doc-Delivery-Number = {{DA3BB}},
Unique-ID = {{ISI:000367669800151}},
DA = {{2018-08-13}},
}

@article{ ISI:000366067600009,
Author = {Kenny, C. R. and Furey, A. and Lucey, B.},
Title = {{A post-antibiotic era looms: can plant natural product research fill the
   void?}},
Journal = {{BRITISH JOURNAL OF BIOMEDICAL SCIENCE}},
Year = {{2015}},
Volume = {{72}},
Number = {{4}},
Pages = {{191-200}},
Abstract = {{Antimicrobial resistance is increasing among certain pathogenic bacteria
   to the extent that treatment efficacy is no longer always assured.
   According to the CDC, as few as six new antibiotics have been released
   for use over the past 30 years. Resistance has already been observed to
   each of these. Eleven plant natural products have been approved for
   therapeutic use during the same period none of them being antimicrobial
   agents. We have learned through experience that some microorganisms will
   inevitably overcome antibiotic treatment in certain situations, and then
   spread. It is clear that the rate of new antimicrobial development is
   insufficient to meet our current and future needs, which should be
   addressed in order to guarantee the effective future of antimicrobial
   chemotherapy. However, in recent years there has been an increase in the
   number of peer-reviewed reports of antimicrobial efficacy among
   plant-derived secondary metabolites. A limitation with these reports is
   the wide range of modified in vitro methods used to determine
   antimicrobial efficacy of these products, showing an absence of the type
   of standardisation that is the norm when testing the efficacy of single-
   or combined-agent conventional antimicrobials in the laboratory, thereby
   making inter-study comparison difficult. Overall, despite the large
   diversity in preparation and testing strategies used currently for
   natural product plant-derived antimicrobials, our investigations suggest
   that the field shows promise in the provision of novel antimicrobial
   agents, even as exemplified by our selected example, mule helenium
   (Elecampane).}},
Publisher = {{STEP PUBLISHING LTD}},
Address = {{SUBSCRIPTION DEPT, NORTH FARM RD, TUNBRIDGE WELLS TN2 3DR, KENT, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Furey, A (Reprint Author), Cork Inst Technol, Dept Phys Sci, Cork, Ireland.
   Kenny, C. R.; Lucey, B., Cork Inst Technol, Dept Biol Sci, Cork, Ireland.
   Kenny, C. R.; Furey, A., Cork Inst Technol, Dept Phys Sci, Cork, Ireland.}},
DOI = {{10.1080/09674845.2015.11665752}},
ISSN = {{0967-4845}},
Keywords = {{Antimicrobial susceptibility testing; Drug resistance, antimicrobial;
   Inula helenium; Natural product research; Plant constituents}},
Keywords-Plus = {{ROOT ESSENTIAL OIL; NEGATIVE AIR IONS; ANTIMICROBIAL ACTIVITY;
   ANTIBACTERIAL ACTIVITY; IN-VITRO; STAPHYLOCOCCUS-AUREUS; INULA-HELENIUM;
   SCREENING METHODS; MEDICINAL-PLANTS; DISK DIFFUSION}},
Research-Areas = {{Medical Laboratory Technology}},
Web-of-Science-Categories  = {{Medical Laboratory Technology}},
Author-Email = {{ambrose.furey@cit.ie}},
ORCID-Numbers = {{Furey, Ambrose/0000-0003-4119-4318}},
Funding-Acknowledgement = {{Cork Institute of Technology}},
Funding-Text = {{CRK is in receipt of an RISAM scholarship from Cork Institute of
   Technology.}},
Cited-References = {{Amirkia V, 2014, PHYTOCHEM LETT, V10.
   Atanasov A. G., 2015, BIOTECHNOL ADV.
   Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106.
   Basri D. F., 2005, Indian Journal of Pharmacology, V37, P26.
   Bassetti M, 2015, CURR OPIN CRIT CARE, V21, P402, DOI 10.1097/MCC.0000000000000235.
   Berkov S, 2014, BIOTECHNOL ADV, V32, P1102, DOI 10.1016/j.biotechadv.2014.04.005.
   Bidlas E, 2008, INT J FOOD MICROBIOL, V126, P140, DOI 10.1016/j.ijfoodmicro.2008.05.023.
   Burgess JG, 1999, J BIOTECHNOL, V70, P27, DOI 10.1016/S0168-1656(99)00054-1.
   Butterweck V, 2012, PLANTA MED, V78, P747, DOI 10.1055/s-0031-1298434.
   Cantrell CL, 1998, PHYTOMEDICINE, V5, P137, DOI 10.1016/S0944-7113(98)80011-1.
   Centers for Disease Control and Prevention, 2015, ANT RES.
   Choma IM, 2015, CHROMATOGRAPHY, V2, P225.
   Choma IM, 2011, J CHROMATOGR A, V1218, P2684, DOI 10.1016/j.chroma.2010.12.069.
   Cos P, 2006, J ETHNOPHARMACOL, V106, P290, DOI 10.1016/j.jep.2006.04.003.
   Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008.
   Cragg GM, 2012, NAT PROD REP, V29, P1407, DOI 10.1039/c2np20091k.
   Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002.
   Das K, 2010, J MED PLANTS RES, V4, P104.
   David B, 2014, HDB CHEM BIOL PLANT.
   David B, 2015, PHYTOCHEM REV, V14, P299, DOI 10.1007/s11101-014-9367-z.
   Deriu A, 2008, INT J ANTIMICROB AG, V31, P588, DOI 10.1016/j.ijantimicag.2008.02.006.
   Dipiro J, 2011, PHARMACOTHERAPY PATH, P1797.
   Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467.
   Gautam R, 2007, J ETHNOPHARMACOL, V110, P200, DOI 10.1016/j.jep.2006.12.031.
   Gokbulut A, 2013, PLANTA MED, V79, P1214.
   HAMBURGER MO, 1987, J NAT PROD, V50, P19, DOI 10.1021/np50049a003.
   Henrich CJ, 2013, NAT PROD REP, V30, P1284, DOI 10.1039/c3np70052f.
   Hombach M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-225.
   Hung MW, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/605303.
   JANSSEN A M, 1987, Planta Medica, V53, P395, DOI 10.1055/s-2006-962755.
   Jiang HL, 2011, TETRAHEDRON, V67, P9193, DOI 10.1016/j.tet.2011.09.070.
   Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952.
   King T, 2008, J AOAC INT, V91, P1423.
   Kloucek P, 2012, FOOD RES INT, V47, P161, DOI 10.1016/j.foodres.2011.04.044.
   Koehn Frank E., 2008, V65.
   Kulah C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-30.
   Lee DS, 2010, BIOORG MED CHEM LETT, V20, P975, DOI 10.1016/j.bmcl.2009.12.049.
   Lellek H, 2015, INT J MED MICROBIOL.
   Liu Zhijun, 2008, Endocrine Metabolic \& Immune Disorders-Drug Targets, V8, P112, DOI 10.2174/187153008784534358.
   Lourens ACU, 2004, J ETHNOPHARMACOL, V95, P253, DOI 10.1016/j.jep.2004.07.027.
   Mbata TI, 2008, AFR J BIOTECHNOL, V7, P1571.
   Medina-Franco JL, 2008, CURR COMPUT-AID DRUG, V4, P322, DOI 10.2174/157340908786786010.
   Mishra KP, 2008, BIOMED PHARMACOTHER, V62, P94, DOI 10.1016/j.biopha.2007.06.012.
   Mondello F, 2009, J MICROBIOL METH, V77, P243, DOI 10.1016/j.mimet.2009.02.012.
   NASIR B, 2015, AUSTIN J MICROBIOL, V1, P1.
   Ncube NS, 2008, AFR J BIOTECHNOL, V7, P1797.
   Nostro A, 2000, LETT APPL MICROBIOL, V30, P379, DOI 10.1046/j.1472-765x.2000.00731.x.
   O'Neill J., 2014, REV ANTIMICROBIAL RE, P1.
   O'Shea S, 2009, BRIT J BIOMED SCI, V66, P186.
   Ogata SK, 2014, BRAZ J MICROBIOL, V45, P1439, DOI 10.1590/S1517-83822014000400039.
   Osato MS, 2000, CURR PHARM DESIGN, V6, P1545, DOI 10.2174/1381612003399059.
   Othman M, 2011, J MICROBIOL METH, V84, P161, DOI 10.1016/j.mimet.2010.11.008.
   Oxford JS, 2003, CLIN MICROBIOL INFEC, V9, P1, DOI 10.1046/j.1469-0691.2003.00564.x.
   Parekh Jigna, 2006, Indian Journal of Pharmaceutical Sciences, V68, P832.
   Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6.
   Pikkemaat MG, 2009, ANAL CHIM ACTA, V637, P298, DOI 10.1016/j.aca.2008.08.023.
   Power O, 2013, AMINO ACIDS, V44, P797, DOI 10.1007/s00726-012-1393-9.
   Qiu JZ, 2011, FEMS MICROBIOL LETT, V324, P147, DOI 10.1111/j.1574-6968.2011.02397.x.
   Radulovic NS, 2014, PHYTOCHEM ANALYSIS, V25, P75, DOI 10.1002/pca.2466.
   RAHALISON L, 1991, PHYTOCHEM ANALYSIS, V2, P199, DOI 10.1002/pca.2800020503.
   Rios JL, 2005, J ETHNOPHARMACOL, V100, P80, DOI 10.1016/j.jep.2005.04.025.
   RIOS JL, 1988, J ETHNOPHARMACOL, V23, P127, DOI 10.1016/0378-8741(88)90001-3.
   Schmourlo G, 2005, J ETHNOPHARMACOL, V96, P563, DOI 10.1016/j.pep.2004.10.007.
   Scorzoni L., 2007, Revista de Ciencias Farmaceuticas Basica e Aplicada, V28, P25.
   Seca AML, 2014, J ETHNOPHARMACOL, V154, P286, DOI 10.1016/j.jep.2014.04.010.
   Shahverdi AR, 2007, J CHROMATOGR B, V850, P528, DOI 10.1016/j.jchromb.2006.11.011.
   Stojakowska A, 2005, FITOTERAPIA, V76, P687, DOI 10.1016/j.fitote.2005.05.003.
   Stojanovic-Radic Z, 2012, EUR J CLIN MICROBIOL, V31, P1015, DOI 10.1007/s10096-011-1400-1.
   Suleiman MM, 2010, AFR J TRADIT COMPLEM, V7, P64.
   Swenson JM, 2009, J CLIN MICROBIOL, V47, P2013, DOI 10.1128/JCM.00221-09.
   Tan JBL, 2015, FOOD CHEM, V172, P814, DOI 10.1016/j.foodchem.2014.09.141.
   Tangahu BV, 2011, INT J CHEM ENG, DOI 10.1155/2011/939161.
   Tepe B, 2004, FOOD CHEM, V84, P519, DOI 10.1016/S0308-8146(03)00267-X.
   Tyagi AK, 2010, INT J FOOD MICROBIOL, V143, P205, DOI 10.1016/j.ijfoodmicro.2010.08.023.
   Tyagi AK, 2012, TRENDS FOOD SCI TECH, V26, P99, DOI 10.1016/j.tifs.2012.02.004.
   Tyagi AK, 2011, FOOD CONTROL, V22, P1707, DOI 10.1016/j.foodcont.2011.04.002.
   Valgas C, 2007, BRAZ J MICROBIOL, V38, P369, DOI 10.1590/S1517-83822007000200034.
   WHO - World Health Organization Media Centre, ANT RES.
   Wolfender JL, 2015, J CHROMATOGR A, V1382, P136, DOI 10.1016/j.chroma.2014.10.091.}},
Number-of-Cited-References = {{79}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{21}},
Journal-ISO = {{Br. J. Biomed. Sci.}},
Doc-Delivery-Number = {{CY0AH}},
Unique-ID = {{ISI:000366067600009}},
DA = {{2018-08-13}},
}

@article{ ISI:000358599100006,
Author = {Su, Xiao and Song, Hao and Niu, Fangfang and Yang, Kaixuan and Kou, Geng
   and Wang, Xiaohang and Chen, Huaiwen and Li, Wei and Guo, Shangjing and
   Li, Jun and Li, Bohua and Feng, Si-shen and Jiang, Jianxin and Yin,
   Chuan and Gao, Jie},
Title = {{Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes
   for enhanced therapy against multidrug resistance}},
Journal = {{NANOMEDICINE}},
Year = {{2015}},
Volume = {{10}},
Number = {{13}},
Pages = {{2033-2050}},
Abstract = {{Aim: To develop novel nanoliposomes (Lip-ADR-Cer) codelivering
   doxorubicin (ADR) and PEGylated C16 ceramide (PEG-ceramide C16) to
   overcome multidrug resistance. Materials \& methods: The antitumor
   activity and mechanism of Lip-ADR-Cer were evaluated. Results \&
   conclusion: The IC50 of Lip-ADR-Cer after 48-h treatment with the
   MCF-7/ADR and HL-60/ADR cancer cells, both being ADR resistant, was
   2.2-and 1.4-fold effective respectively versus the general nanoliposomes
   with no PEG-ceramide C16 (Lip-ADR). The antitumor assay in mice bearing
   MCF-7/ADR or HL-60/ADR xenograft tumors confirmed the superior antitumor
   activity of Lip-ADR-Cer over Lip-ADR. We found that the improved
   therapeutic effect of Lip-ADR-Cer may be attributed to both of the
   cytotoxic effect of PEG-ceramide C16 and glucosylceramide synthase
   overexpression in multidrug resistance cells.}},
Publisher = {{FUTURE MEDICINE LTD}},
Address = {{UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Jiang, JX (Reprint Author), Hubei Prov Tumor Hosp, Dept Hepatobiliary Surg, Wuhan 430079, Hubei, Peoples R China.
   Su, Xiao; Song, Hao; Niu, Fangfang; Yang, Kaixuan; Kou, Geng; Chen, Huaiwen; Li, Wei; Li, Bohua; Feng, Si-shen; Jiang, Jianxin; Gao, Jie, Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China.
   Song, Hao; Kou, Geng; Li, Wei; Guo, Shangjing; Li, Jun; Li, Bohua; Gao, Jie, Liaocheng Univ, Coll Pharm, Liaocheng 25200, Shandong, Peoples R China.
   Song, Hao, Liaocheng Peoples Hosp, Ctr Stem Cell \& Regenerat Med, Liaocheng 252000, Shangdong, Peoples R China.
   Wang, Xiaohang; Yin, Chuan, Second Mil Med Univ, Changzheng Hosp, Dept Gastroenterol, Shanghai 200003, Peoples R China.
   Feng, Si-shen, Natl Univ Singapore, Dept Chem \& Biomol Engn, Singapore 117576, Singapore.
   Feng, Si-shen, Suzhou NanoStar Biopharm Inc Ltd, BioBay, Suzhou 215123, Peoples R China.
   Jiang, Jianxin, Hubei Prov Tumor Hosp, Dept Hepatobiliary Surg, Wuhan 430079, Hubei, Peoples R China.
   Gao, Jie, Second Mil Med Univ, Dept Pharmaceut Sci, Shanghai 200433, Peoples R China.}},
DOI = {{10.2217/NNM.15.50}},
ISSN = {{1743-5889}},
EISSN = {{1748-6963}},
Keywords = {{cancer nanotechnology; glucosylceramide synthase; molecular
   biomaterials; multidrug resistance; nanomedicine; pharmaceutical
   nanotechnology}},
Keywords-Plus = {{PLASMID-LIPID PARTICLES; EQUATION-OF-STATE; DRUG-RESISTANCE; POLYMERIC
   NANOPARTICLES; CANCER-CELLS; GLUCOSYLCERAMIDE SYNTHASE; ANTICANCER
   DRUGS; WATER-INTERFACE; AIR-WATER; IN-VITRO}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Science \& Technology - Other
   Topics}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Nanoscience \& Nanotechnology}},
Author-Email = {{Jjx731003@163.com
   ilse1225@sina.com
   gaojiehighclea@163.com}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}81472829, 81402512];
   Shanghai Young Rising Star of Science {[}12QB1402400]; Shanghai
   Chen'guang Scholar Funding, Ministry of Science and Technology of China
   (973 program project) {[}2012AA020809]; Shanghai Chen'guang Scholar
   Funding, Ministry of Science and Technology of China (863 program
   project) {[}2012AA020809]; National Key Project for Infectious Diseases
   {[}2012ZX10002012-009]; Pudong New Area Science and Technology
   Commission of Ministry of Education of China (Key Laboratory); Ministry
   of Education of China (Key Laboratory); Shanghai Commission of
   Education; National Special Projects for New Drug Development and
   Infectious Diseases}},
Funding-Text = {{This work was financially supported by the National Natural Science
   Foundation of China (project number: 81472829, 81402512), Shanghai Young
   Rising Star of Science (project number: 12QB1402400), Shanghai
   Chen'guang Scholar Funding, Ministry of Science and Technology of China
   (973 \& 863 program projects, project number: 2012AA020809), National
   Key Project for Infectious Diseases (2012ZX10002012-009), Pudong New
   Area Science and Technology Commission of and a special grant from the
   Ministry of Education of China (Key Laboratory) and the Shanghai
   Commission of Education and National Special Projects for New Drug
   Development and Infectious Diseases. The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript apart from those
   disclosed.}},
Cited-References = {{Abraham SA, 2004, CLIN CANCER RES, V10, P728, DOI 10.1158/1078-0432.CCR-1131-03.
   Anbharasi V, 2010, J BIOMED MATER RES A, V94A, P730, DOI 10.1002/jbm.a.32734.
   Cao N, 2008, BIOMATERIALS, V29, P3856, DOI 10.1016/j.biomaterials.2008.05.016.
   Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590.
   Decuzzi P, 2007, BIOMATERIALS, V28, P2915, DOI 10.1016/j.biomaterials.2007.02.013.
   Devalapally H, 2008, CLIN CANCER RES, V14, P3193, DOI 10.1158/1078-0432.CCR-07-4973.
   Devalapally H, 2007, INT J CANCER, V121, P1830, DOI 10.1002/ijc.22886.
   Dumitru CA, 2007, APOPTOSIS, V12, P1533, DOI 10.1007/s10495-007-0081-9.
   Feng SS, 1999, LANGMUIR, V15, P998, DOI 10.1021/la980144f.
   FENG SS, 1995, BIOPHYS J, V69, P460, DOI 10.1016/S0006-3495(95)79919-2.
   Fonseca NA, 2014, J CONTROL RELEASE, V196, P122, DOI 10.1016/j.jconrel.2014.09.024.
   Gao J, 2014, NANOMEDICINE-UK, V9, P181, DOI 10.2217/nnm.13.195.
   Gao J, 2014, NANOMEDICINE-UK, V9, P279, DOI 10.2217/nnm.13.20.
   Gao J, 2012, NANOMEDICINE-UK, V7, P465, DOI {[}10.2217/NNM.12.11, 10.2217/nnm.12.11].
   Gouaze V, 2004, MOL CANCER THER, V3, P633.
   Han L, 2011, J AM CHEM SOC, V133, P11524, DOI {[}10.1021/ja200683t, 10.1021/ja2006831].
   Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599.
   Khazanov E, 2008, LANGMUIR, V24, P6965, DOI 10.1021/la800207z.
   KUMAR VV, 1991, P NATL ACAD SCI USA, V88, P444, DOI 10.1073/pnas.88.2.444.
   Lasic DD, 1991, PERIOD BIOL, V93, P9287.
   Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530.
   Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981.
   Liu YY, 1999, J BIOL CHEM, V274, P1140, DOI 10.1074/jbc.274.2.1140.
   Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com.
   Lucci A, 1999, INT J ONCOL, V15, P541.
   Pedrosa LRC, 2013, PHARM RES-DORDR, V30, P1883, DOI 10.1007/s11095-013-1031-6.
   Rath G, 2009, INT J BIOCHEM CELL B, V41, P1165, DOI 10.1016/j.biocel.2008.10.021.
   Sapra P, 2004, CLIN CANCER RES, V10, P2530, DOI 10.1158/1078-0432.CCR-03-0376.
   Sapra Puja, 2005, Current Drug Delivery, V2, P369, DOI 10.2174/156720105774370159.
   Senchenkov Alex, 2001, Journal of the National Cancer Institute (Bethesda), V93, P347, DOI 10.1093/jnci/93.5.347.
   Shapira A, 2011, DRUG RESIST UPDATE, V14, P150, DOI 10.1016/j.drup.2011.01.003.
   STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9.
   Stover TC, 2008, BIOMATERIALS, V29, P359, DOI 10.1016/j.biomaterials.2007.09.037.
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632.
   van Lummel M, 2011, FASEB J, V25, P280, DOI 10.1096/fj.10-163709.
   van Vlerken LE, 2007, CANCER RES, V67, P4843, DOI 10.1158/0008-5472.CAN-06-1648.
   Veiga MP, 1999, BIOPHYS J, V76, P342, DOI 10.1016/S0006-3495(99)77201-2.
   Veldman RJ, 2005, J PHARMACOL EXP THER, V315, P704, DOI 10.1124/jpet.105.087486.
   Watters Rebecca J, 2012, Methods Enzymol, V508, P89, DOI 10.1016/B978-0-12-391860-4.00005-7.
   Wheeler JJ, 1999, GENE THER, V6, P271, DOI 10.1038/sj.gt.3300821.
   Win KY, 2005, BIOMATERIALS, V26, P2713, DOI 10.1016/j.biomaterials.2004.07.050.
   Zhang SL, 2009, ADV MATER, V21, P419, DOI 10.1002/adma.200801393.
   Zhang YP, 1999, GENE THER, V6, P1438, DOI 10.1038/sj.gt.3300965.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{11}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{14}},
Journal-ISO = {{Nanomedicine}},
Doc-Delivery-Number = {{CN7FH}},
Unique-ID = {{ISI:000358599100006}},
DA = {{2018-08-13}},
}

@article{ ISI:000357937500004,
Author = {Garg, Tarun and Rath, Goutam and Murthy, Rayasa R. and Gupta, Umesh D.
   and Vatsala, Palakkod G. and Goyal, Amit K.},
Title = {{Current Nanotechnological Approaches for an Effective Delivery of
   Bioactive Drug Molecules to Overcome Drug Resistance Tuberculosis}},
Journal = {{CURRENT PHARMACEUTICAL DESIGN}},
Year = {{2015}},
Volume = {{21}},
Number = {{22}},
Pages = {{3076-3089}},
Abstract = {{Tuberculosis (TB) is an airborne communicable disease, mainly caused by
   aerobic, non-motile, rod-shaped, weakly gram-positive, acid-fast
   tubercular bacillus Mycobacterium tuberculosis (MTb). Mycobacterium has
   worsened the problem in humans by acquiring various types of resistances
   like Multi-drug resistance (MDR), Single-drug resistance (SDR), and
   Extensive drug resistance (XDR). Some clinical problems and challenges
   associated with conventional TB chemotherapy include poor patient
   compliance, longer duration of chemotherapy, lesser cell permeability,
   primary drug resistance, difficulty in maintaining higher drug
   concentrations at the infected site, and degradation of the drug before
   reaching the target site. Thus, newer micrometric or nanometric carriers
   drug delivery approaches are needed. Colloidal (vesicular and
   particulate) drug carriers offer numerous advantages over conventional
   therapy such as better systemic bioavailability, rapid onset of
   therapeutic action, avoidance of first-pass metabolism, providing
   sustained and controlled release, fewer dosing frequencies, desired
   pharmacokinetic profile and route of administration. This review article
   present updates and fabrication of drug delivery approaches for
   tuberculosis chemotherapy in order to improve patient compliance.}},
Publisher = {{BENTHAM SCIENCE PUBL LTD}},
Address = {{EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Goyal, AK (Reprint Author), ISF Coll Pharm, Dept Pharmaceut, Moga, Punjab, India.
   Garg, Tarun; Rath, Goutam; Murthy, Rayasa R.; Goyal, Amit K., ISF Coll Pharm, Dept Pharmaceut, Moga, Punjab, India.
   Gupta, Umesh D., Natl Jalma Inst Leprosy \& Other Mycobacterial Dis, Agra, Uttar Pradesh, India.
   Vatsala, Palakkod G., IISc, Dept Biotechnol, Bangalore, India.}},
DOI = {{10.2174/1381612821666150531163254}},
ISSN = {{1381-6128}},
EISSN = {{1873-4286}},
Keywords = {{Colloidal systems; drug delivery; drug resistance; drug targeting;
   patient compliance; tuberculosis}},
Keywords-Plus = {{WATER-SOLUBLE DRUGS; TARGET ALVEOLAR MACROPHAGES; SOLID LIPID
   NANOPARTICLES; IN-VITRO RELEASE; ANTI-TB DRUGS;
   MYCOBACTERIUM-TUBERCULOSIS; SUSCEPTIBILITY ASSAY; POLYMERIC MICELLES;
   RECENT PROGRESS; COMPARATIVE BIOAVAILABILITY}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy}},
Author-Email = {{amitkumargoyal1979@gmail.com}},
Cited-References = {{Agrawal S, 2004, INT J PHARMACEUT, V276, P41, DOI 10.1016/j.ijpharm.2004.02.019.
   Ahmad Z, 2007, NANOMED-NANOTECHNOL, V3, P239, DOI 10.1016/j.nano.2007.05.001.
   Almeida Deepak V, 2014, Mycobact Dis, V4, P145.
   Bandyopadhyay S, 2012, COLLOID SURFACE B, V100, P50, DOI 10.1016/j.colsurfb.2012.05.019.
   Barrow ELW, 1998, ANTIMICROB AGENTS CH, V42, P2682.
   Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094.
   Brewster ME, 2007, ADV DRUG DELIVER REV, V59, P645, DOI 10.1016/j.addr.2007.05.012.
   Buchwald UK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116268.
   Cejkova J, 2013, CURR PHARM DESIGN, V19, P6298.
   Chaubey P, 2014, CARBOHYD POLYM, V101, P1101, DOI 10.1016/j.carbpol.2013.10.044.
   Chaudhary S, 2014, J DRUG TARGET, V22, P871, DOI 10.3109/1061186X.2014.950664.
   Chen WJ, 2011, INT J NANOMED, V6, P1535, DOI 10.2147/IJN.S21881.
   Chono S, 2008, J CONTROL RELEASE, V127, P50, DOI 10.1016/j.jconrel.2007.12.011.
   Cleal K, 2013, CURR PHARM DESIGN, V19, P2878.
   Dang TMH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-49.
   de Paula E, 2012, EXPERT OPIN DRUG DEL, V9, P1505, DOI 10.1517/17425247.2012.738664.
   Deol P, 1997, BBA-GEN SUBJECTS, V1334, P161, DOI 10.1016/S0304-4165(96)00088-8.
   Derrick SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032959.
   Dua K, 2011, J PHARM BIOALLIED SC, V3, P417, DOI 10.4103/0975-7406.84457.
   Dutt M, 2001, INT J ANTIMICROB AG, V17, P115, DOI 10.1016/S0924-8579(00)00330-7.
   El-Ridy MS, 2007, INT J PHARM, V330, P82, DOI 10.1016/j.ijpharm.2006.09.017.
   El-Ridy MS, 2015, DRUG DELIV, V22, P21, DOI 10.3109/10717544.2013.868556.
   Esfahanizadeh M, 2014, IRAN J PHARM RES, V13, P115.
   Fettiplace MR, 2014, J CONTROL RELEASE, V198C, P62.
   Franzblau SG, 2012, TUBERCULOSIS, V92, P453, DOI 10.1016/j.tube.2012.07.003.
   Gagandeep, 2014, EUR J PHARM SCI, V53, P10, DOI 10.1016/j.ejps.2013.11.016.
   Garcia-Contreras L, 2007, ANTIMICROB AGENTS CH, V51, P2830, DOI 10.1128/AAC.01164-06.
   Garg T, 2012, INT J PHARM PHARM SC, V4, P590.
   Garg T, 2014, J DRUG TARGET, P1.
   Garg T, 2012, DRUG DELIVERY LETT, V2, P270.
   Garg T., 2014, DRUG DELIV LETT, V4, P62.
   Garg T, 2014, DRUG DELIV.
   Garg T, 2014, CRIT REV THER DRUG, V31, P531, DOI 10.1615/CritRevTherDrugCarrierSyst.2014011104.
   Garg T, 2014, EXPERT OPIN DRUG DEL, V11, P767, DOI 10.1517/17425247.2014.891014.
   Garg T, 2013, CRIT REV THER DRUG, V30, P369, DOI 10.1615/CritRevTherDrugCarrierSyst.2013007259.
   Garg T, 2012, CRIT REV THER DRUG, V29, P1.
   Gaspar MM, 2008, INT J ANTIMICROB AG, V31, P37, DOI 10.1016/j.ijantimicag.2007.08.008.
   Goyal AK, 2013, DNA RNA NANOBIOTECHN, P67.
   Goyal G, 2013, DRUG DELIV.
   Goyal G, 2014, CRIT REV THER DRUG, V31, P89, DOI 10.1615/CritRevTherDrugCarrierSyst.2014008117.
   Goyal G, 2014, CRIT REV THER DRUG, V31, P365, DOI 10.1615/CritRevTherDrugCarrierSyst.2014010123.
   Gursoy A, 2004, INT J PHARM, V271, P115, DOI 10.1016/j.ijpharm.2003.10.033.
   Hao LH, 2014, INT J TUBERC LUNG D, V18, P1505, DOI 10.5588/ijtld.13.0647.
   Hari BNV, 2010, INDIAN J PHARMACOL, V42, P338, DOI 10.4103/0253-7613.71887.
   He L, 2015, TUBERCULOSIS, V95, P149, DOI 10.1016/j.tube.2014.12.002.
   Hettenhausen C, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0326-z.
   Huang ZK, 2015, J ANTIMICROB CHEMOTH, V70, P456, DOI 10.1093/jac/dku384.
   Huang ZK, 2014, RESPIROLOGY, V19, P132, DOI 10.1111/resp.12192.
   Hussain T, 2014, J BIOMATER TISS ENG, V4, P600, DOI 10.1166/jbt.2014.1214.
   Jain C. P., 2006, Indian Journal of Pharmaceutical Sciences, V68, P575.
   JAIN CP, 1995, J MICROENCAPSUL, V12, P401, DOI 10.3109/02652049509087252.
   Jain JP, 2011, CURR PHARM DESIGN, V17, P65.
   Jamali H, 2015, J DAIRY SCI, V98, P798, DOI 10.3168/jds.2014-8853.
   Johal HS, 2014, DRUG DELIV.
   Joshi D, 2014, CURR DRUG DELIV.
   Joshi D, 2014, DRUG DELIV.
   Kalia V, 2014, ARTIF CELLS NANOMED.
   Kataria K., 2014, DRUG DELIVERY LETT, V4, P79.
   Kaur M, 2014, ARTIF CELLS NANOMED.
   Kaur M, 2015, DRUG DELIV, V22, P328, DOI 10.3109/10717544.2014.894594.
   Kaur M, 2014, CRIT REV THER DRUG, V31, P49, DOI 10.1615/CritRevTherDrugCarrierSyst.2014008285.
   Kaur N, 2014, DRUG DELIV.
   Kaur P, 2014, DRUG DELIV.
   Kaur P, 2014, J DRUG TARGET.
   Kaur R, 2014, ARTIF CELLS NANOMED.
   Kaur R, 2014, DRUG DELIV.
   Kaur R, 2014, CRIT REV THER DRUG, V31, P495, DOI 10.1615/CritRevTherDrugCarrierSyst.2014010527.
   Kaur V, 2014, J DRUG TARGET.
   Khalil NM, 2013, CURR PHARM DESIGN, V19, P7316, DOI 10.2174/138161281941131219135458.
   Kisich KO, 2007, INT J PHARM, V345, P154, DOI 10.1016/j.ijpharm.2007.05.062.
   KLEMENS SP, 1990, ANTIMICROB AGENTS CH, V34, P967, DOI 10.1128/AAC.34.6.967.
   Kumar A, 2013, EUR J PHARM BIOPHARM, V85, P814, DOI 10.1016/j.ejpb.2013.09.013.
   Kumar PV, 2006, J DRUG TARGET, V14, P546, DOI 10.1080/10611860600825159.
   Kweon MN, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.2.
   Kwok PCL, 2014, CURR PHARM DESIGN, V20, P474, DOI 10.2174/13816128113199990400.
   Labana S, 2002, INT J ANTIMICROB AG, V20, P301, DOI 10.1016/S0924-8579(02)00175-9.
   Leung MHM, 2013, CURR PHARM DESIGN, V19, P2070.
   Liu JY, 2013, CURR PHARM DESIGN, V19, P1974.
   Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251.
   Maia CS, 2000, INT J PHARM, V196, P165, DOI 10.1016/S0378-5173(99)00413-5.
   Malik R, 2014, J DRUG TARGET, V23, P1.
   Manalan VP, 2014, INT J BIOL PHARM RES, V5, P913.
   Maretti E, 2014, INT J PHARMACEUT, V462, P74, DOI 10.1016/j.ijpharm.2013.12.034.
   Martin C, 2014, CURR PHARM DESIGN, V21, P43.
   Marwah H, 2014, DRUG DELIV.
   Mathaes R, 2015, EXPERT OPIN DRUG DEL, V12, P481, DOI 10.1517/17425247.2015.963055.
   Mathaes R, 2013, INT J PHARMACEUT, V453, P620, DOI 10.1016/j.ijpharm.2013.05.046.
   Mehta SK, 2007, COLLOID SURFACE B, V60, P95, DOI 10.1016/j.colsurfb.2007.06.012.
   Mehta SK, 2010, J PHARM SCI-US, V99, P1896, DOI 10.1002/jps.21971.
   Mehta SK, 2011, COLLOID SURFACE B, V87, P173, DOI 10.1016/j.colsurfb.2011.05.018.
   Modgill V, 2014, CURR DRUG DELIV.
   Modgill V, 2014, ARTIF CELLS NANOMED.
   Moretton MA, 2013, J BIOMED NANOTECHNOL, V9, P1076, DOI 10.1166/jbn.2013.1600.
   Moretton MA, 2010, COLLOID SURFACE B, V79, P467, DOI 10.1016/j.colsurfb.2010.05.016.
   Moribe K, 2013, CURR PHARM DESIGN, V19, P6246.
   Morie A, 2014, ARTIF CELLS NANOMED.
   Nikonenko B, 2014, ANTIMICROB AGENTS CH, V58, P587, DOI 10.1128/AAC.01254-13.
   Orr MT, 2013, J CONTROL RELEASE, V172, P190, DOI 10.1016/j.jconrel.2013.07.030.
   Outhred AC, 2015, J ANTIMICROB CHEMOTH, V70, P1198, DOI 10.1093/jac/dku508.
   Pabreja S, 2014, ARTIF CELLS NANOMED.
   Pandey R, 2005, J ANTIMICROB CHEMOTH, V55, P430, DOI 10.1093/jac/dki027.
   Pandey R, 2003, J ANTIMICROB CHEMOTH, V52, P981, DOI 10.1093/jac/dkg477.
   Pandey Rajesh, 2006, Indian Journal of Experimental Biology, V44, P357.
   Pandey Rajesh, 2004, Indian Journal of Experimental Biology, V42, P562.
   Parikh R, 2014, DRUG DELIV, V21, P406, DOI 10.3109/10717544.2013.851302.
   Parikh R, 2014, J ANTIBIOT, V67, P387, DOI 10.1038/ja.2014.13.
   Patil SS, 2014, J GLOB INFECT DIS, V6, P151, DOI 10.4103/0974-777X.145239.
   Patomchaiviwat V, 2008, AAPS PHARMSCITECH, V9, P1119, DOI 10.1208/s12249-008-9152-7.
   Pedersen JS, 2012, BIOPHYS J, V102, P2372, DOI 10.1016/j.bpj.2012.03.071.
   Pereira DM, 2014, MAR DRUGS, V12, P6014, DOI 10.3390/md12126014.
   Pourshahab PS, 2011, J MICROENCAPSUL, V28, P605, DOI 10.3109/02652048.2011.599437.
   Puri Anu, 2013, Pharmaceutics, V6, P1, DOI 10.3390/pharmaceutics6010001.
   Raman C, 2005, J CONTROL RELEASE, V103, P149, DOI 10.1016/j.conrel.2004.11.012.
   Rao BP, 2006, ARS PHARM, V47, P39.
   Raza K, 2013, COLLOID SURFACE B, V105, P67, DOI 10.1016/j.colsurfb.2012.12.043.
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI {[}10.1038/nbt1332, 10.1038/nbtl332].
   Ricci M, 2006, INT J PHARM, V311, P172, DOI 10.1016/j.ijpharm.2005.12.031.
   Rijcken CJF, 2007, J CONTROL RELEASE, V124, P144, DOI 10.1016/j.jconrel.2007.09.002.
   Rocha S, 2013, CURR PHARM DESIGN, V19, P6635.
   Rohilla R, 2014, DRUG DELIV.
   Saraogi GK, 2011, J DRUG TARGET, V19, P219, DOI 10.3109/1061186X.2010.492522.
   Saraogi GK, 2010, INT J PHARMACEUT, V385, P143, DOI 10.1016/j.ijpharm.2009.10.004.
   Serpe L, 2013, CURR PHARM DESIGN, V19, P7219.
   Sharma A, 2004, J ANTIMICROB CHEMOTH, V54, P761, DOI 10.1093/jac/dkh411.
   Sharma A, 2014, ARTIF CELLS NANOMED.
   Sharma R, 2001, PHARMACEUT RES, V18, P1405, DOI 10.1023/A:1012296604685.
   Sharma R, 2014, ARTIF CELLS NANOMED.
   Sharma R, 2014, CRIT REV THER DRUG, V31, P187, DOI 10.1615/CritRevTherDrugCarrierSyst.2014008193.
   Shen SC, 2013, CURR PHARM DESIGN, V19, P6270.
   Shen WM, 2007, CHEM COMMUN, P2360, DOI 10.1039/b701256j.
   Silva AC, 2013, CURR PHARM DESIGN, V19, P7185, DOI 10.2174/138161281941131219123329.
   Singh B, 2014, ARTIF CELLS NANOMED.
   Singh B, 2013, COLLOID SURFACE B, V101, P465, DOI 10.1016/j.colsurfb.2012.07.017.
   Singh H, 2014, ARTIF CELLS NANOMED.
   Singh Niti, 2014, Indian J Tuberc, V61, P148.
   Singh O, 2014, J PHARM.
   Sun YD, 2014, CURR PHARM DESIGN, V20, P349, DOI 10.2174/13816128113199990404.
   Tang YH, 2011, CURR PHARM DESIGN, V17, P2308, DOI 10.2174/138161211797052367.
   Thomas TP, 2013, CURR PHARM DESIGN, V19, P6594.
   ul-Ain Q, 2003, ANTIMICROB AGENTS CH, V47, P3005, DOI 10.1128/AAC.47.9.3005-3007.2003.
   Verissimo LMP, 2015, INT J PHARMACEUT, V479, P306, DOI 10.1016/j.ijpharm.2014.12.053.
   Vicario-de-la-Torre M, 2014, INVEST OPHTH VIS SCI, V55, P7839, DOI 10.1167/iovs.14-14700.
   VLADIMIRSKY MA, 1982, BIOMED PHARMACOTHER, V36, P375.
   Vyas A, 2013, CURR PHARM DESIGN, V19, P2047.
   Vyas SP, 2004, INT J PHARM, V269, P37, DOI 10.1016/j.ijpharm.2003.08.017.
   Wang YC, 2014, CURR PHARM DESIGN, V20, P454, DOI 10.2174/13816128113199990403.
   Yang SC, 2003, ANTIMICROB AGENTS CH, V47, P1958, DOI 10.1128/AAC.47.6.1958-1962.2003.
   Yu M, 2014, EUR J PHARM BIOPHARM, V88, P92, DOI 10.1016/j.ejpb.2014.03.019.
   Zahoor A, 2005, INT J ANTIMICROB AG, V26, P298, DOI 10.1016/j.ijantimicag.2005.07.012.
   Zhang X, 2014, CURR PHARM DESIGN, V20, P388, DOI 10.2174/13816128113199990401.}},
Number-of-Cited-References = {{150}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{Curr. Pharm. Design}},
Doc-Delivery-Number = {{CM8GS}},
Unique-ID = {{ISI:000357937500004}},
DA = {{2018-08-13}},
}

@article{ ISI:000356372400013,
Author = {Xu, Youchun and Yan, He and Zhang, Yan and Jiang, Kewei and Lu, Ying and
   Ren, Yonghong and Wang, Hui and Wang, Shan and Xing, Wanli},
Title = {{A fully sealed plastic chip for multiplex PCR and its application in
   bacteria identification}},
Journal = {{LAB ON A CHIP}},
Year = {{2015}},
Volume = {{15}},
Number = {{13}},
Pages = {{2826-2834}},
Abstract = {{Multiplex PCR is an effective tool for simultaneous multiple target
   detection but is limited by the intrinsic interference and competition
   among primer pairs when it is performed in one reaction tube. Dividing a
   multiplex PCR into many single PCRs is a simple strategy to overcome
   this issue. Here, we constructed a plastic, easy-to-use, fully sealed
   multiplex PCR chip based on reversible centrifugation for the
   simultaneous detection of 63 target DNA sequences. The structure of the
   chip is quite simple, which contains sine-shaped infusing channels and a
   number of reaction chambers connecting to one side of these channels.
   Primer pairs for multiplex PCR were sequentially preloaded in the
   different reaction chambers, and the chip was enclosed with
   PCR-compatible adhesive tape. For usage, the PCR master mix containing a
   DNA template is pipetted into the infusing channels and centrifuged into
   the reaction chambers, leaving the infusing channels filled with air to
   avoid cross-contamination of the different chambers. Then, the chip is
   sealed and placed on a flat thermal cycler for PCR. Finally,
   amplification products can be detected in situ using a fluorescence
   scanner or recovered by reverse centrifugation for further analyses.
   Therefore, our chip possesses two functions: 1) it can be used for
   multi-target detection based on end-point in situ fluorescence
   detection; and 2) it can work as a sample preparation unit for analyses
   that need multiplex PCR such as hybridization and target sequencing. The
   performance of this chip was carefully examined and further illustrated
   in the identification of 8 pathogenic bacterial genomic DNA samples and
   13 drug-resistance genes. Due to simplicity of its structure and
   operation, accuracy and generality, high-throughput capacity, and
   versatile functions (i.e., for in situ detection and sample
   preparation), our multiplex PCR chip has great potential in clinical
   diagnostics and nucleic acid-based point-of-care testing.}},
Publisher = {{ROYAL SOC CHEMISTRY}},
Address = {{THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Xing, WL (Reprint Author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.
   Xu, Youchun; Yan, He; Lu, Ying; Xing, Wanli, Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.
   Zhang, Yan; Xing, Wanli, Collaborat Innovat Ctr Diag \& Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.
   Zhang, Yan; Lu, Ying; Xing, Wanli, Natl Engn Res Ctr Beijing Biochip Technol, Beijing 102206, Peoples R China.
   Jiang, Kewei; Wang, Hui; Wang, Shan, Peking Univ, Peoples Hosp, Beijing 100044, Peoples R China.
   Ren, Yonghong, CapitalBio Technol, Beijing 101111, Peoples R China.}},
DOI = {{10.1039/c5lc00244c}},
ISSN = {{1473-0197}},
EISSN = {{1473-0189}},
Keywords-Plus = {{POINT-OF-CARE; POLYMERASE-CHAIN-REACTION; DNA AMPLIFICATION; SURFACE
   PASSIVATION; BETA-LACTAMASE; SYSTEM; MICROARRAY; SILICON; NUMBER; LOCUS}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry; Science \& Technology -
   Other Topics}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience \& Nanotechnology}},
Author-Email = {{wlxing@tsinghua.edu.cn}},
Funding-Acknowledgement = {{National Hi-Tech Program of China {[}2012AA020101]; China Postdoctoral
   Science Foundation {[}2012 M510464]; National Natural Science Foundation
   of China {[}81327005, 81471749]; National Sci-Tech Support Plan
   {[}2012EP001002]; Beijing lab foundation}},
Funding-Text = {{This study was supported by grants from the National Hi-Tech Program of
   China (no. 2012AA020101), the China Postdoctoral Science Foundation (no.
   2012 M510464), the National Natural Science Foundation of China (no.
   81327005 and no. 81471749), the National Sci-Tech Support Plan (no.
   2012EP001002) and the Beijing lab foundation.}},
Cited-References = {{Adessi C, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e87.
   Ahmed R., 2014, J CLIN NEUROSCI, V21, P2042.
   Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a.
   Baker M, 2010, NAT METHODS, V7, P351, DOI 10.1038/nmeth0510-351.
   Butler J. M., 2007, BIOTECHNIQUES, V43.
   CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141.
   Chen J, 2012, LAB CHIP, V12, P1753, DOI 10.1039/c2lc21273k.
   Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000.
   Focke M, 2010, LAB CHIP, V10, P2519, DOI 10.1039/c004954a.
   Han N, 2014, RSC ADV, V4, P9160, DOI 10.1039/c3ra47980c.
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g.
   Jeong JH, 2009, J MICROBIOL, V47, P753, DOI 10.1007/s12275-008-0272-2.
   Ji XH, 2011, LAB CHIP, V11, P2561, DOI 10.1039/c1lc20150f.
   Kim SR, 2009, J VIROL METHODS, V156, P111, DOI 10.1016/j.jviromet.2008.11.007.
   Kivlehan F, 2011, ANALYST, V136, P3635, DOI 10.1039/c1an15289k.
   Kodzius R, 2012, SENSOR ACTUAT B-CHEM, V161, P349, DOI 10.1016/j.snb.2011.10.044.
   Kumaresan P, 2008, ANAL CHEM, V80, P3522, DOI 10.1021/ac800327d.
   Lee SH, 2008, LAB CHIP, V8, P2121, DOI 10.1039/b811131f.
   Li Y, 2011, LAB CHIP, V11, P3609, DOI 10.1039/c1lc20526a.
   Lindstedt BA, 2004, J MICROBIOL METH, V59, P163, DOI 10.1016/j.mimet.2004.06.014.
   Lou XJ, 2004, BIOTECHNIQUES, V36, P248, DOI 10.2144/04362ST01.
   Markoulatos P, 2002, J CLIN LAB ANAL, V16, P47, DOI 10.1002/jcla.2058.
   Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9.
   Morrison T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl639.
   Mousavi MZ, 2013, ANALYST, V138, P2740, DOI 10.1039/c3an36655c.
   Nagai H, 2001, BIOSENS BIOELECTRON, V16, P1015, DOI 10.1016/S0956-5663(01)00248-2.
   Palka-Santini M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-1.
   Park IS, 2004, J MICROBIOL BIOTECHN, V14, P698.
   Ramalingam N, 2009, BIOMED MICRODEVICES, V11, P1007, DOI 10.1007/s10544-009-9318-4.
   Sforza S, 2011, CHEM SOC REV, V40, P221, DOI 10.1039/b907695f.
   Shen F, 2010, ANAL CHEM, V82, P4606, DOI 10.1021/ac1007249.
   Sundberg SO, 2010, ANAL CHEM, V82, P1546, DOI 10.1021/ac902398c.
   Sweryda-Krawiec B, 2004, LANGMUIR, V20, P2054, DOI 10.1021/la034870g.
   Wang C, 2012, ANALYST, V137, P4539, DOI 10.1039/c2an35417a.
   Yang HY, 2009, YONSEI MED J, V50, P764, DOI 10.3349/ymj.2009.50.6.764.
   Zhang SH, 2014, FORENSIC SCI INT-GEN, V13, P112, DOI 10.1016/j.fsigen.2014.06.015.
   Zhu QY, 2012, LAB CHIP, V12, P4755, DOI 10.1039/c2lc40774d.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{9}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{65}},
Journal-ISO = {{Lab Chip}},
Doc-Delivery-Number = {{CK6XP}},
Unique-ID = {{ISI:000356372400013}},
DA = {{2018-08-13}},
}

@article{ ISI:000354671300001,
Author = {Wojtyczka, Robert D. and Zieba, Andrzej and Dziedzic, Arkadiusz and
   Kepa, Malgorzata and Idzik, Danuta},
Title = {{An Activity of Thioacyl Derivatives of 4-Aminoquinolinium Salts towards
   Biofilm Producing and Planktonic Forms of Coagulase-Negative
   Staphylococci}},
Journal = {{BIOMED RESEARCH INTERNATIONAL}},
Year = {{2015}},
Abstract = {{Microorganisms present in different environments have developed specific
   mechanisms of settling on various abiotic and biotic surfaces by forming
   a biofilm. It seems to be well justified to search for new compounds
   enabling biofilm reduction, which is highly resistant to antibiotics.
   This study was thus an initial assessment of the antibacterial activity
   of two new quinoline derivatives of a structure of 3-thioacyl 1-methyl
   4-arylaminoquinolinium salts against coagulase-negative staphylococci (
   CoNS) isolated from a hospital environment, in a form of both biofilms
   and in planktonic form. Thirty-three stains of CoNS isolated from the
   hospital environment (air, surfaces) and seven reference strains from
   the ATCC collection were selected for the study. The mean MIC value for
   1-methyl-3-benzoylthio-4-(4-chlorophenylamino) quinolinum chloride
   (4-chlorophenylamino derivative) was 42.60 +/- 19.91 mu g/mL, and in the
   case of strains subjected to
   1-methyl-3-benzoylthio-4-(4-fluorophenylamino) quinolinum chloride
   (4-fluorophenylamino derivative) activity, the mean MIC value was 43.20
   +/- 14.30 mu g/mL. The mean concentration of 4-chlorophenylamino
   derivative that inhibited biofilm formation was 86.18 +/- 30.64 mu g/mL.
   The mean concentration of 4-fluorophenylamino derivatives that inhibited
   biofilm formation was higher and amounted to 237.09 +/- 160.57 mu g/mL.
   Based on the results, both derivatives of the examined compounds exhibit
   high antimicrobial activity towards strains growing both in planktonic
   and biofilm form.}},
Publisher = {{HINDAWI PUBLISHING CORPORATION}},
Address = {{410 PARK AVENUE, 15TH FLOOR, \#287 PMB, NEW YORK, NY 10022 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wojtyczka, RD (Reprint Author), Med Univ Silesia, Sch Pharm, Dept \& Inst Microbiol \& Virol, Jagiellonska 4, PL-41200 Katowice, Poland.
   Wojtyczka, Robert D.; Kepa, Malgorzata; Idzik, Danuta, Med Univ Silesia, Sch Pharm, Dept \& Inst Microbiol \& Virol, PL-41200 Katowice, Poland.
   Wojtyczka, Robert D.; Zieba, Andrzej; Kepa, Malgorzata; Idzik, Danuta, Med Univ Silesia, Div Lab Med Sosnowiec, PL-41200 Katowice, Poland.
   Zieba, Andrzej, Med Univ Silesia, Sch Pharm, Dept Organ Chem, PL-41200 Katowice, Poland.
   Dziedzic, Arkadiusz, Med Univ Silesia, Dept Conservat Dent Endodont, PL-41902 Katowice, Poland.}},
DOI = {{10.1155/2015/725939}},
Article-Number = {{725939}},
ISSN = {{2314-6133}},
EISSN = {{2314-6141}},
Keywords-Plus = {{POLYSACCHARIDE INTERCELLULAR ADHESIN; BACTERIAL BIOFILMS; IN-VITRO;
   ANTIBIOTIC SUSCEPTIBILITY; ANTIMICROBIAL ACTIVITY; EPIDERMIDIS BIOFILMS;
   IMPLANT INFECTIONS; PHENOTYPIC METHODS; SLIME PRODUCTION; RESISTANCE}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Research \& Experimental Medicine}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Medicine, Research \&
   Experimental}},
Author-Email = {{rwojtyczka@sum.edu.pl}},
ORCID-Numbers = {{Dziedzic, Arkadiusz/0000-0003-0022-8382
   Wojtyczka, Robert Dariusz/0000-0002-0334-0938
   Kepa, Malgorzata/0000-0002-4013-6688}},
Cited-References = {{{[}Anonymous], 2008, M100S18 CLIN LAB STA.
   Arciola CR, 2006, J BIOMED MATER RES A, V76A, P425, DOI 10.1002/jbm.a.30552.
   Beceiro A, 2013, CLIN MICROBIOL REV, V26, P185, DOI 10.1128/CMR.00059-12.
   Bridier A, 2011, BIOFOULING, V27, P1017, DOI 10.1080/08927014.2011.626899.
   Bueno J., 2014, J MICROBIAL BIOCH TE, VS3, DOI {[}10.4172/1948-5948.S3-0043966.x, DOI 10.4172/1948-5948.S3-004].
   Cerca N, 2005, J ANTIMICROB CHEMOTH, V56, P331, DOI 10.1093/jac/dki217.
   Ceri H, 1999, J CLIN MICROBIOL, V37, P1771.
   Chokr A, 2007, MICROB PATHOGENESIS, V42, P94, DOI 10.1016/j.micpath.2006.09.001.
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996.
   Chusri S, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/159797.
   Cochran WL, 2000, J APPL MICROBIOL, V88, P22, DOI 10.1046/j.1365-2672.2000.00825.x.
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318.
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062.
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431.
   Das JR, 1998, J APPL MICROBIOL, V84, P852.
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295.
   de Silva GDI, 2002, J CLIN MICROBIOL, V40, P382, DOI {[}10.1128/JCM.40.02.382-388.2002, 10.1128/JCM.40.2.382-388.2002].
   El-Banna T, 2010, AFR J MICROBIOL RES, V4, P2275.
   Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0.
   Fluckiger U, 2005, INFECT IMMUN, V73, P1811, DOI 10.1128/IAI.73.3.1811-1819.2005.
   FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872.
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586.
   Heikens E, 2005, J CLIN MICROBIOL, V43, P2286, DOI 10.1128/JCM.43.5.2286-2290.2005.
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011.
   Huebner J, 1999, ANNU REV MED, V50, P223.
   Koksal F, 2009, MICROBIOL RES, V164, P404, DOI 10.1016/j.micres.2007.03.004.
   LaPlante KL, 2009, ANTIMICROB AGENTS CH, V53, P3880, DOI 10.1128/AAC.00134-09.
   Liberto MC, 2009, MICROBIOL RES, V164, P522, DOI 10.1016/j.micres.2007.04.004.
   Lin MH, 2011, ANTIMICROB AGENTS CH, V55, P1021, DOI 10.1128/AAC.00843-10.
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996.
   Melendez Gomez C. M., 2013, MICROBIAL PATHOGENS.
   Nishimura S, 2006, J ORTHOP SCI, V11, P46, DOI 10.1007/s00776-005-0968-7.
   Qu Y, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-16.
   Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279.
   Saising J, 2012, ANTIMICROB AGENTS CH, V56, P5804, DOI 10.1128/AAC.01296-12.
   Soto SM, 2013, VIRULENCE, V4, P223, DOI 10.4161/viru.23724.
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1.
   Taraszkiewicz A, 2013, BIOMED RES INT, DOI 10.1155/2013/150653.
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200.
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0.
   Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219.
   Winter RW, 2008, EXP PARASITOL, V118, P487, DOI 10.1016/j.exppara.2007.10.016.
   Wozniak-Kosek A., 2010, MILITARY PHARM MED, V3, P21.
   Wu EC, 2010, J OCUL PHARMACOL TH, V26, P557, DOI 10.1089/jop.2010.0097.
   Zieba A, 2010, FOLIA MICROBIOL, V55, P3, DOI 10.1007/s12223-010-0001-1.
   Zieba A, 2013, ACTA POL PHARM, V70, P163.
   Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{Biomed Res. Int.}},
Doc-Delivery-Number = {{CI3TW}},
Unique-ID = {{ISI:000354671300001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000353658400003,
Author = {Liang, Zhao-Xun},
Title = {{The expanding roles of c-di-GMP in the biosynthesis of
   exopolysaccharides and secondary metabolites}},
Journal = {{NATURAL PRODUCT REPORTS}},
Year = {{2015}},
Volume = {{32}},
Number = {{5}},
Pages = {{663-683}},
Abstract = {{The cyclic dinucleotide c-di-GMP has emerged in the last decade as a
   prevalent intracellular messenger that orchestrates the transition
   between the motile and sessile lifestyles of many bacterial species. The
   motile-to-sessile transition is often associated with the formation of
   extracellular matrix-encased biofilm, an organized community of
   bacterial cells that often contributes to antibiotic resistance and
   host-pathogen interaction. It is increasingly clear that c-di-GMP
   controls motility, biofilm formation and bacterial pathogenicity
   partially through regulating the production of exopolysaccharides (EPS)
   and small-molecule secondary metabolites. This review summarizes our
   current understanding of the regulation of EPS biosynthesis by c-di-GMP
   in a diversity of bacterial species and highlights the emerging role of
   c-di-GMP in the biosynthesis of small-molecule secondary metabolites.}},
Publisher = {{ROYAL SOC CHEMISTRY}},
Address = {{THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Liang, ZX (Reprint Author), Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol \& Biochem, Singapore 637551, Singapore.
   Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol \& Biochem, Singapore 637551, Singapore.}},
DOI = {{10.1039/c4np00086b}},
ISSN = {{0265-0568}},
EISSN = {{1460-4752}},
Keywords-Plus = {{BACTERIAL CELLULOSE SYNTHASE; PSEUDOMONAS-FLUORESCENS SBW25; REGULATES
   BIOFILM FORMATION; HD-GYP DOMAIN; RESPONSIVE TRANSCRIPTION FACTOR;
   ENTERICA SEROVAR TYPHIMURIUM; SIGNAL-TRANSDUCTION SYSTEMS; CYCLIC
   DIGUANYLIC ACID; AIR-LIQUID INTERFACE; ESCHERICHIA-COLI}},
Research-Areas = {{Biochemistry \& Molecular Biology; Pharmacology \& Pharmacy; Chemistry}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Chemistry, Medicinal; Chemistry,
   Organic}},
Author-Email = {{zxliang@ntu.edu.sg}},
ORCID-Numbers = {{Liang, Zhao-Xun/0000-0002-3128-1330}},
Funding-Acknowledgement = {{Ministry of Education of Singapore}},
Funding-Text = {{The research work on the role of c-di-GMP in bacterial biofilm and
   pathogenicity in our lab is supported by a generous academic research
   Tier II grant (Z.-X.L.) from the Ministry of Education of Singapore.}},
Cited-References = {{Abel S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003744.
   Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018.
   Agostoni M., 2013, MBIO, V4.
   Alvarez-Lorenzo C, 2013, ADV DRUG DELIVER REV, V65, P1148, DOI 10.1016/j.addr.2013.04.016.
   Amarasinghe JJ, 2013, INFECT IMMUN, V81, P653, DOI {[}10.1128/IAI.00813, 10.1128/IAI.00813-12].
   Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739.
   An SQ, 2013, EMBO J, V32, P2430, DOI 10.1038/emboj.2013.165.
   Anantharaman V, 2000, TRENDS BIOCHEM SCI, V25, P535, DOI 10.1016/S0968-0004(00)01672-8.
   Andrade MO, 2006, MOL MICROBIOL, V62, P537, DOI 10.1111/j.1365-2958.2006.05386.x.
   Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1016/S0378-1097(01)00394-9.
   Baraquet C, 2012, NUCLEIC ACIDS RES, V40, P7207, DOI 10.1093/nar/gks384.
   Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966.
   Barnhart DM, 2014, J BACTERIOL, V196, P1257, DOI 10.1128/JB.01446-13.
   Barnhart DM, 2013, APPL ENVIRON MICROB, V79, P7188, DOI 10.1128/AEM.02148-13.
   Bassis CM, 2010, J BACTERIOL, V192, P1269, DOI 10.1128/JB.01048-09.
   Begley M, 2009, APPL ENVIRON MICROB, V75, P5451, DOI 10.1128/AEM.00730-09.
   Bellini D, 2014, MOL MICROBIOL, V91, P26, DOI 10.1111/mmi.12447.
   Bellows LE, 2012, MOL MICROBIOL, V86, P661, DOI 10.1111/mmi.12011.
   Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918.
   Beyhan S, 2006, J BACTERIOL, V188, P3600, DOI 10.1128/JB.t88.10.3600-3613.2006.
   Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036.
   Bobrov AG, 2008, ENVIRON MICROBIOL, V10, P1419, DOI 10.1111/j.1462-2920.2007.01554.x.
   Bobrov AG, 2007, ADV EXP MED BIOL, V603, P201.
   Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018.
   Boehm A, 2009, MOL MICROBIOL, V72, P1500, DOI 10.1111/j.1365-2958.2009.06739.x.
   Bokranz W, 2005, J MED MICROBIOL, V54, P1171, DOI 10.1099/jmm.0.46064-0.
   Bomchil N, 2003, J BACTERIOL, V185, P1384, DOI 10.1128/JB.185.4.1384-1390.2003.
   Bragonzi A, 2005, J INFECT DIS, V192, P410, DOI 10.1086/431516.
   Brombacher E, 2006, J BACTERIOL, V188, P2027, DOI 10.1128/JB.188.6.2027-2037.2006.
   Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P7263, DOI 10.1128/AEM.71.11.7263-7270.2005.
   BUGERT P, 1995, MOL MICROBIOL, V15, P917, DOI 10.1111/j.1365-2958.1995.tb02361.x.
   Caetano T, 2011, CHEM BIOL, V18, P90, DOI 10.1016/j.chembiol.2010.11.010.
   Cao Z, 2010, PHOTOCHEM PHOTOBIOL, V86, P606, DOI 10.1111/j.1751-1097.2010.00724.x.
   Casper-Lindley C, 2004, J BACTERIOL, V186, P1574, DOI 10.1128/JB.186.5.1574-1578.2004.
   Challis GL, 2008, MICROBIOL-SGM, V154, P1555, DOI 10.1099/mic.0.2008/018523-0.
   Chambers JR, 2014, MOL MICROBIOL, V92, P471, DOI 10.1111/mmi.12562.
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101.
   Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236.
   Chen AGY, 2011, RNA, V17, P1967, DOI 10.1261/rna.2757311.
   Chen LH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004301.
   Chen MW, 2012, J BACTERIOL, V194, P4837, DOI 10.1128/JB.00560-12.
   Chiang YM, 2011, CURR OPIN CHEM BIOL, V15, P137, DOI 10.1016/j.cbpa.2010.10.011.
   Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09.
   Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104.
   Colvin KM, 2013, J BACTERIOL, V195, P2329, DOI 10.1128/JB.02150-12.
   Colvin KM, 2012, ENVIRON MICROBIOL, V14, P1913, DOI 10.1111/j.1462-2920.2011.02657.x.
   Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264.
   Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1.
   Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006.
   D'Alvise PW, 2014, ENVIRON MICROBIOL, V16, P1252, DOI 10.1111/1462-2920.12265.
   D'Argenio DA, 2004, MICROBIOL-SGM, V150, P2497, DOI 10.1099/mic.0.27099-0.
   Da Re S, 2006, J BACTERIOL, V188, P3073, DOI 10.1128/JB.188.8.3073-3087.2006.
   Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000.
   Darby C, 2008, TRENDS MICROBIOL, V16, P158, DOI 10.1016/j.tim.2008.01.005.
   De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067.
   Deepthi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110912.
   den Hengst CD, 2010, MOL MICROBIOL, V78, P361, DOI 10.1111/j.1365-2958.2010.07338.x.
   Deng YY, 2012, P NATL ACAD SCI USA, V109, P15479, DOI 10.1073/pnas.1205037109.
   Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409.
   Edmunds AC, 2013, J BACTERIOL, V195, P2155, DOI 10.1128/JB.02068-12.
   Engl C., 2014, MBIO, V5.
   Fang X, 2014, MOL MICROBIOL, V93, P439, DOI 10.1111/mmi.12672.
   Fazli M., 2012, MICROBIOLOGYOPEN, V25, P61.
   Fazli M, 2011, MOL MICROBIOL, V82, P327, DOI 10.1111/j.1365-2958.2011.07814.x.
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415.
   Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x.
   Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004.
   Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x.
   Fujiwara T., 2013, BIOCHEM BIOPH RES CO, V4, P02463.
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010.
   Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05.
   Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35.
   Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1016/S0378-1097(01)00326-3.
   Garrison-Schilling KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100890.
   Gerstel U, 2003, MOL MICROBIOL, V49, P639, DOI 10.1046/j.1365-2958.2003.03594.x.
   Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863.
   Guo YZ, 2010, INFECT IMMUN, V78, P1390, DOI 10.1128/IAI.01188-09.
   Guvener ZT, 2007, MOL MICROBIOL, V66, P1459, DOI 10.1111/j.1365-2958.2007.06008.x.
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821.
   Hay ID, 2009, APPL ENVIRON MICROB, V75, P6022, DOI 10.1128/AEM.01078-09.
   Hay ID, 2009, APPL ENVIRON MICROB, V75, P1110, DOI 10.1128/AEM.02416-08.
   He M., 2011, PLOS PATHOG, V7, P30.
   Hefti M. H., 2004, EUR J BIOCHEM, V271, P1198.
   Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109.
   Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x.
   Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102.
   Ho CL, 2013, J AM CHEM SOC, V135, P566, DOI 10.1021/ja310497x.
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011.
   Hu SQ, 2010, P NATL ACAD SCI USA, V107, P17957, DOI 10.1073/pnas.1000601107.
   Huangyutitham V, 2013, MBIO, V4, DOI 10.1128/mBio.00242-13.
   Irie Y, 2012, P NATL ACAD SCI USA, V109, P20632, DOI 10.1073/pnas.1217993109.
   Irie Y, 2010, MOL MICROBIOL, V78, P158, DOI 10.1111/j.1365-2958.2010.07320.x.
   Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07.
   Jackson KD, 2004, J BACTERIOL, V186, P4466, DOI 10.1128/JB.186.14.4466-4475.2004.
   Jimenez-Ferandez A., 2015, ENV MICROBIOL REP, DOI 10.111/1758-2229.12153.
   Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005.
   Kawano Y, 2011, PLANT CELL PHYSIOL, V52, P957, DOI 10.1093/pcp/pcr047.
   Kirillina O, 2004, MOL MICROBIOL, V54, P75, DOI 10.1111/j.1365-2958.2004.04253.x.
   Kitanishi K, 2010, BIOCHEMISTRY-US, V49, P10381, DOI 10.1021/bi100733q.
   Koczan JM, 2009, PHYTOPATHOLOGY, V99, P1237, DOI 10.1094/PHYTO-99-11-1237.
   Koo H, 2013, J DENT RES, V92, P1065, DOI 10.1177/0022034513504218.
   Koza A, 2009, MICROBIOL-SGM, V155, P1397, DOI 10.1099/mic.0.025064-0.
   Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185.
   Kropec A, 2005, INFECT IMMUN, V73, P6868, DOI 10.1128/IAI.73.10.6868-6876.2005.
   Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07.
   Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108.
   Leang C, 2013, ENERG ENVIRON SCI, V6, P1901, DOI 10.1039/c3ee40441b.
   Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x.
   LEIGH JA, 1992, ANNU REV MICROBIOL, V46, P307, DOI 10.1146/annurev.mi.46.100192.001515.
   Levet-Paulo M, 2011, J BIOL CHEM, V286, P31136, DOI 10.1074/jbc.M111.231340.
   Li HL, 2005, INFECT IMMUN, V73, P3188, DOI 10.1128/IAI.73.5.3188-3191.2005.
   Li Y, 2013, J BACTERIOL, V195, P3531, DOI 10.1128/JB.01156-12.
   Li Z, 2012, J BIOL CHEM, V287, P30191, DOI 10.1074/jbc.M112.378273.
   Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x.
   Lim B, 2007, J BACTERIOL, V189, P717, DOI 10.1128/JB.00834-06.
   Linkous DA, 1999, FEMS MICROBIOL LETT, V174, P207, DOI 10.1111/j.1574-6968.1999.tb13570.x.
   Liu N, 2012, BIOCHEMISTRY-US, V51, P2087, DOI 10.1021/bi201753f.
   Lovering AL, 2011, MBIO, V2, DOI {[}10.1128/mBio.00163-11, DOI 10.1128/MBI0.00163-11].
   Ma LY, 2007, J BACTERIOL, V189, P8353, DOI 10.1128/JB.00620-07.
   Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06.
   Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354.
   Malone JG, 2007, MICROBIOL-SGM, V153, P980, DOI 10.1099/mic.0.2006/002824-0.
   Malone J. G., 2012, PLOS PATHOG, V8, P14.
   Malone JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000804.
   Manteca A, 2008, APPL ENVIRON MICROB, V74, P3877, DOI 10.1128/AEM.02715-07.
   Massie JP, 2012, P NATL ACAD SCI USA, V109, P12746, DOI 10.1073/pnas.1115663109.
   Matilla MA, 2011, ENVIRON MICROBIOL, V13, P1745, DOI 10.1111/j.1462-2920.2011.02499.x.
   MATTHYSSE AG, 1995, J BACTERIOL, V177, P1076, DOI 10.1128/jb.177.4.1076-1081.1995.
   Matthysse AG, 2008, APPL ENVIRON MICROB, V74, P2384, DOI 10.1128/AEM.01854-07.
   Matthysse AG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00252.
   Mazur O, 2011, J BIOL CHEM, V286, P17601, DOI 10.1074/jbc.M111.227660.
   Meiser P, 2008, CHEM BIOL, V15, P771, DOI 10.1016/j.chembiol.2008.06.005.
   Meiser P, 2006, P NATL ACAD SCI USA, V103, P19128, DOI 10.1073/pnas.0606039103.
   Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x.
   Mendez-Ortiz MM, 2006, J BIOL CHEM, V281, P8090, DOI 10.1074/jbc.M510701200.
   Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/i.1365-2958.2007.05817.x.
   Merritt JH, 2010, MBIO, V1, DOI 10.1128/mBio.00183-10.
   Mills E, 2011, CELL MICROBIOL, V13, P1122, DOI 10.1111/j.1462-5822.2011.01619.x.
   Minasov G, 2009, J BIOL CHEM, V284, P13174, DOI 10.1074/jbc.M808221200.
   Morgan JLW, 2014, NAT STRUCT MOL BIOL, V21, P489, DOI 10.1038/nsmb.2803.
   Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744.
   Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x.
   Nakhamchik A, 2008, APPL ENVIRON MICROB, V74, P4199, DOI 10.1128/AEM.00176-08.
   Navarro M., 2011, PLOS BIOL, V9.
   Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI {[}10.1016/j.str.2009.06.010, 10.1016/i.str.2009.06.010].
   Newell P. D., 2011, PLOS BIOL, V9.
   Newell PD, 2011, J BACTERIOL, V193, P4685, DOI 10.1128/JB.05483-11.
   Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106.
   Nimtz M, 1996, CARBOHYD RES, V287, P59, DOI 10.1016/0008-6215(96)00070-5.
   Nwodo UU, 2012, INT J MOL SCI, V13, P14002, DOI 10.3390/ijms131114002.
   Ochi K, 2013, APPL MICROBIOL BIOT, V97, P87, DOI 10.1007/s00253-012-4551-9.
   Oglesby LL, 2008, MICROBIOL-SGM, V154, P1605, DOI 10.1099/mic.0.2007/015305-0.
   Olano C, 2014, MICROB BIOTECHNOL, V7, P242, DOI 10.1111/1751-7915.12116.
   Omadjela O, 2013, P NATL ACAD SCI USA, V110, P17856, DOI 10.1073/pnas.1314063110.
   Overhage J, 2005, APPL ENVIRON MICROB, V71, P4407, DOI 10.1128/AEM.71.8.4407-4413.2005.
   Ozaki S, 2014, MOL MICROBIOL, V94, P580, DOI 10.1111/mmi.12777.
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504.
   Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x.
   Perez-Mendoza D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091645.
   Perez-Mendoza D, 2011, MICROBIOL-SGM, V157, P3340, DOI 10.1099/mic.0.050450-0.
   PERRY RD, 1990, J BACTERIOL, V172, P5929, DOI 10.1128/jb.172.10.5929-5937.1990.
   Petters T, 2012, MOL MICROBIOL, V84, P147, DOI 10.1111/j.1365-2958.2012.08015.x.
   Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023.
   Pultz IS, 2012, MOL MICROBIOL, V86, P1424, DOI 10.1111/mmi.12066.
   Purcell EB, 2012, J BACTERIOL, V194, P3307, DOI 10.1128/JB.00100-12.
   Qi YN, 2012, J BACTERIOL, V194, P5922, DOI 10.1128/JB.00767-12.
   Qi YN, 2011, J BIOL CHEM, V286, P2910, DOI 10.1074/jbc.M110.196220.
   Qi YN, 2009, BIOCHEMISTRY-US, V48, P10275, DOI 10.1021/bi901121w.
   Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08.
   Rehm BHA, 2010, NAT REV MICROBIOL, V8, P578, DOI 10.1038/nrmicro2354.
   Rehm BHA, 1997, APPL MICROBIOL BIOT, V48, P281, DOI 10.1007/s002530051051.
   Rehman Z. U., 2013, APPL ENVIRON MICROB, V18, P18.
   Rehman ZU, 2013, APPL ENVIRON MICROB, V79, P3264, DOI 10.1128/AEM.00460-13.
   Rodrigue A, 2000, TRENDS MICROBIOL, V8, P498, DOI 10.1016/S0966-842X(00)01833-3.
   Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x.
   Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x.
   Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5.
   Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12.
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0.
   ROSS P, 1990, J BIOL CHEM, V265, P18933.
   Ruffing AM, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-17.
   Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279.
   Ryan RP, 2012, TRENDS MICROBIOL, V20, P235, DOI 10.1016/j.tim.2012.02.008.
   Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103.
   Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005.
   Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200.
   Savakis P, 2012, MOL MICROBIOL, V85, P239, DOI 10.1111/j.1365-2958.2012.08106.x.
   Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203.
   Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005.
   Serra DO, 2013, J BACTERIOL, V195, P5540, DOI 10.1128/JB.00946-13.
   Seshasayee ASN, 2010, NUCLEIC ACIDS RES, V38, P5970, DOI 10.1093/nar/gkq382.
   Shikuma N. J., 2012, PLOS PATHOG, V8, P24.
   Simm R, 2005, J BACTERIOL, V187, P6816, DOI 10.1128/JB.187.19.6816-6823.2005.
   Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x.
   Simm R, 2007, J BACTERIOL, V189, P3613, DOI 10.1128/JB.01719-06.
   Singh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091352.
   SMIT G, 1992, MOL MICROBIOL, V6, P2897, DOI 10.1111/j.1365-2958.1992.tb01748.x.
   Smith KD, 2011, BIOCHEM SOC T, V39, P647, DOI 10.1042/BST0390647.
   Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702.
   Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x.
   Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106.
   Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008.
   Song ZJ, 2003, J MED MICROBIOL, V52, P731, DOI 10.1099/jmm.0.05122-0.
   Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x.
   Spiers AJ, 2005, MICROBIOL-SGM, V151, P2829, DOI {[}10.1099/mic.0.27984-0, 10.1099/mic.027984-0].
   Srivastava D, 2011, J BACTERIOL, V193, P6331, DOI 10.1128/JB.05167-11.
   Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09.
   Steiner S., 2012, EMBO J, V30, P315.
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1.
   Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519.
   Sun F., 2012, PLOS ONE, V7, P21.
   Sun Y. C., 2011, PLOS ONE, V6.
   Sun YC, 2012, J BACTERIOL, V194, P2020, DOI 10.1128/JB.06243-11.
   Sunagawa N, 2013, J BIOSCI BIOENG, V115, P607, DOI 10.1016/j.jbiosc.2012.12.021.
   Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3.
   Tagliabue L, 2010, MICROBIOL-SGM, V156, P2901, DOI 10.1099/mic.0.041350-0.
   Tal R, 1998, J BACTERIOL, V180, P4416.
   Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200.
   Tan H, 2014, MICROBIOL-SGM, V160, P1427, DOI 10.1099/mic.0.076828-0.
   Tarutina M, 2006, J BIOL CHEM, V281, P34751, DOI 10.1074/jbc.M604819200.
   Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479.
   Tran NT, 2011, J BACTERIOL, V193, P3100, DOI 10.1128/JB.01460-10.
   Tschowri N, 2014, CELL, V158, P1136, DOI 10.1016/j.cell.2014.07.022.
   Tuckerman JR, 2011, J MOL BIOL, V407, P633, DOI 10.1016/j.jmb.2011.02.019.
   Tuckerman JR, 2009, BIOCHEMISTRY-US, V48, P9764, DOI 10.1021/bi901409g.
   Ude S, 2006, ENVIRON MICROBIOL, V8, P1997, DOI 10.1111/j.1462-2920.2006.01080.x.
   Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006.
   Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0.
   Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004.
   Wang YW, 2010, ACTA BIOCH BIOPH SIN, V42, P410, DOI 10.1093/abbs/gmq034.
   Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016.
   Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07.
   Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x.
   Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x.
   Weinhouse H, 1997, FEBS LETT, V416, P207, DOI 10.1016/S0014-5793(97)01202-7.
   West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7.
   Whitney JC, 2012, J BIOL CHEM, V287, P23582, DOI 10.1074/jbc.M112.375378.
   Whitney JC, 2011, P NATL ACAD SCI USA, V108, P13083, DOI 10.1073/pnas.1104984108.
   Wigren E, 2014, MOL MICROBIOL, V91, P1, DOI 10.1111/mmi.12463.
   Wozniak DJ, 2003, P NATL ACAD SCI USA, V100, P7907, DOI 10.1073/pnas.1231792100.
   Yang CY, 2011, ACTA CRYSTALLOGR D, V67, P997, DOI 10.1107/S090744491104039X.
   Ye LB, 2014, GLYCOBIOLOGY, V24, P351, DOI 10.1093/glycob/cwu001.
   Yoong P., 2012, PIER, V3.
   Zahringer F, 2013, STRUCTURE, V21, P1149, DOI 10.1016/j.str.2013.04.026.
   Zazopoulos E, 2003, NAT BIOTECHNOL, V21, P187, DOI 10.1038/nbt784.
   Zhan XB, 2012, APPL MICROBIOL BIOT, V93, P525, DOI 10.1007/s00253-011-3740-2.
   Zhang RR, 2014, BIOMACROMOLECULES, V15, P1079, DOI 10.1021/bm500038g.
   Zhang YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059428.
   Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x.}},
Number-of-Cited-References = {{249}},
Times-Cited = {{23}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{44}},
Journal-ISO = {{Nat. Prod. Rep.}},
Doc-Delivery-Number = {{CG9RY}},
Unique-ID = {{ISI:000353658400003}},
DA = {{2018-08-13}},
}

@article{ ISI:000352757900006,
Author = {Kubera, Lukasz and Studzinska, Joanna and Dokladna, Wioletta and
   Malecka-Adamowicz, Marta and Donderski, Wojciech},
Title = {{MICROBIOLOGICAL AIR QUALITY IN SOME KINDERGARTENS AND ANTIBIOTIC
   RESISTANCE OF BACTERIA OF THE STAPHYLOCOCCUS SPP. GENUS}},
Journal = {{MEDYCYNA PRACY}},
Year = {{2015}},
Volume = {{66}},
Number = {{1}},
Pages = {{49-56}},
Abstract = {{Background: Microbiological contamination of the air and the acquisition
   of the antibiotic resistance by pathogenic bacteria is a growing
   phenomenon that has a substantial impact on the quality of our health.
   This problem applies mainly to public areas where we spend a large part
   of our lives. This study was focused on the microbiological analysis of
   the air in some kindergartens and antibiotic resistance of bacteria of
   the Stephylococcus spp. genus. The identification of the isolated mould
   fungi has been also made. Material and Methods: Air samples were
   collected from classrooms in the seasonal cycle in the mornings and
   afternoons using 2 methods, sedimentation and impact. Air samples
   collected outside the kindergartens served as controls. Air quality
   assessments were based on the groups of indicator microorganisms,
   according to Polish standards. The susceptibility of isolated
   staphylococci was assessed with the disc-diffusion method, using 8
   different classes of antibiotics, in line with the recommendations of
   the European Committee on Antimicrobial Susceptibility Testing (EUCAST).
   Results: The analyses show that, regardless of the method, the total
   number of heterothropic bacteria and staphylococci in the air of the
   analyzed kindergartens exceeded the allowable limits. There was no air
   pollution with the fungal infection. Based on the antibiogram, it was
   found that Staphylococcus spp. strains showed the highest sensitivity to
   chloramphenicol and the lowest to penicillin and gentamicin. Among the
   fungi moulds of the genus Cladosporium predominated. Conclusions: The
   results of the analyses highlight the need for regular health checks and
   further research to help identify biological factors that may
   significantly affect the quality of health of people living in public
   spaces.}},
Publisher = {{NOFER INST OCCUPATIONAL MEDICINE, SW}},
Address = {{TERESY 8, LODZ, 91-348, POLAND}},
Type = {{Article}},
Language = {{Polish}},
Affiliation = {{Kubera, L (Reprint Author), Kazimierz Wielki Univ, Fac Nat Sci, Inst Expt Biol, Dept Microbiol, Bydgoszcz, Poland.
   Kubera, Lukasz; Studzinska, Joanna; Malecka-Adamowicz, Marta; Donderski, Wojciech, Kazimierz Wielki Univ, Fac Nat Sci, Inst Expt Biol, Dept Microbiol, Bydgoszcz, Poland.
   Dokladna, Wioletta, Kazimierz Wielki Univ, Fac Nat Sci, Inst Expt Biol, Dept Immunobiol, Bydgoszcz, Poland.}},
ISSN = {{0465-5893}},
EISSN = {{2353-1339}},
Keywords = {{antibiotic resistance; Staphylococcus spp; moulds; indoor air quality;
   kindergartens; public health}},
Keywords-Plus = {{INDOOR; CONTAMINATION; BIOAEROSOLS; ENVIRONMENT}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Cited-References = {{{[}Anonymous], 1989, PNZ0411102 POLSK KOM.
   {[}Anonymous], 1989, PNZ0411103 POLSK KOM.
   {[}Anonymous], 1989, PNZ0411101 POLSK KOM.
   Brady MT, 2005, AM J INFECT CONTROL, V33, P276, DOI 10.1016/j.ajic.2004.11.007.
   Butarewicz Andrzej, 2005, Rocz Panstw Zakl Hig, V56, P199.
   Fair Richard J, 2014, Perspect Medicin Chem, V6, P25, DOI 10.4137/PMC.S14459.
   Feller W., 1950, INTRO PROBABILITY TH.
   Filipiak M., 2004, POSTEP DERM ALERGOL, V21, P121.
   Frankel M, 2012, APPL ENVIRON MICROB, V78, P8289, DOI 10.1128/AEM.02069-12.
   Gandara A, 2006, ENVIRON HEALTH PERSP, V114, P1859, DOI 10.1289/ehp.9585.
   Gladysz J., 2010, PROBL HIG EPIDEMIOL, V91, P178.
   Golofit-Szymczak M., 2013, PODST MET OCENY SROD, V2, P5.
   Gutarowska B., 2007, MIKROBIOLOGIA TECHNI, P224.
   Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867.
   Jo WK, 2005, CHEMOSPHERE, V61, P1570, DOI 10.1016/j.chemosphere.2005.04.103.
   Jung JH, 2009, SCI TOTAL ENVIRON, V407, P4723, DOI 10.1016/j.scitotenv.2009.05.008.
   Kalwasinska A, 2012, ANN AGR ENV MED, V19, P25.
   Karwowska E, 2005, POL J ENVIRON STUD, V14, P445.
   Karwowska E, 2003, POL J ENVIRON STUD, V12, P181.
   Kim KY, 2010, IND HEALTH, V48, P236, DOI 10.2486/indhealth.48.236.
   Kruczalak K, 2004, POL J ENVIRON STUD, V13, P537.
   Rywotycki R, 2002, MED WETER, V58, P356.
   Sahoo KC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-629.
   Samson R.A., 2000, INTRO FOOD AIRBORNE.
   The European Committee on Antimicrobial Susceptibility Testing, BREAKP TABL INT MICS.
   Zhou F, 2013, INT J ENV RES PUB HE, V10, P2412, DOI 10.3390/ijerph10062412.
   Zmyslowska I., 2009, MIKROBIOLOGIA OGOLNA.}},
Number-of-Cited-References = {{27}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{10}},
Journal-ISO = {{Med. Pr.}},
Doc-Delivery-Number = {{CF7SZ}},
Unique-ID = {{ISI:000352757900006}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000349059500009,
Author = {Chaitanya, G. and Arivazhagan, A. and Sinha, S. and Reddy, K. R.
   Madhusudan and Thennarasu, K. and Bharath, R. D. and Rao, M. Bhaskara
   and Chandramouli, B. A. and Satishchandra, P.},
Title = {{Dexmedetomidine anesthesia enhances spike generation during
   intra-operative electrocorticography: A promising adjunct for epilepsy
   surgery}},
Journal = {{EPILEPSY RESEARCH}},
Year = {{2015}},
Volume = {{109}},
Pages = {{65-71}},
Month = {{JAN}},
Abstract = {{Background: Anesthetic-induced suppression of cortical electrical
   activity is a major concern during epilepsy surgery. Dexmedetomidine
   (Dex) has been recently evaluated in a few small series for its effect
   on the electrocorticographic spikes intra-operatively.
   Methods: In this prospective study, electrocorticogram (ECoG) was
   monitored during dexnnedetomidine infusion in 34 patients (M: F = 23:11,
   age = 29.2 +/- 10.9 years; duration of epilepsy = 15.3 +/- 8.9 years)
   undergoing anterior temporal lobe resection with amygdalohippocampectomy
   for drug-resistant mesial temporal lobe epilepsy (Right: 18, Left: 16).
   Anesthesia was induced with thiopental/propofol and maintained with
   oxygen-N2O-isoflurane. ECoG was recorded for 5 min after the end tidal
   MAC of N2O and isoflurane were decreased to zero; anesthesia was
   maintained with 02:Air = 50:50, vecuronium and fentanyl. ECoG was
   recorded using a 4-contact strip electrode for: (a) 5 min prior to
   dexmedetomidine (PreDEX), (b) 5 min during dexmedetomidine infusion
   (DEX; 1 mu g/kg) and (c) 5 min after stopping dexmedetomidine (PostDEX).
   Results: The ECoG spikes were manually counted in all the channels. The
   mean spike rate in the 2 channels with maximum spikes (MAX CH A and MAX
   CH B) was normalized to a 3-min duration. RM-ANOVA and post hoc
   comparison of three phases were used to compare the spike rates. The
   mean spike rate during Dex phase was higher compared to preDEX (MAX CH
   B: p = 0.007 and MAX CH A: p = 0.079) and PostDEX (MAX CH B: p = 0.17,
   MAX CH A: p = 0.79) phases. The spike rate increased in 67.6\% patients,
   while 11.8\% patients showed <= 25\% reduction and 20.6\% patients
   showed >25\% reduction in spike frequency.
   Conclusion: Dexmedetomidine is useful during intra-operative ECoG
   recording in epilepsy surgery as it enhances or does not alter spike
   rate in most of the cases, without any major adverse effects. (C) 2014
   Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Arivazhagan, A (Reprint Author), Natl Inst Mental Hlth \& Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India.
   Chaitanya, G., Natl Inst Mental Hlth \& Neurosci, Dept Clin Neurosci, Bangalore 560029, Karnataka, India.
   Arivazhagan, A.; Rao, M. Bhaskara; Chandramouli, B. A., Natl Inst Mental Hlth \& Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India.
   Sinha, S.; Satishchandra, P., Natl Inst Mental Hlth \& Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India.
   Reddy, K. R. Madhusudan, Natl Inst Mental Hlth \& Neurosci, Dept Neuro Anesthesiol, Bangalore 560029, Karnataka, India.
   Thennarasu, K., Natl Inst Mental Hlth \& Neurosci, Dept Biostat, Bangalore 560029, Karnataka, India.
   Bharath, R. D., Natl Inst Mental Hlth \& Neurosci, Dept Neuroimaging \& Intervent Radiol, Bangalore 560029, Karnataka, India.}},
DOI = {{10.1016/j.eplepsyres.2014.10.006}},
ISSN = {{0920-1211}},
EISSN = {{1872-6844}},
Keywords = {{Dexmedetomidine; Electrocorticography; Drug-resistant epilepsy; Mesial
   temporal sclerosis, Anesthesia}},
Keywords-Plus = {{TEMPORAL-LOBE EPILEPSY; EPILEPTIFORM DISCHARGES; AWAKE CRANIOTOMY;
   PROPOFOL; REMIFENTANIL; SEVOFLURANE; ACTIVATION; RESECTION; ISOFLURANE;
   SEDATION}},
Research-Areas = {{Neurosciences \& Neurology}},
Web-of-Science-Categories  = {{Clinical Neurology}},
Author-Email = {{arivazhagan.a@gmail.com}},
ORCID-Numbers = {{Chaitanya, Ganne/0000-0002-1578-4210
   Bharath, Rose Dawn/0000-0002-7464-4250}},
Funding-Acknowledgement = {{National Institute of Mental Health And Neuro Sciences (NIMHANS),
   Bangalore, India}},
Funding-Text = {{The study was funded by the research grant from the ``National Institute
   of Mental Health And Neuro Sciences (NIMHANS){''}, Bangalore, India.}},
Cited-References = {{Bekker AY, 2001, ANESTH ANALG, V92, P1251.
   Cascino GD, 1998, ELECTROEN CLIN NEURO, P70.
   Chui J, 2013, ANESTH ANALG, V117, P479, DOI 10.1213/ANE.0b013e318297390c.
   Daniel SJ, 2011, SEIZURE-EUR J EPILEP, V20, P564, DOI 10.1016/j.seizure.2011.04.006.
   EBRAHIM ZY, 1994, ANESTH ANALG, V78, P275, DOI 10.1213/00000539-199402000-00013.
   Elias WJ, 2008, MOVEMENT DISORD, V23, P1317, DOI 10.1002/mds.22080.
   FREDMAN B, 1994, ANESTH ANALG, V79, P75.
   Herrick IA, 2002, J NEUROSURG ANESTH, V14, P55, DOI 10.1097/00008506-200201000-00011.
   Hewitt PB, 1999, BRIT J ANAESTH, V82, P199, DOI 10.1093/bja/82.2.199.
   Hisada K, 2001, J NEUROSURG ANESTH, V13, P333, DOI 10.1097/00008506-200110000-00010.
   Kuruvilla A, 2003, SEIZURE-EUR J EPILEP, V12, P577, DOI 10.1016/S1059-1311(03)00095-5.
   McGuire G, 2003, BRIT J ANAESTH, V91, P651, DOI 10.1093/bja/aeg241.
   Nelson LE, 2003, ANESTHESIOLOGY, V98, P428, DOI 10.1097/00000542-200302000-00024.
   Oda Y, 2007, ANESTH ANALG, V105, P1272, DOI 10.1213/01.ane.0000281075.77316.98.
   Oliveira PAL, 2006, SEIZURE-EUR J EPILEP, V15, P541, DOI 10.1016/j.seizure.2006.06.009.
   Rozet I, 2006, ANESTH ANALG, V103, P1224, DOI 10.1213/01.ane.0000239331.53085.94.
   Rozet I, 2008, CURR OPIN ANESTHESIO, V21, P537, DOI 10.1097/ACO.0b013e32830edafd.
   SAMRA SK, 1995, ANESTHESIOLOGY, V82, P843.
   Smith M, 1996, BRIT J ANAESTH, V76, P499.
   Souter MJ, 2007, J NEUROSURG ANESTH, V19, P38, DOI 10.1097/01.ana.0000211027.26550.24.
   Talke P, 2007, J NEUROSURG ANESTH, V19, P195, DOI 10.1097/ANA.0b013e318060d281.
   Tripathi M, 2010, EPILEPSY RES, V89, P133, DOI 10.1016/j.eplepsyres.2009.12.007.
   Van Gompim JJ, 2009, J NEUROSURG, V110, P1179, DOI 10.3171/2008.10.JNS08722.
   Wass CT, 2001, EPILEPSIA, V42, P1340, DOI 10.1046/j.1528-1157.2001.05901.x.
   Watts ADJ, 1999, ANESTH ANALG, V89, P1275, DOI 10.1213/00000539-199911000-00037.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Epilepsy Res.}},
Doc-Delivery-Number = {{CA6XA}},
Unique-ID = {{ISI:000349059500009}},
DA = {{2018-08-13}},
}

@article{ ISI:000345520000075,
Author = {Zhang, Xiangyu and Li, Meng and He, Xiaojing and Huang, Xiaobo and Hang,
   Ruiqiang and Tang, Bin},
Title = {{Effects of silver concentrations on microstructure and properties of
   nanostructured titania films}},
Journal = {{MATERIALS \& DESIGN}},
Year = {{2015}},
Volume = {{65}},
Pages = {{600-605}},
Month = {{JAN}},
Abstract = {{To prevent bacterial proliferation on biomedical titanium implants,
   significant efforts have been focused on modifying its surface
   composition and structure. In this study, nanostructured titania (TiO2)
   films with different concentrations of silver were prepared by magnetron
   sputtering and subsequently annealed at 600 degrees C in air. The
   effects of silver concentrations on microstructure, antibacterial
   property, corrosion resistance and hardness were studied. The results
   indicate that silver contribute to the growth of the TiO2 grains and is
   uniformly dispersed on the surface of annealed samples. The annealed
   films with a thickness of about 2.5 mu m are uniform and mainly composed
   of rutile phase and pure titanium. Silver mainly exists in the metallic
   state in the TiO2 films. The Ag-doped TiO2 films can effectively kill
   Staphylococcus aureus within 24 h and the antibacterial ability
   increases with the silver content. The dynamic potential polarization
   results show that silver incorporation into TiO2 films slightly lower
   the corrosion potential, but significantly decrease the current density,
   and the current density decreases as the silver addition increases.
   Moreover, the hardness of the Ag-doped TiO2 films is also greatly
   improved. (C) 2014 Elsevier Ltd. All rights reserved.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Tang, B (Reprint Author), Taiyuan Univ Technol, Res Inst Surface Engn, 79 Yingze St, Taiyuan 030024, Peoples R China.
   Zhang, Xiangyu; Li, Meng; He, Xiaojing; Huang, Xiaobo; Hang, Ruiqiang; Tang, Bin, Taiyuan Univ Technol, Res Inst Surface Engn, Taiyuan 030024, Peoples R China.}},
DOI = {{10.1016/j.matdes.2014.09.060}},
ISSN = {{0264-1275}},
EISSN = {{1873-4197}},
Keywords-Plus = {{ANTIBACTERIAL PROPERTIES; ANTIMICROBIAL ACTIVITY; COPPER NANOPARTICLES;
   BIOACTIVITY; NANOTUBES; SURFACE; DEPOSITION}},
Research-Areas = {{Materials Science}},
Web-of-Science-Categories  = {{Materials Science, Multidisciplinary}},
Author-Email = {{tangbin@tyut.edu.cn}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}51171125]; Qualified
   Personnel Foundation of Taiyuan University of Technology (QPFT)
   {[}2011257a]; Shanxi Province Science and Technology Key Project of
   China {[}201120321051]}},
Funding-Text = {{This work was supported by the National Natural Science Foundation of
   China (No. 51171125), the Qualified Personnel Foundation of Taiyuan
   University of Technology (QPFT) (No. 2011257a) and the Shanxi Province
   Science and Technology Key Project of China (No. 201120321051).}},
Cited-References = {{Abidov A, 2014, J CRYST GROWTH, V401, P584, DOI 10.1016/j.jcrysgro.2013.12.018.
   Ewald A, 2011, ACTA BIOMATER, V7, P4064, DOI 10.1016/j.actbio.2011.06.049.
   Gallardo-Moreno AM, 2010, BIOMATERIALS, V31, P5159, DOI 10.1016/j.biomaterials.2010.03.005.
   Gao A, 2014, BIOMATERIALS, V35, P4223, DOI 10.1016/j.biomaterials.2014.01.058.
   Garcia-Serrano J, 2009, CURR APPL PHYS, V9, P1097, DOI 10.1016/j.cap.2008.12.008.
   Goudouri OM, 2014, ACTA BIOMATER, V10, P3795, DOI 10.1016/j.actbio.2014.03.028.
   Hang RQ, 2012, ELECTROCHIM ACTA, V70, P382, DOI 10.1016/j.electacta.2012.03.085.
   Hassan IA, 2014, J MATER CHEM B, V2, P2855, DOI 10.1039/c4tb00196f.
   Hempel F, 2014, SURF COAT TECH, V256, P52, DOI 10.1016/j.surfcoat.2014.01.027.
   Hodgkinson JL, 2013, SURF COAT TECH, V230, P260, DOI 10.1016/j.surfcoat.2013.06.053.
   Huang JH, 2011, THIN SOLID FILMS, V520, P1379, DOI 10.1016/j.tsf.2011.08.094.
   Jaiswal S, 2013, COLLOID SURFACE B, V102, P412, DOI 10.1016/j.colsurfb.2012.07.047.
   Jaiswal S, 2012, COLLOID SURFACE B, V94, P170, DOI 10.1016/j.colsurfb.2012.01.035.
   Jia BQ, 2012, ACS APPL MATER INTER, V4, P2897, DOI 10.1021/am3007609.
   Kelly PJ, 2009, SURF COAT TECH, V204, P1137, DOI 10.1016/j.surfcoat.2009.05.012.
   Li JH, 2013, RSC ADV, V3, P11214, DOI 10.1039/c3ra23252b.
   Mei SL, 2014, BIOMATERIALS, V35, P4255, DOI 10.1016/j.biomaterials.2014.02.005.
   Qian S, 2013, SURF COAT TECH, V229, P156, DOI 10.1016/j.surfcoat.2012.07.048.
   Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006.
   Song J, 2013, ACS APPL MATER INTER, V5, P11563, DOI 10.1021/am402310u.
   Song WH, 2007, J BIOMED MATER RES A, V88A, P246.
   Taglietti A, 2014, BIOMATERIALS, V35, P1779, DOI 10.1016/j.biomaterials.2013.11.047.
   Yao XH, 2014, APPL SURF SCI, V292, P944, DOI 10.1016/j.apsusc.2013.12.083.
   Zhang XY, 2013, SURF COAT TECH, V235, P748, DOI 10.1016/j.surfcoat.2013.08.062.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{13}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{47}},
Journal-ISO = {{Mater. Des.}},
Doc-Delivery-Number = {{AU3NI}},
Unique-ID = {{ISI:000345520000075}},
DA = {{2018-08-13}},
}

@article{ ISI:000367289700001,
Author = {Diab-Elschahawi, Magda and Lusignani, Luigi Segagni and Starzengruber,
   Peter and Mitteregger, Dieter and Wagner, Andrea and Assadian, Ojan and
   Presterl, Elisabeth},
Title = {{The strength of coughing may forecast the likelihood of spread of
   multi-drug resistant microorganisms from the respiratory tract of
   colonized patients}},
Journal = {{ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL}},
Year = {{2014}},
Volume = {{3}},
Month = {{DEC 12}},
Abstract = {{Background: Current recommendations indicate that patients who are
   coughing and have multidrug resistant microorganisms (MDROs) in their
   sputum are considered to be shedders and should be cared for in single
   room isolation at least until symptoms resolve. Airborne spread and
   subsequent contamination of surfaces adjacent to patients may contribute
   to transmission. Hence, isolation measures for patients colonized or
   infected with MDRO at their respiratory tract are intended to interrupt
   such transmission. However, the potential for microbial shedding in
   patients with MDRO-positive microbiological reports from their
   respiratory tract and factors justifying the need for single room
   isolation are viewed controversially.
   Methods: Cough aerosol produced by patients colonized with MDROs was
   measured for viable counts. Descriptive analysis together with logistic
   regression analysis was performed to assess the impact of strength of
   cough on growth of MDRO on culture plates.
   Results: In 18\% (23/128) MDRO were transmitted. Multivariate analysis
   revealed that strength of cough significantly predicts the yield of MDRO
   on culture plates (P = 0.012).
   Conclusion: Based on these results it can be concluded that risk
   stratification for decision of single room isolation of patients
   colonized or infected with MDROs at their respiratory tract may also
   take the severity of cough into consideration. However, more work is
   required in order to assess the severity of cough objectively.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Assadian, O (Reprint Author), Vienna Gen Hosp, Dept Hosp Hyg \& Infect Control, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
   Diab-Elschahawi, Magda; Lusignani, Luigi Segagni; Starzengruber, Peter; Wagner, Andrea; Assadian, Ojan; Presterl, Elisabeth, Vienna Gen Hosp, Dept Hosp Hyg \& Infect Control, A-1090 Vienna, Austria.
   Mitteregger, Dieter, Med Univ Vienna, Div Clin Microbiol, Dept Lab Med, Vienna, Austria.}},
DOI = {{10.1186/s13756-014-0038-z}},
Article-Number = {{38}},
ISSN = {{2047-2994}},
Keywords = {{Multidrug resistant microorganism; Cough; Aerogene spread; Risk factors;
   Single room isolation; Infection Control}},
Keywords-Plus = {{STAPHYLOCOCCUS-AUREUS; ENVIRONMENTAL CONTAMINATION; TRANSMISSION;
   ACQUISITION; ENTEROCOCCI; RISK}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases;
   Microbiology}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases;
   Microbiology}},
Author-Email = {{ojan.assadian@meduniwien.ac.at}},
Funding-Acknowledgement = {{Medical Scientific Fund of the Mayor of the City of Vienna {[}13010]}},
Funding-Text = {{This study was supported by the Medical Scientific Fund of the Mayor of
   the City of Vienna, Grant-No.: 13010.}},
Cited-References = {{{[}Anonymous], 2012, BUNDESGESUNDHEITSBL, V55, P1311.
   Cooper BS, 2004, BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533.
   Drees M, 2008, CLIN INFECT DIS, V46, P678, DOI 10.1086/527394.
   Gehanno JF, 2009, J HOSP INFECT, V71, P256, DOI 10.1016/j.jhin.2008.11.015.
   Hardy KJ, 2006, INFECT CONT HOSP EP, V27, P127, DOI 10.1086/500622.
   Muzslay M, 2013, AM J INFECT CONTROL, V41, P57, DOI 10.1016/j.ajic.2012.01.031.
   Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2.
   Shiomori T, 2001, ARCH OTOLARYNGOL, V127, P644, DOI 10.1001/archotol.127.6.644.
   Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007.
   Wigglesworth N, 2006, J HOSP INFECT, V63, P156, DOI 10.1016/j.jhin.2006.02.008.}},
Number-of-Cited-References = {{10}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{Antimicrob. Resist. Infect. Control}},
Doc-Delivery-Number = {{CZ7OW}},
Unique-ID = {{ISI:000367289700001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000349929300014,
Author = {Jomha, Mariam Yousif and Yusef, Hoda and Holail, Hanafy},
Title = {{Antimicrobial and biocide resistance of bacteria in a Lebanese tertiary
   care hospital}},
Journal = {{JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE}},
Year = {{2014}},
Volume = {{2}},
Number = {{4}},
Pages = {{299-305}},
Month = {{DEC}},
Abstract = {{The environment in a Lebanese tertiary-level care hospital was examined
   for bacterial contamination. In total, 8 open-air and 62 surface samples
   were taken and CPU were enumerated. Morphologically different isolates
   (n = 104) were obtained and tested for resistance to a wide range of
   antibiotics by the Kirby-Bauer disc diffusion method. Minimum
   bactericidal concentrations of isolates to seven different biocides used
   within this facility were also determined using both qualitative and
   quantitative methods. Gram-positive bacteria (82.7\% of isolates) were
   encountered more often than Gram-negative bacteria (17.3\%), and the
   genus Staphylococcus was most prevalent among isolates (59.6\% of the
   isolates). Gram-positive isolates showed the highest resistance to
   penicillin (60.6\%), clindamycin (54.5\%) and ceftazidime (39.4\%); the
   lowest frequencies of resistance were seen with vancomycin (0\% of
   isolates), nitrofurantoin (3.5\%), tetracycline (12.1\%) and
   ciprofloxacin (12.1\%). The prevalence of meticillin-resistant
   Staphylococcus aureus (MRSA) and meticillin-resistant coagulase negative
   staphylococci among all environmental samples was 3.8\% and 11.5\% of
   isolates, respectively. All Gram-negative isolates were
   multidrug-resistant (MDR). With respect to biocides, the highest
   frequency of resistance was to quaternary ammonium compounds (QACs)
   (13.5\% of isolates) and the lowest frequency of resistance was to
   QAC/biguanide complex (<1\% of isolates) and Anios DVA (3.8\%). MDR
   bacteria can pose a serious threat in the hospital environment, showing
   the need for prudent use of antibiotics and correct infection control
   procedures. (C) 2014 International Society for Chemotherapy of Infection
   and Cancer. Published by Elsevier Ltd. All rights reserved.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Jomha, MY (Reprint Author), Beirut Arab Univ, Fac Sci, Dept Biol \& Environm Sci, Beirut, Lebanon.
   Jomha, Mariam Yousif; Yusef, Hoda; Holail, Hanafy, Beirut Arab Univ, Fac Sci, Dept Biol \& Environm Sci, Beirut, Lebanon.}},
DOI = {{10.1016/j.jgar.2014.09.001}},
ISSN = {{2213-7165}},
Keywords = {{Antibiotics; Biocides; Resistance; Healthcare environment; Bacterial
   contamination}},
Keywords-Plus = {{PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE;
   CONTAMINATION; ENVIRONMENT; PATHOGENS; ENTEROCOCCI; MECHANISMS; UNIT;
   MRSA}},
Research-Areas = {{Infectious Diseases; Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Infectious Diseases; Pharmacology \& Pharmacy}},
Author-Email = {{mariam\_jomha@hotmail.com}},
ORCID-Numbers = {{Yusef, Hoda/0000-0001-8388-7089
   Jomha, Mariam/0000-0003-3436-2205}},
Cited-References = {{Al-Tawfiq JA, 2010, EXPERT REV ANTI-INFE, V8, P765, DOI 10.1586/ERI.10.56.
   Amer RA, 2013, AFR J MICROBIOL RES, V7, P3321.
   American Academy of Microbiology, 2009, ANT RES EC PERSP OLD.
   Borg MA, 2008, J ANTIMICROB CHEMOTH, V62, P830, DOI 10.1093/jac/dkn260.
   Bures S, 2000, AM J INFECT CONTROL, V28, P465, DOI 10.1067/mic.2000.107267.
   Carling PC, 2008, INFECT CONT HOSP EP, V29, P1, DOI 10.1086/524329.
   Carson RT, 2008, J ANTIMICROB CHEMOTH, V62, P1160, DOI 10.1093/jac/dkn332.
   Chapman JS, 2003, INT BIODETER BIODEGR, V51, P271, DOI 10.1016/S0964-8305(03)00044-1.
   {*}CLIN LAB STAND I, 2005, M100S15 CLSI.
   Cowan S.T., 1984, MANUAL IDENTIFICATIO.
   Ekrami A, 2011, JUNDISHAPUR J MICROB, V4, P75.
   Gad GF, 2007, J ANTIMICROB CHEMOTH, V60, P1010, DOI 10.1093/jac/dkm348.
   Giamarellou H, 2008, CRIT CARE CLIN, V24, P261, DOI 10.1016/j.ccc.2007.12.004.
   Griffith CJ, 2000, J HOSP INFECT, V45, P19, DOI 10.1053/jhin.1999.0717.
   Hamze M, 2003, PATHOL BIOL, V51, P21, DOI 10.1016/S0369-8114(02)00315-2.
   Hardy KJ, 2006, INFECT CONT HOSP EP, V27, P127, DOI 10.1086/500622.
   Holt J.G, 1994, BERGEYS MANUAL DETER, P527.
   Lemmen SW, 2004, J HOSP INFECT, V56, P191, DOI 10.1016/j.jhin.2003.12.004.
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x.
   Monsen T, 2005, INFECT CONT HOSP EP, V26, P76, DOI 10.1086/502490.
   Mulvey MR, 2009, CAN MED ASSOC J, V180, P408, DOI 10.1503/cmaj.080239.
   Noskin GA, 2000, AM J INFECT CONTROL, V28, P311, DOI 10.1067/mic.2000.108129.
   Pasquarella C, 2000, J HOSP INFECT, V46, P241, DOI 10.1053/jhin.2000.0820.
   Reybrouck G, 1998, INT BIODETER BIODEGR, V41, P269, DOI 10.1016/S0964-8305(98)00024-9.
   Rohr U, 2009, INT J HYG ENVIR HEAL, V212, P209, DOI 10.1016/j.ijheh.2008.05.003.
   Russell AD, 2000, J HOSP INFECT, V44, P1, DOI 10.1053/jhin.1999.0654.
   Russell AD, 2002, J APPL MICROBIOL, V92, P121.
   SCENIHR, 2009, ASS ANT RES EFF BIOC.
   STICKLER DJ, 1980, J CLIN PATHOL, V33, P288, DOI 10.1136/jcp.33.3.288.
   Zachary KC, 2001, INFECT CONT HOSP EP, V22, P560, DOI 10.1086/501952.
   Zhanel GG, 2008, ANTIMICROB AGENTS CH, V52, P1430, DOI 10.1128/AAC.01538-07.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{J. Glob. Antimicrob. Resist.}},
Doc-Delivery-Number = {{CB9CJ}},
Unique-ID = {{ISI:000349929300014}},
DA = {{2018-08-13}},
}

@article{ ISI:000346697000008,
Author = {Mund, R. and Panda, N. and Nimesh, S. and Biswas, A.},
Title = {{Novel titanium oxide nanoparticles for effective delivery of paclitaxel
   to human breast cancer cells}},
Journal = {{JOURNAL OF NANOPARTICLE RESEARCH}},
Year = {{2014}},
Volume = {{16}},
Number = {{12}},
Month = {{DEC}},
Abstract = {{Novel titanium oxide (TiO2) nanoparticles were fabricated via a modified
   propanol drying step. These nanoparticles were loaded with anti-cancer
   drug paclitaxel (PTX) to yield PTX-TiO2 nanocomposites. The
   nanocomposites were characterized for their size and surface morphology
   employing nanoparticle tracking analysis (NTA) and scanning electron
   microscopy (SEM). The SEM images showed spherical particles with smooth
   surface and narrow size distribution of similar to 30-40 nm, which was
   also supported by NTA analysis data. The drug loading efficiency of the
   air-dried nanoparticles was observed to be similar to 63.61 \% while
   those prepared through propanol-induced drying step showed similar to
   69.70 \%, thereby demonstrating higher efficiency of the latter. In
   vitro pH-dependent release of the loaded PTX was observed with higher
   release at acidic pH compared with physiological pH. Cell uptake studies
   suggested of time-dependent internalization of nanocomposites with
   significant improvement in uptake by increasing incubation time from 2
   to 24 h, as evidenced by flow cytometry. Further, the cell viability as
   a measure of anti-cancer activity revealed that cell viability upon
   exposure to PTX only was 40.5 \% while that of PTX-TiO2 nanocomposite
   showed 21.6 \% viability after 24 h, suggesting better anti-cancer
   efficacy of nanocomposites. Apoptosis studies revealed that cells
   treated with PTX-TiO2 nanocomposites possessed more amount of apoptotic
   bodies as compared to those treated with PTX only.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Biswas, A (Reprint Author), Natl Inst Technol, Dept Biotechnol \& Med Engn, Rourkela 769008, Odisha, India.
   Mund, R.; Panda, N.; Biswas, A., Natl Inst Technol, Dept Biotechnol \& Med Engn, Rourkela 769008, Odisha, India.
   Nimesh, S., Cent Univ Rajasthan, Sch Life Sci, Dept Biotechnol, Ajmer 305801, Rajasthan, India.}},
DOI = {{10.1007/s11051-014-2739-x}},
Article-Number = {{2739}},
ISSN = {{1388-0764}},
EISSN = {{1572-896X}},
Keywords = {{Titanium oxide; Nanoparticles; Nanocomposites; Paclitaxel; Anti-cancer;
   Apoptosis; Nanomedicine}},
Keywords-Plus = {{DRUG-DELIVERY; MULTIDRUG-RESISTANCE; TIO2 NANOPARTICLES}},
Research-Areas = {{Chemistry; Science \& Technology - Other Topics; Materials Science}},
Web-of-Science-Categories  = {{Chemistry, Multidisciplinary; Nanoscience \& Nanotechnology; Materials
   Science, Multidisciplinary}},
Author-Email = {{rachnamund@gmail.com
   niladri1panda@gmail.com
   surendranimesh@curaj.ac.in
   amitb79@gmail.com}},
ResearcherID-Numbers = {{Biswas, Amit/O-7144-2017}},
Funding-Acknowledgement = {{NIT, Rourkela}},
Funding-Text = {{The authors highly appreciate the support of Director of NIT, Rourkela
   for funding and Mr L. B. Sukla, Chief Scientist IMMT, Bhubaneswar for
   providing the lab facility to carry out certain portion of the research
   work.}},
Cited-References = {{Bhattacharyya S, 2011, PHARM RES-DORDR, V28, P237, DOI 10.1007/s11095-010-0318-0.
   Chen Y, 2010, ACS APPL MATER INTER, V2, P3532, DOI 10.1021/am100709d.
   Cho EC, 2011, NAT NANOTECHNOL, V6, P385, DOI {[}10.1038/nnano.2011.58, 10.1038/NNANO.2011.58].
   Constantine GD, 2003, CURR OPIN PHARMACOL, V3, P626, DOI 10.1016/j.coph.2003.07.003.
   E.J. Verwey, 1948, THEORY STABILITY LYO.
   Eisenhauer EA, 1998, DRUGS, V55, P5, DOI 10.2165/00003495-199855010-00002.
   Emerich DF, 2007, J DRUG TARGET, V15, P163, DOI 10.1080/10611860701231810.
   Fan WM, 1999, BIOCHEM PHARMACOL, V57, P1215.
   Hankinson SE, 2004, BREAST CANCER RES, V6, P213, DOI 10.1186/bcr921.
   Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10.
   Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30.
   Jordan MA, 1999, METHOD CELL BIOL, V61, P267.
   Kocbek P, 2010, SMALL, V6, P1908, DOI 10.1002/smll.201000032.
   Kolen'ko YV, 2003, MATER LETT, V57, P1124, DOI 10.1016/S0167-577X(02)00943-6.
   Kunjachan S, 2012, EUR J PHARM SCI, V45, P421, DOI 10.1016/j.ejps.2011.08.028.
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024.
   MATSUMURA Y, 1986, CANCER RES, V46, P6387.
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4.
   Prabaharan M, 2009, BIOMATERIALS, V30, P5757, DOI 10.1016/j.biomaterials.2009.07.020.
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020.
   Seo JH, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1164-2.
   Syres K, 2010, LANGMUIR, V26, P14548, DOI 10.1021/la1016092.
   Vamanu CI, 2008, TOXICOL IN VITRO, V22, P1689, DOI 10.1016/j.tiv.2008.07.002.
   Yoo HS, 2000, J CONTROL RELEASE, V68, P419, DOI 10.1016/S0168-3659(00)00280-7.
   Zhang HJ, 2012, INT J NANOMED, V7, P235, DOI 10.2147/IJN.S27722.
   Zhang HJ, 2011, J NANOSCI NANOTECHNO, V11, P1834, DOI 10.1166/jnn.2011.3114.}},
Number-of-Cited-References = {{26}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{27}},
Journal-ISO = {{J. Nanopart. Res.}},
Doc-Delivery-Number = {{AX1GY}},
Unique-ID = {{ISI:000346697000008}},
DA = {{2018-08-13}},
}

@article{ ISI:000345596000004,
Author = {Hawn, Thomas R. and Day, Tracey A. and Scriba, Thomas J. and Hatherill,
   Mark and Hanekom, Willem A. and Evans, Thomas G. and Churchyard, Gavin
   J. and Kublin, James G. and Bekker, Linda-Gail and Self, Steven G.},
Title = {{Tuberculosis Vaccines and Prevention of Infection}},
Journal = {{MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS}},
Year = {{2014}},
Volume = {{78}},
Number = {{4}},
Pages = {{650-671}},
Month = {{DEC}},
Abstract = {{Tuberculosis (TB) is a leading cause of death worldwide despite the
   availability of effective chemotherapy for over 60 years. Although
   Mycobacterium bovis bacillus Calmette-Guerin (BCG) vaccination protects
   against active TB disease in some populations, its efficacy is
   suboptimal. Development of an effective TB vaccine is a top global
   priority that has been hampered by an incomplete understanding of
   protective immunity to TB. Thus far, preventing TB disease, rather than
   infection, has been the primary target for vaccine development. Several
   areas of research highlight the importance of including preinfection
   vaccines in the development pipeline. First, epidemiology and
   mathematical modeling studies indicate that a preinfection vaccine would
   have a high population-level impact for control of TB disease. Second,
   immunology studies support the rationale for targeting prevention of
   infection, with evidence that host responses may be more effective
   during acute infection than during chronic infection. Third, natural
   history studies indicate that resistance to TB infection occurs in a
   small percentage of the population. Fourth, case-control studies of BCG
   indicate that it may provide protection from infection. Fifth,
   prevention-of-infection trials would have smaller sample sizes and a
   shorter duration than disease prevention trials and would enable
   opportunities to search for correlates of immunity as well as serve as a
   criterion for selecting a vaccine product for testing in a larger TB
   disease prevention trial. Together, these points support expanding the
   focus of TB vaccine development efforts to include prevention of
   infection as a primary goal along with vaccines or other interventions
   that reduce the rate of transmission and reactivation.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Hawn, TR (Reprint Author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.
   Hawn, Thomas R., Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.
   Day, Tracey A.; Kublin, James G., Fred Hutchinson Canc Res Ctr, Vaccine \& Infect Dis Div, HIV Vaccine Trials Network, Seattle, WA 98104 USA.
   Scriba, Thomas J.; Hatherill, Mark; Hanekom, Willem A., Univ Cape Town, Inst Infect Dis \& Mol Med, South African TB Vaccine Initiat, ZA-7925 Cape Town, South Africa.
   Scriba, Thomas J.; Hatherill, Mark; Hanekom, Willem A., Univ Cape Town, Dept Paediat \& Child Hlth, ZA-7925 Cape Town, South Africa.
   Hanekom, Willem A., Bill \& Melinda Gates Fdn, Seattle, WA USA.
   Evans, Thomas G., Aeras, Rockville, MD USA.
   Churchyard, Gavin J., Aurum Inst, Johannesburg, South Africa.
   Churchyard, Gavin J., Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.
   Bekker, Linda-Gail, Univ Cape Town, Inst Infect Dis \& Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.
   Self, Steven G., Fred Hutchinson Canc Res Ctr, Stat Ctr HIV Res, Vaccine \& Infect Dis Div, Seattle, WA 98104 USA.
   Kublin, James G., Univ Washington, Sch Med, Dept Med, Dept Global Hlth, Seattle, WA 98195 USA.}},
DOI = {{10.1128/MMBR.00021-14}},
ISSN = {{1092-2172}},
EISSN = {{1098-5557}},
Keywords-Plus = {{BACILLUS-CALMETTE-GUERIN; T-CELL RESPONSES; EXPERIMENTAL AIRBORNE
   TUBERCULOSIS; DRUG-RESISTANT TUBERCULOSIS; HOST-PARASITE RELATIONSHIPS;
   HIV-ASSOCIATED TUBERCULOSIS; PRIME-BOOST VACCINATION; BOVIS BCG
   VACCINATION; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{thawn@u.washington.edu}},
Funding-Acknowledgement = {{Bill and Melinda Gates Foundation}},
Funding-Text = {{Several authors participate in research and clinical trials of some of
   the candidate TB vaccines listed in Table 1. T.G.E. is the President and
   CEO of Aeras, a nonprofit organization that partners with other groups
   to conduct TB vaccine trials. T.J.S., M.H., and previously W.A.H. are
   members of the South African TB Vaccine Initiative, a research and TB
   vaccine testing site that collaborates with multiple groups to conduct
   vaccine trials. W.A.H. participates in TB vaccine trials funded by the
   Bill and Melinda Gates Foundation. T.R.H., T.A.D., G.J.C., J.G.K., and
   S.G. S. are involved with the evaluation of TB vaccines through the HIV
   Vaccine Trials Network. L.-G.B. leads a clinical trial site and
   contributes to HVTN and Aeras vaccine studies.}},
Cited-References = {{Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285.
   Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106.
   Achkar JM, 2013, CELL HOST MICROBE, V13, P250, DOI 10.1016/j.chom.2013.02.009.
   ADAMS JM, 1959, DIS CHEST, V35, P348.
   Ameni G, 2010, CLIN VACCINE IMMUNOL, V17, P1533, DOI 10.1128/CVI.00222-10.
   Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211.
   Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951.
   {[}Anonymous], 1972, Bull World Health Organ, V46, P371.
   {[}Anonymous], 2009, WHO REP GLOB TUB CON.
   ARONSON JD, 1951, AM REV TUBERC PULM, V63, P121.
   Baldwin SL, 2013, J IMMUNOL, V191, P2514, DOI 10.4049/jimmunol.1301161.
   BARCLAY W R, 1970, Infection and Immunity, V2, P574.
   BARCLAY WR, 1973, AM REV RESPIR DIS, V107, P351.
   BERGGREN SA, 1977, BRIT VET J, V133, P490, DOI 10.1016/S0007-1935(17)33991-X.
   BERGGREN SA, 1981, BRIT VET J, V137, P88.
   Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x.
   Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094.
   Billeskov R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039909.
   Bjartveit K, 2003, INT J TUBERC LUNG D, V7, P306.
   Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8.
   Black GF, 2001, J INFECT DIS, V184, P322, DOI 10.1086/322042.
   Bold TD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002063.
   Brehony C, 2014, CLIN VACCINE IMMUNOL, V21, P847, DOI 10.1128/CVI.00133-14.
   Brennan MJ, 2012, TUBERCULOSIS, V92, pS6, DOI 10.1016/S1472-9792(12)70005-7.
   Brooks-Pollock E, 2011, J INFECT DIS, V203, P1582, DOI 10.1093/infdis/jir162.
   BUDDLE BM, 1995, RES VET SCI, V59, P10, DOI 10.1016/0034-5288(95)90023-3.
   BUDDLE BM, 1995, VACCINE, V13, P1123, DOI 10.1016/0264-410X(94)00055-R.
   Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003.
   Cardona PJ, 2006, TUBERCULOSIS, V86, P273, DOI 10.1016/j.tube.2006.01.024.
   Carter SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049833.
   Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002.
   Chaisson RE, 2008, NEW ENGL J MED, V358, P1089, DOI 10.1056/NEJMp0800809.
   Charalambous S, 2008, INT J TUBERC LUNG D, V12, P942.
   Churchyard GJ, 2014, NEW ENGL J MED, V370, P301, DOI 10.1056/NEJMoa1214289.
   Cobat A, 2009, J EXP MED, V206, P2583, DOI 10.1084/jem.20090892.
   COHN ML, 1958, SCIENCE, V128, P1282, DOI 10.1126/science.128.3334.1282.
   COLDITZ GA, 1995, PEDIATRICS, V96, P29.
   COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698.
   Coler RN, 2005, TRENDS PARASITOL, V21, P244, DOI 10.1016/j.pt.2005.03.006.
   COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243.
   Cooper AM, 1997, TUBERCLE LUNG DIS, V78, P67, DOI 10.1016/S0962-8479(97)90017-4.
   Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091.
   DAHLSTROM ARTHUR W., 1940, AMER REV TUBERC, V42, P471.
   Dannenberg AM, 2010, CLIN MICROBIOL REV, V23, P781, DOI 10.1128/CMR.00005-10.
   Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014.
   Day CL, 2013, AM J RESP CRIT CARE, V188, P492, DOI 10.1164/rccm.201208-1385OC.
   de Bruyn G., 2003, COCHRANE DB SYST REV, V2003.
   Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002.
   Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904.
   Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6.
   Donald PR, 2004, INT J TUBERC LUNG D, V8, P627.
   ELLWOOD DC, 1975, BRIT VET J, V131, P186, DOI 10.1016/S0007-1935(17)35339-3.
   ELLWOOD DC, 1972, BRIT VET J, V128, P619, DOI 10.1016/S0007-1935(17)36634-4.
   Elvang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005139.
   Ernst JD, 1998, INFECT IMMUN, V66, P1277.
   Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259.
   Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043.
   Fine PEM, 1996, LANCET, V348, P17.
   Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962.
   FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249.
   Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033.
   Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7.
   Fortune SM, 2004, J IMMUNOL, V172, P6272, DOI 10.4049/jimmunol.172.10.6272.
   Gallegos AM, 2008, J EXP MED, V205, P2359, DOI 10.1084/jem.20080353.
   Gelien A, 1913, B JOHNS HOPKINS HOSP, V24, P180.
   GORDIN FM, 1991, AM REV RESPIR DIS, V144, P560, DOI 10.1164/ajrccm/144.3\_Pt\_1.560.
   Gormus BJ, 2004, J MED PRIMATOL, V33, P134, DOI 10.1111/j.1600-0684.2004.00062.x.
   Griffin J. F. T., 1999, Tubercle and Lung Disease, V79, P135, DOI 10.1054/tuld.1998.0202.
   Griffin JFT, 2006, VACCINE, V24, P835, DOI 10.1016/j.vaccine.2005.07.033.
   Griffin JFT, 2000, CLIN INFECT DIS, V30, pS223, DOI 10.1086/313865.
   Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617.
   Grode L, 2013, VACCINE, V31, P1340, DOI 10.1016/j.vaccine.2012.12.053.
   Grover A, 2009, INFECT IMMUN, V77, P4837, DOI 10.1128/IAI.00704-09.
   Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390.
   Guwatudde D, 2003, B WORLD HEALTH ORGAN, V81, P799.
   Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227.
   Halloran ME, 2010, DESIGN ANAL VACCINE.
   Harris SA, 2014, J INFECT DIS, V209, P1259, DOI 10.1093/infdis/jit647.
   Hawn TR, 2013, MICROBIOL MOL BIOL R, V77, P608, DOI 10.1128/MMBR.00032-13.
   Henao-Tamayo M, 2014, TUBERCULOSIS, V94, P455, DOI 10.1016/j.tube.2014.05.001.
   Henao-Tamayo MI, 2010, CLIN VACCINE IMMUNOL, V17, P618, DOI 10.1128/CVI.00368-09.
   Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095.
   Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192.
   Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947.
   Hope JC, 2005, CLIN EXP IMMUNOL, V139, P48, DOI 10.1111/j.1365-2249.2004.02668.x.
   Hussey G, 2007, PAEDIATR RESPIR REV, V8, P148, DOI 10.1016/j.prrv.2007.04.009.
   Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750.
   JANICKI BW, 1973, AM REV RESPIR DIS, V107, P359.
   Jaspan HB, 2006, J ADOLESCENT HEALTH, V39, P642, DOI 10.1016/j.jadohealth.2006.05.016.
   Johnson CM, 1997, TUBERCLE LUNG DIS, V78, P257, DOI 10.1016/S0962-8479(97)90006-X.
   Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI {[}10.1164/rrcm.201003-0334OC, 10.1164/rccm.201003-0334OC].
   Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8.
   Katoch K, 2008, VACCINE, V26, P1228, DOI 10.1016/j.vaccine.2007.12.025.
   Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016.
   Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545.
   Kincaid EZ, 2003, J IMMUNOL, V171, P2042, DOI 10.4049/jimmunol.171.4.2042.
   Kondratieva TK, 2010, J IMMUNOL, V184, P1227, DOI 10.4049/jimmunol.0902011.
   Kozakiewicz L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003472.
   Kritzinger FE, 2009, TROP MED INT HEALTH, V14, P136, DOI 10.1111/j.1365-3156.2008.02213.x.
   Lachenbruch PA, 1998, CONTROL CLIN TRIALS, V19, P569, DOI 10.1016/S0197-2456(98)00042-7.
   Lahey T, 2010, VACCINE, V28, P7652, DOI 10.1016/j.vaccine.2010.09.041.
   Lambert PH, 2009, CLIN CHEST MED, V30, P811, DOI 10.1016/j.ccm.2009.08.014.
   Lancioni C, 2012, AM J RESP CRIT CARE, V185, P206, DOI 10.1164/rccm.201107-1355OC.
   Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051.
   Langermans JAM, 2001, P NATL ACAD SCI USA, V98, P11497, DOI 10.1073/pnas.201404898.
   Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018.
   Lawn SD, 2011, SAMJ S AFR MED J, V101, P258, DOI 10.7196/SAMJ.4392.
   Lin PL, 2012, J CLIN INVEST, V122, P303, DOI 10.1172/JCI46252.
   Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014.
   Lopez-Valencia G, 2010, RES VET SCI, V88, P44, DOI 10.1016/j.rvsc.2009.05.022.
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(10)61257-3.
   Lucas M, 2010, THORAX, V65, P442, DOI 10.1136/thx.2009.127555.
   Machingaidze S, 2012, AM J RESP CRIT CARE, V186, P1051, DOI 10.1164/rccm.201206-1134OC.
   Mahan CS, 2012, AM J TROP MED HYG, V86, P690, DOI 10.4269/ajtmh.2012.11-0553.
   Mahomed H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059652.
   Mahomed H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017984.
   Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007.
   Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017.
   Mayanja-Kizza H, 2005, J INFECT DIS, V191, P856, DOI 10.1086/427995.
   Mayanja-Kizza H, 2001, J INFECT DIS, V183, P1805, DOI 10.1086/320725.
   McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3.
   McMurray DN, 2000, CLIN INFECT DIS, V30, pS210, DOI 10.1086/313885.
   Mehra S, 2013, J INFECT DIS, V207, P1115, DOI 10.1093/infdis/jis778.
   Meyer J, 2013, EXPERT REV VACCINES, V12, P443, DOI {[}10.1586/ERV.13.19, 10.1586/erv.13.19].
   Michelsen SW, 2014, THORAX, V69, P851, DOI 10.1136/thoraxjnl-2014-205688.
   Middelkoop K, 2012, INT J TUBERC LUNG D, V16, P1510, DOI 10.5588/ijtld.12.0049.
   Middelkoop K, 2008, CLIN INFECT DIS, V47, P349, DOI 10.1086/589750.
   Middelkoop K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-156.
   Miller J, 2010, NY TIMES BK REV, P6.
   MILLS CC, 1960, B JOHNS HOPKINS HOSP, V106, P36.
   Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104.
   Montoya J, 2013, J CLIN IMMUNOL, V33, P1360, DOI 10.1007/s10875-013-9949-3.
   NYBOE J, 1957, Bull World Health Organ, V17, P319.
   Olsen AW, 2001, INFECT IMMUN, V69, P2773, DOI 10.1128/IAI.69.5.2773-2778.2001.
   Ordway D, 2008, CLIN VACCINE IMMUNOL, V15, P1248, DOI 10.1128/CVI.00019-08.
   Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522.
   Orr MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083884.
   Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607.
   PANCHOLI P, 1993, SCIENCE, V260, P984, DOI 10.1126/science.8098550.
   PEREZSTABLE EJ, 1988, AM REV RESPIR DIS, V137, P801, DOI 10.1164/ajrccm/137.4.801.
   Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657107.
   Pitt JM, 2013, MICROB PATHOGENESIS, V58, P2, DOI 10.1016/j.micpath.2012.12.002.
   POULSEN A, 1950, Acta Tuberc Scand, V24, P311.
   Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07.
   Reiley WW, 2008, P NATL ACAD SCI USA, V105, P10961, DOI 10.1073/pnas.0801496105.
   RIEDER HL, 1995, TUBERCLE LUNG DIS, V76, P114, DOI 10.1016/0962-8479(95)90552-9.
   Rieder HL, 1999, INT J TUBERC LUNG D, V3, P177.
   Rieder HL, 1999, EPIDEMIOLOGICAL BASI.
   RILEY RL, 1995, AM J EPIDEMIOL, V142, P3, DOI 10.1093/oxfordjournals.aje.a117542.
   RILEY RL, 1957, AM REV TUBERC PULM, V76, P931.
   RILEY RL, 1962, AM REV RESPIR DIS, V85, P511.
   Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643.
   Roy RB, 2012, AM J RESP CRIT CARE, V186, P378, DOI 10.1164/rccm.201201-0026OC.
   Russell DG, 2011, IMMUNOL REV, V240, P252, DOI 10.1111/j.1600-065X.2010.00984.x.
   Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784.
   Rustomjee R, 2013, TUBERCULOSIS, V93, P136, DOI 10.1016/j.tube.2012.11.005.
   Saini D, 2012, TUBERCULOSIS, V92, P160, DOI 10.1016/j.tube.2011.11.007.
   Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06.
   Scriba TJ, 2011, J INFECT DIS, V203, P1832, DOI 10.1093/infdis/jir195.
   Sebina I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051381.
   Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885.
   Shah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026787.
   Shanaube K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007749.
   Sharpe SA, 2010, CLIN VACCINE IMMUNOL, V17, P1170, DOI 10.1128/CVI.00079-10.
   Shenoi S, 2009, ANNU REV MED, V60, P307, DOI 10.1146/annurev.med.60.053107.103955.
   SMITH DW, 1966, J BACTERIOL, V91, P718.
   SMITH DW, 1970, AM REV RESPIR DIS, V102, P937.
   Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5.
   Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4.
   Stein CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004094.
   STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277.
   Sutherland I, 1968, 2550 INDIVIDUALS AGE.
   Tailleux L, 2005, PLOS MED, V2, P1269, DOI 10.1371/journal.pmed.0020381.
   Tailleux L, 2003, TRENDS MICROBIOL, V11, P259, DOI 10.1016/S0966-842X(03)00102-1.
   Tameris M, 2013, TUBERCULOSIS, V93, P143, DOI 10.1016/j.tube.2013.01.003.
   Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4.
   Torrelles JB, 2008, CURR DRUG TARGETS, V9, P102.
   Hoang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080579.
   Tuberculosis Research Center, 2013, INDIAN J MED RES, V137.
   Turner J, 2001, EXP GERONTOL, V36, P537, DOI 10.1016/S0531-5565(00)00257-6.
   Van Rhijn I, 2013, ADV EXP MED BIOL, V783, P181, DOI 10.1007/978-1-4614-6111-1\_10.
   Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602.
   Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110.
   Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC.
   Vilaplana C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020404.
   von Reyn CF, 2010, AIDS, V24, P675, DOI 10.1097/QAD.0b013e3283350f1b.
   Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09.
   Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002.
   Vynnycky E, 1999, INT J EPIDEMIOL, V28, P327, DOI 10.1093/ije/28.2.327.
   Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247.
   WADDINGTON FG, 1972, BRIT VET J, V128, P541, DOI 10.1016/S0007-1935(17)36683-6.
   WALLGREN A, 1948, Tubercle, V29, P245, DOI 10.1016/S0041-3879(48)80033-4.
   Walsh GP, 1996, NAT MED, V2, P430, DOI 10.1038/nm0496-430.
   Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357.
   Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040.
   Wedlock DN, 2007, VET IMMUNOL IMMUNOP, V118, P50, DOI 10.1016/j.vetimm.2007.04.005.
   Whalen CC, 2005, JAMA-J AM MED ASSOC, V293, P2785, DOI 10.1001/jama.293.22.2785.
   Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201.
   Whalen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016137.
   Wiker HG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-37.
   Williams A, 2004, IMMUNOLOGY, V111, P328, DOI 10.1111/j.1365-2567.2004.01809.x.
   Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367.
   Wood R, 2010, INT J TUBERC LUNG D, V14, P406.
   Wood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025098.
   World Health Organization, 2013, GLOB TUB REP.
   Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894.}},
Number-of-Cited-References = {{206}},
Times-Cited = {{44}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{50}},
Journal-ISO = {{Microbiol. Mol. Biol. Rev.}},
Doc-Delivery-Number = {{AU4QE}},
Unique-ID = {{ISI:000345596000004}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000348529400003,
Author = {Fakruddin, Md and Rahaman, Mizanur and Ahmed, Monzur Morshed and Hoque,
   Md Mahfuzul},
Title = {{Stress tolerant virulent strains of Cronobacter sakazakii from food}},
Journal = {{BIOLOGICAL RESEARCH}},
Year = {{2014}},
Volume = {{47}},
Month = {{NOV 25}},
Abstract = {{Background: Cronobacter sakazakii is considered as an emerging foodborne
   pathogen. The aim of this study was to isolate and characterize virulent
   strains of Cronobacter sakazakii from food samples of Bangladesh.
   Result: Six (6) Cronobacter sakazakii was isolated and identified from
   54 food samples on the basis of biochemical characteristics, sugar
   fermentation, SDS-PAGE of whole cell protein, plasmid profile and PCR of
   Cronobacter spp. specific genes (esak, gluA, zpx, ompA, ERIC, BOX-AIR)
   and sequencing. These strains were found to have moderately high
   antibiotic resistance against common antibiotics and some are ESBL
   producer. Most of the C. sakazakii isolates were capable of producing
   biofilm (strong biofilm producer), extracellular protease and
   siderophores, curli expression, haemolysin, haemagglutinin, mannose
   resistant haemagglutinin, had high cell surface hydrophobicity,
   significant resistance to human serum, can tolerate high concentration
   of salt, bile and DNase production. Most of them produced enterotoxins
   of different molecular weight. The isolates pose significant serological
   cross-reactivity with other gram negative pathogens such as serotypes of
   Salmonella spp., Shigella boydii, Shigella sonnei, Shigella flexneri and
   Vibrio cholerae. They had significant tolerance to high temperature, low
   pH, dryness and osmotic stress.
   Conclusion: Special attention should be given in ensuring hygiene in
   production and post-processing to prevent contamination of food with
   such stress-tolerant virulent Cronobacter sakazakii.}},
Publisher = {{SOC BIOLGIA CHILE}},
Address = {{CASILLA 16164, SANTIAGO 9, CHILE}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ahmed, MM (Reprint Author), BCSIR, IFST, Ind Microbiol Lab, Dhaka, Bangladesh.
   Fakruddin, Md; Ahmed, Monzur Morshed, BCSIR, IFST, Ind Microbiol Lab, Dhaka, Bangladesh.
   Rahaman, Mizanur; Hoque, Md Mahfuzul, Univ Dhaka, Dept Microbiol, Dhaka 1000, Bangladesh.}},
DOI = {{10.1186/0717-6287-47-63}},
Article-Number = {{63}},
ISSN = {{0716-9760}},
EISSN = {{0717-6287}},
Keywords = {{Cronobacter; Food; Virulent; Bangladesh}},
Keywords-Plus = {{16S RIBOSOMAL-RNA; ENTEROBACTER-SAKAZAKII; INFANT FORMULA; GENE;
   IDENTIFICATION; PCR; SURVIVAL; MILK; SIDEROPHORES; ENTEROTOXIN}},
Research-Areas = {{Life Sciences \& Biomedicine - Other Topics}},
Web-of-Science-Categories  = {{Biology}},
Author-Email = {{monzur\_29@yahoo.com}},
Cited-References = {{Al-Holy MA, 2009, J FOOD SAFETY, V29, P287, DOI 10.1111/j.1745-4565.2009.00157.x.
   Banu A, 2011, J CLIN DIAGN RES, V5, P486.
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493.
   Beuchat LR, 2009, INT J FOOD MICROBIOL, V136, P204, DOI 10.1016/j.ijfoodmicro.2009.02.029.
   Breeuwer P, 2003, J APPL MICROBIOL, V95, P967, DOI 10.1046/j.1365-2672.2003.02067.x.
   Cawthorn DM, 2008, INT J FOOD MICROBIOL, V127, P129, DOI 10.1016/j.ijfoodmicro.2008.06.024.
   CCLS, 2007, 17 INFL SUPPL JAN, V27.
   Dancer GI, 2009, J APPL MICROBIOL, V107, P1606, DOI 10.1111/j.1365-2672.2009.04347.x.
   Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000.
   Emody L, 2003, Int J Antimicrob Agents, V22 Suppl 2, P29.
   Epstein EA, 2008, CELL MICROBIOL, V10, P1413, DOI 10.1111/j.1462-5822.2008.01148.x.
   Fakruddin M., 2013, International Journal of Biomedical and Advance Research, V4, P349.
   Fakruddin M, 2015, BRIT MICROBIOL RES J, V5, P25.
   Fakruddin M, 2014, INT J MICROBIOL IMMU, V3, P12.
   Fakruddin M, 2013, INDIAN J MED RES, V137, P988.
   {*}FDA, 2002, IS EN ENT SAK DEH PO.
   Gurtler JB, 2005, INT J FOOD MICROBIOL, V104, P1, DOI 10.1016/j.ijfoodmicro.2005.02.013.
   Hassan AA, 2007, INT J FOOD MICROBIOL, V116, P214, DOI 10.1016/j.ijfoodmicro.2006.12.011.
   Iversen C, 2004, LETT APPL MICROBIOL, V38, P378, DOI 10.1111/j.1472-765X.2004.01507.x.
   Iversen C, 2007, J CLIN MICROBIOL, V45, P3814, DOI 10.1128/JCM.01026-07.
   Iversen C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-94.
   Kim HY, 2014, FOODBORNE PATHOG DIS, V11, P119, DOI 10.1089/fpd.2013.1581.
   KOEUTH T, 1995, GENOME RES, V5, P408, DOI 10.1101/gr.5.4.408.
   Kothary MH, 2007, APPL ENVIRON MICROB, V73, P4142, DOI 10.1128/AEM.02729-06.
   Lai KK, 2001, MEDICINE, V80, P113, DOI 10.1097/00005792-200103000-00004.
   Lehner A, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-15.
   Lehner A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-43.
   Lehner A, 2009, 1 INT M CRON ENT SAK.
   LOCKWOOD DE, 1982, INFECT IMMUN, V35, P702.
   Loffler FE, 2000, APPL ENVIRON MICROB, V66, P1369, DOI 10.1128/AEM.66.4.1369-1374.2000.
   MacLean LL, 2009, CARBOHYD RES, V344, P667, DOI 10.1016/j.carres.2009.01.020.
   Mittal R, 2009, LAB INVEST, V89, P263, DOI 10.1038/labinvest.2008.164.
   Mofokeng L, 2011, J FOOD SAFETY, V31, P96.
   Nair MKM, 2007, PEDIATR RES, V62, P664.
   Nair MKM, 2006, APPL ENVIRON MICROB, V72, P2539, DOI 10.1128/AEM.72.4.2539-2546.2006.
   Nazarowec-White M, 1999, J MED MICROBIOL, V48, P559, DOI 10.1099/00222615-48-6-559.
   Pagotto FJ, 2003, J FOOD PROTECT, V66, P370, DOI 10.4315/0362-028X-66.3.370.
   PAYNE SM, 1994, METHOD ENZYMOL, V235, P329.
   Proudy I, 2008, J APPL MICROBIOL, V104, P26, DOI 10.1111/j.1365-2672.2007.03526.x.
   Proudy I, 2007, J APPL MICROBIOL, V105, P550.
   Raghav M, 2007, CAN J MICROBIOL, V53, P750, DOI 10.1139/W07-037.
   Richards GM, 2005, J APPL MICROBIOL, V99, P844, DOI 10.1111/j.1365-2672.2005.02656.x.
   Shaker R, 2007, FOOD CONTROL, V18, P1241, DOI 10.1016/j.foodcont.2006.07.020.
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121.
   Townsend SM, 2008, MICROBIOL-SGM, V154, P3659, DOI 10.1099/mic.0.2008/021980-0.
   Van Acker J, 2001, J CLIN MICROBIOL, V39, P293, DOI 10.1128/JCM.39.1.293-297.2001.
   VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823.
   Weir E, 2002, CAN MED ASSOC J, V166, P1570.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{35}},
Journal-ISO = {{Biol. Res.}},
Doc-Delivery-Number = {{AZ9JK}},
Unique-ID = {{ISI:000348529400003}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000347709300120,
Author = {Kumari, Priyanka and Choi, Hong L.},
Title = {{Seasonal Variability in Airborne Biotic Contaminants in Swine
   Confinement Buildings}},
Journal = {{PLOS ONE}},
Year = {{2014}},
Volume = {{9}},
Number = {{11}},
Month = {{NOV 13}},
Abstract = {{Little is known about the seasonal dynamics of biotic contaminants in
   swine confinement buildings (SCBs). The biotic contaminants of seven
   SCBs were monitored during one visit in the winter and one during the
   summer. Paired-end Illumina sequencing of the 16S rRNA gene, V3 region,
   was used to examine seasonal shifts in bacterial community composition
   and diversity. The abundances of 16S rRNA genes and six tetracycline
   resistance genes (tetB, tetH, tetZ, tetO, tetQ, and tetW) were also
   quantified using real-time PCR. Bacterial abundances, community
   composition and diversity all showed strong seasonal patterns defined by
   winter peaks in abundance and diversity. Microclimatic variables of
   SCBs, particularly air speed, PM2.5 and total suspended particles (TSP)
   were found significantly correlated to abundances, community
   composition, and diversity of bacterial bioaerosols. Seasonal
   fluctuations were also observed for four tetracycline resistance genes,
   tetH, tetO, tetQ, and tetW. The frequency of occurrences of these
   resistance genes were significantly higher in samples collected during
   winter and was also significantly correlated with air speed, PM2.5 and
   TSP. Overall, our results indicate that biotic contaminants in SCBs
   exhibit seasonal trends, and these could be associated with the
   microclimatic variables of SCBs. The correlations established in the
   current study could be helpful in establishing better management
   strategies to minimize the potential health impacts on both livestock
   and humans working in this environment.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Choi, HL (Reprint Author), Seoul Natl Univ, Res Inst Agr \& Life Sci, Dept Agr Biotechnol, Seoul, South Korea.
   Kumari, Priyanka; Choi, Hong L., Seoul Natl Univ, Res Inst Agr \& Life Sci, Dept Agr Biotechnol, Seoul, South Korea.}},
DOI = {{10.1371/journal.pone.0112897}},
Article-Number = {{e112897}},
ISSN = {{1932-6203}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE GENES; CULTURE-INDEPENDENT CHARACTERIZATION;
   TETRACYCLINE RESISTANCE; RESPIRATORY SYMPTOMS; MICROBIAL DIVERSITY;
   LIVESTOCK BUILDINGS; RARE BIOSPHERE; BACTERIA; PIG; GENERATION}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{ulsoo8@snu.ac.kr}},
Funding-Acknowledgement = {{Ministry of Agriculture, Food, and Rural Affairs (MAFRA)
   {[}312036-03-2-HD030]; Ministry of Trade, Industry and Energy (MOTIE)
   {[}2012-3020090040]}},
Funding-Text = {{This work was supported by Korea Institute of Planning and Evaluation
   for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) from
   the Ministry of Agriculture, Food, and Rural Affairs (MAFRA) through
   project no. 312036-03-2-HD030, and in part by Korea Institute of Energy
   Technology Evaluation and Planning (KETEP) from the Ministry of Trade,
   Industry and Energy (MOTIE) through project no. 2012-3020090040. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.}},
Cited-References = {{Aminov RI, 2001, APPL ENVIRON MICROB, V67, P22, DOI 10.1128/AEM.67.1.22-32.2001.
   Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006.
   Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10.
   Bent SJ, 2007, APPL ENVIRON MICROB, V73, P2399, DOI 10.1128/AEM.02383-06.
   Blake DP, 2003, J APPL MICROBIOL, V95, P428, DOI 10.1046/j.1365-2672.2003.01988.x.
   Cambra-Lopez M, 2010, ENVIRON POLLUT, V158, P1, DOI 10.1016/j.envpol.2009.07.011.
   CARPENTER GA, 1986, J AGR ENG RES, V33, P227, DOI 10.1016/S0021-8634(86)80038-5.
   Chang CW, 2001, APPL ENVIRON MICROB, V67, P155, DOI 10.1128/AEM.67.1.155-161.2001.
   Charavaryamath C, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-10.
   Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35.
   Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001.
   CHOUDAT D, 1994, SCAND J WORK ENV HEA, V20, P48, DOI 10.5271/sjweh.1429.
   CORMIER Y, 1990, AM IND HYG ASSOC J, V51, P304, DOI 10.1202/0002-8894(1990)051<0304:AMCITT>2.0.CO;2.
   Delsol AA, 2003, J APPL MICROBIOL, V95, P1226, DOI 10.1046/j.1365-2672.2003.02088.x.
   DONHAM K, 1989, BRIT J IND MED, V46, P31.
   Dosman JA, 2004, EUR RESPIR J, V24, P698, DOI 10.1183/09031936.04.00112102.
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381.
   FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3.
   Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377.
   Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910.
   Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106.
   HEEDERIK D, 1991, INT ARCH OCC ENV HEA, V62, P595, DOI 10.1007/BF00381114.
   Hong PY, 2012, ENVIRON MICROBIOL, V14, P1420, DOI 10.1111/j.1462-2920.2012.02726.x.
   Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x.
   Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255.
   Israel-Assayag E, 2002, EUR RESPIR J, V19, P833, DOI 10.1183/09031936.02.02182001.
   Kembel SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087093.
   Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211.
   Kilburn KH, 2012, J ENVIRON PUBLIC HEA, DOI 10.1155/2012/565690.
   Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0.
   Kristiansen A, 2012, FEMS MICROBIOL ECOL, V80, P390, DOI 10.1111/j.1574-6941.2012.01305.x.
   Letourneau V, 2010, INT J HYG ENVIR HEAL, V213, P444, DOI 10.1016/j.ijheh.2010.09.008.
   Levy SB, 1999, ANTIMICROB AGENTS CH, V43, P1523.
   Ling AL, 2013, ENVIRON SCI TECHNOL, V47, P4046, DOI 10.1021/es400238g.
   Mackiewicz B, 1998, ANN AGR ENV MED, V5, P169.
   MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI {[}10.1038/nrmicro2088, 10.1038/nrmicro2122].
   McKinney CW, 2010, ENVIRON SCI TECHNOL, V44, P6102, DOI 10.1021/es9038165.
   Ministry of Environment Republic of Korea, 2008, ENV STAT YB, V12.
   Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x.
   Nehme B, 2009, APPL ENVIRON MICROB, V75, P5445, DOI 10.1128/AEM.00726-09.
   Nonnenmann MW, 2010, J OCCUP ENVIRON HYG, V7, P693, DOI 10.1080/15459624.2010.526893.
   Oksanen J, 2007, VEGAN PACKAGE COMMUN.
   ONEILL DH, 1992, J AGR ENG RES, V53, P23, DOI 10.1016/0021-8634(92)80072-Z.
   Otake S, 2010, VET MICROBIOL, V145, P198, DOI 10.1016/j.vetmic.2010.03.028.
   Pavilonis BT, 2013, ENVIRON RES, V122, P74, DOI 10.1016/j.envres.2012.12.008.
   R Development Core Team, 2008, R LANG ENV STAT COMP.
   Roberts MC, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00384.
   Santamaria J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00252.
   Schinasi L, 2011, EPIDEMIOLOGY, V22, P208, DOI 10.1097/EDE.0b013e3182093c8b.
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09.
   Smit LAM, 2014, OCCUP ENVIRON MED, V71, P134, DOI 10.1136/oemed-2013-101485.
   Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103.
   White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352.
   Yang Y, 2013, ENVIRON SCI TECHNOL, V47, P10197, DOI 10.1021/es4017365.
   Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160.
   Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110.}},
Number-of-Cited-References = {{56}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{32}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{AY6YT}},
Unique-ID = {{ISI:000347709300120}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000343785400018,
Author = {Zhao, Hui and Li, Wenxing and Gao, Yanfeng and Li, Jianqiang and Wang,
   Haibin},
Title = {{Exposure to particular matter increases susceptibility to respiratory
   Staphylococcus aureus infection in rats via reducing pulmonary natural
   killer cells}},
Journal = {{TOXICOLOGY}},
Year = {{2014}},
Volume = {{325}},
Pages = {{180-188}},
Month = {{NOV 5}},
Abstract = {{Epidemiological studies have shown a correlation between exposure to
   fine particular matter (PM2.5) and increased respiratory infection, but
   the mechanisms have remained poorly defined.
   By using an experimental system we evaluated the effect of PM2.5
   exposure on susceptibility to subsequent pulmonary Staphylococcus aureus
   (S. aureus) infection and its potential mechanisms. Rats were
   intratracheally instilled with a single dose of PM2.5 sample or PBS
   followed by an intratracheal inoculation with bacteria S. aureus at 24 h
   after PM2.5 exposure. The rats were examined at 24 h post infection. We
   found that exposure of rats to PM2.5 significantly increased
   inflammatory cells and levels of IL-6 and TNF-alpha in bronchoalveolar
   lavage fluids (BALF). Prior PM2.5 exposure markedly increased the
   susceptibility of rats to subsequent S. aureus infection. The
   mechanistic studies showed that alveolar macrophages (AMs) from
   PM2.5-experienced lungs had depressed phagocytosis of S. aureus, and
   prior PM2.5 exposure significantly decreased the natural killer (NK)
   cells recruited into the airways following subsequent S. aureus
   infection. Further, adoptive transfer of naive NK cells to the lung of
   prior PM2.5-exposed rats restored PM2.5-impaired antibacterial host
   defense. The presence of NK cells markedly enhanced the ability of AMs
   to phagocytose S. aureus ex vivo. Thus, our study identifies
   PM2.5-impaired NK cell response in the lung to be a novel critical
   mechanism for PM2.5-mediated susceptibility to S. aureus bacterial
   infection, which provides a potential mechanism to explain the
   epidemiological findings that associate ambient air pollution and
   increased lung bacterial infections. Our findings also suggest that
   enhancing pulmonary NK cells may be considered for future therapeutic
   approaches to clinically antibiotic-resistant S. aureus infection in the
   lung. (C) 2014 Elsevier Ireland Ltd. All rights reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wang, HB (Reprint Author), Shanxi Med Univ, Dept Resp Med, Hosp 2, Taiyuan 030001, Shanxi Province, Peoples R China.
   Zhao, Hui; Gao, Yanfeng; Li, Jianqiang; Wang, Haibin, Shanxi Med Univ, Dept Resp Med, Hosp 2, Taiyuan 030001, Shanxi Province, Peoples R China.
   Li, Wenxing, Shanxi Med Univ, Dept Surg, Hosp 2, Taiyuan 030001, Shanxi Province, Peoples R China.
   Wang, Haibin, Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Allergy \& Inflammat,Dept Med, Boston, MA 02115 USA.}},
DOI = {{10.1016/j.tox.2014.09.006}},
ISSN = {{0300-483X}},
Keywords = {{PM2.5; S. aureus; Pulmonary infection; Alveolar macrophages; NK cells}},
Keywords-Plus = {{COMMUNITY-ACQUIRED PNEUMONIA; EMERGENCY-DEPARTMENT VISITS; DIESEL
   EXHAUST PARTICLES; AIR-POLLUTION PARTICLES; RETROSPECTIVE COHORT;
   HOSPITAL ADMISSIONS; NK CELLS; CLEARANCE; LUNG; MICE}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{hwang1@bidmc.harvard.edu}},
Funding-Acknowledgement = {{Shanxi Natural Science Foundation {[}20090311059-1]; Health Department
   of Shanxi Province, China {[}20100206]}},
Funding-Text = {{This study was financially supported in part by a grant (No.
   20090311059-1) from Shanxi Natural Science Foundation, and a grant (No.
   20100206) from the Health Department of Shanxi Province, China.}},
Cited-References = {{Costa DL, 2006, TOXICOL SCI, V91, P237, DOI 10.1093/toxsci/kfj123.
   Costa DL, 1997, ENVIRON HEALTH PERSP, V105, P1053, DOI 10.2307/3433509.
   Drews Timothy D, 2006, WMJ, V105, P52.
   Fusco D, 2001, EUR RESPIR J, V17, P1143, DOI 10.1183/09031936.01.00005501.
   Gavett SH, 2003, ENVIRON HEALTH PERSP, V111, P981, DOI 10.1289/ehp.5931.
   Ghio AJ, 2001, AM J RESP CRIT CARE, V164, P704, DOI 10.1164/ajrccm.164.4.2011089.
   Ghio AJ, 2012, OCCUP ENVIRON MED, V69, P170, DOI 10.1136/oem.2011.065276.
   Gillet Y, 2007, CLIN INFECT DIS, V45, P315, DOI 10.1086/519263.
   HAHON N, 1985, ENVIRON RES, V37, P44, DOI 10.1016/0013-9351(85)90048-9.
   Haller D, 2002, CLIN DIAGN LAB IMMUN, V9, P649, DOI 10.1128/CDLI.9.3.649-657.2002.
   Harris AM, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-93.
   Lim SH, 2012, J CHINESE CINEMAS, V6, P3, DOI 10.1386/jcc.6.1.3\_2.
   Longhin E., 2014, PART FIBRE TOXICOL, V10, P63.
   Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159.
   Mikerov AN, 2008, AM J PHYSIOL-LUNG C, V294, pL121, DOI 10.1152/ajplung.00288.2007.
   Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356.
   Moran GJ, 2012, CLIN INFECT DIS, V54, P1126, DOI 10.1093/cid/cis022.
   Nemmar A, 2010, TOXICOL LETT, V194, P58, DOI 10.1016/j.toxlet.2010.02.001.
   Neupane B, 2010, AM J RESP CRIT CARE, V181, P47, DOI {[}10.1164/rccm.200901-0160oc, 10.1164/rccm.200901-0160OC].
   Peel JL, 2005, EPIDEMIOLOGY, V16, P164, DOI 10.1097/01.ede.0000152905.42113.db.
   Schins RPF, 2004, TOXICOL APPL PHARM, V195, P1, DOI 10.1016/j.taap.2003.10.002.
   Shen M, 2009, ENVIRON HEALTH PERSP, V117, P261, DOI 10.1289/ehp.11521.
   Sigaud S, 2007, TOXICOL APPL PHARM, V223, P1, DOI 10.1016/j.taap.2007.04.014.
   Small CL, 2008, J IMMUNOL, V180, P5558, DOI 10.4049/jimmunol.180.8.5558.
   Stieb DM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-25.
   Stralin K, 2006, CHEST, V130, P623, DOI 10.1378/chest.130.2.623a.
   Walters DM, 2001, AM J RESP CRIT CARE, V164, P1438, DOI 10.1164/ajrccm.164.8.2007121.
   WOLFF RK, 1986, ENVIRON HEALTH PERSP, V66, P223, DOI 10.2307/3430237.
   Yang HM, 2001, ENVIRON HEALTH PERSP, V109, P515, DOI 10.2307/3454711.
   Zanobetti A, 2000, ENVIRON HEALTH PERSP, V108, P1071, DOI 10.2307/3434961.
   Zhou HW, 2007, AM J RESP CELL MOL, V36, P460, DOI 10.1165/rcmb.2006-0293OC.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{14}},
Usage-Count-Last-180-days = {{9}},
Usage-Count-Since-2013 = {{41}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{AR7UO}},
Unique-ID = {{ISI:000343785400018}},
DA = {{2018-08-13}},
}

@article{ ISI:000346951200009,
Author = {Ahlberg, Sebastian and Meinke, Martina C. and Werner, Luise and Epple,
   Matthias and Diendorf, Joerg and Blume-Peytavi, Ulrike and Lademann,
   Juergen and Vogt, Annika and Rancan, Fiorenza},
Title = {{Comparison of silver nanoparticles stored under air or argon with
   respect to the induction of intracellular free radicals and toxic
   effects toward keratinocytes}},
Journal = {{EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS}},
Year = {{2014}},
Volume = {{88}},
Number = {{3}},
Pages = {{651-657}},
Month = {{NOV}},
Abstract = {{Bacterial infections decreased considerably after the discovery of
   antibiotics. Nevertheless, because of the rising rate of infections
   caused by antibiotic-resistant bacteria strains, the search for new
   bactericidal agents has again become a crucial topic in clinical
   medicine. Silver nanoparticles (AgNP) have a huge potential in
   dermatology and wound care management because of their ability to
   release silver ions (Ag+ ions) in a prolonged and sustained way.
   However, negative effects of silver on the patient's cells should not be
   underestimated. Furthermore, it has been controversially discussed
   whether AgNP are responsible for nanoparticle-specific outcomes or not.
   In this study, we investigated the effects of AgNP on human skin
   keratinocytes (HaCaT) in order to better understand the mechanisms of
   cytotoxicity and to improve the use of this highly reactive biocide in
   wound healing. We found that most of the cells with internalized AgNP
   displayed the typical morphological signs of apoptosis. The cell
   viability assay (XTT) showed concentration-dependent toxic effects of
   the AgNP toward HaCaT cells. The generation of reactive oxygen species
   (ROS) induced by AgNP was investigated in cell suspensions by means of
   electron paramagnetic resonance (EPR) spectroscopy. In order to
   distinguish between the effects of Ag+ ions released during AgNP storage
   and those of Ag+ ions released after nanoparticle application, we
   compared AgNP stored under air (O-2) with AgNP stored under argon (Ar).
   Dispersions of AgNP stored under Ar have a low content of Ag+ ions
   because of the absence of oxygen which is needed for oxidative
   dissolution. The results show that Ag+ ions released during particle
   storage are responsible for most of the ROS produced during 1 h
   incubation with the cells. AgNP (Ar) also induced intracellular ROS but
   to a much smaller extent compared to AgNP (O-2). These findings
   highlight the complexity of experiments to assess the toxicity of AgNP
   and suggest the possibility of reducing AgNP toxic effects by storing
   AgNP formulations and even silver-containing wound dressing under an
   inert gas atmosphere. (C) 2014 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Rancan, F (Reprint Author), Charite, Dept Dermatol \& Allergy, Clin Res Ctr Hair \& Skin Sci, Charitepl 1, D-10117 Berlin, Germany.
   Ahlberg, Sebastian; Meinke, Martina C.; Werner, Luise; Blume-Peytavi, Ulrike; Lademann, Juergen; Vogt, Annika; Rancan, Fiorenza, Charite, Dept Dermatol Venerol \& Allergol, D-10117 Berlin, Germany.
   Epple, Matthias; Diendorf, Joerg, Univ Duisburg Essen, Inorgan Chem \& Ctr Nanointegrat Duisburg Essen Ce, Essen, Germany.}},
DOI = {{10.1016/j.ejpb.2014.07.012}},
ISSN = {{0939-6411}},
EISSN = {{1873-3441}},
Keywords = {{AgNP; Nanoparticles; Electron paramagnetic resonance spectroscopy;
   Keratinocytes; Skin; Cytotoxity; Cellular uptake}},
Keywords-Plus = {{OXIDATIVE STRESS; HUMAN SKIN; CELL-LINE; IN-VIVO; APOPTOSIS; IONS;
   DIFFERENTIATION; PROLIFERATION; DISSOLUTION; EXPRESSION}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy}},
Author-Email = {{fiorenza.rancan@charite.de}},
Funding-Acknowledgement = {{Deutsche Forschungsgemeinschaft (DFG) {[}SPP 1313 Bio-Nano-Responses]}},
Funding-Text = {{This work was supported by the Deutsche Forschungsgemeinschaft (DFG)
   (SPP 1313 Bio-Nano-Responses).}},
Cited-References = {{ASHARANI PV, 2008, ACS NANO, V3, P279, DOI DOI 10.1021/NN800596W.
   Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010.
   Barbacanne MA, 2000, FREE RADICAL BIO MED, V29, P388, DOI 10.1016/S0891-5849(00)00336-1.
   BERGER TJ, 1976, ANTIMICROB AGENTS CH, V9, P357, DOI 10.1128/AAC.9.2.357.
   Bondarenko O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064060.
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761.
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8.
   Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923.
   Cho JW, 2007, INT J MOL MED, V19, P469.
   Chopra I, 2007, J ANTIMICROB CHEMOTH, V59, P587, DOI 10.1093/jac/dkm006.
   DanenVanOorschot AAAM, 1997, P NATL ACAD SCI USA, V94, P5843.
   Eichler M, 2007, PHOTOMED LASER SURG, V25, P170, DOI 10.1089/pho.2007.2046.
   Foldbjerg R, 2009, TOXICOL LETT, V190, P156, DOI 10.1016/j.toxlet.2009.07.009.
   Gandarillas A, 1999, EXP DERMATOL, V8, P71, DOI 10.1111/j.1600-0625.1999.tb00350.x.
   He D, 2011, J PHYS CHEM C, V115, P5461, DOI 10.1021/jp111275a.
   Johnston HJ, 2010, CRIT REV TOXICOL, V40, P328, DOI 10.3109/10408440903453074.
   Keck C., 2013, INT J PHARMACEUT, V462, P44.
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001.
   Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001.
   Kittler S, 2010, CHEM MATER, V22, P4548, DOI 10.1021/cm100023p.
   Kuhn DM, 2003, J CLIN MICROBIOL, V41, P506, DOI 10.1128/JCM.41.1.506-508.2003.
   Larese FF, 2009, TOXICOLOGY, V255, P33, DOI 10.1016/j.tox.2008.09.025.
   Lauer AC, 2013, SKIN PHARMACOL PHYS, V26, P147, DOI 10.1159/000350833.
   Loza K, 2014, J MATER CHEM B, V2, P1634, DOI 10.1039/c3tb21569e.
   Mahl D, 2011, COLLOID SURFACE A, V377, P386, DOI 10.1016/j.colsurfa.2011.01.031.
   Mannello F, 2007, STEM CELLS, V25, P1603, DOI 10.1634/stemcells.2007-0127.
   Paddle-Ledinek JE, 2006, PLAST RECONSTR SURG, V117, p110S, DOI 10.1097/01.prs.0000225439.39352.ce.
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002.
   Rancan F., 2013, SKIN RES TECHNOL, V20, P182.
   ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U.
   Samberg ME, 2010, ENVIRON HEALTH PERSP, V118, P407, DOI 10.1289/ehp.0901398.
   Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x.
   Singh S, 2007, TOXICOL APPL PHARM, V222, P141, DOI 10.1016/j.taap.2007.05.001.
   Tenzer S, 2011, ACS NANO, V5, P7155, DOI 10.1021/nn201950e.
   Thurn KT, 2007, NANOSCALE RES LETT, V2, P430, DOI 10.1007/s11671-007-9081-5.
   Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v.
   Wang HS, 2005, COLLOID SURFACE A, V256, P111, DOI 10.1016/j.colsurfa.2004.12.058.
   Wieder T, 1998, J BIOL CHEM, V273, P11025, DOI 10.1074/jbc.273.18.11025.
   Wijnhoven SWP, 2009, NANOTOXICOLOGY, V3, P109, DOI 10.1080/17435390902725914.
   Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w.
   Zanette C, 2011, TOXICOL IN VITRO, V25, P1053, DOI 10.1016/j.tiv.2011.04.005.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{19}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{37}},
Journal-ISO = {{Eur. J. Pharm. Biopharm.}},
Doc-Delivery-Number = {{AX5FC}},
Unique-ID = {{ISI:000346951200009}},
DA = {{2018-08-13}},
}

@article{ ISI:000347131800016,
Author = {Asai, Satomi and Umezawa, Kazuo and Iwashita, Hideo and Ohshima, Toshio
   and Ohashi, Maya and Sasaki, Mika and Hayashi, Hideki and Matsui, Mari
   and Shibayama, Keigo and Inokuchi, Sadaki and Miyachi, Hayato},
Title = {{An outbreak of bla(OXA-51-like)(-) and bla(OXA-66)(-) positive
   Acinetobacter baumannii ST208 in the emergency intensive care unit}},
Journal = {{JOURNAL OF MEDICAL MICROBIOLOGY}},
Year = {{2014}},
Volume = {{63}},
Number = {{11}},
Pages = {{1517-1523}},
Month = {{NOV}},
Abstract = {{A series of clinical isolates of drug-resistant (DR) Acinetobacter
   baumannii with diverse drug susceptibility was detected from eight
   patients in the emergency intensive care unit of Tokai University
   Hospital. The initial isolate was obtained in March 2010 (A. baumannii
   Tokai strain 1); subsequently, seven isolates were obtained from
   patients (A. baumannii Tokai strains 2-8) and one isolate was obtained
   from an air-fluidized bed used by five of the patients during the 3
   months from August to November 2011. The isolates were classified into
   three types of antimicrobial drug resistance patterns (RRR, SRR and SSR)
   according to their susceptibility (S) or resistance (R) to imipenem,
   amikacin and ciprofloxacin, respectively. Genotyping of these isolates
   by multilocus sequence typing revealed one sequence type, ST208, whilst
   that by a DiversiLab analysis revealed two subtypes. All the isolates
   were positive for bla(OXA-51-like) and bla(OXA-66), as assessed by PCR
   and DNA sequencing. A. baumannii Tokai strains 1-8 and 10 (RRR, SRR and
   SSR) had quinolone resistance-associated mutations in gyrA/parC, as
   revealed by DNA sequencing. The ISAba / upstream of bla(OXA-51-like) and
   aminoglycoside resistance-associated gene, armA, were detected in A.
   baumannii Tokai strains 1-7 and 10 (RRR and SRR) as assessed by PCR.
   Among the genes encoding resistance nodulation division family pumps
   (adeB, adeG and adeJ) and outer-membrane porins (oprD and carO)
   overexpression of adeB and adeJ and suppression of oprD and car were
   seen in isolates of A. baumannii Tokai strain 2 (RRR), as assessed by
   realtime PCR. Thus, the molecular characterization of a series of
   isolates of DR A. baumannii revealed the outbreak of ST208 and diverse
   antimicrobial drug susceptibilities, which almost correlated with
   differential gene alterations responsible for each type of drug
   resistance.}},
Publisher = {{SOC GENERAL MICROBIOLOGY}},
Address = {{MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG,
   BERKS, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Asai, S (Reprint Author), Tokai Univ, Sch Med, Dept Lab Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.
   Asai, Satomi; Iwashita, Hideo; Miyachi, Hayato, Tokai Univ, Sch Med, Dept Lab Med, Isehara, Kanagawa 2591193, Japan.
   Asai, Satomi; Ohshima, Toshio; Ohashi, Maya; Sasaki, Mika; Miyachi, Hayato, Tokai Univ Hosp, Infect Control Div, Isehara, Kanagawa 2591193, Japan.
   Umezawa, Kazuo; Inokuchi, Sadaki, Tokai Univ, Sch Med, Dept Crit Care \& Emergency Med, Isehara, Kanagawa 2591193, Japan.
   Hayashi, Hideki, Tokai Univ, Sch Med, Support Ctr Med Res \& Educ, Isehara, Kanagawa 2591193, Japan.
   Matsui, Mari; Shibayama, Keigo, Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan.}},
DOI = {{10.1099/jmm.0.077503-0}},
ISSN = {{0022-2615}},
EISSN = {{1473-5644}},
Keywords-Plus = {{PORIN-ENCODING GENES; MOLECULAR EPIDEMIOLOGY; MULTIDRUG-RESISTANCE;
   EFFLUX PUMPS; DIVISION PUMP; SUSCEPTIBILITY; EXPRESSION; HOSPITALS;
   CONVERSION; PATHOGEN}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{sa@is.icc.u-tokai.ac.jp}},
Funding-Acknowledgement = {{Japan Society for the Promotion of Science, the Ministry of Education,
   Culture, Sports, Science and Technology {[}23590691]}},
Funding-Text = {{This work was supported by the Japan Society for the Promotion of
   Science, the Ministry of Education, Culture, Sports, Science and
   Technology {[}Grant-in-Aid (23590691) for Scientific Research (C)].}},
Cited-References = {{Amin IM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-158.
   Arakawa Y, 2000, J CLIN MICROBIOL, V38, P40.
   Asai S., 2011, INFECT DIS CLIN PRAC, V19, P38.
   Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005.
   Bayram Y, 2013, INT J MED SCI, V10, P19, DOI 10.7150/ijms.4723.
   Carretto E, 2008, DIAGN MICR INFEC DIS, V60, P1, DOI 10.1016/j.diagmicrobio.2007.07.002.
   Clinical and Laboratory Standards Institute (CLSI), 2009, M100S19 CLSI.
   Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P4389, DOI 10.1128/AAC.00155-10.
   Endo S, 2012, J ANTIMICROB CHEMOTH, V67, P1623, DOI 10.1093/jac/dks094.
   Fernando D, 2013, CAN J INFECT DIS MED, V24, P17, DOI 10.1155/2013/696043.
   Fernando D, 2012, J ANTIMICROB CHEMOTH, V67, P569, DOI 10.1093/jac/dkr519.
   Guzek A, 2013, ADV EXP MED BIOL, V788, P109, DOI 10.1007/978-94-007-6627-3\_17.
   Higgins PG, 2012, J CLIN MICROBIOL, V50, P3493, DOI 10.1128/JCM.01759-12.
   Higgins PG, 2010, ANTIMICROB AGENTS CH, V54, P5021, DOI 10.1128/AAC.00598-10.
   Ho PL, 2010, J HOSP INFECT, V74, P358, DOI 10.1016/j.jhin.2009.10.015.
   Hou PF, 2012, CHEMOTHERAPY, V58, P152, DOI 10.1159/000335599.
   Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700.
   Liu YH, 2012, J MICROBIOL IMMUNOL, V45, P108, DOI 10.1016/j.jmii.2011.09.001.
   Ohashi M., 2013, JPN J BURN INJURIES, V39, P69.
   Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07.
   Rumbo C, 2013, ANTIMICROB AGENTS CH, V57, P5247, DOI 10.1128/AAC.00730-13.
   Singh H, 2013, J CLIN DIAGN RES, V7, P2602, DOI 10.7860/JCDR/2013/6337.3626.
   Srinivasan VB, 2011, J ANTIMICROB CHEMOTH, V66, P499, DOI 10.1093/jac/dkq469.
   Suzuki M., 2013, GENOME ANNOUNC, V1.
   Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x.
   Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509.
   Wendt C, 1997, J CLIN MICROBIOL, V35, P1394.
   Wisplinghoff H, 2000, CLIN INFECT DIS, V31, P690, DOI 10.1086/314040.
   Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004.
   Yamada Y, 2013, J MED MICROBIOL, V62, P618, DOI 10.1099/jmm.0.048991-0.
   Yamane K, 2005, EMERG INFECT DIS, V11, P951.
   Zander E, 2013, J ANTIMICROB CHEMOTH, V68, P308, DOI 10.1093/jac/dks382.
   Zheng WD, 2013, AM J INFECT CONTROL, V41, pE73, DOI 10.1016/j.ajic.2012.11.004.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{11}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{J. Med. Microbiol.}},
Doc-Delivery-Number = {{AX8AD}},
Unique-ID = {{ISI:000347131800016}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000345268000006,
Author = {Malavaud, S.},
Title = {{Infection control in urology: Standard and isolation precautions}},
Journal = {{PROGRES EN UROLOGIE}},
Year = {{2014}},
Volume = {{24}},
Number = {{14}},
Pages = {{934-938}},
Month = {{NOV}},
Abstract = {{Objectives. - To provide a structured review of good hygiene practices
   in infection control.
   Material. - A review of existing recommendations on standard
   precautions, isolation precautions and specific recommendations in
   infection control.
   Results. - Isolation precautions complement standard precautions when a
   patient is identified as a carrier of bacteria showing resistance to
   antibiotics, virulence characteristics and/or epidemic potential. Full
   compliance with hand hygiene recommendations and standard precautions is
   mandatory as it optimizes safety when patient's viral and/or bacterial
   status is unknown. Acknowledging the routes of transmission, the value
   of individual protection equipment and good hygiene practices is
   therefore crucial in modern infection control. For specific
   micro-organisms, isolation precautions are needed against airborne,
   droplets and/or contact cross-contamination routes. Within isolation
   precautions, contact precautions are the most widely indicated as they
   control the risks of contamination from germs involved in cutaneous or
   enteric infections and of transmission of multi-resistant bacteria
   (MRB). In addition, specific recommendations have been defined for
   emerging resistant MRB.
   Conclusion. - MRB are becoming worldwide a major issue in public health.
   Reducing crosscontamination is, with lesser and better use of
   antibiotics, one of the main avenue in their control. (C) 2014 Published
   by Elsevier Masson SAS.}},
Publisher = {{ELSEVIER MASSON}},
Address = {{VIA PALEOCAPA 7, 20121 MILANO, ITALY}},
Type = {{Article}},
Language = {{French}},
Affiliation = {{Malavaud, S (Reprint Author), CHU Toulouse, UOH, Hop Rangueil, 1 Ave Jean Poulhes, F-31059 Toulouse, France.
   CHU Toulouse, UOH, Hop Rangueil, F-31059 Toulouse, France.}},
DOI = {{10.1016/j.purol.2014.06.001}},
ISSN = {{1166-7087}},
Research-Areas = {{Urology \& Nephrology}},
Web-of-Science-Categories  = {{Urology \& Nephrology}},
Author-Email = {{malavaud.s@gmail.com}},
Cited-References = {{Meunier O, 2014, HYGIENES, VXXII, P61.
   Ministere de la sante, 1998, 98249 DGSDH MIN SANT.
   Ministere de la Sante HCSP SFHH, 2010, SURV PREV INF ASS SO.
   SF2H, 2009, REC HYG MAINS.
   SF2H, 2009, REC NAT PREV TRANSM.
   SF2H, 2013, REC NAT PREV TRANSM.
   World Health Organization, 2014, ANT RES GLOB REP SUR.}},
Number-of-Cited-References = {{7}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Prog. Urol.}},
Doc-Delivery-Number = {{AT9TD}},
Unique-ID = {{ISI:000345268000006}},
DA = {{2018-08-13}},
}

@article{ ISI:000345151900001,
Author = {Olejnickova, Katerina and Hola, Veronika and Ruzicka, Filip},
Title = {{Catheter-related infections caused by Pseudomonas aeruginosa: virulence
   factors involved and their relationships}},
Journal = {{PATHOGENS AND DISEASE}},
Year = {{2014}},
Volume = {{72}},
Number = {{2}},
Pages = {{87-94}},
Month = {{NOV}},
Abstract = {{The nosocomial pathogen Pseudomonas aeruginosa is equipped with a large
   arsenal of cell-associated and secreted virulence factors which enhance
   its invasive potential. The complex relationships among virulence
   determinants have hitherto not been fully elucidated. In the present
   study, 175 catheter-related isolates were observed for the presence of
   selected virulence factors, namely extracellular enzymes and siderophore
   production, biofilm formation, resistance to antibiotics, and motility.
   A high percentage of the strains produced most of the tested virulence
   factors. A positive correlation was identified between the production of
   several exoproducts, and also between the formation of both types of
   biofilm. An opposite trend was observed between the two types of biofilm
   and the production of siderophores. Whereas the relationship between the
   submerged biofilm production (i.e. the biofilm formed on the solid
   surface below the water level) and the siderophore secretion was
   negative, the production of air-liquid interface (A-L) biofilm (i.e. the
   biofilm floating on the surface of the cultivation medium) and the
   siderophore secretion were positively correlated. All correlations were
   statistically significant at the level P=0.05 with the correlation
   coefficient 0.50. Our results suggest that: (1) the co-production of the
   lytic enzymes and siderophores can play an important role in the
   pathogenesis of the catheter-related infections and should be taken into
   account when the virulence potential is assessed; (2) biofilm-positive
   strains are capable of forming both submerged and non-attached A-L
   biofilms; and (3) the different micro-environment in the submerged
   biofilm and A-L biofilm layers have opposite consequences for the
   production of other virulence factors.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hola, V (Reprint Author), Masaryk Univ, Inst Microbiol, Fac Med, Pekarska 53, CZ-65691 Brno, Czech Republic.
   Hola, Veronika, Masaryk Univ, Inst Microbiol, Fac Med, CZ-65691 Brno, Czech Republic.
   Hola, Veronika, St Annes Univ Hosp Brno, CZ-65691 Brno, Czech Republic.}},
DOI = {{10.1111/2049-632X.12188}},
ISSN = {{2049-632X}},
Keywords = {{antibiotic resistance; biofilm; blood stream; Pseudomonas aeruginosa;
   urinary tract; virulence factors}},
Keywords-Plus = {{CYSTIC-FIBROSIS; URINARY-TRACT; BIOFILM; COLONIZATION; DEFICIENT}},
Research-Areas = {{Immunology; Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Immunology; Infectious Diseases; Microbiology}},
Author-Email = {{veronika.hola@fnusa.cz}},
ResearcherID-Numbers = {{Hola, Veronika/J-5014-2014}},
ORCID-Numbers = {{Hola, Veronika/0000-0002-3169-7483}},
Funding-Acknowledgement = {{ {[}IGA MZ NT-13242]}},
Funding-Text = {{The research was supported by the project IGA MZ NT-13242. The authors
   would like to thank Jaroslav Hrabak, PhD (1st Faculty of Medicine,
   Charles University in Prague) for performing the MBL spectrophotometric
   assay.}},
Cited-References = {{Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x.
   Bachofen R, 2008, MICROBIOLOGY MANUAL, P553.
   Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002.
   Brandel J, 2012, DALTON T, V41, P2820, DOI 10.1039/c1dt11804h.
   CLSI-Clinical and Laboratory Standards Institute, 2011, M100S2131 CLSI.
   Deligianni E, 2010, BMC MICROBIOL, V8, P10, DOI DOI 10.1186/1471-2180-10-38.
   Deziel E, 2001, J BACTERIOL, V183, P1195, DOI 10.1128/JB.183.4.1195-1204.2001.
   Fernandez-Pinar R, 2011, RES MICROBIOL, V162, P773, DOI 10.1016/j.resmic.2011.06.013.
   Fonseca AP, 2008, FOLIA MICROBIOL, V53, P540, DOI 10.1007/s12223-008-0086-y.
   Hamood AN, 1996, INFECT IMMUN, V64, P3154.
   Hola V, 2012, FEMS IMMUNOL MED MIC, V65, P343, DOI 10.1111/j.1574-695X.2012.00976.x.
   Hola V, 2010, FEMS IMMUNOL MED MIC, V59, P525, DOI 10.1111/j.1574-695X.2010.00703.x.
   Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004.
   Kohler T, 2010, THORAX, V65, P703, DOI 10.1136/thx.2009.133082.
   Koza A, 2009, MICROBIOL-SGM, V155, P1397, DOI 10.1099/mic.0.025064-0.
   Leone I, 2008, EUR J CLIN MICROBIOL, V27, P1093, DOI 10.1007/s10096-008-0551-1.
   Lep J, 2000, MULTIVARIATE ANAL EC.
   Marti Sara, 2011, BMC Res Notes, V4, P5, DOI 10.1186/1756-0500-4-5.
   Mittal R, 2006, INDIAN J MED RES, V123, P67.
   Mittal Rahul, 2009, J Infect Public Health, V2, P101, DOI 10.1016/j.jiph.2009.08.003.
   Palleroni N, 2005, BERGEYS MANUAL SYSTE, V2, P323.
   Rampioni G, 2009, FEMS MICROBIOL LETT, V301, P210, DOI 10.1111/j.1574-6968.2009.01817.x.
   Rasband WS, 2011, IMAGEJ.
   Rossolini GM, 2005, CLIN MICROBIOL INFEC, V11, P17, DOI 10.1111/j.1469-0691.2005.01161.x.
   Schobert M, 2010, INT J MED MICROBIOL, V300, P549, DOI 10.1016/j.ijmm.2010.08.007.
   Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a.
   StatSoft Inc, 2012, STAT DAT AN SOFTW SY.
   Stehling EG, 2008, BRAZ J INFECT DIS, V12, P86, DOI 10.1590/S1413-86702008000100018.
   Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm\_630.x.
   ter Braak C. J. F., 1999, CANOCO WINDOWS VERSI.
   Trautner BW, 2004, ARCH INTERN MED, V164, P842, DOI 10.1001/archinte.164.8.842.
   Van Gennip M, 2009, APMIS, V117, P537, DOI 10.1111/j.1600-0463.2009.02466.x.
   WOODS DE, 1986, J CLIN MICROBIOL, V24, P260.
   Yadav V, 2004, FOLIA MICROBIOL, V49, P465, DOI 10.1007/BF02931610.
   Zolfaghar I, 2003, INFECT IMMUN, V71, P5389, DOI 10.1128/IAI.71.9.5389-5393.2003.}},
Number-of-Cited-References = {{35}},
Times-Cited = {{7}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{12}},
Journal-ISO = {{Pathog. Dis.}},
Doc-Delivery-Number = {{AT7YZ}},
Unique-ID = {{ISI:000345151900001}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000344316700007,
Author = {Herrmann, Mathias and Jungmann, Sven and Halfmann, Alexander and Dawson,
   Alik and Kaase, Martin and Gatermann, Soeren and von Mueller, Lutz and
   Gaertner, Barbara C.},
Title = {{A Pseudo-Outbreak due to Acinetobacter Species (GIM-1) Contamination of
   the Pneumatic Transport System of a Large University Hospital}},
Journal = {{INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY}},
Year = {{2014}},
Volume = {{35}},
Number = {{11}},
Pages = {{1364-1372}},
Month = {{NOV}},
Abstract = {{OBJECTIVE. To establish the source and contamination routes resulting in
   positive clinical and surveillance microbiological cultures with
   carbapenem-resistant, GIM-1 metallo-beta-lactamase-positive
   Acinetobacter pitii and Acinetobacter radioresistens from 21 patients in
   8 departments.
   DESIGN. Retrospective, descriptive study.
   SETTING. A 1,300-bed tertiary care academic medical facility consisting
   of 90 buildings linked by a pneumatic transport system (PTS).
   METHODS. Microbiological workup of the cluster strains included
   matrix-assisted laser desorption/ionization time-of-flight species
   identification, phenotypic carbapenemase tests, polymerase chain
   reaction-based genotyping of carbapenemase, and pulsed-field gel
   electrophoresis. Outbreak management procedures were employed according
   to institutional regulations.
   RESULTS. The rarity of GIM-1 Acinetobacter species in the hospital and
   region, the lack of epidemiological links between patients, and the fact
   that in some patients the apparent colonization was clearly
   nonnosocomial prompted the suspicion of a pseudo-outbreak. Numerous
   environmental cultures were positive for GIM-1-positive Acinetobacter
   (including archived sample requisition forms, PTS capsules, cultures
   from line-diverter and dispenser stations, and sterilized transport
   capsules following PTS delivery). Moreover, it was observed that
   condensation fluid from subterranean PTS tubing resulted in water entry
   in PTS capsules, possibly conferring specimen contamination. After
   extensive system disinfection, environmental surveys of the PTS were
   negative, and no further positive patient specimens were encountered.
   CONCLUSIONS. This is the first report of a PTS-associated
   pseudo-outbreak. The large number of falsely positive patient-related
   specimens in conjunction with the potential hazard of airborne and
   contact spread of multidrug-resistant microorganisms (in this case,
   GIM-1 carbapenem-resistant Acinetobacter species) underscores the need
   for implementation of infection control-based monitoring and operating
   procedures in a hospital PTS.}},
Publisher = {{CAMBRIDGE UNIV PRESS}},
Address = {{32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Herrmann, M (Reprint Author), Univ Saarland, Med Ctr, Inst Med Microbiol \& Hyg, Kirrberger Str 100,Bldg 43, D-66421 Homburg, Germany.
   Herrmann, Mathias; Jungmann, Sven; Halfmann, Alexander; Dawson, Alik; von Mueller, Lutz; Gaertner, Barbara C., Univ Saarland, Med Ctr, Inst Med Microbiol \& Hyg, D-66421 Homburg, Germany.
   Kaase, Martin; Gatermann, Soeren, Ruhr Univ Bochum, Inst Med Microbiol, Bochum, Germany.}},
DOI = {{10.1086/678413}},
ISSN = {{0899-823X}},
EISSN = {{1559-6834}},
Keywords-Plus = {{METALLO-BETA-LACTAMASE; TUBE SYSTEM; MULTIPLEX PCR; ENTEROBACTERIACEAE;
   CARBAPENEMASES; GERMANY}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{mathias.herrmann@uks.eu}},
ResearcherID-Numbers = {{Herrmann, Mathias/B-6475-2013
   }},
ORCID-Numbers = {{von Muller, Lutz/0000-0001-9013-4245}},
Funding-Acknowledgement = {{Robert-Koch-Institut; German Ministry of Health {[}1369-402,
   IIA5-2509NIK008/321-4532-04/21]; state of Saarland}},
Funding-Text = {{Financial support. Carbapenemase detection was supported by the
   Robert-Koch-Institut, with funds provided by the German Ministry of
   Health (grant 1369-402). Work on multidrug-resistant microorganisms at
   the Saarland University Medical Center Institute of Medical Microbiology
   and Hygiene is supported by a grant from the German Ministry of Health
   (IIA5-2509NIK008/321-4532-04/21) and by the state of Saarland.}},
Cited-References = {{Alpat SN, 2009, MIKROBIYOL BUL, V43, P449.
   Castanheira M, 2004, ANTIMICROB AGENTS CH, V48, P4654, DOI 10.1128/AAC.48.12.4654-4661.2004.
   Dickinson H, 2012, PEDIATR NEPHROL, V27, P1029, DOI 10.1007/s00467-012-2102-3.
   Glasner C, 2013, EURO SURVEILL, V18.
   Gomez-Rioja R, 2013, CLIN CHEM LAB MED, V51, pE231, DOI 10.1515/cclm-2013-0171.
   Hamprecht A, 2013, J ANTIMICROB CHEMOTH, V68, P558, DOI 10.1093/jac/dks447.
   Herrmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073876.
   Kaase M, 2014, J ANTIMICROB CHEMOTH, V69, P81, DOI 10.1093/jac/dkt325.
   Kaase M, 2012, J CLIN MICROBIOL, V50, P3115, DOI 10.1128/JCM.00991-12.
   Lance MD, 2012, THROMB RES, V130, pE147, DOI 10.1016/j.thromres.2012.05.002.
   Pitout JDD, 2005, J CLIN MICROBIOL, V43, P3129, DOI 10.1128/JCM.43.7.3129-3135.2005.
   Savard P, 2012, CURR OPIN INFECT DIS, V25, P371, DOI 10.1097/QCO.0b013e3283558c17.
   Stadler S, 1989, MLO Med Lab Obs, V21, P55.
   Steinmann J, 2011, EURO SURVEILL, V16.
   TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233.
   Wallin O, 2008, CLIN CHEM LAB MED, V46, P1443, DOI 10.1515/CCLM.2008.288.
   Wendt C, 2010, EUR J CLIN MICROBIOL, V29, P563, DOI 10.1007/s10096-010-0896-0.
   Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004.}},
Number-of-Cited-References = {{18}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Infect. Control Hosp. Epidemiol.}},
Doc-Delivery-Number = {{AS5NF}},
Unique-ID = {{ISI:000344316700007}},
DA = {{2018-08-13}},
}

@article{ ISI:000344125700002,
Author = {Becerra, Mercedes C. and Swaminathan, Sournya},
Title = {{A targets framework: Dismantling the invisibility trap for children with
   drug-resistant tuberculosis}},
Journal = {{JOURNAL OF PUBLIC HEALTH POLICY}},
Year = {{2014}},
Volume = {{35}},
Number = {{4}},
Pages = {{425-454}},
Month = {{NOV}},
Abstract = {{Tuberculosis (TB) is an airborne infectious disease that is both
   preventable and curable, yet it kills more than a million people every
   year. Children are highly vulnerable, but often invisible casualties.
   Drug-resistant forms of TB are on the rise globally, and children are as
   vulnerable as adults but less likely to be counted as cases of
   drug-resistant disease if they become sick. Four factors make children
   with drug-resistant TB `invisible': first, the nature of the disease in
   children; second, deficiencies in existing diagnostic tools; third,
   overreliance on these tools; and fourth, our collective failure to
   deploy one effective tool for finding and treating children contact
   investigation. We describe a nascent science-advocacy network the
   Sentinel Project on Pediatric Drug-Resistant Tuberculosis whose goal is
   to end child deaths from this disease. Provisional annual targets,
   focused on children exposed at home to multidrug-resistant TB, to be
   updated every year, constitute a framework to focus attention and
   collective actions at the community, national, and global levels. The
   targets in two age groups, under 5 and 5-14 years old, tell us the
   number of: (i). children who require complete evaluation for TB disease
   and infection; (ii) children who require treatment for TB disease; and
   (iii) children who would benefit from preventive therapy.}},
Publisher = {{PALGRAVE MACMILLAN LTD}},
Address = {{BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND}},
Type = {{Editorial Material}},
Language = {{English}},
Affiliation = {{Becerra, MC (Reprint Author), Harvard Univ, Sch Med, Dept Global Hlth \& Social Med, 641 Huntington Ave, Boston, MA 02115 USA.
   Becerra, Mercedes C., Harvard Univ, Sch Med, Dept Global Hlth \& Social Med, Boston, MA 02115 USA.
   Swaminathan, Sournya, Natl Inst Res TB, Madras, Tamil Nadu, India.}},
DOI = {{10.1057/jphp.2014.35}},
ISSN = {{0197-5897}},
EISSN = {{1745-655X}},
Keywords = {{pediatric; contact investigation; prevention; monitoring; MDR-TB}},
Keywords-Plus = {{PULMONARY TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; PEDIATRIC TUBERCULOSIS;
   MYCOBACTERIUM-TUBERCULOSIS; INTRATHORACIC TUBERCULOSIS; GLOBAL
   EPIDEMIOLOGY; PREVENTIVE THERAPY; TREATMENT OUTCOMES; UNITED-STATES;
   MDR-TB}},
Research-Areas = {{Health Care Sciences \& Services; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Health Care Sciences \& Services; Health Policy \& Services; Public,
   Environmental \& Occupational Health}},
Author-Email = {{mbecerra@post.harvard.edu}},
Cited-References = {{Action Project, 2011, CHILD TUB EXP HIDD E.
   Advisory Committee on Immunization Practices, 2000, MMWR Recomm Rep, V49, P1.
   Amanullah F, 2014, INT J TUBERC LUNG D, V18, P520, DOI 10.5588/ijtld.13.0593.
   Bamrah S, 2014, INT J TUBERC LUNG D, V18, P912, DOI 10.5588/ijtld.13.0028.
   Becerra M. C., 2011, 42 UN WORLD C LUNG H.
   Becerra MC, 2013, PEDIATR INFECT DIS J, V32, P115, DOI 10.1097/INF.0b013e31826f6063.
   Beyers N, 1997, INT J TUBERC LUNG D, V1, P38.
   Beyers N, 2013, PUBLIC HEALTH ACTION, V3, P190, DOI 10.5588/pha.13.0076.
   Brent AJ, 2008, T ROY SOC TROP MED H, V102, P217, DOI 10.1016/j.trstmh.2007.09.011.
   Brent AJ, 2012, J TROP MED, DOI 10.1155/2012/865436.
   Centers for Disease Control and Prevention, 1990, MMWR-MORBID MORTAL W, V39, P9.
   Centers for Disease Control and Prevention, 2005, MORBIDITY MORTALITY, V54.
   Centers for Disease Control and Prevention, 1995, MORBIDITY MORTALITY, V44.
   Childhood TB Subgroup of the Stop TB Partnership, 2013, ROADM CHILDH TUB ZER.
   CHIN J, 1990, B WORLD HEALTH ORGAN, V68, P1.
   Cohen T, 2008, AM J RESP CRIT CARE, V177, P1302, DOI 10.1164/rccm.200801-175PP.
   COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P827.
   Connell TG, 2011, J INFECT DIS, V204, pS1151, DOI 10.1093/infdis/jir413.
   Cuevas LE, 2012, PAEDIATR INT CHILD H, V32, DOI 10.1179/2046904712Z.00000000076.
   Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1.
   Donald PR, 2002, CURR OPIN PULM MED, V8, P178, DOI 10.1097/00063198-200205000-00005.
   Donald RR, 2007, INT J TUBERC LUNG D, V11, P370.
   du Cros P, 2011, B WORLD HEALTH ORGAN, V89, P855, DOI 10.2471/BLT.11.098582.
   Enarson Donald A, 2004, Paediatr Respir Rev, V5 Suppl A, pS143, DOI 10.1016/S1526-0542(04)90027-9.
   Ettehad D, 2012, LANCET INFECT DIS, V12, P449, DOI 10.1016/S1473-3099(12)70033-6.
   European Center for Disease Prevention and Control, 2012, MAN CONT MDR TB XDR.
   Fairlie L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-28.
   Feja K, 2005, CLIN CHEST MED, V26, P295, DOI 10.1016/j.ccm.2005.02.010.
   Feja K, 2008, PEDIATR INFECT DIS J, V27, P907, DOI 10.1097/INF.0b013e3181783aca.
   Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812.
   FRIEDMAN CR, 1995, AM J RESP CRIT CARE, V152, P355, DOI 10.1164/ajrccm.152.1.7599845.
   Graham S., 2010, DESK GUIDE DIAGNOSIS.
   Graham SM, 2014, LANCET, V383, P1605, DOI 10.1016/S0140-6736(14)60420-7.
   Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008.
   GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90.
   Gupta A, 2007, CLIN INFECT DIS, V45, P241, DOI 10.1086/518974.
   Heymann SJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e1.
   Hill PC, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001105.
   HSU KHK, 1984, JAMA-J AM MED ASSOC, V251, P1283, DOI 10.1001/jama.251.10.1283.
   HSU KHK, 1963, AM J PUBLIC HEALTH N, V53, P1761, DOI 10.2105/AJPH.53.11.1761.
   Jaganath D, 2013, CLIN INFECT DIS, V57, P1685, DOI 10.1093/cid/cit645.
   Jenkins HE, 2014, LANCET, V383, P1572, DOI 10.1016/S0140-6736(14)60195-1.
   Jereb J A, 1991, MMWR CDC Surveill Summ, V40, P23.
   Jones C, 2011, PAEDIATR RESPIR REV, V12, P3, DOI 10.1016/j.prrv.2010.09.006.
   Kali PBN, 2006, JAIDS-J ACQ IMM DEF, V42, P379, DOI 10.1097/01.qai.0000218434.20404.9c.
   Keshavjee S., 2009, ADDRESSING THREAT DR.
   Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429.
   Keshavjee S, 2010, NEW ENGL J MED, V363, P1781, DOI 10.1056/NEJMp1010023.
   KHAN EA, 1995, EMERG INFECT DIS, V1, P115, DOI 10.3201/eid0104.950402.
   Kimerling ME, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e53.
   Lobato MN, 2008, ARCH PEDIAT ADOL MED, V162, P426, DOI 10.1001/archpedi.162.5.426.
   Mandalakas AM, 2013, THORAX, V68, P247, DOI 10.1136/thoraxjnl-2011-200933.
   Marais BJ, 2010, INFECT DIS CLIN N AM, V24, P727, DOI 10.1016/j.idc.2010.04.004.
   Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO.
   Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392.
   Marquez L, 2012, PEDIATR INFECT DIS J, V31, P1144, DOI 10.1097/INF.0b013e318266b6c4.
   Medecins Sans Frontieres, 2011, OUT DARK M NEEDS CHI.
   MEHTA JB, 1992, AM J PREV MED, V8, P283.
   Mitnick CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058664.
   Mitnick CD, 2013, INT J TUBERC LUNG D, V17, P427, DOI 10.5588/ijtld.13.0110.
   Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9.
   Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6.
   Nachega J, 2003, AIDS, V17, P1398, DOI 10.1097/01.aids.0000060408.18106.d9.
   National Research Council, 2011, JOINT WORKSH I MED R.
   National Research Council, 2013, WORKSH SUMM.
   National Research Council, 2011, JOINT WORKSH I MED A.
   National Research Council, 2012, JOINT WORKSH I MED I.
   National Research Council, 2014, JOINT WORKSH I MED I.
   Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636.
   Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8.
   NOLAN RJ, 1986, AM J PUBLIC HEALTH, V76, P26, DOI 10.2105/AJPH.76.1.26.
   Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6.
   Partners In Health, 2003, PIH GUID MED MAN MUL.
   Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049.
   Reubenson G, 2011, PEDIATR DRUGS, V13, P349, DOI 10.2165/11593160-000000000-00000.
   RIEDER HL, 1994, TUBERCLE LUNG DIS, V75, P321, DOI 10.1016/0962-8479(94)90075-2.
   Rutherford ME, 2012, TROP MED INT HEALTH, V17, P1264, DOI 10.1111/j.1365-3156.2012.03053.x.
   Schaaf HS, 2011, PAEDIATR RESPIR REV, V12, P31, DOI 10.1016/j.prrv.2010.09.010.
   Schaaf HS, 2002, PEDIATRICS, V109, P765, DOI 10.1542/peds.109.5.765.
   Schaaf HS, 2000, PEDIATR INFECT DIS J, V19, P695.
   Schaaf HS, 2000, INT J TUBERC LUNG D, V4, P1149.
   Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876.
   Seddon JA, 2013, J PEDIATR INFECT DIS, V2, P100, DOI 10.1093/jpids/pit012.
   Seddon JA, 2013, CLIN INFECT DIS, V57, P1676, DOI 10.1093/cid/cit655.
   Seddon JA, 2012, AM J RESP CRIT CARE, V186, P953, DOI 10.1164/rccm.201206-1001CI.
   Seddon JA, 2012, LANCET INFECT DIS, V12, P469, DOI 10.1016/S1473-3099(11)70366-8.
   Seddon JA, 2012, TUBERCULOSIS, V92, P9, DOI 10.1016/j.tube.2011.11.001.
   Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005.
   SFI.1, 2012, OECD FAMIL DAT.
   Shah NS, 2014, CLIN INFECT DIS, V58, P381, DOI 10.1093/cid/cit643.
   Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0.
   Starke J R, 2001, Paediatr Respir Rev, V2, P103, DOI 10.1053/prrv.2001.0117.
   STARKE JR, 1992, J PEDIATR-US, V120, P839, DOI 10.1016/S0022-3476(05)81949-3.
   Starke JR, 2003, TUBERCULOSIS, V83, P208, DOI 10.1016/S1472-9792(02)00088-4.
   Starke JR, 1996, PEDIATRICS, V98, P123.
   STEINER P, 1985, AM J DIS CHILD, V139, P780, DOI 10.1001/archpedi.1985.02140100042023.
   Stop TB Partnership, 2012, NO MOR CRY NO MORE D.
   Swaminathan S, 2008, INDIAN PEDIATR, V45, P743.
   Talukder K, 2012, INT J TUBERC LUNG D, V16, P70, DOI 10.5588/ijtld.11.0060.
   The Sentinel Project on Pediatric Drug-Resistant Tuberculosis, 2010, MAN MULT DRUG RES TU.
   The Sentinel Project on Pediatric Drug-Resistant Tuberculosis, 2012, BEING BRAV STOR CHIL.
   The Sentinel Project on Pediatric Drug-Resistant Tuberculosis and Treatment Action Group, 2013, WE CAN HEAL PREV DIA.
   Tuberculosis Coalition for Technical Assistance, 2006, INT STAND TUB CAR IS.
   Ussery XT, 1996, PEDIATR INFECT DIS J, V15, P697, DOI 10.1097/00006454-199608000-00013.
   van der Werf MJ, 2012, INT J TUBERC LUNG D, V16, P288, DOI 10.5588/ijtld.11.0437.
   Van Rie A, 2013, LANCET GLOB HEALTH, V1, pE60, DOI 10.1016/S2214-109X(13)70049-4.
   Walls T, 2004, J INFECTION, V48, P13, DOI 10.1016/S0163-4453(03)00121-X.
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1.
   WHO, 2014, GUID NAT TUB PROGR M.
   WHO, 2013, AUT REAL TIM NUCL AC.
   Williams B, 2013, PEDIATR INFECT DIS J, V32, P926, DOI 10.1097/INF.0b013e31829157e9.
   World Health Organization, 2011, TUB PREV SURV HDB.
   World Health Organization, 2012, REC INV CONT PERS IN.
   World Health Organization, 2006, GUID NAT TUB PROGR M.
   World Health Organization, 2013, SYST SCREEN ACT TUB.
   World Health Organization, 2006, GUID PROGR MAN DRUG.
   World Health Organization Global Tuberculosis Programme, 1994, FRAM EFF TUB CONTR.
   Yuen CM, 2013, PEDIATR INFECT DIS J, V32, pE217, DOI 10.1097/INF.0b013e3182865409.
   Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789.
   Zignol M., 2012, EUROPEAN RESP J, V42, P701.}},
Number-of-Cited-References = {{120}},
Times-Cited = {{17}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{J. Public Health Policy}},
Doc-Delivery-Number = {{AS2QW}},
Unique-ID = {{ISI:000344125700002}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000342684500100,
Author = {Zhang, Husen and Chen, Xi and Braithwaite, Daniel and He, Zhen},
Title = {{Phylogenetic and Metagenomic Analyses of Substrate-Dependent Bacterial
   Temporal Dynamics in Microbial Fuel Cells}},
Journal = {{PLOS ONE}},
Year = {{2014}},
Volume = {{9}},
Number = {{9}},
Month = {{SEP 9}},
Abstract = {{Understanding the microbial community structure and genetic potential of
   anode biofilms is key to improve extracellular electron transfers in
   microbial fuel cells. We investigated effect of substrate and temporal
   dynamics of anodic biofilm communities using phylogenetic and
   metagenomic approaches in parallel with electrochemical
   characterizations. The startup non-steady state anodic bacterial
   structures were compared for a simple substrate, acetate, and for a
   complex substrate, landfill leachate, using a single-chamber air-cathode
   microbial fuel cell. Principal coordinate analysis showed that distinct
   community structures were formed with each substrate type. The bacterial
   diversity measured as Shannon index decreased with time in acetate
   cycles, and was restored with the introduction of leachate. The change
   of diversity was accompanied by an opposite trend in the relative
   abundance of Geobacter-affiliated phylotypes, which were acclimated to
   over 40\% of total Bacteria at the end of acetate-fed conditions then
   declined in the leachate cycles. The transition from acetate to leachate
   caused a decrease in output power density from 243 +/- 13 mW/m(2) to 140
   +/- 11 mW/m(2), accompanied by a decrease in Coulombic electron recovery
   from 18 +/- 3\% to 9 +/- 3\%. The leachate cycles selected
   protein-degrading phylotypes within phylum Synergistetes. Metagenomic
   shotgun sequencing showed that leachate-fed communities had higher cell
   motility genes including bacterial chemotaxis and flagellar assembly,
   and increased gene abundance related to metal resistance, antibiotic
   resistance, and quorum sensing. These differentially represented genes
   suggested an altered anodic biofilm community in response to additional
   substrates and stress from the complex landfill leachate.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Zhang, HS (Reprint Author), Virginia Polytech Inst \& State Univ, Dept Civil \& Environm Engn, Blacksburg, VA 24061 USA.
   Zhang, Husen; He, Zhen, Virginia Polytech Inst \& State Univ, Dept Civil \& Environm Engn, Blacksburg, VA 24061 USA.
   Zhang, Husen; Chen, Xi, Univ Cent Florida, Dept Civil Environm \& Construct Engn, Orlando, FL 32816 USA.
   Braithwaite, Daniel, Argonne Natl Lab, Inst Genom \& Syst Biol, Chicago, IL USA.}},
DOI = {{10.1371/journal.pone.0107460}},
Article-Number = {{e107460}},
ISSN = {{1932-6203}},
Keywords-Plus = {{EXTRACELLULAR ELECTRON-TRANSFER; LANDFILL LEACHATE TREATMENT;
   WASTE-WATER TREATMENT; GEOBACTER-LOVLEYI; COMMUNITIES; ELECTRICITY;
   DIVERSITY; EXCHANGE; ECOLOGY; GENES}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{husen@vt.edu}},
ResearcherID-Numbers = {{He, Zhen/D-1275-2009}},
ORCID-Numbers = {{He, Zhen/0000-0001-6302-6556}},
Funding-Acknowledgement = {{K-Base}},
Funding-Text = {{DB acknowledges support by K-Base. The funder had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.}},
Cited-References = {{Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x.
   Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X.
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303.
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318.
   Cupples AM, 2011, J MICROBIOL METH, V85, P83, DOI 10.1016/j.mimet.2011.02.011.
   Damiano L, 2014, APPL BIOCHEM BIOTECH, V173, P472, DOI 10.1007/s12010-014-0854-x.
   Diaz RL, 2004, J NUTR, V134, P2359.
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461.
   Fleming EJ, 2006, APPL ENVIRON MICROB, V72, P457, DOI 10.1128/AEM.72.1.457-464.2006.
   Galvez A, 2009, BIORESOURCE TECHNOL, V100, P5085, DOI 10.1016/j.biortech.2009.05.061.
   Ganesan A, 2008, INT J SYST EVOL MICR, V58, P2003, DOI 10.1099/ijs.0.65645-0.
   Girguis PR, 2010, CURR OPIN BIOTECH, V21, P252, DOI 10.1016/j.copbio.2010.03.015.
   Gomez-Alvarez V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-122.
   Greenberg A.E., 1992, STANDARD METHODS EXA.
   HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x.
   Ishii S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2615.
   Ishii S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030495.
   Jung S, 2007, APPL MICROBIOL BIOT, V77, P393, DOI 10.1007/s00253-007-1162-y.
   Jung S, 2011, APPL ENVIRON MICROB, V77, P564, DOI 10.1128/AEM.01392-10.
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27.
   Kjeldsen P, 2002, CRIT REV ENV SCI TEC, V32, P297, DOI 10.1080/10643380290813462.
   Kozich J. J., 2013, APPL ENV MICROBIOL.
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102.
   Li WW, 2014, ENERG ENVIRON SCI, V7, P911, DOI 10.1039/c3ee43106a.
   Liu H, 2005, ENVIRON SCI TECHNOL, V39, P658, DOI 10.1021/es048927c.
   Liu H, 2004, ENVIRON SCI TECHNOL, V38, P4040, DOI 10.1021/es0499344.
   Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491.
   Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016.
   Logan BE, 2006, TRENDS MICROBIOL, V14, P512, DOI 10.1016/j.tim.2006.10.003.
   Lovley DR, 2011, CURR OPIN BIOTECH, V22, P441, DOI 10.1016/j.copbio.2011.01.009.
   Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06.
   Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386.
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490.
   Puig S, 2011, J HAZARD MATER, V185, P763, DOI 10.1016/j.jhazmat.2010.09.086.
   Rabaey K, 2007, ISME J, V1, P9, DOI 10.1038/ismej.2007.4.
   Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1.
   Sadler WR, 1967, MINER DEPOSITA, V2, P158.
   Singleton DR, 2005, APPL ENVIRON MICROB, V71, P1202, DOI 10.1128/AEM.71.3.1202-1209.2005.
   Strycharz SM, 2008, APPL ENVIRON MICROB, V74, P5943, DOI 10.1128/AEM.00961-08.
   Sung Y, 2006, APPL ENVIRON MICROB, V72, P2775, DOI 10.1128/AEM.72.4.2775-2782.2006.
   Tamaki H, 2012, ENVIRON MICROBIOL, V14, P441, DOI 10.1111/j.1462-2920.2011.02630.x.
   Torres CI, 2009, ENVIRON SCI TECHNOL, V43, P9519, DOI 10.1021/es902165y.
   Torres CI, 2010, FEMS MICROBIOL REV, V34, P3, DOI 10.1111/j.1574-6976.2009.00191.x.
   Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146.
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07.
   Watson VJ, 2011, ELECTROCHEM COMMUN, V13, P54, DOI 10.1016/j.elecom.2010.11.011.
   Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108.
   Yates MD, 2012, ISME J, V6, P2002, DOI 10.1038/ismej.2012.42.
   Zhang F, 2009, ELECTROCHEM COMMUN, V11, P2177, DOI 10.1016/j.elecom.2009.09.024.
   Zhang W, 2014, BIORESOURCE TECHNOL, V151, P397, DOI 10.1016/j.biortech.2013.10.004.
   Zhu XP, 2014, ENVIRON SCI TECHNOL, V48, P1352, DOI 10.1021/es404690q.}},
Number-of-Cited-References = {{51}},
Times-Cited = {{9}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{60}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{AQ3IF}},
Unique-ID = {{ISI:000342684500100}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000344723700007,
Author = {Gaertner, A. and Gessner, A. and Martin, E. and Schneider, D. and
   Jaeckel, U.},
Title = {{Emissions from poultry houses - Investigation on the composition of
   bacterial community and antibiotic resistance - Part 2: Results}},
Journal = {{GEFAHRSTOFFE REINHALTUNG DER LUFT}},
Year = {{2014}},
Volume = {{74}},
Number = {{9}},
Pages = {{377-383}},
Month = {{SEP}},
Abstract = {{The goal of the joint project of the North Rhine-Westphalian State
   Agency for Nature, Environment and Consumer Protection (LANUV NRW) and
   the Federal Institute for Occupational Safety and Health (BAuA) was the
   determination of antibiotic resistant bacteria in the exhaust air of
   broiler houses. Methicillin-resistant Staphylococcus aureus strains were
   detected in only one of the stables. Resistant Enterococcus faecalis
   could be found in nearly all samples in concentrations below the
   detection limit, whereas E. faecium, Acinetobacter spp. and species of
   the family Enterobacteriaceae (z.B. Escherichia coli) were not present
   on the basis of cultivation. Furthermore, the suitability of
   commercially available selective nutrition media was tested for the
   quantification and qualification of bacterial species and genera and
   cultivation independent analyses regarding the airborne bacteria were
   made.}},
Publisher = {{SPRINGER-V D I VERLAG GMBH \& CO KG}},
Address = {{VDI-PLATZ 1, D-40468 DUSSELDORF, GERMANY}},
Type = {{Article}},
Language = {{German}},
Affiliation = {{Gartner, A (Reprint Author), Landesamt Nat Umwelt \& Verbraucherschutz Nordrh W, Dienstort Essen, Germany.
   Gaertner, A.; Gessner, A., Landesamt Nat Umwelt \& Verbraucherschutz Nordrh W, Dienstort Essen, Germany.
   Martin, E.; Schneider, D.; Jaeckel, U., Bundesanstalt Arbeitsschutz \& Arbeitsmed, Berlin, Germany.}},
ISSN = {{0949-8036}},
EISSN = {{1436-4891}},
Keywords-Plus = {{LIVESTOCK-ASSOCIATED MRSA; STAPHYLOCOCCUS-AUREUS; SOIL SURFACES; AIR;
   CONTAMINATION; PREVALENCE; VICINITY; WORKING; BARNS}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Engineering, Civil; Environmental Sciences}},
ResearcherID-Numbers = {{Amoako, Daniel Gyamfi/I-4223-2018}},
Cited-References = {{{[}Anonymous], 2011, VDI 4257 BLATT 2.
   {[}Anonymous], 2013, VDI 4253 BLATT 4.
   Bisdorff B, 2012, EPIDEMIOL INFECT, V140, P1800, DOI 10.1017/S0950268811002378.
   Friese A, 2013, APPL ENVIRON MICROB, V79, P2759, DOI 10.1128/AEM.03939-12.
   Gartner A, 2011, GEFAHRST REINHALT L, V71, P362.
   Gartner A, 2013, GEFAHRST REINHALT L, V73, P372.
   Geenen PL, 2013, EPIDEMIOL INFECT, V141, P1099, DOI 10.1017/S0950268812001616.
   Klug K, 2012, GEFAHRST REINHALT L, V72, P373.
   Martin E, 2012, GEFAHRST REINHALT L, V72, P99.
   Martin E, 2009, GEFAHRST REINHALT L, V69, P97.
   Martin E., 2012, ANN OCCUP HYG, V54, P217.
   Martin E, 2011, J ENVIRON MONITOR, V13, P464, DOI 10.1039/c0em00272k.
   Mulders MN, 2010, EPIDEMIOL INFECT, V138, P743, DOI 10.1017/S0950268810000075.
   Nemeghaire S, 2013, AVIAN PATHOL, V42, P342, DOI 10.1080/03079457.2013.805183.
   Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12.
   WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/jb.173.2.697-703.1991.}},
Number-of-Cited-References = {{16}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{10}},
Journal-ISO = {{Gefahrst. Reinhalt. Luft}},
Doc-Delivery-Number = {{AT1XG}},
Unique-ID = {{ISI:000344723700007}},
DA = {{2018-08-13}},
}

@article{ ISI:000343113000008,
Author = {Riva, Michele A.},
Title = {{From milk to rifampicin and back again: history of failures and
   successes in the treatment for tuberculosis}},
Journal = {{JOURNAL OF ANTIBIOTICS}},
Year = {{2014}},
Volume = {{67}},
Number = {{9, SI}},
Pages = {{661-665}},
Month = {{SEP}},
Abstract = {{The millennial flight against tuberculosis has been characterized by
   several defeats. Roman physicians suggested to consumptives better
   nutrition, sea voyages and change of air, while, during the Middle Ages,
   `royal touch' were considered as an effective remedy for scrofula. In
   the following centuries, phthisis was cured using old herbal
   preparations and new chemical compounds, mainly aimed at soothing
   symptoms; in addition, harmful approaches (for example, bleeding and
   purging) were commonly accepted, according to medical theories of that
   time. In the second part of the nineteenth century, the discovery of the
   contagious nature of consumption (Villemin, Koch) addressed physicians
   and scientists toward often-unsuccessful remedies, such as antiparasitic
   treatment, immunomodulants, vaccination and serum therapy. In that
   period only sanatorium regimen-based on aerotherapy, bed rest, better
   nutrition, sunbathing and moderate physical exercise-appeared to provide
   first partial successes. In these structures, more invasive approaches
   were also employed, such as lung collapse surgical interventions (for
   example, phrenicotomy, thoracoplasty) and artificial pneumothorax. Since
   the second part of the twentieth century, the industrialization of
   pharmacotherapy, the development of antimicrobial chemotherapy and the
   introduction of new antibiotics (streptomycin, isoniazid,
   para-aminosalicylic acid, ethambutol and pyrazinamide) deeply
   revolutionized treatment for tuberculosis, allowing to achieve important
   successes. In this same period, the figure of Piero Sensi (1920-2013)
   deserves to be recalled for his contribution in the development of
   rifampicin that played a decisive role in the chemical fight against the
   white plague. Nowadays, antibiotic resistance is an emerging problem,
   representing a new challenge for physicians and scientists who sometimes
   re-proposed old `historical' approaches.}},
Publisher = {{JAPAN ANTIBIOTICS RESEARCH ASSOC}},
Address = {{2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Riva, MA (Reprint Author), Univ Milano Bicocca, Osped San Gerardo, Via Pergolesi 33, I-20900 Monza, Italy.
   Riva, Michele A., Univ Milano Bicocca, I-20900 Monza, Italy.}},
DOI = {{10.1038/ja.2014.108}},
ISSN = {{0021-8820}},
Keywords-Plus = {{DRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; THERAPY;
   STREPTOMYCIN; SANATORIA; IDEA}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Immunology; Microbiology;
   Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Immunology; Microbiology;
   Pharmacology \& Pharmacy}},
Author-Email = {{michele.riva@unimib.it}},
ResearcherID-Numbers = {{Riva, Michele Augusto/R-7600-2017}},
ORCID-Numbers = {{Riva, Michele Augusto/0000-0001-7147-3460}},
Cited-References = {{Alvarez N, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-S1-S3.
   Aronson J, 1999, BRIT MED J, V319, P972, DOI 10.1136/bmj.319.7215.972.
   BAYER R, 1995, LANCET, V345, P1545, DOI 10.1016/S0140-6736(95)91090-5.
   Benedek TG, 2004, J HIST MED ALL SCI, V59, P50, DOI 10.1093/jhmas/jrh042.
   Bernardi A., 2012, MORBO OSCURO STORIA, P23.
   Cambau E, 2014, CLIN MICROBIOL INFEC, V20, P196, DOI 10.1111/1469-0691.12555.
   Clark J., 1829, INFLUENCE CLIMATE PR.
   Cosmacini G., 2008, ARTE LUNGA STORIA ME, P326.
   Cosmacini G, 2004, PESTE BIANCA MILANO.
   Daniel TM, 2006, RESP MED, V100, P1862, DOI 10.1016/j.rmed.2006.08.006.
   Daniel TM, 2005, INT J TUBERC LUNG D, V9, P120.
   Dheda K, 2012, LANCET, V379, P773, DOI 10.1016/S0140-6736(11)61062-3.
   Diacon AH, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13665.
   Dossey L, 2013, EXPLORE-NY, V9, P121, DOI 10.1016/j.explore.2013.03.001.
   Doster B., 1973, AM REV RESPIR DIS, V107, P117.
   FOX W, 1956, Q J MED, V25, P221.
   Friedman Meyer, 1998, MED 10 GREATEST DISC.
   Glatman-Freedman A, 1998, CLIN MICROBIOL REV, V11, P514.
   GRMEK M. D., 1983, MALADIES AUBE CIVILI.
   Hawgood Barbara J, 2007, J Med Biogr, V15, P139.
   Hong Kong Chest Service/ British Medical research Council, 1979, TUBERCLE, V60, P201.
   Hughes J, 2012, LANCET, V379, P2148, DOI 10.1016/S0140-6736(12)60940-4.
   Iseman M D, 2002, Eur Respir J Suppl, V36, p87s.
   Lehmann J, 1994, AM REV RESPIR DIS, V90, P953.
   Manzini E., 2012, DAL MAL SOTTILE TUBE, P39.
   MCDERMOTT W, 1969, J INFECT DIS, V119, P678, DOI 10.1093/infdis/119.6.678.
   Medical Research Council, 1955, BRIT MED J, V1, P435.
   Motus IY, 2006, INT J TUBERC LUNG D, V10, P571.
   {*}MRC, 1948, BRIT MED J, V2, P769.
   Riva MA, 2014, BIOTECH HISTOCHEM, V89, P81, DOI 10.3109/10520295.2013.822559.
   Riva MA, 2013, MED LAV, V104, P359.
   Riva M. A., 2012, DAL MAL SOTTILE TUBE, P45.
   SAKULA A, 1983, THORAX, V38, P326, DOI 10.1136/thx.38.5.326.
   Sbarbaro JA, 1997, CLIN INFECT DIS, V25, P664, DOI 10.1086/513773.
   Schatz A, 1944, P SOC EXP BIOL MED, V55, P66.
   SENSI P, 1983, REV INFECT DIS, V5, pS402.
   Sensi P., 1982, CHRONICLES DRUG DISC, P201.
   Tognotti E., 2012, MORBO LENTO TISI NEL.
   {*}TUB CHEM CTR, 1959, B WORLD HEALTH ORGAN, V21, P51.
   Yang HL, 2012, FEMS IMMUNOL MED MIC, V66, P273, DOI 10.1111/j.1574-695X.2012.01002.x.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{27}},
Journal-ISO = {{J. Antibiot.}},
Doc-Delivery-Number = {{AQ8VE}},
Unique-ID = {{ISI:000343113000008}},
DA = {{2018-08-13}},
}

@article{ ISI:000342264800003,
Author = {Hu, Jinyu and Li, Yanyan and Zhang, Hailing and Tan, Yanzhen and Wang,
   Xiaoyuan},
Title = {{Construction of a novel expression system for use in Corynebacterium
   glutamicum}},
Journal = {{PLASMID}},
Year = {{2014}},
Volume = {{75}},
Pages = {{18-26}},
Month = {{SEP}},
Abstract = {{Corynebacterium glutamicum is an important microorganism for production
   of amino acids in industrial fermentation. Suitable vectors are needed
   for metabolic engineering in C. glutamicum. Most available vectors used
   in C. glutamicum carry antibiotic resistant genes as a genetic labeling
   for rapid identification of recombinant strains, and antibiotics have to
   be added to maintain the vector when growing the cells. These vectors,
   though excellent for laboratory use, are not preferable choices for
   industry-scale fermentation. In this work, we developed a novel
   expression system for use in C. glutamicum, which do not require
   antibiotics when used for industrial fermentation. This system includes
   two vectors: the shuttle vector pJYW-4 for expression of genes and the
   vector pJYW-6 for deletion of the essential gene air in C. glutamicum.
   The vector pJYW-4 contains a large multiple cloning site for cloning
   multiple genes and two selective markers: one is the kanamycin-resistant
   gene kan and the other is an essential gene air. The selective marker
   kan facilitates molecular manipulation or fermentations in the
   laboratory, and the selection marker air is good for use in
   industry-scale fermentation, allowing in vivo maintenance of the
   expression vector through auxotrophic complementation; therefore, the
   two selection markers in pJYW-4 make it useful for both laboratory
   research and industrial fermentation, and convenient to transfer
   valuable laboratory-developed strains into industrial production. This
   newly-constructed expression system was successfully used to increase
   L-valine production in C. glutamicum ATCC 14067, indicating its
   potential on developing amino acid-producing C. glutamicum strains. (C)
   2014 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wang, XY (Reprint Author), Jiangnan Univ, State Key Lab Food Sci \& Technol, 1800 Lihu Ave, Wuxi 214000, Peoples R China.
   Hu, Jinyu; Li, Yanyan; Tan, Yanzhen; Wang, Xiaoyuan, Jiangnan Univ, State Key Lab Food Sci \& Technol, Wuxi 214000, Peoples R China.
   Hu, Jinyu; Zhang, Hailing, Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Minist Educ, Wuxi 214122, Peoples R China.
   Li, Yanyan; Wang, Xiaoyuan, Jiangnan Univ, Synerget Innovat Ctr Food Safety \& Nutr, Wuxi 214122, Peoples R China.}},
DOI = {{10.1016/j.plasmid.2014.07.005}},
ISSN = {{0147-619X}},
EISSN = {{1095-9890}},
Keywords = {{Corynebacterium glutamicum; Auxotrophic complementation expression
   system; Shuttle vector; Metabolic engineering; L-valine production}},
Keywords-Plus = {{L-VALINE PRODUCTION; ACETOHYDROXY ACID SYNTHASE; PLASMID SELECTION
   SYSTEM; ALANINE RACEMASE GENE; ESCHERICHIA-COLI; BREVIBACTERIUM-FLAVUM;
   L-ISOLEUCINE; AMINO-ACIDS; CORYNEFORM BACTERIA; GENOME SEQUENCE}},
Research-Areas = {{Genetics \& Heredity; Microbiology}},
Web-of-Science-Categories  = {{Genetics \& Heredity; Microbiology}},
Author-Email = {{xiaoyuanwang@hotmail.com}},
Funding-Acknowledgement = {{National Key Basic Research Program of China (973 Program)
   {[}2012CB725202]; National Natural Science Foundation of China
   {[}NSFC31370131]}},
Funding-Text = {{Funding was provided by grants from National Key Basic Research Program
   of China (973 Program 2012CB725202) and National Natural Science
   Foundation of China (NSFC31370131).}},
Cited-References = {{Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7.
   Balbas P, 2001, MOL BIOTECHNOL, V19, P251, DOI 10.1385/MB:19:3:251.
   Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8.
   BENTLEY WE, 1990, BIOTECHNOL BIOENG, V35, P668, DOI 10.1002/bit.260350704.
   Blombach B, 2008, APPL MICROBIOL BIOT, V79, P471, DOI 10.1007/s00253-008-1444-z.
   Blombach B, 2007, APPL ENVIRON MICROB, V73, P2079, DOI 10.1128/AEM.02826-06.
   Borsuk S, 2007, TUBERCULOSIS, V87, P474, DOI 10.1016/j.tube.2007.07.006.
   Burkovski A., 2008, CORYNEBACTERIA GENOM.
   Dong WR, 2010, APPL ENVIRON MICROB, V76, P2295, DOI 10.1128/AEM.02462-09.
   EGGELING I, 1987, APPL MICROBIOL BIOT, V25, P346.
   Eggeling L, 2005, HDB CORYNEBACTERIM G.
   Elisakova V, 2005, APPL ENVIRON MICROB, V71, P207, DOI 10.1128/AEM.71.1.207-213.2005.
   FERRARI E, 1985, BIO-TECHNOL, V3, P1003, DOI 10.1038/nbt1185-1003.
   FOLLETTIE MT, 1986, J BACTERIOL, V167, P695, DOI 10.1128/jb.167.2.695-702.1986.
   FURUKAWA S, 1988, APPL MICROBIOL BIOT, V29, P248.
   Glenting J, 2002, APPL ENVIRON MICROB, V68, P5051, DOI 10.1128/AEM.68.10.5051-5056.2002.
   HAYASHI H, 1990, ANNU REV BIOCHEM, V59, P87, DOI 10.1146/annurev.biochem.59.1.87.
   Hermann T, 2003, J BIOTECHNOL, V104, P155, DOI 10.1016/S0168-1656(03)00149-4.
   Hou XH, 2012, AMINO ACIDS, V43, P2301, DOI 10.1007/s00726-012-1308-9.
   Hou XH, 2012, J IND MICROBIOL BIOT, V39, P63, DOI 10.1007/s10295-011-1000-1.
   Hu JY, 2013, PLASMID, V70, P303, DOI 10.1016/j.plasmid.2013.07.001.
   Huser AT, 2005, APPL ENVIRON MICROB, V71, P3255, DOI 10.1128/AEM.71.6.3255-3268.2005.
   ISHIDA M, 1993, BIOSCI BIOTECH BIOCH, V57, P1755, DOI 10.1271/bbb.57.1755.
   Kabus A, 2007, APPL MICROBIOL BIOT, V75, P47, DOI 10.1007/s00253-006-0804-9.
   Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8.
   Kennerknecht N, 2002, J BACTERIOL, V184, P3947, DOI 10.1128/JB.184.14.3947-3956.2002.
   Kirchner O, 2003, J BIOTECHNOL, V104, P287, DOI 10.1016/S0168-1656(03)00148-2.
   Koros A, 2008, J CHROMATOGR A, V1203, P146, DOI 10.1016/j.chroma.2008.07.035.
   Lv YY, 2012, J BACTERIOL, V194, P742, DOI 10.1128/JB.06514-11.
   Marienhagen J, 2008, APPL ENVIRON MICROB, V74, P7457, DOI 10.1128/AEM.01025-08.
   Marx A, 2003, J BIOTECHNOL, V104, P185, DOI 10.1016/S0168-1656(03)00153-6.
   MIYAJIMA R, 1972, J BIOCHEM-TOKYO, V71, P951, DOI 10.1093/oxfordjournals.jbchem.a129866.
   Morbach S, 2000, J BIOSCI BIOENG, V90, P501, DOI 10.1016/S1389-1723(01)80030-X.
   MORONA R, 1991, GENE, V107, P139, DOI 10.1016/0378-1119(91)90307-W.
   NAKAYAMA K, 1988, BIO-TECHNOL, V6, P693, DOI 10.1038/nbt0688-693.
   Nakayama K., 1981, PRESCOTT DUNNS IND M, P748.
   Nam SH, 2011, J BACTERIOL, V193, P1014, DOI 10.1128/JB.01394-10.
   Nesvera J, 1997, J BACTERIOL, V179, P1525, DOI 10.1128/jb.179.5.1525-1532.1997.
   Radmacher E, 2002, APPL ENVIRON MICROB, V68, P2246, DOI 10.1128/AEM.68.5.2246-2250.2002.
   Ryan ET, 2000, INFECT IMMUN, V68, P221, DOI 10.1128/IAI.68.1.221-226.2000.
   Sahm H, 1999, APPL ENVIRON MICROB, V65, P1973.
   Sambrook J, 2001, MOL CLONING LAB MANU.
   Smith MA, 1998, CAN J MICROBIOL, V44, P351, DOI 10.1139/cjm-44-4-351.
   Tada K, 2000, J BIOSCI BIOENG, V90, P669, DOI 10.1263/jbb.90.669.
   Tauch A, 2002, J BIOTECHNOL, V99, P79, DOI 10.1016/S0168-1656(02)00159-1.
   Tauch A, 2002, CURR MICROBIOL, V45, P362, DOI 10.1007/s00284-002-3728-3.
   Xu DQ, 2011, WORLD J MICROB BIOT, V27, P961, DOI 10.1007/s11274-010-0539-8.
   Xu DQ, 2010, PLASMID, V64, P85, DOI 10.1016/j.plasmid.2010.05.004.
   Xu DQ, 2010, J MICROBIOL METH, V80, P86, DOI 10.1016/j.mimet.2009.11.003.
   Yamada K, 1972, MICROBIAL PRODUCTION.
   Yin L, 2013, J APPL MICROBIOL, V114, P1369, DOI 10.1111/jam.12141.}},
Number-of-Cited-References = {{51}},
Times-Cited = {{12}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{31}},
Journal-ISO = {{Plasmid}},
Doc-Delivery-Number = {{AP7NU}},
Unique-ID = {{ISI:000342264800003}},
DA = {{2018-08-13}},
}

@article{ ISI:000341300500018,
Author = {Li, Tee Chin and Ambu, Stephen and Mohandas, Kavitha and Wah, Mak Joon
   and Sulaiman, Lokman Hakim and Murgaiyah, Malathi},
Title = {{Bacterial constituents of indoor air in a high throughput building in
   the tropics}},
Journal = {{TROPICAL BIOMEDICINE}},
Year = {{2014}},
Volume = {{31}},
Number = {{3}},
Pages = {{540-556}},
Month = {{SEP}},
Abstract = {{Airborne bacteria are significant biotic constituents of bioaerosol.
   Bacteria at high concentrations in the air can compromise indoor air
   quality (IAQ) and result in many diseases. In tropical environments like
   Malaysia that extensively utilize air-conditioning systems, this is
   particularly significant due to continuous recirculation of indoor air
   and the potential implications for human health. Currently, there is a
   lack of knowledge regarding the impact of airborne bacteria on IAQ in
   Malaysia. This study was prompted by a need for reliable baseline data
   on airborne bacteria in the indoor environment of tropical equatorial
   Malaysia, that may be used as a reference for further investigations on
   the potential role played by airborne bacteria as an agent of disease in
   this region. It was further necessitated due to the threat of
   bioterrorism with the potentiality of release of exotic pathogenic
   microorganisms into indoor or outdoor air. Before scientists can detect
   the latter, a gauge of the common microorganisms in indoor (as well as
   outdoor) air needs to be ascertained, hence the expediency of this
   study. Bacterial counts from the broad-based and targeted study were
   generally n the order of 102 colony-forming units (CFU) per m(3) of air.
   The most prevalent airborne bacteria found in the broad-based study that
   encompassed all five levels of the building were Gram-positive cocci
   (67.73\%), followed by Gram-positive rods (24.26\%) and Gram-negative
   rods (7.10\%). Gram-negative cocci were rarely detected (0.71\%).
   Amongst the genera identified, Kytococcus sp., Micrococcus sp.,
   Staphylococcus sp., Leifsonia sp., Bacillus sp. and Corynebacterium sp.
   predominated in indoor air. The most dominant bacterial species were
   Kytococcus sedentarius, Staphylococcus epidermidis and Micrococcus
   luteus. The opportunistic and nosocomial pathogen, Stenotrophomonas
   maltophilia was also discovered at a high percentage in the cafeteria.
   The bacteria isolated in this study have been increasingly documented to
   cause opportunistic infections in immuno-compromised patients, sometimes
   with fatal outcomes. Furthermore, some of them are becoming increasingly
   resistant to antibiotics. Hence, we propose that indoor reservoirs of
   these bacteria and their associated clinical and more subtle health
   effects, if any, be investigated further.}},
Publisher = {{MALAYSIAN SOC PARASITOLOGY TROPICAL MEDICINE}},
Address = {{C/O INST MEDICAL REEARCH, JALAN PAHANG, KUALA LUMPUR, 50588, MALAYSIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ambu, S (Reprint Author), Int Med Univ, 126,Jalan 19-155B, Kuala Lumpur 57000, Malaysia.
   Li, Tee Chin; Ambu, Stephen; Mohandas, Kavitha; Wah, Mak Joon; Murgaiyah, Malathi, Int Med Univ, Kuala Lumpur 57000, Malaysia.
   Sulaiman, Lokman Hakim, Minist Hlth Malaysia, Dis Control Div, Putrajaya 62590, Malaysia.}},
ISSN = {{0127-5720}},
Keywords-Plus = {{PROSTHETIC VALVE ENDOCARDITIS; KYTOCOCCUS-SCHROETERI;
   STENOTROPHOMONAS-MALTOPHILIA; AIRBORNE BACTERIA;
   MICROCOCCUS-SEDENTARIUS; HOSPITAL ENVIRONMENT; RELATIVE-HUMIDITY;
   INFECTION; PNEUMONIA; PATHOGEN}},
Research-Areas = {{Parasitology; Tropical Medicine}},
Web-of-Science-Categories  = {{Parasitology; Tropical Medicine}},
Author-Email = {{stephen\_ambu@imu.edu.my}},
ORCID-Numbers = {{Ambu, Stephen/0000-0001-7840-6113}},
Funding-Acknowledgement = {{International Medical University (IMU), Malaysia; Ministry of Health
   (MOH), Malaysia}},
Funding-Text = {{We would like to thank the International Medical University (IMU),
   Malaysia, and the Ministry of Health (MOH), Malaysia, for their generous
   financial support for this research.}},
Cited-References = {{ADANG RP, 1992, LEUKEMIA, V6, P224.
   Aepinus C, 2008, WIEN KLIN WOCHENSCHR, V120, P46, DOI 10.1007/s00508-007-0903-3.
   Alexis N, 2001, J ALLERGY CLIN IMMUN, V107, P31, DOI 10.1067/mai.2001.111594.
   ANDERSON RL, 1969, APPL MICROBIOL, V18, P180.
   {[}Anonymous], 2009, J ROYAL SOC INTER S6, V6, pS737.
   Aydogdu H, 2005, INDOOR BUILT ENVIRON, V14, P411, DOI 10.1177/1420326X05057539.
   Aydogdu H., 2009, ENV MONITORING ASSES.
   Bartlett KH, 2004, J OCCUP ENVIRON HYG, V1, P639, DOI 10.1080/15459620490497744.
   Becker K, 2003, EMERG INFECT DIS, V9, P1493, DOI 10.3201/eid0911.020683.
   Beggs CB, 2003, INDOOR BUILT ENVIRON, V12, P9, DOI 10.1177/142032603032201.
   Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104.
   Chan PL, 2009, J ENVIRON SCI-CHINA, V21, P1148, DOI 10.1016/S1001-0742(08)62395-5.
   CULLMANN W, 1990, CHEMOTHERAPY, V36, P117, DOI 10.1159/000238757.
   Daisey JM, 2003, INDOOR AIR, V13, P53, DOI 10.1034/j.1600-0668.2003.00153.x.
   de Goffau MC, 2009, ENVIRON MICROBIOL, V11, P809, DOI 10.1111/j.1462-2920.2008.01802.x.
   Denton M, 1998, CLIN MICROBIOL REV, V11, P57.
   Fabian MP, 2005, J AEROSOL SCI, V36, P763, DOI 10.1016/j.jaerosci.2004.11.018.
   Fang Zhi-guo, 2006, Weishengwu Xuebao, V46, P618.
   Fang ZG, 2007, MICROB ECOL, V54, P487, DOI 10.1007/s00248-007-9216-3.
   GERBA CP, 1975, APPL MICROBIOL, V30, P229.
   Goh I., 2000, AIRBORNE BACTERIA FU.
   Gopalakrishnan R, 1999, HEART LUNG, V28, P134, DOI 10.1053/hl.1999.v28.a96418.
   GREENE GR, 1980, J NEUROSURG, V52, P126, DOI 10.3171/jns.1980.52.1.0126.
   HEATH T, 1995, J HOSP INFECT, V30, P309, DOI 10.1016/0195-6701(95)90266-X.
   Hodiamont CJ, 2010, INFECTION, V38, P138, DOI 10.1007/s15010-009-9295-4.
   HUGENHOLTZ P, 1992, APPL ENVIRON MICROB, V58, P3914.
   HUGH R, 1961, J GEN MICROBIOL, V26, P123.
   Jourdain Sarah, 2009, Int J Infect Dis, V13, pe153, DOI 10.1016/j.ijid.2008.09.004.
   Kampfer P, 2009, SYST APPL MICROBIOL, V32, P301, DOI 10.1016/j.syapm.2009.05.004.
   Kalogerakis N, 2005, J AEROSOL SCI, V36, P751, DOI 10.1016/j.jaerosci.2005.02.004.
   Kim JH, 2002, J KOREAN MED SCI, V17, P263, DOI 10.3346/jkms.2002.17.2.263.
   Kim KY, 2007, INDOOR BUILT ENVIRON, V16, P465, DOI 10.1177/1420326X07082534.
   Koneman EW, 1997, COLOR ATLAS TXB DIAG.
   Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0.
   LAING FPY, 1995, J CLIN MICROBIOL, V33, P513.
   Le Brun C, 2005, EMERG INFECT DIS, V11, P179, DOI 10.3201/eid1101.040761.
   Levenga H, 2004, ANN HEMATOL, V83, P447, DOI 10.1007/s00277-003-0831-x.
   LOPEZ M, 1985, CLIN REV ALLERG, V3, P183, DOI 10.1007/BF02992982.
   Lund BM, 2000, MICROBIOLOGICAL SAFE.
   MAGEE JT, 1990, J HOSP INFECT, V16, P67, DOI 10.1016/0195-6701(90)90050-X.
   Mahon CR, 2007, TXB DIAGNOSTIC MICRO.
   MANCINELLI RL, 1978, APPL ENVIRON MICROB, V35, P1095.
   MCDADE JJ, 1964, AM J HYG, V80, P192, DOI 10.1093/oxfordjournals.aje.a120468.
   MCDONALD GR, 1993, SOUTHERN MED J, V86, P967, DOI 10.1097/00007611-199308000-00025.
   Michel O, 2003, J ALLERGY CLIN IMMUN, V112, P923, DOI 10.1067/mai.2003.1781.
   Mnif B, 2006, J CLIN MICROBIOL, V44, P1187, DOI 10.1128/JCM.44.3.1187-1189.2006.
   Mohammedi I, 2005, J Infect, V51, pE11, DOI 10.1016/j.jinf.2004.06.013.
   Muder R R, 1987, Arch Intern Med, V147, P1672.
   Nevalainen A, 2005, INDOOR AIR, V15, P58, DOI 10.1111/j.1600-0668.2005.00344.x.
   Nilsson A, 2004, INDOOR AIR, V14, P74, DOI 10.1046/j.1600-0668.2003.00178.x.
   NORBACK D, 1989, ENVIRON INT, V15, P129, DOI 10.1016/0160-4120(89)90018-4.
   Obbard JP, 2003, WATER AIR SOIL POLL, V144, P333, DOI 10.1023/A:1022973402453.
   OMAHONY M, 1989, EPIDEMIOL INFECT, V103, P285, DOI 10.1017/S0950268800030648.
   Pastuszka JS, 2000, ATMOS ENVIRON, V34, P3833, DOI 10.1016/S1352-2310(99)00527-0.
   Pospisil S, 1998, CAN J MICROBIOL, V44, P1007, DOI 10.1139/cjm-44-10-1007.
   Renvoise A, 2008, INT J INFECT DIS, V12, P223, DOI 10.1016/j.ijid.2007.06.011.
   Roscetto E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-202.
   Rylander R, 1999, ENVIRON HEALTH PERSP, V107, P501, DOI 10.1289/ehp.99107s3501.
   Saravanan N., 2004, RESONANCE, V9, P6.
   Singapore Institute of Environmental Epidemiology, 1996, ENV MONTHL.
   SPENDLOVE JC, 1983, PUBLIC HEALTH REP, V98, P229.
   STACKEBRANDT E, 1995, INT J SYST BACTERIOL, V45, P682, DOI 10.1099/00207713-45-4-682.
   Stetzenbach L.D., 2007, SAMPLING ANAL INDOOR, P123.
   Susan M., 1996, J ENV HLTH, V58.
   Szczerba I., 2002, MED DOSW MIKROBIOL, V55, P67.
   Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus.
   Tong YY, 1997, PHOTOCHEM PHOTOBIOL, V65, P103, DOI 10.1111/j.1751-1097.1997.tb01884.x.
   USEP Agency, 1991, AIR RAD.
   Wu Ping-Sheng, 2006, Journal of Microbiology Immunology and Infection, V39, P144.
   ZHONG W-P, 1990, Zhonghua Yufang Yixue Zazhi, V24, P257.
   Zhu Hong, 2003, Aerobiologia, V19, P201, DOI 10.1023/B:AERO.0000006571.23160.8a.}},
Number-of-Cited-References = {{71}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{13}},
Journal-ISO = {{Trop. Biomed.}},
Doc-Delivery-Number = {{AO4IK}},
Unique-ID = {{ISI:000341300500018}},
DA = {{2018-08-13}},
}

@article{ ISI:000341283800003,
Author = {Dharmadhikari, A. S. and Mphahlele, M. and Venter, K. and Stoltz, A. and
   Mathebula, R. and Masotla, T. and van der Walt, M. and Pagano, M. and
   Jensen, P. and Nardell, E.},
Title = {{Rapid impact of effective treatment on transmission of
   multidrug-resistant tuberculosis}},
Journal = {{INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE}},
Year = {{2014}},
Volume = {{18}},
Number = {{9}},
Pages = {{1019-1025}},
Month = {{SEP}},
Abstract = {{BACKGROUND: Effective treatment for drug-susceptible tuberculosis (TB)
   rapidly renders patients noninfectious, long before conversion of sputum
   acid-fast smear or culture to negative. Multidrug-resistant TB (MDR-TB)
   patients on treatment are currently assumed to remain infectious for
   months. While the resources required for prolonged hospitalization are a
   barrier to the scale-up of MDR-TB treatment, the safety of community
   treatment is clear.
   OBJECTIVES: To estimate the impact of treatment on infectiousness among
   MDR-TB patients.
   METHODS: A series of five human-to-guinea pig TB transmission studies
   was conducted to test various interventions for infection control.
   Guinea pigs in adjacent chambers were exposed to exhaust air from a
   hospital ward occupied by mostly sputum smear- and culture-positive
   MDR-TB patients. The guinea pigs then underwent tuberculin skin testing
   for infection. Only the control groups of guinea pigs from each study
   (no interventions used) provide the data for this analysis. The number
   of guinea pigs infected in each study is reported and correlated with
   Mycobacterium tuberculosis drug susceptibility relative to treatment.
   RESULTS: Despite exposure to presumably infectious MDR-TB patients,
   infection percentages among guinea pigs ranged from 1\% to 77\% in the
   five experiments conducted. In one experiment in which guinea pigs were
   exposed to 27 MDR-TB patients newly started on effective treatment for 3
   months, there was minimal transmission. In four other experiments with
   greater transmission, guinea pigs had been exposed to patients with
   unsuspected extensively drug-resistant tuberculosis who were not on
   effective treatment.
   CONCLUSIONS: In this model, effective treatment appears to render MDR-TB
   patients rapidly noninfectious. Further prospective studies on this
   subject are needed.}},
Publisher = {{INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)}},
Address = {{68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dharmadhikari, AS (Reprint Author), Harvard Univ, Sch Med, Brigham \& Womens Hosp, 641 Huntington Ave,Suite 3A03, Boston, MA 02115 USA.
   Dharmadhikari, A. S.; Nardell, E., Harvard Univ, Sch Med, Brigham \& Womens Hosp, Div Pulm \& Crit Care Med, Boston, MA 02115 USA.
   Dharmadhikari, A. S.; Nardell, E., Harvard Univ, Sch Med, Brigham \& Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA.
   Mphahlele, M.; Venter, K.; Mathebula, R.; Masotla, T.; van der Walt, M., South African Med Res Council, Pretoria, South Africa.
   Stoltz, A., Univ Pretoria, ZA-0002 Pretoria, South Africa.
   Pagano, M., Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   Jensen, P., Ctr Dis Control \& Prevent, Atlanta, GA USA.}},
DOI = {{10.5588/ijtld.13.0834}},
ISSN = {{1027-3719}},
EISSN = {{1815-7920}},
Keywords = {{multidrug-resistant tuberculosis; impact of treatment; transmission;
   extensively drug-resistant tuberculosis}},
Keywords-Plus = {{MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; TUBERCLE-BACILLI;
   SOUTH-AFRICA; CHEMOTHERAPY; INFECTION; VARIABILITY; SETTINGS; WARD}},
Research-Areas = {{Infectious Diseases; Respiratory System}},
Web-of-Science-Categories  = {{Infectious Diseases; Respiratory System}},
Author-Email = {{adharmadhikari@partners.org}},
Funding-Acknowledgement = {{NIOSH {[}R01OH009050]}},
Funding-Text = {{Sources of support/funding: NIOSH R01OH009050.}},
Cited-References = {{ANDREWS R H, 1960, Bull World Health Organ, V23, P463.
   BROOKS SM, 1973, AM REV RESPIR DIS, V108, P799.
   Carvalho Anna C C, 2010, Expert Rev Respir Med, V4, P189, DOI 10.1586/ers.10.7.
   Crofton J., 1962, B INT UNION TUBERC, V32, P643.
   Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002.
   Directorate for Drug-resistant Tuberculosis TB \& HIV Chief Directorate for TB Control and Management, 2010, MULT TUB POL FRAM DE.
   Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188.
   Fennelly KP, 2007, CLIN INFECT DIS, V44, P1358, DOI 10.1086/516617.
   Fennelly KP, 2012, AM J RESP CRIT CARE, V186, P450, DOI 10.1164/rccm.201203-0444OC.
   Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000.
   Fitzwater SP, 2010, CLIN INFECT DIS, V51, P371, DOI 10.1086/655127.
   FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406.
   Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1.
   Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331.
   Glynn JR, 2002, EMERG INFECT DIS, V8, P843.
   GUNNELS JJ, 1974, AM REV RESPIR DIS, V109, P323.
   Kanjee Z, 2011, J HOSP INFECT, V79, P333, DOI 10.1016/j.jhin.2011.06.017.
   LOUDON RG, 1969, AM REV RESPIR DIS, V100, P172.
   Loveday M, 2012, INT J TUBERC LUNG D, V16, P209, DOI 10.5588/ijtld.11.0401.
   Menzies D, 1997, INFECT CONT HOSP EP, V18, P582.
   Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2.
   Nardell E, 2010, INT J TUBERC LUNG D, V14, P1233.
   RILEY RL, 1995, AM J EPIDEMIOL, V142, P3, DOI 10.1093/oxfordjournals.aje.a117542.
   RILEY RL, 1962, AM REV RESPIR DIS, V85, P511.
   ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2.
   Rusch-Gerdes S, 2006, J CLIN MICROBIOL, V44, P688, DOI 10.1128/JCM.44.3.688-692.2006.
   Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1.
   Telzak EE, 1997, CLIN INFECT DIS, V25, P666, DOI 10.1086/513772.
   van Geuns H A, 1975, Bull Int Union Tuberc, V50, P107.
   Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105.
   World Health Organization, 2009, WHO POL TB INF CONTR.
   World Health Organization, 2012, WHOHTMTB20103.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{50}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{10}},
Journal-ISO = {{Int. J. Tuberc. Lung Dis.}},
Doc-Delivery-Number = {{AO4CM}},
Unique-ID = {{ISI:000341283800003}},
OA = {{green\_accepted}},
DA = {{2018-08-13}},
}

@article{ ISI:000340393500009,
Author = {Escalante, Guisella and Leon, Carla G. and Giacomozzi, Benner and
   Guzman, Victor and Mondaca, Maria Angelica and Urrutia, Roberto and
   Smith, Carlos and Campos, Victor L.},
Title = {{Unusual pathogenic bacterium isolated from microbial communities of
   bioaerosols at Chilean Patagonian lakes}},
Journal = {{AEROBIOLOGIA}},
Year = {{2014}},
Volume = {{30}},
Number = {{3}},
Pages = {{323-331}},
Month = {{SEP}},
Abstract = {{Bioaerosols are transported from warm regions and lower latitudes of the
   planet to colder regions and higher latitudes, such as the Chilean
   Patagonia. The role of bioaerosols deposition in remote lake ecosystems
   is a potentially important process, but it has not yet been fully
   studied. The aim of this study was to detect and characterize
   potentially pathogenic viable microorganisms in bioaerosols in a
   pristine area. Samples were collected from the air, at three remote
   lakes in the Chilean Patagonia, using a sterile filtration system
   equipped with 0.2-mu m-pore-size nitrocellulose filters. The bacterial
   community present in bioaerosols was studied using scanning electron
   microscopy (SEM) and denaturing gradient gel electrophoresis. Isolates
   were identified and characterized for phenotypic and 16S rDNA analysis
   and antibiotic resistance. SEM observations of samples from each lake
   showed the presence of bacteria with different morphologies, and after
   culturing, the identification results revealed that they were strains of
   Acinetobacter, Alcaligenes, Edwarsiella, Pseudomonas, Burklolderia,
   Moraxella, Sphingomonas and CDC NO-1. CDC NO-1, uncommonly isolated
   worldwide, stands out from the rest of the isolates because it is a
   rarely found bacterium so far associated with dog and cat bites and was
   found at two out of three pristine lakes studied (Alto and Verde). This
   work demonstrates, for the first time, the presence of CDC NO-1, a
   clinically important Gram-negative microorganism, in bioaerosols and
   first report of CDC-NO1 isolation in Chile. Besides its presence in
   remote lakes, its antibiotic resistance is worth mentioning.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Campos, VL (Reprint Author), Univ Concepcion, Dept Microbiol, Fac Biol Sci, POB 160-C,Mail 3, Concepcion, Chile.
   Escalante, Guisella; Leon, Carla G.; Giacomozzi, Benner; Guzman, Victor; Mondaca, Maria Angelica; Smith, Carlos; Campos, Victor L., Univ Concepcion, Dept Microbiol, Fac Biol Sci, Concepcion, Chile.
   Escalante, Guisella; Urrutia, Roberto, Univ Concepcion, EULA CHILE Ctr, Concepcion, Chile.}},
DOI = {{10.1007/s10453-014-9330-x}},
ISSN = {{0393-5965}},
EISSN = {{1573-3025}},
Keywords = {{Bioaerosols; Patagonian lakes; CDC NO-1; Air microbiota}},
Keywords-Plus = {{CAT BITES; POPULATIONS; TRANSPORT; AEROSOLS; DESERT; DUST;
   MICROORGANISMS; ATMOSPHERE; DEPOSITION; DIVERSITY}},
Research-Areas = {{Life Sciences \& Biomedicine - Other Topics; Environmental Sciences \&
   Ecology}},
Web-of-Science-Categories  = {{Biology; Environmental Sciences}},
Author-Email = {{guiescalante@hotmail.com
   vcampos@udec.cl}},
Funding-Acknowledgement = {{Conicyt {[}24110114]; DIUC {[}211.36.39.1]}},
Funding-Text = {{This work was supported by Conicyt Project No. 24110114 and DIUC
   Project: 211.36.39.1. The authors also thank Jorge Jimenez, PhD, of the
   University of Concepcion, Chile.}},
Cited-References = {{Augustowska M, 2006, ANN AGR ENV MED, V13, P99.
   Bauer H, 2002, ATMOS RES, V64, P109, DOI 10.1016/S0169-8095(02)00084-4.
   Beggs CB, 2008, AM J INFECT CONTROL, V36, P250, DOI 10.1016/j.ajic.2007.07.012.
   Birch ME, 1998, ANALYST, V123, P851.
   Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104.
   BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801.
   Campos VL, 2011, ARCH ENVIRON CON TOX, V61, P185, DOI 10.1007/s00244-010-9601-7.
   Catalan J, 2006, LIMNETICA, V25, P551.
   Clinical and Laboratory Standard Institute, 2008, M45A CLIN LAB STAND.
   Cox CS., 1995, BIOAEROSOLS HDB.
   Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032.
   Dowd S., 2000, ENVIRON MICROBIOL, P91.
   Echigo A., 2005, SALINE SYSTEMS, V1.
   Fahlgren C, 2010, APPL ENVIRON MICROB, V76, P3015, DOI 10.1128/AEM.02092-09.
   Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340.
   Griffin D. W., 2001, AEROBIOLOGIA, V17, P203, DOI DOI 10.1023/A:1011868218901.
   Griffin DW, 2006, AEROBIOLOGIA, V22, P211, DOI 10.1007/s10453-006-9033-z.
   Griffin Dale W., 2004, Aerobiologia, V20, P135, DOI 10.1023/B:AERO.0000032948.84077.12.
   Griffin Dale W., 2003, Aerobiologia, V19, P143, DOI 10.1023/B:AERO.0000006530.32845.8d.
   Grimalt JO, 2001, ENVIRON SCI TECHNOL, V35, P2690, DOI 10.1021/es000278r.
   Haas C.N., 1999, QUANTITATIVE MICROBI.
   Hameed AAA, 2001, J ENVIRON MONITOR, V3, P206, DOI 10.1039/b007159p.
   Harper Tisha A M, 2013, Infect Ecol Epidemiol, V3, DOI 10.3402/iee.v3i0.20376.
   HOLLIS DG, 1993, J CLIN MICROBIOL, V31, P746.
   Isard SA, 2001, FLOW LIFE ATMOSPHERE, P304.
   Jones AM, 2004, SCI TOTAL ENVIRON, V326, P151, DOI 10.1016/j.scitotenv.2003.11.021.
   Jones SE, 2008, FEMS MICROBIOL ECOL, V64, P388, DOI 10.1111/j.1574-6941.2008.00476.x.
   Kaiser RM, 2002, EMERG INFECT DIS, V8, P171, DOI 10.3201/eid0802.010139.
   Kuske CR, 2006, CURR OPIN BIOTECH, V17, P291, DOI 10.1016/j.copbio.2006.04.001.
   Lacey M.E., 2006, AIR SPORA MANUAL CAT.
   Leon C, 2012, WORLD J MICROB BIOT, V28, P1511, DOI 10.1007/s11274-011-0953-6.
   LIGHTHART B, 1994, ATMOS ENVIRON, V28, P1267, DOI 10.1016/1352-2310(94)90273-9.
   Mendoza G, 2006, ENVIRON SCI POLLUT R, V13, P67, DOI 10.1065/espr2006.01.011.
   Morales-Baquero R., 2006, LIMNETICA, V25, P171.
   Moulin C, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025923.
   Neff JC, 2008, NAT GEOSCI, V1, P189, DOI 10.1038/ngeo133.
   Polymenakou PN, 2012, ATMOSPHERE-BASEL, V3, P87, DOI 10.3390/atmos3010087.
   Prospero JM, 2005, AEROBIOLOGIA, V21, P1, DOI 10.1007/s10453-004-5872-7.
   Sarica S, 2002, INDOOR BUILT ENVIRON, V11, P285, DOI 10.1159/000066523.
   Sattler B, 2001, GEOPHYS RES LETT, V28, P239, DOI 10.1029/2000GL011684.
   Smith DJ, 2012, MICROB ECOL, V64, P973, DOI 10.1007/s00248-012-0088-9.
   Stetzenbach LD, 2004, CURR OPIN BIOTECH, V15, P170, DOI 10.1016/j.copbio.2004.04.009.
   Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus.
   Vighi M, 2006, ECOTOX ENVIRON SAFE, V63, P1, DOI 10.1016/j.ecoenv.2005.12.006.
   Ward BB, 1997, MICROBIAL ECOL, V33, P87, DOI 10.1007/s002489900011.
   Winn W, 2008, KONEMAN DIAGNOSTICO.
   Zucker BA, 2000, J VET MED B, V47, P37, DOI 10.1046/j.1439-0450.2000.00308.x.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{19}},
Journal-ISO = {{Aerobiologia}},
Doc-Delivery-Number = {{AN2DH}},
Unique-ID = {{ISI:000340393500009}},
DA = {{2018-08-13}},
}

@article{ ISI:000339827500022,
Author = {Lago, Magali and Aguiar, Ana and Natario, Andre and Fernandes, Carla and
   Faria, Miguel and Pinto, Eugenia},
Title = {{Does fungicide application in vineyards induce resistance to medical
   azoles in Aspergillus species?}},
Journal = {{ENVIRONMENTAL MONITORING AND ASSESSMENT}},
Year = {{2014}},
Volume = {{186}},
Number = {{9}},
Pages = {{5581-5593}},
Month = {{SEP}},
Abstract = {{This study assessed if the use of sterol demethylase inhibitor
   fungicides in vineyard production can induce resistance to azoles in
   Aspergillus strains and if it can induce selection of resistant species.
   We also tried to identify the Aspergillus species most prevalent in the
   vineyards. Two vineyards from northern Portugal were selected from
   ``Vinhos Verdes{''} and ``Douro{''} regions. The vineyards were divided
   into plots that were treated or not with penconazole (PEN). In each
   vineyard, air, soil, and plant samples were collected at three different
   times. The strains of Aspergillus spp. were isolated and identified by
   morphological and molecular techniques. We identified 46 Aspergillus
   section Nigri, eight Aspergillus fumigatus, seven Aspergillus lentulus,
   four Aspergillus wentii, two Aspergillus flavus, two Aspergillus
   terreus, one Aspergillus calidoustus, one Aspergillus westerdijkiae, one
   Aspergillus tamarii, and one Eurotium amstelodami. Aspergillus strains
   were evaluated for their susceptibility to medical azoles used in human
   therapy (itraconazole, posaconazole, and voriconazole) and to
   agricultural azoles (PEN) used in the prevention and treatment of plant
   diseases. The isolates showed moderate susceptibility to voriconazole.
   We did not observe any decrease of susceptibility to the medical azoles
   tested throughout the testing period in any of the treated plots,
   although some of the resistant species were isolated from there.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Pinto, E (Reprint Author), Univ Porto, Fac Farm, Dept Ciencias Biol, CEQUIMED UP Serv Microbiol, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.
   Lago, Magali; Natario, Andre; Fernandes, Carla; Pinto, Eugenia, Univ Porto, Fac Farm, Dept Ciencias Biol, CEQUIMED UP Serv Microbiol, P-4050313 Oporto, Portugal.
   Aguiar, Ana, Univ Porto, Dept Geociencias Ambiente \& Ordenamento Terr, Fac Ciencias, REQUIMTE I3A, P-4485661 Vila Do Conde, Portugal.
   Faria, Miguel, Univ Porto, Dept Chem, REQUIMTE, Fac Pharm, P-4050313 Oporto, Portugal.}},
DOI = {{10.1007/s10661-014-3804-8}},
ISSN = {{0167-6369}},
EISSN = {{1573-2959}},
Keywords = {{Susceptibility to azoles; Aspergillus; Vineyards; DMI fungicides}},
Keywords-Plus = {{ANTIFUNGAL RESISTANCE; HEMATOLOGICAL MALIGNANCIES; INVASIVE
   ASPERGILLOSIS; LOW-PREVALENCE; FRENCH COHORT; FUMIGATUS; EPIDEMIOLOGY;
   INFECTIONS; ORIGIN; AGENT}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{epinto@ff.up.pt}},
ResearcherID-Numbers = {{Faria, Miguel/J-3371-2013
   Scientific output, CIIMAR/E-5122-2012
   Scientific Productivity, CIIMAR/N-6498-2017
   }},
ORCID-Numbers = {{Faria, Miguel/0000-0001-9366-0443
   Scientific output, CIIMAR/0000-0001-6270-2153
   Scientific Productivity, CIIMAR/0000-0002-3703-4402
   Pinto, Eugenia/0000-0003-2948-5809
   Aguiar, Ana/0000-0002-5606-5060}},
Funding-Acknowledgement = {{Fundacao para a Ciencia e a Tecnologia (FCT)
   {[}CEQUIMED-PEst-OE/SAU/UI4040/2011]; Reitoria da Universidade do Porto
   {[}PP-IJUP2010]; European Union (FEDER funds through COMPETE); FCT,
   Fundacao para a Ciencia e Tecnologia {[}Pest-C/EQB/LA0006/2013];
   European Union (FEDER funds) under the framework of QREN
   {[}NORTE-07-0124-FEDER-000069]}},
Funding-Text = {{The authors are grateful to Fundacao para a Ciencia e a Tecnologia (FCT)
   through grants: CEQUIMED-PEst-OE/SAU/UI4040/2011; Reitoria da
   Universidade do Porto-PP-IJUP2010. The authors would also like to
   acknowledge the technical association ADVID and the viticulture
   companies Quinta da Aveleda and Symington Family Estates for the
   facilities in fields experiments. M. A. Faria thanks financial support
   from the European Union (FEDER funds through COMPETE) and National Funds
   (FCT, Fundacao para a Ciencia e Tecnologia) through project
   Pest-C/EQB/LA0006/2013. The work also received financial support from
   the European Union (FEDER funds) under the framework of QREN through
   Project NORTE-07-0124-FEDER-000069. To all financing sources, the
   authors are greatly indebted.}},
Cited-References = {{Alanio A, 2011, J ANTIMICROB CHEMOTH, V66, P371, DOI 10.1093/jac/dkq450.
   Amaro P., 2001, PROTECCAO INTEGRADA.
   {[}Anonymous], 2012, PPDB PESTICIDES PROP.
   Brent K. J., 1998, FRAC MONOGRAPH, V2.
   Bueid A, 2010, J ANTIMICROB CHEMOTH, V65, P2116, DOI 10.1093/jac/dkq279.
   Chiotta ML, 2009, INT J FOOD MICROBIOL, V136, P137, DOI 10.1016/j.ijfoodmicro.2009.08.013.
   Clinical and Laboratory Standards Institute. CLSI, 2008, M38A2 CLSI.
   Coelho D, 2011, MED MYCOL, V49, P755, DOI 10.3109/13693786.2011.556672.
   Copping L., 2003, Pesticide Outlook, V14, P276, DOI 10.1039/b308486h.
   Crous PW, 2004, STUDIES MYCOLOGY, V50, P19.
   European Commission, 2012, SUST US PEST.
   European Commission - Scientific Steering Committee, 2002, SSC REP OP AZ ANT RE.
   FRAC (Fungicide Resistance Action Committee), 2013, FRAC COD LIST 2013 F.
   GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323.
   Hedayati MT, 2010, ENVIRON MONIT ASSESS, V168, P481, DOI 10.1007/s10661-009-1128-x.
   Hof H, 2001, ANTIMICROB AGENTS CH, V45, P2987, DOI 10.1128/AAC.45.11.2987-2990.2001.
   Hof H, 2008, DRUG RESIST UPDATE, V11, P25, DOI 10.1016/j.drup.2008.01.001.
   Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043.
   Lamb DC, 2001, BIOCHEM BIOPH RES CO, V284, P845, DOI 10.1006/bbrc.2001.5010.
   Lass-Florl C, 2008, MYCOSES, V51, P437, DOI 10.1111/j.1439-0507.2008.01510.x.
   Lass-Florl C, 2009, ANTIMICROB AGENTS CH, V53, P794, DOI 10.1128/AAC.00335-08.
   Lucas J., 2003, Pesticide Outlook, V14, P268, DOI 10.1039/b314850p.
   Malani AN, 2007, DRUGS, V67, P1803, DOI 10.2165/00003495-200767130-00001.
   Matthews G., 2000, PESTICIDE APPL METHO.
   Mayr A, 2011, EUR J MED RES, V16, P153, DOI 10.1186/2047-783X-16-4-153.
   Miceli MH, 2011, MYCOSES, V54, pE666, DOI 10.1111/j.1439-0507.2011.02032.x.
   Mortensen KL, 2010, ANTIMICROB AGENTS CH, V54, P4545, DOI 10.1128/AAC.00692-10.
   Moslem MA, 2010, GENET MOL RES, V9, P2283, DOI 10.4238/vol9-4gmr936.
   Noon R., 2004, NEW DEV FUNGICIDES.
   O'Donnell Kerry, 2000, Mycoscience, V41, P61, DOI 10.1007/BF02464387.
   Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3.
   Pfaller M, 2011, J CLIN MICROBIOL, V49, P1110, DOI 10.1128/JCM.02432-10.
   Pfaller MA, 2008, J CLIN MICROBIOL, V46, P2568, DOI 10.1128/JCM.00535-08.
   Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06.
   Pfaller MA, 2009, J CLIN MICROBIOL, V47, P3142, DOI 10.1128/JCM.00940-09.
   Samson R. A., 2010, FOOD INDOOR FUNGI.
   Serra R, 2006, MYCOL RES, V110, P971, DOI 10.1016/j.mycres.2006.05.010.
   Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002.
   Snelders E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031801.
   Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09.
   Steinkellner S, 2001, BODENKULTUR, V52, P293.
   Steva H., 1988, PHYTOMA, V402, P49.
   Varga J, 2008, EUKARYOT CELL, V7, P630, DOI 10.1128/EC.00425-07.
   Vermeulen E., 2012, EUROSURVEILLANCE, V17.
   Verweij PE, 2011, J ANTIMICROB CHEMOTH, V66, P954, DOI 10.1093/jac/dkr008.
   Verweij PE, 2009, LANCET INFECT DIS, V9, P789, DOI 10.1016/S1473-3099(09)70265-8.
   Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258.
   White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{26}},
Journal-ISO = {{Environ. Monit. Assess.}},
Doc-Delivery-Number = {{AM4MB}},
Unique-ID = {{ISI:000339827500022}},
DA = {{2018-08-13}},
}

@article{ ISI:000338763500006,
Author = {Jungnick, Nadine and Ma, Yunbing and Mukherjee, Bratati and Cronan,
   Julie C. and Speed, Dequantarius J. and Laborde, Susan M. and
   Longstreth, David J. and Moroney, James V.},
Title = {{The carbon concentrating mechanism in Chlamydomonas reinhardtii: finding
   the missing pieces}},
Journal = {{PHOTOSYNTHESIS RESEARCH}},
Year = {{2014}},
Volume = {{121}},
Number = {{2-3, SI}},
Pages = {{159-173}},
Month = {{SEP}},
Abstract = {{The photosynthetic, unicellular green alga, Chlamydomonas reinhardtii,
   lives in environments that often contain low concentrations of CO2 and
   HCO3 (-), the utilizable forms of inorganic carbon (C-i). C. reinhardtii
   possesses a carbon concentrating mechanism (CCM) which can provide
   suitable amounts of C-i for growth and development. This CCM is induced
   when the CO2 concentration is at air levels or lower and is comprised of
   a set of proteins that allow the efficient uptake of C-i into the cell
   as well as its directed transport to the site where Rubisco fixes CO2
   into biomolecules. While several components of the CCM have been
   identified in recent years, the picture is still far from complete. To
   further improve our knowledge of the CCM, we undertook a mutagenesis
   project where an antibiotic resistance cassette was randomly inserted
   into the C. reinhardtii genome resulting in the generation of 22,000
   mutants. The mutant collection was screened using both a published
   PCR-based approach (Gonzalez-Ballester et al. 2011) and a phenotypic
   growth screen. The PCR-based screen did not rely on a colony having an
   altered growth phenotype and was used to identify colonies with
   disruptions in genes previously identified as being associated with the
   CCM-related gene. Eleven independent insertional mutations were
   identified in eight different genes showing the usefulness of this
   approach in generating mutations in CCM-related genes of interest as
   well as identifying new CCM components. Further improvements of this
   method are also discussed.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Moroney, JV (Reprint Author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.
   Jungnick, Nadine; Ma, Yunbing; Mukherjee, Bratati; Cronan, Julie C.; Speed, Dequantarius J.; Laborde, Susan M.; Longstreth, David J.; Moroney, James V., Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.}},
DOI = {{10.1007/s11120-014-0004-x}},
ISSN = {{0166-8595}},
EISSN = {{1573-5079}},
Keywords = {{Calvin-Benson-Bassham cycle; Carbon concentrating mechanism; Carbonic
   anhydrase; Chlamydomonas; Rubisco}},
Keywords-Plus = {{GREEN-ALGA; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; INSERTIONAL
   MUTANTS; INTACT CHLOROPLASTS; PYRENOID FORMATION; RUBISCO ACTIVASE; GENE
   CAH1; LOW CO2; ANHYDRASE; PHOTOSYNTHESIS}},
Research-Areas = {{Plant Sciences}},
Web-of-Science-Categories  = {{Plant Sciences}},
Author-Email = {{btmoro@lsu.edu}},
ResearcherID-Numbers = {{Ma, Yunbing/I-3799-2014
   }},
ORCID-Numbers = {{Ma, Yunbing/0000-0002-3744-8832
   Mukherjee, Bratati/0000-0003-4801-5554}},
Cited-References = {{Blanco-Rivero A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049063.
   Borkhsenious ON, 1998, PLANT PHYSIOL, V116, P1585, DOI 10.1104/pp.116.4.1585.
   Brueggeman AJ, 2012, PLANT CELL, V24, P1860, DOI 10.1105/tpc.111.093435.
   Burow MD, 1996, PLANT MOL BIOL, V31, P443, DOI 10.1007/BF00021807.
   Colombo SL, 2002, FUNCT PLANT BIOL, V29, P231, DOI 10.1071/PP01189.
   Dent RM, 2005, PLANT PHYSIOL, V137, P545, DOI 10.1104/pp.104.055244.
   Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397.
   Duanmu D, 2009, P NATL ACAD SCI USA, V106, P5990, DOI 10.1073/pnas.0812885106.
   Fang W, 2012, PLANT CELL, V24, P1876, DOI 10.1105/tpc.112.097949.
   Fukuzawa H, 2001, P NATL ACAD SCI USA, V98, P5347, DOI 10.1073/pnas.081593498.
   Genkov T, 2010, J BIOL CHEM, V285, P19833, DOI 10.1074/jbc.M110.124230.
   Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052.
   Gonzalez-Ballester D, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-24.
   Gowik U, 2011, PLANT PHYSIOL, V155, P56, DOI 10.1104/pp.110.165308.
   Hanson DT, 2003, PLANT PHYSIOL, V132, P2267, DOI 10.1104/pp.103.023481.
   Im CS, 2002, PLANT J, V30, P301, DOI 10.1046/j.1365-313X.2001.01287.x.
   Karlsson J, 1998, EMBO J, V17, P1208, DOI 10.1093/emboj/17.5.1208.
   Ma YB, 2011, PLANT PHYSIOL, V156, P884, DOI 10.1104/pp.111.173922.
   Mariscal V, 2006, PROTIST, V157, P421, DOI 10.1016/j.protis.2006.06.003.
   MASON CB, 1991, PLANT PHYSIOL, V97, P1576, DOI 10.1104/pp.97.4.1576.
   MCKAY RML, 1991, PROTOPLASMA, V162, P38, DOI 10.1007/BF01403899.
   Meyer M, 2013, J EXP BOT, V64, P769, DOI 10.1093/jxb/ers390.
   Meyer MT, 2012, P NATL ACAD SCI USA, V109, P19474, DOI 10.1073/pnas.1210993109.
   Miura K, 2004, PLANT PHYSIOL, V135, P1595, DOI 10.1104/pp.104.041400.
   Morita E, 1997, J PHYCOL, V33, P68, DOI 10.1111/j.0022-3646.1997.00068.x.
   Moroney JV, 2007, EUKARYOT CELL, V6, P1251, DOI 10.1128/EC.00064-07.
   Moroney JV, 2013, PHOTOSYNTH RES, V117, P121, DOI 10.1007/s11120-013-9865-7.
   Moroney JV, 2011, PHOTOSYNTH RES, V109, P133, DOI 10.1007/s11120-011-9635-3.
   MORONEY JV, 1985, PLANT PHYSIOL, V79, P177, DOI 10.1104/pp.79.1.177.
   MORONEY JV, 1987, PLANT PHYSIOL, V83, P460, DOI 10.1104/pp.83.3.460.
   MORONEY JV, 1986, MOL GEN GENET, V204, P199, DOI 10.1007/BF00425498.
   MORONEY JV, 1989, PLANT PHYSIOL, V89, P897, DOI 10.1104/pp.89.3.897.
   Mukherjee B, 2013, THESIS.
   Mukherjee B, 2012, P 15 INT C PHOT.
   Ohnishi N, 2010, PLANT CELL, V22, P3105, DOI 10.1105/tpc.109.071811.
   Pollock SV, 2004, PLANT MOL BIOL, V56, P125, DOI 10.1007/s11103-004-2650-4.
   Pollock SV, 2003, PLANT PHYSIOL, V133, P1854, DOI 10.1104/pp.103.032078.
   Price GD, 2013, J EXP BOT, V64, P753, DOI 10.1093/jxb/ers257.
   Price GD, 2011, PHOTOSYNTH RES, V109, P47, DOI 10.1007/s11120-010-9608-y.
   Price GD, 2011, PLANT PHYSIOL, V155, P20, DOI 10.1104/pp.110.164681.
   Price GD, 2004, P NATL ACAD SCI USA, V101, P18228, DOI 10.1073/pnas.0405211101.
   Qu ZQ, 2008, AM J PHYSIOL-CELL PH, V294, pC1371, DOI 10.1152/ajpcell.00398.2007.
   RAMAZANOV Z, 1993, PLANT PHYSIOL, V101, P1195, DOI 10.1104/pp.101.4.1195.
   Raven JA, 2012, PHILOS T R SOC B, V367, P493, DOI 10.1098/rstb.2011.0212.
   Raven JA, 2011, PHOTOSYNTH RES, V109, P281, DOI 10.1007/s11120-011-9632-6.
   Rawat M, 1996, PLANTA, V198, P263.
   Shimogawara K, 1998, GENETICS, V148, P1821.
   Sinetova MA, 2012, BBA-BIOENERGETICS, V1817, P1248, DOI 10.1016/j.bbabio.2012.02.014.
   Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3.
   SPALDING MH, 1983, PLANT PHYSIOL, V73, P273, DOI 10.1104/pp.73.2.273.
   SPALDING MH, 1983, PLANT PHYSIOL, V73, P268, DOI 10.1104/pp.73.2.268.
   SULTEMEYER DF, 1989, PLANT PHYSIOL, V89, P1213, DOI 10.1104/pp.89.4.1213.
   Van K, 1999, PLANT PHYSIOL, V120, P757, DOI 10.1104/pp.120.3.757.
   Villand P, 1997, BIOCHEM J, V327, P51, DOI 10.1042/bj3270051.
   von Caemmerer S, 2012, SCIENCE, V336, P1671, DOI 10.1126/science.1220177.
   Wang YJ, 2006, P NATL ACAD SCI USA, V103, P10110, DOI 10.1073/pnas.0603402103.
   Woodger FJ, 2005, PLANT PHYSIOL, V139, P1959, DOI 10.1104/pp.105.069146.
   Xiang YB, 2001, P NATL ACAD SCI USA, V98, P5341, DOI 10.1073/pnas.101534498.
   Yamano T, 2010, PLANT CELL PHYSIOL, V51, P1453, DOI 10.1093/pcp/pcq105.
   Yamano T, 2009, J BASIC MICROB, V49, P42, DOI 10.1002/jobm.200800352.
   Ynalvez RA, 2008, PHYSIOL PLANTARUM, V133, P15, DOI 10.1111/j.1399-3054.2007.01043.x.
   Yoshioka S, 2004, PLANT CELL, V16, P1466, DOI 10.1105/tpc.021162.
   Zhu XG, 2008, CURR OPIN BIOTECH, V19, P153, DOI 10.1016/j.copbio.2008.02.004.
   Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206.}},
Number-of-Cited-References = {{64}},
Times-Cited = {{21}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{60}},
Journal-ISO = {{Photosynth. Res.}},
Doc-Delivery-Number = {{AK9RD}},
Unique-ID = {{ISI:000338763500006}},
DA = {{2018-08-13}},
}

@article{ ISI:000340692900023,
Author = {Laube, H. and Friese, A. and von Salviati, C. and Guerra, B. and
   Roesler, U.},
Title = {{Transmission of ESBL/AmpC-producing Escherichia coli from broiler
   chicken farms to surrounding areas}},
Journal = {{VETERINARY MICROBIOLOGY}},
Year = {{2014}},
Volume = {{172}},
Number = {{3-4}},
Pages = {{519-527}},
Month = {{AUG 27}},
Abstract = {{Although previous studies have demonstrated high carriage of
   ESBL/AmpC-producing Escherichia coli in livestock, especially in broiler
   chickens, data on emission sources of these bacteria into the
   environment are still rare. Therefore, this study was designed to
   systematically investigate the occurrence of ESBL/AmpC-producing E. coli
   in slurry, air (inside animal houses), ambient air (outside animal
   houses) and on soil surfaces in the areas surrounding of seven
   ESBL/AmpC-positive broiler chicken fattening farms, including
   investigation of the possible spread of these bacteria via the faecal
   route and/or exhaust air into the environment. Seven German broiler
   fattening farms were each investigated at three points in time (3-36 h
   after restocking, 14-18 and 26-35 days after housing) during one
   fattening period. The occurrence of ESBL/AmpC genes in the investigated
   samples was confirmed by PCR, detecting bla(CTX-M), bla(SHV), bla(TEM)
   and bla(CMY)-genes, and, if necessary, by sequencing and/or the disc
   diffusion method. The results showed a wide spread of
   ESBL/AmpC-producing E. coli in broiler farms, as well as emissions into
   the surroundings. 12 out of 14 (86\%) slurry samples were positive for
   ESBL/AmpC-producing E. coli. Additionally, 28.8\% (n = 23/80) of boot
   swabs taken from various surfaces in the areas surrounding of the farms
   as well as 7.5\% (n = 3/40) of the exhaust air samples turned out to be
   positive for these microorganisms. Moreover, a small proportion of air
   samples from inside the barns were ESBL/AmpC-positive. By comparing
   selected isolates using pulsed field gel electrophoresis, we proved that
   faecal and airborne transfer of ESBL/AmpC-producing microorganisms from
   broiler fattening farms to the surrounding areas is possible. Two
   isolates from farm G2 (slurry and boot swab 50 m downwind), two isolates
   from farm G3 (slurry and individual animal swab) as well as two isolates
   from farm G6 (air sample in the barn and air sample 50 m downwind)
   showed 100\% similarity in PFGE analysis. (C) 2014 Elsevier B.V. All
   rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Laube, H (Reprint Author), Free Univ Berlin, Inst Anim Hyg \& Environm Hlth, Robert von Ostertag Str 7-13, D-14163 Berlin, Germany.
   Laube, H.; Friese, A.; von Salviati, C.; Roesler, U., Free Univ Berlin, Inst Anim Hyg \& Environm Hlth, D-14163 Berlin, Germany.
   Guerra, B., Fed Inst Risk Assessment, Dept Biol Safety, Natl Reference Lab Antimicrobial Resistance, D-10589 Berlin, Germany.}},
DOI = {{10.1016/j.vetmic.2014.06.008}},
ISSN = {{0378-1135}},
EISSN = {{1873-2542}},
Keywords = {{Antimicrobial resistance; CTX-M; SHV; Livestock; Environment; Broiler}},
Keywords-Plus = {{SPECTRUM BETA-LACTAMASES; FIELD GEL-ELECTROPHORESIS; RESISTANT
   STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; LIVESTOCK BUILDINGS;
   SALMONELLA; ENVIRONMENT; ANIMALS; FRANCE; GENES}},
Research-Areas = {{Microbiology; Veterinary Sciences}},
Web-of-Science-Categories  = {{Microbiology; Veterinary Sciences}},
Author-Email = {{henriette.laube@fu-berlin.de}},
ResearcherID-Numbers = {{Amoako, Daniel Gyamfi/I-4223-2018}},
Funding-Acknowledgement = {{Federal Ministry of Education and Research, joint research consortium
   RESET {[}01KI1013C]}},
Funding-Text = {{This work was financially supported by the Federal Ministry of Education
   and Research (funding number 01KI1013C) as part of the joint research
   consortium RESET (http://www.reset-verbund.de). We gratefully thank N.
   Roschanski, L. Kreienbrock, A. Kasbohrer, I. Rodriguez, B. Etschmann and
   J. Fischer for their scientific advice. All cooperating farmers and
   veterinarians, as well as the excellent technical assistance of H.
   Jansen, M. Thieck, S. Sellenthin and K. Fiedler (Institute for Animal
   Hygiene and Environmental Health), are gratefully acknowledged.}},
Cited-References = {{Bardon J, 2012, Klin Mikrobiol Infekc Lek, V18, P65.
   Batchelor M, 2005, ANTIMICROB AGENTS CH, V49, P1319, DOI 10.1128/AAC.49.4.1319-1322.2005.
   Batchelor Miranda, 2005, Expert Rev Anti Infect Ther, V3, P403, DOI 10.1586/14787210.3.3.403.
   BENBOUGH JE, 1967, J GEN MICROBIOL, V47, P325, DOI 10.1099/00221287-47-3-325.
   Carattoli A, 2008, J CLIN MICROBIOL, V46, P103, DOI 10.1128/JCM.01542-07.
   Carrico JA, 2005, J CLIN MICROBIOL, V43, P5483, DOI 10.1128/JCM.43.11.5483-5490.2005.
   Chinivasagam HN, 2010, J APPL MICROBIOL, V108, P1657, DOI 10.1111/j.1365-2672.2009.04571.x.
   Chinivasagam HN, 2009, APPL ENVIRON MICROB, V75, P7417, DOI 10.1128/AEM.01380-09.
   Chmelnitsky I, 2005, ANTIMICROB AGENTS CH, V49, P4745, DOI 10.1128/AAC.49.11.4745-4750.2005.
   CLSI, 2012, PERF STAND ANT DISK.
   Dierikx C., 2012, J ANTIMICROB CHEMOTH, V68, P60, DOI DOI 10.1093/JAC/DKS349.
   Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x.
   Friese A, 2013, APPL ENVIRON MICROB, V79, P2759, DOI 10.1128/AEM.03939-12.
   Friese A, 2013, BERL MUNCH TIERARZTL, V126, P175, DOI 10.2376/0005-9366-126-175.
   Friese A, 2012, VET MICROBIOL, V158, P129, DOI 10.1016/j.vetmic.2012.01.019.
   Gregova G, 2012, ANN AGR ENV MED, V19, P75.
   Guenther S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050331.
   Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246.
   Guerra B, 2001, ANTIMICROB AGENTS CH, V45, P1305, DOI 10.1128/AAC.45.4.1305-1308.2001.
   HANDLEY BA, 1995, J APPL BACTERIOL, V79, P368, DOI 10.1111/j.1365-2672.1995.tb03150.x.
   Hartmann A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00083.
   Hartung J, 1998, DEUT TIERARZTL WOCH, V105, P213.
   Heuer H, 2009, ENVIRON MICROBIOL, V11, P937, DOI 10.1111/j.1462-2920.2008.01819.x.
   Jones AM, 2004, SCI TOTAL ENVIRON, V326, P151, DOI 10.1016/j.scitotenv.2003.11.021.
   Korzeniewska E, 2013, ECOTOX ENVIRON SAFE, V91, P96, DOI 10.1016/j.ecoenv.2013.01.014.
   Laube H, 2013, APPL ENVIRON MICROB, V79, P4815, DOI 10.1128/AEM.00856-13.
   Looper ML, 2009, LETT APPL MICROBIOL, V48, P513, DOI 10.1111/j.1472-765X.2009.02563.x.
   PEARSON CC, 1995, J AGR ENG RES, V60, P145, DOI 10.1006/jaer.1995.1008.
   Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59.
   del Castillo BR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-84.
   Sabia C, 2012, NEW MICROBIOL, V35, P221.
   Seedorf J., 2002, KTBL SCHRIFT, P393.
   TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233.
   Terzieva S, 1996, APPL ENVIRON MICROB, V62, P2264.
   Weill FX, 2004, J CLIN MICROBIOL, V42, P2432, DOI 10.1128/JCM.42.6.2432-2437.2004.
   Zhao SH, 2001, ANTIMICROB AGENTS CH, V45, P3647, DOI 10.1128/AAC.45.12.3647-3650.2001.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{36}},
Usage-Count-Last-180-days = {{5}},
Usage-Count-Since-2013 = {{46}},
Journal-ISO = {{Vet. Microbiol.}},
Doc-Delivery-Number = {{AN6GL}},
Unique-ID = {{ISI:000340692900023}},
DA = {{2018-08-13}},
}

@article{ ISI:000341986000029,
Author = {Abayomi, A. and Cowan, M. N.},
Title = {{The HIV/AIDS epidemic in South Africa: Convergence with tuberculosis,
   socioecological vulnerability, and climate change patterns}},
Journal = {{SAMJ SOUTH AFRICAN MEDICAL JOURNAL}},
Year = {{2014}},
Volume = {{104}},
Number = {{8}},
Pages = {{583+}},
Month = {{AUG}},
Abstract = {{Recent assessment reports suggest that climate change patterns are
   threatening social and ecological vulnerability and resilience, with the
   strong potential of negatively affecting human health. Persons living
   with HIV/AIDS (PLWHA) have weakened physiological responses and are
   immunologically vulnerable to pathogens and stressors in their
   environment, putting them at a health disadvantage in climate-based
   rising temperatures, water scarcity, air pollution, potential water-and
   vector-borne disease outbreaks, and habitat redistributions. These
   climatic aberrations may lead to increased surface drying and decreased
   availability of arable land, threatening food/nutrition security and
   sanitary water practices. Coupled with HIV/AIDS, climate change
   threatens ecological biodiversity via a larger-scale socioeconomic
   recourse to natural resources. Corresponding human and environmental
   activity shape conditions conducive to exacerbating high rates of
   HIV/AIDS. In South Africa, this epidemic is forming a `syndemic' with
   tuberculosis (TB), which has come to include multidrug-resistant TB
   (MDR-TB) and extremely drug-resistant TB (XDR-TB) strains. Because of
   high convergence rates, one epidemic cannot be addressed without
   understanding the other. Concurrent climate change mitigation and
   adaptation strategies are becoming increasingly important to curb
   changes that negatively affect the biospheres on which civilisation is
   ultimately dependent - from an agricultural, a developmental, and
   especially a health standpoint. Mitigation strategies such as reducing
   carbon emissions are essential, but may be only partially effective in
   slowing the rate of surface warming. However, global climate assessments
   assert that these are not sufficient to halt climate change patterns.
   The roles of regionally specific climate research, socioecologically
   sustainable industrialisation paths for developing countries, and
   adoption of health system strengthening strategies are therefore vital.}},
Publisher = {{SA MEDICAL ASSOC}},
Address = {{BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3,
   PRETORIA, 0002, SOUTH AFRICA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Abayomi, A (Reprint Author), Univ Stellenbosch, Fac Med \& Hlth Sci, Dept Pathol, Div Haematol, Cape Town, South Africa.
   Abayomi, A., Univ Stellenbosch, Fac Med \& Hlth Sci, Dept Pathol, Div Haematol, Cape Town, South Africa.
   Abayomi, A., Tygerberg Hosp, Natl Hlth Lab Serv, Cape Town, South Africa.
   Abayomi, A., Registered Humanitarian \& Environm Nongovt Org, Margo Lutzi MAMIE Fdn, Ibadan, Nigeria.
   Cowan, M. N., Univ Virginia, Dept Biol, Charlottesville, VA USA.}},
DOI = {{10.7196/SAMJ.8645}},
ISSN = {{0256-9574}},
EISSN = {{2078-5135}},
Keywords-Plus = {{MORTALITY}},
Research-Areas = {{General \& Internal Medicine}},
Web-of-Science-Categories  = {{Medicine, General \& Internal}},
Author-Email = {{abayomi@sun.ac.za}},
Cited-References = {{Abayomi EA, 2011, TRANSFUS APHER SCI, V44, P161, DOI 10.1016/j.transci.2011.01.007.
   Abayomi EA, 2013, CLIMATE VULNERABILIT, V1, P125.
   Abrado M, 2013, IMPACTS ADAPTATION V.
   Biggs R., 2004, ECOSYSTEM SERVICES S.
   Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x.
   Christy JR, 2009, J CLIMATE, V22, P3342, DOI 10.1175/2008JCLI2726.1.
   Cohen J, 2013, SCIENCE, V339, P898, DOI 10.1126/science.339.6122.898.
   Gallopin GC, 2006, GLOBAL ENVIRON CHANG, V16, P293, DOI 10.1016/j.gloenvcha.2006.02.004.
   Hunter LM, 2007, SCAND J PUBLIC HEALT, V35, P165, DOI 10.1080/14034950701356385.
   McGarry DK, 2009, J CHILDREN POVERTY, V15, P19, DOI DOI 10.1080/10796120802677594.
   Mittal ML, 2007, ATMOS ENVIRON, V41, P6572, DOI 10.1016/j.atmosenv.2007.04.035.
   Muchie M, 2012, INNOVATION SUSTAINAB.
   Niehof A, 2012, AIDS RURAL LIVELIHOO.
   Pielke RA, 2007, J GEOPHYS RES, V112.
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132.
   Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999.
   Shisana O, 2012, S AFRICAN NATL HIV P.
   Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325.
   South African Department of Environmental Affairs, 2010, S AFR 2 NAT COMM UN.
   Tanser F, 2013, SCIENCE, V339, P996.
   US Global Change Research Program, 2014, US NAT CLIM ASS OUR, P19.
   Vincent K., 2004, 56 U EAST ANGL TYND.
   World Health Organization, 2013, GLOB TUB REP 2013, P45.
   Zweig P, 2013, REGIONAL DISASTER RI.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{35}},
Journal-ISO = {{SAMJ S. Afr. Med. J.}},
Doc-Delivery-Number = {{AP3OM}},
Unique-ID = {{ISI:000341986000029}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000338837600014,
Author = {Preston, Mark D. and Campino, Susana and Assefa, Samuel A. and
   Echeverry, Diego F. and Ocholla, Harold and Amambua-Ngwa, Alfred and
   Stewart, Lindsay B. and Conway, David J. and Borrmann, Steffen and
   Michon, Pascal and Zongo, Issaka and Ouedraogo, Jean-Bosco and Djimde,
   Abdoulaye A. and Doumbo, Ogobara K. and Nosten, Francois and Pain, Arnab
   and Bousema, Teun and Drakeley, Chris J. and Fairhurst, Rick M. and
   Sutherland, Colin J. and Roper, Cally and Clark, Taane G.},
Title = {{A barcode of organellar genome polymorphisms identifies the geographic
   origin of Plasmodium falciparum strains}},
Journal = {{NATURE COMMUNICATIONS}},
Year = {{2014}},
Volume = {{5}},
Month = {{JUN}},
Abstract = {{Malaria is a major public health problem that is actively being
   addressed in a global eradication campaign. Increased population
   mobility through international air travel has elevated the risk of
   re-introducing parasites to elimination areas and dispersing
   drug-resistant parasites to new regions. A simple genetic marker that
   quickly and accurately identifies the geographic origin of infections
   would be a valuable public health tool for locating the source of
   imported outbreaks. Here we analyse the mitochondrion and apicoplast
   genomes of 711 Plasmodium falciparum isolates from 14 countries, and
   find evidence that they are non-recombining and co-inherited. The high
   degree of linkage produces a panel of relatively few single-nucleotide
   polymorphisms (SNPs) that is geographically informative. We design a
   23-SNP barcode that is highly predictive (similar to 92\%) and easily
   adapted to aid case management in the field and survey parasite
   migration worldwide.}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Clark, TG (Reprint Author), London Sch Hyg \& Trop Med, Immunol \& Infect Dept, London WC1E 7HT, England.
   Preston, Mark D.; Assefa, Samuel A.; Stewart, Lindsay B.; Conway, David J.; Bousema, Teun; Drakeley, Chris J.; Sutherland, Colin J.; Roper, Cally; Clark, Taane G., London Sch Hyg \& Trop Med, Immunol \& Infect Dept, London WC1E 7HT, England.
   Campino, Susana; Djimde, Abdoulaye A., Wellcome Trust Sanger Inst, Malaria Programme, Hinxton CB10 1SA, England.
   Echeverry, Diego F., Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.
   Echeverry, Diego F., Int Ctr Med Res \& Training, Cali, Colombia.
   Ocholla, Harold, Univ Malawi, Coll Med, Blantyre 3, Malawi.
   Ocholla, Harold, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre 30096 BT3, Malawi.
   Ocholla, Harold, Univ Liverpool Liverpool Sch Trop Med, Malaria Capac Dev Consortium, Liverpool L3 5QA, Merseyside, England.
   Amambua-Ngwa, Alfred; Conway, David J., Med Res Council Labs UK, Fajara, Gambia.
   Borrmann, Steffen, KEMRI Wellcome Trust Res Programme, Kilifi 80108, Kenya.
   Borrmann, Steffen, Univ Tubingen, Dept Parasitol, Inst Trop Med, D-72074 Tubingen, Germany.
   Michon, Pascal, Divine Word Univ, Fac Hlth Sci, Dept Rural Hlth, Madang, Papua N Guinea.
   Zongo, Issaka; Ouedraogo, Jean-Bosco, Inst Rech Sci Sant, Bobo Dioulasso, Burkina Faso.
   Djimde, Abdoulaye A.; Doumbo, Ogobara K., Univ Bamako, Fac Med Pharm \& Dent, Malaria Res \& Training Ctr, Bamako BP1805, Mali.
   Nosten, Francois, Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford OX3 9DS, England.
   Nosten, Francois, Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot 63110, Thailand.
   Pain, Arnab, King Abdullah Univ Sci \& Technol, Pathogen Genom Lab, Thuwal 239556900, Saudi Arabia.
   Fairhurst, Rick M., NIAID, Malaria Pathogenesis \& Human Immun Unit, Lab Malaria \& Vector Res, NIH, Bethesda, MD 20892 USA.}},
DOI = {{10.1038/ncomms5052}},
Article-Number = {{4052}},
ISSN = {{2041-1723}},
Keywords-Plus = {{MITOCHONDRIAL-DNA; MALARIA PARASITE; LINKAGE DISEQUILIBRIUM; COPY
   NUMBER; APICOPLAST; EVOLUTION; ARTEMISININ; GAMETOCYTOGENESIS;
   SUSCEPTIBILITY; REPLICATION}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{cally.roper@lshtm.ac.uk
   taane.clark@lshtm.ac.uk}},
ResearcherID-Numbers = {{Bousema, Teun/N-3574-2014
   Roper, Cally/K-2989-2013
   Pain, Arnab/L-5766-2015
   Preston, Mark/P-1429-2015
   }},
ORCID-Numbers = {{Bousema, Teun/0000-0003-2666-094X
   Roper, Cally/0000-0002-6545-309X
   Pain, Arnab/0000-0002-1755-2819
   Preston, Mark/0000-0002-6506-3104
   Borrmann, Steffen/0000-0001-9189-4393
   Conway, David/0000-0002-8711-3037
   Nosten, Francois/0000-0002-7951-0745}},
Funding-Acknowledgement = {{UK Medical Research Council; Malaria Capacity Development Consortium;
   Wellcome Trust {[}WT084289MA]; Public Health England; Intramural
   Research Program of the NIH, NIAID; Medical Research Council
   {[}MC\_EX\_MR/K02440X/1]}},
Funding-Text = {{M. D. P. and T. G. C. received funding from the UK Medical Research
   Council. H.O. is supported by the Malaria Capacity Development
   Consortium, which is funded by The Wellcome Trust (WT084289MA). C.J.S.
   is supported by Public Health England. We wish to thank Scott Jackson,
   Catherine Hill, Tim Anderson and the malaria research team at CIDEIM for
   providing Colombian parasite samples, and the investigators who placed
   their sequencing data into the public domain. We wish to thank the
   Malaria Programs at the Wellcome Trust Sanger and Broad Institutes for
   putting raw sequence data into the public domain. This work was
   supported in part by the Intramural Research Program of the NIH, NIAID.}},
Cited-References = {{Amambua-Ngwa A, 2012, MOL BIOL EVOL, V29, P3249, DOI 10.1093/molbev/mss151.
   Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876.
   Arisue N, 2012, MOL BIOL EVOL, V29, P2095, DOI 10.1093/molbev/mss082.
   Auburn S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032891.
   Baker DA, 2010, MOL BIOCHEM PARASIT, V172, P57, DOI 10.1016/j.molbiopara.2010.03.019.
   Bender A, 2003, MOL BIOCHEM PARASIT, V132, P59, DOI 10.1016/j.molbiopara.2003.07.001.
   Bispo NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059288.
   Borrmann S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03318.
   Breiman L, 1984, CLASSIFICATION REGRE.
   CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0.
   Conway DJ, 2000, MOL BIOCHEM PARASIT, V111, P163, DOI 10.1016/S0166-6851(00)00313-3.
   CREASEY A, 1994, MOL BIOCHEM PARASIT, V65, P95, DOI 10.1016/0166-6851(94)90118-X.
   Dahl EL, 2008, TRENDS PARASITOL, V24, P279, DOI 10.1016/j.pt.2008.03.007.
   Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223.
   Echeverri-Garcia D. F., 2013, POPULATION GENETICS.
   Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132.
   Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599.
   Friesen J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001058.
   Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311.
   Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611.
   Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1.
   Imazio S, 2006, GENET RESOUR CROP EV, V53, P1003, DOI 10.1007/s10722-004-6896-0.
   Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449.
   Liaw A, 2002, R NEWS, V2, P18, DOI DOI 10.1177/154405910408300516.
   Lim L, 2010, PHILOS T R SOC B, V365, P749, DOI 10.1098/rstb.2009.0273.
   Luo HM, 2013, NEW ENGL J MED, V369, P1981, DOI 10.1056/NEJMoa1303368.
   Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624.
   Mobegi V. A, 2014, MOL BIOL EVOL.
   Mueller JC, 2004, BRIEF BIOINFORM, V5, P355, DOI 10.1093/bib/5.4.355.
   Musset L, 2007, MOL BIOL EVOL, V24, P1582, DOI 10.1093/molbev/msm087.
   Okamoto N, 2009, EUKARYOT CELL, V8, P128, DOI 10.1128/EC.00267-08.
   Olson MS, 2000, P ROY SOC B-BIOL SCI, V267, P1801, DOI 10.1098/rspb.2000.1213.
   Park DJ, 2012, P NATL ACAD SCI USA, V109, P13052, DOI 10.1073/pnas.1210585109.
   Pecnikar ZF, 2014, J APPL GENET, V55, P43, DOI 10.1007/s13353-013-0180-y.
   Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X.
   Preston MD, 2014, J INFECT DIS, V209, P1808, DOI 10.1093/infdis/jit812.
   Preston MD, 2012, BIOINFORMATICS, V28, P2983, DOI 10.1093/bioinformatics/bts557.
   Ralph SA, 2001, DRUG RESIST UPDATE, V4, P145, DOI 10.1054/drup.2001.0205.
   Robinson T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023204.
   Seow F, 2005, MOL BIOCHEM PARASIT, V141, P145, DOI 10.1016/j.molbiopara.2005.02.002.
   Sepulveda N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-128.
   Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115.
   TAJIMA F, 1989, GENETICS, V123, P585.
   Thyssen G, 2012, PLANT J, V72, P84, DOI 10.1111/j.1365-313X.2012.05057.x.
   Walter RF, 2005, CURR ISSUES MOL BIOL, V7, P57.
   Wang J, 2010, PLOS ONE, V5, pA158, DOI 10.1371/journal.pone.0009582.
   WHO, 2012, WORLD MALARIA REPORT 2012, P1.
   Williamson DH, 2002, MOL MICROBIOL, V45, P533, DOI 10.1046/j.1365-2958.2002.03033.x.
   Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449.
   Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813.}},
Number-of-Cited-References = {{50}},
Times-Cited = {{36}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{10}},
Journal-ISO = {{Nat. Commun.}},
Doc-Delivery-Number = {{AL0SR}},
Unique-ID = {{ISI:000338837600014}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000338009600013,
Author = {Poor, Alexander E. and Ercan, Utku K. and Yost, Adam and Brooks, Ari D.
   and Joshi, Suresh G.},
Title = {{Control of Multi-Drug-Resistant Pathogens with
   Non-Thermal-Plasma-Treated Alginate Wound Dressing}},
Journal = {{SURGICAL INFECTIONS}},
Year = {{2014}},
Volume = {{15}},
Number = {{3}},
Pages = {{233-243}},
Month = {{JUN}},
Abstract = {{Background: Non-thermal dielectric-barrier discharge plasma (non-thermal
   plasma) is being investigated for use in wound healing. Alginate gel,
   already in clinical use, is non-toxic but has no meaningful
   antimicrobial property. This study reports that a
   non-thermal-plasma-treated alginate wound dressing has strong
   antimicrobial properties. Methods: Alginate gel was treated with
   non-thermal plasma in room air and inoculated with bacterial pathogens.
   At 15min after this, bacterial cell viability was determined by colony
   assay or 2,3-bis-(2-methoxy-4-
   nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay. The
   anti-biofilm efficacy of the non-thermal-plasma-treated alginate gel was
   investigated and the treated gel was tested against vascular endothelial
   cells for a cytotoxic effect. The proliferation and migration of
   bacterial cells before and after exposure to the treated gel were
   investigated with an in vitro wound testing assay. Scanning electron
   microscopy was used to observe changes in the gel surface associated
   with exposure to bacterial pathogens. The treated gel was tested against
   Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, S.
   epidermidis, Candida albicans, and C. glabrata as representative
   pathogens (at 10(6)-10(9) colony-forming units {[}CFU]/mL), and the
   thickness of a plasma-treated gel dressing and distance between a glass
   dielectric-barrier discharge plasma probe and the gel surface were kept
   constant. Results: Non-thermal-plasma-treated alginate gel exhibited a
   strong biocidal property and inactivated all of the pathogens included
   in the study at counts of 10(8) CFU/mL and within 15sec of treatment.
   The treated gel inactivated 10(9) CFU/mL of the organisms within 1min,
   and 3 min of exposure to the treated gel inactivated pathogens embedded
   in biofilms. The plasma-treated gel showed no significant cytotoxicity,
   and endothelial cells exposed to the treated gel proliferated and
   migrated well across a wound area over a period of time. Dressings made
   with the treated gel retained their biocidal effects for about a month.
   Scanning electron microscopy showed no damage to the surfaces of treated
   gels, but damage to the bacterial pathogens on plasma exposure.
   Conclusion: A non-thermal-plasma-treated alginate gel dressing has the
   clinical potential to decontaminate wounds, prevent surgical site
   infection, and promote wound healing.}},
Publisher = {{MARY ANN LIEBERT, INC}},
Address = {{140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Joshi, SG (Reprint Author), Drexel Univ, Coll Med, Dept Surg, 245 North 15th St,Suite 7150,Mail Stop 413, Philadelphia, PA 19102 USA.
   Poor, Alexander E.; Ercan, Utku K.; Yost, Adam; Brooks, Ari D.; Joshi, Suresh G., Drexel Univ, Coll Med, Dept Surg, Philadelphia, PA 19102 USA.}},
DOI = {{10.1089/sur.2013.050}},
ISSN = {{1096-2964}},
EISSN = {{1557-8674}},
Keywords-Plus = {{DIELECTRIC-BARRIER DISCHARGE; CALCIUM ALGINATE; IN-VITRO; SILVER;
   EFFICACY; BIOFILMS}},
Research-Areas = {{Infectious Diseases; Surgery}},
Web-of-Science-Categories  = {{Infectious Diseases; Surgery}},
Author-Email = {{Suresh.Joshi@drexelmed.edu}},
ResearcherID-Numbers = {{Ercan, Utku/A-1658-2012}},
ORCID-Numbers = {{Ercan, Utku/0000-0002-9762-2265}},
Funding-Acknowledgement = {{Department of Surgery of the Drexel University College of Medicine;
   government of Turkey}},
Funding-Text = {{The research reported in this paper was supported by funding from the
   Department of Surgery of the Drexel University College of Medicine. Dr.
   Alexander Poor is a resident research fellow and Utku Ercan is a PhD
   candidate at Drexel University who has a fellowship sponsored by the
   government of Turkey. The authors thank Ms. Diana Winters, Academic
   Publishing Services for critical reading of the manuscript.}},
Cited-References = {{Agren MS, 1996, BRIT J PLAST SURG, V49, P129, DOI 10.1016/S0007-1226(96)90088-0.
   ATTWOOD AI, 1989, BRIT J PLAST SURG, V42, P373, DOI 10.1016/0007-1226(89)90001-5.
   Block SS, 2001, DISINFECTION STERILI, P324.
   Caddow P, 1989, APPL MICROBIOLOGY, P17.
   Cooper M, 2010, J APPL MICROBIOL, V109, P2039, DOI 10.1111/j.1365-2672.2010.04834.x.
   Draget KI, 2000, INT J BIOL MACROMOL, V27, P117, DOI 10.1016/S0141-8130(00)00115-X.
   Faria G, 2007, J ENDODONT, V33, P715, DOI 10.1016/j.joen.2006.12.023.
   FRIDMAN A, 2008, PLASMA CHEM, P848.
   Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4.
   HOFF JC, 1986, ENVIRON HEALTH PERSP, V69, P7, DOI 10.2307/3430366.
   Ip M, 2006, J MED MICROBIOL, V55, P59, DOI 10.1099/jmm.0.46124-0.
   Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10.
   Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002.
   Lalau JD, 2002, DIABETES METAB, V28, P223.
   Lee WR, 2009, WOUND REPAIR REGEN, V17, P505, DOI 10.1111/j.1524-475X.2009.00496.x.
   Patel HA, 1993, US Patent, Patent No. {[}5,470,576, 19935470576].
   Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010.
   Percival SL, 2005, J HOSP INFECT, V60, P1, DOI 10.1016/j.jhin.2004.11.014.
   Percival SL, 2011, INT WOUND J, V8, P237, DOI 10.1111/j.1742-481X.2011.00774.x.
   Percival SL, 2010, MICROBIOLOGY OF WOUNDS, P187, DOI 10.1201/9781420079944-c6.
   PIACQUADIO D, 1992, J DERMATOL SURG ONC, V18, P992, DOI 10.1111/j.1524-4725.1992.tb02773.x.
   Rioux LE, 2007, CARBOHYD POLYM, V69, P530, DOI 10.1016/j.carbpol.2007.01.009.
   Thomas A, 2000, BIOMATERIALS, V21, P1797, DOI 10.1016/S0142-9612(00)00072-7.
   Thomas S, 2000, J Wound Care, V9, P56.
   Thomas S, 2000, J Wound Care, V9, P163.
   Thomas S, 2000, J Wound Care, V9, P115.
   Trial C, 2010, J WOUND CARE, V19, P20, DOI 10.12968/jowc.2010.19.1.46095.
   Wiegand C, 2009, WOUND REPAIR REGEN, V17, P511, DOI 10.1111/j.1524-475X.2009.00503.x.
   Wolcott RD, 2010, J WOUND CARE, V19, P45, DOI 10.12968/jowc.2010.19.2.46966.
   Wolcott RD, 2010, J WOUND CARE, V19, P2.
   ZIEGLER UE, 2003, MMW-FORTSCH  S1 0410, P19.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{10}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{14}},
Journal-ISO = {{Surg. Infect.}},
Doc-Delivery-Number = {{AJ9EI}},
Unique-ID = {{ISI:000338009600013}},
DA = {{2018-08-13}},
}

@article{ ISI:000337353100009,
Author = {Boots, A. W. and Smolinska, A. and van Berkel, J. J. B. N. and Fijten,
   R. R. R. and Stobberingh, E. E. and Boumans, M. L. L. and Moonen, E. J.
   and Wouters, E. F. M. and Dallinga, J. W. and Van Schooten, F. J.},
Title = {{Identification of microorganisms based on headspace analysis of volatile
   organic compounds by gas chromatography-mass spectrometry}},
Journal = {{JOURNAL OF BREATH RESEARCH}},
Year = {{2014}},
Volume = {{8}},
Number = {{2}},
Month = {{JUN}},
Abstract = {{The identification of specific volatile organic compounds (VOCs)
   produced by microorganisms may assist in developing a fast and accurate
   methodology for the determination of pulmonary bacterial infections in
   exhaled air. As a first step, pulmonary bacteria were cultured and their
   headspace analyzed for the total amount of excreted VOCs to select those
   compounds which are exclusively associated with specific microorganisms.
   Development of a rapid, noninvasive methodology for identification of
   bacterial species may improve diagnostics and antibiotic therapy,
   ultimately leading to controlling the antibiotic resistance problem. Two
   hundred bacterial headspace samples from four different microorganisms
   (Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and
   Klebsiella pneumoniae) were analyzed by gas chromatography-mass
   spectrometry to detect a wide array of VOCs. Statistical analysis of
   these volatiles enabled the characterization of specific VOC profiles
   indicative for each microorganism. Differences in VOC abundance between
   the bacterial types were determined using ANalysis of VAriance-principal
   component analysis (ANOVA-PCA). These differences were visualized with
   PCA. Cross validation was applied to validate the results. We identified
   a large number of different compounds in the various headspaces, thus
   demonstrating a highly significant difference in VOC occurrence of
   bacterial cultures compared to the medium and between the cultures
   themselves. Additionally, a separation between a methicillin-resistant
   and a methicillin-sensitive isolate of S. aureus could be made due to
   significant differences between compounds. ANOVA-PCA analysis showed
   that 25 VOCs were differently profiled across the various
   microorganisms, whereas a PCA score plot enabled the visualization of
   these clear differences between the bacterial types. We demonstrated
   that identification of the studied microorganisms, including an
   antibiotic susceptible and resistant S. aureus substrain, is possible
   based on a selected number of compounds measured in the headspace of
   these cultures. These in vitro results may translate into a breath
   analysis approach that has the potential to be used as a diagnostic tool
   in medical microbiology.}},
Publisher = {{IOP PUBLISHING LTD}},
Address = {{TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Boots, AW (Reprint Author), Maastricht Univ, Dept Toxicol, Maastricht, Netherlands.
   Boots, A. W.; Smolinska, A.; van Berkel, J. J. B. N.; Fijten, R. R. R.; Moonen, E. J.; Dallinga, J. W.; Van Schooten, F. J., Maastricht Univ, Dept Toxicol, Maastricht, Netherlands.
   Smolinska, A., Top Inst Food \& Nutr, Wageningen, Netherlands.
   Stobberingh, E. E.; Boumans, M. L. L., Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands.
   Wouters, E. F. M., Maastricht Univ, Med Ctr, Dept Resp Med, Maastricht, Netherlands.}},
DOI = {{10.1088/1752-7155/8/2/027106}},
Article-Number = {{027106}},
ISSN = {{1752-7155}},
EISSN = {{1752-7163}},
Keywords = {{microbial infections; exhaled volatiles; GC-tof-MS; antibiotic
   resistance}},
Keywords-Plus = {{VENTILATOR-ASSOCIATED PNEUMONIA; OBSTRUCTIVE PULMONARY-DISEASE;
   SOLID-PHASE MICROEXTRACTION; CROSS-MODEL VALIDATION;
   PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; BRONCHOALVEOLAR LAVAGE;
   RESPIRATORY PATHOGENS; STAPHYLOCOCCUS-AUREUS; EXHALED BREATH}},
Research-Areas = {{Biochemistry \& Molecular Biology; Respiratory System}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Respiratory System}},
Author-Email = {{a.boots@maastrichtuniversity.nl}},
ORCID-Numbers = {{Fijten, Rianne/0000-0002-1964-6317}},
Funding-Acknowledgement = {{province of Limburg (The Netherlands)}},
Funding-Text = {{The authors acknowledge the province of Limburg (The Netherlands) for
   the financial support and Matthew J Randall for critically reading this
   paper.}},
Cited-References = {{Afonso ASM, 2011, RESP MED, V105, P1872, DOI 10.1016/j.rmed.2011.06.012.
   Allardyce RA, 2006, DIAGN MICR INFEC DIS, V55, P255, DOI 10.1016/j.diagmicrobio.2006.01.031.
   Anderssen E, 2006, CHEMOMETR INTELL LAB, V84, P69, DOI 10.1016/j.chemolab.2006.04.021.
   Anzueto A, 2010, EUR RESPIR REV, V19, P113, DOI 10.1183/09059180.00002610.
   Armstrong DS, 1996, PEDIATR PULM, V21, P267, DOI 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.3.CO;2-G.
   Baranska A, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/3/037104.
   Bean HD, 2012, J CHROMATOGR B, V901, P41, DOI 10.1016/j.jchromb.2012.05.038.
   Bergmans D C, 1999, THESIS MAASTRICHT U.
   Bonten MJM, 2011, CLIN INFECT DIS, V52, P115, DOI 10.1093/cid/ciq075.
   Boots AW, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/2/027108.
   Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311.
   Bunge M, 2008, APPL ENVIRON MICROB, V74, P2179, DOI 10.1128/AEM.02069-07.
   Carroll W, 2005, PEDIATR PULM, V39, P452, DOI 10.1002/ppul.20170.
   Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/rccm.2105078.
   Crespo E, 2012, RAPID COMMUN MASS SP, V26, P679, DOI 10.1002/rcm.6139.
   Crespo E, 2011, J MICROBIOL METH, V86, P8, DOI 10.1016/j.mimet.2011.01.025.
   Critchley A, 2004, INT J MASS SPECTROM, V239, P235, DOI 10.1016/j.ijms.2004.08.008.
   Dallinga JW, 2010, CLIN EXP ALLERGY, V40, P68, DOI 10.1111/j.1365-2222.2009.03343.x.
   Davis Kimberly A, 2006, J Intensive Care Med, V21, P211, DOI 10.1177/0885066606288837.
   de Haan JR, 2007, BIOINFORMATICS, V23, P184, DOI 10.1093/bioinformatics/btl572.
   de Haan JR, 2009, CHEMOMETR INTELL LAB, V98, P38, DOI 10.1016/j.chemolab.2009.04.011.
   Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655.
   Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127.
   Filipiak W, 2012, MICROBIOL-SGM, V158, P3044, DOI 10.1099/mic.0.062687-0.
   Filipiak W, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-113.
   GELADI P, 1989, CHEMOMETR INTELL LAB, V5, P209, DOI 10.1016/0169-7439(89)80049-8.
   Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO.
   Gidskehaug L, 2008, CHEMOMETR INTELL LAB, V93, P1, DOI 10.1016/j.chemolab.2008.01.005.
   Joseph NM, 2010, EUR J INTERN MED, V21, P360, DOI 10.1016/j.ejim.2010.07.006.
   Junger M, 2012, APPL MICROBIOL BIOT, V93, P2603, DOI 10.1007/s00253-012-3924-4.
   Julak J, 2000, Med Sci Monit, V6, P605.
   Kiviranta H, 1998, Cent Eur J Public Health, V6, P296.
   Korpi A, 2009, CRIT REV TOXICOL, V39, P139, DOI {[}10.1080/10408440802291497 , 10.1080/10408440802291497].
   Kunze N, 2013, APPL MICROBIOL BIOT, V97, P3665, DOI 10.1007/s00253-013-4762-8.
   LABOWS JN, 1980, J CLIN MICROBIOL, V12, P521.
   Lechner M, 2006, HELICOBACTER, V11, P66, DOI 10.1111/j.0083-8703.2006.00372.x.
   Maddula S, 2009, ANAL BIOANAL CHEM, V394, P791, DOI 10.1007/s00216-009-2758-0.
   Maffei ME, 2011, NAT PROD REP, V28, P1359, DOI 10.1039/c1np00021g.
   Messika J, 2012, INTENS CARE MED, V38, P2007, DOI 10.1007/s00134-012-2699-5.
   Nicholas B, 2009, BIOCHEM SOC T, V37, P868, DOI 10.1042/BST0370868.
   Nielsen NPV, 1998, J CHROMATOGR A, V805, P17, DOI 10.1016/S0021-9673(98)00021-1.
   O'Hara M, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/2/027001.
   Park David R, 2005, Respir Care, V50, P742.
   Park DR, 2005, RESP CARE, V50, P763.
   Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759.
   Pletz MW, 2010, EUR J MED RES, V15, P507, DOI 10.1186/2047-783X-15-12-507.
   Preti G, 2009, J CHROMATOGR B, V877, P2011, DOI 10.1016/j.jchromb.2009.05.028.
   Ramirez P, 2007, SEMIN RESP CRIT CARE, V28, P525, DOI 10.1055/s-2007-991524.
   Robroeks CMHHT, 2010, PEDIATR RES, V68, P75, DOI 10.1203/00006450-201011001-00143.
   Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h.
   Scott-Thomas AJ, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-56.
   Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353.
   Smith D, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/4/044001.
   Storer MK, 2011, J MICROBIOL METH, V87, P111, DOI 10.1016/j.mimet.2011.06.012.
   Syhre M, 2008, MED MYCOL, V46, P209, DOI 10.1080/13693780701753800.
   Sykes Annemarie, 2007, Proc Am Thorac Soc, V4, P642, DOI 10.1513/pats.200707-101TH.
   Thorn RMS, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/2/024001.
   Thorn RMS, 2011, J MICROBIOL METH, V84, P258, DOI 10.1016/j.mimet.2010.12.001.
   Van Berkel J J, 2010, THESIS MAASTRICHT U.
   Van Berkel JJBN, 2008, J CHROMATOGR B, V861, P101, DOI 10.1016/j.jchromb.2007.11.008.
   Van Berkel JJBN, 2010, RESP MED, V104, P557, DOI 10.1016/j.rmed.2009.10.018.
   Walczak B., 2000, WAVELETS CHEM.
   Zakharkina T, 2011, RESPIROLOGY, V16, P932, DOI 10.1111/j.1440-1843.2011.01977.x.
   ZECHMAN JM, 1986, J CHROMATOGR, V377, P49, DOI 10.1016/S0378-4347(00)80760-4.
   Zhu H, 2013, FOOD MICROBIOL, V34, P412.
   Zhu JJ, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/1/016003.
   Zhu JJ, 2010, J CLIN MICROBIOL, V48, P4426, DOI 10.1128/JCM.00392-10.}},
Number-of-Cited-References = {{67}},
Times-Cited = {{36}},
Usage-Count-Last-180-days = {{8}},
Usage-Count-Since-2013 = {{73}},
Journal-ISO = {{J. Breath Res.}},
Doc-Delivery-Number = {{AJ0OB}},
Unique-ID = {{ISI:000337353100009}},
DA = {{2018-08-13}},
}

@article{ ISI:000336738000004,
Author = {Xu, Li-Chong and Siedlecki, Christopher A.},
Title = {{Staphylococcus epidermidis adhesion on hydrophobic and hydrophilic
   textured biomaterial surfaces}},
Journal = {{BIOMEDICAL MATERIALS}},
Year = {{2014}},
Volume = {{9}},
Number = {{3}},
Month = {{JUN}},
Abstract = {{It is of great interest to use nano-or micro-structured surfaces to
   inhibit microbial adhesion and biofilm formation and thereby to prevent
   biomaterial-associated infection, without modification of the surface
   chemistry or bulk properties of the materials and without use of the
   drugs. Our previous study showed that a submicron textured polyurethane
   surface can inhibit staphylococcal bacterial adhesion and biofilm
   formation. To further understand the effect of the geometry of textures
   on bacterial adhesion as well as the underlying mechanism, in this
   study, submicron and micron textured polyurethane surfaces featuring
   ordered arrays of pillars were fabricated and modified to have different
   wettabilities. All the textured surfaces were originally hydrophobic and
   showed significant reductions in Staphylococcus epidermidis RP62A
   adhesion in phosphate buffered saline or 25\% platelet poor plasma
   solutions under shear, as compared to smooth surfaces. After being
   subjected to an air glow discharge plasma treatment, all polyurethane
   surfaces were modified to hydrophilic, and reductions in bacterial
   adhesion on surfaces were subsequently found to be dependent on the size
   of the patterns. The submicron patterned surfaces reduced bacterial
   adhesion, while the micron patterned surfaces led to increased bacterial
   adhesion. The extracellular polymeric substances (EPS) from the S.
   epidermidis cell surfaces were extracted and purified, and were coated
   on a glass colloidal surface so that the adhesion force and separation
   energy in interactions of the EPS and the surface could be measured by
   colloidal probe atomic force microscopy. These results were consistent
   with the bacterial adhesion observations. Overall, the data suggest that
   the increased surface hydrophobicity and the decreased availability of
   the contact area contributes to a reduction in bacterial adhesion to the
   hydrophobic textured surfaces, while the availability of the contact
   area is the primary determinant factor for bacterial adhesion on
   hydrophilic textured surfaces.}},
Publisher = {{IOP PUBLISHING LTD}},
Address = {{TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Xu, LC (Reprint Author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, H151,500 Univ Dr, Hershey, PA 17033 USA.
   Xu, Li-Chong; Siedlecki, Christopher A., Penn State Univ, Inst Biomed Engn, Coll Med, Dept Surg, Hershey, PA 17033 USA.
   Siedlecki, Christopher A., Penn State Univ, Inst Biomed Engn, Coll Med, Dept Bioengn, Hershey, PA 17033 USA.}},
DOI = {{10.1088/1748-6041/9/3/035003}},
Article-Number = {{035003}},
ISSN = {{1748-6041}},
EISSN = {{1748-605X}},
Keywords = {{bacterial adhesion; textured surface; S. epidermidis; hydrophobicity;
   AFM}},
Keywords-Plus = {{CARE-ASSOCIATED INFECTIONS; BIOFILM FORMATION; BACTERIAL ADHESION;
   GLOW-DISCHARGE; POLYURETHANE BIOMATERIALS; ANTIBIOTIC-RESISTANCE;
   PLATELET-ADHESION; PROTEIN; AUREUS; ATTACHMENT}},
Research-Areas = {{Engineering; Materials Science}},
Web-of-Science-Categories  = {{Engineering, Biomedical; Materials Science, Biomaterials}},
Author-Email = {{lxx5@psu.edu}},
Funding-Acknowledgement = {{National Science Foundation {[}DMR-0804873]; Surgery Feasibility Grant
   of Penn State College of Medicine}},
Funding-Text = {{This study is financially supported from the National Science Foundation
   (DMR-0804873), Surgery Feasibility Grant of Penn State College of
   Medicine. The authors also would like to acknowledge Dr Paul Ehrlich in
   Penn State College of Medicine for help in lyophilization of EPS.}},
Cited-References = {{ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90.
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B.
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001.
   Balazs DJ, 2003, SURF INTERFACE ANAL, V35, P301, DOI 10.1002/sia.1533.
   Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096.
   Bazaka K, 2011, ACTA BIOMATER, V7, P2015, DOI 10.1016/j.actbio.2010.12.024.
   Bhushan B, 2011, PROG MATER SCI, V56, P1, DOI 10.1016/j.pmatsci.2010.04.003.
   Bhushan B, 2009, PHILOS T R SOC A, V367, P1631, DOI 10.1098/rsta.2009.0014.
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044.
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022.
   Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x.
   Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405.
   Delgado S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-82.
   Diaz C, 2007, LANGMUIR, V23, P11206, DOI 10.1021/la700650q.
   Donlan RM, 2000, ASAIO J, V46, pS47, DOI 10.1097/00002480-200011000-00037.
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226.
   Dumitrescu O, 2010, M S-MED SCI, V26, P943, DOI 10.1051/medsci/20102611943.
   Edwards KJ, 2001, CHEM GEOL, V180, P19, DOI 10.1016/S0009-2541(01)00303-5.
   Epstein AK, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494007.
   Estrela AB, 2009, CURR MED CHEM, V16, P1512, DOI 10.2174/092986709787909640.
   Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56.
   FLETCHER M, 1982, APPL ENVIRON MICROB, V44, P184.
   Francolini I, 2010, ACTA BIOMATER, V6, P3482, DOI 10.1016/j.actbio.2010.03.042.
   Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x.
   Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001.
   Guerrero G, 2009, PATHOL BIOL, V57, P36, DOI 10.1016/j.patbio.2008.07.032.
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x.
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011.
   Hussain M, 1997, INFECT IMMUN, V65, P519.
   Jabbouri S, 2010, FEMS IMMUNOL MED MIC, V59, P280, DOI 10.1111/j.1574-695X.2010.00695.x.
   Katsikogianni M, 2008, COLLOID SURFACE B, V65, P257, DOI 10.1016/j.colsurfb.2008.04.017.
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37.
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205.
   LELAH MD, 1985, J BIOMED MATER RES, V19, P1011, DOI 10.1002/jbm.820190913.
   Lelievre C, 2002, CHEM ENG SCI, V57, P1287, DOI 10.1016/S0009-2509(02)00019-2.
   Ma HY, 2013, APPL MICROBIOL BIOT, V97, P317, DOI 10.1007/s00253-012-4179-9.
   Magin CM, 2010, MATER TODAY, V13, P36, DOI 10.1016/S1369-7021(10)70058-4.
   Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001.
   Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08.
   Milner KR, 2006, J BIOMED MATER RES A, V76A, P561, DOI 10.1002/jbm.a.30554.
   O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08.
   Pavithra D, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034003.
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081.
   Quere D, 2002, NAT MATER, V1, P14, DOI 10.1038/nmat715.
   Rabbi M, 2008, SINGLE MOL TECHNIQUE, P371.
   Rothstein JP, 2010, ANNU REV FLUID MECH, V42, P89, DOI 10.1146/annurev-fluid-121108-145558.
   Ruiz-Cabello FJM, 2011, LANGMUIR, V27, P9638, DOI 10.1021/la201248z.
   Rupp ME, 1999, INFECT IMMUN, V67, P2627.
   Sanchis MR, 2007, J APPL POLYM SCI, V105, P1077, DOI 10.1002/app.26250.
   Sartori S, 2008, REACT FUNCT POLYM, V68, P809, DOI 10.1016/j.reactfunctpolym.2007.12.002.
   Scardino AJ, 2009, BIOFOULING, V25, P757, DOI 10.1080/08927010903165936.
   Scardino AJ, 2009, BIOFOULING, V25, P83, DOI 10.1080/08927010802538480.
   Scardino AJ, 2011, BIOFOULING, V27, P73, DOI 10.1080/08927014.2010.536837.
   Schumacher JF, 2008, LANGMUIR, V24, P4931, DOI 10.1021/la703421v.
   Schumacher JF, 2007, BIOFOULING, V23, P55, DOI 10.1080/08927010601136957.
   Sousa C, 2009, J ADHES SCI TECHNOL, V23, P1657, DOI 10.1163/156856109X452710.
   Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196.
   Tang HY, 2009, J BIOMED MATER RES A, V88A, P454, DOI 10.1002/jbm.a.31788.
   Tang PF, 2011, J NANOMATER, DOI 10.1155/2011/178921.
   Trujillo NA, 2012, MAT SCI ENG C-MATER, V32, P2135, DOI 10.1016/j.msec.2012.05.012.
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F.
   Vadillo-Rodriguez V, 2006, ENVIRON SCI TECHNOL, V40, P2983, DOI 10.1021/es052365v.
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408.
   Wenzel RP, 2007, CLIN INFECT DIS, V45, P85, DOI 10.1086/518136.
   Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487.
   Whitehead KA, 2006, FOOD BIOPROD PROCESS, V84, P253, DOI 10.1205/fbp06035.
   Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.10.010.
   Xu LC, 2005, ENVIRON SCI TECHNOL, V39, P3592, DOI 10.1021/es048377i.
   Xu LC, 2007, J BIOMAT SCI-POLYM E, V18, P353, DOI 10.1163/156856207780425013.
   Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009.
   Xu LC, 2010, ACTA BIOMATER, V6, P1938, DOI 10.1016/j.actbio.2009.11.031.
   Xu LC, 2010, J BIOMED MATER RES A, V92A, P126, DOI 10.1002/jbm.a.32340.
   Xu LC, 2009, LANGMUIR, V25, P3675, DOI 10.1021/la803258h.
   Yoshimitsu Z, 2002, LANGMUIR, V18, P5818, DOI 10.1021/la020088p.
   Zhang L, 2011, INT J ANTIMICROB AG, V38, P9, DOI 10.1016/j.ijantimicag.2011.01.020.}},
Number-of-Cited-References = {{75}},
Times-Cited = {{17}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{71}},
Journal-ISO = {{Biomed. Mater.}},
Doc-Delivery-Number = {{AI3DA}},
Unique-ID = {{ISI:000336738000004}},
DA = {{2018-08-13}},
}

@article{ ISI:000335970000008,
Author = {Ziolkowska, Grazyna and Tokarzewski, Stanislaw and Nowakiewicz, Aneta},
Title = {{Drug resistance of Aspergillus fumigatus strains isolated from flocks of
   domestic geese in Poland}},
Journal = {{POULTRY SCIENCE}},
Year = {{2014}},
Volume = {{93}},
Number = {{5}},
Pages = {{1106-1112}},
Month = {{MAY}},
Abstract = {{The aim of the study was to determine the in vitro susceptibility of 85
   Aspergillus fumigatus strains isolated from domestic geese and from
   their environment to amphotericin B, clotrimazole, voriconazole,
   itraconazole, enilconazole, miconazole, ketoconazole, and tioconazole.
   Samples were collected from clinically healthy birds (oral cavity) and
   from birds with aspergillosis (lungs and air sacs). The study was
   carried out using the disk diffusion method according to the Clinical
   Laboratory and Standards Institute (CLSI) M44-A2 procedure in parallel
   with the microdilution broth method according to CLSI M38-A2. The disk
   diffusion method showed that the all of the strains, irrespective of
   source, were resistant to miconazole. Resistance to the remaining azoles
   and amphotericin B ranged from 90.6 to 70.6\%. Complete susceptibility
   was noted for voriconazole and enilconazole. Determination of the
   minimum inhibitory concentration (MIC) confirmed the high resistance of
   the strains tested to clotrimazole (MIC90 = 16 mu g.mL(-1)),
   amphotericin B (MIC90 = 16 mu g.mL(-1)), varied susceptibility to
   itraconazole (MIC 0.5-8 mu g.mL(-1)), and 100\% susceptibility to
   enilconazole and voriconazole. A correlation was noted between the
   susceptibility of the strains and their source. The highest percentage
   of resistant strains was noted in isolates from the lungs (100\% for
   amphotericin B and clotrimazole and 35.7\% for itraconazole). To the
   best of our knowledge, this is the first monitoring conducted in Poland
   in this area of research.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Nowakiewicz, A (Reprint Author), Univ Life Sci, Fac Vet Med, Inst Biol Bases Anim Dis, Sub Dept Vet Microbiol, Akad 12, PL-20033 Lublin, Poland.
   Ziolkowska, Grazyna; Tokarzewski, Stanislaw; Nowakiewicz, Aneta, Univ Life Sci, Fac Vet Med, Inst Biol Bases Anim Dis, Sub Dept Vet Microbiol, PL-20033 Lublin, Poland.}},
DOI = {{10.3382/ps.2013-03702}},
ISSN = {{0032-5791}},
EISSN = {{1525-3171}},
Keywords = {{aspergillosis; Aspergillus fumigatus; domestic geese; resistance}},
Keywords-Plus = {{IN-VITRO ACTIVITIES; AMPHOTERICIN-B; FILAMENTOUS FUNGI; AZOLE
   RESISTANCE; WILD-TYPE; ITRACONAZOLE; VORICONAZOLE; SUSCEPTIBILITY;
   POSACONAZOLE; SPP.}},
Research-Areas = {{Agriculture}},
Web-of-Science-Categories  = {{Agriculture, Dairy \& Animal Science}},
Author-Email = {{anowakiewicz@gmail.com}},
ORCID-Numbers = {{Nowakiewicz, Aneta/0000-0003-3961-5291}},
Cited-References = {{Arikan S, 2008, MED MYCOL, V46, P567, DOI 10.1080/13693780801975576.
   Balajee SA, 2006, EUKARYOT CELL, V5, P1705, DOI 10.1128/EC.00162-06.
   Beernaert LA, 2010, AVIAN PATHOL, V39, P325, DOI 10.1080/03079457.2010.506210.
   Beernaert LA, 2009, ANTIMICROB AGENTS CH, V53, P2199, DOI 10.1128/AAC.01492-08.
   BRAEM G, 1986, Israel Journal of Veterinary Medicine, V42, P108.
   Clinical and Laboratory Standards Institute, 2009, M44A2 CLSI.
   Clinical and Laboratory Standards Institute. CLSI, 2008, M38A2 CLSI.
   de Hoog GS, 2000, ATLAS CLIN FUNGI CEN.
   Espinel-Ingroff A, 2007, J CLIN MICROBIOL, V45, P1811, DOI 10.1128/JCM.00134-07.
   Espinel-Ingroff A, 2010, J CLIN MICROBIOL, V48, P3251, DOI 10.1128/JCM.00536-10.
   Espinel-Ingroff A, 2008, J ANTIMICROB CHEMOTH, V61, P616, DOI 10.1093/jac/dkm518.
   Guinea J, 2005, ANTIMICROB AGENTS CH, V49, P3495, DOI 10.1128/AAC.49.8.3495-3497.2005.
   Hof H, 2001, ANTIMICROB AGENTS CH, V45, P2987, DOI 10.1128/AAC.45.11.2987-2990.2001.
   Howard S. J., 2011, MED MYCOL, V49, P90, DOI DOI 10.3109/13693786.2010.50846.
   Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043.
   Kirchgessner M, 2008, J EXOT PET MED, V17, P54, DOI 10.1053/j.jepm.2007.12.010.
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x.
   Mortensen KL, 2010, ANTIMICROB AGENTS CH, V54, P4545, DOI 10.1128/AAC.00692-10.
   Mosquera J, 2002, ANTIMICROB AGENTS CH, V46, P556, DOI 10.1128/AAC.46.2.556-557.2002.
   Orosz SE, 2000, SEMIN AVIAN EXOT PET, V9, P59, DOI 10.1053/AX.2000.4618.
   Pfaller MA, 2002, ANTIMICROB AGENTS CH, V46, P1032, DOI 10.1128/AAC.46.4.1032-1037.2002.
   Pfaller MA., 2012, AM J MED, V125, P3.
   REDIG PT, 1985, AVIAN DIS, V29, P649, DOI 10.2307/1590656.
   Redmann T., 1989, DTSCH TIERARZTLICHE, V95, P15.
   Rochette F, 2003, J VET PHARMACOL THER, V26, P31, DOI 10.1046/j.1365-2885.2003.00457.x.
   Silvanose CD, 2006, VET REC, V159, P282, DOI 10.1136/vr.159.9.282.
   Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219.
   Tashiro M, 2012, ANTIMICROB AGENTS CH, V56, P4870, DOI 10.1128/AAC.00514-12.
   Van Waeyenberghe L, 2011, AVIAN PATHOL, V40, P73, DOI 10.1080/03079457.2010.540229.
   Verweij PE, 2009, DRUG RESIST UPDATE, V12, P141, DOI 10.1016/j.drup.2009.09.002.
   Verweij PE, 2002, J CLIN MICROBIOL, V40, P2648, DOI 10.1128/JCM.40.7.2648-2650.2002.
   Xiao L, 2004, ANTIMICROB AGENTS CH, V48, P568, DOI 10.1128/AAC.48.2.568-574.2004.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{Poult. Sci.}},
Doc-Delivery-Number = {{AH2RY}},
Unique-ID = {{ISI:000335970000008}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000334433700033,
Author = {Wei, Ting and Ishida, Ryuichi and Miyanaga, Kazuhiko and Tanji, Yasunori},
Title = {{Seasonal variations in bacterial communities and antibiotic-resistant
   strains associated with green bottle flies (Diptera: Calliphoridae)}},
Journal = {{APPLIED MICROBIOLOGY AND BIOTECHNOLOGY}},
Year = {{2014}},
Volume = {{98}},
Number = {{9}},
Pages = {{4197-4208}},
Month = {{MAY}},
Abstract = {{Green bottle flies occur frequently around human environments in Japan.
   Many species of green bottle flies have been studied with regard to
   their importance in forensic examinations or clinical therapies, but the
   bacterial communities associated with this group of flies have not been
   comprehensively investigated. In this research, 454 pyrosequencing was
   used to reveal the bacterial communities in green bottle flies collected
   in different seasons. Meanwhile, the bacteria were screened with
   selective media and tested for antibiotic susceptibility. Samples
   collected in three different seasons harbored distinctive bacterial
   communities. The predominant genera associated with green bottles flies
   were Staphylococcus in spring, Ignatzschineria in summer, and
   Vagococcus, Dysgonomonas, and an unclassified Acetobacteraceae in
   autumn. An upward trend in bacterial community diversity was observed
   from spring to autumn. Changes in climatic conditions could be the cause
   of these seasonal variations in fly-associated bacterial communities.
   The species of isolated antibiotic-resistant bacteria also differed
   across seasons, but it was difficult to correlate seasonal changes in
   antibiotic-resistant bacteria with changes in whole communities. A
   number of multiple-antibiotic-resistant bacteria were isolated, and some
   of these strains were closely affiliated with pathogens such as
   Enterococcus faecalis and Enterococcus faecium, which could cause
   serious threats to public health. Overall, this research provided us
   with information about the composition and seasonality of bacterial
   communities in green bottle flies, and highlighted the risks of
   fly-mediated dissemination of antibiotic-resistant pathogens.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Tanji, Y (Reprint Author), Tokyo Inst Technol, Dept Bioengn, Midori Ku, 4259 J2-15 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.
   Wei, Ting; Ishida, Ryuichi; Miyanaga, Kazuhiko; Tanji, Yasunori, Tokyo Inst Technol, Dept Bioengn, Midori Ku, Yokohama, Kanagawa 2268501, Japan.}},
DOI = {{10.1007/s00253-013-5498-1}},
ISSN = {{0175-7598}},
EISSN = {{1432-0614}},
Keywords = {{Green bottle fly; Bacterial community; 454 pyrosequencing; Multidrug
   resistance}},
Keywords-Plus = {{SP-NOV.; MICROBIAL COMMUNITIES; DIVERSITY MEASURES; AIRBORNE BACTERIA;
   MUSCA-DOMESTICA; GUT; SARCOPHAGIDAE; ENVIRONMENTS; WOLBACHIA; SEQUENCES}},
Research-Areas = {{Biotechnology \& Applied Microbiology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology}},
Author-Email = {{ytanji@bio.titech.ac.jp}},
ResearcherID-Numbers = {{Tanji, Yasunori/C-9329-2015
   Miyanaga, Kazuhiko/B-9809-2015
   Wei, Ting/I-4380-2017}},
ORCID-Numbers = {{Tanji, Yasunori/0000-0003-2134-7276
   Miyanaga, Kazuhiko/0000-0002-3483-9491
   Wei, Ting/0000-0003-2926-5849}},
Funding-Acknowledgement = {{Ministry of Education, Culture, Sports, Science and Technology of Japan
   {[}25670210]}},
Funding-Text = {{This study was supported in part by a grant (25670210) from the Ministry
   of Education, Culture, Sports, Science and Technology of Japan.}},
Cited-References = {{Ahmad A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-23.
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389.
   Amendt J, 2004, NATURWISSENSCHAFTEN, V91, P51, DOI 10.1007/s00114-003-0493-5.
   Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl\_1.5.
   Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x.
   Behar A, 2008, ISR J ECOL EVOL, V54, P181, DOI 10.1080/15659801.2008.10639612.
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303.
   Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272.
   CHAO A, 1984, SCAND J STAT, V11, P265.
   Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006.
   Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038.
   Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06.
   De Luna CJ, 2009, EXP APPL ACAROL, V48, P105, DOI 10.1007/s10493-008-9230-2.
   Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416.
   Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x.
   Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-125.
   Dybwad M, 2012, APPL ENVIRON MICROB, V78, P1917, DOI 10.1128/AEM.07212-11.
   Forster M, 2007, PARASITOL RES, V101, P243, DOI 10.1007/s00436-007-0522-y.
   Graczyk TK, 2001, MICROBES INFECT, V3, P231, DOI 10.1016/S1286-4579(01)01371-5.
   Graham JP, 2009, SCI TOTAL ENVIRON, V407, P2701, DOI 10.1016/j.scitotenv.2008.11.056.
   Gupta AK, 2012, FEMS MICROBIOL ECOL, V79, P581, DOI 10.1111/j.1574-6941.2011.01248.x.
   Gupta AK, 2011, INT J SYST EVOL MICR, V61, P1360, DOI 10.1099/ijs.0.018622-0.
   Hayes JR, 2004, APPL ENVIRON MICROB, V70, P6005, DOI 10.1128/AEM.70.10.6005-6011.2004.
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418.
   Higashiguchi D. T., 2005, P 5 INT C URB PESTS, P189.
   Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1016/S0168-6496(02)00449-X.
   Hofstad T, 2000, INT J SYST EVOL MICR, V50, P2189, DOI 10.1099/00207713-50-6-2189.
   Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007.
   Juteau P, 2004, APPL MICROBIOL BIOT, V66, P115, DOI 10.1007/s00253-004-1692-5.
   Kaltenpoth M, 2009, TRENDS MICROBIOL, V17, P529, DOI 10.1016/j.tim.2009.09.006.
   Kautz S, 2013, APPL ENVIRON MICROB, V79, P525, DOI 10.1128/AEM.03107-12.
   Lawson PA, 2002, SYST APPL MICROBIOL, V25, P194, DOI 10.1078/0723-2020-00107.
   Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005.
   Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06.
   Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x.
   Rahuma N, 2005, ANN TROP MED PARASIT, V99, P795, DOI 10.1179/136485905X65134.
   Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759.
   Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56.
   Schloss PD, 2006, ENVIRON ENTOMOL, V35, P625, DOI 10.1603/0046-225X-35.3.625.
   Seino K, 2005, ATMOS ENVIRON, V39, P337, DOI 10.1016/j.atmosenv.2004.09.030.
   Toth E, 2001, INT J SYST EVOL MICR, V51, P401, DOI 10.1099/00207713-51-2-401.
   TOWNSEND M. T., 1928, ANN ENT SOC AMER, V21, P121.
   Unno T, 2010, SCI TOTAL ENVIRON, V408, P3499, DOI 10.1016/j.scitotenv.2010.04.046.
   Wei T, 2013, APPL MICROBIOL BIOT, V97, P1775, DOI 10.1007/s00253-012-4024-1.
   Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587.
   Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07.
   Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x.
   Zheng LY, 2013, J MED ENTOMOL, V50, P647, DOI 10.1603/ME12199.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{14}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{25}},
Journal-ISO = {{Appl. Microbiol. Biotechnol.}},
Doc-Delivery-Number = {{AF0VX}},
Unique-ID = {{ISI:000334433700033}},
DA = {{2018-08-13}},
}

@article{ ISI:000334113400004,
Author = {Ali, S. A. and Hasan, K. A. and Bin Asif, H. and Abbasi, A.},
Title = {{Environmental enterococci: I. Prevalence of virulence, antibiotic
   resistance and species distribution in poultry and its related
   environment in Karachi, Pakistan}},
Journal = {{LETTERS IN APPLIED MICROBIOLOGY}},
Year = {{2014}},
Volume = {{58}},
Number = {{5}},
Pages = {{423-432}},
Month = {{MAY}},
Abstract = {{Enterococci are well-established causative agents of a number of
   diseases in humans and animals alike. A total of 1047 isolates (838
   presumptive enterococci and 209 non-enterococci), related to poultry
   environment (faeces/manure, feed, water and air), were evaluated for
   species diversity, virulence potential, antibiotic resistance and
   associated threats. Multiplex PCR of 204 presumptive enterococci using
   genus (16s rDNA)- and species-specific (superoxide dismutase) primer set
   leads to identification of six Enterococcus spp., i.e. Ent.faecium,
   Ent.faecalis, Ent.mundtti, Ent.hirae, Ent.gallinarum and
   Ent.casseliflavus. BOX-PCR analysis of the representative strains
   confirmed inter-strain variation among species. Although enterococci
   generally appear to be catalase negative, Ent.faecalis from some faecal,
   water and air samples showed catalase production. In vitro assays
   identified poultry environment as a reservoir of MVD and MAR enterococci
   and non-enterococci. In addition to vancomycin, high-level-ampicillin-,
   clarithromycin-, erythromycin-, kanamycin- and gentamicin-resistant
   enterococci and non-enterococci are also indicated. Our results show
   that virulence potential and resistance vary with the source of
   isolation. Our studies on MAR and MVD enterococci in environment,
   especially in air and water, clearly indicate the need for a serious
   commitment to deal with pathogenic enterococci associated with poultry
   for preventing transmission of infectious agent to humans.
   Significance and Impact of the Study
   This study demonstrates that poultry environment of Karachi city
   harbours a diverse reservoir of Enterococcus spp. with multiple
   antibiotic resistance and virulence determinants. It is expected that
   the results will help in assessing the impact of multiple antibiotic
   resistance and virulent enterococci on public health, improvement of
   farm management practices and preventing their dissemination. Our
   findings strongly suggest the need for reducing antibiotic usage during
   poultry production, particularly those that are being used to treat
   human infections.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ali, SA (Reprint Author), Univ Karachi, HEJ Res Inst Chem, Int Ctr Chem \& Biol Sci ICCBS, Karachi 75270, Pakistan.
   Ali, S. A.; Hasan, K. A.; Bin Asif, H.; Abbasi, A., Univ Karachi, HEJ Res Inst Chem, Int Ctr Chem \& Biol Sci ICCBS, Karachi 75270, Pakistan.}},
DOI = {{10.1111/lam.12208}},
ISSN = {{0266-8254}},
EISSN = {{1472-765X}},
Keywords = {{environmental indicator organism; multiple virulence determinants;
   multiple antibiotic resistance; enterococci; multiplex PCR; Box-PCR}},
Keywords-Plus = {{ANTIMICROBIAL RESISTANCE; VANCOMYCIN-RESISTANT; FECAL ENTEROCOCCI;
   BROILER; IDENTIFICATION; CHICKENS; CECORUM; SPP.; PCR; GELATINASE}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Microbiology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Microbiology}},
Author-Email = {{dr.syedabidali@gmail.com}},
Funding-Acknowledgement = {{Higher Education Commission (HEC), Islamabad, Pakistan {[}20-1339/RD/09]}},
Funding-Text = {{This project was financially supported by Higher Education Commission
   (HEC), Islamabad, Pakistan, to SA Ali (HEC No. 20-1339/R\&D/09).}},
Cited-References = {{Baele M, 2000, J CLIN MICROBIOL, V38, P4201.
   Berrang M. E., 1995, Journal of Applied Poultry Research, V4, P83.
   Bridier A, 2010, J MICROBIOL METH, V82, P64, DOI 10.1016/j.mimet.2010.04.006.
   Champagne J, 2011, APPL ENVIRON MICROB, V77, P2625, DOI 10.1128/AEM.00263-11.
   Chan YY, 2008, INT J FOOD MICROBIOL, V122, P221, DOI 10.1016/j.ijfoodmicro.2007.11.063.
   CLYNE M, 1988, J CLIN MICROBIOL, V26, P535.
   De Baere T, 2000, J CLIN MICROBIOL, V38, P3511.
   De Niederhausern S, 2013, J ENVIRON SCI HEAL A, V48, P939, DOI 10.1080/10934529.2013.762739.
   del Campo R, 2001, ANTIMICROB AGENTS CH, V45, P905, DOI 10.1128/AAC.45.3.905-912.2001.
   DEVRIESE LA, 1995, INT J FOOD MICROBIOL, V26, P187, DOI 10.1016/0168-1605(94)00119-Q.
   Diarra MS, 2010, APPL ENVIRON MICROB, V76, P8033, DOI 10.1128/AEM.01545-10.
   Expert Panel on Antibiotic Resistance, 2005, REV IMP US ANT AN PL.
   Frankenberg L, 2002, J BACTERIOL, V184, P6351, DOI 10.1128/JB.184.22.6351-6356.2002.
   Furtula V, 2013, INT J ENV RES PUB HE, V10, P1020, DOI 10.3390/ijerph10031020.
   Giard JC, 2001, ELECTROPHORESIS, V22, P2947, DOI 10.1002/1522-2683(200108)22:14<2947::AID-ELPS2947>3.3.CO;2-B.
   Gilmore MS, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P301.
   Greub G, 1997, EUR J CLIN MICROBIOL, V16, P594, DOI 10.1007/BF02447923.
   Jackson CR, 2012, MICROB ECOL, V64, P378, DOI 10.1007/s00248-012-0027-9.
   Jackson CR, 2004, J CLIN MICROBIOL, V42, P3558, DOI 10.1128/JCM.42.8.3558-3565.2004.
   Jackson CR, 2006, AVIAN DIS, V50, P115, DOI 10.1637/7367-041305R.1.
   Kak V, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P355.
   Kakinuma Y, 1998, MICROBIOL MOL BIOL R, V62, P1021.
   Kapoor L, 2005, JPN J INFECT DIS, V58, P101.
   Kaszanyitzky EJ, 2007, INT J FOOD MICROBIOL, V115, P119, DOI 10.1016/j.ijfoodmicro.2006.10.004.
   da Costa PMM, 2006, J ENVIRON SCI HEAL B, V41, P1393, DOI 10.1080/03601230600964258.
   Moraes PM, 2012, J APPL MICROBIOL, V113, P318, DOI 10.1111/j.1365-2672.2012.05341.x.
   Moreno MRF, 2006, INT J FOOD MICROBIOL, V106, P1, DOI 10.1016/j.ijfoodmicro.2005.06.026.
   MUNDT JO, 1968, J BACTERIOL, V95, P2005.
   {*}NAT COMM CLIN LAB, 1997, SC21LM7A4 NCCLS.
   Oliveira M, 2010, POULTRY SCI, V89, P1065, DOI 10.3382/ps.2008-00436.
   Poeta P, 2006, INT J ANTIMICROB AG, V27, P131, DOI 10.1016/j.ijantimicag.2005.09.018.
   Poeta P, 2006, J VET MED B, V53, P203, DOI 10.1111/j.1439-0450.2006.00941.x.
   Poulsen LL, 2012, EMERG INFECT DIS, V18, P1096, DOI 10.3201/eid1807.111754.
   Sapkota AR, 2011, ENVIRON HEALTH PERSP, V119, P1622, DOI 10.1289/ehp.1003350.
   Stalker MJ, 2010, J VET DIAGN INVEST, V22, P643, DOI 10.1177/104063871002200426.
   Tyne D. V., 2013, TOXINS, V5, P895.
   Upadhyaya GPM, 2010, J LAB PHYS, V2, P100.
   Velkers FC, 2011, VET QUART, V31, P3, DOI 10.1080/01652176.2011.570107.
   WHALEY DN, 1982, J CLIN MICROBIOL, V16, P224.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{11}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{40}},
Journal-ISO = {{Lett. Appl. Microbiol.}},
Doc-Delivery-Number = {{AE6OM}},
Unique-ID = {{ISI:000334113400004}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000338875900057,
Author = {Schildgen, Verena and Mai, Stephanie and Khalfaoui, Soumaya and
   Luesebrink, Jessica and Pieper, Monika and Tillmann, Ramona L. and
   Brockmann, Michael and Schildgen, Oliver},
Title = {{Pneumocystis jirovecii Can Be Productively Cultured in Differentiated
   CuFi-8 Airway Cells}},
Journal = {{MBIO}},
Year = {{2014}},
Volume = {{5}},
Number = {{3}},
Month = {{MAY-JUN}},
Abstract = {{Although Pneumocystis jirovecii is a well-known and serious pathogen,
   all previous attempts to isolate, cultivate, and propagate this fungus
   have failed. This serious challenge in microbiology was addressed in the
   present study. We examined whether P. jirovecii could be cultured in a
   permanent three-dimensional air-liquid interface culture system formed
   by CuFi-8 cells, a differentiated pseudostratified airway epithelial
   cell line. Cultured pseudostratified cells were inoculated with
   bronchoalveolar fluid that had been confirmed to be positive for P.
   jirovecii using PCR. Five days later, the cells and basal medium were
   harvested and tested for P. jirovecii using quantitative PCR (qPCR),
   commercially available immunofluorescence detection assays, and Grocott
   staining of formalin-fixed, paraffin-embedded thin sections of
   infected-cell cultures. We successfully productively cultivated and
   propagated P. jirovecii from these P. jirovecii-positive bronchoalveolar
   lavage fluid (BALF) samples. Furthermore, we provide evidence that P.
   jirovecii induced cytopathic effects on lung epithelial cells and was
   even invasive in cell culture. To the best of our knowledge, the cell
   culture system developed herein represents the first methodology to
   enable molecular analyses of this pathogen's life cycle and further in
   vitro studies of P. jirovecii, such as assessments of drug sensitivity
   and resistance as well as investigations of the pathogen's stability
   against environmental factors and disinfectants.
   IMPORTANCE This is the first report of the successful productive
   cultivation and propagation of Pneumocystis jirovecii, a
   human-pathogenic fungus of major clinical significance. These findings
   are groundbreaking because they will influence the field of diagnostic
   microbiology, facilitate the testing of antibiotics against P.
   jirovecii, and enable stability studies of this pathogen when exposed to
   the environmental factors and chemicals that hospitals are required to
   use for disinfection. Because productively culturing P. jirovecii has
   been attempted unsuccessfully for several decades, this study represents
   a breakthrough in this field.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Schildgen, O (Reprint Author), Klinikum Privaten Univ Witten Herdecke Sitz Koln, Kliniken Stadt Koln gGmbH, Inst Pathol, Cologne, Germany.
   Schildgen, Verena; Mai, Stephanie; Khalfaoui, Soumaya; Luesebrink, Jessica; Pieper, Monika; Tillmann, Ramona L.; Brockmann, Michael; Schildgen, Oliver, Klinikum Privaten Univ Witten Herdecke Sitz Koln, Kliniken Stadt Koln gGmbH, Inst Pathol, Cologne, Germany.}},
DOI = {{10.1128/mBio.01186-14}},
Article-Number = {{e01186-14}},
ISSN = {{2150-7511}},
Keywords-Plus = {{OBSTRUCTIVE PULMONARY-DISEASE; CARINII; AUTOFLUORESCENCE; COLONIZATION;
   COLLAGEN; PATHOGENESIS; PROPAGATION; INFECTION; DNA}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{schildgeno@kliniken-koeln.de}},
ResearcherID-Numbers = {{Schildgen, Oliver/D-5327-2014}},
ORCID-Numbers = {{Schildgen, Oliver/0000-0003-4297-9627}},
Funding-Acknowledgement = {{Else Kroner-Fresenius Stiftung, Germany {[}2013\_A100]; Beatrix-Lichtken
   Stiftung (Cologne, Germany); Private University of Witten/Herdecke,
   Germany {[}11630]}},
Funding-Text = {{This work was supported by grants from the Else Kroner-Fresenius
   Stiftung, Germany (project 2013\_A100), a grant from the
   Beatrix-Lichtken Stiftung (Cologne, Germany), and an internal grant from
   the Private University of Witten/Herdecke, Germany (project 11630).}},
Cited-References = {{Banerjee B, 1999, J INVEST MED, V47, P326.
   BARTLETT MS, 1979, J CLIN MICROBIOL, V10, P796.
   BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991.
   Botterel F, 2012, J CLIN MICROBIOL, V50, P227, DOI 10.1128/JCM.06036-11.
   Carinii A., 1910, COMMUN SOC MED SAO P, V16, P204.
   Chabe M, 2011, FEMS YEAST RES, V11, P2, DOI 10.1111/j.1567-1364.2010.00698.x.
   Chagas C., 1909, Memorias do Instituto Oswaldo Cruz, V1.
   Cisse OH, 2013, MBIO, V4, DOI 10.1128/mBio.00428-12.
   CUSHION MT, 1985, EXP PARASITOL, V60, P43, DOI 10.1016/S0014-4894(85)80021-7.
   Delanoe P, 1912, CR HEBD ACAD SCI, V155, P658.
   Deng XF, 2014, J VIROL METHODS, V195, P112, DOI 10.1016/j.jviromet.2013.10.012.
   DVORAK J, 1952, Pediatr Listy, V7, P264.
   Egelandsdal B, 2005, MEAT SCI, V69, P35, DOI 10.1016/j.meatsci.2004.06.004.
   Gill EM, 2003, PHOTOCHEM PHOTOBIOL, V77, P653, DOI 10.1562/0031-8655(2003)077<0653:RBCAOT>2.0.CO;2.
   Hauser PM, 2010, CLIN INFECT DIS, V51, pE28, DOI 10.1086/655145.
   Huang QF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002899.
   JIROVEC O, 1954, Monatsschr Kinderheilkd, V102, P476.
   Kling HM, 2010, INFECT IMMUN, V78, P4320, DOI 10.1128/IAI.00507-10.
   Morris A, 2008, COPD, V5, P43, DOI 10.1080/15412550701817656.
   Morris A, 2008, CLIN INFECT DIS, V47, pE64, DOI 10.1086/591701.
   Morris A, 2012, CLIN MICROBIOL REV, V25, P297, DOI 10.1128/CMR.00013-12.
   Norris KA, 2011, IMMUNOL RES, V50, P175, DOI 10.1007/s12026-011-8218-x.
   PIFER LL, 1978, INFECT IMMUN, V20, P66.
   PIFER LL, 1977, PEDIATR RES, V11, P305, DOI 10.1203/00006450-197704000-00010.
   PINTOZZI RL, 1978, J CLIN PATHOL, V31, P803, DOI 10.1136/jcp.31.8.803.
   Ponce CA, 2010, CLIN INFECT DIS, V50, P347, DOI 10.1086/649868.
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1.
   Stringer JR, 2002, EMERG INFECT DIS, V8, P891, DOI 10.3201/eid0809.020096.
   Thomas CF, 2007, NAT REV MICROBIOL, V5, P298, DOI 10.1038/nrmicro1621.
   Vanek J., 1951, Casopis Lekaru Ceskych Prague, V90, P1121.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{21}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{mBio}},
Doc-Delivery-Number = {{AL1HH}},
Unique-ID = {{ISI:000338875900057}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000332942800018,
Author = {Li, Zhou and Tang, Haoying and Yuan, Weiwei and Song, Wei and Niu,
   Yongshan and Yan, Ling and Yu, Min and Dai, Ming and Feng, Siyu and
   Wang, Menghang and Liu, Tengjiao and Jiang, Peng and Fan, Yubo and Wang,
   Zhong Lin},
Title = {{Ag nanoparticle-ZnO nanowire hybrid nanostructures as enhanced and
   robust antimicrobial textiles via a green chemical approach}},
Journal = {{NANOTECHNOLOGY}},
Year = {{2014}},
Volume = {{25}},
Number = {{14}},
Month = {{APR 11}},
Abstract = {{A new approach for fabrication of a long-term and recoverable
   antimicrobial nanostructure/textile hybrid without increasing the
   antimicrobial resistance is demonstrated. Using in situ synthesized Ag
   nanoparticles (NPs) anchored on ZnO nanowires (NWs) grown on textiles by
   a ` dip-in and light-irradiation' green chemical method, we obtained
   ZnONW@ AgNP nanocomposites with small-size and uniform Ag NPs, which
   have shown superior performance for antibacterial applications. These
   new Ag/ZnO/textile antimicrobial composites can be used for wound
   dressings and medical textiles for topical and prophylactic
   antibacterial treatments, point-of-use water treatment to improve the
   cleanliness of water and antimicrobial air filters to prevent
   bioaerosols accumulating in ventilation, heating, and air-conditioning
   systems.}},
Publisher = {{IOP PUBLISHING LTD}},
Address = {{TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Li, Z (Reprint Author), Beihang Univ, Sch Biol Sci \& Med Engn, Minist Educ, Key Lab Biomech \& Mechanobiol, Beijing 100191, Peoples R China.
   Li, Zhou; Yuan, Weiwei; Song, Wei; Niu, Yongshan; Yan, Ling; Yu, Min; Dai, Ming; Feng, Siyu; Wang, Menghang; Fan, Yubo, Beihang Univ, Sch Biol Sci \& Med Engn, Minist Educ, Key Lab Biomech \& Mechanobiol, Beijing 100191, Peoples R China.
   Tang, Haoying; Liu, Tengjiao; Jiang, Peng, Natl Ctr Nanosci \& Technol, Beijing 100191, Peoples R China.
   Wang, Zhong Lin, Georgia Inst Technol, Sch Mat Sci \& Engn, Atlanta, GA 30332 USA.
   Song, Wei; Wang, Zhong Lin, Chinese Acad Sci, Beijing Inst Nanoenergy \& Nanosyst, Beijing 100083, Peoples R China.}},
DOI = {{10.1088/0957-4484/25/14/145702}},
Article-Number = {{145702}},
ISSN = {{0957-4484}},
EISSN = {{1361-6528}},
Keywords = {{silver nanoparticles; ZnO nanowires; antibacterial activity;
   biocompatibility; antibacterial textiles}},
Keywords-Plus = {{PLASMID DNA DELIVERY; SILVER NANOPARTICLES; ESCHERICHIA-COLI; BACTERIA;
   NANOBELTS; NITRATE; MODEL; IONS}},
Research-Areas = {{Science \& Technology - Other Topics; Materials Science; Physics}},
Web-of-Science-Categories  = {{Nanoscience \& Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied}},
Author-Email = {{yubofan@buaa.edu.cn
   zhong.wang@mse.gatech.edu}},
ResearcherID-Numbers = {{Li, Zhou/E-7734-2018
   Wang, Zhong Lin/E-2176-2011}},
ORCID-Numbers = {{Li, Zhou/0000-0002-9952-7296
   Wang, Zhong Lin/0000-0002-5530-0380}},
Funding-Acknowledgement = {{NSFC {[}31200702, 11120101001, 10925208, 50772024, 11202018]; Beijing
   Municipal Natural Science Foundation {[}713212]; Beijing Nova Program
   {[}Z121103002512019]; RFDP {[}20111102120038]; Knowledge Innovation
   Program of the Chinese Academy of Sciences {[}KJCX2-YWM13]; National
   Basic Research Program of China {[}2009CB930702];  {[}NCET-12-0027]}},
Funding-Text = {{The work was supported by the NSFC (No 31200702, 11120101001,10925208,
   50772024, 11202018), Beijing Municipal Natural Science Foundation (No
   713212), NCET-12-0027, Beijing Nova Program (Z121103002512019), the RFDP
   (20111102120038), the Knowledge Innovation Program of the Chinese
   Academy of Sciences (KJCX2-YWM13), and the National Basic Research
   Program of China (2009CB930702).}},
Cited-References = {{Alammar T, 2009, J MATER SCI, V44, P3218, DOI 10.1007/s10853-009-3429-4.
   Around the World, 2011, SCIENCE, V332, P288.
   Blaser M, 2011, NATURE, V476, P393, DOI 10.1038/476393a.
   Dankovich TA, 2011, ENVIRON SCI TECHNOL, V45, P1992, DOI 10.1021/es103302t.
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3.
   Gogoi SK, 2006, LANGMUIR, V22, P9322, DOI 10.1021/la060661v.
   Gravante G, 2009, ANN PLAS SURG, V63, P201, DOI 10.1097/SAP.0b013e3181893825.
   Hong H, 2011, NANO LETT.
   Karunakaran C, 2011, SUPERLATTICE MICROST, V50, P234, DOI 10.1016/j.spmi.2011.06.005.
   Karunakaran C, 2011, MAT SCI.
   Koga H, 2009, J MATER CHEM, V19, P2135, DOI 10.1039/b820310e.
   Li HY, 2011, MATER CHEM PHYS, V129, P905, DOI 10.1016/j.matchemphys.2011.05.031.
   Li Z, 2010, ADV MATER, V22, P2534, DOI 10.1002/adma.200904355.
   Li Z, 2008, J PHYS CHEM C, V112, P20114, DOI 10.1021/jp808878p.
   Liau SY, 1997, LETT APPL MICROBIOL, V25, P279, DOI 10.1046/j.1472-765X.1997.00219.x.
   Lieber CM, 2007, MRS BULL, V32, P99, DOI 10.1557/mrs2007.41.
   Liu L, 2011, NEW J CHEM, V35, P1418, DOI 10.1039/c1nj20076c.
   Lu WW, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/44/445711.
   Lv M, 2010, ADV MATER, V22, P5463, DOI 10.1002/adma.201001934.
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y.
   Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003.
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059.
   Nie L, 2006, SMALL, V2, P621, DOI 10.1002/smll.200500193.
   Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120.
   Podsiadlo P, 2005, LANGMUIR, V21, P11915, DOI 10.1021/la051284+.
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002.
   Schmidt M A, 1993, ANTIBIOTICS 50 SO WA.
   Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002.
   Shvalagin VV, 2007, J NANOPART RES, V9, P427, DOI 10.1007/s11051-006-9086-5.
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012.
   Tang HY, 2013, J NANOSCI NANOTECHNO, V13, P1385, DOI 10.1166/jnn.2013.6067.
   Tang HY, 2011, CRYSTENGCOMM, V13, P5052, DOI 10.1039/c1ce05532a.
   Vaidyanathan R, 2009, BIOTECHNOL ADV, V27, P924, DOI 10.1016/j.biotechadv.2009.08.001.
   Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7.
   Wang ZL, 2008, SCI AM, V298, P82, DOI 10.1038/scientificamerican0108-82.
   Wang ZL, 2010, NANO TODAY, V5, P540, DOI 10.1016/j.nantod.2010.10.008.
   Willatzen M, 2011, J APPL PHYS, V109.
   William K, 2000, RES POLICY, V29, P679.
   Wong KKY, 2010, MEDCHEMCOMM, V1, P125, DOI 10.1039/c0md00069h.
   Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w.
   Xu S, 2011, NANO RES, V4, P1013, DOI 10.1007/s12274-011-0160-7.
   Yang Y, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/12/125201.
   Yeh PH, 2009, ADV MATER, V21, P4975, DOI 10.1002/adma.200902172.
   Zhang P, 2010, BIOMATERIALS, V31, P3087, DOI 10.1016/j.biomaterials.2010.01.007.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{9}},
Usage-Count-Last-180-days = {{7}},
Usage-Count-Since-2013 = {{131}},
Journal-ISO = {{Nanotechnology}},
Doc-Delivery-Number = {{AD0RW}},
Unique-ID = {{ISI:000332942800018}},
DA = {{2018-08-13}},
}

@article{ ISI:000335762700043,
Author = {Goldstein, Rachel E. Rosenberg and Micallef, Shirley A. and Gibbs, Shawn
   G. and He, Xin and George, Ashish and Sapkota, Amir and Joseph, Sam W.
   and Sapkota, Amy R.},
Title = {{Occupational Exposure to Staphylococcus aureus and Enterococcus spp.
   among Spray Irrigation Workers Using Reclaimed Water}},
Journal = {{INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH}},
Year = {{2014}},
Volume = {{11}},
Number = {{4}},
Pages = {{4340-4355}},
Month = {{APR}},
Abstract = {{As reclaimed water use expands, it is important to evaluate potential
   occupational health risks from exposure to this alternative water
   source. We compared odds of colonization with methicillin-resistant
   Staphylococcus aureus (MRSA), methicillin-susceptible S. aureus (MSSA),
   vancomycin-resistant enterococci (VRE), and vancomycin-susceptible
   enterococci (VSE) between spray irrigation workers using reclaimed water
   and office worker controls. Nasal and dermal swabs from 19 spray
   irrigation workers and 24 office worker controls were collected and
   analyzed for MRSA, MSSA, VRE, and VSE. Isolates were confirmed using
   standard biochemical tests and polymerase chain reaction assays.
   Antimicrobial susceptibility testing was performed by Sensititre((R))
   microbroth dilution. Data were analyzed by two-sample proportion,
   chi-square, Fisher's exact tests, and logistic regression. No MRSA or
   VRE were detected in any samples. MSSA was detected in 26\% and 29\% of
   spray irrigators and controls, respectively. VSE was detected in 11\%
   and 0\% of spray irrigation workers and controls, respectively. The
   adjusted odds of MSSA, multidrug-resistant MSSA, and either MSSA or VSE
   colonization were greater among spray irrigation workers, however
   results were not statistically significant. Future studies with larger
   sample sizes are needed to further evaluate this relationship.}},
Publisher = {{MDPI AG}},
Address = {{POSTFACH, CH-4005 BASEL, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Sapkota, AR (Reprint Author), Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA.
   Goldstein, Rachel E. Rosenberg; Micallef, Shirley A.; George, Ashish; Sapkota, Amir; Joseph, Sam W.; Sapkota, Amy R., Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA.
   Micallef, Shirley A., Univ Maryland, Dept Plant Sci \& Landscape Architecture, College Pk, MD 20742 USA.
   Micallef, Shirley A., Univ Maryland, Ctr Food Safety \& Secur Syst, College Pk, MD 20742 USA.
   Gibbs, Shawn G., Univ Nebraska Med Ctr, Dept Environm Agr \& Occupat Hlth, Coll Publ Hlth, Omaha, NE 68198 USA.
   He, Xin, Univ Maryland, Sch Publ Hlth, Dept Epidemiol \& Biostat, College Pk, MD 20742 USA.
   Joseph, Sam W., Univ Maryland, Dept Cell Biol \& Mol Genet, College Pk, MD 20742 USA.}},
DOI = {{10.3390/ijerph110404340}},
ISSN = {{1660-4601}},
Keywords = {{antibiotic-resistance; Staphylococcus aureus; enterococci; spray
   irrigation; occupational exposure}},
Keywords-Plus = {{VANCOMYCIN-RESISTANT ENTEROCOCCI; MUNICIPAL WASTE-WATER; TREATMENT
   PLANTS; UNITED-STATES; REUSE; COLONIZATION; PREVALENCE; INFECTION; AIR;
   SURVEILLANCE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{rerosenb@umd.edu
   smicall@umd.edu
   sgibbs@unmc.edu
   xinhe@umd.edu
   ashishbg88@gmail.com
   amirsap@umd.edu
   swj@umd.edu
   ars@umd.edu}},
ResearcherID-Numbers = {{He, Xin/N-6742-2016
   Sapkota, Amir/A-5968-2011
   Sapkota, Amy/A-6046-2011}},
Funding-Acknowledgement = {{National Institute for Occupational Safety and Health, Centers for
   Disease Control and Prevention (CDC) {[}1-R03-OH009598-01]; Maryland
   Water Resources Research Center}},
Funding-Text = {{We thank the operators and workers at the spray irrigation sites, and
   the office worker controls for their participation and assistance. This
   work was supported by R03 Small Grants Program, Grant
   \#1-R03-OH009598-01 from the National Institute for Occupational Safety
   and Health, Centers for Disease Control and Prevention (CDC). Its
   contents are solely the responsibility of the authors and do not
   represent the official views of CDC. The Maryland Water Resources
   Research Center also provided a summer fellowship to Rachel E. Rosenberg
   Goldstein that supported this work.}},
Cited-References = {{Anzar E., 2004, REV ESP QUIM, V17, P263.
   Araujo C, 2010, J BASIC MICROB, V50, P605, DOI 10.1002/jobm.201000102.
   Bassetti M, 2009, INT J ANTIMICROB AG, V34, pS15, DOI 10.1016/S0924-8579(09)70544-8.
   Bassetti S, 2005, INFECT CONT HOSP EP, V26, P196, DOI 10.1086/502526.
   Blumenthal UJ, 2001, T ROY SOC TROP MED H, V95, P131, DOI 10.1016/S0035-9203(01)90136-1.
   Borjesson S, 2009, WATER RES, V43, P925, DOI 10.1016/j.watres.2008.11.036.
   Brissaud F, 2008, WATER SCI TECHNOL, V57, P781, DOI 10.2166/wst.2008.162.
   CAMANN DE, 1988, J WATER POLLUT CON F, V60, P1960.
   CLSI, 2013, M100S23 CLSI, VM100-S23.
   Crook J., 2005, IRRIGATION PARKS PLA.
   Devaux I, 2001, WATER SCI TECHNOL, V43, P53.
   DURAND R, 1989, AM J PUBLIC HEALTH, V79, P1659, DOI 10.2105/AJPH.79.12.1659.
   Fang H, 2003, J CLIN MICROBIOL, V41, P2894, DOI 10.1128/JCM.41.7.2894-2899.2003.
   FDA, 2009, BAD BUG BOOK STAPH A.
   Fracchia L, 2006, WATER RES, V40, P1985, DOI 10.1016/j.watres.2006.03.016.
   Goldstein RER, 2014, SCI TOTAL ENVIRON, V466, P404, DOI 10.1016/j.scitotenv.2013.07.039.
   Goldstein RER, 2012, ENVIRON HEALTH PERSP, V120, P1551, DOI 10.1289/ehp.1205436.
   Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494.
   Hendrix CW, 2001, ANN SURG, V233, P259, DOI 10.1097/00000658-200102000-00016.
   Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861.
   Jjemba PK, 2010, APPL ENVIRON MICROB, V76, P4169, DOI 10.1128/AEM.03147-09.
   John J.J., 1999, STAPHYLOCOCCUS AUREU, P325.
   Korzeniewska E, 2009, WATER RES, V43, P2841, DOI 10.1016/j.watres.2009.03.050.
   Kotzamanidis C, 2009, J APPL MICROBIOL, V107, P997, DOI 10.1111/j.1365-2672.2009.04274.x.
   Kullander J, 2009, CANCER EPIDEM BIOMAR, V18, P472, DOI 10.1158/1055-9965.EPI-08-0905.
   Luczkiewicz A, 2010, WATER RES, V44, P5089, DOI 10.1016/j.watres.2010.08.007.
   Mainous I., 2011, PUBLIC HLTH REP, V126, P354.
   McDonald LC, 1997, EMERG INFECT DIS, V3, P311, DOI 10.3201/eid0303.970307.
   Micallef SA, 2013, FOOD MICROBIOL, V36, P465, DOI 10.1016/j.fm.2013.04.016.
   Miller W., 2011, P NWRA ANN C REN NV.
   Murray P. R., 2002, MED MICROBIOLOGY.
   Nagulapally SR, 2009, WATER ENVIRON RES, V81, P82, DOI 10.2175/106143008X304596.
   NRC, 2012, WAT REUS POT EXP NAT.
   Ochei J. O., 2000, MED LAB SCI THEORY P.
   PALMER CJ, 1995, APPL ENVIRON MICROB, V61, P407.
   Poole TL, 2005, ANTIMICROB AGENTS CH, V49, P4382, DOI 10.1128/AAC.49.10.4382-4385.2005.
   Stevenson KB, 2005, EMERG INFECT DIS, V11, P895, DOI 10.3201/eid1106.050156.
   Talebi M, 2008, CURR MICROBIOL, V56, P468, DOI 10.1007/s00284-008-9113-0.
   Warren DK, 2004, INFECT CONT HOSP EP, V25, P99, DOI 10.1086/502357.
   Wendt C, 1999, J HOSP INFECT, V42, P193, DOI 10.1053/jhin.1999.0597.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{9}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{17}},
Journal-ISO = {{Int. J. Environ. Res. Public Health}},
Doc-Delivery-Number = {{AG9TM}},
Unique-ID = {{ISI:000335762700043}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000332685100001,
Author = {Knoester, M. and de Boer, M. G. J. and Maarleveld, J. J. and Claas, E.
   C. J. and Bernards, A. T. and de Jonge, E. and van Dissel, J. T. and
   Veldkamp, K. E.},
Title = {{An integrated approach to control a prolonged outbreak of
   multidrug-resistant Pseudomonas aeruginosa in an intensive care unit}},
Journal = {{CLINICAL MICROBIOLOGY AND INFECTION}},
Year = {{2014}},
Volume = {{20}},
Number = {{4}},
Pages = {{O207-O215}},
Month = {{APR}},
Abstract = {{In this paper we aim to provide insight into the complexity of outbreak
   management in an intensive care unit (ICU) setting. In October 2010 four
   patients on the ICU of our tertiary care centre were colonized or
   infected with a multidrug-resistant strain of Pseudomonas aeruginosa
   (MDR-PA). An outbreak investigation was carried out and infection
   control measures were taken in an attempt to identify a potential source
   and stop transmission. The outbreak investigation included descriptive
   epidemiology, comprising retrospective case finding by reviewing the
   laboratory information system back to 2004 and prospective case finding
   by patient screening for MDR-PA. Furthermore, microbiological analysis,
   environmental screening and a case-control study were carried out.
   Infection control measures consisted of re-education of healthcare
   personnel on basic hygiene measures, auditing of hygiene procedures used
   in daily practice by infection control practitioners, and stepwise
   up-regulation of isolation measures. From February 2009 to January 2012,
   44 patients on our ICU were found to be MDR-PA positive. MDR-PA isolates
   of the 44 patients showed two distinct AFLP patterns, with homology
   within each of the AFLP clusters of more than 93\%. The VIM
   metallo--lactamase gene was detected in 20 of 21 tested isolates. A
   descriptive epidemiology investigation identified the rooms with the
   highest numbers of MDR-PA positive patients. The case-control study
   showed three factors to be independently associated with MDR-PA
   positivity: admission to ICU subunit 1 (OR, 6.1; 95\% CI, 1.7, 22),
   surgery prior to or during admission (OR, 5.7; 95\% CI, 1.6, 20) and
   being warmed-up with the warm-air blanket (OR, 3.6; 95\% CI, 1.2, 11).
   After three environmental screening rounds, with sampling of sinks,
   furniture and devices in the ICU, without revealing a clear common
   source, a fourth environmental investigation included culturing of
   faucet aerators. Two faucets were found to be positive for MDR-PA and
   were replaced. The occurrence of new cases decreased with the
   strengthening of infection control measures and declined further with
   the removal of the common source. With this integrated approach a
   prolonged outbreak of P. aeruginosa was controlled. Contaminated faucet
   aerators on the ICU probably served as a persisting source, while
   interpatient transmission by medical staff was a likely way of spread.
   Seven months after the last case (January 2012) and 3months after
   cessation of extended isolation measures (May 2012), single cases
   started to occur on the ICU, with a total of seven patients in the past
   year. No common source has yet been found.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Knoester, M (Reprint Author), Leiden Univ, Med Ctr, Dept Med Microbiol, KML,Postal Zone L4,POB 9600, NL-2300 RC Leiden, Netherlands.
   Knoester, M.; Claas, E. C. J.; Bernards, A. T.; Veldkamp, K. E., Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands.
   de Boer, M. G. J.; Maarleveld, J. J.; van Dissel, J. T., Leiden Univ, Med Ctr, Dept Infect Dis, NL-2300 RC Leiden, Netherlands.
   de Jonge, E., Leiden Univ, Med Ctr, Dept Intens Care, NL-2300 RC Leiden, Netherlands.}},
DOI = {{10.1111/1469-0691.12372}},
ISSN = {{1198-743X}},
EISSN = {{1469-0691}},
Keywords = {{Case-control study; intensive care unit; multidrug resistance; outbreak
   management; Pseudomonas aeruginosa}},
Keywords-Plus = {{TAP-WATER; RISK-FACTORS; ICU PATIENTS; COLONIZATION; TRANSMISSION;
   INFECTION; CONTAMINATION; EPIDEMIOLOGY; NETHERLANDS; TRACT}},
Research-Areas = {{Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Infectious Diseases; Microbiology}},
Author-Email = {{m.knoester@lumc.nl}},
Cited-References = {{Cortes JA, 2009, BRAZ J INFECT DIS, V13, P99, DOI 10.1590/S1413-86702009000200005.
   Bergmans DCJJ, 1998, THORAX, V53, P1053, DOI 10.1136/thx.53.12.1053.
   Bert F, 1998, J HOSP INFECT, V39, P53, DOI 10.1016/S0195-6701(98)90243-2.
   Bertrand X, 2000, Clin Infect Dis, V31, pE9, DOI 10.1086/318117.
   Blanc DS, 2004, INTENS CARE MED, V30, P1964, DOI 10.1007/s00134-004-2389-z.
   Breathnach AS, 2012, J HOSP INFECT, V82, P19, DOI 10.1016/j.jhin.2012.06.007.
   Cuttelod M, 2011, CLIN MICROBIOL INFEC, V17, P57, DOI 10.1111/j.1469-0691.2010.03164.x.
   de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394.
   DiazGranados CA, 2009, INFECT CONT HOSP EP, V30, P550, DOI 10.1086/597235.
   DORING G, 1991, ZBL HYG UMWELTMED, V191, P494.
   Eckmanns T, 2008, CLIN MICROBIOL INFEC, V14, P454, DOI 10.1111/j.1469-0691.2008.01949.x.
   Ferroni A, 1998, J HOSP INFECT, V39, P301, DOI 10.1016/S0195-6701(98)90295-X.
   Foca M, 2000, NEW ENGL J MED, V343, P695, DOI 10.1056/NEJM200009073431004.
   Hota S, 2009, INFECT CONT HOSP EP, V30, P25, DOI 10.1086/592700.
   Iversen BG, 2010, J ORAL MICROBIOL, P2, DOI 10.3402/jom.v2i0.5123.
   Jefferies JMC, 2012, J MED MICROBIOL, V61, P1052, DOI 10.1099/jmm.0.044818-0.
   Kikuchi T, 2007, J HOSP INFECT, V65, P54, DOI 10.1016/j.jhin.2006.07.017.
   Kirschke DL, 2003, NEW ENGL J MED, V348, P214, DOI 10.1056/NEJMoa021791.
   Kohlenberg A, 2010, J HOSP INFECT, V74, P350, DOI 10.1016/j.jhin.2009.10.024.
   Lanini S., 2011, PLOS ONE, V6.
   Moolenaar RL, 2000, INFECT CONT HOSP EP, V21, P80, DOI 10.1086/501739.
   Muscarella LF, 2004, INFECT CONT HOSP EP, V25, P342, DOI 10.1086/502402.
   Naze F, 2010, J CLIN MICROBIOL, V48, P3146, DOI 10.1128/JCM.00402-10.
   Reingold AL, 1998, EMERG INFECT DIS, V4, P21, DOI 10.3201/eid0401.980104.
   Reuter S, 2002, CRIT CARE MED, V30, P2222, DOI 10.1097/01.CCM.0000025907.12833.10.
   Rogues AM, 2007, J HOSP INFECT, V67, P72, DOI 10.1016/j.jhin.2007.06.019.
   Trautmann M, 2001, INFECT CONT HOSP EP, V22, P49, DOI 10.1086/501828.
   Van der Bij AK, 2012, CLIN MICROBIOL INFEC, V18, pE369, DOI 10.1111/j.1469-0691.2012.03969.x.
   Van der Bij AK, 2011, INT J ANTIMICROB AG, V37, P513, DOI 10.1016/j.ijantimicag.2011.02.010.
   VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{14}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{8}},
Journal-ISO = {{Clin. Microbiol. Infect.}},
Doc-Delivery-Number = {{AC7CR}},
Unique-ID = {{ISI:000332685100001}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000334124300015,
Author = {Van Meervenne, Eva and De Weirdt, Rosemarie and Van Coillie, Els and
   Devlieghere, Frank and Herman, Lieve and Boon, Nico},
Title = {{Biofilm models for the food industry: hot spots for plasmid transfer?}},
Journal = {{PATHOGENS AND DISEASE}},
Year = {{2014}},
Volume = {{70}},
Number = {{3, SI}},
Pages = {{332-338}},
Month = {{APR}},
Abstract = {{Biofilms represent a substantial problem in the food industry, with food
   spoilage, equipment failure, and public health aspects to consider.
   Besides, biofilms may be a hot spot for plasmid transfer, by which
   antibiotic resistance can be disseminated to potential foodborne
   pathogens. This study investigated biomass and plasmid transfer in
   dual-species (Pseudomonas putida and Escherichia coli) biofilm models
   relevant to the food industry. Two different configurations
   (flow-through and drip-flow) and two different inoculation procedures
   (donor-recipient and recipient-donor) were tested. The drip-flow
   configuration integrated stainless steel coupons in the setup while the
   flow-through configuration included a glass flow cell and silicone
   tubing. The highest biomass density {[}10 log (cells cm-(2))] was
   obtained in the silicone tubing when first the recipient strain was
   inoculated. High plasmid transfer ratios, up to 1/10
   (transconjugants/total bacteria), were found. Depending on the order of
   inoculation, a difference in transfer efficiency between the biofilm
   models could be found. The ease by which the multiresistance plasmid was
   transferred highlights the importance of biofilms in the food industry
   as hot spots for the acquisition of multiresistance plasmids. This can
   impede the treatment of foodborne illnesses if pathogens acquire this
   multiresistance in or from the biofilm.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Boon, N (Reprint Author), Univ Ghent, LabMET, Coupure Links 653, B-9000 Ghent, Belgium.
   Van Meervenne, Eva; De Weirdt, Rosemarie; Boon, Nico, Univ Ghent, LabMET, B-9000 Ghent, Belgium.
   Van Meervenne, Eva; Van Coillie, Els; Herman, Lieve, Inst Agr \& Fisheries Res ILVO, Technol \& Food Sci Unit, Melle, Belgium.
   Van Meervenne, Eva; Devlieghere, Frank, Univ Ghent, LFMFP, B-9000 Ghent, Belgium.}},
DOI = {{10.1111/2049-632X.12134}},
ISSN = {{2049-632X}},
Keywords = {{dual-species biofilms; conjugation; antibiotic resistance}},
Keywords-Plus = {{GRADIENT GEL-ELECTROPHORESIS; ESCHERICHIA-COLI BIOFILMS; SURFACE MATING
   SYSTEMS; AIR-LIQUID INTERFACE; ANTIBIOTIC-RESISTANCE; ACTIVATED-SLUDGE;
   ANTIMICROBIAL RESISTANCE; MICROBIAL COMMUNITY; ABIOTIC SURFACES;
   RIBOSOMAL-RNA}},
Research-Areas = {{Immunology; Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Immunology; Infectious Diseases; Microbiology}},
Author-Email = {{Nico.Boon@UGent.be}},
ResearcherID-Numbers = {{Boon, Nico/B-4083-2011}},
ORCID-Numbers = {{Boon, Nico/0000-0002-7734-3103}},
Funding-Acknowledgement = {{Federal Public Service of Health, Food Chain Safety and Environment
   {[}RF 6219]}},
Funding-Text = {{This study was funded by the Federal Public Service of Health, Food
   Chain Safety and Environment (contract RF 6219). This research has
   benefitted from a statistical consult with Ghent University FIRE
   (Fostering Innovative Research based on Evidence). The authors thank Tim
   Lacoere for the technical assistance and for designing the overview
   figure. The authors thank Siska Maertens for the technical assistance.
   The authors thank Massimo Marzorati for his detailed review of the
   paper.}},
Cited-References = {{Andersen TE, 2010, J MICROBIOL METH, V81, P135, DOI 10.1016/j.mimet.2010.02.009.
   ANGLES ML, 1993, APPL ENVIRON MICROB, V59, P843.
   Boon N, 2000, APPL ENVIRON MICROB, V66, P2906, DOI 10.1128/AEM.66.7.2906-2913.2000.
   BOS R, 1994, J MICROBIOL METH, V20, P289, DOI 10.1016/0167-7012(94)90053-1.
   BRADLEY DE, 1983, J GEN MICROBIOL, V129, P2545.
   BRADLEY DE, 1980, J BACTERIOL, V143, P1466.
   Brooks JD, 2008, INT J FOOD SCI TECH, V43, P2163, DOI 10.1111/j.1365-2621.2008.01839.x.
   Buckingham-Meyer K, 2007, J MICROBIOL METH, V70, P236, DOI 10.1016/j.mimet.2007.04.010.
   Burmolle M, 2008, MICROBIOL-SGM, V154, P187, DOI 10.1099/mic.0.2007/010454-0.
   Cabellos-Avelar T, 2006, FEMS MICROBIOL ECOL, V58, P414, DOI 10.1111/j.1574-6941.2006.00186.x.
   Capita R, 2013, CRIT REV FOOD SCI, V53, P11, DOI 10.1080/10408398.2010.519837.
   Casamayor EO, 2000, APPL ENVIRON MICROB, V66, P499, DOI 10.1128/AEM.66.2.499-508.2000.
   Castonguay MH, 2006, RES MICROBIOL, V157, P471, DOI 10.1016/j.resmic.2005.10.003.
   Christensen BB, 1998, APPL ENVIRON MICROB, V64, P2247.
   Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018.
   Colon-Gonzalez M, 2004, RES MICROBIOL, V155, P514, DOI 10.1016/j.resmic.2004.03.004.
   DALTON HM, 1994, J BACTERIOL, V176, P6900.
   De Gelder L, 2005, APPL ENVIRON MICROB, V71, P5309, DOI 10.1128/AEM.71.9.5309-5317.2005.
   De Roy K, 2012, WATER RES, V46, P907, DOI 10.1016/j.watres.2011.11.076.
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002.
   Drenkard E, 2003, MICROBES INFECT, V5, P1213, DOI 10.1016/j.micinf.2003.08.009.
   Droge M, 2000, MOL GEN GENET, V263, P471, DOI 10.1007/s004380051191.
   Dudley EG, 2006, INFECT IMMUN, V74, P2102, DOI 10.1128/IAI.74.4.2102-2114.2006.
   Feliciano L, 2010, J FOOD SCI, V75, pM231, DOI 10.1111/j.1750-3841.2010.01583.x.
   Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581.
   Gilbert ES, 2003, APPL MICROBIOL BIOT, V61, P77, DOI 10.1007/s00253-002-1203-5.
   Goeres DM, 2009, NAT PROTOC, V4, P783, DOI 10.1038/nprot.2009.59.
   Goulter RM, 2009, LETT APPL MICROBIOL, V49, P1, DOI 10.1111/j.1472-765X.2009.02591.x.
   Gunasekera TS, 2002, APPL ENVIRON MICROB, V68, P1988, DOI 10.1128/AEM.68.4.1988-1993.2002.
   He H, 2009, J FOOD PROTECT, V72, P572, DOI 10.4315/0362-028X-72.3.572.
   Hennequin C, 2012, J ANTIMICROB CHEMOTH, V67, P2123, DOI 10.1093/jac/dks169.
   Jahid IK, 2012, FOOD SCI BIOTECHNOL, V21, P299, DOI 10.1007/s10068-012-0041-1.
   Krol JE, 2011, APPL ENVIRON MICROB, V77, P5079, DOI 10.1128/AEM.00090-11.
   Lampkowska J, 2008, INT J FOOD MICROBIOL, V127, P172, DOI 10.1016/j.ijfoodmicro.2008.06.017.
   Lilley AK, 2002, FEMS MICROBIOL ECOL, V42, P243, DOI {[}10.1016/S0168-6496(02)00371-9, 10.1111/j.1574-6941.2002.tb01014.x].
   Luo HL, 2005, APPL ENVIRON MICROB, V71, P2970, DOI 10.1128/AEM.71.6.2970-2978.2005.
   Lyautey E, 2005, WATER RES, V39, P380, DOI 10.1016/j.watres.2004.09.025.
   Madsen JS, 2012, FEMS IMMUNOL MED MIC, V65, P183, DOI 10.1111/j.1574-695X.2012.00960.x.
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2.
   Marchand S, 2012, COMPR REV FOOD SCI F, V11, P133, DOI 10.1111/j.1541-4337.2011.00183.x.
   Molin S, 2003, CURR OPIN BIOTECH, V14, P255, DOI 10.1016/S0958-1669(03)00036-3.
   MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695.
   Nguyen KT, 2010, J BACTERIOL, V192, P5134, DOI 10.1128/JB.00650-10.
   Reisner A, 2006, J BACTERIOL, V188, P3582, DOI 10.1128/JB.188.10.3582-3588.2006.
   Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3.
   Riemann L, 1999, DEEP-SEA RES PT II, V46, P1791, DOI 10.1016/S0967-0645(99)00044-2.
   Roder HL, 2013, FEMS MICROBIOL LETT, V344, P186, DOI 10.1111/1574-6968.12175.
   Savage VJ, 2013, ANTIMICROB AGENTS CH, V57, P1968, DOI 10.1128/AAC.02008-12.
   Schauer M, 2000, FEMS MICROBIOL ECOL, V33, P51, DOI 10.1016/S0168-6496(00)00043-X.
   Settanni L, 2013, INT J FOOD MICROBIOL, V160, P344, DOI 10.1016/j.ijfoodmicro.2012.11.011.
   Shi XM, 2009, TRENDS FOOD SCI TECH, V20, P407, DOI 10.1016/j.tifs.2009.01.054.
   Sofos JN, 2010, MEAT SCI, V86, P2, DOI 10.1016/j.meatsci.2010.04.015.
   Speranza B, 2011, J FOOD SCI, V76, pM12, DOI 10.1111/j.1750-3841.2010.01936.x.
   Van Meervenne E, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/834598.
   Verraes C, 2013, INT J ENV RES PUB HE, V10, P2643, DOI 10.3390/ijerph10072643.
   ZOTTOLA EA, 1994, INT J FOOD MICROBIOL, V23, P125, DOI 10.1016/0168-1605(94)90047-7.}},
Number-of-Cited-References = {{56}},
Times-Cited = {{9}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{55}},
Journal-ISO = {{Pathog. Dis.}},
Doc-Delivery-Number = {{AE6SH}},
Unique-ID = {{ISI:000334124300015}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000334124300017,
Author = {Kerns, Patrick W. and Ackhart, David F. and Basaraba, Randall J. and
   Leid, Jeff G. and Shirtliff, Mark E.},
Title = {{Mycobacterium tuberculosis pellicles express unique proteins recognized
   by the host humoral response}},
Journal = {{PATHOGENS AND DISEASE}},
Year = {{2014}},
Volume = {{70}},
Number = {{3, SI}},
Pages = {{347-358}},
Month = {{APR}},
Abstract = {{Mycobacterium tuberculosis (MTB) causes both acute and chronic
   infections in humans characterized by tolerance to antibiotics and
   reactivation to cause secondary tuberculosis. These characteristics have
   led to renewed interest in the in vitro pellicle, or biofilm mode of
   growth, where bacteria grow to produce a thick aggregate at the
   air-liquid interface and exhibit increased phenotypic resistance to
   antibiotics. We infected guinea pigs with the virulent H37Rv strain of
   MTB for 60days at which point we collected blood. To identify antigenic
   proteins, membrane protein extracts of MTB H37Ra pellicles and shaken
   cultures grown for 3, 5, or 7weeks were probed with the infected
   animals' sera after the proteins were separated by two-dimensional gel
   electrophoresis (2DGE). Antigenic proteins were then identified using
   MALDI-TOF/TOF mass spectrometry peptide mass fingerprinting. Antigenic
   pellicle proteins were compared across the three timepoints to identify
   those that were produced consistently during pellicle growth. They were
   also compared to those membrane proteins identified from harvested
   shaken cultures to determine pellicle-specific vs. universally expressed
   proteins. Using this technique, we identified 44 distinct antigenic
   proteins, nine of which were pellicle-specific. The sequence of
   antigenic pellicle-specific proteins was checked for sequence
   conservation across 15 sequenced MTB clinical isolates, three other
   members of the MTB complex, as well as M.avium and M.smegmatis. The
   antigenic pellicle-specific protein Rv0097 was found to have very high
   sequence conservation within the MTB complex but not with related
   mycobacteria, while FabG4 was highly conserved in all mycobacteria
   analyzed. These conserved pellicle-specific proteins represent targets
   for the development of future diagnostic tests and vaccines.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Shirtliff, ME (Reprint Author), Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, 8th Floor South 650 W,Baltimore St, Baltimore, MD 21201 USA.
   Kerns, Patrick W., Univ Maryland, Grad Program Mol Microbiol \& Immunol, Baltimore, MD 21201 USA.
   Ackhart, David F.; Basaraba, Randall J., Colorado State Univ, Coll Vet Med \& Biomed Sci, Dept Microbiol Immunol \& Pathol, Ft Collins, CO 80523 USA.
   Leid, Jeff G., WL Gore, Flagstaff, AZ USA.
   Shirtliff, Mark E., Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA.
   Shirtliff, Mark E., Univ Maryland, Sch Med, Dept Microbiol \& Immunol, Baltimore, MD 21201 USA.}},
DOI = {{10.1111/2049-632X.12142}},
ISSN = {{2049-632X}},
Keywords = {{tuberculosis; humoral; proteomics; pellicle; biofilm}},
Keywords-Plus = {{IN-SILICO IDENTIFICATION; T-CELL EPITOPES; CAVITARY TUBERCULOSIS;
   ISONIAZID RESISTANCE; ESCHERICHIA-COLI; CULTURE FILTRATE;
   IMMUNE-RESPONSE; BOVIS BCG; INFECTION; VACCINE}},
Research-Areas = {{Immunology; Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Immunology; Infectious Diseases; Microbiology}},
Author-Email = {{mshirtliff@umaryland.edu}},
ResearcherID-Numbers = {{Shirtliff, Mark/H-2563-2017}},
ORCID-Numbers = {{Shirtliff, Mark/0000-0002-8913-3445}},
Funding-Acknowledgement = {{National Institutes of Health, National Institute of Allergy and
   Infectious Diseases {[}R01 AI069568-02, AI069568]; National Institute of
   Dental and Craniofacial Research {[}2T32 DE007309]; National Institute
   of Allergy and Infectious Diseases {[}1R01AI106733-01]}},
Funding-Text = {{This research work was supported by a grant from the National Institutes
   of Health, National Institute of Allergy and Infectious Diseases (R01
   AI069568-02 and ARRA supplement AI069568), a grant from the National
   Institute of Dental and Craniofacial Research (2T32 DE007309), and a
   grant from the National Institute of Allergy and Infectious Diseases
   (1R01AI106733-01). The authors would also like to thank Rebecca Brady,
   Anil Ojha, Jan Harro, Nate Archer, Brian Peters, and Megan Prior.}},
Cited-References = {{Allard STM, 2001, CELL MOL LIFE SCI, V58, P1650, DOI 10.1007/PL00000803.
   Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289.
   Behr MA, 2002, LANCET INFECT DIS, V2, P86, DOI 10.1016/S1473-3099(02)00182-2.
   Beste DJV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005349.
   Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06.
   Brady RA, 2007, APPL ENVIRON MICROB, V73, P6612, DOI 10.1128/AEM.00855-07.
   Brady RA, 2011, INFECT IMMUN, V79, P1797, DOI 10.1128/IAI.00451-10.
   Cade CE, 2010, PROTEIN SCI, V19, P458, DOI 10.1002/pro.324.
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421.
   Chaitra MG, 2005, VACCINE, V23, P1265, DOI 10.1016/j.vaccine.2004.08.046.
   Chen P, 1998, INFECT IMMUN, V66, P5099.
   Cholo MC, 2006, J ANTIMICROB CHEMOTH, V57, P79, DOI 10.1093/jac/dki409.
   Cole S T, 2002, Eur Respir J Suppl, V36, p78s.
   Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8.
   Dutta D, 2013, BIOCHEM J, V450, P127, DOI 10.1042/BJ20121107.
   Ehlers S, 1999, IMMUNOLOGY, V98, P313.
   Ewer K, 2006, CLIN VACCINE IMMUNOL, V13, P90, DOI 10.1128/CVI.13.1.90-97.2006.
   Florczyk MA, 2001, INFECT IMMUN, V69, P5777, DOI 10.1128/IAI.69.9.5777-5785.2001.
   Forbes John, 1821, TREATISE DIS CHEST W.
   Furuya T, 2011, J BACTERIOL, V193, P5817, DOI 10.1128/JB.05525-11.
   Gao Q, 2004, TUBERCULOSIS, V84, P188, DOI 10.1016/j.tube.2003.12.013.
   Gee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002525.
   Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003.
   Guirado E, 2006, MICROBES INFECT, V8, P1252, DOI 10.1016/j.micinf.2005.12.004.
   Gupta A, 2012, IMMUNOBIOLOGY, V217, P363, DOI 10.1016/j.imbio.2011.07.008.
   Hamasur B, 2004, CLIN EXP IMMUNOL, V138, P30, DOI 10.1111/j.1365-2249.2004.02593.x.
   HART P D, 1974, Infection and Immunity, V10, P742.
   Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4.
   Hotter GS, 2005, J BACTERIOL, V187, P2267, DOI 10.1128/JB.187.7.2267-2277.2005.
   Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371.
   Jin LJ, 2010, VACCINE, V28, P6041, DOI 10.1016/j.vaccine.2010.06.081.
   Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC.
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2.
   Kenrick K G, 1970, Anal Biochem, V33, P204, DOI 10.1016/0003-2697(70)90454-9.
   Khan FA, 2012, CLIN INFECT DIS, V55, P1154, DOI 10.1093/cid/cis630.
   Kotani T, 2007, J BACTERIOL, V189, P886, DOI 10.1128/JB.01054-06.
   Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107.
   Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008.
   Liu J, 2009, HUM VACCINES, V5, P70, DOI 10.4161/hv.5.2.7210.
   Lopez Y, 2009, INT J MED MICROBIOL, V299, P447, DOI 10.1016/j.ijmm.2008.10.007.
   LUKINS HB, 1963, J BACTERIOL, V85, P1074.
   MACKANESS GB, 1954, AM REV TUBERC PULM, V69, P479.
   Malen H, 2008, SCAND J IMMUNOL, V67, P245, DOI 10.1111/j.1365-3083.2007.02064.x.
   May A, 2013, METAB ENG, V15, P218, DOI 10.1016/j.ymben.2012.08.001.
   Miekisch W, 2001, CLIN CHEM, V47, P1053.
   Moore T, 2003, J INFECT DIS, V188, P617, DOI 10.1086/377134.
   NAGAI S, 1991, INFECT IMMUN, V59, P372.
   Naito M, 1998, INT J LEPROSY, V66, P208.
   Nedeltchev GG, 2009, INFECT IMMUN, V77, P598, DOI 10.1128/IAI.01132-08.
   Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x.
   Olivares N, 2013, PATHOG DIS, V69, P176, DOI 10.1111/2049-632X.12069.
   Orme IM, 2014, TUBERCULOSIS, V94, P8, DOI 10.1016/j.tube.2013.07.004.
   OSLER W, 1892, PRINCIPLES PRACTICES.
   Palanisamy GS, 2008, TUBERCULOSIS, V88, P295, DOI 10.1016/j.tube.2007.12.003.
   Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720.
   Pheiffer C, 2005, MICROBIOL-SGM, V151, P1139, DOI 10.1099/mic.0.27518-0.
   Pichugin AV, 2009, AM J PATHOL, V174, P2190, DOI 10.2353/ajpath.2009.081075.
   Ramsugit S, 2013, ANTON LEEUW INT J G, V104, P725, DOI 10.1007/s10482-013-9981-6.
   Ribeiro-Guimaraes ML, 2007, MICROB PATHOGENESIS, V43, P173, DOI 10.1016/j.micpath.2007.05.010.
   Rindi L, 2005, INT J TUBERC LUNG D, V9, P94.
   Roumestand C, 2011, STRUCTURE, V19, P1525, DOI 10.1016/j.str.2011.07.011.
   Rousseau C, 2004, CELL MICROBIOL, V6, P277, DOI 10.1111/j.1462-5822.2004.00368.x.
   Sambandan D, 2013, MBIO, V4, DOI 10.1128/mBio.00222-13.
   Sharma P, 2010, INDIAN J MED RES, V132, P400.
   Sirgel FA, 2005, AM J RESP CRIT CARE, V172, P128, DOI 10.1164/rccm.200411-1557OC.
   Skerry C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066310.
   Sundaramurthi JC, 2012, INFECT GENET EVOL, V12, P1312, DOI 10.1016/j.meegid.2012.03.023.
   Tang ST, 2011, J IMMUNOL, V186, P1068, DOI 10.4049/jimmunol.1002212.
   Teitelbaum R, 1998, P NATL ACAD SCI USA, V95, P15688, DOI 10.1073/pnas.95.26.15688.
   Tuli SM, 2007, CLIN ORTHOP RELAT R, P29, DOI 10.1097/BLO.0b013e318065b75e.
   Vordermeier HM, 1996, CLIN EXP IMMUNOL, V106, P312, DOI 10.1046/j.1365-2249.1996.d01-845.x.
   Wallis RS, 1999, ANTIMICROB AGENTS CH, V43, P2600.
   Wang JL, 2010, MOL BIOL REP, V37, P1793, DOI 10.1007/s11033-009-9613-4.
   Weichart D, 2003, J BACTERIOL, V185, P115, DOI 10.1128/JB.185.1.115-125.2003.
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1.
   Zhang L, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-12.
   ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0.
   Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375.
   Zvi A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-18.}},
Number-of-Cited-References = {{79}},
Times-Cited = {{14}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{14}},
Journal-ISO = {{Pathog. Dis.}},
Doc-Delivery-Number = {{AE6SH}},
Unique-ID = {{ISI:000334124300017}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000333662700025,
Author = {Alvarenga, Rene F. Ramos and Wan, Baojie and Inui, Taichi and Franzblau,
   Scott G. and Pauli, Guido F. and Jaki, Birgit U.},
Title = {{Airborne Antituberculosis Activity of Eucalyptus citriodora Essential
   Oil}},
Journal = {{JOURNAL OF NATURAL PRODUCTS}},
Year = {{2014}},
Volume = {{77}},
Number = {{3}},
Pages = {{603-610}},
Month = {{MAR}},
Abstract = {{The rapid emergence of multi- and extensively drug-resistant
   tuberculosis (MDR/XDR-TB) has created a pressing public health problem,
   which mostly affects regions with HIV/AIDS prevalence and represents a
   new constraint in the already challenging disease management of
   tuberculosis (TB). The present work responds to the need to reduce the
   number of contagious MDR/XRD-TB patients, protect their immediate
   environment, and interrupt the rapid spread by laying the groundwork for
   an inhalation therapy based on anti-TB-active constituents of the
   essential oil (EO) of Eucalyptus citriodora. In order to address the
   metabolomic complexity of EO constituents and active principles in
   botanicals, this study applied biochemometrics, a 3-D analytical
   approach that involves high-resolution CCC fractionation, GC-MS
   analysis, bioactivity measurements, and chemometric analysis. Thus, 32
   airborne anti-TB-active compounds were identified in E. citriodora EO:
   the monoterpenes citronellol (1), linalool (3), isopulegol (5), and
   a-terpineol (7) and the sesquiterpenoids spathulenol (11), beta-eudesmol
   (23), and tau-cadinol (25). The impact of the interaction of multiple
   components in EOs was studied using various artificial mixtures (AMxs)
   of the active monoterpenes 1, 2, and 5 and the inactive eucalyptol (33).
   Both neat 1 and the AMx containing 1, 2, and 33 showed airborne TB
   inhibition of >90\%, while the major E. citriodora EO component, 2, was
   only weakly active, at 18\% inhibition.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Jaki, BU (Reprint Author), Univ Illinois, Coll Pharm, Inst TB Res, 833 South Wood St, Chicago, IL 60612 USA.
   Wan, Baojie; Inui, Taichi; Franzblau, Scott G.; Pauli, Guido F.; Jaki, Birgit U., Univ Illinois, Coll Pharm, Inst TB Res, Chicago, IL 60612 USA.
   Alvarenga, Rene F. Ramos; Pauli, Guido F.; Jaki, Birgit U., Univ Illinois, Coll Pharm, Dept Med Chem \& Pharmacognosy, Chicago, IL 60612 USA.}},
DOI = {{10.1021/np400872m}},
ISSN = {{0163-3864}},
EISSN = {{1520-6025}},
Keywords-Plus = {{ANTIMYCOBACTERIAL NATURAL-PRODUCTS; COUNTER-CURRENT CHROMATOGRAPHY;
   FOENICULUM-VULGARE MILL.; TEA TREE OIL; ANTIBACTERIAL ACTIVITY;
   CHEMICAL-COMPOSITION; MYCOBACTERIUM-TUBERCULOSIS; MAJOR CONSTITUENTS;
   GAS-CHROMATOGRAPHY; ESCHERICHIA-COLI}},
Research-Areas = {{Plant Sciences; Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Plant Sciences; Chemistry, Medicinal; Pharmacology \& Pharmacy}},
Author-Email = {{bjaki@uic.edu}},
ResearcherID-Numbers = {{Ramos Alvarenga, Rene F./M-6267-2017
   }},
ORCID-Numbers = {{Ramos Alvarenga, Rene F./0000-0002-0311-7090
   Pauli, Guido/0000-0003-1022-4326
   Franzblau, Scott/0000-0002-8698-0243}},
Cited-References = {{Alvarez-Ordonez A, 2013, J APPL MICROBIOL, V115, P50, DOI 10.1111/jam.12216.
   Babushok VI, 2011, J PHYS CHEM REF DATA, V40, DOI 10.1063/1.3653552.
   Berthod A, 2007, ANAL CHEM, V79, P3371, DOI 10.1021/ac062397g.
   Cantrell CL, 2001, PLANTA MED, V67, P685, DOI 10.1055/s-2001-18365.
   Case RJ, 2006, J ETHNOPHARMACOL, V106, P82, DOI 10.1016/j.jep.2005.12.005.
   Case RJ, 2007, J CHROMATOGR A, V1151, P169, DOI 10.1016/j.chroma.2007.01.022.
   CASTELLO G, 1993, J CHROMATOGR, V635, P103, DOI 10.1016/0021-9673(93)83119-D.
   Chalchat J. C., 2009, J ESSENT OIL RES, V21, P295.
   Chalchat JC, 2000, J ESSENT OIL RES, V12, P695, DOI 10.1080/10412905.2000.9712194.
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P452, DOI 10.1016/j.biortech.2008.02.038.
   Cimanga K, 2002, J ETHNOPHARMACOL, V79, P213, DOI 10.1016/S0378-8741(01)00384-1.
   Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004.
   Copp BR, 2003, NAT PROD REP, V20, P535, DOI 10.1039/b212154a.
   Copp BR, 2007, NAT PROD REP, V24, P278, DOI 10.1039/b513520f.
   Cox SD, 2000, J APPL MICROBIOL, V88, P170, DOI 10.1046/j.1365-2672.2000.00943.x.
   Cristani M, 2007, J AGR FOOD CHEM, V55, P6300, DOI 10.1021/jf070094x.
   Devi KP, 2010, J ETHNOPHARMACOL, V130, P107, DOI 10.1016/j.jep.2010.04.025.
   Diao WR, 2014, FOOD CONTROL, V35, P109, DOI 10.1016/j.foodcont.2013.06.056.
   Friesen JB, 2007, J CHROMATOGR A, V1151, P51, DOI 10.1016/j.chroma.2007.01.126.
   Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2.
   Gbenou JD, 2013, MOL BIOL REP, V40, P1127, DOI 10.1007/s11033-012-2155-1.
   Georgiev V. S., 1994, INT J ANTIMICROB AG, P157.
   GUAN YF, 1991, J CHROMATOGR, V552, P187, DOI 10.1016/S0021-9673(01)95933-3.
   Gusmao NMS, 2013, J STORED PROD RES, V54, P41, DOI 10.1016/j.jspr.2013.02.002.
   Gustafson JE, 1998, LETT APPL MICROBIOL, V26, P194, DOI 10.1046/j.1472-765X.1998.00317.x.
   Harold F., 1969, ADV MICROB PHYSL, V4, P45.
   Helander IM, 1998, J AGR FOOD CHEM, V46, P3590, DOI 10.1021/jf980154m.
   Hendry ER, 2009, J ANTIMICROB CHEMOTH, V64, P1219, DOI 10.1093/jac/dkp362.
   Hostettmann K, 2001, J LIQ CHROMATOGR R T, V24, P1711, DOI 10.1081/JLC-100104373.
   Inouye S, 2001, J Infect Chemother, V7, P251, DOI 10.1007/s101560170022.
   Inouye S, 2001, J ANTIMICROB CHEMOTH, V47, P565, DOI 10.1093/jac/47.5.565.
   Inui T, 2012, FITOTERAPIA, V83, P1218, DOI 10.1016/j.fitote.2012.06.012.
   Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3.
   Kalemba D, 2003, CURR MED CHEM, V10, P813, DOI 10.2174/0929867033457719.
   Kloucek P, 2012, FOOD RES INT, V47, P161, DOI 10.1016/j.foodres.2011.04.044.
   Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657.
   Lahlou M, 2004, PHYTOTHER RES, V18, P435, DOI 10.1002/ptr.1465.
   Lambert RJW, 2001, J APPL MICROBIOL, V91, P453, DOI 10.1046/j.1365-2672.2001.01428.x.
   Lee YS, 2008, FLAVOUR FRAG J, V23, P23, DOI 10.1002/ffj.1850.
   Leela NK, 2012, J ESSENT OIL RES, V24, P507, DOI 10.1080/10412905.2012.728084.
   Leite CQF, 1998, FITOTERAPIA, V69, P282.
   LOW D, 1974, PLANTA MED, V26, P184, DOI 10.1055/s-0028-1097987.
   Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9.
   Marston A, 2007, PHYTOCHEMISTRY, V68, P2786, DOI 10.1016/j.phytochem.2007.08.004.
   Mulyaningsih, 2011, PHARM BIOL, V49, P893, DOI 10.3109/13880209.2011.553625.
   Mulyaningsih S, 2010, PHYTOMEDICINE, V17, P1061, DOI {[}10.1016/j.phymed.2010.06.18, 10.1016/j.phymed.2010.06.018].
   Murrell W, 1899, Br Med J, V1, P202.
   Newton SM, 2000, PHYTOTHER RES, V14, P303, DOI 10.1002/1099-1573(200008)14:5<303::AID-PTR712>3.0.CO;2-N.
   Pauli GF, 2005, LIFE SCI, V78, P485, DOI 10.1016/j/lfs.2005.09.004.
   Pauli GF, 2008, J NAT PROD, V71, P1489, DOI 10.1021/np800144q.
   Petrini B, 1999, INT J ANTIMICROB AG, V13, P93, DOI 10.1016/S0924-8579(99)00111-9.
   Rao BRR, 2003, FLAVOUR FRAG J, V18, P133, DOI 10.1002/ffj.1157.
   Saad NY, 2013, FLAVOUR FRAG J, V28, P269, DOI 10.1002/ffj.3165.
   Sharma A, 2013, J FOOD SAFETY, V33, P197, DOI 10.1111/jfs.12040.
   Sherry E, 2004, PHYTOMEDICINE, V11, P95, DOI 10.1078/0944-7113-00378.
   Shkurupii V A, 2006, Probl Tuberk Bolezn Legk, P43.
   Shkurupii V A, 2002, Probl Tuberk, P36.
   SIKKEMA J, 1995, MICROBIOL REV, V59, P201.
   Silva F, 2011, J MED MICROBIOL, V60, P1479, DOI 10.1099/jmm.0.034157-0.
   Singh HP, 2012, LWT-FOOD SCI TECHNOL, V48, P237, DOI 10.1016/j.lwt.2012.03.019.
   STEIN SE, 1994, J AM SOC MASS SPECTR, V5, P316, DOI 10.1016/1044-0305(94)85022-4.
   SUN YL, 1993, J CHROMATOGR A, V657, P1.
   Traore N, 2010, J ESSENT OIL RES, V22, P510, DOI 10.1080/10412905.2010.9700385.
   Trombetta D, 2005, ANTIMICROB AGENTS CH, V49, P2474, DOI 10.1128/AAC.49.6.2474-2478.2005.
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1.
   Xu J, 2008, LETT APPL MICROBIOL, V47, P174, DOI 10.1111/j.1472-765X.2008.02407.x.
   Zhang JB, 2012, PLANT GROWTH REGUL, V68, P231, DOI 10.1007/s10725-012-9711-5.
   Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320.}},
Number-of-Cited-References = {{68}},
Times-Cited = {{8}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{44}},
Journal-ISO = {{J. Nat. Prod.}},
Doc-Delivery-Number = {{AE0NJ}},
Unique-ID = {{ISI:000333662700025}},
DA = {{2018-08-13}},
}

@article{ ISI:000332406600023,
Author = {Wolf, Nina M. and Abad-Zapatero, Celerino and Johnson, Michael E. and
   Fung, Leslie W. -M.},
Title = {{Structures of SAICAR synthetase (PurC) from Streptococcus pneumoniae
   with ADP, Mg2+, AIR and Asp}},
Journal = {{ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY}},
Year = {{2014}},
Volume = {{70}},
Number = {{3}},
Pages = {{841-850}},
Month = {{MAR}},
Abstract = {{Streptococcus pneumoniae is a multidrug-resistant pathogen that is a
   target of considerable interest for antibacterial drug development. One
   strategy for drug discovery is to inhibit an essential metabolic enzyme.
   The seventh step of the de novo purine-biosynthesis pathway converts
   carboxyaminoimidazoleribonucleotide (CAIR) and L-aspartic acid (Asp) to
   4-(N-succino)-5-aminoimidazole-4-carboxamide ribonucleotide (SAICAR) in
   the presence of adenosine 5'-triphosphate (ATP) using the enzyme PurC.
   PurC has been shown to be conditionally essential for bacterial
   replication. Two crystal structures of this essential enzyme from
   Streptococcus pneumoniae (spPurC) in the presence of adenosine
   5'-diphosphate (ADP), Mg2+, aminoimidazoleribonucleotide (AIR) and/or
   Asp have been obtained. This is the first structural study of spPurC, as
   well as the first of PurC from any species with Asp in the active site.
   Based on these findings, two model structures are proposed for the
   active site with all of the essential ligands (ATP, Mg2+, Asp and CAIR)
   present, and a relay mechanism for the formation of the product SAICAR
   is suggested.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fung, LWM (Reprint Author), Univ Illinois, Dept Chem, Chicago, IL 60607 USA.
   Wolf, Nina M.; Fung, Leslie W. -M., Univ Illinois, Dept Chem, Chicago, IL 60607 USA.
   Abad-Zapatero, Celerino; Johnson, Michael E., Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA.}},
DOI = {{10.1107/S139900471303366X}},
ISSN = {{1399-0047}},
Keywords-Plus = {{X-RAY-DIFFRACTION; PURINE BIOSYNTHETIC-PATHWAY; NUCLEOTIDE BIOSYNTHESIS;
   CRYSTAL-STRUCTURE; ENZYME PAICS; SYNTHASE; COMPLEX; AMPK}},
Research-Areas = {{Biochemistry \& Molecular Biology; Biophysics; Crystallography}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Biochemistry \& Molecular Biology;
   Biophysics; Crystallography}},
Author-Email = {{lfung@uic.edu}},
Funding-Acknowledgement = {{Defense Threat Reduction Agency (DTRA) {[}HDTRA1-11-C-0011];
   Chancellor's Graduate Research Fellowship at the University of Illinois
   at Chicago; US Department of Energy, Office of Science, Office of Basic
   Energy Sciences {[}W-31-109-Eng-38]; Searle Funds at the Chicago
   Community Trust}},
Funding-Text = {{This work was supported in part by the Defense Threat Reduction Agency
   (DTRA) with contract HDTRA1-11-C-0011 and the Chancellor's Graduate
   Research Fellowship (to NMW) at the University of Illinois at Chicago.
   Use of the Advanced Photon Source was supported by the US Department of
   Energy, Office of Science, Office of Basic Energy Sciences under
   Contract No. W-31-109-Eng-38. The mass-spectrometry facility at RRC was
   established in part by a grant from the Searle Funds at the Chicago
   Community Trust to the Chicago Biomedical Consortium. The authors thank
   Claire Marquis in MEJ's laboratory for preparing the plasmid containing
   the spPurC gene and Loredana Huma in MEJ's laboratory for preparing
   CAIR. We are most grateful to Professor Daesung Lee of UIC for helpful
   discussion and for pointing out the possible relay mechanism for
   activating CAIR and to Professor Duncan Wardrop of UIC for discussion of
   ligand conformation and insights into the reaction mechanism.}},
Cited-References = {{Antonyuk SV, 2001, CRYSTALLOGR REP+, V46, P620, DOI 10.1134/1.1387127.
   Cornick JE, 2012, MICROBES INFECT, V14, P573, DOI 10.1016/j.micinf.2012.01.012.
   Day P, 2007, ACTA CRYSTALLOGR D, V63, P587, DOI {[}10.1107/S0907444907009110, 10.1107/S09074449070091].
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493.
   Frey P. A., 2007, ENYMATIC REACTION ME, P547.
   Ginder ND, 2006, J BIOL CHEM, V281, P20680, DOI 10.1074/jbc.M602109200.
   GROZIAK MP, 1988, P NATL ACAD SCI USA, V85, P7174, DOI 10.1073/pnas.85.19.7174.
   HUI FM, 1993, J BACTERIOL, V175, P6364.
   Jin XS, 2007, STRUCTURE, V15, P1285, DOI 10.1016/j.str.2007.07.017.
   Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860.
   Levdikov VM, 1998, STRUCTURE, V6, P363, DOI 10.1016/S0969-2126(98)00038-0.
   Li SX, 2007, J MOL BIOL, V366, P1603, DOI 10.1016/j.jmb.2006.12.027.
   Liao JC, 2004, EUR BIOPHYS J BIOPHY, V33, P29, DOI 10.1007/s00249-003-0339-2.
   LITCHFIELD GJ, 1971, J CHEM SOC B, P1474, DOI 10.1039/j29710001474.
   Lynch JP, 2010, CURR OPIN PULM MED, V16, P217, DOI 10.1097/MCP.0b013e3283385653.
   Manjunath K, 2013, INT J BIOL MACROMOL, V53, P7, DOI 10.1016/j.ijbiomac.2012.10.028.
   Mehl RA, 2002, J LABELLED COMPD RAD, V45, P1097, DOI 10.1002/jlcr.627.
   Nelson SW, 2005, BIOCHEMISTRY-US, V44, P766, DOI 10.1021/bi048191w.
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X.
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084.
   Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037.
   Shomura Y, 2012, PROTEIN SCI, V21, P707, DOI 10.1002/pro.2058.
   Smith AJT, 2009, ORG BIOMOL CHEM, V7, P2716, DOI 10.1039/b901429b.
   Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327.
   Taschner M, 2013, PROTEINS, V81, P1473, DOI 10.1002/prot.24296.
   Urusova DV, 2006, CRYSTALLOGR REP+, V51, P824, DOI 10.1134/S1063774506050129.
   Urusova DV, 2003, CRYSTALLOGR REP+, V48, P763, DOI 10.1134/1.1612597.
   van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4.
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749.
   Zhang RG, 2006, ACTA CRYSTALLOGR F, V62, P335, DOI 10.1107/S1744309106009651.
   Zhang Y, 2008, CELL MOL LIFE SCI, V65, P3699, DOI 10.1007/s00018-008-8295-8.
   Zhang Y, 2008, BIOCHEMISTRY-US, V47, P205, DOI 10.1021/bi701406g.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{6}},
Journal-ISO = {{Acta Crystallogr. Sect. D-Biol. Crystallogr.}},
Doc-Delivery-Number = {{AC3HC}},
Unique-ID = {{ISI:000332406600023}},
DA = {{2018-08-13}},
}

@article{ ISI:000331851500017,
Author = {Gao, Jing and Zhao, Xiaonan and Bao, Ying and Ma, Ruihua and Zhou, Yufa
   and Li, Xinxian and Chai, Tongjie and Cai, Yumei},
Title = {{Antibiotic resistance and OXA-type carbapenemases-encoding genes in
   airborne Acinetobacter baumannii isolated from burn wards}},
Journal = {{BURNS}},
Year = {{2014}},
Volume = {{40}},
Number = {{2}},
Pages = {{295-299}},
Month = {{MAR}},
Abstract = {{The study was conducted to investigate drug resistance, OXA-type
   carbapenemases-encoding genes and genetic diversity in airborne
   Acinetobacter baumannii (A. baumannii) in burn wards. Airborne A.
   baumannii were collected in burn wards and their corridors using
   Andersen 6-stage air sampler from January to June 2011. The isolates
   susceptibility to 13 commonly used antibiotics was examined according to
   the CLSI guidelines; OXA-type carbapenemases-encoding genes and
   molecular diversity of isolates were analyzed, respectively. A total of
   16 non-repetitive A. baumannii were isolated, with 10 strains having a
   resistance rate of greater than 50\% against the 13 antibiotics. The
   resistance rate against ceftriaxone, cyclophosvnamide, ciprofloxacin,
   and imipenem was 93.75\% (15/16), but no isolate observed to be
   resistant to cefoperazone/sulbactam. Resistance gene analyses showed
   that all 16 isolates carried OXA-51, and 15 isolates carried OXA-23
   except No.15; but OXA-24 and 0)CA-58 resistance genes not detected. The
   isolates were classified into 13 genotypes (A-M) according to repetitive
   extragenic palindromic sequence PCR (REP-PCR) results and only six
   isolates had a homology >= 90\%. In conclusion, airborne A. baumannii in
   the burn wards had multidrug resistance and complex molecular diversity,
   and OXA-23 and OXA-51 were dominant mechanisms for resisting
   carbapenems. (C) 2013 Elsevier Ltd and ISBI. All rights reserved.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chai, TJ (Reprint Author), Shandong Agr Univ, Coll Anim Sci \& Vet Med, Daizong St 61, Tai An 271018, Shandong, Peoples R China.
   Gao, Jing; Zhao, Xiaonan; Li, Xinxian; Chai, Tongjie; Cai, Yumei, Shandong Agr Univ, Coll Anim Sci \& Vet Med, Sino German Cooperat Res Ctr Zoonosis Anim Origin, Tai An 271018, Shandong, Peoples R China.
   Gao, Jing; Bao, Ying; Li, Xinxian, Taian City Cent Hosp, Tai An, Shandong, Peoples R China.
   Ma, Ruihua; Li, Xinxian, Shandong Agr Univ, Affiliated Hosp, Tai An 271018, Shandong, Peoples R China.
   Zhou, Yufa; Li, Xinxian, Daiyue Husb Bur Taian, Tai An, Shandong, Peoples R China.}},
DOI = {{10.1016/j.burns.2013.06.003}},
ISSN = {{0305-4179}},
EISSN = {{1879-1409}},
Keywords = {{Burn wards; Airborne Acinetobacter baumannii; OXA-type
   carbapenemases-encoding resistance genes; REP-PCR; Molecular diversity}},
Keywords-Plus = {{HOSPITAL OUTBREAK; INFECTION; CHINA; PCR}},
Research-Areas = {{General \& Internal Medicine; Dermatology; Surgery}},
Web-of-Science-Categories  = {{Critical Care Medicine; Dermatology; Surgery}},
Author-Email = {{chaitj117@163.com
   caiyum@163.com}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}31270172]; State Key
   Laboratory for Environmental Protection, Using of Environmental
   Microbiology and Security Controls {[}MARC2011D061]; Postdoctoral
   Science Foundation {[}110017]}},
Funding-Text = {{This study was sponsored by the Project of National Natural Science
   Foundation of China {[}31270172] ``Studies on transmission mode of the
   bacteria aerosols carrying pan-resistance and toxin genes in rearing
   environment based on the genomics traceability technology{''}; The open
   fund 2011 of the State Key Laboratory for Environmental Protection,
   Using of Environmental Microbiology and Security Controls {[}No.
   MARC2011D061]; and the Postdoctoral Science Foundation ``Occurrence and
   dissemination of airborne resistant bacteria in hospital environment
   {[}110017]{''}.}},
Cited-References = {{ALLEN KD, 1987, J HOSP INFECT, V9, P110, DOI 10.1016/0195-6701(87)90048-X.
   Amudhan SM, 2011, INDIAN J MED MICROBI, V29, P269, DOI 10.4103/0255-0857.83911.
   ANDERSEN AA, 1958, J BACTERIOL, V76, P471.
   Apisarnthanarak A, 2013, CLIN INFECT DIS, V56, P1057, DOI 10.1093/cid/cis1024.
   Bogaerts P, 2006, J CLIN MICROBIOL, V44, P4189, DOI 10.1128/JCM.00796-06.
   Chen ZH, 2012, J BASIC MICROB, V52, P1.
   Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI.
   Hu QJ, 2011, J BASIC MICROB, V51, P467, DOI 10.1002/jobm.201000402.
   Jeong SH, 2006, J MICROBIOL, V44, P423.
   Lee JY, 2012, J BACT VIROL, V42, P1.
   {[}李耘 Li Yun], 2011, {[}中华医院感染学杂志, Chinese Journal of Nosocomiology], V21, P5133.
   {[}梁伟 Liang Wei], 2012, {[}中南大学学报. 医学版, Journal of Central South University. Medical Sciences], V37, P521.
   Mendes RE, 2009, CLIN MICROBIOL INFEC, V15, P588, DOI 10.1111/j.1469-0691.2009.02770.x.
   Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741.
   Obbard JP, 2003, WATER AIR SOIL POLL, V144, P333, DOI 10.1023/A:1022973402453.
   Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06.
   Snelling AM, 1996, J CLIN MICROBIOL, V34, P1193.
   Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06.
   VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823.
   Walther-Rasmussen J, 2006, J ANTIMICROB CHEMOTH, V57, P373, DOI 10.1093/jac/dki482.
   Wang F., 2010, CHIN J INFECT CHEMOT, V10, P325.
   Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004.
   Xu YM, 2011, J KUNMING MED U, V9, P92.
   Yang SC, 2010, EUR J CLIN MICROBIOL, V29, P601, DOI 10.1007/s10096-010-0878-2.
   {[}周秀珍 Zhou Xiuzhen], 2011, {[}中国临床药理学杂志, The Chinese Journal of Clinical Pharmacology], V27, P755.
   Zong Z, 2008, INT J ANTIMICROB AG, V31, P50, DOI 10.1016/j.ijantimicag.2007.08.019.
   陈佰义, 2012, {[}中华医学杂志, National Medical Journal of China], V92, P76.}},
Number-of-Cited-References = {{27}},
Times-Cited = {{13}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{11}},
Journal-ISO = {{Burns}},
Doc-Delivery-Number = {{AB5TL}},
Unique-ID = {{ISI:000331851500017}},
DA = {{2018-08-13}},
}

@article{ ISI:000328518200036,
Author = {Yu, Tao and Jiang, Xiaojie},
Title = {{Prevalence and characterization of Listeria monocytogenes isolated from
   retail food in Henan, China}},
Journal = {{FOOD CONTROL}},
Year = {{2014}},
Volume = {{37}},
Pages = {{228-231}},
Month = {{MAR}},
Abstract = {{Listeria monocytogenes, an important foodborne pathogen, is the causal
   agent of listeriosis. In this study, a total of 954 food samples
   originating from raw meat, cooked meat products, seafood, and vegetables
   purchased from supermarkets and open-air markets in Henan province,
   China, were analyzed for the presence of L. monocytogenes. All L
   monocytogenes isolates were subjected to serotyping, pulsed-field gel
   electrophoresis (PFGE), and antimicrobial resistance. The overall
   percentage of L monocytogenes prevalence was 6.2\% (n = 59) with the
   highest rate of 7.4\% for cooked meat products followed by raw meat
   (6.7\%). The isolates belonged to five serotypes (1/2a, 1/2b, 1/2c, 4b,
   and 4c), with serotype 1/2a being predominant (55.9\%). PFGE revealed a
   low genetic diversity among the isolates, irrespective of their sources,
   suggesting that dominant clones are widespread in different food
   products in Henan. Resistance to cefotaxime (30.5\%) and ciprofloxacin
   (13.5\%) was most often, whereas resistance to tetracycline,
   trimethoprim/sulfamethoxazole, and erythromycin was observed less
   frequently. The presence of L. monocytogenes in food products and
   antimicrobial resistance among the isolates represents a potential
   public health risk. Our results indicate that effective hygienic
   measures and bacteriological controls are necessary in China to reduce
   the contamination of retail food samples by L. monocytogenes. (C) 2013
   Elsevier Ltd. All rights reserved.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Yu, T (Reprint Author), Xinxiang Univ, Dept Chem \& Chem Engn, Xinxiang 453000, Peoples R China.
   Yu, Tao, Xinxiang Univ, Dept Chem \& Chem Engn, Xinxiang 453000, Peoples R China.
   Jiang, Xiaojie, Zhengzhou Univ, Coll Chem \& Mol Engn, Henan Prov Key Lab Chem Biol \& Organ Chem, Zhengzhou 450000, Peoples R China.}},
DOI = {{10.1016/j.foodcont.2013.09.047}},
ISSN = {{0956-7135}},
EISSN = {{1873-7129}},
Keywords = {{Listeria monocytogenes; Antimicrobial resistance; Retail food}},
Keywords-Plus = {{FIELD GEL-ELECTROPHORESIS; ANTIBIOTIC SUSCEPTIBILITY; ANTIMICROBIAL
   RESISTANCE; PRODUCTS; CHICKEN; GREECE; SPP.}},
Research-Areas = {{Food Science \& Technology}},
Web-of-Science-Categories  = {{Food Science \& Technology}},
Author-Email = {{yutao7777@hotmail.com}},
ORCID-Numbers = {{Yu, Tao/0000-0003-2030-7870}},
Funding-Acknowledgement = {{Key Project of Natural Science of Education Department of Henan
   Province, China {[}13A610839]; Science and Technology Innovation
   Foundation of Xinxiang University {[}12ZA02]}},
Funding-Text = {{This work was supported by the Key Project of Natural Science of
   Education Department of Henan Province, China (13A610839) and the
   Science and Technology Innovation Foundation of Xinxiang University
   (12ZA02).}},
Cited-References = {{Borucki MK, 2003, J CLIN MICROBIOL, V41, P5537, DOI 10.1128/JCM.41.12.5537-5540.2003.
   Chao G., 2005, CHINESE J HLTH LAB T, V15, P519.
   Charpentier E, 1999, ANTIMICROB AGENTS CH, V43, P2103.
   Chen BY, 2010, LETT APPL MICROBIOL, V50, P626, DOI 10.1111/j.1472-765X.2010.02843.x.
   Chen JS, 2009, FOODBORNE PATHOG DIS, V6, P7, DOI 10.1089/fpd.2008.0139.
   Conter M, 2009, INT J FOOD MICROBIOL, V128, P497, DOI 10.1016/j.ijfoodmicro.2008.10.018.
   Filiousis G, 2009, FOOD CONTROL, V20, P314, DOI 10.1016/j.foodcont.2008.05.018.
   Fugett EB, 2007, J CLIN MICROBIOL, V45, P865, DOI 10.1128/JCM.01285-06.
   Garrido V, 2009, FOOD CONTROL, V20, P986, DOI 10.1016/j.foodcont.2008.11.013.
   Granier SA, 2011, APPL ENVIRON MICROB, V77, P2788, DOI 10.1128/AEM.01381-10.
   Graves LM, 2001, INT J FOOD MICROBIOL, V65, P55, DOI 10.1016/S0168-1605(00)00501-8.
   Jalali M, 2008, INT J FOOD MICROBIOL, V122, P336, DOI 10.1016/j.ijfoodmicro.2007.11.082.
   Jiang XB, 2012, MICROBIOL IMMUNOL, V56, P843, DOI 10.1111/j.1348-0421.2012.00506.x.
   Meyer C, 2012, FOOD RES INT, V48, P944, DOI 10.1016/j.foodres.2012.02.022.
   Morvan A, 2010, ANTIMICROB AGENTS CH, V54, P2728, DOI 10.1128/AAC.01557-09.
   Osaili TM, 2011, FOOD CONTROL, V22, P586, DOI 10.1016/j.foodcont.2010.10.008.
   Pan J., 2008, CHINESE J PUBLIC HLT, V24, P107.
   Pan Y, 2010, APPL ENVIRON MICROB, V76, P1433, DOI 10.1128/AEM.02185-09.
   Pesavento G, 2010, FOOD CONTROL, V21, P708, DOI 10.1016/j.foodcont.2009.10.012.
   Safdar A, 2003, J CLIN MICROBIOL, V41, P483, DOI 10.1128/JCM.41.1.483-485.2003.
   Sakaridis I, 2011, J FOOD PROTECT, V74, P1017, DOI 10.4315/0362-028X.JFP-10-545.
   Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011.
   Todd ECD, 2011, FOOD CONTROL, V22, P1484, DOI 10.1016/j.foodcont.2010.07.021.
   Yan H, 2010, INT J FOOD MICROBIOL, V144, P310, DOI 10.1016/j.ijfoodmicro.2010.10.015.
   Zhang YF, 2007, INT J FOOD MICROBIOL, V113, P47, DOI 10.1016/j.ijfoodmicro.2006.07.010.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{16}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{34}},
Journal-ISO = {{Food Control}},
Doc-Delivery-Number = {{273EQ}},
Unique-ID = {{ISI:000328518200036}},
DA = {{2018-08-13}},
}

@article{ ISI:000331711900067,
Author = {Waman, Vaishali P. and Kolekar, Pandurang S. and Kale, Mohan M. and
   Kulkarni-Kale, Urmila},
Title = {{Population Structure and Evolution of Rhinoviruses}},
Journal = {{PLOS ONE}},
Year = {{2014}},
Volume = {{9}},
Number = {{2}},
Month = {{FEB 19}},
Abstract = {{Rhinoviruses, formerly known as Human rhinoviruses, are the most common
   cause of air-borne upper respiratory tract infections in humans.
   Rhinoviruses belong to the family Picornaviridae and are divided into
   three species namely, Rhinovirus A, -B and -C, which are antigenically
   diverse. Genetic recombination is found to be one of the important
   causes for diversification of Rhinovirus species. Although emerging
   lineages within Rhinoviruses have been reported, their population
   structure has not been studied yet. The availability of complete genome
   sequences facilitates study of population structure, genetic diversity
   and underlying evolutionary forces, such as mutation, recombination and
   selection pressure. Analysis of complete genomes of Rhinoviruses using a
   model-based population genetics approach provided a strong evidence for
   existence of seven genetically distinct subpopulations. As a result of
   diversification, Rhinovirus A and -C populations are divided into four
   and two subpopulations, respectively. Genetically, the Rhinovirus B
   population was found to be homogeneous. Intra-species recombination was
   observed to be prominent in Rhinovirus A and -C species. Significant
   evidence of episodic positive selection was obtained for several sites
   within coding sequences of structural and nonstructural proteins. This
   corroborates well with known phenotypic properties such as antigenicity
   of structural proteins. Episodic positive selection appears to be
   responsible for emergence of new lineages especially in Rhinovirus A. In
   summary, the Rhinovirus population is an ensemble of seven distinct
   lineages. In case of Rhinovirus A, intra-species recombination and
   episodic positive selection contribute to its further diversification.
   In case of Rhinovirus C, intra- and inter-species recombinations are
   responsible for observed diversity. Population genetics approach was
   further useful to analyze phylogenetic tree topologies pertaining to
   recombinant strains, especially when trees are derived using complete
   genomes. Understanding of population structure serves as a foundation
   for designing new vaccines and drugs as well as to explain emergence of
   drug resistance amongst subpopulations.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kulkarni-Kale, U (Reprint Author), Univ Pune, Bioinformat Ctr, Pune, Maharashtra, India.
   Waman, Vaishali P.; Kolekar, Pandurang S.; Kulkarni-Kale, Urmila, Univ Pune, Bioinformat Ctr, Pune, Maharashtra, India.
   Kale, Mohan M., Univ Pune, Dept Stat, Pune, Maharashtra, India.}},
DOI = {{10.1371/journal.pone.0088981}},
Article-Number = {{e88981}},
ISSN = {{1932-6203}},
Keywords-Plus = {{DEPENDENT RNA-POLYMERASE; MULTILOCUS GENOTYPE DATA; COMMON COLD VIRUS;
   GENETIC-STRUCTURE; SPECIES C; RECOMBINANT SEQUENCES; PHYLOGENETIC
   ANALYSIS; CELLULAR RECEPTOR; MOSAIC STRUCTURE; INFECTIONS}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{urmila@bioinfo.net.in}},
ORCID-Numbers = {{Kolekar, Pandurang/0000-0003-0044-0076}},
Funding-Acknowledgement = {{Center of Excellence (CoE) grant from the Department of Information
   Technology (DeitY); Ministry of Communications \& Information Technology
   (MCIT); Government of India, New Delhi; Department of Biotechnology
   (DBT), Government of India, New Delhi}},
Funding-Text = {{This work is supported by Center of Excellence (CoE) grant from the
   Department of Information Technology (DeitY), Ministry of Communications
   \& Information Technology (MCIT), Government of India, New Delhi. UKK
   acknowledges DeitY, MCIT for financial assistance. VPW acknowledges the
   fellowship awarded by Department of Biotechnology (DBT), Government of
   India, New Delhi. PSK acknowledges the BioInformatics National
   Certification (BINC) fellowship awarded by DBT, Government of India, New
   Delhi. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.}},
Cited-References = {{ABZUG MJ, 1990, PEDIATR INFECT DIS J, V9, P881, DOI 10.1097/00006454-199012000-00005.
   APPLEYARD G, 1990, J GEN VIROL, V71, P1275, DOI 10.1099/0022-1317-71-6-1275.
   Baranowski E, 2001, SCIENCE, V292, P1102, DOI 10.1126/science.1058613.
   Basta HA, 2014, VIROLOGY, V448, P176, DOI 10.1016/j.virol.2013.10.006.
   Becquet C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030066.
   Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI 10.1093/nar/gks1195.
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235.
   Bertino JS, 2002, AM J MED, V112, p42S.
   Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874.
   Collinson J, 1996, THORAX, V51, P1115, DOI 10.1136/thx.51.11.1115.
   Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429.
   DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003.
   Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910.
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x.
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47.
   Falush D, 2003, GENETICS, V164, P1567.
   Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857.
   Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487.
   Fischer W, 2012, J VIROL, V86, P13217, DOI 10.1128/JVI.01862-12.
   Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573.
   GORBALENYA AE, 1990, FEBS LETT, V262, P145, DOI 10.1016/0014-5793(90)80175-I.
   HAMPARIAN VV, 1987, VIROLOGY, V159, P191.
   Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847.
   Hewat EA, 2000, EMBO J, V19, P6317, DOI 10.1093/emboj/19.23.6317.
   HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839.
   Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006355.
   KAPIKIAN A Z, 1967, Nature (London), V213, P761.
   Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195.
   Khetsuriani N, 2008, EMERG INFECT DIS, V14, P1793, DOI 10.3201/eid1411.080386.
   Kolatkar PR, 1999, EMBO J, V18, P6249, DOI 10.1093/emboj/18.22.6249.
   Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062.
   Laine P, 2005, J GEN VIROL, V86, P697, DOI 10.1099/vir.0.80445-0.
   Lauber C, 2012, J VIROL, V86, P3905, DOI 10.1128/JVI.07174-11.
   Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004.
   Lewis-Rogers N, 2009, MOL BIOL EVOL, V26, P969, DOI 10.1093/molbev/msp009.
   Li HF, 2009, J GENET, V88, P197, DOI 10.1007/s12041-009-0028-8.
   Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187.
   Love RA, 2004, STRUCTURE, V12, P1533, DOI 10.1016/j.str.2004.05.024.
   Lukashev AN, 2005, REV MED VIROL, V15, P157, DOI 10.1002/rmv.457.
   Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562.
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467.
   Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98.
   McIntyre CL, 2013, ARCH VIROL, V158, P1497, DOI 10.1007/s00705-013-1634-6.
   McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10.
   Miller EK, 2009, J CLIN VIROL, V46, P85, DOI 10.1016/j.jcv.2009.06.007.
   MORI J, 1994, J MED VIROL, V44, P323, DOI 10.1002/jmv.1890440403.
   Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863.
   Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335.
   Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764.
   Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056.
   Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557.
   Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443.
   Petersen JFW, 1999, EMBO J, V18, P5463, DOI 10.1093/emboj/18.20.5463.
   PEVEAR DC, 1989, J VIROL, V63, P2002.
   Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125.
   Pond SLK, 2005, STAT BIOL HEALTH, P125, DOI 10.1007/0-387-27733-1\_6.
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105.
   Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320.
   Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698.
   Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s0023901-0034-9.
   Prasanna HC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-220.
   Pritchard JK, 2000, GENETICS, V155, P945.
   Privman E, 2012, MOL BIOL EVOL, V29, P1, DOI 10.1093/molbev/msr177.
   Rathe JA, 2010, ARCH VIROL, V155, P83, DOI 10.1007/s00705-009-0549-8.
   Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311.
   Savolainen C, 2004, J GEN VIROL, V85, P2271, DOI 10.1099/vir.0.79897-0.
   Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333.
   Schibler M, 2012, J GEN VIROL, V93, P93, DOI 10.1099/vir.0.035808-0.
   Seemungal TAR, 2000, EUR RESPIR J, V16, P677, DOI 10.1034/j.1399-3003.2000.16d19.x.
   SHERRY B, 1986, J VIROL, V57, P246.
   Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06.
   Simmonds P, 2010, J GEN VIROL, V91, P2409, DOI 10.1099/vir.0.023994-0.
   SMITH JM, 1992, J MOL EVOL, V34, P126.
   STOTT EJ, 1968, J MED MICROBIOL, V1, P109, DOI 10.1099/00222615-1-1-109.
   Subramaniam S, 2013, INFECT GENET EVOL, V18, P1, DOI 10.1016/j.meegid.2013.04.027.
   Szmaragd C, 2007, MOL ECOL, V16, P4747, DOI 10.1111/j.1365-294X.2007.03564.x.
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121.
   Tan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051439.
   Tapparel C, 2009, EMERG INFECT DIS, V15, P719, DOI 10.3201/eid1505.081286.
   UNCAPHER CR, 1991, VIROLOGY, V180, P814, DOI 10.1016/0042-6822(91)90098-V.
   Wisdom A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008518.}},
Number-of-Cited-References = {{81}},
Times-Cited = {{13}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{14}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{AB3TA}},
Unique-ID = {{ISI:000331711900067}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000330089500021,
Author = {Torres Mena, Julia Esperanza and Sanchez Rodriguez, Ricardo and
   Quintanar Jurado, Valeria and Mojica Espinosa, Raul and Del Pozo Yauner,
   Luis and Melendez Zajgla, Jorge and Villa Trevino, Saul and Perez
   Carreon, Julio Isael},
Title = {{Laser capture microdissection after gamma-glutamyl transferase
   histochemistry: An optimization for gene expression analysis}},
Journal = {{ANALYTICAL BIOCHEMISTRY}},
Year = {{2014}},
Volume = {{447}},
Pages = {{126-132}},
Month = {{FEB 15}},
Abstract = {{gamma-Glutamyl transferase (GGT) is useful as a marker in pathological
   conditions, including several types of cancer. We optimized the
   histochemical detection of GGT to assay the gene expression profiles of
   phenotype-specific cells selected by laser capture microdissection
   (LCM). For optimization, we used the livers of rats subjected to
   hepatocarcinogenesis. This model induced nodules of hepatocytes and
   tumors with GGT activity. To obtain sufficient high-quality RNA after
   histochemistry and LCM, we included an RNase inhibitor and air-dried the
   tissue sections. This optimization allowed the visualization of GGT
   activity in situ and a yield of 1.4 to 2.0 mu g of total RNA from 15 to
   18 mm(2) of microdissected tissue (20 mu m thickness). The average RNA
   integrity number in GGT-positive tissue, determined by chip capillary
   electrophoresis, was 6.9, and the 28S/18S ribosomal RNA (rRNA) ratio was
   1.4. The RNAs were processed for the Rat Gene 1.0 ST Array (Affymetrix).
   Comparable quality control metrics, such as signal intensity and RNA
   degradation plots, were found between the LCM samples and non-LCM
   tissue. The increased expression of Ggt1 expected in GGT-positive tissue
   was confirmed by microarrays and quantitative reverse transcriptase
   polymerase chain reaction (qRT PCR). This optimization provided a
   suitable method for whole-transcript analysis of GGT-positive tissue
   isolated using LCM. (C) 2013 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Carreon, JIP (Reprint Author), Inst Natl Med Genom, Mexico City, DF, Mexico.
   Torres Mena, Julia Esperanza; Sanchez Rodriguez, Ricardo; Quintanar Jurado, Valeria; Mojica Espinosa, Raul; Del Pozo Yauner, Luis; Melendez Zajgla, Jorge; Perez Carreon, Julio Isael, Inst Natl Med Genom, Mexico City, DF, Mexico.
   Torres Mena, Julia Esperanza; Villa Trevino, Saul, Ctr Invest \& Estudios Avanzados IPN, Dept Biol Celular, Mexico City, DF, Mexico.}},
DOI = {{10.1016/j.ab.2013.11.015}},
ISSN = {{0003-2697}},
EISSN = {{1096-0309}},
Keywords = {{RNA; Carcinoma; Atherosclerosis; Liver neoplasms; Reverse transcriptase
   PCR; DNA microarrays}},
Keywords-Plus = {{MESSENGER-RNA ANALYSIS; DRUG-RESISTANCE; HEPATOCELLULAR-CARCINOMA;
   TRANSPEPTIDASE ACTIVITY; LIVER CARCINOGENESIS; BREAST-TISSUE;
   CANCER-CELLS; IMMUNO-LCM; IN-SITU; GST-P}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Biochemistry \& Molecular Biology;
   Chemistry, Analytical}},
Author-Email = {{jiperez@inmegen.gob.mx}},
ResearcherID-Numbers = {{Mojica Espinosa, Raul/I-8374-2017}},
ORCID-Numbers = {{Mojica Espinosa, Raul/0000-0003-0855-7594}},
Funding-Acknowledgement = {{Fondo Sectorial de Investigacion en Salud y Seguridad Social
   SSA/IMSS/ISSSTE-CONACYT {[}SALUD-2009-01-115431]; Institutional Project
   {[}77-10/2011/I]}},
Funding-Text = {{We greatly appreciate the technical assistance of Karol Carrillo
   Sanchez, Nayeli Belem Gabino Lopez, and Dan Jerzain Gutierrez Fuentes
   from the high-technology units at INMEGEN. Thanks also go to Evelia Arce
   Popoca, Sergio Hernandez Garcia, and Ruth Pacheco for their technical
   assistance at CINVESTAV. This work was supported by Fondo Sectorial de
   Investigacion en Salud y Seguridad Social SSA/IMSS/ISSSTE-CONACYT
   SALUD-2009-01-115431 and Institutional Project 77-10/2011/I.}},
Cited-References = {{ALBERT Z, 1970, ACTA HISTOCHEM, V37, P74.
   ARAI K, 1995, BBA-PROTEIN STRUCT M, V1253, P33, DOI 10.1016/0167-4838(95)00141-G.
   Archer KJ, 2006, BIOSTATISTICS, V7, P198, DOI 10.1093/biostatistics/kxj001.
   BERGER SL, 1975, ANAL BIOCHEM, V67, P428, DOI 10.1016/0003-2697(75)90315-2.
   Blair SL, 1997, CANCER RES, V57, P152.
   Buckanovich RJ, 2006, CANCER BIOL THER, V5, P635, DOI 10.4161/cbt.5.6.2676.
   CAMERON R, 1978, CANCER RES, V38, P823.
   Clement-Ziza M, 2008, RNA, V14, P2698, DOI 10.1261/rna.1261708.
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25.
   Corti A, 2010, ANTICANCER RES, V30, P1169.
   Durham JR, 1997, BREAST CANCER RES TR, V45, P55, DOI 10.1023/A:1005889006557.
   Eijssen LMT, 2013, NUCLEIC ACIDS RES, V41, pW71, DOI 10.1093/nar/gkt293.
   ENOMOTO K, 1982, CANCER RES, V42, P2330.
   Fend F, 1999, AM J PATHOL, V154, P61, DOI 10.1016/S0002-9440(10)65251-0.
   FIALA S, 1980, CANCER DETECT PREV, V3, P471.
   Fink L, 2000, LAB INVEST, V80, P327, DOI 10.1038/labinvest.3780037.
   FLEMING N, 1977, HISTOCHEMISTRY, V51, P209, DOI 10.1007/BF00567225.
   Frierson HF, 1997, MODERN PATHOL, V10, P1.
   HANIGAN MH, 1985, CARCINOGENESIS, V6, P165, DOI 10.1093/carcin/6.2.165.
   HANIGAN MH, 1994, CANCER RES, V54, P286.
   Hanigan MH, 1999, HUM PATHOL, V30, P300, DOI 10.1016/S0046-8177(99)90009-6.
   Hochwald SN, 1997, ANN SURG ONCOL, V4, P303, DOI 10.1007/BF02303579.
   Ibberson D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-102.
   Kube DM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-25.
   Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806.
   Maellaro E, 2000, J CELL SCI, V113, P2671.
   MarcheCova A, 1995, ARCH MED RES, V26, pS169.
   Mason Jennifer E, 2010, Prev Cardiol, V13, P36, DOI 10.1111/j.1751-7141.2009.00054.x.
   Mazzantini RP, 2008, J CELL BIOCHEM, V103, P538, DOI 10.1002/jcb.21420.
   Michel C, 2003, AM J PATHOL, V163, P2191, DOI 10.1016/S0002-9440(10)63577-8.
   Morrogh M, 2007, BIOTECHNIQUES, V43, P41, DOI 10.2144/000112497.
   Ordway GA, 2009, J NEUROSCI RES, V87, P2430, DOI 10.1002/jnr.22078.
   Perez-Carreon JI, 2006, NEOPLASIA, V8, P373, DOI 10.1593/neo.05841.
   Pettersen I, 2003, BBA-PROTEINS PROTEOM, V1648, P210, DOI 10.1016/S1570-9639(03)00146-8.
   Pompella A, 2006, BIOCHEM PHARMACOL, V71, P231, DOI 10.1016/j.bcp.2005.10.005.
   Pompella A, 2007, CURR OPIN PHARMACOL, V7, P360, DOI 10.1016/j.coph.2007.04.004.
   RUTENBURG AM, 1969, J HISTOCHEM CYTOCHEM, V17, P517, DOI 10.1177/17.8.517.
   SOLT DB, 1977, AM J PATHOL, V88, P595.
   Sonne SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005536.
   Suzuki S, 2004, CARCINOGENESIS, V25, P439, DOI 10.1093/carcin/bgh030.
   TAGER M, 1995, ANN HEMATOL, V70, P237.
   Tsutsumi M, 1996, HEPATOLOGY, V23, P1093.
   Vanderburg CR, 2013, MOL CELL BIOCHEM, V375, P159, DOI 10.1007/s11010-012-1538-x.
   VANDERLAAN M, 1981, HISTOCHEM J, V13, P865, DOI 10.1007/BF01003295.
   Wang WZ, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-69.
   WARD JP, 1975, ANN ROY COLL SURG, V57, P248.
   YOSHIDA KI, 1991, J UROLOGY, V146, P895, DOI 10.1016/S0022-5347(17)37956-9.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{19}},
Journal-ISO = {{Anal. Biochem.}},
Doc-Delivery-Number = {{295AR}},
Unique-ID = {{ISI:000330089500021}},
DA = {{2018-08-13}},
}

@article{ ISI:000331927000014,
Author = {Gao, Bin and Zhu, Shunyi},
Title = {{An Insect Defensin-Derived beta-Hairpin Peptide with Enhanced
   Antibacterial Activity}},
Journal = {{ACS CHEMICAL BIOLOGY}},
Year = {{2014}},
Volume = {{9}},
Number = {{2}},
Pages = {{405-413}},
Month = {{FEB}},
Abstract = {{Insect defensins are a class of small, cysteine-rich antimicrobial
   peptides primarily active on Gram-positive bacteria. Their roles in
   maggot therapy for treating chronic wound infection have been reported
   recently. However, a relatively narrow antibacterial spectrum together
   with the lack of a cost-effective means of commercial-scale production
   has limited their application. To further exploit the therapeutic
   potential of these molecules, we engineered the carboxyl-terminal
   beta-sheet of navidefensin2-2, an insect defensin from Nasonia
   vitripennis, based on its structural similarity to naturally occurring
   microbicidal beta-hairpin peptides. The designed peptide of 14 residues,
   referred to as N nu BH, spans the beta-sheet region of the defensin with
   two amino acids substituted for assembly of a disulfide-bonded
   amphipathic beta-hairpin structure. Liquid chromatography-tandem mass
   spectrometry (LC-MS/MS) combined with circular dichroism (CD) analysis
   shows that the oxidized N nu BH (oN nu BH), produced from the synthetic
   peptide by air oxidization in an alkaline environment, folds into a
   typical beta-hairpin structure linked by two disulfide bridges
   (Cys1-Cys4; Cys2-Cys3). However, such a structure appears not to be
   functionally necessary as synthetic N nu BH with a spontaneously
   oxidized disulfide bridge (Cys2-Cys3) (termed poN nu BH) displayed
   similar antibacterial potency to oN nu BH. In comparison with oN nu BH,
   poN nu BH exhibited higher serum stability and more resistance on
   tryptic digestion. These two forms of peptides are capable of killing an
   array of Gram-positive (including antibiotic-resistant strains of
   Staphylococcus) and Gram-negative bacterial pathogens at low micromolar
   concentrations through a membrane disruptive mode of action. Our work
   indicates that the beta-sheet region of insect defensins is a promising
   subdomain of proteins in anti-infective drug discovery.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Zhu, SY (Reprint Author), Chinese Acad Sci, Inst Zool, Grp Anim Innate Immun, State Key Lab Integrated Management Pest Insects, 1 Beichen West Rd, Beijing 100101, Peoples R China.
   Gao, Bin; Zhu, Shunyi, Chinese Acad Sci, Inst Zool, Grp Anim Innate Immun, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China.}},
DOI = {{10.1021/cb400591d}},
ISSN = {{1554-8929}},
EISSN = {{1554-8937}},
Keywords-Plus = {{ANTIMICROBIAL ACTIVITY; FUNGAL DEFENSIN; DISULFIDE BONDS;
   BROAD-SPECTRUM; PORE FORMATION; PROTEGRIN-1; LOOP; INVERTEBRATES;
   EVOLUTION; BACTERIA}},
Research-Areas = {{Biochemistry \& Molecular Biology}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology}},
Author-Email = {{zhusy@ioz.ac.cn}},
Funding-Acknowledgement = {{National Basic Research Program of China {[}2010CB945300]; National
   Natural Science Foundation of China {[}31221091]}},
Funding-Text = {{This work was supported by the National Basic Research Program of China
   (2010CB945300) and the National Natural Science Foundation of China
   (31221091).}},
Cited-References = {{Andersen AS, 2010, J ANTIMICROB CHEMOTH, V65, P1646, DOI 10.1093/jac/dkq165.
   Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180.
   Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x.
   CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0.
   Dassanayake RS, 2007, PEPTIDES, V28, P62, DOI 10.1016/j.peptides.2006.09.022.
   Dawson RM, 2010, INT J ANTIMICROB AG, V36, P579, DOI 10.1016/j.ijantimicag.2010.08.011.
   Dimarcq JL, 1998, BIOPOLYMERS, V47, P465, DOI 10.1002/(SICI)1097-0282(1998)47:6<465::AID-BIP5>3.0.CO;2-\#.
   Fahrner RL, 1996, CHEM BIOL, V3, P543, DOI 10.1016/S1074-5521(96)90145-3.
   Fazio MA, 2007, BIOPOLYMERS, V88, P386, DOI 10.1002/bip.20660.
   Gao B, 2012, BIOCHEM BIOPH RES CO, V426, P630, DOI 10.1016/j.bbrc.2012.08.143.
   Gao B, 2010, DEV COMP IMMUNOL, V34, P659, DOI 10.1016/j.dci.2010.01.012.
   Gao B, 2009, FASEB J, V23, P1230, DOI 10.1096/fj.08-122317.
   Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903.
   Hook E. W., 1988, PRINCIPLES PRACTICE, P1256.
   Hultmark D, 1998, TECHNIQUES INSECT IM, P103.
   Hwang J. S., 2009, INT J PEPT.
   Juvvadi P, 1996, J PEPT SCI, V2, P223, DOI 10.1002/psc.63.
   Laederach A, 2002, BIOCHEMISTRY-US, V41, P12359, DOI 10.1021/bi026185z.
   Lai JR, 2002, BIOCHEMISTRY-US, V41, P12835, DOI 10.1021/bi026127d.
   LAMBERT J, 1989, P NATL ACAD SCI USA, V86, P262, DOI 10.1073/pnas.86.1.262.
   Landon C, 2008, PROTEINS, V72, P229, DOI 10.1002/prot.21912.
   Lazaridis T, 2013, BIOPHYS J, V104, P633, DOI 10.1016/j.bpj.2012.12.038.
   Lee KH, 1998, BIOCHEM J, V334, P99, DOI 10.1042/bj3340099.
   Mandard N, 1999, J BIOMOL STRUCT DYN, V17, P367, DOI 10.1080/07391102.1999.10508368.
   Mandard N, 2002, EUR J BIOCHEM, V269, P1190, DOI 10.1046/j.0014-2956.2002.02760.x.
   Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x.
   Marcellini L, 2010, METHODS MOL BIOL, V618, P249, DOI 10.1007/978-1-60761-594-1\_16.
   MATSUYAMA K, 1988, J BIOL CHEM, V263, P17112.
   Powers JPS, 2004, BBA-PROTEINS PROTEOM, V1698, P239, DOI 10.1016/j.bbapap.2003.12.009.
   Romestand B, 2003, EUR J BIOCHEM, V270, P2805, DOI 10.1046/j.1432-1033.2003.03657.x.
   Sabatier J. M., 1999, ANIMAL TOXINS, P196.
   Schaaper WMM, 2001, J PEPT RES, V57, P409, DOI 10.1034/j.1399-3011.2001.00842.x.
   Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723.
   Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674.
   Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738.
   van den Bogaart G, 2008, J BIOL CHEM, V283, P33854, DOI 10.1074/jbc.M805171200.
   Wang YB, 2011, DEV COMP IMMUNOL, V35, P1128, DOI 10.1016/j.dci.2011.03.030.
   Watt PM, 2006, NAT BIOTECHNOL, V24, P177, DOI 10.1038/nbt1190.
   Xu W, 2010, MOL IMMUNOL, V47, P2138, DOI 10.1016/j.molimm.2010.01.025.
   Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101.
   Yu JK, 2008, DEV GENES EVOL, V218, P723, DOI 10.1007/s00427-008-0228-x.
   Zhu S, 2005, CELL MOL LIFE SCI, V62, P2257, DOI 10.1007/s00018-005-5200-6.
   Zhu SY, 2008, MOL IMMUNOL, V45, P828, DOI 10.1016/j.molimm.2007.06.354.
   Zhu SY, 2012, P NATL ACAD SCI USA, V109, P8495, DOI 10.1073/pnas.1201263109.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{12}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{41}},
Journal-ISO = {{ACS Chem. Biol.}},
Doc-Delivery-Number = {{AB6VG}},
Unique-ID = {{ISI:000331927000014}},
DA = {{2018-08-13}},
}

@article{ ISI:000331019600011,
Author = {Zhu, Shengwei and Srebric, Jelena and Rudnick, Stephen N. and Vincent,
   Richard L. and Nardell, Edward A.},
Title = {{Numerical modeling of indoor environment with a ceiling fan and an
   upper-room ultraviolet germicidal irradiation system}},
Journal = {{BUILDING AND ENVIRONMENT}},
Year = {{2014}},
Volume = {{72}},
Pages = {{116-124}},
Month = {{FEB}},
Abstract = {{This study proposes a numerical modeling method for the indoor
   environment with ceiling fans and upper-room ultraviolet germicidal
   irradiation (UR-UVGI) fixtures. The numerical modeling deployed
   steady-state Computational Fluid Dynamics (CFD) with a rotating
   reference frame to simulate the rotation of fan blades. CFD was
   validated with experimental data of velocity field and fraction of
   microorganism remaining at the exhaust diffuser. The fraction of
   microorganism remaining represented the ratio of the concentration of
   airborne microorganisms measured with UVGI turned on to the one measured
   with UVGI turned off. According to the validation results, the CFD model
   correctly reproduced the air movement induced by the rotation of ceiling
   fan. When the ambient ventilation rate was 2 ACH (air changes per hour)
   or 6 ACH, the CFD model accurately predicted the average vertical speeds
   in the section 2.44 m above the floor with the errors less than 10\%,
   regardless of the ceiling fan's rotational direction or speed. In
   addition, the simulation results showed that the fraction of
   microorganism remaining increased with the ambient air exchange rate
   when the fan blew air downward with a rotational speed as high as 235
   rpm, which corresponded with the experimental results. Furthermore, the
   simulation results accurately predicted the fraction of microorganism
   remaining when the ambient air exchange rate was 2 ACH. We conclude that
   this novel numerical model can reproduce the effects of ceiling fans and
   UR-UVGI fixtures on indoor environment, and should aid in the
   investigation of the impact of ceiling fans on UR-UVGI disinfection
   efficacy. (C) 2013 Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Zhu, SW (Reprint Author), Huazhong Univ Sci \& Technol, Sch Architecture \& Urban Planning, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.
   Zhu, Shengwei, Huazhong Univ Sci \& Technol, Sch Architecture \& Urban Planning, Wuhan 430074, Hubei, Peoples R China.
   Srebric, Jelena, Penn State Univ, Dept Architectural Engn, State Coll, PA USA.
   Rudnick, Stephen N.; Nardell, Edward A., Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Vincent, Richard L., Mt Sinai Sch Med, New York, NY USA.
   Nardell, Edward A., Brigham \& Womens Hosp, Boston, MA 02115 USA.}},
DOI = {{10.1016/j.buildenv.2013.10.019}},
ISSN = {{0360-1323}},
EISSN = {{1873-684X}},
Keywords = {{Upper-room ultraviolet germicidal irradiation; Ceiling fan;
   Computational fluid dynamics; Airborne infection control; Fraction of
   microorganism remaining}},
Keywords-Plus = {{DRUG-RESISTANT TUBERCULOSIS; AIR DISINFECTION; OUTBREAK; DESIGN}},
Research-Areas = {{Construction \& Building Technology; Engineering}},
Web-of-Science-Categories  = {{Construction \& Building Technology; Engineering, Environmental;
   Engineering, Civil}},
Author-Email = {{szhu@hust.edu.cn}},
ORCID-Numbers = {{Vincent, Richard/0000-0003-3453-4070}},
Funding-Acknowledgement = {{Fogarty Grant project ``Sustainable Air Design Technology Innovations
   for Resource Limited Settings{''} {[}R24TW008821]; American Recovery and
   Reinvestment Act (ARRA) by Fogarty International Center, National
   Institutes of Health, USA}},
Funding-Text = {{This study was supported by the Fogarty Grant project ``Sustainable Air
   Design Technology Innovations for Resource Limited Settings{''} (Grant
   number: R24TW008821), which was funded under the American Recovery and
   Reinvestment Act (ARRA) of 2009 by Fogarty International Center,
   National Institutes of Health, USA. The authors would like to thank Dr.
   Melvin First in Harvard School of Public Health, who was the main member
   of the project and passed away in 2011, for his great contribution to
   the project.}},
Cited-References = {{{[}Anonymous], 2011, US GUID STAR CCM 6 0.
   Bland JM, 1983, STATISTICIAN, V32, P307.
   Breathnach AS, 1998, J HOSP INFECT, V39, P111, DOI 10.1016/S0195-6701(98)90324-3.
   Cavet, 2010, INT LIGHT CONTR TECH.
   Dieker H, 2007, P SOC PHOTO-OPT INS, V6797, P67901.
   Escombe A.R., 2009, PLOS MED, V6, P0312.
   First M, 2007, J OCCUP ENVIRON HYG, V4, P321, DOI 10.1080/15459620701271693.
   Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229.
   Heidarinejad Mohammad, 2013, World Review of Science, Technology and Sustainable Development, V10, P78.
   Momoi Y, 2007, P 10 INT C AIR DISTR, P1141.
   Momoi Y., 2004, P 9 INT C AIR DISTR, P145.
   Noakes CJ, 2006, INDOOR BUILT ENVIRON, V15, P347, DOI 10.1177/1420356X0607353.
   Patankar SV, 1980, NUMERICAL HEAT TRANS.
   Qian H, 2009, BUILD ENVIRON, V44, P1651, DOI 10.1016/j.buildenv.2008.11.002.
   RILEY RL, 1972, APPL MICROBIOL, V23, P1113.
   RILEY RL, 1971, ARCH ENVIRON HEALTH, V22, P208, DOI 10.1080/00039896.1971.10665834.
   RILEY RL, 1971, ARCH ENVIRON HEALTH, V23, P35, DOI 10.1080/00039896.1971.10665951.
   Rodi W., 1991, P AIAA 29 AER SCI M, P13.
   Rudnick SN, 2007, J OCCUP ENVIRON HYG, V4, P352, DOI 10.1080/15459620701298167.
   Rudnick SN, 2012, HVAC\&R RES, V18, P774, DOI 10.1080/10789669.2012.667863.
   SHIH TH, 1995, COMPUT FLUIDS, V24, P227, DOI 10.1016/0045-7930(94)00032-T.
   Sung M, 2010, BUILD ENVIRON, V45, P1626, DOI 10.1016/j.buildenv.2010.01.011.
   US-NIOSH, 2009, ENV CONTR TUB BAS UP.
   Wells WF, 1942, AM J HYG, V35, P97, DOI 10.1093/oxfordjournals.aje.a118789.
   WHO, 2011, WHO REP 2012 GLOB TU.
   WOLFSHTE.M, 1969, INT J HEAT MASS TRAN, V12, P301, DOI 10.1016/0017-9310(69)90012-X.
   Zhu SW, 2013, PHOTOCHEM PHOTOBIOL, V89, P782, DOI 10.1111/php.12039.}},
Number-of-Cited-References = {{27}},
Times-Cited = {{14}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{13}},
Journal-ISO = {{Build. Environ.}},
Doc-Delivery-Number = {{AA3UK}},
Unique-ID = {{ISI:000331019600011}},
OA = {{green\_accepted}},
DA = {{2018-08-13}},
}

@article{ ISI:000330914000001,
Author = {Zheng, Guo-Xia and Zhang, Xue-Mei and Yang, Yu-Suo and Zeng, Shu-Rui and
   Wei, Jun-Feng and Wang, Yun-Hua and Li, Ya-Jie},
Title = {{An integrated microfludic device for culturing and screening of Giardia
   lamblia}},
Journal = {{EXPERIMENTAL PARASITOLOGY}},
Year = {{2014}},
Volume = {{137}},
Pages = {{1-7}},
Month = {{FEB}},
Abstract = {{In vitro culturing of trophozoites was important for research of Giardia
   lamblia (G. lamblia), especially in discovery of anti-Giardia agents.
   The current culture methods mainly suffer from lab-intension or the
   obstacle in standardizing the gas condition. Thus, it could benefit from
   a more streamlined and integrated approach. Microfluidics offers a way
   to accomplish this goal. Here we presented an integrated microfluidic
   device for culturing and screening of G. lambda. The device consisted of
   a polydimethylsiloxane (PDMS) microchip with an aerobic culture system.
   In the microchip, the functionality of integrated concentration gradient
   generator (CGG) with micro-scale cell culture enables dose response
   experiment to be performed in a simple and reagent-saving way. The
   diffusion-based culture chambers allowed growing G. lamblia at the in
   vivo like environment. It notable that the highly air permeable material
   of parallel chambers maintain uniform anaerobic environment in different
   chambers easily. Using this device, G. lamblia were successfully
   cultured and stressed on-chip. In all cases, a dose-related inhibitory
   response was detected. The application of this device for these purposes
   represents the first step in developing a completely integrated
   microfluidic platform for high-throughput screening and might be
   expanded to other assays based on in vitro culture of G. lamblia with
   further tests. (C) 2013 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wang, YH (Reprint Author), Dalian Univ, Sch Med, Dalian 116622, Peoples R China.
   Zheng, Guo-Xia; Yang, Yu-Suo; Wei, Jun-Feng, Dalian Univ, Environm \& Chem Engn Sch, Dalian 116622, Peoples R China.
   Zhang, Xue-Mei; Zeng, Shu-Rui; Wang, Yun-Hua; Li, Ya-Jie, Dalian Univ, Sch Med, Dalian 116622, Peoples R China.
   Zheng, Guo-Xia; Zhang, Xue-Mei; Yang, Yu-Suo; Zeng, Shu-Rui; Wei, Jun-Feng; Wang, Yun-Hua; Li, Ya-Jie, Dalian Univ, Microfluid Res Inst, Dalian 116622, Peoples R China.}},
DOI = {{10.1016/j.exppara.2013.11.009}},
ISSN = {{0014-4894}},
EISSN = {{1090-2449}},
Keywords = {{Giardia; Microfluidics; Screening; Culture}},
Keywords-Plus = {{ENTAMOEBA-HISTOLYTICA; DRUG-RESISTANCE; SYSTEMS}},
Research-Areas = {{Parasitology}},
Web-of-Science-Categories  = {{Parasitology}},
Author-Email = {{yunhua1977@126.com
   liyj@dlu.edu.cn}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}41006071, 30901253,
   30872207]; Scientific Research Project of Liaoning Education Department
   {[}L2013478, 2013479]}},
Funding-Text = {{This work was supported by grants from National Natural Science
   Foundation of China (Nos. 41006071, 30901253 and 30872207) and
   Scientific Research Project of Liaoning Education Department (Nos.
   L2013478 and 2013479).}},
Cited-References = {{Alonso J.G., 2009, BIOSENS BIOELECTRON, V24, P1508.
   Benere E, 2007, J MICROBIOL METH, V71, P101, DOI 10.1016/j.mimet.2007.07.014.
   Busatti HGNO, 2007, PARASITOL RES, V101, P819, DOI 10.1007/s00436-007-0525-8.
   Calzada F, 2006, J ETHNOPHARMACOL, V108, P367, DOI 10.1016/j.jep.2006.05.025.
   Carranza PG, 2010, MICROBES INFECT, V12, P71, DOI 10.1016/j.micinf.2009.09.008.
   Faghiri Z, 2011, PARASITOLOGY, V138, P194, DOI 10.1017/S0031182010001101.
   Gut J, 2011, J MICROBIOL METH, V84, P398, DOI 10.1016/j.mimet.2010.12.026.
   Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b.
   Lalle Marco, 2010, Infectious Disorders - Drug Targets, V10, P283.
   Liu TJ, 2010, LAB CHIP, V10, P1671, DOI 10.1039/c000022a.
   MacDonald MP, 2003, NATURE, V426, P421, DOI 10.1038/nature02144.
   Manna D, 2010, ANTIMICROB AGENTS CH, V54, P4825, DOI 10.1128/AAC.00546-10.
   McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C.
   Tian Hai-Feng, 2010, Infectious Disorders - Drug Targets, V10, P295.
   Wei CJ, 2010, EXP PARASITOL, V126, P489, DOI 10.1016/j.exppara.2010.05.028.
   West J, 2008, ANAL CHEM, V80, P4403, DOI 10.1021/ac800680j.
   Ye NN, 2007, LAB CHIP, V7, P1696, DOI 10.1039/b711513j.
   Zheng GX, 2013, MAR POLLUT BULL, V72, P231, DOI 10.1016/j.marpolbul.2013.03.035.}},
Number-of-Cited-References = {{18}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{63}},
Journal-ISO = {{Exp. Parasitol.}},
Doc-Delivery-Number = {{AA2GV}},
Unique-ID = {{ISI:000330914000001}},
DA = {{2018-08-13}},
}

@article{ ISI:000331162900001,
Author = {Lim, Ji Youn and Pinkner, Jerome S. and Cegelski, Lynette},
Title = {{Community behavior and amyloid-associated phenotypes among a panel of
   uropathogenic E. coli}},
Journal = {{BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS}},
Year = {{2014}},
Volume = {{443}},
Number = {{2}},
Pages = {{345-350}},
Month = {{JAN 10}},
Abstract = {{Uropathogenic Escherichia coli (UPEC) are the major causative agents of
   urinary tract infection and engage in a coordinated genetic and
   molecular cascade to colonize the urinary tract. Disrupting the assembly
   and/or function of virulence factors and bacterial biofilms has emerged
   as an attractive target for the development of new therapeutic
   strategies to prevent and treat urinary tract infection, particularly in
   the era of increasing antibiotic resistance among human pathogens. UPEC
   vary widely in their genetic and molecular phenotypes and more data are
   needed to understand the features that distinguish isolates as more or
   less virulent and as more robust biofilm formers or poor biofilm
   formers. Curli are extracellular functional amyloid fibers produced by
   E. coli that contribute to pathogenesis and influence the host response
   during urinary tract infection (UTI). We have examined the production of
   curli and curli-associated phenotypes including biofilm formation among
   a specific panel of human clinical UPEC that has been studied
   extensively in the mouse model of UTI. Motility, curli production, and
   curli-associated biofilm formation attached to plastic were the most
   prevalent behaviors, shared by most clinical isolates. We discuss these
   results in the context on the previously reported behavior and
   phenotypes of these isolates in the murine cystitis model in vivo. (C)
   2013 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Cegelski, L (Reprint Author), Stanford Univ, Dept Chem, Mudd Bldg,Room 121,333 Campus Dr, Stanford, CA 94305 USA.
   Lim, Ji Youn; Cegelski, Lynette, Stanford Univ, Dept Chem, Stanford, CA 94305 USA.
   Pinkner, Jerome S., Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA.}},
DOI = {{10.1016/j.bbrc.2013.11.026}},
ISSN = {{0006-291X}},
EISSN = {{1090-2104}},
Keywords = {{Curli; Functional amyloid; Biofilm; Amyloid; Congo Red; Uropathogenic E.
   coli}},
Keywords-Plus = {{URINARY-TRACT-INFECTIONS; INTEGRATED BIOFILM FORMATION; AIR-LIQUID
   INTERFACE; ESCHERICHIA-COLI; CURLI FIBERS; GENETIC-ANALYSIS; PILI;
   BIOGENESIS; MORPHOGENESIS; PATHOGENESIS}},
Research-Areas = {{Biochemistry \& Molecular Biology; Biophysics}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Biophysics}},
Author-Email = {{cegelski@stanford.edu}},
Funding-Acknowledgement = {{NIH {[}1DP2OD007488, AI048689, DK0645400]; Stanford University; Stanford
   Terman Fellowship; Burroughs Wellcome Fund}},
Funding-Text = {{We thank Prof. Scott Hultgren for valuable discussions and for curli and
   type 1 pili antibodies. L.C. acknowledges support from the NIH
   Director's New Innovator Award (1DP2OD007488), Stanford University, and
   the Stanford Terman Fellowship. L.C. holds a Career Award at the
   Scientific Interface from the Burroughs Wellcome Fund. J.S.P.
   acknowledges funding from NIH AI048689 and DK0645400.}},
Cited-References = {{Alteri CJ, 2007, P NATL ACAD SCI USA, V104, P5145, DOI 10.1073/pnas.0602304104.
   Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550.
   Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106.
   Bian Z, 2000, J INFECT DIS, V181, P602, DOI 10.1086/315233.
   Bian Z, 2001, J INFECT DIS, V183, P612, DOI 10.1086/318528.
   Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10.
   BOCK K, 1985, J BIOL CHEM, V260, P8545.
   Capstick DS, 2011, P NATL ACAD SCI USA, V108, P9821, DOI 10.1073/pnas.1018715108.
   Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818.
   Cegelski L, 2009, NAT CHEM BIOL, V5, P913, DOI 10.1038/nchembio.242.
   Dietrich LEP, 2013, J BACTERIOL, V195, P1371, DOI 10.1128/JB.02273-12.
   Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x.
   Eden C S, 1980, Scand J Infect Dis Suppl, VSuppl 24, P144.
   Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7.
   Garofalo CK, 2007, INFECT IMMUN, V75, P52, DOI 10.1128/IAI.01123-06.
   Gualdi L, 2008, MICROBIOL-SGM, V154, P2017, DOI 10.1099/mic.0.2008/018093-0.
   Hadjifrangiskou M, 2012, J BACTERIOL, V194, P6195, DOI 10.1128/JB.01012-12.
   Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100.
   Kai-Larsen Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001010.
   Kudinha T, 2013, PEDIATR INFECT DIS J, V32, P543, DOI 10.1097/INF.0b013e31828ba3f1.
   KUEHN MJ, 1992, NATURE, V356, P252, DOI 10.1038/356252a0.
   Lim JY, 2012, APPL ENVIRON MICROB, V78, P3369, DOI 10.1128/AEM.07743-11.
   Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803.
   McCrate OA, 2013, CHEM COMMUN, V49, P4193, DOI 10.1039/c2cc37792f.
   Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494.
   Mulvey MA, 2002, CELL MICROBIOL, V4, P257, DOI 10.1046/j.1462-5822.2002.00193.x.
   Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103.
   O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x.
   OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0.
   Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x.
   Rapsinski GJ, 2013, J BIOL CHEM, V288, P14178, DOI 10.1074/jbc.M112.447060.
   Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107.
   Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329.
   Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x.
   Sauer FG, 2000, CURR OPIN MICROBIOL, V3, P65, DOI 10.1016/S1369-5274(99)00053-3.
   Sharma VK, 2013, APPL ENVIRON MICROB, V79, P2384, DOI 10.1128/AEM.02998-12.
   Soto SM, 2007, J UROLOGY, V177, P365, DOI 10.1016/j.juro.2006.08.081.
   Szabo E, 2005, FOLIA MICROBIOL, V50, P40, DOI 10.1007/BF02931292.
   Tukel C, 2010, CELL MICROBIOL, V12, P1495, DOI 10.1111/j.1462-5822.2010.01485.x.
   Wu C, 2013, LANGMUIR, V29, P920, DOI 10.1021/la304710k.
   Wu C, 2012, BIOPHYS J, V103, P464, DOI 10.1016/j.bpj.2012.06.049.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{7}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{15}},
Journal-ISO = {{Biochem. Biophys. Res. Commun.}},
Doc-Delivery-Number = {{AA5TQ}},
Unique-ID = {{ISI:000331162900001}},
OA = {{green\_accepted}},
DA = {{2018-08-13}},
}

@inproceedings{ ISI:000358678400100,
Author = {Weeresinghe, S.},
Editor = {{Amaratunga, D and Haigh, R}},
Title = {{The influence of social factors towards resurgent Malaria and its
   mitigation using Sri Lanka as a case-study}},
Booktitle = {{4TH INTERNATIONAL CONFERENCE ON BUILDING RESILIENCE, INCORPORATING THE
   3RD ANNUAL CONFERENCE OF THE ANDROID DISASTER RESILIENCE NETWORK}},
Series = {{Procedia Economics and Finance}},
Year = {{2014}},
Volume = {{18}},
Pages = {{802-806}},
Note = {{4th International Conference on Building Resilience, Building
   Resilience, Univ Colombo, ENGLAND, SEP 08-11, 2014}},
Organization = {{Univ Salford, Sch Built Environm, Ctr Disaster Resilience; Univ
   Huddersfield, Global Disaster Resilience Ctr; ANDROID Disaster
   Resilience Network; Royal Melbourne Inst Technol Univ; Australia \&
   Queensland Univ Technol; Univ Moratuwa; Univ Peradeniya; United Nat Dev
   Programme Sri Lanka; Minist Disaster Management, Disaster Management
   Ctr; Cent Environm Author; Minist Environm; Chamber Construct Ind Sri
   Lanka}},
Abstract = {{Social factors of malaria were examined using the case-study of malaria
   incidence in Sri Lanka. Sri Lanka has currently achieved eradication of
   malaria but as it is a small island, developing country, it is
   vulnerable to climate change threats. Therefore the social influences,
   host immunity, anti-malarial resistance, prosperity and travel, were
   investigated with particular reference to potential climate
   change-induced malaria. Development of immunity depends on the intensity
   and stability of transmission within the region. Although Sri Lanka
   recently eradicated malaria, it was previously considered a region of
   low to moderate transmission, with most individual inoculation resulting
   in infection and disease at all ages. Self-medication when unrequired is
   particularly significant in contributing to the global issue of
   anti-malarial resistance. Despite known drug resistance, distribution
   continues to be widespread due to low over-the-counter cost and rapid
   relief of symptoms. Poverty promotes transmission of malaria and in turn
   malaria impedes economic growth. Malaria imposes economic loss beyond
   direct medical costs and associated effects to macroenomic costs by
   impacts on worker productivity, school children performance, etc.
   However improved economic growth is insufficient to eradicate malaria
   e.g. Oman. Air travel is a vital factor in malaria transmission due to
   conveyance of asymptomatic carriers from endemic to non-endemic
   countries, leading to outbreaks of epidemic malaria. Incidence of
   imported malaria has been observed mainly due to lapse or absence of
   prophylaxis. The management of malaria was examined under the categories
   of public healthcare services and mitigation measures. Mitigation
   measures were evaluated in relation to social factors, to determine
   their efficacy in the event of resurgent malaria. Mitigation techniques
   of prominence were anti-malarial therapy, Indoor Residual Spraying,
   Insecticide Treated Nets and Long Lasting Insecticide Treated Nets and
   lastly environmental management. Malaria is borne out of multiple risks;
   both environmental (i.e. climate change and environmental degradation)
   and social (i.e. anti-malarial resistance, migration and poverty). As
   observed in Sri Lanka, strong political commitment in prioritising
   malaria control with sustained resource allocation is vital to eliminate
   malaria. A multi-measure approach cross cutting public health care
   services and malaria interventions has proven effective despite some
   evident climate change impacts. (C) 2014 Published by Elsevier B.V.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Proceedings Paper}},
Language = {{English}},
Affiliation = {{Weeresinghe, S (Reprint Author), Univ Moratuwa, Dept Civil Engn, Moratuwa, Sri Lanka.
   Univ Moratuwa, Dept Civil Engn, Moratuwa, Sri Lanka.}},
DOI = {{10.1016/S2212-5671(14)01005-3}},
ISSN = {{2212-5671}},
Keywords = {{Healthcare; Malaria; Mitigation; National Planning; Development}},
Research-Areas = {{Business \& Economics}},
Web-of-Science-Categories  = {{Business, Finance; Economics}},
Author-Email = {{shayani\_w@outlook.com}},
Cited-References = {{Alles HK, 1998, PARASITOL TODAY, V14, P369, DOI 10.1016/S0169-4758(98)01296-4.
   Baird Kevin J., 2000, DRUGS, V59, P719.
   Fernando, 2011, 100 YEARS MALARIA CO.
   Intergovernmental Panel on Climate Change (IPCC), 2007, CLIMATE CHANGE 2007.
   Konradsen F, 2000, MALARIA SRI LANKA CU.
   McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001.
   Mendez F, 2000, T ROY SOC TROP MED H, V94, P367, DOI 10.1016/S0035-9203(00)90106-8.
   Okomu, 2011, MALARIA J, V10, P1.
   Sachs, 2002, NATURE, V415, P680.
   Shiff C, 2002, CLIN MICROBIOL REV, V15, P278, DOI 10.1128/CMR.15.2.278-293.2002.
   van Lieshout M, 2004, GLOBAL ENVIRON CHANG, V14, P87, DOI 10.1016/j.gloenvcha.2003.10.009.
   WHO, 2011, WORLD MALARIA REPORT 2011, P1.}},
Number-of-Cited-References = {{12}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{2}},
Doc-Delivery-Number = {{BD2DX}},
Unique-ID = {{ISI:000358678400100}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000346554500001,
Author = {Alnimr, A. M.},
Title = {{Streptococcus pseudopneumoniae: prospective detection among community
   lower respiratory isolates in Eastern Saudi Arabia}},
Journal = {{BRITISH JOURNAL OF BIOMEDICAL SCIENCE}},
Year = {{2014}},
Volume = {{71}},
Number = {{4}},
Pages = {{139-144}},
Abstract = {{Streptococcus pseudopneumoniae is a distinct pathogen and the available
   evidence suggests its significance in lower respiratory tract
   infections. The purpose of this study is to investigate the occurrence
   of this new species in patients presenting with community-acquired
   pneumonia in a university hospital setting using routine laboratory
   tests. Sputum samples (n=213) submitted to the microbiology laboratory
   for culture from cases clinically diagnosed as community-acquired
   pneumonia are studied. Optochin variability in ambient air and 5\% CO2
   was the criterion used to identify S. pseudopneumoniae. Disc-diffusion
   and E-test on Muller Hinton blood-based agar were used for antibiotic
   susceptibility testing following Clinical Laboratory Standard Institute
   breakpoints. Out of the screened isolates, only six (3\%) were
   identified as S. pseudopneumoniae. None of the commercial tests
   differentiated the pathogens from viridans streptococci so diagnostic
   laboratories need to provide an alternative identification algorithm.
   The six isolates showed susceptibility to penicillin, and five isolates
   were susceptible to vancomycin, but one exhibited low-level resistance
   (minimum inhibitory concentration {[}MIC]: 1 mu g/mL). All isolates
   showed high-level resistance to macrolides (MIC: 24- > 256 mu g/mL).
   Although S. pseudopneumoniae strains were not sufficiently frequent to
   justify routine additional incubation of sputum samples in ambient air,
   the high resistance pattern is alarming. Further surveillance is needed
   in diagnostic laboratories to understand the epidemiology and clinical
   significance of the newly described pathogen.}},
Publisher = {{STEP PUBLISHING LTD}},
Address = {{SUBSCRIPTION DEPT, NORTH FARM RD, TUNBRIDGE WELLS TN2 3DR, KENT, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Alnimr, AM (Reprint Author), Univ Dammam, Univ Coll Med, King Fahad Hosp, Dammam, Saudi Arabia.
   Univ Dammam, Univ Coll Med, King Fahad Hosp, Dammam, Saudi Arabia.}},
ISSN = {{0967-4845}},
Keywords = {{Respiratory tract infection; Streptococcus; Streptococcus mitis}},
Keywords-Plus = {{VIRIDANS GROUP STREPTOCOCCI; HOSPITAL-ACQUIRED PNEUMONIA; ANTIMICROBIAL
   RESISTANCE; UNITED-STATES; IDENTIFICATION; PNEUMOCOCCI; RATES; CHILDREN;
   LEVEL; OROPHARYNX}},
Research-Areas = {{Medical Laboratory Technology}},
Web-of-Science-Categories  = {{Medical Laboratory Technology}},
Author-Email = {{amalnimr@uod.edu.sa}},
ResearcherID-Numbers = {{Alnimr, Amani/A-4531-2015}},
Funding-Acknowledgement = {{University of Dammam Research Grant {[}2013216]}},
Funding-Text = {{This work was carried out under University of Dammam Research Grant
   2013216. The author acknowledges the university for funding, and the
   microbiology section technical staff at King Fahad Hospital for
   technical support.}},
Cited-References = {{Alam S, 1999, J CLIN MICROBIOL, V37, P2772.
   Amoroso A, 2001, ANTIMICROB AGENTS CH, V45, P2075, DOI 10.1128/AAC.45.7.2075-2081.2001.
   Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004.
   AUSTRIAN R, 1966, J BACTERIOL, V92, P1281.
   Balsalobre L, 2013, ANTIMICROB AGENTS CH, V57, P254, DOI 10.1128/AAC.01357-12.
   Cochetti I, 2005, ANTIMICROB AGENTS CH, V49, P4999, DOI 10.1128/AAC.49.12.4999-5006.2005.
   Doern GV, 1996, ANTIMICROB AGENTS CH, V40, P891.
   Dubois D, 2013, J CLIN MICROBIOL, V51, P1861, DOI 10.1128/JCM.03069-12.
   Freitas M, 2006, ARCH DIS CHILD, V91, P779, DOI 10.1136/adc.2006.094847.
   Gardam MA, 1998, J CLIN MICROBIOL, V36, P833.
   GAUDREAU C, 1981, CAN MED ASSOC J, V125, P1246.
   Harf-Monteil C, 2006, J CLIN MICROBIOL, V44, P2240, DOI 10.1128/JCM.02643-05.
   Hauser C, 2004, ANTIMICROB AGENTS CH, V48, P3563, DOI 10.1128/AAC.48.9.3563-3566.2004.
   Ioannidou S, 2003, INT J ANTIMICROB AG, V22, P626, DOI 10.1016/j.ijantimicag.2003.05.001.
   Ioannidou S, 2001, INT J ANTIMICROB AG, V17, P195, DOI 10.1016/S0924-8579(00)00338-1.
   Jacobs JA, 1996, J CLIN MICROBIOL, V34, P1717.
   Karlowsky JA, 2003, CLIN INFECT DIS, V36, P963, DOI 10.1086/374052.
   Keith ER, 2008, ANTIMICROB AGENTS CH, V52, P2998, DOI 10.1128/AAC.01526-07.
   Keith ER, 2006, J CLIN MICROBIOL, V44, P923, DOI 10.1128/JCM.44.3.923-927.2006.
   Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683.
   Ligozzi M, 2002, J CLIN MICROBIOL, V40, P1681, DOI 10.1128/JCM.40.5.1681-1686.2002.
   Limia A, 2000, EUR J CLIN MICROBIOL, V19, P128, DOI 10.1007/s100960050444.
   MARRIE TJ, 1993, CLIN INVEST MED, V16, P38.
   Mohammadi JS, 2012, INDIAN J MED RES, V136, P877.
   MUNOZ R, 1990, DIAGN MICR INFEC DIS, V13, P63, DOI 10.1016/0732-8893(90)90056-2.
   Niederman MS, 2010, CLIN INFECT DIS, V51, pS12, DOI 10.1086/653035.
   Nunes S, 2008, J CLIN MICROBIOL, V46, P321, DOI 10.1128/JCM.02097-07.
   Prabhu RM, 2005, EUR J CLIN MICROBIOL, V24, P832, DOI 10.1007/s10096-005-0037-3.
   Richter SS, 2008, J CLIN MICROBIOL, V46, P2184, DOI 10.1128/JCM.00461-08.
   Sethi Sanjay, 2004, Proc Am Thorac Soc, V1, P109, DOI 10.1513/pats.2306029.
   Shahinas D, 2011, J BACTERIOL, V193, P6102, DOI 10.1128/JB.06075-11.
   Simoes AS, 2010, J CLIN MICROBIOL, V48, P238, DOI 10.1128/JCM.01313-09.
   Slotved HC, 2004, J CLIN MICROBIOL, V42, P2518, DOI 10.1128/JCM.42.6.2518-2522.2004.
   Teles C, 2011, EUR J CLIN MICROBIOL, V30, P243, DOI 10.1007/s10096-010-1076-y.
   Torres A, 2009, INTENS CARE MED, V35, P9, DOI 10.1007/s00134-008-1336-9.
   Wester CW, 2002, DIAGN MICR INFEC DIS, V42, P263, DOI 10.1016/S0732-8893(01)00358-3.
   Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Br. J. Biomed. Sci.}},
Doc-Delivery-Number = {{AW9CF}},
Unique-ID = {{ISI:000346554500001}},
DA = {{2018-08-13}},
}

@article{ ISI:000346111100003,
Author = {Vellingiri, K. and Ramachandran, T. and Senthilkumar, P.},
Title = {{Functional characteristics of textile fabrics by plasma-nano treatment}},
Journal = {{INTERNATIONAL JOURNAL OF CLOTHING SCIENCE AND TECHNOLOGY}},
Year = {{2014}},
Volume = {{26}},
Number = {{6}},
Pages = {{456-479}},
Abstract = {{Purpose - Any change in physical performance of the fibre corresponds to
   a change in its molecular structure. Basically polyester is hydrophobic
   in nature due to the absence of attracting polar groups and the dense
   packing in its polymeric structure. Due to the dense packing in
   polymeric structure and lack of hydroxyl groups of polyester it does not
   absorb water hence breathability is poor. The possibility of using air
   and oxygen plasma treatments for fibre surface activation to facilitate
   the improvement of hydrophilicity is attempted and has been improved.
   The purpose of this paper is to study the possibility of engineering the
   multifunctional of fabrics.
   Design/methodology/approach - The treated fabric is evaluated through
   measuring the ultraviolet protection factor, thermal resistance, and
   antibacterial activity properties. Scanning electron microscopy and
   transmission electron microscopy graphs show deposition of nano
   particles (NPs) of Chitosan, TiO2 and ZnO onto the fibre after washing
   several times.
   Findings - Air plasma-nano Chitosan treatment affects positively the
   antibacterial activity, thermal resistance of the fibre and air
   plasma-nano TiO2 and ZnO the fibre protection against ultraviolet rays.
   Furthermore, the plasma treatment solves an environmental problem which
   offers safe production process and working place and decreases the unit
   cost.
   Originality/Value - The authors are confident that textiles will adopt
   this technology in the future.}},
Publisher = {{EMERALD GROUP PUBLISHING LIMITED}},
Address = {{HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Vellingiri, K (Reprint Author), PSG Coll Technol, Dept Fash Technol, Coimbatore, Tamil Nadu, India.
   Vellingiri, K., PSG Coll Technol, Dept Fash Technol, Coimbatore, Tamil Nadu, India.
   Ramachandran, T., Karpagam Inst Technol, Coimbatore, Tamil Nadu, India.
   Senthilkumar, P., PSG Coll Technol, Dept Text Technol, Coimbatore, Tamil Nadu, India.}},
DOI = {{10.1108/IJCST-05-2013-0053}},
ISSN = {{0955-6222}},
EISSN = {{1758-5953}},
Keywords = {{Polyester; Cotton; Eco-friendly; Plasma; Ultraviolet protection;
   Wickability}},
Keywords-Plus = {{POLYESTER; SURFACE}},
Research-Areas = {{Materials Science}},
Web-of-Science-Categories  = {{Materials Science, Textiles}},
Author-Email = {{rkvgiri@yahoo.com}},
ORCID-Numbers = {{PANDURANGAN, SENTHILKUMAR/0000-0003-2726-7584}},
Cited-References = {{Alfredo Calvimontes R.S., 2011, AUTEX RES J, V11, P24.
   Bhat NV, 1999, TEXT RES J, V69, P38, DOI 10.1177/004051759906900107.
   Diener Electronic, 2009, PLASM SURF TECHN.
   El-Nagar K, 2006, J TEXT I, V97, P111, DOI 10.1533/joti.2005.0169.
   FERGUSON CA, 1982, AM DYEST REP, V71, P43.
   Hocker H.T., 1994, MELLIAND TEXTILBER, V75, P506.
   Karmakar S.R, 1999, TEXT SCI TECHNOL, V12, P395.
   Lieberman M.A., 1994, INTRO PRINCIPLE PLAS, P1.
   Maximov A.I., 1997, TEXTILE CHEM THEORY.
   RAKOWSKI W, 1982, MELLIAND TEXTILBERIC, V11, P301.
   Reichel K., 2001, PLASMA TREATMENT PRO.
   Riccobono PX, 1973, TEXT CHEM COLOR, V5, P239.
   Roshan S., 1996, J IND TEXT, V26, P26.
   Sekar N, 2000, COLOURAGE        JUN, P39.
   Sun D, 2005, TEXT RES J, V75, P639, DOI 10.1177/0040517505057637.
   Thomas M., 1993, TETILE WORLD, V143, P62.
   Tomasino C., 1995, J COATED FABRICS, V25, P115.}},
Number-of-Cited-References = {{17}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{17}},
Journal-ISO = {{Int. J. Cloth. Sci. Technol.}},
Doc-Delivery-Number = {{AW2IJ}},
Unique-ID = {{ISI:000346111100003}},
DA = {{2018-08-13}},
}

@inproceedings{ ISI:000343858400070,
Author = {Bezanson, G. S. and Ells, T. C. and Prange, R. K.},
Editor = {{Biala, J and Prange, R and Raviv, M}},
Title = {{Effect of Composting on Microbial Contamination and Quality of Fresh
   Fruits and Vegetables - a Mini-Review}},
Booktitle = {{I INTERNATIONAL SYMPOSIUM ON ORGANIC MATTER MANAGEMENT AND COMPOST USE
   IN HORTICULTURE}},
Series = {{Acta Horticulturae}},
Year = {{2014}},
Volume = {{1018}},
Pages = {{631-638}},
Note = {{1st International Symposium on Organic Matter Management and Compost Use
   in Horticulture, Adelaide, AUSTRALIA, APR 07, 2011}},
Organization = {{Int Soc Hort Sci}},
Abstract = {{There are 3 main types of compost: animal-based, plant-based and
   `biosolids'. Most of the attention in the literature has been centred on
   animal-based compost because of concerns related to its potential to
   serve as a source of microorganisms pathogenic to humans. It will be the
   focus of this presentation. It is now widely-accepted that non-composted
   animal waste can have a negative effect on the microbial quality of
   vegetables and fruits, especially those subject to little or no
   processing prior to their ingestion. Although a major goal of proper
   composting is the elimination of pathogenic microbes all that may be
   achieved is a reduction, usually of 3-4 logs. Thus, even if composted
   material is applied, there is still a crop contamination risk. This is
   dependant on several factors, including the amount of crop contact with
   the soil, physical condition of the crop, soil type and moisture
   content. For example, root and tuber crops are generally the most
   exposed to incorporated compost, followed by low-growing leafy
   vegetables and similar crops. Injured leafy vegetables are more
   susceptible to compost-borne, human bacterial pathogens than are
   non-injured plants. Another less appreciated scientific observation is
   that, given the appropriate conditions, i.e., post-processing storage at
   22 or 35 degrees C, or slow compost cooling, significant re-growth of
   low concentration pathogens, e. g., Escherichia coli 0157:H7, Salmonella
   spp. and Listeria monocytogenes, can occur in properly-composted
   material. Furthermore, there are reports that properly-composted
   materials can serve as a milieu for the proliferation of bacterial
   pathogens introduced after the composting was completed. During
   horticultural production, re-introduction could occur via the
   application of contaminated irrigation water, the deposition of bird or
   animal fecal material, or as a result of the settling of air-borne
   materials. One special concern is the possibility of antibiotic
   resistance occurring in the microbial population of compost derived from
   the waste of animals exposed to antibiotics.}},
Publisher = {{INT SOC HORTICULTURAL SCIENCE}},
Address = {{PO BOX 500, 3001 LEUVEN 1, BELGIUM}},
Type = {{Proceedings Paper}},
Language = {{English}},
Affiliation = {{Bezanson, GS (Reprint Author), Agr \& Agri Food Canada, Atlantic Food \& Hort Res Ctr, 32 Main St, Kentville, NS B4N 1J5, Canada.
   Bezanson, G. S.; Ells, T. C.; Prange, R. K., Agr \& Agri Food Canada, Atlantic Food \& Hort Res Ctr, Kentville, NS B4N 1J5, Canada.}},
ISSN = {{0567-7572}},
ISBN = {{978-94-62610-04-0}},
Keywords = {{compost; manure; human pathogens; gastrointestinal infections; foodborne
   disease; food safety}},
Keywords-Plus = {{ESCHERICHIA-COLI O157-H7; ENTERICA SEROVAR TYPHIMURIUM; BOVINE MANURE;
   LISTERIA-MONOCYTOGENES; ANTIBIOTIC-RESISTANCE; FOODBORNE OUTBREAKS;
   PATHOGEN SURVIVAL; IRRIGATION WATER; SALMONELLA SPP.; PRODUCE}},
Research-Areas = {{Agriculture}},
Web-of-Science-Categories  = {{Agronomy; Horticulture}},
Author-Email = {{Robert.Prange@AGR.GC.CA}},
ORCID-Numbers = {{Ells, Timothy/0000-0002-9720-5779}},
Cited-References = {{{[}Anonymous], 1999, FOOD CONTROL, V10, P117.
   Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x.
   Beuchat LR, 1996, J FOOD PROTECT, V59, P204, DOI 10.4315/0362-028X-59.2.204.
   Beuchat LR, 2002, MICROBES INFECT, V4, P413, DOI 10.1016/S1286-4579(02)01555-1.
   Cornu M, 2002, INT J FOOD MICROBIOL, V73, P261, DOI 10.1016/S0168-1605(01)00658-4.
   Dimitri C., 2009, EC INFORM B, V58.
   Francis GA, 1999, INT J FOOD SCI TECH, V34, P1, DOI 10.1046/j.1365-2621.1999.00253.x.
   Guan TY, 2003, J ENVIRON QUAL, V32, P383, DOI 10.2134/jeq2003.0383.
   Halet D, 2006, J BIOSCI BIOENG, V101, P297, DOI 10.1263/jbb.101.297.
   Heringa S, 2010, FOODBORNE PATHOG DIS, V7, P1297, DOI 10.1089/fpd.2010.0544.
   Hill WE, 1996, CRIT REV FOOD SCI, V36, P123, DOI 10.1080/10408399609527721.
   Holden N, 2009, FEMS MICROBIOL REV, V33, P689, DOI 10.1111/j.1574-6976.2008.00153.x.
   Islam M, 2005, FOOD MICROBIOL, V22, P63, DOI 10.1016/j.fm.2004.04.007.
   Islam M, 2004, J FOOD PROTECT, V67, P1365, DOI 10.4315/0362-028X-67.7.1365.
   Islam Mahbub, 2004, Foodborne Pathog Dis, V1, P27, DOI 10.1089/153531404772914437.
   Jiang XP, 2003, J FOOD PROTECT, V66, P25, DOI 10.4315/0362-028X-66.1.25.
   Khachatourians GG, 1998, CAN MED ASSOC J, V159, P1129.
   Kim J, 2010, J APPL MICROBIOL, V109, P2095, DOI 10.1111/j.1365-2672.2010.04841.x.
   Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166.
   Lung AJ, 2001, J FOOD PROTECT, V64, P1309, DOI 10.4315/0362-028X-64.9.1309.
   Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969.
   Mukherjee A, 2004, J FOOD PROTECT, V67, P894, DOI 10.4315/0362-028X-67.5.894.
   Natvig EE, 2002, APPL ENVIRON MICROB, V68, P2737, DOI 10.1128/AEM.68.6.2737-2744.2002.
   Nicholson FA, 2005, BIORESOURCE TECHNOL, V96, P135, DOI {[}10.1016/j.biortech.2004.02.030, 10.1016/j.biotech.2004.02.030].
   Ongeng D, 2011, J APPL MICROBIOL, V110, P1007, DOI 10.1111/j.1365-2672.2011.04956.x.
   Ovreas L, 1998, MICROBIAL ECOL, V36, P303, DOI 10.1007/s002489900117.
   Rosengren LB, 2008, CAN J VET RES, V72, P151.
   RUSS CF, 1981, APPL ENVIRON MICROB, V41, P597.
   SCHLECH WF, 1983, NEW ENGL J MED, V308, P203, DOI 10.1056/NEJM198301273080407.
   Sengelov G, 2003, ENVIRON INT, V28, P587, DOI 10.1016/S0160-4120(02)00084-3.
   Sewell AM, 2001, J FOOD PROTECT, V64, P1863, DOI 10.4315/0362-028X-64.11.1863.
   Shepherd MW, 2007, J FOOD PROTECT, V70, P2708, DOI 10.4315/0362-028X-70.12.2708.
   Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342.
   Suslow T.V., 2003, COMP REV FOOD SCI S, V2, P38, DOI {[}10.1111/j.1541-4337.2003.tb00030.x, DOI 10.1111/J.1541-4337.2003.TB00030.X].
   Toze S, 1999, WATER RES, V33, P3545, DOI 10.1016/S0043-1354(99)00071-8.
   Wang GD, 1998, J FOOD PROTECT, V61, P662, DOI 10.4315/0362-028X-61.6.662.
   Warriner K, 2009, ADV FOOD NUTR RES, V57, P155, DOI 10.1016/S1043-4526(09)57004-0.
   You YW, 2006, APPL ENVIRON MICROB, V72, P5777, DOI 10.1128/AEM.00791-06.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{19}},
Doc-Delivery-Number = {{BB5GK}},
Unique-ID = {{ISI:000343858400070}},
DA = {{2018-08-13}},
}

@inproceedings{ ISI:000342765800023,
Author = {Leach, Timothy and Scheir, Robert},
Book-Group-Author = {{ASHRAE}},
Title = {{Ultraviolet Germicidal Irradiation (UVGI) in Hospital HVAC Decreases
   Ventilator Associated Pneumonia}},
Booktitle = {{ASHRAE TRANSACTIONS 2014, VOL 120, PT 1}},
Series = {{ASHRAE Transactions}},
Year = {{2014}},
Volume = {{120}},
Number = {{1}},
Note = {{ASHRAE Winter Conference, New York, NY, 2014}},
Organization = {{ASHRAE}},
Abstract = {{Hospital Acquired Infections (HAIs) constitute a major health threat
   impacting millions of people globally, and increase patient morbidity
   and mortality with an economic impact of up to \$45 billion in the US
   alone. Gram negative bacteria are of particular concern, are responsible
   for more than 30\% of all HAIs and are becoming increasingly multidrug
   resistant. These universal health concerns surrounding HAIs have driven
   organizations such as ASHRAE to investigate reservoirs of pathogenic
   microorganisms and the role of the HVAC in the amplification and
   transmission of HAIs. (ASHRAE HVAC Design Manual for Hospitals and
   Clinics).
   The objective of this study was to evaluate the role of HVAC systems
   serving hospital critical patient care areas, as potential environmental
   reservoirs for opportunistic Gram negative bacteria attributed to
   Hospital Acquired Infections. This prospective interventional pre and
   post multi-center trial was conducted in six tertiary care hospitals. A
   total of thirteen HVAC systems were sampled for microbial loads. The
   hospitals were located in New York (1), Michigan (1), Pennsylvania (2)
   and Washington, DC (2). was An aim was to determine if the installation
   of Ultraviolet Germicidal Irradiation (UVGI) systems in the HVAC
   equipment would reduce HVAC and patient care environment microbial loads
   and lead to reduced incidence of Ventilator Associated Pneumonia (VAP)
   in critically ill patients. All thirteen HVAC systems demonstrated the
   presence of gram negative bacteria with 65 of 65 cultures testing
   positive prior to UVGI intervention. Pseudomonas species was isolated in
   50.1\% and Acinetobacter species in 18.5\% of samples cultured. The 65
   samples that were cultured 90 days post UVGI intervention demonstrated a
   5 log reduction in colony forming units (CFU). Additional studies by the
   New York hospital demonstrated a reduced incidence of VAP in a high risk
   cohort. The Incidence of VAP fell from 74\% (n=31) to 39\% (n = 18) and
   the number of episodes per patient decreased (control: 1.2 pre UVGI
   intervention to 0.4 post UVGI intervention). (Ryan et al)}},
Publisher = {{AMER SOC HEATING, REFRIGERATING AND AIR-CONDITIONING ENGS}},
Address = {{1791 TULLIE CIRCLE NE, ATLANTA, GA 30329 USA}},
Type = {{Proceedings Paper}},
Language = {{English}},
Affiliation = {{Leach, T (Reprint Author), Steril Aire Inc, Burbank, CA 91501 USA.
   Leach, Timothy; Scheir, Robert, Steril Aire Inc, Burbank, CA 91501 USA.}},
ISSN = {{0001-2505}},
Keywords-Plus = {{AIR; TRANSMISSION; BACTERIA; OUTBREAK; VIRUS; INFECTION}},
Research-Areas = {{Thermodynamics; Construction \& Building Technology}},
Web-of-Science-Categories  = {{Thermodynamics; Construction \& Building Technology}},
Cited-References = {{{[}Anonymous], 2005, ASHRAE HDB FUND, P252.
   ASHRAE, 2013, HVAC DES MAN HOSP CL.
   ASHRAE, 2009, ASHRAE ASOH REFR AIR.
   Beggs C. B., 2003, INDOOR BUILT ENV.
   Brickner PW, 2003, PUBLIC HEALTH REP, V118, P99, DOI 10.1093/phr/118.2.99.
   CDC, 1999, GUID APPL UPP ROOM U.
   CDC, 1994, GUID PREV TRANSM MYC.
   Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/rccm.2105078.
   Environmental Protection Agency (EPA), 1991, SICK BUILD SYNDR, P4.
   Goldner J L, 1980, Ann N Y Acad Sci, V353, P271, DOI 10.1111/j.1749-6632.1980.tb18930.x.
   Gundermann K O, 1980, Ann N Y Acad Sci, V353, P209, DOI 10.1111/j.1749-6632.1980.tb18924.x.
   HUGENHOLTZ P, 1992, APPL ENVIRON MICROB, V58, P3914.
   Jones AM, 2003, THORAX, V58, P525, DOI 10.1136/thorax.58.6.525.
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205.
   Koenig SM, 2006, CLIN MICROBIOL REV, V19, P637, DOI 10.1128/CMR.00051-05.
   Kowalski WJ, 2000, DESIGN BASICS AIR SU, V2n1, P100.
   KOWALSKI WJ, 2000, ASHRAE T, V106, P4.
   Kumari DNP, 1998, J HOSP INFECT, V39, P127, DOI 10.1016/S0195-6701(98)90326-7.
   Prazmo Z, 2003, ANN AGR ENV MED, V10, P93.
   RILEY RL, 1989, AM REV RESPIR DIS, V139, P1286, DOI 10.1164/ajrccm/139.5.1286.
   Rotstein Coleman, 2008, CLIN PRACTICE GUIDEL.
   Ryan R. M., 2011, J PERINATOLOGY, P1.
   Sagripanti JL, 2007, PHOTOCHEM PHOTOBIOL, V83, P1278, DOI 10.1111/j.1751-1097.2007.00177.x.
   SAWYER LA, 1988, AM J EPIDEMIOL, V127, P1261, DOI 10.1093/oxfordjournals.aje.a114918.
   Scott RD, 2009, DIVISION HEALTHCARE.
   Sehulster LM, 2004, GUIDELINES ENV INFEC.
   Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426.
   Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754.
   WOODS GL, 1988, INFECT CONT HOSP EP, V9, P451.
   World Health Organization, 2007, AV INFL INCL INFL H5.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{2}},
Doc-Delivery-Number = {{BB3GM}},
Unique-ID = {{ISI:000342765800023}},
DA = {{2018-08-13}},
}

@article{ ISI:000342527200015,
Author = {Wolny-Koladka, Katarzyna and Lenart-Boron, Anna and Kasprowicz, Andrzej},
Title = {{Disc-diffusion and PCR Detection of Methicillin Resistance in
   Environmental Airborne Strains of Staphylococcus spp.}},
Journal = {{POLISH JOURNAL OF MICROBIOLOGY}},
Year = {{2014}},
Volume = {{63}},
Number = {{3}},
Pages = {{363-368}},
Abstract = {{The aim of this study was to assess the species composition of airborne
   Staphylococcus spp. in public premises, to determine the methicillin
   resistance of the isolates and the prevalence of mecA gene, determining
   resistance to beta-lactams. In total 65 Staphylococcus strains were
   isolated from 54 sites. Four strains exhibited phenotypic methicillin
   resistance, while the presence of mecA gene was found in 11 strains. The
   results of both assays were compared, showing that the phenotypic tests
   revealed methicillin resistance only in 36\% of the examined samples.
   This study revealed high species diversity among airborne Staphylococcus
   spp. population, which consists of multidrug resistant strains.}},
Publisher = {{POLSKIE TOWARZYSTWO MIKROBIOLOGOW-POLISH SOCIETY OF MICROBIOLOGISTS}},
Address = {{CHELMSKA STR 30-34, WARSAW, 00-725, POLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wolny-Koladka, K (Reprint Author), Agr Univ Krakow, Mickiewicza Ave 24-28, PL-30059 Krakow, Poland.
   Wolny-Koladka, Katarzyna; Lenart-Boron, Anna, Agr Univ Krakow, PL-30059 Krakow, Poland.
   Kasprowicz, Andrzej, Ctr Microbiol \& Autovaccines Cracow, Krakow, Poland.}},
ISSN = {{1733-1331}},
Keywords = {{airborne Staphylococcus spp.; disc-diffusion method; mecA gene;
   methicillin resistance; PCR}},
Keywords-Plus = {{COAGULASE-NEGATIVE STAPHYLOCOCCI; CLINICAL-SIGNIFICANCE; IDENTIFICATION;
   PATHOGENS; AUREUS; MECA}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{k.wolny@unkrakow.pl}},
Cited-References = {{{[}Anonymous], 1999, AM J INFECT CONTROL, V27, P520.
   Banerjee R, 2010, ANTIMICROB AGENTS CH, V54, P4900, DOI 10.1128/AAC.00594-10.
   Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1.
   Bastos MCF, 1999, EUR J CLIN MICROBIOL, V18, P393, DOI 10.1007/s100960050306.
   Bonetta S, 2010, ENVIRON MONIT ASSESS, V161, P473, DOI 10.1007/s10661-009-0761-8.
   Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781.
   Gaillot O, 2000, J CLIN MICROBIOL, V38, P1587.
   Gaska-Jedruch U., 2009, POLISH ENV ENG 5 YEA, P31.
   GEHA DJ, 1994, J CLIN MICROBIOL, V32, P1768.
   GEORGOPAPADAKOU NH, 1993, ANTIMICROB AGENTS CH, V37, P2045, DOI 10.1128/AAC.37.10.2045.
   Golofit-Szymczak M., 2005, OCCUPATIONAL SAFETY, V3, P29.
   Idzik D., 2000, EXP MED MICROBIOL, V52, P327.
   KLOOS WE, 1975, INT J SYST BACTERIOL, V25, P62, DOI 10.1099/00207713-25-1-62.
   KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117.
   Lee JH, 2006, ENVIRON RES, V101, P11, DOI 10.1016/j.envres.2005.08.009.
   PATRICK CC, 1990, J PEDIATR-US, V116, P497, DOI 10.1016/S0022-3476(05)81593-8.
   von Eiff C, 2001, POSTGRAD MED, V110, P63, DOI 10.3810/pgm.2001.10.1046.
   Wanner H., 1993, EUROPEAN COLLABORATI.
   York MK, 1996, J CLIN MICROBIOL, V34, P249.
   Zabicka D., 2010, RECOMMENDATIONS SELE.
   Zmyslowska I., 2005, ARCH ENVIRON PROT, V31, P13.}},
Number-of-Cited-References = {{21}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Pol. J. Microbiol.}},
Doc-Delivery-Number = {{AQ1FL}},
Unique-ID = {{ISI:000342527200015}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000337977300028,
Author = {Mastronicola, Daniela and Falabella, Micol and Testa, Fabrizio and
   Pucillo, Leopoldo Paolo and Teixeira, Miguel and Sarti, Paolo and
   Saraiva, Ligia M. and Giuffre, Alessandro},
Title = {{Functional Characterization of Peroxiredoxins from the Human Protozoan
   Parasite Giardia intestinalis}},
Journal = {{PLOS NEGLECTED TROPICAL DISEASES}},
Year = {{2014}},
Volume = {{8}},
Number = {{1}},
Month = {{JAN}},
Abstract = {{The microaerophilic protozoan parasite Giardia intestinalis, causative
   of one of the most common human intestinal diseases worldwide, infects
   the mucosa of the proximal small intestine, where it has to cope with
   O-2 and nitric oxide (NO). Elucidating the antioxidant defense system of
   this pathogen lacking catalase and other conventional antioxidant
   enzymes is thus important to unveil novel potential drug targets.
   Enzymes metabolizing O-2, NO and superoxide anion (O-2(-center dot))
   have been recently reported for Giardia, but it is yet unknown how the
   parasite copes with H2O2 and peroxynitrite (ONOO2). Giardia encodes two
   yet uncharacterized 2-cys peroxiredoxins (Prxs), GiPrx1a and GiPrx1b.
   Peroxiredoxins are peroxidases implicated in virulence and drug
   resistance in several parasitic protozoa, able to protect from
   nitroxidative stress and repair oxidatively damaged molecules. GiPrx1a
   and a truncated form of GiPrx1b (deltaGiPrx1b) were expressed in
   Escherichia coli, purified and functionally characterized. Both Prxs
   effectively metabolize H2O2 and alkyl-hydroperoxides (cumyl-and
   tert-butyl-hydroperoxide) in the presence of NADPH and E. coli
   thioredoxin reductase/thioredoxin as the reducing system. Stopped-flow
   experiments show that both proteins in the reduced state react with
   ONOO- rapidly (k=4 x 10(5) M-1 s(-1) and 2 x 10(5) M-1 s(-1) at 4
   degrees C, for GiPrx1a and deltaGiPrx1b, respectively). Consistent with
   a protective role against oxidative stress, expression of GiPrx1a (but
   not deltaGiPrx1b) is induced in parasitic cells exposed to air O-2 for
   24 h. Based on these results, GiPrx1a and deltaGiPrx1b are suggested to
   play an important role in the antioxidant defense of Giardia, possibly
   contributing to pathogenesis.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mastronicola, D (Reprint Author), CNR, Inst Mol Biol \& Pathol, Rome, Italy.
   Mastronicola, Daniela; Sarti, Paolo; Giuffre, Alessandro, CNR, Inst Mol Biol \& Pathol, Rome, Italy.
   Falabella, Micol; Testa, Fabrizio; Sarti, Paolo, Univ Roma La Sapienza, Dept Biochem Sci, Rome, Italy.
   Falabella, Micol; Testa, Fabrizio; Sarti, Paolo, Univ Roma La Sapienza, Fdn Cenci Bolognetti, Ist Pasteur, Rome, Italy.
   Pucillo, Leopoldo Paolo, IRCCS, L Spallanzani Natl Inst Infect Dis, Rome, Italy.
   Teixeira, Miguel; Saraiva, Ligia M., Univ Nova Lisboa, Inst Tecnol Quim \& Biol, P-2780156 Oeiras, Portugal.}},
DOI = {{10.1371/journal.pntd.0002631}},
Article-Number = {{e2631}},
ISSN = {{1935-2735}},
Keywords-Plus = {{ENTAMOEBA-HISTOLYTICA; TRYPAREDOXIN PEROXIDASE; GASTROINTESTINAL-TRACT;
   THIOREDOXIN REDUCTASE; 2-CYS PEROXIREDOXIN; TRYPANOSOMA-CRUZI;
   NITRIC-OXIDE; PLASMODIUM-FALCIPARUM; PROTEOMIC ANALYSIS; LAMBLIA}},
Research-Areas = {{Infectious Diseases; Parasitology; Tropical Medicine}},
Web-of-Science-Categories  = {{Infectious Diseases; Parasitology; Tropical Medicine}},
Author-Email = {{alessandro.giuffre@uniroma1.it}},
ResearcherID-Numbers = {{Saraiva, Ligia/H-8537-2012
   Teixeira, Miguel/A-9098-2011
   Giuffre, Alessandro/K-4341-2015
   }},
ORCID-Numbers = {{Saraiva, Ligia/0000-0002-0675-129X
   Teixeira, Miguel/0000-0003-4124-6237
   Giuffre, Alessandro/0000-0001-5301-0681
   Sarti, Paolo/0000-0002-8219-4827}},
Funding-Acknowledgement = {{Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy
   {[}FIRB RBFR08F41U\_001, FIRB RBIN06E9Z8, PRIN 20107Z8XBW\_005];
   Consiglio Nazionale delle Ricerche of Italy; Fundacao para a Ciencia e
   Tecnologia of Portugal}},
Funding-Text = {{Work partially supported by Ministero dell'Istruzione, dell'Universita e
   della Ricerca of Italy (FIRB RBFR08F41U\_001 to AG, FIRB RBIN06E9Z8 and
   PRIN 20107Z8XBW\_005 to PS). We also acknowledge a bilateral grant award
   by Consiglio Nazionale delle Ricerche of Italy and Fundacao para a
   Ciencia e Tecnologia of Portugal. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.}},
Cited-References = {{Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001.
   Andrade HM, 2008, J PROTEOME RES, V7, P2357, DOI 10.1021/pr700659m.
   Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317.
   Bagchi S, 2012, PARASITOLOGY, V139, P894, DOI 10.1017/S003118201200011X.
   Boucher IW, 2006, MOL MICROBIOL, V61, P948, DOI 10.1111/j.1365-2958.2006.05303.x.
   BROWN DM, 1995, MOL BIOCHEM PARASIT, V72, P47, DOI 10.1016/0166-6851(95)00065-9.
   Brown DM, 1996, EUR J BIOCHEM, V241, P155, DOI 10.1111/j.1432-1033.1996.0155t.x.
   Brown DM, 1996, MOL BIOCHEM PARASIT, V83, P211, DOI 10.1016/S0166-6851(96)02776-4.
   Bryk R, 2000, NATURE, V407, P211.
   CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017.
   Choi MH, 2005, MOL BIOCHEM PARASIT, V143, P80, DOI 10.1016/j.molbipara.2005.04.014.
   CROUCH AA, 1991, T ROY SOC TROP MED H, V85, P375, DOI 10.1016/0035-9203(91)90297-C.
   Davis PH, 2006, MOL MICROBIOL, V61, P1523, DOI 10.1111/j.1365-2958.2006.05344.x.
   DAWSON AM, 1965, NATURE, V206, P943, DOI 10.1038/206943b0.
   Di Matteo A, 2008, J BIOL CHEM, V283, P4061, DOI 10.1074/jbc.M705605200.
   EDWARDS MR, 1992, MOL BIOCHEM PARASIT, V53, P97, DOI 10.1016/0166-6851(92)90011-8.
   Espey MG, 2013, FREE RADICAL BIO MED, V55, P130, DOI 10.1016/j.freeradbiomed.2012.10.554.
   Fernandes PD, 1997, BRAZ J MED BIOL RES, V30, P93, DOI 10.1590/S0100-879X1997000100015.
   Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313.
   Gretes MC, 2012, ANTIOXID REDOX SIGN, V17, P608, DOI 10.1089/ars.2011.4404.
   Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624.
   He GL, 1999, P NATL ACAD SCI USA, V96, P4586, DOI 10.1073/pnas.96.8.4586.
   HILDEBRANDT AG, 1975, ARCH BIOCHEM BIOPHYS, V171, P385, DOI 10.1016/0003-9861(75)90047-8.
   HILL DR, 1987, INFECT IMMUN, V55, P3155.
   HUGHES MN, 1968, J CHEM SOC A, P450, DOI 10.1039/j19680000450.
   Ishii T, 2012, J CLIN BIOCHEM NUTR, V50, P91, DOI 10.3164/jcbn.11-109.
   Iyer JP, 2008, MOL MICROBIOL, V68, P372, DOI 10.1111/j.1365-2958.2008.06154.x.
   KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7.
   Kimura R, 2013, PARASITOL INT, V62, P137, DOI 10.1016/j.parint.2012.11.005.
   Kolli VK, 2008, ARCH TOXICOL, V82, P763, DOI 10.1007/s00204-008-0287-9.
   Kumsta C, 2009, BIOCHEMISTRY-US, V48, P4666, DOI 10.1021/bi9003556.
   Lane S, 2002, CRIT REV MICROBIOL, V28, P123, DOI 10.1080/10408410490435133.
   Leitsch D, 2011, J ANTIMICROB CHEMOTH, V66, P1756, DOI 10.1093/jac/dkr192.
   Leitsch D, 2009, MOL MICROBIOL, V72, P518, DOI 10.1111/j.1365-2958.2009.06675.x.
   Li L, 2006, MOL MICROBIOL, V59, P202, DOI 10.1111/j.1365-2958.2005.04896.x.
   Lloyd D, 2000, MICROBIOL-UK, V146, P3109, DOI 10.1099/00221287-146-12-3109.
   Lundberg JO, 2013, GUT, V62, P616, DOI 10.1136/gutjnl-2011-301649.
   Lush CW, 2003, GASTROENTEROLOGY, V124, P118, DOI 10.1053/gast.2003.50001.
   Ma'ayeh SY, 2012, INT J PARASITOL, V42, P501, DOI 10.1016/j.ijpara.2012.04.004.
   Mastronicola D, 2011, IUBMB LIFE, V63, P21, DOI 10.1002/iub.409.
   Mastronicola D, 2010, BIOCHEM BIOPH RES CO, V399, P654, DOI 10.1016/j.bbrc.2010.07.137.
   Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837.
   Nogueira F, 2009, PARASITOL RES, V104, P835, DOI 10.1007/s00436-008-1264-1.
   Ortega-Pierres G, 2009, TRENDS PARASITOL, V25, P410, DOI 10.1016/j.pt.2009.06.002.
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701.
   Piacenza L, 2009, INT J PARASITOL, V39, P1455, DOI 10.1016/j.ijpara.2009.05.010.
   Pineyro MD, 2005, J STRUCT BIOL, V150, P11, DOI 10.1016/j.jsb.2004.12.005.
   Poole L. B., 2011, CURR PROTOC TOXICOL, V49, P791, DOI 10.1002/0471140856.tx0709s49.
   RADI R, 1991, J BIOL CHEM, V266, P4244.
   Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936.
   Rafferty S, 2010, BIOCHEM BIOPH RES CO, V399, P347, DOI 10.1016/j.bbrc.2010.07.073.
   Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481.
   Ringqvist E, 2008, MOL BIOCHEM PARASIT, V159, P85, DOI 10.1016/j.molbiopara.2008.02.005.
   SHERIDAN WG, 1990, AM J SURG, V159, P314, DOI 10.1016/S0002-9610(05)81226-7.
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75.
   Testa F, 2011, FREE RADICAL BIO MED, V51, P1567, DOI 10.1016/j.freeradbiomed.2011.07.017.
   Trujillo M, 2008, METHOD ENZYMOL, V441, P173, DOI 10.1016/S0076-6879(08)01210-X.
   Vicente JB, 2009, CELL MICROBIOL, V11, P51, DOI 10.1111/j.1462-5822.2008.01236.x.
   Wassmann C, 1999, J BIOL CHEM, V274, P26051, DOI 10.1074/jbc.274.37.26051.
   Wilkinson SR, 2003, J BIOL CHEM, V278, P31640, DOI 10.1074/jbc.M303035200.
   Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009.
   Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770.
   Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200.
   Yano K, 2006, MOL BIOCHEM PARASIT, V148, P44, DOI 10.1016/j.molbiopara.2006.02.018.
   Yano K, 2008, MOL BIOCHEM PARASIT, V159, P142, DOI 10.1016/j.molbiopara.2008.03.002.}},
Number-of-Cited-References = {{65}},
Times-Cited = {{15}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{11}},
Journal-ISO = {{Plos Neglect. Trop. Dis.}},
Doc-Delivery-Number = {{AJ8SI}},
Unique-ID = {{ISI:000337977300028}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000337145200057,
Author = {Ghosh, Srabanti and Chakraborty, Prabal and Saha, Partha and Acharya,
   Somobrata and Ray, Manju},
Title = {{Polymer based nanoformulation of methylglyoxal as an antimicrobial
   agent: efficacy against resistant bacteria}},
Journal = {{RSC ADVANCES}},
Year = {{2014}},
Volume = {{4}},
Number = {{44}},
Pages = {{23251-23261}},
Abstract = {{Bacterial resistance to antibiotics is a severe health crisis across the
   globe and in the present scenario, nanoscale materials have emerged as
   efficient antimicrobial agents. Silver nanoparticles are
   well-established antibacterial agents but detrimental to eukaryotes
   through cytotoxicity and genotoxicity. An alternative bioactive normal
   metabolite, methylglyoxal (MG) possesses superior antimicrobial activity
   but instability in air and strong enzyme induced degradation limit its
   application. To circumvent this emerging problem, we have developed a
   green strategy of using multivalent, biodegradable polymers such as
   chitosan, and dendrimers for the facile preparation of conjugated
   nanoformulations (NMG \& DMG) of methylglyoxal as an antimicrobial agent
   against resistant bacteria. Interestingly, nanoformulated methylglyoxal
   selectively interferes with the bacterial pathogens while remaining
   biocompatible to the mammalian cells as reflected in therapeutic index.
   The functional group, cationic charge and nanosize of methylglyoxal
   allows them to attach to and insert into membrane bilayers of bacteria
   and could be the defining mechanisms of antimicrobial activity. This
   scalable approach of the fabrication of biocompatible nanoformulated
   methylglyoxal with desired selectivity can revolutionize the treatment
   of bacterial infection, minimizing human health and environment risks.}},
Publisher = {{ROYAL SOC CHEMISTRY}},
Address = {{THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ghosh, S (Reprint Author), Indian Assoc Cultivat Sci, Ctr Adv Mat, Kolkata 700032, India.
   Ghosh, Srabanti; Acharya, Somobrata; Ray, Manju, Indian Assoc Cultivat Sci, Ctr Adv Mat, Kolkata 700032, India.
   Chakraborty, Prabal; Saha, Partha, Saha Inst Nucl Phys, Crystallog \& Mol Biol Div, Kolkata 700064, W Bengal, India.
   Ray, Manju, Bose Inst, Div Mol Med, Kolkata 700054, India.}},
DOI = {{10.1039/c4ra00075g}},
ISSN = {{2046-2069}},
Keywords-Plus = {{ANTIBACTERIAL AGENTS; MULTIDRUG-RESISTANCE; MOLECULAR-MECHANISMS;
   ESCHERICHIA-COLI; DRUG-DELIVERY; BEARING MICE; DNA-DAMAGE; IN-VITRO;
   DENDRIMERS; CANCER}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Multidisciplinary}},
Author-Email = {{ghosh.srabanti@gmail.com
   manju.ray.iacs@gmail.com}},
Funding-Acknowledgement = {{DST, India {[}SR/S5/NM-47/2005, SR/NM/NS-49/2009]; Council of Scientific
   and Industrial Research, India}},
Funding-Text = {{Financial support under Grant \#SR/S5/NM-47/2005 and Grant
   \#SR/NM/NS-49/2009 from DST, India are gratefully acknowledged. S. G.
   and M. R. gratefully acknowledge the Council of Scientific and
   Industrial Research, India for financial support. The authors thank
   Prof. S. Ghosh, Ballygunge Science College, Kolkata for providing
   superoxide measurements in bacterial cells.}},
Cited-References = {{Adolfsson-Erici M, 2002, CHEMOSPHERE, V46, P1485, DOI 10.1016/S0045-6535(01)00255-7.
   Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004.
   Amin K, 2006, J PHARM SCI-US, V95, P1173, DOI 10.1002/jps.20627.
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w.
   Banerjee D, 2000, DRUGS, V60, P1053, DOI 10.2165/00003495-200060050-00006.
   Campos FM, 2009, INT J FOOD MICROBIOL, V135, P144, DOI 10.1016/j.ijfoodmicro.2009.07.031.
   Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200.
   Cox SD, 1998, LETT APPL MICROBIOL, V26, P355.
   DEAN AM, 1990, SCIENCE, V249, P1044, DOI 10.1126/science.2204110.
   DEBOCK CA, 1957, NATURE, V179, P706, DOI 10.1038/179706a0.
   Dobrovoiskaia MA, 2008, NANO LETT, V8, P2180, DOI 10.1021/nl0805615.
   Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958.
   EGYUD LG, 1968, SCIENCE, V160, P1140, DOI 10.1126/science.160.3832.1140.
   Geerts N, 2008, LANGMUIR, V24, P5118, DOI 10.1021/la7036789.
   Ghosh M, 2006, TOXICOL APPL PHARM, V212, P45, DOI 10.1016/j.taap.2005.07.003.
   Ghosh S, 2011, NANOSCALE, V3, P1139, DOI 10.1039/c0nr00610f.
   Ghosh S, 2014, PHYS CHEM CHEM PHYS, V16, P5276, DOI 10.1039/c3cp53489h.
   Gillies ER, 2005, DRUG DISCOV TODAY, V10, P35, DOI 10.1016/S1359-6446(04)03276-3.
   GONZALEZFLECHA B, 1995, J BIOL CHEM, V270, P13681, DOI 10.1074/jbc.270.23.13681.
   Guo YY, 2014, MOL PHARMACEUT, V11, P59, DOI 10.1021/mp400514t.
   Haldar J, 2006, P NATL ACAD SCI USA, V103, P17667, DOI 10.1073/pnas.0608803103.
   HALDER J, 1993, INT J CANCER, V54, P443, DOI 10.1002/ijc.2910540315.
   HARA S, 1988, ANAL CHIM ACTA, V215, P267, DOI 10.1016/S0003-2670(00)85285-X.
   HILL MJ, 1995, EUR J CANCER PREV, V4, P127.
   Hugo WB, 1982, PRINCIPLES PRACTICE, P38.
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536.
   Kamboj M, 2009, LANCET ONCOL, V10, P589, DOI 10.1016/S1470-2045(09)70069-5.
   Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q.
   Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333.
   Kumar A, 2008, NAT MATER, V7, P236, DOI 10.1038/nmat2099.
   Lax AJ, 2005, NAT REV MICROBIOL, V3, P343, DOI 10.1038/nrmicro1130.
   Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015.
   Lu Y, 2014, BIOMATERIALS, V35, P1716, DOI 10.1016/j.biomaterials.2013.11.015.
   Lu Y, 2013, BIOMACROMOLECULES, V14, P3589, DOI 10.1021/bm400961r.
   Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003.
   Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282.
   Medina SH, 2009, CHEM REV, V109, P3141, DOI 10.1021/cr900174j.
   Midorikawa Y., 2008, J APPL MICROBIOL, V70, P291.
   Pal A, 2009, MOL IMMUNOL, V46, P2039, DOI 10.1016/j.molimm.2009.03.014.
   Patra S, 2012, AMINO ACIDS, V42, P2319, DOI 10.1007/s00726-011-0974-3.
   POOLMAN B, 1987, MICROBIOL REV, V51, P498.
   Schipper ML, 2008, NAT NANOTECHNOL, V3, P216, DOI 10.1038/nnano.2008.68.
   Schipper NGM, 1999, EUR J PHARM SCI, V8, P335, DOI 10.1016/S0928-0987(99)00032-9.
   Senel S, 2000, INT J PHARM, V193, P197, DOI 10.1016/S0378-5173(99)00334-8.
   Stark M, 2002, ANTIMICROB AGENTS CH, V46, P3585, DOI 10.1128/AAC.46.11.3585.3590.2002.
   Sun B, 2012, BIOMACROMOLECULES, V13, P3343, DOI 10.1021/bm301109c.
   Tachon S, 2009, MICROBIOL-SGM, V155, P2941, DOI 10.1099/mic.0.029678-0.
   Talukdar Dipa, 2008, Drug Metabolism and Drug Interactions, V23, P175.
   TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381.
   TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331.
   VISTICA DT, 1991, CANCER RES, V51, P2515.
   Voet D., 2006, FUNDAMENTALS BIOCH.
   Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219.
   Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956.
   Woodford N, 2009, J INFECTION, V59, pS4, DOI 10.1016/S0163-4453(09)60003-7.
   Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614.
   Zhang R, 2010, TOXICOL LETT, V192, P108, DOI 10.1016/j.toxlet.2009.10.012.
   Zheng Y, 2009, RADIAT RES, V172, P114, DOI 10.1667/RR1689.1.}},
Number-of-Cited-References = {{58}},
Times-Cited = {{8}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{23}},
Journal-ISO = {{RSC Adv.}},
Doc-Delivery-Number = {{AI8FQ}},
Unique-ID = {{ISI:000337145200057}},
DA = {{2018-08-13}},
}

@article{ ISI:000332526500035,
Author = {Letoffe, Sylvie and Audrain, Bianca and Bernier, Steve P. and
   Delepierre, Muriel and Ghigo, Jean-Marc},
Title = {{Aerial Exposure to the Bacterial Volatile Compound Trimethylamine
   Modifies Antibiotic Resistance of Physically Separated Bacteria by
   Raising Culture Medium pH}},
Journal = {{MBIO}},
Year = {{2014}},
Volume = {{5}},
Number = {{1}},
Month = {{JAN-FEB}},
Abstract = {{Bacteria release a wide diversity of small bioactive molecules that
   often correspond to secondary metabolites. Among them, volatile
   molecules produced under various growth conditions were shown to mediate
   cross-kingdom interactions with plants, nematodes, and fungi. Although
   the role of volatile compounds in bacterial biology is not well
   understood, recent reports indicated that they could play a role in
   airborne interactions between bacteria and influence antibiotic
   resistance, biofilm formation, and virulence. In this study, we
   investigated long-distance effects of 14 previously described
   Escherichia coli volatile compounds upon the bacteria E. coli,
   Pseudomonas aeruginosa, Staphylococcus aureus, and Bacillus subtilis. We
   show that several of these molecules constitute chemical cues
   influencing growth, adhesion, and motility in exposed bacteria.
   Moreover, we show that aerial exposure to trimethylamine (TMA), a
   volatile compound produced in animal intestines and tissues upon
   biogenic reduction of trimethylamine oxide (TMAO), modifies the
   antibiotic resistance profiles of all tested Gram-positive and
   Gram-negative bacteria. We demonstrate that the TMA mode of action is
   distinct from that previously described for ammonia and results from
   nonspecific transient alteration of antibiotic uptake due to pH increase
   in the environment of bacteria aerially exposed to TMA. Our study
   therefore presents a new way by which volatile compounds can affect
   community behavior and structure in physically separated bacteria. It
   further demonstrates that bacterial gases and volatile compounds mediate
   chemical interactions, triggering functional responses that play an
   important role in the development of bacterial communities.
   IMPORTANCE Bacteria release many different volatile compounds during
   food transformation and fermentation. Here we sought to investigate the
   role of several bacterial volatile molecules released by Escherichia
   coli during long-distance airborne interactions with other bacteria.
   While several tested volatiles affect bacterial motility and surface
   adhesion, we show that aerial exposure to trimethylamine, a molecule
   produced by E. coli and many other Gram-negative bacteria in animal
   intestines and infected tissues, also modulates antibiotic resistance in
   all tested bacteria. We demonstrate that exposure to trimethylamine
   increases the pH of the growth medium of exposed bacteria, resulting in
   modifications in antibiotic uptake and transient alteration of
   antibiotic resistance. Our study therefore presents a new mechanism by
   which volatile compounds can affect community behavior and structure in
   physically separated bacteria, and it illustrates how airborne chemical
   interactions between bacteria contribute to the development of bacterial
   communities.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ghigo, JM (Reprint Author), Inst Pasteur, Unite Genet Biofilms, Dept Microbiol, Paris, France.
   Letoffe, Sylvie; Audrain, Bianca; Bernier, Steve P.; Ghigo, Jean-Marc, Inst Pasteur, Unite Genet Biofilms, Dept Microbiol, Paris, France.
   Audrain, Bianca, Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.
   Delepierre, Muriel, Inst Pasteur, Unite Resonance Magnet Nucl Biomol, Paris, France.
   Delepierre, Muriel, CNRS, UMR 3528, Paris, France.}},
DOI = {{10.1128/mBio.00944-13}},
Article-Number = {{e00944-13}},
ISSN = {{2150-7511}},
Keywords-Plus = {{ESCHERICHIA-COLI; BIOFILM FORMATION; AMINOGLYCOSIDE ANTIBIOTICS;
   AIRBORNE SIGNALS; ALKALINE PH; OXIDE; COMMUNICATION; ACCUMULATION;
   TRANSPORT; SYSTEM}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{jean-marc.ghigo@pasteur.fr}},
Funding-Acknowledgement = {{Institut Pasteur; French Government's Investissement d'Avenir program,
   Laboratoire d'Excellence ``Integrative Biology of Emerging Infectious
   Diseases{''} {[}ANR-10-LABX-62-IBEID]; Canadian Louis Pasteur Foundation}},
Funding-Text = {{This work was supported by grants from the Institut Pasteur and from the
   French Government's Investissement d'Avenir program, Laboratoire
   d'Excellence ``Integrative Biology of Emerging Infectious Diseases{''}
   (grant no. ANR-10-LABX-62-IBEID). S.P.B. was the recipient of a
   postdoctoral fellowship from the Canadian Louis Pasteur Foundation.}},
Cited-References = {{ALWAIZ M, 1992, METABOLISM, V41, P135, DOI 10.1016/0026-0495(92)90140-6.
   Ansaldi M, 2007, MOL MICROBIOL, V66, P484, DOI 10.1111/j.1365-2958.2007.05936.x.
   Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050.
   BARRETT EL, 1985, ANNU REV MICROBIOL, V39, P131, DOI 10.1146/annurev.mi.39.100185.001023.
   Bernier SP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00020.
   Bernier SP, 2011, MOL MICROBIOL, V81, P705, DOI 10.1111/j.1365-2958.2011.07724.x.
   Blom D, 2011, APPL ENVIRON MICROB, V77, P1000, DOI 10.1128/AEM.01968-10.
   Bordi C, 2003, MOL MICROBIOL, V48, P211, DOI 10.1046/j.1365-2958.2003.03428.x.
   Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311.
   Bunge M, 2008, APPL ENVIRON MICROB, V74, P2179, DOI 10.1128/AEM.02069-07.
   BURKHOLDER PR, 1947, AM J BOT, V34, P345, DOI 10.2307/2437147.
   BURNS JL, 1987, ANTIMICROB AGENTS CH, V31, P686, DOI 10.1128/AAC.31.5.686.
   Cepl JJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-139.
   Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97.
   CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A.
   Da Re S, 2007, APPL ENVIRON MICROB, V73, P3391, DOI 10.1128/AEM.02625-06.
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297.
   Di Martino P, 2003, CAN J MICROBIOL, V49, P443, DOI 10.1139/W03-056.
   Domka J, 2006, APPL ENVIRON MICROB, V72, P2449, DOI 10.1128/AEM.72.4.2449-2459.2006.
   Dunkel M, 2009, NUCLEIC ACIDS RES, V37, pD291, DOI 10.1093/nar/gkn695.
   Effmert U, 2012, J CHEM ECOL, V38, P665, DOI 10.1007/s10886-012-0135-5.
   Farag MA, 2006, PHYTOCHEMISTRY, V67, P2262, DOI 10.1016/j.phytochem.2006.07.021.
   Gennis RB, 2005, ECOSAL ESCHERICHIA C, DOI DOI 10.1126/EC0SAL.17.
   Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581.
   Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699.
   Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439.
   Guyer M S, 1981, Cold Spring Harb Symp Quant Biol, V45 Pt 1, P135.
   Heal RD, 2002, J APPL MICROBIOL, V92, P1116, DOI 10.1046/j.1365-2672.2002.01647.x.
   Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10.
   Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912.
   Hu MX, 2010, INDIAN J MICROBIOL, V50, P362, DOI 10.1007/s12088-011-0142-1.
   Joffraud JJ, 2001, INT J FOOD MICROBIOL, V66, P175, DOI 10.1016/S0168-1605(00)00532-8.
   Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3.
   Kappes RM, 1996, J BACTERIOL, V178, P5071, DOI 10.1128/jb.178.17.5071-5079.1996.
   Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383.
   Kesarwani M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002192.
   Kim KS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2789.
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145.
   Korpi A, 1998, APPL ENVIRON MICROB, V64, P2914.
   Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354.
   Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x.
   Loftin KA, 2008, J ENVIRON QUAL, V37, P378, DOI 10.2134/jeq2007.0230.
   Lubitz SP, 2003, ARCH BIOCHEM BIOPHYS, V418, P205, DOI 10.1016/j.abb.2003.08.008.
   Ma Q, 2012, ISME J, V6, P1356, DOI 10.1038/ismej.2011.210.
   McCrindle SL, 2005, ADV MICROB PHYSIOL, V50, P147, DOI 10.1016/S0065-2911(05)50004-3.
   Miller J. H., 1992, SHORT COURSE BACTERI.
   MINAKAMI H, 1990, J BACTERIOL, V172, P691, DOI 10.1128/jb.172.2.691-695.1990.
   Monds RD, 2008, CHEMICAL COMMUNICATION AMONG BACTERIA, P105.
   Nijland R, 2010, BIOTECHNOL J, V5, P974, DOI 10.1002/biot.201000174.
   NIKAIDO H, 1993, J BIOENERG BIOMEMBR, V25, P581.
   Niu QH, 2010, P NATL ACAD SCI USA, V107, P16631, DOI 10.1073/pnas.1007276107.
   Nostro A, 2012, APMIS, V120, P733, DOI 10.1111/j.1600-0463.2012.02900.x.
   Piccirillo S, 2010, GENETICS, V184, P707, DOI 10.1534/genetics.109.113480.
   Rebouche CJ, 1998, ANNU REV NUTR, V18, P39, DOI 10.1146/annurev.nutr.18.1.39.
   Sargent F, 2002, ARCH MICROBIOL, V178, P77, DOI 10.1007/s00203-002-0434-2.
   Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h.
   Seibel BA, 2002, J EXP BIOL, V205, P297.
   Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855.
   SPEER BS, 1992, CLIN MICROBIOL REV, V5, P387.
   Straight PD, 2009, ANNU REV MICROBIOL, V63, P99, DOI 10.1146/annurev.micro.091208.073248.
   Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636.
   TABER HW, 1987, MICROBIOL REV, V51, P439.
   Thorn RMS, 2011, J MICROBIOL METH, V84, P258, DOI 10.1016/j.mimet.2010.12.001.
   Vyikova S, 2011, MBIO, V2, DOI DOI 10.1128/MBI0.00055-11.
   Wheatley RE, 2002, ANTON LEEUW INT J G, V81, P357, DOI 10.1023/A:1020592802234.
   WILLIAMS DH, 1989, J NAT PROD, V52, P1189, DOI 10.1021/np50066a001.
   YAMAGUCHI A, 1991, ANTIMICROB AGENTS CH, V35, P53, DOI 10.1128/AAC.35.1.53.
   Ziegler C, 2010, MOL MICROBIOL, V78, P13, DOI 10.1111/j.1365-2958.2010.07332.x.}},
Number-of-Cited-References = {{68}},
Times-Cited = {{34}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{24}},
Journal-ISO = {{mBio}},
Doc-Delivery-Number = {{AC4YF}},
Unique-ID = {{ISI:000332526500035}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000329165600006,
Author = {Zhou, Qi (Tony) and Gengenbach, Thomas and Denman, John A. and Yu, Heidi
   H. and Li, Jian and Chan, Hak Kim},
Title = {{Synergistic Antibiotic Combination Powders of Colistin and Rifampicin
   Provide High Aerosolization Efficiency and Moisture Protection}},
Journal = {{AAPS JOURNAL}},
Year = {{2014}},
Volume = {{16}},
Number = {{1}},
Pages = {{37-47}},
Month = {{JAN}},
Abstract = {{For many respiratory infections caused by multidrug-resistant
   Gram-negative bacteria, colistin is the only effective antibiotic
   despite its nephrotoxicity. A novel inhaled combination formulation of
   colistin with a synergistic antimicrobial component of rifampicin was
   prepared via co-spray drying, aiming to deliver the drug directly to the
   respiratory tract and minimize drug resistance and adverse effects.
   Synergistic antibacterial activity against Acinetobacter baumannii was
   demonstrated for the combination formulation with high emitted doses
   (96\%) and fine particle fraction total (FPFtotal; 92\%). Storage of the
   spray-dried colistin alone formulation in the elevated relative humidity
   (RH) of 75\% resulted in a substantial deterioration in the
   aerosolization performance because the amorphous colistin powders
   absorbed significant amount of water up to 30\% by weight. In contrast,
   the FPFtotal values of the combination formulation stored at various RH
   were unchanged, which was similar to the aerosolization behavior of the
   spray-dried rifampicin-alone formulation. Advanced surface chemistry
   measurements by XPS and ToF-SIMS demonstrated a dominance of rifampicin
   on the combination particle surfaces, which contributed to the moisture
   protection at the elevated RH. This study shows a novel inhalable powder
   formulation of antibiotic combination with the combined beneficial
   properties of synergistic antibacterial activity, high aerosolization
   efficiency, and moisture protection.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chan, HK (Reprint Author), Univ Sydney, Adv Drug Delivery Grp, Fac Pharm, Sydney, NSW 2006, Australia.
   Zhou, Qi (Tony); Chan, Hak Kim, Univ Sydney, Adv Drug Delivery Grp, Fac Pharm, Sydney, NSW 2006, Australia.
   Gengenbach, Thomas, CSIRO Mat Sci \& Engn, Clayton, Vic, Australia.
   Denman, John A., Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA, Australia.
   Yu, Heidi H.; Li, Jian, Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.}},
DOI = {{10.1208/s12248-013-9537-8}},
ISSN = {{1550-7416}},
Keywords = {{combination antibiotics; dry powder inhaler; moisture protection;
   respiratory infection; synergistic antibacterial activity}},
Keywords-Plus = {{RESISTANT ACINETOBACTER-BAUMANNII; CYSTIC-FIBROSIS THERAPY;
   HEALTHY-VOLUNTEERS; SURFACE-PROPERTIES; RESPIRATORY-TRACT; INHALED
   COLISTIN; AIR CLASSIFIER; DRY; FORMULATION; INHALATION}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy}},
Author-Email = {{kim.chan@sydney.edu.au}},
ResearcherID-Numbers = {{Li, Jian/I-5538-2016
   Chan, Hak-Kim/O-9264-2017
   }},
ORCID-Numbers = {{Li, Jian/0000-0001-7953-8230
   Chan, Hak-Kim/0000-0002-7054-3137
   Denman, John/0000-0002-7048-1175}},
Funding-Acknowledgement = {{Australian Research Council (ARC) {[}DP120102778, DP0985367]; NHMRC}},
Funding-Text = {{HKC acknowledges the Australian Research Council (ARC, grant DP120102778
   and DP0985367) for the financial support of this study. JL is a National
   Health and Medical Research Council (NHMRC) Senior Research Fellow. QTZ
   is supported by an NHMRC Early Career Fellowship. The authors are
   grateful for the scientific and technical assistance of the Australian
   Microscopy \& Microanalysis Research Facility at the Australian Centre
   for Microscopy and Microanalysis, The University of Sydney and the Ian
   Wark Research Institute, University of South Australia. Capsugel
   Australia is acknowledged for the kind donation of the capsules.}},
Cited-References = {{Antoniu SA, 2012, EXPERT OPIN DRUG DEL, V9, P333, DOI 10.1517/17425247.2012.660480.
   Asking L, 1997, AEROSOL SCI TECH, V27, P39, DOI 10.1080/02786829708965456.
   Beamson G, 1992, HIGH RESOLUTION XPS.
   Bergen PJ, 2006, ANTIMICROB AGENTS CH, V50, P1953, DOI 10.1128/AAC.00035-06.
   Chan JGY, 2013, EUR J PHARM BIOPHARM, V83, P285, DOI 10.1016/j.ejpb.2012.08.007.
   Chew NYK, 2001, PHARMACEUT RES, V18, P1570, DOI 10.1023/A:1013082531394.
   CLARK AR, 1993, J AEROSOL MED, V6, P99, DOI 10.1089/jam.1993.6.99.
   de Boer AH, 2006, EUR J PHARM SCI, V28, P171, DOI 10.1016/j.ejps.2005.11.013.
   de Boer AH, 2002, EUR J PHARM BIOPHARM, V54, P17, DOI 10.1016/S0939-6411(02)00043-7.
   de Boer AH, 2012, J PHARM PHARMACOL, V64, P1316, DOI 10.1111/j.2042-7158.2012.01511.x.
   Edwards B, 2007, AUSTR LUNG FDN CASE, P9.
   European Medicines Agency, 2012, COL EUR PUBL ASS REP.
   Feeley JC, 2002, J MATER SCI, V37, P217, DOI 10.1023/A:1013103521464.
   Garonzik SM, 2011, ANTIMICROB AGENTS CH, V55, P3284, DOI 10.1128/AAC.01733-10.
   Geller DE, 2007, PEDIATR PULM, V42, P307, DOI 10.1002/ppal.20594.
   Grasmeijer F, 2012, INT J PHARMACEUT, V437, P242, DOI 10.1016/j.ijpharm.2012.08.020.
   Hogg GM, 1998, J ANTIMICROB CHEMOTH, V41, P494, DOI 10.1093/jac/41.4.494.
   Kim CS, 2004, AEROSOL SCI TECH, V38, P525, DOI 10.1080/02786820490465513.
   Kumon M, 2010, EUR J PHARM SCI, V40, P16, DOI 10.1016/j.ejps.2010.02.004.
   Le Brun PPH, 2002, EUR J PHARM BIOPHARM, V54, P25, DOI 10.1016/S0939-6411(02)00044-9.
   Lee HJ, 2013, ANTIMICROB AGENTS CH, V57, P3738, DOI 10.1128/AAC.00703-13.
   Li J, 2005, INT J ANTIMICROB AG, V25, P11, DOI 10.1016/j.ijantimicag.2004.10.001.
   Li J, 2007, CLIN INFECT DIS, V45, P594, DOI 10.1086/520658.
   Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1.
   Li J, 2006, ANTIMICROB AGENTS CH, V50, P2946, DOI 10.1128/AAC.00103-06.
   Nation RL, 2009, CURR OPIN INFECT DIS, V22, P535, DOI 10.1097/QCO.0b013e328332e672.
   Pantopoulou A, 2007, INT J ANTIMICROB AG, V29, P51, DOI 10.1016/j.ijantimicag.2006.09.009.
   Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06.
   Petrosillo N, 2008, CLIN MICROBIOL INFEC, V14, P816, DOI 10.1111/j.1469-0691.2008.02061.x.
   Pilcer G, 2010, INT J PHARMACEUT, V392, P1, DOI 10.1016/j.ijpharm.2010.03.017.
   Pilcer G, 2009, J PHARM SCI-US, V98, P1463, DOI 10.1002/jps.21545.
   Ratjen F, 2006, J ANTIMICROB CHEMOTH, V57, P306, DOI 10.1093/jac/dki461.
   Schuster A, 2013, THORAX, V68, P344, DOI 10.1136/thoraxjnl-2012-202059.
   Song JY, 2008, INT J ANTIMICROB AG, V32, P281, DOI 10.1016/j.ijantimicag.2008.04.013.
   Traini D, 2009, EXPERT OPIN DRUG DEL, V6, P897, DOI 10.1517/17425240903110710.
   Vehring R, 2008, PHARM RES, V25, P999, DOI 10.1007/s11095-007-9475-1.
   Zhang J, 2011, ADV DRUG DELIVER REV, V63, P441, DOI 10.1016/j.addr.2010.11.002.
   Zhou Q, 2013, J PHARM SCI-US, V102, P3736, DOI 10.1002/jps.23685.
   Zhou QT, 2013, AAPS J, V15, P511, DOI 10.1208/s12248-013-9458-6.
   Zhou Q, 2012, ADV DRUG DELIVER REV, V64, P275, DOI 10.1016/j.addr.2011.07.002.
   Zhou Q, 2011, J PHARM SCI-US, V100, P3421, DOI 10.1002/jps.22547.
   Zhou Q, 2011, INT J PHARMACEUT, V413, P36, DOI 10.1016/j.ijpharm.2011.04.014.
   Zhou QT, 2010, EUR J PHARM SCI, V40, P412, DOI 10.1016/j.ejps.2010.04.012.
   Zhu KW, 2008, J AEROSOL SCI, V39, P510, DOI 10.1016/j.jaerosci.2008.02.003.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{29}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{11}},
Journal-ISO = {{AAPS J.}},
Doc-Delivery-Number = {{282IX}},
Unique-ID = {{ISI:000329165600006}},
OA = {{green\_published}},
DA = {{2018-08-13}},
}

@inproceedings{ ISI:000378846000028,
Author = {Ivbule, Meldra and Valdovska, Anda},
Editor = {{Treija, S and Skujeniece, S}},
Title = {{STAPHYLOCOCCUS SPECIES IN DIFFERENT AGE GROUPS OF PIGS IN LATVIA}},
Booktitle = {{RESEARCH FOR RURAL DEVELOPMENT 2014, VOL 1}},
Series = {{Research for Rural Development}},
Year = {{2014}},
Pages = {{176-181}},
Note = {{20th Annual International Scientific Conference on Research for Rural
   Development, Latvia Univ Agr, Jelgava, LATVIA, MAY 21-23, 2014}},
Abstract = {{Antibiotic resistance of Staphylococcus is increasing worldwide. New
   antibiotics are used in big amounts in the meat production more and
   more. As a zoonosis, Staphylococcus aureus (S. aureus) is found in
   various species of animals and people, especially in those, who are
   working on commercial swine farms and slaughterhouses. The aim of the
   study was to find out the occurrence of S. aureus in different age
   groups of pigs on commercial swine farms in Latvia. Microbiological
   samples (n=702) including nasal, rectal, milk and air samples were
   collected during October 2013 from three closed farms of different sizes
   and several age groups of pigs and investigated with microbiological
   standard methods. S. aureus was found in all swine farms. The occurrence
   of S. aureus in Latvian pig farms was 41\% and the highest occurrence of
   S. aureus was among 3-3.5 month old piglets. S. aureus was 1.8 times
   more frequently found in nasal than in rectal samples, and only in
   28.38\% of pigs S. aureus was in both - nasal and rectal samples. Si
   aureus was found also in sow milk in 13\% of samples and in 3 samples of
   air (n=23).}},
Publisher = {{LATVIA UNIV AGRICULTURE}},
Address = {{LIELA IELA 2, JELGAVA, LV-3001, LATVIA}},
Type = {{Proceedings Paper}},
Language = {{English}},
Affiliation = {{Ivbule, M (Reprint Author), Latvia Univ Agr, Jelgava, Latvia.
   Ivbule, Meldra; Valdovska, Anda, Latvia Univ Agr, Jelgava, Latvia.}},
ISSN = {{1691-4031}},
Keywords = {{staphylococcus; S. aureus; pig farms}},
Keywords-Plus = {{AUREUS; PRODUCTIVITY}},
Research-Areas = {{Agriculture; Food Science \& Technology; Veterinary Sciences}},
Web-of-Science-Categories  = {{Agriculture, Multidisciplinary; Food Science \& Technology; Veterinary
   Sciences}},
Author-Email = {{Meldra.Ivbule@llu.lv}},
Cited-References = {{{[}Anonymous], 2009, OFFICIAL J EUROPEAN, P5.
   {[}Anonymous], 2009, ASS PUBL HLTH SIGN M.
   BEATTIE VE, 1995, ANIM WELFARE, V4, P207.
   BOER E., 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007.
   Boucher H, 2010, CLIN INFECT DIS   S2, V51, P183.
   Brown D., 2005, J ANTIMICROB CHEMOTH, P1000.
   Carr J., 1998, GARTH PIG STOCKMANSH.
   Charlier C, 2009, INT J FOOD MICROBIOL, V131, P30, DOI 10.1016/j.ijfoodmicro.2008.06.032.
   De Jonge F., 1996, J PHYSL BEHAV, p389 .
   Dewaele I, 2013, METHICILLIN RESISTAN.
   Ekkel ED, 1996, J ANIM SCI, V74, P2081.
   Friese A., 2011, Animal hygiene and sustainable livestock production. Proceedings of the XVth International Congress of the International Society for Animal Hygiene, Vienna, Austria, 3-7 July 2011, Volume 1, P515.
   Hickey MC, 2003, J ANIM SCI, V81, P2847.
   Kock R., 2009, EUROPEAN J CILINICAL, P1375.
   Kuller WI, 2004, J ANIM SCI, V82, P405.
   Morgan M, 2008, J ANTIMICROB CHEMOTH, V62, P1181, DOI 10.1093/jac/dkn405.
   Muirhead M.R., 2013, MANAGING PIG HLTH RE.
   Schulz J., 2011, Animal hygiene and sustainable livestock production. Proceedings of the XVth International Congress of the International Society for Animal Hygiene, Vienna, Austria, 3-7 July 2011, Volume 1, P523.
   Smith C., 2009, METHICILLIN RESISTAN.
   Sommerhauser J, 2003, VET MICROBIOL, V96, P91, DOI 10.1016/S0378-1135(03)00204-9.
   Weese J., 2009, VET MICROBIOL, V140, p418 .}},
Number-of-Cited-References = {{21}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Doc-Delivery-Number = {{BF0HD}},
Unique-ID = {{ISI:000378846000028}},
DA = {{2018-08-13}},
}

@article{ ISI:000330917800014,
Author = {Kubota, Noriko and Kuzumoto, Kei and Hidaka, Eiko and Yoshizawa, Katsumi
   and Yumoto, Kayoko and Oana, Kozue and Ogiso, Yoshifumi and Nakamura,
   Tomohiko and Kawakami, Yoshiyuki},
Title = {{First isolation of oleate-dependent Enterococcus faecalis small-colony
   variants from the umbilical exudate of a paediatric patient with
   omphalitis}},
Journal = {{JOURNAL OF MEDICAL MICROBIOLOGY}},
Year = {{2013}},
Volume = {{62}},
Number = {{12}},
Pages = {{1883-1890}},
Month = {{DEC}},
Abstract = {{An oleate-dependent Enterococcus faecalis isolate representing
   small-colony variants (SCVs) was isolated from the umbilical exudate of
   a 31-month-old Japanese male patient in Nagano Children's Hospital,
   Azumino, Japan. The patient had been suffering from recurrent omphalitis
   since early infancy. The initial E. faecalis SCV isolate formed small
   colonies on sheep blood agar plates and tiny colonies on chocolate and
   modified Drigalski agar, although no visible growth was observed in
   HK-semi solid medium after 48 h incubation in ambient air. Moreover, the
   SCV isolate, the colonial morphology of which was reminiscent of
   Streptococcus species, could not be identified using the MicroScan
   WalkAway-40 and API 20 Strep systems, both of which yielded profile
   numbers that did not correspond to any bacterial species, probably as a
   result of insufficient growth of the isolate. The SCV isolate was
   subsequently identified as E. faecalis based on its morphological,
   cultural and biochemical properties, and this was confirmed by
   sequencing the 16S rRNA gene of the organism. Investigations revealed
   that the addition of oleate, an unsaturated fatty acid, enabled the
   isolate to grow on every medium with normal-sized colony morphology.
   Although it has long been known that long-chain fatty acids, especially
   unsaturated oleic acid, have a major inhibitory effect on the growth of
   a variety of microorganisms, including not only mycobacteria but also
   streptococci, this is, to the best of our knowledge, the first clinical
   isolation of an oleate-dependent E. faecalis SCV isolate. In addition,
   oleic acid might be considered to affect the cell membrane permeability
   of carbohydrates or antimicrobial agents such as beta-lactams.}},
Publisher = {{SOC GENERAL MICROBIOLOGY}},
Address = {{MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG,
   BERKS, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kawakami, Y (Reprint Author), Shinshu Univ, Grad Sch Med, Dept Hlth \& Med Sci, Div Infect Control \& Microbiol Regulat, Matsumoto, Nagano 3908621, Japan.
   Kubota, Noriko; Kuzumoto, Kei; Hidaka, Eiko; Yumoto, Kayoko; Ogiso, Yoshifumi, Nagano Childrens Hosp, Dept Lab Med, Azumino 3998288, Japan.
   Yoshizawa, Katsumi, Nagano Childrens Hosp, Dept Surg, Azumino 3998288, Japan.
   Oana, Kozue; Kawakami, Yoshiyuki, Shinshu Univ, Grad Sch Med, Dept Hlth \& Med Sci, Div Infect Control \& Microbiol Regulat, Matsumoto, Nagano 3908621, Japan.
   Oana, Kozue; Kawakami, Yoshiyuki, Shinshu Univ, Sch Med, Sch Hlth Sci, Dept Biomed Lab Sci,Div Clin Microbiol, Matsumoto, Nagano 3908621, Japan.}},
DOI = {{10.1099/jmm.0.062752-0}},
ISSN = {{0022-2615}},
EISSN = {{1473-5644}},
Keywords-Plus = {{STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; CYSTIC-FIBROSIS;
   FATTY-ACIDS; MUTANT; PERSISTENT; MUTATIONS; GROWTH; LYSIS}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{yk23724@shinshu-u.ac.jp}},
Funding-Acknowledgement = {{Ministry of Health and Welfare of Japan}},
Funding-Text = {{This study was funded by a grant for scientific research from the
   Ministry of Health and Welfare of Japan.}},
Cited-References = {{{[}Anonymous], 2012, M100S22 CLSI.
   Bauernfeind J. C., 1942, INDUST AND ENGINEER CHEM ANALYT ED, V14, P666, DOI 10.1021/i560108a022.
   Besier S, 2008, ANTIMICROB AGENTS CH, V52, P2183, DOI 10.1128/AAC.01395-07.
   CARSON DD, 1980, J BACTERIOL, V141, P1122.
   Chatterjee I, 2008, J BACTERIOL, V190, P834, DOI 10.1128/JB.00912-07.
   Chatterjee I, 2007, J BACTERIOL, V189, P2936, DOI 10.1128/JB.01444-06.
   Cohen S, 1941, J BACTERIOL, V41, P581.
   DUBOS RJ, 1950, J EXP MED, V92, P319, DOI 10.1084/jem.92.4.319.
   GALBRAITH H, 1973, J APPL BACTERIOL, V36, P659, DOI 10.1111/j.1365-2672.1973.tb04151.x.
   GILLIGAN PH, 1987, J CLIN MICROBIOL, V25, P1258.
   Grobner S, 2012, INT J MED MICROBIOL, V302, P40, DOI 10.1016/j.ijmm.2011.07.001.
   Kahl B, 1998, J INFECT DIS, V177, P1023, DOI 10.1086/515238.
   Kahl BC, 2003, J CLIN MICROBIOL, V41, P410, DOI 10.1128/JCM.41.1.410-413.2003.
   Kahl BC, 2005, INFECT IMMUN, V73, P4119, DOI 10.1128/IAI.73.7.4119-4126.2005.
   Kohler C, 2003, J BACTERIOL, V185, P6928, DOI 10.1128/JB.185.23.6928-6937.2003.
   Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173.
   Neilan BA, 1997, INT J SYST BACTERIOL, V47, P693, DOI 10.1099/00207713-47-3-693.
   NIEMAN C, 1954, BACTERIOL REV, V18, P147.
   Oana K, 2013, JPN J INFECT DIS, V66, P241, DOI 10.7883/yoken.66.241.
   Oana K, 2009, MICROBIOL IMMUNOL, V53, P45, DOI 10.1111/j.1348-0421.2008.00084.x.
   Pezzo M., 1995, CLIN MICROBIOLOGY PR.
   POLLOCK MR, 1947, BRIT J EXP PATHOL, V28, P295.
   Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384.
   Proctor RA, 1998, CLIN INFECT DIS, V27, pS68, DOI 10.1086/514906.
   Schaaff F, 2003, INT J MED MICROBIOL, V293, P427, DOI 10.1078/1438-4221-00282.
   Stolz J, 1999, J BIOL CHEM, V274, P18741, DOI 10.1074/jbc.274.26.18741.
   Strong F. N., 1942, INDUST AND ENGINEER CHEM ANALYT ED, V14, P909, DOI 10.1021/i560111a039.
   vonEiff C, 1997, J BACTERIOL, V179, P4706, DOI 10.1128/jb.179.15.4706-4712.1997.
   Walker JE, 1926, J INFECT DIS, V38, P127, DOI 10.1093/infdis/38.2.127.
   Wang HH, 2004, J BIOL CHEM, V279, P34489, DOI 10.1074/jbc.M403874200.
   Wellinghausen N, 2009, J CLIN MICROBIOL, V47, P2802, DOI 10.1128/JCM.00485-09.
   WILLETT NP, 1966, J BACTERIOL, V91, P2245.
   WILLIAMS WL, 1947, J BIOL CHEM, V170, P619.
   WILSON G, 1970, BIOCHEM BIOPH RES CO, V38, P617, DOI 10.1016/0006-291X(70)90625-X.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{12}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{6}},
Journal-ISO = {{J. Med. Microbiol.}},
Doc-Delivery-Number = {{AA2IH}},
Unique-ID = {{ISI:000330917800014}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000330085900002,
Author = {Peman, Javier and Zaragoza, Rafael and Salavert, Miguel},
Title = {{Prevention and control of nosocomial and health-care facilities
   associated infections caused by species of Candida and other yeasts}},
Journal = {{REVISTA ESPANOLA DE QUIMIOTERAPIA}},
Year = {{2013}},
Volume = {{26}},
Number = {{4}},
Pages = {{298-311}},
Month = {{DEC}},
Abstract = {{Knowledge of the epidemiology of invasive fungal diseases caused by
   yeasts (Candida spp., especially) in health care settings allows the
   establishment of the levels necessary for its prevention. A first step
   is to identify groups of patients at high risk of nosocomial invasive
   fungal infections, establish accurate risk factors, observing the
   periods of greatest risk, and analyze the epidemiological profile in
   genera and species as well as the patterns of antifungal resistance.
   Secondly, mechanisms to avoid persistent exposure to potential fungal
   pathogens must be programed, protecting areas and recommending measures
   such as the control of the quality of the air and water, inside and
   outside the hospital, and other products or substances able to cause
   outbreaks. Finally, apart from the correct implementation of these
   measures, in selected patients at very high risk, the use of antifungal
   prophylaxis should be considered following the guidelines published.}},
Publisher = {{SOCIEDAD ESPANOLA QUIMIOTERAPIA}},
Address = {{UNIV COMPLUTENSE MADRID, MICROBIOLOGY DEPT, SCHOOL MEDICINE, AVDA
   COMPLUTENSE S/N, MADRID, 28040, SPAIN}},
Type = {{Review}},
Language = {{Spanish}},
Affiliation = {{Salavert, M (Reprint Author), Hosp Univ \& Politecn La Fe, Unidad Enfermedades Infecciosas, Boulevar S-N, Valencia 46026, Spain.
   Peman, Javier, Hosp Univ \& Politecn La Fe, Microbiol Serv, Valencia 46026, Spain.
   Zaragoza, Rafael, Hosp Univ Dr Peset, Serv Med Intens, Valencia, Spain.
   Salavert, Miguel, Hosp Univ \& Politecn La Fe, Unidad Enfermedades Infecciosas, Valencia 46026, Spain.}},
ISSN = {{0214-3429}},
Keywords = {{invasive fungal disease; yeasts; Candida app.; prevention}},
Keywords-Plus = {{BLOOD-STREAM INFECTIONS; INVASIVE FUNGAL-INFECTIONS; HEMATOPOIETIC-CELL
   TRANSPLANTATION; SACCHAROMYCES-CEREVISIAE FUNGEMIA; CATHETER-RELATED
   INFECTIONS; OF-THE-LITERATURE; MOLECULAR EVIDENCE; INTERHUMAN
   TRANSMISSION; PNEUMOCYSTIS-JIROVECII; ANTIFUNGAL THERAPY}},
Research-Areas = {{Microbiology; Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Microbiology; Pharmacology \& Pharmacy}},
Author-Email = {{Salavert\_mig@gva.es}},
ORCID-Numbers = {{Peman, Javier/0000-0003-3222-5653}},
Cited-References = {{Aguado JM, 2011, ENFERM INFEC MICR CL, V29, P345, DOI 10.1016/j.eimc.2011.01.008.
   Alangaden GJ, 2011, INFECT DIS CLIN N AM, V25, P201, DOI 10.1016/j.idc.2010.11.003.
   Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005.
   Asmundsdottir LR, 2008, CLIN INFECT DIS, V47, pE17, DOI 10.1086/589298.
   Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F.
   Bouza E, 2004, Rev Esp Quimioter, V17, P227.
   Bovers M, 2008, REV IBEROAM MICOL, V25, pS4, DOI 10.1016/S1130-1406(08)70019-6.
   Boyce J, 2002, MMWR RECOMM REP, V51, pCE41.
   Boyce John M, 2002, MMWR Recomm Rep, V51, P1.
   Caira M, 2011, EXPERT REV ANTI-INFE, V9, P1067, DOI {[}10.1586/ERI.11.124, 10.1586/eri.11.124].
   Calderon EJ, 2009, J MYCOL MED, V19, P270, DOI 10.1016/j.mycmed.2009.08.001.
   Calderon EJ, 2010, EXPERT REV ANTI-INFE, V8, P683, DOI {[}10.1586/ERI.10.42, 10.1586/eri.10.11].
   Cervera C, 2012, ENFERM INFEC MICR CL, V30, P483, DOI 10.1016/j.eimc.2012.02.003.
   Comely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI DOI 10.1111/1469-0691.12039.
   Cornely OA, 2011, EUR J HAEMATOL, V87, P289, DOI 10.1111/j.1600-0609.2011.01682.x.
   de Boer MGJ, 2007, CLIN INFECT DIS, V44, P1143, DOI 10.1086/513198.
   de Boer MGJ, 2012, CLIN INFECT DIS, V54, P1445, DOI 10.1093/cid/cis216.
   Enache-Angoulvant A, 2005, CLIN INFECT DIS, V41, P1559, DOI 10.1086/497832.
   Fridkin SK, 2005, CLIN INFECT DIS, V41, P1455, DOI 10.1086/497138.
   Garnacho-Montero J, 2012, ENFERM INFEC MICR CL, V30, P338, DOI 10.1016/j.eimc.2012.02.011.
   Gea-Banacloche J, 2009, BONE MARROW TRANSPL, V44, P489, DOI 10.1038/bmt.2009.260.
   Gianella S, 2009, SWISS MED WKLY, V139, p5S.
   Groll AH, 2010, CLIN MICROBIOL INFEC, V16, P1343, DOI 10.1111/j.1469-0691.2010.03334.x.
   Guembe M, 2012, EUR J CLIN MICROBIOL, V31, P2799, DOI 10.1007/s10096-012-1630-x.
   Gurgui M, 2011, J HOSP INFECT, V78, P274, DOI 10.1016/j.jhin.2011.01.027.
   Hale KA, 2010, BRIT J HAEMATOL, V149, P263, DOI 10.1111/j.1365-2141.2009.08072.x.
   Herbrecht R, 2005, CLIN INFECT DIS, V40, P1635, DOI 10.1086/429926.
   Hernendez-Castro R, 2010, EUR J PEDIATR, V169, P783, DOI 10.1007/s00431-009-1109-7.
   Hocker B, 2005, EMERG INFECT DIS, V11, P330.
   Hong AL, 2013, J HEALTHC QUAL, DOI {[}10.1111/j.1945-1474.2012.00210.x, DOI 10.1111/J.1945-1474.2012.00210X].
   Hope WW, 2012, CLIN MICROBIOL INFEC, V18, P38, DOI 10.1111/1469-0691.12040.
   Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039.
   Kaufman DA, 2010, CURR MED RES OPIN, V26, P1769, DOI 10.1185/03007995.2010.487799.
   Krcmery V, 2002, J HOSP INFECT, V50, P243, DOI 10.1053/jhin.2001.1151.
   Lipitz-Snyderman A, 2011, ARCH INTERN MED, V171, P856, DOI 10.1001/archinternmed.2011.161.
   Manoloff ES, 2003, EMERG INFECT DIS, V9, P132, DOI 10.3201/eid0901.020141.
   Marschall J, 2008, INFECT CONT HOSP EP, V29, pS22, DOI 10.1086/591059.
   Martino R, 2004, CLIN INFECT DIS, V38, P335, DOI 10.1086/380643.
   Menzin J, 2009, AM J HEALTH-SYST PH, V66, P1711, DOI 10.2146/ajhp080325.
   Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8.
   Mikulska M, 2011, MEDITERR J HEMATOL I, V3, DOI DOI 10.4084/MJHID.2011.007.
   Mor M, 2011, PEDIATR BLOOD CANCER, V56, P1092, DOI 10.1002/pbc.23005.
   Morris A, 2012, CLIN MICROBIOL REV, V25, P297, DOI 10.1128/CMR.00013-12.
   Munoz P, 2005, CLIN INFECT DIS, V40, P1625, DOI 10.1086/429916.
   Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846.
   Neofytos D, 2010, TRANSPL INFECT DIS, V12, P220, DOI 10.1111/j.1399-3062.2010.00492.x.
   O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003.
   O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257.
   O'Grady Naomi P, 2002, MMWR Recomm Rep, V51, P1.
   Martinez MP, 2010, MED INTENSIVA, V34, P581, DOI 10.1016/j.medin.2010.07.005.
   Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757.
   Partridge-Hinckley K, 2009, MYCOPATHOLOGIA, V168, P329, DOI 10.1007/s11046-009-9247-z.
   Peman J, 2005, EUR J CLIN MICROBIOL, V24, P23, DOI 10.1007/s10096-004-1267-5.
   Peman J, 2012, J ANTIMICROB CHEMOTH, V67, P1181, DOI 10.1093/jac/dks019.
   Peman J, 2011, REV IBEROAM MICOL, V28, P91, DOI 10.1016/j.riam.2011.02.005.
   Peman J, 2010, MYCOSES, V53, P424, DOI 10.1111/j.1439-0507.2009.01732.x.
   Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444.
   Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115.
   Rabodonirina L, 2004, EMERG INFECT DIS, V10, P1766.
   Repetto EC, 2012, EUR J CLIN MICROBIOL, V31, P2897, DOI 10.1007/s10096-012-1661-3.
   Rogers TR, 2011, BRIT J HAEMATOL, V153, P681, DOI 10.1111/j.1365-2141.2011.08650.x.
   Salavert M, 2008, INT J ANTIMICROB AG, V32, pS149, DOI 10.1016/S0924-8579(08)70017-7.
   Sassi M, 2012, CLIN INFECT DIS, V54, P1437, DOI 10.1093/cid/cis217.
   Schmoldt S, 2007, INT J MED MICROBIOL, V297, P64.
   Segal BH, 2002, INFECT DIS CLIN N AM, V16, P935, DOI 10.1016/S0891-5520(02)00043-0.
   Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1.
   Sole A, 2009, CURR OPIN PULM MED, V15, P243, DOI 10.1097/MCP.0b013e328326f410.
   Tablan Ofelia C, 2004, MMWR Recomm Rep, V53, P1.
   Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019.
   Tragiannidis A, 2012, DRUGS, V72, P685, DOI 10.2165/11599810-000000000-00000.
   Vonberg RP, 2006, J HOSP INFECT, V63, P246, DOI 10.1016/j.jhin.2006.02.014.
   Weber DJ, 2011, INFECT DIS CLIN N AM, V25, P77, DOI 10.1016/j.idc.2010.11.012.
   Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946.
   Wohl AR, 2002, AIDS, V16, P1821, DOI 10.1097/00002030-200209060-00016.
   Zaragoza R, 2008, REV IBEROAM MICOL, V25, P203, DOI 10.1016/S1130-1406(08)70049-4.
   Zaragoza Rafael, 2008, Ther Clin Risk Manag, V4, P1261.}},
Number-of-Cited-References = {{76}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{Rev. Esp. Quim.}},
Doc-Delivery-Number = {{294ZH}},
Unique-ID = {{ISI:000330085900002}},
DA = {{2018-08-13}},
}

@article{ ISI:000329480700004,
Author = {Bouchikh, M. and Achir, A. and Caidi, M. and El Aziz, S. and Benosman,
   A.},
Title = {{Role of pulmonary resections in management of multidrug-resistant
   tuberculosis. A monocentric series of 29 patients}},
Journal = {{REVUE DE PNEUMOLOGIE CLINIQUE}},
Year = {{2013}},
Volume = {{69}},
Number = {{6}},
Pages = {{326-330}},
Month = {{DEC}},
Abstract = {{Introduction. - Multidrug-resistant tuberculosis (MDR-TB) is a worldwide
   health problem. Surgery is often used as an adjuvent therapy with
   anti-tuberculosis agents. The aim of this study is to present our
   results of pulmonary resections in the treatment of MDR-TB.
   Materiel and methods. - This is a retrospective nnonocentric study of 29
   patients operated on between 1995 and 2010 for MDR-TB.
   Results. - Tuberculosis was evolving from 9 to 108 months with a median
   of 34.77 +/- 19.88 months. The average number of tuberculosis relapses
   was 2.73 per patient. All patients had a destroyed and/or cavitary
   parenchyma and 17 had bacilli in sputum at the time of surgery.
   Lobectomy (51.17\%) and pneumonectomy (41.37\%) were the main
   interventions carried out. The operative mortality was 3.44\%.
   Complications such prolonged air leaking and emoyema had occurred in 9
   patients. The rate of postoperative microbiological conversion was
   88.23\%. One patient had a relapse 5 months after surgery.
   Conclusion. - Surgery associated with medical treatment provides a high
   cure rate to the detriment of an acceptable morbidity and mortality. (C)
   2013 Elsevier Masson SAS. All rights reserved.}},
Publisher = {{ELSEVIER}},
Address = {{685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA}},
Type = {{Article}},
Language = {{French}},
Affiliation = {{Bouchikh, M (Reprint Author), CHU Ibn Sina, Serv Chirurg Thorac, BP 353, Rabat 10001, Morocco.
   Bouchikh, M.; Achir, A.; Caidi, M.; El Aziz, S.; Benosman, A., CHU Ibn Sina, Serv Chirurg Thorac, Rabat 10001, Morocco.
   Bouchikh, M.; Achir, A.; Benosman, A., Fac Med, Unite Pedag \& Rech Chirurg Thorac, Rabat, Morocco.}},
DOI = {{10.1016/j.pneumo.2013.09.002}},
ISSN = {{0761-8417}},
EISSN = {{1776-2561}},
Keywords = {{Tuberculosis; Multidrug resistant tuberculosis; Pulmonary resection;
   Pneumonectomy; Lobectomy}},
Keywords-Plus = {{TREATMENT OUTCOMES; SURGICAL-TREATMENT; SURGERY; METAANALYSIS; CURE}},
Research-Areas = {{Respiratory System}},
Web-of-Science-Categories  = {{Respiratory System}},
Author-Email = {{m.bouchikh@um5s.net.ma}},
Cited-References = {{Dravniece G, 2009, EUR RESPIR J, V34, P180, DOI 10.1183/09031936.00047208.
   Gegia M, 2012, INT J INFECT DIS, V16, pE391, DOI 10.1016/j.ijid.2011.12.018.
   Kang MW, 2010, ANN THORAC SURG, V89, P1597, DOI 10.1016/j.athoracsur.2010.02.020.
   Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003.
   Kempker RR, 2012, LANCET INFECT DIS, V12, P157, DOI 10.1016/S1473-3099(11)70244-4.
   Kim HJ, 2006, EUR RESPIR J, V28, P576, DOI 10.1183/09031936.06.00023006.
   Kir A, 2006, J THORAC CARDIOV SUR, V131, P693, DOI 10.1016/j.jtcvs.2005.09.033.
   Kwon YS, 2008, CLIN INFECT DIS, V47, P496, DOI 10.1086/590005.
   Marrone MT, 2013, INT J TUBERC LUNG D, V17, P6, DOI 10.5588/ijtld.12.0198.
   Mordant P, 2012, REV PNEUMOL CLIN, V68, P77, DOI 10.1016/j.pneumo.2012.01.003.
   Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6.
   Ots ON, 2009, PROBL TUBERK BOLEZN, V2, P42.
   Park SK, 2009, INT J INFECT DIS, V13, P170, DOI 10.1016/j.ijid.2008.06.001.
   Park SK, 2002, INT J TUBERC LUNG D, V6, P143.
   Phua CK, 2011, ANN ACAD MED SINGAP, V40, P132.
   Pomerantz BJ, 2001, J THORAC CARDIOV SUR, V121, P448, DOI 10.1067/mtc.2001.112339.
   Shiraishi Y, 2009, J THORAC CARDIOV SUR, V138, P1180, DOI 10.1016/j.jtcvs.2009.07.018.
   Somocurcio JG, 2007, THORAX, V62, P416, DOI 10.1136/thx.2005.051961.
   Sung SW, 1999, EUR J CARDIO-THORAC, V16, P187, DOI 10.1016/S1010-7940(99)00158-X.
   Takeda S, 2005, ANN THORAC SURG, V79, P959, DOI 10.1016/j.athoracsur.2004.09.007.
   Vashakidze S, 2013, ANN THORAC SURG, V95, P1892, DOI 10.1016/j.athoracsur.2013.03.067.
   Wang HF, 2008, ANN THORAC SURG, V86, P1640, DOI 10.1016/j.athoracsur.2008.07.056.
   Yen YT, 2013, ANN THORAC SURG, V95, P257, DOI 10.1016/j.athoracsur.2012.09.034.}},
Number-of-Cited-References = {{23}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Rev. Pneumol. Clin.}},
Doc-Delivery-Number = {{286PH}},
Unique-ID = {{ISI:000329480700004}},
DA = {{2018-08-13}},
}

@article{ ISI:000327498600005,
Author = {Wu, Longhhua and Pan, Xia and Chen, Like and Huang, Yujuan and Teng,
   Ying and Luo, Yongming and Christie, Peter},
Title = {{Occurrence and distribution of heavy metals and tetracyclines in
   agricultural soils after typical land use change in east China}},
Journal = {{ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH}},
Year = {{2013}},
Volume = {{20}},
Number = {{12}},
Pages = {{8342-8354}},
Month = {{DEC}},
Note = {{Contaminated land, ecological assessment, and remediation conference
   series (CLEAR), Hangzhou, PEOPLES R CHINA, NOV 04-08, 2012}},
Abstract = {{Land use in east China tends to change from paddy rice to vegetables or
   other high-value cash crops, resulting in high input rates of organic
   manures and increased risk of contamination with both heavy metals (HMs)
   and antibiotics. This investigation was conducted to determine the
   accumulation, distribution and risks of HMs and tetracyclines (TCs) in
   surface soils and profiles receiving different amounts of farmyard
   manure. Soil samples collected from suburbs of Hangzhou city, Zhejiang
   province were introduced to represent three types of land use change
   from paddy rice to asparagus production, vineyards and field mustard
   cultivation, and divided into two portions, one of which was air-dried
   and sieved through 2-, 0.3- and 0.149-mm nylon mesh for determination of
   pH and heavy metals. The other portion was frozen at -20 A degrees C,
   freeze-dried and sieved through a 0.3-mm nylon mesh for tetracyline
   determination. HM and TC concentrations in surface soils of 14-year-old
   mustard fields were the highest with total Cu, Zn, Cd and aTCs of 50.5,
   196, 1.03 mg kg(-1) and 22.9 mu g kg(-1), respectively, on average. The
   total Cu sequence was field mustard > vineyards > asparagus when
   duration of land use change was considered; oxytetracycline (OTC) and
   doxycycline were dominant in soils used for asparagus production; OTC
   was dominant in vineyards and chlortetracycline (CTC) was dominant in
   mustard soils. There were positive pollution relationships among Cu, Zn
   and aTCs, especially between Cu and Zn or Cu and aTCs. Repeated and
   excessive application of manures from intensive farming systems may
   produce combined contamination with HMs and TCs which were found in the
   top 20 cm of the arable soil profiles and also extended to 20-40 cm
   depth. Increasing manure application rate and cultivation time led to
   continuing increases in residue concentrations and movement down the
   soil profile.}},
Publisher = {{SPRINGER HEIDELBERG}},
Address = {{TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Wu, LH (Reprint Author), Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm \& Pollut Remediat, Nanjing 210008, Jiangsu, Peoples R China.
   Wu, Longhhua; Pan, Xia; Chen, Like; Huang, Yujuan; Teng, Ying; Luo, Yongming, Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm \& Pollut Remediat, Nanjing 210008, Jiangsu, Peoples R China.
   Pan, Xia, Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   Luo, Yongming, Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai 264003, Peoples R China.
   Christie, Peter, Agri Food \& Biosci Inst, Agrienvironm Branch, Belfast BT9 5PX, Antrim, North Ireland.}},
DOI = {{10.1007/s11356-013-1532-1}},
ISSN = {{0944-1344}},
EISSN = {{1614-7499}},
Keywords = {{Heavy metals; Tetracyclines; Farmyard manure; Land use change; Cropping
   systems; Correlation analysis}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE GENES; VETERINARY ANTIBIOTICS; TRACE-ELEMENTS;
   JIANGSU PROVINCE; MANURE; ENVIRONMENT; COPPER; FATE; ZN; PB}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{lhwu@issas.ac.cn}},
ResearcherID-Numbers = {{Christie, Peter/B-7919-2008}},
ORCID-Numbers = {{Christie, Peter/0000-0002-1939-7277}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}40930739]; National
   High-Technology Research and Development Program of China
   {[}2012AA06A204]}},
Funding-Text = {{This research was supported by the National Natural Science Foundation
   of China (Project 40930739) and the National High-Technology Research
   and Development Program of China (Project 2012AA06A204).}},
Cited-References = {{Abaye DA, 2005, EUR J SOIL SCI, V56, P93, DOI 10.1111/j.1365-2389.2004.00648.x.
   ARTHUR JR, 1982, INORG BIOCHEM, V3, P344, DOI 10.1039/9781847556363-00344.
   Berenguer P, 2008, AGRON J, V100, P1056, DOI 10.2134/agronj2007.0321.
   Blackwell PA, 2009, CHEMOSPHERE, V75, P13, DOI 10.1016/j.chemosphere.2008.11.070.
   Bolan NS, 2004, CRIT REV ENV SCI TEC, V34, P291, DOI 10.1080/10643380490434128.
   Bound JP, 2004, CHEMOSPHERE, V56, P1143, DOI 10.1016/j.chemosphere.2004.05.010.
   Boxall ABA, 2003, ENVIRON SCI TECHNOL, V37, p286A, DOI 10.1021/es032519b.
   Brambilla G, 2007, ANAL CHIM ACTA, V586, P326, DOI 10.1016/j.aca.2006.11.019.
   Chee-Sanford JC, 2009, J ENVIRON QUAL, V38, P1086, DOI 10.2134/jeq2008.0128.
   Chen YS, 2012, ENVIRON MONIT ASSESS, V184, P2205, DOI 10.1007/s10661-011-2110-y.
   Chen YS, 2012, CHINESE SCI BULL, V57, P606, DOI 10.1007/s11434-011-4830-3.
   Cooperative Research Group on Chinese Soil Taxonomy, 2001, CHINESE SOIL TAXONOM, P83.
   Fernandez-Calvino D, 2008, LAND DEGRAD DEV, V19, P165, DOI 10.1002/ldr.831.
   Halling-Sorensen B, 1998, CHEMOSPHERE, V36, P357, DOI 10.1016/S0045-6535(97)00354-8.
   Hamscher G, 2005, ENVIRON TOXICOL CHEM, V24, P861, DOI 10.1897/04-182R.1.
   Hamscher G, 2002, ANAL CHEM, V74, P1509, DOI 10.1021/ac015588m.
   Hu XG, 2010, ENVIRON POLLUT, V158, P2992, DOI 10.1016/j.envpol.2010.05.023.
   Huang SS, 2007, CHEMOSPHERE, V67, P2148, DOI 10.1016/j.chemosphere.2006.12.043.
   Kirchmann H, 2000, EUR J AGRON, V12, P145, DOI 10.1016/S1161-0301(99)00053-2.
   Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x.
   KORNEGAY ET, 1976, PLANT SOIL, V45, P151, DOI 10.1007/BF00011137.
   Kumar K, 2005, J ENVIRON QUAL, V34, P2082, DOI 10.2134/jeq2005.0026.
   Kumar K, 2005, ADV AGRON, V87, P1, DOI 10.1016/S0065-2113(05)87001-4.
   Kumpiene J, 2008, WASTE MANAGE, V28, P215, DOI 10.1016/j.wasman.2006.12.012.
   Li YW, 2011, J AGR FOOD CHEM, V59, P7268, DOI 10.1021/jf1047578.
   Lopes C, 2011, ENVIRON SCI POLLUT R, V18, P918, DOI 10.1007/s11356-011-0444-1.
   Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483.
   MCGRATH SP, 1985, J SCI FOOD AGR, V36, P794, DOI 10.1002/jsfa.2740360906.
   Nicholson FA, 2003, SCI TOTAL ENVIRON, V311, P205, DOI 10.1016/S0048-9697(03)00139-6.
   Nicholson FA, 1999, BIORESOURCE TECHNOL, V70, P23, DOI 10.1016/S0960-8524(99)00017-6.
   Nkana JCV, 2003, LAND DEGRAD DEV, V14, P57, DOI 10.1002/ldr.519.
   Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483.
   Pinamonti F, 1997, RESOUR CONSERV RECY, V21, P129, DOI 10.1016/S0921-3449(97)00032-3.
   Poulsen HD, 1998, J ANIM FEED SCI, V7, P135, DOI 10.22358/jafs/69961/1998.
   Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026.
   Sassman SA, 2005, ENVIRON SCI TECHNOL, V39, P7452, DOI 10.1021/es0480217.
   Shi Z, 2002, ENVIRON MANAGE, V30, P142, DOI 10.1007/s00267-001-2645-8.
   State Environmental Protection Administration of China SEPA, 1995, GB156181995 SEPA.
   Tolls J, 2001, ENVIRON SCI TECHNOL, V35, P3397, DOI 10.1021/es0003021.
   TUFFT LS, 1991, POULTRY SCI, V70, P2439, DOI 10.3382/ps.0702439.
   Veeken A, 2002, SCI TOTAL ENVIRON, V300, P87, DOI 10.1016/S0048-9697(01)01103-2.
   Wei X, 2009, J ENVIRON SCI HEAL B, V44, P461, DOI 10.1080/03601230902935139.
   Wu LH, 2012, GEODERMA, V173, P224, DOI 10.1016/j.geoderma.2011.12.003.
   Zhao L, 2010, SCI TOTAL ENVIRON, V408, P1069, DOI 10.1016/j.scitotenv.2009.11.014.
   Zhou QX, 2006, PEDOSPHERE, V16, P297, DOI 10.1016/S1002-0160(06)60055-6.
   Zhou SL, 2008, CHINESE SCI BULL, V53, P177, DOI 10.1007/s11434-008-5008-5.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{35}},
Usage-Count-Last-180-days = {{12}},
Usage-Count-Since-2013 = {{204}},
Journal-ISO = {{Environ. Sci. Pollut. Res.}},
Doc-Delivery-Number = {{259AA}},
Unique-ID = {{ISI:000327498600005}},
DA = {{2018-08-13}},
}

@article{ ISI:000326980000006,
Author = {Novais, Carla and Freitas, Ana R. and Silveira, Eduarda and Antunes,
   Patricia and Silva, Ricardo and Coque, Teresa M. and Peixe, Luisa},
Title = {{Spread of multidrug-resistant Enterococcus to animals and humans: an
   underestimated role for the pig farm environment}},
Journal = {{JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY}},
Year = {{2013}},
Volume = {{68}},
Number = {{12}},
Pages = {{2746-2754}},
Month = {{DEC}},
Abstract = {{Objectives: The aim of this study was to discover the potential role of
   the pig farm environment in the spread of multidrug-resistant (MDR)
   Enterococcus strains, including high-risk clones, to animals and humans.
   Methods: Enterococcus isolates were recovered from a variety of samples
   (n = 82; swine, feed/medicines/antiseptics and pig farm facilities) from
   six Portuguese farms, most using antibiotics. Antimicrobial
   susceptibility/conjugation assays were performed by standard procedures,
   bacterial identification/screening of antibiotic resistance genes were
   performed by PCR and clonality was determined using PFGE/multilocus
   sequence typing.
   Results: Enterococcus isolates resistant to antibiotics (n = 473) were
   recovered from samples of different origin (swine, feed/antiseptics,
   animal residues and pig farm facilities), but only the clinically
   relevant species Enterococcus faecium (n = 171) and Enterococcus
   faecalis (n = 78) were included for further comprehensive molecular
   analysis. Isolates resistant to vancomycin, ampicillin, tetracyclines,
   erythromycin and aminoglycosides were better recovered in
   Slanetz-Bartley medium with these antibiotics present than in media not
   supplemented with antibiotics (P < 0.05). E. faecium was more frequently
   resistant to ampicillin, ciprofloxacin or nitrofurantoin and E. faecalis
   to tetracyclines, chloramphenicol or aminoglycosides (P < 0.05).
   Glycopeptide and erythromycin resistance rates were similar in both
   species. The transfer of resistance to several antibiotics, including
   vancomycin and ampicillin, was demonstrated. Clones associated with
   human infections were detected in different samples from the same farm
   {[}E. faecium from sequence type (ST) 78 lineage and E. faecalis ST16;
   manure, waste lagoons, faeces and drinking water] and in geographically
   distant farms {[}E. faecium clonal complex (CC) 5; E. faecalis CC21 and
   ST16].
   Conclusions: The pig farm environment has an underestimated potential
   role in the transmission of MDR Enterococcus to animals and, possibly,
   to humans. The continuous contact of swine with MDR Enterococcus by
   different routes (e. g. feed, dust, air and rooms) might decrease the
   impact of restrictive antibiotic use policies and reinforces the need
   for different and preliminary interventions at the husbandry management
   level.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Peixe, L (Reprint Author), Univ Porto, REQUIMTE, Microbiol Lab, Fac Farm, Rua Campo Alegre 823, P-4100 Oporto, Portugal.
   Novais, Carla; Freitas, Ana R.; Silveira, Eduarda; Antunes, Patricia; Peixe, Luisa, Univ Porto, REQUIMTE, Microbiol Lab, Fac Farm, P-4100 Oporto, Portugal.
   Freitas, Ana R.; Coque, Teresa M., Hosp Univ Ramon y Cajal FiBioHRYC, IRYCIS, Fdn Invest Biomed, Madrid, Spain.
   Antunes, Patricia, Univ Porto, Fac Ciencias Nutr \& Alimentacao, P-4100 Oporto, Portugal.
   Silva, Ricardo, Univ Fernando Pessoa, Fac Ciencias Saude, Oporto, Portugal.
   Coque, Teresa M., CSIC, Unidad Resistencia Antibiot \& Virulencia Bacteria, Madrid, Spain.
   Coque, Teresa M., CIBER Epidemiol \& Salud Publ CIBERESP, Madrid, Spain.}},
DOI = {{10.1093/jac/dkt289}},
ISSN = {{0305-7453}},
EISSN = {{1460-2091}},
Keywords = {{swine; vanA; high-risk clones; co-resistance; indirect contamination
   routes}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; FECAL INDICATORS;
   FAECALIS; MANURE; GENES; BACTERIA; FAECIUM; SUSCEPTIBILITY;
   IDENTIFICATION}},
Research-Areas = {{Infectious Diseases; Microbiology; Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Infectious Diseases; Microbiology; Pharmacology \& Pharmacy}},
Author-Email = {{lpeixe@ff.up.pt}},
ResearcherID-Numbers = {{Freitas, Ana/D-6158-2013
   Coque, Teresa/F-5013-2015
   Peixe, Luisa/D-8715-2013
   Antunes, Patricia/D-4977-2013
   Novais, Carla/E-6094-2010
   Peixe, Luisa/H-7347-2016
   Silva, Ricardo/K-5451-2012
   REQUIMTE, UCIBIO/N-9846-2013
   }},
ORCID-Numbers = {{Freitas, Ana/0000-0002-7326-4133
   Coque, Teresa/0000-0002-8228-3491
   Peixe, Luisa/0000-0001-5810-8215
   Antunes, Patricia/0000-0002-3553-2678
   Peixe, Luisa/0000-0001-5810-8215
   Silva, Ricardo/0000-0002-7276-4435
   Silveira, Eduarda/0000-0001-6760-0148
   Novais, Carla/0000-0002-3826-6731}},
Funding-Acknowledgement = {{Fundacao para a Ciencia e a Tecnologia, Ministry of Science, Technology
   and Innovation of Portugal {[}POCI/AMB/61814/2004,
   PEst-C/EQB/LA0006/2011]; Fundacao para a Ciencia e a Tecnologia
   {[}SFRH/BD/63955/2009]; European Union {[}EVOTAR-LSHM-2011-282004];
   Ministry of Economy and Competitiveness of Spain {[}PI12/01581];
   regional government of Madrid {[}S2010/BMD2414\_PROMPT-CM]}},
Funding-Text = {{This work was supported by Fundacao para a Ciencia e a Tecnologia, which
   belongs to the Ministry of Science, Technology and Innovation of
   Portugal (grant numbers POCI/AMB/61814/2004 and PEst-C/EQB/LA0006/2011).
   E. S. is supported by a PhD fellowship from Fundacao para a Ciencia e a
   Tecnologia (grant number SFRH/BD/63955/2009; POPH-QREN). Work in the
   laboratory of T. M C. is funded by grants from the European Union
   (EVOTAR-LSHM-2011-282004), the Ministry of Economy and Competitiveness
   of Spain (PI12/01581) and the regional government of Madrid
   (S2010/BMD2414\_PROMPT-CM).}},
Cited-References = {{Aarestrup FM, 2000, DIAGN MICR INFEC DIS, V37, P127, DOI 10.1016/S0732-8893(00)00130-9.
   Aarestrup Frank M., 2008, Animal Health Research Reviews, V9, P135, DOI 10.1017/S1466252308001503.
   Arias CA, 2006, J CLIN MICROBIOL, V44, P1567, DOI 10.1128/JCM.44.4.1567-1570.2006.
   Baquero F., 2012, MBIO, V3.
   BIOHAZ EFSA Panel on Biological Hazards, 2011, EFSA J, V9, P2322, DOI DOI 10.2903/J.EFSA.2011.2322.
   Blanco G, 2009, ENVIRON RES, V109, P405, DOI 10.1016/j.envres.2009.01.007.
   Bogo JL, 2003, APMIS, V111, P669.
   Braga TM, 2012, VET MICROBIOL, V161, P344.
   Canton R, 2011, CURR OPIN PHARMACOL, V11, P477, DOI 10.1016/j.coph.2011.07.007.
   Chee-Sanford JC, 2009, J ENVIRON QUAL, V38, P1086, DOI 10.2134/jeq2008.0128.
   Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI.
   de Jong A, 2011, J ANTIMICROB CHEMOTH, V67, P638.
   European Food Safety Authority, 2010, EFSA J, V8, P1597.
   European Food Safety Authority European Centre for Disease Prevention and Control., 2011, EFSA J, V9, P2154.
   European Medicines Agency, 2013, TRENDS SAL VET ANT A.
   Freitas AR, 2011, J CLIN MICROBIOL, V49, P925, DOI 10.1128/JCM.01750-10.
   Gibbs SG, 2004, J OCCUP ENVIRON HYG, V1, P699, DOI 10.1080/15459620490515824.
   Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009.
   Heuer OE, 2002, MICROB DRUG RESIST, V8, P355, DOI 10.1089/10766290260469624.
   Holzel CS, 2010, ENVIRON RES, V110, P318, DOI 10.1016/j.envres.2010.02.009.
   Johnsen PJ, 2011, J ANTIMICROB CHEMOTH, V66, P608, DOI 10.1093/jac/dkq512.
   Johnston LM, 2004, APPL ENVIRON MICROB, V70, P3133, DOI 10.1128/AEM.70.5.3133-3137.2004.
   Kaszanyitzky EJ, 2007, INT J FOOD MICROBIOL, V115, P119, DOI 10.1016/j.ijfoodmicro.2006.10.004.
   Kuch A, 2012, J ANTIMICROB CHEMOTH, V67, P551, DOI 10.1093/jac/dkr544.
   Larsen J, 2010, EMERG INFECT DIS, V16, P682, DOI 10.3201/eid1604.090500.
   Leavis HL, 2006, CURR OPIN MICROBIOL, V9, P454, DOI 10.1016/j.mib.2006.07.001.
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x.
   McLaughlin MR, 2012, WATER RES, V46, P4949, DOI 10.1016/j.watres.2012.06.023.
   Novais C, 2004, ANTIMICROB AGENTS CH, V48, P3613, DOI 10.1128/AAC.48.9.3613-3617.2004.
   Patterson AJ, 2007, ENVIRON MICROBIOL, V9, P703, DOI 10.1111/j.1462-2920.2006.01190.x.
   Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483.
   Ramos S, 2012, VET J, V193, P301, DOI 10.1016/j.tvjl.2011.12.007.
   Rice LB, 2005, ANTIMICROB AGENTS CH, V49, P5007, DOI 10.1128/AAC.49.12.5007-5012.2005.
   Rizzotti L, 2005, FOOD PROT, V68, P955.
   Rule Ana M, 2008, J Infect Public Health, V1, P33, DOI 10.1016/j.jiph.2008.08.001.
   Sapkota AR, 2007, ENVIRON HEALTH PERSP, V115, P1040, DOI 10.1289/ehp.9770.
   Spigaglia P, 2008, ANTIMICROB AGENTS CH, V52, P770, DOI 10.1128/AAC.00957-07.
   TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233.
   Werner G, 2008, J ANTIMICROB CHEMOTH, V61, P1182, DOI 10.1093/jac/dkn065.
   Willems RJ, 2012, MBIO, V3, DOI DOI 10.1128/MBI0.
   Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x.
   Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI {[}10.2217/fmb.09.82, 10.2217/FMB.09.82].}},
Number-of-Cited-References = {{42}},
Times-Cited = {{29}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{50}},
Journal-ISO = {{J. Antimicrob. Chemother.}},
Doc-Delivery-Number = {{252BS}},
Unique-ID = {{ISI:000326980000006}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000341274700010,
Author = {Kolbe, Emily A.},
Title = {{``Won't You Be My Neighbor?{''} Living with Concentrated Animal Feeding
   Operations}},
Journal = {{IOWA LAW REVIEW}},
Year = {{2013}},
Volume = {{99}},
Number = {{1}},
Pages = {{415-443}},
Month = {{NOV}},
Abstract = {{Concentrated animal feeding operations ({''}CAFOs{''}) are prevalent
   throughout the nation and represent a serious and increasing problem for
   the United States. Proponents of CAFOs argue that such operations are
   necessary to meet this country's demand for low-cost, readily available
   meat. Opponents point to the ever-increasing risks that CAFOs pose to
   humans, animals, and the environment. CAFOs in Iowa have operated under
   the minimum level of federally required regulations for a number of
   years. The negative effects of this lack of regulation are starting to
   take a toll on Iowans. Emerging public health concerns such as air
   quality and antibiotic resistance, individual health problems, animal
   welfare concerns, and the basic right to enjoy one's property are
   becoming controversial issues and demand increased attention from the
   state's government, courts, and citizens. This Note argues that Iowans
   should look to a variety of mechanisms to address these issues,
   including judicial action, increased legislation, and grassroots
   organizing efforts to ensure that Iowa remains not only an agricultural
   force in the United States, but also a safe and healthy environment for
   its present and future citizens.}},
Publisher = {{UNIV IOWA, COLL LAW}},
Address = {{290 BOYD LAW BLDG, IOWA CITY, IA 52242 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kolbe, EA (Reprint Author), Univ Iowa, Coll Law, Iowa City, IA 52242 USA.
   Univ Iowa, Coll Law, Iowa City, IA 52242 USA.}},
ISSN = {{0021-0552}},
Research-Areas = {{Government \& Law}},
Web-of-Science-Categories  = {{Law}},
Cited-References = {{Abraham Emily, 2012, WILL MORATORIUM CONF.
   Adams Susan, 2007, LEGAL RIGHTS FARM AN, p{[}18, 20].
   AM. PUB. HEALTH ASS'N, 2003, PRECAUTIONARY MORATO.
   {[}Anonymous], DNR AN FEED OP CONT.
   {[}Anonymous], WHAT IS CAFO.
   {[}Anonymous], ANIMAL WELFARE.
   {[}Anonymous], REG ENF LEG.
   {[}Anonymous], 2012, BOARD SUP M OCT 15 2.
   {[}Anonymous], MAST MATR.
   {[}Anonymous], PREC REQ PERM OP.
   {[}Anonymous], PUBL M MAY23.
   {[}Anonymous], COMP ARE THERE CAFOS.
   {[}Anonymous], 2012, IOW ENV COUNC URG ST.
   {[}Anonymous], IOWA CAFO WAT PROGR.
   {[}Anonymous], AN FEED OP.
   {[}Anonymous], LEG REG REG FACT FAR.
   {[}Anonymous], 2013, WORLD PLAN AGREEMENT, P7.
   {[}Anonymous], RESOURCES.
   Becker John C., 2010, KY J EQUINE AGR NAT, V3, P71.
   Becker John C., 2010, KY J EQUINE AGR NAT, V3, P75.
   Beeman Perry, 2012, RUNOFF IOWA FARMS GR.
   Braunig WA, 2005, NEW YORK U LAW REV, V80, P1505.
   Braunig Warren A., 2005, NEW YORK U LAW REV, V80, P1507.
   Centner Terence J., 2006, B C ENVTL AFF L REV, V33, P88.
   Centner Terence J., 2006, BOSTON COLL ENV AFFA, V33, P87.
   EISNITZ GAIL A., 1997, SLAUGHTERHOUSE SHOCK, P220.
   Flynn Dan, 2012, FOOD SAFETY NEW 0326.
   Ghosh S, 2007, ISME J, V1, P191, DOI 10.1038/ismej.2007.31.
   Greger Michael, 2010, FAM COMMUNITY HEALTH, V33, P373, DOI DOI 10.1097/FCH.
   GURIAN-SHERMAN DOUG, 2008, CAFOS UNCOVERED UNTO, P4.
   Head III Thomas R., 2000, ENVIRON LAW, V6, P529.
   Head III Thomas R., 2000, ENVTL LAW, V6, P503.
   Heederik D, 2007, ENVIRON HEALTH PERSP, V115, P298, DOI 10.1289/ehp.8835.
   Heederik Dick, 2007, ENV HLTH PERSP, V115, P300.
   HILMAR CARRIE, 2010, UNDERSTANDING CONCEN, P1.
   Hodne Carol J., 2004, CRITICAL ISSUES RURA, p{[}61, 64].
   IOWA CITIZENS FOR CMTY. IMPROVEMENT, 2012, WAS YEAR HEADLINES, P1.
   IOWA DEP'T NATURAL RES, CONSTR REV NUMB.
   IOWA DEP'T NATURAL RES, APP C MAST MATR.
   IOWA DEP'T NATURAL RES, BAS AFO DAT ANIMAL U.
   IOWA DEP'T NATURAL RES, 2012, RESP US EPA REG, P7.
   IOWA ECON. DEV. AUTH, 2012, TRADE STAT.
   Kilpatrick John A., 2001, APPRAISAL J, V69, P305.
   Kilpatrick John A., 2001, APPRAISAL J, V69, P301.
   Leahy Cheryl L., 2011, J ANIMAL L ETHICS, V4, P89.
   Leahy Cheryl L., 2011, J ANIMAL L ETHICS, V4, P63.
   Midlciff Ken, CAFOS.
   Mitloehner FM, 2008, J AGRIC SAF HEALTH, V14, P163, DOI 10.13031/2013.24349.
   Pearce James I., 2011, DUKE ENV L POLY F, V21, P440.
   Pearce James I., 2011, DUKE ENV L POLY F, V21, P433.
   Pitt David, 2012, EPA IOWA MUST FIX RE.
   Poll-Klaessy Susan, 2008, PUB INT L REP, V13, P107.
   Pruden A, 2009, EMERG TOP ECOTOXICOL, V1, P71, DOI 10.1007/978-0-387-92834-0\_10.
   Redick Thomas P., 2005, STAT ENV MAN IN CAFO, P28.
   REGION 7 U.S. ENVTL. PROT. AGENCY, 2012, PREL RES INF INV NAT, P4.
   Richards R. Jason, 2011, KY J EQUINE AGR NAT, V4, P31.
   Richardson Jr Jesse J., 2000, DRAKE J AGR LAW, V5, P121.
   RichardsonJr Jesse J., 2000, DRAKE J AGR L, V5, P136.
   Teel Ryan, 2007, DRAKE L REV, V55, P497.
   Teel Ryan, 2007, DRAKE L REV, V55, P521.
   Thompson P. B, 2004, ANIMAL PRAGMATISM RE, P140.
   Thorne Peter S., 2002, IOWA CONCENTRATED AN, p{[}35, 35].
   U.S. ENTL. PROT. AGENCY, REG DEF LARG CAFOS M.
   Wasson Erik, 2012, HILL.
   WEIDA WIILIAM J., 2004, CONSIDERING RATIONAL, P1.
   Wender Melanie J., 2011, VILL ENVTL L J, V22, p{[}141, 141].
   Williams D.R., 2002, WASH U JL POLY, V9, P21.
   Williams Douglas R., 2002, WASH U JL POLY, V9, P25.}},
Number-of-Cited-References = {{68}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{31}},
Journal-ISO = {{Iowa Law Rev.}},
Doc-Delivery-Number = {{AO3YZ}},
Unique-ID = {{ISI:000341274700010}},
DA = {{2018-08-13}},
}

@article{ ISI:000325846200007,
Author = {Ponyai, K. and Mihalik, N. and Ostorhazi, E. and Farkas, B. and Parducz,
   L. and Marschalko, M. and Karpati, S. and Rozgonyi, F.},
Title = {{Incidence and antibiotic susceptibility of genital mycoplasmas in
   sexually active individuals in Hungary}},
Journal = {{EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY \& INFECTIOUS DISEASES}},
Year = {{2013}},
Volume = {{32}},
Number = {{11}},
Pages = {{1423-1426}},
Month = {{NOV}},
Abstract = {{The aim of this study was to examine the incidence and antibiotic
   sensitivity of Ureaplasma urealyticum and Mycoplasma hominis strains
   cultured from the genital discharges of sexually active individuals who
   attended our STD outpatient service. Samples were taken with universal
   swab (BiolabA (R), Budapest, Hungary) into the Urea-Myco DUO kit
   (Bio-RadA (R), Budapest, Hungary) and incubated in ambient air for 48 h
   at 37 A degrees C. The determination of antibiotic sensitivity was
   performed in U9 and arginin broth using the SIR Mycoplasma kit (Bio-RadA
   (R), Budapest, Hungary) under the same conditions. Between 01.05.2008
   and 31.12.2011, 373/4,466 (8.35 \%) genito-urethral samples with U.
   urealyticum and 41/4,466 (0.91 \%) genito-urethral samples with M.
   hominis infection were diagnosed in sexually active individuals in the
   National STD Center, Semmelweis University. U. urealyticum was isolated
   in 12.54 \% in the cervix and 4.1 \% in the male urethra, while M.
   hominis was isolated in 1.33 \% in the cervix and 0.51 \% in the male
   urethra. The affected age group was between 21 and 60 years old. U.
   urealyticum strains were sensitive to tetracycline (95.9 \%),
   doxycycline (97.32 \%), and azithromycin (85.79 \%), and resistant to
   erythromycin (81.23 \%), clindamycin (75.06 \%), and ofloxacin (25.2
   \%). Cross-resistance occurred in 38.71 \% of patients to erythromycin
   and clindamycin. M. hominis strains were sensitive to clindamycin,
   ofloxacin, and doxycycline in more than 95 \%, to tetracycline in 82.92
   \%, and no cross-resistance was detected among the antibiotics. Our
   study confirms that the continuously changing antibiotic resistance of
   ureaplasmas and mycoplasmas should be followed at least in a few centers
   in every country, so as to determine the best local therapy options for
   sexually transmitted infection (STI) patients.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mihalik, N (Reprint Author), Semmelweis Univ, Natl STD Diagnost \& Therapy Ctr, Dept Dermatol Venereol \& Dermatooncol, Maria U 41, H-1085 Budapest, Hungary.
   Ponyai, K.; Mihalik, N.; Ostorhazi, E.; Marschalko, M.; Karpati, S.; Rozgonyi, F., Semmelweis Univ, Natl STD Diagnost \& Therapy Ctr, Dept Dermatol Venereol \& Dermatooncol, H-1085 Budapest, Hungary.
   Parducz, L., Bekes Cty Kalman Pandy Municipal Hosp, Dept Obstet \& Gynecol, Gyula, Hungary.}},
DOI = {{10.1007/s10096-013-1892-y}},
ISSN = {{0934-9723}},
EISSN = {{1435-4373}},
Keywords-Plus = {{UREAPLASMA-UREALYTICUM; RESISTANCE; HOMINIS; MUTATIONS; PARVUM;
   IDENTIFICATION; TETRACYCLINES; PREVALENCE; MACROLIDES}},
Research-Areas = {{Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Infectious Diseases; Microbiology}},
Author-Email = {{noemihalik@gmail.com}},
ResearcherID-Numbers = {{Karpati, Sarolta/E-5786-2018}},
ORCID-Numbers = {{Karpati, Sarolta/0000-0002-8472-0712}},
Cited-References = {{Bayraktar MR, 2010, INT J INFECT DIS, V14, pE90, DOI 10.1016/j.ijid.2009.03.020.
   Beeton ML, 2009, J ANTIMICROB CHEMOTH, V64, P529, DOI 10.1093/jac/dkp218.
   Beeton ML, 2009, ANTIMICROB AGENTS CH, V53, P2020, DOI 10.1128/AAC.01349-08.
   Bihari A, 1997, HUNG MED J, V138, P799.
   Degrange S, 2008, ANTIMICROB AGENTS CH, V52, P742, DOI 10.1128/AAC.00960-07.
   Diaz-Garcia FJ, 2006, HUM REPROD, V21, P1591, DOI 10.1093/humrep/de1032.
   Garcia-Castillo M, 2008, J ANTIMICROB CHEMOTH, V62, P1027, DOI 10.1093/jac/dkn337.
   Karabay O, 2006, Clin Exp Obstet Gynecol, V33, P36.
   Kilic D, 2004, JPN J INFECT DIS, V57, P17.
   Krausse R, 2010, CLIN MICROBIOL INFEC, V16, P1649, DOI {[}10.1111/j.1469-0691.2010.03155.x, 10.1111/j.1469-0691.2009.03155.x].
   Lu C, 2010, CURR MICROBIOL, V61, P44, DOI 10.1007/s00284-009-9574-9.
   Patel Meghan Arvind, 2010, Curr Infect Dis Rep, V12, P417, DOI 10.1007/s11908-010-0136-x.
   Pereyre S, 2007, INT J ANTIMICROB AG, V29, P207, DOI 10.1016/j.ijantimicag.2006.09.008.
   Uuskula A, 2002, INT J STD AIDS, V13, P79, DOI 10.1258/0956462021924695.
   Varkonyi V, 2006, STD ATLASZ GYAKORLO, P119.
   Waites KB, 2009, SEMIN FETAL NEONAT M, V14, P190, DOI 10.1016/j.siny.2008.11.009.
   Xiao L, 2012, ANTIMICROB AGENTS CH, V56, P2780, DOI 10.1128/AAC.06342-11.
   Xie XY, 2006, FEMS MICROBIOL LETT, V259, P181, DOI 10.1111/j.1574-6968.2006.00239.x.}},
Number-of-Cited-References = {{18}},
Times-Cited = {{11}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{5}},
Journal-ISO = {{Eur. J. Clin. Microbiol. Infect. Dis.}},
Doc-Delivery-Number = {{237CQ}},
Unique-ID = {{ISI:000325846200007}},
DA = {{2018-08-13}},
}

@article{ ISI:000324960200041,
Author = {Dheilly, Alexandra and Le Devendec, Laetitia and Mourand, Gwenaelle and
   Jouy, Eric and Kempf, Isabelle},
Title = {{Antimicrobial resistance selection in avian pathogenic E. coli during
   treatment}},
Journal = {{VETERINARY MICROBIOLOGY}},
Year = {{2013}},
Volume = {{166}},
Number = {{3-4}},
Pages = {{655-658}},
Month = {{OCT 25}},
Abstract = {{An experiment was performed to compare the microbiological efficacy of
   four treatments (oxytetracycline, trimethoprim-sulphonamide, amoxicillin
   (AMX) or enrofloxacin (ENR)) to control experimental colibacillosis
   induced by an avian pathogenic Escherichia coli (APEC) with reduced
   susceptibility to fluoroquinolones. The protocol was also developed in
   order to study resistance gene transfer. Broilers were first orally
   inoculated with multiresistant E. coli bearing plasmid genes conferring
   resistance to fluoroquinolones (qnr), cephalosporins (bla(CTX-M) or
   bla(FOX)), tetracycline or trimethoprim-sulphonamide. They were then
   inoculated in their air sacs with the APEC and treated as soon as
   symptoms appeared. Internal organs from dead or sacrificed birds were
   cultivated on non-supplemented or supplemented media. The inoculated 078
   APEC was recovered significantly less frequently in ENR treated group
   (26\%) compared to untreated group (47\%). This was not true for other
   treated groups. Isolates obtained on non-supplemented media had the same
   susceptibility profile as the inoculated APEC. However, one isolate from
   the AMX-treated group obtained on AMX-supplemented media was resistant
   to AMX only, and one isolate from the same group obtained on
   ENR-supplemented media, showed a resistance profile suggesting
   acquisition of one of the multiresistance plasmids present in the
   intestinal microbiota. Molecular analysis performed on this
   multiresistant isolate confirmed the presence of a conjugative plasmid
   with qnr and bla(CTX-M) resistance genes. Thus, the experiment
   illustrated the emergence of resistant isolates in internal organs,
   probably via acquisition of a plasmid from the intestinal microbiota.
   (C) 2013 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kempf, I (Reprint Author), ANSES, Lab Ploufragan, Unite Mycoplasmol Bacteriol, F-22440 Ploufragan, France.
   Dheilly, Alexandra; Le Devendec, Laetitia; Mourand, Gwenaelle; Jouy, Eric; Kempf, Isabelle, ANSES, Lab Ploufragan, Unite Mycoplasmol Bacteriol, F-22440 Ploufragan, France.
   Dheilly, Alexandra; Le Devendec, Laetitia; Mourand, Gwenaelle; Jouy, Eric; Kempf, Isabelle, Univ Europeenne Bretagne, Bretagne, France.}},
DOI = {{10.1016/j.vetmic.2013.06.013}},
ISSN = {{0378-1135}},
Keywords = {{Chicken; Colibacillosis; Treatment; Antimicrobial resistance; Gene
   transfer}},
Keywords-Plus = {{MULTIPLEX PCR; GENES; QNR}},
Research-Areas = {{Microbiology; Veterinary Sciences}},
Web-of-Science-Categories  = {{Microbiology; Veterinary Sciences}},
Author-Email = {{isabelle.kempf@anses.fr}},
ORCID-Numbers = {{Kempf, Isabelle/0000-0002-8912-3044}},
Funding-Acknowledgement = {{PNRA grant from the ``Agence Nationale de la Recherche{''} (ANR);
   Conseil General des Cotes d'Armor}},
Funding-Text = {{This work was supported by a PNRA grant from the ``Agence Nationale de
   la Recherche{''} (project PNRA Evalu-Fq-Vol, ANR) and by the ``Conseil
   General des Cotes d'Armor{''}. The authors are very grateful to Prof. G.
   Jacoby, Lahey Clinic, Burlington, MA, USA, for the kind gift of
   J53pMG252 and J53pMG298, Dr Llagostera, UAB, Barcelona, Spain for the E.
   coli HB101 UA6190 strain and Dr A. Carattoli for providing reference
   strains and protocols for replicon-typing. They thank Michel Amelot and
   Odile Balan (ANSES, Ploufragan laboratory) for technical help in the
   animal facilities.}},
Cited-References = {{Baquero F, 1997, J CHEMOTHERAPY, V9, P29.
   CA-SFM, 2008, REC 2008 COM ANT SOC.
   Cattoir V, 2007, J ANTIMICROB CHEMOTH, V60, P394, DOI 10.1093/jac/dkm204.
   Dheilly A, 2012, ANTIMICROB AGENTS CH, V56, P189, DOI 10.1128/AAC.05617-11.
   Dheilly A, 2011, VET MICROBIOL, V149, P422, DOI 10.1016/j.vetmic.2010.11.033.
   Everett MJ, 1996, ANTIMICROB AGENTS CH, V40, P2380.
   Humphrey TJ, 2005, ANTIMICROB AGENTS CH, V49, P690, DOI 10.1128/AAC.49.2.690-698.2005.
   Le Devendec L, 2011, MICROB DRUG RESIST, V17, P129, DOI 10.1089/mdr.2010.0096.
   TAKAHASHI S, 1984, J CLIN MICROBIOL, V20, P608.
   Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412.}},
Number-of-Cited-References = {{10}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{38}},
Journal-ISO = {{Vet. Microbiol.}},
Doc-Delivery-Number = {{225JW}},
Unique-ID = {{ISI:000324960200041}},
DA = {{2018-08-13}},
}

@article{ ISI:000326019400091,
Author = {Buonanno, Manuela and Randers-Pehrson, Gerhard and Bigelow, Alan W. and
   Trivedi, Sheetal and Lowy, Franklin D. and Spotnitz, Henry M. and
   Hammer, Scott M. and Brenner, David J.},
Title = {{207-nm UV Light - A Promising Tool for Safe Low-Cost Reduction of
   Surgical Site Infections. I: In Vitro Studies}},
Journal = {{PLOS ONE}},
Year = {{2013}},
Volume = {{8}},
Number = {{10}},
Month = {{OCT 16}},
Abstract = {{Background: 0.5\% to 10\% of clean surgeries result in surgical-site
   infections, and attempts to reduce this rate have had limited success.
   Germicidal UV lamps, with a broad wavelength spectrum from 200 to 400 nm
   are an effective bactericidal option against drug-resistant and
   drug-sensitive bacteria, but represent a health hazard to patient and
   staff. By contrast, because of its limited penetration, similar to 200
   nm far-UVC light is predicted to be effective in killing bacteria, but
   without the human health hazards to skin and eyes associated with
   conventional germicidal UV exposure.
   Aims: The aim of this work was to test the biophysically-based
   hypothesis that,200 nm UV light is significantly cytotoxic to bacteria,
   but minimally cytotoxic or mutagenic to human cells either isolated or
   within tissues.
   Methods: A Kr-Br excimer lamp was used, which produces 207-nm UV light,
   with a filter to remove higher-wavelength components. Comparisons were
   made with results from a conventional broad spectrum 254-nm UV
   germicidal lamp. First, cell inactivation vs. UV fluence data were
   generated for methicillin-resistant S. aureus (MRSA) bacteria and also
   for normal human fibroblasts. Second, yields of the main UV-associated
   pre-mutagenic DNA lesions (cyclobutane pyrimidine dimers and 6-4
   photoproducts) were measured, for both UV radiations incident on 3-D
   human skin tissue.
   Results: We found that 207-nm UV light kills MRSA efficiently but,
   unlike conventional germicidal UV lamps, produces little cell killing in
   human cells. In a 3-D human skin model, 207-nm UV light produced almost
   no pre-mutagenic UV-associated DNA lesions, in contrast to significant
   yields induced by a conventional germicidal UV lamp.
   Conclusions: As predicted based on biophysical considerations, 207-nm
   light kills bacteria efficiently but does not appear to be significantly
   cytotoxic or mutagenic to human cells. Used appropriately, 207-nm light
   may have the potential for safely and inexpensively reducing
   surgical-site infection rates, including those of drug-resistant origin.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Brenner, DJ (Reprint Author), Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA.
   Buonanno, Manuela; Randers-Pehrson, Gerhard; Bigelow, Alan W.; Brenner, David J., Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA.
   Trivedi, Sheetal; Lowy, Franklin D.; Hammer, Scott M., Columbia Univ, Dept Med, Div Infect Dis, Med Ctr, New York, NY USA.
   Spotnitz, Henry M., Columbia Univ, Dept Med, Dept Surg, Med Ctr, New York, NY USA.}},
DOI = {{10.1371/journal.pone.0076968}},
Article-Number = {{e76968}},
ISSN = {{1932-6203}},
Keywords-Plus = {{ULTRAVIOLET GERMICIDAL IRRADIATION; RESISTANT STAPHYLOCOCCUS-AUREUS;
   CARE-ASSOCIATED INFECTIONS; MAMMALIAN-CELLS; LASER-RADIATION; VACUUM
   ULTRAVIOLET; AIR DISINFECTION; SKIN-CANCER; DNA-DAMAGE; NM}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{djb3@columbia.edu}},
ORCID-Numbers = {{buonanno, manuela/0000-0002-3455-3602}},
Funding-Acknowledgement = {{Columbia University Medical Center}},
Funding-Text = {{This was funded through internal funding at Columbia University Medical
   Center. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.}},
Cited-References = {{Anderson DJ, 2007, INFECT CONT HOSP EP, V28, P1047, DOI 10.1086/520731.
   Avdeev SM, 2008, LIGHT ENG, V16, P32.
   BASFORD JR, 1986, ARCH PHYS MED REHAB, V67, P151, DOI 10.1016/0003-9993(86)90053-5.
   BERG M, 1991, J BONE JOINT SURG BR, V73, P811.
   Broex ECJ, 2009, J HOSP INFECT, V72, P193, DOI 10.1016/j.jhin.2009.03.020.
   Conner-Kerr T A, 1998, Ostomy Wound Manage, V44, P50.
   COOHILL TP, 1986, PHOTOCHEM PHOTOBIOL, V44, P359, DOI 10.1111/j.1751-1097.1986.tb04676.x.
   Crolla RMPH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044599.
   Dai TH, 2012, EXPERT REV ANTI-INFE, V10, P185, DOI {[}10.1586/eri.11.166, 10.1586/ERI.11.166].
   Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7.
   Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043.
   Frei E, 2011, VASC ENDOVASC SURG, V45, P688, DOI 10.1177/1538574411419528.
   Fry DE, 2011, SURG INFECT, V12, P191, DOI 10.1089/sur.2011.068.
   GOLDFARB AR, 1951, SCIENCE, V114, P156, DOI 10.1126/science.114.2954.156.
   Gosden PE, 1998, J HOSP INFECT, V39, P173, DOI 10.1016/S0195-6701(98)90255-9.
   GREEN H, 1987, CANCER RES, V47, P410.
   Haley VB, 2012, INFECT CONT HOSP EP, V33, P565, DOI 10.1086/665710.
   Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861.
   Hitzschke L, 2001, P 9 INT S SCI TECHN, P411.
   JOSE JG, 1985, EXP EYE RES, V41, P545, DOI 10.1016/S0014-4835(85)80011-7.
   Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572.
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205.
   Koch-Paiz CA, 2004, MUTAT RES-FUND MOL M, V549, P65, DOI 10.1016/j.mrfmmm.2004.01.010.
   KOCHEVAR IE, 1991, CANCER RES, V51, P288.
   KOCHEVAR IE, 1990, RADIAT RES, V122, P142, DOI 10.2307/3577598.
   Kolozsvari L, 2002, INVEST OPHTH VIS SCI, V43, P2165.
   Kreusch S, 2003, ANAL BIOCHEM, V313, P208, DOI 10.1016/S0003-2697(02)00460-8.
   Kubilus J, 2004, ATLA-ALTERN LAB ANIM, V32, P75.
   Lessa FC, 2012, CLIN INFECT DIS, V55, P232, DOI 10.1093/cid/cis408.
   LIDWELL OM, 1983, J HOSP INFECT, V4, P111, DOI 10.1016/0195-6701(83)90041-5.
   LORIAN V, 1985, DIAGN MICR INFEC DIS, V3, P433, DOI 10.1016/0732-8893(85)90082-3.
   Matafonova GG, 2008, LETT APPL MICROBIOL, V47, P508, DOI 10.1111/j.1472-765X.2008.02461.x.
   McDonald RS, 2013, EUR CELLS MATER, V25, P204, DOI 10.22203/eCM.v025a15.
   Metzler D. E., 2001, BIOCH CHEM REACTIONS.
   Miller J, 2011, APPL OPTICS, V50, P876, DOI 10.1364/AO.50.000876.
   MITCHELL DL, 1988, PHOTODERMATOLOGY, V5, P61.
   Nardell EA, 2008, PUBLIC HEALTH REP, V123, P52, DOI 10.1177/003335490812300108.
   PAPADOPOULO D, 1990, P NATL ACAD SCI USA, V87, P8383, DOI 10.1073/pnas.87.21.8383.
   Pfeifer GP, 2012, PHOTOCH PHOTOBIO SCI, V11, P90, DOI 10.1039/c1pp05144j.
   Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057.
   Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289.
   PREISS JW, 1956, J CHEM PHYS, V25, P138, DOI 10.1063/1.1742806.
   PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653.
   QIN XS, 1994, CANCER LETT, V83, P291, DOI 10.1016/0304-3835(94)90332-8.
   QUICKENDEN TI, 1980, J CHEM PHYS, V72, P4416, DOI 10.1063/1.439733.
   Rao BK, 2011, OSTOMY WOUND MANAG, V57, P46.
   Reed NG, 2010, PUBLIC HEALTH REP, V125, P15, DOI 10.1177/003335491012500105.
   Ritter MA, 2007, J BONE JOINT SURG AM, V89A, P1935, DOI 10.2106/JBJS.F.01037.
   Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020.
   Russell LM, 2008, EUR J PHARM BIOPHARM, V69, P861, DOI 10.1016/j.ejpb.2008.02.002.
   Salvermoser M, 2003, APPL PHYS LETT, V83, P1932, DOI 10.1063/1.1605798.
   Scott R. D., 2009, DIRECT MED COSTS HEA.
   Sliney D, 2013, PHOTOCHEM PHOTOBIOL, V89, P770, DOI 10.1111/php.12093.
   SODERBERG PG, 1988, ACTA OPHTHALMOL, V66, P141.
   Sommer R, 1996, APPL ENVIRON MICROB, V62, P1977.
   Sosnin EA, 2005, INSTRUM EXP TECH+, V48, P663, DOI 10.1007/s10786-005-0118-7.
   Sosnin EA, 2006, J PHOTOCH PHOTOBIO C, V7, P145, DOI 10.1016/j.jphotochemrev.2006.12.002.
   Stocks GW, 2011, J ARTHROPLASTY, V26, P771, DOI 10.1016/j.arth.2010.07.001.
   Stolper G, 2011, 651 MATTEK CORP.
   TAYLOR GJS, 1995, J HOSP INFECT, V30, P85, DOI 10.1016/0195-6701(95)90148-5.
   Tscherteu G, 2012, KPN TOWER ROTTERDAM.
   Volkova G. A., 1984, Journal of Applied Spectroscopy, V41, P1194, DOI 10.1007/BF00659516.
   Vollkommer F., 1998, Proceedings of 8th International Symposium on the Science and Technology of Light Sources (LS-8), P51.
   Wang D, 2010, PHOTOCHEM PHOTOBIOL, V86, P176, DOI 10.1111/j.1751-1097.2009.00640.x.
   Wengraitis S, 2012, PHOTOCHEM PHOTOBIOL, V88, P1480, DOI 10.1111/j.1751-1097.2012.01193.x.
   ZOLZER F, 1984, PHOTOCHEM PHOTOBIOL, V40, P49, DOI 10.1111/j.1751-1097.1984.tb04552.x.}},
Number-of-Cited-References = {{66}},
Times-Cited = {{21}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{16}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{239JR}},
Unique-ID = {{ISI:000326019400091}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000326203400097,
Author = {Korzeniewska, Ewa and Harnisz, Monika},
Title = {{Extended-spectrum beta-lactamase (ESBL)-positive Enterobacteriaceae in
   municipal sewage and their emission to the environment}},
Journal = {{JOURNAL OF ENVIRONMENTAL MANAGEMENT}},
Year = {{2013}},
Volume = {{128}},
Pages = {{904-911}},
Month = {{OCT 15}},
Abstract = {{The spread of Gram-negative bacteria with plasmid-borne
   extended-spectrum beta-lactamases (ESBLs) has become a worldwide
   problem. Their prevalence is increasing, both in hospitals and in the
   environment The aim of this study was to investigate the presence of
   ESBL-positive Enterobacteriaceae in municipal sewage and their emission
   to the ambient air and the river receiving effluent from wastewater
   treatment plant (WWTP). In the group of 455 isolated strains, up to
   19.8\% (90 isolates) were phenotypic ESBL-producers. They were detected
   in the 63 (100\%) of sewage samples analyzed, 7 (33.3\%) of river water
   and in 10 (23.8\%) of air samples collected at the WWTP area. The
   plasmid-mediated genes encoding beta-lactams resistance were detected in
   almost 10\% out of bacteria of the WWTP's final effluents and in above
   32\% out of bacteria of air at the WWTP area. It confirms that those
   genes are released into the environment, which might facilitate further
   dissemination among environmental bacteria. Moreover, genes encoding
   antibiotic resistance were shown to be transferrable to an Escherichia
   coli recipient strain, which indicates a high possibility of horizontal
   gene transfer among strains of different genera within the sewage and
   environmental samples. This study demonstrated that despite the
   treatment, the municipal sewage may be a reservoir of
   antibiotic-resistant microorganisms and plasmid-mediated antibiotic
   resistance genes. This may pose a public health risk, which requires
   future evaluation and control. (C) 2013 Elsevier Ltd. All rights
   reserved.}},
Publisher = {{ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD}},
Address = {{24-28 OVAL RD, LONDON NW1 7DX, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Korzeniewska, E (Reprint Author), Univ Warmia \& Mazury, Fac Environm Sci, Dept Environm Microbiol, Prawochenskiego 1, PL-10957 Olsztyn, Poland.
   Korzeniewska, Ewa; Harnisz, Monika, Univ Warmia \& Mazury, Fac Environm Sci, Dept Environm Microbiol, PL-10957 Olsztyn, Poland.}},
DOI = {{10.1016/j.jenvman.2013.06.051}},
ISSN = {{0301-4797}},
EISSN = {{1095-8630}},
Keywords = {{ESBL; Enterobacteriaceae; Beta-lactamase; WWTP; Sewage; Air; River}},
Keywords-Plus = {{WATER TREATMENT-PLANT; DOMESTIC WASTE-WATER; ESCHERICHIA-COLI;
   RISK-ASSESSMENT; KLEBSIELLA-PNEUMONIAE; ANTIBIOTICS; BACTERIA;
   RESISTANCE; DIVERSITY; SLUDGE}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{ewa.korzeniewska@uwm.edu.pl}},
ResearcherID-Numbers = {{Korzeniewska, Ewa/J-6408-2013
   Harnisz, Monika/N-3040-2018
   }},
ORCID-Numbers = {{Harnisz, Monika/0000-0002-2907-4199
   Korzeniewska, Ewa/0000-0002-3106-2381}},
Funding-Acknowledgement = {{Ministry of Science and Higher Education (Poland) {[}N305 156836]}},
Funding-Text = {{This study was supported by grant No. N305 156836 from the Ministry of
   Science and Higher Education (Poland).}},
Cited-References = {{APHA American Public Health Association, 1998, STANDARD METHODS EXA.
   BLANCHARD DC, 1982, APPL ENVIRON MICROB, V43, P1001.
   Brooks J.P., 2004, J RESIDUALS SCI TECH, V1, P13.
   Bunger J, 2007, INT ARCH OCC ENV HEA, V80, P306, DOI 10.1007/s00420-006-0135-2.
   Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09.
   Chagas TPG, 2011, J APPL MICROBIOL, V111, P572, DOI 10.1111/j.1365-2672.2011.05072.x.
   Clinical and Laboratory Standards Institute, 2007, M100S17 CLSI.
   CLSI, 2007, M2A9 CLSI.
   Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032.
   Dzierzanowska D, 2010, INT J ANTIMICROB AG, V35, P392, DOI 10.1016/j.ijantimicag.2009.12.010.
   Eisner A, 2006, ANTIMICROB AGENTS CH, V50, P785, DOI 10.1128/AAC.50.2.785-787.2006.
   Figueira V, 2011, SCI TOTAL ENVIRON, V409, P1017, DOI 10.1016/j.scitotenv.2010.12.011.
   Filipkowska Z, 2000, POL J ENVIRON STUD, V9, P273.
   Filipkowska Zofia, 2003, Acta Microbiologica Polonica, V52, P57.
   Gillan DC, 1998, APPL ENVIRON MICROB, V64, P3464.
   Gotkowska-Plachta A, 2013, CLEAN-SOIL AIR WATER, V41, P429, DOI 10.1002/clen.201100466.
   Harnisz M, 2013, ENVIRON POLLUT, V174, P85, DOI 10.1016/j.envpol.2012.11.005.
   Heinonen-Tanski H, 2009, WATER RES, V43, P2558, DOI 10.1016/j.watres.2009.03.006.
   Kelly BG, 2009, FOOD CHEM TOXICOL, V47, P978, DOI 10.1016/j.fct.2008.06.012.
   Kim S, 2007, J TOXICOL ENV HEAL B, V10, P559, DOI 10.1080/15287390600975137.
   Kiratisin P, 2008, ANTIMICROB AGENTS CH, V52, P2818, DOI 10.1128/AAC.00171-08.
   Knapp C. W., 2010, ENVIRON POLLUT, V158, P506, DOI {[}10.1016/j.envpol.2009.12.020, DOI 10.1016/J.ENVPOL.2009.12.020].
   Korzeniewska E, 2009, WATER RES, V43, P2841, DOI 10.1016/j.watres.2009.03.050.
   Korzeniewska E, 2013, J ENVIRON MANAGE, V123, P1, DOI 10.1016/j.jenvman.2013.03.024.
   Korzeniewska E, 2013, ECOTOX ENVIRON SAFE, V91, P96, DOI 10.1016/j.ecoenv.2013.01.014.
   Korzeniewska E, 2012, WATER AIR SOIL POLL, V223, P4039, DOI 10.1007/s11270-012-1171-z.
   Korzeniewska Ewa, 2011, Front Biosci (Schol Ed), V3, P393, DOI 10.2741/s159.
   Korzeniewska E, 2008, ARCH ENVIRON PROT, V34, P13.
   Koton-Czarnecka M, 2003, POL J ENVIRON STUD, V12, P325.
   Krajewski JA, 2004, ANN AGR ENV MED, V11, P199.
   Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086.
   Langin A, 2009, CHEMOSPHERE, V75, P347, DOI 10.1016/j.chemosphere.2008.12.032.
   Le Corre KS, 2012, ENVIRON INT, V45, P99, DOI 10.1016/j.envint.2012.03.008.
   Leung HW, 2012, ENVIRON INT, V42, P1, DOI 10.1016/j.envint.2011.03.004.
   Li B, 2009, ANAL CHIM ACTA, V645, P64, DOI 10.1016/j.aca.2009.04.042.
   Lu SY, 2010, APPL ENVIRON MICROB, V76, P5972, DOI 10.1128/AEM.00711-10.
   Manaia CM, 2010, WATER AIR SOIL POLL, V208, P335, DOI 10.1007/s11270-009-0171-0.
   Medema G, 2004, WA SCI TECHNOL, V4, P125.
   Mesa RJ, 2006, J ANTIMICROB CHEMOTH, V58, P211, DOI 10.1093/jac/dkl211.
   Mokracka J, 2012, WATER RES, V46, P3353, DOI 10.1016/j.watres.2012.03.037.
   Mugnaioli C, 2006, ANTIMICROB AGENTS CH, V50, P2700, DOI 10.1128/AAC.00068-06.
   Naas T, 2008, CLIN MICROBIOL INFEC, V14, P42, DOI 10.1111/j.1469-0691.2007.01861.x.
   Paterson DL, 2006, AM J MED, V119, pS20, DOI 10.1016/j.amjmed.2006.03.013.
   Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005.
   Prado T, 2008, LETT APPL MICROBIOL, V46, P136, DOI 10.1111/j.1472-765X.2007.02275.x.
   Reinthaler FF, 2010, WATER RES, V44, P1981, DOI 10.1016/j.watres.2009.11.052.
   Schluter A, 2007, FEMS MICROBIOL REV, V31, P449, DOI 10.1111/j.1574-6976.2007.00074.x.
   Szczepanowski R, 2009, MICROBIOL-SGM, V155, P2306, DOI 10.1099/mic.0.028233-0.
   Vinue L, 2009, CLIN MICROBIOL INFEC, V15, P954, DOI {[}10.1111/j.1469-0691.2009.02803.x, 10.1111/1469-0691.2009.02803.x].
   Westrell T, 2004, WATER SCI TECHNOL, V50, P23.
   Yang CM, 2009, LETT APPL MICROBIOL, V48, P560, DOI 10.1111/j.1472-765X.2009.02572.x.
   Zou SC, 2011, ENVIRON POLLUT, V159, P2913, DOI 10.1016/j.envpol.2011.04.037.}},
Number-of-Cited-References = {{52}},
Times-Cited = {{52}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{58}},
Journal-ISO = {{J. Environ. Manage.}},
Doc-Delivery-Number = {{241YA}},
Unique-ID = {{ISI:000326203400097}},
DA = {{2018-08-13}},
}

@article{ ISI:000330520500009,
Author = {Zhou, Feng and Wang, Yuyan},
Title = {{Characteristics of Antibiotic Resistance of Airborne Staphylococcus
   Isolated from Metro Stations (vol 10, pg 2412, 2013)}},
Journal = {{INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH}},
Year = {{2013}},
Volume = {{10}},
Number = {{10}},
Pages = {{4667-4668}},
Month = {{OCT}},
Publisher = {{MDPI AG}},
Address = {{POSTFACH, CH-4005 BASEL, SWITZERLAND}},
Type = {{Correction}},
Language = {{English}},
Affiliation = {{Wang, YY (Reprint Author), Fudan Univ, Dept Med Microbiol \& Parasitol, Sch Basic Med Sci, Shanghai 200032, Peoples R China.
   Zhou, Feng, Fudan Univ, Dept Clin Med, Sch Basic Med Sci, Shanghai 200032, Peoples R China.
   Wang, Yuyan, Fudan Univ, Dept Med Microbiol \& Parasitol, Sch Basic Med Sci, Shanghai 200032, Peoples R China.}},
DOI = {{10.3390/ijerph10104667}},
ISSN = {{1660-4601}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{09301010100@fudan.edu.cn
   yuyanss@fudan.edu.cn}},
Cited-References = {{Zhou F, 2013, INT J ENV RES PUB HE, V10, P2412, DOI 10.3390/ijerph10062412.}},
Number-of-Cited-References = {{1}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{Int. J. Environ. Res. Public Health}},
Doc-Delivery-Number = {{301GJ}},
Unique-ID = {{ISI:000330520500009}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000324314200025,
Author = {Zhou, Qi (Tony) and Morton, David A. V. and Yu, Heidi H. and Jacob,
   Jovan and Wang, Jiping and Li, Jian and Chan, Hak Kim},
Title = {{Colistin Powders with High Aerosolisation Efficiency for Respiratory
   Infection: Preparation and In Vitro Evaluation}},
Journal = {{JOURNAL OF PHARMACEUTICAL SCIENCES}},
Year = {{2013}},
Volume = {{102}},
Number = {{10}},
Pages = {{3736-3747}},
Month = {{OCT}},
Abstract = {{In many respiratory infections caused by multi-drug-resistant
   Gram-negative bacteria, colistin is often the last-line drug for
   treatment despite its nephrotoxicity when administered parenterally.
   Inhalation therapy of colistin has great potential to improve the
   efficacy while reducing adverse effects. In this study, inhalable powder
   formulations of colistin (sulphate) were produced via spray drying. The
   colistin powders were found to have intact antimicrobial activity
   against Acinetobacter baumannii measured by broth micro-dilution. Both
   the raw material and spray-dried formulations were amorphous and
   absorbed significant amount of water up to 30\% (w/w) at relative
   humidity (RH) of at least 70\%. The spray-dried formulations were
   physically stable in the amorphous form at 60\% RH and 25 degrees C,
   having a high aerosol efficiency (emitted dose >86\% and fine particle
   fraction total >83\%) which remained unchanged after a 3-month storage.
   Storage at an elevated RH of 75\% resulted in the aerosolisation
   performance significantly decreased, and at RH 90\%, the formulation
   particles fused together (but without re-crystallisation). Although
   spray drying has been extensively used for generating inhalable drug
   particles, this is the first report that colistin powder can be
   physically stable in the amorphous form at ambient conditions,
   indicating that spray-drying approach is suitable for producing
   inhalable colistin powder formulation. (c) 2013 Wiley Periodicals, Inc.
   and the American Pharmacists Association J Pharm Sci 102:3736-3747, 2013}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chan, HK (Reprint Author), Univ Sydney, Fac Pharm, Adv Drug Delivery Grp, Sydney, NSW 2006, Australia.
   Zhou, Qi (Tony); Chan, Hak Kim, Univ Sydney, Fac Pharm, Adv Drug Delivery Grp, Sydney, NSW 2006, Australia.
   Morton, David A. V.; Yu, Heidi H.; Jacob, Jovan; Wang, Jiping; Li, Jian, Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.}},
DOI = {{10.1002/jps.23685}},
ISSN = {{0022-3549}},
EISSN = {{1520-6017}},
Keywords = {{colistin; respiratory infections; dry powder inhaler; aerosolisation
   efficiency; spray drying}},
Keywords-Plus = {{PULMONARY DRUG-DELIVERY; CYSTIC-FIBROSIS THERAPY; CRITICALLY-ILL
   PATIENTS; PSEUDOMONAS-AERUGINOSA; MULTIDRUG-RESISTANT;
   HEALTHY-VOLUNTEERS; MOISTURE SORPTION; RELATIVE-HUMIDITY; INHALED
   COLISTIN; AIR CLASSIFIER}},
Research-Areas = {{Pharmacology \& Pharmacy; Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology \&
   Pharmacy}},
Author-Email = {{kim.chan@sydney.edu.au}},
ResearcherID-Numbers = {{Chan, Hak-Kim/O-9264-2017
   Li, Jian/I-5538-2016}},
ORCID-Numbers = {{Chan, Hak-Kim/0000-0002-7054-3137
   Li, Jian/0000-0001-7953-8230}},
Funding-Acknowledgement = {{Australian Research Council (ARC) {[}DP120102778]; Australian NHMRC}},
Funding-Text = {{This study is supported by Australian Research Council (ARC, grant
   DP120102778). Jian Li is an Australian National Health and Medical
   Research Council (NHMRC) Senior Research Fellow. Qi (Tony) Zhou is
   supported by Australian NHMRC Early Career Fellowship. The authors
   acknowledge the facilities, and the scientific and technical assistance,
   of the Australian Microscopy \& Microanalysis Research Facility at the
   Australian Centre for Microscopy and Microanalysis, The University of
   Sydney. Capsugel Australia is acknowledged for the kind donation of
   capsules.}},
Cited-References = {{Adi S, 2008, EUR J PHARM SCI, V35, P12, DOI 10.1016/j.ejps.2008.05.009.
   Adi S, 2011, J AEROSOL SCI, V42, P285, DOI 10.1016/j.jaerosci.2011.02.002.
   Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl\_1.5.
   Antoniu SA, 2012, EXPERT OPIN DRUG DEL, V9, P333, DOI 10.1517/17425247.2012.660480.
   Asking L, 1997, AEROSOL SCI TECH, V27, P39, DOI 10.1080/02786829708965456.
   Bergen PJ, 2006, ANTIMICROB AGENTS CH, V50, P1953, DOI 10.1128/AAC.00035-06.
   Chan HK, 2003, ADV DRUG DELIVER REV, V55, P793, DOI 10.1016/S0169-409X(03)00078-4.
   Chan JGY, 2013, EUR J PHARM BIOPHARM, V83, P285, DOI 10.1016/j.ejpb.2012.08.007.
   Chew NYK, 2002, J PHARM PHARM SCI, V5, P162.
   Chew NYK, 2001, PHARMACEUT RES, V18, P1570, DOI 10.1023/A:1013082531394.
   Chow AHL, 2007, PHARM RES, V24, P411, DOI 10.1007/s11095-006-9174-3.
   CLARK AR, 1993, J AEROSOL MED, V6, P99, DOI 10.1089/jam.1993.6.99.
   de Boer AH, 2012, ADV DRUG DELIVER REV, V64, P257, DOI 10.1016/j.addr.2011.04.004.
   de Boer AH, 2006, EUR J PHARM SCI, V28, P171, DOI 10.1016/j.ejps.2005.11.013.
   de Boer AH, 2002, EUR J PHARM BIOPHARM, V54, P17, DOI 10.1016/S0939-6411(02)00043-7.
   de Boer AH, 2012, J PHARM PHARMACOL, V64, P1316, DOI 10.1111/j.2042-7158.2012.01511.x.
   Decolin D, 1997, J CHROMATOGR SCI, V35, P557, DOI 10.1093/chromsci/35.12.557.
   Feeley JC, 2002, J MATER SCI, V37, P217, DOI 10.1023/A:1013103521464.
   Garonzik SM, 2011, ANTIMICROB AGENTS CH, V55, P3284, DOI 10.1128/AAC.01733-10.
   Geller DE, 2007, PEDIATR PULM, V42, P307, DOI 10.1002/ppal.20594.
   Grasmeijer F, 2012, INT J PHARMACEUT, V437, P242, DOI 10.1016/j.ijpharm.2012.08.020.
   Hartzell JD, 2009, CLIN INFECT DIS, V48, P1724, DOI 10.1086/599225.
   Hoiby N, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-32.
   Kumon M, 2010, EUR J PHARM SCI, V40, P16, DOI 10.1016/j.ejps.2010.02.004.
   Le Brun PPH, 2002, EUR J PHARM BIOPHARM, V54, P25, DOI 10.1016/S0939-6411(02)00044-9.
   Li J, 2005, INT J ANTIMICROB AG, V25, P11, DOI 10.1016/j.ijantimicag.2004.10.001.
   Markou N, 2008, CLIN THER, V30, P143, DOI 10.1016/j.clinthera.2008.01.015.
   Morton D.A.V., 2011, RESP DRUG DELIVERY E, P367.
   Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06.
   Pilcer G, 2010, INT J PHARMACEUT, V392, P1, DOI 10.1016/j.ijpharm.2010.03.017.
   Pilcer G, 2009, J PHARM SCI-US, V98, P1463, DOI 10.1002/jps.21545.
   Podczeck F, 1997, INT J PHARM, V149, P151, DOI 10.1016/S0378-5173(97)04869-2.
   Ratjen F, 2006, J ANTIMICROB CHEMOTH, V57, P306, DOI 10.1093/jac/dki461.
   Raula J, 2008, PHARM RES-DORDR, V25, P2250, DOI 10.1007/s11095-008-9613-4.
   Reychler G, 2004, CHEST, V125, P502, DOI 10.1378/chest.125.2.502.
   Shur J, 2012, AAPS J, V14, P667, DOI 10.1208/s12248-012-9379-9.
   Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819.
   Tang P, 2012, PHARM RES-DORDR, V29, P1797, DOI 10.1007/s11095-012-0703-y.
   Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468.
   Telko MJ, 2005, RESP CARE, V50, P209.
   Vehring R, 2008, PHARM RES, V25, P999, DOI 10.1007/s11095-007-9475-1.
   Wahl M, 2006, CHEM ENG TECHNOL, V29, P674, DOI 10.1002/ceat.200600067.
   YORK P, 1981, J PHARM PHARMACOL, V33, P269, DOI 10.1111/j.2042-7158.1981.tb13779.x.
   Zhou QT, 2013, AAPS J, V15, P511, DOI 10.1208/s12248-013-9458-6.
   Zhou QT, 2010, EUR J PHARM SCI, V40, P412, DOI 10.1016/j.ejps.2010.04.012.
   Zhu KW, 2008, J AEROSOL SCI, V39, P510, DOI 10.1016/j.jaerosci.2008.02.003.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{24}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{23}},
Journal-ISO = {{J. Pharm. Sci.}},
Doc-Delivery-Number = {{216VS}},
Unique-ID = {{ISI:000324314200025}},
DA = {{2018-08-13}},
}

@article{ ISI:000326647900005,
Author = {Cristina, Maria Luisa and Spagnolo, Anna Maria and Orlando, Paolo and
   Perdelli, Fernanda},
Title = {{The role of the environment in the spread of emerging pathogens in
   at-risk hospital wards}},
Journal = {{REVIEWS IN MEDICAL MICROBIOLOGY}},
Year = {{2013}},
Volume = {{24}},
Number = {{4}},
Pages = {{104-112}},
Month = {{OCT}},
Abstract = {{Infections in hospital high-risk environments due to emerging pathogens
   as Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas
   maltophilia or heterogeneous glycopeptide-intermediate Staphylococcus
   aureus are responsible for a high mortality rate. The severity of these
   infections is due to bacterial virulence factors, their resistance to
   multiple antibiotics and the associated difficulty in treating
   infections.Although resistance to a single antimicrobial agent or class
   is troublesome, of greater concern is the development of resistance to
   multiple agents or classes, which severely limits treatment options.
   This is a major public health problem and a cause of substantial
   morbidity and mortality among hospitalized patients, especially in
   at-risk wards.The hospital environment can act as a reservoir of these
   microorganisms. The main reservoirs identified in hospital settings are
   water, medical devices that are not thoroughly cleaned/disinfected or
   dried, contaminated solutions, hands, colonized or infected patients,
   air and surfaces. To better prevent nosocomial infections related to
   emerging pathogens, the control of the hospital environment, the strict
   application of hand disinfection and other recommended procedures, and
   the investigation of potential cross-transmission in the hospital
   setting are needed.}},
Publisher = {{LIPPINCOTT WILLIAMS \& WILKINS}},
Address = {{TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Spagnolo, AM (Reprint Author), Univ Genoa, Dept Hlth Sci, Via Pastore 1, I-16132 Genoa, Italy.
   Cristina, Maria Luisa; Spagnolo, Anna Maria; Orlando, Paolo; Perdelli, Fernanda, Univ Genoa, Dept Hlth Sci, I-16132 Genoa, Italy.}},
DOI = {{10.1097/MRM.0b013e328365c506}},
ISSN = {{0954-139X}},
EISSN = {{1473-5601}},
Keywords = {{emerging pathogens; hospital environment; hospital infections}},
Keywords-Plus = {{INTENSIVE-CARE-UNIT; RESISTANT ACINETOBACTER-BAUMANNII; BLOOD-STREAM
   INFECTIONS; PSEUDOMONAS-AERUGINOSA INFECTION; GRAM-NEGATIVE PATHOGENS;
   BURKHOLDERIA-CEPACIA; STAPHYLOCOCCUS-AUREUS; NOSOCOMIAL INFECTIONS;
   COMPOUNDING PHARMACY; STENOTROPHOMONAS-MALTOPHILIA}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{am.spagnolo@unige.it}},
ORCID-Numbers = {{CRISTINA, Maria Luisa/0000-0002-7926-7108
   Orlando, Paolo/0000-0002-6576-9860
   Spagnolo, Anna Maria/0000-0001-6559-3626}},
Cited-References = {{Al Maghlouth Adnan, 2004, J Contemp Dent Pract, V5, P91.
   Anaissie EJ, 2002, ARCH INTERN MED, V162, P1483, DOI 10.1001/archinte.162.13.1483.
   {[}Anonymous], 2011, ECDC SURVEILLANCE RE.
   BEARDPEGLER MA, 1988, J MED MICROBIOL, V26, P251, DOI 10.1099/00222615-26-4-251.
   Bernard L, 1999, INFECT CONT HOSP EP, V20, P626, DOI 10.1086/501686.
   Berthelot P, 2005, PATHOL BIOL, V53, P341, DOI 10.1016/j.patbio.2004.09.006.
   Berthelot P, 2001, INTENS CARE MED, V27, P503, DOI 10.1007/s001340100870.
   BERTHELOT P, 1993, J HOSP INFECT, V25, P33, DOI 10.1016/0195-6701(93)90006-L.
   Best EL, 2010, CLIN INFECT DIS, V50, P1450, DOI 10.1086/652648.
   Blanc DS, 2004, INTENS CARE MED, V30, P1964, DOI 10.1007/s00134-004-2389-z.
   Blok HEM, 2003, INFECT CONT HOSP EP, V24, P679, DOI 10.1086/502275.
   Bou R, 2006, J HOSP INFECT, V64, P129, DOI 10.1016/j.jhin.2006.06.014.
   Boyce JM, 2007, J HOSP INFECT, V65, P50, DOI 10.1016/S0195-6701(07)60015-2.
   Brooks SE, 2002, INFECT CONT HOSP EP, V23, P692, DOI 10.1086/501996.
   Burton JL, 2003, J CLIN PATHOL, V56, P254, DOI 10.1136/jcp.56.4.254.
   Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001.
   Cargill J, 2012, J CYST FIBROS, V11, P337, DOI 10.1016/j.jcf.2012.02.004.
   Carmeli Y, 2010, CLIN MICROBIOL INFEC, V16, P102, DOI 10.1111/j.1469-0691.2009.03115.x.
   {*}CDCP, 2002, MMWR-MORBID MORTAL W, V51, P565.
   Centers for Disease Control and Prevention, 1996, MMWR-MORBID MORTAL W, V46, P624.
   Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P813.
   Centers for Disease Control and Prevention (CDCP), 2005, MMWR-MORBID MORTAL W, V54, P269.
   Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781.
   Civen R, 2006, CLIN INFECT DIS, V43, P831, DOI 10.1086/507336.
   Conger NG, 2004, INFECT CONT HOSP EP, V25, P1050, DOI 10.1086/502342.
   Cristina ML, 2013, PUBLIC HEALTH, V127, P386, DOI 10.1016/j.puhe.2013.01.025.
   Cristina M L, 2009, J Prev Med Hyg, V50, P175.
   Cristina ML, 2008, AM J INFECT CONTROL, V36, P304, DOI 10.1016/j.ajic.2007.07.019.
   Cristina ML, 2012, REV MED MICROBIOL, V23, P67, DOI 10.1097/MRM.0b013e3283573643.
   Cristina ML, 2011, AM J INFECT CONTROL, V39, P790, DOI 10.1016/j.ajic.2011.01.016.
   Denton M, 2004, J HOSP INFECT, V56, P106, DOI 10.1016/j.jhin.2003.10.017.
   Dias MBS, 2008, INFECT CONT HOSP EP, V29, P125, DOI 10.1086/526440.
   Doit C, 2004, J CLIN MICROBIOL, V42, P2227, DOI 10.1128/JCM.42.5.2227-2230.2004.
   DUCKWORTH GJ, 1990, J MED MICROBIOL, V32, P195, DOI 10.1099/00222615-32-3-195.
   El Shafie SS, 2004, J HOSP INFECT, V56, P101, DOI 10.1016/j.jhin.2003.09.024.
   Engemann J, 2003, JAMA-J AM MED ASSOC, V289, P291.
   Estivariz CF, 2006, CHEST, V130, P1346, DOI 10.1378/chest.130.5.1346.
   Foca M, 2000, NEW ENGL J MED, V343, P695, DOI 10.1056/NEJM200009073431004.
   Gershman MD, 2008, CLIN INFECT DIS, V47, P1372, DOI 10.1086/592968.
   Gravel D, 2002, INFECT CONT HOSP EP, V23, P103, DOI 10.1086/502017.
   Guinto CH, 2002, AM J INFECT CONTROL, V30, P499, DOI 10.1067/mic.2002.126427.
   Harrel SK, 2004, J AM DENT ASSOC, V135, P429, DOI 10.14219/jada.archive.2004.0207.
   Hayden MK, 2006, CLIN INFECT DIS, V42, P1552, DOI 10.1086/503845.
   Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3.
   Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135.
   Kallen AJ, 2010, INFECT CONT HOSP EP, V31, P528, DOI 10.1086/652152.
   KHARDORI N, 1990, REV INFECT DIS, V12, P997.
   LARSON EL, 1981, AM J INFECT CONTROL, V9, P112, DOI 10.1016/S0196-6553(81)80091-0.
   Leggat PA, 2001, INT DENT J, V51, P39, DOI 10.1002/j.1875-595X.2001.tb00816.x.
   Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128.
   Lockhart SR, 2007, J CLIN MICROBIOL, V45, P3352, DOI 10.1128/JCM.01284-07.
   Matrician L, 2000, INFECT CONT HOSP EP, V21, P739, DOI 10.1086/501719.
   McNeil SA, 2001, CLIN INFECT DIS, V32, P367, DOI 10.1086/318488.
   MILLER RL, 1995, AM IND HYG ASSOC J, V56, P670, DOI 10.1202/0002-8894(1995)056<0670:COBAGB>2.0.CO;2.
   Mineshita M, 2005, INTERNAL MED, V44, P662, DOI 10.2169/internalmedicine.44.662.
   Mouloudi E, 2010, INFECT CONT HOSP EP, V31, P1250, DOI 10.1086/657135.
   Nunez S, 2000, EPIDEMIOL INFECT, V124, P233, DOI 10.1017/S0950268800003563.
   Orlando P, 2008, J Prev Med Hyg, V49, P116.
   Ottria G, 2010, J Prev Med Hyg, V51, P133.
   Perdelli F, 2008, J HOSP INFECT, V70, P174, DOI 10.1016/j.jhin.2008.06.012.
   Perdelli F, 2008, INT J HYG ENVIR HEAL, V211, P213, DOI 10.1016/j.ijheh.2007.04.002.
   Ramsey AH, 2001, INFECT CONT HOSP EP, V22, P423, DOI 10.1086/501928.
   Raymond DP, 2003, CRIT CARE MED, V31, P1035, DOI 10.1097/01.CCM.0000060015.77443.31.
   Ruden H, 1997, INFECTION, V25, P199, DOI 10.1007/BF01713142.
   Rutala WA, 2008, GUIDELINE DISINFECTI.
   Salvia A, 2007, RAPPORTI ISTISAN, V54, P1.
   Samore MH, 1996, AM J MED, V100, P32, DOI 10.1016/S0002-9343(96)90008-X.
   Schabrun S, 2006, J HOSP INFECT, V63, P239, DOI 10.1016/j.jhin.2005.10.013.
   Schelenz S, 2000, J HOSP INFECT, V46, P23, DOI 10.1053/jhin.2000.0800.
   Sehulster L, 2003, GUIDELINES ENV INFEC.
   Sehulster LM, 2004, RECOMMENDATIONS CDC.
   Selenic D, 2003, AM J HEALTH-SYST PH, V60, P1440.
   Siegel J. D., 2007, GUIDELINE ISOLATION.
   SOBEL JD, 1982, AM J MED, V73, P183, DOI 10.1016/0002-9343(82)90176-0.
   Sorin M, 2001, INFECT CONT HOSP EP, V22, P409, DOI 10.1086/501925.
   Souza Dias MB, 2013, AM J INFECT CONTROL, DOI 10.1016/j.ajic.2013.01.033.
   Srinivasan A, 2003, NEW ENGL J MED, V348, P221, DOI 10.1056/NEJMoa021808.
   STRUELENS MJ, 1993, AM J MED, V95, P489, DOI 10.1016/0002-9343(93)90331-I.
   Sunenshine R, 2009, CLIN INFECT DIS, V48, P1580, DOI 10.1086/598938.
   Sunenshine RH, 2007, CLIN INFECT DIS, V45, P527, DOI 10.1086/520664.
   Sydnor ERM, 2011, CLIN MICROBIOL REV, V24, P141, DOI 10.1128/CMR.00027-10.
   Szymanska J, 2005, ANN AGR ENV MED, V12, P137.
   Tammelin A, 2003, INFECT CONT HOSP EP, V24, P686, DOI 10.1086/502277.
   Thompson CA, 2011, AM J HEALTH-SYST PH, V68, P2110, DOI 10.2146/news110075.
   Trautmann M, 2001, INFECT CONT HOSP EP, V22, P49, DOI 10.1086/501828.
   Tumbarello M, 2006, ANTIMICROB AGENTS CH, V50, P498, DOI 10.1128/AAC.50.2.498-504.2006.
   Valles J, 2004, INTENS CARE MED, V30, P1768, DOI 10.1007/s00134-004-2382-6.
   Wang SH, 2003, J HOSP INFECT, V53, P97, DOI 10.1053/jhin.2002.1348.
   Weber DJ, 1999, AM J INFECT CONTROL, V27, P59, DOI 10.1016/S0196-6553(99)70077-5.
   WEEMS JJ, 1993, INFECT CONT HOSP EP, V14, P583.
   Wilcox MH, 2003, J HOSP INFECT, V54, P109, DOI 10.1016/S0195-6701(02)00400-0.
   Wilks M, 2006, INFECT CONT HOSP EP, V27, P654, DOI 10.1086/507011.
   World Health Organization: World Health Organization, 2009, WHO GUID HAND HYG HE.
   Zachary KC, 2001, INFECT CONT HOSP EP, V22, P560, DOI 10.1086/501952.
   Zawacki A, 2004, INFECT CONT HOSP EP, V25, P1083, DOI 10.1086/502348.}},
Number-of-Cited-References = {{95}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{14}},
Journal-ISO = {{Rev. Med. Microbiol.}},
Doc-Delivery-Number = {{247UN}},
Unique-ID = {{ISI:000326647900005}},
DA = {{2018-08-13}},
}

@article{ ISI:000325807200016,
Author = {Veillette, Marc and Knibbs, Luke D. and Pelletier, Ariane and
   Charlebois, Remi and Lecours, Pascale Blais and He, Congrong and
   Morawska, Lidia and Duchaine, Caroline},
Title = {{Microbial Contents of Vacuum Cleaner Bag Dust and Emitted Bioaerosols
   and Their Implications for Human Exposure Indoors}},
Journal = {{APPLIED AND ENVIRONMENTAL MICROBIOLOGY}},
Year = {{2013}},
Volume = {{79}},
Number = {{20}},
Pages = {{6331-6336}},
Month = {{OCT}},
Abstract = {{Vacuum cleaners can release large concentrations of particles, both in
   their exhaust air and from resuspension of settled dust. However, the
   size, variability, and microbial diversity of these emissions are
   unknown, despite evidence to suggest they may contribute to allergic
   responses and infection transmission indoors. This study aimed to
   evaluate bioaerosol emission from various vacuum cleaners. We sampled
   the air in an experimental flow tunnel where vacuum cleaners were run,
   and their airborne emissions were sampled with closed-face cassettes.
   Dust samples were also collected from the dust bag. Total bacteria,
   total archaea, Penicillium/Aspergillus, and total Clostridium cluster 1
   were quantified with specific quantitative PCR protocols, and emission
   rates were calculated. Clostridium botulinum and antibiotic resistance
   genes were detected in each sample using endpoint PCR. Bacterial
   diversity was also analyzed using denaturing gradient gel
   electrophoresis (DGGE), image analysis, and band sequencing. We
   demonstrated that emission of bacteria and molds
   (Penicillium/Aspergillus) can reach values as high as 1E5 cell
   equivalents/min and that those emissions are not related to each other.
   The bag dust bacterial and mold content was also consistent across the
   vacuums we assessed, reaching up to 1E7 bacterial or mold cell
   equivalents/g. Antibiotic resistance genes were detected in several
   samples. No archaea or C. botulinum was detected in any air samples.
   Diversity analyses showed that most bacteria are from human sources, in
   keeping with other recent results. These results highlight the potential
   capability of vacuum cleaners to disseminate appreciable quantities of
   molds and human-associated bacteria indoors and their role as a source
   of exposure to bioaerosols.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Duchaine, C (Reprint Author), Inst Univ Cardiol \& Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada.
   Veillette, Marc; Pelletier, Ariane; Charlebois, Remi; Lecours, Pascale Blais; Duchaine, Caroline, Inst Univ Cardiol \& Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada.
   Knibbs, Luke D., Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia.
   Knibbs, Luke D.; He, Congrong; Morawska, Lidia, Queensland Univ Technol, Int Lab Air Qual \& Hlth, Brisbane, Qld 4001, Australia.
   Duchaine, Caroline, Univ Laval, Fac Sci \& Genie, Dept Biochim Microbiol \& Bioinformat, Quebec City, PQ G1K 7P4, Canada.}},
DOI = {{10.1128/AEM.01583-13}},
ISSN = {{0099-2240}},
EISSN = {{1098-5336}},
Keywords-Plus = {{TIME PCR ASSAYS; EMISSION CHARACTERISTICS; EQUIPPED VACUUM;
   RIBOSOMAL-RNA; GENES; RESISTANCE; PRIMERS; QUANTIFICATION; BACTERIA;
   QPCR}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Microbiology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Microbiology}},
Author-Email = {{caroline.duchaine@bcm.ulaval.ca}},
ORCID-Numbers = {{Morawska, Lidia/0000-0002-0594-9683}},
Funding-Acknowledgement = {{National Sciences and Engineering Council of Canada; NHMRC
   {[}APP1036620]}},
Funding-Text = {{This work was supported by National Sciences and Engineering Council of
   Canada (Discovery grant). C.D. is a senior Fonds de la Recherche du
   Quebec-Sante scholar and member of the FRQ-S Respiratory Health Network.
   She was a visiting fellow at the International Laboratory for Air
   Quality and Health (ILAQH), Queensland University of Technology (QUT),
   when this work was conducted. L.D.K. is supported by an NHMRC Early
   Career (Australian Public Health) Fellowship (APP1036620) and was a
   postdoctoral researcher at the ILAQH, QUT, for the duration of this
   work.}},
Cited-References = {{ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999.
   Bach HJ, 2001, J MICROBIOL METH, V44, P173, DOI 10.1016/S0167-7012(00)00239-6.
   Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009.
   BATE JG, 1958, LANCET, V2, P713.
   Beguin H, 1994, AEROBIOLOGIA, V10, P157.
   BEGUIN H, 1996, AEROBIOLOGIA, V12, P113.
   Bellanti JA, 2000, ANN ALLERG ASTHMA IM, V84, P249, DOI 10.1016/S1081-1206(10)62762-7.
   Chen J, 2007, APPL ENVIRON MICROB, V73, P4407, DOI 10.1128/AEM.02799-06.
   Chiu TH, 2005, INT J FOOD MICROBIOL, V97, P259, DOI 10.1016/j.ijfoodmicro.2004.04.005.
   DUTKAMALEN S, 1995, J CLIN MICROBIOL, V33, P1434.
   Fromin N, 2002, ENVIRON MICROBIOL, V4, P634, DOI 10.1046/j.1462-2920.2002.00358.x.
   HADDOCK RL, 1994, J TROP PEDIATRICS, V40, P53, DOI 10.1093/tropej/40.1.53.
   Haysom IW, 2003, J R SOC PROMO HEALTH, V123, P39, DOI 10.1177/146642400312300114.
   Just N, 2013, CAN J MICROBIOL, V59, P46, DOI 10.1139/cjm-2012-0305.
   Kaarakainen P, 2009, SCI TOTAL ENVIRON, V407, P4673, DOI 10.1016/j.scitotenv.2009.04.046.
   Karkkainen PM, 2010, J ENVIRON MONITOR, V12, P759, DOI 10.1039/b917937b.
   Knibbs LD, 2012, ENVIRON SCI TECHNOL, V46, P534, DOI 10.1021/es202946w.
   Lecours PB, 2012, APPL ENVIRON MICROB, V78, P3242, DOI 10.1128/AEM.07661-11.
   Lecours PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023326.
   Lindstrom M, 2001, APPL ENVIRON MICROB, V67, P5694, DOI 10.1128/AEM.67.12.5694-5699.2001.
   Lutz EA, 2010, ENVIRON SCI TECHNOL, V44, P9451, DOI 10.1021/es1015982.
   MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695.
   Nakamura N, 2009, APPL ENVIRON MICROB, V75, P1121, DOI 10.1128/AEM.02359-07.
   Nevas M, 2005, J CLIN MICROBIOL, V43, P511, DOI 10.1128/JCM.43.1.511-513.2005.
   Peccia J, 2011, ATMOS ENVIRON, V45, P1896, DOI 10.1016/j.atmosenv.2010.11.037.
   Reponen T, 2002, AIHA J, V63, P689.
   Reysenbach A.-L., 1995, ARCHAEA LAB MANUAL T.
   Thibodeau A, 2008, CAN J VET RES, V72, P129.
   Trakumas S, 2001, AIHAJ, V62, P482, DOI 10.1202/0002-8894(2001)062<0482:PECOFE>2.0.CO;2.
   Trakumas S, 2001, AIHAJ, V62, P573, DOI 10.1202/0002-8894(2001)062<0573:COFBCA>2.0.CO;2.
   Willeke K, 2001, AIHAJ, V62, P313, DOI 10.1080/15298660108984633.
   WOODFOLK JA, 1993, J ALLERGY CLIN IMMUN, V91, P829, DOI 10.1016/0091-6749(93)90339-H.
   Yu ZT, 2005, APPL ENVIRON MICROB, V71, P6926, DOI 10.1128/AEM.71.11.6926-6933.2005.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{9}},
Usage-Count-Last-180-days = {{6}},
Usage-Count-Since-2013 = {{52}},
Journal-ISO = {{Appl. Environ. Microbiol.}},
Doc-Delivery-Number = {{236OH}},
Unique-ID = {{ISI:000325807200016}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000325351700020,
Author = {Conner, Gregory E. and Ivonnet, Pedro and Gelin, Murline and Whitney,
   Philip and Salathe, Matthias},
Title = {{H2O2 Stimulates Cystic Fibrosis Transmembrane Conductance Regulator
   through an Autocrine Prostaglandin Pathway, Using Multidrug-Resistant
   Protein-4}},
Journal = {{AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY}},
Year = {{2013}},
Volume = {{49}},
Number = {{4}},
Pages = {{672-679}},
Month = {{OCT}},
Abstract = {{Cystic fibrosis transmembrane conductance regulator (CFTR) activity is
   essential for the maintenance of airway surface liquid depth, and
   therefore mucociliary clearance. Reactive oxygen species, increased
   during inflammatory airway diseases, alter CFTR activity. Here, H2O2
   levels in the surface liquid of normal human bronchial epithelial
   cultures differentiated at the air-liquid interface were estimated, and
   H2O2-mediated changes in CFTR activity were examined. In Ussing
   chambers, H2O2-induced anion currents were sensitive to the CFTR
   inhibitors CFTR(inh)172 and GlyH-101. These currents were absent in
   cells from patients with cystic fibrosis. Responses to greater than 500
   mM H2O2 were transient. Cyclooxygenase inhibitors blocked the H2O2
   response, as did EP1 and EP4 receptor antagonists. Amultidrug-resistant
   protein (MRP) inhibitor and short hairpin RNA directed against MRP4
   blocked H2O2 responses. EP1 and EP4 agonists mimicked H2O2 in both
   control and MRP4 knockdown cells. Thus, H2O2 activates the synthesis,
   export, and binding of prostanoids via EP4 and, interestingly, EP1
   receptors in normal, differentiated human airway epithelial cells to
   activate cyclic adenosine monophosphate pathways that in turn activate
   CFTR channels in the apical membrane.}},
Publisher = {{AMER THORACIC SOC}},
Address = {{61 BROADWAY, FL 4, NEW YORK, NY 10006 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Salathe, M (Reprint Author), Univ Miami, Miller Sch Med, Dept Med, Div Pulm Allergy Crit Care \& Sleep Med, POB 016960, Miami, FL 33101 USA.
   Conner, Gregory E.; Ivonnet, Pedro; Gelin, Murline; Whitney, Philip; Salathe, Matthias, Univ Miami, Miller Sch Med, Dept Med, Div Pulm Allergy Crit Care \& Sleep Med, Miami, FL 33101 USA.
   Conner, Gregory E., Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33101 USA.}},
DOI = {{10.1165/rcmb.2013-0156OC}},
ISSN = {{1044-1549}},
Keywords = {{MRP4; H2O2; CFTR; EP4; EP1}},
Keywords-Plus = {{AIRWAY EPITHELIAL-CELLS; RESPIRATORY-TRACT EPITHELIUM; HYDROGEN-PEROXIDE
   PRODUCTION; SURFACE LIQUID VOLUME; PROSTANOID RECEPTOR; ANION SECRETION;
   HOST-DEFENSE; OXIDANT STRESS; EP1 RECEPTOR; K+ CHANNELS}},
Research-Areas = {{Biochemistry \& Molecular Biology; Cell Biology; Respiratory System}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Cell Biology; Respiratory System}},
Author-Email = {{msalathe@med.miami.edu}},
ORCID-Numbers = {{Salathe, Matthias/0000-0001-9092-4861}},
Funding-Acknowledgement = {{National Institutes of Health {[}HL-66125, HL-60644, HL-89399]; Flight
   Attendant's Medical Research Institute {[}092061, 103027]; James and
   Esther King Biomedical Research Program}},
Funding-Text = {{This work was supported by National Institutes of Health grants HL-66125
   (G. E. C.) and HL-60644 and HL-89399 (M. S.), Flight Attendant's Medical
   Research Institute grants 092061 (G. E. C.) and 103027 (M. S.), and the
   James and Esther King Biomedical Research Program (G.E.C.).}},
Cited-References = {{Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X.
   Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200.
   Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442.
   Billot X, 2003, BIOORG MED CHEM LETT, V13, P1129, DOI 10.1016/S0960-894X(03)00042-8.
   Boots AW, 2009, J BIOL CHEM, V284, P17858, DOI 10.1074/jbc.M809761200.
   Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001.
   Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316.
   Brenneis C, 2006, FASEB J, V20, P1352, DOI 10.1096/fj.05-5346com.
   Button B, 2007, J PHYSIOL-LONDON, V580, P577, DOI 10.1113/jphysiol.2006.126086.
   Clarke DL, 2005, AM J PHYSIOL-LUNG C, V288, pL238, DOI 10.1152/ajplung.00313.2004.
   Conner GE, 2007, FEBS LETT, V581, P271, DOI 10.1016/j.febslet.2006.12.025.
   Cowley EA, 2002, J PHYSIOL-LONDON, V543, P201, DOI 10.1113/jphysiol.2002.022400.
   Cowley EA, 2002, J PHYSIOL-LONDON, V538, P747, DOI 10.1013/jphysiol.2001.013300.
   Dazy AC, 2003, TOXICOL IN VITRO, V17, P575, DOI 10.1016/S0887-2333(03)00092-4.
   Fischer H, 2009, ANTIOXID REDOX SIGN, V11, P2453, DOI {[}10.1089/ars.2009.2558, 10.1089/ARS.2009.2558].
   Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC.
   Gattas MV, 2009, FREE RADICAL BIO MED, V47, P1450, DOI 10.1016/j.freeradbiomed.2009.08.017.
   Gray T, 2004, AM J PHYSIOL-LUNG C, V286, pL320, DOI 10.1152/ajplung.00440.2002.
   Harper RW, 2006, FEBS LETT, V580, P5150, DOI 10.1016/j.febslet.2006.08.048.
   Harper RW, 2005, FEBS LETT, V579, P4911, DOI 10.1016/j.febslet.2005.08.002.
   Harvey PR, 2011, AM J RESP CELL MOL, V45, P592, DOI 10.1165/rcmb.2010-0484OC.
   HEMLER ME, 1979, ARCH BIOCHEM BIOPHYS, V193, P340, DOI 10.1016/0003-9861(79)90038-9.
   Huang Pingbo, 2004, Proc Am Thorac Soc, V1, P33, DOI 10.1513/pats.2306012.
   Jones CL, 2012, J PHARMACOL EXP THER, V341, P552, DOI 10.1124/jpet.111.187138.
   Jones RL, 2009, BRIT J PHARMACOL, V158, P104, DOI 10.1111/j.1476-5381.2009.00317.x.
   Joy AP, 2008, AM J RESP CELL MOL, V38, P143, DOI 10.1165/rcmb.2006-0295OC.
   LAWRENCE RA, 1992, BRIT J PHARMACOL, V105, P271, DOI 10.1111/j.1476-5381.1992.tb14245.x.
   Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037.
   Li CY, 2011, METHODS MOL BIOL, V741, P255, DOI 10.1007/978-1-61779-117-8\_17.
   Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI {[}10.1039/b924455g, 10.1039/B924455G].
   Mall M, 2000, AM J RESP CELL MOL, V23, P283, DOI 10.1165/ajrcmb.23.3.4060.
   Manzanares D, 2011, J BIOL CHEM, V286, P19830, DOI 10.1074/jbc.M110.185074.
   Matlhagela K, 2006, PROSTAG OTH LIPID M, V79, P101, DOI 10.1016/j.prostaglandins.2005.12.002.
   Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9.
   Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC.
   Nlend MC, 2002, AM J RESP CELL MOL, V27, P436, DOI 10.1165/rcmb.2002-0012OC.
   Ohashi T, 2006, J PHARMACOL EXP THER, V318, P296, DOI 10.1124/jpet.106.102541.
   Okada SF, 2011, AM J RESP CELL MOL, V45, P253, DOI 10.1165/rcmb.2010-0253OC.
   Perreira M, 2005, J MED CHEM, V48, P4910, DOI 10.1021/jm050221l.
   Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010.
   Rada B, 2010, FEBS LETT, V584, P917, DOI 10.1016/j.febslet.2010.01.025.
   Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087.
   Reid G, 2003, MOL PHARMACOL, V63, P1094, DOI 10.1124/mol.63.5.1094.
   Rutkai I, 2009, CARDIOVASC RES, V83, P148, DOI 10.1093/cvr/cvp098.
   Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253.
   Schmid A, 2006, J CELL SCI, V119, P4176, DOI 10.1242/jcs.03181.
   Seto V, 2008, AM J RESP CELL MOL, V38, P88, DOI 10.1165/rcmb.2007-0117OC.
   Tang CH, 2005, J BIOL CHEM, V280, P22907, DOI 10.1074/jbc.M500130200.
   Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC.}},
Number-of-Cited-References = {{49}},
Times-Cited = {{10}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{Am. J. Respir. Cell Mol. Biol.}},
Doc-Delivery-Number = {{230OQ}},
Unique-ID = {{ISI:000325351700020}},
OA = {{green\_published}},
DA = {{2018-08-13}},
}

@article{ ISI:000324925200004,
Author = {Leung, Chi Chiu and Lange, Christoph and Zhang, Ying},
Title = {{Tuberculosis: Current state of knowledge An epilogue}},
Journal = {{RESPIROLOGY}},
Year = {{2013}},
Volume = {{18}},
Number = {{7}},
Pages = {{1047-1055}},
Month = {{OCT}},
Abstract = {{Mycobacterium tuberculosis, the causative agent of tuberculosis (TB),
   has developed various mechanisms to survive and cause disease in the
   human host. Incomplete understanding of the complex microbe-host
   interactions has hindered the identification of suitable biomarkers to
   expedite the development of diagnostic tools, drugs and vaccines. The
   field effectiveness of directly observed therapy-short course has been
   compromised by the intrinsic limitations of sputum microscopy and
   suboptimal adherence to the long duration of treatment amid the HIV-TB
   syndemic and various socioeconomic constraints. While molecular tools
   are transforming the diagnostic processes, especially for
   multi-drug-resistant (MDR)-TB, drug development and service provision
   for MDR-TB seriously lag behind. Inappropriate management of detected
   MDR-TB cases may amplify drug resistance, jeopardizing future control.
   Targeted screening and treatment of latent infection with M.tuberculosis
   with the currently available immunodiagnostic tools and treatment
   regimens aim more for personal protection than major epidemiological
   impact or elimination. The interferon- release assays (IGRA) are not
   affected by cross-reaction to the bacillus Calmette-Guerin (BCG) vaccine
   and are increasingly used for such screening before initiation of
   biologics for treatment of rheumatoid arthritis and other autoimmune
   disorders. BCG offers only partial and unreliable protection against
   pulmonary TB in adults, the crucial transmission link for this airborne
   infection. Systems biology and vaccinomics may speed up vaccine
   research. The successful development of a fully effective TB vaccine
   that targets both growing bacteria and non-growing persisters may
   reflect a major breakthrough, as natural infection does not induce
   sufficient immunity to prevent reinfection.}},
Publisher = {{WILEY}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Leung, CC (Reprint Author), Wanchai Chest Clin, 99 Kennedy Rd, Wanchai, Hong Kong, Peoples R China.
   Leung, Chi Chiu, Ctr Hlth Protect, Dept Hlth, TB \& Chest Serv, Hong Kong, Hong Kong, Peoples R China.
   Lange, Christoph, German Ctr Infect Res DZIF, Res Ctr Borstel, Med Clin, Div Clin Infect Dis, Borstel, Germany.
   Zhang, Ying, Johns Hopkins Univ, Dept Mol Microbiol \& Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD USA.}},
DOI = {{10.1111/resp.12156}},
ISSN = {{1323-7799}},
EISSN = {{1440-1843}},
Keywords = {{diagnosis; latent infection; treatment; tuberculosis; vaccine}},
Keywords-Plus = {{MULTIDRUG-RESISTANT TUBERCULOSIS; HIV-INFECTED PATIENTS; ANTIRETROVIRAL
   THERAPY; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; ACTIVE
   TUBERCULOSIS; DRUG-RESISTANCE; HONG-KONG; RHEUMATOID-ARTHRITIS;
   PUBLISHED LITERATURE}},
Research-Areas = {{Respiratory System}},
Web-of-Science-Categories  = {{Respiratory System}},
Author-Email = {{cc\_leung@dh.gov.hk}},
ResearcherID-Numbers = {{Lange, Christoph/J-6289-2012}},
ORCID-Numbers = {{Lange, Christoph/0000-0002-9691-4741}},
Cited-References = {{Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106.
   Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300.
   Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3.
   Aliyu G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063170.
   American Thoracic Society, 2003, AM J RESP CRIT CARE, V167, P603.
   Angeby K, 2012, B WORLD HEALTH ORGAN, V90, P693, DOI 10.2471/BLT.11.096644.
   {[}Anonymous], 1991, AM REV RESPIR DIS, V143, P700.
   Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911.
   Boshoff Helena I M, 2010, Drug Discov Today Dis Mech, V7, pe75, DOI 10.1016/j.ddmec.2010.09.008.
   Brewer TF, 2000, CLIN INFECT DIS, V31, pS64, DOI 10.1086/314072.
   Butov DA, 2012, IMMUNOTHERAPY-UK, V4, P687, DOI {[}10.2217/imt.12.59, 10.2217/IMT.12.59].
   Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488.
   Centers for Disease Control, 1990, JAMA-J AM MED ASSOC, V264, P173.
   Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012.
   Chang KC, 2006, AM J RESP CRIT CARE, V174, P1153, DOI 10.1164/rccm.200605-637OC.
   Chang KC, 2013, ANTIMICROB AGENTS CH, V57, P3445, DOI 10.1128/AAC.00388-13.
   Chang KC, 2013, RESPIROLOGY, V18, P8, DOI 10.1111/j.1440-1843.2012.02257.x.
   Chang KC, 2012, LANCET INFECT DIS, V12, P502, DOI 10.1016/S1473-3099(12)70137-8.
   Chee CBE, 2013, RESPIROLOGY, V18, P205, DOI 10.1111/resp.12002.
   Chiang CY, 2013, RESPIROLOGY, V18, P596, DOI 10.1111/resp.12067.
   {*}CHIN TUB CONTR CO, 1996, LANCET, V347, P358.
   COLDITZ GA, 1995, PEDIATRICS, V96, P29.
   COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698.
   Dey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023360.
   Dheda K, 2013, RESPIROLOGY, V18, P217, DOI 10.1111/resp.12022.
   Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3271, DOI 10.1128/AAC.06126-11.
   Diacon AH, 2012, LANCET, V380, P986, DOI 10.1016/S0140-6736(12)61080-0.
   Dixon WG, 2010, ANN RHEUM DIS, V69, P522, DOI 10.1136/ard.2009.118935.
   Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677.
   Farnia P, 2008, J CLIN MICROBIOL, V46, P796, DOI 10.1128/JCM.01435-07.
   Forty-Fourth World Health Assembly, 2013, TUB CONTR PROGR.
   Fox W, 1999, INT J TUBERC LUNG D, V3, pS231.
   Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x.
   Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433.
   Global Alliance for TB Drug Development, 2001, TUBERCULOSIS EDIN S1, V81, P1.
   GRZYBOWSKI S, 1978, Bulletin of the International Union Against Tuberculosis, V53, P70.
   Gupta M, 2010, INDIAN J MED MICROBI, V28, P363, DOI 10.4103/0255-0857.71816.
   Hanifa Y, 2012, INT J TUBERC LUNG D, V16, P1252, DOI 10.5588/ijtld.11.0733.
   Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607.
   Ho TTY, 1999, INT J STD AIDS, V10, P409, DOI 10.1258/0956462991914221.
   Holland DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030194.
   {*}HONG KONG CHEST S, 1992, AM REV RESPIR DIS, V145, P36.
   Jung YJ, 2012, INT J TUBERC LUNG D, V16, P1300, DOI 10.5588/ijtld.12.0004.
   Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181.
   Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5.
   Kim SY, 2012, INT J TUBERC LUNG D, V16, P1471, DOI 10.5588/ijtld.11.0602.
   Lawn SD, 2012, AIDS, V26, P1635, DOI 10.1097/QAD.0b013e3283553685.
   Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067.
   Lee M, 2012, NEW ENGL J MED, V367, P1508, DOI 10.1056/NEJMoa1201964.
   Lee SW, 2011, EUR RESPIR J, V37, P1447, DOI 10.1183/09031936.00089510.
   Lee SS, 2013, RESPIROLOGY, V18, P912, DOI 10.1111/resp.12120.
   Leung CC, 2011, EUR RESPIR J, V37, P690, DOI 10.1183/09031936.00079310.
   Leung CC, 2004, AM J RESP CRIT CARE, V170, P1027, DOI {[}10.1164/rccm.200404-512OC, 10.1164/rccm.200404-512oc].
   Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075.
   Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297.
   Leung CC, 2012, LANCET INFECT DIS, V12, P6, DOI 10.1016/S1473-3099(11)70215-8.
   Leung CC, 2011, INT J TUBERC LUNG D, V15, P1279, DOI 10.5588/ijtld.11.0425.
   Leung CC, 2011, INT J TUBERC LUNG D, V15, P429, DOI 10.5588/ijtld.11.0081.
   Madhi SA, 2011, NEW ENGL J MED, V365, P21, DOI 10.1056/NEJMoa1011214.
   Manosuthi W, 2012, JAIDS-J ACQ IMM DEF, V60, P377, DOI 10.1097/QAI.0b013e31825b5e06.
   Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136.
   Meijer J, 1971, Bull Int Union Tuberc, V45, P5.
   Metcalfe JZ, 2013, AM J RESP CRIT CARE, V187, P206, DOI 10.1164/rccm.201203-0430OC.
   Minion J, 2011, EUR RESPIR J, V38, P1398, DOI 10.1183/09031936.00025711.
   Minion J, 2010, LANCET INFECT DIS, V10, P688, DOI 10.1016/S1473-3099(10)70165-1.
   MITCHISON DA, 1980, J ROY COLL PHYS LOND, V14, P91.
   MITCHISON DA, 1954, BRIT MED BULL, V10, P115, DOI 10.1093/oxfordjournals.bmb.a069388.
   Ovsyannikova IG, 2011, AAPS J, V13, P438, DOI 10.1208/s12248-011-9281-x.
   Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241.
   Park JH, 2009, J RHEUMATOL, V36, P2158, DOI 10.3899/jrheum.090150.
   Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656.
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688.
   Ramsay A, 2009, J TROP MED, V2009.
   Rangaka MX, 2012, CLIN INFECT DIS, V55, P1698, DOI 10.1093/cid/cis775.
   Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9.
   Reece ST, 2012, CURR OPIN MICROBIOL, V15, P63, DOI 10.1016/j.mib.2011.10.006.
   RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154.
   Sahota T, 2012, ANTIMICROB AGENTS CH, V56, P5442, DOI 10.1128/AAC.05988-11.
   Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3.
   Singapore Tuberculosis Service-British Medical Research Council, 1988, AM REV RESPIR DIS, V137, P1147.
   Singh JA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008794.pub2.
   Smieja MJ, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001363.
   Smith MY, 2012, INT J TUBERC LUNG D, V16, P1168, DOI 10.5588/ijtld.12.0029.
   Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875.
   STYBLO K, 1973, Therapeutische Umschau, V30, P199.
   STYBLO K, 1991, TUBERCULOSIS SURVEIL, V2, P60.
   Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270.
   Swaminathan S, 2010, AM J RESP CRIT CARE, V181, P743, DOI 10.1164/rccm.200903-0439OC.
   Taylor JL, 2012, CELL BIOL, P1.
   To KW, 2013, RESPIROLOGY, V18, P765, DOI 10.1111/resp.12106.
   Torok ME, 2011, CLIN INFECT DIS, V52, P1374, DOI 10.1093/cid/cir230.
   TOMAN K, 1976, WHO CHRON, V30, P51.
   Tubach F, 2009, ARTHRITIS RHEUM-US, V60, P1884, DOI 10.1002/art.24632.
   Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889.
   Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC.
   van't Hoog AH, 2011, INT J TUBERC LUNG D, V15, P1308, DOI 10.5588/ijtld.11.0004.
   Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC.
   Wang CC, 2013, RESPIROLOGY, V18, P412, DOI 10.1111/resp.12052.
   WHO, 2011, FLUOR LIGHT EM DIOD.
   World Health Organization, 2012, WHO TECH REP SER, P1.
   Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC.
   Yew WW, 2000, CHEST, V117, P744, DOI 10.1378/chest.117.3.744.
   Young D, 2008, NAT REV MICROBIOL, V6, P520, DOI 10.1038/nrmicro1919.
   Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320.
   Zhang Y, 2012, ANTIMICROB AGENTS CH, V56, P2223, DOI 10.1128/AAC.06288-11.
   Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789.}},
Number-of-Cited-References = {{106}},
Times-Cited = {{9}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{34}},
Journal-ISO = {{Respirology}},
Doc-Delivery-Number = {{224XJ}},
Unique-ID = {{ISI:000324925200004}},
DA = {{2018-08-13}},
}

@article{ ISI:000324861400008,
Author = {Daniels, Karla J. and Park, Yang-Nim and Srikantha, Thyagarajan and
   Pujol, Claude and Soll, David R.},
Title = {{Impact of Environmental Conditions on the Form and Function of Candida
   albicans Biofilms}},
Journal = {{EUKARYOTIC CELL}},
Year = {{2013}},
Volume = {{12}},
Number = {{10}},
Pages = {{1389-1402}},
Month = {{OCT}},
Abstract = {{Candida albicans, like other pathogens, can form complex biofilms on a
   variety of substrates. However, as the number of studies of gene
   regulation, architecture, and pathogenic traits of C. albicans biofilms
   has increased, so have differences in results. This suggests that
   depending upon the conditions employed, biofilms may vary widely, thus
   hampering attempts at a uniform description. Gene expression studies
   suggest that this may be the case. To explore this hypothesis further,
   we compared the architectures and traits of biofilms formed in RPMI 1640
   and Spider media at 37 degrees C in air. Biofilms formed by a/alpha
   cells in the two media differed to various degrees in cellular
   architecture, matrix deposition, penetrability by leukocytes,
   fluconazole susceptibility, and the facilitation of mating. Similar
   comparisons of a/a cells in the two media, however, were made difficult
   given that in air, although a/a cells form traditional biofilms in RPMI
   medium, they form polylayers composed primarily of yeast cells in Spider
   medium. These polylayers lack an upper hyphal/matrix region, are readily
   penetrated by leukocytes, are highly fluconazole susceptible, and do not
   facilitate mating. If, however, air is replaced with 20\% CO2, a/a cells
   make a biofilm in Spider medium similar architecturally to that of
   a/alpha cells, which facilitates mating. A second, more cursory
   comparison is made between the disparate cellular architectures of a/a
   biofilms formed in air in RPMI and Lee's media. The results demonstrate
   that C. albicans forms very different types of biofilms depending upon
   the composition of the medium, level of CO2 in the atmosphere, and
   configuration of the MTL locus.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Soll, DR (Reprint Author), Univ Iowa, Dept Biol, Dev Studies Hybridoma Bank, Iowa City, IA 52242 USA.
   Daniels, Karla J.; Park, Yang-Nim; Srikantha, Thyagarajan; Pujol, Claude; Soll, David R., Univ Iowa, Dept Biol, Dev Studies Hybridoma Bank, Iowa City, IA 52242 USA.}},
DOI = {{10.1128/EC.00127-13}},
ISSN = {{1535-9778}},
Keywords-Plus = {{HYPHAL DEVELOPMENT; ANTIFUNGAL AGENTS; DRUG-RESISTANCE; OPAQUE CELLS;
   IN-VITRO; WHITE; MATRIX; VIRULENCE; DELETION; RECEPTOR}},
Research-Areas = {{Microbiology; Mycology}},
Web-of-Science-Categories  = {{Microbiology; Mycology}},
Author-Email = {{david-soll@uiowa.edu}},
Funding-Acknowledgement = {{Developmental Studies Hybridoma Bank (DSHB), an NIH National Resource}},
Funding-Text = {{This research was funded by the Developmental Studies Hybridoma Bank
   (DSHB), an NIH National Resource.}},
Cited-References = {{Allison DG, 2003, BIOFOULING, V19, P139, DOI 10.1080/0892701031000072190.
   ANDERSON JM, 1987, J BACTERIOL, V169, P5579, DOI 10.1128/jb.169.12.5579-5588.1987.
   Baillie GS, 2000, J ANTIMICROB CHEMOTH, V46, P397, DOI 10.1093/jac/46.3.397.
   BEDELL GW, 1979, INFECT IMMUN, V26, P348.
   Berggren K, 1999, ANAL BIOCHEM, V276, P129, DOI 10.1006/abio.1999.4364.
   Borth N, 2010, MICROBIOL-SGM, V156, P2962, DOI 10.1099/mic.0.041707-0.
   Calera JA, 2000, INFECT IMMUN, V68, P518, DOI 10.1128/IAI.68.2.518-525.2000.
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001.
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318.
   Daniels KJ, 2006, EMBO J, V25, P2240, DOI 10.1038/sj.emboj.7601099.
   Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12.
   Desai JV, 2013, MBIO, V4, DOI {[}10.1128/mBio.00637-12, DOI 10.1128/MBI0.00637-12].
   Di Poto A, 2009, BIOMATERIALS, V30, P3158, DOI 10.1016/j.biomaterials.2009.02.038.
   Domenech M, 2013, INFECT IMMUN, V81, P2606, DOI 10.1128/IAI.00491-13.
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002.
   Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1.
   ELORZA MV, 1983, J GEN MICROBIOL, V129, P1577.
   Ernst J F, 2000, Contrib Microbiol, V5, P98.
   Fanning S, 2012, EUKARYOT CELL, V11, P896, DOI 10.1128/EC.00103-12.
   Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475.
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415.
   Frank KL, 2007, INFECT IMMUN, V75, P4728, DOI 10.1128/IAI.00640-07.
   Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004.
   HAWSER SP, 1995, ANTIMICROB AGENTS CH, V39, P2128, DOI 10.1128/AAC.39.9.2128.
   Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050.
   Irie Y, 2008, CURR TOP MICROBIOL, V322, P67.
   JONES KL, 1949, J BACTERIOL, V57, P141.
   Joo HS, 2012, CHEM BIOL, V19, P1503, DOI 10.1016/j.chembiol.2012.10.022.
   Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073.
   Krueger KE, 2004, MICROBIOL-SGM, V150, P229, DOI 10.1099/mic.0.26792-0.
   Kuhn Duncan M, 2004, Curr Opin Investig Drugs, V5, P186.
   Leberer E, 1996, P NATL ACAD SCI USA, V93, P13217, DOI 10.1073/pnas.93.23.13217.
   LEE KL, 1975, SABOURAUDIA, V13, P148.
   Lin CH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003305.
   LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058.
   Lockhart SR, 2005, GENETICS, V169, P1883, DOI 10.1534/genetics.104.038737.
   Lockhart SR, 2002, GENETICS, V162, P737.
   Mah TF, 2012, FUTURE MICROBIOL, V7, P1061, DOI {[}10.2217/fmb.12.76, 10.2217/FMB.12.76].
   Midkiff J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025395.
   MOORE GE, 1967, J AMER MED ASSOC, V199, P519, DOI 10.1001/jama.199.8.519.
   Nikawa H, 2000, MYCOSES, V43, P139, DOI 10.1046/j.1439-0507.2000.00564.x.
   Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06.
   Nobile CJ, 2012, CELL, V148, P126, DOI 10.1016/j.cell.2011.10.048.
   Park YN, 2013, EUKARYOT CELL, V12, P1120, DOI 10.1128/EC.00112-13.
   Raines SM, 2013, J BIOL CHEM, V288, P6190, DOI 10.1074/jbc.M112.426197.
   Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005.
   Richard ML, 2005, EUKARYOT CELL, V4, P1493, DOI 10.1128/EC.4.8.1493-1502.2005.
   Sahni N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000363.
   Sahni N, 2009, EUKARYOT CELL, V8, P251, DOI 10.1128/EC.00320-08.
   Sanchez Z, 2013, APPL ENVIRON MICROB, V79, P1396, DOI 10.1128/AEM.02911-12.
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089.
   Sellam A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-25.
   Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163.
   Soll DR, 2014, INFECT GENET EVOL, V22, P235, DOI 10.1016/j.meegid.2013.07.013.
   SOLL DR, 1988, J CELL BIOCHEM, V37, P177, DOI 10.1002/jcb.240370205.
   Srikantha T, 2013, EUKARYOT CELL, V12, P875, DOI 10.1128/EC.00071-13.
   Srikantha T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002476.
   Wilson RB, 1999, J BACTERIOL, V181, P1868.
   Wu W, 2007, MOL MICROBIOL, V64, P1587, DOI 10.1111/j.1365-2958.2007.05759.x.
   Yi S, 2009, MOL MICROBIOL, V71, P925, DOI 10.1111/j.1365-2958.2008.06575.x.
   Yi S, 2008, MOL BIOL CELL, V19, P957, DOI 10.1091/mbc.E07-07-0688.
   Yi S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001117.
   Yi S, 2011, EUKARYOT CELL, V10, P753, DOI 10.1128/EC.05055-11.
   Yi S, 2011, MBIO, V2, DOI 10.1128/mBio.00237-10.
   Zhao X, 2006, MICROBIOL-SGM, V152, P2287, DOI 10.1099/mic.0.28959-0.}},
Number-of-Cited-References = {{65}},
Times-Cited = {{22}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{10}},
Journal-ISO = {{Eukaryot. Cell}},
Doc-Delivery-Number = {{224DE}},
Unique-ID = {{ISI:000324861400008}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000324082700015,
Author = {Tzevelekou, Theofani and Flampouri, Athanasia and Rikos, Andreas and
   Vazdirvanidis, Athanasios and Pantazopoulos, George and Skarmoutsos,
   Dionysios},
Title = {{Hot-water corrosion failure of a hard-drawn copper tube}},
Journal = {{ENGINEERING FAILURE ANALYSIS}},
Year = {{2013}},
Volume = {{33}},
Pages = {{176-183}},
Month = {{OCT}},
Abstract = {{Deoxidized high phosphorus copper (C12200, DHP-Cu) is the principal
   construction element in piping in water distribution systems and HVAC
   (Heating Ventilation and Air-Conditioning) installations due to its
   excellent thermal and electrical conductivity, formability, corrosion
   resistance and antimicrobial activity. However, design and installation
   deficiencies or aggressive environmental parameters, such as improper
   water quality, may lead to unexpected failures causing material losses
   and many times property damage incurring high costs of repair. A
   corroded copper water tube caused leakage in a hot water hydraulic
   installation. The leakage was reported after approximately 6 years in
   service. Tubes were disconnected from a hydraulic installation and
   samples were taken for failure investigation. Failure analysis findings
   suggest strongly that the leakage was caused by tube perforation from
   the inner waterside due to localized pitting corrosion. The main cause
   of the accelerated tube pitting corrosion was the improper water
   chemistry (especially high chlorine content and low pH) inducing
   chemical attack of copper leading to scale layers of cuprite, chlorides
   and sulfates. (C) 2013 Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Pantazopoulos, G (Reprint Author), ELKEME Hellen Res Ctr Met SA, 252 Pireaus Str, Athens 17778, Greece.
   Tzevelekou, Theofani; Flampouri, Athanasia; Rikos, Andreas; Vazdirvanidis, Athanasios; Pantazopoulos, George, ELKEME Hellen Res Ctr Met SA, Athens 17778, Greece.
   Skarmoutsos, Dionysios, Halcor SA Met Works, Oinofyta 32011, Greece.}},
DOI = {{10.1016/j.engfailanal.2013.04.020}},
ISSN = {{1350-6307}},
Keywords = {{DHP-copper; Pitting corrosion; Leakage failure; Corrosion deposits}},
Keywords-Plus = {{PITTING CORROSION; CRACKING; SYSTEMS}},
Research-Areas = {{Engineering; Materials Science}},
Web-of-Science-Categories  = {{Engineering, Mechanical; Materials Science, Characterization \& Testing}},
Author-Email = {{gpantaz@halcor.vionet.gr}},
ResearcherID-Numbers = {{Pantazopoulos, George/Q-3455-2016}},
ORCID-Numbers = {{Pantazopoulos, George/0000-0002-6416-3760}},
Cited-References = {{{[}Anonymous], EN1250222004 BS.
   {[}Anonymous], 1992, ASM HDB, V13.
   Cantor Abigail F, 2000, EFFECT CHLORINE CORR.
   Connolly James R, 2007, INTRO XRAY POWDER DI.
   Duffner DH, 2005, J FAIL ANAL PREV, V5, P79, DOI 10.1361/15477020522122.
   EDWARDS M, 1994, J AM WATER WORKS ASS, V86, P74.
   Farooqi Owais E, 2006, THESIS STATE U.
   Fernandes PJL, 1998, ENG FAIL ANAL, V5, P35, DOI 10.1016/S1350-6307(97)00029-0.
   Jia Z, 2011, J FAILURE ANAL PREVE, V11, P152.
   Jones D., 1996, PRINCIPLES PREVENTIO.
   Klug H.P., 1974, XRAY PROCEDURES POLY.
   Kuznicka B, 2009, ENG FAIL ANAL, V16, P2382, DOI 10.1016/j.engfailanal.2009.03.026.
   Lytle DA, 2010, CORROS SCI, V52, P1927, DOI 10.1016/j.corsci.2010.02.013.
   McDougal JL, 2005, J FAIL ANAL PREV, V5, P13, DOI 10.1361/15477020522140.
   Miyamoto H, 2012, ENG FAIL ANAL, V26, P108, DOI 10.1016/j.engfailanal.2012.07.006.
   MYERS JR, 1995, MATER PERFORMANCE, V34, P60.
   Olszewski A. M., 2007, J FAILURE ANAL PREVE, V7, P238.
   Pantazopoulos G, 2011, ENG FAIL ANAL, V18, P649, DOI 10.1016/j.engfailanal.2010.09.034.
   Pantazopoulos G, 2006, J FAIL ANAL PREV, V6, P8, DOI 10.1361/154770206X156204.
   Stevenson ME, 2005, J FAIL ANAL PREV, V5, P25, DOI 10.1361/154770205X76367.}},
Number-of-Cited-References = {{20}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{23}},
Journal-ISO = {{Eng. Fail. Anal.}},
Doc-Delivery-Number = {{213TI}},
Unique-ID = {{ISI:000324082700015}},
DA = {{2018-08-13}},
}

@article{ ISI:000330094700052,
Author = {Burch, Tucker R. and Sadowsky, Michael J. and LaPara, Timothy M.},
Title = {{Air-Drying Beds Reduce the Quantities of Antibiotic Resistance Genes and
   Class 1 Integrons in Residual Municipal Wastewater Solids}},
Journal = {{ENVIRONMENTAL SCIENCE \& TECHNOLOGY}},
Year = {{2013}},
Volume = {{47}},
Number = {{17}},
Pages = {{9965-9971}},
Month = {{SEP 3}},
Abstract = {{This study investigated whether air-drying beds reduce antibiotic
   resistance gene (ARC) concentrations in residual municipal wastewater
   solids. Three laboratory-scale drying beds were operated for a period of
   nearly 100 days. Real-time PCR was used to quantify 16S rRNA genes, 16S
   rRNA genes specific to fecal bacteria (AllBac) and human fecal bacteria
   (HF183), the integrase gene of class 1 integrons (intI1), and five ARGs
   representing a cross-section of antibiotic classes and resistance
   mechanisms (erm(B), sul1, tet(A), tet(W), and tet(X)). Air-drying beds
   were capable of reducing all gene target concentrations by 1 to 5 orders
   of magnitude, and the nature of this reduction was consistent with both
   a net decrease in the number of bacterial cells and a lack of selection
   within the microbial community. Half-lives varied between 1.5 d (HF183)
   and 5.4 d (tet(X)) during the first 20 d of treatment. After the first
   20 d of treatment, however, half-lives varied between 8.6 d (tet(X)) and
   19.3 d (AllBac), and 16S rRNA gene, intI1, and sul1 concentrations did
   not change (P > 0.05). These results demonstrate that air-drying beds
   can reduce ARG and intI1 concentrations in residual municipal wastewater
   solids within timeframes typical of operating practices.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{LaPara, TM (Reprint Author), Univ Minnesota, Dept Civil Engn, 500 Pillsbury Dr Southeast, Minneapolis, MN 55455 USA.
   Burch, Tucker R.; LaPara, Timothy M., Univ Minnesota, Dept Civil Engn, Minneapolis, MN 55455 USA.
   Sadowsky, Michael J.; LaPara, Timothy M., Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA.
   Sadowsky, Michael J., Univ Minnesota, Dept Soil Water \& Climate, St Paul, MN 55108 USA.}},
DOI = {{10.1021/es4024749}},
ISSN = {{0013-936X}},
EISSN = {{1520-5851}},
Keywords-Plus = {{16S RIBOSOMAL-RNA; REAL-TIME PCR; SEWAGE-TREATMENT PLANTS; TETRACYCLINE
   RESISTANCE; ACTIVATED-SLUDGE; FECAL POLLUTION; STREPTOGRAMIN-B; AQUATIC
   SYSTEMS; QUANTIFICATION; BACTERIA}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences}},
Author-Email = {{lapar001@umn.edu}},
ResearcherID-Numbers = {{Sadowsky, Michael/J-2507-2016}},
ORCID-Numbers = {{Sadowsky, Michael/0000-0001-8779-2781}},
Funding-Acknowledgement = {{National Science Foundation {[}0967176]}},
Funding-Text = {{This work was supported by grant 0967176 from the National Science
   Foundation.}},
Cited-References = {{Aminov RI, 2001, APPL ENVIRON MICROB, V67, P22, DOI 10.1128/AEM.67.1.22-32.2001.
   Auerbach EA, 2007, WATER RES, V41, P1143, DOI 10.1016/j.watres.2006.11.045.
   Beecher N., 2007, FINAL REPORT NATL BI.
   Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P4571, DOI 10.1128/AEM.66.10.4571-4574.2000.
   Borjesson S., 2009, WATER RES, V43, P925.
   Borjesson S, 2009, INT J ENVIRON HEAL R, V19, P219, DOI 10.1080/09603120802449593.
   Burch T. R., 2013, FRONT MICROBIOL, V4, DOI DOI 10.3389/FMICB.2013.00017/ABSTRACT.
   Chen J, 2007, APPL ENVIRON MICROB, V73, P4407, DOI 10.1128/AEM.02799-06.
   Cook R. D., 1999, APPL REGRESSION INCL.
   Diehl DL, 2010, ENVIRON SCI TECHNOL, V44, P9128, DOI 10.1021/es102765a.
   Engemann CA, 2008, ENVIRON SCI TECHNOL, V42, P5131, DOI 10.1021/es800238e.
   Engemann CA, 2006, FEMS MICROBIOL LETT, V263, P176, DOI 10.1111/j.1574-6968.2006.00419.x.
   Ghosh S, 2009, APPL MICROBIOL BIOT, V84, P791, DOI 10.1007/s00253-009-2125-2.
   Goldstein C, 2001, ANTIMICROB AGENTS CH, V45, P723, DOI 10.1128/AAC.45.3.723-726.2001.
   Heuer H, 2007, ENVIRON MICROBIOL, V9, P657, DOI 10.1111/j.1462-2920.2006.01185.x.
   Kim S, 2010, CHEMOSPHERE, V78, P1071, DOI 10.1016/j.chemosphere.2009.12.068.
   Lachmayr KL, 2009, APPL ENVIRON MICROB, V75, P203, DOI 10.1128/AEM.01254-08.
   LaPara TM, 2011, ENVIRON SCI TECHNOL, V45, P9543, DOI 10.1021/es202775r.
   Layton A, 2006, APPL ENVIRON MICROB, V72, P4214, DOI 10.1128/AEM.01036-05.
   Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145.
   Levy SB, 1999, ANTIMICROB AGENTS CH, V43, P1523.
   Levy SB, 2002, ANTIBIOTIC PARADOX M.
   Ma YJ, 2011, ENVIRON SCI TECHNOL, V45, P7855, DOI 10.1021/es200827t.
   Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462.
   Munir M, 2011, WATER RES, V45, P681, DOI 10.1016/j.watres.2010.08.033.
   MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695.
   Ng LK, 2001, MOL CELL PROBE, V15, P209, DOI 10.1006/mcpr.2001.0363.
   Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es0604131.
   Roberts MC, 1999, ANTIMICROB AGENTS CH, V43, P2823.
   Rogers SW, 2011, APPL ENVIRON MICROB, V77, P4839, DOI 10.1128/AEM.02427-10.
   Sambrook J, 1989, MOL CLONING LAB MANU.
   Seurinck S, 2005, ENVIRON MICROBIOL, V7, P249, DOI 10.1111/j.1462-2920.2004.00702.x.
   Stalder T., 2012, FRONT MICROBIOL, V3, DOI DOI 10.3389/FMICB.2012.00119/ABSTRACT.
   Tchobanoglous G., 2003, WASTEWATER ENG TREAT.
   Uyaguari MI, 2011, APPL ENVIRON MICROB, V77, P8226, DOI 10.1128/AEM.02732-10.
   Volkmann H., 2004, J MICROBIOL METH, V56, P277.
   Zhang T, 2009, ENVIRON SCI TECHNOL, V43, P3455, DOI 10.1021/es803309m.
   Zhang W, 2009, ENVIRON SCI TECHNOL, V43, P7643, DOI 10.1021/es9014508.
   Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x.
   Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{19}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{73}},
Journal-ISO = {{Environ. Sci. Technol.}},
Doc-Delivery-Number = {{295CR}},
Unique-ID = {{ISI:000330094700052}},
DA = {{2018-08-13}},
}

@article{ ISI:000337900600009,
Author = {Kompala, Tejaswi and Shenoi, Sheela V. and Friedland, Gerald},
Title = {{Transmission of Tuberculosis in Resource-Limited Settings}},
Journal = {{CURRENT HIV/AIDS REPORTS}},
Year = {{2013}},
Volume = {{10}},
Number = {{3}},
Pages = {{264-272}},
Month = {{SEP}},
Abstract = {{Unrecognized transmission is a major contributor to ongoing TB epidemics
   in high-burden, resource-constrained settings. Limitations in diagnosis,
   treatment, and infection control in health-care and community settings
   allow for continued transmission of drug-sensitive and drug-resistant
   TB, particularly in regions of high HIV prevalence. Health-care
   facilities are common sites of TB transmission. Improved implementation
   of infection control practices appropriate for the local setting and in
   combination, has been associated with reduced transmission. Community
   settings account for the majority of TB transmission and deserve
   increased focus. Strengthening and intensifying existing high-yield
   strategies, including household contact tracing, can reduce onward TB
   transmission. Recent studies documenting high transmission risk
   community sites and strategies for community-based intensive case
   finding hold promise for feasible, effective transmission reduction.
   Infection control in community settings has been neglected and requires
   urgent attention. Developing and implementing improved strategies for
   decreasing transmission to children, within prisons and of
   drug-resistant TB are needed.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Friedland, G (Reprint Author), Yale Univ, Sch Med, 135 Coll St,AIDS Suite 323, New Haven, CT 06520 USA.
   Kompala, Tejaswi, Boston Univ, Sch Med, Boston, MA 02118 USA.
   Kompala, Tejaswi, Philanjalo Care Ctr, Tugela Ferry, South Africa.
   Shenoi, Sheela V.; Friedland, Gerald, Yale Univ, Sch Med, New Haven, CT 06520 USA.}},
DOI = {{10.1007/s11904-013-0164-x}},
ISSN = {{1548-3568}},
EISSN = {{1548-3576}},
Keywords = {{Tuberculosis; Transmission; Resource-limited setting; South Africa;
   Infection control; Nosocomial; MDR/XDRTB; Ventilation; UV light;
   Household contact}},
Keywords-Plus = {{DRUG-RESISTANT TUBERCULOSIS; HEALTH-CARE WORKERS; AIRBORNE
   INFECTION-CONTROL; RURAL SOUTH-AFRICA; MULTIDRUG-RESISTANT; NOSOCOMIAL
   TRANSMISSION; NATURAL VENTILATION; HIGH HIV; COMMUNITY; RISK}},
Research-Areas = {{Infectious Diseases}},
Web-of-Science-Categories  = {{Infectious Diseases}},
Author-Email = {{tkompala@gmail.com
   sheela.shenoi@yale.edu
   gerald.friedland@yale.edu}},
ORCID-Numbers = {{Shenoi, Sheela/0000-0001-7654-4344}},
Funding-Acknowledgement = {{NIMH NIH HHS {[}P30 MH062294]; NIAID NIH HHS {[}K23 AI089260]}},
Cited-References = {{Andrews JR, 2013, AM J EPIDEMIOL, V177, P556, DOI 10.1093/aje/kws331.
   Ayles H, 2011, 42 UN WORLD C LUNG H.
   Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5.
   Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106.
   Becerra MC, 2011, LANCET, V377, P147, DOI 10.1016/S0140-6736(10)61972-1.
   Brust JCM, 2012, INT J TUBERC LUNG D, V16, P998, DOI 10.5588/ijtld.11.0713.
   Claassens M, 2013, S AFRICA PLOS MED, V8.
   Cooke GS, 2011, EMERG INFECT DIS, V17, P2035, DOI 10.3201/eid1711.110291.
   Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0.
   Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC.
   Escombe AR, 2010, INT J TUBERC LUNG D, V14, P1120.
   Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068.
   Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043.
   Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188.
   Friedland G, 2012, 43 UN WORLD C LUNG H.
   Friedland G, 2008, INT J TUBERC LUNG D, V12, P585.
   Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1.
   Gandhi NR, 2013, J INFECT DIS, V207, P9, DOI 10.1093/infdis/jis631.
   Grandjean L, 2011, INT J TUBERC LUNG D, V15, P1164, DOI 10.5588/ijtld.11.0030.
   Jiamjarasrangsi W, 2009, INT J TUBERC LUNG D, V13, P454.
   Johnstone-Robertson S, 2011, SAMJ S AFR MED J, V101, P809.
   Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251.
   Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494.
   Kanjee Z, 2012, J Infect Public Health, V5, P67, DOI 10.1016/j.jiph.2011.10.008.
   Kranzer K, 2010, SAMJ S AFR MED J, V100, P224, DOI 10.7196/SAMJ.3903.
   Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3.
   Li X, 2007, J INFECT DIS, V195, P864, DOI 10.1086/511985.
   Lygizos M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-300.
   Menzies D, 2007, INT J TUBERC LUNG D, V11, P593.
   Menzies D, 2000, ANN INTERN MED, V133, P779, DOI 10.7326/0003-4819-133-10-200011210-00010.
   Middelkoop K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-156.
   Moodley P, 2011, PLOS MED, P6.
   Nardell E, 2010, INT J TUBERC LUNG D, V14, P1233.
   O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008.
   O'Grady J, 2011, TUBERCULOSIS, V91, P173, DOI 10.1016/j.tube.2010.12.002.
   Panlilio Adelisa L., 2005, Morbidity and Mortality Weekly Report, V54, P1.
   RILEY RL, 1957, AM REV TUBERC PULM, V75, P420.
   RILEY RL, 1957, AM REV TUBERC PULM, V76, P931.
   RILEY RL, 1962, AM REV RESPIR DIS, V85, P511.
   Schaaf HS, 2003, INT J TUBERC LUNG D, V7, P426.
   Shapiro AE, 2012, AM J RESP CRIT CARE, V185, P1110, DOI 10.1164/rccm.201111-1941OC.
   Shenoi SV, 2013, PUBLIC HEALTH ACTION, V3, P46, DOI 10.5588/pha.12.0056.
   Shenoi SV, 2010, CLIN INFECT DIS, V50, pS231, DOI 10.1086/651496.
   Shenoi SV, 2012, HIGH YIELD COMMUNITY.
   Sotgiu G, 2008, INT J TUBERC LUNG D, V12, P606.
   Thomas TA, 2010, INT J TUBERC LUNG D, V14, P1244.
   Vella V, 2011, INT J TUBERC LUNG D, V15, P1170, DOI 10.5588/ijtld.10.0781.
   WALLGREN A, 1948, Tubercle, V29, P245, DOI 10.1016/S0041-3879(48)80033-4.
   Wells W.F., 1955, AIRBORNE CONTAGION A.
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1.
   Winetsky DE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001348.
   Wood R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039246.
   Wood R, 2010, CLIN INFECT DIS, V51, P401, DOI 10.1086/655129.
   World Health Organization, 2009, WHO POL TB INF CONTR.
   World Health Organization, 2010, MULT EXT DRUG RES TU.
   World Health Organization, 2011, WHO HIV TB FACTS.
   World Health Organization, 2013, WHAT IS MULT RES TUB.
   Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789.}},
Number-of-Cited-References = {{58}},
Times-Cited = {{17}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{9}},
Journal-ISO = {{Curr. Hiv/Aids Rep.}},
Doc-Delivery-Number = {{AJ7TP}},
Unique-ID = {{ISI:000337900600009}},
OA = {{green\_accepted}},
DA = {{2018-08-13}},
}

@article{ ISI:000325902600007,
Author = {Gartner, A. and Gessner, A. and Martin, E. and Schneider, D. and Jackel,
   U.},
Title = {{Emissions from poultry houses - Investigation on the composition of
   bacterial community and antibiotic resistance - Part 1: Concept and
   methodical approach}},
Journal = {{GEFAHRSTOFFE REINHALTUNG DER LUFT}},
Year = {{2013}},
Volume = {{73}},
Number = {{9}},
Pages = {{372-374}},
Month = {{SEP}},
Abstract = {{The goal of the joint project of the North Rhine-Westphalian State
   Agency for Nature, Environment and Consumer Protection (LANUV NRW) and
   the Federal Institute for Occupational Safety and Health (BAuA) is the
   determination of antibiotic resistant bacteria in the exhaust air of
   broiler houses. For this purpose commercial selective nutrition media
   are used to test the suitability for the quantification and
   qualification of bacterial species and genera. Furthermore, quantitative
   and qualitative cultivation independent analyses regarding the airborne
   bacteria are made. Here, the concept and the proceedings of the project
   are presented.}},
Publisher = {{SPRINGER-V D I VERLAG GMBH \& CO KG}},
Address = {{VDI-PLATZ 1, D-40468 DUSSELDORF, GERMANY}},
Type = {{Article}},
Language = {{German}},
Affiliation = {{Gartner, A (Reprint Author), Landesamt Nat Umwelt \& Verbraucherschutz Nordrhei, Dienstort Essen, Germany.
   Gartner, A.; Gessner, A., Landesamt Nat Umwelt \& Verbraucherschutz Nordrhei, Dienstort Essen, Germany.
   Martin, E.; Schneider, D.; Jackel, U., Bundesanstalt Arbeitsschutz \& Arbeitsmed, Berlin, Germany.}},
ISSN = {{0949-8036}},
EISSN = {{1436-4891}},
Keywords-Plus = {{STAPHYLOCOCCUS-AUREUS; AIRBORNE BACTERIA; SOIL SURFACES; AIR;
   IDENTIFICATION; CONTAMINATION; VICINITY; BARNS}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Engineering, Civil; Environmental Sciences}},
ResearcherID-Numbers = {{Amoako, Daniel Gyamfi/I-4223-2018}},
Cited-References = {{Albrecht A, 2006, GEFAHRST REINHALT L, V66, P365.
   {[}Anonymous], 2013, 4251 VDI.
   {[}Anonymous], 2007, 4251 VDI.
   {[}Anonymous], 2012, 4253 VDI.
   {[}Anonymous], 2011, 4257 VDI.
   Friese A, 2013, APPL ENVIRON MICROB, V79, P2759, DOI 10.1128/AEM.03939-12.
   Gartner A, 2008, GEFAHRST REINHALT L, V68, P351.
   Gartner A., 2011, IMMISSIONSSCHUTZ, V16, P24.
   Gessner A., 2011, GEFAHRSTOFFE REINHAL, V71, P362.
   Martin E, 2012, GEFAHRST REINHALT L, V72, P99.
   Martin E, 2009, GEFAHRST REINHALT L, V69, P97.
   Martin E, 2011, J ENVIRON MONITOR, V13, P464, DOI 10.1039/c0em00272k.
   Martin E, 2010, ANN OCCUP HYG, V54, P217, DOI 10.1093/annhyg/mep088.
   Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12.
   Uberarbeiteter Abschlussbericht, 2012, UB ABSCHL EV ANT HAH.
   Yoon JH, 2003, INT J SYST EVOL MICR, V53, P595, DOI 10.1099/ijs.0.02132-0.}},
Number-of-Cited-References = {{16}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{6}},
Journal-ISO = {{Gefahrst. Reinhalt. Luft}},
Doc-Delivery-Number = {{237WT}},
Unique-ID = {{ISI:000325902600007}},
DA = {{2018-08-13}},
}

@article{ ISI:000323804400006,
Author = {Leung, C. C.},
Title = {{2012: The year in review. Part II: Tuberculosis and lung disease}},
Journal = {{INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE}},
Year = {{2013}},
Volume = {{17}},
Number = {{9}},
Pages = {{1151-1159}},
Month = {{SEP}},
Publisher = {{INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)}},
Address = {{68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Leung, CC (Reprint Author), Dept Hlth, TB \& Chest Serv, Hong Kong, Hong Kong, Peoples R China.
   Dept Hlth, TB \& Chest Serv, Hong Kong, Hong Kong, Peoples R China.}},
DOI = {{10.5588/ijtld.13.0385}},
ISSN = {{1027-3719}},
Keywords-Plus = {{MULTIDRUG-RESISTANT TUBERCULOSIS; HIV-INFECTED PATIENTS; OBSTRUCTIVE
   PULMONARY-DISEASE; SMEAR-NEGATIVE TUBERCULOSIS; XPERT(R) MTB/RIF ASSAY;
   AIR-FLOW OBSTRUCTION; HEALTH-CARE WORKERS; MYCOBACTERIUM-TUBERCULOSIS;
   RISK-FACTORS; ANTIRETROVIRAL THERAPY}},
Research-Areas = {{Infectious Diseases; Respiratory System}},
Web-of-Science-Categories  = {{Infectious Diseases; Respiratory System}},
Author-Email = {{cc\_leung@dh.gov.hk}},
Cited-References = {{Abughosh S, 2012, INT J TUBERC LUNG D, V16, P1551, DOI 10.5588/ijtld.12.0152.
   Adair T, 2012, INT J TUBERC LUNG D, V16, P1699, DOI 10.5588/ijtld.12.0251.
   Adesokan HK, 2012, INT J TUBERC LUNG D, V16, P1388, DOI 10.5588/ijtld.12.0109.
   Alavi-Naini R, 2012, INT J TUBERC LUNG D, V16, P1383, DOI 10.5588/ijtld.11.0827.
   Althomsons SP, 2012, INT J TUBERC LUNG D, V16, P1331, DOI 10.5588/ijtld.11.0812.
   Alvarez GG, 2012, INT J TUBERC LUNG D, V16, P1247, DOI 10.5588/ijtld.11.0743.
   Au-Yeung KY, 2012, INT J TUBERC LUNG D, V16, P1498, DOI 10.5588/ijtld.11.0868.
   Auf RA, 2012, INT J TUBERC LUNG D, V16, P132, DOI 10.5588/ijtld.11.0457.
   Balcells ME, 2012, INT J TUBERC LUNG D, V16, P1349, DOI 10.5588/ijtld.12.0156.
   Barbosa CD, 2012, INT J TUBERC LUNG D, V16, P1377, DOI 10.5588/ijtld.11.0709.
   Bensenor IM, 2012, INT J TUBERC LUNG D, V16, P1692, DOI 10.5588/ijtld.12.0121.
   Bhushan B, 2012, INT J TUBERC LUNG D, V16, P1210, DOI 10.5588/ijtld.11.0778.
   Blondal K, 2012, INT J TUBERC LUNG D, V16, P1228, DOI 10.5588/ijtld.12.0037.
   Breton G, 2012, INT J TUBERC LUNG D, V16, P1365, DOI 10.5588/ijtld.11.0693.
   Chakrabarti S, 2012, INT J TUBERC LUNG D, V16, P1205, DOI 10.5588/ijtld.11.0501.
   Chen J, 2012, INT J TUBERC LUNG D, V16, P1686, DOI 10.5588/ijtld.12.0204.
   Chou PC, 2012, INT J TUBERC LUNG D, V16, P1674, DOI 10.5588/ijtld.11.0672.
   Commons RJ, 2012, INT J TUBERC LUNG D, V16, P670, DOI 10.5588/ijtld.11.0446.
   Conesa-Botella A, 2012, INT J TUBERC LUNG D, V16, P1517, DOI 10.5588/ijtld.11.0146.
   David S, 2012, INT J TUBERC LUNG D, V16, P1535, DOI 10.5588/ijtld.11.0658.
   Deng R, 2012, INT J TUBERC LUNG D, V16, P1574, DOI 10.5588/ijtld.12.0304.
   Denholm JT, 2012, INT J TUBERC LUNG D, V16, P1320, DOI 10.5588/ijtld.12.0092.
   Dhabadi BB, 2012, INT J TUBERC LUNG D, V16, P120, DOI 10.5588/ijtld.11.0195.
   Ellwood P, 2012, INT J TUBERC LUNG D, V16, P687, DOI 10.5588/ijtld.11.0226.
   Faurholt-Jepsen D, 2012, INT J TUBERC LUNG D, V16, P1680, DOI 10.5588/ijtld.12.0360.
   Gardner A, 2012, INT J TUBERC LUNG D, V16, P1241, DOI 10.5588/ijtld.11.0628.
   Gler MT, 2012, INT J TUBERC LUNG D, V16, P1326, DOI 10.5588/ijtld.12.0038.
   Hanifa Y, 2012, INT J TUBERC LUNG D, V16, P1252, DOI 10.5588/ijtld.11.0733.
   He GX, 2012, INT J TUBERC LUNG D, V16, P1485, DOI 10.5588/ijtld.12.0193.
   Henegar C, 2012, INT J TUBERC LUNG D, V16, P1199, DOI 10.5588/ijtld.11.0613.
   Heydari G, 2012, INT J TUBERC LUNG D, V16, P268, DOI {[}10.5588/ijtld.11.0183, 10.5588/ijtld.0183].
   Higuchi K, 2012, INT J TUBERC LUNG D, V16, P1190, DOI 10.5588/ijtld.11.0829.
   Holm M, 2012, INT J TUBERC LUNG D, V16, P553, DOI 10.5588/ijtld.11.0288.
   Hong SJ, 2012, INT J TUBERC LUNG D, V16, P1221, DOI 10.5588/ijtld.11.0782.
   Hou WL, 2012, INT J TUBERC LUNG D, V16, P1433, DOI 10.5588/ijtld.12.0080.
   Huang CT, 2012, INT J TUBERC LUNG D, V16, P539, DOI 10.5588/ijtld.11.0412.
   Isea-Pena MC, 2012, INT J TUBERC LUNG D, V16, P1400, DOI 10.5588/ijtld.12.0142.
   Jeremias E, 2012, INT J TUBERC LUNG D, V16, P273, DOI 10.5588/ijtld.11.0312.
   Jindal SK, 2012, INT J TUBERC LUNG D, V16, P1270, DOI 10.5588/ijtld.12.0005.
   Jung YJ, 2012, INT J TUBERC LUNG D, V16, P1300, DOI 10.5588/ijtld.12.0004.
   Jung YJ, 2012, INT J TUBERC LUNG D, V16, P262, DOI 10.5588/ijtld.10.0720.
   Kattan JA, 2012, INT J TUBERC LUNG D, V16, P1657, DOI 10.5588/ijtld.12.0169.
   Khabour OF, 2012, INT J TUBERC LUNG D, V16, P986, DOI 10.5588/ijtld.11.0764.
   Kim SY, 2012, INT J TUBERC LUNG D, V16, P1471, DOI 10.5588/ijtld.11.0602.
   Kim SY, 2012, INT J TUBERC LUNG D, V16, P1393, DOI 10.5588/ijtld.12.0147.
   Kizub D, 2012, INT J TUBERC LUNG D, V16, P1214, DOI 10.5588/ijtld.11.0626.
   Kolappan C, 2012, INT J TUBERC LUNG D, V16, P1315, DOI 10.5588/ijtld.12.0098.
   Kurbatova EV, 2012, INT J TUBERC LUNG D, V16, P1335, DOI 10.5588/ijtld.11.0811.
   Lam DCL, 2012, INT J TUBERC LUNG D, V16, P681, DOI 10.5588/ijtld.11.0283.
   Lawn SD, 2012, INT J TUBERC LUNG D, V16, P1354, DOI 10.5588/ijtld.12.0174.
   Lee J, 2012, INT J TUBERC LUNG D, V16, P1344, DOI 10.5588/ijtld.12.0113.
   Lehloenya RJ, 2012, INT J TUBERC LUNG D, V16, P1260, DOI 10.5588/ijtld.11.0187.
   Leung CC, 2012, INT J TUBERC LUNG D, V16, P546, DOI 10.5588/ijtld.11.0573.
   Li H, 2012, INT J TUBERC LUNG D, V16, P1668, DOI 10.5588/ijtld.12.0292.
   Lohmann EM, 2012, INT J TUBERC LUNG D, V16, P1477, DOI 10.5588/ijtld.12.0129.
   Mannino DM, 2012, INT J TUBERC LUNG D, V16, P1405, DOI 10.5588/ijtld.12.0054.
   Martinez V, 2012, INT J TUBERC LUNG D, V16, P1180, DOI 10.5588/ijtld.12.0010.
   Masekela R, 2012, INT J TUBERC LUNG D, V16, P114, DOI 10.5588/ijtld.11.0244.
   Middelkoop K, 2012, INT J TUBERC LUNG D, V16, P1510, DOI 10.5588/ijtld.12.0049.
   Mitchison DA, 2012, INT J TUBERC LUNG D, V16, P1186, DOI 10.5588/ijtld.11.0818.
   Miwa S, 2012, INT J TUBERC LUNG D, V16, P1265, DOI 10.5588/ijtld.11.0163.
   Miyake Y, 2012, INT J TUBERC LUNG D, V16, P974, DOI 10.5588/ijtld.11.0608.
   Miyake Y, 2012, INT J TUBERC LUNG D, V16, P756, DOI 10.5588/ijtld.11.0484.
   Miyake Y, 2012, INT J TUBERC LUNG D, V16, P255, DOI 10.5588/ijtld.11.0173.
   Mor Z, 2012, INT J TUBERC LUNG D, V16, P1613, DOI 10.5588/ijtld.12.0296.
   Naidoo S, 2012, INT J TUBERC LUNG D, V16, P1600, DOI 10.5588/ijtld.12.0041.
   Nansera D, 2012, INT J TUBERC LUNG D, V16, P1371, DOI 10.5588/ijtld.11.0589.
   Ntinginya EN, 2012, INT J TUBERC LUNG D, V16, P1468, DOI 10.5588/ijtld.12.0127.
   Okada K, 2012, INT J TUBERC LUNG D, V16, P1619, DOI 10.5588/ijtld.12.0201.
   Park BH, 2012, INT J TUBERC LUNG D, V16, P694, DOI 10.5588/ijtld.11.0180.
   Paulson ML, 2012, INT J TUBERC LUNG D, V16, P561, DOI 10.5588/ijtld.11.0301.
   PrayGod G, 2012, INT J TUBERC LUNG D, V16, P1455, DOI 10.5588/ijtld.11.0532.
   Radwan GN, 2012, INT J TUBERC LUNG D, V16, P1412, DOI 10.5588/ijtld.12.0079.
   Rathored J, 2012, INT J TUBERC LUNG D, V16, P1522, DOI 10.5588/ijtld.12.0122.
   Reid MJA, 2012, INT J TUBERC LUNG D, V16, P1605, DOI 10.5588/ijtld.12.0033.
   Ritchie LMP, 2012, INT J TUBERC LUNG D, V16, P1492, DOI 10.5588/ijtld.12.0206.
   Rose PC, 2012, INT J TUBERC LUNG D, V16, P1588, DOI 10.5588/ijtld.12.0322.
   Rutherford ME, 2012, INT J TUBERC LUNG D, V16, P1594, DOI 10.5588/ijtld.12.0389.
   Saidenberg-Kermanac'h N, 2012, INT J TUBERC LUNG D, V16, P1307, DOI 10.5588/ijtld.12.0111.
   Salinas J, 2012, INT J TUBERC LUNG D, V16, P1193, DOI 10.5588/ijtld.11.0476.
   Sasmono RT, 2012, INT J TUBERC LUNG D, V16, P1441, DOI 10.5588/ijtld.12.0055.
   Seung KJ, 2012, INT J TUBERC LUNG D, V16, P418, DOI 10.5588/ijtld.11.0280.
   Shah NS, 2012, INT J TUBERC LUNG D, V16, P1234, DOI 10.5588/ijtld.11.0794.
   Sharma SK, 2012, INT J TUBERC LUNG D, V16, P1505, DOI 10.5588/ijtld.12.0233.
   Shin SS, 2012, INT J TUBERC LUNG D, V16, P1538, DOI 10.5588/ijtld.12.0071.
   Shin SS, 2012, INT J TUBERC LUNG D, V16, P126, DOI 10.5588/ijtld.11.0044.
   Smith MY, 2012, INT J TUBERC LUNG D, V16, P1168, DOI 10.5588/ijtld.12.0029.
   Sonnenberg P, 2012, INT J TUBERC LUNG D, V16, P1449, DOI 10.5588/ijtld.12.0086.
   Story A, 2012, INT J TUBERC LUNG D, V16, P1461, DOI 10.5588/ijtld.11.0773.
   Sukhsohale ND, 2012, INT J TUBERC LUNG D, V16, P423, DOI 10.5588/ijtld.11.0621.
   Takuva S, 2012, INT J TUBERC LUNG D, V16, P1358, DOI 10.5588/ijtld.11.0769.
   Tee GH, 2012, INT J TUBERC LUNG D, V16, P1126, DOI 10.5588/ijtld.11.0254.
   Thind D, 2012, INT J TUBERC LUNG D, V16, P1643, DOI 10.5588/ijtld.12.0074.
   Tian J, 2012, INT J TUBERC LUNG D, V16, P674, DOI 10.5588/ijtld.11.0429.
   Ullah ANZ, 2012, INT J TUBERC LUNG D, V16, P1637, DOI 10.5588/ijtld.12.0378.
   van der Heijden YF, 2012, INT J TUBERC LUNG D, V16, P1162, DOI 10.5588/ijtld.12.0046.
   van der Kuyp F, 2012, INT J TUBERC LUNG D, V16, P1663, DOI 10.5588/ijtld.12.0238.
   Van Deun A, 2012, INT J TUBERC LUNG D, V16, P1174, DOI 10.5588/ijtld.11.0166.
   van't Hoog AH, 2012, INT J TUBERC LUNG D, V16, P1649, DOI 10.5588/ijtld.12.0135.
   Vu DH, 2012, INT J TUBERC LUNG D, V16, P1625, DOI 10.5588/ijtld.12.0295.
   Yasin SM, 2012, INT J TUBERC LUNG D, V16, P980, DOI 10.5588/ijtld.11.0748.
   Yoon SY, 2012, INT J TUBERC LUNG D, V16, P1544, DOI 10.5588/ijtld.12.0842.
   Zetola NM, 2012, INT J TUBERC LUNG D, V16, P1529, DOI 10.5588/ijtld.12.0026.
   Zhou C, 2012, INT J TUBERC LUNG D, V16, P1630, DOI 10.5588/ijtld.12.0227.}},
Number-of-Cited-References = {{104}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{14}},
Journal-ISO = {{Int. J. Tuberc. Lung Dis.}},
Doc-Delivery-Number = {{210BN}},
Unique-ID = {{ISI:000323804400006}},
DA = {{2018-08-13}},
}

@article{ ISI:000324177100001,
Author = {Huang, Zhuojie and Tatem, Andrew J.},
Title = {{Global malaria connectivity through air travel}},
Journal = {{MALARIA JOURNAL}},
Year = {{2013}},
Volume = {{12}},
Month = {{AUG 2}},
Abstract = {{Background: Air travel has expanded at an unprecedented rate and
   continues to do so. Its effects have been seen on malaria in rates of
   imported cases, local outbreaks in non-endemic areas and the global
   spread of drug resistance. With elimination and global eradication back
   on the agenda, changing levels and compositions of imported malaria in
   malaria-free countries, and the threat of artemisinin resistance
   spreading from Southeast Asia, there is a need to better understand how
   the modern flow of air passengers connects each Plasmodium
   falciparum-and Plasmodium vivax-endemic region to the rest of the world.
   Methods: Recently constructed global P. falciparum and P. vivax malaria
   risk maps, along with data on flight schedules and modelled passenger
   flows across the air network, were combined to describe and quantify
   global malaria connectivity through air travel. Network analysis
   approaches were then utilized to describe and quantify the patterns that
   exist in passenger flows weighted by malaria prevalence. Finally, the
   connectivity within and to the Southeast Asia region where the threat of
   imported artemisinin resistance arising is highest, was examined to
   highlight risk routes for its spread.
   Results: The analyses demonstrate the substantial connectivity that now
   exists between and from malaria-endemic regions through air travel.
   While the air network provides connections to previously isolated
   malarious regions, it is clear that great variations exist, with
   significant regional communities of airports connected by higher rates
   of flow standing out. The structures of these communities are often not
   geographically coherent, with historical, economic and cultural ties
   evident, and variations between P. falciparum and P. vivax clear.
   Moreover, results highlight how well connected the malaria-endemic areas
   of Africa are now to Southeast Asia, illustrating the many possible
   routes that artemisinin-resistant strains could take.
   Discussion: The continuing growth in air travel is playing an important
   role in the global epidemiology of malaria, with the endemic world
   becoming increasingly connected to both malaria-free areas and other
   endemic regions. The research presented here provides an initial effort
   to quantify and analyse the connectivity that exists across the
   malaria-endemic world through air travel, and provide a basic assessment
   of the risks it results in for movement of infections.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Huang, ZJ (Reprint Author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.
   Huang, Zhuojie, Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.
   Huang, Zhuojie, Penn State Univ, Dept Biol, University Pk, PA 16802 USA.
   Huang, Zhuojie, Univ Florida, Dept Geog, Gainesville, FL 32611 USA.
   Huang, Zhuojie, Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   Tatem, Andrew J., Univ Southampton, Dept Geog \& Environm, Southampton, Hants, England.
   Tatem, Andrew J., NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA.}},
DOI = {{10.1186/1475-2875-12-269}},
Article-Number = {{UNSP 269}},
ISSN = {{1475-2875}},
Keywords-Plus = {{PLASMODIUM-FALCIPARUM; ARTEMISININ RESISTANCE; IMPORTED MALARIA;
   PARASITE CLEARANCE; AIRPORT MALARIA; RISK; ELIMINATION; CENTRALITY;
   MOVEMENT; AFRICA}},
Research-Areas = {{Infectious Diseases; Parasitology; Tropical Medicine}},
Web-of-Science-Categories  = {{Infectious Diseases; Parasitology; Tropical Medicine}},
Author-Email = {{seenhzj@gmail.com}},
Funding-Acknowledgement = {{Bill and Melinda Gates Foundation {[}49446, 1032350]; NIH/NIAID
   {[}U19AI089674]; RAPIDD program of the Science \& Technology
   Directorate, Department of Homeland Security; Fogarty International
   Center, National Institutes of Health, USA}},
Funding-Text = {{We thank Dr Peter Gething and Professor Simon Hay for sharing the
   malaria datasets. AJT is supported by grants from the Bill and Melinda
   Gates Foundation (\#49446, \#1032350) and NIH/NIAID (\#U19AI089674). AJT
   also acknowledges funding support from the RAPIDD program of the Science
   \& Technology Directorate, Department of Homeland Security, and the
   Fogarty International Center, National Institutes of Health, USA. This
   work forms part of the output of the Vector-borne disease airport
   importation risk project (www.vbd-air.com) and the human mobility
   mapping project (www.thummp.org).}},
Cited-References = {{Abanyie FA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-340.
   Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562.
   Askling HH, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-328.
   Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101.
   BAUER DF, 1972, J AM STAT ASSOC, V67, P687, DOI 10.2307/2284469.
   Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008.
   Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249.
   Brons M, 2002, J AIR TRANSP MANAG, V8, P165, DOI 10.1016/S0969-6997(01)00050-3.
   {*}CDCP, 2002, MMWR-MORBID MORTAL W, V51, P921.
   Centers for Disease Control and Prevention, 2003, MMWR-MORBID MORTAL W, V52, P908.
   Checkley AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2116.
   Chiyaka C, 2013, SCIENCE, V339, P909, DOI 10.1126/science.1229509.
   Cohen JM, 2012, SCIENCE, V338, P612, DOI 10.1126/science.1229045.
   Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122.
   Danis K, 2011, EUROSURVEILLANCE, V16, P1.
   Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331.
   Fairhurst RM, 2012, AM J TROP MED HYG, V87, P231, DOI 10.4269/ajtmh.2012.12-0025.
   Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339.
   Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002.
   FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543.
   Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814.
   Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378.
   Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92.
   Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102.
   Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6.
   Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265.
   HUANG Z, 2010, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0064317.
   Huang ZJ, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-33.
   International Air Transport Association (IATA), 2012, IATA 2012 ANN REV.
   ISAACSON M, 1989, B WORLD HEALTH ORGAN, V67, P737.
   Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432.
   Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616.
   Khan K, 2012, LANCET INFECT DIS, V12, P222, DOI 10.1016/S1473-3099(11)70313-9.
   Le Menach A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00093.
   LEPERS JP, 1988, LANCET, V1, P586.
   Linard C., 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0031743.
   Loupa CV, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-52.
   Mita T, 2011, J INFECT DIS, V204, P1980, DOI 10.1093/infdis/jir664.
   Naidoo I, 2010, TRENDS PARASITOL, V26, P447, DOI 10.1016/j.pt.2010.05.001.
   Newman MEJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056131.
   Nilles EJ, 2012, AM J EMERG MED, V30, P972, DOI 10.1016/j.ajem.2011.06.016.
   O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7.
   Odolini S, 2012, CLIN MICROBIOL INFEC, V18, P468, DOI 10.1111/j.1469-0691.2011.03596.x.
   OKELLY ME, 1986, TRANSPORT SCI, V20, P92, DOI 10.1287/trsc.20.2.92.
   Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X.
   Pindolia DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-205.
   Talisuna A, 2012, LANCET INFECT DIS, V12, P888, DOI 10.1016/S1473-3099(12)70241-4.
   Tatarsky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023832.
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352.
   Tatem AJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-57.
   Tatem AJ, 2012, AIDS, V26, P2351, DOI 10.1097/QAD.0b013e328359a904.
   Tatem AJ, 2010, P NATL ACAD SCI USA, V107, P12222, DOI 10.1073/pnas.1002971107.
   Tatem AJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-287.
   Thang HD, 2002, NETH J MED, V60, P441.
   Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12.
   UCSF Global Health Group and Malaria Atlas Project, 2011, ATL MAL EL COUNTR.
   Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467.
   WHO, 2010, GLOB REP ANT DRUG EF.
   WHO (World Health Organization), 2007, WORLD HLTH REP 2007.
   Widmer LL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-279.
   WIJESUNDERA MD, 1988, PARASITOL TODAY, V4, P147, DOI 10.1016/0169-4758(88)90193-7.}},
Number-of-Cited-References = {{61}},
Times-Cited = {{22}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{22}},
Journal-ISO = {{Malar. J.}},
Doc-Delivery-Number = {{214YZ}},
Unique-ID = {{ISI:000324177100001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000326733200010,
Author = {Apisarnthanarak, Anucha and Warren, David K. and Mayhall, Clovus Glen},
Title = {{Healthcare-associated infections and their prevention after extensive
   flooding}},
Journal = {{CURRENT OPINION IN INFECTIOUS DISEASES}},
Year = {{2013}},
Volume = {{26}},
Number = {{4}},
Pages = {{359-365}},
Month = {{AUG}},
Abstract = {{Purpose of reviewThis review will focus on the epidemiology of
   healthcare-associated infections (HAIs) after extensive blackwater
   flooding as well as preventive measures.Recent findingsThere is evidence
   suggesting an increased incidence of HAIs and pseudo-outbreaks due to
   molds after extensive flooding in healthcare facilities. However, there
   is no strong evidence of an increased incidence of typical nosocomial
   infections (i.e., ventilator-associated pneumonia, healthcare-associated
   pneumonia, central line-associated bloodstream infection and
   catheter-associated urinary tract infections). The prevalence of
   multidrug-resistant organisms may decrease after extensive flooding, due
   to repeated and thorough environmental cleaning prior to re-opening
   hospitals. Contamination of hospital water sources by enteric
   Gram-negative bacteria (e.g., Aeromonas species), Legionella species and
   nontuberculous Mycobacterium species in flood-affected hospitals has
   been reported. Surveillance is an important initial step to detect
   potential outbreaks/pseudo-outbreaks of HAIs. Hospital preparedness
   policies before extensive flooding, particularly with environmental
   cleaning and mold remediation, are key to reducing the risk of
   flood-related HAIs. These policies are still lacking in most hospitals
   in countries that have experienced or are at risk for extensive
   flooding, which argues for nationwide policies to strengthen
   preparedness planning.SummaryAdditional studies are needed to evaluate
   the epidemiology of flood-related HAIs and the optimal surveillance and
   control methods following extensive flooding.}},
Publisher = {{LIPPINCOTT WILLIAMS \& WILKINS}},
Address = {{530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Apisarnthanarak, A (Reprint Author), Thammasat Univ Hosp, Fac Med, Div Infect Dis, Pathum Thani 12120, Thailand.
   Apisarnthanarak, Anucha, Thammasat Univ Hosp, Div Infect Dis, Pathum Thani 12120, Thailand.
   Warren, David K., Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA.
   Mayhall, Clovus Glen, Univ Texas Med Branch, Dept Healthcare Epidemiol, Galveston, TX 77555 USA.}},
DOI = {{10.1097/QCO.0b013e3283630b1d}},
ISSN = {{0951-7375}},
EISSN = {{1473-6527}},
Keywords = {{black water; cross infection; floods; hospital; infection control;
   infections}},
Keywords-Plus = {{CONTAMINATED ICE MACHINE; SOFT-TISSUE INFECTIONS; PSEUDO-OUTBREAK;
   DEVELOPING-COUNTRIES; TSUNAMI SURVIVORS; AIR-POLLUTION; WATER; MOLD;
   ENVIRONMENTS; THAILAND}},
Research-Areas = {{Infectious Diseases}},
Web-of-Science-Categories  = {{Infectious Diseases}},
Author-Email = {{anapisarn@yahoo.com}},
ORCID-Numbers = {{Warren, David/0000-0001-8679-8241}},
Funding-Acknowledgement = {{National Research University Project of the Thailand Office of Higher
   Education Commission}},
Funding-Text = {{This study was supported by the National Research University Project of
   the Thailand Office of Higher Education Commission (to A.A.).}},
Cited-References = {{Apisarnthanarak A, 2012, CLIN INFECT DIS, V56, P1060.
   Apisarnthanarak A, INFECT CONT IN PRESS.
   Apisarnthanarak A, 2013, INFECT CONT HOSP EP, V34, P200, DOI 10.1086/669094.
   Apisarnthanarak A, 2012, INFECT CONT HOSP EP, V33, P1266, DOI 10.1086/668442.
   Apisarnthanarak A, 2012, INFECT CONT HOSP EP, V33, P1285, DOI 10.1086/668445.
   Apisarnthanarak A, 2012, CLIN INFECT DIS, V55, P1588, DOI 10.1093/cid/cis726.
   Apisarnthanarak A, 2012, INFECT CONT HOSP EP, V33, P952, DOI 10.1086/667394.
   Apisarnthanarak A, 2012, CLIN INFECT DIS, V55, pE9, DOI 10.1093/cid/cis413.
   Apisarnthanarak A, 2012, INFECT CONT HOSP EP, V33, P758, DOI 10.1086/666340.
   Baird SF, 2011, J HOSP INFECT, V79, P339, DOI 10.1016/j.jhin.2011.07.006.
   Benedict K., 2011, Morbidity and Mortality Weekly Report, V60, P992.
   Black H, 2008, ENVIRON HEALTH PERSP, V116, pA390, DOI 10.1289/ehp.116-a390.
   Blossom DB, 2008, INFECT CONT HOSP EP, V29, P57, DOI 10.1086/524328.
   Brown-Elliott BA, 2011, J CLIN MICROBIOL, V49, P4231, DOI 10.1128/JCM.05122-11.
   Bruce N, 2000, B WORLD HEALTH ORGAN, V78, P1078.
   Bush RK, 2006, J ALLERGY CLIN IMMUN, V117, P326, DOI 10.1016/j.jaci.2005.12.001.
   Cann KF, 2013, EPIDEMIOL INFECT, V141, P671, DOI 10.1017/S0950268812001653.
   Centers for Disease Control and Prevention, 2005, MMWR-MORBID MORTAL W, V54, P61.
   Centers for Disease Control and Prevention, CHECKL INF CONTR CON.
   Centers for Disease Control and Prevention (CDC), 2012, MMWR-MORBID MORTAL W, V61, P139.
   Du Weiwei, 2010, Prehosp Disaster Med, V25, P265.
   Euripidou E, 2004, J PUBLIC HEALTH, V26, P376, DOI 10.1093/pubmed/fdh163.
   Fernandez-Rendon E, 2012, J HOSP INFECT, V80, P74, DOI 10.1016/j.jhin.2011.10.003.
   Fisk W, 2013, INDOOR AIR.
   Gebo KA, 2002, CLIN INFECT DIS, V35, P32, DOI 10.1086/340741.
   Ghenghesh KS, 2008, J INFECT DEV COUNTR, V2, P81, DOI 10.3855/T2.2.81.
   Hargreaves J, 2001, INFECT CONT HOSP EP, V22, P202, DOI 10.1086/501889.
   Haupt TE, 2012, INFECT CONT HOSP EP, V33, P185, DOI 10.1086/663711.
   Hewlett AL, 2010, 5 DEC INT C HEALTHC.
   Hiransuthikul N, 2005, CLIN INFECT DIS, V41, pE93, DOI 10.1086/497372.
   Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002.
   Institute of Environmental Epidemiology Ministry of the Environment of Singapore, GUID GOOD IND AIR QU.
   Islam MS, 2007, J APPL MICROBIOL, V103, P80, DOI 10.1111/j.1365-2672.2006.03234.x.
   Khawcharoenporn T, 2013, J HOSP INFECT, V83, P150, DOI 10.1016/j.jhin.2012.11.012.
   Knutsen AP, 2012, J ALLERGY CLIN IMMUN, V129, P280, DOI 10.1016/j.jaci.2011.12.970.
   Kouadio IK, 2009, EPIDEMIOL INFECT, V137, P1593, DOI 10.1017/S0950268809002520.
   Kouadio IK, 2012, EXPERT REV ANTI-INFE, V10, P95, DOI {[}10.1586/ERI.11.155, 10.1586/eri.11.155].
   Lim PL, 2005, ANN ACAD MED SINGAP, V34, P582.
   Lin YE, 2011, CURR OPIN INFECT DIS, V24, P350, DOI 10.1097/QCO.0b013e3283486c6e.
   Massaro T, 2012, G Ital Med Lav Ergon, V34, P581.
   Neblett Fanfair R, 2011, NEW ENGL J MED, V367, P2214.
   Samet JM, 2003, AM J PUBLIC HEALTH, V93, P1489, DOI 10.2105/AJPH.93.9.1489.
   Schirmer WN, 2011, CIENC SAUDE COLETIVA, V16, P3583, DOI 10.1590/S1413-81232011000900026.
   Schuetz AN, 2009, INFECT CONT HOSP EP, V30, P461, DOI 10.1086/596613.
   Tapsell LC, 2011, WORLD REV NUTR DIET, V102, P192, DOI 10.1159/000327823.
   Wada K, 2013, J OCCUP HEALTH, V54, P255.
   Woersching Joanna C, 2004, Disaster Manag Response, V2, P10, DOI 10.1016/j.dmr.2003.12.007.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{12}},
Journal-ISO = {{Curr. Opin. Infect. Dis.}},
Doc-Delivery-Number = {{248VL}},
Unique-ID = {{ISI:000326733200010}},
DA = {{2018-08-13}},
}

@article{ ISI:000322617800010,
Author = {McColley, Susanna A. and Morty, Rory E.},
Title = {{Update in Pediatric Lung Disease 2012}},
Journal = {{AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE}},
Year = {{2013}},
Volume = {{188}},
Number = {{3}},
Pages = {{293-297}},
Month = {{AUG 1}},
Publisher = {{AMER THORACIC SOC}},
Address = {{61 BROADWAY, FL 4, NEW YORK, NY 10006 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{McColley, SA (Reprint Author), Div Pulm Med, 225 East Chicago Ave,Box 43, Chicago, IL 60611 USA.
   McColley, Susanna A., Ann \& Robert H Lurie Childrens Hosp Chicago, Div Pulm Med, Chicago, IL USA.
   McColley, Susanna A., Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.
   Morty, Rory E., Max Planck Inst Heart \& Lung Res, Dept Lung Dev \& Remodeling, Bad Nauheim, Germany.}},
DOI = {{10.1164/rccm.201304-0617UP}},
ISSN = {{1073-449X}},
Keywords-Plus = {{DRUG-RESISTANT TUBERCULOSIS; BRONCHOPULMONARY DYSPLASIA; VITAMIN-D;
   MATERNAL SMOKING; NEXT-GENERATION; AIR-POLLUTION; ASTHMA; CHILDREN;
   CELL; CHILDHOOD}},
Research-Areas = {{General \& Internal Medicine; Respiratory System}},
Web-of-Science-Categories  = {{Critical Care Medicine; Respiratory System}},
Author-Email = {{smccolle@luriechildrens.org}},
Cited-References = {{Alphonse RS, 2012, ANTIOXID REDOX SIGN, V17, P1013, DOI 10.1089/ars.2011.4267.
   Bhattacharya S, 2012, AM J RESP CRIT CARE, V186, P349, DOI 10.1164/rccm.201203-0406OC.
   Butler JP, 2012, NEW ENGL J MED, V367, P244, DOI 10.1056/NEJMoa1203983.
   Cohen T, 2012, AM J RESP CRIT CARE, V186, P399, DOI 10.1164/rccm.201203-0394PP.
   de Benedictis FM, 2012, AM J RESP CRIT CARE, V185, P12, DOI 10.1164/rccm.201107-1174CI.
   DiNubile MJ, 2012, AM J RESP CRIT CARE, V186, P1195, DOI 10.1164/ajrccm.186.11.1195.
   Dogaru CM, 2012, AM J RESP CRIT CARE, V185, P874, DOI 10.1164/rccm.201108-1490OC.
   Goleva E, 2012, J ALLERGY CLIN IMMUN, V129, P1243, DOI 10.1016/j.jaci.2012.01.044.
   Goss CH, 2013, AM J RESP CRIT CARE, V187, P915, DOI 10.1164/rccm.201301-0184UP.
   Grigg J, 2012, AM J RESP CRIT CARE, V186, P1208, DOI 10.1164/rccm.201210-1892ED.
   Guilbert TW, 2012, AM J RESP CRIT CARE, V185, P801, DOI 10.1164/rccm.201202-0239ED.
   Hadchouel A, 2011, AM J RESP CRIT CARE, V184, P1164, DOI 10.1164/rccm.201103-0548OC.
   Hampson NB, 2012, AM J RESP CRIT CARE, V186, P1095, DOI 10.1164/rccm.201207-1284CI.
   Hughes JMB, 2012, AM J RESP CRIT CARE, V186, P132, DOI 10.1164/rccm.201112-2160CI.
   Jarjour NN, 2012, AM J RESP CRIT CARE, V185, P356, DOI 10.1164/rccm.201107-1317PP.
   Katz ES, 2012, AM J RESP CRIT CARE, V185, P805, DOI 10.1164/rccm.201108-1455CI.
   Keeler AM, 2012, HUM GENE THER, V23, P548, DOI 10.1089/hum.2012.087.
   Kotton DN, 2012, AM J RESP CRIT CARE, V185, P1255, DOI 10.1164/rccm.201202-0228PP.
   Litonjua AA, 2012, CURR OPIN ALLERGY CL, V12, P179, DOI 10.1097/ACI.0b013e3283507927.
   Martin TR, 2012, AM J RESP CRIT CARE, V185, P479, DOI 10.1164/rccm.201108-1390PP.
   Miller AC, 2012, AM J RESP CRIT CARE, V185, P1154, DOI 10.1164/rccm.201111-2082CI.
   Narayanan M, 2012, AM J RESP CRIT CARE, V185, P186, DOI 10.1164/rccm.201107-1348OC.
   Neuman A, 2012, AM J RESP CRIT CARE, V186, P1037, DOI 10.1164/rccm.201203-0501OC.
   O'Reilly M, 2012, CLIN PERINATOL, V39, P703, DOI {[}10.1016/j.cip.2012.06.009, 10.1016/j.clp.2012.06.009].
   Paul G, 2012, AM J RESP CRIT CARE, V185, P124, DOI 10.1164/rccm.201108-1502CI.
   Peters-Golden M, 2012, AM J RESP CRIT CARE, V186, P213, DOI 10.1164/rccm.201203-0371PP.
   Rock J, 2012, AM J RESP CRIT CARE, V186, P1213, DOI 10.1164/rccm.201207-1151PP.
   Schultz ES, 2012, AM J RESP CRIT CARE, V186, P1286, DOI 10.1164/rccm.201206-1045OC.
   Seddon JA, 2012, AM J RESP CRIT CARE, V186, P953, DOI 10.1164/rccm.201206-1001CI.
   Simpson A, 2012, AM J RESP CRIT CARE, V185, P1197, DOI 10.1164/rccm.201112-2191OC.
   Tegethoff M, 2012, AM J RESP CRIT CARE, V185, P557, DOI 10.1164/rccm.201108-1482OC.
   Vadivel A, 2012, AM J RESP CRIT CARE, V185, P564, DOI 10.1164/rccm.201103-0545OC.
   Von Mutius E, 2012, AM J RESP C IN PRESS.
   Vosdoganes P, 2012, PEDIATRICS, V130, P727, DOI 10.1542/peds.2011-2576.
   Wambach JA, 2012, PEDIATRICS, V130, pE1575, DOI 10.1542/peds.2012-0918.
   West JB, 2012, AM J RESP CRIT CARE, V186, P1229, DOI 10.1164/rccm.201207-1323CI.
   Wu AC, 2012, AM J RESP CRIT CARE, V186, P508, DOI 10.1164/rccm.201202-0351OC.
   Wu PS, 2012, AM J RESP CRIT CARE, V186, P941, DOI 10.1164/rccm.201209-1618ED.
   Yang IV, 2012, AM J RESP CRIT CARE, V186, P1087, DOI 10.1164/rccm.201207-1178PP.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{Am. J. Respir. Crit. Care Med.}},
Doc-Delivery-Number = {{194GA}},
Unique-ID = {{ISI:000322617800010}},
DA = {{2018-08-13}},
}

@article{ ISI:000320724500012,
Author = {Rams, T. E. and Degener, J. E. and van Winkelhoff, A. J.},
Title = {{Prevalence of -lactamase-producing bacteria in human periodontitis}},
Journal = {{JOURNAL OF PERIODONTAL RESEARCH}},
Year = {{2013}},
Volume = {{48}},
Number = {{4}},
Pages = {{493-499}},
Month = {{AUG}},
Abstract = {{Background and Objective Beta-lactam antibiotics prescribed in
   periodontal therapy are vulnerable to degradation by bacterial
   -lactamases. This study evaluated the occurrence of -lactamase-positive
   subgingival bacteria in chronic periodontitis subjects of USA origin,
   and assessed their in vitro resistance to metronidazole at a breakpoint
   concentration of 4g/mL. Material and Methods Subgingival plaque
   specimens from deep periodontal pockets with bleeding on probing were
   removed from 564 adults with severe chronic periodontitis before
   treatment. The samples were transported in VMGA III and then plated
   onto: (i) nonselective enriched Brucella blood agar (EBBA) and incubated
   anaerobically for 7d; and (ii) selective trypticase
   soy-bacitracin-vancomycin (TSBV) and incubated for 3 d in air + 5\% CO2.
   At the end of the incubation periods, the bacterial test species were
   identified and quantified. Specimen dilutions were also plated onto EBBA
   plates supplemented with 2g/mL of amoxicillin, a combination of 2g/mL of
   amoxicillin plus 2g/mL of the -lactamase inhibitor clavulanic acid, or
   4g/mL of metronidazole, followed by anaerobic incubation for 7d.
   Bacterial test species presumptively positive for -lactamase production
   were identified by growth on EBBA primary isolation plates supplemented
   with amoxicillin alone and no growth on EBBA primary isolation plates
   containing both amoxicillin plus clavulanic acid. A subset of such
   isolates was subjected to nitrocefin-based chromogenic disk testing to
   confirm the presence of -lactamase activity. In vitro resistance to
   4g/mL of metronidazole was noted when growth of test species occurred on
   metronidazole-supplemented EBBA culture plates. Results Two-hundred and
   ninety-four (52.1\%) of the study subjects yielded -lactamase-producing
   subgingival bacterial test species, with Prevotella
   intermedia/nigrescens, Fusobacterium nucleatum and other Prevotella
   species most frequently identified as -lactamase-producing organisms. Of
   the -lactamase-producing bacterial test species strains recovered,
   98.9\% were susceptible in vitro to metronidazole at 4g/mL. Conclusion
   The occurrence of -lactamase-positive subgingival bacterial species in
   more than half of the subjects with severe chronic periodontitis raises
   questions about the therapeutic potential of single-drug regimens with
   -lactam antibiotics in periodontal therapy. The in vitro effectiveness
   of metronidazole against nearly all recovered -lactamase-producing
   subgingival bacterial species further supports clinical periodontitis
   treatment strategies involving the combination of systemic amoxicillin
   plus metronidazole.}},
Publisher = {{WILEY}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Rams, TE (Reprint Author), Temple Univ, Sch Dent, Dept Periodontol \& Oral Implantol, 3223 North Broad St, Philadelphia, PA 19140 USA.
   Rams, T. E., Temple Univ, Sch Dent, Dept Periodontol \& Oral Implantol, Philadelphia, PA 19140 USA.
   Rams, T. E., Temple Univ, Sch Dent, Oral Microbiol Testing Serv Lab, Philadelphia, PA 19140 USA.
   Rams, T. E., Temple Univ, Dept Microbiol \& Immunol, Sch Med, Philadelphia, PA 19140 USA.
   Rams, T. E.; van Winkelhoff, A. J., Univ Groningen, Univ Med Ctr Groningen, Dept Oral Microbiol, Ctr Dent \& Oral Hyg, Groningen, Netherlands.
   Degener, J. E.; van Winkelhoff, A. J., Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.}},
DOI = {{10.1111/jre.12031}},
ISSN = {{0022-3484}},
EISSN = {{1600-0765}},
Keywords = {{beta-lactamase; in vitro; periodontitis; subgingival microbiota}},
Keywords-Plus = {{BETA-LACTAMASE; ANTIBIOTIC-RESISTANCE; ADULT PERIODONTITIS;
   ANTIMICROBIAL SUSCEPTIBILITY; SYSTEMIC AMOXICILLIN/METRONIDAZOLE;
   REFRACTORY PERIODONTITIS; SUBGINGIVAL MICROFLORA; CLINICAL-PARAMETERS;
   ADJUNCTIVE THERAPY; PENICILLIN}},
Research-Areas = {{Dentistry, Oral Surgery \& Medicine}},
Web-of-Science-Categories  = {{Dentistry, Oral Surgery \& Medicine}},
Author-Email = {{trams@temple.edu}},
Funding-Acknowledgement = {{Paul H. Keyes Professorship in Periodontology held by Thomas E. Rams at
   Temple University School of Dentistry}},
Funding-Text = {{The authors thank Diane Feik for her laboratory expertise and
   assistance, and Drs Linda A. Miller and James A. Poupard of SmithKline
   Beecham for their guidance with the clavulanic acid surface-overlay
   technique used in this study. Support for this research was provided, in
   part, by funds from the Paul H. Keyes Professorship in Periodontology
   held by Thomas E. Rams at Temple University School of Dentistry. No
   conflicts of interest, including financial, were reported by any of the
   authors relative to this study.}},
Cited-References = {{Ardila CM, 2010, J PERIODONTAL RES, V45, P557, DOI 10.1111/j.1600-0765.2010.01274.x.
   Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x.
   Bergan T, 1997, SCAND J INFECT DIS, P1.
   DAHLEN G, 1993, ORAL MICROBIOL IMMUN, V8, P375, DOI 10.1111/j.1399-302X.1993.tb00614.x.
   Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09.
   Eick S, 1999, INT J ANTIMICROB AG, V12, P41, DOI 10.1016/S0924-8579(99)00056-4.
   Feres M, 2002, J CLIN PERIODONTOL, V29, P724, DOI 10.1034/j.1600-051X.2002.290809.x.
   Feres M, 1999, J CLIN PERIODONTOL, V26, P784, DOI 10.1111/j.1600-051X.1999.tb02521.x.
   Feres M, 2001, J CLIN PERIODONTOL, V28, P597, DOI 10.1034/j.1600-051x.2001.028007597.x.
   Fosse T, 1999, ORAL MICROBIOL IMMUN, V14, P352, DOI 10.1034/j.1399-302X.1999.140604.x.
   Fosse T, 2002, ORAL MICROBIOL IMMUN, V17, P85, DOI 10.1046/j.0902-0055.2001.00096.x.
   Goossens H, 2007, CLIN INFECT DIS, V44, P1091, DOI 10.1086/512810.
   Handal T, 2000, EUR J ORAL SCI, V108, P163, DOI 10.1034/j.1600-0722.2000.108003163.x.
   Handal T, 2005, FEMS MICROBIOL LETT, V242, P319, DOI 10.1016/j.femsle.2004.11.023.
   Handal T, 2004, ORAL MICROBIOL IMMUN, V19, P303, DOI 10.1111/j.1399-302x.2004.00159.x.
   Handal T, 2003, ANTIMICROB AGENTS CH, V47, P1443, DOI 10.1128/AAC.47.4.1443-1446.2003.
   HEIMDAHL A, 1980, ARCH ORAL BIOL, V25, P689, DOI 10.1016/0003-9969(80)90102-8.
   HELOVUO H, 1989, J PERIODONTOL, V60, P467, DOI 10.1902/jop.1989.60.8.467.
   HELOVUO H, 1991, ORAL SURG ORAL MED O, V71, P543, DOI 10.1016/0030-4220(91)90358-J.
   Herrera D, 2000, J CLIN PERIODONTOL, V27, P520, DOI 10.1034/j.1600-051x.2000.027007520.x.
   Ioannidis I, 2009, J CLIN PERIODONTOL, V36, P569, DOI 10.1111/j.1600-051X.2009.01425.x.
   Kim SM, 2011, J MICROBIOL, V49, P595, DOI 10.1007/s12275-011-0519-1.
   KINDER SA, 1986, J CLIN MICROBIOL, V23, P1127.
   KUNIHIRA DM, 1985, J PERIODONTOL, V56, P352, DOI 10.1902/jop.1985.56.6.352.
   Kuriyama T, 2006, J ANTIMICROB CHEMOTH, V58, P708, DOI 10.1093/jac/dkl287.
   LAI CH, 1983, INT J SYST BACTERIOL, V33, P628, DOI 10.1099/00207713-33-3-628.
   LEGG JA, 1990, BRIT J ORAL MAX SURG, V28, P180, DOI 10.1016/0266-4356(90)90085-Y.
   MACHTEI EE, 1993, J CLIN PERIODONTOL, V20, P81, DOI 10.1111/j.1600-051X.1993.tb00334.x.
   Moller AJ, 1966, ODONTOL TIDSKR     S, V74, P1.
   Mombelli A, 2011, PERIODONTOL 2000, V55, P205, DOI 10.1111/j.1600-0757.2010.00356.x.
   Moore TD, 1996, J CLIN MICROBIOL, V34, P1321.
   Nord C E, 1988, Scand J Infect Dis Suppl, V53, P50.
   PAJUKANTA R, 1993, FEMS IMMUNOL MED MIC, V6, P241.
   Rams TE, 1996, J CLIN PERIODONTOL, V23, P346, DOI 10.1111/j.1600-051X.1996.tb00556.x.
   Rams TE, 2011, ANAEROBE, V17, P201, DOI 10.1016/j.anaerobe.2011.03.017.
   Rauch CA, 2007, CLIN LAB MED, V27, P845, DOI 10.1016/j.cll.2007.07.012.
   Sgolastra F, 2012, J PERIODONTOL, V83, P1257, DOI 10.1902/jop.2012.110625.
   Sgolastra F, 2012, J PERIODONTOL, V83, P731, DOI 10.1902/jop.2011.110432.
   Slots J, 1986, Oral Microbiol Immunol, V1, P48, DOI 10.1111/j.1399-302X.1986.tb00318.x.
   SLOTS J, 1988, Oral Microbiology and Immunology, V3, P47, DOI 10.1111/j.1399-302X.1988.tb00080.x.
   SLOTS J, 1982, J CLIN MICROBIOL, V15, P606.
   SLOTS J, 1990, J CLIN PERIODONTOL, V17, P479.
   Slots Jorgen, 2004, Journal of Periodontology, V75, P1553.
   TOPOLL HH, 1990, J CLIN PERIODONTOL, V17, P268, DOI 10.1111/j.1600-051X.1990.tb00024.x.
   van Winkelhoff AJ, 2000, J CLIN PERIODONTOL, V27, P79, DOI 10.1034/j.1600-051x.2000.027002079.x.
   van Winkelhoff AJ, 2009, J PERIODONTOL, V80, P1555, DOI 10.1902/jop.2009.090276.
   VANOOSTEN MAC, 1986, J PERIODONTOL, V57, P613, DOI 10.1902/jop.1986.57.10.613.
   vanWinkelhoff AJ, 1997, J CLIN PERIODONTOL, V24, P538.
   Walker C B, 1987, Oral Microbiol Immunol, V2, P129, DOI 10.1111/j.1399-302X.1987.tb00276.x.}},
Number-of-Cited-References = {{49}},
Times-Cited = {{22}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{15}},
Journal-ISO = {{J. Periodont. Res.}},
Doc-Delivery-Number = {{168RX}},
Unique-ID = {{ISI:000320724500012}},
DA = {{2018-08-13}},
}

@article{ ISI:000329015300011,
Author = {Lin Mao-hu and He Lei and Gao Jie and Liu Yun-xi and Suo Ji-jiang and
   Xing Yu-bin and Jia Ning},
Title = {{Penetration of erythromycin through Staphylococcus epidermidis biofilm}},
Journal = {{CHINESE MEDICAL JOURNAL}},
Year = {{2013}},
Volume = {{126}},
Number = {{14}},
Pages = {{2647-2651}},
Month = {{JUL 20}},
Abstract = {{Background The catheter related infection caused by Staphylococcus
   epidermidis biofilm is increasing and difficult to treat by
   antimicrobial chemotherapy. The properties of biofilms that give rise to
   antibiotic resistance are only partially understood. This study aimed to
   elucidate the penetration of erythromycin through Staphylococcus
   epidermidis biofilm.
   Methods The penetration ratio of erythromycin through Staphylococcus
   epidermidis biofilms of 1457, 1457-msrA, and wild isolate S68 was
   detected by biofilm penetration model at different time points according
   to the standard regression curve. The RNA/DNA ratio and the cell density
   within the biofilms were observed by confocal laser microscope and
   transmission electromicroscope, respectively.
   Results The penetration ratios of erythromycin through the biofilms of
   1457, 1457-msrA, and S68 after cultivation for 36 hours were 0.93, 0.55
   and 0.4, respectively. The erythromycin penetration ratio through 1457
   biofilm (0.58 after 8 hours) was higher than that through the other two
   (0.499 and 0.31 after 24 hours). Lower growth rate of the cells in
   biofilm was shown, with reduction of RNA/DNA proportion observed by
   confocal laser microscope through acridine orange stain. Compared with
   the control group observed by transmission electrmicroscope, the cell
   density of biofilm air face was lower than that of agar face, with more
   cell debris.
   Conclusions Erythromycin could penetrate to the Staphylococcus
   epidermidis biofilm, but could not kill the cells thoroughly. The lower
   growth rate of the cells within biofilm could help decreasing the
   erythromycin susceptibility.}},
Publisher = {{CHINESE MEDICAL ASSOC}},
Address = {{42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Jia, N (Reprint Author), Peoples Liberat Army Gen Hosp, Dept Nosocomial Infect \& Dis Control, Beijing 100853, Peoples R China.
   Lin Mao-hu, Peoples Liberat Army Gen Hosp, Dept Urol, Affiliated Hosp 1, Beijing 100051, Peoples R China.
   He Lei, Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Beijing 100853, Peoples R China.
   Gao Jie, Peoples Liberat Army Gen Hosp, Dept Pathol, Beijing 100853, Peoples R China.
   Liu Yun-xi; Suo Ji-jiang; Xing Yu-bin; Jia Ning, Peoples Liberat Army Gen Hosp, Dept Nosocomial Infect \& Dis Control, Beijing 100853, Peoples R China.}},
DOI = {{10.3760/cma.j.issn.0366-6999.20130393}},
ISSN = {{0366-6999}},
Keywords = {{Staphylococcus epidermidis; biofilm; antibiotic resistance}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE; AUREUS; MACROLIDE; COST}},
Research-Areas = {{General \& Internal Medicine}},
Web-of-Science-Categories  = {{Medicine, General \& Internal}},
Author-Email = {{jianing@263.net}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}30300296]; Twelfth
   Five-year Military Foundation {[}BWS11J048]}},
Funding-Text = {{The study was supported by the grants from the National Natural Science
   Foundation of China (No. 30300296) and the Twelfth Five-year Military
   Foundation (No. BWS11J048).}},
Cited-References = {{Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P37, DOI 10.1093/jac/dkr456.
   Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000.
   Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002.
   Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319.
   Beaudoin T, 2012, J BACTERIOL, V194, P3128, DOI 10.1128/JB.06178-11.
   Davies J, 2012, J CLIN MICROBIOL, V50, P2056, DOI 10.1128/JCM.06773-11.
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010.
   Gordon RJ, 2012, J INFECT DIS, V205, P1391, DOI 10.1093/infdis/jis218.
   Hennequin C, 2012, J ANTIMICROB CHEMOTH, V67, P2123, DOI 10.1093/jac/dks169.
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011.
   Jefferson KK, 2005, ANTIMICROB AGENTS CH, V49, P2467, DOI 10.1118/AAC.49.6.2467-2473.2005.
   Molloy S, 2012, NAT REV MICROBIOL, V10, DOI 10.1038/nrmicro2756.
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182.
   Shahsavan S, 2012, BURNS, V38, P378, DOI 10.1016/j.burns.2011.09.004.
   Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257.}},
Number-of-Cited-References = {{15}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{21}},
Journal-ISO = {{Chin. Med. J.}},
Doc-Delivery-Number = {{280FY}},
Unique-ID = {{ISI:000329015300011}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000328127500010,
Author = {Broderick, Adam H. and Breitbach, Anthony S. and Frei, Reto and
   Blackwell, Helen E. and Lynn, David M.},
Title = {{Surface-Mediated Release of a Small-Molecule Modulator of Bacterial
   Biofilm Formation: A Non-Bactericidal Approach to Inhibiting Biofilm
   Formation in Pseudomonas aeruginosa}},
Journal = {{ADVANCED HEALTHCARE MATERIALS}},
Year = {{2013}},
Volume = {{2}},
Number = {{7}},
Pages = {{993-1000}},
Month = {{JUL}},
Abstract = {{We report an approach to preventing bacterial biofilm formation that is
   based on the surface-mediated release of
   5,6-dimethyl-2-aminobenzimidazole (DMABI), a potent and non-bactericidal
   small-molecule inhibitor of bacterial biofilm growth. Our results
   demonstrate that DMABI can be encapsulated in thin films of a model
   biocompatible polymer {[}poly(lactide-co-glycolide), PLG] and be
   released in quantities that inhibit the formation of Pseudomonas
   aeruginosa biofilms by up to 75-90\% on surfaces that otherwise support
   robust biofilm growth. This approach enables the release of this new
   anti-biofilm agent for over one month, and it can be used to inhibit
   biofilm growth on both film-coated surfaces and other adjacent surfaces
   (e.g., on other uncoated surfaces and at air/water interfaces). Our
   results demonstrate a non-bactericidal approach to the prevention of
   biofilm growth and provide proof of concept using a clinically relevant
   human pathogen. In contrast to coatings designed to kill bacteria on
   contact, this approach should also permit the design of strategically
   placed depots that disseminate DMABI more broadly and exert inhibitory
   effects over larger areas. In a broader context, the non-bactericidal
   nature of DMABI could also provide opportunities to address concerns
   related to evolved resistance that currently face approaches based on
   the release of traditional microbicidal agents (e.g., antibiotics).
   Finally, the results of initial in vitro mammalian cell culture studies
   indicate that DMABI is not toxic to cells at concentrations required for
   strong anti-biofilm activity, suggesting that this new agent is well
   suited for further investigation in biomedical and personal care
   contexts.}},
Publisher = {{WILEY}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Blackwell, HE (Reprint Author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.
   Broderick, Adam H.; Lynn, David M., Univ Wisconsin, Dept Chem \& Biol Engn, Madison, WI 53706 USA.
   Breitbach, Anthony S.; Frei, Reto; Blackwell, Helen E.; Lynn, David M., Univ Wisconsin, Dept Chem, Madison, WI 53706 USA.}},
DOI = {{10.1002/adhm.201200334}},
ISSN = {{2192-2640}},
EISSN = {{2192-2659}},
Keywords = {{biofilms; thin films; drug delivery; polymers; surfaces and interfaces}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE; INFECTIOUS-DISEASES; CYSTIC-FIBROSIS; DRUG;
   MECHANISMS; STRATEGIES; 2-AMINOBENZIMIDAZOLE; BIOMATERIALS;
   PATHOGENESIS; CATHETERS}},
Research-Areas = {{Engineering; Science \& Technology - Other Topics; Materials Science}},
Web-of-Science-Categories  = {{Engineering, Biomedical; Nanoscience \& Nanotechnology; Materials
   Science, Biomaterials}},
Author-Email = {{blackwell@chem.wisc.edu
   dlynn@engr.wisc.edu}},
Funding-Acknowledgement = {{Office of Naval Research {[}N00014-07-1-0255]; National Institutes of
   Health {[}AI063326]; Burroughs Wellcome Fund; UW Vilas Trust; National
   Science Foundation {[}DMR 1121288]; NIH Chemistry-Biology Interface
   Training Grant {[}NIGMS T32 GM008505]}},
Funding-Text = {{Financial support to H. E. B and D. M. L. was provided by the Office of
   Naval Research (N00014-07-1-0255), the National Institutes of Health
   (AI063326 for H. E. B), the Burroughs Wellcome Fund, and the UW Vilas
   Trust. This work made use of shared facilities supported, in part, by
   the National Science Foundation through a grant to the Materials
   Research Science and Engineering Center (MRSEC) at the University of
   Wisconsin (DMR 1121288). A. H. B. is a NSF Graduate Research Fellow. A.
   S. B. was funded in part by an NIH Chemistry-Biology Interface Training
   Grant (NIGMS T32 GM008505). We gratefully acknowledge Prof. Barbara
   Iglewski (University of Rochester) for donation of the P. aeruginosa
   PAO1 strain.}},
Cited-References = {{Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3.
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215.
   Baveja JK, 2004, BIOMATERIALS, V25, P5003, DOI 10.1016/j.biomaterials.2004.02.051.
   Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001.
   Breitbach AS, 2011, CHEM COMMUN, V47, P370, DOI 10.1039/c0cc02316g.
   Bruellhoff K, 2010, INT J ARTIF ORGANS, V33, P646.
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005.
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.3.CO;2-6.
   Chen X, 2000, WATER RES, V34, P4229, DOI 10.1016/S0043-1354(00)00187-1.
   Coetser SE, 2005, CRIT REV MICROBIOL, V31, P213, DOI 10.1080/10408410500304074.
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318.
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008.
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226.
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002.
   FARBER BF, 1993, J BIOMED MATER RES, V27, P599, DOI 10.1002/jbm.820270506.
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415.
   Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x.
   Fredenberg S, 2011, INT J PHARMACEUT, V415, P34, DOI 10.1016/j.ijpharm.2011.05.049.
   Frei R, 2012, ANGEW CHEM INT EDIT, V51, P5226, DOI 10.1002/anie.201109258.
   Geske GD, 2005, J AM CHEM SOC, V127, P12762, DOI 10.1021/ja0530321.
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011.
   Govan JRW, 1996, MICROBIOL REV, V60, P539.
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821.
   Hancock REW, 2000, DRUG RESIST UPDATE, V3, P247, DOI 10.1054/drup.2000.0152.
   Harmsen M, 2010, FEMS IMMUNOL MED MIC, V59, P253, DOI 10.1111/j.1574-695X.2010.00690.x.
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b.
   Huq A, 2008, CURR OPIN BIOTECH, V19, P244, DOI 10.1016/j.copbio.2008.04.005.
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0.
   Kalia VC, 2011, CRIT REV MICROBIOL, V37, P121, DOI 10.3109/1040841X.2010.532479.
   Kaplan JB, 2009, INT J ARTIF ORGANS, V32, P545.
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2.
   KOCH C, 1993, LANCET, V341, P1065, DOI 10.1016/0140-6736(93)92422-P.
   Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4.
   Melander C, 2009, INT BIODETER BIODEGR, V63, P529, DOI 10.1016/j.ibiod.2008.08.009.
   Mittal R, 2010, FEMS IMMUNOL MED MIC, V58, P237, DOI 10.1111/j.1574-695X.2009.00627.x.
   Njoroge J, 2009, EMBO MOL MED, V1, P201, DOI 10.1002/emmm.200900032.
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4.
   PASSERINI L, 1992, CRIT CARE MED, V20, P665, DOI 10.1097/00003246-199205000-00020.
   Rana D, 2010, CHEM REV, V110, P2448, DOI 10.1021/cr800208y.
   Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013.
   Rogers SA, 2009, J AM CHEM SOC, V131, P9868, DOI 10.1021/ja9024676.
   Simoes M, 2011, CURR MED CHEM, V18, P2129, DOI 10.2174/092986711795656216.
   Sintim HO, 2010, FUTURE MED CHEM, V2, P1005, DOI 10.4155/FMC.10.185.
   Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705.
   Wagner VE, 2008, CLIN REV ALLERG IMMU, V35, P124, DOI 10.1007/s12016-008-8079-9.
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031.
   Xiong YH, 2010, APPL MICROBIOL BIOT, V86, P825, DOI 10.1007/s00253-010-2463-0.
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{14}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{28}},
Journal-ISO = {{Adv. Healthc. Mater.}},
Doc-Delivery-Number = {{267VX}},
Unique-ID = {{ISI:000328127500010}},
OA = {{green\_accepted}},
DA = {{2018-08-13}},
}

@article{ ISI:000328684600019,
Author = {Rams, Thomas E. and Feik, Diane and Mortensen, Joel E. and Degener, John
   E. and van Winkelhoff, Arie J.},
Title = {{Antibiotic Susceptibility of Periodontal Enterococcus faecalis}},
Journal = {{JOURNAL OF PERIODONTOLOGY}},
Year = {{2013}},
Volume = {{84}},
Number = {{7}},
Pages = {{1026-1033}},
Month = {{JUL}},
Abstract = {{Background: Enterococcus faecalis may contribute to periodontal
   breakdown in heavily infected subgingival sites, particularly in
   patients responding poorly to mechanical forms of periodontal therapy.
   Because only limited data are available on the antimicrobial sensitivity
   of enterococci of subgingival origin, this study evaluates the in vitro
   antibiotic susceptibility of E. faecalis isolated from periodontitis
   patients in the United States.
   Methods: Pure cultures of 47 subgingival E. faecalis clinical isolates
   were each inoculated onto specially prepared broth microdilution
   susceptibility panels containing vancomycin, teicoplanin, and six oral
   antibiotics of potential use in periodontal therapy. After incubation in
   ambient air for 18 to 20 hours, minimal inhibitory drug concentrations
   were determined using applicable Clinical and Laboratory Standards
   Institute criteria and interpretative guidelines. The organisms were
   additionally evaluated for in vitro resistance to metronidazole at 4
   mg/mL.
   Results: Periodontal E. faecalis exhibited substantial in vitro
   resistance to tetracycline (53.2\% resistant), erythromycin (80.8\%
   resistant or intermediate resistant), clindamycin (100\% resistant to 2
   mg/mL), and metronidazole (100\% resistant to 4 mg/mL). In comparison,
   the clinical isolates were generally sensitive to ciprofloxacin (89.4\%
   susceptible; 10.6\% intermediate resistant) and 100\% susceptible in
   vitro to ampicillin, amoxicillin/clavulanate, vancomycin, and
   teicoplanin.
   Conclusions: Tetracycline, erythromycin, clindamycin, and metronidazole
   revealed poor in vitro activity against human subgingival E. faecalis
   clinical isolates, and would likely be ineffective therapeutic agents
   against these species in periodontal pockets. Among orally administered
   antibiotics, ampicillin, amoxicillin/clavulanate, and ciprofloxacin
   exhibited marked in vitro inhibitory activity against periodontal E.
   faecalis, and may be clinically useful in treatment of periodontal
   infections involving enterococci.}},
Publisher = {{AMER ACAD PERIODONTOLOGY}},
Address = {{737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Rams, TE (Reprint Author), Temple Univ, Sch Dent, Dept Periodontol \& Oral Implantol, 3223 N Broad St, Philadelphia, PA 19140 USA.
   Rams, Thomas E.; Feik, Diane, Temple Univ, Sch Dent, Dept Periodontol \& Oral Implantol, Oral Microbiol Testing Serv Lab, Philadelphia, PA 19140 USA.
   Rams, Thomas E., Temple Univ, Sch Med, Dept Microbiol \& Immunol, Philadelphia, PA 19140 USA.
   Rams, Thomas E.; van Winkelhoff, Arie J., Univ Groningen, Univ Med Ctr Groningen, Ctr Dent \& Oral Hyg, Groningen, Netherlands.
   Mortensen, Joel E., Cincinnati Childrens Hosp Med Ctr, Dept Pathol \& Lab Med, Cincinnati, OH 45229 USA.
   Degener, John E.; van Winkelhoff, Arie J., Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.}},
DOI = {{10.1902/jop.2012.120050}},
ISSN = {{0022-3492}},
EISSN = {{1943-3670}},
Keywords = {{Anti-infective agents; chronic periodontitis; drug resistance;
   Enterococcus faecalis; in vitro; periodontal pocket}},
Keywords-Plus = {{LACTAMASE-PRODUCING BACTERIA; ANTIMICROBIAL RESISTANCE; SUBGINGIVAL
   BIOFILM; ORAL-CAVITY; POPULATION-STRUCTURE; ADULT PERIODONTITIS;
   DISEASES; METRONIDAZOLE; NETHERLANDS; MICROFLORA}},
Research-Areas = {{Dentistry, Oral Surgery \& Medicine}},
Web-of-Science-Categories  = {{Dentistry, Oral Surgery \& Medicine}},
Author-Email = {{trams@temple.edu}},
Funding-Acknowledgement = {{Paul H. Keyes Professorship in Periodontology at Temple University
   School of Dentistry}},
Funding-Text = {{This work was supported in part by the Paul H. Keyes Professorship in
   Periodontology at Temple University School of Dentistry (TER). The
   authors report no conflicts of interest related to this study.}},
Cited-References = {{Aarestrup FM, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P55.
   Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005.
   Arias CA, 2008, EXPERT REV ANTI-INFE, V6, P637, DOI 10.1586/14787210.6.5.637.
   Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x.
   BROOK I, 1988, SURGERY, V103, P107.
   Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI, P90.
   Colombo AP, 1998, J CLIN PERIODONTOL, V25, P169, DOI 10.1111/j.1600-051X.1998.tb02424.x.
   Colombo AP, 1998, J CLIN PERIODONTOL, V25, P596, DOI 10.1111/j.1600-051X.1998.tb02493.x.
   Colombo APV, 2002, J PERIODONTOL, V73, P360, DOI 10.1902/jop.2002.73.4.360.
   da Silva-Boghossian CM, 2011, ARCH ORAL BIOL, V56, P899, DOI 10.1016/j.archoralbio.2011.02.009.
   Dahlen G, 2000, ORAL MICROBIOL IMMUN, V15, P309, DOI 10.1034/j.1399-302x.2000.150507.x.
   Ramos MPD, 2012, QUINTESSENCE INT, V43, P71.
   Estrela CRD, 2010, J APPL ORAL SCI, V18, P426, DOI 10.1590/S1678-77572010000400018.
   Deshpande LM, 2007, DIAGN MICR INFEC DIS, V58, P163, DOI 10.1016/j.diagmicrobio.2006.12.022.
   Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09.
   Ellington MJ, 2006, ORAL MICROBIOL IMMUN, V21, P164.
   Gaetti-Jardim EC, 2010, J APPL ORAL SCI, V18, P551, DOI 10.1590/S1678-77572010000600004.
   Goncalves LD, 2009, EUR J CLIN MICROBIOL, V28, P1335, DOI 10.1007/s10096-009-0786-5.
   HANCOCK LE, 2006, GRAM POSITIVE PATHOG, P299, DOI DOI 10.1128/9781555816513.CH25.
   Herrera D, 2000, J CLIN PERIODONTOL, V27, P520, DOI 10.1034/j.1600-051x.2000.027007520.x.
   Kuch A, 2012, J ANTIMICROB CHEMOTH, V67, P551, DOI 10.1093/jac/dkr544.
   Larsen T, 2002, ORAL MICROBIOL IMMUN, V17, P267, DOI 10.1034/j.1399-302X.2002.170501.x.
   Moller AJ, 1966, ODONTOL TIDSKR     S, V74, P1.
   Mombelli A, 2004, INT DENT J, V54, P3, DOI 10.1111/j.1875-595X.2004.tb00246.x.
   NAGY E, 1990, EUR J CLIN MICROBIOL, V9, P287, DOI 10.1007/BF01968064.
   NAGY E, 1991, J ANTIMICROB CHEMOTH, V27, P63, DOI 10.1093/jac/27.1.63.
   Pinheiro ET, 2004, INT ENDOD J, V37, P756, DOI 10.1111/j.1365-2591.2004.00865.x.
   Rams TE, 1996, J CLIN PERIODONTOL, V23, P346, DOI 10.1111/j.1600-051X.1996.tb00556.x.
   RAMS TE, 1992, ORAL MICROBIOL IMMUN, V7, P249, DOI 10.1111/j.1399-302X.1992.tb00034.x.
   Rams TE, 2011, ANAEROBE, V17, P201, DOI 10.1016/j.anaerobe.2011.03.017.
   Rauch CA, 2007, CLIN LAB MED, V27, P845, DOI 10.1016/j.cll.2007.07.012.
   Razavi A, 2007, ORAL MICROBIOL IMMUN, V22, P248, DOI 10.1111/j.1399-302X.2006.00349.x.
   Rocas IN, 2004, J ENDODONT, V30, P315, DOI 10.1097/00004770-200405000-00004.
   Salah Randa, 2008, BMC Oral Health, V8, P17, DOI 10.1186/1472-6831-8-17.
   Sedgley CM, 2004, ORAL MICROBIOL IMMUN, V19, P95, DOI 10.1111/j.0902-0055.2004.00122.x.
   Sedlacek MJ, 2007, ORAL MICROBIOL IMMUN, V22, P333, DOI 10.1111/j.1399-302X.2007.00366.x.
   Skucaite N, 2010, J ENDODONT, V36, P1611, DOI 10.1016/j.joen.2010.04.009.
   Slots J, 1986, Oral Microbiol Immunol, V1, P48, DOI 10.1111/j.1399-302X.1986.tb00318.x.
   SLOTS J, 1988, Oral Microbiology and Immunology, V3, P47, DOI 10.1111/j.1399-302X.1988.tb00080.x.
   Slots Jorgen, 2004, Journal of Periodontology, V75, P1553.
   SMILACK JD, 1991, MAYO CLIN PROC, V66, P1270, DOI 10.1016/S0025-6196(12)62479-3.
   Souto R, 2008, ARCH ORAL BIOL, V53, P155, DOI 10.1016/j.archoralbio.2007.08.004.
   Sun J, 2012, EUR J CLIN MICROBIOL, V31, P267, DOI 10.1007/s10096-011-1305-z.
   Sun JL, 2011, J PERIODONTOL, V82, P626, DOI 10.1902/jop.2010.100378.
   Sun JL, 2009, J CLIN MICROBIOL, V47, P2218, DOI 10.1128/JCM.00388-09.
   van Winkelhoff AJ, 2000, J CLIN PERIODONTOL, V27, P79, DOI 10.1034/j.1600-051x.2000.027002079.x.
   van Winkelhoff AJ, 2005, J CLIN PERIODONTOL, V32, P893, DOI 10.1111/j.16000051X.2005.00782.x.
   van Winkelhoff AJ, 2009, J PERIODONTOL, V80, P1555, DOI 10.1902/jop.2009.090276.
   vanWinkelhoff AJ, 1997, J CLIN PERIODONTOL, V24, P538.
   Walker CB, 1996, PERIODONTOL 2000, V10, P79, DOI 10.1111/j.1600-0757.1996.tb00069.x.
   Zehnder M, 2009, INT ENDOD J, V42, P277, DOI 10.1111/j.1365-2591.2008.01537.x.
   Zhu XF, 2010, J ENDODONT, V36, P1950, DOI 10.1016/j.joen.2010.08.053.}},
Number-of-Cited-References = {{52}},
Times-Cited = {{12}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{J. Periodont.}},
Doc-Delivery-Number = {{275NR}},
Unique-ID = {{ISI:000328684600019}},
DA = {{2018-08-13}},
}

@article{ ISI:000321869600001,
Author = {Lygizos, Melissa and Shenoi, Sheela V. and Brooks, Ralph P. and Bhushan,
   Ambika and Brust, James C. M. and Zelterman, Daniel and Deng, Yanhong
   and Northrup, Veronika and Moll, Anthony P. and Friedland, Gerald H.},
Title = {{Natural ventilation reduces high TB transmission risk in traditional
   homes in rural KwaZulu-Natal, South Africa}},
Journal = {{BMC INFECTIOUS DISEASES}},
Year = {{2013}},
Volume = {{13}},
Month = {{JUL 1}},
Abstract = {{Background: Transmission of drug susceptible and drug resistant TB
   occurs in health care facilities, and community and households settings,
   particularly in highly prevalent TB and HIV areas. There is a paucity of
   data regarding factors that may affect TB transmission risk in household
   settings. We evaluated air exchange and the impact of natural
   ventilation on estimated TB transmission risk in traditional Zulu homes
   in rural South Africa.
   Methods: We utilized a carbon dioxide decay technique to measure
   ventilation in air changes per hour (ACH). We evaluated predominant home
   types to determine factors affecting ACH and used the Wells-Riley
   equation to estimate TB transmission risk.
   Results: Two hundred eighteen ventilation measurements were taken in 24
   traditional homes. All had low ventilation at baseline when windows were
   closed (mean ACH = 3, SD = 3.0), with estimated TB transmission risk of
   55.4\% over a ten hour period of exposure to an infectious TB patient.
   There was significant improvement with opening windows and door,
   reaching a mean ACH of 20 (SD = 13.1, p < 0.0001) resulting in
   significant decrease in estimated TB transmission risk to 9.6\% (p <
   0.0001). Multivariate analysis identified factors predicting ACH,
   including ventilation conditions (windows/doors open) and window to
   volume ratio. Expanding ventilation increased the odds of achieving >=
   12 ACH by 60-fold.
   Conclusions: There is high estimated risk of TB transmission in
   traditional homes of infectious TB patients in rural South Africa.
   Improving natural ventilation may decrease household TB transmission
   risk and, combined with other strategies, may enhance TB control
   efforts.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Shenoi, SV (Reprint Author), Yale Univ, Sch Med, AIDS Program, New Haven, CT 06520 USA.
   Lygizos, Melissa, Univ Colorado, Sch Med, Aurora, CO USA.
   Shenoi, Sheela V.; Brooks, Ralph P.; Friedland, Gerald H., Yale Univ, Sch Med, AIDS Program, New Haven, CT 06520 USA.
   Bhushan, Ambika, Harvard Univ, Sch Med, Boston, MA USA.
   Brust, James C. M., Montefiore Med Ctr, Bronx, NY 10467 USA.
   Brust, James C. M., Albert Einstein Coll Med, Bronx, NY 10467 USA.
   Zelterman, Daniel; Deng, Yanhong; Northrup, Veronika, Yale Univ, Sch Publ Hlth, Ctr Analyt Sci, New Haven, CT USA.
   Moll, Anthony P., Church Scotland Hosp, Tugela Ferry, South Africa.}},
DOI = {{10.1186/1471-2334-13-300}},
Article-Number = {{300}},
ISSN = {{1471-2334}},
Keywords = {{Tuberculosis transmission; MDR/XDR TB; Household; South Africa;
   Infection control; Ventilation}},
Keywords-Plus = {{DRUG-RESISTANT TUBERCULOSIS; MULTIDRUG-RESISTANT; AIRBORNE INFECTION;
   HIV-INFECTION; PREVENTION; PREVALENCE; COMMUNITY; HOSPITALS}},
Research-Areas = {{Infectious Diseases}},
Web-of-Science-Categories  = {{Infectious Diseases}},
Author-Email = {{sheela.shenoi@yale.edu}},
ORCID-Numbers = {{Shenoi, Sheela/0000-0001-7654-4344}},
Funding-Acknowledgement = {{Doris Duke Charitable Foundation; Fogarty International Clinical
   Research Fellowship {[}R24TW007988]; Gilead Foundation; President's
   Emergency Plan for AIDS Relief; National Institute of Allergy and
   Infectious Diseases {[}K23AI089260, K23AI083088]; Einstein/Montefiore
   Center for AIDS Research {[}P30AI051519]; Charles Howland Foundation;
   Irene Diamond Fund; NRCC CTSA {[}UL1 RR024139]}},
Funding-Text = {{ML received funding from the Doris Duke Charitable Foundation. SVS
   received funding from Fogarty International Clinical Research Fellowship
   (R24TW007988), Gilead Foundation, the President's Emergency Plan for
   AIDS Relief, and the National Institute of Allergy and Infectious
   Diseases (K23AI089260). JCMB received support from the National
   Institute of Allergy and Infectious Diseases (K23AI083088) and the
   Einstein/Montefiore Center for AIDS Research (P30AI051519). AB received
   support from Charles Howland Foundation. GHF received funding from the
   Irene Diamond Fund, Gilead Foundation and the President's Emergency Plan
   for AIDS Relief. DZ, YD, VN were supported by NRCC CTSA UL1 RR024139.}},
Cited-References = {{Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991.
   Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5.
   Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106.
   Becerra MC, 2011, LANCET, V377, P147, DOI 10.1016/S0140-6736(10)61972-1.
   Cox H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029589.
   Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068.
   Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1.
   Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC.
   Grandjean L, 2011, INT J TUBERC LUNG D, V15, P1164, DOI 10.5588/ijtld.11.0030.
   Heiselberg P, 2010, INDOOR AIR, V20, P126, DOI 10.1111/j.1600-0668.2009.00630.x.
   Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251.
   Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494.
   MENZIES R, 1995, AM J RESP CRIT CARE, V152, P1992, DOI 10.1164/ajrccm.152.6.8520767.
   Middelkoop K, 2008, CLIN INFECT DIS, V47, P349, DOI 10.1086/589750.
   NARDELL EA, 1991, AM REV RESPIR DIS, V144, P302, DOI 10.1164/ajrccm/144.2.302.
   Republic of South Africa Department of Health, 2009, NAT 2009 ANT SENT HI.
   RILEY EC, 1978, AM J EPIDEMIOL, V107, P421, DOI 10.1093/oxfordjournals.aje.a112560.
   Shapiro AE, 2012, AM J RESP CRIT CARE.
   Shenoi SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031786.
   Shenoi SV, 2010, CLIN INFECT DIS, V50, pS231, DOI 10.1086/651496.
   Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1.
   Vella V, 2011, INT J TUBERC LUNG D, V15, P1170, DOI 10.5588/ijtld.10.0781.
   Wells W.F., 1955, AIRBORNE CONTAGION A.
   Whalen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016137.
   WHO, 2010, GUID INT TUB CAS FIN.
   Wood R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039246.
   World Health Organization, 2009, WHO POL TB INF CONTR.
   Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{14}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{17}},
Journal-ISO = {{BMC Infect. Dis.}},
Doc-Delivery-Number = {{184ED}},
Unique-ID = {{ISI:000321869600001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000321046300009,
Author = {Lee, Kenneth K. and Lacerna, Cristine},
Title = {{Patient-days used for isolation in a community hospital}},
Journal = {{AMERICAN JOURNAL OF INFECTION CONTROL}},
Year = {{2013}},
Volume = {{41}},
Number = {{7}},
Pages = {{612-616}},
Month = {{JUL}},
Abstract = {{Background: Isolation of patients with known or suspected infection
   strains the resources of hospitals, but little information exists on the
   actual utilization of isolation beds.
   Methods: The infection control team of a community hospital keeps a log
   of hospital days used for isolation. We obtained information from this
   log for August 2009 through August 2010 on hospital days for isolation
   due to methicillin-resistant Staphylococcus aureus, vancomycin-resistant
   enterococci, Clostridium difficile, other multidrug-resistant organisms,
   and disorders necessitating droplet or airborne isolation, such as
   tuberculosis, meningococcal meningitis, varicella, and influenza. We
   also included days of isolation used to rule out the presence of these
   infections. All data from the medical-surgical and intensive care units
   were included unless the start date or end date of isolation was
   missing. Utilization percentages (isolation days divided by total
   hospital days) were calculated for the total period, for each month, and
   for each category of isolation.
   Results: During the study period, 18.1\% of hospital days were devoted
   to isolation (13.7\% for definite infection and 4.4\% to rule out
   infection). Monthly utilization ranged from 13.4\% to 22\%. Patients
   with confirmed methicillin-resistant S aureus or C difficile infections
   and patients with possible C difficile infection accounted for 75\% of
   the isolation days.
   Conclusions: Isolation beds were required for a substantial portion of
   total patient-days in our study. Our data may help hospitals use
   hospital beds efficiently and predict nursing needs, hospital supply
   needs, and workload for environmental services. Copyright (C) 2013 by
   the Association for Professionals in Infection Control and Epidemiology,
   Inc. Published by Elsevier Inc. All rights reserved.}},
Publisher = {{MOSBY-ELSEVIER}},
Address = {{360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lacerna, C (Reprint Author), 1950 Franklin St,14th Floor, Oakland, CA 94612 USA.
   Lee, Kenneth K.; Lacerna, Cristine, Kaiser Fdn Med Ctr, Infect Control Dept, Div Infect Dis, Roseville, CA USA.}},
DOI = {{10.1016/j.ajic.2012.07.011}},
ISSN = {{0196-6553}},
Keywords = {{Methicillin-resistant Staphylococcus aureus; Clostridium difficile;
   Hospital resources; Infection control}},
Keywords-Plus = {{RESISTANT STAPHYLOCOCCUS-AUREUS; HEALTH-CARE SETTINGS;
   CLOSTRIDIUM-DIFFICILE; UNITED-STATES; DISEASE; IMPACT}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{Cristine.C.Lacerna@kp.org}},
ResearcherID-Numbers = {{Amoako, Daniel Gyamfi/I-4223-2018}},
Cited-References = {{Abbett SK, 2009, INFECT CONT HOSP EP, V30, P1062, DOI 10.1086/644757.
   Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590.
   Caffrey AR, 2011, INFECTION, V40, P291.
   Chaberny IF, 2005, INT J HYG ENVIR HEAL, V208, P447, DOI 10.1016/j.ijheh.2005.08.004.
   Cooper CL, 2002, INFECT CONT HOSP EP, V23, P483, DOI 10.1086/503472.
   Garner J S, 1972, Am J Nurs, V72, P733, DOI 10.2307/3422075.
   Haan MN, 1997, J AM GERIATR SOC, V45, P667, DOI 10.1111/j.1532-5415.1997.tb01468.x.
   KIM MHM, 1987, INFECT CONT HOSP EP, V8, P195, DOI 10.1017/S0195941700065930.
   Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629.
   LANGLEY JM, 1994, AM J INFECT CONTROL, V22, P207, DOI 10.1016/0196-6553(94)90069-8.
   Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007.
   Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/ajic.2007.10.006.
   Song XY, 2008, INFECT CONT HOSP EP, V29, P823, DOI 10.1086/588756.
   Vesteinsdottir I, 2012, EUR J CLIN MICROBIOL, V31, P2601, DOI 10.1007/s10096-012-1603-0.
   Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211.
   Zilberberg MD, 2009, EMERG INFECT DIS, V15, P122, DOI 10.3201/eid1501.080793.}},
Number-of-Cited-References = {{16}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{Am. J. Infect. Control}},
Doc-Delivery-Number = {{172ZI}},
Unique-ID = {{ISI:000321046300009}},
DA = {{2018-08-13}},
}

@article{ ISI:000321158100001,
Author = {Nisiotou, A. and Chorianopoulos, N. G. and Gounadaki, A. and Panagou, E.
   Z. and Nychas, G. -J. E.},
Title = {{Effect of wine-based marinades on the behavior of Salmonella Typhimurium
   and background flora in beef fillets}},
Journal = {{INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY}},
Year = {{2013}},
Volume = {{164}},
Number = {{2-3}},
Pages = {{119-127}},
Month = {{JUN 17}},
Abstract = {{The aim of this study was to evaluate the wine-based marinades to
   control the survival of acid-adapted and non-adapted Salmonella
   Typhimurium and background flora of fresh beef stored aerobically or
   under modified atmosphere. Beef slices were inoculated with a 3-strain
   cocktail of acid-adapted or non-adapted Salmonella Typhimurium strains
   DT 193, 4/74 and DSM 554 and marinated by immersion in wine (W) or wine
   supplemented with 0.3\% thyme essential oil (WEO), for 12 h at 4 degrees
   C. Marinated slices were then stored under air or modified atmosphere
   conditions at 5 degrees C. S. Typhimurium and background flora were
   followed for a 19-day period of storage. S. Typhimurium individual
   strains were monitored by pulsed field gel electrophoresis. Marination
   with wine significantly (P < 0.05) reduced the background flora compared
   to the control (non-marinated). Furthermore, immersion of fillets in W
   or WEO marinades for 12 h significantly (P < 0.05) reduced the levels of
   S. Typhimurium compared to the non-marinated (control) samples by 1.1
   and 1.4 log CFU/g or 2.0 and 1.9 log CFU/g for acid-adapted and
   non-adapted cells, respectively. Acid-adapted cells were more
   susceptible (P < 0.05) to the addition of thyme essential oil in the
   wine marinade. The epidemic multi-drug resistant DT 193, the 4/74 and
   DSM 554 strains survived marination (for both W and WEO) and were
   detected at about similar proportions as revealed by PFGE results.
   Present results indicate that wine-based marinades are efficient, from a
   safety and shelf life stand point, in reducing pathogen's levels as well
   as the background beef flora. (c) 2013 Elsevier B.V. All rights
   reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chorianopoulos, NG (Reprint Author), Vet Res Inst Athens, Neapoleos 25, Aghia Paraskevi 15310, Greece.
   Nisiotou, A., Wine Inst, Hellen Agr Org DEMETER, Lycovrissi 14123, Greece.
   Chorianopoulos, N. G., Vet Res Inst Athens, Hellen Agr Org DEMETER, Aghia Paraskevi 15310, Greece.
   Gounadaki, A.; Panagou, E. Z.; Nychas, G. -J. E., Agr Univ Athens, Dept Food Sci \& Technol, Lab Microbiol \& Biotechnol Foods, GR-11855 Athens, Greece.}},
DOI = {{10.1016/j.ijfoodmicro.2013.04.008}},
ISSN = {{0168-1605}},
Keywords = {{Beef fillets; Wine-based marinades; Thyme essential oil; Salmonella
   Typhimurium; PFGE}},
Keywords-Plus = {{ESCHERICHIA-COLI O157-H7; LISTERIA-MONOCYTOGENES STRAINS; ACID
   TOLERANCE; ENVIRONMENTAL-STRESSES; ESSENTIAL OILS; IN-VITRO; SURVIVAL;
   STORAGE; ADAPTATION; MARINATION}},
Research-Areas = {{Food Science \& Technology; Microbiology}},
Web-of-Science-Categories  = {{Food Science \& Technology; Microbiology}},
Author-Email = {{nchorian@aua.gr}},
ResearcherID-Numbers = {{Nychas, George/B-2734-2009
   }},
ORCID-Numbers = {{Nychas, George/0000-0002-2673-6425
   Panagou, Efstathios/0000-0002-0317-1177}},
Funding-Acknowledgement = {{European Union project (ProSafeBeef) within the 6th Framework Programme
   {[}Food-CT-2006-36241]}},
Funding-Text = {{This work was financially supported by the European Union project
   (ProSafeBeef) within the 6th Framework Programme (ref.
   Food-CT-2006-36241). The authors would like to thank V. Iliopoulos for
   technical support.}},
Cited-References = {{Adams R.P., 2001, MASS SPECTROSCOPY, V469.
   Avery SM, 1997, INT J FOOD MICROBIOL, V34, P319, DOI 10.1016/S0168-1605(96)01191-9.
   Birk T, 2009, J FOOD PROTECT, V72, P549, DOI 10.4315/0362-028X-72.3.549.
   Buchanan RL, 1996, APPL ENVIRON MICROB, V62, P4009.
   Burke RM, 2003, MEAT SCI, V63, P161, DOI 10.1016/S0309-1740(02)00062-1.
   Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022.
   Cadun A, 2008, FOOD CHEM, V109, P81, DOI 10.1016/j.foodchem.2007.12.021.
   Calicioglu M, 2003, INT J FOOD MICROBIOL, V86, P283, DOI 10.1016/S0168-1605(02)00565-2.
   Carlos AMA, 1999, J APPL POULTRY RES, V8, P100, DOI 10.1093/japr/8.1.100.
   Chorianopoulos N, 2004, J AGR FOOD CHEM, V52, P8261, DOI 10.1021/jf049113i.
   Cosentino Cl, 1999, LETT APPL MICROBIOL, V29, P130.
   Dykes GA, 2000, INT J FOOD MICROBIOL, V56, P161, DOI 10.1016/S0168-1605(99)00205-6.
   Friedman M., 2007, J FOOD SCI, V72, P207.
   GILL CO, 1991, FOOD MICROBIOL, V8, P339, DOI 10.1016/S0740-0020(05)80008-5.
   Just JR, 2003, J FOOD SCI, V68, P285, DOI 10.1111/j.1365-2621.2003.tb14154.x.
   Kagkli DM, 2007, J APPL MICROBIOL, V103, P1393, DOI 10.1111/j.1365-2672.2007.03338.x.
   Kagkli DM, 2009, APPL ENVIRON MICROB, V75, P3621, DOI 10.1128/AEM.01571-08.
   Kargiotou C, 2011, FOOD MICROBIOL, V28, P158, DOI 10.1016/j.fm.2010.09.013.
   Koutsoumanis KP, 2004, LETT APPL MICROBIOL, V38, P321, DOI 10.1111/j.1472-765X.2004.01491.x.
   LEYER GJ, 1993, APPL ENVIRON MICROB, V59, P1842.
   LEYER GJ, 1992, APPL ENVIRON MICROB, V58, P2075.
   Lianou A, 2006, J FOOD PROTECT, V69, P2640, DOI 10.4315/0362-028X-69.11.2640.
   Liu CC, 2006, J FOOD PROTECT, V69, P1823, DOI 10.4315/0362-028X-69.8.1823.
   Lopez V, 2007, J FOOD PROTECT, V70, P1513, DOI 10.4315/0362-028X-70.6.1513.
   Lou YQ, 1997, APPL ENVIRON MICROB, V63, P1252.
   Lv F, 2011, FOOD RES INT, V44, P3057, DOI 10.1016/j.foodres.2011.07.030.
   MACPHEE DG, 1973, APPL MICROBIOL, V26, P1004.
   MAGUIRE HCF, 1993, EPIDEMIOL INFECT, V110, P239, DOI 10.1017/S0950268800068151.
   Marimon JM, 1998, J CLIN GASTROENTEROL, V27, P179, DOI 10.1097/00004836-199809000-00021.
   Massada Y, 1976, ANAL ESSENTIAL OIL G.
   MORETRO T, 2004, J FOOD SCI, V69, P251.
   Mukherjee A, 2008, J FOOD PROTECT, V71, P1349, DOI 10.4315/0362-028X-71.7.1349.
   Nychas GJE, 2008, MEAT SCI, V78, P77, DOI 10.1016/j.meatsei.2007.06.020.
   Pontello M, 1998, EPIDEMIOL INFECT, V120, P209, DOI 10.1017/S095026889800870X.
   Rodriguez Vaquero M. J., 2007, Food Control, V18, P93, DOI 10.1016/j.foodcont.2005.08.010.
   Samelis J, 2003, MICROBIAL STRESS ADAPTATION AND FOOD SAFETY, P303.
   Samelis J, 2003, J APPL MICROBIOL, V95, P563, DOI 10.1046/j.1365-2672.2003.02013.x.
   Scott V. N., 2005, Food Protection Trends, V25, P818.
   Stopforth JD, 2007, FOOD MICROBIOL, V24, P530, DOI 10.1016/j.fm.2006.05.007.
   Sugita-Konishi Y, 2001, BIOSCI BIOTECH BIOCH, V65, P954, DOI 10.1271/bbb.65.954.
   Tassou C. C., 2012, HDB HERBS SPICES, VII, P17.
   Vialette M, 2003, INT J FOOD MICROBIOL, V82, P121, DOI 10.1016/S0168-1605(02)00249-0.
   Weisse ME, 1995, BRIT MED J, V311, P1657, DOI 10.1136/bmj.311.7021.1657.
   Yoon Y, 2005, FOOD MICROBIOL, V22, P423, DOI 10.1016/j.fm.2004.09.012.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{11}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{12}},
Journal-ISO = {{Int. J. Food Microbiol.}},
Doc-Delivery-Number = {{174LX}},
Unique-ID = {{ISI:000321158100001}},
DA = {{2018-08-13}},
}

@article{ ISI:000321066100001,
Author = {Heederik, Dick},
Title = {{Potential Public Health Consequences of Exposure Assessment for
   Staphylococcus aureus: Commentary on the Paper by Masclaux et al.}},
Journal = {{ANNALS OF OCCUPATIONAL HYGIENE}},
Year = {{2013}},
Volume = {{57}},
Number = {{5}},
Pages = {{545-549}},
Month = {{JUN}},
Abstract = {{The study of Masclaux et al., in this issue of the Annals of
   Occupational Hygiene, describes measurement of Staphylococcus bacteria
   in pig farms using classical viable measurement techniques and molecular
   techniques. Molecular techniques find application in hygiene field
   studies more often and create new opportunities. Common dust sampling
   approaches can be used in combination with molecular techniques and high
   numbers of samples can be processed creating opportunities for hygiene
   control and for exposure assessment in the context of epidemiological
   surveys. Hygienists should be aware of the advantages and disadvantages
   of the use of these techniques. Aspects of microbial sampling are
   briefly reviewed.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Editorial Material}},
Language = {{English}},
Affiliation = {{Heederik, D (Reprint Author), Univ Utrecht, IRAS, POB 80178, NL-3508 TD Utrecht, Netherlands.
   Univ Utrecht, IRAS, NL-3508 TD Utrecht, Netherlands.}},
DOI = {{10.1093/annhyg/met034}},
ISSN = {{0003-4878}},
Keywords = {{microbial exposure; microbiological assessment; microorganisms; MRSA}},
Keywords-Plus = {{LIVESTOCK-ASSOCIATED MRSA; ANTIBIOTIC-RESISTANT; PIG FARMERS; AIR;
   ST398; ENVIRONMENT; PREVALENCE; OPERATIONS; BACTERIA; GERMANY}},
Research-Areas = {{Public, Environmental \& Occupational Health; Toxicology}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Toxicology}},
Author-Email = {{d.heederik@uu.nl}},
Cited-References = {{Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866.
   Bisdorff B, 2012, EPIDEMIOL INFECT, V140, P1800, DOI 10.1017/S0950268811002378.
   Bos M, 2013, 23 C EP OCC HLTH JUN.
   Friese A, 2013, APPL ENVIRON MICROB, V79, P2759, DOI 10.1128/AEM.03939-12.
   Friese A, 2013, BERL MUNCH TIERARZTL, V126, P175, DOI 10.2376/0005-9366-126-175.
   Friese A, 2012, VET MICROBIOL, V158, P129, DOI 10.1016/j.vetmic.2012.01.019.
   Gibbs SG, 2004, J OCCUP ENVIRON HYG, V1, P699, DOI 10.1080/15459620490515824.
   Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910.
   Gilbert MJ, 2012, OCCUP ENVIRON MED, V69, P472, DOI 10.1136/oemed-2011-100069.
   Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990.
   Green CF, 2006, J OCCUP ENVIRON HYG, V3, P9, DOI 10.1080/15459620500430615.
   Kluytmans J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b364.
   Masclaux F, 2013, ANN OCCUP HYG.
   Oppliger A, 2012, APPL ENVIRON MICROB, V78, P8010, DOI 10.1128/AEM.01902-12.
   Porphyre T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047504.
   Price L.B., 2012, MBIO, V3.
   Schulz J, 2011, AEROBIOLOGIA, V27, P311, DOI 10.1007/s10453-011-9202-6.
   Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069.
   Tringe SG, 2005, NAT REV GENET, V6, P805, DOI 10.1038/nrg1709.
   Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862.
   van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385.
   van Meurs MLJGM, 2013, INFECTION, V41, P339, DOI 10.1007/s15010-012-0319-5.
   Vanderhaeghen W, 2010, EPIDEMIOL INFECT, V138, P606, DOI 10.1017/S0950268809991567.
   Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428.
   Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x.
   Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x.}},
Number-of-Cited-References = {{26}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{11}},
Journal-ISO = {{Ann. Occup. Hyg.}},
Doc-Delivery-Number = {{173GJ}},
Unique-ID = {{ISI:000321066100001}},
DA = {{2018-08-13}},
}

@article{ ISI:000320772800019,
Author = {Zhou, Feng and Wang, Yuyan},
Title = {{Characteristics of Antibiotic Resistance of Airborne Staphylococcus
   Isolated from Metro Stations}},
Journal = {{INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH}},
Year = {{2013}},
Volume = {{10}},
Number = {{6}},
Pages = {{2412-2426}},
Month = {{JUN}},
Abstract = {{This study focused on the presence of antibiotic-resistant bacteria in a
   metro system as an example of a public transportation system. The
   molecular characteristics of Staphylococcus were investigated to discern
   which strains were isolated from metro stations in Shanghai. These were
   compared with strains isolated from hospital treatment rooms and parks.
   Airborne Staphylococcus samples in the metro were resistant to an
   average of 2.64 antibiotic types, and 58.0\% of the strain samples were
   resistant to at least three antibiotics; this was a significantly higher
   rate than strains from the park, but was lower than those from
   hospitals. The presence of two antibiotic resistance genes of
   Staphylococcus strains, mecA (28.0\%) and qac (40.0\%), were also found
   at significantly higher levels in metro samples than park samples, but
   did not differ significantly from hospital samples. Furthermore, 22.0\%
   of the metro Staphylococcus samples were found to be biofilm-positive.
   The high rate of antibiotic resistance found in Staphylococcus samples
   collected from metro stations, and the discovery of antibiotic-resistant
   genes, indicate that the closed indoor environment and crowded
   passengers may accelerate the spread of antibiotic resistant strains.
   More attention should be paid to the inspection and control of
   antibiotic resistant strains in public transportation systems.}},
Publisher = {{MDPI AG}},
Address = {{POSTFACH, CH-4005 BASEL, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wang, YY (Reprint Author), Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol \& Parasitol, Shanghai 200032, Peoples R China.
   Zhou, Feng, Fudan Univ, Sch Basic Med Sci, Dept Clin Med, Shanghai 200032, Peoples R China.
   Wang, Yuyan, Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol \& Parasitol, Shanghai 200032, Peoples R China.}},
DOI = {{10.3390/ijerph10062412}},
ISSN = {{1660-4601}},
Keywords = {{Staphylococci; antibiotic susceptibility; mecA; qac; biofilm; metro
   stations}},
Keywords-Plus = {{COAGULASE-NEGATIVE STAPHYLOCOCCI; METHICILLIN-RESISTANT; BIOFILM
   FORMATION; AUREUS; COMMUNITY; GENE; EPIDERMIDIS; STRAINS; SPP.; MRSA}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{09301010100@fudan.edu.cn
   yuyanss@fudan.edu.cn}},
Funding-Acknowledgement = {{Fudan's Undergraduate Research Opportunity Program (FDUROP) {[}10081];
   Dean's Office of School of Basic Medical Sciences, Fudan University
   (NSFC) {[}J1210041]}},
Funding-Text = {{We thank Di Qu (Shanghai Medical College, Fudan University) for kindly
   providing the facilities used in this study. This work was financially
   supported by the Fudan's Undergraduate Research Opportunity Program
   (FDUROP, No. 10081) and Dean's Office of School of Basic Medical
   Sciences, Fudan University (NSFC grant, No. J1210041).}},
Cited-References = {{Awad AHA, 2002, J OCCUP HEALTH, V44, P112, DOI 10.1539/joh.44.112.
   Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5.
   Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697.
   Barbier F, 2010, J INFECT DIS, V202, P270, DOI 10.1086/653483.
   Bjorland J, 2003, ANTIMICROB AGENTS CH, V47, P3046, DOI 10.1128/AAC.47.10.3046-3052.2003.
   BLAHOVA J, 1993, ACTA VIROL, V37, P429.
   Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476.
   Dong SF, 2010, ENVIRON MONIT ASSESS, V170, P331, DOI 10.1007/s10661-009-1236-7.
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002.
   Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972.
   Dybwad M, 2012, APPL ENVIRON MICROB, V78, P1917, DOI 10.1128/AEM.07212-11.
   Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599.
   Gilleberg SB, 1998, INT BIODETER BIODEGR, V41, P149, DOI 10.1016/S0964-8305(98)00005-5.
   Gillespie BE, 2009, VET MICROBIOL, V134, P65, DOI 10.1016/j.vetmic.2008.09.007.
   Harbarth S, 1998, ARCH INTERN MED, V158, P182, DOI 10.1001/archinte.158.2.182.
   Heir E, 1998, FEMS MICROBIOL LETT, V163, P49, DOI 10.1111/j.1574-6968.1998.tb13025.x.
   Hisata K, 2011, J INFECT CHEMOTHER, V17, P609, DOI 10.1007/s10156-011-0223-4.
   Hwang SH, 2010, ATMOS ENVIRON, V44, P1658, DOI 10.1016/j.atmosenv.2010.01.047.
   HYDER SL, 1978, J INFECT DIS, V138, P281, DOI 10.1093/infdis/138.3.281.
   Kawasaki Tamami, 2010, J Occup Health, V52, P186, DOI 10.1539/joh.O9022.
   Koksal F, 2009, MICROBIOL RES, V164, P404, DOI 10.1016/j.micres.2007.03.004.
   Koskela A, 2009, EUR J CLIN MICROBIOL, V28, P655, DOI 10.1007/s10096-008-0664-6.
   Kuenne C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012511.
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404.
   Li M, 2009, J MED MICROBIOL, V58, P456, DOI 10.1099/jmm.0.007567-0.
   LORENZ MG, 1994, MICROBIOL REV, V58, P563.
   Luthje P, 2007, J ANTIMICROB CHEMOTH, V59, P600, DOI 10.1093/jac/dkm008.
   Luo M., 2010, J MODERN CLIN MED, V5, P83.
   Mandell G. L., 2000, MANDELL DAUGLAS BENN, P2049.
   Ministry coccu of Health Law and Oversight Division, 2002, DIS TECHN SPEC.
   Mitchell BA, 1998, ANTIMICROB AGENTS CH, V42, P475.
   Nobile CGA, 2013, FOOD CONTROL, V32, P715, DOI 10.1016/j.foodcont.2013.02.011.
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49.
   Onni T, 2010, VET MICROBIOL, V144, P347, DOI 10.1016/j.vetmic.2010.01.016.
   POSTON SM, 1991, J MED MICROBIOL, V34, P193, DOI 10.1099/00222615-34-4-193.
   Reynolds KA, 2005, INT J ENVIRON HEAL R, V15, P225, DOI 10.1080/09603120500115298.
   Schnellmann C, 2006, J CLIN MICROBIOL, V44, P4444, DOI 10.1128/JCM.00868-06.
   Schreckenberger PC, 2004, J CLIN MICROBIOL, V42, P2777, DOI 10.1128/JCM.42.6.2777-2779.2004.
   Siddiqui AR, 2010, CLIN DERMATOL, V28, P519, DOI 10.1016/j.clindermatol.2010.03.009.
   Sobhy N, 2012, BRAZ J INFECT DIS, V16, P426, DOI 10.1016/j.bjid.2012.08.004.
   Soge OO, 2009, J ANTIMICROB CHEMOTH, V64, P1148, DOI 10.1093/jac/dkp368.
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121.
   Wang L, 2008, J INFECT DIS, V197, P1254, DOI 10.1086/586714.
   Wei W. P., 2010, CHINA PRAC MED, V5, P67.
   WHO, 1996, WORLD HLTH REP.
   Yeh Pamela J, 2011, Osong Public Health Res Perspect, V2, P202, DOI 10.1016/j.phrp.2011.11.047.
   Zhu B, 2006, WATER RES, V40, P3231, DOI 10.1016/j.watres.2006.06.040.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{16}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{27}},
Journal-ISO = {{Int. J. Environ. Res. Public Health}},
Doc-Delivery-Number = {{169IE}},
Unique-ID = {{ISI:000320772800019}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000321201300037,
Author = {Farag, Tamer H. and Faruque, Abu S. and Wu, Yukun and Das, Sumon K. and
   Hossain, Anowar and Ahmed, Shahnawaz and Ahmed, Dilruba and Nasrin,
   Dilruba and Kotloff, Karen L. and Panchilangam, Sandra and Nataro, James
   P. and Cohen, Dani and Blackwelder, William C. and Levine, Myron M.},
Title = {{Housefly Population Density Correlates with Shigellosis among Children
   in Mirzapur, Bangladesh: A Time Series Analysis}},
Journal = {{PLOS NEGLECTED TROPICAL DISEASES}},
Year = {{2013}},
Volume = {{7}},
Number = {{6}},
Month = {{JUN}},
Abstract = {{Background: Shigella infections are a public health problem in
   developing and transitional countries because of high transmissibility,
   severity of clinical disease, widespread antibiotic resistance and lack
   of a licensed vaccine. Whereas Shigellae are known to be transmitted
   primarily by direct fecal-oral contact and less commonly by contaminated
   food and water, the role of the housefly Musca domestica as a mechanical
   vector of transmission is less appreciated. We sought to assess the
   contribution of houseflies to Shigella-associated moderate-to-severe
   diarrhea (MSD) among children less than five years old in Mirzapur,
   Bangladesh, a site where shigellosis is hyperendemic, and to model the
   potential impact of a housefly control intervention.
   Methods: Stool samples from 843 children presenting to Kumudini Hospital
   during 2009-2010 with new episodes of MSD (diarrhea accompanied by
   dehydration, dysentery or hospitalization) were analyzed. Housefly
   density was measured twice weekly in six randomly selected sentinel
   households. Poisson time series regression was performed and
   autoregression-adjusted attributable fractions (AFs) were calculated
   using the Bruzzi method, with standard errors via jackknife procedure.
   Findings: Dramatic springtime peaks in housefly density in 2009 and 2010
   were followed one to two months later by peaks of Shigella-associated
   MSD among toddlers and pre-school children. Poisson time series
   regression showed that housefly density was associated with Shigella
   cases at three lags (six weeks) (Incidence Rate Ratio = 1.39 {[}95\% CI:
   1.23 to 1.58] for each log increase in fly count), an association that
   was not confounded by ambient air temperature. Autocorrelation-adjusted
   AF calculations showed that a housefly control intervention could have
   prevented approximately 37\% of the Shigella cases over the study
   period.
   Interpretation: Houseflies may play an important role in the seasonal
   transmission of Shigella in some developing country ecologies.
   Interventions to control houseflies should be evaluated as possible
   additions to the public health arsenal to diminish Shigella (and perhaps
   other causes of) diarrheal infection.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Farag, TH (Reprint Author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.
   Farag, Tamer H.; Wu, Yukun; Ahmed, Dilruba; Nasrin, Dilruba; Kotloff, Karen L.; Blackwelder, William C.; Levine, Myron M., Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.
   Faruque, Abu S.; Das, Sumon K.; Hossain, Anowar; Ahmed, Shahnawaz; Ahmed, Dilruba, Int Ctr Diarrhoeal Dis Res ICDDR B, Dhaka, Bangladesh.
   Nataro, James P., Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA.
   Cohen, Dani, Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Ramat Aviv, Israel.}},
DOI = {{10.1371/journal.pntd.0002280}},
Article-Number = {{e2280}},
ISSN = {{1935-2735}},
Keywords-Plus = {{ENTERIC PATHOGENS; MUSCA-DOMESTICA; EPIDEMIOLOGY; TRANSMISSION;
   DIARRHEA; FLIES; DISEASE; SURVEILLANCE; DYSENTERIAE; THAILAND}},
Research-Areas = {{Infectious Diseases; Parasitology; Tropical Medicine}},
Web-of-Science-Categories  = {{Infectious Diseases; Parasitology; Tropical Medicine}},
Author-Email = {{tfarag@medicine.umaryland.edu}},
ResearcherID-Numbers = {{kotloff, karen/E-7768-2012}},
ORCID-Numbers = {{kotloff, karen/0000-0003-1808-6431}},
Funding-Acknowledgement = {{Bill and Melinda Gates Foundation {[}38874]}},
Funding-Text = {{This work was supported by grant ID \#38874 from the Bill and Melinda
   Gates Foundation (MML, principal investigator). The corresponding author
   had full access to all data and has final responsibility for the
   decision to submit for publication. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.}},
Cited-References = {{Agtini MD, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-89.
   BIDAWID S P, 1978, Annals of Tropical Medicine and Parasitology, V72, P117.
   BLACK RE, 1978, AM J EPIDEMIOL, V108, P47.
   Blackwelder WC, 2012, CLIN INFECT DIS, V55, pS246, DOI 10.1093/cid/cis788.
   Brumback BA, 2000, J AM STAT ASSOC, V95, P16.
   BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174.
   Chavasse DC, 1999, LANCET, V353, P22, DOI 10.1016/S0140-6736(98)03366-2.
   Chiou CS, 2001, J CLIN MICROBIOL, V39, P1048, DOI 10.1128/JCM.39.3.1048-1056.2001.
   Chompook P, 2005, B WORLD HEALTH ORGAN, V83, P739.
   COHEN D, 1991, LANCET, V337, P993, DOI 10.1016/0140-6736(91)92657-N.
   DAVIDSON A., 1962, Rivista di Parassitologia, V23, P61.
   Dudgeon LS, 1919, BRIT MED J, V1919, P448.
   DUPONT HL, 1989, J INFECT DIS, V159, P1126, DOI 10.1093/infdis/159.6.1126.
   DUPONT HL, 1970, AM J EPIDEMIOL, V92, P172, DOI 10.1093/oxfordjournals.aje.a121195.
   ECHEVERRIA P, 1983, APPL ENVIRON MICROB, V46, P32.
   FERRECCIO C, 1991, AM J EPIDEMIOL, V134, P614, DOI 10.1093/oxfordjournals.aje.a116134.
   Huang W, 2012, AM J EPIDEMIOL, V175, P556, DOI 10.1093/aje/kwr342.
   Khan AI, 2006, EPIDEMIOL INFECT, V134, P605, DOI 10.1017/S0950268805005534.
   KHAN M, 1980, T ROY SOC TROP MED H, V74, P528, DOI 10.1016/0035-9203(80)90071-1.
   Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753.
   LEVINE MM, 1973, J INFECT DIS, V127, P261, DOI 10.1093/infdis/127.3.261.
   Levine MM, 2009, AM SOC TROP MED HYG.
   LEVINE OS, 1991, REV INFECT DIS, V13, P688.
   LINDSAY DR, 1953, PUBLIC HEALTH REP, V68, P361, DOI 10.2307/4588424.
   LINDSAY DR, 1956, ANNU REV ENTOMOL, V1, P323, DOI 10.1146/annurev.en.01.010156.001543.
   MAURELLI AT, 1984, INFECT IMMUN, V43, P195.
   MER G. G., 1960, Rivista di Parassitologia, V21, P143.
   Nash JTC, 1909, J HYG-CAMBRIDGE, V9, P141, DOI 10.1017/S0022172400016211.
   National Climatic Data Center, 2013, GLOB SUMM DAY DAT DH.
   Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754.
   Peffly RL, 1953, J EGYPTIAN PUBL HLTH, V28, P55.
   PICKERING LK, 1986, REV INFECT DIS, V8, P539.
   Rozendaal JA, 1997, VECTOR CONTROL METHO, P302.
   SCHOOF HERBERT F., 1959, PEST CONTROL, V27, P16.
   SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136.
   STOLL BJ, 1982, J INFECT DIS, V146, P177, DOI 10.1093/infdis/146.2.177.
   TUKEY JW, 1958, ANN MATH STAT, V29, P614.
   WATT J, 1948, PUBLIC HEALTH REP, V63, P1319, DOI 10.2307/4586723.
   Wei W. W. S, 2005, TIME SERIES ANAL UNI.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{18}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{13}},
Journal-ISO = {{Plos Neglect. Trop. Dis.}},
Doc-Delivery-Number = {{175AL}},
Unique-ID = {{ISI:000321201300037}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000317304700012,
Author = {Li, Song and Zhao, Miaoqing and Li, Yanling and Zhang, Ling and Zhang,
   Xianzhong and Miao, Zengmin},
Title = {{Detection and source identification of airborne extended-spectrum
   beta-lactamase-producing Escherichia coli isolates in a chicken house}},
Journal = {{AEROBIOLOGIA}},
Year = {{2013}},
Volume = {{29}},
Number = {{2}},
Pages = {{315-319}},
Month = {{JUN}},
Abstract = {{To identify airborne dissemination of extended-spectrum beta-lactamase
   (ESBL)-producing Escherichia coli (E. coli) in a chicken house, airborne
   E. coli was collected from indoor air of a chicken house using six-stage
   Anderson sampler, and E. coli from chicken fecal samples were also
   isolated simultaneously. ESBL-producing E. coli isolates from indoor air
   and fecal samples were screened by a phenotypic confirmatory test
   according to CLSI recommendations. And then, the enterobacterial
   repetitive intergenic consensus polymerase chain reaction was performed
   to analyze the source of airborne ESBL-producing E. coli. The results
   showed that the ESBL-positive rates of E. coli isolates from feces and
   the indoor air were 56 \% (18/32) and 40 \% (6/15), respectively.
   Furthermore, airborne ESBL-producing E. coli isolates in the chicken
   house had 100 \% genetic similarities with the strains from chicken
   feces, indicating that ESBL-producing E. coli from chicken feces could
   be aerosolized and spread to the air.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Miao, ZM (Reprint Author), Taishan Med Univ, Coll Life Sci, Tai An 271018, Shandong, Peoples R China.
   Li, Song, Taishan Med Univ, Coll Basic Med, Tai An 271018, Shandong, Peoples R China.
   Zhao, Miaoqing, Shandong Prov Hosp, Dept Pathol, Jinan 265200, Shandong, Peoples R China.
   Li, Yanling; Zhang, Ling; Zhang, Xianzhong; Miao, Zengmin, Taishan Med Univ, Coll Life Sci, Tai An 271018, Shandong, Peoples R China.}},
DOI = {{10.1007/s10453-012-9273-z}},
ISSN = {{0393-5965}},
EISSN = {{1573-3025}},
Keywords = {{Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (E.
   coli); Chicken house; Enterobacterial repetitive intergenic consensus
   (ERIC); Genetic similarity}},
Keywords-Plus = {{ANTIMICROBIAL RESISTANCE; FARM-ANIMALS; CTX-M; SEQUENCES; PATTERNS;
   STRAINS; GENOMES; GENES; CHINA}},
Research-Areas = {{Life Sciences \& Biomedicine - Other Topics; Environmental Sciences \&
   Ecology}},
Web-of-Science-Categories  = {{Biology; Environmental Sciences}},
Author-Email = {{zengminmiao@126.com}},
Cited-References = {{Aarestrup FM, 2006, J ANTIMICROB CHEMOTH, V57, P1258, DOI 10.1093/jac/dkl109.
   Amy C., 2005, ENVIRON HEALTH PERSP, V113, P137.
   ANDERSEN AA, 1958, J BACTERIOL, V76, P471.
   Borges L. G., 2003, FEMS MICROBIOL ECOL, V43, P173.
   Canton R, 2008, CLIN MICROBIOL INFEC, V14, P144, DOI 10.1111/j.1469-0691.2007.01850.x.
   Cheng DR, 2006, VET MICROBIOL, V115, P320, DOI 10.1016/j.vetmic.2006.02.013.
   Daniela C., 2009, VET MICROBIOL, V138, P339.
   Duan RS, 2006, MICROB DRUG RESIST, V12, P145, DOI 10.1089/mdr.2006.12.145.
   Franz F. R., 2010, WATER RES, V44, P1981.
   Girlich D, 2007, APPL ENVIRON MICROB, V73, P4681, DOI 10.1128/AEM.02491-06.
   Hu GongZheng, 2005, Agricultural Sciences in China, V4, P877.
   HULTON CSJ, 1991, MOL MICROBIOL, V5, P825, DOI 10.1111/j.1365-2958.1991.tb00755.x.
   Kim TE, 2007, J CLIN MICROBIOL, V45, P3309, DOI 10.1128/JCM.01922-06.
   Kojima A, 2005, ANTIMICROB AGENTS CH, V49, P3533, DOI 10.1128/AAC.49.8.3533-3537.2005.
   Leverstein-van H. M., 2011, CLIN MICROBIOL INFEC, V17, P873.
   LIPMAN LJA, 1995, VET MICROBIOL, V43, P13, DOI 10.1016/0378-1135(94)00070-D.
   Liu JH, 2007, INT J ANTIMICROB AG, V29, P576, DOI 10.1016/j.ijantimicag.2006.12.015.
   MACHER JM, 1989, AM IND HYG ASSOC J, V50, P561, DOI 10.1202/0002-8894(1989)050<0561:PCOMIF>2.0.CO;2.
   McCartney AL, 1996, APPL ENVIRON MICROB, V62, P4608.
   Prado T, 2008, LETT APPL MICROBIOL, V46, P136, DOI 10.1111/j.1472-765X.2007.02275.x.
   Rohlf F. J., 2000, NTSYS PC NUMERICAL T.
   Skurnik D, 2006, J ANTIMICROB CHEMOTH, V57, P1215, DOI 10.1093/jac/dkl122.
   Smet A, 2008, ANTIMICROB AGENTS CH, V52, P1238, DOI 10.1128/AAC.01285-07.
   Sorum H, 2001, VET RES, V32, P227, DOI 10.1051/vetres:2001121.
   VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823.
   Yang CM, 2009, LETT APPL MICROBIOL, V48, P560, DOI 10.1111/j.1472-765X.2009.02572.x.}},
Number-of-Cited-References = {{26}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{18}},
Journal-ISO = {{Aerobiologia}},
Doc-Delivery-Number = {{122FW}},
Unique-ID = {{ISI:000317304700012}},
DA = {{2018-08-13}},
}

@article{ ISI:000318756000014,
Author = {Ling, Alison L. and Pace, Norman R. and Hernandez, Mark T. and LaPara,
   Timothy M.},
Title = {{Tetracycline Resistance and Class 1 Integron Genes Associated with
   Indoor and Outdoor Aerosols}},
Journal = {{ENVIRONMENTAL SCIENCE \& TECHNOLOGY}},
Year = {{2013}},
Volume = {{47}},
Number = {{9}},
Pages = {{4046-4052}},
Month = {{MAY 7}},
Abstract = {{Genes encoding tetracycline resistance and the integrase of Class 1
   integrons were enumerated using quantitative PCR from aerosols collected
   from indoor and outdoor environments. Concentrated animal feeding
   operations (CAFOs) and human-occupied indoor environments (two clinics
   and a homeless shelter) were found to be a source of airborne tet(X) and
   tet(W) genes. The CAFOs had 10- to 100-times higher concentrations of
   airborne 16S rRNA, tet(X), and tet(W) genes than other environments
   sampled, and increased concentrations of aerosolized bacteria correlated
   with increased concentrations of airborne resistance genes. The two
   CAFOs studied had statistically similar concentrations of resistance
   genes in their aerosol samples, even though antibiotic use was markedly
   different between the two operations Additionally, tet(W) genes were
   recovered in outdoor air within 2 km of livestock operations, which
   suggests that antibiotic resistance genes may be transported via
   aerosols on local scales. The integrase gene (intI1) from Class 1
   integrons, which has been associated with multidrug resistance, was
   detected in CAFOs but not in human occupied indoor environments,
   suggesting that CAFO aerosols could serve as a reservoir of multidrug
   resistance. In conclusion, our results show that CAFOs and clinics are
   sources of aerosolized antibiotic resistance genes that can potentially
   be transported via air movement.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{LaPara, TM (Reprint Author), Univ Minnesota, Dept Civil Engn, Minneapolis, MN 55455 USA.
   Ling, Alison L.; Hernandez, Mark T., Univ Colorado, Dept Civil Environm \& Agr Engn, Boulder, CO 80309 USA.
   Pace, Norman R., Univ Colorado, Dept Mol Cellular \& Dev Biol, Boulder, CO 80309 USA.
   LaPara, Timothy M., Univ Minnesota, Dept Civil Engn, Minneapolis, MN 55455 USA.}},
DOI = {{10.1021/es400238g}},
ISSN = {{0013-936X}},
Keywords-Plus = {{ANIMAL FEEDING OPERATION; MUNICIPAL WASTE-WATER; ANTIBIOTIC-RESISTANCE;
   CONFINEMENT BUILDINGS; STAPHYLOCOCCUS-AUREUS; NATURAL ENVIRONMENTS;
   PARTICLE MONITOR; BACTERIA; DIVERSITY; INFECTION}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences}},
Author-Email = {{lapar001@umn.edu}},
Funding-Acknowledgement = {{Department of Energy Office of Science Graduate Fellowship Program (DOE
   SCGF) {[}DE-AC05-06OR23100]; EPA Star Grant {[}R833744]; Alfred P. Sloan
   Foundation Grant}},
Funding-Text = {{This research is supported in part by the Department of Energy Office of
   Science Graduate Fellowship Program (DOE SCGF), made possible in part by
   the American Recovery and Reinvestment Act of 2009, administered by
   ORISE-ORAU under contract DE-AC05-06OR23100. Indoor air sampling and
   sequencing was supported by an Alfred P. Sloan Foundation Grant to
   N.R.P. Outdoor agricultural and urban area sampling was supported by EPA
   Star Grant R833744. Indoor aerosol samples were collected by Piret Koll,
   Mari Envagrov-Rodriguez, and Alison Ling. Outdoor urban and agricultural
   samples were collected by Nicholas Clements and Michael Hannigan as part
   of the CCRUSH study. Outdoor (pristine) samples were collected by
   Benjamin Miller and Alina Handorean. HYSPLIT modeling was performed by
   Nicholas Clements. Thanks to Erin Fletcher, Kevin McCabe, and Roberto
   Rodriguez for help with data analysis methods, and to Tucker Burch and
   Katheryn Hope for help with qPCR procedures.}},
Cited-References = {{Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312.
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999.
   Alvarado CS, 2009, J ENVIRON HEALTH, V71, P40.
   AMANN RI, 1995, MICROBIOL REV, V59, P143.
   Aminov RI, 2001, APPL ENVIRON MICROB, V67, P22, DOI 10.1128/AEM.67.1.22-32.2001.
   {[}Anonymous], ECBCTN28.
   {[}Anonymous], JUD US MED IMP ANT D.
   {[}Anonymous], REP ANT SOLD DISTR U.
   Auerbach EA, 2007, WATER RES, V41, P1143, DOI 10.1016/j.watres.2006.11.045.
   Beggs CB, 2003, INDOOR BUILT ENVIRON, V12, P9, DOI 10.1177/142032603032201.
   Benson DA, 1997, NUCLEIC ACIDS RES, V25, P1, DOI 10.1093/nar/25.1.1.
   Binh CTT, 2009, RES MICROBIOL, V160, P427, DOI 10.1016/j.resmic.2009.06.005.
   Bowers RM, 2009, APPL ENVIRON MICROB, V75, P5121, DOI 10.1128/AEM.00447-09.
   Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104.
   Brooks JP, 2010, SCI TOTAL ENVIRON, V408, P4770, DOI 10.1016/j.scitotenv.2010.06.038.
   Byrne-Bailey KG, 2011, APPL ENVIRON MICROB, V77, P684, DOI 10.1128/AEM.01425-10.
   Chapin A, 2005, ENVIRON HEALTH PERSP, V113, P137, DOI 10.1289/ehp.7473.
   Chee-Sanford JC, 2009, J ENVIRON QUAL, V38, P1086, DOI 10.2134/jeq2008.0128.
   Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001.
   COURVALIN P, 1994, ANTIMICROB AGENTS CH, V38, P1447, DOI 10.1128/AAC.38.7.1447.
   Diehl DL, 2010, ENVIRON SCI TECHNOL, V44, P9128, DOI 10.1021/es102765a.
   Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869.
   Draxier RR, 1998, AUST METEOROL MAG, V47, P295.
   Dzidic S, 2003, ACTA PHARMACOL SIN, V24, P519.
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340.
   FARRINGTON M, 1990, EPIDEMIOL INFECT, V105, P215, DOI 10.1017/S0950268800047828.
   Fierer N, 2008, APPL ENVIRON MICROB, V74, P200, DOI 10.1128/AEM.01467-07.
   Gandara A, 2006, ENVIRON HEALTH PERSP, V114, P1859, DOI 10.1289/ehp.9585.
   Ghosh S, 2007, ISME J, V1, P191, DOI 10.1038/ismej.2007.31.
   Ghosh S, 2009, APPL MICROBIOL BIOT, V84, P791, DOI 10.1007/s00253-009-2125-2.
   Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910.
   Goldstein C, 2001, ANTIMICROB AGENTS CH, V45, P723, DOI 10.1128/AAC.45.3.723-726.2001.
   Graham DW, 2011, ENVIRON SCI TECHNOL, V45, P418, DOI 10.1021/es102473z.
   Hong PY, 2012, ENVIRON MICROBIOL, V14, P1420, DOI 10.1111/j.1462-2920.2012.02726.x.
   Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867.
   Just N. A, 2011, ANN OCCUP HYG, V56, P440.
   Kellogg CA, 2006, TRENDS ECOL EVOL, V21, P638, DOI 10.1016/j.tree.2006.07.004.
   Kellogg Christina A., 2004, Aerobiologia, V20, P99, DOI 10.1023/B:AERO.0000032947.88335.bb.
   Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211.
   Koike S, 2007, APPL ENVIRON MICROB, V73, P4813, DOI 10.1128/AEM.00665-07.
   LaPara TM, 2011, ENVIRON SCI TECHNOL, V45, P9543, DOI 10.1021/es202775r.
   Letourneau V, 2010, INT J HYG ENVIR HEAL, V213, P444, DOI 10.1016/j.ijheh.2010.09.008.
   Leverstein-van Hall MA, 2002, J INFECT DIS, V186, P49.
   Levy S. B., 1992, ANTIBIOTIC PARADOX M.
   Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46.
   LOO BW, 1988, AEROSOL SCI TECH, V9, P167, DOI 10.1080/02786828808959205.
   Lyons C. P, 1992, J AEROSOL SCI     S1, V23, P599.
   Ma YJ, 2011, ENVIRON SCI TECHNOL, V45, P7855, DOI 10.1021/es200827t.
   Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483.
   Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462.
   Miljevic B, 2009, ATMOS ENVIRON, V43, P1372, DOI 10.1016/j.atmosenv.2008.12.001.
   Misra C, 2003, AEROSOL SCI TECH, V37, P271, DOI 10.1080/02786820390125133.
   Misra C, 2001, J AIR WASTE MANAGE, V51, P1309, DOI 10.1080/10473289.2001.10464360.
   Munir M, 2011, WATER RES, V45, P681, DOI 10.1016/j.watres.2010.08.033.
   Peccia J, 2006, ATMOS ENVIRON, V40, P3941, DOI 10.1016/j.atmosenv.2006.02.029.
   Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es0604131.
   Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r.
   Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x.
   Rao GG, 1998, DRUGS, V55, P323, DOI 10.2165/00003495-199855030-00001.
   Schloss P. D, 2009, APPL ENVIRON MICROB, V73, P7537.
   Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904.
   Smith DJ, 2010, AEROBIOLOGIA, V26, P35, DOI 10.1007/s10453-009-9141-7.
   Storteboom H, 2010, ENVIRON SCI TECHNOL, V44, P7397, DOI 10.1021/es101657s.
   WALTER CW, 1963, JAMA-J AM MED ASSOC, V186, P908.
   Wegener HC, 2003, CURR OPIN MICROBIOL, V6, P439, DOI 10.1016/j.mib.2003.09.009.
   Womack AM, 2010, PHILOS T R SOC B, V365, P3645, DOI 10.1098/rstb.2010.0283.
   World Health Organization, 2001, WHOCDSCSRDRS20012.}},
Number-of-Cited-References = {{67}},
Times-Cited = {{25}},
Usage-Count-Last-180-days = {{7}},
Usage-Count-Since-2013 = {{85}},
Journal-ISO = {{Environ. Sci. Technol.}},
Doc-Delivery-Number = {{141WA}},
Unique-ID = {{ISI:000318756000014}},
DA = {{2018-08-13}},
}

@article{ ISI:000320589900005,
Author = {Kim, Kwang-sun and Lee, Soohyun and Ryu, Choong-Min},
Title = {{Interspecific bacterial sensing through airborne signals modulates
   locomotion and drug resistance}},
Journal = {{NATURE COMMUNICATIONS}},
Year = {{2013}},
Volume = {{4}},
Month = {{MAY}},
Abstract = {{Bacteria use chemical signals to sense each other and to regulate
   various physiological functions. Although it is known that some airborne
   volatile organic compounds function as bacterial signalling molecules,
   their identities and effects on global gene expression and bacterial
   physiological processes remain largely unknown. Here we perform
   microarray analyses of Escherichia coli exposed to volatile organic
   compounds emitted from Bacillus subtilis. We find that 2,3-butanedione
   and glyoxylic acid mediate global changes in gene expression related to
   motility and antibiotic resistance. Volatile organic compound-dependent
   phenotypes are conserved among bacteria and are regulated by the
   previously uncharacterized ypdB gene product through the downstream
   transcription factors soxS, rpoS or yjhU. These results strongly suggest
   that bacteria use airborne volatile organic compounds to sense other
   bacteria and to change master regulatory gene activity to adapt.}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ryu, CM (Reprint Author), Korea Res Inst Biosci \& Biotechnol, Superbacteria Res Ctr, 125 Gwahak Ro, Taejon 305806, South Korea.
   Kim, Kwang-sun; Lee, Soohyun; Ryu, Choong-Min, Korea Res Inst Biosci \& Biotechnol, Superbacteria Res Ctr, Taejon 305806, South Korea.
   Kim, Kwang-sun; Ryu, Choong-Min, Univ Sci \& Technol, Taejon 305350, South Korea.}},
DOI = {{10.1038/ncomms2789}},
Article-Number = {{1809}},
ISSN = {{2041-1723}},
Keywords-Plus = {{ESCHERICHIA-COLI K-12; MULTIDRUG TOLERANCE; MICROBIAL COMMUNITIES;
   SYSTEMIC RESISTANCE; GLYOXYLATE CYCLE; PERSISTER CELLS; GENOME SEQUENCE;
   MUSCODOR-ALBUS; DIACETYL; VOLATILES}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{cmryu@kribb.re.kr}},
ORCID-Numbers = {{Ryu, Choong-Min/0000-0002-7276-1189}},
Funding-Acknowledgement = {{Next-Generation BioGreen 21 Program (SSAC grant) {[}PJ009524];
   Industrial Source Technology Development Program of the Ministry of
   Knowledge Economy of Korea {[}10035386]; basic Science Research program
   through the NRF Korea {[}2010-0023011]; KRIBB initiative program}},
Funding-Text = {{We are grateful for the financial support from the Next-Generation
   BioGreen 21 Program (SSAC grant no. PJ009524), the Industrial Source
   Technology Development Program of the Ministry of Knowledge Economy
   (10035386) of Korea, the basic Science Research program through the NRF
   Korea (2010-0023011) and the KRIBB initiative program.}},
Cited-References = {{Adnan M, 2010, MOL CELL BIOCHEM, V342, P207, DOI 10.1007/s11010-010-0485-7.
   Aizenberg-Gershtein Y, 2012, CAN J MICROBIOL, V58, P326, DOI {[}10.1139/w11-138, 10.1139/W11-138].
   Alber BE, 2006, MOL MICROBIOL, V61, P297, DOI 10.1111/j.1365-2958.2006.05238.x.
   Ara K, 2007, BIOTECHNOL APPL BIOC, V46, P169, DOI 10.1042/BA20060111.
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944.
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556.
   Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050.
   Baca-DeLancey RR, 1999, P NATL ACAD SCI USA, V96, P4610, DOI 10.1073/pnas.96.8.4610.
   BACHMANN BJ, 1972, BACTERIOL REV, V36, P525.
   Bari W, 2011, INFECT IMMUN, V79, P3149, DOI 10.1128/IAI.01237-10.
   Bernier SP, 2011, MOL MICROBIOL, V81, P705, DOI 10.1111/j.1365-2958.2011.07724.x.
   BETTERTON EA, 1991, ATMOS ENVIRON A-GEN, V25, P1473, DOI 10.1016/0960-1686(91)90006-S.
   Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501.
   Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036357.
   Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250.
   Bukvicki D, 2012, MOLECULES, V17, P6982, DOI 10.3390/molecules17066982.
   BURKHOLDER PR, 1947, AM J BOT, V34, P345, DOI 10.2307/2437147.
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297.
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008.
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295.
   Ezra D, 2004, MICROBIOL-SGM, V150, P4023, DOI 10.1099/mic.0.27334-0.
   Farag MA, 2006, PHYTOCHEMISTRY, V67, P2262, DOI 10.1016/j.phytochem.2006.07.021.
   Fedan JS, 2006, TOXICOL APPL PHARM, V215, P17, DOI 10.1016/j.tapp.2006.02.001.
   Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110.
   Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449.
   Heal RD, 2002, J APPL MICROBIOL, V92, P1116, DOI 10.1046/j.1365-2672.2002.01647.x.
   HEDGECOCK L. W., 1950, Bact. Proc., P127.
   Hubbs AF, 2008, TOXICOL PATHOL, V36, P330, DOI 10.1177/0192623307312694.
   Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836.
   JAY JM, 1982, APPL ENVIRON MICROB, V44, P525.
   Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3.
   Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988.
   Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.18624.8172-8180.2004.
   Kesarwani M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002192.
   Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027.
   Kim JF, 2010, J BACTERIOL, V192, P6103, DOI 10.1128/JB.00983-10.
   Kim KS, 2012, RNA BIOL, V9, P1167, DOI 10.4161/rna.21499.
   Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049.
   Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x.
   Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05.
   KORNBERG HL, 1966, BIOCHEM J, V99, P1.
   Lee DJ, 2012, ANNU REV MICROBIOL, V66, P125, DOI 10.1146/annurev-micro-092611-150012.
   Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x.
   Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145.
   Lewis K, 2008, CURR TOP MICROBIOL, V322, P107.
   Lim J, 2009, J BACTERIOL, V191, P3758, DOI 10.1128/JB.00349-09.
   Mangwani N, 2012, J MOL MICROB BIOTECH, V22, P215, DOI 10.1159/000341847.
   Martineau B, 1995, AM J ENOL VITICULT, V46, P442.
   Morgan DL, 2008, TOXICOL SCI, V103, P169, DOI 10.1093/toxsci/kfn016.
   MOYED HS, 1983, J BACTERIOL, V155, P768.
   Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304.
   Nijland R, 2010, BIOTECHNOL J, V5, P974, DOI 10.1002/biot.201000174.
   Pesci EC, 2000, TRENDS MICROBIOL, V8, P103, DOI 10.1016/S0966-842X(00)01717-0.
   PIPER KR, 1993, NATURE, V362, P448, DOI 10.1038/362448a0.
   Ren DC, 2005, APPL ENVIRON MICROB, V71, P4022, DOI 10.1128/AEM.71.7.4022-4034.2005.
   Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583.
   Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100.
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374.
   Saxena P, 1996, J ATMOS CHEM, V24, P57, DOI 10.1007/BF00053823.
   Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806.
   Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53.
   Sifri CD, 2008, CLIN INFECT DIS, V47, P1070, DOI 10.1086/592072.
   Strobel GA, 2007, MICROBIOL-SGM, V153, P2613, DOI 10.1099/mic.0.2007/008912-0.
   Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0.
   Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869.
   Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8.
   Yoon SH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r37.
   Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895.
   Zou CS, 2007, SOIL BIOL BIOCHEM, V39, P2371, DOI 10.1016/j.soilbio.2007.04.009.}},
Number-of-Cited-References = {{69}},
Times-Cited = {{33}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{43}},
Journal-ISO = {{Nat. Commun.}},
Doc-Delivery-Number = {{166WI}},
Unique-ID = {{ISI:000320589900005}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000319530300010,
Author = {Peman, Javier and Salavert, Miquel},
Title = {{Epidemiology and prevention of nosocomial invasive infections by
   filamentous fungi and yeasts}},
Journal = {{ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA}},
Year = {{2013}},
Volume = {{31}},
Number = {{5}},
Pages = {{328-341}},
Month = {{MAY}},
Abstract = {{Knowledge of the epidemiology of invasive fungal diseases in health care
   settings helps to establish the action levels necessary for its
   prevention. A first step is to identify groups of patients at high risk
   of invasive fungal diseases, establish accurate risk factors, observing
   the periods of greatest risk, and analyze the epidemiological profile in
   genera and species, as well as the patterns of antifungal resistance.
   Secondly, mechanisms to avoid persistent exposure to potential fungal
   pathogens must be established, protecting areas and recommending
   measures, such as the control of the quality of the air and water inside
   and outside the hospital, and determining and promoting appropriate
   architectural designs of health institutions. Finally, apart from the
   correct implementation of these measures, the use of antifungal
   prophylaxis should be considered in selected patients at very high risk,
   following the guidelines published. (C) 2013 Elsevier Espafia, S.L. All
   rights reserved.}},
Publisher = {{EDICIONES DOYMA S A}},
Address = {{TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN}},
Type = {{Article}},
Language = {{Spanish}},
Affiliation = {{Peman, J (Reprint Author), Univ Hosp, Microbiol Serv, Valencia, Spain.
   Peman, Javier, Univ Hosp, Microbiol Serv, Valencia, Spain.
   Peman, Javier; Salavert, Miquel, Politecn La Fe, Valencia, Spain.
   Salavert, Miquel, Univ Hosp, Unidad Enfermedades Infecciosas, Valencia, Spain.}},
DOI = {{10.1016/j.eimc.2013.02.002}},
ISSN = {{0213-005X}},
EISSN = {{1578-1852}},
Keywords = {{Invasive fungal disease; Protected environment; Prevention}},
Keywords-Plus = {{HEMATOPOIETIC-CELL TRANSPLANTATION; MULTICENTER PROSPECTIVE SURVEY;
   CLINICAL-PRACTICE GUIDELINES; BLOOD-STREAM INFECTIONS; ANTIFUNGAL
   SUSCEPTIBILITY; HEMATOLOGIC MALIGNANCIES; PNEUMOCYSTIS-JIROVECII;
   CUTANEOUS ASPERGILLOSIS; PULMONARY ASPERGILLOSIS; INTERHUMAN
   TRANSMISSION}},
Research-Areas = {{Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Infectious Diseases; Microbiology}},
Author-Email = {{peman\_jav@gva.es}},
ORCID-Numbers = {{Peman, Javier/0000-0003-3222-5653}},
Cited-References = {{Alangaden GJ, 2011, INFECT DIS CLIN N AM, V25, P201, DOI 10.1016/j.idc.2010.11.003.
   Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005.
   Anaissie EJ, 2003, BLOOD, V101, P2542, DOI 10.1182/blood-2002-02-0530.
   Arnold TM, 2009, CLIN CHEST MED, V30, P279, DOI 10.1016/j.ccm.2009.02.007.
   Association for Professionals in Infection Control and Epidemiology, 2008, INF CONTR RISK ASS M.
   Balajee SA, 2009, J CLIN MICROBIOL, V47, P877, DOI 10.1128/JCM.01685-08.
   Bouza E, 2002, J HOSP INFECT, V52, P234, DOI 10.1053/jhin.2002.1316.
   Boyce JM, 2002, MMWR RECOMM REP, V51, pCE1.
   Boyce John M, 2002, MMWR Recomm Rep, V51, P1.
   Bryce EA, 1996, INFECT CONT HOSP EP, V17, P170.
   Bulpa P, 2007, EUR RESPIR J, V30, P782, DOI 10.1183/09031936.00062206.
   Calderon EJ, 2010, EXPERT REV ANTI-INFE, V8, P683, DOI {[}10.1586/ERI.10.42, 10.1586/eri.10.11].
   CCDR, 2001, CONSTR REL NOS INF P.
   Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039.
   Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07.
   de Boer MGJ, 2007, CLIN INFECT DIS, V44, P1143, DOI 10.1086/513198.
   de Boer MGJ, 2012, CLIN INFECT DIS, V54, P1445, DOI 10.1093/cid/cis216.
   Debeaupuis JP, 1997, INFECT IMMUN, V65, P3080.
   Departament de Salut, 2008, GEN CAT PREV INF NOS.
   Fortun J, 2011, ENFERM INFEC MICR CL, V29, P435, DOI 10.1016/j.eimc.2011.01.010.
   Fridkin SK, 2005, CLIN INFECT DIS, V41, P1455, DOI 10.1086/497138.
   Gea-Banacloche J, 2009, BONE MARROW TRANSPL, V44, P489, DOI 10.1038/bmt.2009.260.
   Gianella S, 2010, TRANSPL INFECT DIS, V12, P1, DOI 10.1111/j.1399-3062.2009.00447.x.
   Goebes MD, 2008, INFECT CONT HOSP EP, V29, P462, DOI 10.1086/587189.
   Guembe M, 2012, EUR J CLIN MICROBIOL, V31, P2799, DOI 10.1007/s10096-012-1630-x.
   Gurgui M, 2011, J HOSP INFECT, V78, P274, DOI 10.1016/j.jhin.2011.01.027.
   Hajjeh RA, 2001, CLIN INFECT DIS, V33, P1549, DOI 10.1086/322970.
   Hernendez-Castro R, 2010, EUR J PEDIATR, V169, P783, DOI 10.1007/s00431-009-1109-7.
   Howard SJ, 2010, CLIN MICROBIOL INFEC, V16, P683, DOI 10.1111/j.1469-0691.2009.02911.x.
   Leenders ACAP, 1999, J CLIN MICROBIOL, V37, P1752.
   Marr KA, 2009, BONE MARROW TRANSPL, V44, P483, DOI 10.1038/bmt.2009.259.
   Martino R, 2002, BRIT J HAEMATOL, V116, P475, DOI 10.1046/j.1365-2141.2002.03259.x.
   Mayhall C, 2004, HOSP EPIDEMIOLOGY IN, P1549.
   MCCARTY JM, 1986, J PEDIATR-US, V108, P721, DOI 10.1016/S0022-3476(86)81051-4.
   Menzin J, 2009, AM J HEALTH-SYST PH, V66, P1711, DOI 10.2146/ajhp080325.
   Mikulska M, 2011, MEDITERR J HEMATOL I, V3, DOI DOI 10.4084/MJHID.2011.007.
   Morris A, 2012, CLIN MICROBIOL REV, V25, P297, DOI 10.1128/CMR.00013-12.
   Morris G, 2000, J HOSP INFECT, V44, P81, DOI 10.1053/jhin.1999.0688.
   Mortensen KL, 2010, ANTIMICROB AGENTS CH, V54, P4545, DOI 10.1128/AAC.00692-10.
   Munoz P, 2005, CLIN INFECT DIS, V40, P1625, DOI 10.1086/429916.
   Neofytos D, 2010, TRANSPL INFECT DIS, V12, P220, DOI 10.1111/j.1399-3062.2010.00492.x.
   Nucci M, 2007, CLIN MICROBIOL REV, V20, P695, DOI 10.1128/CMR.00014-07.
   O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003.
   Pagano L, 2008, HAEMATOL-HEMATOL J, V93, P1611, DOI 10.3324/haematol.12939.
   Pagano L, 2006, HAEMATOL-HEMATOL J, V91, P1068.
   Martinez MP, 2010, MED INTENSIVA, V34, P581, DOI 10.1016/j.medin.2010.07.005.
   Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757.
   Partridge-Hinckley K, 2009, MYCOPATHOLOGIA, V168, P329, DOI 10.1007/s11046-009-9247-z.
   Peman J, 2005, EUR J CLIN MICROBIOL, V24, P23, DOI 10.1007/s10096-004-1267-5.
   Peman J, 2012, J ANTIMICROB CHEMOTH, V67, P1181, DOI 10.1093/jac/dks019.
   Peman J, 2011, J CLIN MICROBIOL, V49, P4158, DOI 10.1128/JCM.05474-11.
   Peman J, 2010, MYCOSES, V53, P424, DOI 10.1111/j.1439-0507.2009.01732.x.
   Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444.
   Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115.
   Repetto EC, 2012, EUR J CLIN MICROBIOL, V31, P2897, DOI 10.1007/s10096-012-1661-3.
   Rogers TR, 2011, BRIT J HAEMATOL, V153, P681, DOI 10.1111/j.1365-2141.2011.08650.x.
   Ruiz-Camps I, 2011, CLIN MICROBIOL INFEC, V17, P1, DOI 10.1111/j.1469-0691.2011.03477.x.
   Salavert M, 2008, INT J ANTIMICROB AG, V32, pS149, DOI 10.1016/S0924-8579(08)70017-7.
   Sassi M, 2012, CLIN INFECT DIS, V54, P1437, DOI 10.1093/cid/cis217.
   Schmoldt S, 2008, J CLIN MICROBIOL, V46, P966, DOI 10.1128/JCM.02016-07.
   Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1.
   Sixt N, 2007, J HOSP INFECT, V65, P156, DOI 10.1016/j.jhin.2006.10.013.
   Sociedad Espanola de Medicina Preventiva Salud Publica e Higiene e Insalud, REC VER BIOS AMB BSA.
   Sole A, 2009, CURR OPIN PULM MED, V15, P243, DOI 10.1097/MCP.0b013e328326f410.
   Spellberg B, 2009, CLIN INFECT DIS, V48, P1743, DOI 10.1086/599105.
   Tablan Ofelia C, 2004, MMWR Recomm Rep, V53, P1.
   The American Institute of Architects Academy of Architecture for Health; The Facility Guidelines Institute; With assistance from the U.S. Department of Health and Human Services, 2006, GUID DES CONSTR HOSP.
   Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019.
   Tsiodras S, 2008, MAYO CLIN PROC, V83, P181.
   Valdez JM, 2011, CLIN INFECT DIS, V52, P726, DOI 10.1093/cid/ciq245.
   Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720.
   Verweij PE, 2009, DRUG RESIST UPDATE, V12, P141, DOI 10.1016/j.drup.2009.09.002.
   Vonberg RP, 2006, J HOSP INFECT, V63, P246, DOI 10.1016/j.jhin.2006.02.014.
   Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258.
   Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946.
   Yokoe D, 2009, BONE MARROW TRANSPL, V44, P495, DOI 10.1038/bmt.2009.261.
   Yokoe D, 2009, BONE MARROW TRANSPL, V44, P509, DOI 10.1038/bmt.2009.262.
   Zaragoza R, 2008, REV IBEROAM MICOL, V25, P203, DOI 10.1016/S1130-1406(08)70049-4.
   Zaragoza Rafael, 2008, Ther Clin Risk Manag, V4, P1261.}},
Number-of-Cited-References = {{79}},
Times-Cited = {{7}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{6}},
Journal-ISO = {{Enferm. Infec. Microbiol. Clin.}},
Doc-Delivery-Number = {{152KJ}},
Unique-ID = {{ISI:000319530300010}},
DA = {{2018-08-13}},
}

@article{ ISI:000319048400016,
Author = {Isbary, Georg and Shimizu, Tetsuji and Li, Yang-Fang and Stolz, Wilhelm
   and Thomas, Hubertus M. and Morfill, Gregor E. and Zimmermann, Julia L.},
Title = {{Cold atmospheric plasma devices for medical issues}},
Journal = {{EXPERT REVIEW OF MEDICAL DEVICES}},
Year = {{2013}},
Volume = {{10}},
Number = {{3}},
Pages = {{367-377}},
Month = {{MAY}},
Abstract = {{Cold atmospheric plasma science is an innovative upcoming technology for
   the medical sector. The plasma composition and subsequent effects on
   cells, tissues and pathogens can vary enormously depending on the plasma
   source, the plasma settings and the ambient conditions. Cold atmospheric
   plasmas consist of a highly reactive mix of ions and electrons, reactive
   molecules, excited species, electric fields and to some extent also UV
   radiation. In the last year, this partly ionized gas has been
   demonstrated to have a broad antimicrobial activity, while resistance
   and resistance development are unlikely. Furthermore, recent research
   has indicated that plasmas also have a strong influence on various cell
   lines and cell functions, including anticancer properties. This review
   summarizes the major plasma designs available and their main benefits,
   as well as assessing possible risks of this new technology.}},
Publisher = {{TAYLOR \& FRANCIS LTD}},
Address = {{2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Isbary, G (Reprint Author), Hosp Munich Schwabing, Dept Dermatol Allergol \& Environm Med, Koelner Pl 1, D-80804 Munich, Germany.
   Isbary, Georg; Stolz, Wilhelm, Hosp Munich Schwabing, Dept Dermatol Allergol \& Environm Med, D-80804 Munich, Germany.
   Shimizu, Tetsuji; Li, Yang-Fang; Thomas, Hubertus M.; Morfill, Gregor E.; Zimmermann, Julia L., Max Planck Inst Extraterr Phys, D-85748 Garching, Germany.}},
DOI = {{10.1586/ERD.13.4}},
ISSN = {{1743-4440}},
EISSN = {{1745-2422}},
Keywords = {{cancer therapy; cold atmospheric plasma; disinfection; nonthermal
   plasma; plasma medicine; sterilization; tissue tolerable plasma; wound
   healing}},
Keywords-Plus = {{DIELECTRIC BARRIER DISCHARGE; NONTHERMAL ARGON PLASMA; FACIAL
   REJUVENATION PROCEDURES; RANDOMIZED CONTROLLED-TRIAL; PRESSURE PLASMA;
   ANTIBIOTIC-RESISTANCE; BLOOD-COAGULATION; CHRONIC WOUNDS; AIR PLASMA;
   IN-VITRO}},
Research-Areas = {{Engineering}},
Web-of-Science-Categories  = {{Engineering, Biomedical}},
Author-Email = {{dr.isbary@googlemail.com}},
ResearcherID-Numbers = {{Shimizu, Tetsuji/L-1478-2018}},
ORCID-Numbers = {{Shimizu, Tetsuji/0000-0001-9432-1152}},
Cited-References = {{Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154.
   {[}Anonymous], 2006, BIOL EFF ULTR RAD RE.
   {[}Anonymous], 2004, GUID LIM EXP ULTR RA.
   Ayliffe G, 2000, J HOSP INFECT, V45, P263, DOI 10.1053/jhin.2000.0767.
   Boxhammer V, 2013, MUTAT RES-GEN TOX EN, V753, P23, DOI 10.1016/j.mrgentox.2012.12.015.
   Brun P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033245.
   Cao Z, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3069276.
   Daeschlein G, 2012, J HOSP INFECT, V81, P177, DOI 10.1016/j.jhin.2012.02.012.
   Daeschlein G, 2012, J DTSCH DERMATOL GES, V10, P509, DOI 10.1111/j.1610-0387.2012.07857.x.
   Daeschlein G, 2010, PLASMA PROCESS POLYM, V7, P224, DOI 10.1002/ppap.200900059.
   Dobrynin D, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/10/103033.
   Douat C, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/3/034010.
   Douat C, 2011, IEEE T PLASMA SCI, V39, P2298, DOI 10.1109/TPS.2011.2109740.
   Ehlbeck J, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/1/013002.
   Ermolaeva SA, 2012, J MED MICROBIOL, V61, P793, DOI 10.1099/jmm.0.038117-0.
   Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0.
   Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154.
   Fridman G, 2007, PLASMA PROCESS POLYM, V4, P370, DOI 10.1002/ppap.200600217.
   Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4.
   Heinlin J, 2013, J EUR ACAD DERMATOL, V27, P324, DOI 10.1111/j.1468-3083.2011.04395.x.
   Isbary G, 2013, CLIN PLASMA MED, V1, P36, DOI 10.1016/j.cpme.2012.10.001.
   Isbary G, 2012, BRIT J DERMATOL, V167, P404, DOI 10.1111/j.1365-2133.2012.10923.x.
   Isbary G, 2010, BRIT J DERMATOL, V163, P78, DOI 10.1111/j.1365-2133.2010.09744.x.
   Isbary G, 2011, ARCH DERMATOL, V147, P388, DOI 10.1001/archdermatol.2011.57.
   Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270.
   Kalia YN, 2004, ADV DRUG DELIVER REV, V56, P619, DOI 10.1016/j.addr.2003.10.026.
   Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386.
   Kilmer S, 2005, J AM ACAD DERMATOL, V52, pP44.
   Kilmer S, 2007, LASER MED SCI, V22, P101, DOI 10.1007/s10103-006-0431-9.
   Kim JY, 2011, BIOSENS BIOELECTRON, V28, P333, DOI 10.1016/j.bios.2011.07.039.
   Kim SJ, 2009, APPL PHYS LETT, V94.
   Kim SJ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462293.
   Kim SJ, 2009, PLASMA PROCESS POLYM, V6, P676, DOI 10.1002/ppap.200850001.
   Klampfl TG, 2012, APPL ENVIRON MICROB, V78, P5077, DOI 10.1128/AEM.00583-12.
   Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385.
   Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012.
   Kuchenbecker M, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/4/045212.
   Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2.
   Lademann J, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3247156.
   Lademann O, 2010, LASER PHYS LETT, V7, P458, DOI 10.1002/lapl.200910158.
   Laroussi M, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/341.
   Laroussi M, 2008, IEEE T PLASMA SCI, V36, P1298, DOI 10.1109/TPS.2008.922432.
   Laroussi M, 2007, PLASMA PROCESS POLYM, V4, P777, DOI 10.1002/ppap.200700066.
   Laroussi M, 2006, PLASMA PROCESS POLYM, V3, P470, DOI 10.1002/ppap.200600005.
   Lee HD, 2010, EXP MECH, V50, P661, DOI 10.1007/s11340-009-9245-6.
   Lee HW, 2010, PLASMA PROCESS POLYM, V7, P274, DOI 10.1002/ppap.200900083.
   Lee HW, 2009, J ENDODONT, V35, P587, DOI 10.1016/j.joen.2009.01.008.
   Lee JK, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.08JF01.
   Li YF, 2012, PLASMA PROCESS POLYM, V9, P585, DOI 10.1002/ppap.201100090.
   Maisch T, 2012, J IND MICROBIOL BIOT, V39, P1367, DOI 10.1007/s10295-012-1137-6.
   Maisch T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034610.
   Maisch T, 2012, APPL ENVIRON MICROB, V78, P4242, DOI 10.1128/AEM.07235-11.
   Nagaraj G, 2007, BLOOD, V110, p929A.
   Nosenko T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115013.
   Piddock LJV, 2012, LANCET INFECT DIS, V12, P249, DOI 10.1016/S1473-3099(11)70316-4.
   Sacks R, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3523.
   Sakiyama Y, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/42/425201.
   Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x.
   Shimizu T, 2012, NEW J PHYS, V14, P1.
   Shimizu T, 2008, PLASMA PROCESS POLYM, V5, P577, DOI 10.1002/ppap.200800021.
   Shimizu T, 2010, PLASMA PROCESS POLYM, V7, P288, DOI 10.1002/ppap.200900085.
   Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304.
   Vandamme M, 2012, M S-MED SCI, V28, P154, DOI 10.1051/medsci/2012282013.
   Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252.
   Vandamme M, 2010, PLASMA PROCESS POLYM, V7, P264, DOI 10.1002/ppap.200900080.
   Venkatesh KS, 2002, SURG ENDOSC, V16, P707, DOI 10.1007/s00464-001-8164-0.
   Volotskova O, 2012, SCI REP-UK, V2, DOI 10.1038/srep00636.
   Wang DY, 2010, J ADV OXID TECHNOL, V13, P71.
   Weltmann KD, 2011, EUR PHYS J-APPL PHYS, V55, DOI 10.1051/epjap/2011100452.
   Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067.
   Weltmann KD, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/194008.
   Weltmann KD, 2010, PURE APPL CHEM, V82, P1223, DOI 10.1351/PAC-CON-09-10-35.
   Weltmann KD, 2011, IEEE T PLASMA SCI, V39, P1015, DOI 10.1109/TPS.2011.2112674.
   Welz C, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/4/045401.
   Yan X, 2012, PLASMA PROCESS POLYM, V9, P59, DOI 10.1002/ppap.201100031.
   Zimmermann E, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/103023.
   Zimmermann JL, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/50/505201.}},
Number-of-Cited-References = {{77}},
Times-Cited = {{38}},
Usage-Count-Last-180-days = {{7}},
Usage-Count-Since-2013 = {{103}},
Journal-ISO = {{Expert Rev. Med. Devices}},
Doc-Delivery-Number = {{145VZ}},
Unique-ID = {{ISI:000319048400016}},
DA = {{2018-08-13}},
}

@article{ ISI:000318611200012,
Author = {Lis, Danuta O. and Gorny, Rafal L.},
Title = {{Haemophilus influenzae as an airborne contamination in child day care
   centers}},
Journal = {{AMERICAN JOURNAL OF INFECTION CONTROL}},
Year = {{2013}},
Volume = {{41}},
Number = {{5}},
Pages = {{438-442}},
Month = {{MAY}},
Abstract = {{Background: The aim of this study was to assess the exposure of children
   to airborne Haemophilus influenzae in day care centers.
   Methods: Air samples were taken using an Andersen impactor in 32 rooms
   designed for children stay. The concentrations of airborne bacteria were
   calculated as colony forming units (CFU) (growing on trypticase soy
   agar) per cubic meter of air (CFU/m(3)). The compositions of bioaerosol
   were determined on blood trypticase soy agar and Haemophilus selective
   agar. Isolated strains were identified using API NH strips and apiweb
   software. The antibiotic resistance of H influenzae strains was
   determined by the disk diffusion method.
   Results: Compared with the proposed criteria for microbiologic quality
   of indoor air, the rooms were characterized by the very high bacterial
   contamination of the air. The prevailing component of bacterial aerosol
   was gram-positive cocci. Airborne H influenzae strains were found in
   25\% of the investigated rooms and were mostly classified as biotype II
   (33\%).
   Conclusion: It may be accepted that the exposure to airborne H
   influenzae is typical of child day care centers in contrast to indoor
   environments with older population. Child day care center contribute to
   the expansion of H influenzae in human population via air. Generally,
   airborne H influenzae isolates from the investigated child day care
   centers were susceptible to older antibiotics such as ampicillin and
   amoxicillin-clavulanic acid. Copyright (C) 2013 by the Association for
   Professionals in Infection Control and Epidemiology, Inc. Published by
   Elsevier Inc. All rights reserved.}},
Publisher = {{MOSBY-ELSEVIER}},
Address = {{360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lis, DO (Reprint Author), Inst Occupat Med \& Environm Hlth, Dept Biohazards \& Immunoallergol, 13 Koscielna St, PL-41200 Sosnowiec, Poland.
   Lis, Danuta O., Inst Occupat Med \& Environm Hlth, Dept Biohazards \& Immunoallergol, PL-41200 Sosnowiec, Poland.
   Gorny, Rafal L., Natl Res Inst, Cent Inst Labour Protect, Dept Chem Aerosol \& Biol Hazards, Warsaw, Poland.}},
DOI = {{10.1016/j.ajic.2012.05.023}},
ISSN = {{0196-6553}},
Keywords = {{Children; Respiratory pathogen; Bioaerosol; Antibiotic resistance}},
Keywords-Plus = {{RESPIRATORY-TRACT INFECTIONS; HEMOPHILUS-INFLUENZAE; NASOPHARYNGEAL
   COLONIZATION; ANTIMICROBIAL RESISTANCE; INDOOR ENVIRONMENT; AIR-QUALITY;
   MENINGITIS; PREVALENCE; PATHOGENS; BACTERIAL}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{d.lis@imp.sosnowiec.pl}},
ResearcherID-Numbers = {{Lis, Danuta/H-9921-2013}},
ORCID-Numbers = {{Lis, Danuta/0000-0002-9657-7650}},
Funding-Acknowledgement = {{Polish Ministry of Science and Higher Education, Research {[}N N404
   094435]}},
Funding-Text = {{Supported by the Polish Ministry of Science and Higher Education,
   Research Grant No. N N404 094435, in 2008-2011.}},
Cited-References = {{ALBRITTON WL, 1982, J CLIN MICROBIOL, V16, P826.
   ANDERSEN AA, 1958, J BACTERIOL, V76, P471.
   {[}Anonymous], 2008, M100S18 CLIN LAB STA.
   Bou R, 2000, EUR J EPIDEMIOL, V16, P521, DOI 10.1023/A:1007632122570.
   Brady MT, 2005, AM J INFECT CONTROL, V33, P276, DOI 10.1016/j.ajic.2004.11.007.
   Commission of the European Communities, 1993, 12EUR14988EN ECSCEEC.
   Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477.
   FADEN H, 1995, J INFECT DIS, V172, P132, DOI 10.1093/infdis/172.1.132.
   Finkelstein JA, 2000, ARCH PEDIAT ADOL MED, V154, P395, DOI 10.1001/archpedi.154.4.395.
   Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294.
   Friedman JF, 2003, ARCH PEDIAT ADOL MED, V157, P369, DOI 10.1001/archpedi.157.4.369.
   Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506.
   Gorny RL, 2002, ANN AGR ENV MED, V9, P17.
   Gunnarsson RK, 1998, SCAND J PRIM HEALTH, V16, P13.
   HARPER JJ, 1991, J CLIN MICROBIOL, V29, P2539.
   Hoban D, 2002, J ANTIMICROB CHEMOTH, V50, P49, DOI 10.1093/jac/dkf810.
   Karwowska E, 2003, POL J ENVIRON STUD, V12, P181.
   KILIAN M, 1979, J CLIN MICROBIOL, V9, P409.
   Kunze W, 2008, INFECTION, V36, P74, DOI 10.1007/s15010-007-6048-5.
   Lancaster H, 2003, FEMS MICROBIOL LETT, V228, P99, DOI 10.1016/S0378-1097(03)00740-7.
   Ledeboer N, 2011, MANUAL CLIN MICROBIO, V1, P588.
   Lis DO, 2009, AM J INFECT CONTROL, V37, P177, DOI 10.1016/j.ajic.2008.09.013.
   Lis DO, 2004, J OCCUP ENVIRON HYG, V1, P62, DOI 10.1080/15459620490275489.
   LONG SS, 1983, J INFECT DIS, V147, P800, DOI 10.1093/infdis/147.5.800.
   Mangione-Smith R, 2005, ARCH PEDIAT ADOL MED, V159, P751, DOI 10.1001/archpedi.159.8.751.
   Marrs CF, 2001, FRONT BIOSCI, V6, P41.
   Mlynarczyk G, 2001, INT J ANTIMICROB AG, V18, P497, DOI 10.1016/S0924-8579(01)00455-1.
   Mukundan D, 2007, J CLIN MICROBIOL, V45, P3207, DOI 10.1128/JCM.00492-07.
   Nicolau D, 2002, J ANTIMICROB CHEMOTH, V50, P61, DOI 10.1093/jac/dkf809.
   Pastuszka JS, 2000, ATMOS ENVIRON, V34, P3833, DOI 10.1016/S1352-2310(99)00527-0.
   Peerbooms PGH, 2002, J CLIN MICROBIOL, V40, P2832, DOI 10.1128/JCM.40.8.2832-2836.2002.
   QUENTIN R, 1989, J CLIN MICROBIOL, V27, P2286.
   Reponen T, 1992, INDOOR AIR, V2, P26, DOI DOI 10.1111/J.1600-0668.1992.03-21.X.
   Semczuk K, 2004, INT J ANTIMICROB AG, V23, P39, DOI 10.1016/j.ijantimicag.2003.05.013.
   Slack MPE, 2010, INFECT DIS, P1744.
   Smilack JD, 1999, MAYO CLIN PROC, V74, P727, DOI 10.4065/74.7.727.
   SOTTNEK FO, 1984, J CLIN MICROBIOL, V20, P815.
   Tristram S, 2007, CLIN MICROBIOL REV, V20, P368, DOI 10.1128/CMR.00040-06.
   Tsang RSW, 2007, CLIN INFECT DIS, V44, P1611, DOI 10.1086/518283.
   WALLACE RJ, 1981, J INFECT DIS, V144, P101, DOI 10.1093/infdis/144.2.101.
   Zielinski A, 2003, EUR J EPIDEMIOL, V18, P917, DOI 10.1023/A:1025634831508.
   Zuraimi MS, 2008, ATMOS ENVIRON, V42, P2225, DOI 10.1016/j.atmosenv.2007.11.041.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{20}},
Journal-ISO = {{Am. J. Infect. Control}},
Doc-Delivery-Number = {{139UU}},
Unique-ID = {{ISI:000318611200012}},
DA = {{2018-08-13}},
}

@article{ ISI:000317404300019,
Author = {Molton, James S. and Tambyah, Paul A. and Ang, Brenda S. P. and Ling,
   Moi Lin and Fisher, Dale A.},
Title = {{The Global Spread of Healthcare-Associated Multidrug-Resistant Bacteria:
   A Perspective From Asia}},
Journal = {{CLINICAL INFECTIOUS DISEASES}},
Year = {{2013}},
Volume = {{56}},
Number = {{9}},
Pages = {{1310-1318}},
Month = {{MAY 1}},
Abstract = {{Since antibiotics were first used, each new introduced class has been
   followed by a global wave of emergent resistance, largely originating in
   Europe and North America where they were first used.
   Methicillin-resistant Staphylococcus aureus spread from the United
   Kingdom and North America across Europe and then Asia over more than a
   decade. Vancomycin-resistant enterococci and Klebsiella pneumoniae
   carbapenemase-producing K. pneumoniae followed a similar path some 20
   years later. Recently however, metallo-beta-lactamases have originated
   in Asia. New Delhi metallo-beta-lactamase-1 was found in almost every
   continent within a year of its emergence in India.
   Metallo-beta-lactamase enzymes are encoded on highly transmissible
   plasmids that spread rapidly between bacteria, rather than relying on
   clonal proliferation. Global air travel may have helped facilitate rapid
   dissemination. As the antibiotic pipeline offers little in the short
   term, our most important tools against the spread of antibiotic
   resistant organisms are intensified infection control, surveillance, and
   antimicrobial stewardship.}},
Publisher = {{OXFORD UNIV PRESS INC}},
Address = {{JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fisher, DA (Reprint Author), Natl Univ Hlth Syst, Dept Med, Level 10,1E Kent Ridge Rd, Singapore 119228, Singapore.
   Molton, James S.; Tambyah, Paul A.; Fisher, Dale A., Natl Univ Hlth Syst, Div Infect Dis, Singapore 119228, Singapore.
   Molton, James S.; Tambyah, Paul A.; Fisher, Dale A., Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore.
   Ang, Brenda S. P., Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore.
   Ling, Moi Lin, Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore.}},
DOI = {{10.1093/cid/cit020}},
ISSN = {{1058-4838}},
EISSN = {{1537-6591}},
Keywords = {{bacterial drug resistance; methicillin-resistant Staphylococcus aureus;
   vancomycin-resistant Enterococcus; extended-spectrum beta-lactamase;
   carbapenem-resistant Enterobacteriaceae}},
Keywords-Plus = {{AMPC BETA-LACTAMASES; STAPHYLOCOCCUS-AUREUS; KLEBSIELLA-PNEUMONIAE;
   ANTIBIOTIC-RESISTANCE; ENTEROCOCCUS-FAECIUM; ANTIMICROBIAL STEWARDSHIP;
   HISTORICAL-PERSPECTIVE; SINGAPOREAN HOSPITALS; SURVEILLANCE; OUTBREAK}},
Research-Areas = {{Immunology; Infectious Diseases; Microbiology}},
Web-of-Science-Categories  = {{Immunology; Infectious Diseases; Microbiology}},
Author-Email = {{mdcfda@nus.edu.sg}},
ResearcherID-Numbers = {{Molton, James/M-3267-2016}},
ORCID-Numbers = {{Molton, James/0000-0002-2916-2818}},
Cited-References = {{Ang S. W., 1996, Annals Academy of Medicine Singapore, V25, P270.
   Apisarnthanarak A, 2012, CLIN INFECT DIS, V55, P1588, DOI 10.1093/cid/cis726.
   Balm MND, 2012, J CLIN MICROBIOL, V50, P475, DOI 10.1128/JCM.05914-11.
   BARBER M, 1948, LANCET, V252, P641.
   BARBER M, 1961, J CLIN PATHOL, V14, P385, DOI 10.1136/jcp.14.4.385.
   Bouchillon SK, 2009, INT J ANTIMICROB AG, V33, P130, DOI 10.1016/j.ijantimicag.2008.07.031.
   Cai YY, 2012, ANN ACAD MED SINGAP, V41, P77.
   Castanheira M, 2011, ANTIMICROB AGENTS CH, V55, P1274, DOI 10.1128/AAC.01497-10.
   Chaudhuri B N, 2011, J Assoc Physicians India, V59, P287.
   Chavers LS, 2003, J HOSP INFECT, V53, P159, DOI 10.1053/jhin.2002.1375.
   Chlebicki MP, 2006, INFECT CONT HOSP EP, V27, P991, DOI 10.1086/507289.
   Christiansen KJ, 2004, INFECT CONT HOSP EP, V25, P384, DOI 10.1086/502410.
   Deshpande P, 2010, CLIN INFECT DIS, V51, P1222, DOI 10.1086/656921.
   Falagas ME, 2007, EUR J CLIN MICROBIOL, V26, P857, DOI 10.1007/s10096-007-0365-6.
   Fong RKC, 2009, EUR J CLIN MICROBIOL, V28, P983, DOI 10.1007/s10096-009-0741-5.
   Hanson ND, 2003, J ANTIMICROB CHEMOTH, V52, P2, DOI 10.1093/jac/dkg284.
   Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861.
   Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135.
   Hsu LY, 2010, J MED MICROBIOL, V59, P1509, DOI 10.1099/jmm.0.022533-0.
   Hsu LY, 2010, ANTIMICROB AGENTS CH, V54, P1173, DOI 10.1128/AAC.01076-09.
   Ikeda-Dantsuji Y, 2011, J INFECT CHEMOTHER, V17, P45, DOI 10.1007/s10156-010-0085-1.
   Isozumi R, 2012, EMERG INFECT DIS, V18, P1383, DOI 10.3201/eid1808.111816.
   Johnson AP, 2001, J ANTIMICROB CHEMOTH, V48, P143, DOI 10.1093/jac/48.1.143.
   Koh TH, 2006, J HOSP INFECT, V63, P234, DOI 10.1016/j.jhin.2006.01.028.
   Koh TH, 1999, LANCET, V353, P2162, DOI 10.1016/S0140-6736(05)75604-X.
   Koh TH, 2012, EMERG INFECT DIS, V18, P1524, DOI 10.3201/eid1809.111727.
   Koh TH, 2008, ANN ACAD MED SINGAP, V37, P847.
   Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2.
   Kurup A, 2008, AM J INFECT CONTROL, V36, P206, DOI 10.1016/j.ajic.2007.06.005.
   Liew YX, 2011, INT J ANTIMICROB AG, V37, P87, DOI 10.1016/j.ijantimicag.2010.09.008.
   Liew YX, 2012, INT J ANTIMICROB AG, V40, P55, DOI 10.1016/j.ijantimicag.2012.03.004.
   Liew YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028751.
   Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128.
   Livermore DM, 2012, INT J ANTIMICROB AG, V39, P283, DOI 10.1016/j.ijantimicag.2011.12.012.
   Marimuthu K, 2011, EUR C CLIN MICR INF.
   Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11.
   Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003.
   Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005.
   Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4.
   Oon LLE, 2001, PATHOLOGY, V33, P216.
   Pada SK, 2011, J HOSP INFECT, V78, P36, DOI 10.1016/j.jhin.2010.10.016.
   Penicillin Fleming A., FLEM A PEN.
   Rolain JM, 2012, CLIN MICROBIOL INFEC, V18, P615, DOI 10.1111/j.1469-0691.2012.03902.x.
   Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020.
   Sanchez GM, 2010, JAMA-J AM MED ASSOC, V303, P2260, DOI DOI 10.1001/JAMA.2010.757.
   Sng LH, 2005, INT J ANTIMICROB AG, V25, P177, DOI 10.1016/j.ijantimicag.2004.11.001.
   Song JH, 2011, J ANTIMICROB CHEMOTH, V66, P1061, DOI 10.1093/jac/dkr024.
   Stefani S, 2012, INT J ANTIMICROB AG, V39, P273, DOI 10.1016/j.ijantimicag.2011.09.030.
   Tacconelli E, 2008, INT J ANTIMICROB AG, V31, P99, DOI 10.1016/j.ijantimicag.2007.08.026.
   Tambyah PA, 2008, ANN ACAD MED SINGAP, V37, P855.
   Tan TY, 2010, DIAGN MICR INFEC DIS, V66, P210, DOI 10.1016/j.diagmicrobio.2009.08.019.
   Tan TY, 2008, ANN ACAD MED SINGAP, V37, P819.
   Teo J, 2012, EPIDEMIOL INFECT, V7, P1.
   Teo J, 2012, W PACIFIC SURVEILL R, V3, P1.
   Thati Venubabu, 2011, Indian J Med Res, V134, P704, DOI 10.4103/0971-5916.91001.
   Venkatachalam I, 2012, EMERG INFECT DIS, V18, P1381, DOI 10.3201/eid1808.110893.
   Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7.
   WATANABE M, 1991, ANTIMICROB AGENTS CH, V35, P147, DOI 10.1128/AAC.35.1.147.
   WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1.
   Wilson ME, 2012, CURR INFECT DIS REP, V14, P213, DOI 10.1007/s11908-012-0252-x.
   Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09.}},
Number-of-Cited-References = {{61}},
Times-Cited = {{123}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{39}},
Journal-ISO = {{Clin. Infect. Dis.}},
Doc-Delivery-Number = {{123QC}},
Unique-ID = {{ISI:000317404300019}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000317025500004,
Author = {Barbut, Frederic and Yezli, Saber and Mimoun, Maurice and Julien Pham
   and Chaouat, Marc and Otter, Jonathan A.},
Title = {{Reducing the spread of Acinetobacter baumannii and methicillin-resistant
   Staphylococcus aureus on a burns unit through the intervention of an
   infection control bundle}},
Journal = {{BURNS}},
Year = {{2013}},
Volume = {{39}},
Number = {{3}},
Pages = {{395-403}},
Month = {{MAY}},
Abstract = {{Methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter
   baumannii are major nosocomial pathogens in burns units. We investigated
   the impact of an infection control bundle on the incidence of nosocomial
   MRSA and A. baumannii in our burns unit, comparing a pre-intervention
   period (December 2006-August 2008) with an intervention period
   (September 2008-December 2009). The bundle comprised regular hydrogen
   peroxide vapour (HPV) disinfection of the rooms following discharge of
   patients colonized or infected by multidrug-resistant bacteria,
   pre-emptive cohort isolation of newly admitted patients before being
   proven culture negative, cohorting of colonized or infected patients,
   installation of two air disinfection systems in the corridors of the
   unit and improvement of material storage. We also investigated the
   microbiological efficacy of HPV disinfection by sampling the environment
   before and after HPV treatments. HPV disinfection eliminated pathogens
   from the environment and significantly reduced total bacterial surface
   counts, and total fungal air and surface counts, on both a unit and room
   scale. The incidence of nosocomial MRSA infection or colonization fell
   by 89.3\% from 7.22 to 0.77 cases/1000 patient days (p < 0.0001) and A.
   baumannii fell by 88.8\% from 6.92 to 0.77 cases/1000 patient days (p =
   0.002) in the intervention period with no further outbreaks of these
   organisms occurring in this period. The infection control bundle
   resulted in a significant reduction in the incidence of nosocomial MRSA
   and A. baumannii in our burns unit and prevented further outbreaks of
   these organisms. (c) 2012 Elsevier Ltd and ISBI. All rights reserved.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Barbut, F (Reprint Author), Hop St Antoine, UHLIN, 184 Rue faubourg, F-75012 Paris, France.
   Barbut, Frederic; Mimoun, Maurice; Julien Pham; Chaouat, Marc, Hop St Antoine, F-75012 Paris, France.
   Yezli, Saber; Otter, Jonathan A., Bioquell, Andover, Hants, England.
   Yezli, Saber, Bioquell, Paris, France.}},
DOI = {{10.1016/j.burns.2012.07.007}},
ISSN = {{0305-4179}},
EISSN = {{1879-1409}},
Keywords = {{Acinetobacter baumannii; MRSA; Hydrogen peroxide vapour; HPV}},
Keywords-Plus = {{HYDROGEN-PEROXIDE VAPOR; INTENSIVE-CARE-UNIT; RISK-FACTORS;
   ENVIRONMENTAL CONTAMINATION; NOSOCOMIAL COLONIZATION;
   CLOSTRIDIUM-DIFFICILE; BARRIER PRECAUTIONS; OUTBREAK; DECONTAMINATION;
   MRSA}},
Research-Areas = {{General \& Internal Medicine; Dermatology; Surgery}},
Web-of-Science-Categories  = {{Critical Care Medicine; Dermatology; Surgery}},
Author-Email = {{frederic.barbut@sat.aphp.fr}},
ORCID-Numbers = {{Yezli, Saber/0000-0002-3380-7092}},
Cited-References = {{Al-Haddad AM, 2001, J MED MICROBIOL, V50, P558, DOI 10.1099/0022-1317-50-6-558.
   ALLEN KD, 1987, J HOSP INFECT, V9, P110, DOI 10.1016/0195-6701(87)90048-X.
   Alp E, 2011, BURN CARE RES.
   ARNOW PM, 1982, J TRAUMA, V22, P954, DOI 10.1097/00005373-198211000-00012.
   Association for Professionals in Infection Control and Epidemiology (APIC), 2010, GUID EL MULT RES AC.
   Bates CJ, 2005, J HOSP INFECT, V61, P364, DOI 10.1016/j.jhin.2005.05.003.
   Bayat A, 2003, BURNS, V29, P303, DOI 10.1016/S0305-4179(03)00011-1.
   Bernards AT, 1998, AM J INFECT CONTROL, V26, P544, DOI 10.1053/ic.1998.v26.a84555.
   Boswell TC, 2006, J HOSP INFECT, V63, P47, DOI 10.1016/j.jhin.2005.11.011.
   BOYCE JM, 1981, INFECT CONT HOSP EP, V2, P110, DOI 10.1017/S0195941700053881.
   BOYCE JM, 1983, JAMA-J AM MED ASSOC, V249, P2803, DOI 10.1001/jama.249.20.2803.
   Boyce JM, 2008, INFECT CONT HOSP EP, V29, P723, DOI 10.1086/589906.
   Chai LYA, 2005, CLIN INFECT DIS, V40, P632, DOI 10.1086/427150.
   Cook N, 1998, BURNS, V24, P91, DOI 10.1016/S0305-4179(97)00114-9.
   Danchivijitr Somwang, 1995, Journal of the Medical Association of Thailand, V78, pS11.
   Dansby W, 2008, J BURN CARE RES, V29, P331, DOI 10.1097/BCR.0b013e3181667583.
   Donegan N, 2010, VAPORIZED HYDROGEN P.
   Dryden M, 2008, J HOSP INFECT, V68, P190, DOI 10.1016/j.jhin.2007.11.003.
   French GL, 2004, J HOSP INFECT, V57, P31, DOI 10.1016/j.jhin.2004.03.006.
   GERVICH DH, 1985, AM J INFECT CONTROL, V13, P210, DOI 10.1016/0196-6553(85)90059-8.
   HART CA, 1981, J HYG-CAMBRIDGE, V87, P277, DOI 10.1017/S0022172400069497.
   Herruzo R, 2004, BURNS, V30, P419, DOI 10.1016/j.burns.2004.01.008.
   Huang SS, 2006, ARCH INTERN MED, V166, P1945, DOI 10.1001/archinte.166.18.1945.
   HUNT JL, 1988, AM J SURG, V156, P524, DOI 10.1016/S0002-9610(88)80545-2.
   Jeanes A, 2005, J HOSP INFECT, V61, P85, DOI 10.1016/j.jhin.2005.01.001.
   Kaiser M, 2011, MANAGEMENT MULTIYEAR.
   Manian FA, 2010, 5 DEC M SOC HEALTHC.
   Manian FA, 2011, INFECT CONT HOSP EP, V32, P667, DOI 10.1086/660357.
   Matsumura H, 1996, BURNS, V22, P283, DOI 10.1016/0305-4179(95)00145-X.
   McGregor JC, 1998, J ROY COLL SURG EDIN, V43, P45.
   Moultrie Denise, 2011, AORN J, V94, P27, DOI 10.1016/j.aorn.2010.12.026.
   Nseir S, 2011, CLIN MICROBIOL INFEC, V17, P1201, DOI 10.1111/j.1469-0691.2010.03420.x.
   Otter JA, 2011, INFECT CONT HOSP EP, V32, P687, DOI 10.1086/660363.
   Otter JA, 2010, AM J INFECT CONTROL, V38, P754, DOI 10.1016/j.ajic.2010.03.010.
   Otter JA, 2009, J CLIN MICROBIOL, V47, P205, DOI 10.1128/JCM.02004-08.
   Passaretti CL, 2008, INT C ANT AG CHEM IC.
   Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06.
   Rashid A, 2006, BURNS, V32, P452, DOI 10.1016/j.burns.2005.10.016.
   Roberts SA, 2001, J HOSP INFECT, V48, P228, DOI 10.1053/jhin.2001.0985.
   Rodriguez-Bano J, 2009, AM J INFECT CONTROL, V37, P715, DOI 10.1016/j.ajic.2009.01.008.
   RUTALA WA, 1983, J CLIN MICROBIOL, V18, P683.
   Safdar N, 2002, ANN INTERN MED, V136, P834, DOI 10.7326/0003-4819-136-11-200206040-00013.
   Safdar N, 2006, AM J INFECT CONTROL, V34, P476, DOI 10.1016/j.ajic.2006.01.011.
   SHERIDAN RL, 1994, AM J INFECT CONTROL, V22, P340, DOI 10.1016/0196-6553(94)90032-9.
   Shiomori T, 2001, ARCH OTOLARYNGOL, V127, P644, DOI 10.1001/archotol.127.6.644.
   Simor AE, 2002, INFECT CONT HOSP EP, V23, P261, DOI 10.1086/502046.
   Song XY, 2010, AM J INFECT CONTROL, V38, P607, DOI 10.1016/j.ajic.2010.02.017.
   Villegas MV, 2003, INFECT CONT HOSP EP, V24, P284, DOI 10.1086/502205.
   Weber J, 2004, BURNS, V30, pA16, DOI 10.1016/j.burns.2004.08.003.
   Wilson RD, 2004, ANAESTH INTENS CARE, V32, P202.
   Wisplinghoff H, 1999, CLIN INFECT DIS, V28, P59, DOI 10.1086/515067.
   Wong TH, 2002, BURNS, V28, P349, DOI 10.1016/S0305-4179(02)00012-8.
   Wu Hong, 2010, Zhonghua Shao Shang Za Zhi, V26, P296.
   Zanetti G, 2007, INFECT CONT HOSP EP, V28, P723, DOI 10.1086/517956.}},
Number-of-Cited-References = {{54}},
Times-Cited = {{30}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{26}},
Journal-ISO = {{Burns}},
Doc-Delivery-Number = {{118KX}},
Unique-ID = {{ISI:000317025500004}},
DA = {{2018-08-13}},
}

@article{ ISI:000317030400013,
Author = {Korzeniewska, Ewa and Korzeniewska, Anna and Harnisz, Monika},
Title = {{Antibiotic resistant Escherichia coli in hospital and municipal sewage
   and their emission to the environment}},
Journal = {{ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY}},
Year = {{2013}},
Volume = {{91}},
Pages = {{96-102}},
Month = {{MAY 1}},
Abstract = {{The spreading of antibiotic resistant bacteria in the environment is a
   threat to human health but little is known about the transmission of
   extended-spectrum beta-lactamases (ESBL)-producing Escherichia coli from
   the hospital and municipal sewage to the water basin and to the air at
   the WWTPs (Waste Water Treatment Plants) area and their surroundings.
   Accordingly, it seems particularly interesting to trace the fate of
   these bacteria and their genes encoding antibiotic resistance in both
   untreated sewage from hospitals, and in sewage after different stages of
   purification, and finally to examine the degree of their emissions to
   environment. Although wastewater treatment processes reduce number of
   bacteria in sewage up to 99\%, in the presented study it was reported
   that more than 2.7 x 10(3) CFU/mL E. coli reached the receiving water
   and contributed to dissemination of resistant bacteria into the
   environment. We received 395 E. coli strains from sewage and
   environmental samples and we investigated their antibiotic
   susceptibility and the presence of bla gene encoding TEM, CTX, OXA and
   SHV. From among 167 and 147 E. coli strains isolated from hospital
   effluents and municipal sewage in Olsztyn, Poland, up to 37.1\% and
   17.7\%, respectively, were ESBL-positive. From among 38 and 43 strains
   isolated from river water and the air up to 18.4\% and 27.9\%,
   respectively, were ESBL-producers. The bla(CTX-M) (bla(CTX-M-1),
   bla(CTX-M-3), bla(CTX-M-5), bla(CTX-M-15)) genes were the predominant
   group of the plasmid-coded ESBLs. More than 38\% out of ESBL-producing
   isolates carried several bla genes. The multiple-antibiotic-resistant
   (MAR) indexes for ESBL-positive were higher than for ESBL-negative
   isolates and ranged from 0.45 to 0.63. The MAR indexes for E. coli from
   hospital effluents and air samples were greater than the indexes
   calculated for strains isolated from other samples. Presumably, the
   preliminary disinfection of hospital sewage before its inflow into the
   sewage system might minimize the spreading of antibiotic-resistant
   bacteria to the environment. (c) 2013 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Korzeniewska, E (Reprint Author), Univ Warmia \& Mazury, Dept Environm Microbiol, Fac Environm Sci, Prawochenskiego 1 Str, PL-10720 Olsztyn, Poland.
   Korzeniewska, Ewa; Korzeniewska, Anna; Harnisz, Monika, Univ Warmia \& Mazury, Dept Environm Microbiol, Fac Environm Sci, PL-10720 Olsztyn, Poland.}},
DOI = {{10.1016/j.ecoenv.2013.01.014}},
ISSN = {{0147-6513}},
Keywords = {{Escherichia coli; Multidrug-resistance; Beta-lactamases; Sewage;
   Hospital; WWTP}},
Keywords-Plus = {{WATER TREATMENT-PLANT; SPECTRUM-BETA-LACTAMASE; WASTE-WATER; MOLECULAR
   CHARACTERIZATION; KLEBSIELLA-PNEUMONIAE; GENE-TRANSFER; BACTERIA;
   SLUDGE; EPIDEMIOLOGY; EMERGENCE}},
Research-Areas = {{Environmental Sciences \& Ecology; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Toxicology}},
Author-Email = {{ewa.korzeniewska@uwm.edu.pl}},
ResearcherID-Numbers = {{Korzeniewska, Ewa/J-6408-2013
   Harnisz, Monika/N-3040-2018
   }},
ORCID-Numbers = {{Harnisz, Monika/0000-0002-2907-4199
   Korzeniewska, Ewa/0000-0002-3106-2381}},
Funding-Acknowledgement = {{Ministry of Science and Higher Education (Poland) {[}N305 156836]}},
Funding-Text = {{I would like to thank the staff of the hospitals in Olsztyn and the Lyna
   WWTP for providing samples. I also thank the reviewers for their
   valuable comments. This study was supported by Grant No. N305 156836
   from the Ministry of Science and Higher Education (Poland).}},
Cited-References = {{Bunger J, 2007, INT ARCH OCC ENV HEA, V80, P306, DOI 10.1007/s00420-006-0135-2.
   Bush K, 2010, CRIT CARE, V14, DOI 10.1186/cc8892.
   Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09.
   Chagas TPG, 2011, J APPL MICROBIOL, V111, P572, DOI 10.1111/j.1365-2672.2011.05072.x.
   Chang XS, 2010, ENVIRON POLLUT, V158, P1444, DOI 10.1016/j.envpol.2009.12.034.
   Chen DH, 1999, PLANT MOL BIOL REP, V17, P53, DOI 10.1023/A:1007585532036.
   Clinical and Laboratory Standards Institute, 2007, M100S17 CLSI.
   Clinical and Laboratory Standards Institute (CLSI), 2009, M100S19 CLSI.
   CLSI, 2007, M2A9 CLSI.
   da Silva MF, 2007, FEMS MICROBIOL ECOL, V60, P166, DOI 10.1111/j.1574-6941.2006.00268.x.
   Dzierzanowska D, 2010, INT J ANTIMICROB AG, V35, P392, DOI 10.1016/j.ijantimicag.2009.12.010.
   Eisner A, 2006, ANTIMICROB AGENTS CH, V50, P785, DOI 10.1128/AAC.50.2.785-787.2006.
   European Committee on Antimicrobial Susceptibility Testing, 2012, BREAKP TABL INT MICS.
   Feuerpfeil I., 1992, BUNDESGESUNDHEITSBLA, V35, P61.
   Galani I, 2006, J ANTIMICROB CHEMOTH, V58, P432, DOI 10.1093/jac/dkl240.
   Galvin S, 2010, APPL ENVIRON MICROB, V76, P4772, DOI 10.1128/AEM.02898-09.
   Gotkowska-PPlachtaachta A, CLEAN SOIL IN PRESS.
   Harnisz M, 2013, ENVIRON POLLUT, V174, P85, DOI 10.1016/j.envpol.2012.11.005.
   Huang JJ, 2012, ENVIRON INT, V42, P31, DOI 10.1016/j.envint.2011.03.001.
   Kammerer K., 2009, CHEMOSPHERE, V75, P417.
   Kelly BG, 2009, FOOD CHEM TOXICOL, V47, P978, DOI 10.1016/j.fct.2008.06.012.
   Kim S, 2007, J TOXICOL ENV HEAL B, V10, P559, DOI 10.1080/15287390600975137.
   Kiratisin P, 2008, ANTIMICROB AGENTS CH, V52, P2818, DOI 10.1128/AAC.00171-08.
   Knapp C. W., 2010, ENVIRON POLLUT, V158, P506, DOI {[}10.1016/j.envpol.2009.12.020, DOI 10.1016/J.ENVPOL.2009.12.020].
   Korzeniewska E, 2009, WATER RES, V43, P2841, DOI 10.1016/j.watres.2009.03.050.
   Korzeniewska E, 2012, WATER AIR SOIL POLL, V223, P4039, DOI 10.1007/s11270-012-1171-z.
   Korzeniewska Ewa, 2011, Front Biosci (Schol Ed), V3, P393, DOI 10.2741/s159.
   Korzeniewska E, 2008, ARCH ENVIRON PROT, V34, P13.
   KRUMPERMAN PH, 1983, APPL ENVIRON MICROB, V46, P165.
   Langin A, 2009, CHEMOSPHERE, V75, P347, DOI 10.1016/j.chemosphere.2008.12.032.
   Mansouri S, 2010, IRAN J MED SCI, V35, P101.
   Mugnaioli C, 2006, ANTIMICROB AGENTS CH, V50, P2700, DOI 10.1128/AAC.00068-06.
   Naas T, 2008, CLIN MICROBIOL INFEC, V14, P42, DOI 10.1111/j.1469-0691.2007.01861.x.
   Oteo J, 2008, INT J ANTIMICROB AG, V32, P534, DOI 10.1016/j.ijantimicag.2008.06.012.
   Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005.
   Prado T, 2008, LETT APPL MICROBIOL, V46, P136, DOI 10.1111/j.1472-765X.2007.02275.x.
   Reinthaler FF, 2003, WATER RES, V37, P1685, DOI 10.1016/S0043-1354(02)00569-9.
   Reinthaler FF, 2010, WATER RES, V44, P1981, DOI 10.1016/j.watres.2009.11.052.
   Rusca S, 2008, INT ARCH OCC ENV HEA, V81, P415, DOI 10.1007/s00420-007-0228-6.
   Schluter A, 2007, FEMS MICROBIOL REV, V31, P449, DOI 10.1111/j.1574-6976.2007.00074.x.
   Silva J, 2006, ELECTRON J BIOTECHN, V9, P533, DOI 10.2225/vol9-issue5-fulltext-7.
   Storteboom H, 2010, ENVIRON SCI TECHNOL, V44, P7397, DOI 10.1021/es101657s.
   Summers AO, 2006, ANIM BIOTECHNOL, V17, P125, DOI 10.1080/10495390600957217.
   Szczepanowski R, 2009, MICROBIOL-SGM, V155, P2306, DOI 10.1099/mic.0.028233-0.
   Unno T, 2010, SCI TOTAL ENVIRON, V408, P3499, DOI 10.1016/j.scitotenv.2010.04.046.
   Vinue L, 2009, CLIN MICROBIOL INFEC, V15, P954, DOI {[}10.1111/j.1469-0691.2009.02803.x, 10.1111/1469-0691.2009.02803.x].
   World Health Organization, 2010, EUR 55934 BD 1 HLTH.
   Yang CM, 2009, LETT APPL MICROBIOL, V48, P560, DOI 10.1111/j.1472-765X.2009.02572.x.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{78}},
Usage-Count-Last-180-days = {{7}},
Usage-Count-Since-2013 = {{176}},
Journal-ISO = {{Ecotox. Environ. Safe.}},
Doc-Delivery-Number = {{118MU}},
Unique-ID = {{ISI:000317030400013}},
DA = {{2018-08-13}},
}

@article{ ISI:000318398300014,
Author = {Cristina, M. L. and Spagnolo, A. M. and Cenderello, N. and Fabbri, P.
   and Sartini, M. and Ottria, G. and Orlando, P.},
Title = {{Multidrug-resistant Acinetobacter baumannii outbreak: an investigation
   of the possible routes of transmission}},
Journal = {{PUBLIC HEALTH}},
Year = {{2013}},
Volume = {{127}},
Number = {{4}},
Pages = {{386-391}},
Month = {{APR}},
Abstract = {{Objectives: To establish the possible sources and routes of transmission
   of a multidrug-resistant Acinetobacter baumannii outbreak involving 22
   patients.
   Study design: Descriptive, retrospective study.
   Methods: An environmental investigation was undertaken, monitoring
   surfaces, air and water. Reconstruction of the spread of the infection
   took several factors into account such as intrahospital movements of
   patients and healthcare personnel, hospitalization of patients in the
   same ward and in chronologically compatible periods, and length of stay.
   A. baumannii clinical samples were typed using the Multilocus Sequence
   Typing scheme.
   Results: The outbreak originated from a patient admitted to the
   sub-intensive care unit, and the infection subsequently spread to other
   wards. The allelic profile proved to be the same for all the clinical
   isolates. Environmental monitoring yielded negative results for A.
   baumannii.
   Conclusions: The results suggest that this epidemic spread through
   cross-transmission involving healthcare workers. (C) 2013 The Royal
   Society for Public Health. Published by Elsevier Ltd. All rights
   reserved.}},
Publisher = {{W B SAUNDERS CO LTD}},
Address = {{32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Spagnolo, AM (Reprint Author), Univ Genoa, Dept Hlth Sci, Via Pastore 1, I-16132 Genoa, Italy.
   Cristina, M. L.; Spagnolo, A. M.; Sartini, M.; Ottria, G.; Orlando, P., Univ Genoa, Dept Hlth Sci, I-16132 Genoa, Italy.
   Cenderello, N.; Fabbri, P., Galliera Hosp, Genoa, Italy.}},
DOI = {{10.1016/j.puhe.2013.01.025}},
ISSN = {{0033-3506}},
EISSN = {{1476-5616}},
Keywords = {{Acinetobacter baumannii; Outbreak; Transmission}},
Keywords-Plus = {{INTENSIVE-CARE-UNIT; RISK-FACTORS; ANTIMICROBIAL SUSCEPTIBILITY; BURN
   UNIT; EPIDEMIOLOGY; INFECTION; ACQUISITION; MANAGEMENT}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{am.spagnolo@unige.it}},
ResearcherID-Numbers = {{Sartini, Marina/I-2950-2012
   }},
ORCID-Numbers = {{Orlando, Paolo/0000-0002-6576-9860
   CRISTINA, Maria Luisa/0000-0002-7926-7108
   Spagnolo, Anna Maria/0000-0001-6559-3626}},
Cited-References = {{Chan PC, 2007, INFECT CONT HOSP EP, V28, P423, DOI 10.1086/513120.
   Cristina ML, 2011, AM J INFECT CONTROL, V39, P790, DOI 10.1016/j.ajic.2011.01.016.
   D'Agata EMC, 2000, INFECT CONT HOSP EP, V21, P588, DOI 10.1086/501808.
   Doidge M, 2010, INFECT CONT HOSP EP, V31, P418, DOI 10.1086/651312.
   El Shafie SS, 2004, J HOSP INFECT, V56, P101, DOI 10.1016/j.jhin.2003.09.024.
   Falagas ME, 2008, CLIN INFECT DIS, V46, P1121, DOI 10.1086/528867.
   Fierobe L, 2001, INFECT CONT HOSP EP, V22, P35, DOI 10.1086/501822.
   Fontana C, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-79.
   Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202.
   Garcia-Garmendia JL, 2001, CLIN INFECT DIS, V33, P939, DOI 10.1086/322584.
   GO ES, 1994, LANCET, V344, P1329, DOI 10.1016/S0140-6736(94)90694-7.
   Grisold AJ, 2010, J INFECTION, V60, P44, DOI 10.1016/j.jinf.2009.10.045.
   Halstead DC, 2007, J INFECTION, V55, P49, DOI 10.1016/j.jinf.2006.11.018.
   Health Protection Agency, 2006, WORK PART GUID CONTR.
   Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-2.
   Koeleman JGM, 1997, J HOSP INFECT, V37, P113, DOI 10.1016/S0195-6701(97)90181-X.
   La Forgia C, 2010, AM J INFECT CONTROL, V38, P259, DOI 10.1016/j.ajic.2009.07.012.
   Marchaim D, 2007, INFECT CONT HOSP EP, V28, P945, DOI 10.1086/518970.
   Mathai E, 2010, INFECTION, V38, P349, DOI 10.1007/s15010-010-0047-7.
   Organization WH, WHO GUID HAND HYG HL.
   Oteo J, 2007, J INFECTION, V55, P260, DOI 10.1016/j.jinf.2007.04.009.
   Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07.
   Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06.
   Simor AE, 2002, INFECT CONT HOSP EP, V23, P261, DOI 10.1086/502046.
   Tomas MD, 2005, CLIN MICROBIOL INFEC, V11, P540, DOI 10.1111/j.1469-0691.2005.01184.x.
   Touati A, 2009, ANN EPIDEMIOL, V19, P372, DOI 10.1016/j.annepidem.2009.03.010.
   Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032.
   Villegas MV, 2003, INFECT CONT HOSP EP, V24, P284, DOI 10.1086/502205.
   Wroblewska MM, 2004, J HOSP INFECT, V57, P300, DOI 10.1061/j.jhin.2004.04.009.
   Wybo I, 2007, J HOSP INFECT, V67, P374, DOI 10.1016/j.jhin.2007.09.012.
   Yang SC, 2010, EUR J CLIN MICROBIOL, V29, P601, DOI 10.1007/s10096-010-0878-2.
   Zanetti G, 2007, INFECT CONT HOSP EP, V28, P723, DOI 10.1086/517956.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{11}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{14}},
Journal-ISO = {{Public Health}},
Doc-Delivery-Number = {{136XZ}},
Unique-ID = {{ISI:000318398300014}},
DA = {{2018-08-13}},
}

@article{ ISI:000318748600108,
Author = {Singh, Rishan},
Title = {{Minimum Inhibitory Concentrations: Interpretation and Cross-sectional
   Analysis in An Unstandardised 7H9 Mycobacterium tuberculosis Broth-based
   System - a Hypothetical Case}},
Journal = {{JOURNAL OF PURE AND APPLIED MICROBIOLOGY}},
Year = {{2013}},
Volume = {{7}},
Number = {{1}},
Pages = {{777-784}},
Month = {{MAR}},
Abstract = {{Mycobacterium tuberculosis is an infectious disease of the lungs and is
   spread in the air through respiratory droplets. The living state of
   human beings with tuberculosis infections have become devastating, with
   particular reference to developing countries such as South Africa, China
   and India, because of the lack of resources to perform important
   laboratory procedures like Minimum Inhibitory Concentrations (MICs),
   which are important to determine the lowest concentration of a
   particular drug that would ultimately inhibit the multiplication of
   tuberculosis isolates. MICs thus give scientists an idea as to what
   diagnosis should be made to treat such patients. This article sheds
   light and serves to help the scientific community understand and
   interpret Minimum Inhibitory Concentrations, even where laboratories are
   under-resourced in the world, and thus contributes to the wealth of
   scientific, medical, Microbiological and public knowledge.}},
Publisher = {{DR M N KHAN}},
Address = {{54, NEAR POST OFFICE, THANA ST, BHOPAL, SHAHJAHANABAD 462 001, INDIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Singh, R (Reprint Author), Univ KwaZulu Natal, Durban, South Africa.
   Univ KwaZulu Natal, Durban, South Africa.}},
ISSN = {{0973-7510}},
Keywords = {{Minimum inhibitory concentrations; Susceptibility patterns; Colony
   counts; Dilution factor; Drug resistance}},
Keywords-Plus = {{RESISTANT}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Microbiology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Microbiology}},
Author-Email = {{rshnsingh1@webmail.co.za}},
Cited-References = {{Alexander SK, 2001, MICROBIOLOGY PHOTOGR, P127.
   {[}Anonymous], 2000, 2 WHO.
   {[}Anonymous], 2007, TB154 WHO PAR 4, P1.
   MartinCasabona N, 1997, J CLIN MICROBIOL, V35, P2521.
   Petrini B, 1999, INT J ANTIMICROB AG, V13, P93, DOI 10.1016/S0924-8579(99)00111-9.
   Singh R, 2011, J PURE APPL MICROBIO, V5, P541.
   Todar K, TODARS TXB BACTERIOL.
   Victor TC, 1997, J MED MICROBIOL, V46, P847, DOI 10.1099/00222615-46-10-847.
   WOLINSKY E, 1993, CLIN INFECT DIS, V16, P627, DOI 10.1093/clind/16.5.627.
   World Health Organisation, 1997, ANT DRUG RES SURV 19.
   World Health Organization, 2001, B WHO, V79.}},
Number-of-Cited-References = {{11}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{J. Pure Appl. Microbiol.}},
Doc-Delivery-Number = {{141TE}},
Unique-ID = {{ISI:000318748600108}},
DA = {{2018-08-13}},
}

@article{ ISI:000316961800022,
Author = {Norton, Matthew D. and Spilkia, Allison J. and Godoy, Veronica G.},
Title = {{Antibiotic Resistance Acquired through a DNA Damage-Inducible Response
   in Acinetobacter baumannii}},
Journal = {{JOURNAL OF BACTERIOLOGY}},
Year = {{2013}},
Volume = {{195}},
Number = {{6}},
Pages = {{1335-1345}},
Month = {{MAR}},
Abstract = {{Acinetobacter baumannii is an emerging nosocomial, opportunistic
   pathogen that survives desiccation and quickly acquires resistance to
   multiple antibiotics. Escherichia coli gains antibiotic resistances by
   expressing genes involved in a global response to DNA damage. Therefore,
   we asked whether A. baumannii does the same through a yet undetermined
   DNA damage response akin to the E. coli paradigm. We found that recA and
   all of the multiple error-prone DNA polymerase V (Pol V) genes, those
   organized as umuDC operons and unlinked, are induced upon DNA damage in
   a RecA-mediated fashion. Consequently, we found that the frequency of
   rifampin-resistant (Rif) mutants is dramatically increased upon UV
   treatment, alkylation damage, and desiccation, also in a RecA-mediated
   manner. However, in the recA insertion knockout strain, in which we
   could measure the recA transcript, we found that recA was induced by DNA
   damage, while uvrA and one of the unlinked umuC genes were somewhat
   derepressed in the absence of DNA damage. Thus, the mechanism regulating
   the A. baumannii DNA damage response is likely different from that in E.
   coli. Notably, it appears that the number of DNA Pol V genes may
   directly contribute to desiccation-induced mutagenesis. Sequences of the
   rpoB gene from desiccation-induced Rif mutants showed a signature that
   was consistent with E. coli DNA polymerase V-generated base-pair
   substitutions and that matched that of sequenced A. baumannii clinical
   Rif isolates. These data strongly support an A. baumannii DNA
   damage-inducible response that directly contributes to antibiotic
   resistance acquisition, particularly in hospitals where A. baumannii
   desiccates and tenaciously survives on equipment and surfaces.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Godoy, VG (Reprint Author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.
   Norton, Matthew D.; Spilkia, Allison J.; Godoy, Veronica G., Northeastern Univ, Dept Biol, Boston, MA 02115 USA.}},
DOI = {{10.1128/JB.02176-12}},
ISSN = {{0021-9193}},
Keywords-Plus = {{BASE SUBSTITUTION MUTATIONS; ESCHERICHIA-COLI; Y-FAMILY; LESION-BYPASS;
   INDUCED MUTAGENESIS; RECA PROTEIN; HOMOLOGOUS RECOMBINATION;
   ANTIMICROBIAL RESISTANCE; AIR DISINFECTION; STRESS-RESPONSE}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{v.godoycarter@neu.edu}},
Funding-Acknowledgement = {{NIGMS {[}1RO1GM088230-01A1]}},
Funding-Text = {{This work was supported by the 1RO1GM088230-01A1 award from NIGMS to
   V.G. Godoy.}},
Cited-References = {{Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389.
   Amsterdam D, 1996, ANTIBIOT LAB MED, V4, P52.
   Aranda J, 2011, J BACTERIOL, V193, P3740, DOI 10.1128/JB.00389-11.
   Ausubel FM, 1994, CURRENT PROTOCOLS MO.
   Benson RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019944.
   Bergogne-Berezin E., 2001, CURR INFECT DIS REP, V3, P440, DOI 10.1007/BF03160479.
   Bergogne-Berezin E, 2008, ACINETOBACTER BIOL P, Vxvi.
   BERGOGNEBEREZIN E, 1991, J HOSP INFECT, V18, P250, DOI 10.1016/0195-6701(91)90030-C.
   BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148.
   BERGOGNEBEREZIN E, 1995, J HOSP INFECT, V30, P441, DOI 10.1016/0195-6701(95)90048-9.
   Beuning PJ, 2006, METHOD ENZYMOL, V408, P318, DOI 10.1016/S0076-6879(06)08020-7.
   Bjedov I, 2007, GENETICS, V176, P1431, DOI 10.1534/genetics.107.072405.
   Botzenhart K, 1976, Prakt Anaesth, V11, P320.
   Boudsocq F, 2002, DNA REPAIR, V1, P343, DOI 10.1016/S1568-7864(02)00019-8.
   Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176.
   Cirz RT, 2007, CRIT REV BIOCHEM MOL, V42, P341, DOI 10.1080/10409230701597741.
   Courcelle J, 2001, GENETICS, V158, P41.
   Davis EO, 2002, MOL MICROBIOL, V46, P791, DOI 10.1046/j.1365-2958.2002.03199.x.
   Di Nocera PP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-224.
   Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760.
   Friedberg E.C, 2006, DNA REPAIR MUTAGENES, VDC, P2006.
   Fuchs RP, 2004, ADV PROTEIN CHEM, V69, P229.
   Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502.
   Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7.
   GERISCHER U, 2008, ACINETOBACTER MOL BI.
   Giannouli M, 2012, INT J ANTIMICROB AG, V39, P58, DOI 10.1016/j.ijantimicag.2011.09.016.
   Godoy VG, 2007, MOL CELL, V28, P1058, DOI 10.1016/j.molcel.2007.10.025.
   Godoy VG, 2006, EMBO J, V25, P868, DOI 10.1038/sj.emboj.7600986.
   Hare JM, 2012, FEMS MICROBIOL LETT, V334, P57, DOI 10.1111/j.1574-6968.2012.02618.x.
   Hare JM, 2012, MICROBIOL-SGM, V158, P601, DOI 10.1099/mic.0.054668-0.
   Hare JM, 2006, APPL ENVIRON MICROB, V72, P4036, DOI 10.1128/AEM.02774-05.
   HART D, 1960, JAMA-J AM MED ASSOC, V172, P1019, DOI 10.1001/jama.1960.03020100027006.
   HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4.
   Jarosz DF, 2007, CELL CYCLE, V6, P817, DOI 10.4161/cc.6.7.4065.
   Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318.
   Jawad A, 1998, J CLIN MICROBIOL, V36, P1938.
   Kelley WL, 2006, MOL MICROBIOL, V62, P1228, DOI 10.1111/j.1365-2958.2006.05444.x.
   Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212.
   KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401.
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130.
   Lee AM, 2005, J MED CHEM, V48, P5408, DOI 10.1021/jm.050113z.
   Li BR, 2010, MICROBES INFECT, V12, P662, DOI 10.1016/j.micinf.2010.04.009.
   Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3.
   Lockhart SR, 2007, J CLIN MICROBIOL, V45, P3352, DOI 10.1128/JCM.01284-07.
   Malik M, 2006, MOL MICROBIOL, V61, P810, DOI 10.1111/j.1365-2958.2006.05275.x.
   Maor-Shoshani A, 2000, P NATL ACAD SCI USA, V97, P565, DOI 10.1073/pnas.97.2.565.
   MARKHAM BE, 1984, J MOL BIOL, V178, P237, DOI 10.1016/0022-2836(84)90142-6.
   Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630.
   Neely AN, 1999, CLIN INFECT DIS, V29, P1358, DOI 10.1086/313463.
   Neely AN, 2000, J BURN CARE REHABIL, V21, P523, DOI 10.1067/mbc.2000.111120.
   Nohmi T, 2006, ANNU REV MICROBIOL, V60, P231, DOI 10.1146/annurev.micro.60.080805.142238.
   Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7.
   Petrosino JF, 2009, J BACTERIOL, V191, P5881, DOI 10.1128/JB.00732-09.
   POTTS M, 1994, MICROBIOL REV, V58, P755.
   Rauch PJG, 1996, MICROBIOL-UK, V142, P1025, DOI 10.1099/00221287-142-4-1025.
   Rehrauer WM, 1998, J BIOL CHEM, V273, P32384, DOI 10.1074/jbc.273.49.32384.
   Reuven NB, 1998, MOL CELL, V2, P191, DOI 10.1016/S1097-2765(00)80129-X.
   RILEY RL, 1989, AM REV RESPIR DIS, V139, P1286, DOI 10.1164/ajrccm/139.5.1286.
   RILEY RL, 1971, ARCH ENVIRON HEALTH, V22, P551, DOI 10.1080/00039896.1971.10665899.
   Robinson A, 2010, MICROBIOL MOL BIOL R, V74, P273, DOI 10.1128/MMBR.00048-09.
   Romesberg F, 2009, U.S. patent, Patent No. {[}US 2009/0136518 A1, 20090136518].
   SCHAUB IG, 1948, J BACTERIOL, V56, P379.
   Schlacher K, 2007, NAT REV MOL CELL BIO, V8, P587, DOI 10.1038/nrm2198.
   Seward RJ, 1998, CLIN MICROBIOL INFEC, V4, P248.
   Sexton Jonathan Z, 2010, Curr Chem Genomics, V4, P34, DOI 10.2174/1875397301004010034.
   Singleton SF, 2012, U.S. patent, Patent No. {[}US 2012/0135092 A1, 20120135092].
   Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307.
   Snitkin ES, 2011, P NATL ACAD SCI USA, V108, P13758, DOI 10.1073/pnas.1104404108.
   Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479.
   Tang MJ, 1998, P NATL ACAD SCI USA, V95, P9755, DOI 10.1073/pnas.95.17.9755.
   TANG WJY, 1993, METHOD CELL BIOL, V37, P95, DOI 10.1016/S0091-679X(08)60245-9.
   Thi Thuy Do, 2011, J Antimicrob Chemother, V66, P531, DOI 10.1093/jac/dkq496.
   VILA J, 1995, ANTIMICROB AGENTS CH, V39, P1201, DOI 10.1128/AAC.39.5.1201.
   Vila J, 1997, J ANTIMICROB CHEMOTH, V39, P757, DOI 10.1093/jac/39.6.757.
   Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509.
   Wendt C, 1997, J CLIN MICROBIOL, V35, P1394.
   Wigle TJ, 2009, J BIOMOL SCREEN, V14, P1092, DOI 10.1177/1087057109342126.
   WOODGATE R, 1989, P NATL ACAD SCI USA, V86, P7301, DOI 10.1073/pnas.86.19.7301.
   Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104.
   Yang W, 2011, PROTEIN SCI, V20, P1781, DOI 10.1002/pro.723.
   YASBIN RE, 1992, MOL MICROBIOL, V6, P1263, DOI 10.1111/j.1365-2958.1992.tb00847.x.
   Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895.}},
Number-of-Cited-References = {{82}},
Times-Cited = {{30}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{22}},
Journal-ISO = {{J. Bacteriol.}},
Doc-Delivery-Number = {{117OC}},
Unique-ID = {{ISI:000316961800022}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000315983100013,
Author = {Ozalp, Veli Cengiz and Bilecen, Kivanc and Kavruk, Murat and Oktem,
   Huseyin Avni},
Title = {{Antimicrobial aptamers for detection and inhibition of microbial
   pathogen growth}},
Journal = {{FUTURE MICROBIOLOGY}},
Year = {{2013}},
Volume = {{8}},
Number = {{3}},
Pages = {{387-401}},
Month = {{MAR}},
Abstract = {{Discovery of alternative sources of antimicrobial agents are essential
   in the ongoing battle against microbial pathogens. Legislative and
   scientific challenges considerably hinder the discovery and use of new
   antimicrobial drugs, and new approaches are in urgent demand. On the
   other hand, rapid, specific and sensitive detection of airborne
   pathogens is becoming increasingly critical for public health. In this
   respect affinity oligonucleotides, aptamers, provide unique
   opportunities for the development of nanotechnological solutions for
   such medical applications. In recent years, aptamers specifically
   recognizing microbial cells and viruses showed great potential in a
   range of analytical and therapeutic applications. This article describes
   the significant advances in the development of aptamers targeting
   specific pathogens. Therapeutic application of aptamers as neutralizing
   agents demonstrates great potential as a future source of antimicrobial
   agent.}},
Publisher = {{FUTURE MEDICINE LTD}},
Address = {{UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Ozalp, VC (Reprint Author), Nanobiz Ltd, MetuTechnopolis, Galium Block,2nd Floor,18, TR-06800 Ankara, Turkey.
   Ozalp, Veli Cengiz; Bilecen, Kivanc; Kavruk, Murat; Oktem, Huseyin Avni, Nanobiz Ltd, MetuTechnopolis, TR-06800 Ankara, Turkey.
   Ozalp, Veli Cengiz; Kavruk, Murat; Oktem, Huseyin Avni, Middle E Tech Univ, Dept Biol Sci, TR-06800 Ankara, Turkey.}},
DOI = {{10.2217/FMB.12.149}},
ISSN = {{1746-0913}},
Keywords = {{antibiotics; antimicrobial agents; aptamers; biosensors; hygiene
   monitoring; multidrug resistance; pathogens; riboswitches}},
Keywords-Plus = {{IMMUNODEFICIENCY-VIRUS TYPE-1; SALMONELLA-ENTERICA SEROVARS; VIRAL
   NUCLEOPROTEIN BINDING; DNA APTAMERS; RNA APTAMERS;
   STAPHYLOCOCCUS-AUREUS; ATP BIOLUMINESCENCE; EXPONENTIAL ENRICHMENT;
   STREPTOCOCCUS-PYOGENES; REVERSE-TRANSCRIPTASE}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{cozalp@metu.edu.tr}},
ResearcherID-Numbers = {{ozalp, cengiz/B-2940-2009
   }},
ORCID-Numbers = {{ozalp, cengiz/0000-0002-7659-5990
   Bilecen, Kivanc/0000-0002-6254-3516}},
Funding-Acknowledgement = {{Scientific and Technological Council of Turkey (TUBITAK) {[}BIDEB-2232]}},
Funding-Text = {{VC Ozalp is grateful to The Scientific and Technological Council of
   Turkey (TUBITAK) for fellowship (Doktora Sonrasi Geri Doni
   Programi-BIDEB-2232). The authors have no other relevant affiliations or
   financial involvement with any organization or entity with a financial
   interest in or financial conflict with the subject matter or materials
   discussed in the manuscript apart from those disclosed.}},
Cited-References = {{Aiken ZA, 2011, INFECT CONT HOSP EP, V32, P507, DOI 10.1086/659761.
   Anjum MF, 2006, CLIN VACCINE IMMUNOL, V13, P561, DOI 10.1128/CVI.13.5.561-567.2006.
   Barbas AS, 2010, FUTURE ONCOL, V6, P1117, DOI {[}10.2217/fon.10.67, 10.2217/FON.10.67].
   Beall B, 1996, J CLIN MICROBIOL, V34, P953.
   Blum JH, 2000, P NATL ACAD SCI USA, V97, P2241, DOI 10.1073/pnas.040573397.
   Boisgard R, 2005, EUR J NUCL MED MOL I, V32, P470, DOI 10.1007/s00259-004-1669-8.
   Book B, 2011, BIOTECHNOL BIOENG, V108, P1222, DOI 10.1002/bit.23043.
   Bouchard PR, 2010, ANNU REV PHARMACOL, V50, P237, DOI 10.1146/annurev.pharmtox.010909.105547.
   Breaker RR, 2009, FUTURE MICROBIOL, V4, P771, DOI {[}10.2217/fmb.09.46, 10.2217/FMB.09.46].
   Brenner FW, 2000, J CLIN MICROBIOL, V38, P2465.
   Bruno JG, 2008, FOLIA MICROBIOL, V53, P295, DOI 10.1007/s12223-008-0046-6.
   Bruno JG, 2012, J FLUORESC, V22, P915, DOI 10.1007/s10895-011-1030-0.
   Bruno JG, 2010, IN VITRO CELL DEV-AN, V46, P107, DOI 10.1007/s11626-009-9257-7.
   Cao XX, 2009, NUCLEIC ACIDS RES, V37, P4621, DOI 10.1093/nar/gkp489.
   Carrascosa C, 2012, FOOD CONTROL, V28, P368, DOI 10.1016/j.foodcont.2012.05.001.
   Ozalp VC, 2012, ANAL BIOANAL CHEM, V402, P799, DOI 10.1007/s00216-011-5499-9.
   Ozalp VC, 2011, ANALYST, V136, P5046, DOI 10.1039/c1an15762k.
   Chang YC, 2009, FASEB J, V23, P3078, DOI 10.1096/fj.09-129312.
   Chen F, 2012, MOL BIOL REP, V39, P2157, DOI 10.1007/s11033-011-0963-3.
   Chen F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008142.
   Choi S, 2011, MOL CELLS, V32, P527, DOI 10.1007/s10059-011-0156-x.
   Cibiel A., 2011, PHARMACEUTICALS, V4, P1216, DOI DOI 10.3390/PH4091216.
   Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648.
   Cruz-Toledo J, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas006.
   Deigan KE, 2011, ACCOUNTS CHEM RES, V44, P1329, DOI 10.1021/ar200039b.
   Deng Q, 2003, J CHROMATOGR A, V1005, P123, DOI 10.1016/S0021-9673(03)00812-4.
   Driscoll M, 2006, LUMINESCENCE, V21, P274.
   Duan N, 2012, J AGR FOOD CHEM, V60, P4034, DOI 10.1021/jf300395z.
   Duan N, 2012, ANAL CHIM ACTA, V723, P1, DOI 10.1016/j.aca.2012.02.011.
   Dwivedi HP, 2011, CRIT REV MICROBIOL, V37, P40, DOI 10.3109/1040841X.2010.506430.
   Dwivedi HP, 2010, APPL MICROBIOL BIOT, V87, P2323, DOI 10.1007/s00253-010-2728-7.
   Edwards AL, 2010, NAT ED, V3, P9.
   ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0.
   {[}European CDC European Medicines Agency Joint Working Group], 2009, BACT CHALL TIM REACT.
   Feng H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027862.
   Feng XL, 2011, CHEM COMMUN, V47, P173, DOI 10.1039/c0cc00980f.
   Francischetti IMB, 2012, ARTERIOSCL THROM VAS, V32, P786, DOI 10.1161/ATVBAHA.111.240291.
   Fujita Y, 2012, J BIOSCI BIOENG, V113, P141, DOI 10.1016/j.jbiosc.2011.10.004.
   Fukuba T, 2011, LAB CHIP, V11, P3508, DOI 10.1039/c1lc20523d.
   Gardner SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-668.
   Gopinath SCB, 2012, J VIROL, V86, P6732, DOI 10.1128/JVI.00377-12.
   Hamula CLA, 2011, TRAC-TREND ANAL CHEM, V30, P1587, DOI 10.1016/j.trac.2011.08.006.
   Hamula CLA, 2011, ANAL CHEM, V83, P3640, DOI 10.1021/ac200575e.
   Hannoush RN, 2004, NUCLEIC ACIDS RES, V32, P6164, DOI 10.1093/nar/gkh948.
   Held DM, 2006, J BIOL CHEM, V281, P25712, DOI 10.1074/jbc.M604460200.
   Hernandez FJ, 2012, BIOSENSORS-BASEL, V2, P1, DOI 10.3390/bios2010001.
   Hernandez FJ, 2009, BIOORG MED CHEM LETT, V19, P6585, DOI 10.1016/j.bmcl.2009.10.039.
   Huang LL, 2011, P NATL ACAD SCI USA, V108, P14801, DOI 10.1073/pnas.1111701108.
   Hur J, 2012, FOOD RES INT, V45, P819, DOI 10.1016/j.foodres.2011.05.014.
   Hwang SY, 2012, NUCLEIC ACIDS RES, V40, P2724, DOI 10.1093/nar/gkr1098.
   Hyeon JY, 2012, J MICROBIOL METH, V89, P79, DOI 10.1016/j.mimet.2012.01.014.
   Jayasena SD, 1999, CLIN CHEM, V45, P1628.
   Jin Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr609.
   Joshi P, 2002, J VIROL, V76, P6545, DOI 10.1128/JVI.76.13.6545-6557.2002.
   Joshi R, 2009, MOL CELL PROBE, V23, P20, DOI 10.1016/j.mcp.2008.10.006.
   Jyoti A, 2011, ENVIRON SCI TECHNOL, V45, P8996, DOI 10.1021/es2018994.
   Karkkainen RM, 2011, INT J FOOD SCI TECH, V46, P445, DOI 10.1111/j.1365-2621.2010.02470.x.
   Karmali MA, 2009, KIDNEY INT, V75, pS4, DOI 10.1038/ki.2008.608.
   Khati M, 2003, J VIROL, V77, P12692, DOI 10.1128/JVI.77.23.12692-12698.2003.
   Kim JN, 2009, ACS CHEM BIOL, V4, P915, DOI 10.1021/cb900146k.
   Kim YM, 2009, BIOMARK MED, V3, P193, DOI 10.2217/BMM.09.5.
   Kraemer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026332.
   Kubik MF, 1997, J IMMUNOL, V159, P259.
   Kujau MJ, 1998, NUCLEIC ACIDS RES, V26, P1851, DOI 10.1093/nar/26.7.1851.
   Labib M, 2012, ANAL CHEM, V84, P1813, DOI 10.1021/ac203412m.
   Lee ER, 2009, RNA BIOL, V6, P187, DOI 10.4161/rna.6.2.7727.
   Lee HJ, 2009, BIOSENS BIOELECTRON, V24, P3550, DOI 10.1016/j.bios.2009.05.010.
   Lee YJ, 2012, BIOCHEM BIOPH RES CO, V417, P414, DOI 10.1016/j.bbrc.2011.11.130.
   Li H, 2011, CAN J MICROBIOL, V57, P453, DOI {[}10.1139/W11-030, 10.1139/w11-030].
   Liss M, 2002, ANAL CHEM, V74, P4488, DOI 10.1021/ac011294p.
   Liu GQ, 2012, MICROCHIM ACTA, V178, P237, DOI 10.1007/s00604-012-0825-2.
   Luebbecke M, 2012, ENG LIFE SCI, V12, P144.
   Lunse CE, 2011, ACS CHEM BIOL, V6, P675, DOI 10.1021/cb200016d.
   Mairal T, 2008, ANAL BIOANAL CHEM, V390, P989, DOI 10.1007/s00216-007-1346-4.
   Marimuthu C, 2012, ANALYST, V137, P1307, DOI 10.1039/c2an15905h.
   Mayer G, 2010, NAT PROTOC, V5, P1993, DOI 10.1038/nprot.2010.163.
   Mescalchin A, 2011, MOLECULES, V16, P1271, DOI 10.3390/molecules16021271.
   Moore G, 2002, INT J ENVIRON HEAL R, V12, P317, DOI 10.1080/0960312021000056429.
   Moore MD, 2011, J GEN VIROL, V92, P1493, DOI 10.1099/vir.0.030601-0.
   MUSSER JM, 1995, INFECT IMMUN, V63, P994.
   Negri P, 2012, ANAL CHEM, V84, P5501, DOI 10.1021/ac202427e.
   Negri P, 2011, CHEM COMMUN, V47, P8635, DOI 10.1039/c0cc05433j.
   Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915.
   Nitsche A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-48.
   Ohk SH, 2010, J APPL MICROBIOL, V109, P808, DOI 10.1111/j.1365-2672.2010.04709.x.
   Ozalp V. C., 2011, PHARMACEUTICALS, V4, P1137.
   Ozalp VC, 2010, CHEMBIOCHEM, V11, P2538, DOI 10.1002/cbic.201000500.
   Ozalp VC, 2010, J BIOL CHEM, V285, P37579, DOI 10.1074/jbc.M110.155119.
   Padilla R, 1999, NUCLEIC ACIDS RES, V27, P1561, DOI 10.1093/nar/27.6.1561.
   Pan Q, 2005, ANTIMICROB AGENTS CH, V49, P4052, DOI 10.1128/AAC.49.10.4052-4060.2005.
   Park SY, 2011, NUCLEIC ACID THER, V21, P395, DOI 10.1089/nat.2011.0321.
   Perez F, 2007, CURR OPIN PHARMACOL, V7, P459, DOI 10.1016/j.coph.2007.08.003.
   Planson AG, 2012, CURR OPIN BIOTECH, V23, P948, DOI 10.1016/j.copbio.2012.03.009.
   Punnarak P, 2012, MAR BIOTECHNOL, V14, P752, DOI 10.1007/s10126-012-9448-1.
   Ramalingam D, 2011, J VIROL, V85, P305, DOI 10.1128/JVI.02626-09.
   Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039.
   Ravindranath SP, 2011, SENSOR ACTUAT B-CHEM, V152, P183, DOI 10.1016/j.snb.2010.12.005.
   Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x.
   Schlesinger S. R., 2011, PHARMACEUTICALS, V4, P419, DOI 10.3390/ph4020419.
   Shum KT, 2011, BIOCHEMISTRY-US, V50, P3261, DOI 10.1021/bi2001455.
   Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10.
   Simmel FC, 2007, NANOMEDICINE-UK, V2, P817, DOI 10.2217/17435889.2.6.817.
   Singh G, 2012, ECOTOX ENVIRON SAFE, V78, P320, DOI 10.1016/j.ecoenv.2011.11.039.
   Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937.
   Stadler A, 2010, NANOMEDICINE-UK, V5, P319, DOI 10.2217/nnm.10.2.
   Sudarsan N, 2005, CHEM BIOL, V12, P1325, DOI 10.1016/j.chembiol.2005.10.007.
   Sutcliffe JA, 2005, CURR OPIN MICROBIOL, V8, P534, DOI 10.1016/j.mib.2005.08.004.
   Theuretzbacher U, 2012, INT J ANTIMICROB AG, V39, P295, DOI 10.1016/j.ijantimicag.2011.12.006.
   TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121.
   Veedu RN, 2009, MOL BIOSYST, V5, P787, DOI 10.1039/b905513b.
   Vikesland PJ, 2010, ENVIRON SCI TECHNOL, V44, P3656, DOI 10.1021/es903704z.
   World Health Organization, 2008, 310 WHO.
   Zelada-Guillen GA, 2010, ANAL CHEM, V82, P9254, DOI 10.1021/ac101739b.
   Zhou JH, 2011, OLIGONUCLEOTIDES, V21, P1, DOI 10.1089/oli.2010.0264.
   Zwanikken JW, 2011, J PHYS CHEM C, V115, P16368, DOI 10.1021/jp205583j.}},
Number-of-Cited-References = {{115}},
Times-Cited = {{8}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{43}},
Journal-ISO = {{Future Microbiol.}},
Doc-Delivery-Number = {{104HP}},
Unique-ID = {{ISI:000315983100013}},
DA = {{2018-08-13}},
}

@article{ ISI:000315295000026,
Author = {Muzslay, Monika},
Title = {{Dissemination of antibiotic-resistant enterococci within the ward
   environment: The role of airborne bacteria and the risk posed by
   unrecognized carriers (vol 41, pg 57, 2013)}},
Journal = {{AMERICAN JOURNAL OF INFECTION CONTROL}},
Year = {{2013}},
Volume = {{41}},
Number = {{3}},
Pages = {{283}},
Month = {{MAR}},
Publisher = {{MOSBY-ELSEVIER}},
Address = {{360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Correction}},
Language = {{English}},
DOI = {{10.1016/j.ajic.2012.12.002}},
ISSN = {{0196-6553}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Cited-References = {{MUZSLAY, 2013, AM J INFECT CONTROL, V41, P57, DOI DOI 10.1016/J.AJIC.2012.01.031.}},
Number-of-Cited-References = {{1}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Am. J. Infect. Control}},
Doc-Delivery-Number = {{094WH}},
Unique-ID = {{ISI:000315295000026}},
DA = {{2018-08-13}},
}

@article{ ISI:000314474500015,
Author = {Segawa, Takahiro and Takeuchi, Nozomu and Rivera, Andres and Yamada,
   Akinori and Yoshimura, Yoshitaka and Barcaza, Gonzalo and Shinbori,
   Kunio and Motoyama, Hideaki and Kohshima, Shiro and Ushida, Kazunari},
Title = {{Distribution of antibiotic resistance genes in glacier environments}},
Journal = {{ENVIRONMENTAL MICROBIOLOGY REPORTS}},
Year = {{2013}},
Volume = {{5}},
Number = {{1, SI}},
Pages = {{127-134}},
Month = {{FEB}},
Abstract = {{Antibiotic resistance genes are biologically transmitted from
   microorganism to microorganism in particular micro-environments where
   dense microbial communities are often exposed to an intensive use of
   antibiotics, such as intestinal microflora, and the soil microflora of
   agricultural fields. However, recent studies have detected
   antibiotic-resistant bacteria and/or antibiotic resistance genes in the
   natural environment geographically isolated from such areas. Here we
   sought to examine the prevalence of antibiotic resistance genes in 54
   snow and ice samples collected from the Arctic, Antarctic, Central Asia,
   North and South America and Africa, to evaluate the level of these genes
   in environments supposedly not affected by anthropogenic factors. We
   observed a widespread distribution of antibiotic resistance genes in
   samples from various glaciers in Central Asia, North and South America,
   Greenland and Africa. In contrast, Antarctic glaciers were virtually
   free from these genes. Antibiotic resistance genes, of both clinical
   (i.e. aac(3), blaIMP) and agricultural (i.e. strA and tetW) origin, were
   detected. Our results show regional geographical distribution of
   antibiotic resistance genes, with the most plausible modes of
   transmission through airborne bacteria and migrating birds.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ushida, K (Reprint Author), Kyoto Prefectural Univ, Grad Sch Life \& Environm Sci, Sakyo Ku, Kyoto 6068522, Japan.
   Segawa, Takahiro, Res Org Informat \& Syst, Transdisciplinary Res Intergrat Ctr, Minato Ku, Tokyo 1050001, Japan.
   Segawa, Takahiro, Transdisciplinary Res Intergrat Ctr, Tachikawa, Tokyo 1908518, Japan.
   Motoyama, Hideaki, Natl Inst Polar Res, Meteorol \& Glaciol Grp, Tachikawa, Tokyo 1908518, Japan.
   Takeuchi, Nozomu, Chiba Univ, Dept Earth Sci, Grad Sch Sci, Inage Ku, Chiba 2638522, Japan.
   Rivera, Andres, Ctr Estudios Cient, Valdivia, Chile.
   Yamada, Akinori, Tokyo Inst Technol, Sch \& Grad Sch Bioscience \& Biotechnol, Meguro Ku, Tokyo 1528550, Japan.
   Yoshimura, Yoshitaka, Tamagawa Univ, Coll Agr, Machida, Tokyo 1948610, Japan.
   Barcaza, Gonzalo, Direcc Gen Aguas, Santiago, Chile.
   Shinbori, Kunio, Hokkaido Univ, Tech Div, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan.
   Kohshima, Shiro, Kyoto Univ, Wildlife Res Ctr, Sakyo Ku, Kyoto 6068203, Japan.
   Ushida, Kazunari, Kyoto Prefectural Univ, Grad Sch Life \& Environm Sci, Sakyo Ku, Kyoto 6068522, Japan.}},
DOI = {{10.1111/1758-2229.12011}},
ISSN = {{1758-2229}},
Keywords-Plus = {{SWINE PRODUCTION FACILITIES; BETA-LACTAMASE; NATURAL ENVIRONMENTS;
   ANTIMICROBIAL RESISTANCE; STREPTOMYCIN-RESISTANCE;
   ACINETOBACTER-BAUMANNII; PSEUDOMONAS-AERUGINOSA; PATHOGENIC BACTERIA;
   SERRATIA-MARCESCENS; ESCHERICHIA-COLI}},
Research-Areas = {{Environmental Sciences \& Ecology; Microbiology}},
Web-of-Science-Categories  = {{Environmental Sciences; Microbiology}},
Author-Email = {{k\_ushida@kpu.ac.jp}},
ResearcherID-Numbers = {{Takeuchi, Nozomu/Q-7869-2016
   }},
ORCID-Numbers = {{Takeuchi, Nozomu/0000-0002-3267-5534
   Segawa, Takahiro/0000-0002-3111-708X
   Rivera, Andres/0000-0002-2779-4192}},
Funding-Acknowledgement = {{Transdisciplinary Research Integration Center (TRIC); Japan Society for
   Promotion of Science {[}22241005, 24710020]; National Institute of Polar
   Research}},
Funding-Text = {{This study was supported by a grant from the Transdisciplinary Research
   Integration Center (TRIC) and the Grant-in-Aid for Scientific Research
   (22241005, 24710020) from the Japan Society for Promotion of Science.
   Production of this paper was supported by a National Institute of Polar
   Research publication subsidy. We thank Dr Rustam Aminov, University of
   Aberdeen, for his critical reading of the manuscript, Dr Kazue Suzuki,
   The Institute of Statistical Mathematics, for advice on the aerosol
   research, Mr Dylan Bodington, Tokyo Institute of Technology, for editing
   of English grammar. We also thank for Dr Akinori Takahashi, National
   institute of Polar Research, for comments on bird migrations.}},
Cited-References = {{Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004.
   Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312.
   Allen HK, 2008, ISME J, V3, P243, DOI DOI 10.1038/ISMEJ.2008.86.
   ANDERSEN SR, 1994, APPL ENVIRON MICROB, V60, P908.
   ARAKAWA Y, 1995, ANTIMICROB AGENTS CH, V39, P1612, DOI 10.1128/AAC.39.7.1612.
   Bairlein F, 2012, BIOL LETTERS, V8, P505, DOI 10.1098/rsbl.2011.1223.
   Biedenbach D., 2009, 19 EUR C CLIN MICR I.
   Boehr DD, 2005, FRONTIERS IN ANTIMICROBIAL RESISTANCE: A TRIBUTE TO STUART B. LEVY, P85.
   BURDETT V, 1980, ANTIMICROB AGENTS CH, V18, P753, DOI 10.1128/AAC.18.5.753.
   Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x.
   Chee-Sanford JC, 2001, APPL ENVIRON MICROB, V67, P1494, DOI 10.1128/AEM.67.4.1494-1502.2001.
   D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388.
   Dib Julian R, 2009, Recent Pat Antiinfect Drug Discov, V4, P66.
   Fritsche TR, 2005, CLIN MICROBIOL INFEC, V11, P974, DOI 10.1111/j.1469-0691.2005.01271.x.
   Furushita M, 2003, APPL ENVIRON MICROB, V69, P5336, DOI 10.1128/AEM.69.9.5336-5342.2003.
   Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910.
   Goni-Urriza M, 2000, APPL ENVIRON MICROB, V66, P125, DOI 10.1128/AEM.66.1.125-132.2000.
   Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025.
   Hawkey PM, 2008, J ANTIMICROB CHEMOTH, V62, pI1, DOI 10.1093/jac/dkn241.
   Heuer H, 2002, FEMS MICROBIOL ECOL, V42, P289, DOI {[}10.1111/j.1574-6941.2002.tb01019.x, 10.1016/S0168-6496(02)00342-2].
   HOBBS WH, 1945, J METEOROL, V2, P143, DOI 10.1175/1520-0469(1945)002<0135:TGGA>2.0.CO;2.
   Hughes KA, 2011, BIOL CONSERV, V144, P1682, DOI 10.1016/j.biocon.2011.03.001.
   ITO H, 1995, ANTIMICROB AGENTS CH, V39, P824, DOI 10.1128/AAC.39.4.824.
   Jakobsen L, 2008, ENVIRON INT, V34, P108, DOI 10.1016/j.envint.2007.07.011.
   Klein T, 2002, METEOROL APPL, V9, P407, DOI 10.1017/S1350482702004036.
   Koike S, 2007, APPL ENVIRON MICROB, V73, P4813, DOI 10.1128/AEM.00665-07.
   Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145.
   LIGHTHART B, 1995, APPL ENVIRON MICROB, V61, P1492.
   Mak JK, 2009, J ANTIMICROB CHEMOTH, V63, P47, DOI 10.1093/jac/dkn454.
   Malik A, 2008, FEMS MICROBIOL LETT, V279, P207, DOI 10.1111/j.1574-6968.2007.01030.x.
   Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483.
   Martinez JL, 2009, P ROY SOC B-BIOL SCI, V276, P2521, DOI 10.1098/rspb.2009.0320.
   Mellor M., 1993, 9314 CRREL, P93.
   Minami S, 1996, J ANTIMICROB CHEMOTH, V37, P433, DOI 10.1093/jac/37.3.433.
   OSANO E, 1994, ANTIMICROB AGENTS CH, V38, P71, DOI 10.1128/AAC.38.1.71.
   Patterson AJ, 2007, ANTIMICROB AGENTS CH, V51, P1115, DOI 10.1128/AAC.00725-06.
   Riccio ML, 2000, ANTIMICROB AGENTS CH, V44, P1229, DOI 10.1128/AAC.44.5.1229-1235.2000.
   Scott KP, 2000, ANTIMICROB AGENTS CH, V44, P775, DOI 10.1128/AAC.44.3.775-777.2000.
   Sheridan PP, 2003, APPL ENVIRON MICROB, V69, P2153, DOI 10.1128/AEM.69.4.2153-2160.2003.
   Sjolund M, 2008, EMERG INFECT DIS, V14, P70, DOI 10.3201/eid1401.070704.
   Smith RD, 2002, B WORLD HEALTH ORGAN, V80, P126.
   Soroush Setareh, 2010, Acta Med Iran, V48, P178.
   Stohl A, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001396.
   Sunde M, 2005, J ANTIMICROB CHEMOTH, V56, P87, DOI 10.1093/jac/dki150.
   Sundin GW, 1996, MOL ECOL, V5, P133, DOI 10.1111/j.1365-294X.1996.tb00299.x.
   Thaller MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008989.
   Ushida K, 2010, J GEN APPL MICROBIOL, V56, P43, DOI 10.2323/jgam.56.43.
   Varaiya A, 2008, INDIAN J PATHOL MICR, V51, P200, DOI 10.4103/0377-4929.41683.
   Wernham C, 2002, MIGRATION ATLAS MOVE.
   Zhang RF, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-6.}},
Number-of-Cited-References = {{50}},
Times-Cited = {{52}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{93}},
Journal-ISO = {{Environ. Microbiol. Rep.}},
Doc-Delivery-Number = {{083OO}},
Unique-ID = {{ISI:000314474500015}},
DA = {{2018-08-13}},
}

@article{ ISI:000313764300056,
Author = {Chen, Fan and Zhou, Jing and Huang, Yong-Hao and Huang, Feng-Ying and
   Liu, Qiang and Fang, Zhigang and Yang, Sheng and Xiong, Min and Lin,
   Ying-Ying and Tan, Guang-Hong},
Title = {{Function of ssDNA aptamer and aptamer pool against Mycobacterium
   tuberculosis in a mouse model}},
Journal = {{MOLECULAR MEDICINE REPORTS}},
Year = {{2013}},
Volume = {{7}},
Number = {{2}},
Pages = {{669-673}},
Month = {{FEB}},
Abstract = {{Novel antibacterial agents against Mycobacterium tuberculosis (MTB) are
   crucial due to the high infection and mortality rates associated with
   the disease. Our previous study confirmed that aptamers from a whole
   bacterium obtained by the Systematic Evolution of Ligands by Exponential
   Enrichment method specifically bound to the MTB virulent strain (H37Rv).
   In the present study, the function of aptamers against MTB in a mouse
   model was further determined. It was demonstrated that the NK2 aptamer
   has marked inhibitory effects on the adhesion/invasion of H37Rv to
   macrophages in vitro and stimulates intracellular IFN-gamma production
   in CD4(+) T-cells. The aptamer pool exhibited the strongest inhibitory
   effect on H37Rv adhesion/invasion to CD8(+) T-cells in vitro compared
   with all aptamers-treated and control groups. Histopathological
   examination of lung biopsy specimens revealed a correlation between
   aptamer presence and lower pulmonary alveoli fusion, swelling and more
   prominent air spaces. Acid-fast staining of biopsy specimens from the
   lungs of the mice demonstrated parallel treatment effects. Results of
   the present study indicate that the 10th pool aptamers and NK2 may play
   an active role against H37Rv, however, the effect was different in vivo
   and in vitro. The treatment effect of 10th pool aptamers was found to be
   better in comparison to NK2 in vivo. Additional target sites involved in
   pathogenicity of H37Rv were also revealed and the NK2 binding site and
   aptamers, including the 10th pool aptamers, may antagonize these sites.
   Further studies are required to screen for other valuable aptamers which
   may be used as therapeutic drugs in combination with NK2.}},
Publisher = {{SPANDIDOS PUBL LTD}},
Address = {{POB 18179, ATHENS, 116 10, GREECE}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Tan, GH (Reprint Author), Hainan Med Coll, Hainan Prov Key Lab Trop Med, Sch Pharm, 3 Xueyuan Rd, Haikou 571199, Peoples R China.
   Chen, Fan; Yang, Sheng; Xiong, Min, Hubei Univ, Fac Life Sci, Wuhan 430062, Peoples R China.
   Chen, Fan; Huang, Yong-Hao; Huang, Feng-Ying; Liu, Qiang; Fang, Zhigang; Lin, Ying-Ying; Tan, Guang-Hong, Hainan Med Coll, Hainan Prov Key Lab Trop Med, Sch Pharm, Haikou 571199, Peoples R China.
   Zhou, Jing, Wuhan TB Dispensary, Wuhan 430030, Peoples R China.}},
DOI = {{10.3892/mmr.2012.1229}},
ISSN = {{1791-2997}},
Keywords = {{Mycobacterium tuberculosis; ssDNA aptamer; mouse model}},
Keywords-Plus = {{DRUG-RESISTANCE; STRAINS; BINDING; PROTEIN; SELEX; RNA}},
Research-Areas = {{Oncology; Research \& Experimental Medicine}},
Web-of-Science-Categories  = {{Oncology; Medicine, Research \& Experimental}},
Author-Email = {{scihai@126.com}},
Funding-Acknowledgement = {{Wuhan Health Bureau Funded Projects {[}WH12A03]; Hainan Natural Science
   Fund {[}808162, 812199]}},
Funding-Text = {{This study was supported by Wuhan Health Bureau Funded Projects
   (WH12A03) and the Hainan Natural Science Fund (nos. 808162 and 812199).}},
Cited-References = {{Ahmed N, 2004, INDIAN J MED RES, V120, P207.
   Baptista IMFD, 2002, MEM I OSWALDO CRUZ, V97, P1147, DOI 10.1590/S0074-02762002000800015.
   Blank M, 2001, J BIOL CHEM, V276, P16464, DOI 10.1074/jbc.M100347200.
   Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123.
   Chen F, 2007, BIOCHEM BIOPH RES CO, V357, P743, DOI 10.1016/j.bbrc.2007.04.007.
   Chen F, 2012, MOL BIOL REP, V39, P2157, DOI 10.1007/s11033-011-0963-3.
   Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677.
   FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9.
   Guthrie JW, 2006, METHODS, V38, P324, DOI 10.1016/j.ymeth.2006.01.001.
   Jagannath C, 2000, INT J ANTIMICROB AG, V15, P55, DOI 10.1016/S0924-8579(00)00118-7.
   Jayasena SD, 1999, CLIN CHEM, V45, P1628.
   Jensen KB, 1995, P NATL ACAD SCI USA, V92, P12220, DOI 10.1073/pnas.92.26.12220.
   Jing NJ, 1998, J BIOL CHEM, V273, P34992, DOI 10.1074/jbc.273.52.34992.
   Marimuthu C, 2012, ANALYST, V137, P1307, DOI 10.1039/c2an15905h.
   Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301.
   Pereira M, 2005, INDIAN J MED RES, V121, P235.
   Raviglione MC, 1997, LANCET, V350, P624, DOI 10.1016/S0140-6736(97)04146-9.
   Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00868.x.
   Ulrich H, 2001, BRAZ J MED BIOL RES, V34, P295, DOI 10.1590/S0100-879X2001000300002.
   Yew WW, 2008, AM J RESP CRIT CARE, V177, P479, DOI 10.1164/rccm.200710-1561UP.}},
Number-of-Cited-References = {{20}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{34}},
Journal-ISO = {{Mol. Med. Rep.}},
Doc-Delivery-Number = {{073TB}},
Unique-ID = {{ISI:000313764300056}},
DA = {{2018-08-13}},
}

@article{ ISI:000313594000007,
Author = {Korves, T. M. and Piceno, Y. M. and Tom, L. M. and DeSantis, T. Z. and
   Jones, B. W. and Andersen, G. L. and Hwang, G. M.},
Title = {{Bacterial communities in commercial aircraft high-efficiency particulate
   air (HEPA) filters assessed by PhyloChip analysis}},
Journal = {{INDOOR AIR}},
Year = {{2013}},
Volume = {{23}},
Number = {{1}},
Pages = {{50-61}},
Month = {{FEB}},
Abstract = {{Air travel can rapidly transport infectious diseases globally. To
   facilitate the design of biosensors for infectious organisms in
   commercial aircraft, we characterized bacterial diversity in aircraft
   air. Samples from 61 aircraft high-efficiency particulate air (HEPA)
   filters were analyzed with a custom microarray of 16S rRNA gene
   sequences (PhyloChip), representing bacterial lineages. A total of 606
   subfamilies from 41 phyla were detected. The most abundant bacterial
   subfamilies included bacteria associated with humans, especially skin,
   gastrointestinal and respiratory tracts, and with water and soil
   habitats. Operational taxonomic units that contain important human
   pathogens as well as their close, more benign relatives were detected.
   When compared to 43 samples of urban outdoor air, aircraft samples
   differed in composition, with higher relative abundance of Firmicutes
   and Gammaproteobacteria lineages in aircraft samples, and higher
   relative abundance of Actinobacteria and Betaproteobacteria lineages in
   outdoor air samples. In addition, aircraft and outdoor air samples
   differed in the incidence of taxa containing human pathogens. Overall,
   these results demonstrate that HEPA filter samples can be used to deeply
   characterize bacterial diversity in aircraft air and suggest that the
   presence of close relatives of certain pathogens must be taken into
   account in probe design for aircraft biosensors. Practical Implications
   A biosensor that could be deployed in commercial aircraft would be
   required to function at an extremely low false alarm rate, making an
   understanding of microbial background important. This study reveals a
   diverse bacterial background present on aircraft, including bacteria
   closely related to pathogens of public health concern. Furthermore, this
   aircraft background is different from outdoor air, suggesting different
   probes may be needed to detect airborne contaminants to achieve minimal
   false alarm rates. This study also indicates that aircraft HEPA filters
   could be used with other molecular techniques to further characterize
   background bacteria and in investigations in the wake of a disease
   outbreak.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hwang, GM (Reprint Author), Mitre Corp, Off Chief Engineer, 2275 Rolling Run Dr, Woodlawn, MD 21244 USA.
   Korves, T. M., Mitre Corp, Cognit Tools \& Data Management Dept, Bedford, MA 01730 USA.
   Piceno, Y. M.; Tom, L. M.; Andersen, G. L., Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Ecol, Berkeley, CA 94720 USA.
   DeSantis, T. Z., Second Genome, Dept Bioinformat, San Bruno, CA USA.
   Jones, B. W., Kansas State Univ, Dept Mech \& Nucl Engn, Manhattan, KS 66506 USA.
   Hwang, G. M., Mitre Corp, Off Chief Engineer, Woodlawn, MD 21244 USA.}},
DOI = {{10.1111/j.1600-0668.2012.00787.x}},
ISSN = {{0905-6947}},
Keywords = {{Aircraft biosensor; Probe design; 16S; Microbial diversity; Infectious
   diseases; High-efficiency particulate air filter}},
Keywords-Plus = {{DRUG-RESISTANT TUBERCULOSIS; LARGE PUBLIC BUILDINGS; HVAC FILTERS; CABIN
   AIR; CULTURABLE BACTERIA; DIVERSITY; ENVIRONMENT; AIRPLANE;
   MICROORGANISMS; POPULATIONS}},
Research-Areas = {{Construction \& Building Technology; Engineering; Public, Environmental
   \& Occupational Health}},
Web-of-Science-Categories  = {{Construction \& Building Technology; Engineering, Environmental; Public,
   Environmental \& Occupational Health}},
Author-Email = {{gmhwang@mitre.org}},
ResearcherID-Numbers = {{Piceno, Yvette/I-6738-2016
   Tom, Lauren/E-9739-2015
   Andersen, Gary/G-2792-2015
   }},
ORCID-Numbers = {{Piceno, Yvette/0000-0002-7915-4699
   Andersen, Gary/0000-0002-1618-9827
   Hwang, Grace/0000-0002-3335-8688}},
Funding-Acknowledgement = {{The MITRE Corporation; U. S. Department of Energy {[}DE-AC02-05CH11231];
   Lawrence Berkeley National Laboratory {[}DE-AC02-05CH11231]; U. S.
   Federal Aviation Administration (FAA) {[}07-C-RITE-KSU]}},
Funding-Text = {{We thank anonymous airlines for the contribution of used aircraft air
   filters, Michael Harkin for managing filter acquisition and transfer,
   Songeeta Palchaudhuri for initial HEPA filter extraction coordination,
   and Paul Magoha for recovering filter samples from the HEPA filter
   supports. We also thank Glenn Roberts and Richard Sciambi for
   discussions, which led to the initial set up this project, Marc Colosimo
   for 16S and PhyloChip advice, Jakk Wong for data analysis assistance,
   Joe Lundquist for useful discussions and Jean Watson for critical review
   of this manuscript. The authors also thank the anonymous reviewers for
   their comments and suggestions, which improved the quality of the data
   presented.; This research was funded, in part, by The MITRE Corporation.
   Work with the PhyloChip was supported, in part, by the U. S. Department
   of Energy under Contract No. DE-AC02-05CH11231 with the Lawrence
   Berkeley National Laboratory. Work performed at Kansas State University
   (KSU) was funded, in part, by the U. S. Federal Aviation Administration
   (FAA) Office of Aerospace Medicine through the National Air
   Transportation Center of Excellence for Research in the Intermodal
   Transport Environment ( Cooperative Agreement 07-C-RITE-KSU). The
   contents of this document reflect the views of the authors and The MITRE
   Corporation and do not necessarily reflect the views of the FAA or the
   U. S. Department of Transportation ( DOT). Neither the United States
   Government, the FAA, nor the DOT makes any warranty or guarantee,
   expressed or implied, concerning the content or accuracy of these views.}},
Cited-References = {{Abubakar I, 2010, LANCET INFECT DIS, V10, P176, DOI 10.1016/S1473-3099(10)70028-1.
   Ackelsberg J, 2011, BIOSECUR BIOTERROR, V9, P213, DOI 10.1089/bsp.2010.0064.
   ALVAREZ AJ, 1994, APPL ENVIRON MICROB, V60, P374.
   Andersen GL, 2009, ENCY MICROBIOLOGY.
   Board on Environmental Studies and Toxicology (BEST), 2002, BIOL AG AIRL CAB ENV.
   Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104.
   Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06.
   Bull Karen, 2008, Travel Med Infect Dis, V6, P142, DOI 10.1016/j.tmaid.2007.08.004.
   Clarke K. R., 2006, PRIMER V6 USER MANUA.
   CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x.
   Dechow M, 1997, CHEMOSPHERE, V35, P21, DOI 10.1016/S0045-6535(97)00135-5.
   DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9.
   Drees KP, 2006, APPL ENVIRON MICROB, V72, P7902, DOI 10.1128/AEM.01305-06.
   Farnsworth JE, 2006, J ENVIRON MONITOR, V8, P1006, DOI 10.1039/b606132j.
   Goyal SM, 2011, AM J INFECT CONTROL, V39, pE30, DOI 10.1016/j.ajic.2010.10.036.
   Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979.
   Heidelberg JF, 1997, APPL ENVIRON MICROB, V63, P3585.
   HUNT EH, 1994, INT IN FLIGHT SERV M, P1.
   Hwang GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014520.
   Kelly LC, 2010, MICROB ECOL, V60, P740, DOI 10.1007/s00248-010-9684-8.
   Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501.
   Korves TM, 2011, LETT APPL MICROBIOL, V53, P306, DOI 10.1111/j.1472-765X.2011.03107.x.
   La Duc M., 2006, COMPREHENSIVE ASSESS.
   La Duc MT, 2007, CAN J MICROBIOL, V53, P1259, DOI 10.1139/W07-093.
   La Duc MT, 2009, APPL ENVIRON MICROB, V75, P6559, DOI 10.1128/AEM.01073-09.
   Macnaughton SJ, 1999, J IND MICROBIOL BIOT, V22, P80, DOI 10.1038/sj.jim.2900609.
   Mckernan LT, 2008, ANN OCCUP HYG, V52, P139, DOI 10.1093/annhyg/mem068.
   McManus CJ, 2005, J APPL MICROBIOL, V99, P502, DOI 10.1111/j.1365-2672.2005.02651.x.
   Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715.
   {*}NAT RES COUNC, 2006, DEF US AIR TRANSP SY.
   Noris F, 2011, ATMOS ENVIRON, V45, P338, DOI 10.1016/j.atmosenv.2010.10.017.
   Osman S, 2008, ISME J, V2, P482, DOI 10.1038/ismej.2008.11.
   Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498.
   R Development Core Team, 2011, R LANG ENV STAT COMP.
   Rachael T, 2009, EPIDEMIOL INFECT, V137, P1057, DOI 10.1017/S0950268809002398.
   Radosevich JL, 2002, LETT APPL MICROBIOL, V34, P162, DOI 10.1046/j.1472-765x.2002.01048.x.
   Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56.
   Stanley NJ, 2008, J ENVIRON MONITOR, V10, P474, DOI 10.1039/b719316e.
   Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131.
   Taubel M, 2009, J ALLERGY CLIN IMMUN, V124, P834, DOI 10.1016/j.jaci.2009.07.045.
   Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862.
   Tsai FC, 2005, INDOOR AIR, V15, P71, DOI 10.1111/j.1600-0668.2005.00346.x.
   Tsiamis G, 2008, RES MICROBIOL, V159, P609, DOI 10.1016/j.resmic.2008.09.007.
   Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889.
   US Department of Transportation, 2010, SUMM 2009 TRAFF DAT.
   Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427.
   Wang PD, 2000, AM J INFECT CONTROL, V28, P233, DOI 10.1067/mic.2000.103555.
   Weinert N, 2011, FEMS MICROBIOL ECOL, V75, P497, DOI 10.1111/j.1574-6941.2010.01025.x.
   WICK RL, 1995, AVIAT SPACE ENVIR MD, V66, P220.
   Yergeau E, 2008, ISME J, V3, P340.}},
Number-of-Cited-References = {{50}},
Times-Cited = {{12}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{58}},
Journal-ISO = {{Indoor Air}},
Doc-Delivery-Number = {{071LK}},
Unique-ID = {{ISI:000313594000007}},
DA = {{2018-08-13}},
}

@article{ ISI:000313366200003,
Author = {Landelle, Caroline and Legrand, Patrick and Lesprit, Philippe and
   Cizeau, Florence and Ducellier, David and Gouot, Cyril and Brehaut,
   Paula and Soing-Altrach, Sophan and Girou, Emmanuelle and Brun-Buisson,
   Christian},
Title = {{Protracted Outbreak of Multidrug-Resistant Acinetobacter baumannii after
   Intercontinental Transfer of Colonized Patients}},
Journal = {{INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY}},
Year = {{2013}},
Volume = {{34}},
Number = {{2}},
Pages = {{119-124}},
Month = {{FEB}},
Abstract = {{OBJECTIVE. To describe the course and management of a protracted
   outbreak after intercontinental transfer of 2 patients colonized with
   multidrug-resistant Acinetobacter baumannii (MDRAB).
   DESIGN. An 18-month outbreak investigation.
   SETTING. An 860-bed university hospital in France.
   PATIENTS. Case patients (ie, carriers) were those colonized or infected
   with an MDRAB isolate.
   METHODS. During the epidemic period, all intensive care unit (ICU)
   patients and contacts of carriers who were transferred to wards were
   screened for MDRAB carriage. Contact precautions, environmental
   screening, and auditing of healthcare worker (HCW) practices were
   implemented; rooms were cleaned with hydrogen peroxide mist
   disinfection. One ICU, in which most of the cases occurred, was closed
   on 4 occasions for thorough cleaning and disinfection.
   RESULTS. The 2 index case patients were identified as 2 patients who
   carried the same MDRAB strain and who were admitted to the hospital
   after repatriation from Tahiti 5 months apart. During an 18-month
   period, a total of 84 secondary cases occurred. Reintroduction of MDRAB
   into the ICUs occurred from patients previously colonized or from
   healthcare personnel. Termination of the outbreak was only achieved when
   all carriers from wards or the ICU were cohorted to an isolation unit
   with dedicated healthcare personnel.
   CONCLUSIONS. Intercontinental transfer of carriers of MDRAB can result
   in extensive outbreaks and serious disruption of the hospital's
   organization. Transmission from carriers most likely occurred via the
   hands of HCWs, poor cleaning protocols, airborne spread, and
   contaminated water from sink traps. This protracted outbreak was
   controlled only after implementation of an extensive control program and
   eventual cohorting of all carriers in an isolation unit with dedicated
   healthcare personnel. Infect Control Hosp Epidemiol 2013; 34(2):119-124}},
Publisher = {{UNIV CHICAGO PRESS}},
Address = {{1427 E 60TH ST, CHICAGO, IL 60637-2954 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Landelle, C (Reprint Author), Hop Henri Mondor, AP HP, Unite Controle Epidemiol \& Prevent Infect, F-94010 Creteil, France.
   Landelle, Caroline; Lesprit, Philippe; Cizeau, Florence; Ducellier, David; Gouot, Cyril; Brehaut, Paula; Soing-Altrach, Sophan; Girou, Emmanuelle; Brun-Buisson, Christian, Univ Paris 12, Ctr Hosp Univ Albert Chenevier Henri Mondor, AP HP, Unite Controle Epidemiol \& Prevent Infect, Creteil, France.
   Legrand, Patrick, Univ Paris 12, Ctr Hosp Univ Albert Chenevier Henri Mondor, AP HP, Serv Bacteriol Virol Hyg, Creteil, France.
   Brun-Buisson, Christian, Univ Paris 12, Ctr Hosp Univ Albert Chenevier Henri Mondor, AP HP, Serv Reanimat Med, Creteil, France.}},
DOI = {{10.1086/669093}},
ISSN = {{0899-823X}},
Keywords-Plus = {{INTENSIVE-CARE-UNIT; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS;
   HOSPITAL OUTBREAK; DRY SURFACES; RISK-FACTORS; INFECTION; SURVIVAL;
   SPREAD}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{caroline.landelle@gmail.com}},
Cited-References = {{ALLEN KD, 1987, J HOSP INFECT, V9, P110, DOI 10.1016/0195-6701(87)90048-X.
   {[}Anonymous], 2009, WHO GUID HAND HYG HL.
   Ayats J, 1997, J HOSP INFECT, V37, P287, DOI 10.1016/S0195-6701(97)90145-6.
   Bayuga S, 2002, HEART LUNG, V31, P382, DOI 10.1067/mhl.2002.126103.
   Bernards AT, 1998, AM J INFECT CONTROL, V26, P544, DOI 10.1053/ic.1998.v26.a84555.
   Catalano M, 1999, J HOSP INFECT, V42, P27, DOI 10.1053/jhin.1998.0535.
   D'Agata EMC, 2000, INFECT CONT HOSP EP, V21, P588, DOI 10.1086/501808.
   Falagas ME, 2006, J HOSP INFECT, V64, P7, DOI 10.1016/j.jhin.2006.04.015.
   Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202.
   French GL, 2004, J HOSP INFECT, V57, P31, DOI 10.1016/j.jhin.2004.03.006.
   Hong KB, 2012, PEDIATR INFECT DIS J, V31, P685, DOI 10.1097/INF.0b013e318256f3e6.
   Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002.
   Hota S, 2009, INFECT CONT HOSP EP, V30, P25, DOI 10.1086/592700.
   Jawad A, 1998, J CLIN MICROBIOL, V36, P1938.
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130.
   La Forgia C, 2010, AM J INFECT CONTROL, V38, P259, DOI 10.1016/j.ajic.2009.07.012.
   Lepelletier D, 2011, J TRAVEL MED, V18, P344, DOI 10.1111/j.1708-8305.2011.00547.x.
   Marchaim D, 2007, J CLIN MICROBIOL, V45, P1551, DOI 10.1128/JCM.02424-06.
   Morgan DJ, 2010, INFECT CONT HOSP EP, V31, P716, DOI 10.1086/653201.
   Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741.
   MUSA EK, 1990, J HOSP INFECT, V15, P219, DOI 10.1016/0195-6701(90)90029-N.
   Naas T, 2005, J CLIN MICROBIOL, V43, P4826, DOI 10.1128/JCM.43.9.4826-4829.2005.
   Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07.
   Playford EG, 2007, J HOSP INFECT, V65, P204, DOI 10.1016/j.jhin.2006.11.010.
   Stoeva T, 2008, CLIN MICROBIOL INFEC, V14, P723, DOI 10.1111/j.1469-0691.2008.02018.x.
   TANKOVIC J, 1994, J CLIN MICROBIOL, V32, P2677.
   Uckay I, 2008, J HOSP INFECT, V68, P1, DOI 10.1016/j.jhin.2007.10.018.
   Villegas MV, 2003, INFECT CONT HOSP EP, V24, P284, DOI 10.1086/502205.
   Wendt C, 1997, J CLIN MICROBIOL, V35, P1394.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{24}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{14}},
Journal-ISO = {{Infect. Control Hosp. Epidemiol.}},
Doc-Delivery-Number = {{068KS}},
Unique-ID = {{ISI:000313366200003}},
DA = {{2018-08-13}},
}

@article{ ISI:000314445100006,
Author = {O'Leary, Denis and Mc Cabe, Evonne M. and McCusker, Matthew P. and
   Martins, Marta and Fanning, Seamus and Duffy, Geraldine},
Title = {{Microbiological study of biofilm formation in isolates of Salmonella
   enterica Typhimurium DT104 and DT104b cultured from the modern pork
   chain}},
Journal = {{INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY}},
Year = {{2013}},
Volume = {{161}},
Number = {{1}},
Pages = {{36-43}},
Month = {{JAN 15}},
Abstract = {{The purpose of this study was to characterise 172 Salmonella Typhimurium
   isolates taken from the pork chain for their biofilm forming abilities
   and to analyse their potential to survive on food processing surfaces.
   Many Salmonella have the ability to form biofilms. These natural
   structures, elaborated by bacteria are important in food production
   because their formation contributes to bacterial survival. Adherent
   bacterial cells are more resilient to displacement strategies including
   physical and chemical procedures as a consequence of their altered more
   resistant phenotype. By improving our understanding of the nature of
   biofilms, this data could positively contribute to the development and
   implementation of eradication strategies. In this study, Salmonella
   Typhimurium DT104 and DT104b were investigated for their ability to
   forth biofilms on a range of different surfaces under defined
   environmental growth conditions. Phenotypic characterisation involved
   examining colony morphology on indicator agars, assessing their ability
   to survive chlorine-based challenges and investigating their ability to
   attach to stainless steel and to plastic surfaces. All bacterial
   isolates were investigated for the presence of Salmonella genomic island
   I (SGI1) which is thought to enhance efficient biofilm formation. It was
   found that the majority of strains possess biofilm forming capabilities
   but successful attachment is highly dependent on the surface on which
   the biofilm is forming. The strains readily attached to stainless steel
   and plastic surfaces and survived high chlorine concentrations.
   Molecular and phenotypic comparisons of strong and weak biofilm forming
   strains indicate that biofilm development is not solely dependent on the
   acquirement of SGI1. (c) 2012 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{O'Leary, D (Reprint Author), TEAGASC, Food Res Ctr, Food Safety Dept, Dublin 15, Ireland.
   O'Leary, Denis; Mc Cabe, Evonne M.; Duffy, Geraldine, TEAGASC, Food Res Ctr, Food Safety Dept, Dublin 15, Ireland.
   O'Leary, Denis; Mc Cabe, Evonne M.; McCusker, Matthew P.; Martins, Marta; Fanning, Seamus, Univ Coll Dublin, UCD Ctr Food Safety, UCD Sch Publ Hlth Physiotherapy \& Populat Sci, Dublin 4, Ireland.}},
DOI = {{10.1016/j.ijfoodmicro.2012.11.021}},
ISSN = {{0168-1605}},
Keywords = {{Biofilms; Salmonella Typhimurium DT104; Phenotypic characterisation}},
Keywords-Plus = {{THIN AGGREGATIVE FIMBRIAE; AIR-LIQUID INTERFACE; SEROVAR TYPHIMURIUM;
   SEROTYPE TYPHIMURIUM; MULTIDRUG-RESISTANT; GENOMIC ISLAND-1;
   ANTIMICROBIAL RESISTANCE; RUGOSE PHENOTYPE; STAINLESS-STEEL; CELLULOSE}},
Research-Areas = {{Food Science \& Technology; Microbiology}},
Web-of-Science-Categories  = {{Food Science \& Technology; Microbiology}},
Author-Email = {{denis.oleary@teagasc.ie}},
ORCID-Numbers = {{Martins, Marta/0000-0002-0323-2857
   Fanning, Seamus/0000-0002-1922-8836}},
Funding-Acknowledgement = {{Food Institute Research Measure (FIRM); Department of Agriculture,
   Fisheries and Food (DAFF), Ireland {[}06/TNI/UCD/10]}},
Funding-Text = {{We acknowledge with gratitude the funding from the Food Institute
   Research Measure (FIRM) administrated by the Department of Agriculture,
   Fisheries and Food (DAFF), Ireland, project no: 06/TNI/UCD/10.}},
Cited-References = {{Anriany YA, 2001, APPL ENVIRON MICROB, V67, P4048, DOI 10.1128/AEM.67.9.4048-4056.2001.
   Anriany Y, 2006, APPL ENVIRON MICROB, V72, P5002, DOI 10.1128/AEM.02868-05.
   Assere A, 2008, J APPL MICROBIOL, V104, P1692, DOI 10.1111/j.1365-2672.2007.03711.x.
   Austin JW, 1998, FEMS MICROBIOL LETT, V162, P295, DOI 10.1016/S0378-1097(98)00137-2.
   Boyd D, 2002, ANTIMICROB AGENTS CH, V46, P1714, DOI 10.1128/AAC.46.6.1714-1722.2002.
   Carattoli A, 2002, ANTIMICROB AGENTS CH, V46, P2821, DOI 10.1128/AAC.46.9.2821-2828.2002.
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431.
   Daly M, 2000, APPL ENVIRON MICROB, V66, P4842, DOI 10.1128/AEM.66.11.4842-4848.2000.
   Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002.
   Dorr PM, 2009, APPL ENVIRON MICROB, V75, P1478, DOI 10.1128/AEM.01632-08.
   Duggan SJ, 2010, J FOOD PROTECT, V73, P2148, DOI 10.4315/0362-028X-73.12.2148.
   Finlay JA, 1997, BIOFOULING, V11, P19, DOI 10.1080/08927019709378318.
   Garaizar J, 2002, J CLIN MICROBIOL, V40, P2074, DOI 10.1128/JCM.40.6.2074-2078.2002.
   Giaouris ED, 2006, FOOD MICROBIOL, V23, P747, DOI 10.1016/j.fm.2006.02.006.
   Gilbert ES, 2001, BIOTECHNOL PROGR, V17, P1180, DOI 10.1021/bp0101031.
   Jessen B, 2003, INT BIODETER BIODEGR, V51, P265, DOI 10.1016/S0964-8305(03)00046-5.
   Joseph B, 2001, INT J FOOD MICROBIOL, V64, P367, DOI 10.1016/S0168-1605(00)00466-9.
   Malcova M, 2008, VET MICROBIOL, V129, P360, DOI 10.1016/j.vetmic.2007.12.006.
   Malorny B, 2001, VET RES, V32, P119, DOI 10.1051/vetres:2001116.
   Matiasovicova J, 2007, ARCH MICROBIOL, V187, P415, DOI 10.1007/s00203-006-0205-6.
   Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902.
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49.
   Perron GG, 2007, INFECT GENET EVOL, V7, P223, DOI 10.1016/j.meegid.2006.09.003.
   Pilousova L, 2005, VET MICROBIOL, V111, P191, DOI 10.1016/j.vetmic.2005.10.010.
   Prendergast DM, 2009, INT J FOOD MICROBIOL, V131, P233, DOI 10.1016/j.ijfoodmicro.2009.03.003.
   Prouty AM, 2003, INFECT IMMUN, V71, P7154, DOI 10.1128/IAI.71.12.7154-7158.2003.
   Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x.
   Romling U, 1999, FEMS MICROBIOL LETT, V180, P91.
   Rostagno MH, 2006, POULTRY SCI, V85, P1838, DOI 10.1093/ps/85.10.1838.
   Scher K, 2005, APPL ENVIRON MICROB, V71, P1163, DOI 10.1128/AEM.71.3.1163-1168.2005.
   Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x.
   Solomon EB, 2005, J FOOD PROTECT, V68, P906, DOI 10.4315/0362-028X-68.5.906.
   Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6.
   Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3.
   Verran J, 2001, J FOOD PROTECT, V64, P1377, DOI 10.4315/0362-028X-64.9.1377.
   Vestby LK, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-43.
   Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000.
   White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.3219-3227.2006.
   Zhang X, 2005, CAN VET J, V46, P517.
   Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{14}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{24}},
Journal-ISO = {{Int. J. Food Microbiol.}},
Doc-Delivery-Number = {{083EI}},
Unique-ID = {{ISI:000314445100006}},
DA = {{2018-08-13}},
}

@article{ ISI:000327587700023,
Author = {Herath, Samantha C. and Poole, Phillippa},
Title = {{Prophylactic antibiotic therapy for chronic obstructive pulmonary
   disease (COPD)}},
Journal = {{COCHRANE DATABASE OF SYSTEMATIC REVIEWS}},
Year = {{2013}},
Number = {{11}},
Abstract = {{Background
   There has been renewal of interest in the use of prophylactic
   antibiotics to reduce the frequency of exacerbations and improve quality
   of life in chronic obstructive pulmonary disease (COPD).
   Objectives
   To determine whether or not regular treatment of COPD patients with
   prophylactic antibiotics reduces exacerbations or affects quality of
   life.
   Search methods
   We searched the Cochrane Airways Group Trials Register and
   bibliographies of relevant studies. The latest literature search was
   August 2013.
   Selection criteria
   Randomised controlled trials (RCTs) that compared prophylactic
   antibiotics with placebo in patients with COPD.
   Data collection and analysis
   We used the standard methods of The Cochrane Collaboration. Data were
   extracted and analysed by two independent review authors.
   Main results
   Seven RCTs involving 3170 patients were included in this systematic
   review. All studies were published between 2001 and 2011. Five studies
   were of continuous antibiotics and two studies were of intermittent
   antibiotic prophylaxis (termed `pulsed' for this review). The
   antibiotics investigated were azithromycin, erythromycin, clarithromycin
   and moxifloxacin. Azithromycin, erythromycin and clarithromycin are
   macrolides while moxifloxacin is a fourth-generation synthetic
   fluoroquinolone antibacterial agent. The study duration varied from
   three months to 36 months and all used intention-to-treat analysis. Most
   of the results were of moderate quality. The risk of bias of the
   included studies was generally low, and we did not downgrade the quality
   of evidence for risk of bias.
   The trials recruited participants with a mean age of 66 years and with
   at least a moderate severity of COPD. Three trials included participants
   with frequent exacerbations and two trials recruited participants
   requiring systemic steroids or antibiotics, or both, or who were at the
   end stage of their disease and required oxygen.
   The primary outcomes for this review were the number of exacerbations
   and quality of life.
   With use of continuous prophylactic antibiotics the number of patients
   experiencing an exacerbation was reduced (odds ratio (OR) 0.55; 95\%
   confidence interval (CI) 0.39 to 0.77, 3 studies, 1262 participants,
   high quality). This represented a reduction from 69\% of participants in
   the control group compared to 54\% in the treatment group (95\% CI 46\%
   to 63\%) and the number needed to treat to prevent one exacerbation
   (NNTb) was therefore 8 (95\% CI 5 to 18). The frequency of exacerbations
   was also reduced with continuous prophylactic antibiotic treatment (rate
   ratio 0.73; 95\% CI 0.58 to 0.91).
   Use of pulsed antibiotic treatment showed a non-significant reduction in
   the number of people with exacerbations (OR 0.87; 95\% CI 0.69 to 1.09,
   1 study, 1149 participants, moderate quality) and the test for
   interaction showed that this result was significantly different from the
   effect on exacerbations with continuous antibiotics.
   There was a statistically significant improvement in quality of life
   with both continuous and pulsed antibiotic treatment but this was
   smaller than the four unit improvement that is regarded as being
   clinically significant (MD -1.78; 95\% CI -2.95 to -0.61, 2 studies,
   1962 participants, moderate quality).
   Neither pulsed nor continuous antibiotics showed a significant effect on
   the secondary outcomes of frequency of hospital admissions, change in
   lung function, serious adverse events or all-cause mortality (moderate
   quality evidence).
   The adverse events that were recorded varied among the trials depending
   on the different antibiotics used. Azithromycin was associated with a
   significant hearing loss in the treatment group. The moxifloxacin pulsed
   study reported a significantly higher number of adverse events in the
   treatment arm due to the marked increase in gastrointestinal adverse
   events (P < 0.001). Some adverse events that led to drug
   discontinuation, such as development of long QTc or tinnitus, were not
   significantly more frequent in the treatment group than the placebo
   group but pose important considerations in clinical practice.
   The development of antibiotic resistance in the community is of major
   concern. One study found newly colonised patients to have higher rates
   of antibiotic resistance. Patients colonised with moxifloxacin-sensitive
   pseudomonas at initiation of therapy rapidly became resistant with the
   quinolone treatment.
   Authors' conclusions
   Use of continuous prophylactic antibiotics results in a clinically
   significant benefit in reducing exacerbations in COPD patients. All
   trials of continuous antibiotics used macrolides hence the noted benefit
   applies only to the use of continuous macrolide antibiotics. The impact
   of pulsed antibiotics remains uncertain and requires further research.
   The trials in this review included patients who were frequent
   exacerbators and needed treatment with antibiotics or systemic steroids,
   or who were on supplemental oxygen. There were also older individuals
   with a mean age of 66 years. The results of these trials apply only to
   the group of patients who were studied in these trials and may not be
   generalisable to other groups.
   Because of concerns about antibiotic resistance and specific adverse
   effects, consideration of prophylactic antibiotic use should be mindful
   of the balance between benefits to individual patients and the potential
   harms to society created by antibiotic overuse.}},
Publisher = {{WILEY}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Herath, SC (Reprint Author), Woolcock Inst Med Res, 431 Glebe Point Rd, Sydney, NSW 2037, Australia.
   Herath, Samantha C., Woolcock Inst Med Res, Sydney, NSW 2037, Australia.
   Poole, Phillippa, Univ Auckland, Dept Med, Auckland, New Zealand.}},
DOI = {{10.1002/14651858.CD009764.pub2}},
Article-Number = {{CD009764}},
ISSN = {{1469-493X}},
EISSN = {{1361-6137}},
Keywords-Plus = {{CHRONIC-BRONCHITIS; ACUTE EXACERBATIONS; LONG-TERM; INTERMITTENT
   TETRACYCLINE; BACTERIAL-INFECTION; AIR-POLLUTION; TRIAL; ERYTHROMYCIN;
   CHEMOPROPHYLAXIS; PREVENTION}},
Research-Areas = {{General \& Internal Medicine}},
Web-of-Science-Categories  = {{Medicine, General \& Internal}},
Author-Email = {{scherath@yahoo.com}},
Cited-References = {{Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623.
   Anderson HR, 1997, EUR RESPIR J, V10, P1064, DOI 10.1183/09031936.97.10051064.
   {[}Anonymous], 1966, Br Med J, V1, P1317.
   {[}Anonymous], 2008, REV MAN REVMAN VERS.
   BALL P, 1995, CHEST, V108, pS43, DOI 10.1378/chest.108.2\_Supplement.43S.
   Banerjee D, 2005, RESP MED, V99, P208, DOI 10.1016/j.rmed.2004.06.009.
   Banerjee Dev, 2004, Treat Respir Med, V3, P59, DOI 10.2165/00151829-200403010-00007.
   Beier A, 1971, Wien Med Wochenschr, V121, P642.
   Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581.
   Blasi F, 2010, PULM PHARMACOL THER, V23, P200, DOI 10.1016/j.pupt.2009.12.002.
   Bruninx M, 1973, ACTA TUBERCULOSEA PN, V5-6, P483.
   BUCHANAN J, 1958, LANCET, V2, P719.
   BUSSI S, 1980, REV FR MAL RESPIR, V8, P351.
   CALDER M A, 1968, British Journal of Diseases of the Chest, V62, P93, DOI 10.1016/S0007-0971(68)80040-3.
   Chong J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002309.pub3.
   DAVIS AL, 1961, AM J MED, V31, P365, DOI 10.1016/0002-9343(61)90125-5.
   DOUGLAS AC, 1957, LANCET, V2, P214.
   EDWARDS G, 1958, BRIT MED J, V2, P1010, DOI 10.1136/bmj.2.5103.1010.
   ELMES PC, 1957, BRIT MED J, V2, P1272, DOI 10.1136/bmj.2.5056.1272.
   FRANCIS RS, 1964, BRIT MED J, V1, P728, DOI 10.1136/bmj.1.5385.728.
   FRANCIS RS, 1960, BRIT MED J, V1, P297, DOI 10.1136/bmj.1.5169.297.
   GOSLINGS WR, 1967, DIS CHEST, V52, P376, DOI 10.1378/chest.52.3.376.
   Grossman R, 1998, CHEST, V113, P131, DOI 10.1378/chest.113.1.131.
   GUYATT GH, 1987, THORAX, V42, P773, DOI 10.1136/thx.42.10.773.
   HAHN HH, 1972, ANTIMICROB AGENTS CH, V2, P45, DOI 10.1128/AAC.2.1.45.
   Hallet WY, 1959, CHEMOPROPHYLAXIS EMP, V80, P716.
   He ZY, 2010, RESPIRATION, V80, P445, DOI 10.1159/000321374.
   HELM WH, 1956, LANCET, V270, P775.
   Higgins JP, 2011, COCHRANE COLLABORATI, DOI DOI 10.1002/9780470712184.
   JOHNSTON RN, 1969, BRIT MED J, V4, P265, DOI 10.1136/bmj.4.5678.265.
   JOHNSTON RN, 1961, BRIT MED J, V2, P985, DOI 10.1136/bmj.2.5258.985.
   Jones P., 2009, ST GEORGES RESP QUES, P1.
   Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509.
   Kardos P, 2007, AM J RESP CRIT CARE, V175, P144, DOI 10.1164/rccm.2006.02-244OC.
   KILPATRICK GS, 1954, BMJ-BRIT MED J, V2, P385, DOI 10.1136/bmj.2.4884.385.
   Lee TA, 2007, J GEN INTERN MED, V22, P62, DOI 10.1007/s11606-007-0118-3.
   LEGLER F, 1977, ARZNEIMITTEL-FORSCH, V27-1, P883.
   LIIPPO K, 1987, ACTA MED SCAND, V221, P455.
   Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4.
   Maraffi Tommaso, 2010, Ther Adv Respir Dis, V4, P135, DOI 10.1177/1753465810368552.
   MAY JR, 1956, LANCET, V271, P814.
   McQuay HJ, 1997, ANN INTERN MED, V126, P712, DOI 10.7326/0003-4819-126-9-199705010-00007.
   Miravitlles M, 2009, EUR RESPIR J, V34, P1066, DOI 10.1183/09031936.00195608.
   MONSO E, 1995, AM J RESP CRIT CARE, V152, P1316, DOI 10.1164/ajrccm.152.4.7551388.
   MOYES E N, 1959, Tubercle, V40, P112, DOI 10.1016/S0041-3879(59)80150-1.
   MURDOCH JM, 1959, BRIT MED J, V2, P1277, DOI 10.1136/bmj.2.5162.1277.
   MURRAY E A, 1964, J Coll Gen Pract, V7, P244.
   Mygind LH, 2010, EUR RESP SOC ANN C 2.
   NORMAN PS, 1962, JAMA-J AM MED ASSOC, V179, P833, DOI 10.1001/jama.1962.03050110001001.
   PINES A, 1967, BRIT MED J, V3, P202, DOI 10.1136/bmj.3.5559.202.
   Poole P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001287.pub4.
   PRIDIE RB, 1960, LANCET, V2, P723.
   Ras J, 1984, S AFR MED J, V66, P955.
   Sapey E, 2006, THORAX, V61, P250, DOI 10.1136/thx.2005.041822.
   Seemungal TAR, 2008, AM J RESP CRIT CARE, V178, P1139, DOI 10.1164/rccm.200801-145OC.
   Sethi S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-10.
   Soler N, 1998, AM J RESP CRIT CARE, V157, P1498, DOI 10.1164/ajrccm.157.5.9711044.
   Staykova T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004105.
   SUNYER J, 1993, AM J EPIDEMIOL, V137, P701, DOI 10.1093/oxfordjournals.aje.a116730.
   Suzuki T, 2001, CHEST, V120, P730, DOI 10.1378/chest.120.3.730.
   Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800.
   Torrance G, 1999, PHARMACOECONOMICS, V16, P499, DOI 10.2165/00019053-199916050-00007.
   VANDENBERGH E, 1970, British Journal of Diseases of the Chest, V64, P58, DOI 10.1016/S0007-0971(70)80050-X.
   Wang J, 2012, J CLIN PHARM THER, V37, P204, DOI 10.1111/j.1365-2710.2011.01285.x.
   WATANABE A, 1995, TOHOKU J EXP MED, V176, P25, DOI 10.1620/tjem.176.25.
   WATANABE A, 1991, INFECTION, V19, pS384, DOI 10.1007/BF01715833.
   Watanabe A, 1994, CHEMOTHERAPY, V42, P1194.
   WEBSTER IW, 1971, THORAX, V26, P319, DOI 10.1136/thx.26.3.319.
   Wenzel RP, 2012, NEW ENGL J MED, V367, P340, DOI 10.1056/NEJMct1115170.
   World Health Organization, CHRONIC OBSTRUCTIVE.}},
Number-of-Cited-References = {{70}},
Times-Cited = {{29}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{11}},
Journal-ISO = {{Cochrane Database Syst Rev.}},
Doc-Delivery-Number = {{260IH}},
Unique-ID = {{ISI:000327587700023}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000326796300001,
Author = {Udobi, C. E. and Obajuluwa, A. F. and Onaolapo, J. A.},
Title = {{Prevalence and Antibiotic Resistance Pattern of Methicillin-Resistant
   Staphylococcus aureus from an Orthopaedic Hospital in Nigeria}},
Journal = {{BIOMED RESEARCH INTERNATIONAL}},
Year = {{2013}},
Abstract = {{Patients with surgical wounds have been reported to be at high risk of
   MRSA carriage and infection. The prevalence and antibiotic resistance
   pattern of this organism in the orthopaedic ward of Ahmadu Bello
   University Teaching Hospital (ABUTH), Zaria-Nigeria, a 547-bed Nigerian
   hospital, were thus studied. A total of 185 isolates of Staphylococcus
   aureus were confirmed from 217 samples taken from the orthopaedic wards
   of the hospital using standard isolation methods. Out of these, 44
   (23.8\%) were from the wounds of patients and 70 (37.8\%) from the skin.
   The remaining 65 (35.1\%) and 6 (3.2\%) were from their beds and the
   atmospheric air, respectively. Out of these, 33 (75\%), 36 (51.4\%), and
   48 (73.8\%) from wounds, skin, and bed, respectively, were found to be
   methicillin-resistant Staphylococcus aureus (MRSA) using the
   disc-sensitive test methods. None was detected from the atmosphere. The
   antibiotic susceptibility pattern results showed the level of resistance
   to be ampicillin 100\% in all the three sites, pefloxacin 90.9\%,
   72.2\%, 66.7\%, ceftriaxone 69.7\%, 72.2\%, 70.8\%, gentamicin 54.5\%,
   52.8\%, 37.5\%, and ciprofloxacin 51.5\%, 47.2\%, 35.4\% at the wound,
   skin, and bed sites, respectively. Results confirm that MRSA continues
   to pose a threat to the hospitalized patients, especially those with
   bone and wound infections.}},
Publisher = {{HINDAWI PUBLISHING CORPORATION}},
Address = {{410 PARK AVENUE, 15TH FLOOR, \#287 PMB, NEW YORK, NY 10022 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Udobi, CE (Reprint Author), Univ Uyo, Dept Pharmaceut \& Pharmaceut Technol, Uyo, Nigeria.
   Udobi, C. E., Univ Uyo, Dept Pharmaceut \& Pharmaceut Technol, Uyo, Nigeria.
   Obajuluwa, A. F.; Onaolapo, J. A., Ahmadu Bello Univ, Dept Pharmaceut \& Pharmaceut Microbiol, Zaria, Nigeria.}},
DOI = {{10.1155/2013/860467}},
Article-Number = {{860467}},
ISSN = {{2314-6133}},
EISSN = {{2314-6141}},
Keywords-Plus = {{INFECTION}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Research \& Experimental Medicine}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Medicine, Research \&
   Experimental}},
Author-Email = {{ceudobi@yahoo.com}},
ORCID-Numbers = {{udobi, chinweizu Ejikeme/0000-0002-4076-8810}},
Cited-References = {{Ahmed M. O., 2012, Eastern Mediterranean Health Journal, V18, P37.
   AKONAI AK, 1990, E AFR MED J, V67, P407.
   Andrews JM, 2008, J ANTIMICROB CHEMOTH, V62, P256, DOI 10.1093/jac/dkn194.
   Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204.
   COELLO R, 1994, EUR J CLIN MICROBIOL, V13, P74, DOI 10.1007/BF02026130.
   Emele F E, 1999, West Afr J Med, V18, P97.
   Fayomi O. D., 2011, INT J LAB MED, V4.
   Gross-Schulman S, 1998, JAMA-J AM MED ASSOC, V280, P421, DOI 10.1001/jama.280.5.421.
   Ikeh EI, 2003, AF J CLIN EXP MICROB, V4, P52.
   KRUMPERMAN PH, 1983, APPL ENVIRON MICROB, V46, P165.
   Nwakwo B. O. K., 2010, AFRICAN J CLIN EXPT, V11, P1595.
   Palavecino Elizabeth, 2007, V391, P1.
   Paul S, 1997, LETT APPL MICROBIOL, V24, P169, DOI 10.1046/j.1472-765X.1997.00364.x.
   Shittu A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-286.
   TAIWO S, 2004, AFRI J CLIN EXP MICR, V5, P189.
   Unachukwu C N, 2005, Niger J Med, V14, P173.
   Weems JJ, 2001, POSTGRAD MED, V110, P24, DOI 10.3810/pgm.2001.10.1042.}},
Number-of-Cited-References = {{17}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{8}},
Journal-ISO = {{Biomed Res. Int.}},
Doc-Delivery-Number = {{249SF}},
Unique-ID = {{ISI:000326796300001}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000326096600003,
Author = {Stuckler, David and Steele, Sarah and Lurie, Mark and Basu, Sanjay},
Title = {{INTRODUCTION: `DYING FOR GOLD': THE EFFECTS OF MINERAL MININGON HIV,
   TUBERCULOSIS, SILICOSIS, AND OCCUPATIONAL DISEASES IN SOUTHERN AFRICA}},
Journal = {{INTERNATIONAL JOURNAL OF HEALTH SERVICES}},
Year = {{2013}},
Volume = {{43}},
Number = {{4}},
Pages = {{639-649}},
Abstract = {{Mineral mining is among the world's most hazardous occupations. It is
   especially dangerous in southern Africa, where mining activity is a
   leading cause of HIV and tuberculosis epidemics. Inside mines, silica
   dust exposure causes long-term pulmonary damage. Living conditions are
   often substandard; poorly ventilated living quarters facilitate
   tuberculosis and airborne disease spread, and high rates of alcohol and
   tobacco use compromise immune responses. Family segregation, a legacy of
   apartheid's migrational labor system, increases the likelihood of risky
   sexual activity. Sex trafficking in women increases risks of HIV and
   other sexually transmitted diseases, and labor trafficking in men
   through poorly regulated labor brokering impedes access to health care.
   Labor migration spreads mining hazards to rural, labor-supplying
   communities. Cross-border care is often inadequate or nonexistent,
   contributing to significantly greater rates of extensive and multi-drug
   resistance in miners, ex-miners, their families, and communities. Miners
   in high-income countries, working for the same trans-national companies,
   do not experience elevated rates of death and disability. Cost-effective
   interventions can reduce HIV incidence through social housing, curb
   trafficking of high-risk groups, stop tuberculosis spread through
   screening and detection, and reduce drug resistance by standardizing
   cross-border care. Urgent action is needed to respond to mining's
   staggering, yet avoidable disease toll in sub-Saharan Africa.}},
Publisher = {{BAYWOOD PUBL CO INC}},
Address = {{26 AUSTIN AVE, PO BOX 337, AMITYVILLE, NY 11701 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Stuckler, D (Reprint Author), Univ Oxford, Dept Sociol, Manor Rd Bldg, Oxford OX1 3UQ, England.
   Stuckler, David, Univ Oxford, Oxford OX1 3UQ, England.
   Stuckler, David, Harvard Univ, Cambridge, MA 02138 USA.
   Steele, Sarah, Univ Cambridge, Christs Coll, Cambridge CB2 1TN, England.
   Steele, Sarah, Univ Cambridge, Cambridge CB2 1TN, England.
   Lurie, Mark, Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA.
   Basu, Sanjay, Stanford Prevent Res Ctr, Stanford, CA USA.}},
DOI = {{10.2190/HS.43.4.c}},
ISSN = {{0020-7314}},
EISSN = {{1541-4469}},
Keywords-Plus = {{PULMONARY TUBERCULOSIS; RISK; INFECTION; INDUSTRY; COHORT; HEALTH}},
Research-Areas = {{Health Care Sciences \& Services}},
Web-of-Science-Categories  = {{Health Care Sciences \& Services; Health Policy \& Services}},
Author-Email = {{david.stuckler@sociology.ox.ac.uk}},
ORCID-Numbers = {{Stuckler, David/0000-0002-1288-8401
   Steele, Sarah/0000-0002-1794-7394}},
Funding-Acknowledgement = {{NICHD NIH HHS {[}R24 HD041020]}},
Cited-References = {{Baleta A., 2013, LANCET, V380, P1217.
   Barwise K., 2013, INT J HLTH SERV, V43.
   Basu S., 2009, GLOBAL HLTH, V5.
   BBC, 2010, BBC.
   Braun L, 2006, AM J PUBLIC HEALTH, V96, P1386, DOI 10.2105/AJPH.2005.064998.
   Campbell C, 1997, SOC SCI MED, V45, P273, DOI 10.1016/S0277-9536(96)00343-7.
   Deloitte, 2005, CUTT TRAD AQ COST HI.
   Department of Health South Africa, 2010, REP TUB MIN IND.
   Department of Mineral Resources, 2008, PRES AUD HLTH SAF MI.
   Department of Minerals and Energy Affairs, 1995, REP COMM INQ SAF HLT.
   Dharmadhikari A, 2013, INT J HEALTH SERV, V43, P651, DOI 10.2190/HS.43.4.d.
   Goelzer B., 1996, AM IND HYG ASSOC J, V57, P984.
   Havlir DV, 1999, NEW ENGL J MED, V340, P367, DOI 10.1056/NEJM199902043400507.
   Hnizdo E, 1998, OCCUP ENVIRON MED, V55, P496, DOI 10.1136/oem.55.7.496.
   Jansen JC, 2005, J S AFR I MIN METALL, V105, P719.
   Lim MSC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022807.
   LOEWENSON R, 1999, OCCUPATIONAL HLTH SA.
   London Mining Network, 2010, ALGL CHALL AGM.
   Lowe R., 1994, TUBERCULOSIS AUTOPSY.
   McCulloch J, 2009, J S AFR STUD, V35, P835, DOI 10.1080/03057070903313202.
   Milner Commission, 1903, REP MIN PHTHIS COMM.
   Miners' Phthisis Prevention Committee, 1937, PREV SIL MIN WITW.
   Moyo D., 2012, WINNER TAKE ALL CHIN.
   Murray J, 2000, S AFR MED J, V90, P381.
   Murray J, 2011, J PUBLIC HEALTH POL, V32, pS65, DOI 10.1057/jphp.2011.25.
   Navarro V, 2009, INT J HEALTH SERV, V39, P423, DOI 10.2190/HS.39.3.a.
   Odendal L., 2010, S AFRICAN GOLD MINES.
   Okechukwu P., 2008, EC MIRACLE NO NIGERI.
   Oluwarotimi A., 2012, NIGERIA OBAMA DECLAR.
   Ramazzini B., 1703, MORBIS ARTIFICUM DIA.
   Rosen G., 1943, HIST MINERS DIS MED.
   Soysa I., 2013, SOC SCI MED, V77, P90.
   Steele S, 2013, INT J HEALTH SERV, V43, P665, DOI 10.2190/HS.43.4.e.
   Stuckler D., 2011, GLOB HLTH GOV, VIV.
   Stuckler D, 2011, AM J PUBLIC HEALTH, V101, P524, DOI 10.2105/AJPH.2009.175646.
   Stuckler D, 2011, AM J PUBLIC HEALTH, V101, P165, DOI 10.2105/AJPH.2009.184895.
   Trapido A, 1998, MINERALS ENERGY RAW, V13, P26.
   Trapido A., 2000, ANAL BURDEN OCCUPATI.
   UNAIDS, 2008, ADDR SOC CAUS HIV RI.
   Vaughan M., 1991, CURING THEIR ILLS CO.
   WESTERHOLM P, 1986, ENVIRON RES, V41, P339, DOI 10.1016/S0013-9351(86)80195-5.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{8}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{19}},
Journal-ISO = {{Int. J. Health Serv.}},
Doc-Delivery-Number = {{240LE}},
Unique-ID = {{ISI:000326096600003}},
OA = {{green\_accepted}},
DA = {{2018-08-13}},
}

@article{ ISI:000326096600004,
Author = {Dharmadhikari, Ashwin and Smith, Jonathan and Nardell, Edward and
   Churchyard, Gavin and Keshavjee, Salmaan},
Title = {{ASPIRING TO ZERO TUBERCULOSIS DEATHS AMONG SOUTHERN AFRICA'S MINERS: IS
   THERE A WAY FORWARD?}},
Journal = {{INTERNATIONAL JOURNAL OF HEALTH SERVICES}},
Year = {{2013}},
Volume = {{43}},
Number = {{4}},
Pages = {{651-664}},
Abstract = {{Tuberculosis notification rates among South African miners range from
   4,000 to 7,000 per 100,000 people. These rates far exceed national
   tuberculosis notification rates for the general population. Tuberculosis
   mortality also surpasses deaths caused by mining accidents. These
   extraordinarily high rates of disease are unambiguously linked to a
   series of contributing factors, including exposure to silica dust, HIV
   infection, and poor working and living conditions. We argue that the
   only way to stop the transmission of this airborne disease is to treat
   the mine and its living quarters as one should any other congregate
   setting with individuals who have high rates of infection with
   drug-susceptible and drug-resistant strains of tuberculosis. This means
   implementing interventions that have been demonstrated to stop the
   spread of tuberculosis over the last 60 years: immediate treatment of
   active tuberculosis, concurrent treatment of latent tuberculosis disease
   to reduce the burden of active cases, and appropriate management of
   patients infected with HIV. Because tuberculosis is also a social
   disease, biomedical interventions must be coupled with improved living
   and working conditions. Achieving zero deaths from tuberculosis in the
   mines is possible if a clear commitment is made to a strategy that
   recognizes and ameliorates the biological and social antecedents to this
   epidemic.}},
Publisher = {{SAGE PUBLICATIONS LTD}},
Address = {{1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dharmadhikari, A (Reprint Author), Harvard Univ, Brigham \& Womens Hosp, Sch Med, 641 Huntington Ave,Suite 3A03, Boston, MA 02115 USA.
   Dharmadhikari, Ashwin, Brigham \& Womens Hosp, Boston, MA 02115 USA.
   Dharmadhikari, Ashwin; Nardell, Edward, Harvard Univ, Sch Med, Boston, MA 02115 USA.
   Smith, Jonathan, Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA.
   Nardell, Edward, Boston City Hosp, Boston, MA 02118 USA.
   Nardell, Edward, TB Control City Boston, Boston, MA USA.
   Nardell, Edward, TB Control City Cambridge, Cambridge, England.
   Nardell, Edward, Harvard Univ, Sch Publ Health, Dept Global Hlth \& Social Med, Cambridge, MA 02138 USA.
   Churchyard, Gavin, London Sch Hyg \& Trop Med, London, England.
   Keshavjee, Salmaan, Harvard Univ, Dept Global Hlth \& Social Med, Sch Med, Boston, MA 02115 USA.
   Keshavjee, Salmaan, Brigham \& Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA.}},
DOI = {{10.2190/HS.43.4.d}},
ISSN = {{0020-7314}},
EISSN = {{1541-4469}},
Keywords-Plus = {{DRUG-RESISTANT TUBERCULOSIS; GOLD MINERS; HIV-INFECTION; PULMONARY
   TUBERCULOSIS; PREVENTIVE THERAPY; SILICOSIS; ADULTS; RISK; TRANSMISSION;
   EXPOSURE}},
Research-Areas = {{Health Care Sciences \& Services}},
Web-of-Science-Categories  = {{Health Care Sciences \& Services; Health Policy \& Services}},
Author-Email = {{adharmadhikari@partners.org}},
ORCID-Numbers = {{Smith, Jonathan/0000-0002-6396-9164}},
Cited-References = {{Allen P., 1924, REPORT TUBERCULOSIS.
   Ashanti AngloGold, 2008, W WITS COUNTR REP 20.
   Ashanti AngloGold, 2007, CAS STUD TB CONTR AN.
   Ashanti AngloGold, 2007, INT EFF RED DUST LEV.
   Baleta A, 2012, LANCET, V380, P1217, DOI 10.1016/S0140-6736(12)61698-5.
   Basu S, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-11.
   Bench Marks Foundation, PRINC GLOB CORP RESP.
   Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847.
   Burgos M, 2005, CLIN INFECT DIS, V40, P968, DOI 10.1086/428582.
   Calver AD, 2010, EMERG INFECT DIS, V16, P264, DOI {[}10.3201/eid1602.090968, 10.3201/eid02l0.090968].
   Charalambous S, 2008, INT J TUBERC LUNG D, V12, P942.
   Chaves-Carballo E., 2007, TROPICAL WORLD ST DA.
   Churchyard CJ, 1999, INT J TUBERC LUNG D, V3, P791.
   Churchyard G., 2012, 19 C RETR OPP INF SE.
   Churchyard GJ, 2011, THORAX, V66, P134, DOI 10.1136/thx.2010.139048.
   Churchyard GJ, 2004, OCCUP ENVIRON MED, V61, P811, DOI 10.1136/oem.2003.010967.
   Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI 10.1056/NEJMoa1105243.
   Corbett EL, 2000, AIDS, V14, P2759, DOI 10.1097/00002030-200012010-00016.
   COWIE RL, 1994, AM J RESP CRIT CARE, V150, P1460, DOI 10.1164/ajrccm.150.5.7952577.
   Day JH, 2006, INT J TUBERC LUNG D, V10, P523.
   Deloitte on Mining \& Metals, 2006, TAK GAMBL OUT MIN RE.
   Dharmadhikari A., 2011, 42 WORLD C LUNG HLTH.
   Dorman SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043307.
   Farmer P, 1997, SOC SCI MED, V44, P347, DOI 10.1016/S0277-9536(96)00143-8.
   Fassin D, 2007, BODIES REMEMBER EXPE.
   Fielding K., 2012, C RETR OPP INF SEATT.
   Gebrekristos HT, 2005, SEX TRANSM DIS, V32, P333, DOI 10.1097/01.olq.0000154496.61014.10.
   Godfrey-Faussett P, 2000, LANCET, V356, P1066, DOI 10.1016/S0140-6736(00)02730-6.
   Gold Fields Ltd., 24 HOURS LIF GOLD FI.
   Gold Fields Ltd., 2010, GOLD FIELDS LTD ANN.
   Gorgas General, 1914, NY TIMES.
   Hanifa Y, 2009, INT J TUBERC LUNG D, V13, P39.
   Hnizdo E, 1998, OCCUP ENVIRON MED, V55, P496, DOI 10.1136/oem.55.7.496.
   Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32.
   Hoffman F., 1922, PROBLEM DUST PHTHISI.
   Johnson JL, 2001, AIDS, V15, P2137, DOI 10.1097/00002030-200111090-00009.
   KAMAT SR, 1966, B WORLD HEALTH ORGAN, V34, P517.
   KANTOR HS, 1988, AM J MED, V84, P833, DOI 10.1016/0002-9343(88)90060-5.
   Kistnasamy B., RE CALLING URGENT AC.
   Leon R. N., 1995, COMM INQ SAF HLTH MI, V1.
   Lewis JJ, 2009, AM J RESP CRIT CARE, V180, P1271, DOI 10.1164/rccm.200806-846OC.
   Lilly MDR-TB Partnership, 2009, OUTST BUS ACT STOP T.
   Lurie MN, 2003, AIDS, V17, P2245, DOI {[}10.1097/00002030-200310170-00013, 10.1097/01.aids.0000088197.77946.ba].
   Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011.
   Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136.
   Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99.
   Murray J, 2005, AIDS, V19, P2019, DOI 10.1097/01.aids.0000188424.79914.ad.
   Murray J, 2007, AIDS, V21, pS97, DOI 10.1097/01.aids.0000299416.61808.24.
   MUTATKAR RK, 1995, SOC SCI MED, V41, P977, DOI 10.1016/0277-9536(94)00398-D.
   National Institute of Occupational Health: Mine Health and Safety Council, 2010, WHAT DOES SIL RED ME.
   Osewe P., 2012, WORLD BANK SADC CONS.
   Quigley MA, 2001, AIDS, V15, P215, DOI 10.1097/00002030-200101260-00011.
   Rees D, 2007, INT J TUBERC LUNG D, V11, P474.
   Rees D, 2010, AM J IND MED, V53, P398, DOI 10.1002/ajim.20716.
   Reid PJ, 1996, OCCUP ENVIRON MED, V53, P11, DOI 10.1136/oem.53.1.11.
   Republic of South Africa Department of Health, 2008, TUB STRAT PLAN S AFR.
   Republic of South Africa Department of Mineral Resources, 2009, MIN CHART IMP ASS RE.
   Republic of South Africa National Department of Health, 2010, MAN DRUG RES TUB POL.
   RILEY RL, 1995, AM J EPIDEMIOL, V142, P3, DOI 10.1093/oxfordjournals.aje.a117542.
   RILEY RL, 1962, AM REV RESPIR DIS, V85, P511.
   Ross J, 2010, THORAX, V65, P1010, DOI 10.1136/thx.2009.129999.
   ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2.
   Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3.
   South African Native Affairs Commission, 1905, 19031905 S AFR NAT A.
   Southern African Development Community, DECL TUB MIN SECT.
   Steward D., 2012, POLITICSWEB     0928.
   Stuckler D, 2011, AM J PUBLIC HEALTH, V101, P524, DOI 10.2105/AJPH.2009.175646.
   Tanser F, 2012, 19 C RETR OPP INF SE.
   teWaterNaude JM, 2006, OCCUP ENVIRON MED, V63, P187, DOI 10.1136/oem.2004.018614.
   WHO, 2011, GLOB TUB CONTR.
   WILLIAMS B, 1998, OCCUPATIONAL LUNG DI.
   World Bank, 2012, COST POT POL C UNPUB.
   World Health Organization, 2011, GLOB TUB CONTR WHO R.
   World Health Organization Stop TB Partnership, 2012, TUB MIN CHALL KEY SO.}},
Number-of-Cited-References = {{74}},
Times-Cited = {{8}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{5}},
Journal-ISO = {{Int. J. Health Serv.}},
Doc-Delivery-Number = {{240LE}},
Unique-ID = {{ISI:000326096600004}},
DA = {{2018-08-13}},
}

@article{ ISI:000317428800002,
Author = {Trafny, Elzbieta A.},
Title = {{MICROORGANISMS IN METALWORKING FLUIDS: CURRENT ISSUES IN RESEARCH AND
   MANAGEMENT}},
Journal = {{INTERNATIONAL JOURNAL OF OCCUPATIONAL MEDICINE AND ENVIRONMENTAL HEALTH}},
Year = {{2013}},
Volume = {{26}},
Number = {{1}},
Pages = {{4-15}},
Abstract = {{The microbial contamination of water miscible metalworking fluids (MWFs)
   is a serious problem in metal industry. A good maintenance of MWF
   re-circulation systems can extend the lifetime of coolants and ensure
   the quality of the tools produced. In MWFs, as in the other water-based
   environments, microorganisms usually live in the form of biofilms, the
   communities of bacteria and fungi attached to the surface of sumps,
   metal parts and also to each other. Biofilms exhibit very high
   resistance to biocides. The effect of biocides that are used as
   additives to MWFs to control the growth of the bacterial and fungal
   microbiomes (microorganisms characteristic to the individual coolant
   system) have become the subject of research only in recent years. There
   are also only sparse reports on the impact of biocides on microorganisms
   growing in biofilms in MWF installations. Fast growing mycobacteria are
   important members of these biofilm communities. Their presence has
   recently been linked with the occurrence of cases of hypersensitivity
   pneumonitis, a serious respiratory disorder in the metal industry
   employees. The new, relatively fast and inexpensive techniques to assess
   the species diversity within MWF microbiomes and their population size
   should be developed in order to control the microorganisms'
   proliferation in MWFs and to diminish the occupational exposure to
   harmful bioaerosols in metal industry.}},
Publisher = {{DE GRUYTER OPEN LTD}},
Address = {{SOLIPSKA 14A-1, 02-482 WARSAW, POLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Trafny, EA (Reprint Author), Mil Inst Hyg \& Epidemiol, Dept Microbiol, Kozielska 4, PL-01163 Warsaw, Poland.
   Mil Inst Hyg \& Epidemiol, Dept Microbiol, PL-01163 Warsaw, Poland.}},
DOI = {{10.2478/S13382-013-0075-5}},
ISSN = {{1232-1087}},
EISSN = {{1896-494X}},
Keywords = {{Metalworking fluids; Biofilm; Nontuberculous mycobacteria; Biocides}},
Keywords-Plus = {{METAL-WORKING FLUIDS; REAL-TIME PCR; MYCOBACTERIUM-IMMUNOGENUM;
   NONTUBERCULOUS MYCOBACTERIA; HYPERSENSITIVITY PNEUMONITIS; BIOFILM
   FORMATION; NONFORMALDEHYDE BIOCIDES; PSEUDOMONAS-FLUORESCENS;
   OCCUPATIONAL-EXPOSURE; PATHOGENIC BACTERIA}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{e.trafny@wihe.waw.pl}},
Funding-Acknowledgement = {{second stage of the Multi-annual Program: ``Improving the safety and
   working conditions{''} {[}III.B.05]; Ministry of Science and Higher
   Education/National Center for Research and Development}},
Funding-Text = {{Work reported this paper was supported under the project No III.B.05 of
   the second stage of the Multi-annual Program: ``Improving the safety and
   working conditions{''}, funded in 2011-2013 for research and development
   activities by the Ministry of Science and Higher Education/National
   Center for Research and Development. Coordinator: Central Institute for
   Labour Protection - National Research Institute.}},
Cited-References = {{Bakalova S, 2007, BIOTECHNOL BIOTEC EQ, V21, P437, DOI 10.1080/13102818.2007.10817490.
   Briancesco R, 2010, ANN I SUPER SANITA, V46, P254, DOI 10.4415/ANN\_10\_03\_05.
   Burton CM, 2012, ANN OCCUP HYG, V56, P374, DOI 10.1093/annhyg/mer121.
   CHAZAL PM, 1995, EUR J EPIDEMIOL, V11, P1, DOI 10.1007/BF01719939.
   Cohen H, 2006, J OCCUP ENVIRON HYG, V3, P501, DOI 10.1080/15459620600867872.
   COOK PE, 1988, INT BIODETERIOR, V24, P265, DOI 10.1016/0265-3036(88)90010-3.
   Cyprowski Marcin, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P365, DOI 10.2478/v10001-007-0036-y.
   Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x.
   Falkinham JO, 2002, CLIN CHEST MED, V23, P529, DOI 10.1016/S0272-5231(02)00014-X.
   Falkinham JO, 2009, APPL ENVIRON MICROB, V75, P2057, DOI 10.1128/AEM.02406-08.
   Frenzel E, 2011, APPL ENVIRON MICROB, V77, P3068, DOI 10.1128/AEM.02492-10.
   Geier H, 2008, APPL ENVIRON MICROB, V74, P1798, DOI 10.1128/AEM.02066-07.
   Gilbert Y, 2010, J APPL MICROBIOL, V108, P437, DOI 10.1111/j.1365-2672.2009.04433.x.
   Gordon T, 2006, INHAL TOXICOL, V18, P449, DOI 10.1080/08958370600563904.
   Gupta MK, 2009, J PROTEOME RES, V8, P2319, DOI 10.1021/pr8009462.
   Haussler S, 2010, J BACTERIOL, V192, P2941, DOI 10.1128/JB.00332-10.
   Kapoor R, 2012, FEMS MICROBIOL ECOL, V79, P392, DOI 10.1111/j.1574-6941.2011.01227.x.
   Kapoor R, 2009, MOL CELL PROBE, V23, P75, DOI 10.1016/j.mcp.2008.12.004.
   Katoch VM, 2004, INDIAN J MED RES, V120, P290.
   Khan IUH, 2005, FEMS MICROBIOL ECOL, V54, P329, DOI 10.1016/j.femsec.2005.04.009.
   Lucchesi EG, 2012, J IND MICROBIOL BIOT, V39, P743, DOI 10.1007/s10295-011-1081-x.
   Marchand G, 2010, J OCCUP ENVIRON HYG, V7, P358, DOI 10.1080/15459621003741631.
   MATTSBYBALTZER I, 1989, APPL ENVIRON MICROB, V55, P2681.
   Mena KD, 2009, REV ENVIRON CONTAM T, V201, P71, DOI 10.1007/978-1-4419-0032-6\_3.
   Mirer FE, 2010, AM J IND MED, V53, P792, DOI 10.1002/ajim.20853.
   Moore JS, 2000, AM IND HYG ASSOC J, V61, P205, DOI 10.1202/0002-8894(2000)061<0205:MCOMFI>2.0.CO;2.
   Murat JB, 2012, APPL ENVIRON MICROB, V78, P34, DOI 10.1128/AEM.06230-11.
   Park DU, 2008, J OCCUP HEALTH, V50, P212, DOI 10.1539/joh.O7006.
   Passman FJ, 2009, TRIBOL LUBR TECHNOL, V65, P52.
   Passman FJ, 2008, TRIBOL T, V51, P107, DOI 10.1080/10402000701691720.
   Perkins SD, 2010, FEMS MICROBIOL ECOL, V74, P643, DOI 10.1111/j.1574-6941.2010.00976.x.
   Rabenstein A, 2009, INT BIODETER BIODEGR, V63, P1023, DOI 10.1016/j.ibiod.2009.07.005.
   Rhodes G, 2011, J OCCUP ENVIRON HYG, V8, P478, DOI 10.1080/15459624.2011.590737.
   Rossmoore H. W., 1995, P133.
   Rumbaugh KP, 2012, CURR OPIN MICROBIOL, V15, P162, DOI 10.1016/j.mib.2011.12.003.
   Saha R, 2012, APPL MICROBIOL BIOT, V94, P1119, DOI 10.1007/s00253-012-4055-7.
   Saha R, 2012, APPL MICROBIOL BIOT, V94, P799, DOI 10.1007/s00253-011-3647-y.
   Schaber JA, 2007, INFECT IMMUN, V75, P3715, DOI 10.1128/IAI.00586-07.
   Selvaraju SB, 2008, LETT APPL MICROBIOL, V47, P451, DOI 10.1111/j.1472-765X.2008.02419.x.
   Selvaraju SB, 2005, APPL ENVIRON MICROB, V71, P542, DOI 10.1128/AEM.71.1.542-546.2005.
   Selvaraju SB, 2008, J IND MICROBIOL BIOT, V35, P197, DOI 10.1007/s10295-007-0286-5.
   Selvaraju SB, 2011, INT J MOL SCI, V12, P725, DOI 10.3390/ijms12010725.
   Simpson AT, 2003, ANN OCCUP HYG, V47, P17, DOI 10.1093/annhyg/meg006.
   Steinhauer K, 2008, J APPL MICROBIOL, V104, P454, DOI 10.1111/j.1365-2672.2007.03600.x.
   Tillie-Leblond I, 2011, EUR RESPIR J, V37, P640, DOI 10.1183/09031936.00195009.
   van der Gast CJ, 2003, ENVIRON MICROBIOL, V5, P453, DOI 10.1046/j.1462-2920.2003.00428.x.
   Veillette M, 2004, ANN OCCUP HYG, V48, P541, DOI 10.1093/annhyg/meh043.
   Watt William D, 2003, Appl Occup Environ Hyg, V18, P961.
   Wilinska Ewelina, 2010, Pneumonol Alergol Pol, V78, P138.
   Wilson RW, 2001, INT J SYST EVOL MICR, V51, P1751, DOI 10.1099/00207713-51-5-1751.}},
Number-of-Cited-References = {{50}},
Times-Cited = {{14}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{45}},
Journal-ISO = {{Int. J. Occup. Med. Environ. Health}},
Doc-Delivery-Number = {{123YM}},
Unique-ID = {{ISI:000317428800002}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000316298000005,
Author = {Raffel, Forrest K. and Szelestey, Blake R. and Beatty, Wandy L. and
   Mason, Kevin M.},
Title = {{The Haemophilus influenzae Sap Transporter Mediates Bacterium-Epithelial
   Cell Homeostasis}},
Journal = {{INFECTION AND IMMUNITY}},
Year = {{2013}},
Volume = {{81}},
Number = {{1}},
Pages = {{43-54}},
Month = {{JAN}},
Abstract = {{Nontypeable Haemophilus influenzae (NTHI) is a commensal inhabitant of
   the human nasopharynx and a causative agent of otitis media and other
   diseases of the upper and lower human airway. During colonization within
   the host, NTHI must acquire essential nutrients and evade immune attack.
   We previously demonstrated that the NTHI Sap transporter, an inner
   membrane protein complex, mediates resistance to antimicrobial peptides
   and is required for heme homeostasis. We hypothesized that Sap
   transporter functions are critical for NTHI interaction with the host
   epithelium and establishment of colonization. Thus, we cocultured the
   parent or the sapA mutant on polarized epithelial cells grown at an
   air-liquid interface, as a physiological model of NTHI colonization, to
   determine the contribution of the Sap transporter to bacterium-host cell
   interactions. Although SapA-deficient NTHI was less adherent to
   epithelial cells, we observed a significant increase in invasive
   bacteria compared to the parent strain. Upon internalization, the sapA
   mutant appeared free in the cytoplasm, whereas the parent strain was
   primarily found in endosomes, indicating differential subcellular
   trafficking. Additionally, we observed reduced inflammatory cytokine
   production by the epithelium in response to the sapA mutant strain
   compared to the parental strain. Furthermore, chinchilla middle ears
   challenged with the sapA mutant demonstrated a decrease in disease
   severity compared to ears challenged with the parental strain.
   Collectively, our data suggest that NTHI senses host environmental cues
   via Sap transporter function to mediate interaction with host epithelial
   cells. Epithelial cell invasion and modulation of host inflammatory
   cytokine responses may promote NTHI colonization and access to essential
   nutrients.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mason, KM (Reprint Author), Nationwide Childrens Hosp, Res Inst, Columbus, OH USA.
   Mason, Kevin M., Nationwide Childrens Hosp, Res Inst, Columbus, OH USA.
   Ohio State Univ, Coll Med, Dept Pediat, Ctr Microbial Pathogenesis, Columbus, OH 43210 USA.}},
DOI = {{10.1128/IAI.00942-12}},
ISSN = {{0019-9567}},
EISSN = {{1098-5522}},
Keywords-Plus = {{OBSTRUCTIVE PULMONARY-DISEASE; AERUGINOSA BIOFILM FORMATION;
   OTITIS-MEDIA; RESPIRATORY-TRACT; CHINCHILLA MODEL;
   STREPTOCOCCUS-PNEUMONIAE; CYSTIC-FIBROSIS; IN-VIVO; NUTRITIONAL
   IMMUNITY; CYTOKINE RESPONSES}},
Research-Areas = {{Immunology; Infectious Diseases}},
Web-of-Science-Categories  = {{Immunology; Infectious Diseases}},
Author-Email = {{Kevin.Mason@nationwidechildrens.org}},
Funding-Acknowledgement = {{NIAID/NIH {[}R21 A1070825]}},
Funding-Text = {{This work was supported by grant R21 A1070825 from the NIAID/NIH to
   K.M.M.}},
Cited-References = {{Ahren IL, 2001, MICROB PATHOGENESIS, V31, P151, DOI 10.1006/mpat.2001.0456.
   Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j.
   Armbruster CE, 2009, INFECT IMMUN, V77, P4081, DOI 10.1128/IAI.00320-09.
   Avadhanula V, 2006, INFECT IMMUN, V74, P830, DOI 10.1128/IAI.74.2.830-838.2006.
   Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803.
   Bandi V, 2001, AM J RESP CRIT CARE, V164, P2114, DOI 10.1164/ajrccm.164.11.2104093.
   Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102.
   Bookwalter JE, 2008, INFECT IMMUN, V76, P48, DOI 10.1128/IAI.00980-07.
   Byrd MS, 2011, INFECT IMMUN, V79, P3087, DOI 10.1128/IAI.00057-11.
   Casey JR, 2004, PEDIATR INFECT DIS J, V23, P824, DOI 10.1097/01.inf.0000136871.51792.19.
   Cersini A, 1998, INFECT IMMUN, V66, P549.
   Claverys JP, 2000, RES MICROBIOL, V151, P457, DOI 10.1016/S0923-2508(00)00169-8.
   Clementi CF, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00001.
   Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449.
   CUNDELL DR, 1995, INFECT IMMUN, V63, P2493.
   Diamond G, 2000, IMMUNOL REV, V173, P27, DOI 10.1034/j.1600-065X.2000.917304.x.
   FALKOW S, 1992, ANNU REV CELL BIOL, V8, P333, DOI 10.1146/annurev.cellbio.8.1.333.
   Fink DL, 2002, INFECT IMMUN, V70, P4902, DOI 10.1128/IAI.70.9.4902-4907.2002.
   FORSGREN J, 1994, INFECT IMMUN, V62, P673.
   Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294.
   Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142.
   Goebel W, 2000, CURR OPIN MICROBIOL, V3, P49, DOI 10.1016/S1369-5274(99)00050-8.
   GROENEVELD K, 1990, J INFECT DIS, V161, P512, DOI 10.1093/infdis/161.3.512.
   Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202.
   Hardy Gail G, 2003, Methods Mol Med, V71, P1.
   HERS JFP, 1953, J PATHOL BACTERIOL, V66, P103, DOI 10.1002/path.1700660114.
   Hong WZ, 2007, J BACTERIOL, V189, P8300, DOI 10.1128/JB.00532-07.
   Hong WZ, 2007, INFECT IMMUN, V75, P958, DOI 10.1128/IAI.01691-06.
   Hong WZ, 2009, J INNATE IMMUN, V1, P215, DOI 10.1159/000205937.
   Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836.
   Jurcisek JA, 2007, MOL MICROBIOL, V65, P1288, DOI 10.1111/j.1365-2958.2007.05864.x.
   Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522.
   Kaiser P, 2000, MICROBIOL-UK, V146, P3217, DOI 10.1099/00221287-146-12-3217.
   Klein JO, 1997, PEDIATR INFECT DIS J, V16, pS5, DOI 10.1097/00006454-199702001-00002.
   KRIVAN HC, 1988, P NATL ACAD SCI USA, V85, P6157, DOI 10.1073/pnas.85.16.6157.
   Mason KM, 2006, MOL MICROBIOL, V62, P1357, DOI 10.1111/j.1365-2958.2006.05460.x.
   Mason KM, 2011, J BACTERIOL, V193, P2527, DOI 10.1128/JB.01313-10.
   Mason KM, 2005, INFECT IMMUN, V73, P599, DOI 10.1128/IAI.73.1.599-608.2005.
   Mason KM, 2003, INFECT IMMUN, V71, P3454, DOI 10.1128/IAI.71.6.3454-3462.2003.
   Miyamoto N, 1996, MICROB PATHOGENESIS, V21, P343, DOI 10.1006/mpat.1996.0067.
   Moller LVM, 1998, AM J RESP CRIT CARE, V157, P950.
   MOLLER LVM, 1995, J INFECT DIS, V172, P1388, DOI 10.1093/infdis/172.5.1388.
   Moreau-Marquis S, 2009, AM J RESP CELL MOL, V41, P305, DOI 10.1165/rcmb.2008-0299OC.
   Morey P, 2011, MICROBIOL-SGM, V157, P234, DOI 10.1099/mic.0.040451-0.
   Moxon ER, 2008, TRENDS MICROBIOL, V16, P95, DOI 10.1016/j.tim.2007.12.005.
   MULKS MH, 1980, J INFECT DIS, V141, P450, DOI 10.1093/infdis/141.4.450.
   Murphy TF, 2004, AM J RESP CRIT CARE, V170, P266, DOI 10.1164/rccm.20403-354OC.
   Murphy TF, 2003, CURR OPIN INFECT DIS, V16, P129, DOI 10.1097/01.aco.0000065079.06965.e0.
   NOEL GJ, 1994, INFECT IMMUN, V62, P4028.
   Novotny LA, 2005, INFECT IMMUN, V73, P609, DOI 10.1128/IAI.73.1.609-611.2005.
   O'May CY, 2009, J MED MICROBIOL, V58, P765, DOI 10.1099/jmm.0.004416-0.
   Ojha A, 2007, MOL MICROBIOL, V66, P468, DOI 10.1111/j.1365-2958.2007.05935.x.
   Pang B, 2008, INFECT IMMUN, V76, P2037, DOI 10.1128/IAI.01716-07.
   Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149.
   Petersen BC, 2012, NAT MED, V18, P751, DOI 10.1038/nm.2735.
   Post JC, 2001, LARYNGOSCOPE, V111, P2083, DOI 10.1097/00005537-200112000-00001.
   Prince AS, 2002, NEW ENGL J MED, V347, P1110, DOI 10.1056/NEJMcibr021776.
   Reid DW, 2009, J APPL MICROBIOL, V106, P1058, DOI 10.1111/j.1365-2672.2008.03955.x.
   Ren DB, 2012, EXP BIOL MED, V237, P540, DOI 10.1258/ebm.2012.011377.
   Rhodes ER, 2007, J MED MICROBIOL, V56, P119, DOI 10.1099/jmm.0.46844-0.
   Risberg A, 1999, EUR J BIOCHEM, V261, P171, DOI 10.1046/j.1432-1327.1999.00248.x.
   Roman F, 2004, J CLIN MICROBIOL, V42, P1450, DOI 10.1128/JCM.42.4.1450-1459.2004.
   Ronander E, 2008, MICROBES INFECT, V10, P87, DOI 10.1016/j.micinf.2007.10.006.
   Schilling JD, 2001, J IMMUNOL, V166, P1148, DOI 10.4049/jimmunol.166.2.1148.
   Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206.
   Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001.
   Sharpe SW, 2011, INFECT IMMUN, V79, P4361, DOI 10.1128/IAI.05332-11.
   Shelton CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002360.
   St Geme JW, 2002, CELL MICROBIOL, V4, P191.
   St Geme JW, 2000, VACCINE, V19, pS41, DOI 10.1016/S0264-410X(00)00277-2.
   STGEME JW, 1994, INFECT IMMUN, V62, P3881.
   Sugano N, 2004, ORAL MICROBIOL IMMUN, V19, P121, DOI 10.1046/j.0902-0055.2003.00119.x.
   Svanborg C, 1999, CURR OPIN MICROBIOL, V2, P99, DOI 10.1016/S1369-5274(99)80017-4.
   Swords WE, 2000, MOL MICROBIOL, V37, P13, DOI 10.1046/j.1365-2958.2000.01952.x.
   Swords WE, 2001, CELL MICROBIOL, V3, P525, DOI 10.1046/j.1462-5822.2001.00132.x.
   Swords WE, 2004, INFECT IMMUN, V72, P106, DOI 10.1128/IAI.72.1.106-113.2004.
   Tracy E, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-101.
   VANALPHEN L, 1991, INFECT IMMUN, V59, P4473.
   Vogel AR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00042.
   WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39.
   Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002.
   West-Barnette S, 2006, INFECT IMMUN, V74, P1828, DOI 10.1128/IAI.74.3.1828-1836.2006.
   Wong SMS, 2011, INFECT IMMUN, V79, P1971, DOI 10.1128/IAI.01269-10.
   Wonprompitak P, 2009, ASIAN PAC J ALLERGY, V27, P59.
   Zaharik ML, 2004, INFECT IMMUN, V72, P5522, DOI 10.1128/IAI.72.9.5522-5525.2004.}},
Number-of-Cited-References = {{85}},
Times-Cited = {{13}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{8}},
Journal-ISO = {{Infect. Immun.}},
Doc-Delivery-Number = {{108MQ}},
Unique-ID = {{ISI:000316298000005}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000314832100008,
Author = {Just, Natasha and Lecours, Pascale Blais and Marcoux-Voiselle, Melissa
   and Kirychuk, Shelley and Veillette, Marc and Singh, Baljit and
   Duchaine, Caroline},
Title = {{Archaeal characterization of bioaerosols from cage-housed and
   floor-housed poultry operations}},
Journal = {{CANADIAN JOURNAL OF MICROBIOLOGY}},
Year = {{2013}},
Volume = {{59}},
Number = {{1}},
Pages = {{46-50}},
Month = {{JAN}},
Abstract = {{Although bioaerosols from both cage-housed (CH) and floor-housed (FH)
   poultry operations are highly concentrated, the concentrations of dust,
   endotoxin, and bacteria are significantly higher in FH bioaerosols.
   Workers from CH operations have reported a greater prevalence of
   respiratory symptoms. To date, archaea have been examined in swine and
   dairy bioaerosols but not in poultry bioaerosols. The objective of this
   study was to directly compare methanogenic archaea concentrations in
   bioaerosols from CH and FH poultry facilities. Bioaerosols were
   collected from 15 CH and 15 FH poultry operations, using stationary area
   samplers as well as personal sampling devices. Archaea were quantified
   and their diversity was investigated using polymerase chain reaction
   (PCR) followed by denaturing gradient gel electrophoresis (DGGE) and
   band sequencing. Archaea were significantly higher in area and personal
   bioaerosols of CH poultry operations than in those from FH poultry
   operations (p < 0.001 and p < 0.05, respectively) and did not differ
   significantly between area and personal samples within each barn type.
   Sequences matching Methanobrevibacter woesei, an archaea previously
   found in poultry samples, were detected in bioaerosol samples from CH
   operations. Methanogenic archaea concentrations are significantly
   different between bioaerosols from CH and FH poultry operations.}},
Publisher = {{CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS}},
Address = {{65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Duchaine, C (Reprint Author), Hop Laval, Inst Univ Cardiol \& Pneumol Quebec, 2725 Chemin, Quebec City, PQ G1V 4G5, Canada.
   Just, Natasha; Singh, Baljit, Univ Saskatchewan, Western Coll Vet Med, Dept Vet Biomed Sci, Saskatoon, SK S7N 5B4, Canada.
   Lecours, Pascale Blais; Marcoux-Voiselle, Melissa; Veillette, Marc; Duchaine, Caroline, Hop Laval, Inst Univ Cardiol \& Pneumol Quebec, Quebec City, PQ G1V 4G5, Canada.
   Kirychuk, Shelley, Univ Saskatchewan, Royal Univ Hosp, Canadian Ctr Hlth \& Safety Agr, Saskatoon, SK S7N 0W8, Canada.}},
DOI = {{10.1139/cjm-2012-0305}},
ISSN = {{0008-4166}},
EISSN = {{1480-3275}},
Keywords = {{archaea; bioaerosols; poultry; methanogen; air sampling}},
Keywords-Plus = {{16S RIBOSOMAL-RNA; GRADIENT GEL-ELECTROPHORESIS; METHANOGENIC ARCHAEA;
   ANTIMICROBIAL RESISTANCE; METHANOBREVIBACTER; WORKERS; GENES; PCR;
   QUANTIFICATION; PREVALENCE}},
Research-Areas = {{Biochemistry \& Molecular Biology; Biotechnology \& Applied
   Microbiology; Immunology; Microbiology}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Biotechnology \& Applied
   Microbiology; Immunology; Microbiology}},
Author-Email = {{caroline.duchaine@bcm.ulaval.ca}},
Cited-References = {{Bach HJ, 2002, J MICROBIOL METH, V49, P235, DOI 10.1016/S0167-7012(01)00370-0.
   Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009.
   Cavicchioli R, 2011, NAT REV MICROBIOL, V9, P51, DOI 10.1038/nrmicro2482.
   Chaban B, 2012, ISME J, V6, P430, DOI 10.1038/ismej.2011.96.
   Dighe AS, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-20.
   Donham KJ, 2000, J OCCUP ENVIRON MED, V42, P260, DOI 10.1097/00043764-200003000-00006.
   Dridi B, 2011, J ANTIMICROB CHEMOTH, V66, P2038, DOI 10.1093/jac/dkr251.
   Dridi B, 2011, ANAEROBE, V17, P56, DOI 10.1016/j.anaerobe.2011.03.001.
   Dridi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007063.
   Gilbert Y, 2010, J APPL MICROBIOL, V108, P437, DOI 10.1111/j.1365-2672.2009.04433.x.
   HELANDER I, 1982, INFECT IMMUN, V35, P528.
   Just N, 2011, ENVIRON RES, V111, P492, DOI 10.1016/j.envres.2011.01.009.
   Just Natasha, 2009, J Occup Med Toxicol, V4, P13, DOI 10.1186/1745-6673-4-13.
   Just NA, 2012, ANN OCCUP HYG, V56, P440, DOI 10.1093/annhyg/mer105.
   Kirychuk SP, 2006, J OCCUP ENVIRON MED, V48, P741, DOI 10.1097/01.jom.0000216215.39521.3c.
   Kirychuk Shelley P, 2003, Can Respir J, V10, P375.
   Kirychuk SP, 2010, ANN OCCUP HYG, V54, P824, DOI 10.1093/annhyg/meq047.
   Lecours PB, 2012, APPL ENVIRON MICROB, V78, P3242, DOI 10.1128/AEM.07661-11.
   Lecours PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023326.
   Lin CZ, 1998, ARCH MICROBIOL, V169, P397, DOI 10.1007/s002030050589.
   Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019.
   MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695.
   Nehme B, 2009, APPL ENVIRON MICROB, V75, P5445, DOI 10.1128/AEM.00726-09.
   Reyesenbach A.-L., 1995, ARCHAEA LAB MANUAL T.
   Rimac D, 2010, INT ARCH OCC ENV HEA, V83, P9, DOI 10.1007/s00420-009-0487-5.
   Saengkerdsub S, 2007, LETT APPL MICROBIOL, V45, P629, DOI 10.1111/j.1472-765X.2007.02243.x.
   Saengkerdsub S, 2007, APPL ENVIRON MICROB, V73, P353, DOI 10.1128/AEM.01931-06.
   Simpson JCG, 1998, OCCUP ENVIRON MED, V55, P668, DOI 10.1136/oem.55.10.668.
   WHYTE RT, 1993, WORLD POULTRY SCI J, V49, P139, DOI 10.1079/WPS19930012.
   Yu ZT, 2008, APPL ENVIRON MICROB, V74, P889, DOI 10.1128/AEM.00684-07.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{19}},
Journal-ISO = {{Can. J. Microbiol.}},
Doc-Delivery-Number = {{088KE}},
Unique-ID = {{ISI:000314832100008}},
DA = {{2018-08-13}},
}

@article{ ISI:000314116100004,
Author = {Chang, Kwok-Chiu and Yew, Wing-Wai},
Title = {{Management of difficult multidrug-resistant tuberculosis and extensively
   drug-resistant tuberculosis: Update 2012}},
Journal = {{RESPIROLOGY}},
Year = {{2013}},
Volume = {{18}},
Number = {{1}},
Pages = {{8-21}},
Month = {{JAN}},
Abstract = {{Multidrug-resistant (MDR) tuberculosis (TB) denotes bacillary resistance
   to at least isoniazid and rifampicin. Extensively drug-resistant (XDR)
   TB is MDR-TB with additional bacillary resistance to any fluoroquinolone
   and at least one second-line injectable drugs. Rooted in inadequate TB
   treatment and compounded by a vicious circle of diagnostic delay and
   improper treatment, MDR-TB/XDR-TB has become a global epidemic that is
   fuelled by poverty, human immunodeficiency virus (HIV) and neglect of
   airborne infection control. The majority of MDR-TB cases in some
   settings with high prevalence of MDR-TB are due to transmission of
   drug-resistant bacillary strains to previously untreated patients.
   Global efforts in controlling MDR-TB/XDR-TB can no longer focus solely
   on high-risk patients. It is difficult and costly to treat MDR-TB/XDRTB.
   Without timely implementation of preventive and management strategies,
   difficult MDR-TB/XDR-TB can cripple global TB control efforts.
   Preventive strategies include prompt diagnosis with adequate TB
   treatment using the directly observed therapy, short-course (DOTS)
   strategy and drug-resistance programmes, airborne infection control,
   preventive treatment of TB/HIV, and optimal use of antiretroviral
   therapy. Management strategies for established cases of difficult
   MDR-TB/XDR-TB rely on harnessing existing drugs (notably newer
   generation fluoroquinolones, high-dose isoniazid, linezolid and
   pyrazinamide with in vitro activity) in the best combinations and dosing
   schedules, together with adjunctive surgery in carefully selected cases.
   Immunotherapy may also have a role in the future. New diagnostics, drugs
   and vaccines are required to meet the challenge, but science alone is
   insufficient. Difficult MDR-TB/XDR-TB cannot be tackled without
   achieving high cure rates with quality DOTS and beyond, and concurrently
   addressing poverty and HIV.}},
Publisher = {{WILEY}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Chang, KC (Reprint Author), Wanchai Polyclin 99, Dept Hlth, TB \& Chest Serv, Wanchai Chest Clin, 1st Floor,Kennedy Rd, Wanchai, Hong Kong, Peoples R China.
   Chang, Kwok-Chiu, Chinese Univ Hong Kong, Dept Hlth, TB \& Chest Serv, Hong Kong, Hong Kong, Peoples R China.
   Yew, Wing-Wai, Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.}},
DOI = {{10.1111/j.1440-1843.2012.02257.x}},
ISSN = {{1323-7799}},
EISSN = {{1440-1843}},
Keywords = {{human immunodeficiency virus; multidrug-resistant; prevention;
   treatment; tuberculosis}},
Keywords-Plus = {{RANDOMIZED CONTROLLED-TRIAL; FIXED-DOSE COMBINATION; PUBLIC-PRIVATE MIX;
   EARLY BACTERICIDAL ACTIVITY; COMMUNITY-BASED TREATMENT; HIV-INFECTED
   PATIENTS; IN-VITRO ACTIVITY; POSITIVE PULMONARY TUBERCULOSIS;
   SHORT-COURSE CHEMOTHERAPY; MYCOBACTERIUM-TUBERCULOSIS}},
Research-Areas = {{Respiratory System}},
Web-of-Science-Categories  = {{Respiratory System}},
Author-Email = {{kc\_chang@dh.gov.hk}},
Cited-References = {{Abbate E, 2012, J ANTIMICROB CHEMOTH, V67, P473, DOI 10.1093/jac/dkr500.
   Alcala L, 2003, ANTIMICROB AGENTS CH, V47, P416, DOI 10.1128/AAC.47.1.416-417-2003.
   Amaral L, 2012, INT J ANTIMICROB AG, V39, P376, DOI 10.1016/j.ijantimicag.2012.01.012.
   Andrews JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015735.
   Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753.
   {[}Anonymous], 1948, Br Med J, V2, P769.
   {[}Anonymous], 2003, WHOCDSTB2003313, P313.
   Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2.
   Banu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040545.
   Bartacek A, 2009, INT J TUBERC LUNG D, V13, P760.
   Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5.
   Bergmann JS, 1998, INT J TUBERC LUNG D, V2, P621.
   Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911.
   Blomberg B, 2001, B WORLD HEALTH ORGAN, V79, P61.
   Blondal K, 2012, INT J TUBERC LUNG D, V16, P1228, DOI 10.5588/ijtld.12.0037.
   Blumberg Henry M, 2003, Am J Respir Crit Care Med, V167, P603.
   Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456.
   Brust JCM, 2012, INT J TUBERC LUNG D, V16, P998, DOI 10.5588/ijtld.11.0713.
   Caminero JA, 2008, INT J TUBERC LUNG D, V12, P869.
   Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0.
   Chaisson RE, 2008, NEW ENGL J MED, V358, P1089, DOI 10.1056/NEJMp0800809.
   Chaisson RE, 2012, NEW ENGL J MED, V366, P2223, DOI 10.1056/NEJMe1204478.
   Chambers HF, 1998, CLIN INFECT DIS, V26, P874, DOI 10.1086/513945.
   Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-11590C.
   Chan ED, 2009, CLIN INFECT DIS, V48, pE50, DOI 10.1086/597010.
   Chang KC, 2011, 51 INT C ANT AG CHEM.
   Chang KC, 2011, ANTIMICROB AGENTS CH, V55, P4499, DOI 10.1128/AAC.00630-11.
   Chang KC, 2011, THORAX, V66, P997, DOI 10.1136/thx.2010.148585.
   Chang KC, 2010, J ANTIMICROB CHEMOTH, V65, P1551, DOI 10.1093/jac/dkq202.
   Chang KC, 2012, ANTIMICROB AGENTS CH, V56, P5465, DOI 10.1128/AAC.01300-12.
   Chiang CY, 2010, INT J TUBERC LUNG D, V14, P672.
   Chiang CY, 2001, INT J TUBERC LUNG D, V5, P272.
   Chimbanrai Boonlue, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P526.
   Churchyard GJ, 2009, CLIN CHEST MED, V30, P769, DOI 10.1016/j.ccm.2009.08.009.
   Condos R, 1999, BIODRUGS, V11, P165, DOI 10.2165/00063030-199911030-00003.
   Cox H, 2012, INT J TUBERC LUNG D, V16, P447, DOI 10.5588/ijtld.11.0451.
   CROFTON J, 1960, BRIT MED J, V2, P449, DOI 10.1136/bmj.2.5196.449.
   CYNAMON MH, 1983, ANTIMICROB AGENTS CH, V24, P429, DOI 10.1128/AAC.24.3.429.
   Dauby N, 2011, PEDIATR INFECT DIS J, V30, P812, DOI 10.1097/INF.0b013e3182154b05.
   Davidson H, 2000, INT J TUBERC LUNG D, V4, P860.
   Department of Health and Human Services, 2012, PAN ANT GUID AD AD G.
   DeRiemer K, 2005, LANCET, V365, P1239, DOI 10.1016/S0140-6736(05)74812-1.
   Dewan R K, 1999, Indian J Chest Dis Allied Sci, V41, P83.
   Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC.
   Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3271, DOI 10.1128/AAC.06126-11.
   Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427.
   Dietze R, 2008, AM J RESP CRIT CARE, V178, P1180, DOI 10.1164/rccm.200806-892OC.
   Donald PR, 2001, SCAND J INFECT DIS, V33, P466.
   Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc.
   Dravniece G, 2009, EUR RESPIR J, V34, P180, DOI 10.1183/09031936.00047208.
   Eker B, 2008, EMERG INFECT DIS, V14, P1700, DOI 10.3201/eid1411.080729.
   Erturan Z, 2005, INT J ANTIMICROB AG, V26, P78, DOI 10.1016/j.ijantimicag.2005.03.006.
   Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537.
   Espinal MA, 2005, LANCET, V365, P1206, DOI 10.1016/S0140-6736(05)74788-7.
   Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611.
   Fish DN, 1997, CLIN PHARMACOKINET, V32, P101, DOI 10.2165/00003088-199732020-00002.
   Fox W, 1999, INT J TUBERC LUNG D, V3, pS231.
   FOX W, 1963, Bibl Tuberc, V17, P28.
   Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC.
   Garden B, 2013, SCAND J CARING SCI, V27, P117, DOI 10.1111/j.1471-6712.2012.01009.x.
   Gegia M, 2012, INT J INFECT DIS, V16, pE391, DOI 10.1016/j.ijid.2011.12.018.
   GEISELER PJ, 1985, AM REV RESPIR DIS, V131, P944.
   Gelmanova IY, 2011, INT J TUBERC LUNG D, V15, P1373, DOI 10.5588/ijtld.10.0531.
   Giosue S, 2000, EUR CYTOKINE NETW, V11, P99.
   Gler MT, 2011, INT J TUBERC LUNG D, V15, P652, DOI 10.5588/ijtld.10.0400.
   Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433.
   Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441.
   Grahmann PR, 2008, INT J TUBERC LUNG D, V12, P636.
   Grosset JH, 2012, INT J TUBERC LUNG D, V16, P1005, DOI 10.5588/ijtld.12.0277.
   Gumbo T, 2004, J INFECT DIS, V190, P1642, DOI 10.1086/424849.
   Hasenbosch RE, 2008, INT J TUBERC LUNG D, V12, P967.
   Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607.
   Heller T, 2010, INT J TUBERC LUNG D, V14, P420.
   Holland DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030194.
   Hu Y, 2008, INT J TUBERC LUNG D, V12, P69.
   Huang WL, 2011, J CLIN MICROBIOL, V49, P2502, DOI 10.1128/JCM.00197-11.
   Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498.
   Ibrahim M, 2007, ANTIMICROB AGENTS CH, V51, P1011, DOI 10.1128/AAC.00898-06.
   ISEMAN MD, 1990, AM REV RESPIR DIS, V141, P623, DOI 10.1164/ajrccm/141.3.623.
   Iseman MD, 1998, INT J TUBERC LUNG D, V2, P867.
   Iwanaga T, 1997, Kekkaku, V72, P9.
   Jackson S, 2006, INT J TUBERC LUNG D, V10, P1104.
   Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115.
   Jeon DS, 2009, INT J TUBERC LUNG D, V13, P594.
   Johnson BJ, 1997, TUBERCLE LUNG DIS, V78, P195, DOI 10.1016/S0962-8479(97)90026-5.
   Johnson JL, 2006, INT J TUBERC LUNG D, V10, P605.
   Jouveshomme S, 1998, AM J RESP CRIT CARE, V157, P1609, DOI 10.1164/ajrccm.157.5.9709047.
   Kang MW, 2010, ANN THORAC SURG, V89, P1597, DOI 10.1016/j.athoracsur.2010.02.020.
   Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181.
   Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848.
   Katiyar SK, 2008, INT J TUBERC LUNG D, V12, P139.
   Keshavjee S, 2008, ANN NY ACAD SCI, V1136, P1, DOI 10.1196/annals.1425.009.
   Keshavjee S, 2012, INT J TUBERC LUNG D, V16, P596, DOI 10.5588/ijtld.11.0591.
   Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0.
   Khan MS, 2011, SE ASIAN J TROP MED, V42, P664.
   Kim DH, 2008, AM J RESP CRIT CARE, V178, P1075, DOI 10.1164/rccm.200801-132OC.
   Kim DH, 2010, AM J RESP CRIT CARE, V182, P113, DOI 10.1164/rccm.200911-1656OC.
   Kim HJ, 2006, EUR RESPIR J, V28, P576, DOI 10.1183/09031936.06.00023006.
   Kim HJ, 2012, INT J TUBERC LUNG D, V16, P98, DOI 10.5588/ijtld.10.0739.
   Kim HR, 2007, CLIN INFECT DIS, V45, P1290, DOI 10.1086/522537.
   Kir A, 2006, J THORAC CARDIOV SUR, V131, P693, DOI 10.1016/j.jtcvs.2005.09.033.
   Koh WJ, 2012, J ANTIMICROB CHEMOTH, V67, P1503, DOI 10.1093/jac/dks078.
   Koh WJ, 2009, J ANTIMICROB CHEMOTH, V64, P1119, DOI 10.1093/jac/dkp344.
   Kwon YS, 2008, CLIN INFECT DIS, V47, P496, DOI 10.1086/590005.
   Lal SS, 2011, TROP MED INT HEALTH, V16, P685, DOI 10.1111/j.1365-3156.2011.02749.x.
   Leimane V, 2005, LANCET, V365, P318.
   Leung ECC, 2013, EUR RESPIR J, V41, P901, DOI 10.1183/09031936.00071212.
   Liang LB, 2012, THORAX, V67, P632, DOI 10.1136/thoraxjnl-2011-200018.
   Lienhardt C, 2011, JAMA-J AM MED ASSOC, V305, P1415, DOI 10.1001/jama.2011.436.
   Loddenkemper R, 2012, INT J TUBERC LUNG D, V16, P571, DOI 10.5588/ijtld.12.0199.
   Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68.
   London L, 2009, INT J TUBERC LUNG D, V13, P1200.
   Malla P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008313.
   Malmborg R, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-49.
   Man MA, 2012, EUR J CARDIO-THORAC, V42, pe9, DOI 10.1093/ejcts/ezs215.
   Martins M, 2009, INT J TUBERC LUNG D, V13, P569.
   Martins N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4248.
   Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136.
   Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466.
   Matthys F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007954.
   Maus CE, 2005, ANTIMICROB AGENTS CH, V49, P3192, DOI 10.1128/AAC.49.8.3192-3197.2005.
   Migliori GB, 2008, EUR RESPIR J, V31, P1155, DOI 10.1183/09031936.00028708.
   Migliori GB, 2008, EUR RESPIR J, V31, P904, DOI 10.1183/09031936.00159807.
   Migliori GB, 2007, EUR RESPIR J, V30, P623, DOI 10.1183/09031936.00077307.
   Migliori GB, 2007, EUR RESPIR J, V29, P423, DOI 10.1183/09031936.00001307.
   Milburn H, 2010, THORAX, V65, P559, DOI 10.1136/thx.2009.133173.
   Mitchison DA, 1998, INT J TUBERC LUNG D, V2, P10.
   Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928.
   Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106.
   Mizutani H, 2001, Kekkaku, V76, P667.
   Mohsen T, 2007, J THORAC CARDIOV SUR, V134, P194, DOI 10.1016/j.jtcvs.2007.03.022.
   Moodley P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017513.
   Motus IY, 2006, INT J TUBERC LUNG D, V10, P571.
   Moulding TS, 2004, INT J TUBERC LUNG D, V8, P743.
   Munsiff SS, 2006, INT J TUBERC LUNG D, V10, P639.
   Murthy KJR, 2001, INT J TUBERC LUNG D, V5, P354.
   NADLER JP, 1991, CHEST, V99, P1025, DOI 10.1378/chest.99.4.1025.
   Naidoo Rishen, 2005, Asian Cardiovasc Thorac Ann, V13, P172.
   Nodieva A, 2010, INT J TUBERC LUNG D, V14, P427.
   Nuermberger E, 2008, ANTIMICROB AGENTS CH, V52, P1522, DOI 10.1128/AAC.00074-08.
   O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008.
   Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6.
   Oxlade O, 2012, EUR RESPIR J, V39, P626, DOI 10.1183/09031936.00065311.
   Palmero D, 1999, INT J TUBERC LUNG D, V3, P214.
   Park SK, 2009, INT J INFECT DIS, V13, P170, DOI 10.1016/j.ijid.2008.06.001.
   Park SK, 2002, INT J TUBERC LUNG D, V6, P143.
   Payen MC, 2012, INT J TUBERC LUNG D, V16, P558, DOI 10.5588/ijtld.11.0414.
   Peloquin CA, 2002, DRUGS, V62, P2169, DOI 10.2165/00003495-200262150-00001.
   Pierre-Audigier C, 2012, INT J TUBERC LUNG D, V16, P221, DOI 10.5588/ijtld.11.0266.
   Poissy J, 2010, ANTIMICROB AGENTS CH, V54, P4765, DOI 10.1128/AAC.00968-10.
   Pomerantz BJ, 2001, J THORAC CARDIOV SUR, V121, P448, DOI 10.1067/mtc.2001.112339.
   Probandari A, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-113.
   Quelapio MID, 2010, INT J TUBERC LUNG D, V14, P751.
   Quy HT, 2003, INT J TUBERC LUNG D, V7, P1139.
   Ralph AP, 2008, TRENDS MICROBIOL, V16, P336, DOI 10.1016/j.tim.2008.04.003.
   RILEY RL, 1995, AM J EPIDEMIOL, V142, P3, DOI 10.1093/oxfordjournals.aje.a117542.
   Satti H, 2012, INT J TUBERC LUNG D, V16, P468, DOI 10.5588/ijtld.11.0615.
   Schaaf HS, 2011, PAEDIATR RESPIR REV, V12, P31, DOI 10.1016/j.prrv.2010.09.010.
   Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186.
   Shah NS, 2008, JAMA-J AM MED ASSOC, V300, P2153, DOI 10.1001/jama.300.18.2153.
   Shenoi SV, 2010, CLIN INFECT DIS, V50, pS231, DOI 10.1086/651496.
   Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027.
   Shiraishi Yuji, 2008, Interact Cardiovasc Thorac Surg, V7, P1075, DOI 10.1510/icvts.2008.185124.
   Shiraishi Y, 2009, J THORAC CARDIOV SUR, V138, P1180, DOI 10.1016/j.jtcvs.2009.07.018.
   Sinanovic E, 2006, INT J TUBERC LUNG D, V10, P795.
   Sinanovic E, 2010, GLOB PUBLIC HEALTH, V5, P479, DOI 10.1080/17441690902942498.
   Single N, 2011, INT J TUBERC LUNG D, V15, P1326, DOI 10.5588/ijtld.10.0564.
   SOMNER AR, 1966, BRIT MED J, V1, P775, DOI 10.1136/bmj.1.5490.775.
   Somocurcio JG, 2007, THORAX, V62, P416, DOI 10.1136/thx.2005.051961.
   Sotgiu G, 2012, EUR RESPIR J, V40, P1430, DOI 10.1183/09031936.00022912.
   Stanford JL, 2001, RESP MED, V95, P444, DOI 10.1053/rmed.2001.1065.
   Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X.
   Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561.
   Sung SW, 1999, EUR J CARDIO-THORAC, V16, P187, DOI 10.1016/S1010-7940(99)00158-X.
   Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270.
   Takeda S, 2005, ANN THORAC SURG, V79, P959, DOI 10.1016/j.athoracsur.2004.09.007.
   Tasneen R, 2008, ANTIMICROB AGENTS CH, V52, P3664, DOI 10.1128/AAC.00686-08.
   Tato M, 2006, INT J ANTIMICROB AG, V28, P75, DOI 10.1016/j.ijantimicag.2006.02.011.
   Thee S, 2011, INT J TUBERC LUNG D, V15, P1191, DOI 10.5588/ijtld.10.0707.
   Thiam S, 2007, JAMA-J AM MED ASSOC, V297, P380, DOI 10.1001/jama.297.4.380.
   Torun T, 2007, INT J TUBERC LUNG D, V11, P979.
   Tousek J, 1967, Tubercle, V48, P27, DOI 10.1016/S0041-3879(67)80048-5.
   TREASURE RL, 1995, ANN THORAC SURG, V59, P1405, DOI 10.1016/0003-4975(95)00145-B.
   Tuberculosis Chemotherapy Centre, 1959, B WORLD HEALTH ORGAN, V21, P51.
   Tuberculosis Coalition for Technical Assistance, 2006, INT STAND TUB CAR IS.
   Uhlin M, 2012, J INFECT DIS, V205, pS325, DOI 10.1093/infdis/jis197.
   Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7.
   Uplekar M, 2003, TUBERCULOSIS, V83, P156, DOI 10.1016/S1472-9792(02)00073-2.
   van der Werf MJ, 2012, INT J TUBERC LUNG D, V16, P288, DOI 10.5588/ijtld.11.0437.
   Van Deun A, 2004, INT J TUBERC LUNG D, V8, P560.
   Van Deun A, 2010, INT J TUBERC LUNG D, V14, P131.
   Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC.
   van Halsema CL, 2012, INT J TUBERC LUNG D, V16, P967, DOI 10.5588/ijtld.11.0122.
   VanLeuven M, 1997, ANN THORAC SURG, V63, P1368.
   Varshochi M., 2006, IRAN J CLIN INFECT D, V1, P121.
   Veziris N, 2009, AM J RESP CRIT CARE, V179, P75, DOI 10.1164/rccm.200711-1736OC.
   Vo SK, 2010, J CLIN MICROBIOL, V48, P2934, DOI 10.1128/JCM.00201-10.
   Wang HF, 2008, ANN THORAC SURG, V86, P1640, DOI 10.1016/j.athoracsur.2008.07.056.
   Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC.
   WHO, 2008, POL STAT MOL LIN PRO.
   WHO, 2012, TUB DIAGN XPERT MTB.
   WHO, 2012, STRAT US ANT HELP HI.
   World Health Organisation, 2011, WHOHTMTB201116.
   World Health Organization, 2011, WHOHTMTB20114.
   World Health Organization, 2009, WHOHTMTB2009419.
   World Health Organization, 2008, WHOHTMTB2008402.
   World Health Organization, 2009, WHOHTMTB2008402A.
   World Health Organization, 2011, WHOHTMTB20118.
   World Health Organization, 2004, WHOCDSIMAI20044.
   World Health Organization, 2010, FRAM IMPL NEW TUB DI.
   World Health Organization, 2012, WHOHIV201212.
   World Health Organization, 2011, WHOHTMSTB20102.
   World Health Organization, 2010, WHOHTMTB2009420.
   World Health Organization, 2011, SHORT TERM PRIOR ANT.
   World Health Organization, 2011, WHOHTMTB20119.
   World Health Organization, 2009, RAP ADV ANT THER HIV.
   World Health Organization (WHO), 2011, GUID INT TUB CAS FIN.
   Xu HB, 2014, J ANTIMICROB CHEMOTH, V69, pE1, DOI 10.1093/jac/dks077.
   Yew WW, 2011, EUR RESPIR J, V37, P441, DOI 10.1183/09031936.00033010.
   Yew WW, 2008, RESPIROLOGY, V13, P21, DOI 10.1111/j.1440-1843.2007.01180.x.
   Yew WW, 2009, J ANTIMICROB CHEMOTH, V64, P1119, DOI 10.1093/jac/dkp291.
   Yew WW, 2000, CHEST, V117, P744, DOI 10.1378/chest.117.3.744.
   Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320.
   Zhang Y, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.18.
   Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789.
   ZIERSKI M, 1970, Tubercle, V51, P172, DOI 10.1016/0041-3879(70)90069-3.
   Zvonar R, 2006, AM J HEALTH-SYST PH, V63, P2087, DOI 10.2146/ajhp060024.}},
Number-of-Cited-References = {{227}},
Times-Cited = {{33}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{40}},
Journal-ISO = {{Respirology}},
Doc-Delivery-Number = {{078RD}},
Unique-ID = {{ISI:000314116100004}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000313227600010,
Author = {Vanden Driessche, K. and Marais, B. J. and Wattenberg, M. and
   Magis-Escurra, C. and Reijers, M. and Tuinman, I. L. and Boeree, M. J.
   and van Soolingen, D. and de Groot, R. and Cotton, M. F.},
Title = {{The Cough Cylinder: a tool to study measures against airborne spread of
   (myco-) bacteria}},
Journal = {{INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE}},
Year = {{2013}},
Volume = {{17}},
Number = {{1}},
Pages = {{46-53}},
Month = {{JAN}},
Abstract = {{BACKGROUND: `Covering your cough' reduces droplet number, but its effect
   on airborne pathogen transmission is less clear. The World Health
   Organization specifically recommends cough etiquette to prevent the
   spread of Mycobacterium tuberculosis, but implementation is generally
   poor and evidence supporting its value is lacking.
   METHODS: We constructed a model to assess `real life' transmission risk
   by counting viable pathogens from aerosols produced by coughing
   patients, thus allowing the assessment of outward protection measures in
   a standardised fashion. During the validation process, we focused on
   rod-shaped bacteria as surrogates for M. tuberculosis.
   RESULTS: The Cough Cylinder enabled us to sample Pseudomonas aeruginosa,
   Escherichia coli and mycobacteria from aerosols produced by patients
   with cystic fibrosis, primary ciliary dyskinesia and tuberculosis.
   Pathogens in droplets and in airborne particles could be sampled.
   Delayed air sampling allowed specific measurement of persistent airborne
   particles.
   CONCLUSION: This novel experimental system allows measurement of aerosol
   pathogen spread in a highly standardised fashion. It also offers the
   possibility to assess the impact of different interventions to limit
   aerosol transmission.}},
Publisher = {{INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)}},
Address = {{68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Vanden Driessche, K (Reprint Author), Radboud Univ Nijmegen, Dept Pediat Infect Dis, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.
   Vanden Driessche, K.; de Groot, R., Radboud Univ Nijmegen, Dept Pediat Infect Dis, Med Ctr, NL-6500 HB Nijmegen, Netherlands.
   Marais, B. J., Univ Sydney, Sydney Inst Emerging Infect Dis \& Biosecur, Sydney, NSW 2006, Australia.
   Marais, B. J., Univ Sydney, Childrens Hosp Westmead, Sydney, NSW 2006, Australia.
   Wattenberg, M.; van Soolingen, D., Univ Ctr Chron Dis Dekkerswald, Dept Clin Microbiol, Nijmegen, Netherlands.
   Magis-Escurra, C.; Reijers, M.; Boeree, M. J., Univ Ctr Chron Dis Dekkerswald, Dept Resp Dis, Nijmegen, Netherlands.
   Tuinman, I. L., TNO, NL-2280 AA Rijswijk, Netherlands.
   van Soolingen, D., Natl Inst Publ Hlth \& Environm, Natl Mycobacteria Reference Lab, NL-3720 BA Bilthoven, Netherlands.
   Cotton, M. F., Tygerberg Childrens Hosp, Dept Paediat \& Child Hlth, Tygerberg, South Africa.
   Cotton, M. F., Tygerberg Childrens Hosp, Childrens Infect Dis Clin Res Unit, Tygerberg, South Africa.
   Cotton, M. F., Univ Stellenbosch, Fac Hlth Sci, ZA-7505 Tygerberg, South Africa.}},
DOI = {{10.5588/ijtld.12.0289}},
ISSN = {{1027-3719}},
Keywords = {{infection control; aerosol transmission; tuberculosis; cough etiquette;
   respiratory hygiene}},
Keywords-Plus = {{DRUG-RESISTANT TUBERCULOSIS; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS;
   SELECTIVE MEDIUM; INFECTION; IDENTIFICATION; MORTALITY; AEROSOLS;
   STRAINS; WARD}},
Research-Areas = {{Infectious Diseases; Respiratory System}},
Web-of-Science-Categories  = {{Infectious Diseases; Respiratory System}},
Author-Email = {{Koen@ESCapeTB.org}},
ResearcherID-Numbers = {{Boeree, Martin/G-6132-2010
   Groot, R./H-8039-2014
   Reijers, M.H.E./L-4594-2015}},
Cited-References = {{Adams KL, 2008, ANAL CHEM, V80, P5350, DOI 10.1021/ac8002825.
   ANDERSEN AA, 1958, J BACTERIOL, V76, P471.
   Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106.
   BUCKLAND FE, 1964, J HYG-CAMBRIDGE, V62, P365, DOI 10.1017/S0022172400040080.
   CAMPBELL ME, 1988, J CLIN MICROBIOL, V26, P1910.
   Conway S P, 2005, Chron Respir Dis, V2, P35, DOI 10.1191/1479972305cd045rs.
   Corey M, 1996, AM J EPIDEMIOL, V143, P1007.
   Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC.
   Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002.
   Dharmadhikari AS, 2011, CLIN INFECT DIS, V52, P554, DOI 10.1093/cid/ciq182.
   DUGUID JP, 1946, J HYG-CAMBRIDGE, V44, P471, DOI 10.1017/S0022172400019288.
   Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101.
   Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127.
   Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188.
   Fang M., 2008, HONG KONG MED J, V14, P26.
   Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC.
   FRANKOVA V, 1975, ACTA VIROL, V19, P29.
   GERONE PJ, 1966, BACTERIOL REV, V30, P576.
   Gralton J, 2011, J INFECTION, V62, P1, DOI 10.1016/j.jinf.2010.11.010.
   HARE R, 1946, BRIT MED J, V1, P865, DOI 10.1136/bmj.1.4457.865.
   Haslbeck K, 2010, J AEROSOL SCI, V41, P429, DOI 10.1016/j.jaerosci.2010.02.010.
   Henry DA, 1997, J CLIN MICROBIOL, V35, P614.
   HEYMANN B, 1899, MED MICROBIOL IMMUN, V30, P139.
   Jennison MW, 1942, AEROBIOLOGY, V17, P106.
   Jones AM, 2003, THORAX, V58, P525, DOI 10.1136/thorax.58.6.525.
   Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100.
   Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186.
   Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002.
   Murray P R, 2007, MANUAL CLIN MICROBIO, P543.
   Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076.
   Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105.
   Reichman LB, 2009, LANCET, V373, P28, DOI 10.1016/S0140-6736(08)61952-2.
   RILEY RL, 1974, AM J MED, V57, P466, DOI 10.1016/0002-9343(74)90140-5.
   RILEY RL, 1962, AM REV RESPIR DIS, V85, P511.
   Saiman Lisa, 2003, American Journal of Infection Control, V31, pS1.
   Tang JW, 2009, J R SOC INTERFACE, V6, pS727, DOI 10.1098/rsif.2009.0295.focus.
   TRUEBA FJ, 1980, J BACTERIOL, V142, P869.
   Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889.
   van der Sande M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002618.
   Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427.
   Wainwright CE, 2009, THORAX, V64, P926, DOI 10.1136/thx.2008.112466.
   WHO, 2011, ANT RES.
   World Health Organisation, 2011, WHOHTMTB201116.
   World Health Organization, 2009, WHOHTMTB2009419.
   World Health Organization, 2007, WHOCDSEPR20076.
   Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus.
   Yang SH, 2007, J AEROSOL MED, V20, P484, DOI 10.1089/jam.2007.0610.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{Int. J. Tuberc. Lung Dis.}},
Doc-Delivery-Number = {{066NN}},
Unique-ID = {{ISI:000313227600010}},
DA = {{2018-08-13}},
}

@article{ ISI:000312980600012,
Author = {Muzslay, Monika and Moore, Ginny and Turton, Jane F. and Wilson, A.
   Peter},
Title = {{Dissemination of antibiotic-resistant enterococci within the ward
   environment: The role of airborne bacteria and the risk posed by
   unrecognized carriers}},
Journal = {{AMERICAN JOURNAL OF INFECTION CONTROL}},
Year = {{2013}},
Volume = {{41}},
Number = {{1}},
Pages = {{57-60}},
Month = {{JAN}},
Abstract = {{Background: Colonized or infected patients pose a significant risk to
   noncolonized patients occupying the same room. The aim of this study was
   to investigate how far Enterococcus spp can spread from isolated and
   nonisolated patients.
   Methods: Conventional microbiological methods were used to recover
   enterococci from the air and from 62 high-contact sites located within
   the near-patient and wider ward environment. Samples were collected
   twice weekly for 17 weeks. The similarity between isolates was
   determined via pulsed-field gel electrophoresis.
   Results: Vancomycin-susceptible enterococci (VSE) were recovered from
   352 of 2,046 environmental surfaces (17.2\%) and from 27 of 66 air
   samples (40.9\%). During study week 14, VSE was recovered from 75 of the
   124 surfaces sampled, representing 21.3\% of all VSE-positive sites. A
   gentamicin-resistant VS Enterococcus faecium clone was recovered in high
   numbers from the air (>100 cfu/m(3)) and from surfaces throughout a
   4-bed bay. The same clone was recovered from an adjacent isolation room
   as well. A total of 55 surfaces were contaminated with
   vancomycin-resistant enterococci (VRE). The environment of 2 isolated
   patients accounted for 85\% of contaminated sites. Neither patient was
   known to be VRE-positive.
   Conclusions: Unrecognized colonization and/or the aerosolization of
   enterococci together with inadequate cleaning can lead to heavy,
   widespread, and persistent environmental contamination. All pose a
   significant risk for acquisition of antibiotic-resistant enterococci.
   Copyright (C) 2013 by the Association for Professionals in Infection
   Control and Epidemiology, Inc. Published by Elsevier Inc. All rights
   reserved.}},
Publisher = {{MOSBY-ELSEVIER}},
Address = {{360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Muzslay, M (Reprint Author), Royal Free Hampstead NHS Trust, UCLH Environm Res Grp, Dept Microbiol, Pond St, London NW3 2QG, England.
   Muzslay, Monika; Moore, Ginny; Wilson, A. Peter, Natl Hlth Serv Fdn Trust, Univ Coll London Hosp, Dept Microbiol, London, England.
   Turton, Jane F., Hlth Protect Agcy, Ctr Infect, London, England.}},
DOI = {{10.1016/j.ajic.2012.01.031}},
ISSN = {{0196-6553}},
Keywords = {{Vancomycin-resistant enterococcus; Airborne dissemination; Hospital
   environment contamination}},
Keywords-Plus = {{FIELD GEL-ELECTROPHORESIS; VANCOMYCIN-RESISTANT; STAPHYLOCOCCUS-AUREUS;
   CONTAMINATION; ACQUISITION; FAECIUM; TRANSMISSION; OUTBREAK; SURFACES;
   CONTACT}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{monika.muzslay@uclh.nhs.uk}},
ResearcherID-Numbers = {{Staves, Peter/C-8219-2014
   }},
ORCID-Numbers = {{Wilson, Andrew Peter Richard/0000-0003-1109-5650}},
Funding-Acknowledgement = {{HCAI Technology Innovation Programme in the Department of Health;
   University College London Hospitals/University College London
   Comprehensive Biomedical Research Centre in the National Institute of
   Health Research Biomedical Research Centres funding scheme}},
Funding-Text = {{This report was commissioned and funded by the HCAI Technology
   Innovation Programme in the Department of Health. The views expressed
   are not necessarily those of the Department. A.P.W. was part-funded by
   the University College London Hospitals/University College London
   Comprehensive Biomedical Research Centre in the National Institute of
   Health Research Biomedical Research Centres funding scheme.}},
Cited-References = {{Andrews JM, 2009, J ANTIMICROB CHEMOTH, V64, P454, DOI 10.1093/jac/dkp244.
   Best EL, 2010, CLIN INFECT DIS, V50, P1450, DOI 10.1086/652648.
   Bhalla A, 2004, INFECT CONT HOSP EP, V25, P164, DOI 10.1086/502369.
   Cardo D, 2010, AM J INFECT CONTROL, V38, P671, DOI 10.1016/j.ajic.2010.09.001.
   Cetinkaya Y, 2000, CLIN MICROBIOL REV, V13, P686, DOI 10.1128/CMR.13.4.686-707.2000.
   Clark RP, 2009, J R SOC INTERFACE, V6, pS767, DOI 10.1098/rsif.2009.0236.focus.
   Donskey CJ, 2010, CLIN INFECT DIS, V50, P1458, DOI 10.1086/652649.
   Drees M, 2008, CLIN INFECT DIS, V46, P678, DOI 10.1086/527394.
   French GL, 2005, ADV DRUG DELIVER REV, V57, P1514, DOI 10.1016/j.addr.2005.04.005.
   Hardy KJ, 2006, INFECT CONT HOSP EP, V27, P127, DOI 10.1086/500622.
   Hayden MK, 2008, INFECT CONT HOSP EP, V29, P149, DOI 10.1086/524331.
   Hayden MK, 2006, CLIN INFECT DIS, V42, P1552, DOI 10.1086/503845.
   Hegstad K, 2010, CLIN MICROBIOL INFEC, V16, P541, DOI 10.1111/j.1469-0691.2010.03226.x.
   Hota B, 2009, J HOSP INFECT, V71, P123, DOI 10.1016/j.jhin.2008.10.030.
   Huang SS, 2007, J INFECT DIS, V195, P339, DOI 10.1086/510624.
   JETT BD, 1994, CLIN MICROBIOL REV, V7, P462.
   Jones AM, 2003, THORAX, V58, P525, DOI 10.1136/thorax.58.6.525.
   Kaufmann ME, 1998, METH MOLEC MED, V15, P33, DOI 10.1385/0-89603-498-4:33.
   Kawalec M, 2007, CLIN MICROBIOL INFEC, V13, P893, DOI 10.1111/j.1469-0691.2007.01774.x.
   KORTEN V, 1993, CURR OPIN INFECT DIS, V6, P498, DOI 10.1097/00001432-199308000-00002.
   Moore G, 2006, J HOSP INFECT, V64, P379, DOI 10.1016/j.jhin.2006.08.006.
   Pittet D, 2005, LANCET, V366, P1246, DOI 10.1016/S0140-6736(05)67506-X.
   Rampling A, 2001, J HOSP INFECT, V49, P109, DOI 10.1053/jhin.2001.1013.
   Shiomori T, 2002, J HOSP INFECT, V50, P30, DOI 10.1053/jhin.2001.1136.
   Shiomori T, 2001, ARCH OTOLARYNGOL, V127, P644, DOI 10.1001/archotol.127.6.644.
   Suppola JP, 1999, J CLIN MICROBIOL, V37, P3934.
   TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233.
   Wendt C, 1998, J CLIN MICROBIOL, V36, P3734.
   WESTWOOD JC, 1971, APPL MICROBIOL, V21, P693.
   Wilson APR, 2011, CRIT CARE MED, V39, P651, DOI 10.1097/CCM.0b013e318206bc66.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{13}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{31}},
Journal-ISO = {{Am. J. Infect. Control}},
Doc-Delivery-Number = {{063FC}},
Unique-ID = {{ISI:000312980600012}},
DA = {{2018-08-13}},
}

@article{ ISI:000312887200005,
Author = {Josseaume, Julien and Verner, Laurent and Brady, William J. and
   Duchateau, Francois-Xavier},
Title = {{Multidrug-Resistant Bacteria Among Patients Treated in Foreign
   Hospitals: Management Considerations During Medical Repatriation}},
Journal = {{JOURNAL OF TRAVEL MEDICINE}},
Year = {{2013}},
Volume = {{20}},
Number = {{1}},
Pages = {{22-28}},
Month = {{JAN-FEB}},
Abstract = {{Background The repatriation of patients from foreign hospitals can
   foster the emergence and spread of multidrug-resistant bacteria (MRB).
   We aimed to evaluate the incidence of MRB in patients treated in foreign
   hospitals and repatriated by international inter-hospital air transport
   in order to better manage these patients and adjust our procedures.
   Methods The records from all consecutive aeromedical evacuations and
   overseas repatriations carried out by Mondial Assistance France between
   December 2010 and November 2011 were reviewed for this study. Only
   inter-hospital transfers with inpatient destination of an acute care
   unit were considered. Patients were allocated to one of two groups:
   those identified as MRB carriers at their arrival in France and those
   who were not identified as such (either negative for MRB or not tested).
   Data were compared between the two groups. Results Analysis was
   performed on 223 patients: 16 patients (7\%) were identified as MRB
   carriers. Compared with confirmed non-MRB patients, MRB carriers came
   more frequently from a high-risk unit (88\% vs 59\%, p?=?0.05) and had a
   longer foreign hospital stay {[}13 (320) vs 8 (614)?d, p?=?0.01].
   Conclusions The occurrence of MRB among patients repatriated from
   foreign hospitals is noted in a significant minority of such individuals
   transferred back to their home country. The typical MRB patient was
   admitted to a high-risk unit in a foreign hospital prior to repatriation
   with longer foreign hospital admissions. The prospective identification
   of these patients prior to transport is difficult. While these factors
   are associated with MRB presence, their absence does not rule out highly
   resistant bacterial colonization. A systematic review of this important
   medical issue is warranted with the development of guidelines.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Duchateau, FX (Reprint Author), Mondial Assistance France, Dept Med, 2 Rue Fragonard, F-75017 Paris, France.
   Josseaume, Julien; Verner, Laurent; Duchateau, Francois-Xavier, Mondial Assistance France, Dept Med, F-75017 Paris, France.
   Allianz Global Assistance, Dept Med, Richmond, VA USA.
   Brady, William J., Allianz Global Assistance, Dept Med, Kitchener, ON, Canada.
   Brady, William J., Univ Virginia, Dept Emergency Med, Charlottesville, VA USA.}},
DOI = {{10.1111/j.1708-8305.2012.00668.x}},
ISSN = {{1195-1982}},
EISSN = {{1708-8305}},
Keywords-Plus = {{AEROMEDICAL EVACUATION; TOURISM; FRANCE; RISK; KPC}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases;
   General \& Internal Medicine}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases;
   Medicine, General \& Internal}},
Author-Email = {{francois-xavier.duchateau@mondial-assistance.fr}},
Cited-References = {{{[}Anonymous], 2009, Bull Am Coll Surg, V94, P26.
   Birgand G, 2010, EUROSURVEILLANCE, V15, P8.
   Carbonne A, 2010, EUROSURVEILLANCE, V15, P11.
   Carrera Percivil M, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P447, DOI 10.1586/14737167.6.4.447.
   Duchateau Francois-Xavier, 2012, Air Med J, V31, P92, DOI 10.1016/j.amj.2011.05.006.
   Duchateau FX, 2009, J TRAVEL MED, V16, P391, DOI 10.1111/j.1708-8305.2009.00340.x.
   Fischer D, 2004, J TRAVEL MED, V11, P44, DOI 10.2310/7060.2004.13647.
   Haut Conseil de la Sante Publique, 2010, COMM SPEC SEC PAT IN.
   Hopkins L, 2010, J PUBLIC HEALTH POL, V31, P185, DOI 10.1057/jphp.2010.10.
   Kaiser AM, 2004, CLIN MICROBIOL INFEC, V10, P972, DOI 10.1111/j.1469-0691.2004.01000.x.
   Lepelletier D, 2011, J TRAVEL MED, V18, P344, DOI 10.1111/j.1708-8305.2011.00547.x.
   Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255.
   Lunt N, 2010, MATURITAS, V66, P27, DOI 10.1016/j.maturitas.2010.01.017.
   Naas T, 2005, ANTIMICROB AGENTS CH, V49, P4423, DOI 10.1128/AAC.49.10.4423-4424.2005.
   Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4.
   Poirel L, 2007, FUTURE MICROBIOL, V2, P501, DOI 10.2217/17460913.2.5.501.
   Reed CM, 2008, MED CLIN N AM, V92, P1433, DOI 10.1016/j.mcna.2008.08.001.
   Rogers BA, 2011, CLIN INFECT DIS, V53, P49, DOI 10.1093/cid/cir273.
   Teichman PG, 2007, NEW ENGL J MED, V356, P262, DOI 10.1056/NEJMra063651.
   Vaux S, 2011, EUROSURVEILLANCE, V16, P11.
   Woodford N, 2011, J TRAVEL MED, V18, P297, DOI 10.1111/j.1708-8305.2011.00541.x.}},
Number-of-Cited-References = {{21}},
Times-Cited = {{10}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{5}},
Journal-ISO = {{J. Travel Med.}},
Doc-Delivery-Number = {{061YW}},
Unique-ID = {{ISI:000312887200005}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000312784900002,
Author = {Chapman, Russell Leonard},
Title = {{Algae: the world's most important ``plants{''}-an introduction}},
Journal = {{MITIGATION AND ADAPTATION STRATEGIES FOR GLOBAL CHANGE}},
Year = {{2013}},
Volume = {{18}},
Number = {{1, SI}},
Pages = {{5-12}},
Month = {{JAN}},
Abstract = {{Early in the history of life, algae changed the planet's atmosphere by
   producing oxygen, thus paving the way for the evolution of eukaryotic
   organisms. In an era in which the consumption of fossil fuels is a prime
   topic of concern, few people realize that the oil we currently exploit
   comes mostly from Cretaceous deposits of marine algae. Moving from
   ancient times to the present, the algae remain more important than most
   people realize. Today, the production of oxygen by algae (ca. 50\% of
   all oxygen production) is another reason for saying ``our lives depend
   on algae.{''} Those who love seafood should thank the algae because
   algae are the primary producers upon which aquatic ecosystems depend.
   Thanks should come from all who are vegetarians or omnivores, because
   all land plants derive from a freshwater class of green algae and all
   land-animals-including the cows that provide the steaks for
   meat-lovers-depend directly or indirectly on land plants for food and
   often for shelter as well. As we use up the oil deposits provided by the
   ancient algae, we are turning to the modern algae for help. Given the
   photosynthetic abilities of the algae, they are one of the major focuses
   for sustainable biofuel production and CO2 consumption. Finally, the
   algae that give us the air we breathe, the food we eat, and the fuel for
   our cars (past and, perhaps, future), are also a source of active
   pharmaceutical compounds that can be used against drug-resistant
   bacterial strains, viruses (including Herpes Simplex and AIDS), and
   cancers. Roses are pretty and oak trees are impressive, but no other
   groups of ``plants{''} have done so much, for so long, and, for so many
   as have the algae!.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chapman, RL (Reprint Author), Univ Calif San Diego, Ctr Marine Biodivers \& Conservat, Scripps Inst Oceanog MC 0202, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   Chapman, Russell Leonard, Univ Calif San Diego, Ctr Marine Biodivers \& Conservat, Scripps Inst Oceanog MC 0202, La Jolla, CA 92093 USA.
   Chapman, Russell Leonard, Louisiana State Univ, Dept Oceanog \& Coastal Sci, Baton Rouge, LA 70803 USA.}},
DOI = {{10.1007/s11027-010-9255-9}},
ISSN = {{1381-2386}},
Keywords = {{Algae; Biofuels; Food; Oxygen; Pharmaceuticals; Land plant evolution;
   Sustainable fuels}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{rchapman@ucsd.edu}},
Cited-References = {{Graham L.E., 2000, ALGAE.
   Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5.
   Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587.
   Lee RE, 2008, PHYCOLOGY.
   Mann DG, 2010, ALGAE INTRO PHYCOLOG.
   Meinesz Alexandre, 2001, Biological Invasions, V3, P201, DOI 10.1023/A:1014549500678.
   Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884.}},
Number-of-Cited-References = {{7}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{126}},
Journal-ISO = {{Mitig. Adapt. Strateg. Glob. Chang.}},
Doc-Delivery-Number = {{060NL}},
Unique-ID = {{ISI:000312784900002}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000313467100005,
Author = {Papiashvili, Michael and Bar, Ilan and Sasson, Lior and Lidji, Moshe and
   Litman, Klementy and Hendler, Atara and Polanski, Vladimir and Treizer,
   Leiv and Bendayan, Daniele},
Title = {{Pulmonary Resection for Multidrug-Resistant Tuberculosis: The Israeli
   Experience (1998-2011)}},
Journal = {{ISRAEL MEDICAL ASSOCIATION JOURNAL}},
Year = {{2012}},
Volume = {{14}},
Number = {{12}},
Pages = {{733-736}},
Month = {{DEC}},
Abstract = {{Background: Multidrug-resistant tuberculosis (MDR-TB) presents a
   difficult therapeutic problem due to the failure of medical treatment.
   Pulmonary resection is an important adjunctive therapy for selected
   patients with MDR-TB.
   Objectives: To assess the efficacy of pulmonary resection in the
   management of MDR-TB patients.
   Methods: We retrospectively reviewed the charts of MDR-TB patients
   referred for major pulmonary resections as part of a treatment strategy.
   The operations were performed in the departments of thoracic surgery at
   Assaf Harofeh and Wolfson Medical Centers. For the period under study,
   13 years (1998 2011), we analyzed patients' medical history,
   bacteriological, medical and surgical data, morbidity, mortality, and
   short-term and long-term outcome.
   Results: We identified 19 pulmonary resections (8 pneumonectomies, 4
   lobectomies, 1 segmentectomy, 6 wedge resections) from among 17
   patients, mostly men, with a mean age of 32.9 years (range 18-61 years).
   Postoperative complications developed in six patients (35.3\%)
   (broncho-pleural fistula in one, empyema in two, prolonged air leak in
   two, and acute renal failure in one). Only one patient (5.8\%) died
   during the early postoperative period, three (17.6\%) in the late
   postoperative period, and one within 2 years after the resection. Of 12
   survivors, 9 were cured, 2 are still under medical treatment, and 1 is
   lost from follow-up because of poor compliance.
   Conclusions: Pulmonary resection for MDR-TB patients is an effective
   adjunctive treatment with acceptable morbidity and mortality. IMAJ 2012;
   14:733-736}},
Publisher = {{ISRAEL MEDICAL ASSOC JOURNAL}},
Address = {{2 TWIN TOWERS, 11TH FL, 35 JABOTINSKY ST, PO BOX 3604, RAMAT GAN 52136,
   ISRAEL}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Papiashvili, M (Reprint Author), Wolfson Med Ctr, Dept Cardiothorac Surg, POB 5, IL-58100 Holon, Israel.
   Papiashvili, Michael; Sasson, Lior, Wolfson Med Ctr, Dept Cardiothorac Surg, IL-58100 Holon, Israel.
   Papiashvili, Michael; Bar, Ilan, Assaf Harofeh Med Ctr, Dept Thorac Surg, IL-70300 Zerifin, Israel.
   Lidji, Moshe; Litman, Klementy; Hendler, Atara; Polanski, Vladimir; Treizer, Leiv; Bendayan, Daniele, TB Prevent \& Control Clin, Tel Aviv, Israel.
   Lidji, Moshe; Litman, Klementy; Hendler, Atara; Polanski, Vladimir; Treizer, Leiv; Bendayan, Daniele, Shmuel Harofeh Hosp, Dept Pulm Med \& TB, Beer Yaagov, Israel.
   Papiashvili, Michael; Bar, Ilan; Sasson, Lior; Lidji, Moshe; Litman, Klementy; Hendler, Atara; Polanski, Vladimir; Treizer, Leiv; Bendayan, Daniele, Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel.}},
ISSN = {{1565-1088}},
Keywords = {{multidrug-resistant tuberculosis (MDR-TB); pneumonectomy; pulmonary
   resection; lobectomy; tuberculosis}},
Keywords-Plus = {{SURGERY; PNEUMONECTOMY; MANAGEMENT; CURE}},
Research-Areas = {{General \& Internal Medicine}},
Web-of-Science-Categories  = {{Medicine, General \& Internal}},
Author-Email = {{drmishapapi@yahoo.com}},
Cited-References = {{{[}Anonymous], WHOHTMTB20103.
   Bendayan D, 2011, EUR J CLIN MICROBIOL, V30, P375, DOI 10.1007/s10096-010-1096-7.
   Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-11590C.
   Chiang CY, 2009, INT J TUBERC LUNG D, V13, P304.
   Deschamps C, 2001, ANN THORAC SURG, V72, P243, DOI 10.1016/S0003-4975(01)02681-9.
   Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3.
   Kir A, 2006, J THORAC CARDIOV SUR, V131, P693, DOI 10.1016/j.jtcvs.2005.09.033.
   Mohsen T, 2007, J THORAC CARDIOV SUR, V134, P194, DOI 10.1016/j.jtcvs.2007.03.022.
   Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6.
   Park SK, 2002, INT J TUBERC LUNG D, V6, P143.
   Shiraishi Y, 2004, J THORAC CARDIOV SUR, V128, P523, DOI 10.1016/j.jtcvs.2004.06.012.
   Somocurcio JG, 2007, THORAX, V62, P416, DOI 10.1136/thx.2005.051961.
   Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008.
   Sung SW, 1999, EUR J CARDIO-THORAC, V16, P187, DOI 10.1016/S1010-7940(99)00158-X.
   Tahaoglu K, 2001, NEW ENGL J MED, V345, P170, DOI 10.1056/NEJM200107193450303.
   Takeda S, 2005, ANN THORAC SURG, V79, P959, DOI 10.1016/j.athoracsur.2004.09.007.
   Torun T, 2007, INT J TUBERC LUNG D, V11, P979.
   Wang HF, 2008, ANN THORAC SURG, V86, P1640, DOI 10.1016/j.athoracsur.2008.07.056.
   Yaldiz S, 2011, ANN THORAC CARDIOVAS, V17, P142.
   Yew WW, 2008, RESPIROLOGY, V13, P21, DOI 10.1111/j.1440-1843.2007.01180.x.}},
Number-of-Cited-References = {{20}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Isr. Med. Assoc. J.}},
Doc-Delivery-Number = {{069WF}},
Unique-ID = {{ISI:000313467100005}},
DA = {{2018-08-13}},
}

@article{ ISI:000312750500008,
Author = {Liu, Hua and Wang, Shudong},
Title = {{Preparation of the Cotton Fabric with Ultraviolet Resistance and
   Antibacterial Activity Using Nano Attapulgite Colloidal Particles}},
Journal = {{FIBERS AND POLYMERS}},
Year = {{2012}},
Volume = {{13}},
Number = {{10}},
Pages = {{1272-1279}},
Month = {{DEC}},
Abstract = {{A carefully designed surface modification technique for the preparation
   of multifunctional cotton fabric was successfully developed by the
   functionalization of cotton fabric with nano attapulgite (ATP) colloidal
   particles. The dispersion of the nano ATP colloidal particles, the
   morphology, microstructure, thermal stability, ultraviolet resistance,
   antibacterial activity and air permeability of the treated cotton fabric
   were characterized. The results showed that the particle size of the ATP
   particle distributed between 100 nm to 150 nm after dispersion. The SEM
   (scanning electron microscopy) and FTIR (Fourier transform infrared
   spectra) analysis demonstrated that the ATP particles were successfully
   introduced to surface of the cotton fabric. The structural and thermal
   stability of the treated fabric were higher than those of the untreated
   fabric. The ATP treated cotton fabric possessed excellent ultraviolet
   resistance and antibacterial activity. Furthermore, the treatment did
   not affect the wear ability of the cotton fabric. The multifunctional
   cotton fabric meets the market demand for natural products.}},
Publisher = {{KOREAN FIBER SOC}},
Address = {{KOREA SCIENCE TECHNOLOGY CTR \#501 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wang, SD (Reprint Author), Yancheng Coll Text Vocat Technol, Dept Text Engn, Yancheng 224005, Peoples R China.
   Liu, Hua; Wang, Shudong, Yancheng Coll Text Vocat Technol, Dept Text Engn, Yancheng 224005, Peoples R China.
   Liu, Hua; Wang, Shudong, Yancheng Coll Text Vocat Technol, Jiangsu R\&D Ctr Ecol Text Engn \& Technol, Yancheng 224005, Peoples R China.}},
DOI = {{10.1007/s12221-012-1272-8}},
ISSN = {{1229-9197}},
EISSN = {{1875-0052}},
Keywords = {{Attapulgite; Ultraviolet resistance; Antibacterial properties;
   Fluorescence spectrum; Cotton fabric; Microstructure}},
Keywords-Plus = {{CLAY; NANOCOMPOSITES; COMPOSITES; PROTECTION; SURFACES; POLYMER; FINISH}},
Research-Areas = {{Materials Science; Polymer Science}},
Web-of-Science-Categories  = {{Materials Science, Textiles; Polymer Science}},
Author-Email = {{sdwang1983@163.com}},
Funding-Acknowledgement = {{cooperative innovation in the trinity of enterprises, campuses and
   research institutes in Jiangsu Province, China {[}BY2010129]}},
Funding-Text = {{This research was funded by the cooperative innovation in the trinity of
   enterprises, campuses and research institutes in Jiangsu Province, China
   (BY2010129). And we were also indebted to the Testing Center of Soochow
   University and Yancheng Textile Vocational Technology College for
   experimental support.}},
Cited-References = {{Bang ES, 2007, J APPL POLYM SCI, V106, P938, DOI 10.1002/app.26789.
   Bradley WF, 1940, AM MINERAL, V25, P405.
   Chen ZH, 2010, TEXT RES J, V80, P1982, DOI 10.1177/0040517510373631.
   Cheng XH, 2004, APPL CLAY SCI, V25, P179, DOI 10.1016/j.clay.2003.11.002.
   Esmaeili E, 2009, J EUR CERAM SOC, V29, P1061, DOI 10.1016/j.jeurceramsoc.2008.07.051.
   Gao Y, 2008, TEXT RES J, V78, P60, DOI 10.1177/0040517507082332.
   Ghannam L, 2004, POLYMER, V45, P7035, DOI 10.1016/j.polymer.2004.08.002.
   Guerra DL, 2011, J HAZARD MATER, V186, P675, DOI 10.1016/j.jhazmat.2010.11.054.
   LAVIE S, 1986, APPL ENVIRON MICROB, V51, P74.
   Li GH, 2011, J COLLOID INTERF SCI, V358, P307, DOI 10.1016/j.jcis.2011.02.053.
   Lim SH, 2004, CARBOHYD POLYM, V56, P227, DOI 10.1016/j.carbpol.2004.02.005.
   {[}林鹤鸣 LIN Heming], 2009, {[}纺织学报, Journal of Textile Research], V30, P95.
   Loo LS, 2004, POLYMER, V45, P5933, DOI 10.1016/j.polymer.2004.06.025.
   Lu ZZ, 2009, POWDER TECHNOL, V196, P122, DOI 10.1016/j.powtec.2009.07.006.
   Pan BL, 2006, POLYM TEST, V25, P384, DOI 10.1016/j.polymertesting.2005.11.012.
   Pan HX, 2007, EUR POLYM J, V43, P3766, DOI 10.1016/j.eurpolymj.2007.06.031.
   Shafei A.E., 2011, CARBOHYD POLYM, V83, P920.
   Shen L, 2005, POLYMER, V46, P5758, DOI 10.1016/j.polymer.2005.05.040.
   Su FH, 2008, WEAR, V265, P311, DOI 10.1016/j.wear.2007.10.013.
   Su W, 2009, J HAZARD MATER, V172, P716, DOI 10.1016/j.jhazmat.2009.07.056.
   Ugur SS, 2011, FIBER POLYM, V12, P190, DOI 10.1007/s12221-011-0190-5.
   Wang ZQ, 2010, MATER LETT, V64, P908, DOI 10.1016/j.matlet.2010.01.055.
   Wang ZQ, 2009, J SOLID STATE CHEM, V182, P2130, DOI 10.1016/j.jssc.2009.05.040.
   Xu JM, 2007, J COLLOID INTERF SCI, V315, P170, DOI 10.1016/j.jcis.2007.06.059.
   Xue AL, 2011, J HAZARD MATER, V194, P7, DOI 10.1016/j.jhazmat.2011.06.018.
   Zhang F, 2009, CELLULOSE, V16, P281, DOI 10.1007/s10570-008-9253-1.
   Zhang JP, 2006, CARBOHYD POLYM, V65, P150, DOI 10.1016/j.carbpol.2005.12.035.
   Zohdy MH, 2009, EUR POLYM J, V45, P2926, DOI 10.1016/j.eurpolymj.2009.06.018.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{37}},
Journal-ISO = {{Fiber. Polym.}},
Doc-Delivery-Number = {{060BI}},
Unique-ID = {{ISI:000312750500008}},
DA = {{2018-08-13}},
}

@article{ ISI:000312457900021,
Author = {Thiyagarajan, Magesh and Sarani, Abdollah and Gonzales, Xavier},
Title = {{Characterization of Portable Resistive Barrier Plasma Jet and Its Direct
   and Indirect Treatment for Antibiotic Resistant Bacteria and THP-1
   Leukemia Cancer Cells}},
Journal = {{IEEE TRANSACTIONS ON PLASMA SCIENCE}},
Year = {{2012}},
Volume = {{40}},
Number = {{12, 3}},
Pages = {{3533-3545}},
Month = {{DEC}},
Abstract = {{An atmospheric pressure nonthermal resistive barrier plasma (RBP) jet
   was designed, constructed, and characterized for plasma surface
   treatment procedures applied in biomedical applications. The RBP source
   can operate in both dc (battery) and standard 60/50-Hz low-frequency ac
   excitation and can function effectively in both direct and indirect
   plasma exposure configurations, depending on the type of treatment
   targets and applications. The design and construction aspects of the RBP
   source are presented, including the electrode configuration, electrical,
   cooling, and gas flow aspects. The RBP jet is tested, and its
   characteristics such as the propagation velocity of the plasma jet,
   electrical properties, plasma gas temperature, and nitric oxide
   concentration are characterized using optical laser plasma shadowgraphy,
   voltage-current characterization, optical emission spectroscopy (OES),
   and gas analyzer diagnostic measurements, respectively. Using a laser
   shadowgraphy diagnostic, we have measured the average propagation
   velocity of the plasma jet to be 150-200 m/s at 1 cm from the probe end.
   The discharge power is calculated from voltage-current characterization,
   and the plasma power is 26.33 W. An OES was applied, and the gas
   temperature which is equivalent to the nitrogen rotational (Trot)
   temperatures was measured. After approximately 2 cm from the tip, along
   the axis, the plasma emission drops, and the high-temperature ceramic
   fiber-insulated-wire thermocouple probe was used to measure the
   temperatures of the gas flows along the downstream jet. The addition of
   a small portable external cooling unit has brought the temperatures of
   reactive oxygen species (ROS) and other gases close to room temperature
   at the tip of the handheld plasma source unit. The concentrations of the
   ROS at different spatial distances from the tip of the plasma jet were
   measured; at a 5-cm distance from the electrode, the nitric oxide level
   was measured to be in the range of 500-660 ppm, and it drops to similar
   to 100 ppm at 60 cm. The parts-per-million values of nitric oxides after
   the cooling unit are observed to be of the same order of magnitude as
   compared to that of the plasma jet. The portable RBP source was tested
   to be very effective for the decontamination and disinfection of a wide
   range of food-borne and opportunistic nosocomial pathogens such as
   Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and
   Bacillus cereus, and the preliminary results are presented. The effects
   of the indirect exposure of the portable RBP source on monocytic
   leukemia cancer cells (THP-1) were also tested, and the results
   demonstrate a preference for apoptosis in plasma-treated THP-1 cells
   under particular plasma parameters and dosage levels.}},
Publisher = {{IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC}},
Address = {{445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Thiyagarajan, M (Reprint Author), Texas A\&M Univ, PERL, Coll Sci \& Engn, Corpus Christi, TX 78412 USA.
   Thiyagarajan, Magesh; Sarani, Abdollah; Gonzales, Xavier, Texas A\&M Univ, PERL, Coll Sci \& Engn, Corpus Christi, TX 78412 USA.}},
DOI = {{10.1109/TPS.2012.2222391}},
ISSN = {{0093-3813}},
EISSN = {{1939-9375}},
Keywords = {{Air plasma; atmospheric pressure plasma; bacteria; biomedical; cancer;
   medicine; plasma jet; resistive barrier plasma (RBP)}},
Keywords-Plus = {{ATMOSPHERIC-PRESSURE; NONTHERMAL PLASMA; SURFACE-TREATMENT; AIR;
   DISCHARGE; LASER; MEDICINE; NEEDLE; VOCS; MICRODISCHARGES}},
Research-Areas = {{Physics}},
Web-of-Science-Categories  = {{Physics, Fluids \& Plasmas}},
Author-Email = {{magesh@tamucc.edu}},
Funding-Acknowledgement = {{College of Science and Engineering, School of Engineering and Computing
   Sciences, Texas A\&M University-Corpus Christi; Texas Research and
   Development Fund; Department of Defense/Army {[}W81XWH-10-1-0923]}},
Funding-Text = {{This work was supported in part by the College of Science and
   Engineering, School of Engineering and Computing Sciences, Texas A\&M
   University-Corpus Christi, by the Texas Research and Development Fund,
   and by the Department of Defense/Army Grant W81XWH-10-1-0923
   administered by the U. S. Army Medical Research and Materiel Command and
   the Telemedicine and Advanced Technology Research Center at Fort
   Detrick, MD.}},
Cited-References = {{Akhtar K, 2003, AIP CONF PROC, V694, P411.
   Akishev Y, 2002, PLASMAS POLYM, V7, P261, DOI 10.1023/A:1019990508769.
   Bussiahn R, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3380811.
   CHAN CH, 1973, J APPL PHYS, V44, P1179, DOI 10.1063/1.1662325.
   Chen HL, 2009, ENVIRON SCI TECHNOL, V43, P2216, DOI 10.1021/es802679b.
   Cheruthazhekatt S, 2010, J APPL BIOMED, V8, P55, DOI 10.2478/v10136-009-0013-9.
   Chu PK, 2009, IEEE T PLASMA SCI, V37, P1121, DOI 10.1109/TPS.2009.2023549.
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s.
   Ferreira CM, 2012, CHEM PHYS, V398, P248, DOI 10.1016/j.chemphys.2011.05.024.
   Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154.
   Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4.
   Futamura S, 1997, J ELECTROSTAT, V42, P51, DOI 10.1016/S0304-3886(97)00142-3.
   Futamura S, 2000, IEEE T IND APPL, V36, P1507, DOI 10.1109/28.887200.
   Gaunt LF, 2006, IEEE T PLASMA SCI, V34, P1257, DOI 10.1109/TPS.2006.878381.
   Hayashi N, 2008, IEEE T PLASMA SCI, V36, P1302, DOI 10.1109/TPS.2008.924453.
   Heinlin J, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2010.03702.x.
   Helfritch D. J., 2000, SURF COAT TECH, V131, P528.
   Hensel K, 2005, IEEE T PLASMA SCI, V33, P574, DOI 10.1109/TPS.2005.845389.
   HUTCHINSON H, 2002, PRINCIPLES PLASMA DI, P6.
   Indarto A, 2008, IEEE T DIELECT EL IN, V15, P1038, DOI 10.1109/TDEI.2008.4591225.
   Johnson VS, 2011, IEEE T PLASMA SCI, V39, P2360, DOI 10.1109/TPS.2011.2160737.
   Karakas E, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3499277.
   Kim HH, 2004, PLASMA PROCESS POLYM, V1, P91, DOI 10.1002/ppap.200400028.
   Knorr D, 2011, ANNU REV FOOD SCI T, V2, P203, DOI 10.1146/annurev.food.102308.124129.
   Kolb JF, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2940325.
   KOVACIC N, 1985, SPECTROCHIM ACTA B, V40, P943, DOI 10.1016/0584-8547(85)80065-3.
   Laroussi M, 2002, IEEE T PLASMA SCI, V30, P158, DOI 10.1109/TPS.2002.1003972.
   Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220.
   Laroussi M, 2006, PLASMA PROCESS POLYM, V3, P470, DOI 10.1002/ppap.200600005.
   Laux CO, 2003, PLASMA SOURCES SCI T, V12, P125, DOI 10.1088/0963-0252/12/2/301.
   Lee TI, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2150274.
   Li XC, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3476899.
   LOEB LB, 1948, J APPL PHYS, V19, P882, DOI 10.1063/1.1697894.
   Lu X, 2009, APPL PHYS LETT, V95, p181 501.
   Massines F, 1998, J PHYS D APPL PHYS, V31, P3411, DOI 10.1088/0022-3727/31/24/003.
   Mekki M, 2009, J MED DEVICES, V3, DOI 10.1115/1.3081394.
   Misra NN, 2011, FOOD ENG REV, V3, P159, DOI 10.1007/s12393-011-9041-9.
   Moreau S, 2000, J APPL PHYS, V88, P1166, DOI 10.1063/1.373792.
   NUNEZ CM, 1993, J AIR WASTE MANAGE, V43, P242.
   Oda T, 2003, J ELECTROSTAT, V57, P293, DOI 10.1016/S0304-3886(02)00179-1.
   Perni S, 2008, J FOOD PROTECT, V71, P1619, DOI 10.4315/0362-028X-71.8.1619.
   Sakiyama Y, 2006, J PHYS D APPL PHYS, V39, P3644, DOI 10.1088/0022-3727/39/16/018.
   Sankaran RM, 2001, APPL PHYS LETT, V79, P593, DOI 10.1063/1.1388867.
   Sarani A, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3439685.
   Schutze A, 1998, IEEE T PLASMA SCI, V26, P1685, DOI 10.1109/27.747887.
   Settles G. S, 2001, SCHLIEREN SHADOWGRAP.
   Skalska K, 2010, SCI TOTAL ENVIRON, V408, P3976, DOI 10.1016/j.scitotenv.2010.06.001.
   SNYDER SC, 1993, PHYS REV E, V47, P1996, DOI 10.1103/PhysRevE.47.1996.
   Stoffels E, 2006, PLASMA SOURCES SCI T, V15, P501, DOI 10.1088/0963-0252/15/3/028.
   Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304.
   STROBEL JM, 1991, J ADHES SCI TECHNOL, V5, P119, DOI 10.1163/156856191X00080.
   Stryczewska HD, 2009, PRZ ELEKTROTECHNICZN, V85, P83.
   Thiyagarajan M, 2005, IEEE T PLASMA SCI, V33, P322, DOI 10.1109/TPS.2005.845938.
   Thiyagarajan M., 2004, IEEE Conference Record - Abstracts. 31st IEEE International Conference On Plasma Science (IEEE Cat. No.04CH37537).
   Thiyagarajan M, 2011, P INT C MED PHYS BIO.
   Thiyagarajan M, 2011, P IEEE 18 INT PULS P, VIL.
   Thiyagarajan M, 2012, HLTH TECHNOL INFORM, V173, P518.
   Thiyagarajan M, 2011, P ASME EM TECHN 6 FR.
   Thiyagarajan M, 2003, P GAS EL C AM PHYS S.
   Thiyagarajan M, 2012, HLTH TECHNOL INFORM, V173, P515.
   Thiyagarajan M, 2011, P IEEE 38 ICOPS 24 S, P1.
   Thiyagarajan M, 2011, P 38 IEEE ICOPS 24 S.
   Thiyagarajan M, 2008, IEEE T PLASMA SCI, V36, P2512, DOI 10.1109/TPS.2008.2004259.
   Thiyagarajan M, 2008, J APPL PHYS, V104, DOI 10.1063/1.2952540.
   Van Poucke GE, 2004, IEEE T BIO-MED ENG, V51, P1869, DOI 10.1109/TBME.2004.827935.
   Vidal G, 2011, P SACNAS NAT C SAN J.
   Villagran-Muniz M, 2001, IEEE T PLASMA SCI, V29, P613, DOI 10.1109/27.940956.
   Yan X, 2010, IEEE T PLASMA SCI, V38, P2451, DOI 10.1109/TPS.2010.2056393.
   Yardimci O, 2010, IEEE T PLASMA SCI, V38, P973, DOI 10.1109/TPS.2010.2041674.
   Yu BF, 2009, INT J REFRIG, V32, P3, DOI 10.1016/j.ijrefrig.2008.05.004.}},
Number-of-Cited-References = {{70}},
Times-Cited = {{7}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{53}},
Journal-ISO = {{IEEE Trans. Plasma Sci.}},
Doc-Delivery-Number = {{055ZY}},
Unique-ID = {{ISI:000312457900021}},
DA = {{2018-08-13}},
}

@article{ ISI:000311588100009,
Author = {Naidoo, S. and Seevnarain, K. and Nordstrom, D. L.},
Title = {{Tuberculosis infection control in primary health clinics in eThekwini,
   KwaZulu-Natal, South Africa}},
Journal = {{INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE}},
Year = {{2012}},
Volume = {{16}},
Number = {{12}},
Pages = {{1600-1604}},
Month = {{DEC}},
Abstract = {{SETTING: Primary health clinics in KwaZulu-Natal, South Africa.
   OBJECTIVE: To assess and describe current practices in infection control
   at local government primary health clinics.
   DESIGN: A descriptive study using a standardised tool to assess
   adherence to recommended infection control policies in 51 primary health
   clinics in 2009-2010. Administrative policies, engineering controls and
   personal respiratory protection were assessed by observations and
   interviews at the clinics.
   RESULTS: Of 51 clinics, 11(22\%) had infection control policies, 13
   (26\%) triaged coughing patients and 16 (31\%) had a dedicated nurse and
   a dedicated consulting room for treating tuberculosis (TB) patients.
   Study clinics treated a median of 99 patients (range 3-331) daily and a
   median of 15 TB patients (range 2-73) monthly. Of the rooms in the
   clinics, all of which rely on natural ventilation, half (149/284) had <=
   5.12 air changes per hour. Eleven (22\%) of 51 clinics had N95 masks
   available for staff use.
   CONCLUSION: Limited infection control practices exist in clinics in a
   high TB burden setting in KwaZulu-Natal, South Africa. These practices
   need to be implemented more widely to minimise the spread of TB to
   non-infected patients and health care workers in primary health clinics.}},
Publisher = {{INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)}},
Address = {{68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Naidoo, S (Reprint Author), Univ KwaZulu Natal, Discipline Occupat \& Environm Hlth, Sch Nursing \& Publ Hlth, Private Bag 7, ZA-4013 Congella, Kwazulu Natal, South Africa.
   Naidoo, S.; Seevnarain, K., Univ KwaZulu Natal, Discipline Occupat \& Environm Hlth, Sch Nursing \& Publ Hlth, ZA-4013 Congella, Kwazulu Natal, South Africa.
   Nordstrom, D. L., Univ Wisconsin, Dept Occupat \& Environm Safety \& Hlth, Whitewater, WI 53190 USA.}},
DOI = {{10.5588/ijtld.12.0041}},
ISSN = {{1027-3719}},
EISSN = {{1815-7920}},
Keywords = {{health care workers; occupational safety; primary health care; infection
   control}},
Keywords-Plus = {{DRUG-RESISTANT TUBERCULOSIS; NOSOCOMIAL TRANSMISSION; CARE WORKERS;
   MULTIDRUG-RESISTANT; MYCOBACTERIUM-TUBERCULOSIS; PREVENTION; TB;
   HOSPITALS; SETTINGS; EFFICACY}},
Research-Areas = {{Infectious Diseases; Respiratory System}},
Web-of-Science-Categories  = {{Infectious Diseases; Respiratory System}},
Author-Email = {{naidoos71@ukzn.ac.za}},
ORCID-Numbers = {{Naidoo, Saloshni/0000-0002-8844-0160}},
Funding-Acknowledgement = {{eThekwini municipality; Danish International Development Agency}},
Funding-Text = {{This project was funded by eThekwini municipality with funds from the
   Danish International Development Agency.}},
Cited-References = {{Agerton T, 1997, JAMA-J AM MED ASSOC, V278, P1073, DOI 10.1001/jama.278.13.1073.
   Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947.
   Bock NN, 2007, J INFECT DIS, V196, pS108, DOI 10.1086/518661.
   Department of Occupational and Environmental Health Nelson R Mandela School of Medicine University of KwaZulu-Natal, 2011, ID OCC RISK TUB PRIM.
   Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC.
   Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068.
   eThekwini Municipality, 2010, INT DEV PLAN 2011 20.
   eThekwini Municipality, 2011, MED TERM EXP FRAM MT.
   Farley JE, 2012, INT J TUBERC LUNG D, V16, P82, DOI 10.5588/ijtld.10.0791.
   FRIDKIN SK, 1995, INFECT CONT HOSP EP, V16, P135.
   Harada N, 2008, JPN J INFECT DIS, V61, P415.
   Jarand J, 2010, TROP MED INT HEALTH, V15, P1179, DOI 10.1111/j.1365-3156.2010.02590.x.
   Kagee A, 2010, J HEALTH PSYCHOL, V15, P1001, DOI 10.1177/1359105310378180.
   MALONEY SA, 1995, ANN INTERN MED, V122, P90, DOI 10.7326/0003-4819-122-2-199501150-00002.
   Mehtar S, 2008, J HOSP INFECT, V69, P321, DOI 10.1016/j.jhin.2008.04.015.
   Mehtar S, 2007, J HOSP INFECT, V66, P65, DOI 10.1016/j.jhin.2007.02.008.
   Mehtar S, 2011, INT J INFECT CONTROL, V7, P2.
   Menzies D, 2007, INT J TUBERC LUNG D, V11, P593.
   O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008.
   Padayatchi N, 2010, INT J TUBERC LUNG D, V14, P960.
   Pillay M, 2010, INT J TUBERC LUNG D, V14, P223.
   Sissolak D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-262.
   South Africa National Department of Health, 2012, NAT STRAT PLAN HIV S.
   Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1.
   Vena V, 2011, MAIL GUARDIAN O 0324.
   Willeke K, 1998, AM J INFECT CONTROL, V26, P139, DOI 10.1016/S0196-6553(98)80033-3.
   Wilson I, 2008, S AFR J EDPIDEMIOL I, V23, P17.
   World Health Organization, 1999, WHOCDSTB99269.
   World Health Organization/Centres for Disease Control and Prevention, 2006, TUB INF CONTR ER EXP.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{22}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{8}},
Journal-ISO = {{Int. J. Tuberc. Lung Dis.}},
Doc-Delivery-Number = {{043ZB}},
Unique-ID = {{ISI:000311588100009}},
DA = {{2018-08-13}},
}

@article{ ISI:000311647700001,
Author = {Vela, Javier and Hildebrandt, Kelsie and Metcalfe, Andrew and Rempel,
   Heidi and Bittman, Shabtai and Topp, Edward and Diarra, Moussa},
Title = {{Characterization of Staphylococcus xylosus isolated from broiler chicken
   barn bioaerosol}},
Journal = {{POULTRY SCIENCE}},
Year = {{2012}},
Volume = {{91}},
Number = {{12}},
Pages = {{3003-3012}},
Month = {{DEC}},
Abstract = {{In this study we isolated and characterized Staphylococcus xylosus, a
   coagulase-negative staphylococcal species considered as commensal and
   one of the prevalent staphylococcal species found in poultry bioaerosol.
   Isolates were obtained using air samplers and selective phenylethyl
   alcohol agar for gram-positive bacteria during 35-d periods at different
   times of the day. A total of 200 colonies were recovered and after basic
   biochemical tests were performed, presumptive staphylococci were
   subsequently identified by API Staph strips. A total of 153 (76.5\%)
   staphylococci were found, among which 84 were S. xylosus (46 and 38
   isolated inside and outside, respectively). Biofilm formation was
   observed in 86.9\% of S. xylosus isolates, whereas 79.8\% of them showed
   hemolytic activity. There was a strong correlation (92.5\%) between
   biofilm formation and hemolytic activity. All 84 S. xylosus isolates
   were susceptible to amikacin, ampicillin/sulbactam, chloramphenicol,
   ciprofloxacin, gentamycin, kanamycin, nezolid,
   trimethoprim/sulfamethoxazole, and vancomycin. Resistance to nalidixic
   acid (86.9\%), novobiocin (85.7\%), penicillin (70.2\%), lincomycin
   (46.4\%), oxacillin (42.9\%), ampicillin (27.4\%), tetracycline
   (21.4\%), erythromycin (11.9\%), bacitracin (10.7\%), and streptomycin
   (2.4\%) was observed among the isolates. Resistance to tetracycline,
   lincomycin, erythromycin, and beta-lactam antibiotics was occasionally
   linked to the tetK, linA, ermB, and blaZ genes, respectively. Random
   amplification of polymorphic DNA results showed similarity of 15 to 99\%
   between isolates collected outside and inside the barn, indicating
   genetic diversity of these isolates. Our study indicates that
   characterization of poultry bioaerosol coagulase-negative staphylococcal
   species such as S. xylosus is necessary for assessing their safety
   status for both poultry and humans.}},
Publisher = {{POULTRY SCIENCE ASSOC INC}},
Address = {{1111 N DUNLAP AVE, SAVOY, IL 61874-9604 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Diarra, M (Reprint Author), Agr \& Agri Food Canada, Pacific Agri Food Res Ctr, Agassiz, BC V0M 1A0, Canada.
   Vela, Javier; Hildebrandt, Kelsie; Metcalfe, Andrew; Rempel, Heidi; Bittman, Shabtai; Diarra, Moussa, Agr \& Agri Food Canada, Pacific Agri Food Res Ctr, Agassiz, BC V0M 1A0, Canada.
   Topp, Edward, Agr \& Agri Food Canada, So Crop Protect \& Food Res Ctr, London, ON N5V 4T3, Canada.}},
DOI = {{10.3382/ps.2012-02302}},
ISSN = {{0032-5791}},
Keywords = {{Staphylococcus xylosus; broiler bioaerosol; antimicrobial resistance;
   air microbiology}},
Keywords-Plus = {{COAGULASE-NEGATIVE STAPHYLOCOCCI; GRAM-POSITIVE BACTERIA;
   ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL-RESISTANCE; POULTRY LITTER;
   ENTEROCOCCUS; BIOFILM; GENES; SPP.; SUSCEPTIBILITY}},
Research-Areas = {{Agriculture}},
Web-of-Science-Categories  = {{Agriculture, Dairy \& Animal Science}},
Author-Email = {{moussa.diarra@agr.gc.ca}},
ORCID-Numbers = {{Topp, Ed/0000-0002-8273-9372}},
Funding-Acknowledgement = {{Agriculture and Agri-Food Canada}},
Funding-Text = {{This work was financially supported by Agriculture and Agri-Food Canada.
   We thank G. Block, M. Jackel, and M. Fraser (Pacific Agri-Food Research
   Centre, Agassiz, BC, Canada) for their assistance in this project.
   Pacific Agri-Food Research number 809.}},
Cited-References = {{AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137.
   Bannerman TL, 2003, MANUAL CLIN MICROBIO, P384.
   Baykov B, 1999, FEMS MICROBIOL ECOL, V29, P389, DOI 10.1111/j.1574-6941.1999.tb00629.x.
   Bedidi-Madani N, 1998, VET MICROBIOL, V59, P139, DOI 10.1016/S0378-1135(97)00190-9.
   Brooks JP, 2010, SCI TOTAL ENVIRON, V408, P4770, DOI 10.1016/j.scitotenv.2010.06.038.
   Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003.
   Caierao J, 2006, MEM I OSWALDO CRUZ, V101, P277, DOI 10.1590/S0074-02762006000300009.
   {*}CAN COUNC AN CAR, 1993, GUID CAR US EXP AN, V1.
   Chinivasagam HN, 2009, APPL ENVIRON MICROB, V75, P7417, DOI 10.1128/AEM.01380-09.
   Clinical Laboratory Standards Institute (CLSI), 1999, M31A CLSI NCCLS.
   Diarra MS, 2007, APPL ENVIRON MICROB, V73, P6566, DOI 10.1128/AEM.01086-07.
   Diarra MS, 2010, APPL ENVIRON MICROB, V76, P8033, DOI 10.1128/AEM.01545-10.
   DONHAM KJ, 2000, OCCUP ENVIRON MED, V42, P260.
   Dordet-Frisoni E, 2007, APPL ENVIRON MICROB, V73, P7199, DOI 10.1128/AEM.01629-07.
   Furtula V, 2010, POULTRY SCI, V89, P180, DOI 10.3382/ps.2009-00198.
   HEBERT GA, 1985, J CLIN MICROBIOL, V22, P409.
   Hricak V, 1999, POSTGRAD MED J, V75, P540, DOI 10.1136/pgmj.75.887.540.
   Lai HTL, 2009, POULTRY SCI, V88, P1838, DOI 10.3382/ps.2009-00129.
   Lina G, 1999, ANTIMICROB AGENTS CH, V43, P1062.
   Nandi S, 2004, P NATL ACAD SCI USA, V101, P7118, DOI 10.1073/pnas.0306466101.
   Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174.
   Nawaz MS, 1999, POULTRY SCI, V78, P1191, DOI 10.1093/ps/78.8.1191.
   Nonnenmann MW, 2010, J OCCUP ENVIRON HYG, V7, P693, DOI 10.1080/15459624.2010.526893.
   Oliveira M, 2010, POULTRY SCI, V89, P1065, DOI 10.3382/ps.2008-00436.
   Oppliger A, 2005, ANN OCCUP HYG, V49, P385, DOI 10.1093/annhyg/meh105.
   Oppliger A, 2008, ANN OCCUP HYG, V52, P405, DOI 10.1093/annhyg/men021.
   Orrett F A, 1998, Conn Med, V62, P199.
   Otto M, 2004, FRONT BIOSCI, V9, P841, DOI 10.2741/1295.
   Pinna A, 1999, BRIT J OPHTHALMOL, V83, P771, DOI 10.1136/bjo.83.7.771.
   Planchon S, 2006, INT J FOOD MICROBIOL, V109, P88, DOI 10.1016/j.ijfoodmicro.2006.01.016.
   Popescu S., 2010, ANIM SCI BIOTECHNOL, V43, P119.
   Rantsiou K, 2005, INT J FOOD MICROBIOL, V97, P277, DOI 10.1016/j.ijfoodmicro.2004.02.018.
   Resch M, 2008, INT J FOOD MICROBIOL, V127, P99, DOI 10.1016/j.ijfoodmicro.2008.06.013.
   Rizzotti L, 2005, J FOOD PROTECT, V68, P955, DOI 10.4315/0362-028X-68.5.955.
   Rule Ana M, 2008, J Infect Public Health, V1, P33, DOI 10.1016/j.jiph.2008.08.001.
   SAS, 2000, REL 8 02.
   Scanlan C M, 1989, J Vet Diagn Invest, V1, P170.
   Schnellmann C, 2006, J CLIN MICROBIOL, V44, P4444, DOI 10.1128/JCM.00868-06.
   Sidhu MS, 2007, MICROB DRUG RESIST, V13, P271, DOI 10.1089/mdr.2007.756.
   Simjee S, 2007, AVIAN DIS, V51, P884, DOI 10.1637/7973-032607-REGR.1.
   TSELENISKOTSOWILIS AD, 1982, J CLIN MICROBIOL, V16, P593.
   Vanhee LME, 2008, J MICROBIOL METH, V72, P12, DOI 10.1016/j.mimet.2007.10.004.
   Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001.
   Vucemilo M, 2007, CZECH J ANIM SCI, V52, P170, DOI 10.17221/2318-CJAS.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{7}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{36}},
Journal-ISO = {{Poult. Sci.}},
Doc-Delivery-Number = {{044TX}},
Unique-ID = {{ISI:000311647700001}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000314083300023,
Author = {Mohammadi, J. Sariya and Dhanashree, B.},
Title = {{Streptococcus pseudopneumoniae: an emerging respiratory tract pathogen}},
Journal = {{INDIAN JOURNAL OF MEDICAL RESEARCH}},
Year = {{2012}},
Volume = {{136}},
Number = {{5}},
Pages = {{877-880}},
Month = {{NOV}},
Abstract = {{Background \& objectives: Streptococcus pseudopneumoniae a member of the
   Viridans Streptococci, is known to be associated with chronic
   obstructive pulmonary disease and respiratory tract infections (RTI).
   Very scanty information is available on the isolation of S.
   pseudopneumoniae from India. Hence, the present study was an attempt to
   isolate S. pseudopneumoniae from clinical samples and to study their
   drug resistance pattern.
   Methods: Sputum samples (n=150) submitted to the microbiology laboratory
   for routine culture from patients clinically suspected to have lower
   respiratory tract infection were inoculated onto sheep blood agar and
   chocolate agar plates. Alpha haemolytic colonies were identified as S.
   pseudopneumoniae based on absence of capsule, bile solubility and opto
   chin susceptibility in 5 per cent CO2 and ambient air. Disk diffusion
   method was used for antibiotic sus ceptibilily testing.
   Results: Among the samples screened, 4 per cent showed the growth of
   only S. pseudopneumoniae. Other pathogens isolated were Streptococcus
   pneumoniae, Moraxella catarrhalis, Klebsiella spp., Enterococcus spp.,
   Pseudomonas spp., Haemophilus influenzae, Staphylococcus aureus, Candida
   albicans. All the S. pseudopneumoniae isolates were resistant to
   erythromycin.
   Interpretation \& conclusions: Our preliminary results showed presence
   of S. pseudopneumoniae in this part of the country and these were
   associated with RTI. Currently, most clinical laboratories report
   optochin susceptible isolates in 5 per cent CO2 as S. pneumoniae and the
   resistant ones are not further tested for susceptibility in ambient air.
   As a result, S. pseudopneumoniae may be missed out. Hence, performance
   of at least two tests, viz. optochin susceptibility with incubation in 5
   per cent CO2 and ambient air along with bile solubility is necessary to
   differentiate S. pneumoniae from S. pseudopneumoniae.}},
Publisher = {{INDIAN COUNCIL MEDICAL RES}},
Address = {{PO BOX 4911 ANSARI NAGAR, NEW DELHI 110029, INDIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dhanashree, B (Reprint Author), Manipal Univ, Kasturba Med Coll, Dept Microbiol, Mangalore 575001, India.
   Dhanashree, B., Manipal Univ, Kasturba Med Coll, Dept Microbiol, Mangalore 575001, India.}},
ISSN = {{0971-5916}},
Keywords = {{Antibiotic susceptibility; purulent sputum; respiratory tract pathogen;
   Streptococcus pseudopneumoniae}},
Keywords-Plus = {{SPUTUM}},
Research-Areas = {{Immunology; General \& Internal Medicine; Research \& Experimental
   Medicine}},
Web-of-Science-Categories  = {{Immunology; Medicine, General \& Internal; Medicine, Research \&
   Experimental}},
Author-Email = {{dbiranthabail@yahoo.co.in}},
ResearcherID-Numbers = {{B, Dhanashree/I-4651-2014}},
ORCID-Numbers = {{B, Dhanashree/0000-0002-5370-0663}},
Funding-Acknowledgement = {{Indian Council of Medical Research (ICMR), New Delhi}},
Funding-Text = {{Sariya thanks Indian Council of Medical Research (ICMR), New Delhi, for
   the award of Short-Term Research Studentship (STS) for this study.}},
Cited-References = {{Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004.
   Baur AW, 1966, AM J CLIN PATHOL, V45, P493.
   Clinical and Laboratory Standards Institute, 2007, M100S17 CLSI.
   Goyal R, 2007, Indian J Med Microbiol, V25, P256.
   Harf-Monteil C, 2006, J CLIN MICROBIOL, V44, P2240, DOI 10.1128/JCM.02643-05.
   Keith ER, 2008, ANTIMICROB AGENTS CH, V52, P2998, DOI 10.1128/AAC.01526-07.
   Keith ER, 2006, J CLIN MICROBIOL, V44, P923, DOI 10.1128/JCM.44.3.923-927.2006.
   RUOFF KL, 2003, MANUAL CLIN MICROBIO, P405.}},
Number-of-Cited-References = {{8}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{Indian J. Med. Res.}},
Doc-Delivery-Number = {{078FF}},
Unique-ID = {{ISI:000314083300023}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000308623000031,
Author = {Sharma, Surendra K. and Mohanan, Sandeep and Sharma, Abhishek},
Title = {{Relevance of Latent TB Infection in Areas of High TB Prevalence}},
Journal = {{CHEST}},
Year = {{2012}},
Volume = {{142}},
Number = {{3}},
Pages = {{761-773}},
Month = {{SEP}},
Abstract = {{About one-third of the world population has latent TB infection (LTBI),
   the majority of which is distributed in 22 high-burden countries. Early
   diagnosis and treatment of active TB remains the top priority in
   resource-poor countries with high TB prevalence. Notwithstanding,
   because LTBI contributes significantly to the pool of active TB cases
   later on, its diagnosis and treatment is essential, especially in
   high-risk groups. The lack of a gold standard and several limitations of
   currently available tools, namely the tuberculin skin test and
   interferon-gamma release assays, are major constraints for LTBI
   diagnosis. In areas with high TB prevalence, interferon-gamma release
   assays have not shown superiority over the conventional tuberculin skin
   test and are yet to be systematically studied. Decisions regarding LTBI
   treatment with isoniazid preventive therapy should be made, keeping in
   mind the high prevalence of isoniazid resistance in these settings.
   Although efforts to shorten the LTBI treatment duration are encouraging,
   most trials have focused on adherence and toxicity. Future trials on
   short-duration regimens in high-burden settings should address drug
   efficacy issues as well. LTBI management, therefore, should comprise a
   targeted screening approach and individualization of LTBI treatment
   protocols. In addition, efforts should focus on airborne infection
   control measures in high-burden countries. A high prevalence of
   drug-resistant TB, the HIV epidemic, and delays in the diagnosis of
   active TB cases are other major concerns in areas of high TB prevalence.
   There is ample space for further research in these countries, whose
   outcomes may strengthen future national guidelines. CHEST 2012;
   142(3):761-773}},
Publisher = {{AMER COLL CHEST PHYSICIANS}},
Address = {{3300 DUNDEE ROAD, NORTHBROOK, IL 60062-2348 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Sharma, SK (Reprint Author), All India Inst Med Sci, Dept Med, New Delhi 110029, India.
   Sharma, Surendra K.; Mohanan, Sandeep; Sharma, Abhishek, All India Inst Med Sci, Dept Internal Med, New Delhi 110029, India.
   Sharma, Abhishek, Med Univ Pleven, BU-5800 Pleven, Bulgaria.}},
DOI = {{10.1378/chest.12-0142}},
ISSN = {{0012-3692}},
Keywords-Plus = {{ISONIAZID PREVENTIVE THERAPY; GAMMA RELEASE ASSAYS; MULTIDRUG-RESISTANT
   TUBERCULOSIS; HUMAN-IMMUNODEFICIENCY-VIRUS; BLOOD INTERFERON-GAMMA;
   HEALTH-CARE WORKERS; PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS;
   HIV-INFECTION; HOUSEHOLD CONTACTS}},
Research-Areas = {{General \& Internal Medicine; Respiratory System}},
Web-of-Science-Categories  = {{Critical Care Medicine; Respiratory System}},
Author-Email = {{sksharma.aiims@gmail.com}},
Cited-References = {{Aabye MG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004220.
   Agarwal A, 2010, GUIDELINES AIRBORNE.
   Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3.
   {*}AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT\_.
   {[}Anonymous], 1995, MMWR RECOMM REP, V44, P19.
   Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55.
   Atkinson J, 2009, NATURAL VENTILATION FOR INFECTION CONTROL IN HEALTH-CARE SETTINGS, P1.
   Attamna A, 2009, THORAX, V64, P271, DOI 10.1136/thx.2008.100974.
   Balcells ME, 2006, EMERG INFECT DIS, V12, P744.
   Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236.
   Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947.
   Becerra MC, 2011, LANCET, V377, P147, DOI 10.1016/S0140-6736(10)61972-1.
   Biketov S, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-146.
   Brailey M, 1940, AM J PUBLIC HEALTH N, V30, P816, DOI 10.2105/AJPH.30.7.816.
   Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab.
   CHAKRABARTI A, 1990, INDIAN J MED RES-A, V91, P111.
   Churchyard GJ, 2003, AIDS, V17, P2063, DOI 10.1097/01.aids.0000076319.42412.70.
   Commandeur S, 2011, CLIN VACCINE IMMUNOL, V18, P676, DOI 10.1128/CVI.00492-10.
   Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033.
   Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc.
   Dogra S, 2007, J INFECTION, V54, P267, DOI 10.1016/j.jinf.2006.04.007.
   Drlica K, 2008, LANCET INFECT DIS, V8, P273, DOI 10.1016/S1473-3099(08)70077-X.
   Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449.
   ELLIOTT AM, 1993, J TROP MED HYG, V96, P1.
   European Centre for Disease Prevention and Control, 2011, US INT GAMM REL ASS.
   Fernandez-Guerrero ML, 2007, EMERG INFECT DIS, V13, P1428, DOI 10.3201/eid1309.070070.
   Fitzgerald DW, 2000, LANCET, V356, P1470, DOI 10.1016/S0140-6736(00)02870-1.
   Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0.
   Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391.
   Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441.
   Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358.
   He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166.
   Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362.
   Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235.
   Houben RMGJ, 2011, INT J TUBERC LUNG D, V15, P24.
   Jackson-Sillah D, 2007, T ROY SOC TROP MED H, V101, P594, DOI 10.1016/j.trstmh.2007.02.001.
   Jafri SM, 2011, LIVER TRANSPLANT, V17, P306, DOI 10.1002/lt.22203.
   Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1.
   Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494.
   Kowada A, 2010, MOL DIAGN THER, V14, P367, DOI 10.2165/11586190-000000000-00000.
   Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3.
   Lienhardt C, 2010, CURR OPIN PULM MED, V16, P186, DOI 10.1097/MCP.0b013e328337580c.
   Lobue P, 2010, RESPIROLOGY, V15, P603, DOI 10.1111/j.1440-1843.2010.01751.x.
   Machingaidze S, 2011, PEDIATR INFECT DIS J, V30, P694, DOI 10.1097/INF.0b013e318214b915.
   Madhi SA, 2011, NEW ENGL J MED, V365, P21, DOI 10.1056/NEJMoa1011214.
   Mandalakas AM, 2008, INT J TUBERC LUNG D, V12, P417.
   Mandalakas AM, 2011, INT J TUBERC LUNG D, V15, P1018, DOI 10.5588/ijtld.10.0631.
   Mariette X, 2003, Ann Rheum Dis, V62, P791, DOI 10.1136/ard.62.8.791.
   Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136.
   Menzies D, 2008, ANN INTERN MED, V149, P689, DOI 10.7326/0003-4819-149-10-200811180-00003.
   Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006.
   Menzies D, 2011, INDIAN J MED RES, V133, P257.
   MENZIES R, 1992, AM REV RESPIR DIS, V145, P621, DOI 10.1164/ajrccm/145.3.621.
   Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410.
   Naqvi R, 2010, NEPHROL DIAL TRANSPL, V25, P634, DOI 10.1093/ndt/gfp489.
   National Collaborating Centre for Chronic Conditions and the Centre for Clinical Practice at NICE, 2011, NICE CLIN GUID, V117.
   Nuermberger E, 2005, AM J RESP CRIT CARE, V172, P1452, DOI 10.1164/rccm.200507-1047OC.
   Pai M, 2005, AM J RESP CRIT CARE, V172, P519, DOI 10.1164/rccm.2506003.
   Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241.
   Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5.
   Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7.
   Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5.
   Quigley MA, 2001, AIDS, V15, P215, DOI 10.1097/00002030-200101260-00011.
   Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9.
   Rekha VVB, 2009, INT J TUBERC LUNG D, V13, P1507.
   Revised National Tuberculosis Control Programme. Central TB Division Directorate General of Health Services Ministry of Health and Family Welfare New Delhi, 2005, TECHN OP GUID TUB CO.
   Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3.
   Schaaf HS, 2002, PEDIATRICS, V109, P765, DOI 10.1542/peds.109.5.765.
   SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901.
   Sester M, 2004, KIDNEY INT, V65, P1826, DOI 10.1111/j.1523-1755.2004.00586.x.
   Sharma SK, 2011, INDIAN J MED RES, V133, P312.
   Singh Pushpendra, 2006, J Commun Dis, V38, P216.
   Smieja MJ, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001363.
   Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510.
   Soysal A, 2011, NEPHROL DIAL TRANSPL, V27, P1645.
   Starke IR, 2004, TXB PEDIAT INFECT DI, P1337.
   Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875.
   Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749.
   Teixeira L, 2001, INT J TUBERC LUNG D, V5, P321.
   van Halsema CL, 2010, AIDS, V24, P1051, DOI 10.1097/QAD.0b013e32833849df.
   Van Wyk SS, 2010, INT J TUBERC LUNG D, V14, P650.
   WHO, 2011, WHO PUBL.
   WHO, WHO REP 2011 GLOB TU.
   Wood R, 2010, INT J TUBERC LUNG D, V14, P406.
   World Health Organization, 2008, WHO PUBL.
   World Health Organization, 2008, WHO 3 IS M INT CAS F.
   World Health Organization, 2010, WHO PUBL.
   World Health Organization (WHO), 2011, GUID INT TUB CAS FIN.
   Zhang TY, 2011, AM J RESP CRIT CARE, V184, P732, DOI 10.1164/rccm.201103-0397OC.
   Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180.}},
Number-of-Cited-References = {{90}},
Times-Cited = {{22}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{15}},
Journal-ISO = {{Chest}},
Doc-Delivery-Number = {{003PE}},
Unique-ID = {{ISI:000308623000031}},
DA = {{2018-08-13}},
}

@article{ ISI:000308277500013,
Author = {Fennelly, Kevin P. and Jones-Lopez, Edward C. and Ayakaka, Irene and
   Kims, Soyeon and Menyha, Harriet and Kirenga, Bruce and Muchwa,
   Christopher and Joloba, Moses and Dryden-Peterson, Scott and Reilly,
   Nancy and Okwera, Alphonse and Elliott, Alison M. and Smith, Peter G.
   and Mugerwa, Roy D. and Eisenach, Kathleen D. and Ellner, Jerrold J.},
Title = {{Variability of Infectious Aerosols Produced during Coughing by Patients
   with Pulmonary Tuberculosis}},
Journal = {{AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE}},
Year = {{2012}},
Volume = {{186}},
Number = {{5}},
Pages = {{450-457}},
Month = {{SEP 1}},
Abstract = {{Rationale: Mycobacterium tuberculosis is transmitted by infectious
   aerosols, but assessing infectiousness currently relies on sputum
   microscopy that does not accurately predict the variability in
   transmission.
   Objectives: To evaluate the feasibility, of collecting cough aerosols
   and the risk factors for infectious aerosol production from patients
   with pulmonary tuberculosis (TB) in a resource-limited setting.
   Methods: We enrolled subjects with suspected TB in Kampala, Uganda and
   collected clinical, radiographic, and microbiological data in addition
   to cough aerosol cultures. A subset of 38 subjects was studied on 2 or 3
   consecutive days to assess reproducibility.
   Measurements and Main Results: M. tuberculosis was cultured from cough
   aerosols of 28 of 101 (27.7\%; 95\% confidence interval {[}CI],
   19.9-37.1\%) subjects with culture-confirmed TB, with a median 16
   aerosol cfu (range, 1-701) in 10 minutes of coughing. Nearly all
   (96.4\%) cultivable particles were 0.65 to 4.7 mu m in size. Positive
   aerosol cultures were associated with higher Karnofsky performance
   scores (P = 0.016), higher sputum acid-fast bacilli smear microscopy
   grades (P = 0.007), lower days to positive in liquid culture (P =
   0.004), stronger cough (P = 0.016), and fewer days on TB treatment (P =
   0.047). In multivariable analyses, cough aerosol cultures were
   associated with a salivary/mucosalivary (compared with
   purulent/mucopurulent) appearance of sputum (odds ratio, 4.42; 95\% CI,
   1.23-21.43) and low days to positive (per 1-d decrease; odds ratio,
   1.17; 95\% CI, 1.07-1.33). The within-test (kappa, 0.81; 95\% CI, 0.68
   0.94) and interday test (kappa, 0.62; 95\% CI, 0.43-0.82)
   reproducibility were high.
   Conclusions: A minority of patients with TB (28\%) produced culturable
   cough aerosols. Collection of cough aerosol cultures is feasible and
   reproducible in a resource-limited setting.}},
Publisher = {{AMER THORACIC SOC}},
Address = {{61 BROADWAY, FL 4, NEW YORK, NY 10006 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fennelly, KP (Reprint Author), Univ Florida, Div Mycobacteriol, Dept Med, SE Natl TB Ctr,Emerging Pathogens Inst, Room 257, Gainesville, FL 32610 USA.
   Fennelly, Kevin P., Univ Florida, Div Mycobacteriol, Dept Med, SE Natl TB Ctr,Emerging Pathogens Inst, Gainesville, FL 32610 USA.
   Jones-Lopez, Edward C.; Ellner, Jerrold J., Boston Med Ctr, Infect Dis Sect, Dept Med, Boston, MA USA.
   Jones-Lopez, Edward C.; Ellner, Jerrold J., Boston Univ, Sch Med, Boston, MA 02118 USA.
   Jones-Lopez, Edward C.; Ayakaka, Irene; Mugerwa, Roy D.; Ellner, Jerrold J., Makerere Univ, Univ Med \& Dent New Jersey Res Collaborat, Kampala, Uganda.
   Jones-Lopez, Edward C.; Reilly, Nancy, Univ Med \& Dent New Jersey, Div Infect Dis, Dept Med, Newark, NJ 07103 USA.
   Kims, Soyeon, Univ Med \& Dent New Jersey, Dept Prevent Med \& Community Hlth, New Jersey Med Sch, Newark, NJ 07103 USA.
   Menyha, Harriet; Muchwa, Christopher; Joloba, Moses; Eisenach, Kathleen D., Joint Clin Res Ctr, Mycobacteriol Lab, Kampala, Uganda.
   Kirenga, Bruce; Elliott, Alison M.; Mugerwa, Roy D., Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda.
   Joloba, Moses, Makerere Univ, Dept Microbiol, Coll Hlth Sci, Kampala, Uganda.
   Dryden-Peterson, Scott, Brigham \& Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA.
   Dryden-Peterson, Scott, Harvard Univ, Sch Med, Boston, MA 02115 USA.
   Okwera, Alphonse, Mulago Hosp, TB Clin, Kampala, Uganda.
   Elliott, Alison M., London Sch Hyg \& Trop Med, Dept Clin Res, London WC1, England.
   Smith, Peter G., London Sch Hyg \& Trop Med, Dept Infect Dis Epidemiol, London WC1, England.
   Eisenach, Kathleen D., Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA.}},
DOI = {{10.1164/rccm.201203-0444OC}},
ISSN = {{1073-449X}},
Keywords = {{tuberculosis; cough; air microbiology; infectious disease transmission;
   infection control}},
Keywords-Plus = {{MYCOBACTERIUM-TUBERCULOSIS; TUBERCLE-BACILLI; DRUG-RESISTANT;
   TRANSMISSION; CHEMOTHERAPY; HIV; PATHOGENICITY; EPIDEMIOLOGY; CHILDREN;
   ADULTS}},
Research-Areas = {{General \& Internal Medicine; Respiratory System}},
Web-of-Science-Categories  = {{Critical Care Medicine; Respiratory System}},
Author-Email = {{kevin.fennelly@medicine.ufl.edu}},
ORCID-Numbers = {{Ellner, Jerrold/0000-0001-6150-0082
   Jones Lopez, Edward/0000-0001-6323-286X
   Joloba, Moses/0000-0002-0334-9983
   Smith, Peter/0000-0003-0080-7560
   Elliott, Alison/0000-0003-2818-9549
   Kirenga, Bruce/0000-0002-2023-2840}},
Funding-Acknowledgement = {{Wellcome Trust-Burroughs Wellcome Fund Infectious Diseases Initiative
   grant {[}063410/ABC/00/Z]; National Institute of Health {[}1K23
   AI01676]; American Society for Tropical Medicine and Research; Medical
   Research Council {[}G0700837]}},
Funding-Text = {{Supported by the Wellcome Trust-Burroughs Wellcome Fund Infectious
   Diseases Initiative grant 063410/ABC/00/Z, National Institute of Health
   Career Development Award \#1K23 AI01676 (K.P.F.), and the American
   Society for Tropical Medicine and Research (K.P.F.).}},
Cited-References = {{ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403.
   {[}Anonymous], 1996, BACT 460 SYST PROD P.
   Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5.
   BATES JH, 1974, NEW ENGL J MED, V290, P459, DOI 10.1056/NEJM197402212900811.
   Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0.
   Borgdorff MW, 2001, AM J EPIDEMIOL, V154, P934, DOI 10.1093/aje/154.10.934.
   BROOKS SM, 1973, AM REV RESPIR DIS, V108, P799.
   CASSIDY JT, 1981, MED J AUSTRALIA, V1, P588.
   CLANCY LJ, 1990, EUR RESPIR J, V3, P399.
   Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009.
   Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376.
   Elwood RK, 2005, INT J TUBERC LUNG D, V9, P49.
   Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188.
   Fennelly KP, 2007, CLIN INFECT DIS, V44, P1358, DOI 10.1086/516617.
   Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC.
   Fennelly KP, 2004, AM J RESP CRIT CARE, V169, pA532.
   Fennelly KP, 2005, P AM THORAC SOC, V2, pA552.
   Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1.
   Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951.
   Glover RE, 1944, BRIT J EXP PATHOL, V25, P141.
   HAMBURG MA, 1994, NEW ENGL J MED, V330, P1750, DOI 10.1056/NEJM199406163302410.
   Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759.
   Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1.
   Jones-Lopez EC, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000427.
   Kent PT, 1985, PUBLIC HLTH MYCOBACT.
   Menzies D, 1997, INFECT CONT HOSP EP, V18, P582.
   Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805.
   NOBLE RC, 1981, AM J INFECT CONTROL, V9, P6, DOI 10.1016/S0196-6553(81)80003-X.
   Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205.
   Rieder H. L., 1998, PUBLIC HLTH SERVICE.
   RILEY RL, 1962, AM REV RESPIR DIS, V85, P511.
   ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2.
   Sakundarno Mateus, 2009, BMC Pulm Med, V9, P16, DOI 10.1186/1471-2466-9-16.
   SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402.
   SNIDER DE, 1985, AM REV RESPIR DIS, V132, P125.
   SULTAN L, 1960, AM REV RESPIR DIS, V82, P358.
   Tenover FC, 2011, CLIN INFECT DIS, V52, pS338, DOI 10.1093/cid/cir049.
   van Geuns H A, 1975, Bull Int Union Tuberc, V50, P107.
   van Oosterhout JJG, 2005, JAIDS-J ACQ IMM DEF, V39, P626.
   Wainwright CE, 2009, THORAX, V64, P926, DOI 10.1136/thx.2008.112466.
   Wells WF, 1955, AIRBORNE CONTAGION H.
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338.
   Zayas Gustavo, 2005, BMC Pulm Med, V5, P11, DOI 10.1186/1471-2466-5-11.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{50}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{19}},
Journal-ISO = {{Am. J. Respir. Crit. Care Med.}},
Doc-Delivery-Number = {{998YY}},
Unique-ID = {{ISI:000308277500013}},
OA = {{green\_published}},
DA = {{2018-08-13}},
}

@article{ ISI:000307612900006,
Author = {Guntupalli, Rajesh and Sorokulova, Iryna and Olsen, Eric and Globa,
   Ludmila and Pustovyy, Oleg and Moore, Timothy and Chin, Bryan and
   Barbaree, James and Vodyanoy, Vitaly},
Title = {{Detection and identification of methicillin resistant and sensitive
   strains of Staphylococcus aureus using tandem measurements}},
Journal = {{JOURNAL OF MICROBIOLOGICAL METHODS}},
Year = {{2012}},
Volume = {{90}},
Number = {{3}},
Pages = {{182-191}},
Month = {{SEP}},
Abstract = {{Discrimination of methicillin resistant (MRSA) and sensitive (MSSA)
   strains of Staphylococcus aureus, was achieved by the specially selected
   lytic bacteriophage with a wide host range of S. aureus strains and a
   penicillin-binding protein (PBP 2a) specific antibody. A quartz crystal
   microbalance with dissipation monitoring (QCM-D) was employed to analyze
   bacteria-phage interactions. The lyric phages were transformed into
   phage spheroids by exposure to water-chloroform interface. Phage
   spheroid monolayers were transferred onto QCM-D sensors by
   Langmuir-Blodgett (LB) technique. Biosensors were tested in the flow
   mode with bacterial water suspensions, while collecting frequency and
   energy dissipation changes. Bacteria-spheroid interactions resulted in
   decreased resonance frequency and an increase in dissipation energy for
   both MRSA and MSSA strains. Following the bacterial binding, these
   sensors were further exposed to a flow of the penicillin-binding protein
   (PBP 2a) specific antibody conjugated latex beads. Sensors tested with
   MRSA responded to PBP 2a antibody beads: while sensors examined with
   MSSA gave no response. This experimental difference establishes an
   unambiguous discrimination between methicillin resistant and sensitive
   S. aureus strains. Both free and immobilized bacteriophages strongly
   inhibit bacterial growth on solid/air interfaces and in water
   suspensions. After lytic phages are transformed into spheroids, they
   retain their strong lytic activity and demonstrate high bacterial
   capture efficiency. The phage and phage spheroids can be used for
   screening and disinfection of antibiotic resistant bacteria. Other
   applications may include use on biosensors, bacteriophage therapy, and
   antimicrobial surfaces. (C) 2012 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Vodyanoy, V (Reprint Author), Auburn Univ, Coll Vet Med, Dept Anat Physiol \& Pharmacol, Auburn, AL 36849 USA.
   Guntupalli, Rajesh; Sorokulova, Iryna; Globa, Ludmila; Pustovyy, Oleg; Moore, Timothy; Vodyanoy, Vitaly, Auburn Univ, Coll Vet Med, Dept Anat Physiol \& Pharmacol, Auburn, AL 36849 USA.
   Olsen, Eric, Clin Res Lab, Med Grp 81, Keesler AFB, MS 39534 USA.
   Chin, Bryan, Auburn Univ, Dept Mat Engn, Auburn, AL 36849 USA.
   Barbaree, James, Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.}},
DOI = {{10.1016/j.mimet.2012.05.003}},
ISSN = {{0167-7012}},
Keywords = {{Lytic phage spheroids; Antibody; QCM-D; Langmuir-Blodgett (LB)
   monolayers; MRSA}},
Keywords-Plus = {{QUARTZ-CRYSTAL MICROBALANCE; PENICILLIN-BINDING PROTEINS; MRSA ID
   SYSTEM; FILAMENTOUS BACTERIOPHAGE; ENERGY-DISSIPATION;
   STRUCTURAL-CHANGES; RAPID DETECTION; LYTIC PHAGE; ADSORPTION; QCM}},
Research-Areas = {{Biochemistry \& Molecular Biology; Microbiology}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Microbiology}},
Author-Email = {{vodyavi@auburn.edu}},
Funding-Acknowledgement = {{Auburn University AUDFS; USAF {[}CRADA 07-277-60MDG-01]}},
Funding-Text = {{The work reported herein was supported by grants from Auburn University
   AUDFS and USAF CRADA 07-277-60MDG-01. The views expressed in this
   article are those of the authors, and do not reflect the official policy
   or position of the United States Air Force, Department of Defense, or
   the U.S. Government.}},
Cited-References = {{Aberl F, 1998, METH MOLEC MED, V13, P519, DOI 10.1385/0-89603-485-2:519.
   Aksyuk AA, 2009, EMBO J, V28, P821, DOI 10.1038/emboj.2009.36.
   Arisaka F, 1981, Prog Clin Biol Res, V64, P365.
   Balasubramanian S, 2007, BIOSENS BIOELECTRON, V22, P948, DOI 10.1016/j.bios.2006.04.003.
   Barie PS, 1998, WORLD J SURG, V22, P118, DOI 10.1007/s002689900359.
   Besbes R, 2009, J MOL LIQ, V145, P1, DOI 10.1016/j.molliq.2008.09.009.
   Broughan J, 2011, EXPERT REV VACCINES, V10, P695, DOI {[}10.1586/ERV.11.54, 10.1586/erv.11.54].
   Brown DFJ, 2005, J ANTIMICROB CHEMOTH, V56, P1000, DOI 10.1093/jac/dki372.
   Burrowes B, 2011, EXPERT REV ANTI-INFE, V9, P775, DOI {[}10.1586/eri.11.90, 10.1586/ERI.11.90].
   Byun Dong Euk, 1997, Journal of Korean Medical Science, V12, P190.
   Chakraborty S. P., 2011, Al Ameen Journal of Medical Sciences, V4, P152.
   Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781.
   Coombs David H., 1994, P259.
   Desmond KW, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051305.
   Diekema DJ, 2004, J CLIN MICROBIOL, V42, P2879, DOI 10.1128/JCM.42.7.2879-2883.2004.
   Duan L., 2011, ZHONGHUA YIYUANGANRA, V21, P1667.
   Durgaryan A.A., 2010, ZEKUYTSNER HAYASTANI, V110, P384.
   Edvardsson M, 2005, ANAL CHEM, V77, P4918, DOI 10.1021/ac050116j.
   Garg A, 2008, LANGMUIR, V24, P10887, DOI 10.1021/la8005053.
   GERBERDING JL, 1991, ANTIMICROB AGENTS CH, V35, P2574, DOI 10.1128/AAC.35.12.2574.
   Gervals L, 2007, SENSOR ACTUAT B-CHEM, V125, P615, DOI 10.1016/j.snb.2007.03.007.
   GIAMARELLOU H, 1981, J ANTIMICROB CHEMOTH, V7, P649, DOI 10.1093/jac/7.6.649.
   Grieco SHH, 2009, BIOPROC BIOSYST ENG, V32, P773, DOI 10.1007/s00449-009-0303-3.
   GRIFFITH J, 1981, CELL, V23, P747, DOI 10.1016/0092-8674(81)90438-4.
   Guntupalli R, 2008, BIOSENS BIOELECTRON, V24, P151, DOI 10.1016/j.bios.2008.03.003.
   Guntupalli R, 2011, COLLOID SURFACE B, V82, P182, DOI 10.1016/j.colsurfb.2010.08.032.
   Hall E. A. H., 1991, BIOSENSORS.
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u.
   Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271.
   Hook F, 1998, J COLLOID INTERF SCI, V208, P63, DOI 10.1006/jcis.1998.5774.
   Hosseinidoust Z, 2011, LANGMUIR, V27, P5472, DOI 10.1021/la200102z.
   Hsieh SE, 2011, APPL ENVIRON MICROB, V77, P756, DOI 10.1128/AEM.01848-10.
   HUFF E, 1964, J BACTERIOL, V88, P1155.
   KNAPP CC, 1994, J CLIN MICROBIOL, V32, P2588.
   KNAPP CC, 1994, J CLIN MICROBIOL, V32, P433.
   Knopf HJ, 1997, UROLOGE A, V36, P248, DOI 10.1007/s001200050099.
   Krueger AP, 1930, J GEN PHYSIOL, V14, P223, DOI 10.1085/jgp.14.2.223.
   MANNING M, 1981, J VIROL, V40, P912.
   Marx KA, 2003, BIOTECHNOL PROGR, V19, P987, DOI 10.1021/bp0201096.
   McHale G, 2004, J APPL PHYS, V95, P373, DOI 10.1063/1.1630373.
   Moradpour Z, 2011, BIOTECHNOL ADV, V29, P732, DOI 10.1016/j.biotechadv.2011.06.003.
   Nanduri V, 2007, BIOSENS BIOELECTRON, V22, P986, DOI 10.1016/j.bios.2006.03.025.
   O'Flaherty S, 2005, APPL ENVIRON MICROB, V71, P1836, DOI 10.1128/AEM.71.4.1836-1842.2005.
   Olofsson L, 2001, CHEM BIOL, V8, P661, DOI 10.1016/S1074-5521(01)00041-2.
   Olsen E., 2008, SERIES ACOUSTIC WAVE.
   Olsen E. V., 2007, ECS T, V2, P9.
   Olsen EV, 2006, BIOSENS BIOELECTRON, V21, P1434, DOI 10.1016/j.bios.2005.06.004.
   Olsen EV, 2003, J MICROBIOL METH, V53, P273, DOI 10.1016/S0167-7012(03)00031-9.
   Page K, 2009, J MATER CHEM, V19, P3819, DOI 10.1039/b818698g.
   Pantucek R, 1998, VIROLOGY, V246, P241, DOI 10.1006/viro.1998.9203.
   Pathirana ST, 2000, BIOSENS BIOELECTRON, V15, P135, DOI 10.1016/S0956-5663(00)00067-1.
   Popham DL, 2003, CURR OPIN MICROBIOL, V6, P594, DOI 10.1016/j.mib.2003.10.002.
   QADRI SMH, 1994, J CLIN MICROBIOL, V32, P1830.
   ROBERTS LM, 1993, BIOCHEMISTRY-US, V32, P10479, DOI 10.1021/bi00090a026.
   Rodahl M, 1996, SENSOR ACTUAT B-CHEM, V37, P111, DOI 10.1016/S0925-4005(97)80077-9.
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937.
   Shittu AO, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-92.
   Shorr AF, 2006, CRIT CARE, V10, DOI 10.1186/cc4934.
   STRUELENS MJ, 1995, J CLIN MICROBIOL, V33, P2395.
   Sulakvelidze A, 2005, DRUG DISCOV TODAY, V10, P807, DOI 10.1016/S1359-6446(05)03441-0.
   Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001.
   TO CM, 1969, J MOL BIOL, V46, P493, DOI 10.1016/0022-2836(69)90192-2.
   Tsoularis A, 2002, MATH BIOSCI, V179, P21, DOI 10.1016/S0025-5564(02)00096-2.
   Vainrub A, 2006, OPT LETT, V31, P2855, DOI 10.1364/OL.31.002855.
   VERHULST PF, 1845, NOUVEAUX MEMOIRES AC, V18.
   Vodyanoy V., 2007, SPIE P, V6694.
   Voinova MV, 2002, BIOSENS BIOELECTRON, V17, P835, DOI 10.1016/S0956-5663(02)00050-7.
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391.
   Wei YP, 2003, J BACTERIOL, V185, P4717, DOI 10.1128/JB.185.16.4717-4726.2003.
   White CC, 1999, J CHEM PHYS, V111, P11192, DOI 10.1063/1.480495.
   WOODS GL, 1994, J CLIN MICROBIOL, V32, P1058.
   Zambardi G, 1996, EUR J CLIN MICROBIOL, V15, P747, DOI 10.1007/BF01691964.}},
Number-of-Cited-References = {{72}},
Times-Cited = {{20}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{35}},
Journal-ISO = {{J. Microbiol. Methods}},
Doc-Delivery-Number = {{990ED}},
Unique-ID = {{ISI:000307612900006}},
DA = {{2018-08-13}},
}

@article{ ISI:000307470400014,
Author = {Bernard, Marie Charlotte and Lanotte, Philippe and Lawrence, Christine
   and Goudeau, Alain and Bernard, Louis},
Title = {{Air Contamination around Patients Colonized with Multidrug-Resistant
   Organisms}},
Journal = {{INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY}},
Year = {{2012}},
Volume = {{33}},
Number = {{9}},
Pages = {{949-951}},
Month = {{SEP}},
Abstract = {{Care-related infections are a major public health concern. Their
   transmission can be associated with environmental factors. This study
   looks at air contamination around 45 patients colonized with
   multidrug-resistant organisms (MDROs). We found that 30 hospital rooms
   (67\%) were contaminated with MDRO species and 10 rooms (22\%) were
   contaminated with at least 1 MDRO.}},
Publisher = {{UNIV CHICAGO PRESS}},
Address = {{1427 E 60TH ST, CHICAGO, IL 60637-2954 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Bernard, L (Reprint Author), CHRU Tours, Serv Med Interne \& Malad Infect, 2 Blvd Tonnelle, F-37044 Tours, France.
   Bernard, Louis, CHRU Tours, Serv Malad Infect, F-37044 Tours, France.
   Lanotte, Philippe; Goudeau, Alain, CHRU Tours, Serv Bacteriol \& Virol, F-37044 Tours, France.
   Bernard, Marie Charlotte; Bernard, Louis, Univ Tours, INSERM, U618, Tours, France.
   Lawrence, Christine, Hop Raymond Poincare, AP HP, Garches, France.}},
DOI = {{10.1086/667373}},
ISSN = {{0899-823X}},
Keywords-Plus = {{STAPHYLOCOCCUS-AUREUS; AIRBORNE}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{l.bernard@chu-tours.fr}},
Funding-Acknowledgement = {{French Agency for Food, Environmental and Occupational Health and Safety
   (ANSES)}},
Funding-Text = {{This work was funded by the French Agency for Food, Environmental and
   Occupational Health and Safety (ANSES 2008).}},
Cited-References = {{Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651.
   Best EL, 2010, CLIN INFECT DIS, V50, P1450, DOI 10.1086/652648.
   Choukri F, 2010, CLIN INFECT DIS, V51, P259, DOI 10.1086/653933.
   Collins AS, 2008, PATIENT SAFETY QUALI.
   Gehanno JF, 2009, J HOSP INFECT, V71, P256, DOI 10.1016/j.jhin.2008.11.015.
   Shiomori T, 2002, J HOSP INFECT, V50, P30, DOI 10.1053/jhin.2001.1136.
   Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P1896, DOI 10.1128/AAC.01756-10.
   Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196.
   Wilson RD, 2004, ANAESTH INTENS CARE, V32, P202.}},
Number-of-Cited-References = {{9}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{Infect. Control Hosp. Epidemiol.}},
Doc-Delivery-Number = {{988EE}},
Unique-ID = {{ISI:000307470400014}},
DA = {{2018-08-13}},
}

@article{ ISI:000307831100005,
Author = {Diacon, Andreas H. and von Groote-Bidlingmaier, Florian and Donald,
   Peter R.},
Title = {{From Magic Mountain to Table Mountain}},
Journal = {{SWISS MEDICAL WEEKLY}},
Year = {{2012}},
Volume = {{142}},
Month = {{AUG 22}},
Abstract = {{Prior to the introduction of chemotherapy, tuberculosis management
   relied upon aerotherapy, heliotherapy and good nutrition. This
   ``treatment{''}, exemplified by the regimen applied in Swiss and other
   European mountain resorts, is described by Thomas Mann in the book ``The
   Magic Mountain{''}. Tuberculosis chemotherapy began in 1944 with the
   introduction of streptomycin and para-amino-salicylic acid, later
   augmented by isoniazid. Early experience taught physicians that
   treatment must be given with multiple drugs to prevent emergence of
   resistance and that prolonged treatment adherence for 18-24 months was
   needed for a permanent cure of tuberculosis. Between 1970 and 1980
   rifampicin was introduced and with pyrazinamide it made
   ``short-course{''} treatment possible. For 30 years, a 6-month directly
   observed treatment short-course (DOTS) based on the three compounds
   isoniazid, rifampicin and pyrazinamide was the foundation of
   tuberculosis control strategies world-wide, and in recent years this was
   supplemented with ethambutol in view of increasing rates of isoniazid
   resistance. However, even 6 months of treatment is too long to easily
   ensure the compliance necessary to permanently cure tuberculosis. The
   recent spread of the HIV/AIDS epidemic has placed tuberculosis
   programmes under severe pressure and is accompanied by an increase in
   drug-resistance making tuberculosis virtually untreatable in some
   instances. In 2004 the first of a new generation of anti-tuberculosis
   drugs entered clinical evaluation. A series of clinical trials, often
   conducted at sites in Cape Town, South Africa, has shown them to be
   efficacious and hold promise of being able to shorten tuberculosis
   treatment and treat drug-resistant tuberculosis. Development and
   assessment of these drugs is ongoing but there is renewed hope that
   these new drugs and regimens will assist in finally conquering
   tuberculosis, preventing a return to Magic Mountain where sunshine and
   fresh air was all that could be offered to patients.}},
Publisher = {{E M H SWISS MEDICAL PUBLISHERS LTD}},
Address = {{FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Diacon, AH (Reprint Author), Fac Hlth Sci, Div Med Physiol, Dept Biomed Sci, POB 19063, ZA-7505 Za Tygerberg, South Africa.
   Diacon, Andreas H., Univ Stellenbosch, Dept Biomed Sci, Cape Town, South Africa.
   von Groote-Bidlingmaier, Florian, Univ Stellenbosch, Dept Med, Cape Town, South Africa.
   Donald, Peter R., Univ Stellenbosch, Dept Paediat \& Child Hlth, Cape Town, South Africa.}},
DOI = {{10.4414/smw.2012.13665}},
Article-Number = {{w13665}},
ISSN = {{1424-7860}},
EISSN = {{1424-3997}},
Keywords = {{tuberculosis; treatment; early bactericidal activity; bedaquiline;
   delamanid}},
Keywords-Plus = {{EARLY BACTERICIDAL ACTIVITY; PULMONARY TUBERCULOSIS; DIARYLQUINOLINE
   TMC207; RESISTANT TUBERCULOSIS; CHEMOTHERAPY; TRIAL; DRUG;
   PHARMACOKINETICS; STREPTOMYCIN; MULTICENTER}},
Research-Areas = {{General \& Internal Medicine}},
Web-of-Science-Categories  = {{Medicine, General \& Internal}},
Author-Email = {{ahd@sun.ac.za}},
Funding-Acknowledgement = {{National Research Foundation of South Africa}},
Funding-Text = {{P. R. Donald is supported by the National Research Foundation of South
   Africa. No other potential conflict of interest relevant to this article
   was reported.}},
Cited-References = {{Amberson JB, 1931, AM REV TUBERC, V24, P401.
   Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753.
   {[}Anonymous], 1950, Am Rev Tuberc, V61, P597.
   BALASUBRAMANIAN V, 1994, TUBERCLE LUNG DIS, V75, P168, DOI 10.1016/0962-8479(94)90002-7.
   Bernheim F, 1940, SCIENCE, V92, P204, DOI 10.1126/science.92.2383.204.
   CARR RE, 1962, ARCH OPHTHALMOL-CHIC, V67, P566, DOI 10.1001/archopht.1962.00960020566009.
   Chocano-Bedoya P, 2009, NUTR REV, V67, P289, DOI 10.1111/j.1753-4887.2009.00195.x.
   Chretien J, 1990, Bull Int Union Tuberc Lung Dis, V65, P25.
   Dheda K, 2012, LANCET, V379, P773, DOI 10.1016/S0140-6736(11)61062-3.
   Diacon AH, 2011, INT J TUBERC LUNG D, V15, P949, DOI 10.5588/ijtld.10.0616.
   Diacon AH, 2012, LANCET IN PRESS.
   Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3027, DOI 10.1128/AAC.06125-11.
   Diacon AH, 2010, ANTIMICROB AGENTS CH, V54, P3402, DOI 10.1128/AAC.01354-09.
   Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427.
   DOMAGK G, 1948, Beitr Klin Tuberk Spezif Tuberkuloseforsch, V101, P365, DOI 10.1007/BF02140619.
   DOMAGK G., 1935, Deutsche Medizinische Wochenschrift, V61, P250.
   DUBOVSKY H, 1991, S AFR MED J, V79, P48.
   Feldman W. H., 1944, PROC STAFF MEET MAYO CLINIC, V19, P593.
   Feldman W. H., 1944, AMER REV TUBERC, V50, P418.
   FOX HH, 1953, T NEW YORK ACAD SCI, V15, P234.
   Fox W, 1999, INT J TUBERC LUNG D, V3, pS231.
   FOX W, 1956, Q J MED, V25, P221.
   FOX W, 1954, Q J MED, V23, P347.
   Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433.
   Green M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7505.
   Grumbach F, 1969, Tubercle, V50, P280, DOI 10.1016/0041-3879(69)90053-1.
   HEILMEYER L, 1949, DEUT MED WOCHENSCHR, V74, P161, DOI 10.1055/s-0028-1118299.
   Hong Kong Chest Service/British Medical Research Council, 1987, AM REV RESPIR DIS, V136, P1339.
   Hong Kong Chest Service / British Medical Research Council, 1991, AM REV RESPIR DIS, V143, P700, DOI 10.1164/ajrccm/143.4\_Pt\_1.700.
   ISEMAN MD, 1991, AM REV RESPIR DIS, V143, P697, DOI 10.1164/ajrccm/143.4\_Pt\_1.697.
   Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9.
   Johnson JL, 2006, INT J TUBERC LUNG D, V10, P605.
   Lehmann J, 1994, AM REV RESPIR DIS, V90, P953.
   LINCOLN EM, 1948, B JOHNS HOPKINS HOSP, V82, P56.
   Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9.
   MAGGI N, 1966, CHEMOTHERAPY, V11, P285, DOI 10.1159/000220462.
   Mann T, 1924, ZAUBERBERG.
   MCDERMOTT W, 1956, AM REV TUBERC PULM, V74, P100.
   MCDERMOTT W, 1969, J INFECT DIS, V119, P678, DOI 10.1093/infdis/119.6.678.
   McDermott W, 1960, Bull World Health Organ, V23, P427.
   McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3.
   McMurray DN, 1998, NUTR REV, V56, pS147.
   Medical Research Council, 1948, BMJ-BRIT MED J, V2, P769, DOI DOI 10.1136/BMJ.2.4582.769.
   Medical Research Council/Tuberculosis Chemotherapy Trials Committee, 1962, TUBERCLE, V43, P201.
   Mitchison DA, 2000, INT J TUBERC LUNG D, V4, P796.
   Mitchison DA, 2005, AM J RESP CRIT CARE, V171, P699, DOI 10.1164/rccm.200411-1603OE.
   Murray JF, 2003, AM J RESP CRIT CARE, V168, P1029, DOI 10.1164/rccm.200307-1016OE.
   Narayanan P, 2002, IND J TUB, V49, P27.
   Rustomjee R, 2008, ANTIMICROB AGENTS CH, V52, P2831, DOI 10.1128/AAC.01204-07.
   Ryan Frank, 1992, TUBERCULOSIS GREATES.
   Schatz A, 1944, P SOC EXP BIOL MED, V55, P66.
   SENSI P, 1959, Farmaco Sci, V14, P146.
   SHEPHERD RG, 1962, J MED PHARMACEUT CH, V5, P823, DOI 10.1021/jm01239a017.
   Sirgel FA, 2005, AM J RESP CRIT CARE, V172, P128, DOI 10.1164/rccm.200411-1557OC.
   Sirgel FA, 2000, J ANTIMICROB CHEMOTH, V45, P859, DOI 10.1093/jac/45.6.859.
   Tasneen R, 2011, ANTIMICROB AGENTS CH, V55, P5485, DOI 10.1128/AAC.05293-11.
   TSUKAMURA M, 1985, AM REV RESPIR DIS, V131, P352.
   van Ingen J, 2011, CLIN INFECT DIS, V52, pE194, DOI 10.1093/cid/cir184.
   VERBIST L, 1968, AM REV RESPIR DIS, V98, P923.
   Ziganshina LE, 2005, COCHRANE DB SYST REV, DOI {[}10.1002/14651858.CD004795.pub3, 10.1002/14651858.CD004795.pub2].}},
Number-of-Cited-References = {{60}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{22}},
Journal-ISO = {{Swiss Med. Wkly.}},
Doc-Delivery-Number = {{993CC}},
Unique-ID = {{ISI:000307831100005}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000307139500024,
Author = {Schulz, Jochen and Friese, Anika and Klees, Sylvia and Tenhagen, Bernd
   A. and Fetsch, Alexandra and Roesler, Uwe and Hartung, Joerg},
Title = {{Longitudinal Study of the Contamination of Air and of Soil Surfaces in
   the Vicinity of Pig Barns by Livestock-Associated Methicillin-Resistant
   Staphylococcus aureus}},
Journal = {{APPLIED AND ENVIRONMENTAL MICROBIOLOGY}},
Year = {{2012}},
Volume = {{78}},
Number = {{16}},
Pages = {{5666-5671}},
Month = {{AUG}},
Abstract = {{During 1 year, samples were taken on 4 days, one sample in each season,
   from pigs, the floor, and the air inside pig barns and from the ambient
   air and soil at different distances outside six commercial
   livestock-associated methicillin-resistant Staphylococcus aureus
   (LA-MRSA)-positive pig barns in the north and east of Germany. LA-MRSA
   was isolated from animals, floor, and air samples in the barn, showing a
   range of airborne LA-MRSA between 6 and 3,619 CFU/m(3) (median, 151
   CFU/m(3)). Downwind of the barns, LA-MRSA was detected in low
   concentrations (11 to 14 CFU/m(3)) at distances of 50 and 150 m; all
   upwind air samples were negative. In contrast, LA-MRSA was found on soil
   surfaces at distances of 50, 150, and 300 m downwind from all barns, but
   no statistical differences could be observed between the proportions of
   positive soil surface samples at the three different distances. Upwind
   of the barns, positive soil surface samples were found only
   sporadically. Significantly more positive LA-MRSA samples were found in
   summer than in the other seasons both in air and soil samples upwind and
   downwind of the pig barns. spa typing was used to confirm the identity
   of LA-MRSA types found inside and outside the barns. The results show
   that there is regular airborne LA-MRSA transmission and deposition,
   which are strongly influenced by wind direction and season, of up to at
   least 300 m around positive pig barns. The described boot sampling
   method seems suitable to characterize the contamination of the vicinity
   of LA-MRSA-positive pig barns by the airborne route.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Schulz, J (Reprint Author), Univ Vet Med Hannover, Inst Anim Hyg Anim Welf \& Farm Anim Behav, Hannover, Germany.
   Schulz, Jochen; Hartung, Joerg, Univ Vet Med Hannover, Inst Anim Hyg Anim Welf \& Farm Anim Behav, Hannover, Germany.
   Friese, Anika; Roesler, Uwe, Free Univ Berlin, Inst Anim Hyg \& Environm Hlth, Berlin, Germany.
   Klees, Sylvia, Chem \& Veterinaruntersuchungsamt Ostwestfalen Lip, Detmold, Germany.
   Tenhagen, Bernd A.; Fetsch, Alexandra, Fed Inst Risk Assessment, Berlin, Germany.}},
DOI = {{10.1128/AEM.00550-12}},
ISSN = {{0099-2240}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANT; NORTHERN EUROPE; MRSA; PREVALENCE; EMISSIONS;
   BACTERIA; MICROORGANISMS; BUILDINGS; EVOLUTION; SOFTWARE}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Microbiology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Microbiology}},
Author-Email = {{Jochen.Schulz@tiho-hannover.de}},
Funding-Acknowledgement = {{German Federal Ministry of Food, Agriculture and Consumer Protection
   (BMELV) through the Federal Office for Agriculture and Food (BLE)
   {[}2808HS029, 08HS041]}},
Funding-Text = {{This work was financially supported by the German Federal Ministry of
   Food, Agriculture and Consumer Protection (BMELV) through the Federal
   Office for Agriculture and Food (BLE), grant numbers 2808HS029 and
   08HS041.}},
Cited-References = {{Alt K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-69.
   CHAPPLE RM, 1992, ARCH MICROBIOL, V157, P242, DOI 10.1007/BF00245157.
   de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007.
   de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027.
   Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x.
   European Food Safety Authority, 2009, EFSA J, V7, P1376, DOI DOI 10.2903/J.EFSA.2009.1376.
   Falkinham JO, 2009, APPL ENVIRON MICROB, V75, P2735, DOI 10.1128/AEM.00104-09.
   Fluit AC, 2003, MRSA CURRENT PERSPEC.
   Friedrich A, 2011, TIERAERZTL UMSCHAU, V66, P195.
   Friese A, 2012, VET MICROBIOL, V158, P129, DOI 10.1016/j.vetmic.2012.01.019.
   Gibbs SG, 2004, J OCCUP ENVIRON HYG, V1, P699, DOI 10.1080/15459620490515824.
   Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910.
   Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003.
   Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006.
   LIGHTHART B, 1987, APPL ENVIRON MICROB, V53, P1580.
   Lin XJ, 1999, ATMOS ENVIRON, V33, P4291, DOI 10.1016/S1352-2310(99)00169-7.
   Makison C, 2006, INDOOR BUILT ENVIRON, V15, P85, DOI 10.1177/1420326X06062582.
   Martens W, 2001, INT J HYG ENVIR HEAL, V203, P335, DOI 10.1078/1438-4639-00035.
   MULLER W, 1987, WORLD ANIMAL SCI B, V6, P47.
   Noto MJ, 2008, J BACTERIOL, V190, P1276, DOI 10.1128/JB.01128-07.
   Pasanen T, 2010, APMIS, V118, P74, DOI 10.1111/j.1600-0463.2009.02562.x.
   Robinson DA, 2004, CLIN MICROBIOL INFEC, V10, P92, DOI 10.1111/j.1469-0691.2004.00768.x.
   Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376.
   Schulz J, 2011, AEROBIOLOGIA, V27, P311, DOI 10.1007/s10453-011-9202-6.
   Schulz J, 2009, GEFAHRST REINHALT L, V69, P348.
   Schulz J, 2008, THESIS U BIELEFELD B.
   Seedorf J, 2004, ATMOS ENVIRON, V38, P6565, DOI 10.1016/j.atmosenv.2004.08.023.
   Seedorf J, 1998, J AGR ENG RES, V70, P97, DOI 10.1006/jaer.1997.0281.
   Spohr M, 2011, ZOONOSES PUBLIC HLTH, V58, P252, DOI 10.1111/j.1863-2378.2010.01344.x.
   Stegger M, 2011, J CLIN MICROBIOL, V49, P732, DOI 10.1128/JCM.01970-10.
   Takai H, 1998, J AGR ENG RES, V70, P59, DOI 10.1006/jaer.1997.0280.
   Thrusfield M, 2001, VET REC, V148, P567, DOI 10.1136/vr.148.18.567.
   van de Giessen AW, 2009, PREV VET MED, V91, P270, DOI 10.1016/j.prevetmed.2009.05.016.
   van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384.
   Wulf M, 2008, CLIN MICROBIOL INFEC, V14, P519, DOI 10.1111/j.1469-0691.2008.01970.x.
   Wulf MWH, 2012, EUR J CLIN MICROBIOL, V31, P61, DOI 10.1007/s10096-011-1269-z.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{65}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{34}},
Journal-ISO = {{Appl. Environ. Microbiol.}},
Doc-Delivery-Number = {{983SR}},
Unique-ID = {{ISI:000307139500024}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000306662100015,
Author = {Mohanty, Soumitra and Mishra, Saswati and Jena, Prajna and Jacob, Biju
   and Sarkar, Biplab and Sonawane, Avinash},
Title = {{An investigation on the antibacterial, cytotoxic, and antibiofilm
   efficacy of starch-stabilized silver nanoparticles}},
Journal = {{NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE}},
Year = {{2012}},
Volume = {{8}},
Number = {{6}},
Pages = {{916-924}},
Month = {{AUG}},
Abstract = {{The increased emergence of drug resistant microbes creates a major
   challenge to the scientific community for successful development of
   effective therapeutics. The antimicrobial activities of silver ions are
   well known, but limited information is available on the effects of green
   silver-nanoparticles (AgNPs) on human pathogens. In this article, we
   evaluated the antibacterial activity of starch-stabilized AgNPs against
   a panel of human pathogens commonly associated with air, water and food
   borne infections. The shape and size distribution of AgNPs were
   characterized by transmission electron microscopy. We showed that AgNPs
   were more effective against Gram-positive and Gram-negative pathogens as
   compared with acid-fast bacteria. AgNPs were not cytotoxic to
   macrophages at the bactericidal concentration and can augment
   intracellular killing potential of macrophages. Furthermore, we showed
   that AgNPs disrupt biofilm formation and exhibit better antibacterial
   activity compared to human cationic antimicrobial peptide LL-37. In
   summary, our data suggest AgNPs as a promising template for the design
   of novel antibacterial agents.
   From the Clinical Editor: In this fundamental study, the significance of
   starch-stabilized AgNP-s is studied as antimicrobial agents on a variety
   of human pathogens. AgNP-s are expected to become universally utilized
   agents in our efforts to prevent and fight infections. (C) 2012 Elsevier
   Inc. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Sonawane, A (Reprint Author), KIIT Univ, Sch Biotechnol, Campus 11, Bhubaneswar 751024, Orissa, India.
   Mohanty, Soumitra; Mishra, Saswati; Jena, Prajna; Sarkar, Biplab; Sonawane, Avinash, KIIT Univ, Sch Biotechnol, Bhubaneswar 751024, Orissa, India.
   Jacob, Biju, Catalyz Sci \& Technol Solut, Bangalore, Karnataka, India.}},
DOI = {{10.1016/j.nano.2011.11.007}},
ISSN = {{1549-9634}},
EISSN = {{1549-9642}},
Keywords = {{Starch; Silver nanoparticles; Antibacterial activity; Biofilm;
   Macrophages; Cytotoxicity; Antimicrobial peptide}},
Keywords-Plus = {{GOLD NANOPARTICLES; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; GREEN
   SYNTHESIS; CELLS; LL-37; PEPTIDE}},
Research-Areas = {{Science \& Technology - Other Topics; Research \& Experimental Medicine}},
Web-of-Science-Categories  = {{Nanoscience \& Nanotechnology; Medicine, Research \& Experimental}},
Author-Email = {{asonawane@kiitbiotech.ac.in}},
Funding-Acknowledgement = {{Department of Biotechnology, Government of India
   {[}BT/PR13488/GBD/27/270/2010]}},
Funding-Text = {{This work was supported by grant (BT/PR13488/GBD/27/270/2010) from
   Department of Biotechnology, Government of India to A.S.}},
Cited-References = {{Ahmadi TS, 1996, SCIENCE, V272, P1924, DOI 10.1126/science.272.5270.1924.
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w.
   Castellano Joseph J, 2007, Int Wound J, V4, P114, DOI 10.1111/j.1742-481X.2007.00316.x.
   Chau CF, 2007, TRENDS FOOD SCI TECH, V18, P269, DOI 10.1016/j.tifs.2007.01.007.
   Chen W, 2001, J COLLOID INTERF SCI, V238, P291, DOI 10.1006/jcis.2001.7525.
   Cirioni O, 2008, SHOCK, V30, P443, DOI 10.1097/SHK.0b013e31816d2269.
   Desjardins M, 2003, CURR OPIN CELL BIOL, V15, P498, DOI 10.1016/S0955-0674(03)00083-8.
   Evanoff DD, 2005, CHEMPHYSCHEM, V6, P1221, DOI 10.1002/cphc.200500113.
   Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006.
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3.
   Gong P., 2007, NANOTECHNOLOGY, V18, P604.
   Gordon YJ, 2005, CURR EYE RES, V30, P385, DOI 10.1080/02713680590934111.
   Gutierrez FM, 2010, NANOMED-NANOTECHNOL, V6, P681, DOI DOI 10.1016/J.NAN0.2010.02.001.
   Hauck TS, 2008, SMALL, V4, P153, DOI 10.1002/smll.200700217.
   Hong B, 2008, ADV EXP MED BIOL, V614, P265, DOI 10.1007/978-0-387-74911-2\_30.
   Jaiswal S, 2010, INT J ANTIMICROB AG, V36, P280, DOI 10.1016/j.ijantimicag.2010.05.006.
   Jann NJ, 2009, J LEUKOCYTE BIOL, V86, P1159, DOI 10.1189/jlb.0209053.
   Jefferson KK, 2006, METH MOL B, V341, P119.
   Jordao L, 2008, CELL MICROBIOL, V10, P529, DOI 10.1111/j.1462-5822.2007.01067.x.
   Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014.
   Khan JA, 2007, CHEMBIOCHEM, V8, P1237, DOI 10.1002/cbic.200700165.
   Kong H, 2008, LANGMUIR, V24, P2051, DOI 10.1021/la703085e.
   Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933.
   Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08.
   Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378.
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002.
   Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j.
   Richard JW, 2002, J BURNS SURG WOUND C, V1, P11.
   Salunkhe RB, 2011, APPL BIOCHEM BIOTECH, V165, P221, DOI 10.1007/s12010-011-9245-8.
   Thurn KT, 2011, NANOMED-NANOTECHNOL, V7, P123, DOI 10.1016/j.nano.2010.09.004.
   Travan A, 2009, BIOMACROMOLECULES, V10, P1429, DOI 10.1021/bm900039x.
   Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206.
   Valodkar M, 2010, CARBOHYD RES, V345, P1767, DOI 10.1016/j.carres.2010.05.005.
   Vigneshwaran N, 2007, J NANOSCI NANOTECHNO, V7, P1893, DOI 10.1166/jnn.2007.737.
   Vigneshwaran N, 2006, CARBOHYD RES, V341, P2012, DOI 10.1016/j.carres.2006.04.042.
   Wei DW, 2009, CARBOHYD RES, V344, P2375, DOI 10.1016/j.carres.2009.09.001.
   Yen HJ, 2009, SMALL, V5, P1553, DOI 10.1002/smll.200900126.
   Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{130}},
Usage-Count-Last-180-days = {{6}},
Usage-Count-Since-2013 = {{78}},
Journal-ISO = {{Nanomed.-Nanotechnol. Biol. Med.}},
Doc-Delivery-Number = {{977LJ}},
Unique-ID = {{ISI:000306662100015}},
DA = {{2018-08-13}},
}

@article{ ISI:000306332000003,
Author = {Liou, Je-Wen and Chang, Hsin-Hou},
Title = {{Bactericidal Effects and Mechanisms of Visible Light-Responsive Titanium
   Dioxide Photocatalysts on Pathogenic Bacteria}},
Journal = {{ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS}},
Year = {{2012}},
Volume = {{60}},
Number = {{4}},
Pages = {{267-275}},
Month = {{AUG}},
Abstract = {{This review focuses on the antibacterial activities of visible
   light-responsive titanium dioxide (TiO2) photocatalysts. These
   photocatalysts have a range of applications including disinfection, air
   and water cleaning, deodorization, and pollution and environmental
   control. Titanium dioxide is a chemically stable and inert material, and
   can continuously exert antimicrobial effects when illuminated. The
   energy source could be solar light; therefore, TiO2 photocatalysts are
   also useful in remote areas where electricity is insufficient. However,
   because of its large band gap for excitation, only biohazardous
   ultraviolet (UV) light irradiation can excite TiO2, which limits its
   application in the living environment. To extend its application,
   impurity doping, through metal coating and controlled calcination, has
   successfully modified the substrates of TiO2 to expand its absorption
   wavelengths to the visible light region. Previous studies have
   investigated the antibacterial abilities of visible light-responsive
   photocatalysts using the model bacteria Escherichia coli and human
   pathogens. The modified TiO2 photocatalysts significantly reduced the
   numbers of surviving bacterial cells in response to visible light
   illumination. They also significantly reduced the activity of bacterial
   endospores; reducing their toxicity while retaining their germinating
   abilities. It is suggested that the photocatalytic killing mechanism
   initially damages the surfaces weak points of the bacterial cells,
   before totally breakage of the cell membranes. The internal bacterial
   components then leak from the cells through the damaged sites. Finally,
   the photocatalytic reaction oxidizes the cell debris. In summary,
   visible light-responsive TiO2 photocatalysts are more convenient than
   the traditional UV light-responsive TiO2 photocatalysts because they do
   not require harmful UV light irradiation to function. These
   photocatalysts, thus, provide a promising and feasible approach for
   disinfection of pathogenic bacteria; facilitating the prevention of
   infectious diseases.}},
Publisher = {{SPRINGER BASEL AG}},
Address = {{PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Chang, HH (Reprint Author), Tzu Chi Univ, Dept Mol Biol \& Human Genet, 701 Sec 3,Chung Yang Rd, Hualien 970, Taiwan.
   Chang, Hsin-Hou, Tzu Chi Univ, Dept Mol Biol \& Human Genet, Hualien 970, Taiwan.
   Liou, Je-Wen, Tzu Chi Univ, Sch Med, Dept Biochem, Hualien 970, Taiwan.
   Liou, Je-Wen; Chang, Hsin-Hou, Tzu Chi Univ, Ctr Biomed Nanotechnol Res, Hualien 970, Taiwan.
   Liou, Je-Wen; Chang, Hsin-Hou, Natl Dong Hwa Univ, Nanotechnol Res Ctr, Hualien, Taiwan.}},
DOI = {{10.1007/s00005-012-0178-x}},
ISSN = {{0004-069X}},
Keywords = {{Photocatalysis; Titania; Bactericidal effect; Visible light responsive;
   Bacterial spore; Mode of action}},
Keywords-Plus = {{ANTIMICROBIAL ACTIVITY; EFFICIENT DEGRADATION; ANTIBIOTIC-RESISTANCE;
   OXIDE FILMS; SOLAR-CELL; TIO2; NITROGEN; DISINFECTION; STERILIZATION;
   IRRADIATION}},
Research-Areas = {{Immunology}},
Web-of-Science-Categories  = {{Immunology}},
Author-Email = {{hhchang@mail.tcu.edu.tw}},
ResearcherID-Numbers = {{Gung, Amber/D-9842-2011}},
Funding-Acknowledgement = {{National Science Council of Taiwan ROC {[}94-2120-M-259-003,
   95-2314-B-320-009-MY3, 95-2120-M-259-003]; Ministry of Economic Affairs,
   Taiwan, ROC {[}98-EC-17-A-19-S2-0111]; Tzu Chi University {[}TCIRP
   95002-02, TCIRP 96004-01, TCIRP 98001-01, TCRPP 99020, TCRPP100003]}},
Funding-Text = {{This work was supported by National Science Council of Taiwan ROC under
   grant no. 94-2120-M-259-003, 95-2314-B-320-009-MY3 and
   95-2120-M-259-003, and Ministry of Economic Affairs, Taiwan, ROC under
   grant no. 98-EC-17-A-19-S2-0111, and Tzu Chi University under grant no.
   TCIRP 95002-02, TCIRP 96004-01, TCIRP 98001-01, TCRPP 99020 and
   TCRPP100003.}},
Cited-References = {{Aiello AE, 2003, LANCET INFECT DIS, V3, P501, DOI 10.1016/S1473-3099(03)00723-0.
   Angelo A, 2001, CURR OPIN INFECT DIS, V14, P547.
   Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651.
   Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051.
   BARD AJ, 1982, J PHYS CHEM-US, V86, P172, DOI 10.1021/j100391a008.
   Chamakura K, 2011, COLLOID SURFACE B, V84, P88, DOI 10.1016/j.colsurfb.2010.12.020.
   Chang WK, 2007, APPL CATAL A-GEN, V321, P1, DOI 10.1016/j.apcata.2006.12.021.
   Chang WK, 2009, J ALLOY COMPD, V478, P341, DOI 10.1016/j.jallcom.2008.11.039.
   Chang WK, 2012, NANOMEDICINE NBM, V8.
   Chen FN, 2009, ENVIRON SCI TECHNOL, V43, P4606, DOI 10.1021/es900505h.
   Chen YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031212.
   Cheng CL, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-7.
   Chiou CS, 2001, J CLIN MICROBIOL, V39, P1048, DOI 10.1128/JCM.39.3.1048-1056.2001.
   Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948.
   Cong Y, 2007, J PHYS CHEM C, V111, P10618, DOI 10.1021/jp0727493.
   Cushnie TPT, 2009, CHEMOSPHERE, V74, P1374, DOI 10.1016/j.chemosphere.2008.11.012.
   Ding X, 2011, J HAZARD MATER, V190, P604, DOI 10.1016/j.jhazmat.2011.03.099.
   Ditta IB, 2008, APPL MICROBIOL BIOT, V79, P127, DOI 10.1007/s00253-008-1411-8.
   Foster HA, 2011, APPL MICROBIOL BIOT, V90, P1847, DOI 10.1007/s00253-011-3213-7.
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0.
   Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2.
   Gamage J, 2010, INT J PHOTOENERGY, DOI 10.1155/2010/764870.
   Hamal DB, 2010, LANGMUIR, V26, P2805, DOI 10.1021/la902844r.
   Hirakawa K, 2004, FREE RADICAL RES, V38, P439, DOI 10.1080/1071576042000206487.
   Ho W, 2006, CHEM COMMUN, P1115, DOI 10.1039/b515513d.
   Hu C, 2006, J PHYS CHEM B, V110, P4066, DOI 10.1021/jp0564400.
   Hu C, 2007, LANGMUIR, V23, P4982, DOI 10.1021/la063626x.
   Huang Y, 2008, LANGMUIR, V24, P3510, DOI 10.1021/la703333z.
   Jacoby WA, 1998, ENVIRON SCI TECHNOL, V32, P2650, DOI 10.1021/es980036f.
   Karunakaran C, 2010, J COLLOID INTERF SCI, V352, P68, DOI 10.1016/j.jcis.2010.08.012.
   Kau JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004167.
   Kisch H, 2002, CHEMPHYSCHEM, V3, P399, DOI 10.1002/1439-7641(20020517)3:5<399::AID-CPHC399>3.0.CO;2-H.
   Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049.
   Lee SH, 2005, COLLOID SURFACE B, V40, P93, DOI 10.1016/j.colsurfb.2004.05.005.
   Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015.
   Li WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021082.
   LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013.
   Liou JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019982.
   Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094.
   Mariam SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021147.
   Martino MC, 2005, J INFECT DIS, V192, P136, DOI 10.1086/430740.
   MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211.
   MATSUNAGA T, 1988, APPL ENVIRON MICROB, V54, P1330.
   Matusunga T, 1985, J ANTIBACT ANTIFUNG, V13, P211.
   McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147.
   Nagaveni K, 2004, J PHYS CHEM B, V108, P20204, DOI 10.1021/jp047917v.
   Navon-Venezia S, 2005, CURR OPIN INFECT DIS, V18, P306, DOI 10.1097/01.qco.0000171920.44809.f0.
   Nazeeruddin MK, 2003, J PHYS CHEM B, V107, P8981, DOI 10.1021/jp022656f.
   OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0.
   Pan XB, 2010, COLLOID SURFACE B, V77, P82, DOI 10.1016/j.colsurfb.2010.01.010.
   Ranjit KT, 2001, ENVIRON SCI TECHNOL, V35, P1544, DOI 10.1021/es001613e.
   Rehman S, 2009, J HAZARD MATER, V170, P560, DOI 10.1016/j.jhazmat.2009.05.064.
   Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8.
   SALYERS AA, 1994, BACTERIAL PATHOGENES.
   Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x.
   Tsai TM, 2010, J CHEM TECHNOL BIOT, V85, P1642, DOI 10.1002/jctb.2476.
   Tseng YH, 2006, NANOTECHNOLOGY, V17, P2490, DOI 10.1088/0957-4484/17/10/009.
   Vohra A, 2005, J IND MICROBIOL BIOT, V32, P364, DOI 10.1007/s10295-005-0006-y.
   Wolfrum EJ, 2002, ENVIRON SCI TECHNOL, V36, P3412, DOI 10.1021/es011423j.
   Wong HC, 2000, APPL ENVIRON MICROB, V66, P3981, DOI 10.1128/AEM.66.9.3981-3986.2000.
   Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05.
   Wong MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010394.
   Wu PG, 2010, ENVIRON SCI TECHNOL, V44, P6992, DOI 10.1021/es101343c.
   Wu TS, 2010, ACS APPL MATER INTER, V2, P544, DOI 10.1021/am900743d.
   Yang DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024788.
   Yang MC, 2004, THIN SOLID FILMS, V469, P1, DOI 10.1016/j.tsf.2004.06.189.
   Yang TS, 2004, SURF SCI, V548, P75, DOI 10.1016/j.susc.2003.10.044.
   Yao Y, 2008, J BIOMED MATER RES B, V85B, P453, DOI 10.1002/jbm.b.30965.
   Yu JC, 2005, ENVIRON SCI TECHNOL, V39, P1175, DOI 10.1021/es035374h.
   Zhang ZB, 1998, J PHYS CHEM B, V102, P10871, DOI 10.1021/jp982948+.
   Zhao W, 2004, J AM CHEM SOC, V126, P4782, DOI 10.1021/ja0396753.
   Zhu JF, 2006, APPL CATAL B-ENVIRON, V62, P329, DOI 10.1016/j.apcatb.2005.08.013.
   Zhu JF, 2004, J MOL CATAL A-CHEM, V216, P35, DOI 10.1016/j.molcata.2004.01.008.}},
Number-of-Cited-References = {{73}},
Times-Cited = {{55}},
Usage-Count-Last-180-days = {{6}},
Usage-Count-Since-2013 = {{159}},
Journal-ISO = {{Arch. Immunol. Ther. Exp.}},
Doc-Delivery-Number = {{973CW}},
Unique-ID = {{ISI:000306332000003}},
DA = {{2018-08-13}},
}

@article{ ISI:000305952500034,
Author = {Wellington, Kevin W. and Kolesnikova, Natasha I.},
Title = {{A laccase-catalysed one-pot synthesis of aminonaphthoquinones and their
   anticancer activity}},
Journal = {{BIOORGANIC \& MEDICINAL CHEMISTRY}},
Year = {{2012}},
Volume = {{20}},
Number = {{14}},
Pages = {{4472-4481}},
Month = {{JUL 15}},
Abstract = {{Nuclear monoamination of a 1,4-naphthohydroquinone with primary aromatic
   amines was catalysed by the commercial laccase, Novozym 51003, from
   Novozymes to afford aminonaphthoquinones. The synthesis was accomplished
   by reacting a mixture of the primary amine and 1,4-naphthohydroquinone
   in succinate-lactate buffer and a co-solvent, dimethylformamide, under
   mild reaction conditions in a vessel open to air at pH 4.5 and pH 6.0.
   Anticancer screening showed that the aminonaphthoquinones exhibited
   potent cytostatic effects particularly against the UACC62 (melanoma)
   cancer cell line (GI(50) = 3.98-7.54 mu M). One compound exhibited
   potent cytostatic effects against both the TK10 (renal) and the UACC62
   (melanoma) cancer cell line. The cytostatic effects of this compound
   (GI(50) = 8.38 mu M) against the TK10 cell line was almost as good as
   that of the anticancer agent, etoposide (GI(50) = 7.19 mu M). Two
   compounds exhibited potent cytostatic effects against both the UACC62
   (melanoma) and the MCF7 (breast) cancer cell lines. The total growth
   inhibition (TGI) of most of the compounds was better than that of
   etoposide against the UACC62 cell line. Three compounds (TGI = 7.17-7.94
   mu M) exhibited potent cytostatic effects against the UACC62 cell line
   which was 7 to 8-fold better than that of etoposide (TGI = 52.71 mu M).
   The results are encouraging for further study of the
   aminonaphthoquinones for potential application in anticancer therapy.
   (C) 2012 Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wellington, KW (Reprint Author), CSIR Biosci, POB 395, Pretoria, South Africa.
   Wellington, Kevin W.; Kolesnikova, Natasha I., CSIR Biosci, Pretoria, South Africa.}},
DOI = {{10.1016/j.bmc.2012.05.028}},
ISSN = {{0968-0896}},
EISSN = {{1464-3391}},
Keywords = {{Biocatalysis; Laccase; Oxidative enzymes; 1,4-Naphthohydroquinones;
   Aminonaphthoquinones; C-N bond formation; Primary amines; Monoamination;
   Anticancer agents; Cytostatic effects; Cytotoxic effects; GI(50); TGI;
   LC50}},
Keywords-Plus = {{DNA TOPOISOMERASE-I; MULTIDRUG-RESISTANCE; NUCLEAR AMINATION; FUNGAL
   LACCASES; 1,4-NAPHTHOQUINONE DERIVATIVES; NAPHTHOQUINONYL DERIVATIVES;
   ANTIPROLIFERATIVE ACTIVITY; ANTIALLERGIC ACTIVITIES; CYTOTOXIC PEPTIDES;
   GREEN CHEMISTRY}},
Research-Areas = {{Biochemistry \& Molecular Biology; Pharmacology \& Pharmacy; Chemistry}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Chemistry, Medicinal; Chemistry,
   Organic}},
Author-Email = {{kwellington@csir.co.za}},
ORCID-Numbers = {{Wellington, Kevin/0000-0002-4242-566X}},
Funding-Acknowledgement = {{CSIR}},
Funding-Text = {{We thank the CSIR (Thematic A grant) for financial support and Novozymes
   SA for a donation of Novozym 51003.}},
Cited-References = {{Baldrian P, 2004, APPL MICROBIOL BIOT, V63, P560, DOI 10.1007/s00253-003-1434-0.
   Benites J, 2010, EUR J MED CHEM, V45, P6052, DOI 10.1016/j.ejmech.2010.10.006.
   Burton SG, 2003, CURR ORG CHEM, V7, P1317, DOI 10.2174/1385272033486477.
   Chae GH, 1999, ARCH PHARM RES, V22, P507, DOI 10.1007/BF02979161.
   Chakraborty M, 1998, J ORG CHEM, V63, P7563, DOI 10.1021/jo980541v.
   Claus H, 2004, MICRON, V35, P93, DOI 10.1016/j.micron.2003.10.029.
   da Silva AJM, 2002, BIOORGAN MED CHEM, V10, P2731, DOI 10.1016/S0968-0896(02)00100-1.
   Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9.
   Gao D, 2002, BIOL PHARM BULL, V25, P827, DOI 10.1248/bpb.25.827.
   GEORGIEV GP, 1963, NATURE, V200, P1291, DOI 10.1038/2001291a0.
   Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060.
   HATA T, 1956, J ANTIBIOT, V9, P141.
   Huang LJ, 1998, BIOORGAN MED CHEM, V6, P2261, DOI 10.1016/S0968-0896(98)80006-0.
   Huang ST, 2002, BIOORGAN MED CHEM, V10, P1947, DOI 10.1016/S0968-0896(02)00004-4.
   Huang Y, 2006, CANCER LETT, V239, P168, DOI 10.1016/j.canlet.2005.07.032.
   Ilina T V, 2002, Dokl Biochem Biophys, V382, P56, DOI 10.1023/A:1014467509828.
   Inbaraj JJ, 2004, CHEM RES TOXICOL, V17, P55, DOI 10.1021/tx034132s.
   Jin YR, 2004, PHARMACOLOGY, V70, P195, DOI 10.1159/000075548.
   Kim HJ, 2003, FEBS LETT, V555, P217, DOI 10.1016/S0014-5793(03)01238-9.
   Kim HJ, 2003, ARCH PHARM RES, V26, P405, DOI 10.1007/BF02976698.
   Kim Y, 2001, ARCH PHARM, V334, P318.
   Koroleva OV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P618, DOI 10.1023/A:1010299012591.
   Kumagai Y, 1997, ENVIRON TOXICOL PHAR, V3, P245, DOI 10.1016/S1382-6689(97)00019-7.
   Kurniawati S, 2008, BIORESOURCE TECHNOL, V99, P7825, DOI 10.1016/j.biortech.2008.01.084.
   Kwang-Soo S., 1998, BIOTECHNOL TECH, V12, P101.
   Lee SK, 2002, J AM CHEM SOC, V124, P6180, DOI 10.1021/ja0114052.
   Leonowicz A, 2001, J BASIC MICROB, V41, P185, DOI 10.1002/1521-4028(200107)41:3/4<185::AID-JOBM185>3.0.CO;2-T.
   Lien JC, 2002, CHEM PHARM BULL, V50, P672, DOI 10.1248/cpb.50.672.
   Lien JC, 1996, CHEM PHARM BULL, V44, P1181.
   Litman T, 2001, CELL MOL LIFE SCI, V58, P931, DOI 10.1007/PL00000912.
   LOWN JW, 1977, BIOCHEM BIOPH RES CO, V76, P705.
   Mayer AM, 2002, PHYTOCHEMISTRY, V60, P551, DOI 10.1016/S0031-9422(02)00171-1.
   MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757.
   Morozova V, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1136, DOI 10.1134/S0006297907100112.
   Niedermeyer THJ, 2005, J ORG CHEM, V70, P2002, DOI 10.1021/jo048454s.
   Niedermeyer THJ, 2007, J MOL CATAL B-ENZYM, V45, P113, DOI 10.1016/j.molcatb.2006.12.006.
   Rahimipour S, 1996, LETT PEPT SCI, V3, P263, DOI 10.1007/BF00127660.
   Rahimipour S, 1998, LETT PEPT SCI, V5, P421, DOI 10.1023/A:1008855430212.
   RAO KV, 1963, J AM CHEM SOC, V85, P2532, DOI 10.1021/ja00899a051.
   Ravelo AG, 2004, CURR TOP MED CHEM, V4, P241.
   Richwien A, 2004, PHARMAZIE, V59, P163.
   Riva S, 2006, TRENDS BIOTECHNOL, V24, P219, DOI 10.1016/j.tibtech.2006.03.006.
   Sasaki K, 1970, J Am Chem Soc, V92, P7591, DOI 10.1021/ja00729a018.
   Sasaki K, 2002, BIOL PHARM BULL, V25, P669, DOI 10.1248/bpb.25.669.
   Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2.
   Sellek GA, 1999, ENZYME MICROB TECH, V25, P471, DOI 10.1016/S0141-0229(99)00075-7.
   SENSI P., 1964, RES PROG ORG BIOL MED CHEM, V1, P337.
   Shin KS, 2000, ARCH BIOCHEM BIOPHYS, V384, P109, DOI 10.1006/abbi.2000.2083.
   Shleev S, 2005, BIOELECTROCHEMISTRY, V67, P115, DOI 10.1016/j.bioelechem.2005.02.004.
   Shleev SV, 2004, BIOCHIMIE, V86, P693, DOI 10.1016/j.biochi.2004.08.005.
   SILVERMAN RB, 1992, ORGANIC CHEM DRUG DE.
   SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107.
   Song GY, 2000, EUR J MED CHEM, V35, P291, DOI 10.1016/S0223-5234(00)00129-X.
   Song GY, 1999, BIOORG MED CHEM LETT, V9, P2407, DOI 10.1016/S0960-894X(99)00397-2.
   Song GY, 2000, ARCH PHARM, V333, P87, DOI 10.1002/(SICI)1521-4184(20004)333:4<87::AID-ARDP87>3.0.CO;2-1.
   Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984.
   Tandon V K, 2002, Boll Chim Farm, V141, P304.
   Tandon VK, 2004, BIOORG MED CHEM LETT, V14, P1079, DOI 10.1016/j.bmcl.2004.01.002.
   TEWEY KM, 1984, J BIOL CHEM, V259, P9182.
   Ting C.-Y., 1981, BIOCHEM PHARMACOL, V2003, P66.
   WAKAKI S., 1958, ANTIBIOT AND CHEMOTHER, V8, P228.
   WAKAKI S, 1961, CANCER CHEMOTH REP, P79.
   WEBB JS, 1962, J AM CHEM SOC, V84, P3185, DOI 10.1021/ja00875a032.
   Wellington KW, 2010, BIOORGAN MED CHEM, V18, P1406, DOI 10.1016/j.bmc.2010.01.025.
   Witayakran S, 2009, ADV SYNTH CATAL, V351, P1187, DOI 10.1002/adsc.200800775.
   Wu CC, 2011, SCIENCE, V333, P459, DOI 10.1126/science.1204117.
   Wurm G, 2003, PHARMAZIE, V58, P531.
   Xu F, 1996, BIOCHEMISTRY-US, V35, P7608, DOI 10.1021/bi952971a.
   YAROPOLOV AI, 1994, APPL BIOCHEM BIOTECH, V49, P257, DOI 10.1007/BF02783061.
   Yuk DY, 2000, BIOCHEM PHARMACOL, V60, P1001, DOI 10.1016/S0006-2952(00)00411-1.
   Zhang YH, 2001, BIOL PHARM BULL, V24, P618, DOI 10.1248/bpb.24.618.}},
Number-of-Cited-References = {{71}},
Times-Cited = {{36}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{32}},
Journal-ISO = {{Bioorg. Med. Chem.}},
Doc-Delivery-Number = {{968BR}},
Unique-ID = {{ISI:000305952500034}},
DA = {{2018-08-13}},
}

@article{ ISI:000305675400013,
Author = {Friese, Anika and Schulz, Jochen and Hoehle, Laura and Fetsch, Alexandra
   and Tenhagen, Bernd-Alois and Hartung, Joerg and Roesler, Uwe},
Title = {{Occurrence of MRSA in air and housing environment of pig barns}},
Journal = {{VETERINARY MICROBIOLOGY}},
Year = {{2012}},
Volume = {{158}},
Number = {{1-2}},
Pages = {{129-135}},
Month = {{JUL 6}},
Abstract = {{A high prevalence of MRSA among farm animals, especially pigs, has been
   observed for some time. However, knowledge on transmission routes of
   MRSA in livestock production is still scarce. Therefore, the aim of this
   study was to determine the occurrence of MRSA in pig house air as well
   as in samples from pigs and their housing environment in 27 MRSA
   positive pig barns of different sizes and production types.
   In 85.2\% of all barns MRSA was detected in the animal house air.
   Impingement turned out to be a more sensitive sampling technique than
   filtration. Other environmental samples such as boot swabs or faeces
   showed prevalences of MRSA from 55.6\% to 85.2\% at sample level. The
   level of MRSA was 88.3\% for pooled and 82.1\% for single nasal swabs,
   in skin swabs the one was 87.7\%, the others was 78.7\%. Spa typing of
   isolates from air and nasal swabs showed predominantly spa types toll
   and t034. MRSA prevalences in pigs as well as in various environmental
   samples were significantly higher in fattening farms than in breeding
   farms. This study provides good reference that there could be an
   airborne transmission of MRSA within pig herds indicating a potential
   contamination of the environment of barns. (C) 2012 Elsevier B.V. All
   rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Friese, A (Reprint Author), Free Univ Berlin, Inst Anim Hyg \& Environm Hlth, Philippstr 13, D-10115 Berlin, Germany.
   Friese, Anika; Hoehle, Laura; Roesler, Uwe, Free Univ Berlin, Inst Anim Hyg \& Environm Hlth, D-10115 Berlin, Germany.
   Schulz, Jochen; Hartung, Joerg, Univ Vet Med Hannover, Inst Anim Hyg Anim Welf \& Farm Anim Behav, D-30559 Hannover, Germany.
   Fetsch, Alexandra; Tenhagen, Bernd-Alois, Fed Inst Risk Assessment, D-12277 Berlin, Germany.}},
DOI = {{10.1016/j.vetmic.2012.01.019}},
ISSN = {{0378-1135}},
Keywords = {{Methicillin resistant Staphylococcus aureus MRSA; Antibiotic resistance;
   Air sample; Pig; Livestock}},
Keywords-Plus = {{RESISTANT STAPHYLOCOCCUS-AUREUS; LIVESTOCK-ASSOCIATED MRSA;
   ANTIBIOTIC-RESISTANT; HERD PREVALENCE; SLAUGHTER PIGS; COLONIZATION;
   ANIMALS; HUMANS; FARMS; OPERATIONS}},
Research-Areas = {{Microbiology; Veterinary Sciences}},
Web-of-Science-Categories  = {{Microbiology; Veterinary Sciences}},
Author-Email = {{friese.anika@vetmed.fu-berlin.de}},
Funding-Acknowledgement = {{German Federal Ministry of Food, Agriculture and Consumer Protection
   (BMELV) through the Federal Office for Agriculture and Food (BLE)
   {[}2808HS029, 2808HS041]}},
Funding-Text = {{This work was financially supported by the German Federal Ministry of
   Food, Agriculture and Consumer Protection (BMELV) through the Federal
   Office for Agriculture and Food (BLE), grant number 2808HS029 and
   2808HS041. All cooperating farmers as well as the excellent technical
   assistance of H. Jansen, S. Hansicke and K. Fiedler (Institute for
   Animal Hygiene and Environmental Health) are greatfully acknowledged.}},
Cited-References = {{Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008.
   Broens EM, 2011, PREV VET MED, V102, P41, DOI 10.1016/j.prevetmed.2011.06.005.
   Broens EM, 2011, PREV VET MED, V98, P182, DOI 10.1016/j.prevetmed.2010.10.010.
   Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800.
   Cuny C, 2009, DEUT TIERARZTL WOCH, V116, P284, DOI 10.2376/0341-6593-116-284.
   de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027.
   EFSA (European Food Safety Authority), 2009, EFSA J, V7, P1376, DOI {[}10.2903/j.efsa.2009.1376, DOI 10.2903/J.EFSA.2009.1376].
   EFSA (European Food Safety Authority), 2010, EFSA J, V8, P1597, DOI DOI 10.2903/J.EFSA.2010.1597.
   Floras A, 2010, VET REC, V166, P826, DOI 10.1136/vr.b4870.
   Gibbs SG, 2004, J OCCUP ENVIRON HYG, V1, P699, DOI 10.1080/15459620490515824.
   Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910.
   Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830.
   Green CF, 2006, J OCCUP ENVIRON HYG, V3, P9, DOI 10.1080/15459620500430615.
   Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003.
   Harper AL, 2010, J AGROMEDICINE, V15, P101, DOI 10.1080/10599241003627110.
   Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006.
   Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4.
   Lee JH, 2003, APPL ENVIRON MICROB, V69, P6489, DOI {[}10.1128/AEM.69.11.6489-6494.2003, 10.1128/AEM.69.11.6489-6496.2003].
   Nathaus R, 2011, BERL MUNCH TIERARZTL, V124, P128, DOI 10.2376/0005-9366-124-128.
   Nathaus R, 2010, BERL MUNCH TIERARZTL, V123, P221, DOI 10.2376/0005-9366-123-221.
   Nemati M, 2008, ANTIMICROB AGENTS CH, V52, P3817, DOI 10.1128/AAC.00613-08.
   Overesch G, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-30.
   Pasanen T, 2010, APMIS, V118, P74, DOI 10.1111/j.1600-0463.2009.02562.x.
   Pletinckx LJ, 2011, INFECT GENET EVOL, V11, P2133, DOI 10.1016/j.meegid.2011.07.008.
   Schulz J, 2009, GEFAHRSTOFFE REINHAL, V9, P348.
   Spohr M, 2011, ZOONOSES PUBLIC HLTH, V58, P252, DOI 10.1111/j.1863-2378.2010.01344.x.
   Springer B, 2009, WIEN KLIN WOCHENSCHR, V121, P86, DOI 10.1007/s00508-008-1126-y.
   Szabo I., 2011, APPL ENVIRON MICROB, V78, P541.
   Tenhagen BA, 2009, VET REC, V165, P589, DOI 10.1136/vr.165.20.589.
   Tokateloff N, 2009, CAN VET J, V50, P1177.
   van de Giessen AW, 2009, PREV VET MED, V91, P270, DOI 10.1016/j.prevetmed.2009.05.016.
   Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507.
   Vanderhaeghen W, 2010, EPIDEMIOL INFECT, V138, P606, DOI 10.1017/S0950268809991567.
   Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428.
   Wang Z, 2001, J AEROSOL SCI, V32, P661, DOI 10.1016/S0021-8502(00)00108-7.}},
Number-of-Cited-References = {{35}},
Times-Cited = {{47}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{32}},
Journal-ISO = {{Vet. Microbiol.}},
Doc-Delivery-Number = {{964EB}},
Unique-ID = {{ISI:000305675400013}},
DA = {{2018-08-13}},
}

@article{ ISI:000305977200020,
Author = {Drudge, Christopher N. and Krajden, Sigmund and Summerbell, Richard C.
   and Scott, James A.},
Title = {{Detection of antibiotic resistance genes associated with
   methicillin-resistant Staphylococcus aureus (MRSA) and
   coagulase-negative staphylococci in hospital air filter dust by PCR}},
Journal = {{AEROBIOLOGIA}},
Year = {{2012}},
Volume = {{28}},
Number = {{2}},
Pages = {{285-289}},
Month = {{JUN}},
Abstract = {{Dust from the pre-filters of stand-alone hospital isolation room air
   cleaners was tested by PCR for the presence of antibiotic resistance
   genes associated with methicillin-resistant Staphylococcus aureus (MRSA)
   and coagulase-negative staphylococci. Resistance genes for three classes
   of antibiotics (aac(6')-aph(2 `'), ermA, and mecA) were detected in
   multiple samples, indicating the presence of genetic material and likely
   cells of multidrug-resistant MRSA and other staphylococci in hospital
   air and that stand-alone air cleaners can reduce airborne levels of
   these contaminants. Screening for vanA was negative. Our results further
   suggest that dust may serve as an important reservoir of genetic
   elements that can confer drug resistance.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Scott, JA (Reprint Author), Univ Toronto, Dalla Lana Sch Publ Hlth, 223 Coll St, Toronto, ON M5T 1R4, Canada.
   Drudge, Christopher N.; Summerbell, Richard C.; Scott, James A., Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 1R4, Canada.
   Krajden, Sigmund, St Josephs Hlth Ctr, Toronto, ON M6R 1B5, Canada.
   Summerbell, Richard C.; Scott, James A., Sporometrics, Toronto, ON M6K 1Y9, Canada.}},
DOI = {{10.1007/s10453-011-9219-x}},
ISSN = {{0393-5965}},
Keywords = {{Hospital infection control; Bioaerosols; Drug resistance genes; Air
   cleaners; Dust microbiology}},
Keywords-Plus = {{MULTIPLEX PCR; UNITED-STATES; ENVIRONMENT}},
Research-Areas = {{Life Sciences \& Biomedicine - Other Topics; Environmental Sciences \&
   Ecology}},
Web-of-Science-Categories  = {{Biology; Environmental Sciences}},
Author-Email = {{james.scott@utoronto.ca}},
ResearcherID-Numbers = {{Scott, James/A-8598-2011}},
ORCID-Numbers = {{Scott, James/0000-0002-5073-0832}},
Funding-Acknowledgement = {{AllerGen NCE; Ontario Workplace Safety and Insurance Board (WSIB)}},
Funding-Text = {{This study was funded in part by grants from AllerGen NCE and the
   Ontario Workplace Safety and Insurance Board (WSIB). All authors report
   no potential conflicts of interest with regard to this article.
   Elizabeth Lamb from Abatement Technologies kindly provided performance
   specifications of two of the devices tested.}},
Cited-References = {{Cimolai N, 2008, EUR J CLIN MICROBIOL, V27, P481, DOI 10.1007/s10096-008-0471-0.
   CLARK NC, 1993, ANTIMICROB AGENTS CH, V37, P2311, DOI 10.1128/AAC.37.11.2311.
   Coia JE, 2006, J HOSP INFECT, V63, pS1, DOI 10.1016/j.jhin.2006.01.001.
   Dancer SJ, 2008, LANCET INFECT DIS, V8, P101, DOI 10.1016/S1473-3099(07)70241-4.
   GEHA DJ, 1994, J CLIN MICROBIOL, V32, P1768.
   Gilbert Y, 2010, AEROBIOLOGIA, V26, P185, DOI 10.1007/s10453-010-9155-1.
   Kumari DNP, 1998, J HOSP INFECT, V39, P127, DOI 10.1016/S0195-6701(98)90326-7.
   Lina G, 1999, ANTIMICROB AGENTS CH, V43, P1062.
   Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461.
   Martineau F, 2000, J ANTIMICROB CHEMOTH, V46, P527, DOI 10.1093/jac/46.4.527.
   Otter JA, 2007, INFECT CONT HOSP EP, V28, P1003, DOI 10.1086/519207.
   Sievert DM, 2008, CLIN INFECT DIS, V46, P668, DOI 10.1086/527392.
   Stanley NJ, 2008, J ENVIRON MONITOR, V10, P474, DOI 10.1039/b719316e.}},
Number-of-Cited-References = {{13}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{6}},
Usage-Count-Since-2013 = {{41}},
Journal-ISO = {{Aerobiologia}},
Doc-Delivery-Number = {{968JV}},
Unique-ID = {{ISI:000305977200020}},
DA = {{2018-08-13}},
}

@article{ ISI:000304795300015,
Author = {Liu, Dunjiang and Chai, Tongjie and Xia, Xianzhu and Gao, Yuwei and Cai,
   Yumei and Li, Xiaoxia and Miao, Zengming and Sun, Lingyu and Hao, Haiyu
   and Roesler, Uwe and Wang, Jian},
Title = {{Formation and transmission of Staphylococcus aureus (including MRSA)
   aerosols carrying antibiotic-resistant genes in a poultry farming
   environment}},
Journal = {{SCIENCE OF THE TOTAL ENVIRONMENT}},
Year = {{2012}},
Volume = {{426}},
Pages = {{139-145}},
Month = {{JUN 1}},
Abstract = {{There is a rather limited understanding concerning the
   antibiotic-resistance of the airborne S. aureus and the transmission of
   the antibiotic-resistant genes it carries Therefore, we isolated 149 S.
   aureus strains from the samples collected from the feces, the indoor air
   and the outdoor air of 6 chicken farms, and performed the research on
   them with 15 types of antibiotics and the REP-PCR trace identification.
   The 100\% homologous strains were selected to conduct the research on
   the carrying and transmission status of the antibiotic-resistant genes.
   The results revealed that 5.37\% strains (8/149) were resistant to
   methicillins (MRSA), and 94\% strains (140/149) were resistant to
   compound sulfamethoxazole, etc. In addition, these strains displayed a
   resistance to multiple antibiotics (4, 5 or 6 types) and there were also
   3 strains resistant to 9 antibiotics. It should be noted that the
   antibiotic-resistance of some strains isolated from the feces, the
   indoor and outdoor air was basically the same, and the strains with the
   same REP-PCR trace identification result carried the same type of
   antibiotic-resistant genes. The results showed that airborne
   transmission not only causes the spread of epidemic diseases but also
   exerts threats to the public health of a community. (C) 2012 Elsevier
   B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chai, TJ (Reprint Author), Shandong Agr Univ, Coll Anim Sci \& Vet Med, Sinogerman Cooperat Res Ctr Zoonosis Anim Origin, Daizong St 61, Tai An 271018, Shandong, Peoples R China.
   Liu, Dunjiang; Chai, Tongjie; Cai, Yumei; Sun, Lingyu; Hao, Haiyu, Shandong Agr Univ, Coll Anim Sci \& Vet Med, Sinogerman Cooperat Res Ctr Zoonosis Anim Origin, Tai An 271018, Shandong, Peoples R China.
   Xia, Xianzhu; Gao, Yuwei, Inst Mil Vet PLA, Changchun, Peoples R China.
   Li, Xiaoxia; Miao, Zengming, Taishan Med Univ, Dept Pathogen Biol, Tai An, Shandong, Peoples R China.
   Roesler, Uwe, Free Univ Berlin, Inst Anim Hyg \& Environm Hlth, Berlin, Germany.}},
DOI = {{10.1016/j.scitotenv.2012.03.060}},
ISSN = {{0048-9697}},
Keywords = {{Chicken farming environment; Aerosols of Staphylococcus aureus including
   MRSA; REP-PCR tracing; Antibiotic-resistance; Antibiotic-resistant
   genes; Significance to epidemiology and public health}},
Keywords-Plus = {{AIRBORNE BACTERIA; MULTIPLEX PCR; STRAINS; IDENTIFICATION; PREVALENCE;
   EVOLUTION; INFECTION}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{chaitj117@163.com
   xiaxzh@cae.cn}},
ResearcherID-Numbers = {{Amoako, Daniel Gyamfi/I-4223-2018}},
Funding-Acknowledgement = {{Chinese International Cooperation Program ``Monitoring of animal-borne
   zoonoses{''} {[}2009DFA32890]; State Key Laboratory for Environmental
   Protection, Using of Environmental Microbiology and Security Controls;
   Chinese National Natural Science Foundation {[}81101307]}},
Funding-Text = {{This study was sponsored by the following foundation programs: Chinese
   International Cooperation Program ``Monitoring of animal-borne
   zoonoses{''} {[}2009DFA32890]; the open fund 2011 of the State Key
   Laboratory for Environmental Protection, Using of Environmental
   Microbiology and Security Controls; and Chinese National Natural Science
   Foundation {[}No. 81101307].}},
Cited-References = {{ANDERSEN AA, 1958, J BACTERIOL, V76, P471.
   {[}Anonymous], INTERNET J INFECT DI.
   {[}Anonymous], 2006, M100S15 CLSI.
   Arbuthnott J P, 1990, Soc Appl Bacteriol Symp Ser, V19, p101S.
   Borges LGD, 2003, FEMS MICROBIOL ECOL, V45, P173, DOI 10.1016/S0168-6496(03)00147-8.
   Davies B., 1994, PRACTITIONER TEACHER.
   de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007.
   Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x.
   Donaldson A., 1999, MICROBIOL TODAY, V26, P18.
   Duan HY, 2009, ENVIRON RES, V109, P511, DOI 10.1016/j.envres.2009.02.014.
   Duan Huiyong, 2008, SCI CHINA, V2, P164.
   Duan HY, 2006, BERL MUNCH TIERARZTL, V119, P40.
   ENGEL HWB, 1980, J BACTERIOL, V142, P407.
   Faria NA, 2005, J CLIN MICROBIOL, V43, P1836, DOI 10.1128/JCM.43.4.1836-1842.2005.
   Hiramatsu K, 2002, INT J MED MICROBIOL, V292, P67, DOI 10.1078/1438-4221-00192.
   JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a.
   Kuhn G, 2006, J BACTERIOL, V188, P169, DOI 10.1128/JB.188.1.169-178.2006.
   Lee AKY, 2007, ATMOS ENVIRON, V41, P2831, DOI 10.1016/j.atmosenv.2006.11.047.
   Lim SK, 2007, INT J FOOD MICROBIOL, V116, P283, DOI 10.1016/j.ijfoodmicro.2006.12.014.
   Martineau F, 2000, ANTIMICROB AGENTS CH, V44, P231, DOI 10.1128/AAC.44.2.231-238.2000.
   Mi ZH, 2004, MOD PRACT MED, V16, P13.
   Mi Zuhuang, 2005, J CLIN PEDIAT, V23, P422.
   MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240.
   Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976.
   Ng LK, 2001, MOL CELL PROBE, V15, P209, DOI 10.1006/mcpr.2001.0363.
   Recchia GD, 1999, MOL MICROBIOL, V34, P1146, DOI 10.1046/j.1365-2958.1999.01668.x.
   Solomon S, 2003, AM J INFECT CONTROL, V31, P481.
   Trzcinski K, 2000, J ANTIMICROB CHEMOTH, V45, P763, DOI 10.1093/jac/45.6.763.
   van der Zee A, 1999, J CLIN MICROBIOL, V37, P342.
   VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823.
   Zhong Z, 2009, INDOOR AIR, V19, P511, DOI 10.1111/j.1600-0668.2009.00618.x.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{5}},
Usage-Count-Since-2013 = {{58}},
Journal-ISO = {{Sci. Total Environ.}},
Doc-Delivery-Number = {{952LZ}},
Unique-ID = {{ISI:000304795300015}},
DA = {{2018-08-13}},
}

@article{ ISI:000304788500024,
Author = {Maisch, Tim and Shimizu, Tetsuji and Isbary, Georg and Heinlin, Julia
   and Karrer, Sigrid and Klaempfl, Tobias G. and Li, Yang-Fang and
   Morfill, Gregor and Zimmermann, Julia L.},
Title = {{Contact-Free Inactivation of Candida albicans Biofilms by Cold
   Atmospheric Air Plasma}},
Journal = {{APPLIED AND ENVIRONMENTAL MICROBIOLOGY}},
Year = {{2012}},
Volume = {{78}},
Number = {{12}},
Pages = {{4242-4247}},
Month = {{JUN}},
Abstract = {{Candida albicans is one of the main species able to form a biofilm on
   almost any surface, causing both skin and superficial mucosal
   infections. The worldwide increase in antifungal resistance has led to a
   decrease in the efficacy of standard therapies, prolonging treatment
   time and increasing health care costs. Therefore, the aim of this work
   was to demonstrate the applicability of atmospheric plasma at room
   temperature for inactivating C. albicans growing in biofilms without
   thermally damaging heat-sensitive materials. This so-called cold
   atmospheric plasma is produced by applying high voltage to accelerate
   electrons, which ionize the surrounding air, leading to the production
   of charged particles, reactive species, and photons. A newly developed
   plasma device was used, which exhibits a large plasma-generating surface
   area of 9 by 13 cm (117 cm(2)). Different time points were selected to
   achieve an optimum inactivation efficacy range of >= 3 log(10) to 5
   log(10) reduction in CFU per milliliter, and the results were compared
   with those of 70\% ethanol. The results obtained show that contact-free
   antifungal inactivation of Candida biofilms by cold atmospheric plasma
   is a promising tool for disinfection of surfaces (and items) in both
   health care settings and the food industry, where ethanol disinfection
   should be avoided.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Maisch, T (Reprint Author), Regensburg Univ Hosp, Dept Dermatol, Regensburg, Germany.
   Maisch, Tim; Heinlin, Julia; Karrer, Sigrid, Regensburg Univ Hosp, Dept Dermatol, Regensburg, Germany.
   Shimizu, Tetsuji; Klaempfl, Tobias G.; Li, Yang-Fang; Morfill, Gregor; Zimmermann, Julia L., Max Planck Inst Extraterr Phys, D-37075 Garching, Germany.
   Isbary, Georg, Hosp Munich Schwabing, Dept Dermatol Allergol \& Environm Med, Munich, Germany.}},
DOI = {{10.1128/AEM.07235-11}},
ISSN = {{0099-2240}},
Keywords-Plus = {{ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-AUREUS; PHOTODYNAMIC THERAPY;
   DISCHARGE PLASMA; DRUG-RESISTANCE; CHLORHEXIDINE; PERSPECTIVE;
   INFECTIONS; DEFENSINS; ADHERENCE}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Microbiology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Microbiology}},
Author-Email = {{tim.maisch@klinikuni-regensburg.de}},
ResearcherID-Numbers = {{Shimizu, Tetsuji/L-1478-2018}},
ORCID-Numbers = {{Shimizu, Tetsuji/0000-0001-9432-1152}},
Funding-Acknowledgement = {{Max Planck Institute for Extraterrestrial Physics, Garching, Germany
   {[}M.TT.A.EXT00002]}},
Funding-Text = {{Tim Maisch was supported by a grant (M.TT.A.EXT00002) from the Max
   Planck Institute for Extraterrestrial Physics, Garching, Germany.}},
Cited-References = {{Autio-Gold J, 2008, OPER DENT, V33, P710, DOI 10.2341/08-3.
   Biel MA, 2010, METHODS MOL BIOL, V635, P175, DOI 10.1007/978-1-60761-697-9\_13.
   Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391.
   Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101.
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001.
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002.
   Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1.
   Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0.
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010.
   Ganz T, 2005, COMB CHEM HIGH T SCR, V8, P209, DOI 10.2174/1386207053764594.
   Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180.
   GREENSTEIN G, 1986, J PERIODONTOL, V57, P370, DOI 10.1902/jop.1986.57.6.370.
   Hoyle B D, 1991, Prog Drug Res, V37, P91.
   Hury S, 1998, LETT APPL MICROBIOL, V26, P417.
   Jabra-Rizk MA, 2004, EMERG INFECT DIS, V10, P14, DOI 10.3201/eid1001.030119.
   Jori G, 2006, LASER SURG MED, V38, P468, DOI 10.1002/lsm.20361.
   Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002.
   Kelly-Wintenberg K, 1998, J IND MICROBIOL BIOT, V20, P69, DOI 10.1038/sj.jim.2900482.
   Koban I, 2010, NEW J PHYS, V12, P1.
   Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385.
   KONG MG, 2009, NEW J PHYS, V11, P1.
   Kowalski WJ, 1998, OZONE-SCI ENG, V20, P205, DOI 10.1080/01919519808547272.
   Krautheim AB, 2004, CONTACT DERMATITIS, V50, P113, DOI 10.1111/j.0105-1873.2004.00308.x.
   Lamagni TL, 2001, EPIDEMIOL INFECT, V126, P397, DOI 10.1017/S0950268801005507.
   Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X.
   MORFILL GE, 2009, NEW J PHYS, V11, P10.
   Radford DR, 1998, J DENT, V26, P577, DOI 10.1016/S0300-5712(97)00034-1.
   Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005.
   ROTROSEN D, 1986, REV INFECT DIS, V8, P73.
   SHIMIZU T, 2011, NEW J PHYS, V13, P1.
   Theraud M, 2004, J MED MICROBIOL, V53, P1013, DOI 10.1099/jmm.0.05474-0.
   Uppuluri P, 2009, FUTURE MICROBIOL, V4, P1235, DOI 10.2217/FMB.09.85.
   Uppuluri P, 2009, MYCOPATHOLOGIA, V168, P101, DOI 10.1007/s11046-009-9205-9.
   Zimmermann JL, 2011, J PHYS D, V44, P1.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{45}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{37}},
Journal-ISO = {{Appl. Environ. Microbiol.}},
Doc-Delivery-Number = {{952JJ}},
Unique-ID = {{ISI:000304788500024}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000304866600006,
Author = {Hong, Pei-Ying and Li, Xiangzhen and Yang, Xufei and Shinkai, Takumi and
   Zhang, Yuanhui and Wang, Xinlei and Mackie, Roderick I.},
Title = {{Monitoring airborne biotic contaminants in the indoor environment of pig
   and poultry confinement buildings}},
Journal = {{ENVIRONMENTAL MICROBIOLOGY}},
Year = {{2012}},
Volume = {{14}},
Number = {{6}},
Pages = {{1420-1431}},
Month = {{JUN}},
Abstract = {{Given the growing concerns over human and animal health issues related
   to confined animal feeding operations, an in-depth examination is
   required to monitor for airborne bacteria and associated antibiotic
   resistance genes. Our 16S rRNA-based pyrosequencing revealed that the
   airborne microbial community skewed towards a higher abundance of
   Firmicutes (> 59.2\%) and Bacteroidetes (4.231.4\%) within the
   confinement buildings, while the office environment was predominated by
   Proteobacteria (55.2\%). Furthermore, bioaerosols in the confinement
   buildings were sporadically associated with genera of potential
   pathogens, and these genera were more frequently observed in the
   bioaerosols of pig and layer hen confinement than the turkey confinement
   buildings and office environment. High abundances of tetracycline
   resistance genes (9.55 X 102 to 1.69 X 106 copies ng-1 DNA) were also
   detected in the bioaerosols sampled from confinement buildings.
   Bacterial lineages present in the poultry bioaerosols clustered apart
   from those present in the pig bioaerosols and among the different phases
   of pig production, suggesting that different livestock as well as
   production phase were associated with a distinct airborne microbial
   community. By understanding the diversity of biotic contaminants
   associated with the different confinement buildings, this study
   facilitates the implementation of better management strategies to
   minimize potential health impacts on both livestock and humans working
   in this environment.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mackie, RI (Reprint Author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.
   Hong, Pei-Ying; Li, Xiangzhen; Shinkai, Takumi; Mackie, Roderick I., Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.
   Yang, Xufei; Zhang, Yuanhui; Wang, Xinlei, Univ Illinois, Dept Agr \& Biol Engn, Urbana, IL 61801 USA.
   Mackie, Roderick I., Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.}},
DOI = {{10.1111/j.1462-2920.2012.02726.x}},
ISSN = {{1462-2912}},
Keywords-Plus = {{TETRACYCLINE RESISTANCE GENES; RESPIRATORY-TRACT INFECTIONS; SWINE
   PRODUCTION FACILITIES; ANTIBIOTIC-RESISTANCE; NORTH-CAROLINA; RNA;
   OPERATIONS; DIVERSITY; MORAXELLA; COMMUNITY}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{r-mackie@illinois.edu}},
ResearcherID-Numbers = {{Yang, Xufei/N-3317-2013
   Hong, Peiying/A-4813-2009}},
ORCID-Numbers = {{Hong, Peiying/0000-0002-4474-6600}},
Cited-References = {{Aaarestrup F. M., 2007, INFECT DIS FOODBORNE, P405.
   BENNETT KW, 1993, J MED MICROBIOL, V39, P246, DOI 10.1099/00222615-39-4-246.
   Blake DP, 2003, J APPL MICROBIOL, V95, P428, DOI 10.1046/j.1365-2672.2003.01988.x.
   Bowers RM, 2011, APPL ENVIRON MICROB, V77, P6350, DOI 10.1128/AEM.05498-11.
   Chang CW, 2001, APPL ENVIRON MICROB, V67, P155, DOI 10.1128/AEM.67.1.155-161.2001.
   Chee-Sanford JC, 2001, APPL ENVIRON MICROB, V67, P1494, DOI 10.1128/AEM.67.4.1494-1502.2001.
   Cocchi S, 2007, FEMS IMMUNOL MED MIC, V50, P126, DOI 10.1111/j.1574-695X.2007.00242.x.
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879.
   De Smet S, 2011, APPL ENVIRON MICROB, V77, P1732, DOI 10.1128/AEM.02409-10.
   Dee S, 2009, VET RES, V40, DOI 10.1051/vetres/2009022.
   DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244.
   DONHAM KJ, 1985, AM IND HYG ASSOC J, V46, P658, DOI 10.1202/0002-8894(1985)046<0658:ALOSGI>2.3.CO;2.
   Dumas MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024785.
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381.
   El-Sheikh SM, 1998, TROP MED INT HEALTH, V3, P205.
   Graffelman AW, 2004, BRIT J GEN PRACT, V54, P15.
   GRAHAM DR, 1990, REV INFECT DIS, V12, P423.
   Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000.
   Heederik D, 2007, ENVIRON HEALTH PERSP, V115, P298, DOI 10.1289/ehp.8835.
   Hong PY, 2011, ISME J, V5, P1461, DOI 10.1038/ismej.2011.33.
   Klitgaard K, 2008, J CLIN MICROBIOL, V46, P3012, DOI 10.1128/JCM.00670-08.
   Koike S, 2007, APPL ENVIRON MICROB, V73, P4813, DOI 10.1128/AEM.00665-07.
   Koike S, 2010, MICROB ECOL, V59, P487, DOI 10.1007/s00248-009-9610-0.
   Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725.
   Mackie RI, 1998, J ANIM SCI, V76, P1331.
   McGinn SM, 2003, J ENVIRON QUAL, V32, P1173, DOI 10.2134/jeq2003.1173.
   Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715.
   Minas K, 2011, FEMS MICROBIOL LETT, V325, P162, DOI 10.1111/j.1574-6968.2011.02424.x.
   Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375.
   Nandi S, 2004, P NATL ACAD SCI USA, V101, P7118, DOI 10.1073/pnas.0306466101.
   Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x.
   Nehme B, 2009, APPL ENVIRON MICROB, V75, P5445, DOI 10.1128/AEM.00726-09.
   Nonnenmann MW, 2010, J OCCUP ENVIRON HYG, V7, P693, DOI 10.1080/15459624.2010.526893.
   Pringle M, 2009, VET MICROBIOL, V139, P279, DOI 10.1016/j.vetmic.2009.05.018.
   REBOLI AC, 1989, CLIN MICROBIOL REV, V2, P354.
   Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56.
   Schiffman SS, 2001, AGR FOREST METEOROL, V108, P213, DOI 10.1016/S0168-1923(01)00239-8.
   Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862.
   USDA National Agricultural Statistics Service, 2011, LIV TOT PROD MEAS LB.
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07.
   Wing S, 2000, ENVIRON HEALTH PERSP, V108, P233, DOI 10.2307/3454439.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{32}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{35}},
Journal-ISO = {{Environ. Microbiol.}},
Doc-Delivery-Number = {{953KQ}},
Unique-ID = {{ISI:000304866600006}},
DA = {{2018-08-13}},
}

@article{ ISI:000304913700013,
Author = {Sergent, A. -P. and Slekovec, C. and Pauchot, J. and Jeunet, L. and
   Bertrand, X. and Hocquet, D. and Pazart, L. and Talon, D.},
Title = {{Bacterial contamination of the hospital environment during wound
   dressing change}},
Journal = {{ORTHOPAEDICS \& TRAUMATOLOGY-SURGERY \& RESEARCH}},
Year = {{2012}},
Volume = {{98}},
Number = {{4}},
Pages = {{441-445}},
Month = {{JUN}},
Abstract = {{Introduction: The hospital environment plays a role in the
   cross-transmission of multidrug-resistant bacteria. The aim of this
   study was to evaluate the bacterial contamination of the hospital
   environment during chronic wound dressing change.
   Patients and methods: This study was performed from July 2010 to May
   2011. Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter
   baumannii and Enterobacteriaceae were counted in environmental samples
   (air and surfaces) that were obtained in the rooms of patients with
   wounds colonized (cases, n = 9) or not (controls, n = 15) during or not
   during wound dressing change. Bacterial contamination was compared to
   that found in the rooms of patients without colonized wounds. Results:
   The environment was frequently contaminated during wound dressing change
   (38\% of the sampled series were positive). In comparison, the
   contamination was less frequent in the environment of patients with
   colonized wounds when the wounds were not being dressed (14.3\%) and in
   controls (3.8\%). S. aureus was the most frequent species identified in
   positive samples.
   Discussion: These results suggest that previously recommended measures
   such as hand hygiene after contact with the environment and wearing a
   mask are justified. Moreover, other measures should be suggested, in
   particular cleaning the room before and after dressing change of
   colonized wounds.
   Level of evidence: Level III: case control study. (C) 2012 Elsevier
   Masson SAS. All rights reserved.}},
Publisher = {{ELSEVIER MASSON}},
Address = {{VIA PALEOCAPA 7, 20121 MILANO, ITALY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Talon, D (Reprint Author), Besancon Teaching Hosp Ctr, Chronoenvironm UMR6249, Dept Hosp Hyg, Blvd Fleming, F-25030 Besancon, France.
   Slekovec, C.; Bertrand, X.; Hocquet, D.; Talon, D., Besancon Teaching Hosp Ctr, Chronoenvironm UMR6249, Dept Hosp Hyg, F-25030 Besancon, France.
   Slekovec, C.; Bertrand, X.; Hocquet, D.; Talon, D., Besancon Teaching Hosp Ctr, CIC IT, F-25030 Besancon, France.
   Sergent, A. -P.; Pauchot, J.; Jeunet, L., Besancon Reg Teaching Hosp Ctr, Dept Traumatol Orthopaed \& Reconstruct Surg, F-25030 Besancon, France.
   Pazart, L., Besancon Teaching Hosp Ctr, Dept Clin Invest, F-25030 Besancon, France.}},
DOI = {{10.1016/j.otsr.2012.02.005}},
ISSN = {{1877-0568}},
Keywords = {{Bacteria; Colonized wound; Hospital environment; Cross-transmission;
   Nosocomial transmission prevention}},
Keywords-Plus = {{RESISTANT STAPHYLOCOCCUS-AUREUS; SURFACES; HANDS}},
Research-Areas = {{Orthopedics; Surgery}},
Web-of-Science-Categories  = {{Orthopedics; Surgery}},
Author-Email = {{daniel.talon@univ-fcomte.fr}},
ORCID-Numbers = {{Bertrand, Xavier/0000-0002-8028-1396}},
Cited-References = {{Asoh N, 2005, INTERNAL MED, V44, P41, DOI 10.2169/internalmedicine.44.41.
   Bhalla A, 2004, INFECT CONT HOSP EP, V25, P164, DOI 10.1086/502369.
   Boyce JM, 1997, INFECT CONT HOSP EP, V18, P622.
   Duckro AN, 2005, ARCH INTERN MED, V165, P302, DOI 10.1001/archinte.165.3.302.
   InVS, 2009, ENQ NAT PREV INF NOS.
   Legat S, 2008, HYGIENES, V16, P187.
   Lemmen SW, 2004, J HOSP INFECT, V56, P191, DOI 10.1016/j.jhin.2003.12.004.
   Obee P, 2007, J HOSP INFECT, V65, P35, DOI 10.1016/j.jhin.2006.09.010.
   Pittet D, 2001, J HOSP INFECT, V48, pS40, DOI 10.1053/jhin.2001.0977.
   Sexton T, 2006, J HOSP INFECT, V62, P187, DOI 10.1016/j.jhin.2005.07.017.
   Shiomori T, 2002, J HOSP INFECT, V50, P30, DOI 10.1053/jhin.2001.1136.
   Societe Francaise d'Hygiene Hospitaliere (SFHH), 2010, HYGIENES, V18, P1.
   Talon D., 2008, British Journal of Infection Control, V9, P10, DOI 10.1177/1469044608093936.}},
Number-of-Cited-References = {{13}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{6}},
Journal-ISO = {{Orthop. Traumatol.-Surg. Res.}},
Doc-Delivery-Number = {{953ZS}},
Unique-ID = {{ISI:000304913700013}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000303620400006,
Author = {Fennelly, Kevin P. and Hosford, Jennifer L.},
Title = {{Behind the Mask: Overdue Evidence}},
Journal = {{AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE}},
Year = {{2012}},
Volume = {{185}},
Number = {{10}},
Pages = {{1041-1043}},
Month = {{MAY 15}},
Publisher = {{AMER THORACIC SOC}},
Address = {{61 BROADWAY, FL 4, NEW YORK, NY 10006 USA}},
Type = {{Editorial Material}},
Language = {{English}},
Affiliation = {{Fennelly, KP (Reprint Author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA.
   Fennelly, Kevin P.; Hosford, Jennifer L., Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA.
   Fennelly, Kevin P., VA Natl Ctr Occupat Hlth \& Infect Control, Gainesville, FL USA.}},
DOI = {{10.1164/rccm.201203-0548ED}},
ISSN = {{1073-449X}},
Keywords-Plus = {{HEALTH-CARE WORKERS; DRUG-RESISTANT TUBERCULOSIS; AIRBORNE TRANSMISSION;
   DISSEMINATION}},
Research-Areas = {{General \& Internal Medicine; Respiratory System}},
Web-of-Science-Categories  = {{Critical Care Medicine; Respiratory System}},
Cited-References = {{Belkin NL, 1997, INFECT CONT HOSP EP, V18, P49.
   Capps JA, 1918, J AMER MED ASSOC, V70, P910, DOI 10.1001/jama.1918.26010130001009.
   Center for Disease Control, 1979, CDC PUBL.
   Cherrie JW, 2011, ANN OCCUP HYG, V55, P1006, DOI 10.1093/annhyg/mer092.
   Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC.
   Escombe AR, 2007, CLIN INFECT DIS, V44, P1349, DOI 10.1086/515397.
   Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188.
   Fennelly KP, 2007, CLIN INFECT DIS, V44, P1358, DOI 10.1086/516617.
   Flugge C, 1898, Z HYG INFEKTIONSKR, V29, P107.
   Hamilton A, 1905, J AMER MED ASSOC, V44, P1108.
   Jarand J, 2010, TROP MED INT HEALTH, V15, P1179, DOI 10.1111/j.1365-3156.2010.02590.x.
   Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1.
   MIKULICZ J, 1897, ZENTRALBL CHIR, V24, P713.
   O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008.
   Radonovich LJ, 2009, JAMA-J AM MED ASSOC, V301, P36, DOI 10.1001/jama.2008.894.
   RILEY RL, 1959, AM J HYG, V70, P185, DOI 10.1093/oxfordjournals.aje.a120069.
   Shenal BV, 2012, J OCCUP ENVIRON HYG, V9, P59, DOI 10.1080/15459624.2012.635133.
   Tang JW, 2009, J R SOC INTERFACE, V6, pS727, DOI 10.1098/rsif.2009.0295.focus.
   World Health Organization, 2009, WHO POL TB INF CONTR.}},
Number-of-Cited-References = {{19}},
Times-Cited = {{0}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{Am. J. Respir. Crit. Care Med.}},
Doc-Delivery-Number = {{936WJ}},
Unique-ID = {{ISI:000303620400006}},
DA = {{2018-08-13}},
}

@article{ ISI:000303620400015,
Author = {Dharmadhikari, Ashwin S. and Mphahlele, Matsie and Stoltz, Anton and
   Venter, Kobus and Mathebula, Rirhandzu and Masotla, Thabiso and Lubbe,
   Willem and Pagano, Marcell and First, Melvin and Jensen, Paul A. and van
   der Walt, Martie and Nardell, Edward A.},
Title = {{Surgical Face Masks Worn by Patients with Multidrug-Resistant
   Tuberculosis Impact on Infectivity of Air on a Hospital Ward}},
Journal = {{AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE}},
Year = {{2012}},
Volume = {{185}},
Number = {{10}},
Pages = {{1104-1109}},
Month = {{MAY 15}},
Abstract = {{Rationale: Drug-resistant tuberculosis transmission in hospitals
   threatens staff and patient health. Surgical face masks used by patients
   with tuberculosis (TB) are believed to reduce transmission but have not
   been rigorously tested.
   Objectives: We sought to quantify the efficacy of surgical face masks
   when worn by patients with multidrug-resistant TB (MDR-TB).
   Methods: Over 3 months, 17 patients with pulmonary MDR-TB occupied an
   MDR-TB ward in South Africa and wore face masks on alternate days. Ward
   air was exhausted to two identical chambers, each housing 90
   pathogen-free guinea pigs that breathed ward air either when patients
   wore surgical face masks (intervention group) or when patients did not
   wear masks (control group). Efficacy was based on differences in guinea
   pig infections in each chamber.
   Measurements and Main Results: Sixty-nine of 90 control guinea pigs
   (76.6\%; 95\% confidence interval {[}CI], 68-85\%) became infected,
   compared with 36 of 90 intervention guinea pigs (40\%; 95\% CI,
   31-51\%), representing a 56\% (95\% CI, 33-70.5\%) decreased risk of TB
   transmission when patients used masks.
   Conclusions: Surgical face masks on patients with MDR-TB significantly
   reduced transmission and offer an adjunct measure for reducing TB
   transmission from infectious patients.}},
Publisher = {{AMER THORACIC SOC}},
Address = {{61 BROADWAY, FL 4, NEW YORK, NY 10006 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dharmadhikari, AS (Reprint Author), Harvard Univ, Brigham \& Womens Hosp, Sch Med, Div Pulm \& Crit Care Med,Div Global Hlth Equ, 641 Huntington Ave,Room 3A03, Boston, MA 02115 USA.
   Dharmadhikari, Ashwin S.; Nardell, Edward A., Harvard Univ, Brigham \& Womens Hosp, Sch Med, Div Pulm \& Crit Care Med,Div Global Hlth Equ, Boston, MA 02115 USA.
   Mphahlele, Matsie; Venter, Kobus; Mathebula, Rirhandzu; Masotla, Thabiso; Lubbe, Willem; van der Walt, Martie, S African Med Council, TB Epidemiol \& Intervent Res Unit, Pretoria, South Africa.
   Stoltz, Anton, Univ Pretoria, Div Infect Dis, ZA-0002 Pretoria, South Africa.
   Pagano, Marcell, Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   First, Melvin, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Jensen, Paul A., Ctr Dis Control \& Prevent, Atlanta, GA USA.}},
DOI = {{10.1164/rccm.201107-1190OC}},
ISSN = {{1073-449X}},
Keywords = {{infection control; multidrug-resistant tuberculosis; transmission;
   surgical mask}},
Keywords-Plus = {{HEALTH-CARE WORKERS; MYCOBACTERIUM-TUBERCULOSIS; INDOOR ENVIRONMENTS;
   DROPLET NUCLEI; TRANSMISSION; EMERGENCY; PERU; LIMA}},
Research-Areas = {{General \& Internal Medicine; Respiratory System}},
Web-of-Science-Categories  = {{Critical Care Medicine; Respiratory System}},
Author-Email = {{adharmadhikari@partners.org}},
Funding-Acknowledgement = {{National Institute for Occupational Safety and Health}},
Funding-Text = {{Supported by the National Institute for Occupational Safety and Health.}},
Cited-References = {{Baig AS, 2010, AM J INFECT CONTROL, V38, P18, DOI 10.1016/j.ajic.2009.09.005.
   Barry John M., 2004, GREAT INFLUENZA STOR.
   Brosseau L, 2009, N95 RESP SURG MASKS.
   Centers for Disease Control and Prevention, 2005, MMWR-MORBID MORTAL W, V54, P1.
   CHARNEY W, 1991, J OCCUP ENVIRON MED, V33, P943.
   Chatterjee A, 2007, AM J INFECT CONTROL, V35, P489, DOI 10.1016/j.ajic.2007.02.008.
   CHEN CC, 1992, AM J INFECT CONTROL, V20, P177, DOI 10.1016/S0196-6553(05)80143-9.
   Dharmadhikari A, 2011, AM J RESP CRIT CARE, V183, pA5308.
   Dharmadhikari A. S., 2009, TUBERCULOSIS COMPREH, P8.
   Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002.
   Escombe AR, 2010, INT J TUBERC LUNG D, V14, P1120.
   Escombe AR, 2007, CLIN INFECT DIS, V44, P1349, DOI 10.1086/515397.
   FAIRCHILD CI, 1987, AM IND HYG ASSOC J, V48, P948, DOI 10.1202/0002-8894(1987)048<0948:PCIEB>2.0.CO;2.
   Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1.
   Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331.
   Harrington M, 2010, INT J TUBERC LUNG D, V14, P935.
   Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1.
   Li Y, 2005, INT ARCH OCC ENV HEA, V78, P501, DOI 10.1007/s00420-004-0584-4.
   Maciel ELN, 2005, REV SOC BRAS MED TRO, V38, P469, DOI 10.1590/S0037-86822005000600004.
   MORAN GJ, 1995, ANN EMERG MED, V26, P290, DOI 10.1016/S0196-0644(95)70074-9.
   Morawska L, 2006, INDOOR AIR, V16, P335, DOI 10.1111/j.1600-0668.2006.00432.x.
   Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002.
   Nodieva A, 2010, INT J TUBERC LUNG D, V14, P427.
   O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008.
   Padayatchi N, 2010, INT J TUBERC LUNG D, V14, P960.
   Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105.
   RILEY RL, 1974, AM J MED, V57, P466, DOI 10.1016/0002-9343(74)90140-5.
   RILEY RL, 1989, AM REV RESPIR DIS, V139, P1286, DOI 10.1164/ajrccm/139.5.1286.
   RILEY RL, 1962, AM REV RESPIR DIS, V85, P511.
   Riley RL, 1959, AM J HYG, V70, P2.
   South Africa Department of Health, 2009, MAN DRUG RE IN PRESS.
   {*}STATACORP LP, 2005, STAT STAT SOFTW REL.
   Tang JW, 2009, J R SOC INTERFACE, V6, pS727, DOI 10.1098/rsif.2009.0295.focus.
   Wells W.F., 1955, AIRBORNE CONTAGION A.
   Wells WF, 1934, AM J HYG, V20, P611, DOI 10.1093/oxfordjournals.aje.a118097.
   Willingham FF, 2001, EMERG INFECT DIS, V7, P123, DOI 10.3201/eid0701.010117.
   World Health Organization, 2009, WHO REP 2009 GLOB TU.
   World Health Organization, WHO REP 2009 WHO POL.
   World Health Organization, WHO REP 2010 MULT EX.
   Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2006.00469.x.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{51}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{9}},
Journal-ISO = {{Am. J. Respir. Crit. Care Med.}},
Doc-Delivery-Number = {{936WJ}},
Unique-ID = {{ISI:000303620400015}},
OA = {{green\_published}},
DA = {{2018-08-13}},
}

@article{ ISI:000303622400021,
Author = {Lennartsson, Patrik R. and Ylitervo, Paivi and Larsson, Christer and
   Edebo, Lars and Taherzadeh, Mohammad J.},
Title = {{Growth tolerance of Zygomycetes Mucor indicus in orange peel hydrolysate
   without detoxification}},
Journal = {{PROCESS BIOCHEMISTRY}},
Year = {{2012}},
Volume = {{47}},
Number = {{5}},
Pages = {{836-842}},
Month = {{MAY}},
Abstract = {{The capability of two zygomycetes strains. Mucor indicus and an isolate
   from tempeh (Rhizopus sp.), to grow on orange peel hydrolysate and their
   tolerance to its antimicrobial activity, was investigated. Both fungi,
   in particular M. indicus, tolerated up to 2\% D-limonene in
   semi-synthetic media during cultivation in shake flasks, under aerobic
   as well as anaerobic conditions. The tolerance of M. indicus was also
   tested in a bioreactor, giving rise to varying results in the presence
   of 2\% limonene. Furthermore, both strains were capable of consuming
   galacturonic acid, the main monomer of pectin, under aerobic conditions
   when no other carbon source was present. The orange peel hydrolysate was
   based on 12\% (dry w/v) orange peels, containing D-limonene at a
   concentration of 0.6\% (v/v), which no other microorganism has been
   reported to be able to ferment. However, the hydrolysate was utilised by
   M. indicus under aerobic conditions, resulting in production of 410 and
   400 mg ethanol/g hexoses and 57 and 75 mg fungal biomass/g sugars from
   cultivations in shake flasks and a bioreactor, respectively. Rhizopus
   sp., however, was slow to germinate aerobically, and neither of the
   zygomycetes was able to consistently germinate in orange peel
   hydrolysate. under anaerobic conditions. The zygomycetes strains used in
   the present study demonstrated a relatively high resistance to the
   antimicrobial compounds present in orange peel hydrolysate, and they
   were capable of producing ethanol and biomass in the presence of
   limonene, particularly when cultivated with air supply. (C) 2012
   Elsevier Ltd. All rights reserved.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lennartsson, PR (Reprint Author), Univ Boras, Sch Engn, S-50190 Boras, Sweden.
   Lennartsson, Patrik R.; Ylitervo, Paivi; Taherzadeh, Mohammad J., Univ Boras, Sch Engn, S-50190 Boras, Sweden.
   Lennartsson, Patrik R.; Ylitervo, Paivi; Larsson, Christer, Chalmers, S-41296 Gothenburg, Sweden.
   Edebo, Lars, Univ Gothenburg, Dept Clin Bacteriol, S-41346 Gothenburg, Sweden.}},
DOI = {{10.1016/j.procbio.2012.02.019}},
ISSN = {{1359-5113}},
Keywords = {{Zygomycetes; Mucor indicus; Ethanol; Orange peel; D-Limonene}},
Keywords-Plus = {{YEAST SACCHAROMYCES-CEREVISIAE; ETHANOL-PRODUCTION; CITRUS WASTE;
   FERMENTATION; HYDROLYZATE; CELLULASE; LIMONENE; OIL; CIRCINELLOIDES;
   PECTINASE}},
Research-Areas = {{Biochemistry \& Molecular Biology; Biotechnology \& Applied
   Microbiology; Engineering}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Biotechnology \& Applied
   Microbiology; Engineering, Chemical}},
Author-Email = {{Patrik.Lennartsson@hb.se}},
ResearcherID-Numbers = {{Taherzadeh, Mohammad/B-5950-2009
   }},
ORCID-Numbers = {{Taherzadeh, Mohammad/0000-0003-4887-2433
   Larsson, Christer/0000-0002-0721-5405
   Ylitervo, Paivi/0000-0001-6023-0893
   Lennartsson, Patrik R/0000-0003-3418-1762}},
Funding-Acknowledgement = {{Swedish Energy Agency}},
Funding-Text = {{This work was financially supported by the Swedish Energy Agency. The
   authors would like to thank Bramhults Juice AB for providing the orange
   peel, Mr. Jonas Hanson for his invaluable support in the lab, and Dr.
   Magnus Lundin for his contributions to the statistical analyses.}},
Cited-References = {{Adney B, 1996, NRELTP51042628.
   Benny GL, 2001, MYCOTA, V7, P113.
   Dijksterhuis J, 2006, WOODHEAD PUBL FOOD S, P415.
   Edebo L, 2008, United States Patent, Patent No. {[}20090136617. 20081218, 20090136617].
   GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257.
   GROHMANN K, 1994, APPL BIOCHEM BIOTECH, V45-6, P315, DOI 10.1007/BF02941808.
   GROHMANN K, 1992, BIOTECHNOL LETT, V14, P1169, DOI 10.1007/BF01027023.
   Gursoy N, 2010, INT J FOOD PROP, V13, P983, DOI 10.1080/10942910902927136.
   Ismail AMS, 1996, PROCESS BIOCHEM, V31, P645, DOI 10.1016/S0032-9592(96)00012-X.
   Karimi K, 2006, PROCESS BIOCHEM, V41, P653, DOI 10.1016/j.procbio.2005.08.014.
   Lennartsson PR, 2009, J BIOTECHNOL, V143, P255, DOI 10.1016/j.jbiotec.2009.07.011.
   Mamma D., 2009, BIOTECHNOLOGY AGROIN, P273.
   Mamma D, 2008, BIORESOURCE TECHNOL, V99, P2373, DOI 10.1016/j.biortech.2007.05.018.
   McIntyre M, 2002, APPL MICROBIOL BIOT, V58, P495, DOI 10.1007/s00253-001-0916-1.
   Millati R, 2005, ENZYME MICROB TECH, V36, P294, DOI 10.1016/j.enzmictec.2004.09.007.
   MIZUKI E, 1990, BIOL WASTE, V33, P161, DOI 10.1016/0269-7483(90)90002-A.
   MURDOCK DI, 1960, FOOD TECHNOL-CHICAGO, V14, P441.
   Oberoi HS, 2010, J AGR FOOD CHEM, V58, P3422, DOI 10.1021/jf903163t.
   Patel-Predd P, 2006, ENVIRON SCI TECHNOL, V40, P5170, DOI 10.1021/es062766q.
   Pourbafrani M, 2010, THESIS CHALMERS U TE, P50.
   Pourbafrani M, 2007, INT J MOL SCI, V8, P777, DOI 10.3390/i8080777.
   Pourbafrani M, 2010, BIORESOURCE TECHNOL, V101, P4246, DOI 10.1016/j.biortech.2010.01.077.
   Rangel-Porras RA, 2005, MOL GENET GENOMICS, V274, P354, DOI 10.1007/s00438-005-0025-4.
   Richard P, 2009, APPL MICROBIOL BIOT, V82, P597, DOI 10.1007/s00253-009-1870-6.
   Saxena R.K., 2004, HDB FUNGAL BIOTECHNO, P287.
   Stewart DS, 2008, United States Patent, Patent No. {[}2008021384. 20080409, 20080213849].
   SUBBA MS, 1967, J FOOD SCI, V32, P225, DOI 10.1111/j.1365-2621.1967.tb01299.x.
   Sues A, 2005, FEMS YEAST RES, V5, P669, DOI 10.1016/j.femsyr.2004.10.013.
   Tripodo MM, 2004, BIORESOURCE TECHNOL, V91, P111, DOI 10.1016/S0960-8524(03)00183-4.
   URIBE S, 1990, APPL ENVIRON MICROB, V56, P2114.
   URIBE S, 1990, J CHEM ECOL, V16, P1399, DOI 10.1007/BF01021035.
   URIBE S, 1985, J BACTERIOL, V161, P1195.
   Wilkins MR, 2007, PROCESS BIOCHEM, V42, P1614, DOI 10.1016/j.procbio.2007.09.006.
   Wilkins MR, 2007, WORLD J MICROB BIOT, V23, P1161, DOI 10.1007/s11274-007-9346-2.
   Wilkins MR, 2005, PROC FL STATE HORTIC, V118, P419.
   Wilkins MR, 2007, BIORESOURCE TECHNOL, V98, P1596, DOI 10.1016/j.biortech.2006.06.022.
   Zamani A, 2010, THESIS CHALMERS U TE, P60.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{10}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{13}},
Journal-ISO = {{Process Biochem.}},
Doc-Delivery-Number = {{936XD}},
Unique-ID = {{ISI:000303622400021}},
DA = {{2018-08-13}},
}

@article{ ISI:000302806600007,
Author = {Just, Natasha A. and Letourneau, Valerie and Kirychuk, Shelley P. and
   Singh, Baljit and Duchaine, Caroline},
Title = {{Potentially Pathogenic Bacteria and Antimicrobial Resistance in
   Bioaerosols from Cage-Housed and Floor-Housed Poultry Operations}},
Journal = {{ANNALS OF OCCUPATIONAL HYGIENE}},
Year = {{2012}},
Volume = {{56}},
Number = {{4}},
Pages = {{440-449}},
Month = {{MAY}},
Abstract = {{Antibiotics are used in animal confinement buildings, such as
   cage-housed (CH) and floor-housed (FH) poultry operations, to lower the
   likeliness of disease transmission. In FH facilities, antibiotics may
   also be used at sub-therapeutic levels for growth promotion. Low levels
   of antibiotic create a selective pressure toward antimicrobial
   resistance (AMR) in chicken fecal bacteria.
   The objective of this study was to compare bacteria and AMR genes in
   bioaerosols from CH and FH poultry facilities.
   Bioaerosols were collected from 15 CH and 15 FH poultry operations,
   using stationary area samplers as well as personal sampling devices.
   Bacteria concentrations were determined by genus- or species-specific
   quantitative polymerase chain reaction (PCR) and AMR genes were detected
   using endpoint PCR.
   Enterococcus spp., Escherichia coli, and Staphylococcus spp. were
   significantly higher in bioaerosols of FH poultry operations than CH
   bioaerosols (P < 0.001) while Clostridium perfringens was significantly
   higher in area bioaerosols of CH operations than FH area bioaerosols (P
   < 0.05). Campylobacter spp. were detected only in bioaerosols of FH
   facilities. Zinc bacitracin resistance gene, bcrR, erythromycin
   resistance gene, ermA, and tetracycline resistance gene, tetA/C, were
   more prevalent in bioaerosols of FH facilities than CH bioaerosols (P <
   0.01, P < 0.01, and P < 0.05, respectively).
   Most bacteria are more concentrated and most AMR genes are more
   prevalent in bioaerosols of FH poultry operations, where
   growth-promoting antibiotics may be used.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Duchaine, C (Reprint Author), Inst Univ Cardiol \& Pneumol Quebec, 2725 Chemin St Foy, Quebec City, PQ G1V 4G5, Canada.
   Letourneau, Valerie; Duchaine, Caroline, Inst Univ Cardiol \& Pneumol Quebec, Quebec City, PQ G1V 4G5, Canada.
   Just, Natasha A.; Singh, Baljit, Univ Saskatchewan, Dept Vet Biomed Sci, Western Coll Vet Med, Saskatoon, SK S7N 5B4, Canada.
   Kirychuk, Shelley P., Univ Saskatchewan, Canadian Ctr Hlth \& Safety Agr, Royal Univ Hosp, Saskatoon, SK S7N 0W8, Canada.}},
DOI = {{10.1093/annhyg/mer105}},
ISSN = {{0003-4878}},
Keywords = {{air sampling; antimicrobial resistance; bacteria; bioaerosols; poultry}},
Keywords-Plus = {{REAL-TIME PCR; ANIMAL FEEDING OPERATIONS; SWINE CONFINEMENT BUILDINGS;
   AIRBORNE TRANSMISSION; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; FECAL
   SAMPLES; FOOD ANIMALS; QUANTIFICATION; SALMONELLA}},
Research-Areas = {{Public, Environmental \& Occupational Health; Toxicology}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Toxicology}},
Author-Email = {{caroline.duchaine@bcm.ulaval.ca}},
Funding-Acknowledgement = {{Natural Sciences and Engineering Research Council of Canada (NSERC);
   Canadian Institutes of Health Research (CIHR); Institute of Cancer
   Research; Institute of Circulatory and Respiratory Health; Institute of
   Infection and Immunity; Institute of Population and Public Health}},
Funding-Text = {{B.S. is a recipient of support from the Natural Sciences and Engineering
   Research Council of Canada (NSERC). This research has been funded by the
   Canadian Institutes of Health Research (CIHR) Strategic Training Program
   in Public Health and the Agricultural Rural Ecosystem (PHARE) and
   Partner Institutes including the Institute of Cancer Research, Institute
   of Circulatory and Respiratory Health, Institute of Infection and
   Immunity, and the Institute of Population and Public Health.}},
Cited-References = {{Aarestrup FM, 2000, VET MICROBIOL, V74, P353, DOI 10.1016/S0378-1135(00)00197-8.
   Akwar TH, 2007, MICROB DRUG RESIST, V13, P69, DOI 10.1089/mdr.2006.9999.
   Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5.
   Angulo FJ, 2000, MICROB DRUG RESIST, V6, P77, DOI 10.1089/mdr.2000.6.77.
   Brooks JP, 2010, SCI TOTAL ENVIRON, V408, P4770, DOI 10.1016/j.scitotenv.2010.06.038.
   Chen J, 2007, APPL ENVIRON MICROB, V73, P4407, DOI 10.1128/AEM.02799-06.
   Chinivasagam HN, 2009, APPL ENVIRON MICROB, V75, P7417, DOI 10.1128/AEM.01380-09.
   Depardieu F, 2004, J CLIN MICROBIOL, V42, P5857, DOI 10.1128/JCM.42.12.5857-5860.2004.
   Fallschissel K, 2009, ANN OCCUP HYG, V53, P859, DOI 10.1093/annhyg/mep060.
   Gast RK, 1998, AVIAN DIS, V42, P315, DOI 10.2307/1592482.
   Gibbs SG, 2004, J OCCUP ENVIRON HYG, V1, P699, DOI 10.1080/15459620490515824.
   Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837.
   Gyles Carlton L., 2008, Animal Health Research Reviews, V9, P149, DOI 10.1017/S1466252308001552.
   Hamscher G, 2003, ENVIRON HEALTH PERSP, V111, P1590, DOI 10.1289/ehp.6288.
   Just N, 2011, ENVIRON RES, V111, P492, DOI 10.1016/j.envres.2011.01.009.
   Just Natasha, 2009, J Occup Med Toxicol, V4, P13, DOI 10.1186/1745-6673-4-13.
   Kirychuk SP, 2006, J OCCUP ENVIRON MED, V48, P741, DOI 10.1097/01.jom.0000216215.39521.3c.
   Kirychuk SP, 2010, ANN OCCUP HYG, V54, P824, DOI 10.1093/annhyg/meq047.
   Letourneau V, 2010, INT J HYG ENVIR HEAL, V213, P444, DOI 10.1016/j.ijheh.2010.09.008.
   Lund M, 2004, J CLIN MICROBIOL, V42, P5125, DOI 10.1128/JCM.42.11.5125-5132.2004.
   Malinen E, 2003, MICROBIOL-SGM, V149, P269, DOI 10.1099/mic.0.25975-0.
   Martel JL, 2001, VET RES, V32, P381, DOI 10.1051/vetres:2001131.
   Martin E, 2010, SYST APPL MICROBIOL, V33, P188, DOI 10.1016/j.syapm.2010.03.008.
   McDermott PF, 2005, APPL ENVIRON MICROB, V71, P4986, DOI 10.1128/AEM.71.9.4986-4991.2005.
   McEwen S., 2002, USES ANTIMICROBIALS.
   Murphy MW, 2007, J AGRIC SAF HEALTH, V13, P357, DOI 10.13031/2013.23922.
   Nawaz MS, 1999, POULTRY SCI, V78, P1191, DOI 10.1093/ps/78.8.1191.
   Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x.
   Oppliger A, 2008, ANN OCCUP HYG, V52, P405, DOI 10.1093/annhyg/men021.
   Proux K, 2001, VET RES, V32, P591, DOI 10.1051/vetres:2001148.
   Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x.
   Solberg CO, 2000, SCAND J INFECT DIS, V32, P587, DOI 10.1080/003655400459478.
   Thibodeau A, 2008, CAN J VET RES, V72, P129.
   Thorne PS, 2007, ENVIRON HEALTH PERSP, V115, P296, DOI 10.1289/ehp.8831.
   THRELFALL EJ, 1993, EPIDEMIOL INFECT, V111, P189, DOI 10.1017/S0950268800056892.
   WHYTE RT, 1993, WORLD POULTRY SCI J, V49, P139, DOI 10.1079/WPS19930012.
   Wilson I G, 2004, Commun Dis Public Health, V7, P349.
   Wise MG, 2005, APPL ENVIRON MICROB, V71, P3911, DOI 10.1128/AEM.71.7.3911-3916.2005.
   Yu ZT, 2005, APPL ENVIRON MICROB, V71, P6926, DOI 10.1128/AEM.71.11.6926-6933.2005.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{7}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{43}},
Journal-ISO = {{Ann. Occup. Hyg.}},
Doc-Delivery-Number = {{926BP}},
Unique-ID = {{ISI:000302806600007}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000305349100068,
Author = {Dorokhov, Yuri L. and Komarova, Tatiana V. and Petrunia, Igor V. and
   Kosorukov, Vyacheslav S. and Zinovkin, Roman A. and Shindyapina,
   Anastasia V. and Frolova, Olga Y. and Gleba, Yuri Y.},
Title = {{Methanol May Function as a Cross-Kingdom Signal}},
Journal = {{PLOS ONE}},
Year = {{2012}},
Volume = {{7}},
Number = {{4}},
Month = {{APR 26}},
Abstract = {{Recently, we demonstrated that leaf wounding results in the synthesis of
   pectin methylesterase (PME), which causes the plant to release methanol
   into the air. Methanol emitted by a wounded plant increases the
   accumulation of methanol-inducible gene mRNA and enhances antibacterial
   resistance as well as cell-to-cell communication, which facilitates
   virus spreading in neighboring plants. We concluded that methanol is a
   signaling molecule involved in within-plant and plant-to-plant
   communication. Methanol is considered to be a poison in humans because
   of the alcohol dehydrogenase (ADH)-mediated conversion of methanol into
   toxic formaldehyde. However, recent data showed that methanol is a
   natural compound in normal, healthy humans. These data call into
   question whether human methanol is a metabolic waste product or whether
   methanol has specific function in humans. Here, to reveal human
   methanol-responsive genes (MRGs), we used suppression subtractive
   hybridization cDNA libraries of HeLa cells lacking ADH and exposed to
   methanol. This design allowed us to exclude genes involved in
   formaldehyde and formic acid detoxification from our analysis. We
   identified MRGs and revealed a correlation between increases in methanol
   content in the plasma and changes in human leukocyte MRG mRNA levels
   after fresh salad consumption by volunteers. Subsequently, we showed
   that the methanol generated by the pectin/PME complex in the
   gastrointestinal tract of mice induces the up- and downregulation of
   brain MRG mRNA. We used an adapted Y-maze to measure the locomotor
   behavior of the mice while breathing wounded plant vapors in two-choice
   assays. We showed that mice prefer the odor of methanol to other plant
   volatiles and that methanol changed MRG mRNA accumulation in the mouse
   brain. We hypothesize that the methanol emitted by wounded plants may
   have a role in plant-animal signaling. The known positive effect of
   plant food intake on human health suggests a role for physiological
   methanol in human gene regulation.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dorokhov, YL (Reprint Author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.
   Dorokhov, Yuri L.; Komarova, Tatiana V.; Zinovkin, Roman A.; Shindyapina, Anastasia V., Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.
   Dorokhov, Yuri L.; Komarova, Tatiana V.; Petrunia, Igor V.; Frolova, Olga Y., Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow, Russia.
   Kosorukov, Vyacheslav S., Russian Acad Med Sci, NN Blokhin Natl Canc Res Ctr, Moscow, Russia.
   Gleba, Yuri Y., Nomad Biosci GmbH, Biozentrum Halle, Halle, Saale, Germany.}},
DOI = {{10.1371/journal.pone.0036122}},
Article-Number = {{e36122}},
ISSN = {{1932-6203}},
Keywords-Plus = {{ENZYME PECTIN METHYLESTERASE; TUBE MASS-SPECTROMETRY; MODIFIED CITRUS
   PECTIN; TRANSDUCED HELA-CELLS; MOSAIC-VIRUS MOVEMENT;
   ADENOSYL-L-METHIONINE; U-SHAPED CURVE; PROTEIN CARBOXYMETHYLASE;
   S-ADENOSYLMETHIONINE; ALZHEIMERS-DISEASE}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{dorokhov@genebee.msu.su}},
ResearcherID-Numbers = {{Komarova, Tatiana/D-5824-2012
   Dorokhov, Yuri/D-3565-2012
   Zinovkin, Roman/J-2500-2013}},
ORCID-Numbers = {{Komarova, Tatiana/0000-0001-6558-8755
   Dorokhov, Yuri/0000-0002-4066-8940
   Zinovkin, Roman/0000-0001-5337-4346}},
Funding-Acknowledgement = {{Russian Fund of Basic Research {[}11-04-01152-a]}},
Funding-Text = {{This work was supported by grant (11-04-01152-a) from Russian Fund of
   Basic Research (http://grant.rfbr.ru). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.}},
Cited-References = {{Altorf-van Der Kuil W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012102.
   Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072.
   Arimura G, 2002, PLANT J, V29, P87, DOI 10.1046/j.1365-313x.2002.01198.x.
   Attar N, 2010, ADV ENZYME REGUL, V50, P216, DOI 10.1016/j.advenzreg.2009.10.002.
   Ausubel F.M., 1987, CURRENT PROTOCOLS MO.
   AXELROD J, 1965, SCIENCE, V150, P892, DOI 10.1126/science.150.3698.892.
   Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113.
   Bergman M, 2010, BIOMED PHARMACOTHER, V64, P44, DOI 10.1016/j.biopha.2009.03.004.
   Bosch M, 2005, PLANT CELL, V17, P3219, DOI 10.1105/tpc.105.037473.
   Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865.
   Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76.
   Boyle R, SCEPTICAL CHYMIST CH.
   Brent J, 2010, CLIN TOXICOL, V48, P401, DOI 10.3109/15563650.2010.495347.
   Brent J, 2009, NEW ENGL J MED, V360, P2216, DOI 10.1056/NEJMct0806112.
   Brown L, 1999, AM J CLIN NUTR, V69, P30.
   BYERS JA, 1992, J CHEM ECOL, V18, P2385, DOI 10.1007/BF00984957.
   Chen MH, 2000, EMBO J, V19, P913, DOI 10.1093/emboj/19.5.913.
   Chen MH, 2003, PLANT J, V35, P386, DOI 10.1046/j.1365-313X.2003.01818.x.
   Coppede F, 2010, CURR GENOMICS, V11, P246, DOI 10.2174/138920210791233090.
   Craig WJ, 1997, J AM DIET ASSOC, V97, pS199, DOI 10.1016/S0002-8223(97)00765-7.
   Datta NJ, 2003, DRUG ALCOHOL DEPEN, V71, P87, DOI 10.1016/S0376-8716(03)00066-8.
   De Gouw JA, 2000, ENVIRON SCI TECHNOL, V34, P2640, DOI 10.1021/es991219k.
   De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058.
   DIACHENKO L, 1996, P NATL ACAD SCI USA, V93, P6025.
   DICKSON D, 1981, NATURE, V292, P283, DOI 10.1038/292283b0.
   DILIBERT.EJ, 1974, P NATL ACAD SCI USA, V71, P1701, DOI 10.1073/pnas.71.5.1701.
   DILIBERTO EJ, 1976, P NATL ACAD SCI USA, V73, P4050, DOI 10.1073/pnas.73.11.4050.
   DILIBERTO EJ, 1976, J NEUROCHEM, V26, P1159, DOI 10.1111/j.1471-4159.1976.tb07001.x.
   Divol F, 2005, PLANT MOL BIOL, V57, P517, DOI 10.1007/s11103-005-0338-z.
   Dorokhov YL, 2006, FEBS LETT, V580, P3329, DOI 10.1016/j.febslet.2006.04.090.
   Dorokhov YL, 1999, FEBS LETT, V461, P223, DOI 10.1016/S0014-5793(99)01447-7.
   Dorokhov YL, 2006, FEBS LETT, V580, P3872, DOI 10.1016/j.febslet.2006.06.013.
   Dorokhov YL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002640.
   Downie B, 1998, ANAL BIOCHEM, V264, P149, DOI 10.1006/abio.1998.2847.
   DWYER JT, 1988, AM J CLIN NUTR, V48, P712, DOI 10.1093/ajcn/48.3.712.
   Ehlting J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-154.
   Enderby B, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/3/036001.
   ERIKSEN SP, 1963, SCIENCE, V141, P639, DOI 10.1126/science.141.3581.639.
   Ewen R, 2005, RAPID DIAGNOSIS GAST.
   Fall R, 1996, TRENDS PLANT SCI, V1, P296, DOI 10.1016/S1360-1385(96)88175-0.
   Fedorova E, 2009, CURR OPIN GENET DEV, V19, P166, DOI 10.1016/j.gde.2009.02.003.
   Fisher JW, 2000, TOXICOL SCI, V53, P185, DOI 10.1093/toxsci/53.2.185.
   Fosu-Nyarko J, 2009, MOL PLANT PATHOL, V10, P237, DOI 10.1111/j.1364-3703.2008.00526.x.
   Francies KE, 2007, PLANT PHYSIOL, V142, P1004.
   Frenkel C, 1998, J BIOL CHEM, V273, P4293, DOI 10.1074/jbc.273.8.4293.
   Fuso A, 2012, NEUROBIOL A IN PRESS, DOI {[}10.1016/j.bbr.2011.03.031, DOI 10.1016/J.BBR.2011.03.031].
   GAGNON C, 1978, LIFE SCI, V22, P2155, DOI 10.1016/0024-3205(78)90566-0.
   Gallaher CM, 2009, BRIT J NUTR, V101, P233, DOI 10.1017/S0007114508995684.
   Galli A, 1999, HEPATOLOGY, V29, P1164, DOI 10.1002/hep.510290420.
   Gasanova TV, 2008, MOL BIOL+, V42, P421, DOI 10.1134/S0026893308030102.
   Glinsky VV, 2009, CARBOHYD RES, V344, P1788, DOI 10.1016/j.carres.2008.08.038.
   Goren JL, 2004, PHARMACOTHERAPY, V24, P1501, DOI 10.1592/phco.24.16.1501.50943.
   GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950.
   Haffner HT, 1997, FORENSIC SCI INT, V86, P69, DOI 10.1016/S0379-0738(97)02119-1.
   Hansen JM, 2005, BIRTH DEFECTS RES A, V73, P72, DOI 10.1002/bdra.20094.
   Hasunuma T, 2004, J BIOTECHNOL, V111, P241, DOI 10.1016/j.jbiotec.2004.04.015.
   Hasunuma T, 2003, J BIOTECHNOL, V106, P45, DOI 10.1016/j.jbiotec.2003.07.008.
   Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010.
   Holopainen JK, 2010, TRENDS PLANT SCI, V15, P176, DOI 10.1016/j.tplants.2010.01.006.
   Hoog JO, 2011, CHEM-BIOL INTERACT, V191, P2, DOI 10.1016/j.cbi.2011.01.028.
   Hovda KE, 2008, HUM EXP TOXICOL, V27, P539, DOI 10.1177/0960327108095992.
   Huve K, 2007, J EXP BOT, V58, P1783, DOI 10.1093/jxb/erm038.
   Martin-Subero JI, 2011, ADV EXP MED BIOL, V711, P162.
   Jacobsen D, 1997, J TOXICOL-CLIN TOXIC, V35, P127, DOI 10.3109/15563659709001182.
   JACOBSEN D, 1986, MED TOXICOL ADV DRUG, V1, P309, DOI 10.1007/BF03259846.
   Jenkins J, 2001, J MOL BIOL, V305, P951, DOI 10.1006/jmbi.2000.4324.
   Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002.
   JONES AW, 1987, PHARMACOL TOXICOL, V60, P217, DOI 10.1111/j.1600-0773.1987.tb01737.x.
   Key TJ, 1999, AM J CLIN NUTR, V70, p516S, DOI 10.1093/ajcn/70.3.516s.
   Kimura M, 2011, PSYCHIAT CLIN NEUROS, V65, P213, DOI 10.1111/j.1440-1819.2011.02190.x.
   Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008.
   Korner E, 2009, J EXP BOT, V60, P2631, DOI 10.1093/jxb/erp106.
   Kostic MA, 2003, J TOXICOL-CLIN TOXIC, V41, P793, DOI 10.1081/CLT-120025344.
   Krautt JA, 2008, CLIN J AM SOC NEPHRO, V3, P208, DOI 10.2215/CJN.03220807.
   Lagaert S, 2009, SEMIN CELL DEV BIOL, V20, P1064, DOI 10.1016/j.semcdb.2009.05.008.
   Ledochowski M, 2005, Breath Analysis: for Clinical Diagnosis and ATherapeutic Monitoring, P375, DOI 10.1142/9789812701954\_0026.
   Lee ES, 2008, LIFE SCI, V83, P821, DOI 10.1016/j.lfs.2008.09.020.
   LESTER D, 1962, Q J STUD ALCOHOL, V23, P17.
   Lindinger W, 1997, ALCOHOL CLIN EXP RES, V21, P939.
   Linnebank M, 2010, NEURODEGENER DIS, V7, P373, DOI 10.1159/000309657.
   Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803.
   Liu HY, 2008, WORLD J GASTROENTERO, V14, P7386, DOI 10.3748/wjg.14.7386.
   Liu JR, 2009, J AGR FOOD CHEM, V57, P297, DOI 10.1021/jf801826w.
   Liu L, 2010, CARCINOGENESIS, V31, P1822, DOI 10.1093/carcin/bgq070.
   Louvet R, 2006, PLANTA, V224, P782, DOI 10.1007/s00425-006-0261-9.
   LUKYANOV SA, 1994, BIOORG KHIM+, V20, P701.
   Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x.
   Magnuson BA, 2007, CRIT REV TOXICOL, V37, P629, DOI 10.1080/10408440701516184.
   Markovic O, 2004, CARBOHYD RES, V339, P2281, DOI 10.1016/j.carres.2004.06.023.
   Markovic O, 2002, CELL MOL LIFE SCI, V59, P513, DOI 10.1007/s00018-002-8442-6.
   MARMOT M, 1991, BRIT MED J, V303, P565, DOI 10.1136/bmj.303.6802.565.
   Matsumoto M, 2011, ALCOHOL CLIN EXP RES, V35, P28, DOI 10.1111/j.1530-0277.2010.01319.x.
   Megarbane B, 2005, INTENS CARE MED, V31, P189, DOI 10.1007/s00134-004-2521-0.
   Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3.
   Miura K, 2004, AM J EPIDEMIOL, V159, P572, DOI 10.1093/aje/kwh085.
   Monte W. C., 1984, Journal of Applied Nutrition, V36, P42.
   Monte WC, 2010, MED HYPOTHESES, V74, P493, DOI 10.1016/j.mehy.2009.09.059.
   Nakao H, 2003, J PHARMACOL SCI, V91, P83, DOI 10.1254/jphs.91.83.
   Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854.
   Nassirpour R, 2007, CHANNELS, V1, P331, DOI 10.4161/chan.5191.
   NEMECEKMARSHALL M, 1995, PLANT PHYSIOL, V108, P1359, DOI 10.1104/pp.108.4.1359.
   Neuthouser ML, 2006, CANCER EPIDEM BIOMAR, V15, P1755, DOI 10.1158/1055-9965.EPI-06-0728.
   Oyama Y, 2002, CELL BIOL TOXICOL, V18, P43, DOI 10.1023/A:1014419229301.
   Panza F, 2009, THESCIENTIFICWORLDJO, V9, P373, DOI 10.1100/tsw.2009.48.
   Pelletier S, 2010, NEW PHYTOL, V188, P726, DOI 10.1111/j.1469-8137.2010.03409.x.
   Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001.
   Penuelas J, 2005, NEW PHYTOL, V167, P851, DOI 10.1111/j.1469-8137.2005.01459.x.
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45.
   Potter JD, 1996, IARC SCI PUBL, P61.
   Preston CA, 1999, PLANTA, V209, P87, DOI 10.1007/s004250050609.
   Raiola A, 2011, MOL PLANT MICROBE IN, V24, P432, DOI 10.1094/MPMI-07-10-0157.
   Rebrikov DV, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e90.
   San Jose B, 1999, J STUD ALCOHOL, V60, P725, DOI 10.15288/jsa.1999.60.725.
   Schapira Matthieu, 2011, Curr Chem Genomics, V5, P85, DOI 10.2174/1875397301005010085.
   Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0.
   Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399.
   SMITH RJ, 1981, SCIENCE, V213, P986, DOI 10.1126/science.7268411.
   SNYDER SH, 1967, NATURE, V215, P773, DOI 10.1038/215773b0.
   STASSEWOLTHUIS M, 1980, AM J CLIN NUTR, V33, P1745.
   Steffen LM, 2005, AM J CLIN NUTR, V82, P1169.
   TAUCHER J, 1995, ALCOHOL CLIN EXP RES, V19, P1147, DOI 10.1111/j.1530-0277.1995.tb01593.x.
   TEPHLY TR, 1991, LIFE SCI, V48, P1031, DOI 10.1016/0024-3205(91)90504-5.
   Tian GW, 2006, DEV BIOL, V294, P83, DOI 10.1016/j.ydbio.2006.02.026.
   Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003.
   Trocho C, 1998, LIFE SCI, V63, P337, DOI 10.1016/S0024-3205(98)00282-3.
   Turner C, 2008, RAPID COMMUN MASS SP, V22, P526, DOI 10.1002/rcm.3402.
   Turner C, 2006, PHYSIOL MEAS, V27, P637, DOI 10.1088/0967-3334/27/7/007.
   van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009.
   Velikova V, 2008, PLANT CELL ENVIRON, V31, P1882, DOI 10.1111/j.1365-3040.2008.01893.x.
   Voglesonger KM, 2001, CHEM GEOL, V180, P129, DOI 10.1016/S0009-2541(01)00310-2.
   von Dahl CC, 2006, PLANT J, V46, P948, DOI 10.1111/j.1365-313X.2006.02760.x.
   Walley JW, 2010, J INTEGR PLANT BIOL, V52, P354, DOI 10.1111/j.1744-7909.2010.00940.x.
   Wen FS, 1999, PLANT CELL, V11, P1129, DOI 10.1105/tpc.11.6.1129.
   Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002.
   WESTERN O C, 1949, U S Nav Med Bull, V49, P574.
   Williams LB, 2005, GEOLOGY, V33, P913, DOI 10.1103/G21751.1.
   Williams LB, 2011, EARLIEST LIFE ON EARTH: HABITATS, ENVIORNMENTS AND METHODS OF DETECTION, P79, DOI 10.1007/978-90-481-8794-2\_4.
   WOLF ME, 1985, J NEUROCHEM, V44, P291, DOI 10.1111/j.1471-4159.1985.tb07143.x.
   Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x.
   Wolgemuth DJ, 2008, CELL CYCLE, V7, P3509, DOI 10.4161/cc.7.22.6978.
   Wu JQ, 2009, PLANT CELL ENVIRON, V32, P1161, DOI 10.1111/j.1365-3040.2009.01943.x.
   XIAO Q, 1995, J CLIN INVEST, V96, P2180, DOI 10.1172/JCI118272.
   YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817.
   Zatman L, 1946, BIOCHEM J, V40, P67.}},
Number-of-Cited-References = {{144}},
Times-Cited = {{16}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{28}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{959WQ}},
Unique-ID = {{ISI:000305349100068}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000303444200032,
Author = {Dorokhov, Yuri L. and Komarova, Tatiana V. and Petrunia, Igor V. and
   Frolova, Olga Y. and Pozdyshev, Denis V. and Gleba, Yuri Y.},
Title = {{Airborne Signals from a Wounded Leaf Facilitate Viral Spreading and
   Induce Antibacterial Resistance in Neighboring Plants}},
Journal = {{PLOS PATHOGENS}},
Year = {{2012}},
Volume = {{8}},
Number = {{4}},
Month = {{APR}},
Abstract = {{Many plants release airborne volatile compounds in response to wounding
   due to pathogenic assault. These compounds serve as plant defenses and
   are involved in plant signaling. Here, we study the effects of pectin
   methylesterase (PME)-generated methanol release from wounded plants
   ({''}emitters{''}) on the defensive reactions of neighboring
   ``receiver{''} plants. Plant leaf wounding resulted in the synthesis of
   PME and a spike in methanol released into the air. Gaseous methanol or
   vapors from wounded PME-transgenic plants induced resistance to the
   bacterial pathogen Ralstonia solanacearum in the leaves of non-wounded
   neighboring ``receiver{''} plants. In experiments with different
   volatile organic compounds, gaseous methanol was the only airborne
   factor that could induce antibacterial resistance in neighboring plants.
   In an effort to understand the mechanisms by which methanol stimulates
   the antibacterial resistance of ``receiver{''} plants, we constructed
   forward and reverse suppression subtractive hybridization cDNA libraries
   from Nicotiana benthamiana plants exposed to methanol. We identified
   multiple methanol-inducible genes (MIGs), most of which are involved in
   defense or cell-to-cell trafficking. We then isolated the most affected
   genes for further analysis: beta-1,3-glucanase (BG), a previously
   unidentified gene (MIG-21), and non-cell-autonomous pathway protein
   (NCAPP). Experiments with Tobacco mosaic virus (TMV) and a vector
   encoding two tandem copies of green fluorescent protein as a tracer of
   cell-to-cell movement showed the increased gating capacity of
   plasmodesmata in the presence of BG, MIG-21, and NCAPP. The increased
   gating capacity is accompanied by enhanced TMV reproduction in the
   ``receivers{''}. Overall, our data indicate that methanol emitted by a
   wounded plant acts as a signal that enhances antibacterial resistance
   and facilitates viral spread in neighboring plants.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dorokhov, YL (Reprint Author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.
   Dorokhov, Yuri L.; Komarova, Tatiana V.; Pozdyshev, Denis V., Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.
   Dorokhov, Yuri L.; Petrunia, Igor V.; Frolova, Olga Y., Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow, Russia.
   Gleba, Yuri Y., Nomad Biosci GmbH, Biozentrum Halle, Halle, Saale, Germany.}},
DOI = {{10.1371/journal.ppat.1002640}},
Article-Number = {{e1002640}},
ISSN = {{1553-7374}},
Keywords-Plus = {{ENZYME PECTIN METHYLESTERASE; MOSAIC-VIRUS MOVEMENT; OXIDASE GENE
   FAMILY; POLLEN-TUBE GROWTH; ARABIDOPSIS-THALIANA;
   1-AMINOCYCLOPROPANE-1-CARBOXYLATE OXIDASE; DIFFERENTIAL EXPRESSION;
   METHANOL EMISSION; DEFENSE RESPONSES; TOBACCO-LEAVES}},
Research-Areas = {{Microbiology; Parasitology; Virology}},
Web-of-Science-Categories  = {{Microbiology; Parasitology; Virology}},
Author-Email = {{dorokhov@genebee.msu.su}},
ResearcherID-Numbers = {{Dorokhov, Yuri/D-3565-2012
   Pozdyshev, Denis/D-8496-2012
   Komarova, Tatiana/D-5824-2012}},
ORCID-Numbers = {{Dorokhov, Yuri/0000-0002-4066-8940
   Komarova, Tatiana/0000-0001-6558-8755}},
Funding-Acknowledgement = {{Russian Foundation for Basic Research {[}11-04-01152]}},
Funding-Text = {{This work was partly supported by the Russian Foundation for Basic
   Research (11-04-01152). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.}},
Cited-References = {{Abeles F.B, 1992, ETHYLENE PLANT BIOL.
   ADAMS DO, 1979, P NATL ACAD SCI USA, V76, P170, DOI 10.1073/pnas.76.1.170.
   Allmann S, 2010, SCIENCE, V329, P1075, DOI 10.1126/science.1191634.
   Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072.
   Arimura G, 2002, PLANT J, V29, P87, DOI 10.1046/j.1365-313x.2002.01198.x.
   Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030.
   BALANDIN T, 1995, PLANT MOL BIOL, V27, P1197, DOI 10.1007/BF00020893.
   Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113.
   Barry CS, 1996, PLANT J, V9, P525, DOI 10.1046/j.1365-313X.1996.09040525.x.
   Bednarek P, 2009, SCIENCE, V324, P746, DOI 10.1126/science.1171661.
   Beffa RS, 1996, PLANT CELL, V8, P1001, DOI 10.1105/tpc.8.6.1001.
   Bosch M, 2005, PLANT CELL, V17, P3219, DOI 10.1105/tpc.105.037473.
   Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865.
   Bucher GL, 2001, PLANT J, V28, P361, DOI 10.1046/j.1365-313X.2001.01181.x.
   Burch-Smith TM, 2010, CURR BIOL, V20, P989, DOI 10.1016/j.cub.2010.03.064.
   Camardella L, 2000, EUR J BIOCHEM, V267, P4561, DOI 10.1046/j.1432-1327.2000.01510.x.
   Carr JP, 2010, ADV VIRUS RES, V76, P57, DOI 10.1016/S0065-3527(10)76003-6.
   Chen MH, 2000, EMBO J, V19, P913, DOI 10.1093/emboj/19.5.913.
   Chen MH, 2003, PLANT J, V35, P386, DOI 10.1046/j.1365-313X.2003.01818.x.
   Chen N, 2003, J EXP BOT, V54, P2449, DOI 10.1093/jxb/erg289.
   Crawford KM, 2000, CURR BIOL, V10, P1032, DOI 10.1016/S0960-9822(00)00657-6.
   D'Auria JC, 2007, PLANT J, V49, P194, DOI 10.1111/j.1365-313X.2006.02946.x.
   De Gouw JA, 2000, ENVIRON SCI TECHNOL, V34, P2640, DOI 10.1021/es991219k.
   DIACHENKO L, 1996, P NATL ACAD SCI USA, V93, P6025.
   Diatchenko L, 1999, METHOD ENZYMOL, V303, P349.
   Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002.
   Divol F, 2005, PLANT MOL BIOL, V57, P517, DOI 10.1007/s11103-005-0338-z.
   Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812.
   DOROKHOV YL, 1981, VIROLOGY, V108, P507, DOI 10.1016/0042-6822(81)90458-X.
   Dorokhov YL, 2006, FEBS LETT, V580, P3329, DOI 10.1016/j.febslet.2006.04.090.
   Dorokhov YL, 1999, FEBS LETT, V461, P223, DOI 10.1016/S0014-5793(99)01447-7.
   Dorokhov YL, 2006, FEBS LETT, V580, P3872, DOI 10.1016/j.febslet.2006.06.013.
   Downie A, 2004, PHYTOCHEMISTRY, V65, P2305, DOI 10.1016/j.phytochem.2004.07.006.
   Ehlting J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-154.
   Elmore JM, 2011, CURR OPIN PLANT BIOL, V14, P365, DOI 10.1016/j.pbi.2011.03.011.
   Fall R, 1996, TRENDS PLANT SCI, V1, P296, DOI 10.1016/S1360-1385(96)88175-0.
   Farag MA, 2002, PHYTOCHEMISTRY, V61, P545, DOI 10.1016/S0031-9422(02)00240-6.
   Fosu-Nyarko J, 2009, MOL PLANT PATHOL, V10, P237, DOI 10.1111/j.1364-3703.2008.00526.x.
   Francies KE, 2007, PLANT PHYSIOL, V142, P1004.
   Gallagher KL, 2009, PLANT J, V57, P785, DOI 10.1111/j.1365-313X.2008.03735.x.
   Gasanova TV, 2008, MOL BIOL+, V42, P421, DOI 10.1134/S0026893308030102.
   Gibbs AJ, 2010, J GEN VIROL, V91, P13, DOI 10.1099/vir.0.015925-0.
   GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950.
   Hasunuma T, 2004, J BIOTECHNOL, V111, P241, DOI 10.1016/j.jbiotec.2004.04.015.
   Hasunuma T, 2003, J BIOTECHNOL, V106, P45, DOI 10.1016/j.jbiotec.2003.07.008.
   HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433.
   Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005.
   Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010.
   Heil M, 2009, TRENDS PLANT SCI, V14, P356, DOI 10.1016/j.tplants.2009.04.002.
   Holopainen JK, 2010, TRENDS PLANT SCI, V15, P176, DOI 10.1016/j.tplants.2010.01.006.
   Huve K, 2007, J EXP BOT, V58, P1783, DOI 10.1093/jxb/erm038.
   Ievinsh G, 2001, BIOL PLANTARUM, V44, P233, DOI 10.1023/A:1010299309157.
   Jenkins J, 2001, J MOL BIOL, V305, P951, DOI 10.1006/jmbi.2000.4324.
   Jeong Y, 2011, MOL PLANT PATHOL, V12, P373, DOI 10.1111/j.1364-3703.2010.00679.x.
   Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002.
   Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006.
   Kim YS, 1998, PLANT CELL PHYSIOL, V39, P565, DOI 10.1093/oxfordjournals.pcp.a029406.
   Korner E, 2009, J EXP BOT, V60, P2631, DOI 10.1093/jxb/erp106.
   Komarova T. V., 2011, RNAI TECHNOLOGY, P125.
   Komarova TV, 2010, PLANT MOL BIOL, V74, P591, DOI 10.1007/s11103-010-9700-x.
   Lagaert S, 2009, SEMIN CELL DEV BIOL, V20, P1064, DOI 10.1016/j.semcdb.2009.05.008.
   Lee JY, 2011, TRENDS PLANT SCI, V16, P201, DOI 10.1016/j.tplants.2011.01.004.
   Lee JY, 2003, SCIENCE, V299, P392, DOI 10.1126/science.1077813.
   LEGRAND M, 1987, P NATL ACAD SCI USA, V84, P6750, DOI 10.1073/pnas.84.19.6750.
   Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803.
   Louvet R, 2006, PLANTA, V224, P782, DOI 10.1007/s00425-006-0261-9.
   Lucas WJ, 2009, TRENDS CELL BIOL, V19, P495, DOI 10.1016/j.tcb.2009.07.003.
   Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x.
   Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094.
   Markovic O, 2004, CARBOHYD RES, V339, P2281, DOI 10.1016/j.carres.2004.06.023.
   Markovic O, 2002, CELL MOL LIFE SCI, V59, P513, DOI 10.1007/s00018-002-8442-6.
   Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3.
   Nakatsuka A, 1998, PLANT PHYSIOL, V118, P1295, DOI 10.1104/pp.118.4.1295.
   Navakoudis E, 2007, BBA-BIOENERGETICS, V1767, P948, DOI 10.1016/j.bbabio.2007.05.003.
   NEMECEKMARSHALL M, 1995, PLANT PHYSIOL, V108, P1359, DOI 10.1104/pp.108.4.1359.
   NONOMURA AM, 1992, P NATL ACAD SCI USA, V89, P9794, DOI 10.1073/pnas.89.20.9794.
   Oparka KJ, 1999, CELL, V97, P743, DOI 10.1016/S0092-8674(00)80786-2.
   Pelletier S, 2010, NEW PHYTOL, V188, P726, DOI 10.1111/j.1469-8137.2010.03409.x.
   Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001.
   Penuelas J, 2005, NEW PHYTOL, V167, P851, DOI 10.1111/j.1469-8137.2005.01459.x.
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45.
   Piesik D, 2011, J PLANT PHYSIOL, V168, P878, DOI 10.1016/j.jplph.2010.11.010.
   Poueymiro M, 2009, CURR OPIN MICROBIOL, V12, P44, DOI 10.1016/j.mib.2008.11.008.
   Preston CA, 1999, PLANTA, V209, P87, DOI 10.1007/s004250050609.
   Raiola A, 2011, MOL PLANT MICROBE IN, V24, P432, DOI 10.1094/MPMI-07-10-0157.
   Rebrikov DV, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e90.
   Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707.
   Schilmiller AL, 2005, CURR OPIN PLANT BIOL, V8, P369, DOI 10.1016/j.pbi.2005.05.008.
   Shah J, 2009, CURR OPIN PLANT BIOL, V12, P459, DOI 10.1016/j.pbi.2009.05.011.
   Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0.
   Stonebloom S, 2009, P NATL ACAD SCI USA, V106, P17229, DOI 10.1073/pnas.0909229106.
   Tans-Kersten J, 1998, APPL ENVIRON MICROB, V64, P4918.
   Tasset C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001202.
   Tian GW, 2006, DEV BIOL, V294, P83, DOI 10.1016/j.ydbio.2006.02.026.
   Turlings TCJ, 1998, PLANTA, V207, P146, DOI 10.1007/s004250050466.
   Turra D, 2011, CURR PROTEIN PEPT SC, V12, P374, DOI 10.2174/138920311796391151.
   Velikova V, 2008, PLANT CELL ENVIRON, V31, P1882, DOI 10.1111/j.1365-3040.2008.01893.x.
   von Dahl CC, 2006, PLANT J, V46, P948, DOI 10.1111/j.1365-313X.2006.02760.x.
   Walley JW, 2010, J INTEGR PLANT BIOL, V52, P354, DOI 10.1111/j.1744-7909.2010.00940.x.
   Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768.
   Wen FS, 1999, PLANT CELL, V11, P1129, DOI 10.1105/tpc.11.6.1129.
   Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002.
   Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x.
   Wu JQ, 2009, PLANT CELL ENVIRON, V32, P1161, DOI 10.1111/j.1365-3040.2009.01943.x.
   Xu XM, 2010, CURR OPIN PLANT BIOL, V13, P684, DOI 10.1016/j.pbi.2010.09.003.
   Yi HS, 2009, PLANT PHYSIOL, V151, P2152, DOI 10.1104/pp.109.144782.
   Zavaliev R, 2011, PROTOPLASMA, V248, P117, DOI 10.1007/s00709-010-0247-0.
   Zhu YY, 2001, BIOTECHNIQUES, V30, P892.}},
Number-of-Cited-References = {{108}},
Times-Cited = {{39}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{29}},
Journal-ISO = {{PLoS Pathog.}},
Doc-Delivery-Number = {{934KY}},
Unique-ID = {{ISI:000303444200032}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000303623400008,
Author = {Muscatello, Gary},
Title = {{Rhodococcus equi pneumonia in the foal - Part 2: Diagnostics, treatment
   and disease management}},
Journal = {{VETERINARY JOURNAL}},
Year = {{2012}},
Volume = {{192}},
Number = {{1}},
Pages = {{27-33}},
Month = {{APR}},
Abstract = {{Various challenges face clinicians and farm managers in diagnosing,
   treating and preventing Rhodococcus equi pneumonia. The use of
   ultrasound imaging has aided in the early diagnosis of the disease,
   reducing treatment duration and improving therapeutic outcomes.
   Antimicrobial resistance in R. equi is an emerging issue that
   necessitates prudent antimicrobial therapy of diseased foals.
   Alternative methods of disease transmission, such as contagious
   foal-to-foal aerosol transmission, may need to be addressed to
   complement dust reduction environmental strategies and to minimise the
   overall risk of exposure of foals to highly concentrated inhaled doses
   of the organism. Effective management of foals and land aimed at
   reducing aerosol exposure to virulent R. equi is likely to yield
   significant reductions in the prevalence and severity of R. equi
   pneumonia. (C) 2011 Elsevier Ltd. All rights reserved.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Muscatello, G (Reprint Author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.
   Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.}},
DOI = {{10.1016/j.tvjl.2011.08.009}},
ISSN = {{1090-0233}},
EISSN = {{1532-2971}},
Keywords = {{Rhodococcus equi; Diagnosis; Treatment; Ultrasonography; Antimicrobial
   resistance}},
Keywords-Plus = {{HORSE BREEDING FARMS; BRONCHOALVEOLAR CELLS; HYPERIMMUNE PLASMA;
   ANTIMICROBIAL ACTIVITY; PULMONARY ABSCESSES; GALLIUM MALTOLATE; INFECTED
   FOALS; AIR SAMPLES; BODY-FLUIDS; PROTEIN-A}},
Research-Areas = {{Veterinary Sciences}},
Web-of-Science-Categories  = {{Veterinary Sciences}},
Author-Email = {{gary.muscatello@sydney.edu.au}},
Cited-References = {{Ardans A.A., 1986, P 32 ANN M AM ASS EQ, P129.
   Becu T, 1997, VET MICROBIOL, V56, P193, DOI 10.1016/S0378-1135(97)00088-6.
   Buckley T, 2007, IRISH VET J, V60, P728, DOI 10.1186/2046-0481-60-12-728.
   Carlson KL, 2010, VET THER, V11.
   Cauchard J, 2004, VET MICROBIOL, V104, P73, DOI 10.1016/j.vetmic.2004.09.006.
   Chaffin K.M., 2009, P 55 ANN CONV AM ASS, P36.
   Chaffin MK, 2010, J VET PHARMACOL THER, V33, P376, DOI 10.1111/j.1365-2885.2009.01150.x.
   Chaffin MK, 2008, JAVMA-J AM VET MED A, V232, P1035, DOI 10.2460/javma.232.7.1035.
   Chaffin MK, 2003, J AM VET MED ASSOC, V223, P1791, DOI 10.2460/javma.2003.223.1791.
   Chaffin MK, 2003, J AM VET MED ASSOC, V222, P467, DOI 10.2460/javma.2003.222.467.
   Chaffin MK, 2003, J AM VET MED ASSOC, V222, P476, DOI 10.2460/javma.2003.222.476.
   Cohen ND, 2005, JAVMA-J AM VET MED A, V226, P404, DOI 10.2460/javma.2005.226.404.
   Dabbs ER, 2003, ANTIMICROB AGENTS CH, V47, P1476, DOI 10.1128/AAC.47.4.1476-1478.2003.
   Giacometti A, 2005, J ANTIMICROB CHEMOTH, V56, P410, DOI 10.1093/jac/dki236.
   Giguere S, 1997, VET MICROBIOL, V56, P313, DOI 10.1016/S0378-1135(97)00099-0.
   Giguere S, 2003, J AM VET MED ASSOC, V222, P775, DOI 10.2460/javma.2003.222.775.
   Giguere S, 2002, J AM VET MED ASSOC, V220, P59, DOI 10.2460/javma.2002.220.59.
   Giguere S, 2004, J VET INTERN MED, V18, P568, DOI 10.1892/0891-6640(2004)18<568:RCOACA>2.0.CO;2.
   Giguere S., 1998, P 8 INT C EQ INF DIS, P103.
   Giguere S, 2010, JAVMA-J AM VET MED A, V237, P74, DOI 10.2460/javma.237.1.74.
   Gustafsson A, 1997, EQUINE VET J, V29, P314, DOI 10.1111/j.2042-3306.1997.tb03129.x.
   Harrington JR, 2006, J VET PHARMACOL THER, V29, P121, DOI 10.1111/j.1365-2885.2006.00723.x.
   Hashikura S, 2000, EQUINE VET J, V32, P560, DOI 10.2746/042516400777584587.
   Hebert L, 2010, CURR MICROBIOL, V60, P38, DOI 10.1007/s00284-009-9497-5.
   Higuchi T, 1999, J VET MED B, V46, P641, DOI 10.1046/j.1439-0450.1999.00284.x.
   HILLIDGE CJ, 1987, VET MICROBIOL, V14, P337, DOI 10.1016/0378-1135(87)90121-0.
   Hooper-McGrevy KE, 2001, AM J VET RES, V62, P1307, DOI 10.2460/ajvr.2001.62.1307.
   Horowitz ML, 2001, J VET INTERN MED, V15, P171, DOI 10.1892/0891-6640(2001)015<0171:AOSMLD>2.3.CO;2.
   HUGHES KL, 1987, VET MICROBIOL, V14, P241, DOI 10.1016/0378-1135(87)90111-8.
   HURLEY JR, 1995, AUST VET J, V72, P418, DOI 10.1111/j.1751-0813.1995.tb06192.x.
   Jacks S, 2002, J VET PHARMACOL THER, V25, P359, DOI 10.1046/j.1365-2885.2002.00420.x.
   Jacks S, 2001, AM J VET RES, V62, P1870, DOI 10.2460/ajvr.2001.62.1870.
   Jacks SS, 2003, ANTIMICROB AGENTS CH, V47, P1742, DOI 10.1128/AAC.47.5.1742-1745.2003.
   Jordan MC, 2003, AM J VET RES, V64, P1337, DOI 10.2460/ajvr.2003.64.1337.
   KENNEY DG, 1994, EQUINE VET J, V26, P246, DOI 10.1111/j.2042-3306.1994.tb04379.x.
   Kuskie KR, 2011, AM J VET RES, V72, P73, DOI 10.2460/ajvr.72.1.73.
   LAVOIE JP, 1994, EQUINE VET J, V26, P348, DOI 10.1111/j.2042-3306.1994.tb04401.x.
   Leadon D.P., 1989, EQUINE VET EDUC, V1, P24.
   Leclere M, 2011, VET J, V187, P109, DOI 10.1016/j.tvjl.2009.10.025.
   Letek M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001145.
   Lopez AM, 2002, CLIN DIAGN LAB IMMUN, V9, P1270, DOI 10.1128/CDLI.9.6.1270-1276.2002.
   MADIGAN JE, 1991, J REPROD FERTIL, P571.
   Martens R.J., 1989, P AM ASS EQ PRACT 35, P119.
   MARTENS RJ, 1989, EQUINE VET J, V21, P249, DOI 10.1111/j.2042-3306.1989.tb02161.x.
   Martens RJ, 2007, AM J VET RES, V68, P1041, DOI 10.2460/ajvr.68.10.1041.
   Martens RJ, 2007, J EQUINE VET SCI, V27, P341, DOI 10.1016/j.jevs.2007.06.007.
   Maurin Max, 1993, P23.
   Muscatello G, 2007, EQUINE VET J, V39, P470, DOI 10.2746/042516407X209217.
   Muscatello G, 2006, APPL ENVIRON MICROB, V72, P6152, DOI 10.1128/AEM.00495-06.
   Muscatello G, 2006, EQUINE VET J, V38, P263, DOI 10.2746/042516406776866480.
   Muscatello G, 2004, VET MICROBIOL, V100, P121, DOI 10.1016/j.vetmic.2004.01.016.
   Muscatello G, 2009, J CLIN MICROBIOL, V47, P734, DOI 10.1128/JCM.01395-08.
   Muscatello G., 2006, AUST EQUINE VET, V25, P79.
   Muscatello G., 2006, RATTLES HORSES EFFEC.
   Muscatello G, 2012, VET J, V192, P20, DOI 10.1016/j.tvjl.2011.08.014.
   NORDMANN P, 1992, ANTIMICROB AGENTS CH, V36, P1244, DOI 10.1128/AAC.36.6.1244.
   PRESCOTT JF, 1989, CAN VET J, V30, P871.
   PRESCOTT JF, 1993, VET CLIN N AM-EQUINE, V9, P375, DOI 10.1016/S0749-0739(17)30404-2.
   PRESCOTT JF, 1985, J AM VET MED ASSOC, V187, P725.
   PRESCOTT JF, 1991, CLIN MICROBIOL REV, V4, P20.
   Ramirez S, 2004, VET RADIOL ULTRASOUN, V45, P172, DOI 10.1111/j.1740-8261.2004.04028.x.
   Reef V.B., 1998, EQUINE DIAGNOSTIC UL, P187.
   Reef V.B., 1991, EQUINE RESP DISORDER, P69.
   Ren J, 2003, VET MICROBIOL, V94, P167, DOI 10.1016/S0378-1135(03)00099-3.
   Rodriguez-Lazaro D, 2006, APPL ENVIRON MICROB, V72, P4256, DOI 10.1128/AEM.02706-05.
   Sellon D.C., 2001, J CLIN MICROBIOL, V39, P1633.
   Stratton-Phelps M, 2000, J AM VET MED ASSOC, V217, P68, DOI 10.2460/javma.2000.217.68.
   SWEENEY CR, 1987, VET MICROBIOL, V14, P329, DOI 10.1016/0378-1135(87)90120-9.
   TAKAI S, 1994, J VET MED SCI, V56, P681, DOI 10.1292/jvms.56.681.
   Takai S, 1997, J CLIN MICROBIOL, V35, P1904.
   Takai S., 1994, P 7 INT C EQ INF DIS, P183.
   Varga J, 1997, VET MICROBIOL, V56, P205, DOI 10.1016/S0378-1135(97)00089-8.
   Venner M, 2007, VET J, V174, P418, DOI 10.1016/j.tvjl.2006.08.016.
   Venner M, 2010, N-S ARCH PHARMACOL, V381, P161, DOI 10.1007/s00210-009-0481-1.
   Venner M, 2009, VET J, V179, P301, DOI 10.1016/j.tvjl.2007.10.002.
   Womble A, 2007, J VET PHARMACOL THER, V30, P187, DOI 10.1111/j.1365-2885.2007.00857.x.}},
Number-of-Cited-References = {{76}},
Times-Cited = {{14}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{29}},
Journal-ISO = {{Vet. J.}},
Doc-Delivery-Number = {{936XN}},
Unique-ID = {{ISI:000303623400008}},
DA = {{2018-08-13}},
}

@article{ ISI:000301873000011,
Author = {Sun, Xinbo and Cao, Zhengbing and Porteous, Nuala and Sun, Yuyu},
Title = {{An N-halamine-based rechargeable antimicrobial and biofilm controlling
   polyurethane}},
Journal = {{ACTA BIOMATERIALIA}},
Year = {{2012}},
Volume = {{8}},
Number = {{4}},
Pages = {{1498-1506}},
Month = {{APR}},
Abstract = {{An N-halamine precursor, 5,5-dimethylhydantoin (DMH), was covalently
   linked to the surface of polyurethane (PU) with 1,6-hexamethylene
   diisocyanate (HDI) as the coupling agent. The reaction pathways were
   investigated using propyl isocyanate (PI) as a model compound. The
   results suggested that the imide and amide groups of DMH have very
   similar reactivities toward the isocyanate groups on PU surfaces
   activated with HDI. After bleach treatment the covalently bound DMH
   moieties were transformed into N-halamines. The new N-halamine-based PU
   provided potent antimicrobial effects against Staphylococcus aureus
   (Gram-positive bacterium), Escherichia coli (Gram-negative bacterium),
   methicillin-resistant Staphylococcus aureus (MRSA, drug-resistant
   Gram-positive bacterium), vancomycin-resistant Enterococcus faecium
   (VRE, drug-resistant Gram-positive bacterium), and Candida albicans
   (fungus), and successfully prevented bacterial and fungal biofilm
   formation. The antimicrobial and biofilm controlling effects were stable
   for longer than 6 months under normal storage in open air. Furthermore,
   if the functions were lost due to prolonged use they could be recharged
   by another chlorination treatment. The recharging could be repeated as
   needed to achieve long-term protection against microbial contamination
   and biofilm formation. (C) 2011 Acta Materialia Inc. Published by
   Elsevier Ltd. All rights reserved.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Sun, YY (Reprint Author), Univ S Dakota, Biomed Engn Program, 4800 N Career Ave, Sioux Falls, SD 57107 USA.
   Sun, Xinbo; Cao, Zhengbing; Sun, Yuyu, Univ S Dakota, Biomed Engn Program, Sioux Falls, SD 57107 USA.
   Porteous, Nuala, Univ Texas Hlth Sci Ctr San Antonio, Dept Comprehens Dent, San Antonio, TX 78229 USA.}},
DOI = {{10.1016/j.actbio.2011.12.027}},
ISSN = {{1742-7061}},
Keywords = {{Antimicrobial; Biofilm controlling; N-Halamine; Chlorination;
   Rechargeable}},
Keywords-Plus = {{NOSOCOMIAL INFECTIONS; POLYMERIC BIOCIDES; FIBROUS MATERIALS;
   UNITED-STATES; THERAPY; DISINFECTANTS; OUTBREAKS; AMINE; LATEX}},
Research-Areas = {{Engineering; Materials Science}},
Web-of-Science-Categories  = {{Engineering, Biomedical; Materials Science, Biomaterials}},
Author-Email = {{yuyu.sun@usd.edu}},
Funding-Acknowledgement = {{NIH, NIDCR {[}R01DE018707]}},
Funding-Text = {{This study was sponsored by the NIH, NIDCR (Grant No. R01DE018707).}},
Cited-References = {{Brun-Buisson C, 2001, AM J RESP CRIT CARE, V164, P1557, DOI 10.1164/ajrccm.164.9.2109051.
   Cao Z, 2010, J DENT RES, V89, P1517, DOI 10.1177/0022034510379604.
   Cao ZB, 2008, J BIOMED MATER RES A, V85A, P99, DOI 10.1002/jbm.a.31463.
   Cao ZB, 2009, ACS APPL MATER INTER, V1, P494, DOI 10.1021/am800157a.
   Chen ZB, 2007, BIOMATERIALS, V28, P1597, DOI 10.1016/j.biomaterials.2006.12.001.
   Gastmeier P, 2006, AM J INFECT CONTROL, V34, P603, DOI 10.1016/j.ajic.2006.01.014.
   Goddard JM, 2008, J FOOD PROTECT, V71, P2042, DOI 10.4315/0362-028X-71.10.2042.
   Grapski JA, 2001, BIOMATERIALS, V22, P2239, DOI 10.1016/S0142-9612(00)00412-9.
   Guan JJ, 2000, J BIOMAT SCI-POLYM E, V11, P523, DOI 10.1163/156856200743841.
   HALEY RW, 1981, AM J MED, V70, P947, DOI 10.1016/0002-9343(81)90561-1.
   Hebert C, 2010, CURR OPIN INFECT DIS, V23, P340, DOI 10.1097/QCO.0b013e32833ae214.
   Kocer HB, 2011, ACS APPL MATER INTER, V3, P2845, DOI 10.1021/am200351w.
   LAUTEN SD, 1992, APPL ENVIRON MICROB, V58, P1240.
   Liang J, 2006, BIOMATERIALS, V27, P2495, DOI 10.1016/j.biomaterials.2005.11.020.
   Linde H, 2005, EUR J CLIN MICROBIOL, V24, P419, DOI 10.1007/s10096-005-1341-7.
   Luo J, 2006, J BIOMED MATER RES A, V77A, P823, DOI 10.1002/jbm.a.30689.
   LUO J, 2006, J POLYM SCI A, V44, P3588.
   Luo J, 2008, J BIOMED MATER RES A, V84A, P631, DOI 10.1002/jbm.a.31301.
   Makal U, 2006, BIOMATERIALS, V27, P1316, DOI 10.1016/j.biomaterials.2005.08.038.
   Oertel G., 1993, POLYURETHANE.
   Oertel G, 1994, POLYURETHANE HDB CHE.
   Ouwendyk M, 1996, ANNA J, V23, P572.
   Pavithra D., 2008, BIOMED MATER, V3, P1.
   Pournaras S, 2009, SEMIN HEMATOL, V46, P198, DOI 10.1053/j.seminhematol.2009.03.007.
   Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020.
   Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007.
   Sun XB, 2010, IND ENG CHEM RES, V49, P11206, DOI 10.1021/ie101519u.
   Sun YY, 2001, J APPL POLYM SCI, V81, P617, DOI 10.1002/app.1477.
   Sun YY, 2001, J APPL POLYM SCI, V80, P2460, DOI 10.1002/app.1353.
   Szycher M., 1999, SZYCHERS HDB POLYURE.
   Tan KT, 2007, J MEMBRANE SCI, V289, P199, DOI 10.1016/j.memsci.2006.11.054.
   von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003.
   Wissman H. G., 1964, J APPL POLYM SCI, V8, P2971.
   WORLEY SD, 1988, CRIT REV ENV CONTR, V18, P133, DOI 10.1080/10643388809388345.
   Xu JT, 1998, J APPL POLYM SCI, V69, P965, DOI 10.1002/(SICI)1097-4628(19980801)69:5<965::AID-APP16>3.0.CO;2-N.
   Yao JR, 2008, IND ENG CHEM RES, V47, P5819, DOI 10.1021/ie800139y.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{33}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{46}},
Journal-ISO = {{Acta Biomater.}},
Doc-Delivery-Number = {{913JG}},
Unique-ID = {{ISI:000301873000011}},
OA = {{green\_accepted}},
DA = {{2018-08-13}},
}

@article{ ISI:000300770000006,
Author = {Augustine, Nimmy and Peter, Wilson A. and Kerkar, Savita and Thomas,
   Sabu},
Title = {{Arctic Actinomycetes as Potential Inhibitors of Vibrio cholerae Biofilm}},
Journal = {{CURRENT MICROBIOLOGY}},
Year = {{2012}},
Volume = {{64}},
Number = {{4}},
Pages = {{338-342}},
Month = {{APR}},
Abstract = {{The aim of this study was to identify novel biofilm inhibitors from
   actinomycetes isolated from the Arctic against Vibrio cholerae, the
   causative agent of cholera. The biofilm inhibitory activity of
   actinomycetes was assessed using biofilm assay and was confirmed using
   air-liquid interphase coverslip assay. The potential isolates were
   identified using 16S rRNA gene sequencing. Of all, three isolates showed
   significant biofilm inhibition against V. cholerae. The results showed
   that 20\% of the actinomycetes culture supernatant could inhibit up to
   80\% of the biofilm formation. When different extracted fractions were
   assessed, significant biofilm inhibition activity was only seen in the
   diethyl ether fraction of A745. At 200 mu g ml(-1) of diethyl ether
   fraction, 60\% inhibition of V. cholerae biofilm was observed. The two
   potential isolates were found to be Streptomyces sp. and one isolate
   belonged to Nocardiopsis sp. This is the first report showing a
   Streptomyces sp. and Nocardiopsis sp. isolated from the Arctic having a
   biofilm inhibitory activity against V. cholerae. The spread of drug
   resistant V. cholerae strains is a major clinical problem and the
   ineffectiveness in antibiotic treatment necessitates finding new modes
   of prevention and containment of the disease, cholera. The formation of
   biofilms during the proliferation of V. cholerae is linked to its
   pathogenesis. Hence, the bioactive compound from the culture supernatant
   of the isolates identified in this study may be a promising source for
   the development of a potential quorum sensing inhibitors against V.
   cholerae.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Thomas, S (Reprint Author), Rajiv Gandhi Ctr Biotechnol, Dept Mol Microbiol, Cholera \& Environm Microbiol Lab, Thiruvananthapuram 695014, Kerala, India.
   Augustine, Nimmy; Peter, Wilson A.; Thomas, Sabu, Rajiv Gandhi Ctr Biotechnol, Dept Mol Microbiol, Cholera \& Environm Microbiol Lab, Thiruvananthapuram 695014, Kerala, India.
   Kerkar, Savita, Goa Univ, Dept Biotechnol, Taleigao Plateau 403206, Goa, India.}},
DOI = {{10.1007/s00284-011-0073-4}},
ISSN = {{0343-8651}},
EISSN = {{1432-0991}},
Keywords-Plus = {{QUORUM-SENSING INHIBITORS; EXPRESSION; APHA}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{sabu@rgcb.res.in}},
Funding-Acknowledgement = {{Rajiv Gandhi Centre for Biotechnology, Trivandrum, India}},
Funding-Text = {{This study was supported by an intramural support from Rajiv Gandhi
   Centre for Biotechnology, Trivandrum, India. Dr. Sabu Thomas is thankful
   to Shri. Rasik Ravindra, Director and Dr. S. Rajan, Programme Director,
   National Centre for Antarctic and Ocean Research, Goa and Ministry of
   Earth Science, Govt. of India for having provided all the facilities and
   support during the Indian Arctic Expedition-2009. The authors are
   thankful to Prof. M. Radhakrishna Pillai, Director, RGCB for the
   facilities provided.}},
Cited-References = {{Augustine N, 2010, ARCH MICROBIOL, V192, P1019, DOI 10.1007/s00203-010-0633-1.
   Ghannoum MA, 2004, MICROBIAL BIOFILMS, P320.
   Kamruzzaman M, 2010, P NATL ACAD SCI USA, V107, P1588, DOI 10.1073/pnas.0913404107.
   Kelly RC, 2009, NAT CHEM BIOL, V5, P891, DOI 10.1038/nchembio.237.
   Kierek K, 2003, APPL ENVIRON MICROB, V69, P5079, DOI 10.1128/AEM.69.9.5079-5088.2003.
   Kociolek Martin G., 2009, Anti-Infective Agents in Medicinal Chemistry, V8, P315.
   Ozgur C., 2008, EURASIA J BIOSCI, V2, P73.
   Pana J, 2008, MICROBIOL RES, V163, P711, DOI 10.1016/j.micres.2007.12.002.
   Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x.
   Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005.
   Ren DC, 2005, APPL ENVIRON MICROB, V71, P4022, DOI 10.1128/AEM.71.7.4022-4034.2005.
   Rutherford ST, 2011, GENE DEV, V25, P397, DOI 10.1101/gad.2015011.
   Sultan SZ, 2010, FEMS MICROBIOL LETT, V302, P22, DOI 10.1111/j.1574-6968.2009.01837.x.
   Tamayo R, 2010, INFECT IMMUN, V78, P3560, DOI 10.1128/IAI.00048-10.
   VANDELLEN KL, 2006, DRUG DISCOV TODAY DI, V3, P261.
   WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/jb.173.2.697-703.1991.
   Yang MH, 2010, INFECT IMMUN, V78, P697, DOI 10.1128/IAI.00429-09.}},
Number-of-Cited-References = {{17}},
Times-Cited = {{12}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{19}},
Journal-ISO = {{Curr. Microbiol.}},
Doc-Delivery-Number = {{898VI}},
Unique-ID = {{ISI:000300770000006}},
DA = {{2018-08-13}},
}

@article{ ISI:000301761600016,
Author = {Neustroev, M. P.},
Title = {{On the prospects of microbiological research on mammoth fauna in
   permafrost}},
Journal = {{QUATERNARY INTERNATIONAL}},
Year = {{2012}},
Volume = {{255}},
Pages = {{139-140}},
Month = {{MAR 26}},
Note = {{5th International Conference on Mammoths and their Relatives, Le
   Puy-en-Velay, FRANCE, AUG 30-SEP 04, 2010}},
Abstract = {{Research of mammoth microflora is of current interest in terms of
   psychrophiles, cryoanabiosis, and the peculiar properties of ecology and
   evolution of microorganisms. Recovered Bacillus bacteria strains of the
   mammoths express antagonistic activity against pathogenic and
   opportunistic microorganisms. Moreover, the strains are antibiotic
   resistant and salt tolerant. The obtained data is consistent with
   research on biocoenosis of domestic and wild animals, cryogenic soil,
   air, atmosphere precipitation, and plants. Having high biological
   activity, Bacillus bacteria are the dominant group in the
   microbiocenosis environment in permafrost. (C) 2011 Elsevier Ltd and
   INQUA. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Neustroev, MP (Reprint Author), Russian Acad Agr Sci, Yakut Sci Res Inst Agr, Yakutsk, Russia.
   Russian Acad Agr Sci, Yakut Sci Res Inst Agr, Yakutsk, Russia.}},
DOI = {{10.1016/j.quaint.2011.06.003}},
ISSN = {{1040-6182}},
EISSN = {{1873-4553}},
Research-Areas = {{Physical Geography; Geology}},
Web-of-Science-Categories  = {{Geography, Physical; Geosciences, Multidisciplinary}},
Author-Email = {{yniicx@mail.ru}},
Number-of-Cited-References = {{0}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{6}},
Journal-ISO = {{Quat. Int.}},
Doc-Delivery-Number = {{911YW}},
Unique-ID = {{ISI:000301761600016}},
DA = {{2018-08-13}},
}

@article{ ISI:000302884800004,
Author = {Zhang, John and Levin, Robert and Angelo, Robert and Vincent, Richard
   and Brickner, Philip and Ngai, Peter and Nardell, Edward A.},
Title = {{A Radiometry Protocol for UVGI Fixtures Using a Moving-Mirror Type
   Gonioradiometer}},
Journal = {{JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE}},
Year = {{2012}},
Volume = {{9}},
Number = {{3}},
Pages = {{140-148}},
Month = {{MAR}},
Abstract = {{Ultraviolet germicidal irradiation (UVGI), 254 nm UV-C, is increasingly
   used as an infection control strategy to reduce the spread of airborne
   pathogens such as tuberculosis (TB), influenza viruses, and measles.
   With the appearance of multidrug-resistant TB and emerging infectious
   disease such as severe acute respiratory syndrome (SARS) and H1N1
   influenza viruses, engineering controls using 254 nm UV-C lamps within
   specialized luminaires, herein designated UVGI fixtures, are being
   installed in high-risk settings such as homeless shelters, hospitals,
   jails and prisons, and schools. Studies have established that a
   relatively uniform spatial distribution of UV-C in the upper room can
   effectively cleanse the air of aerosolized pathogens. However; for
   planning purposes, the placement of multiple UVGI fixtures in a space,
   to achieve uniformity of UV-C energy distribution using currently
   available lighting software, is not yet practical because no
   industry-wide standard method exists for radiometric measurement of
   commercial UVGI fixtures. In this article, standard methods for
   photometry and reporting of general fluorescent lighting luminaire
   photometric data are adopted to provide UVGI fixture spatial emission
   distribution data in an electronic file format. The ultimate expectation
   of the authors is that the results will lead to a software program for
   fixture placement, comparable to and as easy to use as the corresponding
   software used for general interior lighting applications. To accomplish
   this goal, a radiometry measurement system is developed to obtain the
   radiant intensity distributions of UVGI fixtures in a three-dimensional
   space. This system includes a moving-mirror Type C goniometer, a mirror,
   a radiometer, a desktop computer, the mechanical control hardware, and
   the data acquisition/presentation software. Repeated measurements were
   made on each of three exemplary UVGI fixtures, and measurement variation
   did not exceed +/- 2.0\%.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Vincent, R (Reprint Author), Mt Sinai Med Ctr, Dept Med, Div Gen Internal Med, 1 Gustave L Levy Pl,Box 1087, New York, NY 10029 USA.
   Zhang, John, Lunera Lighting, Redwood City, CA USA.
   Levin, Robert, OSRAM SYLVANIA, Danvers, MA USA.
   Angelo, Robert, Gigahertz Opt, Newburyport, MA USA.
   Vincent, Richard; Brickner, Philip, Mt Sinai Sch Med, New York, NY USA.
   Ngai, Peter, Acu Brands Lighting, Berkeley, CA USA.
   Nardell, Edward A., Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA.}},
DOI = {{10.1080/15459624.2011.648569}},
ISSN = {{1545-9624}},
Keywords = {{germicidal ultraviolet; gonioradiometer; UV-C; UVGI; UVGI fixtures;
   radiometry measurement method}},
Keywords-Plus = {{ULTRAVIOLET GERMICIDAL IRRADIATION; UPPER-ROOM AIR; TUBERCULOSIS;
   DISINFECTION; TRANSMISSION}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{richard.vincent@mountsinai.org}},
ORCID-Numbers = {{Vincent, Richard/0000-0003-3453-4070}},
Funding-Acknowledgement = {{New York State Energy Research and Development Authority (NYSERDA)
   {[}9425]}},
Funding-Text = {{The authors thank the New York State Energy Research and Development
   Authority (NYSERDA) for sponsoring this work through agreement 9425. In
   addition, we thank Acuity Brands Lighting for the laboratory and
   personnel resources used in conducting the radiometric testing for this
   study.}},
Cited-References = {{American Conference of Governmental Industrial Hygienists (ACGIH), 2008, TLVS AND BEIS.
   American Society of Heating. Refrigerating and Air-Conditioning Engineers Inc. (ASHRAE), 2008, 2008 ASHRAE HDB EQU.
   Brickner P.W., 2004, J HEALTHCARE SAF COM, V4, P123.
   Brickner PW, 2003, PUBLIC HEALTH REP, V118, P99, DOI 10.1093/phr/118.2.99.
   Commission Internationale de PEclairage (CIE), 2003, 155 CIE.
   Dumyahn T, 1999, AM IND HYG ASSOC J, V60, P219, DOI 10.1202/0002-8894(1999)060<0219:COUURA>2.0.CO;2.
   First M., 1999, ASHRAE T, V105, P877.
   First M., 2007, LEUKOS, V3, P181.
   First MW, 2005, J OCCUP ENVIRON HYG, V2, P285, DOI 10.1080/1545962059095224.
   FIRST MW, 1999, ASHRAE T, V105, P869.
   Illuminating Engineering Society of North America (IESNA) Testing Procedures Committee, 1991, LM5491 IESNA TEST PR.
   Illuminating Engineering Society of North America (IESNA) Testing Procedures Committee, 1998, LM4198 IESNA TEST PR.
   Illuminating Engineering Society of North America (IESNA). Testing Procedures Committee, 2002, LM6302 ANSIIESNA.
   Illuminating Engineering Society of North America (IESNA) Testing Procedures Committee, 2001, LM7501 IESNA TEST PR.
   Illuminating Engineering Society of North America (IESNA) Testing Procedures Committee, 1996, LM5596 IESNA TEST PR.
   ISEMAN MD, 1992, ANN INTERN MED, V117, P251, DOI 10.7326/0003-4819-117-3-251.
   Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1.
   Levin R, 1985, LIGHT DESIGN APPL, V15, P44.
   McDevitt JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003186.
   MillerLeiden S, 1996, J AIR WASTE MANAGE, V46, P869, DOI 10.1080/10473289.1996.10467523.
   NARDELL EA, 1995, AM J INFECT CONTROL, V23, P156, DOI 10.1016/0196-6553(95)90261-9.
   Nardell EA, 2008, PUBLIC HEALTH REP, V123, P52, DOI 10.1177/003335490812300108.
   Nicas M, 1999, Appl Occup Environ Hyg, V14, P317.
   Rahn RO, 1999, PHOTOCHEM PHOTOBIOL, V70, P314, DOI 10.1562/0031-8655(1999)070<0314:DORAGN>2.3.CO;2.
   Rea M, 2000, IESNA LIGHT HDB, V9th.
   Riley R.L., 1989, AM REV RESPIR DIS, V139, P286.
   RILEY RL, 1976, AM REV RESPIR DIS, V113, P413.
   Taylor B.N., 1994, 1297 NIST.
   Vincent R.L., 2003, P 5 INT LRO LIGHT RE.
   Xu P, 2003, ATMOS ENVIRON, V37, P405, DOI 10.1016/S1352-2310(02)00825-7.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{5}},
Journal-ISO = {{J. Occup. Environ. Hyg.}},
Doc-Delivery-Number = {{927CO}},
Unique-ID = {{ISI:000302884800004}},
DA = {{2018-08-13}},
}

@article{ ISI:000302032200006,
Author = {Moretro, Trond and Heir, Even and Nesse, Live L. and Vestby, Lene K. and
   Langsrud, Solveig},
Title = {{Control of Salmonella in food related environments by chemical
   disinfection}},
Journal = {{FOOD RESEARCH INTERNATIONAL}},
Year = {{2012}},
Volume = {{45}},
Number = {{2, SI}},
Pages = {{532-544}},
Month = {{MAR}},
Abstract = {{Salmonella may be transferred to food through cross-contamination during
   processing and preparation. To minimise the risk of cross-contamination,
   proper cleaning and disinfection is essential for the food industry.
   Recently, disinfection of areas for preparation and storage of food has
   also gained increased popularity in households. There is a range of
   disinfectants available with different properties and usage areas, and
   care must be taken to choose the proper disinfectant for the specific
   application.
   There are many methods for testing the antimicrobial effect of
   disinfectants. To evaluate whether a disinfectant will be effective in
   practical settings, the test method should model real-life situations.
   Most disinfectants are effective against Salmonella at recommended user
   concentration in suspension tests. However, a number of factors may
   reduce the biocidal effect of disinfectants under practical conditions.
   This include properties of the surface to be disinfected, presence of
   soiling on the surface, the physiological state of the bacteria exposed
   to disinfection, including bacteria embedded in biofilms, and the
   effects of other stresses (e.g. desiccation, starvation and
   temperature).
   Here we review the effects of disinfectants used in food related areas
   in industries and in households against Salmonella. A general overview
   is given for disinfectants in use and methods used to evaluate effects.
   Effects of disinfectants against Salmonella in suspension and on
   surfaces, including biofilms, are presented and compared. Novel control
   strategies such as use of electrolysed water, antimicrobial surfaces,
   and anti-biofilm compounds are also covered. Finally, we review the
   ability of Salmonella to gain reduced susceptibility to disinfectants
   through adaptation and other physiological responses like biofilm
   formation. (C) 2011 Elsevier Ltd. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Moretro, T (Reprint Author), Nofima Mat AS, Osloveien 1, N-1430 As, Norway.
   Moretro, Trond; Heir, Even; Langsrud, Solveig, Nofima Mat AS, N-1430 As, Norway.
   Nesse, Live L.; Vestby, Lene K., Natl Vet Inst, N-0106 Oslo, Norway.}},
DOI = {{10.1016/j.foodres.2011.02.002}},
ISSN = {{0963-9969}},
EISSN = {{1873-7145}},
Keywords = {{Salmonella; Disinfection; Sanitation; Resistance; Cross-contamination;
   Biofilm}},
Keywords-Plus = {{ENTERICA SEROVAR TYPHIMURIUM; ELECTROLYZED OXIDIZING WATER;
   ESCHERICHIA-COLI O157-H7; AIR-LIQUID INTERFACE; LISTERIA-MONOCYTOGENES;
   ANTIBIOTIC-RESISTANCE; BIOFILM FORMATION; STAINLESS-STEEL; INANIMATE
   SURFACES; HYPOCHLOROUS ACID}},
Research-Areas = {{Food Science \& Technology}},
Web-of-Science-Categories  = {{Food Science \& Technology}},
Author-Email = {{trond.moretro@nofima.no
   even.heir@nofima.no
   live.nesse@vetinst.no
   lene.vestby@vetinst.no
   solveig.langsrud@nofima.no}},
ResearcherID-Numbers = {{Langsrud, Solveig/I-1241-2012}},
Funding-Acknowledgement = {{Foundation for Research Levy on Agricultural Products; National
   Veterinary Institute of Norway}},
Funding-Text = {{This work was funded by The Foundation for Research Levy on Agricultural
   Products and the National Veterinary Institute of Norway.}},
Cited-References = {{Aarestrup FM, 2004, VET MICROBIOL, V100, P83, DOI 10.1016/j.vetmic.2004.01.013.
   Aiello AE, 2003, LANCET INFECT DIS, V3, P501, DOI 10.1016/S1473-3099(03)00723-0.
   Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl\_1.5.
   AOAC, 1995, 95511 AOAC INT.
   AOAC, 1995, 99147 AOAC INT.
   ASTM, 2002, E189197 ASTM.
   ASTM, 2002, E2111 ASTM.
   Barker J, 2003, J APPL MICROBIOL, V95, P1351, DOI 10.1046/j.1365-2672.2003.02127.x.
   Berchieri A, 1996, AVIAN PATHOL, V25, P663, DOI 10.1080/03079459608419173.
   Beuchat L.R., 1998, WHO FSF FOS PUBLICAT.
   Birosova L, 2009, J MED MICROBIOL, V58, P436, DOI 10.1099/jmm.0.003657-0.
   Block S. S., 2001, DISINFECTION STERILI, P185.
   Block S.S, 2001, DISINFECTION STERILI.
   Bloomfield S.F., 2010, PREVENTING SPREAD IN.
   Bore E, 2005, J APPL MICROBIOL, V98, P96, DOI 10.1111/j.1365-2672.2004.02436.x.
   Braoudaki M, 2004, J CLIN MICROBIOL, V42, P73, DOI 10.1128/JCM.42.1.73-78.2004.
   Buckingham-Meyer K, 2007, J MICROBIOL METH, V70, P236, DOI 10.1016/j.mimet.2007.04.010.
   Carrique-Mas JJ, 2009, AVIAN PATHOL, V38, P419, DOI 10.1080/03079450903193768.
   CEN, 1997, EN 1040 CHEM DIS ANT.
   CEN, 2002, EN 13697 CHEM DIS AN.
   CEN, 1997, EN 1276 CHEM DIS ANT.
   Chaitiemwong N, 2010, INT J FOOD MICROBIOL, V142, P260, DOI 10.1016/j.ijfoodmicro.2010.06.021.
   Chuanchuen R, 2008, J VET MED SCI, V70, P595, DOI 10.1292/jvms.70.595.
   Cogan TA, 2002, J APPL MICROBIOL, V92, P885, DOI 10.1046/j.1365-2672.2002.01598.x.
   Cogan TA, 1999, LETT APPL MICROBIOL, V29, P354, DOI 10.1046/j.1472-765X.1999.00656.x.
   Copitch JL, 2010, INT J ANTIMICROB AG, V36, P247, DOI 10.1016/j.ijantimicag.2010.04.012.
   Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7.
   Costerton J, 2007, INT J ARTIF ORGANS, V30, P757.
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431.
   Cowan MM, 2003, J IND MICROBIOL BIOT, V30, P102, DOI 10.1007/s10295-002-0022-0.
   CREMIEUX A, 2001, DISINFECTION STERILI, P1305.
   Cutter CN, 1999, J FOOD PROTECT, V62, P474, DOI 10.4315/0362-028X-62.5.474.
   DAVIES RH, 1995, POULTRY SCI, V74, P638, DOI 10.3382/ps.0740638.
   Davison S, 2003, AVIAN DIS, V47, P143, DOI 10.1637/0005-2086(2003)047{[}0143:TRODRO]2.0.CO;2.
   De Muynck W, 2010, J APPL MICROBIOL, V108, P62, DOI 10.1111/j.1365-2672.2009.04395.x.
   de Nys R, 2006, MAR MOL BIOTECHNOL, V42, P55.
   Delhalle L, 2008, J FOOD PROTECT, V71, P1320, DOI 10.4315/0362-028X-71.7.1320.
   Deza MA, 2003, LETT APPL MICROBIOL, V37, P482, DOI 10.1046/j.1472-765X.2003.01433.x.
   DHALIWAL DS, 1992, LETT APPL MICROBIOL, V15, P217, DOI 10.1111/j.1472-765X.1992.tb00767.x.
   DHIR VK, 1995, APPL ENVIRON MICROB, V61, P1731.
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002.
   Duff SB, 2003, J FOOD PROTECT, V66, P2103, DOI 10.4315/0362-028X-66.11.2103.
   Dworjanyn SA, 1999, MAR BIOL, V133, P727, DOI 10.1007/s002270050514.
   Ellis A, 1998, EPIDEMIOL INFECT, V120, P29, DOI 10.1017/S0950268897008376.
   Evans MR, 1996, EPIDEMIOL INFECT, V116, P161, DOI 10.1017/S0950268800052390.
   Fernandez A, 2009, FOOD RES INT, V42, P1105, DOI 10.1016/j.foodres.2009.05.009.
   Giaouris ED, 2006, FOOD MICROBIOL, V23, P747, DOI 10.1016/j.fm.2006.02.006.
   Gilbert P, 2003, CLIN MICROBIOL REV, V16, P189, DOI 10.1128/CMR.16.2.189-208.2003.
   Gilbert P, 2001, J INFECTION, V43, P85, DOI 10.1053/jinf.2001.0853.
   GILBERT P, 1987, J ANTIMICROB CHEMOTH, V20, P147, DOI 10.1093/jac/20.2.147.
   Giraudon I, 2009, PUBLIC HEALTH, V123, P444, DOI 10.1016/j.puhe.2009.03.011.
   Gradel KO, 2005, VET MICROBIOL, V107, P127, DOI 10.1016/j.vetmic.2005.01.013.
   Grinstead D, 2009, WOODHEAD PUBL FOOD S, P331.
   Guentzel JL, 2008, FOOD MICROBIOL, V25, P36, DOI 10.1016/j.fm.2007.08.003.
   Hennessy TW, 1996, NEW ENGL J MED, V334, P1281, DOI 10.1056/NEJM199605163342001.
   Hood SK, 1997, INT J FOOD MICROBIOL, V37, P145, DOI 10.1016/S0168-1605(97)00071-8.
   Hricova D, 2008, J FOOD PROTECT, V71, P1934, DOI 10.4315/0362-028X-71.9.1934.
   Huang YR, 2008, FOOD CONTROL, V19, P329, DOI 10.1016/j.foodcont.2007.08.012.
   Jagusztyn-Krynicka EK, 2008, POL J MICROBIOL, V57, P91.
   Janssens JCA, 2008, APPL ENVIRON MICROB, V74, P6639, DOI 10.1128/AEM.01262-08.
   JOHNSTON MD, 1995, J MICROBIOL METH, V21, P15, DOI 10.1016/0167-7012(94)00023-Z.
   Jolivet-Gougeon A, 2003, CELL BIOL TOXICOL, V19, P83, DOI 10.1023/A:1023355122055.
   Joseph B, 2001, INT J FOOD MICROBIOL, V64, P367, DOI 10.1016/S0168-1605(00)00466-9.
   Junker LM, 2004, J ANTIMICROB CHEMOTH, V53, P989, DOI 10.1093/jac/dkh196.
   Just JR, 2003, J FOOD SCI, V68, P285, DOI 10.1111/j.1365-2621.2003.tb14154.x.
   Kampmann Y, 2008, J APPL MICROBIOL, V104, P1808, DOI 10.1111/j.1365-2672.2008.03727.x.
   Karatzas KAG, 2007, J ANTIMICROB CHEMOTH, V60, P947, DOI 10.1093/jac/dkm314.
   Kieboom J, 2006, J FOOD PROTECT, V69, P2681, DOI 10.4315/0362-028X-69.11.2681.
   KJELLEBERG S, 2001, MICROBIOL TODAY, V28, P134.
   Korber DR, 1997, APPL ENVIRON MICROB, V63, P3352.
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130.
   Kumar CG, 1998, INT J FOOD MICROBIOL, V42, P9, DOI 10.1016/S0168-1605(98)00060-9.
   Kusumaningrum HD, 2003, J FOOD PROTECT, V66, P2289, DOI 10.4315/0362-028X-66.12.2289.
   Langsrud S, 1996, J APPL BACTERIOL, V81, P411.
   LECHEVALLIER MW, 1988, APPL ENVIRON MICROB, V54, P2492.
   Lee JH, 2004, J GASTROEN HEPATOL, V19, P897, DOI 10.1111/j.1400-1746.2004.03375.x.
   Lelieveld H. L. M., 2005, HDB HYGIENE CONTROL.
   Levy SB, 2001, EMERG INFECT DIS, V7, P512, DOI 10.3201/eid0707.017705.
   Leyer GJ, 1997, APPL ENVIRON MICROB, V63, P461.
   Llewellyn LJ, 1998, J EPIDEMIOL COMMUN H, V52, P272, DOI 10.1136/jech.52.4.272.
   Lonn-Stensrud J, 2007, ORAL MICROBIOL IMMUN, V22, P340, DOI 10.1111/j.1399-302X.2007.00367.x.
   Maillard J.-Y., 2005, HDB HYGIENE FOOD IND.
   Mangalappalli-Illathu AK, 2008, ANTIMICROB AGENTS CH, V52, P3669, DOI 10.1128/AAC.00073-08.
   Marriott N., 1995, PRINCIPLES FOOD SANI.
   McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147.
   McDonnell GE, 2007, ANTISEPSIS DISINFECT.
   McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970.
   McMurry LM, 1998, FEMS MICROBIOL LETT, V166, P305, DOI 10.1111/j.1574-6968.1998.tb13905.x.
   Merianos JJ, 2001, DISINFECTION STERILI, P283.
   Mokgatla RM, 2002, J APPL MICROBIOL, V92, P566, DOI 10.1046/j.1365-2672.2002.01565.x.
   Mokgatla RM, 1998, LETT APPL MICROBIOL, V27, P379, DOI 10.1046/j.1472-765X.1998.00432.x.
   Moretro T, 2009, J APPL MICROBIOL, V106, P1005, DOI 10.1111/j.1365-2672.2008.04067.x.
   Moretro T, 2006, J FOOD PROTECT, V69, P627, DOI 10.4315/0362-028X-69.3.627.
   Moretro T, 2003, VET MICROBIOL, V94, P207, DOI 10.1016/S0378-1135(03)00105-6.
   Moretro T., 2011, INT J FOOD IN PRESS.
   Moretro T., 2004, J FOOD SCI, V69, pM151.
   Mueller-Doblies D, 2010, J APPL MICROBIOL, V109, P471, DOI 10.1111/j.1365-2672.2010.04667.x.
   Nikaido E, 2008, J BIOL CHEM, V283, P24245, DOI 10.1074/jbc.M804544200.
   Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003.
   Nishino K, 2009, BBA-PROTEINS PROTEOM, V1794, P834, DOI 10.1016/j.bbapap.2009.02.002.
   OBLINGER JL, 1975, J MILK FOOD TECHNOL, V38, P540, DOI 10.4315/0022-2747-38.9.540.
   Oh SW, 2005, LETT APPL MICROBIOL, V41, P56, DOI 10.1111/j.1472-765X.2005.01711.x.
   Omidbakhsh N, 2006, AM J INFECT CONTROL, V34, P251, DOI 10.1016/j.ajic.2005.06.002.
   Pao S, 2007, J FOOD PROTECT, V70, P629, DOI 10.4315/0362-028X-70.3.629.
   Park EJ, 2009, FOOD MICROBIOL, V26, P386, DOI 10.1016/j.fm.2008.10.013.
   Parnes CA, 1997, J ENVIRON HEALTH, V59, P14.
   Podolak R, 2010, J FOOD PROTECT, V73, P1919, DOI 10.4315/0362-028X-73.10.1919.
   Ramesh N, 2002, POULTRY SCI, V81, P904, DOI 10.1093/ps/81.6.904.
   Randall LP, 2007, J ANTIMICROB CHEMOTH, V60, P1273, DOI 10.1093/jac/dkm359.
   Randall LP, 2004, J ANTIMICROB CHEMOTH, V54, P621, DOI 10.1093/jac/dkh376.
   Randall LP, 2001, J MED MICROBIOL, V50, P919, DOI 10.1099/0022-1317-50-10-919.
   Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005.
   Reij MW, 2004, INT J FOOD MICROBIOL, V91, P1, DOI 10.1016/S0168-1605(03)00295-2.
   RESTAINO L, 1995, APPL ENVIRON MICROB, V61, P3471.
   Romling U, 1999, FEMS MICROBIOL LETT, V180, P91.
   RONNER AB, 1993, J FOOD PROTECT, V56, P750, DOI 10.4315/0362-028X-56.9.750.
   ROWE B, 1987, LANCET, V2, P900.
   Russell A. D., 2001, DISINFECTION STERILI.
   Russell A.D, 1996, UNDERSTANDING ANTIBA.
   Russell AD, 1999, J HOSP INFECT, V43, pS57, DOI 10.1016/S0195-6701(99)90066-X.
   Russell AD, 2002, J APPL MICROBIOL, V92, p121S, DOI 10.1046/j.1365-2672.92.5s1.12.x.
   Rutala WA, 2000, INFECT CONT HOSP EP, V21, P33, DOI 10.1086/501694.
   Scher K, 2005, APPL ENVIRON MICROB, V71, P1163, DOI 10.1128/AEM.71.3.1163-1168.2005.
   Schmidt PL, 2004, J FOOD PROTECT, V67, P1384, DOI 10.4315/0362-028X-67.7.1384.
   Schutze GE, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.1.e1.
   Scott E., 2001, DISINFECTION STERILI, P1205.
   Sheldon AT, 2005, CLIN INFECT DIS, V40, P1650, DOI 10.1086/430063.
   Small A, 2006, J FOOD PROTECT, V69, P2342, DOI 10.4315/0362-028X-69.10.2342.
   Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x.
   Solano C, 1998, J CLIN MICROBIOL, V36, P674.
   Steenackers HP, 2010, BIOORGAN MED CHEM, V18, P5224, DOI 10.1016/j.bmc.2010.05.055.
   Sundheim G, 1995, INT BIODETER BIODEGR, V36, P441, DOI 10.1016/0964-8305(95)00108-5.
   Tabak M, 2007, FEMS MICROBIOL LETT, V267, P200, DOI 10.1111/j.1474-6968.2006.00547.x.
   Tabak M, 2009, FEMS MICROBIOL LETT, V301, P69, DOI 10.1111/j.1574-6968.2009.01804.x.
   Thorrold CA, 2007, INT J FOOD MICROBIOL, V113, P315, DOI 10.1016/j.ijfoodmicro.2006.08.008.
   Todd ECD, 2009, J FOOD PROTECT, V72, P202, DOI 10.4315/0362-028X-72.1.202.
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI 10.1586/ERD.09.36.
   Venkitanarayanan KS, 1999, APPL ENVIRON MICROB, V65, P4276.
   Venkitanarayanan KS, 1999, J FOOD PROTECT, V62, P857, DOI 10.4315/0362-028X-62.8.857.
   Vestby LK, 2010, J APPL MICROBIOL, V108, P771, DOI 10.1111/j.1365-2672.2009.04495.x.
   Vestby LK, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-43.
   Vestby LK, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-20.
   Vieira CD, 2005, AM J INFECT CONTROL, V33, P162, DOI 10.1016/j.ajic.2004.10.007.
   Wang SY, 2010, APPL ENVIRON MICROB, V76, P5013, DOI 10.1128/AEM.00823-10.
   Weavers L.K., 2001, DISINFECTION STERILI, P205.
   Webber MA, 2008, J ANTIMICROB CHEMOTH, V62, P92, DOI 10.1093/jac/dkn138.
   Webber MA, 2008, J ANTIMICROB CHEMOTH, V62, P83, DOI 10.1093/jac/dkn137.
   White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.3219-3227.2006.
   White P., 2006, J BACTERIOL, V188, P8395.
   Wong HS, 2010, J APPL MICROBIOL, V108, P2222, DOI 10.1111/j.1365-2672.2009.04630.x.
   Wong HS, 2010, BIOFOULING, V26, P859, DOI 10.1080/08927014.2010.527959.
   Wood P, 1998, J APPL MICROBIOL, V84, P1092.
   Woodward MJ, 2000, J MED MICROBIOL, V49, P481, DOI 10.1099/0022-1317-49-5-481.
   Yang H, 2009, J FOOD PROTECT, V72, P1201, DOI 10.4315/0362-028X-72.6.1201.
   Yazdankhah SP, 2006, MICROB DRUG RESIST, V12, P83, DOI 10.1089/mdr.2006.12.83.
   YU FPP, 1993, J MICROBIOL METH, V17, P167, DOI 10.1016/0167-7012(93)90044-I.}},
Number-of-Cited-References = {{156}},
Times-Cited = {{48}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{66}},
Journal-ISO = {{Food Res. Int.}},
Doc-Delivery-Number = {{915MU}},
Unique-ID = {{ISI:000302032200006}},
DA = {{2018-08-13}},
}

@article{ ISI:000302187600010,
Author = {Kaske, Martin and Kunz, Hans-Juergen and Reinhold, Petra},
Title = {{An update on respiratory disease in calves}},
Journal = {{PRAKTISCHE TIERARZT}},
Year = {{2012}},
Volume = {{93}},
Number = {{3}},
Pages = {{232+}},
Month = {{MAR 1}},
Abstract = {{Undifferentiated respiratory disease represents one of the most
   important diseases of rearing and veal calves with enormous impact on
   animal welfare and the economic outcome of calf raising. As a typical
   factorial disease, interactions between viral as well as bacterial
   infectious agents and host cells, abiotic factors (such as stocking
   density, ventilation, air quality) and also management factors (such as
   colostral supply, intervals for pen cleaning) play a pivotal role for
   the pathogenesis and the incidence on farms. This review depicts the
   impact of these factors, points out the relation between clinical
   symptoms and the extent of pathomorphologic alterations and describes
   the principles of therapy and prevention.}},
Publisher = {{SCHLUETERSCHE VERLAGSGESELLSCHAFT MBH \& CO KG}},
Address = {{HANS-BOCKLER-ALLEE 7, 30173 HANNOVER, GERMANY}},
Type = {{Article}},
Language = {{German}},
Affiliation = {{Kaske, M (Reprint Author), Univ Vet Med Hannover, Klin Rinder, Bischofsholer Damm 15, D-30173 Hannover, Germany.
   Kaske, Martin, Univ Vet Med Hannover, Klin Rinder, D-30173 Hannover, Germany.
   Kunz, Hans-Juergen, Landwirtschafts Kammer Schleswig Holstein, Lehr \& Versuchszentrum, Schleswig Holstein, Germany.
   Reinhold, Petra, Friedrich Loeffler Inst, Inst Mol Pathogenese, Jena, Germany.}},
ISSN = {{0032-681X}},
Keywords = {{bovine respiratory disease; pathogenesis; therapy; prevention; housing}},
Keywords-Plus = {{VIRAL DIARRHEA VIRUS; PULMONARY-FUNCTION VALUES; ANTIMICROBIAL
   SUSCEPTIBILITY; FEEDLOT CATTLE; MYCOPLASMA-BOVIS; SYNCYTIAL VIRUS;
   NEUTROPHIL GRANULOCYTES; ANTIBACTERIAL TREATMENT; ANTIBIOTIC-RESISTANCE;
   BACTERIAL PNEUMONIA}},
Research-Areas = {{Veterinary Sciences}},
Web-of-Science-Categories  = {{Veterinary Sciences}},
Author-Email = {{martin.kaske@tiho-hannover.de}},
Cited-References = {{ALLEN JW, 1991, CAN J VET RES, V55, P341.
   Bostedt H, 2000, TIERARZTL UMSCHAU, V55, P305.
   Brodersen BW, 1998, AM J VET RES, V59, P1423.
   Buettner-Peter U, 2008, DEUT TIERARZTL WOCH, V115, P308, DOI 10.2376/0341-6593-115-308.
   CASTLEMAN WL, 1990, AM J VET RES, V51, P789.
   Caswell Jeff L., 2007, Animal Health Research Reviews, V8, P161, DOI 10.1017/S1466252307001351.
   Catry B, 2008, J VET PHARMACOL THER, V31, P479, DOI 10.1111/j.1365-2885.2008.00981.x.
   Cemek M, 2006, CELL BIOCHEM FUNCT, V24, P269, DOI 10.1027/cbf.1220.
   Confer Anthony W., 2009, Animal Health Research Reviews, V10, P145, DOI 10.1017/S1466252309990193.
   Coomber BL, 2001, VET J, V161, P41, DOI 10.1053/tvjl.2000.0516.
   CORREA MT, 1988, PREV VET MED, V6, P253, DOI 10.1016/0167-5877(88)90037-2.
   DAOUST PY, 1989, CAN VET J, V30, P155.
   DAVIES CP, 1987, CAN J VET RES, V51, P306.
   Duff GC, 2007, J ANIM SCI, V85, P823, DOI 10.2527/jas.2006-501.
   Ellis J, 2001, J AM VET MED ASSOC, V218, P1973, DOI 10.2460/javma.2001.218.1973.
   Ellis John A., 2009, Animal Health Research Reviews, V10, P149, DOI 10.1017/S146625230999020X.
   Esslemont RJ, 1998, P 20 WORLD BUIATR C, V2, P685.
   Fleming K, 2009, J ANIM SCI, V87, P3805, DOI 10.2527/jas.2008-1569.
   Francoz D, 2005, VET MICROBIOL, V105, P57, DOI 10.1016/j.vetmic.2004.10.006.
   Franklin G., 1986, Proceedings of RF Technology Expo 86, P197.
   Friton GM, 2005, VET REC, V156, P809, DOI 10.1136/vr.156.25.809.
   Friton GM, 2004, BERL MUNCH TIERARZTL, V117, P304.
   Fulton Robert W., 2009, Animal Health Research Reviews, V10, P131, DOI 10.1017/S146625230999017X.
   Fulton RW, 2000, J VET DIAGN INVEST, V12, P33, DOI 10.1177/104063870001200106.
   Gershwin LJ, 2005, VET IMMUNOL IMMUNOP, V107, P119, DOI 10.1016/j.vetimm.2005.04.004.
   Gevaert D, 2006, TIJDSCHR DIERGENEESK, V131, P124.
   GUSTIN P, 1988, RES VET SCI, V45, P405.
   Hagglund S, 2006, VET J, V172, P320, DOI 10.1016/j.tvjl.2005.04.029.
   Haziroglu R, 1997, DTSCH TIERARZTL WOCH, V104, P125.
   Heckert HP, 2006, HALTUNGSOPTIMIERUNG, P154.
   Hoar BR, 1998, CAN VET J, V39, P161.
   Jaeger J, 2007, VET RES, V38, P711, DOI 10.1051/vetres:2007027.
   Jim GK, 1999, CAN VET J, V40, P179.
   Kaske M, 2007, NUTZTIERPRAXIS AKTUE, V20, P12.
   Kaske M, 2005, 23 AM COLL VET INT M, P205.
   Kaske M, 2003, HDB DURCHFALLERKRANK.
   Kemmerling K, 2009, J DAIRY SCI, V92, P4347, DOI 10.3168/jds.2009-2051.
   Kietzmann M, 2004, BERL MUNCH TIERARZTL, V117, P81.
   KIORPES AL, 1988, COMP CONT EDUC PRACT, V10, P248.
   Kirschvink N, 2008, DEUT TIERARZTL WOCH, V115, P265, DOI 10.2376/0341-6593-115-265.
   KOFER J, 1993, DEUT TIERARZTL WOCH, V100, P319.
   KOTLIKOFF MI, 1984, COMP CONT EDUC PRACT, V6, P462.
   Kunz HJ, 2008, KALBER HDB AGRAR VET.
   LEKEUX P, 1984, AM J VET RES, V45, P2003.
   Lekeux P., 2002, RECENT DEV PERSPECTI, P144.
   Lockwood PW, 2003, VET REC, V152, P392, DOI 10.1136/vr.152.13.392.
   Lotthammer KH, 1999, TIERARZTL PRAX G N, V27, P324.
   Luhofer G, 2004, BERL MUNCH TIERARZTL, V117, P245.
   Lykkesfeldt J, 2007, VET J, V173, P502, DOI 10.1016/j.tvjl.2006.06.005.
   MAKRISTATHIS A, 1993, INFECT IMMUN, V61, P1996.
   Potgieter ND, 1997, VET CLIN N AM-FOOD A, V13, P471.
   Radeloff I, 2001, PRAKT TIERARZT, V82, P190.
   Reeve-Johnson L, 2001, VET REC, V149, P549, DOI 10.1136/vr.149.18.549.
   Reinhold P, 2005, BERL MUNCH TIERARZTL, V118, P52.
   Reinhold P, 2002, DEUT TIERARZTL WOCH, V109, P193.
   Reinhold P, 2008, VET J, V175, P202, DOI 10.1016/j.tvjl.2007.01.004.
   RICHER L, 1988, CAN VET J, V29, P713.
   Rocker A, 2001, THESIS TIERARZTLICHE.
   Rohn M, 1998, PRAKT TIERARZT, V79, P851.
   Salt JS, 2007, VET J, V174, P616, DOI 10.1016/j.tvjl.2006.10.007.
   SANFTLEBEN P, 2002, TOP AGRAR, V1, pR22.
   Schwarz S, 2001, VET RES, V32, P201, DOI 10.1051/vetres:2001120.
   Schwarz S, 2003, BERL MUNCH TIERARZTL, V116, P353.
   Scorneaux B, 1999, J DAIRY SCI, V82, P1202, DOI 10.3168/jds.S0022-0302(99)75343-9.
   Selbitz HJ, 2003, KALBERGRIPPE IMPFUNG, P108.
   Snowder GD, 2006, J ANIM SCI, V84, P1999, DOI 10.2527/jas.2006-046.
   Snowder GD, 2005, J ANIM SCI, V83, P1247.
   Tegtmeier C, 2000, VET MICROBIOL, V72, P229, DOI 10.1016/S0378-1135(99)00181-9.
   Theeuwes P, 2003, WELCOME BEHAND LUNG, P114.
   Thompson PN, 2006, J ANIM SCI, V84, P488.
   Tomkins T., 1994, Journal of Animal Science, V72, P49.
   Twomey DF, 2006, VET J, V171, P574, DOI 10.1016/j.tvjl.2004.12.012.
   Van Bommel C, 2000, THESIS TIERARZTLICHE.
   VEIT HP, 1978, CORNELL VET, V68, P555.
   Virtala AMK, 1996, J AM VET MED ASSOC, V208, P2035.
   Virtala AMK, 1999, PREV VET MED, V39, P25, DOI 10.1016/S0167-5877(98)00140-8.
   Wallmann J, 2004, BERL MUNCH TIERARZTL, V117, P480.
   Wallmann J, 2006, INT J MED MICROBIOL, V296, P81, DOI 10.1016/j.ijmm.2006.01.064.
   Warnick L. D., 1994, KENYA VET, V18, P177.
   Wellman NG, 2007, J VET PHARMACOL THER, V30, P234, DOI 10.1111/j.1365-2885.2007.00846.x.
   Williams P, 2007, CATTLE PRACT, V15, P244.
   Wittek T, 2005, BERL MUNCH TIERARZTL, V118, P140.
   Woolums AR, 2007, PROCEEDINGS OF THE FORTIETH ANNUAL CONFERENCE AMERICAN ASSOCIATION OF BOVINE PRACTITIONERS, P10.}},
Number-of-Cited-References = {{83}},
Times-Cited = {{7}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{37}},
Journal-ISO = {{Prakt Tierarzt}},
Doc-Delivery-Number = {{917OM}},
Unique-ID = {{ISI:000302187600010}},
DA = {{2018-08-13}},
}

@article{ ISI:000300587100003,
Author = {Shen, Gwan-Han and Tsao, Thomas Chang-Yao and Kao, Shang-Jyh and Lee,
   Jen-Jyh and Chen, Yen-Hsu and Hsieh, Wei-Chung and Hsu, Gwo-Jong and
   Hsu, Yen-Tao and Huang, Ching-Tai and Lau, Yeu-Jun and Tsao, Shih-Ming
   and Hsueh, Po-Ren},
Title = {{Does empirical treatment of community-acquired pneumonia with
   fluoroquinolones delay tuberculosis treatment and result in
   fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies
   and solutions}},
Journal = {{INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS}},
Year = {{2012}},
Volume = {{39}},
Number = {{3}},
Pages = {{201-205}},
Month = {{MAR}},
Abstract = {{The role of fluoroquinolones (FQs) as empirical therapy for
   community-acquired pneumonia (CAP) remains controversial in countries
   with high tuberculosis (TB) endemicity owing to the possibility of
   delayed TB diagnosis and treatment and the emergence of FQ resistance in
   Mycobacterium tuberculosis. Although the rates of macrolide-resistant
   Streptococcus pneumoniae and amoxicillin/clavulanic acid-resistant
   Haemophilus influenzae have risen to alarming levels, the rates of
   respiratory FQ (RFQ) resistance amongst these isolates remain relatively
   low. It is reported that ca. 1-7\% of CAP cases are re-diagnosed as
   pulmonary TB in Asian countries. A longer duration (>= 7 days) of
   symptoms, a history of night sweats, lack of fever (>38 degrees C),
   infection involving the upper lobe, presence of cavitary infiltrates,
   opacity in the lower lung without the presence of air, low total white
   blood cell count and the presence of lymphopenia are predictive of
   pulmonary TB. Amongst patients with CAP who reside in TB-endemic
   countries who are suspected of having TB, imaging studies as well as
   aggressive microbiological investigations need to be performed early on.
   Previous exposure to a FQ for > 10 days in patients with TB is
   associated with the emergence of FQ-resistant M. tuberculosis isolates.
   However, rates of M. tuberculosis isolates with FQ resistance are
   significantly higher amongst multidrug-resistant M. tuberculosis
   isolates than amongst susceptible isolates. Consequently, in Taiwan and
   also in other countries with TB endemicity, a short-course (5-day)
   regimen of a RFQ is still recommended for empirical therapy for CAP
   patients if the patient is at low risk for TB. (C) 2012 Elsevier B.V.
   and the International Society of Chemotherapy. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Hsueh, PR (Reprint Author), Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Lab Med, 7 Chung Shan S Rd, Taipei 100, Taiwan.
   Hsueh, Po-Ren, Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan.
   Hsueh, Po-Ren, Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.
   Shen, Gwan-Han, Taichung Vet Gen Hosp, Div Resp \& Crit Care Med, Dept Internal Med, Taichung, Taiwan.
   Tsao, Thomas Chang-Yao, Chung Shan Med Univ, Div Resp \& Crit Care Med, Dept Internal Med, Sch Med, Taichung, Taiwan.
   Tsao, Thomas Chang-Yao; Tsao, Shih-Ming, Univ Hosp, Taichung, Taiwan.
   Kao, Shang-Jyh, Shin Kong Wu Ho Su Mem Hosp, Div Pulm, Dept Internal Med, Taipei, Taiwan.
   Lee, Jen-Jyh, Buddhist Tzu Chi Gen Hosp, TB Lab Sect, Dept Internal Med, Hualien, Taiwan.
   Lee, Jen-Jyh, Tzu Chi Univ, Hualien, Taiwan.
   Chen, Yen-Hsu, Kaohsiung Med Univ, Div Infect Dis, Dept Internal Med, Kaohsiung Med Univ Hosp,Grad Inst Med, Kaohsiung, Taiwan.
   Hsieh, Wei-Chung, Da Chien Gen Hosp, Div Resp \& Crit Care Med, Dept Internal Med, Maioli, Taiwan.
   Hsu, Gwo-Jong, Chia Yi Christian Hosp, Ditmanson Med Fdn, Div Infect Dis, Dept Internal Med, Chiayi, Taiwan.
   Hsu, Yen-Tao, Taipei City Hosp, Div Pulm \& Crit Care Med, Heping Fuyou Branch, Dept Internal Med, Taipei, Taiwan.
   Huang, Ching-Tai, Chang Gung Univ, Div Infect Dis, Dept Med, Taipei, Taiwan.
   Lau, Yeu-Jun, Show Chwan Mem Hosp, Dept Internal Med, Taichung, Taiwan.
   Tsao, Shih-Ming, Chung Shan Med Univ, Inst Microbiol \& Immunol, Infect Sect, Dept Internal Med, Taichung, Taiwan.}},
DOI = {{10.1016/j.ijantimicag.2011.11.014}},
ISSN = {{0924-8579}},
Keywords = {{Community-acquired pneumonia; Fluoroquinolones; Tuberculosis;
   Fluoroquinolone resistance; Multidrug-resistant Mycobacterium
   tuberculosis}},
Keywords-Plus = {{RESPIRATORY-TRACT INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; PULMONARY
   TUBERCULOSIS; MEDICAL-CENTER; DRUG-RESISTANCE; TAIWAN; LEVOFLOXACIN;
   GUIDELINES; MANAGEMENT; DIAGNOSIS}},
Research-Areas = {{Infectious Diseases; Microbiology; Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Infectious Diseases; Microbiology; Pharmacology \& Pharmacy}},
Author-Email = {{hsporen@ntu.edu.tw}},
ResearcherID-Numbers = {{Chuang, shengHao/C-8217-2012
   }},
ORCID-Numbers = {{HSUEH, PO-REN/0000-0002-7502-9225}},
Cited-References = {{Chan Yu-Jiun, 2007, Journal of Microbiology Immunology and Infection, V40, P279.
   CHANG SC, 1991, ARCH INTERN MED, V151, P1581, DOI 10.1001/archinte.151.8.1581.
   Chen TC, 2011, INT J INFECT DIS, V15, pE211, DOI 10.1016/j.ijid.2010.11.008.
   Chen YH, 2009, J ANTIMICROB CHEMOTH, V64, P1226, DOI 10.1093/jac/dkp370.
   Chung KP, 2011, J INFECTION, V62, P185, DOI 10.1016/j.jinf.2010.12.001.
   Dooley KE, 2002, CLIN INFECT DIS, V34, P1607, DOI 10.1086/340618.
   Drago L, 2011, J ANTIMICROB CHEMOTH, V66, P845, DOI 10.1093/jac/dkr016.
   Golub JE, 2005, INT J TUBERC LUNG D, V9, P392.
   Griffin AT, 2010, INT J TUBERC LUNG D, V14, P495.
   Ho PL, 2009, J ANTIMICROB CHEMOTH, V63, P836, DOI 10.1093/jac/dkp038.
   Hsieh YC, 2010, CLIN MICROBIOL INFEC, V16, P973, DOI 10.1111/j.1469-0691.2009.02951.x.
   Hsieh YC, 2009, VACCINE, V27, P5513, DOI 10.1016/j.vaccine.2009.06.091.
   Huang TS, 2005, J ANTIMICROB CHEMOTH, V56, P1058, DOI 10.1093/jac/dki353.
   Jean SS, 2011, J FORMOS MED ASSOC, V110, P4, DOI 10.1016/S0929-6646(11)60002-8.
   Lai CC, 2008, CLIN INFECT DIS, V47, pE57, DOI 10.1086/591702.
   Lai CC, 2011, J ANTIMICROB CHEMOTH, V66, P2437, DOI 10.1093/jac/dkr302.
   Lai CC, 2011, INT J ANTIMICROB AG, V38, P125, DOI 10.1016/j.ijantimicag.2011.03.016.
   Lauderdale TL, 2005, RESP MED, V99, P1079, DOI 10.1016/j.rmed.2005.02.026.
   Liam CK, 2006, RESPIROLOGY, V11, P786, DOI 10.1111/j.1400-1843.2006.00947.x.
   Lin CH, 2011, EUR J RADIOL, DOI {[}10.1016/j.ejrad.2011.03.028, DOI 10.1016/J.EJRAD.2011.03.028].
   Lin SH, 2011, EPIDEMIOL INFECT, V139, P1307, DOI 10.1017/S0950268810002402.
   Lo HY, 2011, J FORMOS MED ASSOC, V110, P501, DOI 10.1016/S0929-6646(11)60076-4.
   Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159.
   MATHUR P, 1994, ARCH INTERN MED, V154, P306, DOI 10.1001/archinte.154.3.306.
   Park IN, 2007, INT J TUBERC LUNG D, V11, P319.
   Singh A, 2007, CLIN INFECT DIS, V45, P133, DOI 10.1086/520486.
   van den Boogaard J, 2011, J ANTIMICROB CHEMOTH, V66, P1810, DOI 10.1093/jac/dkr205.
   van Rensburg DJJ, 2010, ANTIMICROB AGENTS CH, V54, P4098, DOI 10.1128/AAC.00295-10.
   Wang H, 2011, INT J ANTIMICROB AG, V38, P376, DOI 10.1016/j.ijantimicag.2011.06.015.
   Wang JY, 2006, THORAX, V61, P903, DOI 10.1136/thx.2005.056887.
   Wang JY, 2007, J ANTIMICROB CHEMOTH, V59, P860, DOI 10.1093/jac/dkm061.
   Wang JY, 2005, INT J TUBERC LUNG D, V9, P777.
   Wispelwey B, 2010, EXPERT REV ANTI-INFE, V8, P1259, DOI 10.1586/ERI.10.110.
   Woodhead M, 2005, EUR RESPIR J, V26, P1138, DOI 10.1183/09031936.05.00055705.
   Yen MY, 2005, J FORMOS MED ASSOC, V104, P724.
   Yoon YS, 2005, INT J TUBERC LUNG D, V9, P1215.
   Yu MC, 2008, EMERG INFECT DIS, V14, P849, DOI 10.3201/eid1405.071398.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{13}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{4}},
Journal-ISO = {{Int. J. Antimicrob. Agents}},
Doc-Delivery-Number = {{896RE}},
Unique-ID = {{ISI:000300587100003}},
DA = {{2018-08-13}},
}

@article{ ISI:000300652700004,
Author = {Alvarado, Carla S. and Gibbs, Shawn G. and Gandara, Angelina and Flores,
   Carissa and Hurd, William W. and Green, Christopher F.},
Title = {{The Potential for Community Exposures to Pathogens From an Urban Dairy}},
Journal = {{JOURNAL OF ENVIRONMENTAL HEALTH}},
Year = {{2012}},
Volume = {{74}},
Number = {{7}},
Pages = {{22-28}},
Month = {{MAR}},
Abstract = {{The objectives of the study described in this article were to evaluate
   the variation and transport of fungal and bacterial concentrations in
   the air of a northern Mexico dairy cattle confined animal feeding
   operation (CAFO) and to determine the concentration and incidence of
   antibiotic-resistant Staphylococcus aureus isolates. Two-stage viable
   cascade impactors were used to measure the culturable airborne fungal
   organisms and bacteria. S. aureus resistant to penicillin, ampicillin,
   or cefaclor was identified.
   Samples were collected at three locations that were designated as on
   site, upwind of the cattle, and downwind of the cattle. The highest
   concentrations of culturable bacterial bioaerosols were consistently
   recovered from the on-site location. More than half of the organisms
   were antibiotic resistant at the on-site location. Elevated levels of
   culturable bacterial bioaerosols were recovered from the upwind site
   that may have been associated with the surrounding community. Bioaerosol
   concentrations were found in higher amounts than in a facility in the
   southwestern U.S. examined in the authors' previous study. The urban
   setting of the CAFO resulted in a higher potential for immediate
   community exposures.}},
Publisher = {{NATL ENVIRON HEALTH ASSOC}},
Address = {{720 S COLORADO BLVD SUITE 970, SOUTH TOWER, DENVER, CO 80246 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Gibbs, SG (Reprint Author), Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Environm Agr \& Occupat Hlth, 985110 Nebraska Med Ctr, Omaha, NE 68198 USA.
   Gibbs, Shawn G., Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Environm Agr \& Occupat Hlth, Omaha, NE 68198 USA.}},
ISSN = {{0022-0892}},
Keywords-Plus = {{ANIMAL FEEDING OPERATIONS; STAPHYLOCOCCUS-AUREUS INFECTIONS;
   ANTIBIOTIC-RESISTANCE; UNITED-STATES; AIR; BACTERIA; HEALTH; FUNGI;
   INDOOR; MEXICO}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{sgibbs@unmc.edu}},
Funding-Acknowledgement = {{Center for Border Health Research (an initiative of the Paso del Norte
   Health Foundation); Center of Environmental Resource Management
   Environmental Protection Agency at The University of Texas at El Paso}},
Funding-Text = {{This research was partially funded by the Center for Border Health
   Research (an initiative of the Paso del Norte Health Foundation) and the
   Center of Environmental Resource Management Environmental Protection
   Agency Student Support Program at The University of Texas at El Paso.
   Editorial support was provided by Susan Navarro and the Hispanic Health
   Disparities Research Center (P20 MD000548-01 NIH/NCMHD).}},
Cited-References = {{Alvarado CS, 2009, J ENVIRON HEALTH, V71, P40.
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493.
   Brown KD, 2006, SCI TOTAL ENVIRON, V366, P772, DOI 10.1016/j.scitotenv.2005.10.007.
   Cole D, 2000, ENVIRON HEALTH PERSP, V108, P685, DOI 10.2307/3434721.
   Donham KJ, 2007, ENVIRON HEALTH PERSP, V115, P317, DOI 10.1289/ehp.8836.
   Ghosh S, 2007, ISME J, V1, P191, DOI 10.1038/ismej.2007.31.
   Gibbs SG, 2004, J OCCUP ENVIRON HYG, V1, P699, DOI 10.1080/15459620490515824.
   Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910.
   Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837.
   Green CF, 2006, J OCCUP ENVIRON HYG, V3, P9, DOI 10.1080/15459620500430615.
   Heederik D, 2007, ENVIRON HEALTH PERSP, V115, P298, DOI 10.1289/ehp.8835.
   Jo WK, 2005, CHEMOSPHERE, V61, P1570, DOI 10.1016/j.chemosphere.2005.04.103.
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536.
   Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763.
   Liao CM, 2005, SCI TOTAL ENVIRON, V347, P78, DOI 10.1016/j.scitotenv.2004.12.036.
   Macher J. M., 1999, BIOAEROSOLS ASSESSME.
   MALLOCH D, 1981, MOULDS THEIR ISOLATI.
   Menetrez MY, 2001, J AIR WASTE MANAGE, V51, P1436, DOI 10.1080/10473289.2001.10464365.
   Mirabelli MC, 2006, ENVIRON HEALTH PERSP, V114, P591, DOI 10.1289/ehp.8586.
   Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356.
   Otte J., 2007, IND LIVE STOCK PRODU.
   Petia S., 2005, SCERP MONOGRAPHS, V11, P325.
   Radon K, 2001, OCCUP ENVIRON MED, V58, P405, DOI 10.1136/oem.58.6.405.
   Ramos IN, 2001, AM J PUBLIC HEALTH, V91, P568, DOI 10.2105/AJPH.91.4.568.
   Rule AM, 2005, ENVIRON SCI TECHNOL, V39, P9649, DOI 10.1021/es0501316.
   Sapkota AR, 2006, LETT APPL MICROBIOL, V43, P534, DOI 10.1111/j.1472-765X.2006.01996.x.
   Speir J., 2003, COMP STANDARDS INTEN.
   Von Essen Susanna G, 2005, J Agromedicine, V10, P55, DOI 10.1300/J096v10n04\_08.
   Whitehouse T, 2003, COMP REGULATION INTE.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{22}},
Journal-ISO = {{J. Environ. Health}},
Doc-Delivery-Number = {{897LR}},
Unique-ID = {{ISI:000300652700004}},
DA = {{2018-08-13}},
}

@article{ ISI:000300268700008,
Author = {Gelhaus, Stacy L. and Gilad, Oren and Hwang, Wei-Ting and Penning,
   Trevor M. and Blair, Ian A.},
Title = {{Multidrug resistance protein (MRP) 4 attenuates
   benzo{[}a]pyrene-mediated DNA-adduct formation in human bronchoalveolar
   H358 cells}},
Journal = {{TOXICOLOGY LETTERS}},
Year = {{2012}},
Volume = {{209}},
Number = {{1}},
Pages = {{58-66}},
Month = {{FEB 25}},
Abstract = {{Multi-drug resistance protein (MRP) 4, an ATP-binding cassette (ABC)
   transporter, has broad substrate specificity. It facilitates the
   transport of bile salt conjugates, conjugated steroids, nucleoside
   analogs, eicosanoids, and cardiovascular drugs. Recent studies in liver
   carcinoma cells and hepatocytes showed that MRP4 expression is regulated
   by the aryl hydrocarbon receptor (AhR) and nuclear factor E2-related
   factor 2 (Nrf2). The AhR has particular importance in the lung and is
   most commonly associated with the up-regulation of cytochrome P-450
   (CYP)-mediated metabolism of benzo{[}a]pyrene (B{[}a]P) to reactive
   intermediates. Treatment of H358, human bronchoalveolar, cells with
   2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or
   (-)-benzo{[}a]pyrene-7,8-dihydro-7,8-diol (B{[}a]P-7,8-dihydrodiol), the
   proximate carcinogen of B{[}a]P, revealed that MRP4 expression was
   increased compared to control. This suggested that MRP4 expression might
   contribute to the paradoxical decrease in
   (+)-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo{[}a]pyrene-2'-deox
   yguanosine ((+)-anti-trans-B{[}a]PDE-dCuo) DNA-adducts observed in
   TCDD-treated H358 cells. We have now found that decreased MRP4
   expression induced by a short hairpin RNA (shRNA), or chemical
   inhibition with probenecid, increased (+)-anti-trans-B{[}a]PDE-dGuo
   formation in cells treated with (-)-B{[}a]P7,8-dihydrodiol, but not the
   ultimate carcinogen (+)-anti-trans-B{[}a]PDE. Thus, up-regulation of
   MRP4 increased cellular efflux of (-)-B{[}a]P-7,8-dihydrodiol, which
   attenuated DNA-adduct formation. This is the first report identifying a
   specific MRP efflux transporter that decreases DNA damage arising from
   an environmental carcinogen. (C) 2011 Elsevier Ireland Ltd. All rights
   reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Blair, IA (Reprint Author), Univ Penn, Perelman Sch Med, Ctr Canc Pharmacol, 421 Curie Blvd,BRB 2-3 854, Philadelphia, PA 19104 USA.
   Gelhaus, Stacy L.; Blair, Ian A., Univ Penn, Perelman Sch Med, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA.
   Gelhaus, Stacy L.; Penning, Trevor M.; Blair, Ian A., Univ Penn, Perelman Sch Med, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA.
   Gilad, Oren, Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.
   Gilad, Oren, Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA.
   Hwang, Wei-Ting, Univ Penn, Perelman Sch Med, Dept Biostat \& Epidemiol, Philadelphia, PA 19104 USA.}},
DOI = {{10.1016/j.toxlet.2011.11.021}},
ISSN = {{0378-4274}},
Keywords = {{Benzopyrene; Environmental carcinogen; LC-MS; Aryl hydrocarbon receptor}},
Keywords-Plus = {{POLYCYCLIC AROMATIC-HYDROCARBONS; ORGANIC ANION TRANSPORTER; CANCER
   RISK-ASSESSMENT; HUMAN LUNG; SIGNALING MOLECULES; EFFLUX TRANSPORTER;
   MASS-SPECTROMETRY; AIR-POLLUTION; EXPRESSION; MRP4/ABCC4}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{gstacy@mail.med.upenn.edu
   gilado@mail.med.upenn.edu
   whwang@mail.med.upenn.edu
   penning@mail.med.upenn.edu
   ianblair@mail.med.upenn.edu}},
ORCID-Numbers = {{Penning, Trevor/0000-0002-3937-1066}},
Funding-Acknowledgement = {{National Institutes of Health National Institute of Environmental Health
   Sciences {[}5F32ES016683, P30ES013508, R01ES015857]; National Cancer
   Institute {[}R01CA130038, R25CA101871]}},
Funding-Text = {{We would like to acknowledge A. Clementina Mesaros and Sankha Basu for
   their careful reading of this manuscript and Eric Brown for assistance
   with lentiviral vector production. This project was supported by the
   National Institutes of Health National Institute of Environmental Health
   Sciences (5F32ES016683, P30ES013508, R01ES015857) and the National
   Cancer Institute (R01CA130038 and R25CA101871).}},
Cited-References = {{Baird WM, 2005, ENVIRON MOL MUTAGEN, V45, P106, DOI 10.1002/em.20095.
   Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451.
   Castano-Vinyals G, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2003.008375.
   Chiba T, 2011, INT ARCH ALLERGY IMM, V155, P129, DOI 10.1159/000327499.
   Gelhaus SL, 2011, CHEM RES TOXICOL, V24, P89, DOI 10.1021/tx100297z.
   Georgiadis P, 1999, MUTAT RES-FUND MOL M, V428, P91, DOI 10.1016/S1383-5742(99)00035-6.
   Gilad O, 2010, CANCER RES, V70, P9693, DOI 10.1158/0008-5472.CAN-10-2286.
   Gradhand U, 2008, DRUG METAB REV, V40, P317, DOI {[}10.1080/03602530801952617, 10.1080/03602530801952617 ].
   GRIMMER G, 1975, J ASSOC OFF ANA CHEM, V58, P725.
   Hara Y, 2011, J CLIN INVEST, V121, P2888, DOI 10.1172/JCI45023.
   Ho LL, 2008, PROSTATE, V68, P1421, DOI 10.1002/pros.20809.
   Hukkanen J, 2002, CRIT REV TOXICOL, V32, P391, DOI 10.1080/20024091064273.
   Jiang H, 2007, CHEM RES TOXICOL, V20, P1331, DOI 10.1021/tx700107z.
   Kruh GD, 2007, CANCER METAST REV, V26, P5, DOI 10.1007/s10555-007-9039-1.
   Lee CH, 2010, METHODS MOL BIOL, V596, P325, DOI 10.1007/978-1-60761-416-6\_14.
   Lee K, 2000, J NATL CANCER I, V92, P1934, DOI 10.1093/jnci/92.23.1934.
   Lee K, 1998, CANCER RES, V58, P2741.
   Lee SH, 2007, METHOD ENZYMOL, V433, P159, DOI 10.1016/S0076-6879(07)33009-7.
   Lemos C, 2009, MOL CANCER THER, V8, P655, DOI 10.1158/1535-7163.MCT-08-0768.
   Lin ZP, 2008, MOL PHARMACOL, V73, P243, DOI 10.1124/mol.107.039594.
   Mangal D, 2009, CHEM RES TOXICOL, V22, P788, DOI 10.1021/tx800343c.
   Mastrangelo G, 1996, ENVIRON HEALTH PERSP, V104, P1166, DOI 10.2307/3432909.
   Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200.
   Monien BH, 2009, TOXICOLOGY, V262, P80, DOI 10.1016/j.tox.2009.05.016.
   Myllynen P, 2007, TOXICOL LETT, V169, P3, DOI 10.1016/j.toxlet.2006.11.006.
   Nebert DW, 2008, J BIOL CHEM, V283, P36061, DOI 10.1074/jbc.R800053200.
   Niestroy J, 2011, TOXICOL IN VITRO, V25, P671, DOI 10.1016/j.tiv.2011.01.008.
   Norris MD, 2005, MOL CANCER THER, V4, P547, DOI 10.1158/1535-7163.MCT-04-0161.
   Park JH, 2008, P NATL ACAD SCI USA, V105, P6846, DOI 10.1073/pnas.0802776105.
   Peluso M, 1998, CANCER EPIDEM BIOMAR, V7, P3.
   Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077.
   Pozzoli L, 2004, ANN CHIM-ROME, V94, P17, DOI 10.1002/adic.200490002.
   Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100.
   Ritter CA, 2005, DRUG METAB REV, V37, P253, DOI 10.1081/DMR-200047984.
   Ruan Q, 2007, CHEM RES TOXICOL, V20, P424, DOI 10.1021/tx060180b.
   Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006.
   Srivastava SK., 2002, MOL CARCINOG, V33, P156.
   Sweet DH, 2005, TOXICOL APPL PHARM, V204, P198, DOI 10.1016/j.taap.2004.10.016.
   Torky ARW, 2005, TOXICOLOGY, V207, P437, DOI 10.1016/j.tox.2004.10.014.
   Uno S, 2004, MOL PHARMACOL, V65, P1225, DOI 10.1124/mol.65.5.1225.
   Van Aubel RAMH, 2002, J AM SOC NEPHROL, V13.
   Wu CP, 2005, FEBS J, V272, P4725, DOI 10.1111/j.1742-4658.2005.04888.x.
   Xu SH, 2010, AM J PHYSIOL-GASTR L, V299, pG126, DOI 10.1152/ajpgi.00522.2010.
   Yeager RL, 2009, TOXICOL SCI, V111, P238, DOI 10.1093/toxsci/kfp115.
   Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886.
   Zhang ZY, 2006, BIOCHEM BIOPH RES CO, V341, P399, DOI 10.1016/j.bbrc.2005.12.203.
   Zmirou D, 2000, J OCCUP ENVIRON MED, V42, P121, DOI 10.1097/00043764-200002000-00004.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{12}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{17}},
Journal-ISO = {{Toxicol. Lett.}},
Doc-Delivery-Number = {{892EE}},
Unique-ID = {{ISI:000300268700008}},
OA = {{green\_accepted}},
DA = {{2018-08-13}},
}

@article{ ISI:000302875500014,
Author = {Chen, Ya-Lei and Chen, Yao-Shen and Chan, Hao and Tseng, Yao-Hsuan and
   Yang, Shu-Ru and Tsai, Hsin-Ying and Liu, Hong-Yi and Sun, Der-Shan and
   Chang, Hsin-Hou},
Title = {{The Use of Nanoscale Visible Light-Responsive Photocatalyst TiO2-Pt for
   the Elimination of Soil-Borne Pathogens}},
Journal = {{PLOS ONE}},
Year = {{2012}},
Volume = {{7}},
Number = {{2}},
Month = {{FEB 22}},
Abstract = {{Exposure to the soil-borne pathogens Burkholderia pseudomallei and
   Burkholderia cenocepacia can lead to severe infections and even
   mortality. These pathogens exhibit a high resistance to antibiotic
   treatments. In addition, no licensed vaccine is currently available. A
   nanoscale platinum-containing titania photocatalyst (TiO2-Pt) has been
   shown to have a superior visible light-responsive photocatalytic ability
   to degrade chemical contaminants like nitrogen oxides. The antibacterial
   activity of the catalyst and its potential use in soil pathogen control
   were evaluated. Using the plating method, we found that TiO2-Pt exerts
   superior antibacterial performance against Escherichia coli compared to
   other commercially available and laboratory prepared ultraviolet/
   visible light-responsive titania photocatalysts. TiO2-Pt-mediated
   photocatalysis also affectively eliminates the soil-borne bacteria B.
   pseudomallei and B. cenocepacia. An air pouch infection mouse model
   further revealed that TiO2-Pt-mediated photocatalysis could reduce the
   pathogenicity of both strains of bacteria. Unexpectedly, water
   containing up to 10\% w/v dissolved soil particles did not reduce the
   antibacterial potency of TiO2-Pt, suggesting that the TiO2-Pt
   photocatalyst is suitable for use in soil-contaminated environments. The
   TiO2-Pt photocatalyst exerted superior antibacterial activity against a
   broad spectrum of human pathogens, including B. pseudomallei and B.
   cenocepacia. Soil particles (<10\% w/v) did not significantly reduce the
   antibacterial activity of TiO2-Pt in water. These findings suggest that
   the TiO2-Pt photocatalyst may have potential applications in the
   development of bactericides for soilborne pathogens.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chen, YL (Reprint Author), Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan.
   Chen, Ya-Lei; Yang, Shu-Ru; Tsai, Hsin-Ying; Liu, Hong-Yi, Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan.
   Chen, Yao-Shen, Kaohsiung Vet Gen Hosp, Div Infect Dis, Kaohsiung, Taiwan.
   Chan, Hao, Tzu Chi Univ, Grad Inst Med Sci, Hualien, Taiwan.
   Tseng, Yao-Hsuan, Natl Taiwan Univ Sci \& Technol, Dept Chem Engn, Taipei, Taiwan.
   Sun, Der-Shan; Chang, Hsin-Hou, Tzu Chi Univ, Dept Mol Biol \& Human Genet, Hualien, Taiwan.
   Chen, Yao-Shen, Natl Yung Ming Univ, Dept Internal Med, Taipei, Taiwan.}},
DOI = {{10.1371/journal.pone.0031212}},
Article-Number = {{e31212}},
ISSN = {{1932-6203}},
Keywords-Plus = {{BURKHOLDERIA-CEPACIA COMPLEX; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS;
   BIOFILM RESISTANCE; HYDROGEN-PEROXIDE; MELIOIDOSIS; PSEUDOMALLEI;
   CENOCEPACIA; TAIWAN; WATER}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{hhchang@mail.tcu.edu.tw}},
Funding-Acknowledgement = {{National Science Council, Taiwan, People's Republic of China
   {[}95-2314-B-320-009-MY3, 98-2320-B-0.17-001-MY3,
   99-2320-B-017-002-MY3]; Ministry of Economic Affairs, Taiwan, People's
   Republic of China {[}98-EC-17-A-19-S2-0111]; Tzu-Chi University {[}TCIRP
   95002-02, TCIRP 98001-01, TCRPP 99020, TCRPP 100003]}},
Funding-Text = {{This work is supported by the National Science Council, Taiwan, People's
   Republic of China, under grant numbers 95-2314-B-320-009-MY3,
   98-2320-B-0.17-001-MY3 and 99-2320-B-017-002-MY3, by the Ministry of
   Economic Affairs, Taiwan, People's Republic of China, under grant number
   98-EC-17-A-19-S2-0111 and by Tzu-Chi University under grant numbers
   TCIRP 95002-02, TCIRP 98001-01, TCRPP 99020 and TCRPP 100003. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.}},
Cited-References = {{ALTERTHUM F, 1989, APPL ENVIRON MICROB, V55, P1943.
   Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051.
   BENVENUTI S, 1995, WEED SCI, V43, P389.
   Bevivino A, 2005, RES MICROBIOL, V156, P974, DOI 10.1016/j.resmic.2005.05.007.
   Brett PJ, 2000, ACTA TROP, V74, P201, DOI 10.1016/S0001-706X(99)00071-6.
   Chang HH, 1999, EXP CELL RES, V250, P387, DOI 10.1006/excr.1999.4547.
   Chang WK, 2012, NANOMEDICIN IN PRESS, V8.
   CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890.
   Chen YS, 2010, J CLIN MICROBIOL, V48, P1432, DOI 10.1128/JCM.01720-09.
   Chen YS, 2009, JPN J INFECT DIS, V62, P155.
   Chen YS, 2009, MICROBIOL IMMUNOL, V53, P184, DOI 10.1111/j.1348-0421.2009.00105.x.
   Chen YS, 2003, FOLIA MICROBIOL, V48, P253, DOI 10.1007/BF02930965.
   Cheng CL, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-7.
   Chou PW, 2006, OBSERVATION CA UNPUB.
   Cunha MV, 2004, J CLIN MICROBIOL, V42, P3052, DOI 10.1128/JCM.42.7.3052-3058.2004.
   Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750.
   Dance DAB, 2000, ACTA TROP, V74, P159, DOI 10.1016/S0001-706X(99)00066-2.
   Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x.
   Elkins JG, 1999, APPL ENVIRON MICROB, V65, P4594.
   Frojd V, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-8.
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0.
   Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030.
   Graindorge A, 2010, DIAGN MICR INFEC DIS, V66, P29, DOI 10.1016/j.diagmicrobio.2009.06.008.
   Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018.
   Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x.
   Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014.
   Iwasaki M, 2000, J COLLOID INTERF SCI, V224, P202, DOI 10.1006/jcis.1999.6694.
   Jin X, 1996, SOIL SCI, V161, P509, DOI 10.1097/00010694-199608000-00006.
   Kau JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004167.
   Klaus K, 2000, SOIL SCI, V165, P305.
   Kuo CF, 1998, INFECT IMMUN, V66, P3931.
   LEELARASAMEE A, 1989, REV INFECT DIS, V11, P413.
   Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001.
   Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015.
   Lin HH, 2007, J HAZARD MATER, V145, P431, DOI 10.1016/j.jhazmat.2006.11.043.
   Lin HH, 2006, J CLIN MICROBIOL, V44, P4596, DOI 10.1128/JCM.01531-06.
   Lin YM, 2006, ENVIRON SCI TECHNOL, V40, P1616, DOI 10.1021/es051007p.
   Liou JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019982.
   LO SJ, 1979, BIOCHEM BIOPH RES CO, V86, P748, DOI 10.1016/0006-291X(79)91776-5.
   Loutet SA, 2010, INFECT IMMUN, V78, P4088, DOI 10.1128/IAI.00212-10.
   Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x.
   Mann T, 2010, INFECTION, V38, P187, DOI 10.1007/s15010-010-0017-0.
   Matsuzawa S, 2008, APPL CATAL B-ENVIRON, V83, P39, DOI 10.1016/j.apcatb.2008.01.036.
   Njoroge J, 2009, EMBO MOL MED, V1, P201, DOI 10.1002/emmm.200900032.
   Peeters E, 2008, J HOSP INFECT, V70, P361, DOI 10.1016/j.jhin.2008.08.015.
   Rajagopal G, 2006, COLLOID SURFACE B, V51, P107, DOI 10.1016/j.colsurfb.2006.06.003.
   Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8.
   Saiman L, 2003, INFECT CONT HOSP EP, V24, pS6, DOI 10.1086/503485.
   Sambrook J., 1989, MOL CLONING LAB MANU.
   Sano T, 2008, J MOL CATAL A-CHEM, V284, P127, DOI 10.1016/j.molcata.2008.01.014.
   Slominski A, 1998, CLIN DERMATOL, V16, P503, DOI 10.1016/S0738-081X(98)00023-6.
   Stone R, 2007, SCIENCE, V317, P1022, DOI 10.1126/science.317.5841.1022.
   Su HP, 2007, J CLIN MICROBIOL, V45, P2599, DOI 10.1128/JCM.00228-07.
   Wattanaphon HT, 2008, J APPL MICROBIOL, V105, P416, DOI 10.1111/j.1365-2672.2008.03755.x.
   Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05.
   Wong MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010394.
   WOOLLEY JT, 1978, PLANT PHYSIOL, V61, P597, DOI 10.1104/pp.61.4.597.
   Yue QL, 2008, J FLUORESC, V18, P11, DOI 10.1007/s10895-007-0228-7.}},
Number-of-Cited-References = {{58}},
Times-Cited = {{16}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{32}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{926ZZ}},
Unique-ID = {{ISI:000302875500014}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000300495100007,
Author = {Yasmin, Sabiha and Alcazar-Fuoli, Laura and Gruendlinger, Mario and
   Puempel, Thomas and Cairns, Timothy and Blatzer, Michael and Lopez,
   Jordi F. and Grimalt, Joan O. and Bignell, Elaine and Haas, Hubertus},
Title = {{Mevalonate governs interdependency of ergosterol and siderophore
   biosyntheses in the fungal pathogen Aspergillus fumigatus}},
Journal = {{PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA}},
Year = {{2012}},
Volume = {{109}},
Number = {{8}},
Pages = {{E497-E504}},
Month = {{FEB 21}},
Abstract = {{Aspergillus fumigatus is the most common airborne fungal pathogen for
   humans. In this mold, iron starvation induces production of the
   siderophore triacetylfusarinine C (TAFC). Here we demonstrate a link
   between TAFC and ergosterol biosynthetic pathways, which are both
   critical for virulence and treatment of fungal infections. Consistent
   with mevalonate being a limiting prerequisite for TAFC biosynthesis, we
   observed increased expression of 3-hydroxy-3-methyl-glutaryl (HMG)-CoA
   reductase (Hmg1) under iron starvation, reduced TAFC biosynthesis
   following lovastatin-mediated Hmg1 inhibition, and increased TAFC
   biosynthesis following Hmg1 overexpression. We identified enzymes, the
   acyl-CoA ligase SidI and the enoyl-CoA hydratase SidH, linking
   biosynthesis of mevalonate and TAFC, deficiency of which under iron
   starvation impaired TAFC biosynthesis, growth, oxidative stress
   resistance, and murine virulence. Moreover, inactivation of these
   enzymes alleviated TAFC-derived biosynthetic demand for mevalonate, as
   evidenced by increased resistance to lovastatin. Concordant with
   bilateral demand for mevalonate, iron starvation decreased the
   ergosterol content and composition, a phenotype that is mitigated in
   TAFC-lacking mutants.}},
Publisher = {{NATL ACAD SCIENCES}},
Address = {{2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Yasmin, S (Reprint Author), Innsbruck Med Univ, Div Mol Biol, Bioctr, A-6020 Innsbruck, Austria.
   Yasmin, Sabiha; Gruendlinger, Mario; Blatzer, Michael; Haas, Hubertus, Innsbruck Med Univ, Div Mol Biol, Bioctr, A-6020 Innsbruck, Austria.
   Alcazar-Fuoli, Laura; Cairns, Timothy; Bignell, Elaine, Univ London Imperial Coll Sci Technol \& Med, Microbiol Sect, London SW7 2AZ, England.
   Puempel, Thomas, Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria.
   Lopez, Jordi F.; Grimalt, Joan O., Inst Environm Assessment \& Water Studies, Dept Environm Chem, Barcelona 08034, Catalonia, Spain.}},
DOI = {{10.1073/pnas.1106399108}},
ISSN = {{0027-8424}},
Keywords = {{siderophore; isoprenoide; statins}},
Keywords-Plus = {{INVASIVE PULMONARY ASPERGILLOSIS; SACCHAROMYCES-CEREVISIAE;
   CRYPTOCOCCUS-NEOFORMANS; METABOLIC PRODUCTS; DRUG-RESISTANCE;
   USTILAGO-MAYDIS; IRON DEPLETION; IN-VITRO; VIRULENCE; CANDIDA}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{dr.sabiha.yasmin@gmail.com
   hubertus.haas@i-med.ac.at}},
ResearcherID-Numbers = {{Lopez Fernandez, Jordi/H-6252-2015
   }},
ORCID-Numbers = {{Lopez Fernandez, Jordi/0000-0001-8255-483X
   Grimalt, Joan/0000-0002-7391-5768
   Cairns, Timothy/0000-0001-7106-224X}},
Funding-Acknowledgement = {{Austrian Science Foundation {[}FWF P-18606-B11, FWF P21643-B11];
   Tyrolean Science Foundation {[}UNI-0404/593]; Biotechnology and
   Biological Sciences Research Council {[}BB/G009619/1]; Medical Research
   Council {[}G0501164]}},
Funding-Text = {{This work was supported by Grants FWF P-18606-B11 and FWF P21643-B11
   from the Austrian Science Foundation and by Grant UNI-0404/593 from the
   Tyrolean Science Foundation.}},
Cited-References = {{Alcazar-Fuoli L, 2006, ANTIMICROB AGENTS CH, V50, P453, DOI 10.1128/AAC.50.2.453-460.2006.
   Alcazar-Fuoli L, 2008, STEROIDS, V73, P339, DOI 10.1016/j.steroids.2007.11.005.
   ANKE H, 1971, FEBS LETT, V17, P115, DOI 10.1016/0014-5793(71)80577-X.
   ANKE H, 1974, ARCH MICROBIOL, V95, P213, DOI 10.1007/BF02451763.
   BASSON ME, 1986, P NATL ACAD SCI USA, V83, P5563, DOI 10.1073/pnas.83.15.5563.
   Bignell E, 2005, MOL MICROBIOL, V55, P1072, DOI 10.1111/j.1365-2958.2004.04472.x.
   BROWN MS, 1980, J LIPID RES, V21, P505.
   Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016.
   Chamilos G, 2005, DRUG RESIST UPDATE, V8, P344, DOI 10.1016/j.drup.2006.01.001.
   Chamilos G, 2006, ANTIMICROB AGENTS CH, V50, P96, DOI 10.1128/AAC.50.1.96-103.2006.
   Chin NX, 1997, ANTIMICROB AGENTS CH, V41, P850.
   DIEKMANN H, 1967, EUR J BIOCHEM, V3, P213, DOI 10.1111/j.1432-1033.1967.tb19518.x.
   Eichhorn H, 2006, PLANT CELL, V18, P3332, DOI 10.1105/tpc.106.043588.
   FENTON RG, 1992, J CELL BIOL, V117, P347, DOI 10.1083/jcb.117.2.347.
   Ferreira MED, 2005, MED MYCOL, V43, pS313, DOI 10.1080/13693780400029114.
   Fluckinger M, 2004, ANTIMICROB AGENTS CH, V48, P3367, DOI 10.1128/AAC.48.9.3367-3372.2004.
   Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338.
   Hissen AHT, 2004, INFECT IMMUN, V72, P1402, DOI 10.1128/IAI.72.3.1402-1408.2004.
   Ibrahim AS, 2010, J ANTIMICROB CHEMOTH, V65, P289, DOI 10.1093/jac/dkp426.
   Kontoyiannis DP, 2007, CANCER, V110, P1303, DOI 10.1002/cncr.22909.
   Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x.
   Latge JP, 1999, CLIN MICROBIOL REV, V12, P310.
   Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4.
   Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927.
   Lian TS, 2005, MOL MICROBIOL, V55, P1452, DOI 10.1111/j.1365-2958.2004.04474.x.
   Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748.
   LORENZ RT, 1990, ANTIMICROB AGENTS CH, V34, P1660, DOI 10.1128/AAC.34.9.1660.
   Macreadie IG, 2006, FEMS MICROBIOL LETT, V262, P9, DOI 10.1111/j.1574-6968.2006.00370.x.
   McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154.
   Natesan SK, 2008, DIAGN MICR INFEC DIS, V60, P369, DOI 10.1016/j.diagmicrobio.2007.10.015.
   Oberegger H, 2001, MOL MICROBIOL, V41, P1077, DOI 10.1046/j.1365-2958.2001.02586.x.
   Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633.
   Petrik M, 2010, J NUCL MED, V51, P639, DOI 10.2967/jnumed.109.072462.
   PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3.
   Prasad T, 2006, ANTIMICROB AGENTS CH, V50, P3597, DOI 10.1128/AAC.00653-06.
   PUNT PJ, 1992, METHOD ENZYMOL, V216, P447.
   PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8.
   Qiao J, 2007, MED MYCOL, V45, P589, DOI 10.1080/13693780701397673.
   Ravid T, 1999, J BIOL CHEM, V274, P29341, DOI 10.1074/jbc.274.41.29341.
   Schrettl M, 2004, BIOMETALS, V17, P647, DOI 10.1007/s10534-004-1230-z.
   Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242.
   Schrettl M, 2008, MOL MICROBIOL, V70, P27, DOI 10.1111/j.1365-2958.2008.06376.x.
   Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128.
   Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124.
   Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642.
   Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710.
   Wallner A, 2009, APPL ENVIRON MICROB, V75, P4194, DOI 10.1128/AEM.00479-09.
   Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258.
   WILLADSEN P, 1975, EUR J BIOCHEM, V54, P247, DOI 10.1111/j.1432-1033.1975.tb04134.x.
   Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200.
   Winterberg B, 2010, MOL MICROBIOL, V75, P1260, DOI 10.1111/j.1365-2958.2010.07048.x.
   Yasmin S, 2009, FUNGAL GENET BIOL, V46, P707, DOI 10.1016/j.fgb.2009.05.003.
   Zadra I, 2000, APPL ENVIRON MICROB, V66, P4810, DOI 10.1128/AEM.66.11.4810-4816.2000.
   Zarember KA, 2007, J IMMUNOL, V178, P6367, DOI 10.4049/jimmunol.178.10.6367.
   Zarember KA, 2009, ANTIMICROB AGENTS CH, V53, P2654, DOI 10.1128/AAC.01547-08.}},
Number-of-Cited-References = {{55}},
Times-Cited = {{39}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{23}},
Journal-ISO = {{Proc. Natl. Acad. Sci. U. S. A.}},
Doc-Delivery-Number = {{895KM}},
Unique-ID = {{ISI:000300495100007}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000301631700010,
Author = {Groeger, Thomas and Nathoo, Safia and Ku, Tabitha and Sikora, Curtis and
   Turner, Raymond J. and Prenner, Elmar J.},
Title = {{Real-time imaging of lipid domains and distinct coexisting membrane
   protein clusters}},
Journal = {{CHEMISTRY AND PHYSICS OF LIPIDS}},
Year = {{2012}},
Volume = {{165}},
Number = {{2}},
Pages = {{216-224}},
Month = {{FEB}},
Abstract = {{A detailed understanding of biomembrane architecture is still a
   challenging task. Many in vitro studies have shown lipid domains but
   much less information is known about the lateral organization of
   membrane proteins because their hydrophobic nature limits the use of
   many experimental methods. We examined lipid domain formation in
   biomimetic Escherichia coli membranes composed of
   phosphatidylethanolamine and phosphatidylglycerol in the absence and
   presence of 1\% and 5\% (mol/mol) membrane multidrug resistance protein,
   EmrE. Monolayer isotherms demonstrated protein insertion into the lipid
   monolayer. Subsequently. Brewster angle microscopy was applied to image
   domains in lipid matrices and lipid-protein mixtures. The images showed
   a concentration dependent impact of the protein on lipid domain size and
   shape and more interestingly distinct coexisting protein clusters.
   Whereas lipid domains varied in size (14-47 mu m), protein clusters
   exhibited a narrow size distribution (2.6-4.8 mu m) suggesting a
   non-random process of cluster formation. A 3-D display clearly indicates
   that these proteins clusters protrude from the membrane plane. These
   data demonstrate distinct co-existing lipid domains and membrane protein
   clusters as the monofilm is being compressed and illustrate the
   significant mutual impact of lipid-protein interactions on lateral
   membrane architecture. (C) 2011 Elsevier Ireland Ltd. All rights
   reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Prenner, EJ (Reprint Author), Univ Calgary, Dept Biol Sci, Fac Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.
   Nathoo, Safia; Ku, Tabitha; Sikora, Curtis; Turner, Raymond J.; Prenner, Elmar J., Univ Calgary, Dept Biol Sci, Fac Sci, Calgary, AB T2N 1N4, Canada.
   Groeger, Thomas, German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, D-85764 Neuherbeg, Germany.}},
DOI = {{10.1016/j.chemphyslip.2011.12.012}},
ISSN = {{0009-3084}},
Keywords = {{Monolayer; Phospholipids; Membrane protein; E. coli; EmrE; Brewster
   angle microscopy}},
Keywords-Plus = {{AIR-WATER-INTERFACE; BREWSTER-ANGLE MICROSCOPY; X-RAY-DIFFRACTION;
   BIOLOGICAL-MEMBRANES; CELL-MEMBRANES; PHOSPHOLIPID MONOLAYERS;
   SIGNAL-TRANSDUCTION; BACTERIAL-MEMBRANE; PHASE-TRANSITIONS; LATERAL
   DIFFUSION}},
Research-Areas = {{Biochemistry \& Molecular Biology; Biophysics}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Biophysics}},
Author-Email = {{eprenner@ucalgary.ca}},
ResearcherID-Numbers = {{Turner, Raymond J./M-3961-2015
   Prenner, Elmar/E-5549-2011}},
ORCID-Numbers = {{Turner, Raymond J./0000-0002-9263-0776
   }},
Funding-Acknowledgement = {{Natural Sciences and Engineering Research Council of Canada}},
Funding-Text = {{This work was supported by discovery grants from the Natural Sciences
   and Engineering Research Council of Canada to RJT and EJP. We
   acknowledge the expert technical assistance by the instrument
   manufacturer, Accurion Inc. (Gottingen, Germany).}},
Cited-References = {{Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886.
   Bay DC, 2008, BBA-BIOMEMBRANES, V1778, P1814, DOI 10.1016/j.bbamem.2007.08.015.
   Bay DC, 2010, BBA-BIOMEMBRANES, V1798, P526, DOI 10.1016/j.bbamem.2009.12.017.
   Birdi KS, 1989, LIPID BIOPOLYMER MON.
   Borioli GA, 2001, BIOCHEM BIOPH RES CO, V280, P9, DOI 10.1006/bbrc.2000.4081.
   Boucher J, 2007, COLLOID SURFACE B, V58, P73, DOI 10.1016/j.colsurfb.2007.03.019.
   BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242.
   BROCKMAN H, 1994, CHEM PHYS LIPIDS, V73, P57, DOI 10.1016/0009-3084(94)90174-0.
   Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851.
   Cruz A, 2004, BIOPHYS J, V86, P308, DOI 10.1016/S0006-3495(04)74106-5.
   Cruz A, 2000, EUR BIOPHYS J BIOPHY, V29, P204, DOI 10.1007/PL00006647.
   de Mul MNG, 1998, LANGMUIR, V14, P2455, DOI 10.1021/la9713154.
   Domenech O, 2006, COLLOID SURFACE B, V47, P102, DOI 10.1016/j.colsurfb.2005.11.025.
   Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199.
   Federkell SL, 2003, BIOCHEM CELL BIOL, V81, P61, DOI 10.1139/O03-031.
   Ferretti A, 1999, BBA-MOL CELL BIOL L, V1438, P329, DOI 10.1016/S1388-1981(99)00071-2.
   FIDELIO GD, 1981, BIOCHEM J, V193, P643, DOI 10.1042/bj1930643.
   FIDELIO GD, 1982, BIOCHEM J, V203, P717, DOI 10.1042/bj2030717.
   Fielding CJ, 2003, BBA-BIOMEMBRANES, V1610, P219, DOI 10.1016/S0005-2736(03)00020-8.
   Garcia-Verdugo I, 2007, BIOPHYS J, V93, P3529, DOI 10.1529/biophysj.107.109793.
   Giocondi MC, 2010, BBA-BIOMEMBRANES, V1798, P703, DOI 10.1016/j.bbamem.2009.09.015.
   GRUNER SM, 1985, ANNU REV BIOPHYS BIO, V14, P211, DOI 10.1146/annurev.bb.14.060185.001235.
   Hagen JP, 1996, BBA-BIOMEMBRANES, V1280, P169, DOI 10.1016/0005-2736(96)00009-0.
   Harder T, 2003, PHILOS T ROY SOC B, V358, P863, DOI 10.1098/rstb.2003.1274.
   HECKL WM, 1985, BIOCHIM BIOPHYS ACTA, V810, P73, DOI 10.1016/0005-2728(85)90207-5.
   HENON S, 1991, REV SCI INSTRUM, V62, P936, DOI 10.1063/1.1142032.
   Hinderliter A, 2004, BIOCHEMISTRY-US, V43, P7102, DOI 10.1021/bi036334t.
   HONIG D, 1991, J PHYS CHEM-US, V95, P4590, DOI 10.1021/j100165a003.
   Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607.
   Hu YF, 2006, BIOPHYS J, V91, P444, DOI 10.1529/biophysj.106.081000.
   JOHANNSSON A, 1981, BIOCHIM BIOPHYS ACTA, V641, P416, DOI 10.1016/0005-2736(81)90498-3.
   KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0.
   Lavoie H, 2002, BIOCHEMISTRY-US, V41, P13424, DOI 10.1021/bi026004t.
   Lavoie H, 1999, MAT SCI ENG C-BIO S, V10, P147, DOI 10.1016/S0928-4931(99)00124-1.
   Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7.
   Lheveder C., 2000, BIOCHIM BIOPHYS ACTA, DOI DOI 10.1016/S0304-4157(96)00009-3).
   Lohner K, 1999, BBA-BIOMEMBRANES, V1462, P141, DOI 10.1016/S0005-2736(99)00204-7.
   London E, 2002, CURR OPIN STRUC BIOL, V12, P480, DOI 10.1016/S0959-440X(02)00351-2.
   Maggio B, 2005, BRAZ J MED BIOL RES, V38, P1735, DOI 10.1590/S0100-879X2005001200002.
   Maggio B, 2008, CELL BIOCHEM BIOPHYS, V50, P79, DOI 10.1007/s12013-007-9004-1.
   Miller D, 2009, J MOL BIOL, V393, P815, DOI 10.1016/j.jmb.2009.08.039.
   Momsen MM, 1997, BIOCHEMISTRY-US, V36, P10073, DOI 10.1021/bi9703857.
   MOURITSEN OG, 1984, BIOPHYS J, V46, P141, DOI 10.1016/S0006-3495(84)84007-2.
   Navas BP, 2005, BBA-BIOMEMBRANES, V1716, P40, DOI 10.1016/j.bbamem.2005.08.003.
   O'Shea P, 2005, PHILOS T ROY SOC A, V363, P575, DOI 10.1098/rsta.2004.1509.
   Opekarova M, 2005, BBA-BIOMEMBRANES, V1711, P87, DOI 10.1016/j.bbamem.2005.02.015.
   Paulsen IT, 1996, MOL MICROBIOL, V19, P1167, DOI 10.1111/j.1365-2958.1996.tb02462.x.
   Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003.
   PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4.
   Poveda JA, 2008, BBA-BIOMEMBRANES, V1778, P1583, DOI 10.1016/j.bbamem.2008.01.021.
   Prenner E, 2000, J MEMBRANE BIOL, V174, P237, DOI 10.1007/s002320001048.
   Prenner E, 2007, CHEM PHYS LIPIDS, V145, P106, DOI 10.1016/j.chemphyslip.2006.11.002.
   Purewal A S, 1990, FEMS Microbiol Lett, V56, P73.
   RIEGLER J, 1986, BIOPHYS J, V49, P1111, DOI 10.1016/S0006-3495(86)83740-7.
   Ruano MLF, 1998, BIOPHYS J, V74, P1101, DOI 10.1016/S0006-3495(98)77828-2.
   SAKO Y, 1994, J CELL BIOL, V125, P1251, DOI 10.1083/jcb.125.6.1251.
   Salamon Z, 1999, TRENDS BIOCHEM SCI, V24, P213, DOI 10.1016/S0968-0004(99)01394-8.
   SALESSE C, 1990, BIOCHEMISTRY-US, V29, P4567, DOI 10.1021/bi00471a010.
   SAXTON MJ, 1982, BIOPHYS J, V39, P165, DOI 10.1016/S0006-3495(82)84504-9.
   Schuldiner S, 2007, SCIENCE, V317, P748.
   Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018.
   Serrano AG, 2006, CHEM PHYS LIPIDS, V141, P105, DOI 10.1016/j.chemphyslip.2006.02.017.
   Siegel S, 1999, MAT SCI ENG C-BIO S, V8-9, P3, DOI 10.1016/S0928-4931(99)00084-3.
   Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803.
   Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052.
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408.
   SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720.
   Smith WL, 2001, J BIOL CHEM, V276, P32393, DOI 10.1074/jbc.R100044200.
   SPEROTTO MM, 1989, CELL BIOPHYS, V14, P79, DOI 10.1007/BF02797393.
   Taneva SG, 2000, BIOCHEMISTRY-US, V39, P6083, DOI 10.1021/bi992074x.
   van Dalen A, 2004, BBA-MOL CELL RES, V1694, P97, DOI 10.1016/j.bbamcr.2004.03.007.
   van Voorst F, 2000, BIOCHEM J, V347, P601, DOI 10.1042/bj3470601.
   Vanounou S, 2003, MOL MICROBIOL, V49, P1067, DOI 10.1046/j.1365-2958.2003.03614.x.
   Verclas SAW, 1999, J MOL BIOL, V287, P837, DOI 10.1006/jmbi.1999.2644.
   Voros J, 2004, BIOPHYS J, V87, P553, DOI 10.1529/biophysj.103.030072.
   Wang TY, 2001, BIOCHEMISTRY-US, V40, P13031, DOI 10.1021/bi0112311.
   Wang TY, 2000, BIOPHYS J, V79, P1478, DOI 10.1016/S0006-3495(00)76399-5.
   Watanabe Y, 2009, PROTEIN J, V28, P66, DOI 10.1007/s10930-009-9165-4.
   Winstone TL, 2005, BIOCHEM BIOPH RES CO, V327, P437, DOI 10.1016/j.bbrc.2004.11.164.
   Winstone TL, 2002, PROTEIN EXPRES PURIF, V26, P111, DOI 10.1016/S1046-5928(02)00525-9.
   Yamamoto T, 2008, THIN SOLID FILMS, V516, P2660, DOI 10.1016/j.tsf.2007.04.079.
   ZACHOWSKI A, 1993, BIOCHEM J, V294, P1.}},
Number-of-Cited-References = {{82}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{21}},
Journal-ISO = {{Chem. Phys. Lipids}},
Doc-Delivery-Number = {{910IZ}},
Unique-ID = {{ISI:000301631700010}},
DA = {{2018-08-13}},
}

@article{ ISI:000299251900005,
Author = {Dichtl, Karl and Helmschrott, Christoph and Dirr, Franziska and Wagener,
   Johannes},
Title = {{Deciphering cell wall integrity signalling in Aspergillus fumigatus:
   identification and functional characterization of cell wall stress
   sensors and relevant Rho GTPases}},
Journal = {{MOLECULAR MICROBIOLOGY}},
Year = {{2012}},
Volume = {{83}},
Number = {{3}},
Pages = {{506-519}},
Month = {{FEB}},
Abstract = {{The fungal cell wall, a conserved and highly dynamic structure, is
   essential for virulence and viability of fungal pathogens and is an
   important antifungal drug target. The cell wall integrity (CWI)
   signalling pathway regulates shape and biosynthesis of the cell wall. In
   this work we identified, localized and functionally characterized four
   putative CWI stress sensors of Aspergillus fumigatus, an airborne
   opportunistic human pathogen and the cause of invasive aspergillosis. We
   show that Wsc1 is specifically required for resistance to echinocandin
   antifungals. MidA is specifically required for elevated temperature
   tolerance and resistance to the cell wall perturbing agents congo red
   and calcofluor white. Wsc1, Wsc3 and MidA additionally have overlapping
   functions and are redundantly required for radial growth and
   conidiation. We have also analysed the roles of three Rho GTPases that
   have been implicated in CWI signalling in other fungi. We show that Rho1
   is essential and that conditional downregulation of rho1 or deletion of
   rho2 or rho4 results in severely impaired CWI. Our data indicate
   significant functional differences between the CWI stress sensors of
   yeasts and moulds.}},
Publisher = {{WILEY}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wagener, J (Reprint Author), Univ Munich, Max Von Pettenkofer Inst, Pettenkoferstr 9A, D-80336 Munich, Germany.
   Dichtl, Karl; Helmschrott, Christoph; Dirr, Franziska; Wagener, Johannes, Univ Munich, Max Von Pettenkofer Inst, D-80336 Munich, Germany.}},
DOI = {{10.1111/j.1365-2958.2011.07946.x}},
ISSN = {{0950-382X}},
EISSN = {{1365-2958}},
Keywords-Plus = {{SACCHAROMYCES-CEREVISIAE; POLARIZED GROWTH; NIDULANS; PROTEIN; PATHWAY;
   GENE; WSC1; VIRULENCE}},
Research-Areas = {{Biochemistry \& Molecular Biology; Microbiology}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Microbiology}},
Author-Email = {{johannes.wagener@med.uni-muenchen.de}},
ResearcherID-Numbers = {{Wagener, Johannes/K-5904-2012}},
Funding-Acknowledgement = {{Forderprogramm fur Forschung und Lehre of the
   Ludwig-Maximilians-Universitat; Munchner Medizinische Wochenschrift;
   Deutsche Forschungsgemeinschaft {[}WA3016/1-1]}},
Funding-Text = {{This work was in part supported by the Forderprogramm fur Forschung und
   Lehre of the Ludwig-Maximilians-Universitat, the Munchner Medizinische
   Wochenschrift and the Deutsche Forschungsgemeinschaft (WA3016/1-1). We
   thank Frank Ebel for critical reading of the manuscript and Vera Meyer
   (Technical University of Berlin, Germany) for providing the pVG2.2
   plasmid.}},
Cited-References = {{Beauvais A, 2001, J BACTERIOL, V183, P2273, DOI 10.1128/JB.183.7.2273-2279.2001.
   Dichtl K, 2010, MOL MICROBIOL, V76, P1191, DOI 10.1111/j.1365-2958.2010.07170.x.
   Dirr F, 2010, INT J MED MICROBIOL, V300, P496, DOI 10.1016/j.ijmm.2010.03.001.
   Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985.
   Fujioka T, 2007, EUKARYOT CELL, V6, P1497, DOI 10.1128/EC.00281-06.
   Guest GM, 2004, FUNGAL GENET BIOL, V41, P13, DOI 10.1016/j.fgb.2003.08.006.
   Heinisch JJ, 2010, INTEGR BIOL-UK, V2, P408, DOI 10.1039/c0ib00012d.
   Hill TW, 2001, FUNGAL GENET NEWSLET, V48, P20.
   Ketela T, 1999, J BACTERIOL, V181, P3330.
   Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006.
   Kwon MJ, 2011, MOL MICROBIOL, V79, P1151, DOI 10.1111/j.1365-2958.2010.07524.x.
   Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005.
   Lodder AL, 1999, GENETICS, V152, P1487.
   Meyer V, 2011, APPL ENVIRON MICROB, V77, P2975, DOI 10.1128/AEM.02740-10.
   Norice CT, 2007, EUKARYOT CELL, V6, P2046, DOI 10.1128/EC.00314-07.
   Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823.
   PUNT PJ, 1992, METHOD ENZYMOL, V216, P447.
   Reinoso-Martin C, 2003, EUKARYOT CELL, V2, P1200, DOI 10.1128/EC.2.6.1200-1210.2003.
   Rodicio R, 2008, FUNGAL GENET BIOL, V45, P422, DOI 10.1016/j.fgab.2007.07.009.
   Ronen R, 2007, CURR GENET, V51, P321, DOI 10.1007/s00294-007-0129-y.
   Serrano R, 2006, J BIOL CHEM, V281, P39785, DOI 10.1074/jbc.M604497200.
   Si HY, 2010, GENETICS, V185, P166, DOI 10.1534/genetics.110.114165.
   STAIB F, 1980, ZBL BAKT-INT J MED M, V247, P530.
   Straede A, 2007, FEBS LETT, V581, P4495, DOI 10.1016/j.febslet.2007.08.027.
   Teepe AG, 2007, FUNGAL GENET BIOL, V44, P554, DOI 10.1016/j.fgb.2006.10.001.
   Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005.
   Vogt K, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-1.
   Wagener J, 2008, EUKARYOT CELL, V7, P1661, DOI 10.1128/EC.00221-08.
   Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847.
   Zucchi PC, 2010, MOL MICROBIOL, V76, P733, DOI 10.1111/j.1365-2958.2010.07137.x.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{50}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{33}},
Journal-ISO = {{Mol. Microbiol.}},
Doc-Delivery-Number = {{878JE}},
Unique-ID = {{ISI:000299251900005}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000298988300008,
Author = {Heller, L. C. and Edelblute, C. M. and Mattson, A. M. and Hao, X. and
   Kolb, J. F.},
Title = {{Inactivation of bacterial opportunistic skin pathogens by nonthermal
   DC-operated afterglow atmospheric plasma}},
Journal = {{LETTERS IN APPLIED MICROBIOLOGY}},
Year = {{2012}},
Volume = {{54}},
Number = {{2}},
Pages = {{126-132}},
Month = {{FEB}},
Abstract = {{Aims: Multidrug-resistant opportunistic pathogens are clinically
   significant and require the development of new antimicrobial methods. In
   this study, Acinetobacter baumannii, Pseudomonas aeruginosa and
   Staphylococcus aureus cells were exposed to atmospheric plasma on agar
   plates and in vitro on porcine skin for the purpose of testing bacterial
   inactivation. Methods and Results: Microbial inactivation at varying
   exposure durations was tested using a nonthermal plasma jet generated
   with a DC voltage from ambient air. The observed reduction in colony
   forming units was quantified as log10 reductions. Conclusions: Direct
   plasma exposure significantly inactivated seeded bacterial cells by
   approx. 6 log10 on agar plates and 2-3 log10 on porcine skin. On agar
   plates, an indirect ` bystander' inactivation outside the plasma
   delivery area was also observed. The reduced inactivation observed on
   the skin surface was most likely due to cell protection by the variable
   surface architecture. Significance and Impact of Study: Atmospheric
   plasma has potential for clinical application as a disinfectant of
   patient skin and medically relevant surfaces.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Heller, LC (Reprint Author), Old Dominion Univ, Frank Reidy Res Ctr Bioelect, 4211 Monarch Way,Suite 300, Norfolk, VA 23505 USA.
   Heller, L. C.; Edelblute, C. M.; Mattson, A. M.; Hao, X.; Kolb, J. F., Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23505 USA.
   Heller, L. C., Old Dominion Univ, Coll Hlth Sci, Norfolk, VA 23505 USA.
   Mattson, A. M.; Kolb, J. F., Old Dominion Univ, Dept Elect \& Comp Engn, Norfolk, VA 23505 USA.
   Hao, X., Jiangnan Univ, Sch Environm \& Civil Engn, Lab Environm Pollut Prevent, Wuxi, Peoples R China.}},
DOI = {{10.1111/j.1472-765X.2011.03186.x}},
ISSN = {{0266-8254}},
Keywords = {{biochemical engineering; biotechnology}},
Keywords-Plus = {{STAPHYLOCOCCUS-AUREUS; NITRIC-OXIDE; ACINETOBACTER-BAUMANNII;
   ESCHERICHIA-COLI; IN-VITRO; TEMPERATURE STERILIZATION; PRESSURE PLASMA;
   GLOW-DISCHARGE; ARGON PLASMA; OXYGEN}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Microbiology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Microbiology}},
Author-Email = {{lheller@odu.edu}},
ResearcherID-Numbers = {{Kolb, Juergen/A-5515-2016}},
ORCID-Numbers = {{Kolb, Juergen/0000-0002-0434-5001}},
Funding-Acknowledgement = {{U.S. Army Medical Research \& Materiel Command and the Telemedicine \&
   Advanced Technology Research Center, at Fort Detrick, MD
   {[}W81XWH-10-1-0376]}},
Funding-Text = {{This research and development project is being conducted by Old Dominion
   University and is made possible by a research grant that was awarded and
   administered by the U.S. Army Medical Research \& Materiel Command and
   the Telemedicine \& Advanced Technology Research Center, at Fort
   Detrick, MD, under Contract Number W81XWH-10-1-0376. The views, opinions
   and/or findings contained in this research are those of the author(s)
   and do not necessarily reflect the views of the Department of Defense
   and should not be construed as an official DoD/Army position, policy or
   decision unless so designated by other documentation. No official
   endorsement should be made.}},
Cited-References = {{Barbero AM, 2009, TOXICOL IN VITRO, V23, P1, DOI 10.1016/j.tiv.2008.10.008.
   Bargo PR, 2010, BRIT J DERMATOL, V162, P724, DOI 10.1111/j.1365-2133.2010.09639.x.
   BENEDIKTSDOTTIR E, 1983, J HOSP INFECT, V4, P141, DOI 10.1016/0195-6701(83)90043-9.
   Bloemen MCT, 2011, J AM ACAD DERMATOL, V64, P706, DOI 10.1016/j.jaad.2010.03.006.
   Cebrian G, 2007, INT J FOOD MICROBIOL, V118, P304, DOI 10.1016/j.ijfoodmicro.2007.07.051.
   Chau TT, 1996, BIOMATERIALS, V17, P1273, DOI 10.1016/S0142-9612(96)80003-2.
   COOK TH, 1982, INT J COSMETIC SCI, V4, P195, DOI 10.1111/j.1467-2494.1982.tb00314.x.
   Crane BR, 2010, ANNU REV BIOCHEM, V79, P445, DOI 10.1146/annurev-biochem-062608-103436.
   Daeschlein G, 2010, PLASMA PROCESS POLYM, V7, P224, DOI 10.1002/ppap.200900059.
   David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09.
   Deng SB, 2007, J FOOD SCI, V72, pM62, DOI 10.1111/j.1750-3841.2007.00275.x.
   Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0.
   Feng HQ, 2009, IEEE T PLASMA SCI, V37, P121, DOI 10.1109/TPS.2008.2008438.
   Fischer TW, 1999, SKIN PHARMACOL APPL, V12, P1, DOI 10.1159/000029840.
   Friedman A, 2011, VIRULENCE, V2, P217, DOI 10.4161/viru.2.3.16161.
   Gusbeth C, 2009, CHEMOSPHERE, V75, P228, DOI 10.1016/j.chemosphere.2008.11.066.
   Hammann A, 2010, SKIN PHARMACOL PHYS, V23, P328, DOI 10.1159/000314724.
   Hassani M, 2006, LETT APPL MICROBIOL, V43, P619, DOI 10.1111/j.1472-765X.2006.02014.x.
   Hury S, 1998, LETT APPL MICROBIOL, V26, P417.
   Isbary G, 2010, BRIT J DERMATOL, V163, P78, DOI 10.1111/j.1365-2133.2010.09744.x.
   Kampf G, 2006, BMC DERMATOL, V6, DOI 10.1186/1471-5945-6-1.
   Kelly-Wintenberg K, 1998, J IND MICROBIOL BIOT, V20, P69, DOI 10.1038/sj.jim.2900482.
   Kelm M, 1999, BBA-BIOENERGETICS, V1411, P273, DOI 10.1016/S0005-2728(99)00020-1.
   Kim SM, 2006, J MICROBIOL, V44, P466.
   KNABEL SJ, 1990, APPL ENVIRON MICROB, V56, P370.
   Kolb JF, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2940325.
   Kunz AN, 2010, CHEMOTHERAPY, V56, P492, DOI 10.1159/000321018.
   Laroussi M, 1996, IEEE T PLASMA SCI, V24, P1188, DOI 10.1109/27.533129.
   Lee K, 2006, J MICROBIOL, V44, P269.
   Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846.
   Lu X, 2008, J APPL PHYS, V104, DOI 10.1063/1.2977674.
   Manuskiatti W, 1998, DERMATOLOGY, V196, P401, DOI 10.1159/000017932.
   Marsili L, 2002, RADIAT PHYS CHEM, V65, P507, DOI 10.1016/S0969-806X(02)00367-5.
   Mihu MR, 2010, VIRULENCE, V1, P62, DOI 10.4161/viru.1.2.10038.
   Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9.
   Montenegro J, 2002, J FOOD SCI, V67, P646, DOI 10.1111/j.1365-2621.2002.tb10653.x.
   Moreau S, 2000, J APPL PHYS, V88, P1166, DOI 10.1063/1.373792.
   Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07.
   Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06.
   Perni S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2458162.
   Philip N, 2002, IEEE T PLASMA SCI, V30, P1429, DOI 10.1109/TPS.2002.804203.
   Privett BJ, 2010, MOL PHARMACEUT, V7, P2289, DOI 10.1021/mp100248e.
   Rahul R, 2005, J PHYS D APPL PHYS, V38, P1750, DOI 10.1088/0022-3727/38/11/016.
   Rudolph B, 2010, J BIOL CHEM, V285, P19029, DOI 10.1074/jbc.M110.103374.
   Rupf S, 2010, J MED MICROBIOL, V59, P206, DOI 10.1099/jmm.0.013714-0.
   Scholtz V, 2007, Prague Med Rep, V108, P128.
   Sohbatzadeh F, 2010, APPL BIOCHEM BIOTECH, V160, P1978, DOI 10.1007/s12010-009-8817-3.
   STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E.
   Sullivan PK, 2004, WOUNDS, V16, P115.
   Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819.
   Van Neste D, 1991, J Dermatol Sci, V2, P119, DOI 10.1016/0923-1811(91)90021-O.
   WALKER GC, 1966, APPL MICROBIOL, V14, P584.
   Yang LQ, 2009, APPL SURF SCI, V255, P8960, DOI 10.1016/j.apsusc.2009.03.026.}},
Number-of-Cited-References = {{53}},
Times-Cited = {{16}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{32}},
Journal-ISO = {{Lett. Appl. Microbiol.}},
Doc-Delivery-Number = {{874WH}},
Unique-ID = {{ISI:000298988300008}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000315865800012,
Author = {Cox, Helen and Escombe, Rod and McDermid, Cheryl and Mtshemla, Yolanda
   and Spelman, Tim and Azevedo, Virginia and London, Leslie},
Title = {{Wind-Driven Roof Turbines: A Novel Way to Improve Ventilation for TB
   Infection Control in Health Facilities}},
Journal = {{PLOS ONE}},
Year = {{2012}},
Volume = {{7}},
Number = {{1}},
Month = {{JAN 9}},
Abstract = {{Objective: Tuberculosis transmission in healthcare facilities
   contributes significantly to the TB epidemic, particularly in high HIV
   settings. Although improving ventilation may reduce transmission, there
   is a lack of evidence to support low-cost practical interventions. We
   assessed the efficacy of wind-driven roof turbines to achieve
   recommended ventilation rates, compared to current recommended practices
   for natural ventilation (opening windows), in primary care clinic rooms
   in Khayelitsha, South Africa.
   Methods: Room ventilation was assessed (CO2 gas tracer technique) in 4
   rooms where roof turbines and air-intake grates were installed, across
   three scenarios: turbine, grate and window closed, only window open, and
   only turbine and grate open, with concurrent wind speed measurement. 332
   measurements were conducted over 24 months.
   Findings: For all 4 rooms combined, median air changes per hour (ACH)
   increased with wind speed quartiles across all scenarios. Higher median
   ACH were recorded with open roof turbines and grates, compared to open
   windows across all wind speed quartiles. Ventilation with open turbine
   and grate exceeded WHO-recommended levels (60 Litres/second/patient) for
   95\% or more of measurements in 3 of the 4 rooms; 47\% in the remaining
   room, where wind speeds were lower and a smaller diameter turbine was
   installed.
   Conclusion: High room ventilation rates, meeting recommended thresholds,
   may be achieved using wind-driven roof turbines and grates, even at low
   wind speeds. Roof turbines and air-intake grates are not easily closed
   by staff, allowing continued ventilation through colder periods. This
   simple, low-cost technology represents an important addition to our
   tools for TB infection control.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Cox, H (Reprint Author), Med Sans Frontieres, Cape Town, South Africa.
   Cox, Helen; McDermid, Cheryl; Mtshemla, Yolanda, Med Sans Frontieres, Cape Town, South Africa.
   Cox, Helen; Spelman, Tim, Burnet Inst Med Res, Melbourne, Vic, Australia.
   Escombe, Rod, Univ London Imperial Coll Sci Technol \& Med, Dept Infect Dis \& Immun, London, England.
   Azevedo, Virginia, City Cape Town, Dept Hlth, Cape Town, South Africa.
   London, Leslie, Univ Cape Town, ZA-7925 Cape Town, South Africa.}},
DOI = {{10.1371/journal.pone.0029589}},
Article-Number = {{e29589}},
ISSN = {{1932-6203}},
Keywords-Plus = {{DRUG-RESISTANT TUBERCULOSIS; MULTIDRUG-RESISTANT; SOUTH-AFRICA}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{hcox@burnet.edu.au}},
ORCID-Numbers = {{Cox, Helen/0000-0002-6538-7192}},
Funding-Acknowledgement = {{Medecins sans Frontieres; Jack and Robert Smorgon Foundation in
   Australia}},
Funding-Text = {{This work was funded by Medecins sans Frontieres. Staff from Medecins
   sans Frontieres were involved in study design, data collection and
   analysis, manuscript preparation and decision to publish. This work was
   also assisted by an award from the Jack and Robert Smorgon Foundation in
   Australia, who had no role in study design, data collection and
   analysis, manuscript preparation and decision to publish.}},
Cited-References = {{Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991.
   Cox HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013901.
   Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068.
   Fennelly KP, 1998, INFECT CONT HOSP EP, V19, P754.
   Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP.
   Medecins Sans Frontieres, 2011, KHAYEL 2001 2011 ACT.
   MENZIES R, 1995, AM J RESP CRIT CARE, V152, P1992, DOI 10.1164/ajrccm.152.6.8520767.
   NARDELL EA, 1991, AM REV RESPIR DIS, V144, P302, DOI 10.1164/ajrccm/144.2.302.
   O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008.
   Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1.
   WHO, 2009, NAT VENT INF CONTR H.
   Windfinder.com, 2011, WIND WEATH STAT CAP.
   Wood R, 2011, SAMJ S AFR MED J, V101, P111, DOI 10.7196/SAMJ.4587.
   World Health Organization, 2009, WHO POL TB INF CONTR.
   World Health Organization, 2007, INF PREV CONTR EP PA.
   World Health Organization, 2010, GLOB TUB CONTR 2010.}},
Number-of-Cited-References = {{16}},
Times-Cited = {{13}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{102TA}},
Unique-ID = {{ISI:000315865800012}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000325186100004,
Author = {Matouskova, Ivanka and Raida, Ludek and Holy, Ondrej},
Title = {{The Incidence of Nonfermentative Gram-Negative Bacilli in the
   Environment of the Transplant Unit, Department of Hemato-Oncology,
   University Hospital Olomouc}},
Journal = {{EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE}},
Year = {{2012}},
Volume = {{61}},
Number = {{4}},
Pages = {{110-115}},
Abstract = {{A study entitled, Surveillance of Infectious Complications in
   Hemato-oncological Patients{''} was conducted at the Department of
   Hemato-Oncology, University Hospital Olomouc from 1 July 2010 to 31
   August 2011. During the study period, a total of 63 patients were
   hospitalized at that department and 33 stem cell transplants were
   performed, 21 autologous and 12 allogeneic. Microbial contamination was
   monitored in indoor air, on selected surfaces, and in health care
   providers (right hand smear, left and right nostril swabs and scalp hair
   smear). Gram-negative bacteria detected by culture were identified
   biochemically. Special attention was paid to nonfermentative
   Gram-negative bacilli which, based on the recent literature, should be
   considered as emerging causative agents of hospital infections.}},
Publisher = {{CESKA LEKARSKA SPOLECNOST J  EV  PURKYNE}},
Address = {{SOKOLSKA 31, PRAGUE, 00000, CZECH REPUBLIC}},
Type = {{Article}},
Language = {{Czech}},
Affiliation = {{Matouskova, I (Reprint Author), Univ Palackeho Olomouci, Lekarska Fak, Ustav Preventivniho Lekarstvi, Hnevotinska 3, Olomouc 77515, Czech Republic.
   Matouskova, Ivanka, Univ Palackeho Olomouci, Lekarska Fak, Ustav Preventivniho Lekarstvi, Olomouc 77515, Czech Republic.
   Fak Nemocnice Olomouc, Hematoonkol Klin, Olomouc, Czech Republic.}},
ISSN = {{1210-7913}},
Keywords = {{nonfermentative Gram-negative bacilli; hemato-oncology patient;
   resistance to antibiotics and biocides}},
Keywords-Plus = {{OCHROBACTRUM-ANTHROPI BACTEREMIA; KINGELLA-KINGAE INFECTIONS;
   STENOTROPHOMONAS-MALTOPHILIA; PSEUDOMONAS-AERUGINOSA; CELL
   TRANSPLANTATION; RISK-FACTORS; PATHOGEN; OUTBREAK}},
Research-Areas = {{Immunology; Microbiology}},
Web-of-Science-Categories  = {{Immunology; Microbiology}},
Author-Email = {{matouski@tunw.upol.cz}},
ORCID-Numbers = {{Matouskova, Ivanka/0000-0002-0417-2729}},
Cited-References = {{Bassetti M, 2011, CRIT CARE, V15, DOI 10.1186/cc9997.
   Bieri S, 2011, EUR J HAEMATOL, V87, P138, DOI 10.1111/j.1600-0609.2011.01638.x.
   Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11.
   Carter JE, 2005, AM J CLIN PATHOL, V123, P334, DOI 10.1309/61XP4KTLJYWM5H35.
   Chotikanatis K, 2011, J CLIN MICROBIOL, V49, P3418, DOI 10.1128/JCM.00625-11.
   Dubnov-Raz G, 2008, PEDIATRICS, V122, P1305, DOI 10.1542/peds.2007-3070.
   Duran R, 2009, INT J INFECT DIS, V13, pE473, DOI {[}10.1016/j.ijid.2008.06.027, 10.1016/j.ijid.2009.01.002].
   Enoch DA, 2007, INT J ANTIMICROB AG, V29, pS33, DOI 10.1016/S0924-8579(07)72176-3.
   EZZEDINE H, 1994, J HOSP INFECT, V27, P35, DOI 10.1016/0195-6701(94)90066-3.
   Fihman V, 2012, J INFECTION, V64, P391, DOI 10.1016/j.jinf.2012.01.001.
   Isozaki A, 2010, J INFECT CHEMOTHER, V16, P436, DOI 10.1007/s10156-010-0067-3.
   Kawamura I, 2011, J INFECT CHEMOTHER, V17, P111, DOI 10.1007/s10156-010-0089-x.
   KERN WV, 1993, INFECTION, V21, P306, DOI 10.1007/BF01712451.
   Kim YH, 2011, CORNEA, V30, P472, DOI 10.1097/ICO.0b013e3181f7f129.
   Mackall C, 2009, BONE MARROW TRANSPL, V44, P457, DOI 10.1038/bmt.2009.255.
   Magauran Claire E., 2011, Infectious Disorders - Drug Targets, V11, P18.
   MUSSO D, 1994, CLIN INFECT DIS, V18, P482, DOI 10.1093/clinids/18.3.482-a.
   Nagao M, 2011, J HOSP INFECT, V79, P49, DOI 10.1016/j.jhin.2011.04.018.
   Nyc O, 2010, FOLIA MICROBIOL, V55, P286, DOI 10.1007/s12223-010-0043-4.
   Paitoonpong L., 2012, HOSP EPIDEMIOLOGY IN.
   Playford EG, 2007, J HOSP INFECT, V65, P204, DOI 10.1016/j.jhin.2006.11.010.
   Rajanna Divya M, 2011, Ear Nose Throat J, V90, pE15.
   Ray M., 2012, EYE CONTACT LENS.
   Sachdeva L. D., 1963, INDIAN J PATHOL BACT, V37, P513.
   Simoes LC, 2011, BIOFOULING, V27, P403, DOI 10.1080/08927014.2011.579599.
   Slonim A, 2003, CLIN INFECT DIS, V37, P521, DOI 10.1086/376913.
   SPENCER RC, 1995, J HOSP INFECT, V30, P453, DOI 10.1016/0195-6701(95)90049-7.
   Tada K., 2012, BONE MARROW TRANSPL, DOI {[}10.1038/bmt.2012.87, DOI 10.1038/BMT.2012.87.{[}].
   TAI T Y, 1963, Chin Med J, V82, P423.
   Tasbakan MS, 2010, MIKROBIYOL BUL, V44, P127.
   Thomas L, 2000, J HOSP INFECT, V46, P297, DOI 10.1053/jhin.2000.0851.
   WEINSTEIN RA, 1976, JAMA-J AM MED ASSOC, V236, P936, DOI 10.1001/jama.236.8.936.
   Wilkinson F H, 1998, Eur J Cancer Care (Engl), V7, P12.
   Yeshurun M, 2010, INFECTION, V38, P211, DOI 10.1007/s15010-010-0023-2.
   Zbinden R., 2011, MANUAL CLIN MICROBIO, P574.}},
Number-of-Cited-References = {{35}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Epidemiol. Mikrobiol. Imunol.}},
Doc-Delivery-Number = {{228KX}},
Unique-ID = {{ISI:000325186100004}},
DA = {{2018-08-13}},
}

@article{ ISI:000321520000008,
Author = {Voravuthikunchai, Supayang Piyawan and Minbutra, Sukanda and Goodla,
   Lavanya and Jefferies, Jennifer and Voravuthikunchai, Somboon},
Title = {{Mixtures of Essential Oils in an Air Conditioning Prototype to Reduce
   the Prevalence of Airborne Pathogenic Bacteria}},
Journal = {{JOURNAL OF ESSENTIAL OIL BEARING PLANTS}},
Year = {{2012}},
Volume = {{15}},
Number = {{5}},
Pages = {{739-749}},
Abstract = {{The rationale for this work was to test the possibility of creating a
   protective atmosphere by using natural compounds to minimize hazards
   from chemicals and to control the risk of common infections. The
   antimicrobial activities of essential oils of Agronis fragrans,
   Cinnamomum zeylanicum, Lavandula angustifolia, Melaleuca alternifolia
   (tea tree), Melaleuca nesophila (honey myrtle), Pelargonium x asperum
   (geranium), Pogostemon cablin (patchouli), Thymus serpyllum, and Thymus
   vulgaris were evaluated against an array of environmental-borne
   pathogenic bacteria. Gram-positive bacteria included Bacillus subtilis
   and Staphylococcus aureus; four Gram-negative bacteria covered
   Acinetobacter baumanii, Escherichia coli, Klebsiella pneumoniae, and
   Pseudomonas aeruginosa. In addition, eleven isolates of
   methicillin-resistant S. aureus (MRSA) and a multidrug-resistant A.
   baumanii were incorporated. In agar disc diffusion tests, cinnamon had
   shown the strongest activity that could inhibit all pathogens, followed
   by lemon thyme, honey myrtle and lavender, while pachouli exhibited the
   weakest inhibition. Though fragonia possessed a broad range of activity
   against all pathogens, it did not inhibit some of the MRSA isolates.
   Cinnamon and lemon thyme demonstrated strong activity measured by
   minimal inhibitory concentrations (MICs) and minimal bactericidal
   concentrations. In disk volatilization assay, thyme oil demonstrated the
   greatest inhibition, followed by lemon thyme, while no inhibition from
   patchouli was observed. Subsequently, the composition of the atmosphere
   generated by three different oil blends in our invented portable
   air-conditioning prototype was assessed. The results showed that mixture
   of oil blend No. 2 can produce good synergistic effect in reducing the
   prevalence of airborne pathogens, and thus preventing the spreading of
   infections.}},
Publisher = {{TAYLOR \& FRANCIS LTD}},
Address = {{4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Voravuthikunchai, SP (Reprint Author), Prince Songkla Univ, Fac Sci, Nat Prod Res Ctr, Hat Yai 90112, Songkhla, Thailand.
   Voravuthikunchai, Supayang Piyawan; Goodla, Lavanya, Prince Songkla Univ, Fac Sci, Nat Prod Res Ctr, Hat Yai 90112, Songkhla, Thailand.
   Voravuthikunchai, Supayang Piyawan; Minbutra, Sukanda, Prince Songkla Univ, Fac Sci, Dept Microbiol, Hat Yai 90112, Songkhla, Thailand.
   Jefferies, Jennifer, Increasing Hlth, Wealth \& San, North Lakes, Qld 4509, Australia.
   Voravuthikunchai, Somboon, Prince Songkla Univ, Fac Engn, Dept Mech Engn, Hat Yai 90112, Songkhla, Thailand.}},
DOI = {{10.1080/0972060X.2012.10644114}},
ISSN = {{0972-060X}},
Keywords = {{Acinetobacter baumanii; Air conditioning system; Essential oil;
   Staphylococcus; aureus; Multidrug-resistant pathogenic bacteria}},
Keywords-Plus = {{ACINETOBACTER-BAUMANNII BACTEREMIA; VAPOR-PHASE; ANTIMICROBIAL ACTIVITY;
   FOODS; SUSCEPTIBILITY; RESISTANCE; VANCOMYCIN; STRAINS}},
Research-Areas = {{Plant Sciences}},
Web-of-Science-Categories  = {{Plant Sciences}},
Author-Email = {{supayang.v@psu.ac.th}},
ResearcherID-Numbers = {{Goodla, Lavanya/M-5158-2013
   }},
ORCID-Numbers = {{Goodla, Lavanya/0000-0002-7616-7152}},
Funding-Acknowledgement = {{Thailand Research Fund}},
Funding-Text = {{Authors are grateful to The Australian Trade Commission, Thailand. This
   work was supported by the Thailand Research Fund, Fiscal year 2012-2014.}},
Cited-References = {{Biedenbacha DJ, 2007, INT J ANTIMICROB AG, V30, P143, DOI 10.1016/j.ijantimicag.2007.03.015.
   Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022.
   Centers for Disease Control and Prevention (CDC), 2002, MMWR-MORBID MORTAL W, V51, P565.
   Choi JY, 2005, INTERN MED J, V35, P599, DOI 10.1111/j.1445-5994.2005.00925.x.
   CLSI, 2009, M02A10 CLSI.
   Emaneini M, 2007, J HOSP INFECT, V66, P92, DOI 10.1016/j.jhin.2007.03.002.
   Friedman M, 2000, J AGR FOOD CHEM, V48, P5702, DOI 10.1021/jf000585g.
   Giamarellou H, 2008, INT J ANTIMICROB AG, V32, P106, DOI 10.1016/j.ijantimicag.2008.02.013.
   Goni P, 2009, FOOD CHEM, V116, P982, DOI 10.1016/j.foodchem.2009.03.058.
   Holley RA, 2005, FOOD MICROBIOL, V22, P273, DOI 10.1016/j.fm.2004.08.006.
   Kordali S, 2005, J AGR FOOD CHEM, V53, P9452, DOI 10.1021/jf0516538.
   Lee NY, 2007, INFECT CONT HOSP EP, V28, P713, DOI 10.1086/517954.
   Lopez P, 2005, J AGR FOOD CHEM, V53, P6939, DOI 10.1021/jf050709v.
   Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198.
   Nedorostova L, 2009, FOOD CONTROL, V20, P157, DOI 10.1016/j.foodcont.2008.03.007.
   Penalver P, 2005, APMIS, V113, P1, DOI 10.1111/j.1600-0463.2005.apm1130101.x.
   Pezo D, 2006, ANAL BIOANAL CHEM, V385, P1241, DOI 10.1007/s00216-006-0395-4.
   Tripathi P, 2004, POSTHARVEST BIOL TEC, V32, P235, DOI 10.1016/j.postharvbio.2003.11.005.}},
Number-of-Cited-References = {{18}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{18}},
Journal-ISO = {{J. Essent. Oil Bear. Plants.}},
Doc-Delivery-Number = {{179KU}},
Unique-ID = {{ISI:000321520000008}},
DA = {{2018-08-13}},
}

@article{ ISI:000307699200011,
Author = {Daskalov, Hristo and Maramski, Alexander},
Title = {{Prevalence and factors affecting the presence of Campylobacter spp. in
   broiler carcasses in Bulgaria}},
Journal = {{TURKISH JOURNAL OF VETERINARY \& ANIMAL SCIENCES}},
Year = {{2012}},
Volume = {{36}},
Number = {{5}},
Pages = {{539-545}},
Abstract = {{In an 11-month study, 292 samples from 13 slaughterhouses in Bulgaria
   were investigated for the presence of Campylobacter spp., and some
   factors affecting Campylobacter prevalence were analyzed. The study
   revealed that 44.9\% of the samples were positive for Campylobacter spp.
   The main species detected were C. coli and C. jejuni. There was also one
   confirmed C. lari isolate. The C. coli strains prevailed over C. jejuni
   at 61.8\% and 37.4\%, respectively. A seasonal variation in the
   Campylobacter spp. presence in slaughter broiler carcasses was found
   with a predominance of positive isolates during June and July 2008. The
   conventional type of rearing was responsible for higher Campylobacter
   contamination (52.2\%) of broiler carcasses compared to free-range
   rearing (38.5\%). The impact of the chilling technology (spray,
   immersion, or air-chilling) on the Campylobacter presence in broiler
   carcasses was also analyzed.}},
Publisher = {{SCIENTIFIC TECHNICAL RESEARCH COUNCIL TURKEY-TUBITAK}},
Address = {{ATATURK BULVARI NO 221, KAVAKLIDERE, TR-06100 ANKARA, TURKEY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Daskalov, H (Reprint Author), Natl Diagnost \& Res Vet Inst, Natl Reference Ctr Food Safety, Natl Reference Lab, Blvd Pencho Slaveykov 15, Sofia 1606, Bulgaria.
   Daskalov, Hristo; Maramski, Alexander, Natl Diagnost \& Res Vet Inst, Natl Reference Ctr Food Safety, Natl Reference Lab, Sofia 1606, Bulgaria.}},
DOI = {{10.3906/vet-1102-788}},
ISSN = {{1300-0128}},
Keywords = {{Campylobacter spp.; broilers; Campylobacter prevalence; type of rearing}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; POULTRY; JEJUNI; MEAT;
   HUMANS; EPIDEMIOLOGY; INFECTION; PRODUCTS; ANIMALS}},
Research-Areas = {{Veterinary Sciences}},
Web-of-Science-Categories  = {{Veterinary Sciences}},
Author-Email = {{hdaskal@yahoo.com}},
Funding-Acknowledgement = {{National Veterinary Service of Bulgaria}},
Funding-Text = {{We are grateful to the Commission Decision from 18 July, notification
   number C (2007) 3440 2007/516/EO, and the National Veterinary Service of
   Bulgaria for financial support. This article is part of a research work
   that was carried out in accordance with a baseline study concerning the
   prevalence of Salmonella and Campylobacter spp. in broiler carcasses in
   European countries. We highly appreciate the competent support of our
   colleagues from the CRL ``Campylobacter{''}, National Veterinary
   Institute, Uppsala, Sweden.}},
Cited-References = {{{[}Anonymous], 2010, EFSA J, V8, P1496.
   {[}Anonymous], 2010, EFSA J, V8, P1503.
   Boyanova L, 2004, DIAGN MICR INFEC DIS, V49, P71, DOI 10.1016/j.diagmicrobio.2003.12.004.
   BRYAN FL, 1995, J FOOD PROTECT, V58, P326, DOI 10.4315/0362-028X-58.3.326.
   Cardinale E, 2006, J APPL MICROBIOL, V100, P209, DOI 10.1111/j.1365-2672.2005.02763.x.
   Dasti JI, 2007, J MED MICROBIOL, V56, P833, DOI 10.1099/jmm.0.47103-0.
   EFSA, 2009, EFSA J, V7, P223.
   French NP, 2009, APPL ENVIRON MICROB, V75, P779, DOI 10.1128/AEM.01979-08.
   Gavrila G., 2005, Revista Romana de Medicina Veterinara, V15, P71.
   Heuer OE, 2001, LETT APPL MICROBIOL, V33, P269, DOI 10.1046/j.1472-765X.2001.00994.x.
   Hussain I., 2006, J FOOD MICROBIOL, V24, P219.
   International Standards Organization, 2006, 102721 ISO.
   Ishihara K, 2006, J APPL MICROBIOL, V100, P153, DOI 10.1111/j.1365-2672.2005.02769.x.
   Louis VR, 2005, APPL ENVIRON MICROB, V71, P85, DOI {[}10.1128/AEM.71.1.85-92.2005, 10.1120/AEM.71.1.85-92.2005].
   Moore JE, 2006, MICROBES INFECT, V8, P1955, DOI 10.1016/j.micinf.2005.12.030.
   Nachamkin I., 2000, FOOD MICROBIOLOGY FU, P179.
   Nauta M, 2009, INT J FOOD MICROBIOL, V129, P107, DOI 10.1016/j.ijfoodmicro.2008.12.001.
   Nylen G, 2002, EPIDEMIOL INFECT, V128, P383, DOI 10.1017/S0950268802006830.
   Padungton P, 2003, J VET MED SCI, V65, P161, DOI 10.1292/jvms.65.161.
   Saenz Y, 2000, ANTIMICROB AGENTS CH, V44, P267, DOI 10.1128/AAC.44.2.267-271.2000.
   Saito S, 2005, FEMS IMMUNOL MED MIC, V45, P311, DOI 10.1016/j.femsim.2005.05.006.
   Son I, 2007, INT J FOOD MICROBIOL, V113, P16, DOI 10.1016/j.ijfoodmicro.2006.06.033.
   Stern NJ, 2001, J FOOD PROTECT, V64, P1705, DOI 10.4315/0362-028X-64.11.1705.
   Stoyanchev T, 2007, ANTON LEEUW INT J G, V92, P285, DOI 10.1007/s10482-007-9154-6.
   Takahashi R, 2006, INT J FOOD MICROBIOL, V110, P240, DOI 10.1016/j.ijfoodmicro.2006.04.043.
   Taremi M, 2006, INT J FOOD MICROBIOL, V108, P401, DOI 10.1016/j.ijfoodmicro.2005.12.010.
   Vandamme P, 2005, BERGEYS MANUAL SYSTE, V2, P1147.
   Vashin I. T., 2004, Bulgarian Journal of Veterinary Medicine, V7, P173.
   Wassenaar TM, 2000, APPL ENVIRON MICROB, V66, P1, DOI 10.1128/AEM.66.1.1-9.2000.
   Weiland B., 2006, J APPL MICROBIOL, V100, P316.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{Turk. J. Vet. Anim. Sci.}},
Doc-Delivery-Number = {{991KF}},
Unique-ID = {{ISI:000307699200011}},
DA = {{2018-08-13}},
}

@article{ ISI:000306505500038,
Author = {Bulard, Emilie and Fontaine-Aupart, Marie-Pierre and Dubost, Henri and
   Zheng, Wanquan and Herry, Jean-Marie and Bellon-Fontaine, Marie-Noelle
   and Briandet, Romain and Bourguignon, Bernard},
Title = {{The Effect of Bacterial Adhesion on Grafted Chains Revealed by the
   Non-Invasive Sum Frequency Generation Spectroscopy}},
Journal = {{SPECTROSCOPY-AN INTERNATIONAL JOURNAL}},
Year = {{2012}},
Volume = {{27}},
Number = {{5-6}},
Pages = {{571-579}},
Abstract = {{In biomedical and food industry, surface colonization by bacteria is
   harmful: it leads to biofilm formation, a microbial consortia more
   resistant to antibiotics than planktonic bacteria. In order to design
   materials able to limit the biofilm formation, the effect of bacteria on
   materials has to be well characterized. In this work, a well-defined
   surface composed of a self-assembled monolayer (SAM) of octadecanethiol
   (ODT) onto a gold surface is probed in situ. The SAM conformation is
   obtained using the femtosecond vibrational sum frequency generation
   (SFG) spectroscopy. This technique provides selectively the molecular
   vibrational signature of the interface. The behaviour of the ODT SAM is
   studied in different environments: in air, in water, and upon exposure
   to hydrophilic or hydrophobic Lactococcus lactis bacteria. Modelling the
   experimental SFG spectra reveals a measurable change of the SAM
   conformation which depends on the environment, especially on the
   hydrophilic-hydrophobic character.}},
Publisher = {{HINDAWI LTD}},
Address = {{ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Bulard, E (Reprint Author), Univ Paris 11, CNRS, ISMO, Bat 425, F-91405 Orsay, France.
   Bulard, Emilie; Fontaine-Aupart, Marie-Pierre; Dubost, Henri; Zheng, Wanquan; Bourguignon, Bernard, Univ Paris 11, CNRS, ISMO, F-91405 Orsay, France.
   Herry, Jean-Marie; Bellon-Fontaine, Marie-Noelle; Briandet, Romain, INRA AgroParisTech, UMR 1319, F-91300 Micalis, Massy, France.}},
DOI = {{10.1155/2012/682591}},
ISSN = {{0712-4813}},
Keywords = {{Bacterial adhesion; SFG spectroscopy; surface; self-assembled
   monolayers; molecular conformation}},
Keywords-Plus = {{LACTOCOCCUS-LACTIS; SURFACES; BIOFILMS; PROTEIN}},
Research-Areas = {{Biochemistry \& Molecular Biology; Spectroscopy}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Spectroscopy}},
Author-Email = {{emilie.bulard@u-psud.fr}},
ORCID-Numbers = {{briandet, romain/0000-0002-8123-3492}},
Cited-References = {{An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B.
   Boonaert CJP, 2001, COLLOID SURFACE B, V22, P171, DOI 10.1016/S0927-7765(01)00196-5.
   Bourguignon B, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125433.
   Bulard E, 2011, LANGMUIR, V27, P4928, DOI 10.1021/la200205e.
   Busson B, 2009, J PHYS CHEM C, V113, P21895, DOI 10.1021/jp908240d.
   Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958.
   Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041.
   Chottard J.-C., 1995, CHIMIE FONDAMENTALE.
   Habimana O, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-36.
   Howell C, 2008, LANGMUIR, V24, P13819, DOI 10.1021/la8027463.
   Koffas TS, 2003, LANGMUIR, V19, P3563, DOI 10.1021/la027041o.
   Lindsay D, 2006, J HOSP INFECT, V64, P313, DOI 10.1016/j.jhin.2006.06.028.
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014.
   Sivakumar PM, 2010, APPL SURF SCI, V256, P6018, DOI 10.1016/j.apsusc.2010.03.112.
   Speranza G, 2004, BIOMATERIALS, V25, P2029, DOI 10.1016/j.biomaterials.2003.08.061.
   Wang J, 2002, J PHYS CHEM B, V106, P11666, DOI 10.1021/jp021363j.
   WIENCEK KM, 1995, J BACTERIOL, V177, P1959, DOI 10.1128/jb.177.8.1959-1966.1995.
   Wong ACL, 1998, J DAIRY SCI, V81, P2765.}},
Number-of-Cited-References = {{18}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{14}},
Journal-ISO = {{Spectr.-Int. J.}},
Doc-Delivery-Number = {{975IR}},
Unique-ID = {{ISI:000306505500038}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000304799600010,
Author = {Narvaez, V, Jhon F. and Jimenez C, Claudio},
Title = {{PHARMACEUTICAL PRODUCTS IN THE ENVIRONMENT: SOURCES, EFFECTS AND RISKS}},
Journal = {{VITAE-REVISTA DE LA FACULTAD DE QUIMICA FARMACEUTICA}},
Year = {{2012}},
Volume = {{19}},
Number = {{1}},
Pages = {{93-108}},
Abstract = {{Pharmaceuticals and personal care products have become an environmental
   problem in recent years. Their physicochemical properties and
   persistence in the environment have allowed the distribution of
   degradates and parent compounds in water, soil, air and food. The
   widespread use of pharmaceuticals and personal care products in
   hospitals, domestic residences, agricultural and industrial facilities
   has increased their discharge into the water bodies, and its toxicity
   has started to manifest in different biological components of
   ecosystems. The development of methods for sample treatment and
   instrumental analysis techniques has enabled the separation,
   identification and quantification of active ingredients and degradates
   with higher environmental impact, at concentrations of parts per billion
   or even parts per trillion. In addition, in vitro and in vivo assays
   have demonstrated their ecotoxicity in water, driving them to the
   classification of emerging organic pollutants, whose waste is
   indeterminate. Although their adverse effects are still unknown, they
   could have strong implications for global public health. This review
   presents the dynamics and the development of research over the past ten
   years about the presence of non-steroidal anti-inflammatory analgesics,
   antihypertensives, antibiotics and other drugs in water bodies.
   Similarly, it described the impact of pharmaceutical activity, hospital
   services and domestic effluents on water quality.}},
Publisher = {{UNIV ANTIOQUIA, FAC QUIMICA FARMACEUTICA}},
Address = {{INST FILOSOFIA, DEPT BIBLIOTECAS SECCION CANJE, CALLE 67 53- 108 BLOQUE
   2 OFICINA 127, MEDELLIN, 00000, COLOMBIA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Jimenez, C (Reprint Author), Corp Univ Lasallista, Grp Invest Aplicada Medio Ambiente GAMA, Fac Ingn, Caldas, Colombia.
   Jimenez C, Claudio, Corp Univ Lasallista, Grp Invest Aplicada Medio Ambiente GAMA, Fac Ingn, Caldas, Colombia.
   Narvaez, Jhon F., V, Univ Antioquia, Grp Invest Gest \& Modelac Ambiental GAIA, Fac Ingn, Medellin 1226, Colombia.}},
ISSN = {{0121-4004}},
Keywords = {{Toxicity tests; environmental pollutants; organic pollutants;
   analgesics; pharmaceuticals and personal care products}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; PERSONAL-CARE PRODUCTS; SOLID-PHASE
   EXTRACTION; PERFORMANCE LIQUID-CHROMATOGRAPHY; MONOLITHIC SILICA
   COLUMNS; WATER TREATMENT PLANTS; MUNICIPAL WASTE-WATER;
   ANTIBIOTIC-RESISTANCE; SURFACE WATERS; EMERGING CONTAMINANTS}},
Author-Email = {{clajimenez@lasallistadocentes.edu.co}},
Funding-Acknowledgement = {{Lasallian Research System (SIL) of the Coorporacion Lasallista
   (Colombia)}},
Funding-Text = {{This research was funded by Lasallian Research System (SIL) of the
   Coorporacion Lasallista (Colombia). The authors thanks to PhD Jaime
   Alberto Palacio Baena for his advices about ecotoxicological topics, and
   GAIA group.}},
Cited-References = {{Akinbowale O, 2007, INT J ANTIMICROB AG, V29, pS113, DOI 10.1016/S0924-8579(07)70357-6.
   Baatrup E, 2008, AQUAT TOXICOL, V87, P234.
   Baillie TA, 2002, TOXICOL APPL PHARM, V182, P188, DOI 10.1006/taap.2002.9440.
   Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006.
   Batt AL, 2008, ANAL CHEM, V80, P5021, DOI 10.1021/ac800066n.
   Benet LZ, 2001, ADV DRUG DELIVER REV, V50, pS3, DOI 10.1016/S0169-409X(01)00178-8.
   Bjorkblom C, 2007, COMP BIOCHEM PHYS C, V146, P431, DOI 10.1016/j.cbpc.2007.05.004.
   Boudou Alain, 1997, Environmental Health Perspectives, V105, P21, DOI 10.2307/3433395.
   Brooks BW, 2003, TOXICOL LETT, V142, P169, DOI 10.1016/S0378-4274(03)00066-3.
   Brown KD, 2006, SCI TOTAL ENVIRON, V366, P772, DOI 10.1016/j.scitotenv.2005.10.007.
   Buerge IJ, 2006, ENVIRON SCI TECHNOL, V40, P7242, DOI 10.1021/es0609405.
   Buser HR, 1999, ENVIRON SCI TECHNOL, V33, P2529, DOI 10.1021/es981014w.
   Caliman FA, 2009, CLEAN-SOIL AIR WATER, V37, P277, DOI 10.1002/clen.200900038.
   Celiz MD, 2009, ENVIRON TOXICOL CHEM, V28, P2473, DOI 10.1897/09-173.1.
   Cleuvers M, 2003, TOXICOL LETT, V142, P185, DOI 10.1016/S0378-4274(03)00068-7.
   Costanzo SD, 2005, MAR POLLUT BULL, V51, P218, DOI 10.1016/j.marpolbul.2004.10.038.
   Cunliffe JM, 2007, J SEP SCI, V30, P3104, DOI 10.1002/jssc.200700260.
   Dang H, 2007, J APPL MICROBIOL, V103, P2580, DOI 10.1111/j.1365-2672.2007.03494.x.
   Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573.
   Dejaegher B, 2008, J SEP SCI, V31, P1438, DOI 10.1002/jssc.200700680.
   Dejaegher B, 2010, COMB CHEM HIGH T SCR, V13, P530, DOI 10.2174/138620710791516030.
   Dejaegher B, 2010, J SEP SCI, V33, P698, DOI 10.1002/jssc.200900742.
   Ding J, 2009, ANAL CHIM ACTA, V634, P215, DOI 10.1016/j.aca.2008.12.022.
   Ellis JB, 2006, ENVIRON POLLUT, V144, P184, DOI 10.1016/j.envpol.2005.12.018.
   Epel D, 1998, COMP BIOCHEM PHYS A, V120, P23, DOI 10.1016/S1095-6433(98)10005-3.
   Farre ML, 2001, J CHROMATOGR A, V938, P187, DOI 10.1016/S0021-9673(01)01154-2.
   FDA, 1998, GUID IND ENV ASS HUM.
   Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009.
   Ferrari B, 2003, ECOTOX ENVIRON SAFE, V55, P359, DOI 10.1016/S0147-6513(02)00082-9.
   Food and DrugAdministration (FDA), 1998, FDA MOD ACT 1997 GUI.
   Gallart-Ayala H, 2010, J CHROMATOGR A, V1217, P3511, DOI 10.1016/j.chroma.2010.03.028.
   Garcia-Ac A, 2009, J ENVIRON MONITOR, V11, P830, DOI 10.1039/b817570e.
   Giudice R, 2004, ENVIRON TOXICOL CHEM, V23, P1344.
   Gomez MJ, 2006, J CHROMATOGR A, V1114, P224, DOI 10.1016/j.chroma.2006.02.038.
   Granelli K, 2009, ANAL CHIM ACTA, V637, P87, DOI 10.1016/j.aca.2008.08.025.
   Greibrokk T, 2003, J CHROMATOGR A, V1000, P743, DOI 10.1016/S0021-9673(02)01963-5.
   Gritti F, 2010, J CHROMATOGR A, V1217, P1589, DOI 10.1016/j.chroma.2009.12.079.
   Grung M, 2007, CHEMOSPHERE, V67, P108, DOI 10.1016/j.chemosphere.2006.09.021.
   Guardabassi L, 1998, APPL ENVIRON MICROB, V64, P3499.
   GUARINO AM, 1986, VET HUM TOXICOL, V28, P38.
   Gulkowska A, 2008, WATER RES, V42, P395, DOI 10.1016/j.watres.2007.07.031.
   Halling-Sorensen B, 1998, CHEMOSPHERE, V36, P357, DOI 10.1016/S0045-6535(97)00354-8.
   Han GH, 2006, ENVIRON TOXICOL CHEM, V25, P265, DOI 10.1897/05-193R.1.
   Hansen PD, 2008, ENG LIFE SCI, V8, P26, DOI 10.1002/elsc.200720228.
   Hartonen K, 2008, TRAC-TREND ANAL CHEM, V27, P1, DOI 10.1016/j.trac.2007.10.010.
   He J, 1997, MED CLIN N AM, V81, P1077, DOI 10.1016/S0025-7125(05)70568-X.
   Heberer T, 2002, J HYDROL, V266, P175, DOI 10.1016/S0022-1694(02)00165-8.
   Henschel KP, 1997, REGUL TOXICOL PHARM, V25, P220, DOI 10.1006/rtph.1997.1102.
   Hernando MD, 2004, J CHROMATOGR A, V1046, P133, DOI 10.1016/j.chroma.2004.06.102.
   Hummel D, 2006, ENVIRON SCI TECHNOL, V40, P7321, DOI 10.1021/es061740w.
   Hutchinson TH, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI 10.1289/ehp.8062.
   Ishizuka N, 2002, J CHROMATOGR A, V960, P85, DOI 10.1016/S0021-9673(01)01580-1.
   JAMES MO, 1986, VET HUM TOXICOL, V28, P2.
   Jimenez C, 2009, VITAE-COLUMBIA, V16, P144.
   Jjemba PK, 2008, PHARM ECOLOGY OCCURR.
   Keith CH, 1976, IDENTIFICATION ANAL, P517.
   Khachatourians GG, 1998, CAN MED ASSOC J, V159, P1129.
   Kloas W, 1999, SCI TOTAL ENVIRON, V225, P59, DOI 10.1016/S0048-9697(98)00332-5.
   Kloas W, 2009, ANN NY ACAD SCI, V1163, P187, DOI 10.1111/j.1749-6632.2009.04453.x.
   Kloskowski R, 2000, P 11 S PEST CHEM SEP, P835.
   Ko WC, 1996, ANTIMICROB AGENTS CH, V40, P1260.
   Koger CS, 2000, MAR ENVIRON RES, V50, P201, DOI 10.1016/S0141-1136(00)00068-4.
   Kummerer K, 2009, J ENVIRON MANAGE, V90, P2354, DOI 10.1016/j.jenvman.2009.01.023.
   KULKARNI GK, 1992, INVERTEBR REPROD DEV, V21, P231, DOI 10.1080/07924259.1992.9672242.
   Kumar A, 2005, ADV DRUG DELIVER REV, V57, P1486, DOI 10.1016/j.addr.2005.04.004.
   Kummerer K, 2008, PHARM ENV SOURCES FA.
   Kummerer K, 2008, PHARM ENV SOURCES FA.
   KURELEC B, 1992, CRIT REV TOXICOL, V22, P23, DOI 10.3109/10408449209145320.
   Lajeunesse A, 2008, ANAL CHEM, V80, P5325, DOI 10.1021/ac800162q.
   Lambert PA, 2005, ADV DRUG DELIVER REV, V57, P1471, DOI 10.1016/j.addr.2005.04.003.
   Lange R, 2001, ENVIRON TOXICOL CHEM, V20, P1216, DOI 10.1897/1551-5028(2001)020<1216:EOTSEE>2.0.CO;2.
   Langford KH, 2009, ENVIRON INT, V35, P766, DOI 10.1016/j.envint.2009.02.007.
   Li B, 2009, ANAL CHIM ACTA, V645, P64, DOI 10.1016/j.aca.2009.04.042.
   Li D, 2008, WATER RES, V42, P307, DOI 10.1016/j.watres.2007.07.016.
   LILIUS H, 1995, ENVIRON TOXICOL CHEM, V14, P2085, DOI 10.1897/1552-8618(1995)14{[}2085:ACOTTO]2.0.CO;2.
   Lin AYC, 2009, SCI TOTAL ENVIRON, V407, P3793, DOI 10.1016/j.scitotenv.2009.03.009.
   Liu GW, 2009, ANAL CHEM, V81, P9225, DOI 10.1021/ac901316w.
   Loffler D, 2003, J CHROMATOGR A, V1000, P583, DOI 10.1016/S0021-9673(03)00059-1.
   Mascolo G, 2009, BIORESOURCE TECHNOL, V101, P2585.
   Michels D, 1999, REV GLOB COMP PHARM.
   Miege C, 2006, TALANTA, V70, P739, DOI 10.1016/j.talanta.2006.07.002.
   {*}MIN SAN CONS, 2004, INF TER SIST NAL SAL, V28, P121.
   Mompelat S, 2009, ENVIRON INT, V35, P803, DOI 10.1016/j.envint.2008.10.008.
   Motokawa M, 2002, J CHROMATOGR A, V961, P53, DOI 10.1016/S0021-9673(02)00133-4.
   Nakata H, 2005, CHEMOSPHERE, V58, P759, DOI 10.1016/j.chemosphere.2004.08.097.
   Nalecz-Jawecki G, 2006, ENVIRON SCI POLLUT R, V13, P22, DOI 10.1065/espr2006.01.005.
   Novakova L, 2009, ANAL CHIM ACTA, V656, P8, DOI 10.1016/j.aca.2009.10.004.
   Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317.
   OECD (Organisation for Economic Co-operation and Development), 2009, GUID DOC DEV OECD GU.
   Oetken M, 2005, ARCH ENVIRON CON TOX, V49, P353, DOI 10.1007/s00244-004-0211-0.
   Onesios KM, 2009, BIODEGRADATION, V20, P441, DOI 10.1007/s10532-008-9237-8.
   Pailler JY, 2009, SCI TOTAL ENVIRON, V407, P4736, DOI 10.1016/j.scitotenv.2009.04.042.
   Petrovic M, 2007, ANAL FATE REMOVAL PH.
   Petrovic M, 2007, ANAL FATE REMOVAL PH.
   Pettersson I, 2007, ENVIRON TOXICOL CHEM, V26, P1005, DOI 10.1897/06-464R.1.
   Pietrogrande MC, 2007, TRAC-TREND ANAL CHEM, V26, P1086, DOI 10.1016/j.trac.2007.09.013.
   Portoles T, 2009, J AGR FOOD CHEM, V57, P4079, DOI 10.1021/jf900099u.
   Quinn B, 2009, SCI TOTAL ENVIRON, V407, P1072, DOI 10.1016/j.scitotenv.2008.10.022.
   Quinn B, 2008, SCI TOTAL ENVIRON, V389, P306, DOI 10.1016/j.scitotenv.2007.08.038.
   Radjenovic J, 2009, ANAL BIOANAL CHEM, V393, P1685, DOI 10.1007/s00216-009-2604-4.
   Rahman S, 2007, J ENV HLTH, V6, P20.
   RICHARDSON ML, 1985, J PHARM PHARMACOL, V37, P1, DOI 10.1111/j.2042-7158.1985.tb04922.x.
   Richardson SD, 2008, ANAL CHEM, V80, P4373, DOI 10.1021/ac800660d.
   Richardson SD, 2006, ANAL CHEM, V78, P4021, DOI 10.1021/ac060682u.
   Richardson SD, 2010, ANAL CHEM, V82, P4742, DOI 10.1021/ac101102d.
   Richardson SD, 2009, ANAL CHEM, V81, P4645, DOI 10.1021/ac9008012.
   Roberts MC, 1999, ANTIMICROB AGENTS CH, V43, P2823.
   Rogers R, 1998, CHEM ENG NEWS, V30, P11.
   Rosal R, 2010, WATER RES, V44, P578, DOI 10.1016/j.watres.2009.07.004.
   Roy A, 2010, MACROMOLECULES, V43, P3710, DOI 10.1021/ma100010e.
   Sanchez-Arguello P, 2009, SCI TOTAL ENVIRON, V407, P1937, DOI 10.1016/j.scitotenv.2008.12.004.
   Santos JL, 2009, J HAZARD MATER, V164, P1509, DOI 10.1016/j.jhazmat.2008.09.073.
   Segura PA, 2007, J ENVIRON MONITOR, V9, P307, DOI 10.1039/b618801j.
   Shakil S, 2008, J BIOMED SCI, V15, P5, DOI 10.1007/s11373-007-9194-y.
   Soge OO, 2009, J APPL MICROBIOL, V106, P34, DOI 10.1111/j.1365-2672.2008.03960.x.
   Stulten D, 2008, SCI TOTAL ENVIRON, V405, P310, DOI 10.1016/j.scitotenv.2008.05.036.
   Stumpf M., 1996, WASSER, V86, P291.
   Ternes T, 2001, J CHROMATOGR A, V938, P175, DOI 10.1016/S0021-9673(01)01205-5.
   Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2.
   TERNES TA, 1998, WASSER, V90, P295.
   Tixier C, 2003, ENVIRON SCI TECHNOL, V37, P1061, DOI 10.1021/es025834r.
   Tsai PS, 2003, GEN COMP ENDOCR, V134, P330, DOI 10.1016/j.ygcen.2003.07.001.
   VanGerven JMA, 1996, BRIT J CLIN PHARMACO, V42, P475, DOI 10.1111/j.1365-2125.1996.tb00011.x.
   Welch CJ, 2010, TRAC-TREND ANAL CHEM, V29, P667, DOI 10.1016/j.trac.2010.03.008.
   WITSCHI E, 1950, ANAT REC, V108, P589.
   Wright GD, 2005, ADV DRUG DELIVER REV, V57, P1451, DOI 10.1016/j.addr.2005.04.002.
   Wu NJ, 2000, J MICROCOLUMN SEP, V12, P462, DOI 10.1002/1520-667X(2000)12:8<462::AID-MCS5>3.0.CO;2-F.
   Ying GG, 2002, ENVIRON INT, V28, P545, DOI 10.1016/S0160-4120(02)00075-2.
   Zarrilli R, 2005, J ANTIMICROB CHEMOTH, V56, P827, DOI 10.1093/jac/dki347.
   Zhou JL, 2009, J HAZARD MATER, V166, P655, DOI 10.1016/j.jhazmat.2008.11.070.
   Zorita S, 2008, ANAL CHIM ACTA, V626, P147, DOI 10.1016/j.aca.2008.07.051.}},
Number-of-Cited-References = {{131}},
Times-Cited = {{8}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{80}},
Journal-ISO = {{Vitae}},
Doc-Delivery-Number = {{952NQ}},
Unique-ID = {{ISI:000304799600010}},
DA = {{2018-08-13}},
}

@article{ ISI:000303242100003,
Author = {Vreuls, C. and Zocchi, G. and Vandegaart, H. and Faure, E. and
   Detrembleur, C. and Duwez, Anne-Sophie and Martial, J. and De Weerdt, C.
   Van},
Title = {{Biomolecule-based antibacterial coating on a stainless steel surface:
   multilayer film build-up optimization and stability study}},
Journal = {{BIOFOULING}},
Year = {{2012}},
Volume = {{28}},
Number = {{4}},
Pages = {{395-404}},
Abstract = {{The goal of this paper was to establish the durability profile of
   antibacterial multilayer thin films under storage and usage conditions.
   Thin films were built on stainless steel (SS) by means of a
   layer-by-layer process alternating a negatively charged polyelectrolyte,
   polyacrylic acid, with a cationic antibacterial peptide, nisin. SS
   coupons coated with the antibacterial film were challenged under
   environmental and usage conditions likely to be encountered in
   real-world applications. The change in antibacterial activity elicited
   by the challenge was used as an indicator of multilayer film resistance.
   Antibacterial SS samples could be stored for several weeks at 4 degrees
   C in ambient air and antibacterial films were resistant to dipping and
   mild wiping in water and neutral detergent. The multilayer coating
   showed some weaknesses, however, that need to be addressed.}},
Publisher = {{TAYLOR \& FRANCIS LTD}},
Address = {{4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Vreuls, C (Reprint Author), Univ Liege, GIGA R, Liege, Belgium.
   Vreuls, C.; Zocchi, G.; Vandegaart, H.; Martial, J.; De Weerdt, C. Van, Univ Liege, GIGA R, Liege, Belgium.
   Faure, E.; Detrembleur, C., Univ Liege, CERM, Liege, Belgium.
   Duwez, Anne-Sophie, Univ Liege, Nanochem \& Mol Syst NANOCHEM, Liege, Belgium.}},
DOI = {{10.1080/08927014.2012.681304}},
ISSN = {{0892-7014}},
Keywords = {{polyelectrolyte multilayer films; polyelectrolyte complexes;
   antibacterial peptides; stainless steel; durability; stability}},
Keywords-Plus = {{POLYELECTROLYTE MULTILAYERS; NANOPARTICLES; PROTECTION; COMPLEXES}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Marine \& Freshwater Biology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Marine \& Freshwater Biology}},
Author-Email = {{C.Vreuls@ulg.ac.be}},
ResearcherID-Numbers = {{Detrembleur, Christophe/D-7079-2011
   }},
ORCID-Numbers = {{Detrembleur, Christophe/0000-0001-7849-6796
   Duwez, Anne-Sophie/0000-0003-1594-2271}},
Funding-Acknowledgement = {{Walloon Region (PPP)}},
Funding-Text = {{This research was partly supported by the Walloon Region (PPP program
   Biocoat). The authors thank the Biocoat team members for their
   contributions, particularly Fabrice Farina (Advanced Coatings and
   Construction Solutions, CRM Group, Liege, Belgium) for providing SS
   coupons, Emilie Faure (Centre d'Etude et de Recherche sur les
   Macromolecules, University of Liege, Belgium) for sharing the
   P(DOPA)-co-P(DMAEMA+) copolymer, GIGA-R, the Systems Biology and
   Chemical Biology Unit (University of Liege, Belgium), and the Centre
   d'Ingenierie des Proteines (University of Liege, Belgium) for sharing
   the B. subtilis 168 strain.}},
Cited-References = {{Ariga K, 2007, CURR OPIN COLLOID IN, V12, P106, DOI 10.1016/j.cocis.2007.05.008.
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039.
   Charlot A, 2009, J MATER CHEM, V19, P4117, DOI 10.1039/b820832h.
   Chollet C, 2007, BIOMOL ENG, V24, P477, DOI 10.1016/j.bioeng.2007.07.012.
   Chua PH, 2008, J BIOMED MATER RES A, V87A, P1061, DOI 10.1002/jbm.a.31854.
   Dai XH, 2005, THIN SOLID FILMS, V474, P159, DOI 10.1016/j.tsf.2004.08.084.
   Etienne O, 2005, BIOMATERIALS, V26, P6704, DOI 10.1016/j.biomaterials.2005.04.068.
   Etienne O, 2004, ANTIMICROB AGENTS CH, V48, P3662, DOI 10.1128/AAC.48.10.3662-3669.2004.
   Guyomard A, 2008, ADV FUNCT MATER, V18, P758, DOI 10.1002/adfm.200700793.
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821.
   Humblot V, 2009, BIOMATERIALS, V30, P3503, DOI 10.1016/j.biomaterials.2009.03.025.
   Klibanov AM, 2007, J MATER CHEM, V17, P2479, DOI 10.1039/b702079a.
   Laugel N, 2006, J PHYS CHEM B, V110, P19443, DOI 10.1021/jp062264z.
   Lichter JA, 2008, BIOMACROMOLECULES, V9, P2967, DOI 10.1021/bm8009335.
   Lichter JA, 2009, MACROMOLECULES, V42, P8573, DOI 10.1021/ma901356s.
   Malcher M, 2008, LANGMUIR, V24, P10209, DOI 10.1021/la8014755.
   Mjahed H, 2010, J COLLOID INTERF SCI, V346, P163, DOI 10.1016/j.jcis.2010.02.042.
   Nuraje N, 2011, LANGMUIR, V27, P782, DOI 10.1021/la103754a.
   Podsiadlo P, 2005, LANGMUIR, V21, P11915, DOI 10.1021/la051284+.
   Podsiadlo P, 2008, NANO LETT, V8, P172.
   Podsiadlo P, 2009, COORDIN CHEM REV, V253, P2835, DOI 10.1016/j.ccr.2009.09.004.
   Rudra JS, 2006, J BIOMAT SCI-POLYM E, V17, P1301, DOI 10.1163/156856206778667433.
   Schlenoff JB, 2009, LANGMUIR, V25, P14007, DOI 10.1021/la901950c.
   Schneider A, 2007, BIOMACROMOLECULES, V8, P139, DOI 10.1021/bm060765k.
   Srivastava S, 2008, ACCOUNTS CHEM RES, V41, P1831, DOI 10.1021/ar8001377.
   Su YL, 2008, APPL SURF SCI, V254, P2003, DOI 10.1016/j.apsusc.2007.08.028.
   Sukhishvili SA, 2006, MACROMOLECULES, V39, P8873, DOI 10.1021/ma061617p.
   Thompson MT, 2006, BIOMACROMOLECULES, V7, P1990, DOI 10.1021/bm060146b.
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098.
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI 10.1586/ERD.09.36.
   Vodouhe C, 2006, BIOMATERIALS, V27, P4149, DOI 10.1016/j.biomaterials.2006.03.024.
   Vreuls C, 2010, BIOFOULING, V26, P645, DOI 10.1080/08927014.2010.506678.
   Yoo D, 1998, MACROMOLECULES, V31, P4309, DOI 10.1021/ma9800360.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{2}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{20}},
Journal-ISO = {{Biofouling}},
Doc-Delivery-Number = {{931TL}},
Unique-ID = {{ISI:000303242100003}},
DA = {{2018-08-13}},
}

@article{ ISI:000302492100013,
Author = {Gregova, Gabriela and Kmetova, Marta and Kmet, Vladimir and Venglovsky,
   Jan and Feher, Alexander},
Title = {{Antibiotic resistance of Escherichia coli isolated from a poultry
   slaughterhouse}},
Journal = {{ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE}},
Year = {{2012}},
Volume = {{19}},
Number = {{1}},
Pages = {{75-77}},
Abstract = {{The aim of the study was to investigate the antibiotic resistant E. coli
   strains isolated from bioaerosols and surface swabs in a slaughterhouse
   as a possible source of poultry meat contamination. The highest air
   coliforms contamination was during shackling, killing and evisceration
   of poultry. The strains showed resistance to ampicillin (89\%),
   ceftiofur (62\%) and cefquinome (22\%), while resistance to ampicillin
   with sulbactam was only 6\%. Resistance to streptomycin and gentamicin
   was detected in 43\% vs. 14\% isolates; to tetracycline 33\%; to
   chloramphenicol and florfenicol in 10\% vs. 18\% isolates; to
   cotrimoxazol in 35\% isolates; to enrofloxacin in 43\% isolates. The
   higher MIC of ceftazidime (3.6 mg.l(-1)) and ceftriaxon (5.2 mg.l(-1))
   revealed the presence of ESBLs in 43\% of isolates. From 19 selected
   phenotypically ESBL positive strains, 16 consisted of CMY-2 genes, while
   CTX-M genes were not detected by PCR. Maldi tof analysis of selected E.
   coli showed a clear clonal relatedness of environmental strains from
   various withdrawals.}},
Publisher = {{INST AGRICULTURAL MEDICINE}},
Address = {{JACZEWSKIEGO 2, PO BOX 185, 20-950 LUBLIN, POLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kmet, V (Reprint Author), Slovak Acad Sci, Inst Anim Physiol, Soltesovej 4, SK-04001 Kosice, Slovakia.
   Kmet, Vladimir, Slovak Acad Sci, Inst Anim Physiol, SK-04001 Kosice, Slovakia.
   Feher, Alexander, Slovak Univ Agr, Nitra, Slovakia.
   Gregova, Gabriela; Venglovsky, Jan, Univ Vet Med \& Pharm, Kosice, Slovakia.
   Kmetova, Marta, Safarik Univ, Fac Med, Dept Med \& Clin Microbiol, Kosice, Slovakia.}},
ISSN = {{1232-1966}},
Keywords = {{Escherichia coli; antibiotic resistance; ESBL; Maldi tof; poultry
   slaughterhouse}},
Keywords-Plus = {{SPECTRUM BETA-LACTAMASES; MASS-SPECTROMETRY; CHICKEN MEAT; SLOVAKIA}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{kmetv@saske.sk}},
ORCID-Numbers = {{Kmet, Vladimir/0000-0002-8081-8579
   Alexander, Feher/0000-0001-8845-4709}},
Funding-Acknowledgement = {{VEGA from Slovak Research and Development Agency {[}1/0495/10,
   2/0005/11, APVV-0009-10]}},
Funding-Text = {{This work was supported VEGA Grants 1/0495/10, 2/0005/11 and
   APVV-0009-10 from the Slovak Research and Development Agency.}},
Cited-References = {{Bolder MN, 1998, MICROBIOLOGY MEAT PO, P158.
   Brtkova A, 2009, J FOOD NUTR RES, V48, P121.
   Carattoli A, 2008, J CLIN MICROBIOL, V46, P103, DOI 10.1128/JCM.01542-07.
   Clinical and Laboratory Standards Institute, 2008, M31A328 CLSI.
   Dieckmann R, 2011, APPL ENVIRON MICROB, V77, P4136, DOI 10.1128/AEM.02418-10.
   Drugdova Z, 2010, J FOOD NUTR RES, V49, P10.
   Fernandez-Lopez J, 2009, HDB POULTRY SCI TECH, P79.
   Gattringer R, 2002, J ANTIMICROB CHEMOTH, V49, P651, DOI 10.1093/jac/49.4.651.
   Kmet V, 2011, MICROORGANISMS IND E, P363.
   Livermore DM, 2001, J ANTIMICROB CHEMOTH, V48, P87, DOI 10.1093/jac/48.suppl\_1.87.
   Marriott NG, 1997, ESSENTIALS FOOD SANI.
   Perez-Perez PJ, 2002, J CLIN MICROBIOL, V40, P2153.
   Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843.
   Tsola E, 2008, FOOD CONTROL, V19, P423, DOI 10.1016/j.foodcont.2007.05.003.
   Warren RE, 2008, J ANTIMICROB CHEMOTH, V61, P504, DOI 10.1093/jac/dkm517.}},
Number-of-Cited-References = {{15}},
Times-Cited = {{16}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{23}},
Journal-ISO = {{Ann. Agr. Env. Med.}},
Doc-Delivery-Number = {{921QL}},
Unique-ID = {{ISI:000302492100013}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000299063000004,
Author = {Dirks, Brian P. and Dobrynin, Danil and Fridman, Gregory and Mukhin,
   Yuri and Fridman, Alexander and Quinlan, Jennifer J.},
Title = {{Treatment of Raw Poultry with Nonthermal Dielectric Barrier Discharge
   Plasma To Reduce Campylobacter jejuni and Salmonella enterica}},
Journal = {{JOURNAL OF FOOD PROTECTION}},
Year = {{2012}},
Volume = {{75}},
Number = {{1}},
Pages = {{22-28}},
Month = {{JAN}},
Abstract = {{Nonthermal plasma has been shown to be effective in reducing pathogens
   on the surface of a range of fresh produce products. The research
   presented here investigated the effectiveness of nonthermal dielectric
   barrier discharge plasma on Salmonella enterica and Campylobacter jejuni
   inoculated onto the surface of boneless skinless chicken breast and
   chicken thigh with skin. Chicken samples were inoculated with
   antibiotic-resistant strains of S. enterica and C. jejuni at levels of
   10(1) to 10(4) CFU and exposed to plasma for a range of time points (0
   to 180 s in 15-s intervals). Surviving antibiotic-resistant pathogens
   were recovered and counted on appropriate agar. In order to determine
   the effect of plasma on background microflora, noninoculated skinless
   chicken breast and thighs with skin were exposed to air plasma at
   ambient pressure. Treatment with plasma resulted in elimination of low
   levels (10(1) CFU) of both S. enterica and C. jejuni on chicken breasts
   and C. jejuni from chicken skin, but viable S. enterica cells remained
   on chicken skin even after 20 s of exposure to plasma. Inoculum levels
   of 10(2), 10(3), and 10(4) CFU of S. enterica on chicken breast and
   chicken skin resulted in maximum reduction levels of 1.85, 2.61, and
   2.54 log, respectively, on chicken breast and 1.25, 1.08, and 1.31 log,
   respectively, on chicken skin following 3 min of plasma exposure.
   Inoculum levels of 10(2), 10(3), and 10(4) CFU of C. jejuni on chicken
   breast and chicken skin resulted in maximum reduction levels of 1.65,
   2.45, and 2.45 log, respectively, on chicken breast and 1.42, 1.87, and
   3.11 log, respectively, on chicken skin following 3 min of plasma
   exposure. Plasma exposure for 30 s reduced background microflora on
   breast and skin by an average of 0.85 and 0.21 log, respectively. This
   research demonstrates the feasibility of nonthermal dielectric barrier
   discharge plasma as an intervention to help reduce foodborne pathogens
   on the surface of raw poultry.}},
Publisher = {{INT ASSOC FOOD PROTECTION}},
Address = {{6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Quinlan, JJ (Reprint Author), Drexel Univ, Dept Biol, Philadelphia, PA 19102 USA.
   Dirks, Brian P.; Quinlan, Jennifer J., Drexel Univ, Dept Biol, Philadelphia, PA 19102 USA.
   Dobrynin, Danil, Drexel Univ, Dept Elect \& Comp Engn, Philadelphia, PA 19102 USA.
   Fridman, Gregory, Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19102 USA.
   Mukhin, Yuri; Fridman, Alexander, Drexel Univ, Dept Mech Engn \& Mech, Philadelphia, PA 19102 USA.
   Quinlan, Jennifer J., Drexel Univ, Dept Nutr Sci, Philadelphia, PA 19102 USA.}},
DOI = {{10.4315/0362-028X.JFP-11-153}},
ISSN = {{0362-028X}},
Keywords-Plus = {{BROILER CARCASSES; ESCHERICHIA-COLI; CHICKEN; INACTIVATION; PREVALENCE;
   BACTERIA; MICROORGANISMS; PATHOGENS; SURFACES; DECONTAMINATION}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Food Science \& Technology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Food Science \& Technology}},
Author-Email = {{jjq26@drexel.edu}},
ResearcherID-Numbers = {{Dobrynin, Danil/A-2121-2009
   }},
ORCID-Numbers = {{Fridman, Gregory/0000-0003-4006-4722}},
Cited-References = {{Berrang ME, 2007, J FOOD PROTECT, V70, P1556, DOI 10.4315/0362-028X-70.7.1556.
   Chouliara E, 2007, FOOD MICROBIOL, V24, P607, DOI 10.1016/j.fm.2006.12.005.
   Critzer FJ, 2007, J FOOD PROTECT, V70, P2290, DOI 10.4315/0362-028X-70.10.2290.
   Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020.
   Dufrenne J, 2001, J FOOD PROTECT, V64, P538, DOI 10.4315/0362-028X-64.4.538.
   Eliezer S., 2001, 4 STATE MATTER INTRO.
   Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0.
   Fernandez A., INT J FOOD IN PRESS.
   Fridman A, 2004, PLASMA PHYS ENG.
   Fridman G, 2007, PLASMA PROCESS POLYM, V4, P370, DOI 10.1002/ppap.200600217.
   Hunt J. M., 2009, BACTERIOLOGICAL ANAL.
   Kim T, 2002, J FOOD PROTECT, V65, P1142, DOI 10.4315/0362-028X-65.7.1142.
   Lee K, 2006, J MICROBIOL, V44, P269.
   Matyas B., 2010, Morbidity and Mortality Weekly Report, V59, P418.
   Miller WG, 2000, APPL ENVIRON MICROB, V66, P5426, DOI 10.1128/AEM.66.12.5426-5436.2000.
   Moran L, 2009, J FOOD PROTECT, V72, P1830, DOI 10.4315/0362-028X-72.9.1830.
   Niemira BA, 2008, J FOOD PROTECT, V71, P1357, DOI 10.4315/0362-028X-71.7.1357.
   Parveen S, 2007, J FOOD PROTECT, V70, P2466, DOI 10.4315/0362-028X-70.11.2466.
   Perni S, 2008, J FOOD PROTECT, V71, P1619, DOI 10.4315/0362-028X-71.8.1619.
   Perni S, 2008, J FOOD PROTECT, V71, P302, DOI 10.4315/0362-028X-71.2.302.
   Rowan NJ, 1999, APPL ENVIRON MICROB, V65, P1312.
   Sarjeant KC, 2005, POULTRY SCI, V84, P955, DOI 10.1093/ps/84.6.955.
   Scholtz V, 2010, PLASMA PROCESS POLYM, V7, P237, DOI 10.1002/ppap.200900072.
   USDA, 1998, MICR LAB GUID.
   Vleugels M, 2005, IEEE T PLASMA SCI, V33, P824, DOI 10.1109/TPS.2005.844524.
   Whyte P, 2001, J FOOD PROTECT, V64, P179, DOI 10.4315/0362-028X-64.2.179.
   Yu H, 2006, J APPL MICROBIOL, V101, P1323, DOI 10.1111/j.1365-2672.2006.03033.x.
   Zhao CW, 2001, APPL ENVIRON MICROB, V67, P5431, DOI 10.1128/AEM.67.12.5431-5436.2001.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{25}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{25}},
Journal-ISO = {{J. Food Prot.}},
Doc-Delivery-Number = {{875VJ}},
Unique-ID = {{ISI:000299063000004}},
DA = {{2018-08-13}},
}

@article{ ISI:000298012000022,
Author = {Mishra, A. and Taneja, N. and Sharma, M.},
Title = {{Environmental and epidemiological surveillance of Vibrio cholerae in a
   cholera-endemic region in India with freshwater environs}},
Journal = {{JOURNAL OF APPLIED MICROBIOLOGY}},
Year = {{2012}},
Volume = {{112}},
Number = {{1}},
Pages = {{225-237}},
Month = {{JAN}},
Abstract = {{Aim: To conduct epidemiological and ecological surveillance of cholera
   in freshwater environments.
   Methods and Results: A freshwater region of India was surveyed between
   April 2007 and December 2008. Vibrio cholerae was isolated from 59.5\%
   of water and plankton samples (n = 357) and 35.5\% of stool samples (n =
   290). Isolation from water was dependent on air (r = 0 44) and water
   temperatures (r = 0 49) (P < 0 01) but was independent of rainfall (r =
   0 15), chlorophyll a (r = 0 18), salinity (r = 0 2) or pH (r = 0 2) (P >
   0 05). Isolation from plankton was dependent on temperature of air (r =
   0 45), water temperature (r = 0 44), chlorophyll a concentration (r = 0
   42), pH (r = 0 23) and salinity (r = 0 39) (P < 0 01). Cholera cases
   correlated with rainfall (r = 0 82, P < 0 01) and chlorophyll a
   concentration (r = 0 42, P < 0 05), but not with air temperature (r = 0
   3, P = 0 37). Vibrio cholerae O1 possessed ctxB, ctxA, rstR and tcpA
   (ElTor), toxR, toxT, rtxA, rtxC, mshA and hylA. Among non-O1-non-O139,
   the distribution of virulence-associated and regulatory protein genes
   was heterogeneous with -0.7, 2 2, 94 77, 97 76, 99 25, 100 and 100\%
   isolates being positive for tcpA, toxT, rtxA, rtxC, hylA, toxR and mshA,
   respectively. Two-thirds of non-O1-non-O139 isolates exhibited
   antibiotic resistance to various antibiotics that did not correlate with
   geographical site or time of origin for the isolates. RAPD and AFLP
   showed V. cholerae to be a diverse bacterium. AFLP demonstrated separate
   lineages for non-O1-non-O139 and O1 isolates.
   Conclusion: Environmental parameters played a significant role in the
   emergence and spread of cholera and the abundance of V. cholerae. But
   based on virulence gene profiling and genetic fingerprinting, the
   possibility of origin of toxigenic isolates from nontoxigenic
   environmental isolates seems unlikely in freshwater environs of India.
   Significance and Impact of the Study: This study explains the ecology,
   epidemiology and seasonality of cholera in freshwater environs.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Taneja, N (Reprint Author), Postgrad Inst Med Educ \& Res, Dept Med Microbiol, Chandigarh 160012, India.
   Mishra, A.; Taneja, N.; Sharma, M., Postgrad Inst Med Educ \& Res, Dept Med Microbiol, Chandigarh 160012, India.}},
DOI = {{10.1111/j.1365-2672.2011.05191.x}},
ISSN = {{1364-5072}},
Keywords = {{cholera; environmental; epidemiological; India; surveillance; V;
   cholerae}},
Keywords-Plus = {{BIOTYPE EL-TOR; MANNOSE-SENSITIVE HEMAGGLUTININ; RTX TOXIN GENE;
   NORTH-INDIA; PCR ASSAY; O1; VIBRIO-CHOLERAE-O1; BANGLADESH; EMERGENCE;
   STRAINS}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Microbiology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Microbiology}},
Author-Email = {{drneelampgi@yahoo.com}},
Funding-Acknowledgement = {{DST, Chandigarh; PGIMER, Chandigarh}},
Funding-Text = {{The help of Directorate of Meteorology, Air Force Headquarters, New
   Delhi, India, is acknowledged. The authors wish to thank Dr G. B. Nair,
   Dr T. Ramamurthy, NICED Kolkata and Dr Sabu Thomas, RGCB, Trivandrum,
   for providing reference strains. This study was partially financed by
   DST, Chandigarh, and PGIMER, Chandigarh.}},
Cited-References = {{{[}Anonymous], 1999, STAND METH EX WAT WA.
   ARITA M, 1986, INFECT IMMUN, V52, P45.
   AUSUBEL FM, 2002, CURRENT PROTOCOLS MO, V1.
   Chatterjee SN, 2004, BBA-MOL BASIS DIS, V1690, P93, DOI 10.1016/j.bbadis.2004.06.006.
   Chow KH, 2001, J CLIN MICROBIOL, V39, P2594, DOI 10.1128/JCM.39.7.2594-2597.2001.
   Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106.
   Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025.
   COLWELL RR, 1977, SCIENCE, V198, P394, DOI 10.1126/science.910135.
   de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105.
   Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102.
   Faruque SM, 2006, J INFECT DIS, V193, P1029, DOI 10.1086/500953.
   Faruque SM, 2004, P NATL ACAD SCI USA, V101, P2123, DOI 10.1073/pnas.0308485100.
   Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301.
   Franco AA, 1997, AM J EPIDEMIOL, V146, P1067.
   Hoshino K, 1998, FEMS IMMUNOL MED MIC, V20, P201, DOI 10.1111/j.1574-695X.1998.tb01128.x.
   HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465.
   Huq A, 2005, APPL ENVIRON MICROB, V71, P4645, DOI 10.1128/AEM.71.8.4645-4654.2005.
   Janda J. M., 1998, TOPLEY WILSONS MICRO, P1065.
   Jesudason MV, 2000, EPIDEMIOL INFECT, V124, P201, DOI 10.1017/S095026889900357X.
   Jouravleva EA, 1998, INFECT IMMUN, V66, P2535.
   KEASLER SP, 1993, LANCET, V341, P1661, DOI 10.1016/0140-6736(93)90792-F.
   Leal NC, 2004, J APPL MICROBIOL, V96, P447, DOI 10.1111/j.1365-2672.2004.02090.x.
   Leclerc H, 2002, CRIT REV MICROBIOL, V28, P371, DOI 10.1080/1040-840291046768.
   Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071.
   Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778.
   Mishra A, 2011, LETT APPL MICROBIOL, V53, P124, DOI 10.1111/j.1472-765X.2011.03077.x.
   Morita M, 2008, MICROBIOL IMMUNOL, V52, P314, DOI 10.1111/j.1348-0421.2008.00041.x.
   Mukhopadhyay AK, 2001, J BACTERIOL, V183, P4737, DOI 10.1128/JB.183.16.4737-4746.2001.
   Nandi B, 2000, J CLIN MICROBIOL, V38, P4145.
   Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204.
   Nusrin S, 2004, J CLIN MICROBIOL, V42, P5854, DOI 10.1128/JCM.42.12.5854-5856.2004.
   Old DC, 1996, MACKIE MCCARTNEY PRA, P425.
   Sedas VTP, 2007, J INFECT DEV COUNTR, V1, P224.
   Rivera ING, 2001, APPL ENVIRON MICROB, V67, P2421, DOI 10.1128/AEM.67.6.2421-2429.2001.
   Safa A, 2010, TRENDS MICROBIOL, V18, P46, DOI 10.1016/j.tim.2009.10.003.
   Sneath PHA, 1973, NUMERICAL TAXONOMY P.
   Taneja N, 2005, JPN J INFECT DIS, V58, P238.
   Taneja N, 2003, INDIAN J MED RES, V117, P243.
   Taneja N, 2010, INDIAN J PATHOL MICR, V53, P865, DOI 10.4103/0377-4929.72014.
   Taneja N, 2009, EMERG INFECT DIS, V15, P352, DOI 10.3201/eid1502.080943.
   Thelin KH, 1996, INFECT IMMUN, V64, P2853.
   VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407.
   XU HS, 1982, MICROBIAL ECOL, V8, P313, DOI 10.1007/BF02010671.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{13}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{13}},
Journal-ISO = {{J. Appl. Microbiol.}},
Doc-Delivery-Number = {{861IG}},
Unique-ID = {{ISI:000298012000022}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000297068500004,
Author = {Hsiao, Pao-Kuei and Chen, Wan-Ting and Chang, Kai-Chih and Ke, Yu-Ju and
   Kuo, Chung-Long and Tseng, Chun-Chieh},
Title = {{Performance of CHROMagar Staph aureus and CHROMagar MRSA for Detection
   of Airborne Methicillin-Resistant and Methicillin-Sensitive
   Staphylococcus aureus}},
Journal = {{AEROSOL SCIENCE AND TECHNOLOGY}},
Year = {{2012}},
Volume = {{46}},
Number = {{3}},
Pages = {{297-308}},
Abstract = {{In recent decades, the rise of methicillin-sensitive Staphylococcus
   aureus (MSSA) and methicillin-resistant S. aureus (MRSA) has become one
   of the most significant problems in public health. The CHROMagar medium,
   which allows for direct color-based identification of target pathogens,
   could potentially be used to rapidly monitor airborne S. aureus and
   MRSA. In this study, the recovery efficiency of CHROMagar Staph aureus
   (CSA) for collecting airborne MSSA was evaluated in a chamber study.
   Subsequently, the colony identification performance of bioaerosol
   samplers combined with CSA and CHROMagar MRSA (C-MRSA) was evaluated in
   a hospital setting. Our results demonstrated that the agar medium, the
   type of bioaerosol sampler used, and the relative humidity all affected
   the recovery of the collected MSSA sample. The sampling stress that
   influenced the recovery of MSSA on CSA did not differ from that used
   when measuring its recovery on the commonly used tryptic soy agar. The
   average sensitivity, specificity, positive predictive value (PPV), and
   negative predictive value (NPV) of the colony identification were 24\%,
   90\%, 13\%, and 95\%, respectively, for CSA and 71\%, 65\%, 16\%, and
   96\%, respectively, for C-MRSA. Both CSA and C-MRSA had low PPV and high
   NPV, suggesting that a nonmauve-colored colony that is recovered on CSA
   or C-MRSA by air sampling can be reported as negative; however, any
   mauve-colored colonies should be subjected to further identification
   processes. On the basis of these findings, and depending upon the
   methods used, using CHROMagar to detect airborne MSSA or MRSA may
   shorten the detection time from 24 to 48 h.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Tseng, CC (Reprint Author), Tzu Chi Univ, Dept Publ Hlth, 701 Sec 3,Jhongyang Rd, Hualien 97004, Taiwan.
   Chen, Wan-Ting; Ke, Yu-Ju; Kuo, Chung-Long; Tseng, Chun-Chieh, Tzu Chi Univ, Dept Publ Hlth, Hualien 97004, Taiwan.
   Chen, Wan-Ting; Ke, Yu-Ju; Kuo, Chung-Long; Tseng, Chun-Chieh, Tzu Chi Univ, Grad Inst Publ Hlth, Hualien 97004, Taiwan.
   Hsiao, Pao-Kuei, Acad Sinica, Res Ctr Environm Changes, Taipei 115, Taiwan.
   Chang, Kai-Chih, Tzu Chi Univ, Dept Lab Med \& Biotechnol, Hualien 97004, Taiwan.}},
DOI = {{10.1080/02786826.2011.626001}},
ISSN = {{0278-6826}},
Keywords-Plus = {{ANTIBIOTIC-RESISTANT; SAMPLING PERFORMANCE; PRESUMPTIVE IDENTIFICATION;
   CLINICAL SPECIMENS; CHROMOGENIC MEDIUM; FUNGAL SPORES; YEAST-CELLS;
   BIOAEROSOLS; COLLECTION; BACTERIA}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology; Meteorology \&
   Atmospheric Sciences}},
Web-of-Science-Categories  = {{Engineering, Chemical; Engineering, Mechanical; Environmental Sciences;
   Meteorology \& Atmospheric Sciences}},
Author-Email = {{tsengcc@mail.tcu.edu.tw}},
ResearcherID-Numbers = {{Robertson, Simon/D-1549-2012
   }},
ORCID-Numbers = {{HSIAO, PAO-KUEI/0000-0003-1212-6535}},
Funding-Acknowledgement = {{National Science Council, Republic of China {[}NSC 99-2314-B-320-005]}},
Funding-Text = {{This work was supported by grant NSC 99-2314-B-320-005 from the National
   Science Council, Republic of China.}},
Cited-References = {{Brown DFJ, 2005, J ANTIMICROB CHEMOTH, V56, P1000, DOI 10.1093/jac/dki372.
   Carricajo A, 2001, J CLIN MICROBIOL, V39, P2581, DOI 10.1128/JCM.39.7.2581-2583.2001.
   Chen PS, 2009, AEROSOL SCI TECH, V43, P290, DOI 10.1080/02786820802621232.
   Chen PS, 2005, AEROSOL SCI TECH, V39, P231, DOI 10.1080/027868290925534.
   CHIHARA S, 2009, INT J MICROBIOL.
   Clinical and Laboratory Standards Institute, 2005, PERF STAND ANT SUSC.
   Cooper BS, 2004, BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533.
   Crook B., 1995, P269.
   Diederen B, 2005, J CLIN MICROBIOL, V43, P1925, DOI 10.1128/JCM.43.4.1925-1927.2005.
   Fang H, 2003, J CLIN MICROBIOL, V41, P2894, DOI 10.1128/JCM.41.7.2894-2899.2003.
   Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148.
   Gaillot O, 2000, J CLIN MICROBIOL, V38, P1587.
   Gandara A, 2006, ENVIRON HEALTH PERSP, V114, P1859, DOI 10.1289/ehp.9585.
   Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910.
   Goodwin KD, 2009, WATER RES, V43, P4802, DOI 10.1016/j.watres.2009.06.025.
   Ho Monto, 1999, Journal of Microbiology Immunology and Infection, V32, P239.
   Hulten KG, 2010, INFECT CONT HOSP EP, V31, P183, DOI 10.1086/649793.
   JUOZAITIS A, 1994, APPL ENVIRON MICROB, V60, P861.
   Li CS, 2003, AEROSOL SCI TECH, V37, P961, DOI 10.1080/02786820390230361.
   Li CS, 1999, AEROSOL SCI TECH, V31, P226, DOI 10.1080/027868299304273.
   Li CS, 1999, AEROSOL SCI TECH, V30, P280, DOI 10.1080/027868299304633.
   Lin WH, 1999, AEROSOL SCI TECH, V30, P109, DOI 10.1080/027868299304714.
   Lin WH, 1998, AEROSOL SCI TECH, V28, P511, DOI 10.1080/02786829808965542.
   Macher J.M., 1992, J AEROSOL SCI, V23, P647.
   Marcinak JF, 2003, CURR OPIN INFECT DIS, V16, P265, DOI 10.1097/01.qco.0000073778.11390.16.
   Merlino J, 2000, J CLIN MICROBIOL, V38, P2378.
   Negrini TD, 2009, J CLIN PEDIATR DENT, V34, P13.
   Pape J, 2006, J CLIN MICROBIOL, V44, P2575, DOI 10.1128/JCM.00399-06.
   Perez JM, 2003, J CLIN MICROBIOL, V41, P1130, DOI 10.1128/JCM.41.3.1130-1134.2003.
   Perry JD, 2007, J APPL MICROBIOL, V103, P2046, DOI 10.1111/j.1365-2672.2007.03442.x.
   Rutala WA, 1997, INFECT CONT HOSP EP, V18, P417.
   Sacar S, 2010, EPIDEMIOL INFECT, V138, P697, DOI 10.1017/S0950268809991063.
   Shiomori T, 2002, J HOSP INFECT, V50, P30, DOI 10.1053/jhin.2001.1136.
   Stapleton Paul D., 2002, Science Progress, V85, P57, DOI 10.3184/003685002783238870.
   STEWART SL, 1995, APPL ENVIRON MICROB, V61, P1232.
   Suller MTE, 1999, J HOSP INFECT, V43, P281, DOI 10.1016/S0195-6701(99)90424-3.
   Tsai TM, 2010, J CHEM TECHNOL BIOT, V85, P1642, DOI 10.1002/jctb.2476.
   Tseng CC, 2005, J AEROSOL SCI, V36, P593, DOI 10.1016/j.jaerosci.2004.12.004.
   Wendt C, 2010, J CLIN MICROBIOL, V48, P2223, DOI 10.1128/JCM.02374-09.
   Wilson RD, 2004, ANAESTH INTENS CARE, V32, P202.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{7}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{9}},
Journal-ISO = {{Aerosol Sci. Technol.}},
Doc-Delivery-Number = {{848QP}},
Unique-ID = {{ISI:000297068500004}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000295662100008,
Author = {Yin, S. and Sze-To, G. N. and Chao, Christopher Y. H.},
Title = {{Retrospective analysis of multi-drug resistant tuberculosis outbreak
   during a flight using computational fluid dynamics and infection risk
   assessment}},
Journal = {{BUILDING AND ENVIRONMENT}},
Year = {{2012}},
Volume = {{47}},
Pages = {{50-57}},
Month = {{JAN}},
Abstract = {{Air travel brings convenience to humans but also hastens the global
   spread of infectious diseases. Not only transporting infectious
   individuals from one place to another, air travel also provides a chance
   for infectious diseases transmission during the flight, especially if
   the disease can be transmitted via the airborne route. A number of
   documented outbreaks of airborne transmissible diseases were associated
   with disease transmission during the air travel. This study performed
   retrospective analysis on an infamous multi-drug resistant Tuberculosis
   (MDR-TB) outbreak on a commercial flight, where 6 people were infected
   with the multi-drug resistant disease during the 8.75 h flight. Airflow
   pattern and the infectious particle dispersion in the aircraft cabin
   were simulated using computational fluid dynamics (CFD). Infection risks
   of the passengers under a range of infectious source strength values
   were then assessed using the dose-response model. Based on the risk
   data, the infectious source strength of the index case passenger was
   estimated by likelihood analysis. A concept of mix-ratio was introduced
   to estimate the impact of human movement and cough behavior on the
   disease transmission. From the maximum likelihood estimation, the index
   case passenger may have generated 17.2 millions of viable bacilli/hr
   during the flight. Spatial pattern of the infection case and the spatial
   variation of infection risk were reflected in this estimation. The
   findings of this study provide additional understanding of infectious
   disease transmission during air travel. The infectious source strength
   of MDR-TB estimated from this study can be used in further risk
   assessment on the disease. (C) 2011 Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chao, CYH (Reprint Author), Hong Kong Univ Sci \& Technol, Dept Mech Engn, Kowloon, Hong Kong, Peoples R China.
   Yin, S.; Chao, Christopher Y. H., Hong Kong Univ Sci \& Technol, Dept Mech Engn, Kowloon, Hong Kong, Peoples R China.
   Sze-To, G. N., Hong Kong Univ Sci \& Technol, Bldg Energy Res Ctr, HKUST Fok Ying Tung Grad Sch, Hong Kong, Hong Kong, Peoples R China.}},
DOI = {{10.1016/j.buildenv.2011.03.011}},
ISSN = {{0360-1323}},
EISSN = {{1873-684X}},
Keywords = {{Multi-drug resistant tuberculosis; Computational fluid dynamics;
   Aircraft cabin; Retrospective analysis; Risk assessment; Maximum
   likelihood estimation}},
Keywords-Plus = {{AIRCRAFT CABIN; EXPIRATORY DROPLETS; HOSPITAL WARD; AIR-TRAVEL;
   TRANSPORT; TRANSMISSION}},
Research-Areas = {{Construction \& Building Technology; Engineering}},
Web-of-Science-Categories  = {{Construction \& Building Technology; Engineering, Environmental;
   Engineering, Civil}},
Author-Email = {{meyhchao@ust.hk}},
Funding-Acknowledgement = {{Government of Hong Kong S.A.R. {[}611509, 611310]}},
Funding-Text = {{This research was financially supported by the Government of Hong Kong
   S.A.R. through General Research Fund Account 611509 and 611310.}},
Cited-References = {{Abubakar I, 2010, LANCET INFECT DIS, V10, P176, DOI 10.1016/S1473-3099(10)70028-1.
   {[}Anonymous], 2008, TUB AIR TRAV GUID PR.
   Baker AJ, 2006, DOTFAAAM0627, P20591.
   Chao CYH, 2008, AEROSOL SCI TECH, V42, P377, DOI 10.1080/02786820802104973.
   Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003.
   Gao NP, 2008, BUILD ENVIRON, V43, P1805, DOI 10.1016/j.buildenv.2007.10.023.
   Gupta JK, 2011, INDOOR AIR, V21, P3, DOI 10.1111/j.1600-0668.2010.00676.x.
   Hinds WC, 1999, AEROSOL TECHNOLOGY, V28, P211.
   Hocking MB, 1998, AM IND HYG ASSOC J, V59, P446, DOI 10.1080/15428119891010181.
   HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968.
   International Civil Aviation Organization, 2009, 992 INT CIV AV ORG.
   Johnson A, 1993, BREATH, V42, P2.
   Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501.
   Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8.
   Mazumdar S, 2009, INDOOR AIR, V19, P3, DOI 10.1111/j.1600-0668.2008.00553.x.
   Nagda NL, 2001, INDOOR AIR, V11, P200, DOI 10.1034/j.1600-0668.2001.011003200.x.
   Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466.
   NYKA W, 1962, AM REV RESPIR DIS, V85, P33.
   PRICE LE, 1987, INFECT CONT HOSP EP, V8, P97, DOI 10.1017/S0195941700067254.
   RILEY EC, 1978, AM J EPIDEMIOL, V107, P421, DOI 10.1093/oxfordjournals.aje.a112560.
   Sze-To GN, 2011, RISK ANAL, V31, P351, DOI 10.1111/j.1539-6924.2010.01525.x.
   To GNS, 2010, INDOOR AIR, V20, P2, DOI 10.1111/j.1600-0668.2009.00621.x.
   Tung YC, 2008, ARCHIT SCI REV, V51, P14.
   Wan MP, 2007, AEROSOL SCI TECH, V41, P244, DOI 10.1080/02786820601146985.
   Wan MP, 2009, AEROSOL SCI TECH, V43, P322, DOI 10.1080/02786820802641461.
   Wells W. F., 1955, AIRBORNE CONTAGION A, P117.
   World Health Organisation, 2006, TUB AIR TRAV GUID PR.
   World Health Organization, 1998, TB AIR TRAV GUID PRE.
   World Health Organization, 2009, UPD TUB FACTS.
   Yan W, 2009, BUILD ENVIRON, V44, P34, DOI 10.1016/j.buildenv.2008.01.010.
   Zhang T, 2007, HVAC\&R RES, V13, P683, DOI 10.1080/10789669.2007.10390980.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{6}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{12}},
Journal-ISO = {{Build. Environ.}},
Doc-Delivery-Number = {{830MW}},
Unique-ID = {{ISI:000295662100008}},
DA = {{2018-08-13}},
}

@article{ ISI:000298111300001,
Author = {Kumar, Ashwani and Farhana, Aisha and Guidry, Loni and Saini, Vikram and
   Hondalus, Mary and Steyn, Adrie J. C.},
Title = {{Redox homeostasis in mycobacteria: the key to tuberculosis control?}},
Journal = {{EXPERT REVIEWS IN MOLECULAR MEDICINE}},
Year = {{2011}},
Volume = {{13}},
Month = {{DEC 16}},
Abstract = {{Mycobacterium tuberculosis (Mtb) is a metabolically flexible pathogen
   that has the extraordinary ability to sense and adapt to the
   continuously changing host environment experienced during decades of
   persistent infection. Mtb is continually exposed to endogenous reactive
   oxygen species (ROS) as part of normal aerobic respiration, as well as
   exogenous ROS and reactive nitrogen species (RNS) generated by the host
   immune system in response to infection. The magnitude of tuberculosis
   (TB) disease is further amplified by exposure to xenobiotics from the
   environment such as cigarette smoke and air pollution, causing
   disruption of the intracellular prooxidant-antioxidant balance. Both
   oxidative and reductive stresses induce redox cascades that alter Mtb
   signal transduction, DNA and RNA synthesis, protein synthesis and
   antimycobacterial drug resistance. As reviewed in this article, Mtb has
   evolved specific mechanisms to protect itself against endogenously
   produced oxidants, as well as defend against host and environmental
   oxidants and reductants found specifically within the microenvironments
   of the lung. Maintaining an appropriate redox balance is critical to the
   clinical outcome because several antimycobacterial prodrugs are only
   effective upon bioreductive activation. Proper homeostasis of
   oxido-reductive systems is essential for Mtb survival, persistence and
   subsequent reactivation. The progress and remaining deficiencies in
   understanding Mtb redox homeostasis are also discussed.}},
Publisher = {{CAMBRIDGE UNIV PRESS}},
Address = {{32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Steyn, AJC (Reprint Author), Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA.
   Farhana, Aisha; Guidry, Loni; Saini, Vikram; Steyn, Adrie J. C., Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA.
   Farhana, Aisha; Guidry, Loni; Saini, Vikram; Steyn, Adrie J. C., Univ Alabama, Ctr AIDS Res, Birmingham, AL 35294 USA.
   Farhana, Aisha; Guidry, Loni; Saini, Vikram; Steyn, Adrie J. C., Univ Alabama, Ctr Free Rad Biol, Birmingham, AL 35294 USA.
   Steyn, Adrie J. C., KwaZulu Natal Res Inst TB \& HIV, Durban, South Africa.
   Hondalus, Mary, Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.
   Kumar, Ashwani, Inst Microbial Technol, Chandigarh 160036, India.}},
DOI = {{10.1017/S1462399411002079}},
Article-Number = {{e39}},
ISSN = {{1462-3994}},
Keywords-Plus = {{NITRIC-OXIDE SYNTHASE; MYCOTHIOL BIOSYNTHESIS PATHWAY; METHIONINE
   SULFOXIDE REDUCTASE; ALTERNATIVE SIGMA-FACTOR; SURVIVAL FOLLOWING HEAT;
   IN-VIVO GROWTH; ESCHERICHIA-COLI; OXIDATIVE STRESS; HYDROGEN-PEROXIDE;
   SUPEROXIDE-DISMUTASE}},
Research-Areas = {{Biochemistry \& Molecular Biology; Research \& Experimental Medicine}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Medicine, Research \& Experimental}},
Author-Email = {{asteyn@uab.edu}},
ResearcherID-Numbers = {{Kumar, Ashwani/L-9269-2017
   }},
ORCID-Numbers = {{Kumar, Ashwani/0000-0002-6240-6810
   Saini, Vikram/0000-0002-0258-2871
   Steyn, Adrie JC/0000-0001-9177-8827}},
Funding-Acknowledgement = {{National Institutes of Health {[}AI058131, AI076389, AI060469];
   University of Alabama at Birmingham (UAB) Center for AIDS Research; UAB
   Center for Free Radical Biology; UAB Center for Emerging Infections and
   Emergency Preparedness}},
Funding-Text = {{We thank the peer reviewers of this manuscript, and members of the Steyn
   laboratory for a critical reading of this manuscript prior to
   submission. Research in our laboratories is supported in whole or in
   part by National Institutes of Health Grants AI058131, AI076389 (to
   A.J.C.S.) and AI060469 (to M.K.H.). This work is also supported by the
   University of Alabama at Birmingham (UAB) Center for AIDS Research, UAB
   Center for Free Radical Biology and UAB Center for Emerging Infections
   and Emergency Preparedness (A.J.C.S.). A.J.C.S. is a Burroughs Wellcome
   Investigator in the Pathogenesis of Infectious Diseases.}},
Cited-References = {{Adams LB, 1997, TUBERCLE LUNG DIS, V78, P237, DOI 10.1016/S0962-8479(97)90004-6.
   Akif M, 2008, J BACTERIOL, V190, P7087, DOI 10.1128/JB.00159-08.
   Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055.
   ANDERSEN P, 1991, INFECT IMMUN, V59, P1905.
   BABIOR BM, 1984, J CLIN INVEST, V73, P599, DOI 10.1172/JCI111249.
   Babior BM, 1999, BLOOD, V93, P1464.
   BABIOR BM, 1988, HEMATOL ONCOL CLIN N, V2, P201.
   Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236.
   Baulard AR, 2000, J BIOL CHEM, V275, P28326.
   Berrios-Rivera SJ, 2002, METAB ENG, V4, P230, DOI 10.1006/mben.2002.0228.
   Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x.
   Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09.
   Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7.
   Bokoch GM, 2006, ANTIOXID REDOX SIGN, V8, P1533, DOI 10.1089/ars.2006.8.1533.
   Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200.
   Brahimi-Horn MC, 2007, FEBS LETT, V581, P3582, DOI 10.1016/j.febsict.2007.06.018.
   Braun R. D, 2001, HEART CIRCULATORY PH, V280, pH2533.
   Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798.
   Buchmeier NA, 2003, MOL MICROBIOL, V47, P1723, DOI 10.1046/j.1365-2958.2003.03416.x.
   Buchmeier NA, 2006, J BACTERIOL, V188, P6245, DOI 10.1128/JB.00393-06.
   BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074.
   Chan ED, 2001, AM J RESP CELL MOL, V25, P606, DOI 10.1165/ajrcmb.25.5.4487.
   CHAN J, 1995, INFECT IMMUN, V63, P736.
   CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111.
   Chim N, 2010, J MOL BIOL, V396, P1211, DOI 10.1016/j.jmb.2009.12.060.
   Coffey MJ, 2001, FREE RADICAL RES, V35, P447, DOI 10.1080/10715760100301471.
   Cooper AM, 2000, INFECT IMMUN, V68, P1231, DOI 10.1128/IAI.68.3.1231-1234.2000.
   Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240.
   DAVIS NK, 1992, MOL GEN GENET, V232, P351.
   den Hengst CD, 2008, BBA-GEN SUBJECTS, V1780, P1201, DOI 10.1016/j.bbagen.2008.01.008.
   DIAZ GA, 1974, AM REV RESPIR DIS, V110, P312, DOI 10.1164/arrd.1974.110.3.312.
   Edwards KM, 2001, AM J RESP CRIT CARE, V164, P2213, DOI 10.1164/rccm2106093.
   Fan F, 2009, CURR OPIN CHEM BIOL, V13, P451, DOI 10.1016/j.cbpa.2009.07.018.
   Farhana A, 2010, ADV MICROB PHYSIOL, V57, P43, DOI 10.1016/B978-0-12-381045-8.00002-3.
   Fernandes ND, 1999, J BACTERIOL, V181, P4266.
   Flynn JL, 1998, J IMMUNOL, V160, P1796.
   Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075.
   Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06.
   Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200.
   Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0.
   GENGHOF DS, 1968, J BACTERIOL, V95, P340.
   Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003.
   Gomez LM, 2007, TUBERCULOSIS, V87, P288, DOI 10.1016/j.tube.2007.03.002.
   GONZALEZFLECHA B, 1995, J BIOL CHEM, V270, P13681, DOI 10.1074/jbc.270.23.13681.
   GOODMAN M, 1988, J MOL EVOL, V27, P236, DOI 10.1007/BF02100080.
   GOPINATHAN KP, 1963, BIOCHEM J, V87, P444, DOI 10.1042/bj0870444.
   Goulding CW, 2004, J BIOL CHEM, V279, P3516, DOI 10.1074/jbc.M311833200.
   HALLIWELL B, 2008, FREE RADICAL BIO MED, P30.
   Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200.
   Hazleton E. B, 1923, BRIT MED J      1027, P763.
   Hu YM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005150.
   Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p.
   JACKETT PS, 1980, J GEN MICROBIOL, V121, P381.
   JACKETT PS, 1978, J GEN MICROBIOL, V107, P273, DOI 10.1099/00221287-107-2-273.
   Jaeger T, 2004, ARCH BIOCHEM BIOPHYS, V423, P182, DOI 10.1016/j.abb.2003.11.021.
   Jaeger Timo, 2007, V44, P207.
   Jung YJ, 2002, J EXP MED, V196, P991, DOI 10.1084/jem.20021186.
   Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799.
   Keating LA, 2005, MOL MICROBIOL, V56, P163, DOI 10.1111/j.1365-2958.2005.04524.x.
   Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x.
   Kim TH, 2005, BIOCHEM BIOPH RES CO, V337, P757, DOI 10.1016/j.bbrc.2005.09.115.
   KLEBANOFF SJ, 1968, J BACTERIOL, V95, P2131.
   KNOX R, 1956, AM REV TUBERC PULM, V73, P726.
   Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007.
   Koledin T, 2002, ARCH MICROBIOL, V178, P331, DOI 10.1007/s00203-002-0462-y.
   Koppenol WH, 2001, REDOX REP, V6, P229, DOI 10.1179/135100001101536373.
   Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200.
   Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104.
   Lee WL, 2009, MOL MICROBIOL, V71, P583, DOI 10.1111/j.1365-2958.2008.06548.x.
   Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09.
   Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549.
   Li ZM, 1998, J INFECT DIS, V177, P1030, DOI 10.1086/515254.
   LLOYD D, 1986, BIOCHEM PHARMACOL, V35, P61, DOI 10.1016/0006-2952(86)90556-3.
   Loebel RO, 1933, J BACTERIOL, V26, P167.
   Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289.
   Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9.
   MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243.
   Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103.
   Master SS, 2002, MICROBIOL-SGM, V148, P3139, DOI 10.1099/00221287-148-10-3139.
   McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074.
   Merrill MH, 1930, J BACTERIOL, V20, P235.
   Miesel L, 1998, J BACTERIOL, V180, P2459.
   MITCHISON DA, 1963, J PATHOL BACTERIOL, V86, P377, DOI 10.1002/path.1700860213.
   Moens L, 1996, MOL BIOL EVOL, V13, P324, DOI 10.1093/oxfordjournals.molbev.a025592.
   Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208.
   Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102.
   Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841.
   Nathan C., 1991, BEHRING I MITT, P200.
   Newton GL, 2006, J BIOL CHEM, V281, P33910, DOI 10.1074/jbc.M604724200.
   Newton GL, 2005, J BACTERIOL, V187, P7309, DOI 10.1128/JB.187.21.7309-7316.2005.
   Newton GL, 2003, J BACTERIOL, V185, P3476, DOI 10.1128/JB.185.11.3476-3479.2003.
   NEWTON GL, 1995, EUR J BIOCHEM, V230, P821.
   Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996.
   Newton GL, 2000, J BACTERIOL, V182, P6958, DOI 10.1128/JB.182.24.6958-6963.2000.
   Newton GL, 1999, BIOCHEM BIOPH RES CO, V255, P239, DOI 10.1006/bbrc.1999.0156.
   Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043.
   Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293.
   Ohno H, 2003, CELL MICROBIOL, V5, P637, DOI 10.1046/j.1462-5822.2003.00307.x.
   Olson JW, 2002, SCIENCE, V298, P1788, DOI 10.1126/science.1077123.
   Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853.
   Ouellet H, 2007, J BIOL CHEM, V282, P7491, DOI 10.1074/jbc.M609155200.
   Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105.
   Patel MP, 2001, BIOCHEMISTRY-US, V40, P5119, DOI 10.1021/bi0029144.
   Patel MP, 1999, BIOCHEMISTRY-US, V38, P11827, DOI 10.1021/bi991025h.
   Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x.
   Paul BD, 2009, CELL DEATH DIFFER, V17, P1134.
   Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001.
   QUEMARD A, 1995, BIOCHEMISTRY-US, V34, P8235, DOI 10.1021/bi00026a004.
   Raghunand TR, 2006, MICROBIOL-SGM, V152, P2735, DOI 10.1099/mic.0.28911-0.
   Raghunand TR, 2006, J BACTERIOL, V188, P6966, DOI 10.1128/JB.00384-06.
   Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087.
   Rahman I, 2003, BIOCHEM BIOPH RES CO, V302, P860, DOI 10.1016/S0006-291X(03)00224-9.
   Raman S, 2001, J BACTERIOL, V183, P6119, DOI 10.1128/JB.183.20.6119-6125.2001.
   Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105.
   RASMUSSEN K N, 1957, Acta Tuberc Scand, V34, P245.
   Rawat M, 2003, MICROBIOL-SGM, V149, P1341, DOI 10.1099/mic.0.26084-0.
   Rawat M, 2002, ANTIMICROB AGENTS CH, V46, P3348, DOI 10.1128/AAC.46.11.3348-3355.2002.
   Rawat M, 2007, BIOCHEM BIOPH RES CO, V363, P71, DOI 10.1016/j.bbrc.2007.08.142.
   Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06.
   REYNOLDS AV, 1981, J ANTIMICROB CHEMOTH, V8, P91, DOI 10.1093/jac/8.2.91.
   Rich AR, 1942, B JOHNS HOPKINS HOSP, V71, P345.
   Rich EA, 1997, TUBERCLE LUNG DIS, V78, P247, DOI 10.1016/S0962-8479(97)90005-8.
   ROSSI F, 1986, BIOCHIM BIOPHYS ACTA, V853, P65, DOI 10.1016/0304-4173(86)90005-4.
   Roy S, 2004, IMMUNOLOGY, V112, P471, DOI 10.1046/j.1365-2567.2004.01905.x.
   Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502.
   Ryan GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011108.
   Sacchettini JC, 2008, NAT REV MICROBIOL, V6, P41, DOI 10.1038/nrmicro1816.
   SAKUDA S, 1994, BIOSCI BIOTECH BIOCH, V58, P1347, DOI 10.1271/bbb.58.1347.
   Sareen D, 2002, BIOCHEMISTRY-US, V41, P6885, DOI 10.1021/bi012212u.
   Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x.
   Scanga CA, 2001, INFECT IMMUN, V69, P7711, DOI 10.1128/IAI.69.12.7711-7717.2001.
   Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4.
   Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590.
   SEGAL W, 1956, J BACTERIOL, V72, P132.
   Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498.
   Shi L, 2008, TUBERCULOSIS, V88, P1, DOI 10.1016/j.tube.2007.08.007.
   Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007.
   Shiloh MU, 2000, CURR OPIN MICROBIOL, V3, P35, DOI 10.1016/S1369-5274(99)00048-X.
   Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104.
   Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545.
   Singh VK, 2003, MICROBIOL-SGM, V149, P2739, DOI 10.1099/mic.0.26442-0.
   Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0.
   SMITH MA, 1995, J ANTIMICROB CHEMOTH, V35, P751, DOI 10.1093/jac/35.6.751.
   Sohaskey CD, 2003, J BACTERIOL, V185, P7247, DOI 10.1128/JB.185.24.7247-7256.2003.
   Song TS, 2003, MOL MICROBIOL, V50, P949, DOI 10.1046/j.1365-2958.2003.03739.x.
   Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707.
   SPIES HSC, 1994, EUR J BIOCHEM, V224, P203, DOI 10.1111/j.1432-1033.1994.tb20013.x.
   St John G, 2001, P NATL ACAD SCI USA, V98, P9901.
   Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399.
   Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931.
   Toledano MB, 2007, FEBS LETT, V581, P3598, DOI 10.1016/j.febslct.2007.07.002.
   Tremblay GA, 2007, INT J TUBERC LUNG D, V11, P722.
   TUGGLE CK, 1985, J BACTERIOL, V162, P448.
   VANDIVIERE H M, 1956, Am J Med Sci, V232, P30, DOI 10.1097/00000441-195607000-00006.
   Velez DR, 2009, HUM GENET, V126, P643, DOI 10.1007/s00439-009-0713-y.
   Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07.
   Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1016/S0168-6445(01)00063-8.
   Vilcheze C, 2005, ANTIMICROB AGENTS CH, V49, P708, DOI 10.1128/AAC.49.2.708-720.2005.
   Vilcheze C, 2008, MOL MICROBIOL, V69, P1316, DOI 10.1111/j.1365-2958.2008.06365.x.
   Voskuil Martin I., 2009, P119.
   Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003.
   Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205.
   Wang CH, 1998, EUR RESPIR J, V11, P809, DOI 10.1183/09031936.98.11040809.
   Wayne LG, 1996, INFECT IMMUN, V64, P2062.
   Wheeler Paul R., 1994, P353.
   WILLIAMS CH, 1995, FASEB J, V9, P1267.
   Wilson Michael, 1999, Proceedings of the National Academy of Sciences of the United States of America, V96, P12833, DOI 10.1073/pnas.96.22.12833.
   Wilson TM, 1996, MOL MICROBIOL, V19, P1025, DOI 10.1046/j.1365-2958.1996.449980.x.
   Xu X, ANTIMICROBIAL AGENTS, V55, P3133.
   ZHANG Y, 1991, MOL MICROBIOL, V5, P381, DOI 10.1111/j.1365-2958.1991.tb02120.x.
   Zhang ZP, 1999, ARCH BIOCHEM BIOPHYS, V363, P19, DOI 10.1006/abbi.1998.1056.}},
Number-of-Cited-References = {{171}},
Times-Cited = {{61}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{25}},
Journal-ISO = {{Expert Rev. Mol. Med.}},
Doc-Delivery-Number = {{862RI}},
Unique-ID = {{ISI:000298111300001}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000297229000012,
Author = {Arslan, S. and Eyi, A. and Ozdemir, F.},
Title = {{Spoilage potentials and antimicrobial resistance of Pseudomonas spp.
   isolated from cheeses}},
Journal = {{JOURNAL OF DAIRY SCIENCE}},
Year = {{2011}},
Volume = {{94}},
Number = {{12}},
Pages = {{5851-5856}},
Month = {{DEC}},
Abstract = {{Pseudomonas spp. are aerobic, gram-negative bacteria that are recognized
   as major food spoilage microorganisms. A total of 32 (22.9\%)
   Pseudomonas spp. from 140 homemade white cheese samples collected from
   the open-air public bazaar were isolated and. characterized. The aim of
   the present study was to investigate the biochemical characteristics,
   the production of extracellular enzymes, slime and beta-lactamase, and
   antimicrobial susceptibility of Pseudomonas spp. isolated from cheeses.
   The identified isolates including Pseudomonas pseudoalcaligenes,
   Pseudomonas alcaligenes, Pseudomonas aeruginosa, Pseudomonas fluorescens
   biovar V, and P. pseudoalcaligenes ssp. citrulli were found to produce
   extracellular enzymes, respectively: protease and lecithinase production
   (100\%), and lipase activity (85.7, 42.9, 100, and 100\%, and
   nonlipolytic, respectively). The isolates did not produce slime and had
   no detectable beta-lactamase activity. The antimicrobial susceptibility
   of the isolates was tested using the disk diffusion method. Pseudomonas
   spp. had the highest resistance to penicillin G (100\%), then
   sulphamethoxazole/trimethoprim (28.1\%). However, all Pseudomonas spp.
   isolates were 100\% susceptible to ceftazidime, ciprofloxacin, amikacin,
   gentamicin, and imipenem. Multidrug-resistance patterns were not
   observed among these isolates. In this study, Pseudomonas spp.,
   exhibiting spoilage features, were isolated mainly from cheeses.
   Isolation of this organism from processed milk highlights the need to
   improve the hygienic practices. All of the stages in the milk processing
   chain during manufacturing have to be under control to achieve the
   quality and safety of dairy products.}},
Publisher = {{ELSEVIER SCIENCE INC}},
Address = {{360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Arslan, S (Reprint Author), Abant Izzet Baysal Univ, Fac Arts \& Sci, Dept Biol, TR-14280 Golkoy Bolu, Turkey.
   Arslan, S.; Eyi, A.; Ozdemir, F., Abant Izzet Baysal Univ, Fac Arts \& Sci, Dept Biol, TR-14280 Golkoy Bolu, Turkey.}},
DOI = {{10.3168/jds.2011-4676}},
ISSN = {{0022-0302}},
Keywords = {{Pseudomonas spp.; cheese; spoilage potential; antimicrobial
   susceptibility}},
Keywords-Plus = {{PSYCHROTROPHIC BACTERIA; RAW-MILK; PHENOTYPIC CHARACTERIZATION;
   ANTIBIOTIC-RESISTANCE; AERUGINOSA; PRODUCTS; SOIL}},
Research-Areas = {{Agriculture; Food Science \& Technology}},
Web-of-Science-Categories  = {{Agriculture, Dairy \& Animal Science; Food Science \& Technology}},
Author-Email = {{arslan\_s3@ibu.edu.tr}},
ResearcherID-Numbers = {{Ozdemir, Fatma/A-5615-2018}},
ORCID-Numbers = {{Ozdemir, Fatma/0000-0002-4804-936X}},
Cited-References = {{BATES JL, 1963, J BACTERIOL, V86, P585.
   Bhunia AK, 2008, FOOD SCI TEXT SER, P1.
   Chen TR, 2011, FOOD CONTROL, V22, P697, DOI 10.1016/j.foodcont.2010.10.004.
   Clinical and Laboratory Standards Institute, 2007, M100S17 CLSI.
   COLLINS CH, 1989, COLLINS LYNES MICROB.
   Corona-Nakamura AL, 2001, ARCH MED RES, V32, P238, DOI 10.1016/S0188-4409(01)00267-3.
   Cousin M. A., 2001, COMPENDIUM METHODS M, P159.
   Dogan B, 2003, APPL ENVIRON MICROB, V69, P130, DOI 10.1128/AEM.69.1.130-138.2003.
   Ercolini D, 2009, FOOD MICROBIOL, V26, P228, DOI 10.1016/j.fm.2008.09.005.
   FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872.
   Garrity G, 2005, BERGEYS MANUAL SYSTE, V2, P323.
   GENNARI M, 1992, J APPL BACTERIOL, V72, P281, DOI 10.1111/j.1365-2672.1992.tb01836.x.
   Herrera AG, 2001, FOOD MICROBIOLOGY PR, P3.
   Hogg S, 2005, ESSENTIAL MICROBIOLO.
   Hsueh PR, 2005, INT J ANTIMICROB AG, V26, P463, DOI 10.1016/j.ijantimicag.2005.08.016.
   Jensen LB, 2001, ENVIRON INT, V26, P581, DOI 10.1016/S0160-4120(01)00045-9.
   KISKA DL, 1999, MANUAL CLIN MICROBIO, P517.
   Leriche F, 2004, J MICROBIOL METH, V59, P33, DOI 10.1016/j.mimet.2004.05.009.
   McDermott PF, 2002, ANIM BIOTECHNOL, V13, P71, DOI 10.1081/ABIO-120005771.
   Meghwanshi GK, 2006, J MOL CATAL B-ENZYM, V40, P127, DOI 10.1016/j.molcatb.2006.02.020.
   Moore E. R. B., 2006, PROKARYOTES, V6, P646, DOI DOI 10.1007/0-387-30746-X\_21.ED.
   Morales P, 2005, J AGR FOOD CHEM, V53, P6835, DOI 10.1021/jf050717b.
   Munsch-Alatossava P, 2007, MICROBIOL RES, V162, P115, DOI 10.1016/j.micres.2006.01.015.
   Munsch-Alatossava P, 2006, MICROBIOL RES, V161, P334, DOI 10.1016/j.micres.2005.12.004.
   Muthu SE, 2006, ARCH MED RES, V37, P95, DOI 10.1016/j.arcmed.2005.04.012.
   Ray B., 2004, FUNDAMENTAL FOOD MIC.
   Richter RL, 2001, COMPENDIUM METHODS M, P483.
   Ryan KJ, 2004, SHERRIS MED MICROBIO.
   Sorhaug T, 1997, TRENDS FOOD SCI TECH, V8, P35, DOI 10.1016/S0924-2244(97)01006-6.
   Uraz G, 1998, J BASIC MICROB, V38, P129, DOI 10.1002/(SICI)1521-4028(199805)38:2<129::AID-JOBM129>3.3.CO;2-D.
   Vermelho AB, 1996, MEM I OSWALDO CRUZ, V91, P755, DOI 10.1590/S0074-02761996000600020.
   Wiedmann M, 2000, APPL ENVIRON MICROB, V66, P2085, DOI 10.1128/AEM.66.5.2085-2095.2000.
   YAHR TL, 2006, PROKARYOTES, V6, P704, DOI DOI 10.1007/0-387-30746-X\_22.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{23}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{63}},
Journal-ISO = {{J. Dairy Sci.}},
Doc-Delivery-Number = {{850WA}},
Unique-ID = {{ISI:000297229000012}},
DA = {{2018-08-13}},
}

@article{ ISI:000298017100002,
Author = {Hoorfar, J.},
Title = {{Rapid detection, characterization, and enumeration of foodborne
   pathogens}},
Journal = {{APMIS}},
Year = {{2011}},
Volume = {{119}},
Number = {{133}},
Pages = {{1-24}},
Month = {{NOV}},
Abstract = {{As food safety management further develops, microbiological testing will
   continue to play an important role in assessing whether Food Safety
   Objectives are achieved. However, traditional microbiological
   culture-based methods are limited, particularly in their ability to
   provide timely data. The present review discusses the reasons for the
   increasing interest in rapid methods; current developments in the field,
   the research needs, and the future trends. The advent of biotechnology
   has introduced new technologies that led to the emergence of rapid
   diagnostic methods and altered food testing practices. Rapid methods are
   comprised of many different detection technologies, including
   specialized enzyme substrates, antibodies and DNA, ranging from simple
   differential plating media to the use of sophisticated instruments. The
   use of non-invasive sampling techniques for live animals especially came
   into focus with the 1990s outbreak of bovine spongiform encephalopathy
   that was linked to the human outbreak of Creutzfeldt Jakob's Disease.
   Serology is still an important tool in preventing foodborne pathogens to
   enter the human food supply through meat and milk from animals. One of
   the primary uses of rapid methods is for fast screening of large number
   of samples, where most of them are expected to be test-negative, leading
   to faster product release for sale. This has been the main strength of
   rapid methods such as real-time Polymerase Chain Reaction (PCR).
   Enrichment PCR, where a primary culture broth is tested in PCR, is the
   most common approach in rapid testing. Recent reports show that it is
   possible both to enrich a sample and enumerate by pathogen-specific
   real-time PCR, if the enrichment time is short. This can be especially
   useful in situations where food producers ask for the level of pathogen
   in a contaminated product. Another key issue is automation, where the
   key drivers are miniaturization and multiple testing, which mean that
   not only one instrument is flexible enough to test for many pathogens
   but also many pathogens can be detected with one test. The review is
   mainly based on the author's scientific work that has contributed with
   the following new developments to this field: (i) serologic tests for
   large-scale screening, surveillance, or eradication programs, (ii)
   same-day detection of Salmonella that otherwise was considered as
   difficult to achieve, (iii) pathogen enumeration following a short
   log-phase enrichment, (iv) detection of foodborne pathogens in air
   samples, and finally (v) biotracing of pathogens based on mathematical
   modeling, even in the absence of isolate. Rapid methods are discussed in
   a broad global health perspective, international food supply, and for
   improvement of quantitative microbial risk assessments. The need for
   quantitative sample preparation techniques, culture-independent,
   metagenomic-based detection, online monitoring, a global validation
   infrastructure has been emphasized. The cost and ease of use of rapid
   assays remain challenging obstacles to surmount.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hoorfar, J (Reprint Author), Tech Univ Denmark, Natl Food Inst, Morkhoj Bygade 19, DK-2860 Soborg, Denmark.
   Tech Univ Denmark, Natl Food Inst, DK-2860 Soborg, Denmark.}},
DOI = {{10.1111/j.1600-0463.2011.02767.x}},
ISSN = {{0903-4641}},
Keywords-Plus = {{REAL-TIME PCR; QUANTITATIVE RISK-ASSESSMENT; LINKED-IMMUNOSORBENT-ASSAY;
   ANTIMICROBIAL RESISTANCE GENES; SALMONELLA-ENTERICA; ESCHERICHIA-COLI;
   DNA MICROARRAY; DIAGNOSTIC PCR; FOOD SAFETY; THERMOTOLERANT
   CAMPYLOBACTERS}},
Research-Areas = {{Immunology; Microbiology; Pathology}},
Web-of-Science-Categories  = {{Immunology; Microbiology; Pathology}},
Author-Email = {{jhoo@food.dtu.dk}},
Funding-Acknowledgement = {{European Union {[}036272]}},
Funding-Text = {{This work was supported in part by the European Union-funded Integrated
   Project BIOTRACER (Contract 036272) under the 6th RTD Framework.}},
Cited-References = {{Abdulmawjood A, 2004, J AOAC INT, V87, P596.
   Abubakar I, 2007, HEALTH TECHNOL ASSES, V11, P1.
   ALVAREZ AJ, 1995, APPL ENVIRON MICROB, V61, P3639.
   Aprodu I, 2011, INT J FOOD MICROBIOL, V145, pS61, DOI 10.1016/j.ijfoodmicro.2010.09.018.
   Barker GC, 2009, TRENDS FOOD SCI TECH, V20, P220, DOI 10.1016/j.tifs.2009.03.002.
   Bauer M, 2010, INT J MED MICROBIOL, V300, P411, DOI 10.1016/j.ijmm.2010.04.006.
   Boone I, 2009, PREV VET MED, V92, P224, DOI 10.1016/j.prevetmed.2009.08.020.
   Brown TM, 2006, AM J PUBLIC HEALTH, V96, P62, DOI 10.2105/AJPH.2004.050831.
   Bruant G, 2006, APPL ENVIRON MICROB, V72, P3780, DOI 10.1128/AEM.72.5.3780-3784.2006.
   Cademartiri R, 2010, BIOMATERIALS, V31, P1904, DOI 10.1016/j.biomaterials.2009.11.029.
   {*}CDC, 2009, MMWR-MORBID MORTAL W, V58, P1.
   {*}CDC, 2007, MMWR-MORBID MORTAL W, V21, P521.
   {*}CDC, 2007, FOODB DIS ACT SURV N, P71726.
   Champion OL, 2005, P NATL ACAD SCI USA, V102, P16043, DOI 10.1073/pnas.0503252102.
   Cole M. B., 2005, Improving the safety of fresh meat, P673, DOI 10.1533/9781845691028.2.673.
   Croci L, 2008, FOOD ANAL METHOD, V1, P73, DOI 10.1007/s12161-008-9025-4.
   D'Agostino M, 2004, J FOOD PROTECT, V67, P1646, DOI 10.4315/0362-028X-67.8.1646.
   D'Aoust JY, 2007, J FOOD PROTECT, V70, P835, DOI 10.4315/0362-028X-70.4.835.
   DaCosta RS, 2007, THESCIENTIFICWORLDJO, V7, P2046, DOI 10.1100/tsw.2007.308.
   Dixon BR, 2011, RAPID DETECTION, CHARACTERIZATION, AND ENUMERATION OF FOODBORNE PATHOGENS, P349.
   Dwivedi HP, 2011, CRIT REV MICROBIOL, V37, P40, DOI 10.3109/1040841X.2010.506430.
   {[}FAO WHO], 1995, APPL RISK AN FOOD ST.
   FAO/WHO, 2003, MICR RISK ASS SER, V3.
   FAO/WHO, 2008, MICR RISK ASS SER, V7.
   {*}FAO WHO, 2002, MICR RISK ASS SER, V2.
   FAO/WHO, 2009, MICR RISK ASS SER, V12.
   Feng P., 2001, FOOD MICROBIOLOGY FU, V2nd, P775.
   Feng P, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P911.
   Food and Agriculture Organization, 2004, FAO WHO TECHN WORKSH.
   Food and Agriculture Organization and World Health Organization {[}FAO/WHO], 2008, MICR RISK ASS SER, V15.
   Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120.
   Goodridge LD, 2011, RAPID DETECTION, CHARACTERIZATION, AND ENUMERATION OF FOODBORNE PATHOGENS, P47.
   Goodridge LD, 2011, RAPID DETECTION, CHARACTERIZATION, AND ENUMERATION OF FOODBORNE PATHOGENS, P15.
   GRONLUND H, 2011, INT J FOOD MICROBIOL, P71726.
   Gullberg M, 2004, P NATL ACAD SCI USA, V101, P8420, DOI 10.1073/pnas.0400552101.
   Hamelin K, 2007, APPL ENVIRON MICROB, V73, P477, DOI 10.1128/AEM.01445-06.
   HOORFAR J, 1995, AM J VET RES, V56, P1549.
   Hoorfar J, 1998, FEMS MICROBIOL LETT, V169, P125, DOI 10.1016/S0378-1097(98)00474-1.
   Hoorfar J, 1996, VET MICROBIOL, V50, P81, DOI 10.1016/0378-1135(95)00199-9.
   Hoorfar J, 2004, APMIS, V112, P808, DOI 10.1111/j.1600-0463.2004.apm11211-1207.x.
   Hoorfar J, 2004, J CLIN MICROBIOL, V42, P1863, DOI 10.1128/JCM.42.5.1863-1868.2004.
   Hoorfar J., 2011, Tracing pathogens in the food chain, P377.
   Hoorfar J, 1997, AM J VET RES, V58, P334.
   Hoorfar J, 1999, ASM NEWS, V65, P799.
   Hoorfar J, 1999, J VET MED B, V46, P189, DOI 10.1046/j.1439-0450.1999.00223.x.
   HOORFAR J, 1995, CAN J VET RES, V59, P142.
   Hoorfar J, 2000, J CLIN MICROBIOL, V38, P3429.
   HOORFAR J, 2010, INT J FOOD MICROBIOL, P71726.
   Hoorfar J., 2002, METHOD MOL BIOL, V216, P51.
   Huehn S, 2009, METHODS MOL BIOL, V551, P249, DOI 10.1007/978-1-60327-999-4\_19.
   Huehn S, 2009, FOODBORNE PATHOG DIS, V6, P431, DOI 10.1089/fpd.2008.0221.
   Huehn S, 2009, APPL ENVIRON MICROB, V75, P1011, DOI 10.1128/AEM.02187-08.
   {*}ISO, 2003, 16140 ISO.
   Jaing C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002163.
   Jensen AN, 2002, J RAPID METH AUT MIC, V10, P231, DOI 10.1111/j.1745-4581.2002.tb00258.x.
   Jordan KN, 2011, WOODHEAD PUBL FOOD S, P23.
   Josefsen MH, 2007, APPL ENVIRON MICROB, V73, P3040, DOI 10.1128/AEM.02823-06.
   Josefsen MH, 2010, APPL ENVIRON MICROB, V76, P5097, DOI 10.1128/AEM.00411-10.
   Josefsen MH, 2009, MOL CELL PROBE, V23, P201, DOI 10.1016/j.mcp.2009.02.003.
   Josefsen MH, 2004, J MICROBIOL METH, V58, P39, DOI 10.1016/j.mimet.2004.03.001.
   Josefsen MH, 2004, APPL ENVIRON MICROB, V70, P3588, DOI 10.1128/AEM.70.6.3588-3592.2004.
   JOSEFSEN MH, 2002, INT J FOOD MICROBIOL, V80, P177.
   Kramer N, 2011, INT J FOOD MICROBIOL, V145, pS86, DOI 10.1016/j.ijfoodmicro.2010.08.026.
   Krause M, 2006, APPL ENVIRON MICROB, V72, P5463, DOI 10.1128/AEM.00291-06.
   Lewis T, 2010, J HOSP INFECT, V75, P37, DOI 10.1016/j.jhin.2010.01.012.
   Lind P, 1997, VET PARASITOL, V71, P1, DOI 10.1016/S0304-4017(97)00010-1.
   Lindqvist R, 2002, INT J FOOD MICROBIOL, V78, P155, DOI 10.1016/S0168-1605(02)00237-4.
   Litrup E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-96.
   Lofstrom C, 2011, INT J FOOD MICROBIOL, V145, pS103, DOI 10.1016/j.ijfoodmicro.2010.03.042.
   Lubeck Peter Stephensen, 2003, Methods Mol Biol, V216, P65.
   Madej RM, 2010, J MOL DIAGN, V12, P133, DOI 10.2353/jmoldx.2010.090067.
   Makino S, 2003, J MICROBIOL METH, V53, P141, DOI 10.1016/S0167-7012(03)00019-8.
   Malorny B, 2003, INT J FOOD MICROBIOL, V83, P39, DOI 10.1016/S0168-1605(02)00322-7.
   Martucci F, 2009, J GEN VIROL, V90, P1048, DOI 10.1099/vir.2008.007120-0.
   Morales-Rayas R, 2009, J FOOD PROTECT, V72, P2178, DOI 10.4315/0362-028X-72.10.2178.
   Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209.
   Myint MS, 2006, FOOD MICROBIOL, V23, P599, DOI 10.1016/j.fm.2005.09.002.
   Nakamura S, 2008, EMERG INFECT DIS, V14, P1784, DOI 10.3201/eid1411.080589.
   Neimann J, 2003, EPIDEMIOL INFECT, V130, P353, DOI 10.1017/S0950268803008355.
   Nielsen B, 1998, J VET DIAGN INVEST, V10, P158, DOI 10.1177/104063879801000207.
   Nielsen B, 1996, VET MICROBIOL, V48, P293, DOI 10.1016/0378-1135(95)00147-6.
   Nogva HK, 2003, BIOTECHNIQUES, V34, P804.
   Olsen KN, 2009, APPL ENVIRON MICROB, V75, P2074, DOI 10.1128/AEM.02182-08.
   Oscar TP, 2004, INT J FOOD MICROBIOL, V93, P231, DOI 10.1016/j.ijfoodmicro.2003.12.002.
   Pagotto F, 2008, J FOOD PROTECT, V71, P1434, DOI 10.4315/0362-028X-71.7.1434.
   Peeters S, 2010, BIOTECHNOL PROGR, V26, P1678, DOI 10.1002/btpr.492.
   Pires SM, 2010, FOODBORNE PATHOG DIS, V7, P1351, DOI 10.1089/fpd.2010.0564.
   Qvist S, 2011, RAPID DETECTION, CHARACTERIZATION, AND ENUMERATION OF FOODBORNE PATHOGENS, P157.
   RASFF, 2010, RASFF PORT.
   Reynisson E, 2006, J MICROBIOL METH, V66, P206, DOI 10.1016/j.mimet.2005.11.006.
   Reynisson E, 2011, RAPID DETECTION, CHARACTERIZATION, AND ENUMERATION OF FOODBORNE PATHOGENS, P63.
   Rider TH, 2003, SCIENCE, V301, P213, DOI 10.1126/science.1084920.
   Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3.
   Ross T, 2002, INT J FOOD MICROBIOL, V77, P39, DOI 10.1016/S0168-1605(02)00061-2.
   Rossmanith P, 2011, RAPID DETECTION, CHARACTERIZATION, AND ENUMERATION OF FOODBORNE PATHOGENS, P121.
   Rudi K, 2007, INT J FOOD MICROBIOL, V120, P95, DOI 10.1016/j.ijfoodmicro.2007.06.004.
   Rudi K, 2007, FOOD MICROBIOL, V24, P474, DOI 10.1016/j.fm.2006.09.006.
   Scheule B., 2001, Journal of Nutrition in Recipe \& Menu Development, V3, P3, DOI 10.1300/J071v03n02\_02.
   Schultz A.C., 2010, INT J FOOD MICROBIOL.
   Schultz AC, 2007, INT J FOOD MICROBIOL, V114, P352, DOI 10.1016/j.ijfoodmicro.2006.09.028.
   SMITH BP, 1995, J VET DIAGN INVEST, V7, P481, DOI 10.1177/104063879500700410.
   STETZENBACH JD, 2004, CURR OPIN BIOTECH, V15, P170.
   Stevens KA, 2004, CRIT REV MICROBIOL, V30, P7, DOI 10.1080/10408410490266410.
   Stromberg M, 2008, BIOSENS BIOELECTRON, V24, P696, DOI 10.1016/j.bios.2008.06.043.
   Tajiri-Utagawa E, 2009, J CLIN MICROBIOL, V47, P435, DOI 10.1128/JCM.01247-08.
   Tolba M, 2010, APPL ENVIRON MICROB, V76, P528, DOI 10.1128/AEM.02294-09.
   Trapmann S, 2004, ACCREDIT QUAL ASSUR, V9, P695, DOI 10.1007/s00769-004-0872-4.
   U.S. Food and Drug Administration, 2010, IMP REF REP OASIS.
   van Schothorst M, 2009, FOOD CONTROL, V20, P967, DOI 10.1016/j.foodcont.2008.11.005.
   Wegener HC, 2003, EMERG INFECT DIS, V9, P774.
   Wegener HC, 2010, MEAT SCI, V84, P276, DOI 10.1016/j.meatsci.2009.06.025.
   Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102.
   {*}WHO, 2007, FOOD SAF HLTH STRAT, P71726.
   Wolffs P, 2005, APPL ENVIRON MICROB, V71, P5759, DOI 10.1128/AEM.71.10.5759-5764.2005.
   World Health Organization, 2005, INT HLTH REG.
   World Trade Organization (WTO), 1995, RES UR ROUND MULT TR, P69.}},
Number-of-Cited-References = {{116}},
Times-Cited = {{31}},
Usage-Count-Last-180-days = {{4}},
Usage-Count-Since-2013 = {{77}},
Journal-ISO = {{APMIS}},
Doc-Delivery-Number = {{861KF}},
Unique-ID = {{ISI:000298017100002}},
DA = {{2018-08-13}},
}

@article{ ISI:000296521400008,
Author = {Marti, Sara and Chabane, Yassine Nait and Alexandre, Stephane and
   Coquet, Laurent and Vila, Jordi and Jouenne, Thierry and De, Emmanuelle},
Title = {{Growth of Acinetobacter baumannii in Pellicle Enhanced the Expression of
   Potential Virulence Factors}},
Journal = {{PLOS ONE}},
Year = {{2011}},
Volume = {{6}},
Number = {{10}},
Month = {{OCT 27}},
Abstract = {{Background: Interestingly, Acinetobacter baumannii presents an enhanced
   capacity to form biofilms (also named pellicles) at the air-liquid
   interface as compared to the other Acinetobacter species. This
   characteristic questions the contribution of this phenotype to an
   increased risk of clinical infections by this pathogen.
   Methodology/Principal Findings: By a proteomic approach using 2-D gel
   electrophoresis-LC-MS/MS mass spectrometry, we compared the membrane
   protein patterns of A. baumannii 77, a pellicle-forming clinical
   isolate, grown in planktonic and in sessile modes. We identified 52
   proteins with a differential expression, including 32 up-regulated and
   20 down-regulated in the pellicle state. Several proteins,
   differentially expressed during pellicle development, were of particular
   interest. We determined the over-expression of four siderophore iron
   uptake systems including the acinetobactin and enterobactin receptors
   and confirmed that the development of this type of biofilm is promoted
   by ferric ions. Two over-expressed proteins, CarO and an OprD-homologue,
   putative carbapenem-resistance associated porins, would be involved in
   the transport of specific compounds, like ornithine, a biosynthesis
   precursor of a siderophore from the hydroxamate family. We evidenced the
   overexpression of a lipase and a transporter of LCFA that may be
   involved in the recycling of lipids inside the pellicle matrix. Finally,
   we demonstrated both by proteomic and by AFM studies that this
   particular type of biofilm required multiple pili systems to maintain
   this cohesive structure at the air-liquid interface; two of these
   systems have never been described in A. baumannii.
   Conclusions/Significance: Our study demonstrated that several proteins,
   overexpressed at a late state of pellicle development, could be
   potentially involved in virulence processes. Therefore, regarding the
   number of potential virulence factors that are over-expressed in this
   growth mode, the pellicle-forming clinical isolates should be kept under
   survey.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Marti, S (Reprint Author), Univ Rouen, Lab Polymeres Biopolymeres Surfaces, UMR 6270, CNRS, Mont St Aignan, France.
   Marti, Sara; Chabane, Yassine Nait; Alexandre, Stephane; Coquet, Laurent; Jouenne, Thierry; De, Emmanuelle, Univ Rouen, CNRS, FR 3038, Lab Polymeres Biopolymeres Surfaces, Mont St Aignan, France.
   Vila, Jordi, Hosp Clin Barcelona, Dept Microbiol, Barcelona, Spain.
   Marti, Sara; Chabane, Yassine Nait; Alexandre, Stephane; Coquet, Laurent; Jouenne, Thierry; De, Emmanuelle, Univ Rouen, Lab Polymeres Biopolymeres Surfaces, UMR 6270, CNRS, Mont St Aignan, France.}},
DOI = {{10.1371/journal.pone.0026030}},
Article-Number = {{e26030}},
ISSN = {{1932-6203}},
Keywords-Plus = {{OUTER-MEMBRANE PROTEIN; PSEUDOMONAS-AERUGINOSA BIOFILMS;
   ESCHERICHIA-COLI; EPITHELIAL-CELLS; ABIOTIC SURFACES; TRANSMEMBRANE
   PASSAGE; MULTIDRUG-RESISTANCE; PROTEOMIC ANALYSIS; FLUORESCENS SBW25;
   DRY SURFACES}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{emmanuelle.de@univ-rouen.fr}},
ResearcherID-Numbers = {{Vila, Jordi/P-3613-2016
   Marti, Sara/D-4823-2014
   Chiang, Vincent, Ming-Hsien/D-4312-2016
   }},
ORCID-Numbers = {{Vila, Jordi/0000-0002-8025-3926
   Marti, Sara/0000-0002-0405-2305
   Chiang, Vincent, Ming-Hsien/0000-0002-2029-7863
   jouenne, thierry/0000-0003-0994-9944}},
Funding-Acknowledgement = {{Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica
   (SEIMC); Haute-Normandie region}},
Funding-Text = {{SM has a post-doctoral fellowship from the Sociedad Espanola de
   Enfermedades Infecciosas y Microbiologia Clinica (SEIMC) and YNC a
   doctoral fellowship from the Haute-Normandie region. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.}},
Cited-References = {{Adewoye LO, 1999, CAN J MICROBIOL, V45, P1033, DOI 10.1139/cjm-45-12-1033.
   Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X.
   Arhin A, 2010, MICROBIOL-SGM, V156, P1415, DOI 10.1099/mic.0.033472-0.
   Azghani AO, 2002, MICROB PATHOGENESIS, V33, P109, DOI 10.1006/mpat.2002.0514.
   Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102.
   Barrios AFG, 2006, BIOTECHNOL BIOENG, V93, P188, DOI 10.1002/bit.20681.
   Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x.
   BLACK PN, 1987, J BIOL CHEM, V262, P1412.
   Blonder J, 2004, EXPERT REV PROTEOMIC, V1, P153, DOI 10.1586/14789450.1.2.153.
   Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006.
   Cai Y, 2009, J PHARM PHARMACOL, V61, P1257, DOI 10.1211/jpp/61.09.0017.
   Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834.
   Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x.
   Collet A, 2008, J PROTEOME RES, V7, P4659, DOI 10.1021/pr8001723.
   Coquet L, 2005, J PROTEOME RES, V4, P1988, DOI 10.1021/pr050165c.
   Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000.
   de Breij A, 2009, RES MICROBIOL, V160, P213, DOI 10.1016/j.resmic.2009.01.002.
   DEBEER D, 1994, APPL ENVIRON MICROB, V60, P4339.
   Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789.
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063.
   Dupont M, 2005, J PROTEOME RES, V4, P2386, DOI 10.1021/rp050143q.
   Eijkelkamp BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-126.
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415.
   Flemming HC, 2001, WATER SCI TECHNOL, V43, P1.
   Folsom JP, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-294.
   Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007.
   Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x.
   Fronzes R, 2008, EMBO J, V27, P2271, DOI 10.1038/emboj.2008.155.
   Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09.
   Gohl O, 2006, APPL ENVIRON MICROB, V72, P1394, DOI 10.1128/AEM.72.2.1394-1401.2006.
   GOLDSTEIN R, 1995, J BACTERIOL, V177, P1039, DOI 10.1128/jb.177.4.1039-1052.1995.
   Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x.
   Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7.
   Hearn EM, 2009, NATURE, V458, P367, DOI 10.1038/nature07678.
   Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09.
   Jawad A, 1996, J CLIN MICROBIOL, V34, P2881.
   Jawad A, 1998, J CLIN MICROBIOL, V36, P1938.
   Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027.
   Kang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013557.
   Koza A, 2009, MICROBIOL-SGM, V155, P1397, DOI 10.1099/mic.0.025064-0.
   Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011.
   LEISMAN GB, 1995, APPL ENVIRON MICROB, V61, P200.
   Leopold K, 1997, MICROBIOL-UK, V143, P1019, DOI 10.1099/00221287-143-3-1019.
   Lower BH, 2005, J BACTERIOL, V187, P2127, DOI 10.1128/JB.187.6.2127-2137.2005.
   Ma Q, 2009, ENVIRON MICROBIOL, V11, P2735, DOI 10.1111/j.1462-2920.2009.02000.x.
   MARTI S, 2006, PROTEOMICS, V6, P82.
   Marti Sara, 2011, BMC Res Notes, V4, P5, DOI 10.1186/1756-0500-4-5.
   Miller RM, 2008, J BACTERIOL, V190, P4038, DOI 10.1128/JB.00129-08.
   Musk DJ, 2005, CHEM BIOL, V12, P789, DOI 10.1016/j.chembiol.2005.05.007.
   Mussi MA, 2005, ANTIMICROB AGENTS CH, V49, P1432, DOI 10.1128/AAC.49.4.1432-1440.2005.
   Mussi MA, 2007, FEBS LETT, V581, P5573, DOI 10.1016/j.febslet.2007.10.063.
   Nucleo E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-270.
   Nwugo CC, 2011, J PROTEOMICS, V74, P44, DOI 10.1016/j.jprot.2010.07.010.
   O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x.
   Otto K, 2002, P NATL ACAD SCI USA, V99, P2287, DOI 10.1073/pnas.042521699.
   Otto Karen, 2001, Journal of Bacteriology, V183, P2445, DOI 10.1128/JB.183.8.2445-2453.2001.
   Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07.
   Pimenta AD, 2003, MICROBES INFECT, V5, P1177, DOI 10.1016/j.micinf.2003.09.002.
   Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4.
   RABILLOUD T, 1994, CELL MOL BIOL, V40, P57.
   Raymond KN, 2004, IRON TRANSPORT IN BACTERIA, P3.
   Rebiere-Huet J, 2002, FEMS MICROBIOL LETT, V215, P121, DOI 10.1016/S0378-1097(02)00920-5.
   Rodriguez-Bano J, 2008, CLIN MICROBIOL INFEC, V14, P276, DOI 10.1111/j.1469-0691.2007.01916.x.
   Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002.
   Scher K, 2007, BIOFOULING, V23, P385, DOI 10.1080/08927010701648265.
   Seyer D, 2005, BIOFILMS, V2, P27, DOI DOI 10.1017/S1479050505001638.
   Shin JH, 2009, J MICROBIOL, V47, P728, DOI 10.1007/s12275-009-0158-y.
   Siroy A, 2006, J PROTEOME RES, V5, P3385, DOI 10.1021/pr060372s.
   Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307.
   Spiers AJ, 2005, MICROBIOL-SGM, V151, P2829, DOI {[}10.1099/mic.0.27984-0, 10.1099/mic.027984-0].
   Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002.
   Tamber S, 2007, J BACTERIOL, V189, P929, DOI 10.1128/JB.01296-06.
   Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0.
   TOWNER K, 2006, PROKARYOTES, V6, P746.
   Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805.
   van den Berg B, 2010, CHEMBIOCHEM, V11, P1339, DOI 10.1002/cbic.201000105.
   Vila J, 2002, J ANTIMICROB CHEMOTH, V49, P471, DOI 10.1093/jac/49.3.471.
   Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509.
   Vilain S, 2004, ANAL BIOCHEM, V329, P120, DOI 10.1016/j.ab.2004.02.014.
   Werner E, 2004, APPL ENVIRON MICROB, V70, P6188, DOI 10.1128/AEM.70.10.6188-6196.2004.
   Xu KD, 1998, APPL ENVIRON MICROB, V64, P4035.
   YAMANO Y, 1993, MOL MICROBIOL, V8, P993, DOI 10.1111/j.1365-2958.1993.tb01643.x.
   Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0.
   Zimbler D, 2009, BIOMETALS, V22, P23, DOI 10.1007/s10534-008-9202-3.}},
Number-of-Cited-References = {{84}},
Times-Cited = {{35}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{16}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{841OJ}},
Unique-ID = {{ISI:000296521400008}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000295837000005,
Author = {Marshall, Bonnie M. and Levy, Stuart B.},
Title = {{Food Animals and Antimicrobials: Impacts on Human Health}},
Journal = {{CLINICAL MICROBIOLOGY REVIEWS}},
Year = {{2011}},
Volume = {{24}},
Number = {{4}},
Pages = {{718+}},
Month = {{OCT}},
Abstract = {{Antimicrobials are valuable therapeutics whose efficacy is seriously
   compromised by the emergence and spread of antimicrobial resistance. The
   provision of antibiotics to food animals encompasses a wide variety of
   nontherapeutic purposes that include growth promotion. The concern over
   resistance emergence and spread to people by nontherapeutic use of
   antimicrobials has led to conflicted practices and opinions.
   Considerable evidence supported the removal of nontherapeutic
   antimicrobials (NTAs) in Europe, based on the ``precautionary
   principle.{''} Still, concrete scientific evidence of the favorable
   versus unfavorable consequences of NTAs is not clear to all
   stakeholders. Substantial data show elevated antibiotic resistance in
   bacteria associated with animals fed NTAs and their food products. This
   resistance spreads to other animals and humans-directly by contact and
   indirectly via the food chain, water, air, and manured and
   sludge-fertilized soils. Modern genetic techniques are making advances
   in deciphering the ecological impact of NTAs, but modeling efforts are
   thwarted by deficits in key knowledge of microbial and antibiotic loads
   at each stage of the transmission chain. Still, the substantial and
   expanding volume of evidence reporting animal-to-human spread of
   resistant bacteria, including that arising from use of NTAs, supports
   eliminating NTA use in order to reduce the growing environmental load of
   resistance genes.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Levy, SB (Reprint Author), Tufts Univ, Sch Med, Dept Mol Biol \& Microbiol, Ctr Adaptat Genet \& Drug Resistance, 136 Harrison Ave,M\&V 803, Boston, MA 02111 USA.
   Marshall, Bonnie M.; Levy, Stuart B., Tufts Univ, Sch Med, Dept Mol Biol \& Microbiol, Ctr Adaptat Genet \& Drug Resistance, Boston, MA 02111 USA.
   Marshall, Bonnie M., Alliance Prudent Use Antibiot, Boston, MA USA.
   Levy, Stuart B., Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA.}},
DOI = {{10.1128/CMR.00002-11}},
ISSN = {{0893-8512}},
EISSN = {{1098-6618}},
Keywords-Plus = {{RESISTANT STAPHYLOCOCCUS-AUREUS; FECAL ESCHERICHIA-COLI; SWINE-FEEDING
   OPERATION; LARGE-SCALE SWINE; METHICILLIN-RESISTANT;
   ENTEROCOCCUS-FAECIUM; VANCOMYCIN-RESISTANT; GROWTH PROMOTERS;
   ANTIBIOTIC-RESISTANCE; CAMPYLOBACTER-JEJUNI}},
Research-Areas = {{Microbiology}},
Web-of-Science-Categories  = {{Microbiology}},
Author-Email = {{stuart.levy@tufts.edu}},
Funding-Acknowledgement = {{Pew Charitable Trusts}},
Funding-Text = {{B. M. Marshall was supported in part by The Pew Charitable Trusts. S. B.
   Levy is a consultant.}},
Cited-References = {{Aarestrup FM, 1998, MICROB DRUG RESIST, V4, P307, DOI 10.1089/mdr.1998.4.307.
   Aarestrup FM, 1999, INT J ANTIMICROB AG, V12, P279, DOI 10.1016/S0924-8579(99)90059-6.
   Aarestrup FM, 2000, MICROB DRUG RESIST, V6, P71, DOI 10.1089/mdr.2000.6.71.
   Aarestrup FM, 1996, ANTIMICROB AGENTS CH, V40, P1938.
   Aarestrup FM, 2001, ANTIMICROB AGENTS CH, V45, P2054, DOI 10.1128/AAC.45.7.2054-2059.2001.
   Aarestrup FM, 2000, DIAGN MICR INFEC DIS, V37, P127, DOI 10.1016/S0732-8893(00)00130-9.
   Aarestrup FM, 2010, AM J VET RES, V71, P726, DOI 10.2460/ajvr.71.7.726.
   Akwar TH, 2007, MICROB DRUG RESIST, V13, P69, DOI 10.1089/mdr.2006.9999.
   Alexander TW, 2008, APPL ENVIRON MICROB, V74, P4405, DOI 10.1128/AEM.00489-08.
   Alexander TW, 2010, INT J FOOD MICROBIOL, V137, P40, DOI 10.1016/j.ijfoodmicro.2009.11.008.
   {*}ALPH INC AN HLTH, 2007, REC, V6, P1.
   Anderson SA, 2001, FOOD CONTROL, V12, P13, DOI 10.1016/S0956-7135(00)00014-1.
   Angulo FJ, 2004, J VET MED B, V51, P374, DOI 10.1111/j.1439-0450.2004.00789.x.
   Arnold S, 2004, PHARMACOEPIDEM DR S, V13, P323, DOI 10.1002/pds.874.
   Aubry-Damon H, 2004, EMERG INFECT DIS, V10, P873, DOI 10.3201/eid1005.030735.
   Bager F, 1999, MICROB DRUG RESIST, V5, P53, DOI 10.1089/mdr.1999.5.53.
   Bager F, 1997, PREV VET MED, V31, P95, DOI 10.1016/S0167-5877(96)01119-1.
   Bailar JC, 2002, CLIN INFECT DIS, V34, pS135, DOI 10.1086/340252.
   Bartholomew MJ, 2005, RISK ANAL, V25, P99, DOI 10.1111/j.0272-4332.2005.00570.x.
   BARTLETT J, 2003, MEDSCAPE INFECT 1215.
   Barza M, 2002, CLIN INFECT DIS, V34, pS76.
   BARZA MD, 2002, CLIN INFECT DIS S3, V34.
   BATES J, 1994, J ANTIMICROB CHEMOTH, V34, P507, DOI 10.1093/jac/34.4.507.
   Benbrook C.M., 2002, ANTIBIOTIC DRUG USE.
   Berge ACB, 2009, J DAIRY SCI, V92, P4707, DOI 10.3168/jds.2009-2199.
   Berge ACB, 2005, PREV VET MED, V69, P25, DOI 10.1016/j.prevetmed.2005.01.013.
   Bertrand S, 2006, J CLIN MICROBIOL, V44, P2897, DOI 10.1128/JCM.02549-05.
   Boerlin P, 2001, J CLIN MICROBIOL, V39, P4193, DOI 10.1128/JCM.39.11.4193-4195.2001.
   Borgen K, 2000, FEMS MICROBIOL LETT, V191, P255, DOI 10.1016/S0378-1097(00)00399-2.
   Brooks JP, 2009, J ENVIRON QUAL, V38, P2431, DOI 10.2134/jeq2008.0471.
   Butaye P, 2003, CLIN MICROBIOL REV, V16, P175, DOI 10.1128/CMR.16.2.175-188.2003.
   Bywater R, 2004, J ANTIMICROB CHEMOTH, V54, P744, DOI 10.1093/jac/dkh422.
   Bywater RJ, 2005, POULTRY SCI, V84, P644, DOI 10.1093/ps/84.4.644.
   Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x.
   Cabello FC, 2004, REV MED CHILE, V132, P1001, DOI 10.4067/S0034-98872004000800014.
   Campagnolo ER, 2002, SCI TOTAL ENVIRON, V299, P89, DOI 10.1016/S0048-9697(02)00233-4.
   Carnevale RA, 2005, MED MALADIES INFECT, V35, P105, DOI 10.1016/j.medmal.2005.01.002.
   Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249.
   {*}CDC, 2010, GET SMART KNOW ANTIB.
   Chapin A, 2005, ENVIRON HEALTH PERSP, V113, P137, DOI 10.1289/ehp.7473.
   CHASLUSDANCLA E, 1991, ANTIMICROB AGENTS CH, V35, P590, DOI 10.1128/AAC.35.3.590.
   Chee-Sanford JC, 2001, APPL ENVIRON MICROB, V67, P1494, DOI 10.1128/AEM.67.4.1494-1502.2001.
   Chiller TM, 2004, J ANTIMICROB CHEMOTH, V54, P275, DOI 10.1093/jac/dkh263.
   Cox LA, 2004, RISK ANAL, V24, P271, DOI 10.1111/j.0272-4332.2004.00428.x.
   Cox LA, 2008, ENVIRON INT, V34, P459, DOI 10.1016/j.envint.2007.10.010.
   Cox LA, 2010, RISK ANAL, V30, P432, DOI 10.1111/j.1539-6924.2009.01340.x.
   da Costa PM, 2010, PREV VET MED, V93, P71, DOI 10.1016/j.prevetmed.2009.09.012.
   {*}DANMAP, 2008, CONS ANT AG OCC ANT.
   de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007.
   de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027.
   Diarra MS, 2007, APPL ENVIRON MICROB, V73, P6566, DOI 10.1128/AEM.01086-07.
   Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634.
   Dolliver H, 2007, J ENVIRON QUAL, V36, P1224, DOI 10.2134/jeq2006.0266.
   Donabedian SM, 2003, J CLIN MICROBIOL, V41, P1109, DOI 10.1128/JCM.41.3.1109-1113.2003.
   Dumonceaux TJ, 2006, APPL ENVIRON MICROB, V72, P2815, DOI 10.1128/AEM.72.4.2815-2823.2006.
   Duran GM, 2005, J FOOD PROTECT, V68, P2395, DOI 10.4315/0362-028X-68.11.2395.
   Dutil L, 2010, EMERG INFECT DIS, V16, P48, DOI 10.3201/eid1601.090729.
   Ekkelenkamp M B, 2006, Ned Tijdschr Geneeskd, V150, P2442.
   Emborg HD, 2007, MICROB DRUG RESIST, V13, P289, DOI 10.1089/mdr.2007.746.
   Emborg HD, 2003, INT J FOOD MICROBIOL, V84, P273, DOI 10.1016/S0168-1605(02)00426-9.
   ENDTZ HP, 1991, J ANTIMICROB CHEMOTH, V27, P199, DOI 10.1093/jac/27.2.199.
   ERVIK A, 1994, DIS AQUAT ORGAN, V18, P45, DOI 10.3354/dao018045.
   Fairchild AS, 2005, APPL ENVIRON MICROB, V71, P5865, DOI 10.1128/AEM.71.10.5865-5872.2005.
   FAO, 2007, STAT WORLD FISH AQ 2.
   FDA, 2009, SUMM REP ANT SOLD DI.
   {*}FDA, 2010, JUD US MED IN PRESS.
   Ferber D, 2002, SCIENCE, V295, P27.
   Fey PD, 2000, NEW ENGL J MED, V342, P1242, DOI 10.1056/NEJM200004273421703.
   Franklin A, 1999, ACTA VET SCAND, P23.
   Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119.
   Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910.
   Gilbert JM, 2007, FUTURE MICROBIOL, V2, P493, DOI 10.2217/17460913.2.5.493.
   Gorbach SL, 2001, NEW ENGL J MED, V345, P1202, DOI 10.1056/NEJM200110183451610.
   Graslund S, 2003, MAR POLLUT BULL, V46, P81, DOI 10.1016/S0025-326X(02)00320-X.
   Grave K, 2006, PREV VET MED, V75, P123, DOI 10.1016/j.prevetmed.2006.02.003.
   Grave K, 2004, PREV VET MED, V62, P59, DOI 10.1016/j.prevetmed.2003.08.009.
   Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990.
   Gupta A, 2004, EMERG INFECT DIS, V10, P1102, DOI 10.3201/eid1006.030635.
   Hammerum AM, 2000, J ANTIMICROB CHEMOTH, V45, P677, DOI 10.1093/jac/45.5.677.
   Hamscher G, 2003, ENVIRON HEALTH PERSP, V111, P1590, DOI 10.1289/ehp.6288.
   Hanselman BA, 2006, EMERG INFECT DIS, V12, P1933.
   Hershberger E, 2005, J ANTIMICROB CHEMOTH, V55, P127, DOI 10.1093/jac/dkh508.
   Heuer OE, 2002, MICROB DRUG RESIST, V8, P355, DOI 10.1089/10766290260469624.
   Heuer OE, 2009, CLIN INFECT DIS, V49, P1248, DOI 10.1086/605667.
   Ho PL, 2010, J MED MICROBIOL, V59, P702, DOI {[}10.1099/jmm.0.015032.0, 10.1099/jmm.0.015032-0].
   HOLMBERG SD, 1984, SCIENCE, V225, P833, DOI 10.1126/science.6382605.
   HOLMBERG SD, 1984, NEW ENGL J MED, V311, P617, DOI 10.1056/NEJM198409063111001.
   HOWELLS CHL, 1975, LANCET, V1, P156.
   HUMMEL R, 1986, J BASIC MICROB, V26, P461, DOI 10.1002/jobm.3620260806.
   Hurd HS, 2008, RISK ANAL, V28, P695, DOI 10.1111/j.1539-6924.2008.01054.x.
   Inglis GD, 2005, APPL ENVIRON MICROB, V71, P3872, DOI 10.1128/AEM.71.7.3872-3881.2005.
   Jackson CR, 2004, APPL ENVIRON MICROB, V70, P4205, DOI 10.1128/AEM.70.7.4205-4210.2004.
   Johnson JR, 2007, EMERG INFECT DIS, V13, P838, DOI 10.3201/eid1306.061576.
   Johnson JR, 2006, J INFECT DIS, V194, P71, DOI 10.1086/504921.
   Jones FT, 2003, POULTRY SCI, V82, P613, DOI 10.1093/ps/82.4.613.
   Kaszanyitzky EJ, 2007, INT J FOOD MICROBIOL, V115, P119, DOI 10.1016/j.ijfoodmicro.2006.10.004.
   Katsunuma Y, 2007, J GEN APPL MICROBIOL, V53, P273, DOI 10.2323/jgam.53.273.
   Kelly L, 2004, INT J ANTIMICROB AG, V24, P205, DOI 10.1016/j.ijantimicag.2004.04.007.
   Khachatryan AR, 2006, APPL ENVIRON MICROB, V72, P4583, DOI 10.1128/AEM.02584-05.
   Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006.
   Klare I, 1999, MICROB DRUG RESIST, V5, P45, DOI 10.1089/mdr.1999.5.45.
   Kriebel D, 2001, ENVIRON HEALTH PERSP, V109, P871, DOI 10.2307/3454986.
   KRUSE H, 1994, APPL ENVIRON MICROB, V60, P4015.
   Kumar K, 2005, ADV AGRON, V87, P1, DOI 10.1016/S0065-2113(05)87001-4.
   Labbate Maurizio, 2009, V532, P103, DOI 10.1007/978-1-60327-853-9\_6.
   Lauderdale TL, 2007, ENVIRON MICROBIOL, V9, P819, DOI 10.1111/j.1462-2920.2006.01189.x.
   Lee JH, 2003, APPL ENVIRON MICROB, V69, P6489, DOI {[}10.1128/AEM.69.11.6489-6494.2003, 10.1128/AEM.69.11.6489-6496.2003].
   LEVY SB, 1976, NEW ENGL J MED, V295, P583, DOI 10.1056/NEJM197609092951103.
   LEVY SB, 1976, NATURE, V260, P40, DOI 10.1038/260040a0.
   Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145.
   Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46.
   Levy SB, 2002, ANTIBIOTIC PARADOX M.
   Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576.
   Luangtongkum T, 2006, APPL ENVIRON MICROB, V72, P3600, DOI 10.1128/AEM.72.5.3600-3607.2006.
   Mellon M., 2001, HOGGING IT ESTIMATES.
   Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902.
   NOBLE WC, 1992, FEMS MICROBIOL LETT, V93, P195.
   Normanno G, 2007, INT J FOOD MICROBIOL, V117, P219, DOI 10.1016/j.ijfoodmicro.2007.04.006.
   Ochieng D. J., 2009, MICROBE, V4, P231.
   Pantosti A, 1999, LANCET, V354, P741, DOI 10.1016/S0140-6736(99)02395-8.
   Perreten V, 2005, FRONTIERS IN ANTIMICROBIAL RESISTANCE: A TRIBUTE TO STUART B. LEVY, P446.
   Petersen A, 2002, APPL ENVIRON MICROB, V68, P6036, DOI 10.1128/AEM.68.12.6036-6042.2002.
   Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483.
   Post V, 2007, ANTIMICROB AGENTS CH, V51, P3467, DOI 10.1128/AAC.00220-07.
   Price LB, 2007, ENVIRON HEALTH PERSP, V115, P1738, DOI 10.1289/ehp.10191.
   Rhodes G, 2000, APPL ENVIRON MICROB, V66, P3883, DOI 10.1128/AEM.66.9.3883-3890.2000.
   SANCHEZ R, 1994, ANTIMICROB AGENTS CH, V38, P1879, DOI 10.1128/AAC.38.9.1879.
   Sapkota AR, 2006, LETT APPL MICROBIOL, V43, P534, DOI 10.1111/j.1472-765X.2006.01996.x.
   Schroeder CM, 2003, INT J FOOD MICROBIOL, V85, P197, DOI 10.1016/S0168-1605(02)00508-1.
   Sharma R, 2008, APPL ENVIRON MICROB, V74, P6178, DOI 10.1128/AEM.00704-08.
   SHOTWELL TK, 2009, SUPERBUGS E COLI SAL.
   Smith DL, 2003, LANCET INFECT DIS, V3, P241, DOI 10.1016/S1473-3099(03)00581-4.
   Smith DL, 2002, P NATL ACAD SCI USA, V99, P6434, DOI 10.1073/pnas.082188899.
   SMITH H. W., 1957, Veterinary Record, V69, P24.
   Smith KE, 1999, NEW ENGL J MED, V340, P1525, DOI 10.1056/NEJM199905203402001.
   Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258.
   Sorensen TL, 2001, NEW ENGL J MED, V345, P1161, DOI 10.1056/NEJMoa010692.
   Sorum H, 1999, ACTA VET SCAND, P29.
   SOrum H., 2006, ANTIMICROBIAL RESIST, P213.
   STOKSTAD ELR, 1950, P SOC EXP BIOL MED, V73, P523.
   Summers AO, 2002, CLIN INFECT DIS, V34, pS85, DOI 10.1086/340245.
   Swann M. M., 1969, REPORT JOINT COMMITT.
   TACKET CO, 1985, JAMA-J AM MED ASSOC, V253, P2058, DOI 10.1001/jama.253.14.2058.
   TSCHAPE H, 1994, FEMS MICROBIOL ECOL, V15, P23, DOI 10.1111/j.1574-6941.1994.tb00226.x.
   U. S. Food and Drug Administration (FDA), 2000, FDA TASK FORC ANT RE.
   van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760.
   van den Bogaard AE, 2000, J ANTIMICROB CHEMOTH, V46, P146, DOI 10.1093/jac/46.1.146.
   van den Bogaard AE, 2002, J ANTIMICROB CHEMOTH, V49, P497, DOI 10.1093/jac/49.3.497.
   van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384.
   van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672.
   VANLEEUWEN WJ, 1986, TIJDSCHR DIERGENEESK, V111, P9.
   Varga C, 2009, FOODBORNE PATHOG DIS, V6, P23, DOI 10.1089/fpd.2008.0118.
   Varga C, 2009, PREV VET MED, V88, P185, DOI 10.1016/j.prevetmed.2008.10.002.
   Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428.
   WEBER JT, 1994, EPIDEMIOL INFECT, V112, P1, DOI 10.1017/S0950268800057368.
   Wegener HC, 2003, ASM NEWS, V69, P443.
   WHO, 2006, ANT US AQ ANT RES RE.
   WHO, 1997, MED IMP US ANT FOOD.
   WHO, 2002, IMP ANT GROWTH PROM.
   Wierup M, 2001, MICROB DRUG RESIST, V7, P183, DOI 10.1089/10766290152045066.
   Winokur PL, 2001, ANTIMICROB AGENTS CH, V45, P2716, DOI 10.1128/AAC.45.10.2716-2722.2001.
   Witte W, 2000, INT J ANTIMICROB AG, V16, pS19.
   Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924.
   Zhang XY, 2009, RES VET SCI, V87, P449, DOI 10.1016/j.rvsc.2009.05.006.
   Zhao S, 2003, J CLIN MICROBIOL, V41, P5366, DOI 10.1128/JCM.41.12.5366-5371.2003.
   2010, HEARING ANTIBIOTIC R.}},
Number-of-Cited-References = {{166}},
Times-Cited = {{499}},
Usage-Count-Last-180-days = {{13}},
Usage-Count-Since-2013 = {{217}},
Journal-ISO = {{Clin. Microbiol. Rev.}},
Doc-Delivery-Number = {{832VL}},
Unique-ID = {{ISI:000295837000005}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000295669000005,
Author = {Di Naso, F. C. and Pereira, J. S. and Schuh, S. J. and Unis, G.},
Title = {{Functional evaluation in patients with pulmonary tuberculosis sequelae}},
Journal = {{REVISTA PORTUGUESA DE PNEUMOLOGIA}},
Year = {{2011}},
Volume = {{17}},
Number = {{5}},
Pages = {{216-221}},
Month = {{SEP-OCT}},
Abstract = {{Introduction: In pulmonary tuberculosis, the presence of extensive
   residual lung lesions can be a predictor of permanent disability due to
   respiratory failure.
   Objective: To compare functional and respiratory changes in patients
   with pulmonary tuberculosis sequel who have completed treatment.
   Method: The study included patients who completed treatment within a
   period of 6 months (group I) and multidrug-resistant pulmonary
   tuberculosis patients who completed treatments of longer duration after
   the failure of the initial treatment (group II). We evaluated lung
   function by spirometry (Microlab ML 3500), the strength of respiratory
   muscles through the manovacuometry (MEP-maximal expiratory pressure and
   MIP- maximal inspiratory pressure) and the distance walked during the
   6-minute walk (6MWT).
   Results: 27 patients were included, 12 of whom belonged to group II,
   multidrug-resistant tuberculosis (MDRTB). Severe combined respiratory
   disorder was the most prevalent problem in group It of MDRTB; it was
   present in 9 patients. The MDRTB group (group II) showed significantly
   lower values when compared to Group I in FVC (72.06 +/- 14.95 vs 43.58
   +/- 16.03\% predicted), FEV1 (66.13 +/- 19.87 vs 33.08 +/- 15.64\%
   predicted), MIP (68.40 +/- 22.78 vs 49.58 +/- 12.55 cmH(2)O), MEP (87.20
   +/- 27.30 vs 59.08 +/- 12.23 cmH(2)O) and distance covered in 6MWT
   (484.21 +/- 74.01 vs 334.75 +/- 104.07 meters).
   Conclusion: Patients with multidrug resistant pulmonary tuberculosis who
   have undergone multiple treatments have more severe respiratory and
   functional impairment than patients who have had just a single
   treatment. (C) 2011 Sociedade Portuguesa de Pneumologia. Published by
   Elsevier Espana, S.L. All rights reserved.}},
Publisher = {{ELSEVIER DOYMA SL}},
Address = {{TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN}},
Type = {{Article}},
Language = {{Portuguese}},
Affiliation = {{Di Naso, FC (Reprint Author), Hosp Sanatorio Partenon, Serv Fisioterapia, Porto Alegre, RS, Brazil.
   Di Naso, F. C.; Pereira, J. S., Hosp Sanatorio Partenon, Serv Fisioterapia, Porto Alegre, RS, Brazil.
   Schuh, S. J., Hosp Sanatorio Partenon, Serv Radiol, Porto Alegre, RS, Brazil.
   Di Naso, F. C.; Unis, G., Hosp Sanatorio Partenon, Serv Pneumol, Porto Alegre, RS, Brazil.}},
DOI = {{10.1016/j.rppneu.2011.06.010}},
ISSN = {{0873-2159}},
Keywords = {{Tuberculosis; Spirometry; Functional}},
Keywords-Plus = {{AIR-FLOW OBSTRUCTION; LUNG-FUNCTION; IMPAIRMENT; GUIDELINES; DIAGNOSIS;
   RECIFE; BRAZIL; DELAY; COPD}},
Research-Areas = {{Respiratory System}},
Web-of-Science-Categories  = {{Respiratory System}},
Author-Email = {{fdinaso@yahoo.com.br}},
Cited-References = {{Ando M, 2003, CHEST, V123, P1988, DOI 10.1378/chest.123.6.1988.
   Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011.
   Conde MB, 2009, J BRAS PNEUMOL, V35, P497, DOI 10.1590/S1806-37132009000600001.
   Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111.
   de Valliere S, 2004, INT J TUBERC LUNG D, V8, P767.
   dos Santos MAPS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-25.
   Fang XZ, 1997, ACTA CYTOL, V41, P1463, DOI 10.1159/000332860.
   Gonzalez C, 2008, CHEST, V133, P941, DOI 10.1378/chest.07-1796.
   Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32.
   Kim HY, 2001, RADIOGRAPHICS, V21, P839, DOI 10.1148/radiographics.21.4.g01jl06839.
   Lee JH, 2003, RESP MED, V97, P1237, DOI 10.1016/S0954-6111(03)00255-5.
   Long R, 1998, CHEST, V113, P933, DOI 10.1378/chest.113.4.933.
   Maguire GP, 2009, INT J TUBERC LUNG D, V13, P1500.
   Maior M, 2007, AM THOR SOC P ATS IN.
   Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC.
   Ministerio da Saude, 2009, INC TUB BRAS PROGR N.
   Pasipanodya JG, 2007, CHEST, V131, P1817, DOI 10.1378/chest.06-2949.
   de Albuquerque MDPM, 2007, CAD SAUDE PUBLICA, V23, P1573, DOI 10.1590/S0102-311X2007000700008.
   PHILLIPS MS, 1989, THORAX, V44, P268, DOI 10.1136/thx.44.4.268.
   Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603.
   Ramos Lucia Maria Macedo, 2006, J. bras. pneumol., V32, P43, DOI 10.1590/S1806-37132006000100010.
   Rech V, 2005, FISIOTER PESQUI, V12, P35.
   SOCIEDADE BRASILEIRA DE PNEUMOLOGIA E TISIOLOGIA, 2002, J PNEUMOL, V22, P122.
   Souza R. B., 2002, J PNEUMOL, V28, P155.
   Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15.
   WILLCOX PA, 1989, RESP MED, V83, P195, DOI 10.1016/S0954-6111(89)80031-9.
   World Health Organization, 2007, EST INC PREV TB MORT.
   Zhou C, 1995, Nihon Kyobu Shikkan Gakkai Zasshi, V33, P416.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{13}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{Rev. Port. Pneumol.}},
Doc-Delivery-Number = {{830PN}},
Unique-ID = {{ISI:000295669000005}},
OA = {{gold}},
DA = {{2018-08-13}},
}

@article{ ISI:000293224500003,
Author = {Krol, Jaroslaw E. and Hung Duc Nguyen and Rogers, Linda M. and Beyenal,
   Haluk and Krone, Stephen M. and Top, Eva M.},
Title = {{Increased Transfer of a Multidrug Resistance Plasmid in Escherichia coli
   Biofilms at the Air-Liquid Interface}},
Journal = {{APPLIED AND ENVIRONMENTAL MICROBIOLOGY}},
Year = {{2011}},
Volume = {{77}},
Number = {{15}},
Pages = {{5079-5088}},
Month = {{AUG}},
Abstract = {{Although biofilms represent a common bacterial lifestyle in clinically
   and environmentally important habitats, there is scant information on
   the extent of gene transfer in these spatially structured populations.
   The objective of this study was to gain insight into factors that affect
   transfer of the promiscuous multidrug resistance plasmid pB10 in
   Escherichia coli biofilms. Biofilms were grown in different experimental
   settings, and plasmid transfer was monitored using laser scanning
   confocal microscopy and plate counting. In closed flow cells, plasmid
   transfer in surface-attached submerged biofilms was negligible. In
   contrast, a high plasmid transfer efficiency was observed in a biofilm
   floating at the air-liquid interface in an open flow cell with low flow
   rates. A vertical flow cell and a batch culture biofilm reactor were
   then used to detect plasmid transfer at different depths away from the
   air-liquid interface. Extensive plasmid transfer occurred only in a
   narrow zone near that interface. The much lower transfer frequencies in
   the lower zones coincided with rapidly decreasing oxygen concentrations.
   However, when an E. coli csrA mutant was used as the recipient, a thick
   biofilm was obtained at all depths, and plasmid transfer occurred at
   similar frequencies throughout. These results and data from separate
   aerobic and anaerobic matings suggest that oxygen can affect IncP-1
   plasmid transfer efficiency, not only directly but also indirectly,
   through influencing population densities and therefore colocalization of
   donors and recipients. In conclusion, the air-liquid interface can be a
   hot spot for plasmid-mediated gene transfer due to high densities of
   juxtaposed donor and recipient cells.}},
Publisher = {{AMER SOC MICROBIOLOGY}},
Address = {{1752 N ST NW, WASHINGTON, DC 20036-2904 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Top, EM (Reprint Author), Univ Idaho, Dept Biol Sci, Initiat Bioinformat \& Evolutionary Studies, POB 443051, Moscow, ID 83844 USA.
   Krol, Jaroslaw E.; Rogers, Linda M.; Krone, Stephen M.; Top, Eva M., Univ Idaho, Dept Biol Sci, Initiat Bioinformat \& Evolutionary Studies, Moscow, ID 83844 USA.
   Hung Duc Nguyen; Beyenal, Haluk, Washington State Univ, Gene \& Linda Voiland Sch Chem Engn \& Bioengn, Pullman, WA 99164 USA.
   Krone, Stephen M., Univ Idaho, Dept Math, Moscow, ID 83844 USA.}},
DOI = {{10.1128/AEM.00090-11}},
ISSN = {{0099-2240}},
Keywords-Plus = {{IN-SITU DETECTION; GREEN FLUORESCENT PROTEIN; MOBILE GENETIC ELEMENTS;
   SEA-SURFACE MICROLAYER; PSEUDOMONAS-PUTIDA; BACTERIAL COMMUNITIES;
   CONJUGATIVE PLASMIDS; HORIZONTAL TRANSFER; ACTIVATED-SLUDGE; INCP-1
   PLASMIDS}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Microbiology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Microbiology}},
Author-Email = {{evatop@uidaho.edu}},
Funding-Acknowledgement = {{National Institute for General Medical Sciences (NIGMS) {[}1R01
   GM73821]; M. J. Murdock Charitable Trust {[}2006-127JVZ022207]; NIH
   {[}1S10RR02260601]}},
Funding-Text = {{This work was supported by NIH grant 1R01 GM73821 from the National
   Institute for General Medical Sciences (NIGMS). Funding for the Olympus
   Fluoview FV1000 multiphoton confocal microscope was obtained from the M.
   J. Murdock Charitable Trust (grant 2006-127JVZ022207) and from the NIH
   (small instrumentation grant 1S10RR02260601).}},
Cited-References = {{Adamczyk M, 2003, ACTA BIOCHIM POL, V50, P425.
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389.
   ANGLES ML, 1993, APPL ENVIRON MICROB, V59, P843.
   Ashelford KE, 1997, FEMS MICROBIOL ECOL, V23, P81, DOI 10.1016/S0168-6496(97)00015-9.
   Aspray TJ, 2005, FEMS MICROBIOL ECOL, V54, P317, DOI 10.1016/j.femsec.2005.04.007.
   Beloin C, 2008, CURR TOP MICROBIOL, V322, P249.
   Beyenal H, 2004, J MICROBIOL METH, V59, P395, DOI 10.1016/j.mimet.2004.08.003.
   Bonot S, 2010, APPL ENVIRON MICROB, V76, P378, DOI 10.1128/AEM.01125-09.
   BRADLEY DE, 1980, J BACTERIOL, V143, P1466.
   Burmolle M, 2008, MICROBIOL-SGM, V154, P187, DOI 10.1099/mic.0.2007/010454-0.
   Cabellos-Avelar T, 2006, FEMS MICROBIOL ECOL, V58, P414, DOI 10.1111/j.1574-6941.2006.00186.x.
   Christensen B B, 1998, APMIS Suppl, V84, P25.
   Christensen BB, 1998, APPL ENVIRON MICROB, V64, P2247.
   Christensen BB, 1996, GENE, V173, P59, DOI 10.1016/0378-1119(95)00707-5.
   Colon-Gonzalez M, 2004, RES MICROBIOL, V155, P514, DOI 10.1016/j.resmic.2004.03.004.
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431.
   Cunliffe M, 2009, ISME J, V3, P1001, DOI 10.1038/ismej.2009.69.
   CURTISS R, 1968, BACTERIOL REV, V32, P320.
   D'Alvise PW, 2010, FEMS MICROBIOL LETT, V312, P84, DOI 10.1111/j.1574-6968.2010.02105.x.
   Dahlberg C, 1997, APPL ENVIRON MICROB, V63, P4692.
   Dahlberg C, 1998, APPL ENVIRON MICROB, V64, P2670.
   Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000.
   De Gelder L, 2005, APPL ENVIRON MICROB, V71, P5309, DOI 10.1128/AEM.71.9.5309-5317.2005.
   DEBEER D, 1994, BIOTECHNOL BIOENG, V43, P1131, DOI 10.1002/bit.260431118.
   Droge M, 2000, MOL GEN GENET, V263, P471, DOI 10.1007/s004380051191.
   Ehlers LJ, 1999, WATER SCI TECHNOL, V39, P163, DOI 10.1016/S0273-1223(99)00164-X.
   Fox RE, 2008, ISME J, V2, P1024, DOI 10.1038/ismej.2008.53.
   Franklin MP, 2005, ENVIRON MICROBIOL, V7, P723, DOI 10.1111/j.1462-2920.2004.00736.x.
   Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581.
   Haagensen JAJ, 2002, FEMS MICROBIOL ECOL, V42, P261, DOI 10.1111/j.1574-6941.2002.tb01016.x.
   Hausner M, 1999, APPL ENVIRON MICROB, V65, P3710.
   HERMANSSON M, 1994, FEMS MICROBIOL ECOL, V15, P47, DOI 10.1111/j.1574-6941.1994.tb00228.x.
   HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990.
   Heuer Holger, 2007, Environmental Biosafety Research, V6, P3, DOI 10.1051/ebr:2007034.
   Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002.
   Jacoby GA, 2009, ANTIMICROB AGENTS CH, V53, P1665, DOI 10.1128/AAC.01447-08.
   Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09.
   JONES GW, 1991, MICROBIAL ECOL, V22, P15, DOI 10.1007/BF02540210.
   Jorquera M, 2006, MICROBES ENVIRON, V21, P101.
   Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818.
   Klayman BJ, 2008, ENVIRON MICROBIOL, V10, P2344, DOI 10.1111/j.1462-2920.2008.01660.x.
   Krol JE, 2010, APPL ENVIRON MICROB, V76, P4553, DOI 10.1128/AEM.00226-10.
   Krone SM, 2007, MICROBIOL-SGM, V153, P2803, DOI 10.1099/mic.0.2006/004531-0.
   Leitet C, 2006, J MAR BIOL ASSOC UK, V86, P567, DOI 10.1017/S0025315406013488.
   Lewandowski Z, 2007, FUNDAMENTALS BIOFILM.
   Licht TR, 1999, MICROBIOL-SGM, V145, P2615, DOI 10.1099/00221287-145-9-2615.
   Lilley AK, 2002, FEMS MICROBIOL ECOL, V42, P243, DOI {[}10.1016/S0168-6496(02)00371-9, 10.1111/j.1574-6941.2002.tb01014.x].
   Molbak L, 2003, APPL ENVIRON MICROB, V69, P5536, DOI 10.1128/AEM.69.9.5536-5542.2003.
   Molbak L, 2007, FEMS MICROBIOL ECOL, V59, P167, DOI 10.1111/j.1574-6941.2006.00229.x.
   Molin S, 2003, CURR OPIN BIOTECH, V14, P255, DOI 10.1016/S0958-1669(03)00036-3.
   Nancharaiah YV, 2003, APPL ENVIRON MICROB, V69, P4846, DOI 10.1128/AEM.69.8.4846-4852.2003.
   Nguyen KT, 2010, J BACTERIOL, V192, P5134, DOI 10.1128/JB.00650-10.
   Normander B, 1998, APPL ENVIRON MICROB, V64, P1902.
   Ong CLY, 2009, APPL ENVIRON MICROB, V75, P6783, DOI 10.1128/AEM.00974-09.
   Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w.
   Reisner A, 2006, J BACTERIOL, V188, P3582, DOI 10.1128/JB.188.10.3582-3588.2006.
   Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x.
   Rittmann BE, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.2307/3432492.
   Salyers AA, 2000, METHODS, V20, P35, DOI 10.1006/meth.1999.0903.
   Sambrook J, 2001, MOL CLONING LAB MANU.
   Schluter A, 2003, MICROBIOL-SGM, V149, P3139, DOI {[}10.1099/mic.0.26570-0, 10.1099/mic.0.026570-0].
   SEOANE J, 2010, FEMS MICROBIOL ECOL, V75, P17.
   SHOEMAKER NB, 1986, J BACTERIOL, V165, P929, DOI 10.1128/jb.165.3.929-936.1986.
   SIMONSEN L, 1990, J GEN MICROBIOL, V136, P1001, DOI 10.1099/00221287-136-6-1001.
   Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232.
   Sorensen SJ, 1998, ANTON LEEUW INT J G, V73, P69, DOI 10.1023/A:1000661115753.
   Tolker-Nielsen T, 2000, MICROBIAL ECOL, V40, P75.
   Top EM, 2003, CURR OPIN BIOTECH, V14, P262, DOI 10.1016/S0958-1669(03)00066-1.
   Yang XO, 2008, APPL ENVIRON MICROB, V74, P2690, DOI 10.1128/AEM.02809-07.
   ZHONG X, 2009, J THEOR BIOL, V262, P711.}},
Number-of-Cited-References = {{70}},
Times-Cited = {{42}},
Usage-Count-Last-180-days = {{3}},
Usage-Count-Since-2013 = {{41}},
Journal-ISO = {{Appl. Environ. Microbiol.}},
Doc-Delivery-Number = {{798PW}},
Unique-ID = {{ISI:000293224500003}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000296269400003,
Author = {Wu, Ming-Ju and Feng, Yun-Shu and Sung, Wen-Pei and Surampalli, Rao Y.},
Title = {{Quantification and Analysis of Airborne Bacterial Characteristics in a
   Nursing Care Institution}},
Journal = {{JOURNAL OF THE AIR \& WASTE MANAGEMENT ASSOCIATION}},
Year = {{2011}},
Volume = {{61}},
Number = {{7}},
Pages = {{732-739}},
Month = {{JUL}},
Abstract = {{Indoor air quality has become a critical issue because people spend most
   of their time in the indoor environment. The factors that influence
   indoor air quality are very important to environmental sanitation and
   air quality improvement. This study focuses on monitoring air quality,
   colony counts, and bacteria species of the indoor air of a nursing care
   institution. The regular colony counts in two different wards range from
   55 to 600 cfu m(-3). Regression analysis results indicate that the
   bacterial colony counts have close correlation with relative humidity or
   carbon dioxide (CO(2)) but not with carbon monoxide (CO) or ozone
   (O(3)). Real-time PCR was used to quantify the bacterial pathogens of
   nosocomial infection, including Acinetobacter baumannii, Citrobacter
   freundii, Escherichia coli, Klebsiella pneumoniae, and
   methicillin-sensitive Staphylococcus aureus. The most abundant bacteria
   species in the air of the nursing care institution is E. coli.}},
Publisher = {{AIR \& WASTE MANAGEMENT ASSOC}},
Address = {{ONE GATEWAY CENTER, THIRD FL, PITTSBURGH, PA 15222 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Sung, WP (Reprint Author), Natl Chin Yi Univ Technol, Dept Landscape Architecture, Integrated Res Ctr Green Living Technol, 35,Lane 215,Chung Shuan Rd,Sect 1, Taichung 41111, Taiwan.
   Sung, Wen-Pei, Natl Chin Yi Univ Technol, Dept Landscape Architecture, Integrated Res Ctr Green Living Technol, Taichung 41111, Taiwan.
   Wu, Ming-Ju, Taichung Vet Gen Hosp, Dept Med, Taichung, Taiwan.
   Feng, Yun-Shu, Natl Yang Ming Univ, Inst Clin Med, Taichung, Taiwan.
   Wu, Ming-Ju, Chung Shan Med Univ, Sch Med, Taichung, Taiwan.
   Surampalli, Rao Y., US EPA, Kansas City, KS USA.}},
DOI = {{10.3155/1047-3289.61.7.732}},
ISSN = {{1047-3289}},
Keywords-Plus = {{RESISTANT STAPHYLOCOCCUS-AUREUS; REAL-TIME PCR; METHICILLIN-RESISTANT;
   KLEBSIELLA-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; INFECTION-CONTROL;
   PATHOGENS; BLOOD; HOSPITALS; IMPACT}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology; Meteorology \&
   Atmospheric Sciences}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences; Meteorology \&
   Atmospheric Sciences}},
Author-Email = {{wps@ncutedu.tw}},
Funding-Acknowledgement = {{National Science Council, Taiwan, Republic of China
   {[}NSC-97-3114-E-167-001]}},
Funding-Text = {{This research was supported by the National Science Council, Taiwan,
   Republic of China (NSC-97-3114-E-167-001). The authors are grateful to
   Ms. Ju-Ling Hsiao for her valuable suggestions. The views and opinions
   expressed in this article are those of the authors and should not be
   construed as the opinions of the U.S. Environmental Protection Agency.}},
Cited-References = {{Abramson MA, 1999, INFECT CONT HOSP EP, V20, P408, DOI 10.1086/501641.
   An HR, 2006, ATMOS ENVIRON, V40, P7924, DOI 10.1016/j.atmosenv.2006.07.020.
   BINGEN E, 1993, PATHOL BIOL, V41, P716.
   Bischoff WE, 2007, INFECT CONT HOSP EP, V28, P1148, DOI 10.1086/520734.
   BJORNSSON E, 1995, CLIN EXP ALLERGY, V25, P423, DOI 10.1111/j.1365-2222.1995.tb01073.x.
   Bolashikov ZD, 2009, BUILD ENVIRON, V44, P1378, DOI 10.1016/j.buildenv.2008.09.001.
   Bolyard EA, 1998, AM J INFECT CONTROL, V26, P289, DOI 10.1016/S0196-6553(98)80015-1.
   Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678.
   Carmeli Y, 1999, ARCH INTERN MED, V159, P1127, DOI 10.1001/archinte.159.10.1127.
   Casolari C, 2005, J HOSP INFECT, V61, P312, DOI 10.1016/j.jhin.2005.03.005.
   {*}CDCP, 1998, LAB METH DIAGN MEN C, P1.
   Chen Ying-Sheng, 2002, Journal of Microbiology Immunology and Infection, V35, P109.
   CHEN YS, 2005, AEROSOL SCI TECHNOL, V39, P371.
   CHOW JW, 1991, ANN INTERN MED, V115, P585, DOI 10.7326/0003-4819-115-8-585.
   COOVADIA YM, 1992, J HOSP INFECT, V22, P197, DOI 10.1016/0195-6701(92)90044-M.
   DATZ C, 1997, LANCET, V350, P1284.
   Donaldson A., 1999, Microbiology Today, V26, P118.
   Duan HY, 2009, ENVIRON RES, V109, P511, DOI 10.1016/j.envres.2009.02.014.
   Emmelin A, 2007, CHEST, V132, P1615, DOI 10.1378/chest.07-1398.
   FRENCH G, 1998, LANCET, V351, P513.
   Graudenz GS, 2005, INDOOR AIR, V15, P62, DOI 10.1111/j.1600-0668.2004.00324.x.
   HATCH MT, 1969, BACTERIAL SURVIVAL C, P267.
   Hinds W. C., 1999, AEROSOL TECHNOLOGY P, P233.
   Hogg GM, 2008, DIAGN MICR INFEC DIS, V61, P446, DOI 10.1016/j.diagmicrobio.2008.03.012.
   Ishihama K, 2009, J HOSP INFECT, V71, P359, DOI 10.1016/j.jhin.2008.12.005.
   Jang TN, 2009, J HOSP INFECT, V73, P143, DOI 10.1016/j.jhin.2009.06.007.
   Khojasteh VJ, 2007, BURNS, V33, P334, DOI 10.1016/j.burns.2006.07.009.
   Kim KY, 2009, J HAZARD MATER, V169, P1054, DOI 10.1016/j.jhazmat.2009.04.059.
   Kim T, 2001, INFECT CONT HOSP EP, V22, P99, DOI 10.1086/501871.
   Kovesi T, 2007, CAN MED ASSOC J, V177, P155, DOI {[}10.1503/cmaj.061574, 10.1503/CMAJ.061574].
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130.
   KREMERY V, 1998, J CHEMOTHER, V10, P320.
   Lee AKY, 2007, ATMOS ENVIRON, V41, P2831, DOI 10.1016/j.atmosenv.2006.11.047.
   Lee SC, 2002, ATMOS ENVIRON, V36, P1929, DOI 10.1016/S1352-2310(02)00176-0.
   Liu CP, 2007, J INFECTION, V55, P363, DOI 10.1016/j.jinf.2007.04.010.
   Mims SA, 2004, ATMOS ENVIRON, V38, P651, DOI 10.1016/j.atmosenv.2003.10.043.
   Mohanty S, 2007, J INFECTION, V54, P58, DOI 10.1016/j.jinf.2006.01.015.
   Mohanty SS, 2004, J BONE JOINT SURG BR, V86B, P266, DOI 10.1302/0301-620X.86B2.14129.
   Monterrubio-Villar J, 2009, EUR J CLIN MICROBIOL, V28, P1281, DOI 10.1007/s10096-009-0777-6.
   Narui K, 2009, J HOSP INFECT, V73, P24, DOI 10.1016/j.jhin.2009.05.019.
   Neely AN, 2000, J BURN CARE REHABIL, V21, P523, DOI 10.1067/mbc.2000.111120.
   Oppliger A, 2008, ANN OCCUP HYG, V52, P405, DOI 10.1093/annhyg/men021.
   OTTEN JA, 1999, BIOAEROSOLS ASSESSME, pCH18.
   Park YK, 2009, DIAGN MICR INFEC DIS, V64, P389, DOI 10.1016/j.diagmicrobio.2009.03.029.
   Shannon KE, 2007, SCI TOTAL ENVIRON, V382, P121, DOI 10.1016/j.scitotenv.2007.02.039.
   Sheng WH, 2005, J HOSP INFECT, V59, P205, DOI 10.1016/j.jhin.2004.06.003.
   Shinn EA, 2000, GEOPHYS RES LETT, V27, P3029, DOI 10.1029/2000GL011599.
   Shiomori T, 2002, J HOSP INFECT, V50, P30, DOI 10.1053/jhin.2001.1136.
   Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032.
   TSUKADAIRA A, 2004, J JPN RESP SOC, V40, P530.
   VERNET V, 1995, FEMS MICROBIOL LETT, V130, P51.
   VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639.
   WALTER MV, 1990, APPL ENVIRON MICROB, V56, P3468.
   WONG D, 1991, BRIT MED J, V303, P1602, DOI 10.1136/bmj.303.6817.1602.
   Zucker BA, 2000, J VET MED B, V47, P37, DOI 10.1046/j.1439-0450.2000.00308.x.}},
Number-of-Cited-References = {{55}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{7}},
Journal-ISO = {{J. Air Waste Manage. Assoc.}},
Doc-Delivery-Number = {{838EK}},
Unique-ID = {{ISI:000296269400003}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000292801800003,
Author = {Hostetter, Karen S. and Lux, Mary and Shelley, Kyna and Drummond, Jan L.
   and Laguna, Patti},
Title = {{MRSA as a Health Concern in Athletic Facilities}},
Journal = {{JOURNAL OF ENVIRONMENTAL HEALTH}},
Year = {{2011}},
Volume = {{74}},
Number = {{1}},
Pages = {{18-25}},
Month = {{JUL-AUG}},
Abstract = {{Methicillin-resistant Staphylococcus aureus (MRSA) is a group of
   bacteria resistant to antibiotic treatment. Open abrasions, therapeutic
   whirlpools, treatment tables, locker rooms (LR), and athletic equipment
   are identified as potential areas of transmission in athletic training
   rooms (AIR) and LR facilities. To determine the prevalence of MRSA and
   to identify control measures in ATR and LR, the authors collected
   samples from nine surfaces at seven high schools over a four-month
   period. Initial analyses considered both suspected colonies and
   confirmed MRSA colonies with analyses of variance revealing significant
   differences of suspected colonies based on regular cleaning product and
   facility surface. Further results, however, focused on MRSA colonies as
   the primary variable, rather than suspected colonies. Results indicate a
   need for more effective cleaning products and schedules in LRs.}},
Publisher = {{NATL ENVIRON HEALTH ASSOC}},
Address = {{720 S COLORADO BLVD SUITE 970, SOUTH TOWER, DENVER, CO 80246 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hostetter, KS (Reprint Author), Univ So Mississippi, 118 Coll Dr 5142, Hattiesburg, MS 39406 USA.
   Hostetter, Karen S., Univ So Mississippi, Hattiesburg, MS 39406 USA.}},
ISSN = {{0022-0892}},
Keywords-Plus = {{RESISTANT STAPHYLOCOCCUS-AUREUS; FOOTBALL TEAM; PREVALENCE; OUTBREAK;
   TURF}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{atcm516@gmail.com}},
Cited-References = {{Adams Brian B, 2008, Dermatol Nurs, V20, P39.
   Beam JW, 2006, J ATHL TRAINING, V41, P337.
   Begier EM, 2004, CLIN INFECT DIS, V39, P1446, DOI 10.1086/425313.
   {*}CDCP, 2010, ENV CLEAN DIS MRSA.
   Centers for Disease Control and Prevention, 2010, PREV INF ADV ATHL.
   Claudio L, 2008, ENVIRON HEALTH PERSP, V116, pA116, DOI 10.1289/ehp.116-a116.
   FAGAN V, 2005, KEEPING LOCKER ROOMS.
   GORWITZ RJ, 2006, MINIMIZING METHICILL.
   GUTTMAN C, 2008, DERMATOLOGY TIM 0501, P48.
   Hawkes M, 2007, CAN MED ASSOC J, V176, P54.
   Levenhagen KM, 2008, PHYSIOTHER RES INT, V13, P9, DOI 10.1002/pri.392.
   Montgomery K, 2010, J ENVIRON HEALTH, V72, P8.
   {*}MS STAT DEP HLTH, 2009, MRSA FACTS PREV.
   {*}MS STAT DEP HLTH, 2007, MISS MORB REP.
   NEWELL K, 2007, COACH ATHLETIC D SEP, P58.
   Romano R, 2006, J ATHL TRAINING, V41, P141.
   Salgado C, 2003, CLIN MICROBIOL NEWSL, V25, P137, DOI {[}10.1016/S0196-4399(03)80042-9, DOI 10.1016/S0196-4399(03)80042-9.].
   Sampathkumar P, 2007, MAYO CLIN PROC, V82, P1463, DOI 10.4065/82.12.1463.
   SAMUELS CA, 2007, ED WEEK         1024.
   Sedgwick PE, 2007, CLIN SPORT MED, V26, P383, DOI 10.1016/j.csm.2007.04.008.
   Stanforth B, 2010, J ENVIRON HEALTH, V72, P12.
   Stevens MP, 2008, SOUTH MED J, V101, P1067, DOI 10.1097/SMJ.0b013e318186b81c.
   STROUT E, 2006, CHRONICLE HIGHER ED, V53.
   {*}US EPA, 2009, LIST H EPAS REG PROD.
   Weiner HR, 2008, J AM COLL HEALTH, V56, P347, DOI 10.3200/JACH.56.44.347-350.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{4}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{10}},
Journal-ISO = {{J. Environ. Health}},
Doc-Delivery-Number = {{793DY}},
Unique-ID = {{ISI:000292801800003}},
DA = {{2018-08-13}},
}

@article{ ISI:000292631900009,
Author = {Dharmadhikari, Ashwin S. and Basaraba, Randall J. and Van Der Walt,
   Martie L. and Weyer, Karin and Mphahlele, Matsie and Venter, Kobus and
   Jensen, Paul A. and First, Melvin W. and Parsons, Sydney and McMurray,
   David N. and Orme, Ian M. and Nardell, Edward A.},
Title = {{Natural infection of guinea pigs exposed to patients with highly
   drug-resistant tuberculosis}},
Journal = {{TUBERCULOSIS}},
Year = {{2011}},
Volume = {{91}},
Number = {{4}},
Pages = {{329-338}},
Month = {{JUL}},
Abstract = {{A natural TB infection model using guinea pigs may provide useful
   information for investigating differences in transmission efficiency and
   establishment of active disease by clinical TB strains in a highly
   susceptible host under controlled environmental conditions. We sought to
   examine the capacity of naturally transmitted multidrug-resistant
   Mycobacterium tuberculosis to establish infection and produce active
   disease in guinea pigs. Guinea pigs were continuously exposed for 4
   months to the exhaust air of a 6-bed multidrug-resistant tuberculosis
   inpatient hospital ward in South Africa. Serial tuberculin skin test
   reactions were measured to determine infection. All animals were
   subsequently evaluated for histologic disease progression at necropsy.
   Although 75\% of the 362 exposed guinea pigs had positive skin test
   reactions {[}>= 6 mm], only 12\% had histopathologic evidence of active
   disease. Reversions (>= 6 mm change) in skin test reactivity were seen
   in 22\% of animals, exclusively among those with reactions of 6 -13 mm.
   Only two of 86 guinea pigs with reversion had histological evidence of
   disease compared to 47\% (31/66) of guinea pigs with large,
   non-reverting reactions. Immunosuppression of half the guinea pigs
   across all skin test categories did not significantly accelerate disease
   progression. In guinea pigs that reverted a skin test, a second positive
   reaction in 27 (33\%) of them strongly suggested re-infection due to
   ongoing exposure. These results show that a large majority of guinea
   pigs naturally exposed to human-source strains of multidrug-resistant
   tuberculosis became infected, but that many resolved their infection and
   a large majority failed to progress to detectable disease. (C) 2011
   Elsevier Ltd. All rights reserved.}},
Publisher = {{CHURCHILL LIVINGSTONE}},
Address = {{JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dharmadhikari, AS (Reprint Author), Harvard Univ, Sch Med, Brigham \& Womens Hosp, Div Pulm \& Crit Care Med, 7th Floor,FXB Bldg,651 Huntington Ave, Boston, MA 02115 USA.
   Dharmadhikari, Ashwin S.; Nardell, Edward A., Harvard Univ, Sch Med, Brigham \& Womens Hosp, Div Pulm \& Crit Care Med, Boston, MA 02115 USA.
   Dharmadhikari, Ashwin S.; Nardell, Edward A., Harvard Univ, Sch Med, Brigham \& Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA.
   Basaraba, Randall J.; Orme, Ian M., Colorado State Univ, Dept Microbiol Immunol \& Pathol, Coll Vet Med \& Biomed Sci, Ft Collins, CO 80523 USA.
   Van Der Walt, Martie L.; Mphahlele, Matsie; Venter, Kobus, S African MRC, TB Epidemiol \& Intervent Res Unit, ZA-0001 Pretoria, South Africa.
   Weyer, Karin, WHO, CH-1211 Geneva, Switzerland.
   Jensen, Paul A., CDC, Atlanta, GA 30333 USA.
   First, Melvin W.; Nardell, Edward A., Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA.
   McMurray, David N., Texas A\&M Hlth Sci Ctr, Dept Microbial \& Mol Pathogenesis, College Stn, TX 77843 USA.}},
DOI = {{10.1016/j.tube.2011.03.002}},
ISSN = {{1472-9792}},
Keywords = {{MDR/XDR tuberculosis; Guinea pig model; Natural infection; Skin test
   reactivity}},
Keywords-Plus = {{MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; ANIMAL-MODELS;
   TRANSMISSION; FITNESS; AIR; EPIDEMIOLOGY; STRATEGIES; DISEASE}},
Research-Areas = {{Immunology; Microbiology; Respiratory System}},
Web-of-Science-Categories  = {{Immunology; Microbiology; Respiratory System}},
Author-Email = {{adharmadhikari@partners.org
   randall.basaraba@colostate.edu
   mvdwalt@mrc.ac.za
   weyerk@who.int
   pej4@cdc.gov
   mfirst@hsph.harvard.edu
   saparsons@csir.co.za
   mcmurray@medicine.tamhsc.edu
   ian.orme@colostate.edu
   enardell@pih.org}},
Funding-Acknowledgement = {{USAID; US Centers for Disease Control and Prevention; National Institute
   of Occupational Safety and Health {[}R01 OH009050, EN]; South African
   Medical Research Council; Center for Scientific and Industrial Research
   (South Africa); Harvard University, with cooperation from the Mpumalanga
   Provincial Department of Health in South Africa; NIAID, NIH
   {[}AI070456];  {[}T32 HL007633];  {[}K23 AI084548]}},
Funding-Text = {{This AIR Facility was established through grants from USAID, US Centers
   for Disease Control and Prevention, National Institute of Occupational
   Safety and Health (R01 OH009050, EN), South African Medical Research
   Council, Center for Scientific and Industrial Research (South Africa),
   and Harvard University, with cooperation from the Mpumalanga Provincial
   Department of Health in South Africa and staff from the eMahlahleni
   (formerly known as Witbank) Hospital. Additional contributions were made
   by Brigham and Women's Hospital. Research was also supported by grant
   AI070456 from the NIAID, NIH. Dr. Dharmadhikari was supported by grants
   T32 HL007633 and K23 AI084548. The funders had no role in the study
   design, the collection, analysis, or interpretation of data, or in the
   writing of the manuscript. The establishment of the AIR Facility was
   largely due to early efforts of Dr. Bernard Fourie and Dr. Charles
   Wells. Dr. Lourens Roberts contributed importantly to the success of
   this experiment.}},
Cited-References = {{Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236.
   Basaraba RJ, 2006, TUBERCULOSIS, V86, P386, DOI 10.1016/j.tube.2005.11.003.
   Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456.
   Cohen T, 2003, LANCET INFECT DIS, V3, P13, DOI 10.1016/S1473-3099(03)00483-3.
   COHN ML, 1954, AM REV TUBERC PULM, V70, P641.
   DHARMADHIKARI AS, 2008, AM J RESP CELL MOL B.
   Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814.
   Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449.
   Escombe AR, 2007, CLIN INFECT DIS, V44, P1349, DOI 10.1086/515397.
   Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043.
   Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188.
   Gagneux S, 2009, CLIN MICROBIOL INFEC, V15, P66, DOI 10.1111/j.1469-0691.2008.02685.x.
   Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1.
   Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075.
   Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331.
   HOBBY GL, 1954, AM REV TUBERC PULM, V70, P527.
   Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907.
   Kruuner A, 2006, J CLIN MICROBIOL, V44, P811, DOI 10.1128/JCM.44.3.811-818.2006.
   McMurray David N., 1994, P135.
   McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3.
   McMurray DN, 2001, TRENDS MOL MED, V7, P135, DOI 10.1016/S1471-4914(00)01901-8.
   McMurray DN, 2001, SCAND J INFECT DIS, V33, P175, DOI 10.1080/00365540151060743.
   MIDDLEBROOK G, 1953, SCIENCE, V118, P297, DOI 10.1126/science.118.3063.297.
   MILLS CC, 1960, B JOHNS HOPKINS HOSP, V106, P36.
   Nardell EA, 2004, AM J RESP CRIT CARE, V169, P553, DOI 10.1164/rccm.2401003.
   Nodieva A, 2010, INT J TUBERC LUNG D, V14, P427.
   ORDWAY DJ, 1820, ANTIMICROB AGENTS CH, V54.
   Palanisamy GS, 2009, TUBERCULOSIS, V89, P203, DOI 10.1016/j.tube.2009.01.005.
   Perla D, 1927, J EXP MED, V45, P1025, DOI 10.1084/jem.45.6.1025.
   RILEY RL, 1957, AM REV TUBERC PULM, V76, P931.
   RILEY RL, 1962, AM REV RESPIR DIS, V85, P511.
   Riley RL, 1959, AM J HYG, V70, P2.
   Rusch-Gerdes S, 2006, J CLIN MICROBIOL, V44, P688, DOI 10.1128/JCM.44.3.688-692.2006.
   SMITH DW, 1989, REV INFECT DIS, V11, pS385.
   SULTAN L, 1960, AM REV RESPIR DIS, V82, P358.
   Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003.
   WEYER K, 2002, INT J TUBERCULOSI S1, V6.
   Williams A, 2009, TUBERCULOSIS, V89, P389, DOI 10.1016/j.tube.2009.08.004.
   World Health Organization, WHO REP 2010 MULT EX.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{42}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{Tuberculosis}},
Doc-Delivery-Number = {{791AJ}},
Unique-ID = {{ISI:000292631900009}},
OA = {{green\_accepted}},
DA = {{2018-08-13}},
}

@article{ ISI:000291640900002,
Author = {Sandstrom, Gunnar and Saeed, Amir and Abd, Hadi},
Title = {{Acanthamoeba-Bacteria: A Model to Study Host Interaction with Human
   Pathogens}},
Journal = {{CURRENT DRUG TARGETS}},
Year = {{2011}},
Volume = {{12}},
Number = {{7}},
Pages = {{936-941}},
Month = {{JUN}},
Abstract = {{Acanthamoebae are free-living amoebae distributed worldwide. They are
   among the most prevalent protozoa found in the environment, and have
   been isolated from a wide variety of public water supplies, swimming
   pools, bottled water, ventilation ducts, soil, air, surgical
   instruments, contact lenses, dental treatment units and hospitals.
   Acanthamoebae feed on bacteria by phagocytosis, but some bacteria are
   able to survive and sometimes multiply in the host, resulting in new
   properties of the bacteria. The intracellular growth of bacteria has
   been associated with enhanced environmental survival of the bacteria,
   increased virulence and increased resistance against antibiotic
   substances. The advantage of utilising free-living amoebae is that
   research can be carried out on non-mammalian cells as a model based on
   natural reality to study bacterial virulence and pathogenicity. Amoebae
   are easy to handle experimentally compared with mammalian cells and
   allow studies on host factors for host-parasite interactions. Bacteria
   are easily manipulated genetically, which creates the possibility of
   research on mutants to study bacteria-host interactions. Thus utilising
   this non-mammalian model can result in better understanding of
   interactions between prokaryotic and eukaryotic cells and assist in the
   development of new therapeutic agents to recognise and treat infections.}},
Publisher = {{BENTHAM SCIENCE PUBL LTD}},
Address = {{EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Sandstrom, G (Reprint Author), Swedish Inst Infect Dis Control, Ctr Microbiol Preparedness, SE-17182 Solna, Sweden.
   Sandstrom, Gunnar; Saeed, Amir; Abd, Hadi, Swedish Inst Infect Dis Control, Ctr Microbiol Preparedness, SE-17182 Solna, Sweden.
   Sandstrom, Gunnar, Karolinska Inst, Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, SE-14186 Stockholm, Sweden.}},
DOI = {{10.2174/138945011795677845}},
ISSN = {{1389-4501}},
EISSN = {{1873-5592}},
Keywords = {{Amoeba; antibiotic; bacteria; interaction; symbionts; symbiosis}},
Keywords-Plus = {{FREE-LIVING AMEBAS; PSEUDOMONAS-AERUGINOSA UTILIZES; III SECRETION
   SYSTEM; VIBRIO-CHOLERAE O139; LEGIONELLA-PNEUMOPHILA;
   FRANCISELLA-TULARENSIS; DICTYOSTELIUM-DISCOIDEUM; INCREASING IMPORTANCE;
   MYCOBACTERIUM-AVIUM; CASTELLANII}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy}},
Author-Email = {{gunnar.sandstrom@smi.se}},
Funding-Acknowledgement = {{Karolinska Institutet, Stockholm, Sweden; Swedish Institute for
   Infectious Disease Control, Solna, Sweden; Swedish Agency for Research
   {[}SWE 2006-044]; Swedish Civil Contingencies Agency {[}800/2008]}},
Funding-Text = {{Karolinska Institutet, Stockholm, Sweden, and the Swedish Institute for
   Infectious Disease Control, Solna, Sweden, financed this project, which
   was also supported by the Swedish Agency for Research Cooperation with
   Developing Countries (project no. SWE 2006-044) and the Swedish Civil
   Contingencies Agency (project no. 800/2008).}},
Cited-References = {{Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003.
   Abd H, 2005, ENVIRON MICROBIOL, V7, P1003, DOI 10.1111/j.1462-2920.2005.00771.x.
   Abd H, 2009, J MED MICROBIOL, V58, P125, DOI 10.1099/jmm.0.004721-0.
   Abd H, 2008, J EUKARYOT MICROBIOL, V55, P235, DOI 10.1111/j.1550-7408.2008.00311.x.
   Abd H, 2007, FEMS MICROBIOL ECOL, V60, P33, DOI 10.1111/j.1574-6941.2006.00254.x.
   Abd H, 2010, ENV MICROBIOL REP, V2, P166, DOI 10.1111/j.1758-2229.2009.00129.x.
   Abu Kwaik Y, 1998, APPL ENVIRON MICROB, V64, P3127.
   ALLEN PG, 1990, J CELL PHYSIOL, V145, P508, DOI 10.1002/jcp.1041450317.
   Alsam S, 2005, PARASITOL RES, V96, P402, DOI 10.1007/s00436-005-1401-z.
   Alsam S, 2006, J MED MICROBIOL, V55, P689, DOI 10.1099/jmm.0.46497-0.
   ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291.
   Barbeau J, 2001, RES MICROBIOL, V152, P753, DOI 10.1016/S0923-2508(01)01256-6.
   Barker J, 1999, FEMS MICROBIOL LETT, V173, P291, DOI 10.1016/S0378-1097(99)00076-2.
   Berk SG, 1998, APPL ENVIRON MICROB, V64, P279.
   BOWERS B, 1972, J CELL BIOL, V53, P681, DOI 10.1083/jcb.53.3.681.
   Brown MRW, 1999, TRENDS MICROBIOL, V7, P46, DOI 10.1016/S0966-842X(98)01425-5.
   CASEMORE DP, 1977, LANCET, V2, P1078.
   Cirillo JD, 1997, INFECT IMMUN, V65, P3759.
   CIRILLO JD, 1994, INFECT IMMUN, V62, P3254.
   Coburn J, 1999, INFECT IMMUN, V67, P3151.
   Cosson P, 2002, J BACTERIOL, V184, P3027, DOI 10.1128/JB.184.11.3027-3033.2002.
   CULBERTSON C. G., 1959, AMER JOUR PATHOL, V35, P185.
   CULBERTSON CG, 1958, SCIENCE, V127, P1506, DOI 10.1126/science.127.3313.1506.
   DROZANSKI W., 1956, ACTA MICROBIOL POLONICA, V5, P315.
   Dykova I, 1999, J PARASITOL, V85, P1106, DOI 10.2307/3285675.
   Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033.
   FERNANDEZ CA, 1989, J PROTOZOOL, V36, P239.
   FORTIER AH, 1995, INFECT IMMUN, V63, P1478.
   Gao LY, 2000, ENVIRON MICROBIOL, V2, P79, DOI 10.1046/j.1462-2920.2000.00076.x.
   Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004.
   GUSTAFSSON K, 1989, CAN J MICROBIOL, V35, P1100, DOI 10.1139/m89-184.
   Harb OS, 2000, ENVIRON MICROBIOL, V2, P251, DOI 10.1046/j.1462-2920.2000.00112.x.
   Hilbi H, 2007, ENVIRON MICROBIOL, V9, P563, DOI 10.1111/j.1462-2920.2007.01238.x.
   Ismail N, 2002, FEMS MICROBIOL LETT, V207, P111, DOI 10.1016/S0378-1097(01)00553-5.
   JAGER BV, 1972, LANCET, V2, P1343.
   JAHNES WG, 1957, P SOC EXP BIOL MED, V96, P484.
   Jeong HJ, 2007, EXP PARASITOL, V115, P181, DOI 10.1016/j.exppara.2006.08.002.
   Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x.
   Khunkitti W, 1998, J INFECTION, V36, P43, DOI 10.1016/S0163-4453(98)93054-7.
   KILVINGTON S, 1990, J APPL BACTERIOL, V68, P519, DOI 10.1111/j.1365-2672.1990.tb02904.x.
   KING CH, 1988, APPL ENVIRON MICROB, V54, P3023.
   KINGSTON D, 1969, J MED MICROBIOL, V2, P27, DOI 10.1099/00222615-2-1-27.
   LALITHA MK, 1985, J CLIN MICROBIOL, V21, P666.
   Lloyd D, 2001, J EUKARYOT MICROBIOL, V48, P11, DOI 10.1111/j.1550-7408.2001.tb00410.x.
   Losch F., 1875, Arch Pathol Anat, V65, P196, DOI 10.1007/BF02028799.
   Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003.
   Martinez AJ, 1997, BRAIN PATHOL, V7, P583, DOI 10.1111/j.1750-3639.1997.tb01076.x.
   MERGERYAN H, 1991, REV INFECT DIS, V13, pS390.
   Michel R, 2001, PARASITOL RES, V87, P248, DOI 10.1007/s004360000318.
   Miltner EC, 2000, ANTIMICROB AGENTS CH, V44, P1990, DOI 10.1128/AAC.44.7.1990-1994.2000.
   NAGINGTON J, 1974, LANCET, V2, P1537.
   NEWSOME AL, 1992, DIAGN CYTOPATHOL, V8, P231, DOI 10.1002/dc.2840080309.
   PAGE FC, 1967, J PROTOZOOL, V14, P709, DOI 10.1111/j.1550-7408.1967.tb02066.x.
   PARKER R R, 1951, Bull Natl Inst Health, V193, P1.
   PASZKOKOLVA C, 1991, APPL ENVIRON MICROB, V57, P163.
   Preston TM, 2001, FEMS MICROBIOL LETT, V194, P143.
   PROCACIOBANU M, 1975, INT J PARASITOL, V5, P49, DOI 10.1016/0020-7519(75)90097-1.
   Pukatzki S, 2002, P NATL ACAD SCI USA, V99, P3159, DOI 10.1073/pnas.052704399.
   QURESHI MN, 1993, J CLIN MICROBIOL, V31, P1908.
   RIVERA F, 1991, REV INFECT DIS, V13, pS388.
   RIVERA F, 1989, ENVIRON RES, V50, P289, DOI 10.1016/S0013-9351(89)80010-6.
   Rocha CL, 2003, INFECT IMMUN, V71, P5296, DOI 10.1128/IAI.71.9.5296-5305.2003.
   RODRIGUEZZARAGOZA S, 1994, CRIT REV MICROBIOL, V20, P225, DOI 10.3109/10408419409114556.
   ROWBOTHAM TJ, 1986, ISRAEL J MED SCI, V22, P678.
   Saeed A, 2009, ARCH MICROBIOL, V191, P83, DOI 10.1007/s00203-008-0422-2.
   Saeed A, 2007, SYMBIOSIS, V44, P153.
   SANDSTORM G, 1994, J CHEM TECHNOL BIOT, V59, P315, DOI 10.1002/jctb.280590402.
   SAWYER TK, 1975, T AM MICROSC SOC, V94, P93, DOI 10.2307/3225534.
   SESMA MJM, 1988, REV SANIDAD HIGIENE, V62, P1405.
   Steinert M, 1997, APPL ENVIRON MICROB, V63, P2047.
   Szenasi Z, 1998, J MED MICROBIOL, V47, P5, DOI 10.1099/00222615-47-1-5.
   TOMLINSON G, 1962, BIOCHIM BIOPHYS ACTA, V63, P194, DOI 10.1016/0006-3002(62)90353-0.
   Turner NA, 2000, J APPL MICROBIOL, V89, P751, DOI 10.1046/j.1365-2672.2000.01176.x.
   VICTORIA EJ, 1975, ARCH BIOCHEM BIOPHYS, V171, P255, DOI 10.1016/0003-9861(75)90030-2.
   WEEKERS PHH, 1993, APPL ENVIRON MICROB, V59, P2317.
   WEISMAN RA, 1976, ANNU REV MICROBIOL, V30, P189, DOI 10.1146/annurev.mi.30.100176.001201.}},
Number-of-Cited-References = {{76}},
Times-Cited = {{10}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{23}},
Journal-ISO = {{Curr. Drug Targets}},
Doc-Delivery-Number = {{777RC}},
Unique-ID = {{ISI:000291640900002}},
DA = {{2018-08-13}},
}

@article{ ISI:000290649600001,
Author = {Manca, Antonella and Sini, Maria Cristina and Izzo, Francesco and
   Ascierto, Paolo A. and Tatangelo, Fabiana and Botti, Gerardo and
   Gentilcore, Giusy and Capone, Marilena and Mozzillo, Nicola and Rozzo,
   Carla and Cossu, Antonio and Tanda, Francesco and Palmieri, Giuseppe},
Title = {{Induction of arginosuccinate synthetase (ASS) expression affects the
   antiproliferative activity of arginine deiminase (ADI) in melanoma cells}},
Journal = {{ONCOLOGY REPORTS}},
Year = {{2011}},
Volume = {{25}},
Number = {{6}},
Pages = {{1495-1502}},
Month = {{JUN}},
Abstract = {{Arginine deiminase (ADI), an arginine-degrading enzyme, has been used in
   the treatment of tumours sensitive to arginine deprivation, such as
   malignant melanoma (MM) and hepatocellular carcinoma (HCC). Endogenous
   production of arginine is mainly dependent on activity of ornithine
   transcarbamylase (OTC) and argininosuccinate synthetase (ASS) enzymes.
   We evaluated the effect of ADI treatment on OTC and ASS expression in a
   series of melanoma cell lines. Twenty-five primary melanoma cell lines
   and normal fibroblasts as controls underwent cell proliferation assays
   and Western blot analyses in the presence or absence of AIR Tissue
   sections from primary MMs (N=20) and HCCs (N=20) were investigated by
   immunohistochemistry for ASS expression. Overall, 21/25 (84\%) MM cell
   lines presented a cell growth inhibition by ADI treatment; none of them
   presented constitutive detectable levels of the ASS protein. However,
   7/21 (33\%) ADI-sensitive melanoma cell lines presented markedly
   increased expression levels of the ASS protein following ADI treatment,
   with a significantly higher IC(50) median value. Growth was not
   inhibited and the 1050 was not reached among the remaining 4/25 (16\%)
   MM cell lines; all of them showed constitutive ASS expression. The OTC
   protein was found expressed in all melanoma cell lines before and after
   the ADI treatment. Lack of ASS immunostaining was observed in all
   analyzed in vivo specimens. Our findings suggest that response to ADI
   treatment in melanoma is significantly correlated with the ability of
   cells to express ASS either constitutively at basal level (inducing drug
   resistance) or after the treatment (reducing sensitivity to ADI).}},
Publisher = {{SPANDIDOS PUBL LTD}},
Address = {{POB 18179, ATHENS, 116 10, GREECE}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Palmieri, G (Reprint Author), CNR, Inst Biomol Chem, Traversa La Crucca 3, I-07100 Sassari, Italy.
   Manca, Antonella; Sini, Maria Cristina; Rozzo, Carla; Palmieri, Giuseppe, CNR, Inst Biomol Chem, I-07100 Sassari, Italy.
   Izzo, Francesco; Ascierto, Paolo A.; Tatangelo, Fabiana; Botti, Gerardo; Gentilcore, Giusy; Capone, Marilena; Mozzillo, Nicola, Natl Canc Inst Fdn Pascale, I-80131 Naples, Italy.
   Cossu, Antonio, Hosp Univ Hlth Unit AOU, Pathol Serv, I-07100 Sassari, Italy.
   Tanda, Francesco, Univ Sassari, Inst Pathol, I-07100 Sassari, Italy.}},
DOI = {{10.3892/or.2011.1220}},
ISSN = {{1021-335X}},
Keywords = {{arginine deiminase; argininosuccinate synthetase; expression analysis;
   malignant melanoma; in vitro proliferation test}},
Keywords-Plus = {{HUMAN HEPATOCELLULAR-CARCINOMA; ARGININOSUCCINATE SYNTHETASE;
   NITRIC-OXIDE; UREA CYCLE; IN-VITRO; DEPRIVATION; PROLIFERATION; CANCER;
   LINES; METABOLISM}},
Research-Areas = {{Oncology}},
Web-of-Science-Categories  = {{Oncology}},
Author-Email = {{gpalmieri@yahoo.com}},
ResearcherID-Numbers = {{Cossu, Antonio/I-8836-2018
   Rozzo, Carla/C-4300-2015
   Manca, Antonella/C-4502-2015
   }},
ORCID-Numbers = {{Cossu, Antonio/0000-0002-2390-2205
   Rozzo, Carla/0000-0001-6581-2227
   Manca, Antonella/0000-0003-2497-1541
   Capone, Mariaelena/0000-0002-1352-2532
   Izzo, Francesco/0000-0003-3093-5408
   Palmieri, Giuseppe/0000-0002-4350-2276}},
Funding-Acknowledgement = {{Polaris Group (San Diego, CA, USA)}},
Funding-Text = {{A special thanks to Drs Stefania D'atri and Elena Pagani, for providing
   most of the melanoma cell lines. Authors are grateful to patients for
   their important contribution to this study. Work was supported by
   Polaris Group (San Diego, CA, USA) (F.I.). Italian Ministry of Health
   Progetto Ricerca Finalizzata, Sardinia Regional Government (Regione
   Autonoma delta Sardegna), and Associazione UMANA Onlus. Polaris Group
   donated the study drug.}},
Cited-References = {{Agarwala S.S., 2010, CANC TREAT REV, V37, P133.
   Ascierto PA, 2005, J CLIN ONCOL, V23, P7660, DOI 10.1200/JCO.2005.02.0933.
   Bowles TL, 2008, INT J CANCER, V123, P1950, DOI 10.1002/ijc.23723.
   Casula C, 2009, BMC CANCER, V9, P352.
   Cheng PNM, 2007, CANCER RES, V67, P309, DOI 10.1158/0008-5472.CAN-06-1945.
   Delage B, 2010, INT J CANCER, V126, P2762, DOI 10.1002/ijc.25202.
   Dillon BJ, 2004, CANCER, V100, P826, DOI 10.1002/cncr.20057.
   Ensor CM, 2002, CANCER RES, V62, P5443.
   Feun Lynn, 2006, Expert Opin Investig Drugs, V15, P815, DOI 10.1517/13543784.15.7.815.
   Flaherty KT, 2010, CANCER-AM CANCER SOC, V116, P4902, DOI 10.1002/cncr.25261.
   Glazer ES, 2010, J CLIN ONCOL, V28, P2220, DOI 10.1200/JCO.2009.26.7765.
   Gong H, 1999, BIOCHEM BIOPH RES CO, V261, P10, DOI 10.1006/bbrc.1999.1004.
   Husson A, 2003, EUR J BIOCHEM, V270, P1887, DOI 10.1046/j.1432-1033.2003.03559.x.
   Izzo F, 2004, J CLIN ONCOL, V22, P1815, DOI 10.1200/JCO.2004.11.120.
   Izzo F, 2007, J GASTROEN HEPATOL, V22, P86, DOI 10.1111/j.1440-1746.2006.04463.x.
   KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0.
   Lam TL, 2009, CANCER LETT, V277, P91, DOI 10.1016/j.canlet.2008.11.031.
   Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547.
   Pisano M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-8.
   Pisano M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-137.
   Savaraj N, 2010, CURR MOL MED, V10, P405, DOI 10.2174/156652410791316995.
   Sini MC, 2008, BRIT J DERMATOL, V158, P243, DOI 10.1111/j.1365-2133.2007.08310.x.
   SUGIMURA K, 1992, MELANOMA RES, V2, P191, DOI 10.1097/00008390-199209000-00007.
   SUMMAR ML, 1993, GENE REV.
   Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P439, DOI 10.1016/S0753-3322(02)00284-6.
   Wheatley DN, 2004, ANTI-CANCER DRUG, V15, P825, DOI 10.1097/00001813-200410000-00002.
   Wu GY, 1998, BIOCHEM J, V336, P1.
   Yoon CY, 2007, INT J CANCER, V120, P897, DOI 10.1002/ijc.22322.
   You M, 2010, BIOCHEM BIOPH RES CO, V394, P760, DOI 10.1016/j.bbrc.2010.03.066.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{9}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{10}},
Journal-ISO = {{Oncol. Rep.}},
Doc-Delivery-Number = {{764RI}},
Unique-ID = {{ISI:000290649600001}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000290532800026,
Author = {Gandolfi, I. and Franzetti, A. and Bertolini, V. and Gaspari, E. and
   Bestetti, G.},
Title = {{Antibiotic resistance in bacteria associated with coarse atmospheric
   particulate matter in an urban area}},
Journal = {{JOURNAL OF APPLIED MICROBIOLOGY}},
Year = {{2011}},
Volume = {{110}},
Number = {{6}},
Pages = {{1612-1620}},
Month = {{JUN}},
Abstract = {{Aims:
   To assess antibiotic resistance in airborne bacteria associated with
   coarse particulate matter (PM10) in an urban area, with specific
   considerations about the Staphylococcus genus.
   Methods and Results:
   Disc diffusion test was performed on 243 microbial strains, isolated
   from PM10 in winter and summer and belonging to families
   Pseudomonadaceae and Enterobacteriaceae and genera Acinetobacter,
   Enterococcus and Staphylococcus. Staphylococci resistances were the most
   heterogeneous, being distributed among almost all tested antibiotics.
   Staphylococcus isolates resistant to some selected antibiotics were
   further investigated for the presence of the corresponding genetic
   determinants. Only tetK, which mediates the tetracycline resistance
   through the action of an efflux protein, was found in almost all
   resistant isolates.
   Conclusions:
   The lack of specific genetic determinants makes their transmission among
   staphylococci less likely. This may reduce the theoretical risk
   associated with the inhalation of airborne micro-organisms.
   Significance and Impact of Study:
   Although the spreading of antibiotic resistant micro-organisms is of
   particular concern in clinical settings, the origin of antibiotic
   resistance genes can be traced in natural environments. As behaviour,
   viability and transport of bacteria in the atmospheric compartment
   suffer from a lack of information, the evaluation of the actual risk
   posed by airborne micro-organisms to human health is still challenging.}},
Publisher = {{WILEY}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Bestetti, G (Reprint Author), Univ Milano Bicocca, Dept Environm Sci, POLARIS Res Ctr, Piazza Sci 1, I-20126 Milan, Italy.
   Gandolfi, I.; Franzetti, A.; Bertolini, V.; Gaspari, E.; Bestetti, G., Univ Milano Bicocca, Dept Environm Sci, POLARIS Res Ctr, I-20126 Milan, Italy.}},
DOI = {{10.1111/j.1365-2672.2011.05018.x}},
ISSN = {{1364-5072}},
EISSN = {{1365-2672}},
Keywords = {{airborne bacteria; antibiotic resistance genes; disc diffusion test;
   PM10; Staphylococcus aureus}},
Keywords-Plus = {{STAPHYLOCOCCUS-AUREUS; GLYCOPEPTIDE RESISTANCE; NATURAL ENVIRONMENTS;
   OUTDOOR ENVIRONMENTS; AIRBORNE BACTERIAL; PCR ASSAY; GENES; AIR;
   MICROORGANISMS; POPULATIONS}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Microbiology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Microbiology}},
Author-Email = {{giuseppina.bestetti@unimib.it}},
ResearcherID-Numbers = {{Franzetti, Andrea/A-6666-2008}},
ORCID-Numbers = {{Franzetti, Andrea/0000-0003-1279-9940}},
Funding-Acknowledgement = {{Fondazione Cariplo (Milano, Italy)}},
Funding-Text = {{This work was partially funded by Fondazione Cariplo (Milano, Italy) in
   the frame of the project TOSCA (Toxicity of particulate matter and
   molecular markers of risk). The authors thank Prof. Marina Camatini for
   the Andersen impactor and Giuseppe Merlino for helping in sampling
   surveys.}},
Cited-References = {{Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312.
   Aminov RI, 2007, FEMS MICROBIOL LETT, V271, P147, DOI 10.1111/j.1574-6968.2007.00757.x.
   Arthur M, 1996, TRENDS MICROBIOL, V4, P401, DOI 10.1016/0966-842X(96)10063-9.
   BAIRDPARKER AC, 1962, J APPL BACTERIOL, V25, P12, DOI 10.1111/j.1365-2672.1962.tb01113.x.
   Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006.
   Boreson J, 2004, ATMOS ENVIRON, V38, P6029, DOI 10.1016/j.atmosenv.2004.06.040.
   Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104.
   Broekema NM, 2009, J CLIN MICROBIOL, V47, P217, DOI 10.1128/JCM.01506-08.
   BROOKS GF, 2001, JAWETZ MELNICK ADELB, P225.
   BUTTNER MP, 2002, MANUAL ENV MICROBIOL, P814.
   {*}CLSI, 2009, PERF STAND ANT DISK, P10.
   DUTKAMALEN S, 1995, J CLIN MICROBIOL, V33, P24.
   Fang ZG, 2007, MICROB ECOL, V54, P487, DOI 10.1007/s00248-007-9216-3.
   Fierer N, 2008, APPL ENVIRON MICROB, V74, P200, DOI 10.1128/AEM.01467-07.
   Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06.
   Harrison RM, 2005, INT J BIOMETEOROL, V49, P167, DOI 10.1007/s00484-004-0225-3.
   Kummerer K, 2009, CHEMOSPHERE, V75, P435, DOI 10.1016/j.chemosphere.2008.12.006.
   Lai KM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S15.
   Leclercq R, 2002, CLIN INFECT DIS, V34, P482, DOI 10.1086/324626.
   Lee SH, 2010, SCI TOTAL ENVIRON, V408, P1349, DOI 10.1016/j.scitotenv.2009.10.061.
   Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255.
   Martinez JL, 2009, ENVIRON POLLUT, V157, P2893, DOI 10.1016/j.envpol.2009.05.051.
   Marcazzan GM, 2001, ATMOS ENVIRON, V35, P4639, DOI 10.1016/S1352-2310(01)00124-8.
   Maron PA, 2005, ATMOS ENVIRON, V39, P3687, DOI 10.1016/j.atosenv.2005.03.002.
   Martineau F, 2000, ANTIMICROB AGENTS CH, V44, P231, DOI 10.1128/AAC.44.2.231-238.2000.
   Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483.
   Polymenakou PN, 2008, ENVIRON HEALTH PERSP, V116, P292, DOI 10.1289/ehp.10684.
   Sambrook J, 2001, MOL CLONING LAB MANU.
   Schwieger F, 1998, APPL ENVIRON MICROB, V64, P4870.
   Septimus EJ, 2009, CLIN PHARMACOL THER, V86, P336, DOI 10.1038/clpt.2009.122.
   Strommenger B, 2003, J CLIN MICROBIOL, V41, P4089, DOI 10.1128/JCM.41.9.4089-4094.2003.
   Zhang KY, 2004, J CLIN MICROBIOL, V42, P4947, DOI 10.1128/JCM.42.11.4947-4955.2004.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{10}},
Usage-Count-Last-180-days = {{7}},
Usage-Count-Since-2013 = {{46}},
Journal-ISO = {{J. Appl. Microbiol.}},
Doc-Delivery-Number = {{763CX}},
Unique-ID = {{ISI:000290532800026}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000293036400018,
Author = {d'Alessandro, E. De Luca and Giraldi, G.},
Title = {{A world wide public health problem: the principal re-emerging infectious
   diseases}},
Journal = {{CLINICA TERAPEUTICA}},
Year = {{2011}},
Volume = {{162}},
Number = {{3}},
Pages = {{E93-E98}},
Month = {{MAY-JUN}},
Abstract = {{The extraordinary progress in the knowledge of infectious disease, the
   discovery of antibiotics and effective vaccines are among the great
   achievement of the nineteenth and twentieth centuries. These achievement
   have led to a dramatic reduction in the levels of mortality from these
   diseases. According to the World Health Organization, the term
   ``re-emerging infectious diseases{''} refers to infectious diseases,
   which although well known, have not been of recent public health
   importance. However, climate change, migration, changes in health
   services, antibiotic resistance, population increase, international
   travel, the increase in the number of immune-depressed patients ,etc
   have lead to the re-emergence of these diseases. The climate changes are
   exposing sectors of the population to inadequate fresh air, water, food
   and resources for survival which, in consequence, provoke increases in
   both internal and international migration. In this particular period in
   which we find ourselves, characterized by globalization, the
   international community has become aware that the re-emergence of these
   diseases poses an important risk for public health underlines the
   necessity to adopt appropriate strategies for their prevention and
   control. The re-emerging diseases of the twenty-first century are a
   serious problem for public health and even though there has been
   enormous progress in medical science and in the battle against
   infectious diseases, they are still a long way from being really brought
   under control. A well organized monitoring system would enable the
   epidemiological characteristics of the infectious diseases to be
   analyzed and the success or otherwise of preventive interventions to be
   precisely evaluated. For this reason, the World Health Organization and
   the European Union have discussed the formation of a collaborative
   network for the monitoring and control of re-emerging diseases and has
   initiated special programmes. The battle between humanity and infectious
   disease has a history lasting thousands of years and is destined to
   continue in the future emphasizing the need to adopt combined policies
   for the prevention and control of re-emerging diseases. Clin Ter 2011;
   162(3):e93-98}},
Publisher = {{SOC EDITRICE UNIV}},
Address = {{VIA G B MORGAGNI 1, ROME, 10061, ITALY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{d'Alessandro, ED (Reprint Author), Univ Roma La Sapienza, Dept Publ Hlth \& Infect Dis, Ple Aldo Moro 5, I-00185 Rome, Italy.
   d'Alessandro, E. De Luca; Giraldi, G., Univ Roma La Sapienza, Dept Publ Hlth \& Infect Dis, I-00185 Rome, Italy.}},
ISSN = {{0009-9074}},
Keywords = {{globalization; re-emerging diseases}},
Keywords-Plus = {{MALARIA ELIMINATION; TUBERCULOSIS; GONORRHEA; EUROPE; COSTS; HIV}},
Research-Areas = {{General \& Internal Medicine; Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Medicine, General \& Internal; Pharmacology \& Pharmacy}},
Author-Email = {{eugenia.deluca@uniroma1.it}},
Cited-References = {{{*}AIPO SIMER, 2006, DOC SULL NUOV TEST I.
   ANGELETTI LR, 2008, STORIA FILOSOFIA ETI.
   {*}ASS CULT G DOSS, 2008, CONV PAT EM RIEM.
   BOCCOLINI S, 2007, NOT I SUPER SANITA, V20, P3.
   Chesson HW, 2010, SEX TRANSM INFECT, V86, P52, DOI 10.1136/sti.2009.040873.
   Cox FEG, 2002, CLIN MICROBIOL REV, V15, P595, DOI 10.1128/CMR.15.4.595-612.2002.
   DEKRUIF P, 1942, CACCIATORI MICROBI.
   FARA GM, 2007, MALATTIE INFETTIVE C.
   Fauci AS, 2001, CLIN INFECT DIS, V32, P675, DOI 10.1086/319235.
   FAUCI AS, 2009, MALATTIE INFETTIVE B.
   FAUCI AS, 2006, EMERGING REEMERGING.
   Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6.
   Field V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-330.
   GIULIANI M, 2006, AGGIORNAMENTI.
   Hoft DF, 2008, LANCET, V372, P164, DOI 10.1016/S0140-6736(08)61036-3.
   Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449.
   Lerner V, 2004, EUR J NEUROL, V11, P371, DOI 10.1111/j.1468-1331.2004.00839.x.
   MANOZZI F, 2004, B OMC O, V4, P10.
   Marshall BDL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-7.
   {*}MIN SAL, 1998, EP TUB IT ANN 1998 2.
   NARASIMHAN V, 2003, MALARIA J, V15, P2.
   Nicoll A, 2002, BRIT MED J, V324, P1324, DOI 10.1136/bmj.324.7349.1324.
   PAGANELLI M, 2009, OSPITE INDESIDERATO.
   PASINI W, 2009, GIORN PREVIDENZA MED, V9, P42.
   PASINI W, 2008, VIAGGI SALUTE NEI 5.
   {*}PRIM CONV INT CHI, 2004, EM REEM INF IMP SOC.
   PULCINELLI C, 2007, CLIMA GLOBALIZZAZION.
   Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273.
   Rogstad KE, 2004, BRIT MED J, V329, P214, DOI 10.1136/bmj.329.7459.214.
   Sabot O, 2010, LANCET, V376, P1604, DOI 10.1016/S0140-6736(10)61355-4.
   SALFA MC, 2010, ATT 44 C NAZ SITI VE.
   Theler Barbara, 2010, Ther Umsch, V67, P187, DOI 10.1024/0040-5930/a000032.
   TOGNOTTI E, 2006, SIFILIDE DALLA PRIMA.
   United Nations, 2008, MILL DEV GOALS IND.
   {*}WHO, 2005, RES WHA58 2 MAL CONT.
   WHO, 2009, GLOB HLTH RISK MORT.
   WHO, 2008, WHO MAL REP 2008.
   {*}WHO, 2008, GLOB STRAT PLAN 2005.
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775.
   World Health Organization (WHO):, 2010, GLOB TUB CONTR REP 2.
   Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258.
   ZAPPA A, 2010, ATT 44 C NAZ SIT VEN.
   2008, GIORNALE PREVIDENZA, V8, P12.
   2010, 39 C NAZ AMCLI ASS M.
   2008, NOTIZIE MED ADNKRONO.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{2}},
Usage-Count-Since-2013 = {{16}},
Journal-ISO = {{Clin. Ter.}},
Doc-Delivery-Number = {{796FE}},
Unique-ID = {{ISI:000293036400018}},
DA = {{2018-08-13}},
}

@article{ ISI:000290088800010,
Author = {Gan, Zhuohui and Audi, Said H. and Bongard, Robert D. and Gauthier,
   Kathryn M. and Merker, Marilyn P.},
Title = {{Quantifying mitochondrial and plasma membrane potentials in intact
   pulmonary arterial endothelial cells based on extracellular disposition
   of rhodamine dyes}},
Journal = {{AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY}},
Year = {{2011}},
Volume = {{300}},
Number = {{5}},
Pages = {{L762-L772}},
Month = {{MAY}},
Abstract = {{Gan Z, Audi SH, Bongard RD, Gauthier KM, Merker MP. Quantifying
   mitochondrial and plasma membrane potentials in intact pulmonary
   arterial endothelial cells based on extracellular disposition of
   rhodamine dyes. Am J Physiol Lung Cell Mol Physiol 300: L762-L772, 2011.
   First published January 14, 2011; doi:10.1152/ajplung.00334.2010.-Our
   goal was to quantify mitochondrial and plasma potential (Delta psi(m)
   and Delta psi(p)) based on the disposition of rhodamine 123 (R123) or
   tetramethylrhodamine ethyl ester (TMRE) in the medium surrounding
   pulmonary endothelial cells. Dyes were added to the medium, and their
   concentrations in extracellular medium ({[}R(e)]) were measured over
   time. R123 {[}R(e)] fell from 10 nM to 6.6 +/- 0.1 (SE) nM over 120 min.
   TMRE {[}R(e)] fell from 20 nM to a steady state of 4.9 +/- 0.4 nM after
   similar to 30 min. Protonophore or high K(+) concentration ({[}K(+)]),
   used to manipulate contributions of membrane potentials, attenuated
   decreases in {[}R(e)], and P-glycoprotein (Pgp) inhibition had the
   opposite effect, demonstrating the qualitative impact of these processes
   on {[}R(e)]. A kinetic model incorporating a modified
   Goldman-Hodgkin-Katz model was fit to {[}R(e)] vs. time data for R123
   and TMRE, respectively, under various conditions to obtain (means +/-
   95\% confidence intervals) Delta psi(m) (-130 +/- 7 and -133 +/- 4 mV),
   Delta psi(p) (-36 +/- 4 and -49 +/- 4 mV), and a Pgp activity parameter
   (K(Pgp), 25 +/- 5 and 51 +/- 11 mu l/min). The higher membrane
   permeability of TMRE also allowed application of steady-state analysis
   to obtain Delta psi(m) (-124 +/- 6 mV). The consistency of kinetic
   parameter values obtained from R123 and TMRE data demonstrates the
   utility of this experimental and theoretical approach for quantifying
   intact cell Delta psi(m) and Delta psi(p). Finally, steady-state
   analysis revealed that although room air-and hyperoxia-exposed (95\%
   O(2) for 48 h) cells have equivalent resting Delta psi(m), hyperoxic
   cell Delta psi(m) was more sensitive to depolarization with
   protonophore, consistent with previous observations of pulmonary
   endothelial hyperoxia-induced mitochondrial dysfunction.}},
Publisher = {{AMER PHYSIOLOGICAL SOC}},
Address = {{9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Merker, MP (Reprint Author), Zablocki VAMC, Res Serv 151, Milwaukee, WI 53295 USA.
   Merker, Marilyn P., Zablocki VAMC, Res Serv 151, Milwaukee, WI 53295 USA.
   Gan, Zhuohui; Audi, Said H., Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA.
   Bongard, Robert D., Med Coll Wisconsin, Dept Pulm Med, Milwaukee, WI 53226 USA.
   Gauthier, Kathryn M.; Merker, Marilyn P., Med Coll Wisconsin, Dept Pharmacol \& Toxicol, Milwaukee, WI 53226 USA.
   Merker, Marilyn P., Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA.}},
DOI = {{10.1152/ajplung.00334.2010}},
ISSN = {{1040-0605}},
Keywords = {{mathematical modeling; rhodamine 123; tetramethylrhodamine ethyl ester;
   multidrug transporter P-glycoprotein; hyperoxia}},
Keywords-Plus = {{REDOX STATUS; ELECTRON-TRANSPORT; RAT LUNGS; MULTIDRUG-RESISTANCE;
   100-PERCENT OXYGEN; REACTIVE OXYGEN; CA2+ ENTRY; HYPEROXIA; APOPTOSIS;
   REDUCTION}},
Research-Areas = {{Physiology; Respiratory System}},
Web-of-Science-Categories  = {{Physiology; Respiratory System}},
Author-Email = {{mmerker@mcw.edu}},
Funding-Acknowledgement = {{National Heart, Lung, and Blood Institute {[}R01 HL-24349, HL-65537,
   HL-51055]; Department of Veterans Affairs}},
Funding-Text = {{This work was supported by National Heart, Lung, and Blood Institute
   Grants R01 HL-24349, HL-65537, and HL-51055 and the Department of
   Veterans Affairs.}},
Cited-References = {{Adams DJ, 2004, J CARDIOVASC ELECTR, V15, P598, DOI 10.1016/j.1540-8167.2004.03277.x.
   Ahmad A, 2006, FREE RADICAL BIO MED, V40, P1108, DOI 10.1016/j.freeradbiomed.2005.10.045.
   Audi SH, 2008, J APPL PHYSIOL, V105, P1114, DOI 10.1152/japplphysiol.00177.2008.
   Audi SH, 2005, AM J PHYSIOL-LUNG C, V289, pL788, DOI 10.1152/ajplung.00064.2005.
   Audi SH, 2003, FREE RADICAL BIO MED, V34, P892, DOI 10.1016/S0891-5849(03)00025-X.
   Baracca A, 2003, BBA-BIOENERGETICS, V1606, P137, DOI 10.1016/S0005-2728(03)00110-5.
   BASSETT DJP, 1986, J APPL PHYSIOL, V60, P1605.
   BASSETT DJP, 1989, J APPL PHYSIOL, V66, P989.
   Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008.
   BATES DM, 1983, NONLINEAR REGRESSION.
   Beard DA, 2005, PHYSIOL GENOMICS, V23, P1, DOI 10.1152/physiolgenomics.00117.2005.
   BONGARD RD, 1995, AM J PHYSIOL-LUNG C, V269, pL78.
   Bongard RD, 2009, FREE RADICAL BIO MED, V46, P25, DOI 10.1016/j.freeradbiomed.2008.09.007.
   CAMPBELL DL, 1991, J MOL CELL CARDIOL, V23, P133, DOI 10.1016/0022-2828(91)90032-H.
   CANNELL MB, 1989, J PHYSIOL-LONDON, V419, P555, DOI 10.1113/jphysiol.1989.sp017886.
   Chatterjee S, 2006, MICROCIRCULATION, V13, P633, DOI 10.1080/10739680600930255.
   Chatterjee S, 2008, CELL BIOCHEM BIOPHYS, V52, P125, DOI 10.1007/s12013-008-9030-7.
   CRAPO JD, 1980, AM REV RESPIR DIS, V122, P123.
   Dedkova EN, 2005, AM J PHYSIOL-CELL PH, V289, pC836, DOI 10.1152/ajpcell.00011.2005.
   DILISA F, 1995, J PHYSIOL-LONDON, V486, P1.
   Duchen MR, 2003, METHOD ENZYMOL, V361, P353.
   EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8.
   FARKAS DL, 1989, BIOPHYS J, V56, P1053, DOI 10.1016/S0006-3495(89)82754-7.
   Han YH, 2010, TOXICOL IN VITRO, V24, P1183, DOI 10.1016/j.tiv.2010.02.013.
   HE P, 1995, MICROVASC RES, V50, P183, DOI 10.1006/mvre.1995.1052.
   Huang M, 2007, ANN BIOMED ENG, V35, P1276, DOI 10.1007/s10439-007-9265-2.
   Huber HJ, 2009, J NEUROSCI METH, V176, P270, DOI 10.1016/j.jneumeth.2008.09.003.
   Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311.
   JOHNS A, 1987, TISSUE CELL, V19, P733, DOI 10.1016/0040-8166(87)90015-2.
   Katzir H, 2010, FEBS J, V277, P1234, DOI 10.1111/j.1742-4658.2009.07555.x.
   Koliwad SK, 1996, J PHYSIOL-LONDON, V491, P1.
   Loetchutinat C, 2003, EUR J BIOCHEM, V270, P476, DOI 10.1046/j.1432-1033.2003.03403.x.
   Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022.
   Mandala M, 1999, ANAL BIOCHEM, V274, P1, DOI 10.1006/abio.1999.4253.
   Merker MP, 2007, AM J PHYSIOL-LUNG C, V293, pL809, DOI 10.1152/ajplung.00448.2006.
   Merker MP, 2006, AM J PHYSIOL-LUNG C, V290, pL607, DOI 10.1152/ajplung.00302.2005.
   Merker MP, 2004, FREE RADICAL BIO MED, V37, P86, DOI 10.1016/j.freeradbiomed.2004.02.078.
   Merker MP, 1996, AM J PHYSIOL-LUNG C, V270, pL251.
   Merker MP, 1997, AM J PHYSIOL-LUNG C, V272, pL673.
   Merker MP, 1998, AM J PHYSIOL-LUNG C, V274, pL685, DOI 10.1152/ajplung.1998.274.5.L685.
   Merker MP, 2002, AM J PHYSIOL-LUNG C, V282, pL36, DOI 10.1152/ajplung.00283.2001.
   MOODY EJ, 2001, PHARM BASIS THERAPEU.
   Mungunsukh O, 2010, AM J PHYSIOL-LUNG C, V298, pL696, DOI 10.1152/ajplung.00322.2009.
   Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200.
   Nicholls DG, 2005, BBA-BIOENERGETICS, V1710, P63, DOI 10.1016/j.bbabio.2005.09.002.
   Nicholls DG, 2000, PHYSIOL REV, V80, P315.
   O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200.
   OLDENDORF WH, 1977, ANN NEUROL, V1, P409, DOI 10.1002/ana.410010502.
   Paffett ML, 2007, AM J PHYSIOL-LUNG C, V293, pL1135, DOI 10.1152/ajplung.00432.2006.
   Park KS, 2002, PFLUG ARCH EUR J PHY, V443, P344, DOI 10.1007/s004240100703.
   PRUIJN FB, 1992, ANN NY ACAD SCI, V663, P453, DOI 10.1111/j.1749-6632.1992.tb38699.x.
   Robertson SJ, 2009, J NEUROCHEM, V111, P132, DOI 10.1111/j.1471-4159.2009.06306.x.
   Roerig DL, 2004, DRUG METAB DISPOS, V32, P953, DOI 10.1124/dmd.104.000042.
   Ruchko M, 2005, AM J PHYSIOL-LUNG C, V288, pL530, DOI 10.1152/ajplung.00255.2004.
   RUGOLO M, 1987, J BIOENERG BIOMEMBR, V19, P705, DOI 10.1007/BF00762304.
   Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0.
   SCHOONEN WGEJ, 1990, J BIOL CHEM, V265, P11118.
   Solaini G, 2007, BIOSCIENCE REP, V27, P11, DOI 10.1007/s10540-007-9033-4.
   STEVENS T, 1994, AM J PHYSIOL, V266, pH1416.
   Sud N, 2008, AM J PHYSIOL-CELL PH, V294, pC1407, DOI 10.1152/ajpcell.00384.2007.
   Terminella C, 2002, AM J PHYSIOL-LUNG C, V283, pL1291, DOI 10.1152/ajplung.00246.2001.
   Voets T, 1996, J PHYSIOL-LONDON, V497, P95, DOI 10.1113/jphysiol.1996.sp021752.
   Wang L, 2008, DRUG METAB DISPOS, V36, P2591, DOI 10.1124/dmd.108.021980.
   Ward MW, 2007, J NEUROSCI, V27, P8238, DOI 10.1523/JNEUROSCI.1984-07.2007.
   Ward MW, 2010, METHODS MOL BIOL, V591, P335, DOI 10.1007/978-1-60761-404-3\_20.
   Ward MW, 2000, J NEUROSCI, V20, P7208.
   Wu SW, 2009, AM J PHYSIOL-LUNG C, V297, pL650, DOI 10.1152/ajplung.00015.2009.
   Yeheskely-Hayon D, 2009, FEBS J, V276, P637, DOI 10.1111/j.1742-4658.2008.06812.x.
   You BR, 2010, TOXICOL IN VITRO, V24, P1111, DOI 10.1016/j.tiv.2010.03.009.
   Zhang QW, 2008, ANTIOXID REDOX SIGN, V10, P679, DOI 10.1089/ars.2007.1521.}},
Number-of-Cited-References = {{70}},
Times-Cited = {{14}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{9}},
Journal-ISO = {{Am. J. Physiol.-Lung Cell. Mol. Physiol.}},
Doc-Delivery-Number = {{757MF}},
Unique-ID = {{ISI:000290088800010}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000290163800008,
Author = {Yaldiz, Sadik and Gursoy, Soner and Ucvet, Ahmet and Kaya, Seyda Ors},
Title = {{Surgery Offers High Cure Rates in Multidrug-resistant Tuberculosis}},
Journal = {{ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY}},
Year = {{2011}},
Volume = {{17}},
Number = {{2}},
Pages = {{143-147}},
Month = {{APR}},
Abstract = {{Purpose: Drug resistance has become a major problem in the treatment of
   tuberculosis, and pulmonary resection in combination with chemotherapy
   appears to be an effective measure for the treatment. The purpose of
   this study was to investigate the results of resection for
   multidrug-resistant pulmonary tuberculosis (MDR-TB).
   Patients and Methods: We retrospectively reviewed case files from
   January 2003 to December 2006 of 13 patients with MDR-TB underwent
   pulmonary resection.
   Results: Of 13 patients, 7 (53.9\%) were sputum positive for
   mycobacterium tuberculosis preoperatively, though after surgery, they
   were sputum negative. Lobectomy was performed in 8 (61.5\%) and
   pneumonectomy, in 5 (38.5\%). In the lobectomy group, 2 patients had an
   additional superior segmentectomy and 1 had a middle lobectomy for other
   segmental or lobar lesions. Operative mortality was 7.6\% (1/13). There
   were no late surgical deaths. In the early postoperative period, 3
   patients had serious complications (postoperative bleeding, prolonged
   air leak, expansion deficit, bronchopleural fistula and empyema) that
   were resolved with surgery (morbidity 23.0\%). The 12 patients who
   survived the operation received appropriate chemotherapy and were
   followed up for 24-37 months. None of the patients relapsed, and the
   overall cure rate was 92.3\% (12/13).
   Conclusion: Even with high morbidity in the early post-operative period,
   surgery, in addition to medical therapy, offers higher cure rates than
   only medical therapy; however, meticulous preoperative evaluation of
   patients is needed.}},
Publisher = {{MEDICAL TRIBUNE INC}},
Address = {{ED COMM ANNALS THORACIC CARDIOVASCULAR SURG, 2-1-30 KUDAN MINAMI,
   CHIYODA-KU, TOKYO, 102-0074, JAPAN}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Yaldiz, S (Reprint Author), Celal Bayar Univ, Dept Thorac Surg, Fac Med, Manisa, Turkey.
   Yaldiz, Sadik, Celal Bayar Univ, Dept Thorac Surg, Fac Med, Manisa, Turkey.
   Gursoy, Soner; Ucvet, Ahmet; Kaya, Seyda Ors, Dr Suat Seren Chest Dis \& Thorac Surg Training Ho, Dept Thorac Surg, Izmir, Turkey.}},
DOI = {{10.5761/atcs.oa.09.01531}},
ISSN = {{1341-1098}},
EISSN = {{2186-1005}},
Keywords = {{multidrug-resistant tuberculosis; pulmonary resection; surgery}},
Keywords-Plus = {{PULMONARY TUBERCULOSIS; SURGICAL-TREATMENT; RESECTION}},
Research-Areas = {{Cardiovascular System \& Cardiology; Surgery}},
Web-of-Science-Categories  = {{Cardiac \& Cardiovascular Systems; Surgery}},
Author-Email = {{msyaldiz@gmail.com}},
Cited-References = {{Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-11590C.
   Gimferrer Josep M, 2005, Asian Cardiovasc Thorac Ann, V13, P201.
   GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802.
   Kir A, 2006, J THORAC CARDIOV SUR, V131, P693, DOI 10.1016/j.jtcvs.2005.09.033.
   Lalloo UG, 2006, CURR OPIN PULM MED, V12, P179, DOI 10.1097/01.mcp.0000219266.27439.52.
   LEE JC, 1996, TUBERC RESP DIS, V43, P14.
   Leuvan M V, 1997, ANN THORAC SURG, V63, P1368.
   Loddenkemper R, 2002, EUR RESPIR J, V20, p66S, DOI 10.1183/09031936.02.00401302.
   MASSARD G, 1992, ANN THORAC SURG, V54, P1159, DOI 10.1016/0003-4975(92)90086-J.
   Pomerantz BJ, 2001, J THORAC CARDIOV SUR, V121, P448, DOI 10.1067/mtc.2001.112339.
   Shiraishi Y, 2004, J THORAC CARDIOV SUR, V128, P523, DOI 10.1016/j.jtcvs.2004.06.012.
   Sung SW, 1999, EUR J CARDIO-THORAC, V16, P187, DOI 10.1016/S1010-7940(99)00158-X.
   Takeda S, 2005, ANN THORAC SURG, V79, P959, DOI 10.1016/j.athoracsur.2004.09.007.
   Wang HF, 2008, ANN THORAC SURG, V86, P1640, DOI 10.1016/j.athoracsur.2008.07.056.
   World Health Organization, 2007, GLOB TUB CONTR SURV.}},
Number-of-Cited-References = {{15}},
Times-Cited = {{5}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{1}},
Journal-ISO = {{Ann. Thorac. Cardiovasc. Surg.}},
Doc-Delivery-Number = {{758KO}},
Unique-ID = {{ISI:000290163800008}},
OA = {{gold\_or\_bronze}},
DA = {{2018-08-13}},
}

@article{ ISI:000291335600027,
Author = {Babu, K. V. Yogeesha and Kumara, Amruta and Vijayanath, V.},
Title = {{Study of Imipenem Resistant Metallo-Beta-lactamase Positive Pseudomonas
   aeruginosa from Different Hospital Environmental Sources}},
Journal = {{JOURNAL OF PURE AND APPLIED MICROBIOLOGY}},
Year = {{2011}},
Volume = {{5}},
Number = {{1}},
Pages = {{195-203}},
Month = {{APR}},
Abstract = {{Imipenem resistant Metallo Beta-lactamase producing Pseudomonas
   aeruginosa (IR-MBLP-PA) are an emerging threat causing noscomial
   infections with increased mortality and morbidity and with a potential
   to spread rapidly and cause outbreaks and epidemics. Very little data is
   available after review of literature on detection of IR-MBLP-PA from
   hospital environmental sources and their role as source and/or reservoir
   of nosocomial infections. The present study was conducted to detect
   IR-MBLP-PA from different hospital environmental sources from different
   areas of hospital, Antibiogram typing, to assess their role as source
   and/or reservoir of nosocomial infections and study the impact of
   infection control measures on environmental sources of IR-MBLP-PA. 460
   environmental specimens collected and processed by standard laboratory
   procedures. Susceptibility testing done by Kirby-Bauer's disc diffusion
   method. IR-MBLP-PA detection was done by IMIPENEM+EDTA combined disc
   test. Antibiogram typing done. Association with clinical cases done by
   strain of same antibiogram type from environmental source and case.
   Impact of Infection control measures were assessed by percentage
   reduction of IR-MBLP-PA isolates from respective environmental sources.
   Study reported an incidence of 24.78 \%;5.65 To and 3.4896;1.08\% for
   Pseudomonas aeruginosa and IR-MBLP-PA respectively, before and after
   strict infection control measures. High incidence of IR-MBLP-PA of
   14.8\% and 10.52\% in suction apparatus and mops respectively, 11.53\%,
   8.89\% and 8.24\% in Burns ward, ICCU and MICU respectively was
   reported. Six of the eight IR-MBLP-PA antibiogram types from
   environmental sources could be associated with fourteen nosocomial
   infections with two strains with no association. Strain 1 (Resistant to
   all antibiotics used) was most common strain (30.76\%) associated with
   six nosocomial infections during the study period. Sinks, suction
   apparatus were observed to be high risk sources and/or reservoirs of
   IR-MBLP-PA. MICU and ICCU were found to be high risk areas of
   environmental isolates necessitating periodic environmental sampling for
   their detection. Hospital air, aprons and gowns of health care workers,
   curtains, beddings and linen were not found to be important reservoirs
   of IR-MBLP-PA. Infection control measures according to CDC guidelines
   reduced the incidence of environmental IR-MBLP-PA isolates.}},
Publisher = {{DR M N KHAN}},
Address = {{54, NEAR POST OFFICE, THANA ST, BHOPAL, SHAHJAHANABAD 462 001, INDIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Babu, KVY (Reprint Author), SS Inst Med Sci \& Res Ctr, Dept Microbiol, NH-4 Bypass Rd, Davangere 577005, India.
   Babu, K. V. Yogeesha, SS Inst Med Sci \& Res Ctr, Dept Microbiol, Davangere 577005, India.
   Kumara, Amruta, Govt Med Coll Mysore \& Res Ctr, Dept Microbiol, Mysore, Karnataka, India.
   Vijayanath, V., SS Inst Med Sci \& Res Ctr, Dept Forens Med, Davangere 577005, India.}},
ISSN = {{0973-7510}},
Keywords = {{Imipenem resistant Metallo-Beta-lactamase positive Pseudomonas
   aeruginosa (IR-MBLP-PA); Environmental sources; Infection control
   measures}},
Keywords-Plus = {{INFECTIONS; STRAINS}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Microbiology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Microbiology}},
Author-Email = {{dr.yogeshb77@yahoo.com}},
Cited-References = {{Behera B, 2008, INDIAN J MED MICROBI, V26, P233.
   Carmeli Y, 1999, ANTIMICROB AGENTS CH, V43, P1379.
   Clinical and Laboratory Standard Institute, 2007, M100517 CLIN LAB STA.
   COLLEE TG, 2006, FRASER PSEUDOMONAS A.
   Crespo MP, 2004, J CLIN MICROBIOL, V42, P5094, DOI 10.1128/JCM.42.11.5094-5101.2004.
   DAVID RP, 2005, RESP CARE, V50, P932.
   Gerard DW, 2007, TRENDS MOL MED, V13, P260.
   JOHANN DD, 2010, J CLIN MICROBIOL, V45, P294.
   Kurokawa H, 1999, LANCET, V354, P955, DOI 10.1016/S0140-6736(05)75707-X.
   Laupland KB, 2005, J INFECT DIS, V192, P1606, DOI 10.1086/444469.
   Rutala WA, 2008, GUIDELINE DISINFECTI.
   Sehulster LM, 2004, GUIDELINES ENV INFEC.
   Tsakris A, 2009, J CLIN MICROBIOL, V47, P3524, DOI 10.1128/JCM.01099-09.
   Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005.
   Yong DE, 2002, J CLIN MICROBIOL, V40, P3798, DOI 10.1128/JCM.40.10.3798-3801.2002.}},
Number-of-Cited-References = {{15}},
Times-Cited = {{1}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{3}},
Journal-ISO = {{J. Pure Appl. Microbiol.}},
Doc-Delivery-Number = {{773UD}},
Unique-ID = {{ISI:000291335600027}},
DA = {{2018-08-13}},
}

@article{ ISI:000289768900005,
Author = {Huang, Qingqing and He, Rong and Kozikowski, Alan P.},
Title = {{Stereochemistry at the Forefront in the Design and Discovery of Novel
   Anti-tuberculosis Agents}},
Journal = {{CURRENT TOPICS IN MEDICINAL CHEMISTRY}},
Year = {{2011}},
Volume = {{11}},
Number = {{7}},
Pages = {{810-818}},
Month = {{APR}},
Abstract = {{Today, 75\% of new drugs introduced to the market are single enantiomers
   and new techniques in asymmetric synthesis and chiral separation
   expedites chiral drug discovery and development worldwide. The
   enantiomers of a chiral drug present unique chemical and pharmacological
   behaviors in a chiral environment, such as the human body, in which the
   stereochemistry of chiral drugs determines their pharmacokinetic,
   pharmacodynamic, and toxicological actions. Thus, it is imperative that
   only the pure and therapeutically active isomer be prepared and
   marketed. Tuberculosis (TB), a highly contagious and airborne disease
   that is caused by infection with Mycobacterium tuberculosis (Mtb),
   currently represents one of the most threatening health problems
   globally. The emergence of multidrug-resistant TB (MDR-TB) and
   extensively drug-resistant TB (XDR-TB), as well as HIV co-infection
   along with a lengthy treatment regimen, highlights an urgent need for
   the development of new anti-TB agents. Currently, new chiral anti-TB
   agents are being developed from some well-known anti-TB agents, high
   throughput screening (HTS) hits, and natural products. This review will
   focus on the reported chiral anti-TB agents together with the clinical
   importance of their chirality and stereochemistry.}},
Publisher = {{BENTHAM SCIENCE PUBL LTD}},
Address = {{EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Kozikowski, AP (Reprint Author), Univ Illinois, Drug Discovery Program, Dept Med Chem \& Pharmacognosy, 833 S Wood St, Chicago, IL 60612 USA.
   Huang, Qingqing; He, Rong; Kozikowski, Alan P., Univ Illinois, Drug Discovery Program, Dept Med Chem \& Pharmacognosy, Chicago, IL 60612 USA.}},
DOI = {{10.2174/156802611795165205}},
ISSN = {{1568-0266}},
Keywords = {{Stereochemistry; chiral drugs; anti-tuberculosis agents}},
Keywords-Plus = {{MULTIDRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS;
   RNA-POLYMERASE; IN-VITRO; BIOLOGICAL-ACTIVITY; NATURAL-PRODUCTS; DRUG
   CANDIDATE; ATP SYNTHASE; ETHAMBUTOL; ANALOGS}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Chemistry, Medicinal}},
Author-Email = {{kozikowa@uic.edu}},
ResearcherID-Numbers = {{Huang, Qingqing/M-6824-2013}},
ORCID-Numbers = {{Huang, Qingqing/0000-0001-7080-7588}},
Cited-References = {{Agranat I, 2002, NAT REV DRUG DISCOV, V1, P753, DOI 10.1038/nrd915.
   Alderwick LJ, 2006, J BIOL CHEM, V281, P15653, DOI 10.1074/jbc.M600045200.
   Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753.
   {[}Anonymous], 1992, FDA POL STAT DEV NEW.
   ARIENS EJ, 1984, EUR J CLIN PHARMACOL, V26, P663, DOI 10.1007/BF00541922.
   Barrera L, 2007, TUBERCULOSIS 2007 BA, P93.
   Barry CE, 2004, CURR PHARM DESIGN, V10, P3239, DOI 10.2174/1381612043383214.
   Bunyapaiboonsri T, 2009, J NAT PROD, V72, P756, DOI 10.1021/np800702c.
   CALDWELL J, 1992, J CLIN PHARMACOL, V32, P925.
   Caldwell J, 2001, HUM PSYCHOPHARM CLIN, V16, pS67, DOI 10.1002/hup.339.
   Carr JF, 2006, J BACTERIOL, V188, P2020, DOI 10.1128/JB.188.5.2020-2023.2006.
   Chen JJ, 2009, J NAT PROD, V72, P223, DOI 10.1021/np800721f.
   Chumkaew P, 2003, J NAT PROD, V66, P540, DOI 10.1021/np0204489.
   COMROE JH, 1978, AM REV RESPIR DIS, V117, P773.
   Copp BR, 2007, NAT PROD REP, V24, P278, DOI 10.1039/b513520f.
   Currens MJ, 1996, J PHARMACOL EXP THER, V279, P645.
   de Jonge MR, 2007, PROTEINS, V67, P971, DOI 10.1002/prot.21376.
   Dietze R, 2001, ANTIMICROB AGENTS CH, V45, P1972, DOI 10.1128/AAC.45.7.1972-1976.2001.
   Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377.
   Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963.
   Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467.
   Floss HG, 2005, CHEM REV, V105, P621, DOI 10.1021/cr030112j.
   FORBES M, 1962, J BACTERIOL, V84, P1099.
   Fraser A, 2006, INT J TUBERC LUNG D, V10, P19.
   Froimowitz M, 1995, CHIRALITY, V7, P518, DOI 10.1002/chir.530070705.
   GODREUIL S, 2007, ENCY INFECT DIS MODE, P1.
   HEIL A, 1970, FEBS LETT, V11, P165, DOI 10.1016/0014-5793(70)80519-1.
   HIRATA T, 1995, ANTIMICROB AGENTS CH, V39, P2295, DOI 10.1128/AAC.39.10.2295.
   HOLMSTEDT B, 1990, CHIRALITY AND BIOLOGICAL ACTIVITY, P1.
   Hutt AJ, 1996, J ANTIMICROB CHEMOTH, V37, P7, DOI 10.1093/jac/37.1.7.
   Kamel HN, 2009, J NAT PROD, V72, P1492, DOI 10.1021/np900326a.
   Kim P, 2009, J MED CHEM, V52, P1329, DOI 10.1021/jm801374t.
   Kim P, 2009, J MED CHEM, V52, P1317, DOI 10.1021/jm801246z.
   Klemens SP, 1996, ANTIMICROB AGENTS CH, V40, P298.
   Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884.
   Lin AS, 2010, J NAT PROD, V73, P275, DOI 10.1021/np900686w.
   Mae T, 1998, XENOBIOTICA, V28, P759, DOI 10.1080/004982598239173.
   Manjunatha Ujjini, 2009, Commun Integr Biol, V2, P215.
   Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466.
   MEILHAC M, 1972, EUR J BIOCHEM, V28, P291.
   Melchert M, 2007, INT J BIOCHEM CELL B, V39, P1489, DOI 10.1016/j.biocel.2007.01.022.
   NAGARAJAN K, 1989, EUR J MED CHEM, V24, P631, DOI 10.1016/0223-5234(89)90034-2.
   Naryshkina T, 2001, J BIOL CHEM, V276, P13308, DOI 10.1074/jbc.M011041200.
   Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v.
   Nuermberger E, 2004, EUR J CLIN MICROBIOL, V23, P243, DOI 10.1007/s10096-004-1109-5.
   Ospina CA, 2009, ORG LETT, V11, P3786, DOI 10.1021/ol901577a.
   Palmer BD, 2010, J MED CHEM, V53, P282, DOI 10.1021/jm901207n.
   RABUSSAY D, 1969, FEBS LETT, V5, P104, DOI 10.1016/0014-5793(69)80305-4.
   RUFFOLO RR, 1985, J PHARMACOL EXP THER, V235, P558.
   Sasaki H, 2006, J MED CHEM, V49, P7854, DOI 10.1021/jm060957y.
   SENSI P, 1983, REV INFECT DIS, V5, pS402.
   Shandil RK, 2007, ANTIMICROB AGENTS CH, V51, P576, DOI 10.1128/AAC.00414-06.
   SHEPHERD RG, 1966, ANN NY ACAD SCI, V135, P686, DOI 10.1111/j.1749-6632.1966.tb45516.x.
   Shinabarger D, 1999, Expert Opin Investig Drugs, V8, P1195, DOI 10.1517/13543784.8.8.1195.
   Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571.
   Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103.
   Sui JJ, 2009, MOL BIOSYST, V5, P603, DOI 10.1039/b903858b.
   Sutherland HS, 2010, J MED CHEM, V53, P855, DOI 10.1021/jm901378u.
   Tenson T, 2006, MOL MICROBIOL, V59, P1664, DOI 10.1111/j.1365-2958.2006.05063.x.
   THOMAS JP, 1961, AM REV RESPIR DIS, V83, P891.
   Thompson AM, 2009, J MED CHEM, V52, P637, DOI 10.1021/jm801087e.
   Upadhayaya RS, 2009, BIOORGAN MED CHEM, V17, P2830, DOI 10.1016/j.bmc.2009.02.026.
   Van Gestel J. F. E., 2004, International patent, Patent No. {[}WO/2004/011436, 2004011436].
   Vera B, 2009, J NAT PROD, V72, P1555, DOI 10.1021/np9004135.
   Vera-Cabrera L, 2006, ANTIMICROB AGENTS CH, V50, P3170, DOI 10.1128/ACC.00571-06.
   Vicens Q, 2003, CHEMBIOCHEM, V4, P1018, DOI 10.1002/cbic.200300684.
   Vicente J, 2009, TETRAHEDRON LETT, V50, P4571, DOI 10.1016/j.tetlet.2009.05.067.
   VILJOEN DL, 1983, J MED GENET, V20, P357, DOI 10.1136/jmg.20.5.357.
   Wehrli W, 1977, Top Curr Chem, V72, P21.
   Wehrli W, 1976, RNA POLYMERASE, P397.
   {*}WHO ORG, 2009, GLOB TUB CONTR SHORT.
   Williams DL, 1998, ANTIMICROB AGENTS CH, V42, P1853.
   Woldemichael GM, 2004, J NAT PROD, V67, P598, DOI 10.1021/np0303411.
   Xu Z Q, 2000, Curr Opin Drug Discov Devel, V3, P155.
   Xu ZQ, 2004, BIOORGAN MED CHEM, V12, P1199, DOI 10.1016/j.bmc.2003.11.012.
   Yang PS, 2009, J NAT PROD, V72, P53, DOI 10.1021/np800504w.
   Yendapally R, 2008, BIOORG MED CHEM LETT, V18, P1607, DOI 10.1016/j.bmcl.2008.01.065.
   2004, THALIDOMIDEA 2 CHANC.}},
Number-of-Cited-References = {{78}},
Times-Cited = {{3}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{16}},
Journal-ISO = {{Curr. Top. Med. Chem.}},
Doc-Delivery-Number = {{753JR}},
Unique-ID = {{ISI:000289768900005}},
DA = {{2018-08-13}},
}

@article{ ISI:000287967400009,
Author = {Korolev, Nadia and Mamiev, Mukhiddin and Zahavi, Tirza and Elad, Yigal},
Title = {{Screening of Botrytis cinerea isolates from vineyards in Israel for
   resistance to fungicides}},
Journal = {{EUROPEAN JOURNAL OF PLANT PATHOLOGY}},
Year = {{2011}},
Volume = {{129}},
Number = {{4}},
Pages = {{591-608}},
Month = {{APR}},
Abstract = {{Plots in two vineyards in the Golan Heights, Israel were treated with
   six botryticides during three growing seasons with 3 applications per
   season. Applications of fenhexamid, pyrimethanil and cyprodinil +
   fludioxonil were effective, resulting in 52-65\% and 53-63\% mean
   reduction in grey mould incidence and severity, respectively.
   Carbendazim, fluazinam and iprodione were ineffective or slightly
   effective. Five hundred and sixteen B. cinerea isolates were collected
   from infected berries or trapped from the air in the vineyards, and
   profiles of sensitivity to benomyl, fenhexamid, fluazinam, fludioxonil,
   iprodione and pyrimethanil were established for each of the isolates
   based on a mycelial growth test. Seventy-four percent of the isolates
   were sensitive to the six tested fungicides, and the other 26\% of the
   isolates were classified into 10 phenotypes characterized by resistance
   to one or more fungicides. Resistant isolates showed fitness parameters
   similar or reduced in comparison to sensitive isolates. Resistance to
   benzimidazoles and to dicarboximides was the most frequent (up to 25\%)
   and apparently pre-existed in the populations tested. Increased
   frequency of benzimidazole resistance, but not dicarboximide resistance,
   was observed following the 3 years of applications of the fungicides.
   High level resistance to pyrimethanil was present at a frequency of
   about 2\% in both vineyards in the first 2 years of the sampling survey
   and reached 10\% in the third year at Site 2. A few isolates were
   resistant to fenhexamid or fludioxonil (0.8 or 0.2\%, respectively). No
   strong resistance to fluazinam was detected, although numerous, less
   sensitive isolates, presumably possessing multi-drug resistance traits,
   were recovered at higher frequency from the plots treated with fluazinam
   than from the untreated plots.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Korolev, N (Reprint Author), Agr Res Org, Volcani Ctr, Dept Plant Pathol \& Weed Res, IL-50250 Bet Dagan, Israel.
   Korolev, Nadia; Mamiev, Mukhiddin; Elad, Yigal, Agr Res Org, Volcani Ctr, Dept Plant Pathol \& Weed Res, IL-50250 Bet Dagan, Israel.
   Zahavi, Tirza, Minist Agr, Extens Serv, Kiryat Shemone, Israel.}},
DOI = {{10.1007/s10658-010-9723-9}},
ISSN = {{0929-1873}},
Keywords = {{Benomyl; Fenhexamid; Fluazinam; Fludioxonil; Iprodione; Pyrimethanil}},
Keywords-Plus = {{BOTRYOTINIA-FUCKELIANA; DICARBOXIMIDE FUNGICIDES; GENETIC-ANALYSIS;
   ANILINOPYRIMIDINE; BENZIMIDAZOLE; PHENYLPYRROLE; FITNESS; FLUDIOXONIL;
   MANAGEMENT; STRAINS}},
Research-Areas = {{Agriculture; Plant Sciences}},
Web-of-Science-Categories  = {{Agronomy; Plant Sciences; Horticulture}},
Author-Email = {{vpptlg@agri.gov.il}},
Funding-Acknowledgement = {{Israeli Ministry of Immigration; Israeli Ministry of Agriculture and
   Rural Development {[}132-1106-03]}},
Funding-Text = {{This research was partially supported by a fellowship from the Israeli
   Ministry of Immigration and by the research fund of the Chief Scientist
   of the Israeli Ministry of Agriculture and Rural Development, project
   no. 132-1106-03. The authors acknowledge Ruth Harpaz for her assistance
   with the disease evaluations and thank Suleiman Farhat for spraying the
   experiments. Contribution No 521/09 from the ARO, Volcani Center,
   Institute of Plant Protection.}},
Cited-References = {{Bardas GA, 2008, PHYTOPATHOLOGY, V98, P443, DOI 10.1094/PHYTO-98-4-0443.
   Baroffio CA, 2003, PLANT DIS, V87, P662, DOI 10.1094/PDIS.2003.87.6.662.
   BEEVER RE, 1989, PLANT PATHOL, V38, P427, DOI 10.1111/j.1365-3059.1989.tb02163.x.
   Campbell C. L., 1990, INTRO PLANT DIS EPID.
   Chapeland F, 1999, PESTIC BIOCHEM PHYS, V64, P85, DOI 10.1006/pest.1999.2414.
   Edwards SG, 2001, LETT APPL MICROBIOL, V32, P63, DOI 10.1046/j.1472-765x.2001.00857.x.
   ELAD Y, 1992, PLANT PATHOL, V41, P41, DOI 10.1111/j.1365-3059.1992.tb02314.x.
   Elmer PAG, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P243.
   Esterio M, 2007, PLANT DIS, V91, P768, DOI 10.1094/PDIS-91-6-0768C.
   Fillinger S, 2008, ANTIMICROB AGENTS CH, V52, P3933, DOI 10.1128/AAC.00615-08.
   FITT BDL, 1985, T BRIT MYCOL SOC, V85, P307, DOI 10.1016/S0007-1536(85)80193-5.
   Forster B, 1996, CROP PROT, V15, P529, DOI 10.1016/0261-2194(96)00021-X.
   Forster H, 2007, PLANT DIS, V91, P209, DOI 10.1094/PDIS-91-2-0209.
   Hanssler G., 1999, PFLANZENSCHUTZ NACHR, V52, P158.
   HILBER UW, 1995, J PHYTOPATHOL, V143, P423, DOI 10.1111/j.1439-0434.1995.tb00287.x.
   Hilber UW, 1998, PLANT DIS, V82, P496, DOI 10.1094/PDIS.1998.82.5.496.
   Jo YK, 2006, PLANT DIS, V90, P807, DOI 10.1094/PD-90-0807.
   Kalamarakis AE, 2000, J PHYTOPATHOL, V148, P449, DOI 10.1046/j.1439-0434.2000.00525.x.
   Koller W, 1997, PHYTOPATHOLOGY, V87, P184, DOI 10.1094/PHYTO.1997.87.2.184.
   Korolev N, 2009, ACTA HORTIC, V808, P367.
   Kretschmer M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000696.
   Leroux P, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P195.
   Leroux P, 1999, CROP PROT, V18, P687, DOI 10.1016/S0261-2194(99)00074-5.
   LOCHER FJ, 1987, CROP PROT, V6, P139, DOI 10.1016/0261-2194(87)90001-9.
   Ma ZH, 2005, PLANT DIS, V89, P1083, DOI 10.1094/PD-89-1083.
   MORTON V, 2008, APSNET FEATURE.
   Myresiotis CK, 2007, PLANT DIS, V91, P407, DOI 10.1094/PDIS-91-4-0407.
   Oshima M, 2002, PHYTOPATHOLOGY, V92, P75, DOI 10.1094/PHYTO.2002.92.1.75.
   Raposo R, 1996, PLANT PATHOL, V45, P497, DOI 10.1046/j.1365-3059.1995.d01-140.x.
   Raposo R, 2000, PHYTOPATHOLOGY, V90, P1246, DOI 10.1094/PHYTO.2000.90.11.1246.
   Savary S, 2009, PHYTOPATHOLOGY, V99, P930, DOI 10.1094/PHYTO-99-8-0930.
   Suty A., 1999, PFLANZENSCHUTZ NACHR, V52, P145.
   Vignutelli A, 2002, MYCOL RES, V106, P329, DOI 10.1017/S0953756202005683.
   Yourman LF, 1999, PLANT DIS, V83, P569, DOI 10.1094/PDIS.1999.83.6.569.
   Yourman LF, 2001, PHYTOPATHOLOGY, V91, P307, DOI 10.1094/PHYTO.2001.91.3.307.
   Ziogas BN, 2005, EUR J PLANT PATHOL, V113, P83, DOI 10.1007/s10658-005-1227-7.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{13}},
Usage-Count-Last-180-days = {{1}},
Usage-Count-Since-2013 = {{25}},
Journal-ISO = {{Eur. J. Plant Pathol.}},
Doc-Delivery-Number = {{729RC}},
Unique-ID = {{ISI:000287967400009}},
DA = {{2018-08-13}},
}

@article{ ISI:000288564600004,
Author = {Basak, Subhash C. and Mills, Denise and Hawkins, Douglas M.},
Title = {{Characterization of Dihydrofolate Reductases from Multiple Strains of
   Plasmodium falciparum Using Mathematical Descriptors of Their Inhibitors}},
Journal = {{CHEMISTRY \& BIODIVERSITY}},
Year = {{2011}},
Volume = {{8}},
Number = {{3}},
Pages = {{440-453}},
Month = {{MAR}},
Abstract = {{Two classes of graph-theoretic molecular descriptors, viz., topological
   indices (TIs) and atom pairs (APs), have been used to derive
   high-quality quantitative structure-activity relationships (QSARs) for
   inhibitors of dihydrofolate reductases (DHFRs) isolated from the wild
   and four mutant strains of Plasmodium falciparum. Of the three methods
   used for QSAR formulation, viz., principal-components regression (PCR),
   partial least squares (PLS), and ridge regression (RR), the RR method
   outperformed the other two. Cohen's kappa values, based on the overlap
   of significant and insignificant structural descriptors calculated for
   the QSAR development, show that DHFR from the wild strain is
   substantially different from the four mutant strains. The differential
   QSAR approach reported in this study can be used in protocols for the
   development of drugs to combat drug-resistant pathogens arising
   continuously in nature due to mutations. The pairwise kappa values in
   conjunction with appropriate drug targets and their corresponding set of
   ligands may be a useful tool in gauging the evolving mutual similarities
   and dissimilarities of pathogenic organisms from purely computed
   mathematical descriptors of the ligands.}},
Publisher = {{WILEY-V C H VERLAG GMBH}},
Address = {{BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Basak, SC (Reprint Author), Univ Minnesota Duluth, Nat Resources Res Inst, 5013 Miller Trunk Highway, Duluth, MN 55811 USA.
   Basak, Subhash C.; Mills, Denise, Univ Minnesota Duluth, Nat Resources Res Inst, Duluth, MN 55811 USA.
   Hawkins, Douglas M., Univ Minnesota Twin Cities, Sch Stat, Minneapolis, MN 55455 USA.}},
DOI = {{10.1002/cbdv.201000111}},
ISSN = {{1612-1872}},
EISSN = {{1612-1880}},
Keywords-Plus = {{CHEMOMETRICS REGRESSION TOOLS; AIR PARTITION-COEFFICIENTS; TAILORED
   SIMILARITY SPACES; NONORTHOGONAL PROBLEMS; MOLECULAR DESCRIPTORS;
   PROPERTY ESTIMATION; RIDGE REGRESSION; STATISTICAL VIEW; HUMAN BLOOD;
   IN-VITRO}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Chemistry, Multidisciplinary}},
Author-Email = {{sbasak@nrri.umn.edu}},
Cited-References = {{Basak SC, 2006, SAR QSAR ENVIRON RES, V17, P515, DOI 10.1080/10629360600934093.
   Basak SC, 2010, SAR QSAR ENVIRON RES, V21, P215, DOI 10.1080/10629361003770951.
   Basak S. C., 1988, POLLY V 2 3.
   Basak S. C., 1993, APPROBE.
   Basak SC, 2006, J CHEM INF MODEL, V46, P65, DOI 10.1021/ci050215y.
   Basak SC, 2005, ARKIVOC, P60.
   Basak SC, 2004, ENVIRON TOXICOL PHAR, V16, P45, DOI 10.1016/j.etap.2003.09.002.
   Basak SC, 2003, RISK ANAL, V23, P1173, DOI 10.1111/j.0272-4332.2003.00390.x.
   Basak SC, 2003, J MOL STRUC-THEOCHEM, V622, P127, DOI 10.1016/S0166-1280(02)00624-3.
   Basak SC, 2002, SAR QSAR ENVIRON RES, V13, P727, DOI 10.1080/1062936021000043463.
   BASAK SC, 2006, TOPICS HETEROCYCLIC, V5, P39.
   Basak SC, 2006, ARKIVOC, P157.
   Basak SC, 2009, CHEM BIODIVERS, V6, P487, DOI 10.1002/cbdv.200800111.
   Basco LK, 2000, AM J TROP MED HYG, V62, P271, DOI 10.4269/ajtmh.2000.62.271.
   CARHART RE, 1985, J CHEM INF COMP SCI, V25, P64, DOI 10.1021/ci00046a002.
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104.
   Filip PA, 1987, J MATH CHEM, V1, P61, DOI 10.1007/BF01205338.
   Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712.
   FRANK IE, 1993, TECHNOMETRICS, V35, P109, DOI 10.2307/1269656.
   Gibbs MJ, 2007, ARCH VIROL, V152, P11, DOI 10.1007/s00705-006-0834-8.
   GOJOBORI T, 1990, P NATL ACAD SCI USA, V87, P10015, DOI 10.1073/pnas.87.24.10015.
   Gurwitz D, 2010, DRUG DEVELOP RES, V71, P1, DOI 10.1002/ddr.20353.
   {*}HALL ASS CONS, 2000, MOLC Z V 3 5.
   Hawkins DM, 2003, J CHEM INF COMP SCI, V43, P579, DOI 10.1021/ci025626i.
   HOERL AE, 1970, TECHNOMETRICS, V12, P69, DOI 10.2307/1267352.
   HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI DOI 10.1080/00401706.1970.10488634.
   HOSKULDSSON A, 1995, J CHEMOMETR, V9, P91, DOI 10.1002/cem.1180090203.
   Hyde JE, 2005, TRENDS PARASITOL, V21, P494, DOI 10.1016/j.pt.2005.08.020.
   Kamchonwongpaisan S, 2004, J MED CHEM, V47, P673, DOI 10.1021/jm030165t.
   Kier L., 1986, MOL CONNECTIVITY STR.
   Kier L. B., 1999, MOL STRUCTURE DESCRI.
   Kraker JJ, 2007, CHEMOMETR INTELL LAB, V87, P33, DOI 10.1016/j.chemolab.2006.03.001.
   Lajiness M. S., 1990, COMPUTATIONAL CHEM G, P299.
   Maude RJ, 2010, DRUG DEVELOP RES, V71, P12, DOI 10.1002/ddr.20344.
   McKie JH, 1998, J MED CHEM, V41, P1367, DOI 10.1021/jm970845u.
   Meppen M, 2009, EUR J MED CHEM, V44, P3765, DOI 10.1016/j.ejmech.2009.04.043.
   Nzila-Mounda A, 1998, ANTIMICROB AGENTS CH, V42, P164.
   PETERSON DS, 1990, P NATL ACAD SCI USA, V87, P3018, DOI 10.1073/pnas.87.8.3018.
   RANDIC M, 1975, J AM CHEM SOC, V97, P6609, DOI 10.1021/ja00856a001.
   Rastelli G, 2000, BIOORGAN MED CHEM, V8, P1117, DOI 10.1016/S0968-0896(00)00022-5.
   ROY AB, 1983, MATH MODELLING SCI T, P745.
   SAS. Institute Inc, 2003, SAS STAT SOFTW VERS.
   Tennenhaus M, 1998, J CHEMOMETR, P211, DOI DOI 10.1002/CEM.1180020306.
   Warsame M, 2010, DRUG DEVELOP RES, V71, P4, DOI 10.1002/ddr.20343.
   WOLD S, 1993, TECHNOMETRICS, V35, P136, DOI 10.2307/1269657.
   World Health Organization, 2008, WORLD MAL REP.
   Yuthavong Y, 2002, MICROBES INFECT, V4, P175, DOI 10.1016/S1286-4579(01)01525-8.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{10}},
Usage-Count-Last-180-days = {{0}},
Usage-Count-Since-2013 = {{2}},
Journal-ISO = {{Chem. Biodivers.}},
Doc-Delivery-Number = {{737JH}},
Unique-ID = {{ISI:000288564600004}},
DA = {{2018-08-13}},
}
